,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
2592,GO:0005886,5.4697736178389e-11,1,333,2818,plasma membrane,CC,DOCK4;FHL1;NT5E;SMURF2;EPN3;TSPAN1;NOS1;F2R;SORL1;FLNC;ADAM19;ETV5;RAB3B;NEURL1;VLDLR;ASAP2;ITGA6;SCN8A;SERPINE2;PEAR1;ADCY7;PRNP;PAG1;ADGRF1;ITGB4;BBS2;MARCKSL1;SH3TC2;SLC16A3;MAP2K1;RAPGEF3;FNDC4;ACVR2B;ANTXR2;SH3KBP1;SLC29A4;ALOX15B;COL13A1;PKN1;DCBLD2;MST1R;MARVELD1;LY6K;DGKA;TNFSF15;SSH1;MAP1B;KCNG1;PTPRS;SDK2;EXOC2;SNTB2;CRTC1;ADGRL1;CAPN2;FCGRT;SNPH;EGFR;STK39;SEMA4B;ANK3;BCORL1;DYSF;ARHGAP12;FYN;TNFRSF6B;TMPRSS11D;TSPAN5;PCDHAC2;SLC33A1;PARVB;ARAP1;DLG1;CSMD3;DLG4;B3GNT3;CD68;CSMD2;PLXNB3;GPC4;SNX9;PODXL;SLCO4A1;NET1;TGM2;XPC;SLC9A7;HTRA1;GLO1;WNT7A;WDFY3;TTC7B;GRK5;HTR7;MALL;ASPH;CEMIP;SDC1;STOM;SHC1;DLG3;DKK1;PAK1;RASA3;CEP170;ATXN10;KIAA1549;MRC2;TGFBR2;PTPN3;SLC2A3;EDNRA;NUCB2;SHANK2;SLITRK6;EPHA1;RALGAPA2;PLPP6;RAC2;CLCA2;CD44;OBSCN;APOE;FKBP1A;ATP7B;RGS14;PKD2;PRKACB;LRP1;ST3GAL5;IDE;AKAP9;EHBP1;RAB11FIP4;ABTB1;DDN;ANXA3;ATF4;ABCA7;LPAR3;FAM155B;FGFR1;ITGA1;EPCAM;TUB;ITGB5;LPCAT1;ITGA2;PTK6;VAMP2;FAT1;ABCG1;PITPNM1;ITPR3;CEACAM1;FERMT1;GSDMC;PRR9;SLC5A1;RAB31;BSG;SH3D19;XRN1;SLC9A3R2;DVL1;CLCN3;NTSR1;MMP14;PLEK2;NLGN2;CD46;MVB12B;EPOR;MPDZ;LRP5;NIPA1;ABHD17C;RABGGTA;CNTN1;TRIB3;CASP4;NTNG1;PCSK6;SLC35G2;TPBG;MOSPD2;RANBP9;RIMS3;PLPPR2;PPP3CB;MYOF;SYTL1;ADGRB2;TTYH3;ZDHHC2;APLP2;COPB1;FNBP1L;ANO8;F2RL1;SLC2A9;GSDMA;PROCR;ATP10D;SLC6A6;CSNK2A1;SLC25A4;ASAP1;PRKAR1A;ANO1;FAM84B;FCHO2;CPEB4;NIPSNAP1;USP6NL;SPRY2;SEPT5;SLC6A14;LMBR1L;MGLL;CD99;ACVR1B;SLC43A1;COL6A1;NGFR;PSKH1;HSPA13;PTPRZ1;IFITM1;GRIN3B;AGPAT3;SKAP2;ARF4;UAP1;CNNM1;HSD17B7;SLC12A7;PCYOX1;SPIRE1;CADM4;MAP2K2;ABHD6;SLC22A17;ARRDC1;SLC38A2;RIN1;TRPC1;RET;SLC13A3;C5;NCKAP1;KCNJ15;SLC30A1;TSPAN3;PSD3;TMBIM1;CCDC88A;SAMD8;SHC2;PRKACA;EPB41L3;PCDH1;RHOBTB1;BCAP29;AP2A2;SLC39A10;CMTM6;IL1RAP;ORAI1;CARD11;FCHO1;LTB4R;LPAR1;CTSZ;AP3D1;ARID4A;ARPC1A;TENM2;IGF2;NRSN2;ITPR2;FNBP1;PJA2;SLC2A13;GRB10;MAP4K2;EFCAB7;SLC10A6;TMEM63A;EVA1A;GRB7;SRPX2;PPL;GPR153;TMEM50B;ATP12A;SLC7A11;ESYT3;ATP6V1B2;RPH3AL;ADAM8;ROBO3;IL20RB;CLDN11;ATP11B;ITGA4;FZD8;WASL;HSPA2;PRSS8;FLNB;LRP6;SYT2;PLCH2;TMEM173;SLC18A2;SEMA6C;SIGMAR1;OMG;ZBTB33;PSEN2;SSFA2;PTCH1;ADCY1;SEPT6;SNX27;AMACR;SLC23A2;RALGPS2;SLC44A1;GNAI1;LRP4;FADD
15543,GO:0071944,2.29594746706639e-10,1,337,2890,cell periphery,CC,DOCK4;FHL1;NT5E;SMURF2;EPN3;TSPAN1;NOS1;F2R;SORL1;FLNC;ADAM19;ETV5;RAB3B;NEURL1;VLDLR;ASAP2;ITGA6;SCN8A;SERPINE2;PEAR1;ADCY7;PRNP;PAG1;ADGRF1;ITGB4;BBS2;MARCKSL1;SH3TC2;SLC16A3;MAP2K1;RAPGEF3;FNDC4;ACVR2B;ANTXR2;SH3KBP1;SLC29A4;ALOX15B;COL13A1;PKN1;DCBLD2;MST1R;MARVELD1;LY6K;DGKA;TNFSF15;SSH1;MAP1B;KCNG1;PTPRS;SDK2;EXOC2;SNTB2;CRTC1;ADGRL1;CAPN2;FCGRT;WIPF1;SNPH;EGFR;STK39;SEMA4B;ANK3;BCORL1;DYSF;ARHGAP12;FYN;TNFRSF6B;TMPRSS11D;TSPAN5;PCDHAC2;SLC33A1;PARVB;ARAP1;DLG1;CSMD3;DLG4;B3GNT3;CD68;CSMD2;PLXNB3;GPC4;SNX9;PODXL;SLCO4A1;NET1;TGM2;XPC;SLC9A7;HTRA1;GLO1;WNT7A;WDFY3;TTC7B;GRK5;HTR7;MALL;ASPH;CEMIP;SEPT10;SDC1;STOM;SHC1;DLG3;DKK1;PAK1;RASA3;CEP170;ATXN10;KIAA1549;MRC2;TGFBR2;PTPN3;SLC2A3;EDNRA;NUCB2;SHANK2;SLITRK6;EPHA1;RALGAPA2;PLPP6;RAC2;CLCA2;CD44;OBSCN;APOE;FKBP1A;ATP7B;RGS14;PKD2;PRKACB;LRP1;ST3GAL5;IDE;AKAP9;EHBP1;RAB11FIP4;ABTB1;DDN;ANXA3;ATF4;ABCA7;LPAR3;FAM155B;FGFR1;ITGA1;EPCAM;TUB;ITGB5;LPCAT1;ITGA2;PTK6;VAMP2;FAT1;ABCG1;PITPNM1;ITPR3;CEACAM1;FERMT1;GSDMC;PRR9;SLC5A1;RAB31;FAM110C;BSG;SH3D19;XRN1;SLC9A3R2;DVL1;CLCN3;NTSR1;MMP14;PLEK2;NLGN2;CD46;MVB12B;EPOR;MPDZ;LRP5;NIPA1;ABHD17C;RABGGTA;CNTN1;TRIB3;CASP4;NTNG1;PCSK6;SLC35G2;TPBG;MOSPD2;RANBP9;RIMS3;PLPPR2;PPP3CB;MYOF;SYTL1;ADGRB2;TTYH3;ZDHHC2;APLP2;COPB1;FNBP1L;ANO8;F2RL1;SLC2A9;GSDMA;PROCR;ATP10D;SLC6A6;CSNK2A1;SLC25A4;ASAP1;PRKAR1A;ANO1;FAM84B;FCHO2;CPEB4;NIPSNAP1;USP6NL;SPRY2;SEPT5;SLC6A14;LMBR1L;MGLL;CD99;ACVR1B;SLC43A1;COL6A1;NGFR;PSKH1;HSPA13;PTPRZ1;IFITM1;GRIN3B;AGPAT3;SKAP2;ARF4;UAP1;CNNM1;HSD17B7;SLC12A7;PCYOX1;SPIRE1;CADM4;MAP2K2;ABHD6;SLC22A17;ARRDC1;SLC38A2;RIN1;TRPC1;RET;SLC13A3;C5;NCKAP1;KCNJ15;SLC30A1;TSPAN3;PSD3;TMBIM1;CCDC88A;SAMD8;SHC2;PRKACA;EPB41L3;PCDH1;RHOBTB1;BCAP29;AP2A2;SLC39A10;CMTM6;IL1RAP;ORAI1;CARD11;FCHO1;LTB4R;LPAR1;CTSZ;AP3D1;ARID4A;ARPC1A;TENM2;IGF2;NRSN2;ITPR2;FNBP1;PJA2;SLC2A13;GRB10;MAP4K2;EFCAB7;SLC10A6;TMEM63A;EVA1A;GRB7;SRPX2;PPL;GPR153;TMEM50B;ATP12A;SLC7A11;ESYT3;ATP6V1B2;RPH3AL;ADAM8;ROBO3;IL20RB;CLDN11;ATP11B;ITGA4;FZD8;WASL;HSPA2;PRSS8;FLNB;LRP6;SYT2;PLCH2;TMEM173;SLC18A2;SEMA6C;SIGMAR1;OMG;ZBTB33;PSEN2;SSFA2;PTCH1;ADCY1;SEPT6;PANK1;SNX27;AMACR;SLC23A2;RALGPS2;SLC44A1;GNAI1;LRP4;FADD
7259,GO:0031226,2.36729505345197e-10,1,119,768,intrinsic component of plasma membrane,CC,TSPAN1;F2R;SORL1;ITGA6;SCN8A;PRNP;PAG1;ITGB4;SLC16A3;ACVR2B;COL13A1;DCBLD2;MST1R;TNFSF15;KCNG1;PTPRS;EGFR;TNFRSF6B;TMPRSS11D;TSPAN5;PCDHAC2;SLC33A1;DLG1;DLG4;B3GNT3;PLXNB3;GPC4;PODXL;SLCO4A1;TGM2;HTR7;SDC1;STOM;DLG3;RASA3;MRC2;TGFBR2;SLC2A3;EDNRA;SHANK2;SLITRK6;EPHA1;CLCA2;CD44;ATP7B;PKD2;LRP1;ST3GAL5;AKAP9;LPAR3;FGFR1;ITGA1;EPCAM;ITGB5;ITGA2;VAMP2;FAT1;ITPR3;CEACAM1;SLC5A1;BSG;CLCN3;NTSR1;MMP14;NLGN2;CD46;EPOR;NTNG1;SLC35G2;TPBG;MOSPD2;PLPPR2;ZDHHC2;F2RL1;SLC2A9;PROCR;SLC6A6;SLC25A4;SLC6A14;LMBR1L;CD99;ACVR1B;SLC43A1;NGFR;PTPRZ1;GRIN3B;SLC12A7;CADM4;ABHD6;SLC22A17;SLC38A2;TRPC1;RET;SLC13A3;C5;KCNJ15;TSPAN3;SAMD8;PCDH1;BCAP29;SLC39A10;IL1RAP;ORAI1;LTB4R;LPAR1;TENM2;SLC2A13;ATP12A;SLC7A11;ESYT3;ADAM8;ITGA4;PRSS8;SLC18A2;SEMA6C;SIGMAR1;PSEN2;ADCY1;SLC23A2
10886,GO:0044425,3.93309152904771e-10,1,399,3690,membrane part,CC,NT5E;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;F2R;SORL1;ADAM19;RAB3B;MBOAT2;KIAA1549L;NEURL1;VLDLR;SYNE3;ITGA6;SCN8A;SERPINE2;PEAR1;ADCY7;PRNP;PAG1;ADGRF1;ITGB4;BBS2;SLC16A3;CMTM4;TMTC4;FAM210B;FNDC4;ACVR2B;ANTXR2;SLC29A4;ALOX15B;LMF1;COL13A1;PKN1;DCBLD2;MST1R;MARCH9;MARVELD1;LY6K;TMEM200A;TNFSF15;SSH1;KCNG1;PTPRS;B4GALT6;SDK2;SNTB2;ADGRL1;DENND5B;AVL9;CAPN2;FCGRT;SNPH;EGFR;STK39;SEMA4B;ANK3;C2CD2;DYSF;ARHGAP12;ARMCX2;FYN;TNFRSF6B;TMPRSS11D;TSPAN5;PCDHAC2;BNIP3;SLC33A1;UBE2J1;UBXN7;ELOVL1;DLG1;CSMD3;DLG4;B3GNT3;TMEM245;CD68;CSMD2;PLXNB3;GPC4;SNX9;PODXL;SLCO4A1;TGM2;SLC9A7;UBXN4;SPTLC2;WDFY3;SEC23A;HTR7;RDH14;MALL;ASPH;MCTP1;CEMIP;SDC1;STOM;MXRA7;SHC1;DLG3;PAK1;RASA3;TMEM154;KIAA1549;MRC2;TGFBR2;PTPN3;SLC2A3;B4GALNT4;EDNRA;SHANK2;SLITRK6;EPHA1;PLPP6;CLCA2;ERO1B;CD44;FKBP1A;BNIP3L;ATP7B;ABCD1;CCPG1;ACP5;RGS14;MCFD2;PKD2;LRP1;ST3GAL5;AKAP9;RAB11FIP4;DDN;ATF4;ABCA7;PIGH;AGPAT4;LPAR3;ELFN2;FAM155B;FGFR1;ITGA1;EPCAM;MARCH4;CMTM7;LPCAT4;ITGB5;SNX14;LPCAT1;AIG1;ITGA2;PTK6;GALNT3;TMX4;VAMP2;FAT1;INPP5F;ABCG1;KIAA1109;PITPNM1;ITPR3;VPS13A;KDSR;CEACAM1;FERMT1;SLC5A1;PDIA5;LMAN1;SLC35F2;SARAF;BSG;EPN2;SLC9A3R2;DVL1;CLCN3;NTSR1;MMP14;PLEK2;NLGN2;CD46;MVB12B;EPOR;ORAI3;MPDZ;LRP5;NIPA1;ABHD17C;TMEM86B;COX18;SEC22C;SLC35B4;CNTN1;CLTCL1;CASP4;NTNG1;SLC35G2;TPBG;VPS11;MOSPD2;DNAJB9;RIMS3;PLPPR2;SEC63;PPP3CB;MYOF;SYTL1;ADGRB2;TTYH3;ZDHHC2;APLP2;COPB1;FAM8A1;COPG1;ANO8;F2RL1;SLC2A9;PROCR;PLD3;ATP10D;SLC6A6;SLC25A4;QSOX1;ASAP1;NDUFV3;PRKAR1A;ANO1;CRLS1;BOK;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;SPRY2;SLC6A14;LMBR1L;MGLL;CD99;CYYR1;ACVR1B;NDUFA4L2;APCDD1L;SLC43A1;NGFR;PSKH1;MVB12A;PTPRZ1;BCL2L1;IFITM1;GRIN3B;AGPAT3;NYNRIN;ARF4;TMEM187;CNNM1;HSD17B7;SLC12A7;XBP1;SPIRE1;SLC46A3;CADM4;MAP2K2;ABHD6;SLC22A17;CYP4F22;MICU3;SLC38A2;TRPC1;RET;STX10;LMBRD2;OSBPL5;SLC13A3;MCTP2;C5;TXNDC11;SMIM19;MBOAT7;TM2D2;NCKAP1;KCNJ15;SLC35F5;SLC30A1;TSPAN3;PSD3;TMBIM1;FAM171A2;SFXN3;TMED4;SAMD8;PRKACA;SLC25A30;RAB1A;ZDHHC1;EPB41L3;SNX30;SEL1L;PCDH1;BCAP29;AP2A2;SRD5A3;SLC39A10;KDELR3;CMTM6;IL1RAP;SLC25A43;ST6GALNAC2;ORAI1;CARD11;FCHO1;LTB4R;FICD;LPAR1;AP3D1;ARPC1A;TENM2;NRSN2;TMEM134;ITPR2;FNBP1;AGPAT1;PJA2;SLC2A13;MAP4K2;EFCAB7;SLC10A6;TMEM63A;SNX6;EVA1A;TRIQK;SRPX2;GPR153;TMEM50B;ATP12A;SLC7A11;ESYT3;CREB3L2;ERP44;ATP6V1B2;ADAM8;ROBO3;IL20RB;CLDN11;WFS1;ATP11B;ITGA4;IKBIP;TMEM229B;CKLF;TMEM9;SSR3;MARCH2;FZD8;TMEM107;REEP6;HSPA2;PRSS8;FLNB;LRP6;SYT2;TMEM173;RNF180;SLC18A2;SEMA6C;SIGMAR1;HPSE;SSR1;INAFM2;COQ2;OMG;GRAMD1C;ARMCX3;DNAJC3;PSEN2;ELOVL4;DNAJC4;HSD17B12;CDS2;PTCH1;ADCY1;SEPT6;TMEM139;RNF103;LRP3;PANK1;REEP3;UFL1;VSIG10L;FAM162A;SNX27;CTXN1;SLC23A2;SLC44A1;GNAI1;LRP4;STT3B;RB1CC1;TMEM42;FADD
2593,GO:0005887,4.00641757515435e-10,1,114,731,integral component of plasma membrane,CC,TSPAN1;F2R;SORL1;ITGA6;SCN8A;PAG1;ITGB4;SLC16A3;ACVR2B;COL13A1;DCBLD2;MST1R;TNFSF15;KCNG1;PTPRS;EGFR;TNFRSF6B;TMPRSS11D;TSPAN5;PCDHAC2;SLC33A1;DLG1;DLG4;B3GNT3;PLXNB3;GPC4;PODXL;SLCO4A1;HTR7;SDC1;STOM;DLG3;MRC2;TGFBR2;SLC2A3;EDNRA;SHANK2;SLITRK6;EPHA1;CLCA2;CD44;ATP7B;PKD2;LRP1;ST3GAL5;AKAP9;LPAR3;FGFR1;ITGA1;EPCAM;ITGB5;ITGA2;VAMP2;FAT1;ITPR3;CEACAM1;SLC5A1;BSG;CLCN3;NTSR1;MMP14;NLGN2;CD46;EPOR;SLC35G2;TPBG;MOSPD2;PLPPR2;ZDHHC2;F2RL1;SLC2A9;PROCR;SLC6A6;SLC25A4;SLC6A14;LMBR1L;CD99;ACVR1B;SLC43A1;NGFR;PTPRZ1;GRIN3B;SLC12A7;CADM4;ABHD6;SLC22A17;SLC38A2;TRPC1;RET;SLC13A3;C5;KCNJ15;TSPAN3;SAMD8;PCDH1;BCAP29;SLC39A10;IL1RAP;ORAI1;LTB4R;LPAR1;TENM2;SLC2A13;ATP12A;SLC7A11;ESYT3;ADAM8;ITGA4;SLC18A2;SEMA6C;SIGMAR1;PSEN2;ADCY1;SLC23A2
10913,GO:0044459,7.56442669246477e-10,1,192,1444,plasma membrane part,CC,EPN3;TSPAN1;NOS1;F2R;SORL1;NEURL1;ITGA6;SCN8A;SERPINE2;PEAR1;PRNP;PAG1;ITGB4;BBS2;SLC16A3;ACVR2B;ANTXR2;SLC29A4;COL13A1;PKN1;DCBLD2;MST1R;TNFSF15;SSH1;KCNG1;PTPRS;SNTB2;ADGRL1;SNPH;EGFR;STK39;ANK3;DYSF;ARHGAP12;FYN;TNFRSF6B;TMPRSS11D;TSPAN5;PCDHAC2;SLC33A1;DLG1;DLG4;B3GNT3;PLXNB3;GPC4;SNX9;PODXL;SLCO4A1;TGM2;HTR7;SDC1;STOM;SHC1;DLG3;PAK1;RASA3;MRC2;TGFBR2;PTPN3;SLC2A3;EDNRA;SHANK2;SLITRK6;EPHA1;CLCA2;CD44;FKBP1A;ATP7B;RGS14;PKD2;LRP1;ST3GAL5;AKAP9;RAB11FIP4;DDN;ATF4;ABCA7;LPAR3;FGFR1;ITGA1;EPCAM;ITGB5;ITGA2;PTK6;VAMP2;FAT1;ABCG1;PITPNM1;ITPR3;CEACAM1;FERMT1;SLC5A1;BSG;SLC9A3R2;DVL1;CLCN3;NTSR1;MMP14;PLEK2;NLGN2;CD46;EPOR;MPDZ;LRP5;ABHD17C;NTNG1;SLC35G2;TPBG;MOSPD2;RIMS3;PLPPR2;PPP3CB;MYOF;SYTL1;ZDHHC2;F2RL1;SLC2A9;PROCR;SLC6A6;SLC25A4;ASAP1;PRKAR1A;ANO1;FCHO2;CPEB4;NIPSNAP1;SPRY2;SLC6A14;LMBR1L;CD99;ACVR1B;SLC43A1;NGFR;PTPRZ1;GRIN3B;ARF4;SLC12A7;SPIRE1;CADM4;MAP2K2;ABHD6;SLC22A17;SLC38A2;TRPC1;RET;SLC13A3;C5;NCKAP1;KCNJ15;SLC30A1;TSPAN3;PSD3;SAMD8;PRKACA;EPB41L3;PCDH1;BCAP29;AP2A2;SLC39A10;IL1RAP;ORAI1;CARD11;LTB4R;LPAR1;ARPC1A;TENM2;PJA2;SLC2A13;MAP4K2;EFCAB7;SRPX2;ATP12A;SLC7A11;ESYT3;ADAM8;ITGA4;FZD8;HSPA2;PRSS8;LRP6;SLC18A2;SEMA6C;SIGMAR1;PSEN2;PTCH1;ADCY1;SEPT6;SNX27;SLC23A2;GNAI1;LRP4;FADD
7257,GO:0031224,8.81269577354219e-09,1,305,2759,intrinsic component of membrane,CC,NT5E;EDEM1;TSPAN1;NOS1;F2R;SORL1;ADAM19;RAB3B;MBOAT2;KIAA1549L;VLDLR;SYNE3;ITGA6;SCN8A;PEAR1;ADCY7;PRNP;PAG1;ADGRF1;ITGB4;SLC16A3;CMTM4;TMTC4;FAM210B;FNDC4;ACVR2B;ANTXR2;SLC29A4;LMF1;COL13A1;DCBLD2;MST1R;MARCH9;MARVELD1;LY6K;TMEM200A;TNFSF15;KCNG1;PTPRS;B4GALT6;SDK2;ADGRL1;DENND5B;AVL9;FCGRT;SNPH;EGFR;SEMA4B;C2CD2;DYSF;ARMCX2;TNFRSF6B;TMPRSS11D;TSPAN5;PCDHAC2;BNIP3;SLC33A1;UBE2J1;ELOVL1;DLG1;CSMD3;DLG4;B3GNT3;TMEM245;CD68;CSMD2;PLXNB3;GPC4;PODXL;SLCO4A1;TGM2;SLC9A7;SPTLC2;HTR7;MALL;ASPH;MCTP1;SDC1;STOM;MXRA7;DLG3;RASA3;TMEM154;KIAA1549;MRC2;TGFBR2;SLC2A3;B4GALNT4;EDNRA;SHANK2;SLITRK6;EPHA1;PLPP6;CLCA2;CD44;FKBP1A;BNIP3L;ATP7B;ABCD1;CCPG1;ACP5;PKD2;LRP1;ST3GAL5;AKAP9;ABCA7;AGPAT4;LPAR3;ELFN2;FAM155B;FGFR1;ITGA1;EPCAM;MARCH4;CMTM7;LPCAT4;ITGB5;SNX14;LPCAT1;AIG1;ITGA2;GALNT3;TMX4;VAMP2;FAT1;ABCG1;KIAA1109;ITPR3;KDSR;CEACAM1;SLC5A1;LMAN1;SLC35F2;SARAF;BSG;CLCN3;NTSR1;MMP14;NLGN2;CD46;EPOR;ORAI3;LRP5;NIPA1;TMEM86B;COX18;SEC22C;SLC35B4;CNTN1;NTNG1;SLC35G2;TPBG;MOSPD2;PLPPR2;SEC63;MYOF;ADGRB2;TTYH3;ZDHHC2;APLP2;FAM8A1;ANO8;F2RL1;SLC2A9;PROCR;PLD3;ATP10D;SLC6A6;SLC25A4;QSOX1;ANO1;CRLS1;BOK;SLC6A14;LMBR1L;CD99;CYYR1;ACVR1B;APCDD1L;SLC43A1;NGFR;PTPRZ1;BCL2L1;IFITM1;GRIN3B;AGPAT3;NYNRIN;TMEM187;CNNM1;HSD17B7;SLC12A7;XBP1;SLC46A3;CADM4;ABHD6;SLC22A17;MICU3;SLC38A2;TRPC1;RET;STX10;LMBRD2;OSBPL5;SLC13A3;MCTP2;C5;TXNDC11;SMIM19;MBOAT7;TM2D2;NCKAP1;KCNJ15;SLC35F5;SLC30A1;TSPAN3;TMBIM1;FAM171A2;SFXN3;TMED4;SAMD8;PRKACA;SLC25A30;ZDHHC1;SEL1L;PCDH1;BCAP29;SRD5A3;SLC39A10;KDELR3;CMTM6;IL1RAP;SLC25A43;ST6GALNAC2;ORAI1;LTB4R;FICD;LPAR1;TENM2;NRSN2;TMEM134;ITPR2;AGPAT1;SLC2A13;SLC10A6;TMEM63A;EVA1A;TRIQK;GPR153;TMEM50B;ATP12A;SLC7A11;ESYT3;CREB3L2;ATP6V1B2;ADAM8;ROBO3;IL20RB;CLDN11;WFS1;ATP11B;ITGA4;IKBIP;TMEM229B;CKLF;TMEM9;SSR3;MARCH2;FZD8;TMEM107;REEP6;HSPA2;PRSS8;FLNB;LRP6;SYT2;TMEM173;RNF180;SLC18A2;SEMA6C;SIGMAR1;SSR1;INAFM2;COQ2;OMG;GRAMD1C;ARMCX3;PSEN2;ELOVL4;DNAJC4;HSD17B12;CDS2;PTCH1;ADCY1;TMEM139;RNF103;LRP3;REEP3;VSIG10L;FAM162A;CTXN1;SLC23A2;SLC44A1;LRP4;STT3B;TMEM42
4807,GO:0012505,1.94490215209957e-08,1,341,3159,endomembrane system,CC,DOCK4;XDH;PLAT;EPN3;EDEM1;NOS1;F2R;SORL1;ADAM19;RAB3B;MBOAT2;VLDLR;PYGL;ASAP2;SYNE3;PYGB;H1F0;SERPINE2;PRSS3;IGFBP4;PRNP;XPOT;POSTN;SH3TC2;SLC16A3;MAP2K1;THBS2;RAPGEF3;FNDC4;ANTXR2;LTBP1;LMF1;COL13A1;PKN1;NAPRT;MARCH9;H6PD;LY6K;APPL2;DDIT3;PTPRS;B4GALT6;PSMD2;LAMB1;SNTB2;AVL9;LTA4H;CAPN2;BRSK1;EGFR;TBC1D14;ANK3;DYSF;PDZD2;LOXL1;FYN;BNIP3;SLC33A1;UBE2J1;UBXN7;ELOVL1;ARAP1;PGM1;ADAMTS7;DLG1;DLG4;B3GNT3;CTSB;CD68;GPC4;SNX9;TGM2;GLUL;EVI5L;SLC9A7;FKBP9;WNT7A;UBXN4;SPTLC2;WDFY3;SEC23A;GRK5;RDH14;MALL;CRTAP;ASPH;MCTP1;GDI1;CEMIP;SDC1;STOM;DKK1;PAK1;SERPING1;SLC2A3;B4GALNT4;LCN2;NUCB2;SCRN1;RAC2;CLCA2;ERO1B;CD44;APOE;FKBP1A;BNIP3L;ATP7B;CCND2;KLHDC2;MCFD2;PKD2;LRP1;ST3GAL5;FYCO1;AKAP9;EHBP1;RAB11FIP4;DDN;ANXA3;ABCA7;PIGH;ICA1;AGPAT4;ITGA1;FAM114A1;MARCH4;LPCAT4;SNX14;LPCAT1;AIG1;OCIAD2;GALNT3;TMX4;VAMP2;INPP5F;CHAC1;FAM20C;AHCYL2;ABCG1;FKBP10;PITPNM1;ITPR3;VPS13A;FBXO2;KDSR;CEACAM1;OBSL1;PDIA5;RAB31;LMAN1;DMXL2;SARAF;BSG;TRIM5;SLC9A3R2;CLCN3;NTSR1;MMP14;ANXA6;CD46;MVB12B;MAP6;LRP5;NIPA1;ABHD17C;DNMBP;TMEM86B;CTSL;DOCK9;CST3;SEC22C;SLC35B4;CLTCL1;CASP4;PCSK6;SLC35G2;TPBG;VPS11;MOSPD2;DNAJB9;SEC63;MYOF;SYTL1;ZDHHC2;APLP2;COPB1;COPG1;ANO8;SCYL3;F2RL1;SLC2A9;RASIP1;C6ORF120;PLD3;ATP10D;PSMD7;PTHLH;QSOX1;BOK;FCHO2;CPEB4;SDCCAG3;ATXN2;USP6NL;SEPT5;TBC1D2B;MGLL;GOLGA6L9;DBNDD1;COL6A1;NGFR;PSKH1;MVB12A;HSPA13;SPESP1;MTA1;AZIN2;BCL2L1;CRAT;YTHDC2;AGPAT3;GLB1;WASF2;ARF4;GOLGA2P5;TMEM187;YPEL5;HSD17B7;XBP1;TXNRD3;MAP2K2;CYP4F22;RET;STX10;LOXL2;VWA1;RAB43;OSBPL5;MCTP2;TXNDC11;MTMR4;ZFYVE9;MBOAT7;GABARAPL2;DNASE1L1;PUM2;SLC30A1;TMBIM1;COL1A2;CCDC88A;TMED4;SAMD8;ADAMTSL1;PRKACA;TMSB4X;TIMP2;RAB1A;ZDHHC1;SNX30;SEL1L;ANGEL1;BCAP29;AP2A2;SRD5A3;KDELR3;CMTM6;ST6GALNAC2;FCHO1;LAMB2;FICD;LPAR1;CTSZ;AP3D1;NIT2;TENM2;IGF2;NRSN2;ITPR2;FNBP1;AGPAT1;PJA2;MAP4K2;ERLEC1;TMEM63A;SNX6;EVA1A;ANKRD50;TRIQK;TMEM50B;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;ADAM8;GARS;WFS1;ATP11B;IKBIP;ACAP2;MPLKIP;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;FZD8;USP32;REEP6;LRP6;SYT2;TMEM173;RNF180;SLC18A2;SIGMAR1;HPSE;GALNS;SSR1;DNAJC3;ZFYVE21;PSEN2;ELOVL4;HSD17B12;CDS2;PTCH1;SEPT6;COG8;OAS1;RNF103;USP25;LRP3;PANK1;REEP3;UFL1;SNX27;STT3B;RB1CC1
5312,GO:0016021,2.97029275405099e-08,1,296,2694,integral component of membrane,CC,EDEM1;TSPAN1;NOS1;F2R;SORL1;ADAM19;MBOAT2;KIAA1549L;VLDLR;SYNE3;ITGA6;SCN8A;PEAR1;ADCY7;PAG1;ADGRF1;ITGB4;SLC16A3;CMTM4;TMTC4;FAM210B;FNDC4;ACVR2B;ANTXR2;SLC29A4;LMF1;COL13A1;DCBLD2;MST1R;MARCH9;MARVELD1;TMEM200A;TNFSF15;KCNG1;PTPRS;B4GALT6;SDK2;ADGRL1;DENND5B;AVL9;FCGRT;SNPH;EGFR;SEMA4B;C2CD2;DYSF;ARMCX2;TNFRSF6B;TMPRSS11D;TSPAN5;PCDHAC2;BNIP3;SLC33A1;UBE2J1;ELOVL1;DLG1;CSMD3;DLG4;B3GNT3;TMEM245;CD68;CSMD2;PLXNB3;GPC4;PODXL;SLCO4A1;SLC9A7;SPTLC2;HTR7;MALL;ASPH;MCTP1;SDC1;STOM;MXRA7;DLG3;TMEM154;KIAA1549;MRC2;TGFBR2;SLC2A3;B4GALNT4;EDNRA;SHANK2;SLITRK6;EPHA1;PLPP6;CLCA2;CD44;FKBP1A;BNIP3L;ATP7B;ABCD1;CCPG1;ACP5;PKD2;LRP1;ST3GAL5;AKAP9;ABCA7;AGPAT4;LPAR3;ELFN2;FAM155B;FGFR1;ITGA1;EPCAM;MARCH4;CMTM7;LPCAT4;ITGB5;SNX14;LPCAT1;AIG1;ITGA2;GALNT3;TMX4;VAMP2;FAT1;ABCG1;KIAA1109;ITPR3;KDSR;CEACAM1;SLC5A1;LMAN1;SLC35F2;SARAF;BSG;CLCN3;NTSR1;MMP14;NLGN2;CD46;EPOR;ORAI3;LRP5;NIPA1;TMEM86B;COX18;SEC22C;SLC35B4;SLC35G2;TPBG;MOSPD2;PLPPR2;SEC63;MYOF;ADGRB2;TTYH3;ZDHHC2;APLP2;FAM8A1;ANO8;F2RL1;SLC2A9;PROCR;PLD3;ATP10D;SLC6A6;SLC25A4;QSOX1;ANO1;CRLS1;BOK;SLC6A14;LMBR1L;CD99;CYYR1;ACVR1B;APCDD1L;SLC43A1;NGFR;PTPRZ1;BCL2L1;IFITM1;GRIN3B;AGPAT3;NYNRIN;TMEM187;CNNM1;HSD17B7;SLC12A7;XBP1;SLC46A3;CADM4;ABHD6;SLC22A17;MICU3;SLC38A2;TRPC1;RET;STX10;LMBRD2;OSBPL5;SLC13A3;MCTP2;C5;TXNDC11;SMIM19;MBOAT7;TM2D2;NCKAP1;KCNJ15;SLC35F5;SLC30A1;TSPAN3;TMBIM1;FAM171A2;SFXN3;TMED4;SAMD8;PRKACA;SLC25A30;ZDHHC1;SEL1L;PCDH1;BCAP29;SRD5A3;SLC39A10;KDELR3;CMTM6;IL1RAP;SLC25A43;ST6GALNAC2;ORAI1;LTB4R;FICD;LPAR1;TENM2;NRSN2;TMEM134;ITPR2;AGPAT1;SLC2A13;SLC10A6;TMEM63A;EVA1A;TRIQK;GPR153;TMEM50B;ATP12A;SLC7A11;ESYT3;CREB3L2;ATP6V1B2;ADAM8;ROBO3;IL20RB;CLDN11;WFS1;ATP11B;ITGA4;IKBIP;TMEM229B;CKLF;TMEM9;SSR3;MARCH2;FZD8;TMEM107;REEP6;HSPA2;PRSS8;FLNB;LRP6;SYT2;TMEM173;RNF180;SLC18A2;SEMA6C;SIGMAR1;SSR1;INAFM2;COQ2;GRAMD1C;ARMCX3;PSEN2;ELOVL4;DNAJC4;HSD17B12;CDS2;PTCH1;ADCY1;TMEM139;RNF103;LRP3;REEP3;VSIG10L;FAM162A;CTXN1;SLC23A2;SLC44A1;LRP4;STT3B;TMEM42
2527,GO:0005783,1.92734504549384e-07,1,159,1323,endoplasmic reticulum,CC,XDH;EDEM1;NOS1;SORL1;MBOAT2;SYNE3;IGFBP4;PRNP;MAP2K1;FNDC4;ANTXR2;LTBP1;LMF1;COL13A1;H6PD;LAMB1;CAPN2;EGFR;ANK3;PDZD2;BNIP3;SLC33A1;UBE2J1;UBXN7;ELOVL1;ADAMTS7;DLG1;DLG4;B3GNT3;TGM2;GLUL;FKBP9;WNT7A;UBXN4;SPTLC2;SEC23A;RDH14;CRTAP;ASPH;MCTP1;CEMIP;STOM;NUCB2;ERO1B;APOE;FKBP1A;BNIP3L;MCFD2;PKD2;DDN;PIGH;AGPAT4;LPCAT4;LPCAT1;TMX4;FAM20C;AHCYL2;ABCG1;FKBP10;PITPNM1;ITPR3;FBXO2;KDSR;PDIA5;LMAN1;SARAF;NTSR1;LRP5;TMEM86B;CST3;SEC22C;SLC35B4;CASP4;PCSK6;TPBG;DNAJB9;SEC63;ZDHHC2;APLP2;COPB1;COPG1;ANO8;PLD3;ATP10D;QSOX1;BOK;CPEB4;MGLL;COL6A1;PSKH1;HSPA13;BCL2L1;CRAT;YTHDC2;AGPAT3;HSD17B7;XBP1;TXNRD3;MAP2K2;CYP4F22;LOXL2;VWA1;OSBPL5;MCTP2;TXNDC11;MBOAT7;DNASE1L1;SLC30A1;COL1A2;CCDC88A;TMED4;SAMD8;ADAMTSL1;RAB1A;ZDHHC1;SEL1L;ANGEL1;BCAP29;SRD5A3;KDELR3;LAMB2;FICD;CTSZ;TENM2;ITPR2;AGPAT1;PJA2;ERLEC1;EVA1A;TRIQK;TMEM50B;SLC7A11;ESYT3;CREB3L2;ERP44;WFS1;ATP11B;IKBIP;IGFBP7;SSR3;MARCH2;REEP6;LRP6;TMEM173;RNF180;SIGMAR1;SSR1;DNAJC3;PSEN2;ELOVL4;HSD17B12;CDS2;OAS1;RNF103;USP25;REEP3;UFL1;STT3B;RB1CC1
11151,GO:0045202,3.93609590971505e-07,1,80,511,synapse,CC,NOS1;ZMYND8;F2R;RAB3B;NEURL1;SERPINE2;PRNP;POSTN;NR1D1;SH3KBP1;COL13A1;MAP1B;PTPRS;SDK2;SNTB2;CRTC1;ADGRL1;BRSK1;SNPH;EGFR;ANK3;FYN;BNIP3;DLG1;DLG4;GLUL;WNT7A;MCTP1;DLG3;SHANK2;FKBP1A;RGS14;AKAP9;DDN;ICA1;ITGA2;VAMP2;MTHFR;PFN2;FBXO2;DMXL2;XRN1;DVL1;CLCN3;NTSR1;NLGN2;MPDZ;ABHD17C;DNMBP;RIMS3;SYTL1;DNAJC6;ASAP1;PRKAR1A;FCHO2;CPEB4;NIPSNAP1;SEPT5;DBNDD1;BCL2L1;GRIN3B;ARF4;PSD3;EPB41L3;LAMB2;LPAR1;AP3D1;TENM2;LAMA5;PJA2;SRPX2;LRP6;SYT2;EEF2K;SLC18A2;SIGMAR1;PSEN2;PTCH1;SEPT6;LRP4
7153,GO:0031012,6.95204150133195e-07,0.999999800544687,46,240,extracellular matrix,CC,ITGA6;MMP1;SERPINE2;POSTN;THBS2;TFPI2;LTBP2;LTBP1;THSD4;LAMB1;LOXL1;ADAMTS7;DLG1;GPC4;TGM2;HTRA1;WNT7A;CRTAP;MXRA7;WISP1;SMOC2;SLITRK6;APOE;ANGPTL4;SMOC1;LTBP4;MMP14;THBS3;CST3;PCSK6;AEBP1;WNT2B;COL6A1;PTPRZ1;LOXL2;VWA1;COL1A2;ADAMTSL1;TIMP2;LAMB2;MMP10;LAMA5;IGFBP7;HPSE;OMG;HSD17B12
10911,GO:0044456,1.69555116689663e-06,0.99999943753798,67,420,synapse part,CC,NOS1;ZMYND8;F2R;RAB3B;NEURL1;PRNP;NR1D1;COL13A1;MAP1B;PTPRS;ADGRL1;BRSK1;SNPH;ANK3;FYN;BNIP3;DLG1;DLG4;GLUL;WNT7A;MCTP1;DLG3;SHANK2;FKBP1A;RGS14;AKAP9;DDN;ICA1;ITGA2;VAMP2;PFN2;FBXO2;DMXL2;DVL1;CLCN3;NTSR1;NLGN2;MPDZ;ABHD17C;RIMS3;SYTL1;DNAJC6;ASAP1;FCHO2;CPEB4;NIPSNAP1;SEPT5;DBNDD1;BCL2L1;GRIN3B;ARF4;PSD3;EPB41L3;LAMB2;LPAR1;AP3D1;TENM2;LAMA5;PJA2;SRPX2;SYT2;EEF2K;SLC18A2;SIGMAR1;PTCH1;SEPT6;LRP4
2405,GO:0005576,2.9619356665231e-06,0.999998194733938,281,2786,extracellular region,CC,XDH;NT5E;PLAT;EPN3;TSPAN1;F2R;SORL1;RAB3B;PGF;PCK2;VLDLR;PYGL;ITGA6;MMP1;PYGB;SERPINE2;PRSS3;CRYL1;IGFBP4;PRNP;ADGRF1;MXRA5;ITGB4;ACTA2;MARCKSL1;POSTN;ADM2;MAP2K1;CMTM4;THBS2;TFPI2;LTBP2;RAPGEF3;FNDC4;ANTXR2;LTBP1;ALOX15B;COL13A1;THSD4;GPX3;NAPRT;APLN;LY6K;TNFSF15;APPL2;PTPRS;PSMD2;LAMB1;SNTB2;LTA4H;CAPN2;EGFR;SEMA4B;DYSF;THEM6;CGREF1;PDZD2;LOXL1;HEBP1;TNFRSF6B;TMPRSS11D;PSAT1;JADE2;PGM1;ADAMTS7;DLG1;IDH2;CTSB;GPC4;SNX9;PODXL;TGM2;XPC;GLUL;HTRA1;GLO1;WNT7A;PGLS;TTBK2;ACOT7;IGIP;CRTAP;CEMIP;SDC1;STOM;MXRA7;DLG3;DKK1;WISP1;SMOC2;ATXN10;SERPING1;SLC2A3;LCN2;HAGH;NUCB2;SLITRK6;RALGAPA2;RAC2;CLCA2;CD44;APOE;FKBP1A;ACP5;ANGPTL4;ALDH1L2;PKD2;PRKACB;LDHA;IDE;RAB11FIP4;ABHD8;UBE2G1;ANXA3;ELFN2;FGFR1;ITGA1;AARS;EPCAM;TUB;CMTM7;SMOC1;ITGB5;HYAL1;GALNT3;VAMP2;FAT1;LTBP4;BIVM;FAM20C;PFN2;FBXO2;NELL2;GAMT;IAH1;KDSR;MBLAC2;CEACAM1;ADM5;SLC5A1;LMAN1;DMXL2;UACA;BSG;SLC9A3R2;MMP14;ANXA6;CD46;MVB12B;EPOR;CTH;NXPH4;THBS3;CTSL;TWF2;CST3;CNTN1;CLTCL1;CASP4;NTNG1;GFPT1;PCSK6;TOM1L2;WASF3;DNAJB9;MYOF;ACOT13;SYTL1;TTYH3;APLP2;SLK;PRDX5;ALDH7A1;FNBP1L;CDC42BPA;PROCR;C6ORF120;TAOK1;PLD3;AEBP1;ABHD15;PSMD7;PTHLH;TST;BLMH;QSOX1;CPNE8;CTBS;ANO1;SLC6A14;WNT2B;ACVR1B;COL6A1;NGFR;BPHL;MVB12A;HSPA13;PTPRZ1;PM20D2;GLB1;WASF2;ARF4;H2AFJ;YPEL5;PCYOX1;SLC46A3;CADM4;MAP2K2;ABHD6;ARRDC1;LYPLAL1;SPATA6;LOXL2;VWA1;TCTN1;RAB43;SLC13A3;C5;MTMR4;NCKAP1;DNASE1L1;C1ORF56;TSPAN3;TMBIM1;FRMD4B;COL1A2;CTSO;TMED4;ADAMTSL1;PRKACA;TMSB4X;TIMP2;RAB1A;ZDHHC1;CMTM6;IL1RAP;CARD11;LAMB2;CTSZ;MMP10;NIT2;BLVRA;ARPC1A;IGF2;LAMA5;PTGR2;TMEM63A;SRPX2;PPL;LYPLA1;ERP44;ATP6V1B2;GARS;CLDN11;ITGA4;WDR60;CKLF;IGFBP7;WASL;HSPA2;PRSS8;FLNB;LRP6;MAGEF1;GGACT;PPT2;HPSE;GALNS;OMG;DNAJC3;AOX1;HSD17B12;ADCY1;OAS1;FAM162A;GALE;SEMA3F;SLC44A1;ADNP;GNAI1;FCGBP
10301,GO:0043062,9.95663257555924e-06,0.999995772937705,44,242,extracellular structure organization,BP,ADAM19;ITGA6;MMP1;ITGB4;POSTN;THBS2;COL13A1;THSD4;LAMB1;CAPN2;LOXL1;HTRA1;SDC1;SMOC2;ERO1B;CD44;APOE;PRKACB;LRP1;ABCA7;ITGA1;ITGB5;HYAL1;ITGA2;ABCG1;FERMT1;BSG;MMP14;THBS3;CTSL;CST3;COL6A1;LOXL2;VWA1;SH3PXD2B;COL1A2;PRKACA;TIMP2;LAMB2;MMP10;LAMA5;ADAM8;ITGA4;HSD17B12
16811,GO:0098657,1.00180122741493e-05,0.999994858091022,73,500,import into cell,BP,TSPAN1;NOS1;SORL1;RAB3B;VLDLR;PEAR1;PRNP;SH3KBP1;APLN;WIPF1;RIN2;ARHGAP12;FYN;DLG4;SNX9;TGM2;GLUL;SLC9A7;MCTP1;DKK1;PAK1;MRC2;TGFBR2;RAC2;APOE;LRP1;EHBP1;ANXA3;ABCA7;FAM155B;TUB;ITGA2;INPP5F;CEACAM1;MAPKAPK3;RAB31;EPN2;NTSR1;NLGN2;LRP5;CLTCL1;DNAJC6;FNBP1L;F2RL1;FCHO2;ATXN2;LMBR1L;BCL2L1;WASF2;RIN1;LOXL2;ZFYVE9;NCKAP1;ELMO3;SLC30A1;RAB1A;SNX30;AP2A2;SLC39A10;FCHO1;ARPC1A;FNBP1;PPARG;SNX6;USP20;ITGA4;MARCH2;WASL;LRP6;SYT2;EEF2K;LRP3;LRP4
4285,GO:0009653,1.10126386949475e-05,0.99999272944809,202,1704,anatomical structure morphogenesis,BP,FHL1;XDH;SMURF2;NOS1;ERCC1;F2R;ETV5;PGF;SH2D2A;CTNNBIP1;VLDLR;SYNE3;ITGA6;SERPINE2;ITGB4;ACTA2;BBS2;POSTN;ADM2;HECW2;NFATC4;ADARB1;MAP2K1;THBS2;FMNL2;RAPGEF3;ACVR2B;SH3KBP1;COL13A1;PKN1;WWTR1;ARHGAP22;APLN;SSH1;MAP1B;PTPRS;PSMD2;LAMB1;SDK2;ELK3;CAPN2;BRSK1;WIPF1;EGFR;SEMA4B;ANK3;ARHGAP12;FYN;BNIP3;KIF13B;PARVB;ARAP1;DLG1;DLG4;PLXNB3;GPC4;PODXL;NET1;TGM2;HTRA1;WNT7A;IGF2BP3;MAP4K4;TTBK2;STRADB;ASPH;GDI1;SDC1;SHC1;DLG3;DKK1;PAK1;TGFBR2;EDNRA;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;OBSCN;APOE;FKBP1A;ACP5;ANGPTL4;PKD2;PRKACB;LRP1;ANXA3;HMGA2;PPARA;LPAR3;FGFR1;ITGA1;E2F5;TMOD2;ITGB5;HYAL1;BTRC;ITGA2;ULK2;FAT1;ATRX;FAM20C;SOX4;GAMT;CEACAM1;OBSL1;BSG;SH3D19;EPN2;MDFI;DVL1;MMP14;MAP6;LRP5;ZMYM3;THBS3;TWF2;CST3;CLTCL1;NTNG1;RANBP9;WASF3;BTBD3;PPP3CB;MYOF;RFX2;ADGRB2;PLAG1;RASIP1;PSMD7;CHD7;PRKAR1A;SPRY2;THRA;WNT2B;COL6A1;NGFR;TSHZ1;PTPRZ1;BCL2L1;RNF165;MEF2D;WASF2;XBP1;RET;LOXL2;TCTN1;SH3PXD2B;C5;MBOAT7;NCKAP1;TMBIM1;ETV1;COL1A2;RAB1A;EPB41L3;RHOBTB1;AP2A2;LAMB2;LPAR1;CTSZ;HOXA3;TENM2;IGF2;LAMA5;GRB10;ZMYM2;PPARG;GRB7;SRPX2;ALDH1A2;TBX1;ADAM8;AKT3;ROBO3;ITGA4;WDR60;ZNF568;DDHD2;FZD8;TMEM107;WASL;FLNB;LRP6;ARID5B;SYT2;E2F7;EEF2K;SEMA6C;HPSE;TET1;OMG;FOXP1;PTCH1;ADCY1;NYAP1;ANKRD6;SEMA3F;ADNP;LRP4
7366,GO:0031410,1.16707167949456e-05,0.999992520619715,182,1602,cytoplasmic vesicle,CC,PLAT;EPN3;F2R;SORL1;RAB3B;PYGL;SCN8A;PYGB;SERPINE2;PRSS3;SH3TC2;MAP2K1;THBS2;ANTXR2;SH3KBP1;PKN1;NAPRT;LY6K;APPL2;DDIT3;PTPRS;PSMD2;SNTB2;AVL9;LTA4H;BRSK1;WIPF1;EGFR;TBC1D14;DYSF;LOXL1;FYN;ARAP1;PGM1;DLG4;CTSB;CD68;SNX9;SLC9A7;WNT7A;SEC23A;MALL;MCTP1;CEMIP;STOM;DKK1;SERPING1;SLC2A3;LCN2;RAC2;CD44;APOE;ATP7B;MCFD2;PKD2;LRP1;FYCO1;EHBP1;RAB11FIP4;ANXA3;ABCA7;ICA1;KIF21B;FGFR1;ITGA1;ITGB5;SNX14;HYAL1;LPCAT1;OCIAD2;VAMP2;ULK2;INPP5F;ABCG1;ITPR3;VPS13A;CEACAM1;RAB31;LMAN1;DMXL2;BSG;EPN2;DVL1;CLCN3;MMP14;ANXA6;CD46;MVB12B;MPDZ;MAP6;NIPA1;ABHD17C;CTSL;CST3;CLTCL1;VPS11;MOSPD2;MYOF;SYTL1;ZDHHC2;APLP2;COPB1;PRDX5;COPG1;FNBP1L;F2RL1;C6ORF120;PSMD7;QSOX1;BOK;FCHO2;SDCCAG3;USP6NL;SEPT5;DBNDD1;NGFR;MVB12A;SPESP1;AZIN2;BCL2L1;GLB1;WASF2;TMEM187;YPEL5;SPIRE1;MAP2K2;ARRDC1;RET;RAB43;MTMR4;ZFYVE9;GABARAPL2;DNASE1L1;TMBIM1;CCDC88A;TMED4;PRKACA;TMSB4X;TIMP2;RAB1A;SNX30;RHOBTB1;AP2A2;KDELR3;CMTM6;LPAR1;CTSZ;AP3D1;NIT2;IGF2;NRSN2;ITPR2;FNBP1;TMEM63A;SNX6;ANKRD50;ERP44;ATP6V1B2;RPH3AL;ADAM8;GARS;ATP11B;ACAP2;TMEM9;TBC1D16;DDHD2;MARCH2;WASL;FLNB;LRP6;SYT2;TMEM173;SLC18A2;SIGMAR1;HPSE;GALNS;DNAJC3;ZFYVE21;PTCH1;SEPT6;PANK1;SNX27
16718,GO:0097708,1.31650659950655e-05,0.99999140384756,182,1604,intracellular vesicle,CC,PLAT;EPN3;F2R;SORL1;RAB3B;PYGL;SCN8A;PYGB;SERPINE2;PRSS3;SH3TC2;MAP2K1;THBS2;ANTXR2;SH3KBP1;PKN1;NAPRT;LY6K;APPL2;DDIT3;PTPRS;PSMD2;SNTB2;AVL9;LTA4H;BRSK1;WIPF1;EGFR;TBC1D14;DYSF;LOXL1;FYN;ARAP1;PGM1;DLG4;CTSB;CD68;SNX9;SLC9A7;WNT7A;SEC23A;MALL;MCTP1;CEMIP;STOM;DKK1;SERPING1;SLC2A3;LCN2;RAC2;CD44;APOE;ATP7B;MCFD2;PKD2;LRP1;FYCO1;EHBP1;RAB11FIP4;ANXA3;ABCA7;ICA1;KIF21B;FGFR1;ITGA1;ITGB5;SNX14;HYAL1;LPCAT1;OCIAD2;VAMP2;ULK2;INPP5F;ABCG1;ITPR3;VPS13A;CEACAM1;RAB31;LMAN1;DMXL2;BSG;EPN2;DVL1;CLCN3;MMP14;ANXA6;CD46;MVB12B;MPDZ;MAP6;NIPA1;ABHD17C;CTSL;CST3;CLTCL1;VPS11;MOSPD2;MYOF;SYTL1;ZDHHC2;APLP2;COPB1;PRDX5;COPG1;FNBP1L;F2RL1;C6ORF120;PSMD7;QSOX1;BOK;FCHO2;SDCCAG3;USP6NL;SEPT5;DBNDD1;NGFR;MVB12A;SPESP1;AZIN2;BCL2L1;GLB1;WASF2;TMEM187;YPEL5;SPIRE1;MAP2K2;ARRDC1;RET;RAB43;MTMR4;ZFYVE9;GABARAPL2;DNASE1L1;TMBIM1;CCDC88A;TMED4;PRKACA;TMSB4X;TIMP2;RAB1A;SNX30;RHOBTB1;AP2A2;KDELR3;CMTM6;LPAR1;CTSZ;AP3D1;NIT2;IGF2;NRSN2;ITPR2;FNBP1;TMEM63A;SNX6;ANKRD50;ERP44;ATP6V1B2;RPH3AL;ADAM8;GARS;ATP11B;ACAP2;TMEM9;TBC1D16;DDHD2;MARCH2;WASL;FLNB;LRP6;SYT2;TMEM173;SLC18A2;SIGMAR1;HPSE;GALNS;DNAJC3;ZFYVE21;PTCH1;SEPT6;PANK1;SNX27
10883,GO:0044421,1.37406017127415e-05,0.999990512916741,253,2506,extracellular region part,CC,XDH;NT5E;PLAT;EPN3;TSPAN1;SORL1;RAB3B;PGF;PCK2;VLDLR;PYGL;ITGA6;MMP1;PYGB;SERPINE2;PRSS3;CRYL1;IGFBP4;PRNP;MXRA5;ITGB4;ACTA2;MARCKSL1;POSTN;MAP2K1;CMTM4;THBS2;TFPI2;LTBP2;RAPGEF3;FNDC4;LTBP1;ALOX15B;THSD4;GPX3;NAPRT;APLN;TNFSF15;APPL2;PTPRS;PSMD2;LAMB1;SNTB2;LTA4H;CAPN2;EGFR;SEMA4B;DYSF;LOXL1;HEBP1;TNFRSF6B;TMPRSS11D;PSAT1;JADE2;PGM1;ADAMTS7;DLG1;IDH2;CTSB;GPC4;SNX9;PODXL;TGM2;XPC;GLUL;HTRA1;GLO1;WNT7A;PGLS;TTBK2;ACOT7;CRTAP;SDC1;STOM;MXRA7;DLG3;DKK1;WISP1;SMOC2;ATXN10;SERPING1;SLC2A3;LCN2;HAGH;NUCB2;SLITRK6;RALGAPA2;RAC2;CD44;APOE;FKBP1A;ACP5;ANGPTL4;ALDH1L2;PKD2;PRKACB;LDHA;IDE;RAB11FIP4;ABHD8;UBE2G1;ANXA3;ELFN2;ITGA1;AARS;EPCAM;CMTM7;SMOC1;ITGB5;HYAL1;GALNT3;VAMP2;FAT1;LTBP4;BIVM;FAM20C;PFN2;FBXO2;GAMT;IAH1;KDSR;MBLAC2;CEACAM1;SLC5A1;LMAN1;DMXL2;UACA;BSG;SLC9A3R2;MMP14;ANXA6;CD46;MVB12B;CTH;THBS3;CTSL;TWF2;CST3;CNTN1;CLTCL1;GFPT1;PCSK6;TOM1L2;WASF3;DNAJB9;MYOF;ACOT13;SYTL1;TTYH3;APLP2;SLK;PRDX5;ALDH7A1;FNBP1L;CDC42BPA;PROCR;C6ORF120;TAOK1;PLD3;AEBP1;PSMD7;PTHLH;TST;BLMH;QSOX1;CPNE8;CTBS;ANO1;SLC6A14;WNT2B;ACVR1B;COL6A1;BPHL;MVB12A;HSPA13;PTPRZ1;PM20D2;GLB1;WASF2;ARF4;H2AFJ;PCYOX1;SLC46A3;CADM4;ABHD6;ARRDC1;LYPLAL1;LOXL2;VWA1;TCTN1;RAB43;SLC13A3;C5;MTMR4;NCKAP1;DNASE1L1;TSPAN3;TMBIM1;FRMD4B;COL1A2;CTSO;TMED4;ADAMTSL1;PRKACA;TMSB4X;TIMP2;RAB1A;ZDHHC1;CMTM6;IL1RAP;CARD11;LAMB2;CTSZ;MMP10;NIT2;BLVRA;ARPC1A;IGF2;LAMA5;PTGR2;TMEM63A;SRPX2;PPL;LYPLA1;ERP44;ATP6V1B2;GARS;CLDN11;ITGA4;WDR60;CKLF;IGFBP7;WASL;HSPA2;PRSS8;FLNB;MAGEF1;GGACT;PPT2;HPSE;GALNS;OMG;DNAJC3;AOX1;HSD17B12;ADCY1;FAM162A;GALE;SEMA3F;SLC44A1;ADNP;GNAI1;FCGBP
5328,GO:0016054,1.41603173140129e-05,0.999994601535251,33,189,organic acid catabolic process,BP,NOS1;PCK2;CBS;CRYL1;GPT2;HADH;TYSND1;GLUL;CEMIP;ACAD11;ARG2;CD44;ABCD1;ALDH1L2;PPARA;ABHD10;HYAL1;AIG1;LONP2;ACAD10;CTH;HIBADH;MLYCD;ALDH7A1;BLMH;CPT2;GLUD1;NPL;CRAT;PM20D2;PCYOX1;ALDH4A1;AMACR
11657,GO:0046395,1.41603173140129e-05,0.999994601535251,33,189,carboxylic acid catabolic process,BP,NOS1;PCK2;CBS;CRYL1;GPT2;HADH;TYSND1;GLUL;CEMIP;ACAD11;ARG2;CD44;ABCD1;ALDH1L2;PPARA;ABHD10;HYAL1;AIG1;LONP2;ACAD10;CTH;HIBADH;MLYCD;ALDH7A1;BLMH;CPT2;GLUD1;NPL;CRAT;PM20D2;PCYOX1;ALDH4A1;AMACR
3567,GO:0007610,1.48351363279462e-05,0.999993091878763,51,311,behavior,BP,ETV5;VLDLR;SERPINE2;PRNP;ADGRF1;BBS2;ADM2;ADARB1;APLN;CRTC1;EGFR;FYN;DLG4;ESPN;DKK1;RAG1;SHANK2;SLITRK6;APOE;CCND2;RGS14;PPARA;ABCA7;TMOD2;INPP5F;ITPR3;VPS13A;DVL1;NTSR1;NLGN2;CST3;PPP3CB;CHD7;THRA;PTPRZ1;PER3;MTA1;ARF4;VWA1;ETV1;PJA2;SRPX2;TBX1;WFS1;DDHD2;RNF180;SLC18A2;ADCY1;PBX3;ADNP;FADD
17056,GO:0099537,1.54945550462355e-05,0.999992969186491,49,296,trans-synaptic signaling,BP,NOS1;ZMYND8;F2R;ETV5;RAB3B;NEURL1;SERPINE2;PRNP;NFATC4;ADARB1;SSH1;CRTC1;BRSK1;SNPH;EGFR;MYCBPAP;DLG1;DLG4;GLUL;WNT7A;HTR7;MCTP1;DLG3;DKK1;SHANK2;APOE;RGS14;AKAP9;LPAR3;TMOD2;VAMP2;PFN2;ITPR3;DVL1;NTSR1;NLGN2;RIMS3;PPP3CB;SYTL1;SEPT5;GRIN3B;SLC12A7;ABHD6;SLC30A1;LRP6;SYT2;SLC18A2;ADNP;GNAI1
2432,GO:0005615,1.64168064772802e-05,0.999988690353324,242,2397,extracellular space,CC,XDH;NT5E;PLAT;EPN3;TSPAN1;SORL1;RAB3B;PGF;PCK2;VLDLR;PYGL;PYGB;SERPINE2;PRSS3;CRYL1;IGFBP4;PRNP;MXRA5;ITGB4;ACTA2;MARCKSL1;POSTN;MAP2K1;CMTM4;THBS2;LTBP2;RAPGEF3;FNDC4;LTBP1;ALOX15B;THSD4;GPX3;NAPRT;APLN;TNFSF15;APPL2;PTPRS;PSMD2;LAMB1;SNTB2;LTA4H;CAPN2;EGFR;SEMA4B;DYSF;LOXL1;HEBP1;TNFRSF6B;TMPRSS11D;PSAT1;JADE2;PGM1;ADAMTS7;DLG1;IDH2;CTSB;GPC4;SNX9;PODXL;TGM2;XPC;GLUL;HTRA1;GLO1;WNT7A;PGLS;TTBK2;ACOT7;CRTAP;SDC1;STOM;DLG3;DKK1;WISP1;ATXN10;SERPING1;SLC2A3;LCN2;HAGH;NUCB2;SLITRK6;RALGAPA2;RAC2;CD44;APOE;FKBP1A;ACP5;ANGPTL4;ALDH1L2;PKD2;PRKACB;LDHA;IDE;RAB11FIP4;ABHD8;UBE2G1;ANXA3;ELFN2;ITGA1;AARS;EPCAM;CMTM7;ITGB5;HYAL1;GALNT3;VAMP2;FAT1;LTBP4;BIVM;FAM20C;PFN2;FBXO2;GAMT;IAH1;KDSR;MBLAC2;CEACAM1;SLC5A1;LMAN1;DMXL2;UACA;BSG;SLC9A3R2;MMP14;ANXA6;CD46;MVB12B;CTH;CTSL;TWF2;CST3;CNTN1;CLTCL1;GFPT1;PCSK6;TOM1L2;WASF3;DNAJB9;MYOF;ACOT13;SYTL1;TTYH3;APLP2;SLK;PRDX5;ALDH7A1;FNBP1L;CDC42BPA;PROCR;C6ORF120;TAOK1;PLD3;AEBP1;PSMD7;PTHLH;TST;BLMH;QSOX1;CPNE8;CTBS;ANO1;SLC6A14;WNT2B;ACVR1B;COL6A1;BPHL;MVB12A;HSPA13;PM20D2;GLB1;WASF2;ARF4;H2AFJ;PCYOX1;SLC46A3;CADM4;ABHD6;ARRDC1;LYPLAL1;LOXL2;VWA1;TCTN1;RAB43;SLC13A3;C5;MTMR4;NCKAP1;DNASE1L1;TSPAN3;TMBIM1;FRMD4B;COL1A2;CTSO;TMED4;PRKACA;TMSB4X;TIMP2;RAB1A;ZDHHC1;CMTM6;IL1RAP;CARD11;LAMB2;CTSZ;MMP10;NIT2;BLVRA;ARPC1A;IGF2;LAMA5;PTGR2;TMEM63A;SRPX2;PPL;LYPLA1;ERP44;ATP6V1B2;GARS;CLDN11;ITGA4;WDR60;CKLF;IGFBP7;WASL;HSPA2;PRSS8;FLNB;MAGEF1;GGACT;PPT2;GALNS;OMG;DNAJC3;AOX1;ADCY1;FAM162A;GALE;SEMA3F;SLC44A1;ADNP;GNAI1;FCGBP
12859,GO:0051179,1.66144800105141e-05,0.999987899772176,430,4302,localization,BP,DOCK4;FHL1;XDH;PLAT;SMURF2;EDEM1;TSPAN1;NOS1;ZMYND8;F2R;SORL1;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;VLDLR;PYGL;ASAP2;SYNE3;ITGA6;MMP1;CYGB;CYP27B1;SCN8A;PYGB;SERPINE2;PEAR1;PRSS3;PRNP;OSBP2;ITGB4;XPOT;BBS2;POSTN;SH3TC2;NR1D1;HECW2;SLC16A3;ADARB1;MAP2K1;LTBP2;RAPGEF3;ACVR2B;ANTXR2;LTBP1;SH3KBP1;SLC29A4;ALOX15B;LMF1;PKN1;NAPRT;APLN;MARVELD1;POU2F2;PITPNC1;APPL2;SSH1;MAP1B;DDIT3;KCNG1;HADH;PSMD2;LAMB1;EXOC2;DENND5B;AVL9;LTA4H;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;DYSF;ARHGAP12;FYN;OSBPL10;TSPAN5;BNIP3;KIF13B;SLC33A1;UBE2J1;ARAP1;PGM1;DLG1;DLG4;IDH2;CTSB;CD68;PLXNB3;SNX9;PODXL;SLCO4A1;NET1;TGM2;GLUL;EVI5L;SLC9A7;WNT7A;IGF2BP3;MAP4K4;TTBK2;SEC23A;TTC7B;STRADB;NME4;MALL;ASPH;MCTP1;GDI1;CEMIP;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;DLG3;DKK1;PAK1;RASA3;SOCS2;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;NUDCD3;EDNRA;LCN2;SHANK2;SCRN1;EPHA1;RAC2;CLCA2;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;RGS14;MCFD2;PKD2;SRGAP2B;LRP1;FYCO1;AKAP9;EHBP1;RAB11FIP4;ANXA3;ATF4;PPARA;ABCA7;ICA1;LPAR3;FAM155B;FGFR1;ITGA1;EPCAM;TUB;SNX14;HYAL1;LPCAT1;ITGA2;PTK6;VAMP2;FAT1;LONP2;LTBP4;INPP5F;ATRX;PFN2;ABCG1;SOX4;PITPNM1;FHOD1;ITPR3;VPS13A;CEP120;CEACAM1;FERMT1;MAPKAPK3;OBSL1;SLC5A1;RAB31;LMAN1;SLC35F2;SARAF;FAM110C;BSG;EPN2;MDFI;TRIM5;DVL1;CLCN3;NTSR1;MMP14;ANXA6;NLGN2;MVB12B;ORAI3;MAP6;LRP5;NIPA1;ABHD17C;TWF2;CST3;COX18;SEC22C;SLC35B4;CNTN1;TRIB3;CLTCL1;PCSK6;TOM1L2;VPS11;MOSPD2;RIMS3;SEC63;PPP3CB;SYTL1;TTYH3;KIAA1147;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;COPG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;SLC2A9;PROCR;C6ORF120;ATP10D;SLC6A6;CSNK2A1;PSMD7;TST;CHD7;SLC25A4;QSOX1;ASAP1;CPT2;ANO1;JMY;BOK;PARP9;FCHO2;SDCCAG3;ATXN2;NACC2;USP6NL;SPRY2;SEPT5;SLC6A14;BEX4;TBC1D2B;THRA;LMBR1L;ACVR1B;NDUFA4L2;SLC43A1;NGFR;PPP1R10;MVB12A;GLUD1;HSPA13;MARK4;AZIN2;BCL2L1;IFITM1;GRIN3B;GLB1;WASF2;ARF4;YPEL5;CNNM1;SLC12A7;PCYOX1;XBP1;SPIRE1;SLC46A3;UBASH3B;MAP2K2;ABHD6;SLC22A17;ARRDC1;MICU3;SLC38A2;RIN1;TRPC1;RET;STX10;LOXL2;TCTN1;RAB43;MLH3;OSBPL5;SLC13A3;NAV1;SH3PXD2B;C5;ZFYVE9;MBOAT7;NOP10;NCKAP1;GABARAPL2;KCNJ15;DNASE1L1;ELMO3;PAK6;SLC30A1;TMBIM1;COL1A2;SFXN3;CCDC88A;CCSAP;TMED4;PRKACA;TMSB4X;SLC25A30;TIMP2;RAB1A;ZDHHC1;EPB41L3;SNX30;SEL1L;RHOBTB1;BCAP29;AP2A2;SLC39A10;KDELR3;CMTM6;IL1RAP;SLC25A43;ORAI1;CARD11;FCHO1;LPAR1;CTSZ;MMP10;AP3D1;NIT2;ARPC1A;IGF2;ITPR2;MOAP1;LAMA5;FNBP1;SLC2A13;GRB10;MAP4K2;EFCAB7;ERLEC1;PPARG;SLC10A6;TMEM63A;SNX6;USP20;ANKRD50;GRB7;SRPX2;LYPLA1;TMEM50B;ATP12A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;ADAM8;AKT3;WFS1;ATP11B;ITGA4;WDR60;ACAP2;CKLF;TBC1D16;SSR3;DDHD2;MARCH2;TMEM107;WASL;REEP6;HSPA2;PRSS8;FLNB;LRP6;ARID5B;SYT2;TMEM173;EEF2K;SLC18A2;SIGMAR1;HPSE;GALNS;SSR1;ARMCX3;DNAJC3;FOXP1;ZFYVE21;PSEN2;PTCH1;SEPT6;COG8;LRP3;UFL1;SNX27;SLC23A2;SEMA3F;SLC44A1;GNAI1;LRP4;FADD
3187,GO:0006810,1.71240024397155e-05,0.999987700186114,341,3344,transport,BP,FHL1;XDH;EDEM1;TSPAN1;NOS1;F2R;SORL1;RAB3B;CCND1;NEURL1;PCK2;VLDLR;PYGL;ASAP2;CYGB;CYP27B1;SCN8A;PYGB;SERPINE2;PEAR1;PRSS3;PRNP;OSBP2;XPOT;BBS2;POSTN;SH3TC2;NR1D1;HECW2;SLC16A3;MAP2K1;LTBP2;RAPGEF3;ACVR2B;ANTXR2;SH3KBP1;SLC29A4;ALOX15B;LMF1;NAPRT;APLN;POU2F2;PITPNC1;APPL2;MAP1B;DDIT3;KCNG1;HADH;PSMD2;EXOC2;DENND5B;LTA4H;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;ANK3;DYSF;ARHGAP12;FYN;OSBPL10;BNIP3;KIF13B;SLC33A1;UBE2J1;ARAP1;PGM1;DLG1;DLG4;IDH2;CTSB;CD68;SNX9;SLCO4A1;TGM2;GLUL;EVI5L;SLC9A7;WNT7A;IGF2BP3;MAP4K4;SEC23A;STRADB;NME4;ASPH;MCTP1;GDI1;CEMIP;UNC119B;SDC1;ARG2;STOM;DLG3;DKK1;PAK1;RASA3;SOCS2;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;EDNRA;LCN2;SHANK2;SCRN1;RAC2;CLCA2;CD44;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;RGS14;MCFD2;PKD2;LRP1;FYCO1;AKAP9;EHBP1;RAB11FIP4;ANXA3;ATF4;PPARA;ABCA7;ICA1;LPAR3;FAM155B;FGFR1;TUB;SNX14;LPCAT1;ITGA2;VAMP2;LONP2;LTBP4;INPP5F;PFN2;ABCG1;SOX4;PITPNM1;FHOD1;ITPR3;VPS13A;CEP120;CEACAM1;FERMT1;MAPKAPK3;SLC5A1;RAB31;LMAN1;SLC35F2;SARAF;BSG;EPN2;DVL1;CLCN3;NTSR1;ANXA6;NLGN2;MVB12B;ORAI3;LRP5;NIPA1;CST3;COX18;SEC22C;SLC35B4;CNTN1;TRIB3;CLTCL1;PCSK6;TOM1L2;VPS11;MOSPD2;RIMS3;SEC63;PPP3CB;SYTL1;TTYH3;ZDHHC2;APLP2;DNAJC6;COPB1;COPG1;FNBP1L;ANO8;F2RL1;SLC2A9;C6ORF120;ATP10D;SLC6A6;PSMD7;TST;CHD7;SLC25A4;QSOX1;ASAP1;CPT2;ANO1;BOK;FCHO2;SDCCAG3;ATXN2;USP6NL;SEPT5;SLC6A14;TBC1D2B;LMBR1L;NDUFA4L2;SLC43A1;NGFR;PPP1R10;MVB12A;GLUD1;HSPA13;AZIN2;BCL2L1;GRIN3B;GLB1;WASF2;ARF4;YPEL5;CNNM1;SLC12A7;PCYOX1;XBP1;SPIRE1;SLC46A3;UBASH3B;MAP2K2;SLC22A17;ARRDC1;MICU3;SLC38A2;RIN1;TRPC1;STX10;LOXL2;RAB43;OSBPL5;SLC13A3;C5;ZFYVE9;NCKAP1;GABARAPL2;KCNJ15;DNASE1L1;ELMO3;SLC30A1;TMBIM1;SFXN3;CCDC88A;TMED4;PRKACA;TMSB4X;SLC25A30;TIMP2;RAB1A;ZDHHC1;SNX30;SEL1L;BCAP29;AP2A2;SLC39A10;KDELR3;CMTM6;IL1RAP;SLC25A43;ORAI1;CARD11;FCHO1;CTSZ;AP3D1;NIT2;ARPC1A;IGF2;ITPR2;MOAP1;FNBP1;SLC2A13;GRB10;MAP4K2;EFCAB7;ERLEC1;PPARG;SLC10A6;TMEM63A;SNX6;USP20;ANKRD50;LYPLA1;TMEM50B;ATP12A;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;ADAM8;WFS1;ATP11B;ITGA4;WDR60;ACAP2;CKLF;TBC1D16;SSR3;DDHD2;MARCH2;WASL;REEP6;HSPA2;PRSS8;LRP6;SYT2;TMEM173;EEF2K;SLC18A2;SIGMAR1;HPSE;GALNS;SSR1;DNAJC3;FOXP1;ZFYVE21;PSEN2;PTCH1;COG8;LRP3;SNX27;SLC23A2;SLC44A1;LRP4
17055,GO:0099536,1.74440036220172e-05,0.99999204677147,49,297,synaptic signaling,BP,NOS1;ZMYND8;F2R;ETV5;RAB3B;NEURL1;SERPINE2;PRNP;NFATC4;ADARB1;SSH1;CRTC1;BRSK1;SNPH;EGFR;MYCBPAP;DLG1;DLG4;GLUL;WNT7A;HTR7;MCTP1;DLG3;DKK1;SHANK2;APOE;RGS14;AKAP9;LPAR3;TMOD2;VAMP2;PFN2;ITPR3;DVL1;NTSR1;NLGN2;RIMS3;PPP3CB;SYTL1;SEPT5;GRIN3B;SLC12A7;ABHD6;SLC30A1;LRP6;SYT2;SLC18A2;ADNP;GNAI1
7602,GO:0031982,1.74869833698971e-05,0.999987550227982,305,3048,vesicle,CC,NT5E;PLAT;EPN3;TSPAN1;NOS1;F2R;SORL1;RAB3B;PCK2;PYGL;SCN8A;PYGB;SERPINE2;PRSS3;CRYL1;PRNP;MXRA5;ITGB4;ACTA2;MARCKSL1;SH3TC2;MAP2K1;THBS2;LTBP2;RAPGEF3;ANTXR2;SH3KBP1;ALOX15B;THSD4;GPX3;PKN1;NAPRT;LY6K;APPL2;DDIT3;PTPRS;PSMD2;LAMB1;SNTB2;AVL9;LTA4H;CAPN2;BRSK1;WIPF1;EGFR;TBC1D14;DYSF;LOXL1;FYN;HEBP1;TMPRSS11D;PSAT1;JADE2;ARAP1;PGM1;DLG1;DLG4;IDH2;CTSB;CD68;GPC4;SNX9;PODXL;TGM2;XPC;GLUL;SLC9A7;HTRA1;GLO1;WNT7A;PGLS;ACOT7;SEC23A;MALL;MCTP1;CEMIP;SDC1;STOM;DKK1;SERPING1;SLC2A3;LCN2;HAGH;NUCB2;RAC2;CD44;APOE;FKBP1A;ATP7B;ACP5;ALDH1L2;MCFD2;PKD2;PRKACB;LRP1;LDHA;FYCO1;EHBP1;RAB11FIP4;ABHD8;UBE2G1;ANXA3;ABCA7;ICA1;KIF21B;FGFR1;ITGA1;AARS;EPCAM;ITGB5;SNX14;HYAL1;LPCAT1;OCIAD2;GALNT3;VAMP2;ULK2;FAT1;LTBP4;INPP5F;FAM20C;PFN2;ABCG1;ITPR3;VPS13A;FBXO2;GAMT;IAH1;MBLAC2;CEACAM1;SLC5A1;RAB31;LMAN1;DMXL2;UACA;BSG;EPN2;SLC9A3R2;DVL1;CLCN3;MMP14;ANXA6;CD46;MVB12B;CTH;MPDZ;MAP6;NIPA1;ABHD17C;CTSL;TWF2;CST3;CNTN1;CLTCL1;GFPT1;TOM1L2;VPS11;MOSPD2;WASF3;DNAJB9;MYOF;ACOT13;SYTL1;TTYH3;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;COPG1;ALDH7A1;FNBP1L;CDC42BPA;F2RL1;PROCR;C6ORF120;TAOK1;PLD3;AEBP1;PSMD7;TST;BLMH;QSOX1;CPNE8;CTBS;ANO1;BOK;FCHO2;SDCCAG3;USP6NL;SEPT5;SLC6A14;ACVR1B;DBNDD1;COL6A1;NGFR;BPHL;MVB12A;HSPA13;SPESP1;AZIN2;BCL2L1;PM20D2;GLB1;WASF2;ARF4;H2AFJ;TMEM187;YPEL5;PCYOX1;SPIRE1;SLC46A3;CADM4;MAP2K2;ABHD6;ARRDC1;LYPLAL1;RET;STX10;VWA1;RAB43;SLC13A3;C5;MTMR4;ZFYVE9;NCKAP1;GABARAPL2;DNASE1L1;TSPAN3;TMBIM1;COL1A2;CCDC88A;TMED4;PRKACA;TMSB4X;TIMP2;RAB1A;ZDHHC1;SNX30;RHOBTB1;AP2A2;KDELR3;CMTM6;CARD11;LAMB2;LPAR1;CTSZ;AP3D1;NIT2;BLVRA;ARPC1A;IGF2;NRSN2;ITPR2;LAMA5;FNBP1;PTGR2;TMEM63A;SNX6;ANKRD50;PPL;LYPLA1;ERP44;ATP6V1B2;RPH3AL;ADAM8;GARS;CLDN11;ATP11B;ITGA4;WDR60;ACAP2;TMEM9;IGFBP7;TBC1D16;DDHD2;MARCH2;WASL;HSPA2;PRSS8;FLNB;LRP6;MAGEF1;SYT2;TMEM173;GGACT;PPT2;SLC18A2;SIGMAR1;HPSE;GALNS;DNAJC3;ZFYVE21;AOX1;PTCH1;ADCY1;SEPT6;PANK1;FAM162A;SNX27;GALE;SLC44A1;GNAI1;FCGBP
17687,GO:1901565,1.83417816408039e-05,0.999988841878156,118,977,organonitrogen compound catabolic process,BP,XDH;NT5E;SMURF2;EDEM1;GID4;NOS1;SORL1;VLDLR;CBS;SERPINE2;GPT2;BTBD2;NR1D1;HECW2;RAPGEF3;WWTR1;DDIT3;PSMD2;LTA4H;CAPN2;EGFR;FYN;BNIP3;UBE2J1;ADAMTS7;CTSB;GPC4;SNX9;GLUL;UBXN4;CEMIP;SDC1;ARG2;TRIB2;PTPN3;CD44;APOE;BNIP3L;ALDH1L2;RBCK1;LRP1;IDE;ABTB1;UBE2G1;RNPEPL1;HYAL1;BTRC;LPCAT1;LONP2;CHAC1;RMND5A;APOBEC3C;FBXO2;CEACAM1;SPATA18;SH3D19;DVL1;MVB12B;CTH;ABHD17C;CTSL;CST3;TRIB3;VPS11;DNAJB9;BTBD3;HIBADH;ALDH7A1;CSNK2A1;PSMD7;TST;BLMH;CTBS;MVB12A;GLUD1;MTA1;AZIN2;RNF165;PM20D2;GLB1;PCYOX1;XBP1;ARRDC1;ANKIB1;LYPLAL1;PDE5A;GABARAPL2;UBE2E1;CTSO;PRKACA;TIMP2;SEL1L;AP2A2;CTSZ;TBL1X;BLVRA;ERLEC1;USP20;LYPLA1;ADAM8;ALDH4A1;WFS1;USP32;MAGEF1;RNF180;GGACT;HPSE;GALNS;TET1;DNAJC3;AOX1;RNF103;USP25;UFL1;KLHL15;SLC44A1;STT3B;FBXL5
5378,GO:0016192,2.53154192186212e-05,0.999983236991314,166,1436,vesicle-mediated transport,BP,TSPAN1;SORL1;RAB3B;VLDLR;PYGL;ASAP2;PYGB;PEAR1;PRSS3;BBS2;MAP2K1;SH3KBP1;LMF1;NAPRT;APLN;APPL2;PSMD2;EXOC2;LTA4H;FCGRT;WIPF1;SNPH;TBC1D14;RIN2;ANK3;DYSF;ARHGAP12;FYN;ARAP1;PGM1;DLG4;CTSB;CD68;SNX9;TGM2;EVI5L;SEC23A;MCTP1;SDC1;STOM;DKK1;PAK1;MRC2;TGFBR2;SERPING1;SLC2A3;LCN2;SCRN1;RAC2;CD44;APOE;MCFD2;LRP1;EHBP1;RAB11FIP4;ANXA3;ABCA7;TUB;LPCAT1;ITGA2;VAMP2;INPP5F;PFN2;VPS13A;CEACAM1;MAPKAPK3;RAB31;LMAN1;EPN2;NLGN2;MVB12B;LRP5;CST3;SEC22C;CLTCL1;VPS11;MOSPD2;RIMS3;PPP3CB;SYTL1;APLP2;DNAJC6;COPB1;COPG1;FNBP1L;F2RL1;C6ORF120;PSMD7;QSOX1;ASAP1;FCHO2;SDCCAG3;ATXN2;USP6NL;SEPT5;TBC1D2B;LMBR1L;MVB12A;HSPA13;BCL2L1;GLB1;WASF2;ARF4;YPEL5;SPIRE1;MAP2K2;RIN1;STX10;LOXL2;RAB43;OSBPL5;ZFYVE9;NCKAP1;GABARAPL2;DNASE1L1;ELMO3;TMBIM1;TMED4;TMSB4X;TIMP2;RAB1A;SNX30;BCAP29;AP2A2;KDELR3;CMTM6;FCHO1;CTSZ;AP3D1;NIT2;ARPC1A;IGF2;FNBP1;MAP4K2;PPARG;TMEM63A;SNX6;USP20;ANKRD50;LYPLA1;TMEM50B;EVI5;CREB3L2;ERP44;RPH3AL;ADAM8;ATP11B;ITGA4;ACAP2;TBC1D16;DDHD2;MARCH2;WASL;HSPA2;LRP6;SYT2;TMEM173;EEF2K;HPSE;GALNS;DNAJC3;ZFYVE21;COG8;LRP3;SNX27;LRP4
2407,GO:0005578,2.61092258268267e-05,0.999989335055824,36,187,proteinaceous extracellular matrix,CC,ITGA6;MMP1;POSTN;THBS2;TFPI2;LTBP2;LTBP1;THSD4;LAMB1;LOXL1;ADAMTS7;DLG1;GPC4;WNT7A;CRTAP;WISP1;SMOC2;SLITRK6;ANGPTL4;SMOC1;LTBP4;CST3;WNT2B;COL6A1;PTPRZ1;LOXL2;VWA1;COL1A2;ADAMTSL1;TIMP2;LAMB2;MMP10;LAMA5;HPSE;OMG;HSD17B12
3456,GO:0007268,2.71283722703222e-05,0.999987354891684,48,294,chemical synaptic transmission,BP,ZMYND8;F2R;ETV5;RAB3B;NEURL1;SERPINE2;PRNP;NFATC4;ADARB1;SSH1;CRTC1;BRSK1;SNPH;EGFR;MYCBPAP;DLG1;DLG4;GLUL;WNT7A;HTR7;MCTP1;DLG3;DKK1;SHANK2;APOE;RGS14;AKAP9;LPAR3;TMOD2;VAMP2;PFN2;ITPR3;DVL1;NTSR1;NLGN2;RIMS3;PPP3CB;SYTL1;SEPT5;GRIN3B;SLC12A7;ABHD6;SLC30A1;LRP6;SYT2;SLC18A2;ADNP;GNAI1
16938,GO:0098916,2.71283722703222e-05,0.999987354891684,48,294,anterograde trans-synaptic signaling,BP,ZMYND8;F2R;ETV5;RAB3B;NEURL1;SERPINE2;PRNP;NFATC4;ADARB1;SSH1;CRTC1;BRSK1;SNPH;EGFR;MYCBPAP;DLG1;DLG4;GLUL;WNT7A;HTR7;MCTP1;DLG3;DKK1;SHANK2;APOE;RGS14;AKAP9;LPAR3;TMOD2;VAMP2;PFN2;ITPR3;DVL1;NTSR1;NLGN2;RIMS3;PPP3CB;SYTL1;SEPT5;GRIN3B;SLC12A7;ABHD6;SLC30A1;LRP6;SYT2;SLC18A2;ADNP;GNAI1
3188,GO:0006811,2.89604525796498e-05,0.999982532944791,108,858,ion transport,BP,FHL1;NOS1;F2R;RAB3B;CYP27B1;SCN8A;SERPINE2;PRNP;HECW2;SLC16A3;PITPNC1;DDIT3;KCNG1;DENND5B;STK39;ANK3;FYN;OSBPL10;SLC33A1;DLG1;DLG4;SLCO4A1;SLC9A7;ASPH;CEMIP;STOM;DLG3;RASA3;PTPN3;SLC2A3;LCN2;SHANK2;CLCA2;APOE;FKBP1A;ATP7B;ABCD1;PKD2;AKAP9;ATF4;PPARA;ABCA7;LPAR3;FAM155B;FGFR1;VAMP2;ABCG1;PITPNM1;ITPR3;CEACAM1;SLC5A1;SARAF;BSG;CLCN3;NTSR1;ANXA6;NLGN2;ORAI3;NIPA1;SLC35B4;CNTN1;TTYH3;ANO8;SLC2A9;ATP10D;SLC6A6;CHD7;SLC25A4;CPT2;ANO1;SLC6A14;NDUFA4L2;SLC43A1;AZIN2;GRIN3B;CNNM1;SLC12A7;PCYOX1;UBASH3B;SLC22A17;MICU3;SLC38A2;TRPC1;OSBPL5;SLC13A3;KCNJ15;SLC30A1;SFXN3;PRKACA;TMSB4X;SLC39A10;ORAI1;ITPR2;SLC2A13;PPARG;SLC10A6;TMEM63A;ATP12A;SLC7A11;ATP6V1B2;WFS1;ATP11B;HSPA2;PRSS8;SLC18A2;PSEN2;SLC23A2;SLC44A1
7334,GO:0031344,4.794788479411e-05,0.999974382012713,65,436,regulation of cell projection organization,BP,ZMYND8;NEURL1;VLDLR;PRNP;HECW2;NFATC4;MAP2K1;SSH1;MAP1B;PTPRS;CRTC1;SEMA4B;FYN;KIF13B;ARAP1;CSMD3;DLG4;PLXNB3;PODXL;ESPN;EVI5L;WNT7A;MAP4K4;GDI1;PAK1;SHANK2;RAC2;CD44;APOE;LRP1;LPAR3;FGFR1;ITGA2;PTK6;ULK2;INPP5F;PFN2;CEP120;OBSL1;FAM110C;DVL1;PLEK2;TWF2;CNTN1;FNBP1L;F2RL1;ASAP1;SPRY2;NGFR;WASF2;RET;NCKAP1;DOCK11;CCDC88A;IL1RAP;LPAR1;CTSZ;TENM2;WASL;SYT2;EEF2K;OMG;SEMA3F;ADNP;LRP4
7926,GO:0032501,5.16133207146514e-05,0.999961204110851,421,4171,multicellular organismal process,BP,DOCK4;FHL1;XDH;PLAT;SMURF2;NOS1;ERCC1;ZMYND8;F2R;SORL1;ADAM19;ETV5;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;ITGA6;CYP27B1;SCN8A;SERPINE2;PRSS3;ADCY7;IGFBP4;PRNP;ADGRF1;OSBP2;ITGB4;ACTA2;BBS2;POSTN;SH3TC2;ADM2;BTBD2;NR1D1;HECW2;NFATC4;ADARB1;MAP2K1;THBS2;FAM210B;TFPI2;RAPGEF3;ACVR2B;LTBP1;SH3KBP1;ALOX15B;LMF1;SALL2;COL13A1;PKN1;WWTR1;CCNI;MST1R;ARHGAP22;MICALCL;APLN;MARVELD1;POU2F2;DHTKD1;DGKA;TEF;SSH1;MAP1B;DDIT3;PTPRS;SMARCA1;SOX12;PSMD2;LAMB1;SDK2;ELK3;CRTC1;ADGRL1;CAPN2;BRSK1;SNPH;EGFR;STK39;SEMA4B;ANK3;DYSF;LOXL1;FYN;MYH15;TNFRSF6B;TMPRSS11D;PCDHAC2;BNIP3;KIF13B;SCMH1;ERCC6;UBE2J1;MAPK13;MYCBPAP;ADAMTS7;ZNF516;DLG1;CSMD3;DLG4;IDH2;CTSB;PLXNB3;GPC4;PODXL;TGM2;ESPN;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;TTBK2;WDFY3;HTR7;RDH14;MALL;CRTAP;ASPH;GDI1;CEMIP;UNC119B;SDC1;ARG2;SHC1;DLG3;DKK1;PAK1;SOCS2;TRIB2;ATXN10;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;EDNRA;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;OBSCN;APOE;FKBP1A;ATP7B;CCND2;ACP5;ANGPTL4;PRR15;RGS14;PKD2;PRKACB;SRGAP2B;LRP1;LDHA;IDE;AKAP9;RAB11FIP4;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;LPAR3;ASNS;FGFR1;ITGA1;AARS;E2F5;EPCAM;TMOD2;TUB;CMTM7;TACC1;TCFL5;SMOC1;NFAT5;ITGB5;HYAL1;BTRC;LPCAT1;ITGA2;PTK6;ULK2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;ABCG1;KIAA1109;SOX4;PITPNM1;ITPR3;VPS13A;GAMT;CEP120;CEACAM1;FERMT1;OBSL1;PRR9;SLC5A1;LMAN1;RCOR1;BSG;EPN2;MDFI;TNRC6B;DVL1;NTSR1;MMP14;ANXA6;NLGN2;CD46;EPOR;CTH;FAM50A;MAP6;LRP5;ZMYM3;THBS3;CTSL;DOCK9;TWF2;CST3;RABGGTA;CNTN1;NTNG1;GFPT1;PCSK6;TPBG;L3MBTL3;RANBP9;WASF3;DNAJB9;BTBD3;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;RFX2;ADGRB2;CEBPG;ALDH7A1;PLAG1;TTC9;F2RL1;DDX60;RASIP1;PROCR;TAOK1;PHC3;AEBP1;CSNK2A1;PSMD7;PTHLH;CHD7;ASAP1;PRKAR1A;ANO1;BOK;NIPSNAP1;SPRY2;THRA;MGLL;WNT2B;ACVR1B;DBNDD1;COL6A1;NGFR;PSKH1;GLUD1;TSHZ1;MARK4;ZNF449;PTPRZ1;SPESP1;PER3;MTA1;AZIN2;BCL2L1;IFITM1;RNF165;MEF2D;WASF2;ARF4;POLL;XBP1;SPIRE1;UBASH3B;TXNRD3;SATB1;SPIN4;REC8;SLC38A2;TRPC1;RET;SPATA6;LOXL2;PDE5A;VWA1;TCTN1;MLH3;NAV1;SH3PXD2B;MCTP2;C5;MBOAT7;NCKAP1;GTF2IRD2;DOCK11;PUM2;SLC30A1;RNF135;TMBIM1;ETV1;COL1A2;CCDC88A;CCSAP;PRKACA;TMSB4X;TIMP2;EIF2AK2;RAB1A;EPB41L3;PCDH1;IFI16;BCAP29;AP2A2;NR2F6;IL1RAP;CARD11;LAMB2;LTB4R;LPAR1;ZNF354A;CTSZ;TBL1X;HOXA3;AP3D1;ARID4A;TENM2;IGF2;ITPR2;LAMA5;AGPAT1;PJA2;GRB10;ZMYM2;PPARG;GRB7;SRPX2;PPL;ALDH1A2;TBX1;SLC7A11;EVI5;CREB3L2;ADAM8;AKT3;ROBO3;IL20RB;CLDN11;WFS1;ENDOG;ITGA4;PHF21A;ZBTB40;WDR60;ZNF568;IGFBP7;DDHD2;FZD8;TMEM107;WASL;RAPGEFL1;REEP6;HSPA2;PRSS8;FLNB;LRP6;ARID5B;SYT2;TMEM173;RNF180;E2F7;EEF2K;SLC18A2;SEMA6C;SIGMAR1;HPSE;TNRC6C;RCAN1;TET1;OMG;FOXP1;PTCH1;ADCY1;KAT2B;SEPT6;RNF103;NYAP1;UFL1;ANKRD6;PBX3;JARID2;SEMA3F;ADNP;LRP4;RB1CC1;DNMT3A;FADD
10803,GO:0044282,5.36966922862235e-05,0.999974828583804,44,301,small molecule catabolic process,BP,NT5E;NOS1;PCK2;CBS;CYP27B1;CRYL1;GPT2;HADH;PGM1;TYSND1;GLUL;CEMIP;ACAD11;ARG2;HAGH;CD44;APOE;ABCD1;ALDH1L2;PPARA;ABHD10;HYAL1;AIG1;LONP2;APOBEC3C;NTSR1;ACAD10;CTH;LRP5;HIBADH;MLYCD;ALDH7A1;BLMH;CPT2;GLUD1;NPL;CRAT;PM20D2;GLB1;PCYOX1;SRD5A3;ALDH4A1;AMACR;GALE
2398,GO:0005543,6.529377782702e-05,0.999968459243959,47,295,phospholipid binding,MF,PITPNC1;DGKA;DYSF;OSBPL10;ARAP1;SNX9;WDFY3;GRK5;NME4;MCTP1;SHC1;APOE;ZCCHC14;ANXA3;LPAR3;TUB;SNX14;VAMP2;PFN2;ABCG1;PITPNM1;ITPR3;GSDMC;PLEK2;ANXA6;PHF12;TWF2;MYOF;SYTL1;GSDMA;ASAP1;FCHO2;OSBPL5;SH3PXD2B;MCTP2;ZFYVE9;CCDC88A;SNX30;LPAR1;ITPR2;SNX6;GRB7;ESYT3;RPH3AL;ACAP2;SYT2;SNX27
6255,GO:0019838,7.24125373158208e-05,0.999977977065468,20,86,growth factor binding,MF,ITGA6;IGFBP4;ITGB4;LTBP2;ACVR2B;LTBP1;EGFR;HTRA1;SHC1;WISP1;TGFBR2;FGFR1;LTBP4;PCSK6;ACVR1B;COL6A1;NGFR;COL1A2;SRPX2;IGFBP7
8196,GO:0032940,7.42498114401089e-05,0.999953238002609,111,930,secretion by cell,BP,F2R;RAB3B;PCK2;PYGL;PYGB;SERPINE2;PRSS3;POSTN;NR1D1;LTBP2;RAPGEF3;ACVR2B;ALOX15B;LMF1;NAPRT;APLN;POU2F2;HADH;PSMD2;EXOC2;LTA4H;BRSK1;SNPH;EGFR;PGM1;IDH2;CTSB;CD68;GLUL;WNT7A;MAP4K4;MCTP1;SDC1;ARG2;STOM;PAK1;SERPING1;SLC2A3;LCN2;SCRN1;RAC2;CD44;ANXA3;ICA1;FGFR1;LPCAT1;VAMP2;LTBP4;PFN2;SOX4;ITPR3;CEACAM1;FERMT1;RAB31;DVL1;NTSR1;NLGN2;LRP5;CST3;SEC22C;PCSK6;VPS11;MOSPD2;RIMS3;PPP3CB;SYTL1;APLP2;COPB1;COPG1;F2RL1;C6ORF120;PSMD7;CHD7;SLC25A4;QSOX1;ANO1;SEPT5;GLUD1;GLB1;YPEL5;XBP1;SLC38A2;C5;DNASE1L1;SLC30A1;TMBIM1;TMSB4X;TIMP2;RAB1A;SEL1L;AP2A2;CMTM6;IL1RAP;CARD11;CTSZ;NIT2;IGF2;ITPR2;TMEM63A;ERP44;RPH3AL;ADAM8;ATP11B;CKLF;SYT2;TMEM173;SLC18A2;HPSE;GALNS;DNAJC3;FOXP1
6647,GO:0023052,7.48230373285464e-05,0.999943528648706,395,3923,signaling,BP,TNIP1;DOCK4;DDIT4L;XDH;PLAT;SMURF2;EDEM1;TSPAN1;NOS1;ZMYND8;F2R;SORL1;FAM83A;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;ASAP2;ITGA6;MMP1;RPS6KA2;CYP27B1;SCN8A;SERPINE2;PEAR1;ADCY7;IGFBP4;PRNP;PAG1;ADGRF1;ITGB4;BBS2;POSTN;SH3TC2;ADM2;NR1D1;NFATC4;ADARB1;MAP2K1;CMTM4;LTBP2;RAPGEF3;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ALOX15B;SALL2;PKN1;WWTR1;DCBLD2;MST1R;ARHGAP22;APLN;PITPNC1;DGKA;TNFSF15;APPL2;EIF4EBP1;SSH1;DDIT3;PTPRS;HADH;PSMD2;ELK3;CRTC1;ADGRL1;BRSK1;FCGRT;WIPF1;SNPH;EGFR;STK39;RIN2;SEMA4B;ANK3;ARHGAP12;FYN;HEBP1;TNFRSF6B;TSPAN5;PCDHAC2;BNIP3;KIF13B;SLC33A1;ERCC6;MAPK13;MYCBPAP;ARAP1;ZNF516;DLG1;DLG4;CTSB;PLXNB3;GPC4;NET1;TGM2;GLUL;HTRA1;WNT7A;MAP4K4;TTBK2;GRK5;HTR7;STRADB;ASPH;MCTP1;GDI1;SDC1;SHC1;DLG3;DKK1;WISP1;DAP;SMOC2;PAK1;RASA3;SOCS2;TRIB2;RHPN1;MRC2;TGFBR2;PTPN3;EDNRA;LCN2;SHANK2;EPHA1;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;BNIP3L;PTPN12;AFAP1;RGS14;PKD2;PRKACB;RBCK1;LRP1;IDE;AKAP9;HMGA2;ATF4;PPARA;ABCA7;WWC3;ICA1;LPAR3;ASNS;FGFR1;ITGA1;EPCAM;TMOD2;CMTM7;SMOC1;NFAT5;ITGB5;BTRC;ITGA2;PTK6;GALNT3;VAMP2;ULK2;FAT1;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;PFN2;SOX4;PITPNM1;ITPR3;CEACAM1;FERMT1;MAPKAPK3;PDIA5;RAB31;MT2A;UACA;FAM110C;BSG;NLK;EPN2;MDFI;TRIM5;RALGAPA1;TNRC6B;DVL1;NTSR1;MMP14;PLEK2;ANXA6;NLGN2;CD46;MVB12B;EPOR;CTH;NXPH4;LRP5;DNMBP;CTSL;DOCK9;CNTN1;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;TOM1L2;RANBP9;DNAJB9;RIMS3;PLPPR2;SEC63;PPP3CB;MYOF;INPP4A;SYTL1;ADGRB2;APLP2;SLK;CDC42BPA;F2RL1;DDX60;RASIP1;TAOK1;CSNK2A1;PSMD7;PTHLH;CHD7;SLC25A4;ASAP1;PRKAR1A;ANO1;JMY;BOK;PARP9;CPEB4;C18ORF32;MAST3;NACC2;SPRY2;SEPT5;THRA;MGLL;WNT2B;ACVR1B;NGFR;PSKH1;MVB12A;GLUD1;PTPRZ1;NUDT6;MTA1;BCL2L1;IFITM1;RNF165;GRIN3B;WASF2;SKAP2;ARF4;SLC12A7;XBP1;UBASH3B;MAP2K2;ABHD6;SLC22A17;PPP1R2;ARRDC1;TLE4;RIN1;TRPC1;RET;PDE5A;TCTN1;RAB43;MCTP2;C5;MTMR4;ZFYVE9;NCKAP1;EPM2A;DOCK11;PAK6;PUM2;SLC30A1;TSPAN3;PSD3;TMBIM1;COL1A2;CCDC88A;TMED4;SHC2;PRKACA;SAMD5;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RAB1A;SEL1L;PCDH1;IFI16;RHOBTB1;AP2A2;NR2F6;SLC39A10;KDELR3;CMTM6;IL1RAP;CARD11;LTB4R;FICD;LPAR1;TBL1X;ARPC1A;TENM2;IGF2;ITPR2;MOAP1;LAMA5;AGPAT1;PJA2;GRB10;MAP4K2;PPARG;SNX6;USP20;GRB7;ALDH1A2;GPR153;ARHGAP29;TBX1;CREB3L2;ATP6V1B2;RPH3AL;ADAM8;AKT3;ROBO3;IL20RB;WFS1;DEPDC1;ITGA4;ACAP2;MAML3;CKLF;TBC1D16;FZD8;WASL;RAPGEFL1;FLNB;LRP6;ARID5B;SYT2;PLCH2;E2F7;SLC18A2;SIGMAR1;HPSE;RALGDS;SSR1;TNRC6C;RCAN1;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;NYAP1;UFL1;FAM162A;ANKRD6;SNX27;SEMA3F;RALGPS2;ADNP;GNAI1;LRP4;RB1CC1;TRIM38;FADD
3294,GO:0006986,7.65322160157375e-05,0.999970641323752,28,157,response to unfolded protein,BP,EDEM1;CCND1;DDIT3;DNAJB5;UBXN4;SHC1;ATF4;ASNS;CHAC1;PDIA5;CTH;GFPT1;DNAJB9;SEC63;BOK;HSPA13;XBP1;EIF2AK2;KDELR3;FICD;CREB3L2;ERP44;WFS1;HSPA2;SSR1;DNAJC3;DNAJC4;STT3B
12623,GO:0050807,7.97199769164808e-05,0.999974682429526,21,93,regulation of synapse organization,BP,ZMYND8;ETV5;NEURL1;PRNP;NFATC4;THBS2;SSH1;ADGRL1;FYN;WNT7A;DKK1;SLITRK6;APOE;NLGN2;TPBG;ADGRB2;IL1RAP;SRPX2;EEF2K;ADNP;LRP4
10892,GO:0044432,8.61384040558431e-05,0.999945162801464,113,962,endoplasmic reticulum part,CC,EDEM1;NOS1;MBOAT2;IGFBP4;ANTXR2;LTBP1;LMF1;COL13A1;H6PD;LAMB1;CAPN2;EGFR;SLC33A1;UBE2J1;UBXN7;ELOVL1;ADAMTS7;DLG1;WNT7A;UBXN4;SPTLC2;SEC23A;RDH14;CRTAP;ASPH;MCTP1;ERO1B;APOE;FKBP1A;MCFD2;PKD2;DDN;PIGH;AGPAT4;LPCAT4;LPCAT1;FAM20C;ABCG1;FKBP10;PITPNM1;ITPR3;KDSR;PDIA5;LMAN1;SARAF;TMEM86B;CST3;SEC22C;SLC35B4;CASP4;DNAJB9;SEC63;APLP2;COPB1;COPG1;ANO8;PLD3;ATP10D;QSOX1;BOK;MGLL;COL6A1;PSKH1;AGPAT3;HSD17B7;XBP1;CYP4F22;VWA1;OSBPL5;TXNDC11;MBOAT7;COL1A2;TMED4;SAMD8;ADAMTSL1;RAB1A;SEL1L;BCAP29;SRD5A3;KDELR3;LAMB2;FICD;CTSZ;ITPR2;AGPAT1;PJA2;ERLEC1;EVA1A;TRIQK;TMEM50B;ESYT3;CREB3L2;ERP44;WFS1;IKBIP;IGFBP7;SSR3;MARCH2;REEP6;TMEM173;RNF180;SIGMAR1;SSR1;DNAJC3;PSEN2;ELOVL4;HSD17B12;CDS2;RNF103;REEP3;UFL1;STT3B;RB1CC1
12893,GO:0051234,8.63624004908746e-05,0.999935274802655,343,3428,establishment of localization,BP,FHL1;XDH;EDEM1;TSPAN1;NOS1;F2R;SORL1;RAB3B;CCND1;NEURL1;PCK2;VLDLR;PYGL;ASAP2;SYNE3;CYGB;CYP27B1;SCN8A;PYGB;SERPINE2;PEAR1;PRSS3;PRNP;OSBP2;XPOT;BBS2;POSTN;SH3TC2;NR1D1;HECW2;SLC16A3;MAP2K1;LTBP2;RAPGEF3;ACVR2B;ANTXR2;SH3KBP1;SLC29A4;ALOX15B;LMF1;NAPRT;APLN;POU2F2;PITPNC1;APPL2;MAP1B;DDIT3;KCNG1;HADH;PSMD2;EXOC2;DENND5B;LTA4H;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;ANK3;DYSF;ARHGAP12;FYN;OSBPL10;BNIP3;KIF13B;SLC33A1;UBE2J1;ARAP1;PGM1;DLG1;DLG4;IDH2;CTSB;CD68;SNX9;SLCO4A1;TGM2;GLUL;EVI5L;SLC9A7;WNT7A;IGF2BP3;MAP4K4;SEC23A;STRADB;NME4;ASPH;MCTP1;GDI1;CEMIP;UNC119B;SDC1;ARG2;STOM;DLG3;DKK1;PAK1;RASA3;SOCS2;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;EDNRA;LCN2;SHANK2;SCRN1;RAC2;CLCA2;CD44;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;RGS14;MCFD2;PKD2;LRP1;FYCO1;AKAP9;EHBP1;RAB11FIP4;ANXA3;ATF4;PPARA;ABCA7;ICA1;LPAR3;FAM155B;FGFR1;TUB;SNX14;LPCAT1;ITGA2;VAMP2;LONP2;LTBP4;INPP5F;PFN2;ABCG1;SOX4;PITPNM1;FHOD1;ITPR3;VPS13A;CEP120;CEACAM1;FERMT1;MAPKAPK3;SLC5A1;RAB31;LMAN1;SLC35F2;SARAF;BSG;EPN2;DVL1;CLCN3;NTSR1;ANXA6;NLGN2;MVB12B;ORAI3;LRP5;NIPA1;CST3;COX18;SEC22C;SLC35B4;CNTN1;TRIB3;CLTCL1;PCSK6;TOM1L2;VPS11;MOSPD2;RIMS3;SEC63;PPP3CB;SYTL1;TTYH3;ZDHHC2;APLP2;DNAJC6;COPB1;COPG1;FNBP1L;ANO8;F2RL1;SLC2A9;C6ORF120;ATP10D;SLC6A6;PSMD7;TST;CHD7;SLC25A4;QSOX1;ASAP1;CPT2;ANO1;BOK;FCHO2;SDCCAG3;ATXN2;USP6NL;SPRY2;SEPT5;SLC6A14;TBC1D2B;LMBR1L;NDUFA4L2;SLC43A1;NGFR;PPP1R10;MVB12A;GLUD1;HSPA13;AZIN2;BCL2L1;GRIN3B;GLB1;WASF2;ARF4;YPEL5;CNNM1;SLC12A7;PCYOX1;XBP1;SPIRE1;SLC46A3;UBASH3B;MAP2K2;SLC22A17;ARRDC1;MICU3;SLC38A2;RIN1;TRPC1;STX10;LOXL2;RAB43;OSBPL5;SLC13A3;C5;ZFYVE9;NCKAP1;GABARAPL2;KCNJ15;DNASE1L1;ELMO3;SLC30A1;TMBIM1;SFXN3;CCDC88A;TMED4;PRKACA;TMSB4X;SLC25A30;TIMP2;RAB1A;ZDHHC1;SNX30;SEL1L;BCAP29;AP2A2;SLC39A10;KDELR3;CMTM6;IL1RAP;SLC25A43;ORAI1;CARD11;FCHO1;CTSZ;AP3D1;NIT2;ARPC1A;IGF2;ITPR2;MOAP1;FNBP1;SLC2A13;GRB10;MAP4K2;EFCAB7;ERLEC1;PPARG;SLC10A6;TMEM63A;SNX6;USP20;ANKRD50;LYPLA1;TMEM50B;ATP12A;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;ADAM8;WFS1;ATP11B;ITGA4;WDR60;ACAP2;CKLF;TBC1D16;SSR3;DDHD2;MARCH2;WASL;REEP6;HSPA2;PRSS8;LRP6;SYT2;TMEM173;EEF2K;SLC18A2;SIGMAR1;HPSE;GALNS;SSR1;DNAJC3;FOXP1;ZFYVE21;PSEN2;PTCH1;COG8;LRP3;SNX27;SLC23A2;SLC44A1;LRP4
5311,GO:0016020,8.73228884012782e-05,0.999933238640221,541,5731,membrane,CC,DOCK4;FHL1;NT5E;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;F2R;SORL1;FLNC;ADAM19;ETV5;RAB3B;PGF;MBOAT2;KIAA1549L;CCND1;NEURL1;VLDLR;ASAP2;SYNE3;ITGA6;CYP27B1;SCN8A;PYGB;SERPINE2;PEAR1;ADCY7;PRNP;PAG1;ADGRF1;OSBP2;ITGB4;BBS2;MARCKSL1;SH3TC2;SLC16A3;MAP2K1;CMTM4;TMTC4;FAM210B;RAPGEF3;FNDC4;ACVR2B;ANTXR2;SH3KBP1;SLC29A4;ALOX15B;LMF1;COL13A1;PKN1;DCBLD2;MST1R;MARCH9;MARVELD1;LY6K;TMEM200A;DGKA;TNFSF15;APPL2;SSH1;MAP1B;KCNG1;PTPRS;B4GALT6;HADH;PSMD2;SDK2;EXOC2;SNTB2;CRTC1;ADGRL1;DENND5B;AVL9;CAPN2;FCGRT;SNPH;EGFR;STK39;SEMA4B;ANK3;BCORL1;C2CD2;DYSF;ARHGAP12;ARMCX2;FYN;TNFRSF6B;TMPRSS11D;TSPAN5;PCDHAC2;BNIP3;HLTF;SLC33A1;UBE2J1;UBXN7;ELOVL1;PARVB;MYCBPAP;ARAP1;DLG1;CSMD3;DLG4;B3GNT3;IDH2;TMEM245;CD68;CSMD2;PLXNB3;GPC4;SNX9;TYSND1;PODXL;SLCO4A1;NET1;TGM2;XPC;SLC9A7;HTRA1;GLO1;WNT7A;UBXN4;SPTLC2;WDFY3;SEC23A;TTC7B;GRK5;HTR7;RDH14;NME4;MALL;ASPH;MCTP1;CEMIP;ACAD11;SDC1;STOM;MXRA7;SHC1;DLG3;DKK1;PAK1;RASA3;TMEM154;CEP170;ATXN10;KIAA1549;MRC2;TGFBR2;PTPN3;SLC2A3;B4GALNT4;EDNRA;NUCB2;SHANK2;SLITRK6;SCRN1;EPHA1;RALGAPA2;PLPP6;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCPG1;CCND2;ACP5;KLHDC2;RGS14;MCFD2;PKD2;PRKACB;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;ABTB1;DDN;ANXA3;ATF4;ABCA7;PIGH;ICA1;AGPAT4;LPAR3;ELFN2;FAM155B;FGFR1;ITGA1;AARS;EPCAM;MARCH4;TUB;CMTM7;LPCAT4;TACC1;ITGB5;SNX14;LPCAT1;AIG1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ULK2;FAT1;LONP2;INPP5F;ABCG1;KIAA1109;PITPNM1;FHOD1;ITPR3;VPS13A;FBXO2;KDSR;CEACAM1;FERMT1;GSDMC;SPATA18;PRR9;SLC5A1;PDIA5;RAB31;LMAN1;DMXL2;SLC35F2;SARAF;MRPS6;BSG;SH3D19;EPN2;XRN1;SLC9A3R2;DVL1;CLCN3;NTSR1;MMP14;PLEK2;PLA2G4D;ANXA6;NLGN2;CD46;MVB12B;EPOR;ORAI3;MPDZ;MAP6;LRP5;NIPA1;ABHD17C;TMEM86B;DOCK9;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;NTNG1;PCSK6;SLC35G2;TPBG;VPS11;MOSPD2;RANBP9;DNAJB9;RIMS3;PLPPR2;SEC63;PPP3CB;MYOF;SYTL1;ADGRB2;TTYH3;ZDHHC2;APLP2;COPB1;FAM8A1;COPG1;FNBP1L;ANO8;F2RL1;SLC2A9;GSDMA;PROCR;PLD3;ATP10D;ABHD15;SLC6A6;CSNK2A1;PSMD7;TST;SLC25A4;QSOX1;ASAP1;NDUFV3;CPT2;PRKAR1A;ANO1;FAM84B;OGFRL1;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;USP6NL;SPRY2;SEPT5;SLC6A14;LMBR1L;MGLL;CD99;CYYR1;ACVR1B;DBNDD1;NDUFA4L2;APCDD1L;SLC43A1;COL6A1;NGFR;BPHL;PSKH1;MVB12A;HSPA13;PTPRZ1;AZIN2;BCL2L1;IFITM1;CRAT;GRIN3B;AGPAT3;NYNRIN;SKAP2;ARF4;GOLGA2P5;TMEM187;UAP1;CNNM1;HSD17B7;SLC12A7;PCYOX1;XBP1;SPIRE1;SLC46A3;CADM4;MAP2K2;ABHD6;SLC22A17;ARRDC1;CYP4F22;MICU3;SLC38A2;RIN1;TRPC1;RET;STX10;LOXL2;TCTN1;LMBRD2;RAB43;OSBPL5;SLC13A3;MCTP2;C5;TXNDC11;MTMR4;ZFYVE9;SMIM19;MBOAT7;TM2D2;NCKAP1;GABARAPL2;KCNJ15;SLC35F5;PUM2;SLC30A1;TSPAN3;PSD3;TMBIM1;FAM171A2;SFXN3;CCDC88A;TMED4;SAMD8;SHC2;PRKACA;SLC25A30;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;SNX30;SEL1L;PCDH1;IFI16;RHOBTB1;BCAP29;AP2A2;SRD5A3;SLC39A10;KDELR3;CMTM6;IL1RAP;SLC25A43;ST6GALNAC2;ORAI1;CARD11;FCHO1;LTB4R;FICD;LPAR1;CTSZ;AP3D1;ARID4A;ARPC1A;TENM2;IGF2;NRSN2;TMEM134;ITPR2;MOAP1;FNBP1;AGPAT1;PJA2;SLC2A13;GRB10;MAP4K2;EFCAB7;SLC10A6;TMEM63A;SNX6;EVA1A;GRB7;TRIQK;SRPX2;PPL;GPR153;TMEM50B;ATP12A;SLC7A11;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;ADAM8;AKT3;ROBO3;IL20RB;CLDN11;WFS1;ATP11B;ITGA4;IKBIP;TMEM229B;ACAP2;CKLF;TMEM9;SSR3;DDHD2;MARCH2;FZD8;TMEM107;WASL;USP32;RAPGEFL1;REEP6;HSPA2;PRSS8;FLNB;LRP6;SYT2;PLCH2;TMEM173;RNF180;SLC18A2;SEMA6C;SIGMAR1;HPSE;SSR1;INAFM2;COQ2;OMG;GRAMD1C;ARMCX3;DNAJC3;ZBTB33;ZFYVE21;PSEN2;ELOVL4;DNAJC4;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;SEPT6;COG8;OAS1;TMEM139;RNF103;LRP3;PANK1;REEP3;UFL1;VSIG10L;FAM162A;SNX27;AMACR;CTXN1;SLC23A2;RALGPS2;SLC44A1;GNAI1;LRP4;STT3B;RB1CC1;TMEM42;FADD
10799,GO:0044273,8.81024322062002e-05,0.999985985143472,10,31,sulfur compound catabolic process,BP,CBS;ACOT7;HYAL1;CHAC1;CTH;MLYCD;BLMH;GLB1;PCYOX1;GALNS
3242,GO:0006897,8.87045755184512e-05,0.999951471338168,64,453,endocytosis,BP,TSPAN1;SORL1;VLDLR;PEAR1;SH3KBP1;APLN;WIPF1;RIN2;ARHGAP12;FYN;DLG4;SNX9;TGM2;MCTP1;DKK1;PAK1;MRC2;TGFBR2;RAC2;APOE;LRP1;EHBP1;ANXA3;ABCA7;TUB;ITGA2;INPP5F;CEACAM1;MAPKAPK3;RAB31;EPN2;NLGN2;LRP5;CLTCL1;DNAJC6;FNBP1L;F2RL1;FCHO2;ATXN2;LMBR1L;BCL2L1;WASF2;RIN1;LOXL2;ZFYVE9;NCKAP1;ELMO3;RAB1A;SNX30;AP2A2;FCHO1;ARPC1A;FNBP1;PPARG;SNX6;USP20;ITGA4;MARCH2;WASL;LRP6;SYT2;EEF2K;LRP3;LRP4
4774,GO:0010959,9.23024144581525e-05,0.99996106937782,33,188,regulation of metal ion transport,BP,FHL1;NOS1;F2R;SERPINE2;PRNP;HECW2;KCNG1;STK39;ANK3;FYN;DLG1;CEMIP;STOM;PTPN3;FKBP1A;PKD2;AKAP9;ATF4;LPAR3;VAMP2;SARAF;NTSR1;CNTN1;CHD7;GRIN3B;UBASH3B;TRPC1;SLC30A1;PRKACA;ORAI1;WFS1;HSPA2;PRSS8
3377,GO:0007154,9.54277313334516e-05,0.999927597138234,396,3949,cell communication,BP,TNIP1;DOCK4;DDIT4L;XDH;PLAT;SMURF2;EDEM1;TSPAN1;NOS1;ZMYND8;F2R;SORL1;FAM83A;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;ASAP2;CBS;ITGA6;MMP1;RPS6KA2;CYP27B1;SCN8A;SERPINE2;PEAR1;ADCY7;IGFBP4;PRNP;PAG1;ADGRF1;ITGB4;BBS2;POSTN;SH3TC2;ADM2;NR1D1;NFATC4;ADARB1;MAP2K1;CMTM4;LTBP2;RAPGEF3;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ALOX15B;SALL2;PKN1;WWTR1;DCBLD2;MST1R;ARHGAP22;APLN;PITPNC1;DGKA;TNFSF15;APPL2;EIF4EBP1;SSH1;DDIT3;PTPRS;HADH;PSMD2;ELK3;CRTC1;ADGRL1;BRSK1;FCGRT;WIPF1;SNPH;EGFR;STK39;RIN2;SEMA4B;ANK3;ARHGAP12;FYN;HEBP1;TNFRSF6B;TSPAN5;PCDHAC2;BNIP3;KIF13B;SLC33A1;ERCC6;MAPK13;MYCBPAP;ARAP1;ZNF516;DLG1;DLG4;CTSB;PLXNB3;GPC4;NET1;TGM2;GLUL;HTRA1;WNT7A;MAP4K4;TTBK2;GRK5;HTR7;STRADB;MCTP1;GDI1;SDC1;SHC1;DLG3;DKK1;WISP1;DAP;SMOC2;PAK1;RASA3;SOCS2;TRIB2;RHPN1;MRC2;TGFBR2;PTPN3;EDNRA;LCN2;SHANK2;EPHA1;IMPACT;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;BNIP3L;PTPN12;AFAP1;RGS14;PKD2;PRKACB;RBCK1;LRP1;IDE;AKAP9;HMGA2;ATF4;PPARA;ABCA7;WWC3;ICA1;LPAR3;ASNS;FGFR1;ITGA1;EPCAM;TMOD2;CMTM7;SMOC1;NFAT5;ITGB5;BTRC;ITGA2;PTK6;GALNT3;VAMP2;ULK2;FAT1;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;PFN2;SOX4;PITPNM1;ITPR3;CEACAM1;FERMT1;MAPKAPK3;PDIA5;RAB31;MT2A;UACA;FAM110C;BSG;NLK;EPN2;MDFI;TRIM5;RALGAPA1;TNRC6B;DVL1;NTSR1;MMP14;PLEK2;ANXA6;NLGN2;CD46;MVB12B;EPOR;CTH;NXPH4;LRP5;DNMBP;CTSL;DOCK9;CNTN1;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;TOM1L2;RANBP9;DNAJB9;RIMS3;PLPPR2;SEC63;PPP3CB;MYOF;INPP4A;SYTL1;ADGRB2;APLP2;SLK;CDC42BPA;F2RL1;DDX60;RASIP1;TAOK1;CSNK2A1;PSMD7;PTHLH;CHD7;SLC25A4;ASAP1;PRKAR1A;ANO1;JMY;BOK;PARP9;CPEB4;C18ORF32;MAST3;NACC2;SPRY2;SEPT5;THRA;MGLL;WNT2B;ACVR1B;NGFR;PSKH1;MVB12A;GLUD1;PTPRZ1;NUDT6;MTA1;BCL2L1;IFITM1;RNF165;GRIN3B;WASF2;SKAP2;ARF4;SLC12A7;XBP1;UBASH3B;MAP2K2;ABHD6;SLC22A17;PPP1R2;ARRDC1;TLE4;SLC38A2;RIN1;RET;PDE5A;TCTN1;RAB43;MCTP2;C5;MTMR4;ZFYVE9;NCKAP1;GABARAPL2;EPM2A;DOCK11;PAK6;PUM2;SLC30A1;TSPAN3;PSD3;TMBIM1;COL1A2;CCDC88A;TMED4;SHC2;PRKACA;SAMD5;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RAB1A;SEL1L;PCDH1;IFI16;RHOBTB1;AP2A2;NR2F6;SLC39A10;KDELR3;CMTM6;IL1RAP;CARD11;LTB4R;FICD;LPAR1;TBL1X;ARPC1A;TENM2;IGF2;ITPR2;MOAP1;LAMA5;AGPAT1;PJA2;GRB10;MAP4K2;PPARG;SNX6;USP20;GRB7;ALDH1A2;GPR153;ARHGAP29;TBX1;CREB3L2;ATP6V1B2;RPH3AL;ADAM8;AKT3;ROBO3;IL20RB;WFS1;DEPDC1;ITGA4;ACAP2;MAML3;CKLF;FZD8;WASL;RAPGEFL1;FLNB;LRP6;ARID5B;SYT2;PLCH2;E2F7;SLC18A2;SIGMAR1;HPSE;RALGDS;SSR1;TNRC6C;RCAN1;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;NYAP1;UFL1;FAM162A;ANKRD6;SNX27;SEMA3F;RALGPS2;ADNP;GNAI1;LRP4;RB1CC1;TRIM38;FADD
11889,GO:0046903,9.77802038949267e-05,0.999937101906533,117,994,secretion,BP,XDH;F2R;RAB3B;CCND1;NEURL1;PCK2;PYGL;PYGB;SERPINE2;PRSS3;POSTN;NR1D1;LTBP2;RAPGEF3;ACVR2B;ALOX15B;LMF1;NAPRT;APLN;POU2F2;HADH;PSMD2;EXOC2;LTA4H;BRSK1;SNPH;EGFR;STK39;PGM1;IDH2;CTSB;CD68;GLUL;WNT7A;MAP4K4;MCTP1;SDC1;ARG2;STOM;PAK1;SOCS2;SERPING1;SLC2A3;LCN2;SCRN1;RAC2;CD44;ATP7B;ANXA3;ICA1;FGFR1;LPCAT1;VAMP2;LTBP4;PFN2;SOX4;ITPR3;CEACAM1;FERMT1;RAB31;DVL1;NTSR1;NLGN2;LRP5;CST3;SEC22C;PCSK6;VPS11;MOSPD2;RIMS3;PPP3CB;SYTL1;APLP2;COPB1;COPG1;F2RL1;C6ORF120;PSMD7;CHD7;SLC25A4;QSOX1;ANO1;SEPT5;GLUD1;GLB1;YPEL5;XBP1;SLC38A2;C5;DNASE1L1;SLC30A1;TMBIM1;TMSB4X;TIMP2;RAB1A;SEL1L;AP2A2;CMTM6;IL1RAP;CARD11;CTSZ;NIT2;IGF2;ITPR2;TMEM63A;ERP44;RPH3AL;ADAM8;ATP11B;CKLF;SYT2;TMEM173;SLC18A2;HPSE;GALNS;DNAJC3;FOXP1
716,GO:0001941,0.000106158742739775,0.999987904376295,8,19,postsynaptic membrane organization,BP,ZMYND8;ETV5;SSH1;DLG4;APOE;DVL1;NLGN2;LRP4
14516,GO:0065008,0.000114677520835789,0.999916140469535,251,2384,regulation of biological quality,BP,DOCK4;FHL1;XDH;PLAT;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;RAB3B;CCND1;NEURL1;PCK2;CTNNBIP1;PYGL;SYNE3;CYP27B1;SCN8A;SERPINE2;ADCY7;PRNP;BBS2;POSTN;ADM2;NR1D1;NFATC4;THBS2;FAM210B;TFPI2;RAPGEF3;ACVR2B;LTBP1;SH3KBP1;PKN1;APLN;DGKA;SSH1;MAP1B;DDIT3;PTPRS;HADH;PSMD2;CRTC1;ADGRL1;BRSK1;WIPF1;SNPH;EGFR;STK39;SEMA4B;ANK3;FYN;BNIP3;ERCC6;PARVB;ARAP1;DLG1;DLG4;PLXNB3;SLCO4A1;TGM2;GLUL;SLC9A7;WNT7A;IGF2BP3;MAP4K4;TTBK2;HTR7;RDH14;MALL;CRTAP;ASPH;MCTP1;GDI1;CEMIP;ARG2;DKK1;PAK1;RASA3;SOCS2;RAG1;PTPN3;SERPING1;EDNRA;LCN2;SHANK2;SLITRK6;RAC2;ERO1B;APOE;FKBP1A;BNIP3L;ATP7B;ACP5;ANGPTL4;RGS14;PKD2;PRKACB;IDE;AKAP9;PPARA;ABCA7;ICA1;LPAR3;FAM155B;FGFR1;ITGA1;AARS;TMOD2;TUB;BTRC;LPCAT1;ITGA2;TMX4;VAMP2;ULK2;LTBP4;ATRX;PFN2;ABCG1;SOX4;ITPR3;VPS13A;NELL2;CEACAM1;PDIA5;LMAN1;DMXL2;MT2A;RCOR1;NLK;MDFI;XRN1;DVL1;CLCN3;NTSR1;ANXA6;NLGN2;LRP5;DOCK9;TWF2;PCSK6;TPBG;L3MBTL3;VPS11;WASF3;RIMS3;PPP3CB;MEX3C;SYTL1;ADGRB2;PRDX5;CEBPG;ALDH7A1;F2RL1;PROCR;ATP10D;PSMD7;CHD7;SLC25A4;QSOX1;PRKAR1A;ANO1;JMY;BOK;SEPT5;THRA;ACVR1B;NGFR;PPP1R10;GLUD1;PER3;BCL2L1;GRIN3B;HSD17B7;SLC12A7;XBP1;SPIRE1;UBASH3B;TXNRD3;ABHD6;SLC22A17;PAIP1;TRPC1;RET;SH3PXD2B;TXNDC11;NOP10;NCKAP1;DOCK11;PUM2;SLC30A1;COL1A2;SFXN3;CCSAP;PRKACA;TMSB4X;RAB1A;EPB41L3;SEL1L;RHOBTB1;SRD5A3;SLC39A10;KDELR3;IL1RAP;CARD11;LPAR1;CTSZ;AP3D1;ARID4A;ARPC1A;IGF2;ITPR2;MOAP1;PPARG;SRPX2;ALDH1A2;ATP12A;SLC7A11;ERP44;ATP6V1B2;RPH3AL;ADAM8;AKT3;IL20RB;WFS1;ENDOG;ATP11B;PHF21A;WASL;FLNB;LRP6;SYT2;RNF180;EEF2K;SLC18A2;HPSE;DEDD2;HSD17B12;PTCH1;ADCY1;OAS1;SEMA3F;SLC44A1;ADNP;LRP4;RB1CC1;FBXL5;FADD
1254,GO:0003008,0.000114865003882868,0.999927900672639,102,801,system process,BP,DOCK4;NOS1;F2R;CTNNBIP1;VLDLR;SCN8A;SERPINE2;ADCY7;PRNP;ADGRF1;ACTA2;BBS2;POSTN;ADM2;ADARB1;PKN1;APLN;CRTC1;EGFR;STK39;ANK3;DYSF;FYN;DLG1;DLG4;ESPN;HTR7;ASPH;CEMIP;ARG2;DKK1;PAK1;RAG1;SERPING1;EDNRA;SHANK2;SLITRK6;APOE;FKBP1A;CCND2;RGS14;PRKACB;AKAP9;PPARA;ABCA7;FGFR1;ITGA1;AARS;TMOD2;TUB;NFAT5;ITGB5;ITGA2;INPP5F;MTHFR;ITPR3;GAMT;CEACAM1;OBSL1;SLC5A1;DVL1;NTSR1;ANXA6;NLGN2;LRP5;RABGGTA;WASF3;PPP3CB;MYOF;ALDH7A1;F2RL1;CHD7;PRKAR1A;ANO1;NIPSNAP1;SPRY2;THRA;MGLL;PTPRZ1;ARF4;TRPC1;PDE5A;COL1A2;PRKACA;NR2F6;LAMB2;LTB4R;ZNF354A;CTSZ;TBL1X;ITPR2;PJA2;PPARG;TBX1;WFS1;DDHD2;REEP6;RCAN1;ADCY1;PBX3;JARID2;ADNP
1496,GO:0003841,0.000132045945713299,0.999984449097136,8,19,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2;AGPAT4;LPCAT4;LPCAT1;CRLS1;AGPAT3;MBOAT7;AGPAT1
15812,GO:0072507,0.000149454982613806,0.999931591662761,37,227,divalent inorganic cation homeostasis,BP,NOS1;F2R;CYP27B1;PRNP;DDIT3;EGFR;ANK3;FYN;BNIP3;DLG4;TGM2;CEMIP;RASA3;EDNRA;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;ITPR3;MT2A;NTSR1;ANXA6;F2RL1;CHD7;BOK;UBASH3B;TRPC1;SLC30A1;PRKACA;SLC39A10;LPAR1;AP3D1;ITPR2;WFS1;LRP6
13278,GO:0051965,0.00015010133521729,0.999972013803433,11,33,positive regulation of synapse assembly,BP,THBS2;ADGRL1;WNT7A;SLITRK6;NLGN2;TPBG;ADGRB2;IL1RAP;SRPX2;EEF2K;ADNP
2395,GO:0005539,0.000161692997436154,0.999945259044237,21,103,glycosaminoglycan binding,MF,PGF;SERPINE2;PRNP;POSTN;THBS2;LTBP2;COL13A1;PTPRS;CEMIP;WISP1;SMOC2;TGFBR2;CD44;APOE;FGFR1;LTBP4;THBS3;PCSK6;APLP2;HSD17B12;PTCH1
17035,GO:0099503,0.000163517818020153,0.999903617807956,75,607,secretory vesicle,CC,PLAT;RAB3B;PYGL;PYGB;SERPINE2;PRSS3;THBS2;NAPRT;LY6K;PTPRS;PSMD2;LTA4H;BRSK1;LOXL1;PGM1;DLG4;CTSB;CD68;MCTP1;STOM;SERPING1;SLC2A3;LCN2;CD44;ANXA3;ICA1;ITGA1;LPCAT1;VAMP2;ITPR3;VPS13A;CEACAM1;RAB31;DMXL2;BSG;CLCN3;CD46;CST3;MOSPD2;SYTL1;APLP2;COPB1;C6ORF120;PSMD7;QSOX1;SEPT5;DBNDD1;SPESP1;BCL2L1;GLB1;YPEL5;DNASE1L1;TMBIM1;PRKACA;TMSB4X;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;IGF2;ITPR2;TMEM63A;ERP44;RPH3AL;ADAM8;GARS;ATP11B;SYT2;TMEM173;SLC18A2;HPSE;GALNS;DNAJC3;SEPT6
6764,GO:0030198,0.000175477666413128,0.999919286604809,37,213,extracellular matrix organization,BP,ADAM19;ITGA6;MMP1;ITGB4;POSTN;THBS2;COL13A1;THSD4;LAMB1;CAPN2;LOXL1;HTRA1;SMOC2;ERO1B;CD44;LRP1;ITGA1;ITGB5;ITGA2;FERMT1;BSG;MMP14;THBS3;CTSL;CST3;COL6A1;LOXL2;VWA1;SH3PXD2B;COL1A2;TIMP2;LAMB2;MMP10;LAMA5;ADAM8;ITGA4;HSD17B12
9892,GO:0042171,0.000194286751883721,0.999975233262281,8,20,lysophosphatidic acid acyltransferase activity,MF,MBOAT2;AGPAT4;LPCAT4;LPCAT1;CRLS1;AGPAT3;MBOAT7;AGPAT1
15377,GO:0071617,0.000194286751883721,0.999975233262281,8,20,lysophospholipid acyltransferase activity,MF,MBOAT2;AGPAT4;LPCAT4;LPCAT1;CRLS1;AGPAT3;MBOAT7;AGPAT1
9408,GO:0035966,0.000206339094895918,0.999913907007002,29,174,response to topologically incorrect protein,BP,EDEM1;CCND1;DDIT3;DNAJB5;UBXN4;SHC1;ATF4;ASNS;CHAC1;PDIA5;CTH;GFPT1;DNAJB9;SEC63;BOK;HSPA13;XBP1;EIF2AK2;KDELR3;FICD;CREB3L2;ERP44;WFS1;HSPA2;SSR1;DNAJC3;DNAJC4;KLHL15;STT3B
16619,GO:0097458,0.000229143860200471,0.999849305088197,115,939,neuron part,CC,DOCK4;NOS1;ZMYND8;RAB3B;NEURL1;CYGB;SCN8A;PRNP;OSBP2;BBS2;NR1D1;SH3KBP1;SSH1;MAP1B;PTPRS;CRTC1;ADGRL1;CAPN2;BRSK1;SNPH;ANK3;FYN;BNIP3;KIF13B;DLG1;DLG4;ESPN;GLUL;WNT7A;WDFY3;HTR7;MCTP1;GDI1;DLG3;PAK1;ATXN10;SHANK2;EPHA1;APOE;FKBP1A;RGS14;LRP1;AKAP9;DDN;ANXA3;ATF4;ICA1;LPAR3;KIF21B;ITGA1;TMOD2;SNX14;ITGA2;VAMP2;INPP5F;PFN2;AHCYL2;ITPR3;FBXO2;DMXL2;XRN1;DVL1;CLCN3;NTSR1;NLGN2;MPDZ;MAP6;ABHD17C;TWF2;CST3;RIMS3;SYTL1;DNAJC6;ASAP1;FCHO2;CPEB4;SEPT5;DBNDD1;NGFR;MARK4;AZIN2;BCL2L1;GRIN3B;ARF4;CNNM1;SLC38A2;RET;NAV1;PSD3;CCSAP;TIMP2;EPB41L3;LPAR1;CTSZ;AP3D1;TENM2;NRSN2;PJA2;ROBO3;GARS;WFS1;ENDOG;REEP6;LRP6;SYT2;EEF2K;SLC18A2;SIGMAR1;PSEN2;PTCH1;SEPT6;UFL1;ADNP;LRP4;FADD
17714,GO:1901626,0.000232823695243704,0.999995814156177,4,5,regulation of postsynaptic membrane organization,BP,ZMYND8;SSH1;APOE;LRP4
16670,GO:0097553,0.000247851246050668,0.999925600202301,17,71,calcium ion transmembrane import into cytosol,BP,NOS1;F2R;PRNP;DDIT3;FYN;CEMIP;RASA3;FKBP1A;PKD2;FAM155B;ITPR3;NTSR1;CHD7;UBASH3B;TRPC1;PRKACA;ITPR2
12620,GO:0050804,0.000253258735411866,0.999889730202563,31,182,modulation of chemical synaptic transmission,BP,ZMYND8;F2R;RAB3B;NEURL1;SERPINE2;PRNP;NFATC4;SSH1;CRTC1;EGFR;DLG4;GLUL;WNT7A;MCTP1;DKK1;SHANK2;APOE;RGS14;VAMP2;PFN2;ITPR3;DVL1;NTSR1;NLGN2;RIMS3;PPP3CB;SEPT5;ABHD6;SLC30A1;ADNP;GNAI1
17025,GO:0099177,0.000253258735411866,0.999889730202563,31,182,regulation of trans-synaptic signaling,BP,ZMYND8;F2R;RAB3B;NEURL1;SERPINE2;PRNP;NFATC4;SSH1;CRTC1;EGFR;DLG4;GLUL;WNT7A;MCTP1;DKK1;SHANK2;APOE;RGS14;VAMP2;PFN2;ITPR3;DVL1;NTSR1;NLGN2;RIMS3;PPP3CB;SEPT5;ABHD6;SLC30A1;ADNP;GNAI1
12619,GO:0050803,0.00026407649817463,0.999907313506465,21,101,regulation of synapse structure or activity,BP,ZMYND8;ETV5;NEURL1;PRNP;NFATC4;THBS2;SSH1;ADGRL1;FYN;WNT7A;DKK1;SLITRK6;APOE;NLGN2;TPBG;ADGRB2;IL1RAP;SRPX2;EEF2K;ADNP;LRP4
16875,GO:0098805,0.000280437284210442,0.999808469386789,135,1195,whole membrane,CC,SMURF2;TSPAN1;NOS1;F2R;SORL1;RAB3B;VLDLR;SYNE3;CYP27B1;PRNP;PAG1;FAM210B;ANTXR2;MARCH9;MARVELD1;LY6K;APPL2;PTPRS;SNTB2;CAPN2;EGFR;ARMCX2;FYN;BNIP3;DLG1;DLG4;CD68;PODXL;SLC9A7;WNT7A;WDFY3;SEC23A;RDH14;MALL;MCTP1;CEMIP;STOM;DKK1;TGFBR2;SLC2A3;RAC2;CD44;APOE;BNIP3L;ABCD1;MCFD2;LRP1;RAB11FIP4;ANXA3;ABCA7;ICA1;ITGA1;SNX14;LPCAT1;VAMP2;ULK2;INPP5F;ITPR3;CEACAM1;SPATA18;RAB31;LMAN1;DMXL2;BSG;EPN2;CLCN3;NTSR1;ANXA6;CD46;MVB12B;MAP6;ABHD17C;CNTN1;CLTCL1;VPS11;MOSPD2;MYOF;ZDHHC2;APLP2;COPB1;COPG1;PRKAR1A;BOK;DBNDD1;COL6A1;BPHL;MVB12A;BCL2L1;PCYOX1;MAP2K2;SLC22A17;RET;RAB43;MTMR4;ZFYVE9;GABARAPL2;TMBIM1;PRKACA;RAB1A;AP2A2;CMTM6;CARD11;LTB4R;AP3D1;ITPR2;MOAP1;TMEM63A;SNX6;EVA1A;TMEM50B;ATP6V1B2;RPH3AL;ADAM8;ATP11B;ACAP2;TMEM9;MARCH2;WASL;LRP6;SYT2;TMEM173;SLC18A2;SIGMAR1;HPSE;ARMCX3;ZFYVE21;PSEN2;PTCH1;ADCY1;SNX27;SLC44A1;GNAI1;LRP4;RB1CC1;FADD
18702,GO:1904062,0.000281440871942023,0.99988275872799,28,157,regulation of cation transmembrane transport,BP,FHL1;NOS1;F2R;PRNP;HECW2;KCNG1;STK39;ANK3;FYN;DLG1;DLG4;CEMIP;STOM;PTPN3;SHANK2;FKBP1A;PKD2;AKAP9;VAMP2;NTSR1;NLGN2;CHD7;UBASH3B;TRPC1;SLC30A1;PRKACA;TMSB4X;HSPA2
3751,GO:0008289,0.000288223229261451,0.999835745370603,62,455,lipid binding,MF,EPN3;OSBP2;ALOX15B;PITPNC1;DGKA;DYSF;OSBPL10;ARAP1;SNX9;WDFY3;GRK5;NME4;MCTP1;UNC119B;SHC1;APOE;ZCCHC14;ANXA3;PPARA;LPAR3;TUB;SNX14;VAMP2;PFN2;ABCG1;PITPNM1;ITPR3;GSDMC;EPN2;PLEK2;ANXA6;PHF12;MVB12B;TWF2;MYOF;SYTL1;FNBP1L;GSDMA;ASAP1;FCHO2;MVB12A;OSBPL5;SH3PXD2B;MCTP2;ZFYVE9;CCDC88A;SNX30;AP2A2;LPAR1;ITPR2;FNBP1;PPARG;SNX6;GRB7;ALDH1A2;ESYT3;RPH3AL;ACAP2;HSPA2;SYT2;PTCH1;SNX27
13094,GO:0051604,0.0002919474319534,0.999869155759878,32,209,protein maturation,BP,PLAT;SORL1;SERPINE2;PRSS3;PRNP;LMF1;CAPN2;TSPAN5;TYSND1;ASPH;SERPING1;ERO1B;FKBP1A;PRKACB;LONP2;CHAC1;SOX4;MMP14;CD46;PCSK6;AEBP1;NFU1;C5;IFI16;CTSZ;ADAM8;WFS1;MAGEF1;PSEN2;PTCH1;KAT2B;FADD
2109,GO:0004888,0.000297787165001701,0.999844573139066,47,321,transmembrane signaling receptor activity,MF,F2R;SORL1;VLDLR;ADGRF1;ACVR2B;ANTXR2;LTBP1;MST1R;ADGRL1;FCGRT;EGFR;TNFRSF6B;PLXNB3;HTR7;MRC2;TGFBR2;EDNRA;EPHA1;CD44;ABCA7;LPAR3;FGFR1;ITGA2;LTBP4;NTSR1;EPOR;LRP5;ADGRB2;F2RL1;ACVR1B;NGFR;PTPRZ1;GRIN3B;SLC22A17;RET;IL1RAP;LTB4R;LPAR1;PPARG;GPR153;IL20RB;FZD8;LRP6;SIGMAR1;ELOVL4;PTCH1;LRP4
16177,GO:0090195,0.000307673570933234,0.999982660455283,5,9,chemokine secretion,BP,POSTN;ALOX15B;F2RL1;C5;FOXP1
17255,GO:0120035,0.000313607600623215,0.999821762476808,61,429,regulation of plasma membrane bounded cell projection organization,BP,ZMYND8;NEURL1;VLDLR;PRNP;HECW2;NFATC4;MAP2K1;SSH1;MAP1B;PTPRS;CRTC1;SEMA4B;FYN;KIF13B;ARAP1;CSMD3;DLG4;PLXNB3;PODXL;ESPN;EVI5L;WNT7A;MAP4K4;GDI1;PAK1;SHANK2;RAC2;CD44;APOE;LRP1;LPAR3;FGFR1;PTK6;ULK2;INPP5F;PFN2;CEP120;OBSL1;DVL1;TWF2;CNTN1;FNBP1L;F2RL1;ASAP1;NGFR;WASF2;RET;NCKAP1;DOCK11;CCDC88A;IL1RAP;LPAR1;CTSZ;TENM2;WASL;SYT2;EEF2K;OMG;SEMA3F;ADNP;LRP4
9614,GO:0036477,0.000319197911305539,0.999814831388189,65,474,somatodendritic compartment,CC,NOS1;ZMYND8;NEURL1;CYGB;PRNP;OSBP2;NR1D1;MAP1B;PTPRS;CRTC1;CAPN2;SNPH;ANK3;FYN;BNIP3;KIF13B;DLG4;GLUL;WDFY3;HTR7;GDI1;DLG3;PAK1;ATXN10;SHANK2;APOE;RGS14;LRP1;AKAP9;DDN;ANXA3;ATF4;KIF21B;ITGA1;SNX14;INPP5F;ITPR3;FBXO2;XRN1;DVL1;NTSR1;MPDZ;MAP6;ABHD17C;CST3;ASAP1;CPEB4;AZIN2;GRIN3B;ARF4;CNNM1;SLC38A2;RET;TIMP2;LPAR1;TENM2;NRSN2;WFS1;ENDOG;LRP6;EEF2K;PSEN2;PTCH1;ADNP;LRP4
11105,GO:0045121,0.000319262117286484,0.999854819389942,33,200,membrane raft,CC,SMURF2;NOS1;F2R;PRNP;PAG1;MARVELD1;LY6K;CAPN2;EGFR;FYN;DLG1;PODXL;MALL;STOM;TGFBR2;ITGA1;BSG;NTSR1;CNTN1;MYOF;PRKAR1A;RET;PRKACA;CARD11;LTB4R;LRP6;HPSE;PSEN2;PTCH1;ADCY1;GNAI1;LRP4;FADD
12894,GO:0051235,0.000323145037901612,0.999847458267664,36,220,maintenance of location,BP,NOS1;F2R;SORL1;SYNE3;LTBP1;DDIT3;ANK3;CEMIP;RASA3;APOE;FKBP1A;ATP7B;PKD2;AKAP9;PPARA;ABCG1;SOX4;ITPR3;VPS13A;MDFI;NTSR1;TWF2;CHD7;THRA;UBASH3B;TRPC1;SLC30A1;PRKACA;TMSB4X;EPB41L3;KDELR3;AP3D1;ITPR2;PPARG;FLNB;SLC18A2
16779,GO:0098589,0.00034328123914707,0.999841149907451,34,208,membrane region,CC,SMURF2;NOS1;F2R;PRNP;PAG1;MARVELD1;LY6K;CAPN2;EGFR;FYN;DLG1;PODXL;MALL;STOM;TGFBR2;ITGA1;BSG;NTSR1;CD46;CNTN1;MYOF;PRKAR1A;RET;PRKACA;CARD11;LTB4R;LRP6;HPSE;PSEN2;PTCH1;ADCY1;GNAI1;LRP4;FADD
17258,GO:0120039,0.000345504428948167,0.999800293488937,64,443,plasma membrane bounded cell projection morphogenesis,BP,VLDLR;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;BRSK1;EGFR;SEMA4B;ANK3;FYN;KIF13B;DLG4;PLXNB3;WNT7A;MAP4K4;GDI1;SHC1;PAK1;SHANK2;SLITRK6;IMPACT;RAC2;CD44;APOE;LPAR3;ITGA1;ULK2;OBSL1;DVL1;MAP6;TWF2;NTNG1;RANBP9;BTBD3;PPP3CB;NGFR;PTPRZ1;RNF165;WASF2;RET;TCTN1;NCKAP1;ETV1;EPB41L3;LAMB2;GRB10;GRB7;ROBO3;WASL;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;NYAP1;SEMA3F;ADNP;LRP4
3568,GO:0007611,0.000348647000696481,0.999861262422022,25,133,learning or memory,BP,VLDLR;PRNP;ADGRF1;CRTC1;EGFR;FYN;DLG4;DKK1;RAG1;SHANK2;APOE;CCND2;RGS14;ABCA7;TMOD2;ITPR3;NTSR1;PPP3CB;THRA;PTPRZ1;ARF4;PJA2;DDHD2;ADCY1;ADNP
16904,GO:0098857,0.000353051598065266,0.999838447038764,33,201,membrane microdomain,CC,SMURF2;NOS1;F2R;PRNP;PAG1;MARVELD1;LY6K;CAPN2;EGFR;FYN;DLG1;PODXL;MALL;STOM;TGFBR2;ITGA1;BSG;NTSR1;CNTN1;MYOF;PRKAR1A;RET;PRKACA;CARD11;LTB4R;LRP6;HPSE;PSEN2;PTCH1;ADCY1;GNAI1;LRP4;FADD
12413,GO:0048858,0.000362055655370629,0.999790316388996,64,444,cell projection morphogenesis,BP,VLDLR;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;BRSK1;EGFR;SEMA4B;ANK3;FYN;KIF13B;DLG4;PLXNB3;WNT7A;MAP4K4;GDI1;SHC1;PAK1;SHANK2;SLITRK6;IMPACT;RAC2;CD44;APOE;LPAR3;ITGA1;ULK2;OBSL1;DVL1;MAP6;TWF2;NTNG1;RANBP9;BTBD3;PPP3CB;NGFR;PTPRZ1;RNF165;WASF2;RET;TCTN1;NCKAP1;ETV1;EPB41L3;LAMB2;GRB10;GRB7;ROBO3;WASL;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;NYAP1;SEMA3F;ADNP;LRP4
11435,GO:0045860,0.000363230171290032,0.999801809876638,52,370,positive regulation of protein kinase activity,BP,F2R;CCND1;NEURL1;VLDLR;ADCY7;PRNP;MAP2K1;ACVR2B;PKN1;MST1R;TNFSF15;EGFR;STK39;ERCC6;DLG1;DLG4;SNX9;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;TGFBR2;CCND2;PKD2;PRKACB;LPAR3;FGFR1;ITGA1;MAPKAPK3;ETAA1;SLK;TAOK1;PRKAR1A;SPRY2;MAP2K2;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;EIF2AK2;LPAR1;IGF2;MAP4K2;ADAM8;FZD8;ADCY1;ADNP
12683,GO:0050896,0.000372831635720433,0.999707248010901,522,5524,response to stimulus,BP,TNIP1;DOCK4;DDIT4L;XDH;NT5E;PLAT;SMURF2;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FAM83A;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;CBS;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;PYGB;SERPINE2;PEAR1;PRSS3;ADCY7;IGFBP4;PRNP;PAG1;ADGRF1;MXRA5;ITGB4;ACTA2;BBS2;POSTN;SH3TC2;ADM2;BTBD2;NR1D1;NFATC4;ADARB1;MAP2K1;CMTM4;FAM210B;TFPI2;LTBP2;RAPGEF3;FNDC4;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ALOX15B;SALL2;GPX3;PKN1;NAPRT;WWTR1;DCBLD2;MST1R;ARHGAP22;APLN;POU2F2;PITPNC1;DGKA;TNFSF15;APPL2;EIF4EBP1;SSH1;DDIT3;PTPRS;HADH;PSMD2;ELK3;CRTC1;ADGRL1;DENND5B;LTA4H;CAPN2;BRSK1;FCGRT;WIPF1;EGFR;STK39;RIN2;SEMA4B;ANK3;DYSF;LOXL1;ARHGAP12;PPP1R14A;FYN;HEBP1;TNFRSF6B;TSPAN5;BNIP3;KIF13B;SLC33A1;ERCC6;UBE2J1;MAPK13;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;DLG4;CTSB;CD68;DNAJB5;PLXNB3;GPC4;NET1;TGM2;XPC;GLUL;HTRA1;WNT7A;UBXN4;MAP4K4;TTBK2;GRK5;HTR7;STRADB;MCTP1;GDI1;SDC1;ARG2;STOM;SHC1;DKK1;WISP1;DAP;SMOC2;PAK1;RASA3;SOCS2;TRIB2;RHPN1;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;EDNRA;LCN2;SHANK2;SLITRK6;EPHA1;IMPACT;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;CCND2;ACP5;ANGPTL4;PTPN12;AFAP1;RGS14;PKD2;PRKACB;RBCK1;LRP1;LDHA;IDE;AKAP9;ABTB1;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;LPAR3;ASNS;FGFR1;ITGA1;EPCAM;TMOD2;TUB;CMTM7;UROS;SMOC1;NFAT5;ITGB5;HYAL1;BTRC;LPCAT1;ITGA2;PTK6;GALNT3;TMX4;VAMP2;ULK2;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;MTHFR;ABCG1;SOX4;PITPNM1;APOBEC3C;ITPR3;FBXO2;DDB2;ENDOV;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;PDIA5;RAB31;LMAN1;MT2A;UACA;FAM110C;RCOR1;BSG;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;PLEK2;ANXA6;NLGN2;CD46;MVB12B;EPOR;CTH;NXPH4;LRP5;ETAA1;DNMBP;CTSL;DOCK9;TWF2;CST3;CNTN1;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;TOM1L2;MOSPD2;RANBP9;DNAJB9;BTBD3;PLPPR2;SEC63;PPP3CB;MYOF;INPP4A;RFX2;ADGRB2;APLP2;COPB1;SLK;PRDX5;MLYCD;CEBPG;CDC42BPA;F2RL1;DDX60;RASIP1;GSDMA;PROCR;C6ORF120;TAOK1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;BLMH;SLC25A4;QSOX1;ASAP1;PRKAR1A;ANO1;MSRB2;JMY;CRLS1;BOK;PARP9;CPEB4;C18ORF32;MAST3;NACC2;SPRY2;SLC6A14;THRA;MGLL;CD99;WNT2B;ACVR1B;COL6A1;NGFR;BPHL;PPP1R10;PSKH1;MVB12A;HSPA13;PTPRZ1;CHD6;NUDT6;PER3;MTA1;BCL2L1;IFITM1;RNF165;YTHDC2;GRIN3B;GLB1;WASF2;SKAP2;ARF4;POLL;YPEL5;HSD17B7;XBP1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SATB1;SLC22A17;PPP1R2;ARRDC1;REC8;TLE4;SLC38A2;RIN1;TRPC1;RET;LOXL2;PDE5A;VWA1;TCTN1;RAB43;MLH3;SLC13A3;MCTP2;C5;TXNDC11;MTMR4;ZFYVE9;NCKAP1;GABARAPL2;EPM2A;RMRP;DNASE1L1;DOCK11;PAK6;PUM2;SLC30A1;TSPAN3;RNF135;PSD3;TMBIM1;ETV1;COL1A2;CCDC88A;TMED4;SHC2;PRKACA;SAMD5;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RAB1A;EEPD1;SEL1L;IFI16;RHOBTB1;AP2A2;NR2F6;SLC39A10;KDELR3;CMTM6;IL1RAP;ORAI1;CARD11;LAMB2;LTB4R;FICD;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;AP3D1;NIT2;ARPC1A;TENM2;IGF2;ITPR2;MOAP1;LAMA5;AGPAT1;PJA2;GRB10;MAP4K2;ERLEC1;PPARG;TMEM63A;CITED4;SNX6;USP20;GRB7;PPL;ALDH1A2;GPR153;ARHGAP29;TBX1;SLC7A11;CREB3L2;ERP44;ATP6V1B2;RPH3AL;ADAM8;AKT3;ROBO3;IL20RB;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;IKBIP;PHF21A;ZBTB40;ACAP2;MAML3;CKLF;IGFBP7;DDHD2;FZD8;WASL;RAPGEFL1;REEP6;HSPA2;FLNB;LRP6;ARID5B;MAGEF1;PLCH2;TMEM173;E2F7;EEF2K;SLC18A2;SEMA6C;SIGMAR1;HPSE;GALNS;RALGDS;SSR1;TNRC6C;RCAN1;ZC3H7A;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;ELOVL4;DNAJC4;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;RNF103;USP25;NYAP1;UFL1;FAM162A;ANKRD6;SNX27;JARID2;SLC23A2;SEMA3F;RALGPS2;KLHL15;ADNP;GNAI1;LRP4;STT3B;RB1CC1;DNMT3A;TRIM38;FADD
7336,GO:0031346,0.000382728107851738,0.999808029682457,41,257,positive regulation of cell projection organization,BP,ZMYND8;NEURL1;VLDLR;MAP2K1;MAP1B;CRTC1;FYN;ARAP1;DLG4;PLXNB3;ESPN;GDI1;PAK1;SHANK2;RAC2;APOE;LPAR3;FGFR1;ITGA2;PTK6;CEP120;OBSL1;DVL1;PLEK2;TWF2;CNTN1;FNBP1L;F2RL1;NGFR;WASF2;RET;NCKAP1;DOCK11;CCDC88A;IL1RAP;LPAR1;TENM2;WASL;SYT2;EEF2K;ADNP
9665,GO:0038023,0.000390539230372896,0.999783774777078,54,385,signaling receptor activity,MF,F2R;SORL1;VLDLR;ADGRF1;NR1D1;ACVR2B;ANTXR2;LTBP1;MST1R;ADGRL1;FCGRT;EGFR;TNFRSF6B;PLXNB3;GPC4;HTR7;MRC2;TGFBR2;EDNRA;EPHA1;CD44;PPARA;ABCA7;LPAR3;FGFR1;ITGA2;LTBP4;TRIM5;NTSR1;EPOR;LRP5;ADGRB2;F2RL1;THRA;ACVR1B;NGFR;PTPRZ1;GRIN3B;SLC22A17;RET;NR2F6;IL1RAP;LTB4R;LPAR1;PPARG;GPR153;IL20RB;ITGA4;FZD8;LRP6;SIGMAR1;ELOVL4;PTCH1;LRP4
13617,GO:0060089,0.000390539230372896,0.999783774777078,54,385,molecular transducer activity,MF,F2R;SORL1;VLDLR;ADGRF1;NR1D1;ACVR2B;ANTXR2;LTBP1;MST1R;ADGRL1;FCGRT;EGFR;TNFRSF6B;PLXNB3;GPC4;HTR7;MRC2;TGFBR2;EDNRA;EPHA1;CD44;PPARA;ABCA7;LPAR3;FGFR1;ITGA2;LTBP4;TRIM5;NTSR1;EPOR;LRP5;ADGRB2;F2RL1;THRA;ACVR1B;NGFR;PTPRZ1;GRIN3B;SLC22A17;RET;NR2F6;IL1RAP;LTB4R;LPAR1;PPARG;GPR153;IL20RB;ITGA4;FZD8;LRP6;SIGMAR1;ELOVL4;PTCH1;LRP4
13621,GO:0060099,0.00040915535740879,0.999991410668391,4,5,regulation of phagocytosis, engulfment,BP,ABCA7;ITGA2;F2RL1;PPARG
13622,GO:0060100,0.00040915535740879,0.999991410668391,4,5,positive regulation of phagocytosis, engulfment,BP,ABCA7;ITGA2;F2RL1;PPARG
19150,GO:1905155,0.00040915535740879,0.999991410668391,4,5,positive regulation of membrane invagination,BP,ABCA7;ITGA2;F2RL1;PPARG
3388,GO:0007165,0.000410383051463622,0.99968142738647,364,3663,signal transduction,BP,TNIP1;DOCK4;DDIT4L;XDH;PLAT;SMURF2;EDEM1;TSPAN1;NOS1;ZMYND8;F2R;SORL1;FAM83A;RAB3B;PGF;CCND1;NEURL1;SH2D2A;CTNNBIP1;VLDLR;ASAP2;ITGA6;MMP1;RPS6KA2;CYP27B1;SERPINE2;PEAR1;ADCY7;IGFBP4;PRNP;PAG1;ADGRF1;ITGB4;BBS2;POSTN;SH3TC2;ADM2;NR1D1;NFATC4;MAP2K1;CMTM4;LTBP2;RAPGEF3;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ALOX15B;SALL2;PKN1;WWTR1;DCBLD2;MST1R;ARHGAP22;APLN;PITPNC1;DGKA;TNFSF15;APPL2;EIF4EBP1;SSH1;DDIT3;PTPRS;PSMD2;ELK3;ADGRL1;BRSK1;FCGRT;WIPF1;EGFR;STK39;RIN2;SEMA4B;ANK3;ARHGAP12;FYN;HEBP1;TNFRSF6B;TSPAN5;BNIP3;KIF13B;SLC33A1;ERCC6;MAPK13;ARAP1;ZNF516;DLG1;DLG4;CTSB;PLXNB3;GPC4;NET1;TGM2;HTRA1;WNT7A;MAP4K4;TTBK2;GRK5;HTR7;STRADB;MCTP1;GDI1;SDC1;SHC1;DKK1;WISP1;DAP;SMOC2;PAK1;RASA3;SOCS2;TRIB2;RHPN1;MRC2;TGFBR2;PTPN3;EDNRA;LCN2;SHANK2;EPHA1;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;BNIP3L;PTPN12;AFAP1;RGS14;PKD2;PRKACB;RBCK1;LRP1;IDE;AKAP9;ATF4;PPARA;ABCA7;WWC3;LPAR3;ASNS;FGFR1;ITGA1;EPCAM;TMOD2;CMTM7;SMOC1;NFAT5;ITGB5;BTRC;ITGA2;PTK6;GALNT3;ULK2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;SOX4;PITPNM1;ITPR3;CEACAM1;FERMT1;MAPKAPK3;PDIA5;RAB31;MT2A;UACA;FAM110C;BSG;NLK;EPN2;MDFI;TRIM5;RALGAPA1;TNRC6B;DVL1;NTSR1;MMP14;PLEK2;ANXA6;NLGN2;CD46;MVB12B;EPOR;CTH;NXPH4;LRP5;DNMBP;CTSL;DOCK9;CNTN1;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;TOM1L2;RANBP9;DNAJB9;PLPPR2;SEC63;PPP3CB;MYOF;INPP4A;ADGRB2;APLP2;SLK;CDC42BPA;F2RL1;DDX60;RASIP1;TAOK1;CSNK2A1;PSMD7;PTHLH;ASAP1;PRKAR1A;ANO1;JMY;BOK;PARP9;CPEB4;C18ORF32;MAST3;NACC2;SPRY2;THRA;MGLL;WNT2B;ACVR1B;NGFR;PSKH1;MVB12A;PTPRZ1;NUDT6;MTA1;BCL2L1;IFITM1;RNF165;GRIN3B;WASF2;SKAP2;ARF4;XBP1;UBASH3B;MAP2K2;ABHD6;SLC22A17;PPP1R2;ARRDC1;TLE4;RIN1;RET;PDE5A;TCTN1;RAB43;MCTP2;C5;MTMR4;ZFYVE9;NCKAP1;EPM2A;DOCK11;PAK6;PUM2;TSPAN3;PSD3;TMBIM1;COL1A2;CCDC88A;TMED4;SHC2;PRKACA;SAMD5;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RAB1A;SEL1L;IFI16;RHOBTB1;AP2A2;NR2F6;SLC39A10;KDELR3;CMTM6;IL1RAP;CARD11;LTB4R;FICD;LPAR1;TBL1X;ARPC1A;TENM2;IGF2;ITPR2;MOAP1;LAMA5;AGPAT1;PJA2;GRB10;MAP4K2;PPARG;SNX6;USP20;GRB7;ALDH1A2;GPR153;ARHGAP29;TBX1;CREB3L2;ATP6V1B2;RPH3AL;ADAM8;AKT3;ROBO3;IL20RB;WFS1;DEPDC1;ITGA4;ACAP2;MAML3;CKLF;FZD8;WASL;RAPGEFL1;FLNB;LRP6;ARID5B;PLCH2;E2F7;SIGMAR1;HPSE;RALGDS;SSR1;TNRC6C;RCAN1;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;NYAP1;UFL1;FAM162A;ANKRD6;SNX27;SEMA3F;RALGPS2;GNAI1;LRP4;RB1CC1;TRIM38;FADD
11134,GO:0045178,0.000425204940819164,0.999908175010207,11,36,basal part of cell,CC,ITGA6;MST1R;EGFR;ANK3;CLCA2;PKD2;ITGA1;ITGA2;CEACAM1;CLDN11;SLC23A2
3499,GO:0007399,0.000447661014166572,0.999679339641924,169,1469,nervous system development,BP,NOS1;ZMYND8;SORL1;ETV5;NEURL1;VLDLR;SCN8A;SERPINE2;ADGRF1;BBS2;POSTN;SH3TC2;BTBD2;HECW2;NFATC4;ADARB1;MAP2K1;THBS2;SH3KBP1;SALL2;MARVELD1;SSH1;MAP1B;PTPRS;SMARCA1;SOX12;LAMB1;SDK2;CRTC1;ADGRL1;BRSK1;SNPH;EGFR;SEMA4B;ANK3;FYN;PCDHAC2;BNIP3;KIF13B;DLG1;CSMD3;DLG4;IDH2;PLXNB3;WNT7A;MAP4K4;TTBK2;MALL;GDI1;UNC119B;SHC1;DLG3;DKK1;PAK1;SOCS2;ATXN10;TGFBR2;EDNRA;SHANK2;SLITRK6;IMPACT;RAC2;APOE;RGS14;PKD2;PRKACB;SRGAP2B;LRP1;ANXA3;LPAR3;FGFR1;ITGA1;AARS;TMOD2;TACC1;PTK6;ULK2;INPP5F;CHAC1;ATRX;SOX4;PITPNM1;VPS13A;CEP120;OBSL1;DVL1;MMP14;NLGN2;EPOR;MAP6;TWF2;CST3;CNTN1;NTNG1;TPBG;RANBP9;WASF3;BTBD3;PPP3CB;ADGRB2;PLAG1;TAOK1;CSNK2A1;CHD7;ASAP1;BOK;THRA;WNT2B;ACVR1B;DBNDD1;NGFR;GLUD1;MARK4;PTPRZ1;RNF165;MEF2D;ARF4;XBP1;SLC38A2;RET;TCTN1;NAV1;MBOAT7;NCKAP1;ETV1;CCDC88A;CCSAP;TIMP2;EPB41L3;PCDH1;NR2F6;IL1RAP;LAMB2;LPAR1;CTSZ;HOXA3;TENM2;GRB10;PPARG;GRB7;SRPX2;ALDH1A2;TBX1;SLC7A11;AKT3;ROBO3;CLDN11;FZD8;TMEM107;WASL;RAPGEFL1;LRP6;SYT2;EEF2K;SEMA6C;SIGMAR1;RCAN1;OMG;PTCH1;ADCY1;RNF103;NYAP1;UFL1;PBX3;JARID2;SEMA3F;ADNP;LRP4;DNMT3A
3462,GO:0007275,0.000470887183881285,0.999635488751575,337,3304,multicellular organism development,BP,FHL1;XDH;SMURF2;NOS1;ERCC1;ZMYND8;SORL1;ADAM19;ETV5;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;ITGA6;CYP27B1;SCN8A;SERPINE2;IGFBP4;ADGRF1;ITGB4;ACTA2;BBS2;POSTN;SH3TC2;ADM2;BTBD2;NR1D1;HECW2;NFATC4;ADARB1;MAP2K1;THBS2;FAM210B;RAPGEF3;ACVR2B;LTBP1;SH3KBP1;ALOX15B;SALL2;COL13A1;PKN1;WWTR1;MST1R;ARHGAP22;MICALCL;APLN;MARVELD1;POU2F2;DHTKD1;TEF;SSH1;MAP1B;DDIT3;PTPRS;SMARCA1;SOX12;PSMD2;LAMB1;SDK2;ELK3;CRTC1;ADGRL1;CAPN2;BRSK1;SNPH;EGFR;SEMA4B;ANK3;LOXL1;FYN;MYH15;TNFRSF6B;PCDHAC2;BNIP3;KIF13B;SCMH1;MYCBPAP;ADAMTS7;ZNF516;DLG1;CSMD3;DLG4;IDH2;CTSB;PLXNB3;GPC4;PODXL;TGM2;HTRA1;GLO1;WNT7A;MAP4K4;TTBK2;WDFY3;MALL;ASPH;GDI1;UNC119B;SDC1;ARG2;SHC1;DLG3;DKK1;PAK1;SOCS2;ATXN10;RAG1;TGFBR2;PTPN3;EDNRA;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;OBSCN;APOE;FKBP1A;ATP7B;ACP5;ANGPTL4;PRR15;RGS14;PKD2;PRKACB;SRGAP2B;LRP1;LDHA;IDE;RAB11FIP4;ANXA3;HMGA2;PPARA;LPAR3;ASNS;FGFR1;ITGA1;AARS;E2F5;EPCAM;TMOD2;TUB;CMTM7;TACC1;TCFL5;SMOC1;ITGB5;HYAL1;BTRC;LPCAT1;ITGA2;PTK6;ULK2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;KIAA1109;SOX4;PITPNM1;VPS13A;GAMT;CEP120;CEACAM1;FERMT1;OBSL1;PRR9;BSG;EPN2;MDFI;TNRC6B;DVL1;MMP14;NLGN2;CD46;EPOR;CTH;MAP6;LRP5;ZMYM3;THBS3;CTSL;TWF2;CST3;CNTN1;NTNG1;PCSK6;TPBG;L3MBTL3;RANBP9;WASF3;DNAJB9;BTBD3;SEC63;PPP3CB;MEX3C;ADGRB2;CEBPG;PLAG1;TTC9;F2RL1;RASIP1;TAOK1;PHC3;AEBP1;CSNK2A1;PSMD7;PTHLH;CHD7;ASAP1;PRKAR1A;ANO1;BOK;SPRY2;THRA;WNT2B;ACVR1B;DBNDD1;COL6A1;NGFR;PSKH1;GLUD1;TSHZ1;MARK4;PTPRZ1;SPESP1;BCL2L1;RNF165;MEF2D;WASF2;ARF4;POLL;XBP1;UBASH3B;TXNRD3;SATB1;REC8;SLC38A2;RET;SPATA6;LOXL2;TCTN1;NAV1;SH3PXD2B;MCTP2;C5;MBOAT7;NCKAP1;GTF2IRD2;DOCK11;SLC30A1;ETV1;COL1A2;CCDC88A;CCSAP;TIMP2;EIF2AK2;EPB41L3;PCDH1;IFI16;AP2A2;NR2F6;IL1RAP;CARD11;LAMB2;LPAR1;ZNF354A;CTSZ;HOXA3;AP3D1;ARID4A;TENM2;IGF2;LAMA5;GRB10;ZMYM2;PPARG;GRB7;SRPX2;PPL;ALDH1A2;TBX1;SLC7A11;EVI5;CREB3L2;ADAM8;AKT3;ROBO3;CLDN11;WFS1;ENDOG;ITGA4;ZBTB40;WDR60;ZNF568;IGFBP7;FZD8;TMEM107;WASL;RAPGEFL1;PRSS8;FLNB;LRP6;ARID5B;SYT2;E2F7;EEF2K;SLC18A2;SEMA6C;SIGMAR1;HPSE;TNRC6C;RCAN1;TET1;OMG;FOXP1;PTCH1;ADCY1;KAT2B;RNF103;NYAP1;UFL1;ANKRD6;PBX3;JARID2;SEMA3F;ADNP;LRP4;RB1CC1;DNMT3A;FADD
12389,GO:0048812,0.000484763454638472,0.999718131307615,62,431,neuron projection morphogenesis,BP,VLDLR;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;BRSK1;EGFR;SEMA4B;ANK3;FYN;KIF13B;DLG4;PLXNB3;WNT7A;MAP4K4;GDI1;SHC1;PAK1;SHANK2;SLITRK6;IMPACT;RAC2;APOE;LPAR3;ITGA1;ULK2;OBSL1;DVL1;MAP6;TWF2;NTNG1;RANBP9;BTBD3;PPP3CB;NGFR;PTPRZ1;RNF165;RET;TCTN1;NCKAP1;ETV1;EPB41L3;LAMB2;GRB10;GRB7;ROBO3;WASL;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;NYAP1;SEMA3F;ADNP;LRP4
13514,GO:0055085,0.000485319308593543,0.999680637524825,102,869,transmembrane transport,BP,FHL1;NOS1;F2R;SCN8A;PRNP;HECW2;SLC16A3;SLC29A4;DDIT3;KCNG1;PSMD2;DENND5B;STK39;ANK3;FYN;SLC33A1;DLG1;DLG4;SLCO4A1;SLC9A7;ASPH;CEMIP;STOM;DLG3;PAK1;RASA3;PTPN3;SLC2A3;EDNRA;SHANK2;CLCA2;FKBP1A;ATP7B;ABCD1;PKD2;AKAP9;ABCA7;FAM155B;VAMP2;ABCG1;ITPR3;SLC5A1;SLC35F2;CLCN3;NTSR1;ANXA6;NLGN2;ORAI3;NIPA1;SLC35B4;TRIB3;CLTCL1;SEC63;TTYH3;ANO8;SLC2A9;ATP10D;SLC6A6;PSMD7;TST;CHD7;SLC25A4;CPT2;ANO1;SLC6A14;NDUFA4L2;SLC43A1;NGFR;AZIN2;GRIN3B;SLC12A7;PCYOX1;SLC46A3;UBASH3B;SLC22A17;MICU3;SLC38A2;TRPC1;SLC13A3;KCNJ15;SLC30A1;SFXN3;PRKACA;TMSB4X;SLC25A30;SEL1L;SLC39A10;SLC25A43;ORAI1;ITPR2;SLC2A13;GRB10;ERLEC1;SLC10A6;ATP12A;SLC7A11;ATP6V1B2;ATP11B;HSPA2;SLC18A2;SLC23A2;SLC44A1
12411,GO:0048856,0.000489785851862108,0.999618596346767,364,3611,anatomical structure development,BP,FHL1;XDH;SMURF2;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;ADAM19;ETV5;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;SYNE3;ITGA6;CYP27B1;SCN8A;SERPINE2;IGFBP4;ADGRF1;OSBP2;ITGB4;ACTA2;BBS2;POSTN;SH3TC2;ADM2;BTBD2;NR1D1;HECW2;NFATC4;ADARB1;MAP2K1;THBS2;FAM210B;FMNL2;RAPGEF3;ACVR2B;LTBP1;SH3KBP1;ALOX15B;SALL2;COL13A1;PKN1;WWTR1;MST1R;ARHGAP22;MICALCL;APLN;MARVELD1;POU2F2;DHTKD1;TEF;SSH1;MAP1B;DDIT3;PTPRS;SMARCA1;SOX12;PSMD2;LAMB1;SDK2;ELK3;CRTC1;ADGRL1;CAPN2;BRSK1;WIPF1;SNPH;EGFR;SEMA4B;ANK3;LOXL1;ARHGAP12;FYN;MYH15;TNFRSF6B;PCDHAC2;BNIP3;KIF13B;SCMH1;UBE2J1;PARVB;MYCBPAP;ARAP1;ADAMTS7;ZNF516;DLG1;CSMD3;DLG4;IDH2;CTSB;PLXNB3;GPC4;PODXL;NET1;TGM2;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;TTBK2;WDFY3;STRADB;MALL;ASPH;GDI1;UNC119B;SDC1;ARG2;SHC1;DLG3;DKK1;PAK1;SOCS2;ATXN10;RAG1;TGFBR2;PTPN3;EDNRA;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;OBSCN;APOE;FKBP1A;ATP7B;ACP5;ANGPTL4;PRR15;PTPN12;RGS14;PKD2;PRKACB;SRGAP2B;LRP1;LDHA;IDE;RAB11FIP4;ANXA3;HMGA2;PPARA;LPAR3;ASNS;FGFR1;ITGA1;AARS;E2F5;EPCAM;TMOD2;TUB;CMTM7;TACC1;TCFL5;SMOC1;ITGB5;HYAL1;BTRC;LPCAT1;ITGA2;PTK6;ULK2;FAT1;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;KIAA1109;SOX4;PITPNM1;VPS13A;GAMT;CEP120;CEACAM1;FERMT1;OBSL1;PRR9;BSG;SH3D19;EPN2;MDFI;TNRC6B;DVL1;MMP14;NLGN2;CD46;EPOR;CTH;MAP6;LRP5;ZMYM3;THBS3;CTSL;TWF2;CST3;CNTN1;CLTCL1;NTNG1;PCSK6;TPBG;L3MBTL3;RANBP9;WASF3;DNAJB9;BTBD3;SEC63;PPP3CB;MEX3C;MYOF;RFX2;ADGRB2;CEBPG;PLAG1;TTC9;F2RL1;RASIP1;TAOK1;PHC3;AEBP1;CSNK2A1;PSMD7;PTHLH;TST;CHD7;ASAP1;PRKAR1A;ANO1;BOK;SPRY2;THRA;WNT2B;ACVR1B;DBNDD1;COL6A1;NGFR;PSKH1;GLUD1;TSHZ1;MARK4;PTPRZ1;SPESP1;BCL2L1;RNF165;MEF2D;WASF2;ARF4;POLL;XBP1;UBASH3B;TXNRD3;SATB1;REC8;SLC38A2;RET;SPATA6;LOXL2;PDE5A;TCTN1;NAV1;SH3PXD2B;MCTP2;C5;MBOAT7;NCKAP1;GTF2IRD2;DOCK11;SLC30A1;TMBIM1;ETV1;COL1A2;CCDC88A;CCSAP;PRKACA;TIMP2;EIF2AK2;RAB1A;EPB41L3;PCDH1;IFI16;RHOBTB1;AP2A2;NR2F6;IL1RAP;CARD11;LAMB2;LPAR1;ZNF354A;CTSZ;HOXA3;AP3D1;ARID4A;TENM2;IGF2;LAMA5;GRB10;ZMYM2;PPARG;GRB7;SRPX2;PPL;ALDH1A2;TBX1;SLC7A11;EVI5;CREB3L2;ADAM8;AKT3;ROBO3;CLDN11;WFS1;ENDOG;ITGA4;ZBTB40;WDR60;ZNF568;IGFBP7;DDHD2;FZD8;TMEM107;WASL;RAPGEFL1;HSPA2;PRSS8;FLNB;LRP6;ARID5B;SYT2;E2F7;EEF2K;SLC18A2;SEMA6C;SIGMAR1;HPSE;TNRC6C;RCAN1;TET1;OMG;FOXP1;PTCH1;ADCY1;KAT2B;RNF103;NYAP1;UFL1;ANKRD6;PBX3;JARID2;SEMA3F;ADNP;LRP4;RB1CC1;DNMT3A;FADD
12622,GO:0050806,0.000490852132550235,0.999835120470639,18,85,positive regulation of synaptic transmission,BP,RAB3B;SERPINE2;PRNP;SSH1;CRTC1;EGFR;DLG4;GLUL;WNT7A;SHANK2;APOE;RGS14;VAMP2;ITPR3;DVL1;NTSR1;NLGN2;RIMS3
18181,GO:1902950,0.000495743936300051,0.999983523225153,4,6,regulation of dendritic spine maintenance,BP,ZMYND8;PRNP;FYN;APOE
15809,GO:0072503,0.000497378500236454,0.999764286774886,34,216,cellular divalent inorganic cation homeostasis,BP,NOS1;F2R;PRNP;DDIT3;FYN;BNIP3;DLG4;TGM2;CEMIP;RASA3;EDNRA;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;ITPR3;MT2A;NTSR1;ANXA6;F2RL1;CHD7;BOK;UBASH3B;TRPC1;SLC30A1;PRKACA;SLC39A10;LPAR1;AP3D1;ITPR2;WFS1;LRP6
3419,GO:0007204,0.000504277440451416,0.999797784356644,24,131,positive regulation of cytosolic calcium ion concentration,BP,NOS1;F2R;PRNP;DDIT3;FYN;DLG4;TGM2;CEMIP;RASA3;EDNRA;FKBP1A;PKD2;LPAR3;FAM155B;ITPR3;NTSR1;F2RL1;CHD7;UBASH3B;TRPC1;PRKACA;LPAR1;ITPR2;LRP6
8230,GO:0032990,0.000521092489939774,0.9996919606643,65,462,cell part morphogenesis,BP,VLDLR;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;BRSK1;EGFR;SEMA4B;ANK3;FYN;KIF13B;DLG4;PLXNB3;WNT7A;MAP4K4;GDI1;SHC1;PAK1;SHANK2;SLITRK6;IMPACT;RAC2;CD44;APOE;LPAR3;ITGA1;ULK2;OBSL1;DVL1;MAP6;TWF2;NTNG1;RANBP9;BTBD3;PPP3CB;NGFR;PTPRZ1;BCL2L1;RNF165;WASF2;RET;TCTN1;NCKAP1;ETV1;EPB41L3;LAMB2;GRB10;GRB7;ROBO3;WASL;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;NYAP1;SEMA3F;ADNP;LRP4
5478,GO:0016411,0.000529981245306304,0.999917349595847,8,23,acylglycerol O-acyltransferase activity,MF,MBOAT2;AGPAT4;LPCAT4;LPCAT1;CRLS1;AGPAT3;MBOAT7;AGPAT1
11962,GO:0047144,0.000530555589347573,0.999966158403233,5,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,MBOAT2;LPCAT4;LPCAT1;CRLS1;MBOAT7
12670,GO:0050877,0.000539425197773441,0.999693392507307,56,406,nervous system process,BP,F2R;VLDLR;SCN8A;SERPINE2;PRNP;ADGRF1;BBS2;ADARB1;CRTC1;EGFR;ANK3;FYN;DLG4;ESPN;CEMIP;DKK1;RAG1;SHANK2;SLITRK6;APOE;CCND2;RGS14;ABCA7;FGFR1;AARS;TMOD2;TUB;ITGA2;ITPR3;DVL1;NTSR1;NLGN2;RABGGTA;WASF3;PPP3CB;ALDH7A1;CHD7;ANO1;NIPSNAP1;SPRY2;THRA;MGLL;PTPRZ1;ARF4;NR2F6;LAMB2;ZNF354A;TBL1X;PJA2;TBX1;WFS1;DDHD2;REEP6;ADCY1;PBX3;ADNP
12356,GO:0048731,0.000561714283853839,0.999567275609838,303,2943,system development,BP,FHL1;XDH;SMURF2;NOS1;ERCC1;ZMYND8;SORL1;ADAM19;ETV5;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;ITGA6;CYP27B1;SCN8A;SERPINE2;IGFBP4;ADGRF1;ITGB4;ACTA2;BBS2;POSTN;SH3TC2;ADM2;BTBD2;HECW2;NFATC4;ADARB1;MAP2K1;THBS2;FAM210B;RAPGEF3;ACVR2B;LTBP1;SH3KBP1;ALOX15B;SALL2;COL13A1;PKN1;WWTR1;ARHGAP22;APLN;MARVELD1;POU2F2;DHTKD1;SSH1;MAP1B;DDIT3;PTPRS;SMARCA1;SOX12;PSMD2;LAMB1;SDK2;ELK3;CRTC1;ADGRL1;BRSK1;SNPH;EGFR;SEMA4B;ANK3;LOXL1;FYN;MYH15;PCDHAC2;BNIP3;KIF13B;ADAMTS7;ZNF516;DLG1;CSMD3;DLG4;IDH2;CTSB;PLXNB3;GPC4;PODXL;TGM2;HTRA1;GLO1;WNT7A;MAP4K4;TTBK2;MALL;GDI1;UNC119B;SDC1;ARG2;SHC1;DLG3;DKK1;PAK1;SOCS2;ATXN10;RAG1;TGFBR2;PTPN3;EDNRA;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;ATP7B;ACP5;ANGPTL4;RGS14;PKD2;PRKACB;SRGAP2B;LRP1;LDHA;RAB11FIP4;ANXA3;HMGA2;PPARA;LPAR3;ASNS;FGFR1;ITGA1;AARS;E2F5;EPCAM;TMOD2;TUB;CMTM7;TACC1;SMOC1;HYAL1;BTRC;LPCAT1;ITGA2;PTK6;ULK2;INPP5F;CHAC1;ATRX;FAM20C;SOX4;PITPNM1;VPS13A;GAMT;CEP120;CEACAM1;FERMT1;OBSL1;PRR9;BSG;EPN2;MDFI;TNRC6B;DVL1;MMP14;NLGN2;CD46;EPOR;CTH;MAP6;LRP5;THBS3;CTSL;TWF2;CST3;CNTN1;NTNG1;PCSK6;TPBG;L3MBTL3;RANBP9;WASF3;DNAJB9;BTBD3;SEC63;PPP3CB;MEX3C;ADGRB2;CEBPG;PLAG1;TTC9;F2RL1;RASIP1;TAOK1;AEBP1;CSNK2A1;PSMD7;PTHLH;CHD7;ASAP1;PRKAR1A;BOK;SPRY2;THRA;WNT2B;ACVR1B;DBNDD1;NGFR;PSKH1;GLUD1;TSHZ1;MARK4;PTPRZ1;BCL2L1;RNF165;MEF2D;WASF2;ARF4;POLL;XBP1;UBASH3B;SATB1;REC8;SLC38A2;RET;LOXL2;TCTN1;NAV1;SH3PXD2B;C5;MBOAT7;NCKAP1;DOCK11;ETV1;COL1A2;CCDC88A;CCSAP;TIMP2;EIF2AK2;EPB41L3;PCDH1;IFI16;AP2A2;NR2F6;IL1RAP;CARD11;LAMB2;LPAR1;ZNF354A;CTSZ;HOXA3;AP3D1;ARID4A;TENM2;IGF2;LAMA5;GRB10;PPARG;GRB7;SRPX2;PPL;ALDH1A2;TBX1;SLC7A11;CREB3L2;ADAM8;AKT3;ROBO3;CLDN11;WFS1;ITGA4;ZBTB40;WDR60;ZNF568;FZD8;TMEM107;WASL;RAPGEFL1;PRSS8;FLNB;LRP6;ARID5B;SYT2;E2F7;EEF2K;SEMA6C;SIGMAR1;HPSE;TNRC6C;RCAN1;OMG;FOXP1;PTCH1;ADCY1;KAT2B;RNF103;NYAP1;UFL1;ANKRD6;PBX3;JARID2;SEMA3F;ADNP;LRP4;RB1CC1;DNMT3A;FADD
10403,GO:0043235,0.000565179405290986,0.999738271551239,32,183,receptor complex,CC,VLDLR;ITGA6;ITGB4;ACVR2B;MST1R;EGFR;DLG1;DLG4;PLXNB3;DLG3;TGFBR2;SHANK2;EPHA1;CD44;LRP1;FGFR1;ITGA1;ITGB5;ITGA2;ITPR3;CEACAM1;LRP5;ACVR1B;GRIN3B;ABHD6;TRPC1;RET;CARD11;ITPR2;ITGA4;LRP6;LRP4
13035,GO:0051491,0.000582568960949046,0.999908981837242,8,22,positive regulation of filopodium assembly,BP,ZMYND8;NEURL1;ARAP1;ESPN;FNBP1L;DOCK11;TENM2;WASL
3203,GO:0006836,0.000585335519143831,0.999767711560612,23,126,neurotransmitter transport,BP,NOS1;RAB3B;APLN;BRSK1;SNPH;GLUL;WNT7A;MCTP1;ICA1;VAMP2;PFN2;DVL1;NTSR1;RIMS3;SYTL1;SLC6A6;SEPT5;SLC6A14;SLC30A1;SLC7A11;SYT2;SLC18A2;SLC44A1
17715,GO:1901628,0.000599174491942068,1,3,3,positive regulation of postsynaptic membrane organization,BP,SSH1;APOE;LRP4
10426,GO:0043269,0.000618270173108385,0.99967515152093,43,296,regulation of ion transport,BP,FHL1;NOS1;F2R;RAB3B;SCN8A;SERPINE2;PRNP;HECW2;KCNG1;STK39;ANK3;FYN;DLG1;DLG4;CEMIP;STOM;PTPN3;SHANK2;APOE;FKBP1A;PKD2;AKAP9;ATF4;ABCA7;LPAR3;FGFR1;VAMP2;SARAF;NTSR1;NLGN2;CNTN1;CHD7;GRIN3B;UBASH3B;TRPC1;KCNJ15;SLC30A1;PRKACA;TMSB4X;ORAI1;WFS1;HSPA2;PRSS8
4352,GO:0009925,0.000628586437127447,0.999902061529957,8,21,basal plasma membrane,CC,ITGA6;MST1R;EGFR;ANK3;CLCA2;PKD2;CEACAM1;SLC23A2
3189,GO:0006812,0.000643920169232597,0.99960434088398,72,574,cation transport,BP,FHL1;NOS1;F2R;RAB3B;CYP27B1;SCN8A;SERPINE2;PRNP;HECW2;DDIT3;KCNG1;DENND5B;STK39;ANK3;FYN;SLC33A1;DLG1;DLG4;SLC9A7;CEMIP;STOM;RASA3;PTPN3;SHANK2;FKBP1A;ATP7B;PKD2;AKAP9;ATF4;LPAR3;FAM155B;VAMP2;ITPR3;SLC5A1;SARAF;NTSR1;ANXA6;NLGN2;ORAI3;NIPA1;CNTN1;SLC2A9;ATP10D;CHD7;ANO1;NDUFA4L2;AZIN2;GRIN3B;SLC12A7;UBASH3B;MICU3;SLC38A2;TRPC1;SLC13A3;KCNJ15;SLC30A1;PRKACA;TMSB4X;SLC39A10;ORAI1;ITPR2;SLC2A13;SLC10A6;ATP12A;ATP6V1B2;WFS1;HSPA2;PRSS8;SLC18A2;PSEN2;SLC23A2;SLC44A1
2102,GO:0004871,0.000646373461241106,0.999588092979732,84,676,signal transducer activity,MF,F2R;SORL1;VLDLR;PRNP;PAG1;ADGRF1;NR1D1;MAP2K1;ACVR2B;ANTXR2;LTBP1;MST1R;ADGRL1;FCGRT;EGFR;FYN;TNFRSF6B;MAPK13;PLXNB3;GPC4;MAP4K4;HTR7;SHC1;DKK1;RASA3;MRC2;TGFBR2;EDNRA;EPHA1;RAC2;CD44;FKBP1A;RGS14;PKD2;PPARA;ABCA7;LPAR3;FGFR1;ITGA2;LTBP4;ITPR3;MAPKAPK3;NLK;TRIM5;NTSR1;EPOR;LRP5;CLTCL1;CASP4;ADGRB2;F2RL1;TAOK1;C18ORF32;THRA;ACVR1B;NGFR;PTPRZ1;IFITM1;GRIN3B;MAP2K2;SLC22A17;RET;TMED4;NEK6;RHOBTB1;NR2F6;IL1RAP;LTB4R;LPAR1;ITPR2;MAP4K2;PPARG;GPR153;IL20RB;ITGA4;FZD8;LRP6;PLCH2;SIGMAR1;ELOVL4;PTCH1;GNAI1;LRP4;TRIM38
4512,GO:0010562,0.000649184433361539,0.99958394593743,86,702,positive regulation of phosphorus metabolic process,BP,XDH;NOS1;F2R;CCND1;NEURL1;VLDLR;ITGA6;ADCY7;IGFBP4;PRNP;MAP2K1;RAPGEF3;ACVR2B;PKN1;MST1R;APLN;TNFSF15;EGFR;STK39;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;TGFBR2;EPHA1;CD44;APOE;CCND2;PKD2;PRKACB;AKAP9;ABCA7;LPAR3;FGFR1;ITGA1;ITGA2;PTK6;PFN2;MAPKAPK3;TRIM5;DVL1;NTSR1;ETAA1;CNTN1;SLK;F2RL1;TAOK1;PTHLH;PRKAR1A;PARP9;SPRY2;ACVR1B;NGFR;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;TMSB4X;TIMP2;EIF2AK2;SLC39A10;LPAR1;IGF2;MAP4K2;TBX1;ADAM8;FZD8;HSPA2;ADCY1;ANKRD6;ADNP;LRP4;RB1CC1
11481,GO:0045937,0.000649184433361539,0.99958394593743,86,702,positive regulation of phosphate metabolic process,BP,XDH;NOS1;F2R;CCND1;NEURL1;VLDLR;ITGA6;ADCY7;IGFBP4;PRNP;MAP2K1;RAPGEF3;ACVR2B;PKN1;MST1R;APLN;TNFSF15;EGFR;STK39;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;TGFBR2;EPHA1;CD44;APOE;CCND2;PKD2;PRKACB;AKAP9;ABCA7;LPAR3;FGFR1;ITGA1;ITGA2;PTK6;PFN2;MAPKAPK3;TRIM5;DVL1;NTSR1;ETAA1;CNTN1;SLK;F2RL1;TAOK1;PTHLH;PRKAR1A;PARP9;SPRY2;ACVR1B;NGFR;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;TMSB4X;TIMP2;EIF2AK2;SLC39A10;LPAR1;IGF2;MAP4K2;TBX1;ADAM8;FZD8;HSPA2;ADCY1;ANKRD6;ADNP;LRP4;RB1CC1
6219,GO:0019752,0.000653956327360186,0.999581195012062,85,750,carboxylic acid metabolic process,BP,NOS1;PCK2;CBS;CYGB;CRYL1;GPT2;NR1D1;SLC16A3;ALOX15B;DHTKD1;PC;HADH;CARS;PSMD2;LTA4H;PSAT1;ELOVL1;PGM1;IDH2;ACOT1;TYSND1;GLUL;GLO1;ACSF2;ACOT7;CRTAP;CEMIP;ACAD11;ARG2;NAGS;CBR4;SLC2A3;HAGH;ERO1B;CD44;ABCD1;ALDH1L2;LDHA;ATF4;PPARA;ASNS;ABHD10;AARS;UROS;HYAL1;AIG1;LONP2;MTHFR;AHCYL2;GAMT;CEACAM1;BSG;ACAD10;CTH;TRIB3;GFPT1;HIBADH;MLYCD;ALDH7A1;SLC6A6;PSMD7;BLMH;CPT2;SLC6A14;MGLL;BPHL;GLUD1;NPL;AZIN2;CRAT;PM20D2;PCYOX1;XBP1;CYP4F22;NIT2;PPARG;PTGR2;ALDH1A2;LYPLA1;ALDH4A1;GARS;ELOVL4;HSD17B12;AMACR;SLC23A2
13032,GO:0051482,0.00068444551640621,0.999947019545094,5,11,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,F2R;TGM2;LPAR3;F2RL1;LPAR1
5063,GO:0015276,0.000694019305266366,0.999838143018233,11,39,ligand-gated ion channel activity,MF,DLG1;DLG4;DLG3;RASA3;CLCA2;PKD2;ITPR3;ANXA6;GRIN3B;KCNJ15;ITPR2
6613,GO:0022834,0.000694019305266366,0.999838143018233,11,39,ligand-gated channel activity,MF,DLG1;DLG4;DLG3;RASA3;CLCA2;PKD2;ITPR3;ANXA6;GRIN3B;KCNJ15;ITPR2
10324,GO:0043113,0.000724639364231658,0.999861672896193,9,29,receptor clustering,BP,ETV5;SSH1;DLG1;DLG4;DLG3;APOE;DVL1;ITGA4;LRP4
8153,GO:0032879,0.000729036017634368,0.999464945013247,183,1685,regulation of localization,BP,DOCK4;FHL1;SMURF2;EDEM1;TSPAN1;NOS1;ZMYND8;F2R;SORL1;RAB3B;PGF;PCK2;ITGA6;CYGB;SCN8A;SERPINE2;PRNP;BBS2;POSTN;SH3TC2;NR1D1;HECW2;ADARB1;MAP2K1;RAPGEF3;ALOX15B;PKN1;APLN;SSH1;MAP1B;DDIT3;KCNG1;HADH;LAMB1;EGFR;TBC1D14;STK39;SEMA4B;ANK3;FYN;UBE2J1;ARAP1;DLG1;DLG4;IDH2;PLXNB3;PODXL;GLUL;EVI5L;WNT7A;MAP4K4;TTBK2;MCTP1;GDI1;CEMIP;SDC1;ARG2;STOM;DKK1;PAK1;RASA3;TGFBR2;PTPN3;SHANK2;EPHA1;RAC2;APOE;FKBP1A;BNIP3L;PKD2;SRGAP2B;LRP1;AKAP9;ANXA3;ATF4;PPARA;ABCA7;ICA1;LPAR3;FGFR1;TUB;HYAL1;ITGA2;VAMP2;INPP5F;PFN2;ABCG1;SOX4;ITPR3;CEP120;CEACAM1;FERMT1;SARAF;FAM110C;TRIM5;DVL1;NTSR1;MMP14;NLGN2;LRP5;ABHD17C;CNTN1;TRIB3;CLTCL1;VPS11;MOSPD2;RIMS3;PPP3CB;SYTL1;DNAJC6;SLK;F2RL1;CSNK2A1;CHD7;SLC25A4;ANO1;BOK;PARP9;ATXN2;USP6NL;SPRY2;SEPT5;BEX4;TBC1D2B;ACVR1B;NGFR;GLUD1;AZIN2;BCL2L1;IFITM1;GRIN3B;XBP1;UBASH3B;MAP2K2;ABHD6;TRPC1;RET;STX10;C5;NOP10;KCNJ15;SLC30A1;TMBIM1;CCDC88A;CCSAP;PRKACA;TMSB4X;RHOBTB1;IL1RAP;ORAI1;LPAR1;MMP10;AP3D1;ITPR2;LAMA5;GRB10;EFCAB7;ERLEC1;PPARG;GRB7;SRPX2;LYPLA1;EVI5;RPH3AL;ADAM8;AKT3;WFS1;ITGA4;TBC1D16;WASL;REEP6;HSPA2;PRSS8;SYT2;TMEM173;EEF2K;FOXP1;PTCH1;UFL1;SEMA3F;GNAI1;LRP4;FADD
13030,GO:0051480,0.000740767727885203,0.999687335259207,25,142,regulation of cytosolic calcium ion concentration,BP,NOS1;F2R;PRNP;DDIT3;FYN;DLG4;TGM2;CEMIP;RASA3;EDNRA;FKBP1A;PKD2;LPAR3;FAM155B;ITPR3;NTSR1;F2RL1;CHD7;BOK;UBASH3B;TRPC1;PRKACA;LPAR1;ITPR2;LRP6
3696,GO:0008201,0.000760794510730865,0.999752529157675,16,77,heparin binding,MF,PGF;SERPINE2;POSTN;THBS2;LTBP2;COL13A1;PTPRS;WISP1;SMOC2;APOE;FGFR1;THBS3;PCSK6;APLP2;HSD17B12;PTCH1
13813,GO:0060402,0.000762634503025242,0.999743055694024,17,79,calcium ion transport into cytosol,BP,NOS1;F2R;PRNP;DDIT3;FYN;CEMIP;RASA3;FKBP1A;PKD2;FAM155B;ITPR3;NTSR1;CHD7;UBASH3B;TRPC1;PRKACA;ITPR2
10266,GO:0043005,0.000765638291876488,0.999498357487849,93,753,neuron projection,CC,DOCK4;NOS1;ZMYND8;NEURL1;CYGB;SCN8A;PRNP;OSBP2;BBS2;NR1D1;SH3KBP1;SSH1;MAP1B;PTPRS;CRTC1;ADGRL1;CAPN2;SNPH;ANK3;FYN;BNIP3;KIF13B;DLG1;DLG4;ESPN;GLUL;WDFY3;HTR7;GDI1;DLG3;PAK1;ATXN10;SHANK2;EPHA1;APOE;FKBP1A;RGS14;LRP1;AKAP9;DDN;ANXA3;ATF4;LPAR3;KIF21B;ITGA1;TMOD2;SNX14;ITGA2;VAMP2;INPP5F;PFN2;AHCYL2;FBXO2;XRN1;DVL1;NTSR1;MPDZ;MAP6;ABHD17C;TWF2;CST3;ASAP1;CPEB4;SEPT5;NGFR;MARK4;AZIN2;ARF4;CNNM1;SLC38A2;RET;NAV1;CCSAP;TIMP2;EPB41L3;LPAR1;CTSZ;AP3D1;TENM2;ROBO3;GARS;WFS1;REEP6;EEF2K;SLC18A2;SIGMAR1;PSEN2;PTCH1;SEPT6;UFL1;ADNP;LRP4;FADD
709,GO:0001934,0.000817944483115711,0.999484464424838,77,622,positive regulation of protein phosphorylation,BP,XDH;F2R;CCND1;NEURL1;VLDLR;ADCY7;IGFBP4;PRNP;MAP2K1;RAPGEF3;ACVR2B;PKN1;MST1R;TNFSF15;EGFR;STK39;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;TGFBR2;EPHA1;CD44;CCND2;PKD2;PRKACB;AKAP9;ABCA7;LPAR3;FGFR1;ITGA1;PTK6;PFN2;MAPKAPK3;TRIM5;DVL1;ETAA1;CNTN1;SLK;F2RL1;TAOK1;PRKAR1A;PARP9;SPRY2;ACVR1B;NGFR;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;TIMP2;EIF2AK2;LPAR1;IGF2;MAP4K2;TBX1;ADAM8;FZD8;HSPA2;ADCY1;ANKRD6;ADNP;LRP4;RB1CC1
13505,GO:0055074,0.000820075061772252,0.999608974498846,32,203,calcium ion homeostasis,BP,NOS1;F2R;CYP27B1;PRNP;DDIT3;FYN;BNIP3;DLG4;TGM2;CEMIP;RASA3;EDNRA;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;ITPR3;NTSR1;ANXA6;F2RL1;CHD7;BOK;UBASH3B;TRPC1;SLC30A1;PRKACA;LPAR1;ITPR2;WFS1;LRP6
8663,GO:0034220,0.000838242505120026,0.999477939569603,73,579,ion transmembrane transport,BP,FHL1;NOS1;F2R;SCN8A;PRNP;HECW2;SLC16A3;DDIT3;KCNG1;DENND5B;STK39;ANK3;FYN;SLC33A1;DLG1;DLG4;SLC9A7;ASPH;CEMIP;STOM;DLG3;RASA3;PTPN3;SHANK2;CLCA2;FKBP1A;ATP7B;PKD2;AKAP9;FAM155B;VAMP2;ITPR3;CLCN3;NTSR1;ANXA6;NLGN2;ORAI3;NIPA1;SLC35B4;TTYH3;ANO8;SLC2A9;ATP10D;SLC6A6;CHD7;CPT2;ANO1;SLC6A14;NDUFA4L2;SLC43A1;GRIN3B;SLC12A7;PCYOX1;UBASH3B;MICU3;SLC38A2;TRPC1;SLC13A3;KCNJ15;SLC30A1;SFXN3;PRKACA;TMSB4X;SLC39A10;ORAI1;ITPR2;SLC2A13;ATP12A;SLC7A11;ATP6V1B2;ATP11B;HSPA2;SLC23A2
6893,GO:0030425,0.000839765178843607,0.99952632378252,51,361,dendrite,CC,NOS1;ZMYND8;NEURL1;PRNP;OSBP2;NR1D1;MAP1B;CRTC1;CAPN2;ANK3;FYN;BNIP3;KIF13B;DLG4;HTR7;DLG3;PAK1;ATXN10;SHANK2;APOE;RGS14;LRP1;AKAP9;DDN;ANXA3;ATF4;KIF21B;SNX14;INPP5F;FBXO2;XRN1;DVL1;NTSR1;MPDZ;MAP6;ABHD17C;ASAP1;CPEB4;AZIN2;ARF4;CNNM1;SLC38A2;RET;LPAR1;TENM2;WFS1;EEF2K;PSEN2;PTCH1;ADNP;LRP4
16612,GO:0097447,0.000839765178843607,0.99952632378252,51,361,dendritic tree,CC,NOS1;ZMYND8;NEURL1;PRNP;OSBP2;NR1D1;MAP1B;CRTC1;CAPN2;ANK3;FYN;BNIP3;KIF13B;DLG4;HTR7;DLG3;PAK1;ATXN10;SHANK2;APOE;RGS14;LRP1;AKAP9;DDN;ANXA3;ATF4;KIF21B;SNX14;INPP5F;FBXO2;XRN1;DVL1;NTSR1;MPDZ;MAP6;ABHD17C;ASAP1;CPEB4;AZIN2;ARF4;CNNM1;SLC38A2;RET;LPAR1;TENM2;WFS1;EEF2K;PSEN2;PTCH1;ADNP;LRP4
5678,GO:0016790,0.000840093745995291,0.999851187565125,8,29,thiolester hydrolase activity,MF,ACOT1;ACOT7;HAGH;ABHD17C;ACOT13;LYPLAL1;LYPLA1;PPT2
16868,GO:0098797,0.000894115783984907,0.999528939910384,41,277,plasma membrane protein complex,CC,NOS1;ITGA6;SCN8A;ITGB4;COL13A1;KCNG1;SNTB2;EGFR;DLG1;DLG4;SHC1;DLG3;TGFBR2;SHANK2;FKBP1A;LRP1;AKAP9;ABCA7;ITGA1;ITGB5;ITGA2;VAMP2;CEACAM1;LRP5;ACVR1B;GRIN3B;ABHD6;RET;C5;AP2A2;CARD11;EFCAB7;ATP12A;ADAM8;ITGA4;FZD8;HSPA2;LRP6;GNAI1;LRP4;FADD
16425,GO:0097060,0.00090238021402239,0.999593355498984,28,158,synaptic membrane,CC,F2R;NEURL1;COL13A1;PTPRS;ADGRL1;SNPH;ANK3;DLG1;DLG4;DLG3;SHANK2;RGS14;AKAP9;DDN;NLGN2;MPDZ;ABHD17C;RIMS3;FCHO2;CPEB4;NIPSNAP1;GRIN3B;PSD3;TENM2;PJA2;SRPX2;SIGMAR1;LRP4
4261,GO:0009605,0.000905295293982807,0.999353212802527,145,1337,response to external stimulus,BP,TNIP1;DOCK4;NT5E;PLAT;NOS1;ERCC1;F2R;PGF;CCND1;PCK2;VLDLR;CBS;ITGA6;CYP27B1;SERPINE2;PRSS3;ACTA2;BBS2;POSTN;NR1D1;ADARB1;MAP2K1;CMTM4;FNDC4;SH3KBP1;MST1R;SSH1;DDIT3;PTPRS;CRTC1;DENND5B;WIPF1;EGFR;STK39;SEMA4B;LOXL1;FYN;TNFRSF6B;BNIP3;MAPK13;PLXNB3;TGM2;XPC;GLUL;HTRA1;ARG2;SHC1;DAP;TGFBR2;SERPING1;LCN2;SLITRK6;IMPACT;RAC2;APOE;BNIP3L;ACP5;PKD2;LDHA;ANXA3;HMGA2;ATF4;PPARA;ASNS;FGFR1;ITGA1;CMTM7;HYAL1;ITGA2;ULK2;INPP5F;MTHFR;PITPNM1;APOBEC3C;CEACAM1;MAPKAPK3;GSDMC;TRIM5;DVL1;NTSR1;MMP14;CD46;CST3;CASP4;MOSPD2;RANBP9;F2RL1;DDX60;GSDMA;ANO1;PARP9;CPEB4;MGLL;WNT2B;NGFR;PER3;MTA1;BCL2L1;IFITM1;RNF165;XBP1;UBASH3B;SATB1;SLC38A2;RET;C5;GABARAPL2;PUM2;ETV1;TMSB4X;EIF2AK2;RAB1A;IFI16;NR2F6;CMTM6;LAMB2;LPAR1;ZNF354A;AP3D1;IGF2;GRB10;PPARG;GRB7;PPL;ALDH1A2;ADAM8;ROBO3;IL20RB;ENDOG;CKLF;WASL;REEP6;TMEM173;SEMA6C;HPSE;DNAJC3;FOXP1;ELOVL4;PTCH1;OAS1;UFL1;SEMA3F;ADNP;DNMT3A;FADD
12898,GO:0051240,0.000924150466160708,0.999365646477443,114,981,positive regulation of multicellular organismal process,BP,SMURF2;NOS1;ZMYND8;F2R;ETV5;PGF;CCND1;NEURL1;CTNNBIP1;VLDLR;CYP27B1;SERPINE2;BBS2;POSTN;ADM2;NFATC4;MAP2K1;THBS2;FAM210B;RAPGEF3;ACVR2B;ALOX15B;WWTR1;APLN;MAP1B;DDIT3;CRTC1;ADGRL1;EGFR;FYN;MAPK13;DLG4;PLXNB3;WNT7A;GDI1;DKK1;PAK1;SOCS2;RAG1;TGFBR2;SHANK2;SLITRK6;EPHA1;IMPACT;APOE;ANGPTL4;RGS14;LRP1;ANXA3;HMGA2;ATF4;ABCA7;LPAR3;FGFR1;HYAL1;ITGA2;PTK6;FAM20C;CEACAM1;FERMT1;OBSL1;DVL1;MMP14;NLGN2;CD46;CTH;TWF2;CNTN1;TPBG;WASF3;ZNF322;ADGRB2;CEBPG;PLAG1;F2RL1;DDX60;CHD7;WNT2B;ACVR1B;NGFR;IFITM1;XBP1;RET;LOXL2;PDE5A;SH3PXD2B;C5;PUM2;RNF135;TMBIM1;TMSB4X;TIMP2;EIF2AK2;IFI16;IL1RAP;CARD11;LPAR1;AP3D1;AGPAT1;PPARG;SRPX2;TBX1;ADAM8;AKT3;IL20RB;LRP6;SYT2;TMEM173;EEF2K;HPSE;FOXP1;UFL1;ADNP;FADD
3224,GO:0006874,0.000926829876450278,0.999560344602693,31,196,cellular calcium ion homeostasis,BP,NOS1;F2R;PRNP;DDIT3;FYN;BNIP3;DLG4;TGM2;CEMIP;RASA3;EDNRA;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;ITPR3;NTSR1;ANXA6;F2RL1;CHD7;BOK;UBASH3B;TRPC1;SLC30A1;PRKACA;LPAR1;ITPR2;WFS1;LRP6
4565,GO:0010646,0.000927781801712166,0.999293292233069,239,2313,regulation of cell communication,BP,TNIP1;DDIT4L;XDH;SMURF2;NOS1;ZMYND8;F2R;SORL1;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;ASAP2;ITGA6;CYP27B1;SERPINE2;PEAR1;IGFBP4;PRNP;PAG1;POSTN;SH3TC2;ADM2;NR1D1;NFATC4;MAP2K1;CMTM4;RAPGEF3;ACVR2B;LTBP1;SH3KBP1;ALOX15B;PKN1;WWTR1;MST1R;ARHGAP22;APLN;TNFSF15;APPL2;SSH1;DDIT3;PTPRS;HADH;PSMD2;CRTC1;EGFR;STK39;ANK3;ARHGAP12;FYN;TSPAN5;BNIP3;ERCC6;ARAP1;DLG1;DLG4;GPC4;NET1;TGM2;GLUL;HTRA1;WNT7A;MAP4K4;GRK5;STRADB;MCTP1;GDI1;SHC1;DKK1;PAK1;RASA3;SOCS2;TRIB2;TGFBR2;PTPN3;SHANK2;EPHA1;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;PTPN12;AFAP1;RGS14;PKD2;PRKACB;RBCK1;LRP1;ABCA7;WWC3;ICA1;LPAR3;FGFR1;ITGA1;TMOD2;CMTM7;NFAT5;BTRC;ITGA2;PTK6;VAMP2;LTBP4;INPP5F;CHAC1;FAM20C;PFN2;SOX4;ITPR3;CEACAM1;FERMT1;MAPKAPK3;UACA;FAM110C;NLK;EPN2;MDFI;TRIM5;RALGAPA1;DVL1;NTSR1;MMP14;NLGN2;CD46;MVB12B;CTH;LRP5;DNMBP;TRIB3;CASP4;PCSK6;RANBP9;DNAJB9;RIMS3;PPP3CB;MYOF;F2RL1;DDX60;TAOK1;CSNK2A1;PSMD7;PTHLH;CHD7;SLC25A4;ASAP1;ANO1;JMY;BOK;PARP9;C18ORF32;NACC2;SPRY2;SEPT5;THRA;MGLL;WNT2B;ACVR1B;NGFR;MVB12A;GLUD1;NUDT6;BCL2L1;RNF165;SKAP2;XBP1;UBASH3B;MAP2K2;ABHD6;PPP1R2;ARRDC1;RET;PDE5A;TCTN1;C5;MTMR4;EPM2A;PAK6;PUM2;SLC30A1;PSD3;TMBIM1;TMED4;SHC2;PRKACA;SAMD5;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RHOBTB1;SLC39A10;CMTM6;CARD11;FICD;LPAR1;TBL1X;IGF2;ITPR2;MOAP1;AGPAT1;PJA2;GRB10;MAP4K2;PPARG;SNX6;USP20;GRB7;ARHGAP29;TBX1;RPH3AL;ADAM8;AKT3;WFS1;ACAP2;MAML3;CKLF;FZD8;LRP6;HPSE;RCAN1;DEDD2;FOXP1;PTCH1;KAT2B;UFL1;FAM162A;ANKRD6;RALGPS2;ADNP;GNAI1;LRP4;RB1CC1;TRIM38;FADD
8942,GO:0034976,0.000956840417167634,0.999521129133389,35,242,response to endoplasmic reticulum stress,BP,EDEM1;CCND1;DDIT3;UBE2J1;UBXN4;SHC1;ATF4;ASNS;TMX4;CHAC1;FBXO2;PDIA5;CTH;TRIB3;CASP4;GFPT1;DNAJB9;SEC63;BOK;XBP1;TXNDC11;EIF2AK2;SEL1L;KDELR3;FICD;ERLEC1;CREB3L2;ERP44;WFS1;SSR1;DNAJC3;RNF103;USP25;UFL1;STT3B
10802,GO:0044281,0.000989522174257475,0.99928557513279,152,1503,small molecule metabolic process,BP,XDH;NT5E;NOS1;SORL1;PCK2;VLDLR;CBS;CYGB;CYP27B1;PRSS3;ADCY7;CRYL1;IGFBP4;GPT2;NR1D1;SLC16A3;RAPGEF3;ALOX15B;LMF1;TK2;NAPRT;H6PD;DHTKD1;PC;B4GALT6;HADH;CARS;PSMD2;LTA4H;PSAT1;ELOVL1;PGM1;DLG1;ISYNA1;DLG4;B3GNT3;IDH2;ACOT1;TYSND1;GLUL;GLO1;ACSF2;PGLS;SPTLC2;ACOT7;NMRK1;RDH14;NME4;CRTAP;CEMIP;ACAD11;ARG2;NAGS;DLG3;CBR4;SLC2A3;HAGH;PLPP6;ERO1B;CD44;APOE;ABCD1;ACP5;ALDH1L2;PKD2;LDHA;AKAP9;ATF4;PPARA;ASNS;FGFR1;ABHD10;AARS;UROS;HYAL1;AIG1;LONP2;FAM20C;MTHFR;AHCYL2;ABCG1;APOBEC3C;GAMT;KDSR;CEACAM1;BSG;NTSR1;ACAD10;CTH;LRP5;TMEM86B;SLC35B4;TRIB3;GFPT1;INPP4A;HIBADH;MLYCD;ALDH7A1;SLC2A9;SLC6A6;PSMD7;PTHLH;TST;BLMH;NDUFV3;CPT2;PARP9;SLC6A14;MGLL;BPHL;GLUD1;NPL;AZIN2;CRAT;PM20D2;GLB1;UAP1;HSD17B7;PCYOX1;XBP1;PANK4;CYP4F22;PDE5A;OSBPL5;TMSB4X;TIMP2;SRD5A3;CARD11;NIT2;IGF2;PPARG;PTGR2;ALDH1A2;LYPLA1;ATP6V1B2;AK9;ALDH4A1;GARS;PLCH2;GALNS;COQ2;ELOVL4;AOX1;HSD17B12;ADCY1;KAT2B;OAS1;PANK1;AMACR;GALE;SLC23A2;ADNP
3081,GO:0006654,0.00102912370832527,0.99979163011376,9,30,phosphatidic acid biosynthetic process,BP,DGKA;AGPAT4;LPCAT4;LPCAT1;PLA2G4D;AGPAT3;ACP6;AGPAT1;DDHD2
16178,GO:0090196,0.00106474135674929,0.999947349155536,4,7,regulation of chemokine secretion,BP,POSTN;ALOX15B;F2RL1;C5
12624,GO:0050808,0.0010825140977999,0.999490410277231,30,175,synapse organization,BP,ZMYND8;F2R;ETV5;NEURL1;PRNP;ADGRF1;NFATC4;THBS2;SSH1;SDK2;ADGRL1;ANK3;FYN;DLG4;WNT7A;DKK1;SHANK2;SLITRK6;APOE;DVL1;NLGN2;TPBG;ADGRB2;IL1RAP;LAMB2;SRPX2;WASL;EEF2K;ADNP;LRP4
7927,GO:0032502,0.00110316064210851,0.999124450092227,385,3894,developmental process,BP,FHL1;XDH;SMURF2;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;ADAM19;ETV5;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;SYNE3;ITGA6;CYP27B1;SCN8A;SERPINE2;IGFBP4;PRNP;ADGRF1;OSBP2;ITGB4;ACTA2;BBS2;POSTN;SH3TC2;ADM2;BTBD2;NR1D1;HECW2;NFATC4;ADARB1;MAP2K1;THBS2;FAM210B;FMNL2;ETV4;RAPGEF3;ACVR2B;LTBP1;SH3KBP1;ALOX15B;SALL2;COL13A1;PKN1;WWTR1;MST1R;ARHGAP22;MICALCL;APLN;MARVELD1;POU2F2;DHTKD1;TEF;SSH1;MAP1B;DDIT3;PTPRS;SMARCA1;SOX12;PSMD2;LAMB1;SDK2;ELK3;CRTC1;ADGRL1;CAPN2;BRSK1;WIPF1;SNPH;EGFR;SEMA4B;ANK3;LOXL1;ARHGAP12;FYN;MYH15;TNFRSF6B;PCDHAC2;BNIP3;KIF13B;SCMH1;ERCC6;UBE2J1;PARVB;MYCBPAP;ARAP1;ADAMTS7;ZNF516;DLG1;CSMD3;DLG4;IDH2;CTSB;PLXNB3;GPC4;PODXL;NET1;TGM2;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;TTBK2;WDFY3;GRK5;STRADB;RDH14;MALL;ASPH;GDI1;UNC119B;SDC1;ARG2;SHC1;DLG3;DKK1;SLFN5;PAK1;SOCS2;TRIB2;ATXN10;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;NUDCD3;EDNRA;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;OBSCN;APOE;FKBP1A;ATP7B;ACP5;ANGPTL4;PRR15;PTPN12;RGS14;PKD2;PRKACB;SRGAP2B;LRP1;LDHA;IDE;RAB11FIP4;ANXA3;HMGA2;PPARA;WWC3;LPAR3;ASNS;FGFR1;ITGA1;AARS;E2F5;EPCAM;TMOD2;TUB;CMTM7;TACC1;TCFL5;SMOC1;ITGB5;HYAL1;BTRC;LPCAT1;ITGA2;PTK6;ULK2;FAT1;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;ABCG1;KIAA1109;SOX4;PITPNM1;VPS13A;GAMT;CEP120;CEACAM1;FERMT1;OBSL1;PRR9;BSG;SH3D19;EPN2;MDFI;TNRC6B;DVL1;MMP14;NLGN2;CD46;EPOR;CTH;MAP6;LRP5;ZMYM3;THBS3;CTSL;TWF2;CST3;CNTN1;TRIB3;CLTCL1;NTNG1;PCSK6;TPBG;L3MBTL3;RANBP9;WASF3;DNAJB9;BTBD3;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;RFX2;ADGRB2;CEBPG;PLAG1;TTC9;F2RL1;UHRF2;RASIP1;TAOK1;PHC3;AEBP1;CSNK2A1;PSMD7;PTHLH;TST;CHD7;ASAP1;PRKAR1A;ANO1;BOK;SPRY2;THRA;WNT2B;ACVR1B;DBNDD1;COL6A1;NGFR;PSKH1;GLUD1;TSHZ1;MARK4;PTPRZ1;SPESP1;BCL2L1;IFITM1;RNF165;MEF2D;WASF2;ARF4;POLL;XBP1;UBASH3B;TXNRD3;SATB1;REC8;SLC38A2;RET;SPATA6;CCDC71L;LOXL2;PDE5A;TCTN1;NAV1;SH3PXD2B;MCTP2;C5;MBOAT7;NCKAP1;GTF2IRD2;DOCK11;SLC30A1;TMBIM1;ETV1;COL1A2;CCDC88A;CCSAP;PRKACA;NEK6;TIMP2;EIF2AK2;RAB1A;EPB41L3;PCDH1;IFI16;RHOBTB1;BCAP29;AP2A2;NR2F6;IL1RAP;CARD11;LAMB2;LPAR1;ZNF354A;CTSZ;HOXA3;AP3D1;ARID4A;TENM2;IGF2;LAMA5;GRB10;ZMYM2;PPARG;CITED4;GRB7;SRPX2;PPL;ALDH1A2;TBX1;SLC7A11;EVI5;CREB3L2;ADAM8;AKT3;ROBO3;CLDN11;WFS1;ENDOG;ITGA4;ZBTB40;WDR60;ZNF568;IGFBP7;DDHD2;FZD8;TMEM107;WASL;RAPGEFL1;HSPA2;PRSS8;FLNB;LRP6;ARID5B;SYT2;E2F7;EEF2K;SLC18A2;SEMA6C;SIGMAR1;HPSE;TNRC6C;RCAN1;TET1;OMG;FOXP1;PTCH1;ADCY1;KAT2B;SEPT6;RNF103;NYAP1;UFL1;ANKRD6;PBX3;JARID2;SEMA3F;ADNP;LRP4;RB1CC1;DNMT3A;FADD
3797,GO:0008374,0.0011049387646725,0.999744835662651,10,38,O-acyltransferase activity,MF,MBOAT2;AGPAT4;LPCAT4;LPCAT1;CPT2;CRLS1;CRAT;AGPAT3;MBOAT7;AGPAT1
2709,GO:0006082,0.00112815873953263,0.999252057456989,91,824,organic acid metabolic process,BP,NOS1;PCK2;CBS;CYGB;CRYL1;GPT2;NR1D1;SLC16A3;ALOX15B;DHTKD1;PC;B4GALT6;HADH;CARS;PSMD2;LTA4H;PSAT1;ELOVL1;PGM1;B3GNT3;IDH2;ACOT1;TYSND1;GLUL;GLO1;ACSF2;ACOT7;CRTAP;CEMIP;ACAD11;ARG2;NAGS;CBR4;SLC2A3;HAGH;ERO1B;CD44;ABCD1;ALDH1L2;LDHA;ATF4;PPARA;ASNS;ABHD10;AARS;UROS;HYAL1;AIG1;LONP2;MTHFR;AHCYL2;GAMT;CEACAM1;BSG;ACAD10;CTH;TRIB3;GFPT1;HIBADH;MLYCD;ALDH7A1;SLC2A9;SLC6A6;PSMD7;TST;BLMH;CPT2;SLC6A14;MGLL;BPHL;GLUD1;NPL;AZIN2;CRAT;PM20D2;GLB1;PCYOX1;XBP1;CYP4F22;NIT2;PPARG;PTGR2;ALDH1A2;LYPLA1;ALDH4A1;GARS;GALNS;ELOVL4;HSD17B12;AMACR;SLC23A2
17709,GO:1901618,0.00116052977766607,0.999860446712915,6,15,organic hydroxy compound transmembrane transporter activity,MF,SLC16A3;ABCG1;CEACAM1;SLC2A13;SLC10A6;SLC18A2
10737,GO:0044093,0.00116182441701406,0.999169609136792,139,1257,positive regulation of molecular function,BP,DOCK4;XDH;NOS1;F2R;SORL1;CCND1;NEURL1;VLDLR;ASAP2;ITGA6;CYP27B1;ADCY7;PRNP;ADGRF1;MAP2K1;RAPGEF3;ACVR2B;LMF1;PKN1;MST1R;ARHGAP22;TNFSF15;DDIT3;CRTC1;EGFR;TBC1D14;STK39;RIN2;ANK3;ARHGAP12;FYN;ERCC6;ARAP1;DLG1;DLG4;SNX9;NET1;EVI5L;MAP4K4;STRADB;ASPH;GDI1;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;RASA3;TGFBR2;EDNRA;EPHA1;RALGAPA2;APOE;FKBP1A;CCND2;RGS14;PKD2;PRKACB;SRGAP2B;RBCK1;LRP1;AKAP9;ANXA3;HMGA2;LPAR3;FGFR1;ITGA1;ITGA2;PFN2;MAPKAPK3;TRIM5;RALGAPA1;TCEA1;NTSR1;MMP14;CTH;LRP5;ETAA1;DNMBP;DOCK9;TRIB3;CASP4;SLK;CEBPG;F2RL1;TAOK1;ASAP1;PRKAR1A;JMY;BOK;PARP9;USP6NL;SPRY2;TBC1D2B;NGFR;AZIN2;ARF4;MAP2K2;RIN1;RET;PDE5A;SH3PXD2B;C5;GABARAPL2;DOCK11;PAK6;CCDC88A;SHC2;PRKACA;TMSB4X;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;IL1RAP;CARD11;LPAR1;IGF2;MAP4K2;PPARG;ARHGAP29;EVI5;ADAM8;DEPDC1;ACAP2;TBC1D16;FZD8;HSPA2;LRP6;ARID5B;TMEM173;PSEN2;ADCY1;FAM162A;ADNP;TRIM38;FADD
10688,GO:0043954,0.0011653018824032,0.999791479786373,8,24,cellular component maintenance,BP,ZMYND8;F2R;PRNP;FYN;APOE;MTHFR;NLGN2;F2RL1
9792,GO:0040011,0.00117537714516898,0.999172056803381,127,1095,locomotion,BP,DOCK4;PLAT;SMURF2;TSPAN1;ZMYND8;F2R;SORL1;PGF;NEURL1;VLDLR;ITGA6;MMP1;CYGB;SERPINE2;PRSS3;ITGB4;BBS2;POSTN;SLC16A3;ADARB1;MAP2K1;CMTM4;SH3KBP1;ALOX15B;PKN1;SSH1;PC;LAMB1;AVL9;EGFR;SEMA4B;FYN;IDH2;PLXNB3;PODXL;NET1;WNT7A;TTBK2;MCTP1;CEMIP;SDC1;SHC1;PAK1;TGFBR2;EPHA1;RAC2;CD44;APOE;SRGAP2B;LRP1;ANXA3;FGFR1;ITGA1;EPCAM;CMTM7;HYAL1;ITGA2;PTK6;FAT1;INPP5F;PFN2;CEACAM1;FERMT1;FAM110C;BSG;TRIM5;DVL1;MMP14;LRP5;MOSPD2;RANBP9;PPP3CB;SLK;CDC42BPA;SCYL3;F2RL1;PROCR;JMY;PARP9;SPRY2;BEX4;ACVR1B;NGFR;IFITM1;RNF165;WASF2;ARF4;XBP1;ABHD6;RET;LOXL2;NAV1;C5;MBOAT7;NCKAP1;ELMO3;PAK6;ETV1;COL1A2;CCDC88A;CCSAP;TMSB4X;RAB1A;RHOBTB1;CMTM6;LAMB2;LPAR1;MMP10;LAMA5;GRB10;PPARG;GRB7;SRPX2;TBX1;SLC7A11;ADAM8;AKT3;ROBO3;ITGA4;CKLF;WASL;ARID5B;SEMA6C;FOXP1;PTCH1;SEMA3F;FADD
6646,GO:0023051,0.00118049915976714,0.999095028017567,241,2345,regulation of signaling,BP,TNIP1;DDIT4L;XDH;SMURF2;NOS1;ZMYND8;F2R;SORL1;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;ASAP2;ITGA6;CYP27B1;SERPINE2;PEAR1;IGFBP4;PRNP;PAG1;POSTN;SH3TC2;ADM2;NR1D1;NFATC4;MAP2K1;CMTM4;RAPGEF3;ACVR2B;LTBP1;SH3KBP1;ALOX15B;PKN1;WWTR1;MST1R;ARHGAP22;APLN;TNFSF15;APPL2;SSH1;DDIT3;PTPRS;HADH;PSMD2;CRTC1;EGFR;STK39;ARHGAP12;FYN;TSPAN5;BNIP3;ERCC6;ARAP1;DLG1;DLG4;GPC4;NET1;TGM2;GLUL;HTRA1;WNT7A;MAP4K4;GRK5;STRADB;ASPH;MCTP1;GDI1;SHC1;DKK1;PAK1;RASA3;SOCS2;TRIB2;TGFBR2;PTPN3;SHANK2;EPHA1;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;PTPN12;AFAP1;RGS14;PKD2;PRKACB;RBCK1;LRP1;ABCA7;WWC3;ICA1;LPAR3;FGFR1;ITGA1;TMOD2;CMTM7;NFAT5;BTRC;ITGA2;PTK6;VAMP2;LTBP4;INPP5F;CHAC1;FAM20C;PFN2;SOX4;ITPR3;CEACAM1;FERMT1;MAPKAPK3;UACA;FAM110C;NLK;EPN2;MDFI;TRIM5;RALGAPA1;DVL1;NTSR1;MMP14;NLGN2;CD46;MVB12B;CTH;LRP5;DNMBP;TRIB3;CASP4;PCSK6;RANBP9;DNAJB9;RIMS3;PPP3CB;MYOF;F2RL1;DDX60;TAOK1;CSNK2A1;PSMD7;PTHLH;CHD7;SLC25A4;ASAP1;ANO1;JMY;BOK;PARP9;C18ORF32;NACC2;SPRY2;SEPT5;THRA;MGLL;WNT2B;ACVR1B;NGFR;MVB12A;GLUD1;NUDT6;BCL2L1;RNF165;SKAP2;XBP1;UBASH3B;MAP2K2;ABHD6;PPP1R2;ARRDC1;TRPC1;RET;PDE5A;TCTN1;C5;MTMR4;EPM2A;PAK6;PUM2;SLC30A1;PSD3;TMBIM1;TMED4;SHC2;PRKACA;SAMD5;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RHOBTB1;SLC39A10;CMTM6;CARD11;FICD;LPAR1;TBL1X;IGF2;ITPR2;MOAP1;AGPAT1;PJA2;GRB10;MAP4K2;PPARG;SNX6;USP20;GRB7;ARHGAP29;TBX1;RPH3AL;ADAM8;AKT3;WFS1;ACAP2;MAML3;CKLF;TBC1D16;FZD8;LRP6;HPSE;RCAN1;DEDD2;FOXP1;PTCH1;KAT2B;UFL1;FAM162A;ANKRD6;RALGPS2;ADNP;GNAI1;LRP4;RB1CC1;TRIM38;FADD
19148,GO:1905153,0.00119381394647309,0.999949317089579,4,6,regulation of membrane invagination,BP,ABCA7;ITGA2;F2RL1;PPARG
6729,GO:0030141,0.00122924277019462,0.999245468169749,64,537,secretory granule,CC,PLAT;RAB3B;PYGL;PYGB;SERPINE2;PRSS3;THBS2;NAPRT;LY6K;PSMD2;LTA4H;LOXL1;PGM1;CTSB;CD68;STOM;SERPING1;SLC2A3;LCN2;CD44;ANXA3;ICA1;ITGA1;LPCAT1;VAMP2;ITPR3;VPS13A;CEACAM1;RAB31;BSG;CLCN3;CD46;CST3;MOSPD2;APLP2;COPB1;C6ORF120;PSMD7;QSOX1;SPESP1;GLB1;YPEL5;DNASE1L1;TMBIM1;PRKACA;TMSB4X;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;IGF2;ITPR2;TMEM63A;ERP44;RPH3AL;ADAM8;GARS;ATP11B;SYT2;TMEM173;HPSE;GALNS;DNAJC3
8836,GO:0034620,0.00124193852447365,0.99948572776225,22,131,cellular response to unfolded protein,BP,EDEM1;CCND1;DDIT3;SHC1;ATF4;ASNS;PDIA5;CTH;GFPT1;DNAJB9;SEC63;BOK;HSPA13;XBP1;EIF2AK2;KDELR3;FICD;CREB3L2;WFS1;HSPA2;SSR1;DNAJC3
19645,GO:1990851,0.0012440543654267,1,3,3,Wnt-Frizzled-LRP5/6 complex,CC,LRP5;FZD8;LRP6
323,GO:0000902,0.0012837440257793,0.999153383775289,88,690,cell morphogenesis,BP,VLDLR;SYNE3;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;FMNL2;SH3KBP1;SSH1;MAP1B;PTPRS;LAMB1;BRSK1;WIPF1;EGFR;SEMA4B;ANK3;FYN;KIF13B;PARVB;ARAP1;DLG1;DLG4;PLXNB3;NET1;WNT7A;MAP4K4;TTBK2;STRADB;GDI1;SHC1;DKK1;PAK1;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;APOE;LPAR3;ITGA1;ULK2;OBSL1;SH3D19;DVL1;MAP6;ZMYM3;TWF2;NTNG1;RANBP9;WASF3;BTBD3;PPP3CB;NGFR;PTPRZ1;RNF165;WASF2;RET;TCTN1;NCKAP1;ETV1;RAB1A;EPB41L3;RHOBTB1;LAMB2;LPAR1;TENM2;LAMA5;GRB10;ZMYM2;GRB7;ADAM8;ROBO3;ITGA4;WASL;FLNB;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;NYAP1;SEMA3F;ADNP;LRP4
10427,GO:0043270,0.001286197814615,0.999479597463135,21,120,positive regulation of ion transport,BP,FHL1;NOS1;F2R;RAB3B;STK39;ANK3;DLG1;CEMIP;APOE;PKD2;AKAP9;ABCA7;LPAR3;NTSR1;CNTN1;TRPC1;TMSB4X;ORAI1;WFS1;HSPA2;PRSS8
6651,GO:0023061,0.00128827965604278,0.999337636243983,36,242,signal release,BP,PCK2;NR1D1;RAPGEF3;ACVR2B;APLN;HADH;BRSK1;SNPH;EGFR;GLUL;WNT7A;MAP4K4;MCTP1;ICA1;FGFR1;VAMP2;LTBP4;PFN2;SOX4;ITPR3;DVL1;NLGN2;LRP5;RIMS3;PPP3CB;SYTL1;CHD7;SLC25A4;ANO1;SEPT5;GLUD1;SLC30A1;RAB1A;ITPR2;SYT2;SLC18A2
46,GO:0000098,0.00129444121388406,0.99993239667178,4,7,sulfur amino acid catabolic process,BP,CBS;CTH;BLMH;PCYOX1
12421,GO:0048869,0.0013047987658808,0.99898543739806,274,2674,cellular developmental process,BP,FHL1;XDH;NOS1;ERCC1;ZMYND8;SORL1;FLNC;ETV5;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;SYNE3;ITGA6;CYP27B1;SERPINE2;ADGRF1;OSBP2;ITGB4;ACTA2;BBS2;POSTN;SH3TC2;BTBD2;NR1D1;HECW2;NFATC4;ADARB1;MAP2K1;FAM210B;FMNL2;ETV4;RAPGEF3;ACVR2B;SH3KBP1;ALOX15B;COL13A1;WWTR1;MST1R;ARHGAP22;MICALCL;POU2F2;DHTKD1;SSH1;MAP1B;DDIT3;PTPRS;SMARCA1;SOX12;PSMD2;LAMB1;SDK2;ELK3;CRTC1;CAPN2;BRSK1;WIPF1;SNPH;EGFR;SEMA4B;ANK3;FYN;BNIP3;KIF13B;UBE2J1;PARVB;MYCBPAP;ARAP1;ADAMTS7;ZNF516;DLG1;CSMD3;DLG4;IDH2;CTSB;PLXNB3;PODXL;NET1;HTRA1;GLO1;WNT7A;MAP4K4;TTBK2;GRK5;STRADB;RDH14;GDI1;UNC119B;SDC1;ARG2;SHC1;DKK1;SLFN5;PAK1;SOCS2;TRIB2;ATXN10;RAG1;MRC2;TGFBR2;EDNRA;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;OBSCN;APOE;ANGPTL4;RGS14;LRP1;HMGA2;PPARA;LPAR3;FGFR1;ITGA1;EPCAM;TMOD2;CMTM7;TCFL5;SMOC1;ITGB5;ITGA2;PTK6;ULK2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;ABCG1;KIAA1109;SOX4;CEP120;CEACAM1;OBSL1;PRR9;SH3D19;MDFI;TNRC6B;DVL1;MMP14;CD46;CTH;MAP6;LRP5;ZMYM3;CTSL;TWF2;CST3;CNTN1;TRIB3;NTNG1;PCSK6;L3MBTL3;RANBP9;WASF3;DNAJB9;BTBD3;PPP3CB;MEX3C;MYOF;RFX2;CEBPG;PLAG1;F2RL1;UHRF2;RASIP1;PSMD7;PTHLH;TST;CHD7;ASAP1;PRKAR1A;BOK;SPRY2;THRA;WNT2B;ACVR1B;DBNDD1;COL6A1;NGFR;PTPRZ1;BCL2L1;IFITM1;RNF165;MEF2D;WASF2;ARF4;XBP1;UBASH3B;TXNRD3;SATB1;REC8;RET;SPATA6;CCDC71L;LOXL2;PDE5A;TCTN1;NAV1;SH3PXD2B;MBOAT7;NCKAP1;DOCK11;ETV1;CCDC88A;CCSAP;PRKACA;NEK6;TIMP2;EIF2AK2;RAB1A;EPB41L3;IFI16;RHOBTB1;BCAP29;NR2F6;IL1RAP;CARD11;LAMB2;LPAR1;ZNF354A;CTSZ;AP3D1;ARID4A;TENM2;IGF2;LAMA5;GRB10;ZMYM2;PPARG;GRB7;PPL;ALDH1A2;TBX1;SLC7A11;CREB3L2;ADAM8;AKT3;ROBO3;ITGA4;FZD8;WASL;HSPA2;PRSS8;FLNB;LRP6;ARID5B;SYT2;E2F7;EEF2K;SEMA6C;TNRC6C;TET1;OMG;FOXP1;PTCH1;ADCY1;KAT2B;SEPT6;NYAP1;UFL1;PBX3;JARID2;SEMA3F;ADNP;LRP4;DNMT3A;FADD
9901,GO:0042219,0.00131571408863628,0.999830487340619,6,17,cellular modified amino acid catabolic process,BP,ALDH1L2;CHAC1;PM20D2;PCYOX1;ALDH4A1;GGACT
10893,GO:0044433,0.00131713757918686,0.99908461834342,114,1037,cytoplasmic vesicle part,CC,SORL1;RAB3B;PYGL;PYGB;PRSS3;ANTXR2;SH3KBP1;NAPRT;APPL2;PTPRS;PSMD2;SNTB2;LTA4H;EGFR;DYSF;PGM1;DLG4;CTSB;CD68;SNX9;SLC9A7;WNT7A;SEC23A;MCTP1;CEMIP;STOM;DKK1;SERPING1;SLC2A3;LCN2;RAC2;CD44;APOE;MCFD2;PKD2;LRP1;RAB11FIP4;ANXA3;ABCA7;ICA1;SNX14;LPCAT1;VAMP2;ULK2;INPP5F;ITPR3;CEACAM1;RAB31;LMAN1;DMXL2;BSG;EPN2;CLCN3;ANXA6;CD46;MVB12B;MAP6;ABHD17C;CTSL;CST3;CLTCL1;VPS11;MOSPD2;MYOF;ZDHHC2;APLP2;COPB1;COPG1;C6ORF120;PSMD7;QSOX1;BOK;DBNDD1;MVB12A;BCL2L1;GLB1;YPEL5;SPIRE1;RET;RAB43;MTMR4;ZFYVE9;DNASE1L1;TMBIM1;TMSB4X;TIMP2;RAB1A;AP2A2;CMTM6;CTSZ;AP3D1;NIT2;IGF2;ITPR2;TMEM63A;SNX6;ERP44;RPH3AL;ADAM8;ATP11B;ACAP2;TMEM9;MARCH2;WASL;LRP6;SYT2;TMEM173;SLC18A2;HPSE;GALNS;DNAJC3;ZFYVE21;PTCH1;SNX27
10310,GO:0043085,0.00132624969470416,0.999075775839865,116,1024,positive regulation of catalytic activity,BP,DOCK4;XDH;NOS1;F2R;SORL1;CCND1;NEURL1;VLDLR;ASAP2;ITGA6;CYP27B1;ADCY7;PRNP;MAP2K1;RAPGEF3;ACVR2B;LMF1;PKN1;MST1R;ARHGAP22;TNFSF15;EGFR;TBC1D14;STK39;RIN2;ARHGAP12;FYN;ERCC6;ARAP1;DLG1;DLG4;SNX9;NET1;EVI5L;MAP4K4;STRADB;ASPH;GDI1;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;RASA3;TGFBR2;EDNRA;EPHA1;RALGAPA2;APOE;CCND2;RGS14;PKD2;PRKACB;SRGAP2B;LPAR3;FGFR1;ITGA1;ITGA2;PFN2;MAPKAPK3;RALGAPA1;TCEA1;MMP14;ETAA1;DNMBP;DOCK9;TRIB3;CASP4;SLK;F2RL1;TAOK1;ASAP1;PRKAR1A;BOK;USP6NL;SPRY2;TBC1D2B;NGFR;AZIN2;ARF4;MAP2K2;RIN1;RET;PDE5A;SH3PXD2B;C5;GABARAPL2;DOCK11;PAK6;CCDC88A;SHC2;PRKACA;TMSB4X;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;LPAR1;IGF2;MAP4K2;PPARG;ARHGAP29;EVI5;ADAM8;DEPDC1;ACAP2;TBC1D16;FZD8;HSPA2;PSEN2;ADCY1;FAM162A;ADNP;FADD
11689,GO:0046473,0.00135359291996482,0.999712619597297,9,31,phosphatidic acid metabolic process,BP,DGKA;AGPAT4;LPCAT4;LPCAT1;PLA2G4D;AGPAT3;ACP6;AGPAT1;DDHD2
7335,GO:0031345,0.00136730494707237,0.999431461041457,22,124,negative regulation of cell projection organization,BP,PRNP;NFATC4;PTPRS;SEMA4B;FYN;PLXNB3;EVI5L;MAP4K4;GDI1;APOE;LRP1;ULK2;INPP5F;PFN2;ASAP1;SPRY2;NGFR;LPAR1;CTSZ;OMG;SEMA3F;LRP4
12679,GO:0050890,0.00141782546326742,0.99935893025842,26,155,cognition,BP,VLDLR;PRNP;ADGRF1;CRTC1;EGFR;FYN;DLG4;DKK1;RAG1;SHANK2;APOE;CCND2;RGS14;ABCA7;TMOD2;ITPR3;NTSR1;PPP3CB;CHD7;THRA;PTPRZ1;ARF4;PJA2;DDHD2;ADCY1;ADNP
17694,GO:1901575,0.00144591693359139,0.998932487054476,166,1624,organic substance catabolic process,BP,XDH;NT5E;SMURF2;EDEM1;GID4;NOS1;SORL1;PCK2;VLDLR;PYGL;CBS;CYP27B1;PYGB;H1F0;SERPINE2;CRYL1;GPT2;BTBD2;NR1D1;HECW2;RAPGEF3;WWTR1;DHTKD1;DDIT3;HADH;PSMD2;LTA4H;CAPN2;EGFR;FYN;BNIP3;UBE2J1;PGM1;ADAMTS7;CTSB;GPC4;SNX9;TYSND1;GLUL;UBXN4;IGF2BP3;ACOT7;CEMIP;ACAD11;SDC1;ARG2;TRIB2;PTPN3;HAGH;CD44;APOE;BNIP3L;ABCD1;ALDH1L2;RBCK1;LRP1;LDHA;IDE;ABTB1;UBE2G1;PPARA;ABHD10;RNPEPL1;HYAL1;BTRC;LPCAT1;AIG1;LONP2;INPP5F;CHAC1;RMND5A;APOBEC3C;FBXO2;IAH1;CEACAM1;SPATA18;SH3D19;XRN1;TNRC6B;DVL1;NTSR1;PLA2G4D;ACAD10;MVB12B;CTH;LRP5;ABHD17C;CTSL;CST3;TRIB3;VPS11;DNAJB9;BTBD3;HIBADH;MLYCD;ALDH7A1;PLD3;CSNK2A1;PSMD7;TST;BLMH;CPT2;CTBS;THRA;MGLL;MVB12A;GLUD1;NPL;MTA1;AZIN2;CRAT;RNF165;PM20D2;GLB1;PCYOX1;XBP1;ABHD6;PAIP1;ARRDC1;ANKIB1;LYPLAL1;PDE5A;GABARAPL2;DNASE1L1;UBE2E1;PUM2;CTSO;PRKACA;TIMP2;SEL1L;AP2A2;SRD5A3;CTSZ;TBL1X;BLVRA;ERLEC1;USP20;LYPLA1;ADAM8;ALDH4A1;WFS1;ENDOG;DDHD2;USP32;MAGEF1;PLCH2;RNF180;GGACT;HPSE;GALNS;TNRC6C;TET1;DEDD2;DNAJC3;AOX1;CNOT11;RNF103;USP25;UFL1;AMACR;GALE;KLHL15;SLC44A1;STT3B;RB1CC1;FBXL5
4967,GO:0015075,0.00149529762877268,0.999102842501882,57,442,ion transmembrane transporter activity,MF,SCN8A;SLC16A3;KCNG1;DENND5B;SLC33A1;DLG1;DLG4;SLCO4A1;SLC9A7;DLG3;RASA3;SLC2A3;CLCA2;ATP7B;PKD2;FAM155B;ITPR3;CEACAM1;SLC5A1;BSG;CLCN3;ANXA6;ORAI3;NIPA1;SLC35B4;TTYH3;ANO8;SLC2A9;SLC6A6;SLC25A4;ANO1;SLC6A14;NDUFA4L2;SLC43A1;AZIN2;GRIN3B;SLC12A7;PCYOX1;SLC22A17;SLC38A2;TRPC1;SLC13A3;KCNJ15;SLC30A1;SFXN3;SLC39A10;ORAI1;ITPR2;SLC2A13;SLC10A6;ATP12A;SLC7A11;ATP6V1B2;ATP11B;SLC18A2;SLC23A2;SLC44A1
6600,GO:0022617,0.00149654847906395,0.999549747222736,13,57,extracellular matrix disassembly,BP,MMP1;CAPN2;HTRA1;CD44;LRP1;BSG;MMP14;CTSL;CST3;SH3PXD2B;TIMP2;MMP10;ADAM8
10081,GO:0042581,0.00150496397246583,0.999431767907635,18,101,specific granule,CC,STOM;SLC2A3;LCN2;ANXA3;CEACAM1;CLCN3;MOSPD2;QSOX1;DNASE1L1;TMBIM1;TIMP2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;HPSE
7458,GO:0031594,0.00151471463818282,0.999636242750916,10,37,neuromuscular junction,CC,F2R;SERPINE2;POSTN;ANK3;DLG1;DLG4;DLG3;PRKAR1A;PSEN2;LRP4
1707,GO:0004252,0.0015193962574337,0.999509602204364,14,73,serine-type endopeptidase activity,MF,PLAT;MMP1;PRSS3;TMPRSS11D;CTSB;TYSND1;HTRA1;LONP2;MMP14;CTSL;PCSK6;MMP10;ADAM8;PRSS8
11434,GO:0045859,0.00151985140454809,0.99903547619631,71,583,regulation of protein kinase activity,BP,F2R;SORL1;CCND1;NEURL1;VLDLR;ADCY7;PRNP;ADARB1;MAP2K1;ACVR2B;PKN1;WWTR1;MST1R;TNFSF15;EGFR;STK39;ERCC6;DLG1;DLG4;SNX9;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;SOCS2;TRIB2;TGFBR2;EPHA1;RAC2;APOE;CCND2;RGS14;PKD2;PRKACB;LPAR3;FGFR1;ITGA1;PTK6;CEACAM1;MAPKAPK3;DVL1;LRP5;ETAA1;TRIB3;SLK;TAOK1;PRKAR1A;SPRY2;UBASH3B;MAP2K2;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;EIF2AK2;LPAR1;IGF2;MAP4K2;SNX6;ADAM8;FZD8;LRP6;DNAJC3;ADCY1;KAT2B;ADNP
2533,GO:0005789,0.00153674796349306,0.998974408392692,89,795,endoplasmic reticulum membrane,CC,EDEM1;NOS1;MBOAT2;ANTXR2;LMF1;EGFR;SLC33A1;UBE2J1;UBXN7;ELOVL1;DLG1;UBXN4;SPTLC2;SEC23A;RDH14;ASPH;MCTP1;ERO1B;FKBP1A;MCFD2;PKD2;DDN;PIGH;AGPAT4;LPCAT4;LPCAT1;ABCG1;PITPNM1;ITPR3;KDSR;PDIA5;LMAN1;SARAF;TMEM86B;SEC22C;SLC35B4;CASP4;DNAJB9;SEC63;COPB1;COPG1;PLD3;ATP10D;BOK;MGLL;PSKH1;AGPAT3;HSD17B7;XBP1;CYP4F22;OSBPL5;TXNDC11;MBOAT7;TMED4;SAMD8;RAB1A;SEL1L;BCAP29;SRD5A3;KDELR3;FICD;ITPR2;AGPAT1;PJA2;EVA1A;TRIQK;TMEM50B;ESYT3;CREB3L2;ERP44;WFS1;IKBIP;SSR3;MARCH2;REEP6;TMEM173;RNF180;SIGMAR1;SSR1;DNAJC3;PSEN2;ELOVL4;HSD17B12;CDS2;RNF103;REEP3;UFL1;STT3B;RB1CC1
6626,GO:0022857,0.0015533638721148,0.99903036432674,66,533,transmembrane transporter activity,MF,SCN8A;SLC16A3;SLC29A4;KCNG1;DENND5B;SLC33A1;DLG1;DLG4;SLCO4A1;SLC9A7;DLG3;RASA3;SLC2A3;CLCA2;ATP7B;ABCD1;PKD2;ABCA7;FAM155B;ABCG1;ITPR3;CEACAM1;SLC5A1;SLC35F2;BSG;CLCN3;ANXA6;ORAI3;NIPA1;SLC35B4;SLC35G2;TTYH3;ANO8;SLC2A9;SLC6A6;SLC25A4;ANO1;SLC6A14;NDUFA4L2;SLC43A1;AZIN2;GRIN3B;SLC12A7;PCYOX1;SLC22A17;SLC38A2;TRPC1;SLC13A3;KCNJ15;SLC30A1;SFXN3;SLC25A30;SLC39A10;SLC25A43;ORAI1;ITPR2;SLC2A13;SLC10A6;ATP12A;SLC7A11;ATP6V1B2;ATP11B;LRP6;SLC18A2;SLC23A2;SLC44A1
12878,GO:0051208,0.00155762925763554,0.999479516530236,15,69,sequestering of calcium ion,BP,NOS1;F2R;DDIT3;CEMIP;RASA3;FKBP1A;ATP7B;PKD2;ITPR3;NTSR1;CHD7;UBASH3B;TRPC1;PRKACA;ITPR2
10377,GO:0043197,0.00156824145752902,0.999390952639446,19,100,dendritic spine,CC,NOS1;ZMYND8;NEURL1;NR1D1;MAP1B;DLG4;SHANK2;RGS14;DDN;FBXO2;DVL1;NTSR1;ABHD17C;ASAP1;CPEB4;ARF4;LPAR1;TENM2;EEF2K
17254,GO:0120034,0.00161049835372461,0.999457574359741,15,72,positive regulation of plasma membrane bounded cell projection assembly,BP,ZMYND8;NEURL1;ARAP1;ESPN;RAC2;CEP120;TWF2;FNBP1L;F2RL1;WASF2;NCKAP1;DOCK11;CCDC88A;TENM2;WASL
2532,GO:0005788,0.00162881001396587,0.999218417165594,29,185,endoplasmic reticulum lumen,CC,IGFBP4;LTBP1;COL13A1;H6PD;LAMB1;ADAMTS7;WNT7A;CRTAP;APOE;FAM20C;FKBP10;PDIA5;CST3;DNAJB9;APLP2;ANO8;QSOX1;COL6A1;VWA1;COL1A2;ADAMTSL1;LAMB2;CTSZ;ERLEC1;EVA1A;ERP44;WFS1;IGFBP7;DNAJC3
7136,GO:0030968,0.0016424347661757,0.999336954511861,20,117,endoplasmic reticulum unfolded protein response,BP,EDEM1;CCND1;DDIT3;SHC1;ATF4;ASNS;PDIA5;CTH;GFPT1;DNAJB9;SEC63;BOK;XBP1;EIF2AK2;KDELR3;FICD;CREB3L2;WFS1;SSR1;DNAJC3
9833,GO:0042058,0.00164556143940119,0.999467067400406,14,69,regulation of epidermal growth factor receptor signaling pathway,BP,NEURL1;SH3KBP1;EGFR;ARAP1;SHC1;PTPN3;PTPN12;ITGA1;PTK6;CEACAM1;MVB12B;SPRY2;MVB12A;SNX6
12718,GO:0050954,0.00165280530953502,0.99944029490942,15,74,sensory perception of mechanical stimulus,BP,SERPINE2;FYN;ESPN;CEMIP;SLITRK6;FGFR1;TUB;ITGA2;ALDH7A1;CHD7;SPRY2;ZNF354A;TBL1X;TBX1;WFS1
16865,GO:0098794,0.00165579080396176,0.999112388345616,39,258,postsynapse,CC,NOS1;ZMYND8;F2R;NEURL1;PRNP;NR1D1;COL13A1;MAP1B;PTPRS;ANK3;FYN;BNIP3;DLG1;DLG4;DLG3;SHANK2;RGS14;DDN;FBXO2;DVL1;NTSR1;NLGN2;MPDZ;ABHD17C;DNAJC6;ASAP1;CPEB4;GRIN3B;ARF4;PSD3;EPB41L3;LPAR1;AP3D1;TENM2;PJA2;EEF2K;SIGMAR1;PTCH1;LRP4
8654,GO:0034199,0.00165856177759896,0.999850878225385,5,10,activation of protein kinase A activity,BP,ADCY7;PRKACB;PRKAR1A;PRKACA;ADCY1
5003,GO:0015145,0.00165964965318241,0.999842242574714,5,11,monosaccharide transmembrane transporter activity,MF,SLC2A3;SLC5A1;SLC2A9;SLC2A13;SLC23A2
17746,GO:1901681,0.0016847847441584,0.99926855394066,23,140,sulfur compound binding,MF,PGF;CBS;SERPINE2;POSTN;THBS2;LTBP2;COL13A1;DHTKD1;PC;PTPRS;GPC4;ACOT7;WISP1;SMOC2;APOE;LRP1;FGFR1;ITGA2;THBS3;PCSK6;APLP2;HSD17B12;PTCH1
4566,GO:0010647,0.00170666193418069,0.99878423122463,126,1150,positive regulation of cell communication,BP,XDH;SMURF2;NOS1;F2R;RAB3B;NEURL1;PCK2;SH2D2A;CYP27B1;SERPINE2;IGFBP4;PRNP;PAG1;NFATC4;MAP2K1;ACVR2B;ALOX15B;PKN1;MST1R;APLN;TNFSF15;SSH1;DDIT3;PSMD2;CRTC1;EGFR;STK39;ANK3;FYN;TSPAN5;BNIP3;ERCC6;ARAP1;DLG4;TGM2;GLUL;WNT7A;MAP4K4;SHC1;DKK1;PAK1;SOCS2;SHANK2;EPHA1;CD44;APOE;FKBP1A;RGS14;PKD2;RBCK1;ABCA7;LPAR3;FGFR1;ITGA1;TMOD2;ITGA2;PTK6;VAMP2;SOX4;ITPR3;FERMT1;MAPKAPK3;FAM110C;EPN2;TRIM5;DVL1;NTSR1;NLGN2;CTH;CASP4;RIMS3;PPP3CB;F2RL1;DDX60;TAOK1;CSNK2A1;PSMD7;ANO1;BOK;PARP9;C18ORF32;NACC2;SPRY2;WNT2B;ACVR1B;NGFR;GLUD1;BCL2L1;RNF165;SKAP2;XBP1;MAP2K2;RET;PDE5A;C5;PUM2;TMED4;SHC2;NEK6;RGL2;TIMP2;EIF2AK2;SLC39A10;CARD11;LPAR1;TBL1X;IGF2;MOAP1;AGPAT1;GRB10;MAP4K2;GRB7;TBX1;ADAM8;AKT3;MAML3;FZD8;LRP6;HPSE;DEDD2;KAT2B;FAM162A;ANKRD6;RB1CC1;TRIM38;FADD
7694,GO:0032147,0.00176055394920519,0.99908609519526,35,237,activation of protein kinase activity,BP,F2R;ADCY7;PRNP;MAP2K1;ACVR2B;PKN1;TNFSF15;EGFR;STK39;ERCC6;DLG1;MAP4K4;STRADB;SHC1;PAK1;TGFBR2;PRKACB;LPAR3;ITGA1;MAPKAPK3;SLK;TAOK1;PRKAR1A;MAP2K2;C5;PAK6;CCDC88A;SHC2;PRKACA;EIF2AK2;LPAR1;IGF2;MAP4K2;ADCY1;ADNP
16886,GO:0098827,0.00178231325662545,0.998803776955382,89,799,endoplasmic reticulum subcompartment,CC,EDEM1;NOS1;MBOAT2;ANTXR2;LMF1;EGFR;SLC33A1;UBE2J1;UBXN7;ELOVL1;DLG1;UBXN4;SPTLC2;SEC23A;RDH14;ASPH;MCTP1;ERO1B;FKBP1A;MCFD2;PKD2;DDN;PIGH;AGPAT4;LPCAT4;LPCAT1;ABCG1;PITPNM1;ITPR3;KDSR;PDIA5;LMAN1;SARAF;TMEM86B;SEC22C;SLC35B4;CASP4;DNAJB9;SEC63;COPB1;COPG1;PLD3;ATP10D;BOK;MGLL;PSKH1;AGPAT3;HSD17B7;XBP1;CYP4F22;OSBPL5;TXNDC11;MBOAT7;TMED4;SAMD8;RAB1A;SEL1L;BCAP29;SRD5A3;KDELR3;FICD;ITPR2;AGPAT1;PJA2;EVA1A;TRIQK;TMEM50B;ESYT3;CREB3L2;ERP44;WFS1;IKBIP;SSR3;MARCH2;REEP6;TMEM173;RNF180;SIGMAR1;SSR1;DNAJC3;PSEN2;ELOVL4;HSD17B12;CDS2;RNF103;REEP3;UFL1;STT3B;RB1CC1
9958,GO:0042327,0.00178446214270348,0.998832916160098,79,656,positive regulation of phosphorylation,BP,XDH;F2R;CCND1;NEURL1;VLDLR;ITGA6;ADCY7;IGFBP4;PRNP;MAP2K1;RAPGEF3;ACVR2B;PKN1;MST1R;APLN;TNFSF15;EGFR;STK39;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;TGFBR2;EPHA1;CD44;CCND2;PKD2;PRKACB;AKAP9;ABCA7;LPAR3;FGFR1;ITGA1;PTK6;PFN2;MAPKAPK3;TRIM5;DVL1;ETAA1;CNTN1;SLK;F2RL1;TAOK1;PRKAR1A;PARP9;SPRY2;ACVR1B;NGFR;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;TIMP2;EIF2AK2;LPAR1;IGF2;MAP4K2;TBX1;ADAM8;FZD8;HSPA2;ADCY1;ANKRD6;ADNP;LRP4;RB1CC1
1479,GO:0003756,0.00178447351018229,0.999755459070129,6,17,protein disulfide isomerase activity,MF,ERO1B;TMX4;PDIA5;QSOX1;TXNDC11;ERP44
5725,GO:0016864,0.00178447351018229,0.999755459070129,6,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,ERO1B;TMX4;PDIA5;QSOX1;TXNDC11;ERP44
13797,GO:0060384,0.00184265891426768,0.999756573966393,6,15,innervation,BP,SERPINE2;ADARB1;SLITRK6;CHD7;RNF165;RET
14312,GO:0061448,0.0018606487754017,0.999171290820988,24,142,connective tissue development,BP,ACTA2;BBS2;ADAMTS7;ZNF516;WNT7A;TGFBR2;CD44;HMGA2;FGFR1;HYAL1;LRP5;THBS3;MEX3C;PTHLH;THRA;WNT2B;MEF2D;XBP1;LOXL2;SH3PXD2B;HOXA3;CREB3L2;LRP6;ARID5B
16813,GO:0098660,0.00186609227668891,0.998890606418819,53,405,inorganic ion transmembrane transport,BP,FHL1;NOS1;F2R;SCN8A;PRNP;HECW2;DDIT3;KCNG1;DENND5B;STK39;ANK3;FYN;SLC33A1;DLG1;SLC9A7;CEMIP;STOM;RASA3;PTPN3;CLCA2;FKBP1A;ATP7B;PKD2;AKAP9;FAM155B;VAMP2;ITPR3;CLCN3;NTSR1;ORAI3;NIPA1;TTYH3;SLC2A9;CHD7;ANO1;NDUFA4L2;GRIN3B;SLC12A7;PCYOX1;UBASH3B;MICU3;TRPC1;KCNJ15;SLC30A1;PRKACA;TMSB4X;SLC39A10;ORAI1;ITPR2;SLC2A13;ATP12A;ATP6V1B2;HSPA2
2384,GO:0005520,0.00189438053123747,0.999742340850933,6,16,insulin-like growth factor binding,MF,ITGA6;IGFBP4;ITGB4;HTRA1;WISP1;IGFBP7
19935,GO:2000463,0.00192670075825277,0.999737034686543,6,16,positive regulation of excitatory postsynaptic potential,BP,SSH1;DLG4;WNT7A;SHANK2;DVL1;NLGN2
3718,GO:0008236,0.00195574399543213,0.999290692334222,16,91,serine-type peptidase activity,MF,PLAT;MMP1;PRSS3;TMPRSS11D;CTSB;TYSND1;HTRA1;LONP2;MMP14;CTSL;PCSK6;AEBP1;ZFYVE9;MMP10;ADAM8;PRSS8
10522,GO:0043436,0.00196219472224325,0.998677737981925,89,817,oxoacid metabolic process,BP,NOS1;PCK2;CBS;CYGB;CRYL1;GPT2;NR1D1;SLC16A3;ALOX15B;DHTKD1;PC;B4GALT6;HADH;CARS;PSMD2;LTA4H;PSAT1;ELOVL1;PGM1;B3GNT3;IDH2;ACOT1;TYSND1;GLUL;GLO1;ACSF2;ACOT7;CRTAP;CEMIP;ACAD11;ARG2;NAGS;CBR4;SLC2A3;HAGH;ERO1B;CD44;ABCD1;ALDH1L2;LDHA;ATF4;PPARA;ASNS;ABHD10;AARS;UROS;HYAL1;AIG1;LONP2;MTHFR;AHCYL2;GAMT;CEACAM1;BSG;ACAD10;CTH;TRIB3;GFPT1;HIBADH;MLYCD;ALDH7A1;SLC6A6;PSMD7;BLMH;CPT2;SLC6A14;MGLL;BPHL;GLUD1;NPL;AZIN2;CRAT;PM20D2;GLB1;PCYOX1;XBP1;CYP4F22;NIT2;PPARG;PTGR2;ALDH1A2;LYPLA1;ALDH4A1;GARS;GALNS;ELOVL4;HSD17B12;AMACR;SLC23A2
8498,GO:0033674,0.00199265111215117,0.998805466442827,54,413,positive regulation of kinase activity,BP,F2R;CCND1;NEURL1;VLDLR;ADCY7;PRNP;MAP2K1;ACVR2B;PKN1;MST1R;TNFSF15;EGFR;STK39;ERCC6;DLG1;DLG4;SNX9;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;TGFBR2;EPHA1;CCND2;PKD2;PRKACB;LPAR3;FGFR1;ITGA1;MAPKAPK3;ETAA1;SLK;TAOK1;PRKAR1A;SPRY2;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;EIF2AK2;LPAR1;IGF2;MAP4K2;ADAM8;FZD8;ADCY1;ADNP
6736,GO:0030154,0.00199631896201989,0.998441040837796,258,2518,cell differentiation,BP,FHL1;XDH;NOS1;ERCC1;ZMYND8;SORL1;FLNC;ETV5;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;ITGA6;CYP27B1;SERPINE2;ADGRF1;OSBP2;ITGB4;ACTA2;BBS2;POSTN;SH3TC2;BTBD2;NR1D1;HECW2;NFATC4;ADARB1;MAP2K1;FAM210B;ETV4;RAPGEF3;ACVR2B;SH3KBP1;ALOX15B;COL13A1;WWTR1;MST1R;ARHGAP22;MICALCL;POU2F2;DHTKD1;SSH1;MAP1B;DDIT3;PTPRS;SMARCA1;SOX12;PSMD2;LAMB1;SDK2;ELK3;CRTC1;CAPN2;BRSK1;SNPH;EGFR;SEMA4B;ANK3;FYN;BNIP3;KIF13B;UBE2J1;PARVB;MYCBPAP;ADAMTS7;ZNF516;CSMD3;DLG4;IDH2;CTSB;PLXNB3;PODXL;NET1;HTRA1;GLO1;WNT7A;MAP4K4;GRK5;RDH14;GDI1;UNC119B;SDC1;SHC1;DKK1;SLFN5;PAK1;SOCS2;TRIB2;ATXN10;RAG1;MRC2;TGFBR2;EDNRA;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;OBSCN;APOE;ANGPTL4;RGS14;LRP1;HMGA2;PPARA;LPAR3;FGFR1;ITGA1;EPCAM;TMOD2;CMTM7;TCFL5;SMOC1;ITGB5;ITGA2;PTK6;ULK2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;ABCG1;KIAA1109;SOX4;CEP120;CEACAM1;OBSL1;PRR9;MDFI;TNRC6B;DVL1;MMP14;CD46;CTH;MAP6;LRP5;CTSL;TWF2;CST3;CNTN1;TRIB3;NTNG1;PCSK6;L3MBTL3;RANBP9;WASF3;DNAJB9;BTBD3;PPP3CB;MEX3C;MYOF;RFX2;CEBPG;PLAG1;F2RL1;UHRF2;RASIP1;PSMD7;PTHLH;TST;CHD7;ASAP1;PRKAR1A;BOK;SPRY2;THRA;WNT2B;ACVR1B;DBNDD1;COL6A1;NGFR;PTPRZ1;BCL2L1;IFITM1;RNF165;MEF2D;WASF2;ARF4;XBP1;UBASH3B;TXNRD3;SATB1;REC8;RET;SPATA6;CCDC71L;LOXL2;PDE5A;TCTN1;NAV1;SH3PXD2B;MBOAT7;NCKAP1;DOCK11;ETV1;CCDC88A;CCSAP;PRKACA;TIMP2;EIF2AK2;RAB1A;EPB41L3;IFI16;BCAP29;NR2F6;IL1RAP;CARD11;LAMB2;LPAR1;CTSZ;AP3D1;ARID4A;TENM2;IGF2;LAMA5;GRB10;PPARG;GRB7;PPL;ALDH1A2;TBX1;SLC7A11;CREB3L2;ADAM8;ROBO3;ITGA4;FZD8;WASL;HSPA2;PRSS8;FLNB;LRP6;ARID5B;SYT2;E2F7;EEF2K;SEMA6C;TNRC6C;TET1;OMG;FOXP1;PTCH1;ADCY1;KAT2B;SEPT6;NYAP1;UFL1;PBX3;JARID2;SEMA3F;ADNP;LRP4;DNMT3A;FADD
2378,GO:0005509,0.00200710007767618,0.998817041101906,51,368,calcium ion binding,MF,EDEM1;VLDLR;PRSS3;THBS2;LTBP2;LTBP1;ALOX15B;DGKA;CAPN2;DYSF;CGREF1;PCDHAC2;FKBP9;ASPH;MCTP1;SMOC2;NUCB2;MCFD2;PKD2;LRP1;RAB11FIP4;PPP2R3B;ANXA3;SMOC1;LPCAT1;GALNT3;FAT1;LTBP4;FAM20C;FKBP10;PITPNM1;ITPR3;NELL2;ANXA6;THBS3;PPP3CB;SYTL1;MICU3;RET;MCTP2;PCDH1;TENM2;ITPR2;EFCAB7;RPH3AL;ADAM8;USP32;SYT2;PLCH2;EEF2K;LRP4
7474,GO:0031638,0.0020195767347055,0.999582799927857,8,31,zymogen activation,BP,PLAT;SERPINE2;PRSS3;ASPH;MMP14;IFI16;CTSZ;FADD
13276,GO:0051963,0.00204635559833187,0.999442287003881,11,43,regulation of synapse assembly,BP,THBS2;ADGRL1;WNT7A;SLITRK6;NLGN2;TPBG;ADGRB2;IL1RAP;SRPX2;EEF2K;ADNP
9893,GO:0042175,0.00205037828518094,0.998613622957175,90,810,nuclear outer membrane-endoplasmic reticulum membrane network,CC,EDEM1;NOS1;MBOAT2;SYNE3;ANTXR2;LMF1;EGFR;SLC33A1;UBE2J1;UBXN7;ELOVL1;DLG1;UBXN4;SPTLC2;SEC23A;RDH14;ASPH;MCTP1;ERO1B;FKBP1A;MCFD2;PKD2;DDN;PIGH;AGPAT4;LPCAT4;LPCAT1;ABCG1;PITPNM1;ITPR3;KDSR;PDIA5;LMAN1;SARAF;TMEM86B;SEC22C;SLC35B4;CASP4;DNAJB9;SEC63;COPB1;COPG1;PLD3;ATP10D;BOK;MGLL;PSKH1;AGPAT3;HSD17B7;XBP1;CYP4F22;OSBPL5;TXNDC11;MBOAT7;TMED4;SAMD8;RAB1A;SEL1L;BCAP29;SRD5A3;KDELR3;FICD;ITPR2;AGPAT1;PJA2;EVA1A;TRIQK;TMEM50B;ESYT3;CREB3L2;ERP44;WFS1;IKBIP;SSR3;MARCH2;REEP6;TMEM173;RNF180;SIGMAR1;SSR1;DNAJC3;PSEN2;ELOVL4;HSD17B12;CDS2;RNF103;REEP3;UFL1;STT3B;RB1CC1
6648,GO:0023056,0.00205230787309462,0.998529415669816,126,1156,positive regulation of signaling,BP,XDH;SMURF2;NOS1;F2R;RAB3B;NEURL1;PCK2;SH2D2A;CYP27B1;SERPINE2;IGFBP4;PRNP;PAG1;NFATC4;MAP2K1;ACVR2B;ALOX15B;PKN1;MST1R;APLN;TNFSF15;SSH1;DDIT3;PSMD2;CRTC1;EGFR;STK39;FYN;TSPAN5;BNIP3;ERCC6;ARAP1;DLG4;TGM2;GLUL;WNT7A;MAP4K4;SHC1;DKK1;PAK1;SOCS2;SHANK2;EPHA1;CD44;APOE;FKBP1A;RGS14;PKD2;RBCK1;ABCA7;LPAR3;FGFR1;ITGA1;TMOD2;ITGA2;PTK6;VAMP2;INPP5F;SOX4;ITPR3;FERMT1;MAPKAPK3;FAM110C;EPN2;TRIM5;DVL1;NTSR1;NLGN2;CTH;CASP4;RIMS3;PPP3CB;F2RL1;DDX60;TAOK1;CSNK2A1;PSMD7;ANO1;BOK;PARP9;C18ORF32;NACC2;SPRY2;WNT2B;ACVR1B;NGFR;GLUD1;BCL2L1;RNF165;SKAP2;XBP1;MAP2K2;RET;PDE5A;C5;PUM2;TMED4;SHC2;NEK6;RGL2;TIMP2;EIF2AK2;SLC39A10;CARD11;LPAR1;TBL1X;IGF2;MOAP1;AGPAT1;GRB10;MAP4K2;GRB7;TBX1;ADAM8;AKT3;MAML3;FZD8;LRP6;HPSE;DEDD2;KAT2B;FAM162A;ANKRD6;RB1CC1;TRIM38;FADD
16895,GO:0098839,0.00209167512638545,0.9998748842246,4,7,postsynaptic density membrane,CC,PTPRS;DLG1;DLG4;DLG3
17098,GO:0099634,0.00209167512638545,0.9998748842246,4,7,postsynaptic specialization membrane,CC,PTPRS;DLG1;DLG4;DLG3
10821,GO:0044309,0.00209716666740272,0.999162312003143,19,102,neuron spine,CC,NOS1;ZMYND8;NEURL1;NR1D1;MAP1B;DLG4;SHANK2;RGS14;DDN;FBXO2;DVL1;NTSR1;ABHD17C;ASAP1;CPEB4;ARF4;LPAR1;TENM2;EEF2K
6652,GO:0030001,0.00214510315694673,0.998684926923347,58,451,metal ion transport,BP,FHL1;NOS1;F2R;CYP27B1;SCN8A;SERPINE2;PRNP;HECW2;DDIT3;KCNG1;DENND5B;STK39;ANK3;FYN;DLG1;SLC9A7;CEMIP;STOM;RASA3;PTPN3;FKBP1A;ATP7B;PKD2;AKAP9;ATF4;LPAR3;FAM155B;VAMP2;ITPR3;SLC5A1;SARAF;NTSR1;ANXA6;ORAI3;NIPA1;CNTN1;CHD7;GRIN3B;SLC12A7;UBASH3B;MICU3;SLC38A2;TRPC1;SLC13A3;KCNJ15;SLC30A1;PRKACA;SLC39A10;ORAI1;ITPR2;SLC10A6;ATP12A;ATP6V1B2;WFS1;HSPA2;PRSS8;PSEN2;SLC23A2
8229,GO:0032989,0.002214723178875,0.99849240810518,93,749,cellular component morphogenesis,BP,VLDLR;SYNE3;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;FMNL2;SH3KBP1;SSH1;MAP1B;PTPRS;LAMB1;BRSK1;WIPF1;EGFR;SEMA4B;ANK3;FYN;KIF13B;PARVB;ARAP1;DLG1;DLG4;PLXNB3;NET1;WNT7A;MAP4K4;TTBK2;STRADB;GDI1;SHC1;DKK1;PAK1;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;OBSCN;APOE;LPAR3;ITGA1;TMOD2;ULK2;OBSL1;SH3D19;DVL1;MAP6;ZMYM3;TWF2;NTNG1;RANBP9;WASF3;BTBD3;PPP3CB;RFX2;PRKAR1A;NGFR;PTPRZ1;BCL2L1;RNF165;WASF2;RET;TCTN1;NCKAP1;ETV1;RAB1A;EPB41L3;RHOBTB1;LAMB2;LPAR1;TENM2;LAMA5;GRB10;ZMYM2;GRB7;ADAM8;ROBO3;ITGA4;WASL;FLNB;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;NYAP1;SEMA3F;ADNP;LRP4
6562,GO:0022008,0.00224245736062929,0.998404823873512,119,1015,neurogenesis,BP,NOS1;ZMYND8;SORL1;ETV5;NEURL1;VLDLR;SERPINE2;ADGRF1;POSTN;SH3TC2;BTBD2;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;SMARCA1;LAMB1;SDK2;CRTC1;BRSK1;SNPH;EGFR;SEMA4B;ANK3;FYN;BNIP3;KIF13B;CSMD3;DLG4;IDH2;PLXNB3;WNT7A;MAP4K4;GDI1;UNC119B;SHC1;DKK1;PAK1;SOCS2;ATXN10;SHANK2;SLITRK6;IMPACT;RAC2;APOE;RGS14;LRP1;LPAR3;FGFR1;ITGA1;PTK6;ULK2;INPP5F;CHAC1;SOX4;CEP120;OBSL1;DVL1;MMP14;MAP6;TWF2;CNTN1;NTNG1;RANBP9;WASF3;BTBD3;PPP3CB;PLAG1;CHD7;ASAP1;BOK;WNT2B;DBNDD1;NGFR;PTPRZ1;RNF165;ARF4;XBP1;RET;TCTN1;NAV1;MBOAT7;NCKAP1;ETV1;CCDC88A;CCSAP;TIMP2;EPB41L3;NR2F6;IL1RAP;LAMB2;LPAR1;CTSZ;TENM2;GRB10;PPARG;GRB7;ALDH1A2;ROBO3;FZD8;WASL;LRP6;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;NYAP1;UFL1;PBX3;SEMA3F;ADNP;LRP4;DNMT3A
16453,GO:0097113,0.0023246779294405,0.999947135503382,3,4,AMPA glutamate receptor clustering,BP,SSH1;DLG4;APOE
16710,GO:0097688,0.0023246779294405,0.999947135503382,3,4,glutamate receptor clustering,BP,SSH1;DLG4;APOE
9272,GO:0035694,0.00234062612654443,0.999946640011549,3,4,mitochondrial protein catabolic process,BP,BNIP3;BNIP3L;SPATA18
4440,GO:0010324,0.0024011826734057,0.999372692826206,10,42,membrane invagination,BP,ARHGAP12;SNX9;RAC2;ABCA7;ITGA2;FNBP1L;F2RL1;FCHO2;SPIRE1;PPARG
9409,GO:0035967,0.00240766408628528,0.99892129188171,23,146,cellular response to topologically incorrect protein,BP,EDEM1;CCND1;DDIT3;SHC1;ATF4;ASNS;PDIA5;CTH;GFPT1;DNAJB9;SEC63;BOK;HSPA13;XBP1;EIF2AK2;KDELR3;FICD;CREB3L2;WFS1;HSPA2;SSR1;DNAJC3;KLHL15
12774,GO:0051049,0.00244153045084097,0.998247706346514,123,1111,regulation of transport,BP,FHL1;EDEM1;TSPAN1;NOS1;F2R;SORL1;RAB3B;PCK2;SCN8A;SERPINE2;PRNP;POSTN;SH3TC2;NR1D1;HECW2;MAP2K1;RAPGEF3;ALOX15B;APLN;MAP1B;KCNG1;HADH;EGFR;TBC1D14;STK39;ANK3;FYN;UBE2J1;DLG1;DLG4;IDH2;GLUL;EVI5L;MAP4K4;MCTP1;GDI1;CEMIP;SDC1;ARG2;STOM;DKK1;PAK1;PTPN3;SHANK2;RAC2;APOE;FKBP1A;BNIP3L;PKD2;LRP1;AKAP9;ATF4;PPARA;ABCA7;ICA1;LPAR3;FGFR1;TUB;ITGA2;VAMP2;INPP5F;PFN2;ABCG1;SOX4;ITPR3;CEACAM1;FERMT1;SARAF;NTSR1;NLGN2;LRP5;CNTN1;TRIB3;CLTCL1;VPS11;RIMS3;PPP3CB;SYTL1;DNAJC6;F2RL1;CHD7;SLC25A4;ANO1;BOK;ATXN2;USP6NL;SEPT5;TBC1D2B;NGFR;GLUD1;AZIN2;GRIN3B;XBP1;UBASH3B;MAP2K2;TRPC1;C5;KCNJ15;SLC30A1;PRKACA;TMSB4X;IL1RAP;ORAI1;ITPR2;GRB10;EFCAB7;ERLEC1;PPARG;LYPLA1;EVI5;RPH3AL;ADAM8;WFS1;TBC1D16;WASL;REEP6;HSPA2;PRSS8;SYT2;TMEM173;EEF2K;FOXP1;PTCH1
16970,GO:0098984,0.00247384297839739,0.998834898301195,26,152,neuron to neuron synapse,CC,NOS1;NEURL1;PRNP;MAP1B;PTPRS;FYN;BNIP3;DLG1;DLG4;DLG3;SHANK2;RGS14;DVL1;NTSR1;NLGN2;MPDZ;ABHD17C;DNAJC6;CPEB4;PSD3;EPB41L3;PJA2;EEF2K;SIGMAR1;PTCH1;LRP4
17022,GO:0099173,0.00247437005034606,0.999164954112271,14,66,postsynapse organization,BP,ZMYND8;ETV5;PRNP;SSH1;FYN;DLG4;WNT7A;SHANK2;APOE;DVL1;NLGN2;WASL;EEF2K;LRP4
13275,GO:0051962,0.00248462519824858,0.998561462425652,46,329,positive regulation of nervous system development,BP,ZMYND8;ETV5;NEURL1;VLDLR;SERPINE2;MAP2K1;THBS2;MAP1B;CRTC1;ADGRL1;FYN;DLG4;PLXNB3;WNT7A;GDI1;DKK1;PAK1;SOCS2;SHANK2;SLITRK6;IMPACT;APOE;RGS14;LPAR3;FGFR1;PTK6;OBSL1;DVL1;NLGN2;TWF2;CNTN1;TPBG;WASF3;ADGRB2;PLAG1;NGFR;RET;TIMP2;IL1RAP;LPAR1;PPARG;SRPX2;SYT2;EEF2K;UFL1;ADNP
4497,GO:0010522,0.00250146873361434,0.99924046263269,12,54,regulation of calcium ion transport into cytosol,BP,NOS1;F2R;PRNP;FYN;CEMIP;FKBP1A;PKD2;NTSR1;CHD7;UBASH3B;TRPC1;PRKACA
12879,GO:0051209,0.00252565916626826,0.99914701158953,14,65,release of sequestered calcium ion into cytosol,BP,NOS1;F2R;DDIT3;CEMIP;RASA3;FKBP1A;PKD2;ITPR3;NTSR1;CHD7;UBASH3B;TRPC1;PRKACA;ITPR2
12928,GO:0051283,0.00252565916626826,0.99914701158953,14,65,negative regulation of sequestering of calcium ion,BP,NOS1;F2R;DDIT3;CEMIP;RASA3;FKBP1A;PKD2;ITPR3;NTSR1;CHD7;UBASH3B;TRPC1;PRKACA;ITPR2
17572,GO:1901184,0.00254464174276116,0.999092196520088,15,79,regulation of ERBB signaling pathway,BP,NEURL1;SH3TC2;SH3KBP1;EGFR;ARAP1;SHC1;PTPN3;PTPN12;ITGA1;PTK6;CEACAM1;MVB12B;SPRY2;MVB12A;SNX6
3508,GO:0007416,0.00255649826883872,0.999062718362842,16,75,synapse assembly,BP,ADGRF1;THBS2;SDK2;ADGRL1;WNT7A;SHANK2;SLITRK6;DVL1;NLGN2;TPBG;ADGRB2;IL1RAP;SRPX2;EEF2K;ADNP;LRP4
4786,GO:0010975,0.00257278169303513,0.998517824864254,45,317,regulation of neuron projection development,BP,ZMYND8;NEURL1;VLDLR;HECW2;NFATC4;MAP2K1;SSH1;MAP1B;PTPRS;CRTC1;SEMA4B;FYN;KIF13B;CSMD3;DLG4;PLXNB3;WNT7A;MAP4K4;GDI1;PAK1;SHANK2;APOE;LRP1;LPAR3;FGFR1;PTK6;ULK2;INPP5F;OBSL1;DVL1;TWF2;CNTN1;ASAP1;NGFR;RET;CCDC88A;IL1RAP;LPAR1;CTSZ;SYT2;EEF2K;OMG;SEMA3F;ADNP;LRP4
7244,GO:0031175,0.00262270954693368,0.998250650435652,81,644,neuron projection development,BP,ZMYND8;NEURL1;VLDLR;ADGRF1;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;LAMB1;CRTC1;BRSK1;EGFR;SEMA4B;ANK3;FYN;KIF13B;CSMD3;DLG4;PLXNB3;WNT7A;MAP4K4;GDI1;SHC1;PAK1;ATXN10;SHANK2;SLITRK6;IMPACT;RAC2;APOE;LRP1;LPAR3;FGFR1;ITGA1;PTK6;ULK2;INPP5F;OBSL1;DVL1;MAP6;TWF2;CNTN1;NTNG1;RANBP9;BTBD3;PPP3CB;ASAP1;DBNDD1;NGFR;PTPRZ1;RNF165;ARF4;RET;TCTN1;NCKAP1;ETV1;CCDC88A;EPB41L3;IL1RAP;LAMB2;LPAR1;CTSZ;GRB10;GRB7;ROBO3;WASL;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;NYAP1;SEMA3F;ADNP;LRP4
4368,GO:0009986,0.00273680480887332,0.998375389881415,49,374,cell surface,CC,NT5E;PLAT;F2R;ITGA6;SERPINE2;PRNP;ITGB4;ANTXR2;DCBLD2;MST1R;EGFR;ANK3;ADAMTS7;PLXNB3;GPC4;WNT7A;SDC1;TGFBR2;SLITRK6;CD44;IDE;ABCA7;ITGA1;EPCAM;ITGB5;ITGA2;ABCG1;CEACAM1;CLCN3;NTSR1;NLGN2;CD46;PCSK6;TPBG;PROCR;ACVR1B;NGFR;TIMP2;LPAR1;CTSZ;SRPX2;SLC7A11;ERP44;ADAM8;ITGA4;HSPA2;LRP6;PSEN2;LRP4
12422,GO:0048870,0.00281464592941054,0.998007205947297,110,951,cell motility,BP,DOCK4;PLAT;SMURF2;TSPAN1;ZMYND8;F2R;SORL1;PGF;NEURL1;ITGA6;MMP1;CYGB;SERPINE2;PRSS3;ITGB4;BBS2;POSTN;SLC16A3;ADARB1;MAP2K1;SH3KBP1;ALOX15B;PKN1;SSH1;LAMB1;AVL9;EGFR;SEMA4B;FYN;IDH2;PLXNB3;PODXL;NET1;WNT7A;TTBK2;MCTP1;CEMIP;SDC1;SHC1;PAK1;TGFBR2;EPHA1;RAC2;CD44;APOE;SRGAP2B;LRP1;ANXA3;FGFR1;ITGA1;EPCAM;HYAL1;ITGA2;PTK6;FAT1;INPP5F;PFN2;CEACAM1;FERMT1;FAM110C;BSG;MMP14;LRP5;MOSPD2;SLK;CDC42BPA;SCYL3;F2RL1;PROCR;JMY;PARP9;SPRY2;BEX4;ACVR1B;IFITM1;WASF2;ARF4;XBP1;ABHD6;RET;LOXL2;NAV1;C5;MBOAT7;NCKAP1;ELMO3;PAK6;COL1A2;CCDC88A;CCSAP;TMSB4X;RAB1A;RHOBTB1;LPAR1;MMP10;LAMA5;PPARG;GRB7;SRPX2;TBX1;SLC7A11;ADAM8;AKT3;ITGA4;CKLF;WASL;ARID5B;FOXP1;SEMA3F;FADD
13128,GO:0051674,0.00281464592941054,0.998007205947297,110,951,localization of cell,BP,DOCK4;PLAT;SMURF2;TSPAN1;ZMYND8;F2R;SORL1;PGF;NEURL1;ITGA6;MMP1;CYGB;SERPINE2;PRSS3;ITGB4;BBS2;POSTN;SLC16A3;ADARB1;MAP2K1;SH3KBP1;ALOX15B;PKN1;SSH1;LAMB1;AVL9;EGFR;SEMA4B;FYN;IDH2;PLXNB3;PODXL;NET1;WNT7A;TTBK2;MCTP1;CEMIP;SDC1;SHC1;PAK1;TGFBR2;EPHA1;RAC2;CD44;APOE;SRGAP2B;LRP1;ANXA3;FGFR1;ITGA1;EPCAM;HYAL1;ITGA2;PTK6;FAT1;INPP5F;PFN2;CEACAM1;FERMT1;FAM110C;BSG;MMP14;LRP5;MOSPD2;SLK;CDC42BPA;SCYL3;F2RL1;PROCR;JMY;PARP9;SPRY2;BEX4;ACVR1B;IFITM1;WASF2;ARF4;XBP1;ABHD6;RET;LOXL2;NAV1;C5;MBOAT7;NCKAP1;ELMO3;PAK6;COL1A2;CCDC88A;CCSAP;TMSB4X;RAB1A;RHOBTB1;LPAR1;MMP10;LAMA5;PPARG;GRB7;SRPX2;TBX1;SLC7A11;ADAM8;AKT3;ITGA4;CKLF;WASL;ARID5B;FOXP1;SEMA3F;FADD
13812,GO:0060401,0.0028305507346476,0.99890471429021,17,89,cytosolic calcium ion transport,BP,NOS1;F2R;PRNP;DDIT3;FYN;CEMIP;RASA3;FKBP1A;PKD2;FAM155B;ITPR3;NTSR1;CHD7;UBASH3B;TRPC1;PRKACA;ITPR2
10365,GO:0043178,0.00285102388429562,0.999175564838274,11,48,alcohol binding,MF,OSBP2;OSBPL10;APOE;ABCG1;ITPR3;ANXA6;TRPC1;OSBPL5;ITPR2;SYT2;PTCH1
5515,GO:0016477,0.00285746587389798,0.99799811603307,103,882,cell migration,BP,DOCK4;PLAT;SMURF2;TSPAN1;ZMYND8;F2R;SORL1;PGF;ITGA6;MMP1;CYGB;SERPINE2;PRSS3;POSTN;SLC16A3;ADARB1;SH3KBP1;ALOX15B;PKN1;SSH1;LAMB1;AVL9;EGFR;SEMA4B;FYN;IDH2;PLXNB3;PODXL;NET1;WNT7A;TTBK2;MCTP1;CEMIP;SDC1;SHC1;PAK1;TGFBR2;EPHA1;RAC2;CD44;APOE;SRGAP2B;LRP1;ANXA3;FGFR1;ITGA1;EPCAM;HYAL1;ITGA2;PTK6;FAT1;PFN2;CEACAM1;FERMT1;FAM110C;BSG;MMP14;LRP5;MOSPD2;SLK;CDC42BPA;SCYL3;F2RL1;PROCR;PARP9;SPRY2;BEX4;ACVR1B;IFITM1;WASF2;ARF4;XBP1;ABHD6;RET;LOXL2;NAV1;C5;MBOAT7;NCKAP1;ELMO3;PAK6;COL1A2;CCDC88A;TMSB4X;RAB1A;RHOBTB1;LPAR1;MMP10;LAMA5;PPARG;GRB7;SRPX2;TBX1;SLC7A11;ADAM8;AKT3;ITGA4;CKLF;WASL;ARID5B;FOXP1;SEMA3F;FADD
3455,GO:0007267,0.0028753156118372,0.99798415178364,103,906,cell-cell signaling,BP,SMURF2;NOS1;ZMYND8;F2R;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;CTNNBIP1;SERPINE2;IGFBP4;PRNP;NR1D1;NFATC4;ADARB1;RAPGEF3;ACVR2B;SH3KBP1;WWTR1;APLN;SSH1;DDIT3;HADH;PSMD2;CRTC1;BRSK1;SNPH;EGFR;PCDHAC2;MYCBPAP;DLG1;DLG4;GPC4;GLUL;WNT7A;MAP4K4;GRK5;HTR7;MCTP1;SDC1;DLG3;DKK1;WISP1;SHANK2;APOE;RGS14;LRP1;AKAP9;HMGA2;ICA1;LPAR3;FGFR1;TMOD2;BTRC;VAMP2;FAT1;LTBP4;PFN2;SOX4;ITPR3;FERMT1;NLK;MDFI;TNRC6B;DVL1;NTSR1;NLGN2;LRP5;RIMS3;PPP3CB;SYTL1;CSNK2A1;PSMD7;PTHLH;CHD7;SLC25A4;ANO1;SEPT5;WNT2B;GLUD1;GRIN3B;SLC12A7;ABHD6;TLE4;SLC30A1;RAB1A;PCDH1;AP2A2;TBL1X;ITPR2;GRB10;FZD8;LRP6;SYT2;SLC18A2;TNRC6C;ZBTB33;ANKRD6;ADNP;GNAI1;LRP4
13500,GO:0055065,0.00287545817118934,0.998350884594038,43,324,metal ion homeostasis,BP,NOS1;F2R;CYP27B1;PRNP;DDIT3;EGFR;ANK3;FYN;BNIP3;DLG4;TGM2;CEMIP;RASA3;EDNRA;LCN2;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;ITPR3;MT2A;NTSR1;ANXA6;F2RL1;CHD7;BOK;SLC12A7;UBASH3B;SLC22A17;TRPC1;SLC30A1;SFXN3;PRKACA;SLC39A10;LPAR1;AP3D1;ITPR2;ATP12A;WFS1;LRP6;FBXL5
5866,GO:0017171,0.00289388947575617,0.998904581646097,16,94,serine hydrolase activity,MF,PLAT;MMP1;PRSS3;TMPRSS11D;CTSB;TYSND1;HTRA1;LONP2;MMP14;CTSL;PCSK6;AEBP1;ZFYVE9;MMP10;ADAM8;PRSS8
12927,GO:0051282,0.0029073091439807,0.999000650792402,14,66,regulation of sequestering of calcium ion,BP,NOS1;F2R;DDIT3;CEMIP;RASA3;FKBP1A;PKD2;ITPR3;NTSR1;CHD7;UBASH3B;TRPC1;PRKACA;ITPR2
13273,GO:0051960,0.00292185515316652,0.998101443001315,70,548,regulation of nervous system development,BP,NOS1;ZMYND8;SORL1;ETV5;NEURL1;VLDLR;SERPINE2;HECW2;NFATC4;MAP2K1;THBS2;SSH1;MAP1B;PTPRS;CRTC1;ADGRL1;SEMA4B;FYN;KIF13B;DLG1;CSMD3;DLG4;IDH2;PLXNB3;WNT7A;MAP4K4;GDI1;DKK1;PAK1;SOCS2;SHANK2;SLITRK6;IMPACT;APOE;RGS14;PRKACB;LRP1;LPAR3;FGFR1;PTK6;ULK2;INPP5F;OBSL1;DVL1;NLGN2;TWF2;CNTN1;TPBG;WASF3;ADGRB2;PLAG1;CHD7;ASAP1;NGFR;PTPRZ1;RET;CCDC88A;TIMP2;IL1RAP;LPAR1;CTSZ;PPARG;SRPX2;SYT2;EEF2K;OMG;UFL1;SEMA3F;ADNP;LRP4
16881,GO:0098815,0.00294014162097792,0.99945025945692,7,23,modulation of excitatory postsynaptic potential,BP,ZMYND8;SSH1;DLG4;WNT7A;SHANK2;DVL1;NLGN2
6948,GO:0030574,0.00296084574097977,0.999211489451438,10,39,collagen catabolic process,BP,MMP1;COL13A1;CTSB;MRC2;MMP14;CTSL;CST3;COL6A1;COL1A2;MMP10
3406,GO:0007187,0.00298292543144056,0.998918485213875,15,78,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,NOS1;ADCY7;ADGRF1;ADM2;GRK5;HTR7;EDNRA;PRKACB;LPAR3;PTHLH;WASF2;LTB4R;LPAR1;ADCY1;GNAI1
4254,GO:0009581,0.00303504744091277,0.999117294482816,11,47,detection of external stimulus,BP,SERPINE2;DENND5B;FYN;PKD2;ITGA2;PITPNM1;NTSR1;ANO1;NR2F6;REEP6;ELOVL4
13874,GO:0060491,0.00310966312480267,0.998638753775101,21,125,regulation of cell projection assembly,BP,ZMYND8;NEURL1;SSH1;ARAP1;PLXNB3;PODXL;ESPN;EVI5L;RAC2;PFN2;CEP120;FAM110C;TWF2;FNBP1L;F2RL1;WASF2;NCKAP1;DOCK11;CCDC88A;TENM2;WASL
6591,GO:0022604,0.00311875546979016,0.998160237546129,47,338,regulation of cell morphogenesis,BP,SYNE3;POSTN;HECW2;NFATC4;MAP2K1;FMNL2;SH3KBP1;SSH1;MAP1B;PTPRS;WIPF1;SEMA4B;FYN;KIF13B;PARVB;ARAP1;DLG1;DLG4;PLXNB3;NET1;WNT7A;TTBK2;GDI1;PAK1;CD44;APOE;LPAR3;ULK2;OBSL1;SH3D19;DVL1;ZMYM3;TWF2;WASF3;NGFR;RET;EPB41L3;RHOBTB1;LPAR1;ZMYM2;WASL;SYT2;EEF2K;OMG;SEMA3F;ADNP;LRP4
10399,GO:0043230,0.00317386485674675,0.997561132342721,193,2042,extracellular organelle,CC,NT5E;PLAT;EPN3;TSPAN1;SORL1;RAB3B;PCK2;PYGL;PYGB;SERPINE2;PRSS3;CRYL1;PRNP;MXRA5;ITGB4;ACTA2;MARCKSL1;MAP2K1;LTBP2;RAPGEF3;ALOX15B;THSD4;GPX3;NAPRT;APPL2;PTPRS;PSMD2;LAMB1;SNTB2;LTA4H;CAPN2;DYSF;HEBP1;TMPRSS11D;PSAT1;JADE2;PGM1;DLG1;IDH2;CTSB;GPC4;SNX9;PODXL;TGM2;XPC;GLUL;HTRA1;GLO1;WNT7A;PGLS;ACOT7;SDC1;STOM;SERPING1;SLC2A3;LCN2;HAGH;NUCB2;RAC2;CD44;APOE;FKBP1A;ACP5;ALDH1L2;PKD2;PRKACB;LDHA;ABHD8;UBE2G1;ANXA3;ITGA1;AARS;EPCAM;ITGB5;HYAL1;GALNT3;VAMP2;FAT1;LTBP4;FAM20C;PFN2;FBXO2;GAMT;IAH1;MBLAC2;CEACAM1;SLC5A1;LMAN1;UACA;BSG;SLC9A3R2;ANXA6;CD46;MVB12B;CTH;CTSL;TWF2;CST3;CNTN1;CLTCL1;GFPT1;TOM1L2;WASF3;DNAJB9;MYOF;ACOT13;SYTL1;TTYH3;APLP2;SLK;PRDX5;ALDH7A1;FNBP1L;CDC42BPA;PROCR;C6ORF120;TAOK1;PLD3;AEBP1;PSMD7;TST;BLMH;QSOX1;CPNE8;CTBS;ANO1;SLC6A14;ACVR1B;COL6A1;BPHL;MVB12A;HSPA13;PM20D2;GLB1;WASF2;ARF4;H2AFJ;PCYOX1;SLC46A3;CADM4;ABHD6;ARRDC1;LYPLAL1;VWA1;RAB43;SLC13A3;C5;NCKAP1;DNASE1L1;TSPAN3;TMBIM1;COL1A2;TMED4;PRKACA;TIMP2;RAB1A;ZDHHC1;CMTM6;CARD11;LAMB2;CTSZ;NIT2;BLVRA;ARPC1A;IGF2;LAMA5;PTGR2;TMEM63A;PPL;LYPLA1;ERP44;ATP6V1B2;GARS;CLDN11;ITGA4;WDR60;IGFBP7;WASL;HSPA2;PRSS8;FLNB;MAGEF1;GGACT;PPT2;GALNS;DNAJC3;AOX1;ADCY1;FAM162A;GALE;SLC44A1;GNAI1;FCGBP
18465,GO:1903561,0.00317386485674675,0.997561132342721,193,2042,extracellular vesicle,CC,NT5E;PLAT;EPN3;TSPAN1;SORL1;RAB3B;PCK2;PYGL;PYGB;SERPINE2;PRSS3;CRYL1;PRNP;MXRA5;ITGB4;ACTA2;MARCKSL1;MAP2K1;LTBP2;RAPGEF3;ALOX15B;THSD4;GPX3;NAPRT;APPL2;PTPRS;PSMD2;LAMB1;SNTB2;LTA4H;CAPN2;DYSF;HEBP1;TMPRSS11D;PSAT1;JADE2;PGM1;DLG1;IDH2;CTSB;GPC4;SNX9;PODXL;TGM2;XPC;GLUL;HTRA1;GLO1;WNT7A;PGLS;ACOT7;SDC1;STOM;SERPING1;SLC2A3;LCN2;HAGH;NUCB2;RAC2;CD44;APOE;FKBP1A;ACP5;ALDH1L2;PKD2;PRKACB;LDHA;ABHD8;UBE2G1;ANXA3;ITGA1;AARS;EPCAM;ITGB5;HYAL1;GALNT3;VAMP2;FAT1;LTBP4;FAM20C;PFN2;FBXO2;GAMT;IAH1;MBLAC2;CEACAM1;SLC5A1;LMAN1;UACA;BSG;SLC9A3R2;ANXA6;CD46;MVB12B;CTH;CTSL;TWF2;CST3;CNTN1;CLTCL1;GFPT1;TOM1L2;WASF3;DNAJB9;MYOF;ACOT13;SYTL1;TTYH3;APLP2;SLK;PRDX5;ALDH7A1;FNBP1L;CDC42BPA;PROCR;C6ORF120;TAOK1;PLD3;AEBP1;PSMD7;TST;BLMH;QSOX1;CPNE8;CTBS;ANO1;SLC6A14;ACVR1B;COL6A1;BPHL;MVB12A;HSPA13;PM20D2;GLB1;WASF2;ARF4;H2AFJ;PCYOX1;SLC46A3;CADM4;ABHD6;ARRDC1;LYPLAL1;VWA1;RAB43;SLC13A3;C5;NCKAP1;DNASE1L1;TSPAN3;TMBIM1;COL1A2;TMED4;PRKACA;TIMP2;RAB1A;ZDHHC1;CMTM6;CARD11;LAMB2;CTSZ;NIT2;BLVRA;ARPC1A;IGF2;LAMA5;PTGR2;TMEM63A;PPL;LYPLA1;ERP44;ATP6V1B2;GARS;CLDN11;ITGA4;WDR60;IGFBP7;WASL;HSPA2;PRSS8;FLNB;MAGEF1;GGACT;PPT2;GALNS;DNAJC3;AOX1;ADCY1;FAM162A;GALE;SLC44A1;GNAI1;FCGBP
679,GO:0001889,0.00319518100038209,0.998702868612216,18,102,liver development,BP,CCND1;PCK2;EGFR;PTPN3;PKD2;ASNS;ITGA2;CEACAM1;SEC63;CEBPG;CSNK2A1;XBP1;ALDH1A2;ARID5B;E2F7;PTCH1;JARID2;RB1CC1
4024,GO:0009056,0.00320274177974082,0.99753543702046,196,1982,catabolic process,BP,XDH;NT5E;SMURF2;EDEM1;GID4;NOS1;SORL1;PCK2;VLDLR;PYGL;CBS;MMP1;CYP27B1;PYGB;H1F0;SERPINE2;CRYL1;ITGB4;GPT2;BTBD2;NR1D1;HECW2;RAPGEF3;COL13A1;GPX3;WWTR1;TRIM65;DHTKD1;DDIT3;HADH;PSMD2;LTA4H;CAPN2;EGFR;TBC1D14;FYN;BNIP3;UBE2J1;PGM1;ADAMTS7;CTSB;GPC4;SNX9;TYSND1;GLUL;UBXN4;IGF2BP3;SPTLC2;ACOT7;WDFY3;CEMIP;ACAD11;SDC1;ARG2;DAP;TRIB2;MRC2;PTPN3;HAGH;CD44;APOE;BNIP3L;ABCD1;ALDH1L2;RBCK1;LRP1;LDHA;FYCO1;IDE;ABTB1;UBE2G1;PPARA;ABHD10;RNPEPL1;SNX14;HYAL1;BTRC;LPCAT1;AIG1;ULK2;LONP2;INPP5F;CHAC1;RMND5A;APOBEC3C;VPS13A;FBXO2;IAH1;CEACAM1;SPATA18;SH3D19;XRN1;TRIM5;TNRC6B;DVL1;NTSR1;MMP14;PLA2G4D;ACAD10;MVB12B;CTH;LRP5;ABHD17C;CTSL;CST3;TRIB3;VPS11;DNAJB9;BTBD3;HIBADH;PRDX5;MLYCD;ALDH7A1;FNBP1L;RASIP1;PLD3;CSNK2A1;PSMD7;TST;BLMH;QSOX1;CPT2;CTBS;BOK;THRA;MGLL;COL6A1;MVB12A;GLUD1;NPL;MTA1;AZIN2;CRAT;RNF165;PM20D2;GLB1;PCYOX1;XBP1;ABHD6;PAIP1;ARRDC1;ANKIB1;LYPLAL1;PDE5A;GABARAPL2;EPM2A;DNASE1L1;UBE2E1;PUM2;COL1A2;CTSO;PRKACA;TIMP2;RAB1A;SEL1L;IFI16;AP2A2;SRD5A3;CTSZ;TBL1X;MMP10;BLVRA;ERLEC1;SNX6;EVA1A;USP20;LYPLA1;ATP6V1B2;ADAM8;ALDH4A1;WFS1;ENDOG;DDHD2;USP32;MAGEF1;PLCH2;RNF180;GGACT;HPSE;GALNS;TNRC6C;TET1;DEDD2;DNAJC3;AOX1;CNOT11;RNF103;USP25;UFL1;AMACR;GALE;KLHL15;SLC44A1;STT3B;RB1CC1;FBXL5
12357,GO:0048732,0.00321253722384091,0.998174296412704,41,296,gland development,BP,XDH;ETV5;CCND1;NEURL1;PCK2;SERPINE2;MAP2K1;ALOX15B;APLN;EGFR;TGM2;SOCS2;RAG1;TGFBR2;PTPN3;ATP7B;PKD2;ASNS;FGFR1;BTRC;ITGA2;CEACAM1;LRP5;CST3;SEC63;CEBPG;PLAG1;CSNK2A1;THRA;XBP1;HOXA3;LAMA5;ALDH1A2;TBX1;LRP6;ARID5B;E2F7;PTCH1;JARID2;RB1CC1;FADD
14548,GO:0070062,0.00327669441136386,0.997481352172272,192,2033,extracellular exosome,CC,NT5E;PLAT;EPN3;TSPAN1;SORL1;RAB3B;PCK2;PYGL;PYGB;PRSS3;CRYL1;PRNP;MXRA5;ITGB4;ACTA2;MARCKSL1;MAP2K1;LTBP2;RAPGEF3;ALOX15B;THSD4;GPX3;NAPRT;APPL2;PTPRS;PSMD2;LAMB1;SNTB2;LTA4H;CAPN2;DYSF;HEBP1;TMPRSS11D;PSAT1;JADE2;PGM1;DLG1;IDH2;CTSB;GPC4;SNX9;PODXL;TGM2;XPC;GLUL;HTRA1;GLO1;WNT7A;PGLS;ACOT7;SDC1;STOM;SERPING1;SLC2A3;LCN2;HAGH;NUCB2;RAC2;CD44;APOE;FKBP1A;ACP5;ALDH1L2;PKD2;PRKACB;LDHA;ABHD8;UBE2G1;ANXA3;ITGA1;AARS;EPCAM;ITGB5;HYAL1;GALNT3;VAMP2;FAT1;LTBP4;FAM20C;PFN2;FBXO2;GAMT;IAH1;MBLAC2;CEACAM1;SLC5A1;LMAN1;UACA;BSG;SLC9A3R2;ANXA6;CD46;MVB12B;CTH;CTSL;TWF2;CST3;CNTN1;CLTCL1;GFPT1;TOM1L2;WASF3;DNAJB9;MYOF;ACOT13;SYTL1;TTYH3;APLP2;SLK;PRDX5;ALDH7A1;FNBP1L;CDC42BPA;PROCR;C6ORF120;TAOK1;PLD3;AEBP1;PSMD7;TST;BLMH;QSOX1;CPNE8;CTBS;ANO1;SLC6A14;ACVR1B;COL6A1;BPHL;MVB12A;HSPA13;PM20D2;GLB1;WASF2;ARF4;H2AFJ;PCYOX1;SLC46A3;CADM4;ABHD6;ARRDC1;LYPLAL1;VWA1;RAB43;SLC13A3;C5;NCKAP1;DNASE1L1;TSPAN3;TMBIM1;COL1A2;TMED4;PRKACA;TIMP2;RAB1A;ZDHHC1;CMTM6;CARD11;LAMB2;CTSZ;NIT2;BLVRA;ARPC1A;IGF2;LAMA5;PTGR2;TMEM63A;PPL;LYPLA1;ERP44;ATP6V1B2;GARS;CLDN11;ITGA4;WDR60;IGFBP7;WASL;HSPA2;PRSS8;FLNB;MAGEF1;GGACT;PPT2;GALNS;DNAJC3;AOX1;ADCY1;FAM162A;GALE;SLC44A1;GNAI1;FCGBP
3225,GO:0006875,0.00330648806477908,0.998159009718683,38,281,cellular metal ion homeostasis,BP,NOS1;F2R;PRNP;DDIT3;FYN;BNIP3;DLG4;TGM2;CEMIP;RASA3;EDNRA;LCN2;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;ITPR3;MT2A;NTSR1;ANXA6;F2RL1;CHD7;BOK;UBASH3B;SLC22A17;TRPC1;SLC30A1;PRKACA;SLC39A10;LPAR1;AP3D1;ITPR2;ATP12A;WFS1;LRP6;FBXL5
19576,GO:1990617,0.00331383472364111,1,2,2,CHOP-ATF4 complex,CC,DDIT3;ATF4
17250,GO:0120025,0.00336419794378539,0.997514737151887,140,1257,plasma membrane bounded cell projection,CC,DOCK4;NOS1;ZMYND8;NEURL1;ITGA6;CYGB;SCN8A;PRNP;OSBP2;ACTA2;BBS2;NR1D1;RAPGEF3;SH3KBP1;WDR66;SSH1;MAP1B;PTPRS;CRTC1;ADGRL1;CAPN2;WIPF1;SNPH;ANK3;DYSF;FYN;BNIP3;KIF13B;PARVB;DLG1;DLG4;SNX9;PODXL;ESPN;GLUL;TTBK2;WDFY3;HTR7;GDI1;UNC119B;DLG3;PAK1;CEP170;ATXN10;SHANK2;EPHA1;RAC2;CD44;APOE;FKBP1A;RGS14;PKD2;PRKACB;LRP1;AKAP9;DDN;ANXA3;ATF4;ABCA7;LPAR3;KIF21B;ITGA1;TMOD2;TUB;SNX14;ITGA2;PTK6;VAMP2;FAT1;INPP5F;PFN2;AHCYL2;FHOD1;FBXO2;CEACAM1;FERMT1;XRN1;DVL1;NTSR1;PLEK2;MPDZ;MAP6;ABHD17C;TWF2;CST3;WASF3;SYTL1;CDC42BPA;SCYL3;F2RL1;ASAP1;PRKAR1A;CPEB4;SPRY2;SEPT5;SLC6A14;NGFR;MARK4;AZIN2;WASF2;ARF4;CNNM1;SLC38A2;RET;SPATA6;TCTN1;NAV1;NCKAP1;PSD3;FRMD4B;CCDC88A;CCSAP;PRKACA;TIMP2;EPB41L3;LPAR1;CTSZ;AP3D1;ARPC1A;TENM2;EFCAB7;ATP6V1B2;ROBO3;GARS;WFS1;WDR60;TMEM107;WASL;ANKS6;REEP6;EEF2K;SLC18A2;SIGMAR1;PSEN2;PTCH1;SEPT6;UFL1;ADNP;LRP4;FADD
3591,GO:0008015,0.0034550624837706,0.998107544240679,36,252,blood circulation,BP,DOCK4;NOS1;F2R;CTNNBIP1;BBS2;POSTN;ADM2;APLN;EGFR;STK39;DLG1;HTR7;ASPH;SERPING1;EDNRA;APOE;AKAP9;PPARA;ITGA1;MTHFR;ITPR3;CEACAM1;NTSR1;LRP5;MYOF;F2RL1;CHD7;THRA;TRPC1;PDE5A;COL1A2;PRKACA;CTSZ;ITPR2;PPARG;RCAN1
17701,GO:1901605,0.00352123897646857,0.998397685987852,22,148,alpha-amino acid metabolic process,BP,NOS1;CBS;GPT2;PSAT1;GLUL;CRTAP;ARG2;NAGS;ERO1B;ASNS;MTHFR;AHCYL2;GAMT;CTH;GFPT1;HIBADH;ALDH7A1;BLMH;GLUD1;AZIN2;NIT2;ALDH4A1
4713,GO:0010875,0.00354100460733267,0.999579565656653,5,12,positive regulation of cholesterol efflux,BP,APOE;LRP1;ABCA7;ABCG1;PTCH1
5519,GO:0016485,0.00355054856626171,0.998352898062863,23,153,protein processing,BP,PLAT;SERPINE2;PRSS3;PRNP;CAPN2;TYSND1;ASPH;SERPING1;ERO1B;PRKACB;LONP2;CHAC1;MMP14;CD46;PCSK6;AEBP1;C5;IFI16;CTSZ;ADAM8;PSEN2;PTCH1;FADD
4709,GO:0010871,0.00356338451860185,0.999905209489962,3,4,negative regulation of receptor biosynthetic process,BP,NR1D1;PPARA;PPARG
12689,GO:0050906,0.00357334296426524,0.999289609359254,7,26,detection of stimulus involved in sensory perception,BP,SERPINE2;FYN;ITGA2;NTSR1;ANO1;NR2F6;REEP6
5151,GO:0015688,0.00361987316060993,1,2,2,iron chelate transport,BP,LCN2;SLC22A17
5260,GO:0015891,0.00361987316060993,1,2,2,siderophore transport,BP,LCN2;SLC22A17
16815,GO:0098662,0.00363491164009847,0.997819938620918,48,372,inorganic cation transmembrane transport,BP,FHL1;NOS1;F2R;SCN8A;PRNP;HECW2;DDIT3;KCNG1;DENND5B;STK39;ANK3;FYN;SLC33A1;DLG1;SLC9A7;CEMIP;STOM;RASA3;PTPN3;FKBP1A;ATP7B;PKD2;AKAP9;FAM155B;VAMP2;ITPR3;NTSR1;ORAI3;NIPA1;SLC2A9;CHD7;NDUFA4L2;GRIN3B;SLC12A7;UBASH3B;MICU3;TRPC1;KCNJ15;SLC30A1;PRKACA;TMSB4X;SLC39A10;ORAI1;ITPR2;SLC2A13;ATP12A;ATP6V1B2;HSPA2
12768,GO:0051043,0.00363739416573005,0.999404413113919,6,19,regulation of membrane protein ectodomain proteolysis,BP,SNX9;PTPN3;APOE;SH3D19;TIMP2;ADAM8
18959,GO:1904724,0.00366577098119386,0.999141579401844,8,37,tertiary granule lumen,CC,PRSS3;LTA4H;PGM1;CST3;QSOX1;YPEL5;TIMP2;NIT2
4255,GO:0009582,0.00369574843199406,0.998893130225542,11,48,detection of abiotic stimulus,BP,SERPINE2;DENND5B;FYN;PKD2;ITGA2;PITPNM1;NTSR1;ANO1;NR2F6;REEP6;ELOVL4
5589,GO:0016614,0.00371459424421781,0.998601648284485,15,93,oxidoreductase activity, acting on CH-OH group of donors,MF,XDH;CRYL1;H6PD;HADH;IDH2;RDH14;CBR4;LDHA;KDSR;HIBADH;HSD17B7;SDR9C7;PTGR2;AOX1;HSD17B12
16260,GO:0090313,0.00372277747506221,0.999254230716004,7,26,regulation of protein targeting to membrane,BP,PRNP;ANK3;FYN;GDI1;CEMIP;STOM;PAK1
13033,GO:0051489,0.0039042687045723,0.999109859425885,8,29,regulation of filopodium assembly,BP,ZMYND8;NEURL1;ARAP1;ESPN;FNBP1L;DOCK11;TENM2;WASL
12428,GO:0048878,0.00393527994323217,0.997366266898756,75,645,chemical homeostasis,BP,FHL1;NOS1;F2R;PCK2;PYGL;CYP27B1;ADCY7;PRNP;NR1D1;DDIT3;EGFR;ANK3;FYN;BNIP3;DLG4;TGM2;SLC9A7;MAP4K4;MALL;CEMIP;RASA3;PTPN3;EDNRA;LCN2;ERO1B;APOE;FKBP1A;ATP7B;ANGPTL4;PKD2;PRKACB;LPAR3;FAM155B;LPCAT1;ABCG1;SOX4;ITPR3;DMXL2;MT2A;CLCN3;NTSR1;ANXA6;LRP5;PPP3CB;F2RL1;CHD7;PRKAR1A;ANO1;BOK;NGFR;SLC12A7;XBP1;UBASH3B;SLC22A17;TRPC1;SLC30A1;SFXN3;PRKACA;SLC39A10;LPAR1;AP3D1;IGF2;ITPR2;PPARG;ATP12A;ATP6V1B2;RPH3AL;WFS1;ENDOG;LRP6;PTCH1;ADCY1;OAS1;ADNP;FBXL5
17994,GO:1902430,0.00394294934056218,0.999685113730092,4,8,negative regulation of amyloid-beta formation,BP,SORL1;PRNP;APOE;ABCA7
12316,GO:0048666,0.00409801171539197,0.997182728085324,86,705,neuron development,BP,ZMYND8;NEURL1;VLDLR;ADGRF1;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;LAMB1;CRTC1;BRSK1;EGFR;SEMA4B;ANK3;FYN;KIF13B;CSMD3;DLG4;PLXNB3;WNT7A;MAP4K4;GDI1;SHC1;PAK1;ATXN10;SHANK2;SLITRK6;IMPACT;RAC2;APOE;LRP1;LPAR3;FGFR1;ITGA1;PTK6;ULK2;INPP5F;OBSL1;DVL1;MAP6;TWF2;CNTN1;NTNG1;RANBP9;BTBD3;PPP3CB;ASAP1;DBNDD1;NGFR;PTPRZ1;RNF165;ARF4;XBP1;RET;TCTN1;NCKAP1;ETV1;CCDC88A;CCSAP;EPB41L3;NR2F6;IL1RAP;LAMB2;LPAR1;CTSZ;TENM2;GRB10;GRB7;ROBO3;WASL;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;NYAP1;PBX3;SEMA3F;ADNP;LRP4
3774,GO:0008328,0.00410879603045992,0.999319452020379,6,18,ionotropic glutamate receptor complex,CC,DLG1;DLG4;DLG3;SHANK2;GRIN3B;ABHD6
16914,GO:0098878,0.00410879603045992,0.999319452020379,6,18,neurotransmitter receptor complex,CC,DLG1;DLG4;DLG3;SHANK2;GRIN3B;ABHD6
14140,GO:0061008,0.00411615467176416,0.998284510484883,18,104,hepaticobiliary system development,BP,CCND1;PCK2;EGFR;PTPN3;PKD2;ASNS;ITGA2;CEACAM1;SEC63;CEBPG;CSNK2A1;XBP1;ALDH1A2;ARID5B;E2F7;PTCH1;JARID2;RB1CC1
12276,GO:0048583,0.00420718740797362,0.996644632032205,268,2712,regulation of response to stimulus,BP,TNIP1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EDEM1;NOS1;ERCC1;ZMYND8;F2R;SORL1;RAB3B;PGF;CCND1;NEURL1;SH2D2A;CTNNBIP1;ASAP2;ITGA6;CYP27B1;SERPINE2;PEAR1;IGFBP4;PRNP;PAG1;BBS2;POSTN;SH3TC2;ADM2;NR1D1;NFATC4;MAP2K1;CMTM4;FNDC4;ACVR2B;LTBP1;SH3KBP1;ALOX15B;PKN1;WWTR1;MST1R;ARHGAP22;APLN;TNFSF15;APPL2;SSH1;DDIT3;PTPRS;PSMD2;FCGRT;WIPF1;EGFR;STK39;SEMA4B;ARHGAP12;FYN;TSPAN5;BNIP3;ERCC6;UBE2J1;MAPK13;ARAP1;DLG1;DLG4;CTSB;GPC4;NET1;TGM2;HTRA1;WNT7A;MAP4K4;GRK5;STRADB;MCTP1;GDI1;ARG2;SHC1;DKK1;PAK1;RASA3;SOCS2;TRIB2;RAG1;TGFBR2;PTPN3;SERPING1;SHANK2;EPHA1;IMPACT;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;ACP5;PTPN12;AFAP1;RGS14;PKD2;PRKACB;RBCK1;LRP1;HMGA2;ATF4;PPARA;ABCA7;WWC3;LPAR3;FGFR1;ITGA1;TMOD2;CMTM7;NFAT5;BTRC;ITGA2;PTK6;LTBP4;INPP5F;CHAC1;FAM20C;SOX4;CEACAM1;FERMT1;MAPKAPK3;UACA;FAM110C;NLK;EPN2;MDFI;TRIM5;RALGAPA1;DVL1;NTSR1;MMP14;NLGN2;CD46;MVB12B;CTH;LRP5;ETAA1;DNMBP;CTSL;TRIB3;CASP4;PCSK6;MOSPD2;RANBP9;DNAJB9;PPP3CB;MYOF;CEBPG;F2RL1;DDX60;TAOK1;CSNK2A1;PSMD7;PTHLH;ASAP1;ANO1;JMY;BOK;PARP9;C18ORF32;NACC2;SPRY2;THRA;MGLL;CD99;WNT2B;ACVR1B;NGFR;PPP1R10;MVB12A;NUDT6;BCL2L1;IFITM1;RNF165;WASF2;SKAP2;XBP1;UBASH3B;MAP2K2;ABHD6;PPP1R2;ARRDC1;RET;PDE5A;TCTN1;C5;MTMR4;NCKAP1;EPM2A;RMRP;PAK6;PUM2;RNF135;PSD3;TMBIM1;COL1A2;TMED4;SHC2;PRKACA;SAMD5;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;IFI16;RHOBTB1;SLC39A10;CMTM6;CARD11;FICD;LPAR1;TBL1X;RNF169;ARPC1A;IGF2;MOAP1;AGPAT1;PJA2;GRB10;MAP4K2;ERLEC1;PPARG;SNX6;USP20;GRB7;ARHGAP29;TBX1;RPH3AL;ADAM8;AKT3;IL20RB;WFS1;ENDOG;ITGA4;ACAP2;MAML3;CKLF;FZD8;WASL;LRP6;MAGEF1;TMEM173;HPSE;RCAN1;DEDD2;DNAJC3;FOXP1;PTCH1;KAT2B;USP25;UFL1;FAM162A;ANKRD6;JARID2;SEMA3F;RALGPS2;KLHL15;GNAI1;LRP4;RB1CC1;TRIM38;FADD
1259,GO:0003013,0.00423263802338932,0.997650090731102,36,254,circulatory system process,BP,DOCK4;NOS1;F2R;CTNNBIP1;BBS2;POSTN;ADM2;APLN;EGFR;STK39;DLG1;HTR7;ASPH;SERPING1;EDNRA;APOE;AKAP9;PPARA;ITGA1;MTHFR;ITPR3;CEACAM1;NTSR1;LRP5;MYOF;F2RL1;CHD7;THRA;TRPC1;PDE5A;COL1A2;PRKACA;CTSZ;ITPR2;PPARG;RCAN1
12339,GO:0048699,0.00424403710275697,0.996951774777205,110,943,generation of neurons,BP,NOS1;ZMYND8;SORL1;ETV5;NEURL1;VLDLR;SERPINE2;ADGRF1;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;SMARCA1;LAMB1;SDK2;CRTC1;BRSK1;SNPH;EGFR;SEMA4B;ANK3;FYN;KIF13B;CSMD3;DLG4;IDH2;PLXNB3;WNT7A;MAP4K4;GDI1;UNC119B;SHC1;DKK1;PAK1;SOCS2;ATXN10;SHANK2;SLITRK6;IMPACT;RAC2;APOE;RGS14;LRP1;LPAR3;FGFR1;ITGA1;PTK6;ULK2;INPP5F;SOX4;OBSL1;DVL1;MAP6;TWF2;CNTN1;NTNG1;RANBP9;BTBD3;PPP3CB;PLAG1;CHD7;ASAP1;WNT2B;DBNDD1;NGFR;PTPRZ1;RNF165;ARF4;XBP1;RET;TCTN1;NAV1;NCKAP1;ETV1;CCDC88A;CCSAP;TIMP2;EPB41L3;NR2F6;IL1RAP;LAMB2;LPAR1;CTSZ;TENM2;GRB10;PPARG;GRB7;ALDH1A2;ROBO3;FZD8;WASL;LRP6;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;NYAP1;UFL1;PBX3;SEMA3F;ADNP;LRP4;DNMT3A
8210,GO:0032963,0.00426739600652364,0.998451958478138,14,73,collagen metabolic process,BP,F2R;MMP1;CYGB;COL13A1;CTSB;MRC2;ITGA2;MMP14;CTSL;CST3;COL6A1;COL1A2;MMP10;PPARG
10423,GO:0043266,0.00427498479173165,0.998786310849547,10,42,regulation of potassium ion transport,BP,FHL1;NOS1;PRNP;KCNG1;STK39;ANK3;DLG1;AKAP9;ATF4;VAMP2
12219,GO:0048468,0.00428530566697244,0.996795464224134,145,1297,cell development,BP,NOS1;ERCC1;ZMYND8;SORL1;FLNC;ETV5;NEURL1;VLDLR;SERPINE2;ADGRF1;OSBP2;ACTA2;BBS2;POSTN;SH3TC2;HECW2;NFATC4;ADARB1;MAP2K1;FAM210B;RAPGEF3;SH3KBP1;POU2F2;SSH1;MAP1B;PTPRS;LAMB1;CRTC1;BRSK1;EGFR;SEMA4B;ANK3;FYN;KIF13B;UBE2J1;PARVB;CSMD3;DLG4;IDH2;PLXNB3;PODXL;NET1;WNT7A;MAP4K4;GDI1;SDC1;SHC1;DKK1;PAK1;SOCS2;ATXN10;TGFBR2;EDNRA;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;OBSCN;APOE;RGS14;LRP1;LPAR3;FGFR1;ITGA1;TMOD2;PTK6;ULK2;INPP5F;ATRX;FAM20C;SOX4;OBSL1;DVL1;MAP6;LRP5;TWF2;CST3;CNTN1;NTNG1;L3MBTL3;RANBP9;WASF3;BTBD3;PPP3CB;MEX3C;RFX2;PLAG1;F2RL1;PTHLH;CHD7;ASAP1;PRKAR1A;DBNDD1;NGFR;PTPRZ1;BCL2L1;RNF165;WASF2;ARF4;XBP1;REC8;RET;PDE5A;TCTN1;NCKAP1;ETV1;CCDC88A;CCSAP;PRKACA;TIMP2;RAB1A;EPB41L3;NR2F6;IL1RAP;LAMB2;LPAR1;CTSZ;ARID4A;TENM2;LAMA5;GRB10;PPARG;GRB7;ALDH1A2;TBX1;ROBO3;ITGA4;WASL;HSPA2;FLNB;ARID5B;SYT2;EEF2K;SEMA6C;OMG;FOXP1;PTCH1;ADCY1;NYAP1;UFL1;PBX3;SEMA3F;ADNP;LRP4
7852,GO:0032412,0.00428914008134259,0.99806766328969,21,125,regulation of ion transmembrane transporter activity,BP,FHL1;NOS1;PRNP;HECW2;KCNG1;STK39;ANK3;DLG1;DLG4;STOM;PTPN3;SHANK2;FKBP1A;PKD2;AKAP9;VAMP2;NTSR1;NLGN2;PRKACA;TMSB4X;HSPA2
10789,GO:0044255,0.0043326322949363,0.997021897507881,84,757,cellular lipid metabolic process,BP,MBOAT2;PCK2;CYGB;CRYL1;ALOX15B;LMF1;DGKA;B4GALT6;HADH;LTA4H;EGFR;FYN;OSBPL10;ELOVL1;ISYNA1;ACOT1;GPC4;TYSND1;ACSF2;SPTLC2;ACOT7;TTC7B;RDH14;ACAD11;SDC1;CBR4;PLPP6;APOE;ABCD1;LRP1;ST3GAL5;PPARA;PIGH;AGPAT4;FGFR1;LPCAT4;LPCAT1;AIG1;LONP2;INPP5F;ABCG1;PITPNM1;KDSR;CEACAM1;PLA2G4D;ACAD10;TMEM86B;TRIB3;PLPPR2;INPP4A;MLYCD;ABHD15;CSNK2A1;CPT2;CRLS1;MGLL;CRAT;AGPAT3;GLB1;XBP1;ABHD6;CCDC71L;OSBPL5;MTMR4;MBOAT7;SAMD8;SEL1L;SRD5A3;ACP6;AGPAT1;PPARG;PTGR2;ALDH1A2;LYPLA1;ESYT3;DDHD2;PLCH2;COQ2;ZFYVE21;ELOVL4;HSD17B12;CDS2;AMACR;SLC44A1
10257,GO:0042995,0.00436135322003763,0.996739069351624,144,1306,cell projection,CC,DOCK4;NOS1;ZMYND8;NEURL1;ITGA6;CYGB;SCN8A;PRNP;OSBP2;ACTA2;BBS2;NR1D1;RAPGEF3;SH3KBP1;WDR66;SSH1;MAP1B;PTPRS;CRTC1;ADGRL1;CAPN2;WIPF1;SNPH;ANK3;DYSF;FYN;BNIP3;KIF13B;PARVB;DLG1;DLG4;SNX9;PODXL;ESPN;GLUL;TTBK2;WDFY3;HTR7;RSPH3;GDI1;UNC119B;DLG3;PAK1;CEP170;ATXN10;SHANK2;EPHA1;RAC2;CD44;APOE;FKBP1A;PTPN12;RGS14;PKD2;PRKACB;LRP1;AKAP9;DDN;ANXA3;ATF4;ABCA7;LPAR3;KIF21B;ITGA1;TMOD2;TUB;SNX14;ITGA2;PTK6;VAMP2;FAT1;INPP5F;PFN2;AHCYL2;FHOD1;FBXO2;CEACAM1;FERMT1;XRN1;DVL1;NTSR1;PLEK2;MPDZ;MAP6;ABHD17C;TWF2;CST3;WASF3;SYTL1;CDC42BPA;SCYL3;F2RL1;ASAP1;PRKAR1A;CPEB4;SPRY2;SEPT5;SLC6A14;NGFR;MARK4;AZIN2;WASF2;ARF4;CNNM1;SLC38A2;RET;SPATA6;TCTN1;NAV1;SH3PXD2B;NCKAP1;PSD3;FRMD4B;CCDC88A;CCSAP;PRKACA;TIMP2;EPB41L3;LPAR1;CTSZ;AP3D1;ARPC1A;TENM2;EFCAB7;GRB7;ATP6V1B2;ROBO3;GARS;WFS1;WDR60;TMEM107;WASL;ANKS6;REEP6;EEF2K;SLC18A2;SIGMAR1;PSEN2;PTCH1;SEPT6;UFL1;ADNP;LRP4;FADD
12612,GO:0050793,0.00438957962832296,0.996637146904744,175,1656,regulation of developmental process,BP,XDH;SMURF2;NOS1;ZMYND8;SORL1;ETV5;PGF;CCND1;NEURL1;CTNNBIP1;VLDLR;SYNE3;CYP27B1;SERPINE2;BBS2;POSTN;ADM2;NR1D1;HECW2;NFATC4;MAP2K1;THBS2;FAM210B;FMNL2;RAPGEF3;ACVR2B;SH3KBP1;ALOX15B;PKN1;WWTR1;SSH1;MAP1B;DDIT3;PTPRS;PSMD2;CRTC1;ADGRL1;WIPF1;EGFR;SEMA4B;FYN;BNIP3;KIF13B;PARVB;ARAP1;ADAMTS7;DLG1;CSMD3;DLG4;IDH2;PLXNB3;GPC4;NET1;WNT7A;MAP4K4;TTBK2;GDI1;ARG2;DKK1;PAK1;SOCS2;TRIB2;RAG1;TGFBR2;SHANK2;SLITRK6;EPHA1;IMPACT;CD44;APOE;ANGPTL4;RGS14;PRKACB;LRP1;ANXA3;HMGA2;PPARA;WWC3;LPAR3;FGFR1;TCFL5;SMOC1;HYAL1;PTK6;ULK2;LTBP4;INPP5F;FAM20C;ABCG1;KIAA1109;GAMT;CEACAM1;FERMT1;OBSL1;SH3D19;EPN2;TNRC6B;DVL1;MMP14;NLGN2;CD46;CTH;LRP5;ZMYM3;CTSL;TWF2;CST3;CNTN1;TRIB3;TPBG;WASF3;ZNF322;MEX3C;ADGRB2;PLAG1;PSMD7;PTHLH;CHD7;ASAP1;SPRY2;THRA;WNT2B;ACVR1B;NGFR;PTPRZ1;IFITM1;XBP1;UBASH3B;RET;CCDC71L;LOXL2;PDE5A;SH3PXD2B;C5;TMBIM1;CCDC88A;CCSAP;PRKACA;NEK6;TIMP2;EIF2AK2;EPB41L3;RHOBTB1;AP2A2;IL1RAP;CARD11;LPAR1;CTSZ;AP3D1;IGF2;LAMA5;ZMYM2;PPARG;SRPX2;TBX1;ADAM8;AKT3;DDHD2;WASL;LRP6;SYT2;EEF2K;HPSE;TNRC6C;OMG;FOXP1;PTCH1;KAT2B;UFL1;ANKRD6;JARID2;SEMA3F;ADNP;LRP4;FADD
6744,GO:0030163,0.00442378885405106,0.996963779213387,83,741,protein catabolic process,BP,SMURF2;EDEM1;GID4;SORL1;VLDLR;SERPINE2;BTBD2;NR1D1;HECW2;WWTR1;DDIT3;PSMD2;CAPN2;EGFR;FYN;BNIP3;UBE2J1;ADAMTS7;CTSB;SNX9;UBXN4;TRIB2;PTPN3;APOE;BNIP3L;RBCK1;LRP1;IDE;ABTB1;UBE2G1;BTRC;LPCAT1;LONP2;RMND5A;FBXO2;CEACAM1;SPATA18;SH3D19;DVL1;MVB12B;ABHD17C;CTSL;CST3;TRIB3;VPS11;DNAJB9;BTBD3;CSNK2A1;PSMD7;MVB12A;MTA1;AZIN2;RNF165;PCYOX1;XBP1;ARRDC1;ANKIB1;LYPLAL1;GABARAPL2;UBE2E1;CTSO;PRKACA;TIMP2;SEL1L;AP2A2;CTSZ;TBL1X;ERLEC1;USP20;LYPLA1;ADAM8;WFS1;USP32;MAGEF1;RNF180;HPSE;DNAJC3;RNF103;USP25;UFL1;KLHL15;STT3B;FBXL5
9064,GO:0035295,0.00443598083532753,0.996981519370768,80,654,tube development,BP,XDH;ETV5;PGF;SH2D2A;CTNNBIP1;ITGA6;SERPINE2;ITGB4;ADM2;NFATC4;MAP2K1;THBS2;RAPGEF3;ACVR2B;SALL2;WWTR1;ARHGAP22;APLN;ELK3;EGFR;DLG1;PODXL;TGM2;WNT7A;SDC1;ARG2;SHC1;PAK1;TGFBR2;EDNRA;EPHA1;APOE;ANGPTL4;PKD2;PRKACB;LRP1;ANXA3;HMGA2;FGFR1;EPCAM;HYAL1;BTRC;PTK6;ATRX;SOX4;CEACAM1;EPN2;DVL1;MMP14;LRP5;ADGRB2;RASIP1;CHD7;SPRY2;THRA;WNT2B;NGFR;WASF2;XBP1;REC8;RET;LOXL2;TCTN1;C5;CTSZ;HOXA3;LAMA5;PPARG;SRPX2;ALDH1A2;TBX1;ADAM8;AKT3;FZD8;TMEM107;LRP6;E2F7;HPSE;FOXP1;PTCH1
6303,GO:0019932,0.004474847883443,0.99781433336035,25,161,second-messenger-mediated signaling,BP,NOS1;ADCY7;PRNP;ADGRF1;ADM2;NFATC4;RAPGEF3;ADGRL1;EGFR;MCTP1;APOE;FKBP1A;PKD2;NFAT5;ITPR3;PPP3CB;ADGRB2;PTHLH;MCTP2;PRKACA;LPAR1;ITPR2;RCAN1;ADCY1;GNAI1
13902,GO:0060546,0.00450984426500241,0.999598343937782,4,9,negative regulation of necroptotic process,BP,RBCK1;SLC25A4;BOK;FADD
3570,GO:0007613,0.00454600103837013,0.998420896792882,13,63,memory,BP,VLDLR;PRNP;ADGRF1;CRTC1;APOE;CCND2;RGS14;ABCA7;ITPR3;PPP3CB;PJA2;ADCY1;ADNP
12278,GO:0048585,0.00455505776269716,0.996680545073472,118,1101,negative regulation of response to stimulus,BP,TNIP1;DDIT4L;XDH;NT5E;PLAT;SMURF2;ERCC1;SORL1;CCND1;NEURL1;CTNNBIP1;ITGA6;SERPINE2;PEAR1;IGFBP4;PRNP;BBS2;NR1D1;NFATC4;FNDC4;LTBP1;SH3KBP1;WWTR1;MST1R;APLN;DDIT3;PTPRS;PSMD2;EGFR;STK39;SEMA4B;ARHGAP12;FYN;UBE2J1;DLG1;HTRA1;MAP4K4;STRADB;MCTP1;ARG2;DKK1;RASA3;SOCS2;TGFBR2;PTPN3;SERPING1;EPHA1;CD44;APOE;ACP5;PTPN12;RGS14;PKD2;PRKACB;LRP1;HMGA2;ATF4;PPARA;WWC3;FGFR1;ITGA1;BTRC;PTK6;INPP5F;CHAC1;CEACAM1;FERMT1;NLK;EPN2;MDFI;DVL1;MMP14;CD46;CTH;TRIB3;RANBP9;DNAJB9;PPP3CB;F2RL1;PSMD7;BOK;SPRY2;PPP1R10;BCL2L1;XBP1;UBASH3B;ARRDC1;RET;C5;MTMR4;EPM2A;RMRP;TMBIM1;TMSB4X;TIMP2;IFI16;LPAR1;RNF169;GRB10;ERLEC1;PPARG;SNX6;RPH3AL;AKT3;IL20RB;WFS1;LRP6;MAGEF1;DNAJC3;FOXP1;PTCH1;USP25;ANKRD6;SEMA3F;KLHL15;LRP4;RB1CC1;FADD
10281,GO:0043025,0.00457045287832699,0.997425588634,37,268,neuronal cell body,CC,NEURL1;CYGB;MAP1B;PTPRS;CRTC1;SNPH;GLUL;WDFY3;GDI1;DLG3;ATXN10;SHANK2;APOE;LRP1;AKAP9;DDN;ANXA3;ITGA1;INPP5F;ITPR3;XRN1;DVL1;NTSR1;CST3;AZIN2;GRIN3B;CNNM1;SLC38A2;RET;TIMP2;LPAR1;NRSN2;ENDOG;LRP6;PSEN2;ADNP;LRP4
3243,GO:0006898,0.00457327960561306,0.997759517816077,25,165,receptor-mediated endocytosis,BP,SORL1;VLDLR;APLN;DLG4;SNX9;DKK1;TGFBR2;APOE;LRP1;INPP5F;CEACAM1;RAB31;CLTCL1;DNAJC6;FNBP1L;FCHO2;ATXN2;LMBR1L;LOXL2;AP2A2;FCHO1;ITGA4;WASL;LRP6;LRP3
12370,GO:0048754,0.00461561678906026,0.998008172408791,19,106,branching morphogenesis of an epithelial tube,BP,ETV5;PGF;CTNNBIP1;NFATC4;DLG1;PAK1;TGFBR2;EDNRA;PKD2;BTRC;MMP14;LRP5;RASIP1;SPRY2;WNT2B;CTSZ;LAMA5;LRP6;PTCH1
6743,GO:0030162,0.00463831396495983,0.997026141915217,59,518,regulation of proteolysis,BP,TNIP1;XDH;PLAT;EDEM1;F2R;SORL1;SERPINE2;PRNP;BTBD2;TFPI2;TNFSF15;FYN;TNFRSF6B;UBE2J1;SNX9;ASPH;DAP;TRIB2;RAG1;PTPN3;SERPING1;CD44;APOE;PRKACB;IDE;ABTB1;BTRC;LTBP4;CHAC1;SH3D19;DVL1;MMP14;CD46;CST3;TRIB3;CASP4;BTBD3;APLP2;PRDX5;CSNK2A1;BOK;NGFR;XBP1;ANKIB1;C5;GABARAPL2;PRKACA;TIMP2;IFI16;CTSZ;ERLEC1;PPARG;ADAM8;MAGEF1;RNF180;USP25;UFL1;FAM162A;FADD
6982,GO:0030658,0.00467085211980697,0.997917827222902,20,126,transport vesicle membrane,CC,RAB3B;PTPRS;SNTB2;SEC23A;MCTP1;MCFD2;ICA1;VAMP2;CEACAM1;LMAN1;DMXL2;CLCN3;MAP6;CLTCL1;DBNDD1;BCL2L1;RAB1A;RPH3AL;SYT2;SLC18A2
3407,GO:0007188,0.00472054561910311,0.998267206648716,14,73,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,NOS1;ADCY7;ADGRF1;ADM2;GRK5;HTR7;EDNRA;PRKACB;PTHLH;WASF2;LTB4R;LPAR1;ADCY1;GNAI1
12631,GO:0050818,0.00472124250735593,0.998614510075163,10,49,regulation of coagulation,BP,PLAT;F2R;SERPINE2;SERPING1;APOE;CEACAM1;F2RL1;PROCR;UBASH3B;HPSE
3857,GO:0008474,0.00472363416870016,0.999551800679011,4,10,palmitoyl-(protein) hydrolase activity,MF,ABHD17C;LYPLAL1;LYPLA1;PPT2
16786,GO:0098599,0.00472363416870016,0.999551800679011,4,10,palmitoyl hydrolase activity,MF,ABHD17C;LYPLAL1;LYPLA1;PPT2
16835,GO:0098734,0.00472363416870016,0.999551800679011,4,10,macromolecule depalmitoylation,BP,ABHD17C;LYPLAL1;LYPLA1;PPT2
12800,GO:0051094,0.00474567446181872,0.996656258245131,95,831,positive regulation of developmental process,BP,SMURF2;ZMYND8;ETV5;PGF;CCND1;NEURL1;CTNNBIP1;VLDLR;CYP27B1;SERPINE2;BBS2;ADM2;MAP2K1;THBS2;FAM210B;RAPGEF3;ACVR2B;ALOX15B;WWTR1;MAP1B;CRTC1;ADGRL1;FYN;BNIP3;DLG4;PLXNB3;NET1;WNT7A;GDI1;ARG2;DKK1;PAK1;SOCS2;RAG1;TGFBR2;SHANK2;SLITRK6;EPHA1;IMPACT;APOE;ANGPTL4;RGS14;ANXA3;HMGA2;LPAR3;FGFR1;HYAL1;PTK6;FAM20C;CEACAM1;OBSL1;DVL1;MMP14;NLGN2;CD46;CTH;LRP5;TWF2;CNTN1;TPBG;WASF3;ZNF322;ADGRB2;PLAG1;CHD7;THRA;WNT2B;ACVR1B;NGFR;IFITM1;XBP1;RET;CCDC71L;LOXL2;PDE5A;SH3PXD2B;C5;TIMP2;IL1RAP;LPAR1;AP3D1;PPARG;SRPX2;TBX1;ADAM8;AKT3;DDHD2;LRP6;SYT2;EEF2K;HPSE;PTCH1;UFL1;ADNP;FADD
6670,GO:0030030,0.00479690973149471,0.996497093586045,119,1044,cell projection organization,BP,ZMYND8;NEURL1;VLDLR;ITGA6;PRNP;ADGRF1;BBS2;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;WWTR1;SSH1;MAP1B;PTPRS;LAMB1;CRTC1;BRSK1;EGFR;SEMA4B;ANK3;FYN;KIF13B;PARVB;ARAP1;CSMD3;DLG4;PLXNB3;PODXL;ESPN;EVI5L;WNT7A;MAP4K4;TTBK2;GDI1;UNC119B;SEPT10;SHC1;PAK1;ATXN10;NUDCD3;SHANK2;SLITRK6;IMPACT;RAC2;CD44;APOE;LRP1;AKAP9;LPAR3;FGFR1;ITGA1;E2F5;PTPDC1;ITGA2;PTK6;ULK2;INPP5F;PFN2;CEP120;OBSL1;FAM110C;DVL1;PLEK2;MAP6;TWF2;CNTN1;NTNG1;RANBP9;WASF3;BTBD3;PPP3CB;RFX2;FNBP1L;F2RL1;ASAP1;SPRY2;SEPT5;DBNDD1;NGFR;MARK4;PTPRZ1;RNF165;WASF2;ARF4;RET;SPATA6;TCTN1;NCKAP1;DOCK11;ETV1;CCDC88A;PRKACA;EPB41L3;IL1RAP;LAMB2;LPAR1;CTSZ;TENM2;LAMA5;GRB10;GRB7;ROBO3;WDR60;TMEM107;WASL;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;SEPT6;NYAP1;SEMA3F;ADNP;LRP4
9389,GO:0035926,0.00482419663801344,0.999791172714149,3,5,chemokine (C-C motif) ligand 2 secretion,BP,POSTN;F2RL1;FOXP1
16873,GO:0098802,0.00482778334161504,0.998081694012783,16,87,plasma membrane receptor complex,CC,ITGA6;ITGB4;DLG1;DLG4;DLG3;TGFBR2;SHANK2;ITGA1;ITGB5;ITGA2;CEACAM1;ACVR1B;GRIN3B;ABHD6;CARD11;ITGA4
6590,GO:0022603,0.00487350842001474,0.996637790509445,84,712,regulation of anatomical structure morphogenesis,BP,XDH;SMURF2;ETV5;PGF;SYNE3;POSTN;ADM2;HECW2;NFATC4;MAP2K1;THBS2;FMNL2;RAPGEF3;SH3KBP1;PKN1;SSH1;MAP1B;PTPRS;PSMD2;WIPF1;SEMA4B;FYN;BNIP3;KIF13B;PARVB;ARAP1;DLG1;DLG4;PLXNB3;GPC4;NET1;WNT7A;TTBK2;GDI1;DKK1;PAK1;TGFBR2;EPHA1;CD44;APOE;ANGPTL4;ANXA3;HMGA2;LPAR3;FGFR1;HYAL1;ULK2;CEACAM1;OBSL1;SH3D19;EPN2;DVL1;ZMYM3;TWF2;CST3;WASF3;ADGRB2;PSMD7;SPRY2;WNT2B;NGFR;XBP1;RET;C5;TMBIM1;EPB41L3;RHOBTB1;AP2A2;LPAR1;ZMYM2;PPARG;SRPX2;TBX1;AKT3;DDHD2;WASL;SYT2;EEF2K;OMG;FOXP1;ANKRD6;SEMA3F;ADNP;LRP4
5081,GO:0015318,0.00495081750478877,0.99694578734032,50,397,inorganic molecular entity transmembrane transporter activity,MF,SCN8A;SLC16A3;KCNG1;DENND5B;SLC33A1;DLG1;DLG4;SLC9A7;DLG3;RASA3;CLCA2;ATP7B;PKD2;FAM155B;ABCG1;ITPR3;CEACAM1;SLC5A1;BSG;CLCN3;ANXA6;ORAI3;NIPA1;TTYH3;ANO8;SLC2A9;SLC6A6;ANO1;SLC6A14;NDUFA4L2;SLC43A1;GRIN3B;SLC12A7;PCYOX1;SLC22A17;SLC38A2;TRPC1;SLC13A3;KCNJ15;SLC30A1;SLC39A10;ORAI1;ITPR2;SLC2A13;SLC10A6;ATP12A;SLC7A11;ATP6V1B2;SLC18A2;SLC23A2
12901,GO:0051247,0.00497516522416253,0.996345095975908,122,1151,positive regulation of protein metabolic process,BP,TNIP1;XDH;SMURF2;EDEM1;NOS1;F2R;SORL1;CCND1;NEURL1;VLDLR;ADCY7;IGFBP4;PRNP;HECW2;MAP2K1;RAPGEF3;ACVR2B;PKN1;MST1R;TNFSF15;EGFR;STK39;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;TRIB2;TGFBR2;EPHA1;IMPACT;CD44;APOE;FKBP1A;CCND2;PKD2;PRKACB;LRP1;IDE;AKAP9;ABCA7;LPAR3;FGFR1;ITGA1;BTRC;LPCAT1;ITGA2;PTK6;PFN2;SOX4;MAPKAPK3;SH3D19;TRIM5;DVL1;MMP14;ETAA1;CNTN1;TRIB3;CASP4;VPS11;SLK;CEBPG;F2RL1;TAOK1;CSNK2A1;PHF1;PRKAR1A;BOK;PARP9;SPRY2;ACVR1B;NGFR;MTA1;XBP1;MAP2K2;PAIP1;ANKIB1;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;CARD11;LPAR1;IGF2;MAP4K2;PPARG;TBX1;ADAM8;WFS1;FZD8;HSPA2;MAGEF1;RNF180;TET1;DNAJC3;ADCY1;FAM162A;ANKRD6;JARID2;ADNP;LRP4;RB1CC1;FBXL5;FADD
6106,GO:0019343,0.00497779738347385,1,2,2,cysteine biosynthetic process via cystathionine,BP,CBS;CTH
2626,GO:0005952,0.00502925702935011,0.999778919363277,3,5,cAMP-dependent protein kinase complex,CC,PRKACB;PRKAR1A;PRKACA
8733,GO:0034380,0.0050352534307651,0.999536941343364,4,9,high-density lipoprotein particle assembly,BP,APOE;PRKACB;ABCA7;PRKACA
6892,GO:0030424,0.00517637211325615,0.996836976180494,48,360,axon,CC,SCN8A;SSH1;MAP1B;PTPRS;ADGRL1;ANK3;KIF13B;DLG1;DLG4;GLUL;WDFY3;GDI1;DLG3;PAK1;SHANK2;FKBP1A;ANXA3;LPAR3;KIF21B;TMOD2;ITGA2;INPP5F;PFN2;DVL1;NTSR1;MAP6;TWF2;CST3;CPEB4;SEPT5;AZIN2;SLC38A2;RET;NAV1;CCSAP;TIMP2;EPB41L3;CTSZ;AP3D1;TENM2;ROBO3;GARS;SLC18A2;SIGMAR1;PSEN2;PTCH1;SEPT6;ADNP
12814,GO:0051119,0.00520092813468017,0.999281598218154,5,14,sugar transmembrane transporter activity,MF,SLC2A3;SLC5A1;SLC2A9;SLC2A13;SLC23A2
7359,GO:0031401,0.00523249552856844,0.996338852520817,89,791,positive regulation of protein modification process,BP,TNIP1;XDH;NOS1;F2R;CCND1;NEURL1;VLDLR;ADCY7;IGFBP4;PRNP;MAP2K1;RAPGEF3;ACVR2B;PKN1;MST1R;TNFSF15;EGFR;STK39;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;TGFBR2;EPHA1;CD44;FKBP1A;CCND2;PKD2;PRKACB;AKAP9;ABCA7;LPAR3;FGFR1;ITGA1;PTK6;PFN2;SOX4;MAPKAPK3;TRIM5;DVL1;ETAA1;CNTN1;TRIB3;SLK;F2RL1;TAOK1;PHF1;PRKAR1A;PARP9;SPRY2;ACVR1B;NGFR;MTA1;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;TIMP2;EIF2AK2;RAB1A;SLC39A10;LPAR1;IGF2;MAP4K2;TBX1;ADAM8;WFS1;FZD8;HSPA2;TET1;ADCY1;ANKRD6;JARID2;ADNP;LRP4;RB1CC1
19238,GO:1905384,0.00526595780991892,1,2,2,regulation of protein localization to presynapse,BP,WNT7A;DVL1
19239,GO:1905386,0.00526595780991892,1,2,2,positive regulation of protein localization to presynapse,BP,WNT7A;DVL1
4362,GO:0009966,0.00527552699862257,0.995846723754112,216,2143,regulation of signal transduction,BP,TNIP1;DDIT4L;XDH;SMURF2;NOS1;ZMYND8;F2R;SORL1;PGF;CCND1;NEURL1;SH2D2A;CTNNBIP1;ASAP2;ITGA6;CYP27B1;SERPINE2;PEAR1;IGFBP4;PRNP;PAG1;POSTN;SH3TC2;ADM2;NR1D1;NFATC4;MAP2K1;CMTM4;ACVR2B;LTBP1;SH3KBP1;ALOX15B;PKN1;WWTR1;MST1R;ARHGAP22;APLN;TNFSF15;APPL2;SSH1;DDIT3;PTPRS;PSMD2;EGFR;STK39;ARHGAP12;FYN;TSPAN5;BNIP3;ERCC6;ARAP1;DLG1;DLG4;GPC4;NET1;TGM2;HTRA1;WNT7A;MAP4K4;GRK5;STRADB;GDI1;SHC1;DKK1;PAK1;RASA3;SOCS2;TRIB2;TGFBR2;PTPN3;SHANK2;EPHA1;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;PTPN12;AFAP1;RGS14;PKD2;PRKACB;RBCK1;LRP1;ABCA7;WWC3;LPAR3;FGFR1;ITGA1;TMOD2;CMTM7;NFAT5;BTRC;PTK6;LTBP4;INPP5F;CHAC1;FAM20C;SOX4;CEACAM1;FERMT1;MAPKAPK3;UACA;FAM110C;NLK;EPN2;MDFI;TRIM5;RALGAPA1;DVL1;NTSR1;MMP14;NLGN2;CD46;MVB12B;CTH;LRP5;DNMBP;TRIB3;CASP4;PCSK6;RANBP9;DNAJB9;MYOF;F2RL1;DDX60;TAOK1;CSNK2A1;PSMD7;PTHLH;ASAP1;JMY;BOK;PARP9;C18ORF32;NACC2;SPRY2;THRA;MGLL;WNT2B;ACVR1B;NGFR;MVB12A;NUDT6;BCL2L1;RNF165;SKAP2;XBP1;UBASH3B;MAP2K2;ABHD6;PPP1R2;ARRDC1;RET;PDE5A;TCTN1;C5;MTMR4;EPM2A;PAK6;PUM2;PSD3;TMBIM1;TMED4;SHC2;PRKACA;SAMD5;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RHOBTB1;SLC39A10;CMTM6;CARD11;FICD;LPAR1;TBL1X;IGF2;MOAP1;AGPAT1;PJA2;GRB10;MAP4K2;PPARG;SNX6;USP20;GRB7;ARHGAP29;TBX1;RPH3AL;ADAM8;AKT3;WFS1;ACAP2;MAML3;CKLF;FZD8;LRP6;HPSE;RCAN1;DEDD2;FOXP1;PTCH1;KAT2B;UFL1;FAM162A;ANKRD6;RALGPS2;GNAI1;LRP4;RB1CC1;TRIM38;FADD
2335,GO:0005355,0.0052771538799046,0.999508002272746,4,9,glucose transmembrane transporter activity,MF,SLC2A3;SLC5A1;SLC2A9;SLC2A13
2606,GO:0005905,0.00530445679266754,0.998215672466278,12,57,clathrin-coated pit,CC,EPN3;VLDLR;EGFR;CEMIP;LRP1;INPP5F;CLTCL1;FCHO2;AP2A2;FCHO1;FNBP1;LRP3
607,GO:0001775,0.00530758300025152,0.996253513997264,93,861,cell activation,BP,ERCC1;F2R;PYGL;CYGB;PYGB;SERPINE2;PRSS3;PRNP;PAG1;PKN1;NAPRT;POU2F2;DGKA;PSMD2;LTA4H;EGFR;FYN;KIF13B;PGM1;DLG1;CTSB;CD68;WNT7A;ARG2;STOM;PAK1;RAG1;TGFBR2;SLC2A3;LCN2;RAC2;CD44;APOE;FKBP1A;LRP1;ANXA3;CMTM7;LPCAT1;VAMP2;SOX4;ITPR3;CEACAM1;RAB31;MMP14;CD46;CST3;MOSPD2;DNAJB9;PPP3CB;COPB1;CEBPG;F2RL1;C6ORF120;PSMD7;CHD7;QSOX1;PRKAR1A;GLB1;SKAP2;YPEL5;XBP1;UBASH3B;SATB1;PDE5A;DNASE1L1;DOCK11;TMBIM1;COL1A2;TIMP2;AP2A2;SLC39A10;CMTM6;CARD11;CTSZ;AP3D1;NIT2;IGF2;ITPR2;TMEM63A;SLC7A11;ERP44;ADAM8;IL20RB;ATP11B;ITGA4;FZD8;TMEM173;HPSE;GALNS;DNAJC3;FOXP1;SNX27;FADD
3761,GO:0008305,0.00532216510699629,0.999083562711172,6,17,integrin complex,CC,ITGA6;ITGB4;ITGA1;ITGB5;ITGA2;ITGA4
16797,GO:0098636,0.00532216510699629,0.999083562711172,6,17,protein complex involved in cell adhesion,CC,ITGA6;ITGB4;ITGA1;ITGB5;ITGA2;ITGA4
7028,GO:0030801,0.00533328433055399,0.999031246753235,6,21,positive regulation of cyclic nucleotide metabolic process,BP,NOS1;RAPGEF3;APOE;PTHLH;TIMP2;ADNP
6079,GO:0019233,0.0053410910906477,0.998541022427539,9,40,sensory perception of pain,BP,F2R;FYN;ITGA2;NTSR1;NLGN2;ANO1;NIPSNAP1;MGLL;NR2F6
6758,GO:0030182,0.00540565520895613,0.996141585753179,100,851,neuron differentiation,BP,ZMYND8;ETV5;NEURL1;VLDLR;ADGRF1;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;SMARCA1;LAMB1;SDK2;CRTC1;BRSK1;SNPH;EGFR;SEMA4B;ANK3;FYN;KIF13B;CSMD3;DLG4;PLXNB3;WNT7A;MAP4K4;GDI1;UNC119B;SHC1;DKK1;PAK1;SOCS2;ATXN10;SHANK2;SLITRK6;IMPACT;RAC2;APOE;LRP1;LPAR3;FGFR1;ITGA1;PTK6;ULK2;INPP5F;SOX4;OBSL1;DVL1;MAP6;TWF2;CNTN1;NTNG1;RANBP9;BTBD3;PPP3CB;ASAP1;WNT2B;DBNDD1;NGFR;PTPRZ1;RNF165;ARF4;XBP1;RET;TCTN1;NCKAP1;ETV1;CCDC88A;CCSAP;TIMP2;EPB41L3;NR2F6;IL1RAP;LAMB2;LPAR1;CTSZ;TENM2;GRB10;GRB7;ALDH1A2;ROBO3;FZD8;WASL;LRP6;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;NYAP1;PBX3;SEMA3F;ADNP;LRP4;DNMT3A
6631,GO:0022898,0.0054415224673447,0.997491159612312,21,128,regulation of transmembrane transporter activity,BP,FHL1;NOS1;PRNP;HECW2;KCNG1;STK39;ANK3;DLG1;DLG4;STOM;PTPN3;SHANK2;FKBP1A;PKD2;AKAP9;VAMP2;NTSR1;NLGN2;PRKACA;TMSB4X;HSPA2
18182,GO:1902951,0.00544782265365171,1,2,2,negative regulation of dendritic spine maintenance,BP,PRNP;FYN
19335,GO:1905664,0.00544782265365171,1,2,2,regulation of calcium ion import across plasma membrane,BP,PRNP;FYN
12068,GO:0048016,0.00546691721203528,0.998671286088708,8,30,inositol phosphate-mediated signaling,BP,PRNP;NFATC4;NFAT5;ITPR3;PPP3CB;ADGRB2;ITPR2;RCAN1
1966,GO:0004675,0.00550973614913892,0.999271066514932,5,12,transmembrane receptor protein serine/threonine kinase activity,MF,ACVR2B;LTBP1;TGFBR2;LTBP4;ACVR1B
17252,GO:0120032,0.00555203984185957,0.997487982385351,20,123,regulation of plasma membrane bounded cell projection assembly,BP,ZMYND8;NEURL1;SSH1;ARAP1;PLXNB3;PODXL;ESPN;EVI5L;RAC2;PFN2;CEP120;TWF2;FNBP1L;F2RL1;WASF2;NCKAP1;DOCK11;CCDC88A;TENM2;WASL
16229,GO:0090276,0.00555519261159197,0.997543443594863,19,117,regulation of peptide hormone secretion,BP,PCK2;NR1D1;RAPGEF3;APLN;HADH;EGFR;GLUL;MAP4K4;ICA1;SOX4;ITPR3;NLGN2;LRP5;PPP3CB;CHD7;SLC25A4;ANO1;GLUD1;ITPR2
552,GO:0001673,0.00560560222208407,0.999440996661128,4,10,male germ cell nucleus,CC,TCFL5;REC8;MLH3;HSPA2
13148,GO:0051716,0.00561973282347978,0.995364775619081,437,4661,cellular response to stimulus,BP,TNIP1;DOCK4;DDIT4L;XDH;PLAT;SMURF2;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FAM83A;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;ASAP2;CBS;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;SERPINE2;PEAR1;ADCY7;IGFBP4;PRNP;PAG1;ADGRF1;ITGB4;BBS2;POSTN;SH3TC2;ADM2;NR1D1;NFATC4;MAP2K1;CMTM4;FAM210B;TFPI2;LTBP2;RAPGEF3;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ALOX15B;SALL2;GPX3;PKN1;WWTR1;DCBLD2;MST1R;ARHGAP22;APLN;PITPNC1;DGKA;TNFSF15;APPL2;EIF4EBP1;SSH1;DDIT3;PTPRS;PSMD2;ELK3;ADGRL1;CAPN2;BRSK1;FCGRT;WIPF1;EGFR;STK39;RIN2;SEMA4B;ANK3;ARHGAP12;PPP1R14A;FYN;HEBP1;TNFRSF6B;TSPAN5;BNIP3;KIF13B;SLC33A1;ERCC6;UBE2J1;MAPK13;ARAP1;ADAMTS7;ZNF516;DLG1;DLG4;CTSB;CD68;PLXNB3;GPC4;NET1;TGM2;XPC;GLUL;HTRA1;WNT7A;UBXN4;MAP4K4;TTBK2;GRK5;HTR7;STRADB;MCTP1;GDI1;SDC1;ARG2;SHC1;DKK1;WISP1;DAP;SMOC2;PAK1;RASA3;SOCS2;TRIB2;RHPN1;MRC2;TGFBR2;PTPN3;EDNRA;LCN2;SHANK2;EPHA1;IMPACT;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;BNIP3L;CCND2;PTPN12;AFAP1;RGS14;PKD2;PRKACB;RBCK1;LRP1;IDE;AKAP9;HMGA2;ATF4;PPARA;ABCA7;WWC3;LPAR3;ASNS;FGFR1;ITGA1;EPCAM;TMOD2;CMTM7;UROS;SMOC1;NFAT5;ITGB5;HYAL1;BTRC;ITGA2;PTK6;GALNT3;TMX4;VAMP2;ULK2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;ABCG1;SOX4;PITPNM1;ITPR3;FBXO2;DDB2;ENDOV;CEACAM1;FERMT1;MAPKAPK3;SPATA18;PDIA5;RAB31;MT2A;UACA;FAM110C;BSG;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;PLEK2;ANXA6;NLGN2;CD46;MVB12B;EPOR;CTH;NXPH4;LRP5;ETAA1;DNMBP;CTSL;DOCK9;TWF2;CST3;CNTN1;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;TOM1L2;MOSPD2;RANBP9;DNAJB9;PLPPR2;SEC63;PPP3CB;MYOF;INPP4A;RFX2;ADGRB2;APLP2;SLK;PRDX5;CEBPG;CDC42BPA;F2RL1;DDX60;RASIP1;TAOK1;CSNK2A1;PHF1;PSMD7;PTHLH;ASAP1;PRKAR1A;ANO1;JMY;BOK;PARP9;CPEB4;C18ORF32;MAST3;NACC2;SPRY2;THRA;MGLL;WNT2B;ACVR1B;COL6A1;NGFR;BPHL;PPP1R10;PSKH1;MVB12A;HSPA13;PTPRZ1;CHD6;NUDT6;MTA1;BCL2L1;IFITM1;RNF165;GRIN3B;WASF2;SKAP2;ARF4;POLL;XBP1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SLC22A17;PPP1R2;ARRDC1;REC8;TLE4;SLC38A2;RIN1;RET;PDE5A;TCTN1;RAB43;MLH3;MCTP2;C5;TXNDC11;MTMR4;ZFYVE9;NCKAP1;GABARAPL2;EPM2A;RMRP;DOCK11;PAK6;PUM2;TSPAN3;PSD3;TMBIM1;COL1A2;CCDC88A;TMED4;SHC2;PRKACA;SAMD5;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RAB1A;EEPD1;SEL1L;IFI16;RHOBTB1;AP2A2;NR2F6;SLC39A10;KDELR3;CMTM6;IL1RAP;CARD11;LAMB2;LTB4R;FICD;LPAR1;TBL1X;RNF169;AP3D1;ARPC1A;TENM2;IGF2;ITPR2;MOAP1;LAMA5;AGPAT1;PJA2;GRB10;MAP4K2;ERLEC1;PPARG;SNX6;USP20;GRB7;ALDH1A2;GPR153;ARHGAP29;TBX1;CREB3L2;ERP44;ATP6V1B2;RPH3AL;ADAM8;AKT3;ROBO3;IL20RB;WFS1;DEPDC1;ENDOG;ITGA4;ZBTB40;ACAP2;MAML3;CKLF;IGFBP7;FZD8;WASL;RAPGEFL1;HSPA2;FLNB;LRP6;ARID5B;MAGEF1;PLCH2;TMEM173;E2F7;EEF2K;SIGMAR1;HPSE;RALGDS;SSR1;TNRC6C;RCAN1;ZC3H7A;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;RNF103;USP25;NYAP1;UFL1;FAM162A;ANKRD6;SNX27;JARID2;SEMA3F;RALGPS2;KLHL15;ADNP;GNAI1;LRP4;STT3B;RB1CC1;DNMT3A;TRIM38;FADD
2975,GO:0006516,0.00567203607816682,0.999182705966525,5,15,glycoprotein catabolic process,BP,EDEM1;FBXO2;CST3;HPSE;STT3B
6695,GO:0030072,0.00570235688126211,0.997299886700519,22,141,peptide hormone secretion,BP,PCK2;NR1D1;RAPGEF3;ACVR2B;APLN;HADH;EGFR;GLUL;MAP4K4;ICA1;LTBP4;SOX4;ITPR3;NLGN2;LRP5;PPP3CB;CHD7;SLC25A4;ANO1;GLUD1;RAB1A;ITPR2
12317,GO:0048667,0.0057287343200967,0.996410219976995,52,386,cell morphogenesis involved in neuron differentiation,BP,VLDLR;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;BRSK1;SEMA4B;ANK3;FYN;KIF13B;DLG4;PLXNB3;WNT7A;GDI1;SHC1;PAK1;SHANK2;SLITRK6;APOE;LPAR3;ULK2;OBSL1;DVL1;MAP6;TWF2;NTNG1;RANBP9;BTBD3;PPP3CB;NGFR;PTPRZ1;RNF165;RET;TCTN1;ETV1;LAMB2;GRB10;GRB7;ROBO3;WASL;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;SEMA3F;ADNP;LRP4
735,GO:0001965,0.00584206657949565,0.999137058918565,5,16,G-protein alpha-subunit binding,MF,F2R;RGS14;LPAR3;F2RL1;LPAR1
15862,GO:0072578,0.00589481156924465,0.999725137024961,3,5,neurotransmitter-gated ion channel clustering,BP,SSH1;DLG4;APOE
4598,GO:0010713,0.00589487720803238,0.999675423447592,3,6,negative regulation of collagen metabolic process,BP,CYGB;CST3;PPARG
3504,GO:0007409,0.00595746134834144,0.996439663517872,43,307,axonogenesis,BP,VLDLR;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;BRSK1;SEMA4B;ANK3;FYN;KIF13B;PLXNB3;WNT7A;GDI1;SHC1;PAK1;SLITRK6;APOE;LPAR3;ULK2;DVL1;TWF2;NTNG1;RANBP9;PPP3CB;NGFR;PTPRZ1;RNF165;RET;TCTN1;ETV1;LAMB2;GRB10;GRB7;ROBO3;SEMA6C;OMG;PTCH1;ADCY1;SEMA3F;ADNP;LRP4
4382,GO:0010033,0.00597449303256752,0.995285632052732,213,2166,response to organic substance,BP,TNIP1;XDH;SMURF2;EDEM1;NOS1;ERCC1;F2R;PGF;CCND1;NEURL1;PCK2;ITGA6;MMP1;CYP27B1;ADCY7;PRNP;MXRA5;BBS2;POSTN;NR1D1;NFATC4;MAP2K1;FAM210B;LTBP2;RAPGEF3;FNDC4;ACVR2B;LTBP1;GPX3;MST1R;APLN;TNFSF15;EIF4EBP1;SSH1;DDIT3;HADH;PSMD2;CAPN2;EGFR;LOXL1;FYN;TNFRSF6B;SLC33A1;UBE2J1;MAPK13;ADAMTS7;CTSB;CD68;DNAJB5;GLUL;HTRA1;WNT7A;UBXN4;MAP4K4;SDC1;SHC1;DKK1;PAK1;SOCS2;TGFBR2;LCN2;IMPACT;CD44;APOE;FKBP1A;ACP5;PTPN12;PKD2;PRKACB;RBCK1;LRP1;LDHA;IDE;AKAP9;ANXA3;ATF4;PPARA;ASNS;FGFR1;TUB;UROS;ITGB5;HYAL1;BTRC;ITGA2;PTK6;GALNT3;VAMP2;LONP2;LTBP4;CHAC1;ATRX;FAM20C;MTHFR;ABCG1;SOX4;FBXO2;CEACAM1;FERMT1;MAPKAPK3;PDIA5;RAB31;MT2A;BSG;NLK;EPN2;XRN1;TRIM5;NTSR1;MMP14;EPOR;CTH;LRP5;CTSL;TWF2;CST3;TRIB3;CASP4;GFPT1;PCSK6;DNAJB9;SEC63;PPP3CB;MYOF;RFX2;F2RL1;CSNK2A1;PSMD7;PRKAR1A;ANO1;CRLS1;BOK;PARP9;CPEB4;SPRY2;THRA;COL6A1;NGFR;HSPA13;PTPRZ1;BCL2L1;IFITM1;RNF165;YTHDC2;GLB1;XBP1;MAP2K2;TLE4;RET;RAB43;MTMR4;ZFYVE9;RMRP;PUM2;COL1A2;PRKACA;TMSB4X;TIMP2;EIF2AK2;SEL1L;NR2F6;KDELR3;IL1RAP;FICD;LPAR1;ZNF354A;IGF2;ITPR2;LAMA5;AGPAT1;GRB10;ERLEC1;PPARG;SNX6;ALDH1A2;TBX1;CREB3L2;ERP44;ATP6V1B2;IL20RB;WFS1;ENDOG;ITGA4;ACAP2;IGFBP7;HSPA2;FLNB;LRP6;ARID5B;TMEM173;EEF2K;SLC18A2;SSR1;ZC3H7A;DNAJC3;FOXP1;DNAJC4;PTCH1;ADCY1;KAT2B;OAS1;RNF103;USP25;UFL1;JARID2;KLHL15;ADNP;GNAI1;LRP4;STT3B;DNMT3A;TRIM38;FADD
16780,GO:0098590,0.00600005180723235,0.995903156315716,76,622,plasma membrane region,CC,NOS1;F2R;NEURL1;ITGA6;BBS2;SLC29A4;COL13A1;PKN1;MST1R;SSH1;PTPRS;ADGRL1;SNPH;EGFR;STK39;ANK3;DLG1;DLG4;PODXL;DLG3;PAK1;TGFBR2;SHANK2;CLCA2;CD44;ATP7B;RGS14;PKD2;LRP1;AKAP9;RAB11FIP4;DDN;ATF4;ABCA7;EPCAM;PITPNM1;CEACAM1;FERMT1;SLC9A3R2;PLEK2;NLGN2;MPDZ;ABHD17C;RIMS3;MYOF;SYTL1;SLC2A9;ASAP1;PRKAR1A;ANO1;FCHO2;CPEB4;NIPSNAP1;SPRY2;SLC6A14;GRIN3B;ARF4;SPIRE1;NCKAP1;PSD3;PRKACA;EPB41L3;ARPC1A;TENM2;PJA2;MAP4K2;EFCAB7;SRPX2;ATP12A;LRP6;SIGMAR1;PSEN2;PTCH1;SEPT6;SLC23A2;LRP4
18183,GO:1902952,0.00610799178002079,1,2,2,positive regulation of dendritic spine maintenance,BP,ZMYND8;APOE
16809,GO:0098655,0.00615439401242282,0.996136998768725,51,412,cation transmembrane transport,BP,FHL1;NOS1;F2R;SCN8A;PRNP;HECW2;DDIT3;KCNG1;DENND5B;STK39;ANK3;FYN;SLC33A1;DLG1;DLG4;SLC9A7;CEMIP;STOM;RASA3;PTPN3;SHANK2;FKBP1A;ATP7B;PKD2;AKAP9;FAM155B;VAMP2;ITPR3;NTSR1;NLGN2;ORAI3;NIPA1;SLC2A9;CHD7;NDUFA4L2;GRIN3B;SLC12A7;UBASH3B;MICU3;TRPC1;KCNJ15;SLC30A1;PRKACA;TMSB4X;SLC39A10;ORAI1;ITPR2;SLC2A13;ATP12A;ATP6V1B2;HSPA2
13903,GO:0060547,0.00629601532079576,0.999350459323419,4,10,negative regulation of necrotic cell death,BP,RBCK1;SLC25A4;BOK;FADD
10494,GO:0043394,0.00629878255432547,0.998639700249145,7,23,proteoglycan binding,MF,PTPRS;CTSB;GPC4;LRP1;ITGA2;CTSL;HPSE
6617,GO:0022839,0.00629881687387731,0.997256552708883,18,106,ion gated channel activity,MF,SCN8A;KCNG1;DLG1;DLG4;DLG3;RASA3;CLCA2;PKD2;FAM155B;ITPR3;CLCN3;ANXA6;TTYH3;ANO8;ANO1;GRIN3B;KCNJ15;ITPR2
3192,GO:0006816,0.00630377251521462,0.996609044620501,30,209,calcium ion transport,BP,NOS1;F2R;CYP27B1;PRNP;DDIT3;DENND5B;FYN;CEMIP;RASA3;FKBP1A;PKD2;LPAR3;FAM155B;ITPR3;SARAF;NTSR1;ANXA6;ORAI3;CHD7;GRIN3B;UBASH3B;MICU3;TRPC1;SLC30A1;PRKACA;ORAI1;ITPR2;WFS1;HSPA2;PSEN2
6414,GO:0021675,0.00633166988600118,0.99808867671318,10,43,nerve development,BP,SERPINE2;ADARB1;SLITRK6;CHD7;RNF165;RET;LPAR1;HOXA3;TBX1;SEMA3F
8924,GO:0034765,0.00634819417252466,0.996584034503996,30,208,regulation of ion transmembrane transport,BP,FHL1;NOS1;F2R;SCN8A;PRNP;HECW2;KCNG1;STK39;ANK3;FYN;DLG1;DLG4;CEMIP;STOM;PTPN3;SHANK2;FKBP1A;PKD2;AKAP9;VAMP2;NTSR1;NLGN2;CHD7;UBASH3B;TRPC1;KCNJ15;SLC30A1;PRKACA;TMSB4X;HSPA2
13249,GO:0051924,0.00640773284113311,0.997124966736942,19,118,regulation of calcium ion transport,BP,NOS1;F2R;PRNP;FYN;CEMIP;FKBP1A;PKD2;LPAR3;SARAF;NTSR1;CHD7;GRIN3B;UBASH3B;TRPC1;SLC30A1;PRKACA;ORAI1;WFS1;HSPA2
3395,GO:0007173,0.00640998834295156,0.997199791558469,18,108,epidermal growth factor receptor signaling pathway,BP,FAM83A;NEURL1;PAG1;SH3KBP1;EGFR;ARAP1;SHC1;PTPN3;PTPN12;ITGA1;PTK6;CEACAM1;MVB12B;SPRY2;MVB12A;ARF4;SNX6;GRB7
17559,GO:1901136,0.00645153928742296,0.997090124785601,19,128,carbohydrate derivative catabolic process,BP,NT5E;EDEM1;RAPGEF3;GPC4;CEMIP;SDC1;CD44;ABHD10;HYAL1;APOBEC3C;FBXO2;CST3;CTBS;NPL;GLB1;PDE5A;HPSE;GALNS;STT3B
6019,GO:0019075,0.00646715272091013,1,2,2,virus maturation,BP,MVB12B;MVB12A
16739,GO:0097755,0.00653783347182648,0.998321914188328,8,35,positive regulation of blood vessel diameter,BP,DOCK4;NOS1;BBS2;APLN;EGFR;APOE;ITGA1;F2RL1
6210,GO:0019725,0.00654804162223401,0.995668792247431,63,548,cellular homeostasis,BP,NOS1;F2R;PCK2;PRNP;NR1D1;DDIT3;FYN;BNIP3;DLG4;TGM2;SLC9A7;MAP4K4;CEMIP;RASA3;EDNRA;LCN2;ERO1B;APOE;FKBP1A;ATP7B;PKD2;IDE;LPAR3;FAM155B;TMX4;SOX4;ITPR3;NELL2;PDIA5;DMXL2;MT2A;CLCN3;NTSR1;ANXA6;LRP5;PPP3CB;PRDX5;F2RL1;CHD7;QSOX1;ANO1;BOK;SLC12A7;XBP1;UBASH3B;TXNRD3;SLC22A17;TRPC1;TXNDC11;SLC30A1;PRKACA;SLC39A10;LPAR1;AP3D1;ITPR2;ATP12A;ERP44;ATP6V1B2;WFS1;ENDOG;LRP6;DEDD2;FBXL5
4424,GO:0010243,0.00657555178607324,0.995497368203145,75,650,response to organonitrogen compound,BP,EDEM1;CCND1;NEURL1;PCK2;ADCY7;PRNP;RAPGEF3;EIF4EBP1;SSH1;HADH;CAPN2;EGFR;FYN;UBE2J1;MAPK13;UBXN4;SDC1;SHC1;PAK1;SOCS2;IMPACT;APOE;FKBP1A;PKD2;PRKACB;LRP1;LDHA;IDE;AKAP9;ATF4;PPARA;ASNS;UROS;ITGA2;VAMP2;MTHFR;FBXO2;CEACAM1;RAB31;BSG;XRN1;LRP5;TRIB3;CASP4;DNAJB9;PRKAR1A;CRLS1;CPEB4;COL6A1;NGFR;BCL2L1;XBP1;COL1A2;PRKACA;SEL1L;ZNF354A;IGF2;ITPR2;GRB10;ERLEC1;PPARG;ATP6V1B2;WFS1;LRP6;EEF2K;SLC18A2;ADCY1;KAT2B;RNF103;USP25;UFL1;GNAI1;STT3B;DNMT3A;FADD
13510,GO:0055080,0.00658324795410225,0.995934093827472,47,380,cation homeostasis,BP,NOS1;F2R;CYP27B1;PRNP;DDIT3;EGFR;ANK3;FYN;BNIP3;DLG4;TGM2;SLC9A7;CEMIP;RASA3;EDNRA;LCN2;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;ITPR3;DMXL2;MT2A;CLCN3;NTSR1;ANXA6;F2RL1;CHD7;BOK;SLC12A7;UBASH3B;SLC22A17;TRPC1;SLC30A1;SFXN3;PRKACA;SLC39A10;LPAR1;AP3D1;ITPR2;ATP12A;ATP6V1B2;WFS1;LRP6;FBXL5
14761,GO:0070435,0.00658684663164141,1,2,2,Shc-EGFR complex,CC,EGFR;SHC1
10899,GO:0044444,0.00661620213658709,0.994537558114026,634,7171,cytoplasmic part,CC,TNIP1;DOCK4;FHL1;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;F2R;SORL1;FLNC;ADAM19;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;XPOT;ACTA2;BBS2;POSTN;SH3TC2;GPT2;BTBD2;NFATC4;ADARB1;MAP2K1;THBS2;FAM210B;FMNL2;RAPGEF3;FNDC4;ANTXR2;LTBP1;SH3KBP1;ALOX15B;MPRIP;LMF1;COL13A1;TK2;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;WDR66;MARCH9;H6PD;APLN;TRIM65;LY6K;DHTKD1;PITPNC1;DGKA;APPL2;EIF4EBP1;SSH1;MAP1B;PC;DDIT3;PTPRS;B4GALT6;HADH;CARS;PSMD2;LAMB1;EXOC2;ELK3;SNTB2;CRTC1;DENND5B;AVL9;LTA4H;CAPN2;BRSK1;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;ANK3;C2CD2;DYSF;PDZD2;LOXL1;ARHGAP12;ARMCX2;PPP1R14A;FYN;MYH15;OSBPL10;PSAT1;BNIP3;KIF13B;SPATS2;SLC33A1;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;ARAP1;PGM1;ADAMTS7;DLG1;ISYNA1;DLG4;B3GNT3;IDH2;CTSB;CD68;DNAJB5;ACOT1;GPC4;DHX32;SNX9;TYSND1;NET1;TGM2;XPC;GLUL;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;TTC7B;RSAD1;GRK5;NMRK1;STRADB;RDH14;NME4;MALL;CRTAP;ASPH;MCTP1;GDI1;CEMIP;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;WISP1;PAK1;RASA3;CEP170;SOCS2;ATXN10;NEK9;RHPN1;CBR4;TGFBR2;SERPING1;SLC2A3;B4GALNT4;LCN2;HAGH;NUCB2;SHANK2;RALGAPA2;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;ACP5;PTPN12;ALDH1L2;AFAP1;MCFD2;PKD2;PRKACB;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;ABTB1;UBE2G1;DDN;ANXA3;ABCA7;PIGH;WWC3;ICA1;EIF4E3;AGPAT4;KIF21B;ASNS;FGFR1;ABHD10;ITGA1;AARS;FAM114A1;TMOD2;MARCH4;TUB;LPCAT4;UROS;NFAT5;ITGB5;SNX14;HYAL1;BTRC;LPCAT1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ULK2;FAT1;LONP2;INPP5F;CHAC1;FAM20C;MTHFR;AHCYL2;ABCG1;FKBP10;SOX4;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;GAMT;CEP120;KDSR;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;OBSL1;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;BSG;SH3D19;NLK;EPN2;XRN1;TRIM5;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLA2G4D;ANXA6;CD46;ACAD10;MVB12B;CTH;MPDZ;MAP6;LRP5;NIPA1;ABHD17C;DNMBP;KLF12;TMEM86B;THBS3;CTSL;DOCK9;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;SLC35G2;TPBG;VPS11;MOSPD2;RANBP9;DNAJB9;FBXL8;BTBD3;RIMS3;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;INPP4A;SYTL1;HIBADH;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;COPG1;ALDH7A1;FNBP1L;ANO8;SCYL3;F2RL1;DDX60;RASIP1;GSDMA;C6ORF120;TAOK1;PLD3;ATP10D;FBXO41;CSNK2A1;PSMD7;PTHLH;TST;BLMH;SLC25A4;QSOX1;SUGCT;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;MSRB2;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;TBC1D2B;THRA;MGLL;GOLGA6L9;ENKD1;ACVR1B;DBNDD1;NDUFA4L2;COL6A1;NGFR;BPHL;PSKH1;MVB12A;GLUD1;HSPA13;MARK4;NPL;NUDT6;SPESP1;MTA1;AZIN2;BCL2L1;CRAT;YTHDC2;AGPAT3;GLB1;WASF2;SKAP2;ARF4;GOLGA2P5;TMEM187;YPEL5;UAP1;HSD17B7;PCYOX1;XBP1;SPIRE1;NFU1;TXNRD3;MAP2K2;ABHD6;SLC22A17;PPP1R2;PAIP1;ARRDC1;CYP4F22;MICU3;LYPLAL1;RIN1;RET;SDR9C7;TUBG2;STX10;LOXL2;PDE5A;VWA1;TCTN1;RAB43;OSBPL5;MCTP2;TXNDC11;MTMR4;ZFYVE9;MBOAT7;NCKAP1;GABARAPL2;RMRP;DNASE1L1;DOCK11;UBE2E1;PUM2;SLC30A1;RNF135;TMBIM1;COL1A2;SFXN3;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;SHC2;PRKACA;NEK6;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;SNX30;S100PBP;SEL1L;CBX7;IFI16;ANGEL1;RHOBTB1;BCAP29;AP2A2;SRD5A3;KDELR3;CMTM6;SLC25A43;ST6GALNAC2;CARD11;FCHO1;LAMB2;FICD;LPAR1;ZNF354A;CTSZ;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;NRSN2;ACP6;TMEM134;ITPR2;MOAP1;FNBP1;AGPAT1;PJA2;GRB10;MAP4K2;ZMYM2;ERLEC1;PPARG;TMEM63A;SNX6;EVA1A;USP20;ANKRD50;GRB7;TRIQK;PPL;ALDH1A2;ARHGAP29;LYPLA1;TMEM50B;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;ADAM8;ALDH4A1;GARS;WFS1;ENDOG;ATP11B;IKBIP;WDR60;ACAP2;MPLKIP;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;OSGEPL1;FZD8;CMC1;WASL;USP32;REEP6;HSPA2;FLNB;LRP6;SYT2;TMEM173;RNF180;PPT2;EEF2K;SLC18A2;SIGMAR1;HPSE;GALNS;RALGDS;SSR1;TNRC6C;COQ2;ARMCX3;DNAJC3;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;REEP3;UFL1;FAM162A;SNX27;N4BP2;AMACR;GALE;JARID2;SLC44A1;GNAI1;STT3B;RB1CC1;ALAS1;TRIM38;FBXL5;FADD
7849,GO:0032409,0.00664367164327067,0.996813030775147,22,139,regulation of transporter activity,BP,FHL1;NOS1;PRNP;HECW2;KCNG1;STK39;ANK3;DLG1;DLG4;STOM;PTPN3;SHANK2;FKBP1A;PKD2;AKAP9;VAMP2;NTSR1;NLGN2;PRKACA;TMSB4X;PPARG;HSPA2
12727,GO:0050974,0.00665941117435509,0.999675021589152,3,5,detection of mechanical stimulus involved in sensory perception,BP,SERPINE2;FYN;ITGA2
324,GO:0000904,0.00665969581821626,0.995617638224054,62,483,cell morphogenesis involved in differentiation,BP,VLDLR;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;LAMB1;BRSK1;SEMA4B;ANK3;FYN;KIF13B;PARVB;DLG4;PLXNB3;NET1;WNT7A;GDI1;SHC1;DKK1;PAK1;SHANK2;SLITRK6;EPHA1;APOE;LPAR3;ULK2;OBSL1;DVL1;MAP6;TWF2;NTNG1;RANBP9;BTBD3;PPP3CB;NGFR;PTPRZ1;RNF165;RET;TCTN1;ETV1;RAB1A;LAMB2;LAMA5;GRB10;GRB7;ROBO3;ITGA4;WASL;FLNB;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;SEMA3F;ADNP;LRP4
5591,GO:0016616,0.00674008978698575,0.997485514919875,13,83,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,CRYL1;H6PD;HADH;IDH2;RDH14;CBR4;LDHA;KDSR;HIBADH;HSD17B7;SDR9C7;PTGR2;HSD17B12
16864,GO:0098793,0.00677093032165172,0.996374346091812,29,209,presynapse,CC,RAB3B;PTPRS;ADGRL1;BRSK1;SNPH;DLG4;GLUL;WNT7A;MCTP1;FKBP1A;ICA1;ITGA2;VAMP2;PFN2;DMXL2;DVL1;CLCN3;NTSR1;NLGN2;RIMS3;SYTL1;FCHO2;SEPT5;DBNDD1;BCL2L1;AP3D1;SYT2;SLC18A2;SEPT6
744,GO:0001974,0.00678314140570149,0.998488459361649,7,25,blood vessel remodeling,BP,ACVR2B;TGM2;CEACAM1;CST3;CHD7;TMBIM1;HOXA3
16261,GO:0090314,0.00680053916044852,0.998686527666968,6,22,positive regulation of protein targeting to membrane,BP,PRNP;ANK3;FYN;CEMIP;STOM;PAK1
6615,GO:0022836,0.00688367133880762,0.996972595300522,18,107,gated channel activity,MF,SCN8A;KCNG1;DLG1;DLG4;DLG3;RASA3;CLCA2;PKD2;FAM155B;ITPR3;CLCN3;ANXA6;TTYH3;ANO8;ANO1;GRIN3B;KCNJ15;ITPR2
8921,GO:0034762,0.00688598128805605,0.996045809282695,36,263,regulation of transmembrane transport,BP,FHL1;NOS1;F2R;SCN8A;PRNP;HECW2;KCNG1;STK39;ANK3;FYN;DLG1;DLG4;CEMIP;STOM;PAK1;PTPN3;SHANK2;FKBP1A;PKD2;AKAP9;VAMP2;NTSR1;NLGN2;TRIB3;CLTCL1;CHD7;NGFR;AZIN2;UBASH3B;TRPC1;KCNJ15;SLC30A1;PRKACA;TMSB4X;GRB10;HSPA2
4857,GO:0014069,0.0069432573988221,0.99654433904928,24,148,postsynaptic density,CC,NOS1;NEURL1;PRNP;MAP1B;PTPRS;FYN;BNIP3;DLG1;DLG4;DLG3;SHANK2;RGS14;DVL1;MPDZ;ABHD17C;DNAJC6;CPEB4;PSD3;EPB41L3;PJA2;EEF2K;SIGMAR1;PTCH1;LRP4
7031,GO:0030804,0.00697652198190436,0.998923543203982,5,16,positive regulation of cyclic nucleotide biosynthetic process,BP,NOS1;APOE;PTHLH;TIMP2;ADNP
6983,GO:0030659,0.00702981050100298,0.995384411986666,60,507,cytoplasmic vesicle membrane,CC,RAB3B;SH3KBP1;PTPRS;SNTB2;EGFR;DYSF;DLG4;CD68;SNX9;WNT7A;SEC23A;MCTP1;CEMIP;STOM;SLC2A3;RAC2;CD44;APOE;MCFD2;PKD2;LRP1;ANXA3;ICA1;LPCAT1;VAMP2;ULK2;ITPR3;CEACAM1;RAB31;LMAN1;DMXL2;BSG;EPN2;CLCN3;CD46;MAP6;CLTCL1;MOSPD2;MYOF;APLP2;COPB1;COPG1;DBNDD1;BCL2L1;SPIRE1;RAB43;TMBIM1;RAB1A;AP2A2;CMTM6;ITPR2;TMEM63A;RPH3AL;ADAM8;ATP11B;WASL;SYT2;TMEM173;SLC18A2;PTCH1
2970,GO:0006508,0.00706969062370566,0.994705636400042,128,1251,proteolysis,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;GID4;F2R;SORL1;ADAM19;MMP1;SERPINE2;PRSS3;PRNP;BTBD2;NR1D1;HECW2;MAP2K1;TFPI2;THSD4;WWTR1;TNFSF15;DDIT3;PSMD2;LTA4H;CAPN2;FYN;TNFRSF6B;TMPRSS11D;UBE2J1;ADAMTS7;CTSB;SNX9;TYSND1;HTRA1;UBXN4;ASPH;DAP;TRIB2;RAG1;PTPN3;SERPING1;SCRN1;CLCA2;ERO1B;CD44;APOE;PRKACB;RBCK1;IDE;ABTB1;UBE2G1;RNPEPL1;BTRC;LONP2;LTBP4;CHAC1;RMND5A;FBXO2;DDB2;SH3D19;DVL1;MMP14;CD46;MVB12B;CTSL;NPEPL1;CST3;TRIB3;CASP4;PCSK6;DNAJB9;BTBD3;APLP2;PRDX5;AEBP1;OTUB2;CSNK2A1;PSMD7;BLMH;BOK;NGFR;MVB12A;MTA1;RNF165;PM20D2;PCYOX1;XBP1;MAP2K2;ARRDC1;ANKIB1;RET;C5;ZFYVE9;GABARAPL2;UBE2E1;RNF135;CTSO;ADAMTSL1;PRKACA;TIMP2;SEL1L;IFI16;CTSZ;TBL1X;MMP10;TENM2;ERLEC1;PPARG;USP20;ADAM8;WFS1;OSGEPL1;USP32;PRSS8;MAGEF1;RNF180;DNAJC3;PSEN2;PTCH1;KAT2B;RNF103;USP25;UFL1;FAM162A;KLHL15;STT3B;FBXL5;FADD
12881,GO:0051216,0.00715770652810533,0.996841291872941,18,106,cartilage development,BP,BBS2;ADAMTS7;WNT7A;TGFBR2;CD44;HMGA2;FGFR1;HYAL1;THBS3;MEX3C;PTHLH;THRA;WNT2B;MEF2D;LOXL2;HOXA3;CREB3L2;LRP6
16981,GO:0099024,0.0071833332154421,0.998133046047412,8,34,plasma membrane invagination,BP,ARHGAP12;SNX9;RAC2;ABCA7;ITGA2;F2RL1;SPIRE1;PPARG
5065,GO:0015279,0.00718511473423476,0.999639236586702,3,5,store-operated calcium channel activity,MF,ORAI3;TRPC1;ORAI1
3194,GO:0006820,0.00730049330870562,0.995569928769696,43,335,anion transport,BP,PRNP;SLC16A3;PITPNC1;STK39;OSBPL10;SLC33A1;SLCO4A1;SLC2A3;CLCA2;APOE;ABCD1;PPARA;ABCA7;FGFR1;VAMP2;ABCG1;PITPNM1;CEACAM1;BSG;CLCN3;NTSR1;SLC35B4;TTYH3;ANO8;SLC2A9;ATP10D;SLC6A6;SLC25A4;CPT2;ANO1;SLC6A14;SLC43A1;SLC12A7;PCYOX1;SLC22A17;SLC38A2;OSBPL5;SLC13A3;PPARG;SLC10A6;SLC7A11;ATP11B;SLC23A2
4712,GO:0010874,0.00730563155102523,0.998902577541034,5,14,regulation of cholesterol efflux,BP,APOE;LRP1;ABCA7;ABCG1;PTCH1
18206,GO:1902994,0.00735902431488532,1,2,2,regulation of phospholipid efflux,BP,APOE;ABCA7
18207,GO:1902995,0.00735902431488532,1,2,2,positive regulation of phospholipid efflux,BP,APOE;ABCA7
8767,GO:0034437,0.00736386508541705,1,2,2,glycoprotein transporter activity,MF,VLDLR;ABCG1
6654,GO:0030003,0.0074203612845735,0.995517223538425,42,335,cellular cation homeostasis,BP,NOS1;F2R;PRNP;DDIT3;FYN;BNIP3;DLG4;TGM2;SLC9A7;CEMIP;RASA3;EDNRA;LCN2;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;ITPR3;DMXL2;MT2A;CLCN3;NTSR1;ANXA6;F2RL1;CHD7;BOK;UBASH3B;SLC22A17;TRPC1;SLC30A1;PRKACA;SLC39A10;LPAR1;AP3D1;ITPR2;ATP12A;ATP6V1B2;WFS1;LRP6;FBXL5
19746,GO:2000124,0.00744030350318528,1,2,2,regulation of endocannabinoid signaling pathway,BP,MGLL;ABHD6
12115,GO:0048167,0.00746618603711553,0.996875282275182,16,92,regulation of synaptic plasticity,BP,NEURL1;SERPINE2;PRNP;NFATC4;SSH1;CRTC1;DLG4;MCTP1;SHANK2;APOE;RGS14;VAMP2;ITPR3;RIMS3;PPP3CB;ABHD6
17075,GO:0099572,0.00756039199916027,0.996207927745096,24,149,postsynaptic specialization,CC,NOS1;NEURL1;PRNP;MAP1B;PTPRS;FYN;BNIP3;DLG1;DLG4;DLG3;SHANK2;RGS14;DVL1;MPDZ;ABHD17C;DNAJC6;CPEB4;PSD3;EPB41L3;PJA2;EEF2K;SIGMAR1;PTCH1;LRP4
7754,GO:0032270,0.00761560671369739,0.994373617343325,114,1081,positive regulation of cellular protein metabolic process,BP,TNIP1;XDH;EDEM1;NOS1;F2R;CCND1;NEURL1;VLDLR;ADCY7;IGFBP4;PRNP;MAP2K1;RAPGEF3;ACVR2B;PKN1;MST1R;TNFSF15;EGFR;STK39;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;TRIB2;TGFBR2;EPHA1;IMPACT;CD44;APOE;FKBP1A;CCND2;PKD2;PRKACB;LRP1;AKAP9;ABCA7;LPAR3;FGFR1;ITGA1;BTRC;ITGA2;PTK6;PFN2;SOX4;MAPKAPK3;SH3D19;TRIM5;DVL1;MMP14;ETAA1;CNTN1;TRIB3;CASP4;VPS11;SLK;F2RL1;TAOK1;PHF1;PRKAR1A;BOK;PARP9;SPRY2;ACVR1B;NGFR;MTA1;XBP1;MAP2K2;PAIP1;ANKIB1;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;LPAR1;IGF2;MAP4K2;PPARG;TBX1;ADAM8;WFS1;FZD8;HSPA2;MAGEF1;RNF180;TET1;DNAJC3;ADCY1;FAM162A;ANKRD6;JARID2;ADNP;LRP4;RB1CC1;FBXL5;FADD
19527,GO:1990425,0.00763241187497568,1,2,2,ryanodine receptor complex,CC,NOS1;FKBP1A
3405,GO:0007186,0.00769054304160958,0.995231454341607,46,374,G-protein coupled receptor signaling pathway,BP,NOS1;F2R;ADCY7;ADGRF1;ADM2;APLN;DGKA;ADGRL1;HEBP1;NET1;TGM2;GRK5;HTR7;EDNRA;RAC2;OBSCN;APOE;RGS14;PRKACB;LRP1;ATF4;LPAR3;TMOD2;ITPR3;NTSR1;NXPH4;ADGRB2;APLP2;F2RL1;PTHLH;ANO1;MGLL;WASF2;ABHD6;C5;LTB4R;LPAR1;PPARG;USP20;GPR153;RPH3AL;FZD8;RAPGEFL1;SIGMAR1;ADCY1;GNAI1
12924,GO:0051279,0.00769130825406636,0.997589601939666,10,46,regulation of release of sequestered calcium ion into cytosol,BP,NOS1;F2R;CEMIP;FKBP1A;PKD2;NTSR1;CHD7;UBASH3B;TRPC1;PRKACA
3683,GO:0008184,0.0076988766238432,1,2,2,glycogen phosphorylase activity,MF,PYGL;PYGB
17134,GO:0102250,0.0076988766238432,1,2,2,linear malto-oligosaccharide phosphorylase activity,MF,PYGL;PYGB
17156,GO:0102499,0.0076988766238432,1,2,2,SHG alpha-glucan phosphorylase activity,MF,PYGL;PYGB
19754,GO:2000145,0.00774148535294586,0.994761557589532,68,569,regulation of cell motility,BP,DOCK4;SMURF2;ZMYND8;F2R;SORL1;PGF;ITGA6;CYGB;SERPINE2;BBS2;POSTN;ADARB1;ALOX15B;PKN1;SSH1;LAMB1;EGFR;SEMA4B;IDH2;PLXNB3;PODXL;WNT7A;TTBK2;MCTP1;CEMIP;PAK1;TGFBR2;EPHA1;RAC2;APOE;SRGAP2B;LRP1;ANXA3;FGFR1;HYAL1;ITGA2;INPP5F;PFN2;CEACAM1;FAM110C;MMP14;MOSPD2;SLK;F2RL1;SPRY2;BEX4;ACVR1B;IFITM1;XBP1;ABHD6;RET;C5;CCSAP;TMSB4X;RHOBTB1;LPAR1;MMP10;LAMA5;PPARG;GRB7;SRPX2;ADAM8;AKT3;ITGA4;WASL;FOXP1;SEMA3F;FADD
5004,GO:0015149,0.00774843878502031,0.999150202084868,4,10,hexose transmembrane transporter activity,MF,SLC2A3;SLC5A1;SLC2A9;SLC2A13
16179,GO:0090197,0.00781085398549775,0.999522541090061,3,6,positive regulation of chemokine secretion,BP,POSTN;ALOX15B;C5
10914,GO:0044463,0.0078269182940981,0.994319772665967,101,891,cell projection part,CC,NOS1;ZMYND8;NEURL1;SCN8A;PRNP;OSBP2;BBS2;NR1D1;WDR66;SSH1;MAP1B;CRTC1;ADGRL1;CAPN2;ANK3;FYN;BNIP3;KIF13B;DLG1;DLG4;PODXL;ESPN;GLUL;TTBK2;HTR7;UNC119B;DLG3;PAK1;CEP170;ATXN10;SHANK2;CD44;APOE;FKBP1A;RGS14;PKD2;PRKACB;LRP1;AKAP9;DDN;ANXA3;ATF4;ABCA7;KIF21B;TMOD2;SNX14;ITGA2;VAMP2;INPP5F;PFN2;FBXO2;CEACAM1;FERMT1;XRN1;DVL1;NTSR1;PLEK2;MPDZ;MAP6;ABHD17C;TWF2;SYTL1;ASAP1;PRKAR1A;CPEB4;SPRY2;SEPT5;SLC6A14;MARK4;AZIN2;ARF4;CNNM1;SLC38A2;RET;SPATA6;TCTN1;NAV1;NCKAP1;PSD3;CCDC88A;CCSAP;PRKACA;TIMP2;EPB41L3;LPAR1;CTSZ;AP3D1;ARPC1A;TENM2;EFCAB7;WFS1;WDR60;TMEM107;EEF2K;SLC18A2;SIGMAR1;PSEN2;PTCH1;SEPT6;ADNP;LRP4
17257,GO:0120038,0.0078269182940981,0.994319772665967,101,891,plasma membrane bounded cell projection part,CC,NOS1;ZMYND8;NEURL1;SCN8A;PRNP;OSBP2;BBS2;NR1D1;WDR66;SSH1;MAP1B;CRTC1;ADGRL1;CAPN2;ANK3;FYN;BNIP3;KIF13B;DLG1;DLG4;PODXL;ESPN;GLUL;TTBK2;HTR7;UNC119B;DLG3;PAK1;CEP170;ATXN10;SHANK2;CD44;APOE;FKBP1A;RGS14;PKD2;PRKACB;LRP1;AKAP9;DDN;ANXA3;ATF4;ABCA7;KIF21B;TMOD2;SNX14;ITGA2;VAMP2;INPP5F;PFN2;FBXO2;CEACAM1;FERMT1;XRN1;DVL1;NTSR1;PLEK2;MPDZ;MAP6;ABHD17C;TWF2;SYTL1;ASAP1;PRKAR1A;CPEB4;SPRY2;SEPT5;SLC6A14;MARK4;AZIN2;ARF4;CNNM1;SLC38A2;RET;SPATA6;TCTN1;NAV1;NCKAP1;PSD3;CCDC88A;CCSAP;PRKACA;TIMP2;EPB41L3;LPAR1;CTSZ;AP3D1;ARPC1A;TENM2;EFCAB7;WFS1;WDR60;TMEM107;EEF2K;SLC18A2;SIGMAR1;PSEN2;PTCH1;SEPT6;ADNP;LRP4
12610,GO:0050790,0.00782891762968584,0.993938295855292,164,1614,regulation of catalytic activity,BP,DOCK4;XDH;NOS1;F2R;SORL1;CCND1;NEURL1;VLDLR;ASAP2;ITGA6;CYGB;CYP27B1;SERPINE2;ADCY7;PRNP;ADARB1;MAP2K1;TFPI2;RAPGEF3;ACVR2B;LMF1;PKN1;WWTR1;MST1R;ARHGAP22;TNFSF15;EGFR;TBC1D14;STK39;RIN2;ARHGAP12;PPP1R14A;FYN;TNFRSF6B;ERCC6;ARAP1;DLG1;DLG4;CTSB;PLXNB3;SNX9;NET1;EVI5L;MAP4K4;STRADB;ASPH;GDI1;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;RAG1;TGFBR2;SERPING1;EDNRA;EPHA1;RALGAPA2;RAC2;CD44;APOE;FKBP1A;CCND2;ANGPTL4;RGS14;PKD2;PRKACB;SRGAP2B;LRP1;AKAP9;PPP2R3B;ANXA3;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;ITGA2;PTK6;PFN2;CEACAM1;MAPKAPK3;RALGAPA1;TCEA1;DVL1;MMP14;LRP5;ETAA1;DNMBP;DOCK9;CST3;TRIB3;CASP4;PCSK6;APLP2;SLK;PRDX5;F2RL1;RASIP1;TAOK1;CSNK2A1;ASAP1;PRKAR1A;BOK;PARP9;USP6NL;SPRY2;TBC1D2B;NGFR;PPP1R10;AZIN2;ARF4;UBASH3B;MAP2K2;PPP1R2;RIN1;RET;PDE5A;SH3PXD2B;C5;GABARAPL2;DOCK11;PAK6;TMBIM1;CCDC88A;SHC2;PRKACA;TMSB4X;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;FICD;LPAR1;IGF2;MAP4K2;PPARG;SNX6;ARHGAP29;LYPLA1;EVI5;ADAM8;DEPDC1;ACAP2;TBC1D16;FZD8;WASL;HSPA2;LRP6;RALGDS;RCAN1;DNAJC3;PSEN2;ADCY1;KAT2B;OAS1;FAM162A;ADNP;FADD
5145,GO:0015672,0.00787169071484222,0.995549403277761,33,249,monovalent inorganic cation transport,BP,FHL1;NOS1;SCN8A;SERPINE2;PRNP;HECW2;KCNG1;STK39;ANK3;SLC33A1;DLG1;SLC9A7;STOM;PTPN3;PKD2;AKAP9;ATF4;VAMP2;SLC5A1;CNTN1;SLC2A9;NDUFA4L2;SLC12A7;SLC38A2;SLC13A3;KCNJ15;TMSB4X;SLC2A13;SLC10A6;ATP12A;ATP6V1B2;PRSS8;SLC23A2
6364,GO:0021545,0.00787259806298439,0.998181122304662,7,26,cranial nerve development,BP,ADARB1;SLITRK6;CHD7;LPAR1;HOXA3;TBX1;SEMA3F
17716,GO:1901629,0.00796926456874078,1,2,2,regulation of presynaptic membrane organization,BP,APOE;LRP4
12728,GO:0050982,0.00800948781788128,0.998836442614598,5,12,detection of mechanical stimulus,BP,SERPINE2;DENND5B;FYN;PKD2;ITGA2
11250,GO:0045454,0.00804836287484836,0.997405965589862,10,57,cell redox homeostasis,BP,NOS1;DDIT3;ERO1B;TMX4;PDIA5;PRDX5;QSOX1;TXNRD3;TXNDC11;ERP44
596,GO:0001763,0.00811763418617227,0.996038685176572,22,136,morphogenesis of a branching structure,BP,ETV5;PGF;CTNNBIP1;NFATC4;COL13A1;DLG1;TGM2;PAK1;TGFBR2;EDNRA;PKD2;FGFR1;BTRC;MMP14;LRP5;RASIP1;SPRY2;WNT2B;CTSZ;LAMA5;LRP6;PTCH1
16438,GO:0097090,0.00815191053850093,0.999570766650021,3,5,presynaptic membrane organization,BP,APOE;NLGN2;LRP4
3069,GO:0006635,0.0081732900952222,0.997198425158188,11,61,fatty acid beta-oxidation,BP,HADH;TYSND1;ACAD11;ABCD1;PPARA;LONP2;ACAD10;MLYCD;CPT2;CRAT;AMACR
7763,GO:0032279,0.00830362468272397,0.995799406842861,24,150,asymmetric synapse,CC,NOS1;NEURL1;PRNP;MAP1B;PTPRS;FYN;BNIP3;DLG1;DLG4;DLG3;SHANK2;RGS14;DVL1;MPDZ;ABHD17C;DNAJC6;CPEB4;PSD3;EPB41L3;PJA2;EEF2K;SIGMAR1;PTCH1;LRP4
5804,GO:0017057,0.00833489747170808,1,2,2,6-phosphogluconolactonase activity,MF,H6PD;PGLS
12991,GO:0051402,0.00842446418686878,0.995779794224968,23,159,neuron apoptotic process,BP,F2R;PRNP;ADARB1;DDIT3;FYN;BNIP3;APOE;LRP1;ATF4;ITGA1;AARS;BOK;CPEB4;NGFR;BCL2L1;CTSZ;ADAM8;WFS1;SIGMAR1;TRIM2;FAM162A;ADNP;FADD
1284,GO:0003091,0.00847980561419873,0.998315648120577,6,20,renal water homeostasis,BP,ADCY7;PRKACB;PRKAR1A;PRKACA;WFS1;ADCY1
12617,GO:0050801,0.00852056983194102,0.994549280477427,51,424,ion homeostasis,BP,FHL1;NOS1;F2R;CYP27B1;PRNP;DDIT3;EGFR;ANK3;FYN;BNIP3;DLG4;TGM2;SLC9A7;CEMIP;RASA3;PTPN3;EDNRA;LCN2;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;ABCG1;ITPR3;DMXL2;MT2A;CLCN3;NTSR1;ANXA6;F2RL1;CHD7;BOK;SLC12A7;XBP1;UBASH3B;SLC22A17;TRPC1;SLC30A1;SFXN3;PRKACA;SLC39A10;LPAR1;AP3D1;ITPR2;ATP12A;ATP6V1B2;WFS1;LRP6;FBXL5
1167,GO:0002790,0.00853736984345115,0.994763857215576,43,346,peptide secretion,BP,F2R;RAB3B;PCK2;POSTN;NR1D1;LTBP2;RAPGEF3;ACVR2B;ALOX15B;LMF1;APLN;POU2F2;HADH;EGFR;IDH2;GLUL;MAP4K4;ARG2;ICA1;LTBP4;SOX4;ITPR3;FERMT1;NLGN2;LRP5;PPP3CB;COPG1;F2RL1;CHD7;SLC25A4;ANO1;GLUD1;XBP1;C5;TMSB4X;RAB1A;SEL1L;IL1RAP;CARD11;ITPR2;RPH3AL;ADAM8;FOXP1
9525,GO:0036230,0.00861725077953397,0.994734273837146,42,360,granulocyte activation,BP,PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;PGM1;CTSB;CD68;STOM;SLC2A3;LCN2;CD44;ANXA3;LPCAT1;VAMP2;CEACAM1;RAB31;CST3;MOSPD2;COPB1;F2RL1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;DNASE1L1;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;ATP11B;TMEM173;HPSE;GALNS;DNAJC3
4295,GO:0009726,0.00862201556470018,1,2,2,detection of endogenous stimulus,BP,PKD2;ABCG1
9198,GO:0035580,0.00873899775680008,0.997607647491642,8,39,specific granule lumen,CC,LCN2;QSOX1;DNASE1L1;TIMP2;CTSZ;NIT2;ERP44;HPSE
14208,GO:0061138,0.00878008617188942,0.995764568233369,21,129,morphogenesis of a branching epithelium,BP,ETV5;PGF;CTNNBIP1;NFATC4;DLG1;TGM2;PAK1;TGFBR2;EDNRA;PKD2;FGFR1;BTRC;MMP14;LRP5;RASIP1;SPRY2;WNT2B;CTSZ;LAMA5;LRP6;PTCH1
9631,GO:0036498,0.00886516863373226,0.996759287222431,12,67,IRE1-mediated unfolded protein response,BP,EDEM1;SHC1;PDIA5;GFPT1;DNAJB9;SEC63;XBP1;KDELR3;FICD;WFS1;SSR1;DNAJC3
6992,GO:0030672,0.00895582401763511,0.997090574258219,10,52,synaptic vesicle membrane,CC,RAB3B;PTPRS;MCTP1;ICA1;VAMP2;DMXL2;DBNDD1;BCL2L1;SYT2;SLC18A2
17034,GO:0099501,0.00895582401763511,0.997090574258219,10,52,exocytic vesicle membrane,CC,RAB3B;PTPRS;MCTP1;ICA1;VAMP2;DMXL2;DBNDD1;BCL2L1;SYT2;SLC18A2
10008,GO:0042426,0.00896119041918801,1,2,2,choline catabolic process,BP,ALDH7A1;SLC44A1
718,GO:0001944,0.00900193686388986,0.994085759832856,57,455,vasculature development,BP,XDH;PGF;SH2D2A;ACTA2;ADM2;NFATC4;MAP2K1;THBS2;RAPGEF3;ACVR2B;LTBP1;ARHGAP22;APLN;DDIT3;ELK3;LOXL1;WNT7A;SHC1;TGFBR2;EDNRA;EPHA1;APOE;ANGPTL4;PKD2;LRP1;ANXA3;HMGA2;FGFR1;HYAL1;SOX4;CEACAM1;EPN2;MMP14;CTH;LRP5;PPP3CB;ADGRB2;RASIP1;CHD7;SPRY2;NGFR;WASF2;XBP1;LOXL2;C5;COL1A2;HOXA3;LAMA5;PPARG;SRPX2;ALDH1A2;TBX1;ADAM8;AKT3;FZD8;E2F7;HPSE
3417,GO:0007200,0.00908488780131733,0.997781254015908,7,31,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,F2R;TGM2;LPAR3;F2RL1;ANO1;LTB4R;LPAR1
12190,GO:0048333,0.00914068095641938,0.998517353913408,5,15,mesodermal cell differentiation,BP,ITGB4;DKK1;HMGA2;FGFR1;ITGA2
12725,GO:0050966,0.00914095573556945,1,2,2,detection of mechanical stimulus involved in sensory perception of pain,BP,FYN;ITGA2
2279,GO:0005229,0.00914877401959164,0.998945800695571,4,10,intracellular calcium activated chloride channel activity,MF,CLCA2;TTYH3;ANO8;ANO1
14454,GO:0061778,0.00914877401959164,0.998945800695571,4,10,intracellular chloride channel activity,MF,CLCA2;TTYH3;ANO8;ANO1
9903,GO:0042221,0.00918598390641027,0.992533758999557,265,2777,response to chemical,BP,TNIP1;DOCK4;XDH;SMURF2;EDEM1;NOS1;ERCC1;F2R;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;VLDLR;ITGA6;MMP1;CYGB;CYP27B1;ADCY7;PRNP;MXRA5;BBS2;POSTN;NR1D1;NFATC4;MAP2K1;CMTM4;FAM210B;LTBP2;RAPGEF3;FNDC4;ACVR2B;LTBP1;SH3KBP1;GPX3;MST1R;APLN;TNFSF15;EIF4EBP1;SSH1;DDIT3;HADH;PSMD2;CAPN2;EGFR;STK39;SEMA4B;ANK3;LOXL1;PPP1R14A;FYN;TNFRSF6B;BNIP3;SLC33A1;ERCC6;UBE2J1;MAPK13;ADAMTS7;CTSB;CD68;DNAJB5;PLXNB3;NET1;XPC;GLUL;HTRA1;WNT7A;UBXN4;MAP4K4;GDI1;SDC1;SHC1;DKK1;PAK1;SOCS2;TGFBR2;LCN2;IMPACT;RAC2;CD44;APOE;FKBP1A;BNIP3L;ATP7B;ACP5;PTPN12;PKD2;PRKACB;RBCK1;LRP1;LDHA;IDE;AKAP9;ANXA3;HMGA2;ATF4;PPARA;ASNS;FGFR1;ITGA1;TUB;CMTM7;UROS;ITGB5;HYAL1;BTRC;ITGA2;PTK6;GALNT3;VAMP2;LONP2;LTBP4;CHAC1;ATRX;FAM20C;MTHFR;ABCG1;SOX4;ITPR3;FBXO2;CEACAM1;FERMT1;MAPKAPK3;PDIA5;RAB31;MT2A;BSG;NLK;EPN2;XRN1;TRIM5;DVL1;NTSR1;MMP14;EPOR;CTH;LRP5;CTSL;TWF2;CST3;TRIB3;CASP4;GFPT1;PCSK6;MOSPD2;RANBP9;DNAJB9;SEC63;PPP3CB;MYOF;RFX2;PRDX5;F2RL1;CSNK2A1;PSMD7;CHD7;BLMH;SLC25A4;PRKAR1A;ANO1;CRLS1;BOK;PARP9;CPEB4;SPRY2;SLC6A14;THRA;COL6A1;NGFR;BPHL;HSPA13;PTPRZ1;CHD6;BCL2L1;IFITM1;RNF165;YTHDC2;GLB1;XBP1;TXNRD3;MAP2K2;TLE4;TRPC1;RET;LOXL2;RAB43;SLC13A3;C5;MTMR4;ZFYVE9;RMRP;PUM2;SLC30A1;ETV1;COL1A2;PRKACA;TMSB4X;TIMP2;EIF2AK2;SEL1L;NR2F6;KDELR3;CMTM6;IL1RAP;LAMB2;FICD;LPAR1;ZNF354A;IGF2;ITPR2;LAMA5;AGPAT1;GRB10;ERLEC1;PPARG;SNX6;GRB7;ALDH1A2;TBX1;SLC7A11;CREB3L2;ERP44;ATP6V1B2;RPH3AL;ADAM8;ROBO3;IL20RB;WFS1;ENDOG;ITGA4;ACAP2;CKLF;IGFBP7;HSPA2;FLNB;LRP6;ARID5B;TMEM173;EEF2K;SLC18A2;SEMA6C;SSR1;ZC3H7A;DNAJC3;FOXP1;DNAJC4;PTCH1;ADCY1;KAT2B;OAS1;RNF103;USP25;UFL1;FAM162A;JARID2;SEMA3F;KLHL15;ADNP;GNAI1;LRP4;STT3B;DNMT3A;TRIM38;FADD
6133,GO:0019395,0.00927448988685524,0.996412470674843,13,78,fatty acid oxidation,BP,CYGB;HADH;TYSND1;ACAD11;ABCD1;PPARA;LONP2;ACAD10;MLYCD;CPT2;CRAT;PPARG;AMACR
12524,GO:0050667,0.00930625758352492,0.998881917344676,4,11,homocysteine metabolic process,BP,CBS;MTHFR;CTH;BLMH
17562,GO:1901143,0.0093250150150376,1,2,2,insulin catabolic process,BP,IDE;CEACAM1
10810,GO:0044297,0.00935666396708826,0.994340145154404,40,312,cell body,CC,NEURL1;CYGB;ACTA2;MAP1B;PTPRS;CRTC1;SNPH;GLUL;WDFY3;GDI1;DLG3;ATXN10;SHANK2;APOE;LRP1;AKAP9;DDN;ANXA3;ITGA1;INPP5F;PITPNM1;ITPR3;XRN1;DVL1;NTSR1;CST3;AZIN2;GRIN3B;CNNM1;SLC38A2;RET;TIMP2;LPAR1;NRSN2;ENDOG;LRP6;PSEN2;ADNP;LRP4;FADD
13548,GO:0060009,0.00937664646904052,0.998911568270942,4,10,Sertoli cell development,BP,SDC1;ATRX;CST3;ARID4A
10380,GO:0043200,0.00944703941485806,0.996196306344522,14,82,response to amino acid,BP,NEURL1;CAPN2;EGFR;FYN;ASNS;MTHFR;CRLS1;CPEB4;COL6A1;BCL2L1;XBP1;COL1A2;UFL1;DNMT3A
13391,GO:0052689,0.00945139910435592,0.996179003881886,14,87,carboxylic ester hydrolase activity,MF,H6PD;ACOT1;PGLS;ACOT7;ABHD10;AARS;PLA2G4D;NLGN2;MGLL;BPHL;ABHD6;LYPLAL1;LYPLA1;DDHD2
18204,GO:1902992,0.0094825160567677,0.998895575112178,4,10,negative regulation of amyloid precursor protein catabolic process,BP,SORL1;PRNP;APOE;ABCA7
17053,GO:0099531,0.00949527271383942,0.996181252203416,14,80,presynaptic process involved in chemical synaptic transmission,BP,RAB3B;BRSK1;SNPH;WNT7A;MCTP1;VAMP2;PFN2;DVL1;RIMS3;SYTL1;SEPT5;SLC30A1;SYT2;SLC18A2
7026,GO:0030799,0.00950106520936723,0.997134237143888,9,42,regulation of cyclic nucleotide metabolic process,BP,NOS1;RAPGEF3;APOE;PKD2;AKAP9;PTHLH;PDE5A;TIMP2;ADNP
2766,GO:0006182,0.00956602905094977,0.998430488677998,5,15,cGMP biosynthetic process,BP,NOS1;ADCY7;APOE;ADCY1;ADNP
10253,GO:0042987,0.00960400525792507,0.997651473979001,7,29,amyloid precursor protein catabolic process,BP,SORL1;PRNP;APOE;FKBP1A;ABCA7;ABCG1;PSEN2
6761,GO:0030193,0.00964674750356561,0.997054147026355,9,46,regulation of blood coagulation,BP,PLAT;F2R;SERPINE2;SERPING1;APOE;CEACAM1;F2RL1;UBASH3B;HPSE
17358,GO:1900046,0.00964674750356561,0.997054147026355,9,46,regulation of hemostasis,BP,PLAT;F2R;SERPINE2;SERPING1;APOE;CEACAM1;F2RL1;UBASH3B;HPSE
12965,GO:0051347,0.00967334996895624,0.993611237352596,57,481,positive regulation of transferase activity,BP,F2R;SORL1;CCND1;NEURL1;VLDLR;ADCY7;PRNP;MAP2K1;ACVR2B;PKN1;MST1R;TNFSF15;EGFR;STK39;ERCC6;DLG1;DLG4;SNX9;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;TGFBR2;EPHA1;CCND2;PKD2;PRKACB;LPAR3;FGFR1;ITGA1;MAPKAPK3;ETAA1;TRIB3;SLK;TAOK1;PRKAR1A;SPRY2;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;EIF2AK2;RAB1A;LPAR1;IGF2;MAP4K2;ADAM8;FZD8;ADCY1;ADNP
4808,GO:0012506,0.00967938268927513,0.993514237862089,61,524,vesicle membrane,CC,NOS1;RAB3B;SH3KBP1;PTPRS;SNTB2;EGFR;DYSF;DLG4;CD68;SNX9;WNT7A;SEC23A;MCTP1;CEMIP;STOM;SLC2A3;RAC2;CD44;APOE;MCFD2;PKD2;LRP1;ANXA3;ICA1;LPCAT1;VAMP2;ULK2;ITPR3;CEACAM1;RAB31;LMAN1;DMXL2;BSG;EPN2;CLCN3;CD46;MAP6;CLTCL1;MOSPD2;MYOF;APLP2;COPB1;COPG1;DBNDD1;BCL2L1;SPIRE1;RAB43;TMBIM1;RAB1A;AP2A2;CMTM6;ITPR2;TMEM63A;RPH3AL;ADAM8;ATP11B;WASL;SYT2;TMEM173;SLC18A2;PTCH1
2272,GO:0005215,0.0096794365420156,0.993233457464985,76,678,transporter activity,MF,VLDLR;SCN8A;SLC16A3;SLC29A4;PITPNC1;KCNG1;DENND5B;OSBPL10;SLC33A1;DLG1;DLG4;SLCO4A1;SLC9A7;DLG3;RASA3;SLC2A3;CLCA2;APOE;ATP7B;ABCD1;PKD2;LRP1;ABCA7;FAM155B;ABCG1;PITPNM1;ITPR3;CEACAM1;SLC5A1;SLC35F2;BSG;CLCN3;ANXA6;ORAI3;NIPA1;COX18;SLC35B4;SLC35G2;TTYH3;ANO8;SLC2A9;ATP10D;SLC6A6;SLC25A4;ANO1;SLC6A14;NDUFA4L2;SLC43A1;AZIN2;GRIN3B;SLC12A7;PCYOX1;SLC22A17;SLC38A2;TRPC1;OSBPL5;SLC13A3;KCNJ15;SLC30A1;SFXN3;SLC25A30;SLC39A10;SLC25A43;ORAI1;AP3D1;ITPR2;SLC2A13;SLC10A6;ATP12A;SLC7A11;ATP6V1B2;ATP11B;LRP6;SLC18A2;SLC23A2;SLC44A1
13740,GO:0060312,0.00970368674613485,0.999356507528057,3,6,regulation of blood vessel remodeling,BP,CEACAM1;CST3;TMBIM1
14517,GO:0065009,0.00970719775522654,0.992211579472108,221,2246,regulation of molecular function,BP,DOCK4;FHL1;XDH;NOS1;F2R;SORL1;PGF;CCND1;NEURL1;CTNNBIP1;VLDLR;ASAP2;ITGA6;CYGB;CYP27B1;SERPINE2;ADCY7;PRNP;ADGRF1;ADM2;HECW2;NFATC4;ADARB1;MAP2K1;CMTM4;TFPI2;RAPGEF3;ACVR2B;LMF1;PKN1;WWTR1;MST1R;ARHGAP22;APLN;TNFSF15;DDIT3;KCNG1;CRTC1;DENND5B;EGFR;TBC1D14;STK39;RIN2;ANK3;ARHGAP12;PPP1R14A;FYN;TNFRSF6B;ERCC6;ARAP1;DLG1;DLG4;CTSB;PLXNB3;SNX9;NET1;EVI5L;WNT7A;MAP4K4;TTBK2;STRADB;ASPH;GDI1;CEMIP;STOM;SHC1;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;RAG1;TGFBR2;PTPN3;SERPING1;EDNRA;SHANK2;EPHA1;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;CCPG1;CCND2;ANGPTL4;RGS14;PKD2;PRKACB;SRGAP2B;RBCK1;LRP1;AKAP9;PPP2R3B;ANXA3;HMGA2;PPARA;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;CMTM7;BTRC;ITGA2;PTK6;VAMP2;PFN2;CEACAM1;MAPKAPK3;MDFI;TRIM5;RALGAPA1;TCEA1;DVL1;NTSR1;MMP14;NLGN2;CTH;LRP5;ETAA1;DNMBP;DOCK9;CST3;TRIB3;CASP4;PCSK6;RANBP9;APLP2;SLK;PRDX5;CEBPG;F2RL1;RASIP1;TAOK1;CSNK2A1;PTHLH;ASAP1;PRKAR1A;JMY;BOK;PARP9;USP6NL;SPRY2;TBC1D2B;THRA;NGFR;PPP1R10;NUDT6;AZIN2;ARF4;UBASH3B;MAP2K2;PPP1R2;RIN1;RET;PDE5A;SH3PXD2B;C5;GABARAPL2;DOCK11;PAK6;SLC30A1;PSD3;TMBIM1;CCDC88A;SHC2;PRKACA;RGL2;TMSB4X;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;CMTM6;IL1RAP;CARD11;FICD;LPAR1;CTSZ;IGF2;MAP4K2;PPARG;SNX6;ARHGAP29;LYPLA1;EVI5;RSF1;ADAM8;WFS1;DEPDC1;ITGA4;ACAP2;CKLF;TBC1D16;FZD8;WASL;RAPGEFL1;HSPA2;PRSS8;LRP6;ARID5B;TMEM173;RALGDS;RCAN1;DNAJC3;PSEN2;PTCH1;ADCY1;KAT2B;OAS1;UFL1;FAM162A;RALGPS2;ADNP;TRIM38;FADD
16493,GO:0097186,0.00974684601874662,0.998393249192864,5,15,amelogenesis,BP,ITGA6;ITGB4;PPARA;FAM20C;TBX1
10356,GO:0043168,0.00978225287839739,0.992207083618629,204,1996,anion binding,MF,XDH;NOS1;RAB3B;PGF;PCK2;PYGL;CBS;RPS6KA2;SCN8A;PYGB;SERPINE2;ADCY7;CRYL1;ACTA2;POSTN;GPT2;MAP2K1;THBS2;LTBP2;RAPGEF3;ACVR2B;COL13A1;TK2;PKN1;MST1R;DHTKD1;PITPNC1;DGKA;PC;PTPRS;SMARCA1;HADH;CARS;BRSK1;EGFR;STK39;DYSF;FYN;MYH15;OSBPL10;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;ARAP1;GPC4;DHX32;SNX9;TGM2;GLUL;ACSF2;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;GRK5;NMRK1;STRADB;NME4;MCTP1;CEMIP;ACAD11;SEPT10;SHC1;NAGS;WISP1;SMOC2;SLFN5;PAK1;NEK9;CBR4;TGFBR2;EPHA1;RAC2;CD44;OBSCN;APOE;ATP7B;ABCD1;CDK17;PRKACB;LRP1;FYCO1;IDE;ZCCHC14;UBE2G1;ANXA3;PPARA;ABCA7;LPAR3;KIF21B;ASNS;FGFR1;AARS;TUB;SNX14;ITGA2;PTK6;VAMP2;ULK2;LONP2;ATRX;FAM20C;MTHFR;PFN2;ABCG1;PITPNM1;ITPR3;MAPKAPK3;GSDMC;RAB31;NLK;CLCN3;PLEK2;ANXA6;ACAD10;PHF12;CTH;THBS3;TWF2;TRIB3;PCSK6;MYOF;SYTL1;APLP2;SLK;CDC42BPA;SCYL3;DDX60;GSDMA;TAOK1;ATP10D;CSNK2A1;CHD7;ASAP1;PRKAR1A;PARP9;FCHO2;MAST3;SEPT5;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;YTHDC2;GRIN3B;ARF4;PANK4;TXNRD3;MAP2K2;TRPC1;RET;TUBG2;PDE5A;RAB43;MLH3;OSBPL5;SH3PXD2B;MCTP2;ZFYVE9;PAK6;UBE2E1;CCDC88A;PRKACA;NEK6;EIF2AK2;RAB1A;SNX30;RHOBTB1;FICD;LPAR1;ITPR2;MAP4K2;PPARG;SNX6;GRB7;ATP12A;ESYT3;ATP6V1B2;RPH3AL;AK9;AKT3;GARS;ATP11B;ACAP2;HSPA2;SYT2;TMEM173;EEF2K;AOX1;HSD17B12;PTCH1;ADCY1;SEPT6;OAS1;PANK1;SNX27;N4BP2;GNAI1;ALAS1
9852,GO:0042098,0.00979126832366852,0.99573795339221,16,106,T cell proliferation,BP,PRNP;FYN;DLG1;ARG2;TGFBR2;RAC2;FKBP1A;CD46;PPP3CB;PRKAR1A;SATB1;PDE5A;CARD11;IGF2;IL20RB;FADD
506,GO:0001568,0.00986826397102872,0.993534779965829,55,436,blood vessel development,BP,XDH;PGF;SH2D2A;ACTA2;ADM2;NFATC4;MAP2K1;THBS2;RAPGEF3;ACVR2B;LTBP1;ARHGAP22;APLN;DDIT3;ELK3;LOXL1;WNT7A;SHC1;TGFBR2;EDNRA;EPHA1;APOE;ANGPTL4;PKD2;LRP1;ANXA3;HMGA2;FGFR1;HYAL1;SOX4;CEACAM1;EPN2;MMP14;LRP5;ADGRB2;RASIP1;CHD7;SPRY2;NGFR;WASF2;XBP1;LOXL2;C5;COL1A2;HOXA3;LAMA5;PPARG;SRPX2;ALDH1A2;TBX1;ADAM8;AKT3;FZD8;E2F7;HPSE
16854,GO:0098771,0.00995678233303703,0.993694602013751,47,388,inorganic ion homeostasis,BP,NOS1;F2R;CYP27B1;PRNP;DDIT3;EGFR;ANK3;FYN;BNIP3;DLG4;TGM2;SLC9A7;CEMIP;RASA3;EDNRA;LCN2;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;ITPR3;DMXL2;MT2A;CLCN3;NTSR1;ANXA6;F2RL1;CHD7;BOK;SLC12A7;UBASH3B;SLC22A17;TRPC1;SLC30A1;SFXN3;PRKACA;SLC39A10;LPAR1;AP3D1;ITPR2;ATP12A;ATP6V1B2;WFS1;LRP6;FBXL5
16130,GO:0090128,0.00996175502671509,0.999332817938052,3,6,regulation of synapse maturation,BP,NEURL1;NFATC4;ADGRL1
9173,GO:0035526,0.00996465207169005,1,2,2,retrograde transport, plasma membrane to Golgi,BP,USP6NL;RAB43
12632,GO:0050819,0.00998368903463746,0.997505766200858,7,32,negative regulation of coagulation,BP,PLAT;SERPINE2;SERPING1;APOE;CEACAM1;PROCR;UBASH3B
8768,GO:0034440,0.0101111759913652,0.99604151685428,13,79,lipid oxidation,BP,CYGB;HADH;TYSND1;ACAD11;ABCD1;PPARA;LONP2;ACAD10;MLYCD;CPT2;CRAT;PPARG;AMACR
12594,GO:0050770,0.010137218902273,0.99514210876158,20,121,regulation of axonogenesis,BP,MAP2K1;SSH1;MAP1B;PTPRS;SEMA4B;KIF13B;PLXNB3;WNT7A;GDI1;PAK1;APOE;LPAR3;ULK2;TWF2;NGFR;RET;OMG;SEMA3F;ADNP;LRP4
7208,GO:0031099,0.0101372822478971,0.995331486934737,18,118,regeneration,BP,PGF;CCND1;POSTN;MAP2K1;PTPRS;EGFR;WNT7A;MAP4K4;TGFBR2;PTPN3;APOE;PTPN12;ANXA3;INPP5F;CSNK2A1;LAMB2;PPARG;PTCH1
3710,GO:0008217,0.0101526657658553,0.995872235854141,14,83,regulation of blood pressure,BP,NOS1;F2R;POSTN;ADM2;APLN;STK39;EDNRA;PPARA;NTSR1;LRP5;F2RL1;COL1A2;CTSZ;PPARG
8716,GO:0034361,0.0103006837955023,0.9992319644543,3,7,very-low-density lipoprotein particle,CC,VLDLR;APOE;PCYOX1
8738,GO:0034385,0.0103006837955023,0.9992319644543,3,7,triglyceride-rich plasma lipoprotein particle,CC,VLDLR;APOE;PCYOX1
2971,GO:0006509,0.0103577009947119,0.997105304936172,8,36,membrane protein ectodomain proteolysis,BP,ADAM19;SNX9;PTPN3;APOE;SH3D19;TIMP2;ADAM8;PSEN2
17750,GO:1901698,0.0103642403177533,0.992635932564185,82,735,response to nitrogen compound,BP,EDEM1;CCND1;NEURL1;PCK2;ADCY7;PRNP;MAP2K1;RAPGEF3;EIF4EBP1;SSH1;HADH;CAPN2;EGFR;FYN;UBE2J1;MAPK13;UBXN4;SDC1;SHC1;PAK1;SOCS2;IMPACT;APOE;FKBP1A;PKD2;PRKACB;LRP1;LDHA;IDE;AKAP9;ATF4;PPARA;ASNS;UROS;ITGA2;VAMP2;ATRX;MTHFR;FBXO2;CEACAM1;RAB31;BSG;XRN1;LRP5;TRIB3;CASP4;DNAJB9;PRKAR1A;CRLS1;CPEB4;COL6A1;NGFR;BCL2L1;XBP1;MAP2K2;RMRP;PUM2;COL1A2;PRKACA;SEL1L;ZNF354A;IGF2;ITPR2;GRB10;ERLEC1;PPARG;ATP6V1B2;WFS1;LRP6;TMEM173;EEF2K;SLC18A2;ZC3H7A;ADCY1;KAT2B;RNF103;USP25;UFL1;GNAI1;STT3B;DNMT3A;FADD
12380,GO:0048771,0.0104094716225809,0.995464418907619,16,96,tissue remodeling,BP,F2R;ACVR2B;EGFR;TGM2;RAC2;ACP5;CEACAM1;MMP14;LRP5;CST3;CHD7;UBASH3B;TMBIM1;HOXA3;ADAM8;LRP6
5464,GO:0016358,0.0104123982950128,0.994536084570586,25,163,dendrite development,BP,ZMYND8;NEURL1;VLDLR;HECW2;NFATC4;MAP1B;PTPRS;CRTC1;FYN;CSMD3;DLG4;WNT7A;SHANK2;APOE;OBSL1;DVL1;MAP6;BTBD3;ASAP1;ARF4;IL1RAP;LPAR1;WASL;EEF2K;LRP4
5479,GO:0016413,0.0105469344497382,0.999278213863898,3,6,O-acetyltransferase activity,MF,LPCAT4;LPCAT1;CRAT
4298,GO:0009743,0.0105472636285813,0.994790593564138,21,145,response to carbohydrate,BP,ERCC1;PCK2;NR1D1;ACVR2B;MAPK13;GLUL;MAP4K4;TGFBR2;LDHA;ITGA2;VAMP2;SOX4;LRP5;CST3;PPP3CB;ANO1;XBP1;PRKACA;IGF2;ENDOG;ADNP
2674,GO:0006026,0.0105595390586834,0.996750227487727,9,43,aminoglycan catabolic process,BP,GPC4;CEMIP;SDC1;CD44;HYAL1;CTBS;GLB1;HPSE;GALNS
15198,GO:0071340,0.01078779794404,0.99925538766789,3,6,skeletal muscle acetylcholine-gated channel clustering,BP,ETV5;DVL1;LRP4
4131,GO:0009190,0.0108736454623043,0.996934414694376,8,36,cyclic nucleotide biosynthetic process,BP,NOS1;ADCY7;APOE;AKAP9;PTHLH;TIMP2;ADCY1;ADNP
13383,GO:0052652,0.0108736454623043,0.996934414694376,8,36,cyclic purine nucleotide metabolic process,BP,NOS1;ADCY7;APOE;AKAP9;PTHLH;TIMP2;ADCY1;ADNP
9887,GO:0042165,0.0108937722967079,0.998069460533449,5,18,neurotransmitter binding,MF,CBS;HTR7;IDE;NIPSNAP1;GRIN3B
2184,GO:0005041,0.0109444632975857,0.998732255615186,4,9,low-density lipoprotein particle receptor activity,MF,SORL1;VLDLR;LRP1;LRP6
16990,GO:0099068,0.0109446932090884,0.998732220900574,4,9,postsynapse assembly,BP,WNT7A;SHANK2;NLGN2;LRP4
8985,GO:0035091,0.011087901598412,0.993978909096305,27,187,phosphatidylinositol binding,MF,PITPNC1;ARAP1;SNX9;WDFY3;ZCCHC14;TUB;SNX14;PFN2;PITPNM1;ITPR3;GSDMC;PLEK2;PHF12;TWF2;GSDMA;ASAP1;FCHO2;OSBPL5;SH3PXD2B;ZFYVE9;CCDC88A;SNX30;ITPR2;SNX6;GRB7;ACAP2;SNX27
2089,GO:0004854,0.0111824176016471,1,2,2,xanthine dehydrogenase activity,MF,XDH;AOX1
4065,GO:0009115,0.0111824176016471,1,2,2,xanthine catabolic process,BP,XDH;AOX1
5641,GO:0016726,0.0111824176016471,1,2,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,XDH;AOX1
13512,GO:0055082,0.0112289269185377,0.992698365495205,51,432,cellular chemical homeostasis,BP,NOS1;F2R;PCK2;PRNP;NR1D1;DDIT3;FYN;BNIP3;DLG4;TGM2;SLC9A7;MAP4K4;CEMIP;RASA3;EDNRA;LCN2;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;SOX4;ITPR3;DMXL2;MT2A;CLCN3;NTSR1;ANXA6;LRP5;PPP3CB;F2RL1;CHD7;ANO1;BOK;XBP1;UBASH3B;SLC22A17;TRPC1;SLC30A1;PRKACA;SLC39A10;LPAR1;AP3D1;ITPR2;ATP12A;ATP6V1B2;WFS1;ENDOG;LRP6;FBXL5
3223,GO:0006873,0.0112584654805972,0.993010890002091,42,343,cellular ion homeostasis,BP,NOS1;F2R;PRNP;DDIT3;FYN;BNIP3;DLG4;TGM2;SLC9A7;CEMIP;RASA3;EDNRA;LCN2;APOE;FKBP1A;ATP7B;PKD2;LPAR3;FAM155B;ITPR3;DMXL2;MT2A;CLCN3;NTSR1;ANXA6;F2RL1;CHD7;BOK;UBASH3B;SLC22A17;TRPC1;SLC30A1;PRKACA;SLC39A10;LPAR1;AP3D1;ITPR2;ATP12A;ATP6V1B2;WFS1;LRP6;FBXL5
7820,GO:0032373,0.0112835941144243,0.998036319050022,5,16,positive regulation of sterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PTCH1
7823,GO:0032376,0.0112835941144243,0.998036319050022,5,16,positive regulation of cholesterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PTCH1
6864,GO:0030334,0.0112932754333565,0.99230297406172,64,538,regulation of cell migration,BP,DOCK4;SMURF2;ZMYND8;F2R;SORL1;PGF;ITGA6;CYGB;SERPINE2;POSTN;ADARB1;ALOX15B;SSH1;LAMB1;EGFR;SEMA4B;IDH2;PLXNB3;PODXL;WNT7A;TTBK2;MCTP1;CEMIP;PAK1;TGFBR2;EPHA1;RAC2;APOE;SRGAP2B;LRP1;ANXA3;FGFR1;HYAL1;ITGA2;PFN2;CEACAM1;FAM110C;MMP14;MOSPD2;SLK;F2RL1;SPRY2;BEX4;ACVR1B;IFITM1;XBP1;ABHD6;RET;C5;TMSB4X;RHOBTB1;LPAR1;MMP10;LAMA5;PPARG;GRB7;SRPX2;ADAM8;AKT3;ITGA4;WASL;FOXP1;SEMA3F;FADD
15765,GO:0072358,0.0113650438187364,0.992435214004556,57,461,cardiovascular system development,BP,XDH;PGF;SH2D2A;ACTA2;ADM2;NFATC4;MAP2K1;THBS2;RAPGEF3;ACVR2B;LTBP1;ARHGAP22;APLN;DDIT3;ELK3;LOXL1;WNT7A;SHC1;TGFBR2;EDNRA;EPHA1;APOE;ANGPTL4;PKD2;LRP1;ANXA3;HMGA2;FGFR1;HYAL1;SOX4;CEACAM1;EPN2;MMP14;CTH;LRP5;PPP3CB;ADGRB2;RASIP1;CHD7;SPRY2;NGFR;WASF2;XBP1;LOXL2;C5;COL1A2;HOXA3;LAMA5;PPARG;SRPX2;ALDH1A2;TBX1;ADAM8;AKT3;FZD8;E2F7;HPSE
12866,GO:0051187,0.0114654548294565,0.997024079791507,7,35,cofactor catabolic process,BP,GPX3;ACOT7;ALDH1L2;CHAC1;PRDX5;PM20D2;BLVRA
16950,GO:0098936,0.0115112889733646,1,2,2,intrinsic component of postsynaptic membrane,CC,PTPRS;NLGN2
16987,GO:0099055,0.0115112889733646,1,2,2,integral component of postsynaptic membrane,CC,PTPRS;NLGN2
17028,GO:0099240,0.0115112889733646,1,2,2,intrinsic component of synaptic membrane,CC,PTPRS;NLGN2
17105,GO:0099699,0.0115112889733646,1,2,2,integral component of synaptic membrane,CC,PTPRS;NLGN2
14331,GO:0061512,0.0115215108626814,0.997065015035817,7,30,protein localization to cilium,BP,BBS2;TUB;ARF4;TCTN1;CCDC88A;EFCAB7;TMEM107
11858,GO:0046847,0.0115296040064106,0.996429364863741,9,40,filopodium assembly,BP,ZMYND8;NEURL1;ITGA6;ARAP1;ESPN;FNBP1L;DOCK11;TENM2;WASL
10032,GO:0042476,0.0116244100911667,0.995206023861325,14,80,odontogenesis,BP,ITGA6;ITGB4;ACVR2B;LAMB1;HTRA1;SDC1;PPARA;FAM20C;BSG;COL1A2;LAMA5;TBX1;LRP6;LRP4
9866,GO:0042119,0.011687183970359,0.992758708163391,41,356,neutrophil activation,BP,PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;PGM1;CTSB;CD68;STOM;SLC2A3;LCN2;CD44;ANXA3;LPCAT1;CEACAM1;RAB31;CST3;MOSPD2;COPB1;F2RL1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;DNASE1L1;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;ATP11B;TMEM173;HPSE;GALNS;DNAJC3
18573,GO:1903800,0.0117514094179471,0.999079179625936,3,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,MAP2K1;EGFR;MAP2K2
3191,GO:0006814,0.0118104869896276,0.994362616622343,19,118,sodium ion transport,BP,NOS1;SCN8A;SERPINE2;HECW2;STK39;ANK3;DLG1;SLC9A7;STOM;PTPN3;PKD2;SLC5A1;CNTN1;SLC38A2;SLC13A3;SLC10A6;ATP12A;PRSS8;SLC23A2
10031,GO:0042475,0.0118552908526269,0.995744699690483,11,56,odontogenesis of dentin-containing tooth,BP,ITGA6;ITGB4;ACVR2B;HTRA1;PPARA;FAM20C;BSG;LAMA5;TBX1;LRP6;LRP4
17256,GO:0120036,0.0118805102391308,0.991081069103291,114,1023,plasma membrane bounded cell projection organization,BP,ZMYND8;NEURL1;VLDLR;ITGA6;PRNP;ADGRF1;BBS2;POSTN;HECW2;NFATC4;ADARB1;MAP2K1;SH3KBP1;WWTR1;SSH1;MAP1B;PTPRS;LAMB1;CRTC1;BRSK1;EGFR;SEMA4B;ANK3;FYN;KIF13B;PARVB;ARAP1;CSMD3;DLG4;PLXNB3;PODXL;ESPN;EVI5L;WNT7A;MAP4K4;TTBK2;GDI1;UNC119B;SEPT10;SHC1;PAK1;ATXN10;NUDCD3;SHANK2;SLITRK6;IMPACT;RAC2;CD44;APOE;LRP1;AKAP9;LPAR3;FGFR1;ITGA1;PTPDC1;PTK6;ULK2;INPP5F;PFN2;CEP120;OBSL1;DVL1;MAP6;TWF2;CNTN1;NTNG1;RANBP9;WASF3;BTBD3;PPP3CB;RFX2;FNBP1L;F2RL1;ASAP1;SEPT5;DBNDD1;NGFR;MARK4;PTPRZ1;RNF165;WASF2;ARF4;RET;SPATA6;TCTN1;NCKAP1;DOCK11;ETV1;CCDC88A;PRKACA;EPB41L3;IL1RAP;LAMB2;LPAR1;CTSZ;TENM2;LAMA5;GRB10;GRB7;ROBO3;WDR60;TMEM107;WASL;SYT2;EEF2K;SEMA6C;OMG;PTCH1;ADCY1;SEPT6;NYAP1;SEMA3F;ADNP;LRP4
5121,GO:0015485,0.0119928328438333,0.996920512844647,7,30,cholesterol binding,MF,OSBP2;OSBPL10;APOE;ABCG1;ANXA6;OSBPL5;PTCH1
11160,GO:0045217,0.0120117680851367,0.999136339685706,3,6,cell-cell junction maintenance,BP,F2R;NLGN2;F2RL1
13126,GO:0051668,0.0120324472973656,0.995003421701214,14,83,localization within membrane,BP,ETV5;MARVELD1;SSH1;DLG1;DLG4;SEC23A;MALL;DLG3;APOE;DVL1;RAB1A;AP3D1;ITGA4;LRP4
12769,GO:0051044,0.0120578976777062,0.998389428220316,4,12,positive regulation of membrane protein ectodomain proteolysis,BP,SNX9;APOE;SH3D19;ADAM8
10307,GO:0043073,0.0120847297901319,0.99838476455279,4,12,germ cell nucleus,CC,TCFL5;REC8;MLH3;HSPA2
10443,GO:0043299,0.0121800479270229,0.992342428092501,43,376,leukocyte degranulation,BP,PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;PGM1;CTSB;CD68;STOM;SLC2A3;LCN2;RAC2;CD44;ANXA3;LPCAT1;VAMP2;CEACAM1;RAB31;CST3;MOSPD2;COPB1;F2RL1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;DNASE1L1;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;ATP11B;TMEM173;HPSE;GALNS;DNAJC3
11156,GO:0045211,0.0122393463996988,0.994144781783283,19,115,postsynaptic membrane,CC,F2R;NEURL1;COL13A1;PTPRS;ANK3;DLG1;DLG4;DLG3;SHANK2;RGS14;NLGN2;MPDZ;ABHD17C;CPEB4;GRIN3B;PSD3;TENM2;PJA2;SIGMAR1
19237,GO:1905383,0.0122460620695799,0.999721604984951,2,3,protein localization to presynapse,BP,WNT7A;DVL1
10882,GO:0044420,0.012358669904295,0.99455333552658,16,85,extracellular matrix component,CC,ITGA6;THBS2;LTBP1;THSD4;LAMB1;LOXL1;DLG1;SMOC2;SMOC1;CST3;PTPRZ1;LOXL2;VWA1;COL1A2;LAMB2;LAMA5
12865,GO:0051186,0.0123782706068268,0.992036881491498,47,430,cofactor metabolic process,BP,NT5E;PCK2;PRSS3;GPT2;GPX3;NAPRT;H6PD;DHTKD1;PC;EGFR;PSAT1;ELOVL1;PGM1;IDH2;ACOT1;GLO1;ACSF2;PGLS;ACOT7;RSAD1;NMRK1;CBR4;SLC2A3;HAGH;RAC2;ALDH1L2;LDHA;PPARA;UROS;CHAC1;MTHFR;AHCYL2;GAMT;ACOT13;PRDX5;MLYCD;PARP9;PM20D2;PANK4;NFU1;BLVRA;PPT2;COQ2;HSD17B12;PANK1;SLC23A2;ALAS1
4031,GO:0009063,0.012380925345694,0.995232058473791,12,73,cellular amino acid catabolic process,BP,NOS1;CBS;GPT2;GLUL;ARG2;CTH;HIBADH;ALDH7A1;BLMH;GLUD1;PCYOX1;ALDH4A1
10586,GO:0043549,0.0123871468047321,0.991321783836567,72,641,regulation of kinase activity,BP,F2R;SORL1;CCND1;NEURL1;VLDLR;ADCY7;PRNP;ADARB1;MAP2K1;ACVR2B;PKN1;WWTR1;MST1R;TNFSF15;EGFR;STK39;ERCC6;DLG1;DLG4;SNX9;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;SOCS2;TRIB2;TGFBR2;EPHA1;RAC2;APOE;CCND2;RGS14;PKD2;PRKACB;LPAR3;FGFR1;ITGA1;PTK6;CEACAM1;MAPKAPK3;DVL1;LRP5;ETAA1;TRIB3;SLK;TAOK1;PRKAR1A;SPRY2;UBASH3B;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;EIF2AK2;LPAR1;IGF2;MAP4K2;SNX6;ADAM8;FZD8;LRP6;DNAJC3;ADCY1;KAT2B;ADNP
4725,GO:0010887,0.0124581929258759,0.999091686033544,3,6,negative regulation of cholesterol storage,BP,PPARA;ABCG1;PPARG
10839,GO:0044332,0.0125364212992326,0.999222052997221,3,5,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,LRP5;LRP6;LRP4
2348,GO:0005402,0.0126455493635185,0.998334251130741,4,11,carbohydrate:cation symporter activity,MF,SLC5A1;SLC2A9;SLC2A13;SLC23A2
14350,GO:0061564,0.0126748640459023,0.991998766909536,44,332,axon development,BP,VLDLR;ADARB1;MAP2K1;SH3KBP1;SSH1;MAP1B;PTPRS;BRSK1;SEMA4B;ANK3;FYN;KIF13B;PLXNB3;WNT7A;GDI1;SHC1;PAK1;SLITRK6;APOE;LPAR3;ULK2;INPP5F;DVL1;TWF2;NTNG1;RANBP9;PPP3CB;NGFR;PTPRZ1;RNF165;RET;TCTN1;ETV1;LAMB2;GRB10;GRB7;ROBO3;SEMA6C;OMG;PTCH1;ADCY1;SEMA3F;ADNP;LRP4
9501,GO:0036148,0.0127918010927352,0.998309106602068,4,11,phosphatidylglycerol acyl-chain remodeling,BP,LPCAT4;LPCAT1;PLA2G4D;CRLS1
4946,GO:0014911,0.012937174905864,0.997148768139444,6,21,positive regulation of smooth muscle cell migration,BP,DOCK4;POSTN;SSH1;PAK1;ITGA2;LPAR1
12920,GO:0051270,0.0129720552516576,0.990919400069945,71,612,regulation of cellular component movement,BP,DOCK4;SMURF2;ZMYND8;F2R;SORL1;PGF;ITGA6;CYGB;SERPINE2;BBS2;POSTN;ADARB1;ALOX15B;PKN1;SSH1;LAMB1;EGFR;SEMA4B;ARAP1;DLG1;IDH2;PLXNB3;PODXL;WNT7A;TTBK2;MCTP1;CEMIP;PAK1;TGFBR2;EPHA1;RAC2;APOE;SRGAP2B;LRP1;AKAP9;ANXA3;FGFR1;HYAL1;ITGA2;INPP5F;PFN2;CEACAM1;FAM110C;MMP14;MOSPD2;SLK;F2RL1;SPRY2;BEX4;ACVR1B;IFITM1;XBP1;ABHD6;RET;C5;CCSAP;TMSB4X;RHOBTB1;LPAR1;MMP10;LAMA5;PPARG;GRB7;SRPX2;ADAM8;AKT3;ITGA4;WASL;FOXP1;SEMA3F;FADD
18006,GO:1902474,0.0129971156269017,0.999036931015603,3,6,positive regulation of protein localization to synapse,BP,WNT7A;DVL1;NLGN2
16823,GO:0098703,0.0130091361007143,0.999035699282485,3,6,calcium ion import across plasma membrane,BP,PRNP;FYN;FAM155B
18074,GO:1902656,0.0130091361007143,0.999035699282485,3,6,calcium ion import into cytosol,BP,PRNP;FYN;FAM155B
14130,GO:0060996,0.0130488471153258,0.994764955678239,13,70,dendritic spine development,BP,ZMYND8;NEURL1;PTPRS;DLG4;WNT7A;SHANK2;APOE;DVL1;ASAP1;ARF4;LPAR1;WASL;EEF2K
10733,GO:0044089,0.0130637238883988,0.991591613760659,47,383,positive regulation of cellular component biogenesis,BP,ERCC1;ZMYND8;NEURL1;MMP1;THBS2;RAPGEF3;ADGRL1;WIPF1;ARAP1;DLG1;SNX9;ESPN;WNT7A;SDC1;PAK1;SLITRK6;EPHA1;RAC2;IDE;AKAP9;HYAL1;PFN2;FHOD1;DDB2;CEP120;NLGN2;TWF2;TPBG;ADGRB2;FNBP1L;F2RL1;ASAP1;JMY;WASF2;SPIRE1;SH3PXD2B;NCKAP1;DOCK11;CCDC88A;IL1RAP;LPAR1;ARPC1A;TENM2;SRPX2;WASL;EEF2K;ADNP
8518,GO:0033700,0.0130686549509411,0.999029593752567,3,6,phospholipid efflux,BP,APOE;ABCA7;ABCG1
12671,GO:0050878,0.013087636431747,0.992001239515972,38,307,regulation of body fluid levels,BP,XDH;PLAT;F2R;CCND1;NEURL1;SERPINE2;ADCY7;TFPI2;APLN;DGKA;STK39;FYN;SOCS2;SERPING1;RAC2;APOE;ATP7B;PRKACB;ITGA2;ITPR3;CEACAM1;LMAN1;RCOR1;DOCK9;F2RL1;PROCR;PRKAR1A;XBP1;UBASH3B;DOCK11;COL1A2;PRKACA;ITPR2;SLC7A11;WFS1;PHF21A;HPSE;ADCY1
18013,GO:1902495,0.0130906455485,0.993822362135374,18,112,transmembrane transporter complex,CC,NOS1;SCN8A;KCNG1;DLG1;DLG4;DLG3;SHANK2;FKBP1A;AKAP9;ABCA7;VAMP2;TTYH3;ANO1;GRIN3B;ABHD6;PRKACA;ATP12A;HSPA2
8728,GO:0034374,0.0130916537911447,0.99969154464795,2,3,low-density lipoprotein particle remodeling,BP,APOE;ABCG1
14846,GO:0070588,0.0131215445442072,0.993165174771742,23,154,calcium ion transmembrane transport,BP,NOS1;F2R;PRNP;DDIT3;DENND5B;FYN;CEMIP;RASA3;FKBP1A;PKD2;FAM155B;ITPR3;NTSR1;ORAI3;CHD7;GRIN3B;UBASH3B;MICU3;TRPC1;PRKACA;ORAI1;ITPR2;HSPA2
10784,GO:0044242,0.0131336473453108,0.993479152713428,20,146,cellular lipid catabolic process,BP,PCK2;HADH;TYSND1;ACAD11;APOE;ABCD1;PPARA;AIG1;LONP2;INPP5F;PLA2G4D;ACAD10;MLYCD;CPT2;MGLL;CRAT;ABHD6;SRD5A3;DDHD2;AMACR
9504,GO:0036151,0.0131398777318434,0.997558090470818,5,18,phosphatidylcholine acyl-chain remodeling,BP,MBOAT2;LPCAT4;LPCAT1;PLA2G4D;TMEM86B
15481,GO:0071825,0.0131468829164606,0.997020255884135,6,24,protein-lipid complex subunit organization,BP,SNX9;APOE;PRKACB;ABCA7;ABCG1;PRKACA
539,GO:0001657,0.0131626330107646,0.994945573175427,12,63,ureteric bud development,BP,PGF;CTNNBIP1;DLG1;SDC1;ARG2;PKD2;FGFR1;EPCAM;WNT2B;RET;LAMA5;PTCH1
6750,GO:0030170,0.0132442586136007,0.996500861808202,7,32,pyridoxal phosphate binding,MF,PYGL;CBS;PYGB;GPT2;SPTLC2;CTH;ALAS1
14673,GO:0070279,0.0132442586136007,0.996500861808202,7,32,vitamin B6 binding,MF,PYGL;CBS;PYGB;GPT2;SPTLC2;CTH;ALAS1
2985,GO:0006528,0.0133480190229408,0.999682215150713,2,3,asparagine metabolic process,BP,ASNS;NIT2
3382,GO:0007159,0.0133517306196008,0.992793772604111,25,189,leukocyte cell-cell adhesion,BP,TNIP1;NT5E;PRNP;PAG1;FYN;DLG1;ARG2;PAK1;RAG1;TGFBR2;RAC2;CD44;PPARA;CEACAM1;CD46;PRKAR1A;XBP1;PDE5A;CARD11;AP3D1;IGF2;ADAM8;IL20RB;ITGA4;FADD
18347,GO:1903317,0.0134108589463402,0.995354186609546,10,53,regulation of protein maturation,BP,SERPINE2;PRNP;SERPING1;PRKACB;CHAC1;SOX4;CD46;C5;CTSZ;ADAM8
17561,GO:1901142,0.0134305059748734,0.998992237557489,3,6,insulin metabolic process,BP,ERO1B;IDE;CEACAM1
8330,GO:0033173,0.0134573008976755,0.996956091528971,6,23,calcineurin-NFAT signaling cascade,BP,PRNP;NFATC4;NFAT5;PPP3CB;ADGRB2;RCAN1
15139,GO:0071230,0.0134896457461144,0.9953392498894,10,51,cellular response to amino acid stimulus,BP,NEURL1;CAPN2;EGFR;FYN;CPEB4;COL6A1;BCL2L1;XBP1;COL1A2;DNMT3A
9885,GO:0042159,0.0134968464934721,0.998134838741032,4,12,lipoprotein catabolic process,BP,APOE;ABHD17C;LYPLAL1;LYPLA1
19368,GO:1905809,0.013520569530335,0.998182464391643,4,11,negative regulation of synapse organization,BP,PRNP;NFATC4;FYN;APOE
7053,GO:0030828,0.0135945287649864,0.998874207660316,3,7,positive regulation of cGMP biosynthetic process,BP,NOS1;APOE;ADNP
989,GO:0002446,0.0136005298570791,0.991486336985574,41,359,neutrophil mediated immunity,BP,PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;PGM1;CTSB;CD68;STOM;SLC2A3;LCN2;CD44;ANXA3;LPCAT1;CEACAM1;RAB31;CST3;MOSPD2;COPB1;F2RL1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;DNASE1L1;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;ATP11B;TMEM173;HPSE;GALNS;DNAJC3
4292,GO:0009719,0.0136697159654865,0.989675629407132,114,1066,response to endogenous stimulus,BP,SMURF2;NOS1;PGF;CCND1;NEURL1;PCK2;ADCY7;PRNP;MXRA5;BBS2;POSTN;NR1D1;FAM210B;LTBP2;RAPGEF3;FNDC4;ACVR2B;LTBP1;APLN;EIF4EBP1;SSH1;HADH;CAPN2;EGFR;FYN;SLC33A1;MAPK13;ADAMTS7;CTSB;HTRA1;WNT7A;SDC1;SHC1;DKK1;PAK1;SOCS2;TGFBR2;IMPACT;CD44;APOE;FKBP1A;PTPN12;PKD2;PRKACB;LRP1;IDE;AKAP9;ANXA3;ATF4;PPARA;ASNS;FGFR1;TUB;UROS;ITGB5;HYAL1;ITGA2;GALNT3;VAMP2;LTBP4;FAM20C;ABCG1;CEACAM1;FERMT1;RAB31;BSG;NLK;XRN1;MMP14;LRP5;CTSL;CST3;TRIB3;CASP4;PCSK6;CSNK2A1;PRKAR1A;CRLS1;CPEB4;SPRY2;THRA;COL6A1;NGFR;BCL2L1;RNF165;GLB1;XBP1;MTMR4;ZFYVE9;COL1A2;PRKACA;TIMP2;NR2F6;IGF2;ITPR2;GRB10;PPARG;SNX6;ALDH1A2;TBX1;ATP6V1B2;ENDOG;ACAP2;IGFBP7;LRP6;EEF2K;FOXP1;PTCH1;ADCY1;KAT2B;UFL1;GNAI1;LRP4;DNMT3A
3572,GO:0007616,0.0136787044876895,0.99691960767494,6,22,long-term memory,BP,PRNP;APOE;CCND2;RGS14;PJA2;ADCY1
4787,GO:0010976,0.0137142482884867,0.992419493123323,27,186,positive regulation of neuron projection development,BP,ZMYND8;NEURL1;VLDLR;MAP2K1;MAP1B;CRTC1;FYN;DLG4;PLXNB3;GDI1;PAK1;SHANK2;APOE;LPAR3;FGFR1;PTK6;OBSL1;DVL1;TWF2;CNTN1;NGFR;RET;IL1RAP;LPAR1;SYT2;EEF2K;ADNP
2978,GO:0006520,0.0138705763179413,0.991859213789085,32,276,cellular amino acid metabolic process,BP,NOS1;CBS;GPT2;CARS;PSMD2;PSAT1;GLUL;CRTAP;ARG2;NAGS;ERO1B;ATF4;ASNS;AARS;MTHFR;AHCYL2;GAMT;CTH;GFPT1;HIBADH;ALDH7A1;SLC6A6;PSMD7;BLMH;SLC6A14;BPHL;GLUD1;AZIN2;PCYOX1;NIT2;ALDH4A1;GARS
19061,GO:1904928,0.0141617629390433,1,2,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,LRP5;LRP6
4266,GO:0009612,0.0142793646963776,0.992878366263389,20,134,response to mechanical stimulus,BP,SERPINE2;POSTN;DENND5B;EGFR;FYN;BNIP3;XPC;TGFBR2;SLITRK6;PKD2;ASNS;ITGA2;MMP14;SLC38A2;ETV1;PPARG;PPL;ENDOG;PTCH1;FADD
13668,GO:0060191,0.0144516980263096,0.995278946545507,9,46,regulation of lipase activity,BP,LMF1;EGFR;EDNRA;ANGPTL4;LRP1;FGFR1;PCSK6;ARF4;LPAR1
18445,GO:1903530,0.0145130283470838,0.990588426769224,47,398,regulation of secretion by cell,BP,F2R;RAB3B;PCK2;POSTN;NR1D1;RAPGEF3;ALOX15B;APLN;HADH;EGFR;IDH2;GLUL;MAP4K4;MCTP1;SDC1;ARG2;RAC2;ICA1;FGFR1;VAMP2;PFN2;SOX4;ITPR3;CEACAM1;FERMT1;NTSR1;NLGN2;LRP5;RIMS3;PPP3CB;SYTL1;F2RL1;CHD7;SLC25A4;ANO1;SEPT5;GLUD1;XBP1;C5;SLC30A1;TMSB4X;IL1RAP;ITPR2;RPH3AL;ADAM8;SYT2;FOXP1
896,GO:0002275,0.0145321661377654,0.990756044386971,43,380,myeloid cell activation involved in immune response,BP,PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;PGM1;CTSB;CD68;STOM;SLC2A3;LCN2;RAC2;CD44;ANXA3;LPCAT1;VAMP2;CEACAM1;RAB31;CST3;MOSPD2;COPB1;F2RL1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;DNASE1L1;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;ATP11B;TMEM173;HPSE;GALNS;DNAJC3
10455,GO:0043312,0.014579363090222,0.990886321596544,40,350,neutrophil degranulation,BP,PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;PGM1;CTSB;CD68;STOM;SLC2A3;LCN2;CD44;ANXA3;LPCAT1;CEACAM1;RAB31;CST3;MOSPD2;COPB1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;DNASE1L1;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;ATP11B;TMEM173;HPSE;GALNS;DNAJC3
6107,GO:0019344,0.0145977365047464,0.999635331476804,2,3,cysteine biosynthetic process,BP,CBS;CTH
14514,GO:0065005,0.0146143746303134,0.997209142807958,5,18,protein-lipid complex assembly,BP,SNX9;APOE;PRKACB;ABCA7;PRKACA
9713,GO:0038127,0.0146310885609174,0.992835914391413,19,125,ERBB signaling pathway,BP,FAM83A;NEURL1;PAG1;SH3TC2;SH3KBP1;EGFR;ARAP1;SHC1;PTPN3;PTPN12;ITGA1;PTK6;CEACAM1;MVB12B;SPRY2;MVB12A;ARF4;SNX6;GRB7
17115,GO:0101023,0.0148456578414856,0.997946630820886,4,11,vascular endothelial cell proliferation,BP,APLN;FGFR1;PPARG;AKT3
19299,GO:1905562,0.0148456578414856,0.997946630820886,4,11,regulation of vascular endothelial cell proliferation,BP,APLN;FGFR1;PPARG;AKT3
17702,GO:1901606,0.014852292474548,0.994724149357029,10,59,alpha-amino acid catabolic process,BP,NOS1;CBS;GPT2;GLUL;ARG2;HIBADH;ALDH7A1;BLMH;GLUD1;ALDH4A1
11343,GO:0045666,0.0148937641302076,0.99125789924865,32,233,positive regulation of neuron differentiation,BP,ZMYND8;ETV5;NEURL1;VLDLR;MAP2K1;MAP1B;CRTC1;FYN;DLG4;PLXNB3;GDI1;DKK1;PAK1;SOCS2;SHANK2;IMPACT;APOE;LPAR3;FGFR1;PTK6;OBSL1;DVL1;TWF2;CNTN1;NGFR;RET;TIMP2;IL1RAP;LPAR1;SYT2;EEF2K;ADNP
3457,GO:0007269,0.0149333275572654,0.99386845021987,13,75,neurotransmitter secretion,BP,BRSK1;SNPH;WNT7A;MCTP1;VAMP2;PFN2;DVL1;RIMS3;SYTL1;SEPT5;SLC30A1;SYT2;SLC18A2
17104,GO:0099643,0.0149333275572654,0.99386845021987,13,75,signal release from synapse,BP,BRSK1;SNPH;WNT7A;MCTP1;VAMP2;PFN2;DVL1;RIMS3;SYTL1;SEPT5;SLC30A1;SYT2;SLC18A2
5322,GO:0016048,0.0150519780305856,0.998704087453467,3,7,detection of temperature stimulus,BP,NTSR1;ANO1;NR2F6
12722,GO:0050961,0.0150519780305856,0.998704087453467,3,7,detection of temperature stimulus involved in sensory perception,BP,NTSR1;ANO1;NR2F6
12724,GO:0050965,0.0150519780305856,0.998704087453467,3,7,detection of temperature stimulus involved in sensory perception of pain,BP,NTSR1;ANO1;NR2F6
6791,GO:0030228,0.0151525843321307,0.99796551315072,4,10,lipoprotein particle receptor activity,MF,SORL1;VLDLR;LRP1;LRP6
5166,GO:0015711,0.0152431832050308,0.990864161817134,34,265,organic anion transport,BP,SLC16A3;PITPNC1;STK39;OSBPL10;SLC33A1;SLCO4A1;SLC2A3;APOE;ABCD1;PPARA;ABCA7;VAMP2;ABCG1;PITPNM1;CEACAM1;BSG;NTSR1;SLC35B4;SLC2A9;ATP10D;SLC6A6;SLC25A4;CPT2;SLC6A14;SLC43A1;SLC22A17;SLC38A2;OSBPL5;SLC13A3;PPARG;SLC10A6;SLC7A11;ATP11B;SLC23A2
902,GO:0002283,0.015250697709471,0.99043663845853,40,351,neutrophil activation involved in immune response,BP,PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;PGM1;CTSB;CD68;STOM;SLC2A3;LCN2;CD44;ANXA3;LPCAT1;CEACAM1;RAB31;CST3;MOSPD2;COPB1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;DNASE1L1;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;ATP11B;TMEM173;HPSE;GALNS;DNAJC3
9027,GO:0035239,0.0154506970043424,0.989267341806889,65,539,tube morphogenesis,BP,XDH;ETV5;PGF;SH2D2A;CTNNBIP1;ADM2;NFATC4;THBS2;RAPGEF3;ACVR2B;ARHGAP22;APLN;ELK3;EGFR;DLG1;PODXL;TGM2;WNT7A;SHC1;PAK1;TGFBR2;EDNRA;EPHA1;APOE;ANGPTL4;PKD2;PRKACB;LRP1;ANXA3;HMGA2;FGFR1;HYAL1;BTRC;SOX4;CEACAM1;EPN2;DVL1;MMP14;LRP5;ADGRB2;RASIP1;CHD7;SPRY2;WNT2B;NGFR;WASF2;XBP1;RET;LOXL2;TCTN1;C5;CTSZ;HOXA3;LAMA5;PPARG;SRPX2;TBX1;ADAM8;AKT3;FZD8;LRP6;E2F7;HPSE;FOXP1;PTCH1
1777,GO:0004385,0.0155301475480775,0.997822102653867,4,11,guanylate kinase activity,MF,DLG1;DLG4;DLG3;CARD11
16723,GO:0097720,0.0156485815480389,0.996311686939751,6,24,calcineurin-mediated signaling,BP,PRNP;NFATC4;NFAT5;PPP3CB;ADGRB2;RCAN1
4128,GO:0009187,0.0156858961191737,0.99411274484224,11,58,cyclic nucleotide metabolic process,BP,NOS1;ADCY7;RAPGEF3;APOE;PKD2;AKAP9;PTHLH;PDE5A;TIMP2;ADCY1;ADNP
3894,GO:0008528,0.0157387626546615,0.99621918099931,6,27,G-protein coupled peptide receptor activity,MF,F2R;EDNRA;NTSR1;F2RL1;LTB4R;SIGMAR1
9440,GO:0036017,0.0157676696087024,0.99942449701986,2,4,response to erythropoietin,BP,MT2A;EPOR
9441,GO:0036018,0.0157676696087024,0.99942449701986,2,4,cellular response to erythropoietin,BP,MT2A;EPOR
14948,GO:0070838,0.0158130407424242,0.990661399766472,32,243,divalent metal ion transport,BP,NOS1;F2R;CYP27B1;PRNP;DDIT3;DENND5B;FYN;CEMIP;RASA3;FKBP1A;PKD2;LPAR3;FAM155B;ITPR3;SARAF;NTSR1;ANXA6;ORAI3;NIPA1;CHD7;GRIN3B;UBASH3B;MICU3;TRPC1;SLC30A1;PRKACA;SLC39A10;ORAI1;ITPR2;WFS1;HSPA2;PSEN2
4032,GO:0009064,0.0158705724630724,0.994710758586848,9,48,glutamine family amino acid metabolic process,BP,NOS1;GLUL;ARG2;NAGS;ASNS;GFPT1;GLUD1;NIT2;ALDH4A1
8766,GO:0034436,0.0159451103625675,0.99958224073862,2,3,glycoprotein transport,BP,VLDLR;ABCG1
10640,GO:0043649,0.0159510504623317,0.997628175051826,4,13,dicarboxylic acid catabolic process,BP,GLUL;ALDH1L2;GLUD1;PM20D2
15652,GO:0072163,0.016009115539064,0.99367226445199,12,64,mesonephric epithelium development,BP,PGF;CTNNBIP1;DLG1;SDC1;ARG2;PKD2;FGFR1;EPCAM;WNT2B;RET;LAMA5;PTCH1
15653,GO:0072164,0.016009115539064,0.99367226445199,12,64,mesonephric tubule development,BP,PGF;CTNNBIP1;DLG1;SDC1;ARG2;PKD2;FGFR1;EPCAM;WNT2B;RET;LAMA5;PTCH1
1121,GO:0002710,0.0160135626682739,0.998499154831563,3,8,negative regulation of T cell mediated immunity,BP,CEACAM1;PPP3CB;IL20RB
18412,GO:1903441,0.0160939756624217,0.9985783433092,3,7,protein localization to ciliary membrane,BP,BBS2;TUB;EFCAB7
6057,GO:0019205,0.0162281321370998,0.994992564586854,8,42,nucleobase-containing compound kinase activity,MF,TK2;DLG1;DLG4;NME4;DLG3;CARD11;AK9;N4BP2
987,GO:0002444,0.016242211496752,0.989590384089599,43,383,myeloid leukocyte mediated immunity,BP,PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;PGM1;CTSB;CD68;STOM;SLC2A3;LCN2;RAC2;CD44;ANXA3;LPCAT1;VAMP2;CEACAM1;RAB31;CST3;MOSPD2;COPB1;F2RL1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;DNASE1L1;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;ATP11B;TMEM173;HPSE;GALNS;DNAJC3
9503,GO:0036150,0.0162535257557678,0.997623111898872,4,12,phosphatidylserine acyl-chain remodeling,BP,OSBPL10;LPCAT4;PLA2G4D;OSBPL5
10091,GO:0042592,0.0163579178470798,0.98756449626231,113,1100,homeostatic process,BP,FHL1;NOS1;ERCC1;F2R;PCK2;PYGL;CYP27B1;ADCY7;PRNP;BBS2;NR1D1;FAM210B;PKN1;APLN;DDIT3;CRTC1;EGFR;STK39;ANK3;FYN;BNIP3;ERCC6;DLG4;TGM2;SLC9A7;MAP4K4;MALL;CEMIP;RASA3;RAG1;PTPN3;EDNRA;LCN2;RAC2;ERO1B;APOE;FKBP1A;ATP7B;ACP5;ANGPTL4;PKD2;PRKACB;IDE;LPAR3;FAM155B;TUB;LPCAT1;TMX4;ATRX;ABCG1;SOX4;ITPR3;NELL2;PDIA5;DMXL2;MT2A;XRN1;CLCN3;NTSR1;ANXA6;LRP5;L3MBTL3;PPP3CB;MEX3C;PRDX5;CEBPG;F2RL1;CHD7;QSOX1;PRKAR1A;ANO1;BOK;THRA;ACVR1B;NGFR;PPP1R10;SLC12A7;XBP1;UBASH3B;TXNRD3;SLC22A17;TRPC1;TXNDC11;NOP10;DOCK11;SLC30A1;SFXN3;PRKACA;SLC39A10;CARD11;LPAR1;AP3D1;ARID4A;IGF2;ITPR2;PPARG;ATP12A;ERP44;ATP6V1B2;RPH3AL;ADAM8;AKT3;IL20RB;WFS1;ENDOG;LRP6;DEDD2;PTCH1;ADCY1;OAS1;ADNP;FBXL5;FADD
18280,GO:1903169,0.0163819751214164,0.993183065356602,13,76,regulation of calcium ion transmembrane transport,BP,NOS1;F2R;PRNP;FYN;CEMIP;FKBP1A;PKD2;NTSR1;CHD7;UBASH3B;TRPC1;PRKACA;HSPA2
16986,GO:0099054,0.01647354059803,0.997647568002586,4,11,presynapse assembly,BP,WNT7A;DVL1;NLGN2;LRP4
2996,GO:0006541,0.0165336276426457,0.996780211989378,5,17,glutamine metabolic process,BP,GLUL;ASNS;GFPT1;GLUD1;NIT2
19278,GO:1905475,0.0166392912842479,0.991892977244001,18,125,regulation of protein localization to membrane,BP,ZMYND8;PRNP;SSH1;EGFR;ANK3;FYN;DLG1;GDI1;CEMIP;STOM;PAK1;LRP1;CSNK2A1;BCL2L1;TMBIM1;EFCAB7;LYPLA1;LRP4
16426,GO:0097061,0.0168176614794654,0.993993469311807,10,50,dendritic spine organization,BP,ZMYND8;PRNP;FYN;DLG4;WNT7A;SHANK2;APOE;DVL1;WASL;EEF2K
6722,GO:0030133,0.0168480677646768,0.990067370945889,31,252,transport vesicle,CC,RAB3B;PTPRS;SNTB2;BRSK1;DLG4;SEC23A;MCTP1;MCFD2;ICA1;VAMP2;CEACAM1;LMAN1;DMXL2;CLCN3;MAP6;CLTCL1;SYTL1;COPB1;COPG1;SEPT5;DBNDD1;AZIN2;BCL2L1;TMEM187;RAB1A;KDELR3;NRSN2;RPH3AL;SYT2;SLC18A2;SEPT6
15815,GO:0072511,0.0168568162128943,0.989993576204286,32,244,divalent inorganic cation transport,BP,NOS1;F2R;CYP27B1;PRNP;DDIT3;DENND5B;FYN;CEMIP;RASA3;FKBP1A;PKD2;LPAR3;FAM155B;ITPR3;SARAF;NTSR1;ANXA6;ORAI3;NIPA1;CHD7;GRIN3B;UBASH3B;MICU3;TRPC1;SLC30A1;PRKACA;SLC39A10;ORAI1;ITPR2;WFS1;HSPA2;PSEN2
10240,GO:0042953,0.0169237389112833,0.998611672388996,3,6,lipoprotein transport,BP,UNC119B;LRP1;PPARG
11027,GO:0044872,0.0169237389112833,0.998611672388996,3,6,lipoprotein localization,BP,UNC119B;LRP1;PPARG
13831,GO:0060429,0.0169474500927274,0.987543457530177,88,812,epithelium development,BP,XDH;SMURF2;ETV5;PGF;CCND1;PCK2;CTNNBIP1;CYP27B1;SERPINE2;ACTA2;NFATC4;MAP2K1;RAPGEF3;ACVR2B;ALOX15B;SALL2;WWTR1;PTPRS;PSMD2;EGFR;ARHGAP12;DLG1;CTSB;GPC4;PODXL;TGM2;WNT7A;SDC1;ARG2;DLG3;DKK1;PAK1;TGFBR2;EDNRA;SLITRK6;CD44;PKD2;PRKACB;FGFR1;EPCAM;BTRC;ITGA2;PTK6;ATRX;FAM20C;KIAA1109;SOX4;CEACAM1;FERMT1;PRR9;DVL1;MMP14;LRP5;CTSL;CST3;PCSK6;F2RL1;RASIP1;PSMD7;TST;CHD7;SPRY2;THRA;WNT2B;ACVR1B;XBP1;RET;TCTN1;AP2A2;LAMB2;CTSZ;ARID4A;LAMA5;PPARG;PPL;ALDH1A2;TBX1;SLC7A11;TMEM107;PRSS8;FLNB;LRP6;E2F7;HPSE;FOXP1;PTCH1;ANKRD6;LRP4
4199,GO:0009306,0.0169628020413588,0.989301084518009,40,331,protein secretion,BP,F2R;RAB3B;PCK2;POSTN;NR1D1;LTBP2;RAPGEF3;ACVR2B;ALOX15B;LMF1;POU2F2;HADH;EGFR;IDH2;GLUL;MAP4K4;ARG2;ICA1;SOX4;ITPR3;FERMT1;NLGN2;LRP5;PPP3CB;COPG1;F2RL1;SLC25A4;ANO1;GLUD1;XBP1;C5;TMSB4X;RAB1A;SEL1L;IL1RAP;CARD11;ITPR2;RPH3AL;ADAM8;FOXP1
7604,GO:0031984,0.0170025704913531,0.98685305166085,128,1274,organelle subcompartment,CC,EDEM1;NOS1;SORL1;MBOAT2;ASAP2;POSTN;ANTXR2;LMF1;MARCH9;B4GALT6;EGFR;SLC33A1;UBE2J1;UBXN7;ELOVL1;ARAP1;DLG1;B3GNT3;SNX9;SLC9A7;UBXN4;SPTLC2;SEC23A;RDH14;MALL;ASPH;MCTP1;B4GALNT4;ERO1B;FKBP1A;ATP7B;MCFD2;PKD2;ST3GAL5;AKAP9;DDN;ABCA7;PIGH;ICA1;AGPAT4;MARCH4;LPCAT4;LPCAT1;GALNT3;VAMP2;CHAC1;ABCG1;PITPNM1;ITPR3;KDSR;PDIA5;RAB31;LMAN1;SARAF;BSG;CLCN3;DNMBP;TMEM86B;SEC22C;SLC35B4;CLTCL1;CASP4;DNAJB9;SEC63;COPB1;COPG1;RASIP1;PLD3;ATP10D;QSOX1;BOK;ATXN2;USP6NL;MGLL;PSKH1;AZIN2;AGPAT3;GOLGA2P5;HSD17B7;XBP1;CYP4F22;STX10;RAB43;OSBPL5;TXNDC11;MBOAT7;GABARAPL2;TMED4;SAMD8;RAB1A;SEL1L;BCAP29;SRD5A3;KDELR3;ST6GALNAC2;FICD;CTSZ;AP3D1;ITPR2;AGPAT1;PJA2;MAP4K2;EVA1A;TRIQK;TMEM50B;ESYT3;CREB3L2;ERP44;WFS1;IKBIP;SSR3;MARCH2;REEP6;TMEM173;RNF180;SIGMAR1;SSR1;DNAJC3;PSEN2;ELOVL4;HSD17B12;CDS2;COG8;RNF103;REEP3;UFL1;STT3B;RB1CC1
2826,GO:0006290,0.0170901192117814,0.998455049546587,3,7,pyrimidine dimer repair,BP,ERCC1;ERCC6;DDB2
10495,GO:0043395,0.0171035852984327,0.997615997881781,4,10,heparan sulfate proteoglycan binding,MF,PTPRS;GPC4;LRP1;ITGA2
12242,GO:0048514,0.0171123978562453,0.988802749501937,47,376,blood vessel morphogenesis,BP,XDH;PGF;SH2D2A;ADM2;NFATC4;THBS2;RAPGEF3;ARHGAP22;APLN;ELK3;WNT7A;SHC1;TGFBR2;EDNRA;EPHA1;APOE;ANGPTL4;PKD2;LRP1;ANXA3;HMGA2;FGFR1;HYAL1;SOX4;CEACAM1;EPN2;MMP14;LRP5;ADGRB2;RASIP1;CHD7;SPRY2;NGFR;WASF2;XBP1;LOXL2;C5;HOXA3;LAMA5;PPARG;SRPX2;TBX1;ADAM8;AKT3;FZD8;E2F7;HPSE
16494,GO:0097187,0.0171195413736294,0.999533880330043,2,3,dentinogenesis,BP,HTRA1;FAM20C
11618,GO:0046320,0.0172073428276335,0.996661753304112,5,16,regulation of fatty acid oxidation,BP,TYSND1;PPARA;LONP2;MLYCD;PPARG
2273,GO:0005216,0.017258613538821,0.990910453418528,22,149,ion channel activity,MF,SCN8A;KCNG1;DENND5B;DLG1;DLG4;DLG3;RASA3;CLCA2;PKD2;FAM155B;ITPR3;CLCN3;ANXA6;ORAI3;TTYH3;ANO8;ANO1;GRIN3B;TRPC1;KCNJ15;ORAI1;ITPR2
10508,GO:0043410,0.0173035464487119,0.989010248344302,41,335,positive regulation of MAPK cascade,BP,XDH;F2R;IGFBP4;MAP2K1;PKN1;MST1R;EGFR;STK39;ERCC6;WNT7A;MAP4K4;SHC1;DKK1;PAK1;EPHA1;CD44;ABCA7;LPAR3;FGFR1;ITGA1;MAPKAPK3;TRIM5;F2RL1;TAOK1;SPRY2;NGFR;MAP2K2;RET;PDE5A;C5;SHC2;TIMP2;EIF2AK2;LPAR1;IGF2;MAP4K2;TBX1;ADAM8;FZD8;ANKRD6;RB1CC1
463,GO:0001501,0.0173409137870803,0.989064710393335,40,311,skeletal system development,BP,IGFBP4;BBS2;POSTN;ACVR2B;COL13A1;ADAMTS7;DLG1;WNT7A;TGFBR2;CD44;ACP5;HMGA2;FGFR1;HYAL1;FAM20C;SOX4;MDFI;MMP14;LRP5;THBS3;MEX3C;TTC9;AEBP1;PTHLH;CHD7;THRA;WNT2B;MEF2D;WASF2;LOXL2;SH3PXD2B;COL1A2;HOXA3;IGF2;TBX1;CREB3L2;WDR60;LRP6;ARID5B;FOXP1
17752,GO:1901700,0.0173549055040624,0.98688575008178,106,1020,response to oxygen-containing compound,BP,TNIP1;EDEM1;NOS1;ERCC1;F2R;CCND1;NEURL1;PCK2;CYP27B1;ADCY7;PRNP;POSTN;NR1D1;NFATC4;FAM210B;RAPGEF3;ACVR2B;GPX3;EIF4EBP1;SSH1;HADH;CAPN2;EGFR;LOXL1;FYN;TNFRSF6B;BNIP3;ERCC6;MAPK13;NET1;GLUL;WNT7A;MAP4K4;SDC1;SHC1;DKK1;PAK1;SOCS2;TGFBR2;IMPACT;APOE;ACP5;PKD2;PRKACB;LRP1;LDHA;IDE;AKAP9;ATF4;PPARA;ASNS;HYAL1;ITGA2;PTK6;VAMP2;MTHFR;SOX4;CEACAM1;MAPKAPK3;RAB31;BSG;XRN1;TRIM5;LRP5;TWF2;CST3;TRIB3;CASP4;PPP3CB;PRDX5;CSNK2A1;PRKAR1A;ANO1;CRLS1;CPEB4;COL6A1;NGFR;BCL2L1;GLB1;XBP1;TXNRD3;RET;COL1A2;PRKACA;LPAR1;ZNF354A;IGF2;ITPR2;GRB10;PPARG;ALDH1A2;TBX1;ATP6V1B2;ENDOG;IGFBP7;LRP6;EEF2K;FOXP1;PTCH1;ADCY1;KAT2B;UFL1;ADNP;GNAI1;DNMT3A;FADD
12308,GO:0048646,0.0175107635714097,0.987310330499216,80,691,anatomical structure formation involved in morphogenesis,BP,NOS1;ERCC1;PGF;SH2D2A;ITGA6;ITGB4;ADM2;NFATC4;MAP2K1;THBS2;RAPGEF3;ACVR2B;PKN1;ARHGAP22;APLN;LAMB1;SDK2;ELK3;CAPN2;PODXL;TGM2;HTRA1;WNT7A;SHC1;DKK1;TGFBR2;EDNRA;EPHA1;OBSCN;FKBP1A;ANGPTL4;PRKACB;ANXA3;HMGA2;PPARA;FGFR1;TMOD2;ITGB5;HYAL1;ITGA2;FAM20C;SOX4;CEACAM1;OBSL1;EPN2;DVL1;MMP14;THBS3;PPP3CB;MYOF;RFX2;ADGRB2;RASIP1;PRKAR1A;SPRY2;WNT2B;COL6A1;NGFR;WASF2;XBP1;RET;LOXL2;TCTN1;C5;MBOAT7;EPB41L3;HOXA3;LAMA5;PPARG;SRPX2;TBX1;ADAM8;AKT3;ITGA4;FZD8;LRP6;E2F7;HPSE;TET1;PTCH1
3564,GO:0007605,0.01755420206904,0.992921453417521,12,70,sensory perception of sound,BP,ESPN;CEMIP;SLITRK6;FGFR1;TUB;ALDH7A1;CHD7;SPRY2;ZNF354A;TBL1X;TBX1;WFS1
15865,GO:0072583,0.0176176391002316,0.994573025099662,8,36,clathrin-dependent endocytosis,BP,INPP5F;DNAJC6;FNBP1L;FCHO2;AP2A2;FCHO1;ITGA4;WASL
10514,GO:0043418,0.0176634427117702,0.999510841812918,2,3,homocysteine catabolic process,BP,CBS;BLMH
8887,GO:0034702,0.0177172545806308,0.99177070179881,16,99,ion channel complex,CC,NOS1;SCN8A;KCNG1;DLG1;DLG4;DLG3;SHANK2;FKBP1A;AKAP9;VAMP2;TTYH3;ANO1;GRIN3B;ABHD6;PRKACA;HSPA2
12897,GO:0051239,0.0178177774799348,0.985674182974346,184,1833,regulation of multicellular organismal process,BP,DOCK4;XDH;PLAT;SMURF2;NOS1;ZMYND8;F2R;SORL1;ETV5;PGF;CCND1;NEURL1;CTNNBIP1;VLDLR;CYP27B1;SERPINE2;PRNP;BBS2;POSTN;ADM2;HECW2;NFATC4;MAP2K1;THBS2;FAM210B;RAPGEF3;ACVR2B;ALOX15B;WWTR1;APLN;SSH1;MAP1B;DDIT3;PTPRS;PSMD2;CRTC1;ADGRL1;EGFR;STK39;SEMA4B;FYN;KIF13B;UBE2J1;MAPK13;ADAMTS7;DLG1;CSMD3;DLG4;IDH2;PLXNB3;GPC4;WNT7A;IGF2BP3;MAP4K4;ASPH;GDI1;ARG2;DKK1;PAK1;SOCS2;TRIB2;RAG1;TGFBR2;SERPING1;SHANK2;SLITRK6;EPHA1;IMPACT;APOE;ACP5;ANGPTL4;RGS14;PRKACB;LRP1;AKAP9;ANXA3;HMGA2;ATF4;ABCA7;WWC3;LPAR3;FGFR1;SMOC1;HYAL1;ITGA2;PTK6;ULK2;INPP5F;FAM20C;PFN2;KIAA1109;ITPR3;GAMT;CEACAM1;FERMT1;OBSL1;EPN2;TNRC6B;DVL1;NTSR1;MMP14;ANXA6;NLGN2;CD46;CTH;LRP5;CTSL;TWF2;CST3;CNTN1;TPBG;WASF3;ZNF322;ADGRB2;CEBPG;PLAG1;F2RL1;DDX60;PROCR;PSMD7;PTHLH;CHD7;ASAP1;SPRY2;THRA;MGLL;WNT2B;ACVR1B;NGFR;PTPRZ1;PER3;IFITM1;XBP1;UBASH3B;TRPC1;RET;LOXL2;PDE5A;SH3PXD2B;C5;MTMR4;PUM2;RNF135;TMBIM1;CCDC88A;CCSAP;PRKACA;TMSB4X;TIMP2;EIF2AK2;IFI16;AP2A2;IL1RAP;CARD11;LPAR1;CTSZ;AP3D1;ITPR2;LAMA5;AGPAT1;PPARG;SRPX2;TBX1;ADAM8;AKT3;IL20RB;LRP6;SYT2;TMEM173;EEF2K;HPSE;TNRC6C;OMG;FOXP1;PTCH1;KAT2B;UFL1;ANKRD6;PBX3;JARID2;SEMA3F;ADNP;LRP4;FADD
467,GO:0001505,0.0178348581509878,0.990405372113979,23,166,regulation of neurotransmitter levels,BP,NOS1;RAB3B;BRSK1;SNPH;GLUL;WNT7A;MCTP1;ARG2;ACP5;PKD2;VAMP2;PFN2;DVL1;NTSR1;RIMS3;SYTL1;ALDH7A1;SEPT5;SLC30A1;SYT2;RNF180;SLC18A2;SLC44A1
695,GO:0001915,0.0178562944587387,0.999502576819954,2,3,negative regulation of T cell mediated cytotoxicity,BP,CEACAM1;PPP3CB
6587,GO:0022417,0.0180704946681685,0.998148055362191,3,9,protein maturation by protein folding,BP,ERO1B;FKBP1A;WFS1
10248,GO:0042982,0.0181502449106065,0.99429579329509,8,41,amyloid precursor protein metabolic process,BP,SORL1;PRNP;DLG1;APOE;FKBP1A;ABCA7;ABCG1;PSEN2
14559,GO:0070081,0.01815578595792,0.999489642505801,2,3,clathrin-sculpted monoamine transport vesicle,CC,VAMP2;SLC18A2
14560,GO:0070083,0.01815578595792,0.999489642505801,2,3,clathrin-sculpted monoamine transport vesicle membrane,CC,VAMP2;SLC18A2
17644,GO:1901379,0.0182499464395584,0.994322489135161,8,37,regulation of potassium ion transmembrane transport,BP,FHL1;PRNP;KCNG1;STK39;ANK3;DLG1;AKAP9;VAMP2
4355,GO:0009950,0.0183002923486697,0.997300428176457,4,11,dorsal/ventral axis specification,BP,MDFI;LRP5;LRP6;LRP4
11197,GO:0045321,0.0183529868525119,0.986646903030163,80,766,leukocyte activation,BP,ERCC1;PYGL;PYGB;PRSS3;PRNP;PAG1;PKN1;NAPRT;POU2F2;PSMD2;LTA4H;FYN;KIF13B;PGM1;DLG1;CTSB;CD68;ARG2;STOM;PAK1;RAG1;TGFBR2;SLC2A3;LCN2;RAC2;CD44;FKBP1A;ANXA3;CMTM7;LPCAT1;VAMP2;SOX4;CEACAM1;RAB31;MMP14;CD46;CST3;MOSPD2;DNAJB9;PPP3CB;COPB1;CEBPG;F2RL1;C6ORF120;PSMD7;CHD7;QSOX1;PRKAR1A;GLB1;SKAP2;YPEL5;XBP1;SATB1;PDE5A;DNASE1L1;DOCK11;TMBIM1;TIMP2;AP2A2;SLC39A10;CMTM6;CARD11;CTSZ;AP3D1;NIT2;IGF2;TMEM63A;ERP44;ADAM8;IL20RB;ATP11B;ITGA4;FZD8;TMEM173;HPSE;GALNS;DNAJC3;FOXP1;SNX27;FADD
886,GO:0002252,0.0183532817607733,0.986698869631929,78,749,immune effector process,BP,ERCC1;PYGL;PYGB;PRSS3;ADARB1;PKN1;NAPRT;POU2F2;PSMD2;LTA4H;WIPF1;FYN;BNIP3;PGM1;DLG1;CTSB;CD68;HTRA1;STOM;PAK1;SERPING1;SLC2A3;LCN2;RAC2;CD44;BNIP3L;LRP1;ANXA3;LPCAT1;VAMP2;APOBEC3C;CEACAM1;RAB31;TRIM5;CD46;CST3;MOSPD2;PPP3CB;COPB1;CEBPG;F2RL1;DDX60;C6ORF120;PSMD7;QSOX1;PARP9;IFITM1;GLB1;WASF2;YPEL5;XBP1;C5;NCKAP1;DNASE1L1;DOCK11;PUM2;TMBIM1;TIMP2;EIF2AK2;IFI16;AP2A2;CMTM6;CTSZ;NIT2;ARPC1A;TMEM63A;ERP44;ADAM8;IL20RB;ATP11B;WASL;TMEM173;HPSE;GALNS;DNAJC3;FOXP1;OAS1;FADD
9248,GO:0035641,0.0183949358092847,0.99828914997781,3,7,locomotory exploration behavior,BP,DLG4;APOE;NLGN2
14508,GO:0062013,0.0184601663173252,0.991605749678976,15,96,positive regulation of small molecule metabolic process,BP,NOS1;NR1D1;RAPGEF3;APOE;PPARA;ABCG1;NTSR1;MLYCD;PTHLH;TMSB4X;TIMP2;IGF2;PPARG;KAT2B;ADNP
12591,GO:0050767,0.0186548677406346,0.987098273841386,60,499,regulation of neurogenesis,BP,NOS1;ZMYND8;SORL1;ETV5;NEURL1;VLDLR;SERPINE2;HECW2;NFATC4;MAP2K1;SSH1;MAP1B;PTPRS;CRTC1;SEMA4B;FYN;KIF13B;CSMD3;DLG4;IDH2;PLXNB3;WNT7A;MAP4K4;GDI1;DKK1;PAK1;SOCS2;SHANK2;IMPACT;APOE;RGS14;LRP1;LPAR3;FGFR1;PTK6;ULK2;INPP5F;OBSL1;DVL1;TWF2;CNTN1;PLAG1;CHD7;ASAP1;NGFR;PTPRZ1;RET;CCDC88A;TIMP2;IL1RAP;LPAR1;CTSZ;PPARG;SYT2;EEF2K;OMG;UFL1;SEMA3F;ADNP;LRP4
11540,GO:0046068,0.018664868060636,0.995453096743007,6,23,cGMP metabolic process,BP,NOS1;ADCY7;APOE;PDE5A;ADCY1;ADNP
3595,GO:0008021,0.0186910644986761,0.991450216515442,15,104,synaptic vesicle,CC,RAB3B;PTPRS;BRSK1;DLG4;MCTP1;ICA1;VAMP2;DMXL2;CLCN3;SEPT5;DBNDD1;BCL2L1;SYT2;SLC18A2;SEPT6
3252,GO:0006911,0.0187362953209125,0.995369582129582,6,25,phagocytosis, engulfment,BP,ARHGAP12;RAC2;ABCA7;ITGA2;F2RL1;PPARG
6865,GO:0030335,0.0187541319237449,0.988168800777501,39,314,positive regulation of cell migration,BP,DOCK4;SMURF2;F2R;PGF;ITGA6;POSTN;SSH1;LAMB1;EGFR;SEMA4B;PODXL;WNT7A;CEMIP;PAK1;TGFBR2;EPHA1;RAC2;ANXA3;FGFR1;HYAL1;ITGA2;FAM110C;MMP14;MOSPD2;F2RL1;SPRY2;ACVR1B;XBP1;RET;TMSB4X;LPAR1;GRB7;SRPX2;ADAM8;AKT3;ITGA4;FOXP1;SEMA3F;FADD
8476,GO:0033619,0.0187597950165242,0.993122353882119,10,55,membrane protein proteolysis,BP,ADAM19;SNX9;PTPN3;APOE;SH3D19;NGFR;RET;TIMP2;ADAM8;PSEN2
4891,GO:0014812,0.0189582488438749,0.99305987399344,10,53,muscle cell migration,BP,DOCK4;PLAT;SORL1;POSTN;SSH1;NET1;PAK1;LRP1;ITGA2;LPAR1
6130,GO:0019388,0.0190235938386515,0.998095168267478,3,8,galactose catabolic process,BP,PGM1;GLB1;GALE
634,GO:0001823,0.019032413307645,0.992269901920241,12,66,mesonephros development,BP,PGF;CTNNBIP1;DLG1;SDC1;ARG2;PKD2;FGFR1;EPCAM;WNT2B;RET;LAMA5;PTCH1
14867,GO:0070640,0.019054772707684,0.99945010037194,2,3,vitamin D3 metabolic process,BP,CYP27B1;FGFR1
6418,GO:0021681,0.0190574817820375,0.998203055827459,3,7,cerebellar granular layer development,BP,SERPINE2;WNT7A;TTBK2
3556,GO:0007596,0.0191266263799043,0.989064178211877,27,213,blood coagulation,BP,PLAT;F2R;SERPINE2;TFPI2;DGKA;FYN;SERPING1;RAC2;APOE;PRKACB;ITGA2;ITPR3;CEACAM1;LMAN1;RCOR1;DOCK9;F2RL1;PROCR;PRKAR1A;UBASH3B;DOCK11;COL1A2;PRKACA;ITPR2;SLC7A11;PHF21A;HPSE
535,GO:0001653,0.0191396628085619,0.995170377242385,6,28,peptide receptor activity,MF,F2R;EDNRA;NTSR1;F2RL1;LTB4R;SIGMAR1
4965,GO:0015057,0.0193390379189062,0.999437375282834,2,3,thrombin-activated receptor activity,MF,F2R;F2RL1
14730,GO:0070382,0.0194098848190866,0.990820585885289,16,113,exocytic vesicle,CC,RAB3B;PTPRS;BRSK1;DLG4;MCTP1;ICA1;VAMP2;DMXL2;CLCN3;SYTL1;SEPT5;DBNDD1;BCL2L1;SYT2;SLC18A2;SEPT6
4944,GO:0014909,0.0194386725247455,0.993332848139403,9,45,smooth muscle cell migration,BP,DOCK4;PLAT;SORL1;POSTN;SSH1;PAK1;LRP1;ITGA2;LPAR1
5002,GO:0015144,0.0194878617498589,0.995947553997689,5,19,carbohydrate transmembrane transporter activity,MF,SLC2A3;SLC5A1;SLC2A9;SLC2A13;SLC23A2
13279,GO:0051966,0.0194881473135418,0.99517112341835,6,24,regulation of synaptic transmission, glutamatergic,BP,SERPINE2;EGFR;GLUL;DKK1;SHANK2;NLGN2
11817,GO:0046710,0.0195188709751389,0.996979974514475,4,12,GDP metabolic process,BP,DLG1;DLG4;DLG3;CARD11
17526,GO:1901016,0.019525970457372,0.994465578612765,7,30,regulation of potassium ion transmembrane transporter activity,BP,FHL1;KCNG1;STK39;ANK3;DLG1;AKAP9;VAMP2
4349,GO:0009914,0.0196072914062711,0.989200985964838,24,175,hormone transport,BP,PCK2;NR1D1;RAPGEF3;ACVR2B;APLN;HADH;EGFR;SLCO4A1;GLUL;MAP4K4;ICA1;FGFR1;LTBP4;SOX4;ITPR3;NLGN2;LRP5;PPP3CB;CHD7;SLC25A4;ANO1;GLUD1;RAB1A;ITPR2
19392,GO:1905897,0.0196324857867526,0.992291690713697,11,67,regulation of response to endoplasmic reticulum stress,BP,EDEM1;DDIT3;UBE2J1;DNAJB9;BOK;XBP1;FICD;ERLEC1;WFS1;DNAJC3;USP25
1606,GO:0004029,0.0196640013216735,0.996882144603629,4,13,aldehyde dehydrogenase (NAD) activity,MF,ALDH1L2;ALDH7A1;ALDH1A2;ALDH4A1
10492,GO:0043392,0.019709997325454,0.993709317133706,8,41,negative regulation of DNA binding,BP,CTNNBIP1;DDIT3;HMGA2;PPARA;MDFI;TMSB4X;IFI16;RSF1
12615,GO:0050796,0.01971321352419,0.990690281676075,16,106,regulation of insulin secretion,BP,PCK2;NR1D1;RAPGEF3;HADH;GLUL;MAP4K4;ICA1;SOX4;ITPR3;NLGN2;LRP5;PPP3CB;SLC25A4;ANO1;GLUD1;ITPR2
10577,GO:0043539,0.0197769373288629,0.994996359259919,6,27,protein serine/threonine kinase activator activity,MF,MAP2K1;ETAA1;TAOK1;SPRY2;MAP2K2;IGF2
9727,GO:0038171,0.0197817380563681,0.999417348090461,2,3,cannabinoid signaling pathway,BP,MGLL;ABHD6
15534,GO:0071926,0.0197817380563681,0.999417348090461,2,3,endocannabinoid signaling pathway,BP,MGLL;ABHD6
15881,GO:0072606,0.0198331412797649,0.996789175853939,4,14,interleukin-8 secretion,BP,F2R;F2RL1;TMSB4X;RAB1A
18005,GO:1902473,0.0200914651643552,0.998066267265202,3,7,regulation of protein localization to synapse,BP,WNT7A;DVL1;NLGN2
18369,GO:1903365,0.0202012637323625,0.999398135202517,2,3,regulation of fear response,BP,RAG1;APOE
20131,GO:2000822,0.0202012637323625,0.999398135202517,2,3,regulation of behavioral fear response,BP,RAG1;APOE
3229,GO:0006882,0.0202340289804618,0.995676194742759,5,21,cellular zinc ion homeostasis,BP,ATP7B;MT2A;SLC30A1;SLC39A10;AP3D1
13502,GO:0055069,0.0202340289804618,0.995676194742759,5,21,zinc ion homeostasis,BP,ATP7B;MT2A;SLC30A1;SLC39A10;AP3D1
707,GO:0001932,0.0202497971431721,0.984739020440809,99,940,regulation of protein phosphorylation,BP,TNIP1;XDH;F2R;SORL1;CCND1;NEURL1;VLDLR;ADCY7;IGFBP4;PRNP;ADARB1;MAP2K1;RAPGEF3;ACVR2B;PKN1;WWTR1;MST1R;TNFSF15;EGFR;STK39;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;SOCS2;TRIB2;TGFBR2;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;CCND2;RGS14;PKD2;PRKACB;AKAP9;ABCA7;LPAR3;FGFR1;ITGA1;PTK6;INPP5F;PFN2;CEACAM1;MAPKAPK3;TRIM5;DVL1;LRP5;ETAA1;CNTN1;TRIB3;RANBP9;SLK;F2RL1;TAOK1;PRKAR1A;PARP9;SPRY2;ACVR1B;NGFR;UBASH3B;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;TIMP2;EIF2AK2;LPAR1;IGF2;MAP4K2;SNX6;TBX1;ADAM8;FZD8;HSPA2;LRP6;EEF2K;DNAJC3;ADCY1;KAT2B;ANKRD6;ADNP;LRP4;RB1CC1
7578,GO:0031941,0.0202689060126976,0.994870049474223,6,26,filamentous actin,CC,ESPN;PAK1;PKD2;FERMT1;NCKAP1;TMSB4X
6616,GO:0022838,0.0202918009266167,0.989130678825974,22,152,substrate-specific channel activity,MF,SCN8A;KCNG1;DENND5B;DLG1;DLG4;DLG3;RASA3;CLCA2;PKD2;FAM155B;ITPR3;CLCN3;ANXA6;ORAI3;TTYH3;ANO8;ANO1;GRIN3B;TRPC1;KCNJ15;ORAI1;ITPR2
4526,GO:0010591,0.0203562995150666,0.994872565052912,6,25,regulation of lamellipodium assembly,BP,SSH1;PLXNB3;RAC2;TWF2;WASF2;NCKAP1
9835,GO:0042060,0.0205180157602685,0.986806071140858,41,343,wound healing,BP,PLAT;F2R;SERPINE2;POSTN;TFPI2;DCBLD2;DGKA;ELK3;EGFR;DYSF;FYN;WNT7A;SDC1;PAK1;TGFBR2;SERPING1;RAC2;CD44;APOE;PTPN12;PRKACB;PPARA;ITGA2;ITPR3;CEACAM1;LMAN1;RCOR1;DOCK9;MYOF;F2RL1;PROCR;PRKAR1A;XBP1;UBASH3B;DOCK11;COL1A2;PRKACA;ITPR2;SLC7A11;PHF21A;HPSE
12630,GO:0050817,0.0205684666302492,0.988162516111999,27,214,coagulation,BP,PLAT;F2R;SERPINE2;TFPI2;DGKA;FYN;SERPING1;RAC2;APOE;PRKACB;ITGA2;ITPR3;CEACAM1;LMAN1;RCOR1;DOCK9;F2RL1;PROCR;PRKAR1A;UBASH3B;DOCK11;COL1A2;PRKACA;ITPR2;SLC7A11;PHF21A;HPSE
15524,GO:0071902,0.0206062375582281,0.987450173840634,33,264,positive regulation of protein serine/threonine kinase activity,BP,F2R;CCND1;MAP2K1;PKN1;MST1R;TNFSF15;EGFR;STK39;ERCC6;MAP4K4;CEMIP;SHC1;DKK1;PAK1;CCND2;PKD2;LPAR3;FGFR1;ITGA1;MAPKAPK3;ETAA1;TAOK1;SPRY2;MAP2K2;PDE5A;C5;SHC2;EIF2AK2;LPAR1;IGF2;MAP4K2;ADAM8;FZD8
9793,GO:0040012,0.0206108579567483,0.985257191511236,70,617,regulation of locomotion,BP,DOCK4;SMURF2;ZMYND8;F2R;SORL1;PGF;ITGA6;CYGB;SERPINE2;BBS2;POSTN;ADARB1;ALOX15B;PKN1;SSH1;PC;LAMB1;EGFR;SEMA4B;IDH2;PLXNB3;PODXL;WNT7A;TTBK2;MCTP1;CEMIP;PAK1;TGFBR2;EPHA1;RAC2;APOE;SRGAP2B;LRP1;ANXA3;FGFR1;HYAL1;ITGA2;INPP5F;PFN2;CEACAM1;FAM110C;TRIM5;MMP14;MOSPD2;SLK;F2RL1;SPRY2;BEX4;ACVR1B;IFITM1;XBP1;ABHD6;RET;C5;CCSAP;TMSB4X;RHOBTB1;LPAR1;MMP10;LAMA5;PPARG;GRB7;SRPX2;ADAM8;AKT3;ITGA4;WASL;FOXP1;SEMA3F;FADD
6608,GO:0022804,0.020616713690546,0.98815794554279,27,201,active transmembrane transporter activity,MF,SLC16A3;SLC29A4;SLC33A1;SLCO4A1;SLC9A7;ATP7B;ABCD1;ABCA7;ABCG1;SLC5A1;CLCN3;SLC2A9;SLC6A6;SLC25A4;SLC6A14;SLC12A7;PCYOX1;SLC22A17;SLC38A2;SLC13A3;SLC2A13;SLC10A6;ATP12A;SLC7A11;ATP6V1B2;SLC18A2;SLC23A2
10995,GO:0044794,0.0206181467612867,0.996682565314514,4,13,positive regulation by host of viral process,BP,PC;STOM;APOE;YTHDC2
3260,GO:0006928,0.0206693054787603,0.983813552919544,135,1263,movement of cell or subcellular component,BP,DOCK4;PLAT;SMURF2;TSPAN1;ZMYND8;F2R;SORL1;PGF;NEURL1;VLDLR;ITGA6;MMP1;CYGB;SERPINE2;PRSS3;ITGB4;BBS2;POSTN;SLC16A3;ADARB1;MAP2K1;SH3KBP1;ALOX15B;PKN1;WDR66;SSH1;MAP1B;LAMB1;AVL9;WIPF1;EGFR;SEMA4B;FYN;MYH15;KIF13B;ARAP1;DLG1;IDH2;PLXNB3;PODXL;NET1;WNT7A;TTBK2;MCTP1;CEMIP;SDC1;SHC1;PAK1;TGFBR2;EPHA1;RAC2;CD44;APOE;SRGAP2B;LRP1;FYCO1;ANXA3;KIF21B;FGFR1;ITGA1;EPCAM;HYAL1;ITGA2;PTK6;FAT1;INPP5F;PFN2;CEACAM1;FERMT1;FAM110C;BSG;DVL1;MMP14;LRP5;MOSPD2;RANBP9;SLK;COPG1;FNBP1L;CDC42BPA;SCYL3;F2RL1;PROCR;JMY;PARP9;SPRY2;BEX4;ACVR1B;NGFR;IFITM1;RNF165;WASF2;ARF4;XBP1;ABHD6;RET;LOXL2;NAV1;C5;MBOAT7;NCKAP1;ELMO3;PAK6;ETV1;COL1A2;CCDC88A;CCSAP;TMSB4X;RAB1A;RHOBTB1;AP2A2;LAMB2;LPAR1;MMP10;AP3D1;LAMA5;GRB10;PPARG;GRB7;SRPX2;TBX1;SLC7A11;ADAM8;AKT3;ROBO3;ITGA4;WDR60;CKLF;WASL;ARID5B;SEMA6C;FOXP1;PTCH1;SEMA3F;FADD
17402,GO:1900133,0.0207185080031608,0.999374136251162,2,3,regulation of renin secretion into blood stream,BP,F2R;F2RL1
5267,GO:0015914,0.0207542308883822,0.992784445105149,9,46,phospholipid transport,BP,PITPNC1;OSBPL10;APOE;ABCA7;ABCG1;PITPNM1;ATP10D;OSBPL5;ATP11B
5754,GO:0016903,0.0208011221180795,0.993932215168591,7,34,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,XDH;DHTKD1;ALDH1L2;ALDH7A1;ALDH1A2;ALDH4A1;AOX1
4265,GO:0009611,0.0208129952266172,0.98612105442859,48,416,response to wounding,BP,PLAT;F2R;SERPINE2;ITGB4;POSTN;MAP2K1;TFPI2;DCBLD2;DGKA;PTPRS;ELK3;EGFR;DYSF;FYN;WNT7A;SDC1;PAK1;TGFBR2;SERPING1;RAC2;CD44;APOE;PTPN12;PRKACB;PPARA;ITGA2;INPP5F;ITPR3;CEACAM1;LMAN1;RCOR1;DOCK9;CST3;MYOF;F2RL1;PROCR;PRKAR1A;ARF4;XBP1;UBASH3B;DOCK11;COL1A2;PRKACA;LAMB2;ITPR2;SLC7A11;PHF21A;HPSE
3879,GO:0008509,0.0208202210223091,0.988306361872601,25,187,anion transmembrane transporter activity,MF,SLC16A3;SLC33A1;SLCO4A1;SLC2A3;CLCA2;CEACAM1;BSG;CLCN3;SLC35B4;TTYH3;ANO8;SLC2A9;SLC6A6;SLC25A4;ANO1;SLC6A14;SLC43A1;SLC12A7;PCYOX1;SLC22A17;SLC38A2;SLC13A3;SLC10A6;SLC7A11;SLC23A2
13080,GO:0051588,0.0208588642188959,0.992712846730238,9,48,regulation of neurotransmitter transport,BP,NOS1;RAB3B;APLN;MCTP1;PFN2;NTSR1;RIMS3;SEPT5;SLC30A1
7029,GO:0030802,0.0208862937018849,0.994649104100835,6,27,regulation of cyclic nucleotide biosynthetic process,BP,NOS1;APOE;AKAP9;PTHLH;TIMP2;ADNP
8698,GO:0034331,0.021066234908573,0.997934664543911,3,7,cell junction maintenance,BP,F2R;NLGN2;F2RL1
17071,GO:0099565,0.0210868559745383,0.992633450332528,9,47,chemical synaptic transmission, postsynaptic,BP,ZMYND8;SSH1;DLG4;WNT7A;SHANK2;DVL1;NTSR1;NLGN2;GRIN3B
449,GO:0001222,0.0211260315111102,0.996575087072637,4,13,transcription corepressor binding,MF,NR1D1;PHF12;PER3;NEK6
12277,GO:0048584,0.02115470610144,0.983303027664385,143,1438,positive regulation of response to stimulus,BP,TNIP1;XDH;SMURF2;EDEM1;NOS1;F2R;RAB3B;PGF;NEURL1;SH2D2A;CYP27B1;IGFBP4;PRNP;PAG1;NR1D1;NFATC4;MAP2K1;ACVR2B;ALOX15B;PKN1;MST1R;TNFSF15;SSH1;DDIT3;PTPRS;PSMD2;WIPF1;EGFR;STK39;FYN;TSPAN5;BNIP3;ERCC6;MAPK13;ARAP1;DLG4;CTSB;TGM2;WNT7A;MAP4K4;ARG2;SHC1;DKK1;PAK1;SOCS2;TGFBR2;SERPING1;SHANK2;EPHA1;RAC2;CD44;FKBP1A;PKD2;PRKACB;RBCK1;HMGA2;ABCA7;LPAR3;FGFR1;ITGA1;TMOD2;BTRC;ITGA2;PTK6;SOX4;CEACAM1;FERMT1;MAPKAPK3;FAM110C;EPN2;TRIM5;DVL1;NTSR1;NLGN2;CD46;CTH;CTSL;CASP4;MOSPD2;PPP3CB;CEBPG;F2RL1;DDX60;TAOK1;CSNK2A1;PSMD7;ANO1;BOK;PARP9;C18ORF32;NACC2;SPRY2;WNT2B;ACVR1B;NGFR;BCL2L1;RNF165;WASF2;SKAP2;XBP1;MAP2K2;RET;PDE5A;C5;NCKAP1;PUM2;TMED4;SHC2;PRKACA;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;IFI16;SLC39A10;CARD11;LPAR1;TBL1X;ARPC1A;IGF2;MOAP1;AGPAT1;GRB10;MAP4K2;GRB7;TBX1;ADAM8;AKT3;ENDOG;MAML3;FZD8;WASL;LRP6;TMEM173;HPSE;DEDD2;KAT2B;FAM162A;ANKRD6;RB1CC1;TRIM38;FADD
1503,GO:0003857,0.0211973308546855,0.997690037595612,3,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,CRYL1;HADH;HSD17B12
12685,GO:0050900,0.0212331632051982,0.987608936458909,28,225,leukocyte migration,BP,PGF;ITGA6;MMP1;SLC16A3;FYN;SDC1;SHC1;RAC2;CD44;ITGA1;EPCAM;ITGA2;CEACAM1;BSG;MMP14;MOSPD2;F2RL1;PROCR;RET;C5;COL1A2;GRB7;SLC7A11;ADAM8;ITGA4;CKLF;WASL;FADD
4033,GO:0009065,0.0213019838554724,0.995423760678538,5,20,glutamine family amino acid catabolic process,BP,NOS1;GLUL;ARG2;GLUD1;ALDH4A1
5071,GO:0015294,0.0214198971129549,0.992001444620594,10,53,solute:cation symporter activity,MF,SLC33A1;SLC5A1;SLC2A9;SLC6A6;SLC6A14;SLC12A7;SLC13A3;SLC2A13;SLC10A6;SLC23A2
2604,GO:0005902,0.0215364762560631,0.992433974610872,9,48,microvillus,CC,BBS2;RAPGEF3;KIF13B;PODXL;ESPN;CD44;CEACAM1;SYTL1;ATP6V1B2
7818,GO:0032371,0.021539244558915,0.994471675613324,6,26,regulation of sterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PPARG;PTCH1
7821,GO:0032374,0.021539244558915,0.994471675613324,6,26,regulation of cholesterol transport,BP,APOE;LRP1;ABCA7;ABCG1;PPARG;PTCH1
19499,GO:1990351,0.0216231896421039,0.989173885753355,18,120,transporter complex,CC,NOS1;SCN8A;KCNG1;DLG1;DLG4;DLG3;SHANK2;FKBP1A;AKAP9;ABCA7;VAMP2;TTYH3;ANO1;GRIN3B;ABHD6;PRKACA;ATP12A;HSPA2
15893,GO:0072657,0.0216402449908319,0.985507598977174,48,452,protein localization to membrane,BP,ZMYND8;ETV5;SYNE3;PRNP;BBS2;SSH1;EGFR;ANK3;FYN;TSPAN5;DLG1;DLG4;TTC7B;GDI1;CEMIP;STOM;DLG3;PAK1;APOE;LRP1;TUB;VAMP2;RAB31;BSG;DVL1;NLGN2;COX18;SEC63;ZDHHC2;CSNK2A1;FCHO2;BCL2L1;GRIN3B;SH3PXD2B;TMBIM1;ZDHHC1;EPB41L3;AP3D1;MOAP1;LAMA5;EFCAB7;LYPLA1;ITGA4;SSR3;LRP6;SSR1;PTCH1;LRP4
3555,GO:0007595,0.0216778561747097,0.993668095247175,7,32,lactation,BP,XDH;CCND1;NEURL1;APLN;SOCS2;ATP7B;XBP1
8771,GO:0034447,0.0216947924050625,0.999059624550361,2,4,very-low-density lipoprotein particle clearance,BP,VLDLR;APOE
3521,GO:0007494,0.0217386230434191,0.997842421717259,3,7,midgut development,BP,EGFR;RET;ALDH1A2
3527,GO:0007501,0.0218277596369171,0.999321526059505,2,3,mesodermal cell fate specification,BP,DKK1;FGFR1
10127,GO:0042661,0.0218277596369171,0.999321526059505,2,3,regulation of mesodermal cell fate specification,BP,DKK1;FGFR1
19356,GO:1905770,0.0218277596369171,0.999321526059505,2,3,regulation of mesodermal cell differentiation,BP,DKK1;FGFR1
19394,GO:1905902,0.0218277596369171,0.999321526059505,2,3,regulation of mesoderm formation,BP,DKK1;FGFR1
18920,GO:1904645,0.021862025704236,0.995363357049742,5,18,response to amyloid-beta,BP,PRNP;FYN;LRP1;CASP4;NGFR
8194,GO:0032934,0.0219402221318647,0.99355138267443,7,33,sterol binding,MF,OSBP2;OSBPL10;APOE;ABCG1;ANXA6;OSBPL5;PTCH1
710,GO:0001935,0.0219701163827611,0.990098761081234,14,89,endothelial cell proliferation,BP,XDH;PGF;APLN;DLG1;PLXNB3;APOE;FGFR1;MMP14;NGFR;XBP1;LOXL2;PPARG;ALDH1A2;AKT3
3559,GO:0007599,0.0220053470475513,0.987255679806876,27,216,hemostasis,BP,PLAT;F2R;SERPINE2;TFPI2;DGKA;FYN;SERPING1;RAC2;APOE;PRKACB;ITGA2;ITPR3;CEACAM1;LMAN1;RCOR1;DOCK9;F2RL1;PROCR;PRKAR1A;UBASH3B;DOCK11;COL1A2;PRKACA;ITPR2;SLC7A11;PHF21A;HPSE
9202,GO:0035584,0.022059762355745,0.997479711457454,3,10,calcium-mediated signaling using intracellular calcium source,BP,PRNP;ADGRL1;PRKACA
17200,GO:0106027,0.0221201913767601,0.991710173064506,10,52,neuron projection organization,BP,ZMYND8;PRNP;FYN;DLG4;WNT7A;SHANK2;APOE;DVL1;WASL;EEF2K
1495,GO:0003839,0.0221463588690397,0.999029261183998,2,4,gamma-glutamylcyclotransferase activity,MF,CHAC1;GGACT
3536,GO:0007528,0.0221670746254168,0.993579541576678,7,29,neuromuscular junction development,BP,F2R;ETV5;ANK3;SHANK2;DVL1;LAMB2;LRP4
7052,GO:0030826,0.0221935967833627,0.997641011232902,3,8,regulation of cGMP biosynthetic process,BP,NOS1;APOE;ADNP
3560,GO:0007600,0.0222379858834684,0.987122998452433,27,209,sensory perception,BP,F2R;SERPINE2;BBS2;FYN;ESPN;CEMIP;SLITRK6;FGFR1;TUB;ITGA2;ITPR3;NTSR1;NLGN2;RABGGTA;ALDH7A1;CHD7;ANO1;NIPSNAP1;SPRY2;MGLL;NR2F6;LAMB2;ZNF354A;TBL1X;TBX1;WFS1;REEP6
9065,GO:0035296,0.0224221728819311,0.991025260930175,11,66,regulation of tube diameter,BP,DOCK4;NOS1;F2R;BBS2;APLN;EGFR;HTR7;EDNRA;APOE;ITGA1;F2RL1
16734,GO:0097746,0.0224221728819311,0.991025260930175,11,66,regulation of blood vessel diameter,BP,DOCK4;NOS1;F2R;BBS2;APLN;EGFR;HTR7;EDNRA;APOE;ITGA1;F2RL1
16090,GO:0090066,0.0224297966282706,0.985576468397885,40,327,regulation of anatomical structure size,BP,DOCK4;NOS1;F2R;RAB3B;BBS2;APLN;SSH1;MAP1B;PTPRS;WIPF1;EGFR;SEMA4B;DLG1;WNT7A;HTR7;GDI1;PAK1;EDNRA;RAC2;APOE;LPAR3;ITGA1;TMOD2;ULK2;PFN2;CLCN3;TWF2;F2RL1;JMY;SLC12A7;SPIRE1;RET;NCKAP1;TMSB4X;ARPC1A;AKT3;WASL;SEMA3F;ADNP;RB1CC1
480,GO:0001525,0.0224499785057533,0.985570848590118,40,320,angiogenesis,BP,PGF;SH2D2A;ADM2;NFATC4;THBS2;RAPGEF3;ARHGAP22;APLN;ELK3;WNT7A;SHC1;TGFBR2;EDNRA;EPHA1;ANGPTL4;ANXA3;HMGA2;FGFR1;HYAL1;CEACAM1;EPN2;MMP14;ADGRB2;RASIP1;SPRY2;NGFR;WASF2;XBP1;LOXL2;C5;HOXA3;LAMA5;PPARG;SRPX2;TBX1;ADAM8;AKT3;FZD8;E2F7;HPSE
11970,GO:0047192,0.0224703491328232,0.999290344801639,2,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,LPCAT4;LPCAT1
7540,GO:0031802,0.0225370074790261,0.999287080972197,2,3,type 5 metabotropic glutamate receptor binding,MF,PRNP;FYN
19756,GO:2000147,0.0225384554179344,0.985586284113648,39,319,positive regulation of cell motility,BP,DOCK4;SMURF2;F2R;PGF;ITGA6;POSTN;SSH1;LAMB1;EGFR;SEMA4B;PODXL;WNT7A;CEMIP;PAK1;TGFBR2;EPHA1;RAC2;ANXA3;FGFR1;HYAL1;ITGA2;FAM110C;MMP14;MOSPD2;F2RL1;SPRY2;ACVR1B;XBP1;RET;TMSB4X;LPAR1;GRB7;SRPX2;ADAM8;AKT3;ITGA4;FOXP1;SEMA3F;FADD
12244,GO:0048518,0.0225415075443317,0.980912999303348,363,3892,positive regulation of biological process,BP,TNIP1;DOCK4;FHL1;XDH;SMURF2;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;ITGA6;MMP1;RPS6KA2;CYP27B1;SERPINE2;ADCY7;IGFBP4;PRNP;PAG1;ADGRF1;ACTA2;BBS2;MARCKSL1;POSTN;ADM2;NR1D1;HECW2;NFATC4;ADARB1;MAP2K1;THBS2;FAM210B;ETV4;RAPGEF3;ACVR2B;ALOX15B;SALL2;PKN1;WWTR1;PEG3;MST1R;APLN;POU2F2;TRIM65;TEF;TNFSF15;EIF4EBP1;SSH1;MAP1B;PC;DDIT3;PTPRS;SMARCA1;SOX12;PSMD2;LAMB1;ELK3;CRTC1;ADGRL1;WIPF1;EGFR;STK39;SEMA4B;ANK3;FYN;TSPAN5;BNIP3;HLTF;ERCC6;MAPK13;ARAP1;ZNF516;DLG1;DLG4;CTSB;PLXNB3;SNX9;PODXL;NET1;TGM2;ESPN;GLUL;HTRA1;WNT7A;MAP4K4;SPTLC2;GRK5;STRADB;ASPH;GDI1;CEMIP;SDC1;ARG2;STOM;SHC1;DLG3;DKK1;DAP;SMOC2;PAK1;SOCS2;TRIB2;RAG1;TGFBR2;SERPING1;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;OBSCN;APOE;FKBP1A;BNIP3L;CCPG1;CCND2;ANGPTL4;RGS14;PKD2;PRKACB;RBCK1;LRP1;LDHA;FYCO1;IDE;AKAP9;RAB11FIP4;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;LPAR3;ASNS;FGFR1;ITGA1;E2F5;EPCAM;TMOD2;TUB;NFAT5;HYAL1;BTRC;LPCAT1;ITGA2;PTK6;VAMP2;INPP5F;ATRX;FAM20C;CHURC1;PFN2;ABCG1;SOX4;FHOD1;ITPR3;DDB2;CEP120;CEACAM1;FERMT1;MAPKAPK3;OBSL1;LMAN1;ATF7IP;FAM110C;SH3D19;EPN2;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;PLEK2;NLGN2;CD46;MVB12B;CTH;LRP5;ETAA1;ABHD17C;CTSL;TWF2;CST3;CNTN1;TRIB3;CLTCL1;CASP4;TPBG;VPS11;MOSPD2;WASF3;RIMS3;ZNF322;PPP3CB;RFX2;ADGRB2;SLK;MLYCD;CEBPG;PLAG1;FNBP1L;F2RL1;DDX60;UHRF2;TAOK1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;ASAP1;PRKAR1A;ANO1;JMY;BOK;PARP9;C18ORF32;NACC2;SPRY2;THRA;WNT2B;ACVR1B;NGFR;PPP1R10;MVB12A;GLUD1;MARK4;CHD6;MTA1;AZIN2;BCL2L1;IFITM1;RNF165;YTHDC2;MEF2D;WASF2;SKAP2;ARF4;XBP1;SPIRE1;MAP2K2;ABHD6;PAIP1;ANKIB1;TRPC1;RET;CCDC71L;LOXL2;PDE5A;SH3PXD2B;C5;NOP10;NCKAP1;EPM2A;RMRP;DOCK11;PAK6;EAPP;PUM2;RNF135;TMBIM1;ETV1;CCDC88A;TMED4;SHC2;PRKACA;ZNF398;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;IL1RAP;ORAI1;CARD11;LPAR1;CTSZ;TBL1X;HOXA3;AP3D1;ARID4A;ARPC1A;TENM2;IGF2;MOAP1;AGPAT1;GRB10;MAP4K2;EFCAB7;PPARG;CITED4;GRB7;SRPX2;ALDH1A2;TBX1;CREB3L2;RPH3AL;RSF1;ADAM8;AKT3;IL20RB;WFS1;ENDOG;ITGA4;MAML3;DDHD2;FZD8;WASL;HSPA2;PRSS8;LRP6;ARID5B;MAGEF1;SYT2;TMEM173;RNF180;E2F7;EEF2K;HPSE;SSR1;TNRC6C;TET1;ARMCX3;DEDD2;DNAJC3;FOXP1;PSEN2;HSD17B12;PTCH1;ADCY1;KAT2B;CNOT11;UFL1;FAM162A;ANKRD6;PBX3;JARID2;SEMA3F;ADNP;GNAI1;LRP4;RB1CC1;DNMT3A;TRIM38;FBXL5;FADD
18624,GO:1903911,0.0225462656861138,0.999286627223977,2,3,positive regulation of receptor clustering,BP,SSH1;LRP4
6052,GO:0019199,0.0225538027876361,0.991550918511929,10,50,transmembrane receptor protein kinase activity,MF,ACVR2B;LTBP1;MST1R;EGFR;TGFBR2;EPHA1;FGFR1;LTBP4;ACVR1B;RET
12616,GO:0050798,0.0228362633423132,0.993972708503719,6,29,activated T cell proliferation,BP,PRNP;FYN;PRKAR1A;SATB1;IGF2;FADD
4505,GO:0010544,0.0228598481352987,0.996132744129239,4,14,negative regulation of platelet activation,BP,SERPINE2;APOE;CEACAM1;UBASH3B
7612,GO:0031998,0.0228756968244296,0.996381842714359,4,11,regulation of fatty acid beta-oxidation,BP,TYSND1;PPARA;LONP2;MLYCD
4030,GO:0009062,0.022978497850077,0.989893471591306,13,88,fatty acid catabolic process,BP,PCK2;HADH;TYSND1;ACAD11;ABCD1;PPARA;AIG1;LONP2;ACAD10;MLYCD;CPT2;CRAT;AMACR
752,GO:0001991,0.0230232495819346,0.997517577196921,3,8,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,F2R;F2RL1;CTSZ
3066,GO:0006629,0.0230343005787775,0.982532628677385,99,976,lipid metabolic process,BP,SORL1;MBOAT2;PCK2;VLDLR;CYGB;CYP27B1;CRYL1;NR1D1;ALOX15B;LMF1;DGKA;PC;B4GALT6;HADH;LTA4H;EGFR;FYN;OSBPL10;ELOVL1;ISYNA1;ACOT1;GPC4;TYSND1;ACSF2;SPTLC2;ACOT7;TTC7B;RDH14;ACAD11;SDC1;CBR4;PLPP6;APOE;ABCD1;ANGPTL4;LRP1;ST3GAL5;PPARA;PIGH;AGPAT4;FGFR1;LPCAT4;LPCAT1;AIG1;LONP2;INPP5F;ABCG1;PITPNM1;IAH1;KDSR;CEACAM1;PLA2G4D;ACAD10;LRP5;TMEM86B;TRIB3;PLPPR2;INPP4A;MLYCD;PLD3;ABHD15;CSNK2A1;CPT2;CRLS1;THRA;MGLL;CRAT;AGPAT3;GLB1;HSD17B7;XBP1;ABHD6;CCDC71L;OSBPL5;MTMR4;MBOAT7;SAMD8;SEL1L;SRD5A3;TBL1X;ACP6;AGPAT1;PPARG;PTGR2;ALDH1A2;LYPLA1;ESYT3;IGFBP7;DDHD2;PLCXD1;PLCH2;COQ2;ZFYVE21;ELOVL4;HSD17B12;CDS2;AMACR;SLC44A1;ALAS1
9325,GO:0035799,0.0230444001353189,0.999262058051763,2,3,ureter maturation,BP,RET;ALDH1A2
18474,GO:1903573,0.0230588733775402,0.993085256838676,7,36,negative regulation of response to endoplasmic reticulum stress,BP,UBE2J1;DNAJB9;XBP1;ERLEC1;WFS1;DNAJC3;USP25
4669,GO:0010817,0.0230665079505021,0.985705142420062,34,280,regulation of hormone levels,BP,PCK2;CYP27B1;NR1D1;RAPGEF3;ACVR2B;APLN;HADH;EGFR;SLCO4A1;GLUL;MAP4K4;RDH14;ERO1B;IDE;ICA1;FGFR1;LTBP4;SOX4;ITPR3;NLGN2;LRP5;PCSK6;PPP3CB;CHD7;SLC25A4;ANO1;GLUD1;HSD17B7;RAB1A;SRD5A3;CTSZ;ITPR2;ALDH1A2;HSD17B12
4223,GO:0009397,0.0231885729303251,0.999254890362551,2,3,folic acid-containing compound catabolic process,BP,ALDH1L2;PM20D2
10068,GO:0042560,0.0231885729303251,0.999254890362551,2,3,pteridine-containing compound catabolic process,BP,ALDH1L2;PM20D2
3582,GO:0007626,0.0231901447397733,0.988859518255071,16,101,locomotory behavior,BP,ETV5;DLG4;ESPN;SLITRK6;APOE;CCND2;INPP5F;VPS13A;NTSR1;NLGN2;PPP3CB;CHD7;MTA1;DDHD2;SLC18A2;PBX3
13723,GO:0060291,0.0232746197845891,0.99237381393598,8,39,long-term synaptic potentiation,BP,SERPINE2;PRNP;CRTC1;SHANK2;APOE;RGS14;VAMP2;ITPR3
10504,GO:0043406,0.0233006758729276,0.986613629943093,26,196,positive regulation of MAP kinase activity,BP,F2R;MAP2K1;PKN1;MST1R;EGFR;STK39;ERCC6;MAP4K4;SHC1;DKK1;PAK1;LPAR3;FGFR1;ITGA1;MAPKAPK3;TAOK1;MAP2K2;PDE5A;C5;SHC2;EIF2AK2;LPAR1;IGF2;MAP4K2;ADAM8;FZD8
12368,GO:0048752,0.0233036993193216,0.999249148523246,2,3,semicircular canal morphogenesis,BP,CHD7;TBX1
2675,GO:0006027,0.0234240419172102,0.992275782191226,8,41,glycosaminoglycan catabolic process,BP,GPC4;CEMIP;SDC1;CD44;HYAL1;GLB1;HPSE;GALNS
11565,GO:0046110,0.0234383514936576,0.999242412364595,2,3,xanthine metabolic process,BP,XDH;AOX1
19698,GO:2000026,0.023540110091784,0.981511555544188,132,1276,regulation of multicellular organismal development,BP,XDH;SMURF2;NOS1;ZMYND8;SORL1;ETV5;PGF;CCND1;NEURL1;CTNNBIP1;VLDLR;CYP27B1;SERPINE2;ADM2;HECW2;NFATC4;MAP2K1;THBS2;FAM210B;RAPGEF3;ACVR2B;ALOX15B;WWTR1;SSH1;MAP1B;DDIT3;PTPRS;PSMD2;CRTC1;ADGRL1;EGFR;SEMA4B;FYN;KIF13B;ADAMTS7;DLG1;CSMD3;DLG4;IDH2;PLXNB3;GPC4;WNT7A;MAP4K4;GDI1;DKK1;PAK1;SOCS2;RAG1;TGFBR2;SHANK2;SLITRK6;EPHA1;IMPACT;APOE;ANGPTL4;RGS14;PRKACB;LRP1;ANXA3;HMGA2;LPAR3;FGFR1;HYAL1;PTK6;ULK2;INPP5F;FAM20C;KIAA1109;CEACAM1;FERMT1;OBSL1;EPN2;TNRC6B;DVL1;MMP14;NLGN2;CD46;CTH;CTSL;TWF2;CNTN1;TPBG;WASF3;ADGRB2;PLAG1;PSMD7;PTHLH;CHD7;ASAP1;SPRY2;WNT2B;ACVR1B;NGFR;PTPRZ1;XBP1;UBASH3B;RET;LOXL2;SH3PXD2B;C5;CCDC88A;CCSAP;TIMP2;EIF2AK2;AP2A2;IL1RAP;CARD11;LPAR1;CTSZ;AP3D1;LAMA5;PPARG;SRPX2;TBX1;ADAM8;AKT3;LRP6;SYT2;EEF2K;HPSE;TNRC6C;OMG;FOXP1;PTCH1;KAT2B;UFL1;ANKRD6;JARID2;SEMA3F;ADNP;LRP4;FADD
4357,GO:0009953,0.0235518139135727,0.9915948962798,9,48,dorsal/ventral pattern formation,BP,DDIT3;WNT7A;PRKACB;MDFI;LRP5;TCTN1;LRP6;PTCH1;LRP4
1168,GO:0002791,0.0236187472093131,0.98544770576353,33,271,regulation of peptide secretion,BP,F2R;PCK2;POSTN;NR1D1;RAPGEF3;ALOX15B;APLN;HADH;EGFR;IDH2;GLUL;MAP4K4;ARG2;ICA1;SOX4;ITPR3;FERMT1;NLGN2;LRP5;PPP3CB;F2RL1;CHD7;SLC25A4;ANO1;GLUD1;XBP1;C5;TMSB4X;IL1RAP;ITPR2;RPH3AL;ADAM8;FOXP1
4788,GO:0010977,0.0237038394587802,0.988569829481312,16,103,negative regulation of neuron projection development,BP,NFATC4;PTPRS;SEMA4B;MAP4K4;GDI1;APOE;LRP1;ULK2;INPP5F;ASAP1;NGFR;LPAR1;CTSZ;OMG;SEMA3F;LRP4
15594,GO:0072073,0.0237816942073636,0.988869889199304,15,91,kidney epithelium development,BP,PGF;CTNNBIP1;WWTR1;DLG1;PODXL;SDC1;ARG2;PKD2;FGFR1;EPCAM;WNT2B;RET;LAMB2;LAMA5;PTCH1
4363,GO:0009967,0.0238239221358367,0.981687183652926,109,1065,positive regulation of signal transduction,BP,XDH;SMURF2;NOS1;F2R;NEURL1;SH2D2A;CYP27B1;IGFBP4;PAG1;NFATC4;MAP2K1;ACVR2B;ALOX15B;PKN1;MST1R;TNFSF15;SSH1;DDIT3;PSMD2;EGFR;STK39;FYN;TSPAN5;BNIP3;ERCC6;ARAP1;DLG4;TGM2;WNT7A;MAP4K4;SHC1;DKK1;PAK1;SOCS2;SHANK2;EPHA1;CD44;FKBP1A;PKD2;RBCK1;ABCA7;LPAR3;FGFR1;ITGA1;TMOD2;PTK6;SOX4;FERMT1;MAPKAPK3;FAM110C;EPN2;TRIM5;DVL1;NTSR1;NLGN2;CTH;CASP4;F2RL1;DDX60;TAOK1;CSNK2A1;PSMD7;BOK;PARP9;C18ORF32;NACC2;SPRY2;WNT2B;ACVR1B;NGFR;BCL2L1;RNF165;SKAP2;XBP1;MAP2K2;RET;PDE5A;C5;PUM2;TMED4;SHC2;NEK6;RGL2;TIMP2;EIF2AK2;SLC39A10;CARD11;LPAR1;TBL1X;IGF2;MOAP1;AGPAT1;GRB10;MAP4K2;GRB7;TBX1;ADAM8;AKT3;MAML3;FZD8;LRP6;HPSE;DEDD2;KAT2B;FAM162A;ANKRD6;RB1CC1;TRIM38;FADD
11876,GO:0046883,0.0238966277948223,0.987381742709127,20,144,regulation of hormone secretion,BP,PCK2;NR1D1;RAPGEF3;APLN;HADH;EGFR;GLUL;MAP4K4;ICA1;FGFR1;SOX4;ITPR3;NLGN2;LRP5;PPP3CB;CHD7;SLC25A4;ANO1;GLUD1;ITPR2
18858,GO:1904491,0.0238986680718317,0.998908166667894,2,4,protein localization to ciliary transition zone,BP,TCTN1;TMEM107
12226,GO:0048483,0.0239097051655178,0.993787966968439,6,24,autonomic nervous system development,BP,ADARB1;EDNRA;SOX4;RET;TBX1;SEMA3F
3190,GO:0006813,0.0240260770912648,0.988712472407593,15,95,potassium ion transport,BP,FHL1;NOS1;PRNP;KCNG1;STK39;ANK3;DLG1;SLC9A7;PKD2;AKAP9;ATF4;VAMP2;SLC12A7;KCNJ15;ATP12A
7672,GO:0032101,0.0241588144829876,0.983655980888235,49,437,regulation of response to external stimulus,BP,TNIP1;NT5E;PLAT;F2R;PGF;CYP27B1;SERPINE2;BBS2;MAP2K1;FNDC4;PTPRS;EGFR;STK39;SEMA4B;MAPK13;TGM2;HTRA1;ARG2;TGFBR2;SERPING1;RAC2;APOE;ACP5;PPARA;FGFR1;ITGA2;INPP5F;CEACAM1;TRIM5;DVL1;CD46;CASP4;MOSPD2;F2RL1;DDX60;PARP9;MGLL;UBASH3B;C5;PUM2;TMSB4X;LPAR1;PPARG;ADAM8;IL20RB;TMEM173;HPSE;FOXP1;SEMA3F
14891,GO:0070679,0.0241592927303729,0.997720848078844,3,6,inositol 1,4,5 trisphosphate binding,MF,ITPR3;TRPC1;ITPR2
17336,GO:1900006,0.0241807575480048,0.990803854601541,10,52,positive regulation of dendrite development,BP,ZMYND8;NEURL1;VLDLR;CRTC1;SHANK2;APOE;OBSL1;IL1RAP;LPAR1;EEF2K
2297,GO:0005262,0.0241992037170336,0.990811634436023,10,51,calcium channel activity,MF,DENND5B;RASA3;PKD2;FAM155B;ITPR3;ORAI3;GRIN3B;TRPC1;ORAI1;ITPR2
2328,GO:0005343,0.0242619150171812,0.995893116660664,4,13,organic acid:sodium symporter activity,MF,SLC6A6;SLC13A3;SLC10A6;SLC23A2
5319,GO:0016042,0.0245090729709523,0.985983523936933,25,203,lipid catabolic process,BP,PCK2;CYP27B1;HADH;TYSND1;ACAD11;APOE;ABCD1;PPARA;AIG1;LONP2;INPP5F;IAH1;PLA2G4D;ACAD10;MLYCD;PLD3;CPT2;THRA;MGLL;CRAT;ABHD6;SRD5A3;DDHD2;PLCH2;AMACR
6681,GO:0030046,0.0246310403614523,0.999181789241487,2,3,parallel actin filament bundle assembly,BP,ESPN;SPIRE1
13608,GO:0060078,0.0246734015815195,0.991121903122931,9,48,regulation of postsynaptic membrane potential,BP,ZMYND8;SSH1;DLG4;WNT7A;SHANK2;DVL1;NTSR1;NLGN2;GRIN3B
986,GO:0002443,0.0249734573016412,0.982788456706814,53,501,leukocyte mediated immunity,BP,ERCC1;PYGL;PYGB;PRSS3;NAPRT;POU2F2;PSMD2;LTA4H;PGM1;DLG1;CTSB;CD68;STOM;SERPING1;SLC2A3;LCN2;RAC2;CD44;ANXA3;LPCAT1;VAMP2;CEACAM1;RAB31;CD46;CST3;MOSPD2;PPP3CB;COPB1;CEBPG;F2RL1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;C5;DNASE1L1;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;IL20RB;ATP11B;TMEM173;HPSE;GALNS;DNAJC3;FADD
11341,GO:0045664,0.0249904247632816,0.983018894890739,50,411,regulation of neuron differentiation,BP,ZMYND8;ETV5;NEURL1;VLDLR;HECW2;NFATC4;MAP2K1;SSH1;MAP1B;PTPRS;CRTC1;SEMA4B;FYN;KIF13B;CSMD3;DLG4;PLXNB3;WNT7A;MAP4K4;GDI1;DKK1;PAK1;SOCS2;SHANK2;IMPACT;APOE;LRP1;LPAR3;FGFR1;PTK6;ULK2;INPP5F;OBSL1;DVL1;TWF2;CNTN1;ASAP1;NGFR;RET;CCDC88A;TIMP2;IL1RAP;LPAR1;CTSZ;SYT2;EEF2K;OMG;SEMA3F;ADNP;LRP4
11058,GO:0045055,0.0250825380870012,0.982594518562445,55,510,regulated exocytosis,BP,PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;SNPH;PGM1;CTSB;CD68;STOM;SERPING1;SLC2A3;LCN2;RAC2;CD44;ANXA3;LPCAT1;VAMP2;PFN2;CEACAM1;RAB31;CST3;MOSPD2;RIMS3;PPP3CB;SYTL1;APLP2;COPB1;F2RL1;C6ORF120;PSMD7;QSOX1;SEPT5;GLB1;YPEL5;DNASE1L1;TMBIM1;TMSB4X;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;IGF2;TMEM63A;ERP44;RPH3AL;ADAM8;ATP11B;SYT2;TMEM173;HPSE;GALNS;DNAJC3
15744,GO:0072320,0.0251306194171046,0.99915588957731,2,3,volume-sensitive chloride channel activity,MF,CLCN3;TTYH3
5721,GO:0016860,0.0251563871370342,0.992238679047069,7,40,intramolecular oxidoreductase activity,MF,HYI;ERO1B;TMX4;PDIA5;QSOX1;TXNDC11;ERP44
14719,GO:0070365,0.0251787371817064,0.997188432788925,3,8,hepatocyte differentiation,BP,PCK2;ITGA2;E2F7
794,GO:0002062,0.025215859416402,0.989781331665225,11,61,chondrocyte differentiation,BP,ADAMTS7;WNT7A;TGFBR2;HMGA2;FGFR1;MEX3C;PTHLH;WNT2B;MEF2D;LOXL2;CREB3L2
5313,GO:0016024,0.0253892220267678,0.99564054223262,4,13,CDP-diacylglycerol biosynthetic process,BP,AGPAT4;AGPAT3;AGPAT1;CDS2
12771,GO:0051046,0.0254826767734872,0.982776437816971,48,423,regulation of secretion,BP,F2R;RAB3B;PCK2;POSTN;NR1D1;RAPGEF3;ALOX15B;APLN;HADH;EGFR;STK39;IDH2;GLUL;MAP4K4;MCTP1;SDC1;ARG2;RAC2;ICA1;FGFR1;VAMP2;PFN2;SOX4;ITPR3;CEACAM1;FERMT1;NTSR1;NLGN2;LRP5;RIMS3;PPP3CB;SYTL1;F2RL1;CHD7;SLC25A4;ANO1;SEPT5;GLUD1;XBP1;C5;SLC30A1;TMSB4X;IL1RAP;ITPR2;RPH3AL;ADAM8;SYT2;FOXP1
18233,GO:1903037,0.0255276486275993,0.985940371580038,22,171,regulation of leukocyte cell-cell adhesion,BP,PRNP;PAG1;FYN;DLG1;ARG2;PAK1;RAG1;TGFBR2;CD44;PPARA;CEACAM1;CD46;PRKAR1A;XBP1;PDE5A;CARD11;AP3D1;IGF2;ADAM8;IL20RB;ITGA4;FADD
10592,GO:0043558,0.0256690279912786,0.995497315490884,4,14,regulation of translational initiation in response to stress,BP,IMPACT;ATF4;EIF2AK2;DNAJC3
18203,GO:1902991,0.0258195045861679,0.994163784472822,5,20,regulation of amyloid precursor protein catabolic process,BP,SORL1;PRNP;APOE;FKBP1A;ABCA7
6806,GO:0030252,0.0258814672893148,0.997248838646492,3,7,growth hormone secretion,BP,LTBP4;CHD7;RAB1A
19023,GO:1904861,0.0259352051694273,0.997240863530987,3,7,excitatory synapse assembly,BP,WNT7A;SHANK2;NLGN2
13533,GO:0055114,0.0259547151927139,0.981159947665479,70,717,oxidation-reduction process,BP,XDH;NOS1;PCK2;PYGL;CBS;CYGB;CYP27B1;PYGB;CRYL1;NR1D1;NFATC4;ALOX15B;GPX3;H6PD;DHTKD1;HADH;LOXL1;BNIP3;PGM1;IDH2;TYSND1;RSAD1;RDH14;ASPH;ACAD11;CBR4;ERO1B;ABCD1;ALDH1L2;LDHA;PPARA;TMX4;LONP2;MTHFR;KDSR;PDIA5;ACAD10;GFPT1;HIBADH;PRDX5;MLYCD;ALDH7A1;QSOX1;NDUFV3;CPT2;MSRB2;DHRS12;NDUFA4L2;GLUD1;CRAT;HSD17B7;PCYOX1;TXNRD3;PPP1R2;CYP4F22;SDR9C7;LOXL2;SH3PXD2B;SRD5A3;BLVRA;IGF2;PPARG;PTGR2;ALDH1A2;ALDH4A1;TET1;AOX1;HSD17B12;AMACR;RB1CC1
9868,GO:0042127,0.0259720542835087,0.980051808279872,105,1033,regulation of cell proliferation,BP,XDH;F2R;ETV5;PGF;CCND1;NEURL1;CTNNBIP1;RPS6KA2;CYP27B1;SERPINE2;PRNP;MARCKSL1;NR1D1;ADARB1;MAP2K1;ALOX15B;PKN1;WWTR1;MST1R;APLN;LAMB1;EGFR;CGREF1;FYN;TNFRSF6B;DLG1;IDH2;PLXNB3;TGM2;GLUL;HTRA1;WNT7A;GRK5;ASPH;ARG2;SHC1;DLG3;PAK1;TGFBR2;EPHA1;RAC2;APOE;CCPG1;CCND2;PKD2;HMGA2;FGFR1;ITGA1;EPCAM;TCFL5;HYAL1;ITGA2;PTK6;SOX4;FBXO2;CEACAM1;FERMT1;CD46;LRP5;CST3;PLAG1;CSNK2A1;PTHLH;PRKAR1A;BOK;NACC2;SPRY2;BEX4;NGFR;PTPRZ1;BCL2L1;IFITM1;MEF2D;SKAP2;XBP1;PDE5A;C1ORF56;EAPP;CCDC88A;TIMP2;EIF2AK2;SLC39A10;CARD11;CTSZ;HOXA3;IGF2;LAMA5;PPARG;ALDH1A2;TBX1;AKT3;IL20RB;IGFBP7;LRP6;E2F7;HPSE;SSR1;TET1;FOXP1;PTCH1;KAT2B;UFL1;JARID2;MXD4;FADD
20284,GO:2001257,0.0262112328590261,0.988333155904624,13,79,regulation of cation channel activity,BP,NOS1;KCNG1;ANK3;DLG1;DLG4;STOM;SHANK2;FKBP1A;PKD2;VAMP2;NTSR1;NLGN2;PRKACA
15746,GO:0072329,0.0263240140043759,0.987777180537872,14,99,monocarboxylic acid catabolic process,BP,PCK2;CRYL1;HADH;TYSND1;ACAD11;ABCD1;PPARA;AIG1;LONP2;ACAD10;MLYCD;CPT2;CRAT;AMACR
426,GO:0001133,0.0265163768873231,0.995384244951399,4,13,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,NR1D1;PPARA;THRA;PPARG
10736,GO:0044092,0.0266719061077083,0.980305475933781,78,751,negative regulation of molecular function,BP,NOS1;SORL1;CTNNBIP1;CYP27B1;SERPINE2;PRNP;HECW2;NFATC4;ADARB1;TFPI2;PKN1;WWTR1;DDIT3;STK39;ANK3;PPP1R14A;TNFRSF6B;PLXNB3;TTBK2;DLG3;DKK1;DAP;SOCS2;TRIB2;RAG1;SERPING1;EPHA1;CD44;APOE;FKBP1A;ANGPTL4;RGS14;PKD2;RBCK1;AKAP9;ANXA3;HMGA2;PPARA;ELFN2;PPP1R35;BTRC;PTK6;CEACAM1;MDFI;DVL1;LRP5;CST3;TRIB3;APLP2;PRDX5;CEBPG;CSNK2A1;PRKAR1A;PARP9;SPRY2;THRA;NGFR;PPP1R10;UBASH3B;PPP1R2;C5;TMBIM1;TMSB4X;TIMP2;IFI16;FICD;CTSZ;PPARG;SNX6;RSF1;WFS1;ITGA4;LRP6;DNAJC3;PTCH1;KAT2B;UFL1;ADNP
812,GO:0002084,0.0267596719638422,0.996807062284488,3,9,protein depalmitoylation,BP,ABHD17C;LYPLAL1;LYPLA1
1104,GO:0002693,0.0268023521537163,0.99693269739278,3,8,positive regulation of cellular extravasation,BP,ADAM8;ITGA4;FADD
13609,GO:0060079,0.026933506957016,0.990856160912999,8,42,excitatory postsynaptic potential,BP,ZMYND8;SSH1;DLG4;WNT7A;SHANK2;DVL1;NLGN2;GRIN3B
12716,GO:0050951,0.0269439977690586,0.996910076765109,3,8,sensory perception of temperature stimulus,BP,NTSR1;ANO1;NR2F6
6763,GO:0030195,0.0270197040644866,0.992554334675419,6,30,negative regulation of blood coagulation,BP,PLAT;SERPINE2;SERPING1;APOE;CEACAM1;UBASH3B
17359,GO:1900047,0.0270197040644866,0.992554334675419,6,30,negative regulation of hemostasis,BP,PLAT;SERPINE2;SERPING1;APOE;CEACAM1;UBASH3B
8735,GO:0034382,0.0270270154794241,0.998679414655678,2,4,chylomicron remnant clearance,BP,LMF1;APOE
15484,GO:0071830,0.0270270154794241,0.998679414655678,2,4,triglyceride-rich lipoprotein particle clearance,BP,LMF1;APOE
3922,GO:0008593,0.0270610534536592,0.988335085149024,12,74,regulation of Notch signaling pathway,BP,NEURL1;PEAR1;POSTN;EGFR;TSPAN5;CHAC1;EPN2;MMP14;CD46;ARRDC1;MAML3;KAT2B
16446,GO:0097106,0.0272187449915652,0.997048353653139,3,7,postsynaptic density organization,BP,ZMYND8;SHANK2;NLGN2
17001,GO:0099084,0.0272187449915652,0.997048353653139,3,7,postsynaptic specialization organization,BP,ZMYND8;SHANK2;NLGN2
1085,GO:0002673,0.0272997057694978,0.992459007158216,6,30,regulation of acute inflammatory response,BP,SERPING1;CD46;C5;PPARG;ADAM8;IL20RB
4760,GO:0010939,0.0273159951967052,0.993558262602489,5,24,regulation of necrotic cell death,BP,BNIP3;RBCK1;SLC25A4;BOK;FADD
14937,GO:0070820,0.0275502820083068,0.986745046352789,15,107,tertiary granule,CC,PRSS3;LTA4H;PGM1;STOM;SLC2A3;CEACAM1;CST3;COPB1;QSOX1;YPEL5;TIMP2;AP2A2;NIT2;TMEM63A;ADAM8
12519,GO:0050662,0.0276151932459269,0.983823234735746,26,220,coenzyme binding,MF,XDH;NOS1;PYGL;CBS;PYGB;CRYL1;GPT2;H6PD;DHTKD1;PC;HADH;IDH2;SPTLC2;ACOT7;ACAD11;CBR4;LDHA;MTHFR;ACAD10;CTH;HIBADH;GLUD1;NUDT6;TXNRD3;AOX1;ALAS1
16427,GO:0097062,0.0276523042675649,0.995122245504547,4,13,dendritic spine maintenance,BP,ZMYND8;PRNP;FYN;APOE
11140,GO:0045185,0.0277330942509365,0.987106571062062,14,89,maintenance of protein location,BP,SORL1;SYNE3;LTBP1;ANK3;PKD2;SOX4;VPS13A;MDFI;TWF2;THRA;TMSB4X;EPB41L3;KDELR3;FLNB
16211,GO:0090244,0.0278657578981313,0.999008899042545,2,3,Wnt signaling pathway involved in somitogenesis,BP,DKK1;LRP6
899,GO:0002278,0.0278833204211726,0.998614069857183,2,4,eosinophil activation involved in immune response,BP,VAMP2;F2RL1
990,GO:0002447,0.0278833204211726,0.998614069857183,2,4,eosinophil mediated immunity,BP,VAMP2;F2RL1
10451,GO:0043307,0.0278833204211726,0.998614069857183,2,4,eosinophil activation,BP,VAMP2;F2RL1
10452,GO:0043308,0.0278833204211726,0.998614069857183,2,4,eosinophil degranulation,BP,VAMP2;F2RL1
2177,GO:0005024,0.0279869888199411,0.996931296096833,3,7,transforming growth factor beta-activated receptor activity,MF,LTBP1;TGFBR2;LTBP4
12321,GO:0048671,0.0281726428366151,0.99899186716422,2,3,negative regulation of collateral sprouting,BP,PTPRS;ULK2
3451,GO:0007263,0.0281907194043956,0.99670887051165,3,8,nitric oxide mediated signal transduction,BP,NOS1;EGFR;APOE
12218,GO:0048408,0.0282012503455417,0.998589515733834,2,4,epidermal growth factor binding,MF,EGFR;SHC1
3195,GO:0006821,0.0282334291330403,0.990327118692013,8,42,chloride transport,BP,PRNP;CLCA2;CLCN3;TTYH3;ANO8;ANO1;SLC12A7;PCYOX1
15251,GO:0071417,0.0282808183232865,0.981023595150265,45,377,cellular response to organonitrogen compound,BP,NEURL1;PCK2;ADCY7;PRNP;RAPGEF3;EIF4EBP1;SSH1;CAPN2;EGFR;FYN;MAPK13;SHC1;PAK1;SOCS2;IMPACT;PKD2;PRKACB;LRP1;IDE;AKAP9;ATF4;UROS;VAMP2;CEACAM1;RAB31;XRN1;TRIB3;CASP4;PRKAR1A;CPEB4;COL6A1;NGFR;BCL2L1;XBP1;COL1A2;PRKACA;IGF2;ITPR2;GRB10;PPARG;ATP6V1B2;EEF2K;ADCY1;KAT2B;DNMT3A
14997,GO:0070915,0.0283041665991544,0.99858153359916,2,4,lysophosphatidic acid receptor activity,MF,LPAR3;LPAR1
11872,GO:0046879,0.0283118211672538,0.984041019504702,23,172,hormone secretion,BP,PCK2;NR1D1;RAPGEF3;ACVR2B;APLN;HADH;EGFR;GLUL;MAP4K4;ICA1;FGFR1;LTBP4;SOX4;ITPR3;NLGN2;LRP5;PPP3CB;CHD7;SLC25A4;ANO1;GLUD1;RAB1A;ITPR2
1264,GO:0003018,0.0283148573207724,0.98721108750971,13,84,vascular process in circulatory system,BP,DOCK4;NOS1;F2R;CTNNBIP1;BBS2;APLN;EGFR;HTR7;EDNRA;APOE;ITGA1;CEACAM1;F2RL1
2526,GO:0005782,0.0283610090762768,0.992066274363725,6,31,peroxisomal matrix,CC,IDE;LONP2;PRDX5;MLYCD;CRAT;AMACR
7565,GO:0031907,0.0283610090762768,0.992066274363725,6,31,microbody lumen,CC,IDE;LONP2;PRDX5;MLYCD;CRAT;AMACR
10503,GO:0043405,0.028405473599865,0.982377338185502,32,260,regulation of MAP kinase activity,BP,F2R;SORL1;MAP2K1;PKN1;MST1R;EGFR;STK39;ERCC6;MAP4K4;SHC1;DKK1;PAK1;TRIB2;APOE;RGS14;LPAR3;FGFR1;ITGA1;MAPKAPK3;TRIB3;TAOK1;SPRY2;MAP2K2;PDE5A;C5;SHC2;EIF2AK2;LPAR1;IGF2;MAP4K2;ADAM8;FZD8
10424,GO:0043267,0.0284080873814746,0.994945906844513,4,13,negative regulation of potassium ion transport,BP,NOS1;STK39;ANK3;ATF4
12248,GO:0048522,0.0284303958805246,0.975886356872211,327,3481,positive regulation of cellular process,BP,TNIP1;DOCK4;XDH;SMURF2;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;ITGA6;MMP1;RPS6KA2;CYP27B1;SERPINE2;ADCY7;IGFBP4;PRNP;PAG1;MARCKSL1;POSTN;NR1D1;NFATC4;MAP2K1;THBS2;FAM210B;ETV4;RAPGEF3;ACVR2B;ALOX15B;SALL2;PKN1;WWTR1;PEG3;MST1R;APLN;POU2F2;TRIM65;TEF;TNFSF15;EIF4EBP1;SSH1;MAP1B;DDIT3;SMARCA1;SOX12;PSMD2;LAMB1;ELK3;CRTC1;ADGRL1;WIPF1;EGFR;STK39;SEMA4B;ANK3;FYN;TSPAN5;BNIP3;HLTF;ERCC6;ARAP1;ZNF516;DLG1;DLG4;PLXNB3;SNX9;PODXL;NET1;TGM2;ESPN;GLUL;HTRA1;WNT7A;MAP4K4;SPTLC2;GRK5;STRADB;ASPH;GDI1;CEMIP;SDC1;ARG2;SHC1;DLG3;DKK1;DAP;PAK1;SOCS2;TRIB2;RAG1;TGFBR2;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;OBSCN;APOE;FKBP1A;BNIP3L;CCPG1;CCND2;RGS14;PKD2;PRKACB;RBCK1;LRP1;LDHA;FYCO1;IDE;AKAP9;RAB11FIP4;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;LPAR3;ASNS;FGFR1;ITGA1;E2F5;EPCAM;TMOD2;TUB;NFAT5;HYAL1;BTRC;ITGA2;PTK6;VAMP2;INPP5F;ATRX;FAM20C;CHURC1;PFN2;SOX4;FHOD1;ITPR3;DDB2;CEP120;CEACAM1;FERMT1;MAPKAPK3;OBSL1;LMAN1;ATF7IP;FAM110C;SH3D19;EPN2;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;PLEK2;NLGN2;CD46;CTH;LRP5;ETAA1;TWF2;CST3;CNTN1;TRIB3;CASP4;TPBG;VPS11;MOSPD2;WASF3;RIMS3;PPP3CB;RFX2;ADGRB2;SLK;MLYCD;CEBPG;PLAG1;FNBP1L;F2RL1;DDX60;UHRF2;TAOK1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;ASAP1;PRKAR1A;ANO1;JMY;BOK;PARP9;C18ORF32;NACC2;SPRY2;THRA;WNT2B;ACVR1B;NGFR;PPP1R10;GLUD1;MARK4;CHD6;MTA1;BCL2L1;IFITM1;RNF165;MEF2D;WASF2;SKAP2;ARF4;XBP1;SPIRE1;MAP2K2;PAIP1;ANKIB1;TRPC1;RET;CCDC71L;LOXL2;PDE5A;SH3PXD2B;C5;NCKAP1;EPM2A;DOCK11;PAK6;EAPP;PUM2;ETV1;CCDC88A;TMED4;SHC2;PRKACA;ZNF398;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;IL1RAP;CARD11;LPAR1;CTSZ;TBL1X;HOXA3;AP3D1;ARID4A;ARPC1A;TENM2;IGF2;MOAP1;AGPAT1;GRB10;MAP4K2;EFCAB7;PPARG;CITED4;GRB7;SRPX2;ALDH1A2;TBX1;CREB3L2;RPH3AL;RSF1;ADAM8;AKT3;WFS1;ENDOG;ITGA4;MAML3;DDHD2;FZD8;WASL;HSPA2;LRP6;MAGEF1;SYT2;TMEM173;RNF180;E2F7;EEF2K;HPSE;SSR1;TNRC6C;TET1;ARMCX3;DEDD2;DNAJC3;FOXP1;PSEN2;PTCH1;ADCY1;KAT2B;CNOT11;UFL1;FAM162A;ANKRD6;PBX3;JARID2;SEMA3F;ADNP;LRP4;RB1CC1;DNMT3A;TRIM38;FBXL5;FADD
7050,GO:0030823,0.0284381906456069,0.994847917544785,4,14,regulation of cGMP metabolic process,BP,NOS1;APOE;PDE5A;ADNP
17021,GO:0099172,0.028515177260937,0.994920792011558,4,13,presynapse organization,BP,WNT7A;DVL1;NLGN2;LRP4
4051,GO:0009092,0.0285623222085769,0.998561438678071,2,4,homoserine metabolic process,BP,CBS;CTH
6108,GO:0019346,0.0285623222085769,0.998561438678071,2,4,transsulfuration,BP,CBS;CTH
12249,GO:0048523,0.0286804388632315,0.975742189651922,307,3280,negative regulation of cellular process,BP,TNIP1;FHL1;DDIT4L;XDH;PLAT;SMURF2;NOS1;ERCC1;ZMYND8;F2R;SORL1;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;CYGB;RPS6KA2;CYP27B1;SERPINE2;PEAR1;IGFBP4;PRNP;PAG1;POSTN;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;TFPI2;RAPGEF3;ACVR2B;LTBP1;SH3KBP1;ALOX15B;SALL2;PKN1;WWTR1;DCBLD2;PEG3;MST1R;APLN;EIF4EBP1;DDIT3;PTPRS;HADH;PSMD2;ELK3;BRSK1;EGFR;TBC1D14;STK39;SEMA4B;ANK3;CGREF1;ARHGAP12;PPP1R14A;FYN;TNFRSF6B;BNIP3;SCMH1;UBE2J1;ARAP1;ADAMTS7;DLG1;DLG4;IDH2;DNAJB5;PLXNB3;PODXL;ESPN;XPC;EVI5L;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;TTBK2;GRK5;STRADB;CRTAP;ASPH;MCTP1;GDI1;CEMIP;ARG2;SHC1;DLG3;DKK1;WISP1;DAP;PAK1;RASA3;SOCS2;TRIB2;RAG1;TGFBR2;PTPN3;SERPING1;SHANK2;EPHA1;IMPACT;CD44;APOE;FKBP1A;BNIP3L;CCND2;ACP5;ANGPTL4;PTPN12;RGS14;PKD2;PRKACB;SRGAP2B;RBCK1;LRP1;IDE;AKAP9;PPP2R3B;HMGA2;ATF4;PPARA;ABCA7;WWC3;ELFN2;ASNS;FGFR1;ITGA1;AARS;PPP1R35;EPCAM;TMOD2;TCFL5;HYAL1;BTRC;LPCAT1;PTK6;ULK2;INPP5F;CHAC1;ATRX;PFN2;ABCG1;SOX4;APOBEC3C;ITPR3;FBXO2;CEACAM1;FERMT1;ZNF692;ATF7IP;RCOR1;NLK;EPN2;MDFI;XRN1;TNRC6B;DVL1;NTSR1;MMP14;HES2;CD46;PHF12;CTH;LRP5;ETAA1;KLF12;TWF2;CST3;TRIB3;TOM1L2;RANBP9;DNAJB9;MEX3C;APLP2;PRDX5;F2RL1;UHRF2;RASIP1;TAOK1;PHC3;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;SLC25A4;QSOX1;ASAP1;PRKAR1A;JMY;BOK;PARP9;CPEB4;ATXN2;NACC2;SPRY2;BEX4;THRA;ACVR1B;NGFR;PPP1R10;TSHZ1;PER3;MTA1;BCL2L1;IFITM1;WASF2;SKAP2;ARF4;H2AFJ;XBP1;UBASH3B;MAP2K2;ABHD6;SATB1;PPP1R2;PAIP1;ARRDC1;TLE4;TRPC1;RET;LOXL2;PDE5A;C5;MTMR4;GABARAPL2;EPM2A;RMRP;EAPP;PUM2;SLC30A1;TMBIM1;PRKACA;RGL2;TMSB4X;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;SLC39A10;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;ARID4A;TENM2;IGF2;ITPR2;GRB10;ERLEC1;PPARG;SNX6;GRB7;ALDH1A2;LYPLA1;TBX1;RPH3AL;RSF1;ADAM8;AKT3;IL20RB;WFS1;DEPDC1;PHF21A;ZNF568;IGFBP7;FZD8;WASL;HSPA2;LRP6;ARID5B;MAGEF1;E2F7;EEF2K;SLC18A2;TNRC6C;TET1;OMG;ZC3H7A;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;PTCH1;KAT2B;CNOT11;USP25;PRMT3;UFL1;ANKRD6;JARID2;SEMA3F;KLHL15;MXD4;ADNP;GNAI1;LRP4;RB1CC1;DNMT3A;FADD
16230,GO:0090277,0.0287057171857315,0.989301013569615,9,53,positive regulation of peptide hormone secretion,BP,PCK2;APLN;EGFR;GLUL;SOX4;NLGN2;PPP3CB;ANO1;GLUD1
6208,GO:0019722,0.0287370006260805,0.98655848797951,14,91,calcium-mediated signaling,BP,NOS1;PRNP;NFATC4;ADGRL1;EGFR;MCTP1;FKBP1A;PKD2;NFAT5;PPP3CB;ADGRB2;MCTP2;PRKACA;RCAN1
6336,GO:0021510,0.0287403681697432,0.989392953183854,9,47,spinal cord development,BP,VLDLR;ADARB1;PTPRS;SOX12;PKD2;SOX4;TCTN1;PTCH1;PBX3
617,GO:0001786,0.0287403683237552,0.992068473371452,6,27,phosphatidylserine binding,MF,OSBPL10;GSDMC;GSDMA;ASAP1;FCHO2;OSBPL5
774,GO:0002028,0.028772434407798,0.988665972874904,10,56,regulation of sodium ion transport,BP,NOS1;SERPINE2;HECW2;STK39;ANK3;DLG1;STOM;PTPN3;CNTN1;PRSS8
14146,GO:0061024,0.0290072773655308,0.978800427882878,71,664,membrane organization,BP,ZMYND8;ETV5;SH3TC2;SH3KBP1;MARVELD1;SSH1;EGFR;TBC1D14;ANK3;DYSF;ARHGAP12;BNIP3;DLG1;DLG4;SNX9;EVI5L;SEC23A;MALL;NEK9;RAC2;APOE;BNIP3L;MCFD2;ABCA7;ITGA2;VAMP2;LMAN1;EPN2;DVL1;NLGN2;COX18;SEC22C;CLTCL1;VPS11;MYOF;SYTL1;DNAJC6;FNBP1L;F2RL1;ATP10D;SLC25A4;ASAP1;BOK;FCHO2;USP6NL;TBC1D2B;SPESP1;AZIN2;BCL2L1;GRIN3B;SPIRE1;STX10;CCDC88A;NEK6;RAB1A;EPB41L3;AP2A2;FCHO1;CTSZ;AP3D1;ARPC1A;MOAP1;FNBP1;PPARG;EVI5;ATP11B;TBC1D16;WASL;SYT2;REEP3;LRP4
71,GO:0000147,0.0291484257299123,0.998937000891077,2,3,actin cortical patch assembly,BP,WIPF1;WASL
10872,GO:0044396,0.0291484257299123,0.998937000891077,2,3,actin cortical patch organization,BP,WIPF1;WASL
13125,GO:0051666,0.0291484257299123,0.998937000891077,2,3,actin cortical patch localization,BP,WIPF1;WASL
5284,GO:0015937,0.0291992310393358,0.996279244969715,3,10,coenzyme A biosynthetic process,BP,ACOT7;PANK4;PANK1
7911,GO:0032484,0.0292124346888125,0.998933364189496,2,3,Ral protein signal transduction,BP,RGL2;RALGPS2
7912,GO:0032485,0.0292124346888125,0.998933364189496,2,3,regulation of Ral protein signal transduction,BP,RGL2;RALGPS2
8645,GO:0034185,0.0293156038775614,0.994845104747593,4,12,apolipoprotein binding,MF,VLDLR;LRP1;LRP6;LRP4
7502,GO:0031674,0.0294563312988702,0.986714788546139,13,75,I band,CC,NOS1;FLNC;SCN8A;ANK3;PARVB;PAK1;OBSCN;FKBP1A;OBSL1;PPP3CB;FLNB;PSEN2;KAT2B
4945,GO:0014910,0.0294598387800939,0.989871651711815,8,40,regulation of smooth muscle cell migration,BP,DOCK4;SORL1;POSTN;SSH1;PAK1;LRP1;ITGA2;LPAR1
10603,GO:0043576,0.0294656953308441,0.994696491807483,4,13,regulation of respiratory gaseous exchange,BP,APLN;NTSR1;NLGN2;PBX3
7806,GO:0032355,0.0298166383370525,0.986879965908412,12,82,response to estradiol,BP,CCND1;POSTN;FAM210B;EGFR;WNT7A;SOCS2;ITGA2;CST3;ALDH1A2;ENDOG;PTCH1;DNMT3A
9894,GO:0042176,0.0298481584266571,0.98096763907438,35,300,regulation of protein catabolic process,BP,SMURF2;EDEM1;SORL1;SERPINE2;HECW2;EGFR;FYN;UBE2J1;SNX9;TRIB2;PTPN3;APOE;LRP1;IDE;BTRC;LPCAT1;SH3D19;DVL1;CST3;TRIB3;VPS11;CSNK2A1;AZIN2;XBP1;ANKIB1;GABARAPL2;PRKACA;TIMP2;ERLEC1;ADAM8;MAGEF1;RNF180;USP25;UFL1;FBXL5
6672,GO:0030032,0.03002324219077,0.988791001569479,9,49,lamellipodium assembly,BP,SSH1;PARVB;PLXNB3;RAC2;TWF2;WASF3;WASF2;NCKAP1;CCDC88A
16156,GO:0090170,0.0302207530012017,0.998429894447622,2,4,regulation of Golgi inheritance,BP,MAP2K1;MAP2K2
3266,GO:0006936,0.0302495616645165,0.982845748912315,23,169,muscle contraction,BP,DOCK4;NOS1;F2R;ACTA2;BBS2;DYSF;DLG1;HTR7;ASPH;ARG2;EDNRA;FKBP1A;ITGA1;TMOD2;ITGB5;ITGA2;GAMT;OBSL1;ANXA6;MYOF;PDE5A;PRKACA;LTB4R
10787,GO:0044248,0.0302615140486738,0.975399337813353,169,1796,cellular catabolic process,BP,XDH;NT5E;SMURF2;EDEM1;GID4;NOS1;PCK2;VLDLR;PYGL;CBS;CYP27B1;PYGB;H1F0;CRYL1;ITGB4;GPT2;BTBD2;NR1D1;HECW2;RAPGEF3;GPX3;WWTR1;TRIM65;DHTKD1;DDIT3;HADH;PSMD2;LTA4H;CAPN2;TBC1D14;BNIP3;UBE2J1;PGM1;ADAMTS7;CTSB;SNX9;TYSND1;GLUL;UBXN4;IGF2BP3;SPTLC2;ACOT7;WDFY3;CEMIP;ACAD11;ARG2;DAP;TRIB2;PTPN3;HAGH;CD44;APOE;BNIP3L;ABCD1;ALDH1L2;RBCK1;LRP1;LDHA;FYCO1;IDE;ABTB1;UBE2G1;PPARA;ABHD10;RNPEPL1;SNX14;HYAL1;BTRC;AIG1;ULK2;LONP2;INPP5F;CHAC1;RMND5A;APOBEC3C;VPS13A;FBXO2;SPATA18;SH3D19;XRN1;TRIM5;TNRC6B;DVL1;PLA2G4D;ACAD10;MVB12B;CTH;CTSL;CST3;TRIB3;VPS11;DNAJB9;BTBD3;HIBADH;PRDX5;MLYCD;ALDH7A1;FNBP1L;RASIP1;CSNK2A1;PSMD7;TST;BLMH;QSOX1;CPT2;CTBS;BOK;MGLL;MVB12A;GLUD1;NPL;MTA1;CRAT;RNF165;PM20D2;GLB1;PCYOX1;XBP1;ABHD6;PAIP1;ARRDC1;ANKIB1;PDE5A;GABARAPL2;EPM2A;DNASE1L1;UBE2E1;PUM2;CTSO;PRKACA;TIMP2;RAB1A;SEL1L;IFI16;AP2A2;SRD5A3;CTSZ;TBL1X;BLVRA;ERLEC1;SNX6;EVA1A;USP20;ATP6V1B2;ADAM8;ALDH4A1;WFS1;ENDOG;DDHD2;USP32;MAGEF1;RNF180;HPSE;GALNS;TNRC6C;TET1;DEDD2;DNAJC3;AOX1;CNOT11;RNF103;USP25;UFL1;AMACR;KLHL15;SLC44A1;STT3B;RB1CC1;FBXL5
14854,GO:0070613,0.0304748153834323,0.988536045739535,9,52,regulation of protein processing,BP,SERPINE2;PRNP;SERPING1;PRKACB;CHAC1;CD46;C5;CTSZ;ADAM8
97,GO:0000187,0.0305279963343517,0.985143320455602,15,103,activation of MAPK activity,BP,MAP2K1;PKN1;STK39;ERCC6;SHC1;LPAR3;ITGA1;MAPKAPK3;TAOK1;MAP2K2;C5;SHC2;LPAR1;IGF2;MAP4K2
13547,GO:0060008,0.0305765997539228,0.994331632157215,4,14,Sertoli cell differentiation,BP,SDC1;ATRX;CST3;ARID4A
16232,GO:0090279,0.0306257264319771,0.994319624529558,4,14,regulation of calcium ion import,BP,PRNP;FYN;PKD2;SLC30A1
18105,GO:1902743,0.0306353731366096,0.990306641629605,7,34,regulation of lamellipodium organization,BP,SSH1;PLXNB3;RAC2;CD44;TWF2;WASF2;NCKAP1
4597,GO:0010712,0.0307887665127058,0.992546212401284,5,23,regulation of collagen metabolic process,BP,F2R;CYGB;ITGA2;CST3;PPARG
2382,GO:0005518,0.0308090125872613,0.989263926059698,8,42,collagen binding,MF,CTSB;PAK1;MRC2;CD44;ITGA1;ITGA2;CTSL;HSD17B12
8154,GO:0032880,0.0308674716676286,0.977266194218263,73,688,regulation of protein localization,BP,EDEM1;ZMYND8;F2R;SORL1;PCK2;PRNP;POSTN;SH3TC2;NR1D1;RAPGEF3;ALOX15B;SSH1;HADH;EGFR;ANK3;FYN;UBE2J1;DLG1;IDH2;GLUL;WNT7A;MAP4K4;TTBK2;GDI1;CEMIP;ARG2;STOM;PAK1;RAC2;FKBP1A;BNIP3L;LRP1;ICA1;VAMP2;SOX4;ITPR3;CEP120;FERMT1;TRIM5;DVL1;NLGN2;LRP5;ABHD17C;VPS11;PPP3CB;F2RL1;CSNK2A1;SLC25A4;ANO1;PARP9;NGFR;GLUD1;BCL2L1;XBP1;STX10;C5;TMBIM1;CCDC88A;TMSB4X;IL1RAP;ITPR2;EFCAB7;ERLEC1;LYPLA1;RPH3AL;ADAM8;WASL;TMEM173;FOXP1;PTCH1;UFL1;GNAI1;LRP4
17036,GO:0099504,0.0310148292245608,0.985860904627932,13,79,synaptic vesicle cycle,BP,SNPH;WNT7A;VAMP2;PFN2;NLGN2;RIMS3;SYTL1;DNAJC6;FCHO2;SEPT5;AP3D1;SYT2;SLC18A2
11636,GO:0046341,0.031015412985418,0.994224146855977,4,14,CDP-diacylglycerol metabolic process,BP,AGPAT4;AGPAT3;AGPAT1;CDS2
7051,GO:0030825,0.0310301753668173,0.996075118343507,3,9,positive regulation of cGMP metabolic process,BP,NOS1;APOE;ADNP
1697,GO:0004175,0.031149655195361,0.981352068736352,27,228,endopeptidase activity,MF,PLAT;ADAM19;MMP1;PRSS3;PSMD2;CAPN2;TMPRSS11D;ADAMTS7;CTSB;TYSND1;HTRA1;CLCA2;IDE;LONP2;MMP14;CTSL;CASP4;PCSK6;BLMH;CTSO;CTSZ;MMP10;USP20;ADAM8;OSGEPL1;PRSS8;PSEN2
6989,GO:0030667,0.0313445386338859,0.981670454037381,25,196,secretory granule membrane,CC,CD68;STOM;SLC2A3;CD44;ICA1;LPCAT1;VAMP2;ITPR3;CEACAM1;RAB31;BSG;CD46;MOSPD2;APLP2;COPB1;TMBIM1;AP2A2;CMTM6;ITPR2;TMEM63A;RPH3AL;ADAM8;ATP11B;SYT2;TMEM173
4991,GO:0015125,0.0314807771483408,0.998327151216117,2,4,bile acid transmembrane transporter activity,MF,CEACAM1;SLC10A6
17751,GO:1901699,0.0314915689672284,0.978092490871281,52,450,cellular response to nitrogen compound,BP,NEURL1;PCK2;ADCY7;PRNP;MAP2K1;RAPGEF3;EIF4EBP1;SSH1;CAPN2;EGFR;FYN;MAPK13;SHC1;PAK1;SOCS2;IMPACT;PKD2;PRKACB;LRP1;IDE;AKAP9;ATF4;UROS;VAMP2;ATRX;CEACAM1;RAB31;XRN1;TRIB3;CASP4;PRKAR1A;CPEB4;COL6A1;NGFR;BCL2L1;XBP1;MAP2K2;RMRP;PUM2;COL1A2;PRKACA;IGF2;ITPR2;GRB10;PPARG;ATP6V1B2;TMEM173;EEF2K;ZC3H7A;ADCY1;KAT2B;DNMT3A
13700,GO:0060252,0.0315031872797255,0.996156393685279,3,8,positive regulation of glial cell proliferation,BP,ETV5;PLAG1;UFL1
3029,GO:0006575,0.031570309089797,0.9837087221128,17,134,cellular modified amino acid metabolic process,BP,OSBPL10;GLO1;CRTAP;HAGH;ERO1B;ALDH1L2;LPCAT4;CHAC1;MTHFR;AHCYL2;GAMT;PLA2G4D;ALDH7A1;PM20D2;PCYOX1;OSBPL5;ALDH4A1
4371,GO:0009991,0.0316143611867771,0.979235786093553,39,341,response to extracellular stimulus,BP,ERCC1;CCND1;PCK2;CBS;ITGA6;CYP27B1;BBS2;POSTN;SSH1;DDIT3;EGFR;FYN;GLUL;DAP;TGFBR2;IMPACT;APOE;LDHA;ATF4;PPARA;ASNS;ITGA2;ULK2;MTHFR;CST3;CPEB4;WNT2B;XBP1;SLC38A2;GABARAPL2;EIF2AK2;IFI16;ZNF354A;IGF2;PPARG;ALDH1A2;UFL1;ADNP;DNMT3A
15468,GO:0071804,0.0316881978359835,0.985487161688091,13,81,cellular potassium ion transport,BP,FHL1;PRNP;KCNG1;STK39;ANK3;DLG1;SLC9A7;PKD2;AKAP9;VAMP2;SLC12A7;KCNJ15;ATP12A
15469,GO:0071805,0.0316881978359835,0.985487161688091,13,81,potassium ion transmembrane transport,BP,FHL1;PRNP;KCNG1;STK39;ANK3;DLG1;SLC9A7;PKD2;AKAP9;VAMP2;SLC12A7;KCNJ15;ATP12A
18468,GO:1903566,0.031735506509604,0.99878637616721,2,3,positive regulation of protein localization to cilium,BP,CCDC88A;EFCAB7
3389,GO:0007166,0.0317488941569217,0.973991281658959,182,1866,cell surface receptor signaling pathway,BP,XDH;PLAT;SMURF2;TSPAN1;ZMYND8;FAM83A;PGF;CCND1;NEURL1;SH2D2A;CTNNBIP1;VLDLR;ITGA6;MMP1;SERPINE2;PEAR1;IGFBP4;PRNP;PAG1;ADGRF1;ITGB4;BBS2;POSTN;SH3TC2;NFATC4;LTBP2;ACVR2B;LTBP1;SH3KBP1;WWTR1;MST1R;APLN;TNFSF15;EIF4EBP1;SSH1;DDIT3;PSMD2;ADGRL1;FCGRT;WIPF1;EGFR;SEMA4B;FYN;TNFRSF6B;TSPAN5;SLC33A1;MAPK13;ARAP1;DLG4;PLXNB3;GPC4;HTRA1;WNT7A;TTBK2;GRK5;STRADB;SDC1;SHC1;DKK1;WISP1;PAK1;SOCS2;TGFBR2;PTPN3;LCN2;SHANK2;EPHA1;CD44;APOE;FKBP1A;PTPN12;RGS14;PRKACB;RBCK1;LRP1;IDE;ABCA7;FGFR1;ITGA1;ITGB5;BTRC;ITGA2;PTK6;GALNT3;LTBP4;CHAC1;FAM20C;SOX4;CEACAM1;FERMT1;MAPKAPK3;MT2A;BSG;NLK;EPN2;MDFI;TRIM5;TNRC6B;DVL1;NTSR1;MMP14;NLGN2;CD46;MVB12B;EPOR;LRP5;CNTN1;CASP4;PCSK6;PPP3CB;MYOF;ADGRB2;F2RL1;CSNK2A1;PSMD7;BOK;PARP9;CPEB4;SPRY2;WNT2B;ACVR1B;NGFR;MVB12A;PTPRZ1;BCL2L1;IFITM1;RNF165;GRIN3B;WASF2;ARF4;UBASH3B;ARRDC1;TLE4;RET;TCTN1;C5;MTMR4;ZFYVE9;NCKAP1;TSPAN3;TMBIM1;COL1A2;SHC2;PRKACA;TMSB4X;SEL1L;AP2A2;SLC39A10;IL1RAP;CARD11;TBL1X;ARPC1A;IGF2;MOAP1;LAMA5;AGPAT1;GRB10;PPARG;SNX6;GRB7;ATP6V1B2;ROBO3;IL20RB;ITGA4;MAML3;FZD8;WASL;LRP6;ARID5B;TNRC6C;DEDD2;ZBTB33;PSEN2;PTCH1;KAT2B;OAS1;ANKRD6;SEMA3F;LRP4;RB1CC1;TRIM38;FADD
6368,GO:0021549,0.0317505450342013,0.987283247521795,10,56,cerebellum development,BP,SERPINE2;MAP2K1;PTPRS;WNT7A;TTBK2;PAK1;AARS;CNTN1;LPAR1;LRP6
1906,GO:0004594,0.0317999182174217,0.998300749304992,2,4,pantothenate kinase activity,MF,PANK4;PANK1
16553,GO:0097320,0.03182888176335,0.994023532177319,4,14,plasma membrane tubulation,BP,SNX9;FNBP1L;ASAP1;WASL
17332,GO:0150034,0.0318544869765787,0.98159640219743,24,179,distal axon,CC,SSH1;ADGRL1;GLUL;DLG3;SHANK2;FKBP1A;KIF21B;TMOD2;ITGA2;PFN2;DVL1;NTSR1;TWF2;CPEB4;SEPT5;TIMP2;CTSZ;AP3D1;TENM2;SLC18A2;SIGMAR1;PSEN2;PTCH1;SEPT6
9444,GO:0036021,0.031897746663402,0.998292625673424,2,4,endolysosome lumen,CC,CTSB;CTSL
5068,GO:0015291,0.0319482124362011,0.983229176284637,18,126,secondary active transmembrane transporter activity,MF,SLC16A3;SLC33A1;SLCO4A1;SLC9A7;SLC5A1;CLCN3;SLC2A9;SLC6A6;SLC25A4;SLC6A14;SLC12A7;SLC22A17;SLC38A2;SLC13A3;SLC2A13;SLC10A6;SLC7A11;SLC23A2
4527,GO:0010592,0.0319677530061539,0.993989109252541,4,14,positive regulation of lamellipodium assembly,BP,RAC2;TWF2;WASF2;NCKAP1
13281,GO:0051968,0.0320320087058861,0.994078758375312,4,13,positive regulation of synaptic transmission, glutamatergic,BP,EGFR;GLUL;SHANK2;NLGN2
14999,GO:0070920,0.0320848678658402,0.993870279565193,4,15,regulation of production of small RNA involved in gene silencing by RNA,BP,MAP2K1;EGFR;MAP2K2;RMRP
3418,GO:0007202,0.0322093558585823,0.995733869906921,3,10,activation of phospholipase C activity,BP,EGFR;EDNRA;LPAR1
9789,GO:0040007,0.0322105622576978,0.976287877124985,72,650,growth,BP,FHL1;ERCC1;CYP27B1;SERPINE2;IGFBP4;BBS2;POSTN;ADARB1;ACVR2B;ALOX15B;WWTR1;DCBLD2;MAP1B;PTPRS;EGFR;SEMA4B;ERCC6;PLXNB3;NET1;HTRA1;WNT7A;GDI1;SHC1;WISP1;PAK1;SOCS2;TGFBR2;SHANK2;SLITRK6;IMPACT;APOE;PTPN12;HMGA2;WWC3;LPAR3;FGFR1;HYAL1;PTK6;ULK2;LTBP4;ATRX;KIAA1109;GAMT;CEACAM1;MT2A;DVL1;MMP14;THBS3;TWF2;PPP3CB;MEX3C;PLAG1;CSNK2A1;CHD7;PRKAR1A;SPRY2;ACVR1B;BCL2L1;SH3PXD2B;EPB41L3;LAMB2;PPARG;WFS1;IGFBP7;LRP6;ARID5B;SYT2;PTCH1;JARID2;SEMA3F;ADNP;LRP4
8372,GO:0033267,0.0323411963348787,0.979899848210554,31,242,axon part,CC,SCN8A;SSH1;ADGRL1;ANK3;KIF13B;DLG1;DLG4;GLUL;DLG3;SHANK2;FKBP1A;KIF21B;TMOD2;ITGA2;PFN2;DVL1;NTSR1;TWF2;CPEB4;SEPT5;NAV1;TIMP2;EPB41L3;CTSZ;AP3D1;TENM2;SLC18A2;SIGMAR1;PSEN2;PTCH1;SEPT6
6807,GO:0030258,0.0324354728603987,0.980972725275083,25,195,lipid modification,BP,CYGB;DGKA;HADH;EGFR;FYN;TYSND1;TTC7B;ACAD11;PLPP6;APOE;ABCD1;PPARA;FGFR1;LONP2;INPP5F;ABCG1;ACAD10;PLPPR2;MLYCD;CPT2;CRAT;MTMR4;PPARG;ZFYVE21;AMACR
17024,GO:0099175,0.032470408774787,0.989597121191605,7,34,regulation of postsynapse organization,BP,ZMYND8;PRNP;SSH1;FYN;APOE;EEF2K;LRP4
14506,GO:0062009,0.0325210331965057,0.995981568817452,3,8,secondary palate development,BP,DLG1;TSHZ1;TBX1
12344,GO:0048705,0.0325595258535558,0.982549635509337,19,132,skeletal system morphogenesis,BP,ACVR2B;COL13A1;DLG1;WNT7A;TGFBR2;ACP5;FGFR1;HYAL1;MDFI;MMP14;LRP5;THBS3;THRA;MEF2D;SH3PXD2B;HOXA3;TBX1;WDR60;ARID5B
9007,GO:0035150,0.0328226819963102,0.98599965923446,11,70,regulation of tube size,BP,DOCK4;NOS1;F2R;BBS2;APLN;EGFR;HTR7;EDNRA;APOE;ITGA1;F2RL1
12673,GO:0050880,0.0328226819963102,0.98599965923446,11,70,regulation of blood vessel size,BP,DOCK4;NOS1;F2R;BBS2;APLN;EGFR;HTR7;EDNRA;APOE;ITGA1;F2RL1
12922,GO:0051272,0.033027763871073,0.978255850401404,39,328,positive regulation of cellular component movement,BP,DOCK4;SMURF2;F2R;PGF;ITGA6;POSTN;SSH1;LAMB1;EGFR;SEMA4B;PODXL;WNT7A;CEMIP;PAK1;TGFBR2;EPHA1;RAC2;ANXA3;FGFR1;HYAL1;ITGA2;FAM110C;MMP14;MOSPD2;F2RL1;SPRY2;ACVR1B;XBP1;RET;TMSB4X;LPAR1;GRB7;SRPX2;ADAM8;AKT3;ITGA4;FOXP1;SEMA3F;FADD
13116,GO:0051651,0.0331690208342594,0.985259230507001,12,74,maintenance of location in cell,BP,SORL1;SYNE3;ANK3;APOE;AKAP9;SOX4;VPS13A;TWF2;TMSB4X;EPB41L3;KDELR3;FLNB
44,GO:0000096,0.0333541138294498,0.990340251313135,6,30,sulfur amino acid metabolic process,BP,CBS;MTHFR;AHCYL2;CTH;BLMH;PCYOX1
12302,GO:0048640,0.0333783429443588,0.985794051831725,11,65,negative regulation of developmental growth,BP,BBS2;PTPRS;SEMA4B;PAK1;SOCS2;TGFBR2;WWC3;ULK2;PTCH1;JARID2;SEMA3F
378,GO:0001010,0.0334804831267633,0.993610879484281,4,14,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,NR1D1;PPARA;THRA;PPARG
3390,GO:0007167,0.0335753158941538,0.975025470799779,76,692,enzyme linked receptor protein signaling pathway,BP,XDH;PLAT;SMURF2;FAM83A;PGF;NEURL1;SH2D2A;IGFBP4;PAG1;SH3TC2;LTBP2;ACVR2B;LTBP1;SH3KBP1;WWTR1;MST1R;APLN;EIF4EBP1;EGFR;FYN;SLC33A1;MAPK13;ARAP1;HTRA1;SHC1;DKK1;PAK1;SOCS2;TGFBR2;PTPN3;EPHA1;FKBP1A;PTPN12;RGS14;LRP1;IDE;FGFR1;ITGA1;ITGB5;PTK6;GALNT3;LTBP4;FAM20C;CEACAM1;FERMT1;MAPKAPK3;NLK;EPN2;MVB12B;PCSK6;MYOF;SPRY2;ACVR1B;NGFR;MVB12A;RNF165;WASF2;ARF4;UBASH3B;RET;MTMR4;ZFYVE9;NCKAP1;COL1A2;SHC2;AP2A2;ARPC1A;IGF2;GRB10;SNX6;GRB7;ATP6V1B2;WASL;ARID5B;PSEN2;LRP4
6580,GO:0022407,0.0337839217005761,0.979436403193863,28,231,regulation of cell-cell adhesion,BP,ITGA6;SERPINE2;PRNP;PAG1;ANK3;FYN;DLG1;PODXL;ARG2;PAK1;RAG1;TGFBR2;CD44;PPARA;EPCAM;CEACAM1;CD46;PRKAR1A;XBP1;UBASH3B;PDE5A;CARD11;AP3D1;IGF2;ADAM8;IL20RB;ITGA4;FADD
11436,GO:0045861,0.0338459187551612,0.980016077556891,25,210,negative regulation of proteolysis,BP,PLAT;SORL1;SERPINE2;PRNP;TFPI2;TNFRSF6B;UBE2J1;RAG1;PTPN3;SERPING1;CD44;IDE;CHAC1;CST3;APLP2;PRDX5;CSNK2A1;NGFR;C5;GABARAPL2;TIMP2;IFI16;CTSZ;ERLEC1;USP25
8888,GO:0034703,0.0339052737501691,0.984881750617979,12,74,cation channel complex,CC,NOS1;SCN8A;KCNG1;DLG4;DLG3;FKBP1A;AKAP9;VAMP2;GRIN3B;ABHD6;PRKACA;HSPA2
3883,GO:0008514,0.0340067880716373,0.981980376885486,18,132,organic anion transmembrane transporter activity,MF,SLC16A3;SLC33A1;SLCO4A1;SLC2A3;CEACAM1;BSG;SLC35B4;SLC2A9;SLC6A6;SLC25A4;SLC6A14;SLC43A1;SLC22A17;SLC38A2;SLC13A3;SLC10A6;SLC7A11;SLC23A2
11712,GO:0046503,0.0340883859276151,0.99007617352233,6,30,glycerolipid catabolic process,BP,APOE;INPP5F;PLA2G4D;MGLL;ABHD6;DDHD2
4897,GO:0014824,0.0340989661456838,0.998106091899285,2,4,artery smooth muscle contraction,BP,BBS2;EDNRA
15483,GO:0071827,0.0341030839289124,0.991565941662606,5,22,plasma lipoprotein particle organization,BP,APOE;PRKACB;ABCA7;ABCG1;PRKACA
16273,GO:0090331,0.0341939475966366,0.99550485701269,3,9,negative regulation of platelet aggregation,BP,SERPINE2;CEACAM1;UBASH3B
12484,GO:0050435,0.0342980112346347,0.990081950830445,6,28,amyloid-beta metabolic process,BP,SORL1;PRNP;APOE;IDE;ABCA7;PSEN2
3067,GO:0006631,0.0343214658078532,0.978672743751718,30,260,fatty acid metabolic process,BP,PCK2;CYGB;CRYL1;ALOX15B;HADH;ELOVL1;ACOT1;TYSND1;ACSF2;ACOT7;ACAD11;CBR4;ABCD1;PPARA;AIG1;LONP2;CEACAM1;ACAD10;TRIB3;MLYCD;CPT2;MGLL;CRAT;XBP1;PPARG;PTGR2;LYPLA1;ELOVL4;HSD17B12;AMACR
12556,GO:0050708,0.0343881384634848,0.978472459176122,31,259,regulation of protein secretion,BP,F2R;PCK2;POSTN;NR1D1;RAPGEF3;ALOX15B;HADH;EGFR;IDH2;GLUL;MAP4K4;ARG2;ICA1;SOX4;ITPR3;FERMT1;NLGN2;LRP5;PPP3CB;F2RL1;SLC25A4;ANO1;GLUD1;XBP1;C5;TMSB4X;IL1RAP;ITPR2;RPH3AL;ADAM8;FOXP1
12824,GO:0051129,0.034411716737737,0.975665744808901,55,491,negative regulation of cellular component organization,BP,ERCC1;SORL1;CTNNBIP1;PRNP;POSTN;NFATC4;RAPGEF3;PTPRS;SEMA4B;FYN;BNIP3;ARAP1;DLG4;PLXNB3;ESPN;EVI5L;MAP4K4;TTBK2;MCTP1;GDI1;DKK1;IMPACT;APOE;LRP1;TMOD2;ULK2;INPP5F;ATRX;PFN2;XRN1;MMP14;TWF2;CST3;TOM1L2;PHF1;ASAP1;PRKAR1A;BOK;ATXN2;SPRY2;THRA;NGFR;BCL2L1;WASF2;TMSB4X;LPAR1;CTSZ;WASL;HSPA2;TET1;OMG;KAT2B;JARID2;SEMA3F;LRP4
5070,GO:0015293,0.0344254239365293,0.98460140909045,12,75,symporter activity,MF,SLC16A3;SLC33A1;SLC5A1;SLC2A9;SLC6A6;SLC6A14;SLC12A7;SLC38A2;SLC13A3;SLC2A13;SLC10A6;SLC23A2
5234,GO:0015850,0.0347913713813915,0.982783137093928,15,102,organic hydroxy compound transport,BP,NOS1;RAB3B;SLC16A3;APOE;LRP1;ABCA7;ABCG1;CEACAM1;OSBPL5;SLC2A13;PPARG;SLC10A6;LRP6;SLC18A2;PTCH1
14933,GO:0070814,0.0348884213282072,0.998037464003399,2,4,hydrogen sulfide biosynthetic process,BP,CBS;CTH
10171,GO:0042758,0.0350162412574513,0.998026267593043,2,4,long-chain fatty acid catabolic process,BP,ABCD1;AIG1
4957,GO:0015026,0.0350281325006038,0.991402619497189,5,20,coreceptor activity,MF,GPC4;LRP5;NGFR;ITGA4;LRP6
3159,GO:0006766,0.035081088253943,0.983581178737756,13,92,vitamin metabolic process,BP,CYP27B1;PRSS3;PC;PSAT1;SLC2A3;ACP5;ALDH1L2;FGFR1;MTHFR;PM20D2;ALDH1A2;AOX1;SLC23A2
14062,GO:0060840,0.035085412374872,0.985768969813803,10,53,artery development,BP,ACVR2B;LTBP1;LOXL1;APOE;PKD2;LRP1;SOX4;CHD7;TBX1;AKT3
12593,GO:0050769,0.0351910676480241,0.977011452147737,37,298,positive regulation of neurogenesis,BP,ZMYND8;ETV5;NEURL1;VLDLR;SERPINE2;MAP2K1;MAP1B;CRTC1;FYN;DLG4;PLXNB3;GDI1;DKK1;PAK1;SOCS2;SHANK2;IMPACT;APOE;RGS14;LPAR3;FGFR1;PTK6;OBSL1;DVL1;TWF2;CNTN1;PLAG1;NGFR;RET;TIMP2;IL1RAP;LPAR1;PPARG;SYT2;EEF2K;UFL1;ADNP
11204,GO:0045334,0.0353158229055497,0.988408929215421,7,36,clathrin-coated endocytic vesicle,CC,EGFR;CEMIP;APOE;INPP5F;EPN2;CLTCL1;AP2A2
7084,GO:0030878,0.0354740595546019,0.993001682082348,4,15,thyroid gland development,BP,MAP2K1;THRA;HOXA3;TBX1
2596,GO:0005891,0.0355245845525239,0.995258207877881,3,9,voltage-gated calcium channel complex,CC,NOS1;FKBP1A;HSPA2
4635,GO:0010757,0.0356976538155788,0.997966181771468,2,4,negative regulation of plasminogen activation,BP,SERPINE2;CTSZ
18364,GO:1903358,0.0357344185645657,0.992933744306699,4,15,regulation of Golgi organization,BP,MAP2K1;AKAP9;USP6NL;MAP2K2
5058,GO:0015267,0.0357788015221268,0.979627803860442,22,163,channel activity,MF,SCN8A;KCNG1;DENND5B;DLG1;DLG4;DLG3;RASA3;CLCA2;PKD2;FAM155B;ITPR3;CLCN3;ANXA6;ORAI3;TTYH3;ANO8;ANO1;GRIN3B;TRPC1;KCNJ15;ORAI1;ITPR2
6607,GO:0022803,0.0357788015221268,0.979627803860442,22,163,passive transmembrane transporter activity,MF,SCN8A;KCNG1;DENND5B;DLG1;DLG4;DLG3;RASA3;CLCA2;PKD2;FAM155B;ITPR3;CLCN3;ANXA6;ORAI3;TTYH3;ANO8;ANO1;GRIN3B;TRPC1;KCNJ15;ORAI1;ITPR2
18225,GO:1903026,0.0358651176302825,0.997637436527477,2,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,DDIT3;TMSB4X
10378,GO:0043198,0.0359960574730873,0.991028723344102,5,21,dendritic shaft,CC,ZMYND8;DLG3;NTSR1;LPAR1;PSEN2
16108,GO:0090087,0.0360747688600456,0.974564494898717,53,488,regulation of peptide transport,BP,EDEM1;F2R;SORL1;PCK2;PRNP;POSTN;SH3TC2;NR1D1;RAPGEF3;ALOX15B;APLN;HADH;EGFR;ANK3;FYN;UBE2J1;IDH2;GLUL;MAP4K4;GDI1;CEMIP;ARG2;STOM;PAK1;RAC2;BNIP3L;LRP1;ICA1;VAMP2;SOX4;ITPR3;FERMT1;NLGN2;LRP5;VPS11;PPP3CB;F2RL1;CHD7;SLC25A4;ANO1;GLUD1;XBP1;C5;TMSB4X;IL1RAP;ITPR2;EFCAB7;ERLEC1;LYPLA1;RPH3AL;ADAM8;TMEM173;FOXP1
13839,GO:0060439,0.0360935977538944,0.995151533754917,3,9,trachea morphogenesis,BP,MAP2K1;TGFBR2;LRP6
13182,GO:0051787,0.0362395359597507,0.990830653696044,5,23,misfolded protein binding,MF,EDEM1;DNAJB9;HSPA13;HSPA2;DNAJC3
13750,GO:0060324,0.0362784051052227,0.986944450187437,8,42,face development,BP,MAP2K1;ASPH;DKK1;CHD7;ALDH1A2;TBX1;LRP6;ARID5B
1928,GO:0004622,0.0363737535323913,0.992675966619701,4,16,lysophospholipase activity,MF,PLA2G4D;MGLL;LYPLAL1;LYPLA1
4703,GO:0010863,0.0364131916632482,0.992755831473629,4,15,positive regulation of phospholipase C activity,BP,EGFR;EDNRA;FGFR1;LPAR1
17178,GO:0102991,0.036500065078601,0.997572180771226,2,5,myristoyl-CoA hydrolase activity,MF,ACOT1;ACOT7
6932,GO:0030534,0.0365434338480189,0.984218332608697,11,65,adult behavior,BP,BBS2;SHANK2;SLITRK6;CCND2;PPARA;INPP5F;NTSR1;CHD7;RNF180;PBX3;FADD
8376,GO:0033273,0.0366638518530495,0.984823217810728,10,63,response to vitamin,BP,CCND1;CYP27B1;POSTN;EGFR;ITGA2;MTHFR;ZNF354A;PPARG;ALDH1A2;DNMT3A
1086,GO:0002674,0.0368721581084689,0.997861055092263,2,4,negative regulation of acute inflammatory response,BP,PPARG;IL20RB
8715,GO:0034358,0.0368875372029765,0.992538992496312,4,16,plasma lipoprotein particle,CC,SORL1;VLDLR;APOE;PCYOX1
19622,GO:1990777,0.0368875372029765,0.992538992496312,4,16,lipoprotein particle,CC,SORL1;VLDLR;APOE;PCYOX1
8835,GO:0034618,0.0368969957474841,0.997858810738115,2,4,arginine binding,MF,NOS1;NAGS
1280,GO:0003081,0.0370557755998818,0.994810833636274,3,10,regulation of systemic arterial blood pressure by renin-angiotensin,BP,F2R;F2RL1;CTSZ
2403,GO:0005548,0.0375209516452118,0.986406508962874,8,42,phospholipid transporter activity,MF,PITPNC1;OSBPL10;ABCA7;ABCG1;PITPNM1;ATP10D;OSBPL5;ATP11B
16787,GO:0098609,0.03755646030046,0.973748139427296,50,441,cell-cell adhesion,BP,TNIP1;NT5E;ITGA6;SERPINE2;PRNP;PAG1;COL13A1;LAMB1;SDK2;ADGRL1;EGFR;ANK3;FYN;PCDHAC2;DLG1;PLXNB3;PODXL;ARG2;SHC1;PAK1;RAG1;TGFBR2;RAC2;CD44;PPARA;EPCAM;ITGB5;FAT1;CEACAM1;NLGN2;CD46;PRKAR1A;XBP1;UBASH3B;CADM4;RET;PDE5A;PCDH1;CARD11;AP3D1;TENM2;IGF2;SRPX2;SLC7A11;ADAM8;IL20RB;CLDN11;ITGA4;LRP6;FADD
8102,GO:0032787,0.0376583118602177,0.974164030933794,45,417,monocarboxylic acid metabolic process,BP,PCK2;CYGB;CRYL1;NR1D1;SLC16A3;ALOX15B;DHTKD1;PC;HADH;ELOVL1;PGM1;IDH2;ACOT1;TYSND1;GLO1;ACSF2;ACOT7;ACAD11;CBR4;HAGH;ABCD1;LDHA;PPARA;ASNS;ABHD10;AIG1;LONP2;CEACAM1;BSG;ACAD10;TRIB3;MLYCD;CPT2;MGLL;CRAT;XBP1;NIT2;PPARG;PTGR2;ALDH1A2;LYPLA1;ALDH4A1;ELOVL4;HSD17B12;AMACR
15540,GO:0071936,0.0379590899172202,0.995009122044746,3,8,coreceptor activity involved in Wnt signaling pathway,MF,GPC4;LRP5;LRP6
4335,GO:0009887,0.0382375211374589,0.971640341298342,71,643,animal organ morphogenesis,BP,FHL1;SMURF2;ETV5;PGF;CTNNBIP1;ITGA6;ITGB4;ACTA2;BBS2;ADARB1;MAP2K1;ACVR2B;COL13A1;WWTR1;PSMD2;LAMB1;SDK2;EGFR;DLG1;GPC4;TGM2;HTRA1;WNT7A;SDC1;DKK1;TGFBR2;SHANK2;SLITRK6;FKBP1A;ACP5;PKD2;PPARA;FGFR1;E2F5;HYAL1;BTRC;ITGA2;FAM20C;SOX4;GAMT;CEACAM1;BSG;MDFI;DVL1;MMP14;LRP5;THBS3;PLAG1;PSMD7;CHD7;SPRY2;THRA;WNT2B;TSHZ1;MEF2D;XBP1;SH3PXD2B;COL1A2;AP2A2;CTSZ;HOXA3;LAMA5;ALDH1A2;TBX1;AKT3;WDR60;LRP6;ARID5B;PTCH1;ANKRD6;LRP4
3772,GO:0008324,0.0383516960359835,0.974893437092306,36,306,cation transmembrane transporter activity,MF,SCN8A;KCNG1;DENND5B;SLC33A1;SLC9A7;RASA3;ATP7B;PKD2;FAM155B;ITPR3;SLC5A1;ORAI3;NIPA1;SLC2A9;SLC6A6;ANO1;SLC6A14;NDUFA4L2;AZIN2;GRIN3B;SLC12A7;SLC38A2;TRPC1;SLC13A3;KCNJ15;SLC30A1;SLC39A10;ORAI1;ITPR2;SLC2A13;SLC10A6;ATP12A;ATP6V1B2;SLC18A2;SLC23A2;SLC44A1
11285,GO:0045595,0.0385558584675352,0.969464296632834,118,1155,regulation of cell differentiation,BP,XDH;NOS1;ZMYND8;SORL1;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;CYP27B1;SERPINE2;POSTN;NR1D1;HECW2;NFATC4;MAP2K1;FAM210B;ACVR2B;ALOX15B;WWTR1;SSH1;MAP1B;DDIT3;PTPRS;PSMD2;CRTC1;EGFR;SEMA4B;FYN;KIF13B;ADAMTS7;CSMD3;DLG4;IDH2;PLXNB3;NET1;WNT7A;MAP4K4;GDI1;DKK1;PAK1;SOCS2;TRIB2;RAG1;TGFBR2;SHANK2;IMPACT;APOE;RGS14;LRP1;PPARA;LPAR3;FGFR1;TCFL5;SMOC1;PTK6;ULK2;LTBP4;INPP5F;FAM20C;ABCG1;KIAA1109;CEACAM1;OBSL1;TNRC6B;DVL1;MMP14;CD46;CTH;LRP5;CTSL;TWF2;CNTN1;TRIB3;MEX3C;PLAG1;PSMD7;PTHLH;CHD7;ASAP1;SPRY2;THRA;ACVR1B;NGFR;PTPRZ1;IFITM1;XBP1;UBASH3B;RET;CCDC71L;LOXL2;PDE5A;SH3PXD2B;CCDC88A;PRKACA;TIMP2;EIF2AK2;IL1RAP;CARD11;LPAR1;CTSZ;AP3D1;IGF2;PPARG;TBX1;ADAM8;SYT2;EEF2K;TNRC6C;OMG;FOXP1;PTCH1;KAT2B;UFL1;SEMA3F;ADNP;LRP4;FADD
14545,GO:0070059,0.0386520087023435,0.985731420098716,8,49,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,DDIT3;ATF4;CHAC1;TRIB3;CASP4;BOK;XBP1;WFS1
4710,GO:0010872,0.0387705070235374,0.997333521177664,2,5,regulation of cholesterol esterification,BP,APOE;ABCG1
9297,GO:0035739,0.038802180774875,0.997684063414073,2,4,CD4-positive, alpha-beta T cell proliferation,BP,ARG2;TGFBR2
19974,GO:2000561,0.038802180774875,0.997684063414073,2,4,regulation of CD4-positive, alpha-beta T cell proliferation,BP,ARG2;TGFBR2
4240,GO:0009438,0.038878022401711,0.997322015385545,2,5,methylglyoxal metabolic process,BP,GLO1;HAGH
9870,GO:0042129,0.0388815621055309,0.982145183415694,12,86,regulation of T cell proliferation,BP,PRNP;DLG1;ARG2;TGFBR2;RAC2;CD46;PRKAR1A;PDE5A;CARD11;IGF2;IL20RB;FADD
6204,GO:0019695,0.0389504775892285,0.997670247916576,2,4,choline metabolic process,BP,ALDH7A1;SLC44A1
11679,GO:0046461,0.0389967260318023,0.991969888823954,4,16,neutral lipid catabolic process,BP,APOE;MGLL;ABHD6;DDHD2
11682,GO:0046464,0.0389967260318023,0.991969888823954,4,16,acylglycerol catabolic process,BP,APOE;MGLL;ABHD6;DDHD2
11403,GO:0045793,0.0389976700006348,0.994596130745371,3,9,positive regulation of cell size,BP,RET;AKT3;RB1CC1
15558,GO:0072001,0.0389996807720489,0.976486280912537,26,194,renal system development,BP,PGF;CTNNBIP1;ITGA6;ITGB4;ACTA2;ACVR2B;WWTR1;DLG1;PODXL;SDC1;ARG2;PKD2;FGFR1;EPCAM;SOX4;SEC63;WNT2B;RET;LAMB2;ZNF354A;LAMA5;ALDH1A2;WFS1;ARID5B;PTCH1;LRP4
1943,GO:0004645,0.0390492314008393,0.99766103090893,2,4,phosphorylase activity,MF,PYGL;PYGB
20106,GO:2000778,0.0390501039083186,0.991955346354416,4,16,positive regulation of interleukin-6 secretion,BP,F2R;F2RL1;XBP1;IL1RAP
4567,GO:0010648,0.0392231756938495,0.96967202846131,95,934,negative regulation of cell communication,BP,TNIP1;DDIT4L;XDH;SMURF2;SORL1;CCND1;NEURL1;CTNNBIP1;ITGA6;SERPINE2;PEAR1;IGFBP4;PRNP;NR1D1;NFATC4;LTBP1;SH3KBP1;WWTR1;MST1R;APLN;DDIT3;PTPRS;HADH;PSMD2;EGFR;ARHGAP12;FYN;DLG1;HTRA1;MAP4K4;STRADB;DKK1;RASA3;SOCS2;TGFBR2;PTPN3;SHANK2;EPHA1;CD44;APOE;PTPN12;RGS14;PKD2;PRKACB;LRP1;WWC3;FGFR1;ITGA1;BTRC;PTK6;INPP5F;CHAC1;CEACAM1;FERMT1;NLK;EPN2;MDFI;DVL1;MMP14;CD46;CTH;TRIB3;RANBP9;DNAJB9;F2RL1;PSMD7;BOK;SPRY2;BCL2L1;XBP1;UBASH3B;ABHD6;ARRDC1;RET;MTMR4;EPM2A;SLC30A1;TMBIM1;TMSB4X;TIMP2;LPAR1;GRB10;PPARG;SNX6;RPH3AL;WFS1;LRP6;FOXP1;PTCH1;ANKRD6;ADNP;GNAI1;LRP4;RB1CC1;FADD
16089,GO:0090065,0.0392909666587467,1,1,1,regulation of production of siRNA involved in RNA interference,BP,RMRP
16818,GO:0098680,0.0392909666587467,1,1,1,template-free RNA nucleotidyltransferase,MF,RMRP
18523,GO:1903704,0.0392909666587467,1,1,1,negative regulation of production of siRNA involved in RNA interference,BP,RMRP
19561,GO:1990572,0.0392909666587467,1,1,1,TERT-RMRP complex,CC,RMRP
759,GO:0001999,0.0393577810590077,0.99763214559767,2,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,F2R;F2RL1
760,GO:0002001,0.0393577810590077,0.99763214559767,2,4,renin secretion into blood stream,BP,F2R;F2RL1
11381,GO:0045746,0.0394347335809378,0.988027960593801,6,32,negative regulation of Notch signaling pathway,BP,NEURL1;PEAR1;EGFR;CHAC1;MMP14;ARRDC1
10565,GO:0043523,0.0394687070858063,0.978685368491583,18,136,regulation of neuron apoptotic process,BP,F2R;PRNP;DDIT3;FYN;APOE;LRP1;ATF4;ITGA1;AARS;BOK;CPEB4;BCL2L1;CTSZ;ADAM8;WFS1;SIGMAR1;TRIM2;ADNP
2108,GO:0004887,0.0394913342880698,0.997619601828972,2,4,thyroid hormone receptor activity,MF,THRA;NR2F6
12931,GO:0051287,0.0396890864531068,0.985207780437397,8,52,NAD binding,MF,CRYL1;HADH;IDH2;LDHA;HIBADH;GLUD1;NUDT6;AOX1
11709,GO:0046500,0.0398193330015402,0.994260876232265,3,10,S-adenosylmethionine metabolic process,BP,MTHFR;AHCYL2;GAMT
2425,GO:0005604,0.0398296755097614,0.981914616052277,12,67,basement membrane,CC,ITGA6;THBS2;LAMB1;LOXL1;DLG1;SMOC2;SMOC1;CST3;LOXL2;VWA1;LAMB2;LAMA5
9633,GO:0036500,0.0398325422665007,0.994258207692852,3,10,ATF6-mediated unfolded protein response,BP,DDIT3;XBP1;WFS1
18623,GO:1903909,0.040002520673707,0.99757136126196,2,4,regulation of receptor clustering,BP,SSH1;LRP4
4984,GO:0015108,0.0402101357262773,0.986424569882472,7,36,chloride transmembrane transporter activity,MF,CLCA2;CLCN3;TTYH3;ANO8;ANO1;SLC12A7;PCYOX1
9421,GO:0035987,0.040329413368588,0.98645621060504,7,34,endodermal cell differentiation,BP,LAMB1;DKK1;HMGA2;ITGB5;MMP14;COL6A1;ITGA4
17486,GO:1900402,0.040348986521579,0.994562080385928,3,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,NR1D1;PPARA;KAT2B
13952,GO:0060633,0.0403622516040572,0.997537197177518,2,4,negative regulation of transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1;THRA
19752,GO:2000143,0.0403622516040572,0.997537197177518,2,4,negative regulation of DNA-templated transcription, initiation,BP,CTNNBIP1;THRA
2621,GO:0005940,0.0403629879136596,0.994328801473197,3,9,septin ring,CC,SEPT10;SEPT5;SEPT6
7213,GO:0031105,0.0403629879136596,0.994328801473197,3,9,septin complex,CC,SEPT10;SEPT5;SEPT6
7700,GO:0032160,0.0403629879136596,0.994328801473197,3,9,septin filament array,CC,SEPT10;SEPT5;SEPT6
14781,GO:0070482,0.0405317228933057,0.974028758883322,32,282,response to oxygen levels,BP,PLAT;NOS1;PGF;CYGB;POSTN;PSMD2;CAPN2;BNIP3;PAK1;TGFBR2;EDNRA;BNIP3L;ANGPTL4;LDHA;PPARA;ITGA2;MTHFR;MMP14;CST3;PSMD7;CPEB4;LOXL2;LPAR1;ZNF354A;ITPR2;PPARG;ADAM8;ENDOG;EEF2K;PSEN2;FAM162A;DNMT3A
12775,GO:0051050,0.0405373165100081,0.970217289940047,65,606,positive regulation of transport,BP,FHL1;EDEM1;TSPAN1;NOS1;F2R;SORL1;RAB3B;PCK2;PRNP;POSTN;RAPGEF3;ALOX15B;APLN;EGFR;STK39;ANK3;FYN;DLG1;GLUL;CEMIP;SDC1;STOM;PAK1;RAC2;APOE;PKD2;LRP1;AKAP9;ABCA7;LPAR3;FGFR1;TUB;ITGA2;VAMP2;ABCG1;SOX4;FERMT1;NTSR1;NLGN2;CNTN1;CLTCL1;VPS11;PPP3CB;F2RL1;ANO1;BOK;GLUD1;AZIN2;XBP1;TRPC1;C5;TMSB4X;IL1RAP;ORAI1;EFCAB7;PPARG;RPH3AL;ADAM8;WFS1;WASL;HSPA2;PRSS8;TMEM173;EEF2K;PTCH1
18127,GO:1902816,0.0405843082931768,0.997516019240386,2,4,regulation of protein localization to microtubule,BP,TTBK2;ABHD17C
18128,GO:1902817,0.0405843082931768,0.997516019240386,2,4,negative regulation of protein localization to microtubule,BP,TTBK2;ABHD17C
8424,GO:0033500,0.040691933720923,0.977529824408317,19,146,carbohydrate homeostasis,BP,PCK2;PYGL;NR1D1;MAP4K4;ERO1B;SOX4;LRP5;PPP3CB;ANO1;NGFR;XBP1;PRKACA;IGF2;PPARG;RPH3AL;WFS1;ENDOG;PTCH1;OAS1
10092,GO:0042593,0.040691933720923,0.977529824408317,19,146,glucose homeostasis,BP,PCK2;PYGL;NR1D1;MAP4K4;ERO1B;SOX4;LRP5;PPP3CB;ANO1;NGFR;XBP1;PRKACA;IGF2;PPARG;RPH3AL;WFS1;ENDOG;PTCH1;OAS1
7765,GO:0032281,0.0407553833785061,0.994070850477264,3,10,AMPA glutamate receptor complex,CC,DLG4;DLG3;ABHD6
19658,GO:1990909,0.0408066064656209,0.994475156403748,3,8,Wnt signalosome,CC,DVL1;LRP5;LRP6
895,GO:0002274,0.0409337228296336,0.971736084261197,45,427,myeloid leukocyte activation,BP,PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;PGM1;CTSB;CD68;STOM;TGFBR2;SLC2A3;LCN2;RAC2;CD44;ANXA3;LPCAT1;VAMP2;CEACAM1;RAB31;CST3;MOSPD2;COPB1;F2RL1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;DNASE1L1;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;ATP11B;TMEM173;HPSE;GALNS;DNAJC3;FOXP1
4723,GO:0010885,0.0409489283873872,0.994212879423762,3,9,regulation of cholesterol storage,BP,PPARA;ABCG1;PPARG
9796,GO:0040015,0.0409810100911364,0.994206511839522,3,9,negative regulation of multicellular organism growth,BP,BBS2;SOCS2;PTCH1
8730,GO:0034377,0.0410055294100735,0.991417929448302,4,16,plasma lipoprotein particle assembly,BP,APOE;PRKACB;ABCA7;PRKACA
6664,GO:0030018,0.0410219670161291,0.981231784785339,12,70,Z disc,CC,NOS1;FLNC;SCN8A;ANK3;PARVB;PAK1;OBSCN;FKBP1A;OBSL1;PPP3CB;FLNB;PSEN2
13040,GO:0051496,0.0410880482808937,0.98602481939069,7,37,positive regulation of stress fiber assembly,BP,RAPGEF3;PAK1;EPHA1;PFN2;FHOD1;SH3PXD2B;LPAR1
8190,GO:0032928,0.041254015099763,0.993822951744437,3,11,regulation of superoxide anion generation,BP,EGFR;ACP5;F2RL1
14626,GO:0070193,0.0413291179842355,0.993953455979541,3,10,synaptonemal complex organization,BP,REC8;MLH3;HSPA2
6757,GO:0030178,0.0413365164797584,0.977103595692451,19,151,negative regulation of Wnt signaling pathway,BP,CCND1;CTNNBIP1;IGFBP4;NFATC4;WWTR1;DDIT3;PSMD2;DKK1;APOE;LRP1;FERMT1;NLK;MDFI;DVL1;PSMD7;GRB10;LRP6;ANKRD6;LRP4
12739,GO:0051004,0.0413972436449132,0.993939470223824,3,10,regulation of lipoprotein lipase activity,BP,LMF1;ANGPTL4;PCSK6
3234,GO:0006887,0.0414683152333283,0.969698161633867,62,598,exocytosis,BP,RAB3B;PYGL;PYGB;PRSS3;NAPRT;PSMD2;EXOC2;LTA4H;SNPH;PGM1;CTSB;CD68;SDC1;STOM;PAK1;SERPING1;SLC2A3;LCN2;SCRN1;RAC2;CD44;ANXA3;LPCAT1;VAMP2;PFN2;CEACAM1;RAB31;CST3;SEC22C;VPS11;MOSPD2;RIMS3;PPP3CB;SYTL1;APLP2;COPB1;F2RL1;C6ORF120;PSMD7;QSOX1;SEPT5;GLB1;YPEL5;DNASE1L1;TMBIM1;TMSB4X;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;IGF2;TMEM63A;ERP44;RPH3AL;ADAM8;ATP11B;SYT2;TMEM173;HPSE;GALNS;DNAJC3
11884,GO:0046898,0.0415511016342652,0.997423026447777,2,4,response to cycloheximide,BP,XRN1;BCL2L1
9798,GO:0040017,0.0416009126858845,0.971960205565782,40,344,positive regulation of locomotion,BP,DOCK4;SMURF2;F2R;PGF;ITGA6;POSTN;SSH1;PC;LAMB1;EGFR;SEMA4B;PODXL;WNT7A;CEMIP;PAK1;TGFBR2;EPHA1;RAC2;ANXA3;FGFR1;HYAL1;ITGA2;FAM110C;MMP14;MOSPD2;F2RL1;SPRY2;ACVR1B;XBP1;RET;TMSB4X;LPAR1;GRB7;SRPX2;ADAM8;AKT3;ITGA4;FOXP1;SEMA3F;FADD
3875,GO:0008504,0.0419380080922014,0.997385453550869,2,4,monoamine transmembrane transporter activity,MF,SLC29A4;SLC18A2
6649,GO:0023057,0.0419661146345153,0.967442656021964,95,937,negative regulation of signaling,BP,TNIP1;DDIT4L;XDH;SMURF2;SORL1;CCND1;NEURL1;CTNNBIP1;ITGA6;SERPINE2;PEAR1;IGFBP4;PRNP;NR1D1;NFATC4;LTBP1;SH3KBP1;WWTR1;MST1R;APLN;DDIT3;PTPRS;HADH;PSMD2;EGFR;ARHGAP12;FYN;DLG1;HTRA1;MAP4K4;STRADB;DKK1;RASA3;SOCS2;TGFBR2;PTPN3;SHANK2;EPHA1;CD44;APOE;PTPN12;RGS14;PKD2;PRKACB;LRP1;WWC3;FGFR1;ITGA1;BTRC;PTK6;INPP5F;CHAC1;CEACAM1;FERMT1;NLK;EPN2;MDFI;DVL1;MMP14;CD46;CTH;TRIB3;RANBP9;DNAJB9;F2RL1;PSMD7;BOK;SPRY2;BCL2L1;XBP1;UBASH3B;ABHD6;ARRDC1;RET;MTMR4;EPM2A;SLC30A1;TMBIM1;TMSB4X;TIMP2;LPAR1;GRB10;PPARG;SNX6;RPH3AL;WFS1;LRP6;FOXP1;PTCH1;ANKRD6;ADNP;GNAI1;LRP4;RB1CC1;FADD
12955,GO:0051336,0.0420209939189799,0.967529730342889,92,897,regulation of hydrolase activity,BP,DOCK4;XDH;NOS1;F2R;SORL1;ASAP2;ITGA6;SERPINE2;TFPI2;RAPGEF3;LMF1;ARHGAP22;TNFSF15;EGFR;TBC1D14;RIN2;ARHGAP12;PPP1R14A;FYN;TNFRSF6B;ARAP1;PLXNB3;SNX9;NET1;EVI5L;ASPH;GDI1;DLG3;DAP;RASA3;RAG1;SERPING1;EDNRA;EPHA1;RALGAPA2;CD44;FKBP1A;ANGPTL4;RGS14;SRGAP2B;LRP1;PPP2R3B;ELFN2;FGFR1;ITGA1;PPP1R35;ITGA2;PFN2;RALGAPA1;TCEA1;MMP14;DNMBP;DOCK9;CST3;CASP4;PCSK6;APLP2;PRDX5;F2RL1;RASIP1;CSNK2A1;ASAP1;BOK;USP6NL;SPRY2;TBC1D2B;NGFR;PPP1R10;ARF4;PPP1R2;RIN1;C5;GABARAPL2;DOCK11;TMSB4X;TIMP2;EIF2AK2;IFI16;SLC39A10;FICD;LPAR1;PPARG;ARHGAP29;EVI5;DEPDC1;ACAP2;TBC1D16;HSPA2;RCAN1;OAS1;FAM162A;FADD
10421,GO:0043260,0.0421038054937279,0.998110975544532,2,3,laminin-11 complex,CC,LAMB2;LAMA5
15225,GO:0071377,0.0421288389252886,0.988958885737714,5,22,cellular response to glucagon stimulus,BP,ADCY7;PRKACB;PRKAR1A;PRKACA;ADCY1
10420,GO:0043259,0.0421575862393324,0.998107184189691,2,3,laminin-10 complex,CC,LAMB1;LAMA5
5451,GO:0016323,0.0422636803372493,0.977066313583826,18,125,basolateral plasma membrane,CC,ITGA6;MST1R;EGFR;STK39;ANK3;DLG1;DLG4;DLG3;CLCA2;ATP7B;PKD2;LRP1;EPCAM;CEACAM1;SLC2A9;MAP4K2;ATP12A;SLC23A2
9541,GO:0036293,0.0422832818428002,0.973227299587239,30,262,response to decreased oxygen levels,BP,PLAT;NOS1;PGF;CYGB;POSTN;PSMD2;CAPN2;BNIP3;PAK1;TGFBR2;EDNRA;BNIP3L;ANGPTL4;LDHA;PPARA;ITGA2;MTHFR;MMP14;CST3;PSMD7;CPEB4;LOXL2;ZNF354A;ITPR2;ADAM8;ENDOG;EEF2K;PSEN2;FAM162A;DNMT3A
7382,GO:0031434,0.0422960498451676,0.984303807902428,8,42,mitogen-activated protein kinase kinase binding,MF,MST1R;EGFR;DLG1;TRIB2;EPHA1;FGFR1;TRIB3;RET
6555,GO:0021987,0.0423727556916171,0.979738791414819,13,82,cerebral cortex development,BP,BBS2;PTPRS;LAMB1;EGFR;BNIP3;LRP1;TACC1;CEP120;BTBD3;CSNK2A1;SLC38A2;MBOAT7;LRP6
3951,GO:0008652,0.0424184722641684,0.982913747019889,9,58,cellular amino acid biosynthetic process,BP,CBS;GPT2;PSAT1;GLUL;NAGS;ASNS;GAMT;CTH;GLUD1
13604,GO:0060074,0.0425335224453631,0.993895838283491,3,9,synapse maturation,BP,NEURL1;NFATC4;ADGRL1
12597,GO:0050773,0.0425722408809953,0.978386319400259,15,99,regulation of dendrite development,BP,ZMYND8;NEURL1;VLDLR;HECW2;NFATC4;PTPRS;CRTC1;CSMD3;SHANK2;APOE;OBSL1;ASAP1;IL1RAP;LPAR1;EEF2K
12806,GO:0051100,0.0428252580216297,0.977562311369001,16,123,negative regulation of binding,BP,SORL1;CTNNBIP1;NFATC4;DDIT3;TTBK2;DKK1;HMGA2;PPARA;MDFI;DVL1;TMSB4X;IFI16;CTSZ;RSF1;ITGA4;ADNP
16458,GO:0097119,0.0428707616058135,0.99729403745213,2,4,postsynaptic density protein 95 clustering,BP,ZMYND8;NLGN2
10030,GO:0042474,0.0429417168341914,0.993465799485723,3,11,middle ear morphogenesis,BP,FGFR1;TSHZ1;TBX1
5323,GO:0016049,0.0429954180291841,0.970942691925933,40,346,cell growth,BP,FHL1;CYP27B1;SERPINE2;IGFBP4;POSTN;DCBLD2;MAP1B;PTPRS;EGFR;SEMA4B;PLXNB3;NET1;HTRA1;GDI1;WISP1;PAK1;SOCS2;TGFBR2;IMPACT;APOE;LPAR3;HYAL1;ULK2;LTBP4;KIAA1109;CEACAM1;DVL1;MMP14;TWF2;PPP3CB;MEX3C;CSNK2A1;ACVR1B;EPB41L3;LAMB2;PPARG;IGFBP7;SYT2;SEMA3F;ADNP
13670,GO:0060193,0.043003996513519,0.986710866520896,6,31,positive regulation of lipase activity,BP,LMF1;EGFR;EDNRA;FGFR1;ARF4;LPAR1
11900,GO:0046923,0.0430458863149655,0.996862026052261,2,5,ER retention sequence binding,MF,CEMIP;KDELR3
14876,GO:0070661,0.0431033209684473,0.975980045280153,19,156,leukocyte proliferation,BP,PRNP;PKN1;FYN;DLG1;ARG2;TGFBR2;RAC2;FKBP1A;CD46;PPP3CB;F2RL1;PRKAR1A;SATB1;PDE5A;SLC39A10;CARD11;IGF2;IL20RB;FADD
6696,GO:0030073,0.0432257660999259,0.976885127604138,17,124,insulin secretion,BP,PCK2;NR1D1;RAPGEF3;ACVR2B;HADH;GLUL;MAP4K4;ICA1;SOX4;ITPR3;NLGN2;LRP5;PPP3CB;SLC25A4;ANO1;GLUD1;ITPR2
17340,GO:1900019,0.0432515752955641,0.997256377125028,2,4,regulation of protein kinase C activity,BP,EGFR;CEMIP
17341,GO:1900020,0.0432515752955641,0.997256377125028,2,4,positive regulation of protein kinase C activity,BP,EGFR;CEMIP
11472,GO:0045926,0.0434111328862712,0.975054852509467,21,166,negative regulation of growth,BP,FHL1;CYP27B1;SERPINE2;BBS2;ALOX15B;DCBLD2;PTPRS;SEMA4B;PAK1;SOCS2;TGFBR2;WWC3;HYAL1;PTK6;ULK2;MT2A;ACVR1B;PPARG;PTCH1;JARID2;SEMA3F
8405,GO:0033344,0.0437852226450408,0.988401220292934,5,22,cholesterol efflux,BP,APOE;LRP1;ABCA7;ABCG1;PTCH1
3746,GO:0008283,0.0437888778949758,0.96476613221001,130,1329,cell proliferation,BP,XDH;TSPAN1;ERCC1;F2R;FAM83A;ETV5;PGF;CCND1;NEURL1;SH2D2A;CTNNBIP1;RPS6KA2;CYP27B1;SERPINE2;IGFBP4;PRNP;MARCKSL1;NR1D1;ADARB1;MAP2K1;RAPGEF3;ALOX15B;PKN1;WWTR1;MST1R;APLN;APPL2;LAMB1;EGFR;CGREF1;FYN;TNFRSF6B;DLG1;IDH2;PLXNB3;GPC4;TGM2;GLUL;HTRA1;WNT7A;GRK5;ASPH;ARG2;SHC1;DLG3;PAK1;TGFBR2;EDNRA;EPHA1;RAC2;APOE;FKBP1A;CCPG1;CCND2;PKD2;LRP1;HMGA2;FGFR1;ITGA1;EPCAM;TACC1;TCFL5;HYAL1;BTRC;ITGA2;PTK6;SOX4;FBXO2;CEP120;CEACAM1;FERMT1;MMP14;CD46;LRP5;CST3;PPP3CB;PLAG1;F2RL1;UHRF2;CSNK2A1;PTHLH;PRKAR1A;BOK;NACC2;SPRY2;BEX4;WNT2B;NGFR;PTPRZ1;BCL2L1;IFITM1;MEF2D;SKAP2;XBP1;SATB1;LOXL2;PDE5A;C1ORF56;EAPP;CCDC88A;TIMP2;EIF2AK2;IFI16;SLC39A10;CARD11;CTSZ;HOXA3;IGF2;LAMA5;PPARG;ALDH1A2;TBX1;EVI5;AKT3;IL20RB;CKLF;IGFBP7;LRP6;E2F7;HPSE;SSR1;TET1;FOXP1;PTCH1;KAT2B;CNOT11;UFL1;JARID2;MXD4;FADD
6396,GO:0021602,0.0438063584245039,0.990746519524382,4,15,cranial nerve morphogenesis,BP,ADARB1;HOXA3;TBX1;SEMA3F
19457,GO:1990138,0.0439180729533946,0.976574112043898,17,112,neuron projection extension,BP,POSTN;MAP1B;PTPRS;SEMA4B;PLXNB3;GDI1;PAK1;IMPACT;APOE;ULK2;DVL1;TWF2;PPP3CB;LAMB2;SYT2;SEMA3F;ADNP
7209,GO:0031100,0.0439508852256253,0.982199777387867,9,57,animal organ regeneration,BP,PGF;CCND1;EGFR;TGFBR2;PTPN3;ANXA3;CSNK2A1;PPARG;PTCH1
6725,GO:0030136,0.0441512094263344,0.9763350931573,17,123,clathrin-coated vesicle,CC,EPN3;EGFR;SNX9;MALL;CEMIP;APOE;LRP1;VAMP2;INPP5F;EPN2;DVL1;CLTCL1;VPS11;FCHO2;AP2A2;SYT2;SLC18A2
12324,GO:0048675,0.0442757558581333,0.978062461535098,14,87,axon extension,BP,MAP1B;PTPRS;SEMA4B;PLXNB3;GDI1;PAK1;APOE;ULK2;DVL1;TWF2;PPP3CB;LAMB2;SEMA3F;ADNP
11619,GO:0046321,0.0445133560770532,0.993755765070717,3,8,positive regulation of fatty acid oxidation,BP,PPARA;MLYCD;PPARG
13251,GO:0051928,0.0445423660261372,0.981959505079756,9,55,positive regulation of calcium ion transport,BP,F2R;CEMIP;PKD2;LPAR3;NTSR1;TRPC1;ORAI1;WFS1;HSPA2
466,GO:0001504,0.0445931903511464,0.990408831558206,4,16,neurotransmitter uptake,BP,NOS1;RAB3B;GLUL;NTSR1
9472,GO:0036091,0.0446725590742901,0.997114131383819,2,4,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,ATF4;CHD6
4623,GO:0010743,0.0447377557054436,0.990367558291301,4,16,regulation of macrophage derived foam cell differentiation,BP,ALOX15B;PPARA;ABCG1;PPARG
15215,GO:0071361,0.0448120960904613,0.993696619422928,3,8,cellular response to ethanol,BP,ADCY7;ITPR2;DNMT3A
17932,GO:1902259,0.0448719337743862,0.993418672257779,3,9,regulation of delayed rectifier potassium channel activity,BP,KCNG1;ANK3;VAMP2
3686,GO:0008188,0.0450685534620675,0.996629147360802,2,5,neuropeptide receptor activity,MF,NTSR1;LTB4R
8047,GO:0032700,0.0451135810879313,0.996623892563913,2,5,negative regulation of interleukin-17 production,BP,PRNP;ARG2
1436,GO:0003415,0.0453343370580265,0.997046965339367,2,4,chondrocyte hypertrophy,BP,TGFBR2;MEX3C
5539,GO:0016528,0.0453381447985414,0.98293631226162,8,42,sarcoplasm,CC,XDH;NOS1;FLNC;ANK3;ASPH;FKBP1A;ITPR3;ITPR2
12831,GO:0051138,0.0454234118342122,0.997037880450628,2,4,positive regulation of NK T cell differentiation,BP,TGFBR2;AP3D1
9950,GO:0042311,0.045551906480817,0.989939504552011,4,18,vasodilation,BP,NOS1;BBS2;APOE;ITGA1
2097,GO:0004864,0.0456645286261132,0.987616991088958,5,24,protein phosphatase inhibitor activity,MF,PPP1R14A;ELFN2;PPP1R35;PPP1R10;PPP1R2
15051,GO:0070997,0.0457322304321357,0.97135724426465,28,234,neuron death,BP,F2R;SORL1;PRNP;ADARB1;SSH1;DDIT3;FYN;BNIP3;DKK1;APOE;LRP1;ATF4;PPARA;ITGA1;AARS;BOK;CPEB4;NGFR;BCL2L1;CTSZ;ADAM8;WFS1;ENDOG;SIGMAR1;TRIM2;FAM162A;ADNP;FADD
13558,GO:0060021,0.045837258287985,0.980411312017572,10,57,roof of mouth development,BP,ACVR2B;DLG1;WNT7A;ASPH;TGFBR2;CHD7;TSHZ1;TBX1;LRP6;ARID5B
12885,GO:0051223,0.0459131103220194,0.967319434371749,51,474,regulation of protein transport,BP,EDEM1;F2R;SORL1;PCK2;PRNP;POSTN;SH3TC2;NR1D1;RAPGEF3;ALOX15B;HADH;EGFR;ANK3;FYN;UBE2J1;IDH2;GLUL;MAP4K4;GDI1;CEMIP;ARG2;STOM;PAK1;RAC2;BNIP3L;LRP1;ICA1;VAMP2;SOX4;ITPR3;FERMT1;NLGN2;LRP5;VPS11;PPP3CB;F2RL1;SLC25A4;ANO1;GLUD1;XBP1;C5;TMSB4X;IL1RAP;ITPR2;EFCAB7;ERLEC1;LYPLA1;RPH3AL;ADAM8;TMEM173;FOXP1
7930,GO:0032507,0.0459218933734192,0.980275482089939,10,61,maintenance of protein location in cell,BP,SORL1;SYNE3;ANK3;SOX4;VPS13A;TWF2;TMSB4X;EPB41L3;KDELR3;FLNB
19188,GO:1905271,0.0459471379284091,1,1,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,TMSB4X
19189,GO:1905273,0.0459471379284091,1,1,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,TMSB4X
10255,GO:0042989,0.0459824570265048,0.99623379503688,2,6,sequestering of actin monomers,BP,TWF2;TMSB4X
11394,GO:0045776,0.046041839825564,0.987486030730808,5,24,negative regulation of blood pressure,BP,NOS1;ADM2;APLN;PPARA;NTSR1
11869,GO:0046873,0.0460704042360734,0.971740510727256,26,199,metal ion transmembrane transporter activity,MF,SCN8A;KCNG1;DENND5B;SLC9A7;RASA3;ATP7B;PKD2;FAM155B;ITPR3;SLC5A1;ORAI3;NIPA1;SLC6A6;SLC6A14;GRIN3B;SLC12A7;TRPC1;SLC13A3;KCNJ15;SLC30A1;SLC39A10;ORAI1;ITPR2;SLC10A6;ATP12A;SLC23A2
12823,GO:0051128,0.0460967360174148,0.961799168619268,178,1801,regulation of cellular component organization,BP,FHL1;TSPAN1;NOS1;ERCC1;ZMYND8;SORL1;ETV5;NEURL1;CTNNBIP1;VLDLR;SYNE3;MMP1;CYP27B1;SERPINE2;IGFBP4;PRNP;POSTN;HECW2;NFATC4;MAP2K1;THBS2;FMNL2;RAPGEF3;SH3KBP1;DCBLD2;APLN;SSH1;MAP1B;PTPRS;CRTC1;ADGRL1;CAPN2;WIPF1;EGFR;TBC1D14;SEMA4B;FYN;BNIP3;KIF13B;PARVB;ARAP1;DLG1;CSMD3;DLG4;PLXNB3;SNX9;PODXL;NET1;ESPN;EVI5L;HTRA1;WNT7A;MAP4K4;TTBK2;ASPH;MCTP1;GDI1;SDC1;DKK1;WISP1;PAK1;SOCS2;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;CD44;APOE;BNIP3L;AFAP1;LRP1;FYCO1;IDE;AKAP9;ABCA7;LPAR3;FGFR1;TMOD2;TUB;HYAL1;ITGA2;PTK6;ULK2;LTBP4;INPP5F;ATRX;MTHFR;PFN2;KIAA1109;FHOD1;DDB2;CEP120;CEACAM1;OBSL1;LMAN1;ATF7IP;FAM110C;SH3D19;XRN1;DVL1;MMP14;PLEK2;NLGN2;LRP5;ZMYM3;TWF2;CST3;CNTN1;TPBG;TOM1L2;VPS11;WASF3;ADGRB2;DNAJC6;SLK;FNBP1L;F2RL1;UHRF2;TAOK1;CSNK2A1;PHF1;ASAP1;PRKAR1A;JMY;BOK;ATXN2;USP6NL;SPRY2;TBC1D2B;THRA;ACVR1B;NGFR;PPP1R10;BCL2L1;WASF2;SPIRE1;MAP2K2;RET;SH3PXD2B;NCKAP1;DOCK11;CCDC88A;CCSAP;PRKACA;NEK6;TMSB4X;EIF2AK2;EPB41L3;RHOBTB1;IL1RAP;LPAR1;CTSZ;ARPC1A;TENM2;IGF2;MOAP1;ZMYM2;PPARG;SRPX2;EVI5;ENDOG;IGFBP7;TBC1D16;DDHD2;WASL;HSPA2;SYT2;EEF2K;TET1;OMG;KAT2B;FAM162A;JARID2;SEMA3F;ADNP;GNAI1;LRP4
8926,GO:0034767,0.0462635602000225,0.979134199186067,11,70,positive regulation of ion transmembrane transport,BP,NOS1;F2R;STK39;ANK3;CEMIP;PKD2;AKAP9;NTSR1;TRPC1;TMSB4X;HSPA2
7496,GO:0031667,0.0463216371526703,0.969177051560871,36,318,response to nutrient levels,BP,ERCC1;CCND1;PCK2;CYP27B1;BBS2;POSTN;SSH1;DDIT3;EGFR;FYN;GLUL;DAP;TGFBR2;IMPACT;APOE;LDHA;ATF4;PPARA;ASNS;ITGA2;ULK2;MTHFR;CST3;CPEB4;WNT2B;XBP1;SLC38A2;GABARAPL2;EIF2AK2;IFI16;ZNF354A;IGF2;PPARG;ALDH1A2;UFL1;DNMT3A
2717,GO:0006094,0.0464039288243099,0.982178790075742,8,51,gluconeogenesis,BP,PCK2;NR1D1;PC;PGM1;ATF4;PPARA;SLC35B4;KAT2B
6630,GO:0022890,0.0464193674235821,0.96993987520888,32,268,inorganic cation transmembrane transporter activity,MF,SCN8A;KCNG1;DENND5B;SLC33A1;SLC9A7;RASA3;ATP7B;PKD2;FAM155B;ITPR3;SLC5A1;ORAI3;NIPA1;SLC2A9;SLC6A6;ANO1;SLC6A14;NDUFA4L2;GRIN3B;SLC12A7;TRPC1;SLC13A3;KCNJ15;SLC30A1;SLC39A10;ORAI1;ITPR2;SLC2A13;SLC10A6;ATP12A;ATP6V1B2;SLC23A2
5667,GO:0016776,0.0464290800991949,0.985287942118596,6,33,phosphotransferase activity, phosphate group as acceptor,MF,DLG1;DLG4;NME4;DLG3;CARD11;AK9
4625,GO:0010745,0.0464822691803654,0.993083749837738,3,9,negative regulation of macrophage derived foam cell differentiation,BP,PPARA;ABCG1;PPARG
9377,GO:0035904,0.0465093296284718,0.983879942934336,7,34,aorta development,BP,LTBP1;LOXL1;PKD2;LRP1;SOX4;CHD7;TBX1
18230,GO:1903034,0.0467545639316282,0.976486584194929,14,100,regulation of response to wounding,BP,PLAT;F2R;SERPINE2;MAP2K1;PTPRS;TGFBR2;SERPING1;APOE;INPP5F;CEACAM1;F2RL1;XBP1;UBASH3B;HPSE
9949,GO:0042310,0.0468167898930803,0.983569865025805,7,38,vasoconstriction,BP,DOCK4;F2R;BBS2;APLN;EGFR;HTR7;EDNRA
4060,GO:0009109,0.047031633348384,0.99257554206577,3,11,coenzyme catabolic process,BP,ACOT7;ALDH1L2;PM20D2
4647,GO:0010769,0.0470703200778821,0.971069987885857,26,198,regulation of cell morphogenesis involved in differentiation,BP,POSTN;HECW2;NFATC4;MAP2K1;SSH1;MAP1B;PTPRS;SEMA4B;KIF13B;PLXNB3;NET1;WNT7A;GDI1;PAK1;APOE;LPAR3;ULK2;OBSL1;TWF2;NGFR;RET;EEF2K;OMG;SEMA3F;ADNP;LRP4
6071,GO:0019220,0.0471210546437638,0.962276065232688,120,1195,regulation of phosphate metabolic process,BP,TNIP1;XDH;NOS1;F2R;SORL1;CCND1;NEURL1;VLDLR;ITGA6;ADCY7;IGFBP4;PRNP;ADARB1;MAP2K1;RAPGEF3;ACVR2B;PKN1;WWTR1;MST1R;APLN;TNFSF15;EGFR;STK39;PPP1R14A;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;SOCS2;TRIB2;TGFBR2;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;CCND2;RGS14;PKD2;PRKACB;AKAP9;PPP2R3B;PPARA;ABCA7;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;LPCAT1;ITGA2;PTK6;INPP5F;PFN2;CEACAM1;MAPKAPK3;TRIM5;DVL1;NTSR1;LRP5;ETAA1;CNTN1;TRIB3;RANBP9;SLK;F2RL1;TAOK1;CSNK2A1;PTHLH;PRKAR1A;PARP9;SPRY2;ACVR1B;NGFR;PPP1R10;UBASH3B;MAP2K2;PPP1R2;RET;PDE5A;C5;MTMR4;PAK6;CCDC88A;SHC2;PRKACA;TMSB4X;TIMP2;EIF2AK2;SLC39A10;LPAR1;IGF2;GRB10;MAP4K2;SNX6;SRPX2;TBX1;ADAM8;FZD8;HSPA2;LRP6;EEF2K;RCAN1;DNAJC3;ADCY1;KAT2B;ANKRD6;ADNP;LRP4;RB1CC1
13560,GO:0060023,0.0474001815577593,0.99683357264406,2,4,soft palate development,BP,TSHZ1;TBX1
11812,GO:0046697,0.0474751600206889,0.989577318418507,4,16,decidualization,BP,CYP27B1;CTSB;BSG;EPOR
7647,GO:0032058,0.0475871526677376,0.996813982857264,2,4,positive regulation of translational initiation in response to stress,BP,IMPACT;DNAJC3
7608,GO:0031994,0.0476617388489045,0.992835223396854,3,9,insulin-like growth factor I binding,MF,ITGA6;IGFBP4;ITGB4
14607,GO:0070166,0.0477161552430064,0.992823692263996,3,9,enamel mineralization,BP,PPARA;FAM20C;TBX1
8213,GO:0032966,0.0477479272049507,0.996311171055258,2,5,negative regulation of collagen biosynthetic process,BP,CYGB;PPARG
12279,GO:0048588,0.0477970280217307,0.972749254103499,20,142,developmental cell growth,BP,POSTN;MAP1B;PTPRS;SEMA4B;PLXNB3;GDI1;PAK1;TGFBR2;IMPACT;APOE;LPAR3;ULK2;DVL1;TWF2;PPP3CB;MEX3C;LAMB2;SYT2;SEMA3F;ADNP
12019,GO:0047617,0.0478161057892742,0.992255942840788,3,12,acyl-CoA hydrolase activity,MF,ACOT1;ACOT7;ACOT13
17377,GO:1900101,0.0478323197137317,0.986794341963347,5,25,regulation of endoplasmic reticulum unfolded protein response,BP,DNAJB9;BOK;XBP1;FICD;WFS1
537,GO:0001655,0.0478650720650304,0.969956010562284,28,217,urogenital system development,BP,PGF;CTNNBIP1;ITGA6;ITGB4;ACTA2;ACVR2B;ALOX15B;WWTR1;DLG1;PODXL;SDC1;ARG2;PKD2;FGFR1;EPCAM;SOX4;SEC63;PLAG1;WNT2B;RET;LAMB2;ZNF354A;LAMA5;ALDH1A2;WFS1;ARID5B;PTCH1;LRP4
2317,GO:0005319,0.0479582254952107,0.977333902313166,12,80,lipid transporter activity,MF,PITPNC1;OSBPL10;APOE;ABCD1;ABCA7;ABCG1;PITPNM1;CEACAM1;ATP10D;OSBPL5;SLC10A6;ATP11B
3392,GO:0007169,0.0481607413238229,0.965188933126925,55,495,transmembrane receptor protein tyrosine kinase signaling pathway,BP,XDH;PLAT;FAM83A;PGF;NEURL1;SH2D2A;IGFBP4;PAG1;SH3TC2;SH3KBP1;MST1R;APLN;EIF4EBP1;EGFR;FYN;MAPK13;ARAP1;SHC1;PAK1;SOCS2;PTPN3;EPHA1;PTPN12;RGS14;LRP1;IDE;FGFR1;ITGA1;PTK6;GALNT3;FAM20C;CEACAM1;MAPKAPK3;EPN2;MVB12B;MYOF;SPRY2;NGFR;MVB12A;WASF2;ARF4;UBASH3B;RET;NCKAP1;SHC2;AP2A2;ARPC1A;IGF2;GRB10;SNX6;GRB7;ATP6V1B2;WASL;ARID5B;PSEN2
14932,GO:0070813,0.0481653888160413,0.996260666694938,2,5,hydrogen sulfide metabolic process,BP,CBS;CTH
10731,GO:0044087,0.0482638188700315,0.963641205173029,72,667,regulation of cellular component biogenesis,BP,ERCC1;ZMYND8;SORL1;NEURL1;CTNNBIP1;MMP1;THBS2;RAPGEF3;SSH1;ADGRL1;WIPF1;TBC1D14;ARAP1;DLG1;PLXNB3;SNX9;PODXL;ESPN;EVI5L;WNT7A;SDC1;DKK1;PAK1;SLITRK6;EPHA1;IMPACT;RAC2;APOE;IDE;AKAP9;TMOD2;HYAL1;PFN2;FHOD1;DDB2;CEP120;ATF7IP;FAM110C;MMP14;NLGN2;TWF2;TPBG;VPS11;ADGRB2;SLK;FNBP1L;F2RL1;ASAP1;JMY;ATXN2;THRA;WASF2;SPIRE1;SH3PXD2B;NCKAP1;DOCK11;CCDC88A;CCSAP;SAMD8;PRKACA;TMSB4X;EIF2AK2;IL1RAP;LPAR1;ARPC1A;TENM2;SRPX2;WASL;HSPA2;EEF2K;KAT2B;ADNP
891,GO:0002263,0.0483259905344778,0.965698739044082,49,471,cell activation involved in immune response,BP,ERCC1;PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;PGM1;CTSB;CD68;STOM;SLC2A3;LCN2;RAC2;CD44;LRP1;ANXA3;LPCAT1;VAMP2;CEACAM1;RAB31;CD46;CST3;MOSPD2;COPB1;F2RL1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;XBP1;DNASE1L1;DOCK11;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;ATP11B;TMEM173;HPSE;GALNS;DNAJC3;FOXP1
3160,GO:0006767,0.0483932351183204,0.978915957319025,10,66,water-soluble vitamin metabolic process,BP,PRSS3;PC;PSAT1;SLC2A3;ACP5;ALDH1L2;MTHFR;PM20D2;AOX1;SLC23A2
2140,GO:0004953,0.0483970275709514,0.996232532102081,2,5,icosanoid receptor activity,MF,LTB4R;PPARG
12062,GO:0048010,0.0484230129114128,0.977957267121377,11,72,vascular endothelial growth factor receptor signaling pathway,BP,PGF;SH2D2A;FYN;MAPK13;MAPKAPK3;EPN2;MYOF;WASF2;NCKAP1;SHC2;GRB10
2390,GO:0005527,0.0484487649795775,0.99211159577801,3,12,macrolide binding,MF,FKBP9;FKBP1A;FKBP10
2391,GO:0005528,0.0484487649795775,0.99211159577801,3,12,FK506 binding,MF,FKBP9;FKBP1A;FKBP10
4596,GO:0010711,0.0485721751307788,1,1,1,negative regulation of collagen catabolic process,BP,CST3
13737,GO:0060309,0.0485721751307788,1,1,1,elastin catabolic process,BP,CST3
13738,GO:0060310,0.0485721751307788,1,1,1,regulation of elastin catabolic process,BP,CST3
13739,GO:0060311,0.0485721751307788,1,1,1,negative regulation of elastin catabolic process,BP,CST3
540,GO:0001658,0.0485914135163543,0.982893072111753,7,36,branching involved in ureteric bud morphogenesis,BP,PGF;CTNNBIP1;DLG1;PKD2;WNT2B;LAMA5;PTCH1
12825,GO:0051130,0.0485991148407795,0.962079304199883,94,906,positive regulation of cellular component organization,BP,TSPAN1;NOS1;ERCC1;ZMYND8;NEURL1;VLDLR;MMP1;MAP2K1;THBS2;RAPGEF3;APLN;SSH1;MAP1B;CRTC1;ADGRL1;WIPF1;FYN;BNIP3;ARAP1;DLG1;DLG4;PLXNB3;SNX9;NET1;ESPN;WNT7A;GDI1;SDC1;PAK1;SHANK2;SLITRK6;EPHA1;RAC2;APOE;LRP1;FYCO1;IDE;AKAP9;ABCA7;LPAR3;FGFR1;TUB;HYAL1;ITGA2;PTK6;ATRX;PFN2;FHOD1;DDB2;CEP120;OBSL1;LMAN1;DVL1;PLEK2;NLGN2;LRP5;TWF2;CNTN1;TPBG;VPS11;ADGRB2;FNBP1L;F2RL1;PHF1;ASAP1;JMY;BOK;NGFR;PPP1R10;WASF2;SPIRE1;RET;SH3PXD2B;NCKAP1;DOCK11;CCDC88A;IL1RAP;LPAR1;ARPC1A;TENM2;IGF2;MOAP1;PPARG;SRPX2;ENDOG;DDHD2;WASL;SYT2;EEF2K;TET1;FAM162A;JARID2;ADNP;LRP4
10630,GO:0043627,0.0486568877975075,0.981186923988757,8,49,response to estrogen,BP,CCND1;CYP27B1;WNT7A;TGFBR2;LDHA;MMP14;PPARG;CITED4
5569,GO:0016581,0.0488001988742351,0.989319275171255,4,15,NuRD complex,CC,SALL2;APPL2;CSNK2A1;NACC2
16332,GO:0090545,0.0488001988742351,0.989319275171255,4,15,CHD-type complex,CC,SALL2;APPL2;CSNK2A1;NACC2
414,GO:0001101,0.0489634166029565,0.96940233893932,27,228,response to acid chemical,BP,NEURL1;NFATC4;CAPN2;EGFR;FYN;DKK1;PKD2;ASNS;ITGA2;PTK6;MTHFR;TWF2;CRLS1;CPEB4;COL6A1;BCL2L1;XBP1;RET;COL1A2;ZNF354A;PPARG;ALDH1A2;TBX1;IGFBP7;PTCH1;UFL1;DNMT3A
12216,GO:0048406,0.0490219736954558,0.996662135171504,2,4,nerve growth factor binding,MF,PCSK6;NGFR
2665,GO:0006012,0.049177708735732,0.992094765066628,3,11,galactose metabolic process,BP,PGM1;GLB1;GALE
8343,GO:0033189,0.0492750923584487,0.992072730523994,3,11,response to vitamin A,BP,PPARG;ALDH1A2;DNMT3A
10639,GO:0043648,0.0492817797470961,0.977385989882393,11,79,dicarboxylic acid metabolic process,BP,PCK2;GPT2;IDH2;GLUL;NAGS;ALDH1L2;MTHFR;GLUD1;PM20D2;NIT2;ALDH4A1
3273,GO:0006950,0.0493682132704357,0.958085784436978,243,2656,response to stress,BP,TNIP1;XDH;NT5E;PLAT;EDEM1;NOS1;ERCC1;F2R;ETV5;PGF;CCND1;PCK2;CTNNBIP1;CBS;CYGB;RPS6KA2;CYP27B1;SERPINE2;IGFBP4;PRNP;ITGB4;POSTN;BTBD2;NR1D1;NFATC4;ADARB1;MAP2K1;TFPI2;FNDC4;GPX3;PKN1;NAPRT;DCBLD2;MST1R;DGKA;DDIT3;PTPRS;PSMD2;ELK3;CAPN2;BRSK1;EGFR;STK39;DYSF;FYN;TNFRSF6B;BNIP3;ERCC6;UBE2J1;MAPK13;ZNF516;DLG1;CTSB;DNAJB5;NET1;TGM2;XPC;GLUL;HTRA1;WNT7A;UBXN4;MAP4K4;STRADB;MCTP1;SDC1;ARG2;SHC1;DKK1;DAP;PAK1;RAG1;TGFBR2;SERPING1;EDNRA;LCN2;IMPACT;RAC2;CD44;APOE;BNIP3L;ACP5;ANGPTL4;PTPN12;RGS14;PKD2;PRKACB;LDHA;ABTB1;ANXA3;HMGA2;ATF4;PPARA;ASNS;HYAL1;BTRC;ITGA2;PTK6;TMX4;ULK2;INPP5F;CHAC1;ATRX;MTHFR;SOX4;APOBEC3C;ITPR3;FBXO2;DDB2;ENDOV;CEACAM1;MAPKAPK3;GSDMC;SPATA18;PDIA5;LMAN1;MT2A;RCOR1;TRIM5;TCEA1;MMP14;CD46;CTH;ETAA1;CTSL;DOCK9;CST3;TRIB3;CASP4;GFPT1;DNAJB9;BTBD3;SEC63;MYOF;SLK;PRDX5;MLYCD;CEBPG;F2RL1;DDX60;GSDMA;PROCR;TAOK1;PHF1;PSMD7;PRKAR1A;ANO1;MSRB2;JMY;BOK;PARP9;CPEB4;NACC2;THRA;MGLL;WNT2B;NGFR;PPP1R10;HSPA13;CHD6;MTA1;BCL2L1;IFITM1;ARF4;POLL;XBP1;UBASH3B;TXNRD3;MAP2K2;REC8;SLC38A2;RET;LOXL2;VWA1;RAB43;MLH3;C5;TXNDC11;GABARAPL2;DOCK11;PAK6;PUM2;SLC30A1;RNF135;COL1A2;PRKACA;NEK6;TMSB4X;EIF2AK2;RAB1A;EEPD1;SEL1L;IFI16;KDELR3;IL1RAP;CARD11;LAMB2;LTB4R;FICD;ZNF354A;RNF169;ITPR2;MOAP1;MAP4K2;ERLEC1;PPARG;SLC7A11;CREB3L2;ERP44;ADAM8;AKT3;IL20RB;WFS1;ENDOG;PHF21A;ZBTB40;IGFBP7;FZD8;HSPA2;FLNB;MAGEF1;TMEM173;E2F7;EEF2K;HPSE;SSR1;DNAJC3;FOXP1;PSEN2;DNAJC4;CNOT11;OAS1;RNF103;USP25;UFL1;FAM162A;ANKRD6;SLC23A2;KLHL15;STT3B;RB1CC1;DNMT3A;TRIM38;FADD
13121,GO:0051660,0.0494708089660946,0.9966140866742,2,4,establishment of centrosome localization,BP,DLG1;FHOD1
17570,GO:1901165,0.0494814049265525,0.996099775156633,2,5,positive regulation of trophoblast cell migration,BP,SMURF2;ACVR1B
9040,GO:0035254,0.0494897758596539,0.984284338384353,6,29,glutamate receptor binding,MF,PRNP;FYN;DLG1;DLG4;DLG3;SHANK2
12359,GO:0048736,0.0496427009656327,0.972505023358757,18,127,appendage development,BP,ITGA6;ITGB4;WNT7A;ASPH;DKK1;FGFR1;SMOC1;ATRX;SOX4;LRP5;CHD7;RNF165;ALDH1A2;TMEM107;LRP6;PTCH1;KAT2B;LRP4
13660,GO:0060173,0.0496427009656327,0.972505023358757,18,127,limb development,BP,ITGA6;ITGB4;WNT7A;ASPH;DKK1;FGFR1;SMOC1;ATRX;SOX4;LRP5;CHD7;RNF165;ALDH1A2;TMEM107;LRP6;PTCH1;KAT2B;LRP4
12856,GO:0051174,0.0496593352113753,0.960116323716979,121,1208,regulation of phosphorus metabolic process,BP,TNIP1;XDH;NOS1;F2R;SORL1;CCND1;NEURL1;VLDLR;ITGA6;ADCY7;IGFBP4;PRNP;ADARB1;MAP2K1;RAPGEF3;ACVR2B;PKN1;WWTR1;MST1R;APLN;TNFSF15;EGFR;STK39;PPP1R14A;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;SOCS2;TRIB2;TGFBR2;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;CCND2;RGS14;PKD2;PRKACB;AKAP9;PPP2R3B;PPARA;ABCA7;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;LPCAT1;ITGA2;PTK6;INPP5F;FAM20C;PFN2;CEACAM1;MAPKAPK3;TRIM5;DVL1;NTSR1;LRP5;ETAA1;CNTN1;TRIB3;RANBP9;SLK;F2RL1;TAOK1;CSNK2A1;PTHLH;PRKAR1A;PARP9;SPRY2;ACVR1B;NGFR;PPP1R10;UBASH3B;MAP2K2;PPP1R2;RET;PDE5A;C5;MTMR4;PAK6;CCDC88A;SHC2;PRKACA;TMSB4X;TIMP2;EIF2AK2;SLC39A10;LPAR1;IGF2;GRB10;MAP4K2;SNX6;SRPX2;TBX1;ADAM8;FZD8;HSPA2;LRP6;EEF2K;RCAN1;DNAJC3;ADCY1;KAT2B;ANKRD6;ADNP;LRP4;RB1CC1
10256,GO:0042994,0.0497688108360246,0.988685188726197,4,18,cytoplasmic sequestering of transcription factor,BP,PKD2;MDFI;THRA;TMSB4X
6686,GO:0030054,0.0499512676652999,0.961077889967131,92,871,cell junction,CC,FHL1;TSPAN1;FLNC;CCND1;NEURL1;ITGA6;ITGB4;MAP2K1;SH3KBP1;MPRIP;COL13A1;ARHGAP22;MAP1B;PTPRS;SDK2;SNTB2;ADGRL1;CAPN2;BRSK1;SNPH;EGFR;ANK3;PDZD2;PARVB;DLG1;DLG4;PODXL;TGM2;MCTP1;DLG3;PAK1;MRC2;SHANK2;RAC2;CLCA2;CD44;PTPN12;AFAP1;RGS14;PKD2;LRP1;ABCA7;ICA1;ITGA1;EPCAM;ITGB5;ITGA2;VAMP2;FAT1;FHOD1;DDB2;CEACAM1;FERMT1;OBSL1;DMXL2;BSG;SLC9A3R2;MMP14;ANXA6;NLGN2;CD46;MPDZ;ABHD17C;DNMBP;RIMS3;CDC42BPA;PROCR;CPEB4;CD99;BCL2L1;GRIN3B;WASF2;CADM4;MAP2K2;SH3PXD2B;NCKAP1;PAK6;PSD3;FRMD4B;EPB41L3;PCDH1;TENM2;PJA2;GRB7;SRPX2;PPL;CLDN11;ITGA4;FLNB;SYT2;SIGMAR1;ZFYVE21
5186,GO:0015749,0.0500564493325887,0.97712518368056,11,70,monosaccharide transmembrane transport,BP,PAK1;SLC2A3;EDNRA;SLC5A1;TRIB3;CLTCL1;SLC2A9;NGFR;SLC2A13;GRB10;SLC23A2
2319,GO:0005326,0.0500806484468838,0.986140610708409,5,23,neurotransmitter transporter activity,MF,SLC6A6;SLC6A14;SLC7A11;SLC18A2;SLC44A1
15854,GO:0072567,0.0503562412033905,0.991671499542193,3,12,chemokine (C-X-C motif) ligand 2 production,BP,POSTN;F2RL1;FOXP1
2276,GO:0005220,0.0503986743884395,0.997492661422354,2,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,ITPR3;ITPR2
15766,GO:0072359,0.0504077737653326,0.961731098532138,75,679,circulatory system development,BP,XDH;ADAM19;PGF;SH2D2A;ACTA2;ADM2;NFATC4;MAP2K1;THBS2;RAPGEF3;ACVR2B;LTBP1;ARHGAP22;APLN;DDIT3;ELK3;EGFR;LOXL1;WNT7A;SHC1;DKK1;PAK1;TGFBR2;EDNRA;EPHA1;APOE;FKBP1A;ANGPTL4;PKD2;LRP1;ANXA3;HMGA2;PPARA;FGFR1;HYAL1;SOX4;CEACAM1;OBSL1;EPN2;DVL1;MMP14;EPOR;CTH;LRP5;PPP3CB;ADGRB2;RASIP1;CHD7;PRKAR1A;SPRY2;NGFR;PSKH1;MEF2D;WASF2;XBP1;LOXL2;SH3PXD2B;C5;COL1A2;HOXA3;LAMA5;PPARG;SRPX2;ALDH1A2;TBX1;ADAM8;AKT3;FZD8;LRP6;E2F7;HPSE;PTCH1;KAT2B;JARID2;RB1CC1
6790,GO:0030226,0.0504865356459523,0.9974857567985,2,3,apolipoprotein receptor activity,MF,LRP1;ABCA7
17445,GO:1900221,0.0504988510443336,0.992226471861182,3,9,regulation of amyloid-beta clearance,BP,APOE;LRP1;ABCA7
6838,GO:0030301,0.0507744772790613,0.980226811185937,8,48,cholesterol transport,BP,APOE;LRP1;ABCA7;ABCG1;OSBPL5;PPARG;LRP6;PTCH1
10831,GO:0044324,0.0509467453941629,1,1,1,regulation of transcription involved in anterior/posterior axis specification,BP,DDIT3
19693,GO:2000016,0.0509467453941629,1,1,1,negative regulation of determination of dorsal identity,BP,DDIT3
12595,GO:0050771,0.051088229050842,0.980216466446986,8,44,negative regulation of axonogenesis,BP,PTPRS;SEMA4B;GDI1;ULK2;NGFR;OMG;SEMA3F;LRP4
9632,GO:0036499,0.0511358157827767,0.988270335871746,4,18,PERK-mediated unfolded protein response,BP,DDIT3;ATF4;ASNS;BOK
16530,GO:0097242,0.0512440455821612,0.988762789924839,4,14,amyloid-beta clearance,BP,APOE;LRP1;IDE;ABCA7
14074,GO:0060872,0.0513935423663745,0.996405322259594,2,4,semicircular canal development,BP,CHD7;TBX1
6727,GO:0030139,0.0515620148999258,0.968255949641928,25,208,endocytic vesicle,CC,SH3KBP1;EGFR;DYSF;DLG4;WNT7A;CEMIP;RAC2;APOE;LRP1;RAB11FIP4;ANXA3;ITGB5;INPP5F;RAB31;EPN2;CLCN3;CLTCL1;VPS11;RAB43;AP2A2;LPAR1;ADAM8;WASL;FLNB;PTCH1
11788,GO:0046651,0.0518051587024913,0.970981015203722,18,149,lymphocyte proliferation,BP,PRNP;PKN1;FYN;DLG1;ARG2;TGFBR2;RAC2;FKBP1A;CD46;PPP3CB;PRKAR1A;SATB1;PDE5A;SLC39A10;CARD11;IGF2;IL20RB;FADD
6899,GO:0030433,0.0518685642146663,0.977082346871758,10,68,ubiquitin-dependent ERAD pathway,BP,EDEM1;UBE2J1;UBXN4;FBXO2;DNAJB9;SEL1L;ERLEC1;WFS1;RNF103;STT3B
595,GO:0001759,0.0519865283212338,0.99145173998912,3,11,organ induction,BP,DKK1;FGFR1;WNT2B
5540,GO:0016529,0.052010852964453,0.981407580696301,7,36,sarcoplasmic reticulum,CC,XDH;NOS1;ANK3;ASPH;FKBP1A;ITPR3;ITPR2
9373,GO:0035897,0.0520473270759522,0.995778805209159,2,5,proteolysis in other organism,BP,MAP2K1;MAP2K2
17838,GO:1902003,0.052167839184123,0.988185175984238,4,16,regulation of amyloid-beta formation,BP,SORL1;PRNP;APOE;ABCA7
7205,GO:0031094,0.0522458075036993,0.992170860169558,3,8,platelet dense tubular network,CC,F2R;ITPR3;ITPR2
1415,GO:0003352,0.0523890051070434,0.995735346231944,2,5,regulation of cilium movement,BP,BBS2;CCSAP
1416,GO:0003356,0.0523890051070434,0.995735346231944,2,5,regulation of cilium beat frequency,BP,BBS2;CCSAP
13727,GO:0060295,0.0523890051070434,0.995735346231944,2,5,regulation of cilium movement involved in cell motility,BP,BBS2;CCSAP
13728,GO:0060296,0.0523890051070434,0.995735346231944,2,5,regulation of cilium beat frequency involved in ciliary motility,BP,BBS2;CCSAP
17843,GO:1902019,0.0523890051070434,0.995735346231944,2,5,regulation of cilium-dependent cell motility,BP,BBS2;CCSAP
1787,GO:0004415,0.0524031001584046,0.995733549837311,2,5,hyalurononglucosaminidase activity,MF,CEMIP;HYAL1
4804,GO:0010998,0.0524191925494449,0.991552631465535,3,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,IMPACT;EIF2AK2;DNAJC3
6572,GO:0022037,0.0524731773458053,0.976921936721483,10,61,metencephalon development,BP,SERPINE2;MAP2K1;PTPRS;WNT7A;TTBK2;PAK1;AARS;CNTN1;LPAR1;LRP6
6016,GO:0019068,0.0526259156284852,0.982664356942215,6,36,virion assembly,BP,PC;APOE;USP6NL;MVB12A;RAB43;RAB1A
3047,GO:0006601,0.0526460209964447,1,1,1,creatine biosynthetic process,BP,GAMT
7019,GO:0030731,0.0526460209964447,1,1,1,guanidinoacetate N-methyltransferase activity,MF,GAMT
13900,GO:0060544,0.0526492558831954,0.987710210859621,4,19,regulation of necroptotic process,BP,RBCK1;SLC25A4;BOK;FADD
11287,GO:0045597,0.0527026182818359,0.960665758887049,65,602,positive regulation of cell differentiation,BP,ZMYND8;ETV5;NEURL1;CTNNBIP1;VLDLR;CYP27B1;SERPINE2;MAP2K1;FAM210B;ACVR2B;ALOX15B;WWTR1;MAP1B;CRTC1;FYN;DLG4;PLXNB3;NET1;GDI1;DKK1;PAK1;SOCS2;RAG1;TGFBR2;SHANK2;IMPACT;APOE;RGS14;LPAR3;FGFR1;PTK6;FAM20C;CEACAM1;OBSL1;DVL1;MMP14;CD46;CTH;LRP5;TWF2;CNTN1;PLAG1;THRA;ACVR1B;NGFR;IFITM1;XBP1;RET;CCDC71L;LOXL2;PDE5A;SH3PXD2B;TIMP2;IL1RAP;LPAR1;AP3D1;PPARG;TBX1;ADAM8;SYT2;EEF2K;PTCH1;UFL1;ADNP;FADD
2747,GO:0006145,0.0527168274986433,0.99625890156743,2,4,purine nucleobase catabolic process,BP,XDH;AOX1
3313,GO:0007016,0.0528332107060696,0.99204598033753,3,8,cytoskeletal anchoring at plasma membrane,BP,ANK3;EPB41L3;FLNB
4468,GO:0010464,0.0529057894445485,0.985130167944903,5,23,regulation of mesenchymal cell proliferation,BP,CTNNBIP1;TGFBR2;FGFR1;LRP5;TBX1
6724,GO:0030135,0.0529527723125047,0.967314752148711,25,207,coated vesicle,CC,EPN3;EGFR;SNX9;SEC23A;MALL;CEMIP;APOE;MCFD2;LRP1;VAMP2;INPP5F;LMAN1;EPN2;DVL1;CLTCL1;VPS11;COPB1;COPG1;FCHO2;TMED4;AP2A2;CTSZ;DDHD2;SYT2;SLC18A2
8233,GO:0032994,0.0530863404124767,0.987671597246604,4,18,protein-lipid complex,CC,SORL1;VLDLR;APOE;PCYOX1
12318,GO:0048668,0.0531333892269319,0.987767254511309,4,17,collateral sprouting,BP,PTPRS;LPAR3;ULK2;DVL1
8686,GO:0034284,0.0531998939143764,0.970724043302587,17,131,response to monosaccharide,BP,PCK2;NR1D1;ACVR2B;GLUL;MAP4K4;TGFBR2;LDHA;ITGA2;VAMP2;SOX4;LRP5;PPP3CB;ANO1;XBP1;PRKACA;IGF2;ENDOG
12354,GO:0048729,0.053206821656413,0.961776107971634,51,450,tissue morphogenesis,BP,SMURF2;ETV5;PGF;CTNNBIP1;ITGB4;ACTA2;NFATC4;ADARB1;PSMD2;EGFR;ARHGAP12;DLG1;GPC4;PODXL;TGM2;WNT7A;DLG3;DKK1;PAK1;TGFBR2;EDNRA;CD44;FKBP1A;PKD2;PRKACB;HMGA2;FGFR1;BTRC;ITGA2;SOX4;CEACAM1;DVL1;MMP14;LRP5;RASIP1;PSMD7;CHD7;PRKAR1A;SPRY2;WNT2B;RET;TCTN1;AP2A2;CTSZ;LAMA5;ALDH1A2;TBX1;LRP6;FOXP1;PTCH1;ANKRD6
9956,GO:0042325,0.0532273372247427,0.957742871961619,105,1041,regulation of phosphorylation,BP,TNIP1;XDH;F2R;SORL1;CCND1;NEURL1;VLDLR;ITGA6;ADCY7;IGFBP4;PRNP;ADARB1;MAP2K1;RAPGEF3;ACVR2B;PKN1;WWTR1;MST1R;APLN;TNFSF15;EGFR;STK39;PPP1R14A;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;SOCS2;TRIB2;TGFBR2;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;CCND2;RGS14;PKD2;PRKACB;AKAP9;PPARA;ABCA7;LPAR3;FGFR1;ITGA1;PTK6;INPP5F;PFN2;CEACAM1;MAPKAPK3;TRIM5;DVL1;LRP5;ETAA1;CNTN1;TRIB3;RANBP9;SLK;F2RL1;TAOK1;PRKAR1A;PARP9;SPRY2;ACVR1B;NGFR;UBASH3B;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;TIMP2;EIF2AK2;LPAR1;IGF2;GRB10;MAP4K2;SNX6;SRPX2;TBX1;ADAM8;FZD8;HSPA2;LRP6;EEF2K;DNAJC3;ADCY1;KAT2B;ANKRD6;ADNP;LRP4;RB1CC1
6064,GO:0019212,0.0535187896605544,0.984750872456804,5,25,phosphatase inhibitor activity,MF,PPP1R14A;ELFN2;PPP1R35;PPP1R10;PPP1R2
14645,GO:0070229,0.053600973475679,0.9846518680165,5,26,negative regulation of lymphocyte apoptotic process,BP,ARG2;RAG1;SLC39A10;FOXP1;FADD
11245,GO:0045444,0.0537619948806168,0.969296464817987,19,148,fat cell differentiation,BP,CCND1;ITGA6;BBS2;NR1D1;WWTR1;DDIT3;BNIP3;ZNF516;GRK5;TRIB2;HMGA2;LRP5;TRIB3;MEX3C;XBP1;CCDC71L;SH3PXD2B;PPARG;ARID5B
13742,GO:0060314,0.0538024993204769,0.987561711126988,4,17,regulation of ryanodine-sensitive calcium-release channel activity,BP,NOS1;FKBP1A;PKD2;PRKACA
12926,GO:0051281,0.0538855236308396,0.984692575743235,5,24,positive regulation of release of sequestered calcium ion into cytosol,BP,F2R;CEMIP;PKD2;NTSR1;TRPC1
7817,GO:0032370,0.0539509415534729,0.982257672767499,6,33,positive regulation of lipid transport,BP,APOE;LRP1;ABCA7;ABCG1;NTSR1;PTCH1
6462,GO:0021783,0.0539716724458955,0.991197411151883,3,10,preganglionic parasympathetic fiber development,BP,ADARB1;TBX1;SEMA3F
6595,GO:0022612,0.0540544481054353,0.973118880903224,13,86,gland morphogenesis,BP,ETV5;EGFR;TGM2;TGFBR2;FGFR1;BTRC;CEACAM1;LRP5;PLAG1;XBP1;LAMA5;LRP6;PTCH1
4336,GO:0009888,0.0541480470958646,0.956239670097256,124,1231,tissue development,BP,XDH;SMURF2;ETV5;PGF;CCND1;NEURL1;PCK2;CTNNBIP1;ITGA6;CYP27B1;SERPINE2;ITGB4;ACTA2;BBS2;POSTN;NFATC4;ADARB1;MAP2K1;RAPGEF3;ACVR2B;ALOX15B;SALL2;WWTR1;PTPRS;PSMD2;LAMB1;EGFR;SEMA4B;ARHGAP12;MYH15;ADAMTS7;ZNF516;DLG1;CTSB;GPC4;PODXL;TGM2;WNT7A;SDC1;ARG2;DLG3;DKK1;PAK1;TGFBR2;EDNRA;SLITRK6;CD44;FKBP1A;PTPN12;PKD2;PRKACB;HMGA2;PPARA;FGFR1;EPCAM;ITGB5;HYAL1;BTRC;ITGA2;PTK6;ATRX;FAM20C;KIAA1109;SOX4;CEACAM1;FERMT1;OBSL1;PRR9;BSG;DVL1;MMP14;EPOR;LRP5;THBS3;CTSL;CST3;PCSK6;MEX3C;F2RL1;RASIP1;PSMD7;PTHLH;TST;CHD7;PRKAR1A;SPRY2;THRA;WNT2B;ACVR1B;COL6A1;MEF2D;XBP1;SATB1;RET;LOXL2;TCTN1;SH3PXD2B;AP2A2;LAMB2;CTSZ;HOXA3;ARID4A;LAMA5;PPARG;PPL;ALDH1A2;TBX1;SLC7A11;CREB3L2;ITGA4;ZBTB40;TMEM107;PRSS8;FLNB;LRP6;ARID5B;E2F7;HPSE;FOXP1;PTCH1;ANKRD6;JARID2;SEMA3F;LRP4
2990,GO:0006534,0.0541635887139949,0.990942826473588,3,11,cysteine metabolic process,BP,CBS;AHCYL2;CTH
18466,GO:1903564,0.0541668852481474,0.996095909025962,2,4,regulation of protein localization to cilium,BP,CCDC88A;EFCAB7
3139,GO:0006732,0.0542373737246656,0.964304480259428,32,295,coenzyme metabolic process,BP,NT5E;PCK2;NAPRT;H6PD;DHTKD1;PC;ELOVL1;PGM1;IDH2;ACOT1;ACSF2;PGLS;ACOT7;NMRK1;CBR4;SLC2A3;ALDH1L2;LDHA;PPARA;MTHFR;AHCYL2;GAMT;ACOT13;MLYCD;PARP9;PM20D2;PANK4;PPT2;COQ2;HSD17B12;PANK1;SLC23A2
488,GO:0001540,0.0543107446767248,0.980166336831123,7,41,amyloid-beta binding,MF,SORL1;PRNP;APOE;IDE;ITGA2;FBXO2;CST3
3999,GO:0008903,0.0544075774705857,1,1,1,hydroxypyruvate isomerase activity,MF,HYI
8198,GO:0032943,0.0544549703999654,0.969299734971064,18,150,mononuclear cell proliferation,BP,PRNP;PKN1;FYN;DLG1;ARG2;TGFBR2;RAC2;FKBP1A;CD46;PPP3CB;PRKAR1A;SATB1;PDE5A;SLC39A10;CARD11;IGF2;IL20RB;FADD
2264,GO:0005179,0.0546483097978881,0.9870856437536,4,19,hormone activity,MF,ADM2;APLN;PTHLH;IGF2
12900,GO:0051246,0.0546679577083847,0.954185340708352,189,2017,regulation of protein metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;NOS1;F2R;SORL1;CCND1;NEURL1;VLDLR;SERPINE2;ADCY7;IGFBP4;PRNP;BTBD2;HECW2;ADARB1;MAP2K1;TFPI2;RAPGEF3;ACVR2B;PKN1;WWTR1;MST1R;TNFSF15;EIF4EBP1;SSH1;EGFR;STK39;PPP1R14A;FYN;TNFRSF6B;ERCC6;UBE2J1;DLG1;DLG4;SNX9;WNT7A;IGF2BP3;MAP4K4;STRADB;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;SOCS2;TRIB2;RAG1;TGFBR2;PTPN3;SERPING1;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;CCND2;RGS14;PKD2;PRKACB;LRP1;IDE;AKAP9;PPP2R3B;ABTB1;ATF4;ABCA7;EIF4E3;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;BTRC;LPCAT1;ITGA2;PTK6;LTBP4;INPP5F;CHAC1;ATRX;MTHFR;PFN2;SOX4;FBXO2;CEACAM1;MAPKAPK3;SH3D19;XRN1;TRIM5;TNRC6B;DVL1;MMP14;CD46;LRP5;ETAA1;CST3;CNTN1;TRIB3;CASP4;VPS11;RANBP9;BTBD3;MEX3C;APLP2;SLK;PRDX5;CEBPG;F2RL1;TAOK1;CSNK2A1;PHF1;PRKAR1A;BOK;PARP9;CPEB4;ATXN2;SPRY2;BEX4;ACVR1B;NGFR;PPP1R10;MTA1;AZIN2;PM20D2;XBP1;UBASH3B;MAP2K2;PPP1R2;PAIP1;ANKIB1;RET;PDE5A;C5;GABARAPL2;PAK6;PUM2;CCDC88A;SHC2;PRKACA;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;CARD11;SECISBP2L;LPAR1;CTSZ;IGF2;MAP4K2;ERLEC1;PPARG;SNX6;GRB7;TBX1;ADAM8;WFS1;FZD8;HSPA2;LRP6;MAGEF1;RNF180;EEF2K;TNRC6C;RCAN1;TET1;ZC3H7A;DNAJC3;ADCY1;KAT2B;CNOT11;USP25;PRMT3;UFL1;FAM162A;ANKRD6;JARID2;ADNP;LRP4;RB1CC1;FBXL5;FADD
16131,GO:0090129,0.0548835968055147,0.995412989108743,2,5,positive regulation of synapse maturation,BP,NEURL1;ADGRL1
7699,GO:0032156,0.0549624997855021,0.990968343235209,3,10,septin cytoskeleton,CC,SEPT10;SEPT5;SEPT6
6943,GO:0030551,0.0550606952394633,0.987304234983294,4,16,cyclic nucleotide binding,MF,RAPGEF3;PRKAR1A;PDE5A;TMEM173
3255,GO:0006915,0.055243046389901,0.954996637206674,133,1394,apoptotic process,BP,XDH;F2R;NEURL1;ITGA6;RPS6KA2;H1F0;PRNP;NFATC4;ADARB1;MAP2K1;SH3KBP1;ALOX15B;PKN1;PEG3;MST1R;TNFSF15;DDIT3;EGFR;STK39;FYN;TNFRSF6B;BNIP3;ERCC6;CTSB;NET1;TGM2;GLO1;WNT7A;MAP4K4;GRK5;STRADB;NME4;ARG2;SHC1;DKK1;DAP;PAK1;SOCS2;RAG1;TGFBR2;LCN2;EPHA1;CD44;OBSCN;APOE;BNIP3L;CCND2;ANGPTL4;RBCK1;LRP1;LDHA;HMGA2;ATF4;ASNS;FGFR1;ITGA1;AARS;CHAC1;SOX4;UACA;NTSR1;ANXA6;CTH;LRP5;CTSL;CST3;RABGGTA;TRIB3;CASP4;SLK;PRDX5;PLAG1;GSDMA;C6ORF120;TAOK1;CSNK2A1;SLC25A4;JMY;BOK;CPEB4;NACC2;SPRY2;THRA;ACVR1B;NGFR;PPP1R10;BCL2L1;MEF2D;ARF4;XBP1;MAP2K2;SATB1;RET;BEX2;NCKAP1;ELMO3;PAK6;TMBIM1;NEK6;RGL2;EIF2AK2;EPB41L3;IFI16;BCAP29;SLC39A10;CARD11;LPAR1;CTSZ;IGF2;MOAP1;MAP4K2;PPARG;EVA1A;ALDH1A2;TBX1;ADAM8;WFS1;ENDOG;LRP6;TMEM173;EEF2K;SIGMAR1;TRIM2;DEDD2;DNAJC3;FOXP1;PSEN2;UFL1;FAM162A;ADNP;RB1CC1;DNMT3A;FADD
4351,GO:0009922,0.0552947715549953,0.99535900646873,2,5,fatty acid elongase activity,MF,ELOVL1;ELOVL4
6119,GO:0019367,0.0552947715549953,0.99535900646873,2,5,fatty acid elongation, saturated fatty acid,BP,ELOVL1;ELOVL4
6120,GO:0019368,0.0552947715549953,0.99535900646873,2,5,fatty acid elongation, unsaturated fatty acid,BP,ELOVL1;ELOVL4
8838,GO:0034625,0.0552947715549953,0.99535900646873,2,5,fatty acid elongation, monounsaturated fatty acid,BP,ELOVL1;ELOVL4
8839,GO:0034626,0.0552947715549953,0.99535900646873,2,5,fatty acid elongation, polyunsaturated fatty acid,BP,ELOVL1;ELOVL4
17135,GO:0102336,0.0552947715549953,0.99535900646873,2,5,3-oxo-arachidoyl-CoA synthase activity,MF,ELOVL1;ELOVL4
17136,GO:0102337,0.0552947715549953,0.99535900646873,2,5,3-oxo-cerotoyl-CoA synthase activity,MF,ELOVL1;ELOVL4
17137,GO:0102338,0.0552947715549953,0.99535900646873,2,5,3-oxo-lignoceronyl-CoA synthase activity,MF,ELOVL1;ELOVL4
17168,GO:0102756,0.0552947715549953,0.99535900646873,2,5,very-long-chain 3-ketoacyl-CoA synthase activity,MF,ELOVL1;ELOVL4
12963,GO:0051345,0.0553297624566196,0.959060257387155,60,561,positive regulation of hydrolase activity,BP,DOCK4;XDH;F2R;ASAP2;ITGA6;RAPGEF3;LMF1;ARHGAP22;TNFSF15;EGFR;TBC1D14;RIN2;ARHGAP12;FYN;ARAP1;SNX9;NET1;EVI5L;ASPH;GDI1;DAP;RASA3;EDNRA;EPHA1;RALGAPA2;RGS14;SRGAP2B;FGFR1;ITGA1;ITGA2;PFN2;RALGAPA1;TCEA1;MMP14;DNMBP;DOCK9;CASP4;F2RL1;ASAP1;BOK;USP6NL;TBC1D2B;NGFR;ARF4;RIN1;GABARAPL2;DOCK11;TMSB4X;IFI16;SLC39A10;LPAR1;PPARG;ARHGAP29;EVI5;DEPDC1;ACAP2;TBC1D16;HSPA2;FAM162A;FADD
14737,GO:0070403,0.0554247641599552,0.990467219611779,3,12,NAD+ binding,MF,CRYL1;HADH;GLUD1
13948,GO:0060627,0.0554549619486455,0.96193803554583,39,343,regulation of vesicle-mediated transport,BP,TSPAN1;SORL1;RAB3B;MAP2K1;APLN;TBC1D14;DLG4;EVI5L;MCTP1;SDC1;DKK1;RAC2;APOE;LRP1;ABCA7;TUB;ITGA2;VAMP2;INPP5F;PFN2;CEACAM1;VPS11;RIMS3;SYTL1;DNAJC6;F2RL1;ATXN2;USP6NL;SEPT5;TBC1D2B;MAP2K2;PPARG;LYPLA1;EVI5;RPH3AL;TBC1D16;WASL;SYT2;EEF2K
8718,GO:0034363,0.055572638741245,1,1,1,intermediate-density lipoprotein particle,CC,APOE
8720,GO:0034365,0.055572638741245,1,1,1,discoidal high-density lipoprotein particle,CC,APOE
8726,GO:0034371,0.055572638741245,1,1,1,chylomicron remodeling,BP,APOE
11892,GO:0046911,0.055572638741245,1,1,1,metal chelating activity,MF,APOE
16384,GO:0090731,0.055572638741245,1,1,1,cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
17717,GO:1901630,0.055572638741245,1,1,1,negative regulation of presynaptic membrane organization,BP,APOE
18211,GO:1903000,0.055572638741245,1,1,1,regulation of lipid transport across blood brain barrier,BP,APOE
18212,GO:1903002,0.055572638741245,1,1,1,positive regulation of lipid transport across blood brain barrier,BP,APOE
19376,GO:1905853,0.055572638741245,1,1,1,regulation of heparan sulfate binding,BP,APOE
19377,GO:1905855,0.055572638741245,1,1,1,positive regulation of heparan sulfate binding,BP,APOE
19378,GO:1905858,0.055572638741245,1,1,1,regulation of heparan sulfate proteoglycan binding,BP,APOE
19379,GO:1905860,0.055572638741245,1,1,1,positive regulation of heparan sulfate proteoglycan binding,BP,APOE
19387,GO:1905890,0.055572638741245,1,1,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,APOE
331,GO:0000921,0.0557189888829532,0.990792225596023,3,10,septin ring assembly,BP,SEPT10;SEPT5;SEPT6
6172,GO:0019534,0.0558157782383946,0.995907359636218,2,4,toxin transmembrane transporter activity,MF,ABCG1;LRP6
4226,GO:0009403,0.0558436908220415,0.995286567160949,2,5,toxin biosynthetic process,BP,CBS;CTH
15753,GO:0072341,0.0559563006002139,0.97767165999072,8,51,modified amino acid binding,MF,CBS;OSBPL10;MTHFR;GSDMC;GSDMA;ASAP1;FCHO2;OSBPL5
11967,GO:0047184,0.056078357343943,0.995255469255554,2,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,LPCAT4;LPCAT1
11688,GO:0046471,0.0562212561378515,0.983755786160894,5,25,phosphatidylglycerol metabolic process,BP,LPCAT4;LPCAT1;PLA2G4D;CRLS1;CDS2
6147,GO:0019433,0.0562498526487064,0.990446690233984,3,11,triglyceride catabolic process,BP,APOE;MGLL;DDHD2
15980,GO:0080134,0.0563848334723348,0.955485829836196,97,984,regulation of response to stress,BP,TNIP1;XDH;NT5E;PLAT;EDEM1;ERCC1;F2R;SERPINE2;NR1D1;MAP2K1;FNDC4;PKN1;DDIT3;PTPRS;PSMD2;EGFR;STK39;FYN;ERCC6;UBE2J1;MAPK13;DLG1;CTSB;TGM2;HTRA1;WNT7A;MAP4K4;MCTP1;ARG2;DKK1;PAK1;RAG1;TGFBR2;SERPING1;IMPACT;CD44;APOE;ACP5;PRKACB;HMGA2;ATF4;PPARA;BTRC;ITGA2;INPP5F;CEACAM1;MAPKAPK3;TRIM5;CD46;ETAA1;CTSL;CASP4;DNAJB9;CEBPG;F2RL1;DDX60;TAOK1;PSMD7;BOK;PARP9;NACC2;MGLL;PPP1R10;BCL2L1;XBP1;UBASH3B;MAP2K2;C5;PUM2;RNF135;PRKACA;NEK6;TMSB4X;EIF2AK2;IFI16;CARD11;FICD;RNF169;MAP4K2;ERLEC1;PPARG;ADAM8;AKT3;IL20RB;WFS1;ENDOG;FZD8;MAGEF1;TMEM173;HPSE;DNAJC3;FOXP1;USP25;ANKRD6;KLHL15;RB1CC1;FADD
10425,GO:0043268,0.0564445397857438,0.987033168888761,4,15,positive regulation of potassium ion transport,BP,FHL1;STK39;DLG1;AKAP9
10418,GO:0043256,0.0564681542841797,0.99125960070908,3,8,laminin complex,CC,LAMB1;LAMB2;LAMA5
10790,GO:0044257,0.0568255879166137,0.957358851337003,65,633,cellular protein catabolic process,BP,SMURF2;EDEM1;GID4;VLDLR;BTBD2;NR1D1;HECW2;WWTR1;DDIT3;PSMD2;CAPN2;BNIP3;UBE2J1;ADAMTS7;CTSB;UBXN4;TRIB2;APOE;BNIP3L;RBCK1;LRP1;IDE;ABTB1;UBE2G1;BTRC;LONP2;RMND5A;FBXO2;SPATA18;DVL1;MVB12B;CTSL;TRIB3;VPS11;DNAJB9;BTBD3;PSMD7;MVB12A;MTA1;RNF165;PCYOX1;XBP1;ARRDC1;ANKIB1;GABARAPL2;UBE2E1;CTSO;PRKACA;SEL1L;AP2A2;CTSZ;TBL1X;ERLEC1;USP20;WFS1;USP32;MAGEF1;RNF180;DNAJC3;RNF103;USP25;UFL1;KLHL15;STT3B;FBXL5
9717,GO:0038132,0.0568569977367487,0.995786552116314,2,4,neuregulin binding,MF,ITGA6;ITGB4
2515,GO:0005768,0.0569593349808235,0.956812512746277,70,677,endosome,CC,F2R;SORL1;SH3TC2;MAP2K1;ANTXR2;PKN1;APPL2;DDIT3;AVL9;EGFR;TBC1D14;DYSF;FYN;CTSB;CD68;SNX9;SLC9A7;MCTP1;DKK1;APOE;ATP7B;LRP1;FYCO1;EHBP1;RAB11FIP4;ABCA7;SNX14;OCIAD2;INPP5F;ABCG1;RAB31;CLCN3;MMP14;ANXA6;MVB12B;NIPA1;ABHD17C;CTSL;CST3;CLTCL1;VPS11;ZDHHC2;F2RL1;BOK;SDCCAG3;NGFR;MVB12A;WASF2;MAP2K2;RET;RAB43;MTMR4;ZFYVE9;TMBIM1;RAB1A;SNX30;AP2A2;LPAR1;AP3D1;SNX6;ANKRD50;ATP11B;ACAP2;TMEM9;TBC1D16;MARCH2;LRP6;ZFYVE21;PANK1;SNX27
12449,GO:0050152,0.0571887510301691,1,1,1,omega-amidase activity,MF,NIT2
16796,GO:0098634,0.0572947614834442,0.995735359372985,2,4,cell-matrix adhesion mediator activity,MF,ITGA1;ITGA2
16798,GO:0098639,0.0572947614834442,0.995735359372985,2,4,collagen binding involved in cell-matrix adhesion,MF,ITGA1;ITGA2
4644,GO:0010766,0.0573426087244761,0.990410679255515,3,10,negative regulation of sodium ion transport,BP,SERPINE2;HECW2;STK39
14996,GO:0070914,0.0573503093423596,0.990181706887276,3,11,UV-damage excision repair,BP,ERCC1;XPC;DDB2
3514,GO:0007431,0.0573645028632183,0.980961145957371,6,31,salivary gland development,BP,EGFR;TGM2;FGFR1;CST3;XBP1;LAMA5
5185,GO:0015748,0.0573765087909829,0.974231362670351,10,66,organophosphate ester transport,BP,PITPNC1;OSBPL10;APOE;ABCA7;ABCG1;PITPNM1;ATP10D;SLC25A4;OSBPL5;ATP11B
17469,GO:1900274,0.0576460166288776,0.98636350424178,4,17,regulation of phospholipase C activity,BP,EGFR;EDNRA;FGFR1;LPAR1
11534,GO:0046058,0.0578915960756328,0.978689836783803,7,38,cAMP metabolic process,BP,ADCY7;RAPGEF3;PKD2;AKAP9;PTHLH;TIMP2;ADCY1
17303,GO:0140096,0.057900815884419,0.951854326987122,166,1695,catalytic activity, acting on a protein,MF,PLAT;SMURF2;GID4;ADAM19;CCND1;NEURL1;MMP1;RPS6KA2;PRSS3;HECW2;MAP2K1;ACVR2B;LTBP1;THSD4;PKN1;MST1R;SSH1;PTPRS;PSMD2;LTA4H;CAPN2;BRSK1;EGFR;STK39;LOXL1;FYN;TMPRSS11D;HLTF;UBE2J1;MAPK13;ADAMTS7;DLG1;B3GNT3;CTSB;TYSND1;TGM2;HTRA1;FKBP9;MAP4K4;TTBK2;GRK5;STRADB;ASPH;PAK1;NEK9;RAG1;TGFBR2;PTPN3;B4GALNT4;SCRN1;EPHA1;CLCA2;ERO1B;OBSCN;FKBP1A;PTPN12;CDK17;ZNF862;PRKACB;RBCK1;IDE;PPP2R3B;UBE2G1;HMGA2;PCMTD2;FGFR1;MARCH4;PTPDC1;RNPEPL1;BTRC;PTK6;GALNT3;TMX4;ULK2;LONP2;LTBP4;FAM20C;FKBP10;RMND5A;FBXO2;DDB2;MAPKAPK3;PDIA5;RCOR1;NLK;TRIM5;MMP14;ABHD17C;CTSL;NPEPL1;RABGGTA;CASP4;PCSK6;FBXL8;PPP3CB;ZDHHC2;DNAJC6;SLK;CDC42BPA;UHRF2;TAOK1;AEBP1;FBXO41;OTUB2;CSNK2A1;BLMH;QSOX1;KLHL29;MAST3;NACC2;ACVR1B;PSKH1;MARK4;PTPRZ1;MTA1;RNF165;PM20D2;UBASH3B;MAP2K2;ANKIB1;LYPLAL1;RET;LOXL2;TXNDC11;MTMR4;ZFYVE9;PAK6;UBE2E1;RNF135;CTSO;ADAMTSL1;PRKACA;NEK6;UNKL;EIF2AK2;ZDHHC1;FICD;CTSZ;MMP10;ARID4A;PJA2;MAP4K2;ZMYM2;USP20;LYPLA1;ERP44;ADAM8;AKT3;PHF21A;MARCH2;OSGEPL1;USP32;PRSS8;ARID5B;RNF180;PPT2;EEF2K;TRIM2;PSEN2;RNF103;USP25;PRMT3;UFL1;PPM1M;KLHL15;FBXL5
17703,GO:1901607,0.0579189047876719,0.976663040394432,8,53,alpha-amino acid biosynthetic process,BP,CBS;PSAT1;GLUL;NAGS;ASNS;GAMT;CTH;GLUD1
16599,GO:0097421,0.0581396642616751,0.982894709810423,5,27,liver regeneration,BP,CCND1;EGFR;PTPN3;CSNK2A1;PTCH1
5580,GO:0016597,0.0581554281013631,0.980458085646301,6,34,amino acid binding,MF,NOS1;GLUL;NAGS;AARS;GLUD1;GRIN3B
2590,GO:0005884,0.0582391294603208,0.972630321926864,11,73,actin filament,CC,WIPF1;FYN;ESPN;PAK1;RAC2;PKD2;FERMT1;TWF2;NCKAP1;TMSB4X;WASL
1582,GO:0003993,0.0582421527374425,0.994552189239009,2,6,acid phosphatase activity,MF,ACP5;ACP6
6731,GO:0030145,0.058244809803327,0.97839068293589,7,41,manganese ion binding,MF,PCK2;GLUL;ARG2;GALNT3;FAM20C;NPEPL1;PPM1M
16507,GO:0097202,0.0583563444491454,0.989748193285337,3,12,activation of cysteine-type endopeptidase activity,BP,ASPH;IFI16;FADD
7467,GO:0031625,0.058398595315148,0.961884670879483,30,268,ubiquitin protein ligase binding,MF,CBS;BTBD2;EGFR;HLTF;UBE2J1;UBXN7;SNX9;DLG3;TRIB2;PRKACB;ABTB1;UBE2G1;NLK;TRIB3;BTBD3;PRKAR1A;BOK;ACVR1B;NGFR;PER3;UBASH3B;ARRDC1;GABARAPL2;PRKACA;NEK6;MOAP1;WFS1;FZD8;TMEM173;USP25
16812,GO:0098659,0.0584815105901744,0.980495829266962,6,31,inorganic cation import across plasma membrane,BP,PRNP;FYN;SLC9A7;FAM155B;SLC30A1;SLC39A10
17078,GO:0099587,0.0584815105901744,0.980495829266962,6,31,inorganic ion import across plasma membrane,BP,PRNP;FYN;SLC9A7;FAM155B;SLC30A1;SLC39A10
2087,GO:0004852,0.0585502874599587,1,1,1,uroporphyrinogen-III synthase activity,MF,UROS
15252,GO:0071418,0.0585502874599587,1,1,1,cellular response to amine stimulus,BP,UROS
947,GO:0002366,0.0587562157081376,0.95784777420352,48,468,leukocyte activation involved in immune response,BP,ERCC1;PYGL;PYGB;PRSS3;NAPRT;PSMD2;LTA4H;PGM1;CTSB;CD68;STOM;SLC2A3;LCN2;RAC2;CD44;ANXA3;LPCAT1;VAMP2;CEACAM1;RAB31;CD46;CST3;MOSPD2;COPB1;F2RL1;C6ORF120;PSMD7;QSOX1;GLB1;YPEL5;XBP1;DNASE1L1;DOCK11;TMBIM1;TIMP2;AP2A2;CMTM6;CTSZ;NIT2;TMEM63A;ERP44;ADAM8;ATP11B;TMEM173;HPSE;GALNS;DNAJC3;FOXP1
10825,GO:0044317,0.0587779240235165,1,1,1,rod spherule,CC,REEP6
10374,GO:0043194,0.0588407657278756,0.990350175459082,3,9,axon initial segment,CC,SCN8A;ANK3;NAV1
2490,GO:0005737,0.0588637040733412,0.949142189386893,720,8359,cytoplasm,CC,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;FAM83A;ADAM19;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;ADARB1;MAP2K1;THBS2;FAM210B;FMNL2;RAPGEF3;FNDC4;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ALOX15B;MPRIP;LMF1;COL13A1;TK2;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;MICALCL;WDR66;MARCH9;H6PD;APLN;MARVELD1;POU2F2;TRIM65;LY6K;DHTKD1;PITPNC1;DGKA;APPL2;EIF4EBP1;SSH1;MAP1B;PC;DDIT3;PTPRS;B4GALT6;CCNG2;HADH;CARS;PSMD2;LAMB1;EXOC2;ELK3;SNTB2;CRTC1;DENND5B;AVL9;LTA4H;CAPN2;BRSK1;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;ANK3;C2CD2;DYSF;PDZD2;LOXL1;ARHGAP12;ARMCX2;PPP1R14A;FYN;HEBP1;MYH15;OSBPL10;PSAT1;BNIP3;HLTF;KIF13B;SPATS2;SLC33A1;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;MYCBPAP;ARAP1;PGM1;ADAMTS7;DLG1;ISYNA1;DLG4;B3GNT3;IDH2;CTSB;CD68;DNAJB5;ACOT1;GPC4;DHX32;SNX9;TYSND1;PODXL;NET1;TGM2;ESPN;XPC;GLUL;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;TTC7B;RSAD1;GRK5;NMRK1;STRADB;RDH14;NME4;MALL;CRTAP;RSPH3;ASPH;GLCCI1;MCTP1;GDI1;CEMIP;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;WISP1;PAK1;RASA3;CEP170;SOCS2;TRIB2;ATXN10;NEK9;RHPN1;CBR4;TGFBR2;PTPN3;SERPING1;SLC2A3;NUDCD3;B4GALNT4;LCN2;HAGH;NUCB2;SHANK2;SCRN1;EPHA1;IMPACT;RALGAPA2;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;ACP5;PTPN12;ALDH1L2;CDK17;AFAP1;RGS14;MCFD2;PKD2;PRKACB;SRGAP2B;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;ABTB1;UBE2G1;DDN;ANXA3;ATF4;ABCA7;PIGH;WWC3;ICA1;EIF4E3;AGPAT4;PCMTD2;KIF21B;ASNS;FGFR1;ABHD10;ITGA1;AARS;E2F5;FAM114A1;TMOD2;MARCH4;TUB;PTPDC1;LPCAT4;TACC1;RNPEPL1;UROS;NFAT5;ITGB5;SNX14;HYAL1;BTRC;LPCAT1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ULK2;FAT1;LONP2;INPP5F;CHAC1;BIVM;FAM20C;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;GAMT;CEP120;ENDOV;KDSR;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;OBSL1;PRR9;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLEK2;PLA2G4D;ANXA6;CD46;ACAD10;MVB12B;CTH;MPDZ;MAP6;LRP5;NIPA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;THBS3;CTSL;DOCK9;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;SLC35G2;TPBG;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;FBXL8;BTBD3;RIMS3;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;INPP4A;RFX2;SYTL1;HIBADH;KIAA1147;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;COPG1;ALDH7A1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;DDX60;RASIP1;GSDMA;C6ORF120;TAOK1;PLD3;AEBP1;ATP10D;FBXO41;CSNK2A1;PHF1;PSMD7;PTHLH;TST;BLMH;SLC25A4;QSOX1;SUGCT;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;ANO1;MSRB2;FAM84B;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;BEX4;TBC1D2B;THRA;MGLL;GOLGA6L9;CD99;ENKD1;ACVR1B;DBNDD1;NDUFA4L2;COL6A1;NGFR;BPHL;PSKH1;MVB12A;GLUD1;HSPA13;MARK4;NPL;NUDT6;SPESP1;PER3;MTA1;AZIN2;BCL2L1;CRAT;RNF165;YTHDC2;PM20D2;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;SKAP2;ARF4;GOLGA2P5;TMEM187;YPEL5;UAP1;HSD17B7;PCYOX1;XBP1;PANK4;SPIRE1;NFU1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SLC22A17;PPP1R2;PAIP1;ARRDC1;CYP4F22;ANKIB1;MICU3;LYPLAL1;RIN1;RET;SDR9C7;TUBG2;STX10;LOXL2;PDE5A;VWA1;TCTN1;RAB43;OSBPL5;NAV1;SH3PXD2B;MCTP2;BEX2;TXNDC11;MTMR4;ZFYVE9;MBOAT7;NCKAP1;GABARAPL2;RMRP;GTF2IRD2;DNASE1L1;ELMO3;DOCK11;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;RNF135;TMBIM1;FRMD4B;COL1A2;SFXN3;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;SHC2;PRKACA;NEK6;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;SNX30;S100PBP;SEL1L;CBX7;IFI16;ANGEL1;RHOBTB1;BCAP29;AP2A2;SRD5A3;KDELR3;CMTM6;SLC25A43;ST6GALNAC2;CARD11;FCHO1;LAMB2;FICD;LPAR1;ZNF354A;CTSZ;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;NRSN2;ACP6;TMEM134;ITPR2;MOAP1;FNBP1;AGPAT1;PJA2;GRB10;MAP4K2;ZMYM2;ERLEC1;PPARG;PTGR2;TMEM63A;CITED4;SNX6;EVA1A;USP20;ANKRD50;GRB7;TRIQK;SRPX2;PPL;ALDH1A2;ARHGAP29;LYPLA1;TMEM50B;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;ADAM8;ALDH4A1;AKT3;GARS;WFS1;ENDOG;ATP11B;IKBIP;WDR60;ACAP2;MPLKIP;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;OSGEPL1;PLCXD1;FZD8;CMC1;WASL;USP32;ANKS6;REEP6;HSPA2;FLNB;LRP6;SYT2;PLCH2;TMEM173;RNF180;PPT2;EEF2K;SLC18A2;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;TNRC6C;TRIM2;COQ2;RCAN1;ARMCX3;DNAJC3;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;REEP3;UFL1;FAM162A;ANKRD6;SNX27;N4BP2;AMACR;GALE;JARID2;SLC23A2;RALGPS2;SLC44A1;ADNP;GNAI1;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
7037,GO:0030810,0.0588964743125658,0.980200820134769,6,33,positive regulation of nucleotide biosynthetic process,BP,NOS1;APOE;PTHLH;TMSB4X;TIMP2;ADNP
17480,GO:1900373,0.0588964743125658,0.980200820134769,6,33,positive regulation of purine nucleotide biosynthetic process,BP,NOS1;APOE;PTHLH;TMSB4X;TIMP2;ADNP
8662,GO:0034219,0.058901198489787,0.972287232643074,11,72,carbohydrate transmembrane transport,BP,PAK1;SLC2A3;EDNRA;SLC5A1;TRIB3;CLTCL1;SLC2A9;NGFR;SLC2A13;GRB10;SLC23A2
7753,GO:0032269,0.058984758244452,0.954098968003778,84,849,negative regulation of cellular protein metabolic process,BP,TNIP1;XDH;PLAT;SORL1;SERPINE2;PRNP;ADARB1;MAP2K1;TFPI2;PKN1;WWTR1;EIF4EBP1;EGFR;STK39;PPP1R14A;FYN;TNFRSF6B;UBE2J1;DLG1;IGF2BP3;CRTAP;DKK1;SOCS2;TRIB2;RAG1;PTPN3;SERPING1;EPHA1;IMPACT;CD44;APOE;FKBP1A;RGS14;IDE;ATF4;ELFN2;PPP1R35;PTK6;INPP5F;CHAC1;SOX4;CEACAM1;XRN1;TNRC6B;DVL1;LRP5;CST3;TRIB3;RANBP9;MEX3C;APLP2;PRDX5;F2RL1;CSNK2A1;PHF1;PRKAR1A;CPEB4;SPRY2;BEX4;NGFR;PPP1R10;UBASH3B;MAP2K2;PPP1R2;C5;GABARAPL2;PUM2;TIMP2;EIF2AK2;IFI16;CTSZ;ERLEC1;PPARG;SNX6;GRB7;LRP6;TNRC6C;ZC3H7A;DNAJC3;KAT2B;USP25;PRMT3;UFL1;JARID2
2399,GO:0005544,0.0591467081142227,0.980095448365722,6,33,calcium-dependent phospholipid binding,MF,DYSF;ANXA3;ANXA6;SYTL1;RPH3AL;SYT2
15138,GO:0071229,0.0592785107371205,0.966328821185253,18,137,cellular response to acid chemical,BP,NEURL1;NFATC4;CAPN2;EGFR;FYN;PKD2;PTK6;TWF2;CPEB4;COL6A1;BCL2L1;XBP1;RET;COL1A2;PPARG;ALDH1A2;TBX1;DNMT3A
7503,GO:0031681,0.059326958692425,0.994817045578567,2,5,G-protein beta-subunit binding,MF,F2R;F2RL1
3250,GO:0006909,0.0594066382203332,0.965633074694566,19,151,phagocytosis,BP,PEAR1;WIPF1;ARHGAP12;FYN;TGM2;PAK1;RAC2;LRP1;ANXA3;ABCA7;TUB;ITGA2;F2RL1;WASF2;NCKAP1;ELMO3;ARPC1A;PPARG;WASL
8603,GO:0034111,0.0594597052176276,0.989667524932221,3,11,negative regulation of homotypic cell-cell adhesion,BP,SERPINE2;CEACAM1;UBASH3B
6634,GO:0023014,0.0594620253871091,0.955263577398672,65,624,signal transduction by protein phosphorylation,BP,TNIP1;XDH;F2R;SORL1;IGFBP4;MAP2K1;ACVR2B;PKN1;MST1R;PSMD2;EGFR;STK39;FYN;ERCC6;MAPK13;DLG1;DLG4;WNT7A;MAP4K4;STRADB;SHC1;DKK1;PAK1;RASA3;TRIB2;TGFBR2;EPHA1;CD44;APOE;RGS14;AKAP9;ABCA7;LPAR3;FGFR1;ITGA1;BTRC;CEACAM1;MAPKAPK3;NLK;TRIM5;TRIB3;RANBP9;SLK;F2RL1;TAOK1;PSMD7;SPRY2;ACVR1B;NGFR;MAP2K2;RET;PDE5A;C5;PAK6;SHC2;TIMP2;EIF2AK2;LPAR1;IGF2;MAP4K2;TBX1;ADAM8;FZD8;ANKRD6;RB1CC1
12573,GO:0050727,0.0595516220139306,0.964445953523097,21,179,regulation of inflammatory response,BP,TNIP1;NT5E;FNDC4;EGFR;STK39;MAPK13;TGM2;SERPING1;APOE;ACP5;PPARA;ITGA2;CD46;CASP4;MGLL;C5;TMSB4X;PPARG;ADAM8;IL20RB;FOXP1
3222,GO:0006869,0.0595800029549544,0.962806799223063,25,200,lipid transport,BP,SORL1;VLDLR;OSBP2;PITPNC1;OSBPL10;NME4;APOE;ABCD1;LRP1;PPARA;ABCA7;ABCG1;PITPNM1;CEACAM1;NTSR1;ATP10D;CPT2;OSBPL5;PPARG;SLC10A6;ESYT3;ATP11B;LRP6;SIGMAR1;PTCH1
7764,GO:0032280,0.0597382827857498,0.995445275994132,2,4,symmetric synapse,CC,NTSR1;NLGN2
15177,GO:0071310,0.0598228605325337,0.950065671173377,171,1804,cellular response to organic substance,BP,TNIP1;XDH;SMURF2;EDEM1;NOS1;PGF;CCND1;NEURL1;PCK2;ITGA6;MMP1;CYP27B1;ADCY7;PRNP;BBS2;POSTN;NR1D1;NFATC4;MAP2K1;FAM210B;LTBP2;RAPGEF3;ACVR2B;LTBP1;MST1R;APLN;TNFSF15;EIF4EBP1;SSH1;DDIT3;PSMD2;CAPN2;EGFR;FYN;TNFRSF6B;SLC33A1;MAPK13;ADAMTS7;CTSB;CD68;HTRA1;WNT7A;MAP4K4;SDC1;SHC1;DKK1;PAK1;SOCS2;TGFBR2;LCN2;IMPACT;CD44;FKBP1A;PTPN12;PKD2;PRKACB;RBCK1;LRP1;IDE;AKAP9;ATF4;PPARA;ASNS;FGFR1;UROS;ITGB5;HYAL1;BTRC;ITGA2;PTK6;GALNT3;VAMP2;LTBP4;FAM20C;SOX4;CEACAM1;FERMT1;PDIA5;RAB31;MT2A;NLK;EPN2;XRN1;TRIM5;EPOR;CTH;LRP5;CTSL;TWF2;TRIB3;CASP4;GFPT1;PCSK6;DNAJB9;SEC63;PPP3CB;MYOF;RFX2;F2RL1;PSMD7;PRKAR1A;ANO1;BOK;PARP9;CPEB4;SPRY2;THRA;COL6A1;NGFR;HSPA13;PTPRZ1;BCL2L1;IFITM1;RNF165;XBP1;MAP2K2;TLE4;RET;RAB43;MTMR4;ZFYVE9;RMRP;PUM2;COL1A2;PRKACA;TMSB4X;EIF2AK2;NR2F6;KDELR3;IL1RAP;FICD;LPAR1;IGF2;ITPR2;LAMA5;AGPAT1;GRB10;PPARG;SNX6;ALDH1A2;TBX1;CREB3L2;ATP6V1B2;IL20RB;WFS1;ENDOG;ITGA4;ACAP2;IGFBP7;HSPA2;FLNB;LRP6;ARID5B;TMEM173;EEF2K;SSR1;ZC3H7A;DNAJC3;FOXP1;PTCH1;ADCY1;KAT2B;OAS1;UFL1;JARID2;KLHL15;GNAI1;LRP4;DNMT3A;TRIM38;FADD
11071,GO:0045071,0.059923777574,0.977464415448106,7,45,negative regulation of viral genome replication,BP,TNIP1;HMGA2;APOBEC3C;IFITM1;EIF2AK2;IFI16;OAS1
11501,GO:0045981,0.0601263074983261,0.977487633754293,7,42,positive regulation of nucleotide metabolic process,BP,NOS1;RAPGEF3;APOE;PTHLH;TMSB4X;TIMP2;ADNP
17504,GO:1900544,0.0601263074983261,0.977487633754293,7,42,positive regulation of purine nucleotide metabolic process,BP,NOS1;RAPGEF3;APOE;PTHLH;TMSB4X;TIMP2;ADNP
1997,GO:0004720,0.0603728260960231,0.994672778456515,2,5,protein-lysine 6-oxidase activity,MF,LOXL1;LOXL2
3411,GO:0007193,0.0606423842180234,0.979588708731294,6,31,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,ADCY7;HTR7;EDNRA;LPAR1;ADCY1;GNAI1
12181,GO:0048306,0.0606981134738879,0.979188220866852,6,38,calcium-dependent protein binding,MF,VLDLR;ANXA3;VAMP2;ANXA6;S100PBP;WFS1
12440,GO:0050104,0.0608466984323745,1,1,1,L-gulonate 3-dehydrogenase activity,MF,CRYL1
10413,GO:0043250,0.0608783526171959,1,1,1,sodium-dependent organic anion transmembrane transporter activity,MF,SLC10A6
10414,GO:0043251,0.0608783526171959,1,1,1,sodium-dependent organic anion transport,BP,SLC10A6
16912,GO:0098876,0.060936895640906,0.972332558783206,10,66,vesicle-mediated transport to the plasma membrane,BP,BBS2;EXOC2;ANK3;VAMP2;RAB31;SDCCAG3;OSBPL5;ANKRD50;LYPLA1;SNX27
16445,GO:0097105,0.0610694455814247,0.995284174045549,2,4,presynaptic membrane assembly,BP,NLGN2;LRP4
17389,GO:1900115,0.0611432248520051,0.989251328658078,3,11,extracellular regulation of signal transduction,BP,LTBP1;DKK1;CD46
17390,GO:1900116,0.0611432248520051,0.989251328658078,3,11,extracellular negative regulation of signal transduction,BP,LTBP1;DKK1;CD46
610,GO:0001778,0.0611601322677441,0.995273120455714,2,4,plasma membrane repair,BP,DYSF;MYOF
3544,GO:0007566,0.0611933461014637,0.9791180605251,6,35,embryo implantation,BP,SMURF2;TGFBR2;BSG;CST3;ACVR1B;IGFBP7
9480,GO:0036114,0.0613122580687696,1,1,1,medium-chain fatty-acyl-CoA catabolic process,BP,ACOT7
9481,GO:0036115,0.0613122580687696,1,1,1,fatty-acyl-CoA catabolic process,BP,ACOT7
9482,GO:0036116,0.0613122580687696,1,1,1,long-chain fatty-acyl-CoA catabolic process,BP,ACOT7
17500,GO:1900533,0.0613122580687696,1,1,1,palmitic acid metabolic process,BP,ACOT7
17501,GO:1900535,0.0613122580687696,1,1,1,palmitic acid biosynthetic process,BP,ACOT7
6818,GO:0030276,0.0614023917770555,0.975166011850338,8,47,clathrin binding,MF,CEMIP;LRP1;CLTCL1;TOM1L2;SYTL1;DNAJC6;AP2A2;SYT2
6409,GO:0021644,0.0614144501635542,1,1,1,vagus nerve morphogenesis,BP,TBX1
14595,GO:0070141,0.0615298455834468,0.99451142491143,2,5,response to UV-A,BP,CCND1;EGFR
6099,GO:0019319,0.0615565230523531,0.974850936372112,8,54,hexose biosynthetic process,BP,PCK2;NR1D1;PC;PGM1;ATF4;PPARA;SLC35B4;KAT2B
13079,GO:0051586,0.0615713922555732,1,1,1,positive regulation of dopamine uptake involved in synaptic transmission,BP,RAB3B
13262,GO:0051944,0.0615713922555732,1,1,1,positive regulation of catecholamine uptake involved in synaptic transmission,BP,RAB3B
18704,GO:1904064,0.0615948761407933,0.972004315703196,10,65,positive regulation of cation transmembrane transport,BP,NOS1;F2R;ANK3;CEMIP;PKD2;AKAP9;NTSR1;TRPC1;TMSB4X;HSPA2
2274,GO:0005217,0.0616752758485076,0.985402204766425,4,15,intracellular ligand-gated ion channel activity,MF,RASA3;PKD2;ITPR3;ITPR2
5064,GO:0015278,0.0616752758485076,0.985402204766425,4,15,calcium-release channel activity,MF,RASA3;PKD2;ITPR3;ITPR2
16416,GO:0097049,0.0616811817504244,0.994490184394547,2,5,motor neuron apoptotic process,BP,ADARB1;FADD
3965,GO:0008747,0.0617592780316516,1,1,1,N-acetylneuraminate lyase activity,MF,NPL
7752,GO:0032268,0.0618015151099348,0.94819012025597,178,1899,regulation of cellular protein metabolic process,BP,TNIP1;XDH;PLAT;EDEM1;NOS1;F2R;SORL1;CCND1;NEURL1;VLDLR;SERPINE2;ADCY7;IGFBP4;PRNP;ADARB1;MAP2K1;TFPI2;RAPGEF3;ACVR2B;PKN1;WWTR1;MST1R;TNFSF15;EIF4EBP1;SSH1;EGFR;STK39;PPP1R14A;FYN;TNFRSF6B;ERCC6;UBE2J1;DLG1;DLG4;SNX9;WNT7A;IGF2BP3;MAP4K4;STRADB;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;SOCS2;TRIB2;RAG1;TGFBR2;PTPN3;SERPING1;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;CCND2;RGS14;PKD2;PRKACB;LRP1;IDE;AKAP9;PPP2R3B;ATF4;ABCA7;EIF4E3;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;BTRC;ITGA2;PTK6;INPP5F;CHAC1;ATRX;MTHFR;PFN2;SOX4;FBXO2;CEACAM1;MAPKAPK3;SH3D19;XRN1;TRIM5;TNRC6B;DVL1;MMP14;LRP5;ETAA1;CST3;CNTN1;TRIB3;CASP4;VPS11;RANBP9;MEX3C;APLP2;SLK;PRDX5;F2RL1;TAOK1;CSNK2A1;PHF1;PRKAR1A;BOK;PARP9;CPEB4;ATXN2;SPRY2;BEX4;ACVR1B;NGFR;PPP1R10;MTA1;PM20D2;XBP1;UBASH3B;MAP2K2;PPP1R2;PAIP1;ANKIB1;RET;PDE5A;C5;GABARAPL2;PAK6;PUM2;CCDC88A;SHC2;PRKACA;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;SECISBP2L;LPAR1;CTSZ;IGF2;MAP4K2;ERLEC1;PPARG;SNX6;GRB7;TBX1;ADAM8;WFS1;FZD8;HSPA2;LRP6;MAGEF1;RNF180;EEF2K;TNRC6C;RCAN1;TET1;ZC3H7A;DNAJC3;ADCY1;KAT2B;CNOT11;USP25;PRMT3;UFL1;FAM162A;ANKRD6;JARID2;ADNP;LRP4;RB1CC1;FBXL5;FADD
1706,GO:0004222,0.0618780140598205,0.973251568214887,9,57,metalloendopeptidase activity,MF,ADAM19;MMP1;ADAMTS7;CLCA2;IDE;MMP14;MMP10;ADAM8;OSGEPL1
4493,GO:0010518,0.061949965330043,0.981597762717455,5,25,positive regulation of phospholipase activity,BP,EGFR;EDNRA;FGFR1;ARF4;LPAR1
16393,GO:0097006,0.0620023187074007,0.974692335141345,8,52,regulation of plasma lipoprotein particle levels,BP,VLDLR;LMF1;APOE;PRKACB;ABCA7;ABCG1;PRKACA;AP2A2
16133,GO:0090131,0.0621102455940028,1,1,1,mesenchyme migration,BP,ACTA2
10591,GO:0043555,0.0621871250117116,0.984776343430924,4,18,regulation of translation in response to stress,BP,IMPACT;ATF4;EIF2AK2;DNAJC3
3277,GO:0006955,0.062261576438099,0.94969445355629,115,1223,immune response,BP,TNIP1;ERCC1;PYGL;CYP27B1;PYGB;PRSS3;PRNP;PAG1;NR1D1;ADARB1;PKN1;NAPRT;MST1R;APLN;POU2F2;TNFSF15;PTPRS;PSMD2;LTA4H;FCGRT;WIPF1;FYN;TNFRSF6B;PGM1;DLG1;CTSB;CD68;ARG2;STOM;SHC1;PAK1;RAG1;SERPING1;SLC2A3;LCN2;RAC2;CD44;FKBP1A;PRKACB;RBCK1;LRP1;ANXA3;BTRC;LPCAT1;PTK6;VAMP2;APOBEC3C;CEACAM1;MAPKAPK3;RAB31;MT2A;TRIM5;CD46;CTSL;CST3;CASP4;MOSPD2;PPP3CB;COPB1;CEBPG;F2RL1;DDX60;C6ORF120;PSMD7;QSOX1;PARP9;CD99;NGFR;IFITM1;GLB1;WASF2;SKAP2;YPEL5;XBP1;RAB43;C5;NCKAP1;DNASE1L1;DOCK11;PUM2;RNF135;TMBIM1;COL1A2;PRKACA;TIMP2;EIF2AK2;IFI16;AP2A2;SLC39A10;CMTM6;IL1RAP;ORAI1;CARD11;LTB4R;CTSZ;NIT2;ARPC1A;MAP4K2;PPARG;TMEM63A;ERP44;ADAM8;IL20RB;ATP11B;ITGA4;WASL;FLNB;TMEM173;HPSE;GALNS;DNAJC3;FOXP1;OAS1;TRIM38;FADD
16740,GO:0097756,0.062290180218183,0.976580629619697,7,40,negative regulation of blood vessel diameter,BP,DOCK4;F2R;BBS2;APLN;EGFR;HTR7;EDNRA
12229,GO:0048486,0.0623431629372486,0.988951563788857,3,11,parasympathetic nervous system development,BP,ADARB1;TBX1;SEMA3F
1567,GO:0003974,0.0625986770482514,1,1,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,GALE
1571,GO:0003978,0.0625986770482514,1,1,1,UDP-glucose 4-epimerase activity,MF,GALE
1170,GO:0002793,0.0626979692154108,0.963463142210433,19,154,positive regulation of peptide secretion,BP,F2R;PCK2;POSTN;ALOX15B;APLN;EGFR;GLUL;SOX4;FERMT1;NLGN2;PPP3CB;F2RL1;ANO1;GLUD1;XBP1;C5;IL1RAP;RPH3AL;ADAM8
5701,GO:0016829,0.0628629912929633,0.965946153494323,15,128,lyase activity,MF,PCK2;CBS;ADCY7;GLUL;GLO1;HMGA2;UROS;CHAC1;CTH;MLYCD;NPL;AZIN2;POLL;GGACT;ADCY1
7337,GO:0031347,0.0629203543658529,0.954801947466249,47,453,regulation of defense response,BP,TNIP1;NT5E;NR1D1;FNDC4;PTPRS;PSMD2;EGFR;STK39;FYN;MAPK13;CTSB;TGM2;HTRA1;ARG2;PAK1;RAG1;SERPING1;APOE;ACP5;PRKACB;PPARA;BTRC;ITGA2;CEACAM1;MAPKAPK3;TRIM5;CD46;CTSL;CASP4;F2RL1;DDX60;PSMD7;PARP9;MGLL;C5;PUM2;RNF135;PRKACA;TMSB4X;IFI16;CARD11;PPARG;ADAM8;IL20RB;TMEM173;FOXP1;FADD
10867,GO:0044389,0.0629571529034385,0.958302166630392,31,281,ubiquitin-like protein ligase binding,MF,CBS;BTBD2;EGFR;HLTF;UBE2J1;UBXN7;SNX9;DLG3;TRIB2;PRKACB;ABTB1;UBE2G1;NLK;TRIB3;BTBD3;PRKAR1A;BOK;PARP9;ACVR1B;NGFR;PER3;UBASH3B;ARRDC1;GABARAPL2;PRKACA;NEK6;MOAP1;WFS1;FZD8;TMEM173;USP25
18974,GO:1904754,0.0629711481306423,0.989375320262864,3,9,positive regulation of vascular associated smooth muscle cell migration,BP,DOCK4;SSH1;PAK1
811,GO:0002083,0.063029933536711,1,1,1,4-hydroxybenzoate decaprenyltransferase activity,MF,COQ2
11985,GO:0047293,0.063029933536711,1,1,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,COQ2
11668,GO:0046439,0.0630731841833773,0.994293345743735,2,5,L-cysteine metabolic process,BP,CBS;AHCYL2
5904,GO:0018117,0.0631526415813129,1,1,1,protein adenylylation,BP,FICD
5916,GO:0018175,0.0631526415813129,1,1,1,protein nucleotidylation,BP,FICD
10942,GO:0044601,0.0631526415813129,1,1,1,protein denucleotidylation,BP,FICD
10943,GO:0044602,0.0631526415813129,1,1,1,protein deadenylylation,BP,FICD
10944,GO:0044603,0.0631526415813129,1,1,1,protein adenylylhydrolase activity,MF,FICD
14908,GO:0070733,0.0631526415813129,1,1,1,protein adenylyltransferase activity,MF,FICD
14133,GO:0060999,0.063178519114115,0.978585754306176,6,30,positive regulation of dendritic spine development,BP,ZMYND8;NEURL1;SHANK2;APOE;LPAR1;EEF2K
4815,GO:0014009,0.0631918718147451,0.981313608837748,5,23,glial cell proliferation,BP,ETV5;IDH2;SOX4;PLAG1;UFL1
10203,GO:0042813,0.0631968517047776,0.984738049936314,4,16,Wnt-activated receptor activity,MF,LRP5;FZD8;LRP6;LRP4
16444,GO:0097104,0.0632091784510248,0.995020715987487,2,4,postsynaptic membrane assembly,BP,NLGN2;LRP4
3280,GO:0006958,0.0633422940485616,0.988488707431515,3,12,complement activation, classical pathway,BP,SERPING1;CD46;C5
10384,GO:0043204,0.0633547289350208,0.972456580436941,9,58,perikaryon,CC,NEURL1;PTPRS;GLUL;WDFY3;DDN;ITGA1;NTSR1;AZIN2;ENDOG
694,GO:0001914,0.0633809750334884,0.988303254851276,3,13,regulation of T cell mediated cytotoxicity,BP,CEACAM1;PPP3CB;FADD
18673,GO:1904018,0.0634241159162742,0.96579721136419,15,110,positive regulation of vasculature development,BP,PGF;ADM2;RAPGEF3;TGFBR2;EPHA1;ANGPTL4;ANXA3;HMGA2;HYAL1;CEACAM1;CTH;XBP1;C5;SRPX2;AKT3
16302,GO:0090407,0.0634301004179042,0.953648572775456,52,500,organophosphate biosynthetic process,BP,NOS1;MBOAT2;PYGL;ADCY7;CRYL1;TK2;NAPRT;DHTKD1;DGKA;PGM1;ISYNA1;IDH2;SPTLC2;ACOT7;NMRK1;NME4;APOE;LDHA;AKAP9;PPARA;PIGH;AGPAT4;FGFR1;LPCAT4;LPCAT1;INPP5F;PITPNM1;NTSR1;PLA2G4D;INPP4A;CSNK2A1;PTHLH;CRLS1;PARP9;AGPAT3;PANK4;MTMR4;MBOAT7;SAMD8;TMSB4X;TIMP2;SRD5A3;ACP6;AGPAT1;AK9;GARS;DDHD2;CDS2;ADCY1;PANK1;SLC44A1;ADNP
12307,GO:0048645,0.0634313609822259,0.978156778560712,6,35,animal organ formation,BP,MAP2K1;DKK1;TGFBR2;FGFR1;WNT2B;HOXA3
10991,GO:0044788,0.0636068881452255,0.984310119221966,4,18,modulation by host of viral process,BP,PC;STOM;APOE;YTHDC2
7085,GO:0030879,0.0636855456632905,0.966511394813032,14,99,mammary gland development,BP,XDH;ETV5;CCND1;NEURL1;APLN;SOCS2;TGFBR2;ATP7B;BTRC;ITGA2;LRP5;XBP1;LRP6;PTCH1
9674,GO:0038034,0.0637674855361368,0.973754585829197,8,54,signal transduction in absence of ligand,BP,FYN;STRADB;FGFR1;BOK;BCL2L1;RET;MOAP1;FADD
16497,GO:0097192,0.0637674855361368,0.973754585829197,8,54,extrinsic apoptotic signaling pathway in absence of ligand,BP,FYN;STRADB;FGFR1;BOK;BCL2L1;RET;MOAP1;FADD
9127,GO:0035438,0.0637779287600159,1,1,1,cyclic-di-GMP binding,MF,TMEM173
14328,GO:0061507,0.0637779287600159,1,1,1,cyclic-GMP-AMP binding,MF,TMEM173
12025,GO:0047658,0.0638840786907996,1,1,1,alpha-amino-acid esterase activity,MF,BPHL
1965,GO:0004674,0.0639084372994908,0.954305183885286,46,394,protein serine/threonine kinase activity,MF,CCND1;RPS6KA2;MAP2K1;ACVR2B;LTBP1;PKN1;MST1R;BRSK1;EGFR;STK39;MAPK13;MAP4K4;TTBK2;GRK5;STRADB;PAK1;NEK9;TGFBR2;EPHA1;OBSCN;CDK17;PRKACB;HMGA2;FGFR1;ULK2;LTBP4;FAM20C;MAPKAPK3;NLK;SLK;CDC42BPA;TAOK1;CSNK2A1;MAST3;ACVR1B;PSKH1;MARK4;MAP2K2;RET;PAK6;PRKACA;NEK6;EIF2AK2;MAP4K2;AKT3;EEF2K
1260,GO:0003014,0.0639350833693056,0.972154763348001,9,58,renal system process,BP,F2R;ADCY7;PKN1;PRKACB;F2RL1;PRKAR1A;PRKACA;WFS1;ADCY1
9255,GO:0035659,0.0641260357553775,1,1,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,WNT7A
11128,GO:0045167,0.0641260357553775,1,1,1,asymmetric protein localization involved in cell fate determination,BP,WNT7A
19043,GO:1904889,0.0641260357553775,1,1,1,regulation of excitatory synapse assembly,BP,WNT7A
19044,GO:1904891,0.0641260357553775,1,1,1,positive regulation of excitatory synapse assembly,BP,WNT7A
14295,GO:0061395,0.0641939171140274,1,1,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,ATF4
19301,GO:1905564,0.0642598307073005,0.988732074908409,3,10,positive regulation of vascular endothelial cell proliferation,BP,APLN;FGFR1;AKT3
3491,GO:0007369,0.064347230139614,0.96379658498312,17,122,gastrulation,BP,ITGB4;ACVR2B;APLN;LAMB1;DKK1;TGFBR2;HMGA2;FGFR1;ITGB5;ITGA2;DVL1;MMP14;LRP5;PRKAR1A;COL6A1;ITGA4;LRP6
6343,GO:0021517,0.0643589104971697,0.984201514991644,4,17,ventral spinal cord development,BP,VLDLR;SOX4;TCTN1;PTCH1
18849,GO:1904464,0.0644571901365838,1,1,1,regulation of matrix metallopeptidase secretion,BP,IDH2
18850,GO:1904465,0.0644571901365838,1,1,1,negative regulation of matrix metallopeptidase secretion,BP,IDH2
19619,GO:1990773,0.0644571901365838,1,1,1,matrix metallopeptidase secretion,BP,IDH2
6284,GO:0019888,0.0645579351494095,0.971716806454644,9,62,protein phosphatase regulator activity,MF,PPP1R14A;PPP2R3B;ELFN2;PPP1R35;CSNK2A1;PPP1R10;PPP1R2;EIF2AK2;RCAN1
1561,GO:0003962,0.0645996342677601,1,1,1,cystathionine gamma-synthase activity,MF,CTH
1664,GO:0004123,0.0645996342677601,1,1,1,cystathionine gamma-lyase activity,MF,CTH
5944,GO:0018272,0.0645996342677601,1,1,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,CTH
9370,GO:0035887,0.0645996342677601,1,1,1,aortic smooth muscle cell differentiation,BP,CTH
10919,GO:0044524,0.0645996342677601,1,1,1,protein sulfhydration,BP,CTH
10926,GO:0044540,0.0645996342677601,1,1,1,L-cystine L-cysteine-lyase (deaminating),MF,CTH
12055,GO:0047982,0.0645996342677601,1,1,1,homocysteine desulfhydrase activity,MF,CTH
15156,GO:0071266,0.0645996342677601,1,1,1,'de novo' L-methionine biosynthetic process,BP,CTH
15983,GO:0080146,0.0645996342677601,1,1,1,L-cysteine desulfhydrase activity,MF,CTH
19009,GO:1904829,0.0645996342677601,1,1,1,regulation of aortic smooth muscle cell differentiation,BP,CTH
19010,GO:1904831,0.0645996342677601,1,1,1,positive regulation of aortic smooth muscle cell differentiation,BP,CTH
15551,GO:0071963,0.0646220947150387,1,1,1,establishment or maintenance of cell polarity regulating cell shape,BP,PARVB
16517,GO:0097224,0.0646370636811757,1,1,1,sperm connecting piece,CC,SPATA6
11699,GO:0046487,0.0646379886659998,0.993584946944122,2,6,glyoxylate metabolic process,BP,IDH2;ALDH4A1
3831,GO:0008430,0.0648313214931924,1,1,1,selenium binding,MF,GPX3
969,GO:0002416,0.0648686071020251,1,1,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,FCGRT
6222,GO:0019770,0.0648686071020251,1,1,1,IgG receptor activity,MF,FCGRT
6270,GO:0019864,0.0648686071020251,1,1,1,IgG binding,MF,FCGRT
6840,GO:0030305,0.0649058697648255,1,1,1,heparanase activity,MF,HPSE
5714,GO:0016846,0.0649064954681348,0.993208924108265,2,7,carbon-sulfur lyase activity,MF,GLO1;CTH
7475,GO:0031639,0.0649217587629657,0.988080329998751,3,12,plasminogen activation,BP,PLAT;SERPINE2;CTSZ
3509,GO:0007417,0.0649965386319869,0.950963932949767,64,587,central nervous system development,BP,NEURL1;VLDLR;SERPINE2;BBS2;ADARB1;MAP2K1;PTPRS;SMARCA1;SOX12;LAMB1;SNPH;EGFR;FYN;BNIP3;WNT7A;TTBK2;DKK1;PAK1;TGFBR2;SHANK2;PKD2;LRP1;ANXA3;FGFR1;AARS;TACC1;ATRX;SOX4;PITPNM1;CEP120;EPOR;CST3;CNTN1;WASF3;BTBD3;CSNK2A1;CHD7;BOK;THRA;WNT2B;ACVR1B;GLUD1;PTPRZ1;ARF4;SLC38A2;TCTN1;MBOAT7;NCKAP1;TIMP2;LAMB2;LPAR1;PPARG;ALDH1A2;TBX1;SLC7A11;AKT3;LRP6;RCAN1;PTCH1;ADCY1;RNF103;PBX3;JARID2;SEMA3F
2516,GO:0005769,0.0650248452157404,0.957162756116169,30,258,early endosome,CC,F2R;SORL1;MAP2K1;APPL2;EGFR;DYSF;DKK1;APOE;LRP1;ABCA7;INPP5F;RAB31;CLCN3;MVB12B;NIPA1;VPS11;F2RL1;BOK;SDCCAG3;WASF2;MAP2K2;RET;MTMR4;ZFYVE9;RAB1A;SNX6;ATP11B;TBC1D16;LRP6;SNX27
13072,GO:0051575,0.0650892665512952,0.994003592682894,2,5,5'-deoxyribose-5-phosphate lyase activity,MF,HMGA2;POLL
17953,GO:1902305,0.0652270438960437,0.975268022467711,7,39,regulation of sodium ion transmembrane transport,BP,NOS1;HECW2;STK39;ANK3;DLG1;STOM;PTPN3
16676,GO:0097581,0.0654153141628449,0.969939035858903,10,65,lamellipodium organization,BP,SSH1;PARVB;PLXNB3;RAC2;CD44;TWF2;WASF3;WASF2;NCKAP1;CCDC88A
3920,GO:0008591,0.0654694873937736,1,1,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,DKK1
10128,GO:0042662,0.0654694873937736,1,1,1,negative regulation of mesodermal cell fate specification,BP,DKK1
11409,GO:0045813,0.0654694873937736,1,1,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,DKK1
14437,GO:0061743,0.0654694873937736,1,1,1,motor learning,BP,DKK1
16102,GO:0090081,0.0654694873937736,1,1,1,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,DKK1
16103,GO:0090082,0.0654694873937736,1,1,1,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,DKK1
16289,GO:0090381,0.0654694873937736,1,1,1,regulation of heart induction,BP,DKK1
16916,GO:0098883,0.0654694873937736,1,1,1,synapse disassembly,BP,DKK1
17108,GO:0100012,0.0654694873937736,1,1,1,regulation of heart induction by canonical Wnt signaling pathway,BP,DKK1
17610,GO:1901296,0.0654694873937736,1,1,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
17623,GO:1901321,0.0654694873937736,1,1,1,positive regulation of heart induction,BP,DKK1
18943,GO:1904701,0.0654694873937736,1,1,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
18948,GO:1904711,0.0654694873937736,1,1,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
18958,GO:1904723,0.0654694873937736,1,1,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,DKK1
19124,GO:1905067,0.0654694873937736,1,1,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,DKK1
19357,GO:1905771,0.0654694873937736,1,1,1,negative regulation of mesodermal cell differentiation,BP,DKK1
19395,GO:1905903,0.0654694873937736,1,1,1,negative regulation of mesoderm formation,BP,DKK1
9139,GO:0035470,0.0655211425061653,1,1,1,positive regulation of vascular wound healing,BP,XBP1
13980,GO:0060690,0.0655211425061653,1,1,1,epithelial cell differentiation involved in salivary gland development,BP,XBP1
13981,GO:0060691,0.0655211425061653,1,1,1,epithelial cell maturation involved in salivary gland development,BP,XBP1
17375,GO:1900098,0.0655211425061653,1,1,1,regulation of plasma cell differentiation,BP,XBP1
17376,GO:1900100,0.0655211425061653,1,1,1,positive regulation of plasma cell differentiation,BP,XBP1
18423,GO:1903489,0.0655211425061653,1,1,1,positive regulation of lactation,BP,XBP1
13379,GO:0052642,0.0656169607697428,1,1,1,lysophosphatidic acid phosphatase activity,MF,ACP6
20310,GO:2001311,0.0656169607697428,1,1,1,lysobisphosphatidic acid metabolic process,BP,ACP6
8373,GO:0033268,0.0657267744952612,0.988708657603906,3,9,node of Ranvier,CC,SCN8A;ANK3;DLG1
4301,GO:0009749,0.0658810011905949,0.963412064438321,16,125,response to glucose,BP,PCK2;NR1D1;ACVR2B;GLUL;MAP4K4;TGFBR2;LDHA;VAMP2;SOX4;LRP5;PPP3CB;ANO1;XBP1;PRKACA;IGF2;ENDOG
547,GO:0001666,0.0661573196745532,0.956959739432943,28,254,response to hypoxia,BP,PLAT;NOS1;PGF;CYGB;POSTN;PSMD2;CAPN2;BNIP3;PAK1;TGFBR2;EDNRA;BNIP3L;ANGPTL4;LDHA;PPARA;ITGA2;MTHFR;MMP14;CST3;PSMD7;LOXL2;ZNF354A;ITPR2;ADAM8;ENDOG;PSEN2;FAM162A;DNMT3A
19913,GO:2000409,0.0661596554685461,1,1,1,positive regulation of T cell extravasation,BP,FADD
19931,GO:2000451,0.0661596554685461,1,1,1,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
19933,GO:2000454,0.0661596554685461,1,1,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
2113,GO:0004900,0.0661742596621902,1,1,1,erythropoietin receptor activity,MF,EPOR
9723,GO:0038162,0.0661742596621902,1,1,1,erythropoietin-mediated signaling pathway,BP,EPOR
10506,GO:0043408,0.066258386409042,0.951604100141432,51,476,regulation of MAPK cascade,BP,TNIP1;XDH;F2R;SORL1;IGFBP4;MAP2K1;PKN1;MST1R;EGFR;STK39;ERCC6;DLG1;WNT7A;MAP4K4;SHC1;DKK1;PAK1;TRIB2;EPHA1;CD44;APOE;RGS14;ABCA7;LPAR3;FGFR1;ITGA1;CEACAM1;MAPKAPK3;TRIM5;TRIB3;RANBP9;F2RL1;TAOK1;SPRY2;NGFR;MAP2K2;RET;PDE5A;C5;PAK6;SHC2;TIMP2;EIF2AK2;LPAR1;IGF2;MAP4K2;TBX1;ADAM8;FZD8;ANKRD6;RB1CC1
13983,GO:0060694,0.0662691074425411,1,1,1,regulation of cholesterol transporter activity,BP,PPARG
15754,GO:0072343,0.0662691074425411,1,1,1,pancreatic stellate cell proliferation,BP,PPARG
17683,GO:1901558,0.0662691074425411,1,1,1,response to metformin,BP,PPARG
19300,GO:1905563,0.0662691074425411,1,1,1,negative regulation of vascular endothelial cell proliferation,BP,PPARG
19793,GO:2000229,0.0662691074425411,1,1,1,regulation of pancreatic stellate cell proliferation,BP,PPARG
19794,GO:2000230,0.0662691074425411,1,1,1,negative regulation of pancreatic stellate cell proliferation,BP,PPARG
12122,GO:0048185,0.066308953922821,0.987942664087282,3,11,activin binding,MF,ACVR2B;FKBP1A;ACVR1B
14028,GO:0060753,0.0663535634279848,0.993315379284623,2,6,regulation of mast cell chemotaxis,BP,PGF;RAC2
4649,GO:0010771,0.0664112424059481,0.969424684095842,10,64,negative regulation of cell morphogenesis involved in differentiation,BP,POSTN;NFATC4;PTPRS;SEMA4B;GDI1;ULK2;NGFR;OMG;SEMA3F;LRP4
5001,GO:0015143,0.0664220345012103,1,1,1,urate transmembrane transporter activity,MF,SLC2A9
17754,GO:1901702,0.0664220345012103,1,1,1,salt transmembrane transporter activity,MF,SLC2A9
4492,GO:0010517,0.0664499113035017,0.976967151349613,6,33,regulation of phospholipase activity,BP,EGFR;EDNRA;LRP1;FGFR1;ARF4;LPAR1
18178,GO:1902947,0.0664662986117575,0.993802534511025,2,5,regulation of tau-protein kinase activity,BP,SORL1;DKK1
5096,GO:0015370,0.0665154960931901,0.977078174636263,6,31,solute:sodium symporter activity,MF,SLC5A1;SLC6A6;SLC6A14;SLC13A3;SLC10A6;SLC23A2
18716,GO:1904152,0.0665311810530814,0.987659643310709,3,12,regulation of retrograde protein transport, ER to cytosol,BP,EDEM1;UBE2J1;ERLEC1
4716,GO:0010878,0.0666017341578434,0.98786708753951,3,11,cholesterol storage,BP,PPARA;ABCG1;PPARG
16447,GO:0097107,0.0666301403196382,0.994588092811703,2,4,postsynaptic density assembly,BP,SHANK2;NLGN2
16821,GO:0098698,0.0666301403196382,0.994588092811703,2,4,postsynaptic specialization assembly,BP,SHANK2;NLGN2
599,GO:0001766,0.0666543009176562,0.99326768918201,2,6,membrane raft polarization,BP,MARVELD1;MALL
7446,GO:0031580,0.0666543009176562,0.99326768918201,2,6,membrane raft distribution,BP,MARVELD1;MALL
14694,GO:0070314,0.0667614321979973,0.993759111608076,2,5,G1 to G0 transition,BP,CYP27B1;RAB11FIP4
665,GO:0001868,0.0667775048141719,1,1,1,regulation of complement activation, lectin pathway,BP,SERPING1
666,GO:0001869,0.0667775048141719,1,1,1,negative regulation of complement activation, lectin pathway,BP,SERPING1
15941,GO:0072740,0.0667992075451761,1,1,1,cellular response to anisomycin,BP,MAPK13
10308,GO:0043083,0.0668476152042508,0.994560119537441,2,4,synaptic cleft,CC,LAMB2;LAMA5
13554,GO:0060017,0.0668784450553665,0.993741863288933,2,5,parathyroid gland development,BP,HOXA3;TBX1
1926,GO:0004620,0.066886971826745,0.970549478637488,9,60,phospholipase activity,MF,EDNRA;PLA2G4D;PLD3;MGLL;ABHD6;LYPLAL1;LYPLA1;DDHD2;PLCH2
9876,GO:0042137,0.0669581505302096,1,1,1,sequestering of neurotransmitter,BP,SLC18A2
2760,GO:0006171,0.0669785050630092,0.97965121071774,5,25,cAMP biosynthetic process,BP,ADCY7;AKAP9;PTHLH;TIMP2;ADCY1
18008,GO:1902476,0.0670137709680446,0.976789402344547,6,32,chloride transmembrane transport,BP,CLCA2;CLCN3;TTYH3;ANO1;SLC12A7;PCYOX1
10204,GO:0042816,0.0670557624488726,0.993715690879634,2,5,vitamin B6 metabolic process,BP,PSAT1;AOX1
11965,GO:0047166,0.0671167275359996,1,1,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,LPCAT4
2376,GO:0005506,0.0672172819165691,0.966281125875506,12,89,iron ion binding,MF,XDH;NOS1;CYGB;CYP27B1;ALOX15B;LCN2;ACP5;NFU1;CYP4F22;TET1;AOX1;FBXL5
5716,GO:0016853,0.0672231566528977,0.964089750490331,14,120,isomerase activity,MF,PGM1;ISYNA1;FKBP9;HYI;ERO1B;FKBP1A;TMX4;FKBP10;PDIA5;QSOX1;TXNDC11;ERP44;AMACR;GALE
9035,GO:0035249,0.0673533872339656,0.976714779855298,6,31,synaptic transmission, glutamatergic,BP,SERPINE2;EGFR;GLUL;DKK1;SHANK2;NLGN2
2329,GO:0005344,0.0676046252590448,1,1,1,oxygen carrier activity,MF,CYGB
12048,GO:0047888,0.0676046252590448,1,1,1,fatty acid peroxidase activity,MF,CYGB
5431,GO:0016289,0.0676463899180709,0.987012510287144,3,14,CoA hydrolase activity,MF,ACOT1;ACOT7;ACOT13
18617,GO:1903900,0.0676519972707871,0.963930995375487,14,111,regulation of viral life cycle,BP,TNIP1;ADARB1;PC;STOM;HMGA2;APOBEC3C;TRIM5;MVB12A;IFITM1;YTHDC2;EIF2AK2;IFI16;OAS1;TRIM38
7043,GO:0030816,0.0677732090277613,0.987331870599276,3,12,positive regulation of cAMP metabolic process,BP,RAPGEF3;PTHLH;TIMP2
12423,GO:0048871,0.067815479875861,0.957456674462813,24,201,multicellular organismal homeostasis,BP,F2R;ADCY7;BBS2;NR1D1;APLN;CRTC1;EGFR;STK39;ERCC6;RAC2;ACP5;PRKACB;TUB;LPCAT1;NTSR1;MEX3C;PRKAR1A;UBASH3B;PRKACA;ADAM8;AKT3;IL20RB;WFS1;ADCY1
1918,GO:0004611,0.0678544664009344,1,1,1,phosphoenolpyruvate carboxykinase activity,MF,PCK2
1919,GO:0004613,0.0678544664009344,1,1,1,phosphoenolpyruvate carboxykinase (GTP) activity,MF,PCK2
6176,GO:0019543,0.0678544664009344,1,1,1,propionate catabolic process,BP,PCK2
11625,GO:0046327,0.0678544664009344,1,1,1,glycerol biosynthetic process from pyruvate,BP,PCK2
1982,GO:0004702,0.0678967070939362,0.965000495738156,13,87,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,ACVR2B;MST1R;EGFR;MAPK13;MAP4K4;TGFBR2;EPHA1;FGFR1;NLK;TAOK1;ACVR1B;RET;MAP4K2
3641,GO:0008111,0.0679541663028273,1,1,1,alpha-methylacyl-CoA racemase activity,MF,AMACR
3837,GO:0008442,0.0680181888417316,1,1,1,3-hydroxyisobutyrate dehydrogenase activity,MF,HIBADH
15369,GO:0071606,0.0680466257863244,1,1,1,chemokine (C-C motif) ligand 4 production,BP,ARG2
15396,GO:0071643,0.0680466257863244,1,1,1,regulation of chemokine (C-C motif) ligand 4 production,BP,ARG2
15397,GO:0071644,0.0680466257863244,1,1,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,ARG2
15885,GO:0072615,0.0680466257863244,1,1,1,interleukin-17 secretion,BP,ARG2
19130,GO:1905076,0.0680466257863244,1,1,1,regulation of interleukin-17 secretion,BP,ARG2
19131,GO:1905077,0.0680466257863244,1,1,1,negative regulation of interleukin-17 secretion,BP,ARG2
19245,GO:1905403,0.0680466257863244,1,1,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,ARG2
16778,GO:0098588,0.0682870714733579,0.943434540909569,145,1517,bounding membrane of organelle,CC,EDEM1;TSPAN1;NOS1;SORL1;RAB3B;VLDLR;ASAP2;SYNE3;CYP27B1;BBS2;FAM210B;ANTXR2;MARCH9;APPL2;PTPRS;B4GALT6;SNTB2;EGFR;ARMCX2;BNIP3;SLC33A1;ARAP1;DLG4;B3GNT3;CD68;SLC9A7;WNT7A;WDFY3;SEC23A;RDH14;MALL;ASPH;MCTP1;CEMIP;STOM;DKK1;SLC2A3;B4GALNT4;SHANK2;RAC2;CD44;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;MCFD2;PKD2;LRP1;ST3GAL5;RAB11FIP4;ANXA3;ABCA7;ICA1;MARCH4;SNX14;LPCAT1;GALNT3;VAMP2;INPP5F;ABCG1;PITPNM1;ITPR3;CEACAM1;SPATA18;RAB31;LMAN1;DMXL2;BSG;EPN2;CLCN3;ANXA6;CD46;MVB12B;MAP6;ABHD17C;SLC35B4;CLTCL1;VPS11;MOSPD2;ZDHHC2;APLP2;COPB1;COPG1;QSOX1;BOK;USP6NL;DBNDD1;COL6A1;BPHL;MVB12A;AZIN2;BCL2L1;AGPAT3;GOLGA2P5;PCYOX1;MAP2K2;SLC22A17;RET;STX10;RAB43;MTMR4;ZFYVE9;GABARAPL2;TMBIM1;SAMD8;RAB1A;AP2A2;KDELR3;CMTM6;ST6GALNAC2;CTSZ;AP3D1;ITPR2;MOAP1;PJA2;MAP4K2;EFCAB7;TMEM63A;SNX6;EVA1A;TMEM50B;ATP6V1B2;RPH3AL;ADAM8;ATP11B;ACAP2;TMEM9;MARCH2;WASL;LRP6;SYT2;TMEM173;SLC18A2;SIGMAR1;HPSE;ARMCX3;DNAJC3;ZFYVE21;PSEN2;PTCH1;COG8;SNX27;SLC44A1;GNAI1
6544,GO:0021956,0.0682879102666834,1,1,1,central nervous system interneuron axonogenesis,BP,TCTN1
13719,GO:0060284,0.0684293533032793,0.9483255672143,63,571,regulation of cell development,BP,NOS1;ZMYND8;SORL1;ETV5;NEURL1;VLDLR;SERPINE2;POSTN;HECW2;NFATC4;MAP2K1;SSH1;MAP1B;PTPRS;CRTC1;SEMA4B;FYN;KIF13B;CSMD3;DLG4;IDH2;PLXNB3;NET1;WNT7A;MAP4K4;GDI1;DKK1;PAK1;SOCS2;SHANK2;IMPACT;APOE;RGS14;LRP1;LPAR3;FGFR1;PTK6;ULK2;INPP5F;OBSL1;DVL1;TWF2;CNTN1;PLAG1;CHD7;ASAP1;NGFR;PTPRZ1;RET;PDE5A;CCDC88A;TIMP2;IL1RAP;LPAR1;CTSZ;PPARG;SYT2;EEF2K;OMG;UFL1;SEMA3F;ADNP;LRP4
2128,GO:0004930,0.0684844770377327,0.961677384961655,16,133,G-protein coupled receptor activity,MF,F2R;ADGRF1;ADGRL1;HTR7;EDNRA;LPAR3;NTSR1;ADGRB2;F2RL1;LTB4R;LPAR1;PPARG;GPR153;FZD8;SIGMAR1;ELOVL4
15351,GO:0071579,0.0685284416547067,1,1,1,regulation of zinc ion transport,BP,SLC30A1
15352,GO:0071580,0.0685284416547067,1,1,1,regulation of zinc ion transmembrane transport,BP,SLC30A1
15353,GO:0071581,0.0685284416547067,1,1,1,regulation of zinc ion transmembrane import,BP,SLC30A1
15354,GO:0071582,0.0685284416547067,1,1,1,negative regulation of zinc ion transport,BP,SLC30A1
15355,GO:0071583,0.0685284416547067,1,1,1,negative regulation of zinc ion transmembrane transport,BP,SLC30A1
15356,GO:0071584,0.0685284416547067,1,1,1,negative regulation of zinc ion transmembrane import,BP,SLC30A1
15357,GO:0071585,0.0685284416547067,1,1,1,detoxification of cadmium ion,BP,SLC30A1
19466,GO:1990170,0.0685284416547067,1,1,1,stress response to cadmium ion,BP,SLC30A1
6434,GO:0021700,0.0687744477034223,0.959502212905226,19,149,developmental maturation,BP,NEURL1;NFATC4;FAM210B;POU2F2;DDIT3;ADGRL1;DLG4;FGFR1;FAM20C;FERMT1;THBS3;L3MBTL3;XBP1;REC8;RET;PRKACA;AP3D1;PPARG;ALDH1A2
1711,GO:0004303,0.0688857268475526,0.992544075984065,2,7,estradiol 17-beta-dehydrogenase activity,MF,HSD17B7;HSD17B12
625,GO:0001808,0.0689089684002363,1,1,1,negative regulation of type IV hypersensitivity,BP,IL20RB
1205,GO:0002865,0.0689089684002363,1,1,1,negative regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB
1214,GO:0002884,0.0689089684002363,1,1,1,negative regulation of hypersensitivity,BP,IL20RB
18923,GO:1904659,0.068909779278661,0.968028210539973,10,65,glucose transmembrane transport,BP,PAK1;SLC2A3;EDNRA;SLC5A1;TRIB3;CLTCL1;SLC2A9;NGFR;SLC2A13;GRB10
1812,GO:0004462,0.0689511391506202,1,1,1,lactoylglutathione lyase activity,MF,GLO1
5894,GO:0018076,0.0690807105586601,0.994269650590831,2,4,N-terminal peptidyl-lysine acetylation,BP,SOX4;KAT2B
8200,GO:0032945,0.0691733485200025,0.973205187034528,7,43,negative regulation of mononuclear cell proliferation,BP,PRNP;PKN1;DLG1;ARG2;PRKAR1A;PDE5A;IL20RB
12528,GO:0050672,0.0691733485200025,0.973205187034528,7,43,negative regulation of lymphocyte proliferation,BP,PRNP;PKN1;DLG1;ARG2;PRKAR1A;PDE5A;IL20RB
9402,GO:0035947,0.0692119986085151,0.993394074505243,2,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,NR1D1;KAT2B
2211,GO:0005102,0.0692403559826918,0.945415414957521,87,881,signaling receptor binding,MF,DOCK4;PLAT;SMURF2;F2R;PGF;ITGA6;SERPINE2;IGFBP4;PRNP;PAG1;ITGB4;ADM2;NFATC4;CMTM4;PKN1;APLN;TNFSF15;EGFR;SEMA4B;FYN;ARAP1;DLG1;DLG4;WNT7A;SHC1;DLG3;DKK1;WISP1;SOCS2;TGFBR2;SHANK2;APOE;FKBP1A;PKD2;LRP1;IDE;AKAP9;FGFR1;ITGA1;CMTM7;ITGA2;PTK6;LONP2;LTBP4;CHAC1;PITPNM1;SLC9A3R2;DVL1;MMP14;NLGN2;NXPH4;SYTL1;PRDX5;MLYCD;F2RL1;PTHLH;BOK;ATXN2;WNT2B;NUDT6;CRAT;ARF4;CADM4;C5;GABARAPL2;TMBIM1;SHC2;TIMP2;CMTM6;LAMB2;IGF2;LAMA5;GRB10;PPARG;USP20;SRPX2;CKLF;FZD8;LRP6;FOXP1;SSFA2;PTCH1;AMACR;SEMA3F;GNAI1;LRP4;FADD
12403,GO:0048844,0.0693033524119857,0.973473487357223,7,37,artery morphogenesis,BP,APOE;PKD2;LRP1;SOX4;CHD7;TBX1;AKT3
15880,GO:0072604,0.0693153149895407,0.982262162070133,4,19,interleukin-6 secretion,BP,F2R;F2RL1;XBP1;IL1RAP
1581,GO:0003991,0.0693437094996009,1,1,1,acetylglutamate kinase activity,MF,NAGS
1613,GO:0004042,0.0693437094996009,1,1,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,NAGS
17180,GO:0103045,0.0693437094996009,1,1,1,methione N-acyltransferase activity,MF,NAGS
1813,GO:0004463,0.0693576963715911,1,1,1,leukotriene-A4 hydrolase activity,MF,LTA4H
10101,GO:0042610,0.0693996434125477,1,1,1,CD8 receptor binding,MF,FYN
19255,GO:1905429,0.0693996434125477,1,1,1,response to glycine,BP,FYN
19256,GO:1905430,0.0693996434125477,1,1,1,cellular response to glycine,BP,FYN
17498,GO:1900477,0.0694136212494182,1,1,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,NACC2
18171,GO:1902936,0.069550261482743,0.967592892394542,10,68,phosphatidylinositol bisphosphate binding,MF,SNX14;PFN2;GSDMC;PLEK2;TWF2;GSDMA;ASAP1;FCHO2;SH3PXD2B;ACAP2
10438,GO:0043292,0.0696347465830807,0.95966399535572,18,133,contractile fiber,CC,NOS1;FLNC;SCN8A;ANK3;MYH15;PARVB;PAK1;OBSCN;FKBP1A;TMOD2;OBSL1;LMAN1;TWF2;CST3;PPP3CB;FLNB;PSEN2;KAT2B
5685,GO:0016801,0.0696366988157814,0.986635992876552,3,13,hydrolase activity, acting on ether bonds,MF,LTA4H;AHCYL2;TMEM86B
8212,GO:0032965,0.069656038993382,0.982024055955098,4,20,regulation of collagen biosynthetic process,BP,F2R;CYGB;ITGA2;PPARG
13943,GO:0060612,0.0696989716668107,0.978484440656948,5,26,adipose tissue development,BP,ZNF516;LRP5;XBP1;SH3PXD2B;ARID5B
935,GO:0002335,0.0698397582986198,0.982082193261264,4,19,mature B cell differentiation,BP,POU2F2;CMTM7;XBP1;DOCK11
10717,GO:0044033,0.0698875288804844,0.992746832111064,2,6,multi-organism metabolic process,BP,MAP2K1;MAP2K2
2708,GO:0006081,0.0699543829373879,0.970544816369737,8,57,cellular aldehyde metabolic process,BP,H6PD;IDH2;GLO1;PGLS;HAGH;ALDH7A1;ALDH1A2;ALDH4A1
1945,GO:0004648,0.0700056587578082,1,1,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,PSAT1
3530,GO:0007512,0.0700646840474891,0.99326518942974,2,5,adult heart development,BP,CHD7;MEF2D
12320,GO:0048670,0.0701073412919759,0.986708617691068,3,12,regulation of collateral sprouting,BP,PTPRS;LPAR3;ULK2
18440,GO:1903523,0.0703254339479399,0.982209184313028,4,17,negative regulation of blood circulation,BP,DOCK4;F2R;APLN;PDE5A
12956,GO:0051338,0.0703462431392305,0.94557368076708,74,731,regulation of transferase activity,BP,F2R;SORL1;CCND1;NEURL1;VLDLR;ADCY7;PRNP;ADARB1;MAP2K1;ACVR2B;PKN1;WWTR1;MST1R;TNFSF15;EGFR;STK39;ERCC6;DLG1;DLG4;SNX9;MAP4K4;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;SOCS2;TRIB2;TGFBR2;EPHA1;RAC2;APOE;CCND2;RGS14;PKD2;PRKACB;LPAR3;FGFR1;ITGA1;PTK6;CEACAM1;MAPKAPK3;DVL1;LRP5;ETAA1;TRIB3;SLK;TAOK1;PRKAR1A;SPRY2;UBASH3B;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;EIF2AK2;RAB1A;LPAR1;IGF2;MAP4K2;PPARG;SNX6;ADAM8;FZD8;LRP6;DNAJC3;ADCY1;KAT2B;ADNP
2098,GO:0004865,0.0704994119325396,0.992267765355,2,7,protein serine/threonine phosphatase inhibitor activity,MF,PPP1R14A;PPP1R2
6581,GO:0022408,0.070502304806422,0.963224591970787,13,99,negative regulation of cell-cell adhesion,BP,SERPINE2;PRNP;PAG1;DLG1;PODXL;ARG2;PPARA;EPCAM;CEACAM1;PRKAR1A;UBASH3B;PDE5A;IL20RB
1988,GO:0004708,0.070765033986869,0.986531302890924,3,12,MAP kinase kinase activity,MF,MAP2K1;MAPKAPK3;MAP2K2
4770,GO:0010955,0.0707885574422926,0.978049293543983,5,26,negative regulation of protein processing,BP,SERPINE2;PRNP;SERPING1;CHAC1;CTSZ
18348,GO:1903318,0.0707885574422926,0.978049293543983,5,26,negative regulation of protein maturation,BP,SERPINE2;PRNP;SERPING1;CHAC1;CTSZ
18159,GO:1902905,0.0709119610124842,0.958701259349309,18,145,positive regulation of supramolecular fiber organization,BP,RAPGEF3;WIPF1;DLG1;PAK1;EPHA1;RAC2;APOE;AKAP9;PFN2;FHOD1;F2RL1;JMY;SPIRE1;SH3PXD2B;NCKAP1;LPAR1;ARPC1A;WASL
10648,GO:0043666,0.0709435442207695,0.964131666710565,12,87,regulation of phosphoprotein phosphatase activity,BP,PPP1R14A;FKBP1A;PPP2R3B;ELFN2;ITGA1;PPP1R35;CSNK2A1;PPP1R10;PPP1R2;EIF2AK2;SLC39A10;RCAN1
4364,GO:0009968,0.0709965365732513,0.943884570846983,88,886,negative regulation of signal transduction,BP,TNIP1;DDIT4L;XDH;SMURF2;SORL1;CCND1;NEURL1;CTNNBIP1;ITGA6;SERPINE2;PEAR1;IGFBP4;PRNP;NR1D1;NFATC4;LTBP1;SH3KBP1;WWTR1;MST1R;APLN;DDIT3;PTPRS;PSMD2;EGFR;ARHGAP12;FYN;DLG1;HTRA1;STRADB;DKK1;RASA3;SOCS2;TGFBR2;PTPN3;EPHA1;CD44;APOE;PTPN12;RGS14;PKD2;PRKACB;LRP1;WWC3;FGFR1;ITGA1;BTRC;PTK6;INPP5F;CHAC1;CEACAM1;FERMT1;NLK;EPN2;MDFI;DVL1;MMP14;CD46;CTH;TRIB3;RANBP9;DNAJB9;F2RL1;PSMD7;BOK;SPRY2;BCL2L1;XBP1;UBASH3B;ARRDC1;RET;MTMR4;EPM2A;TMBIM1;TMSB4X;TIMP2;LPAR1;GRB10;PPARG;SNX6;RPH3AL;WFS1;LRP6;FOXP1;PTCH1;ANKRD6;LRP4;RB1CC1;FADD
14126,GO:0060992,0.0710061939364272,0.986712336118266,3,11,response to fungicide,BP,IMPACT;XRN1;BCL2L1
12439,GO:0050080,0.0710072110249867,1,1,1,malonyl-CoA decarboxylase activity,MF,MLYCD
20302,GO:2001294,0.0710072110249867,1,1,1,malonyl-CoA catabolic process,BP,MLYCD
8113,GO:0032799,0.0710136403007063,0.981677561238586,4,19,low-density lipoprotein receptor particle metabolic process,BP,VLDLR;APOE;AP2A2;PPARG
9601,GO:0036458,0.0710209578607783,1,1,1,hepatocyte growth factor binding,MF,SRPX2
3734,GO:0008269,0.0712132337902368,1,1,1,JAK pathway signal transduction adaptor activity,MF,SOCS2
18921,GO:1904646,0.0713353201388967,0.981865598582743,4,17,cellular response to amyloid-beta,BP,PRNP;LRP1;CASP4;NGFR
11807,GO:0046688,0.0713696670585807,0.981216780670919,4,22,response to copper ion,BP,PRNP;ATP7B;MT2A;LOXL2
12884,GO:0051222,0.0713936438273778,0.951529194406739,33,298,positive regulation of protein transport,BP,EDEM1;F2R;SORL1;PCK2;PRNP;POSTN;RAPGEF3;ALOX15B;EGFR;ANK3;FYN;GLUL;CEMIP;STOM;PAK1;RAC2;LRP1;VAMP2;SOX4;FERMT1;NLGN2;VPS11;PPP3CB;F2RL1;ANO1;GLUD1;XBP1;C5;IL1RAP;EFCAB7;RPH3AL;ADAM8;TMEM173
15522,GO:0071900,0.0715052785467508,0.949149397187137,42,391,regulation of protein serine/threonine kinase activity,BP,F2R;SORL1;CCND1;MAP2K1;PKN1;MST1R;TNFSF15;EGFR;STK39;ERCC6;MAP4K4;CEMIP;SHC1;DKK1;PAK1;TRIB2;APOE;CCND2;RGS14;PKD2;LPAR3;FGFR1;ITGA1;MAPKAPK3;LRP5;ETAA1;TRIB3;TAOK1;PRKAR1A;SPRY2;MAP2K2;PDE5A;C5;SHC2;EIF2AK2;LPAR1;IGF2;MAP4K2;ADAM8;FZD8;LRP6;KAT2B
14979,GO:0070887,0.0717107654720639,0.939128354099669,196,2119,cellular response to chemical stimulus,BP,TNIP1;DOCK4;XDH;SMURF2;EDEM1;NOS1;ETV5;PGF;CCND1;NEURL1;PCK2;ITGA6;MMP1;CYGB;CYP27B1;ADCY7;PRNP;BBS2;POSTN;NR1D1;NFATC4;MAP2K1;FAM210B;LTBP2;RAPGEF3;ACVR2B;LTBP1;GPX3;MST1R;APLN;TNFSF15;EIF4EBP1;SSH1;DDIT3;PSMD2;CAPN2;EGFR;ANK3;PPP1R14A;FYN;TNFRSF6B;BNIP3;SLC33A1;MAPK13;ADAMTS7;CTSB;CD68;PLXNB3;NET1;HTRA1;WNT7A;MAP4K4;SDC1;SHC1;DKK1;PAK1;SOCS2;TGFBR2;LCN2;IMPACT;RAC2;CD44;APOE;FKBP1A;BNIP3L;PTPN12;PKD2;PRKACB;RBCK1;LRP1;IDE;AKAP9;HMGA2;ATF4;PPARA;ASNS;FGFR1;ITGA1;UROS;ITGB5;HYAL1;BTRC;ITGA2;PTK6;GALNT3;VAMP2;LTBP4;ATRX;FAM20C;SOX4;CEACAM1;FERMT1;PDIA5;RAB31;MT2A;NLK;EPN2;XRN1;TRIM5;EPOR;CTH;LRP5;CTSL;TWF2;CST3;TRIB3;CASP4;GFPT1;PCSK6;MOSPD2;DNAJB9;SEC63;PPP3CB;MYOF;RFX2;PRDX5;F2RL1;PSMD7;PRKAR1A;ANO1;BOK;PARP9;CPEB4;SPRY2;THRA;COL6A1;NGFR;BPHL;HSPA13;PTPRZ1;CHD6;BCL2L1;IFITM1;RNF165;XBP1;TXNRD3;MAP2K2;TLE4;RET;RAB43;C5;MTMR4;ZFYVE9;RMRP;PUM2;COL1A2;PRKACA;TMSB4X;EIF2AK2;NR2F6;KDELR3;IL1RAP;FICD;LPAR1;IGF2;ITPR2;LAMA5;AGPAT1;GRB10;PPARG;SNX6;ALDH1A2;TBX1;CREB3L2;ATP6V1B2;ADAM8;IL20RB;WFS1;ENDOG;ITGA4;ACAP2;CKLF;IGFBP7;HSPA2;FLNB;LRP6;ARID5B;TMEM173;EEF2K;SSR1;ZC3H7A;DNAJC3;FOXP1;PTCH1;ADCY1;KAT2B;OAS1;UFL1;FAM162A;JARID2;KLHL15;GNAI1;LRP4;DNMT3A;TRIM38;FADD
1585,GO:0003996,0.0717881471298245,1,1,1,acyl-CoA ligase activity,MF,ACSF2
12562,GO:0050714,0.0719079099910493,0.958035613797104,18,146,positive regulation of protein secretion,BP,F2R;PCK2;POSTN;ALOX15B;EGFR;GLUL;SOX4;FERMT1;NLGN2;PPP3CB;F2RL1;ANO1;GLUD1;XBP1;C5;IL1RAP;RPH3AL;ADAM8
10111,GO:0042628,0.0719450937188371,1,1,1,mating plug formation,BP,SERPINE2
11194,GO:0045297,0.0719450937188371,1,1,1,post-mating behavior,BP,SERPINE2
14199,GO:0061107,0.0719450937188371,1,1,1,seminal vesicle development,BP,SERPINE2
14200,GO:0061108,0.0719450937188371,1,1,1,seminal vesicle epithelium development,BP,SERPINE2
1849,GO:0004512,0.0719655509019532,1,1,1,inositol-3-phosphate synthase activity,MF,ISYNA1
5728,GO:0016872,0.0719655509019532,1,1,1,intramolecular lyase activity,MF,ISYNA1
4806,GO:0012501,0.0720215764308923,0.940401300974562,139,1484,programmed cell death,BP,XDH;F2R;NEURL1;PYGL;ITGA6;RPS6KA2;H1F0;PRNP;NFATC4;ADARB1;MAP2K1;SH3KBP1;ALOX15B;PKN1;PEG3;MST1R;TNFSF15;DDIT3;EGFR;STK39;FYN;TNFRSF6B;BNIP3;ERCC6;CTSB;NET1;TGM2;GLO1;WNT7A;MAP4K4;GRK5;STRADB;NME4;ARG2;SHC1;DKK1;DAP;PAK1;SOCS2;RAG1;TGFBR2;LCN2;EPHA1;CD44;OBSCN;APOE;BNIP3L;CCND2;ANGPTL4;RBCK1;LRP1;LDHA;HMGA2;ATF4;ASNS;FGFR1;ITGA1;AARS;CHAC1;SOX4;GSDMC;UACA;NTSR1;ANXA6;CTH;LRP5;CTSL;CST3;RABGGTA;TRIB3;CASP4;PCSK6;SLK;PRDX5;PLAG1;GSDMA;C6ORF120;TAOK1;CSNK2A1;SLC25A4;JMY;BOK;CPEB4;NACC2;SPRY2;THRA;ACVR1B;NGFR;PPP1R10;MARK4;BCL2L1;MEF2D;ARF4;XBP1;MAP2K2;SATB1;RET;BEX2;NCKAP1;ELMO3;PAK6;TMBIM1;NEK6;RGL2;EIF2AK2;EPB41L3;IFI16;BCAP29;SLC39A10;CARD11;LPAR1;CTSZ;IGF2;MOAP1;MAP4K2;PPARG;EVA1A;PPL;ALDH1A2;TBX1;ADAM8;WFS1;ENDOG;PRSS8;LRP6;TMEM173;EEF2K;SIGMAR1;TRIM2;DEDD2;DNAJC3;FOXP1;PSEN2;UFL1;FAM162A;ADNP;RB1CC1;DNMT3A;FADD
19991,GO:2000587,0.0720303339116626,0.992964427344902,2,5,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PTPN12;LRP1
13909,GO:0060560,0.0720378550675967,0.95620948278054,21,156,developmental growth involved in morphogenesis,BP,POSTN;MAP1B;PTPRS;SEMA4B;PLXNB3;GDI1;PAK1;TGFBR2;IMPACT;APOE;LPAR3;ULK2;DVL1;TWF2;PPP3CB;SPRY2;LAMB2;LRP6;SYT2;SEMA3F;ADNP
2440,GO:0005640,0.0720819860403242,0.981610402058491,4,17,nuclear outer membrane,CC,SYNE3;ITPR3;BOK;SIGMAR1
13953,GO:0060638,0.0721688564924468,0.992943040813322,2,5,mesenchymal-epithelial cell signaling,BP,FGFR1;WNT2B
6420,GO:0021683,0.0722027946430185,0.992937797263045,2,5,cerebellar granular layer morphogenesis,BP,SERPINE2;WNT7A
5946,GO:0018279,0.0722936158806688,0.974086736259325,6,38,protein N-linked glycosylation via asparagine,BP,UBE2J1;MCFD2;ST3GAL5;LMAN1;ST6GALNAC2;STT3B
9871,GO:0042130,0.0723826914179604,0.974158084667871,6,36,negative regulation of T cell proliferation,BP,PRNP;DLG1;ARG2;PRKAR1A;PDE5A;IL20RB
11707,GO:0046498,0.0725687075347392,0.992303705964271,2,6,S-adenosylhomocysteine metabolic process,BP,AHCYL2;GAMT
1850,GO:0004513,0.0726049937191995,1,1,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,ST3GAL5
11984,GO:0047291,0.0726049937191995,1,1,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,ST3GAL5
12227,GO:0048484,0.0727535265477872,0.992852496850529,2,5,enteric nervous system development,BP,EDNRA;RET
15038,GO:0070981,0.0728491488785082,1,1,1,L-asparagine biosynthetic process,BP,ASNS
15039,GO:0070982,0.0728491488785082,1,1,1,L-asparagine metabolic process,BP,ASNS
12467,GO:0050321,0.0729173798874383,0.986201010607648,3,11,tau-protein kinase activity,MF,BRSK1;TTBK2;MARK4
1510,GO:0003870,0.0729981714359925,1,1,1,5-aminolevulinate synthase activity,MF,ALAS1
5654,GO:0016749,0.0729981714359925,1,1,1,N-succinyltransferase activity,MF,ALAS1
8598,GO:0034103,0.0730447107268796,0.971396054598145,7,42,regulation of tissue remodeling,BP,EGFR;CEACAM1;LRP5;CST3;UBASH3B;TMBIM1;ADAM8
7944,GO:0032535,0.0730798280598621,0.950974934183997,31,265,regulation of cellular component size,BP,RAB3B;SSH1;MAP1B;PTPRS;WIPF1;SEMA4B;DLG1;WNT7A;GDI1;PAK1;RAC2;APOE;LPAR3;TMOD2;ULK2;PFN2;CLCN3;TWF2;F2RL1;JMY;SLC12A7;SPIRE1;RET;NCKAP1;TMSB4X;ARPC1A;AKT3;WASL;SEMA3F;ADNP;RB1CC1
11370,GO:0045732,0.0731195819628967,0.955302367614396,21,176,positive regulation of protein catabolic process,BP,SMURF2;EDEM1;SORL1;HECW2;SNX9;TRIB2;APOE;LRP1;IDE;LPCAT1;SH3D19;DVL1;TRIB3;VPS11;CSNK2A1;XBP1;ANKIB1;ADAM8;MAGEF1;RNF180;FBXL5
3256,GO:0006919,0.0731521195923812,0.965376320426674,10,77,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;TNFSF15;DAP;CASP4;BOK;NGFR;PPARG;FAM162A;FADD
10135,GO:0042693,0.0731860745817703,0.992200245937861,2,6,muscle cell fate commitment,BP,DKK1;TBX1
17856,GO:1902045,0.0732282214535735,1,1,1,negative regulation of Fas signaling pathway,BP,TMBIM1
19953,GO:2000504,0.0732282214535735,1,1,1,positive regulation of blood vessel remodeling,BP,TMBIM1
8484,GO:0033630,0.0732847582111719,0.985845140698365,3,12,positive regulation of cell adhesion mediated by integrin,BP,PODXL;FERMT1;RET
5945,GO:0018277,0.0733228613310444,1,1,1,protein deamination,BP,LOXL1
18471,GO:1903569,0.0734039427317478,1,1,1,positive regulation of protein localization to ciliary membrane,BP,EFCAB7
10668,GO:0043890,0.0734309621446695,1,1,1,N-acetylgalactosamine-6-sulfatase activity,MF,GALNS
20212,GO:2001138,0.0734897698208766,0.992149156906361,2,6,regulation of phospholipid transport,BP,APOE;ABCA7
20213,GO:2001140,0.0734897698208766,0.992149156906361,2,6,positive regulation of phospholipid transport,BP,APOE;ABCA7
1369,GO:0003254,0.0736481730238827,0.976804977596093,5,27,regulation of membrane depolarization,BP,FHL1;ANK3;PTPN3;NTSR1;BOK
13672,GO:0060198,0.0736744644925389,0.992118023921501,2,6,clathrin-sculpted vesicle,CC,VAMP2;SLC18A2
11568,GO:0046113,0.0737260268422113,0.992700903530351,2,5,nucleobase catabolic process,BP,XDH;AOX1
3719,GO:0008237,0.0738436686433022,0.961232632596347,13,97,metallopeptidase activity,MF,ADAM19;MMP1;LTA4H;ADAMTS7;CLCA2;IDE;RNPEPL1;MMP14;NPEPL1;AEBP1;MMP10;ADAM8;OSGEPL1
10029,GO:0042473,0.073847161936287,0.992088870320329,2,6,outer ear morphogenesis,BP,FGFR1;TBX1
662,GO:0001865,0.0739521312657402,0.992665481827596,2,5,NK T cell differentiation,BP,TGFBR2;AP3D1
12830,GO:0051136,0.0739521312657402,0.992665481827596,2,5,regulation of NK T cell differentiation,BP,TGFBR2;AP3D1
11880,GO:0046887,0.0739689784527112,0.965057714453903,10,71,positive regulation of hormone secretion,BP,PCK2;APLN;EGFR;GLUL;FGFR1;SOX4;NLGN2;PPP3CB;ANO1;GLUD1
4395,GO:0010070,0.074024489513443,1,1,1,zygote asymmetric cell division,BP,RGS14
841,GO:0002153,0.074098569655033,1,1,1,steroid receptor RNA activator RNA binding,MF,THRA
11471,GO:0045925,0.074098569655033,1,1,1,positive regulation of female receptivity,BP,THRA
4300,GO:0009746,0.0741274148701623,0.958128145762603,16,127,response to hexose,BP,PCK2;NR1D1;ACVR2B;GLUL;MAP4K4;TGFBR2;LDHA;VAMP2;SOX4;LRP5;PPP3CB;ANO1;XBP1;PRKACA;IGF2;ENDOG
4410,GO:0010165,0.0742994578260491,0.973495592968157,6,33,response to X-ray,BP,ERCC1;CCND1;ERCC6;CCND2;HMGA2;IKBIP
17225,GO:0106104,0.0744417537322861,1,1,1,regulation of glutamate receptor clustering,BP,SSH1
18953,GO:1904717,0.0744417537322861,1,1,1,regulation of AMPA glutamate receptor clustering,BP,SSH1
18954,GO:1904719,0.0744417537322861,1,1,1,positive regulation of AMPA glutamate receptor clustering,BP,SSH1
3864,GO:0008483,0.0745669321931253,0.985491853474172,3,12,transaminase activity,MF,GPT2;PSAT1;GFPT1
11656,GO:0046394,0.0746306375372803,0.949751205482232,31,285,carboxylic acid biosynthetic process,BP,CBS;GPT2;NR1D1;ALOX15B;DHTKD1;LTA4H;PSAT1;ELOVL1;PGM1;GLUL;ACOT7;CEMIP;NAGS;CBR4;LDHA;PPARA;ASNS;UROS;HYAL1;GAMT;CEACAM1;CTH;TRIB3;MLYCD;MGLL;GLUD1;XBP1;ALDH1A2;ELOVL4;HSD17B12;AMACR
2523,GO:0005777,0.0747969716592597,0.96052487448481,13,105,peroxisome,CC,XDH;IDH2;TYSND1;ACAD11;ABCD1;IDE;LONP2;PRDX5;MLYCD;CRAT;MAP2K2;TMEM173;AMACR
10080,GO:0042579,0.0747969716592597,0.96052487448481,13,105,microbody,CC,XDH;IDH2;TYSND1;ACAD11;ABCD1;IDE;LONP2;PRDX5;MLYCD;CRAT;MAP2K2;TMEM173;AMACR
12245,GO:0048519,0.0749715097384581,0.934536531702476,328,3629,negative regulation of biological process,BP,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;NOS1;ERCC1;ZMYND8;F2R;SORL1;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;CYGB;RPS6KA2;CYP27B1;SERPINE2;PEAR1;IGFBP4;PRNP;PAG1;BBS2;POSTN;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;THBS2;TFPI2;RAPGEF3;FNDC4;ACVR2B;LTBP1;SH3KBP1;ALOX15B;SALL2;PKN1;WWTR1;DCBLD2;PEG3;MST1R;APLN;EIF4EBP1;MAP1B;PC;DDIT3;PTPRS;HADH;PSMD2;ELK3;CRTC1;BRSK1;EGFR;TBC1D14;STK39;SEMA4B;ANK3;CGREF1;ARHGAP12;PPP1R14A;FYN;TNFRSF6B;BNIP3;SCMH1;UBE2J1;ARAP1;ADAMTS7;DLG1;DLG4;IDH2;DNAJB5;PLXNB3;PODXL;ESPN;XPC;EVI5L;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;TTBK2;GRK5;STRADB;CRTAP;ASPH;MCTP1;GDI1;CEMIP;ARG2;SHC1;DLG3;DKK1;WISP1;DAP;PAK1;RASA3;SOCS2;TRIB2;RAG1;TGFBR2;PTPN3;SERPING1;SHANK2;EPHA1;IMPACT;CD44;APOE;FKBP1A;BNIP3L;CCND2;ACP5;ANGPTL4;PTPN12;RGS14;PKD2;PRKACB;SRGAP2B;RBCK1;LRP1;IDE;AKAP9;PPP2R3B;HMGA2;ATF4;PPARA;ABCA7;WWC3;ELFN2;ASNS;FGFR1;ITGA1;AARS;PPP1R35;EPCAM;TMOD2;TCFL5;HYAL1;BTRC;LPCAT1;PTK6;ULK2;INPP5F;CHAC1;ATRX;PFN2;ABCG1;SOX4;APOBEC3C;ITPR3;FBXO2;CEACAM1;FERMT1;ZNF692;MT2A;ATF7IP;RCOR1;NLK;EPN2;MDFI;XRN1;TRIM5;TNRC6B;DVL1;NTSR1;MMP14;HES2;CD46;PHF12;CTH;LRP5;ETAA1;ABHD17C;KLF12;TWF2;CST3;TRIB3;TOM1L2;RANBP9;DNAJB9;PPP3CB;MEX3C;ADGRB2;APLP2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;RASIP1;PROCR;TAOK1;PHC3;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;SLC25A4;QSOX1;ASAP1;PRKAR1A;JMY;BOK;PARP9;CPEB4;ATXN2;NACC2;SPRY2;BEX4;THRA;ACVR1B;NGFR;PPP1R10;TSHZ1;PER3;MTA1;AZIN2;BCL2L1;IFITM1;WASF2;SKAP2;ARF4;H2AFJ;XBP1;UBASH3B;MAP2K2;ABHD6;SATB1;PPP1R2;PAIP1;ARRDC1;TLE4;TRPC1;RET;LOXL2;PDE5A;C5;MTMR4;GABARAPL2;EPM2A;RMRP;EAPP;PUM2;SLC30A1;RNF135;TMBIM1;PRKACA;RGL2;TMSB4X;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;SLC39A10;FICD;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;ARID4A;TENM2;IGF2;ITPR2;GRB10;ERLEC1;PPARG;SNX6;GRB7;ALDH1A2;LYPLA1;TBX1;RPH3AL;RSF1;ADAM8;AKT3;IL20RB;WFS1;DEPDC1;PHF21A;ZNF568;IGFBP7;FZD8;WASL;HSPA2;LRP6;ARID5B;MAGEF1;E2F7;EEF2K;SLC18A2;TNRC6C;TET1;OMG;ZC3H7A;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;PTCH1;KAT2B;CNOT11;OAS1;USP25;PRMT3;UFL1;ANKRD6;JARID2;SEMA3F;KLHL15;MXD4;ADNP;GNAI1;LRP4;RB1CC1;DNMT3A;FADD
9013,GO:0035176,0.0749835343877759,0.973347821875997,6,31,social behavior,BP,DLG4;SHANK2;VPS13A;DVL1;PPP3CB;TBX1
13138,GO:0051703,0.0749835343877759,0.973347821875997,6,31,intraspecies interaction between organisms,BP,DLG4;SHANK2;VPS13A;DVL1;PPP3CB;TBX1
7667,GO:0032096,0.0750085161834846,0.991891742984217,2,6,negative regulation of response to food,BP,BBS2;PPARA
7670,GO:0032099,0.0750085161834846,0.991891742984217,2,6,negative regulation of appetite,BP,BBS2;PPARA
1842,GO:0004498,0.0750464310275614,1,1,1,calcidiol 1-monooxygenase activity,MF,CYP27B1
20017,GO:2000637,0.075240245715009,0.980200323071124,4,19,positive regulation of gene silencing by miRNA,BP,MAP2K1;EGFR;MAP2K2;PUM2
14193,GO:0061098,0.0752621026745763,0.976145947383539,5,27,positive regulation of protein tyrosine kinase activity,BP,NEURL1;PRNP;ERCC6;DLG4;DLG3
12996,GO:0051413,0.0753148762009805,1,1,1,response to cortisone,BP,GLB1
16642,GO:0097501,0.0754310780901584,0.991399713587572,2,7,stress response to metal ion,BP,MT2A;SLC30A1
955,GO:0002376,0.0755970622082731,0.936316063955094,170,1853,immune system process,BP,TNIP1;ERCC1;RAB3B;PGF;CTNNBIP1;PYGL;ITGA6;MMP1;CYP27B1;PYGB;PRSS3;PRNP;PAG1;NR1D1;SLC16A3;ADARB1;MAP2K1;FAM210B;PKN1;NAPRT;MST1R;APLN;POU2F2;DHTKD1;TNFSF15;PTPRS;PSMD2;LTA4H;FCGRT;WIPF1;FYN;TNFRSF6B;BNIP3;KIF13B;PGM1;DLG1;CTSB;CD68;HTRA1;GLO1;SEC23A;SDC1;ARG2;STOM;SHC1;PAK1;RAG1;TGFBR2;SERPING1;SLC2A3;LCN2;RAC2;CD44;FKBP1A;BNIP3L;PRKACB;RBCK1;LRP1;ANXA3;ITGA1;EPCAM;CMTM7;ITGB5;BTRC;LPCAT1;ITGA2;PTK6;VAMP2;FAM20C;SOX4;APOBEC3C;CEACAM1;MAPKAPK3;RAB31;MT2A;BSG;TRIM5;TNRC6B;MMP14;CD46;LRP5;CTSL;CST3;CASP4;L3MBTL3;MOSPD2;DNAJB9;PPP3CB;COPB1;CEBPG;F2RL1;DDX60;PROCR;C6ORF120;PSMD7;CHD7;QSOX1;PRKAR1A;PARP9;THRA;CD99;WNT2B;ACVR1B;NGFR;PTPRZ1;IFITM1;GLB1;WASF2;SKAP2;POLL;YPEL5;XBP1;UBASH3B;SATB1;RET;PDE5A;RAB43;C5;NCKAP1;DNASE1L1;DOCK11;PUM2;RNF135;TMBIM1;COL1A2;PRKACA;TIMP2;EIF2AK2;IFI16;AP2A2;SLC39A10;CMTM6;IL1RAP;ORAI1;CARD11;LTB4R;CTSZ;HOXA3;AP3D1;ARID4A;NIT2;ARPC1A;IGF2;MAP4K2;PPARG;TMEM63A;GRB7;TBX1;SLC7A11;ERP44;ADAM8;IL20RB;ATP11B;ITGA4;CKLF;FZD8;WASL;FLNB;TMEM173;HPSE;GALNS;TNRC6C;DNAJC3;FOXP1;KAT2B;OAS1;SNX27;JARID2;TRIM38;FADD
10329,GO:0043121,0.0756197422611219,0.9924021822481,2,5,neurotrophin binding,MF,PCSK6;NGFR
17138,GO:0102339,0.0757307112239858,1,1,1,3-oxo-arachidoyl-CoA reductase activity,MF,HSD17B12
17139,GO:0102340,0.0757307112239858,1,1,1,3-oxo-behenoyl-CoA reductase activity,MF,HSD17B12
17140,GO:0102341,0.0757307112239858,1,1,1,3-oxo-lignoceroyl-CoA reductase activity,MF,HSD17B12
17141,GO:0102342,0.0757307112239858,1,1,1,3-oxo-cerotoyl-CoA reductase activity,MF,HSD17B12
3549,GO:0007576,0.0757843503585842,1,1,1,nucleolar fragmentation,BP,ZNF354A
16925,GO:0098902,0.0759395075578112,0.992351282892093,2,5,regulation of membrane depolarization during action potential,BP,ANK3;PTPN3
8433,GO:0033540,0.0759627296173331,0.98488052932763,3,13,fatty acid beta-oxidation using acyl-CoA oxidase,BP,ABCD1;CRAT;AMACR
4629,GO:0010750,0.0759988798663791,1,1,1,positive regulation of nitric oxide mediated signal transduction,BP,EGFR
8458,GO:0033594,0.0759988798663791,1,1,1,response to hydroxyisoflavone,BP,EGFR
10267,GO:0043006,0.0759988798663791,1,1,1,activation of phospholipase A2 activity by calcium-mediated signaling,BP,EGFR
16633,GO:0097489,0.0759988798663791,1,1,1,multivesicular body, internal vesicle lumen,CC,EGFR
3429,GO:0007217,0.0760793197654404,1,1,1,tachykinin receptor signaling pathway,BP,GRK5
6662,GO:0030016,0.0760809034712591,0.956190429611772,17,124,myofibril,CC,NOS1;FLNC;SCN8A;ANK3;MYH15;PARVB;PAK1;OBSCN;FKBP1A;TMOD2;OBSL1;LMAN1;TWF2;PPP3CB;FLNB;PSEN2;KAT2B
4498,GO:0010523,0.0763162231449156,0.984780426259978,3,13,negative regulation of calcium ion transport into cytosol,BP,NOS1;PKD2;NTSR1
7625,GO:0032024,0.0763226150933308,0.969651982306115,7,45,positive regulation of insulin secretion,BP,PCK2;GLUL;SOX4;NLGN2;PPP3CB;ANO1;GLUD1
19945,GO:2000482,0.076335438636928,0.984774978755619,3,13,regulation of interleukin-8 secretion,BP,F2R;F2RL1;TMSB4X
2004,GO:0004728,0.0763876506270021,1,1,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,MAP2K1
4398,GO:0010107,0.0764235030994754,0.979934035267244,4,18,potassium ion import,BP,DLG1;SLC12A7;KCNJ15;ATP12A
18942,GO:1904700,0.0764948945635153,1,1,1,granulosa cell apoptotic process,BP,BOK
18947,GO:1904708,0.0764948945635153,1,1,1,regulation of granulosa cell apoptotic process,BP,BOK
1663,GO:0004122,0.0765351116397134,1,1,1,cystathionine beta-synthase activity,MF,CBS
2991,GO:0006535,0.0765351116397134,1,1,1,cysteine biosynthetic process from serine,BP,CBS
4052,GO:0009093,0.0765351116397134,1,1,1,cysteine catabolic process,BP,CBS
5614,GO:0016662,0.0765351116397134,1,1,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,CBS
6151,GO:0019448,0.0765351116397134,1,1,1,L-cysteine catabolic process,BP,CBS
12477,GO:0050421,0.0765351116397134,1,1,1,nitrite reductase (NO-forming) activity,MF,CBS
14529,GO:0070025,0.0765351116397134,1,1,1,carbon monoxide binding,MF,CBS
16877,GO:0098809,0.0765351116397134,1,1,1,nitrite reductase activity,MF,CBS
790,GO:0002053,0.0765587814106386,0.979886291730076,4,18,positive regulation of mesenchymal cell proliferation,BP,TGFBR2;FGFR1;LRP5;TBX1
4038,GO:0009070,0.0766209534205258,0.984503277794125,3,14,serine family amino acid biosynthetic process,BP,CBS;PSAT1;CTH
11523,GO:0046037,0.0767019940174728,0.979682126606083,4,19,GMP metabolic process,BP,DLG1;DLG4;DLG3;CARD11
5711,GO:0016842,0.0767245663270978,0.991166210772809,2,7,amidine-lyase activity,MF,CHAC1;GGACT
4605,GO:0010720,0.0768266732957852,0.945828310838199,39,340,positive regulation of cell development,BP,ZMYND8;ETV5;NEURL1;VLDLR;SERPINE2;MAP2K1;MAP1B;CRTC1;FYN;DLG4;PLXNB3;NET1;GDI1;DKK1;PAK1;SOCS2;SHANK2;IMPACT;APOE;RGS14;LPAR3;FGFR1;PTK6;OBSL1;DVL1;TWF2;CNTN1;PLAG1;NGFR;RET;PDE5A;TIMP2;IL1RAP;LPAR1;PPARG;SYT2;EEF2K;UFL1;ADNP
9585,GO:0036403,0.0768702848531504,1,1,1,arachidonate 8(S)-lipoxygenase activity,MF,ALOX15B
6131,GO:0019389,0.0770714338803989,1,1,1,glucuronoside metabolic process,BP,ABHD10
6132,GO:0019391,0.0770714338803989,1,1,1,glucuronoside catabolic process,BP,ABHD10
17146,GO:0102390,0.0770714338803989,1,1,1,mycophenolic acid acyl-glucuronide esterase activity,MF,ABHD10
5327,GO:0016053,0.0771767881065885,0.947864783132345,31,286,organic acid biosynthetic process,BP,CBS;GPT2;NR1D1;ALOX15B;DHTKD1;LTA4H;PSAT1;ELOVL1;PGM1;GLUL;ACOT7;CEMIP;NAGS;CBR4;LDHA;PPARA;ASNS;UROS;HYAL1;GAMT;CEACAM1;CTH;TRIB3;MLYCD;MGLL;GLUD1;XBP1;ALDH1A2;ELOVL4;HSD17B12;AMACR
4499,GO:0010524,0.0772818715945596,0.975314793084833,5,27,positive regulation of calcium ion transport into cytosol,BP,F2R;CEMIP;PKD2;NTSR1;TRPC1
3226,GO:0006878,0.077289082835558,0.984503847024013,3,13,cellular copper ion homeostasis,BP,PRNP;ATP7B;MT2A
7935,GO:0032515,0.0772917007080229,0.971933505256244,6,36,negative regulation of phosphoprotein phosphatase activity,BP,PPP1R14A;FKBP1A;ELFN2;PPP1R35;PPP1R10;PPP1R2
3889,GO:0008521,0.0773128821812871,1,1,1,acetyl-CoA transmembrane transporter activity,MF,SLC33A1
5249,GO:0015876,0.0773128821812871,1,1,1,acetyl-CoA transport,BP,SLC33A1
5268,GO:0015916,0.0773128821812871,1,1,1,fatty-acyl-CoA transport,BP,SLC33A1
5347,GO:0016095,0.0773128821812871,1,1,1,polyprenol catabolic process,BP,SRD5A3
17145,GO:0102389,0.0773128821812871,1,1,1,polyprenol reductase activity,MF,SRD5A3
17627,GO:1901337,0.0773128821812871,1,1,1,thioester transport,BP,SLC33A1
1449,GO:0003680,0.077375132434739,0.991484265694806,2,6,AT DNA binding,MF,H1F0;HMGA2
4271,GO:0009628,0.0774762775030191,0.938692426177327,85,868,response to abiotic stimulus,BP,PLAT;NOS1;ERCC1;PGF;CCND1;CYGB;SERPINE2;POSTN;NFATC4;PKN1;PSMD2;CRTC1;DENND5B;CAPN2;BRSK1;EGFR;STK39;FYN;BNIP3;ERCC6;MAPK13;ZNF516;NET1;XPC;PAK1;RAG1;TGFBR2;EDNRA;SLITRK6;IMPACT;BNIP3L;CCND2;ANGPTL4;RGS14;PKD2;LDHA;AKAP9;HMGA2;ATF4;PPARA;ASNS;HYAL1;ITGA2;MTHFR;PITPNM1;DDB2;NTSR1;MMP14;LRP5;CST3;MYOF;PSMD7;ANO1;CPEB4;THRA;HSPA13;PER3;MTA1;BCL2L1;SLC38A2;LOXL2;ETV1;PRKACA;IFI16;NR2F6;LPAR1;ZNF354A;ITPR2;PPARG;PPL;ADAM8;ENDOG;IKBIP;IGFBP7;DDHD2;REEP6;HSPA2;EEF2K;DNAJC3;PSEN2;ELOVL4;PTCH1;FAM162A;DNMT3A;FADD
3178,GO:0006793,0.0775694016393149,0.933522310530474,218,2361,phosphorus metabolic process,BP,TNIP1;XDH;NT5E;NOS1;F2R;SORL1;MBOAT2;CCND1;NEURL1;PCK2;VLDLR;PYGL;ITGA6;RPS6KA2;ADCY7;CRYL1;IGFBP4;PRNP;ADM2;ADARB1;MAP2K1;RAPGEF3;ACVR2B;TK2;PKN1;NAPRT;WWTR1;MST1R;H6PD;APLN;DHTKD1;DGKA;TNFSF15;SSH1;PTPRS;PSMD2;BRSK1;EGFR;STK39;PPP1R14A;FYN;OSBPL10;ERCC6;MAPK13;ELOVL1;PGM1;DLG1;ISYNA1;DLG4;IDH2;ACOT1;SNX9;WNT7A;ACSF2;PGLS;MAP4K4;TTBK2;SPTLC2;ACOT7;TTC7B;GRK5;NMRK1;STRADB;NME4;CEMIP;SHC1;DLG3;DKK1;PAK1;RASA3;SOCS2;TRIB2;NEK9;CBR4;TGFBR2;PTPN3;EPHA1;IMPACT;PLPP6;RAC2;CD44;OBSCN;APOE;FKBP1A;CCND2;ACP5;PTPN12;CDK17;RGS14;PKD2;PRKACB;LDHA;AKAP9;PPP2R3B;HMGA2;PPARA;ABCA7;PIGH;AGPAT4;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;PTPDC1;LPCAT4;BTRC;LPCAT1;ITGA2;PTK6;ULK2;INPP5F;FAM20C;PFN2;PITPNM1;CEACAM1;MAPKAPK3;NLK;TRIM5;DVL1;NTSR1;PLA2G4D;LRP5;ETAA1;TMEM86B;CNTN1;TRIB3;GFPT1;RANBP9;PLPPR2;PPP3CB;ACOT13;INPP4A;DNAJC6;SLK;MLYCD;CDC42BPA;SCYL3;F2RL1;TAOK1;CSNK2A1;PSMD7;PTHLH;NDUFV3;PRKAR1A;CRLS1;PARP9;MAST3;SPRY2;ACVR1B;NGFR;PPP1R10;PSKH1;MARK4;PTPRZ1;AGPAT3;UAP1;PANK4;NT5DC1;UBASH3B;MAP2K2;ABHD6;PPP1R2;RET;PDE5A;OSBPL5;C5;MTMR4;MBOAT7;PAK6;CCDC88A;SAMD8;SHC2;PRKACA;NEK6;TMSB4X;TIMP2;EIF2AK2;SRD5A3;SLC39A10;CARD11;LPAR1;IGF2;ACP6;AGPAT1;GRB10;MAP4K2;ZMYM2;SNX6;SRPX2;TBX1;ATP6V1B2;AK9;ADAM8;AKT3;GARS;DDHD2;FZD8;HSPA2;LRP6;PLCH2;PPT2;EEF2K;RCAN1;DNAJC3;ZFYVE21;HSD17B12;CDS2;ADCY1;KAT2B;PANK1;ANKRD6;N4BP2;PPM1M;SLC44A1;ADNP;LRP4;RB1CC1
5600,GO:0016638,0.0777641534262338,0.9845989190434,3,12,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,LOXL1;GLUD1;LOXL2
3171,GO:0006782,0.0778472962300731,0.990961587925184,2,7,protoporphyrinogen IX biosynthetic process,BP,UROS;ALAS1
7357,GO:0031399,0.0779285268216373,0.935979719565748,123,1263,regulation of protein modification process,BP,TNIP1;XDH;NOS1;F2R;SORL1;CCND1;NEURL1;VLDLR;ADCY7;IGFBP4;PRNP;ADARB1;MAP2K1;RAPGEF3;ACVR2B;PKN1;WWTR1;MST1R;TNFSF15;EGFR;STK39;PPP1R14A;FYN;ERCC6;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;CRTAP;CEMIP;SHC1;DLG3;DKK1;PAK1;SOCS2;TRIB2;TGFBR2;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;CCND2;RGS14;PKD2;PRKACB;AKAP9;PPP2R3B;ABCA7;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;PTK6;INPP5F;ATRX;MTHFR;PFN2;SOX4;FBXO2;CEACAM1;MAPKAPK3;TRIM5;DVL1;LRP5;ETAA1;CNTN1;TRIB3;RANBP9;SLK;F2RL1;TAOK1;CSNK2A1;PHF1;PRKAR1A;PARP9;SPRY2;BEX4;ACVR1B;NGFR;PPP1R10;MTA1;UBASH3B;MAP2K2;PPP1R2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;TIMP2;EIF2AK2;RAB1A;SLC39A10;LPAR1;IGF2;MAP4K2;SNX6;TBX1;ADAM8;WFS1;FZD8;HSPA2;LRP6;EEF2K;RCAN1;TET1;DNAJC3;ADCY1;KAT2B;PRMT3;UFL1;ANKRD6;JARID2;ADNP;LRP4;RB1CC1
3495,GO:0007387,0.0780043287319968,1,1,1,anterior compartment pattern formation,BP,PBX3
3496,GO:0007388,0.0780043287319968,1,1,1,posterior compartment specification,BP,PBX3
6663,GO:0030017,0.0780263024669959,0.956690140816235,15,107,sarcomere,CC,NOS1;FLNC;SCN8A;ANK3;PARVB;PAK1;OBSCN;FKBP1A;TMOD2;OBSL1;LMAN1;PPP3CB;FLNB;PSEN2;KAT2B
8763,GO:0034433,0.0781465902242078,0.990906735917872,2,7,steroid esterification,BP,APOE;ABCG1
8764,GO:0034434,0.0781465902242078,0.990906735917872,2,7,sterol esterification,BP,APOE;ABCG1
8765,GO:0034435,0.0781465902242078,0.990906735917872,2,7,cholesterol esterification,BP,APOE;ABCG1
12280,GO:0048589,0.0782379431024577,0.943174794343997,46,395,developmental growth,BP,ERCC1;BBS2;POSTN;ADARB1;ACVR2B;WWTR1;MAP1B;PTPRS;SEMA4B;ERCC6;PLXNB3;WNT7A;GDI1;PAK1;SOCS2;TGFBR2;SHANK2;SLITRK6;IMPACT;APOE;PTPN12;WWC3;LPAR3;FGFR1;ULK2;ATRX;GAMT;DVL1;THBS3;TWF2;PPP3CB;MEX3C;PLAG1;CHD7;PRKAR1A;SPRY2;SH3PXD2B;LAMB2;LRP6;ARID5B;SYT2;PTCH1;JARID2;SEMA3F;ADNP;LRP4
14411,GO:0061687,0.0783219101242892,0.990874545434064,2,7,detoxification of inorganic compound,BP,MT2A;SLC30A1
815,GO:0002087,0.0784619676542987,0.991945145838544,2,5,regulation of respiratory gaseous exchange by neurological system process,BP,NLGN2;PBX3
17812,GO:1901917,0.0785086588015816,1,1,1,regulation of exoribonuclease activity,BP,TCEA1
17813,GO:1901919,0.0785086588015816,1,1,1,positive regulation of exoribonuclease activity,BP,TCEA1
19363,GO:1905779,0.0785086588015816,1,1,1,positive regulation of exonuclease activity,BP,TCEA1
8202,GO:0032947,0.0785096615000561,0.961166118203216,11,72,protein-containing complex scaffold activity,MF,DLG1;SEPT10;SHANK2;RGS14;AKAP9;WWC3;SLC9A3R2;SEPT5;DEDD2;SEPT6;RB1CC1
5717,GO:0016854,0.0785459605132147,0.984144181978475,3,13,racemase and epimerase activity,MF,HYI;AMACR;GALE
14003,GO:0060718,0.0785772388243732,0.991926390980051,2,5,chorionic trophoblast cell differentiation,BP,HTRA1;E2F7
9514,GO:0036179,0.0786029011427397,1,1,1,osteoclast maturation,BP,FAM20C
9492,GO:0036128,0.0786971787857917,1,1,1,CatSper complex,CC,HSPA2
3554,GO:0007589,0.0788928758450915,0.966105719422458,8,52,body fluid secretion,BP,XDH;CCND1;NEURL1;APLN;STK39;SOCS2;ATP7B;XBP1
12590,GO:0050766,0.0789930694621831,0.974605114158818,5,27,positive regulation of phagocytosis,BP,ABCA7;TUB;ITGA2;F2RL1;PPARG
7945,GO:0032536,0.079003724360311,0.991199390348602,2,6,regulation of cell projection size,BP,WNT7A;TWF2
13699,GO:0060251,0.0790535466636272,0.979180777596337,4,17,regulation of glial cell proliferation,BP,ETV5;IDH2;PLAG1;UFL1
13904,GO:0060548,0.0792242026733899,0.938892613938921,68,687,negative regulation of cell death,BP,F2R;SORL1;ITGA6;PRNP;MST1R;EGFR;FYN;TNFRSF6B;BNIP3;GLO1;WNT7A;MAP4K4;GRK5;STRADB;ARG2;SHC1;DKK1;WISP1;SOCS2;RAG1;EPHA1;IMPACT;CD44;APOE;BNIP3L;CCND2;ANGPTL4;RBCK1;LRP1;HMGA2;ATF4;PPARA;ASNS;FGFR1;AARS;SOX4;NTSR1;CTH;CST3;PRDX5;CSNK2A1;SLC25A4;BOK;CPEB4;SPRY2;NGFR;PPP1R10;BCL2L1;ARF4;XBP1;RET;TMBIM1;RGL2;EIF2AK2;SLC39A10;IGF2;TBX1;ADAM8;WFS1;LRP6;EEF2K;DNAJC3;FOXP1;PSEN2;UFL1;ADNP;RB1CC1;FADD
18504,GO:1903649,0.0793458739973165,0.978735491323316,4,19,regulation of cytoplasmic transport,BP,SORL1;MAP2K1;VPS11;MAP2K2
7258,GO:0031225,0.0793557410343201,0.963581765943362,9,69,anchored component of membrane,CC,NT5E;RAB3B;PRNP;LY6K;GPC4;CNTN1;NTNG1;PRSS8;OMG
1647,GO:0004092,0.0795069313413993,1,1,1,carnitine O-acetyltransferase activity,MF,CRAT
17699,GO:1901585,0.0795204547691858,1,1,1,regulation of acid-sensing ion channel activity,BP,STOM
18030,GO:1902533,0.079565562123939,0.938745517216776,67,663,positive regulation of intracellular signal transduction,BP,XDH;NOS1;F2R;IGFBP4;MAP2K1;PKN1;MST1R;TNFSF15;DDIT3;EGFR;STK39;FYN;ERCC6;TGM2;WNT7A;MAP4K4;SHC1;DKK1;PAK1;EPHA1;CD44;FKBP1A;PKD2;RBCK1;ABCA7;LPAR3;FGFR1;ITGA1;PTK6;MAPKAPK3;FAM110C;TRIM5;CTH;F2RL1;DDX60;TAOK1;BOK;PARP9;C18ORF32;NACC2;SPRY2;NGFR;BCL2L1;MAP2K2;RET;PDE5A;C5;PUM2;TMED4;SHC2;NEK6;RGL2;TIMP2;EIF2AK2;CARD11;LPAR1;IGF2;MAP4K2;TBX1;ADAM8;AKT3;FZD8;HPSE;ANKRD6;RB1CC1;TRIM38;FADD
1298,GO:0003131,0.0795813212052039,1,1,1,mesodermal-endodermal cell signaling,BP,HMGA2
7169,GO:0031049,0.0795813212052039,1,1,1,programmed DNA elimination,BP,HMGA2
7171,GO:0031052,0.0795813212052039,1,1,1,chromosome breakage,BP,HMGA2
9151,GO:0035501,0.0795813212052039,1,1,1,MH1 domain binding,MF,HMGA2
9415,GO:0035978,0.0795813212052039,1,1,1,histone H2A-S139 phosphorylation,BP,HMGA2
20057,GO:2000685,0.0795813212052039,1,1,1,positive regulation of cellular response to X-ray,BP,HMGA2
4729,GO:0010891,0.0795990629268639,0.99175939495175,2,5,negative regulation of sequestering of triglyceride,BP,PPARA;PPARG
13840,GO:0060440,0.079692251611139,0.991077862376017,2,6,trachea formation,BP,MAP2K1;TGFBR2
4894,GO:0014820,0.0796941090259153,0.991077533660673,2,6,tonic smooth muscle contraction,BP,BBS2;EDNRA
5034,GO:0015205,0.0797001638487412,0.991076462077889,2,6,nucleobase transmembrane transporter activity,MF,SLC25A4;SLC23A2
502,GO:0001558,0.0797491497434049,0.945642685219394,32,286,regulation of cell growth,BP,FHL1;CYP27B1;SERPINE2;IGFBP4;DCBLD2;MAP1B;PTPRS;EGFR;SEMA4B;NET1;HTRA1;GDI1;WISP1;PAK1;SOCS2;APOE;LPAR3;HYAL1;ULK2;LTBP4;KIAA1109;CEACAM1;MMP14;TWF2;CSNK2A1;ACVR1B;EPB41L3;PPARG;IGFBP7;SYT2;SEMA3F;ADNP
10818,GO:0044306,0.0798069699582911,0.9602211424804,11,79,neuron projection terminus,CC,DLG4;GLUL;FKBP1A;ITGA2;VAMP2;PFN2;NTSR1;SEPT5;AP3D1;SLC18A2;SEPT6
18015,GO:1902499,0.0798317301924756,1,1,1,positive regulation of protein autoubiquitination,BP,MTA1
9882,GO:0042149,0.0798326359742854,0.970765908360896,6,36,cellular response to glucose starvation,BP,IMPACT;ATF4;ASNS;CPEB4;XBP1;IFI16
14665,GO:0070265,0.0801864062717872,0.97036579112937,6,40,necrotic cell death,BP,PYGL;BNIP3;RBCK1;SLC25A4;BOK;FADD
8923,GO:0034764,0.0801942407151274,0.956277144542774,14,102,positive regulation of transmembrane transport,BP,NOS1;F2R;STK39;ANK3;CEMIP;PAK1;PKD2;AKAP9;NTSR1;CLTCL1;AZIN2;TRPC1;TMSB4X;HSPA2
15020,GO:0070950,0.0802654766232053,1,1,1,regulation of neutrophil mediated killing of bacterium,BP,F2RL1
15021,GO:0070951,0.0802654766232053,1,1,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,F2RL1
15025,GO:0070962,0.0802654766232053,1,1,1,positive regulation of neutrophil mediated killing of bacterium,BP,F2RL1
15026,GO:0070963,0.0802654766232053,1,1,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,F2RL1
16180,GO:0090198,0.0802654766232053,1,1,1,negative regulation of chemokine secretion,BP,F2RL1
16408,GO:0097029,0.0802654766232053,1,1,1,mature conventional dendritic cell differentiation,BP,F2RL1
17404,GO:1900135,0.0802654766232053,1,1,1,positive regulation of renin secretion into blood stream,BP,F2RL1
2381,GO:0005516,0.0803554993594794,0.952622711894356,18,129,calmodulin binding,MF,NOS1;MARCKSL1;SNTB2;EGFR;MYH15;OBSCN;VAMP2;CEACAM1;MAPKAPK3;CTH;MAP6;PPP3CB;AEBP1;NGFR;ORAI1;WFS1;EEF2K;ADCY1
194,GO:0000412,0.0803875870056412,1,1,1,histone peptidyl-prolyl isomerization,BP,FKBP10
1853,GO:0004516,0.0804554458907187,1,1,1,nicotinate phosphoribosyltransferase activity,MF,NAPRT
2762,GO:0006174,0.0804554458907187,1,1,1,dADP phosphorylation,BP,AK9
2769,GO:0006186,0.0804554458907187,1,1,1,dGDP phosphorylation,BP,AK9
3156,GO:0006756,0.0804554458907187,1,1,1,AMP phosphorylation,BP,AK9
3975,GO:0008792,0.0804554458907187,1,1,1,arginine decarboxylase activity,MF,AZIN2
5032,GO:0015203,0.0804554458907187,1,1,1,polyamine transmembrane transporter activity,MF,AZIN2
5122,GO:0015489,0.0804554458907187,1,1,1,putrescine transmembrane transporter activity,MF,AZIN2
5232,GO:0015847,0.0804554458907187,1,1,1,putrescine transport,BP,AZIN2
6112,GO:0019357,0.0804554458907187,1,1,1,nicotinate nucleotide biosynthetic process,BP,NAPRT
6113,GO:0019358,0.0804554458907187,1,1,1,nicotinate nucleotide salvage,BP,NAPRT
6118,GO:0019365,0.0804554458907187,1,1,1,pyridine nucleotide salvage,BP,NAPRT
8470,GO:0033608,0.0804554458907187,1,1,1,formyl-CoA transferase activity,MF,SUGCT
8713,GO:0034355,0.0804554458907187,1,1,1,NAD salvage,BP,NAPRT
11138,GO:0045183,0.0804554458907187,1,1,1,translation factor activity, non-nucleic acid binding,MF,NEURL1
11706,GO:0046497,0.0804554458907187,1,1,1,nicotinate nucleotide metabolic process,BP,NAPRT
11993,GO:0047369,0.0804554458907187,1,1,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,SUGCT
12458,GO:0050262,0.0804554458907187,1,1,1,ribosylnicotinamide kinase activity,MF,NMRK1
14329,GO:0061508,0.0804554458907187,1,1,1,CDP phosphorylation,BP,AK9
14351,GO:0061565,0.0804554458907187,1,1,1,dAMP phosphorylation,BP,AK9
14352,GO:0061566,0.0804554458907187,1,1,1,CMP phosphorylation,BP,AK9
14353,GO:0061567,0.0804554458907187,1,1,1,dCMP phosphorylation,BP,AK9
14354,GO:0061568,0.0804554458907187,1,1,1,GDP phosphorylation,BP,AK9
14355,GO:0061569,0.0804554458907187,1,1,1,UDP phosphorylation,BP,AK9
14356,GO:0061570,0.0804554458907187,1,1,1,dCDP phosphorylation,BP,AK9
14357,GO:0061571,0.0804554458907187,1,1,1,TDP phosphorylation,BP,AK9
14450,GO:0061769,0.0804554458907187,1,1,1,ribosylnicotinate kinase activity,MF,NMRK1
16552,GO:0097310,0.0804554458907187,1,1,1,cap2 mRNA methylation,BP,CMTR2
16703,GO:0097655,0.0804554458907187,1,1,1,serpin family protein binding,MF,CTSL
16792,GO:0098629,0.0804554458907187,1,1,1,trans-Golgi network membrane organization,BP,AZIN2
19611,GO:1990755,0.0804554458907187,1,1,1,mitotic spindle microtubule depolymerization,BP,CCSAP
569,GO:0001710,0.0806055175433122,0.990915671289152,2,6,mesodermal cell fate commitment,BP,DKK1;FGFR1
12902,GO:0051248,0.0806829322541456,0.935917703649823,86,886,negative regulation of protein metabolic process,BP,TNIP1;XDH;PLAT;SORL1;SERPINE2;PRNP;ADARB1;MAP2K1;TFPI2;PKN1;WWTR1;EIF4EBP1;EGFR;STK39;PPP1R14A;FYN;TNFRSF6B;UBE2J1;DLG1;IGF2BP3;CRTAP;DKK1;SOCS2;TRIB2;RAG1;PTPN3;SERPING1;EPHA1;IMPACT;CD44;APOE;FKBP1A;RGS14;IDE;ATF4;ABCA7;ELFN2;PPP1R35;PTK6;INPP5F;CHAC1;SOX4;CEACAM1;XRN1;TNRC6B;DVL1;LRP5;CST3;TRIB3;RANBP9;MEX3C;APLP2;PRDX5;F2RL1;CSNK2A1;PHF1;PRKAR1A;CPEB4;SPRY2;BEX4;NGFR;PPP1R10;AZIN2;UBASH3B;MAP2K2;PPP1R2;C5;GABARAPL2;PUM2;TIMP2;EIF2AK2;IFI16;CTSZ;ERLEC1;PPARG;SNX6;GRB7;LRP6;TNRC6C;ZC3H7A;DNAJC3;KAT2B;USP25;PRMT3;UFL1;JARID2
8717,GO:0034362,0.0807950940981552,0.990881861479585,2,6,low-density lipoprotein particle,CC,SORL1;APOE
17686,GO:1901564,0.0808719128843309,0.928678105124508,426,4898,organonitrogen compound metabolic process,BP,TNIP1;XDH;NT5E;PLAT;SMURF2;EDEM1;GID4;NOS1;ZMYND8;F2R;SORL1;ADAM19;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;VLDLR;CBS;MMP1;RPS6KA2;SERPINE2;PRSS3;ADCY7;IGFBP4;PRNP;ADM2;GPT2;BTBD2;NR1D1;HECW2;ADARB1;MAP2K1;TFPI2;RAPGEF3;ACVR2B;LTBP1;LMF1;TK2;THSD4;PKN1;NAPRT;WWTR1;MST1R;MARCH9;H6PD;LY6K;DHTKD1;TNFSF15;EIF4EBP1;SSH1;PC;DDIT3;PTPRS;B4GALT6;CARS;PSMD2;LAMB1;LTA4H;CAPN2;BRSK1;EGFR;STK39;LOXL1;PPP1R14A;FYN;TNFRSF6B;TMPRSS11D;OSBPL10;TSPAN5;PSAT1;JADE2;BNIP3;HLTF;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PGM1;ADAMTS7;DLG1;DLG4;B3GNT3;IDH2;CTSB;GPC4;SNX9;TYSND1;TGM2;GLUL;HTRA1;GLO1;FKBP9;WNT7A;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;RSAD1;GRK5;NMRK1;STRADB;NME4;CRTAP;ASPH;CEMIP;SDC1;ARG2;SHC1;NAGS;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;NEK9;RAG1;TGFBR2;PTPN3;SERPING1;HAGH;SCRN1;EPHA1;IMPACT;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;CCND2;ACP5;PTPN12;ALDH1L2;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;RBCK1;LRP1;LDHA;ST3GAL5;IDE;AKAP9;PPP2R3B;ABTB1;UBE2G1;HMGA2;ATF4;PPARA;ABCA7;PIGH;EIF4E3;LPAR3;PCMTD2;ELFN2;ASNS;FGFR1;ITGA1;AARS;PPP1R35;MARCH4;PTPDC1;LPCAT4;RNPEPL1;UROS;HYAL1;DCAF10;BTRC;LPCAT1;ITGA2;PTK6;GALNT3;ULK2;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;SOX4;RMND5A;APOBEC3C;FBXO2;DDB2;GAMT;KDSR;CEACAM1;MAPKAPK3;SPATA18;OBSL1;PRR9;LMAN1;MRPS6;RCOR1;SH3D19;NLK;XRN1;TRIM5;TNRC6B;DVL1;MMP14;PLA2G4D;CD46;MVB12B;CTH;LRP5;ETAA1;ABHD17C;TMEM86B;CTSL;NPEPL1;CST3;RABGGTA;CNTN1;TRIB3;CASP4;NTNG1;GFPT1;PCSK6;VPS11;RANBP9;DNAJB9;FBXL8;BTBD3;PPP3CB;MEX3C;HIBADH;ZDHHC2;APLP2;DNAJC6;SLK;PRDX5;CEBPG;ALDH7A1;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;SLC2A9;TAOK1;AEBP1;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;BLMH;QSOX1;NDUFV3;PRKAR1A;CTBS;MSRB2;BOK;PARP9;CPEB4;ATXN2;KLHL29;MAST3;NACC2;SPRY2;SLC6A14;BEX4;ACVR1B;NGFR;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;MARK4;PTPRZ1;MTA1;AZIN2;CRAT;RNF165;PM20D2;GLB1;TRIM7;ARF4;ANAPC13;PCYOX1;XBP1;PANK4;NFU1;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;ARRDC1;ANKIB1;LYPLAL1;RET;LOXL2;PDE5A;VWA1;OSBPL5;C5;MTMR4;ZFYVE9;GABARAPL2;PAK6;UBE2E1;PUM2;RNF135;CCDC88A;CTSO;SAMD8;ADAMTSL1;SHC2;PRKACA;NEK6;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;ZDHHC1;SEL1L;IFI16;AP2A2;SRD5A3;SLC39A10;IL1RAP;ST6GALNAC2;CARD11;LAMB2;FICD;SECISBP2L;LPAR1;CTSZ;TBL1X;MMP10;RNF169;ARID4A;NIT2;BLVRA;TENM2;IGF2;PJA2;MAP4K2;ZMYM2;ERLEC1;PPARG;SNX6;EVA1A;USP20;GRB7;LYPLA1;TBX1;ESYT3;ERP44;ATP6V1B2;AK9;ADAM8;ALDH4A1;AKT3;GARS;WFS1;PHF21A;IGFBP7;MARCH2;OSGEPL1;FZD8;USP32;HSPA2;PRSS8;LRP6;ARID5B;MAGEF1;RNF180;GGACT;EEF2K;HPSE;GALNS;TNRC6C;TRIM2;RCAN1;TET1;DNAJC3;PSEN2;ELOVL4;AOX1;PTCH1;ADCY1;KAT2B;CNOT11;RNF103;USP25;PANK1;PRMT3;UFL1;FAM162A;ANKRD6;JARID2;PPM1M;KLHL15;SLC44A1;ADNP;LRP4;STT3B;RB1CC1;ALAS1;TRIM38;FBXL5;FADD
13968,GO:0060675,0.0811215130641479,0.967563655587996,7,40,ureteric bud morphogenesis,BP,PGF;CTNNBIP1;DLG1;PKD2;WNT2B;LAMA5;PTCH1
15656,GO:0072171,0.0811215130641479,0.967563655587996,7,40,mesonephric tubule morphogenesis,BP,PGF;CTNNBIP1;DLG1;PKD2;WNT2B;LAMA5;PTCH1
9247,GO:0035640,0.0811280494603043,0.983641225019249,3,12,exploration behavior,BP,DLG4;APOE;NLGN2
2247,GO:0005159,0.081192949550407,0.983622566549735,3,12,insulin-like growth factor receptor binding,MF,SHC1;SOCS2;IGF2
16357,GO:0090647,0.0813217606313549,0.990787677926911,2,6,modulation of age-related behavioral decline,BP,PRNP;DKK1
14159,GO:0061041,0.0813678351199226,0.959278943173801,11,80,regulation of wound healing,BP,PLAT;F2R;SERPINE2;TGFBR2;SERPING1;APOE;CEACAM1;F2RL1;XBP1;UBASH3B;HPSE
9042,GO:0035256,0.0814339545982989,0.990767565761104,2,6,G-protein coupled glutamate receptor binding,MF,PRNP;FYN
7738,GO:0032233,0.0814652021321181,0.967212637833155,7,43,positive regulation of actin filament bundle assembly,BP,RAPGEF3;PAK1;EPHA1;PFN2;FHOD1;SH3PXD2B;LPAR1
17490,GO:1900424,0.0815118651929166,0.983285097119142,3,13,regulation of defense response to bacterium,BP,ARG2;F2RL1;FOXP1
14160,GO:0061042,0.0815331232377843,0.99074977435622,2,6,vascular wound healing,BP,XBP1;HPSE
7272,GO:0031252,0.0816591068422404,0.943009073561303,36,301,cell leading edge,CC,ITGB4;ACTA2;RAPGEF3;SSH1;WIPF1;DYSF;PARVB;SNX9;PODXL;PAK1;RAC2;CD44;PKD2;DDN;ATF4;ABCA7;PTK6;FAT1;FERMT1;PLEK2;TWF2;WASF3;SLK;CDC42BPA;SCYL3;JMY;SPRY2;WASF2;ARF4;NCKAP1;PSD3;FRMD4B;CCDC88A;EPB41L3;ATP6V1B2;WASL
10816,GO:0044304,0.0816994709727024,0.967344852223243,7,39,main axon,CC,SCN8A;ANK3;KIF13B;DLG1;DLG4;NAV1;EPB41L3
4293,GO:0009720,0.0817125421736264,1,1,1,detection of hormone stimulus,BP,ABCG1
8575,GO:0034041,0.0817125421736264,1,1,1,sterol-transporting ATPase activity,MF,ABCG1
10571,GO:0043533,0.081741399685604,0.991404953791523,2,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,ITPR3;SYT2
7701,GO:0032173,0.0819165420656266,1,1,1,septin collar,CC,SEPT6
12864,GO:0051185,0.0821249466283205,0.990643321313293,2,6,coenzyme transmembrane transporter activity,MF,SLC33A1;SLC23A2
14879,GO:0070664,0.0825725028139379,0.966553057575416,7,45,negative regulation of leukocyte proliferation,BP,PRNP;PKN1;DLG1;ARG2;PRKAR1A;PDE5A;IL20RB
6291,GO:0019901,0.0826770419683163,0.937767770486255,56,525,protein kinase binding,MF,TNIP1;DOCK4;FAM83A;CCND1;PAG1;ACTA2;PKN1;MST1R;MICALCL;EXOC2;BRSK1;EGFR;TBC1D14;STK39;KIF13B;DLG1;GRK5;SHC1;PAK1;TRIB2;NEK9;TGFBR2;EPHA1;RAC2;CCND2;RGS14;ATF4;FGFR1;PITPNM1;CEACAM1;MAPKAPK3;TRIM5;DVL1;TWF2;TRIB3;TOM1L2;PRKAR1A;SPRY2;BCL2L1;SLC12A7;RET;CCDC88A;SHC2;PRKACA;NEK6;RHOBTB1;AP2A2;IL1RAP;PJA2;MAP4K2;GRB7;TMEM173;DNAJC3;KAT2B;LRP4;RB1CC1
2424,GO:0005600,0.0827254980492319,1,1,1,collagen type XIII trimer,CC,COL13A1
7121,GO:0030936,0.0827254980492319,1,1,1,transmembrane collagen trimer,CC,COL13A1
5473,GO:0016406,0.0827332686367637,0.99053340741668,2,6,carnitine O-acyltransferase activity,MF,CPT2;CRAT
6779,GO:0030214,0.0827702906696405,0.98291622859819,3,13,hyaluronan catabolic process,BP,CEMIP;CD44;HYAL1
7491,GO:0031659,0.0830109605975717,0.99119216172072,2,5,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;PKD2
3715,GO:0008233,0.0831944770689757,0.940831484356293,39,373,peptidase activity,MF,PLAT;ADAM19;MMP1;PRSS3;THSD4;PSMD2;LTA4H;CAPN2;TMPRSS11D;ADAMTS7;CTSB;TYSND1;HTRA1;SCRN1;CLCA2;IDE;RNPEPL1;LONP2;MMP14;CTSL;NPEPL1;CASP4;PCSK6;AEBP1;OTUB2;BLMH;PM20D2;ZFYVE9;CTSO;ADAMTSL1;CTSZ;MMP10;USP20;ADAM8;OSGEPL1;USP32;PRSS8;PSEN2;USP25
6306,GO:0019935,0.0831992649221759,0.959943758427427,10,67,cyclic-nucleotide-mediated signaling,BP,NOS1;ADCY7;ADGRF1;ADM2;RAPGEF3;APOE;PTHLH;LPAR1;ADCY1;GNAI1
18780,GO:1904293,0.0832100847206489,0.982786708485961,3,13,negative regulation of ERAD pathway,BP,UBE2J1;ERLEC1;USP25
17467,GO:1900272,0.0835719155332675,0.990381059525425,2,6,negative regulation of long-term synaptic potentiation,BP,PRNP;APOE
3109,GO:0006686,0.0836222763223838,0.990371880892539,2,6,sphingomyelin biosynthetic process,BP,SPTLC2;SAMD8
15411,GO:0071673,0.0836281372066909,1,1,1,positive regulation of smooth muscle cell chemotaxis,BP,LPAR1
18882,GO:1904565,0.0836281372066909,1,1,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,LPAR1
18883,GO:1904566,0.0836281372066909,1,1,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,LPAR1
12526,GO:0050670,0.0837091808529445,0.953829397575184,14,116,regulation of lymphocyte proliferation,BP,PRNP;PKN1;DLG1;ARG2;TGFBR2;RAC2;CD46;PRKAR1A;PDE5A;SLC39A10;CARD11;IGF2;IL20RB;FADD
18442,GO:1903525,0.0837885722409254,0.991060819878507,2,5,regulation of membrane tubulation,BP,ASAP1;WASL
7240,GO:0031161,0.0838923112896376,1,1,1,phosphatidylinositol catabolic process,BP,INPP5F
5921,GO:0018196,0.0839117944506676,0.968676982944461,6,39,peptidyl-asparagine modification,BP,UBE2J1;MCFD2;ST3GAL5;LMAN1;ST6GALNAC2;STT3B
7683,GO:0032127,0.0839464649566645,1,1,1,dense core granule membrane,CC,ADAM8
15086,GO:0071065,0.0839464649566645,1,1,1,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,ADAM8
15100,GO:0071133,0.0839464649566645,1,1,1,alpha9-beta1 integrin-ADAM8 complex,CC,ADAM8
15833,GO:0072535,0.0839464649566645,1,1,1,tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
15911,GO:0072680,0.0839464649566645,1,1,1,extracellular matrix-dependent thymocyte migration,BP,ADAM8
15912,GO:0072681,0.0839464649566645,1,1,1,fibronectin-dependent thymocyte migration,BP,ADAM8
19837,GO:2000307,0.0839464649566645,1,1,1,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19838,GO:2000309,0.0839464649566645,1,1,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,ADAM8
19914,GO:2000410,0.0839464649566645,1,1,1,regulation of thymocyte migration,BP,ADAM8
19915,GO:2000412,0.0839464649566645,1,1,1,positive regulation of thymocyte migration,BP,ADAM8
19916,GO:2000413,0.0839464649566645,1,1,1,regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
19917,GO:2000415,0.0839464649566645,1,1,1,positive regulation of fibronectin-dependent thymocyte migration,BP,ADAM8
16607,GO:0097440,0.083988135564987,0.983120824786165,3,11,apical dendrite,CC,NEURL1;OSBP2;MAP1B
18234,GO:1903038,0.0848876766252058,0.960663621979169,9,64,negative regulation of leukocyte cell-cell adhesion,BP,PRNP;PAG1;DLG1;ARG2;PPARA;CEACAM1;PRKAR1A;PDE5A;IL20RB
7518,GO:0031704,0.0848917580697937,1,1,1,apelin receptor binding,MF,APLN
10496,GO:0043396,0.0848917580697937,1,1,1,corticotropin-releasing hormone secretion,BP,APLN
10497,GO:0043397,0.0848917580697937,1,1,1,regulation of corticotropin-releasing hormone secretion,BP,APLN
13029,GO:0051466,0.0848917580697937,1,1,1,positive regulation of corticotropin-releasing hormone secretion,BP,APLN
13665,GO:0060183,0.0848917580697937,1,1,1,apelin receptor signaling pathway,BP,APLN
18677,GO:1904022,0.0848917580697937,1,1,1,positive regulation of G-protein coupled receptor internalization,BP,APLN
1991,GO:0004712,0.0849807392291168,0.968367486949359,6,36,protein serine/threonine/tyrosine kinase activity,MF,RPS6KA2;MAP2K1;ACVR2B;MAPKAPK3;MAP2K2;PRKACA
19553,GO:1990523,0.0849860004033037,1,1,1,bone regeneration,BP,POSTN
2196,GO:0005070,0.0851733666816153,0.968350218019981,6,35,SH3/SH2 adaptor activity,MF,SH2D2A;PAG1;SOCS2;SKAP2;GRB10;GRB7
15855,GO:0072570,0.0851810261117585,1,1,1,ADP-D-ribose binding,MF,PARP9
10432,GO:0043277,0.0852144885936418,0.971983271330891,5,27,apoptotic cell clearance,BP,PEAR1;TGM2;RAC2;LRP1;ABCA7
1497,GO:0003842,0.0853086561344061,1,1,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,ALDH4A1
565,GO:0001706,0.0853294321405159,0.965400952164109,7,41,endoderm formation,BP,LAMB1;DKK1;HMGA2;ITGB5;MMP14;COL6A1;ITGA4
6401,GO:0021615,0.0853489355603867,1,1,1,glossopharyngeal nerve morphogenesis,BP,HOXA3
15992,GO:0085032,0.0856841121167196,1,1,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,TNIP1
11069,GO:0045069,0.0857379390087833,0.958246516843065,10,75,regulation of viral genome replication,BP,TNIP1;ADARB1;STOM;HMGA2;APOBEC3C;IFITM1;YTHDC2;EIF2AK2;IFI16;OAS1
19249,GO:1905407,0.0857777995177128,1,1,1,regulation of creatine transmembrane transporter activity,BP,STK39
19250,GO:1905408,0.0857777995177128,1,1,1,negative regulation of creatine transmembrane transporter activity,BP,STK39
12644,GO:0050848,0.0857917216192832,0.965044416173034,7,43,regulation of calcium-mediated signaling,BP,NOS1;PRNP;FKBP1A;PKD2;NFAT5;PRKACA;RCAN1
10349,GO:0043153,0.0858807334287246,0.976187898685037,4,20,entrainment of circadian clock by photoperiod,BP,CRTC1;PER3;MTA1;NR2F6
4856,GO:0014068,0.0859676922238808,0.967902758087977,6,36,positive regulation of phosphatidylinositol 3-kinase signaling,BP,F2R;FYN;FGFR1;F2RL1;RGL2;IGF2
5662,GO:0016769,0.0859809738144598,0.98196348421,3,13,transferase activity, transferring nitrogenous groups,MF,GPT2;PSAT1;GFPT1
2994,GO:0006538,0.0859891161163816,0.989936668437631,2,6,glutamate catabolic process,BP,GLUL;GLUD1
15350,GO:0071578,0.0860729019837786,0.989921124560147,2,6,zinc ion import across plasma membrane,BP,SLC30A1;SLC39A10
17083,GO:0099604,0.0863240596483214,0.976559434606193,4,17,ligand-gated calcium channel activity,MF,RASA3;PKD2;ITPR3;ITPR2
9666,GO:0038024,0.0865794697695152,0.964707532300749,7,42,cargo receptor activity,MF,SORL1;VLDLR;LRP1;ABCA7;LOXL2;AP2A2;LRP6
8116,GO:0032802,0.086680374826289,0.98175374338224,3,13,low-density lipoprotein particle receptor catabolic process,BP,VLDLR;APOE;AP2A2
3085,GO:0006658,0.086901979084044,0.975662913342327,4,21,phosphatidylserine metabolic process,BP,OSBPL10;LPCAT4;PLA2G4D;OSBPL5
11698,GO:0046486,0.0870738331089704,0.939091974841663,35,317,glycerolipid metabolic process,BP,MBOAT2;PCK2;LMF1;DGKA;EGFR;FYN;OSBPL10;TTC7B;APOE;PIGH;AGPAT4;FGFR1;LPCAT4;LPCAT1;INPP5F;PITPNM1;PLA2G4D;TMEM86B;INPP4A;CSNK2A1;CRLS1;MGLL;AGPAT3;ABHD6;OSBPL5;MTMR4;MBOAT7;SEL1L;ACP6;AGPAT1;DDHD2;PLCH2;ZFYVE21;CDS2;SLC44A1
14966,GO:0070861,0.0871641686787613,0.975867194581778,4,19,regulation of protein exit from endoplasmic reticulum,BP,EDEM1;SORL1;UBE2J1;ERLEC1
10652,GO:0043687,0.0872043437781755,0.939595605377075,33,318,post-translational protein modification,BP,IGFBP4;LTBP1;LY6K;PSMD2;LAMB1;UBXN7;CRTAP;SOCS2;APOE;DCAF10;BTRC;FAM20C;FBXO2;DDB2;OBSL1;CST3;RABGGTA;NTNG1;FBXL8;APLP2;ANO8;FBXO41;PSMD7;QSOX1;VWA1;RAB1A;LAMB2;EVA1A;WFS1;IGFBP7;DNAJC3;STT3B;FBXL5
7986,GO:0032602,0.0872534313695867,0.96394900754109,7,50,chemokine production,BP,POSTN;ALOX15B;ARG2;F2RL1;C5;EIF2AK2;FOXP1
11645,GO:0046364,0.0873165546104313,0.961365819560986,8,59,monosaccharide biosynthetic process,BP,PCK2;NR1D1;PC;PGM1;ATF4;PPARA;SLC35B4;KAT2B
14666,GO:0070266,0.0874188074693159,0.970750219597429,5,30,necroptotic process,BP,PYGL;RBCK1;SLC25A4;BOK;FADD
4972,GO:0015085,0.0875966521237572,0.957558631909668,10,63,calcium ion transmembrane transporter activity,MF,DENND5B;RASA3;PKD2;FAM155B;ITPR3;ORAI3;GRIN3B;TRPC1;ORAI1;ITPR2
13765,GO:0060341,0.0879000427104251,0.93243673861286,63,615,regulation of cellular localization,BP,EDEM1;NOS1;ZMYND8;F2R;SORL1;RAB3B;PRNP;SH3TC2;NR1D1;MAP2K1;RAPGEF3;SSH1;MAP1B;EGFR;ANK3;FYN;UBE2J1;DLG1;MAP4K4;TTBK2;MCTP1;GDI1;CEMIP;STOM;PAK1;RAC2;FKBP1A;BNIP3L;PKD2;LRP1;VAMP2;INPP5F;PFN2;SOX4;DVL1;NTSR1;NLGN2;LRP5;ABHD17C;VPS11;RIMS3;PPP3CB;CSNK2A1;CHD7;ANO1;PARP9;SEPT5;NGFR;BCL2L1;UBASH3B;MAP2K2;TRPC1;SLC30A1;TMBIM1;CCDC88A;PRKACA;EFCAB7;ERLEC1;LYPLA1;REEP6;TMEM173;GNAI1;LRP4
633,GO:0001822,0.0879869091462077,0.943815874951391,23,184,kidney development,BP,PGF;CTNNBIP1;ACTA2;ACVR2B;WWTR1;DLG1;PODXL;SDC1;ARG2;PKD2;FGFR1;EPCAM;SOX4;WNT2B;RET;LAMB2;ZNF354A;LAMA5;ALDH1A2;WFS1;ARID5B;PTCH1;LRP4
3967,GO:0008753,0.0879869439546093,1,1,1,NADPH dehydrogenase (quinone) activity,MF,CBR4
8199,GO:0032944,0.0880251428302583,0.951055339941773,14,117,regulation of mononuclear cell proliferation,BP,PRNP;PKN1;DLG1;ARG2;TGFBR2;RAC2;CD46;PRKAR1A;PDE5A;SLC39A10;CARD11;IGF2;IL20RB;FADD
3720,GO:0008238,0.0880759472287218,0.958879802066745,9,64,exopeptidase activity,MF,LTA4H;SCRN1;RNPEPL1;MMP14;NPEPL1;AEBP1;BLMH;PM20D2;CTSZ
10460,GO:0043317,0.0882475505731749,1,1,1,regulation of cytotoxic T cell degranulation,BP,CEACAM1
10461,GO:0043318,0.0882475505731749,1,1,1,negative regulation of cytotoxic T cell degranulation,BP,CEACAM1
4854,GO:0014066,0.0883148342740632,0.958816295950176,9,62,regulation of phosphatidylinositol 3-kinase signaling,BP,F2R;SERPINE2;EGFR;FYN;FGFR1;CEACAM1;F2RL1;RGL2;IGF2
1752,GO:0004352,0.0883904655623066,1,1,1,glutamate dehydrogenase (NAD+) activity,MF,GLUD1
1753,GO:0004353,0.0883904655623066,1,1,1,glutamate dehydrogenase [NAD(P)+] activity,MF,GLUD1
5601,GO:0016639,0.0883904655623066,1,1,1,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,GLUD1
6904,GO:0030479,0.0884065734189847,0.990265177896248,2,5,actin cortical patch,CC,WIPF1;WASL
14396,GO:0061645,0.0884065734189847,0.990265177896248,2,5,endocytic patch,CC,WIPF1;WASL
13036,GO:0051492,0.0884607797503601,0.958850567804857,9,59,regulation of stress fiber assembly,BP,RAPGEF3;ARAP1;PAK1;EPHA1;PFN2;FHOD1;WASF2;SH3PXD2B;LPAR1
4025,GO:0009057,0.088489807600341,0.927810537864686,106,1127,macromolecule catabolic process,BP,SMURF2;EDEM1;GID4;SORL1;VLDLR;PYGL;PYGB;H1F0;SERPINE2;BTBD2;NR1D1;HECW2;WWTR1;DDIT3;PSMD2;CAPN2;EGFR;FYN;BNIP3;UBE2J1;PGM1;ADAMTS7;CTSB;GPC4;SNX9;UBXN4;IGF2BP3;CEMIP;SDC1;TRIB2;PTPN3;CD44;APOE;BNIP3L;RBCK1;LRP1;IDE;ABTB1;UBE2G1;HYAL1;BTRC;LPCAT1;LONP2;RMND5A;FBXO2;CEACAM1;SPATA18;SH3D19;XRN1;TNRC6B;DVL1;MVB12B;ABHD17C;CTSL;CST3;TRIB3;VPS11;DNAJB9;BTBD3;CSNK2A1;PSMD7;CTBS;MVB12A;MTA1;AZIN2;RNF165;GLB1;PCYOX1;XBP1;PAIP1;ARRDC1;ANKIB1;LYPLAL1;GABARAPL2;DNASE1L1;UBE2E1;PUM2;CTSO;PRKACA;TIMP2;SEL1L;AP2A2;CTSZ;TBL1X;ERLEC1;USP20;LYPLA1;ADAM8;WFS1;ENDOG;USP32;MAGEF1;RNF180;HPSE;GALNS;TNRC6C;DEDD2;DNAJC3;CNOT11;RNF103;USP25;UFL1;KLHL15;STT3B;RB1CC1;FBXL5
14833,GO:0070570,0.0886106966296267,0.975162160026476,4,20,regulation of neuron projection regeneration,BP,MAP2K1;PTPRS;MAP4K4;INPP5F
6668,GO:0030027,0.0887915785014505,0.945253439684919,20,155,lamellipodium,CC,ACTA2;RAPGEF3;SSH1;DYSF;PARVB;PODXL;PAK1;RAC2;CD44;PKD2;FAT1;PLEK2;TWF2;WASF3;CDC42BPA;SCYL3;WASF2;NCKAP1;CCDC88A;WASL
6677,GO:0030038,0.0888730721543067,0.956636265489988,10,68,contractile actin filament bundle assembly,BP,RAPGEF3;ARAP1;PAK1;EPHA1;ITGB5;PFN2;FHOD1;WASF2;SH3PXD2B;LPAR1
10348,GO:0043149,0.0888730721543067,0.956636265489988,10,68,stress fiber assembly,BP,RAPGEF3;ARAP1;PAK1;EPHA1;ITGB5;PFN2;FHOD1;WASF2;SH3PXD2B;LPAR1
5677,GO:0016788,0.0890581260838209,0.932551666212966,56,555,hydrolase activity, acting on ester bonds,MF,NT5E;ERCC1;MAP2K1;H6PD;SSH1;PTPRS;DLG1;ACOT1;PGLS;ACOT7;RAG1;PTPN3;EDNRA;HAGH;PLPP6;ACP5;PTPN12;PPP2R3B;ABHD10;AARS;PTPDC1;INPP5F;ENDOV;XRN1;PLA2G4D;NLGN2;ABHD17C;PLPPR2;PPP3CB;ACOT13;INPP4A;DNAJC6;PLD3;ABHD15;LACTB2;MGLL;BPHL;PTPRZ1;NT5DC1;UBASH3B;ABHD6;LYPLAL1;PDE5A;MTMR4;DNASE1L1;FICD;ACP6;LYPLA1;ENDOG;DDHD2;PLCXD1;PLCH2;PPT2;GALNS;N4BP2;PPM1M
7645,GO:0032056,0.0891190669005717,0.989349656307092,2,6,positive regulation of translation in response to stress,BP,IMPACT;DNAJC3
10642,GO:0043651,0.0892540675852262,0.980741492292838,3,14,linoleic acid metabolic process,BP,ALOX15B;ELOVL1;ABCD1
3378,GO:0007155,0.0893991881417902,0.928908179387995,83,795,cell adhesion,BP,TNIP1;NT5E;ITGA6;SERPINE2;PRNP;PAG1;ITGB4;POSTN;THBS2;COL13A1;PTPRS;LAMB1;SDK2;ADGRL1;EGFR;ANK3;CGREF1;PDZD2;FYN;PCDHAC2;PARVB;DLG1;PLXNB3;PODXL;NET1;TGM2;ARG2;SHC1;WISP1;SMOC2;PAK1;RAG1;TGFBR2;EPHA1;RAC2;CLCA2;CD44;PPARA;ITGA1;EPCAM;ITGB5;HYAL1;ITGA2;FAT1;CEACAM1;FERMT1;MMP14;NLGN2;CD46;MPDZ;THBS3;CNTN1;TPBG;SLK;PRKAR1A;CD99;COL6A1;XBP1;UBASH3B;CADM4;RET;LOXL2;PDE5A;RAB1A;PCDH1;CARD11;LAMB2;AP3D1;TENM2;IGF2;LAMA5;SRPX2;SLC7A11;ADAM8;IL20RB;CLDN11;ITGA4;IGFBP7;LRP6;HPSE;OMG;HSD17B12;FADD
1614,GO:0004043,0.0894202245750537,1,1,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,ALDH7A1
3979,GO:0008802,0.0894202245750537,1,1,1,betaine-aldehyde dehydrogenase activity,MF,ALDH7A1
6093,GO:0019285,0.0894202245750537,1,1,1,glycine betaine biosynthetic process from choline,BP,ALDH7A1
7395,GO:0031455,0.0894202245750537,1,1,1,glycine betaine metabolic process,BP,ALDH7A1
7396,GO:0031456,0.0894202245750537,1,1,1,glycine betaine biosynthetic process,BP,ALDH7A1
8002,GO:0032625,0.0894266042492166,1,1,1,interleukin-21 production,BP,FOXP1
15887,GO:0072619,0.0894266042492166,1,1,1,interleukin-21 secretion,BP,FOXP1
9829,GO:0042048,0.0894478234610838,0.990082101983994,2,5,olfactory behavior,BP,CHD7;WFS1
3998,GO:0008900,0.0896494259921924,1,1,1,potassium:proton exchanging ATPase activity,MF,ATP12A
7214,GO:0031106,0.089794419676528,0.98109001276815,3,12,septin ring organization,BP,SEPT10;SEPT5;SEPT6
13751,GO:0060325,0.0899227584238272,0.970073245265364,5,26,face morphogenesis,BP,ASPH;DKK1;TBX1;LRP6;ARID5B
12577,GO:0050731,0.0900649796729958,0.951064087171197,13,103,positive regulation of peptidyl-tyrosine phosphorylation,BP,NEURL1;PRNP;FYN;ERCC6;DLG4;DLG3;CD44;PTK6;CNTN1;PARP9;IGF2;ADNP;LRP4
54,GO:0000111,0.0901048599301473,1,1,1,nucleotide-excision repair factor 2 complex,CC,XPC
11081,GO:0045081,0.0901111566913345,1,1,1,negative regulation of interleukin-10 biosynthetic process,BP,TRIB2
3251,GO:0006910,0.0902704790810164,0.989130444154887,2,6,phagocytosis, recognition,BP,PEAR1;TUB
1909,GO:0004597,0.0902871380174882,1,1,1,peptide-aspartate beta-dioxygenase activity,MF,ASPH
6054,GO:0019201,0.0903910806819948,0.97448667638255,4,20,nucleotide kinase activity,MF,DLG1;DLG4;DLG3;CARD11
16810,GO:0098656,0.090479185981323,0.944778831390597,19,152,anion transmembrane transport,BP,PRNP;SLC16A3;STK39;CLCA2;CLCN3;NTSR1;SLC35B4;TTYH3;SLC6A6;CPT2;ANO1;SLC6A14;SLC43A1;SLC12A7;PCYOX1;SLC38A2;SLC13A3;SLC7A11;SLC23A2
13124,GO:0051665,0.0905021347729613,0.988532235902307,2,7,membrane raft localization,BP,MARVELD1;MALL
13939,GO:0060603,0.0905697411767434,0.969920925721997,5,25,mammary gland duct morphogenesis,BP,ETV5;BTRC;LRP5;LRP6;PTCH1
13643,GO:0060148,0.0908757533142566,0.974301904232844,4,20,positive regulation of posttranscriptional gene silencing,BP,MAP2K1;EGFR;MAP2K2;PUM2
3948,GO:0008645,0.0910728846937507,0.955319856178564,10,69,hexose transmembrane transport,BP,PAK1;SLC2A3;EDNRA;SLC5A1;TRIB3;CLTCL1;SLC2A9;NGFR;SLC2A13;GRB10
7891,GO:0032459,0.0910759910851497,0.969152037082287,5,30,regulation of protein oligomerization,BP,SORL1;MMP1;SNX9;APOE;IDE
17459,GO:1900246,0.0911282520443129,0.989783807859823,2,5,positive regulation of RIG-I signaling pathway,BP,DDX60;PUM2
3747,GO:0008284,0.0911475569439289,0.931032469445551,55,542,positive regulation of cell proliferation,BP,F2R;ETV5;PGF;CCND1;MARCKSL1;WWTR1;MST1R;APLN;LAMB1;EGFR;DLG1;PLXNB3;TGM2;GLUL;HTRA1;WNT7A;GRK5;SHC1;PAK1;TGFBR2;EPHA1;RAC2;CCPG1;CCND2;HMGA2;FGFR1;EPCAM;HYAL1;ITGA2;SOX4;CD46;LRP5;CST3;PLAG1;CSNK2A1;PTHLH;NACC2;BCL2L1;MEF2D;XBP1;EAPP;SLC39A10;CARD11;CTSZ;HOXA3;IGF2;ALDH1A2;TBX1;AKT3;HPSE;SSR1;TET1;FOXP1;UFL1;FADD
12529,GO:0050673,0.0911756667455193,0.93828595912653,29,257,epithelial cell proliferation,BP,XDH;PGF;CCND1;IGFBP4;NR1D1;MAP2K1;APLN;LAMB1;EGFR;DLG1;PLXNB3;GLUL;HTRA1;WNT7A;APOE;FGFR1;HYAL1;BTRC;CEACAM1;FERMT1;MMP14;NGFR;XBP1;LOXL2;PPARG;ALDH1A2;TBX1;AKT3;PTCH1
545,GO:0001664,0.0911919133688296,0.947906954917811,15,124,G-protein coupled receptor binding,MF,PRNP;ITGB4;APLN;FYN;ARAP1;DLG4;WNT7A;DVL1;WNT2B;C5;USP20;CKLF;LRP6;PTCH1;GNAI1
3204,GO:0006837,0.0915916008575065,0.988876766961405,2,6,serotonin transport,BP,NOS1;SLC18A2
18107,GO:1902745,0.0916034191191609,0.974193912503519,4,19,positive regulation of lamellipodium organization,BP,RAC2;TWF2;WASF2;NCKAP1
14644,GO:0070228,0.0916273932303397,0.964932883335383,6,40,regulation of lymphocyte apoptotic process,BP,ARG2;RAG1;SLC39A10;ADAM8;FOXP1;FADD
14293,GO:0061387,0.0916718718825004,0.95330744779683,11,74,regulation of extent of cell growth,BP,MAP1B;PTPRS;SEMA4B;GDI1;PAK1;APOE;LPAR3;ULK2;TWF2;SEMA3F;ADNP
6351,GO:0021532,0.0917336495325867,0.96916784616203,5,27,neural tube patterning,BP,PRKACB;TCTN1;TMEM107;LRP6;PTCH1
15946,GO:0072755,0.0918826910782269,1,1,1,cellular response to benomyl,BP,IMPACT
17684,GO:1901561,0.0918826910782269,1,1,1,response to benomyl,BP,IMPACT
484,GO:0001534,0.0919671570860109,1,1,1,radial spoke,CC,WDR66
485,GO:0001536,0.0919671570860109,1,1,1,radial spoke stalk,CC,WDR66
2194,GO:0005057,0.0920492005453164,0.946500779841353,16,119,signal transducer activity, downstream of receptor,MF,MAP2K1;ACVR2B;MST1R;EGFR;MAPK13;MAP4K4;TGFBR2;EPHA1;RGS14;FGFR1;NLK;TAOK1;ACVR1B;IFITM1;RET;MAP4K2
7078,GO:0030866,0.0920911614049462,0.96515016343036,6,34,cortical actin cytoskeleton organization,BP,FMNL2;WIPF1;DLG1;NCKAP1;EPB41L3;WASL
3124,GO:0006703,0.0922263229700051,0.987769140891485,2,8,estrogen biosynthetic process,BP,HSD17B7;HSD17B12
3981,GO:0008808,0.09235674741764,1,1,1,cardiolipin synthase activity,MF,CRLS1
6947,GO:0030572,0.09235674741764,1,1,1,phosphatidyltransferase activity,MF,CRLS1
10471,GO:0043337,0.09235674741764,1,1,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,CRLS1
19347,GO:1905711,0.09235674741764,1,1,1,response to phosphatidylethanolamine,BP,CRLS1
19280,GO:1905477,0.0923818990987176,0.951024982189145,12,93,positive regulation of protein localization to membrane,BP,PRNP;SSH1;EGFR;ANK3;FYN;DLG1;CEMIP;STOM;PAK1;LRP1;EFCAB7;LRP4
17067,GO:0099552,0.0924103508236015,1,1,1,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,F2R
17068,GO:0099553,0.0924103508236015,1,1,1,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,F2R
17403,GO:1900134,0.0924103508236015,1,1,1,negative regulation of renin secretion into blood stream,BP,F2R
828,GO:0002114,0.0924519842590545,1,1,1,interleukin-33 receptor activity,MF,IL1RAP
9728,GO:0038172,0.0924519842590545,1,1,1,interleukin-33-mediated signaling pathway,BP,IL1RAP
18169,GO:1902931,0.0925328084629552,0.988121720056154,2,7,negative regulation of alcohol biosynthetic process,BP,CYP27B1;APOE
11787,GO:0046649,0.0926214536005337,0.932944213233559,41,392,lymphocyte activation,BP,ERCC1;PRNP;PAG1;PKN1;POU2F2;FYN;KIF13B;DLG1;ARG2;PAK1;RAG1;TGFBR2;RAC2;FKBP1A;CMTM7;SOX4;CEACAM1;MMP14;CD46;DNAJB9;PPP3CB;CEBPG;F2RL1;CHD7;PRKAR1A;SKAP2;XBP1;SATB1;PDE5A;DOCK11;SLC39A10;CARD11;AP3D1;IGF2;ADAM8;IL20RB;ITGA4;FZD8;FOXP1;SNX27;FADD
2146,GO:0004962,0.0926239191343903,1,1,1,endothelin receptor activity,MF,EDNRA
16058,GO:0086100,0.0926239191343903,1,1,1,endothelin receptor signaling pathway,BP,EDNRA
11038,GO:0045010,0.0926637604359075,0.964561740651203,6,38,actin nucleation,BP,WIPF1;JMY;SPIRE1;NCKAP1;ARPC1A;WASL
7662,GO:0032091,0.0926710088966196,0.954113878005331,10,78,negative regulation of protein binding,BP,SORL1;CTNNBIP1;NFATC4;TTBK2;DKK1;PPARA;DVL1;CTSZ;ITGA4;ADNP
5780,GO:0017002,0.0928203145202165,0.989479923506131,2,5,activin-activated receptor activity,MF,ACVR2B;ACVR1B
16838,GO:0098739,0.0928726966927062,0.961433020492325,7,43,import across plasma membrane,BP,PRNP;FYN;SLC9A7;FAM155B;NTSR1;SLC30A1;SLC39A10
15319,GO:0071528,0.0933372846309882,1,1,1,tRNA re-export from nucleus,BP,XPOT
4901,GO:0014829,0.0933722050683126,0.980002341357153,3,12,vascular smooth muscle contraction,BP,DOCK4;BBS2;EDNRA
7541,GO:0031811,0.0934814144516457,1,1,1,G-protein coupled nucleotide receptor binding,MF,DLG4
7542,GO:0031812,0.0934814144516457,1,1,1,P2Y1 nucleotide receptor binding,MF,DLG4
15472,GO:0071813,0.0935181783900966,0.979957544534554,3,12,lipoprotein particle binding,MF,SORL1;VLDLR;APOE
15473,GO:0071814,0.0935181783900966,0.979957544534554,3,12,protein-lipid complex binding,MF,SORL1;VLDLR;APOE
20108,GO:2000780,0.0936407737537169,0.973415407434868,4,19,negative regulation of double-strand break repair,BP,HMGA2;RNF169;MAGEF1;KLHL15
8086,GO:0032768,0.0936858454246261,0.963997990894574,6,39,regulation of monooxygenase activity,BP,CYGB;CYP27B1;EGFR;APOE;LYPLA1;WASL
5432,GO:0016290,0.0937342864461861,0.987450946811444,2,8,palmitoyl-CoA hydrolase activity,MF,ACOT1;ACOT7
1602,GO:0004021,0.093761810688624,1,1,1,L-alanine:2-oxoglutarate aminotransferase activity,MF,GPT2
2980,GO:0006522,0.093761810688624,1,1,1,alanine metabolic process,BP,GPT2
2981,GO:0006524,0.093761810688624,1,1,1,alanine catabolic process,BP,GPT2
4042,GO:0009078,0.093761810688624,1,1,1,pyruvate family amino acid metabolic process,BP,GPT2
4043,GO:0009080,0.093761810688624,1,1,1,pyruvate family amino acid catabolic process,BP,GPT2
10218,GO:0042851,0.093761810688624,1,1,1,L-alanine metabolic process,BP,GPT2
10219,GO:0042853,0.093761810688624,1,1,1,L-alanine catabolic process,BP,GPT2
12024,GO:0047635,0.093761810688624,1,1,1,alanine-oxo-acid transaminase activity,MF,GPT2
19470,GO:1990175,0.0938641039968675,1,1,1,EH domain binding,MF,EPN3
3040,GO:0006591,0.0939381324154832,0.987834324895065,2,7,ornithine metabolic process,BP,ARG2;AZIN2
14189,GO:0061088,0.094018629401511,0.988404762239335,2,6,regulation of sequestering of zinc ion,BP,SLC30A1;AP3D1
6594,GO:0022610,0.0940642298089134,0.924968285196644,83,798,biological adhesion,BP,TNIP1;NT5E;ITGA6;SERPINE2;PRNP;PAG1;ITGB4;POSTN;THBS2;COL13A1;PTPRS;LAMB1;SDK2;ADGRL1;EGFR;ANK3;CGREF1;PDZD2;FYN;PCDHAC2;PARVB;DLG1;PLXNB3;PODXL;NET1;TGM2;ARG2;SHC1;WISP1;SMOC2;PAK1;RAG1;TGFBR2;EPHA1;RAC2;CLCA2;CD44;PPARA;ITGA1;EPCAM;ITGB5;HYAL1;ITGA2;FAT1;CEACAM1;FERMT1;MMP14;NLGN2;CD46;MPDZ;THBS3;CNTN1;TPBG;SLK;PRKAR1A;CD99;COL6A1;XBP1;UBASH3B;CADM4;RET;LOXL2;PDE5A;RAB1A;PCDH1;CARD11;LAMB2;AP3D1;TENM2;IGF2;LAMA5;SRPX2;SLC7A11;ADAM8;IL20RB;CLDN11;ITGA4;IGFBP7;LRP6;HPSE;OMG;HSD17B12;FADD
1258,GO:0003012,0.0941011116442085,0.937619083049237,26,221,muscle system process,BP,DOCK4;NOS1;F2R;ACTA2;BBS2;DYSF;DLG1;HTR7;ASPH;ARG2;PAK1;EDNRA;FKBP1A;ITGA1;TMOD2;ITGB5;ITGA2;INPP5F;GAMT;OBSL1;ANXA6;MYOF;PDE5A;PRKACA;LTB4R;JARID2
11964,GO:0047159,0.0941125181985507,1,1,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,LPCAT1
11969,GO:0047191,0.0941125181985507,1,1,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,LPCAT1
20278,GO:2001246,0.0941125181985507,1,1,1,negative regulation of phosphatidylcholine biosynthetic process,BP,LPCAT1
9287,GO:0035725,0.0942441051881812,0.951722048188588,11,75,sodium ion transmembrane transport,BP,NOS1;SCN8A;HECW2;STK39;ANK3;DLG1;SLC9A7;STOM;PTPN3;PKD2;ATP12A
11438,GO:0045869,0.0942729251231089,0.987765461625922,2,7,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C
4622,GO:0010742,0.0945003516307222,0.972908193174027,4,20,macrophage derived foam cell differentiation,BP,ALOX15B;PPARA;ABCG1;PPARG
16099,GO:0090077,0.0945003516307222,0.972908193174027,4,20,foam cell differentiation,BP,ALOX15B;PPARA;ABCG1;PPARG
4971,GO:0015081,0.0947695798746375,0.953258904219006,10,66,sodium ion transmembrane transporter activity,MF,SCN8A;SLC9A7;PKD2;SLC5A1;SLC6A6;SLC6A14;SLC13A3;SLC10A6;ATP12A;SLC23A2
10157,GO:0042737,0.0947751620512156,0.954796675971337,9,73,drug catabolic process,BP,NT5E;NOS1;PCK2;GPX3;IDE;PRDX5;CTBS;NPL;PM20D2
2010,GO:0004736,0.0948651592941809,1,1,1,pyruvate carboxylase activity,MF,PC
7041,GO:0030814,0.0950711053996029,0.967585801634148,5,28,regulation of cAMP metabolic process,BP,RAPGEF3;PKD2;AKAP9;PTHLH;TIMP2
11391,GO:0045766,0.0952296813594159,0.947885357997408,13,98,positive regulation of angiogenesis,BP,PGF;ADM2;RAPGEF3;TGFBR2;EPHA1;ANGPTL4;ANXA3;HMGA2;HYAL1;XBP1;C5;SRPX2;AKT3
5092,GO:0015362,0.0953288195390355,1,1,1,high-affinity sodium:dicarboxylate symporter activity,MF,SLC13A3
2644,GO:0005980,0.0955310664439851,0.97268723055281,4,19,glycogen catabolic process,BP,PYGL;PYGB;PGM1;RB1CC1
14855,GO:0070615,0.0955570928224811,1,1,1,nucleosome-dependent ATPase activity,MF,SMARCA1
16329,GO:0090537,0.0955570928224811,1,1,1,CERF complex,CC,SMARCA1
14524,GO:0070011,0.095560975261293,0.931824328042897,37,356,peptidase activity, acting on L-amino acid peptides,MF,PLAT;ADAM19;MMP1;PRSS3;PSMD2;LTA4H;CAPN2;TMPRSS11D;ADAMTS7;CTSB;TYSND1;HTRA1;SCRN1;CLCA2;IDE;RNPEPL1;LONP2;MMP14;CTSL;NPEPL1;CASP4;PCSK6;AEBP1;OTUB2;BLMH;PM20D2;ZFYVE9;CTSO;CTSZ;MMP10;USP20;ADAM8;OSGEPL1;USP32;PRSS8;PSEN2;USP25
13095,GO:0051606,0.0955851232547573,0.946195625811032,14,115,detection of stimulus,BP,SERPINE2;DENND5B;FYN;PKD2;HMGA2;ITGA2;ABCG1;SOX4;PITPNM1;NTSR1;ANO1;NR2F6;REEP6;ELOVL4
4847,GO:0014054,0.0960221916663892,1,1,1,positive regulation of gamma-aminobutyric acid secretion,BP,NTSR1
5522,GO:0016492,0.0960221916663892,1,1,1,G-protein coupled neurotensin receptor activity,MF,NTSR1
13687,GO:0060228,0.0961296744027159,0.997574073668791,1,2,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,APOE
10583,GO:0043546,0.0961574211476491,0.987982430995642,2,6,molybdopterin cofactor binding,MF,XDH;AOX1
19728,GO:2000096,0.0962021775658459,0.987973529649402,2,6,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,DKK1;ANKRD6
12390,GO:0048813,0.0962111061996624,0.946054328063732,14,101,dendrite morphogenesis,BP,VLDLR;HECW2;NFATC4;FYN;DLG4;WNT7A;SHANK2;OBSL1;DVL1;MAP6;BTBD3;WASL;EEF2K;LRP4
1102,GO:0002691,0.0963801357687196,0.978765390360442,3,13,regulation of cellular extravasation,BP,ADAM8;ITGA4;FADD
4504,GO:0010543,0.0964857924894752,0.971973611521702,4,21,regulation of platelet activation,BP,SERPINE2;APOE;CEACAM1;UBASH3B
13545,GO:0060005,0.0965129751720712,1,1,1,vestibular reflex,BP,SLITRK6
13546,GO:0060007,0.0965129751720712,1,1,1,linear vestibuloocular reflex,BP,SLITRK6
10323,GO:0043112,0.0966720124462777,0.943235026993311,16,130,receptor metabolic process,BP,VLDLR;NR1D1;APLN;ARAP1;DLG4;DKK1;APOE;LRP1;PPARA;INPP5F;CEACAM1;RAB31;ATXN2;AP2A2;PPARG;TBC1D16
4633,GO:0010755,0.0968381577641331,0.987232774602328,2,7,regulation of plasminogen activation,BP,SERPINE2;CTSZ
18580,GO:1903825,0.0968643269716451,0.950005414649897,11,79,organic acid transmembrane transport,BP,SLC16A3;STK39;NTSR1;SLC6A6;CPT2;SLC6A14;SLC43A1;SLC38A2;SLC13A3;SLC7A11;SLC23A2
19108,GO:1905039,0.0968643269716451,0.950005414649897,11,79,carboxylic acid transmembrane transport,BP,SLC16A3;STK39;NTSR1;SLC6A6;CPT2;SLC6A14;SLC43A1;SLC38A2;SLC13A3;SLC7A11;SLC23A2
829,GO:0002115,0.0969948000410929,0.978571098117177,3,13,store-operated calcium entry,BP,SARAF;ORAI3;ORAI1
8962,GO:0035025,0.097032405744645,0.978559192356685,3,13,positive regulation of Rho protein signal transduction,BP,F2R;F2RL1;LPAR1
14192,GO:0061097,0.097308241281462,0.956032367901766,8,56,regulation of protein tyrosine kinase activity,BP,NEURL1;PRNP;ERCC6;DLG4;SHC1;DLG3;PTK6;SNX6
7427,GO:0031528,0.097494621253486,0.978412680732503,3,13,microvillus membrane,CC,PODXL;CEACAM1;SYTL1
448,GO:0001221,0.0975347455706964,0.962427574551499,6,35,transcription cofactor binding,MF,NR1D1;PPARA;PHF12;CHD6;PER3;NEK6
12736,GO:0050999,0.0976899918591337,0.966207879156372,5,30,regulation of nitric-oxide synthase activity,BP,CYGB;EGFR;APOE;LYPLA1;WASL
9273,GO:0035695,0.0977784203594709,1,1,1,mitophagy by induced vacuole formation,BP,SPATA18
10064,GO:0042554,0.0979484410541705,0.977778028417411,3,15,superoxide anion generation,BP,EGFR;ACP5;F2RL1
8512,GO:0033690,0.0982573065254552,0.987561996522893,2,6,positive regulation of osteoblast proliferation,BP,LRP5;HPSE
1754,GO:0004356,0.0983232035349355,1,1,1,glutamate-ammonia ligase activity,MF,GLUL
2997,GO:0006542,0.0983232035349355,1,1,1,glutamine biosynthetic process,BP,GLUL
5386,GO:0016211,0.0983232035349355,1,1,1,ammonia ligase activity,MF,GLUL
6198,GO:0019676,0.0983232035349355,1,1,1,ammonia assimilation cycle,BP,GLUL
3431,GO:0007219,0.0983623768388411,0.942125850181431,16,128,Notch signaling pathway,BP,NEURL1;PEAR1;POSTN;EGFR;TSPAN5;TGFBR2;CHAC1;EPN2;MMP14;CD46;CNTN1;ARRDC1;SEL1L;MAML3;PSEN2;KAT2B
13519,GO:0055090,0.0986254064941603,0.977785901188629,3,14,acylglycerol homeostasis,BP,APOE;ANGPTL4;XBP1
14704,GO:0070328,0.0986254064941603,0.977785901188629,3,14,triglyceride homeostasis,BP,APOE;ANGPTL4;XBP1
16482,GO:0097164,0.0988005765254139,0.942771917937637,15,131,ammonium ion metabolic process,BP,MBOAT2;SPTLC2;CBR4;LPCAT4;LPCAT1;KDSR;PLA2G4D;TMEM86B;ALDH7A1;CSNK2A1;AZIN2;CRAT;SAMD8;RNF180;SLC44A1
5235,GO:0015851,0.0989398316737449,0.986789722924169,2,7,nucleobase transport,BP,SLC25A4;SLC23A2
4420,GO:0010224,0.0991220567882506,0.977625463984888,3,14,response to UV-B,BP,ERCC6;XPC;HYAL1
6376,GO:0021561,0.0991374501218766,0.987384077990297,2,6,facial nerve development,BP,ADARB1;SEMA3F
6399,GO:0021610,0.0991374501218766,0.987384077990297,2,6,facial nerve morphogenesis,BP,ADARB1;SEMA3F
6900,GO:0030449,0.099183417580731,0.977605615866574,3,14,regulation of complement activation,BP,SERPING1;CD46;C5
19808,GO:2000257,0.099183417580731,0.977605615866574,3,14,regulation of protein activation cascade,BP,SERPING1;CD46;C5
15383,GO:0071625,0.0993355469243464,0.978531736041214,3,11,vocalization behavior,BP,DLG4;SHANK2;SRPX2
604,GO:0001772,0.0994000338041646,0.970991284300933,4,20,immunological synapse,CC,DLG1;PRKAR1A;CARD11;SNX27
16559,GO:0097338,0.0994147165524531,1,1,1,response to clozapine,BP,PRKACB
1098,GO:0002687,0.099423568738396,0.952170787306045,9,71,positive regulation of leukocyte migration,BP,PGF;RAC2;ITGA2;MMP14;MOSPD2;F2RL1;ADAM8;ITGA4;FADD
958,GO:0002380,0.0995285286547257,1,1,1,immunoglobulin secretion involved in immune response,BP,POU2F2
5283,GO:0015936,0.0996279520452503,0.977230538691451,3,15,coenzyme A metabolic process,BP,ACOT7;PANK4;PANK1
10304,GO:0043067,0.0996408208562115,0.918277046226281,105,1110,regulation of programmed cell death,BP,XDH;F2R;NEURL1;ITGA6;RPS6KA2;PRNP;NFATC4;MAP2K1;MST1R;TNFSF15;DDIT3;EGFR;STK39;FYN;TNFRSF6B;BNIP3;CTSB;NET1;TGM2;GLO1;WNT7A;MAP4K4;GRK5;STRADB;NME4;ARG2;SHC1;DKK1;DAP;PAK1;SOCS2;RAG1;EPHA1;CD44;OBSCN;APOE;BNIP3L;CCND2;ANGPTL4;RBCK1;LRP1;LDHA;HMGA2;ATF4;ASNS;FGFR1;ITGA1;AARS;SOX4;NTSR1;CTH;LRP5;CST3;RABGGTA;CASP4;SLK;PRDX5;TAOK1;CSNK2A1;SLC25A4;JMY;BOK;CPEB4;NACC2;SPRY2;THRA;NGFR;PPP1R10;MARK4;BCL2L1;ARF4;XBP1;MAP2K2;RET;BEX2;PAK6;TMBIM1;RGL2;EIF2AK2;SLC39A10;CARD11;LPAR1;CTSZ;IGF2;MOAP1;MAP4K2;PPARG;ALDH1A2;TBX1;ADAM8;WFS1;ENDOG;LRP6;EEF2K;SIGMAR1;TRIM2;DEDD2;DNAJC3;FOXP1;PSEN2;UFL1;FAM162A;ADNP;RB1CC1;FADD
8220,GO:0032977,0.0997455856136215,1,1,1,membrane insertase activity,MF,COX18
8221,GO:0032978,0.0997455856136215,1,1,1,protein insertion into membrane from inner side,BP,COX18
8222,GO:0032979,0.0997455856136215,1,1,1,protein insertion into mitochondrial membrane from inner side,BP,COX18
18778,GO:1904290,0.0998231492756165,1,1,1,negative regulation of mitotic DNA damage checkpoint,BP,PPP1R10
8602,GO:0034110,0.0998604807542645,0.970639874331154,4,21,regulation of homotypic cell-cell adhesion,BP,SERPINE2;ANK3;CEACAM1;UBASH3B
12662,GO:0050866,0.099881284250381,0.9447601300858,13,105,negative regulation of cell activation,BP,CYGB;SERPINE2;PRNP;PAG1;PKN1;DLG1;ARG2;APOE;CEACAM1;PRKAR1A;UBASH3B;PDE5A;IL20RB
14834,GO:0070571,0.09990130730088,0.977644554529213,3,13,negative regulation of neuron projection regeneration,BP,PTPRS;MAP4K4;INPP5F
9963,GO:0042340,0.0999274360062125,0.986579475517774,2,7,keratan sulfate catabolic process,BP,GLB1;GALNS
15144,GO:0071243,0.100248354464873,0.976825846437982,3,16,cellular response to arsenic-containing substance,BP,MAPK13;ATF4;UROS
15970,GO:0080025,0.100467338503754,0.970568775424482,4,20,phosphatidylinositol-3,5-bisphosphate binding,MF,SNX14;PLEK2;SH3PXD2B;ACAP2
12084,GO:0048037,0.100581372654781,0.928544773179521,35,354,cofactor binding,MF,XDH;NOS1;PYGL;CBS;CYGB;CYP27B1;PYGB;CRYL1;GPT2;NR1D1;H6PD;DHTKD1;PC;HADH;HEBP1;IDH2;SPTLC2;ACOT7;RSAD1;ACAD11;CBR4;LDHA;ASNS;UROS;MTHFR;ACAD10;CTH;HIBADH;GLUD1;NUDT6;NFU1;TXNRD3;CYP4F22;AOX1;ALAS1
548,GO:0001667,0.100723980836147,0.930222412323528,31,271,ameboidal-type cell migration,BP,SMURF2;CYGB;PRSS3;PKN1;SEMA4B;WNT7A;PAK1;TGFBR2;APOE;ANXA3;FGFR1;HYAL1;ITGA2;PFN2;CEACAM1;FERMT1;LRP5;ACVR1B;WASF2;RET;LOXL2;TMSB4X;LAMA5;PPARG;SRPX2;TBX1;AKT3;ITGA4;ARID5B;FOXP1;SEMA3F
16455,GO:0097116,0.100755591196749,1,1,1,gephyrin clustering involved in postsynaptic density assembly,BP,NLGN2
1017,GO:0002514,0.100935288941832,1,1,1,B cell tolerance induction,BP,TGFBR2
1076,GO:0002649,0.100935288941832,1,1,1,regulation of tolerance induction to self antigen,BP,TGFBR2
1077,GO:0002651,0.100935288941832,1,1,1,positive regulation of tolerance induction to self antigen,BP,TGFBR2
1079,GO:0002661,0.100935288941832,1,1,1,regulation of B cell tolerance induction,BP,TGFBR2
1080,GO:0002663,0.100935288941832,1,1,1,positive regulation of B cell tolerance induction,BP,TGFBR2
2179,GO:0005026,0.100935288941832,1,1,1,transforming growth factor beta receptor activity, type II,MF,TGFBR2
19209,GO:1905317,0.100935288941832,1,1,1,inferior endocardial cushion morphogenesis,BP,TGFBR2
6687,GO:0030055,0.100985509628631,0.927277930319767,38,360,cell-substrate junction,CC,FHL1;FLNC;ITGA6;ITGB4;MAP2K1;SH3KBP1;MPRIP;ARHGAP22;SNTB2;CAPN2;EGFR;PARVB;TGM2;PAK1;MRC2;RAC2;CD44;PTPN12;AFAP1;LRP1;ITGA1;ITGB5;ITGA2;FAT1;FERMT1;BSG;SLC9A3R2;MMP14;ANXA6;CD46;PROCR;CD99;MAP2K2;NCKAP1;GRB7;ITGA4;FLNB;ZFYVE21
4726,GO:0010888,0.101192142752835,0.977228947798275,3,13,negative regulation of lipid storage,BP,PPARA;ABCG1;PPARG
1632,GO:0004074,0.101239565128944,0.997301865649131,1,2,biliverdin reductase activity,MF,BLVRA
15440,GO:0071713,0.101281871190078,1,1,1,para-aminobenzoyl-glutamate hydrolase activity,MF,PM20D2
17573,GO:1901185,0.101430696734004,0.956654990006121,7,48,negative regulation of ERBB signaling pathway,BP,SH3KBP1;EGFR;PTPN3;PTPN12;ITGA1;SPRY2;SNX6
5605,GO:0016646,0.10150608714924,0.976850087021567,3,14,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,ALDH1L2;MTHFR;ALDH4A1
3550,GO:0007584,0.101537956972888,0.938812461363626,17,145,response to nutrient,BP,ERCC1;CCND1;CYP27B1;POSTN;SSH1;EGFR;FYN;TGFBR2;LDHA;ITGA2;MTHFR;XBP1;ZNF354A;PPARG;ALDH1A2;UFL1;DNMT3A
9636,GO:0036503,0.101641708943551,0.946876450273078,11,86,ERAD pathway,BP,EDEM1;UBE2J1;UBXN4;FBXO2;DNAJB9;SEL1L;ERLEC1;WFS1;RNF103;USP25;STT3B
6290,GO:0019900,0.101761963259876,0.921332270492834,61,585,kinase binding,MF,TNIP1;DOCK4;FAM83A;CCND1;PAG1;ACTA2;PKN1;MST1R;MICALCL;EXOC2;BRSK1;EGFR;TBC1D14;STK39;KIF13B;DLG1;DLG4;GRK5;SHC1;DLG3;PAK1;TRIB2;NEK9;TGFBR2;EPHA1;RAC2;CCND2;RGS14;LDHA;ATF4;WWC3;FGFR1;PITPNM1;CEACAM1;MAPKAPK3;TRIM5;DVL1;TWF2;TRIB3;TOM1L2;PRKAR1A;SPRY2;PER3;BCL2L1;SLC12A7;RET;CCDC88A;SHC2;PRKACA;NEK6;RHOBTB1;AP2A2;IL1RAP;PJA2;MAP4K2;GRB7;TMEM173;DNAJC3;KAT2B;LRP4;RB1CC1
9048,GO:0035264,0.101804916458903,0.942334601858907,14,104,multicellular organism growth,BP,ERCC1;BBS2;ADARB1;WWTR1;ERCC6;SOCS2;SLITRK6;ATRX;GAMT;PLAG1;CHD7;SH3PXD2B;ARID5B;PTCH1
14313,GO:0061450,0.101833655938858,0.985687772170738,2,8,trophoblast cell migration,BP,SMURF2;ACVR1B
17568,GO:1901163,0.101833655938858,0.985687772170738,2,8,regulation of trophoblast cell migration,BP,SMURF2;ACVR1B
2175,GO:0005011,0.101872260939713,1,1,1,macrophage colony-stimulating factor receptor activity,MF,MST1R
10078,GO:0042577,0.102054779316256,0.986122155509777,2,7,lipid phosphatase activity,MF,PLPP6;PLPPR2
509,GO:0001572,0.102126606032223,1,1,1,lactosylceramide biosynthetic process,BP,B4GALT6
11694,GO:0046478,0.102126606032223,1,1,1,lactosylceramide metabolic process,BP,B4GALT6
3136,GO:0006726,0.102203049841318,1,1,1,eye pigment biosynthetic process,BP,AP3D1
5373,GO:0016182,0.102203049841318,1,1,1,synaptic vesicle budding from endosome,BP,AP3D1
10015,GO:0042441,0.102203049841318,1,1,1,eye pigment metabolic process,BP,AP3D1
10465,GO:0043324,0.102203049841318,1,1,1,pigment metabolic process involved in developmental pigmentation,BP,AP3D1
10534,GO:0043474,0.102203049841318,1,1,1,pigment metabolic process involved in pigmentation,BP,AP3D1
16889,GO:0098830,0.102203049841318,1,1,1,presynaptic endosome,CC,AP3D1
10774,GO:0044220,0.102301996389764,1,1,1,host cell perinuclear region of cytoplasm,CC,LMAN1
9834,GO:0042059,0.102398414731742,0.95970323480161,6,39,negative regulation of epidermal growth factor receptor signaling pathway,BP,SH3KBP1;EGFR;PTPN3;ITGA1;SPRY2;SNX6
15697,GO:0072224,0.10240043413291,0.986715763638423,2,6,metanephric glomerulus development,BP,RET;LAMB2
20095,GO:2000759,0.102543522023077,1,1,1,regulation of N-terminal peptidyl-lysine acetylation,BP,SOX4
20096,GO:2000761,0.102543522023077,1,1,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,SOX4
7397,GO:0031460,0.102707929839745,1,1,1,glycine betaine transport,BP,SLC38A2
3523,GO:0007497,0.10275625431227,1,1,1,posterior midgut development,BP,RET
4034,GO:0009066,0.102827727470711,0.959417029292745,6,40,aspartate family amino acid metabolic process,BP,ASNS;MTHFR;AHCYL2;CTH;ALDH7A1;NIT2
5270,GO:0015918,0.103063122950111,0.952879124863627,8,55,sterol transport,BP,APOE;LRP1;ABCA7;ABCG1;OSBPL5;PPARG;LRP6;PTCH1
6380,GO:0021566,0.103084100166479,1,1,1,hypoglossal nerve development,BP,ADARB1
6402,GO:0021618,0.103084100166479,1,1,1,hypoglossal nerve morphogenesis,BP,ADARB1
16891,GO:0098833,0.103127912988014,1,1,1,presynaptic endocytic zone,CC,FCHO2
16892,GO:0098835,0.103127912988014,1,1,1,presynaptic endocytic zone membrane,CC,FCHO2
1608,GO:0004031,0.103200732422707,1,1,1,aldehyde oxidase activity,MF,AOX1
5594,GO:0016623,0.103200732422707,1,1,1,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,AOX1
17172,GO:0102797,0.103200732422707,1,1,1,geranial:oxygen oxidoreductase activity,MF,AOX1
17173,GO:0102798,0.103200732422707,1,1,1,heptaldehyde:oxygen oxidoreductase activity,MF,AOX1
6676,GO:0030037,0.103302260349375,1,1,1,actin filament reorganization involved in cell cycle,BP,ARAP1
9790,GO:0040008,0.103339906704768,0.922861399921421,47,447,regulation of growth,BP,FHL1;CYP27B1;SERPINE2;IGFBP4;BBS2;ALOX15B;DCBLD2;MAP1B;PTPRS;EGFR;SEMA4B;NET1;HTRA1;GDI1;SHC1;WISP1;PAK1;SOCS2;TGFBR2;APOE;HMGA2;WWC3;LPAR3;FGFR1;HYAL1;PTK6;ULK2;LTBP4;KIAA1109;GAMT;CEACAM1;MT2A;MMP14;TWF2;CSNK2A1;CHD7;ACVR1B;SH3PXD2B;EPB41L3;PPARG;WFS1;IGFBP7;SYT2;PTCH1;JARID2;SEMA3F;ADNP
18553,GO:1903764,0.103632499567381,1,1,1,regulation of potassium ion export across plasma membrane,BP,DLG1
11556,GO:0046092,0.103855782039334,1,1,1,deoxycytidine metabolic process,BP,TK2
1294,GO:0003127,0.103943765355742,1,1,1,detection of nodal flow,BP,PKD2
15283,GO:0071464,0.103943765355742,1,1,1,cellular response to hydrostatic pressure,BP,PKD2
15587,GO:0072055,0.103943765355742,1,1,1,renal cortex development,BP,PKD2
15588,GO:0072059,0.103943765355742,1,1,1,cortical collecting duct development,BP,PKD2
15674,GO:0072194,0.103943765355742,1,1,1,kidney smooth muscle tissue development,BP,PKD2
15685,GO:0072208,0.103943765355742,1,1,1,metanephric smooth muscle tissue development,BP,PKD2
15689,GO:0072214,0.103943765355742,1,1,1,metanephric cortex development,BP,PKD2
15694,GO:0072219,0.103943765355742,1,1,1,metanephric cortical collecting duct development,BP,PKD2
18808,GO:1904375,0.103955008811723,0.947528784356384,10,73,regulation of protein localization to cell periphery,BP,PRNP;EGFR;DLG1;LRP1;CSNK2A1;BCL2L1;TMBIM1;EFCAB7;LYPLA1;GNAI1
4686,GO:0010835,0.104003018555746,0.985698040611757,2,7,regulation of protein ADP-ribosylation,BP,KAT2B;ADNP
13843,GO:0060443,0.104136358624507,0.959169645967968,6,35,mammary gland morphogenesis,BP,ETV5;TGFBR2;BTRC;LRP5;LRP6;PTCH1
7995,GO:0032613,0.104137715470862,0.968486298032616,4,24,interleukin-10 production,BP,TRIB2;CD46;F2RL1;IL20RB
12241,GO:0048513,0.104263638530376,0.910050636607178,201,2135,animal organ development,BP,FHL1;XDH;SMURF2;ERCC1;ADAM19;ETV5;PGF;CCND1;NEURL1;PCK2;CTNNBIP1;VLDLR;ITGA6;CYP27B1;SERPINE2;ITGB4;ACTA2;BBS2;NFATC4;ADARB1;MAP2K1;FAM210B;ACVR2B;LTBP1;ALOX15B;SALL2;COL13A1;PKN1;WWTR1;APLN;POU2F2;DHTKD1;PTPRS;SMARCA1;SOX12;PSMD2;LAMB1;SDK2;SNPH;EGFR;SEMA4B;FYN;MYH15;BNIP3;ADAMTS7;ZNF516;DLG1;CTSB;GPC4;PODXL;TGM2;HTRA1;GLO1;WNT7A;TTBK2;SDC1;ARG2;SHC1;DKK1;PAK1;SOCS2;RAG1;TGFBR2;PTPN3;EDNRA;SHANK2;SLITRK6;CD44;FKBP1A;ATP7B;ACP5;PKD2;LRP1;LDHA;RAB11FIP4;ANXA3;HMGA2;PPARA;ASNS;FGFR1;AARS;E2F5;EPCAM;TUB;CMTM7;TACC1;SMOC1;HYAL1;BTRC;LPCAT1;ITGA2;ATRX;FAM20C;SOX4;PITPNM1;GAMT;CEP120;CEACAM1;FERMT1;OBSL1;PRR9;BSG;MDFI;TNRC6B;DVL1;MMP14;CD46;EPOR;LRP5;THBS3;CTSL;CST3;CNTN1;PCSK6;L3MBTL3;DNAJB9;BTBD3;SEC63;PPP3CB;MEX3C;CEBPG;PLAG1;TTC9;F2RL1;AEBP1;CSNK2A1;PSMD7;PTHLH;CHD7;PRKAR1A;BOK;SPRY2;THRA;WNT2B;ACVR1B;PSKH1;GLUD1;TSHZ1;PTPRZ1;BCL2L1;MEF2D;WASF2;ARF4;XBP1;UBASH3B;SATB1;REC8;SLC38A2;RET;LOXL2;TCTN1;SH3PXD2B;MBOAT7;DOCK11;ETV1;COL1A2;EIF2AK2;IFI16;AP2A2;CARD11;LAMB2;LPAR1;ZNF354A;CTSZ;HOXA3;AP3D1;ARID4A;IGF2;LAMA5;PPARG;PPL;ALDH1A2;TBX1;SLC7A11;CREB3L2;ADAM8;AKT3;WFS1;ITGA4;ZBTB40;WDR60;ZNF568;FZD8;PRSS8;FLNB;LRP6;ARID5B;E2F7;HPSE;TNRC6C;FOXP1;PTCH1;ADCY1;KAT2B;ANKRD6;PBX3;JARID2;SEMA3F;LRP4;RB1CC1;FADD
5640,GO:0016725,0.104470695659732,0.986284656248451,2,6,oxidoreductase activity, acting on CH or CH2 groups,MF,XDH;AOX1
19997,GO:2000601,0.104576835794474,0.986262406205866,2,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,NCKAP1;WASL
13226,GO:0051886,0.104601580995593,1,1,1,negative regulation of timing of anagen,BP,FERMT1
20251,GO:2001203,0.104601580995593,1,1,1,positive regulation of transforming growth factor-beta secretion,BP,FERMT1
712,GO:0001937,0.104626534428433,0.968905655961511,4,20,negative regulation of endothelial cell proliferation,BP,XDH;APOE;NGFR;PPARG
10776,GO:0044224,0.104791902130082,0.986217278007935,2,6,juxtaparanode region of axon,CC,DLG4;EPB41L3
3093,GO:0006666,0.104886692836343,1,1,1,3-keto-sphinganine metabolic process,BP,KDSR
12016,GO:0047560,0.104886692836343,1,1,1,3-dehydrosphinganine reductase activity,MF,KDSR
2295,GO:0005254,0.1048883439478,0.963037090925336,5,29,chloride channel activity,MF,CLCA2;CLCN3;TTYH3;ANO8;ANO1
7468,GO:0031626,0.104893441321767,1,1,1,beta-endorphin binding,MF,IDE
9072,GO:0035308,0.10494637114283,0.958425986280327,6,39,negative regulation of protein dephosphorylation,BP,PPP1R14A;FKBP1A;ELFN2;PPP1R35;PPP1R10;PPP1R2
8804,GO:0034505,0.104953132645505,0.976348002242116,3,12,tooth mineralization,BP,PPARA;FAM20C;TBX1
14132,GO:0060998,0.105031574915608,0.951991711315721,8,51,regulation of dendritic spine development,BP,ZMYND8;NEURL1;PTPRS;SHANK2;APOE;ASAP1;LPAR1;EEF2K
12709,GO:0050927,0.105136257568002,0.975652878871249,3,14,positive regulation of positive chemotaxis,BP,PGF;ITGA2;F2RL1
17238,GO:0110053,0.105507239803509,0.93174187099062,22,188,regulation of actin filament organization,BP,RAPGEF3;SSH1;WIPF1;ARAP1;DLG1;PAK1;EPHA1;RAC2;TMOD2;PFN2;FHOD1;TWF2;F2RL1;JMY;WASF2;SPIRE1;SH3PXD2B;NCKAP1;TMSB4X;LPAR1;ARPC1A;WASL
19829,GO:2000297,0.105562888497014,1,1,1,negative regulation of synapse maturation,BP,NFATC4
5521,GO:0016491,0.105615573179167,0.920613171370928,48,529,oxidoreductase activity,MF,XDH;NOS1;CBS;CYGB;CYP27B1;CRYL1;ALOX15B;GPX3;H6PD;DHTKD1;HADH;LOXL1;IDH2;RSAD1;RDH14;ASPH;ACAD11;CBR4;ERO1B;ALDH1L2;LDHA;MTHFR;KDSR;PDIA5;ACAD10;HIBADH;PRDX5;ALDH7A1;QSOX1;NDUFV3;MSRB2;DHRS12;NDUFA4L2;GLUD1;HSD17B7;PCYOX1;TXNRD3;CYP4F22;SDR9C7;LOXL2;SRD5A3;BLVRA;PTGR2;ALDH1A2;ALDH4A1;TET1;AOX1;HSD17B12
8192,GO:0032930,0.105744437659245,0.984804106610052,2,8,positive regulation of superoxide anion generation,BP,EGFR;F2RL1
18492,GO:1903613,0.105870482278494,1,1,1,regulation of protein tyrosine phosphatase activity,BP,SLC39A10
18493,GO:1903615,0.105870482278494,1,1,1,positive regulation of protein tyrosine phosphatase activity,BP,SLC39A10
10725,GO:0044060,0.10588328622877,0.968215969413103,4,21,regulation of endocrine process,BP,F2R;APLN;FGFR1;F2RL1
8008,GO:0032637,0.105900729278687,0.957800971215845,6,41,interleukin-8 production,BP,F2R;DDIT3;F2RL1;TMSB4X;RAB1A;FADD
4047,GO:0009084,0.105950587615609,0.975381597684558,3,14,glutamine family amino acid biosynthetic process,BP,GLUL;NAGS;GLUD1
3908,GO:0008555,0.106042531637981,1,1,1,chloride-transporting ATPase activity,MF,PCYOX1
2296,GO:0005261,0.1060459876083,0.939538017181675,14,104,cation channel activity,MF,SCN8A;KCNG1;DENND5B;RASA3;PKD2;FAM155B;ITPR3;ORAI3;ANO1;GRIN3B;TRPC1;KCNJ15;ORAI1;ITPR2
15561,GO:0072006,0.106098344821676,0.942603075412574,12,85,nephron development,BP,PGF;CTNNBIP1;ACTA2;WWTR1;DLG1;PODXL;PKD2;WNT2B;RET;LAMB2;LAMA5;PTCH1
11483,GO:0045940,0.106136469038849,0.975068152474338,3,15,positive regulation of steroid metabolic process,BP,NR1D1;APOE;ABCG1
16867,GO:0098796,0.106447129434736,0.916102842614684,69,727,membrane protein complex,CC,NOS1;SYNE3;ITGA6;SCN8A;ITGB4;COL13A1;KCNG1;SNTB2;EGFR;UBXN7;DLG1;DLG4;SPTLC2;SEC23A;SHC1;DLG3;TGFBR2;SHANK2;FKBP1A;LRP1;AKAP9;ABCA7;PIGH;ITGA1;ITGB5;ITGA2;VAMP2;CEACAM1;EPN2;MVB12B;LRP5;SEC22C;CLTCL1;VPS11;TTYH3;COPB1;COPG1;NDUFV3;ANO1;SDCCAG3;ACVR1B;NDUFA4L2;MVB12A;GRIN3B;ABHD6;RET;STX10;C5;PRKACA;SEL1L;AP2A2;CARD11;AP3D1;EFCAB7;SNX6;ATP12A;ATP6V1B2;ADAM8;ITGA4;FZD8;HSPA2;LRP6;DNAJC3;PANK1;SNX27;GNAI1;LRP4;STT3B;FADD
19732,GO:2000105,0.10669546659668,0.975429011066257,3,13,positive regulation of DNA-dependent DNA replication,BP,FGFR1;ATRX;E2F7
2408,GO:0005579,0.106817082042224,1,1,1,membrane attack complex,CC,C5
7706,GO:0032185,0.106824959887669,0.975386115697336,3,13,septin cytoskeleton organization,BP,SEPT10;SEPT5;SEPT6
12822,GO:0051127,0.106891694005019,0.975716750251498,3,12,positive regulation of actin nucleation,BP,WIPF1;NCKAP1;WASL
4385,GO:0010038,0.106993645977622,0.929148269235807,24,221,response to metal ion,BP,ERCC1;CCND1;PRNP;NFATC4;EGFR;ANK3;BNIP3;GDI1;SDC1;FKBP1A;ATP7B;PKD2;ATF4;UROS;ITPR3;MT2A;BSG;TRPC1;LOXL2;SLC30A1;ENDOG;EEF2K;ADCY1;DNMT3A
9987,GO:0042383,0.107281594984198,0.943643272702608,11,77,sarcolemma,CC,NOS1;FLNC;ANK3;DYSF;DLG1;OBSCN;BSG;PPP3CB;COL6A1;SLC38A2;SLC30A1
9628,GO:0036494,0.107377299879068,1,1,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,DNAJC3
14669,GO:0070269,0.10742714467142,0.98441747998729,2,8,pyroptosis,BP,GSDMC;GSDMA
9861,GO:0042110,0.107488914051794,0.925902280495582,29,270,T cell activation,BP,PRNP;PAG1;FYN;KIF13B;DLG1;ARG2;PAK1;RAG1;TGFBR2;RAC2;FKBP1A;SOX4;CEACAM1;CD46;PPP3CB;F2RL1;CHD7;PRKAR1A;XBP1;SATB1;PDE5A;CARD11;AP3D1;IGF2;ADAM8;IL20RB;FZD8;FOXP1;FADD
7166,GO:0031045,0.107571538003028,0.985628716549945,2,6,dense core granule,CC,VPS13A;ADAM8
14878,GO:0070663,0.107620014619325,0.938163909759961,14,121,regulation of leukocyte proliferation,BP,PRNP;PKN1;DLG1;ARG2;TGFBR2;RAC2;CD46;PRKAR1A;PDE5A;SLC39A10;CARD11;IGF2;IL20RB;FADD
19115,GO:1905049,0.107622748512845,0.98561778109903,2,6,negative regulation of metallopeptidase activity,BP,SORL1;TIMP2
13959,GO:0060665,0.107720456041224,1,1,1,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,FGFR1
16228,GO:0090272,0.107720456041224,1,1,1,negative regulation of fibroblast growth factor production,BP,FGFR1
18421,GO:1903465,0.107720456041224,1,1,1,positive regulation of mitotic cell cycle DNA replication,BP,FGFR1
20137,GO:2000830,0.107720456041224,1,1,1,positive regulation of parathyroid hormone secretion,BP,FGFR1
2400,GO:0005545,0.10772615944003,0.975443326531045,3,12,1-phosphatidylinositol binding,MF,SNX9;WDFY3;ZFYVE9
9197,GO:0035579,0.108021045331751,0.950087002095368,8,55,specific granule membrane,CC,STOM;SLC2A3;CEACAM1;MOSPD2;TMBIM1;CMTM6;TMEM63A;ADAM8
19279,GO:1905476,0.108089613683749,0.967146240976774,4,22,negative regulation of protein localization to membrane,BP,GDI1;BCL2L1;TMBIM1;LYPLA1
465,GO:0001503,0.108322451706516,0.925903545557791,28,242,ossification,BP,CTNNBIP1;CYP27B1;ACVR2B;COL13A1;WWTR1;EGFR;RDH14;DKK1;MRC2;SMOC1;FAM20C;MMP14;LRP5;THBS3;PTHLH;THRA;COL6A1;IFITM1;MEF2D;SH3PXD2B;PRKACA;BCAP29;IGF2;ZBTB40;LRP6;PTCH1;UFL1;LRP4
2090,GO:0004855,0.108377228614448,1,1,1,xanthine oxidase activity,MF,XDH
5642,GO:0016727,0.108377228614448,1,1,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,XDH
20256,GO:2001213,0.108377228614448,1,1,1,negative regulation of vasculogenesis,BP,XDH
8872,GO:0034676,0.108485256386822,1,1,1,integrin alpha6-beta4 complex,CC,ITGA6
19624,GO:1990782,0.108517160621872,0.94991349923743,8,53,protein tyrosine kinase binding,MF,DOCK4;PAG1;SHC1;PITPNM1;CEACAM1;SHC2;IL1RAP;LRP4
2537,GO:0005794,0.108558432001018,0.910064220173729,112,1144,Golgi apparatus,CC,DOCK4;EDEM1;F2R;SORL1;ADAM19;ASAP2;H1F0;PRNP;POSTN;MAP2K1;LMF1;MARCH9;B4GALT6;CAPN2;EGFR;TBC1D14;ANK3;SLC33A1;ARAP1;DLG1;B3GNT3;GPC4;SNX9;SLC9A7;WNT7A;SEC23A;MALL;GDI1;SDC1;B4GALNT4;NUCB2;CD44;APOE;ATP7B;MCFD2;ST3GAL5;FYCO1;AKAP9;ABCA7;ICA1;FAM114A1;MARCH4;LPCAT1;GALNT3;VAMP2;CHAC1;FAM20C;ABCG1;PITPNM1;OBSL1;RAB31;LMAN1;BSG;CLCN3;NTSR1;MMP14;MAP6;DNMBP;SLC35B4;CLTCL1;PCSK6;SLC35G2;ZDHHC2;COPB1;COPG1;SCYL3;F2RL1;RASIP1;PTHLH;QSOX1;BOK;ATXN2;USP6NL;GOLGA6L9;PSKH1;MVB12A;AZIN2;AGPAT3;GLB1;ARF4;GOLGA2P5;MAP2K2;STX10;RAB43;GABARAPL2;SLC30A1;TMBIM1;CCDC88A;TMED4;SAMD8;RAB1A;ZDHHC1;ANGEL1;KDELR3;ST6GALNAC2;CTSZ;AP3D1;TENM2;PJA2;MAP4K2;TMEM50B;EVI5;ATP11B;MPLKIP;DDHD2;FZD8;USP32;LRP6;TMEM173;PSEN2;PTCH1;COG8
10311,GO:0043086,0.10859810199741,0.917133645624713,53,538,negative regulation of catalytic activity,BP,NOS1;SORL1;CYP27B1;SERPINE2;PRNP;ADARB1;TFPI2;PKN1;WWTR1;PPP1R14A;TNFRSF6B;PLXNB3;DLG3;SOCS2;TRIB2;RAG1;SERPING1;EPHA1;CD44;APOE;FKBP1A;ANGPTL4;RGS14;AKAP9;ANXA3;ELFN2;PPP1R35;PTK6;CEACAM1;DVL1;LRP5;CST3;TRIB3;APLP2;PRDX5;CSNK2A1;PRKAR1A;PARP9;SPRY2;NGFR;PPP1R10;UBASH3B;PPP1R2;C5;TMBIM1;TIMP2;IFI16;FICD;PPARG;SNX6;LRP6;DNAJC3;KAT2B
7815,GO:0032368,0.108671575474198,0.949718180022905,8,55,regulation of lipid transport,BP,APOE;LRP1;PPARA;ABCA7;ABCG1;NTSR1;PPARG;PTCH1
15846,GO:0072557,0.108772590648528,0.996872618659348,1,2,IPAF inflammasome complex,CC,CASP4
10828,GO:0044321,0.108836327801675,0.97441230004891,3,14,response to leptin,BP,CCND1;BBS2;NR1D1
12325,GO:0048677,0.108907460371948,1,1,1,axon extension involved in regeneration,BP,LAMB2
15706,GO:0072244,0.108907460371948,1,1,1,metanephric glomerular epithelium development,BP,LAMB2
15707,GO:0072248,0.108907460371948,1,1,1,metanephric glomerular visceral epithelial cell differentiation,BP,LAMB2
15708,GO:0072249,0.108907460371948,1,1,1,metanephric glomerular visceral epithelial cell development,BP,LAMB2
15719,GO:0072274,0.108907460371948,1,1,1,metanephric glomerular basement membrane development,BP,LAMB2
15740,GO:0072312,0.108907460371948,1,1,1,metanephric glomerular epithelial cell differentiation,BP,LAMB2
15741,GO:0072313,0.108907460371948,1,1,1,metanephric glomerular epithelial cell development,BP,LAMB2
15564,GO:0072009,0.109105535346147,0.9445965530148,10,68,nephron epithelium development,BP,PGF;CTNNBIP1;WWTR1;DLG1;PODXL;PKD2;WNT2B;LAMB2;LAMA5;PTCH1
6473,GO:0021812,0.109159710066925,1,1,1,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,LAMB1
10419,GO:0043257,0.109159710066925,1,1,1,laminin-8 complex,CC,LAMB1
20054,GO:2000678,0.109341398258031,0.974241380099464,3,14,negative regulation of transcription regulatory region DNA binding,BP,DDIT3;PPARA;TMSB4X
9502,GO:0036149,0.109581084957023,0.984455928514058,2,7,phosphatidylinositol acyl-chain remodeling,BP,PLA2G4D;MBOAT7
4467,GO:0010463,0.109588455285512,0.961118886545796,5,27,mesenchymal cell proliferation,BP,CTNNBIP1;TGFBR2;FGFR1;LRP5;TBX1
3239,GO:0006893,0.109637366329766,0.952374200024092,7,46,Golgi to plasma membrane transport,BP,BBS2;EXOC2;ANK3;VAMP2;RAB31;OSBPL5;LYPLA1
12862,GO:0051182,0.109866260539998,0.9843913243274,2,7,coenzyme transport,BP,SLC33A1;SLC23A2
3381,GO:0007158,0.109915117802378,0.985124868052846,2,6,neuron cell-cell adhesion,BP,NLGN2;RET
861,GO:0002192,0.109944896109222,0.996802799464366,1,2,IRES-dependent translational initiation of linear mRNA,BP,EIF4EBP1
17229,GO:0110017,0.109944896109222,0.996802799464366,1,2,cap-independent translational initiation of linear mRNA,BP,EIF4EBP1
7034,GO:0030807,0.109945030801982,1,1,1,positive regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7049,GO:0030822,0.109945030801982,1,1,1,positive regulation of cAMP catabolic process,BP,RAPGEF3
8296,GO:0033123,0.109945030801982,1,1,1,positive regulation of purine nucleotide catabolic process,BP,RAPGEF3
5349,GO:0016101,0.110021890040377,0.95203878934405,7,48,diterpenoid metabolic process,BP,EGFR;GPC4;RDH14;SDC1;APOE;LRP1;ALDH1A2
3368,GO:0007130,0.11014270179181,0.984328596933592,2,7,synaptonemal complex assembly,BP,REC8;MLH3
11637,GO:0046348,0.110214506227483,0.983768609654367,2,8,amino sugar catabolic process,BP,CTBS;NPL
12731,GO:0050994,0.110333209911589,0.96051072118939,5,29,regulation of lipid catabolic process,BP,TYSND1;PPARA;LONP2;MLYCD;THRA
14648,GO:0070232,0.110414536252491,0.965885783204648,4,24,regulation of T cell apoptotic process,BP,ARG2;RAG1;ADAM8;FADD
1421,GO:0003366,0.110519642771516,1,1,1,cell-matrix adhesion involved in ameboidal cell migration,BP,ITGA4
8869,GO:0034669,0.110519642771516,1,1,1,integrin alpha4-beta7 complex,CC,ITGA4
19618,GO:1990771,0.110519642771516,1,1,1,clathrin-dependent extracellular exosome endocytosis,BP,ITGA4
13485,GO:0055022,0.110555668388179,0.973828919751468,3,14,negative regulation of cardiac muscle tissue growth,BP,PAK1;TGFBR2;JARID2
14203,GO:0061117,0.110555668388179,0.973828919751468,3,14,negative regulation of heart growth,BP,PAK1;TGFBR2;JARID2
3551,GO:0007585,0.110616297603949,0.955719473420851,6,37,respiratory gaseous exchange,BP,APLN;TMPRSS11D;EDNRA;NTSR1;NLGN2;PBX3
19168,GO:1905208,0.110660976359556,0.974104210250187,3,13,negative regulation of cardiocyte differentiation,BP,EGFR;DKK1;PAK1
8725,GO:0034370,0.110826155649869,0.996749775916657,1,2,triglyceride-rich lipoprotein particle remodeling,BP,APOE
8727,GO:0034372,0.110826155649869,0.996749775916657,1,2,very-low-density lipoprotein particle remodeling,BP,APOE
6304,GO:0019933,0.110846045925893,0.945814589765109,9,62,cAMP-mediated signaling,BP,NOS1;ADCY7;ADGRF1;ADM2;RAPGEF3;PTHLH;LPAR1;ADCY1;GNAI1
8189,GO:0032927,0.110865262977903,0.98491861746751,2,6,positive regulation of activin receptor signaling pathway,BP,ACVR2B;ACVR1B
3930,GO:0008610,0.110992097634621,0.915623078348943,51,512,lipid biosynthetic process,BP,MBOAT2;PCK2;CYP27B1;NR1D1;ALOX15B;DGKA;B4GALT6;ELOVL1;ISYNA1;SPTLC2;ACOT7;CBR4;PLPP6;APOE;ST3GAL5;PIGH;AGPAT4;FGFR1;LPCAT4;LPCAT1;INPP5F;ABCG1;PITPNM1;KDSR;CEACAM1;PLA2G4D;TRIB3;INPP4A;MLYCD;CSNK2A1;CRLS1;MGLL;AGPAT3;HSD17B7;XBP1;ABHD6;MTMR4;MBOAT7;SAMD8;SRD5A3;ACP6;AGPAT1;ALDH1A2;IGFBP7;DDHD2;COQ2;ELOVL4;HSD17B12;CDS2;AMACR;SLC44A1
15907,GO:0072676,0.111043762485259,0.955179472594732,6,41,lymphocyte migration,BP,RET;ADAM8;ITGA4;CKLF;WASL;FADD
18962,GO:1904738,0.111212843559442,0.974289888726872,3,12,vascular associated smooth muscle cell migration,BP,DOCK4;SSH1;PAK1
18972,GO:1904752,0.111212843559442,0.974289888726872,3,12,regulation of vascular associated smooth muscle cell migration,BP,DOCK4;SSH1;PAK1
4281,GO:0009648,0.111487488527708,0.965736854444534,4,22,photoperiodism,BP,CRTC1;PER3;MTA1;NR2F6
6718,GO:0030128,0.111608142404978,0.973784370339049,3,13,clathrin coat of endocytic vesicle,CC,EGFR;EPN2;AP2A2
2992,GO:0006536,0.111724895269734,0.965479403488401,4,23,glutamate metabolic process,BP,GLUL;NAGS;GLUD1;ALDH4A1
4241,GO:0009439,0.111804072780151,0.996690395039346,1,2,cyanate metabolic process,BP,TST
4242,GO:0009440,0.111804072780151,0.996690395039346,1,2,cyanate catabolic process,BP,TST
10670,GO:0043900,0.112002647999353,0.922380196121187,29,283,regulation of multi-organism process,BP,TNIP1;SMURF2;ADARB1;PC;EXOC2;HTRA1;ARG2;STOM;APOE;HMGA2;APOBEC3C;TRIM5;MVB12B;F2RL1;DDX60;PARP9;ACVR1B;MVB12A;IFITM1;YTHDC2;PDE5A;PUM2;EIF2AK2;IFI16;RSF1;TMEM173;FOXP1;OAS1;TRIM38
2426,GO:0005605,0.112159147864446,0.966569449340265,4,17,basal lamina,CC,LAMB1;DLG1;LAMB2;LAMA5
10804,GO:0044283,0.11221729375377,0.9143469986824,52,542,small molecule biosynthetic process,BP,XDH;NT5E;PCK2;CBS;CYP27B1;GPT2;NR1D1;RAPGEF3;ALOX15B;TK2;DHTKD1;PC;LTA4H;PSAT1;ELOVL1;PGM1;ISYNA1;GLUL;SPTLC2;ACOT7;NME4;CEMIP;NAGS;CBR4;PLPP6;APOE;LDHA;ATF4;PPARA;ASNS;UROS;HYAL1;ABCG1;GAMT;CEACAM1;NTSR1;CTH;SLC35B4;TRIB3;MLYCD;MGLL;GLUD1;HSD17B7;XBP1;PDE5A;SRD5A3;ALDH1A2;COQ2;ELOVL4;HSD17B12;KAT2B;AMACR
8658,GO:0034205,0.112312369656573,0.965568227593856,4,21,amyloid-beta formation,BP,SORL1;PRNP;APOE;ABCA7
11288,GO:0045598,0.112349014490867,0.940239504966763,11,84,regulation of fat cell differentiation,BP,NR1D1;WWTR1;DDIT3;TRIB2;LRP5;TRIB3;MEX3C;XBP1;CCDC71L;SH3PXD2B;PPARG
18834,GO:1904427,0.112365586818512,0.954737341586779,6,38,positive regulation of calcium ion transmembrane transport,BP,F2R;CEMIP;PKD2;NTSR1;TRPC1;HSPA2
3309,GO:0007009,0.112380450693038,0.945002023989981,9,60,plasma membrane organization,BP,SH3TC2;ANK3;DYSF;SNX9;MYOF;FNBP1L;ASAP1;EPB41L3;WASL
1251,GO:0003002,0.11250761871685,0.925871727589039,23,198,regionalization,BP,CTNNBIP1;ACVR2B;DDIT3;SCMH1;WNT7A;DKK1;PRKACB;FGFR1;MDFI;LRP5;PCSK6;WNT2B;TSHZ1;TCTN1;HOXA3;ALDH1A2;TBX1;TMEM107;LRP6;PTCH1;PBX3;SEMA3F;LRP4
3291,GO:0006982,0.112592514457896,0.996642103934781,1,2,response to lipid hydroperoxide,BP,GPX3
10649,GO:0043679,0.112821671111801,0.944465935230647,9,66,axon terminus,CC,GLUL;FKBP1A;ITGA2;PFN2;NTSR1;SEPT5;AP3D1;SLC18A2;SEPT6
12776,GO:0051051,0.112823680870533,0.922343438365052,28,263,negative regulation of transport,BP,NOS1;F2R;SERPINE2;HECW2;MAP1B;HADH;STK39;ANK3;UBE2J1;DLG4;IDH2;MAP4K4;MCTP1;GDI1;ARG2;PKD2;ATF4;SOX4;CEACAM1;NTSR1;F2RL1;BOK;ATXN2;SLC30A1;TMSB4X;GRB10;ERLEC1;LYPLA1
18231,GO:1903035,0.112920567989162,0.947191603128143,8,57,negative regulation of response to wounding,BP,PLAT;SERPINE2;PTPRS;SERPING1;APOE;INPP5F;CEACAM1;UBASH3B
7675,GO:0032104,0.112947481649905,0.973010133377488,3,14,regulation of response to extracellular stimulus,BP,CYP27B1;BBS2;PPARA
7678,GO:0032107,0.112947481649905,0.973010133377488,3,14,regulation of response to nutrient levels,BP,CYP27B1;BBS2;PPARA
2339,GO:0005368,0.113035282665208,1,1,1,taurine transmembrane transporter activity,MF,SLC6A6
2340,GO:0005369,0.113035282665208,1,1,1,taurine:sodium symporter activity,MF,SLC6A6
5177,GO:0015734,0.113035282665208,1,1,1,taurine transport,BP,SLC6A6
12287,GO:0048608,0.11307631061528,0.919750382593371,33,301,reproductive structure development,BP,ERCC1;CCND1;CYP27B1;SERPINE2;MAP2K1;ALOX15B;EGFR;DLG1;CTSB;HTRA1;WNT7A;SDC1;PKD2;ATRX;BSG;MDFI;MMP14;EPOR;CST3;PLAG1;CHD7;BOK;WNT2B;BCL2L1;REC8;ARID4A;IGF2;PPARG;ZNF568;LRP6;ARID5B;E2F7;PTCH1
19138,GO:1905114,0.113122374218847,0.915469338923208,45,429,cell surface receptor signaling pathway involved in cell-cell signaling,BP,SMURF2;ZMYND8;CCND1;CTNNBIP1;IGFBP4;NFATC4;WWTR1;SSH1;DDIT3;PSMD2;DLG4;GPC4;WNT7A;GRK5;SDC1;DKK1;WISP1;SHANK2;APOE;LRP1;BTRC;SOX4;FERMT1;NLK;MDFI;TNRC6B;DVL1;NTSR1;NLGN2;LRP5;PPP3CB;CSNK2A1;PSMD7;WNT2B;GRIN3B;TLE4;AP2A2;TBL1X;GRB10;FZD8;LRP6;TNRC6C;ZBTB33;ANKRD6;LRP4
13252,GO:0051930,0.113447313438046,0.972837968476708,3,14,regulation of sensory perception of pain,BP,F2R;NTSR1;MGLL
13253,GO:0051931,0.113447313438046,0.972837968476708,3,14,regulation of sensory perception,BP,F2R;NTSR1;MGLL
9623,GO:0036488,0.113502940656929,0.996585879258399,1,2,CHOP-C/EBP complex,CC,DDIT3
21,GO:0000038,0.113542274462131,0.964567929757753,4,24,very long-chain fatty acid metabolic process,BP,ELOVL1;ACOT1;ABCD1;ELOVL4
4747,GO:0010917,0.113586574230262,0.982969641573962,2,8,negative regulation of mitochondrial membrane potential,BP,BNIP3;BNIP3L
11424,GO:0045837,0.113586574230262,0.982969641573962,2,8,negative regulation of membrane potential,BP,BNIP3;BNIP3L
8639,GO:0034164,0.113870184739798,1,1,1,negative regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
16954,GO:0098948,0.113870184739798,1,1,1,intrinsic component of postsynaptic specialization membrane,CC,PTPRS
16988,GO:0099060,0.113870184739798,1,1,1,integral component of postsynaptic specialization membrane,CC,PTPRS
16989,GO:0099061,0.113870184739798,1,1,1,integral component of postsynaptic density membrane,CC,PTPRS
17017,GO:0099146,0.113870184739798,1,1,1,intrinsic component of postsynaptic density membrane,CC,PTPRS
5968,GO:0018400,0.113876177328859,1,1,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,CRTAP
7673,GO:0032102,0.113963704196098,0.926273193092736,21,188,negative regulation of response to external stimulus,BP,NT5E;PLAT;SERPINE2;BBS2;FNDC4;PTPRS;SEMA4B;HTRA1;ARG2;SERPING1;APOE;ACP5;PPARA;INPP5F;CEACAM1;DVL1;UBASH3B;C5;PPARG;IL20RB;SEMA3F
14419,GO:0061709,0.114046882769572,1,1,1,reticulophagy,BP,RB1CC1
20271,GO:2001239,0.114120150974119,0.958198883355576,5,34,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,FYN;STRADB;FGFR1;BCL2L1;RET
3917,GO:0008584,0.114165584428434,0.937168857234266,12,94,male gonad development,BP,ERCC1;CCND1;SDC1;ATRX;MMP14;CST3;BOK;WNT2B;BCL2L1;REC8;ARID4A;ARID5B
14799,GO:0070513,0.114201772603524,0.982822233974559,2,8,death domain binding,MF,DAP;BCL2L1
11018,GO:0044853,0.11423565699739,0.943899356384311,9,60,plasma membrane raft,CC,NOS1;F2R;TGFBR2;MYOF;PRKAR1A;PRKACA;LRP6;PTCH1;LRP4
4177,GO:0009251,0.114254875406791,0.964956003799567,4,20,glucan catabolic process,BP,PYGL;PYGB;PGM1;RB1CC1
13489,GO:0055026,0.11440737690471,0.964692215398278,4,21,negative regulation of cardiac muscle tissue development,BP,DKK1;PAK1;TGFBR2;JARID2
5688,GO:0016805,0.114475264909054,0.983332427484176,2,7,dipeptidase activity,MF,SCRN1;PM20D2
9041,GO:0035255,0.114677074767153,0.964779686063954,4,20,ionotropic glutamate receptor binding,MF,DLG1;DLG4;DLG3;SHANK2
16814,GO:0098661,0.114689717628744,0.949692166671833,7,45,inorganic anion transmembrane transport,BP,PRNP;CLCA2;CLCN3;TTYH3;ANO1;SLC12A7;PCYOX1
13844,GO:0060444,0.114847380838072,0.96470848987057,4,20,branching involved in mammary gland duct morphogenesis,BP,ETV5;BTRC;LRP5;LRP6
2362,GO:0005464,0.114874161970343,1,1,1,UDP-xylose transmembrane transporter activity,MF,SLC35B4
5197,GO:0015790,0.114874161970343,1,1,1,UDP-xylose transmembrane transport,BP,SLC35B4
4231,GO:0009409,0.114916902363981,0.958114475706586,5,31,response to cold,BP,ZNF516;THRA;PPARG;HSPA2;DNAJC3
12576,GO:0050730,0.114929126837827,0.929445365784792,17,149,regulation of peptidyl-tyrosine phosphorylation,BP,NEURL1;PRNP;EGFR;FYN;ERCC6;DLG4;SHC1;DLG3;CD44;PTK6;INPP5F;CNTN1;PARP9;IGF2;SNX6;ADNP;LRP4
11793,GO:0046658,0.115036066891904,0.963933432151095,4,24,anchored component of plasma membrane,CC,PRNP;GPC4;NTNG1;PRSS8
17545,GO:1901074,0.115106430366144,1,1,1,regulation of engulfment of apoptotic cell,BP,ABCA7
17546,GO:1901076,0.115106430366144,1,1,1,positive regulation of engulfment of apoptotic cell,BP,ABCA7
6298,GO:0019911,0.115170128293467,0.982589181684846,2,8,structural constituent of myelin sheath,MF,MARVELD1;MALL
3712,GO:0008219,0.115422573169422,0.90210587967463,144,1570,cell death,BP,XDH;F2R;SORL1;NEURL1;PYGL;ITGA6;RPS6KA2;H1F0;PRNP;NFATC4;ADARB1;MAP2K1;SH3KBP1;ALOX15B;PKN1;PEG3;MST1R;TNFSF15;SSH1;DDIT3;EGFR;STK39;FYN;TNFRSF6B;BNIP3;ERCC6;CTSB;NET1;TGM2;GLO1;WNT7A;MAP4K4;GRK5;STRADB;NME4;ARG2;SHC1;DKK1;WISP1;DAP;PAK1;SOCS2;RAG1;TGFBR2;LCN2;EPHA1;IMPACT;CD44;OBSCN;APOE;BNIP3L;CCND2;ANGPTL4;RBCK1;LRP1;LDHA;HMGA2;ATF4;PPARA;ASNS;FGFR1;ITGA1;AARS;CHAC1;SOX4;GSDMC;UACA;NTSR1;ANXA6;CTH;LRP5;CTSL;CST3;RABGGTA;TRIB3;CASP4;PCSK6;SLK;PRDX5;PLAG1;GSDMA;C6ORF120;TAOK1;CSNK2A1;SLC25A4;JMY;BOK;CPEB4;NACC2;SPRY2;THRA;ACVR1B;NGFR;PPP1R10;MARK4;BCL2L1;MEF2D;ARF4;XBP1;MAP2K2;SATB1;RET;BEX2;NCKAP1;ELMO3;PAK6;TMBIM1;NEK6;RGL2;EIF2AK2;EPB41L3;IFI16;BCAP29;SLC39A10;CARD11;LPAR1;CTSZ;IGF2;MOAP1;MAP4K2;PPARG;EVA1A;PPL;ALDH1A2;TBX1;ADAM8;WFS1;ENDOG;PRSS8;LRP6;TMEM173;EEF2K;SIGMAR1;TRIM2;DEDD2;DNAJC3;FOXP1;PSEN2;UFL1;FAM162A;ADNP;RB1CC1;DNMT3A;FADD
3293,GO:0006984,0.115458750398358,0.952976478645756,6,40,ER-nucleus signaling pathway,BP,DDIT3;ATF4;ASNS;BOK;XBP1;WFS1
2616,GO:0005925,0.115512857272789,0.916135531603527,37,355,focal adhesion,CC,FHL1;FLNC;ITGA6;MAP2K1;SH3KBP1;MPRIP;ARHGAP22;SNTB2;CAPN2;EGFR;PARVB;TGM2;PAK1;MRC2;RAC2;CD44;PTPN12;AFAP1;LRP1;ITGA1;ITGB5;ITGA2;FAT1;FERMT1;BSG;SLC9A3R2;MMP14;ANXA6;CD46;PROCR;CD99;MAP2K2;NCKAP1;GRB7;ITGA4;FLNB;ZFYVE21
19707,GO:2000048,0.115615432932062,0.996453506991664,1,2,negative regulation of cell-cell adhesion mediated by cadherin,BP,EPCAM
11373,GO:0045738,0.11569399235214,0.964151046665371,4,21,negative regulation of DNA repair,BP,HMGA2;RNF169;MAGEF1;KLHL15
3888,GO:0008520,0.115742140352893,1,1,1,L-ascorbate:sodium symporter activity,MF,SLC23A2
5046,GO:0015229,0.115742140352893,1,1,1,L-ascorbic acid transmembrane transporter activity,MF,SLC23A2
5254,GO:0015882,0.115742140352893,1,1,1,L-ascorbic acid transmembrane transport,BP,SLC23A2
14982,GO:0070890,0.115742140352893,1,1,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,SLC23A2
14993,GO:0070904,0.115742140352893,1,1,1,transepithelial L-ascorbic acid transport,BP,SLC23A2
18069,GO:1902630,0.115810330251537,1,1,1,regulation of membrane hyperpolarization,BP,CRTC1
18070,GO:1902631,0.115810330251537,1,1,1,negative regulation of membrane hyperpolarization,BP,CRTC1
9199,GO:0035581,0.115966949552076,0.983791764731661,2,6,sequestering of extracellular ligand from receptor,BP,LTBP1;CD46
2337,GO:0005366,0.115985133334765,1,1,1,myo-inositol:proton symporter activity,MF,SLC2A13
9103,GO:0035372,0.11605175852848,0.972266458209083,3,13,protein localization to microtubule,BP,TTBK2;DVL1;ABHD17C
6987,GO:0030665,0.116081031698108,0.942474114114676,9,67,clathrin-coated vesicle membrane,CC,EGFR;CEMIP;APOE;VAMP2;EPN2;CLTCL1;AP2A2;SYT2;SLC18A2
12520,GO:0050663,0.116228164093093,0.933997880441799,13,108,cytokine secretion,BP,F2R;POSTN;ALOX15B;ARG2;FERMT1;F2RL1;XBP1;C5;TMSB4X;RAB1A;IL1RAP;CARD11;FOXP1
19578,GO:1990622,0.11638844550038,0.996404399369034,1,2,CHOP-ATF3 complex,CC,DDIT3
14649,GO:0070233,0.116446737825259,0.971512900799879,3,15,negative regulation of T cell apoptotic process,BP,ARG2;RAG1;FADD
1975,GO:0004691,0.116451852158596,0.983682963009743,2,6,cAMP-dependent protein kinase activity,MF,PRKACB;PRKACA
602,GO:0001770,0.116493754021929,1,1,1,establishment of natural killer cell polarity,BP,SNX27
9470,GO:0036089,0.116552885007782,0.982846049729893,2,7,cleavage furrow formation,BP,SNX9;SPIRE1
12386,GO:0048799,0.116570799553518,0.972483215496321,3,12,animal organ maturation,BP,THBS3;RET;ALDH1A2
4762,GO:0010941,0.11674704501502,0.902939168519356,111,1188,regulation of cell death,BP,XDH;F2R;SORL1;NEURL1;ITGA6;RPS6KA2;PRNP;NFATC4;MAP2K1;MST1R;TNFSF15;SSH1;DDIT3;EGFR;STK39;FYN;TNFRSF6B;BNIP3;CTSB;NET1;TGM2;GLO1;WNT7A;MAP4K4;GRK5;STRADB;NME4;ARG2;SHC1;DKK1;WISP1;DAP;PAK1;SOCS2;RAG1;EPHA1;IMPACT;CD44;OBSCN;APOE;BNIP3L;CCND2;ANGPTL4;RBCK1;LRP1;LDHA;HMGA2;ATF4;PPARA;ASNS;FGFR1;ITGA1;AARS;SOX4;NTSR1;CTH;LRP5;CST3;RABGGTA;CASP4;SLK;PRDX5;TAOK1;CSNK2A1;SLC25A4;JMY;BOK;CPEB4;NACC2;SPRY2;THRA;NGFR;PPP1R10;MARK4;BCL2L1;ARF4;XBP1;MAP2K2;RET;BEX2;PAK6;TMBIM1;RGL2;EIF2AK2;SLC39A10;CARD11;LPAR1;CTSZ;IGF2;MOAP1;MAP4K2;PPARG;ALDH1A2;TBX1;ADAM8;WFS1;ENDOG;LRP6;EEF2K;SIGMAR1;TRIM2;DEDD2;DNAJC3;FOXP1;PSEN2;UFL1;FAM162A;ADNP;RB1CC1;DNMT3A;FADD
16943,GO:0098923,0.116835959003011,1,1,1,retrograde trans-synaptic signaling by soluble gas,BP,NOS1
16944,GO:0098924,0.116835959003011,1,1,1,retrograde trans-synaptic signaling by nitric oxide,BP,NOS1
17019,GO:0099163,0.116835959003011,1,1,1,synaptic signaling by nitric oxide,BP,NOS1
17061,GO:0099543,0.116835959003011,1,1,1,trans-synaptic signaling by soluble gas,BP,NOS1
17064,GO:0099548,0.116835959003011,1,1,1,trans-synaptic signaling by nitric oxide,BP,NOS1
17320,GO:0140196,0.116835959003011,1,1,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
1834,GO:0004489,0.116877215088941,1,1,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,MTHFR
8377,GO:0033274,0.116877215088941,1,1,1,response to vitamin B2,BP,MTHFR
18571,GO:1903798,0.116919412261175,0.971631986624516,3,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,MAP2K1;EGFR;MAP2K2
7210,GO:0031102,0.117145795614159,0.952269768000582,6,38,neuron projection regeneration,BP,MAP2K1;PTPRS;MAP4K4;APOE;INPP5F;LAMB2
14643,GO:0070227,0.117172087016304,0.947881447386212,7,52,lymphocyte apoptotic process,BP,PKN1;ARG2;RAG1;SLC39A10;ADAM8;FOXP1;FADD
9854,GO:0042101,0.117267042752803,0.982677569245755,2,7,T cell receptor complex,CC,CEACAM1;CARD11
3794,GO:0008361,0.117396729335903,0.929177765061808,16,123,regulation of cell size,BP,MAP1B;PTPRS;SEMA4B;GDI1;PAK1;APOE;LPAR3;ULK2;CLCN3;TWF2;SLC12A7;RET;AKT3;SEMA3F;ADNP;RB1CC1
9364,GO:0035878,0.117498089385018,0.982622920422361,2,7,nail development,BP,ITGA6;ITGB4
8729,GO:0034375,0.117924382944035,0.981919486988187,2,8,high-density lipoprotein particle remodeling,BP,APOE;ABCG1
2615,GO:0005924,0.117955326216203,0.914188829016577,37,356,cell-substrate adherens junction,CC,FHL1;FLNC;ITGA6;MAP2K1;SH3KBP1;MPRIP;ARHGAP22;SNTB2;CAPN2;EGFR;PARVB;TGM2;PAK1;MRC2;RAC2;CD44;PTPN12;AFAP1;LRP1;ITGA1;ITGB5;ITGA2;FAT1;FERMT1;BSG;SLC9A3R2;MMP14;ANXA6;CD46;PROCR;CD99;MAP2K2;NCKAP1;GRB7;ITGA4;FLNB;ZFYVE21
18618,GO:1903901,0.117971872700215,0.944081562988444,8,61,negative regulation of viral life cycle,BP,TNIP1;HMGA2;APOBEC3C;TRIM5;IFITM1;EIF2AK2;IFI16;OAS1
11575,GO:0046128,0.117974969062597,0.944035482046211,8,62,purine ribonucleoside metabolic process,BP,NT5E;DLG1;DLG4;NME4;DLG3;AHCYL2;GAMT;CARD11
15306,GO:0071495,0.118013599851272,0.903636788298822,91,909,cellular response to endogenous stimulus,BP,SMURF2;PGF;NEURL1;PCK2;ADCY7;PRNP;BBS2;POSTN;NR1D1;FAM210B;LTBP2;RAPGEF3;ACVR2B;LTBP1;APLN;EIF4EBP1;SSH1;CAPN2;EGFR;FYN;SLC33A1;MAPK13;ADAMTS7;CTSB;HTRA1;WNT7A;SHC1;DKK1;PAK1;SOCS2;TGFBR2;IMPACT;CD44;FKBP1A;PTPN12;PKD2;PRKACB;LRP1;IDE;AKAP9;ATF4;PPARA;ASNS;FGFR1;UROS;ITGB5;HYAL1;ITGA2;GALNT3;VAMP2;LTBP4;FAM20C;CEACAM1;FERMT1;RAB31;NLK;XRN1;CTSL;TRIB3;CASP4;PCSK6;PRKAR1A;CPEB4;SPRY2;THRA;COL6A1;NGFR;BCL2L1;RNF165;XBP1;MTMR4;ZFYVE9;COL1A2;PRKACA;NR2F6;IGF2;ITPR2;GRB10;PPARG;SNX6;TBX1;ATP6V1B2;ACAP2;IGFBP7;EEF2K;FOXP1;ADCY1;KAT2B;UFL1;LRP4;DNMT3A
4316,GO:0009798,0.118133309394495,0.944348321934755,8,54,axis specification,BP,DDIT3;WNT7A;MDFI;LRP5;PCSK6;LRP6;PTCH1;LRP4
16603,GO:0097428,0.118158666990333,0.981042090838324,2,10,protein maturation by iron-sulfur cluster transfer,BP,NFU1;MAGEF1
14127,GO:0060993,0.118263766074973,0.941490252672546,9,60,kidney morphogenesis,BP,PGF;CTNNBIP1;WWTR1;DLG1;PKD2;SOX4;WNT2B;LAMA5;PTCH1
11512,GO:0046006,0.118395511526902,0.962353446593291,4,25,regulation of activated T cell proliferation,BP,PRNP;PRKAR1A;IGF2;FADD
9086,GO:0035337,0.118423731642344,0.956323423555066,5,32,fatty-acyl-CoA metabolic process,BP,ELOVL1;ACOT7;CBR4;PPT2;HSD17B12
1971,GO:0004686,0.118443704677923,1,1,1,elongation factor-2 kinase activity,MF,EEF2K
15275,GO:0071454,0.118443704677923,1,1,1,cellular response to anoxia,BP,EEF2K
10958,GO:0044706,0.118624215946444,0.928109108662219,16,135,multi-multicellular organism process,BP,SMURF2;PGF;CYP27B1;SERPINE2;ADCY7;CTSB;TGFBR2;ITGA2;BSG;EPOR;CST3;PTHLH;ACVR1B;SLC38A2;SH3PXD2B;IGFBP7
10263,GO:0043001,0.118736454536804,0.956400388969478,5,30,Golgi to plasma membrane protein transport,BP,BBS2;ANK3;VAMP2;RAB31;LYPLA1
14789,GO:0070493,0.118882777073075,0.982293956632768,2,7,thrombin-activated receptor signaling pathway,BP,F2R;F2RL1
4181,GO:0009258,0.119067584590176,1,1,1,10-formyltetrahydrofolate catabolic process,BP,ALDH1L2
5366,GO:0016155,0.119067584590176,1,1,1,formyltetrahydrofolate dehydrogenase activity,MF,ALDH1L2
9505,GO:0036152,0.119097482644669,0.970573665830404,3,15,phosphatidylethanolamine acyl-chain remodeling,BP,MBOAT2;LPCAT4;PLA2G4D
8541,GO:0033866,0.119104458947377,0.970318155467939,3,16,nucleoside bisphosphate biosynthetic process,BP,ACOT7;PANK4;PANK1
8565,GO:0034030,0.119104458947377,0.970318155467939,3,16,ribonucleoside bisphosphate biosynthetic process,BP,ACOT7;PANK4;PANK1
8568,GO:0034033,0.119104458947377,0.970318155467939,3,16,purine nucleoside bisphosphate biosynthetic process,BP,ACOT7;PANK4;PANK1
11454,GO:0045906,0.119233950278064,0.983053051710602,2,6,negative regulation of vasoconstriction,BP,DOCK4;APLN
3179,GO:0006796,0.119254665116062,0.896307000756415,209,2289,phosphate-containing compound metabolic process,BP,TNIP1;XDH;NT5E;NOS1;F2R;SORL1;MBOAT2;CCND1;NEURL1;PCK2;VLDLR;PYGL;ITGA6;RPS6KA2;ADCY7;CRYL1;IGFBP4;PRNP;ADM2;ADARB1;MAP2K1;RAPGEF3;ACVR2B;TK2;PKN1;NAPRT;WWTR1;MST1R;H6PD;APLN;DHTKD1;DGKA;TNFSF15;SSH1;PTPRS;PSMD2;BRSK1;EGFR;STK39;PPP1R14A;FYN;OSBPL10;ERCC6;MAPK13;PGM1;DLG1;ISYNA1;DLG4;IDH2;SNX9;WNT7A;PGLS;MAP4K4;TTBK2;SPTLC2;ACOT7;TTC7B;GRK5;NMRK1;STRADB;NME4;CEMIP;SHC1;DLG3;DKK1;PAK1;RASA3;SOCS2;TRIB2;NEK9;TGFBR2;PTPN3;EPHA1;IMPACT;PLPP6;RAC2;CD44;OBSCN;APOE;FKBP1A;CCND2;ACP5;PTPN12;CDK17;RGS14;PKD2;PRKACB;LDHA;AKAP9;PPP2R3B;HMGA2;PPARA;ABCA7;PIGH;AGPAT4;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;PTPDC1;LPCAT4;BTRC;LPCAT1;ITGA2;PTK6;ULK2;INPP5F;FAM20C;PFN2;PITPNM1;CEACAM1;MAPKAPK3;NLK;TRIM5;DVL1;NTSR1;PLA2G4D;LRP5;ETAA1;TMEM86B;CNTN1;TRIB3;GFPT1;RANBP9;PLPPR2;PPP3CB;INPP4A;DNAJC6;SLK;CDC42BPA;SCYL3;F2RL1;TAOK1;CSNK2A1;PSMD7;PTHLH;NDUFV3;PRKAR1A;CRLS1;PARP9;MAST3;SPRY2;ACVR1B;NGFR;PPP1R10;PSKH1;MARK4;PTPRZ1;AGPAT3;PANK4;NT5DC1;UBASH3B;MAP2K2;ABHD6;PPP1R2;RET;PDE5A;OSBPL5;C5;MTMR4;MBOAT7;PAK6;CCDC88A;SAMD8;SHC2;PRKACA;NEK6;TMSB4X;TIMP2;EIF2AK2;SRD5A3;SLC39A10;CARD11;LPAR1;IGF2;ACP6;AGPAT1;GRB10;MAP4K2;ZMYM2;SNX6;SRPX2;TBX1;ATP6V1B2;AK9;ADAM8;AKT3;GARS;DDHD2;FZD8;HSPA2;LRP6;PLCH2;EEF2K;RCAN1;DNAJC3;ZFYVE21;CDS2;ADCY1;KAT2B;PANK1;ANKRD6;N4BP2;PPM1M;SLC44A1;ADNP;LRP4;RB1CC1
1399,GO:0003333,0.119315321770679,0.94699900875786,7,47,amino acid transmembrane transport,BP,STK39;NTSR1;SLC6A6;SLC6A14;SLC43A1;SLC38A2;SLC7A11
5617,GO:0016670,0.119475719372283,0.982152332106237,2,7,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,QSOX1;PCYOX1
3272,GO:0006949,0.119596747560397,0.956113963229884,5,29,syncytium formation,BP,NOS1;ERCC1;RAPGEF3;CAPN2;MYOF
2982,GO:0006525,0.119604189052977,0.970392967668775,3,15,arginine metabolic process,BP,NOS1;ARG2;NAGS
4860,GO:0014074,0.119815616081195,0.933515443070861,12,93,response to purine-containing compound,BP,RAPGEF3;SSH1;SDC1;FKBP1A;PKD2;LDHA;AKAP9;BSG;XRN1;ITPR2;PPARG;EEF2K
6685,GO:0030050,0.119865230055012,0.982908778865651,2,6,vesicle transport along actin filament,BP,FNBP1L;WASL
4767,GO:0010951,0.119882380934888,0.928394548045462,15,135,negative regulation of endopeptidase activity,BP,SORL1;SERPINE2;TFPI2;TNFRSF6B;RAG1;SERPING1;CD44;CST3;APLP2;PRDX5;CSNK2A1;NGFR;C5;TIMP2;IFI16
3947,GO:0008643,0.119977770263881,0.933409298842445,12,93,carbohydrate transport,BP,PAK1;SLC2A3;EDNRA;SLC5A1;SLC35B4;TRIB3;CLTCL1;SLC2A9;NGFR;SLC2A13;GRB10;SLC23A2
304,GO:0000813,0.120026366238486,0.981401611394747,2,8,ESCRT I complex,CC,MVB12B;MVB12A
8994,GO:0035107,0.120237293478236,0.930006444380484,14,105,appendage morphogenesis,BP,WNT7A;ASPH;DKK1;FGFR1;ATRX;SOX4;LRP5;CHD7;RNF165;ALDH1A2;TMEM107;LRP6;PTCH1;LRP4
8995,GO:0035108,0.120237293478236,0.930006444380484,14,105,limb morphogenesis,BP,WNT7A;ASPH;DKK1;FGFR1;ATRX;SOX4;LRP5;CHD7;RNF165;ALDH1A2;TMEM107;LRP6;PTCH1;LRP4
11443,GO:0045879,0.120299622113786,0.962407031837822,4,20,negative regulation of smoothened signaling pathway,BP,SERPINE2;PRKACB;BTRC;PTCH1
10643,GO:0043652,0.120301167213633,0.98133347482004,2,8,engulfment of apoptotic cell,BP,RAC2;ABCA7
13791,GO:0060378,0.120528167698098,1,1,1,regulation of brood size,BP,SH3PXD2B
11408,GO:0045807,0.120622683268981,0.934975271675255,11,84,positive regulation of endocytosis,BP,TSPAN1;APLN;APOE;LRP1;ABCA7;TUB;ITGA2;F2RL1;PPARG;WASL;EEF2K
10306,GO:0043069,0.120783942282611,0.905382295998844,61,629,negative regulation of programmed cell death,BP,F2R;ITGA6;PRNP;MST1R;EGFR;FYN;TNFRSF6B;BNIP3;GLO1;WNT7A;MAP4K4;GRK5;STRADB;ARG2;SHC1;DKK1;SOCS2;RAG1;EPHA1;CD44;APOE;BNIP3L;CCND2;ANGPTL4;RBCK1;LRP1;HMGA2;ASNS;FGFR1;AARS;NTSR1;CTH;PRDX5;CSNK2A1;SLC25A4;BOK;CPEB4;SPRY2;NGFR;PPP1R10;BCL2L1;ARF4;XBP1;RET;TMBIM1;RGL2;EIF2AK2;SLC39A10;IGF2;TBX1;ADAM8;WFS1;LRP6;EEF2K;DNAJC3;FOXP1;PSEN2;UFL1;ADNP;RB1CC1;FADD
4406,GO:0010157,0.120822274411225,1,1,1,response to chlorate,BP,PTCH1
16448,GO:0097108,0.120822274411225,1,1,1,hedgehog family protein binding,MF,PTCH1
4518,GO:0010571,0.120893391196856,0.982672743217056,2,6,positive regulation of nuclear cell cycle DNA replication,BP,FGFR1;ATRX
4429,GO:0010259,0.121135529008612,0.961835773685577,4,21,multicellular organism aging,BP,ERCC1;IDE;SEC63;RNF165
8404,GO:0033343,0.121161892886062,1,1,1,positive regulation of collagen binding,BP,ITGA2
17922,GO:1902235,0.121216567726238,0.961128422589523,4,25,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,DDIT3;BOK;XBP1;WFS1
4643,GO:0010765,0.121302152127953,0.961764207859993,4,21,positive regulation of sodium ion transport,BP,NOS1;ANK3;CNTN1;PRSS8
563,GO:0001704,0.121456916298966,0.9346129089468,11,79,formation of primary germ layer,BP,ITGB4;LAMB1;DKK1;HMGA2;FGFR1;ITGB5;ITGA2;MMP14;PRKAR1A;COL6A1;ITGA4
10359,GO:0043171,0.12146544208883,0.961324834682653,4,23,peptide catabolic process,BP,LTA4H;IDE;RNPEPL1;CHAC1
10382,GO:0043202,0.121510860198388,0.939032401120245,9,71,lysosomal lumen,CC,CTSB;GPC4;SDC1;HYAL1;CTSL;GLB1;PPT2;HPSE;GALNS
7346,GO:0031379,0.121791695588558,0.996051081980345,1,2,RNA-directed RNA polymerase complex,CC,RMRP
19947,GO:2000484,0.121806998472799,0.980958333817751,2,8,positive regulation of interleukin-8 secretion,BP,F2R;F2RL1
17718,GO:1901631,0.121844858272903,1,1,1,positive regulation of presynaptic membrane organization,BP,LRP4
18820,GO:1904393,0.121844858272903,1,1,1,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,LRP4
18821,GO:1904395,0.121844858272903,1,1,1,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,LRP4
11137,GO:0045182,0.121861377299151,0.949626675751979,6,40,translation regulator activity,MF,NEURL1;EIF4EBP1;IGF2BP3;CPEB4;PAIP1;EIF2AK2
3587,GO:0007635,0.121909177392993,0.982438261008058,2,6,chemosensory behavior,BP,CHD7;WFS1
19734,GO:2000107,0.122015504899118,0.954579493298477,5,32,negative regulation of leukocyte apoptotic process,BP,ARG2;RAG1;SLC39A10;FOXP1;FADD
13085,GO:0051593,0.122026034990844,0.980903516830613,2,8,response to folic acid,BP,MTHFR;ZNF354A
12258,GO:0048538,0.122208429286658,0.949719498826235,6,37,thymus development,BP,MAP2K1;RAG1;HOXA3;TBX1;JARID2;FADD
9380,GO:0035909,0.122251741155725,0.961815263017069,4,19,aorta morphogenesis,BP,LRP1;SOX4;CHD7;TBX1
11735,GO:0046546,0.1222713401864,0.931849184927511,12,95,development of primary male sexual characteristics,BP,ERCC1;CCND1;SDC1;ATRX;MMP14;CST3;BOK;WNT2B;BCL2L1;REC8;ARID4A;ARID5B
4884,GO:0014802,0.122333035534702,0.996014709893254,1,2,terminal cisterna,CC,FKBP1A
17632,GO:1901342,0.122368149349445,0.919338912621907,22,189,regulation of vasculature development,BP,XDH;PGF;ADM2;THBS2;RAPGEF3;TGFBR2;EPHA1;ANGPTL4;ANXA3;HMGA2;HYAL1;CEACAM1;EPN2;CTH;ADGRB2;SPRY2;NGFR;XBP1;C5;PPARG;SRPX2;AKT3
19502,GO:1990379,0.122592110784208,0.995997239903196,1,2,lipid transport across blood brain barrier,BP,APOE
14131,GO:0060997,0.122734208401782,0.949546772992856,6,36,dendritic spine morphogenesis,BP,DLG4;WNT7A;SHANK2;DVL1;WASL;EEF2K
14314,GO:0061458,0.122760696153856,0.912136520989504,33,304,reproductive system development,BP,ERCC1;CCND1;CYP27B1;SERPINE2;MAP2K1;ALOX15B;EGFR;DLG1;CTSB;HTRA1;WNT7A;SDC1;PKD2;ATRX;BSG;MDFI;MMP14;EPOR;CST3;PLAG1;CHD7;BOK;WNT2B;BCL2L1;REC8;ARID4A;IGF2;PPARG;ZNF568;LRP6;ARID5B;E2F7;PTCH1
4062,GO:0009111,0.122796353824109,0.98071023123048,2,8,vitamin catabolic process,BP,CYP27B1;PM20D2
15832,GO:0072534,0.122815834903551,1,1,1,perineuronal net,CC,PTPRZ1
1038,GO:0002551,0.123385463249644,0.980561886528898,2,8,mast cell chemotaxis,BP,PGF;RAC2
3430,GO:0007218,0.123403979860625,0.968529609816639,3,17,neuropeptide signaling pathway,BP,NTSR1;NXPH4;LTB4R
2732,GO:0006111,0.123457373966617,0.960637246458403,4,22,regulation of gluconeogenesis,BP,NR1D1;PPARA;SLC35B4;KAT2B
3878,GO:0008508,0.123560444343063,0.995931581767576,1,2,bile acid:sodium symporter activity,MF,SLC10A6
4715,GO:0010877,0.123568451960785,0.995931036430046,1,2,lipid transport involved in lipid storage,BP,APOE
13726,GO:0060294,0.123628162372845,0.98050063916513,2,8,cilium movement involved in cell motility,BP,BBS2;CCSAP
12807,GO:0051101,0.123686692525546,0.932794205290612,11,91,regulation of DNA binding,BP,CTNNBIP1;DDIT3;HMGA2;PPARA;ITGA2;MDFI;CEBPG;TMSB4X;IFI16;PPARG;RSF1
9054,GO:0035272,0.123749631326166,0.94880931317792,6,38,exocrine system development,BP,EGFR;TGM2;FGFR1;CST3;XBP1;LAMA5
819,GO:0002091,0.123758096477446,0.981116038867403,2,7,negative regulation of receptor internalization,BP,DLG4;ATXN2
7868,GO:0032429,0.123829720068908,0.981098506342686,2,7,regulation of phospholipase A2 activity,BP,EGFR;LRP1
624,GO:0001807,0.12392720640729,0.995906564348194,1,2,regulation of type IV hypersensitivity,BP,IL20RB
2092,GO:0004857,0.123970466890154,0.916371817416694,24,231,enzyme inhibitor activity,MF,SERPINE2;TFPI2;PPP1R14A;SOCS2;TRIB2;SERPING1;ANGPTL4;ANXA3;ELFN2;PPP1R35;CST3;TRIB3;APLP2;PRDX5;PRKAR1A;PARP9;SPRY2;PPP1R10;PPP1R2;C5;TIMP2;LRP6;DNAJC3;KAT2B
1620,GO:0004053,0.124000453056014,0.995901558262919,1,2,arginase activity,MF,ARG2
6178,GO:0019547,0.124000453056014,0.995901558262919,1,2,arginine catabolic process to ornithine,BP,ARG2
19911,GO:2000406,0.124001765869678,0.968809238345926,3,15,positive regulation of T cell migration,BP,ADAM8;ITGA4;FADD
12417,GO:0048864,0.124102058460023,0.940692903823269,8,57,stem cell development,BP,SEMA4B;WNT7A;EDNRA;RET;LAMA5;ALDH1A2;TBX1;SEMA3F
17836,GO:1901998,0.124138307307514,0.953432153622482,5,33,toxin transport,BP,ANTXR2;BNIP3;ABCG1;RAB43;LRP6
7870,GO:0032431,0.124185125092731,0.995888922232464,1,2,activation of phospholipase A2 activity,BP,EGFR
14976,GO:0070884,0.124264738748807,0.969023511839152,3,14,regulation of calcineurin-NFAT signaling cascade,BP,PRNP;NFAT5;RCAN1
17208,GO:0106056,0.124264738748807,0.969023511839152,3,14,regulation of calcineurin-mediated signaling,BP,PRNP;NFAT5;RCAN1
14530,GO:0070026,0.124405577540511,0.995873810739485,1,2,nitric oxide binding,MF,CBS
16430,GO:0097066,0.124445504090359,0.968647895736258,3,15,response to thyroid hormone,BP,CTSB;CTSL;CRLS1
7682,GO:0032119,0.124680070945063,0.980234284963678,2,8,sequestering of zinc ion,BP,SLC30A1;AP3D1
5851,GO:0017147,0.124820534008836,0.960243822620016,4,21,Wnt-protein binding,MF,LRP5;FZD8;LRP6;LRP4
8584,GO:0034063,0.124900135732491,0.969159687413415,3,13,stress granule assembly,BP,ATXN2;PUM2;GRB7
11802,GO:0046683,0.124954749739403,0.932154289374272,11,85,response to organophosphorus,BP,RAPGEF3;SSH1;SDC1;PKD2;LDHA;AKAP9;BSG;CRLS1;LPAR1;ITPR2;EEF2K
7893,GO:0032461,0.124990226669377,0.968179756336327,3,16,positive regulation of protein oligomerization,BP,MMP1;SNX9;IDE
3169,GO:0006780,0.125092839646452,0.995826510315413,1,2,uroporphyrinogen III biosynthetic process,BP,UROS
11711,GO:0046502,0.125092839646452,0.995826510315413,1,2,uroporphyrinogen III metabolic process,BP,UROS
8246,GO:0033017,0.125137560296087,0.960329311518501,4,20,sarcoplasmic reticulum membrane,CC,NOS1;ASPH;FKBP1A;ITPR2
19243,GO:1905397,0.125329919745244,0.995810126542338,1,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,ARG2
19244,GO:1905402,0.125329919745244,0.995810126542338,1,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,ARG2
4858,GO:0014070,0.125336663746815,0.901198856776049,63,634,response to organic cyclic compound,BP,CCND1;PCK2;ITGA6;CYP27B1;POSTN;NR1D1;NFATC4;MAP2K1;FAM210B;RAPGEF3;EIF4EBP1;SSH1;EGFR;WNT7A;SDC1;PAK1;SOCS2;TGFBR2;IMPACT;FKBP1A;PKD2;PRKACB;LDHA;AKAP9;ANXA3;ATF4;PPARA;ASNS;BTRC;ITGA2;LONP2;MTHFR;BSG;XRN1;MMP14;CST3;CSNK2A1;CRLS1;THRA;BCL2L1;GLB1;MAP2K2;RMRP;PUM2;PRKACA;NR2F6;ZNF354A;ITPR2;PPARG;ALDH1A2;ENDOG;IGFBP7;LRP6;TMEM173;EEF2K;ZC3H7A;FOXP1;PTCH1;ADCY1;UFL1;GNAI1;DNMT3A;FADD
18416,GO:1903450,0.125376455586132,1,1,1,regulation of G1 to G0 transition,BP,RAB11FIP4
18417,GO:1903452,0.125376455586132,1,1,1,positive regulation of G1 to G0 transition,BP,RAB11FIP4
1757,GO:0004360,0.125488616044923,1,1,1,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,GFPT1
14817,GO:0070548,0.125488616044923,1,1,1,L-glutamine aminotransferase activity,MF,GFPT1
10673,GO:0043903,0.125710154726035,0.919458461572069,19,178,regulation of symbiosis, encompassing mutualism through parasitism,BP,TNIP1;ADARB1;PC;EXOC2;STOM;APOE;HMGA2;APOBEC3C;TRIM5;MVB12B;F2RL1;MVB12A;IFITM1;YTHDC2;EIF2AK2;IFI16;RSF1;OAS1;TRIM38
5652,GO:0016747,0.126025240479712,0.919297206395531,19,172,transferase activity, transferring acyl groups other than amino-acyl groups,MF,MBOAT2;ELOVL1;SPTLC2;NAGS;AGPAT4;LPCAT4;LPCAT1;ZDHHC2;CPT2;CRLS1;CRAT;AGPAT3;MBOAT7;ZDHHC1;AGPAT1;OSGEPL1;ELOVL4;KAT2B;ALAS1
2859,GO:0006349,0.126029912476225,0.968755041682621,3,13,regulation of gene expression by genetic imprinting,BP,ARID4A;IGF2;DNMT3A
18066,GO:1902624,0.126053108356121,0.967340939507407,3,18,positive regulation of neutrophil migration,BP,RAC2;MOSPD2;ADAM8
13503,GO:0055070,0.126198854681298,0.967734492077378,3,16,copper ion homeostasis,BP,PRNP;ATP7B;MT2A
5899,GO:0018105,0.126215124757887,0.914860962091669,24,209,peptidyl-serine phosphorylation,BP,RAPGEF3;PKN1;EGFR;STK39;MAPK13;TTBK2;DKK1;PAK1;TGFBR2;CD44;AKAP9;HMGA2;INPP5F;PFN2;MAPKAPK3;NLK;MAST3;SPRY2;PSKH1;MAP2K2;RET;PRKACA;NEK6;AKT3
12659,GO:0050863,0.126217974659241,0.918130744598997,20,184,regulation of T cell activation,BP,PRNP;PAG1;FYN;DLG1;ARG2;PAK1;RAG1;TGFBR2;RAC2;CEACAM1;CD46;PRKAR1A;XBP1;PDE5A;CARD11;AP3D1;IGF2;ADAM8;IL20RB;FADD
16550,GO:0097306,0.126320023724961,0.943403103734441,7,43,cellular response to alcohol,BP,ADCY7;XRN1;ITPR2;PPARG;LRP6;PTCH1;DNMT3A
13610,GO:0060080,0.126353701394898,0.981397293142993,2,6,inhibitory postsynaptic potential,BP,NTSR1;NLGN2
16471,GO:0097151,0.126353701394898,0.981397293142993,2,6,positive regulation of inhibitory postsynaptic potential,BP,NTSR1;NLGN2
16887,GO:0098828,0.126353701394898,0.981397293142993,2,6,modulation of inhibitory postsynaptic potential,BP,NTSR1;NLGN2
9714,GO:0038128,0.12643753172618,0.952526071634544,5,31,ERBB2 signaling pathway,BP,EGFR;SHC1;PTPN12;PTK6;GRB7
19867,GO:2000345,0.126506872756091,0.980438463744068,2,7,regulation of hepatocyte proliferation,BP,CEACAM1;XBP1
6671,GO:0030031,0.126632000494908,0.90416037420702,46,437,cell projection assembly,BP,ZMYND8;NEURL1;ITGA6;BBS2;WWTR1;SSH1;PARVB;ARAP1;PLXNB3;PODXL;ESPN;EVI5L;TTBK2;UNC119B;SEPT10;ATXN10;NUDCD3;RAC2;AKAP9;LPAR3;PTPDC1;PFN2;CEP120;FAM110C;TWF2;WASF3;RFX2;FNBP1L;F2RL1;ASAP1;SEPT5;MARK4;WASF2;SPATA6;TCTN1;NCKAP1;DOCK11;CCDC88A;PRKACA;LPAR1;TENM2;LAMA5;WDR60;TMEM107;WASL;SEPT6
3717,GO:0008235,0.126696357775718,0.952398402862249,5,31,metalloexopeptidase activity,MF,LTA4H;RNPEPL1;MMP14;NPEPL1;AEBP1
1638,GO:0004081,0.126866936640314,0.995703075460752,1,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,GARS
3977,GO:0008796,0.126866936640314,0.995703075460752,1,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,GARS
5392,GO:0016229,0.126950014887815,0.966817672817581,3,19,steroid dehydrogenase activity,MF,HSD17B7;SRD5A3;HSD17B12
14633,GO:0070201,0.127012365669675,0.902395964878667,51,513,regulation of establishment of protein localization,BP,EDEM1;F2R;SORL1;PCK2;PRNP;POSTN;SH3TC2;NR1D1;RAPGEF3;ALOX15B;HADH;EGFR;ANK3;FYN;UBE2J1;IDH2;GLUL;MAP4K4;GDI1;CEMIP;ARG2;STOM;PAK1;RAC2;BNIP3L;LRP1;ICA1;VAMP2;SOX4;ITPR3;FERMT1;NLGN2;LRP5;VPS11;PPP3CB;F2RL1;SLC25A4;ANO1;GLUD1;XBP1;C5;TMSB4X;IL1RAP;ITPR2;EFCAB7;ERLEC1;LYPLA1;RPH3AL;ADAM8;TMEM173;FOXP1
8306,GO:0033138,0.1271967288997,0.938706060400286,8,60,positive regulation of peptidyl-serine phosphorylation,BP,RAPGEF3;EGFR;PAK1;CD44;AKAP9;PFN2;SPRY2;RET
12664,GO:0050868,0.127286827224159,0.938652585775169,8,60,negative regulation of T cell activation,BP,PRNP;PAG1;DLG1;ARG2;CEACAM1;PRKAR1A;PDE5A;IL20RB
531,GO:0001649,0.12730020340127,0.92081515168973,17,140,osteoblast differentiation,BP,CTNNBIP1;ACVR2B;WWTR1;RDH14;MRC2;SMOC1;FAM20C;LRP5;PTHLH;COL6A1;IFITM1;MEF2D;SH3PXD2B;PRKACA;BCAP29;PTCH1;UFL1
12770,GO:0051045,0.127361318660325,0.980225874935892,2,7,negative regulation of membrane protein ectodomain proteolysis,BP,PTPN3;TIMP2
15538,GO:0071933,0.127894706450546,0.98009269428965,2,7,Arp2/3 complex binding,MF,SNX9;JMY
17251,GO:0120031,0.127927228271456,0.903400366018262,45,427,plasma membrane bounded cell projection assembly,BP,ZMYND8;NEURL1;ITGA6;BBS2;WWTR1;SSH1;PARVB;ARAP1;PLXNB3;PODXL;ESPN;EVI5L;TTBK2;UNC119B;SEPT10;ATXN10;NUDCD3;RAC2;AKAP9;LPAR3;PTPDC1;PFN2;CEP120;TWF2;WASF3;RFX2;FNBP1L;F2RL1;ASAP1;SEPT5;MARK4;WASF2;SPATA6;TCTN1;NCKAP1;DOCK11;CCDC88A;PRKACA;LPAR1;TENM2;LAMA5;WDR60;TMEM107;WASL;SEPT6
7060,GO:0030838,0.128015363700953,0.935007341148501,9,72,positive regulation of actin filament polymerization,BP,WIPF1;DLG1;RAC2;PFN2;JMY;SPIRE1;NCKAP1;ARPC1A;WASL
1744,GO:0004344,0.128036642240689,1,1,1,glucose dehydrogenase activity,MF,H6PD
12052,GO:0047936,0.128036642240689,1,1,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,H6PD
82,GO:0000165,0.128044852845236,0.899487047875232,60,606,MAPK cascade,BP,TNIP1;XDH;F2R;SORL1;IGFBP4;MAP2K1;PKN1;MST1R;PSMD2;EGFR;STK39;FYN;ERCC6;MAPK13;DLG1;DLG4;WNT7A;MAP4K4;SHC1;DKK1;PAK1;RASA3;TRIB2;EPHA1;CD44;APOE;RGS14;AKAP9;ABCA7;LPAR3;FGFR1;ITGA1;BTRC;CEACAM1;MAPKAPK3;NLK;TRIM5;TRIB3;RANBP9;F2RL1;TAOK1;PSMD7;SPRY2;NGFR;MAP2K2;RET;PDE5A;C5;PAK6;SHC2;TIMP2;EIF2AK2;LPAR1;IGF2;MAP4K2;TBX1;ADAM8;FZD8;ANKRD6;RB1CC1
8191,GO:0032929,0.128123648971838,0.99561447249594,1,2,negative regulation of superoxide anion generation,BP,ACP5
14546,GO:0070060,0.128147020912255,1,1,1,'de novo' actin filament nucleation,BP,JMY
17566,GO:1901160,0.128170632655347,0.980023656460194,2,7,primary amino compound metabolic process,BP,AZIN2;RNF180
4470,GO:0010466,0.128639951363608,0.922271748685858,15,137,negative regulation of peptidase activity,BP,SORL1;SERPINE2;TFPI2;TNFRSF6B;RAG1;SERPING1;CD44;CST3;APLP2;PRDX5;CSNK2A1;NGFR;C5;TIMP2;IFI16
12708,GO:0050926,0.128644196597179,0.96710742773038,3,15,regulation of positive chemotaxis,BP,PGF;ITGA2;F2RL1
2630,GO:0005956,0.128697026742658,0.995573725372214,1,2,protein kinase CK2 complex,CC,CSNK2A1
8526,GO:0033762,0.128697122199145,0.951537980057084,5,30,response to glucagon,BP,ADCY7;PRKACB;PRKAR1A;PRKACA;ADCY1
14294,GO:0061394,0.128723001168337,0.995571874718508,1,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,ATF4
6841,GO:0030306,0.128744257297995,0.980827328302489,2,6,ADP-ribosylation factor binding,MF,SORL1;RAB11FIP4
10932,GO:0044550,0.128921864134247,0.967329999081719,3,14,secondary metabolite biosynthetic process,BP,CBS;CTH;TRPC1
9274,GO:0035697,0.128961082204654,0.995554892355074,1,2,CD8-positive, alpha-beta T cell extravasation,BP,FADD
9275,GO:0035698,0.128961082204654,0.995554892355074,1,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
15914,GO:0072683,0.128961082204654,0.995554892355074,1,2,T cell extravasation,BP,FADD
19912,GO:2000407,0.128961082204654,0.995554892355074,1,2,regulation of T cell extravasation,BP,FADD
19930,GO:2000449,0.128961082204654,0.995554892355074,1,2,regulation of CD8-positive, alpha-beta T cell extravasation,BP,FADD
19932,GO:2000452,0.128961082204654,0.995554892355074,1,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,FADD
8289,GO:0033106,0.12908391667095,0.995546116929585,1,2,cis-Golgi network membrane,CC,BOK
13075,GO:0051582,0.12913571060131,0.995542413936338,1,2,positive regulation of neurotransmitter uptake,BP,RAB3B
3408,GO:0007189,0.129144782358841,0.94593880974454,6,38,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1;ADCY7;ADGRF1;ADM2;PTHLH;ADCY1
15187,GO:0071322,0.129216934192878,0.929231791450852,11,90,cellular response to carbohydrate stimulus,BP,PCK2;NR1D1;MAPK13;MAP4K4;SOX4;LRP5;PPP3CB;ANO1;XBP1;PRKACA;ENDOG
7273,GO:0031253,0.129291903874219,0.912599638274203,24,202,cell projection membrane,CC,BBS2;DLG1;PODXL;PAK1;SHANK2;CD44;PKD2;DDN;ATF4;ABCA7;CEACAM1;FERMT1;PLEK2;SYTL1;ASAP1;SPRY2;SLC6A14;ARF4;NCKAP1;PSD3;EPB41L3;ARPC1A;EFCAB7;PTCH1
5229,GO:0015842,0.129450610501697,0.995519864756095,1,2,aminergic neurotransmitter loading into synaptic vesicle,BP,SLC18A2
16822,GO:0098700,0.129450610501697,0.995519864756095,1,2,neurotransmitter loading into synaptic vesicle,BP,SLC18A2
2936,GO:0006457,0.129610327397736,0.914523581783309,21,210,protein folding,BP,DNAJB5;FKBP9;CRTAP;NUDCD3;ERO1B;FKBP1A;FYCO1;TMX4;LTBP4;FKBP10;PDIA5;LMAN1;CSNK2A1;QSOX1;HSPA13;TXNDC11;ERP44;WFS1;HSPA2;DNAJC4;GNAI1
132,GO:0000272,0.129643152104088,0.95813150407639,4,21,polysaccharide catabolic process,BP,PYGL;PYGB;PGM1;RB1CC1
10786,GO:0044247,0.129643152104088,0.95813150407639,4,21,cellular polysaccharide catabolic process,BP,PYGL;PYGB;PGM1;RB1CC1
11010,GO:0044829,0.129711875934995,0.979636248426525,2,7,positive regulation by host of viral genome replication,BP,STOM;YTHDC2
6988,GO:0030666,0.129733541421941,0.924835412428845,13,112,endocytic vesicle membrane,CC,EGFR;DLG4;WNT7A;RAC2;APOE;LRP1;ANXA3;RAB31;EPN2;RAB43;AP2A2;WASL;PTCH1
3439,GO:0007229,0.129790792231331,0.934428530734511,9,61,integrin-mediated signaling pathway,BP,ITGA6;ITGB4;ITGA1;ITGB5;ITGA2;CEACAM1;FERMT1;LAMA5;ITGA4
14670,GO:0070273,0.129856551521008,0.957636726333908,4,23,phosphatidylinositol-4-phosphate binding,MF,GSDMC;GSDMA;OSBPL5;SH3PXD2B
14420,GO:0061711,0.129910214757046,0.995486844190392,1,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,OSGEPL1
751,GO:0001990,0.129982868551444,0.966327021691062,3,16,regulation of systemic arterial blood pressure by hormone,BP,F2R;F2RL1;CTSZ
13838,GO:0060438,0.130027221480626,0.966594557172279,3,15,trachea development,BP,MAP2K1;TGFBR2;LRP6
6347,GO:0021523,0.130219057419153,0.995464582154481,1,2,somatic motor neuron differentiation,BP,TCTN1
5764,GO:0016936,0.130387658178173,0.995452404267971,1,2,galactoside binding,MF,GLB1
20175,GO:2001021,0.130535883703896,0.936617371615229,8,62,negative regulation of response to DNA damage stimulus,BP,ERCC1;CD44;HMGA2;PPP1R10;BCL2L1;RNF169;MAGEF1;KLHL15
17447,GO:1900223,0.130613660490374,0.980376732240758,2,6,positive regulation of amyloid-beta clearance,BP,LRP1;ABCA7
15346,GO:0071568,0.130692516785789,0.99543034013336,1,2,UFM1 transferase activity,MF,UFL1
1699,GO:0004177,0.13089262548385,0.950077716842853,5,33,aminopeptidase activity,MF,LTA4H;RNPEPL1;MMP14;NPEPL1;BLMH
17230,GO:0110020,0.130899982392079,0.933635667057354,9,63,regulation of actomyosin structure organization,BP,RAPGEF3;ARAP1;PAK1;EPHA1;PFN2;FHOD1;WASF2;SH3PXD2B;LPAR1
6294,GO:0019904,0.130927761064356,0.897730080864737,57,559,protein domain specific binding,MF,DOCK4;EPN3;ERCC1;ADAM19;SH2D2A;CTNNBIP1;PAG1;RAPGEF3;SH3KBP1;POU2F2;DDIT3;WIPF1;FYN;DLG1;DLG4;PLXNB3;TGM2;ESPN;DLG3;DAP;SHANK2;PTPN12;PKD2;HMGA2;ATF4;PPARA;ICA1;ATRX;FHOD1;NLK;CLCN3;CASP4;VPS11;DNAJC6;PRKAR1A;BOK;THRA;MVB12A;BCL2L1;WASF2;MAP2K2;SH3PXD2B;ZFYVE9;ELMO3;TCEAL8;ANGEL1;AP2A2;CARD11;LPAR1;TBL1X;HOXA3;PPARG;ARHGAP29;RPH3AL;FZD8;HSPA2;FADD
2307,GO:0005294,0.131001840306287,1,1,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,SLC7A11
5085,GO:0015327,0.131001840306287,1,1,1,cystine:glutamate antiporter activity,MF,SLC7A11
5086,GO:0015328,0.131001840306287,1,1,1,cystine secondary active transmembrane transporter activity,MF,SLC7A11
17745,GO:1901680,0.131001840306287,1,1,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,SLC7A11
18703,GO:1904063,0.131078145913901,0.944707744934716,6,40,negative regulation of cation transmembrane transport,BP,HECW2;STK39;ANK3;PKD2;NTSR1;SLC30A1
16878,GO:0098810,0.131573362165645,0.978452969664405,2,8,neurotransmitter reuptake,BP,NOS1;RAB3B
13911,GO:0060562,0.131801077041641,0.90920016625834,26,222,epithelial tube morphogenesis,BP,ETV5;PGF;CTNNBIP1;NFATC4;DLG1;PODXL;PAK1;TGFBR2;EDNRA;PKD2;PRKACB;BTRC;SOX4;DVL1;MMP14;LRP5;RASIP1;SPRY2;WNT2B;RET;TCTN1;CTSZ;LAMA5;LRP6;FOXP1;PTCH1
7676,GO:0032105,0.131849577347026,0.978380300518604,2,8,negative regulation of response to extracellular stimulus,BP,BBS2;PPARA
7679,GO:0032108,0.131849577347026,0.978380300518604,2,8,negative regulation of response to nutrient levels,BP,BBS2;PPARA
3018,GO:0006563,0.131905533121604,0.977823232873078,2,9,L-serine metabolic process,BP,CBS;PSAT1
5857,GO:0017156,0.131970096265695,0.932821961881293,9,66,calcium ion regulated exocytosis,BP,SNPH;VAMP2;PFN2;RIMS3;PPP3CB;SYTL1;SEPT5;RPH3AL;SYT2
7669,GO:0032098,0.131990766459911,0.978343116925168,2,8,regulation of appetite,BP,BBS2;PPARA
16855,GO:0098772,0.13214199456655,0.889739658681795,107,1131,molecular function regulator,MF,DOCK4;NOS1;PGF;CCND1;ASAP2;SERPINE2;ADM2;MAP2K1;CMTM4;TFPI2;RAPGEF3;ARHGAP22;APLN;TNFSF15;APPL2;PSMD2;DENND5B;EGFR;TBC1D14;RIN2;SEMA4B;ARHGAP12;PPP1R14A;FYN;ERCC6;ARAP1;DLG1;DLG4;NET1;EVI5L;WNT7A;GDI1;SHC1;DKK1;RASA3;SOCS2;TRIB2;PTPN3;SERPING1;RALGAPA2;RAC2;OBSCN;APOE;ANGPTL4;RGS14;SRGAP2B;AKAP9;PPP2R3B;ANXA3;ELFN2;FGFR1;PPP1R35;CMTM7;RALGAPA1;MMP14;ETAA1;DNMBP;DOCK9;CST3;TRIB3;RANBP9;APLP2;PRDX5;TAOK1;CSNK2A1;PTHLH;ASAP1;PRKAR1A;PARP9;USP6NL;SPRY2;TBC1D2B;PPP1R10;NUDT6;AZIN2;ARF4;MAP2K2;PPP1R2;RIN1;RET;SH3PXD2B;C5;DOCK11;SLC30A1;PSD3;SHC2;RGL2;TIMP2;EIF2AK2;CMTM6;IGF2;ARHGAP29;EVI5;DEPDC1;ACAP2;CKLF;TBC1D16;WASL;RAPGEFL1;PRSS8;LRP6;RALGDS;RCAN1;DNAJC3;KAT2B;SEMA3F;RALGPS2
20103,GO:2000774,0.132267093142444,0.97772568428406,2,9,positive regulation of cellular senescence,BP,ARG2;HMGA2
12989,GO:0051393,0.132288205422623,0.967515365163381,3,11,alpha-actinin binding,MF,PKD2;OBSL1;PPARG
12990,GO:0051400,0.132359490190074,0.978245887600862,2,8,BH domain binding,MF,BOK;BCL2L1
14002,GO:0060717,0.132448229280856,0.978941000640176,2,7,chorion development,BP,HTRA1;E2F7
8510,GO:0033688,0.132516881112612,0.966001929350152,3,14,regulation of osteoblast proliferation,BP,LRP5;EIF2AK2;HPSE
9932,GO:0042278,0.132545159019985,0.935317750801077,8,64,purine nucleoside metabolic process,BP,NT5E;DLG1;DLG4;NME4;DLG3;AHCYL2;GAMT;CARD11
4569,GO:0010650,0.132582427630917,1,1,1,positive regulation of cell communication by electrical coupling,BP,ANK3
15894,GO:0072658,0.132582427630917,1,1,1,maintenance of protein location in membrane,BP,ANK3
15896,GO:0072660,0.132582427630917,1,1,1,maintenance of protein location in plasma membrane,BP,ANK3
17521,GO:1900827,0.132582427630917,1,1,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
1805,GO:0004450,0.132678498338513,0.995285201329203,1,2,isocitrate dehydrogenase (NADP+) activity,MF,IDH2
2719,GO:0006097,0.132678498338513,0.995285201329203,1,2,glyoxylate cycle,BP,IDH2
1285,GO:0003093,0.132697351039192,0.978156641497615,2,8,regulation of glomerular filtration,BP,F2R;F2RL1
1885,GO:0004566,0.132713917463971,0.995282590725741,1,2,beta-glucuronidase activity,MF,HPSE
15769,GO:0072363,0.132917568732587,1,1,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
15772,GO:0072366,0.132917568732587,1,1,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
9576,GO:0036378,0.132994585989873,0.995261876320405,1,2,calcitriol biosynthetic process from calciol,BP,CYP27B1
3925,GO:0008597,0.133032642418958,0.995259063858664,1,2,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,RCAN1
763,GO:0002009,0.133110444327238,0.900156565967118,42,394,morphogenesis of an epithelium,BP,SMURF2;ETV5;PGF;CTNNBIP1;NFATC4;PSMD2;EGFR;ARHGAP12;DLG1;GPC4;PODXL;TGM2;WNT7A;DLG3;DKK1;PAK1;TGFBR2;EDNRA;CD44;PKD2;PRKACB;FGFR1;BTRC;SOX4;CEACAM1;DVL1;MMP14;LRP5;RASIP1;PSMD7;SPRY2;WNT2B;RET;TCTN1;AP2A2;CTSZ;LAMA5;ALDH1A2;LRP6;FOXP1;PTCH1;ANKRD6
16548,GO:0097300,0.133195465912603,0.948707029253267,5,35,programmed necrotic cell death,BP,PYGL;RBCK1;SLC25A4;BOK;FADD
5962,GO:0018352,0.133278806898421,0.995240850059187,1,2,protein-pyridoxal-5-phosphate linkage,BP,CTH
3409,GO:0007190,0.133387863178503,0.965677466441567,3,14,activation of adenylate cyclase activity,BP,ADCY7;EDNRA;ADCY1
10841,GO:0044335,0.133390921598389,1,1,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,LRP6
19714,GO:2000055,0.133390921598389,1,1,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,LRP6
19365,GO:1905794,0.133433640935866,1,1,1,response to puromycin,BP,XRN1
19366,GO:1905795,0.133433640935866,1,1,1,cellular response to puromycin,BP,XRN1
11056,GO:0045053,0.133482094615938,0.981144650664147,2,5,protein retention in Golgi apparatus,BP,SORL1;VPS13A
19569,GO:1990590,0.133785920772649,0.995203210249918,1,2,ATF1-ATF4 transcription factor complex,CC,ATF4
10125,GO:0042659,0.133786206982394,0.978597594909459,2,7,regulation of cell fate specification,BP,DKK1;FGFR1
14262,GO:0061317,0.133939593259538,0.995191772671802,1,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
17609,GO:1901295,0.133939593259538,0.995191772671802,1,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,DKK1
19123,GO:1905066,0.133939593259538,0.995191772671802,1,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,DKK1
17803,GO:1901896,0.134026886304659,0.995185269082345,1,2,positive regulation of calcium-transporting ATPase activity,BP,HSPA2
9422,GO:0035988,0.13416274530536,0.978500544116081,2,7,chondrocyte proliferation,BP,HMGA2;MMP14
5779,GO:0017001,0.134266868347179,0.954896630879614,4,28,antibiotic catabolic process,BP,PCK2;GPX3;PRDX5;NPL
9479,GO:0036112,0.13427995809694,0.995166387785412,1,2,medium-chain fatty-acyl-CoA metabolic process,BP,ACOT7
14522,GO:0070006,0.134377810900673,0.964963749372281,3,15,metalloaminopeptidase activity,MF,LTA4H;RNPEPL1;MMP14
2543,GO:0005802,0.134603805644908,0.913074855363185,19,167,trans-Golgi network,CC,SORL1;POSTN;MARCH9;ARAP1;SNX9;SLC9A7;ATP7B;MARCH4;VAMP2;CHAC1;RAB31;CLTCL1;BOK;ATXN2;USP6NL;AZIN2;STX10;RAB43;COG8
10453,GO:0043309,0.134613283634132,0.995141458265233,1,2,regulation of eosinophil degranulation,BP,F2RL1
10454,GO:0043311,0.134613283634132,0.995141458265233,1,2,positive regulation of eosinophil degranulation,BP,F2RL1
18043,GO:1902566,0.134613283634132,0.995141458265233,1,2,regulation of eosinophil activation,BP,F2RL1
18044,GO:1902568,0.134613283634132,0.995141458265233,1,2,positive regulation of eosinophil activation,BP,F2RL1
7993,GO:0032611,0.13495932396703,0.942424276689268,6,42,interleukin-1 beta production,BP,F2R;ARG2;ACP5;F2RL1;IFI16;FOXP1
2396,GO:0005540,0.135013160763146,0.977540932963377,2,8,hyaluronic acid binding,MF,CEMIP;CD44
3132,GO:0006720,0.135030969706898,0.930609498449718,9,73,isoprenoid metabolic process,BP,EGFR;GPC4;RDH14;SDC1;APOE;LRP1;SRD5A3;ALDH1A2;COQ2
14531,GO:0070032,0.135385117166682,0.995083467863287,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,VAMP2
14532,GO:0070033,0.135385117166682,0.995083467863287,1,2,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,VAMP2
1353,GO:0003221,0.135386304834809,1,1,1,right ventricular cardiac muscle tissue morphogenesis,BP,CHD7
1356,GO:0003226,0.135386304834809,1,1,1,right ventricular compact myocardium morphogenesis,BP,CHD7
6369,GO:0021553,0.135386304834809,1,1,1,olfactory nerve development,BP,CHD7
2377,GO:0005507,0.135478764689035,0.947449040956388,5,36,copper ion binding,MF,PRNP;LOXL1;ATP7B;LOXL2;ADNP
15019,GO:0070949,0.135486375556345,0.995075832529069,1,2,regulation of neutrophil mediated killing of symbiont cell,BP,F2RL1
15023,GO:0070960,0.135486375556345,0.995075832529069,1,2,positive regulation of neutrophil mediated cytotoxicity,BP,F2RL1
15024,GO:0070961,0.135486375556345,0.995075832529069,1,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,F2RL1
20255,GO:2001212,0.135609455653301,0.978125995726488,2,7,regulation of vasculogenesis,BP,XDH;CEACAM1
7162,GO:0031032,0.135741099273962,0.916241904613288,16,124,actomyosin structure organization,BP,RAPGEF3;ARAP1;PAK1;EPHA1;OBSCN;TMOD2;ITGB5;PFN2;FHOD1;OBSL1;CDC42BPA;PRKAR1A;WASF2;SH3PXD2B;EPB41L3;LPAR1
11949,GO:0047025,0.135800725683478,0.995052088524304,1,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,CBR4
5144,GO:0015671,0.135962561164774,0.995039840545358,1,2,oxygen transport,BP,CYGB
3416,GO:0007198,0.13598119484238,0.995038429271821,1,2,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,HTR7
2066,GO:0004820,0.1360668410239,0.995031939841584,1,2,glycine-tRNA ligase activity,MF,GARS
2916,GO:0006426,0.1360668410239,0.995031939841584,1,2,glycyl-tRNA aminoacylation,BP,GARS
14599,GO:0070150,0.1360668410239,0.995031939841584,1,2,mitochondrial glycyl-tRNA aminoacylation,BP,GARS
3659,GO:0008140,0.136209816552473,0.977220053955267,2,8,cAMP response element binding protein binding,MF,DDIT3;CRTC1
13039,GO:0051495,0.136227798990205,0.913018432355581,18,158,positive regulation of cytoskeleton organization,BP,RAPGEF3;WIPF1;DLG1;PAK1;EPHA1;RAC2;AKAP9;PFN2;FHOD1;CEP120;F2RL1;JMY;SPIRE1;SH3PXD2B;NCKAP1;LPAR1;ARPC1A;WASL
3068,GO:0006633,0.136631313215804,0.924274261656276,11,93,fatty acid biosynthetic process,BP,ALOX15B;ELOVL1;ACOT7;CBR4;CEACAM1;TRIB3;MLYCD;MGLL;XBP1;ELOVL4;HSD17B12
11532,GO:0046056,0.13667283758843,0.994985892931706,1,2,dADP metabolic process,BP,AK9
2214,GO:0005109,0.13680114357085,0.954509996380414,4,23,frizzled binding,MF,WNT7A;DVL1;WNT2B;LRP6
9121,GO:0035418,0.13686552221384,0.954683532553115,4,22,protein localization to synapse,BP,DLG4;WNT7A;DVL1;NLGN2
2289,GO:0005247,0.136886943822467,0.977793062607312,2,7,voltage-gated chloride channel activity,MF,CLCN3;ANO1
10129,GO:0042663,0.136929665601264,0.994966308755527,1,2,regulation of endodermal cell fate specification,BP,DKK1
2104,GO:0004879,0.137070130296574,0.947206705951175,5,31,nuclear receptor activity,MF,NR1D1;PPARA;THRA;NR2F6;PPARG
16753,GO:0098531,0.137070130296574,0.947206705951175,5,31,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,NR1D1;PPARA;THRA;NR2F6;PPARG
6258,GO:0019842,0.137119782306958,0.926448379500384,10,83,vitamin binding,MF,PYGL;CBS;PYGB;GPT2;DHTKD1;PC;SPTLC2;CTH;ALDH1A2;ALAS1
5184,GO:0015747,0.137415186053844,0.994929173557075,1,2,urate transport,BP,SLC2A9
15192,GO:0071332,0.137716713893293,0.994906037111303,1,2,cellular response to fructose stimulus,BP,XBP1
4003,GO:0008941,0.137807600224242,0.994899052213882,1,2,nitric oxide dioxygenase activity,MF,CYGB
5629,GO:0016708,0.137807600224242,0.994899052213882,1,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,CYGB
7640,GO:0032050,0.137853239706657,0.977539864987912,2,7,clathrin heavy chain binding,MF,CEMIP;LRP1
11994,GO:0047372,0.137942346496905,0.97675220295047,2,8,acylglycerol lipase activity,MF,MGLL;ABHD6
18114,GO:1902769,0.137959235224814,1,1,1,regulation of choline O-acetyltransferase activity,BP,SORL1
18115,GO:1902771,0.137959235224814,1,1,1,positive regulation of choline O-acetyltransferase activity,BP,SORL1
18179,GO:1902948,0.137959235224814,1,1,1,negative regulation of tau-protein kinase activity,BP,SORL1
18186,GO:1902955,0.137959235224814,1,1,1,positive regulation of early endosome to recycling endosome transport,BP,SORL1
18209,GO:1902997,0.137959235224814,1,1,1,negative regulation of neurofibrillary tangle assembly,BP,SORL1
7559,GO:0031901,0.137993879355681,0.91930686660402,13,107,early endosome membrane,CC,APPL2;EGFR;DKK1;ABCA7;INPP5F;RAB31;CLCN3;BOK;MTMR4;ZFYVE9;SNX6;LRP6;SNX27
3783,GO:0008344,0.138007892240564,0.941035480451404,6,39,adult locomotory behavior,BP,SLITRK6;CCND2;INPP5F;NTSR1;CHD7;PBX3
12886,GO:0051224,0.138069895308262,0.921072681522922,12,104,negative regulation of protein transport,BP,F2R;HADH;UBE2J1;IDH2;MAP4K4;GDI1;ARG2;SOX4;F2RL1;TMSB4X;ERLEC1;LYPLA1
15669,GO:0072189,0.138116337263509,0.977470722190554,2,7,ureter development,BP,RET;ALDH1A2
20130,GO:2000821,0.138174626871103,0.994870792627869,1,2,regulation of grooming behavior,BP,DLG4
9606,GO:0036465,0.138196743136454,0.941148649664712,6,37,synaptic vesicle recycling,BP,WNT7A;NLGN2;DNAJC6;FCHO2;AP3D1;SYT2
6788,GO:0030224,0.138514061120302,0.953541499266812,4,24,monocyte differentiation,BP,CTNNBIP1;IFI16;PPARG;FOXP1
18268,GO:1903131,0.138514061120302,0.953541499266812,4,24,mononuclear cell differentiation,BP,CTNNBIP1;IFI16;PPARG;FOXP1
2063,GO:0004817,0.138545389360822,0.994842159995009,1,2,cysteine-tRNA ligase activity,MF,CARS
2913,GO:0006423,0.138545389360822,0.994842159995009,1,2,cysteinyl-tRNA aminoacylation,BP,CARS
1788,GO:0004416,0.138566384723608,0.994840536030778,1,2,hydroxyacylglutathione hydrolase activity,MF,HAGH
6086,GO:0019243,0.138566384723608,0.994840536030778,1,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,HAGH
13087,GO:0051596,0.138566384723608,0.994840536030778,1,2,methylglyoxal catabolic process,BP,HAGH
14426,GO:0061727,0.138566384723608,0.994840536030778,1,2,methylglyoxal catabolic process to lactate,BP,HAGH
7666,GO:0032095,0.138609625433273,0.97657097825826,2,8,regulation of response to food,BP,BBS2;PPARA
12984,GO:0051387,0.138621983624257,0.994836234197066,1,2,negative regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
15015,GO:0070944,0.138789256028471,0.99482328024071,1,2,neutrophil mediated killing of bacterium,BP,F2RL1
15016,GO:0070945,0.138789256028471,0.99482328024071,1,2,neutrophil mediated killing of gram-negative bacterium,BP,F2RL1
13061,GO:0051561,0.138920861121207,0.975899707831273,2,9,positive regulation of mitochondrial calcium ion concentration,BP,BNIP3;TGM2
9000,GO:0035120,0.138923376936228,1,1,1,post-embryonic appendage morphogenesis,BP,ATRX
9001,GO:0035127,0.138923376936228,1,1,1,post-embryonic limb morphogenesis,BP,ATRX
9002,GO:0035128,0.138923376936228,1,1,1,post-embryonic forelimb morphogenesis,BP,ATRX
16588,GO:0097393,0.138923376936228,1,1,1,telomeric repeat-containing RNA transcription,BP,ATRX
16589,GO:0097394,0.138923376936228,1,1,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,ATRX
17696,GO:1901580,0.138923376936228,1,1,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,ATRX
17697,GO:1901581,0.138923376936228,1,1,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,ATRX
17698,GO:1901582,0.138923376936228,1,1,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,ATRX
19525,GO:1990421,0.138923376936228,1,1,1,subtelomeric heterochromatin,CC,ATRX
19592,GO:1990707,0.138923376936228,1,1,1,nuclear subtelomeric heterochromatin,CC,ATRX
2941,GO:0006468,0.139154864287858,0.882054788971502,126,1319,protein phosphorylation,BP,TNIP1;XDH;F2R;SORL1;CCND1;NEURL1;VLDLR;RPS6KA2;ADCY7;IGFBP4;PRNP;ADM2;ADARB1;MAP2K1;RAPGEF3;ACVR2B;PKN1;WWTR1;MST1R;TNFSF15;PSMD2;BRSK1;EGFR;STK39;FYN;ERCC6;MAPK13;DLG1;DLG4;SNX9;WNT7A;MAP4K4;TTBK2;GRK5;STRADB;CEMIP;SHC1;DLG3;DKK1;PAK1;RASA3;SOCS2;TRIB2;NEK9;TGFBR2;EPHA1;IMPACT;RAC2;CD44;OBSCN;APOE;FKBP1A;CCND2;CDK17;RGS14;PKD2;PRKACB;AKAP9;HMGA2;ABCA7;LPAR3;FGFR1;ITGA1;BTRC;PTK6;ULK2;INPP5F;FAM20C;PFN2;CEACAM1;MAPKAPK3;NLK;TRIM5;DVL1;LRP5;ETAA1;CNTN1;TRIB3;RANBP9;PPP3CB;SLK;CDC42BPA;SCYL3;F2RL1;TAOK1;CSNK2A1;PSMD7;PRKAR1A;PARP9;MAST3;SPRY2;ACVR1B;NGFR;PSKH1;MARK4;UBASH3B;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;NEK6;TIMP2;EIF2AK2;LPAR1;IGF2;MAP4K2;ZMYM2;SNX6;TBX1;ADAM8;AKT3;FZD8;HSPA2;LRP6;EEF2K;DNAJC3;ADCY1;KAT2B;ANKRD6;ADNP;LRP4;RB1CC1
4282,GO:0009649,0.139210094816656,0.953221691296825,4,24,entrainment of circadian clock,BP,CRTC1;PER3;MTA1;NR2F6
3579,GO:0007623,0.139239570829869,0.91353324217296,16,134,circadian rhythm,BP,NR1D1;CRTC1;EGFR;HEBP1;HTR7;ATF4;PPARA;BTRC;CST3;GFPT1;NGFR;PER3;MTA1;NR2F6;PPARG;ADCY1
12293,GO:0048627,0.139314504077157,0.994782490126293,1,2,myoblast development,BP,SDC1
19420,GO:1990005,0.13941312707301,0.994774811943558,1,2,granular vesicle,CC,AZIN2
11513,GO:0046007,0.13946325122357,0.976338307476302,2,8,negative regulation of activated T cell proliferation,BP,PRNP;PRKAR1A
12285,GO:0048598,0.139514940544491,0.895293191512694,41,380,embryonic morphogenesis,BP,ITGB4;ACVR2B;APLN;LAMB1;DLG1;WNT7A;DKK1;TGFBR2;SLITRK6;PKD2;PRKACB;HMGA2;FGFR1;ITGB5;HYAL1;ITGA2;SOX4;MDFI;DVL1;MMP14;LRP5;CHD7;PRKAR1A;SPRY2;WNT2B;COL6A1;TSHZ1;RET;TCTN1;HOXA3;IGF2;LAMA5;ALDH1A2;TBX1;ITGA4;WDR60;ZNF568;TMEM107;LRP6;PTCH1;LRP4
14828,GO:0070564,0.139950892144754,0.994732837744061,1,2,positive regulation of vitamin D receptor signaling pathway,BP,CYP27B1
1597,GO:0004016,0.139973549444219,0.97805651048416,2,6,adenylate cyclase activity,MF,ADCY7;ADCY1
1776,GO:0004383,0.139973549444219,0.97805651048416,2,6,guanylate cyclase activity,MF,ADCY7;ADCY1
3621,GO:0008074,0.139973549444219,0.97805651048416,2,6,guanylate cyclase complex, soluble,CC,ADCY7;ADCY1
2001,GO:0004725,0.140329355247473,0.924637223482995,10,76,protein tyrosine phosphatase activity,MF,MAP2K1;SSH1;PTPRS;PTPN3;PTPN12;PTPDC1;DNAJC6;PTPRZ1;UBASH3B;MTMR4
19524,GO:1990418,0.140355011696678,0.994701175789002,1,2,response to insulin-like growth factor stimulus,BP,XBP1
9698,GO:0038094,0.140457738992925,0.930786457558612,8,59,Fc-gamma receptor signaling pathway,BP,FCGRT;WIPF1;FYN;PAK1;WASF2;NCKAP1;ARPC1A;WASL
9483,GO:0036117,0.140507084124384,0.994689234716387,1,2,hyaluranon cable,CC,HYAL1
12883,GO:0051220,0.140661376922948,0.952552748097267,4,24,cytoplasmic sequestering of protein,BP,PKD2;MDFI;THRA;TMSB4X
8723,GO:0034368,0.140773766047099,0.975380860775934,2,9,protein-lipid complex remodeling,BP,APOE;ABCG1
8724,GO:0034369,0.140773766047099,0.975380860775934,2,9,plasma lipoprotein particle remodeling,BP,APOE;ABCG1
20199,GO:2001056,0.140791134991351,0.917102454640775,13,119,positive regulation of cysteine-type endopeptidase activity,BP,XDH;F2R;TNFSF15;FYN;ASPH;DAP;CASP4;BOK;NGFR;IFI16;PPARG;FAM162A;FADD
10093,GO:0042594,0.140927894559365,0.912227098373217,16,139,response to starvation,BP,PCK2;DDIT3;GLUL;DAP;IMPACT;ATF4;ASNS;ULK2;CPEB4;WNT2B;XBP1;SLC38A2;GABARAPL2;EIF2AK2;IFI16;PPARG
8119,GO:0032805,0.140971239163249,0.994652698529359,1,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE
10519,GO:0043433,0.140987659158549,0.915338958509825,14,120,negative regulation of DNA binding transcription factor activity,BP,CTNNBIP1;PRNP;DDIT3;DAP;PKD2;RBCK1;BTRC;MDFI;CEBPG;THRA;TMSB4X;WFS1;PTCH1;UFL1
14180,GO:0061077,0.141010511161104,0.930043070763165,8,67,chaperone-mediated protein folding,BP,FKBP9;CRTAP;FKBP1A;FYCO1;FKBP10;CSNK2A1;HSPA13;HSPA2
5230,GO:0015844,0.141259185146583,0.952276367573993,4,24,monoamine transport,BP,NOS1;RAB3B;SLC29A4;SLC18A2
5465,GO:0016361,0.14127491905197,0.99462872107315,1,2,activin receptor activity, type I,MF,ACVR1B
12120,GO:0048179,0.14127491905197,0.99462872107315,1,2,activin receptor complex,CC,ACVR1B
8012,GO:0032642,0.141445999766018,0.938605583144062,6,45,regulation of chemokine production,BP,POSTN;ALOX15B;ARG2;F2RL1;C5;EIF2AK2
4396,GO:0010092,0.141534147181973,0.961906308666873,3,16,specification of animal organ identity,BP,DKK1;FGFR1;WNT2B
12343,GO:0048704,0.141568573635812,0.930168877498383,8,58,embryonic skeletal system morphogenesis,BP,DLG1;TGFBR2;HYAL1;MDFI;MMP14;HOXA3;TBX1;WDR60
2394,GO:0005537,0.14158018603767,0.975757253049537,2,8,mannose binding,MF,LMAN1;BSG
4110,GO:0009165,0.14162255795026,0.902869606027091,24,234,nucleotide biosynthetic process,BP,NOS1;ADCY7;TK2;NAPRT;DHTKD1;PGM1;IDH2;ACOT7;NMRK1;NME4;APOE;LDHA;AKAP9;PPARA;PTHLH;PARP9;PANK4;TMSB4X;TIMP2;AK9;GARS;ADCY1;PANK1;ADNP
11901,GO:0046928,0.141697800699451,0.944844441560268,5,31,regulation of neurotransmitter secretion,BP,MCTP1;PFN2;RIMS3;SEPT5;SLC30A1
19533,GO:1990440,0.141847645681376,0.975078097461752,2,9,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,DDIT3;ATF4
15940,GO:0072739,0.141885291131197,0.994580353161724,1,2,response to anisomycin,BP,MAPK13
2944,GO:0006471,0.142062155000032,0.951904374710841,4,24,protein ADP-ribosylation,BP,PARP9;ARF4;KAT2B;ADNP
3748,GO:0008285,0.142068075439774,0.890998355306992,47,472,negative regulation of cell proliferation,BP,XDH;F2R;NEURL1;CTNNBIP1;RPS6KA2;CYP27B1;SERPINE2;PRNP;ADARB1;MAP2K1;ALOX15B;PKN1;APLN;CGREF1;DLG1;IDH2;ASPH;ARG2;DLG3;PAK1;TGFBR2;APOE;PKD2;ITGA1;SOX4;FBXO2;CEACAM1;FERMT1;PTHLH;PRKAR1A;NACC2;SPRY2;NGFR;IFITM1;SKAP2;PDE5A;TIMP2;EIF2AK2;PPARG;ALDH1A2;IL20RB;IGFBP7;E2F7;PTCH1;KAT2B;JARID2;MXD4
16300,GO:0090402,0.142158829319813,0.99455860112549,1,2,oncogene-induced cell senescence,BP,HMGA2
1629,GO:0004066,0.142184523567838,0.994556555475826,1,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,ASNS
2986,GO:0006529,0.142184523567838,0.994556555475826,1,2,asparagine biosynthetic process,BP,ASNS
1492,GO:0003831,0.142257077192847,0.975570245364883,2,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,B4GALT6;WDFY3
9836,GO:0042063,0.142470574115314,0.906167805019261,20,175,gliogenesis,BP,ETV5;SERPINE2;SH3TC2;MAP2K1;LAMB1;EGFR;BNIP3;IDH2;LRP1;SOX4;MMP14;WASF3;PLAG1;BOK;PTPRZ1;MBOAT7;LAMB2;LPAR1;PPARG;UFL1
2207,GO:0005093,0.142621968005938,0.994521664589598,1,2,Rab GDP-dissociation inhibitor activity,MF,GDI1
10247,GO:0042981,0.142863768208111,0.880719188948567,102,1098,regulation of apoptotic process,BP,XDH;F2R;NEURL1;ITGA6;RPS6KA2;PRNP;NFATC4;MAP2K1;MST1R;TNFSF15;DDIT3;EGFR;STK39;FYN;TNFRSF6B;BNIP3;CTSB;NET1;TGM2;GLO1;WNT7A;MAP4K4;GRK5;STRADB;NME4;ARG2;SHC1;DKK1;DAP;PAK1;SOCS2;RAG1;EPHA1;CD44;OBSCN;APOE;BNIP3L;CCND2;ANGPTL4;RBCK1;LRP1;LDHA;HMGA2;ATF4;ASNS;FGFR1;ITGA1;AARS;SOX4;NTSR1;CTH;LRP5;RABGGTA;CASP4;SLK;PRDX5;TAOK1;CSNK2A1;JMY;BOK;CPEB4;NACC2;SPRY2;THRA;NGFR;PPP1R10;BCL2L1;ARF4;XBP1;MAP2K2;RET;BEX2;PAK6;TMBIM1;RGL2;EIF2AK2;SLC39A10;CARD11;LPAR1;CTSZ;IGF2;MOAP1;MAP4K2;PPARG;ALDH1A2;TBX1;ADAM8;WFS1;ENDOG;LRP6;EEF2K;SIGMAR1;TRIM2;DEDD2;DNAJC3;FOXP1;PSEN2;UFL1;FAM162A;ADNP;RB1CC1;FADD
14438,GO:0061744,0.142906783688256,0.994498882764951,1,2,motor behavior,BP,ADARB1
15989,GO:0080184,0.143053456792606,0.99448713076182,1,2,response to phenylpropanoid,BP,EGFR
8185,GO:0032922,0.143206855879449,0.933456386070266,7,46,circadian regulation of gene expression,BP,NR1D1;ATF4;PPARA;GFPT1;NGFR;PER3;MTA1
6582,GO:0022409,0.143210363100376,0.910510940416479,16,143,positive regulation of cell-cell adhesion,BP,ITGA6;ANK3;FYN;PODXL;PAK1;RAG1;TGFBR2;CD44;CD46;XBP1;CARD11;AP3D1;IGF2;ADAM8;ITGA4;FADD
7138,GO:0030970,0.143412202885036,0.951098820376024,4,25,retrograde protein transport, ER to cytosol,BP,EDEM1;UBE2J1;SEL1L;ERLEC1
18431,GO:1903513,0.143412202885036,0.951098820376024,4,25,endoplasmic reticulum to cytosol transport,BP,EDEM1;UBE2J1;SEL1L;ERLEC1
7860,GO:0032420,0.143464977862809,0.951252397539635,4,24,stereocilium,CC,DOCK4;BBS2;ESPN;TWF2
4829,GO:0014033,0.143467994463013,0.929008340601437,8,58,neural crest cell differentiation,BP,SEMA4B;EDNRA;RET;LAMA5;ALDH1A2;TBX1;LRP6;SEMA3F
13749,GO:0060323,0.143515943220426,0.943908660132167,5,31,head morphogenesis,BP,ASPH;DKK1;TBX1;LRP6;ARID5B
711,GO:0001936,0.143537698677133,0.922469803551774,10,78,regulation of endothelial cell proliferation,BP,XDH;PGF;APLN;PLXNB3;APOE;FGFR1;NGFR;PPARG;ALDH1A2;AKT3
822,GO:0002094,0.143575295788606,0.994445209179872,1,2,polyprenyltransferase activity,MF,COQ2
1507,GO:0003865,0.143707142235737,0.994434590228298,1,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,SRD5A3
8528,GO:0033765,0.143707142235737,0.994434590228298,1,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,SRD5A3
9263,GO:0035671,0.143707142235737,0.994434590228298,1,2,enone reductase activity,MF,SRD5A3
12038,GO:0047751,0.143707142235737,0.994434590228298,1,2,cholestenone 5-alpha-reductase activity,MF,SRD5A3
8889,GO:0034704,0.143721345099767,0.951328609237679,4,23,calcium channel complex,CC,NOS1;FKBP1A;PRKACA;HSPA2
14627,GO:0070194,0.143880539835945,0.994420608049188,1,2,synaptonemal complex disassembly,BP,HSPA2
1394,GO:0003308,0.143899816815568,0.994419052449527,1,2,negative regulation of Wnt signaling pathway involved in heart development,BP,DKK1
11764,GO:0046621,0.143907081432463,0.95145790689429,4,22,negative regulation of organ growth,BP,PAK1;TGFBR2;WWC3;JARID2
4154,GO:0009216,0.143993360888856,0.994411500369832,1,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,AK9
525,GO:0001631,0.144131482892578,0.994400339294399,1,2,cysteinyl leukotriene receptor activity,MF,LTB4R
526,GO:0001632,0.144131482892578,0.994400339294399,1,2,leukotriene B4 receptor activity,MF,LTB4R
2153,GO:0004974,0.144131482892578,0.994400339294399,1,2,leukotriene receptor activity,MF,LTB4R
14432,GO:0061737,0.144131482892578,0.994400339294399,1,2,leukotriene signaling pathway,BP,LTB4R
19990,GO:2000586,0.144141514042489,0.975863504605495,2,7,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,PTPN12;LRP1
12819,GO:0051124,0.144149783750934,0.976986962028953,2,6,synaptic growth at neuromuscular junction,BP,SHANK2;LRP4
13772,GO:0060350,0.144551837727199,0.943373570114507,5,31,endochondral bone morphogenesis,BP,COL13A1;TGFBR2;MMP14;THBS3;MEF2D
14502,GO:0061971,0.144551837727199,0.943373570114507,5,31,replacement bone morphogenesis,BP,COL13A1;TGFBR2;MMP14;THBS3;MEF2D
5368,GO:0016165,0.14459944661685,0.99436243556219,1,2,linoleate 13S-lipoxygenase activity,MF,ALOX15B
11106,GO:0045123,0.144886268187008,0.950786706519794,4,23,cellular extravasation,BP,ITGA1;ADAM8;ITGA4;FADD
4714,GO:0010876,0.145080538440109,0.899565229522342,25,224,lipid localization,BP,SORL1;VLDLR;OSBP2;PITPNC1;OSBPL10;NME4;APOE;ABCD1;LRP1;PPARA;ABCA7;ABCG1;PITPNM1;CEACAM1;NTSR1;ATP10D;CPT2;OSBPL5;PPARG;SLC10A6;ESYT3;ATP11B;LRP6;SIGMAR1;PTCH1
5911,GO:0018153,0.145113136375834,0.994320668934424,1,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,TGM2
5942,GO:0018262,0.145113136375834,0.994320668934424,1,2,isopeptide cross-linking,BP,TGM2
10160,GO:0042743,0.145240104142286,0.949783522276671,4,28,hydrogen peroxide metabolic process,BP,GPX3;EGFR;RAC2;PRDX5
3020,GO:0006565,0.145446157100905,0.994293502884615,1,2,L-serine catabolic process,BP,CBS
2327,GO:0005342,0.145503960260336,0.918462283706314,11,90,organic acid transmembrane transporter activity,MF,SLC16A3;CEACAM1;BSG;SLC6A6;SLC6A14;SLC43A1;SLC38A2;SLC13A3;SLC10A6;SLC7A11;SLC23A2
11911,GO:0046943,0.145503960260336,0.918462283706314,11,90,carboxylic acid transmembrane transporter activity,MF,SLC16A3;CEACAM1;BSG;SLC6A6;SLC6A14;SLC43A1;SLC38A2;SLC13A3;SLC10A6;SLC7A11;SLC23A2
566,GO:0001707,0.145532774116357,0.936876643427016,6,39,mesoderm formation,BP,ITGB4;DKK1;HMGA2;FGFR1;ITGA2;PRKAR1A
14796,GO:0070509,0.145596033331689,0.942832783375518,5,31,calcium ion import,BP,PRNP;FYN;PKD2;FAM155B;SLC30A1
13837,GO:0060437,0.14561550603174,0.994279661406014,1,2,lung growth,BP,SPRY2
6898,GO:0030432,0.145658819202228,0.994276118356371,1,2,peristalsis,BP,DLG1
10819,GO:0044307,0.145680890492593,1,1,1,dendritic branch,CC,AKAP9
3753,GO:0008294,0.145759631538129,1,1,1,calcium- and calmodulin-responsive adenylate cyclase activity,MF,ADCY1
11390,GO:0045765,0.145807175337841,0.903689940865019,20,173,regulation of angiogenesis,BP,PGF;ADM2;THBS2;RAPGEF3;TGFBR2;EPHA1;ANGPTL4;ANXA3;HMGA2;HYAL1;CEACAM1;EPN2;ADGRB2;SPRY2;NGFR;XBP1;C5;PPARG;SRPX2;AKT3
19891,GO:2000380,0.145811851131129,0.97540989536674,2,7,regulation of mesoderm development,BP,DKK1;FGFR1
16420,GO:0097055,0.145818216208374,0.99426306934097,1,2,agmatine biosynthetic process,BP,AZIN2
17567,GO:1901162,0.145818216208374,0.99426306934097,1,2,primary amino compound biosynthetic process,BP,AZIN2
9993,GO:0042402,0.145818348558559,0.97345000761674,2,10,cellular biogenic amine catabolic process,BP,ALDH7A1;SLC44A1
9721,GO:0038158,0.145888158654153,0.994257338436543,1,2,granulocyte colony-stimulating factor signaling pathway,BP,CEACAM1
12221,GO:0048471,0.146017435483505,0.886246663293957,52,513,perinuclear region of cytoplasm,CC,EPN3;TSPAN1;NOS1;RAB3B;NEURL1;APLN;LAMB1;CAPN2;EGFR;DLG1;CTSB;SEC23A;STOM;ATXN10;ATP7B;ABCD1;PRKACB;RAB11FIP4;ITGA2;GALNT3;VAMP2;FAT1;OBSL1;MT2A;ANXA6;MAP6;THBS3;TWF2;CST3;SLK;PRDX5;RASIP1;GSDMA;CPEB4;ATXN2;AZIN2;GLB1;SPIRE1;MAP2K2;STX10;PUM2;PRKACA;EIF2AK2;ANGEL1;TMEM134;PPARG;USP20;ALDH1A2;TMEM173;PSEN2;PTCH1;FBXL5
1438,GO:0003417,0.146027629252049,0.974517788838482,2,8,growth plate cartilage development,BP,TGFBR2;THBS3
13597,GO:0060066,0.14614527309493,0.994236244526174,1,2,oviduct development,BP,WNT7A
16558,GO:0097332,0.146162704356526,0.994234812934205,1,2,response to antipsychotic drug,BP,PRKACB
6189,GO:0019637,0.146598253739347,0.880349679032152,78,848,organophosphate metabolic process,BP,XDH;NT5E;NOS1;MBOAT2;PCK2;PYGL;ADCY7;CRYL1;RAPGEF3;TK2;NAPRT;H6PD;DHTKD1;DGKA;EGFR;FYN;OSBPL10;PGM1;DLG1;ISYNA1;DLG4;IDH2;PGLS;SPTLC2;ACOT7;TTC7B;NMRK1;NME4;DLG3;APOE;PKD2;LDHA;AKAP9;PPARA;PIGH;AGPAT4;FGFR1;LPCAT4;LPCAT1;INPP5F;FAM20C;PITPNM1;NTSR1;PLA2G4D;TMEM86B;GFPT1;PLPPR2;INPP4A;CSNK2A1;PTHLH;NDUFV3;CRLS1;PARP9;AGPAT3;PANK4;ABHD6;PDE5A;OSBPL5;MTMR4;MBOAT7;SAMD8;TMSB4X;TIMP2;SRD5A3;CARD11;ACP6;AGPAT1;ATP6V1B2;AK9;GARS;DDHD2;PLCH2;ZFYVE21;CDS2;ADCY1;PANK1;SLC44A1;ADNP
12974,GO:0051371,0.146643547869974,0.978033821584549,2,5,muscle alpha-actinin binding,MF,PKD2;OBSL1
11792,GO:0046657,0.14666504063306,0.994193474450734,1,2,folic acid catabolic process,BP,PM20D2
2857,GO:0006346,0.146696051953864,0.960204429224693,3,15,methylation-dependent chromatin silencing,BP,UHRF2;TET1;DNMT3A
7202,GO:0031091,0.146710041467367,0.930925505524387,7,52,platelet alpha granule,CC,SERPINE2;THBS2;SERPING1;APLP2;QSOX1;TMSB4X;IGF2
13748,GO:0060322,0.146741238497509,0.885985013152963,51,481,head development,BP,NEURL1;SERPINE2;BBS2;MAP2K1;PTPRS;SMARCA1;LAMB1;SNPH;EGFR;FYN;BNIP3;WNT7A;TTBK2;ASPH;DKK1;PAK1;TGFBR2;EDNRA;SHANK2;LRP1;ANXA3;FGFR1;AARS;TACC1;ATRX;PITPNM1;CEP120;MMP14;EPOR;CST3;CNTN1;BTBD3;CSNK2A1;CHD7;BOK;THRA;WNT2B;GLUD1;ARF4;SLC38A2;TCTN1;MBOAT7;LPAR1;ALDH1A2;TBX1;SLC7A11;AKT3;LRP6;ARID5B;PTCH1;ADCY1
17753,GO:1901701,0.146854762217713,0.88151154304457,70,714,cellular response to oxygen-containing compound,BP,TNIP1;NEURL1;PCK2;CYP27B1;ADCY7;PRNP;NR1D1;NFATC4;FAM210B;RAPGEF3;EIF4EBP1;SSH1;CAPN2;EGFR;FYN;BNIP3;MAPK13;NET1;MAP4K4;SHC1;PAK1;SOCS2;IMPACT;PKD2;PRKACB;LRP1;IDE;AKAP9;ATF4;ITGA2;PTK6;VAMP2;SOX4;CEACAM1;RAB31;XRN1;TRIM5;LRP5;TWF2;CST3;TRIB3;CASP4;PPP3CB;PRDX5;PRKAR1A;ANO1;CPEB4;COL6A1;NGFR;BCL2L1;XBP1;RET;COL1A2;PRKACA;LPAR1;IGF2;ITPR2;GRB10;PPARG;ALDH1A2;TBX1;ATP6V1B2;ENDOG;LRP6;EEF2K;PTCH1;ADCY1;KAT2B;GNAI1;DNMT3A
17325,GO:0150011,0.146968384771486,0.975093777995044,2,7,regulation of neuron projection arborization,BP,DLG4;DVL1
17326,GO:0150012,0.146968384771486,0.975093777995044,2,7,positive regulation of neuron projection arborization,BP,DLG4;DVL1
5653,GO:0016748,0.147070496212932,0.994159991890265,1,2,succinyltransferase activity,MF,ALAS1
681,GO:0001891,0.147143198642383,0.959693266027216,3,16,phagocytic cup,CC,PEAR1;ARHGAP12;ABCA7
2401,GO:0005546,0.147168100390924,0.93556950656321,6,43,phosphatidylinositol-4,5-bisphosphate binding,MF,PFN2;GSDMC;TWF2;GSDMA;ASAP1;FCHO2
1655,GO:0004109,0.147319676770608,0.994139362813654,1,2,coproporphyrinogen oxidase activity,MF,RSAD1
7249,GO:0031205,0.147332736459949,0.994138280546126,1,2,endoplasmic reticulum Sec complex,CC,DNAJC3
936,GO:0002337,0.147342763226239,0.994137449546062,1,2,B-1a B cell differentiation,BP,CMTM7
3952,GO:0008654,0.147525613474757,0.897597270638007,25,231,phospholipid biosynthetic process,BP,MBOAT2;DGKA;ISYNA1;SPTLC2;PIGH;AGPAT4;FGFR1;LPCAT4;LPCAT1;INPP5F;PITPNM1;PLA2G4D;INPP4A;CSNK2A1;CRLS1;AGPAT3;MTMR4;MBOAT7;SAMD8;SRD5A3;ACP6;AGPAT1;DDHD2;CDS2;SLC44A1
1252,GO:0003006,0.147618758418339,0.887796946197603,43,415,developmental process involved in reproduction,BP,ERCC1;ETV5;CCND1;NEURL1;CYP27B1;SERPINE2;OSBP2;BBS2;MAP2K1;ALOX15B;EGFR;UBE2J1;DLG1;CTSB;HTRA1;WNT7A;SDC1;PKD2;ATRX;BSG;MDFI;MMP14;EPOR;CST3;RFX2;PLAG1;CHD7;BOK;WNT2B;ACVR1B;BCL2L1;REC8;PDE5A;PRKACA;ARID4A;IGF2;PPARG;ZNF568;HSPA2;LRP6;ARID5B;E2F7;PTCH1
2142,GO:0004955,0.147929023812438,0.994088750395734,1,2,prostaglandin receptor activity,MF,PPARG
6894,GO:0030426,0.14795129005974,0.908900781310717,15,121,growth cone,CC,SSH1;ADGRL1;DLG3;SHANK2;KIF21B;TMOD2;DVL1;TWF2;CPEB4;TIMP2;CTSZ;TENM2;SIGMAR1;PSEN2;PTCH1
734,GO:0001964,0.147970650375793,0.974818478255277,2,7,startle response,BP,SLITRK6;DVL1
17476,GO:1900369,0.148074191573042,0.994076657972942,1,2,negative regulation of RNA interference,BP,RMRP
7234,GO:0031133,0.148079459907898,0.994076218870777,1,2,regulation of axon diameter,BP,WNT7A
2170,GO:0005006,0.148297815083936,0.994058004014757,1,2,epidermal growth factor-activated receptor activity,MF,EGFR
10303,GO:0043066,0.148303476473044,0.88246367886855,59,616,negative regulation of apoptotic process,BP,F2R;ITGA6;PRNP;MST1R;EGFR;FYN;TNFRSF6B;BNIP3;GLO1;WNT7A;MAP4K4;GRK5;STRADB;ARG2;SHC1;DKK1;SOCS2;RAG1;EPHA1;CD44;APOE;BNIP3L;CCND2;ANGPTL4;LRP1;HMGA2;ASNS;FGFR1;AARS;NTSR1;CTH;PRDX5;CSNK2A1;BOK;CPEB4;SPRY2;NGFR;PPP1R10;BCL2L1;ARF4;XBP1;RET;TMBIM1;RGL2;EIF2AK2;SLC39A10;IGF2;TBX1;ADAM8;WFS1;LRP6;EEF2K;DNAJC3;FOXP1;PSEN2;UFL1;ADNP;RB1CC1;FADD
5902,GO:0018108,0.148342182684682,0.896960717518238,25,231,peptidyl-tyrosine phosphorylation,BP,NEURL1;PRNP;MAP2K1;MST1R;EGFR;FYN;ERCC6;DLG4;SHC1;DLG3;EPHA1;CD44;FGFR1;PTK6;INPP5F;CNTN1;PARP9;MAP2K2;RET;EIF2AK2;IGF2;ZMYM2;SNX6;ADNP;LRP4
438,GO:0001172,0.148420518764383,0.994047754962142,1,2,transcription, RNA-templated,BP,RMRP
1564,GO:0003968,0.148420518764383,0.994047754962142,1,2,RNA-directed 5'-3' RNA polymerase activity,MF,RMRP
11999,GO:0047408,0.14848701402203,0.994042196823532,1,2,alkenylglycerophosphocholine hydrolase activity,MF,TMEM86B
12000,GO:0047409,0.14848701402203,0.994042196823532,1,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,TMEM86B
993,GO:0002455,0.148568428812749,0.958568665806644,3,18,humoral immune response mediated by circulating immunoglobulin,BP,SERPING1;CD46;C5
18422,GO:1903487,0.148848821484136,0.9940119051548,1,2,regulation of lactation,BP,XBP1
3600,GO:0008028,0.148948438374556,0.948321102838523,4,26,monocarboxylic acid transmembrane transporter activity,MF,SLC16A3;CEACAM1;BSG;SLC10A6
2334,GO:0005351,0.14905551723775,0.973659467758998,2,8,carbohydrate:proton symporter activity,MF,SLC2A9;SLC2A13
12210,GO:0048388,0.149074755395416,0.993992947013387,1,2,endosomal lumen acidification,BP,CLCN3
3569,GO:0007612,0.149161198300306,0.918919801628385,10,75,learning,BP,FYN;DLG4;DKK1;RAG1;SHANK2;RGS14;NTSR1;PPP3CB;ARF4;DDHD2
7130,GO:0030953,0.149199561008008,0.974479216892776,2,7,astral microtubule organization,BP,DLG1;CEP120
13363,GO:0052548,0.149249637636679,0.895262890178025,26,267,regulation of endopeptidase activity,BP,XDH;F2R;SORL1;SERPINE2;TFPI2;TNFSF15;FYN;TNFRSF6B;ASPH;DAP;RAG1;SERPING1;CD44;CST3;CASP4;APLP2;PRDX5;CSNK2A1;BOK;NGFR;C5;TIMP2;IFI16;PPARG;FAM162A;FADD
7938,GO:0032526,0.149364904432959,0.92157095542913,9,72,response to retinoic acid,BP,DKK1;PTK6;TWF2;RET;PPARG;ALDH1A2;TBX1;IGFBP7;PTCH1
1974,GO:0004690,0.14943880340917,0.974412951471753,2,7,cyclic nucleotide-dependent protein kinase activity,MF,PRKACB;PRKACA
3257,GO:0006921,0.149487884610724,0.948064164216615,4,26,cellular component disassembly involved in execution phase of apoptosis,BP,H1F0;BOK;ENDOG;DEDD2
7994,GO:0032612,0.149501433210499,0.929067971262163,7,55,interleukin-1 production,BP,F2R;ARG2;ACP5;CEACAM1;F2RL1;IFI16;FOXP1
3079,GO:0006650,0.149541829905726,0.893106470150017,29,271,glycerophospholipid metabolic process,BP,MBOAT2;DGKA;EGFR;FYN;OSBPL10;TTC7B;PIGH;AGPAT4;FGFR1;LPCAT4;LPCAT1;INPP5F;PITPNM1;PLA2G4D;TMEM86B;INPP4A;CSNK2A1;CRLS1;AGPAT3;OSBPL5;MTMR4;MBOAT7;ACP6;AGPAT1;DDHD2;PLCH2;ZFYVE21;CDS2;SLC44A1
6260,GO:0019852,0.149545893121473,0.972863670311289,2,9,L-ascorbic acid metabolic process,BP,SLC2A3;SLC23A2
11277,GO:0045582,0.149571503638332,0.934126450093721,6,44,positive regulation of T cell differentiation,BP,RAG1;TGFBR2;CD46;XBP1;AP3D1;ADAM8
16923,GO:0098900,0.149734523646709,0.94099566894907,5,29,regulation of action potential,BP,ANK3;DLG1;PTPN3;AKAP9;NTSR1
8438,GO:0033555,0.149817083631171,0.940488669161356,5,32,multicellular organismal response to stress,BP,NOS1;RAG1;APOE;RET;VWA1
11914,GO:0046949,0.149888059326048,0.948045562963576,4,25,fatty-acyl-CoA biosynthetic process,BP,ELOVL1;CBR4;PPT2;HSD17B12
11710,GO:0046501,0.149992208396623,0.972732924094707,2,9,protoporphyrinogen IX metabolic process,BP,UROS;ALAS1
6088,GO:0019254,0.150110661144703,0.993905607869693,1,2,carnitine metabolic process, CoA-linked,BP,CRAT
5615,GO:0016667,0.150445888336361,0.933180093646642,6,50,oxidoreductase activity, acting on a sulfur group of donors,MF,ERO1B;PDIA5;QSOX1;MSRB2;PCYOX1;TXNRD3
11750,GO:0046596,0.150484972441001,0.95778953759905,3,18,regulation of viral entry into host cell,BP,TRIM5;IFITM1;TRIM38
3278,GO:0006956,0.150488100696108,0.958052657236059,3,17,complement activation,BP,SERPING1;CD46;C5
9846,GO:0042091,0.150540097576233,0.993869200737427,1,2,interleukin-10 biosynthetic process,BP,TRIB2
11074,GO:0045074,0.150540097576233,0.993869200737427,1,2,regulation of interleukin-10 biosynthetic process,BP,TRIB2
12531,GO:0050679,0.150577084766539,0.908588628431356,14,119,positive regulation of epithelial cell proliferation,BP,PGF;CCND1;APLN;LAMB1;EGFR;PLXNB3;GLUL;HTRA1;WNT7A;FGFR1;HYAL1;XBP1;TBX1;AKT3
3017,GO:0006562,0.150590358015768,0.993864932023957,1,2,proline catabolic process,BP,ALDH4A1
4401,GO:0010133,0.150590358015768,0.993864932023957,1,2,proline catabolic process to glutamate,BP,ALDH4A1
15394,GO:0071641,0.150669399140659,0.993858215651764,1,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,ARG2
18739,GO:1904207,0.150841108291164,0.993843611245829,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
18740,GO:1904209,0.150841108291164,0.993843611245829,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,POSTN
549,GO:0001669,0.151001579632841,0.928302734985115,7,53,acrosomal vesicle,CC,LY6K;LOXL1;ITGA1;BSG;CD46;SPESP1;PRKACA
1983,GO:0004703,0.151247962600777,0.9938089318485,1,2,G-protein coupled receptor kinase activity,MF,GRK5
12030,GO:0047696,0.151247962600777,0.9938089318485,1,2,beta-adrenergic receptor kinase activity,MF,GRK5
8896,GO:0034713,0.151389955727117,0.972989741183803,2,8,type I transforming growth factor beta receptor binding,MF,TGFBR2;FKBP1A
11437,GO:0045862,0.151588628270728,0.892011306412403,28,281,positive regulation of proteolysis,BP,TNIP1;XDH;EDEM1;F2R;TNFSF15;FYN;SNX9;ASPH;DAP;TRIB2;APOE;BTRC;SH3D19;DVL1;MMP14;TRIB3;CASP4;BOK;NGFR;XBP1;ANKIB1;IFI16;PPARG;ADAM8;MAGEF1;RNF180;FAM162A;FADD
4727,GO:0010889,0.151645048112924,0.972916137492862,2,8,regulation of sequestering of triglyceride,BP,PPARA;PPARG
3933,GO:0008614,0.151996324669279,0.993744866826698,1,2,pyridoxine metabolic process,BP,PSAT1
3934,GO:0008615,0.151996324669279,0.993744866826698,1,2,pyridoxine biosynthetic process,BP,PSAT1
2415,GO:0005589,0.152117643932887,0.993734447312811,1,2,collagen type VI trimer,CC,COL6A1
16805,GO:0098647,0.152117643932887,0.993734447312811,1,2,collagen beaded filament,CC,COL6A1
20043,GO:2000666,0.152213211006232,0.993726232896231,1,2,negative regulation of interleukin-13 secretion,BP,ARG2
6833,GO:0030295,0.152249602839312,0.927626247452774,7,52,protein kinase activator activity,MF,MAP2K1;ERCC6;ETAA1;TAOK1;SPRY2;MAP2K2;IGF2
4374,GO:0009996,0.152288112539332,0.993719790689294,1,2,negative regulation of cell fate specification,BP,DKK1
15926,GO:0072709,0.152391652397289,0.993710879415189,1,2,cellular response to sorbitol,BP,MAPK13
18173,GO:1902938,0.152430727451452,0.993707514593042,1,2,regulation of intracellular calcium activated chloride channel activity,BP,PRNP
11687,GO:0046470,0.15243861278206,0.927309318764092,7,55,phosphatidylcholine metabolic process,BP,MBOAT2;LPCAT4;LPCAT1;PLA2G4D;TMEM86B;CSNK2A1;SLC44A1
19949,GO:2000490,0.1528848579896,0.993668336889467,1,2,negative regulation of hepatic stellate cell activation,BP,CYGB
17608,GO:1901293,0.152978610653119,0.894038367138291,24,237,nucleoside phosphate biosynthetic process,BP,NOS1;ADCY7;TK2;NAPRT;DHTKD1;PGM1;IDH2;ACOT7;NMRK1;NME4;APOE;LDHA;AKAP9;PPARA;PTHLH;PARP9;PANK4;TMSB4X;TIMP2;AK9;GARS;ADCY1;PANK1;ADNP
9979,GO:0042369,0.15299283214966,0.99365900255074,1,2,vitamin D catabolic process,BP,CYP27B1
13826,GO:0060423,0.153042998043394,0.993654663179924,1,2,foregut regionalization,BP,WNT2B
13827,GO:0060424,0.153042998043394,0.993654663179924,1,2,lung field specification,BP,WNT2B
13875,GO:0060492,0.153042998043394,0.993654663179924,1,2,lung induction,BP,WNT2B
7170,GO:0031050,0.153079381877155,0.932418347588792,6,41,dsRNA fragmentation,BP,MAP2K1;EGFR;MAP2K2;RMRP;PUM2;ZC3H7A
14998,GO:0070918,0.153079381877155,0.932418347588792,6,41,production of small RNA involved in gene silencing by RNA,BP,MAP2K1;EGFR;MAP2K2;RMRP;PUM2;ZC3H7A
17704,GO:1901611,0.153137575551394,0.971804188921822,2,9,phosphatidylglycerol binding,MF,PITPNC1;NME4
3594,GO:0008020,0.153204103263249,0.993640716602441,1,2,G-protein coupled photoreceptor activity,MF,ELOVL4
13140,GO:0051705,0.153257258088562,0.932651936763097,6,38,multi-organism behavior,BP,DLG4;SHANK2;VPS13A;DVL1;PPP3CB;TBX1
1570,GO:0003977,0.153433009142171,0.993620872029293,1,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,UAP1
6583,GO:0022410,0.153445916280519,0.971712456422726,2,9,circadian sleep/wake cycle process,BP,CST3;PER3
12618,GO:0050802,0.153445916280519,0.971712456422726,2,9,circadian sleep/wake cycle, sleep,BP,CST3;PER3
11304,GO:0045621,0.153446526334193,0.926769121366566,7,54,positive regulation of lymphocyte differentiation,BP,RAG1;TGFBR2;MMP14;CD46;XBP1;AP3D1;ADAM8
9113,GO:0035402,0.153573844364877,0.99360864588098,1,2,histone kinase activity (H3-T11 specific),MF,PKN1
9118,GO:0035407,0.153573844364877,0.99360864588098,1,2,histone H3-T11 phosphorylation,BP,PKN1
19975,GO:2000562,0.153603842040802,0.99360604008734,1,2,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,ARG2
12799,GO:0051093,0.153631576658077,0.878470371396526,57,563,negative regulation of developmental process,BP,XDH;SORL1;CCND1;BBS2;POSTN;NFATC4;THBS2;RAPGEF3;WWTR1;DDIT3;PTPRS;EGFR;SEMA4B;BNIP3;ADAMTS7;IDH2;WNT7A;MAP4K4;GDI1;DKK1;PAK1;SOCS2;TRIB2;TGFBR2;APOE;PRKACB;LRP1;HMGA2;PPARA;WWC3;ULK2;INPP5F;ABCG1;CEACAM1;FERMT1;EPN2;LRP5;CST3;TRIB3;ADGRB2;PTHLH;ASAP1;SPRY2;NGFR;XBP1;UBASH3B;LOXL2;LPAR1;CTSZ;PPARG;TBX1;AKT3;OMG;PTCH1;JARID2;SEMA3F;LRP4
7966,GO:0032571,0.153856906234795,0.993584034300167,1,2,response to vitamin K,BP,POSTN
15176,GO:0071307,0.153856906234795,0.993584034300167,1,2,cellular response to vitamin K,BP,POSTN
6706,GO:0030111,0.15387813223421,0.891028309786094,27,255,regulation of Wnt signaling pathway,BP,SMURF2;CCND1;CTNNBIP1;IGFBP4;NFATC4;WWTR1;DDIT3;PSMD2;WNT7A;DKK1;APOE;LRP1;BTRC;SOX4;FERMT1;NLK;MDFI;DVL1;LRP5;CSNK2A1;PSMD7;WNT2B;TBL1X;GRB10;LRP6;ANKRD6;LRP4
16487,GO:0097169,0.153965114590449,0.99151189775057,1,3,AIM2 inflammasome complex,CC,CASP4
15599,GO:0072078,0.154000267914312,0.92698328522082,7,47,nephron tubule morphogenesis,BP,PGF;CTNNBIP1;DLG1;PKD2;WNT2B;LAMA5;PTCH1
5120,GO:0015467,0.154082025416593,0.993564423989486,1,2,G-protein activated inward rectifier potassium channel activity,MF,KCNJ15
18469,GO:1903567,0.154330713869255,0.993542722709693,1,2,regulation of protein localization to ciliary membrane,BP,EFCAB7
3274,GO:0006952,0.154419082849207,0.872767008177105,83,910,defense response,BP,TNIP1;NT5E;F2R;CTNNBIP1;CYP27B1;IGFBP4;NR1D1;NFATC4;ADARB1;FNDC4;MST1R;PTPRS;PSMD2;EGFR;STK39;FYN;TNFRSF6B;BNIP3;MAPK13;CTSB;TGM2;HTRA1;SDC1;ARG2;SHC1;PAK1;RAG1;SERPING1;LCN2;CD44;APOE;BNIP3L;ACP5;PRKACB;ANXA3;PPARA;HYAL1;BTRC;ITGA2;PTK6;APOBEC3C;CEACAM1;MAPKAPK3;GSDMC;MT2A;TRIM5;CD46;CTSL;CST3;CASP4;PRDX5;CEBPG;F2RL1;DDX60;GSDMA;PSMD7;PARP9;MGLL;NGFR;IFITM1;RAB43;C5;PUM2;RNF135;PRKACA;TMSB4X;EIF2AK2;RAB1A;IFI16;IL1RAP;CARD11;LTB4R;MAP4K2;PPARG;ADAM8;IL20RB;FLNB;TMEM173;DNAJC3;FOXP1;OAS1;TRIM38;FADD
1828,GO:0004483,0.154443732106999,0.99353284727909,1,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,CMTR2
5537,GO:0016524,0.154443732106999,0.99353284727909,1,2,latrotoxin receptor activity,MF,ADGRL1
9596,GO:0036451,0.154443732106999,0.99353284727909,1,2,cap mRNA methylation,BP,CMTR2
16551,GO:0097309,0.154443732106999,0.99353284727909,1,2,cap1 mRNA methylation,BP,CMTR2
19920,GO:2000418,0.154455654535083,0.993531805029667,1,2,positive regulation of eosinophil migration,BP,ADAM8
15185,GO:0071320,0.154473727024641,0.938338198118985,5,30,cellular response to cAMP,BP,RAPGEF3;PKD2;AKAP9;ITPR2;EEF2K
9662,GO:0038016,0.15455018396707,0.993523538106866,1,2,insulin receptor internalization,BP,CEACAM1
1188,GO:0002835,0.154599652134894,0.993519209657203,1,2,negative regulation of response to tumor cell,BP,CEACAM1
1191,GO:0002838,0.154599652134894,0.993519209657203,1,2,negative regulation of immune response to tumor cell,BP,CEACAM1
1196,GO:0002856,0.154599652134894,0.993519209657203,1,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,CEACAM1
1199,GO:0002859,0.154599652134894,0.993519209657203,1,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,CEACAM1
16905,GO:0098858,0.154650398662718,0.90405365407305,15,122,actin-based cell projection,CC,DOCK4;ITGA6;ACTA2;BBS2;RAPGEF3;KIF13B;PODXL;ESPN;CD44;FAT1;CEACAM1;TWF2;SYTL1;TENM2;ATP6V1B2
7736,GO:0032231,0.154702711509735,0.918441270404923,9,66,regulation of actin filament bundle assembly,BP,RAPGEF3;ARAP1;PAK1;EPHA1;PFN2;FHOD1;WASF2;SH3PXD2B;LPAR1
427,GO:0001134,0.154826804644658,0.946089088132848,4,23,transcription factor activity, transcription factor recruiting,MF,NR1D1;PPARA;THRA;PPARG
19451,GO:1990126,0.15502718230745,0.956510457513559,3,16,retrograde transport, endosome to plasma membrane,BP,SDCCAG3;ANKRD50;SNX27
9416,GO:0035981,0.155080326656564,0.993477068871862,1,2,tongue muscle cell differentiation,BP,TBX1
18126,GO:1902811,0.155080326656564,0.993477068871862,1,2,positive regulation of skeletal muscle fiber differentiation,BP,TBX1
20188,GO:2001035,0.155080326656564,0.993477068871862,1,2,regulation of tongue muscle cell differentiation,BP,TBX1
20189,GO:2001037,0.155080326656564,0.993477068871862,1,2,positive regulation of tongue muscle cell differentiation,BP,TBX1
19535,GO:1990442,0.155080971589801,0.991383594620223,1,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,DDIT3
12780,GO:0051055,0.155185607001508,0.937258154766315,5,35,negative regulation of lipid biosynthetic process,BP,CYP27B1;APOE;LPCAT1;CEACAM1;TRIB3
5802,GO:0017055,0.155220313740471,0.993464768250584,1,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,THRA
9270,GO:0035692,0.155245207354904,0.993462579536107,1,2,macrophage migration inhibitory factor receptor complex,CC,CD44
18224,GO:1903025,0.155376617491787,0.971135275636126,2,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,DDIT3;TMSB4X
6710,GO:0030120,0.155435853431826,0.925712189309923,7,52,vesicle coat,CC,EGFR;SEC23A;EPN2;CLTCL1;COPB1;COPG1;AP2A2
218,GO:0000454,0.155442331781581,0.991341822327792,1,3,snoRNA guided rRNA pseudouridine synthesis,BP,NOP10
10653,GO:0043691,0.155470169192852,0.971802536209243,2,8,reverse cholesterol transport,BP,APOE;ABCG1
5687,GO:0016803,0.155526493369954,0.970544171895567,2,10,ether hydrolase activity,MF,LTA4H;TMEM86B
10166,GO:0042752,0.155593806685658,0.917755367996428,9,68,regulation of circadian rhythm,BP,NR1D1;CRTC1;PPARA;BTRC;PER3;MTA1;NR2F6;PPARG;ADCY1
16953,GO:0098943,0.155618083403912,0.993429747529326,1,2,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,AP3D1
3543,GO:0007565,0.155637586725907,0.904931777460598,14,121,female pregnancy,BP,SMURF2;PGF;CYP27B1;ADCY7;CTSB;TGFBR2;ITGA2;BSG;EPOR;CST3;PTHLH;ACVR1B;SLC38A2;IGFBP7
6429,GO:0021695,0.155695944425533,0.937529840556459,5,31,cerebellar cortex development,BP,SERPINE2;MAP2K1;WNT7A;TTBK2;AARS
10226,GO:0042904,0.155703711297247,0.993422195293821,1,2,9-cis-retinoic acid biosynthetic process,BP,ALDH1A2
10227,GO:0042905,0.155703711297247,0.993422195293821,1,2,9-cis-retinoic acid metabolic process,BP,ALDH1A2
5801,GO:0017053,0.155764500262815,0.914607209075587,10,74,transcriptional repressor complex,CC,CCND1;SALL2;APPL2;RCOR1;PHF12;CSNK2A1;NACC2;TBL1X;ARID4A;DEPDC1
20056,GO:2000683,0.155823228308932,0.993411646200601,1,2,regulation of cellular response to X-ray,BP,HMGA2
13614,GO:0060086,0.155855327244739,0.993408811441121,1,2,circadian temperature homeostasis,BP,NR1D1
967,GO:0002414,0.156059226839746,0.993390788917327,1,2,immunoglobulin transcytosis in epithelial cells,BP,FCGRT
6221,GO:0019763,0.156059226839746,0.993390788917327,1,2,immunoglobulin receptor activity,MF,FCGRT
19460,GO:1990164,0.156166986807363,0.993381253279138,1,2,histone H2A phosphorylation,BP,HMGA2
4294,GO:0009725,0.156289102484855,0.874537397487797,64,649,response to hormone,BP,NOS1;PGF;CCND1;PCK2;ADCY7;BBS2;POSTN;NR1D1;FAM210B;EIF4EBP1;HADH;EGFR;FYN;CTSB;WNT7A;SDC1;SHC1;PAK1;SOCS2;TGFBR2;PRKACB;IDE;ANXA3;PPARA;ASNS;TUB;ITGA2;VAMP2;ABCG1;CEACAM1;RAB31;BSG;XRN1;MMP14;LRP5;CTSL;CST3;TRIB3;CSNK2A1;PRKAR1A;CRLS1;THRA;NGFR;GLB1;XBP1;PRKACA;TIMP2;NR2F6;IGF2;GRB10;PPARG;ALDH1A2;ATP6V1B2;ENDOG;IGFBP7;LRP6;EEF2K;FOXP1;PTCH1;ADCY1;KAT2B;UFL1;GNAI1;DNMT3A
9289,GO:0035727,0.156318698145779,0.993367815715302,1,2,lysophosphatidic acid binding,MF,LPAR1
11375,GO:0045740,0.156385277148342,0.930333855906888,6,43,positive regulation of DNA replication,BP,EGFR;SHC1;FGFR1;ATRX;CST3;E2F7
14035,GO:0060764,0.156493039900399,0.993352355378823,1,2,cell-cell signaling involved in mammary gland development,BP,LRP5
1096,GO:0002685,0.156573933408986,0.910664239750338,11,100,regulation of leukocyte migration,BP,PGF;RAC2;ITGA2;MMP14;MOSPD2;F2RL1;C5;ADAM8;ITGA4;WASL;FADD
5709,GO:0016840,0.156627881689129,0.970206708944617,2,10,carbon-nitrogen lyase activity,MF,CHAC1;GGACT
747,GO:0001977,0.156656487663909,0.970750010730139,2,9,renal system process involved in regulation of blood volume,BP,F2R;F2RL1
2318,GO:0005324,0.156660545381931,0.993337482808458,1,2,long-chain fatty acid transporter activity,MF,ABCD1
5265,GO:0015910,0.156660545381931,0.993337482808458,1,2,peroxisomal long-chain fatty acid import,BP,ABCD1
630,GO:0001819,0.156974512226217,0.889269990997437,26,254,positive regulation of cytokine production,BP,F2R;POSTN;NFATC4;ALOX15B;DDIT3;MAPK13;ATF4;FERMT1;CD46;CEBPG;F2RL1;DDX60;XBP1;C5;PUM2;RNF135;EIF2AK2;IFI16;IL1RAP;CARD11;AGPAT1;ADAM8;IL20RB;TMEM173;HPSE;FADD
2686,GO:0006048,0.157110057542287,0.970612971337781,2,9,UDP-N-acetylglucosamine biosynthetic process,BP,GFPT1;UAP1
7106,GO:0030902,0.157129567166773,0.910794184027076,11,85,hindbrain development,BP,SERPINE2;MAP2K1;PTPRS;WNT7A;TTBK2;PAK1;AARS;CNTN1;LPAR1;ALDH1A2;LRP6
5769,GO:0016964,0.157358863184141,1,1,1,alpha-2 macroglobulin receptor activity,MF,LRP1
7328,GO:0031338,0.157395303611054,0.924768086025027,7,49,regulation of vesicle fusion,BP,TBC1D14;EVI5L;VPS11;USP6NL;TBC1D2B;EVI5;TBC1D16
12160,GO:0048268,0.157739180225784,0.955762860450388,3,15,clathrin coat assembly,BP,CLTCL1;FCHO2;FCHO1
3687,GO:0008190,0.15775455563251,0.971128640347068,2,8,eukaryotic initiation factor 4E binding,MF,EIF4EBP1;ANGEL1
11553,GO:0046086,0.157790233266919,0.993236706527861,1,2,adenosine biosynthetic process,BP,NT5E
16272,GO:0090330,0.158094965131833,0.955249406447598,3,16,regulation of platelet aggregation,BP,SERPINE2;CEACAM1;UBASH3B
1720,GO:0004312,0.158150174476405,0.97029771571029,2,9,fatty acid synthase activity,MF,ELOVL1;ELOVL4
13988,GO:0060700,0.158687259581998,0.970134382386083,2,9,regulation of ribonuclease activity,BP,TCEA1;OAS1
7854,GO:0032414,0.158705408017823,0.923976747667565,7,49,positive regulation of ion transmembrane transporter activity,BP,STK39;ANK3;PKD2;AKAP9;NTSR1;TMSB4X;HSPA2
11090,GO:0045091,0.159225595873339,0.969970296445575,2,9,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C
8810,GO:0034515,0.159416573831187,0.993090176235801,1,2,proteasome storage granule,CC,PSMD2
8144,GO:0032869,0.159518863766508,0.89576710319005,18,157,cellular response to insulin stimulus,BP,PCK2;EIF4EBP1;SHC1;PAK1;SOCS2;IDE;VAMP2;CEACAM1;RAB31;TRIB3;NGFR;XBP1;IGF2;GRB10;PPARG;ATP6V1B2;EEF2K;KAT2B
13073,GO:0051580,0.15958861332928,0.969859437793358,2,9,regulation of neurotransmitter uptake,BP,NOS1;RAB3B
7364,GO:0031406,0.159617687616853,0.906174321478963,12,107,carboxylic acid binding,MF,NOS1;PYGL;PC;GLUL;CEMIP;NAGS;CD44;PPARA;AARS;GLUD1;GRIN3B;PPARG
2733,GO:0006112,0.15966887516588,0.918941367620359,8,58,energy reserve metabolic process,BP,PYGL;PYGB;NR1D1;PGM1;GFPT1;PPP1R2;IGF2;RB1CC1
12555,GO:0050707,0.159723933694828,0.908659848936764,11,95,regulation of cytokine secretion,BP,F2R;POSTN;ALOX15B;ARG2;FERMT1;F2RL1;XBP1;C5;TMSB4X;IL1RAP;FOXP1
2048,GO:0004797,0.159737202535515,0.993061086000677,1,2,thymidine kinase activity,MF,TK2
13093,GO:0051603,0.159953920055214,0.872989877872061,57,590,proteolysis involved in cellular protein catabolic process,BP,SMURF2;EDEM1;GID4;BTBD2;NR1D1;HECW2;WWTR1;DDIT3;PSMD2;CAPN2;UBE2J1;ADAMTS7;CTSB;UBXN4;TRIB2;RBCK1;IDE;ABTB1;UBE2G1;BTRC;LONP2;RMND5A;FBXO2;DVL1;MVB12B;CTSL;TRIB3;DNAJB9;BTBD3;PSMD7;MVB12A;MTA1;RNF165;PCYOX1;XBP1;ARRDC1;ANKIB1;GABARAPL2;UBE2E1;CTSO;PRKACA;SEL1L;CTSZ;TBL1X;ERLEC1;USP20;WFS1;USP32;MAGEF1;RNF180;DNAJC3;RNF103;USP25;UFL1;KLHL15;STT3B;FBXL5
9442,GO:0036019,0.160147302410897,0.954398761014649,3,16,endolysosome,CC,CTSB;CTSL;AP2A2
5042,GO:0015222,0.160167515641185,0.993021939434702,1,2,serotonin transmembrane transporter activity,MF,SLC18A2
18609,GO:1903892,0.16025523453078,0.993013944701609,1,2,negative regulation of ATF6-mediated unfolded protein response,BP,WFS1
16658,GO:0097531,0.160355608495627,0.969624655392813,2,9,mast cell migration,BP,PGF;RAC2
10459,GO:0043316,0.160491960288621,0.992992344491956,1,2,cytotoxic T cell degranulation,BP,CEACAM1
3892,GO:0008526,0.160660069906286,0.970261977235924,2,8,phosphatidylinositol transporter activity,MF,PITPNC1;PITPNM1
18155,GO:1902897,0.1606717724807,0.992975913078618,1,2,regulation of postsynaptic density protein 95 clustering,BP,ZMYND8
19382,GO:1905874,0.1606717724807,0.992975913078618,1,2,regulation of postsynaptic density organization,BP,ZMYND8
10110,GO:0042627,0.160689562164125,0.990722946737458,1,3,chylomicron,CC,APOE
5651,GO:0016746,0.16069656909451,0.892165133543232,20,190,transferase activity, transferring acyl groups,MF,MBOAT2;ELOVL1;TGM2;SPTLC2;NAGS;AGPAT4;LPCAT4;LPCAT1;ZDHHC2;CPT2;CRLS1;CRAT;AGPAT3;MBOAT7;ZDHHC1;AGPAT1;OSGEPL1;ELOVL4;KAT2B;ALAS1
12158,GO:0048265,0.160906874090617,0.970187868750806,2,8,response to pain,BP,RET;VWA1
10412,GO:0043249,0.160922653500256,0.969450593505692,2,9,erythrocyte maturation,BP,FAM210B;L3MBTL3
17584,GO:1901214,0.16117851205448,0.889663360946567,22,205,regulation of neuron death,BP,F2R;SORL1;PRNP;SSH1;DDIT3;FYN;DKK1;APOE;LRP1;ATF4;PPARA;ITGA1;AARS;BOK;CPEB4;BCL2L1;CTSZ;ADAM8;WFS1;SIGMAR1;TRIM2;ADNP
6362,GO:0021543,0.161207686198765,0.901138150577937,14,113,pallium development,BP,BBS2;PTPRS;LAMB1;EGFR;BNIP3;LRP1;ANXA3;TACC1;CEP120;BTBD3;CSNK2A1;SLC38A2;MBOAT7;LRP6
4711,GO:0010873,0.161208377968842,0.990660500578947,1,3,positive regulation of cholesterol esterification,BP,APOE
479,GO:0001523,0.161217831919976,0.927547582915075,6,43,retinoid metabolic process,BP,GPC4;RDH14;SDC1;APOE;LRP1;ALDH1A2
5158,GO:0015696,0.161235589174279,0.927351118479828,6,45,ammonium transport,BP,NOS1;RAB3B;AZIN2;SLC38A2;SLC18A2;SLC44A1
18717,GO:1904153,0.161261174001917,0.969346483514645,2,9,negative regulation of retrograde protein transport, ER to cytosol,BP,UBE2J1;ERLEC1
12925,GO:0051280,0.161335064156808,0.968746621272457,2,10,negative regulation of release of sequestered calcium ion into cytosol,BP,PKD2;NTSR1
12929,GO:0051284,0.161335064156808,0.968746621272457,2,10,positive regulation of sequestering of calcium ion,BP,PKD2;NTSR1
5931,GO:0018209,0.161350370943963,0.886792197766537,25,227,peptidyl-serine modification,BP,RAPGEF3;PKN1;EGFR;STK39;MAPK13;TTBK2;DKK1;PAK1;TGFBR2;CD44;AKAP9;HMGA2;GALNT3;INPP5F;PFN2;MAPKAPK3;NLK;MAST3;SPRY2;PSKH1;MAP2K2;RET;PRKACA;NEK6;AKT3
16403,GO:0097021,0.161371826079589,0.992911741342599,1,2,lymphocyte migration into lymphoid organs,BP,RET
8949,GO:0034991,0.161503660000257,0.992899620877688,1,2,nuclear meiotic cohesin complex,CC,REC8
1700,GO:0004180,0.161599623382919,0.953463464877719,3,17,carboxypeptidase activity,MF,AEBP1;BLMH;CTSZ
7603,GO:0031983,0.161653500094979,0.88905008731491,22,229,vesicle lumen,CC,PYGL;PYGB;NAPRT;PSMD2;EGFR;SERPING1;LCN2;APOE;C6ORF120;PSMD7;QSOX1;GLB1;DNASE1L1;TMSB4X;TIMP2;CTSZ;NIT2;IGF2;ERP44;HPSE;GALNS;DNAJC3
10727,GO:0044065,0.161671192574701,0.969957877567375,2,8,regulation of respiratory system process,BP,NLGN2;PBX3
16668,GO:0097546,0.161689229370938,0.942338892202362,4,25,ciliary base,CC,PRKACB;PRKAR1A;PRKACA;WDR60
8148,GO:0032874,0.161823503951663,0.902616152755584,13,108,positive regulation of stress-activated MAPK cascade,BP,XDH;PKN1;ERCC6;WNT7A;DKK1;PAK1;F2RL1;TAOK1;EIF2AK2;MAP4K2;FZD8;ANKRD6;RB1CC1
2984,GO:0006527,0.16186068345347,0.969161747227102,2,9,arginine catabolic process,BP,NOS1;ARG2
3010,GO:0006555,0.161866690034036,0.953351130482494,3,17,methionine metabolic process,BP,MTHFR;AHCYL2;CTH
8022,GO:0032656,0.161920202457688,0.969143381548205,2,9,regulation of interleukin-13 production,BP,ARG2;IL1RAP
4775,GO:0010960,0.162080615585889,0.970810500213339,2,7,magnesium ion homeostasis,BP,EGFR;ANK3
16279,GO:0090343,0.162141550960001,0.968493570693653,2,10,positive regulation of cell aging,BP,ARG2;HMGA2
15193,GO:0071333,0.162242544304793,0.909837333907108,10,84,cellular response to glucose stimulus,BP,PCK2;NR1D1;MAP4K4;SOX4;LRP5;PPP3CB;ANO1;XBP1;PRKACA;ENDOG
1547,GO:0003943,0.162341358759299,0.992822340708845,1,2,N-acetylgalactosamine-4-sulfatase activity,MF,GALNS
5934,GO:0018212,0.162493243386984,0.885819899692734,25,234,peptidyl-tyrosine modification,BP,NEURL1;PRNP;MAP2K1;MST1R;EGFR;FYN;ERCC6;DLG4;SHC1;DLG3;EPHA1;CD44;FGFR1;PTK6;INPP5F;CNTN1;PARP9;MAP2K2;RET;EIF2AK2;IGF2;ZMYM2;SNX6;ADNP;LRP4
14125,GO:0060988,0.162577271701434,0.99280049455269,1,2,lipid tube assembly,BP,SNX9
19623,GO:1990778,0.16272433001404,0.887537880080332,23,208,protein localization to cell periphery,BP,PRNP;BBS2;EGFR;ANK3;TSPAN5;DLG1;TTC7B;LRP1;TUB;VAMP2;RAB31;BSG;CSNK2A1;FCHO2;BCL2L1;TMBIM1;EPB41L3;LAMA5;EFCAB7;LYPLA1;LRP6;PTCH1;GNAI1
6759,GO:0030183,0.16283340509383,0.909649171920712,10,79,B cell differentiation,BP,POU2F2;RAG1;CMTM7;MMP14;DNAJB9;CEBPG;XBP1;DOCK11;CARD11;ITGA4
8187,GO:0032925,0.162871843759153,0.953260862757114,3,16,regulation of activin receptor signaling pathway,BP,ACVR2B;FKBP1A;ACVR1B
14225,GO:0061178,0.163070054987164,0.932880512535204,5,36,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1;MAP4K4;LRP5;PPP3CB;ANO1
10566,GO:0043524,0.163365196169968,0.906259609940469,11,92,negative regulation of neuron apoptotic process,BP,F2R;FYN;APOE;LRP1;AARS;BOK;CPEB4;BCL2L1;ADAM8;WFS1;ADNP
17059,GO:0099541,0.163371403635991,0.992726689132306,1,2,trans-synaptic signaling by lipid,BP,F2R
17060,GO:0099542,0.163371403635991,0.992726689132306,1,2,trans-synaptic signaling by endocannabinoid,BP,F2R
1887,GO:0004568,0.163420122445677,0.992722147881841,1,2,chitinase activity,MF,CTBS
2677,GO:0006030,0.163420122445677,0.992722147881841,1,2,chitin metabolic process,BP,CTBS
2678,GO:0006032,0.163420122445677,0.992722147881841,1,2,chitin catabolic process,BP,CTBS
3615,GO:0008061,0.163420122445677,0.992722147881841,1,2,chitin binding,MF,CTBS
16265,GO:0090322,0.163509062158016,0.952102104151066,3,19,regulation of superoxide metabolic process,BP,EGFR;ACP5;F2RL1
9068,GO:0035304,0.16354456447648,0.903569128480213,12,102,regulation of protein dephosphorylation,BP,PPP1R14A;FKBP1A;PPP2R3B;ELFN2;ITGA1;PPP1R35;CSNK2A1;PPP1R10;PPP1R2;EIF2AK2;SLC39A10;RCAN1
4771,GO:0010956,0.163594539528777,0.992705877149918,1,2,negative regulation of calcidiol 1-monooxygenase activity,BP,CYP27B1
7939,GO:0032527,0.163603116485198,0.932842206676308,5,34,protein exit from endoplasmic reticulum,BP,EDEM1;SORL1;UBE2J1;SEL1L;ERLEC1
691,GO:0001911,0.163625828527742,0.968025643221405,2,10,negative regulation of leukocyte mediated cytotoxicity,BP,CEACAM1;PPP3CB
15246,GO:0071403,0.16384433820834,0.992682539738042,1,2,cellular response to high density lipoprotein particle stimulus,BP,ABCG1
17005,GO:0099094,0.163896147710026,0.933129598551692,5,31,ligand-gated cation channel activity,MF,RASA3;PKD2;ITPR3;KCNJ15;ITPR2
12611,GO:0050792,0.163901089705136,0.893640389393232,17,163,regulation of viral process,BP,TNIP1;ADARB1;PC;STOM;APOE;HMGA2;APOBEC3C;TRIM5;MVB12B;MVB12A;IFITM1;YTHDC2;EIF2AK2;IFI16;RSF1;OAS1;TRIM38
19908,GO:2000403,0.164088263785931,0.95241301487297,3,17,positive regulation of lymphocyte migration,BP,ADAM8;ITGA4;FADD
6060,GO:0019208,0.164127155369009,0.911934651675821,9,73,phosphatase regulator activity,MF,PPP1R14A;PPP2R3B;ELFN2;PPP1R35;CSNK2A1;PPP1R10;PPP1R2;EIF2AK2;RCAN1
9150,GO:0035500,0.164214032594335,0.99264792625577,1,2,MH2 domain binding,MF,HMGA2
10041,GO:0042493,0.164276580746133,0.869002334282654,58,607,response to drug,BP,NOS1;RAB3B;PGF;CCND1;PCK2;CYGB;ADCY7;PRNP;EIF4EBP1;SSH1;HADH;EGFR;STK39;PPP1R14A;FYN;BNIP3;MAPK13;NET1;XPC;SDC1;TGFBR2;IMPACT;FKBP1A;PRKACB;LDHA;HMGA2;ATF4;PPARA;ASNS;ITGA2;ATRX;MTHFR;MT2A;XRN1;NTSR1;CST3;PPP3CB;BLMH;SLC25A4;CRLS1;BCL2L1;RET;SLC13A3;TIMP2;ZNF354A;ITPR2;PPARG;SLC7A11;RPH3AL;ENDOG;IGFBP7;SLC18A2;PTCH1;ADCY1;UFL1;GNAI1;DNMT3A;FADD
8077,GO:0032757,0.164287067892818,0.940688954675913,4,27,positive regulation of interleukin-8 production,BP,F2R;DDIT3;F2RL1;FADD
10904,GO:0044449,0.164425010536265,0.896994623633585,15,120,contractile fiber part,CC,NOS1;FLNC;SCN8A;ANK3;PARVB;PAK1;OBSCN;FKBP1A;TMOD2;OBSL1;LMAN1;PPP3CB;FLNB;PSEN2;KAT2B
7046,GO:0030819,0.164450441923615,0.968358431669576,2,9,positive regulation of cAMP biosynthetic process,BP,PTHLH;TIMP2
1751,GO:0004351,0.164528552107671,0.992618408296337,1,2,glutamate decarboxylase activity,MF,GLUL
6715,GO:0030125,0.164637835463083,0.941095185211415,4,24,clathrin vesicle coat,CC,EGFR;EPN2;CLTCL1;AP2A2
12614,GO:0050795,0.164647546018065,0.941090392675203,4,24,regulation of behavior,BP,DLG4;RAG1;APOE;PER3
18019,GO:1902512,0.164876357248058,0.99021253554766,1,3,positive regulation of apoptotic DNA fragmentation,BP,ENDOG
13082,GO:0051590,0.164878195446576,0.95207786969275,3,17,positive regulation of neurotransmitter transport,BP,RAB3B;APLN;NTSR1
18675,GO:1904020,0.164936510757649,0.992580024566704,1,2,regulation of G-protein coupled receptor internalization,BP,APLN
19235,GO:1905371,0.164956518385428,0.992578139300666,1,2,ceramide phosphoethanolamine metabolic process,BP,SAMD8
19236,GO:1905373,0.164956518385428,0.992578139300666,1,2,ceramide phosphoethanolamine biosynthetic process,BP,SAMD8
10428,GO:0043271,0.164995615845943,0.911463280668667,9,71,negative regulation of ion transport,BP,NOS1;SERPINE2;HECW2;STK39;ANK3;PKD2;ATF4;NTSR1;SLC30A1
3887,GO:0008519,0.165013243192902,0.952020490183539,3,17,ammonium transmembrane transporter activity,MF,AZIN2;SLC18A2;SLC44A1
922,GO:0002317,0.165234067914622,0.990168240086821,1,3,plasma cell differentiation,BP,XBP1
13673,GO:0060199,0.165404142339317,0.992535892333776,1,2,clathrin-sculpted glutamate transport vesicle,CC,VAMP2
13676,GO:0060203,0.165404142339317,0.992535892333776,1,2,clathrin-sculpted glutamate transport vesicle membrane,CC,VAMP2
3133,GO:0006721,0.165438766499242,0.919475819816226,7,54,terpenoid metabolic process,BP,EGFR;GPC4;RDH14;SDC1;APOE;LRP1;ALDH1A2
818,GO:0002090,0.165655570102109,0.94038021017022,4,25,regulation of receptor internalization,BP,APLN;DLG4;DKK1;ATXN2
2349,GO:0005412,0.165782290790467,0.992500100198241,1,2,glucose:sodium symporter activity,MF,SLC5A1
3669,GO:0008158,0.165940938560809,0.992485056109304,1,2,hedgehog receptor activity,MF,PTCH1
16454,GO:0097114,0.165994004583101,0.992480020334578,1,2,NMDA glutamate receptor clustering,BP,APOE
17855,GO:1902044,0.166138544183412,0.992466294678255,1,2,regulation of Fas signaling pathway,BP,TMBIM1
12543,GO:0050692,0.166185102219264,0.992461870551928,1,2,DBD domain binding,MF,PPARG
11896,GO:0046916,0.166201376808718,0.910340422879368,9,78,cellular transition metal ion homeostasis,BP,PRNP;LCN2;ATP7B;MT2A;SLC22A17;SLC30A1;SLC39A10;AP3D1;FBXL5
18561,GO:1903779,0.166217330804755,0.925085487708482,6,39,regulation of cardiac conduction,BP,NOS1;ASPH;ITPR3;TRPC1;PRKACA;ITPR2
591,GO:0001755,0.166381506948847,0.93146631915327,5,33,neural crest cell migration,BP,SEMA4B;RET;LAMA5;TBX1;SEMA3F
18547,GO:1903756,0.166571276771883,0.992425119901221,1,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8
18548,GO:1903758,0.166571276771883,0.992425119901221,1,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,ZMYND8
20209,GO:2001135,0.166577359100543,0.968464040422274,2,8,regulation of endocytic recycling,BP,SORL1;INPP5F
14942,GO:0070828,0.166821607186207,0.951988362564584,3,15,heterochromatin organization,BP,HMGA2;MTHFR;LOXL2
18600,GO:1903867,0.166873760106191,0.968372821924409,2,8,extraembryonic membrane development,BP,HTRA1;E2F7
7696,GO:0032153,0.166891897044617,0.910266725478979,9,70,cell division site,CC,PKN1;SSH1;SEPT10;RAB11FIP4;PITPNM1;SEPT5;SPIRE1;RHOBTB1;SEPT6
5859,GO:0017158,0.167178119246478,0.92417705161585,6,42,regulation of calcium ion-dependent exocytosis,BP,PFN2;RIMS3;SYTL1;SEPT5;RPH3AL;SYT2
7480,GO:0031644,0.167230247750398,0.931001697906132,5,33,regulation of neurological system process,BP,F2R;ITGA2;NTSR1;WASF3;MGLL
20136,GO:2000828,0.167311169535691,0.992354433740163,1,2,regulation of parathyroid hormone secretion,BP,FGFR1
13096,GO:0051607,0.167429137677399,0.891054749619725,17,159,defense response to virus,BP,ADARB1;BNIP3;HTRA1;BNIP3L;APOBEC3C;TRIM5;F2RL1;DDX60;PARP9;IFITM1;PUM2;EIF2AK2;IFI16;TMEM173;DNAJC3;OAS1;FADD
8036,GO:0032682,0.167450450162639,0.966806748923903,2,10,negative regulation of chemokine production,BP,ARG2;F2RL1
5703,GO:0016831,0.167675465379979,0.938829072138852,4,28,carboxy-lyase activity,MF,PCK2;GLUL;MLYCD;AZIN2
10364,GO:0043177,0.16783099982055,0.900374738386168,12,108,organic acid binding,MF,NOS1;PYGL;PC;GLUL;CEMIP;NAGS;CD44;PPARA;AARS;GLUD1;GRIN3B;PPARG
17110,GO:0101002,0.167857467184731,0.89390653864716,15,146,ficolin-1-rich granule,CC,PYGL;PSMD2;LTA4H;PGM1;CTSB;SLC2A3;CST3;COPB1;PSMD7;GLB1;YPEL5;TIMP2;AP2A2;CTSZ;ADAM8
2195,GO:0005068,0.167892527896345,0.969088163463068,2,7,transmembrane receptor protein tyrosine kinase adaptor activity,MF,PAG1;SHC1
3077,GO:0006644,0.168248218662089,0.874266007565867,35,343,phospholipid metabolic process,BP,MBOAT2;DGKA;EGFR;FYN;OSBPL10;ISYNA1;SPTLC2;TTC7B;PIGH;AGPAT4;FGFR1;LPCAT4;LPCAT1;INPP5F;PITPNM1;PLA2G4D;TMEM86B;PLPPR2;INPP4A;CSNK2A1;CRLS1;AGPAT3;ABHD6;OSBPL5;MTMR4;MBOAT7;SAMD8;SRD5A3;ACP6;AGPAT1;DDHD2;PLCH2;ZFYVE21;CDS2;SLC44A1
8534,GO:0033842,0.168417505317268,0.992248067560635,1,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,B4GALNT4
11860,GO:0046849,0.168565239329054,0.91778321947457,7,51,bone remodeling,BP,EGFR;RAC2;ACP5;LRP5;UBASH3B;ADAM8;LRP6
17924,GO:1902237,0.168703724643168,0.966403216864018,2,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,DDIT3;BOK
12488,GO:0050473,0.16873879089706,0.992217027258394,1,2,arachidonate 15-lipoxygenase activity,MF,ALOX15B
15175,GO:0071306,0.168751726586487,0.992215776080404,1,2,cellular response to vitamin E,BP,PPARG
4789,GO:0010979,0.168797021862336,0.992211394118474,1,2,regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
4790,GO:0010980,0.168797021862336,0.992211394118474,1,2,positive regulation of vitamin D 24-hydroxylase activity,BP,CYP27B1
19069,GO:1904950,0.168804411770812,0.899686305783237,12,108,negative regulation of establishment of protein localization,BP,F2R;HADH;UBE2J1;IDH2;MAP4K4;GDI1;ARG2;SOX4;F2RL1;TMSB4X;ERLEC1;LYPLA1
5520,GO:0016486,0.168979341559867,0.950324626290372,3,17,peptide hormone processing,BP,ERO1B;PCSK6;CTSZ
17743,GO:1901678,0.168993005007869,0.966928655940885,2,9,iron coordination entity transport,BP,LCN2;SLC22A17
14689,GO:0070304,0.169227102381092,0.897297777618955,13,109,positive regulation of stress-activated protein kinase signaling cascade,BP,XDH;PKN1;ERCC6;WNT7A;DKK1;PAK1;F2RL1;TAOK1;EIF2AK2;MAP4K2;FZD8;ANKRD6;RB1CC1
13835,GO:0060434,0.169245995629869,0.992167886267657,1,2,bronchus morphogenesis,BP,TGFBR2
3759,GO:0008300,0.169393584928772,0.992153555069764,1,2,isoprenoid catabolic process,BP,SRD5A3
6586,GO:0022414,0.169590630145807,0.860084508908256,79,824,reproductive process,BP,SMURF2;ERCC1;ETV5;PGF;CCND1;NEURL1;CYP27B1;SERPINE2;ADCY7;OSBP2;BBS2;MAP2K1;ANTXR2;ALOX15B;CCNI;MST1R;MICALCL;EGFR;SCMH1;UBE2J1;MYCBPAP;DLG1;CTSB;HTRA1;WNT7A;CRTAP;SDC1;TGFBR2;PKD2;PRKACB;TCFL5;ITGA2;ATRX;GAMT;BSG;MDFI;MMP14;CD46;EPOR;FAM50A;CST3;RFX2;PLAG1;PTHLH;CHD7;PRKAR1A;BOK;THRA;WNT2B;ACVR1B;ZNF449;SPESP1;AZIN2;BCL2L1;SPIRE1;TXNRD3;SPIN4;REC8;SLC38A2;SPATA6;TUBG2;PDE5A;MLH3;SH3PXD2B;PRKACA;ARID4A;IGF2;PPARG;CLDN11;ZNF568;IGFBP7;HSPA2;LRP6;ARID5B;E2F7;PTCH1;SEPT6;ADNP;DNMT3A
5089,GO:0015349,0.169600849192911,0.992133405049809,1,2,thyroid hormone transmembrane transporter activity,MF,SLCO4A1
12752,GO:0051020,0.169712509425573,0.8650305057399,56,523,GTPase binding,MF,DOCK4;SORL1;ASAP2;XPOT;FMNL2;RAPGEF3;PKN1;APPL2;EXOC2;DENND5B;EGFR;TBC1D14;RIN2;FYN;BNIP3;ARAP1;DLG4;NET1;EVI5L;GDI1;SHC1;PAK1;OBSCN;SRGAP2B;AKAP9;RAB11FIP4;FGFR1;DMXL2;DVL1;DNMBP;DOCK9;RABGGTA;RANBP9;RIMS3;SYTL1;FNBP1L;ASAP1;USP6NL;TBC1D2B;NGFR;ARF4;RIN1;RET;NCKAP1;DOCK11;PAK6;PSD3;SHC2;RGL2;EVI5;RPH3AL;ACAP2;TBC1D16;RAPGEFL1;RALGDS;RALGPS2
2736,GO:0006116,0.169911668499151,0.992103134353275,1,2,NADH oxidation,BP,PCK2
16682,GO:0097623,0.170016702644418,0.992092890651242,1,2,potassium ion export across plasma membrane,BP,DLG1
10245,GO:0042978,0.170149598957855,0.992079919179553,1,2,ornithine decarboxylase activator activity,MF,AZIN2
17939,GO:1902269,0.170149598957855,0.992079919179553,1,2,positive regulation of polyamine transmembrane transport,BP,AZIN2
6847,GO:0030315,0.170205102426512,0.929865869822521,5,30,T-tubule,CC,NOS1;ANK3;DYSF;PPP3CB;SLC30A1
8672,GO:0034242,0.170250747006624,0.992070038705218,1,2,negative regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3
15189,GO:0071326,0.170383696223328,0.90428342902801,10,85,cellular response to monosaccharide stimulus,BP,PCK2;NR1D1;MAP4K4;SOX4;LRP5;PPP3CB;ANO1;XBP1;PRKACA;ENDOG
15191,GO:0071331,0.170383696223328,0.90428342902801,10,85,cellular response to hexose stimulus,BP,PCK2;NR1D1;MAP4K4;SOX4;LRP5;PPP3CB;ANO1;XBP1;PRKACA;ENDOG
8722,GO:0034367,0.170509347383407,0.96581827083327,2,10,protein-containing complex remodeling,BP,APOE;ABCG1
5593,GO:0016620,0.170628386569604,0.937694649032877,4,26,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,ALDH1L2;ALDH7A1;ALDH1A2;ALDH4A1
11791,GO:0046655,0.170681786092335,0.949590326950045,3,17,folic acid metabolic process,BP,ALDH1L2;MTHFR;PM20D2
5596,GO:0016627,0.170787284320527,0.921405945037423,6,49,oxidoreductase activity, acting on the CH-CH group of donors,MF,RSAD1;ACAD11;ACAD10;SRD5A3;BLVRA;PTGR2
5734,GO:0016880,0.17087511437171,0.992008898686323,1,2,acid-ammonia (or amide) ligase activity,MF,GLUL
5062,GO:0015275,0.170887093779151,0.992007723103677,1,2,stretch-activated, cation-selective, calcium channel activity,MF,FAM155B
17314,GO:0140135,0.170887093779151,0.992007723103677,1,2,mechanosensitive cation channel activity,MF,FAM155B
12563,GO:0050715,0.170959608745216,0.911296343092838,8,65,positive regulation of cytokine secretion,BP,F2R;POSTN;ALOX15B;FERMT1;F2RL1;XBP1;C5;IL1RAP
14308,GO:0061441,0.171124400896289,0.991984415720097,1,2,renal artery morphogenesis,BP,PKD2
2594,GO:0005889,0.171245896466094,0.991972468467764,1,2,potassium:proton exchanging ATPase complex,CC,ATP12A
16577,GO:0097367,0.171310702234571,0.851410871438201,151,1579,carbohydrate derivative binding,MF,NOS1;RAB3B;PGF;PCK2;PYGL;RPS6KA2;SCN8A;SERPINE2;ADCY7;PRNP;ACTA2;POSTN;MAP2K1;THBS2;LTBP2;RAPGEF3;ACVR2B;COL13A1;TK2;PKN1;MST1R;DGKA;PC;PTPRS;SMARCA1;CARS;BRSK1;EGFR;STK39;FYN;MYH15;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;CTSB;GPC4;DHX32;TGM2;GLUL;ACSF2;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;CEMIP;SEPT10;WISP1;SMOC2;SLFN5;PAK1;NEK9;TGFBR2;EPHA1;RAC2;CD44;OBSCN;APOE;ATP7B;ABCD1;CDK17;PRKACB;LRP1;FYCO1;IDE;UBE2G1;ABCA7;KIF21B;ASNS;FGFR1;AARS;ITGA2;PTK6;ULK2;LONP2;LTBP4;ATRX;FAM20C;ABCG1;MAPKAPK3;RAB31;NLK;CLCN3;ANXA6;THBS3;CTSL;TWF2;TRIB3;GFPT1;PCSK6;APLP2;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;PRKAR1A;CTBS;PARP9;MAST3;SEPT5;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;YTHDC2;GLB1;ARF4;PANK4;MAP2K2;RET;TUBG2;PDE5A;RAB43;MLH3;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;RAB1A;RHOBTB1;FICD;LPAR1;MAP4K2;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;TMEM173;EEF2K;HPSE;HSD17B12;PTCH1;ADCY1;SEPT6;OAS1;PANK1;N4BP2;GNAI1
6140,GO:0019408,0.171465874061415,0.991950812125033,1,2,dolichol biosynthetic process,BP,SRD5A3
12596,GO:0050772,0.171536013309407,0.907427963297481,9,66,positive regulation of axonogenesis,BP,MAP2K1;MAP1B;PLXNB3;GDI1;PAK1;LPAR3;TWF2;NGFR;ADNP
17728,GO:1901657,0.171541609126735,0.89755952833703,12,115,glycosyl compound metabolic process,BP,NT5E;TK2;DLG1;DLG4;NME4;DLG3;CBR4;ABHD10;AHCYL2;APOBEC3C;GAMT;CARD11
19868,GO:2000346,0.171785890167126,0.991919249954544,1,2,negative regulation of hepatocyte proliferation,BP,CEACAM1
5837,GO:0017124,0.171951979331494,0.897842773043722,12,96,SH3 domain binding,MF,DOCK4;ADAM19;SH2D2A;SH3KBP1;WIPF1;ESPN;SHANK2;PTPN12;DNAJC6;MVB12A;WASF2;ELMO3
5341,GO:0016079,0.17198721999081,0.915752171282784,7,50,synaptic vesicle exocytosis,BP,SNPH;VAMP2;PFN2;RIMS3;SYTL1;SEPT5;SYT2
20020,GO:2000641,0.172061978351142,0.948992231129649,3,17,regulation of early endosome to late endosome transport,BP,MAP2K1;VPS11;MAP2K2
4481,GO:0010498,0.172077827239216,0.86848788730315,40,415,proteasomal protein catabolic process,BP,SMURF2;EDEM1;GID4;BTBD2;NR1D1;HECW2;WWTR1;DDIT3;PSMD2;UBE2J1;UBXN4;TRIB2;RBCK1;ABTB1;BTRC;RMND5A;FBXO2;DVL1;TRIB3;DNAJB9;BTBD3;PSMD7;MTA1;RNF165;XBP1;ANKIB1;GABARAPL2;UBE2E1;PRKACA;SEL1L;TBL1X;ERLEC1;WFS1;RNF180;RNF103;USP25;UFL1;KLHL15;STT3B;FBXL5
11833,GO:0046777,0.172094819821137,0.883666561412114,20,171,protein autophosphorylation,BP,EGFR;STK39;FYN;GRK5;PAK1;EPHA1;IMPACT;FGFR1;PTK6;ULK2;MAPKAPK3;NLK;SLK;TAOK1;CSNK2A1;ACVR1B;MAP2K2;NEK6;EIF2AK2;EEF2K
18341,GO:1903305,0.172167885184089,0.906664248861805,9,72,regulation of regulated secretory pathway,BP,RAC2;PFN2;CEACAM1;RIMS3;SYTL1;F2RL1;SEPT5;RPH3AL;SYT2
8648,GO:0034189,0.172263241064421,0.991872044195908,1,2,very-low-density lipoprotein particle binding,MF,VLDLR
8018,GO:0032651,0.17241736684826,0.927727500628476,5,36,regulation of interleukin-1 beta production,BP,F2R;ARG2;ACP5;IFI16;FOXP1
2,GO:0000003,0.172471493470297,0.857539673448781,79,825,reproduction,BP,SMURF2;ERCC1;ETV5;PGF;CCND1;NEURL1;CYP27B1;SERPINE2;ADCY7;OSBP2;BBS2;MAP2K1;ANTXR2;ALOX15B;CCNI;MST1R;MICALCL;EGFR;SCMH1;UBE2J1;MYCBPAP;DLG1;CTSB;HTRA1;WNT7A;CRTAP;SDC1;TGFBR2;PKD2;PRKACB;TCFL5;ITGA2;ATRX;GAMT;BSG;MDFI;MMP14;CD46;EPOR;FAM50A;CST3;RFX2;PLAG1;PTHLH;CHD7;PRKAR1A;BOK;THRA;WNT2B;ACVR1B;ZNF449;SPESP1;AZIN2;BCL2L1;SPIRE1;TXNRD3;SPIN4;REC8;SLC38A2;SPATA6;TUBG2;PDE5A;MLH3;SH3PXD2B;PRKACA;ARID4A;IGF2;PPARG;CLDN11;ZNF568;IGFBP7;HSPA2;LRP6;ARID5B;E2F7;PTCH1;SEPT6;ADNP;DNMT3A
1673,GO:0004137,0.172485455748361,0.991850017582762,1,2,deoxycytidine kinase activity,MF,TK2
1442,GO:0003430,0.172558158665082,0.991842803928233,1,2,growth plate cartilage chondrocyte growth,BP,TGFBR2
13362,GO:0052547,0.172700021059881,0.875761403782499,27,284,regulation of peptidase activity,BP,XDH;F2R;SORL1;SERPINE2;TFPI2;TNFSF15;FYN;TNFRSF6B;ASPH;DAP;RAG1;SERPING1;CD44;MMP14;CST3;CASP4;APLP2;PRDX5;CSNK2A1;BOK;NGFR;C5;TIMP2;IFI16;PPARG;FAM162A;FADD
887,GO:0002253,0.17284711569291,0.870389019805113,35,356,activation of immune response,BP,TNIP1;PRNP;PAG1;NR1D1;PTPRS;PSMD2;WIPF1;FYN;CTSB;PAK1;SERPING1;PRKACB;RBCK1;BTRC;CEACAM1;MAPKAPK3;TRIM5;CD46;CTSL;F2RL1;DDX60;PSMD7;WASF2;SKAP2;C5;NCKAP1;PUM2;PRKACA;IFI16;SLC39A10;CARD11;ARPC1A;WASL;TMEM173;FADD
19976,GO:2000563,0.172856484927237,0.991813166964123,1,2,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,TGFBR2
8627,GO:0034143,0.172887341352548,0.965681950723507,2,9,regulation of toll-like receptor 4 signaling pathway,BP,NR1D1;F2RL1
13060,GO:0051560,0.173065122800982,0.948238450462641,3,18,mitochondrial calcium ion homeostasis,BP,BNIP3;TGM2;ANXA6
10685,GO:0043949,0.173272234180149,0.948827250711049,3,16,regulation of cAMP-mediated signaling,BP,NOS1;LPAR1;GNAI1
18777,GO:1904289,0.173392312331423,0.99175978721343,1,2,regulation of mitotic DNA damage checkpoint,BP,PPP1R10
9515,GO:0036194,0.173524440082788,0.989111130570255,1,3,muscle cell projection,CC,ARPC1A
9516,GO:0036195,0.173524440082788,0.989111130570255,1,3,muscle cell projection membrane,CC,ARPC1A
5840,GO:0017127,0.173571075828855,0.964816786588467,2,10,cholesterol transporter activity,MF,APOE;ABCG1
10079,GO:0042578,0.173572338714922,0.874481417696703,28,267,phosphoric ester hydrolase activity,MF,NT5E;MAP2K1;SSH1;PTPRS;DLG1;PTPN3;EDNRA;PLPP6;ACP5;PTPN12;PPP2R3B;PTPDC1;INPP5F;PLPPR2;PPP3CB;INPP4A;DNAJC6;PLD3;PTPRZ1;NT5DC1;UBASH3B;PDE5A;MTMR4;FICD;ACP6;PLCXD1;PLCH2;PPM1M
10047,GO:0042501,0.173601723224115,0.964806700830918,2,10,serine phosphorylation of STAT protein,BP,NLK;RET
6491,GO:0021846,0.173619041301007,0.949574432839753,3,14,cell proliferation in forebrain,BP,WNT7A;FGFR1;CEP120
3727,GO:0008253,0.173687679077054,0.965423344234704,2,9,5'-nucleotidase activity,MF,NT5E;NT5DC1
17664,GO:1901509,0.173704799203115,0.991728568807374,1,2,regulation of endothelial tube morphogenesis,BP,FOXP1
18254,GO:1903077,0.173765928929308,0.948250398078652,3,17,negative regulation of protein localization to plasma membrane,BP,BCL2L1;TMBIM1;LYPLA1
2942,GO:0006469,0.17383328128739,0.880815077990776,21,202,negative regulation of protein kinase activity,BP,SORL1;ADARB1;PKN1;WWTR1;SOCS2;TRIB2;EPHA1;APOE;RGS14;PTK6;CEACAM1;DVL1;LRP5;TRIB3;PRKAR1A;SPRY2;UBASH3B;SNX6;LRP6;DNAJC3;KAT2B
582,GO:0001735,0.173869648970971,0.991712073637467,1,2,prenylcysteine oxidase activity,MF,PCYOX1
6859,GO:0030328,0.173869648970971,0.991712073637467,1,2,prenylcysteine catabolic process,BP,PCYOX1
6860,GO:0030329,0.173869648970971,0.991712073637467,1,2,prenylcysteine metabolic process,BP,PCYOX1
6253,GO:0019834,0.173905126919043,0.989061177509267,1,3,phospholipase A2 inhibitor activity,MF,ANXA3
8168,GO:0032902,0.174344566194144,0.991664451451814,1,2,nerve growth factor production,BP,PCSK6
6688,GO:0030056,0.174394924696642,0.968617238601944,2,6,hemidesmosome,CC,ITGA6;ITGB4
18779,GO:1904292,0.174400527967281,0.935783893486635,4,26,regulation of ERAD pathway,BP,EDEM1;UBE2J1;ERLEC1;USP25
7497,GO:0031668,0.174552880802448,0.881520145443373,20,187,cellular response to extracellular stimulus,BP,CBS;ITGA6;CYP27B1;POSTN;SSH1;FYN;GLUL;DAP;IMPACT;ATF4;ASNS;CPEB4;WNT2B;XBP1;SLC38A2;GABARAPL2;EIF2AK2;IFI16;PPARG;ADNP
16606,GO:0097435,0.174565560099776,0.862976534906757,49,469,supramolecular fiber organization,BP,LTBP2;RAPGEF3;SSH1;MAP1B;WIPF1;LOXL1;ARHGAP12;ARAP1;DLG1;ESPN;TTBK2;PAK1;EPHA1;RAC2;OBSCN;APOE;FKBP1A;AKAP9;TMOD2;ITGB5;FAT1;PFN2;FHOD1;CEP120;OBSL1;DVL1;TWF2;CST3;RANBP9;WASF3;SLK;F2RL1;PRKAR1A;MSRB2;JMY;WASF2;SPIRE1;TUBG2;LOXL2;SH3PXD2B;NCKAP1;COL1A2;CCDC88A;CCSAP;TMSB4X;RHOBTB1;LPAR1;ARPC1A;WASL
10331,GO:0043123,0.174590755590261,0.889015083125285,15,141,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,F2R;FYN;TGM2;FKBP1A;RBCK1;TRIM5;CTH;F2RL1;C18ORF32;TMED4;NEK6;CARD11;LPAR1;TRIM38;FADD
12147,GO:0048251,0.174613357575444,0.96595192376768,2,8,elastic fiber assembly,BP,THSD4;LOXL1
6326,GO:0020012,0.174736779430307,0.991625009149301,1,2,evasion or tolerance of host immune response,BP,EIF2AK2
6999,GO:0030682,0.174736779430307,0.991625009149301,1,2,evasion or tolerance of host defense response,BP,EIF2AK2
7000,GO:0030683,0.174736779430307,0.991625009149301,1,2,evasion or tolerance by virus of host immune response,BP,EIF2AK2
13195,GO:0051805,0.174736779430307,0.991625009149301,1,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,EIF2AK2
13197,GO:0051807,0.174736779430307,0.991625009149301,1,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,EIF2AK2
11519,GO:0046033,0.174774221316958,0.964419935065164,2,10,AMP metabolic process,BP,NT5E;AK9
6271,GO:0019865,0.174809034130335,0.988942069317589,1,3,immunoglobulin binding,MF,FCGRT
16759,GO:0098542,0.174876750181787,0.875736253245812,25,260,defense response to other organism,BP,ADARB1;BNIP3;HTRA1;ARG2;SHC1;BNIP3L;ACP5;ANXA3;APOBEC3C;GSDMC;TRIM5;F2RL1;DDX60;GSDMA;PARP9;IFITM1;PUM2;EIF2AK2;RAB1A;IFI16;TMEM173;DNAJC3;FOXP1;OAS1;FADD
12330,GO:0048682,0.17521325001865,0.991576955720241,1,2,sprouting of injured axon,BP,LAMB2
4968,GO:0015077,0.175302500895802,0.883648145013747,18,166,monovalent inorganic cation transmembrane transporter activity,MF,SCN8A;KCNG1;SLC33A1;SLC9A7;PKD2;SLC5A1;SLC2A9;SLC6A6;SLC6A14;NDUFA4L2;SLC12A7;SLC13A3;KCNJ15;SLC2A13;SLC10A6;ATP12A;ATP6V1B2;SLC23A2
1594,GO:0004012,0.175769712749878,0.949227630429488,3,13,phospholipid-translocating ATPase activity,MF,ABCA7;ATP10D;ATP11B
6342,GO:0021516,0.175931351010513,0.99150424705323,1,2,dorsal spinal cord development,BP,PBX3
1487,GO:0003824,0.176048291417852,0.84103021210749,378,4343,catalytic activity,MF,XDH;NT5E;PLAT;SMURF2;EDEM1;GID4;NOS1;ERCC1;ADAM19;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;PYGL;CBS;MMP1;CYGB;RPS6KA2;CYP27B1;PYGB;PRSS3;ADCY7;CRYL1;GPT2;HECW2;ADARB1;MAP2K1;ACVR2B;LTBP1;ALOX15B;TK2;THSD4;GPX3;PKN1;NAPRT;MST1R;MARCH9;H6PD;DHTKD1;DGKA;SSH1;PC;PTPRS;B4GALT6;SMARCA1;HADH;CARS;PSMD2;LTA4H;CAPN2;BRSK1;EGFR;STK39;LOXL1;FYN;MYH15;TMPRSS11D;PSAT1;JADE2;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;ELOVL1;PGM1;ADAMTS7;DLG1;ISYNA1;DLG4;B3GNT3;IDH2;CTSB;ACOT1;DHX32;TYSND1;TGM2;GLUL;HTRA1;GLO1;FKBP9;ACSF2;PGLS;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;RSAD1;GRK5;NMRK1;STRADB;RDH14;NME4;ASPH;CEMIP;ACAD11;SEPT10;ARG2;NAGS;DLG3;HYI;PAK1;NEK9;CBR4;RAG1;TGFBR2;PTPN3;B4GALNT4;EDNRA;HAGH;SCRN1;EPHA1;PLPP6;RAC2;CLCA2;ERO1B;OBSCN;FKBP1A;ATP7B;ABCD1;ACP5;PTPN12;ALDH1L2;CDK17;ZNF862;PRKACB;RBCK1;LDHA;ST3GAL5;IDE;PPP2R3B;ABHD8;UBE2G1;HMGA2;ABCA7;PIGH;AGPAT4;PCMTD2;KIF21B;ASNS;FGFR1;ABHD10;AARS;MARCH4;PTPDC1;LPCAT4;RNPEPL1;UROS;HYAL1;BTRC;LPCAT1;AIG1;PTK6;GALNT3;TMX4;ULK2;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;RMND5A;APOBEC3C;FBXO2;DDB2;GAMT;ENDOV;IAH1;KDSR;MBLAC2;MAPKAPK3;PDIA5;RAB31;ATF7IP;RCOR1;NLK;XRN1;TRIM5;MMP14;PLA2G4D;NLGN2;ACAD10;CTH;ABHD17C;TMEM86B;CTSL;NPEPL1;RABGGTA;CASP4;GFPT1;PCSK6;FBXL8;PLPPR2;PPP3CB;MEX3C;ACOT13;INPP4A;HIBADH;ZDHHC2;DNAJC6;SLK;PRDX5;MLYCD;ALDH7A1;CDC42BPA;DDX60;UHRF2;TAOK1;PLD3;AEBP1;ATP10D;ABHD15;FBXO41;OTUB2;CSNK2A1;TST;CHD7;BLMH;QSOX1;SUGCT;NDUFV3;CPT2;CTBS;MSRB2;CRLS1;PARP9;KLHL29;MAST3;NACC2;DHRS12;SEPT5;LACTB2;MGLL;ACVR1B;NDUFA4L2;BPHL;PSKH1;GLUD1;HSPA13;MARK4;NPL;PTPRZ1;CHD6;NUDT6;MTA1;AZIN2;CRAT;MYH16;RNF165;YTHDC2;PM20D2;AGPAT3;GLB1;TRIM7;ARF4;POLL;UAP1;HSD17B7;PCYOX1;PANK4;NT5DC1;UBASH3B;TXNRD3;MAP2K2;ABHD6;CYP4F22;ANKIB1;LYPLAL1;RET;SDR9C7;TUBG2;LOXL2;PDE5A;RAB43;MLH3;TXNDC11;MTMR4;ZFYVE9;MBOAT7;RMRP;DNASE1L1;PAK6;UBE2E1;RNF135;CTSO;SAMD8;ADAMTSL1;PRKACA;NEK6;UNKL;EIF2AK2;RAB1A;ZDHHC1;RHOBTB1;SRD5A3;ST6GALNAC2;CARD11;FICD;CTSZ;MMP10;RNF169;ARID4A;NIT2;BLVRA;ACP6;AGPAT1;PJA2;MAP4K2;ZMYM2;PTGR2;USP20;ALDH1A2;LYPLA1;ATP12A;ERP44;ATP6V1B2;AK9;ADAM8;ALDH4A1;AKT3;GARS;ENDOG;ATP11B;PHF21A;WDR60;DDHD2;MARCH2;OSGEPL1;PLCXD1;USP32;HSPA2;PRSS8;ARID5B;PLCH2;RNF180;GGACT;PPT2;EEF2K;HPSE;GALNS;CMTR2;TRIM2;COQ2;TET1;ZFYVE21;PSEN2;ELOVL4;AOX1;HSD17B12;CDS2;ADCY1;KAT2B;SEPT6;OAS1;RNF103;USP25;PANK1;PRMT3;UFL1;N4BP2;AMACR;GALE;PPM1M;KLHL15;GNAI1;STT3B;DNMT3A;ALAS1;TRIM38;FBXL5
650,GO:0001840,0.176071529018443,0.965487420599243,2,8,neural plate development,BP,DVL1;PTCH1
17824,GO:1901981,0.17609293751175,0.892347242758334,13,109,phosphatidylinositol phosphate binding,MF,ARAP1;SNX14;PFN2;GSDMC;PLEK2;TWF2;GSDMA;ASAP1;FCHO2;OSBPL5;SH3PXD2B;ACAP2;SNX27
3094,GO:0006667,0.176141042344484,0.991482950585474,1,2,sphinganine metabolic process,BP,SPTLC2
11714,GO:0046511,0.176141042344484,0.991482950585474,1,2,sphinganine biosynthetic process,BP,SPTLC2
19070,GO:1904951,0.176148966624581,0.868853189306993,33,330,positive regulation of establishment of protein localization,BP,EDEM1;F2R;SORL1;PCK2;PRNP;POSTN;RAPGEF3;ALOX15B;EGFR;ANK3;FYN;GLUL;CEMIP;STOM;PAK1;RAC2;LRP1;VAMP2;SOX4;FERMT1;NLGN2;VPS11;PPP3CB;F2RL1;ANO1;GLUD1;XBP1;C5;IL1RAP;EFCAB7;RPH3AL;ADAM8;TMEM173
17875,GO:1902109,0.176264642855291,0.988748784854942,1,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BNIP3
8391,GO:0033300,0.176277788629706,0.991469046667228,1,2,dehydroascorbic acid transmembrane transporter activity,MF,SLC2A3
14947,GO:0070837,0.176277788629706,0.991469046667228,1,2,dehydroascorbic acid transport,BP,SLC2A3
13003,GO:0051428,0.176338831028808,0.963901070218628,2,10,peptide hormone receptor binding,MF,FYN;PTHLH
7358,GO:0031400,0.176505963074102,0.862671604333616,45,459,negative regulation of protein modification process,BP,TNIP1;XDH;SORL1;PRNP;ADARB1;PKN1;WWTR1;STK39;PPP1R14A;FYN;DLG1;CRTAP;DKK1;SOCS2;TRIB2;EPHA1;IMPACT;APOE;FKBP1A;RGS14;ELFN2;PPP1R35;PTK6;INPP5F;SOX4;CEACAM1;DVL1;LRP5;TRIB3;RANBP9;F2RL1;PHF1;PRKAR1A;SPRY2;BEX4;PPP1R10;UBASH3B;PPP1R2;SNX6;LRP6;DNAJC3;KAT2B;PRMT3;UFL1;JARID2
3284,GO:0006971,0.176639790788509,0.965305680182451,2,8,hypotonic response,BP,STK39;ITGA2
7251,GO:0031209,0.176661064138696,0.965298868745071,2,8,SCAR complex,CC,WASF2;NCKAP1
1176,GO:0002823,0.176863675205138,0.94656541349999,3,18,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,CEACAM1;PPP3CB;IL20RB
10114,GO:0042632,0.177105043863074,0.925103129481662,5,36,cholesterol homeostasis,BP,MALL;APOE;ABCG1;LRP5;XBP1
13521,GO:0055092,0.177105043863074,0.925103129481662,5,36,sterol homeostasis,BP,MALL;APOE;ABCG1;LRP5;XBP1
6288,GO:0019898,0.177108480458213,0.878452717645884,21,187,extrinsic component of membrane,CC,EPN3;SERPINE2;PRNP;ALOX15B;STK39;FYN;DLG4;SNX9;WDFY3;SEC23A;FKBP1A;PTK6;VPS13A;SYTL1;MGLL;SNX30;EFCAB7;SNX6;ESYT3;PRSS8;GNAI1
9962,GO:0042339,0.177231365613663,0.934144322278249,4,27,keratan sulfate metabolic process,BP,B4GALT6;B3GNT3;GLB1;GALNS
2361,GO:0005462,0.177231480758187,0.99137173069269,1,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,SLC35B4
19559,GO:1990569,0.177231480758187,0.99137173069269,1,2,UDP-N-acetylglucosamine transmembrane transport,BP,SLC35B4
7757,GO:0032273,0.177363347930959,0.896414047331166,11,95,positive regulation of protein polymerization,BP,WIPF1;DLG1;PAK1;RAC2;AKAP9;PFN2;JMY;SPIRE1;NCKAP1;ARPC1A;WASL
8204,GO:0032956,0.177613240432241,0.872915604174309,26,241,regulation of actin cytoskeleton organization,BP,RAPGEF3;SSH1;WIPF1;ARAP1;DLG1;PAK1;EPHA1;RAC2;LRP1;TMOD2;PFN2;FHOD1;TWF2;F2RL1;TAOK1;JMY;WASF2;SPIRE1;SH3PXD2B;NCKAP1;CCDC88A;TMSB4X;RHOBTB1;LPAR1;ARPC1A;WASL
6346,GO:0021522,0.177826151799858,0.946841472955848,3,16,spinal cord motor neuron differentiation,BP,SOX4;TCTN1;PTCH1
15729,GO:0072300,0.177877778233143,0.99130543560761,1,2,positive regulation of metanephric glomerulus development,BP,RET
14926,GO:0070777,0.177901948654224,0.991302950856109,1,2,D-aspartate transport,BP,NTSR1
14928,GO:0070779,0.177901948654224,0.991302950856109,1,2,D-aspartate import across plasma membrane,BP,NTSR1
8146,GO:0032872,0.177972462614677,0.881688406931014,18,161,regulation of stress-activated MAPK cascade,BP,XDH;MAP2K1;PKN1;EGFR;ERCC6;DLG1;WNT7A;MAP4K4;DKK1;PAK1;F2RL1;TAOK1;MAP2K2;EIF2AK2;MAP4K2;FZD8;ANKRD6;RB1CC1
2045,GO:0004792,0.178026172716884,0.988512433581487,1,3,thiosulfate sulfurtransferase activity,MF,TST
4098,GO:0009152,0.178034562466493,0.881458933194027,18,172,purine ribonucleotide biosynthetic process,BP,NOS1;ADCY7;DHTKD1;PGM1;ACOT7;NME4;APOE;LDHA;AKAP9;PPARA;PTHLH;PANK4;TMSB4X;TIMP2;AK9;ADCY1;PANK1;ADNP
9667,GO:0038025,0.178241804884321,0.991267971713607,1,2,reelin receptor activity,MF,VLDLR
12932,GO:0051289,0.178443970942167,0.911160271975432,7,57,protein homotetramerization,BP,GPX3;CRTC1;CBR4;PKD2;IDE;CTH;ACOT13
2393,GO:0005536,0.178498942570331,0.963851564746397,2,9,glucose binding,MF,PYGL;SLC2A3
15605,GO:0072088,0.178548169193046,0.911752471333966,7,49,nephron epithelium morphogenesis,BP,PGF;CTNNBIP1;DLG1;PKD2;WNT2B;LAMA5;PTCH1
19413,GO:1905954,0.178609571403019,0.917083581133738,6,45,positive regulation of lipid localization,BP,APOE;LRP1;ABCA7;ABCG1;NTSR1;PTCH1
12189,GO:0048332,0.178744404325234,0.917440934880628,6,41,mesoderm morphogenesis,BP,ITGB4;DKK1;HMGA2;FGFR1;ITGA2;PRKAR1A
13023,GO:0051458,0.178765373586706,0.991213932657672,1,2,corticotropin secretion,BP,APLN
13024,GO:0051459,0.178765373586706,0.991213932657672,1,2,regulation of corticotropin secretion,BP,APLN
13025,GO:0051461,0.178765373586706,0.991213932657672,1,2,positive regulation of corticotropin secretion,BP,APLN
19742,GO:2000116,0.178810763449633,0.879328337132253,19,191,regulation of cysteine-type endopeptidase activity,BP,XDH;F2R;TNFSF15;FYN;TNFRSF6B;ASPH;DAP;RAG1;CD44;CST3;CASP4;PRDX5;CSNK2A1;BOK;NGFR;IFI16;PPARG;FAM162A;FADD
10493,GO:0043393,0.178828348788188,0.880880567519573,18,170,regulation of protein binding,BP,SORL1;CTNNBIP1;NFATC4;TTBK2;DKK1;APOE;FKBP1A;CCPG1;LRP1;PPARA;DVL1;TRIB3;UBASH3B;PRKACA;CTSZ;ITGA4;TMEM173;ADNP
20028,GO:2000649,0.179219306250934,0.924509254631634,5,32,regulation of sodium ion transmembrane transporter activity,BP,HECW2;STK39;ANK3;STOM;PTPN3
17586,GO:1901216,0.179451704317998,0.905837134627935,8,64,positive regulation of neuron death,BP,PRNP;SSH1;DDIT3;FYN;DKK1;ATF4;ITGA1;CTSZ
13635,GO:0060134,0.179473058696337,0.991140597904622,1,2,prepulse inhibition,BP,DVL1
12480,GO:0050431,0.179475910633081,0.946549653594773,3,15,transforming growth factor beta binding,MF,LTBP1;TGFBR2;LTBP4
5517,GO:0016480,0.179573752771083,0.988302573847626,1,3,negative regulation of transcription by RNA polymerase III,BP,PRDX5
15339,GO:0071559,0.179600389563579,0.879058309248463,19,168,response to transforming growth factor beta,BP,SMURF2;MXRA5;POSTN;LTBP2;FNDC4;LTBP1;FYN;HTRA1;WNT7A;TGFBR2;FKBP1A;ITGB5;LTBP4;FERMT1;NLK;MTMR4;ZFYVE9;COL1A2;SNX6
9988,GO:0042391,0.179741439396031,0.876289612892475,21,194,regulation of membrane potential,BP,FHL1;ZMYND8;SCN8A;SSH1;CRTC1;ANK3;BNIP3;DLG1;DLG4;WNT7A;PTPN3;SHANK2;BNIP3L;AKAP9;DVL1;NTSR1;NLGN2;RIMS3;BOK;BCL2L1;GRIN3B
6985,GO:0030662,0.179838731322763,0.8871882984068,14,127,coated vesicle membrane,CC,EGFR;SEC23A;CEMIP;APOE;MCFD2;VAMP2;LMAN1;EPN2;CLTCL1;COPB1;COPG1;AP2A2;SYT2;SLC18A2
16255,GO:0090308,0.179926702809102,0.964246554783195,2,8,regulation of methylation-dependent chromatin silencing,BP,UHRF2;TET1
14423,GO:0061723,0.180042103354386,0.991081385785605,1,2,glycophagy,BP,RB1CC1
17505,GO:1900623,0.180175224174727,0.991067502417334,1,2,regulation of monocyte aggregation,BP,CD44
17506,GO:1900625,0.180175224174727,0.991067502417334,1,2,positive regulation of monocyte aggregation,BP,CD44
11108,GO:0045125,0.18033693984373,0.962560904504519,2,10,bioactive lipid receptor activity,MF,LPAR3;LPAR1
18443,GO:1903526,0.180344775806746,0.9910498023552,1,2,negative regulation of membrane tubulation,BP,WASL
291,GO:0000795,0.180496930746191,0.945282995245765,3,17,synaptonemal complex,CC,REC8;MLH3;HSPA2
17002,GO:0099086,0.180496930746191,0.945282995245765,3,17,synaptonemal structure,CC,REC8;MLH3;HSPA2
1810,GO:0004459,0.180577165896301,0.988165396234626,1,3,L-lactate dehydrogenase activity,MF,LDHA
13083,GO:0051591,0.180583887996662,0.905294541450961,8,61,response to cAMP,BP,RAPGEF3;SDC1;PKD2;LDHA;AKAP9;BSG;ITPR2;EEF2K
3468,GO:0007288,0.180637488677495,0.96314349808868,2,9,sperm axoneme assembly,BP,NEURL1;BBS2
8621,GO:0034137,0.180692504605229,0.988149572143685,1,3,positive regulation of toll-like receptor 2 signaling pathway,BP,F2RL1
2282,GO:0005234,0.180700874262766,0.991012565027521,1,2,extracellularly glutamate-gated ion channel activity,MF,GRIN3B
6990,GO:0030669,0.180713209756206,0.932761722879809,4,25,clathrin-coated endocytic vesicle membrane,CC,EGFR;APOE;EPN2;AP2A2
2679,GO:0006040,0.180753982976932,0.9323265594458,4,27,amino sugar metabolic process,BP,GFPT1;CTBS;NPL;UAP1
3537,GO:0007529,0.180821049898458,0.99099997894616,1,2,establishment of synaptic specificity at neuromuscular junction,BP,F2R
6909,GO:0030497,0.181004621312552,0.962335098473679,2,10,fatty acid elongation,BP,ELOVL1;ELOVL4
10174,GO:0042761,0.181004621312552,0.962335098473679,2,10,very long-chain fatty acid biosynthetic process,BP,ELOVL1;ELOVL4
8019,GO:0032652,0.181097756973004,0.915303419951086,6,48,regulation of interleukin-1 production,BP,F2R;ARG2;ACP5;CEACAM1;IFI16;FOXP1
16572,GO:0097360,0.18115237485997,0.990965228635071,1,2,chorionic trophoblast cell proliferation,BP,BOK
17647,GO:1901382,0.18115237485997,0.990965228635071,1,2,regulation of chorionic trophoblast cell proliferation,BP,BOK
8211,GO:0032964,0.181328025326517,0.932028864173056,4,27,collagen biosynthetic process,BP,F2R;CYGB;ITGA2;PPARG
15858,GO:0072574,0.181360565752761,0.962902778135495,2,9,hepatocyte proliferation,BP,CEACAM1;XBP1
15859,GO:0072575,0.181360565752761,0.962902778135495,2,9,epithelial cell proliferation involved in liver morphogenesis,BP,CEACAM1;XBP1
4021,GO:0009051,0.181511506602557,0.988036875195532,1,3,pentose-phosphate shunt, oxidative branch,BP,PGLS
3071,GO:0006637,0.181554300161522,0.900067197129404,9,78,acyl-CoA metabolic process,BP,ELOVL1;ACOT1;ACSF2;ACOT7;CBR4;ACOT13;MLYCD;PPT2;HSD17B12
9108,GO:0035383,0.181554300161522,0.900067197129404,9,78,thioester metabolic process,BP,ELOVL1;ACOT1;ACSF2;ACOT7;CBR4;ACOT13;MLYCD;PPT2;HSD17B12
7445,GO:0031579,0.18160428131622,0.944151367639614,3,19,membrane raft organization,BP,MARVELD1;DLG1;MALL
4384,GO:0010035,0.181646577866205,0.863638081387253,34,349,response to inorganic substance,BP,ERCC1;CCND1;PRNP;NFATC4;EGFR;ANK3;BNIP3;ERCC6;MAPK13;NET1;GDI1;SDC1;IMPACT;FKBP1A;ATP7B;PKD2;LDHA;ATF4;UROS;ATRX;ITPR3;MT2A;BSG;CST3;TXNRD3;TRPC1;LOXL2;SLC30A1;ENDOG;EEF2K;PTCH1;ADCY1;ADNP;DNMT3A
10918,GO:0044501,0.181653288353139,0.990912550836788,1,2,modulation of signal transduction in other organism,BP,TNIP1
13297,GO:0052027,0.181653288353139,0.990912550836788,1,2,modulation by symbiont of host signal transduction pathway,BP,TNIP1
13331,GO:0052250,0.181653288353139,0.990912550836788,1,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,TNIP1
1482,GO:0003779,0.181751257455231,0.86448747237253,33,292,actin binding,MF,FLNC;SYNE3;MARCKSL1;FMNL2;MPRIP;SSH1;MAP1B;SNTB2;WIPF1;EGFR;MYH15;PARVB;ESPN;IMPACT;AFAP1;TMOD2;PFN2;FHOD1;CEACAM1;OBSL1;TWF2;WASF3;MSRB2;JMY;WASF2;SPIRE1;CCDC88A;TMSB4X;EPB41L3;ARPC1A;WASL;FLNB;SSFA2
4123,GO:0009182,0.181891998366652,0.987984319977951,1,3,purine deoxyribonucleoside diphosphate metabolic process,BP,AK9
11538,GO:0046066,0.181891998366652,0.987984319977951,1,3,dGDP metabolic process,BP,AK9
1024,GO:0002526,0.181938667774181,0.908811784533041,7,59,acute inflammatory response,BP,CTNNBIP1;SERPING1;CD46;C5;PPARG;ADAM8;IL20RB
14134,GO:0061000,0.182260299727927,0.963486430699651,2,8,negative regulation of dendritic spine development,BP,PTPRS;ASAP1
2728,GO:0006107,0.182329456988816,0.961885354405299,2,10,oxaloacetate metabolic process,BP,PCK2;NIT2
693,GO:0001913,0.182442870531185,0.943503406123544,3,20,T cell mediated cytotoxicity,BP,CEACAM1;PPP3CB;FADD
7997,GO:0032616,0.182513002105217,0.961822868636997,2,10,interleukin-13 production,BP,ARG2;IL1RAP
9810,GO:0040038,0.182555434562615,0.990817250794593,1,2,polar body extrusion after meiotic divisions,BP,SPIRE1
14872,GO:0070649,0.182555434562615,0.990817250794593,1,2,formin-nucleated actin cable assembly,BP,SPIRE1
17227,GO:0110009,0.182555434562615,0.990817250794593,1,2,formin-nucleated actin cable organization,BP,SPIRE1
9895,GO:0042177,0.182652898478603,0.892611581267833,11,97,negative regulation of protein catabolic process,BP,SERPINE2;EGFR;FYN;UBE2J1;PTPN3;CST3;AZIN2;GABARAPL2;TIMP2;ERLEC1;USP25
17724,GO:1901653,0.182706244956662,0.867908749968308,27,254,cellular response to peptide,BP,PCK2;ADCY7;PRNP;EIF4EBP1;FYN;SHC1;PAK1;SOCS2;PRKACB;LRP1;IDE;VAMP2;CEACAM1;RAB31;TRIB3;CASP4;PRKAR1A;NGFR;XBP1;PRKACA;IGF2;GRB10;PPARG;ATP6V1B2;EEF2K;ADCY1;KAT2B
19529,GO:1990428,0.182755480632474,0.990796044030149,1,2,miRNA transport,BP,TGFBR2
20277,GO:2001245,0.182791530345627,0.990792219544064,1,2,regulation of phosphatidylcholine biosynthetic process,BP,LPCAT1
1854,GO:0004517,0.182813592003101,0.990789878606441,1,2,nitric-oxide synthase activity,MF,NOS1
9781,GO:0039692,0.182904486064458,0.961689448331671,2,10,single stranded viral RNA replication via double stranded DNA intermediate,BP,HMGA2;APOBEC3C
10723,GO:0044057,0.18291541271632,0.86776763040435,27,251,regulation of system process,BP,DOCK4;NOS1;F2R;APLN;EGFR;STK39;DLG1;ASPH;PAK1;AKAP9;FGFR1;ITGA2;ITPR3;NTSR1;ANXA6;NLGN2;WASF3;F2RL1;THRA;MGLL;TRPC1;PDE5A;MTMR4;PRKACA;ITPR2;PBX3;JARID2
17858,GO:1902065,0.18292257485704,0.962380508819053,2,9,response to L-glutamate,BP,FYN;UFL1
8668,GO:0034237,0.182931996413494,0.945028278763231,3,15,protein kinase A regulatory subunit binding,MF,AKAP9;PRKACA;PJA2
12687,GO:0050904,0.18296135703251,0.990774190939061,1,2,diapedesis,BP,ITGA4
10957,GO:0044703,0.183045928642189,0.854249458676686,53,544,multi-organism reproductive process,BP,SMURF2;ERCC1;ETV5;PGF;NEURL1;CYP27B1;SERPINE2;ADCY7;OSBP2;BBS2;CCNI;MST1R;MICALCL;SCMH1;UBE2J1;MYCBPAP;CTSB;CRTAP;TGFBR2;TCFL5;ITGA2;ATRX;GAMT;BSG;CD46;EPOR;FAM50A;CST3;RFX2;PTHLH;PRKAR1A;THRA;ACVR1B;ZNF449;SPESP1;AZIN2;BCL2L1;SPIRE1;TXNRD3;SPIN4;REC8;SLC38A2;SPATA6;PDE5A;MLH3;SH3PXD2B;PRKACA;ARID4A;CLDN11;IGFBP7;HSPA2;SEPT6;DNMT3A
14268,GO:0061333,0.183201387327791,0.908822327499034,7,49,renal tubule morphogenesis,BP,PGF;CTNNBIP1;DLG1;PKD2;WNT2B;LAMA5;PTCH1
11372,GO:0045737,0.183414838822526,0.93075685658729,4,28,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CCND1;EGFR;CCND2;PKD2
17316,GO:0140161,0.183418411829031,0.987772217150108,1,3,monocarboxylate:sodium symporter activity,MF,SLC10A6
10800,GO:0044275,0.183477353065934,0.921780772160163,5,34,cellular carbohydrate catabolic process,BP,PYGL;PYGB;PGM1;ABHD10;RB1CC1
26,GO:0000050,0.183632672261993,0.961440755491722,2,10,urea cycle,BP,ARG2;NAGS
6188,GO:0019627,0.183632672261993,0.961440755491722,2,10,urea metabolic process,BP,ARG2;NAGS
7077,GO:0030865,0.183770356988626,0.914296290125959,6,42,cortical cytoskeleton organization,BP,FMNL2;WIPF1;DLG1;NCKAP1;EPB41L3;WASL
3611,GO:0008050,0.184016765960356,0.990661712310427,1,2,female courtship behavior,BP,THRA
11470,GO:0045924,0.184016765960356,0.990661712310427,1,2,regulation of female receptivity,BP,THRA
1649,GO:0004096,0.184024662822136,0.987687411604003,1,3,catalase activity,MF,CYGB
10564,GO:0043522,0.184038677093229,0.961301800365077,2,10,leucine zipper domain binding,MF,DDIT3;ATF4
2774,GO:0006196,0.184062136766943,0.990656860068938,1,2,AMP catabolic process,BP,NT5E
15282,GO:0071462,0.184220265039112,0.990639937922482,1,2,cellular response to water stimulus,BP,PKD2
14687,GO:0070302,0.184346264412127,0.87676680090067,18,162,regulation of stress-activated protein kinase signaling cascade,BP,XDH;MAP2K1;PKN1;EGFR;ERCC6;DLG1;WNT7A;MAP4K4;DKK1;PAK1;F2RL1;TAOK1;MAP2K2;EIF2AK2;MAP4K2;FZD8;ANKRD6;RB1CC1
18381,GO:1903385,0.184379727308562,0.990622855847982,1,2,regulation of homophilic cell adhesion,BP,CEACAM1
15705,GO:0072243,0.184417346568906,0.944369716774413,3,15,metanephric nephron epithelium development,BP,WWTR1;PKD2;LAMB2
3497,GO:0007389,0.184431514859347,0.866535544527425,27,251,pattern specification process,BP,CTNNBIP1;ACVR2B;DDIT3;SCMH1;WNT7A;ASPH;DKK1;TGFBR2;PKD2;PRKACB;FGFR1;MDFI;LRP5;PCSK6;WNT2B;PSKH1;TSHZ1;TCTN1;HOXA3;ALDH1A2;TBX1;TMEM107;LRP6;PTCH1;PBX3;SEMA3F;LRP4
729,GO:0001958,0.184478039592638,0.943500263941468,3,17,endochondral ossification,BP,COL13A1;MMP14;MEF2D
9467,GO:0036075,0.184478039592638,0.943500263941468,3,17,replacement ossification,BP,COL13A1;MMP14;MEF2D
1118,GO:0002707,0.184550654619089,0.942543077871123,3,20,negative regulation of lymphocyte mediated immunity,BP,CEACAM1;PPP3CB;IL20RB
8866,GO:0034665,0.184680355762283,0.990590604718644,1,2,integrin alpha1-beta1 complex,CC,ITGA1
10832,GO:0044325,0.184798391568458,0.894490698722479,10,82,ion channel binding,MF,FHL1;NOS1;PRNP;ANK3;FYN;DLG1;FKBP1A;PKD2;AKAP9;RIMS3
6748,GO:0030168,0.184861673321269,0.888362974580625,12,103,platelet activation,BP,F2R;SERPINE2;DGKA;FYN;RAC2;APOE;ITPR3;CEACAM1;UBASH3B;COL1A2;ITPR2;SLC7A11
12180,GO:0048305,0.185159029568795,0.960345372569946,2,11,immunoglobulin secretion,BP,POU2F2;XBP1
17793,GO:1901873,0.185177775370679,0.990537107310355,1,2,regulation of post-translational protein modification,BP,CRTAP
17794,GO:1901874,0.185177775370679,0.990537107310355,1,2,negative regulation of post-translational protein modification,BP,CRTAP
4361,GO:0009957,0.185240473274165,0.990530352235672,1,2,epidermal cell fate specification,BP,PTCH1
2369,GO:0005496,0.185307085665878,0.906955582362853,7,55,steroid binding,MF,OSBP2;OSBPL10;APOE;ABCG1;ANXA6;OSBPL5;PTCH1
4683,GO:0010831,0.185377696092382,0.942747273298389,3,18,positive regulation of myotube differentiation,BP,MMP14;THRA;TBX1
10672,GO:0043902,0.185409297691522,0.880885125643302,15,143,positive regulation of multi-organism process,BP,SMURF2;ADARB1;PC;STOM;APOE;MVB12B;F2RL1;DDX60;ACVR1B;MVB12A;YTHDC2;PDE5A;PUM2;RSF1;TRIM38
12137,GO:0048232,0.185536043280677,0.863918983587011,29,282,male gamete generation,BP,ERCC1;ETV5;NEURL1;OSBP2;BBS2;CCNI;MICALCL;SCMH1;UBE2J1;MYCBPAP;CRTAP;TCFL5;ATRX;GAMT;FAM50A;RFX2;ZNF449;AZIN2;BCL2L1;TXNRD3;REC8;SPATA6;MLH3;PRKACA;ARID4A;CLDN11;HSPA2;SEPT6;DNMT3A
5179,GO:0015740,0.185639309069782,0.961464793997987,2,9,C4-dicarboxylate transport,BP,NTSR1;SLC13A3
158,GO:0000320,0.185771909387834,0.99047298800723,1,2,re-entry into mitotic cell cycle,BP,CCND1
2148,GO:0004966,0.185785215254778,0.98743931508279,1,3,galanin receptor activity,MF,LTB4R
19906,GO:2000401,0.185848314035176,0.92967029678856,4,27,regulation of lymphocyte migration,BP,ADAM8;ITGA4;WASL;FADD
6197,GO:0019674,0.185849876747288,0.912412740637836,6,48,NAD metabolic process,BP,NT5E;PCK2;NAPRT;NMRK1;LDHA;PARP9
3466,GO:0007284,0.185933458969323,0.990455511981819,1,2,spermatogonial cell division,BP,ZNF449
16449,GO:0097109,0.186048662817941,0.990443038677356,1,2,neuroligin family protein binding,MF,DLG4
13283,GO:0051971,0.186095101567123,0.990438008126467,1,2,positive regulation of transmission of nerve impulse,BP,ITGA2
6058,GO:0019206,0.186211982262637,0.959977621289724,2,11,nucleoside kinase activity,MF,TK2;AK9
4601,GO:0010716,0.186237266182969,0.98737517435257,1,3,negative regulation of extracellular matrix disassembly,BP,CST3
7621,GO:0032011,0.18631795870619,0.91300502779323,6,40,ARF protein signal transduction,BP,ASAP2;APPL2;ARAP1;ASAP1;PSD3;ACAP2
7622,GO:0032012,0.18631795870619,0.91300502779323,6,40,regulation of ARF protein signal transduction,BP,ASAP2;APPL2;ARAP1;ASAP1;PSD3;ACAP2
12104,GO:0048143,0.186590913199259,0.96205784294984,2,8,astrocyte activation,BP,EGFR;LRP1
2478,GO:0005712,0.186728147260345,0.990369286060939,1,2,chiasma,CC,MLH3
7068,GO:0030855,0.186840647362136,0.854704861093643,43,436,epithelial cell differentiation,BP,XDH;CCND1;PCK2;CYP27B1;ACTA2;MAP2K1;RAPGEF3;ACVR2B;ALOX15B;WWTR1;PTPRS;CTSB;PODXL;WNT7A;SDC1;SLITRK6;FGFR1;ITGA2;PTK6;ATRX;FAM20C;KIAA1109;SOX4;CEACAM1;PRR9;CTSL;CST3;PCSK6;F2RL1;TST;THRA;XBP1;LAMB2;ARID4A;LAMA5;PPARG;PPL;TBX1;SLC7A11;PRSS8;FLNB;E2F7;PTCH1
738,GO:0001968,0.186869823506123,0.942419404191217,3,17,fibronectin binding,MF,CTSL;ITGA4;HSD17B12
8304,GO:0033135,0.186901713386758,0.89289030712639,10,85,regulation of peptidyl-serine phosphorylation,BP,RAPGEF3;EGFR;DKK1;PAK1;CD44;AKAP9;INPP5F;PFN2;SPRY2;RET
481,GO:0001527,0.18693567104519,0.961943110918386,2,8,microfibril,CC,LTBP1;THSD4
1483,GO:0003785,0.187002493392185,0.942007969960707,3,18,actin monomer binding,MF,PFN2;TWF2;TMSB4X
14968,GO:0070863,0.187161213220331,0.961867972711454,2,8,positive regulation of protein exit from endoplasmic reticulum,BP,EDEM1;SORL1
3465,GO:0007283,0.187238410450841,0.863312878520326,28,272,spermatogenesis,BP,ERCC1;ETV5;NEURL1;OSBP2;BBS2;CCNI;MICALCL;SCMH1;UBE2J1;MYCBPAP;CRTAP;TCFL5;ATRX;GAMT;FAM50A;RFX2;ZNF449;AZIN2;BCL2L1;TXNRD3;REC8;SPATA6;PRKACA;ARID4A;CLDN11;HSPA2;SEPT6;DNMT3A
20029,GO:2000650,0.187277758154352,0.961829121581821,2,8,negative regulation of sodium ion transmembrane transporter activity,BP,HECW2;STK39
1248,GO:0002949,0.187304691429113,0.987223007932857,1,3,tRNA threonylcarbamoyladenosine modification,BP,OSGEPL1
19568,GO:1990589,0.187322969899286,0.99030446464824,1,2,ATF4-CREB1 transcription factor complex,CC,ATF4
8024,GO:0032660,0.187419139397713,0.959554251843339,2,11,regulation of interleukin-17 production,BP,PRNP;ARG2
3434,GO:0007223,0.187426515415906,0.919861074109577,5,32,Wnt signaling pathway, calcium modulating pathway,BP,DKK1;NLK;TNRC6B;PPP3CB;TNRC6C
15172,GO:0071300,0.187447978743015,0.91183327281553,6,44,cellular response to retinoic acid,BP,PTK6;TWF2;RET;PPARG;ALDH1A2;TBX1
16632,GO:0097487,0.1875118779466,0.987193356613084,1,3,multivesicular body, internal vesicle,CC,EGFR
8402,GO:0033341,0.187524642469547,0.990282432412667,1,2,regulation of collagen binding,BP,ITGA2
2277,GO:0005225,0.187615346124533,0.961716488780535,2,8,volume-sensitive anion channel activity,MF,CLCN3;TTYH3
5436,GO:0016298,0.187634199672719,0.896082242071835,9,75,lipase activity,MF,EDNRA;PLA2G4D;PLD3;MGLL;ABHD6;LYPLAL1;LYPLA1;DDHD2;PLCH2
14783,GO:0070486,0.187657907409545,0.960053797862967,2,10,leukocyte aggregation,BP,RAC2;CD44
16906,GO:0098862,0.187865768612277,0.892402228427367,10,81,cluster of actin-based cell projections,CC,DOCK4;BBS2;ESPN;SHANK2;ITPR3;TWF2;SLC6A14;SLC38A2;FLNB;RALGDS
15223,GO:0071375,0.187867795188051,0.866531253238283,24,223,cellular response to peptide hormone stimulus,BP,PCK2;ADCY7;EIF4EBP1;FYN;SHC1;PAK1;SOCS2;PRKACB;IDE;VAMP2;CEACAM1;RAB31;TRIB3;PRKAR1A;NGFR;XBP1;PRKACA;IGF2;GRB10;PPARG;ATP6V1B2;EEF2K;ADCY1;KAT2B
7254,GO:0031213,0.187918795018501,0.990239292092989,1,2,RSF complex,CC,RSF1
1874,GO:0004550,0.187937028386531,0.9588909404812,2,12,nucleoside diphosphate kinase activity,MF,NME4;AK9
5088,GO:0015347,0.188023670196168,0.960653422589204,2,9,sodium-independent organic anion transmembrane transporter activity,MF,SLCO4A1;SLC22A17
8509,GO:0033687,0.188076280680879,0.941871410073383,3,17,osteoblast proliferation,BP,LRP5;EIF2AK2;HPSE
15850,GO:0072562,0.188133194363371,0.918442723507361,5,39,blood microparticle,CC,STOM;SERPING1;APOE;ANGPTL4;HSPA2
12199,GO:0048369,0.188183887455162,0.990210217857885,1,2,lateral mesoderm morphogenesis,BP,FGFR1
12200,GO:0048370,0.188183887455162,0.990210217857885,1,2,lateral mesoderm formation,BP,FGFR1
12201,GO:0048371,0.188183887455162,0.990210217857885,1,2,lateral mesodermal cell differentiation,BP,FGFR1
12202,GO:0048372,0.188183887455162,0.990210217857885,1,2,lateral mesodermal cell fate commitment,BP,FGFR1
12203,GO:0048377,0.188183887455162,0.990210217857885,1,2,lateral mesodermal cell fate specification,BP,FGFR1
12204,GO:0048378,0.188183887455162,0.990210217857885,1,2,regulation of lateral mesodermal cell fate specification,BP,FGFR1
6895,GO:0030427,0.188187068571497,0.879220743294133,15,125,site of polarized growth,CC,SSH1;ADGRL1;DLG3;SHANK2;KIF21B;TMOD2;DVL1;TWF2;CPEB4;TIMP2;CTSZ;TENM2;SIGMAR1;PSEN2;PTCH1
12310,GO:0048660,0.188204943947349,0.891980100606813,10,85,regulation of smooth muscle cell proliferation,BP,CTNNBIP1;APLN;EGFR;TGM2;PAK1;TGFBR2;ITGA2;MEF2D;PPARG;FOXP1
18550,GO:1903760,0.18823103704016,0.990205041660404,1,2,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,DLG1
19100,GO:1905024,0.18823103704016,0.990205041660404,1,2,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,DLG1
791,GO:0002054,0.188344036577565,0.987073882856364,1,3,nucleobase binding,MF,PYGL
793,GO:0002060,0.188344036577565,0.987073882856364,1,3,purine nucleobase binding,MF,PYGL
12896,GO:0051238,0.188426870273358,0.959199384358776,2,11,sequestering of metal ion,BP,SLC30A1;AP3D1
4707,GO:0010869,0.188446432383925,0.941702906175783,3,17,regulation of receptor biosynthetic process,BP,NR1D1;PPARA;PPARG
3373,GO:0007143,0.188555333015944,0.941298230776826,3,18,female meiotic nuclear division,BP,PRKAR1A;SPIRE1;MLH3
12485,GO:0050436,0.188614346439897,0.990162904643974,1,2,microfibril binding,MF,LTBP1
5604,GO:0016645,0.18864790316963,0.940940908053948,3,19,oxidoreductase activity, acting on the CH-NH group of donors,MF,ALDH1L2;MTHFR;ALDH4A1
8823,GO:0034596,0.188735630722506,0.961341701983447,2,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,INPP5F;INPP4A
11399,GO:0045785,0.188769849413035,0.864746059153425,25,239,positive regulation of cell adhesion,BP,ITGA6;ANK3;FYN;PODXL;NET1;TGM2;SMOC2;PAK1;RAG1;TGFBR2;EPHA1;CD44;HYAL1;ITGA2;FERMT1;CD46;XBP1;RET;CARD11;AP3D1;IGF2;ADAM8;ITGA4;HSD17B12;FADD
16264,GO:0090317,0.188883587011981,0.927700733459654,4,29,negative regulation of intracellular protein transport,BP,UBE2J1;GDI1;SOX4;ERLEC1
1156,GO:0002764,0.189112386840878,0.857408746007611,34,349,immune response-regulating signaling pathway,BP,TNIP1;PRNP;PAG1;NR1D1;PTPRS;PSMD2;FCGRT;WIPF1;FYN;CTSB;SHC1;PAK1;PRKACB;RBCK1;BTRC;CEACAM1;MAPKAPK3;TRIM5;CTSL;PPP3CB;F2RL1;DDX60;PSMD7;WASF2;SKAP2;NCKAP1;PUM2;PRKACA;SLC39A10;CARD11;ARPC1A;IL20RB;WASL;FADD
14012,GO:0060733,0.189168937152517,0.990101760953059,1,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,IMPACT
15153,GO:0071262,0.189168937152517,0.990101760953059,1,2,regulation of translational initiation in response to starvation,BP,IMPACT
15154,GO:0071264,0.189168937152517,0.990101760953059,1,2,positive regulation of translational initiation in response to starvation,BP,IMPACT
13134,GO:0051694,0.189180990930545,0.990100429686493,1,2,pointed-end actin filament capping,BP,TMOD2
12967,GO:0051349,0.189232863070068,0.960239203684074,2,9,positive regulation of lyase activity,BP,NOS1;TIMP2
19430,GO:1990037,0.189328982645776,0.986931685868485,1,3,Lewy body core,CC,ATF4
17312,GO:0140115,0.189378900413807,0.960189052475512,2,9,export across plasma membrane,BP,DLG1;ATP12A
12861,GO:0051181,0.189485327973595,0.927381173263203,4,29,cofactor transport,BP,SLC33A1;LCN2;SLC22A17;SLC23A2
9420,GO:0035986,0.189535495002734,0.986901763241062,1,3,senescence-associated heterochromatin focus assembly,BP,HMGA2
4275,GO:0009636,0.189604285747055,0.858936749772937,31,324,response to toxic substance,BP,CCND1;CYGB;ADCY7;GPX3;FYN;BNIP3;ERCC6;MAPK13;NET1;SDC1;IMPACT;APOE;LDHA;PPARA;ASNS;MT2A;XRN1;CST3;PRDX5;BLMH;SLC6A14;BPHL;BCL2L1;TXNRD3;SLC30A1;EIF2AK2;ITPR2;SLC7A11;ENDOG;SLC18A2;DNMT3A
2158,GO:0004985,0.189609069265845,0.986891093608734,1,3,opioid receptor activity,MF,SIGMAR1
15568,GO:0072015,0.189736534608627,0.96100553420462,2,8,glomerular visceral epithelial cell development,BP,PODXL;LAMB2
15738,GO:0072310,0.189736534608627,0.96100553420462,2,8,glomerular epithelial cell development,BP,PODXL;LAMB2
8151,GO:0032877,0.189866125094712,0.990024597276604,1,2,positive regulation of DNA endoreduplication,BP,E2F7
2358,GO:0005457,0.189915298718714,0.990019142248095,1,2,GDP-fucose transmembrane transporter activity,MF,SLC35B4
5194,GO:0015783,0.189915298718714,0.990019142248095,1,2,GDP-fucose transmembrane transport,BP,SLC35B4
9468,GO:0036080,0.189915298718714,0.990019142248095,1,2,purine nucleotide-sugar transmembrane transporter activity,MF,SLC35B4
14967,GO:0070862,0.190204539299665,0.959165617911328,2,10,negative regulation of protein exit from endoplasmic reticulum,BP,UBE2J1;ERLEC1
7233,GO:0031128,0.190209230957395,0.940898018969117,3,17,developmental induction,BP,DKK1;FGFR1;WNT2B
3082,GO:0006655,0.190301150246663,0.959131760169163,2,10,phosphatidylglycerol biosynthetic process,BP,CRLS1;CDS2
15141,GO:0071236,0.190361258390333,0.884278994807164,12,106,cellular response to antibiotic,BP,ADCY7;BNIP3;MAPK13;NET1;IMPACT;XRN1;CST3;ITPR2;ENDOG;ADCY1;GNAI1;DNMT3A
6379,GO:0021564,0.190406272172133,0.989964585695582,1,2,vagus nerve development,BP,TBX1
15014,GO:0070943,0.19049976421463,0.986761547540383,1,3,neutrophil mediated killing of symbiont cell,BP,F2RL1
7206,GO:0031095,0.190664077270827,0.961941650924226,2,7,platelet dense tubular network membrane,CC,ITPR3;ITPR2
10584,GO:0043547,0.190692528877508,0.856974879268804,33,302,positive regulation of GTPase activity,BP,DOCK4;F2R;ASAP2;ITGA6;RAPGEF3;ARHGAP22;TBC1D14;RIN2;ARHGAP12;ARAP1;SNX9;NET1;EVI5L;GDI1;RASA3;EPHA1;RALGAPA2;RGS14;SRGAP2B;RALGAPA1;DNMBP;DOCK9;F2RL1;ASAP1;USP6NL;TBC1D2B;RIN1;DOCK11;ARHGAP29;EVI5;DEPDC1;ACAP2;TBC1D16
18064,GO:1902622,0.190694458394932,0.939455127558036,3,21,regulation of neutrophil migration,BP,RAC2;MOSPD2;ADAM8
11249,GO:0045453,0.190721664641848,0.91747613441592,5,35,bone resorption,BP,EGFR;RAC2;ACP5;UBASH3B;ADAM8
5142,GO:0015669,0.190787693752412,0.986719520200091,1,3,gas transport,BP,CYGB
14376,GO:0061614,0.190798220037503,0.917751915429732,5,33,pri-miRNA transcription by RNA polymerase II,BP,NFATC4;APLN;PPARA;NGFR;PPARG
6745,GO:0030165,0.191088949859711,0.898516292395938,8,59,PDZ domain binding,MF,DOCK4;DLG4;DLG3;CLCN3;MAP2K2;LPAR1;ARHGAP29;FZD8
2431,GO:0005614,0.191109147888686,0.960542498831425,2,8,interstitial matrix,CC,SMOC2;VWA1
13099,GO:0051611,0.191204152978936,0.989875573139482,1,2,regulation of serotonin uptake,BP,NOS1
13100,GO:0051612,0.191204152978936,0.989875573139482,1,2,negative regulation of serotonin uptake,BP,NOS1
7332,GO:0031342,0.191632302144066,0.958061901388485,2,11,negative regulation of cell killing,BP,CEACAM1;PPP3CB
10829,GO:0044322,0.1916509176648,0.92681824119273,4,26,endoplasmic reticulum quality control compartment,CC,EDEM1;SEL1L;ERLEC1;RNF103
18792,GO:1904321,0.191703821232869,0.96034116612258,2,8,response to forskolin,BP,ADCY1;GNAI1
18793,GO:1904322,0.191703821232869,0.96034116612258,2,8,cellular response to forskolin,BP,ADCY1;GNAI1
1745,GO:0004345,0.1917143345002,0.989818427514409,1,2,glucose-6-phosphate dehydrogenase activity,MF,H6PD
15399,GO:0071650,0.191749937605132,0.986578535725655,1,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,ARG2
10172,GO:0042759,0.191837566000182,0.959340673022815,2,9,long-chain fatty acid biosynthetic process,BP,ALOX15B;ACOT7
15573,GO:0072028,0.191877242994569,0.903194115618441,7,50,nephron morphogenesis,BP,PGF;CTNNBIP1;DLG1;PKD2;WNT2B;LAMA5;PTCH1
9607,GO:0036466,0.191948385247326,0.989792151532464,1,2,synaptic vesicle recycling via endosome,BP,AP3D1
12392,GO:0048817,0.191989929892931,0.989787483536902,1,2,negative regulation of hair follicle maturation,BP,FERMT1
8375,GO:0033270,0.19206685267186,0.960218042293754,2,8,paranode region of axon,CC,KIF13B;EPB41L3
6678,GO:0030041,0.192223128498214,0.877977704265249,14,127,actin filament polymerization,BP,WIPF1;DLG1;RAC2;TMOD2;PFN2;TWF2;WASF3;MSRB2;JMY;SPIRE1;NCKAP1;TMSB4X;ARPC1A;WASL
3427,GO:0007215,0.19231132593067,0.916712058246317,5,34,glutamate receptor signaling pathway,BP,DLG4;SHANK2;NLGN2;CPEB4;GRIN3B
52,GO:0000109,0.19231734841319,0.958422455805123,2,10,nucleotide-excision repair complex,CC,ERCC1;XPC
4202,GO:0009310,0.192425400020835,0.957778419035124,2,11,amine catabolic process,BP,ALDH7A1;SLC44A1
15822,GO:0072522,0.192431338701473,0.868772602667211,19,186,purine-containing compound biosynthetic process,BP,NT5E;NOS1;ADCY7;DHTKD1;PGM1;ACOT7;NME4;APOE;LDHA;AKAP9;PPARA;PTHLH;PANK4;TMSB4X;TIMP2;AK9;ADCY1;PANK1;ADNP
8878,GO:0034684,0.19261493754594,0.989717113750191,1,2,integrin alphav-beta5 complex,CC,ITGB5
12749,GO:0051017,0.192838347878426,0.880063139667877,13,110,actin filament bundle assembly,BP,RAPGEF3;ARAP1;ESPN;PAK1;EPHA1;ITGB5;PFN2;FHOD1;WASF2;SPIRE1;SH3PXD2B;RHOBTB1;LPAR1
10487,GO:0043382,0.192911662057441,0.986407232375881,1,3,positive regulation of memory T cell differentiation,BP,CD46
12804,GO:0051098,0.192982526169701,0.858506832506183,28,283,regulation of binding,BP,SORL1;CTNNBIP1;NFATC4;DDIT3;TTBK2;DKK1;APOE;FKBP1A;CCPG1;LRP1;HMGA2;PPARA;ITGA2;MDFI;DVL1;TRIB3;CEBPG;PARP9;UBASH3B;PRKACA;TMSB4X;IFI16;CTSZ;PPARG;RSF1;ITGA4;TMEM173;ADNP
10099,GO:0042608,0.192996148471279,0.986394727699204,1,3,T cell receptor binding,MF,FYN
6492,GO:0021847,0.193110587534848,0.989661117129847,1,2,ventricular zone neuroblast division,BP,FGFR1
9221,GO:0035607,0.193110587534848,0.989661117129847,1,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,FGFR1
1025,GO:0002528,0.19348419079099,0.989618796956864,1,2,regulation of vascular permeability involved in acute inflammatory response,BP,CTNNBIP1
6008,GO:0019050,0.193623610781881,0.986301660080288,1,3,suppression by virus of host apoptotic process,BP,BCL2L1
9763,GO:0039526,0.193623610781881,0.986301660080288,1,3,modulation by virus of host apoptotic process,BP,BCL2L1
7941,GO:0032530,0.193726760410513,0.958683614233086,2,9,regulation of microvillus organization,BP,PODXL;TWF2
18539,GO:1903729,0.193754629400043,0.958673887772325,2,9,regulation of plasma membrane organization,BP,ASAP1;WASL
18945,GO:1904706,0.193823450144984,0.957276732692826,2,11,negative regulation of vascular smooth muscle cell proliferation,BP,APLN;PPARG
12217,GO:0048407,0.193852377158215,0.959610092254787,2,8,platelet-derived growth factor binding,MF,COL6A1;COL1A2
9391,GO:0035928,0.193923811079137,0.986257009660981,1,3,rRNA import into mitochondrion,BP,TST
12699,GO:0050917,0.194094587299267,0.989549446675121,1,2,sensory perception of umami taste,BP,ITPR3
4828,GO:0014032,0.194126875407314,0.901374786004638,7,54,neural crest cell development,BP,SEMA4B;EDNRA;RET;LAMA5;ALDH1A2;TBX1;SEMA3F
14702,GO:0070326,0.194219951443726,0.986212884690006,1,3,very-low-density lipoprotein particle receptor binding,MF,APOE
5233,GO:0015849,0.19432801862308,0.867454708146334,19,175,organic acid transport,BP,SLC16A3;STK39;APOE;ABCD1;PPARA;VAMP2;CEACAM1;BSG;NTSR1;SLC6A6;CPT2;SLC6A14;SLC43A1;SLC38A2;SLC13A3;PPARG;SLC10A6;SLC7A11;SLC23A2
11910,GO:0046942,0.19432801862308,0.867454708146334,19,175,carboxylic acid transport,BP,SLC16A3;STK39;APOE;ABCD1;PPARA;VAMP2;CEACAM1;BSG;NTSR1;SLC6A6;CPT2;SLC6A14;SLC43A1;SLC38A2;SLC13A3;PPARG;SLC10A6;SLC7A11;SLC23A2
4867,GO:0014719,0.194485387467191,0.986173268459143,1,3,skeletal muscle satellite cell activation,BP,WNT7A
18439,GO:1903522,0.194648843732813,0.874203688295693,15,130,regulation of blood circulation,BP,DOCK4;NOS1;F2R;APLN;EGFR;DLG1;ASPH;AKAP9;ITPR3;F2RL1;THRA;TRPC1;PDE5A;PRKACA;ITPR2
160,GO:0000323,0.194759163676484,0.84542780829607,49,517,lytic vacuole,CC,TSPAN1;VLDLR;PYGB;NAPRT;MARCH9;CAPN2;ANK3;CTSB;CD68;GPC4;RDH14;SDC1;STOM;ACP5;LRP1;FYCO1;SNX14;HYAL1;LPCAT1;ANXA6;CTSL;CST3;VPS11;C6ORF120;CTBS;COL6A1;GLB1;PCYOX1;ZFYVE9;TMBIM1;CTSO;AP2A2;CMTM6;CTSZ;AP3D1;FNBP1;TMEM63A;EVA1A;ATP6V1B2;ADAM8;ATP11B;TMEM9;MARCH2;PPT2;HPSE;GALNS;DNAJC3;PSEN2;GNAI1
2511,GO:0005764,0.194759163676484,0.84542780829607,49,517,lysosome,CC,TSPAN1;VLDLR;PYGB;NAPRT;MARCH9;CAPN2;ANK3;CTSB;CD68;GPC4;RDH14;SDC1;STOM;ACP5;LRP1;FYCO1;SNX14;HYAL1;LPCAT1;ANXA6;CTSL;CST3;VPS11;C6ORF120;CTBS;COL6A1;GLB1;PCYOX1;ZFYVE9;TMBIM1;CTSO;AP2A2;CMTM6;CTSZ;AP3D1;FNBP1;TMEM63A;EVA1A;ATP6V1B2;ADAM8;ATP11B;TMEM9;MARCH2;PPT2;HPSE;GALNS;DNAJC3;PSEN2;GNAI1
17951,GO:1902302,0.194970613023882,0.989449467203961,1,2,regulation of potassium ion export,BP,DLG1
9919,GO:0042264,0.195312980606672,0.989410249096502,1,2,peptidyl-aspartic acid hydroxylation,BP,ASPH
16968,GO:0098982,0.195343128309351,0.989406791800064,1,2,GABA-ergic synapse,CC,NLGN2
16969,GO:0098983,0.195343128309351,0.989406791800064,1,2,symmetric, GABA-ergic, inhibitory synapse,CC,NLGN2
5072,GO:0015295,0.19535877918629,0.938152181389586,3,18,solute:proton symporter activity,MF,SLC33A1;SLC2A9;SLC2A13
16399,GO:0097016,0.195382740963926,0.989402248119773,1,2,L27 domain binding,MF,DLG1
12327,GO:0048679,0.195397917802357,0.938133911614711,3,18,regulation of axon regeneration,BP,MAP2K1;PTPRS;INPP5F
16690,GO:0097635,0.195432328736808,0.989396558735035,1,2,extrinsic component of autophagosome membrane,CC,WDFY3
10651,GO:0043686,0.195490754600195,0.986022649773675,1,3,co-translational protein modification,BP,STT3B
9085,GO:0035336,0.195625736697811,0.937697401709927,3,19,long-chain fatty-acyl-CoA metabolic process,BP,ELOVL1;ACOT7;HSD17B12
6017,GO:0019072,0.195670206216868,0.989369242517235,1,2,viral genome packaging,BP,PC
6018,GO:0019074,0.195670206216868,0.989369242517235,1,2,viral RNA genome packaging,BP,PC
5148,GO:0015680,0.195729768899325,0.985986709600638,1,3,intracellular copper ion transport,BP,ATP7B
12854,GO:0051172,0.195916036219516,0.828199033213563,161,1773,negative regulation of nitrogen compound metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;ERCC1;ZMYND8;SORL1;CCND1;CTNNBIP1;VLDLR;SERPINE2;PRNP;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;TFPI2;ACVR2B;SALL2;PKN1;WWTR1;PEG3;EIF4EBP1;DDIT3;ELK3;EGFR;STK39;PPP1R14A;FYN;TNFRSF6B;SCMH1;UBE2J1;DLG1;DNAJB5;IGF2BP3;CRTAP;SHC1;DKK1;DAP;SOCS2;TRIB2;RAG1;PTPN3;SERPING1;EPHA1;IMPACT;CD44;APOE;FKBP1A;ACP5;RGS14;IDE;AKAP9;HMGA2;ATF4;PPARA;ABCA7;WWC3;ELFN2;FGFR1;PPP1R35;TCFL5;BTRC;LPCAT1;PTK6;INPP5F;CHAC1;ATRX;SOX4;CEACAM1;ZNF692;ATF7IP;RCOR1;MDFI;XRN1;TNRC6B;DVL1;HES2;PHF12;LRP5;KLF12;CST3;TRIB3;RANBP9;MEX3C;APLP2;PRDX5;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PRKAR1A;PARP9;CPEB4;NACC2;SPRY2;BEX4;THRA;NGFR;PPP1R10;TSHZ1;PER3;MTA1;AZIN2;H2AFJ;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;TLE4;LOXL2;C5;GABARAPL2;RMRP;EAPP;PUM2;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;ZNF354A;CTSZ;TBL1X;RNF169;ARID4A;TENM2;IGF2;ERLEC1;PPARG;SNX6;GRB7;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;LRP6;ARID5B;MAGEF1;E2F7;TNRC6C;TET1;ZC3H7A;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;KAT2B;USP25;PRMT3;UFL1;JARID2;KLHL15;MXD4;DNMT3A
5702,GO:0016830,0.195925950480665,0.913670213687216,5,41,carbon-carbon lyase activity,MF,PCK2;GLUL;MLYCD;NPL;AZIN2
20182,GO:2001028,0.195946962357613,0.957905682955676,2,9,positive regulation of endothelial cell chemotaxis,BP,FGFR1;TMSB4X
8032,GO:0032677,0.19596592737438,0.913878563805985,5,39,regulation of interleukin-8 production,BP,F2R;DDIT3;F2RL1;TMSB4X;FADD
18583,GO:1903828,0.196018737628849,0.89022113297592,9,77,negative regulation of cellular protein localization,BP,UBE2J1;TTBK2;GDI1;SOX4;ABHD17C;BCL2L1;TMBIM1;ERLEC1;LYPLA1
19727,GO:2000095,0.196021263431118,0.957879541410136,2,9,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,DKK1;ANKRD6
18314,GO:1903238,0.196044271192647,0.989326208183715,1,2,positive regulation of leukocyte tethering or rolling,BP,ITGA4
15512,GO:0071887,0.196160525525433,0.894444848162094,8,69,leukocyte apoptotic process,BP,PKN1;ARG2;RAG1;CTSL;SLC39A10;ADAM8;FOXP1;FADD
623,GO:0001806,0.196499292868689,0.985870651884984,1,3,type IV hypersensitivity,BP,IL20RB
683,GO:0001893,0.196645299008584,0.9241537151131,4,26,maternal placenta development,BP,CYP27B1;CTSB;BSG;EPOR
6737,GO:0030155,0.196773038779013,0.84627787406177,43,421,regulation of cell adhesion,BP,ITGA6;SERPINE2;PRNP;PAG1;POSTN;ANK3;FYN;DLG1;PLXNB3;PODXL;NET1;TGM2;ARG2;SMOC2;PAK1;RAG1;TGFBR2;EPHA1;RAC2;CD44;PPARA;EPCAM;HYAL1;ITGA2;CEACAM1;FERMT1;MMP14;CD46;SLK;PRKAR1A;XBP1;UBASH3B;RET;PDE5A;CARD11;AP3D1;IGF2;LAMA5;ADAM8;IL20RB;ITGA4;HSD17B12;FADD
3177,GO:0006790,0.196947724071212,0.856910155947531,26,274,sulfur compound metabolic process,BP,CBS;PC;B4GALT6;ELOVL1;B3GNT3;ACOT1;GLO1;ACSF2;ACOT7;CBR4;HAGH;HYAL1;CHAC1;MTHFR;AHCYL2;GAMT;CTH;ACOT13;MLYCD;BLMH;GLB1;PCYOX1;NFU1;PPT2;GALNS;HSD17B12
12309,GO:0048659,0.196958496459018,0.885779026336058,10,86,smooth muscle cell proliferation,BP,CTNNBIP1;APLN;EGFR;TGM2;PAK1;TGFBR2;ITGA2;MEF2D;PPARG;FOXP1
7677,GO:0032106,0.197047961198981,0.985787580628682,1,3,positive regulation of response to extracellular stimulus,BP,CYP27B1
7680,GO:0032109,0.197047961198981,0.985787580628682,1,3,positive regulation of response to nutrient levels,BP,CYP27B1
690,GO:0001910,0.197135642677211,0.923105052415751,4,30,regulation of leukocyte mediated cytotoxicity,BP,CEACAM1;PPP3CB;F2RL1;FADD
807,GO:0002079,0.197155158046124,0.989197834190573,1,2,inner acrosomal membrane,CC,CD46
10894,GO:0044437,0.197194481026283,0.845777723386942,43,452,vacuolar part,CC,TSPAN1;VLDLR;PYGB;NAPRT;MARCH9;CTSB;CD68;GPC4;WDFY3;RDH14;SDC1;STOM;LRP1;SNX14;HYAL1;LPCAT1;ANXA6;CTSL;VPS11;C6ORF120;COL6A1;GLB1;PCYOX1;SLC22A17;ZFYVE9;GABARAPL2;TMBIM1;AP2A2;CMTM6;AP3D1;TMEM63A;EVA1A;TMEM50B;ATP6V1B2;ATP11B;TMEM9;MARCH2;PPT2;HPSE;GALNS;DNAJC3;PSEN2;GNAI1
4037,GO:0009069,0.197302505079541,0.923014614956391,4,30,serine family amino acid metabolic process,BP,CBS;PSAT1;AHCYL2;CTH
2219,GO:0005119,0.197367769891961,0.989173167119894,1,2,smoothened binding,MF,PTCH1
11654,GO:0046390,0.197463280669325,0.8647983063103,19,187,ribose phosphate biosynthetic process,BP,NOS1;PYGL;ADCY7;DHTKD1;PGM1;ACOT7;NME4;APOE;LDHA;AKAP9;PPARA;PTHLH;PANK4;TMSB4X;TIMP2;AK9;ADCY1;PANK1;ADNP
18798,GO:1904340,0.197555247164049,0.985710535820031,1,3,positive regulation of dopaminergic neuron differentiation,BP,DKK1
19075,GO:1904958,0.197555247164049,0.985710535820031,1,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,DKK1
4941,GO:0014902,0.197732551195914,0.899125585894349,7,53,myotube differentiation,BP,NOS1;CAPN2;MMP14;MYOF;THRA;XBP1;TBX1
2161,GO:0004993,0.197768207771233,0.985678123611447,1,3,G-protein coupled serotonin receptor activity,MF,HTR7
3423,GO:0007210,0.197768207771233,0.985678123611447,1,3,serotonin receptor signaling pathway,BP,HTR7
10363,GO:0043176,0.197768207771233,0.985678123611447,1,3,amine binding,MF,HTR7
12976,GO:0051378,0.197768207771233,0.985678123611447,1,3,serotonin binding,MF,HTR7
16816,GO:0098664,0.197768207771233,0.985678123611447,1,3,G-protein coupled serotonin receptor signaling pathway,BP,HTR7
17079,GO:0099589,0.197768207771233,0.985678123611447,1,3,serotonin receptor activity,MF,HTR7
14938,GO:0070821,0.197910087899594,0.905384596967958,6,44,tertiary granule membrane,CC,STOM;SLC2A3;CEACAM1;COPB1;TMEM63A;ADAM8
2538,GO:0005795,0.19793477696508,0.876125396436273,13,115,Golgi stack,CC,SORL1;ASAP2;MARCH9;B4GALT6;ARAP1;B4GALNT4;AKAP9;MARCH4;GALNT3;PITPNM1;DNMBP;RASIP1;GOLGA2P5
1173,GO:0002820,0.198127318251131,0.936519406735246,3,19,negative regulation of adaptive immune response,BP,CEACAM1;PPP3CB;IL20RB
6924,GO:0030516,0.198166400169526,0.889337468512553,9,67,regulation of axon extension,BP,MAP1B;PTPRS;SEMA4B;GDI1;PAK1;APOE;TWF2;SEMA3F;ADNP
4068,GO:0009119,0.198196192981258,0.888427068716548,9,83,ribonucleoside metabolic process,BP,NT5E;DLG1;DLG4;NME4;DLG3;AHCYL2;APOBEC3C;GAMT;CARD11
4863,GO:0014704,0.19832852603171,0.913563819480625,5,32,intercalated disc,CC,ANK3;DLG1;PAK1;FHOD1;OBSL1
19002,GO:1904813,0.198342158699869,0.88098518720914,11,109,ficolin-1-rich granule lumen,CC,PYGL;PSMD2;LTA4H;PGM1;CTSB;CST3;PSMD7;GLB1;YPEL5;TIMP2;CTSZ
19024,GO:1904862,0.198716181573209,0.989015993611591,1,2,inhibitory synapse assembly,BP,NLGN2
5597,GO:0016628,0.198885952669397,0.935589334271101,3,21,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,SRD5A3;BLVRA;PTGR2
5447,GO:0016316,0.198920862820083,0.988992024927889,1,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,INPP4A
5861,GO:0017161,0.198920862820083,0.988992024927889,1,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,INPP4A
8824,GO:0034597,0.198920862820083,0.988992024927889,1,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,INPP4A
13426,GO:0052828,0.198920862820083,0.988992024927889,1,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,INPP4A
13209,GO:0051851,0.198978401644156,0.904294672118501,6,48,modification by host of symbiont morphology or physiology,BP,PC;STOM;APOE;HMGA2;F2RL1;YTHDC2
1157,GO:0002765,0.199040097138181,0.98548370006028,1,3,immune response-inhibiting signal transduction,BP,IL20RB
15528,GO:0071910,0.199060331594084,0.988975676064464,1,2,determination of liver left/right asymmetry,BP,PKD2
7207,GO:0031098,0.199065429932393,0.857408171250952,24,229,stress-activated protein kinase signaling cascade,BP,XDH;MAP2K1;PKN1;EGFR;STK39;ERCC6;MAPK13;DLG1;WNT7A;MAP4K4;STRADB;DKK1;PAK1;BTRC;SLK;F2RL1;TAOK1;MAP2K2;PAK6;EIF2AK2;MAP4K2;FZD8;ANKRD6;RB1CC1
16257,GO:0090310,0.199436950656309,0.988931460127745,1,2,negative regulation of methylation-dependent chromatin silencing,BP,TET1
16239,GO:0090287,0.199448818518728,0.863491913695821,19,171,regulation of cellular response to growth factor stimulus,BP,XDH;SMURF2;LTBP1;APLN;HTRA1;DKK1;TGFBR2;FGFR1;LTBP4;FAM20C;FERMT1;EPN2;PCSK6;MYOF;SPRY2;RNF165;MTMR4;GRB10;SNX6
8454,GO:0033590,0.199548150653937,0.985405633232874,1,3,response to cobalamin,BP,EGFR
10170,GO:0042756,0.199584317340027,0.985400067089519,1,3,drinking behavior,BP,APLN
1296,GO:0003129,0.199703320870066,0.985381743872504,1,3,heart induction,BP,DKK1
11628,GO:0046330,0.199728956818637,0.880586054744582,11,92,positive regulation of JNK cascade,BP,PKN1;ERCC6;WNT7A;DKK1;PAK1;F2RL1;TAOK1;MAP4K2;FZD8;ANKRD6;RB1CC1
3215,GO:0006858,0.199914097022496,0.985349259076596,1,3,extracellular transport,BP,ARRDC1
3279,GO:0006957,0.200108252155939,0.988852402417364,1,2,complement activation, alternative pathway,BP,C5
18660,GO:1903976,0.200202594810556,0.985304731237621,1,3,negative regulation of glial cell migration,BP,IDH2
15823,GO:0072523,0.200209507198951,0.911504751078431,5,38,purine-containing compound catabolic process,BP,XDH;NT5E;RAPGEF3;PDE5A;AOX1
5906,GO:0018125,0.200563692961136,0.98524889274332,1,3,peptidyl-cysteine methylation,BP,RAB3B
5679,GO:0016791,0.20060265412601,0.858427365723157,22,209,phosphatase activity,MF,NT5E;MAP2K1;SSH1;PTPRS;DLG1;PTPN3;PLPP6;ACP5;PTPN12;PPP2R3B;PTPDC1;INPP5F;PLPPR2;PPP3CB;INPP4A;DNAJC6;PTPRZ1;NT5DC1;UBASH3B;MTMR4;ACP6;PPM1M
11541,GO:0046069,0.200630745306807,0.988790651751821,1,2,cGMP catabolic process,BP,PDE5A
14358,GO:0061572,0.200675245172499,0.874210785903819,13,111,actin filament bundle organization,BP,RAPGEF3;ARAP1;ESPN;PAK1;EPHA1;ITGB5;PFN2;FHOD1;WASF2;SPIRE1;SH3PXD2B;RHOBTB1;LPAR1
18191,GO:1902960,0.200685151310943,0.988784210830138,1,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
19180,GO:1905246,0.200685151310943,0.988784210830138,1,2,negative regulation of aspartic-type peptidase activity,BP,SORL1
11363,GO:0045722,0.200924347257071,0.956139117461337,2,9,positive regulation of gluconeogenesis,BP,PPARA;KAT2B
9026,GO:0035235,0.200999527085352,0.956112195808815,2,9,ionotropic glutamate receptor signaling pathway,BP,CPEB4;GRIN3B
2754,GO:0006164,0.201098824687529,0.863478436508947,18,176,purine nucleotide biosynthetic process,BP,NOS1;ADCY7;DHTKD1;PGM1;ACOT7;NME4;APOE;LDHA;AKAP9;PPARA;PTHLH;PANK4;TMSB4X;TIMP2;AK9;ADCY1;PANK1;ADNP
7282,GO:0031267,0.201211831817303,0.840454838613839,48,447,small GTPase binding,MF,DOCK4;SORL1;ASAP2;XPOT;FMNL2;RAPGEF3;PKN1;APPL2;EXOC2;DENND5B;EGFR;TBC1D14;RIN2;FYN;ARAP1;DLG4;NET1;EVI5L;GDI1;SHC1;PAK1;OBSCN;SRGAP2B;AKAP9;RAB11FIP4;FGFR1;DMXL2;DVL1;DNMBP;RABGGTA;RANBP9;RIMS3;SYTL1;ASAP1;USP6NL;TBC1D2B;NGFR;RIN1;RET;NCKAP1;DOCK11;PAK6;SHC2;RGL2;EVI5;RPH3AL;ACAP2;TBC1D16
8693,GO:0034314,0.20160222388166,0.920851636176236,4,29,Arp2/3 complex-mediated actin nucleation,BP,JMY;NCKAP1;ARPC1A;WASL
16975,GO:0099003,0.201655719206739,0.879279908187669,11,90,vesicle-mediated transport in synapse,BP,SNPH;VAMP2;PFN2;NLGN2;RIMS3;SYTL1;DNAJC6;FCHO2;SEPT5;AP3D1;SYT2
12530,GO:0050678,0.201762549868855,0.856330854701522,23,218,regulation of epithelial cell proliferation,BP,XDH;PGF;CCND1;NR1D1;APLN;LAMB1;EGFR;DLG1;PLXNB3;GLUL;HTRA1;WNT7A;APOE;FGFR1;HYAL1;CEACAM1;NGFR;XBP1;PPARG;ALDH1A2;TBX1;AKT3;PTCH1
2428,GO:0005607,0.20189785531935,0.988640105822505,1,2,laminin-2 complex,CC,LAMB1
11202,GO:0045332,0.202345129759752,0.936788291733238,3,14,phospholipid translocation,BP,ABCA7;ATP10D;ATP11B
12425,GO:0048873,0.202433412495519,0.93447298331557,3,19,homeostasis of number of cells within a tissue,BP,F2R;AKT3;IL20RB
3265,GO:0006935,0.202439280131366,0.84506671929142,36,353,chemotaxis,BP,DOCK4;PGF;VLDLR;MAP2K1;CMTM4;SH3KBP1;SEMA4B;FYN;PLXNB3;SHC1;RAC2;FGFR1;ITGA1;CMTM7;ITGA2;DVL1;MOSPD2;RANBP9;F2RL1;NGFR;RNF165;RET;C5;ETV1;TMSB4X;CMTM6;LAMB2;LPAR1;GRB10;GRB7;ADAM8;ROBO3;CKLF;SEMA6C;PTCH1;SEMA3F
9826,GO:0042043,0.202482350953005,0.9555797489269,2,9,neurexin family protein binding,MF,NLGN2;SYTL1
5719,GO:0016857,0.202552377939797,0.95474183795947,2,10,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,HYI;GALE
14139,GO:0061005,0.202635927948918,0.910848875170609,5,33,cell differentiation involved in kidney development,BP,ACTA2;WWTR1;PODXL;LAMB2;PTCH1
9687,GO:0038064,0.202697541618741,0.988544515803639,1,2,collagen receptor activity,MF,ITGA2
14163,GO:0061045,0.202713642688482,0.902156322069475,6,46,negative regulation of wound healing,BP,PLAT;SERPINE2;SERPING1;APOE;CEACAM1;UBASH3B
1556,GO:0003955,0.202762724760115,0.984906315090303,1,3,NAD(P)H dehydrogenase (quinone) activity,MF,CBR4
2363,GO:0005471,0.202830675832433,0.984895659962319,1,3,ATP:ADP antiporter activity,MF,SLC25A4
5035,GO:0015207,0.202830675832433,0.984895659962319,1,3,adenine transmembrane transporter activity,MF,SLC25A4
5226,GO:0015837,0.203164531513469,0.919996689767136,4,29,amine transport,BP,RAB3B;STK39;NTSR1;SLC18A2
18847,GO:1904455,0.203392522471462,0.988461077210753,1,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,USP25
15775,GO:0072369,0.203407073715856,0.98845932657919,1,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,PPARA
4528,GO:0010593,0.203705775089061,0.98842335752253,1,2,negative regulation of lamellipodium assembly,BP,PLXNB3
9003,GO:0035136,0.203756911073222,0.920307094566247,4,26,forelimb morphogenesis,BP,WNT7A;ATRX;RNF165;ALDH1A2
15895,GO:0072659,0.20388421664236,0.858473952185369,20,184,protein localization to plasma membrane,BP,PRNP;BBS2;EGFR;ANK3;TSPAN5;DLG1;TTC7B;LRP1;VAMP2;RAB31;BSG;CSNK2A1;FCHO2;BCL2L1;TMBIM1;EPB41L3;LAMA5;LYPLA1;LRP6;PTCH1
17190,GO:0106003,0.203889312320383,0.955071986852754,2,9,amyloid-beta complex,CC,PRNP;APOE
7159,GO:0031021,0.204337382798267,0.984658329476921,1,3,interphase microtubule organizing center,CC,WDR60
4595,GO:0010710,0.20446329326713,0.984638403768116,1,3,regulation of collagen catabolic process,BP,CST3
20123,GO:2000809,0.204477719323014,0.988330110804707,1,2,positive regulation of synaptic vesicle clustering,BP,NLGN2
10623,GO:0043619,0.204504159161444,0.954849311958821,2,9,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,ATF4;CHD6
19692,GO:2000015,0.204588590544738,0.9846185608764,1,3,regulation of determination of dorsal identity,BP,DDIT3
2411,GO:0005584,0.204626837215906,0.988312049826277,1,2,collagen type I trimer,CC,COL1A2
18253,GO:1903076,0.204647221616862,0.888954052415874,8,65,regulation of protein localization to plasma membrane,BP,PRNP;EGFR;DLG1;LRP1;CSNK2A1;BCL2L1;TMBIM1;LYPLA1
1470,GO:0003726,0.204650046068488,0.988309237389787,1,2,double-stranded RNA adenosine deaminase activity,MF,ADARB1
6389,GO:0021587,0.204821249098133,0.92024969941233,4,24,cerebellum morphogenesis,BP,SERPINE2;MAP2K1;WNT7A;LRP6
4821,GO:0014015,0.204848243059996,0.908888422137487,5,37,positive regulation of gliogenesis,BP,ETV5;SERPINE2;PLAG1;PPARG;UFL1
15910,GO:0072679,0.204866012453721,0.984574576041726,1,3,thymocyte migration,BP,ADAM8
8346,GO:0033197,0.204930837050592,0.953201616262399,2,11,response to vitamin E,BP,CCND1;PPARG
9977,GO:0042365,0.204994840922779,0.984554126815525,1,3,water-soluble vitamin catabolic process,BP,PM20D2
12621,GO:0050805,0.205170596076179,0.908844810821229,5,36,negative regulation of synaptic transmission,BP,SHANK2;ABHD6;SLC30A1;ADNP;GNAI1
10162,GO:0042745,0.205216510443979,0.953094718833467,2,11,circadian sleep/wake cycle,BP,CST3;PER3
8235,GO:0033002,0.205420590087882,0.870499269343846,13,116,muscle cell proliferation,BP,CTNNBIP1;APLN;EGFR;TGM2;PAK1;TGFBR2;FGFR1;ITGA2;PRKAR1A;MEF2D;PPARG;FOXP1;JARID2
12070,GO:0048018,0.205455543266623,0.863371726380525,16,167,receptor ligand activity,MF,PGF;ADM2;CMTM4;APLN;TNFSF15;SEMA4B;WNT7A;DKK1;CMTM7;PTHLH;NUDT6;C5;CMTM6;IGF2;CKLF;SEMA3F
15601,GO:0072080,0.205477803260365,0.888765961386088,8,60,nephron tubule development,BP,PGF;CTNNBIP1;WWTR1;DLG1;PKD2;WNT2B;LAMA5;PTCH1
11215,GO:0045348,0.205579489335744,0.984461135589167,1,3,positive regulation of MHC class II biosynthetic process,BP,XBP1
9960,GO:0042330,0.20572237671611,0.842272346169074,36,354,taxis,BP,DOCK4;PGF;VLDLR;MAP2K1;CMTM4;SH3KBP1;SEMA4B;FYN;PLXNB3;SHC1;RAC2;FGFR1;ITGA1;CMTM7;ITGA2;DVL1;MOSPD2;RANBP9;F2RL1;NGFR;RNF165;RET;C5;ETV1;TMSB4X;CMTM6;LAMB2;LPAR1;GRB10;GRB7;ADAM8;ROBO3;CKLF;SEMA6C;PTCH1;SEMA3F
2735,GO:0006114,0.205809327214712,0.9844244940078,1,3,glycerol biosynthetic process,BP,PCK2
6547,GO:0021965,0.205896774463294,0.988157601457505,1,2,spinal cord ventral commissure morphogenesis,BP,ADARB1
7264,GO:0031232,0.205967596977996,0.98439923425594,1,3,extrinsic component of external side of plasma membrane,CC,SERPINE2
15163,GO:0071280,0.205992142358797,0.952252135195629,2,12,cellular response to copper ion,BP,PRNP;MT2A
17954,GO:1902306,0.206086118193703,0.954274201332745,2,9,negative regulation of sodium ion transmembrane transport,BP,HECW2;STK39
16101,GO:0090080,0.206236194378419,0.988116128856682,1,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,FGFR1
14943,GO:0070829,0.20632471751837,0.988105299125993,1,2,heterochromatin maintenance,BP,MTHFR
19763,GO:2000171,0.206467329529393,0.93328805674911,3,17,negative regulation of dendrite development,BP,NFATC4;PTPRS;ASAP1
680,GO:0001890,0.206487155445669,0.869698112548529,13,116,placenta development,BP,CYP27B1;MAP2K1;EGFR;CTSB;HTRA1;PKD2;BSG;MDFI;EPOR;IGF2;PPARG;ZNF568;E2F7
15870,GO:0072589,0.206498118674078,0.982465862071696,1,4,box H/ACA scaRNP complex,CC,NOP10
15548,GO:0071955,0.206504762871043,0.988083255679466,1,2,recycling endosome to Golgi transport,BP,TBC1D14
4580,GO:0010665,0.206550873058976,0.932848389066529,3,18,regulation of cardiac muscle cell apoptotic process,BP,BNIP3;PPP1R10;RGL2
1393,GO:0003307,0.206628868713969,0.984293450150322,1,3,regulation of Wnt signaling pathway involved in heart development,BP,DKK1
18208,GO:1902996,0.206775330234551,0.988050086281933,1,2,regulation of neurofibrillary tangle assembly,BP,SORL1
5602,GO:0016641,0.20716290291662,0.953040308122186,2,10,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,LOXL1;LOXL2
19285,GO:1905517,0.207268826269812,0.93154437071231,3,21,macrophage migration,BP,MMP14;C5;CKLF
11469,GO:0045923,0.207314523755235,0.932882336506296,3,17,positive regulation of fatty acid metabolic process,BP,PPARA;MLYCD;PPARG
9840,GO:0042078,0.207341040569827,0.984179079925629,1,3,germ-line stem cell division,BP,ETV5
12103,GO:0048133,0.207341040569827,0.984179079925629,1,3,male germ-line stem cell asymmetric division,BP,ETV5
16833,GO:0098728,0.207341040569827,0.984179079925629,1,3,germline stem cell asymmetric division,BP,ETV5
15018,GO:0070948,0.207495094187138,0.984154279333776,1,3,regulation of neutrophil mediated cytotoxicity,BP,F2RL1
19927,GO:2000427,0.207532561346585,0.987956980504073,1,2,positive regulation of apoptotic cell clearance,BP,ABCA7
358,GO:0000976,0.207663120195874,0.833948894203663,50,496,transcription regulatory region sequence-specific DNA binding,MF,ZMYND8;ETV5;NR1D1;NFATC4;ZC3H6;ETV4;SALL2;POU2F2;TEF;DDIT3;SOX12;ELK3;HLTF;ZNF516;DDN;HMGA2;ATF4;PPARA;TCFL5;NFAT5;SOX4;ZNF692;HES2;PHF12;ZNF704;RFX2;CEBPG;PLAG1;AEBP1;CHD7;NACC2;THRA;PER3;MTA1;MEF2D;XBP1;SATB1;ETV1;IFI16;NR2F6;PPARG;CREB3L2;PHF21A;ZNF568;ARID5B;E2F7;KAT2B;PBX3;JARID2;RFX7
7861,GO:0032421,0.207719580176087,0.917687052143966,4,28,stereocilium bundle,CC,DOCK4;BBS2;ESPN;TWF2
1292,GO:0003105,0.207896005593375,0.984089636847066,1,3,negative regulation of glomerular filtration,BP,F2R
7044,GO:0030817,0.207901335218412,0.931840484800316,3,19,regulation of cAMP biosynthetic process,BP,AKAP9;PTHLH;TIMP2
3312,GO:0007015,0.208110267090807,0.844497698426817,30,283,actin filament organization,BP,RAPGEF3;SSH1;WIPF1;ARHGAP12;ARAP1;DLG1;ESPN;PAK1;EPHA1;RAC2;TMOD2;ITGB5;FAT1;PFN2;FHOD1;OBSL1;TWF2;WASF3;F2RL1;MSRB2;JMY;WASF2;SPIRE1;SH3PXD2B;NCKAP1;TMSB4X;RHOBTB1;LPAR1;ARPC1A;WASL
13574,GO:0060041,0.208146329117656,0.878283021767752,10,77,retina development in camera-type eye,BP,ACVR2B;SDK2;RAB11FIP4;TUB;LPCAT1;LRP5;CHD7;RET;LAMB2;LRP6
3268,GO:0006939,0.208150538172766,0.892204000789674,7,54,smooth muscle contraction,BP,DOCK4;F2R;BBS2;DLG1;HTR7;EDNRA;ITGA2
17253,GO:0120033,0.208153917747407,0.931717965941569,3,19,negative regulation of plasma membrane bounded cell projection assembly,BP,PLXNB3;EVI5L;PFN2
14165,GO:0061047,0.208251070288353,0.984032264645768,1,3,positive regulation of branching involved in lung morphogenesis,BP,WNT2B
19840,GO:2000311,0.208312407649811,0.953459523825439,2,9,regulation of AMPA receptor activity,BP,SHANK2;NLGN2
13199,GO:0051817,0.208364870166186,0.881614766610284,9,77,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,TNIP1;PC;STOM;APOE;HMGA2;F2RL1;BCL2L1;YTHDC2;EIF2AK2
12236,GO:0048499,0.20841340875705,0.984005995417038,1,3,synaptic vesicle membrane organization,BP,AP3D1
18269,GO:1903135,0.208435813792595,0.98400236800432,1,3,cupric ion binding,MF,PRNP
3073,GO:0006639,0.20846130547161,0.886282405394056,8,66,acylglycerol metabolic process,BP,PCK2;LMF1;DGKA;APOE;MGLL;ABHD6;SEL1L;DDHD2
5618,GO:0016671,0.208570699227297,0.951269610569522,2,12,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,ERO1B;MSRB2
13233,GO:0051896,0.208841263662677,0.865500695027313,14,124,regulation of protein kinase B signaling,BP,XDH;MST1R;DDIT3;EGFR;FYN;DLG1;FGFR1;INPP5F;FAM110C;TRIB3;SPRY2;IGF2;ADAM8;HPSE
7460,GO:0031597,0.208875704360053,0.951152825069162,2,12,cytosolic proteasome complex,CC,PSMD2;IDE
6635,GO:0023016,0.208898962758136,0.98778794589967,1,2,signal transduction by trans-phosphorylation,BP,STK39
2668,GO:0006015,0.20900072621978,0.983910756770896,1,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,PYGL
11655,GO:0046391,0.20900072621978,0.983910756770896,1,3,5-phosphoribose 1-diphosphate metabolic process,BP,PYGL
1963,GO:0004672,0.209119022650143,0.833118433417986,49,472,protein kinase activity,MF,CCND1;RPS6KA2;MAP2K1;ACVR2B;LTBP1;PKN1;MST1R;BRSK1;EGFR;STK39;FYN;MAPK13;MAP4K4;TTBK2;GRK5;STRADB;PAK1;NEK9;TGFBR2;EPHA1;OBSCN;CDK17;PRKACB;HMGA2;FGFR1;PTK6;ULK2;LTBP4;FAM20C;MAPKAPK3;NLK;SLK;CDC42BPA;TAOK1;CSNK2A1;MAST3;ACVR1B;PSKH1;MARK4;MAP2K2;RET;PAK6;PRKACA;NEK6;EIF2AK2;MAP4K2;ZMYM2;AKT3;EEF2K
3165,GO:0006776,0.209132039574512,0.983889420210798,1,3,vitamin A metabolic process,BP,ALDH1A2
3742,GO:0008277,0.209178405670346,0.88098865613826,9,78,regulation of G-protein coupled receptor protein signaling pathway,BP,NOS1;APLN;GRK5;RGS14;TMOD2;MGLL;ABHD6;USP20;RPH3AL
13771,GO:0060349,0.209260869331204,0.891563344099805,7,53,bone morphogenesis,BP,COL13A1;TGFBR2;ACP5;MMP14;LRP5;THBS3;MEF2D
2141,GO:0004954,0.209333783049408,0.983856609152461,1,3,prostanoid receptor activity,MF,PPARG
7499,GO:0031670,0.209426071926517,0.897911623948018,6,46,cellular response to nutrient,BP,CYP27B1;POSTN;SSH1;FYN;XBP1;PPARG
7226,GO:0031120,0.209639838585718,0.981900363649872,1,4,snRNA pseudouridine synthesis,BP,NOP10
8136,GO:0032835,0.209662565526253,0.906491291009712,5,34,glomerulus development,BP,ACTA2;WWTR1;PODXL;RET;LAMB2
10567,GO:0043525,0.209744383544659,0.905812501270841,5,38,positive regulation of neuron apoptotic process,BP,PRNP;DDIT3;ATF4;ITGA1;CTSZ
14261,GO:0061316,0.209846026834407,0.983773132446915,1,3,canonical Wnt signaling pathway involved in heart development,BP,DKK1
9849,GO:0042094,0.209873283864644,0.951337432165643,2,11,interleukin-2 biosynthetic process,BP,IL1RAP;CARD11
16380,GO:0090722,0.209980832606971,0.987653169869924,1,2,receptor-receptor interaction,MF,FGFR1
19019,GO:1904849,0.209980832606971,0.987653169869924,1,2,positive regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1
19970,GO:2000546,0.209980832606971,0.987653169869924,1,2,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
12740,GO:0051005,0.210045699438755,0.983740528427008,1,3,negative regulation of lipoprotein lipase activity,BP,ANGPTL4
13014,GO:0051447,0.210235051278838,0.951891530676285,2,10,negative regulation of meiotic cell cycle,BP,PRKACB;PRKAR1A
10199,GO:0042803,0.210302350203267,0.831859402423632,49,531,protein homodimerization activity,MF,XDH;PGF;PYGL;CBS;CRYL1;WWTR1;DDIT3;CARS;BNIP3;SNX9;SLC9A7;ACOT7;STOM;RAG1;APOE;FKBP1A;BNIP3L;ABCD1;PKD2;IDE;RAB11FIP4;ASNS;FGFR1;INPP5F;ABCG1;CEACAM1;TRIM5;CLCN3;NTSR1;ANXA6;SLK;CEBPG;PSMD7;BOK;NACC2;MGLL;BCL2L1;MEF2D;CADM4;CCDC88A;FICD;TENM2;SNX6;TBX1;LRP6;TMEM173;AOX1;GALE;LRP4
7289,GO:0031281,0.210306736226298,0.951864582252734,2,10,positive regulation of cyclase activity,BP,NOS1;TIMP2
15245,GO:0071402,0.210330167620464,0.931021621863848,3,18,cellular response to lipoprotein particle stimulus,BP,APOE;ABCG1;PPARG
11824,GO:0046718,0.210332425712104,0.880175526712635,9,78,viral entry into host cell,BP,EGFR;CTSB;IDE;ITGB5;ITGA2;TRIM5;CD46;IFITM1;TRIM38
10847,GO:0044342,0.210356322456582,0.951153561905445,2,11,type B pancreatic cell proliferation,BP,IGFBP4;NR1D1
18694,GO:1904047,0.210506245609522,0.98366518833348,1,3,S-adenosyl-L-methionine binding,MF,CBS
1922,GO:0004616,0.210599539748267,0.983649902896847,1,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,HIBADH
18944,GO:1904705,0.2106827139587,0.9160444665806,4,28,regulation of vascular smooth muscle cell proliferation,BP,APLN;PAK1;MEF2D;PPARG
19649,GO:1990874,0.2106827139587,0.9160444665806,4,28,vascular smooth muscle cell proliferation,BP,APLN;PAK1;MEF2D;PPARG
5846,GO:0017137,0.21072856805024,0.856219779568019,18,158,Rab GTPase binding,MF,DENND5B;TBC1D14;RIN2;EVI5L;GDI1;RAB11FIP4;DMXL2;RABGGTA;RIMS3;SYTL1;USP6NL;TBC1D2B;NGFR;RIN1;EVI5;RPH3AL;ACAP2;TBC1D16
10352,GO:0043161,0.210918485978576,0.838312185205254,35,370,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,SMURF2;EDEM1;GID4;BTBD2;HECW2;WWTR1;DDIT3;PSMD2;UBE2J1;UBXN4;TRIB2;RBCK1;ABTB1;BTRC;RMND5A;FBXO2;DVL1;TRIB3;DNAJB9;BTBD3;PSMD7;MTA1;RNF165;ANKIB1;UBE2E1;SEL1L;TBL1X;ERLEC1;WFS1;RNF180;RNF103;UFL1;KLHL15;STT3B;FBXL5
16450,GO:0097110,0.210924683088694,0.897072627260301,6,45,scaffold protein binding,MF,NOS1;MAP2K1;DLG4;MAP2K2;ITPR2;LRP4
3167,GO:0006778,0.211011827029399,0.91529270244313,4,31,porphyrin-containing compound metabolic process,BP,RSAD1;UROS;BLVRA;ALAS1
6378,GO:0021563,0.211054198698785,0.987518630202684,1,2,glossopharyngeal nerve development,BP,HOXA3
15541,GO:0071941,0.211107544925396,0.950867012956835,2,11,nitrogen cycle metabolic process,BP,ARG2;NAGS
18235,GO:1903039,0.211154923182632,0.865972599668929,13,123,positive regulation of leukocyte cell-cell adhesion,BP,FYN;PAK1;RAG1;TGFBR2;CD44;CD46;XBP1;CARD11;AP3D1;IGF2;ADAM8;ITGA4;FADD
14964,GO:0070859,0.211329483407839,0.98353003350647,1,3,positive regulation of bile acid biosynthetic process,BP,NR1D1
18764,GO:1904253,0.211329483407839,0.98353003350647,1,3,positive regulation of bile acid metabolic process,BP,NR1D1
808,GO:0002080,0.211451142988601,0.951433483781423,2,10,acrosomal membrane,CC,BSG;CD46
4236,GO:0009416,0.211524712486465,0.848313097544986,23,224,response to light stimulus,BP,ERCC1;CCND1;NFATC4;CRTC1;BRSK1;EGFR;ERCC6;MAPK13;XPC;RAG1;IMPACT;RGS14;ATF4;ASNS;HYAL1;PITPNM1;DDB2;PER3;MTA1;NR2F6;DDHD2;REEP6;ELOVL4
17054,GO:0099532,0.211677685661167,0.987440102996131,1,2,synaptic vesicle endosomal processing,BP,AP3D1
8653,GO:0034198,0.211722632873278,0.904481357960219,5,39,cellular response to amino acid starvation,BP,DAP;IMPACT;ATF4;SLC38A2;EIF2AK2
2519,GO:0005773,0.211834286293082,0.828072311488442,56,599,vacuole,CC,TSPAN1;VLDLR;PYGB;NAPRT;PEG3;MST1R;MARCH9;CAPN2;TBC1D14;ANK3;CTSB;CD68;GPC4;WDFY3;RDH14;SDC1;STOM;ACP5;LRP1;FYCO1;SNX14;HYAL1;LPCAT1;ANXA6;CTSL;CST3;VPS11;C6ORF120;CTBS;COL6A1;GLB1;PCYOX1;SLC22A17;ZFYVE9;GABARAPL2;TMBIM1;CTSO;AP2A2;CMTM6;CTSZ;AP3D1;FNBP1;TMEM63A;EVA1A;TMEM50B;ATP6V1B2;ADAM8;ATP11B;TMEM9;MARCH2;PPT2;HPSE;GALNS;DNAJC3;PSEN2;GNAI1
3666,GO:0008154,0.211873796441105,0.858719805817695,16,149,actin polymerization or depolymerization,BP,SSH1;WIPF1;DLG1;RAC2;TMOD2;PFN2;TWF2;WASF3;F2RL1;MSRB2;JMY;SPIRE1;NCKAP1;TMSB4X;ARPC1A;WASL
19122,GO:1905065,0.211921164905118,0.983432511735456,1,3,positive regulation of vascular smooth muscle cell differentiation,BP,CTH
4267,GO:0009615,0.211927207853843,0.849083760213925,22,223,response to virus,BP,ACTA2;ADARB1;MST1R;BNIP3;HTRA1;BNIP3L;HMGA2;HYAL1;APOBEC3C;TRIM5;F2RL1;DDX60;PARP9;BCL2L1;IFITM1;PUM2;EIF2AK2;IFI16;TMEM173;DNAJC3;OAS1;FADD
18093,GO:1902722,0.211943965267665,0.983428747339229,1,3,positive regulation of prolactin secretion,BP,EGFR
6341,GO:0021515,0.212102635120017,0.930572347679929,3,17,cell differentiation in spinal cord,BP,SOX4;TCTN1;PTCH1
11274,GO:0045579,0.212111440973399,0.951183993106075,2,10,positive regulation of B cell differentiation,BP,MMP14;XBP1
14452,GO:0061771,0.212189264521224,0.983388217729225,1,3,response to caloric restriction,BP,APOE
5532,GO:0016509,0.212360058993533,0.983359965653085,1,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,HSD17B12
4575,GO:0010660,0.21272347899699,0.904158536782482,5,37,regulation of muscle cell apoptotic process,BP,BNIP3;PPP1R10;RGL2;PPARG;LRP6
13993,GO:0060707,0.212801761669054,0.950922566925154,2,10,trophoblast giant cell differentiation,BP,MDFI;E2F7
19612,GO:1990756,0.212997605034936,0.983254269523236,1,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,ARRDC1
2641,GO:0005977,0.213058148801951,0.889042117424526,7,53,glycogen metabolic process,BP,PYGL;PYGB;NR1D1;PGM1;PPP1R2;IGF2;RB1CC1
8419,GO:0033484,0.213295604299771,0.983204737679525,1,3,nitric oxide homeostasis,BP,ADNP
16234,GO:0090281,0.213305761823652,0.983203047914909,1,3,negative regulation of calcium ion import,BP,SLC30A1
18854,GO:1904475,0.213407610748309,0.987220767531476,1,2,regulation of Ras GTPase binding,BP,CCPG1
20205,GO:2001106,0.213407610748309,0.987220767531476,1,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,CCPG1
13577,GO:0060044,0.213604319912255,0.950617876012844,2,10,negative regulation of cardiac muscle cell proliferation,BP,TGFBR2;JARID2
14701,GO:0070325,0.213728272872349,0.9293637538877,3,18,lipoprotein particle receptor binding,MF,DKK1;APOE;LRP1
9438,GO:0036015,0.213793211827835,0.983121846424628,1,3,response to interleukin-3,BP,MT2A
9439,GO:0036016,0.213793211827835,0.983121846424628,1,3,cellular response to interleukin-3,BP,MT2A
16463,GO:0097129,0.213855896393848,0.983111388338094,1,3,cyclin D2-CDK4 complex,CC,CCND2
9704,GO:0038108,0.213890769295733,0.983105568696228,1,3,negative regulation of appetite by leptin-mediated signaling pathway,BP,BBS2
18685,GO:1904031,0.213926623878002,0.9138350299925,4,30,positive regulation of cyclin-dependent protein kinase activity,BP,CCND1;EGFR;CCND2;PKD2
12491,GO:0050501,0.214105045951762,0.983069785376065,1,3,hyaluronan synthase activity,MF,HYAL1
1277,GO:0003071,0.214133674093375,0.9497053996451,2,11,renal system process involved in regulation of systemic arterial blood pressure,BP,F2R;F2RL1
5665,GO:0016774,0.214424787423744,0.983016311442482,1,3,phosphotransferase activity, carboxyl group as acceptor,MF,NAGS
17747,GO:1901682,0.214461299457105,0.929004222554102,3,18,sulfur compound transmembrane transporter activity,MF,SLC33A1;SLC6A6;SLC7A11
7869,GO:0032430,0.214587543813975,0.982989055793326,1,3,positive regulation of phospholipase A2 activity,BP,EGFR
13647,GO:0060154,0.21482696328018,0.982948917666774,1,3,cellular process regulating host cell cycle in response to virus,BP,BCL2L1
12496,GO:0050542,0.2150458874018,0.980904031120947,1,4,icosanoid binding,MF,PPARG
12497,GO:0050543,0.2150458874018,0.980904031120947,1,4,icosatetraenoic acid binding,MF,PPARG
12498,GO:0050544,0.2150458874018,0.980904031120947,1,4,arachidonic acid binding,MF,PPARG
7620,GO:0032010,0.2151181687909,0.982900026673079,1,3,phagolysosome,CC,ADAM8
12197,GO:0048365,0.215179761260348,0.887727992193195,7,52,Rac GTPase binding,MF,DOCK4;PKN1;PAK1;SRGAP2B;DVL1;NCKAP1;PAK6
11805,GO:0046686,0.215185696150215,0.90178172586209,5,44,response to cadmium ion,BP,ERCC1;PRNP;EGFR;MT2A;SLC30A1
123,GO:0000253,0.215284150820382,0.980859439101577,1,4,3-keto sterol reductase activity,MF,HSD17B7
1213,GO:0002883,0.215433161739416,0.982847054117653,1,3,regulation of hypersensitivity,BP,IL20RB
11972,GO:0047223,0.215453596537176,0.982843614430747,1,3,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT3
1417,GO:0003357,0.215471701915844,0.986956258569066,1,2,noradrenergic neuron differentiation,BP,SOX4
13694,GO:0060244,0.215482446648156,0.982838757581879,1,3,negative regulation of cell proliferation involved in contact inhibition,BP,PAK1
17527,GO:1901017,0.215513004058598,0.950781965798628,2,9,negative regulation of potassium ion transmembrane transporter activity,BP,STK39;ANK3
17645,GO:1901380,0.215513004058598,0.950781965798628,2,9,negative regulation of potassium ion transmembrane transport,BP,STK39;ANK3
3488,GO:0007354,0.215652438087686,0.982810124358341,1,3,zygotic determination of anterior/posterior axis, embryo,BP,PCSK6
20249,GO:2001201,0.215674308506462,0.986930130049725,1,2,regulation of transforming growth factor-beta secretion,BP,FERMT1
9795,GO:0040014,0.215675988132042,0.894157457924339,6,44,regulation of multicellular organism growth,BP,BBS2;SOCS2;GAMT;CHD7;SH3PXD2B;PTCH1
3461,GO:0007274,0.216127183009405,0.950550570607279,2,9,neuromuscular synaptic transmission,BP,ETV5;ADARB1
1875,GO:0004551,0.216158955623885,0.948328466378233,2,12,nucleotide diphosphatase activity,MF,NUDT6;GARS
19605,GO:1990743,0.216204023090905,0.982717032503892,1,3,protein sialylation,BP,ST6GALNAC2
1202,GO:0002862,0.216222960389316,0.980683176019038,1,4,negative regulation of inflammatory response to antigenic stimulus,BP,IL20RB
6283,GO:0019887,0.216252862261053,0.857222876413592,15,146,protein kinase regulator activity,MF,CCND1;MAP2K1;ERCC6;SOCS2;TRIB2;RAC2;ETAA1;TRIB3;TAOK1;PRKAR1A;SPRY2;MAP2K2;IGF2;DNAJC3;KAT2B
16872,GO:0098801,0.216370205564239,0.948839351774586,2,11,regulation of renal system process,BP,F2R;F2RL1
4904,GO:0014834,0.216411157841334,0.982682001630982,1,3,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,WNT7A
14025,GO:0060749,0.216489951055316,0.948792802487215,2,11,mammary gland alveolus development,BP,CCND1;SOCS2
14289,GO:0061377,0.216489951055316,0.948792802487215,2,11,mammary gland lobule development,BP,CCND1;SOCS2
16431,GO:0097067,0.216584624761168,0.949479253715351,2,10,cellular response to thyroid hormone stimulus,BP,CTSB;CTSL
12111,GO:0048156,0.216627033393714,0.948739491241653,2,11,tau protein binding,MF,FYN;APOE
2653,GO:0005996,0.216781400662357,0.847917614944736,20,197,monosaccharide metabolic process,BP,PCK2;CRYL1;IGFBP4;NR1D1;H6PD;PC;PGM1;SLC2A3;ATF4;PPARA;ABHD10;LRP5;SLC35B4;MLYCD;GLB1;IGF2;KAT2B;OAS1;GALE;SLC23A2
9321,GO:0035791,0.216890401268766,0.950262364690638,2,9,platelet-derived growth factor receptor-beta signaling pathway,BP,PTPN12;LRP1
6747,GO:0030167,0.216968203918008,0.982587597033995,1,3,proteoglycan catabolic process,BP,HPSE
6766,GO:0030200,0.216968203918008,0.982587597033995,1,3,heparan sulfate proteoglycan catabolic process,BP,HPSE
2521,GO:0005775,0.216973520651298,0.861473947029364,13,126,vacuolar lumen,CC,PYGB;NAPRT;CTSB;GPC4;SDC1;HYAL1;CTSL;C6ORF120;GLB1;PPT2;HPSE;GALNS;DNAJC3
19508,GO:1990391,0.216974843966076,0.901733894695767,5,36,DNA repair complex,CC,ERCC1;XPC;RCOR1;MLH3;PHF21A
14321,GO:0061478,0.217182163596451,0.950151996562531,2,9,response to platelet aggregation inhibitor,BP,ADCY1;GNAI1
869,GO:0002218,0.217229993373513,0.846108307952844,21,210,activation of innate immune response,BP,TNIP1;NR1D1;PTPRS;PSMD2;FYN;CTSB;PAK1;PRKACB;BTRC;MAPKAPK3;TRIM5;CTSL;F2RL1;DDX60;PSMD7;PUM2;PRKACA;IFI16;CARD11;TMEM173;FADD
16355,GO:0090630,0.217254494061327,0.875767071254982,9,70,activation of GTPase activity,BP,TBC1D14;EVI5L;EPHA1;RALGAPA2;RALGAPA1;USP6NL;TBC1D2B;EVI5;TBC1D16
19336,GO:1905666,0.217396488729981,0.950070853421186,2,9,regulation of protein localization to endosome,BP,SORL1;ABHD17C
19337,GO:1905668,0.217396488729981,0.950070853421186,2,9,positive regulation of protein localization to endosome,BP,SORL1;ABHD17C
9688,GO:0038065,0.2175108682578,0.951181778114466,2,8,collagen-activated signaling pathway,BP,ITGA2;UBASH3B
12311,GO:0048661,0.217520077298736,0.885777914664667,7,56,positive regulation of smooth muscle cell proliferation,BP,EGFR;TGM2;PAK1;TGFBR2;ITGA2;MEF2D;FOXP1
18193,GO:1902962,0.217570014479253,0.986684224155067,1,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
18194,GO:1902963,0.217570014479253,0.986684224155067,1,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
13045,GO:0051525,0.21780941981294,0.986652984825532,1,2,NFAT protein binding,MF,PPARA
3818,GO:0008410,0.217841791236141,0.982438970170274,1,3,CoA-transferase activity,MF,SUGCT
10611,GO:0043589,0.217878740634458,0.94988806296817,2,9,skin morphogenesis,BP,ITGA2;COL1A2
18809,GO:1904376,0.218097016823523,0.926831037266255,3,19,negative regulation of protein localization to cell periphery,BP,BCL2L1;TMBIM1;LYPLA1
18330,GO:1903286,0.218751734352695,0.982283407834285,1,3,regulation of potassium ion import,BP,DLG1
255,GO:0000720,0.218758768425014,0.982282202316907,1,3,pyrimidine dimer repair by nucleotide-excision repair,BP,ERCC1
2714,GO:0006089,0.218868275512417,0.947864464895103,2,11,lactate metabolic process,BP,HAGH;LDHA
6558,GO:0021997,0.219128499291287,0.986480118947547,1,2,neural plate axis specification,BP,PTCH1
19712,GO:2000053,0.219395401154022,0.986444988205378,1,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,LRP6
16618,GO:0097457,0.219410612045479,0.986442984529933,1,2,hippocampal mossy fiber,CC,MAP1B
7287,GO:0031279,0.219487550278421,0.926137703766952,3,19,regulation of cyclase activity,BP,NOS1;AKAP9;TIMP2
2290,GO:0005248,0.219506644396491,0.950439113320262,2,8,voltage-gated sodium channel activity,MF,SCN8A;PKD2
8107,GO:0032793,0.219648309116381,0.948297035071863,2,10,positive regulation of CREB transcription factor activity,BP,ADGRF1;CRTC1
14638,GO:0070208,0.219706971041219,0.948274282413556,2,10,protein heterotrimerization,BP,COL6A1;COL1A2
1308,GO:0003156,0.219780958173,0.925648666882381,3,20,regulation of animal organ formation,BP,DKK1;FGFR1;WNT2B
3072,GO:0006638,0.219890434425145,0.878323156529926,8,67,neutral lipid metabolic process,BP,PCK2;LMF1;DGKA;APOE;MGLL;ABHD6;SEL1L;DDHD2
18506,GO:1903651,0.219916355253996,0.949112515306032,2,9,positive regulation of cytoplasmic transport,BP,SORL1;VPS11
7942,GO:0032532,0.219944422906059,0.982078346742667,1,3,regulation of microvillus length,BP,TWF2
19909,GO:2000404,0.219948187318432,0.925564724704479,3,20,regulation of T cell migration,BP,ADAM8;ITGA4;FADD
11393,GO:0045773,0.21998781645877,0.90043898207951,5,33,positive regulation of axon extension,BP,MAP1B;GDI1;PAK1;TWF2;ADNP
14957,GO:0070848,0.220017902074574,0.824322118074556,47,472,response to growth factor,BP,XDH;SMURF2;NOS1;MXRA5;POSTN;LTBP2;FNDC4;ACVR2B;LTBP1;APLN;EGFR;FYN;SLC33A1;ADAMTS7;HTRA1;WNT7A;SHC1;DKK1;TGFBR2;CD44;FKBP1A;PTPN12;ANXA3;FGFR1;ITGB5;HYAL1;GALNT3;LTBP4;FAM20C;FERMT1;NLK;EPN2;TWF2;PCSK6;MYOF;SPRY2;NGFR;RNF165;MTMR4;ZFYVE9;COL1A2;GRB10;SNX6;TBX1;ACAP2;EEF2K;LRP4
2698,GO:0006063,0.220270823852392,0.946703753275428,2,12,uronic acid metabolic process,BP,CRYL1;ABHD10
6184,GO:0019585,0.220270823852392,0.946703753275428,2,12,glucuronate metabolic process,BP,CRYL1;ABHD10
7649,GO:0032060,0.220326179901537,0.948033849533381,2,10,bleb assembly,BP,LPAR3;LPAR1
13677,GO:0060205,0.220560700829046,0.843172970671053,21,228,cytoplasmic vesicle lumen,CC,PYGL;PYGB;NAPRT;PSMD2;SERPING1;LCN2;APOE;C6ORF120;PSMD7;QSOX1;GLB1;DNASE1L1;TMSB4X;TIMP2;CTSZ;NIT2;IGF2;ERP44;HPSE;GALNS;DNAJC3
9814,GO:0042015,0.220611223791502,0.981963127495592,1,3,interleukin-20 binding,MF,IL20RB
13084,GO:0051592,0.220669073048746,0.868791453106803,10,85,response to calcium ion,BP,CCND1;EGFR;GDI1;SDC1;PKD2;ITPR3;TRPC1;ENDOG;EEF2K;ADCY1
13757,GO:0060333,0.220735869303423,0.883056757502845,7,63,interferon-gamma-mediated signaling pathway,BP,CD44;MT2A;TRIM5;PARP9;PPARG;OAS1;TRIM38
14267,GO:0061326,0.220911409623912,0.878074170600271,8,61,renal tubule development,BP,PGF;CTNNBIP1;WWTR1;DLG1;PKD2;WNT2B;LAMA5;PTCH1
9477,GO:0036109,0.220969314206218,0.947038344014469,2,11,alpha-linolenic acid metabolic process,BP,ELOVL1;ABCD1
15307,GO:0071496,0.220970956910048,0.839344660690295,24,238,cellular response to external stimulus,BP,CBS;ITGA6;CYP27B1;POSTN;SSH1;EGFR;FYN;BNIP3;GLUL;DAP;IMPACT;ATF4;ASNS;ITGA2;CPEB4;WNT2B;XBP1;SLC38A2;GABARAPL2;EIF2AK2;IFI16;PPARG;ADNP;FADD
5292,GO:0015960,0.221209725444144,0.981859358291235,1,3,diadenosine polyphosphate biosynthetic process,BP,GARS
5294,GO:0015965,0.221209725444144,0.981859358291235,1,3,diadenosine tetraphosphate metabolic process,BP,GARS
5295,GO:0015966,0.221209725444144,0.981859358291235,1,3,diadenosine tetraphosphate biosynthetic process,BP,GARS
19361,GO:1905777,0.221384561643956,0.981828982064456,1,3,regulation of exonuclease activity,BP,TCEA1
9188,GO:0035567,0.221398854360056,0.855635808524346,14,132,non-canonical Wnt signaling pathway,BP,SMURF2;PSMD2;GPC4;WNT7A;DKK1;NLK;TNRC6B;DVL1;PPP3CB;PSMD7;AP2A2;FZD8;TNRC6C;ANKRD6
708,GO:0001933,0.22142714600653,0.831518676710385,32,327,negative regulation of protein phosphorylation,BP,TNIP1;XDH;SORL1;PRNP;ADARB1;PKN1;WWTR1;STK39;DLG1;DKK1;SOCS2;TRIB2;EPHA1;IMPACT;APOE;FKBP1A;RGS14;PTK6;INPP5F;CEACAM1;DVL1;LRP5;TRIB3;RANBP9;F2RL1;PRKAR1A;SPRY2;UBASH3B;SNX6;LRP6;DNAJC3;KAT2B
17557,GO:1901099,0.221436620395876,0.924225423838982,3,22,negative regulation of signal transduction in absence of ligand,BP,FYN;STRADB;BCL2L1
20272,GO:2001240,0.221436620395876,0.924225423838982,3,22,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,FYN;STRADB;BCL2L1
9493,GO:0036132,0.221479607525493,0.981812456764839,1,3,13-prostaglandin reductase activity,MF,PTGR2
12012,GO:0047522,0.221479607525493,0.981812456764839,1,3,15-oxoprostaglandin 13-oxidase activity,MF,PTGR2
18718,GO:1904154,0.221483598102091,0.98181176275327,1,3,positive regulation of retrograde protein transport, ER to cytosol,BP,EDEM1
9546,GO:0036301,0.221568924643838,0.98179691984725,1,3,macrophage colony-stimulating factor production,BP,FOXP1
17599,GO:1901256,0.221568924643838,0.98179691984725,1,3,regulation of macrophage colony-stimulating factor production,BP,FOXP1
6524,GO:0021904,0.221648341988626,0.925443501586373,3,18,dorsal/ventral neural tube patterning,BP,PRKACB;TCTN1;PTCH1
8731,GO:0034378,0.221679807669919,0.981777621164574,1,3,chylomicron assembly,BP,APOE
19704,GO:2000042,0.22171235934033,0.948424610825251,2,9,negative regulation of double-strand break repair via homologous recombination,BP,MAGEF1;KLHL15
9718,GO:0038145,0.221747067259108,0.981765909366985,1,3,macrophage colony-stimulating factor signaling pathway,BP,MST1R
9911,GO:0042246,0.22180878225556,0.909566956921121,4,29,tissue regeneration,BP,POSTN;WNT7A;TGFBR2;PTPN12
15542,GO:0071942,0.221844158011308,0.981748995695069,1,3,XPC complex,CC,XPC
4772,GO:0010957,0.22187263721248,0.981744032818325,1,3,negative regulation of vitamin D biosynthetic process,BP,CYP27B1
11584,GO:0046137,0.22187263721248,0.981744032818325,1,3,negative regulation of vitamin metabolic process,BP,CYP27B1
18448,GO:1903533,0.222030391825331,0.867382773166711,10,94,regulation of protein targeting,BP,PRNP;ANK3;FYN;GDI1;CEMIP;STOM;PAK1;RAC2;BNIP3L;VPS11
9484,GO:0036118,0.222166739493737,0.981692737453762,1,3,hyaluranon cable assembly,BP,HYAL1
17380,GO:1900104,0.222166739493737,0.981692737453762,1,3,regulation of hyaluranon cable assembly,BP,HYAL1
17381,GO:1900106,0.222166739493737,0.981692737453762,1,3,positive regulation of hyaluranon cable assembly,BP,HYAL1
6214,GO:0019740,0.222358242083822,0.981659293546888,1,3,nitrogen utilization,BP,GLUL
12326,GO:0048678,0.222418885816283,0.889223045110203,6,49,response to axon injury,BP,MAP2K1;PTPRS;INPP5F;CST3;ARF4;LAMB2
8114,GO:0032800,0.222590300677524,0.92458191481713,3,19,receptor biosynthetic process,BP,NR1D1;PPARA;PPARG
11387,GO:0045762,0.222656331655509,0.98601159577241,1,2,positive regulation of adenylate cyclase activity,BP,TIMP2
1485,GO:0003810,0.222681048151628,0.981602841537407,1,3,protein-glutamine gamma-glutamyltransferase activity,MF,TGM2
6331,GO:0020037,0.222685044014283,0.882036659783007,7,59,heme binding,MF,NOS1;CBS;CYGB;CYP27B1;NR1D1;HEBP1;CYP4F22
8895,GO:0034711,0.222702534259537,0.981599080620948,1,3,inhibin binding,MF,ACVR1B
1593,GO:0004008,0.222718232982631,0.986003293984232,1,2,copper-exporting ATPase activity,MF,ATP7B
10650,GO:0043682,0.222718232982631,0.986003293984232,1,2,copper-transporting ATPase activity,MF,ATP7B
13543,GO:0060003,0.222718232982631,0.986003293984232,1,2,copper ion export,BP,ATP7B
8600,GO:0034105,0.222738651377922,0.92450722683605,3,19,positive regulation of tissue remodeling,BP,EGFR;TMBIM1;ADAM8
7338,GO:0031348,0.222881565133881,0.859889025988216,12,114,negative regulation of defense response,BP,NT5E;FNDC4;HTRA1;ARG2;SERPING1;APOE;ACP5;PPARA;CEACAM1;IFI16;PPARG;IL20RB
12064,GO:0048012,0.222895778094691,0.946275906017423,2,11,hepatocyte growth factor receptor signaling pathway,BP,MST1R;PAK1
18125,GO:1902809,0.222954976015887,0.981554861122811,1,3,regulation of skeletal muscle fiber differentiation,BP,TBX1
10161,GO:0042744,0.223110988522763,0.945568817606663,2,12,hydrogen peroxide catabolic process,BP,GPX3;PRDX5
4461,GO:0010454,0.223232048550198,0.981506258714524,1,3,negative regulation of cell fate commitment,BP,DKK1
7566,GO:0031914,0.223381185459656,0.981480068360085,1,3,negative regulation of synaptic plasticity,BP,RGS14
15047,GO:0070991,0.223506074119811,0.981458120341233,1,3,medium-chain-acyl-CoA dehydrogenase activity,MF,ACAD11
15437,GO:0071709,0.223524371771833,0.924503423082753,3,18,membrane assembly,BP,ANK3;NLGN2;LRP4
1851,GO:0004514,0.223623993144345,0.981437383808573,1,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,NAPRT
18222,GO:1903019,0.223722692237283,0.945323020984407,2,12,negative regulation of glycoprotein metabolic process,BP,ABCA7;CST3
2705,GO:0006071,0.223737583852037,0.945941254661361,2,11,glycerol metabolic process,BP,PCK2;COQ2
3589,GO:0008009,0.223771904061769,0.944337238299831,2,14,chemokine activity,MF,C5;CKLF
3292,GO:0006983,0.224040777046831,0.946581303687456,2,10,ER overload response,BP,DDIT3;WFS1
19640,GO:1990834,0.224146723369115,0.981345303245894,1,3,response to odorant,BP,MMP14
19491,GO:1990266,0.224188441974962,0.896334856986738,5,43,neutrophil migration,BP,RAC2;ITGA1;MOSPD2;ADAM8;CKLF
19948,GO:2000489,0.224260548987138,0.981325218662864,1,3,regulation of hepatic stellate cell activation,BP,CYGB
11782,GO:0046640,0.224368511042263,0.945689842169912,2,11,regulation of alpha-beta T cell proliferation,BP,ARG2;TGFBR2
3482,GO:0007342,0.224506748676562,0.979088909778183,1,4,fusion of sperm to egg plasma membrane involved in single fertilization,BP,SPESP1
8521,GO:0033745,0.224587416479719,0.981267475419575,1,3,L-methionine-(R)-S-oxide reductase activity,MF,MSRB2
594,GO:0001758,0.224806277309073,0.981228756405233,1,3,retinal dehydrogenase activity,MF,ALDH1A2
18918,GO:1904636,0.224818425749527,0.98122660589296,1,3,response to ionomycin,BP,NFATC4
18919,GO:1904637,0.224818425749527,0.98122660589296,1,3,cellular response to ionomycin,BP,NFATC4
15860,GO:0072576,0.224935747953858,0.946228722259567,2,10,liver morphogenesis,BP,CEACAM1;XBP1
19711,GO:2000052,0.225014242180693,0.946197750367182,2,10,positive regulation of non-canonical Wnt signaling pathway,BP,DKK1;ANKRD6
10729,GO:0044070,0.225179535192568,0.887640434411622,6,47,regulation of anion transport,BP,PRNP;STK39;APOE;ABCA7;FGFR1;NTSR1
18813,GO:1904380,0.225194930269202,0.923266604108094,3,19,endoplasmic reticulum mannose trimming,BP,EDEM1;SEL1L;RNF103
2429,GO:0005608,0.225243087448228,0.985662292789436,1,2,laminin-3 complex,CC,LAMB2
11795,GO:0046661,0.225269283366813,0.858361587097265,12,106,male sex differentiation,BP,ERCC1;CCND1;SDC1;ATRX;MMP14;CST3;BOK;WNT2B;BCL2L1;REC8;ARID4A;ARID5B
11660,GO:0046404,0.225393677886705,0.98112461687304,1,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,N4BP2
13160,GO:0051733,0.225393677886705,0.98112461687304,1,3,polydeoxyribonucleotide kinase activity,MF,N4BP2
13161,GO:0051734,0.225393677886705,0.98112461687304,1,3,ATP-dependent polynucleotide kinase activity,MF,N4BP2
6248,GO:0019825,0.225406271924474,0.945275207650018,2,11,oxygen binding,MF,CBS;CYGB
18823,GO:1904398,0.225488963612602,0.985628836100033,1,2,positive regulation of neuromuscular junction development,BP,LRP4
1120,GO:0002709,0.225651530924675,0.906793168083092,4,32,regulation of T cell mediated immunity,BP,CEACAM1;PPP3CB;IL20RB;FADD
16543,GO:0097284,0.225746094085736,0.945139133516557,2,11,hepatocyte apoptotic process,BP,BCL2L1;DNMT3A
3511,GO:0007420,0.225753904035209,0.819799641645965,46,448,brain development,BP,NEURL1;SERPINE2;BBS2;MAP2K1;PTPRS;SMARCA1;LAMB1;SNPH;EGFR;FYN;BNIP3;WNT7A;TTBK2;DKK1;PAK1;TGFBR2;SHANK2;LRP1;ANXA3;FGFR1;AARS;TACC1;ATRX;PITPNM1;CEP120;EPOR;CST3;CNTN1;BTBD3;CSNK2A1;CHD7;BOK;THRA;WNT2B;GLUD1;ARF4;SLC38A2;TCTN1;MBOAT7;LPAR1;ALDH1A2;SLC7A11;AKT3;LRP6;PTCH1;ADCY1
16105,GO:0090084,0.225773168763148,0.945897893860296,2,10,negative regulation of inclusion body assembly,BP,SORL1;HSPA2
3588,GO:0007638,0.22605812546448,0.947966571040167,2,8,mechanosensory behavior,BP,SLITRK6;ETV1
9453,GO:0036042,0.22622593345309,0.978749218280643,1,4,long-chain fatty acyl-CoA binding,MF,ACOT7
3940,GO:0008626,0.226433916577364,0.980939401261683,1,3,granzyme-mediated apoptotic signaling pathway,BP,BNIP3
15147,GO:0071248,0.226647569020307,0.86041111442105,11,101,cellular response to metal ion,BP,PRNP;NFATC4;EGFR;ANK3;BNIP3;PKD2;ATF4;MT2A;ENDOG;EEF2K;ADCY1
14654,GO:0070243,0.226653767063324,0.944774952832191,2,11,regulation of thymocyte apoptotic process,BP,RAG1;ADAM8
9315,GO:0035773,0.226801266726841,0.895083781928532,5,40,insulin secretion involved in cellular response to glucose stimulus,BP,NR1D1;MAP4K4;LRP5;PPP3CB;ANO1
4827,GO:0014031,0.226819937492951,0.879486048386405,7,56,mesenchymal cell development,BP,SEMA4B;EDNRA;RET;LAMA5;ALDH1A2;TBX1;SEMA3F
6061,GO:0019209,0.22719190808667,0.879053990586682,7,58,kinase activator activity,MF,MAP2K1;ERCC6;ETAA1;TAOK1;SPRY2;MAP2K2;IGF2
12844,GO:0051154,0.227339117899131,0.922578326334536,3,18,negative regulation of striated muscle cell differentiation,BP,DKK1;PAK1;XBP1
8488,GO:0033634,0.227349604128992,0.980775522081545,1,3,positive regulation of cell-cell adhesion mediated by integrin,BP,PODXL
4999,GO:0015141,0.227369640383668,0.980771927420667,1,3,succinate transmembrane transporter activity,MF,SLC13A3
5182,GO:0015744,0.227369640383668,0.980771927420667,1,3,succinate transport,BP,SLC13A3
15255,GO:0071422,0.227369640383668,0.980771927420667,1,3,succinate transmembrane transport,BP,SLC13A3
8046,GO:0032696,0.227369897208537,0.980771881341824,1,3,negative regulation of interleukin-13 production,BP,ARG2
18810,GO:1904377,0.227449462039562,0.886398348983826,6,45,positive regulation of protein localization to cell periphery,BP,PRNP;EGFR;DLG1;LRP1;EFCAB7;GNAI1
1267,GO:0003044,0.227545540443722,0.921392794081817,3,21,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,F2R;F2RL1;CTSZ
5264,GO:0015909,0.227580662882388,0.895043826359628,5,37,long-chain fatty acid transport,BP,APOE;ABCD1;NTSR1;CPT2;PPARG
9627,GO:0036493,0.227613491574762,0.980728148372499,1,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,DNAJC3
1901,GO:0004586,0.227658391287048,0.980720081352465,1,3,ornithine decarboxylase activity,MF,AZIN2
8414,GO:0033387,0.227658391287048,0.980720081352465,1,3,putrescine biosynthetic process from ornithine,BP,AZIN2
19364,GO:1905793,0.227730161627599,0.985321827772214,1,2,protein localization to pericentriolar material,BP,NUDCD3
17378,GO:1900102,0.227783029180366,0.944320395503066,2,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,DNAJB9;WFS1
7139,GO:0030971,0.22787199078674,0.886121593635576,6,45,receptor tyrosine kinase binding,MF,DOCK4;PAG1;SHC1;PITPNM1;SHC2;LRP4
12251,GO:0048525,0.2279133885947,0.872374694732056,8,72,negative regulation of viral process,BP,TNIP1;HMGA2;APOBEC3C;TRIM5;IFITM1;EIF2AK2;IFI16;OAS1
3168,GO:0006779,0.22796068065918,0.921179562034459,3,21,porphyrin-containing compound biosynthetic process,BP,RSAD1;UROS;ALAS1
15820,GO:0072520,0.228103853023445,0.944972463345831,2,10,seminiferous tubule development,BP,ATRX;REC8
10200,GO:0042805,0.228213966674836,0.9236998177433,3,15,actinin binding,MF,PKD2;OBSL1;PPARG
17065,GO:0099550,0.228242647877008,0.980614936579595,1,3,trans-synaptic signaling, modulating synaptic transmission,BP,F2R
19918,GO:2000416,0.228410079677829,0.980584745787292,1,3,regulation of eosinophil migration,BP,ADAM8
13833,GO:0060431,0.228421078768914,0.980582761541085,1,3,primary lung bud formation,BP,WNT2B
16499,GO:0097194,0.22843034812953,0.872072424303582,8,71,execution phase of apoptosis,BP,H1F0;CASP4;TAOK1;BOK;BCL2L1;SATB1;ENDOG;DEDD2
17317,GO:0140192,0.228551712307727,0.985208363056527,1,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
18157,GO:1902903,0.228584633797413,0.830921038837998,26,250,regulation of supramolecular fiber organization,BP,RAPGEF3;SSH1;MAP1B;WIPF1;ARAP1;DLG1;TTBK2;PAK1;EPHA1;RAC2;APOE;AKAP9;TMOD2;PFN2;FHOD1;TWF2;F2RL1;JMY;WASF2;SPIRE1;SH3PXD2B;NCKAP1;TMSB4X;LPAR1;ARPC1A;WASL
16939,GO:0098917,0.228588910644616,0.980552470387361,1,3,retrograde trans-synaptic signaling,BP,NOS1
4366,GO:0009975,0.228594301417676,0.945751247251114,2,9,cyclase activity,MF,ADCY7;ADCY1
14161,GO:0061043,0.22881256603735,0.980512062695808,1,3,regulation of vascular wound healing,BP,XBP1
8020,GO:0032653,0.228876439254933,0.920416085654864,3,22,regulation of interleukin-10 production,BP,TRIB2;CD46;IL20RB
8667,GO:0034236,0.229004520124023,0.943826879175387,2,11,protein kinase A catalytic subunit binding,MF,PRKAR1A;PJA2
9084,GO:0035335,0.22903689770359,0.867002498035869,9,75,peptidyl-tyrosine dephosphorylation,BP,SSH1;PTPRS;PTPN3;PTPN12;PTPDC1;DNAJC6;PTPRZ1;UBASH3B;MTMR4
13845,GO:0060445,0.229071277525757,0.922155102858976,3,17,branching involved in salivary gland morphogenesis,BP,TGM2;FGFR1;LAMA5
6174,GO:0019541,0.229172880621671,0.980446865756209,1,3,propionate metabolic process,BP,PCK2
4853,GO:0014065,0.229185142504206,0.862548982628373,10,85,phosphatidylinositol 3-kinase signaling,BP,F2R;SERPINE2;EGFR;FYN;FGFR1;CEACAM1;F2RL1;RGL2;IGF2;NYAP1
19041,GO:1904886,0.229644392702777,0.921406201707982,3,18,beta-catenin destruction complex disassembly,BP,DVL1;LRP5;LRP6
12904,GO:0051250,0.229675734694995,0.866246427028505,9,80,negative regulation of lymphocyte activation,BP,PRNP;PAG1;PKN1;DLG1;ARG2;CEACAM1;PRKAR1A;PDE5A;IL20RB
12680,GO:0050891,0.229748255214113,0.884890362482811,6,45,multicellular organismal water homeostasis,BP,ADCY7;PRKACB;PRKAR1A;PRKACA;WFS1;ADCY1
5153,GO:0015691,0.230008441861577,0.980295204502226,1,3,cadmium ion transport,BP,SLC30A1
14837,GO:0070574,0.230008441861577,0.980295204502226,1,3,cadmium ion transmembrane transport,BP,SLC30A1
11563,GO:0046104,0.230012737377611,0.980294423128801,1,3,thymidine metabolic process,BP,TK2
11573,GO:0046125,0.230012737377611,0.980294423128801,1,3,pyrimidine deoxyribonucleoside metabolic process,BP,TK2
2707,GO:0006073,0.230042271109315,0.877480910997397,7,54,cellular glucan metabolic process,BP,PYGL;PYGB;NR1D1;PGM1;PPP1R2;IGF2;RB1CC1
10721,GO:0044042,0.230042271109315,0.877480910997397,7,54,glucan metabolic process,BP,PYGL;PYGB;NR1D1;PGM1;PPP1R2;IGF2;RB1CC1
5168,GO:0015718,0.230199515086501,0.861697420697968,10,87,monocarboxylic acid transport,BP,SLC16A3;APOE;ABCD1;PPARA;CEACAM1;BSG;NTSR1;CPT2;PPARG;SLC10A6
16966,GO:0098976,0.230248361976163,0.980251535283788,1,3,excitatory chemical synaptic transmission,BP,SSH1
16955,GO:0098953,0.230472375649817,0.98021071221642,1,3,receptor diffusion trapping,BP,DLG4
16961,GO:0098970,0.230472375649817,0.98021071221642,1,3,postsynaptic neurotransmitter receptor diffusion trapping,BP,DLG4
17094,GO:0099628,0.230472375649817,0.98021071221642,1,3,neurotransmitter receptor diffusion trapping,BP,DLG4
17801,GO:1901894,0.230564029792755,0.980193995985022,1,3,regulation of calcium-transporting ATPase activity,BP,HSPA2
15317,GO:0071514,0.2305705114665,0.920933454465796,3,18,genetic imprinting,BP,ARID4A;IGF2;DNMT3A
6699,GO:0030098,0.230670624451104,0.835225339685438,21,203,lymphocyte differentiation,BP,POU2F2;RAG1;TGFBR2;CMTM7;SOX4;MMP14;CD46;DNAJB9;PPP3CB;CEBPG;CHD7;XBP1;SATB1;DOCK11;CARD11;AP3D1;ADAM8;ITGA4;FZD8;FOXP1;FADD
10792,GO:0044262,0.230749092765185,0.836698872744051,20,189,cellular carbohydrate metabolic process,BP,PCK2;PYGL;PYGB;IGFBP4;NR1D1;PGM1;ISYNA1;B3GNT3;IDH2;PPARA;ABHD10;NTSR1;SLC35B4;MLYCD;GLB1;PPP1R2;IGF2;COQ2;KAT2B;RB1CC1
5715,GO:0016849,0.230926212075714,0.944831919621904,2,9,phosphorus-oxygen lyase activity,MF,ADCY7;ADCY1
8657,GO:0034204,0.231009692237479,0.922299226141927,3,15,lipid translocation,BP,ABCA7;ATP10D;ATP11B
9344,GO:0035850,0.231011201257613,0.905002846211963,4,26,epithelial cell differentiation involved in kidney development,BP,ACTA2;WWTR1;PODXL;LAMB2
9152,GO:0035502,0.23104886052402,0.980105438640423,1,3,metanephric part of ureteric bud development,BP,PKD2
18852,GO:1904468,0.231189291292837,0.980079746580126,1,3,negative regulation of tumor necrosis factor secretion,BP,ARG2
10259,GO:0042997,0.231250806016392,0.980068486476611,1,3,negative regulation of Golgi to plasma membrane protein transport,BP,LYPLA1
11638,GO:0046349,0.231319933214971,0.942886156028837,2,11,amino sugar biosynthetic process,BP,GFPT1;UAP1
4066,GO:0009116,0.231499979708074,0.860205994493176,10,99,nucleoside metabolic process,BP,NT5E;TK2;DLG1;DLG4;NME4;DLG3;AHCYL2;APOBEC3C;GAMT;CARD11
9991,GO:0042398,0.231841562955826,0.903020765716512,4,33,cellular modified amino acid biosynthetic process,BP,HAGH;CHAC1;GAMT;ALDH7A1
4407,GO:0010159,0.231892126530765,0.979950881227564,1,3,specification of animal organ position,BP,HOXA3
15684,GO:0072207,0.231953446232658,0.92068983467757,3,17,metanephric epithelium development,BP,WWTR1;PKD2;LAMB2
14212,GO:0061146,0.232180401426985,0.979897890559733,1,3,Peyer's patch morphogenesis,BP,RET
6077,GO:0019229,0.232541667940726,0.903603343359451,4,28,regulation of vasoconstriction,BP,DOCK4;F2R;APLN;EGFR
10498,GO:0043398,0.23264903189494,0.979811578884631,1,3,HLH domain binding,MF,PKD2
3573,GO:0007617,0.232931112502741,0.942227512607219,2,11,mating behavior,BP,SERPINE2;THRA
6531,GO:0021934,0.233092680232464,0.98457220803478,1,2,hindbrain tangential cell migration,BP,TTBK2
6532,GO:0021935,0.233092680232464,0.98457220803478,1,2,cerebellar granule cell precursor tangential migration,BP,TTBK2
13587,GO:0060054,0.233202644940828,0.979709346902875,1,3,positive regulation of epithelial cell proliferation involved in wound healing,BP,WNT7A
20185,GO:2001032,0.233257825237815,0.942093549322411,2,11,regulation of double-strand break repair via nonhomologous end joining,BP,HMGA2;PARP9
9268,GO:0035690,0.233276139636939,0.829082903456692,24,241,cellular response to drug,BP,PCK2;ADCY7;PRNP;EIF4EBP1;SSH1;EGFR;PPP1R14A;FYN;BNIP3;MAPK13;NET1;IMPACT;HMGA2;ATF4;ATRX;MT2A;XRN1;CST3;PPP3CB;ITPR2;ENDOG;ADCY1;GNAI1;DNMT3A
18483,GO:1903588,0.233305757268298,0.97969027371649,1,3,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NGFR
4993,GO:0015129,0.233345255375747,0.979682964886646,1,3,lactate transmembrane transporter activity,MF,SLC16A3
16250,GO:0090303,0.233449847064484,0.902844915342152,4,29,positive regulation of wound healing,BP,F2R;TGFBR2;XBP1;HPSE
12517,GO:0050660,0.233582282778446,0.874502018374668,7,60,flavin adenine dinucleotide binding,MF,XDH;NOS1;ACAD11;MTHFR;ACAD10;TXNRD3;AOX1
1996,GO:0004719,0.233608816191993,0.979634157003552,1,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,PCMTD2
13717,GO:0060282,0.233860171422231,0.979587547961148,1,3,positive regulation of oocyte development,BP,PDE5A
19386,GO:1905881,0.233860171422231,0.979587547961148,1,3,positive regulation of oogenesis,BP,PDE5A
12756,GO:0051024,0.233952662019787,0.977184695718849,1,4,positive regulation of immunoglobulin secretion,BP,XBP1
1016,GO:0002513,0.234029250461667,0.979556161697816,1,3,tolerance induction to self antigen,BP,TGFBR2
5770,GO:0016971,0.234137107292745,0.979536125961193,1,3,flavin-linked sulfhydryl oxidase activity,MF,QSOX1
7315,GO:0031324,0.234156495873494,0.792142183233844,170,1888,negative regulation of cellular metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;ERCC1;ZMYND8;SORL1;CCND1;CTNNBIP1;VLDLR;CYP27B1;SERPINE2;PRNP;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;TFPI2;ACVR2B;SALL2;PKN1;WWTR1;PEG3;EIF4EBP1;DDIT3;ELK3;EGFR;TBC1D14;STK39;PPP1R14A;FYN;TNFRSF6B;BNIP3;SCMH1;UBE2J1;DLG1;DLG4;DNAJB5;IGF2BP3;CRTAP;SHC1;DLG3;DKK1;DAP;SOCS2;TRIB2;RAG1;PTPN3;SERPING1;EPHA1;IMPACT;CD44;APOE;FKBP1A;ACP5;RGS14;IDE;AKAP9;HMGA2;ATF4;PPARA;ABCA7;WWC3;ELFN2;FGFR1;PPP1R35;TCFL5;BTRC;LPCAT1;PTK6;INPP5F;CHAC1;ATRX;SOX4;CEACAM1;ZNF692;ATF7IP;RCOR1;MDFI;XRN1;TNRC6B;DVL1;HES2;PHF12;LRP5;KLF12;CST3;TRIB3;RANBP9;MEX3C;APLP2;PRDX5;F2RL1;UHRF2;RASIP1;AEBP1;CSNK2A1;PHF1;QSOX1;PRKAR1A;PARP9;CPEB4;ATXN2;NACC2;SPRY2;BEX4;THRA;NGFR;PPP1R10;TSHZ1;PER3;MTA1;H2AFJ;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;TLE4;LOXL2;C5;GABARAPL2;RMRP;EAPP;PUM2;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;ZNF354A;CTSZ;TBL1X;RNF169;ARID4A;TENM2;IGF2;GRB10;ERLEC1;PPARG;SNX6;GRB7;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;LRP6;ARID5B;MAGEF1;E2F7;SLC18A2;TNRC6C;TET1;ZC3H7A;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;KAT2B;USP25;PRMT3;UFL1;JARID2;KLHL15;MXD4;DNMT3A
15432,GO:0071702,0.23418892745498,0.792035434775467,171,1931,organic substance transport,BP,EDEM1;NOS1;F2R;SORL1;RAB3B;PCK2;VLDLR;PRNP;OSBP2;XPOT;BBS2;POSTN;SH3TC2;NR1D1;SLC16A3;LTBP2;RAPGEF3;ACVR2B;SLC29A4;ALOX15B;LMF1;APLN;POU2F2;PITPNC1;HADH;EXOC2;EGFR;TBC1D14;STK39;ANK3;FYN;OSBPL10;KIF13B;SLC33A1;UBE2J1;IDH2;SNX9;SLCO4A1;GLUL;EVI5L;IGF2BP3;MAP4K4;SEC23A;STRADB;NME4;GDI1;CEMIP;UNC119B;ARG2;STOM;PAK1;TGFBR2;SLC2A3;EDNRA;RAC2;APOE;BNIP3L;ABCD1;MCFD2;LRP1;EHBP1;PPARA;ABCA7;ICA1;SNX14;VAMP2;LONP2;LTBP4;ABCG1;SOX4;PITPNM1;ITPR3;VPS13A;CEACAM1;FERMT1;SLC5A1;RAB31;BSG;NTSR1;NLGN2;MVB12B;LRP5;COX18;SEC22C;SLC35B4;TRIB3;CLTCL1;TOM1L2;VPS11;SEC63;PPP3CB;SYTL1;ZDHHC2;COPB1;COPG1;F2RL1;SLC2A9;ATP10D;SLC6A6;TST;CHD7;SLC25A4;CPT2;ANO1;SDCCAG3;ATXN2;USP6NL;SLC6A14;TBC1D2B;SLC43A1;NGFR;PPP1R10;MVB12A;GLUD1;AZIN2;ARF4;XBP1;SPIRE1;SLC22A17;ARRDC1;SLC38A2;STX10;RAB43;OSBPL5;SLC13A3;C5;ZFYVE9;GABARAPL2;TMED4;TMSB4X;RAB1A;ZDHHC1;SNX30;SEL1L;BCAP29;AP2A2;KDELR3;IL1RAP;CARD11;AP3D1;ITPR2;SLC2A13;GRB10;EFCAB7;ERLEC1;PPARG;SLC10A6;SNX6;ANKRD50;LYPLA1;TMEM50B;SLC7A11;EVI5;ESYT3;ATP6V1B2;RPH3AL;ADAM8;ATP11B;TBC1D16;SSR3;LRP6;TMEM173;SLC18A2;SIGMAR1;SSR1;FOXP1;PTCH1;COG8;SNX27;SLC23A2;SLC44A1
720,GO:0001946,0.234197866466622,0.943530612435845,2,9,lymphangiogenesis,BP,ACVR2B;PPP3CB
3515,GO:0007435,0.234511912145841,0.902703282424877,4,27,salivary gland morphogenesis,BP,EGFR;TGM2;FGFR1;LAMA5
17393,GO:1900119,0.234613669469022,0.940866204572271,2,12,positive regulation of execution phase of apoptosis,BP,BOK;ENDOG
18567,GO:1903793,0.234671093355883,0.917703009787635,3,21,positive regulation of anion transport,BP,APOE;ABCA7;NTSR1
12300,GO:0048638,0.234738964760985,0.830720542176236,22,198,regulation of developmental growth,BP,BBS2;MAP1B;PTPRS;SEMA4B;GDI1;PAK1;SOCS2;TGFBR2;APOE;WWC3;LPAR3;FGFR1;ULK2;GAMT;TWF2;CHD7;SH3PXD2B;SYT2;PTCH1;JARID2;SEMA3F;ADNP
2059,GO:0004813,0.234755792801307,0.979420983756637,1,3,alanine-tRNA ligase activity,MF,AARS
2909,GO:0006419,0.234755792801307,0.979420983756637,1,3,alanyl-tRNA aminoacylation,BP,AARS
8647,GO:0034188,0.234828638579132,0.984324967562263,1,2,apolipoprotein A-I receptor activity,MF,ABCA7
16333,GO:0090554,0.234828638579132,0.984324967562263,1,2,phosphatidylcholine-translocating ATPase activity,MF,ABCA7
16334,GO:0090556,0.234828638579132,0.984324967562263,1,2,phosphatidylserine-translocating ATPase activity,MF,ABCA7
18447,GO:1903532,0.235108218041354,0.83011067959045,22,218,positive regulation of secretion by cell,BP,F2R;PCK2;POSTN;ALOX15B;APLN;EGFR;GLUL;SDC1;FGFR1;SOX4;FERMT1;NTSR1;NLGN2;PPP3CB;F2RL1;ANO1;GLUD1;XBP1;C5;IL1RAP;RPH3AL;ADAM8
5891,GO:0018057,0.235412158580367,0.979298430687826,1,3,peptidyl-lysine oxidation,BP,LOXL2
3276,GO:0006954,0.235444716350815,0.817933312130503,34,364,inflammatory response,BP,TNIP1;NT5E;F2R;CTNNBIP1;IGFBP4;NFATC4;FNDC4;EGFR;STK39;TNFRSF6B;MAPK13;TGM2;SDC1;SERPING1;APOE;ACP5;PPARA;HYAL1;ITGA2;CD46;CASP4;PRDX5;F2RL1;MGLL;NGFR;C5;TMSB4X;IFI16;IL1RAP;LTB4R;PPARG;ADAM8;IL20RB;FOXP1
5361,GO:0016137,0.235556410021193,0.939909429920729,2,13,glycoside metabolic process,BP,CBR4;ABHD10
9642,GO:0036510,0.235630187897325,0.97925763062872,1,3,trimming of terminal mannose on C branch,BP,EDEM1
3467,GO:0007286,0.235641905844495,0.867164615015437,8,68,spermatid development,BP,NEURL1;OSBP2;BBS2;UBE2J1;RFX2;REC8;PRKACA;HSPA2
18312,GO:1903236,0.235671437943503,0.979249906366599,1,3,regulation of leukocyte tethering or rolling,BP,ITGA4
703,GO:0001923,0.235737150014514,0.979237598126877,1,3,B-1 B cell differentiation,BP,CMTM7
17585,GO:1901215,0.235966516585672,0.844315103658364,14,131,negative regulation of neuron death,BP,F2R;SORL1;FYN;APOE;LRP1;ATF4;PPARA;AARS;BOK;CPEB4;BCL2L1;ADAM8;WFS1;ADNP
2943,GO:0006470,0.236249416783447,0.825501754823523,25,246,protein dephosphorylation,BP,SSH1;PTPRS;PPP1R14A;DLG1;PTPN3;FKBP1A;PTPN12;PPP2R3B;ELFN2;ITGA1;PPP1R35;PTPDC1;BTRC;PPP3CB;DNAJC6;CSNK2A1;PPP1R10;PTPRZ1;UBASH3B;PPP1R2;MTMR4;EIF2AK2;SLC39A10;RCAN1;PPM1M
9374,GO:0035898,0.236292604863307,0.979133393795053,1,3,parathyroid hormone secretion,BP,FGFR1
20179,GO:2001025,0.236371638194616,0.940132508193493,2,12,positive regulation of response to drug,BP,RAB3B;ENDOG
932,GO:0002331,0.236382255338114,0.98410178936721,1,2,pre-B cell allelic exclusion,BP,RAG1
17391,GO:1900117,0.236416653406958,0.916789473622824,3,21,regulation of execution phase of apoptosis,BP,BOK;BCL2L1;ENDOG
6778,GO:0030213,0.236585846998068,0.940721177244572,2,11,hyaluronan biosynthetic process,BP,CEMIP;HYAL1
2320,GO:0005328,0.236718251920908,0.941492250460448,2,10,neurotransmitter:sodium symporter activity,MF,SLC6A6;SLC6A14
12914,GO:0051260,0.236745112409236,0.830062192600013,21,214,protein homooligomerization,BP,PRNP;GPX3;KCNG1;CRTC1;TYSND1;TGM2;GLUL;STOM;ATXN10;CBR4;APOE;ANGPTL4;PKD2;IDE;ITPR3;ANXA6;CTH;ACOT13;NACC2;SIGMAR1;KCTD18
9957,GO:0042326,0.236773133629114,0.816872563667341,34,351,negative regulation of phosphorylation,BP,TNIP1;XDH;SORL1;PRNP;ADARB1;PKN1;WWTR1;STK39;DLG1;DKK1;SOCS2;TRIB2;EPHA1;IMPACT;APOE;FKBP1A;RGS14;PPARA;PTK6;INPP5F;CEACAM1;DVL1;LRP5;TRIB3;RANBP9;F2RL1;PRKAR1A;SPRY2;UBASH3B;GRB10;SNX6;LRP6;DNAJC3;KAT2B
1913,GO:0004605,0.236904451365678,0.979018269486086,1,3,phosphatidate cytidylyltransferase activity,MF,CDS2
10520,GO:0043434,0.236933460771145,0.819990397108957,30,297,response to peptide hormone,BP,PCK2;ADCY7;EIF4EBP1;HADH;FYN;SHC1;PAK1;SOCS2;PRKACB;IDE;PPARA;VAMP2;CEACAM1;RAB31;BSG;LRP5;TRIB3;PRKAR1A;NGFR;XBP1;PRKACA;IGF2;GRB10;PPARG;ATP6V1B2;LRP6;EEF2K;ADCY1;KAT2B;GNAI1
11296,GO:0045606,0.236973502126649,0.916835852179154,3,20,positive regulation of epidermal cell differentiation,BP,CYP27B1;ALOX15B;PTCH1
359,GO:0000977,0.237017289047172,0.811277042408763,43,433,RNA polymerase II regulatory region sequence-specific DNA binding,MF,ZMYND8;ETV5;NR1D1;NFATC4;ZC3H6;ETV4;SALL2;POU2F2;TEF;DDIT3;ELK3;HLTF;DDN;HMGA2;ATF4;PPARA;TCFL5;NFAT5;ZNF692;HES2;PHF12;RFX2;CEBPG;PLAG1;AEBP1;CHD7;NACC2;THRA;MEF2D;XBP1;SATB1;ETV1;IFI16;NR2F6;PPARG;CREB3L2;PHF21A;ARID5B;E2F7;KAT2B;PBX3;JARID2;RFX7
13269,GO:0051956,0.237312325806184,0.978941325670242,1,3,negative regulation of amino acid transport,BP,STK39
13210,GO:0051852,0.237323817795611,0.976482582062955,1,4,disruption by host of symbiont cells,BP,F2RL1
13216,GO:0051873,0.237323817795611,0.976482582062955,1,4,killing by host of symbiont cells,BP,F2RL1
15213,GO:0071359,0.237478376268812,0.87198102699617,7,58,cellular response to dsRNA,BP,MAP2K1;EGFR;MAP2K2;RMRP;PUM2;TMEM173;ZC3H7A
3617,GO:0008064,0.237512860502904,0.843072362298621,14,132,regulation of actin polymerization or depolymerization,BP,SSH1;WIPF1;DLG1;RAC2;TMOD2;PFN2;TWF2;F2RL1;JMY;SPIRE1;NCKAP1;TMSB4X;ARPC1A;WASL
7248,GO:0031204,0.237540424863244,0.978898226397292,1,3,posttranslational protein targeting to membrane, translocation,BP,SEC63
8834,GO:0034617,0.23755332389878,0.978895787640662,1,3,tetrahydrobiopterin binding,MF,NOS1
3296,GO:0006990,0.237558719463677,0.978894767480781,1,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,XBP1
3803,GO:0008381,0.237605623307768,0.978885898020253,1,3,mechanosensitive ion channel activity,MF,FAM155B
15824,GO:0072524,0.237662516864901,0.842926664328007,14,133,pyridine-containing compound metabolic process,BP,NT5E;PCK2;NAPRT;H6PD;DHTKD1;PSAT1;PGM1;IDH2;PGLS;NMRK1;LDHA;PPARA;PARP9;AOX1
7851,GO:0032411,0.237664241220128,0.87203906460434,7,56,positive regulation of transporter activity,BP,STK39;ANK3;PKD2;AKAP9;NTSR1;TMSB4X;HSPA2
321,GO:0000839,0.237714200934333,0.978865358047496,1,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,SEL1L
7674,GO:0032103,0.237748961814085,0.837999729975794,16,161,positive regulation of response to external stimulus,BP,TNIP1;PGF;CYP27B1;EGFR;MAPK13;TGM2;RAC2;FGFR1;ITGA2;MOSPD2;F2RL1;DDX60;PUM2;TMSB4X;LPAR1;ADAM8
5438,GO:0016301,0.237855327866928,0.802870383861443,63,633,kinase activity,MF,CCND1;RPS6KA2;MAP2K1;ACVR2B;LTBP1;TK2;PKN1;MST1R;DGKA;BRSK1;EGFR;STK39;FYN;MAPK13;DLG1;DLG4;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;NAGS;DLG3;PAK1;NEK9;TGFBR2;EPHA1;OBSCN;CDK17;PRKACB;HMGA2;FGFR1;PTK6;ULK2;LTBP4;FAM20C;MAPKAPK3;NLK;SLK;CDC42BPA;TAOK1;CSNK2A1;MAST3;ACVR1B;PSKH1;MARK4;PANK4;MAP2K2;RET;PAK6;PRKACA;NEK6;EIF2AK2;CARD11;MAP4K2;ZMYM2;AK9;AKT3;EEF2K;ZFYVE21;PANK1;N4BP2
555,GO:0001676,0.23787694897069,0.871369782446979,7,62,long-chain fatty acid metabolic process,BP,ALOX15B;ELOVL1;ACOT1;ACOT7;ABCD1;AIG1;MGLL
827,GO:0002102,0.237968058702852,0.900680780966577,4,27,podosome,CC,PTPN12;ASAP1;SH3PXD2B;ADAM8
13077,GO:0051584,0.238061670293263,0.976327317136334,1,4,regulation of dopamine uptake involved in synaptic transmission,BP,RAB3B
13260,GO:0051940,0.238061670293263,0.976327317136334,1,4,regulation of catecholamine uptake involved in synaptic transmission,BP,RAB3B
4682,GO:0010830,0.238069117024695,0.90013333413231,4,29,regulation of myotube differentiation,BP,MMP14;THRA;XBP1;TBX1
10895,GO:0044438,0.23807495575456,0.865033310400103,8,74,microbody part,CC,ABCD1;IDE;LONP2;PRDX5;MLYCD;CRAT;MAP2K2;AMACR
10896,GO:0044439,0.23807495575456,0.865033310400103,8,74,peroxisomal part,CC,ABCD1;IDE;LONP2;PRDX5;MLYCD;CRAT;MAP2K2;AMACR
14904,GO:0070723,0.238125121842531,0.91751764167216,3,17,response to cholesterol,BP,TGFBR2;LRP6;PTCH1
15767,GO:0072361,0.238297278493697,0.983824207372911,1,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
16817,GO:0098679,0.238297278493697,0.983824207372911,1,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
13940,GO:0060605,0.238338037211888,0.978747126342855,1,3,tube lumen cavitation,BP,TGM2
13957,GO:0060662,0.238338037211888,0.978747126342855,1,3,salivary gland cavitation,BP,TGM2
17475,GO:1900368,0.23849968427692,0.978716429621255,1,3,regulation of RNA interference,BP,RMRP
294,GO:0000798,0.238519184726262,0.978712724800749,1,3,nuclear cohesin complex,CC,REC8
11582,GO:0046135,0.238527729239773,0.938652828220017,2,13,pyrimidine nucleoside catabolic process,BP,NT5E;APOBEC3C
3575,GO:0007619,0.238699525175452,0.978678445299851,1,3,courtship behavior,BP,THRA
4638,GO:0010760,0.238805471002436,0.976170220422181,1,4,negative regulation of macrophage chemotaxis,BP,C5
19287,GO:1905522,0.238805471002436,0.976170220422181,1,4,negative regulation of macrophage migration,BP,C5
11751,GO:0046597,0.238831388526227,0.939099249158469,2,12,negative regulation of viral entry into host cell,BP,TRIM5;IFITM1
843,GO:0002155,0.238958584798257,0.978629148141933,1,3,regulation of thyroid hormone mediated signaling pathway,BP,THRA
136,GO:0000285,0.239069779752193,0.978607968817772,1,3,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,ZFYVE21
3758,GO:0008299,0.239075146196809,0.915081774783122,3,22,isoprenoid biosynthetic process,BP,SRD5A3;ALDH1A2;COQ2
12964,GO:0051346,0.239119852701774,0.820815331673069,27,279,negative regulation of hydrolase activity,BP,NOS1;SORL1;SERPINE2;TFPI2;PPP1R14A;TNFRSF6B;PLXNB3;DLG3;RAG1;SERPING1;CD44;FKBP1A;ANGPTL4;ELFN2;PPP1R35;CST3;APLP2;PRDX5;CSNK2A1;SPRY2;NGFR;PPP1R10;PPP1R2;C5;TIMP2;IFI16;FICD
12239,GO:0048511,0.239322297649613,0.829689071125539,20,188,rhythmic process,BP,NR1D1;TEF;CRTC1;EGFR;HEBP1;HTR7;ATF4;PPARA;BTRC;CST3;GFPT1;CSNK2A1;NGFR;PER3;MTA1;NR2F6;PPARG;ADCY1;KAT2B;ADNP
14813,GO:0070541,0.239428268506442,0.978539606650866,1,3,response to platinum ion,BP,UROS
816,GO:0002088,0.239441967997444,0.87860842010086,6,44,lens development in camera-type eye,BP,DLG1;WNT7A;TGFBR2;SLITRK6;WNT2B;SLC7A11
18616,GO:1903899,0.239474184969476,0.978530841683827,1,3,positive regulation of PERK-mediated unfolded protein response,BP,BOK
9437,GO:0036010,0.239632726387259,0.916251447554038,3,18,protein localization to endosome,BP,SORL1;ABHD17C;ACAP2
19601,GO:1990737,0.239720577913111,0.978483773315113,1,3,response to manganese-induced endoplasmic reticulum stress,BP,ATF4
5278,GO:0015929,0.239754969639099,0.938709274215043,2,12,hexosaminidase activity,MF,CEMIP;HYAL1
684,GO:0001894,0.239777691012208,0.84402018419222,13,122,tissue homeostasis,BP,F2R;BBS2;EGFR;STK39;ERCC6;RAC2;ACP5;TUB;LPCAT1;UBASH3B;ADAM8;AKT3;IL20RB
10159,GO:0042742,0.239833843582011,0.858214035905172,9,93,defense response to bacterium,BP,ARG2;SHC1;ACP5;ANXA3;GSDMC;F2RL1;GSDMA;RAB1A;FOXP1
11504,GO:0045988,0.23984957834262,0.978459107158161,1,3,negative regulation of striated muscle contraction,BP,PDE5A
13535,GO:0055118,0.23984957834262,0.978459107158161,1,3,negative regulation of cardiac muscle contraction,BP,PDE5A
14500,GO:0061951,0.239974941446834,0.886927497569565,5,39,establishment of protein localization to plasma membrane,BP,BBS2;ANK3;VAMP2;RAB31;LYPLA1
7999,GO:0032620,0.240028546823984,0.938013778463714,2,13,interleukin-17 production,BP,PRNP;ARG2
3801,GO:0008379,0.240341597716836,0.974349863574552,1,5,thioredoxin peroxidase activity,MF,PRDX5
16363,GO:0090661,0.240391880063531,0.974338505351543,1,5,box H/ACA telomerase RNP complex,CC,NOP10
10236,GO:0042940,0.240612612465546,0.978312880564032,1,3,D-amino acid transport,BP,NTSR1
9365,GO:0035879,0.240671655219931,0.978301542381999,1,3,plasma membrane lactate transport,BP,SLC16A3
2336,GO:0005365,0.240702163030799,0.983471714654545,1,2,myo-inositol transmembrane transporter activity,MF,SLC2A13
18185,GO:1902954,0.240944903740161,0.983435892931456,1,2,regulation of early endosome to recycling endosome transport,BP,SORL1
53,GO:0000110,0.241165167452114,0.978206640387342,1,3,nucleotide-excision repair factor 1 complex,CC,ERCC1
18419,GO:1903463,0.241174363001353,0.978204869866793,1,3,regulation of mitotic cell cycle DNA replication,BP,FGFR1
1226,GO:0002903,0.241370417044848,0.938024526419298,2,12,negative regulation of B cell apoptotic process,BP,SLC39A10;FOXP1
4299,GO:0009744,0.241442086825695,0.978153286359991,1,3,response to sucrose,BP,ERCC1
8687,GO:0034285,0.241442086825695,0.978153286359991,1,3,response to disaccharide,BP,ERCC1
3237,GO:0006891,0.241467732119907,0.89790097747536,4,30,intra-Golgi vesicle-mediated transport,BP,COPB1;COPG1;GABARAPL2;COG8
541,GO:0001659,0.24164686421049,0.914029590388333,3,21,temperature homeostasis,BP,NR1D1;APLN;NTSR1
1249,GO:0002950,0.241655184796116,0.978112178520307,1,3,ceramide phosphoethanolamine synthase activity,MF,SAMD8
8342,GO:0033188,0.241655184796116,0.978112178520307,1,3,sphingomyelin synthase activity,MF,SAMD8
12007,GO:0047493,0.241655184796116,0.978112178520307,1,3,ceramide cholinephosphotransferase activity,MF,SAMD8
834,GO:0002133,0.241706030191437,0.983323283260588,1,2,polycystin complex,CC,PKD2
15571,GO:0072021,0.241706030191437,0.983323283260588,1,2,ascending thin limb development,BP,PKD2
15662,GO:0072177,0.241706030191437,0.983323283260588,1,2,mesonephric duct development,BP,PKD2
15693,GO:0072218,0.241706030191437,0.983323283260588,1,2,metanephric ascending thin limb development,BP,PKD2
15770,GO:0072364,0.241752625929082,0.983316375126365,1,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,PPARA
2603,GO:0005901,0.241791108942262,0.869488571688244,7,53,caveola,CC,NOS1;F2R;TGFBR2;MYOF;LRP6;PTCH1;LRP4
6794,GO:0030234,0.241811339898386,0.797798268207542,68,734,enzyme regulator activity,MF,DOCK4;CCND1;ASAP2;SERPINE2;MAP2K1;TFPI2;ARHGAP22;APPL2;PSMD2;EGFR;TBC1D14;RIN2;ARHGAP12;PPP1R14A;ERCC6;ARAP1;EVI5L;GDI1;RASA3;SOCS2;TRIB2;SERPING1;RALGAPA2;RAC2;APOE;ANGPTL4;RGS14;SRGAP2B;PPP2R3B;ANXA3;ELFN2;PPP1R35;RALGAPA1;MMP14;ETAA1;CST3;TRIB3;APLP2;PRDX5;TAOK1;CSNK2A1;ASAP1;PRKAR1A;PARP9;USP6NL;SPRY2;TBC1D2B;PPP1R10;AZIN2;MAP2K2;PPP1R2;RIN1;SH3PXD2B;C5;TIMP2;EIF2AK2;IGF2;ARHGAP29;EVI5;DEPDC1;ACAP2;TBC1D16;WASL;LRP6;RALGDS;RCAN1;DNAJC3;KAT2B
12588,GO:0050764,0.242053107898153,0.885601231445358,5,39,regulation of phagocytosis,BP,ABCA7;TUB;ITGA2;F2RL1;PPARG
7124,GO:0030947,0.24228055128751,0.914429272857091,3,19,regulation of vascular endothelial growth factor receptor signaling pathway,BP,EPN2;MYOF;GRB10
8481,GO:0033627,0.242352651914073,0.885568667422628,5,38,cell adhesion mediated by integrin,BP,ITGA6;PODXL;ITGA2;FERMT1;RET
6385,GO:0021575,0.242513865226482,0.898280114747288,4,26,hindbrain morphogenesis,BP,SERPINE2;MAP2K1;WNT7A;LRP6
12548,GO:0050700,0.242538660048926,0.938231123648495,2,11,CARD domain binding,MF,CASP4;CARD11
1460,GO:0003707,0.2425538995004,0.885608525289993,5,37,steroid hormone receptor activity,MF,NR1D1;PPARA;THRA;NR2F6;PPARG
11342,GO:0045665,0.242652966328913,0.834465190501897,16,144,negative regulation of neuron differentiation,BP,NFATC4;PTPRS;SEMA4B;MAP4K4;GDI1;APOE;LRP1;ULK2;INPP5F;ASAP1;NGFR;LPAR1;CTSZ;OMG;SEMA3F;LRP4
19581,GO:1990637,0.242670648478216,0.97791568847172,1,3,response to prolactin,BP,EEF2K
5346,GO:0016094,0.242697888680754,0.977910403853362,1,3,polyprenol biosynthetic process,BP,SRD5A3
1021,GO:0002521,0.242719633762623,0.815001410681028,30,301,leukocyte differentiation,BP,CTNNBIP1;POU2F2;GLO1;RAG1;TGFBR2;CMTM7;FAM20C;SOX4;CEACAM1;MMP14;CD46;L3MBTL3;DNAJB9;PPP3CB;CEBPG;F2RL1;CHD7;XBP1;UBASH3B;SATB1;DOCK11;IFI16;CARD11;AP3D1;PPARG;ADAM8;ITGA4;FZD8;FOXP1;FADD
15359,GO:0071593,0.242747123958724,0.977900850357951,1,3,lymphocyte aggregation,BP,RAC2
13544,GO:0060004,0.242794912953875,0.938980698897343,2,10,reflex,BP,SLITRK6;SATB1
9419,GO:0035985,0.242929266799788,0.975288642602528,1,4,senescence-associated heterochromatin focus,CC,HMGA2
1808,GO:0004457,0.243183051580893,0.975233800678707,1,4,lactate dehydrogenase activity,MF,LDHA
1232,GO:0002920,0.243242519565938,0.912864842803914,3,22,regulation of humoral immune response,BP,SERPING1;CD46;C5
6154,GO:0019471,0.243267186629202,0.937216248727325,2,12,4-hydroxyproline metabolic process,BP,ERO1B;ALDH4A1
19701,GO:2000036,0.243272527254481,0.914342350468226,3,18,regulation of stem cell population maintenance,BP,HMGA2;ZNF322;LOXL2
6858,GO:0030327,0.243322361038845,0.977789059322566,1,3,prenylated protein catabolic process,BP,PCYOX1
9874,GO:0042135,0.243361473057128,0.937883379177049,2,11,neurotransmitter catabolic process,BP,ALDH7A1;SLC44A1
12957,GO:0051339,0.243449467086257,0.913420997686817,3,20,regulation of lyase activity,BP,NOS1;AKAP9;TIMP2
16240,GO:0090288,0.243454840291396,0.847982645426755,11,95,negative regulation of cellular response to growth factor stimulus,BP,XDH;SMURF2;LTBP1;APLN;HTRA1;DKK1;TGFBR2;EPN2;SPRY2;MTMR4;SNX6
7018,GO:0030730,0.243686698613221,0.93774569082958,2,11,sequestering of triglyceride,BP,PPARA;PPARG
16432,GO:0097068,0.24378431932844,0.97769905133205,1,3,response to thyroxine,BP,CRLS1
18818,GO:1904386,0.24378431932844,0.97769905133205,1,3,response to L-phenylalanine derivative,BP,CRLS1
5998,GO:0019005,0.243978912010316,0.874607777850749,6,52,SCF ubiquitin ligase complex,CC,BTBD2;ABTB1;BTRC;FBXO2;BTBD3;FBXL5
17040,GO:0099515,0.244068255184115,0.939523260679886,2,9,actin filament-based transport,BP,FNBP1L;WASL
12688,GO:0050905,0.244330702242496,0.875195004792902,6,45,neuromuscular process,BP,ADARB1;DLG4;SLITRK6;AARS;DVL1;NLGN2
11462,GO:0045916,0.244356683685629,0.977587245573347,1,3,negative regulation of complement activation,BP,SERPING1
19809,GO:2000258,0.244356683685629,0.977587245573347,1,3,negative regulation of protein activation cascade,BP,SERPING1
12541,GO:0050690,0.244390792727651,0.912568103846638,3,21,regulation of defense response to virus by virus,BP,FYN;EIF2AK2;AP2A2
9148,GO:0035497,0.244418062805542,0.93743556457943,2,11,cAMP response element binding,MF,HMGA2;CREB3L2
9941,GO:0042296,0.244607764370965,0.974924655383003,1,4,ISG15 transferase activity,MF,UBE2E1
572,GO:0001714,0.244644606190715,0.974916632527465,1,4,endodermal cell fate specification,BP,DKK1
19899,GO:2000389,0.244697959756963,0.977520429761325,1,3,regulation of neutrophil extravasation,BP,ADAM8
19900,GO:2000391,0.244697959756963,0.977520429761325,1,3,positive regulation of neutrophil extravasation,BP,ADAM8
8599,GO:0034104,0.244834861976948,0.937258519938321,2,11,negative regulation of tissue remodeling,BP,CST3;UBASH3B
979,GO:0002433,0.244892995434685,0.866817356095584,7,58,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,WIPF1;FYN;PAK1;WASF2;NCKAP1;ARPC1A;WASL
9700,GO:0038096,0.244892995434685,0.866817356095584,7,58,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,WIPF1;FYN;PAK1;WASF2;NCKAP1;ARPC1A;WASL
9378,GO:0035905,0.244921625583408,0.977476578767227,1,3,ascending aorta development,BP,SOX4
9381,GO:0035910,0.244921625583408,0.977476578767227,1,3,ascending aorta morphogenesis,BP,SOX4
7628,GO:0032027,0.244967632584304,0.977467552815645,1,3,myosin light chain binding,MF,SPATA6
18868,GO:1904527,0.245048598106508,0.977451663493951,1,3,negative regulation of microtubule binding,BP,TTBK2
7465,GO:0031623,0.245232641107419,0.866488445235252,7,59,receptor internalization,BP,APLN;DLG4;DKK1;LRP1;CEACAM1;RAB31;ATXN2
16641,GO:0097500,0.24525451004072,0.977411225063374,1,3,receptor localization to non-motile cilium,BP,TUB
454,GO:0001227,0.245266450962582,0.830091263430489,17,161,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,NR1D1;NFATC4;HMGA2;PPARA;TCFL5;ZNF692;RCOR1;HES2;AEBP1;NACC2;TSHZ1;SATB1;IFI16;NR2F6;ARID5B;E2F7;JARID2
15727,GO:0072298,0.245269230356912,0.977408332610298,1,3,regulation of metanephric glomerulus development,BP,RET
6010,GO:0019058,0.245356207056884,0.817722692506028,25,255,viral life cycle,BP,TNIP1;ADARB1;PC;EGFR;CTSB;STOM;APOE;IDE;HMGA2;ITGB5;ITGA2;APOBEC3C;TRIM5;CD46;MVB12B;USP6NL;MVB12A;IFITM1;YTHDC2;RAB43;EIF2AK2;RAB1A;IFI16;OAS1;TRIM38
7151,GO:0031010,0.245385384480662,0.93789579052857,2,10,ISWI-type complex,CC,SMARCA1;RSF1
9009,GO:0035166,0.245415750452798,0.977379530844479,1,3,post-embryonic hemopoiesis,BP,ERCC1
8432,GO:0033539,0.245467965572461,0.936272621959414,2,12,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,ACAD11;ACAD10
8929,GO:0034774,0.245601636874367,0.824021382615405,20,220,secretory granule lumen,CC,PYGL;PYGB;NAPRT;PSMD2;SERPING1;LCN2;C6ORF120;PSMD7;QSOX1;GLB1;DNASE1L1;TMSB4X;TIMP2;CTSZ;NIT2;IGF2;ERP44;HPSE;GALNS;DNAJC3
12329,GO:0048681,0.245777391822323,0.936857340480321,2,11,negative regulation of axon regeneration,BP,PTPRS;INPP5F
4824,GO:0014022,0.245895966464557,0.977284987805162,1,3,neural plate elongation,BP,DVL1
6561,GO:0022007,0.245895966464557,0.977284987805162,1,3,convergent extension involved in neural plate elongation,BP,DVL1
805,GO:0002074,0.246059098373354,0.977252820115398,1,3,extraocular skeletal muscle development,BP,MYH15
7888,GO:0032455,0.246059757474461,0.977252690096014,1,3,nerve growth factor processing,BP,PCSK6
9403,GO:0035948,0.246067962534644,0.977251071467262,1,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,KAT2B
19155,GO:1905167,0.246165778000136,0.982654626739975,1,2,positive regulation of lysosomal protein catabolic process,BP,LRP1
3793,GO:0008360,0.246234966369702,0.836471617599993,14,123,regulation of cell shape,BP,SYNE3;SH3KBP1;WIPF1;FYN;PARVB;ARAP1;DLG1;PLXNB3;TTBK2;WASF3;EPB41L3;RHOBTB1;LPAR1;WASL
4356,GO:0009952,0.246277186759164,0.836404511778208,14,124,anterior/posterior pattern specification,BP,CTNNBIP1;ACVR2B;DDIT3;SCMH1;DKK1;LRP5;PCSK6;WNT2B;TSHZ1;HOXA3;ALDH1A2;TBX1;LRP6;PBX3
7108,GO:0030904,0.246374760292625,0.911861434999029,3,20,retromer complex,CC,SDCCAG3;SNX6;SNX27
15776,GO:0072376,0.246385029543254,0.911178866222571,3,22,protein activation cascade,BP,SERPING1;CD46;C5
8851,GO:0034644,0.246670296207442,0.859184818198055,8,69,cellular response to UV,BP,ERCC1;NFATC4;MAPK13;XPC;IMPACT;ATF4;HYAL1;DDB2
3726,GO:0008252,0.246732563854984,0.936449621008351,2,11,nucleotidase activity,MF,NT5E;NT5DC1
3372,GO:0007141,0.246871119553596,0.935667739229807,2,12,male meiosis I,BP,REC8;HSPA2
13741,GO:0060313,0.246882465164921,0.97709006744879,1,3,negative regulation of blood vessel remodeling,BP,CST3
10645,GO:0043654,0.246952014912296,0.97707628956359,1,3,recognition of apoptotic cell,BP,PEAR1
5329,GO:0016055,0.246998448935685,0.805320572103582,38,388,Wnt signaling pathway,BP,SMURF2;CCND1;CTNNBIP1;IGFBP4;NFATC4;WWTR1;DDIT3;PSMD2;GPC4;WNT7A;GRK5;SDC1;DKK1;WISP1;APOE;LRP1;BTRC;SOX4;FERMT1;NLK;MDFI;TNRC6B;DVL1;LRP5;PPP3CB;CSNK2A1;PSMD7;WNT2B;TLE4;AP2A2;TBL1X;GRB10;FZD8;LRP6;TNRC6C;ZBTB33;ANKRD6;LRP4
7375,GO:0031427,0.247174506462151,0.977032182136944,1,3,response to methotrexate,BP,ASNS
3267,GO:0006937,0.24721480238216,0.853472018808633,9,79,regulation of muscle contraction,BP,DOCK4;NOS1;F2R;DLG1;AKAP9;ITGA2;ANXA6;PDE5A;PRKACA
11861,GO:0046850,0.247279536029525,0.895162359508804,4,27,regulation of bone remodeling,BP,EGFR;LRP5;UBASH3B;ADAM8
14463,GO:0061819,0.247437752795404,0.976979933158645,1,3,telomeric DNA-containing double minutes formation,BP,ERCC1
19352,GO:1905764,0.247437752795404,0.976979933158645,1,3,regulation of protection from non-homologous end joining at telomere,BP,ERCC1
19353,GO:1905765,0.247437752795404,0.976979933158645,1,3,negative regulation of protection from non-homologous end joining at telomere,BP,ERCC1
19572,GO:1990599,0.247437752795404,0.976979933158645,1,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,ERCC1
8143,GO:0032868,0.247561279177507,0.822818674268345,20,192,response to insulin,BP,PCK2;EIF4EBP1;HADH;SHC1;PAK1;SOCS2;IDE;PPARA;VAMP2;CEACAM1;RAB31;TRIB3;NGFR;XBP1;IGF2;GRB10;PPARG;ATP6V1B2;EEF2K;KAT2B
5548,GO:0016553,0.247564049940565,0.93609374746467,2,11,base conversion or substitution editing,BP,ADARB1;APOBEC3C
12374,GO:0048763,0.247708471075123,0.982419800708083,1,2,calcium-induced calcium release activity,MF,PKD2
1595,GO:0004013,0.247749757943984,0.976917919219023,1,3,adenosylhomocysteinase activity,MF,AHCYL2
5686,GO:0016802,0.247749757943984,0.976917919219023,1,3,trialkylsulfonium hydrolase activity,MF,AHCYL2
8744,GO:0034392,0.247782974730216,0.97691131149005,1,3,negative regulation of smooth muscle cell apoptotic process,BP,LRP6
18151,GO:1902893,0.247799385410539,0.894851296918749,4,27,regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4;APLN;PPARA;NGFR
13074,GO:0051581,0.247875254162203,0.976892948943493,1,3,negative regulation of neurotransmitter uptake,BP,NOS1
7834,GO:0032387,0.247898655147939,0.881406379216548,5,42,negative regulation of intracellular transport,BP,MAP1B;UBE2J1;GDI1;SOX4;ERLEC1
5849,GO:0017145,0.248012376427449,0.894723758703968,4,27,stem cell division,BP,ETV5;WWTR1;WNT7A;FGFR1
6451,GO:0021769,0.24801652832896,0.976864820939024,1,3,orbitofrontal cortex development,BP,FGFR1
16459,GO:0097120,0.248089084049815,0.910942562683485,3,20,receptor localization to synapse,BP,DLG1;DLG4;DLG3
9063,GO:0035290,0.24818769856393,0.976830714508405,1,3,trunk segmentation,BP,SEMA3F
9620,GO:0036484,0.24818769856393,0.976830714508405,1,3,trunk neural crest cell migration,BP,SEMA3F
9621,GO:0036486,0.24818769856393,0.976830714508405,1,3,ventral trunk neural crest cell migration,BP,SEMA3F
17571,GO:1901166,0.24818769856393,0.976830714508405,1,3,neural crest cell migration involved in autonomic nervous system development,BP,SEMA3F
546,GO:0001665,0.248383540179255,0.974094896089763,1,4,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,ST6GALNAC2
8770,GO:0034446,0.248581012777496,0.857953988007087,8,67,substrate adhesion-dependent cell spreading,BP,POSTN;LAMB1;PARVB;NET1;EPHA1;RAB1A;LAMA5;ITGA4
101,GO:0000212,0.248691433146272,0.936498824832383,2,10,meiotic spindle organization,BP,ATRX;TUBG2
11784,GO:0046642,0.248714275651498,0.976725612616326,1,3,negative regulation of alpha-beta T cell proliferation,BP,ARG2
15562,GO:0072007,0.2488462564685,0.976699227589905,1,3,mesangial cell differentiation,BP,ACTA2
15563,GO:0072008,0.2488462564685,0.976699227589905,1,3,glomerular mesangial cell differentiation,BP,ACTA2
15645,GO:0072143,0.2488462564685,0.976699227589905,1,3,mesangial cell development,BP,ACTA2
15646,GO:0072144,0.2488462564685,0.976699227589905,1,3,glomerular mesangial cell development,BP,ACTA2
18757,GO:1904238,0.2488462564685,0.976699227589905,1,3,pericyte cell differentiation,BP,ACTA2
16339,GO:0090568,0.24892611555815,0.894176017476995,4,27,nuclear transcriptional repressor complex,CC,SALL2;APPL2;CSNK2A1;NACC2
7697,GO:0032154,0.249180351523081,0.871528200215699,6,48,cleavage furrow,CC,PKN1;SSH1;RAB11FIP4;PITPNM1;SPIRE1;SEPT6
9046,GO:0035261,0.249264739926612,0.982181061582876,1,2,external genitalia morphogenesis,BP,LRP6
13979,GO:0060689,0.249439398174648,0.976580439427187,1,3,cell differentiation involved in salivary gland development,BP,XBP1
13664,GO:0060180,0.249679710082243,0.976532214504486,1,3,female mating behavior,BP,THRA
3028,GO:0006574,0.249881616717175,0.973761455754946,1,4,valine catabolic process,BP,HIBADH
12384,GO:0048791,0.250106820602402,0.910713591205283,3,18,calcium ion-regulated exocytosis of neurotransmitter,BP,RIMS3;SYTL1;SYT2
3359,GO:0007095,0.250114837154551,0.910256233461118,3,19,mitotic G2 DNA damage checkpoint,BP,BRSK1;HMGA2;TAOK1
10741,GO:0044107,0.250222647816722,0.973685212947682,1,4,cellular alcohol metabolic process,BP,CYP27B1
10742,GO:0044108,0.250222647816722,0.973685212947682,1,4,cellular alcohol biosynthetic process,BP,CYP27B1
12698,GO:0050916,0.25030561499183,0.976406345236705,1,3,sensory perception of sweet taste,BP,ITPR3
11290,GO:0045600,0.250461041860312,0.8800310988173,5,40,positive regulation of fat cell differentiation,BP,LRP5;XBP1;CCDC71L;SH3PXD2B;PPARG
5236,GO:0015853,0.25050153969123,0.973622769474402,1,4,adenine transport,BP,SLC25A4
187,GO:0000404,0.250514152700508,0.976364323285227,1,3,heteroduplex DNA loop binding,MF,XPC
7572,GO:0031933,0.250612033645285,0.976344584848673,1,3,telomeric heterochromatin,CC,ATRX
270,GO:0000768,0.250833927998672,0.892759883660236,4,28,syncytium formation by plasma membrane fusion,BP,NOS1;RAPGEF3;CAPN2;MYOF
8624,GO:0034140,0.250861516494765,0.976294232322814,1,3,negative regulation of toll-like receptor 3 signaling pathway,BP,F2RL1
56,GO:0000118,0.251003949847411,0.862822445820148,7,55,histone deacetylase complex,CC,SALL2;APPL2;PHF12;CSNK2A1;NACC2;TBL1X;PHF21A
6062,GO:0019210,0.251059605776845,0.855726918236039,8,73,kinase inhibitor activity,MF,SOCS2;TRIB2;TRIB3;PRKAR1A;SPRY2;LRP6;DNAJC3;KAT2B
704,GO:0001927,0.25106108226879,0.976253910568334,1,3,exocyst assembly,BP,EXOC2
10415,GO:0043252,0.25113629377685,0.934554775868577,2,11,sodium-independent organic anion transport,BP,SLCO4A1;SLC22A17
8497,GO:0033673,0.251200345572539,0.818054632060439,21,214,negative regulation of kinase activity,BP,SORL1;ADARB1;PKN1;WWTR1;SOCS2;TRIB2;EPHA1;APOE;RGS14;PTK6;CEACAM1;DVL1;LRP5;TRIB3;PRKAR1A;SPRY2;UBASH3B;SNX6;LRP6;DNAJC3;KAT2B
7862,GO:0032422,0.251341874866643,0.976197111079779,1,3,purine-rich negative regulatory element binding,MF,ELK3
17466,GO:1900271,0.251421076484027,0.909553085962761,3,19,regulation of long-term synaptic potentiation,BP,PRNP;CRTC1;APOE
8165,GO:0032898,0.251451450928207,0.976174924779054,1,3,neurotrophin production,BP,PCSK6
12867,GO:0051188,0.251494427751683,0.814918490924603,23,241,cofactor biosynthetic process,BP,NAPRT;DHTKD1;PSAT1;ELOVL1;PGM1;IDH2;ACOT7;RSAD1;NMRK1;CBR4;HAGH;LDHA;PPARA;UROS;CHAC1;MLYCD;PARP9;PANK4;PPT2;COQ2;HSD17B12;PANK1;ALAS1
59,GO:0000122,0.251547102604221,0.79204922596169,58,603,negative regulation of transcription by RNA polymerase II,BP,SMURF2;ZMYND8;CCND1;CTNNBIP1;VLDLR;NR1D1;NFATC4;ACVR2B;SALL2;WWTR1;PEG3;DDIT3;DLG1;DNAJB5;DKK1;IMPACT;HMGA2;PPARA;WWC3;FGFR1;TCFL5;ATRX;ZNF692;ATF7IP;RCOR1;MDFI;HES2;PHF12;KLF12;TRIB3;AEBP1;PARP9;NACC2;THRA;TSHZ1;PER3;SATB1;TLE4;LOXL2;EAPP;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;TENM2;IGF2;PPARG;WFS1;PHF21A;ZNF568;FZD8;ARID5B;E2F7;PTCH1;JARID2;MXD4;DNMT3A
17031,GO:0099403,0.25157755993504,0.98182282519704,1,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,ATRX
17032,GO:0099404,0.25157755993504,0.98182282519704,1,2,mitotic sister chromatid cohesion, telomeric,BP,ATRX
19052,GO:1904907,0.25157755993504,0.98182282519704,1,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,ATRX
19053,GO:1904908,0.25157755993504,0.98182282519704,1,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,ATRX
7627,GO:0032026,0.251742984916996,0.936322778453157,2,9,response to magnesium ion,BP,CCND1;ANK3
1286,GO:0003094,0.252051878229317,0.934157700654678,2,11,glomerular filtration,BP,F2R;F2RL1
10205,GO:0042819,0.252263911948375,0.976010055272906,1,3,vitamin B6 biosynthetic process,BP,PSAT1
13250,GO:0051926,0.252559488327856,0.891015412864377,4,31,negative regulation of calcium ion transport,BP,NOS1;PKD2;NTSR1;SLC30A1
6421,GO:0021684,0.252580310029065,0.975945674610559,1,3,cerebellar granular layer formation,BP,WNT7A
6436,GO:0021707,0.252580310029065,0.975945674610559,1,3,cerebellar granule cell differentiation,BP,WNT7A
6693,GO:0030070,0.252607719788946,0.975940092647264,1,3,insulin processing,BP,ERO1B
4522,GO:0010575,0.252806266020781,0.908805144229192,3,19,positive regulation of vascular endothelial growth factor production,BP,ATF4;C5;HPSE
6135,GO:0019401,0.252899525300827,0.973082410714513,1,4,alditol biosynthetic process,BP,PCK2
7377,GO:0031429,0.253033233960766,0.971393171748793,1,5,box H/ACA snoRNP complex,CC,NOP10
8809,GO:0034513,0.253033233960766,0.971393171748793,1,5,box H/ACA snoRNA binding,MF,NOP10
13518,GO:0055089,0.253187212996114,0.93366383284167,2,11,fatty acid homeostasis,BP,APOE;XBP1
722,GO:0001951,0.25331821453397,0.975795143699335,1,3,intestinal D-glucose absorption,BP,SLC5A1
17189,GO:0106001,0.25331821453397,0.975795143699335,1,3,intestinal hexose absorption,BP,SLC5A1
4763,GO:0010942,0.253352857657125,0.7951915389594,46,497,positive regulation of cell death,BP,XDH;F2R;NEURL1;ITGA6;RPS6KA2;PRNP;NFATC4;TNFSF15;SSH1;DDIT3;FYN;BNIP3;NET1;TGM2;DKK1;DAP;OBSCN;BNIP3L;RBCK1;LRP1;LDHA;HMGA2;ATF4;ITGA1;SOX4;NTSR1;CASP4;JMY;BOK;NACC2;NGFR;MARK4;BCL2L1;RET;LPAR1;CTSZ;MOAP1;PPARG;ALDH1A2;ADAM8;ENDOG;DEDD2;PSEN2;FAM162A;DNMT3A;FADD
380,GO:0001012,0.253396172470193,0.796811300171363,43,436,RNA polymerase II regulatory region DNA binding,MF,ZMYND8;ETV5;NR1D1;NFATC4;ZC3H6;ETV4;SALL2;POU2F2;TEF;DDIT3;ELK3;HLTF;DDN;HMGA2;ATF4;PPARA;TCFL5;NFAT5;ZNF692;HES2;PHF12;RFX2;CEBPG;PLAG1;AEBP1;CHD7;NACC2;THRA;MEF2D;XBP1;SATB1;ETV1;IFI16;NR2F6;PPARG;CREB3L2;PHF21A;ARID5B;E2F7;KAT2B;PBX3;JARID2;RFX7
4577,GO:0010662,0.253431778835824,0.908055631491035,3,20,regulation of striated muscle cell apoptotic process,BP,BNIP3;PPP1R10;RGL2
11718,GO:0046519,0.253440994060764,0.932801835026625,2,12,sphingoid metabolic process,BP,SPTLC2;KDSR
19067,GO:1904948,0.253510929561157,0.933522714618607,2,11,midbrain dopaminergic neuron differentiation,BP,DKK1;LRP6
16937,GO:0098915,0.253577204708401,0.975742183345861,1,3,membrane repolarization during ventricular cardiac muscle cell action potential,BP,DLG1
6068,GO:0019217,0.253752128606725,0.860674406315299,7,57,regulation of fatty acid metabolic process,BP,TYSND1;PPARA;LONP2;CEACAM1;TRIB3;MLYCD;PPARG
15249,GO:0071409,0.25386659186614,0.975682929105353,1,3,cellular response to cycloheximide,BP,XRN1
664,GO:0001867,0.253900582815125,0.972854999481909,1,4,complement activation, lectin pathway,BP,SERPING1
764,GO:0002011,0.254124358758438,0.868706312720285,6,44,morphogenesis of an epithelial sheet,BP,ARHGAP12;WNT7A;CD44;CEACAM1;DVL1;LRP6
11352,GO:0045684,0.254230815972936,0.889792538640615,4,32,positive regulation of epidermis development,BP,CYP27B1;ALOX15B;HPSE;PTCH1
11255,GO:0045494,0.254235679826981,0.907618197006013,3,20,photoreceptor cell maintenance,BP,BBS2;ERCC6;TUB
12116,GO:0048168,0.254247081270819,0.890440298275107,4,29,regulation of neuronal synaptic plasticity,BP,NEURL1;DLG4;MCTP1;APOE
9209,GO:0035591,0.254506864649439,0.860347211674762,7,55,signaling adaptor activity,MF,SH2D2A;PAG1;SHC1;SOCS2;SKAP2;GRB10;GRB7
15263,GO:0071435,0.254596504902255,0.975533107507491,1,3,potassium ion export,BP,DLG1
2783,GO:0006213,0.254940226811224,0.888660823733513,4,36,pyrimidine nucleoside metabolic process,BP,NT5E;TK2;NME4;APOBEC3C
16312,GO:0090480,0.255104013853032,0.975428626989867,1,3,purine nucleotide-sugar transmembrane transport,BP,SLC35B4
994,GO:0002456,0.255187754826853,0.866767688154597,6,54,T cell mediated immunity,BP,DLG1;CEACAM1;CD46;PPP3CB;IL20RB;FADD
5787,GO:0017016,0.255520890005868,0.795096503203745,43,407,Ras GTPase binding,MF,DOCK4;XPOT;FMNL2;RAPGEF3;PKN1;EXOC2;DENND5B;EGFR;TBC1D14;RIN2;FYN;DLG4;NET1;EVI5L;GDI1;SHC1;PAK1;OBSCN;SRGAP2B;AKAP9;RAB11FIP4;FGFR1;DMXL2;DVL1;DNMBP;RABGGTA;RANBP9;RIMS3;SYTL1;USP6NL;TBC1D2B;NGFR;RIN1;RET;NCKAP1;DOCK11;PAK6;SHC2;RGL2;EVI5;RPH3AL;ACAP2;TBC1D16
19832,GO:2000300,0.255531378355033,0.907326810797206,3,19,regulation of synaptic vesicle exocytosis,BP,PFN2;RIMS3;SEPT5
4183,GO:0009260,0.255553468453299,0.819470928287629,18,184,ribonucleotide biosynthetic process,BP,NOS1;ADCY7;DHTKD1;PGM1;ACOT7;NME4;APOE;LDHA;AKAP9;PPARA;PTHLH;PANK4;TMSB4X;TIMP2;AK9;ADCY1;PANK1;ADNP
2263,GO:0005178,0.255702900883385,0.847358344408565,9,76,integrin binding,MF,ITGA6;EGFR;WISP1;ITGA2;LTBP4;MMP14;TIMP2;LAMB2;LAMA5
1204,GO:0002864,0.255755752634319,0.972430693805719,1,4,regulation of acute inflammatory response to antigenic stimulus,BP,IL20RB
9809,GO:0040037,0.255763240565702,0.932537146919678,2,11,negative regulation of fibroblast growth factor receptor signaling pathway,BP,APLN;SPRY2
3786,GO:0008349,0.255820942303571,0.933439022879283,2,10,MAP kinase kinase kinase kinase activity,MF,MAP4K4;MAP4K2
4766,GO:0010950,0.256001628388771,0.830879937328215,13,135,positive regulation of endopeptidase activity,BP,XDH;F2R;TNFSF15;FYN;ASPH;DAP;CASP4;BOK;NGFR;IFI16;PPARG;FAM162A;FADD
14703,GO:0070327,0.256006248843376,0.975242256900353,1,3,thyroid hormone transport,BP,SLCO4A1
5091,GO:0015355,0.256200669844504,0.972328380125711,1,4,secondary active monocarboxylate transmembrane transporter activity,MF,SLC10A6
13492,GO:0055037,0.256202968762947,0.825634944965153,15,143,recycling endosome,CC,SORL1;SH3TC2;AVL9;TBC1D14;SLC9A7;MCTP1;RAB11FIP4;INPP5F;ABCG1;ABHD17C;ZDHHC2;BOK;SDCCAG3;ATP11B;PANK1
5924,GO:0018199,0.256331021319047,0.972298363675114,1,4,peptidyl-glutamine modification,BP,TGM2
16113,GO:0090092,0.256370147921453,0.825610788913004,15,139,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SMURF2;ACVR2B;LTBP1;WWTR1;HTRA1;DKK1;TGFBR2;FKBP1A;LTBP4;FERMT1;PCSK6;ACVR1B;RNF165;MTMR4;SNX6
11360,GO:0045717,0.256440677605032,0.931474833088674,2,12,negative regulation of fatty acid biosynthetic process,BP,CEACAM1;TRIB3
10437,GO:0043291,0.256492704681483,0.981047778244033,1,2,RAVE complex,CC,DMXL2
11480,GO:0045936,0.256556312982234,0.794472644763388,42,441,negative regulation of phosphate metabolic process,BP,TNIP1;XDH;SORL1;PRNP;ADARB1;PKN1;WWTR1;STK39;PPP1R14A;DLG1;DLG3;DKK1;SOCS2;TRIB2;EPHA1;IMPACT;APOE;FKBP1A;RGS14;AKAP9;PPARA;ELFN2;PPP1R35;LPCAT1;PTK6;INPP5F;CEACAM1;DVL1;LRP5;TRIB3;RANBP9;F2RL1;PRKAR1A;SPRY2;PPP1R10;UBASH3B;PPP1R2;GRB10;SNX6;LRP6;DNAJC3;KAT2B
3248,GO:0006906,0.256575200072098,0.830851146767049,13,121,vesicle fusion,BP,TBC1D14;DYSF;EVI5L;VAMP2;SEC22C;VPS11;SYTL1;USP6NL;TBC1D2B;STX10;EVI5;TBC1D16;SYT2
1987,GO:0004707,0.256647846543599,0.93138275757259,2,12,MAP kinase activity,MF,MAPK13;NLK
9475,GO:0036094,0.256815660446178,0.771174743414729,166,1808,small molecule binding,MF,XDH;NT5E;NOS1;RAB3B;PCK2;PYGL;CBS;RPS6KA2;SCN8A;PYGB;ADCY7;CRYL1;OSBP2;ACTA2;GPT2;MAP2K1;RAPGEF3;ACVR2B;TK2;PKN1;MST1R;H6PD;DHTKD1;DGKA;PC;SMARCA1;HADH;CARS;BRSK1;EGFR;STK39;FYN;MYH15;OSBPL10;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;IDH2;DHX32;TGM2;GLUL;ACSF2;MAP4K4;TTBK2;SPTLC2;GRK5;NMRK1;STRADB;NME4;CEMIP;ACAD11;SEPT10;NAGS;SLFN5;PAK1;NEK9;CBR4;TGFBR2;SLC2A3;LCN2;EPHA1;RAC2;CD44;OBSCN;APOE;ATP7B;ABCD1;CDK17;PRKACB;LDHA;FYCO1;IDE;UBE2G1;PPARA;ABCA7;KIF21B;ASNS;FGFR1;AARS;PTK6;ULK2;LONP2;ATRX;FAM20C;MTHFR;ABCG1;ITPR3;MAPKAPK3;RAB31;LMAN1;BSG;NLK;CLCN3;ANXA6;ACAD10;CTH;TWF2;TRIB3;VPS11;HIBADH;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;PRKAR1A;MAST3;SEPT5;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;NUDT6;YTHDC2;GRIN3B;ARF4;PANK4;TXNRD3;MAP2K2;TRPC1;RET;TUBG2;PDE5A;RAB43;MLH3;OSBPL5;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;RAB1A;RHOBTB1;LTB4R;FICD;ITPR2;MAP4K2;PPARG;ALDH1A2;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;SYT2;TMEM173;EEF2K;ZBTB33;AOX1;PTCH1;ADCY1;SEPT6;OAS1;PANK1;N4BP2;GNAI1;ALAS1
12645,GO:0050849,0.257015748669397,0.931219108424658,2,12,negative regulation of calcium-mediated signaling,BP,PRNP;PKD2
556,GO:0001678,0.257028625152501,0.841315453507179,10,92,cellular glucose homeostasis,BP,PCK2;NR1D1;MAP4K4;SOX4;LRP5;PPP3CB;ANO1;XBP1;PRKACA;ENDOG
13736,GO:0060307,0.257078779200245,0.932892488052693,2,10,regulation of ventricular cardiac muscle cell membrane repolarization,BP,DLG1;AKAP9
13137,GO:0051702,0.257140039352385,0.865626635340853,6,52,interaction with symbiont,BP,PC;STOM;APOE;HMGA2;F2RL1;YTHDC2
17333,GO:0198738,0.257260097677968,0.796294736106723,38,390,cell-cell signaling by wnt,BP,SMURF2;CCND1;CTNNBIP1;IGFBP4;NFATC4;WWTR1;DDIT3;PSMD2;GPC4;WNT7A;GRK5;SDC1;DKK1;WISP1;APOE;LRP1;BTRC;SOX4;FERMT1;NLK;MDFI;TNRC6B;DVL1;LRP5;PPP3CB;CSNK2A1;PSMD7;WNT2B;TLE4;AP2A2;TBL1X;GRB10;FZD8;LRP6;TNRC6C;ZBTB33;ANKRD6;LRP4
6994,GO:0030674,0.257426539220781,0.827363699877599,14,129,protein binding, bridging,MF,SH2D2A;PAG1;ANK3;SHC1;SOCS2;OBSL1;TRIM5;VPS11;SKAP2;ARRDC1;COL1A2;AP2A2;GRB10;GRB7
16608,GO:0097441,0.257628395537413,0.97490515412356,1,3,basal dendrite,CC,MAP1B
267,GO:0000737,0.257665552507994,0.905026180248629,3,22,DNA catabolic process, endonucleolytic,BP,H1F0;DNASE1L1;ENDOG
11594,GO:0046173,0.257688124454516,0.87501389400862,5,42,polyol biosynthetic process,BP,PCK2;CYP27B1;ISYNA1;SPTLC2;NTSR1
699,GO:0001919,0.257774295928658,0.905683234728665,3,20,regulation of receptor recycling,BP,ARAP1;INPP5F;TBC1D16
19442,GO:1990086,0.257873437503169,0.974854004731945,1,3,lens fiber cell apoptotic process,BP,TGFBR2
15013,GO:0070942,0.257930475796149,0.971928549642522,1,4,neutrophil mediated cytotoxicity,BP,F2RL1
1150,GO:0002758,0.258001990333374,0.815609092644468,19,195,innate immune response-activating signal transduction,BP,TNIP1;NR1D1;PTPRS;PSMD2;FYN;CTSB;PAK1;PRKACB;BTRC;MAPKAPK3;TRIM5;CTSL;F2RL1;DDX60;PSMD7;PUM2;PRKACA;CARD11;FADD
9019,GO:0035196,0.258334410781267,0.875217388285803,5,38,production of miRNAs involved in gene silencing by miRNA,BP,MAP2K1;EGFR;MAP2K2;PUM2;ZC3H7A
16068,GO:0090023,0.258547044161842,0.928867447024732,2,15,positive regulation of neutrophil chemotaxis,BP,RAC2;MOSPD2
15508,GO:0071879,0.258548295585604,0.974712828845401,1,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1
7054,GO:0030832,0.258658540188244,0.82625299259242,14,133,regulation of actin filament length,BP,SSH1;WIPF1;DLG1;RAC2;TMOD2;PFN2;TWF2;F2RL1;JMY;SPIRE1;NCKAP1;TMSB4X;ARPC1A;WASL
3534,GO:0007520,0.258727429712643,0.905159414265275,3,20,myoblast fusion,BP,NOS1;CAPN2;MYOF
3138,GO:0006730,0.258803497738958,0.904738713333777,3,21,one-carbon metabolic process,BP,ALDH1L2;MTHFR;AHCYL2
3662,GO:0008144,0.258948525317534,0.773113407201044,121,1262,drug binding,MF,NOS1;PYGL;CBS;CYGB;RPS6KA2;SCN8A;PYGB;ADCY7;ACTA2;GPT2;MAP2K1;ACVR2B;TK2;PKN1;MST1R;DGKA;PC;SMARCA1;CARS;BRSK1;EGFR;STK39;FYN;MYH15;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;DHX32;GLUL;FKBP9;ACSF2;MAP4K4;TTBK2;SPTLC2;GRK5;NMRK1;STRADB;NME4;SLFN5;PAK1;NEK9;TGFBR2;EPHA1;OBSCN;FKBP1A;ATP7B;ABCD1;CDK17;PRKACB;FYCO1;IDE;UBE2G1;PPARA;ABCA7;KIF21B;ASNS;FGFR1;AARS;PTK6;ULK2;LONP2;ATRX;FAM20C;ABCG1;FKBP10;ITPR3;MAPKAPK3;MT2A;NLK;CLCN3;CTH;TWF2;TRIB3;PPP3CB;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;CTBS;MAST3;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;YTHDC2;GRIN3B;PANK4;MAP2K2;RET;MLH3;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;FICD;MAP4K2;PPARG;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;TMEM173;EEF2K;SIGMAR1;ADCY1;OAS1;PANK1;N4BP2;ALAS1
13267,GO:0051954,0.258970103692475,0.930346853093385,2,12,positive regulation of amine transport,BP,RAB3B;NTSR1
3199,GO:0006828,0.258971244158928,0.974624120340546,1,3,manganese ion transport,BP,TRPC1
3164,GO:0006775,0.258971263540735,0.903710638601755,3,24,fat-soluble vitamin metabolic process,BP,CYP27B1;FGFR1;ALDH1A2
8683,GO:0034274,0.258978571841553,0.974622581879174,1,3,Atg12-Atg5-Atg16 complex,CC,WDFY3
19641,GO:1990837,0.25916708115718,0.787467204895717,52,529,sequence-specific double-stranded DNA binding,MF,ZMYND8;ETV5;H1F0;NR1D1;NFATC4;ZC3H6;ETV4;SALL2;POU2F2;TEF;DDIT3;SOX12;ELK3;HLTF;ZNF516;DDN;HMGA2;ATF4;PPARA;TCFL5;NFAT5;SOX4;ZNF692;HES2;PHF12;ZNF704;RFX2;CEBPG;PLAG1;AEBP1;CHD7;NACC2;THRA;PER3;MTA1;MEF2D;XBP1;SATB1;MLH3;ETV1;IFI16;NR2F6;PPARG;CREB3L2;PHF21A;ZNF568;ARID5B;E2F7;KAT2B;PBX3;JARID2;RFX7
4730,GO:0010893,0.259236271484694,0.930227677819602,2,12,positive regulation of steroid biosynthetic process,BP,NR1D1;ABCG1
12156,GO:0048263,0.259350221736722,0.971597954494646,1,4,determination of dorsal identity,BP,DDIT3
4561,GO:0010642,0.259400998245395,0.930931611221523,2,11,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,PTPN12;LRP1
1959,GO:0004663,0.259474786329859,0.971568844149442,1,4,Rab geranylgeranyltransferase activity,MF,RABGGTA
14977,GO:0070885,0.259648153775065,0.974481776598817,1,3,negative regulation of calcineurin-NFAT signaling cascade,BP,PRNP
17209,GO:0106057,0.259648153775065,0.974481776598817,1,3,negative regulation of calcineurin-mediated signaling,BP,PRNP
19907,GO:2000402,0.259845906898238,0.974440106140112,1,3,negative regulation of lymphocyte migration,BP,WASL
3764,GO:0008308,0.259916437278773,0.929922722089657,2,12,voltage-gated anion channel activity,MF,CLCN3;ANO1
9668,GO:0038026,0.259947974569617,0.974418583256868,1,3,reelin-mediated signaling pathway,BP,VLDLR
13893,GO:0060535,0.260175001618837,0.974370673162977,1,3,trachea cartilage morphogenesis,BP,LRP6
18054,GO:1902600,0.260322356173275,0.848409730332598,8,82,proton transmembrane transport,BP,SLC33A1;SLC9A7;SLC2A9;NDUFA4L2;TMSB4X;SLC2A13;ATP12A;ATP6V1B2
10198,GO:0042802,0.26036387282038,0.774101839411061,102,1163,identical protein binding,MF,TNIP1;XDH;SMURF2;PGF;PYGL;CBS;CRYL1;PRNP;UHRF1BP1;MPRIP;WWTR1;PC;DDIT3;CARS;EGFR;FYN;BNIP3;SNX9;GLUL;SLC9A7;HTRA1;ACOT7;SDC1;STOM;ATXN10;RAG1;APOE;FKBP1A;BNIP3L;ABCD1;ANGPTL4;PKD2;LDHA;IDE;RAB11FIP4;ASNS;FGFR1;PTK6;INPP5F;ABCG1;FHOD1;CEACAM1;MDFI;TRIM5;DVL1;CLCN3;NTSR1;ANXA6;NLGN2;EPOR;CTH;CST3;APLP2;SLK;MLYCD;CEBPG;CDC42BPA;CSNK2A1;PSMD7;BLMH;BOK;FCHO2;NACC2;MGLL;GLUD1;NPL;BCL2L1;MEF2D;UAP1;XBP1;UBASH3B;CADM4;ARRDC1;VWA1;RNF135;COL1A2;CCDC88A;EIF2AK2;SCAND1;ORAI1;FICD;TENM2;FNBP1;PPARG;SNX6;GRB7;SRPX2;TBX1;ALDH4A1;GARS;CLDN11;FLNB;LRP6;TMEM173;E2F7;FOXP1;AOX1;GALE;LRP4;DNMT3A;ALAS1;FADD
17933,GO:1902260,0.260403789629663,0.974322339533287,1,3,negative regulation of delayed rectifier potassium channel activity,BP,ANK3
4513,GO:0010563,0.260616876357709,0.790863815736668,42,442,negative regulation of phosphorus metabolic process,BP,TNIP1;XDH;SORL1;PRNP;ADARB1;PKN1;WWTR1;STK39;PPP1R14A;DLG1;DLG3;DKK1;SOCS2;TRIB2;EPHA1;IMPACT;APOE;FKBP1A;RGS14;AKAP9;PPARA;ELFN2;PPP1R35;LPCAT1;PTK6;INPP5F;CEACAM1;DVL1;LRP5;TRIB3;RANBP9;F2RL1;PRKAR1A;SPRY2;PPP1R10;UBASH3B;PPP1R2;GRB10;SNX6;LRP6;DNAJC3;KAT2B
4841,GO:0014047,0.260691471058183,0.904502526171123,3,19,glutamate secretion,BP,VAMP2;NTSR1;SLC38A2
1378,GO:0003274,0.260717821997213,0.97425591232747,1,3,endocardial cushion fusion,BP,TGFBR2
7466,GO:0031624,0.260717909574523,0.886738998424634,4,28,ubiquitin conjugating enzyme binding,MF,PPARA;ANKIB1;ZMYM2;RNF180
2151,GO:0004970,0.261157613948695,0.974162718005502,1,3,ionotropic glutamate receptor activity,MF,GRIN3B
3127,GO:0006706,0.261160617172776,0.928706404407638,2,13,steroid catabolic process,BP,CYP27B1;APOE
17690,GO:1901568,0.261502024610139,0.837570754441371,10,99,fatty acid derivative metabolic process,BP,ALOX15B;LTA4H;ELOVL1;ACOT7;CBR4;MGLL;CYP4F22;PTGR2;PPT2;HSD17B12
4574,GO:0010659,0.261588817542283,0.903580150411985,3,20,cardiac muscle cell apoptotic process,BP,BNIP3;PPP1R10;RGL2
15536,GO:0071930,0.261633996984867,0.97406155216648,1,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,E2F7
11867,GO:0046870,0.261656161713771,0.974056839697689,1,3,cadmium ion binding,MF,NOS1
3453,GO:0007265,0.261658272769961,0.793181671613347,37,365,Ras protein signal transduction,BP,F2R;RAB3B;ASAP2;RAPGEF3;APPL2;ARAP1;NET1;GDI1;SHC1;PAK1;RASA3;RAC2;OBSCN;APOE;MAPKAPK3;RAB31;DNMBP;F2RL1;ASAP1;SPRY2;NGFR;WASF2;RAB43;NCKAP1;PAK6;PSD3;COL1A2;SHC2;RGL2;TIMP2;RAB1A;RHOBTB1;LPAR1;ARHGAP29;ACAP2;RALGDS;RALGPS2
14248,GO:0061298,0.261864832124749,0.931988476954416,2,9,retina vasculature development in camera-type eye,BP,ACVR2B;LRP5
615,GO:0001783,0.261907032814708,0.902672153249682,3,22,B cell apoptotic process,BP,PKN1;SLC39A10;FOXP1
9451,GO:0036038,0.262035899141213,0.928308427747269,2,13,MKS complex,CC,TCTN1;TMEM107
1385,GO:0003289,0.262040482919726,0.973975050723065,1,3,atrial septum primum morphogenesis,BP,SOX4
4895,GO:0014821,0.262044754133986,0.970964468158324,1,4,phasic smooth muscle contraction,BP,DLG1
12057,GO:0048003,0.262142055176513,0.973953410065885,1,3,antigen processing and presentation of lipid antigen via MHC class Ib,BP,AP3D1
12059,GO:0048007,0.262142055176513,0.973953410065885,1,3,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,AP3D1
5379,GO:0016197,0.262177934382173,0.814166899052204,18,175,endosomal transport,BP,SORL1;TBC1D14;SNX9;RAB11FIP4;INPP5F;MVB12B;CLTCL1;SDCCAG3;MVB12A;STX10;ZFYVE9;AP3D1;SNX6;ANKRD50;TMEM50B;EVI5;ZFYVE21;SNX27
719,GO:0001945,0.262643243524185,0.903907929686085,3,18,lymph vessel development,BP,ACVR2B;PPP3CB;TBX1
4985,GO:0015111,0.262666036786705,0.973841608436543,1,3,iodide transmembrane transporter activity,MF,ANO1
14788,GO:0070492,0.262766598723906,0.970793412388838,1,4,oligosaccharide binding,MF,LOXL2
2294,GO:0005253,0.262784186751272,0.871948144264463,5,40,anion channel activity,MF,CLCA2;CLCN3;TTYH3;ANO8;ANO1
1816,GO:0004466,0.262865340404556,0.970769969105918,1,4,long-chain-acyl-CoA dehydrogenase activity,MF,ACAD11
5825,GO:0017099,0.262865340404556,0.970769969105918,1,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,ACAD11
9799,GO:0040018,0.263004858018712,0.903225718949098,3,19,positive regulation of multicellular organism growth,BP,BBS2;CHD7;SH3PXD2B
8581,GO:0034059,0.263128687727798,0.973742664637199,1,3,response to anoxia,BP,EEF2K
6356,GO:0021537,0.263144583545842,0.815542471760844,17,158,telencephalon development,BP,BBS2;PTPRS;LAMB1;EGFR;BNIP3;LRP1;ANXA3;TACC1;CEP120;BTBD3;CSNK2A1;CHD7;SLC38A2;TCTN1;MBOAT7;LPAR1;LRP6
8638,GO:0034163,0.263290958461824,0.973707910229257,1,3,regulation of toll-like receptor 9 signaling pathway,BP,PTPRS
7236,GO:0031143,0.263366971428213,0.92836646627708,2,12,pseudopodium,CC,CAPN2;F2RL1
646,GO:0001836,0.263446507259332,0.870348996284294,5,49,release of cytochrome c from mitochondria,BP,BNIP3;BOK;BCL2L1;MOAP1;FAM162A
7276,GO:0031258,0.263481246007795,0.902961974870869,3,19,lamellipodium membrane,CC,CD44;PLEK2;NCKAP1
5466,GO:0016362,0.263580308939203,0.979896964819468,1,2,activin receptor activity, type II,MF,ACVR2B
8243,GO:0033013,0.26383131369926,0.870674507307749,5,44,tetrapyrrole metabolic process,BP,PRSS3;RSAD1;UROS;BLVRA;ALAS1
1716,GO:0004308,0.26385431129346,0.97053457681891,1,4,exo-alpha-sialidase activity,MF,GLB1
5775,GO:0016997,0.26385431129346,0.97053457681891,1,4,alpha-sialidase activity,MF,GLB1
12396,GO:0048821,0.264063497450808,0.901817563865154,3,21,erythrocyte development,BP,FAM210B;L3MBTL3;ARID4A
9390,GO:0035927,0.264121403909122,0.970470819829523,1,4,RNA import into mitochondrion,BP,TST
2099,GO:0004866,0.264146695718451,0.84586661804083,8,77,endopeptidase inhibitor activity,MF,SERPINE2;TFPI2;SERPING1;CST3;APLP2;PRDX5;C5;TIMP2
6888,GO:0030414,0.264146695718451,0.84586661804083,8,77,peptidase inhibitor activity,MF,SERPINE2;TFPI2;SERPING1;CST3;APLP2;PRDX5;C5;TIMP2
6741,GO:0030159,0.264509329276647,0.902391845383844,3,19,receptor signaling complex scaffold activity,MF,SHANK2;RGS14;DEDD2
18441,GO:1903524,0.264530619780054,0.88343284811387,4,32,positive regulation of blood circulation,BP,F2R;APLN;EGFR;F2RL1
402,GO:0001078,0.264556883449119,0.831482878642133,11,100,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NR1D1;NFATC4;HMGA2;PPARA;TCFL5;ZNF692;RCOR1;HES2;NACC2;TSHZ1;IFI16
15487,GO:0071839,0.264709788200763,0.970330091330944,1,4,apoptotic process in bone marrow,BP,BCL2L1
10486,GO:0043380,0.264786365863532,0.970311747631664,1,4,regulation of memory T cell differentiation,BP,CD46
3158,GO:0006760,0.264792484728203,0.901058063571629,3,22,folic acid-containing compound metabolic process,BP,ALDH1L2;MTHFR;PM20D2
6792,GO:0030229,0.264850088336454,0.973372638097453,1,3,very-low-density lipoprotein particle receptor activity,MF,VLDLR
16834,GO:0098732,0.264911525239931,0.831206254606802,11,100,macromolecule deacylation,BP,RCOR1;ABHD17C;NACC2;BEX4;MTA1;LYPLAL1;TBL1X;ARID4A;LYPLA1;PHF21A;PPT2
9918,GO:0042262,0.264933084488222,0.96845499732263,1,5,DNA protection,BP,CBS
13841,GO:0060441,0.26493743531374,0.901719196995705,3,20,epithelial tube branching involved in lung morphogenesis,BP,SPRY2;WNT2B;CTSZ
6040,GO:0019136,0.26501694820291,0.970256474088172,1,4,deoxynucleoside kinase activity,MF,TK2
2246,GO:0005158,0.265390443525565,0.902942473125576,3,17,insulin receptor binding,MF,SHC1;IGF2;GRB10
11147,GO:0045197,0.265551985596295,0.883487020920319,4,29,establishment or maintenance of epithelial cell apical/basal polarity,BP,DLG1;DLG4;DLG3;ARF4
1876,GO:0004553,0.265599073276217,0.85173797897959,7,62,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,EDEM1;CEMIP;ABHD10;HYAL1;CTBS;GLB1;HPSE
7791,GO:0032331,0.265743944165305,0.927285469685655,2,12,negative regulation of chondrocyte differentiation,BP,ADAMTS7;PTHLH
13828,GO:0060425,0.265975523065206,0.869994391864655,5,39,lung morphogenesis,BP,MAP2K1;TGFBR2;SPRY2;WNT2B;CTSZ
1310,GO:0003158,0.266012411276323,0.839616524301894,9,76,endothelium development,BP,XDH;RAPGEF3;ACVR2B;PTPRS;WNT7A;CEACAM1;F2RL1;LAMA5;FOXP1
13193,GO:0051799,0.266050971261642,0.973112738991332,1,3,negative regulation of hair follicle development,BP,FERMT1
6059,GO:0019207,0.266353482279548,0.814773569890645,16,162,kinase regulator activity,MF,CCND1;MAP2K1;ERCC6;SOCS2;TRIB2;RAC2;ETAA1;TRIB3;TAOK1;PRKAR1A;SPRY2;MAP2K2;IGF2;LRP6;DNAJC3;KAT2B
4572,GO:0010657,0.266363757950248,0.869569422853079,5,40,muscle cell apoptotic process,BP,BNIP3;PPP1R10;RGL2;PPARG;LRP6
11386,GO:0045761,0.266538818918225,0.927732001956661,2,11,regulation of adenylate cyclase activity,BP,AKAP9;TIMP2
19938,GO:2000467,0.266565837096116,0.973000865714148,1,3,positive regulation of glycogen (starch) synthase activity,BP,IGF2
14333,GO:0061515,0.266635283065372,0.859389333118429,6,49,myeloid cell development,BP,FAM210B;FAM20C;L3MBTL3;WASF2;ARID4A;FOXP1
9660,GO:0038003,0.266773985505757,0.969833364971975,1,4,opioid receptor signaling pathway,BP,SIGMAR1
12220,GO:0048469,0.26688218427764,0.833711015311502,10,93,cell maturation,BP,FAM210B;POU2F2;FGFR1;FAM20C;L3MBTL3;XBP1;REC8;RET;PRKACA;PPARG
8892,GO:0034707,0.266990327690206,0.926715725576196,2,12,chloride channel complex,CC,TTYH3;ANO1
14538,GO:0070044,0.267865028353444,0.969568917242439,1,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,VAMP2
7498,GO:0031669,0.26802063414919,0.811329156992725,17,166,cellular response to nutrient levels,BP,CYP27B1;POSTN;SSH1;FYN;GLUL;DAP;IMPACT;ATF4;ASNS;CPEB4;WNT2B;XBP1;SLC38A2;GABARAPL2;EIF2AK2;IFI16;PPARG
8867,GO:0034666,0.26803504861006,0.97268015730085,1,3,integrin alpha2-beta1 complex,CC,ITGA2
4811,GO:0014002,0.268207796904723,0.900330120827441,3,19,astrocyte development,BP,EGFR;LRP1;LAMB2
12023,GO:0047631,0.268315542205279,0.967590083182369,1,5,ADP-ribose diphosphatase activity,MF,NUDT6
8714,GO:0034356,0.26840804615109,0.926065221914613,2,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,NAPRT;PARP9
8574,GO:0034040,0.268446270724466,0.972590003008798,1,3,lipid-transporting ATPase activity,MF,ABCG1
10246,GO:0042979,0.268458304660527,0.9694245657381,1,4,ornithine decarboxylase regulator activity,MF,AZIN2
17937,GO:1902267,0.268458304660527,0.9694245657381,1,4,regulation of polyamine transmembrane transport,BP,AZIN2
11272,GO:0045577,0.268678757691001,0.899226456723654,3,21,regulation of B cell differentiation,BP,MMP14;XBP1;CARD11
4845,GO:0014052,0.26918303562393,0.972428050827087,1,3,regulation of gamma-aminobutyric acid secretion,BP,NTSR1
17923,GO:1902236,0.269329628451982,0.924953451422063,2,13,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,XBP1;WFS1
8842,GO:0034629,0.269402326050804,0.898458121819726,3,22,cellular protein-containing complex localization,BP,DLG1;NACC2;WASL
1522,GO:0003886,0.26941527635094,0.972376886923637,1,3,DNA (cytosine-5-)-methyltransferase activity,MF,DNMT3A
8093,GO:0032776,0.26941527635094,0.972376886923637,1,3,DNA methylation on cytosine,BP,DNMT3A
16127,GO:0090116,0.26941527635094,0.972376886923637,1,3,C-5 methylation of cytosine,BP,DNMT3A
3420,GO:0007205,0.269626074196466,0.89909041225415,3,20,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,F2R;DGKA;LRP1
8520,GO:0033743,0.269708351538124,0.969119136984749,1,4,peptide-methionine (R)-S-oxide reductase activity,MF,MSRB2
2375,GO:0005504,0.269765246373043,0.924166069406528,2,14,fatty acid binding,MF,PPARA;PPARG
12796,GO:0051090,0.270300473577929,0.791992003109816,29,302,regulation of DNA binding transcription factor activity,BP,CTNNBIP1;PRNP;ADGRF1;DDIT3;CRTC1;DAP;PKD2;RBCK1;ANXA3;BTRC;MDFI;TRIM5;CTH;LRP5;CEBPG;JMY;THRA;TMSB4X;EIF2AK2;IL1RAP;CARD11;PPARG;ADAM8;WFS1;LRP6;ARID5B;PTCH1;UFL1;TRIM38
18072,GO:1902652,0.270372081682495,0.826753900640703,11,104,secondary alcohol metabolic process,BP,SORL1;VLDLR;CYP27B1;LMF1;PLPP6;APOE;FGFR1;ABCG1;LRP5;HSD17B7;OSBPL5
8049,GO:0032703,0.270395533007464,0.92514891390853,2,12,negative regulation of interleukin-2 production,BP,PRNP;IL20RB
4190,GO:0009267,0.270630327591274,0.822837716479073,12,114,cellular response to starvation,BP,GLUL;DAP;IMPACT;ATF4;ASNS;CPEB4;WNT2B;XBP1;SLC38A2;GABARAPL2;EIF2AK2;IFI16
8496,GO:0033668,0.271194078965506,0.968753866973312,1,4,negative regulation by symbiont of host apoptotic process,BP,BCL2L1
13302,GO:0052041,0.271194078965506,0.968753866973312,1,4,negative regulation by symbiont of host programmed cell death,BP,BCL2L1
13356,GO:0052490,0.271194078965506,0.968753866973312,1,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,BCL2L1
12600,GO:0050776,0.271211301384977,0.776425764524502,52,577,regulation of immune response,BP,TNIP1;PRNP;PAG1;NR1D1;PKN1;PTPRS;PSMD2;FCGRT;WIPF1;FYN;CTSB;ARG2;SHC1;PAK1;SERPING1;RAC2;FKBP1A;PRKACB;RBCK1;BTRC;CEACAM1;MAPKAPK3;TRIM5;CD46;CTSL;PPP3CB;F2RL1;DDX60;PSMD7;PARP9;CD99;IFITM1;WASF2;SKAP2;XBP1;C5;NCKAP1;PUM2;RNF135;COL1A2;PRKACA;IFI16;SLC39A10;CARD11;ARPC1A;PPARG;ADAM8;IL20RB;ITGA4;WASL;TMEM173;FADD
4434,GO:0010273,0.271246379523062,0.966829893571353,1,5,detoxification of copper ion,BP,MT2A
19465,GO:1990169,0.271246379523062,0.966829893571353,1,5,stress response to copper ion,BP,MT2A
5922,GO:0018197,0.271524358646263,0.971909741829918,1,3,peptidyl-aspartic acid modification,BP,ASPH
12899,GO:0051241,0.27160588444448,0.77215370874508,63,679,negative regulation of multicellular organismal process,BP,DOCK4;XDH;PLAT;F2R;SORL1;SERPINE2;PRNP;BBS2;NFATC4;THBS2;APLN;DDIT3;PTPRS;EGFR;STK39;SEMA4B;ADAMTS7;IDH2;WNT7A;MAP4K4;GDI1;ARG2;DKK1;PAK1;SOCS2;TRIB2;TGFBR2;SERPING1;APOE;ACP5;PRKACB;LRP1;WWC3;FGFR1;ULK2;INPP5F;PFN2;CEACAM1;FERMT1;EPN2;LRP5;CST3;ADGRB2;F2RL1;PROCR;PTHLH;ASAP1;SPRY2;NGFR;UBASH3B;LOXL2;PDE5A;RNF135;TMSB4X;LPAR1;CTSZ;PPARG;IL20RB;OMG;PTCH1;JARID2;SEMA3F;LRP4
7097,GO:0030893,0.27176529336479,0.971856089273719,1,3,meiotic cohesin complex,CC,REC8
18368,GO:1903364,0.272001393986306,0.821671768163057,12,116,positive regulation of cellular protein catabolic process,BP,EDEM1;TRIB2;APOE;LRP1;DVL1;TRIB3;VPS11;XBP1;ANKIB1;MAGEF1;RNF180;FBXL5
13098,GO:0051610,0.272012156454354,0.971801055333435,1,3,serotonin uptake,BP,NOS1
20101,GO:2000772,0.272171228000059,0.878856841897964,4,31,regulation of cellular senescence,BP,ARG2;HMGA2;NEK6;AKT3
18152,GO:1902894,0.272326391486717,0.926107115710158,2,10,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,NFATC4;PPARA
20076,GO:2000726,0.272545186064677,0.924988891905711,2,11,negative regulation of cardiac muscle cell differentiation,BP,DKK1;PAK1
3447,GO:0007257,0.272579954209509,0.879364581359857,4,28,activation of JUN kinase activity,BP,PKN1;ERCC6;TAOK1;MAP4K2
511,GO:0001574,0.272585534400237,0.968409546149737,1,4,ganglioside biosynthetic process,BP,ST3GAL5
13678,GO:0060211,0.272864306469516,0.924841851809535,2,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,TNRC6B;TNRC6C
13680,GO:0060213,0.272864306469516,0.924841851809535,2,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,TNRC6B;TNRC6C
16262,GO:0090315,0.27308624026211,0.968285116387891,1,4,negative regulation of protein targeting to membrane,BP,GDI1
2206,GO:0005092,0.273159164052468,0.923164290978552,2,13,GDP-dissociation inhibitor activity,MF,GDI1;RGS14
8057,GO:0032722,0.273174472286179,0.877794275451623,4,33,positive regulation of chemokine production,BP,POSTN;ALOX15B;C5;EIF2AK2
15385,GO:0071630,0.273188058030572,0.971538056533556,1,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,KLHL15
15409,GO:0071671,0.273209946337308,0.96825433123512,1,4,regulation of smooth muscle cell chemotaxis,BP,LPAR1
12592,GO:0050768,0.273371847350109,0.803083639588385,19,178,negative regulation of neurogenesis,BP,SORL1;NFATC4;PTPRS;SEMA4B;IDH2;WNT7A;MAP4K4;GDI1;APOE;LRP1;ULK2;INPP5F;ASAP1;NGFR;LPAR1;CTSZ;OMG;SEMA3F;LRP4
18180,GO:1902949,0.273549126698497,0.968169836059299,1,4,positive regulation of tau-protein kinase activity,BP,DKK1
13624,GO:0060117,0.273562424254785,0.924519725420155,2,11,auditory receptor cell development,BP,SLITRK6;FGFR1
10163,GO:0042747,0.273571778038826,0.968164188674497,1,4,circadian sleep/wake cycle, REM sleep,BP,CST3
12797,GO:0051091,0.273674064714767,0.804472780516929,18,181,positive regulation of DNA binding transcription factor activity,BP,ADGRF1;DDIT3;CRTC1;RBCK1;ANXA3;TRIM5;CTH;LRP5;CEBPG;JMY;EIF2AK2;IL1RAP;CARD11;PPARG;ADAM8;LRP6;ARID5B;TRIM38
3380,GO:0007157,0.273778890186697,0.896332712878325,3,21,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,ADGRL1;CADM4;TENM2
18835,GO:1904428,0.273874155505923,0.971383954901684,1,3,negative regulation of tubulin deacetylation,BP,BEX4
2956,GO:0006487,0.274083519035478,0.838399739033321,8,78,protein N-linked glycosylation,BP,UBE2J1;MCFD2;ST3GAL5;LMAN1;GFPT1;SRD5A3;ST6GALNAC2;STT3B
8065,GO:0032733,0.274138453182944,0.922104876143054,2,14,positive regulation of interleukin-10 production,BP,CD46;IL20RB
7928,GO:0032504,0.274193662382827,0.777654306157076,44,461,multicellular organism reproduction,BP,ERCC1;ETV5;NEURL1;CYP27B1;SERPINE2;ADCY7;OSBP2;BBS2;CCNI;MICALCL;EGFR;SCMH1;UBE2J1;MYCBPAP;CTSB;CRTAP;TCFL5;ATRX;GAMT;BSG;EPOR;FAM50A;RFX2;PRKAR1A;THRA;ZNF449;SPESP1;AZIN2;BCL2L1;SPIRE1;TXNRD3;SPIN4;REC8;SPATA6;PDE5A;MLH3;SH3PXD2B;PRKACA;ARID4A;CLDN11;HSPA2;SEPT6;ADNP;DNMT3A
9808,GO:0040036,0.27420434060143,0.896089876107846,3,21,regulation of fibroblast growth factor receptor signaling pathway,BP,APLN;FAM20C;SPRY2
14263,GO:0061318,0.274264281236298,0.924195241426954,2,11,renal filtration cell differentiation,BP,PODXL;LAMB2
15626,GO:0072112,0.274264281236298,0.924195241426954,2,11,glomerular visceral epithelial cell differentiation,BP,PODXL;LAMB2
15739,GO:0072311,0.274264281236298,0.924195241426954,2,11,glomerular epithelial cell differentiation,BP,PODXL;LAMB2
17346,GO:1900028,0.274296477322979,0.967983205402807,1,4,negative regulation of ruffle assembly,BP,PFN2
2662,GO:0006006,0.274391643667458,0.813480586682789,14,135,glucose metabolic process,BP,PCK2;IGFBP4;NR1D1;H6PD;PC;PGM1;ATF4;PPARA;LRP5;SLC35B4;MLYCD;IGF2;KAT2B;OAS1
1656,GO:0004111,0.274415090738708,0.967953527455723,1,4,creatine kinase activity,MF,MAP4K4
4152,GO:0009214,0.274563140224379,0.925086790490377,2,10,cyclic nucleotide catabolic process,BP,RAPGEF3;PDE5A
6945,GO:0030553,0.274658529596633,0.971207191021173,1,3,cGMP binding,MF,PDE5A
5342,GO:0016080,0.274727158422848,0.971191695153071,1,3,synaptic vesicle targeting,BP,SEPT5
19331,GO:1905651,0.275116879192908,0.971103607828333,1,3,regulation of artery morphogenesis,BP,AKT3
19332,GO:1905653,0.275116879192908,0.971103607828333,1,3,positive regulation of artery morphogenesis,BP,AKT3
464,GO:0001502,0.275225011047159,0.923750046725538,2,11,cartilage condensation,BP,WNT7A;THRA
16840,GO:0098743,0.275225011047159,0.923750046725538,2,11,cell aggregation,BP,WNT7A;THRA
13113,GO:0051648,0.275383662520195,0.79948885473762,20,194,vesicle localization,BP,BBS2;SNPH;SEC23A;MCFD2;FYCO1;VAMP2;PFN2;LMAN1;NLGN2;RIMS3;SYTL1;FNBP1L;SEPT5;RAB1A;CTSZ;AP3D1;MAP4K2;ITGA4;WASL;SYT2
6956,GO:0030593,0.275401728107057,0.875825958692302,4,36,neutrophil chemotaxis,BP,RAC2;ITGA1;MOSPD2;CKLF
11028,GO:0044877,0.275545798250971,0.76859191731964,63,666,protein-containing complex binding,MF,SORL1;FLNC;VLDLR;SYNE3;ITGA6;PRNP;ADM2;ACVR2B;SMARCA1;FCGRT;WIPF1;EGFR;FYN;MYH15;ERCC6;DLG4;CTSB;SNX9;ESPN;CRTAP;SHC1;WISP1;PAK1;MRC2;IMPACT;CD44;APOE;FKBP1A;LRP1;HMGA2;ITGA1;EPCAM;ITGA2;LTBP4;MTHFR;DDB2;OBSL1;MMP14;CTSL;TWF2;CSNK2A1;PHF1;JMY;CPEB4;ACVR1B;WASF2;NCKAP1;RNF135;TIMP2;FCHO1;LAMB2;SECISBP2L;RNF169;ARPC1A;IGF2;LAMA5;GRB10;WASL;SSFA2;HSD17B12;PTCH1;KAT2B;GNAI1
14462,GO:0061817,0.275668699250315,0.970978615910145,1,3,endoplasmic reticulum-plasma membrane tethering,BP,ESYT3
364,GO:0000982,0.275790997789416,0.789460826325879,27,267,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NR1D1;NFATC4;ETV4;POU2F2;TEF;DDIT3;SOX12;ELK3;HLTF;DDN;HMGA2;ATF4;PPARA;TCFL5;NFAT5;SOX4;ZNF692;RCOR1;HES2;CEBPG;PLAG1;NACC2;TSHZ1;MEF2D;ETV1;IFI16;CREB3L2
3152,GO:0006750,0.275871165015922,0.921281307120744,2,14,glutathione biosynthetic process,BP,HAGH;CHAC1
4582,GO:0010667,0.275952824342253,0.92255967498064,2,12,negative regulation of cardiac muscle cell apoptotic process,BP,PPP1R10;RGL2
1279,GO:0003073,0.276158752591372,0.86282587045014,5,41,regulation of systemic arterial blood pressure,BP,F2R;POSTN;NTSR1;F2RL1;CTSZ
13008,GO:0051434,0.276298840317484,0.967480086570602,1,4,BH3 domain binding,MF,BCL2L1
10028,GO:0042472,0.276634168528447,0.85263642329225,6,47,inner ear morphogenesis,BP,SLITRK6;FGFR1;DVL1;CHD7;SPRY2;TBX1
3031,GO:0006577,0.276678488834822,0.921503253188124,2,13,amino-acid betaine metabolic process,BP,ALDH7A1;CRAT
19925,GO:2000425,0.276973677918858,0.970681785784495,1,3,regulation of apoptotic cell clearance,BP,ABCA7
7032,GO:0030805,0.276979180078639,0.970680530566286,1,3,regulation of cyclic nucleotide catabolic process,BP,RAPGEF3
7047,GO:0030820,0.276979180078639,0.970680530566286,1,3,regulation of cAMP catabolic process,BP,RAPGEF3
8294,GO:0033121,0.276979180078639,0.970680530566286,1,3,regulation of purine nucleotide catabolic process,BP,RAPGEF3
8527,GO:0033764,0.277064186786229,0.919735465867332,2,16,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,HSD17B7;HSD17B12
6153,GO:0019470,0.277160945278685,0.967262086378065,1,4,4-hydroxyproline catabolic process,BP,ALDH4A1
19074,GO:1904956,0.277197946897618,0.967252711094556,1,4,regulation of midbrain dopaminergic neuron differentiation,BP,DKK1
12816,GO:0051121,0.277318371878649,0.967222187760032,1,4,hepoxilin metabolic process,BP,ALOX15B
12817,GO:0051122,0.277318371878649,0.967222187760032,1,4,hepoxilin biosynthetic process,BP,ALOX15B
18119,GO:1902803,0.277328696803481,0.894713255806734,3,20,regulation of synaptic vesicle transport,BP,PFN2;RIMS3;SEPT5
7914,GO:0032487,0.277464785915254,0.970569625922272,1,3,regulation of Rap protein signal transduction,BP,TIMP2
7055,GO:0030833,0.277653954953539,0.817157963489192,12,116,regulation of actin filament polymerization,BP,WIPF1;DLG1;RAC2;TMOD2;PFN2;TWF2;JMY;SPIRE1;NCKAP1;TMSB4X;ARPC1A;WASL
6704,GO:0030104,0.277810864983813,0.851664506239766,6,48,water homeostasis,BP,ADCY7;PRKACB;PRKAR1A;PRKACA;WFS1;ADCY1
8309,GO:0033141,0.277822860074068,0.967094141081556,1,4,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,RET
3622,GO:0008076,0.277833534499623,0.875506360679659,4,30,voltage-gated potassium channel complex,CC,KCNG1;DLG4;AKAP9;VAMP2
8216,GO:0032970,0.278182116791052,0.787394031135737,27,266,regulation of actin filament-based process,BP,RAPGEF3;SSH1;WIPF1;ARAP1;DLG1;PAK1;EPHA1;RAC2;LRP1;AKAP9;TMOD2;PFN2;FHOD1;TWF2;F2RL1;TAOK1;JMY;WASF2;SPIRE1;SH3PXD2B;NCKAP1;CCDC88A;TMSB4X;RHOBTB1;LPAR1;ARPC1A;WASL
4600,GO:0010715,0.278245401072646,0.922342677960207,2,11,regulation of extracellular matrix disassembly,BP,LRP1;CST3
9363,GO:0035877,0.278260528851086,0.966982822069228,1,4,death effector domain binding,MF,FADD
18725,GO:1904177,0.278345895854639,0.970367775571343,1,3,regulation of adipose tissue development,BP,SH3PXD2B
18726,GO:1904179,0.278345895854639,0.970367775571343,1,3,positive regulation of adipose tissue development,BP,SH3PXD2B
11646,GO:0046365,0.278570447495551,0.860476195480496,5,46,monosaccharide catabolic process,BP,CRYL1;PGM1;LRP5;GLB1;GALE
16526,GO:0097237,0.278626260728082,0.806919122666399,15,160,cellular response to toxic substance,BP,CYGB;ADCY7;GPX3;BNIP3;MAPK13;NET1;IMPACT;APOE;XRN1;CST3;PRDX5;TXNRD3;ITPR2;ENDOG;DNMT3A
15461,GO:0071797,0.278634790022772,0.966887459310688,1,4,LUBAC complex,CC,RBCK1
15382,GO:0071624,0.278840040036778,0.918875365325868,2,16,positive regulation of granulocyte chemotaxis,BP,RAC2;MOSPD2
8993,GO:0035102,0.279124958568601,0.921063796007297,2,12,PRC1 complex,CC,PHC3;CBX7
12741,GO:0051006,0.27914938285339,0.966756081811916,1,4,positive regulation of lipoprotein lipase activity,BP,LMF1
14285,GO:0061365,0.27914938285339,0.966756081811916,1,4,positive regulation of triglyceride lipase activity,BP,LMF1
17935,GO:1902262,0.279158148071634,0.966753841431073,1,4,apoptotic process involved in blood vessel morphogenesis,BP,LRP5
1884,GO:0004565,0.279316394723702,0.966713378835527,1,4,beta-galactosidase activity,MF,GLB1
11088,GO:0045088,0.279461449240792,0.786050355667267,27,287,regulation of innate immune response,BP,TNIP1;NR1D1;PTPRS;PSMD2;FYN;CTSB;PAK1;SERPING1;PRKACB;BTRC;CEACAM1;MAPKAPK3;TRIM5;CTSL;F2RL1;DDX60;PSMD7;PARP9;PUM2;RNF135;PRKACA;IFI16;CARD11;PPARG;ADAM8;TMEM173;FADD
12678,GO:0050886,0.279479985694698,0.860569463748039,5,41,endocrine process,BP,F2R;APLN;FGFR1;F2RL1;CTSZ
9288,GO:0035726,0.279562780800099,0.96665032331958,1,4,common myeloid progenitor cell proliferation,BP,CEACAM1
5568,GO:0016580,0.279631915921007,0.921692685708105,2,11,Sin3 complex,CC,PHF12;CSNK2A1
16404,GO:0097025,0.279890837358345,0.970011920749684,1,3,MPP7-DLG1-LIN7 complex,CC,DLG1
12938,GO:0051295,0.279947321200104,0.969998863877193,1,3,establishment of meiotic spindle localization,BP,SPIRE1
12301,GO:0048639,0.280020629934594,0.815771136171849,12,104,positive regulation of developmental growth,BP,BBS2;MAP1B;GDI1;PAK1;TGFBR2;LPAR3;FGFR1;TWF2;CHD7;SH3PXD2B;SYT2;ADNP
15171,GO:0071295,0.280028563935471,0.893161803327918,3,20,cellular response to vitamin,BP,CYP27B1;POSTN;PPARG
12750,GO:0051018,0.280164944610755,0.860827523445159,5,37,protein kinase A binding,MF,AKAP9;PRKAR1A;WASF2;PRKACA;PJA2
6500,GO:0021869,0.280201684588434,0.96994002411568,1,3,forebrain ventricular zone progenitor cell division,BP,FGFR1
9971,GO:0042359,0.280261741919707,0.919176881580459,2,14,vitamin D metabolic process,BP,CYP27B1;FGFR1
977,GO:0002431,0.280272853143321,0.841138343247089,7,61,Fc receptor mediated stimulatory signaling pathway,BP,WIPF1;FYN;PAK1;WASF2;NCKAP1;ARPC1A;WASL
1023,GO:0002524,0.280431838014803,0.966427365301475,1,4,hypersensitivity,BP,IL20RB
6809,GO:0030260,0.280602358790092,0.823002629906221,10,94,entry into host cell,BP,EXOC2;EGFR;CTSB;IDE;ITGB5;ITGA2;TRIM5;CD46;IFITM1;TRIM38
10875,GO:0044409,0.280602358790092,0.823002629906221,10,94,entry into host,BP,EXOC2;EGFR;CTSB;IDE;ITGB5;ITGA2;TRIM5;CD46;IFITM1;TRIM38
13196,GO:0051806,0.280602358790092,0.823002629906221,10,94,entry into cell of other organism involved in symbiotic interaction,BP,EXOC2;EGFR;CTSB;IDE;ITGB5;ITGA2;TRIM5;CD46;IFITM1;TRIM38
13203,GO:0051828,0.280602358790092,0.823002629906221,10,94,entry into other organism involved in symbiotic interaction,BP,EXOC2;EGFR;CTSB;IDE;ITGB5;ITGA2;TRIM5;CD46;IFITM1;TRIM38
4628,GO:0010749,0.280655651883484,0.969834845575281,1,3,regulation of nitric oxide mediated signal transduction,BP,EGFR
18497,GO:1903626,0.280713513244475,0.966354917849935,1,4,positive regulation of DNA catabolic process,BP,ENDOG
562,GO:0001702,0.280809614561687,0.893704265185567,3,18,gastrulation with mouth forming second,BP,ACVR2B;LRP5;LRP6
13186,GO:0051792,0.281026512098019,0.966274308594203,1,4,medium-chain fatty acid biosynthetic process,BP,ACOT7
13236,GO:0051899,0.281040980860275,0.849106846743477,6,50,membrane depolarization,BP,FHL1;SCN8A;ANK3;PTPN3;NTSR1;BOK
2685,GO:0006047,0.281041405845749,0.919421684503018,2,13,UDP-N-acetylglucosamine metabolic process,BP,GFPT1;UAP1
4302,GO:0009750,0.281058181985523,0.966266146201106,1,4,response to fructose,BP,XBP1
15925,GO:0072708,0.281068183106517,0.966263568340609,1,4,response to sorbitol,BP,MAPK13
11398,GO:0045780,0.281211893942886,0.920948976280456,2,11,positive regulation of bone resorption,BP,EGFR;ADAM8
11863,GO:0046852,0.281211893942886,0.920948976280456,2,11,positive regulation of bone remodeling,BP,EGFR;ADAM8
3146,GO:0006741,0.281300593859066,0.966203630909322,1,4,NADP biosynthetic process,BP,IDH2
9036,GO:0035250,0.281590614194181,0.891113267195514,3,23,UDP-galactosyltransferase activity,MF,B4GALT6;B3GNT3;WDFY3
3452,GO:0007264,0.281595211637541,0.770071855094025,46,457,small GTPase mediated signal transduction,BP,DOCK4;F2R;RAB3B;ASAP2;RAPGEF3;ARHGAP22;APPL2;RIN2;ARHGAP12;ARAP1;NET1;GDI1;SHC1;PAK1;RASA3;RALGAPA2;RAC2;OBSCN;APOE;MAPKAPK3;RAB31;RALGAPA1;DNMBP;DOCK9;F2RL1;ASAP1;SPRY2;NGFR;WASF2;RAB43;NCKAP1;DOCK11;PAK6;PSD3;COL1A2;SHC2;RGL2;TIMP2;RAB1A;RHOBTB1;LPAR1;ARHGAP29;ACAP2;RAPGEFL1;RALGDS;RALGPS2
9858,GO:0042107,0.281611906596298,0.839881442403466,7,64,cytokine metabolic process,BP,TNFSF15;UBE2J1;IGF2BP3;TRIB2;CEBPG;IL1RAP;CARD11
17665,GO:1901522,0.281661455809593,0.892219146680411,3,20,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,ATF4;CHD6;XBP1
11894,GO:0046914,0.281803812667052,0.761324064403007,68,729,transition metal ion binding,MF,XDH;NOS1;PCK2;MMP1;CYGB;CYP27B1;PRNP;NR1D1;ALOX15B;MARCH9;TRIM65;LTA4H;LOXL1;HLTF;GLUL;GLO1;SEC23A;ARG2;RAG1;LCN2;ATP7B;ACP5;IDE;ZCCHC14;PPARA;MARCH4;RNPEPL1;GALNT3;FAM20C;CHURC1;APOBEC3C;MT2A;TRIM5;TCEA1;MMP14;ZMYM3;NPEPL1;RABGGTA;L3MBTL3;APLP2;PHC3;AEBP1;MSRB2;LACTB2;THRA;MTA1;RNF165;TRIM7;NFU1;CYP4F22;LOXL2;TIMP2;NR2F6;MMP10;BLVRA;ZMYM2;PPARG;USP20;ADAM8;ZNF92;MARCH2;TRIM2;TET1;AOX1;PPM1M;ADNP;TRIM38;FBXL5
15285,GO:0071467,0.281940947382119,0.918989425988809,2,13,cellular response to pH,BP,IMPACT;HYAL1
761,GO:0002002,0.281991163074553,0.966025175923467,1,4,regulation of angiotensin levels in blood,BP,CTSZ
762,GO:0002003,0.281991163074553,0.966025175923467,1,4,angiotensin maturation,BP,CTSZ
7157,GO:0031017,0.282015206333856,0.966018952992834,1,4,exocrine pancreas development,BP,XBP1
16627,GO:0097479,0.282139961478219,0.827104477550239,9,79,synaptic vesicle localization,BP,SNPH;VAMP2;PFN2;NLGN2;RIMS3;SYTL1;SEPT5;AP3D1;SYT2
12703,GO:0050921,0.282255907592357,0.832371320214429,8,76,positive regulation of chemotaxis,BP,PGF;RAC2;FGFR1;ITGA2;MOSPD2;F2RL1;TMSB4X;LPAR1
17493,GO:1900449,0.282412578393577,0.891784433047401,3,20,regulation of glutamate receptor signaling pathway,BP,DLG4;SHANK2;NLGN2
2124,GO:0004920,0.282831908552051,0.965807182765189,1,4,interleukin-10 receptor activity,MF,IL20RB
13563,GO:0060026,0.282832700413629,0.920182701154948,2,11,convergent extension,BP,DVL1;LRP6
17213,GO:0106071,0.283027549924986,0.969281838237039,1,3,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1
9310,GO:0035766,0.283110737066609,0.96926233731039,1,3,cell chemotaxis to fibroblast growth factor,BP,FGFR1
9312,GO:0035768,0.283110737066609,0.96926233731039,1,3,endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
19018,GO:1904847,0.283110737066609,0.96926233731039,1,3,regulation of cell chemotaxis to fibroblast growth factor,BP,FGFR1
19969,GO:2000544,0.283110737066609,0.96926233731039,1,3,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,FGFR1
12669,GO:0050873,0.283163231320087,0.890194401211375,3,23,brown fat cell differentiation,BP,ITGA6;BNIP3;ZNF516
1291,GO:0003104,0.283189700277844,0.965714169108139,1,4,positive regulation of glomerular filtration,BP,F2RL1
5324,GO:0016050,0.283264161106158,0.778760434554033,31,319,vesicle organization,BP,F2R;SERPINE2;TBC1D14;DYSF;DLG4;SNX9;EVI5L;SEC23A;SDC1;MCFD2;VAMP2;LMAN1;CLCN3;SEC22C;VPS11;RFX2;SYTL1;FNBP1L;USP6NL;TBC1D2B;MVB12A;STX10;RAB1A;SNX30;CTSZ;AP3D1;SNX6;EVI5;TBC1D16;WASL;SYT2
17458,GO:1900245,0.283685176954747,0.96912747955834,1,3,positive regulation of MDA-5 signaling pathway,BP,DDX60
2210,GO:0005096,0.283712288380136,0.786433118914022,24,225,GTPase activator activity,MF,DOCK4;ASAP2;ARHGAP22;APPL2;TBC1D14;RIN2;ARHGAP12;ARAP1;EVI5L;GDI1;RASA3;RALGAPA2;RGS14;SRGAP2B;RALGAPA1;ASAP1;USP6NL;TBC1D2B;RIN1;ARHGAP29;EVI5;DEPDC1;ACAP2;TBC1D16
10813,GO:0044300,0.28379840884706,0.969100856337668,1,3,cerebellar mossy fiber,CC,DLG4
6742,GO:0030160,0.283812241635689,0.969097603041859,1,3,GKAP/Homer scaffold activity,MF,SHANK2
14652,GO:0070236,0.283864378531206,0.965538379892552,1,4,negative regulation of activation-induced cell death of T cells,BP,FADD
10815,GO:0044302,0.283957834832334,0.969063349307283,1,3,dentate gyrus mossy fiber,CC,MAP1B
9897,GO:0042180,0.284106286053868,0.802344408652645,15,162,cellular ketone metabolic process,BP,NR1D1;PSMD2;TYSND1;GLO1;CBR4;HAGH;PPARA;LONP2;KDSR;CEACAM1;TRIB3;MLYCD;PSMD7;PPARG;COQ2
20211,GO:2001137,0.284375543405443,0.968964952567157,1,3,positive regulation of endocytic recycling,BP,SORL1
17195,GO:0106017,0.284770171985306,0.96887182579401,1,3,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,INPP4A
16190,GO:0090209,0.28480047923002,0.965293618489788,1,4,negative regulation of triglyceride metabolic process,BP,APOE
12243,GO:0048515,0.28495202624808,0.830613957694006,8,72,spermatid differentiation,BP,NEURL1;OSBP2;BBS2;UBE2J1;RFX2;REC8;PRKACA;HSPA2
11089,GO:0045089,0.285130123202933,0.786202514375884,23,242,positive regulation of innate immune response,BP,TNIP1;NR1D1;PTPRS;PSMD2;FYN;CTSB;PAK1;PRKACB;BTRC;MAPKAPK3;TRIM5;CTSL;F2RL1;DDX60;PSMD7;PARP9;PUM2;PRKACA;IFI16;CARD11;ADAM8;TMEM173;FADD
16846,GO:0098754,0.285211724160727,0.836412775859115,7,75,detoxification,BP,CYGB;GPX3;APOE;MT2A;PRDX5;TXNRD3;SLC30A1
9432,GO:0036003,0.285299212388874,0.888941509034965,3,23,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,DDIT3;ATF4;CHD6
7597,GO:0031968,0.285317111788692,0.79904888390907,16,163,organelle outer membrane,CC,SYNE3;CYP27B1;FAM210B;ARMCX2;BNIP3;BNIP3L;ITPR3;SPATA18;BOK;BPHL;BCL2L1;MOAP1;TMEM173;SIGMAR1;ARMCX3;SLC44A1
6315,GO:0019960,0.285702050114189,0.968651271713327,1,3,C-X3-C chemokine binding,MF,ITGA4
3107,GO:0006684,0.285854582402922,0.917096518399209,2,13,sphingomyelin metabolic process,BP,SPTLC2;SAMD8
3128,GO:0006707,0.285933854904544,0.964995939202325,1,4,cholesterol catabolic process,BP,APOE
5356,GO:0016127,0.285933854904544,0.964995939202325,1,4,sterol catabolic process,BP,APOE
11775,GO:0046633,0.285936980381817,0.917056450186866,2,13,alpha-beta T cell proliferation,BP,ARG2;TGFBR2
14170,GO:0061052,0.286006143297441,0.96497690304543,1,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,PAK1
18444,GO:1903527,0.286073112701995,0.968563197605538,1,3,positive regulation of membrane tubulation,BP,ASAP1
11857,GO:0046839,0.286108496757527,0.870467477624788,4,29,phospholipid dephosphorylation,BP,PLPP6;INPP5F;PLPPR2;MTMR4
3235,GO:0006888,0.286141666318615,0.796128346101802,17,170,ER to Golgi vesicle-mediated transport,BP,SORL1;LMF1;ANK3;SEC23A;MCFD2;LMAN1;SEC22C;COPB1;COPG1;ARF4;TMED4;RAB1A;BCAP29;CTSZ;CREB3L2;DDHD2;COG8
6975,GO:0030638,0.286163639710353,0.962804098143871,1,5,polyketide metabolic process,BP,CBR4
6979,GO:0030647,0.286163639710353,0.962804098143871,1,5,aminoglycoside antibiotic metabolic process,BP,CBR4
10939,GO:0044597,0.286163639710353,0.962804098143871,1,5,daunorubicin metabolic process,BP,CBR4
10940,GO:0044598,0.286163639710353,0.962804098143871,1,5,doxorubicin metabolic process,BP,CBR4
9549,GO:0036309,0.286164833463963,0.975962134357775,1,2,protein localization to M-band,BP,OBSCN
17723,GO:1901652,0.286316550661449,0.774309890488535,33,338,response to peptide,BP,PCK2;ADCY7;PRNP;EIF4EBP1;HADH;FYN;SHC1;PAK1;SOCS2;PRKACB;LRP1;IDE;PPARA;VAMP2;CEACAM1;RAB31;BSG;LRP5;TRIB3;CASP4;PRKAR1A;NGFR;XBP1;PRKACA;IGF2;GRB10;PPARG;ATP6V1B2;LRP6;EEF2K;ADCY1;KAT2B;GNAI1
5476,GO:0016409,0.286343032792597,0.869343966933135,4,33,palmitoyltransferase activity,MF,SPTLC2;ZDHHC2;CPT2;ZDHHC1
15370,GO:0071608,0.286350869430691,0.964886042049974,1,4,macrophage inflammatory protein-1 alpha production,BP,ARG2
15393,GO:0071640,0.286350869430691,0.964886042049974,1,4,regulation of macrophage inflammatory protein 1 alpha production,BP,ARG2
6430,GO:0021696,0.286645377730882,0.889802151323506,3,19,cerebellar cortex morphogenesis,BP,SERPINE2;MAP2K1;WNT7A
12753,GO:0051021,0.286648074386518,0.964807597423438,1,4,GDP-dissociation inhibitor binding,MF,PLXNB3
12754,GO:0051022,0.286648074386518,0.964807597423438,1,4,Rho GDP-dissociation inhibitor binding,MF,PLXNB3
8076,GO:0032755,0.286769363058163,0.855260020376992,5,43,positive regulation of interleukin-6 production,BP,F2R;MAPK13;F2RL1;XBP1;IL1RAP
15486,GO:0071838,0.286774918137062,0.964774087390637,1,4,cell proliferation in bone marrow,BP,HMGA2
4100,GO:0009154,0.286893018917779,0.888356128483239,3,22,purine ribonucleotide catabolic process,BP,NT5E;RAPGEF3;PDE5A
8734,GO:0034381,0.286923700199677,0.868761532837655,4,34,plasma lipoprotein particle clearance,BP,VLDLR;LMF1;APOE;AP2A2
19743,GO:2000117,0.287185367529143,0.828562196713222,8,77,negative regulation of cysteine-type endopeptidase activity,BP,TNFRSF6B;RAG1;CD44;CST3;PRDX5;CSNK2A1;NGFR;IFI16
10554,GO:0043507,0.287347277921761,0.83632993013801,7,57,positive regulation of JUN kinase activity,BP,PKN1;ERCC6;DKK1;PAK1;TAOK1;MAP4K2;FZD8
6944,GO:0030552,0.287458827929474,0.917976922441037,2,11,cAMP binding,MF,RAPGEF3;PRKAR1A
859,GO:0002190,0.287496056845769,0.962431639953792,1,5,cap-independent translational initiation,BP,EIF4EBP1
3398,GO:0007176,0.287497160971834,0.888000496018247,3,22,regulation of epidermal growth factor-activated receptor activity,BP,NEURL1;SHC1;SNX6
11448,GO:0045898,0.28758356834202,0.916253894513529,2,13,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,ATF7IP;THRA
10545,GO:0043492,0.28759520632928,0.823106835870822,9,76,ATPase activity, coupled to movement of substances,MF,ATP7B;ABCD1;ABCA7;ABCG1;ATP10D;PCYOX1;ATP12A;ATP6V1B2;ATP11B
18014,GO:1902498,0.28760357651627,0.968198411674702,1,3,regulation of protein autoubiquitination,BP,MTA1
4761,GO:0010940,0.287708911351974,0.962371942164462,1,5,positive regulation of necrotic cell death,BP,BNIP3
13507,GO:0055076,0.28772975747955,0.817110033985265,10,100,transition metal ion homeostasis,BP,PRNP;LCN2;ATP7B;MT2A;SLC22A17;SLC30A1;SFXN3;SLC39A10;AP3D1;FBXL5
3403,GO:0007183,0.287756701135907,0.917833945640901,2,11,SMAD protein complex assembly,BP,FKBP1A;ZFYVE9
2605,GO:0005903,0.287820387685133,0.835868878823479,7,58,brush border,CC,ESPN;SHANK2;ITPR3;SLC6A14;SLC38A2;FLNB;RALGDS
806,GO:0002076,0.287850403547716,0.917788945481979,2,11,osteoblast development,BP,LRP5;PTHLH
10375,GO:0043195,0.287858552149985,0.854824835065138,5,41,terminal bouton,CC,PFN2;NTSR1;SEPT5;AP3D1;SLC18A2
6021,GO:0019079,0.287867985119488,0.817142845505548,10,97,viral genome replication,BP,TNIP1;ADARB1;STOM;HMGA2;APOBEC3C;IFITM1;YTHDC2;EIF2AK2;IFI16;OAS1
18611,GO:1903894,0.287971229953895,0.91606443127623,2,13,regulation of IRE1-mediated unfolded protein response,BP,DNAJB9;FICD
10027,GO:0042471,0.288195041318051,0.835484407739149,7,59,ear morphogenesis,BP,SLITRK6;FGFR1;DVL1;CHD7;SPRY2;TSHZ1;TBX1
889,GO:0002260,0.288223351970983,0.854255498689483,5,43,lymphocyte homeostasis,BP,PKN1;RAG1;PPP3CB;DOCK11;FADD
17092,GO:0099625,0.288330869212402,0.917558025532283,2,11,ventricular cardiac muscle cell membrane repolarization,BP,DLG1;AKAP9
9295,GO:0035733,0.28861816022719,0.964285054813199,1,4,hepatic stellate cell activation,BP,CYGB
1911,GO:0004601,0.288751043746655,0.885528146562287,3,28,peroxidase activity,MF,CYGB;GPX3;PRDX5
6090,GO:0019262,0.288759189754574,0.962076580905922,1,5,N-acetylneuraminate catabolic process,BP,NPL
8259,GO:0033036,0.288782897814307,0.738892783654319,200,2265,macromolecule localization,BP,EDEM1;ZMYND8;F2R;SORL1;ETV5;RAB3B;PCK2;VLDLR;SYNE3;PRNP;OSBP2;XPOT;BBS2;POSTN;SH3TC2;NR1D1;LTBP2;RAPGEF3;ACVR2B;LTBP1;ALOX15B;LMF1;MARVELD1;POU2F2;PITPNC1;SSH1;DDIT3;HADH;EXOC2;EGFR;TBC1D14;ANK3;FYN;OSBPL10;TSPAN5;KIF13B;UBE2J1;DLG1;DLG4;IDH2;SNX9;GLUL;EVI5L;WNT7A;IGF2BP3;MAP4K4;TTBK2;SEC23A;TTC7B;STRADB;NME4;MALL;GDI1;CEMIP;UNC119B;SEPT10;ARG2;STOM;DLG3;PAK1;TGFBR2;NUDCD3;RAC2;OBSCN;APOE;FKBP1A;BNIP3L;ABCD1;MCFD2;PKD2;LRP1;EHBP1;PPARA;ABCA7;ICA1;TUB;SNX14;ITGA2;VAMP2;LONP2;ATRX;ABCG1;SOX4;PITPNM1;ITPR3;VPS13A;CEP120;CEACAM1;FERMT1;OBSL1;RAB31;BSG;MDFI;TRIM5;DVL1;NTSR1;NLGN2;MVB12B;LRP5;ABHD17C;TWF2;COX18;SEC22C;CLTCL1;TOM1L2;VPS11;SEC63;PPP3CB;SYTL1;ZDHHC2;COPB1;COPG1;F2RL1;ATP10D;CSNK2A1;TST;SLC25A4;CPT2;ANO1;PARP9;FCHO2;SDCCAG3;ATXN2;NACC2;USP6NL;SEPT5;TBC1D2B;THRA;NGFR;PPP1R10;MVB12A;GLUD1;BCL2L1;GRIN3B;ARF4;XBP1;SPIRE1;ARRDC1;STX10;TCTN1;RAB43;MLH3;OSBPL5;SH3PXD2B;C5;ZFYVE9;NOP10;GABARAPL2;TMBIM1;CCDC88A;TMED4;TMSB4X;RAB1A;ZDHHC1;EPB41L3;SNX30;SEL1L;BCAP29;AP2A2;KDELR3;IL1RAP;CARD11;AP3D1;ITPR2;MOAP1;LAMA5;EFCAB7;ERLEC1;PPARG;SLC10A6;SNX6;ANKRD50;LYPLA1;TMEM50B;EVI5;ESYT3;ATP6V1B2;RPH3AL;ADAM8;ATP11B;ITGA4;ACAP2;TBC1D16;SSR3;TMEM107;WASL;FLNB;LRP6;TMEM173;SIGMAR1;SSR1;ARMCX3;FOXP1;PTCH1;SEPT6;COG8;UFL1;SNX27;GNAI1;LRP4
9087,GO:0035338,0.288817832435555,0.915649985693414,2,13,long-chain fatty-acyl-CoA biosynthetic process,BP,ELOVL1;HSD17B12
1184,GO:0002831,0.288868840176177,0.816402236784501,10,96,regulation of response to biotic stimulus,BP,HTRA1;ARG2;CEACAM1;TRIM5;F2RL1;DDX60;PARP9;PUM2;TMEM173;FOXP1
3400,GO:0007179,0.288894002204082,0.801766024782033,14,130,transforming growth factor beta receptor signaling pathway,BP,SMURF2;LTBP2;LTBP1;HTRA1;TGFBR2;FKBP1A;ITGB5;LTBP4;FERMT1;NLK;MTMR4;ZFYVE9;COL1A2;SNX6
11247,GO:0045446,0.288906792733875,0.828023225334543,8,67,endothelial cell differentiation,BP,XDH;RAPGEF3;ACVR2B;PTPRS;WNT7A;CEACAM1;F2RL1;LAMA5
14539,GO:0070050,0.288915650042873,0.964205762493423,1,4,neuron cellular homeostasis,BP,NELL2
7331,GO:0031341,0.288916192819787,0.8670857864106,4,36,regulation of cell killing,BP,CEACAM1;PPP3CB;F2RL1;FADD
4780,GO:0010966,0.288962977634735,0.967872341916641,1,3,regulation of phosphate transport,BP,FGFR1
19733,GO:2000106,0.289200452858127,0.842672109460753,6,55,regulation of leukocyte apoptotic process,BP,ARG2;RAG1;SLC39A10;ADAM8;FOXP1;FADD
8593,GO:0034092,0.289417194565843,0.967762960013846,1,3,negative regulation of maintenance of sister chromatid cohesion,BP,ATRX
8643,GO:0034183,0.289417194565843,0.967762960013846,1,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,ATRX
18838,GO:1904431,0.289484608612374,0.96405383048599,1,4,positive regulation of t-circle formation,BP,ERCC1
13274,GO:0051961,0.289504201741929,0.787556556841208,20,190,negative regulation of nervous system development,BP,SORL1;NFATC4;PTPRS;SEMA4B;IDH2;WNT7A;MAP4K4;GDI1;APOE;PRKACB;LRP1;ULK2;INPP5F;ASAP1;NGFR;LPAR1;CTSZ;OMG;SEMA3F;LRP4
19102,GO:1905031,0.289595906314473,0.967719864267632,1,3,regulation of membrane repolarization during cardiac muscle cell action potential,BP,DLG1
14055,GO:0060828,0.289680918456913,0.788949792651154,19,195,regulation of canonical Wnt signaling pathway,BP,SMURF2;IGFBP4;WWTR1;DDIT3;PSMD2;WNT7A;DKK1;APOE;BTRC;SOX4;FERMT1;DVL1;LRP5;PSMD7;WNT2B;TBL1X;LRP6;ANKRD6;LRP4
20121,GO:2000807,0.289732043388099,0.967687012738442,1,3,regulation of synaptic vesicle clustering,BP,NLGN2
13756,GO:0060332,0.289858290507711,0.967656530362684,1,3,positive regulation of response to interferon-gamma,BP,PARP9
13759,GO:0060335,0.289858290507711,0.967656530362684,1,3,positive regulation of interferon-gamma-mediated signaling pathway,BP,PARP9
15883,GO:0072610,0.289906157743767,0.963941022143771,1,4,interleukin-12 secretion,BP,FOXP1
20237,GO:2001182,0.289906157743767,0.963941022143771,1,4,regulation of interleukin-12 secretion,BP,FOXP1
4127,GO:0009186,0.290011896074453,0.961722556530686,1,5,deoxyribonucleoside diphosphate metabolic process,BP,AK9
14647,GO:0070231,0.290201379677856,0.866427449881917,4,35,T cell apoptotic process,BP,ARG2;RAG1;ADAM8;FADD
6701,GO:0030100,0.290241442158928,0.795103974251996,16,156,regulation of endocytosis,BP,TSPAN1;APLN;DLG4;MCTP1;DKK1;APOE;LRP1;ABCA7;TUB;ITGA2;DNAJC6;F2RL1;ATXN2;PPARG;WASL;EEF2K
4331,GO:0009880,0.29061009124381,0.853675484073724,5,37,embryonic pattern specification,BP,WNT7A;PCSK6;LRP6;PTCH1;SEMA3F
4571,GO:0010656,0.290676520093337,0.886121575339823,3,22,negative regulation of muscle cell apoptotic process,BP,PPP1R10;RGL2;LRP6
18940,GO:1904694,0.29070530543657,0.96745158491232,1,3,negative regulation of vascular smooth muscle contraction,BP,DOCK4
4839,GO:0014045,0.290948700440278,0.963661155425177,1,4,establishment of endothelial blood-brain barrier,BP,WNT7A
6563,GO:0022009,0.290948700440278,0.963661155425177,1,4,central nervous system vasculogenesis,BP,WNT7A
2200,GO:0005085,0.290956706455354,0.778899559866784,25,230,guanyl-nucleotide exchange factor activity,MF,DOCK4;RAPGEF3;DENND5B;EGFR;RIN2;FYN;DLG4;NET1;SHC1;OBSCN;AKAP9;FGFR1;DNMBP;DOCK9;RANBP9;ARF4;RIN1;RET;DOCK11;PSD3;SHC2;RGL2;RAPGEFL1;RALGDS;RALGPS2
15162,GO:0071279,0.290994466839742,0.963648840933925,1,4,cellular response to cobalt ion,BP,BNIP3
16207,GO:0090238,0.291113094109162,0.963616910333834,1,4,positive regulation of arachidonic acid secretion,BP,NTSR1
578,GO:0001730,0.291164285314826,0.963603126319049,1,4,2'-5'-oligoadenylate synthetase activity,MF,OAS1
15236,GO:0071392,0.291623013186487,0.885199392393579,3,23,cellular response to estradiol stimulus,BP,FAM210B;EGFR;ITGA2
16508,GO:0097205,0.291924397880476,0.914895309906677,2,12,renal filtration,BP,F2R;F2RL1
8455,GO:0033591,0.291930866882342,0.963396351152473,1,4,response to L-ascorbic acid,BP,ITGA2
4262,GO:0009607,0.2920092745117,0.759308557190269,48,549,response to biotic stimulus,BP,TNIP1;NOS1;F2R;PCK2;CYP27B1;PRSS3;ACTA2;NR1D1;ADARB1;MST1R;DDIT3;WIPF1;LOXL1;TNFRSF6B;BNIP3;HTRA1;ARG2;SHC1;LCN2;BNIP3L;ACP5;ANXA3;HMGA2;HYAL1;APOBEC3C;CEACAM1;MAPKAPK3;GSDMC;TRIM5;F2RL1;DDX60;GSDMA;PARP9;NGFR;BCL2L1;IFITM1;XBP1;PUM2;EIF2AK2;RAB1A;IFI16;WFS1;WASL;TMEM173;DNAJC3;FOXP1;OAS1;FADD
7009,GO:0030695,0.2921531402886,0.776462999357997,26,249,GTPase regulator activity,MF,DOCK4;ASAP2;ARHGAP22;APPL2;TBC1D14;RIN2;ARHGAP12;ARAP1;EVI5L;GDI1;RASA3;RALGAPA2;RGS14;SRGAP2B;RALGAPA1;ASAP1;USP6NL;TBC1D2B;RIN1;ARHGAP29;EVI5;DEPDC1;ACAP2;TBC1D16;WASL;RALGDS
9890,GO:0042168,0.292180647748525,0.884236776722916,3,25,heme metabolic process,BP,UROS;BLVRA;ALAS1
18458,GO:1903546,0.29221635579237,0.963319171075346,1,4,protein localization to photoreceptor outer segment,BP,TUB
8369,GO:0033262,0.292379240274178,0.91467218504246,2,12,regulation of nuclear cell cycle DNA replication,BP,FGFR1;ATRX
8106,GO:0032792,0.292676062418087,0.963194694593991,1,4,negative regulation of CREB transcription factor activity,BP,DDIT3
18201,GO:1902988,0.292856585885981,0.966927657125695,1,3,neurofibrillary tangle assembly,BP,SORL1
20173,GO:2001016,0.292895517579941,0.963135185803519,1,4,positive regulation of skeletal muscle cell differentiation,BP,TBX1
16836,GO:0098735,0.292899418035171,0.966917176058985,1,3,positive regulation of the force of heart contraction,BP,NOS1
3578,GO:0007622,0.29291022972663,0.884431676371555,3,23,rhythmic behavior,BP,CST3;PER3;MTA1
12240,GO:0048512,0.29291022972663,0.884431676371555,3,23,circadian behavior,BP,CST3;PER3;MTA1
1704,GO:0004197,0.293220952363974,0.824088263834898,8,75,cysteine-type endopeptidase activity,MF,CAPN2;CTSB;CTSL;CASP4;BLMH;CTSO;CTSZ;USP20
8862,GO:0034657,0.293292198501907,0.963027478130384,1,4,GID complex,CC,RMND5A
8925,GO:0034766,0.293438083812388,0.840067104908853,6,51,negative regulation of ion transmembrane transport,BP,HECW2;STK39;ANK3;PKD2;NTSR1;SLC30A1
191,GO:0000408,0.293461599424149,0.960737851127826,1,5,EKC/KEOPS complex,CC,OSGEPL1
15217,GO:0071363,0.29347662326321,0.760305874360014,44,455,cellular response to growth factor stimulus,BP,XDH;SMURF2;NOS1;POSTN;LTBP2;ACVR2B;LTBP1;APLN;EGFR;FYN;SLC33A1;ADAMTS7;HTRA1;WNT7A;SHC1;DKK1;TGFBR2;CD44;FKBP1A;PTPN12;FGFR1;ITGB5;HYAL1;GALNT3;LTBP4;FAM20C;FERMT1;NLK;EPN2;TWF2;PCSK6;MYOF;SPRY2;NGFR;RNF165;MTMR4;ZFYVE9;COL1A2;GRB10;SNX6;TBX1;ACAP2;EEF2K;LRP4
16120,GO:0090103,0.293638752412613,0.914052918894412,2,12,cochlea morphogenesis,BP,DVL1;TBX1
9820,GO:0042026,0.293683058814944,0.883638501931855,3,24,protein refolding,BP,FKBP1A;HSPA13;HSPA2
17106,GO:0099738,0.293713037123225,0.865827607314175,4,28,cell cortex region,CC,PKD2;RIMS3;CTSZ;GNAI1
18612,GO:1903895,0.293873708122519,0.962869256340424,1,4,negative regulation of IRE1-mediated unfolded protein response,BP,DNAJB9
18528,GO:1903715,0.294231322831723,0.962771759255301,1,4,regulation of aerobic respiration,BP,BNIP3
1584,GO:0003995,0.294481273617779,0.912853401107103,2,13,acyl-CoA dehydrogenase activity,MF,ACAD11;ACAD10
1648,GO:0004095,0.294539353847837,0.962687661472834,1,4,carnitine O-palmitoyltransferase activity,MF,CPT2
5482,GO:0016416,0.294539353847837,0.962687661472834,1,4,O-palmitoyltransferase activity,MF,CPT2
11008,GO:0044827,0.294596888052298,0.913580445736222,2,12,modulation by host of viral genome replication,BP,STOM;YTHDC2
4768,GO:0010952,0.294783872175574,0.796275501526213,14,151,positive regulation of peptidase activity,BP,XDH;F2R;TNFSF15;FYN;ASPH;DAP;MMP14;CASP4;BOK;NGFR;IFI16;PPARG;FAM162A;FADD
3557,GO:0007597,0.294789397086506,0.960354993496376,1,5,blood coagulation, intrinsic pathway,BP,SERPING1
11430,GO:0045843,0.294853920507253,0.864003261277157,4,32,negative regulation of striated muscle tissue development,BP,DKK1;PAK1;TGFBR2;JARID2
17791,GO:1901862,0.294853920507253,0.864003261277157,4,32,negative regulation of muscle tissue development,BP,DKK1;PAK1;TGFBR2;JARID2
3603,GO:0008037,0.294858337890043,0.830311225900524,7,61,cell recognition,BP,PEAR1;DLG1;TUB;SPESP1;CADM4;LAMA5;ROBO3
19417,GO:1990000,0.294878443121361,0.912655705164855,2,13,amyloid fibril formation,BP,APOE;FKBP1A
10512,GO:0043415,0.294907925267154,0.962586890561932,1,4,positive regulation of skeletal muscle tissue regeneration,BP,TGFBR2
10513,GO:0043416,0.294907925267154,0.962586890561932,1,4,regulation of skeletal muscle tissue regeneration,BP,TGFBR2
956,GO:0002377,0.295070798368459,0.829868351646789,7,64,immunoglobulin production,BP,ERCC1;PKN1;POU2F2;DNAJB9;POLL;XBP1;CARD11
12656,GO:0050860,0.295104199741569,0.911875976798802,2,14,negative regulation of T cell receptor signaling pathway,BP,PRNP;CEACAM1
19398,GO:1905908,0.295244672554002,0.962494682909399,1,4,positive regulation of amyloid fibril formation,BP,APOE
2699,GO:0006064,0.295379013107523,0.96018429651023,1,5,glucuronate catabolic process,BP,CRYL1
6190,GO:0019640,0.295379013107523,0.96018429651023,1,5,glucuronate catabolic process to xylulose 5-phosphate,BP,CRYL1
12849,GO:0051167,0.295379013107523,0.96018429651023,1,5,xylulose 5-phosphate metabolic process,BP,CRYL1
17565,GO:1901159,0.295379013107523,0.96018429651023,1,5,xylulose 5-phosphate biosynthetic process,BP,CRYL1
5901,GO:0018107,0.295602575313555,0.811394348009685,10,90,peptidyl-threonine phosphorylation,BP,MAP2K1;PKN1;STK39;CEMIP;TGFBR2;NLK;CSNK2A1;SPRY2;ACVR1B;PSKH1
1803,GO:0004448,0.295771308632461,0.960070490511566,1,5,isocitrate dehydrogenase activity,MF,IDH2
6896,GO:0030430,0.295792456843192,0.96234440817001,1,4,host cell cytoplasm,CC,LMAN1
8495,GO:0033655,0.295792456843192,0.96234440817001,1,4,host cell cytoplasm part,CC,LMAN1
16139,GO:0090141,0.295801924518456,0.912195232180343,2,13,positive regulation of mitochondrial fission,BP,BNIP3;DDHD2
3399,GO:0007178,0.296010379368981,0.778552381685903,22,214,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SMURF2;LTBP2;ACVR2B;LTBP1;WWTR1;SLC33A1;HTRA1;DKK1;TGFBR2;FKBP1A;ITGB5;LTBP4;FERMT1;NLK;PCSK6;ACVR1B;RNF165;MTMR4;ZFYVE9;COL1A2;SNX6;LRP4
4606,GO:0010721,0.296014456817376,0.780202841631887,21,202,negative regulation of cell development,BP,SORL1;POSTN;NFATC4;PTPRS;SEMA4B;IDH2;WNT7A;MAP4K4;GDI1;PAK1;APOE;LRP1;ULK2;INPP5F;ASAP1;NGFR;LPAR1;CTSZ;OMG;SEMA3F;LRP4
8389,GO:0033293,0.296037472439449,0.862784081767249,4,34,monocarboxylic acid binding,MF,PYGL;PC;PPARA;PPARG
12855,GO:0051173,0.296225375884782,0.732476178540248,188,2097,positive regulation of nitrogen compound metabolic process,BP,TNIP1;XDH;SMURF2;EDEM1;NOS1;ERCC1;F2R;SORL1;ETV5;CCND1;NEURL1;VLDLR;ITGA6;ADCY7;IGFBP4;PRNP;NR1D1;HECW2;NFATC4;MAP2K1;ETV4;RAPGEF3;ACVR2B;SALL2;PKN1;WWTR1;PEG3;MST1R;APLN;POU2F2;TEF;TNFSF15;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;STK39;FYN;HLTF;ERCC6;ZNF516;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;TRIB2;TGFBR2;EPHA1;IMPACT;CD44;APOE;FKBP1A;CCPG1;CCND2;PKD2;PRKACB;LRP1;IDE;AKAP9;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;LPAR3;FGFR1;ITGA1;E2F5;EPCAM;NFAT5;BTRC;LPCAT1;ITGA2;PTK6;ATRX;CHURC1;PFN2;SOX4;FHOD1;MAPKAPK3;ATF7IP;SH3D19;TRIM5;TCEA1;TNRC6B;DVL1;MMP14;LRP5;ETAA1;CST3;CNTN1;TRIB3;CASP4;VPS11;PPP3CB;RFX2;SLK;CEBPG;PLAG1;F2RL1;TAOK1;CSNK2A1;PHF1;PTHLH;CHD7;PRKAR1A;BOK;PARP9;SPRY2;THRA;ACVR1B;NGFR;PPP1R10;CHD6;MTA1;MEF2D;ARF4;XBP1;MAP2K2;PAIP1;ANKIB1;RET;PDE5A;C5;PAK6;EAPP;ETV1;CCDC88A;SHC2;PRKACA;ZNF398;TMSB4X;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;CARD11;LPAR1;TBL1X;ARID4A;IGF2;MAP4K2;EFCAB7;PPARG;CITED4;TBX1;CREB3L2;RSF1;ADAM8;WFS1;ENDOG;MAML3;FZD8;HSPA2;LRP6;MAGEF1;TMEM173;RNF180;E2F7;TNRC6C;TET1;ARMCX3;DNAJC3;PTCH1;ADCY1;KAT2B;FAM162A;ANKRD6;PBX3;JARID2;ADNP;LRP4;RB1CC1;FBXL5;FADD
14033,GO:0060762,0.296338228153588,0.962194338937343,1,4,regulation of branching involved in mammary gland duct morphogenesis,BP,ETV5
3111,GO:0006688,0.296507621439876,0.911842599121889,2,13,glycosphingolipid biosynthetic process,BP,B4GALT6;ST3GAL5
18608,GO:1903891,0.296603590704007,0.962121247785518,1,4,regulation of ATF6-mediated unfolded protein response,BP,WFS1
2723,GO:0006102,0.296623002802143,0.959822766461023,1,5,isocitrate metabolic process,BP,IDH2
9589,GO:0036438,0.296668320153586,0.962103406352256,1,4,maintenance of lens transparency,BP,STK39
311,GO:0000822,0.296672756730258,0.965986203985369,1,3,inositol hexakisphosphate binding,MF,ITPR3
9413,GO:0035976,0.296802185357289,0.959770536776937,1,5,transcription factor AP-1 complex,CC,DDIT3
10903,GO:0044448,0.296818977384501,0.795321748696955,14,127,cell cortex part,CC,RAPGEF3;EXOC2;CAPN2;WIPF1;DLG4;ASPH;SEPT10;PKD2;RIMS3;SEPT5;CTSZ;WASL;SEPT6;GNAI1
10390,GO:0043219,0.296947044345736,0.962026525660621,1,4,lateral loop,CC,DLG1
8890,GO:0034705,0.297055319298925,0.862795572390503,4,31,potassium channel complex,CC,KCNG1;DLG4;AKAP9;VAMP2
15096,GO:0071107,0.297276726764197,0.965835785021234,1,3,response to parathyroid hormone,BP,ITGA2
17614,GO:1901300,0.297338409818764,0.961918422371989,1,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
20301,GO:2001293,0.297475061122657,0.965786304950116,1,3,malonyl-CoA metabolic process,BP,MLYCD
16182,GO:0090200,0.297666910310533,0.880388237883314,3,27,positive regulation of release of cytochrome c from mitochondria,BP,BNIP3;MOAP1;FAM162A
7489,GO:0031657,0.297788915680876,0.911997758601423,2,12,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR;PKD2
2670,GO:0006021,0.297857586762714,0.961774739492706,1,4,inositol biosynthetic process,BP,ISYNA1
1082,GO:0002666,0.297919548255173,0.961757570581243,1,4,positive regulation of T cell tolerance induction,BP,TGFBR2
3290,GO:0006979,0.298029338249682,0.767453963875414,29,322,response to oxidative stress,BP,ERCC1;ETV5;CYGB;PRNP;GPX3;NAPRT;EGFR;BNIP3;ERCC6;MAPK13;NET1;MCTP1;SDC1;IMPACT;APOE;RGS14;PKD2;LDHA;ATF4;HYAL1;MMP14;CST3;PRDX5;MSRB2;CHD6;TXNRD3;SLC7A11;ENDOG;SLC23A2
6134,GO:0019400,0.298070823812366,0.910382040809835,2,14,alditol metabolic process,BP,PCK2;COQ2
3485,GO:0007350,0.298148360586925,0.911818703347565,2,12,blastoderm segmentation,BP,PCSK6;SEMA3F
5758,GO:0016918,0.298377411155099,0.959309689364271,1,5,retinal binding,MF,ALDH1A2
12959,GO:0051341,0.298425013751768,0.835962682482811,6,55,regulation of oxidoreductase activity,BP,CYGB;CYP27B1;EGFR;APOE;LYPLA1;WASL
3206,GO:0006842,0.298504288730256,0.961595324246695,1,4,tricarboxylic acid transport,BP,SLC13A3
4997,GO:0015137,0.298504288730256,0.961595324246695,1,4,citrate transmembrane transporter activity,MF,SLC13A3
5000,GO:0015142,0.298504288730256,0.961595324246695,1,4,tricarboxylic acid transmembrane transporter activity,MF,SLC13A3
5183,GO:0015746,0.298504288730256,0.961595324246695,1,4,citrate transport,BP,SLC13A3
17379,GO:1900103,0.298783772983114,0.910700768256779,2,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,BOK;XBP1
9100,GO:0035368,0.298877568698601,0.961491542552544,1,4,selenocysteine insertion sequence binding,MF,SECISBP2L
14723,GO:0070372,0.298910217210445,0.785324154903218,17,171,regulation of ERK1 and ERK2 cascade,BP,TNIP1;F2R;MAP2K1;MST1R;EGFR;DLG1;SHC1;EPHA1;CD44;RGS14;ABCA7;FGFR1;CEACAM1;RANBP9;F2RL1;SPRY2;RET
10312,GO:0043087,0.299060683586993,0.759907448198738,37,362,regulation of GTPase activity,BP,DOCK4;F2R;ASAP2;ITGA6;RAPGEF3;ARHGAP22;TBC1D14;RIN2;ARHGAP12;ARAP1;PLXNB3;SNX9;NET1;EVI5L;GDI1;RASA3;EPHA1;RALGAPA2;RGS14;SRGAP2B;RALGAPA1;DNMBP;DOCK9;F2RL1;RASIP1;ASAP1;USP6NL;SPRY2;TBC1D2B;RIN1;DOCK11;FICD;ARHGAP29;EVI5;DEPDC1;ACAP2;TBC1D16
9553,GO:0036314,0.299270965278515,0.88235307588392,3,19,response to sterol,BP,TGFBR2;LRP6;PTCH1
18461,GO:1903553,0.299525430802777,0.961311033268812,1,4,positive regulation of extracellular exosome assembly,BP,SDC1
7143,GO:0030983,0.299532219744613,0.910323825107951,2,13,mismatched DNA binding,MF,XPC;MLH3
1149,GO:0002757,0.299557976152463,0.76514832590409,30,325,immune response-activating signal transduction,BP,TNIP1;PRNP;PAG1;NR1D1;PTPRS;PSMD2;WIPF1;FYN;CTSB;PAK1;PRKACB;RBCK1;BTRC;CEACAM1;MAPKAPK3;TRIM5;CTSL;F2RL1;DDX60;PSMD7;WASF2;SKAP2;NCKAP1;PUM2;PRKACA;SLC39A10;CARD11;ARPC1A;WASL;FADD
16225,GO:0090269,0.299655888163886,0.965239465360323,1,3,fibroblast growth factor production,BP,FGFR1
16226,GO:0090270,0.299655888163886,0.965239465360323,1,3,regulation of fibroblast growth factor production,BP,FGFR1
11417,GO:0045824,0.299817623501179,0.860277106821139,4,34,negative regulation of innate immune response,BP,SERPING1;CEACAM1;IFI16;PPARG
4332,GO:0009881,0.300073665947246,0.961157898887038,1,4,photoreceptor activity,MF,ELOVL4
3153,GO:0006751,0.300427969736432,0.958705230536189,1,5,glutathione catabolic process,BP,CHAC1
4460,GO:0010453,0.300499662397893,0.90983549857288,2,13,regulation of cell fate commitment,BP,DKK1;FGFR1
19068,GO:1904949,0.300514785824378,0.81266428994075,9,81,ATPase complex,CC,SALL2;APPL2;SMARCA1;ABCA7;ATRX;CSNK2A1;NACC2;ATP12A;RSF1
3283,GO:0006970,0.3007053147873,0.834520430210745,6,53,response to osmotic stress,BP,PKN1;EGFR;STK39;MAPK13;PKD2;ITGA2
3182,GO:0006801,0.300851383662347,0.859194131152526,4,36,superoxide metabolic process,BP,EGFR;ACP5;F2RL1;SH3PXD2B
2482,GO:0005720,0.300877083538255,0.859788120363014,4,33,nuclear heterochromatin,CC,ATRX;UHRF2;SATB1;DNMT3A
15088,GO:0071072,0.301054271496587,0.960883115922797,1,4,negative regulation of phospholipid biosynthetic process,BP,LPCAT1
1295,GO:0003128,0.301182875927287,0.958481402229788,1,5,heart field specification,BP,DKK1
13051,GO:0051541,0.301289694869012,0.96081697833965,1,4,elastin metabolic process,BP,CST3
12259,GO:0048539,0.301537602997322,0.96074726311432,1,4,bone marrow development,BP,LRP5
5444,GO:0016311,0.301538093858824,0.75904622091534,35,363,dephosphorylation,BP,NT5E;SSH1;PTPRS;PPP1R14A;DLG1;DLG3;PTPN3;PLPP6;FKBP1A;ACP5;PTPN12;PPP2R3B;ELFN2;ITGA1;PPP1R35;PTPDC1;BTRC;ITGA2;INPP5F;PLPPR2;PPP3CB;INPP4A;DNAJC6;CSNK2A1;PPP1R10;PTPRZ1;NT5DC1;UBASH3B;PPP1R2;MTMR4;EIF2AK2;SLC39A10;ACP6;RCAN1;PPM1M
15241,GO:0071397,0.301731279669662,0.910996956269162,2,11,cellular response to cholesterol,BP,LRP6;PTCH1
3074,GO:0006641,0.301887320469029,0.83365279841092,6,53,triglyceride metabolic process,BP,PCK2;LMF1;APOE;MGLL;SEL1L;DDHD2
9855,GO:0042102,0.301977286362506,0.843938339531143,5,48,positive regulation of T cell proliferation,BP,TGFBR2;CD46;CARD11;IGF2;FADD
9975,GO:0042363,0.301978903049752,0.960622984851278,1,4,fat-soluble vitamin catabolic process,BP,CYP27B1
2636,GO:0005968,0.302025747358242,0.960609779198625,1,4,Rab-protein geranylgeranyltransferase complex,CC,RABGGTA
536,GO:0001654,0.30211278972119,0.771789988055706,23,220,eye development,BP,ACVR2B;SALL2;SDK2;EGFR;MYH15;DLG1;WNT7A;TGFBR2;SLITRK6;RAB11FIP4;TUB;SMOC1;LPCAT1;LRP5;CST3;CHD7;WNT2B;RET;SH3PXD2B;LAMB2;ALDH1A2;SLC7A11;LRP6
6712,GO:0030122,0.302195995236644,0.909790738458941,2,12,AP-2 adaptor complex,CC,EGFR;AP2A2
13530,GO:0055106,0.302244915503678,0.907151438484641,2,16,ubiquitin-protein transferase regulator activity,MF,TRIB2;TRIB3
12045,GO:0047844,0.302387373860628,0.958122820071599,1,5,deoxycytidine deaminase activity,MF,APOBEC3C
14187,GO:0061086,0.302396488813505,0.960505174304844,1,4,negative regulation of histone H3-K27 methylation,BP,PHF1
1456,GO:0003696,0.302396864226528,0.96050506829997,1,4,satellite DNA binding,MF,MLH3
18557,GO:1903772,0.302526501482083,0.958081286372901,1,5,regulation of viral budding via host ESCRT complex,BP,MVB12A
15723,GO:0072284,0.3026804025856,0.960424958636901,1,4,metanephric S-shaped body morphogenesis,BP,PKD2
13704,GO:0060260,0.30282822567346,0.87844833897927,3,23,regulation of transcription initiation from RNA polymerase II promoter,BP,CTNNBIP1;ATF7IP;THRA
18244,GO:1903054,0.30283655656982,0.957988639991019,1,5,negative regulation of extracellular matrix organization,BP,CST3
7109,GO:0030905,0.302877428951477,0.960369236003839,1,4,retromer, tubulation complex,CC,SNX6
6897,GO:0030431,0.303108788113302,0.907818467838102,2,14,sleep,BP,CST3;PER3
14784,GO:0070487,0.303214744274145,0.960273731056907,1,4,monocyte aggregation,BP,CD44
4667,GO:0010815,0.30324870235614,0.960264108998016,1,4,bradykinin catabolic process,BP,IDE
19393,GO:1905898,0.303491559022686,0.857825040324227,4,34,positive regulation of response to endoplasmic reticulum stress,BP,EDEM1;DDIT3;BOK;XBP1
14763,GO:0070444,0.303558802705598,0.960176178909154,1,4,oligodendrocyte progenitor proliferation,BP,PTPRZ1
14764,GO:0070445,0.303558802705598,0.960176178909154,1,4,regulation of oligodendrocyte progenitor proliferation,BP,PTPRZ1
5041,GO:0015220,0.303759420049174,0.96011923277806,1,4,choline transmembrane transporter activity,MF,SLC44A1
1993,GO:0004714,0.303792672987565,0.844269155249206,5,38,transmembrane receptor protein tyrosine kinase activity,MF,MST1R;EGFR;EPHA1;FGFR1;RET
12574,GO:0050728,0.303889986762065,0.822950738022189,7,67,negative regulation of inflammatory response,BP,NT5E;FNDC4;APOE;ACP5;PPARA;PPARG;IL20RB
1022,GO:0002523,0.303909634123728,0.957667082678651,1,5,leukocyte migration involved in inflammatory response,BP,ADAM8
13139,GO:0051704,0.304086035704717,0.728939245298637,136,1579,multi-organism process,BP,TNIP1;SMURF2;NOS1;ERCC1;F2R;ETV5;PGF;NEURL1;PCK2;MMP1;CYP27B1;SERPINE2;PRSS3;ADCY7;OSBP2;ACTA2;BBS2;NR1D1;ADARB1;MAP2K1;CCNI;MST1R;MICALCL;PC;EXOC2;CRTC1;WIPF1;EGFR;LOXL1;FYN;TNFRSF6B;BNIP3;SCMH1;UBE2J1;MYCBPAP;DLG1;DLG4;CTSB;HTRA1;CRTAP;ARG2;STOM;SHC1;TGFBR2;LCN2;SHANK2;APOE;BNIP3L;ACP5;RBCK1;IDE;RAB11FIP4;ANXA3;HMGA2;TCFL5;ITGB5;HYAL1;BTRC;ITGA2;ULK2;ATRX;APOBEC3C;VPS13A;GAMT;MAPKAPK3;GSDMC;ATF7IP;RCOR1;BSG;TRIM5;DVL1;CD46;MVB12B;EPOR;MPDZ;FAM50A;CST3;PPP3CB;RFX2;COPB1;F2RL1;DDX60;GSDMA;PTHLH;SLC25A4;PRKAR1A;PARP9;USP6NL;THRA;ACVR1B;NGFR;MVB12A;ZNF449;CHD6;SPESP1;AZIN2;BCL2L1;IFITM1;YTHDC2;WASF2;XBP1;SPIRE1;TXNRD3;MAP2K2;SATB1;SPIN4;REC8;SLC38A2;SPATA6;PDE5A;RAB43;MLH3;SH3PXD2B;NCKAP1;PUM2;PRKACA;EIF2AK2;RAB1A;IFI16;AP2A2;ARID4A;TBX1;RSF1;CLDN11;IGFBP7;WASL;HSPA2;TMEM173;DNAJC3;FOXP1;KAT2B;SEPT6;OAS1;DNMT3A;TRIM38;FADD
12657,GO:0050861,0.304189106335647,0.959997104789042,1,4,positive regulation of B cell receptor signaling pathway,BP,SLC39A10
16157,GO:0090174,0.30425557443442,0.792017895788142,13,126,organelle membrane fusion,BP,TBC1D14;DYSF;EVI5L;VAMP2;SEC22C;VPS11;SYTL1;USP6NL;TBC1D2B;STX10;EVI5;TBC1D16;SYT2
14253,GO:0061303,0.304303015193366,0.959964692428286,1,4,cornea development in camera-type eye,BP,WNT2B
971,GO:0002420,0.30433582478298,0.959955353736962,1,4,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,CEACAM1
972,GO:0002423,0.30433582478298,0.959955353736962,1,4,natural killer cell mediated immune response to tumor cell,BP,CEACAM1
1195,GO:0002855,0.30433582478298,0.959955353736962,1,4,regulation of natural killer cell mediated immune response to tumor cell,BP,CEACAM1
1198,GO:0002858,0.30433582478298,0.959955353736962,1,4,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,CEACAM1
19557,GO:1990564,0.304336624647184,0.95753873581865,1,5,protein polyufmylation,BP,UFL1
19570,GO:1990592,0.304336624647184,0.95753873581865,1,5,protein K69-linked ufmylation,BP,UFL1
8407,GO:0033363,0.304458175779373,0.878253221139526,3,21,secretory granule organization,BP,F2R;SERPINE2;RFX2
3221,GO:0006868,0.304518665448234,0.959903287992612,1,4,glutamine transport,BP,SLC38A2
5023,GO:0015186,0.304518665448234,0.959903287992612,1,4,L-glutamine transmembrane transporter activity,MF,SLC38A2
16839,GO:0098742,0.304558859424161,0.795782248139692,12,106,cell-cell adhesion via plasma-membrane adhesion molecules,BP,SDK2;ADGRL1;PCDHAC2;PLXNB3;TGFBR2;FAT1;CEACAM1;CADM4;RET;PCDH1;TENM2;CLDN11
5385,GO:0016209,0.304696007041252,0.841439301477545,5,53,antioxidant activity,MF,CYGB;GPX3;APOE;PRDX5;TXNRD3
17729,GO:1901658,0.304776112472423,0.876034833145846,3,27,glycosyl compound catabolic process,BP,NT5E;ABHD10;APOBEC3C
7149,GO:0031000,0.304798340066081,0.908475573987805,2,12,response to caffeine,BP,FKBP1A;PPARG
9536,GO:0036270,0.304798340066081,0.908475573987805,2,12,response to diuretic,BP,FKBP1A;PPARG
2773,GO:0006195,0.304879570320904,0.856894668228454,4,34,purine nucleotide catabolic process,BP,XDH;NT5E;RAPGEF3;PDE5A
11890,GO:0046906,0.305176409570548,0.822146588751865,7,65,tetrapyrrole binding,MF,NOS1;CBS;CYGB;CYP27B1;NR1D1;HEBP1;CYP4F22
6811,GO:0030262,0.305197397142934,0.876653714792934,3,24,apoptotic nuclear changes,BP,H1F0;ENDOG;DEDD2
4843,GO:0014049,0.305309154439042,0.959677734023841,1,4,positive regulation of glutamate secretion,BP,NTSR1
7104,GO:0030900,0.305330076460342,0.767527871982872,24,230,forebrain development,BP,BBS2;PTPRS;LAMB1;EGFR;FYN;BNIP3;WNT7A;DKK1;LRP1;ANXA3;FGFR1;TACC1;ATRX;CEP120;BTBD3;CSNK2A1;CHD7;WNT2B;SLC38A2;TCTN1;MBOAT7;LPAR1;ALDH1A2;LRP6
16637,GO:0097494,0.305401731095736,0.959651270400707,1,4,regulation of vesicle size,BP,RAB3B
6573,GO:0022038,0.305570835698846,0.907255649947008,2,13,corpus callosum development,BP,PTPRS;LPAR1
17090,GO:0099623,0.305603362140861,0.909057631088049,2,11,regulation of cardiac muscle cell membrane repolarization,BP,DLG1;AKAP9
17539,GO:1901068,0.305651138222302,0.841593010620367,5,46,guanosine-containing compound metabolic process,BP,DLG1;DLG4;NME4;DLG3;CARD11
5815,GO:0017080,0.305845737408882,0.876986499094297,3,22,sodium channel regulator activity,MF,NOS1;PTPN3;PRSS8
4521,GO:0010574,0.30592961729824,0.876935202156022,3,22,regulation of vascular endothelial growth factor production,BP,ATF4;C5;HPSE
11332,GO:0045655,0.306136791248324,0.906965633809359,2,13,regulation of monocyte differentiation,BP,CTNNBIP1;FOXP1
1698,GO:0004176,0.306247505075284,0.959409031304531,1,4,ATP-dependent peptidase activity,MF,LONP2
5855,GO:0017153,0.306315819285341,0.959389428408734,1,4,sodium:dicarboxylate symporter activity,MF,SLC13A3
6816,GO:0030274,0.306320061352638,0.959388210957148,1,4,LIM domain binding,MF,RPH3AL
6762,GO:0030194,0.306326669856252,0.906163526088115,2,14,positive regulation of blood coagulation,BP,F2R;HPSE
17360,GO:1900048,0.306326669856252,0.906163526088115,2,14,positive regulation of hemostasis,BP,F2R;HPSE
3238,GO:0006892,0.306333669106221,0.802822716077225,10,90,post-Golgi vesicle-mediated transport,BP,SORL1;BBS2;EXOC2;ANK3;VAMP2;VPS13A;RAB31;OSBPL5;AP3D1;LYPLA1
17515,GO:1900747,0.30650434374094,0.959335302282865,1,4,negative regulation of vascular endothelial growth factor signaling pathway,BP,XDH
18034,GO:1902548,0.30650434374094,0.959335302282865,1,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,XDH
9324,GO:0035795,0.306624052581728,0.956847329225279,1,5,negative regulation of mitochondrial membrane permeability,BP,BNIP3
19345,GO:1905709,0.306624052581728,0.956847329225279,1,5,negative regulation of membrane permeability,BP,BNIP3
12185,GO:0048313,0.306705921317644,0.905967577936822,2,14,Golgi inheritance,BP,MAP2K1;MAP2K2
8982,GO:0035088,0.306736041580535,0.856356917362266,4,31,establishment or maintenance of apical/basal cell polarity,BP,DLG1;DLG4;DLG3;ARF4
14245,GO:0061245,0.306736041580535,0.856356917362266,4,31,establishment or maintenance of bipolar cell polarity,BP,DLG1;DLG4;DLG3;ARF4
4001,GO:0008934,0.306883634144872,0.959226278939033,1,4,inositol monophosphate 1-phosphatase activity,MF,INPP5F
13430,GO:0052832,0.306883634144872,0.959226278939033,1,4,inositol monophosphate 3-phosphatase activity,MF,INPP5F
13431,GO:0052833,0.306883634144872,0.959226278939033,1,4,inositol monophosphate 4-phosphatase activity,MF,INPP5F
13432,GO:0052834,0.306883634144872,0.959226278939033,1,4,inositol monophosphate phosphatase activity,MF,INPP5F
18545,GO:1903753,0.306918255619598,0.959216318842095,1,4,negative regulation of p38MAPK cascade,BP,DLG1
13588,GO:0060055,0.307168891086262,0.906435662304797,2,13,angiogenesis involved in wound healing,BP,XBP1;HPSE
13484,GO:0055021,0.307254821568112,0.856008876414935,4,31,regulation of cardiac muscle tissue growth,BP,PAK1;TGFBR2;FGFR1;JARID2
3694,GO:0008199,0.307514627689658,0.956576386371906,1,5,ferric iron binding,MF,ACP5
4377,GO:0010008,0.307526953347992,0.754373320598297,34,367,endosome membrane,CC,SORL1;ANTXR2;APPL2;EGFR;CD68;SLC9A7;DKK1;RAB11FIP4;ABCA7;SNX14;INPP5F;RAB31;CLCN3;ANXA6;MVB12B;ABHD17C;VPS11;ZDHHC2;BOK;MVB12A;RET;MTMR4;ZFYVE9;TMBIM1;AP2A2;AP3D1;SNX6;ATP11B;ACAP2;TMEM9;MARCH2;LRP6;ZFYVE21;SNX27
13951,GO:0060632,0.307572954080048,0.905518893357868,2,14,regulation of microtubule-based movement,BP,BBS2;CCSAP
8244,GO:0033014,0.307632399822178,0.875155782450652,3,24,tetrapyrrole biosynthetic process,BP,RSAD1;UROS;ALAS1
4345,GO:0009897,0.307736149289731,0.796672713615887,11,108,external side of plasma membrane,CC,ITGA6;SERPINE2;PRNP;ANTXR2;GPC4;SDC1;TGFBR2;ITGA1;ITGA2;ABCG1;CLCN3
1905,GO:0004591,0.307772180455206,0.958970207158316,1,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,DHTKD1
9014,GO:0035184,0.307815765110404,0.958957622315943,1,4,histone threonine kinase activity,MF,PKN1
9116,GO:0035405,0.307815765110404,0.958957622315943,1,4,histone-threonine phosphorylation,BP,PKN1
7156,GO:0031016,0.30786016596714,0.84080959803632,5,41,pancreas development,BP,ACVR2B;SOX4;XBP1;ALDH1A2;WFS1
14800,GO:0070522,0.308001837653898,0.958903869469591,1,4,ERCC4-ERCC1 complex,CC,ERCC1
15565,GO:0072010,0.308146853403798,0.906770250599412,2,12,glomerular epithelium development,BP,PODXL;LAMB2
7974,GO:0032588,0.308279232662514,0.81978360649196,7,65,trans-Golgi network membrane,CC,ATP7B;RAB31;BOK;USP6NL;STX10;RAB43;COG8
5173,GO:0015727,0.308355354232997,0.958801631923402,1,4,lactate transport,BP,SLC16A3
9362,GO:0035873,0.308355354232997,0.958801631923402,1,4,lactate transmembrane transport,BP,SLC16A3
45,GO:0000097,0.308680803357241,0.90494414120214,2,14,sulfur amino acid biosynthetic process,BP,CBS;CTH
16181,GO:0090199,0.308686395409721,0.853399468372794,4,39,regulation of release of cytochrome c from mitochondria,BP,BNIP3;BCL2L1;MOAP1;FAM162A
6782,GO:0030217,0.308713017873793,0.785055309103328,14,137,T cell differentiation,BP,RAG1;TGFBR2;SOX4;CD46;PPP3CB;CHD7;XBP1;SATB1;CARD11;AP3D1;ADAM8;FZD8;FOXP1;FADD
6273,GO:0019867,0.308786756671286,0.779226375786679,16,165,outer membrane,CC,SYNE3;CYP27B1;FAM210B;ARMCX2;BNIP3;BNIP3L;ITPR3;SPATA18;BOK;BPHL;BCL2L1;MOAP1;TMEM173;SIGMAR1;ARMCX3;SLC44A1
18625,GO:1903912,0.308997471334551,0.958615550732945,1,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,DNAJC3
11266,GO:0045541,0.309388961634732,0.956002929493258,1,5,negative regulation of cholesterol biosynthetic process,BP,APOE
16187,GO:0090206,0.309388961634732,0.956002929493258,1,5,negative regulation of cholesterol metabolic process,BP,APOE
16751,GO:0098528,0.309403005418212,0.958497777007163,1,4,skeletal muscle fiber differentiation,BP,TBX1
16924,GO:0098901,0.309710101227523,0.876046841578731,3,19,regulation of cardiac muscle cell action potential,BP,ANK3;DLG1;AKAP9
15842,GO:0072553,0.309759470497914,0.958394092030195,1,4,terminal button organization,BP,NLGN2
6866,GO:0030336,0.309768701823001,0.776216673464548,17,165,negative regulation of cell migration,BP,ZMYND8;CYGB;ADARB1;ALOX15B;IDH2;PLXNB3;MCTP1;EPHA1;APOE;SRGAP2B;LRP1;PFN2;IFITM1;ABHD6;C5;PPARG;WASL
4184,GO:0009261,0.309789001918618,0.874177050985904,3,23,ribonucleotide catabolic process,BP,NT5E;RAPGEF3;PDE5A
15340,GO:0071560,0.309853568100469,0.776144077341161,17,165,cellular response to transforming growth factor beta stimulus,BP,SMURF2;POSTN;LTBP2;LTBP1;FYN;HTRA1;WNT7A;TGFBR2;FKBP1A;ITGB5;LTBP4;FERMT1;NLK;MTMR4;ZFYVE9;COL1A2;SNX6
1920,GO:0004614,0.30986920877912,0.958362141992188,1,4,phosphoglucomutase activity,MF,PGM1
4573,GO:0010658,0.30991186824029,0.87448992905257,3,22,striated muscle cell apoptotic process,BP,BNIP3;PPP1R10;RGL2
2993,GO:0006537,0.309946802461888,0.958339542116987,1,4,glutamate biosynthetic process,BP,GLUD1
13115,GO:0051650,0.310018732153192,0.771638212379134,19,188,establishment of vesicle localization,BP,BBS2;SNPH;SEC23A;MCFD2;FYCO1;VAMP2;PFN2;LMAN1;RIMS3;SYTL1;FNBP1L;SEPT5;RAB1A;CTSZ;AP3D1;MAP4K2;ITGA4;WASL;SYT2
12231,GO:0048488,0.310043847644714,0.854701216327879,4,29,synaptic vesicle endocytosis,BP,NLGN2;DNAJC6;FCHO2;SYT2
7451,GO:0031587,0.31007929561917,0.962555067432542,1,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
18637,GO:1903936,0.310224367460657,0.955745924958331,1,5,cellular response to sodium arsenite,BP,MAPK13
1869,GO:0004534,0.31026496730662,0.962506181011519,1,3,5'-3' exoribonuclease activity,MF,XRN1
19114,GO:1905048,0.310417434393846,0.904758407449861,2,13,regulation of metallopeptidase activity,BP,SORL1;TIMP2
19892,GO:2000381,0.31046711982852,0.958187809459119,1,4,negative regulation of mesoderm development,BP,DKK1
12288,GO:0048609,0.310477889599859,0.745371412106523,43,456,multicellular organismal reproductive process,BP,ERCC1;ETV5;NEURL1;CYP27B1;SERPINE2;ADCY7;OSBP2;BBS2;CCNI;MICALCL;EGFR;SCMH1;UBE2J1;MYCBPAP;CTSB;CRTAP;TCFL5;ATRX;GAMT;BSG;EPOR;FAM50A;RFX2;PRKAR1A;THRA;ZNF449;AZIN2;BCL2L1;SPIRE1;TXNRD3;SPIN4;REC8;SPATA6;PDE5A;MLH3;SH3PXD2B;PRKACA;ARID4A;CLDN11;HSPA2;SEPT6;ADNP;DNMT3A
3524,GO:0007498,0.310480523645285,0.811044143046174,8,71,mesoderm development,BP,ITGB4;ACVR2B;DKK1;HMGA2;FGFR1;ITGA2;PRKAR1A;TBX1
18170,GO:1902932,0.310481885156572,0.904724990054293,2,13,positive regulation of alcohol biosynthetic process,BP,ABCG1;NTSR1
12641,GO:0050839,0.310599681312337,0.749266390517424,37,393,cell adhesion molecule binding,MF,ITGA6;POSTN;FMNL2;MPRIP;ADGRL1;EGFR;ANK3;DLG1;SNX9;WISP1;LDHA;EPCAM;ITGA2;LTBP4;BSG;EPN2;SLC9A3R2;MMP14;NLGN2;CD46;DOCK9;TWF2;SLK;FNBP1L;ASAP1;WASF2;CADM4;PAK6;TIMP2;RAB1A;LAMB2;TENM2;LAMA5;PPL;ADAM8;ITGA4;FLNB
14206,GO:0061135,0.310675792612192,0.810093653881094,8,82,endopeptidase regulator activity,MF,SERPINE2;TFPI2;SERPING1;CST3;APLP2;PRDX5;C5;TIMP2
14636,GO:0070206,0.310685401303428,0.852768660489137,4,35,protein trimerization,BP,ATXN10;COL6A1;COL1A2;SIGMAR1
12772,GO:0051047,0.310699120345016,0.765508413279532,22,230,positive regulation of secretion,BP,F2R;PCK2;POSTN;ALOX15B;APLN;EGFR;GLUL;SDC1;FGFR1;SOX4;FERMT1;NTSR1;NLGN2;PPP3CB;F2RL1;ANO1;GLUD1;XBP1;C5;IL1RAP;RPH3AL;ADAM8
4344,GO:0009896,0.3107473403311,0.753387083890284,32,329,positive regulation of catabolic process,BP,SMURF2;EDEM1;SORL1;HECW2;RAPGEF3;TRIM65;BNIP3;SNX9;SPTLC2;TRIB2;APOE;BNIP3L;LRP1;FYCO1;IDE;PPARA;LPCAT1;SH3D19;TNRC6B;DVL1;TRIB3;VPS11;CSNK2A1;XBP1;ANKIB1;EPM2A;ADAM8;ENDOG;MAGEF1;RNF180;TNRC6C;FBXL5
3505,GO:0007411,0.310805642900823,0.771350599257949,19,171,axon guidance,BP,VLDLR;SH3KBP1;SEMA4B;FYN;PLXNB3;SHC1;DVL1;RANBP9;NGFR;RNF165;RET;ETV1;LAMB2;GRB10;GRB7;ROBO3;SEMA6C;PTCH1;SEMA3F
16557,GO:0097329,0.310853720979149,0.905380941727988,2,12,response to antimetabolite,BP,ASNS;ATRX
7642,GO:0032052,0.310960917970753,0.955518609614541,1,5,bile acid binding,MF,PYGL
13268,GO:0051955,0.311325232775286,0.904287213244137,2,13,regulation of amino acid transport,BP,STK39;NTSR1
19869,GO:2000347,0.311354264682471,0.957928359290188,1,4,positive regulation of hepatocyte proliferation,BP,XBP1
15297,GO:0071481,0.311357104853984,0.906139723755775,2,11,cellular response to X-ray,BP,CCND2;HMGA2
18822,GO:1904396,0.311655027186004,0.962138986950945,1,3,regulation of neuromuscular junction development,BP,LRP4
13894,GO:0060536,0.311729711997418,0.957818274649046,1,4,cartilage morphogenesis,BP,LRP6
14725,GO:0070374,0.311804430529545,0.789323482247074,12,117,positive regulation of ERK1 and ERK2 cascade,BP,F2R;MAP2K1;MST1R;EGFR;SHC1;EPHA1;CD44;ABCA7;FGFR1;F2RL1;SPRY2;RET
12966,GO:0051348,0.31188175835124,0.764370547345649,22,237,negative regulation of transferase activity,BP,SORL1;ADARB1;PKN1;WWTR1;SOCS2;TRIB2;EPHA1;APOE;RGS14;PTK6;CEACAM1;DVL1;LRP5;TRIB3;PRKAR1A;SPRY2;UBASH3B;PPARG;SNX6;LRP6;DNAJC3;KAT2B
5771,GO:0016972,0.31199739095517,0.957739685784385,1,4,thiol oxidase activity,MF,QSOX1
10793,GO:0044264,0.312063321355169,0.809806850262303,8,71,cellular polysaccharide metabolic process,BP,PYGL;PYGB;NR1D1;PGM1;B3GNT3;PPP1R2;IGF2;RB1CC1
16520,GO:0097227,0.312127433169965,0.957701475273433,1,4,sperm annulus,CC,SEPT6
5338,GO:0016075,0.312272555975058,0.902447066422755,2,15,rRNA catabolic process,BP,XRN1;DEDD2
15917,GO:0072687,0.312275896242803,0.957657827396125,1,4,meiotic spindle,CC,HSPA2
7447,GO:0031581,0.312289276458943,0.905662913039805,2,11,hemidesmosome assembly,BP,ITGA6;ITGB4
8406,GO:0033353,0.312363917053336,0.957631936980002,1,4,S-adenosylmethionine cycle,BP,AHCYL2
15700,GO:0072235,0.312378177407808,0.961947124488085,1,3,metanephric distal tubule development,BP,PKD2
5169,GO:0015721,0.312658650547795,0.903593127322689,2,13,bile acid and bile salt transport,BP,CEACAM1;SLC10A6
13282,GO:0051969,0.31270080070988,0.957532760432934,1,4,regulation of transmission of nerve impulse,BP,ITGA2
15701,GO:0072236,0.312728021070266,0.961854099790292,1,3,metanephric loop of Henle development,BP,PKD2
9670,GO:0038028,0.31274363712993,0.95752013990606,1,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,IGF2
15821,GO:0072521,0.312873231131207,0.749374458703149,34,393,purine-containing compound metabolic process,BP,XDH;NT5E;NOS1;ADCY7;RAPGEF3;DHTKD1;PGM1;DLG1;DLG4;ACOT7;NME4;DLG3;APOE;PKD2;LDHA;AKAP9;PPARA;FAM20C;AHCYL2;GAMT;SLC2A9;PTHLH;NDUFV3;PANK4;PDE5A;TMSB4X;TIMP2;CARD11;ATP6V1B2;AK9;AOX1;ADCY1;PANK1;ADNP
15216,GO:0071362,0.312886057800338,0.957478163922809,1,4,cellular response to ether,BP,NFATC4
16002,GO:0086010,0.313290632020405,0.873853161828202,3,19,membrane depolarization during action potential,BP,SCN8A;ANK3;PTPN3
12820,GO:0051125,0.313320985941744,0.872381146574941,3,22,regulation of actin nucleation,BP,WIPF1;NCKAP1;WASL
16578,GO:0097368,0.313376899229137,0.957333310811279,1,4,establishment of Sertoli cell barrier,BP,ARID4A
12346,GO:0048708,0.313690273585171,0.836644805662643,5,41,astrocyte differentiation,BP,SERPINE2;MAP2K1;EGFR;LRP1;LAMB2
17998,GO:1902455,0.31371769911709,0.957232566806597,1,4,negative regulation of stem cell population maintenance,BP,LOXL2
5263,GO:0015908,0.313723147418001,0.825015538962582,6,52,fatty acid transport,BP,APOE;ABCD1;PPARA;NTSR1;CPT2;PPARG
9639,GO:0036507,0.313742422421761,0.872119468773616,3,22,protein demannosylation,BP,EDEM1;SEL1L;RNF103
9640,GO:0036508,0.313742422421761,0.872119468773616,3,22,protein alpha-1,2-demannosylation,BP,EDEM1;SEL1L;RNF103
732,GO:0001961,0.313760472652458,0.851117175361009,4,33,positive regulation of cytokine-mediated signaling pathway,BP,CASP4;PARP9;AGPAT1;FADD
13158,GO:0051731,0.313925153954247,0.95717117275613,1,4,polynucleotide 5'-hydroxyl-kinase activity,MF,N4BP2
3520,GO:0007492,0.313986499959604,0.816142503841025,7,58,endoderm development,BP,LAMB1;DKK1;HMGA2;ITGB5;MMP14;COL6A1;ITGA4
1439,GO:0003418,0.314207657118329,0.957087485871342,1,4,growth plate cartilage chondrocyte differentiation,BP,TGFBR2
1443,GO:0003431,0.314207657118329,0.957087485871342,1,4,growth plate cartilage chondrocyte development,BP,TGFBR2
1785,GO:0004407,0.314279942849597,0.836043346881695,5,42,histone deacetylase activity,MF,RCOR1;NACC2;MTA1;ARID4A;PHF21A
9337,GO:0035821,0.314301395749374,0.801111836373907,9,91,modification of morphology or physiology of other organism,BP,TNIP1;PC;STOM;APOE;HMGA2;F2RL1;BCL2L1;YTHDC2;EIF2AK2
8628,GO:0034144,0.31436179509506,0.957041784634623,1,4,negative regulation of toll-like receptor 4 signaling pathway,BP,NR1D1
5705,GO:0016833,0.314411744500633,0.954444564518555,1,5,oxo-acid-lyase activity,MF,NPL
20053,GO:2000677,0.314506995851267,0.850608979865125,4,33,regulation of transcription regulatory region DNA binding,BP,DDIT3;HMGA2;PPARA;TMSB4X
3371,GO:0007140,0.314566012903414,0.871211404818055,3,23,male meiotic nuclear division,BP,REC8;MLH3;HSPA2
6857,GO:0030326,0.314798232373067,0.796057918382242,10,89,embryonic limb morphogenesis,BP,WNT7A;DKK1;FGFR1;LRP5;CHD7;ALDH1A2;TMEM107;LRP6;PTCH1;LRP4
8997,GO:0035113,0.314798232373067,0.796057918382242,10,89,embryonic appendage morphogenesis,BP,WNT7A;DKK1;FGFR1;LRP5;CHD7;ALDH1A2;TMEM107;LRP6;PTCH1;LRP4
8613,GO:0034122,0.315136119645214,0.871690301902203,3,21,negative regulation of toll-like receptor signaling pathway,BP,NR1D1;PTPRS;F2RL1
9109,GO:0035384,0.315229168336499,0.835190877236995,5,43,thioester biosynthetic process,BP,ELOVL1;CBR4;MLYCD;PPT2;HSD17B12
15376,GO:0071616,0.315229168336499,0.835190877236995,5,43,acyl-CoA biosynthetic process,BP,ELOVL1;CBR4;MLYCD;PPT2;HSD17B12
151,GO:0000306,0.31531444871905,0.956758693335505,1,4,extrinsic component of vacuolar membrane,CC,WDFY3
19176,GO:1905232,0.315565460070502,0.956683920880217,1,4,cellular response to L-glutamate,BP,FYN
10084,GO:0042584,0.315683041200222,0.956648869165564,1,4,chromaffin granule membrane,CC,SYT2
6109,GO:0019348,0.315797591215159,0.954009019931633,1,5,dolichol metabolic process,BP,SRD5A3
12298,GO:0048635,0.315867860323446,0.849680949187752,4,33,negative regulation of muscle organ development,BP,DKK1;PAK1;TGFBR2;JARID2
19411,GO:1905952,0.316204295131727,0.806312475273351,8,74,regulation of lipid localization,BP,APOE;LRP1;PPARA;ABCA7;ABCG1;NTSR1;PPARG;PTCH1
12544,GO:0050693,0.316248035190561,0.956480208432459,1,4,LBD domain binding,MF,PPARG
3571,GO:0007614,0.316350827027964,0.953834472839686,1,5,short-term memory,BP,ADNP
5932,GO:0018210,0.316369506194407,0.789893826237118,11,102,peptidyl-threonine modification,BP,MAP2K1;PKN1;STK39;CEMIP;TGFBR2;GALNT3;NLK;CSNK2A1;SPRY2;ACVR1B;PSKH1
8742,GO:0034390,0.31662797608653,0.901513054604261,2,13,smooth muscle cell apoptotic process,BP,PPARG;LRP6
8743,GO:0034391,0.31662797608653,0.901513054604261,2,13,regulation of smooth muscle cell apoptotic process,BP,PPARG;LRP6
892,GO:0002265,0.316657214537637,0.9608000566615,1,3,astrocyte activation involved in immune response,BP,LRP1
9094,GO:0035356,0.316684745145221,0.953728934069559,1,5,cellular triglyceride homeostasis,BP,XBP1
8350,GO:0033206,0.317150566560337,0.95620998829232,1,4,meiotic cytokinesis,BP,SPIRE1
20051,GO:2000675,0.317173625249778,0.956203071584376,1,4,negative regulation of type B pancreatic cell apoptotic process,BP,WFS1
6007,GO:0019049,0.31729408385723,0.956166928258941,1,4,evasion or tolerance of host defenses by virus,BP,EIF2AK2
10876,GO:0044413,0.31729408385723,0.956166928258941,1,4,avoidance of host defenses,BP,EIF2AK2
10878,GO:0044415,0.31729408385723,0.956166928258941,1,4,evasion or tolerance of host defenses,BP,EIF2AK2
13204,GO:0051832,0.31729408385723,0.956166928258941,1,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,EIF2AK2
13206,GO:0051834,0.31729408385723,0.956166928258941,1,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,EIF2AK2
1957,GO:0004661,0.31743987539513,0.953489746921249,1,5,protein geranylgeranyltransferase activity,MF,RABGGTA
2430,GO:0005610,0.317529393705964,0.960563773187577,1,3,laminin-5 complex,CC,LAMA5
16504,GO:0097199,0.317663523060382,0.953418768293896,1,5,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,CASP4
18576,GO:1903817,0.317714671246291,0.95604059453971,1,4,negative regulation of voltage-gated potassium channel activity,BP,ANK3
9561,GO:0036337,0.317830882939202,0.956005649817113,1,4,Fas signaling pathway,BP,TMBIM1
13534,GO:0055117,0.317902371219992,0.833613569372015,5,41,regulation of cardiac muscle contraction,BP,NOS1;DLG1;AKAP9;PDE5A;PRKACA
10854,GO:0044352,0.317951630319625,0.955969323922103,1,4,pinosome,CC,MMP14
10855,GO:0044354,0.317951630319625,0.955969323922103,1,4,macropinosome,CC,MMP14
5445,GO:0016312,0.317977774216101,0.955961456415651,1,4,inositol bisphosphate phosphatase activity,MF,INPP4A
11107,GO:0045124,0.317993019438397,0.869910696473962,3,21,regulation of bone resorption,BP,EGFR;UBASH3B;ADAM8
12903,GO:0051249,0.318035140090844,0.757397027648372,23,248,regulation of lymphocyte activation,BP,PRNP;PAG1;PKN1;FYN;DLG1;ARG2;PAK1;RAG1;TGFBR2;RAC2;CEACAM1;MMP14;CD46;PRKAR1A;XBP1;PDE5A;SLC39A10;CARD11;AP3D1;IGF2;ADAM8;IL20RB;FADD
10897,GO:0044440,0.318196304782348,0.74307537141703,36,393,endosomal part,CC,SORL1;ANTXR2;APPL2;EGFR;CTSB;CD68;SLC9A7;DKK1;RAB11FIP4;ABCA7;SNX14;INPP5F;RAB31;CLCN3;ANXA6;MVB12B;ABHD17C;CTSL;VPS11;ZDHHC2;BOK;MVB12A;RET;MTMR4;ZFYVE9;TMBIM1;AP2A2;AP3D1;SNX6;ATP11B;ACAP2;TMEM9;MARCH2;LRP6;ZFYVE21;SNX27
16630,GO:0097485,0.318199288893251,0.764922034094157,19,172,neuron projection guidance,BP,VLDLR;SH3KBP1;SEMA4B;FYN;PLXNB3;SHC1;DVL1;RANBP9;NGFR;RNF165;RET;ETV1;LAMB2;GRB10;GRB7;ROBO3;SEMA6C;PTCH1;SEMA3F
20186,GO:2001033,0.318527131811989,0.953144092429139,1,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,HMGA2
2220,GO:0005123,0.319262460216168,0.899372428570201,2,14,death receptor binding,MF,TMBIM1;FADD
2427,GO:0005606,0.319408719167451,0.960051773260386,1,3,laminin-1 complex,CC,LAMB1
14722,GO:0070371,0.319448854785951,0.765425662157446,18,184,ERK1 and ERK2 cascade,BP,TNIP1;F2R;MAP2K1;MST1R;EGFR;DLG1;SHC1;EPHA1;CD44;RGS14;ABCA7;FGFR1;CEACAM1;RANBP9;F2RL1;SPRY2;MAP2K2;RET
4750,GO:0010921,0.319656406245795,0.775901912586496,14,135,regulation of phosphatase activity,BP,PPP1R14A;DLG3;FKBP1A;PPP2R3B;ELFN2;ITGA1;PPP1R35;ITGA2;CSNK2A1;PPP1R10;PPP1R2;EIF2AK2;SLC39A10;RCAN1
17520,GO:1900825,0.319684507518796,0.955446057425704,1,4,regulation of membrane depolarization during cardiac muscle cell action potential,BP,ANK3
17558,GO:1901135,0.319693941990315,0.723315527598099,78,908,carbohydrate derivative metabolic process,BP,TNIP1;NT5E;EDEM1;NOS1;PYGL;ADCY7;CRYL1;RAPGEF3;LMF1;TK2;H6PD;DHTKD1;B4GALT6;UBE2J1;PGM1;ADAMTS7;DLG1;DLG4;B3GNT3;GPC4;PGLS;ACOT7;NME4;CEMIP;SDC1;DLG3;CBR4;CD44;APOE;MCFD2;PKD2;LDHA;ST3GAL5;AKAP9;PPARA;ABCA7;PIGH;ABHD10;HYAL1;GALNT3;FAM20C;AHCYL2;APOBEC3C;FBXO2;GAMT;LMAN1;CST3;GFPT1;PCSK6;PTHLH;NDUFV3;CTBS;NPL;GLB1;UAP1;PANK4;PDE5A;ADAMTSL1;TMSB4X;TIMP2;RAB1A;SEL1L;SRD5A3;ST6GALNAC2;CARD11;ACP6;ESYT3;ERP44;ATP6V1B2;AK9;HPSE;GALNS;TET1;ADCY1;RNF103;PANK1;ADNP;STT3B
9056,GO:0035278,0.319777560759061,0.900732420368071,2,12,miRNA mediated inhibition of translation,BP,TNRC6B;TNRC6C
9806,GO:0040033,0.319777560759061,0.900732420368071,2,12,negative regulation of translation, ncRNA-mediated,BP,TNRC6B;TNRC6C
11497,GO:0045974,0.319777560759061,0.900732420368071,2,12,regulation of translation, ncRNA-mediated,BP,TNRC6B;TNRC6C
18349,GO:1903319,0.319893592237107,0.899786108442301,2,13,positive regulation of protein maturation,BP,SOX4;ADAM8
14305,GO:0061438,0.319969140949551,0.955359760368022,1,4,renal system vasculature morphogenesis,BP,PKD2
14306,GO:0061439,0.319969140949551,0.955359760368022,1,4,kidney vasculature morphogenesis,BP,PKD2
11286,GO:0045596,0.320037717948,0.738584305953061,40,420,negative regulation of cell differentiation,BP,XDH;SORL1;CCND1;POSTN;NFATC4;WWTR1;DDIT3;PTPRS;EGFR;SEMA4B;ADAMTS7;IDH2;WNT7A;MAP4K4;GDI1;DKK1;PAK1;TRIB2;APOE;LRP1;PPARA;ULK2;INPP5F;ABCG1;CEACAM1;LRP5;TRIB3;PTHLH;ASAP1;NGFR;XBP1;UBASH3B;LPAR1;CTSZ;PPARG;TBX1;OMG;PTCH1;SEMA3F;LRP4
12155,GO:0048262,0.320124787124157,0.95263345710353,1,5,determination of dorsal/ventral asymmetry,BP,DDIT3
5777,GO:0016999,0.320233348439153,0.796035912199921,9,97,antibiotic metabolic process,BP,PCK2;GPX3;DHTKD1;EGFR;IDH2;CBR4;RAC2;PRDX5;NPL
5202,GO:0015800,0.320301991464616,0.847155520469334,4,31,acidic amino acid transport,BP,VAMP2;NTSR1;SLC38A2;SLC7A11
2330,GO:0005345,0.320646679799097,0.952465949995893,1,5,purine nucleobase transmembrane transporter activity,MF,SLC25A4
8626,GO:0034142,0.320878738982415,0.898508293228475,2,14,toll-like receptor 4 signaling pathway,BP,NR1D1;F2RL1
250,GO:0000710,0.321007347334152,0.955044156175429,1,4,meiotic mismatch repair,BP,ERCC1
9899,GO:0042182,0.321027072948529,0.952343640512359,1,5,ketone catabolic process,BP,HAGH
7646,GO:0032057,0.321182440221797,0.954990800611238,1,4,negative regulation of translational initiation in response to stress,BP,ATF4
6798,GO:0030239,0.321647137170422,0.847155080356161,4,28,myofibril assembly,BP,OBSCN;TMOD2;OBSL1;PRKAR1A
14768,GO:0070459,0.321777849902699,0.952101699508969,1,5,prolactin secretion,BP,EGFR
7117,GO:0030917,0.322010248541137,0.954738039732642,1,4,midbrain-hindbrain boundary development,BP,LRP6
6903,GO:0030478,0.322172223760668,0.954688485009756,1,4,actin cap,CC,WASL
4819,GO:0014013,0.322591608067414,0.808863608586683,7,64,regulation of gliogenesis,BP,ETV5;SERPINE2;IDH2;PLAG1;PTPRZ1;PPARG;UFL1
3174,GO:0006787,0.322612861278401,0.950036951526709,1,6,porphyrin-containing compound catabolic process,BP,BLVRA
8245,GO:0033015,0.322612861278401,0.950036951526709,1,6,tetrapyrrole catabolic process,BP,BLVRA
9889,GO:0042167,0.322612861278401,0.950036951526709,1,6,heme catabolic process,BP,BLVRA
11587,GO:0046149,0.322612861278401,0.950036951526709,1,6,pigment catabolic process,BP,BLVRA
9414,GO:0035977,0.322663184309908,0.954538085087832,1,4,protein deglycosylation involved in glycoprotein catabolic process,BP,EDEM1
16621,GO:0097466,0.322663184309908,0.954538085087832,1,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,EDEM1
18815,GO:1904382,0.322663184309908,0.954538085087832,1,4,mannose trimming involved in glycoprotein ERAD pathway,BP,EDEM1
18899,GO:1904587,0.322663184309908,0.954538085087832,1,4,response to glycoprotein,BP,EDEM1
7211,GO:0031103,0.322709913897452,0.845233222672488,4,32,axon regeneration,BP,MAP2K1;PTPRS;INPP5F;LAMB2
4179,GO:0009256,0.3227729972882,0.954504404960814,1,4,10-formyltetrahydrofolate metabolic process,BP,ALDH1L2
18864,GO:1904505,0.32287250032513,0.954473874233132,1,4,regulation of telomere maintenance in response to DNA damage,BP,ERCC1
18865,GO:1904506,0.32287250032513,0.954473874233132,1,4,negative regulation of telomere maintenance in response to DNA damage,BP,ERCC1
18366,GO:1903362,0.322900745520688,0.760196215220423,19,201,regulation of cellular protein catabolic process,BP,EDEM1;UBE2J1;TRIB2;APOE;LRP1;BTRC;DVL1;TRIB3;VPS11;XBP1;ANKIB1;GABARAPL2;PRKACA;ERLEC1;MAGEF1;RNF180;USP25;UFL1;FBXL5
2325,GO:0005337,0.32292050435577,0.951732095832466,1,5,nucleoside transmembrane transporter activity,MF,SLC29A4
5238,GO:0015858,0.32292050435577,0.951732095832466,1,5,nucleoside transport,BP,SLC29A4
17722,GO:1901642,0.32292050435577,0.951732095832466,1,5,nucleoside transmembrane transport,BP,SLC29A4
13571,GO:0060038,0.323182440489731,0.845174985408538,4,31,cardiac muscle cell proliferation,BP,TGFBR2;FGFR1;PRKAR1A;JARID2
19706,GO:2000047,0.323183145137793,0.951646906424759,1,5,regulation of cell-cell adhesion mediated by cadherin,BP,EPCAM
20180,GO:2001026,0.323422140863054,0.898803674495987,2,12,regulation of endothelial cell chemotaxis,BP,FGFR1;TMSB4X
15142,GO:0071241,0.323457741427718,0.779474665081955,12,121,cellular response to inorganic substance,BP,PRNP;NFATC4;EGFR;ANK3;BNIP3;PKD2;ATF4;ATRX;MT2A;ENDOG;EEF2K;ADCY1
3636,GO:0008104,0.323852743837456,0.706545269288514,180,2056,protein localization,BP,EDEM1;ZMYND8;F2R;SORL1;ETV5;RAB3B;PCK2;VLDLR;SYNE3;PRNP;XPOT;BBS2;POSTN;SH3TC2;NR1D1;LTBP2;RAPGEF3;ACVR2B;LTBP1;ALOX15B;LMF1;MARVELD1;POU2F2;SSH1;DDIT3;HADH;EXOC2;EGFR;TBC1D14;ANK3;FYN;TSPAN5;KIF13B;UBE2J1;DLG1;DLG4;IDH2;SNX9;GLUL;EVI5L;WNT7A;MAP4K4;TTBK2;SEC23A;TTC7B;STRADB;MALL;GDI1;CEMIP;UNC119B;SEPT10;ARG2;STOM;DLG3;PAK1;NUDCD3;RAC2;OBSCN;APOE;FKBP1A;BNIP3L;MCFD2;PKD2;LRP1;EHBP1;ABCA7;ICA1;TUB;SNX14;ITGA2;VAMP2;LONP2;ATRX;ABCG1;SOX4;PITPNM1;ITPR3;VPS13A;CEP120;FERMT1;OBSL1;RAB31;BSG;MDFI;TRIM5;DVL1;NLGN2;MVB12B;LRP5;ABHD17C;TWF2;COX18;SEC22C;CLTCL1;TOM1L2;VPS11;SEC63;PPP3CB;SYTL1;ZDHHC2;COPB1;COPG1;F2RL1;CSNK2A1;SLC25A4;ANO1;PARP9;FCHO2;SDCCAG3;NACC2;USP6NL;SEPT5;TBC1D2B;THRA;NGFR;PPP1R10;MVB12A;GLUD1;BCL2L1;GRIN3B;ARF4;XBP1;SPIRE1;ARRDC1;STX10;TCTN1;RAB43;MLH3;SH3PXD2B;C5;ZFYVE9;GABARAPL2;TMBIM1;CCDC88A;TMED4;TMSB4X;RAB1A;ZDHHC1;EPB41L3;SNX30;SEL1L;BCAP29;AP2A2;KDELR3;IL1RAP;CARD11;AP3D1;ITPR2;MOAP1;LAMA5;EFCAB7;ERLEC1;PPARG;SNX6;ANKRD50;LYPLA1;TMEM50B;EVI5;ATP6V1B2;RPH3AL;ADAM8;ITGA4;ACAP2;TBC1D16;SSR3;TMEM107;WASL;FLNB;LRP6;TMEM173;SSR1;ARMCX3;FOXP1;PTCH1;SEPT6;COG8;UFL1;SNX27;GNAI1;LRP4
12118,GO:0048170,0.323880133164795,0.954164019063554,1,4,positive regulation of long-term neuronal synaptic plasticity,BP,NEURL1
17543,GO:1901072,0.323881386413516,0.951419998331034,1,5,glucosamine-containing compound catabolic process,BP,CTBS
11909,GO:0046940,0.323936362472707,0.95140210624532,1,5,nucleoside monophosphate phosphorylation,BP,AK9
12447,GO:0050145,0.323936362472707,0.95140210624532,1,5,nucleoside phosphate kinase activity,MF,AK9
7339,GO:0031349,0.324020655671074,0.74658408496249,27,297,positive regulation of defense response,BP,TNIP1;NR1D1;PTPRS;PSMD2;EGFR;FYN;MAPK13;CTSB;TGM2;PAK1;PRKACB;BTRC;ITGA2;MAPKAPK3;TRIM5;CTSL;F2RL1;DDX60;PSMD7;PARP9;PUM2;PRKACA;IFI16;CARD11;ADAM8;TMEM173;FADD
1384,GO:0003284,0.324142185460287,0.954083232588947,1,4,septum primum development,BP,SOX4
15981,GO:0080135,0.324184298395566,0.72942070666222,49,537,regulation of cellular response to stress,BP,XDH;EDEM1;ERCC1;MAP2K1;PKN1;DDIT3;PTPRS;EGFR;ERCC6;UBE2J1;DLG1;WNT7A;MAP4K4;ARG2;DKK1;PAK1;IMPACT;CD44;HMGA2;ATF4;INPP5F;ETAA1;DNAJB9;CEBPG;F2RL1;TAOK1;BOK;PARP9;NACC2;PPP1R10;BCL2L1;XBP1;MAP2K2;NEK6;EIF2AK2;FICD;RNF169;MAP4K2;ERLEC1;AKT3;WFS1;ENDOG;FZD8;MAGEF1;DNAJC3;USP25;ANKRD6;KLHL15;RB1CC1
17873,GO:1902107,0.324247444853306,0.793230209835848,9,89,positive regulation of leukocyte differentiation,BP,CTNNBIP1;RAG1;TGFBR2;MMP14;CD46;XBP1;AP3D1;ADAM8;FADD
14156,GO:0061037,0.324361142528816,0.896634617663736,2,14,negative regulation of cartilage development,BP,ADAMTS7;PTHLH
14678,GO:0070290,0.324412371715657,0.953999850598753,1,4,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,PLD3
796,GO:0002064,0.32445893007061,0.768882389881917,15,143,epithelial cell development,BP,ACTA2;RAPGEF3;PTPRS;PODXL;WNT7A;SDC1;SLITRK6;FGFR1;ATRX;CST3;F2RL1;XBP1;LAMB2;ARID4A;FLNB
8186,GO:0032924,0.324601438016913,0.865301790640996,3,22,activin receptor signaling pathway,BP,ACVR2B;FKBP1A;ACVR1B
10152,GO:0042730,0.324900176856426,0.895683729906267,2,15,fibrinolysis,BP,PLAT;SERPING1
2720,GO:0006098,0.324995706363409,0.895059057811378,2,16,pentose-phosphate shunt,BP,H6PD;PGLS
15903,GO:0072672,0.325065974514327,0.953797773160923,1,4,neutrophil extravasation,BP,ADAM8
13081,GO:0051589,0.325687921506898,0.896687065126093,2,13,negative regulation of neurotransmitter transport,BP,NOS1;SLC30A1
13369,GO:0052564,0.325707376274971,0.950823655699024,1,5,response to immune response of other organism involved in symbiotic interaction,BP,EIF2AK2
13371,GO:0052572,0.325707376274971,0.950823655699024,1,5,response to host immune response,BP,EIF2AK2
6937,GO:0030545,0.325821757423374,0.764236773940507,16,183,receptor regulator activity,MF,PGF;ADM2;CMTM4;APLN;TNFSF15;SEMA4B;WNT7A;DKK1;CMTM7;PTHLH;NUDT6;C5;CMTM6;IGF2;CKLF;SEMA3F
7916,GO:0032489,0.325950194303031,0.953523561636859,1,4,regulation of Cdc42 protein signal transduction,BP,APOE
3477,GO:0007320,0.326007106343494,0.953505879399373,1,4,insemination,BP,SERPINE2
10156,GO:0042734,0.326190302967531,0.827995915093173,5,39,presynaptic membrane,CC,ADGRL1;SNPH;NLGN2;RIMS3;FCHO2
1968,GO:0004677,0.326762218529711,0.958010482631389,1,3,DNA-dependent protein kinase activity,MF,HMGA2
10385,GO:0043207,0.326785901884632,0.729028783994863,45,523,response to external biotic stimulus,BP,TNIP1;NOS1;F2R;PCK2;CYP27B1;PRSS3;ACTA2;NR1D1;ADARB1;MST1R;WIPF1;LOXL1;TNFRSF6B;BNIP3;HTRA1;ARG2;SHC1;LCN2;BNIP3L;ACP5;ANXA3;HMGA2;HYAL1;APOBEC3C;MAPKAPK3;GSDMC;TRIM5;F2RL1;DDX60;GSDMA;PARP9;NGFR;BCL2L1;IFITM1;XBP1;PUM2;EIF2AK2;RAB1A;IFI16;WASL;TMEM173;DNAJC3;FOXP1;OAS1;FADD
13141,GO:0051707,0.326785901884632,0.729028783994863,45,523,response to other organism,BP,TNIP1;NOS1;F2R;PCK2;CYP27B1;PRSS3;ACTA2;NR1D1;ADARB1;MST1R;WIPF1;LOXL1;TNFRSF6B;BNIP3;HTRA1;ARG2;SHC1;LCN2;BNIP3L;ACP5;ANXA3;HMGA2;HYAL1;APOBEC3C;MAPKAPK3;GSDMC;TRIM5;F2RL1;DDX60;GSDMA;PARP9;NGFR;BCL2L1;IFITM1;XBP1;PUM2;EIF2AK2;RAB1A;IFI16;WASL;TMEM173;DNAJC3;FOXP1;OAS1;FADD
14029,GO:0060754,0.326860533113336,0.95044484802854,1,5,positive regulation of mast cell chemotaxis,BP,PGF
18232,GO:1903036,0.326986514990929,0.841782629837198,4,34,positive regulation of response to wounding,BP,F2R;TGFBR2;XBP1;HPSE
7731,GO:0032226,0.327085990846747,0.950370586331741,1,5,positive regulation of synaptic transmission, dopaminergic,BP,RAB3B
10165,GO:0042749,0.327235473825928,0.950321313304352,1,5,regulation of circadian sleep/wake cycle,BP,PER3
11142,GO:0045187,0.327235473825928,0.950321313304352,1,5,regulation of circadian sleep/wake cycle, sleep,BP,PER3
12518,GO:0050661,0.32723867868625,0.841173829684499,4,36,NADP binding,MF,NOS1;H6PD;CBR4;MTHFR
18184,GO:1902953,0.327357537228195,0.953085141160117,1,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,SORL1
9452,GO:0036041,0.327389951538604,0.948421242452739,1,6,long-chain fatty acid binding,MF,PPARG
16314,GO:0090482,0.327676330208876,0.895613288428471,2,13,vitamin transmembrane transporter activity,MF,SLC2A3;SLC23A2
16655,GO:0097527,0.327766272660535,0.950146117486476,1,5,necroptotic signaling pathway,BP,FADD
10735,GO:0044091,0.327917990705628,0.862773793843704,3,23,membrane biogenesis,BP,ANK3;NLGN2;LRP4
13576,GO:0060043,0.327937538056047,0.863178207221342,3,22,regulation of cardiac muscle cell proliferation,BP,TGFBR2;FGFR1;JARID2
16634,GO:0097490,0.327942571454739,0.952902172453467,1,4,sympathetic neuron projection extension,BP,SEMA3F
16635,GO:0097491,0.327942571454739,0.952902172453467,1,4,sympathetic neuron projection guidance,BP,SEMA3F
5214,GO:0015813,0.327991146580312,0.895442798724005,2,13,L-glutamate transmembrane transport,BP,NTSR1;SLC7A11
4556,GO:0010637,0.328020812196988,0.950061975316342,1,5,negative regulation of mitochondrial fusion,BP,BNIP3
4473,GO:0010469,0.328029454840314,0.755452025353904,19,216,regulation of signaling receptor activity,BP,PGF;NEURL1;ADM2;CMTM4;APLN;TNFSF15;DLG4;WNT7A;SHC1;DKK1;SHANK2;CMTM7;NLGN2;PTHLH;NUDT6;CMTM6;IGF2;SNX6;CKLF
14164,GO:0061046,0.328033258958799,0.950057858697254,1,5,regulation of branching involved in lung morphogenesis,BP,WNT2B
13566,GO:0060029,0.328058867088712,0.95286575092271,1,4,convergent extension involved in organogenesis,BP,DVL1
2228,GO:0005131,0.328191771015743,0.9528241075943,1,4,growth hormone receptor binding,MF,SOCS2
15878,GO:0072602,0.328300226516582,0.952790108661017,1,4,interleukin-4 secretion,BP,IL1RAP
6217,GO:0019748,0.328410517867962,0.840355308172492,4,36,secondary metabolic process,BP,CBS;CBR4;CTH;TRPC1
4246,GO:0009446,0.328414366093338,0.949931715391989,1,5,putrescine biosynthetic process,BP,AZIN2
9856,GO:0042104,0.328584428440216,0.893088442977264,2,16,positive regulation of activated T cell proliferation,BP,IGF2;FADD
18270,GO:1903136,0.328698384574067,0.949837585867975,1,5,cuprous ion binding,MF,PRNP
10626,GO:0043622,0.328737384882898,0.952652920001432,1,4,cortical microtubule organization,BP,DLG1
4520,GO:0010573,0.328767475690951,0.862229565205438,3,23,vascular endothelial growth factor production,BP,ATF4;C5;HPSE
4648,GO:0010770,0.328777834926806,0.775495760934133,12,110,positive regulation of cell morphogenesis involved in differentiation,BP,MAP2K1;MAP1B;PLXNB3;NET1;GDI1;PAK1;LPAR3;OBSL1;TWF2;NGFR;EEF2K;ADNP
13978,GO:0060688,0.328882296700451,0.84046097003618,4,34,regulation of morphogenesis of a branching structure,BP,ETV5;PGF;FGFR1;WNT2B
13773,GO:0060351,0.329052003302259,0.894867315586495,2,13,cartilage development involved in endochondral bone morphogenesis,BP,TGFBR2;THBS3
5676,GO:0016787,0.329143839366073,0.70300529246928,159,1816,hydrolase activity,MF,NT5E;PLAT;EDEM1;ERCC1;ADAM19;RAB3B;MMP1;PRSS3;ADARB1;MAP2K1;THSD4;H6PD;SSH1;PTPRS;SMARCA1;PSMD2;LTA4H;CAPN2;MYH15;TMPRSS11D;HLTF;KIF13B;ERCC6;ADAMTS7;DLG1;CTSB;ACOT1;DHX32;TYSND1;HTRA1;PGLS;ACOT7;CEMIP;SEPT10;ARG2;RAG1;PTPN3;EDNRA;HAGH;SCRN1;PLPP6;RAC2;CLCA2;ATP7B;ABCD1;ACP5;PTPN12;IDE;PPP2R3B;ABHD8;ABCA7;KIF21B;ABHD10;AARS;PTPDC1;RNPEPL1;HYAL1;AIG1;LONP2;INPP5F;ATRX;PFN2;AHCYL2;ABCG1;APOBEC3C;ENDOV;IAH1;MBLAC2;RAB31;ATF7IP;RCOR1;XRN1;MMP14;PLA2G4D;NLGN2;ACAD10;ABHD17C;TMEM86B;CTSL;NPEPL1;CASP4;PCSK6;PLPPR2;PPP3CB;ACOT13;INPP4A;DNAJC6;DDX60;PLD3;AEBP1;ATP10D;ABHD15;OTUB2;CHD7;BLMH;CTBS;NACC2;SEPT5;LACTB2;MGLL;BPHL;HSPA13;PTPRZ1;CHD6;NUDT6;MTA1;MYH16;YTHDC2;PM20D2;GLB1;ARF4;PCYOX1;NT5DC1;UBASH3B;ABHD6;LYPLAL1;TUBG2;PDE5A;RAB43;MLH3;MTMR4;ZFYVE9;DNASE1L1;CTSO;ADAMTSL1;RAB1A;RHOBTB1;FICD;CTSZ;MMP10;ARID4A;NIT2;ACP6;USP20;LYPLA1;ATP12A;ATP6V1B2;ADAM8;GARS;ENDOG;ATP11B;PHF21A;WDR60;DDHD2;OSGEPL1;PLCXD1;USP32;HSPA2;PRSS8;PLCH2;PPT2;HPSE;GALNS;PSEN2;SEPT6;USP25;N4BP2;PPM1M;GNAI1
14114,GO:0060969,0.329204969586793,0.862367843984786,3,22,negative regulation of gene silencing,BP,RMRP;PPARG;TET1
1350,GO:0003215,0.329275687155628,0.895669073933147,2,12,cardiac right ventricle morphogenesis,BP,SOX4;CHD7
17919,GO:1902231,0.329367197189706,0.947743679007038,1,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,NACC2
16394,GO:0097009,0.329378848710237,0.894689709144088,2,13,energy homeostasis,BP,CRTC1;MEX3C
1115,GO:0002704,0.329566841266972,0.86066419961741,3,26,negative regulation of leukocyte mediated immunity,BP,CEACAM1;PPP3CB;IL20RB
12691,GO:0050908,0.329837658575228,0.952306589222474,1,4,detection of light stimulus involved in visual perception,BP,REEP6
12723,GO:0050962,0.329837658575228,0.952306589222474,1,4,detection of light stimulus involved in sensory perception,BP,REEP6
6716,GO:0030126,0.33000651695696,0.892888283752528,2,15,COPI vesicle coat,CC,COPB1;COPG1
9804,GO:0040031,0.330278414627413,0.947429676861891,1,6,snRNA modification,BP,NOP10
11087,GO:0045087,0.330317490852107,0.72414810400661,48,553,innate immune response,BP,TNIP1;CYP27B1;NR1D1;ADARB1;MST1R;PTPRS;PSMD2;FYN;CTSB;ARG2;PAK1;SERPING1;LCN2;CD44;PRKACB;BTRC;PTK6;APOBEC3C;CEACAM1;MAPKAPK3;MT2A;TRIM5;CD46;CTSL;CASP4;CEBPG;F2RL1;DDX60;PSMD7;PARP9;IFITM1;RAB43;C5;PUM2;RNF135;PRKACA;EIF2AK2;IFI16;IL1RAP;CARD11;MAP4K2;PPARG;ADAM8;FLNB;TMEM173;OAS1;TRIM38;FADD
10118,GO:0042636,0.330455649100614,0.952111409543162,1,4,negative regulation of hair cycle,BP,FERMT1
18568,GO:1903795,0.330608909038627,0.952062932401137,1,4,regulation of inorganic anion transmembrane transport,BP,PRNP
12557,GO:0050709,0.330716317227048,0.80215336215294,7,68,negative regulation of protein secretion,BP,F2R;HADH;IDH2;MAP4K4;ARG2;F2RL1;TMSB4X
9174,GO:0035529,0.330885745017693,0.949109159754955,1,5,NADH pyrophosphatase activity,MF,NUDT6
12992,GO:0051403,0.331039166171876,0.751199001144104,20,206,stress-activated MAPK cascade,BP,XDH;MAP2K1;PKN1;EGFR;ERCC6;MAPK13;DLG1;WNT7A;MAP4K4;DKK1;PAK1;BTRC;F2RL1;TAOK1;MAP2K2;EIF2AK2;MAP4K2;FZD8;ANKRD6;RB1CC1
11808,GO:0046689,0.331090839890093,0.949040542563086,1,5,response to mercury ion,BP,BSG
10100,GO:0042609,0.331165416456888,0.949015578482452,1,5,CD4 receptor binding,MF,FYN
17292,GO:0140058,0.331189220985266,0.894634493214486,2,12,neuron projection arborization,BP,DLG4;DVL1
8440,GO:0033558,0.33136120630794,0.823435907009191,5,43,protein deacetylase activity,MF,RCOR1;NACC2;MTA1;ARID4A;PHF21A
13912,GO:0060563,0.331381814653522,0.838953299395453,4,33,neuroepithelial cell differentiation,BP,SLITRK6;FGFR1;FAM20C;SOX4
701,GO:0001921,0.331402846072319,0.893586701089768,2,13,positive regulation of receptor recycling,BP,ARAP1;INPP5F
5443,GO:0016310,0.331643153547462,0.701764032114792,146,1645,phosphorylation,BP,TNIP1;XDH;F2R;SORL1;CCND1;NEURL1;VLDLR;ITGA6;RPS6KA2;ADCY7;IGFBP4;PRNP;ADM2;ADARB1;MAP2K1;RAPGEF3;ACVR2B;TK2;PKN1;WWTR1;MST1R;APLN;DHTKD1;DGKA;TNFSF15;PSMD2;BRSK1;EGFR;STK39;PPP1R14A;FYN;ERCC6;MAPK13;PGM1;DLG1;DLG4;SNX9;WNT7A;MAP4K4;TTBK2;TTC7B;GRK5;NMRK1;STRADB;NME4;CEMIP;SHC1;DLG3;DKK1;PAK1;RASA3;SOCS2;TRIB2;NEK9;TGFBR2;EPHA1;IMPACT;RAC2;CD44;OBSCN;APOE;FKBP1A;CCND2;CDK17;RGS14;PKD2;PRKACB;LDHA;AKAP9;HMGA2;PPARA;ABCA7;LPAR3;FGFR1;ITGA1;BTRC;PTK6;ULK2;INPP5F;FAM20C;PFN2;CEACAM1;MAPKAPK3;NLK;TRIM5;DVL1;LRP5;ETAA1;CNTN1;TRIB3;RANBP9;PPP3CB;SLK;CDC42BPA;SCYL3;F2RL1;TAOK1;CSNK2A1;PSMD7;NDUFV3;PRKAR1A;PARP9;MAST3;SPRY2;ACVR1B;NGFR;PSKH1;MARK4;PANK4;UBASH3B;MAP2K2;RET;PDE5A;C5;PAK6;CCDC88A;SHC2;PRKACA;NEK6;TIMP2;EIF2AK2;LPAR1;IGF2;GRB10;MAP4K2;ZMYM2;SNX6;SRPX2;TBX1;AK9;ADAM8;AKT3;FZD8;HSPA2;LRP6;EEF2K;DNAJC3;ZFYVE21;ADCY1;KAT2B;PANK1;ANKRD6;N4BP2;ADNP;LRP4;RB1CC1
16656,GO:0097529,0.331686823320896,0.793308615171616,8,84,myeloid leukocyte migration,BP,PGF;RAC2;ITGA1;MMP14;MOSPD2;C5;ADAM8;CKLF
16516,GO:0097223,0.331813040444639,0.787032757321102,9,90,sperm part,CC,LY6K;LOXL1;ITGA1;BSG;CD46;SPESP1;SPATA6;PRKACA;SEPT6
5850,GO:0017146,0.331868707483012,0.951663347090114,1,4,NMDA selective glutamate receptor complex,CC,GRIN3B
7705,GO:0032184,0.331896425509295,0.951654533307915,1,4,SUMO polymer binding,MF,SIMC1
18307,GO:1903224,0.3320091519791,0.951618678704417,1,4,regulation of endodermal cell differentiation,BP,DKK1
14651,GO:0070235,0.332037391163687,0.948723155020388,1,5,regulation of activation-induced cell death of T cells,BP,FADD
15305,GO:0071494,0.332086163171274,0.951594174894652,1,4,cellular response to UV-C,BP,IMPACT
19286,GO:1905521,0.332128731556855,0.891716197341186,2,15,regulation of macrophage migration,BP,MMP14;C5
3926,GO:0008603,0.332201347817923,0.948668060741116,1,5,cAMP-dependent protein kinase regulator activity,MF,PRKAR1A
19884,GO:2000370,0.332344502480061,0.951511921410536,1,4,positive regulation of clathrin-dependent endocytosis,BP,WASL
7449,GO:0031584,0.332497953528272,0.948568303800146,1,5,activation of phospholipase D activity,BP,ARF4
19888,GO:2000377,0.332661095657637,0.775838604009661,11,114,regulation of reactive oxygen species metabolic process,BP,XDH;EGFR;BNIP3;ARG2;TGFBR2;RAC2;ACP5;PKD2;F2RL1;ARF4;SLC18A2
13239,GO:0051902,0.332733501090873,0.948489001064565,1,5,negative regulation of mitochondrial depolarization,BP,BOK
18727,GO:1904180,0.332733501090873,0.948489001064565,1,5,negative regulation of membrane depolarization,BP,BOK
3144,GO:0006739,0.332845119495511,0.858240322545783,3,27,NADP metabolic process,BP,H6PD;IDH2;PGLS
148,GO:0000302,0.333003897411451,0.760927736145557,15,165,response to reactive oxygen species,BP,EGFR;BNIP3;ERCC6;MAPK13;NET1;SDC1;IMPACT;APOE;PKD2;LDHA;HYAL1;CST3;PRDX5;TXNRD3;ENDOG
17691,GO:1901569,0.333075097942209,0.94837386621662,1,5,fatty acid derivative catabolic process,BP,ACOT7
8117,GO:0032803,0.333162515664501,0.948344377794954,1,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,APOE
1978,GO:0004694,0.333305580713559,0.951205192521345,1,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,EIF2AK2
6843,GO:0030308,0.33376644888573,0.770776606505066,12,122,negative regulation of cell growth,BP,FHL1;CYP27B1;SERPINE2;DCBLD2;PTPRS;SEMA4B;PAK1;HYAL1;ULK2;ACVR1B;PPARG;SEMA3F
5015,GO:0015175,0.333873730792573,0.858551300231789,3,24,neutral amino acid transmembrane transporter activity,MF,SLC43A1;SLC38A2;SLC7A11
15408,GO:0071670,0.333885331392538,0.948100171133901,1,5,smooth muscle cell chemotaxis,BP,LPAR1
5613,GO:0016661,0.333981914529903,0.948067488574665,1,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,CBS
14318,GO:0061470,0.334076625228173,0.95095828228454,1,4,T follicular helper cell differentiation,BP,FOXP1
11476,GO:0045932,0.334304849398164,0.891195309785731,2,14,negative regulation of muscle contraction,BP,DOCK4;PDE5A
15310,GO:0071500,0.334316940379231,0.947954025744859,1,5,cellular response to nitrosative stress,BP,DDIT3
7946,GO:0032541,0.334349592410607,0.947942959698384,1,5,cortical endoplasmic reticulum,CC,ASPH
6407,GO:0021636,0.33436783654146,0.950864835528767,1,4,trigeminal nerve morphogenesis,BP,SEMA3F
6408,GO:0021637,0.33436783654146,0.950864835528767,1,4,trigeminal nerve structural organization,BP,SEMA3F
837,GO:0002138,0.334608186678823,0.947855270865237,1,5,retinoic acid biosynthetic process,BP,ALDH1A2
5350,GO:0016102,0.334608186678823,0.947855270865237,1,5,diterpenoid biosynthetic process,BP,ALDH1A2
11380,GO:0045745,0.334839133925714,0.891701502869471,2,13,positive regulation of G-protein coupled receptor protein signaling pathway,BP,NOS1;TMOD2
7204,GO:0031093,0.334942762993168,0.835764159199397,4,36,platelet alpha granule lumen,CC,SERPING1;QSOX1;TMSB4X;IGF2
12154,GO:0048261,0.335190611806215,0.890704361752939,2,14,negative regulation of receptor-mediated endocytosis,BP,DLG4;ATXN2
4802,GO:0010996,0.335565796804354,0.89224989240301,2,12,response to auditory stimulus,BP,XPC;SLITRK6
12067,GO:0048015,0.335643331750992,0.773812350833692,11,104,phosphatidylinositol-mediated signaling,BP,F2R;SERPINE2;EGFR;FYN;FGFR1;INPP5F;CEACAM1;F2RL1;RGL2;IGF2;NYAP1
4861,GO:0014075,0.335707092168373,0.857750414403781,3,23,response to amine,BP,UROS;ITGA2;SLC18A2
13898,GO:0060541,0.335832080203187,0.762268089591815,14,131,respiratory system development,BP,MAP2K1;ACVR2B;EGFR;TGFBR2;FGFR1;MMP14;CHD7;SPRY2;THRA;WNT2B;CTSZ;LAMA5;ALDH1A2;LRP6
6377,GO:0021562,0.335887897951639,0.950375345669337,1,4,vestibulocochlear nerve development,BP,SLITRK6
16111,GO:0090090,0.335935927901087,0.768720002249483,12,128,negative regulation of canonical Wnt signaling pathway,BP,IGFBP4;WWTR1;DDIT3;PSMD2;DKK1;APOE;FERMT1;DVL1;PSMD7;LRP6;ANKRD6;LRP4
10173,GO:0042760,0.335958503582551,0.947395963950057,1,5,very long-chain fatty acid catabolic process,BP,ABCD1
9004,GO:0035137,0.336034270583765,0.857967370581227,3,22,hindlimb morphogenesis,BP,WNT7A;CHD7;PTCH1
628,GO:0001817,0.336051950783281,0.725951691112067,37,412,regulation of cytokine production,BP,F2R;PRNP;POSTN;NFATC4;ALOX15B;DDIT3;PTPRS;UBE2J1;MAPK13;IGF2BP3;ARG2;TRIB2;ACP5;ATF4;FGFR1;CEACAM1;FERMT1;CD46;CEBPG;F2RL1;DDX60;XBP1;C5;PUM2;RNF135;TMSB4X;EIF2AK2;IFI16;IL1RAP;CARD11;AGPAT1;ADAM8;IL20RB;TMEM173;HPSE;FOXP1;FADD
15909,GO:0072678,0.336096274996322,0.856748122966379,3,25,T cell migration,BP,ADAM8;ITGA4;FADD
19682,GO:2000002,0.336180813437565,0.947320117534358,1,5,negative regulation of DNA damage checkpoint,BP,PPP1R10
6076,GO:0019228,0.33650960533855,0.891732302541859,2,12,neuronal action potential,BP,SCN8A;ANK3
15517,GO:0071895,0.336534077485692,0.947199459993294,1,5,odontoblast differentiation,BP,FAM20C
8321,GO:0033157,0.336588802751325,0.746228064086358,20,210,regulation of intracellular protein transport,BP,EDEM1;SORL1;PRNP;SH3TC2;RAPGEF3;ANK3;FYN;UBE2J1;GDI1;CEMIP;STOM;PAK1;RAC2;BNIP3L;VAMP2;SOX4;VPS11;EFCAB7;ERLEC1;TMEM173
4731,GO:0010894,0.33672805791946,0.889155233190996,2,15,negative regulation of steroid biosynthetic process,BP,CYP27B1;APOE
7453,GO:0031589,0.336908673793278,0.741015898594536,23,224,cell-substrate adhesion,BP,ITGA6;ITGB4;POSTN;COL13A1;LAMB1;PARVB;NET1;SMOC2;EPHA1;RAC2;CD44;ITGA1;ITGB5;ITGA2;FERMT1;MMP14;THBS3;SLK;RAB1A;LAMA5;ITGA4;HPSE;HSD17B12
8604,GO:0034112,0.337158407362696,0.946985820492131,1,5,positive regulation of homotypic cell-cell adhesion,BP,ANK3
9201,GO:0035583,0.337170324319337,0.955016660192035,1,3,sequestering of TGFbeta in extracellular matrix,BP,LTBP1
12182,GO:0048308,0.337234023898099,0.888871765538674,2,15,organelle inheritance,BP,MAP2K1;MAP2K2
10599,GO:0043568,0.337282889984684,0.949923588698259,1,4,positive regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4
524,GO:0001618,0.337285541805976,0.818877313271053,5,44,virus receptor activity,MF,EGFR;IDE;ITGB5;ITGA2;CD46
17188,GO:0104005,0.337285541805976,0.818877313271053,5,44,hijacked molecular function,MF,EGFR;IDE;ITGB5;ITGA2;CD46
8989,GO:0035095,0.337385201835009,0.949890359885935,1,4,behavioral response to nicotine,BP,PPARA
15869,GO:0072588,0.337568547676383,0.942443524876303,1,8,box H/ACA RNP complex,CC,NOP10
17857,GO:1902047,0.337748559734522,0.946783406885976,1,5,polyamine transmembrane transport,BP,AZIN2
16755,GO:0098533,0.337931674739943,0.889991368544689,2,13,ATPase dependent transmembrane transport complex,CC,ABCA7;ATP12A
11789,GO:0046653,0.338013508518766,0.888434383424932,2,15,tetrahydrofolate metabolic process,BP,ALDH1L2;MTHFR
10120,GO:0042640,0.338132746546511,0.94964717409597,1,4,anagen,BP,FERMT1
13224,GO:0051884,0.338132746546511,0.94964717409597,1,4,regulation of timing of anagen,BP,FERMT1
8096,GO:0032781,0.338680135137473,0.832194391173462,4,41,positive regulation of ATPase activity,BP,PFN2;GABARAPL2;TMSB4X;HSPA2
7976,GO:0032590,0.338782607916967,0.888702630033667,2,14,dendrite membrane,CC,DDN;ATF4
13907,GO:0060558,0.338889982508695,0.946390619604051,1,5,regulation of calcidiol 1-monooxygenase activity,BP,CYP27B1
18671,GO:1904016,0.338899962434529,0.949396859421748,1,4,response to Thyroglobulin triiodothyronine,BP,GLB1
7290,GO:0031282,0.339202194611146,0.946282882971413,1,5,regulation of guanylate cyclase activity,BP,NOS1
7291,GO:0031284,0.339202194611146,0.946282882971413,1,5,positive regulation of guanylate cyclase activity,BP,NOS1
5247,GO:0015872,0.339441594398261,0.887630933377638,2,15,dopamine transport,BP,RAB3B;SLC18A2
13752,GO:0060326,0.339465342918305,0.761863619090296,13,141,cell chemotaxis,BP,DOCK4;PGF;PLXNB3;RAC2;FGFR1;ITGA1;MOSPD2;F2RL1;C5;TMSB4X;LPAR1;ADAM8;CKLF
882,GO:0002248,0.339481593163407,0.946186360842609,1,5,connective tissue replacement involved in inflammatory response wound healing,BP,F2R
13177,GO:0051782,0.339601941499834,0.88824360334047,2,14,negative regulation of cell division,BP,E2F7;PTCH1
6855,GO:0030324,0.339623554260831,0.766304307470699,12,111,lung development,BP,MAP2K1;ACVR2B;EGFR;TGFBR2;FGFR1;MMP14;SPRY2;THRA;WNT2B;CTSZ;LAMA5;ALDH1A2
13265,GO:0051952,0.339637623106768,0.854428180914658,3,25,regulation of amine transport,BP,RAB3B;STK39;NTSR1
14656,GO:0070245,0.339910771944148,0.946037895053461,1,5,positive regulation of thymocyte apoptotic process,BP,ADAM8
4913,GO:0014850,0.339917120948104,0.888066785088889,2,14,response to muscle activity,BP,POSTN;ITGA2
3784,GO:0008347,0.339982841335043,0.832888587851902,4,33,glial cell migration,BP,LAMB1;IDH2;MMP14;MBOAT7
9123,GO:0035426,0.340030016411099,0.949026815591477,1,4,extracellular matrix-cell signaling,BP,LRP5
14390,GO:0061631,0.340105240196175,0.853787243261562,3,26,ubiquitin conjugating enzyme activity,MF,UBE2J1;UBE2G1;UBE2E1
15884,GO:0072611,0.340227298759971,0.945928243630243,1,5,interleukin-13 secretion,BP,ARG2
20042,GO:2000665,0.340227298759971,0.945928243630243,1,5,regulation of interleukin-13 secretion,BP,ARG2
1169,GO:0002792,0.340393475255555,0.794428428532643,7,69,negative regulation of peptide secretion,BP,F2R;HADH;IDH2;MAP4K4;ARG2;F2RL1;TMSB4X
19120,GO:1905063,0.340528649784598,0.945823726810476,1,5,regulation of vascular smooth muscle cell differentiation,BP,CTH
6048,GO:0019184,0.34065351104374,0.886333967087539,2,16,nonribosomal peptide biosynthetic process,BP,HAGH;CHAC1
10868,GO:0044390,0.340945853004459,0.83220434772638,4,33,ubiquitin-like protein conjugating enzyme binding,MF,PPARA;ANKIB1;ZMYM2;RNF180
10014,GO:0042440,0.341113827073505,0.815399324137394,5,48,pigment metabolic process,BP,UROS;TRPC1;AP3D1;BLVRA;ALAS1
8629,GO:0034145,0.341162596799016,0.94560346584099,1,5,positive regulation of toll-like receptor 4 signaling pathway,BP,F2RL1
14236,GO:0061200,0.341246188648101,0.945574382820846,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,VAMP2
14237,GO:0061202,0.341246188648101,0.945574382820846,1,5,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,VAMP2
16104,GO:0090083,0.341303573173276,0.887287383905146,2,14,regulation of inclusion body assembly,BP,SORL1;HSPA2
1818,GO:0004468,0.341332730588321,0.94859823602017,1,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,KAT2B
5577,GO:0016594,0.341402676787471,0.945519913161201,1,5,glycine binding,MF,GRIN3B
7623,GO:0032020,0.342004999462925,0.943289601686729,1,6,ISG15-protein conjugation,BP,UBE2E1
10330,GO:0043122,0.342085715501352,0.747841368129662,17,181,regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;F2R;FYN;TGM2;FKBP1A;RBCK1;BTRC;TRIM5;CTH;F2RL1;C18ORF32;TMED4;NEK6;CARD11;LPAR1;TRIM38;FADD
14528,GO:0070022,0.342112814623003,0.948340570512161,1,4,transforming growth factor beta receptor complex,CC,TGFBR2
6431,GO:0021697,0.342242825822634,0.88856256216158,2,12,cerebellar cortex formation,BP,MAP2K1;WNT7A
9195,GO:0035577,0.342312598353029,0.814645361326104,5,47,azurophil granule membrane,CC,CD68;STOM;LPCAT1;CMTM6;ATP11B
10016,GO:0042445,0.342422992104124,0.767520863582043,11,117,hormone metabolic process,BP,CYP27B1;RDH14;ERO1B;IDE;FGFR1;PCSK6;HSD17B7;SRD5A3;CTSZ;ALDH1A2;HSD17B12
14304,GO:0061437,0.342456284108006,0.886637407527114,2,14,renal system vasculature development,BP,ACTA2;PKD2
14307,GO:0061440,0.342456284108006,0.886637407527114,2,14,kidney vasculature development,BP,ACTA2;PKD2
16769,GO:0098563,0.342791932507229,0.885735199138235,2,15,intrinsic component of synaptic vesicle membrane,CC,RAB3B;PTPRS
20261,GO:2001225,0.342839427112471,0.945018304134736,1,5,regulation of chloride transport,BP,PRNP
8922,GO:0034763,0.342876963055585,0.792730457074726,7,66,negative regulation of transmembrane transport,BP,HECW2;STK39;ANK3;PKD2;NTSR1;SLC30A1;GRB10
1931,GO:0004630,0.342934712331391,0.944984940942602,1,5,phospholipase D activity,MF,PLD3
10620,GO:0043615,0.342990217723882,0.944965500731322,1,5,astrocyte cell migration,BP,MMP14
3619,GO:0008066,0.343048784016727,0.948030399233254,1,4,glutamate receptor activity,MF,GRIN3B
7512,GO:0031697,0.343130952546172,0.948003116386594,1,4,beta-1 adrenergic receptor binding,MF,DLG4
4341,GO:0009893,0.343323378912355,0.686145368114653,209,2364,positive regulation of metabolic process,BP,TNIP1;XDH;SMURF2;EDEM1;NOS1;ERCC1;F2R;SORL1;ETV5;CCND1;NEURL1;VLDLR;ITGA6;CYP27B1;ADCY7;IGFBP4;PRNP;ACTA2;ADM2;NR1D1;HECW2;NFATC4;MAP2K1;ETV4;RAPGEF3;ACVR2B;SALL2;PKN1;WWTR1;PEG3;MST1R;APLN;POU2F2;TRIM65;TEF;TNFSF15;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;STK39;ANK3;FYN;BNIP3;HLTF;ERCC6;ARAP1;ZNF516;DLG1;DLG4;SNX9;WNT7A;MAP4K4;SPTLC2;STRADB;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;TRIB2;TGFBR2;EPHA1;IMPACT;CD44;APOE;FKBP1A;BNIP3L;CCPG1;CCND2;PKD2;PRKACB;LRP1;FYCO1;IDE;AKAP9;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;LPAR3;FGFR1;ITGA1;E2F5;EPCAM;NFAT5;BTRC;LPCAT1;ITGA2;PTK6;INPP5F;ATRX;CHURC1;PFN2;ABCG1;SOX4;FHOD1;MAPKAPK3;ATF7IP;SH3D19;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;CD46;LRP5;ETAA1;CST3;CNTN1;TRIB3;CASP4;VPS11;PPP3CB;RFX2;SLK;MLYCD;CEBPG;PLAG1;F2RL1;TAOK1;CSNK2A1;PHF1;PTHLH;CHD7;PRKAR1A;BOK;PARP9;SPRY2;THRA;ACVR1B;NGFR;PPP1R10;CHD6;MTA1;MEF2D;ARF4;XBP1;MAP2K2;ABHD6;PAIP1;ANKIB1;RET;PDE5A;SH3PXD2B;C5;EPM2A;RMRP;PAK6;EAPP;ETV1;CCDC88A;SHC2;PRKACA;ZNF398;TMSB4X;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;CARD11;LPAR1;TBL1X;ARID4A;IGF2;AGPAT1;MAP4K2;EFCAB7;PPARG;CITED4;ALDH1A2;TBX1;CREB3L2;RSF1;ADAM8;WFS1;ENDOG;MAML3;FZD8;HSPA2;LRP6;MAGEF1;TMEM173;RNF180;E2F7;TNRC6C;TET1;ARMCX3;DNAJC3;PTCH1;ADCY1;KAT2B;FAM162A;ANKRD6;PBX3;JARID2;ADNP;LRP4;RB1CC1;FBXL5;FADD
14963,GO:0070857,0.34354607528706,0.944770592185783,1,5,regulation of bile acid biosynthetic process,BP,NR1D1
3660,GO:0008142,0.343612514683729,0.947843048695131,1,4,oxysterol binding,MF,OSBPL5
4141,GO:0009202,0.343673317663879,0.942685526283829,1,6,deoxyribonucleoside triphosphate biosynthetic process,BP,AK9
3383,GO:0007160,0.343865589886874,0.749448369588349,16,149,cell-matrix adhesion,BP,ITGA6;ITGB4;POSTN;COL13A1;EPHA1;CD44;ITGA1;ITGB5;ITGA2;FERMT1;MMP14;THBS3;SLK;LAMA5;ITGA4;HPSE
9184,GO:0035556,0.343882188195011,0.687467757872001,178,1984,intracellular signal transduction,BP,TNIP1;DOCK4;XDH;NOS1;F2R;SORL1;RAB3B;ASAP2;RPS6KA2;SERPINE2;ADCY7;IGFBP4;PRNP;PAG1;ADGRF1;ADM2;NFATC4;MAP2K1;RAPGEF3;PKN1;WWTR1;MST1R;ARHGAP22;DGKA;TNFSF15;APPL2;EIF4EBP1;DDIT3;PSMD2;ADGRL1;BRSK1;EGFR;STK39;RIN2;ARHGAP12;FYN;BNIP3;ERCC6;MAPK13;ARAP1;DLG1;DLG4;NET1;TGM2;WNT7A;MAP4K4;STRADB;MCTP1;GDI1;SHC1;DKK1;PAK1;RASA3;SOCS2;TRIB2;EPHA1;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;RGS14;PKD2;RBCK1;AKAP9;ATF4;ABCA7;WWC3;LPAR3;FGFR1;ITGA1;NFAT5;BTRC;PTK6;INPP5F;CHAC1;ATRX;SOX4;ITPR3;CEACAM1;MAPKAPK3;RAB31;UACA;FAM110C;NLK;TRIM5;RALGAPA1;DVL1;PLEK2;CTH;DNMBP;DOCK9;TRIB3;CASP4;RANBP9;PPP3CB;ADGRB2;SLK;CDC42BPA;F2RL1;DDX60;TAOK1;CSNK2A1;PSMD7;PTHLH;ASAP1;PRKAR1A;JMY;BOK;PARP9;C18ORF32;MAST3;NACC2;SPRY2;NGFR;PSKH1;BCL2L1;WASF2;XBP1;MAP2K2;RET;PDE5A;RAB43;MCTP2;C5;NCKAP1;EPM2A;DOCK11;PAK6;PUM2;PSD3;COL1A2;CCDC88A;TMED4;SHC2;PRKACA;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RAB1A;IFI16;RHOBTB1;CARD11;LPAR1;IGF2;ITPR2;MOAP1;PJA2;MAP4K2;ARHGAP29;TBX1;ADAM8;AKT3;WFS1;DEPDC1;ACAP2;FZD8;RAPGEFL1;PLCH2;E2F7;HPSE;RALGDS;RCAN1;DEDD2;ZBTB33;PSEN2;ADCY1;CNOT11;NYAP1;ANKRD6;RALGPS2;GNAI1;RB1CC1;TRIM38;FADD
19967,GO:2000542,0.343898961401472,0.947747696387689,1,4,negative regulation of gastrulation,BP,DKK1
14095,GO:0060923,0.343903442008747,0.944645067241311,1,5,cardiac muscle cell fate commitment,BP,DKK1
5377,GO:0016191,0.343928082550678,0.947737996715467,1,4,synaptic vesicle uncoating,BP,DNAJC6
19946,GO:2000483,0.34418777636884,0.944545073944389,1,5,negative regulation of interleukin-8 secretion,BP,TMSB4X
8694,GO:0034315,0.344255763217654,0.885619152971322,2,14,regulation of Arp2/3 complex-mediated actin nucleation,BP,NCKAP1;WASL
18106,GO:1902744,0.34439107638622,0.947583638067945,1,4,negative regulation of lamellipodium organization,BP,PLXNB3
13235,GO:0051898,0.344443114534688,0.829459124512459,4,34,negative regulation of protein kinase B signaling,BP,XDH;DDIT3;DLG1;TRIB3
11661,GO:0046415,0.344497565280345,0.944436006843037,1,5,urate metabolic process,BP,SLC2A9
18482,GO:1903587,0.344511590119676,0.944431066117322,1,5,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NGFR
3796,GO:0008373,0.34461635222907,0.885414583549739,2,14,sialyltransferase activity,MF,ST3GAL5;ST6GALNAC2
16644,GO:0097503,0.34461635222907,0.885414583549739,2,14,sialylation,BP,ST3GAL5;ST6GALNAC2
7227,GO:0031122,0.344825403991792,0.801483793161017,6,51,cytoplasmic microtubule organization,BP,DLG1;CEP120;DVL1;SLK;TUBG2;CCDC88A
2629,GO:0005955,0.345071504879004,0.947356294003369,1,4,calcineurin complex,CC,PPP3CB
10435,GO:0043280,0.345131601907425,0.770017170311603,10,109,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;TNFSF15;DAP;CASP4;BOK;NGFR;PPARG;FAM162A;FADD
15829,GO:0072529,0.345403642071782,0.849964957655433,3,27,pyrimidine-containing compound catabolic process,BP,NT5E;APOBEC3C;TET1
783,GO:0002040,0.345525758220861,0.783039199270107,8,72,sprouting angiogenesis,BP,PGF;CEACAM1;EPN2;NGFR;LOXL2;SRPX2;AKT3;E2F7
12550,GO:0050702,0.345531856982362,0.850902816672082,3,24,interleukin-1 beta secretion,BP,ARG2;F2RL1;FOXP1
15747,GO:0072330,0.346059634615714,0.73980389854236,19,202,monocarboxylic acid biosynthetic process,BP,NR1D1;ALOX15B;DHTKD1;ELOVL1;PGM1;ACOT7;CBR4;LDHA;PPARA;ASNS;CEACAM1;TRIB3;MLYCD;MGLL;XBP1;ALDH1A2;ELOVL4;HSD17B12;AMACR
11752,GO:0046598,0.346069698417407,0.941811196964523,1,6,positive regulation of viral entry into host cell,BP,TRIM38
5201,GO:0015798,0.34613587161611,0.952337742960197,1,3,myo-inositol transport,BP,SLC2A13
14941,GO:0070827,0.346139634082187,0.946998223397028,1,4,chromatin maintenance,BP,MTHFR
13313,GO:0052150,0.34620544080286,0.943832427914094,1,5,modulation by symbiont of host apoptotic process,BP,BCL2L1
1437,GO:0003416,0.346342250149113,0.885275420824379,2,13,endochondral bone growth,BP,TGFBR2;THBS3
1955,GO:0004659,0.346361584464828,0.883698653869926,2,15,prenyltransferase activity,MF,RABGGTA;COQ2
15168,GO:0071286,0.346388745111018,0.952260823648877,1,3,cellular response to magnesium ion,BP,ANK3
12312,GO:0048662,0.346768187658468,0.849054079055899,3,27,negative regulation of smooth muscle cell proliferation,BP,CTNNBIP1;APLN;PPARG
16170,GO:0090188,0.346807950192348,0.946773443208807,1,4,negative regulation of pancreatic juice secretion,BP,STK39
8043,GO:0032692,0.346849194667598,0.88279003443731,2,16,negative regulation of interleukin-1 production,BP,ACP5;CEACAM1
7562,GO:0031904,0.346924806850025,0.882746462343692,2,16,endosome lumen,CC,CTSB;CTSL
4412,GO:0010171,0.347197780869434,0.811818113141054,5,42,body morphogenesis,BP,ASPH;DKK1;TBX1;LRP6;ARID5B
2785,GO:0006216,0.347198565029613,0.941396607333016,1,6,cytidine catabolic process,BP,APOBEC3C
4365,GO:0009972,0.347198565029613,0.941396607333016,1,6,cytidine deamination,BP,APOBEC3C
11554,GO:0046087,0.347198565029613,0.941396607333016,1,6,cytidine metabolic process,BP,APOBEC3C
14272,GO:0061343,0.34722536333695,0.946632762049119,1,4,cell adhesion involved in heart morphogenesis,BP,TGFBR2
1106,GO:0002695,0.347227023769103,0.774378365652354,9,90,negative regulation of leukocyte activation,BP,PRNP;PAG1;PKN1;DLG1;ARG2;CEACAM1;PRKAR1A;PDE5A;IL20RB
10625,GO:0043621,0.34743619222036,0.811450967693982,5,43,protein self-association,MF,VAMP2;FHOD1;PPARG;ADAM8;FOXP1
16119,GO:0090102,0.347650446042187,0.849902720486095,3,23,cochlea development,BP,SLITRK6;DVL1;TBX1
16124,GO:0090110,0.347680574712445,0.884516206391813,2,13,cargo loading into COPII-coated vesicle,BP,SEC23A;RAB1A
18801,GO:1904352,0.34772478118562,0.94646415027427,1,4,positive regulation of protein catabolic process in the vacuole,BP,LRP1
697,GO:0001917,0.347809703169362,0.849796887197461,3,23,photoreceptor inner segment,CC,NOS1;SHANK2;REEP6
11691,GO:0046475,0.34781398221571,0.882865091583067,2,15,glycerophospholipid catabolic process,BP,INPP5F;PLA2G4D
3247,GO:0006904,0.347868369727335,0.826325852667025,4,37,vesicle docking involved in exocytosis,BP,RAB3B;EXOC2;SNPH;VPS11
3626,GO:0008081,0.34789341810915,0.79854758034681,6,55,phosphoric diester hydrolase activity,MF,EDNRA;PLD3;PDE5A;FICD;PLCXD1;PLCH2
12666,GO:0050870,0.347918766901687,0.762916958520472,11,116,positive regulation of T cell activation,BP,FYN;PAK1;RAG1;TGFBR2;CD46;XBP1;CARD11;AP3D1;IGF2;ADAM8;FADD
19554,GO:1990535,0.348006614014495,0.946368858064492,1,4,neuron projection maintenance,BP,PRNP
2781,GO:0006211,0.348019816302486,0.951762876303144,1,3,5-methylcytosine catabolic process,BP,TET1
6264,GO:0019857,0.348019816302486,0.951762876303144,1,3,5-methylcytosine metabolic process,BP,TET1
47,GO:0000099,0.348041597196292,0.94635702259946,1,4,sulfur amino acid transmembrane transporter activity,MF,SLC7A11
7275,GO:0031256,0.348127192046174,0.75907411717103,12,111,leading edge membrane,CC,PAK1;CD44;DDN;ATF4;ABCA7;FERMT1;PLEK2;SPRY2;ARF4;NCKAP1;PSD3;EPB41L3
13644,GO:0060149,0.348153541556489,0.883398536757997,2,14,negative regulation of posttranscriptional gene silencing,BP,RMRP;PPARG
14112,GO:0060967,0.348153541556489,0.883398536757997,2,14,negative regulation of gene silencing by RNA,BP,RMRP;PPARG
4599,GO:0010714,0.348183254846692,0.88265270140991,2,15,positive regulation of collagen metabolic process,BP,F2R;ITGA2
8214,GO:0032967,0.348183254846692,0.88265270140991,2,15,positive regulation of collagen biosynthetic process,BP,F2R;ITGA2
4969,GO:0015078,0.348228200754432,0.787692131148774,7,75,proton transmembrane transporter activity,MF,SLC33A1;SLC9A7;SLC2A9;NDUFA4L2;SLC2A13;ATP12A;ATP6V1B2
507,GO:0001569,0.348247047386417,0.849506091742099,3,23,branching involved in blood vessel morphogenesis,BP,NFATC4;TGFBR2;EDNRA
12274,GO:0048569,0.34836155653659,0.883279449503382,2,14,post-embryonic animal organ development,BP,ERCC1;LDHA
12633,GO:0050820,0.348420371393874,0.882516224229465,2,15,positive regulation of coagulation,BP,F2R;HPSE
17946,GO:1902287,0.348533406299608,0.88623455633185,2,11,semaphorin-plexin signaling pathway involved in axon guidance,BP,PLXNB3;SEMA3F
13090,GO:0051599,0.348619044133137,0.946161435168861,1,4,response to hydrostatic pressure,BP,PKD2
12700,GO:0050918,0.348647144978981,0.826200544636077,4,35,positive chemotaxis,BP,PGF;PLXNB3;ITGA2;F2RL1
5009,GO:0015166,0.348963120061815,0.946044689940925,1,4,polyol transmembrane transporter activity,MF,SLC2A13
8486,GO:0033632,0.349100651463651,0.942800355564369,1,5,regulation of cell-cell adhesion mediated by integrin,BP,PODXL
15948,GO:0075044,0.349134529906695,0.945986473826036,1,4,autophagy of host cells involved in interaction with symbiont,BP,ULK2
15949,GO:0075071,0.349134529906695,0.945986473826036,1,4,autophagy involved in symbiotic interaction,BP,ULK2
16793,GO:0098631,0.349210128382779,0.825794276366087,4,35,cell adhesion mediator activity,MF,PLXNB3;ITGA1;EPCAM;ITGA2
12015,GO:0047555,0.349259672615646,0.945943947678239,1,4,3',5'-cyclic-GMP phosphodiesterase activity,MF,PDE5A
16142,GO:0090150,0.34927305390474,0.732427708273512,21,266,establishment of protein localization to membrane,BP,SYNE3;PRNP;BBS2;EGFR;ANK3;FYN;GDI1;CEMIP;STOM;PAK1;VAMP2;RAB31;COX18;SEC63;ZDHHC2;GRIN3B;ZDHHC1;MOAP1;LYPLA1;SSR3;SSR1
4970,GO:0015079,0.349382684317489,0.797513845256028,6,54,potassium ion transmembrane transporter activity,MF,KCNG1;SLC9A7;PKD2;SLC12A7;KCNJ15;ATP12A
13076,GO:0051583,0.349444313766898,0.940566635529878,1,6,dopamine uptake involved in synaptic transmission,BP,RAB3B
13256,GO:0051934,0.349444313766898,0.940566635529878,1,6,catecholamine uptake involved in synaptic transmission,BP,RAB3B
16315,GO:0090493,0.349444313766898,0.940566635529878,1,6,catecholamine uptake,BP,RAB3B
16316,GO:0090494,0.349444313766898,0.940566635529878,1,6,dopamine uptake,BP,RAB3B
15333,GO:0071549,0.349508248927435,0.84753560010651,3,26,cellular response to dexamethasone stimulus,BP,PCK2;EIF4EBP1;EGFR
16439,GO:0097091,0.349836616344664,0.945747630132703,1,4,synaptic vesicle clustering,BP,NLGN2
10009,GO:0042428,0.349865006028147,0.945737958902191,1,4,serotonin metabolic process,BP,RNF180
2117,GO:0004908,0.349897926866432,0.942514178504236,1,5,interleukin-1 receptor activity,MF,IL1RAP
6777,GO:0030212,0.350162879180727,0.847441750438161,3,25,hyaluronan metabolic process,BP,CEMIP;CD44;HYAL1
7087,GO:0030881,0.350201616365062,0.940285193190713,1,6,beta-2-microglobulin binding,MF,FCGRT
17955,GO:1902307,0.350276105968788,0.883036891990946,2,13,positive regulation of sodium ion transmembrane transport,BP,NOS1;ANK3
13041,GO:0051497,0.350403353863851,0.882964133012706,2,13,negative regulation of stress fiber assembly,BP,ARAP1;WASF2
4233,GO:0009411,0.35049565916149,0.756515720351321,12,123,response to UV,BP,ERCC1;CCND1;NFATC4;BRSK1;EGFR;ERCC6;MAPK13;XPC;IMPACT;ATF4;HYAL1;DDB2
9507,GO:0036155,0.350643712104963,0.942245712227167,1,5,acylglycerol acyl-chain remodeling,BP,MGLL
7969,GO:0032580,0.350770974228748,0.786326063875993,7,67,Golgi cisterna membrane,CC,ASAP2;B4GALT6;ARAP1;B4GALNT4;GALNT3;PITPNM1;GOLGA2P5
15347,GO:0071569,0.350802742256631,0.9400612297884,1,6,protein ufmylation,BP,UFL1
15835,GO:0072537,0.350913861951794,0.942148280073575,1,5,fibroblast activation,BP,CYGB
7402,GO:0031465,0.351095860555658,0.942082585262091,1,5,Cul4B-RING E3 ubiquitin ligase complex,CC,DDB2
14718,GO:0070358,0.351179643366369,0.942052327787372,1,5,actin polymerization-dependent cell motility,BP,JMY
16600,GO:0097422,0.351432278974694,0.941961033403916,1,5,tubular endosome,CC,SNX6
5858,GO:0017157,0.351500116809356,0.755736668002028,12,121,regulation of exocytosis,BP,RAB3B;SDC1;RAC2;VAMP2;PFN2;CEACAM1;RIMS3;SYTL1;F2RL1;SEPT5;RPH3AL;SYT2
9464,GO:0036066,0.35176426257451,0.881323086790545,2,14,protein O-linked fucosylation,BP,ADAMTS7;ADAMTSL1
3019,GO:0006564,0.351932955868063,0.939638793159955,1,6,L-serine biosynthetic process,BP,PSAT1
5923,GO:0018198,0.352335923421454,0.822887419866609,4,38,peptidyl-cysteine modification,BP,NOS1;RAB3B;ZDHHC2;ZDHHC1
2536,GO:0005793,0.352372353745464,0.764275452500063,10,102,endoplasmic reticulum-Golgi intermediate compartment,CC,NUCB2;MCFD2;LMAN1;COPB1;COPG1;AZIN2;TMED4;CTSZ;ERP44;DDHD2
17043,GO:0099518,0.352536489144736,0.807782103519978,5,42,vesicle cytoskeletal trafficking,BP,FYCO1;FNBP1L;RAB1A;AP3D1;WASL
7201,GO:0031090,0.352605049537353,0.67833505478918,188,2223,organelle membrane,CC,EDEM1;TSPAN1;NOS1;SORL1;RAB3B;VLDLR;ASAP2;SYNE3;CYP27B1;PRNP;BBS2;SLC16A3;FAM210B;ANTXR2;SH3KBP1;MARCH9;APPL2;PTPRS;B4GALT6;HADH;SNTB2;SNPH;EGFR;DYSF;ARMCX2;BNIP3;SLC33A1;ARAP1;DLG4;B3GNT3;IDH2;CD68;SNX9;SLC9A7;WNT7A;WDFY3;SEC23A;GRK5;RDH14;NME4;MALL;ASPH;MCTP1;CEMIP;ACAD11;STOM;DKK1;PAK1;SLC2A3;B4GALNT4;SHANK2;SCRN1;RAC2;CLCA2;CD44;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;KLHDC2;MCFD2;PKD2;LRP1;ST3GAL5;RAB11FIP4;ANXA3;ABCA7;ICA1;MARCH4;SNX14;LPCAT1;OCIAD2;GALNT3;VAMP2;ULK2;INPP5F;ABCG1;PITPNM1;ITPR3;FBXO2;CEACAM1;SPATA18;RAB31;LMAN1;DMXL2;MRPS6;BSG;EPN2;CLCN3;ANXA6;CD46;MVB12B;MAP6;ABHD17C;CST3;COX18;SLC35B4;CLTCL1;VPS11;MOSPD2;MYOF;ZDHHC2;APLP2;COPB1;COPG1;TST;SLC25A4;QSOX1;NDUFV3;CPT2;CRLS1;BOK;NIPSNAP1;USP6NL;DBNDD1;NDUFA4L2;COL6A1;BPHL;MVB12A;AZIN2;BCL2L1;CRAT;AGPAT3;GOLGA2P5;PCYOX1;SPIRE1;MAP2K2;SLC22A17;CYP4F22;MICU3;RET;STX10;RAB43;MTMR4;ZFYVE9;GABARAPL2;PUM2;SLC30A1;TMBIM1;SFXN3;SAMD8;SLC25A30;RAB1A;AP2A2;KDELR3;CMTM6;SLC25A43;ST6GALNAC2;CTSZ;AP3D1;ITPR2;MOAP1;PJA2;MAP4K2;EFCAB7;TMEM63A;SNX6;EVA1A;TMEM50B;ATP6V1B2;RPH3AL;AK9;ADAM8;ATP11B;ACAP2;TMEM9;MARCH2;WASL;LRP6;SYT2;TMEM173;SLC18A2;SIGMAR1;HPSE;COQ2;ARMCX3;DNAJC3;ZFYVE21;PSEN2;CDS2;PTCH1;COG8;SNX27;SLC44A1;GNAI1;RB1CC1
401,GO:0001077,0.352684365399,0.738778282657069,17,170,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,ETV4;POU2F2;TEF;DDIT3;SOX12;ELK3;HLTF;HMGA2;ATF4;PPARA;NFAT5;SOX4;CEBPG;PLAG1;MEF2D;ETV1;CREB3L2
2347,GO:0005391,0.352783713260777,0.941471210438263,1,5,sodium:potassium-exchanging ATPase activity,MF,ATP12A
3909,GO:0008556,0.352783713260777,0.941471210438263,1,5,potassium-transporting ATPase activity,MF,ATP12A
15032,GO:0070973,0.35286551284158,0.944709960346112,1,4,protein localization to endoplasmic reticulum exit site,BP,BCAP29
13200,GO:0051818,0.352888151133502,0.939280396827347,1,6,disruption of cells of other organism involved in symbiotic interaction,BP,F2RL1
13223,GO:0051883,0.352888151133502,0.939280396827347,1,6,killing of cells in other organism involved in symbiotic interaction,BP,F2RL1
6585,GO:0022412,0.353036731447253,0.735950268762713,18,185,cellular process involved in reproduction in multicellular organism,BP,ERCC1;ETV5;NEURL1;OSBP2;BBS2;UBE2J1;RFX2;PRKAR1A;ZNF449;SPESP1;BCL2L1;SPIRE1;REC8;PDE5A;MLH3;PRKACA;HSPA2;DNMT3A
15882,GO:0072608,0.353039882213789,0.939223350045368,1,6,interleukin-10 secretion,BP,F2RL1
11690,GO:0046474,0.353052311596752,0.733751442998977,19,194,glycerophospholipid biosynthetic process,BP,DGKA;PIGH;AGPAT4;FGFR1;LPCAT4;LPCAT1;INPP5F;PITPNM1;PLA2G4D;INPP4A;CSNK2A1;CRLS1;AGPAT3;MTMR4;ACP6;AGPAT1;DDHD2;CDS2;SLC44A1
17726,GO:1901655,0.353222110086437,0.784553748097728,7,65,cellular response to ketone,BP,PCK2;EIF4EBP1;EGFR;XRN1;PPARG;ADCY1;GNAI1
17491,GO:1900425,0.353488716820964,0.941214707648911,1,5,negative regulation of defense response to bacterium,BP,ARG2
2520,GO:0005774,0.35351402979245,0.715351489538647,31,342,vacuolar membrane,CC,TSPAN1;VLDLR;MARCH9;CD68;WDFY3;RDH14;STOM;LRP1;SNX14;LPCAT1;ANXA6;VPS11;COL6A1;PCYOX1;SLC22A17;ZFYVE9;GABARAPL2;TMBIM1;AP2A2;CMTM6;AP3D1;TMEM63A;EVA1A;TMEM50B;ATP6V1B2;ATP11B;TMEM9;MARCH2;HPSE;PSEN2;GNAI1
15278,GO:0071458,0.353564517199164,0.941187089134805,1,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2
8586,GO:0034067,0.353571972803102,0.846907791319143,3,21,protein localization to Golgi apparatus,BP,SORL1;VPS13A;OBSL1
17853,GO:1902042,0.354024832720436,0.844171363165095,3,27,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,BCL2L1;TMBIM1;FADD
14227,GO:0061180,0.354234534488541,0.793846439940716,6,53,mammary gland epithelium development,BP,ETV5;CCND1;BTRC;LRP5;LRP6;PTCH1
7567,GO:0031915,0.354260450120298,0.940933157474427,1,5,positive regulation of synaptic plasticity,BP,SSH1
9434,GO:0036005,0.354347407017972,0.940901382702452,1,5,response to macrophage colony-stimulating factor,BP,MST1R
9435,GO:0036006,0.354347407017972,0.940901382702452,1,5,cellular response to macrophage colony-stimulating factor stimulus,BP,MST1R
243,GO:0000578,0.354357526076041,0.845876736311087,3,22,embryonic axis specification,BP,WNT7A;PCSK6;PTCH1
14057,GO:0060831,0.354639805030374,0.880529243300271,2,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB;PTCH1
19515,GO:1990405,0.354844619210597,0.944025542460294,1,4,protein antigen binding,MF,ITGA4
15493,GO:0071863,0.355044195489656,0.940646401216155,1,5,regulation of cell proliferation in bone marrow,BP,HMGA2
15494,GO:0071864,0.355044195489656,0.940646401216155,1,5,positive regulation of cell proliferation in bone marrow,BP,HMGA2
62,GO:0000125,0.355067305095565,0.940637933276721,1,5,PCAF complex,CC,KAT2B
12661,GO:0050865,0.355426440785549,0.716956511570108,28,309,regulation of cell activation,BP,CYGB;SERPINE2;PRNP;PAG1;PKN1;FYN;DLG1;ARG2;PAK1;RAG1;TGFBR2;RAC2;APOE;CEACAM1;MMP14;CD46;F2RL1;PRKAR1A;XBP1;UBASH3B;PDE5A;SLC39A10;CARD11;AP3D1;IGF2;ADAM8;IL20RB;FADD
5163,GO:0015705,0.35572205620477,0.943720482189841,1,4,iodide transport,BP,ANO1
14400,GO:0061650,0.355943888086924,0.842869208614729,3,27,ubiquitin-like protein conjugating enzyme activity,MF,UBE2J1;UBE2G1;UBE2E1
5381,GO:0016199,0.355974435400266,0.943632551940083,1,4,axon midline choice point recognition,BP,ROBO3
918,GO:0002313,0.356159036173639,0.878020073909631,2,15,mature B cell differentiation involved in immune response,BP,XBP1;DOCK11
12654,GO:0050858,0.356431740341603,0.877205946897735,2,16,negative regulation of antigen receptor-mediated signaling pathway,BP,PRNP;CEACAM1
17847,GO:1902033,0.356713965392274,0.94003269312136,1,5,regulation of hematopoietic stem cell proliferation,BP,EIF2AK2
6100,GO:0019320,0.356871194286202,0.819576538950952,4,38,hexose catabolic process,BP,PGM1;LRP5;GLB1;GALE
8561,GO:0033993,0.356925079177932,0.696946470994156,53,591,response to lipid,BP,TNIP1;NOS1;F2R;CCND1;PCK2;CYP27B1;POSTN;NR1D1;NFATC4;FAM210B;EIF4EBP1;EGFR;LOXL1;TNFRSF6B;WNT7A;SDC1;DKK1;PAK1;SOCS2;TGFBR2;ACP5;ANXA3;PPARA;ITGA2;PTK6;ABCG1;MAPKAPK3;XRN1;TRIM5;NTSR1;TWF2;CST3;CSNK2A1;CRLS1;THRA;NGFR;GLB1;XBP1;RET;NR2F6;LPAR1;PPARG;ALDH1A2;TBX1;ENDOG;IGFBP7;LRP6;FOXP1;PTCH1;ADCY1;UFL1;GNAI1;DNMT3A
10485,GO:0043379,0.356974403184705,0.939936630753407,1,5,memory T cell differentiation,BP,CD46
16378,GO:0090713,0.356974403184705,0.939936630753407,1,5,immunological memory process,BP,CD46
16379,GO:0090715,0.356974403184705,0.939936630753407,1,5,immunological memory formation process,BP,CD46
11473,GO:0045927,0.357014439409189,0.734974379917017,17,169,positive regulation of growth,BP,BBS2;MAP1B;EGFR;GDI1;PAK1;TGFBR2;LPAR3;FGFR1;HYAL1;MMP14;TWF2;CSNK2A1;CHD7;SH3PXD2B;WFS1;SYT2;ADNP
2044,GO:0004791,0.357284421251595,0.937614571132018,1,6,thioredoxin-disulfide reductase activity,MF,TXNRD3
14700,GO:0070324,0.357519723946024,0.939735190969555,1,5,thyroid hormone binding,MF,THRA
9679,GO:0038044,0.357672979223517,0.943038615548784,1,4,transforming growth factor-beta secretion,BP,FERMT1
9864,GO:0042117,0.357685622228706,0.939673828470888,1,5,monocyte activation,BP,FOXP1
4330,GO:0009855,0.357838956740839,0.772792373289192,8,74,determination of bilateral symmetry,BP,ACVR2B;DDIT3;TGFBR2;PKD2;PCSK6;PSKH1;ALDH1A2;TBX1
12256,GO:0048536,0.357893829233705,0.84260921263736,3,24,spleen development,BP,PKN1;JARID2;FADD
8038,GO:0032687,0.357990770503133,0.939560862396163,1,5,negative regulation of interferon-alpha production,BP,PTPRS
2345,GO:0005385,0.358050860264259,0.87690849763669,2,15,zinc ion transmembrane transporter activity,MF,SLC30A1;SLC39A10
15349,GO:0071577,0.358050860264259,0.87690849763669,2,15,zinc ion transmembrane transport,BP,SLC30A1;SLC39A10
16067,GO:0090022,0.358282589626263,0.875025553244355,2,18,regulation of neutrophil chemotaxis,BP,RAC2;MOSPD2
16065,GO:0089720,0.358290814209094,0.937229446267551,1,6,caspase binding,MF,FADD
7913,GO:0032486,0.358319926780166,0.878394310823064,2,13,Rap protein signal transduction,BP,RAPGEF3;TIMP2
1407,GO:0003341,0.35833813827362,0.842307604269807,3,24,cilium movement,BP,BBS2;WDR66;CCSAP
8452,GO:0033578,0.3583791538514,0.939416899365246,1,5,protein glycosylation in Golgi,BP,LMF1
849,GO:0002175,0.358692348179201,0.942680363861519,1,4,protein localization to paranode region of axon,BP,EPB41L3
10608,GO:0043586,0.358746603738777,0.87725931370222,2,14,tongue development,BP,EGFR;TBX1
2385,GO:0005521,0.3588228228262,0.877214586713098,2,14,lamin binding,MF,PRNP;BNIP3L
9771,GO:0039535,0.35882589717942,0.878099342450313,2,13,regulation of RIG-I signaling pathway,BP,DDX60;PUM2
11210,GO:0045342,0.358954714167501,0.939203177162565,1,5,MHC class II biosynthetic process,BP,XBP1
11213,GO:0045346,0.358954714167501,0.939203177162565,1,5,regulation of MHC class II biosynthetic process,BP,XBP1
7528,GO:0031748,0.359118595587556,0.939142240668306,1,5,D1 dopamine receptor binding,MF,DLG4
1324,GO:0003175,0.359223467543515,0.942493167208852,1,4,tricuspid valve development,BP,TGFBR2
1332,GO:0003186,0.359223467543515,0.942493167208852,1,4,tricuspid valve morphogenesis,BP,TGFBR2
3791,GO:0008356,0.359361483374627,0.876898262851554,2,14,asymmetric cell division,BP,ETV5;RGS14
4069,GO:0009120,0.359504243672683,0.936763210632894,1,6,deoxyribonucleoside metabolic process,BP,TK2
9548,GO:0036303,0.359536586868017,0.878733317419504,2,12,lymph vessel morphogenesis,BP,ACVR2B;PPP3CB
5691,GO:0016811,0.359629700577852,0.778898023101831,7,70,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,RCOR1;NACC2;MTA1;PM20D2;ARID4A;NIT2;PHF21A
13266,GO:0051953,0.359742900189011,0.938909768101363,1,5,negative regulation of amine transport,BP,STK39
2094,GO:0004860,0.3597684433449,0.778697853986027,7,71,protein kinase inhibitor activity,MF,SOCS2;TRIB2;TRIB3;PRKAR1A;SPRY2;DNAJC3;KAT2B
5160,GO:0015698,0.360087069971041,0.764007701707325,9,85,inorganic anion transport,BP,PRNP;CLCA2;FGFR1;CLCN3;TTYH3;ANO8;ANO1;SLC12A7;PCYOX1
14148,GO:0061028,0.360372305686896,0.818177363173943,4,33,establishment of endothelial barrier,BP,RAPGEF3;PTPRS;WNT7A;F2RL1
12836,GO:0051146,0.360416063217773,0.73759436869574,15,146,striated muscle cell differentiation,BP,NOS1;FLNC;CAPN2;SDC1;DKK1;PAK1;OBSCN;TMOD2;OBSL1;MMP14;MYOF;PRKAR1A;THRA;XBP1;TBX1
1344,GO:0003207,0.360434495669824,0.942064952167397,1,4,cardiac chamber formation,BP,SOX4
1347,GO:0003211,0.360434495669824,0.942064952167397,1,4,cardiac ventricle formation,BP,SOX4
18565,GO:1903789,0.361151019414317,0.938383471532747,1,5,regulation of amino acid transmembrane transport,BP,STK39
3217,GO:0006863,0.361278515879303,0.936077769066819,1,6,purine nucleobase transport,BP,SLC25A4
2222,GO:0005125,0.361284267966431,0.776779883596209,7,80,cytokine activity,MF,CMTM4;TNFSF15;WNT7A;CMTM7;C5;CMTM6;CKLF
11377,GO:0045742,0.361914453630859,0.839479408518351,3,25,positive regulation of epidermal growth factor receptor signaling pathway,BP,NEURL1;ARAP1;PTK6
9697,GO:0038093,0.36194433660617,0.73886923100755,14,154,Fc receptor signaling pathway,BP,PSMD2;FCGRT;WIPF1;FYN;SHC1;PAK1;BTRC;PPP3CB;PSMD7;WASF2;NCKAP1;CARD11;ARPC1A;WASL
4541,GO:0010614,0.362093054119724,0.875288061083387,2,14,negative regulation of cardiac muscle hypertrophy,BP,PAK1;JARID2
4879,GO:0014741,0.362093054119724,0.875288061083387,2,14,negative regulation of muscle hypertrophy,BP,PAK1;JARID2
2983,GO:0006526,0.362149879919611,0.93800849373231,1,5,arginine biosynthetic process,BP,NAGS
8286,GO:0033089,0.362203912897926,0.937988170461721,1,5,positive regulation of T cell differentiation in thymus,BP,ADAM8
11404,GO:0045794,0.362280342039717,0.941408568657491,1,4,negative regulation of cell volume,BP,CLCN3
11158,GO:0045214,0.362294617385044,0.841029838326547,3,21,sarcomere organization,BP,OBSCN;OBSL1;PRKAR1A
5269,GO:0015917,0.362315878712655,0.941395887887152,1,4,aminophospholipid transport,BP,ATP11B
1233,GO:0002921,0.362332497880558,0.937939790052718,1,5,negative regulation of humoral immune response,BP,SERPING1
15848,GO:0072559,0.362334098569908,0.935667875815903,1,6,NLRP3 inflammasome complex,CC,CASP4
12060,GO:0048008,0.362465115825181,0.800402704358576,5,41,platelet-derived growth factor receptor signaling pathway,BP,PLAT;PTPN12;RGS14;LRP1;ARID5B
788,GO:0002051,0.362471951442762,0.941340175820606,1,4,osteoblast fate commitment,BP,SH3PXD2B
3030,GO:0006576,0.3625118402448,0.838071336302456,3,28,cellular biogenic amine metabolic process,BP,ALDH7A1;AZIN2;SLC44A1
16212,GO:0090245,0.362692325957595,0.941261455863619,1,4,axis elongation involved in somitogenesis,BP,LRP6
17862,GO:1902075,0.362734720095725,0.935511900002588,1,6,cellular response to salt,BP,MAPK13
10408,GO:0043243,0.362746891569651,0.839730919618239,3,23,positive regulation of protein complex disassembly,BP,BNIP3;FYCO1;F2RL1
19166,GO:1905206,0.362797933973057,0.937764478905116,1,5,positive regulation of hydrogen peroxide-induced cell death,BP,ENDOG
13520,GO:0055091,0.362936340644127,0.941174216815445,1,4,phospholipid homeostasis,BP,ABCG1
1444,GO:0003433,0.363006344384689,0.937685882638996,1,5,chondrocyte development involved in endochondral bone morphogenesis,BP,TGFBR2
12250,GO:0048524,0.363092646273035,0.760844455466501,9,95,positive regulation of viral process,BP,ADARB1;PC;STOM;APOE;MVB12B;MVB12A;YTHDC2;RSF1;TRIM38
13511,GO:0055081,0.363186453031281,0.816394285142373,4,32,anion homeostasis,BP,APOE;ABCG1;SLC12A7;XBP1
14326,GO:0061502,0.36323782917008,0.94106632166828,1,4,early endosome to recycling endosome transport,BP,SORL1
14731,GO:0070383,0.363340977450124,0.93527543298952,1,6,DNA cytosine deamination,BP,APOBEC3C
195,GO:0000413,0.363535480751384,0.836815035500415,3,30,protein peptidyl-prolyl isomerization,BP,FKBP9;FKBP1A;FKBP10
1478,GO:0003755,0.363535480751384,0.836815035500415,3,30,peptidyl-prolyl cis-trans isomerase activity,MF,FKBP9;FKBP1A;FKBP10
4425,GO:0010248,0.363580401041115,0.93518190450852,1,6,establishment or maintenance of transmembrane electrochemical gradient,BP,ATP12A
6920,GO:0030512,0.363615191592309,0.78628880355635,6,54,negative regulation of transforming growth factor beta receptor signaling pathway,BP,SMURF2;LTBP1;HTRA1;TGFBR2;MTMR4;SNX6
4842,GO:0014048,0.363820058951404,0.937378441043904,1,5,regulation of glutamate secretion,BP,NTSR1
4740,GO:0010907,0.363837997505836,0.839457975792486,3,22,positive regulation of glucose metabolic process,BP,PPARA;IGF2;KAT2B
11284,GO:0045591,0.363932495138026,0.935044215447402,1,6,positive regulation of regulatory T cell differentiation,BP,CD46
9449,GO:0036035,0.363937690843786,0.875099691304887,2,13,osteoclast development,BP,FAM20C;FOXP1
11482,GO:0045939,0.36414918868429,0.872617363109953,2,16,negative regulation of steroid metabolic process,BP,CYP27B1;APOE
11059,GO:0045056,0.364395075609099,0.873923131923262,2,14,transcytosis,BP,FCGRT;LRP1
15258,GO:0071425,0.364410110106228,0.873914193679031,2,14,hematopoietic stem cell proliferation,BP,WNT2B;EIF2AK2
16206,GO:0090237,0.364668419627592,0.937056939293434,1,5,regulation of arachidonic acid secretion,BP,NTSR1
5693,GO:0016813,0.364856891988017,0.934681889720833,1,6,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,ARG2
11468,GO:0045922,0.364923832263413,0.872828884399774,2,15,negative regulation of fatty acid metabolic process,BP,CEACAM1;TRIB3
3460,GO:0007272,0.365215081546985,0.759930062657165,9,82,ensheathment of neurons,BP,SCN8A;SH3TC2;MARVELD1;DLG1;MALL;WASF3;EPB41L3;LPAR1;CLDN11
3795,GO:0008366,0.365215081546985,0.759930062657165,9,82,axon ensheathment,BP,SCN8A;SH3TC2;MARVELD1;DLG1;MALL;WASF3;EPB41L3;LPAR1;CLDN11
7141,GO:0030976,0.36541066340386,0.936774839077946,1,5,thiamine pyrophosphate binding,MF,DHTKD1
3703,GO:0008210,0.365635194078303,0.871130046401927,2,17,estrogen metabolic process,BP,HSD17B7;HSD17B12
11289,GO:0045599,0.365652995334361,0.814022193820754,4,34,negative regulation of fat cell differentiation,BP,WWTR1;DDIT3;TRIB2;TRIB3
15874,GO:0072593,0.365906615205608,0.732192308883627,15,165,reactive oxygen species metabolic process,BP,XDH;NOS1;GPX3;EGFR;BNIP3;ARG2;TGFBR2;RAC2;ACP5;PKD2;PRDX5;F2RL1;ARF4;SH3PXD2B;SLC18A2
14407,GO:0061673,0.365995283778587,0.936552110689905,1,5,mitotic spindle astral microtubule,CC,CCSAP
10482,GO:0043374,0.366050894473787,0.936530899569424,1,5,CD8-positive, alpha-beta T cell differentiation,BP,SATB1
7882,GO:0032449,0.366099783693924,0.936512248635424,1,5,CBM complex,CC,CARD11
5326,GO:0016052,0.366156670142299,0.739056517977293,13,133,carbohydrate catabolic process,BP,PYGL;PYGB;CRYL1;DHTKD1;PGM1;LDHA;PPARA;ABHD10;LRP5;CTBS;GLB1;GALE;RB1CC1
3271,GO:0006942,0.366353625090697,0.796812044802941,5,44,regulation of striated muscle contraction,BP,NOS1;DLG1;AKAP9;PDE5A;PRKACA
9098,GO:0035360,0.366392775090297,0.936400405022076,1,5,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B
2093,GO:0004859,0.366443395771252,0.932411813810657,1,7,phospholipase inhibitor activity,MF,ANXA3
16066,GO:0090009,0.366685115436643,0.939824091951326,1,4,primitive streak formation,BP,LRP6
3494,GO:0007386,0.366818620768661,0.93623763531796,1,5,compartment pattern specification,BP,PBX3
12166,GO:0048284,0.367041961560643,0.734633110626492,14,146,organelle fusion,BP,TBC1D14;DYSF;BNIP3;EVI5L;VAMP2;SEC22C;VPS11;SYTL1;USP6NL;TBC1D2B;STX10;EVI5;TBC1D16;SYT2
627,GO:0001816,0.367075893629508,0.694959038764441,40,451,cytokine production,BP,F2R;PRNP;POSTN;NFATC4;ALOX15B;DDIT3;PTPRS;UBE2J1;MAPK13;DLG1;IGF2BP3;ARG2;TRIB2;ACP5;ATF4;FGFR1;NFAT5;CEACAM1;FERMT1;CD46;CEBPG;F2RL1;DDX60;XBP1;C5;PUM2;RNF135;TMSB4X;EIF2AK2;RAB1A;IFI16;IL1RAP;CARD11;AGPAT1;ADAM8;IL20RB;TMEM173;HPSE;FOXP1;FADD
13495,GO:0055056,0.367266310051452,0.936066245844235,1,5,D-glucose transmembrane transporter activity,MF,SLC2A3
6952,GO:0030579,0.367475009704542,0.935986254245788,1,5,ubiquitin-dependent SMAD protein catabolic process,BP,SMURF2
2639,GO:0005975,0.367612483819714,0.694482309802884,40,447,carbohydrate metabolic process,BP,PCK2;PYGL;PYGB;CRYL1;IGFBP4;NR1D1;H6PD;DHTKD1;PC;B4GALT6;PGM1;ISYNA1;B3GNT3;IDH2;GLO1;PGLS;SLC2A3;LDHA;ST3GAL5;ATF4;PPARA;ABHD10;HYAL1;GALNT3;NTSR1;LRP5;SLC35B4;MLYCD;CTBS;NPL;GLB1;PPP1R2;ST6GALNAC2;IGF2;COQ2;KAT2B;OAS1;GALE;SLC23A2;RB1CC1
4317,GO:0009799,0.368069233996465,0.764235415450104,8,75,specification of symmetry,BP,ACVR2B;DDIT3;TGFBR2;PKD2;PCSK6;PSKH1;ALDH1A2;TBX1
20197,GO:2001054,0.368111023067353,0.93574210715811,1,5,negative regulation of mesenchymal cell apoptotic process,BP,TBX1
14939,GO:0070822,0.368161459559624,0.871674250018717,2,14,Sin3-type complex,CC,PHF12;CSNK2A1
2026,GO:0004758,0.368176337908121,0.935717002928081,1,5,serine C-palmitoyltransferase activity,MF,SPTLC2
5506,GO:0016454,0.368176337908121,0.935717002928081,1,5,C-palmitoyltransferase activity,MF,SPTLC2
9049,GO:0035265,0.368507320319847,0.751190061255337,10,92,organ growth,BP,ACVR2B;PAK1;TGFBR2;WWC3;FGFR1;THBS3;PLAG1;PRKAR1A;SPRY2;JARID2
17707,GO:1901616,0.368556647180533,0.811151100086583,4,37,organic hydroxy compound catabolic process,BP,CYP27B1;APOE;NTSR1;SRD5A3
4836,GO:0014042,0.368664705211954,0.93910362660945,1,4,positive regulation of neuron maturation,BP,RET
6523,GO:0021903,0.368709143038394,0.935511994329158,1,5,rostrocaudal neural tube patterning,BP,LRP6
18462,GO:1903555,0.368717266609293,0.771483531957257,7,70,regulation of tumor necrosis factor superfamily cytokine production,BP,NFATC4;UBE2J1;ARG2;ACP5;ADAM8;FOXP1;FADD
15773,GO:0072367,0.368745844295542,0.9390739850795,1,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,PPARA
9669,GO:0038027,0.368788748251866,0.939058307967003,1,4,apolipoprotein A-I-mediated signaling pathway,BP,ABCA7
13755,GO:0060331,0.368912076198289,0.933078115735424,1,6,negative regulation of response to interferon-gamma,BP,PPARG
13760,GO:0060336,0.368912076198289,0.933078115735424,1,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,PPARG
5624,GO:0016684,0.369178564768041,0.832403453904388,3,32,oxidoreductase activity, acting on peroxide as acceptor,MF,CYGB;GPX3;PRDX5
5813,GO:0017075,0.36928695193399,0.870998438324688,2,14,syntaxin-1 binding,MF,SNPH;VAMP2
12228,GO:0048485,0.369467024274672,0.87181474069956,2,13,sympathetic nervous system development,BP,SOX4;SEMA3F
3015,GO:0006560,0.369475918911549,0.932853271443775,1,6,proline metabolic process,BP,ALDH4A1
7238,GO:0031146,0.369567678182221,0.77984177064318,6,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,WWTR1;PSMD2;BTRC;FBXO2;PSMD7;FBXL5
3800,GO:0008378,0.369762126425646,0.833358048921659,3,27,galactosyltransferase activity,MF,B4GALT6;B3GNT3;WDFY3
4039,GO:0009071,0.369784226728898,0.932730135381696,1,6,serine family amino acid catabolic process,BP,CBS
18933,GO:1904684,0.370238101441457,0.938527271937918,1,4,negative regulation of metalloendopeptidase activity,BP,SORL1
10083,GO:0042583,0.370323678935579,0.934888357017501,1,5,chromaffin granule,CC,SYT2
4023,GO:0009055,0.370384350034092,0.76882813586291,7,88,electron transfer activity,MF,XDH;ASPH;NDUFA4L2;TXNRD3;LOXL2;ALDH4A1;AOX1
12069,GO:0048017,0.370442270356123,0.744072707240212,11,107,inositol lipid-mediated signaling,BP,F2R;SERPINE2;EGFR;FYN;FGFR1;INPP5F;CEACAM1;F2RL1;RGL2;IGF2;NYAP1
20102,GO:2000773,0.37054580411321,0.870240480976544,2,14,negative regulation of cellular senescence,BP,HMGA2;AKT3
19681,GO:2000001,0.371008201848528,0.86847034797228,2,16,regulation of DNA damage checkpoint,BP,ETAA1;PPP1R10
12232,GO:0048489,0.371113840365901,0.76161035625289,8,76,synaptic vesicle transport,BP,SNPH;VAMP2;PFN2;RIMS3;SYTL1;SEPT5;AP3D1;SYT2
16628,GO:0097480,0.371113840365901,0.76161035625289,8,76,establishment of synaptic vesicle localization,BP,SNPH;VAMP2;PFN2;RIMS3;SYTL1;SEPT5;AP3D1;SYT2
17587,GO:1901222,0.371264478961159,0.792319643451624,5,48,regulation of NIK/NF-kappaB signaling,BP,TNFSF15;EGFR;UACA;TMSB4X;EIF2AK2
13628,GO:0060123,0.37132903365197,0.938125708600077,1,4,regulation of growth hormone secretion,BP,CHD7
10258,GO:0042996,0.371330829431217,0.934497492689025,1,5,regulation of Golgi to plasma membrane protein transport,BP,LYPLA1
2823,GO:0006287,0.371397966532478,0.934471387201033,1,5,base-excision repair, gap-filling,BP,POLL
17081,GO:0099601,0.37154524437024,0.833230270386916,3,24,regulation of neurotransmitter receptor activity,BP,DLG4;SHANK2;NLGN2
18509,GO:1903670,0.371589464237738,0.792743537105753,5,44,regulation of sprouting angiogenesis,BP,CEACAM1;EPN2;NGFR;SRPX2;AKT3
5132,GO:0015616,0.371591768201243,0.938028760138751,1,4,DNA translocase activity,MF,ATRX
19458,GO:1990144,0.371621185502454,0.931993651471356,1,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,BNIP3
7500,GO:0031672,0.371646354496915,0.835878886640163,3,19,A band,CC,OBSCN;OBSL1;KAT2B
772,GO:0002026,0.371916902917054,0.869412451949115,2,14,regulation of the force of heart contraction,BP,NOS1;APLN
3123,GO:0006702,0.371947423399609,0.934257500723924,1,5,androgen biosynthetic process,BP,SRD5A3
13538,GO:0055123,0.372111357904123,0.754110178762496,9,82,digestive system development,BP,ITGA6;ITGB4;ACVR2B;EGFR;TGFBR2;PTK6;XBP1;RET;ALDH1A2
18636,GO:1903935,0.372119253863525,0.931793130967888,1,6,response to sodium arsenite,BP,MAPK13
3581,GO:0007625,0.372337106017774,0.931705312718275,1,6,grooming behavior,BP,DLG4
12760,GO:0051029,0.372618193634322,0.931591903094607,1,6,rRNA transport,BP,TST
19771,GO:2000181,0.372660940409602,0.768960825742094,7,63,negative regulation of blood vessel morphogenesis,BP,XDH;THBS2;EPN2;ADGRB2;SPRY2;NGFR;PPARG
10388,GO:0043217,0.37279442650949,0.870922750099904,2,12,myelin maintenance,BP,SH3TC2;EPB41L3
10190,GO:0042789,0.372920936988636,0.868804452381122,2,14,mRNA transcription by RNA polymerase II,BP,DDIT3;ATF4
320,GO:0000836,0.373060208433859,0.933823035406987,1,5,Hrd1p ubiquitin ligase complex,CC,SEL1L
11078,GO:0045078,0.373087823922566,0.933812231442639,1,5,positive regulation of interferon-gamma biosynthetic process,BP,CEBPG
13600,GO:0060070,0.37310841662921,0.709643089906861,22,238,canonical Wnt signaling pathway,BP,SMURF2;CCND1;IGFBP4;WWTR1;DDIT3;PSMD2;WNT7A;SDC1;DKK1;APOE;BTRC;SOX4;FERMT1;DVL1;LRP5;PSMD7;WNT2B;TBL1X;FZD8;LRP6;ANKRD6;LRP4
14254,GO:0061304,0.37312726354281,0.93746031453705,1,4,retinal blood vessel morphogenesis,BP,LRP5
13867,GO:0060484,0.373127663732639,0.933796643094718,1,5,lung-associated mesenchyme development,BP,FGFR1
12613,GO:0050794,0.37313292015719,0.652073362947528,615,7104,regulation of cellular process,BP,TNIP1;DOCK4;FHL1;DDIT4L;XDH;PLAT;SMURF2;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FAM83A;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;ASAP2;SYNE3;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;SERPINE2;PEAR1;ADCY7;IGFBP4;PRNP;PAG1;ADGRF1;ITGB4;BBS2;MARCKSL1;POSTN;SH3TC2;ADM2;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;CMTM4;THBS2;FAM210B;FMNL2;ETV4;TFPI2;LTBP2;RAPGEF3;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;ALOX15B;LMF1;SALL2;PKN1;WWTR1;DCBLD2;PEG3;CCNI;MST1R;ARHGAP22;APLN;POU2F2;TRIM65;PITPNC1;DGKA;TEF;TNFSF15;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;DDIT3;KCNG1;PTPRS;CCNG2;SMARCA1;HADH;SOX12;PSMD2;LAMB1;ELK3;CRTC1;ADGRL1;CAPN2;BRSK1;FCGRT;WIPF1;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;BCORL1;CGREF1;ARHGAP12;PPP1R14A;FYN;HEBP1;TNFRSF6B;TSPAN5;BNIP3;HLTF;KIF13B;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;PARVB;ARAP1;ADAMTS7;ZNF516;DLG1;CSMD3;DLG4;IDH2;CTSB;DNAJB5;PLXNB3;GPC4;SNX9;TYSND1;PODXL;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;EVI5L;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;TTBK2;SPTLC2;GRK5;HTR7;STRADB;NME4;CRTAP;ASPH;MCTP1;GDI1;CEMIP;SDC1;ARG2;SHC1;DLG3;DKK1;WISP1;DAP;SMOC2;PAK1;RASA3;SOCS2;TRIB2;KIAA1549;RHPN1;ZNF652;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;EDNRA;LCN2;SHANK2;SLITRK6;EPHA1;IMPACT;RALGAPA2;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;CCPG1;CCND2;ACP5;ANGPTL4;PTPN12;AFAP1;RGS14;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;FYCO1;IDE;AKAP9;RAB11FIP4;FAM208A;PPP2R3B;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;ICA1;EIF4E3;LPAR3;ELFN2;ASNS;FGFR1;ITGA1;AARS;PPP1R35;E2F5;EPCAM;TMOD2;TUB;CMTM7;TCFL5;SMOC1;NFAT5;ITGB5;HYAL1;BTRC;LPCAT1;ITGA2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;ABCG1;KIAA1109;SOX4;PITPNM1;APOBEC3C;FHOD1;ITPR3;FBXO2;DDB2;CEP120;ZNF558;CEACAM1;FERMT1;MAPKAPK3;ZNF692;OBSL1;PDIA5;RAB31;LMAN1;MT2A;UACA;ATF7IP;FAM110C;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;PLEK2;HES2;ANXA6;NLGN2;CD46;ZBTB10;PHF12;MVB12B;EPOR;CTH;ZNF704;NXPH4;LRP5;ETAA1;ZMYM3;DNMBP;KLF12;CTSL;DOCK9;TWF2;CST3;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;TPBG;TOM1L2;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;RIMS3;PLPPR2;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;INPP4A;RFX2;SYTL1;ADGRB2;APLP2;DNAJC6;SLK;PRDX5;MLYCD;CEBPG;PLAG1;FNBP1L;CDC42BPA;F2RL1;DDX60;UHRF2;RASIP1;TAOK1;PHC3;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;SLC25A4;QSOX1;ASAP1;PRKAR1A;ANO1;MSRB2;JMY;BOK;PARP9;CPEB4;SDCCAG3;C18ORF32;ATXN2;MAST3;NACC2;USP6NL;SPRY2;SEPT5;ZNF337;BEX4;TBC1D2B;THRA;MGLL;WNT2B;ACVR1B;NGFR;ZNF280D;PPP1R10;PSKH1;MVB12A;GLUD1;TSHZ1;MARK4;ZNF449;PTPRZ1;CHD6;NUDT6;PER3;MTA1;BCL2L1;IFITM1;RNF165;PM20D2;GRIN3B;MEF2D;WASF2;SKAP2;ARF4;H2AFJ;XBP1;SPIRE1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SATB1;SLC22A17;PPP1R2;PAIP1;ARRDC1;ANKIB1;TLE4;RIN1;TRPC1;RET;CCDC71L;LOXL2;PDE5A;TCTN1;RAB43;SH3PXD2B;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;THAP10;NCKAP1;GABARAPL2;EPM2A;RMRP;GTF2IRD2;C1ORF56;DOCK11;PAK6;EAPP;PUM2;SLC30A1;TSPAN3;PSD3;TMBIM1;ETV1;COL1A2;CCDC88A;CCSAP;TMED4;SAMD8;SHC2;PRKACA;SAMD5;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;EPB41L3;SEL1L;CBX7;IFI16;RHOBTB1;AP2A2;NR2F6;SLC39A10;KDELR3;CMTM6;SCAND1;IL1RAP;SBNO1;CARD11;LTB4R;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;AP3D1;ARID4A;ARPC1A;TENM2;IGF2;ITPR2;MOAP1;LAMA5;AGPAT1;PJA2;ZSCAN18;GRB10;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;CITED4;SNX6;USP20;ZFP30;GRB7;SRPX2;ALDH1A2;GPR153;ARHGAP29;LYPLA1;ZNF37A;TBX1;EVI5;CREB3L2;ERP44;ATP6V1B2;RPH3AL;RSF1;ADAM8;AKT3;ROBO3;IL20RB;WFS1;DEPDC1;ENDOG;ITGA4;PHF21A;ZBTB40;ZNF92;ACAP2;MAML3;CKLF;ZNF568;IGFBP7;TBC1D16;DDHD2;FZD8;WASL;RAPGEFL1;HSPA2;ZNF107;FLNB;LRP6;ARID5B;MAGEF1;ZNF165;SYT2;PLCH2;TMEM173;RNF180;E2F7;EEF2K;ZNF320;SLC18A2;SIGMAR1;HPSE;RALGDS;SSR1;TNRC6C;TRIM2;RCAN1;TET1;OMG;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;USP25;PRMT3;NYAP1;UFL1;FAM162A;ANKRD6;SNX27;PBX3;JARID2;SEMA3F;RALGPS2;KLHL15;MXD4;ADNP;GNAI1;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FBXL5;FADD
12152,GO:0048259,0.373172676365028,0.778368858840806,6,56,regulation of receptor-mediated endocytosis,BP,APLN;DLG4;DKK1;DNAJC6;ATXN2;WASL
5375,GO:0016188,0.373310456863931,0.933725092094313,1,5,synaptic vesicle maturation,BP,DLG4
9244,GO:0035637,0.37333203114073,0.747202498333109,10,90,multicellular organismal signaling,BP,NOS1;SCN8A;ANK3;ASPH;AKAP9;ITGA2;ITPR3;TRPC1;PRKACA;ITPR2
5867,GO:0017176,0.373381829913399,0.929574403653961,1,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,PIGH
4227,GO:0009404,0.373523584194737,0.866320497650965,2,17,toxin metabolic process,BP,CBS;CTH
20257,GO:2001214,0.373615383942993,0.933605629836015,1,5,positive regulation of vasculogenesis,BP,CEACAM1
5549,GO:0016554,0.373640285904593,0.931178566414091,1,6,cytidine to uridine editing,BP,APOBEC3C
19615,GO:1990763,0.373659219792888,0.933588445411727,1,5,arrestin family protein binding,MF,ARRDC1
4014,GO:0009008,0.373692597906197,0.933575358797785,1,5,DNA-methyltransferase activity,MF,DNMT3A
3219,GO:0006865,0.37402484999888,0.759090445290305,8,77,amino acid transport,BP,STK39;VAMP2;NTSR1;SLC6A6;SLC6A14;SLC43A1;SLC38A2;SLC7A11
2946,GO:0006474,0.374065046691757,0.868109930000954,2,14,N-terminal protein amino acid acetylation,BP,SOX4;KAT2B
12788,GO:0051082,0.374223645917216,0.751100882920908,9,101,unfolded protein binding,MF,DNAJB5;NUDCD3;ERO1B;FYCO1;LMAN1;HSPA13;ERLEC1;HSPA2;DNAJC4
2216,GO:0005113,0.374257106569036,0.933353794261921,1,5,patched binding,MF,PTCH1
5345,GO:0016093,0.374631735682181,0.930776186744269,1,6,polyprenol metabolic process,BP,SRD5A3
8040,GO:0032689,0.374636802686496,0.865634819518816,2,17,negative regulation of interferon-gamma production,BP,PRNP;IL20RB
13606,GO:0060076,0.375569182205941,0.868140653321446,2,13,excitatory synapse,CC,DLG4;SRPX2
726,GO:0001955,0.375807244991388,0.932743077323832,1,5,blood vessel maturation,BP,DDIT3
9460,GO:0036056,0.375859801816775,0.936440876690004,1,4,filtration diaphragm,CC,PODXL
9461,GO:0036057,0.375859801816775,0.936440876690004,1,4,slit diaphragm,CC,PODXL
6398,GO:0021604,0.375887060398211,0.932711540514227,1,5,cranial nerve structural organization,BP,SEMA3F
6400,GO:0021612,0.375887060398211,0.932711540514227,1,5,facial nerve structural organization,BP,SEMA3F
2542,GO:0005801,0.375958755249393,0.788967592659153,5,46,cis-Golgi network,CC,AKAP9;BOK;AZIN2;GOLGA2P5;ANGEL1
11344,GO:0045667,0.375976476509779,0.757538363335105,8,76,regulation of osteoblast differentiation,BP,CTNNBIP1;ACVR2B;SMOC1;FAM20C;LRP5;IFITM1;PRKACA;PTCH1
649,GO:0001839,0.375994814532808,0.932668950276375,1,5,neural plate morphogenesis,BP,DVL1
1797,GO:0004435,0.376133419863438,0.866849741904764,2,14,phosphatidylinositol phospholipase C activity,MF,EDNRA;PLCH2
5961,GO:0018345,0.376420780828021,0.828689998816272,3,27,protein palmitoylation,BP,ABHD17C;ZDHHC2;ZDHHC1
13636,GO:0060135,0.376550188725234,0.788862298333318,5,44,maternal process involved in female pregnancy,BP,CYP27B1;ADCY7;CTSB;BSG;EPOR
1018,GO:0002517,0.376881817365637,0.932317737443328,1,5,T cell tolerance induction,BP,TGFBR2
1081,GO:0002664,0.376881817365637,0.932317737443328,1,5,regulation of T cell tolerance induction,BP,TGFBR2
16217,GO:0090257,0.377110609970642,0.733639882796303,12,119,regulation of muscle system process,BP,DOCK4;NOS1;F2R;DLG1;PAK1;AKAP9;ITGA2;ANXA6;PDE5A;MTMR4;PRKACA;JARID2
17711,GO:1901621,0.377138213166133,0.932216009679892,1,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
19412,GO:1905953,0.377143813281372,0.829316740942347,3,24,negative regulation of lipid localization,BP,PPARA;ABCG1;PPARG
17415,GO:1900151,0.377152657861914,0.86622657456577,2,14,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,TNRC6B;TNRC6C
17417,GO:1900153,0.377152657861914,0.86622657456577,2,14,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,TNRC6B;TNRC6C
6820,GO:0030278,0.377401236010344,0.733431115697183,12,118,regulation of ossification,BP,CTNNBIP1;CYP27B1;ACVR2B;DKK1;SMOC1;FAM20C;LRP5;IFITM1;PRKACA;LRP6;PTCH1;LRP4
9215,GO:0035601,0.377626662843045,0.742931482355877,10,99,protein deacylation,BP,RCOR1;ABHD17C;NACC2;BEX4;MTA1;LYPLAL1;TBL1X;ARID4A;LYPLA1;PHF21A
4206,GO:0009314,0.377758606441439,0.692983714285395,31,341,response to radiation,BP,ERCC1;CCND1;NFATC4;CRTC1;BRSK1;EGFR;ERCC6;MAPK13;NET1;XPC;RAG1;IMPACT;CCND2;RGS14;HMGA2;ATF4;ASNS;HYAL1;PITPNM1;DDB2;LRP5;PER3;MTA1;BCL2L1;IFI16;NR2F6;IKBIP;DDHD2;REEP6;ELOVL4;DNMT3A
7316,GO:0031325,0.377774608756336,0.653698244700951,193,2180,positive regulation of cellular metabolic process,BP,TNIP1;XDH;EDEM1;NOS1;ERCC1;F2R;ETV5;CCND1;NEURL1;VLDLR;ITGA6;ADCY7;IGFBP4;PRNP;NR1D1;NFATC4;MAP2K1;ETV4;RAPGEF3;ACVR2B;SALL2;PKN1;WWTR1;PEG3;MST1R;APLN;POU2F2;TRIM65;TEF;TNFSF15;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;STK39;FYN;BNIP3;HLTF;ERCC6;ARAP1;ZNF516;DLG1;DLG4;SNX9;WNT7A;MAP4K4;SPTLC2;STRADB;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;TRIB2;TGFBR2;EPHA1;IMPACT;CD44;APOE;FKBP1A;BNIP3L;CCPG1;CCND2;PKD2;PRKACB;LRP1;FYCO1;AKAP9;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;LPAR3;FGFR1;ITGA1;E2F5;EPCAM;NFAT5;BTRC;ITGA2;PTK6;INPP5F;ATRX;CHURC1;PFN2;SOX4;FHOD1;MAPKAPK3;ATF7IP;SH3D19;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;LRP5;ETAA1;CST3;CNTN1;TRIB3;CASP4;VPS11;PPP3CB;RFX2;SLK;MLYCD;CEBPG;PLAG1;F2RL1;TAOK1;PHF1;PTHLH;CHD7;PRKAR1A;BOK;PARP9;SPRY2;THRA;ACVR1B;NGFR;PPP1R10;CHD6;MTA1;MEF2D;ARF4;XBP1;MAP2K2;PAIP1;ANKIB1;RET;PDE5A;C5;EPM2A;PAK6;EAPP;ETV1;CCDC88A;SHC2;PRKACA;ZNF398;TMSB4X;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;CARD11;LPAR1;TBL1X;ARID4A;IGF2;AGPAT1;MAP4K2;EFCAB7;PPARG;CITED4;TBX1;CREB3L2;RSF1;ADAM8;WFS1;ENDOG;MAML3;FZD8;HSPA2;LRP6;MAGEF1;TMEM173;RNF180;E2F7;TNRC6C;TET1;ARMCX3;DNAJC3;PTCH1;ADCY1;KAT2B;FAM162A;ANKRD6;PBX3;JARID2;ADNP;LRP4;RB1CC1;FBXL5;FADD
6305,GO:0019934,0.377912952183616,0.931908059855874,1,5,cGMP-mediated signaling,BP,APOE
12843,GO:0051153,0.378095630568618,0.774261474146464,6,57,regulation of striated muscle cell differentiation,BP,DKK1;PAK1;MMP14;THRA;XBP1;TBX1
16407,GO:0097028,0.378120164334089,0.863478128555025,2,17,dendritic cell differentiation,BP,TGFBR2;F2RL1
13247,GO:0051920,0.378261394471535,0.926229973614801,1,8,peroxiredoxin activity,MF,PRDX5
4579,GO:0010664,0.378704664508623,0.8644527653436,2,15,negative regulation of striated muscle cell apoptotic process,BP,PPP1R10;RGL2
10417,GO:0043255,0.378851988197878,0.774197953189733,6,53,regulation of carbohydrate biosynthetic process,BP,NR1D1;PPARA;NTSR1;SLC35B4;IGF2;KAT2B
20025,GO:2000646,0.378867703326831,0.931527390284387,1,5,positive regulation of receptor catabolic process,BP,APOE
5157,GO:0015695,0.378876545296338,0.827304205339792,3,26,organic cation transport,BP,AZIN2;SLC38A2;SLC44A1
8307,GO:0033139,0.379035302058457,0.928971855965416,1,6,regulation of peptidyl-serine phosphorylation of STAT protein,BP,RET
1464,GO:0003714,0.379367100629259,0.714778684281464,17,178,transcription corepressor activity,MF,ZMYND8;CCND1;NR1D1;WWTR1;DDIT3;ELK3;ATF7IP;RCOR1;PHF12;KLF12;TRIB3;AEBP1;MTA1;TLE4;TBL1X;E2F7;MXD4
6708,GO:0030118,0.379606664267242,0.786272667276034,5,45,clathrin coat,CC,EGFR;EPN2;CLTCL1;AP2A2;PANK1
5720,GO:0016859,0.379801092012604,0.825134563369309,3,31,cis-trans isomerase activity,MF,FKBP9;FKBP1A;FKBP10
9095,GO:0035357,0.379953615567449,0.86450662630499,2,14,peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B;PPARG
1559,GO:0003958,0.379983854479177,0.931080732189254,1,5,NADPH-hemoprotein reductase activity,MF,NOS1
12345,GO:0048706,0.37999338683561,0.754159076843027,8,76,embryonic skeletal system development,BP,DLG1;TGFBR2;HYAL1;MDFI;MMP14;HOXA3;TBX1;WDR60
881,GO:0002246,0.380198214524541,0.928490670024843,1,6,wound healing involved in inflammatory response,BP,F2R
12093,GO:0048069,0.380229812299323,0.930982067945681,1,5,eye pigmentation,BP,AP3D1
1989,GO:0004709,0.380237607371196,0.773385426121678,6,51,MAP kinase kinase kinase activity,MF,MST1R;EGFR;EPHA1;FGFR1;TAOK1;RET
16820,GO:0098693,0.380306367287477,0.803339000696511,4,33,regulation of synaptic vesicle cycle,BP,PFN2;NLGN2;RIMS3;SEPT5
10445,GO:0043301,0.380709648828483,0.930789337660945,1,5,negative regulation of leukocyte degranulation,BP,CEACAM1
8704,GO:0034341,0.380943018830613,0.734184156018767,11,124,response to interferon-gamma,BP,CYP27B1;CD44;MT2A;TRIM5;PARP9;IFITM1;RAB43;PPARG;FLNB;OAS1;TRIM38
11267,GO:0045542,0.381102578693972,0.930631270509587,1,5,positive regulation of cholesterol biosynthetic process,BP,ABCG1
16086,GO:0090050,0.381478499663189,0.862734943577743,2,15,positive regulation of cell migration involved in sprouting angiogenesis,BP,SRPX2;AKT3
5910,GO:0018149,0.381682425565926,0.824052710176113,3,30,peptide cross-linking,BP,TGM2;ABCA7;PRR9
11301,GO:0045618,0.381891912202484,0.862478000660119,2,15,positive regulation of keratinocyte differentiation,BP,CYP27B1;ALOX15B
6697,GO:0030091,0.381901923493799,0.925993843201616,1,7,protein repair,BP,MSRB2
12144,GO:0048246,0.382158241146716,0.860397837993396,2,18,macrophage chemotaxis,BP,C5;CKLF
6173,GO:0019538,0.382258756830173,0.643739729974188,356,4202,protein metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;GID4;NOS1;ZMYND8;F2R;SORL1;ADAM19;RAB3B;CCND1;NEURL1;VLDLR;MMP1;RPS6KA2;SERPINE2;PRSS3;ADCY7;IGFBP4;PRNP;ADM2;BTBD2;NR1D1;HECW2;ADARB1;MAP2K1;TFPI2;RAPGEF3;ACVR2B;LTBP1;LMF1;THSD4;PKN1;WWTR1;MST1R;MARCH9;LY6K;TNFSF15;EIF4EBP1;SSH1;DDIT3;PTPRS;B4GALT6;CARS;PSMD2;LAMB1;LTA4H;CAPN2;BRSK1;EGFR;STK39;LOXL1;PPP1R14A;FYN;TNFRSF6B;TMPRSS11D;TSPAN5;JADE2;BNIP3;HLTF;ERCC6;UBE2J1;UBXN7;MAPK13;ADAMTS7;DLG1;DLG4;B3GNT3;CTSB;SNX9;TYSND1;TGM2;HTRA1;FKBP9;WNT7A;UBXN4;IGF2BP3;MAP4K4;TTBK2;GRK5;STRADB;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;NEK9;RAG1;TGFBR2;PTPN3;SERPING1;SCRN1;EPHA1;IMPACT;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;CCND2;PTPN12;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;RBCK1;LRP1;ST3GAL5;IDE;AKAP9;PPP2R3B;ABTB1;UBE2G1;HMGA2;ATF4;PPARA;ABCA7;PIGH;EIF4E3;LPAR3;PCMTD2;ELFN2;FGFR1;ITGA1;AARS;PPP1R35;MARCH4;PTPDC1;RNPEPL1;HYAL1;DCAF10;BTRC;LPCAT1;ITGA2;PTK6;GALNT3;ULK2;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;MTHFR;PFN2;ABCG1;FKBP10;SOX4;RMND5A;FBXO2;DDB2;CEACAM1;MAPKAPK3;SPATA18;OBSL1;PRR9;LMAN1;MRPS6;RCOR1;SH3D19;NLK;XRN1;TRIM5;TNRC6B;DVL1;MMP14;CD46;MVB12B;CTH;LRP5;ETAA1;ABHD17C;CTSL;NPEPL1;CST3;RABGGTA;CNTN1;TRIB3;CASP4;NTNG1;GFPT1;PCSK6;VPS11;RANBP9;DNAJB9;FBXL8;BTBD3;PPP3CB;MEX3C;ZDHHC2;APLP2;DNAJC6;SLK;PRDX5;CEBPG;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;TAOK1;AEBP1;FBXO41;OTUB2;CSNK2A1;PHF1;PSMD7;BLMH;QSOX1;PRKAR1A;MSRB2;BOK;PARP9;CPEB4;ATXN2;KLHL29;MAST3;NACC2;SPRY2;BEX4;ACVR1B;NGFR;PPP1R10;PSKH1;MVB12A;MARK4;PTPRZ1;MTA1;AZIN2;RNF165;PM20D2;TRIM7;ARF4;ANAPC13;PCYOX1;XBP1;NFU1;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;ARRDC1;ANKIB1;LYPLAL1;RET;LOXL2;PDE5A;VWA1;C5;MTMR4;ZFYVE9;GABARAPL2;PAK6;UBE2E1;PUM2;RNF135;CCDC88A;CTSO;ADAMTSL1;SHC2;PRKACA;NEK6;UNKL;TIMP2;EIF2AK2;RAB1A;ZDHHC1;SEL1L;IFI16;AP2A2;SRD5A3;SLC39A10;IL1RAP;ST6GALNAC2;CARD11;LAMB2;FICD;SECISBP2L;LPAR1;CTSZ;TBL1X;MMP10;RNF169;ARID4A;TENM2;IGF2;PJA2;MAP4K2;ZMYM2;ERLEC1;PPARG;SNX6;EVA1A;USP20;GRB7;LYPLA1;TBX1;ERP44;ADAM8;AKT3;GARS;WFS1;PHF21A;IGFBP7;MARCH2;OSGEPL1;FZD8;USP32;HSPA2;PRSS8;LRP6;ARID5B;MAGEF1;RNF180;EEF2K;HPSE;TNRC6C;TRIM2;RCAN1;TET1;DNAJC3;PSEN2;PTCH1;ADCY1;KAT2B;CNOT11;RNF103;USP25;PRMT3;UFL1;FAM162A;ANKRD6;JARID2;PPM1M;KLHL15;ADNP;LRP4;STT3B;RB1CC1;TRIM38;FBXL5;FADD
7066,GO:0030853,0.382279911869313,0.930156339756069,1,5,negative regulation of granulocyte differentiation,BP,CEACAM1
3032,GO:0006578,0.382315277827672,0.927609622915509,1,6,amino-acid betaine biosynthetic process,BP,ALDH7A1
15584,GO:0072050,0.382381962511434,0.927581764849296,1,6,S-shaped body morphogenesis,BP,PKD2
13914,GO:0060571,0.382393076252151,0.862166198771652,2,15,morphogenesis of an epithelial fold,BP,EGFR;WNT2B
15908,GO:0072677,0.382474708563943,0.927543008630955,1,6,eosinophil migration,BP,ADAM8
13234,GO:0051897,0.382722408852951,0.744695283352469,9,87,positive regulation of protein kinase B signaling,BP,MST1R;EGFR;FYN;FGFR1;FAM110C;SPRY2;IGF2;ADAM8;HPSE
14157,GO:0061038,0.382743521422047,0.933827894081262,1,4,uterus morphogenesis,BP,WNT7A
16907,GO:0098868,0.382811474516283,0.862740487935949,2,14,bone growth,BP,TGFBR2;THBS3
16610,GO:0097443,0.382944203313751,0.929887496089365,1,5,sorting endosome,CC,CLTCL1
2100,GO:0004867,0.382960929324957,0.799670456551479,4,40,serine-type endopeptidase inhibitor activity,MF,SERPINE2;TFPI2;SERPING1;APLP2
19092,GO:1904996,0.383269163334127,0.929755753017141,1,5,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,ITGA4
4583,GO:0010668,0.383347472645393,0.929723982845286,1,5,ectodermal cell differentiation,BP,ITGA6
6854,GO:0030323,0.383361181008988,0.728343441557574,12,115,respiratory tube development,BP,MAP2K1;ACVR2B;EGFR;TGFBR2;FGFR1;MMP14;SPRY2;THRA;WNT2B;CTSZ;LAMA5;ALDH1A2
7853,GO:0032413,0.383388460743314,0.80020819156785,4,36,negative regulation of ion transmembrane transporter activity,BP,HECW2;STK39;ANK3;PKD2
4533,GO:0010604,0.38341446829613,0.648084996804996,195,2219,positive regulation of macromolecule metabolic process,BP,TNIP1;XDH;SMURF2;EDEM1;NOS1;ERCC1;F2R;SORL1;ETV5;CCND1;NEURL1;VLDLR;ITGA6;ADCY7;IGFBP4;PRNP;ACTA2;ADM2;NR1D1;HECW2;NFATC4;MAP2K1;ETV4;RAPGEF3;ACVR2B;SALL2;PKN1;WWTR1;PEG3;MST1R;APLN;POU2F2;TEF;TNFSF15;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;STK39;ANK3;FYN;HLTF;ERCC6;ARAP1;ZNF516;DLG1;DLG4;SNX9;WNT7A;MAP4K4;STRADB;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;TRIB2;TGFBR2;EPHA1;IMPACT;CD44;APOE;FKBP1A;CCPG1;CCND2;PKD2;PRKACB;LRP1;IDE;AKAP9;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;LPAR3;FGFR1;ITGA1;E2F5;EPCAM;NFAT5;BTRC;LPCAT1;ITGA2;PTK6;INPP5F;ATRX;CHURC1;PFN2;SOX4;FHOD1;MAPKAPK3;ATF7IP;SH3D19;TRIM5;TCEA1;TNRC6B;DVL1;MMP14;CD46;LRP5;ETAA1;CST3;CNTN1;TRIB3;CASP4;VPS11;PPP3CB;RFX2;SLK;CEBPG;PLAG1;F2RL1;TAOK1;CSNK2A1;PHF1;CHD7;PRKAR1A;BOK;PARP9;SPRY2;THRA;ACVR1B;NGFR;PPP1R10;CHD6;MTA1;MEF2D;ARF4;XBP1;MAP2K2;PAIP1;ANKIB1;RET;PDE5A;SH3PXD2B;C5;RMRP;PAK6;EAPP;ETV1;CCDC88A;SHC2;PRKACA;ZNF398;TIMP2;EIF2AK2;RAB1A;IFI16;SLC39A10;CARD11;LPAR1;TBL1X;ARID4A;IGF2;MAP4K2;EFCAB7;PPARG;CITED4;ALDH1A2;TBX1;CREB3L2;RSF1;ADAM8;WFS1;ENDOG;MAML3;FZD8;HSPA2;LRP6;MAGEF1;TMEM173;RNF180;E2F7;TNRC6C;TET1;ARMCX3;DNAJC3;PTCH1;ADCY1;KAT2B;FAM162A;ANKRD6;PBX3;JARID2;ADNP;LRP4;RB1CC1;FBXL5;FADD
11626,GO:0046328,0.383516886021717,0.723898251095608,13,130,regulation of JNK cascade,BP,PKN1;EGFR;ERCC6;WNT7A;MAP4K4;DKK1;PAK1;F2RL1;TAOK1;MAP4K2;FZD8;ANKRD6;RB1CC1
4375,GO:0010001,0.383562821016599,0.723778386446405,13,132,glial cell differentiation,BP,SERPINE2;SH3TC2;MAP2K1;EGFR;BNIP3;LRP1;SOX4;WASF3;BOK;PTPRZ1;LAMB2;LPAR1;PPARG
18526,GO:1903708,0.383594398820578,0.732204349272204,11,116,positive regulation of hemopoiesis,BP,CTNNBIP1;FAM210B;RAG1;TGFBR2;MMP14;CD46;ACVR1B;XBP1;AP3D1;ADAM8;FADD
10922,GO:0044531,0.384030864143714,0.926890853833393,1,6,modulation of programmed cell death in other organism,BP,BCL2L1
10923,GO:0044532,0.384030864143714,0.926890853833393,1,6,modulation of apoptotic process in other organism,BP,BCL2L1
13301,GO:0052040,0.384030864143714,0.926890853833393,1,6,modulation by symbiont of host programmed cell death,BP,BCL2L1
13330,GO:0052248,0.384030864143714,0.926890853833393,1,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,BCL2L1
13354,GO:0052433,0.384030864143714,0.926890853833393,1,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,BCL2L1
12365,GO:0048745,0.384116286068424,0.862907830193811,2,13,smooth muscle tissue development,BP,DLG1;PKD2
9554,GO:0036315,0.384117501446619,0.862907078877314,2,13,cellular response to sterol,BP,LRP6;PTCH1
16097,GO:0090074,0.384219747102427,0.929369507701012,1,5,negative regulation of protein homodimerization activity,BP,ITGA4
5275,GO:0015925,0.384274429886684,0.926788459100851,1,6,galactosidase activity,MF,GLB1
10251,GO:0042985,0.384306563080111,0.926774943851186,1,6,negative regulation of amyloid precursor protein biosynthetic process,BP,ABCA7
1075,GO:0002645,0.384441746782075,0.929279117697894,1,5,positive regulation of tolerance induction,BP,TGFBR2
7898,GO:0032466,0.384694795390448,0.926611533289349,1,6,negative regulation of cytokinesis,BP,E2F7
14058,GO:0060836,0.384718918497162,0.933066106150125,1,4,lymphatic endothelial cell differentiation,BP,ACVR2B
13515,GO:0055086,0.384782474800789,0.674801146193562,45,546,nucleobase-containing small molecule metabolic process,BP,XDH;NT5E;NOS1;PCK2;ADCY7;RAPGEF3;TK2;NAPRT;H6PD;DHTKD1;PGM1;DLG1;DLG4;IDH2;PGLS;ACOT7;NMRK1;NME4;DLG3;APOE;PKD2;LDHA;AKAP9;PPARA;FAM20C;AHCYL2;APOBEC3C;GAMT;GFPT1;PTHLH;NDUFV3;PARP9;UAP1;PANK4;PDE5A;TMSB4X;TIMP2;CARD11;ATP6V1B2;AK9;GARS;AOX1;ADCY1;PANK1;ADNP
10891,GO:0044431,0.384900589815923,0.665589587297184,65,717,Golgi apparatus part,CC,EDEM1;SORL1;ASAP2;POSTN;MARCH9;B4GALT6;EGFR;SLC33A1;ARAP1;B3GNT3;GPC4;SNX9;SLC9A7;WNT7A;SEC23A;MALL;SDC1;B4GALNT4;ATP7B;MCFD2;ST3GAL5;AKAP9;ABCA7;ICA1;MARCH4;LPCAT1;GALNT3;VAMP2;CHAC1;ABCG1;PITPNM1;RAB31;LMAN1;BSG;CLCN3;MMP14;DNMBP;SLC35B4;CLTCL1;PCSK6;COPB1;COPG1;RASIP1;QSOX1;BOK;ATXN2;USP6NL;AZIN2;AGPAT3;GOLGA2P5;STX10;RAB43;GABARAPL2;SAMD8;RAB1A;ANGEL1;KDELR3;ST6GALNAC2;CTSZ;AP3D1;PJA2;MAP4K2;TMEM50B;PSEN2;COG8
17529,GO:1901019,0.384949815270187,0.782043674080793,5,45,regulation of calcium ion transmembrane transporter activity,BP,NOS1;FKBP1A;PKD2;PRKACA;HSPA2
13905,GO:0060556,0.384964562160881,0.92649785570768,1,6,regulation of vitamin D biosynthetic process,BP,CYP27B1
689,GO:0001909,0.38503571177845,0.780742886739093,5,53,leukocyte mediated cytotoxicity,BP,CEACAM1;PPP3CB;CEBPG;F2RL1;FADD
4960,GO:0015035,0.385039821334364,0.857626161381631,2,20,protein disulfide oxidoreductase activity,MF,ERO1B;TXNRD3
7482,GO:0031646,0.385329753776152,0.861174766685592,2,14,positive regulation of neurological system process,BP,ITGA2;WASF3
9862,GO:0042113,0.38533294316499,0.718457912704415,14,145,B cell activation,BP,ERCC1;PKN1;POU2F2;RAG1;CMTM7;MMP14;DNAJB9;CEBPG;SKAP2;XBP1;DOCK11;SLC39A10;CARD11;ITGA4
2715,GO:0006090,0.385372624668801,0.736118051075272,10,101,pyruvate metabolic process,BP,PCK2;SLC16A3;DHTKD1;PC;PGM1;GLO1;HAGH;LDHA;PPARA;BSG
20276,GO:2001244,0.38542613364662,0.797083279961749,4,44,positive regulation of intrinsic apoptotic signaling pathway,BP,DDIT3;BOK;NACC2;BCL2L1
5231,GO:0015846,0.385670408783953,0.926199911754131,1,6,polyamine transport,BP,AZIN2
8482,GO:0033628,0.385769801144386,0.822042295464944,3,27,regulation of cell adhesion mediated by integrin,BP,PODXL;FERMT1;RET
2291,GO:0005249,0.385989186909755,0.822630768649269,3,25,voltage-gated potassium channel activity,MF,KCNG1;PKD2;KCNJ15
11420,GO:0045833,0.386053648713205,0.780344555721427,5,50,negative regulation of lipid metabolic process,BP,CYP27B1;APOE;LPCAT1;CEACAM1;TRIB3
2404,GO:0005575,0.386086447616243,0.686749110177588,980,11683,cellular_component,CC,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;FAM83A;ADAM19;ETV5;RAB3B;PGF;MBOAT2;KIAA1549L;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PEAR1;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;PAG1;ADGRF1;MXRA5;OSBP2;ITGB4;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;CMTM4;THBS2;TMTC4;FAM210B;FMNL2;ETV4;TFPI2;LTBP2;RAPGEF3;FNDC4;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;SLC29A4;ALOX15B;MPRIP;LMF1;SALL2;COL13A1;TK2;THSD4;GPX3;PKN1;NAPRT;WWTR1;DCBLD2;PEG3;MST1R;ARHGAP22;MICALCL;WDR66;MARCH9;H6PD;APLN;RBMS2;MARVELD1;POU2F2;TRIM65;LY6K;DHTKD1;PITPNC1;TMEM200A;DGKA;TEF;TNFSF15;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;KCNG1;PTPRS;B4GALT6;CCNG2;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;SDK2;EXOC2;ELK3;SNTB2;CRTC1;ADGRL1;DENND5B;AVL9;LTA4H;CAPN2;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;BCORL1;C2CD2;DYSF;THEM6;CGREF1;PDZD2;LOXL1;ARHGAP12;ARMCX2;PPP1R14A;FYN;HEBP1;MYH15;TNFRSF6B;TMPRSS11D;OSBPL10;TSPAN5;PCDHAC2;PSAT1;JADE2;BNIP3;HLTF;KIF13B;SPATS2;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;MYCBPAP;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;CSMD3;DLG4;B3GNT3;IDH2;TMEM245;CTSB;CD68;DNAJB5;CSMD2;ACOT1;PLXNB3;GPC4;DHX32;SNX9;TYSND1;PODXL;SLCO4A1;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;EVI5L;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;TTC7B;RSAD1;GRK5;HTR7;IGIP;NMRK1;STRADB;RDH14;NME4;MALL;CRTAP;RSPH3;ASPH;GLCCI1;MCTP1;GDI1;CEMIP;VWA5A;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;MXRA7;SHC1;NAGS;DLG3;DKK1;WISP1;SMOC2;HYI;SLFN5;PAK1;RASA3;TMEM154;CEP170;SOCS2;TRIB2;ATXN10;NEK9;KIAA1549;RHPN1;ZNF652;CBR4;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;NUDCD3;B4GALNT4;EDNRA;LCN2;HAGH;NUCB2;SHANK2;SLITRK6;SCRN1;EPHA1;IMPACT;RALGAPA2;PLPP6;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCPG1;CCND2;ACP5;ANGPTL4;TIGD2;KLHDC2;PTPN12;ALDH1L2;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;FAM208A;PPP2R3B;ABHD8;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;ICA1;EIF4E3;AGPAT4;LPAR3;PCMTD2;ELFN2;FAM155B;KIF21B;ASNS;FGFR1;ABHD10;ITGA1;AARS;E2F5;FAM114A1;EPCAM;TMOD2;MARCH4;TUB;PTPDC1;CMTM7;LPCAT4;TACC1;TCFL5;RNPEPL1;UROS;SMOC1;NFAT5;ITGB5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;AIG1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;FAT1;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;BIVM;ATRX;FAM20C;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;NELL2;GAMT;CEP120;ENDOV;IAH1;ZNF558;KDSR;MBLAC2;CEACAM1;ADM5;FERMT1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PRR9;SLC5A1;PDIA5;RAB31;LMAN1;DMXL2;SLC35F2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLEK2;PLA2G4D;HES2;ANXA6;NLGN2;CD46;ZBTB10;ACAD10;PHF12;MVB12B;EPOR;CTH;ORAI3;ZNF704;NXPH4;MPDZ;FAM50A;MAP6;LRP5;ETAA1;NIPA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;THBS3;CTSL;DOCK9;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;NTNG1;GFPT1;PCSK6;SLC35G2;TPBG;TOM1L2;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;FBXL8;BTBD3;RIMS3;PLPPR2;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;INPP4A;RFX2;SYTL1;HIBADH;ADGRB2;TTYH3;KIAA1147;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;FAM8A1;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;DDX60;UHRF2;SLC2A9;RASIP1;GSDMA;PROCR;C6ORF120;TAOK1;PLD3;PHC3;AEBP1;ATP10D;ABHD15;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;CPNE8;SUGCT;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;ANO1;MSRB2;FAM84B;OGFRL1;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;KLHL29;MAST3;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;SLC6A14;ZNF337;BEX4;TBC1D2B;THRA;LMBR1L;MGLL;GOLGA6L9;CD99;WNT2B;CYYR1;ENKD1;ACVR1B;DBNDD1;NDUFA4L2;APCDD1L;SLC43A1;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;MARK4;NPL;ZNF449;PTPRZ1;CHD6;NUDT6;SPESP1;PER3;MTA1;AZIN2;BCL2L1;IFITM1;CRAT;MYH16;RNF165;YTHDC2;PM20D2;GRIN3B;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;NYNRIN;SKAP2;ARF4;GOLGA2P5;H2AFJ;POLL;TMEM187;ANAPC13;YPEL5;UAP1;CNNM1;HSD17B7;SLC12A7;PCYOX1;XBP1;PANK4;SPIRE1;SLC46A3;NFU1;UBASH3B;TXNRD3;CADM4;MAP2K2;ABHD6;SATB1;SLC22A17;GPATCH8;PPP1R2;PAIP1;ARRDC1;REC8;CYP4F22;ANKIB1;MICU3;LYPLAL1;TLE4;SLC38A2;RIN1;TRPC1;RET;SPATA6;SDR9C7;FAM222B;TUBG2;STX10;LOXL2;PDE5A;VWA1;TCTN1;LMBRD2;RAB43;MLH3;OSBPL5;SLC13A3;NAV1;SH3PXD2B;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;SMIM19;MBOAT7;NOP10;TM2D2;NCKAP1;GABARAPL2;EPM2A;KCNJ15;RMRP;GTF2IRD2;DNASE1L1;C1ORF56;ELMO3;DOCK11;PAK6;EAPP;UBE2E1;SLC35F5;PUM2;SLC30A1;TSPAN3;RNF135;PSD3;TMBIM1;ETV1;FRMD4B;COL1A2;FAM171A2;SFXN3;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;SNX30;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;RHOBTB1;BCAP29;AP2A2;SRD5A3;NR2F6;SLC39A10;KDELR3;CMTM6;SCAND1;IL1RAP;SBNO1;SLC25A43;ST6GALNAC2;ORAI1;CARD11;FCHO1;LAMB2;LTB4R;FICD;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;NRSN2;ACP6;TMEM134;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;SLC2A13;ZSCAN18;GRB10;LARP1B;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;SLC10A6;TMEM63A;CITED4;SNX6;EVA1A;USP20;ANKRD50;ZFP30;GRB7;TRIQK;SRPX2;PPL;ALDH1A2;GPR153;ARHGAP29;LYPLA1;TMEM50B;ATP12A;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;ROBO3;GARS;IL20RB;CLDN11;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;IKBIP;PHF21A;ZBTB40;ZNF92;WDR60;TMEM229B;ACAP2;MPLKIP;MAML3;CKLF;ZNF568;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;OSGEPL1;PLCXD1;FZD8;TMEM107;CMC1;WASL;USP32;ANKS6;RAPGEFL1;REEP6;HSPA2;PRSS8;ZNF107;FLNB;LRP6;ARID5B;MAGEF1;ZNF165;SYT2;PLCH2;TMEM173;RNF180;GGACT;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;SEMA6C;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;TNRC6C;INAFM2;TRIM2;COQ2;RCAN1;TET1;OMG;SH3TC1;GRAMD1C;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;DNAJC4;AOX1;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;TMEM139;RNF103;USP25;LRP3;PANK1;PRMT3;REEP3;NYAP1;UFL1;VSIG10L;FAM162A;ANKRD6;SNX27;N4BP2;AMACR;GALE;PBX3;CTXN1;JARID2;PPM1M;SLC23A2;SEMA3F;RALGPS2;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FCGBP;TMEM42;FADD
2513,GO:0005766,0.386143649647642,0.729713856241815,11,122,primary lysosome,CC,PYGB;NAPRT;CD68;STOM;LPCAT1;C6ORF120;GLB1;CMTM6;ATP11B;GALNS;DNAJC3
10082,GO:0042582,0.386143649647642,0.729713856241815,11,122,azurophil granule,CC,PYGB;NAPRT;CD68;STOM;LPCAT1;C6ORF120;GLB1;CMTM6;ATP11B;GALNS;DNAJC3
10845,GO:0044340,0.386156193952899,0.928578680339307,1,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,LRP6
18763,GO:1904251,0.386161466213748,0.925992200094431,1,6,regulation of bile acid metabolic process,BP,NR1D1
4576,GO:0010661,0.386608754731121,0.859529491570834,2,15,positive regulation of muscle cell apoptotic process,BP,BNIP3;PPARG
14207,GO:0061136,0.386944512507176,0.716763439880603,14,153,regulation of proteasomal protein catabolic process,BP,EDEM1;UBE2J1;TRIB2;BTRC;DVL1;TRIB3;XBP1;ANKIB1;GABARAPL2;PRKACA;ERLEC1;RNF180;USP25;UFL1
567,GO:0001708,0.38695777596188,0.798002284239045,4,34,cell fate specification,BP,DKK1;FGFR1;TBX1;PTCH1
2724,GO:0006103,0.387122743016092,0.858470341865364,2,16,2-oxoglutarate metabolic process,BP,GPT2;IDH2
12877,GO:0051205,0.387180101776734,0.796249807288719,4,41,protein insertion into membrane,BP,EGFR;COX18;GRIN3B;MOAP1
16413,GO:0097039,0.387199574642885,0.928150341836085,1,5,protein linear polyubiquitination,BP,RBCK1
4422,GO:0010226,0.387443193680023,0.859004638775551,2,15,response to lithium ion,BP,NFATC4;ADCY1
16640,GO:0097499,0.387471288509282,0.925436423452318,1,6,protein localization to non-motile cilium,BP,TUB
931,GO:0002329,0.387480853978343,0.931991994794039,1,4,pre-B cell differentiation,BP,RAG1
2171,GO:0005007,0.387613678946356,0.927979905718452,1,5,fibroblast growth factor-activated receptor activity,MF,FGFR1
1998,GO:0004721,0.387653649228348,0.716385230219904,14,145,phosphoprotein phosphatase activity,MF,MAP2K1;SSH1;PTPRS;DLG1;PTPN3;PTPN12;PPP2R3B;PTPDC1;PPP3CB;DNAJC6;PTPRZ1;UBASH3B;MTMR4;PPM1M
17820,GO:1901977,0.387692081178487,0.925342488757764,1,6,negative regulation of cell cycle checkpoint,BP,PPP1R10
19755,GO:2000146,0.38775798660356,0.707278463355727,17,175,negative regulation of cell motility,BP,ZMYND8;CYGB;ADARB1;ALOX15B;IDH2;PLXNB3;MCTP1;EPHA1;APOE;SRGAP2B;LRP1;PFN2;IFITM1;ABHD6;C5;PPARG;WASL
487,GO:0001539,0.387799936849664,0.859630335308983,2,14,cilium or flagellum-dependent cell motility,BP,BBS2;CCSAP
13720,GO:0060285,0.387799936849664,0.859630335308983,2,14,cilium-dependent cell motility,BP,BBS2;CCSAP
13108,GO:0051642,0.387895333464304,0.822667202780473,3,22,centrosome localization,BP,DLG1;AKAP9;FHOD1
16175,GO:0090193,0.388096376299223,0.925170297681882,1,6,positive regulation of glomerulus development,BP,RET
14653,GO:0070242,0.388309496357464,0.857719538596019,2,16,thymocyte apoptotic process,BP,RAG1;ADAM8
17945,GO:1902285,0.388510591562652,0.861350369875488,2,12,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,PLXNB3;SEMA3F
10066,GO:0042558,0.388566239096731,0.819699480256555,3,28,pteridine-containing compound metabolic process,BP,ALDH1L2;MTHFR;PM20D2
15304,GO:0071493,0.388590269375769,0.924959618751694,1,6,cellular response to UV-B,BP,HYAL1
18659,GO:1903975,0.389012058885814,0.924779411347853,1,6,regulation of glial cell migration,BP,IDH2
5930,GO:0018208,0.389069505409055,0.794614188986628,4,42,peptidyl-proline modification,BP,FKBP9;CRTAP;FKBP1A;FKBP10
15742,GO:0072318,0.389081733927002,0.927373695774581,1,5,clathrin coat disassembly,BP,DNAJC6
10018,GO:0042447,0.38916881234381,0.924712372144519,1,6,hormone catabolic process,BP,IDE
18590,GO:1903845,0.389496892644017,0.765087022767468,6,56,negative regulation of cellular response to transforming growth factor beta stimulus,BP,SMURF2;LTBP1;HTRA1;TGFBR2;MTMR4;SNX6
14851,GO:0070603,0.389701777274807,0.754372493222087,7,67,SWI/SNF superfamily-type complex,CC,SALL2;APPL2;SMARCA1;ATRX;CSNK2A1;NACC2;RSF1
12347,GO:0048709,0.389950192100573,0.764329933789772,6,59,oligodendrocyte differentiation,BP,BNIP3;WASF3;BOK;PTPRZ1;LPAR1;PPARG
4751,GO:0010922,0.390094918509978,0.820581485317536,3,23,positive regulation of phosphatase activity,BP,ITGA1;ITGA2;SLC39A10
7281,GO:0031265,0.390097008372774,0.924314662128077,1,6,CD95 death-inducing signaling complex,CC,FADD
20187,GO:2001034,0.390158653641978,0.926927020034229,1,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,PARP9
9489,GO:0036124,0.390194734482284,0.858124874386831,2,14,histone H3-K9 trimethylation,BP,ATRX;ARID4A
10021,GO:0042451,0.390234326046803,0.85429924853077,2,20,purine nucleoside biosynthetic process,BP,NT5E;NME4
11576,GO:0046129,0.390234326046803,0.85429924853077,2,20,purine ribonucleoside biosynthetic process,BP,NT5E;NME4
3374,GO:0007144,0.390243669637461,0.924251704421122,1,6,female meiosis I,BP,MLH3
9053,GO:0035270,0.39025928549532,0.75390479455738,7,67,endocrine system development,BP,MAP2K1;SOX4;THRA;HOXA3;ALDH1A2;TBX1;ARID5B
1269,GO:0003056,0.390268778932378,0.926881248638379,1,5,regulation of vascular smooth muscle contraction,BP,DOCK4
5371,GO:0016176,0.390303074061583,0.926866990961888,1,5,superoxide-generating NADPH oxidase activator activity,MF,SH3PXD2B
15680,GO:0072202,0.390342851307944,0.858031498207323,2,14,cell differentiation involved in metanephros development,BP,WWTR1;LAMB2
6707,GO:0030117,0.390347740553272,0.737797510072586,9,92,membrane coat,CC,EGFR;SEC23A;EPN2;CLTCL1;COPB1;COPG1;AP2A2;AP3D1;PANK1
12222,GO:0048475,0.390347740553272,0.737797510072586,9,92,coated membrane,CC,EGFR;SEC23A;EPN2;CLTCL1;COPB1;COPG1;AP2A2;AP3D1;PANK1
13143,GO:0051709,0.390353482148723,0.922335610061814,1,7,regulation of killing of cells of other organism,BP,F2RL1
13145,GO:0051712,0.390353482148723,0.922335610061814,1,7,positive regulation of killing of cells of other organism,BP,F2RL1
13824,GO:0060420,0.390389603208617,0.795103409424399,4,35,regulation of heart growth,BP,PAK1;TGFBR2;FGFR1;JARID2
16278,GO:0090342,0.390582993799907,0.794461287006173,4,37,regulation of cell aging,BP,ARG2;HMGA2;NEK6;AKT3
1068,GO:0002634,0.39074496901371,0.926683127502261,1,5,regulation of germinal center formation,BP,PKN1
1097,GO:0002686,0.390760368513712,0.855509541172405,2,17,negative regulation of leukocyte migration,BP,C5;WASL
6233,GO:0019784,0.3910275709336,0.92203921623417,1,7,NEDD8-specific protease activity,MF,OTUB2
11888,GO:0046902,0.391210931353911,0.762536598107712,6,66,regulation of mitochondrial membrane permeability,BP,BNIP3;BNIP3L;SLC25A4;BOK;BCL2L1;MOAP1
12575,GO:0050729,0.391581580634626,0.762532378823413,6,63,positive regulation of inflammatory response,BP,TNIP1;EGFR;MAPK13;TGM2;ITGA2;ADAM8
11937,GO:0046983,0.391633961951381,0.656964653188196,71,857,protein dimerization activity,MF,XDH;PGF;PYGL;CBS;CRYL1;WWTR1;DDIT3;CARS;CAPN2;EGFR;BNIP3;SNX9;SLC9A7;ACOT7;STOM;RAG1;RALGAPA2;APOE;FKBP1A;BNIP3L;ABCD1;PKD2;ZNF862;IDE;RAB11FIP4;ATF4;ASNS;FGFR1;E2F5;TCFL5;BTRC;ITGA2;INPP5F;ABCG1;SOX4;CEACAM1;TRIM5;RALGAPA1;CLCN3;NTSR1;HES2;ANXA6;RABGGTA;PPP3CB;SLK;PRDX5;CEBPG;PSMD7;ANO1;BOK;NACC2;MGLL;BCL2L1;MEF2D;H2AFJ;XBP1;CADM4;CCDC88A;FICD;TENM2;PPARG;SNX6;TBX1;GARS;LRP6;TMEM173;HPSE;AOX1;GALE;MXD4;LRP4
19197,GO:1905288,0.391724275158335,0.926274649408452,1,5,vascular associated smooth muscle cell apoptotic process,BP,PPARG
19270,GO:1905459,0.391724275158335,0.926274649408452,1,5,regulation of vascular associated smooth muscle cell apoptotic process,BP,PPARG
19271,GO:1905461,0.391724275158335,0.926274649408452,1,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,PPARG
3083,GO:0006656,0.391761838261775,0.817387607826603,3,28,phosphatidylcholine biosynthetic process,BP,LPCAT1;CSNK2A1;SLC44A1
717,GO:0001942,0.391787002298807,0.752621716187962,7,67,hair follicle development,BP,EGFR;DKK1;FERMT1;ACVR1B;LAMA5;HPSE;LRP4
3592,GO:0008016,0.391857330488161,0.725297778023591,11,109,regulation of heart contraction,BP,NOS1;APLN;DLG1;ASPH;AKAP9;ITPR3;THRA;TRPC1;PDE5A;PRKACA;ITPR2
19509,GO:1990393,0.391903980097932,0.926199541606956,1,5,3M complex,CC,OBSL1
11455,GO:0045907,0.391993696477703,0.855376093115321,2,16,positive regulation of vasoconstriction,BP,F2R;EGFR
8737,GO:0034384,0.392095619226586,0.923453964428862,1,6,high-density lipoprotein particle clearance,BP,APOE
16168,GO:0090186,0.392102922874945,0.926116338630532,1,5,regulation of pancreatic juice secretion,BP,STK39
12257,GO:0048537,0.392331582519517,0.923351955293041,1,6,mucosal-associated lymphoid tissue development,BP,RET
12260,GO:0048541,0.392331582519517,0.923351955293041,1,6,Peyer's patch development,BP,RET
9785,GO:0039706,0.392432047053432,0.92330849836975,1,6,co-receptor binding,MF,DKK1
7224,GO:0031118,0.392738446353244,0.919874732954058,1,8,rRNA pseudouridine synthesis,BP,NOP10
11804,GO:0046685,0.392752472730187,0.816355660704173,3,29,response to arsenic-containing substance,BP,MAPK13;ATF4;UROS
10336,GO:0043129,0.39280639883453,0.925821665553485,1,5,surfactant homeostasis,BP,LPCAT1
16128,GO:0090118,0.392837149356191,0.925808768309464,1,5,receptor-mediated endocytosis involved in cholesterol transport,BP,LRP6
6801,GO:0030242,0.392981849609896,0.925748060313608,1,5,autophagy of peroxisome,BP,RB1CC1
514,GO:0001578,0.393207883639401,0.775640420346548,5,44,microtubule bundle formation,BP,NEURL1;BBS2;MAP1B;MARK4;NAV1
17534,GO:1901029,0.39321026805116,0.9210747814922,1,7,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
5666,GO:0016775,0.393560057876986,0.922819533398489,1,6,phosphotransferase activity, nitrogenous group as acceptor,MF,MAP4K4
15492,GO:0071855,0.393721183426134,0.92084798889965,1,7,neuropeptide receptor binding,MF,APLN
1710,GO:0004301,0.393819547973897,0.920804279935353,1,7,epoxide hydrolase activity,MF,LTA4H
10992,GO:0044789,0.393880404926432,0.925370395029405,1,5,modulation by host of viral release from host cell,BP,PC
10993,GO:0044791,0.393880404926432,0.925370395029405,1,5,positive regulation by host of viral release from host cell,BP,PC
16762,GO:0098552,0.394057880648446,0.687011046669687,24,262,side of membrane,CC,ITGA6;SERPINE2;PRNP;ANTXR2;FYN;DLG1;DLG4;GPC4;SNX9;SDC1;RASA3;TGFBR2;PTPN3;FKBP1A;PKD2;ITGA1;ITGA2;PTK6;ABCG1;CLCN3;NTSR1;MAP2K2;ESYT3;GNAI1
7737,GO:0032232,0.394184293133407,0.855598990422535,2,14,negative regulation of actin filament bundle assembly,BP,ARAP1;WASF2
2608,GO:0005912,0.394217854603072,0.668826321291082,41,447,adherens junction,CC,FHL1;FLNC;ITGA6;MAP2K1;SH3KBP1;MPRIP;ARHGAP22;SNTB2;CAPN2;EGFR;PARVB;DLG1;TGM2;PAK1;MRC2;RAC2;CD44;PTPN12;AFAP1;LRP1;ITGA1;ITGB5;ITGA2;FAT1;CEACAM1;FERMT1;BSG;SLC9A3R2;MMP14;ANXA6;CD46;PROCR;CD99;CADM4;MAP2K2;NCKAP1;FRMD4B;GRB7;ITGA4;FLNB;ZFYVE21
11292,GO:0045602,0.394515676183734,0.925102678470763,1,5,negative regulation of endothelial cell differentiation,BP,XDH
16466,GO:0097136,0.394570847560233,0.922379767352643,1,6,Bcl-2 family protein complex,CC,BCL2L1
15120,GO:0071205,0.394827567205782,0.929083340966346,1,4,protein localization to juxtaparanode region of axon,BP,EPB41L3
8625,GO:0034141,0.394930158093324,0.922223073466038,1,6,positive regulation of toll-like receptor 3 signaling pathway,BP,F2RL1
15426,GO:0071695,0.394987731696557,0.72791639354257,10,98,anatomical structure maturation,BP,FAM210B;DDIT3;FAM20C;FERMT1;THBS3;L3MBTL3;XBP1;REC8;RET;ALDH1A2
14031,GO:0060760,0.3950074952433,0.791042088517617,4,37,positive regulation of response to cytokine stimulus,BP,CASP4;PARP9;AGPAT1;FADD
3444,GO:0007253,0.395148988165909,0.920212092136673,1,7,cytoplasmic sequestering of NF-kappaB,BP,TMSB4X
17705,GO:1901612,0.395168456752446,0.922119045802965,1,6,cardiolipin binding,MF,NME4
692,GO:0001912,0.39516968393189,0.852676946491596,2,17,positive regulation of leukocyte mediated cytotoxicity,BP,F2RL1;FADD
11268,GO:0045545,0.395419942430766,0.924720585357636,1,5,syndecan binding,MF,HPSE
10224,GO:0042895,0.395684690506782,0.92189339576053,1,6,antibiotic transmembrane transporter activity,MF,SLC13A3
8067,GO:0032736,0.395697586628252,0.921887753646586,1,6,positive regulation of interleukin-13 production,BP,IL1RAP
5598,GO:0016634,0.39607357222082,0.921723148561899,1,6,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,RSAD1
13381,GO:0052650,0.396170405585914,0.919755283639216,1,7,NADP-retinol dehydrogenase activity,MF,RDH14
4642,GO:0010764,0.396187332232785,0.921673303073561,1,6,negative regulation of fibroblast migration,BP,CYGB
15552,GO:0071971,0.396208341588885,0.921664095415888,1,6,extracellular exosome assembly,BP,SDC1
18460,GO:1903551,0.396208341588885,0.921664095415888,1,6,regulation of extracellular exosome assembly,BP,SDC1
15777,GO:0072378,0.3962910813446,0.919701208803504,1,7,blood coagulation, fibrin clot formation,BP,SERPING1
1665,GO:0004126,0.396323186779255,0.919686818610318,1,7,cytidine deaminase activity,MF,APOBEC3C
2506,GO:0005759,0.396635492006335,0.675959234316159,30,393,mitochondrial matrix,CC,PCK2;GPT2;TK2;DHTKD1;PC;HADH;IDH2;ACSF2;NME4;ARG2;SHC1;NAGS;CBR4;HAGH;ALDH1L2;ABHD10;MRPS6;ACAD10;HIBADH;PRDX5;MLYCD;ALDH7A1;TST;LACTB2;GLUD1;BCL2L1;ACP6;ALDH4A1;GARS;ALAS1
5454,GO:0016328,0.396765889884127,0.772584992299933,5,45,lateral plasma membrane,CC,ANK3;DLG1;EPCAM;CEACAM1;DVL1
4981,GO:0015103,0.396824514364634,0.739758240317972,8,77,inorganic anion transmembrane transporter activity,MF,CLCA2;CLCN3;TTYH3;ANO8;ANO1;SLC12A7;PCYOX1;SLC22A17
8619,GO:0034135,0.396842685081507,0.921385773084024,1,6,regulation of toll-like receptor 2 signaling pathway,BP,F2RL1
5960,GO:0018344,0.396852897170894,0.921381287521058,1,6,protein geranylgeranylation,BP,RABGGTA
11334,GO:0045657,0.396869075317026,0.921374181103738,1,6,positive regulation of monocyte differentiation,BP,CTNNBIP1
8108,GO:0032794,0.39701665932628,0.853792136447139,2,14,GTPase activating protein binding,MF,RGS14;GNAI1
2181,GO:0005031,0.397348326002412,0.850676657259919,2,18,tumor necrosis factor-activated receptor activity,MF,TNFRSF6B;NGFR
2183,GO:0005035,0.397348326002412,0.850676657259919,2,18,death receptor activity,MF,TNFRSF6B;NGFR
6202,GO:0019693,0.397414096952669,0.673300567227827,32,384,ribose phosphate metabolic process,BP,NT5E;NOS1;PYGL;ADCY7;RAPGEF3;H6PD;DHTKD1;PGM1;DLG1;DLG4;PGLS;ACOT7;NME4;DLG3;APOE;PKD2;LDHA;AKAP9;PPARA;FAM20C;PTHLH;NDUFV3;PANK4;PDE5A;TMSB4X;TIMP2;CARD11;ATP6V1B2;AK9;ADCY1;PANK1;ADNP
17111,GO:0101003,0.397427972367315,0.789162104856021,4,37,ficolin-1-rich granule membrane,CC,SLC2A3;COPB1;AP2A2;ADAM8
7423,GO:0031519,0.397458902183588,0.771664591918964,5,47,PcG protein complex,CC,PHC3;CSNK2A1;PHF1;CBX7;JARID2
13506,GO:0055075,0.397481795082077,0.85349432857158,2,14,potassium ion homeostasis,BP,SLC12A7;ATP12A
7936,GO:0032516,0.39754429042498,0.853454291978443,2,14,positive regulation of phosphoprotein phosphatase activity,BP,ITGA1;SLC39A10
5060,GO:0015271,0.397715542646213,0.923745214226189,1,5,outward rectifier potassium channel activity,MF,PKD2
6098,GO:0019318,0.39772609740556,0.700793627210137,16,172,hexose metabolic process,BP,PCK2;IGFBP4;NR1D1;H6PD;PC;PGM1;ATF4;PPARA;LRP5;SLC35B4;MLYCD;GLB1;IGF2;KAT2B;OAS1;GALE
14841,GO:0070579,0.397799403204246,0.927885285259068,1,4,methylcytosine dioxygenase activity,MF,TET1
7975,GO:0032589,0.397985641862452,0.81440221570518,3,24,neuron projection membrane,CC,DDN;ATF4;EPB41L3
4245,GO:0009445,0.398056881650491,0.918907410351251,1,7,putrescine metabolic process,BP,AZIN2
14317,GO:0061469,0.398513281282106,0.920649893725957,1,6,regulation of type B pancreatic cell proliferation,BP,NR1D1
18984,GO:1904778,0.398586180121156,0.923373268221595,1,5,positive regulation of protein localization to cell cortex,BP,GNAI1
19099,GO:1905007,0.398629559206149,0.923354707031025,1,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
8344,GO:0033192,0.398643877955222,0.923348579667807,1,5,calmodulin-dependent protein phosphatase activity,MF,PPP3CB
6817,GO:0030275,0.398824332564695,0.850980551786193,2,16,LRR domain binding,MF,DDIT3;ATF4
1225,GO:0002902,0.398835227312803,0.85030120263118,2,17,regulation of B cell apoptotic process,BP,SLC39A10;FOXP1
13517,GO:0055088,0.398928040021098,0.746290344554467,7,70,lipid homeostasis,BP,MALL;APOE;ANGPTL4;ABCG1;LRP5;XBP1;PPARG
10826,GO:0044319,0.39903024176759,0.813200474137423,3,25,wound healing, spreading of cells,BP,WNT7A;CD44;CEACAM1
16323,GO:0090505,0.39903024176759,0.813200474137423,3,25,epiboly involved in wound healing,BP,WNT7A;CD44;CEACAM1
2502,GO:0005751,0.399192476287131,0.914915035935195,1,10,mitochondrial respiratory chain complex IV,CC,NDUFA4L2
10853,GO:0044351,0.399227288189484,0.920334099174377,1,6,macropinocytosis,BP,MAPKAPK3
13559,GO:0060022,0.399329569463882,0.923054801089063,1,5,hard palate development,BP,DLG1
3162,GO:0006771,0.399368409541923,0.920271592280245,1,6,riboflavin metabolic process,BP,ACP5
13317,GO:0052173,0.399478820315325,0.920222667062407,1,6,response to defenses of other organism involved in symbiotic interaction,BP,EIF2AK2
13322,GO:0052200,0.399478820315325,0.920222667062407,1,6,response to host defenses,BP,EIF2AK2
15954,GO:0075136,0.399478820315325,0.920222667062407,1,6,response to host,BP,EIF2AK2
11552,GO:0046085,0.399493052917958,0.920216358972712,1,6,adenosine metabolic process,BP,NT5E
4215,GO:0009374,0.400118702386968,0.922715846089165,1,5,biotin binding,MF,PC
12159,GO:0048266,0.400323085604436,0.922627907854449,1,5,behavioral response to pain,BP,VWA1
7543,GO:0031821,0.400450411898682,0.91979134126388,1,6,G-protein coupled serotonin receptor binding,MF,GNAI1
6115,GO:0019362,0.400661390849966,0.712425876395562,12,128,pyridine nucleotide metabolic process,BP,NT5E;PCK2;NAPRT;H6PD;DHTKD1;PGM1;IDH2;PGLS;NMRK1;LDHA;PPARA;PARP9
11705,GO:0046496,0.400661390849966,0.712425876395562,12,128,nicotinamide nucleotide metabolic process,BP,NT5E;PCK2;NAPRT;H6PD;DHTKD1;PGM1;IDH2;PGLS;NMRK1;LDHA;PPARA;PARP9
2248,GO:0005160,0.400892646971204,0.811430292515047,3,26,transforming growth factor beta receptor binding,MF,SMURF2;TGFBR2;FKBP1A
3379,GO:0007156,0.400926295187071,0.73725934415118,8,67,homophilic cell adhesion via plasma membrane adhesion molecules,BP,SDK2;PCDHAC2;PLXNB3;FAT1;CEACAM1;CADM4;RET;PCDH1
12997,GO:0051414,0.400995175739656,0.922338298163907,1,5,response to cortisol,BP,IGFBP7
6986,GO:0030663,0.401031191988757,0.848270544102677,2,18,COPI-coated vesicle membrane,CC,COPB1;COPG1
8001,GO:0032623,0.401125755178135,0.786044801393484,4,38,interleukin-2 production,BP,PRNP;IL1RAP;CARD11;IL20RB
2244,GO:0005154,0.401214276145591,0.811193860621705,3,26,epidermal growth factor receptor binding,MF,SHC1;ATXN2;ARF4
10284,GO:0043029,0.401244993936026,0.810451142930119,3,28,T cell homeostasis,BP,RAG1;PPP3CB;FADD
16562,GO:0097342,0.402121819612072,0.919045997773502,1,6,ripoptosome,CC,FADD
12921,GO:0051271,0.40221123427408,0.689175659354813,19,197,negative regulation of cellular component movement,BP,ZMYND8;CYGB;ADARB1;ALOX15B;SEMA4B;IDH2;PLXNB3;MCTP1;EPHA1;APOE;SRGAP2B;LRP1;PFN2;IFITM1;ABHD6;C5;PPARG;WASL;SEMA3F
6122,GO:0019370,0.402625902902394,0.916831265207872,1,7,leukotriene biosynthetic process,BP,LTA4H
8005,GO:0032633,0.402730543555732,0.847755604353818,2,17,interleukin-4 production,BP,IL1RAP;IL20RB
1494,GO:0003836,0.402760585341776,0.918760028979218,1,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,ST3GAL5
8622,GO:0034138,0.40289080454635,0.847650410341409,2,17,toll-like receptor 3 signaling pathway,BP,F2RL1;FADD
5011,GO:0015171,0.40305102237673,0.76695728857284,5,48,amino acid transmembrane transporter activity,MF,SLC6A6;SLC6A14;SLC43A1;SLC38A2;SLC7A11
18017,GO:1902510,0.403135005446134,0.916597940745632,1,7,regulation of apoptotic DNA fragmentation,BP,ENDOG
7977,GO:0032591,0.403166091543947,0.921398262294498,1,5,dendritic spine membrane,CC,DDN
17574,GO:1901186,0.40328448352604,0.809292408170687,3,27,positive regulation of ERBB signaling pathway,BP,NEURL1;ARAP1;PTK6
2659,GO:0006002,0.403408497993093,0.918469331729924,1,6,fructose 6-phosphate metabolic process,BP,GFPT1
2701,GO:0006066,0.403660024738002,0.683362991232264,21,232,alcohol metabolic process,BP,SORL1;PCK2;VLDLR;CYP27B1;LMF1;ISYNA1;SPTLC2;RDH14;PLPP6;APOE;FGFR1;ABCG1;NTSR1;LRP5;INPP4A;HSD17B7;OSBPL5;SRD5A3;ALDH1A2;PLCH2;COQ2
14724,GO:0070373,0.403706667930174,0.766259457104974,5,49,negative regulation of ERK1 and ERK2 cascade,BP,TNIP1;DLG1;RGS14;RANBP9;SPRY2
1100,GO:0002689,0.403783359039254,0.916300216931611,1,7,negative regulation of leukocyte chemotaxis,BP,C5
10109,GO:0042626,0.40394178262192,0.742446483691951,7,66,ATPase activity, coupled to transmembrane movement of substances,MF,ATP7B;ABCD1;ABCA7;ABCG1;PCYOX1;ATP12A;ATP6V1B2
13716,GO:0060281,0.404106690433933,0.918155360495234,1,6,regulation of oocyte development,BP,PDE5A
19384,GO:1905879,0.404106690433933,0.918155360495234,1,6,regulation of oogenesis,BP,PDE5A
11040,GO:0045017,0.40415230885687,0.685105652510239,20,212,glycerolipid biosynthetic process,BP,PCK2;DGKA;PIGH;AGPAT4;FGFR1;LPCAT4;LPCAT1;INPP5F;PITPNM1;PLA2G4D;INPP4A;CSNK2A1;CRLS1;AGPAT3;MTMR4;ACP6;AGPAT1;DDHD2;CDS2;SLC44A1
15687,GO:0072210,0.404577466857337,0.809123962140708,3,25,metanephric nephron development,BP,PKD2;RET;LAMB2
10046,GO:0042500,0.404843214715836,0.917823346660061,1,6,aspartic endopeptidase activity, intramembrane cleaving,MF,PSEN2
3606,GO:0008045,0.404929165382744,0.848684301997192,2,14,motor neuron axon guidance,BP,RNF165;SEMA3F
3053,GO:0006612,0.404947595191865,0.707463838278784,12,164,protein targeting to membrane,BP,PRNP;ANK3;FYN;GDI1;CEMIP;STOM;PAK1;SEC63;ZDHHC2;ZDHHC1;SSR3;SSR1
14226,GO:0061179,0.405016757608645,0.915732032984944,1,7,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,MAP4K4
457,GO:0001302,0.405240760909402,0.917643795033507,1,6,replicative cell aging,BP,ERCC1
3202,GO:0006835,0.405265915128154,0.765501681792088,5,46,dicarboxylic acid transport,BP,VAMP2;NTSR1;SLC38A2;SLC13A3;SLC7A11
13724,GO:0060292,0.405338914735725,0.847512025535167,2,15,long term synaptic depression,BP,SHANK2;ABHD6
2841,GO:0006309,0.405413107534696,0.845989959961116,2,17,apoptotic DNA fragmentation,BP,H1F0;ENDOG
2558,GO:0005838,0.405990731669288,0.843537314789586,2,21,proteasome regulatory particle,CC,PSMD2;PSMD7
16719,GO:0097709,0.406112452504443,0.917249250704467,1,6,connective tissue replacement,BP,F2R
18862,GO:1904502,0.406161796276831,0.920089579554654,1,5,regulation of lipophagy,BP,SPTLC2
18863,GO:1904504,0.406161796276831,0.920089579554654,1,5,positive regulation of lipophagy,BP,SPTLC2
4739,GO:0010906,0.406210325624897,0.740512413533469,7,66,regulation of glucose metabolic process,BP,IGFBP4;NR1D1;PPARA;SLC35B4;MLYCD;IGF2;KAT2B
16706,GO:0097677,0.406254256273995,0.917184957725487,1,6,STAT family protein binding,MF,PARP9
2491,GO:0005739,0.4062551894133,0.633945589845134,111,1425,mitochondrion,CC,NOS1;PCK2;CYP27B1;GPT2;MAP2K1;FAM210B;TK2;DHTKD1;PC;HADH;ELK3;SNPH;ARMCX2;FYN;BNIP3;IDH2;CTSB;DHX32;TGM2;XPC;GLUL;ACSF2;SPTLC2;ACOT7;RSAD1;RDH14;NME4;ACAD11;ARG2;STOM;SHC1;NAGS;CBR4;HAGH;BNIP3L;ATP7B;ABCD1;ALDH1L2;IDE;ABHD10;AARS;UROS;OCIAD2;ABCG1;SOX4;GSDMC;SPATA18;MRPS6;BSG;NTSR1;ANXA6;ACAD10;LRP5;COX18;CASP4;ACOT13;HIBADH;PRDX5;MLYCD;ALDH7A1;TST;SLC25A4;SUGCT;NDUFV3;CPT2;MSRB2;CRLS1;BOK;PARP9;NIPSNAP1;NACC2;LACTB2;NDUFA4L2;BPHL;GLUD1;NUDT6;AZIN2;BCL2L1;CRAT;NFU1;TXNRD3;MAP2K2;ABHD6;MICU3;RMRP;SFXN3;PRKACA;SLC25A30;SLC25A43;NIT2;ACP6;MOAP1;PPL;LYPLA1;ALDH4A1;GARS;ENDOG;OSGEPL1;CMC1;HSPA2;TMEM173;COQ2;ARMCX3;PSEN2;CDS2;OAS1;FAM162A;AMACR;JARID2;SLC44A1;ALAS1
16932,GO:0098909,0.406380588371079,0.919993475010183,1,5,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,AKAP9
11005,GO:0044818,0.406440146389931,0.807333893346322,3,26,mitotic G2/M transition checkpoint,BP,BRSK1;HMGA2;TAOK1
1930,GO:0004629,0.406513819313394,0.846741598126838,2,15,phospholipase C activity,MF,EDNRA;PLCH2
139,GO:0000289,0.406566368032321,0.782518237393473,4,35,nuclear-transcribed mRNA poly(A) tail shortening,BP,TNRC6B;PAIP1;TNRC6C;CNOT11
3061,GO:0006623,0.406602511044145,0.782771442992081,4,34,protein targeting to vacuole,BP,SORL1;VPS13A;AP3D1;TMEM50B
10444,GO:0043300,0.406608914404745,0.806828548882867,3,27,regulation of leukocyte degranulation,BP,RAC2;CEACAM1;F2RL1
13848,GO:0060449,0.406670446988191,0.916996081639486,1,6,bud elongation involved in lung branching,BP,SPRY2
4718,GO:0010880,0.406773939984628,0.846570760921412,2,15,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,CHD7;PRKACA
4586,GO:0010676,0.406884297190761,0.782549747943761,4,34,positive regulation of cellular carbohydrate metabolic process,BP,PPARA;NTSR1;IGF2;KAT2B
13857,GO:0060462,0.406935034186428,0.919749613822859,1,5,lung lobe development,BP,TGFBR2
13858,GO:0060463,0.406935034186428,0.919749613822859,1,5,lung lobe morphogenesis,BP,TGFBR2
4067,GO:0009117,0.406946277147181,0.657947235193759,39,476,nucleotide metabolic process,BP,XDH;NT5E;NOS1;PCK2;ADCY7;RAPGEF3;TK2;NAPRT;H6PD;DHTKD1;PGM1;DLG1;DLG4;IDH2;PGLS;ACOT7;NMRK1;NME4;DLG3;APOE;PKD2;LDHA;AKAP9;PPARA;FAM20C;PTHLH;NDUFV3;PARP9;PANK4;PDE5A;TMSB4X;TIMP2;CARD11;ATP6V1B2;AK9;GARS;ADCY1;PANK1;ADNP
7991,GO:0032609,0.407200635245326,0.762809845196869,5,53,interferon-gamma production,BP,PRNP;CEBPG;F2RL1;IL20RB;FADD
2203,GO:0005088,0.407216930796123,0.687294940822589,18,173,Ras guanyl-nucleotide exchange factor activity,MF,RAPGEF3;DENND5B;EGFR;RIN2;FYN;DLG4;NET1;SHC1;OBSCN;AKAP9;FGFR1;DNMBP;RANBP9;RIN1;RET;DOCK11;SHC2;RGL2
9358,GO:0035869,0.407304541029501,0.763160128112889,5,50,ciliary transition zone,CC,TTBK2;UNC119B;TCTN1;CCSAP;TMEM107
1001,GO:0002475,0.407417739732633,0.916656266834378,1,6,antigen processing and presentation via MHC class Ib,BP,AP3D1
15904,GO:0072673,0.407532300527615,0.84607214680987,2,15,lamellipodium morphogenesis,BP,CD44;WASF2
4684,GO:0010832,0.408155926275301,0.919211007542486,1,5,negative regulation of myotube differentiation,BP,XBP1
5648,GO:0016742,0.408330650267696,0.916239993004573,1,6,hydroxymethyl-, formyl- and related transferase activity,MF,ALDH1L2
12065,GO:0048013,0.408932282846963,0.737570669763358,7,72,ephrin receptor signaling pathway,BP,FYN;PAK1;EPHA1;AP2A2;ARPC1A;WASL;PSEN2
4061,GO:0009110,0.409016572509446,0.843601978884519,2,17,vitamin biosynthetic process,BP,CYP27B1;PSAT1
10686,GO:0043950,0.4091531044648,0.918769435257344,1,5,positive regulation of cAMP-mediated signaling,BP,NOS1
1047,GO:0002573,0.409305672909284,0.704802536388114,12,125,myeloid leukocyte differentiation,BP,CTNNBIP1;GLO1;TGFBR2;FAM20C;CEACAM1;L3MBTL3;F2RL1;UBASH3B;IFI16;PPARG;FOXP1;FADD
5570,GO:0016584,0.409351509033664,0.913716451336864,1,7,nucleosome positioning,BP,RSF1
8275,GO:0033077,0.409354458692901,0.76180161856745,5,48,T cell differentiation in thymus,BP,RAG1;CARD11;ADAM8;FZD8;FADD
14655,GO:0070244,0.409427312632075,0.91573823777723,1,6,negative regulation of thymocyte apoptotic process,BP,RAG1
20268,GO:2001236,0.40960703955732,0.709019412887709,11,120,regulation of extrinsic apoptotic signaling pathway,BP,ITGA6;FYN;STRADB;RBCK1;FGFR1;BCL2L1;RET;TMBIM1;DEDD2;RB1CC1;FADD
7450,GO:0031585,0.40968201131629,0.922969477450345,1,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,PKD2
4980,GO:0015101,0.409833261848954,0.843058177971973,2,17,organic cation transmembrane transporter activity,MF,AZIN2;SLC44A1
7064,GO:0030851,0.409881549420439,0.843025995201852,2,17,granulocyte differentiation,BP,CEACAM1;L3MBTL3
3140,GO:0006733,0.409915319386151,0.699773602484667,13,143,oxidoreduction coenzyme metabolic process,BP,NT5E;PCK2;NAPRT;H6PD;DHTKD1;PGM1;IDH2;PGLS;NMRK1;LDHA;PPARA;PARP9;COQ2
13487,GO:0055024,0.409920317197431,0.761691742567808,5,46,regulation of cardiac muscle tissue development,BP,DKK1;PAK1;TGFBR2;FGFR1;JARID2
17725,GO:1901654,0.410196890996938,0.703915715773464,12,127,response to ketone,BP,CCND1;PCK2;EIF4EBP1;EGFR;XRN1;CSNK2A1;BCL2L1;GLB1;PPARG;IGFBP7;ADCY1;GNAI1
15155,GO:0071265,0.41048557276522,0.913184292667461,1,7,L-methionine biosynthetic process,BP,CTH
5380,GO:0016198,0.410643505118768,0.918106653098447,1,5,axon choice point recognition,BP,ROBO3
18213,GO:1903003,0.410676803956904,0.915164301637888,1,6,positive regulation of protein deubiquitination,BP,TNIP1
17492,GO:1900426,0.410779348024927,0.913046110285382,1,7,positive regulation of defense response to bacterium,BP,F2RL1
12238,GO:0048505,0.41106032473281,0.914987653701709,1,6,regulation of timing of cell differentiation,BP,SERPINE2
16862,GO:0098791,0.411091354015804,0.642791627409709,59,659,Golgi subcompartment,CC,EDEM1;SORL1;ASAP2;POSTN;MARCH9;B4GALT6;EGFR;SLC33A1;ARAP1;B3GNT3;SNX9;SLC9A7;SEC23A;MALL;B4GALNT4;ATP7B;MCFD2;ST3GAL5;AKAP9;ABCA7;ICA1;MARCH4;LPCAT1;GALNT3;VAMP2;CHAC1;ABCG1;PITPNM1;RAB31;LMAN1;BSG;CLCN3;DNMBP;SLC35B4;CLTCL1;COPB1;COPG1;RASIP1;QSOX1;BOK;ATXN2;USP6NL;AZIN2;AGPAT3;GOLGA2P5;STX10;RAB43;GABARAPL2;SAMD8;RAB1A;KDELR3;ST6GALNAC2;CTSZ;AP3D1;PJA2;MAP4K2;TMEM50B;PSEN2;COG8
12409,GO:0048854,0.411187142067756,0.805169345362759,3,23,brain morphogenesis,BP,BBS2;SHANK2;AKT3
1186,GO:0002833,0.411201474138498,0.803401708251399,3,27,positive regulation of response to biotic stimulus,BP,F2RL1;DDX60;PUM2
1187,GO:0002834,0.411456127714499,0.914805110394278,1,6,regulation of response to tumor cell,BP,CEACAM1
1190,GO:0002837,0.411456127714499,0.914805110394278,1,6,regulation of immune response to tumor cell,BP,CEACAM1
15422,GO:0071688,0.411474900461636,0.929848037478294,1,3,striated muscle myosin thick filament assembly,BP,OBSL1
16533,GO:0097264,0.411586573160854,0.914744896239282,1,6,self proteolysis,BP,TENM2
842,GO:0002154,0.411629830579097,0.917666200051827,1,5,thyroid hormone mediated signaling pathway,BP,THRA
7698,GO:0032155,0.412078490933416,0.746009977100376,6,58,cell division site part,CC,PKN1;SSH1;RAB11FIP4;PITPNM1;SPIRE1;SEPT6
1239,GO:0002931,0.412100812313435,0.802727499731997,3,27,response to ischemia,BP,MLYCD;CPEB4;EEF2K
15699,GO:0072234,0.412824030288424,0.843498926434402,2,14,metanephric nephron tubule development,BP,WWTR1;PKD2
10305,GO:0043068,0.412890756953518,0.650943727959773,41,471,positive regulation of programmed cell death,BP,XDH;F2R;NEURL1;ITGA6;RPS6KA2;PRNP;NFATC4;TNFSF15;DDIT3;BNIP3;NET1;TGM2;DAP;OBSCN;BNIP3L;RBCK1;LDHA;HMGA2;ATF4;ITGA1;SOX4;NTSR1;CASP4;JMY;BOK;NACC2;NGFR;MARK4;BCL2L1;RET;LPAR1;CTSZ;MOAP1;PPARG;ALDH1A2;ADAM8;ENDOG;DEDD2;PSEN2;FAM162A;FADD
12915,GO:0051261,0.412909277531464,0.72603392517295,8,75,protein depolymerization,BP,MAP1B;TTBK2;ASPH;TMOD2;TWF2;DNAJC6;F2RL1;CCSAP
20196,GO:2001053,0.413095069185653,0.9140466548845,1,6,regulation of mesenchymal cell apoptotic process,BP,TBX1
1201,GO:0002861,0.413276542403003,0.910305439054963,1,8,regulation of inflammatory response to antigenic stimulus,BP,IL20RB
2517,GO:0005770,0.413345264827556,0.683555310334414,17,189,late endosome,CC,F2R;MAP2K1;DDIT3;EGFR;DYSF;ATP7B;FYCO1;SNX14;CLCN3;ANXA6;MVB12B;CST3;CLTCL1;VPS11;MVB12A;MAP2K2;TMEM9
11376,GO:0045741,0.413364027353122,0.913921791094439,1,6,positive regulation of epidermal growth factor-activated receptor activity,BP,NEURL1
14070,GO:0060850,0.413398349390426,0.913905849025158,1,6,regulation of transcription involved in cell fate commitment,BP,PPARG
11848,GO:0046826,0.41355548192967,0.911733613739674,1,7,negative regulation of protein export from nucleus,BP,SOX4
10270,GO:0043010,0.413602773219088,0.678797033196571,19,191,camera-type eye development,BP,ACVR2B;SDK2;EGFR;MYH15;DLG1;WNT7A;TGFBR2;SLITRK6;RAB11FIP4;TUB;LPCAT1;LRP5;CHD7;WNT2B;RET;LAMB2;ALDH1A2;SLC7A11;LRP6
2881,GO:0006382,0.413773618975656,0.916703796722033,1,5,adenosine to inosine editing,BP,ADARB1
6568,GO:0022027,0.413803815485142,0.921216768343577,1,4,interkinetic nuclear migration,BP,CEP120
7903,GO:0032471,0.413945542484369,0.911548229391954,1,7,negative regulation of endoplasmic reticulum calcium ion concentration,BP,TGM2
9794,GO:0040013,0.414003173365627,0.676038988414773,20,209,negative regulation of locomotion,BP,ZMYND8;CYGB;ADARB1;ALOX15B;SEMA4B;IDH2;PLXNB3;MCTP1;EPHA1;APOE;SRGAP2B;LRP1;PFN2;TRIM5;IFITM1;ABHD6;C5;PPARG;WASL;SEMA3F
13047,GO:0051537,0.414025406437309,0.839069787787497,2,19,2 iron, 2 sulfur cluster binding,MF,XDH;AOX1
4109,GO:0009164,0.414034767536562,0.838565367738697,2,20,nucleoside catabolic process,BP,NT5E;APOBEC3C
20192,GO:2001040,0.414086330814529,0.91358590611114,1,6,positive regulation of cellular response to drug,BP,ENDOG
13522,GO:0055093,0.41409142155376,0.840207296034714,2,17,response to hyperoxia,BP,BNIP3;PPARG
7686,GO:0032135,0.41412804578808,0.913566483099468,1,6,DNA insertion or deletion binding,MF,XPC
14637,GO:0070207,0.414385290090822,0.839383287401392,2,18,protein homotrimerization,BP,ATXN10;SIGMAR1
2017,GO:0004745,0.414715839442522,0.911181424525399,1,7,retinol dehydrogenase activity,MF,SDR9C7
13493,GO:0055038,0.414919222292628,0.74299974846021,6,63,recycling endosome membrane,CC,SLC9A7;RAB11FIP4;ABHD17C;ZDHHC2;BOK;ATP11B
12751,GO:0051019,0.415281843372582,0.800724016950964,3,26,mitogen-activated protein kinase binding,MF,TNIP1;MICALCL;MAPKAPK3
17212,GO:0106070,0.415327003007082,0.916002084817166,1,5,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,NOS1
10491,GO:0043388,0.415404169617648,0.77410143222043,4,41,positive regulation of DNA binding,BP,HMGA2;ITGA2;CEBPG;PPARG
6187,GO:0019626,0.416218985110338,0.910462945784489,1,7,short-chain fatty acid catabolic process,BP,PCK2
13658,GO:0060170,0.416270378998969,0.756649825380008,5,45,ciliary membrane,CC,BBS2;SHANK2;PKD2;EFCAB7;PTCH1
2096,GO:0004862,0.416431168092964,0.910361237655924,1,7,cAMP-dependent protein kinase inhibitor activity,MF,PRKAR1A
2640,GO:0005976,0.416465675172823,0.722564725423295,8,79,polysaccharide metabolic process,BP,PYGL;PYGB;NR1D1;PGM1;B3GNT3;PPP1R2;IGF2;RB1CC1
4961,GO:0015036,0.416530402191188,0.797332349323825,3,34,disulfide oxidoreductase activity,MF,ERO1B;PDIA5;TXNRD3
6461,GO:0021782,0.416600116678204,0.731372666023173,7,68,glial cell development,BP,SH3TC2;EGFR;LRP1;SOX4;WASF3;LAMB2;LPAR1
2436,GO:0005635,0.416716476322612,0.653303793991555,34,376,nuclear envelope,CC,SORL1;SYNE3;PRNP;XPOT;SLC16A3;EGFR;BNIP3;UBXN4;WDFY3;GRK5;PAK1;NUCB2;SCRN1;RAC2;CLCA2;BNIP3L;CCND2;KLHDC2;ITPR3;CST3;MYOF;SLC2A9;BOK;MTA1;BCL2L1;AGPAT3;PUM2;SLC30A1;AK9;ATP11B;RNF180;SIGMAR1;PSEN2;RB1CC1
2792,GO:0006228,0.417043437361356,0.908478163905075,1,8,UTP biosynthetic process,BP,NME4
6287,GO:0019897,0.417195034409127,0.708161243504828,10,100,extrinsic component of plasma membrane,CC,EPN3;SERPINE2;FYN;DLG4;SNX9;PTK6;SYTL1;ESYT3;PRSS8;GNAI1
4445,GO:0010359,0.417284794291767,0.912088798527253,1,6,regulation of anion channel activity,BP,PRNP
18619,GO:1903902,0.417385880398569,0.754686891266001,5,51,positive regulation of viral life cycle,BP,ADARB1;PC;STOM;YTHDC2;TRIM38
11072,GO:0045072,0.417433165609328,0.912018962689308,1,6,regulation of interferon-gamma biosynthetic process,BP,CEBPG
16596,GO:0097413,0.41749433907787,0.909850540066603,1,7,Lewy body,CC,ATF4
4059,GO:0009108,0.41750953534886,0.679664898019194,17,191,coenzyme biosynthetic process,BP,NAPRT;DHTKD1;ELOVL1;PGM1;IDH2;ACOT7;NMRK1;CBR4;LDHA;PPARA;MLYCD;PARP9;PANK4;PPT2;COQ2;HSD17B12;PANK1
13879,GO:0060509,0.417605363244427,0.91496622887413,1,5,Type I pneumocyte differentiation,BP,THRA
12696,GO:0050913,0.417643598818895,0.909778698997969,1,7,sensory perception of bitter taste,BP,ITPR3
14809,GO:0070536,0.417696600574268,0.799327193296372,3,25,protein K63-linked deubiquitination,BP,OTUB2;USP20;USP25
6302,GO:0019919,0.417717787744652,0.909742977518357,1,7,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,PRMT3
9030,GO:0035242,0.417717787744652,0.909742977518357,1,7,protein-arginine omega-N asymmetric methyltransferase activity,MF,PRMT3
3870,GO:0008494,0.417725993200432,0.909739026105135,1,7,translation activator activity,MF,PAIP1
4221,GO:0009395,0.417943128150246,0.797959899347079,3,28,phospholipid catabolic process,BP,INPP5F;PLA2G4D;ABHD6
5663,GO:0016772,0.417991535899711,0.631783508975503,71,777,transferase activity, transferring phosphorus-containing groups,MF,CCND1;RPS6KA2;MAP2K1;ACVR2B;LTBP1;TK2;PKN1;MST1R;DGKA;BRSK1;EGFR;STK39;FYN;MAPK13;DLG1;DLG4;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;NAGS;DLG3;PAK1;NEK9;TGFBR2;EPHA1;OBSCN;CDK17;PRKACB;HMGA2;FGFR1;PTK6;ULK2;LTBP4;FAM20C;MAPKAPK3;NLK;SLK;CDC42BPA;TAOK1;CSNK2A1;CRLS1;MAST3;ACVR1B;PSKH1;MARK4;POLL;UAP1;PANK4;MAP2K2;RET;RMRP;PAK6;SAMD8;PRKACA;NEK6;EIF2AK2;CARD11;FICD;MAP4K2;ZMYM2;AK9;AKT3;EEF2K;ZFYVE21;CDS2;OAS1;PANK1;N4BP2
13982,GO:0060693,0.418063988625803,0.911721660465245,1,6,regulation of branching involved in salivary gland morphogenesis,BP,FGFR1
12863,GO:0051184,0.418071975168136,0.838236772046237,2,16,cofactor transmembrane transporter activity,MF,SLC33A1;SLC23A2
575,GO:0001726,0.418295901078763,0.688937257371692,14,138,ruffle,CC,WIPF1;SNX9;PODXL;PAK1;ABCA7;PTK6;FERMT1;SPRY2;WASF2;ARF4;NCKAP1;PSD3;FRMD4B;ATP6V1B2
14618,GO:0070181,0.418400376821994,0.907814358189316,1,8,small ribosomal subunit rRNA binding,MF,MRPS6
15169,GO:0071287,0.418410142762378,0.911558255728905,1,6,cellular response to manganese ion,BP,ATF4
11382,GO:0045747,0.418773265462569,0.772822350021646,4,35,positive regulation of Notch signaling pathway,BP,TSPAN5;EPN2;MAML3;KAT2B
7609,GO:0031995,0.418896727854189,0.911328241872654,1,6,insulin-like growth factor II binding,MF,IGFBP4
17999,GO:1902459,0.418957484129984,0.914347735030765,1,5,positive regulation of stem cell population maintenance,BP,ZNF322
12010,GO:0047498,0.419070761436964,0.911245884195142,1,6,calcium-dependent phospholipase A2 activity,MF,PLA2G4D
8956,GO:0035019,0.419174347478248,0.753516812886988,5,49,somatic stem cell population maintenance,BP,WNT7A;EPHA1;SOX4;LRP5;FOXP1
15308,GO:0071498,0.419250394505233,0.836718243240157,2,17,cellular response to fluid shear stress,BP,TFPI2;PKD2
6981,GO:0030656,0.419258263801926,0.908999269753967,1,7,regulation of vitamin metabolic process,BP,CYP27B1
17917,GO:1902229,0.419376140896956,0.795399610799255,3,33,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,CD44;NACC2;BCL2L1
637,GO:0001826,0.419615320190107,0.914045810679466,1,5,inner cell mass cell differentiation,BP,TET1
5664,GO:0016773,0.419765458229304,0.636382029425587,55,579,phosphotransferase activity, alcohol group as acceptor,MF,CCND1;RPS6KA2;MAP2K1;ACVR2B;LTBP1;PKN1;MST1R;DGKA;BRSK1;EGFR;STK39;FYN;MAPK13;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;PAK1;NEK9;TGFBR2;EPHA1;OBSCN;CDK17;PRKACB;HMGA2;FGFR1;PTK6;ULK2;LTBP4;FAM20C;MAPKAPK3;NLK;SLK;CDC42BPA;TAOK1;CSNK2A1;MAST3;ACVR1B;PSKH1;MARK4;PANK4;MAP2K2;RET;PAK6;PRKACA;NEK6;EIF2AK2;MAP4K2;ZMYM2;AKT3;EEF2K;ZFYVE21;PANK1;N4BP2
10048,GO:0042509,0.419896687183325,0.770109026242614,4,43,regulation of tyrosine phosphorylation of STAT protein,BP,FYN;PTK6;INPP5F;PARP9
16856,GO:0098773,0.419905036670261,0.728407316245121,7,69,skin epidermis development,BP,EGFR;DKK1;FERMT1;ACVR1B;LAMA5;HPSE;LRP4
17602,GO:1901264,0.42011014939918,0.751857000695278,5,55,carbohydrate derivative transport,BP,VLDLR;SLC29A4;ABCG1;SLC35B4;SLC25A4
7644,GO:0032055,0.420286379073244,0.910669292358473,1,6,negative regulation of translation in response to stress,BP,ATF4
14188,GO:0061087,0.420538261485293,0.910549528849101,1,6,positive regulation of histone H3-K27 methylation,BP,PHF1
5794,GO:0017034,0.420539894402078,0.913620338648502,1,5,Rap guanyl-nucleotide exchange factor activity,MF,RAPGEF3
11397,GO:0045779,0.420710913754443,0.910467379512153,1,6,negative regulation of bone resorption,BP,UBASH3B
13481,GO:0055017,0.42084751779856,0.752657032799259,5,46,cardiac muscle tissue growth,BP,PAK1;TGFBR2;FGFR1;PRKAR1A;JARID2
11422,GO:0045835,0.420866477263139,0.910393320934285,1,6,negative regulation of meiotic nuclear division,BP,PRKAR1A
11441,GO:0045875,0.421029172924915,0.913394649496891,1,5,negative regulation of sister chromatid cohesion,BP,ATRX
96,GO:0000186,0.421113110704306,0.752630918598655,5,45,activation of MAPKK activity,BP,F2R;EGFR;ERCC6;TAOK1;EIF2AK2
603,GO:0001771,0.421406889077443,0.910135752634023,1,6,immunological synapse formation,BP,DLG1
15690,GO:0072215,0.421483369340542,0.835922442386022,2,16,regulation of metanephros development,BP,WWTR1;RET
6031,GO:0019098,0.421684105363021,0.835058912941804,2,17,reproductive behavior,BP,SERPINE2;THRA
13770,GO:0060348,0.421690849928872,0.69393498478756,12,118,bone development,BP,COL13A1;TGFBR2;ACP5;FAM20C;MMP14;LRP5;THBS3;TTC9;MEF2D;WASF2;SH3PXD2B;FOXP1
13270,GO:0051957,0.4216929948374,0.909999203945974,1,6,positive regulation of amino acid transport,BP,NTSR1
10864,GO:0044381,0.421929501929325,0.83740714599799,2,14,glucose import in response to insulin stimulus,BP,PAK1;NGFR
20293,GO:2001273,0.421929501929325,0.83740714599799,2,14,regulation of glucose import in response to insulin stimulus,BP,PAK1;NGFR
14046,GO:0060795,0.422040639385231,0.834815101128211,2,17,cell fate commitment involved in formation of primary germ layer,BP,DKK1;FGFR1
11800,GO:0046677,0.422072125376765,0.670350825934363,19,218,response to antibiotic,BP,CCND1;ADCY7;FYN;BNIP3;MAPK13;NET1;SDC1;IMPACT;LDHA;UROS;HYAL1;XRN1;CST3;BCL2L1;ITPR2;ENDOG;ADCY1;GNAI1;DNMT3A
19943,GO:2000480,0.422133581826747,0.907600999219414,1,7,negative regulation of cAMP-dependent protein kinase activity,BP,PRKAR1A
7324,GO:0031333,0.422161209492158,0.709845636040823,9,93,negative regulation of protein complex assembly,BP,SORL1;CTNNBIP1;DKK1;IMPACT;TMOD2;PFN2;TWF2;THRA;TMSB4X
20107,GO:2000779,0.422407489708347,0.750821302993476,5,49,regulation of double-strand break repair,BP,HMGA2;PARP9;RNF169;MAGEF1;KLHL15
15435,GO:0071706,0.422442454812694,0.725717639780518,7,74,tumor necrosis factor superfamily cytokine production,BP,NFATC4;UBE2J1;ARG2;ACP5;ADAM8;FOXP1;FADD
13767,GO:0060343,0.422553675573052,0.8360253318287,2,15,trabecula formation,BP,FKBP1A;THBS3
15424,GO:0071692,0.422556854385162,0.912687601612232,1,5,protein localization to extracellular region,BP,LTBP1
15425,GO:0071694,0.422556854385162,0.912687601612232,1,5,maintenance of protein location in extracellular region,BP,LTBP1
16549,GO:0097305,0.422600077693589,0.697620972338555,11,114,response to alcohol,BP,CCND1;ADCY7;FYN;TGFBR2;XRN1;BCL2L1;ITPR2;PPARG;LRP6;PTCH1;DNMT3A
12430,GO:0048934,0.422691947188298,0.909521424135391,1,6,peripheral nervous system neuron differentiation,BP,ETV1
12431,GO:0048935,0.422691947188298,0.909521424135391,1,6,peripheral nervous system neuron development,BP,ETV1
13557,GO:0060020,0.422722292938879,0.909506885665682,1,6,Bergmann glial cell differentiation,BP,MAP2K1
6830,GO:0030291,0.422747699137617,0.793642766885338,3,30,protein serine/threonine kinase inhibitor activity,MF,PRKAR1A;SPRY2;KAT2B
11586,GO:0046148,0.422844167187542,0.768318725758745,4,40,pigment biosynthetic process,BP,UROS;TRPC1;AP3D1;ALAS1
10241,GO:0042954,0.422914265366788,0.912521662936959,1,5,lipoprotein transporter activity,MF,LRP1
18582,GO:1903827,0.423284825074085,0.644268607551195,37,414,regulation of cellular protein localization,BP,EDEM1;ZMYND8;SORL1;PRNP;SH3TC2;RAPGEF3;SSH1;EGFR;ANK3;FYN;UBE2J1;DLG1;TTBK2;GDI1;CEMIP;STOM;PAK1;RAC2;BNIP3L;LRP1;VAMP2;SOX4;DVL1;ABHD17C;VPS11;CSNK2A1;PARP9;NGFR;BCL2L1;TMBIM1;CCDC88A;EFCAB7;ERLEC1;LYPLA1;TMEM173;GNAI1;LRP4
18399,GO:1903427,0.42333237763872,0.83328502172862,2,18,negative regulation of reactive oxygen species biosynthetic process,BP,ACP5;SLC18A2
1392,GO:0003306,0.423337517410508,0.909211821115131,1,6,Wnt signaling pathway involved in heart development,BP,DKK1
9978,GO:0042368,0.423511818633873,0.906926065655615,1,7,vitamin D biosynthetic process,BP,CYP27B1
16063,GO:0089717,0.423546610831686,0.912227593624264,1,5,spanning component of membrane,CC,NLGN2
13523,GO:0055094,0.423553385046786,0.834509877883261,2,16,response to lipoprotein particle,BP,APOE;PPARG
2299,GO:0005272,0.423849694175543,0.836107167535149,2,14,sodium channel activity,MF,SCN8A;PKD2
6081,GO:0019237,0.423934487290052,0.908924938694139,1,6,centromeric DNA binding,MF,MLH3
7383,GO:0031435,0.423966691739465,0.834227093127312,2,16,mitogen-activated protein kinase kinase kinase binding,MF,TGFBR2;MAP4K2
568,GO:0001709,0.424367566983464,0.833219310749692,2,17,cell fate determination,BP,WNT7A;PTCH1
5227,GO:0015838,0.424420582749681,0.908690921329727,1,6,amino-acid betaine transport,BP,SLC38A2
16014,GO:0086023,0.424455791562504,0.916571699244551,1,4,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,NOS1
95,GO:0000185,0.424911109679107,0.833579987109766,2,16,activation of MAPKKK activity,BP,MAP4K4;MAP4K2
11185,GO:0045277,0.4249397218688,0.901454025255187,1,11,respiratory chain complex IV,CC,NDUFA4L2
6577,GO:0022404,0.424978409417906,0.723997497550248,7,69,molting cycle process,BP,EGFR;DKK1;FERMT1;ACVR1B;LAMA5;HPSE;LRP4
6578,GO:0022405,0.424978409417906,0.723997497550248,7,69,hair cycle process,BP,EGFR;DKK1;FERMT1;ACVR1B;LAMA5;HPSE;LRP4
3172,GO:0006783,0.425093286278638,0.832071087066147,2,18,heme biosynthetic process,BP,UROS;ALAS1
3426,GO:0007214,0.425141634459553,0.908343100023022,1,6,gamma-aminobutyric acid signaling pathway,BP,ATF4
5362,GO:0016139,0.425154779727047,0.906117503402384,1,7,glycoside catabolic process,BP,ABHD10
9696,GO:0038092,0.425384434638314,0.908225792076049,1,6,nodal signaling pathway,BP,ACVR1B
13259,GO:0051938,0.425547966578107,0.908146729440302,1,6,L-glutamate import,BP,NTSR1
16827,GO:0098712,0.425547966578107,0.908146729440302,1,6,L-glutamate import across plasma membrane,BP,NTSR1
11895,GO:0046915,0.425562180609871,0.792141939455797,3,28,transition metal ion transmembrane transporter activity,MF,ATP7B;SLC30A1;SLC39A10
4534,GO:0010605,0.425578600915047,0.608535871411025,171,2012,negative regulation of macromolecule metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;ERCC1;ZMYND8;SORL1;CCND1;CTNNBIP1;VLDLR;SERPINE2;PRNP;BBS2;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;TFPI2;ACVR2B;SALL2;PKN1;WWTR1;PEG3;APLN;EIF4EBP1;PC;DDIT3;PSMD2;ELK3;EGFR;STK39;PPP1R14A;FYN;TNFRSF6B;SCMH1;UBE2J1;DLG1;DLG4;DNAJB5;IGF2BP3;CRTAP;SHC1;DKK1;DAP;SOCS2;TRIB2;RAG1;PTPN3;SERPING1;EPHA1;IMPACT;CD44;APOE;FKBP1A;RGS14;IDE;HMGA2;ATF4;PPARA;ABCA7;WWC3;ELFN2;FGFR1;PPP1R35;TCFL5;BTRC;PTK6;INPP5F;CHAC1;ATRX;SOX4;CEACAM1;FERMT1;ZNF692;ATF7IP;RCOR1;MDFI;XRN1;TNRC6B;DVL1;HES2;CD46;PHF12;LRP5;KLF12;CST3;TRIB3;RANBP9;MEX3C;APLP2;PRDX5;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PRKAR1A;PARP9;CPEB4;ATXN2;NACC2;SPRY2;BEX4;THRA;ACVR1B;NGFR;PPP1R10;TSHZ1;PER3;MTA1;AZIN2;H2AFJ;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;TLE4;LOXL2;C5;GABARAPL2;RMRP;EAPP;PUM2;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;ZNF354A;CTSZ;TBL1X;RNF169;ARID4A;TENM2;IGF2;ERLEC1;PPARG;SNX6;GRB7;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;LRP6;ARID5B;MAGEF1;E2F7;TNRC6C;TET1;ZC3H7A;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;USP25;PRMT3;UFL1;JARID2;KLHL15;MXD4;ADNP;DNMT3A
5938,GO:0018230,0.425672641185284,0.83167070154714,2,18,peptidyl-L-cysteine S-palmitoylation,BP,ZDHHC2;ZDHHC1
5939,GO:0018231,0.425672641185284,0.83167070154714,2,18,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,ZDHHC2;ZDHHC1
15276,GO:0071455,0.425894287251739,0.907979153673697,1,6,cellular response to hyperoxia,BP,PPARG
12773,GO:0051048,0.425991209398574,0.699763366000613,10,109,negative regulation of secretion,BP,F2R;HADH;STK39;IDH2;MAP4K4;ARG2;CEACAM1;F2RL1;SLC30A1;TMSB4X
15286,GO:0071468,0.42599647368635,0.907929671795126,1,6,cellular response to acidic pH,BP,IMPACT
5690,GO:0016810,0.426382464156819,0.699359382204505,10,110,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,ADARB1;ARG2;APOBEC3C;RCOR1;NACC2;MTA1;PM20D2;ARID4A;NIT2;PHF21A
4256,GO:0009583,0.426429487409199,0.791474924868741,3,28,detection of light stimulus,BP,PITPNM1;REEP6;ELOVL4
11783,GO:0046641,0.426438117800322,0.905482896807569,1,7,positive regulation of alpha-beta T cell proliferation,BP,TGFBR2
10436,GO:0043281,0.426509405094944,0.67709512260506,15,176,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,XDH;F2R;TNFSF15;TNFRSF6B;DAP;RAG1;CD44;CASP4;PRDX5;CSNK2A1;BOK;NGFR;PPARG;FAM162A;FADD
12271,GO:0048565,0.42660998445718,0.714012360892627,8,75,digestive tract development,BP,ITGA6;ITGB4;ACVR2B;EGFR;TGFBR2;PTK6;RET;ALDH1A2
13805,GO:0060394,0.42662911017151,0.905388224160582,1,7,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,DKK1
13944,GO:0060613,0.427314698423219,0.907289854504271,1,6,fat pad development,BP,ARID5B
6871,GO:0030346,0.427320785635293,0.907286893566494,1,6,protein phosphatase 2B binding,MF,PPP3CB
5722,GO:0016861,0.427342027735168,0.903365704955422,1,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,HYI
10699,GO:0043983,0.427476475032472,0.904967483431102,1,7,histone H4-K12 acetylation,BP,JADE2
682,GO:0001892,0.427745825524102,0.721477592700962,7,70,embryonic placenta development,BP,MAP2K1;EGFR;PKD2;MDFI;IGF2;ZNF568;E2F7
6915,GO:0030506,0.427795533171196,0.834557344692202,2,13,ankyrin binding,MF,FLNC;OBSCN
4888,GO:0014808,0.428005061244057,0.831450920253853,2,16,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,CHD7;PRKACA
18432,GO:1903514,0.428005061244057,0.831450920253853,2,16,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,CHD7;PRKACA
3200,GO:0006829,0.428246817096154,0.8305413757433,2,17,zinc ion transport,BP,SLC30A1;SLC39A10
2767,GO:0006183,0.428650674451726,0.901405698992274,1,9,GTP biosynthetic process,BP,NME4
10353,GO:0043162,0.428809970603802,0.829493998087823,2,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,MVB12B;MVB12A
7641,GO:0032051,0.428937295321811,0.909695454712812,1,5,clathrin light chain binding,MF,CLTCL1
19865,GO:2000343,0.429012233265684,0.902520300805608,1,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN
4624,GO:0010744,0.429101391151462,0.904157409588505,1,7,positive regulation of macrophage derived foam cell differentiation,BP,ALOX15B
11716,GO:0046513,0.429109296695953,0.763016295455989,4,41,ceramide biosynthetic process,BP,B4GALT6;SPTLC2;ST3GAL5;SAMD8
8991,GO:0035098,0.42913250865148,0.830671599289904,2,16,ESC/E(Z) complex,CC,PHF1;JARID2
14471,GO:0061842,0.429471625744971,0.790825244572201,3,24,microtubule organizing center localization,BP,DLG1;AKAP9;FHOD1
18446,GO:1903531,0.429496216239856,0.702975905354147,9,98,negative regulation of secretion by cell,BP,F2R;HADH;IDH2;MAP4K4;ARG2;CEACAM1;F2RL1;SLC30A1;TMSB4X
13527,GO:0055102,0.429643338363003,0.902199663533384,1,8,lipase inhibitor activity,MF,ANXA3
13648,GO:0060155,0.429666130046279,0.903874864242461,1,7,platelet dense granule organization,BP,F2R
9765,GO:0039529,0.429856498834574,0.831022764378304,2,15,RIG-I signaling pathway,BP,DDX60;PUM2
13109,GO:0051643,0.430120819114763,0.909133448325512,1,5,endoplasmic reticulum localization,BP,ESYT3
3154,GO:0006753,0.430347630925396,0.635571668635349,39,481,nucleoside phosphate metabolic process,BP,XDH;NT5E;NOS1;PCK2;ADCY7;RAPGEF3;TK2;NAPRT;H6PD;DHTKD1;PGM1;DLG1;DLG4;IDH2;PGLS;ACOT7;NMRK1;NME4;DLG3;APOE;PKD2;LDHA;AKAP9;PPARA;FAM20C;PTHLH;NDUFV3;PARP9;PANK4;PDE5A;TMSB4X;TIMP2;CARD11;ATP6V1B2;AK9;GARS;ADCY1;PANK1;ADNP
5670,GO:0016780,0.43040539549779,0.828381544847235,2,18,phosphotransferase activity, for other substituted phosphate groups,MF,CRLS1;SAMD8
14826,GO:0070562,0.43043306076932,0.90576526282984,1,6,regulation of vitamin D receptor signaling pathway,BP,CYP27B1
14418,GO:0061702,0.430448092760393,0.903482782161066,1,7,inflammasome complex,CC,CASP4
1329,GO:0003181,0.430539995947083,0.831535833068241,2,14,atrioventricular valve morphogenesis,BP,TGFBR2;SOX4
16344,GO:0090594,0.430727844198771,0.903342270635624,1,7,inflammatory response to wounding,BP,F2R
9133,GO:0035456,0.430734514355023,0.827037770979111,2,20,response to interferon-beta,BP,IFITM1;TMEM173
9844,GO:0042089,0.430890267503665,0.729325043263785,6,63,cytokine biosynthetic process,BP,UBE2J1;IGF2BP3;TRIB2;CEBPG;IL1RAP;CARD11
16186,GO:0090205,0.431289002880595,0.905344058112937,1,6,positive regulation of cholesterol metabolic process,BP,ABCG1
14011,GO:0060732,0.431328763274079,0.905324463591135,1,6,positive regulation of inositol phosphate biosynthetic process,BP,NTSR1
9547,GO:0036302,0.4313607143549,0.908542314279198,1,5,atrioventricular canal development,BP,CHD7
1454,GO:0003690,0.431364180722977,0.625089524108044,55,601,double-stranded DNA binding,MF,ZMYND8;ETV5;H1F0;NR1D1;NFATC4;ZC3H6;ETV4;SALL2;POU2F2;TEF;DDIT3;SOX12;ELK3;EGFR;HLTF;ZNF516;XPC;DDN;HMGA2;ATF4;PPARA;TCFL5;NFAT5;SOX4;ZNF692;HES2;PHF12;ZNF704;RFX2;CEBPG;PLAG1;DDX60;AEBP1;CHD7;NACC2;THRA;PER3;MTA1;MEF2D;XBP1;SATB1;MLH3;ETV1;IFI16;NR2F6;PPARG;CREB3L2;PHF21A;ZNF568;ARID5B;E2F7;KAT2B;PBX3;JARID2;RFX7
2958,GO:0006489,0.431592868856953,0.90290698433945,1,7,dolichyl diphosphate biosynthetic process,BP,SRD5A3
11683,GO:0046465,0.431592868856953,0.90290698433945,1,7,dolichyl diphosphate metabolic process,BP,SRD5A3
5291,GO:0015959,0.431668696430021,0.902868769130601,1,7,diadenosine polyphosphate metabolic process,BP,GARS
12583,GO:0050750,0.431688422989103,0.828147100754368,2,17,low-density lipoprotein particle receptor binding,MF,DKK1;APOE
7260,GO:0031227,0.431994002465288,0.688546524797958,11,126,intrinsic component of endoplasmic reticulum membrane,CC,EDEM1;ELOVL1;PKD2;SARAF;SLC35B4;SEC63;SAMD8;FICD;ESYT3;WFS1;ELOVL4
13734,GO:0060304,0.432171347912385,0.908154527498452,1,5,regulation of phosphatidylinositol dephosphorylation,BP,MTMR4
3546,GO:0007568,0.432314894863041,0.660865488479482,19,213,aging,BP,ERCC1;PRNP;MAP2K1;ARG2;DKK1;TGFBR2;SERPING1;LRP1;IDE;HMGA2;SEC63;RNF165;LOXL2;NEK6;TIMP2;ZNF354A;AKT3;ENDOG;DNMT3A
15743,GO:0072319,0.432380968597349,0.904804995774848,1,6,vesicle uncoating,BP,DNAJC6
16657,GO:0097530,0.43246197449595,0.741332697123911,5,56,granulocyte migration,BP,RAC2;ITGA1;MOSPD2;ADAM8;CKLF
12742,GO:0051010,0.432601064994113,0.831270660967707,2,13,microtubule plus-end binding,MF,CLIP2;TTBK2
17795,GO:1901879,0.432728921884524,0.728801768840593,6,55,regulation of protein depolymerization,BP,MAP1B;TTBK2;ASPH;TMOD2;TWF2;F2RL1
3775,GO:0008329,0.432834028412813,0.902280288145111,1,7,signaling pattern recognition receptor activity,MF,TRIM5
9734,GO:0038187,0.432834028412813,0.902280288145111,1,7,pattern recognition receptor activity,MF,TRIM5
9604,GO:0036462,0.433258533181726,0.902065364977545,1,7,TRAIL-activated apoptotic signaling pathway,BP,FADD
13592,GO:0060059,0.433652267716821,0.912424983358132,1,4,embryonic retina morphogenesis in camera-type eye,BP,LRP6
10469,GO:0043331,0.433668313629476,0.715985177093417,7,73,response to dsRNA,BP,MAP2K1;EGFR;MAP2K2;RMRP;PUM2;TMEM173;ZC3H7A
16845,GO:0098751,0.433722173311516,0.787060318645488,3,25,bone cell development,BP,FAM20C;WASF2;FOXP1
8075,GO:0032754,0.433729843141263,0.904136451858433,1,6,positive regulation of interleukin-5 production,BP,IL1RAP
10074,GO:0042572,0.433813063637716,0.825992920609741,2,18,retinol metabolic process,BP,RDH14;ALDH1A2
17538,GO:1901033,0.433901889245768,0.901739076011571,1,7,positive regulation of response to reactive oxygen species,BP,ENDOG
3386,GO:0007163,0.433984502845213,0.667816064442311,16,159,establishment or maintenance of cell polarity,BP,MAP1B;BRSK1;PARVB;DLG1;DLG4;WNT7A;DLG3;PAK1;FAT1;FERMT1;SPRY2;MARK4;ARF4;FRMD4B;RHOBTB1;SNX27
5578,GO:0016595,0.434114675194483,0.90394517806098,1,6,glutamate binding,MF,GLUL
17502,GO:1900542,0.434263923296013,0.68697750052788,11,115,regulation of purine nucleotide metabolic process,BP,NOS1;RAPGEF3;APOE;PKD2;AKAP9;PPARA;PTHLH;PDE5A;TMSB4X;TIMP2;ADNP
13393,GO:0052695,0.434332196629814,0.90152045913586,1,7,cellular glucuronidation,BP,ABHD10
12838,GO:0051148,0.434653849632839,0.785891279780848,3,26,negative regulation of muscle cell differentiation,BP,DKK1;PAK1;XBP1
13129,GO:0051683,0.434683707736601,0.901341648809488,1,7,establishment of Golgi localization,BP,COPG1
9376,GO:0035902,0.434725317305789,0.826019910348036,2,17,response to immobilization stress,BP,ERCC1;PPARG
14269,GO:0061337,0.435009917084017,0.715546201722566,7,66,cardiac conduction,BP,NOS1;ASPH;AKAP9;ITPR3;TRPC1;PRKACA;ITPR2
1589,GO:0004000,0.435245212440581,0.903381877877994,1,6,adenosine deaminase activity,MF,ADARB1
10644,GO:0043653,0.435317646769022,0.899287267069396,1,8,mitochondrial fragmentation involved in apoptotic process,BP,BNIP3
15681,GO:0072203,0.435366721905109,0.90332121139406,1,6,cell proliferation involved in metanephros development,BP,PTCH1
4590,GO:0010694,0.435482742578446,0.906559657109885,1,5,positive regulation of alkaline phosphatase activity,BP,ITGA2
19963,GO:2000535,0.43559490416782,0.903207221239523,1,6,regulation of entry of bacterium into host cell,BP,EXOC2
877,GO:0002230,0.435663729058188,0.825359849690042,2,17,positive regulation of defense response to virus by host,BP,PARP9;TMEM173
2342,GO:0005375,0.435893756290246,0.903057799567077,1,6,copper ion transmembrane transporter activity,MF,ATP7B
9124,GO:0035434,0.435893756290246,0.903057799567077,1,6,copper ion transmembrane transport,BP,ATP7B
319,GO:0000835,0.436193475221021,0.902907798786247,1,6,ER ubiquitin ligase complex,CC,SEL1L
18796,GO:1904338,0.436376658677426,0.90281604879265,1,6,regulation of dopaminergic neuron differentiation,BP,DKK1
14596,GO:0070142,0.436587274381084,0.902710491542202,1,6,synaptic vesicle budding,BP,AP3D1
8400,GO:0033327,0.436617986805836,0.902695092930548,1,6,Leydig cell differentiation,BP,CCND1
4553,GO:0010634,0.436672783694541,0.690495080360603,10,102,positive regulation of epithelial cell migration,BP,WNT7A;TGFBR2;ANXA3;FGFR1;HYAL1;ITGA2;TMSB4X;SRPX2;AKT3;FOXP1
4530,GO:0010595,0.436790925298122,0.713428641710966,7,71,positive regulation of endothelial cell migration,BP,WNT7A;ANXA3;FGFR1;TMSB4X;SRPX2;AKT3;FOXP1
20269,GO:2001237,0.436897105275887,0.71295227258688,7,75,negative regulation of extrinsic apoptotic signaling pathway,BP,ITGA6;FYN;STRADB;BCL2L1;TMBIM1;RB1CC1;FADD
9769,GO:0039533,0.436971436414133,0.902517769751926,1,6,regulation of MDA-5 signaling pathway,BP,DDX60
12558,GO:0050710,0.437080174748568,0.782522151628783,3,30,negative regulation of cytokine secretion,BP,ARG2;F2RL1;TMSB4X
5343,GO:0016081,0.437148104261294,0.902429060503955,1,6,synaptic vesicle docking,BP,SNPH
6938,GO:0030546,0.437173377869377,0.902416365852944,1,6,receptor activator activity,MF,IGF2
15118,GO:0071203,0.437420221327822,0.902292324410284,1,6,WASH complex,CC,SNX27
16322,GO:0090504,0.437642597513333,0.783559647938337,3,26,epiboly,BP,WNT7A;CD44;CEACAM1
840,GO:0002151,0.43767476959744,0.902164307224837,1,6,G-quadruplex RNA binding,MF,XRN1
17286,GO:0140035,0.437708272571383,0.902147450072055,1,6,ubiquitination-like modification-dependent protein binding,MF,IDE
17287,GO:0140036,0.437708272571383,0.902147450072055,1,6,ubiquitin-dependent protein binding,MF,IDE
8576,GO:0034045,0.437909933094555,0.824540513934879,2,16,phagophore assembly site membrane,CC,ULK2;RB1CC1
9891,GO:0042169,0.43795732687619,0.783762961875911,3,25,SH2 domain binding,MF,PAG1;NLK;SH3PXD2B
16100,GO:0090079,0.437987492530461,0.82371975617091,2,17,translation regulator activity, nucleic acid binding,MF,CPEB4;PAIP1
3317,GO:0007020,0.438070122724325,0.783225169735904,3,26,microtubule nucleation,BP,AKAP9;RANBP9;TUBG2
6200,GO:0019682,0.438085841514912,0.821833621171334,2,20,glyceraldehyde-3-phosphate metabolic process,BP,H6PD;PGLS
7378,GO:0031430,0.438432287056711,0.827236933908581,2,13,M band,CC,OBSCN;OBSL1
3367,GO:0007129,0.438489759426744,0.822686864706162,2,18,synapsis,BP,REC8;MLH3
19097,GO:1905005,0.438768089351511,0.901613253768687,1,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
10982,GO:0044773,0.438768133287869,0.694568447629077,9,99,mitotic DNA damage checkpoint,BP,CCND1;BRSK1;XPC;HMGA2;SOX4;TAOK1;PPP1R10;E2F7;CNOT11
4578,GO:0010663,0.438804827680699,0.901594703069044,1,6,positive regulation of striated muscle cell apoptotic process,BP,BNIP3
4581,GO:0010666,0.438804827680699,0.901594703069044,1,6,positive regulation of cardiac muscle cell apoptotic process,BP,BNIP3
7788,GO:0032328,0.438927839054017,0.901532573492009,1,6,alanine transport,BP,SLC38A2
14907,GO:0070728,0.438928647633811,0.901532165021014,1,6,leucine binding,MF,GLUD1
10806,GO:0044291,0.439008501920215,0.737563208006542,5,45,cell-cell contact zone,CC,ANK3;DLG1;PAK1;FHOD1;OBSL1
6374,GO:0021559,0.439102540538558,0.901444294180865,1,6,trigeminal nerve development,BP,SEMA3F
4677,GO:0010825,0.439141986932623,0.901424354420313,1,6,positive regulation of centrosome duplication,BP,CEP120
13185,GO:0051791,0.439215095764872,0.899018333328905,1,7,medium-chain fatty acid metabolic process,BP,ACOT7
10089,GO:0042589,0.43940752952657,0.898918917439701,1,7,zymogen granule membrane,CC,VAMP2
11580,GO:0046133,0.439453957478849,0.897130543983768,1,8,pyrimidine ribonucleoside catabolic process,BP,APOBEC3C
4081,GO:0009135,0.43951550727662,0.694280091911942,9,93,purine nucleoside diphosphate metabolic process,BP,DHTKD1;PGM1;DLG1;DLG4;DLG3;LDHA;PPARA;CARD11;AK9
4120,GO:0009179,0.43951550727662,0.694280091911942,9,93,purine ribonucleoside diphosphate metabolic process,BP,DHTKD1;PGM1;DLG1;DLG4;DLG3;LDHA;PPARA;CARD11;AK9
4559,GO:0010640,0.439528054164039,0.82339782784112,2,16,regulation of platelet-derived growth factor receptor signaling pathway,BP,PTPN12;LRP1
6756,GO:0030177,0.439862445836457,0.676562788200604,12,135,positive regulation of Wnt signaling pathway,BP,SMURF2;PSMD2;WNT7A;DKK1;SOX4;DVL1;CSNK2A1;PSMD7;WNT2B;TBL1X;LRP6;ANKRD6
14602,GO:0070161,0.439880816892788,0.624434264835446,42,464,anchoring junction,CC,FHL1;FLNC;ITGA6;MAP2K1;SH3KBP1;MPRIP;ARHGAP22;SNTB2;CAPN2;EGFR;PARVB;DLG1;TGM2;PAK1;MRC2;RAC2;CD44;PTPN12;AFAP1;LRP1;ITGA1;ITGB5;ITGA2;FAT1;CEACAM1;FERMT1;BSG;SLC9A3R2;MMP14;ANXA6;CD46;PROCR;CD99;CADM4;MAP2K2;NCKAP1;FRMD4B;GRB7;PPL;ITGA4;FLNB;ZFYVE21
3385,GO:0007162,0.440001624074191,0.661889905390955,16,169,negative regulation of cell adhesion,BP,SERPINE2;PRNP;PAG1;POSTN;DLG1;PLXNB3;PODXL;ARG2;PPARA;EPCAM;CEACAM1;MMP14;PRKAR1A;UBASH3B;PDE5A;IL20RB
19396,GO:1905906,0.440058776308758,0.898582011518449,1,7,regulation of amyloid fibril formation,BP,APOE
13854,GO:0060457,0.44005963841392,0.900959771900582,1,6,negative regulation of digestive system process,BP,STK39
17311,GO:0140112,0.440119351817714,0.820921836739609,2,19,extracellular vesicle biogenesis,BP,SDC1;ARRDC1
10337,GO:0043130,0.440253100405355,0.720965268999001,6,65,ubiquitin binding,MF,UBXN7;RBCK1;OTUB2;MVB12A;MARK4;USP25
13743,GO:0060315,0.44032021997379,0.896675237505244,1,8,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,PKD2
2493,GO:0005741,0.440353898407403,0.671721970215955,13,148,mitochondrial outer membrane,CC,CYP27B1;FAM210B;ARMCX2;BNIP3;BNIP3L;SPATA18;BOK;BPHL;BCL2L1;MOAP1;TMEM173;ARMCX3;SLC44A1
3688,GO:0008191,0.440786506003616,0.898204704991431,1,7,metalloendopeptidase inhibitor activity,MF,TIMP2
11590,GO:0046165,0.440954944925226,0.686092901166977,10,111,alcohol biosynthetic process,BP,PCK2;CYP27B1;ISYNA1;SPTLC2;PLPP6;APOE;ABCG1;NTSR1;HSD17B7;SRD5A3
17689,GO:1901567,0.440960511989091,0.819287658283692,2,21,fatty acid derivative binding,MF,ACOT7;PPARG
20177,GO:2001023,0.441002388509094,0.753014179197176,4,42,regulation of response to drug,BP,RAB3B;STK39;HMGA2;ENDOG
12702,GO:0050920,0.441037509471394,0.680535120927705,11,120,regulation of chemotaxis,BP,PGF;SEMA4B;RAC2;FGFR1;ITGA2;MOSPD2;F2RL1;C5;TMSB4X;LPAR1;SEMA3F
7059,GO:0030837,0.441111800899613,0.753816957517235,4,38,negative regulation of actin filament polymerization,BP,TMOD2;PFN2;TWF2;TMSB4X
15109,GO:0071158,0.441997714796778,0.70817121756246,7,78,positive regulation of cell cycle arrest,BP,PKD2;HMGA2;SOX4;UHRF2;PRKACA;E2F7;CNOT11
18728,GO:1904181,0.442030180810887,0.897557854513673,1,7,positive regulation of membrane depolarization,BP,ANK3
14803,GO:0070527,0.442173038478556,0.752464540375928,4,40,platelet aggregation,BP,SERPINE2;CEACAM1;UBASH3B;SLC7A11
15679,GO:0072201,0.442296959075036,0.899821287502293,1,6,negative regulation of mesenchymal cell proliferation,BP,CTNNBIP1
4926,GO:0014877,0.442305693683129,0.903218466135002,1,5,response to muscle inactivity involved in regulation of muscle adaptation,BP,MTMR4
4934,GO:0014894,0.442305693683129,0.903218466135002,1,5,response to denervation involved in regulation of muscle adaptation,BP,MTMR4
12140,GO:0048240,0.442321746235233,0.897405834466056,1,7,sperm capacitation,BP,PRKACA
17633,GO:1901343,0.442407101035055,0.708777571575176,7,68,negative regulation of vasculature development,BP,XDH;THBS2;EPN2;ADGRB2;SPRY2;NGFR;PPARG
9316,GO:0035774,0.442436828592047,0.819261564205117,2,19,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,PPP3CB;ANO1
12269,GO:0048562,0.442560831782311,0.659612893807472,16,165,embryonic organ morphogenesis,BP,DLG1;TGFBR2;SLITRK6;PKD2;FGFR1;HYAL1;MDFI;DVL1;MMP14;CHD7;SPRY2;TSHZ1;HOXA3;TBX1;WDR60;LRP6
9303,GO:0035748,0.442590154328074,0.899671482090764,1,6,myelin sheath abaxonal region,CC,DLG1
8300,GO:0033130,0.442825020026087,0.899551377471896,1,6,acetylcholine receptor binding,MF,DLG4
2284,GO:0005242,0.442978258983906,0.897063013737428,1,7,inward rectifier potassium channel activity,MF,KCNJ15
16263,GO:0090316,0.443098892025335,0.665465767232307,14,154,positive regulation of intracellular protein transport,BP,EDEM1;SORL1;PRNP;RAPGEF3;ANK3;FYN;CEMIP;STOM;PAK1;RAC2;VAMP2;VPS11;EFCAB7;TMEM173
3891,GO:0008525,0.443370146783456,0.899272262450048,1,6,phosphatidylcholine transporter activity,MF,ABCA7
1304,GO:0003148,0.443529570732214,0.820555338798523,2,16,outflow tract septum morphogenesis,BP,TGFBR2;TBX1
10296,GO:0043045,0.443563426893112,0.8991731817157,1,6,DNA methylation involved in embryo development,BP,DNMT3A
17677,GO:1901538,0.443563426893112,0.8991731817157,1,6,changes to DNA methylation involved in embryo development,BP,DNMT3A
14086,GO:0060911,0.443797215619423,0.896634356880509,1,7,cardiac cell fate commitment,BP,DKK1
8928,GO:0034773,0.444290009073979,0.898800163811663,1,6,histone H4-K20 trimethylation,BP,ARID4A
14346,GO:0061549,0.444311954476185,0.898788883748322,1,6,sympathetic ganglion development,BP,SEMA3F
2313,GO:0005313,0.444319195733338,0.898785161532407,1,6,L-glutamate transmembrane transporter activity,MF,SLC7A11
5012,GO:0015172,0.444319195733338,0.898785161532407,1,6,acidic amino acid transmembrane transporter activity,MF,SLC7A11
1992,GO:0004713,0.444475204198639,0.677830989889535,11,111,protein tyrosine kinase activity,MF,MAP2K1;MST1R;EGFR;FYN;EPHA1;FGFR1;PTK6;MAP2K2;RET;EIF2AK2;ZMYM2
9807,GO:0040034,0.444991785207374,0.896007082306111,1,7,regulation of development, heterochronic,BP,SERPINE2
19062,GO:1904929,0.445053205952834,0.898407408534845,1,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,GPC4
7322,GO:0031331,0.445136858455719,0.635878160211709,26,282,positive regulation of cellular catabolic process,BP,EDEM1;RAPGEF3;TRIM65;BNIP3;SNX9;SPTLC2;TRIB2;APOE;BNIP3L;LRP1;FYCO1;PPARA;SH3D19;TNRC6B;DVL1;TRIB3;VPS11;XBP1;ANKIB1;EPM2A;ADAM8;ENDOG;MAGEF1;RNF180;TNRC6C;FBXL5
9626,GO:0036492,0.44530354393715,0.898278369966797,1,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,DNAJC3
13122,GO:0051661,0.445348329809771,0.901704368817401,1,5,maintenance of centrosome location,BP,AKAP9
13611,GO:0060081,0.445616555192973,0.895678058436532,1,7,membrane hyperpolarization,BP,CRTC1
13618,GO:0060090,0.445878285272578,0.663112056200944,14,147,molecular adaptor activity,MF,SH2D2A;PAG1;ANK3;SHC1;SOCS2;OBSL1;TRIM5;VPS11;SKAP2;ARRDC1;COL1A2;AP2A2;GRB10;GRB7
15655,GO:0072170,0.446219697366529,0.819528832945407,2,15,metanephric tubule development,BP,WWTR1;PKD2
17089,GO:0099622,0.446241698957135,0.818615207688657,2,16,cardiac muscle cell membrane repolarization,BP,DLG1;AKAP9
14398,GO:0061647,0.446241798157759,0.750080523307556,4,36,histone H3-K9 modification,BP,ATRX;ARID4A;KAT2B;JARID2
4844,GO:0014051,0.446318037500094,0.901218665220988,1,5,gamma-aminobutyric acid secretion,BP,NTSR1
1605,GO:0004028,0.446487945343321,0.895218060260106,1,7,3-chloroallyl aldehyde dehydrogenase activity,MF,ALDH1A2
9450,GO:0036037,0.446511529813076,0.895205592485298,1,7,CD8-positive, alpha-beta T cell activation,BP,SATB1
3454,GO:0007266,0.446687398300878,0.659096978856748,15,150,Rho protein signal transduction,BP,F2R;ARAP1;NET1;PAK1;RAC2;OBSCN;APOE;DNMBP;F2RL1;NGFR;PAK6;COL1A2;RHOBTB1;LPAR1;ARHGAP29
5246,GO:0015871,0.446896208665176,0.897454985436228,1,6,choline transport,BP,SLC44A1
16297,GO:0090398,0.446943845026099,0.729508118481308,5,52,cellular senescence,BP,MAP2K1;ARG2;HMGA2;NEK6;AKT3
18982,GO:1904776,0.446996536761107,0.897402976241149,1,6,regulation of protein localization to cell cortex,BP,GNAI1
12860,GO:0051180,0.447037383203095,0.816560422750214,2,18,vitamin transport,BP,SLC2A3;SLC23A2
5133,GO:0015629,0.447738925001472,0.624796277553957,33,348,actin cytoskeleton,CC,H1F0;RAPGEF3;MPRIP;MST1R;CAPN2;WIPF1;FYN;MYH15;PARVB;PGM1;ESPN;PAK1;RAC2;PTPN12;AFAP1;PKD2;TMOD2;FHOD1;FERMT1;OBSL1;TWF2;CDC42BPA;ASAP1;MYH16;WASF2;SH3PXD2B;NCKAP1;TMSB4X;ARPC1A;ADAM8;WASL;FLNB;KAT2B
4917,GO:0014855,0.447752493664878,0.748544152918644,4,37,striated muscle cell proliferation,BP,TGFBR2;FGFR1;PRKAR1A;JARID2
11136,GO:0045180,0.447770133200721,0.900488485586953,1,5,basal cortex,CC,PKD2
9767,GO:0039531,0.447920210293782,0.817408970261156,2,16,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,DDX60;PUM2
11663,GO:0046425,0.447928663894893,0.702799924556724,7,79,regulation of JAK-STAT cascade,BP,FYN;SOCS2;PTK6;INPP5F;NLK;PARP9;RET
416,GO:0001103,0.448110942627966,0.774119841578069,3,29,RNA polymerase II repressing transcription factor binding,MF,BBS2;PPARA;MTA1
15294,GO:0071478,0.448134543706388,0.664701074761887,13,142,cellular response to radiation,BP,ERCC1;NFATC4;MAPK13;NET1;XPC;IMPACT;CCND2;HMGA2;ATF4;HYAL1;DDB2;BCL2L1;IFI16
12099,GO:0048102,0.448275856677469,0.894270232832664,1,7,autophagic cell death,BP,BNIP3
16974,GO:0098993,0.448468043312635,0.892330742398917,1,8,anchored component of synaptic vesicle membrane,CC,RAB3B
14424,GO:0061724,0.448675567533134,0.89653009521667,1,6,lipophagy,BP,SPTLC2
5128,GO:0015556,0.44877250659533,0.894005984992365,1,7,C4-dicarboxylate transmembrane transporter activity,MF,SLC13A3
7934,GO:0032511,0.448970485561359,0.892059142334454,1,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,TMEM50B
19883,GO:2000369,0.448975033992988,0.817554262246102,2,15,regulation of clathrin-dependent endocytosis,BP,DNAJC6;WASL
4078,GO:0009132,0.449197668673049,0.678648903105376,10,109,nucleoside diphosphate metabolic process,BP,DHTKD1;PGM1;DLG1;DLG4;NME4;DLG3;LDHA;PPARA;CARD11;AK9
7594,GO:0031965,0.449487402295867,0.636558690019573,23,252,nuclear membrane,CC,SYNE3;PRNP;SLC16A3;EGFR;WDFY3;GRK5;PAK1;SCRN1;CLCA2;CCND2;KLHDC2;ITPR3;CST3;MYOF;BOK;BCL2L1;PUM2;SLC30A1;AK9;ATP11B;SIGMAR1;PSEN2;RB1CC1
9850,GO:0042095,0.449511161695407,0.893612203475971,1,7,interferon-gamma biosynthetic process,BP,CEBPG
9105,GO:0035374,0.44978817078661,0.895949093768648,1,6,chondroitin sulfate binding,MF,PTPRS
4585,GO:0010675,0.449845926932133,0.692772471487774,8,80,regulation of cellular carbohydrate metabolic process,BP,IGFBP4;NR1D1;PPARA;NTSR1;SLC35B4;MLYCD;IGF2;KAT2B
11385,GO:0045760,0.449885896012726,0.89589796280731,1,6,positive regulation of action potential,BP,ANK3
16768,GO:0098562,0.449895988806296,0.663171694344371,13,139,cytoplasmic side of membrane,CC,FYN;DLG1;DLG4;SNX9;RASA3;PTPN3;FKBP1A;PKD2;PTK6;NTSR1;MAP2K2;ESYT3;GNAI1
16556,GO:0097327,0.450187649015588,0.701220037874843,7,74,response to antineoplastic agent,BP,PCK2;EIF4EBP1;EGFR;MAPK13;ASNS;ATRX;XRN1
2840,GO:0006308,0.450245283443834,0.772072224165505,3,30,DNA catabolic process,BP,H1F0;DNASE1L1;ENDOG
10602,GO:0043574,0.450406492497425,0.814115619146611,2,18,peroxisomal transport,BP,ABCD1;LONP2
5301,GO:0015991,0.450697893644708,0.812718170282624,2,20,ATP hydrolysis coupled proton transport,BP,ATP12A;ATP6V1B2
8087,GO:0032769,0.451077158598657,0.892774300610651,1,7,negative regulation of monooxygenase activity,BP,CYP27B1
7255,GO:0031214,0.451142120656461,0.700877410109752,7,69,biomineral tissue development,BP,CYP27B1;ACVR2B;PPARA;FAM20C;PTHLH;TBX1;ZBTB40
12602,GO:0050778,0.451142912022966,0.616483557568808,38,446,positive regulation of immune response,BP,TNIP1;PRNP;PAG1;NR1D1;PTPRS;PSMD2;WIPF1;FYN;CTSB;PAK1;SERPING1;PRKACB;RBCK1;BTRC;CEACAM1;MAPKAPK3;TRIM5;CD46;CTSL;F2RL1;DDX60;PSMD7;PARP9;WASF2;SKAP2;XBP1;C5;NCKAP1;PUM2;PRKACA;IFI16;SLC39A10;CARD11;ARPC1A;ADAM8;WASL;TMEM173;FADD
13575,GO:0060042,0.451214262608219,0.773796695270825,3,24,retina morphogenesis in camera-type eye,BP,SDK2;LRP5;LRP6
4443,GO:0010340,0.451799544976727,0.892386375553797,1,7,carboxyl-O-methyltransferase activity,MF,PCMTD2
13296,GO:0051998,0.451799544976727,0.892386375553797,1,7,protein carboxyl O-methyltransferase activity,MF,PCMTD2
16926,GO:0098903,0.451962051105581,0.894807914451414,1,6,regulation of membrane repolarization during action potential,BP,DLG1
7813,GO:0032366,0.451989978092122,0.813666780031474,2,17,intracellular sterol transport,BP,ABCG1;LRP6
7814,GO:0032367,0.451989978092122,0.813666780031474,2,17,intracellular cholesterol transport,BP,ABCG1;LRP6
14176,GO:0061072,0.452042220494057,0.894765677910384,1,6,iris morphogenesis,BP,WNT2B
12549,GO:0050701,0.452189379251989,0.770509849509473,3,30,interleukin-1 secretion,BP,ARG2;F2RL1;FOXP1
13569,GO:0060033,0.452194171270978,0.894685594340248,1,6,anatomical structure regression,BP,LRP5
2620,GO:0005938,0.452227513657076,0.63606379415472,22,226,cell cortex,CC,RAPGEF3;EXOC2;CAPN2;WIPF1;DLG4;ASPH;SEPT10;PKD2;FAM110C;RIMS3;FNBP1L;SEPT5;SPIRE1;RHOBTB1;CTSZ;ITPR2;FNBP1;WASL;FLNB;PSEN2;SEPT6;GNAI1
19134,GO:1905097,0.452292472160101,0.894633765521537,1,6,regulation of guanyl-nucleotide exchange factor activity,BP,CCPG1
12813,GO:0051117,0.452381397236805,0.724501576625613,5,54,ATPase binding,MF,PTPN3;PKD2;GABARAPL2;WFS1;USP25
12373,GO:0048762,0.45262138244639,0.660704880706712,13,137,mesenchymal cell differentiation,BP,WWTR1;SEMA4B;TGFBR2;EDNRA;HMGA2;FGFR1;RET;LOXL2;LAMA5;ALDH1A2;TBX1;LRP6;SEMA3F
4419,GO:0010216,0.452775676348312,0.894378761460619,1,6,maintenance of DNA methylation,BP,UHRF2
11086,GO:0045086,0.453034579658127,0.891721096501976,1,7,positive regulation of interleukin-2 biosynthetic process,BP,CARD11
10593,GO:0043559,0.453152027849771,0.897752150096892,1,5,insulin binding,MF,IDE
11413,GO:0045820,0.453276427803117,0.894114082399241,1,6,negative regulation of glycolytic process,BP,PPARA
12875,GO:0051198,0.453276427803117,0.894114082399241,1,6,negative regulation of coenzyme metabolic process,BP,PPARA
17392,GO:1900118,0.453360239195519,0.891545239076457,1,7,negative regulation of execution phase of apoptosis,BP,BCL2L1
12383,GO:0048788,0.453371322852662,0.903095111889766,1,4,cytoskeleton of presynaptic active zone,CC,RIMS3
17073,GO:0099569,0.453371322852662,0.903095111889766,1,4,presynaptic cytoskeleton,CC,RIMS3
11697,GO:0046485,0.453435032602451,0.891504824757414,1,7,ether lipid metabolic process,BP,TMEM86B
18221,GO:1903018,0.453497917883457,0.769455441227949,3,30,regulation of glycoprotein metabolic process,BP,ABCA7;CST3;RAB1A
7058,GO:0030836,0.453526996621582,0.891455119262779,1,7,positive regulation of actin filament depolymerization,BP,F2RL1
4008,GO:0008970,0.453605082318875,0.891412903494139,1,7,phosphatidylcholine 1-acylhydrolase activity,MF,PLA2G4D
696,GO:0001916,0.453615374489803,0.889527801739842,1,8,positive regulation of T cell mediated cytotoxicity,BP,FADD
671,GO:0001881,0.453689452516639,0.770012523016426,3,28,receptor recycling,BP,ARAP1;INPP5F;TBC1D16
9538,GO:0036289,0.453837674213124,0.893816925733025,1,6,peptidyl-serine autophosphorylation,BP,MAP2K2
10297,GO:0043046,0.453853300454876,0.891278639136748,1,7,DNA methylation involved in gamete generation,BP,DNMT3A
7179,GO:0031061,0.453874694303069,0.813095744031601,2,16,negative regulation of histone methylation,BP,PHF1;JARID2
11503,GO:0045987,0.453882291169633,0.81157551524334,2,18,positive regulation of smooth muscle contraction,BP,F2R;ITGA2
19634,GO:1990823,0.453900362262627,0.697887751191677,7,74,response to leukemia inhibitory factor,BP,CTH;RFX2;SPRY2;XBP1;TLE4;ARID5B;JARID2
19637,GO:1990830,0.453900362262627,0.697887751191677,7,74,cellular response to leukemia inhibitory factor,BP,CTH;RFX2;SPRY2;XBP1;TLE4;ARID5B;JARID2
3244,GO:0006900,0.454047939717028,0.688467084773495,8,86,vesicle budding from membrane,BP,SEC23A;MCFD2;LMAN1;FNBP1L;RAB1A;CTSZ;AP3D1;WASL
471,GO:0001514,0.4540741151495,0.891159109076215,1,7,selenocysteine incorporation,BP,SECISBP2L
2934,GO:0006451,0.4540741151495,0.891159109076215,1,7,translational readthrough,BP,SECISBP2L
4340,GO:0009892,0.454115427626599,0.579552831632064,183,2162,negative regulation of metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;ERCC1;ZMYND8;SORL1;CCND1;CTNNBIP1;VLDLR;CYGB;CYP27B1;SERPINE2;PRNP;BBS2;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;TFPI2;ACVR2B;SALL2;PKN1;WWTR1;PEG3;APLN;EIF4EBP1;PC;DDIT3;PSMD2;ELK3;EGFR;TBC1D14;STK39;PPP1R14A;FYN;TNFRSF6B;BNIP3;SCMH1;UBE2J1;DLG1;DLG4;DNAJB5;IGF2BP3;CRTAP;SHC1;DLG3;DKK1;DAP;SOCS2;TRIB2;RAG1;PTPN3;SERPING1;EPHA1;IMPACT;CD44;APOE;FKBP1A;ACP5;RGS14;IDE;AKAP9;HMGA2;ATF4;PPARA;ABCA7;WWC3;ELFN2;FGFR1;PPP1R35;TCFL5;BTRC;LPCAT1;PTK6;INPP5F;CHAC1;ATRX;SOX4;CEACAM1;FERMT1;ZNF692;ATF7IP;RCOR1;MDFI;XRN1;TNRC6B;DVL1;HES2;CD46;PHF12;LRP5;KLF12;CST3;TRIB3;RANBP9;MEX3C;APLP2;PRDX5;PLAG1;F2RL1;UHRF2;RASIP1;AEBP1;CSNK2A1;PHF1;PSMD7;QSOX1;PRKAR1A;PARP9;CPEB4;ATXN2;NACC2;SPRY2;BEX4;THRA;ACVR1B;NGFR;PPP1R10;TSHZ1;PER3;MTA1;AZIN2;H2AFJ;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;TLE4;LOXL2;C5;GABARAPL2;RMRP;EAPP;PUM2;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;ZNF354A;CTSZ;TBL1X;RNF169;ARID4A;TENM2;IGF2;GRB10;ERLEC1;PPARG;SNX6;GRB7;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;LRP6;ARID5B;MAGEF1;E2F7;SLC18A2;TNRC6C;TET1;ZC3H7A;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;USP25;PRMT3;UFL1;JARID2;KLHL15;MXD4;ADNP;DNMT3A
6732,GO:0030148,0.454302430694404,0.697251035393264,7,77,sphingolipid biosynthetic process,BP,B4GALT6;ELOVL1;SPTLC2;ST3GAL5;KDSR;SAMD8;ELOVL4
7036,GO:0030809,0.454457083418846,0.811865078354492,2,17,negative regulation of nucleotide biosynthetic process,BP,AKAP9;PPARA
17479,GO:1900372,0.454457083418846,0.811865078354492,2,17,negative regulation of purine nucleotide biosynthetic process,BP,AKAP9;PPARA
5786,GO:0017015,0.454463892345247,0.688497481957964,8,81,regulation of transforming growth factor beta receptor signaling pathway,BP,SMURF2;LTBP1;HTRA1;TGFBR2;LTBP4;FERMT1;MTMR4;SNX6
19523,GO:1990416,0.454626692613348,0.893398274476227,1,6,cellular response to brain-derived neurotrophic factor stimulus,BP,EEF2K
12304,GO:0048642,0.454723584382087,0.8908070586226,1,7,negative regulation of skeletal muscle tissue development,BP,DKK1
1349,GO:0003214,0.454747944207627,0.893333845459184,1,6,cardiac left ventricle morphogenesis,BP,TGFBR2
11490,GO:0045953,0.454757872667839,0.888899476726616,1,8,negative regulation of natural killer cell mediated cytotoxicity,BP,CEACAM1
13191,GO:0051797,0.455055008172868,0.810714383763674,2,18,regulation of hair follicle development,BP,FERMT1;HPSE
18322,GO:1903265,0.455076849293887,0.888723650134453,1,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,CASP4
10223,GO:0042891,0.45509170352257,0.890607195559569,1,7,antibiotic transport,BP,SLC13A3
9067,GO:0035303,0.455126337623406,0.650858215623891,15,159,regulation of dephosphorylation,BP,PPP1R14A;DLG3;FKBP1A;PPP2R3B;ELFN2;ITGA1;PPP1R35;ITGA2;CSNK2A1;PPP1R10;PPP1R2;MTMR4;EIF2AK2;SLC39A10;RCAN1
19936,GO:2000465,0.455207930124537,0.893089198432409,1,6,regulation of glycogen (starch) synthase activity,BP,IGF2
12117,GO:0048169,0.455213277280028,0.811310997394172,2,17,regulation of long-term neuronal synaptic plasticity,BP,NEURL1;DLG4
3574,GO:0007618,0.455342021269783,0.810503311973304,2,18,mating,BP,SERPINE2;THRA
10149,GO:0042726,0.455359161739716,0.890461838626004,1,7,flavin-containing compound metabolic process,BP,ACP5
3769,GO:0008318,0.455430885548612,0.890422837643438,1,7,protein prenyltransferase activity,MF,RABGGTA
4800,GO:0010992,0.455546858102218,0.890359757002103,1,7,ubiquitin recycling,BP,IDE
8511,GO:0033689,0.45555118938057,0.892906400135437,1,6,negative regulation of osteoblast proliferation,BP,EIF2AK2
7943,GO:0032534,0.455701066328076,0.892826522531463,1,6,regulation of microvillus assembly,BP,PODXL
10553,GO:0043506,0.455916702533806,0.69647983517114,7,70,regulation of JUN kinase activity,BP,PKN1;ERCC6;DKK1;PAK1;TAOK1;MAP4K2;FZD8
11487,GO:0045947,0.456002171635025,0.810017358820353,2,18,negative regulation of translational initiation,BP,EIF4EBP1;ATF4
8845,GO:0034637,0.456235070300035,0.707356763441476,6,61,cellular carbohydrate biosynthetic process,BP,PCK2;NR1D1;PGM1;ISYNA1;B3GNT3;IGF2
7069,GO:0030856,0.456743033495335,0.678442219379439,9,95,regulation of epithelial cell differentiation,BP,XDH;CCND1;CYP27B1;ALOX15B;WWTR1;KIAA1109;CEACAM1;CTSL;PTCH1
4353,GO:0009931,0.456917419174418,0.889612521306364,1,7,calcium-dependent protein serine/threonine kinase activity,MF,MAPKAPK3
7614,GO:0032000,0.45705474361133,0.895738016438584,1,5,positive regulation of fatty acid beta-oxidation,BP,PPARA
12527,GO:0050671,0.457729014495423,0.705022204589826,6,70,positive regulation of lymphocyte proliferation,BP,TGFBR2;CD46;SLC39A10;CARD11;IGF2;FADD
6739,GO:0030157,0.457757634923038,0.891726616903976,1,6,pancreatic juice secretion,BP,STK39
2671,GO:0006022,0.457781746062289,0.665151794110099,11,118,aminoglycan metabolic process,BP,B4GALT6;B3GNT3;GPC4;CEMIP;SDC1;CD44;HYAL1;CTBS;GLB1;HPSE;GALNS
14832,GO:0070569,0.457826463830836,0.889115123221746,1,7,uridylyltransferase activity,MF,UAP1
14995,GO:0070911,0.458183587955193,0.765036823168227,3,32,global genome nucleotide-excision repair,BP,ERCC1;XPC;DDB2
13693,GO:0060242,0.458326152023299,0.88884110410134,1,7,contact inhibition,BP,PAK1
15513,GO:0071888,0.458327002808603,0.886922033330495,1,8,macrophage apoptotic process,BP,CTSL
6842,GO:0030307,0.458535410098149,0.664499903820056,11,117,positive regulation of cell growth,BP,MAP1B;EGFR;GDI1;PAK1;LPAR3;HYAL1;MMP14;TWF2;CSNK2A1;SYT2;ADNP
19544,GO:1990462,0.458572869571804,0.888705650125534,1,7,omegasome,CC,TRIM5
19045,GO:1904892,0.458825472971468,0.692915312257085,7,80,regulation of STAT cascade,BP,FYN;SOCS2;PTK6;INPP5F;NLK;PARP9;RET
3058,GO:0006620,0.458970260823797,0.888487251496284,1,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,SEC63
12109,GO:0048148,0.459080027079185,0.888426877939247,1,7,behavioral response to cocaine,BP,FADD
6065,GO:0019213,0.459180069188576,0.719034540848181,5,51,deacetylase activity,MF,RCOR1;NACC2;MTA1;ARID4A;PHF21A
242,GO:0000506,0.459296952694786,0.884892061763345,1,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,PIGH
10544,GO:0043491,0.459305255037305,0.650407944510222,14,150,protein kinase B signaling,BP,XDH;MST1R;DDIT3;EGFR;FYN;DLG1;FGFR1;INPP5F;FAM110C;TRIB3;SPRY2;IGF2;ADAM8;HPSE
9985,GO:0042379,0.459358782325152,0.805334923983191,2,22,chemokine receptor binding,MF,C5;CKLF
4126,GO:0009185,0.459599248369252,0.675814889478537,9,95,ribonucleoside diphosphate metabolic process,BP,DHTKD1;PGM1;DLG1;DLG4;DLG3;LDHA;PPARA;CARD11;AK9
7865,GO:0032426,0.459637758884717,0.888119792739298,1,7,stereocilium tip,CC,ESPN
2746,GO:0006144,0.459845637356172,0.806532211216586,2,19,purine nucleobase metabolic process,BP,XDH;AOX1
18281,GO:1903170,0.459989314091555,0.806425249010363,2,19,negative regulation of calcium ion transmembrane transport,BP,PKD2;NTSR1
3541,GO:0007548,0.460120195462249,0.64284861879647,16,172,sex differentiation,BP,ERCC1;CCND1;WNT7A;SDC1;ATRX;MMP14;CST3;CHD7;BOK;WNT2B;ACVR1B;BCL2L1;REC8;ARID4A;LRP6;ARID5B
981,GO:0002438,0.46017287686685,0.885890641550561,1,8,acute inflammatory response to antigenic stimulus,BP,IL20RB
10373,GO:0043190,0.460230729974801,0.890394410561187,1,6,ATP-binding cassette (ABC) transporter complex,CC,ABCA7
2250,GO:0005164,0.460474937430664,0.804968367158373,2,21,tumor necrosis factor receptor binding,MF,TNFSF15;FADD
2539,GO:0005796,0.460664390753815,0.718263767863982,5,48,Golgi lumen,CC,GPC4;WNT7A;SDC1;MMP14;PCSK6
12677,GO:0050885,0.460702335561421,0.765176589771068,3,26,neuromuscular process controlling balance,BP,DLG4;AARS;NLGN2
20098,GO:2000766,0.460711570971474,0.890134178313399,1,6,negative regulation of cytoplasmic translation,BP,CPEB4
7755,GO:0032271,0.460810681675422,0.648851354279283,14,154,regulation of protein polymerization,BP,WIPF1;DLG1;PAK1;RAC2;AKAP9;TMOD2;PFN2;TWF2;JMY;SPIRE1;NCKAP1;TMSB4X;ARPC1A;WASL
6802,GO:0030246,0.460876095211018,0.662077071447394,11,122,carbohydrate binding,MF,PYGL;ADGRL1;MRC2;SLC2A3;GALNT3;FBXO2;LMAN1;BSG;CNTN1;UAP1;LOXL2
1995,GO:0004716,0.460884689239292,0.890040389420687,1,6,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,EGFR
3402,GO:0007182,0.460975263404147,0.889991299329144,1,6,common-partner SMAD protein phosphorylation,BP,TGFBR2
5280,GO:0015932,0.461003284524119,0.762735358519095,3,32,nucleobase-containing compound transmembrane transporter activity,MF,SLC29A4;SLC35B4;SLC25A4
3855,GO:0008469,0.461035598893581,0.885406547769177,1,8,histone-arginine N-methyltransferase activity,MF,PRMT3
16409,GO:0097035,0.4610592847961,0.76488651591321,3,26,regulation of membrane lipid distribution,BP,ABCA7;ATP10D;ATP11B
3258,GO:0006924,0.461165502958798,0.885333542538665,1,8,activation-induced cell death of T cells,BP,FADD
19090,GO:1904994,0.461175738560274,0.88727019424895,1,7,regulation of leukocyte adhesion to vascular endothelial cell,BP,ITGA4
10302,GO:0043065,0.46124309544128,0.605065006650715,40,468,positive regulation of apoptotic process,BP,XDH;F2R;NEURL1;ITGA6;RPS6KA2;PRNP;NFATC4;TNFSF15;DDIT3;BNIP3;NET1;TGM2;DAP;OBSCN;BNIP3L;RBCK1;LDHA;HMGA2;ATF4;ITGA1;SOX4;NTSR1;CASP4;JMY;BOK;NACC2;NGFR;BCL2L1;RET;LPAR1;CTSZ;MOAP1;PPARG;ALDH1A2;ADAM8;ENDOG;DEDD2;PSEN2;FAM162A;FADD
7790,GO:0032330,0.461327880009208,0.764229269301586,3,27,regulation of chondrocyte differentiation,BP,ADAMTS7;PTHLH;LOXL2
19167,GO:1905207,0.461447916731372,0.763725935266122,3,28,regulation of cardiocyte differentiation,BP,EGFR;DKK1;PAK1
6721,GO:0030132,0.46154865354296,0.806634861212121,2,17,clathrin coat of coated pit,CC,EGFR;AP2A2
12842,GO:0051152,0.461567632000907,0.885107361028336,1,8,positive regulation of smooth muscle cell differentiation,BP,CTH
15813,GO:0072509,0.461937469500078,0.805618530944248,2,18,divalent inorganic cation transmembrane transporter activity,MF,SLC30A1;SLC39A10
15170,GO:0071294,0.461994248244354,0.884867096166717,1,8,cellular response to zinc ion,BP,MT2A
11530,GO:0046051,0.461996241585939,0.883359846890408,1,9,UTP metabolic process,BP,NME4
7845,GO:0032402,0.462250646044059,0.804737624944646,2,19,melanosome transport,BP,BBS2;RAB1A
13241,GO:0051904,0.462250646044059,0.804737624944646,2,19,pigment granule transport,BP,BBS2;RAB1A
2201,GO:0005086,0.462332286169456,0.807819875971144,2,15,ARF guanyl-nucleotide exchange factor activity,MF,ARF4;PSD3
4096,GO:0009150,0.462510127873153,0.614620540099305,29,356,purine ribonucleotide metabolic process,BP,NT5E;NOS1;ADCY7;RAPGEF3;DHTKD1;PGM1;DLG1;DLG4;ACOT7;NME4;DLG3;APOE;PKD2;LDHA;AKAP9;PPARA;FAM20C;PTHLH;NDUFV3;PANK4;PDE5A;TMSB4X;TIMP2;CARD11;ATP6V1B2;AK9;ADCY1;PANK1;ADNP
10026,GO:0042470,0.462750894710277,0.680088878989231,8,92,melanosome,CC,CTSB;STOM;BSG;MMP14;ANXA6;SYTL1;RAB1A;ATP6V1B2
12379,GO:0048770,0.462750894710277,0.680088878989231,8,92,pigment granule,CC,CTSB;STOM;BSG;MMP14;ANXA6;SYTL1;RAB1A;ATP6V1B2
15434,GO:0071705,0.462786818001759,0.574496780179122,143,1701,nitrogen compound transport,BP,EDEM1;NOS1;F2R;SORL1;RAB3B;PCK2;VLDLR;PRNP;XPOT;BBS2;POSTN;SH3TC2;NR1D1;LTBP2;RAPGEF3;ACVR2B;SLC29A4;ALOX15B;LMF1;APLN;POU2F2;HADH;EXOC2;EGFR;TBC1D14;STK39;ANK3;FYN;KIF13B;UBE2J1;IDH2;SNX9;GLUL;EVI5L;IGF2BP3;MAP4K4;SEC23A;STRADB;GDI1;CEMIP;UNC119B;ARG2;STOM;PAK1;TGFBR2;RAC2;APOE;BNIP3L;MCFD2;LRP1;EHBP1;ICA1;SNX14;VAMP2;LONP2;LTBP4;ABCG1;SOX4;PITPNM1;ITPR3;VPS13A;FERMT1;RAB31;NTSR1;NLGN2;MVB12B;LRP5;COX18;SEC22C;SLC35B4;CLTCL1;TOM1L2;VPS11;SEC63;PPP3CB;SYTL1;ZDHHC2;COPB1;COPG1;F2RL1;SLC2A9;SLC6A6;TST;CHD7;SLC25A4;ANO1;SDCCAG3;ATXN2;USP6NL;SLC6A14;TBC1D2B;SLC43A1;NGFR;PPP1R10;MVB12A;GLUD1;AZIN2;ARF4;XBP1;SPIRE1;ARRDC1;SLC38A2;STX10;RAB43;C5;ZFYVE9;GABARAPL2;TMED4;TMSB4X;RAB1A;ZDHHC1;SNX30;SEL1L;BCAP29;AP2A2;KDELR3;IL1RAP;CARD11;AP3D1;ITPR2;EFCAB7;ERLEC1;PPARG;SNX6;ANKRD50;LYPLA1;TMEM50B;SLC7A11;EVI5;ATP6V1B2;RPH3AL;ADAM8;ATP11B;TBC1D16;SSR3;TMEM173;SLC18A2;SSR1;FOXP1;COG8;SNX27;SLC23A2;SLC44A1
3450,GO:0007260,0.462880086413355,0.733964224266899,4,45,tyrosine phosphorylation of STAT protein,BP,FYN;PTK6;INPP5F;PARP9
13221,GO:0051881,0.463003439290285,0.733348749575298,4,48,regulation of mitochondrial membrane potential,BP,BNIP3;BNIP3L;BOK;BCL2L1
10228,GO:0042908,0.463302083358664,0.888725365608149,1,6,xenobiotic transport,BP,SLC6A6
10229,GO:0042910,0.463302083358664,0.888725365608149,1,6,xenobiotic transmembrane transporter activity,MF,SLC6A6
8352,GO:0033210,0.463350304367101,0.886061923113087,1,7,leptin-mediated signaling pathway,BP,BBS2
3303,GO:0007000,0.46363989731042,0.885900392484555,1,7,nucleolus organization,BP,ZNF354A
19153,GO:1905165,0.463716341983718,0.888499007155067,1,6,regulation of lysosomal protein catabolic process,BP,LRP1
9486,GO:0036120,0.463749091368094,0.805824915975632,2,16,cellular response to platelet-derived growth factor stimulus,BP,FYN;HYAL1
9196,GO:0035578,0.463758615325986,0.699724612827688,6,69,azurophil granule lumen,CC,PYGB;NAPRT;C6ORF120;GLB1;GALNS;DNAJC3
11589,GO:0046164,0.463871436393483,0.761016498770799,3,30,alcohol catabolic process,BP,APOE;NTSR1;SRD5A3
18836,GO:1904429,0.463891161267532,0.885760122548662,1,7,regulation of t-circle formation,BP,ERCC1
14509,GO:0062014,0.463942151901062,0.700104563037191,6,64,negative regulation of small molecule metabolic process,BP,CYP27B1;APOE;AKAP9;PPARA;CEACAM1;TRIB3
9132,GO:0035455,0.46411049073497,0.803343779924643,2,19,response to interferon-alpha,BP,IFITM1;EIF2AK2
7605,GO:0031985,0.464161805049118,0.679228045198817,8,86,Golgi cisterna,CC,SORL1;ASAP2;B4GALT6;ARAP1;B4GALNT4;GALNT3;PITPNM1;GOLGA2P5
12124,GO:0048193,0.464234000117392,0.614625009144629,28,309,Golgi vesicle transport,BP,SORL1;BBS2;LMF1;EXOC2;TBC1D14;ANK3;SEC23A;MCFD2;VAMP2;VPS13A;RAB31;LMAN1;SEC22C;COPB1;COPG1;ARF4;OSBPL5;GABARAPL2;TMED4;RAB1A;BCAP29;KDELR3;CTSZ;AP3D1;LYPLA1;CREB3L2;DDHD2;COG8
16071,GO:0090026,0.464278170589785,0.883575375317536,1,8,positive regulation of monocyte chemotaxis,BP,MOSPD2
12290,GO:0048617,0.464292152954873,0.891935638967682,1,5,embryonic foregut morphogenesis,BP,ACVR2B
8678,GO:0034249,0.464884491567222,0.627566158423083,20,231,negative regulation of cellular amide metabolic process,BP,SORL1;PRNP;MAP2K1;EIF4EBP1;EGFR;IGF2BP3;APOE;ATF4;ABCA7;XRN1;TNRC6B;MEX3C;CPEB4;MAP2K2;PUM2;EIF2AK2;PPARG;GRB7;TNRC6C;ZC3H7A
7164,GO:0031034,0.465084089085587,0.897261440849199,1,4,myosin filament assembly,BP,OBSL1
17663,GO:1901505,0.465174635143233,0.759311318250498,3,32,carbohydrate derivative transmembrane transporter activity,MF,SLC29A4;SLC35B4;SLC25A4
544,GO:0001662,0.465544611618133,0.802918935700507,2,18,behavioral fear response,BP,RAG1;APOE
868,GO:0002209,0.465544611618133,0.802918935700507,2,18,behavioral defense response,BP,RAG1;APOE
10095,GO:0042596,0.465544611618133,0.802918935700507,2,18,fear response,BP,RAG1;APOE
10167,GO:0042753,0.465909075474656,0.887295925630043,1,6,positive regulation of circadian rhythm,BP,BTRC
7909,GO:0032482,0.466021946263195,0.711998796374211,5,58,Rab protein signal transduction,BP,RAB3B;GDI1;RAB31;RAB43;RAB1A
8950,GO:0034992,0.466036560008985,0.891005969795209,1,5,microtubule organizing center attachment site,CC,SYNE3
8951,GO:0034993,0.466036560008985,0.891005969795209,1,5,meiotic nuclear membrane microtubule tethering complex,CC,SYNE3
16238,GO:0090286,0.466036560008985,0.891005969795209,1,5,cytoskeletal anchoring at nuclear membrane,BP,SYNE3
17220,GO:0106083,0.466036560008985,0.891005969795209,1,5,nuclear membrane protein complex,CC,SYNE3
17223,GO:0106094,0.466036560008985,0.891005969795209,1,5,nuclear membrane microtubule tethering complex,CC,SYNE3
2512,GO:0005765,0.466119507248205,0.6155007953316,26,298,lysosomal membrane,CC,TSPAN1;VLDLR;MARCH9;CD68;RDH14;STOM;LRP1;SNX14;LPCAT1;ANXA6;VPS11;COL6A1;ZFYVE9;TMBIM1;AP2A2;CMTM6;AP3D1;TMEM63A;EVA1A;ATP6V1B2;ATP11B;TMEM9;MARCH2;HPSE;PSEN2;GNAI1
16902,GO:0098852,0.466119507248205,0.6155007953316,26,298,lytic vacuole membrane,CC,TSPAN1;VLDLR;MARCH9;CD68;RDH14;STOM;LRP1;SNX14;LPCAT1;ANXA6;VPS11;COL6A1;ZFYVE9;TMBIM1;AP2A2;CMTM6;AP3D1;TMEM63A;EVA1A;ATP6V1B2;ATP11B;TMEM9;MARCH2;HPSE;PSEN2;GNAI1
3120,GO:0006699,0.466346659185733,0.801660893248635,2,19,bile acid biosynthetic process,BP,NR1D1;AMACR
6262,GO:0019855,0.466478019820428,0.882322498798202,1,8,calcium channel inhibitor activity,MF,SLC30A1
13713,GO:0060272,0.46706872024142,0.881984618213385,1,8,embryonic skeletal joint morphogenesis,BP,HYAL1
17710,GO:1901620,0.467209125372755,0.883897477259495,1,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,PRKACB
12712,GO:0050930,0.467256442307466,0.8818771115149,1,8,induction of positive chemotaxis,BP,PGF
871,GO:0002221,0.467338443565314,0.656029503950544,11,122,pattern recognition receptor signaling pathway,BP,TNIP1;NR1D1;PTPRS;CTSB;MAPKAPK3;TRIM5;CTSL;F2RL1;DDX60;PUM2;FADD
5299,GO:0015988,0.467415834059974,0.799736109274799,2,21,energy coupled proton transmembrane transport, against electrochemical gradient,BP,ATP12A;ATP6V1B2
1262,GO:0003016,0.467496505698777,0.802189066756401,2,17,respiratory system process,BP,NLGN2;PBX3
6218,GO:0019751,0.46773885050356,0.675938827681015,8,86,polyol metabolic process,BP,PCK2;CYP27B1;ISYNA1;SPTLC2;NTSR1;INPP4A;PLCH2;COQ2
1145,GO:0002741,0.467886581609861,0.883514788712224,1,7,positive regulation of cytokine secretion involved in immune response,BP,F2RL1
15326,GO:0071542,0.468237445153288,0.801631443616547,2,17,dopaminergic neuron differentiation,BP,DKK1;LRP6
4354,GO:0009948,0.468567557245319,0.757886613943481,3,28,anterior/posterior axis specification,BP,DDIT3;PCSK6;LRP6
11175,GO:0045252,0.468758274336602,0.883021187913696,1,7,oxoglutarate dehydrogenase complex,CC,DHTKD1
12145,GO:0048247,0.469068225802273,0.798479599329171,2,21,lymphocyte chemotaxis,BP,ADAM8;CKLF
19709,GO:2000050,0.469114817818031,0.80181157797525,2,16,regulation of non-canonical Wnt signaling pathway,BP,DKK1;ANKRD6
821,GO:0002093,0.469300407642843,0.88271352552309,1,7,auditory receptor cell morphogenesis,BP,SLITRK6
17037,GO:0099512,0.469309354394564,0.588141028343039,55,598,supramolecular fiber,CC,NOS1;FLNC;SCN8A;CLIP2;LTBP1;THSD4;MAP1B;SNTB2;WIPF1;SNPH;ANK3;FYN;MYH15;KIF13B;PARVB;DLG1;ESPN;PAK1;CEP170;SHANK2;RAC2;OBSCN;FKBP1A;RGS14;PKD2;KIF21B;TMOD2;FERMT1;OBSL1;LMAN1;FAM110C;DVL1;MAP6;TWF2;CST3;PPP3CB;SPRY2;BEX4;ENKD1;COL6A1;MTA1;MAP2K2;TUBG2;NAV1;NCKAP1;COL1A2;CCSAP;NEK6;TMSB4X;TBL1X;WASL;FLNB;PSEN2;KAT2B;REEP3
6307,GO:0019941,0.469585519447245,0.59336111379343,45,521,modification-dependent protein catabolic process,BP,SMURF2;EDEM1;GID4;BTBD2;HECW2;WWTR1;DDIT3;PSMD2;UBE2J1;UBXN4;TRIB2;RBCK1;ABTB1;UBE2G1;BTRC;RMND5A;FBXO2;DVL1;MVB12B;TRIB3;DNAJB9;BTBD3;PSMD7;MVB12A;MTA1;RNF165;PCYOX1;XBP1;ARRDC1;ANKIB1;UBE2E1;SEL1L;TBL1X;ERLEC1;USP20;WFS1;USP32;MAGEF1;RNF180;RNF103;USP25;UFL1;KLHL15;STT3B;FBXL5
13064,GO:0051567,0.469757697730878,0.757765251038464,3,26,histone H3-K9 methylation,BP,ATRX;ARID4A;JARID2
16328,GO:0090533,0.469883143226681,0.882382241906896,1,7,cation-transporting ATPase complex,CC,ATP12A
17308,GO:0140103,0.470061911894036,0.798847906786165,2,19,catalytic activity, acting on a glycoprotein,MF,B3GNT3;B4GALNT4
3713,GO:0008227,0.470150584141475,0.880211726347035,1,8,G-protein coupled amine receptor activity,MF,HTR7
10000,GO:0042415,0.470236297411018,0.882181182292745,1,7,norepinephrine metabolic process,BP,RNF180
8125,GO:0032813,0.470517823843052,0.754600935887462,3,33,tumor necrosis factor receptor superfamily binding,MF,TNFSF15;TMBIM1;FADD
1101,GO:0002690,0.47061744490006,0.726936830125045,4,47,positive regulation of leukocyte chemotaxis,BP,PGF;RAC2;MOSPD2;F2RL1
3412,GO:0007194,0.470619029171994,0.881963034004433,1,7,negative regulation of adenylate cyclase activity,BP,AKAP9
7288,GO:0031280,0.470619029171994,0.881963034004433,1,7,negative regulation of cyclase activity,BP,AKAP9
12755,GO:0051023,0.470867649800394,0.878232912757751,1,9,regulation of immunoglobulin secretion,BP,XBP1
8335,GO:0033180,0.470913667903514,0.879770132552654,1,8,proton-transporting V-type ATPase, V1 domain,CC,ATP6V1B2
10416,GO:0043254,0.470999676789493,0.605433374367794,30,338,regulation of protein complex assembly,BP,ERCC1;SORL1;CTNNBIP1;MMP1;WIPF1;DLG1;SNX9;DKK1;PAK1;IMPACT;RAC2;APOE;IDE;AKAP9;TMOD2;PFN2;DDB2;ATF7IP;TWF2;VPS11;ASAP1;JMY;ATXN2;THRA;SPIRE1;NCKAP1;TMSB4X;EIF2AK2;ARPC1A;WASL
8201,GO:0032946,0.471054035057948,0.692950258282235,6,71,positive regulation of mononuclear cell proliferation,BP,TGFBR2;CD46;SLC39A10;CARD11;IGF2;FADD
16188,GO:0090207,0.471226357127532,0.797961876371144,2,19,regulation of triglyceride metabolic process,BP,LMF1;APOE
17772,GO:1901799,0.471257990751225,0.727330782844421,4,42,negative regulation of proteasomal protein catabolic process,BP,UBE2J1;GABARAPL2;ERLEC1;USP25
14684,GO:0070296,0.47132631997214,0.799297682579517,2,17,sarcoplasmic reticulum calcium ion transport,BP,CHD7;PRKACA
6603,GO:0022624,0.471501880024108,0.79529359936355,2,24,proteasome accessory complex,CC,PSMD2;PSMD7
7802,GO:0032351,0.471512615546966,0.881452699208065,1,7,negative regulation of hormone metabolic process,BP,CYP27B1
7804,GO:0032353,0.471512615546966,0.881452699208065,1,7,negative regulation of hormone biosynthetic process,BP,CYP27B1
7781,GO:0032305,0.47155564431628,0.879397815846219,1,8,positive regulation of icosanoid secretion,BP,NTSR1
19775,GO:2000193,0.47155564431628,0.879397815846219,1,8,positive regulation of fatty acid transport,BP,NTSR1
8491,GO:0033646,0.471702864042464,0.881343863667589,1,7,host intracellular part,CC,LMAN1
10646,GO:0043656,0.471702864042464,0.881343863667589,1,7,intracellular region of host,CC,LMAN1
17732,GO:1901661,0.472081945662802,0.795250219880257,2,23,quinone metabolic process,BP,CBR4;COQ2
1099,GO:0002688,0.472244288020613,0.706224521897323,5,60,regulation of leukocyte chemotaxis,BP,PGF;RAC2;MOSPD2;F2RL1;C5
6795,GO:0030235,0.472247255820972,0.881032077852341,1,7,nitric-oxide synthase regulator activity,MF,EGFR
15420,GO:0071682,0.472319665347674,0.878953756011111,1,8,endocytic vesicle lumen,CC,APOE
3463,GO:0007276,0.472486476232749,0.600588448619212,33,372,gamete generation,BP,ERCC1;ETV5;NEURL1;OSBP2;BBS2;CCNI;MICALCL;SCMH1;UBE2J1;MYCBPAP;CRTAP;TCFL5;ATRX;GAMT;FAM50A;RFX2;PRKAR1A;ZNF449;AZIN2;BCL2L1;SPIRE1;TXNRD3;SPIN4;REC8;SPATA6;PDE5A;MLH3;PRKACA;ARID4A;CLDN11;HSPA2;SEPT6;DNMT3A
2254,GO:0005168,0.472599713736587,0.883573361453573,1,6,neurotrophin TRKA receptor binding,MF,SHC1
6370,GO:0021554,0.472692041200267,0.883521444344462,1,6,optic nerve development,BP,LPAR1
16830,GO:0098722,0.47280763755762,0.880710583592185,1,7,asymmetric stem cell division,BP,ETV5
10865,GO:0044387,0.473042000356971,0.880575962470093,1,7,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,ADARB1
2281,GO:0005231,0.473048736486495,0.880572091702146,1,7,excitatory extracellular ligand-gated ion channel activity,MF,GRIN3B
7665,GO:0032094,0.473482274152186,0.796908000132179,2,18,response to food,BP,BBS2;PPARA
5727,GO:0016868,0.473705880166366,0.878145391249892,1,8,intramolecular transferase activity, phosphotransferases,MF,PGM1
8540,GO:0033865,0.473835850176423,0.751834906108118,3,33,nucleoside bisphosphate metabolic process,BP,ACOT7;PANK4;PANK1
8546,GO:0033875,0.473835850176423,0.751834906108118,3,33,ribonucleoside bisphosphate metabolic process,BP,ACOT7;PANK4;PANK1
8567,GO:0034032,0.473835850176423,0.751834906108118,3,33,purine nucleoside bisphosphate metabolic process,BP,ACOT7;PANK4;PANK1
12609,GO:0050789,0.474108465326657,0.553019545887922,642,7497,regulation of biological process,BP,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FAM83A;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;ASAP2;SYNE3;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;SCN8A;SERPINE2;PEAR1;ADCY7;IGFBP4;PRNP;PAG1;ADGRF1;ITGB4;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;ADM2;BTBD2;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;CMTM4;THBS2;FAM210B;FMNL2;ETV4;TFPI2;LTBP2;RAPGEF3;FNDC4;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;ALOX15B;LMF1;SALL2;PKN1;WWTR1;DCBLD2;PEG3;CCNI;MST1R;ARHGAP22;APLN;POU2F2;TRIM65;PITPNC1;DGKA;TEF;TNFSF15;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;KCNG1;PTPRS;CCNG2;SMARCA1;HADH;SOX12;PSMD2;LAMB1;EXOC2;ELK3;CRTC1;ADGRL1;CAPN2;BRSK1;FCGRT;WIPF1;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;BCORL1;CGREF1;ARHGAP12;PPP1R14A;FYN;HEBP1;TNFRSF6B;TSPAN5;BNIP3;HLTF;KIF13B;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;PARVB;ARAP1;ADAMTS7;ZNF516;DLG1;CSMD3;DLG4;IDH2;CTSB;DNAJB5;PLXNB3;GPC4;SNX9;TYSND1;PODXL;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;EVI5L;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;TTBK2;SPTLC2;GRK5;HTR7;STRADB;NME4;CRTAP;ASPH;MCTP1;GDI1;CEMIP;SDC1;ARG2;STOM;SHC1;DLG3;DKK1;WISP1;DAP;SMOC2;PAK1;RASA3;SOCS2;TRIB2;KIAA1549;RHPN1;ZNF652;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;EDNRA;LCN2;SHANK2;SLITRK6;EPHA1;IMPACT;RALGAPA2;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;CCPG1;CCND2;ACP5;ANGPTL4;PTPN12;AFAP1;RGS14;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;FYCO1;IDE;AKAP9;RAB11FIP4;FAM208A;PPP2R3B;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;ICA1;EIF4E3;LPAR3;ELFN2;ASNS;FGFR1;ITGA1;AARS;PPP1R35;E2F5;EPCAM;TMOD2;TUB;CMTM7;TCFL5;SMOC1;NFAT5;ITGB5;HYAL1;BTRC;LPCAT1;ITGA2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;ABCG1;KIAA1109;SOX4;PITPNM1;APOBEC3C;FHOD1;ITPR3;FBXO2;DDB2;GAMT;CEP120;ZNF558;CEACAM1;FERMT1;MAPKAPK3;ZNF692;OBSL1;PDIA5;RAB31;LMAN1;MT2A;UACA;SARAF;ATF7IP;FAM110C;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;PLEK2;HES2;ANXA6;NLGN2;CD46;ZBTB10;PHF12;MVB12B;EPOR;CTH;ZNF704;NXPH4;LRP5;ETAA1;ABHD17C;ZMYM3;DNMBP;KLF12;CTSL;DOCK9;TWF2;CST3;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;TPBG;TOM1L2;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;BTBD3;RIMS3;PLPPR2;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;INPP4A;RFX2;SYTL1;ADGRB2;APLP2;DNAJC6;SLK;PRDX5;MLYCD;CEBPG;PLAG1;FNBP1L;CDC42BPA;F2RL1;DDX60;UHRF2;RASIP1;PROCR;TAOK1;PHC3;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;SLC25A4;QSOX1;ASAP1;CPT2;PRKAR1A;ANO1;MSRB2;JMY;BOK;PARP9;CPEB4;SDCCAG3;C18ORF32;ATXN2;MAST3;NACC2;USP6NL;SPRY2;SEPT5;ZNF337;BEX4;TBC1D2B;THRA;MGLL;CD99;WNT2B;ACVR1B;NGFR;ZNF280D;PPP1R10;PSKH1;MVB12A;GLUD1;TSHZ1;MARK4;ZNF449;PTPRZ1;CHD6;NUDT6;PER3;MTA1;AZIN2;BCL2L1;IFITM1;RNF165;YTHDC2;PM20D2;GRIN3B;MEF2D;WASF2;SKAP2;ARF4;H2AFJ;XBP1;SPIRE1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SATB1;SLC22A17;PPP1R2;PAIP1;ARRDC1;ANKIB1;TLE4;RIN1;TRPC1;RET;CCDC71L;STX10;LOXL2;PDE5A;TCTN1;RAB43;SH3PXD2B;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;THAP10;NOP10;NCKAP1;GABARAPL2;EPM2A;KCNJ15;RMRP;GTF2IRD2;C1ORF56;DOCK11;PAK6;EAPP;PUM2;SLC30A1;TSPAN3;RNF135;PSD3;TMBIM1;ETV1;COL1A2;CCDC88A;CCSAP;TMED4;SAMD8;SHC2;PRKACA;SAMD5;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;EPB41L3;SEL1L;CBX7;IFI16;RHOBTB1;AP2A2;NR2F6;SLC39A10;KDELR3;CMTM6;SCAND1;IL1RAP;SBNO1;ORAI1;CARD11;LTB4R;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;AP3D1;ARID4A;ARPC1A;TENM2;IGF2;ITPR2;MOAP1;LAMA5;AGPAT1;PJA2;ZSCAN18;GRB10;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;CITED4;SNX6;USP20;ZFP30;GRB7;SRPX2;ALDH1A2;GPR153;ARHGAP29;LYPLA1;ZNF37A;TBX1;EVI5;CREB3L2;ERP44;ATP6V1B2;RPH3AL;RSF1;ADAM8;AKT3;ROBO3;IL20RB;WFS1;DEPDC1;ENDOG;ITGA4;PHF21A;ZBTB40;ZNF92;ACAP2;MAML3;CKLF;ZNF568;IGFBP7;TBC1D16;DDHD2;FZD8;WASL;RAPGEFL1;REEP6;HSPA2;PRSS8;ZNF107;FLNB;LRP6;ARID5B;MAGEF1;ZNF165;SYT2;PLCH2;TMEM173;RNF180;E2F7;EEF2K;ZNF320;SLC18A2;SIGMAR1;HPSE;RALGDS;SSR1;TNRC6C;TRIM2;RCAN1;TET1;OMG;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;HSD17B12;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;USP25;PRMT3;NYAP1;UFL1;FAM162A;ANKRD6;SNX27;PBX3;JARID2;SEMA3F;RALGPS2;KLHL15;MXD4;ADNP;GNAI1;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
6472,GO:0021801,0.47425065629637,0.797074659120428,2,17,cerebral cortex radial glia guided migration,BP,LAMB1;MBOAT7
6571,GO:0022030,0.47425065629637,0.797074659120428,2,17,telencephalon glial cell migration,BP,LAMB1;MBOAT7
6504,GO:0021873,0.474258806124648,0.88263814219606,1,6,forebrain neuroblast division,BP,FGFR1
870,GO:0002220,0.474294437167677,0.669242284426092,8,95,innate immune response activating cell surface receptor signaling pathway,BP,PSMD2;FYN;PAK1;PRKACB;BTRC;PSMD7;PRKACA;CARD11
872,GO:0002223,0.474294437167677,0.669242284426092,8,95,stimulatory C-type lectin receptor signaling pathway,BP,PSMD2;FYN;PAK1;PRKACB;BTRC;PSMD7;PRKACA;CARD11
10502,GO:0043403,0.474341205800832,0.795581475846919,2,19,skeletal muscle tissue regeneration,BP,WNT7A;TGFBR2
3269,GO:0006940,0.474380043194357,0.752321698687443,3,30,regulation of smooth muscle contraction,BP,DOCK4;F2R;ITGA2
4075,GO:0009128,0.474390849565033,0.877744677748381,1,8,purine nucleoside monophosphate catabolic process,BP,NT5E
4104,GO:0009158,0.474390849565033,0.877744677748381,1,8,ribonucleoside monophosphate catabolic process,BP,NT5E
4114,GO:0009169,0.474390849565033,0.877744677748381,1,8,purine ribonucleoside monophosphate catabolic process,BP,NT5E
12983,GO:0051386,0.474418534101388,0.879783285927154,1,7,regulation of neurotrophin TRK receptor signaling pathway,BP,SPRY2
2745,GO:0006140,0.474494308792464,0.649440212177595,11,119,regulation of nucleotide metabolic process,BP,NOS1;RAPGEF3;APOE;PKD2;AKAP9;PPARA;PTHLH;PDE5A;TMSB4X;TIMP2;ADNP
11252,GO:0045472,0.474568416317225,0.87969677203658,1,7,response to ether,BP,NFATC4
11630,GO:0046332,0.474619213628395,0.6914210215642,6,57,SMAD binding,MF,SMURF2;TGFBR2;FKBP1A;HMGA2;ACVR1B;COL1A2
600,GO:0001767,0.474926110339391,0.882260619263389,1,6,establishment of lymphocyte polarity,BP,SNX27
382,GO:0001016,0.474991662588209,0.879452252138018,1,7,RNA polymerase III regulatory region DNA binding,MF,PRDX5
2753,GO:0006163,0.475414061635567,0.600817319015889,30,372,purine nucleotide metabolic process,BP,XDH;NT5E;NOS1;ADCY7;RAPGEF3;DHTKD1;PGM1;DLG1;DLG4;ACOT7;NME4;DLG3;APOE;PKD2;LDHA;AKAP9;PPARA;FAM20C;PTHLH;NDUFV3;PANK4;PDE5A;TMSB4X;TIMP2;CARD11;ATP6V1B2;AK9;ADCY1;PANK1;ADNP
5352,GO:0016114,0.475475132331747,0.877108631833528,1,8,terpenoid biosynthetic process,BP,ALDH1A2
6925,GO:0030517,0.475884325712598,0.752234492462732,3,27,negative regulation of axon extension,BP,PTPRS;SEMA4B;SEMA3F
10671,GO:0043901,0.475903838368817,0.653359018802018,10,118,negative regulation of multi-organism process,BP,TNIP1;HTRA1;ARG2;HMGA2;APOBEC3C;TRIM5;IFITM1;EIF2AK2;IFI16;OAS1
18932,GO:1904683,0.475947325262773,0.881681350390579,1,6,regulation of metalloendopeptidase activity,BP,SORL1
3059,GO:0006621,0.476036103548882,0.876778729333839,1,8,protein retention in ER lumen,BP,KDELR3
5107,GO:0015399,0.476132434794577,0.677764617316918,7,73,primary active transmembrane transporter activity,MF,ATP7B;ABCD1;ABCA7;ABCG1;PCYOX1;ATP12A;ATP6V1B2
5108,GO:0015405,0.476132434794577,0.677764617316918,7,73,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,ATP7B;ABCD1;ABCA7;ABCG1;PCYOX1;ATP12A;ATP6V1B2
18589,GO:1903844,0.476180862329183,0.6683779349132,8,83,regulation of cellular response to transforming growth factor beta stimulus,BP,SMURF2;LTBP1;HTRA1;TGFBR2;LTBP4;FERMT1;MTMR4;SNX6
15097,GO:0071108,0.476355174736268,0.75279007171415,3,25,protein K48-linked deubiquitination,BP,OTUB2;USP20;USP25
3231,GO:0006884,0.476382529444506,0.795445697582324,2,17,cell volume homeostasis,BP,CLCN3;SLC12A7
9177,GO:0035542,0.476407434509317,0.878631994286646,1,7,regulation of SNARE complex assembly,BP,VPS11
18647,GO:1903959,0.476454734634193,0.795390402077031,2,17,regulation of anion transmembrane transport,BP,PRNP;STK39
7648,GO:0032059,0.476469091466335,0.878596190335874,1,7,bleb,CC,FHOD1
2832,GO:0006298,0.476584970249091,0.750141460241922,3,31,mismatch repair,BP,ERCC1;XPC;MLH3
13685,GO:0060219,0.476595087312027,0.881312960370529,1,6,camera-type eye photoreceptor cell differentiation,BP,SDK2
8999,GO:0035116,0.476880963946304,0.794304502960756,2,18,embryonic hindlimb morphogenesis,BP,WNT7A;CHD7
3458,GO:0007270,0.476892674134763,0.881143469862782,1,6,neuron-neuron synaptic transmission,BP,TMOD2
6749,GO:0030169,0.476902092070782,0.881138103312513,1,6,low-density lipoprotein particle binding,MF,SORL1
2387,GO:0005523,0.476903722879491,0.876267367763957,1,8,tropomyosin binding,MF,TMOD2
11743,GO:0046579,0.477127950187711,0.750775802623102,3,28,positive regulation of Ras protein signal transduction,BP,F2R;F2RL1;LPAR1
13447,GO:0052866,0.477175940081867,0.751611902694414,3,26,phosphatidylinositol phosphate phosphatase activity,MF,INPP5F;INPP4A;MTMR4
2111,GO:0004896,0.477302077883017,0.721858488019335,4,43,cytokine receptor activity,MF,CD44;EPOR;IL1RAP;IL20RB
16908,GO:0098869,0.477423257776258,0.701246449486925,5,63,cellular oxidant detoxification,BP,CYGB;GPX3;APOE;PRDX5;TXNRD3
14249,GO:0061299,0.477554985679803,0.880765686373342,1,6,retina vasculature morphogenesis in camera-type eye,BP,LRP5
3552,GO:0007586,0.477559420450339,0.72206723083295,4,41,digestion,BP,PRSS3;ADM2;STK39;SLC5A1
16472,GO:0097152,0.477567865720918,0.877956991060595,1,7,mesenchymal cell apoptotic process,BP,TBX1
7833,GO:0032386,0.47783918178016,0.601312621702222,28,318,regulation of intracellular transport,BP,EDEM1;SORL1;PRNP;SH3TC2;MAP2K1;RAPGEF3;MAP1B;ANK3;FYN;UBE2J1;GDI1;CEMIP;STOM;PAK1;RAC2;BNIP3L;VAMP2;INPP5F;PFN2;SOX4;VPS11;RIMS3;SEPT5;MAP2K2;EFCAB7;ERLEC1;REEP6;TMEM173
3528,GO:0007507,0.477849602325463,0.594576219073749,34,356,heart development,BP,ADAM19;NFATC4;MAP2K1;ACVR2B;LTBP1;APLN;EGFR;SHC1;DKK1;PAK1;TGFBR2;EDNRA;FKBP1A;PKD2;PPARA;FGFR1;SOX4;OBSL1;DVL1;EPOR;PPP3CB;CHD7;PRKAR1A;PSKH1;MEF2D;SH3PXD2B;PPARG;ALDH1A2;TBX1;LRP6;PTCH1;KAT2B;JARID2;RB1CC1
873,GO:0002224,0.477892263968752,0.666238353875144,8,90,toll-like receptor signaling pathway,BP,TNIP1;NR1D1;PTPRS;CTSB;MAPKAPK3;CTSL;F2RL1;FADD
5099,GO:0015377,0.478155339098522,0.880422570496298,1,6,cation:chloride symporter activity,MF,SLC12A7
5101,GO:0015379,0.478155339098522,0.880422570496298,1,6,potassium:chloride symporter activity,MF,SLC12A7
4164,GO:0009226,0.478209340610447,0.791452298287456,2,21,nucleotide-sugar biosynthetic process,BP,GFPT1;UAP1
13706,GO:0060263,0.478211325502337,0.875494107256278,1,8,regulation of respiratory burst,BP,RAC2
11862,GO:0046851,0.478222774344174,0.877574972474459,1,7,negative regulation of bone remodeling,BP,UBASH3B
10017,GO:0042446,0.478306378805245,0.720586080453295,4,45,hormone biosynthetic process,BP,CYP27B1;HSD17B7;SRD5A3;HSD17B12
16132,GO:0090130,0.478328301248208,0.617259986422429,19,204,tissue migration,BP,PRSS3;ACTA2;PKN1;WNT7A;TGFBR2;APOE;ANXA3;FGFR1;HYAL1;ITGA2;PFN2;CEACAM1;FERMT1;LOXL2;TMSB4X;PPARG;SRPX2;AKT3;FOXP1
13286,GO:0051974,0.47837357700978,0.875397941970955,1,8,negative regulation of telomerase activity,BP,PPARG
16290,GO:0090382,0.478546075503096,0.747882914142987,3,33,phagosome maturation,BP,RAB31;RAB43;ATP6V1B2
4153,GO:0009215,0.478902420303931,0.873467138220475,1,9,purine deoxyribonucleoside triphosphate metabolic process,BP,AK9
8608,GO:0034116,0.479109144602308,0.874961375579896,1,8,positive regulation of heterotypic cell-cell adhesion,BP,CD44
15398,GO:0071649,0.47928407077202,0.876954259776583,1,7,regulation of chemokine (C-C motif) ligand 5 production,BP,ARG2
2286,GO:0005244,0.479476831592669,0.686297514971302,6,62,voltage-gated ion channel activity,MF,SCN8A;KCNG1;PKD2;CLCN3;ANO1;KCNJ15
6612,GO:0022832,0.479476831592669,0.686297514971302,6,62,voltage-gated channel activity,MF,SCN8A;KCNG1;PKD2;CLCN3;ANO1;KCNJ15
20285,GO:2001258,0.4796326859192,0.790894378136243,2,20,negative regulation of cation channel activity,BP,ANK3;PKD2
10268,GO:0043008,0.479769155384801,0.874568813862127,1,8,ATP-dependent protein binding,MF,PRNP
17588,GO:1901223,0.47985816362404,0.874515812681088,1,8,negative regulation of NIK/NF-kappaB signaling,BP,TMSB4X
10757,GO:0044183,0.479926686440505,0.746718888053593,3,33,protein binding involved in protein folding,MF,FYCO1;HSPA13;HSPA2
9096,GO:0035358,0.480020207375844,0.876522526207081,1,7,regulation of peroxisome proliferator activated receptor signaling pathway,BP,ALOX15B
13136,GO:0051701,0.480110993338636,0.630339444913473,14,159,interaction with host,BP,TNIP1;PC;EXOC2;EGFR;CTSB;IDE;ITGB5;ITGA2;TRIM5;CD46;BCL2L1;IFITM1;EIF2AK2;TRIM38
4103,GO:0009157,0.480307815211277,0.87262143257994,1,9,deoxyribonucleoside monophosphate biosynthetic process,BP,TK2
7639,GO:0032049,0.480433532324504,0.874172852567407,1,8,cardiolipin biosynthetic process,BP,CRLS1
1896,GO:0004579,0.480454005437934,0.872533253292097,1,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,STT3B
12100,GO:0048103,0.480709049225462,0.792987781299867,2,16,somatic stem cell division,BP,WNT7A;FGFR1
9430,GO:0035999,0.480712978944097,0.874006064596359,1,8,tetrahydrofolate interconversion,BP,MTHFR
6584,GO:0022411,0.48082426444881,0.585872695995729,40,477,cellular component disassembly,BP,MMP1;H1F0;MAP1B;CAPN2;BNIP3;HTRA1;TTBK2;ASPH;DKK1;NEK9;CD44;BNIP3L;LRP1;FYCO1;TMOD2;SNX14;SPATA18;MRPS6;BSG;DVL1;MMP14;LRP5;CTSL;TWF2;CST3;DNAJC6;F2RL1;BOK;SH3PXD2B;GABARAPL2;CCSAP;NEK6;TIMP2;MMP10;ADAM8;ENDOG;HSPA2;LRP6;DEDD2;RB1CC1
12846,GO:0051156,0.480978861007395,0.789297572970563,2,21,glucose 6-phosphate metabolic process,BP,H6PD;PGLS
278,GO:0000780,0.481013401547643,0.789820691911952,2,20,condensed nuclear chromosome, centromeric region,CC,ATRX;REC8
6656,GO:0030007,0.481192595034577,0.875832912913114,1,7,cellular potassium ion homeostasis,BP,ATP12A
14685,GO:0070300,0.48139837595527,0.79081619599429,2,18,phosphatidic acid binding,MF,PITPNC1;PITPNM1
12306,GO:0048644,0.481450494861332,0.70022845117795,5,46,muscle organ morphogenesis,BP,ADARB1;FKBP1A;CHD7;TBX1;ARID5B
12539,GO:0050688,0.481595494853373,0.698808109907296,5,53,regulation of defense response to virus,BP,HTRA1;DDX60;PARP9;PUM2;TMEM173
9575,GO:0036376,0.481845176378774,0.875447976567675,1,7,sodium ion export across plasma membrane,BP,ATP12A
11356,GO:0045713,0.481874681415715,0.875430554249219,1,7,low-density lipoprotein particle receptor biosynthetic process,BP,PPARG
13735,GO:0060306,0.48209750277908,0.79191706638356,2,16,regulation of membrane repolarization,BP,DLG1;AKAP9
14650,GO:0070234,0.482269813515061,0.871434710464321,1,9,positive regulation of T cell apoptotic process,BP,ADAM8
7,GO:0000014,0.482280908999072,0.875190521552095,1,7,single-stranded DNA endodeoxyribonuclease activity,MF,ERCC1
3763,GO:0008307,0.482326883057814,0.748341419040937,3,24,structural constituent of muscle,MF,ASPH;OBSCN;OBSL1
11715,GO:0046512,0.482370487907992,0.873013841196981,1,8,sphingosine biosynthetic process,BP,SPTLC2
11599,GO:0046185,0.482605658553343,0.871230861635627,1,9,aldehyde catabolic process,BP,HAGH
884,GO:0002250,0.482648949468458,0.617977490969107,17,197,adaptive immune response,BP,ERCC1;PAG1;PKN1;POU2F2;FYN;DLG1;ARG2;RAG1;SERPING1;CEACAM1;CD46;CTSL;PPP3CB;C5;ORAI1;IL20RB;FADD
5198,GO:0015791,0.482710012027594,0.877798521157873,1,6,polyol transport,BP,SLC2A13
14950,GO:0070841,0.482727206091028,0.789784012271932,2,18,inclusion body assembly,BP,SORL1;HSPA2
6610,GO:0022824,0.482868334529178,0.874842891458556,1,7,transmitter-gated ion channel activity,MF,GRIN3B
6614,GO:0022835,0.482868334529178,0.874842891458556,1,7,transmitter-gated channel activity,MF,GRIN3B
15636,GO:0072132,0.482871517051467,0.746375662981482,3,27,mesenchyme morphogenesis,BP,ACTA2;TGFBR2;FGFR1
17556,GO:1901098,0.482883540839054,0.877697812358718,1,6,positive regulation of autophagosome maturation,BP,FYCO1
13037,GO:0051493,0.483142983800062,0.587286850076535,36,395,regulation of cytoskeleton organization,BP,RAPGEF3;SSH1;MAP1B;CAPN2;WIPF1;ARAP1;DLG1;ESPN;TTBK2;PAK1;EPHA1;RAC2;AFAP1;LRP1;AKAP9;TMOD2;PFN2;FHOD1;CEP120;TWF2;F2RL1;TAOK1;JMY;WASF2;SPIRE1;SH3PXD2B;NCKAP1;CCDC88A;CCSAP;TMSB4X;RHOBTB1;LPAR1;ARPC1A;WASL;KAT2B;GNAI1
3046,GO:0006600,0.483461487568202,0.872357993630584,1,8,creatine metabolic process,BP,GAMT
16337,GO:0090559,0.483584515294818,0.681525118908077,6,71,regulation of membrane permeability,BP,BNIP3;BNIP3L;SLC25A4;BOK;BCL2L1;MOAP1
10326,GO:0043116,0.484075415408862,0.874126585385579,1,7,negative regulation of vascular permeability,BP,CEACAM1
18255,GO:1903078,0.484139946842794,0.716777778804085,4,39,positive regulation of protein localization to plasma membrane,BP,PRNP;EGFR;DLG1;LRP1
5213,GO:0015812,0.4841492174799,0.876961627964882,1,6,gamma-aminobutyric acid transport,BP,NTSR1
7488,GO:0031652,0.484192558872285,0.871917290103496,1,8,positive regulation of heat generation,BP,APLN
7126,GO:0030949,0.484263045421371,0.874015003289518,1,7,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,GRB10
6309,GO:0019953,0.484337562954916,0.584191479652001,38,435,sexual reproduction,BP,ERCC1;ETV5;NEURL1;SERPINE2;OSBP2;BBS2;CCNI;MST1R;MICALCL;SCMH1;UBE2J1;MYCBPAP;CRTAP;TCFL5;ATRX;GAMT;CD46;FAM50A;RFX2;PRKAR1A;THRA;ZNF449;SPESP1;AZIN2;BCL2L1;SPIRE1;TXNRD3;SPIN4;REC8;SPATA6;PDE5A;MLH3;PRKACA;ARID4A;CLDN11;HSPA2;SEPT6;DNMT3A
2332,GO:0005347,0.48435115992298,0.871821552501409,1,8,ATP transmembrane transporter activity,MF,SLC25A4
16364,GO:0090662,0.484594004003787,0.786466879768839,2,21,ATP hydrolysis coupled transmembrane transport,BP,ATP12A;ATP6V1B2
17014,GO:0099131,0.484594004003787,0.786466879768839,2,21,ATP hydrolysis coupled ion transmembrane transport,BP,ATP12A;ATP6V1B2
1322,GO:0003171,0.484597326854416,0.789981690472926,2,16,atrioventricular valve development,BP,TGFBR2;SOX4
2258,GO:0005172,0.484647642364839,0.871642460139055,1,8,vascular endothelial growth factor receptor binding,MF,PGF
6295,GO:0019905,0.484776336351174,0.681319825462177,6,63,syntaxin binding,MF,SNPH;VAMP2;VPS11;SYTL1;STX10;SYT2
6826,GO:0030285,0.484782208218894,0.873705926084397,1,7,integral component of synaptic vesicle membrane,CC,PTPRS
137,GO:0000287,0.484855820554512,0.625886144492708,14,156,magnesium ion binding,MF,RPS6KA2;BRSK1;PGM1;IDH2;GLUL;PRKACB;ENDOV;NLK;CDC42BPA;ATP10D;MAST3;NEK6;ATP11B;GNAI1
5459,GO:0016338,0.485114354571122,0.869701547623845,1,9,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN11
3635,GO:0008097,0.485212802105752,0.868321210078325,1,10,5S rRNA binding,MF,TST
5805,GO:0017059,0.485312845610294,0.87124004935476,1,8,serine C-palmitoyltransferase complex,CC,SPTLC2
7253,GO:0031211,0.485312845610294,0.87124004935476,1,8,endoplasmic reticulum palmitoyltransferase complex,CC,SPTLC2
19416,GO:1905961,0.485312845610294,0.87124004935476,1,8,protein-cysteine S-palmitoyltransferase complex,CC,SPTLC2
15464,GO:0071800,0.485327898434804,0.787755876147001,2,18,podosome assembly,BP,ASAP1;SH3PXD2B
18240,GO:1903050,0.485650655424224,0.62131613212164,15,174,regulation of proteolysis involved in cellular protein catabolic process,BP,EDEM1;UBE2J1;TRIB2;BTRC;DVL1;TRIB3;XBP1;ANKIB1;GABARAPL2;PRKACA;ERLEC1;MAGEF1;RNF180;USP25;UFL1
5893,GO:0018065,0.48578875104201,0.866887557818378,1,11,protein-cofactor linkage,BP,CTH
10325,GO:0043114,0.485831891823608,0.788140086061373,2,17,regulation of vascular permeability,BP,CTNNBIP1;CEACAM1
18495,GO:1903624,0.485949327198269,0.870854248627481,1,8,regulation of DNA catabolic process,BP,ENDOG
2589,GO:0005883,0.485971723325182,0.872995903869059,1,7,neurofilament,CC,SHANK2
3698,GO:0008203,0.486000891857763,0.650871205359003,9,100,cholesterol metabolic process,BP,SORL1;VLDLR;LMF1;PLPP6;APOE;ABCG1;LRP5;HSD17B7;OSBPL5
6922,GO:0030514,0.486034249464124,0.743701898635836,3,27,negative regulation of BMP signaling pathway,BP,SMURF2;HTRA1;DKK1
6074,GO:0019226,0.486036120045016,0.744164955791476,3,26,transmission of nerve impulse,BP,SCN8A;ANK3;ITGA2
9625,GO:0036491,0.486125865187879,0.872903706816759,1,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,DNAJC3
10063,GO:0042552,0.486295043027001,0.659214336566227,8,80,myelination,BP,SCN8A;SH3TC2;MARVELD1;DLG1;MALL;WASF3;EPB41L3;LPAR1
10049,GO:0042531,0.486509931691855,0.740850348971668,3,34,positive regulation of tyrosine phosphorylation of STAT protein,BP,FYN;PTK6;PARP9
4452,GO:0010390,0.48665054267929,0.742351205181814,3,29,histone monoubiquitination,BP,RAG1;DDB2;UBE2E1
10409,GO:0043244,0.486672512977224,0.658955697758406,8,79,regulation of protein complex disassembly,BP,MAP1B;BNIP3;TTBK2;ASPH;FYCO1;TMOD2;TWF2;F2RL1
17015,GO:0099132,0.487039511063733,0.741649999730691,3,30,ATP hydrolysis coupled cation transmembrane transport,BP,ATP7B;ATP12A;ATP6V1B2
15334,GO:0071550,0.487044666753986,0.868516862812262,1,9,death-inducing signaling complex assembly,BP,FADD
3446,GO:0007256,0.487056212648292,0.875259815534015,1,6,activation of JNKK activity,BP,ERCC6
4749,GO:0010919,0.487192423614253,0.872264570365084,1,7,regulation of inositol phosphate biosynthetic process,BP,NTSR1
4923,GO:0014870,0.487199954104521,0.875175269277196,1,6,response to muscle inactivity,BP,MTMR4
18537,GO:1903726,0.487251534408877,0.870062585674451,1,8,negative regulation of phospholipid metabolic process,BP,LPCAT1
18674,GO:1904019,0.487251988190697,0.679173222613181,6,62,epithelial cell apoptotic process,BP,TGFBR2;ANGPTL4;BOK;BCL2L1;WFS1;DNMT3A
4679,GO:0010827,0.487277632473762,0.694184503922117,5,50,regulation of glucose transmembrane transport,BP,PAK1;TRIB3;CLTCL1;NGFR;GRB10
15298,GO:0071482,0.487323274982866,0.657649880464337,8,87,cellular response to light stimulus,BP,ERCC1;NFATC4;MAPK13;XPC;IMPACT;ATF4;HYAL1;DDB2
3942,GO:0008630,0.487348812262563,0.657120352680453,8,94,intrinsic apoptotic signaling pathway in response to DNA damage,BP,NFATC4;ERCC6;CD44;BOK;NACC2;BCL2L1;IFI16;MOAP1
8996,GO:0035112,0.487463505345289,0.875020155481892,1,6,genitalia morphogenesis,BP,LRP6
7035,GO:0030808,0.48768254123016,0.657392051297724,8,86,regulation of nucleotide biosynthetic process,BP,NOS1;APOE;AKAP9;PPARA;PTHLH;TMSB4X;TIMP2;ADNP
17478,GO:1900371,0.48768254123016,0.657392051297724,8,86,regulation of purine nucleotide biosynthetic process,BP,NOS1;APOE;AKAP9;PPARA;PTHLH;TMSB4X;TIMP2;ADNP
13570,GO:0060037,0.488147554434156,0.786328382894853,2,17,pharyngeal system development,BP,TBX1;PTCH1
5595,GO:0016624,0.488193525350618,0.869487952676697,1,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,DHTKD1
12427,GO:0048875,0.488250594164074,0.871628393943089,1,7,chemical homeostasis within a tissue,BP,LPCAT1
11076,GO:0045076,0.488368604450071,0.869380969359762,1,8,regulation of interleukin-2 biosynthetic process,BP,CARD11
17281,GO:0140029,0.488484871172972,0.69212526496056,5,56,exocytic process,BP,RAB3B;EXOC2;SNPH;VPS11;SEPT5
13754,GO:0060330,0.488692885399205,0.783794305568251,2,20,regulation of response to interferon-gamma,BP,PARP9;PPARG
13758,GO:0060334,0.488692885399205,0.783794305568251,2,20,regulation of interferon-gamma-mediated signaling pathway,BP,PARP9;PPARG
15167,GO:0071285,0.488839470372504,0.869092960655309,1,8,cellular response to lithium ion,BP,NFATC4
14563,GO:0070087,0.488980078476773,0.874125117410476,1,6,chromo shadow domain binding,MF,ATRX
15087,GO:0071071,0.489386985954515,0.868757549759349,1,8,regulation of phospholipid biosynthetic process,BP,LPCAT1
16082,GO:0090043,0.489636009753068,0.870792356851935,1,7,regulation of tubulin deacetylation,BP,BEX4
7307,GO:0031307,0.489823691485116,0.782335594824131,2,21,integral component of mitochondrial outer membrane,CC,BNIP3;ARMCX3
325,GO:0000910,0.489918090773617,0.625221211712718,13,140,cytokinesis,BP,ANK3;SNX9;SEPT10;PAK1;RAB11FIP4;SDCCAG3;SEPT5;BCL2L1;SPIRE1;PAK6;RHOBTB1;E2F7;SEPT6
17708,GO:1901617,0.490250331445873,0.620502169651879,14,162,organic hydroxy compound biosynthetic process,BP,PCK2;CYP27B1;NR1D1;PSAT1;ISYNA1;SPTLC2;PLPP6;APOE;ABCG1;NTSR1;HSD17B7;TRPC1;SRD5A3;AMACR
17087,GO:0099612,0.490327510882176,0.873326383872051,1,6,protein localization to axon,BP,EPB41L3
5077,GO:0015301,0.490374628638395,0.783789798857482,2,18,anion:anion antiporter activity,MF,SLC25A4;SLC7A11
18195,GO:1902965,0.49050292796739,0.873222155743641,1,6,regulation of protein localization to early endosome,BP,SORL1
18196,GO:1902966,0.49050292796739,0.873222155743641,1,6,positive regulation of protein localization to early endosome,BP,SORL1
1182,GO:0002829,0.49050992962786,0.868067880335399,1,8,negative regulation of type 2 immune response,BP,ARG2
970,GO:0002418,0.490773637392985,0.86790557973823,1,8,immune response to tumor cell,BP,CEACAM1
2587,GO:0005881,0.490821507597341,0.690618057921705,5,52,cytoplasmic microtubule,CC,CLIP2;SNPH;ENKD1;TUBG2;CCSAP
3246,GO:0006903,0.490853939603083,0.663725504678794,7,77,vesicle targeting,BP,SEC23A;MCFD2;LMAN1;SEPT5;RAB1A;CTSZ;MAP4K2
4721,GO:0010883,0.490949529167669,0.738309934620084,3,30,regulation of lipid storage,BP,PPARA;ABCG1;PPARG
3823,GO:0008420,0.491046898218444,0.867737262530421,1,8,CTD phosphatase activity,MF,PPM1M
15764,GO:0072357,0.491070718247327,0.869922834439101,1,7,PTW/PP1 phosphatase complex,CC,PPP1R10
14587,GO:0070127,0.491149603467262,0.867673964306406,1,8,tRNA aminoacylation for mitochondrial protein translation,BP,GARS
4405,GO:0010155,0.491178832640274,0.86595618824165,1,9,regulation of proton transport,BP,TMSB4X
7735,GO:0032230,0.491289799456004,0.869789722022856,1,7,positive regulation of synaptic transmission, GABAergic,BP,NLGN2
9485,GO:0036119,0.491305887434565,0.783843732013477,2,17,response to platelet-derived growth factor,BP,FYN;HYAL1
19288,GO:1905523,0.491321292390578,0.867568106721415,1,8,positive regulation of macrophage migration,BP,MMP14
13892,GO:0060534,0.491445448675146,0.869695096400497,1,7,trachea cartilage development,BP,LRP6
16579,GO:0097371,0.491866845013235,0.869438686403829,1,7,MDM2/MDM4 family protein binding,MF,PPARA
13823,GO:0060419,0.491888664467459,0.68999600549376,5,50,heart growth,BP,PAK1;TGFBR2;FGFR1;PRKAR1A;JARID2
4554,GO:0010635,0.491939405954577,0.867186541898328,1,8,regulation of mitochondrial fusion,BP,BNIP3
6754,GO:0030175,0.492152852698943,0.663468323184238,7,68,filopodium,CC,ITGA6;ACTA2;RAPGEF3;PODXL;FAT1;TWF2;TENM2
19751,GO:2000142,0.492565776768266,0.736923178187267,3,30,regulation of DNA-templated transcription, initiation,BP,CTNNBIP1;ATF7IP;THRA
10767,GO:0044212,0.492694489025958,0.565058636078604,55,608,transcription regulatory region DNA binding,MF,ZMYND8;ETV5;NR1D1;NFATC4;ZC3H6;ETV4;SALL2;POU2F2;TEF;DDIT3;SOX12;ELK3;HLTF;ZNF516;DDN;HMGA2;ATF4;PPARA;TCFL5;NFAT5;SOX4;ZNF692;RCOR1;HES2;PHF12;ZNF704;ZNF322;RFX2;PRDX5;CEBPG;PLAG1;AEBP1;CHD7;NACC2;THRA;PER3;MTA1;MEF2D;XBP1;SATB1;ETV1;IFI16;NR2F6;TBL1X;ARID4A;PPARG;CREB3L2;PHF21A;ZNF568;ARID5B;E2F7;KAT2B;PBX3;JARID2;RFX7
15825,GO:0072525,0.492807385612447,0.644558755981399,9,98,pyridine-containing compound biosynthetic process,BP,NAPRT;DHTKD1;PSAT1;PGM1;IDH2;NMRK1;LDHA;PPARA;PARP9
18946,GO:1904707,0.492980693423344,0.781725977888183,2,18,positive regulation of vascular smooth muscle cell proliferation,BP,PAK1;MEF2D
11034,GO:0045006,0.493399078919794,0.863203598186462,1,10,DNA deamination,BP,APOBEC3C
1435,GO:0003413,0.493443332482285,0.868476502102787,1,7,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,TGFBR2
12136,GO:0048227,0.49348567545716,0.866228883812595,1,8,plasma membrane to endosome transport,BP,USP6NL
14205,GO:0061134,0.493699606963917,0.643110618432111,9,108,peptidase regulator activity,MF,SERPINE2;TFPI2;SERPING1;MMP14;CST3;APLP2;PRDX5;C5;TIMP2
2367,GO:0005484,0.493901214029499,0.734504010245953,3,34,SNAP receptor activity,MF,VAMP2;SEC22C;STX10
3464,GO:0007281,0.493917905589388,0.625766585586506,12,132,germ cell development,BP,ERCC1;ETV5;NEURL1;OSBP2;BBS2;UBE2J1;RFX2;BCL2L1;REC8;PDE5A;PRKACA;HSPA2
9311,GO:0035767,0.494025081595996,0.780895864368431,2,18,endothelial cell chemotaxis,BP,FGFR1;TMSB4X
188,GO:0000405,0.494025262480259,0.86812016042812,1,7,bubble DNA binding,MF,XPC
6124,GO:0019372,0.494207303109205,0.864059972362505,1,9,lipoxygenase pathway,BP,ALOX15B
2591,GO:0005885,0.494209457870041,0.86269010077082,1,10,Arp2/3 protein complex,CC,ARPC1A
4835,GO:0014041,0.494250125136707,0.867982297735459,1,7,regulation of neuron maturation,BP,RET
14175,GO:0061061,0.494443598639399,0.577185247980498,35,378,muscle structure development,BP,FHL1;NOS1;FLNC;NEURL1;NFATC4;ADARB1;DDIT3;CAPN2;MYH15;SDC1;DKK1;PAK1;TGFBR2;OBSCN;FKBP1A;FGFR1;TMOD2;OBSL1;MMP14;CTH;MYOF;AEBP1;CHD7;PRKAR1A;THRA;RNF165;MEF2D;XBP1;ETV1;IGF2;LAMA5;TBX1;FLNB;ARID5B;JARID2
2972,GO:0006511,0.494654185026316,0.569365573752476,44,513,ubiquitin-dependent protein catabolic process,BP,SMURF2;EDEM1;GID4;BTBD2;HECW2;WWTR1;DDIT3;PSMD2;UBE2J1;UBXN4;TRIB2;RBCK1;ABTB1;UBE2G1;BTRC;RMND5A;FBXO2;DVL1;MVB12B;TRIB3;DNAJB9;BTBD3;PSMD7;MVB12A;MTA1;RNF165;XBP1;ARRDC1;ANKIB1;UBE2E1;SEL1L;TBL1X;ERLEC1;USP20;WFS1;USP32;MAGEF1;RNF180;RNF103;USP25;UFL1;KLHL15;STT3B;FBXL5
1355,GO:0003223,0.494815772494344,0.870641815298237,1,6,ventricular compact myocardium morphogenesis,BP,CHD7
13868,GO:0060485,0.494841886199957,0.612759307483073,15,163,mesenchyme development,BP,ACTA2;WWTR1;SEMA4B;TGFBR2;EDNRA;PKD2;HMGA2;FGFR1;RET;LOXL2;LAMA5;ALDH1A2;TBX1;LRP6;SEMA3F
4342,GO:0009894,0.494884114213676,0.558068549998424,66,768,regulation of catabolic process,BP,SMURF2;EDEM1;SORL1;SERPINE2;HECW2;RAPGEF3;TRIM65;PSMD2;EGFR;TBC1D14;FYN;BNIP3;UBE2J1;SNX9;TYSND1;IGF2BP3;SPTLC2;DAP;TRIB2;PTPN3;APOE;BNIP3L;LRP1;FYCO1;IDE;PPARA;BTRC;LPCAT1;ULK2;LONP2;SH3D19;XRN1;TNRC6B;DVL1;CST3;TRIB3;VPS11;MLYCD;RASIP1;CSNK2A1;PSMD7;QSOX1;BOK;THRA;AZIN2;XBP1;PAIP1;ANKIB1;GABARAPL2;EPM2A;PUM2;PRKACA;TIMP2;IFI16;ERLEC1;SNX6;ATP6V1B2;ADAM8;ENDOG;MAGEF1;RNF180;TNRC6C;USP25;UFL1;RB1CC1;FBXL5
4870,GO:0014731,0.494955234918079,0.870557804189321,1,6,spectrin-associated cytoskeleton,CC,ANK3
15379,GO:0071621,0.495035447296114,0.705212809508114,4,48,granulocyte chemotaxis,BP,RAC2;ITGA1;MOSPD2;CKLF
15292,GO:0071476,0.495055180152002,0.867487946057282,1,7,cellular hypotonic response,BP,STK39
12164,GO:0048278,0.495713987302371,0.685526807834933,5,56,vesicle docking,BP,RAB3B;EXOC2;SNPH;VPS11;STX10
2441,GO:0005641,0.496308008178688,0.866716222453106,1,7,nuclear envelope lumen,CC,SORL1
1889,GO:0004571,0.496805972326495,0.866408666433766,1,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,EDEM1
18007,GO:1902475,0.497014379491593,0.733087723089358,3,30,L-alpha-amino acid transmembrane transport,BP,NTSR1;SLC43A1;SLC7A11
11365,GO:0045724,0.49706215512108,0.778472012991354,2,18,positive regulation of cilium assembly,BP,CEP120;CCDC88A
3674,GO:0008171,0.497494263144274,0.776197652233426,2,21,O-methyltransferase activity,MF,PCMTD2;CMTR2
13016,GO:0051451,0.497596485281357,0.863661013425578,1,8,myoblast migration,BP,NET1
8418,GO:0033483,0.497599576232119,0.863659070598248,1,8,gas homeostasis,BP,ADNP
15711,GO:0072257,0.497650311425607,0.868927236334323,1,6,metanephric nephron tubule epithelial cell differentiation,BP,WWTR1
15735,GO:0072307,0.497650311425607,0.868927236334323,1,6,regulation of metanephric nephron tubule epithelial cell differentiation,BP,WWTR1
14747,GO:0070417,0.497886399598437,0.865739763174391,1,7,cellular response to cold,BP,DNAJC3
8034,GO:0032680,0.49791262370366,0.668691217128848,6,67,regulation of tumor necrosis factor production,BP,NFATC4;UBE2J1;ARG2;ACP5;FOXP1;FADD
5384,GO:0016208,0.498385971893359,0.861415022255923,1,9,AMP binding,MF,PYGL
2000,GO:0004723,0.498438663752086,0.865397002350686,1,7,calcium-dependent protein serine/threonine phosphatase activity,MF,PPP3CB
10574,GO:0043536,0.498472900765927,0.703525738122643,4,41,positive regulation of blood vessel endothelial cell migration,BP,FGFR1;TMSB4X;SRPX2;AKT3
396,GO:0001067,0.498833851362293,0.558973220096174,55,609,regulatory region nucleic acid binding,MF,ZMYND8;ETV5;NR1D1;NFATC4;ZC3H6;ETV4;SALL2;POU2F2;TEF;DDIT3;SOX12;ELK3;HLTF;ZNF516;DDN;HMGA2;ATF4;PPARA;TCFL5;NFAT5;SOX4;ZNF692;RCOR1;HES2;PHF12;ZNF704;ZNF322;RFX2;PRDX5;CEBPG;PLAG1;AEBP1;CHD7;NACC2;THRA;PER3;MTA1;MEF2D;XBP1;SATB1;ETV1;IFI16;NR2F6;TBL1X;ARID4A;PPARG;CREB3L2;PHF21A;ZNF568;ARID5B;E2F7;KAT2B;PBX3;JARID2;RFX7
4699,GO:0010857,0.498943815034243,0.862812423709572,1,8,calcium-dependent protein kinase activity,MF,MAPKAPK3
17706,GO:1901615,0.498947955332263,0.580537862917348,28,327,organic hydroxy compound metabolic process,BP,SORL1;PCK2;VLDLR;CYP27B1;NR1D1;LMF1;PSAT1;ISYNA1;SPTLC2;RDH14;HAGH;PLPP6;APOE;LDHA;FGFR1;ABCG1;NTSR1;LRP5;INPP4A;HSD17B7;TRPC1;OSBPL5;SRD5A3;ALDH1A2;PLCH2;RNF180;COQ2;AMACR
11421,GO:0045834,0.499180018832117,0.655912164895424,7,77,positive regulation of lipid metabolic process,BP,NR1D1;APOE;PPARA;ABCG1;MLYCD;ABHD6;PPARG
11275,GO:0045580,0.499680145947573,0.655257646154936,7,79,regulation of T cell differentiation,BP,RAG1;TGFBR2;CD46;XBP1;CARD11;AP3D1;ADAM8
15607,GO:0072091,0.499958907767495,0.702432365747277,4,40,regulation of stem cell proliferation,BP,HMGA2;EPCAM;FERMT1;EIF2AK2
5053,GO:0015248,0.500056970100104,0.774705068505121,2,20,sterol transporter activity,MF,APOE;ABCG1
2251,GO:0005165,0.50027355050111,0.864254053009156,1,7,neurotrophin receptor binding,MF,SHC1
2253,GO:0005167,0.50027355050111,0.864254053009156,1,7,neurotrophin TRK receptor binding,MF,SHC1
5912,GO:0018158,0.500409280589039,0.860122357721579,1,9,protein oxidation,BP,LOXL2
13564,GO:0060027,0.500435284657791,0.864153003633451,1,7,convergent extension involved in gastrulation,BP,DVL1
9612,GO:0036475,0.50043581379783,0.775042487223821,2,19,neuron death in response to oxidative stress,BP,ATF4;ENDOG
11257,GO:0045499,0.50084971123519,0.776239099124792,2,17,chemorepellent activity,MF,SEMA4B;SEMA3F
12781,GO:0051056,0.500928701278468,0.581997785012361,26,266,regulation of small GTPase mediated signal transduction,BP,F2R;ASAP2;ARHGAP22;APPL2;ARHGAP12;ARAP1;NET1;GDI1;RASA3;RALGAPA2;RAC2;OBSCN;APOE;RALGAPA1;DNMBP;F2RL1;ASAP1;SPRY2;PSD3;RGL2;TIMP2;RHOBTB1;LPAR1;ARHGAP29;ACAP2;RALGPS2
9412,GO:0035973,0.501020264515742,0.863787102108823,1,7,aggrephagy,BP,WDFY3
6464,GO:0021785,0.501161269752337,0.866782768930266,1,6,branchiomotor neuron axon guidance,BP,SEMA3F
5103,GO:0015386,0.501515157492458,0.863477042653755,1,7,potassium:proton antiporter activity,MF,SLC9A7
16946,GO:0098927,0.501575043059581,0.70073003774184,4,41,vesicle-mediated transport between endosomal compartments,BP,SORL1;MAP2K1;VPS11;MAP2K2
12845,GO:0051155,0.501590069058638,0.728425790811715,3,32,positive regulation of striated muscle cell differentiation,BP,MMP14;THRA;TBX1
5572,GO:0016589,0.501895820884035,0.863238233727408,1,7,NURF complex,CC,SMARCA1
10472,GO:0043353,0.501907102727872,0.863231151868037,1,7,enucleate erythrocyte differentiation,BP,CEBPG
14686,GO:0070301,0.501910143066307,0.664631769941255,6,70,cellular response to hydrogen peroxide,BP,BNIP3;MAPK13;NET1;IMPACT;CST3;ENDOG
9839,GO:0042074,0.502089032818969,0.866212244534597,1,6,cell migration involved in gastrulation,BP,LRP5
2002,GO:0004726,0.502139199014678,0.86078603969715,1,8,non-membrane spanning protein tyrosine phosphatase activity,MF,PTPN12
7844,GO:0032401,0.502372712387185,0.772827543450687,2,20,establishment of melanosome localization,BP,BBS2;RAB1A
13242,GO:0051905,0.502372712387185,0.772827543450687,2,20,establishment of pigment granule localization,BP,BBS2;RAB1A
7163,GO:0031033,0.502460469528555,0.870381942132699,1,5,myosin filament organization,BP,OBSL1
18028,GO:1902531,0.502649201030904,0.538662633635628,115,1313,regulation of intracellular signal transduction,BP,TNIP1;XDH;NOS1;F2R;SORL1;ASAP2;SERPINE2;IGFBP4;PRNP;MAP2K1;PKN1;MST1R;ARHGAP22;TNFSF15;APPL2;DDIT3;EGFR;STK39;ARHGAP12;FYN;ERCC6;ARAP1;DLG1;NET1;TGM2;WNT7A;MAP4K4;GDI1;SHC1;DKK1;PAK1;RASA3;SOCS2;TRIB2;EPHA1;RALGAPA2;RAC2;CD44;OBSCN;APOE;FKBP1A;RGS14;PKD2;RBCK1;ABCA7;WWC3;LPAR3;FGFR1;ITGA1;NFAT5;BTRC;PTK6;INPP5F;CEACAM1;MAPKAPK3;UACA;FAM110C;NLK;TRIM5;RALGAPA1;CTH;DNMBP;TRIB3;RANBP9;F2RL1;DDX60;TAOK1;CSNK2A1;ASAP1;JMY;BOK;PARP9;C18ORF32;NACC2;SPRY2;NGFR;BCL2L1;XBP1;MAP2K2;RET;PDE5A;C5;EPM2A;PAK6;PUM2;PSD3;TMED4;SHC2;PRKACA;NEK6;RGL2;TMSB4X;TIMP2;EIF2AK2;RHOBTB1;CARD11;LPAR1;IGF2;PJA2;MAP4K2;ARHGAP29;TBX1;ADAM8;AKT3;WFS1;ACAP2;FZD8;HPSE;RCAN1;ANKRD6;RALGPS2;GNAI1;RB1CC1;TRIM38;FADD
9883,GO:0042157,0.502665991366469,0.621999307996274,11,131,lipoprotein metabolic process,BP,LY6K;APOE;LRP1;PPARA;PIGH;ABHD17C;NTNG1;ZDHHC2;LYPLAL1;ZDHHC1;LYPLA1
6957,GO:0030594,0.502668043278459,0.772004498644835,2,21,neurotransmitter receptor activity,MF,HTR7;GRIN3B
12554,GO:0050706,0.502716495035812,0.772548079718476,2,20,regulation of interleukin-1 beta secretion,BP,ARG2;FOXP1
8016,GO:0032649,0.502721061292061,0.69845271661629,4,47,regulation of interferon-gamma production,BP,PRNP;CEBPG;IL20RB;FADD
8595,GO:0034097,0.502822338521346,0.550057027585854,66,814,response to cytokine,BP,CCND1;PCK2;MMP1;CYP27B1;BBS2;POSTN;MST1R;TNFSF15;PSMD2;FYN;TNFRSF6B;MAPK13;ADAMTS7;SDC1;SHC1;SOCS2;LCN2;CD44;FKBP1A;ACP5;PTPN12;RBCK1;HYAL1;BTRC;MTHFR;CEACAM1;MAPKAPK3;MT2A;TRIM5;EPOR;CTH;CASP4;PPP3CB;RFX2;F2RL1;PSMD7;PARP9;SPRY2;NGFR;PTPRZ1;BCL2L1;IFITM1;YTHDC2;XBP1;TLE4;RAB43;COL1A2;PRKACA;TMSB4X;TIMP2;EIF2AK2;IL1RAP;LAMA5;AGPAT1;PPARG;ALDH1A2;IL20RB;ENDOG;ITGA4;FLNB;ARID5B;TMEM173;OAS1;JARID2;TRIM38;FADD
15900,GO:0072666,0.502876043748459,0.699799686942664,4,40,establishment of protein localization to vacuole,BP,SORL1;VPS13A;AP3D1;TMEM50B
3281,GO:0006959,0.503018085622459,0.662540650235254,6,82,humoral immune response,BP,PRSS3;POU2F2;SERPING1;LCN2;CD46;C5
3576,GO:0007620,0.50304143973601,0.860210337336102,1,8,copulation,BP,SERPINE2
7812,GO:0032365,0.503065280761909,0.72821035957211,3,29,intracellular lipid transport,BP,ABCG1;CPT2;LRP6
7517,GO:0031702,0.503548532340147,0.862198209946243,1,7,type 1 angiotensin receptor binding,MF,ARAP1
14691,GO:0070306,0.503585550727457,0.773215768031324,2,18,lens fiber cell differentiation,BP,WNT7A;SLC7A11
12981,GO:0051384,0.503685670535787,0.64179457968918,8,92,response to glucocorticoid,BP,CCND1;PCK2;EIF4EBP1;EGFR;SDC1;ANXA3;GLB1;IGFBP7
15760,GO:0072350,0.503750170937335,0.72593107144383,3,34,tricarboxylic acid metabolic process,BP,DHTKD1;IDH2;GLUD1
10010,GO:0042430,0.503949899621757,0.859629086694088,1,8,indole-containing compound metabolic process,BP,RNF180
5656,GO:0016755,0.504010869486067,0.857801867386751,1,9,transferase activity, transferring amino-acyl groups,MF,TGM2
10808,GO:0044294,0.504292880463061,0.861728103413854,1,7,dendritic growth cone,CC,PTCH1
2937,GO:0006458,0.50440235333121,0.697110145464775,4,46,'de novo' protein folding,BP,FKBP1A;FYCO1;HSPA13;HSPA2
9033,GO:0035247,0.504423924670024,0.857534135425922,1,9,peptidyl-arginine omega-N-methylation,BP,PRMT3
13258,GO:0051937,0.505080611404465,0.770621100841639,2,20,catecholamine transport,BP,RAB3B;SLC18A2
19482,GO:1990247,0.505194231824399,0.861157421200663,1,7,N6-methyladenosine-containing RNA binding,MF,YTHDC2
4055,GO:0009100,0.505224689906691,0.575849803821406,27,307,glycoprotein metabolic process,BP,TNIP1;EDEM1;LMF1;B4GALT6;UBE2J1;ADAMTS7;B3GNT3;MCFD2;ST3GAL5;ABCA7;HYAL1;GALNT3;FBXO2;LMAN1;CST3;GFPT1;PCSK6;ADAMTSL1;RAB1A;SEL1L;SRD5A3;ST6GALNAC2;ERP44;HPSE;TET1;RNF103;STT3B
13067,GO:0051570,0.505364546657734,0.772590651931322,2,17,regulation of histone H3-K9 methylation,BP,ATRX;JARID2
20267,GO:2001235,0.505458660325618,0.613933199565514,12,150,positive regulation of apoptotic signaling pathway,BP,NFATC4;DDIT3;BNIP3;RBCK1;BOK;NACC2;BCL2L1;RET;MOAP1;DEDD2;FAM162A;FADD
10069,GO:0042562,0.505466543020731,0.696749247649081,4,43,hormone binding,MF,EGFR;SHC1;IDE;THRA
20283,GO:2001256,0.505501079352181,0.858632937260853,1,8,regulation of store-operated calcium entry,BP,SARAF
10051,GO:0042533,0.505554818864371,0.858598343169774,1,8,tumor necrosis factor biosynthetic process,BP,UBE2J1
10052,GO:0042534,0.505554818864371,0.858598343169774,1,8,regulation of tumor necrosis factor biosynthetic process,BP,UBE2J1
4563,GO:0010644,0.505583946675504,0.770862344343133,2,19,cell communication by electrical coupling,BP,ANK3;PRKACA
2929,GO:0006446,0.506223845485083,0.660581966935778,6,70,regulation of translational initiation,BP,EIF4EBP1;IMPACT;ATF4;PAIP1;EIF2AK2;DNAJC3
5538,GO:0016525,0.506578282656467,0.661334701708309,6,61,negative regulation of angiogenesis,BP,THBS2;EPN2;ADGRB2;SPRY2;NGFR;PPARG
1159,GO:0002768,0.506749164475682,0.58458048724278,21,251,immune response-regulating cell surface receptor signaling pathway,BP,PRNP;PAG1;PSMD2;FCGRT;WIPF1;FYN;SHC1;PAK1;PRKACB;RBCK1;BTRC;CEACAM1;PPP3CB;PSMD7;WASF2;NCKAP1;PRKACA;SLC39A10;CARD11;ARPC1A;WASL
17692,GO:1901570,0.506944499040331,0.674744313889429,5,59,fatty acid derivative biosynthetic process,BP,LTA4H;ELOVL1;CBR4;PPT2;HSD17B12
16417,GO:0097050,0.507060170908094,0.857627023263791,1,8,type B pancreatic cell apoptotic process,BP,WFS1
20050,GO:2000674,0.507060170908094,0.857627023263791,1,8,regulation of type B pancreatic cell apoptotic process,BP,WFS1
8623,GO:0034139,0.507202810599834,0.857534758191545,1,8,regulation of toll-like receptor 3 signaling pathway,BP,F2RL1
10641,GO:0043650,0.507435328320512,0.857384271822842,1,8,dicarboxylic acid biosynthetic process,BP,GLUD1
6723,GO:0030134,0.507458504929633,0.659634556161116,6,68,COPII-coated ER to Golgi transport vesicle,CC,SEC23A;MCFD2;LMAN1;TMED4;CTSZ;DDHD2
19450,GO:1990124,0.507734659454707,0.859540590998432,1,7,messenger ribonucleoprotein complex,CC,CPEB4
3089,GO:0006662,0.507818916296964,0.855321028106864,1,9,glycerol ether metabolic process,BP,TMEM86B
14491,GO:0061900,0.507824317543818,0.770589015281203,2,17,glial cell activation,BP,EGFR;LRP1
7850,GO:0032410,0.507911248076081,0.694747655965073,4,42,negative regulation of transporter activity,BP,HECW2;STK39;ANK3;PKD2
768,GO:0002020,0.508144603970467,0.637754965162214,8,89,protease binding,MF,PRNP;TYSND1;LRP1;LONP2;CST3;COL1A2;TIMP2;FADD
16998,GO:0099081,0.508153315312497,0.549738563838503,55,604,supramolecular polymer,CC,NOS1;FLNC;SCN8A;CLIP2;LTBP1;THSD4;MAP1B;SNTB2;WIPF1;SNPH;ANK3;FYN;MYH15;KIF13B;PARVB;DLG1;ESPN;PAK1;CEP170;SHANK2;RAC2;OBSCN;FKBP1A;RGS14;PKD2;KIF21B;TMOD2;FERMT1;OBSL1;LMAN1;FAM110C;DVL1;MAP6;TWF2;CST3;PPP3CB;SPRY2;BEX4;ENKD1;COL6A1;MTA1;MAP2K2;TUBG2;NAV1;NCKAP1;COL1A2;CCSAP;NEK6;TMSB4X;TBL1X;WASL;FLNB;PSEN2;KAT2B;REEP3
14692,GO:0070307,0.5083391281397,0.856798332233089,1,8,lens fiber cell development,BP,WNT7A
508,GO:0001570,0.508730100997375,0.674688567714565,5,49,vasculogenesis,BP,XDH;WNT7A;TGFBR2;CEACAM1;RASIP1
13834,GO:0060433,0.508834199453973,0.856476701088481,1,8,bronchus development,BP,TGFBR2
1127,GO:0002716,0.508895282436904,0.854614680195385,1,9,negative regulation of natural killer cell mediated immunity,BP,CEACAM1
5630,GO:0016709,0.50895049604505,0.767447234316848,2,20,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,NOS1;CYP27B1
9974,GO:0042362,0.509074080886859,0.854497127013564,1,9,fat-soluble vitamin biosynthetic process,BP,CYP27B1
7940,GO:0032528,0.509074368530596,0.768739881087459,2,18,microvillus organization,BP,PODXL;TWF2
1893,GO:0004576,0.50927984540984,0.852910462737212,1,10,oligosaccharyl transferase activity,MF,STT3B
5683,GO:0016798,0.509407568336788,0.645615641659278,7,84,hydrolase activity, acting on glycosyl bonds,MF,EDEM1;CEMIP;ABHD10;HYAL1;CTBS;GLB1;HPSE
1105,GO:0002694,0.509442733564778,0.576262261698837,24,284,regulation of leukocyte activation,BP,PRNP;PAG1;PKN1;FYN;DLG1;ARG2;PAK1;RAG1;TGFBR2;RAC2;CEACAM1;MMP14;CD46;F2RL1;PRKAR1A;XBP1;PDE5A;SLC39A10;CARD11;AP3D1;IGF2;ADAM8;IL20RB;FADD
252,GO:0000715,0.509493199877977,0.765382081061499,2,23,nucleotide-excision repair, DNA damage recognition,BP,XPC;DDB2
7380,GO:0031432,0.509524030591468,0.858394305898587,1,7,titin binding,MF,OBSCN
8601,GO:0034109,0.509816415703678,0.672794299401883,5,54,homotypic cell-cell adhesion,BP,SERPINE2;ANK3;CEACAM1;UBASH3B;SLC7A11
12424,GO:0048872,0.510076275117225,0.597639104725872,15,172,homeostasis of number of cells,BP,F2R;FAM210B;PKN1;RAG1;L3MBTL3;PPP3CB;CEBPG;THRA;ACVR1B;DOCK11;CARD11;ARID4A;AKT3;IL20RB;FADD
1702,GO:0004185,0.510122714689053,0.855637358125708,1,8,serine-type carboxypeptidase activity,MF,AEBP1
3009,GO:0006554,0.51031417128469,0.855512366328745,1,8,lysine catabolic process,BP,ALDH7A1
7113,GO:0030913,0.510369774991996,0.857850361662343,1,7,paranodal junction assembly,BP,EPB41L3
3361,GO:0007097,0.510410894447426,0.769415435665314,2,16,nuclear migration,BP,FHOD1;CEP120
10609,GO:0043587,0.510435140836721,0.855433354856387,1,8,tongue morphogenesis,BP,TBX1
18021,GO:1902514,0.510484726358563,0.857776323232683,1,7,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1
18403,GO:1903431,0.510682827334876,0.857648669286087,1,7,positive regulation of cell maturation,BP,RET
6844,GO:0030309,0.510774863656096,0.853375792163065,1,9,poly-N-acetyllactosamine metabolic process,BP,B3GNT3
6845,GO:0030311,0.510774863656096,0.853375792163065,1,9,poly-N-acetyllactosamine biosynthetic process,BP,B3GNT3
4097,GO:0009151,0.510778179017579,0.851913954059414,1,10,purine deoxyribonucleotide metabolic process,BP,AK9
3298,GO:0006995,0.510944231078511,0.85180324378709,1,10,cellular response to nitrogen starvation,BP,GABARAPL2
10595,GO:0043562,0.510944231078511,0.85180324378709,1,10,cellular response to nitrogen levels,BP,GABARAPL2
7333,GO:0031343,0.511004412375756,0.764618353502474,2,22,positive regulation of cell killing,BP,F2RL1;FADD
12322,GO:0048672,0.51115107762203,0.853126984781249,1,9,positive regulation of collateral sprouting,BP,LPAR3
16138,GO:0090140,0.511702268781197,0.765838548805587,2,19,regulation of mitochondrial fission,BP,BNIP3;DDHD2
15107,GO:0071156,0.511854538605461,0.633633894370928,8,97,regulation of cell cycle arrest,BP,CCND1;PKD2;HMGA2;SOX4;UHRF2;PRKACA;E2F7;CNOT11
10249,GO:0042983,0.511888338623985,0.852638592489079,1,9,amyloid precursor protein biosynthetic process,BP,ABCA7
10250,GO:0042984,0.511888338623985,0.852638592489079,1,9,regulation of amyloid precursor protein biosynthetic process,BP,ABCA7
16565,GO:0097345,0.512198941865574,0.689455155118238,4,49,mitochondrial outer membrane permeabilization,BP,BNIP3;BNIP3L;BOK;MOAP1
12254,GO:0048534,0.512392943773524,0.546843843171995,52,620,hematopoietic or lymphoid organ development,BP,ERCC1;CTNNBIP1;MAP2K1;FAM210B;PKN1;POU2F2;DHTKD1;PSMD2;GLO1;RAG1;TGFBR2;CMTM7;FAM20C;SOX4;CEACAM1;TNRC6B;MMP14;CD46;LRP5;L3MBTL3;DNAJB9;PPP3CB;CEBPG;F2RL1;PSMD7;CHD7;THRA;WNT2B;ACVR1B;PTPRZ1;WASF2;XBP1;UBASH3B;SATB1;RET;DOCK11;EIF2AK2;IFI16;CARD11;HOXA3;AP3D1;ARID4A;PPARG;TBX1;ADAM8;ITGA4;FZD8;TNRC6C;FOXP1;KAT2B;JARID2;FADD
15371,GO:0071609,0.51243613990492,0.854122245201916,1,8,chemokine (C-C motif) ligand 5 production,BP,ARG2
10983,GO:0044774,0.512473170352847,0.625282665530074,9,105,mitotic DNA integrity checkpoint,BP,CCND1;BRSK1;XPC;HMGA2;SOX4;TAOK1;PPP1R10;E2F7;CNOT11
10076,GO:0042574,0.512578681665821,0.854028548499397,1,8,retinal metabolic process,BP,ALDH1A2
7030,GO:0030803,0.512669556576324,0.853968793051408,1,8,negative regulation of cyclic nucleotide biosynthetic process,BP,AKAP9
7045,GO:0030818,0.512669556576324,0.853968793051408,1,8,negative regulation of cAMP biosynthetic process,BP,AKAP9
4752,GO:0010923,0.51272544185648,0.643255911089782,7,75,negative regulation of phosphatase activity,BP,PPP1R14A;DLG3;FKBP1A;ELFN2;PPP1R35;PPP1R10;PPP1R2
7606,GO:0031987,0.513200565135533,0.856019625675419,1,7,locomotion involved in locomotory behavior,BP,PPP3CB
253,GO:0000717,0.513380716314214,0.762642549874191,2,22,nucleotide-excision repair, DNA duplex unwinding,BP,XPC;DDB2
6890,GO:0030422,0.513636368214849,0.851476339190917,1,9,production of siRNA involved in RNA interference,BP,RMRP
20270,GO:2001238,0.513779030129037,0.688537387518024,4,46,positive regulation of extrinsic apoptotic signaling pathway,BP,RBCK1;RET;DEDD2;FADD
19863,GO:2000341,0.51378032534633,0.8499039324716,1,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,POSTN
7256,GO:0031223,0.513792813669237,0.858874942171986,1,6,auditory behavior,BP,SLITRK6
11581,GO:0046134,0.513913572760527,0.761254225092645,2,24,pyrimidine nucleoside biosynthetic process,BP,TK2;NME4
6780,GO:0030215,0.513922694613732,0.765583924928439,2,17,semaphorin receptor binding,MF,SEMA4B;SEMA3F
19890,GO:2000379,0.513961039844784,0.668467636641835,5,57,positive regulation of reactive oxygen species metabolic process,BP,XDH;EGFR;TGFBR2;PKD2;F2RL1
14880,GO:0070665,0.51397545644576,0.652859312290437,6,74,positive regulation of leukocyte proliferation,BP,TGFBR2;CD46;SLC39A10;CARD11;IGF2;FADD
10271,GO:0043011,0.514072838286336,0.851185190406366,1,9,myeloid dendritic cell differentiation,BP,TGFBR2
10635,GO:0043632,0.514108497294305,0.549356456987276,45,530,modification-dependent macromolecule catabolic process,BP,SMURF2;EDEM1;GID4;BTBD2;HECW2;WWTR1;DDIT3;PSMD2;UBE2J1;UBXN4;TRIB2;RBCK1;ABTB1;UBE2G1;BTRC;RMND5A;FBXO2;DVL1;MVB12B;TRIB3;DNAJB9;BTBD3;PSMD7;MVB12A;MTA1;RNF165;PCYOX1;XBP1;ARRDC1;ANKIB1;UBE2E1;SEL1L;TBL1X;ERLEC1;USP20;WFS1;USP32;MAGEF1;RNF180;RNF103;USP25;UFL1;KLHL15;STT3B;FBXL5
12206,GO:0048384,0.514277043469677,0.762438220801671,2,21,retinoic acid receptor signaling pathway,BP,ALDH1A2;TBX1
11350,GO:0045682,0.514663283726778,0.652820771882954,6,68,regulation of epidermis development,BP,CYP27B1;ALOX15B;FERMT1;CTSL;HPSE;PTCH1
17827,GO:1901985,0.51473839675212,0.71650761914201,3,33,positive regulation of protein acetylation,BP,NOS1;RAPGEF3;SOX4
16890,GO:0098831,0.514833977282066,0.862828095698529,1,5,presynaptic active zone cytoplasmic component,CC,RIMS3
12080,GO:0048029,0.51515584571994,0.687269451868697,4,46,monosaccharide binding,MF,PYGL;SLC2A3;LMAN1;BSG
12912,GO:0051258,0.515268019727029,0.583446447075,18,206,protein polymerization,BP,WIPF1;DLG1;PAK1;RAC2;AKAP9;TMOD2;PFN2;TWF2;RANBP9;WASF3;MSRB2;JMY;SPIRE1;TUBG2;NCKAP1;TMSB4X;ARPC1A;WASL
929,GO:0002327,0.515523327982913,0.857767768367407,1,6,immature B cell differentiation,BP,RAG1
8137,GO:0032836,0.515651564430449,0.854421884466384,1,7,glomerular basement membrane development,BP,LAMB2
15332,GO:0071548,0.515651887324615,0.715692238638739,3,33,response to dexamethasone,BP,PCK2;EIF4EBP1;EGFR
16997,GO:0099080,0.515690098988382,0.542224809697983,55,605,supramolecular complex,CC,NOS1;FLNC;SCN8A;CLIP2;LTBP1;THSD4;MAP1B;SNTB2;WIPF1;SNPH;ANK3;FYN;MYH15;KIF13B;PARVB;DLG1;ESPN;PAK1;CEP170;SHANK2;RAC2;OBSCN;FKBP1A;RGS14;PKD2;KIF21B;TMOD2;FERMT1;OBSL1;LMAN1;FAM110C;DVL1;MAP6;TWF2;CST3;PPP3CB;SPRY2;BEX4;ENKD1;COL6A1;MTA1;MAP2K2;TUBG2;NAV1;NCKAP1;COL1A2;CCSAP;NEK6;TMSB4X;TBL1X;WASL;FLNB;PSEN2;KAT2B;REEP3
13769,GO:0060347,0.515708345876676,0.851961256027847,1,8,heart trabecula formation,BP,FKBP1A
685,GO:0001895,0.516000149654232,0.715381071316858,3,33,retina homeostasis,BP,BBS2;ERCC6;TUB
15201,GO:0071346,0.516371719334957,0.62122701721193,9,110,cellular response to interferon-gamma,BP,CD44;MT2A;TRIM5;PARP9;RAB43;PPARG;FLNB;OAS1;TRIM38
795,GO:0002063,0.51642126024937,0.763515681124912,2,17,chondrocyte development,BP,TGFBR2;MEX3C
1410,GO:0003344,0.516500316527647,0.857140131537817,1,6,pericardium morphogenesis,BP,LRP6
14037,GO:0060766,0.516568956630077,0.851389391872175,1,8,negative regulation of androgen receptor signaling pathway,BP,FOXP1
4072,GO:0009125,0.516705004463484,0.849421379691073,1,9,nucleoside monophosphate catabolic process,BP,NT5E
9550,GO:0036310,0.516707586320819,0.851297137158421,1,8,annealing helicase activity,MF,SMARCA1
13927,GO:0060589,0.516791390128191,0.566045208138513,26,284,nucleoside-triphosphatase regulator activity,MF,DOCK4;ASAP2;ARHGAP22;APPL2;TBC1D14;RIN2;ARHGAP12;ARAP1;EVI5L;GDI1;RASA3;RALGAPA2;RGS14;SRGAP2B;RALGAPA1;ASAP1;USP6NL;TBC1D2B;RIN1;ARHGAP29;EVI5;DEPDC1;ACAP2;TBC1D16;WASL;RALGDS
6769,GO:0030203,0.516808119021026,0.61456836119668,10,111,glycosaminoglycan metabolic process,BP,B4GALT6;B3GNT3;GPC4;CEMIP;SDC1;CD44;HYAL1;GLB1;HPSE;GALNS
11882,GO:0046889,0.516990674721514,0.685772594516404,4,45,positive regulation of lipid biosynthetic process,BP,NR1D1;APOE;ABCG1;ABHD6
6821,GO:0030279,0.517285267552674,0.686389247105892,4,41,negative regulation of ossification,BP,DKK1;LRP5;PTCH1;LRP4
13877,GO:0060502,0.517615198045366,0.850692201717431,1,8,epithelial cell proliferation involved in lung morphogenesis,BP,MAP2K1
1990,GO:0004711,0.517695088346999,0.85308075712212,1,7,ribosomal protein S6 kinase activity,MF,RPS6KA2
3433,GO:0007221,0.517758391187239,0.763364267676725,2,16,positive regulation of transcription of Notch receptor target,BP,MAML3;KAT2B
4035,GO:0009067,0.517916067373442,0.759394170968769,2,21,aspartate family amino acid biosynthetic process,BP,ASNS;CTH
11346,GO:0045669,0.518081724000595,0.685654042977595,4,41,positive regulation of osteoblast differentiation,BP,CTNNBIP1;ACVR2B;FAM20C;IFITM1
16280,GO:0090344,0.518141347047512,0.760485234117321,2,19,negative regulation of cell aging,BP,HMGA2;AKT3
16118,GO:0090101,0.518147577396622,0.638166046560846,7,74,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,SMURF2;LTBP1;HTRA1;DKK1;TGFBR2;MTMR4;SNX6
14122,GO:0060982,0.518435318706202,0.852592928038651,1,7,coronary artery morphogenesis,BP,TBX1
15125,GO:0071214,0.518759315681247,0.575045783501556,20,231,cellular response to abiotic stimulus,BP,ERCC1;NFATC4;EGFR;STK39;BNIP3;MAPK13;NET1;XPC;IMPACT;CCND2;PKD2;HMGA2;ATF4;HYAL1;ITGA2;DDB2;BCL2L1;SLC38A2;IFI16;FADD
17187,GO:0104004,0.518759315681247,0.575045783501556,20,231,cellular response to environmental stimulus,BP,ERCC1;NFATC4;EGFR;STK39;BNIP3;MAPK13;NET1;XPC;IMPACT;CCND2;PKD2;HMGA2;ATF4;HYAL1;ITGA2;DDB2;BCL2L1;SLC38A2;IFI16;FADD
15266,GO:0071439,0.51875944313558,0.849927214624848,1,8,clathrin complex,CC,CLTCL1
18153,GO:1902895,0.518963766822,0.759796572598076,2,19,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,APLN;NGFR
12342,GO:0048703,0.519033689169652,0.852197796965528,1,7,embryonic viscerocranium morphogenesis,BP,TBX1
10573,GO:0043535,0.51907341564254,0.648978372402826,6,65,regulation of blood vessel endothelial cell migration,BP,APOE;FGFR1;TMSB4X;PPARG;SRPX2;AKT3
9737,GO:0038191,0.519189007181545,0.761212596534036,2,17,neuropilin binding,MF,SEMA4B;SEMA3F
296,GO:0000800,0.51924145106987,0.852060436794625,1,7,lateral element,CC,REC8
16722,GO:0097718,0.519391842621736,0.713378097070996,3,30,disordered domain specific binding,MF,FYN;AP2A2;HSPA2
10355,GO:0043167,0.519503417985914,0.507566155246413,382,4366,ion binding,MF,FHL1;XDH;NT5E;EDEM1;NOS1;ZMYND8;ADAM19;RAB3B;PGF;NEURL1;PCK2;VLDLR;PYGL;ASAP2;CBS;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;SERPINE2;PRSS3;ADCY7;CRYL1;PRNP;ACTA2;POSTN;GPT2;NR1D1;ZC3H6;ADARB1;MAP2K1;THBS2;LTBP2;RAPGEF3;ACVR2B;ANTXR2;LTBP1;ZKSCAN1;ALOX15B;SALL2;COL13A1;TK2;PKN1;PEG3;MST1R;MARCH9;TRIM65;DHTKD1;PITPNC1;DGKA;ZKSCAN2;PC;PTPRS;B4GALT6;SMARCA1;HADH;CARS;LTA4H;CAPN2;BRSK1;EGFR;STK39;DYSF;CGREF1;LOXL1;FYN;MYH15;OSBPL10;PCDHAC2;JADE2;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;ARAP1;PGM1;ADAMTS7;ZNF516;IDH2;GPC4;DHX32;SNX9;ZSCAN30;TGM2;GLUL;GLO1;FKBP9;ACSF2;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;RSAD1;GRK5;HTR7;NMRK1;STRADB;NME4;ASPH;MCTP1;CEMIP;ACAD11;SEPT10;ARG2;SHC1;NAGS;WISP1;SMOC2;SLFN5;PAK1;RASA3;NEK9;ZNF652;CBR4;RAG1;TGFBR2;LCN2;HAGH;NUCB2;EPHA1;RAC2;CLCA2;CD44;OBSCN;APOE;ATP7B;ABCD1;ACP5;CDK17;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;FYCO1;IDE;ZCCHC14;RAB11FIP4;PPP2R3B;UBE2G1;ANXA3;PPARA;ABCA7;LPAR3;KIF21B;ASNS;FGFR1;ITGA1;AARS;MARCH4;TUB;RNPEPL1;SMOC1;SNX14;LPCAT1;ITGA2;PTK6;GALNT3;VAMP2;ULK2;LENG9;ZNF559;FAT1;ZNF81;LONP2;LTBP4;ATRX;FAM20C;CHURC1;MTHFR;PFN2;ABCG1;FKBP10;PITPNM1;APOBEC3C;ITPR3;NELL2;ENDOV;ZNF558;MBLAC2;MAPKAPK3;GSDMC;ZNF692;RAB31;LMAN1;MT2A;NLK;TRIM5;TCEA1;CLCN3;MMP14;PLEK2;PLA2G4D;ANXA6;ZBTB10;ACAD10;PHF12;CTH;ZNF704;ZMYM3;KLF12;THBS3;NPEPL1;TWF2;RABGGTA;TRIB3;PCSK6;L3MBTL3;VPS11;ZNF322;PPP3CB;MEX3C;MYOF;SYTL1;APLP2;SLK;PLAG1;CDC42BPA;SCYL3;DDX60;UHRF2;GSDMA;TAOK1;PHC3;AEBP1;ATP10D;CSNK2A1;PHF1;CHD7;ASAP1;PRKAR1A;MSRB2;PARP9;FCHO2;CPEB4;MAST3;SEPT5;LACTB2;ZNF337;THRA;ACVR1B;ZNF280D;PPP1R10;PSKH1;GLUD1;HSPA13;TSHZ1;MARK4;ZNF449;CHD6;MTA1;RNF165;YTHDC2;GRIN3B;TRIM7;ARF4;POLL;YPEL5;PANK4;NT5DC1;NFU1;TXNRD3;MAP2K2;GPATCH8;CYP4F22;ANKIB1;MICU3;TRPC1;RET;TUBG2;LOXL2;PDE5A;RAB43;MLH3;OSBPL5;SH3PXD2B;MCTP2;MTMR4;ZFYVE9;THAP10;PAK6;UBE2E1;RNF135;COL1A2;CCDC88A;PRKACA;ZNF398;NEK6;UNKL;TIMP2;EIF2AK2;RAB1A;SNX30;PCDH1;RHOBTB1;NR2F6;FICD;LPAR1;ZNF354A;MMP10;RNF169;BLVRA;TENM2;ITPR2;PJA2;ZSCAN18;MAP4K2;ZMYM2;EFCAB7;PPARG;SNX6;USP20;ZFP30;GRB7;ARHGAP29;ATP12A;ZNF37A;ESYT3;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;AKT3;GARS;ENDOG;ATP11B;ITGA4;PHF21A;ZBTB40;ZNF92;ACAP2;ZNF568;DDHD2;MARCH2;OSGEPL1;CMC1;USP32;HSPA2;ZNF107;ZNF165;SYT2;PLCH2;TMEM173;RNF180;EEF2K;ZNF320;GALNS;TRIM2;TET1;ZC3H7A;FOXP1;ZBTB33;ZFYVE21;AOX1;HSD17B12;PTCH1;ADCY1;SEPT6;OAS1;RNF103;PANK1;PRMT3;SNX27;N4BP2;PPM1M;ADNP;GNAI1;LRP4;STT3B;DNMT3A;ALAS1;TRIM38;FBXL5
2578,GO:0005868,0.519544204306444,0.758633674303548,2,20,cytoplasmic dynein complex,CC,NUDCD3;WDR60
11070,GO:0045070,0.519712930354031,0.712720828001532,3,31,positive regulation of viral genome replication,BP,ADARB1;STOM;YTHDC2
475,GO:0001518,0.520047864511972,0.854845474574051,1,6,voltage-gated sodium channel complex,CC,SCN8A
7280,GO:0031264,0.520135390283361,0.847101941599908,1,9,death-inducing signaling complex,CC,FADD
2866,GO:0006357,0.520324842822937,0.517780667296738,139,1595,regulation of transcription by RNA polymerase II,BP,TNIP1;SMURF2;NOS1;ZMYND8;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;NR1D1;NFATC4;ZC3H6;ETV4;ACVR2B;SALL2;PKN1;WWTR1;PEG3;APLN;POU2F2;TEF;ZKSCAN2;DDIT3;SOX12;PSMD2;ELK3;CRTC1;EGFR;HLTF;SLC33A1;DLG1;DNAJB5;HTRA1;GLO1;WNT7A;DKK1;KIAA1549;IMPACT;APOE;CCPG1;PKD2;DDN;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;ATRX;SOX4;FHOD1;ZNF692;ATF7IP;RCOR1;MDFI;HES2;PHF12;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;PCSK6;ZNF322;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;AEBP1;PSMD7;CHD7;PRKAR1A;JMY;PARP9;NACC2;THRA;ACVR1B;NGFR;TSHZ1;CHD6;PER3;RNF165;MEF2D;ARF4;XBP1;SATB1;TLE4;LOXL2;THAP10;GTF2IRD2;EAPP;ETV1;ZNF398;TCEAL8;UNKL;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;ZNF37A;TBX1;CREB3L2;WFS1;PHF21A;MAML3;ZNF568;FZD8;LRP6;ARID5B;TMEM173;E2F7;TET1;ARMCX3;FOXP1;ZBTB33;PTCH1;KAT2B;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;DNMT3A;FADD
9976,GO:0042364,0.520351936234336,0.848858208747185,1,8,water-soluble vitamin biosynthetic process,BP,PSAT1
8252,GO:0033028,0.520560662275705,0.757168257310445,2,21,myeloid cell apoptotic process,BP,CTSL;THRA
8316,GO:0033148,0.52056584234981,0.848714232407993,1,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,PAK1
16005,GO:0086013,0.521225099273951,0.848269922594854,1,8,membrane repolarization during cardiac muscle cell action potential,BP,DLG1
5008,GO:0015165,0.521268566623472,0.846330563947205,1,9,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,SLC35B4
5332,GO:0016064,0.521568502026743,0.66116218401295,5,58,immunoglobulin mediated immune response,BP,ERCC1;POU2F2;SERPING1;CD46;C5
6209,GO:0019724,0.521568502026743,0.66116218401295,5,58,B cell mediated immunity,BP,ERCC1;POU2F2;SERPING1;CD46;C5
6765,GO:0030199,0.521668927431394,0.712159516313166,3,28,collagen fibril organization,BP,LOXL1;LOXL2;COL1A2
2223,GO:0005126,0.52171902232877,0.603212153389366,11,137,cytokine receptor binding,MF,SMURF2;PGF;TNFSF15;SHC1;SOCS2;TGFBR2;FKBP1A;C5;TMBIM1;CKLF;FADD
6465,GO:0021794,0.521793629307968,0.850366100928755,1,7,thalamus development,BP,LRP6
608,GO:0001776,0.521847773167808,0.661187232473184,5,56,leukocyte homeostasis,BP,PKN1;RAG1;PPP3CB;DOCK11;FADD
12130,GO:0048207,0.522268940068903,0.660788685941039,5,56,vesicle targeting, rough ER to cis-Golgi,BP,SEC23A;MCFD2;LMAN1;RAB1A;CTSZ
12131,GO:0048208,0.522268940068903,0.660788685941039,5,56,COPII vesicle coating,BP,SEC23A;MCFD2;LMAN1;RAB1A;CTSZ
2827,GO:0006293,0.522356882745648,0.755649800600056,2,21,nucleotide-excision repair, preincision complex stabilization,BP,ERCC1;DDB2
2829,GO:0006295,0.522356882745648,0.755649800600056,2,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,ERCC1;DDB2
7901,GO:0032469,0.52236157066268,0.756258589588316,2,20,endoplasmic reticulum calcium ion homeostasis,BP,TGM2;WFS1
9872,GO:0042133,0.522536825282637,0.633450050170806,7,79,neurotransmitter metabolic process,BP,NOS1;ARG2;ACP5;PKD2;ALDH7A1;RNF180;SLC44A1
13071,GO:0051574,0.522588454470224,0.849835788953785,1,7,positive regulation of histone H3-K9 methylation,BP,JARID2
7306,GO:0031306,0.522600514489979,0.754888759224525,2,22,intrinsic component of mitochondrial outer membrane,CC,BNIP3;ARMCX3
150,GO:0000305,0.522607064956116,0.754378988566189,2,23,response to oxygen radical,BP,ERCC6;TXNRD3
4515,GO:0010565,0.522676092516808,0.608231550627093,10,123,regulation of cellular ketone metabolic process,BP,NR1D1;PSMD2;TYSND1;PPARA;LONP2;CEACAM1;TRIB3;MLYCD;PSMD7;PPARG
3113,GO:0006690,0.522895947824278,0.659508251769008,5,61,icosanoid metabolic process,BP,ALOX15B;LTA4H;MGLL;CYP4F22;PTGR2
3944,GO:0008635,0.523102466396454,0.845076704703325,1,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,BOK
5039,GO:0015217,0.523454149619661,0.844835478011058,1,9,ADP transmembrane transporter activity,MF,SLC25A4
5243,GO:0015866,0.523454149619661,0.844835478011058,1,9,ADP transport,BP,SLC25A4
13107,GO:0051641,0.523724440861583,0.510110208212896,186,2184,cellular localization,BP,EDEM1;NOS1;ZMYND8;F2R;SORL1;ETV5;RAB3B;SYNE3;PRNP;XPOT;BBS2;SH3TC2;NR1D1;MAP2K1;LTBP2;RAPGEF3;LMF1;MARVELD1;SSH1;MAP1B;DDIT3;EXOC2;BRSK1;WIPF1;SNPH;EGFR;TBC1D14;ANK3;FYN;TSPAN5;KIF13B;UBE2J1;DLG1;DLG4;SNX9;EVI5L;WNT7A;MAP4K4;TTBK2;SEC23A;TTC7B;STRADB;MALL;MCTP1;GDI1;CEMIP;SEPT10;STOM;DLG3;PAK1;RASA3;NUDCD3;RAC2;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;RGS14;MCFD2;PKD2;LRP1;FYCO1;AKAP9;RAB11FIP4;ABCA7;FAM155B;TUB;VAMP2;LONP2;INPP5F;ATRX;PFN2;ABCG1;SOX4;FHOD1;ITPR3;VPS13A;CEP120;OBSL1;RAB31;LMAN1;BSG;DVL1;NTSR1;NLGN2;MVB12B;MAP6;LRP5;ABHD17C;TWF2;COX18;SEC22C;CLTCL1;TOM1L2;VPS11;RIMS3;SEC63;PPP3CB;SYTL1;ZDHHC2;DNAJC6;COPB1;COPG1;FNBP1L;CSNK2A1;CHD7;CPT2;ANO1;PARP9;FCHO2;SDCCAG3;NACC2;USP6NL;SPRY2;SEPT5;TBC1D2B;NGFR;PPP1R10;MVB12A;MARK4;BCL2L1;GRIN3B;ARF4;SPIRE1;UBASH3B;MAP2K2;TRPC1;STX10;TCTN1;RAB43;SH3PXD2B;ZFYVE9;SLC30A1;TMBIM1;CCDC88A;TMED4;PRKACA;TMSB4X;RAB1A;ZDHHC1;EPB41L3;SEL1L;BCAP29;AP2A2;KDELR3;CTSZ;AP3D1;ITPR2;MOAP1;LAMA5;MAP4K2;EFCAB7;ERLEC1;SNX6;ANKRD50;LYPLA1;TMEM50B;EVI5;ESYT3;CREB3L2;RPH3AL;ITGA4;WDR60;ACAP2;TBC1D16;SSR3;DDHD2;TMEM107;WASL;REEP6;FLNB;LRP6;SYT2;TMEM173;SLC18A2;SSR1;ARMCX3;ZFYVE21;PTCH1;SEPT6;COG8;SNX27;GNAI1;LRP4
15975,GO:0080111,0.523769862711142,0.755749717334408,2,19,DNA demethylation,BP,APOBEC3C;TET1
11508,GO:0045992,0.523857124308328,0.75567588584001,2,19,negative regulation of embryonic development,BP,DKK1;PRKACB
4529,GO:0010594,0.523929272015079,0.607671811420371,10,110,regulation of endothelial cell migration,BP,WNT7A;APOE;ANXA3;FGFR1;CEACAM1;TMSB4X;PPARG;SRPX2;AKT3;FOXP1
11115,GO:0045137,0.524033345286618,0.591690556432833,13,148,development of primary sexual characteristics,BP,ERCC1;CCND1;SDC1;ATRX;MMP14;CST3;BOK;WNT2B;ACVR1B;BCL2L1;REC8;ARID4A;ARID5B
9137,GO:0035461,0.524087741812926,0.846330512899503,1,8,vitamin transmembrane transport,BP,SLC23A2
5159,GO:0015697,0.524117279233236,0.846310415657593,1,8,quaternary ammonium group transport,BP,SLC38A2
11621,GO:0046323,0.524311881987464,0.659685128972791,5,51,glucose import,BP,PAK1;CLTCL1;NGFR;SLC2A13;GRB10
19800,GO:2000243,0.524538990251927,0.707698190891579,3,33,positive regulation of reproductive process,BP,SMURF2;ACVR1B;PDE5A
7340,GO:0031362,0.52468697121966,0.843987881497532,1,9,anchored component of external side of plasma membrane,CC,PRNP
5907,GO:0018126,0.524755856306047,0.754229798426215,2,20,protein hydroxylation,BP,CRTAP;ASPH
16174,GO:0090192,0.524812796588576,0.843901199897528,1,9,regulation of glomerulus development,BP,RET
14015,GO:0060736,0.52493340515094,0.848263871220501,1,7,prostate gland growth,BP,PLAG1
5073,GO:0015296,0.524986800857582,0.848227949643292,1,7,anion:cation symporter activity,MF,SLC12A7
4346,GO:0009898,0.52503721913526,0.600709717501022,11,120,cytoplasmic side of plasma membrane,CC,FYN;DLG1;DLG4;SNX9;RASA3;PTPN3;PTK6;NTSR1;MAP2K2;ESYT3;GNAI1
15485,GO:0071837,0.525257909414895,0.845532984308445,1,8,HMG box domain binding,MF,HOXA3
434,GO:0001162,0.525279737295056,0.845518081213207,1,8,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6
6755,GO:0030176,0.525297150879263,0.605662719675606,10,123,integral component of endoplasmic reticulum membrane,CC,EDEM1;ELOVL1;PKD2;SARAF;SLC35B4;SEC63;SAMD8;FICD;WFS1;ELOVL4
8785,GO:0034464,0.52538727023707,0.843505033958363,1,9,BBSome,CC,BBS2
16568,GO:0097352,0.525557879938904,0.706468334467394,3,34,autophagosome maturation,BP,FYCO1;SNX14;GABARAPL2
3608,GO:0008047,0.525696826616162,0.546035139582247,35,393,enzyme activator activity,MF,DOCK4;ASAP2;MAP2K1;ARHGAP22;APPL2;TBC1D14;RIN2;ARHGAP12;ERCC6;ARAP1;EVI5L;GDI1;RASA3;RALGAPA2;APOE;RGS14;SRGAP2B;RALGAPA1;MMP14;ETAA1;TAOK1;ASAP1;USP6NL;SPRY2;TBC1D2B;AZIN2;MAP2K2;RIN1;SH3PXD2B;IGF2;ARHGAP29;EVI5;DEPDC1;ACAP2;TBC1D16
8026,GO:0032663,0.526226048411944,0.706494917818894,3,32,regulation of interleukin-2 production,BP,PRNP;CARD11;IL20RB
7779,GO:0032303,0.526403070520279,0.842802878863536,1,9,regulation of icosanoid secretion,BP,NTSR1
4237,GO:0009435,0.526769564743987,0.705367270304365,3,34,NAD biosynthetic process,BP,NAPRT;NMRK1;PARP9
3353,GO:0007084,0.526986608469197,0.840847428157895,1,10,mitotic nuclear envelope reassembly,BP,REEP3
1095,GO:0002684,0.527277971696956,0.532484352098268,51,616,positive regulation of immune system process,BP,TNIP1;PGF;CTNNBIP1;PRNP;PAG1;NR1D1;FAM210B;PTPRS;PSMD2;WIPF1;FYN;CTSB;PAK1;RAG1;TGFBR2;SERPING1;RAC2;PRKACB;RBCK1;BTRC;ITGA2;CEACAM1;MAPKAPK3;TRIM5;MMP14;CD46;CTSL;MOSPD2;F2RL1;DDX60;PSMD7;PARP9;ACVR1B;WASF2;SKAP2;XBP1;C5;NCKAP1;PUM2;PRKACA;IFI16;SLC39A10;CARD11;AP3D1;ARPC1A;IGF2;ADAM8;ITGA4;WASL;TMEM173;FADD
12993,GO:0051409,0.527356082361032,0.842142212546278,1,9,response to nitrosative stress,BP,DDIT3
5244,GO:0015867,0.527497622630071,0.842043932922774,1,9,ATP transport,BP,SLC25A4
11015,GO:0044848,0.527645230966912,0.843897306934501,1,8,biological phase,BP,FERMT1
11017,GO:0044851,0.527645230966912,0.843897306934501,1,8,hair cycle phase,BP,FERMT1
12394,GO:0048819,0.527645230966912,0.843897306934501,1,8,regulation of hair follicle maturation,BP,FERMT1
9823,GO:0042035,0.52780229964189,0.655385152813965,5,57,regulation of cytokine biosynthetic process,BP,UBE2J1;IGF2BP3;TRIB2;CEBPG;CARD11
7297,GO:0031295,0.528183061154503,0.704387916607902,3,33,T cell costimulation,BP,FYN;PAK1;CARD11
14072,GO:0060856,0.528359473707586,0.841444615336152,1,9,establishment of blood-brain barrier,BP,WNT7A
9279,GO:0035710,0.528374141091966,0.675386211489341,4,44,CD4-positive, alpha-beta T cell activation,BP,ARG2;TGFBR2;SATB1;FOXP1
992,GO:0002449,0.528547665086433,0.596614187943767,11,134,lymphocyte mediated immunity,BP,ERCC1;POU2F2;DLG1;SERPING1;CEACAM1;CD46;PPP3CB;CEBPG;C5;IL20RB;FADD
15160,GO:0071276,0.528817382873787,0.748601627803963,2,24,cellular response to cadmium ion,BP,EGFR;MT2A
11016,GO:0044849,0.529106120518852,0.840924179098024,1,9,estrous cycle,BP,ADNP
8592,GO:0034091,0.529226123359875,0.842807779989793,1,8,regulation of maintenance of sister chromatid cohesion,BP,ATRX
8642,GO:0034182,0.529226123359875,0.842807779989793,1,8,regulation of maintenance of mitotic sister chromatid cohesion,BP,ATRX
19071,GO:1904953,0.529262223769983,0.842782840618232,1,8,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,LRP6
3677,GO:0008174,0.529309328059897,0.840782339127813,1,9,mRNA methyltransferase activity,MF,CMTR2
14830,GO:0070567,0.529488087874377,0.840657493720637,1,9,cytidylyltransferase activity,MF,CDS2
10088,GO:0042588,0.529878076966303,0.84038489850585,1,9,zymogen granule,CC,VAMP2
8149,GO:0032875,0.529889711183443,0.844905078011857,1,7,regulation of DNA endoreduplication,BP,E2F7
12601,GO:0050777,0.530284150866666,0.625509960592749,7,84,negative regulation of immune response,BP,ARG2;SERPING1;CEACAM1;PPP3CB;IFI16;PPARG;IL20RB
10350,GO:0043154,0.530467828311356,0.637356847810837,6,71,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,TNFRSF6B;RAG1;CD44;PRDX5;CSNK2A1;NGFR
11719,GO:0046520,0.530515806034715,0.839938463813086,1,9,sphingoid biosynthetic process,BP,SPTLC2
17428,GO:1900182,0.530518690656913,0.652941296005902,5,56,positive regulation of protein localization to nucleus,BP,FYN;PARP9;NGFR;EFCAB7;TMEM173
7431,GO:0031532,0.530573268066916,0.625755952247705,7,78,actin cytoskeleton reorganization,BP,RAPGEF3;PARVB;ARAP1;SHC1;PAK1;RAC2;CDC42BPA
8006,GO:0032634,0.530580468295085,0.841870328642678,1,8,interleukin-5 production,BP,IL1RAP
8030,GO:0032674,0.530580468295085,0.841870328642678,1,8,regulation of interleukin-5 production,BP,IL1RAP
4924,GO:0014874,0.530697247560868,0.844353116726879,1,7,response to stimulus involved in regulation of muscle adaptation,BP,MTMR4
7178,GO:0031060,0.531017315613036,0.65330498907851,5,51,regulation of histone methylation,BP,ATRX;MTHFR;PHF1;TET1;JARID2
16222,GO:0090263,0.531136748602771,0.606807769701211,9,110,positive regulation of canonical Wnt signaling pathway,BP,SMURF2;PSMD2;WNT7A;SOX4;DVL1;PSMD7;WNT2B;TBL1X;LRP6
15248,GO:0071407,0.531582043733332,0.538215088786594,37,421,cellular response to organic cyclic compound,BP,PCK2;ITGA6;CYP27B1;NR1D1;NFATC4;MAP2K1;FAM210B;RAPGEF3;EIF4EBP1;SSH1;EGFR;PAK1;IMPACT;PKD2;AKAP9;ATF4;PPARA;BTRC;ITGA2;XRN1;THRA;MAP2K2;RMRP;PUM2;PRKACA;NR2F6;ITPR2;PPARG;LRP6;TMEM173;EEF2K;ZC3H7A;FOXP1;PTCH1;ADCY1;UFL1;GNAI1
12071,GO:0048019,0.531589806208007,0.837607200160308,1,10,receptor antagonist activity,MF,DKK1
9624,GO:0036490,0.531609281250365,0.841155693829849,1,8,regulation of translation in response to endoplasmic reticulum stress,BP,DNAJC3
17364,GO:1900076,0.531671840874798,0.652154763089291,5,54,regulation of cellular response to insulin stimulus,BP,PAK1;SOCS2;NGFR;IGF2;GRB10
13220,GO:0051880,0.532028091795052,0.843440571932212,1,7,G-quadruplex DNA binding,MF,XRN1
19608,GO:1990748,0.532067928434487,0.65007267818372,5,67,cellular detoxification,BP,CYGB;GPX3;APOE;PRDX5;TXNRD3
13712,GO:0060271,0.532242398011514,0.552074445620458,25,284,cilium assembly,BP,NEURL1;BBS2;WWTR1;EVI5L;TTBK2;UNC119B;SEPT10;ATXN10;NUDCD3;AKAP9;PTPDC1;CEP120;RFX2;FNBP1L;ASAP1;SEPT5;MARK4;SPATA6;TCTN1;CCDC88A;PRKACA;LAMA5;WDR60;TMEM107;SEPT6
10158,GO:0042738,0.532521411790891,0.838529000062785,1,9,exogenous drug catabolic process,BP,NOS1
7125,GO:0030948,0.532659103919674,0.84042422475218,1,8,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,EPN2
8441,GO:0033559,0.532665151934168,0.650065485145003,5,62,unsaturated fatty acid metabolic process,BP,ALOX15B;ELOVL1;ABCD1;MGLL;PTGR2
7180,GO:0031062,0.533006592665895,0.701040878503933,3,30,positive regulation of histone methylation,BP,PHF1;TET1;JARID2
8719,GO:0034364,0.533020684946423,0.836591069139534,1,10,high-density lipoprotein particle,CC,APOE
8074,GO:0032753,0.533275767116888,0.836409477190109,1,10,positive regulation of interleukin-4 production,BP,IL20RB
3517,GO:0007440,0.533540132044445,0.845890925827035,1,6,foregut morphogenesis,BP,ACVR2B
6958,GO:0030595,0.533695967737013,0.612103698907052,8,102,leukocyte chemotaxis,BP,PGF;RAC2;ITGA1;MOSPD2;F2RL1;C5;ADAM8;CKLF
7486,GO:0031650,0.533932369386007,0.837532448900871,1,9,regulation of heat generation,BP,APLN
446,GO:0001205,0.533954245475699,0.746346265171289,2,20,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,MEF2D;PBX3
13408,GO:0052745,0.534222046981213,0.746815378953525,2,19,inositol phosphate phosphatase activity,MF,INPP5F;INPP4A
7285,GO:0031272,0.534239836534258,0.837314738797038,1,9,regulation of pseudopodium assembly,BP,F2RL1
7286,GO:0031274,0.534239836534258,0.837314738797038,1,9,positive regulation of pseudopodium assembly,BP,F2RL1
15502,GO:0071872,0.534299783155218,0.839276527771166,1,8,cellular response to epinephrine stimulus,BP,PRKACA
17051,GO:0099528,0.534323653581762,0.837255355907563,1,9,G-protein coupled neurotransmitter receptor activity,MF,HTR7
11902,GO:0046929,0.534949414606821,0.838820557703418,1,8,negative regulation of neurotransmitter secretion,BP,SLC30A1
4191,GO:0009268,0.535035490235263,0.744206881013405,2,22,response to pH,BP,IMPACT;HYAL1
9865,GO:0042118,0.535055688762186,0.83874588179123,1,8,endothelial cell activation,BP,FOXP1
15661,GO:0072176,0.53514136212372,0.841291697806399,1,7,nephric duct development,BP,PKD2
9110,GO:0035385,0.535259844260319,0.841209525041162,1,7,Roundabout signaling pathway,BP,ROBO3
8333,GO:0033178,0.535649174375151,0.83471335779948,1,10,proton-transporting two-sector ATPase complex, catalytic domain,CC,ATP6V1B2
1701,GO:0004181,0.5358933946278,0.838156429855914,1,8,metallocarboxypeptidase activity,MF,AEBP1
18799,GO:1904350,0.535989159364247,0.838088952298887,1,8,regulation of protein catabolic process in the vacuole,BP,LRP1
10528,GO:0043462,0.53599576962756,0.666743926110648,4,52,regulation of ATPase activity,BP,PFN2;GABARAPL2;TMSB4X;HSPA2
13768,GO:0060346,0.536114777348395,0.840615733376221,1,7,bone trabecula formation,BP,THBS3
12198,GO:0048368,0.53648981781926,0.837735869399807,1,8,lateral mesoderm development,BP,FGFR1
15623,GO:0072109,0.536546072667019,0.835675478269858,1,9,glomerular mesangium development,BP,ACTA2
2514,GO:0005767,0.537019522323427,0.833728696891048,1,10,secondary lysosome,CC,ADAM8
776,GO:0002031,0.5373376779226,0.8334995234492,1,10,G-protein coupled receptor internalization,BP,APLN
1283,GO:0003085,0.537545471138811,0.834961664718039,1,9,negative regulation of systemic arterial blood pressure,BP,NTSR1
12402,GO:0048843,0.537605689832585,0.744673270444524,2,18,negative regulation of axon extension involved in axon guidance,BP,SEMA4B;SEMA3F
583,GO:0001736,0.537699070240143,0.600393623439388,9,109,establishment of planar polarity,BP,SMURF2;PSMD2;GPC4;DLG3;DKK1;DVL1;PSMD7;AP2A2;ANKRD6
3387,GO:0007164,0.537699070240143,0.600393623439388,9,109,establishment of tissue polarity,BP,SMURF2;PSMD2;GPC4;DLG3;DKK1;DVL1;PSMD7;AP2A2;ANKRD6
5738,GO:0016885,0.537938829783756,0.836711035277925,1,8,ligase activity, forming carbon-carbon bonds,MF,PC
17797,GO:1901881,0.538212070915202,0.834484388151547,1,9,positive regulation of protein depolymerization,BP,F2RL1
6726,GO:0030137,0.538509676608211,0.740652114651735,2,23,COPI-coated vesicle,CC,COPB1;COPG1
11780,GO:0046638,0.53858697613179,0.741108190186401,2,22,positive regulation of alpha-beta T cell differentiation,BP,TGFBR2;AP3D1
7516,GO:0031701,0.538888688619148,0.836036859673591,1,8,angiotensin receptor binding,MF,ARAP1
7978,GO:0032592,0.538943345339583,0.643665054672071,5,65,integral component of mitochondrial membrane,CC,BNIP3;COX18;SLC25A4;COQ2;ARMCX3
8010,GO:0032640,0.538986141535438,0.629193660961848,6,70,tumor necrosis factor production,BP,NFATC4;UBE2J1;ARG2;ACP5;FOXP1;FADD
12905,GO:0051251,0.539314627707131,0.576187224023873,13,158,positive regulation of lymphocyte activation,BP,FYN;PAK1;RAG1;TGFBR2;MMP14;CD46;XBP1;SLC39A10;CARD11;AP3D1;IGF2;ADAM8;FADD
4205,GO:0009313,0.539343286994529,0.833672319383214,1,9,oligosaccharide catabolic process,BP,CTBS
18867,GO:1904526,0.53941636736099,0.833619764554926,1,9,regulation of microtubule binding,BP,TTBK2
12063,GO:0048011,0.539734658005397,0.741318928699501,2,20,neurotrophin TRK receptor signaling pathway,BP,SPRY2;NGFR
7325,GO:0031334,0.539743368510801,0.561789970730679,17,199,positive regulation of protein complex assembly,BP,ERCC1;MMP1;WIPF1;DLG1;SNX9;PAK1;RAC2;IDE;AKAP9;PFN2;DDB2;ASAP1;JMY;SPIRE1;NCKAP1;ARPC1A;WASL
8998,GO:0035115,0.539885463971773,0.740547961611501,2,21,embryonic forelimb morphogenesis,BP,WNT7A;ALDH1A2
18190,GO:1902959,0.539924503898322,0.83529952585745,1,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,SORL1
19179,GO:1905245,0.539924503898322,0.83529952585745,1,8,regulation of aspartic-type peptidase activity,BP,SORL1
9115,GO:0035404,0.540275679606829,0.833000957924505,1,9,histone-serine phosphorylation,BP,HMGA2
15967,GO:0080009,0.540513656727728,0.831200124157252,1,10,mRNA methylation,BP,CMTR2
17612,GO:1901298,0.540639288584765,0.832738648015922,1,9,regulation of hydrogen peroxide-mediated programmed cell death,BP,ENDOG
13038,GO:0051494,0.54078508312919,0.598026777059316,9,98,negative regulation of cytoskeleton organization,BP,ARAP1;ESPN;TTBK2;TMOD2;PFN2;TWF2;WASF2;TMSB4X;KAT2B
15780,GO:0072383,0.540832934518065,0.837311558066062,1,7,plus-end-directed vesicle transport along microtubule,BP,FYCO1
7302,GO:0031301,0.540880603902385,0.584155556651387,11,140,integral component of organelle membrane,CC,PTPRS;BNIP3;ABCD1;COX18;SLC35B4;SLC25A4;QSOX1;SLC22A17;SAMD8;COQ2;ARMCX3
15806,GO:0072498,0.540956216720088,0.830878020904003,1,10,embryonic skeletal joint development,BP,HYAL1
14787,GO:0070491,0.541322287885857,0.642546622986882,5,56,repressing transcription factor binding,MF,ZMYND8;BBS2;PPARA;MTA1;TLE4
5102,GO:0015385,0.541647466867691,0.83406807108233,1,8,sodium:proton antiporter activity,MF,SLC9A7
8044,GO:0032693,0.541679038479738,0.830351045382402,1,10,negative regulation of interleukin-10 production,BP,TRIB2
7296,GO:0031294,0.542021357411215,0.691327853393374,3,34,lymphocyte costimulation,BP,FYN;PAK1;CARD11
2186,GO:0005044,0.542322507516663,0.738407058385056,2,21,scavenger receptor activity,MF,LRP1;LOXL2
11754,GO:0046600,0.542471987520622,0.833476552587462,1,8,negative regulation of centriole replication,BP,KAT2B
13992,GO:0060706,0.542479528874391,0.738268768446545,2,21,cell differentiation involved in embryonic placenta development,BP,MDFI;E2F7
2293,GO:0005251,0.542526650360488,0.83343728634735,1,8,delayed rectifier potassium channel activity,MF,KCNG1
4532,GO:0010603,0.542553783377538,0.836094901919509,1,7,regulation of cytoplasmic mRNA processing body assembly,BP,ATXN2
15389,GO:0071636,0.542681194914332,0.833326237465656,1,8,positive regulation of transforming growth factor beta production,BP,CD46
11623,GO:0046325,0.542683303343566,0.831258885131256,1,9,negative regulation of glucose import,BP,GRB10
5547,GO:0016540,0.542832015845557,0.83115087974664,1,9,protein autoprocessing,BP,CAPN2
5337,GO:0016074,0.543159524893456,0.826819239199219,1,12,snoRNA metabolic process,BP,NOP10
13017,GO:0051452,0.543306535121924,0.689287992939202,3,37,intracellular pH reduction,BP,DMXL2;CLCN3;ATP6V1B2
12968,GO:0051350,0.543356014959854,0.830769941208184,1,9,negative regulation of lyase activity,BP,AKAP9
15103,GO:0071141,0.543377928322454,0.835510028545717,1,7,SMAD protein complex,CC,HMGA2
8473,GO:0033613,0.543417662023757,0.6408365938005,5,54,activating transcription factor binding,MF,ZNF516;MEF2D;NEK6;PPARG;WFS1
4108,GO:0009163,0.54358398947332,0.688318941911299,3,40,nucleoside biosynthetic process,BP,NT5E;TK2;NME4
409,GO:0001094,0.543605868248698,0.830588096851663,1,9,TFIID-class transcription factor binding,MF,ERCC1
11258,GO:0045503,0.543672970966689,0.742470451760376,2,15,dynein light chain binding,MF,GLUL;WDR60
14345,GO:0061548,0.543696357941178,0.832595532906633,1,8,ganglion development,BP,SEMA3F
1994,GO:0004715,0.543791535102784,0.6906920059882,3,31,non-membrane spanning protein tyrosine kinase activity,MF,FYN;PTK6;EIF2AK2
20022,GO:2000643,0.543844547032724,0.832488685675441,1,8,positive regulation of early endosome to late endosome transport,BP,VPS11
6466,GO:0021795,0.544105778053393,0.690785709538032,3,30,cerebral cortex cell migration,BP,LAMB1;EGFR;MBOAT7
17842,GO:1902018,0.544155670312045,0.830187481277875,1,9,negative regulation of cilium assembly,BP,EVI5L
17876,GO:1902110,0.544219724312509,0.659049360749958,4,51,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BNIP3;BNIP3L;BOK;MOAP1
14079,GO:0060896,0.544347380799617,0.832125786321802,1,8,neural plate pattern specification,BP,PTCH1
12626,GO:0050811,0.544935093158964,0.829618449332222,1,9,GABA receptor binding,MF,GABARAPL2
9186,GO:0035562,0.545692791814024,0.831152156545706,1,8,negative regulation of chromatin binding,BP,NFATC4
3151,GO:0006749,0.546062740534873,0.685576896613791,3,42,glutathione metabolic process,BP,GLO1;HAGH;CHAC1
15827,GO:0072527,0.546078591710865,0.636734382370945,5,65,pyrimidine-containing compound metabolic process,BP,NT5E;TK2;NME4;APOBEC3C;TET1
3230,GO:0006883,0.546203389534345,0.830781647432075,1,8,cellular sodium ion homeostasis,BP,ATP12A
6675,GO:0030036,0.546235719973792,0.518754437323153,43,471,actin cytoskeleton organization,BP,FMNL2;RAPGEF3;SSH1;WIPF1;ARHGAP12;PARVB;ARAP1;DLG1;ESPN;SHC1;PAK1;EPHA1;RAC2;OBSCN;LRP1;TMOD2;ITGB5;FAT1;PFN2;FHOD1;OBSL1;PLEK2;TWF2;WASF3;CDC42BPA;F2RL1;TAOK1;PRKAR1A;MSRB2;JMY;WASF2;SPIRE1;SH3PXD2B;NCKAP1;PAK6;CCDC88A;TMSB4X;EPB41L3;RHOBTB1;LPAR1;ARPC1A;WASL;FLNB
14147,GO:0061025,0.546264143537455,0.561593987382978,15,177,membrane fusion,BP,TBC1D14;DYSF;BNIP3;EVI5L;VAMP2;SEC22C;VPS11;SYTL1;USP6NL;TBC1D2B;SPESP1;STX10;EVI5;TBC1D16;SYT2
12165,GO:0048280,0.54627007692603,0.82697796235434,1,10,vesicle fusion with Golgi apparatus,BP,SEC22C
113,GO:0000235,0.546437963410311,0.830611245780392,1,8,astral microtubule,CC,CCSAP
2549,GO:0005818,0.546437963410311,0.830611245780392,1,8,aster,CC,CCSAP
4182,GO:0009259,0.546981283895422,0.531019104770791,29,370,ribonucleotide metabolic process,BP,NT5E;NOS1;ADCY7;RAPGEF3;DHTKD1;PGM1;DLG1;DLG4;ACOT7;NME4;DLG3;APOE;PKD2;LDHA;AKAP9;PPARA;FAM20C;PTHLH;NDUFV3;PANK4;PDE5A;TMSB4X;TIMP2;CARD11;ATP6V1B2;AK9;ADCY1;PANK1;ADNP
4107,GO:0009162,0.547189934945895,0.82493909289693,1,11,deoxyribonucleoside monophosphate metabolic process,BP,TK2
12650,GO:0050854,0.547325126934868,0.686366740456414,3,34,regulation of antigen receptor-mediated signaling pathway,BP,PRNP;CEACAM1;SLC39A10
5673,GO:0016783,0.547437618605419,0.823626845773589,1,12,sulfurtransferase activity,MF,TST
5325,GO:0016051,0.547512012417716,0.568048950981578,13,156,carbohydrate biosynthetic process,BP,PCK2;NR1D1;PC;PGM1;ISYNA1;B3GNT3;ATF4;PPARA;GALNT3;NTSR1;SLC35B4;IGF2;KAT2B
14507,GO:0062012,0.547706627866715,0.531843243471867,28,335,regulation of small molecule metabolic process,BP,NOS1;CYP27B1;IGFBP4;NR1D1;RAPGEF3;LMF1;PSMD2;TYSND1;APOE;PKD2;AKAP9;PPARA;LONP2;ABCG1;CEACAM1;NTSR1;SLC35B4;TRIB3;MLYCD;PSMD7;PTHLH;PDE5A;TMSB4X;TIMP2;IGF2;PPARG;KAT2B;ADNP
16059,GO:0086103,0.547733209398067,0.832395457198989,1,7,G-protein coupled receptor signaling pathway involved in heart process,BP,NOS1
15758,GO:0072348,0.548329501177835,0.733086379417558,2,21,sulfur compound transport,BP,SLC33A1;SLC6A6
14362,GO:0061577,0.548658765096801,0.828992172841561,1,8,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,NOS1
18614,GO:1903897,0.548670125946793,0.826873606868676,1,9,regulation of PERK-mediated unfolded protein response,BP,BOK
5799,GO:0017049,0.549188045253117,0.732320828942751,2,21,GTP-Rho binding,MF,PKN1;NET1
11407,GO:0045806,0.549385762678368,0.684127497192065,3,35,negative regulation of endocytosis,BP,DLG4;MCTP1;ATXN2
3008,GO:0006553,0.549532833261936,0.826235354822605,1,9,lysine metabolic process,BP,ALDH7A1
2797,GO:0006241,0.549608569552942,0.821991722608233,1,12,CTP biosynthetic process,BP,NME4
11522,GO:0046036,0.549608569552942,0.821991722608233,1,12,CTP metabolic process,BP,NME4
72,GO:0000149,0.549861053661331,0.59670785342957,8,93,SNARE binding,MF,SNPH;VAMP2;SEC22C;VPS11;SYTL1;STX10;GABARAPL2;SYT2
7703,GO:0032182,0.549972098299953,0.606328715289524,7,82,ubiquitin-like protein binding,MF,UBXN7;RBCK1;OTUB2;MVB12A;MARK4;SIMC1;USP25
15161,GO:0071277,0.549986189160145,0.655290855007443,4,42,cellular response to calcium ion,BP,PKD2;ENDOG;EEF2K;ADCY1
3896,GO:0008532,0.550162643128307,0.824082636226107,1,10,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,B3GNT3
366,GO:0000987,0.550352019923943,0.532283355263947,26,295,proximal promoter sequence-specific DNA binding,MF,NR1D1;NFATC4;ETV4;POU2F2;DDIT3;ELK3;HLTF;ZNF516;DDN;HMGA2;ATF4;PPARA;TCFL5;NFAT5;ZNF692;HES2;RFX2;CEBPG;PLAG1;CHD7;NACC2;MEF2D;ETV1;IFI16;CREB3L2;RFX7
7301,GO:0031300,0.550488565311526,0.56931058517946,12,154,intrinsic component of organelle membrane,CC,RAB3B;PTPRS;BNIP3;ABCD1;COX18;SLC35B4;SLC25A4;QSOX1;SLC22A17;SAMD8;COQ2;ARMCX3
11253,GO:0045475,0.550721697287831,0.827478735924759,1,8,locomotor rhythm,BP,MTA1
10039,GO:0042491,0.55085816420646,0.731483304814891,2,20,inner ear auditory receptor cell differentiation,BP,SLITRK6;FGFR1
1305,GO:0003149,0.550877500474536,0.825237336552861,1,9,membranous septum morphogenesis,BP,TGFBR2
7843,GO:0032400,0.550891103211757,0.730205604966827,2,22,melanosome localization,BP,BBS2;RAB1A
13217,GO:0051875,0.550891103211757,0.730205604966827,2,22,pigment granule localization,BP,BBS2;RAB1A
3027,GO:0006573,0.550974718882771,0.82516502916157,1,9,valine metabolic process,BP,HIBADH
9021,GO:0035198,0.550987518482158,0.730712109594608,2,21,miRNA binding,MF,PUM2;ZC3H7A
9766,GO:0039530,0.551327469808937,0.824902494588176,1,9,MDA-5 signaling pathway,BP,DDX60
19214,GO:1905330,0.551720606083276,0.568421557886328,12,144,regulation of morphogenesis of an epithelium,BP,SMURF2;ETV5;PSMD2;GPC4;DKK1;FGFR1;DVL1;PSMD7;WNT2B;AP2A2;FOXP1;ANKRD6
7462,GO:0031618,0.551721879151692,0.826741675034985,1,8,nuclear pericentric heterochromatin,CC,ATRX
10317,GO:0043097,0.551767895550706,0.821499608915315,1,11,pyrimidine nucleoside salvage,BP,TK2
4962,GO:0015037,0.552234653881649,0.820000097893173,1,12,peptide disulfide oxidoreductase activity,MF,PDIA5
3441,GO:0007249,0.552335147319739,0.548968537153016,17,206,I-kappaB kinase/NF-kappaB signaling,BP,TNIP1;F2R;FYN;TGM2;FKBP1A;RBCK1;BTRC;TRIM5;CTH;F2RL1;C18ORF32;TMED4;NEK6;CARD11;LPAR1;TRIM38;FADD
8938,GO:0034969,0.552360028798746,0.822433723506072,1,10,histone arginine methylation,BP,PRMT3
687,GO:0001906,0.552534709951587,0.630191390870381,5,67,cell killing,BP,CEACAM1;PPP3CB;CEBPG;F2RL1;FADD
2312,GO:0005310,0.552701839808452,0.729832361755506,2,20,dicarboxylic acid transmembrane transporter activity,MF,SLC13A3;SLC7A11
16496,GO:0097191,0.552710150127573,0.558655276271119,14,170,extrinsic apoptotic signaling pathway,BP,ITGA6;FYN;STRADB;RBCK1;FGFR1;BOK;ACVR1B;BCL2L1;RET;TMBIM1;MOAP1;DEDD2;RB1CC1;FADD
9686,GO:0038063,0.552770322010449,0.828743057997746,1,7,collagen-activated tyrosine kinase receptor signaling pathway,BP,UBASH3B
3186,GO:0006809,0.552842075221252,0.651843706178783,4,45,nitric oxide biosynthetic process,BP,NOS1;ARG2;ACP5;PKD2
2976,GO:0006517,0.552857874588057,0.681812578709976,3,32,protein deglycosylation,BP,EDEM1;SEL1L;RNF103
9706,GO:0038110,0.552942790842201,0.82583902667704,1,8,interleukin-2-mediated signaling pathway,BP,SHC1
3743,GO:0008278,0.552945665188096,0.825836897804998,1,8,cohesin complex,CC,REC8
18197,GO:1902969,0.55302294446028,0.823636875198326,1,9,mitotic DNA replication,BP,FGFR1
13380,GO:0052646,0.553084716390259,0.825733888730618,1,8,alditol phosphate metabolic process,BP,ACP6
8305,GO:0033137,0.553126785102011,0.728196445245145,2,22,negative regulation of peptidyl-serine phosphorylation,BP,DKK1;INPP5F
12667,GO:0050871,0.553323656602999,0.650970074912504,4,47,positive regulation of B cell activation,BP,MMP14;XBP1;SLC39A10;CARD11
3097,GO:0006670,0.55340021256695,0.821649507628043,1,10,sphingosine metabolic process,BP,SPTLC2
4194,GO:0009299,0.553530550692771,0.729088346299629,2,20,mRNA transcription,BP,DDIT3;ATF4
920,GO:0002315,0.553631746423166,0.825328242717991,1,8,marginal zone B cell differentiation,BP,DOCK11
266,GO:0000733,0.553637872591722,0.823176307144324,1,9,DNA strand renaturation,BP,SMARCA1
2518,GO:0005771,0.553738521675967,0.726607886404163,2,24,multivesicular body,CC,EGFR;CST3
13601,GO:0060071,0.553954908644914,0.59221007118998,8,99,Wnt signaling pathway, planar cell polarity pathway,BP,SMURF2;PSMD2;GPC4;DKK1;DVL1;PSMD7;AP2A2;ANKRD6
8745,GO:0034393,0.554244905405901,0.82272084483744,1,9,positive regulation of smooth muscle cell apoptotic process,BP,PPARG
4358,GO:0009954,0.554332715861185,0.727706511855147,2,21,proximal/distal pattern formation,BP,ALDH1A2;LRP4
11578,GO:0046131,0.554336634758646,0.725194743404711,2,26,pyrimidine ribonucleoside metabolic process,BP,NME4;APOBEC3C
4916,GO:0014854,0.554343242125664,0.824799667721378,1,8,response to inactivity,BP,MTMR4
3512,GO:0007422,0.554427310349529,0.630435165978414,5,52,peripheral nervous system development,BP,SCN8A;SH3TC2;ADGRB2;ETV1;LAMB2
5909,GO:0018146,0.554855258494676,0.726637115579332,2,22,keratan sulfate biosynthetic process,BP,B4GALT6;B3GNT3
419,GO:0001106,0.554987173024838,0.727116203593053,2,21,RNA polymerase II transcription corepressor activity,MF,ZMYND8;PHF12
15928,GO:0072711,0.555164981365428,0.824187823842215,1,8,cellular response to hydroxyurea,BP,ATRX
14533,GO:0070034,0.555187010549158,0.72693580407476,2,21,telomerase RNA binding,MF,XRN1;NOP10
4370,GO:0009988,0.555338989719159,0.724703521704314,2,25,cell-cell recognition,BP,DLG1;SPESP1
9185,GO:0035561,0.555503007212987,0.726650401013334,2,21,regulation of chromatin binding,BP,NFATC4;PARP9
13112,GO:0051647,0.555517040705344,0.728859014051144,2,18,nucleus localization,BP,FHOD1;CEP120
16313,GO:0090481,0.555790971218292,0.819838098594141,1,10,pyrimidine nucleotide-sugar transmembrane transport,BP,SLC35B4
7039,GO:0030812,0.555922698723429,0.823622346684995,1,8,negative regulation of nucleotide catabolic process,BP,PPARA
18430,GO:1903510,0.555999934919082,0.600602197162618,7,79,mucopolysaccharide metabolic process,BP,B4GALT6;B3GNT3;CEMIP;CD44;HYAL1;GLB1;GALNS
3637,GO:0008106,0.556005770784047,0.817113656049669,1,12,alcohol dehydrogenase (NADP+) activity,MF,RDH14
9136,GO:0035459,0.556156732558618,0.726722609045108,2,20,cargo loading into vesicle,BP,SEC23A;RAB1A
1345,GO:0003208,0.556534983847198,0.649199902768653,4,41,cardiac ventricle morphogenesis,BP,TGFBR2;FKBP1A;SOX4;CHD7
15029,GO:0070970,0.556646778875228,0.82308080296402,1,8,interleukin-2 secretion,BP,CARD11
6310,GO:0019955,0.556673902802731,0.627239805979788,5,58,cytokine binding,MF,LTBP1;TGFBR2;LTBP4;IL20RB;ITGA4
8162,GO:0032891,0.556838683627134,0.822937084393905,1,8,negative regulation of organic acid transport,BP,STK39
5958,GO:0018342,0.556872873424973,0.820739769724695,1,9,protein prenylation,BP,RABGGTA
16569,GO:0097354,0.556872873424973,0.820739769724695,1,9,prenylation,BP,RABGGTA
7266,GO:0031234,0.557039676639324,0.611885421678056,6,66,extrinsic component of cytoplasmic side of plasma membrane,CC,FYN;DLG4;SNX9;PTK6;ESYT3;GNAI1
6918,GO:0030510,0.557578513500846,0.627332160926642,5,52,regulation of BMP signaling pathway,BP,SMURF2;HTRA1;DKK1;PCSK6;RNF165
16770,GO:0098573,0.557664901513725,0.62524123512838,5,66,intrinsic component of mitochondrial membrane,CC,BNIP3;COX18;SLC25A4;COQ2;ARMCX3
12668,GO:0050872,0.557813055637533,0.820027342725117,1,9,white fat cell differentiation,BP,PPARG
554,GO:0001675,0.557840993081384,0.822185140188428,1,8,acrosome assembly,BP,RFX2
3697,GO:0008202,0.557869252260544,0.546319050942648,16,198,steroid metabolic process,BP,SORL1;VLDLR;CYP27B1;NR1D1;LMF1;PLPP6;APOE;FGFR1;ABCG1;LRP5;HSD17B7;OSBPL5;SRD5A3;IGFBP7;HSD17B12;AMACR
3596,GO:0008022,0.557936835078634,0.553620966571902,14,162,protein C-terminus binding,MF,ERCC1;MAP2K1;ERCC6;DLG1;DLG4;SDC1;DLG3;ATF4;CEP120;SLC9A3R2;MPDZ;ATXN2;TBL1X;PPARG
10687,GO:0043951,0.558081243416588,0.819823765944584,1,9,negative regulation of cAMP-mediated signaling,BP,LPAR1
6877,GO:0030371,0.558234355634719,0.724842432292207,2,20,translation repressor activity,MF,EIF4EBP1;CPEB4
7065,GO:0030852,0.558446340624608,0.819546372267398,1,9,regulation of granulocyte differentiation,BP,CEACAM1
7626,GO:0032025,0.558517034804361,0.817757312144144,1,10,response to cobalt ion,BP,BNIP3
14186,GO:0061085,0.55854161017754,0.819473940014363,1,9,regulation of histone H3-K27 methylation,BP,PHF1
12837,GO:0051147,0.558560459286928,0.58808020806865,8,92,regulation of muscle cell differentiation,BP,DKK1;PAK1;MMP14;CTH;THRA;XBP1;IGF2;TBX1
4312,GO:0009790,0.558604300498028,0.496709605276747,60,672,embryo development,BP,ERCC1;ITGB4;MAP2K1;ACVR2B;SALL2;APLN;LAMB1;CAPN2;EGFR;DLG1;DLG4;WNT7A;DLG3;DKK1;TGFBR2;EDNRA;SLITRK6;PKD2;PRKACB;HMGA2;FGFR1;ITGB5;HYAL1;ITGA2;SOX4;MDFI;DVL1;MMP14;LRP5;PCSK6;CHD7;PRKAR1A;SPRY2;WNT2B;ACVR1B;COL6A1;TSHZ1;BCL2L1;RET;TCTN1;C5;SLC30A1;CCSAP;HOXA3;IGF2;LAMA5;ALDH1A2;TBX1;ENDOG;ITGA4;WDR60;ZNF568;TMEM107;LRP6;E2F7;TET1;PTCH1;SEMA3F;LRP4;DNMT3A
14089,GO:0060914,0.558976283358982,0.81599098913427,1,11,heart formation,BP,DKK1
3750,GO:0008287,0.559135420686558,0.64550766051542,4,46,protein serine/threonine phosphatase complex,CC,PPP2R3B;PPP3CB;PPP1R10;PPP1R2
18333,GO:1903293,0.559135420686558,0.64550766051542,4,46,phosphatase complex,CC,PPP2R3B;PPP3CB;PPP1R10;PPP1R2
19497,GO:1990316,0.559343624680016,0.821053723164404,1,8,Atg1/ULK1 kinase complex,CC,RB1CC1
2818,GO:0006282,0.55946418432334,0.596775820180339,7,83,regulation of DNA repair,BP,EGFR;HMGA2;CEBPG;PARP9;RNF169;MAGEF1;KLHL15
12882,GO:0051219,0.559662755058381,0.609534884455538,6,64,phosphoprotein binding,MF,PLAT;SHC1;PTPN3;PKD2;BTRC;UBASH3B
8915,GO:0034754,0.559938445584345,0.623219808087826,5,64,cellular hormone metabolic process,BP,RDH14;HSD17B7;SRD5A3;ALDH1A2;HSD17B12
11432,GO:0045851,0.560170954568527,0.673055901973827,3,38,pH reduction,BP,DMXL2;CLCN3;ATP6V1B2
12676,GO:0050884,0.560263586949612,0.820358581343643,1,8,neuromuscular process controlling posture,BP,ADARB1
5582,GO:0016600,0.560361593763153,0.820284415545069,1,8,flotillin complex,CC,LRP4
16505,GO:0097200,0.560362739593974,0.814918299866594,1,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,CASP4
4438,GO:0010310,0.560415536972554,0.816298494737925,1,10,regulation of hydrogen peroxide metabolic process,BP,RAC2
4550,GO:0010631,0.560531297219198,0.538233881368819,18,202,epithelial cell migration,BP,PRSS3;PKN1;WNT7A;TGFBR2;APOE;ANXA3;FGFR1;HYAL1;ITGA2;PFN2;CEACAM1;FERMT1;LOXL2;TMSB4X;PPARG;SRPX2;AKT3;FOXP1
15152,GO:0071260,0.56059681440882,0.623215858499257,5,59,cellular response to mechanical stimulus,BP,EGFR;BNIP3;ITGA2;SLC38A2;FADD
17541,GO:1901070,0.560622914400429,0.812542518860464,1,13,guanosine-containing compound biosynthetic process,BP,NME4
13669,GO:0060192,0.560704085543716,0.816076072450942,1,10,negative regulation of lipase activity,BP,ANGPTL4
11622,GO:0046324,0.560748015959839,0.644834005258759,4,42,regulation of glucose import,BP,PAK1;CLTCL1;NGFR;GRB10
5616,GO:0016668,0.561265893318629,0.814217235095304,1,11,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,TXNRD3
15415,GO:0071677,0.561645150532335,0.813922297421338,1,11,positive regulation of mononuclear cell migration,BP,MOSPD2
6252,GO:0019829,0.561725809678581,0.672687540136779,3,34,cation-transporting ATPase activity,MF,ATP7B;ATP12A;ATP6V1B2
6300,GO:0019915,0.561881733737488,0.642817177061213,4,46,lipid storage,BP,APOE;PPARA;ABCG1;PPARG
1678,GO:0004143,0.561931222314352,0.819093723057472,1,8,diacylglycerol kinase activity,MF,DGKA
584,GO:0001738,0.561960639132403,0.569227775525961,10,121,morphogenesis of a polarized epithelium,BP,SMURF2;PSMD2;GPC4;DLG3;DKK1;DVL1;PSMD7;AP2A2;LAMA5;ANKRD6
8115,GO:0032801,0.56223219757783,0.672876729588795,3,32,receptor catabolic process,BP,VLDLR;APOE;AP2A2
2555,GO:0005832,0.562410904994055,0.814756610840983,1,10,chaperonin-containing T-complex,CC,FYCO1
7095,GO:0030890,0.562584775473146,0.719046734282997,2,23,positive regulation of B cell proliferation,BP,SLC39A10;CARD11
14168,GO:0061050,0.562640955631193,0.816338240156704,1,9,regulation of cell growth involved in cardiac muscle cell development,BP,PAK1
5146,GO:0015677,0.562721469413778,0.818492192419459,1,8,copper ion import,BP,ATP7B
3903,GO:0008542,0.562749656747253,0.672752659375843,3,31,visual learning,BP,RAG1;RGS14;DDHD2
15452,GO:0071772,0.563133080667564,0.575737361448774,9,97,response to BMP,BP,SMURF2;ACVR2B;SLC33A1;ADAMTS7;HTRA1;DKK1;PCSK6;RNF165;LRP4
15453,GO:0071773,0.563133080667564,0.575737361448774,9,97,cellular response to BMP stimulus,BP,SMURF2;ACVR2B;SLC33A1;ADAMTS7;HTRA1;DKK1;PCSK6;RNF165;LRP4
3724,GO:0008250,0.563347284226086,0.811404043325059,1,12,oligosaccharyltransferase complex,CC,STT3B
10598,GO:0043567,0.563381176194524,0.815768046739114,1,9,regulation of insulin-like growth factor receptor signaling pathway,BP,IGFBP4
11903,GO:0046930,0.563457793500676,0.812508210802857,1,11,pore complex,CC,C5
6205,GO:0019706,0.563560828508293,0.718149378986215,2,23,protein-cysteine S-palmitoyltransferase activity,MF,ZDHHC2;ZDHHC1
6206,GO:0019707,0.563560828508293,0.718149378986215,2,23,protein-cysteine S-acyltransferase activity,MF,ZDHHC2;ZDHHC1
10012,GO:0042438,0.563969123657527,0.817539664985929,1,8,melanin biosynthetic process,BP,TRPC1
8464,GO:0033601,0.563981044505798,0.817530547264679,1,8,positive regulation of mammary gland epithelial cell proliferation,BP,CCND1
4855,GO:0014067,0.564191343622363,0.815142571355291,1,9,negative regulation of phosphatidylinositol 3-kinase signaling,BP,SERPINE2
6936,GO:0030544,0.564200838879433,0.669706800562964,3,36,Hsp70 protein binding,MF,FKBP1A;DNAJB9;FICD
20190,GO:2001038,0.564479763839213,0.717302986408723,2,23,regulation of cellular response to drug,BP,HMGA2;ENDOG
9250,GO:0035646,0.564712106624732,0.812967354966513,1,10,endosome to melanosome transport,BP,AP3D1
10538,GO:0043485,0.564712106624732,0.812967354966513,1,10,endosome to pigment granule transport,BP,AP3D1
12372,GO:0048757,0.564712106624732,0.812967354966513,1,10,pigment granule maturation,BP,AP3D1
2280,GO:0005230,0.564767906424296,0.814696552397763,1,9,extracellular ligand-gated ion channel activity,MF,GRIN3B
15380,GO:0071622,0.564779017470552,0.715627708192013,2,26,regulation of granulocyte chemotaxis,BP,RAC2;MOSPD2
8988,GO:0035094,0.564909115296907,0.718074201935817,2,21,response to nicotine,BP,PPARA;SLC7A11
11771,GO:0046628,0.565026458813329,0.816729725730688,1,8,positive regulation of insulin receptor signaling pathway,BP,IGF2
5694,GO:0016814,0.565231226924778,0.716609726609569,2,23,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,ADARB1;APOBEC3C
10677,GO:0043922,0.565233782305962,0.812560084205264,1,10,negative regulation by host of viral transcription,BP,HMGA2
8485,GO:0033631,0.565500423957275,0.814128815558964,1,9,cell-cell adhesion mediated by integrin,BP,PODXL
6773,GO:0030207,0.565504692263256,0.814125503889162,1,9,chondroitin sulfate catabolic process,BP,HYAL1
3799,GO:0008376,0.565678696626378,0.66887866062034,3,34,acetylgalactosaminyltransferase activity,MF,B3GNT3;B4GALNT4;GALNT3
2298,GO:0005267,0.565696407033217,0.668861542558232,3,34,potassium channel activity,MF,KCNG1;PKD2;KCNJ15
6636,GO:0023019,0.565729393781141,0.813951105874143,1,9,signal transduction involved in regulation of gene expression,BP,EPCAM
15890,GO:0072643,0.565995484244186,0.813744437967758,1,9,interferon-gamma secretion,BP,F2RL1
15691,GO:0072216,0.566224783437868,0.811784725616024,1,10,positive regulation of metanephros development,BP,RET
10391,GO:0043220,0.566363474182474,0.813458364334633,1,9,Schmidt-Lanterman incisure,CC,MPDZ
3632,GO:0008092,0.566449542011145,0.488369141430014,61,671,cytoskeletal protein binding,MF,FLNC;RAB3B;SYNE3;CLIP2;PRNP;MARCKSL1;FMNL2;MPRIP;SSH1;MAP1B;SNTB2;CAPN2;BRSK1;WIPF1;EGFR;ANK3;FYN;MYH15;KIF13B;PARVB;DLG1;ESPN;TTBK2;PTPN3;IMPACT;OBSCN;APOE;AFAP1;RGS14;PKD2;KIF21B;TMOD2;PFN2;FHOD1;CEACAM1;OBSL1;FAM110C;MAP6;TWF2;WASF3;MSRB2;JMY;BEX4;MARK4;WASF2;SPIRE1;SPATA6;GABARAPL2;CCDC88A;CCSAP;NEK6;TMSB4X;EPB41L3;ARPC1A;PPARG;SNX6;RPH3AL;WASL;FLNB;SSFA2;ADNP
8225,GO:0032982,0.566715708469998,0.818344559859173,1,7,myosin filament,CC,MYH15
8596,GO:0034098,0.566742412122199,0.813163461508927,1,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,UBXN7
996,GO:0002460,0.566785196947633,0.558278977337591,11,135,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,ERCC1;PKN1;POU2F2;DLG1;SERPING1;CEACAM1;CD46;PPP3CB;C5;IL20RB;FADD
15417,GO:0071679,0.566805932016518,0.815360977958367,1,8,commissural neuron axon guidance,BP,PTCH1
20023,GO:2000644,0.566844486309941,0.813083968538194,1,9,regulation of receptor catabolic process,BP,APOE
6083,GO:0019239,0.566938853202829,0.714521143161078,2,24,deaminase activity,MF,ADARB1;APOBEC3C
8618,GO:0034134,0.567139834946571,0.811066823418505,1,10,toll-like receptor 2 signaling pathway,BP,F2RL1
3692,GO:0008195,0.56714247696146,0.812851766206327,1,9,phosphatidate phosphatase activity,MF,PLPPR2
9880,GO:0042147,0.567444847399539,0.601236363554603,6,68,retrograde transport, endosome to Golgi,BP,TBC1D14;CLTCL1;STX10;SNX6;EVI5;ZFYVE21
9818,GO:0042023,0.567739649250395,0.814639936695079,1,8,DNA endoreduplication,BP,E2F7
14825,GO:0070561,0.567905086646597,0.812256608552452,1,9,vitamin D receptor signaling pathway,BP,CYP27B1
15501,GO:0071871,0.568067107645404,0.812129994708386,1,9,response to epinephrine,BP,PRKACA
12273,GO:0048568,0.56811130386239,0.517537879399992,24,272,embryonic organ development,BP,ERCC1;MAP2K1;EGFR;DLG1;TGFBR2;SLITRK6;PKD2;FGFR1;HYAL1;MDFI;DVL1;MMP14;CHD7;SPRY2;TSHZ1;HOXA3;IGF2;ALDH1A2;TBX1;WDR60;ZNF568;LRP6;E2F7;PTCH1
5706,GO:0016835,0.568179382665823,0.635359535373638,4,53,carbon-oxygen lyase activity,MF,CBS;HMGA2;UROS;POLL
14118,GO:0060976,0.568365967608643,0.667738352547132,3,30,coronary vasculature development,BP,LTBP1;APLN;TBX1
6752,GO:0030173,0.568475163590999,0.665567012435629,3,36,integral component of Golgi membrane,CC,SLC35B4;QSOX1;SAMD8
3901,GO:0008540,0.568613971979526,0.807233510498179,1,12,proteasome regulatory particle, base subcomplex,CC,PSMD2
2690,GO:0006054,0.568777454543171,0.809777304060503,1,10,N-acetylneuraminate metabolic process,BP,NPL
938,GO:0002347,0.568880978143595,0.809695581624516,1,10,response to tumor cell,BP,CEACAM1
18078,GO:1902668,0.569253971677821,0.715500441285678,2,19,negative regulation of axon guidance,BP,SEMA4B;SEMA3F
17918,GO:1902230,0.569496599229611,0.711242117350141,2,26,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,CD44;BCL2L1
19839,GO:2000310,0.5696057206928,0.810924662799437,1,9,regulation of NMDA receptor activity,BP,DLG4
769,GO:0002021,0.569622469858991,0.809109529890789,1,10,response to dietary excess,BP,APOE
16081,GO:0090042,0.569829865224662,0.810748623027691,1,9,tubulin deacetylation,BP,BEX4
7574,GO:0031936,0.57009620768388,0.812811415055116,1,8,negative regulation of chromatin silencing,BP,TET1
17366,GO:1900078,0.57019851017956,0.714626094438234,2,19,positive regulation of cellular response to insulin stimulus,BP,PAK1;IGF2
510,GO:0001573,0.570273871515669,0.808593650593609,1,10,ganglioside metabolic process,BP,ST3GAL5
10134,GO:0042692,0.570463843775435,0.528142901113969,18,201,muscle cell differentiation,BP,NOS1;FLNC;NFATC4;CAPN2;SDC1;DKK1;PAK1;OBSCN;TMOD2;OBSL1;MMP14;CTH;MYOF;PRKAR1A;THRA;XBP1;IGF2;TBX1
4257,GO:0009584,0.570475653579245,0.712305715703604,2,22,detection of visible light,BP,REEP6;ELOVL4
10289,GO:0043034,0.570495223445705,0.716158776232171,2,17,costamere,CC,FLNC;ANK3
16134,GO:0090132,0.570717273321793,0.52783622519039,18,203,epithelium migration,BP,PRSS3;PKN1;WNT7A;TGFBR2;APOE;ANXA3;FGFR1;HYAL1;ITGA2;PFN2;CEACAM1;FERMT1;LOXL2;TMSB4X;PPARG;SRPX2;AKT3;FOXP1
3459,GO:0007271,0.570834947053564,0.809957844128936,1,9,synaptic transmission, cholinergic,BP,APOE
20286,GO:2001259,0.570840168907975,0.664933282199341,3,31,positive regulation of cation channel activity,BP,ANK3;PKD2;NTSR1
10928,GO:0044546,0.571085337949946,0.809760484080811,1,9,NLRP3 inflammasome complex assembly,BP,EIF2AK2
17449,GO:1900225,0.571085337949946,0.809760484080811,1,9,regulation of NLRP3 inflammasome complex assembly,BP,EIF2AK2
8489,GO:0033643,0.571252799043348,0.80962841030212,1,9,host cell part,CC,LMAN1
570,GO:0001711,0.571389342330539,0.807708004165491,1,10,endodermal cell fate commitment,BP,DKK1
3513,GO:0007423,0.571693801080077,0.507764549868297,28,311,sensory organ development,BP,ACVR2B;SALL2;SDK2;EGFR;MYH15;DLG1;WNT7A;TGFBR2;SLITRK6;RAB11FIP4;FGFR1;TUB;SMOC1;LPCAT1;DVL1;LRP5;CST3;CHD7;SPRY2;WNT2B;TSHZ1;RET;SH3PXD2B;LAMB2;ALDH1A2;TBX1;SLC7A11;LRP6
114,GO:0000242,0.571877664456053,0.71306774053471,2,19,pericentriolar material,CC,TUBG2;WDR60
10794,GO:0044265,0.571943218074956,0.47663174374761,78,960,cellular macromolecule catabolic process,BP,SMURF2;EDEM1;GID4;VLDLR;H1F0;BTBD2;NR1D1;HECW2;WWTR1;DDIT3;PSMD2;CAPN2;BNIP3;UBE2J1;ADAMTS7;CTSB;UBXN4;IGF2BP3;TRIB2;APOE;BNIP3L;RBCK1;LRP1;IDE;ABTB1;UBE2G1;BTRC;LONP2;RMND5A;FBXO2;SPATA18;XRN1;TNRC6B;DVL1;MVB12B;CTSL;CST3;TRIB3;VPS11;DNAJB9;BTBD3;PSMD7;MVB12A;MTA1;RNF165;PCYOX1;XBP1;PAIP1;ARRDC1;ANKIB1;GABARAPL2;DNASE1L1;UBE2E1;PUM2;CTSO;PRKACA;SEL1L;AP2A2;CTSZ;TBL1X;ERLEC1;USP20;WFS1;ENDOG;USP32;MAGEF1;RNF180;HPSE;TNRC6C;DEDD2;DNAJC3;CNOT11;RNF103;USP25;UFL1;KLHL15;STT3B;FBXL5
360,GO:0000978,0.571988760825182,0.51182578606382,25,288,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,NR1D1;NFATC4;ETV4;POU2F2;DDIT3;ELK3;HLTF;DDN;HMGA2;ATF4;PPARA;TCFL5;NFAT5;ZNF692;HES2;RFX2;CEBPG;PLAG1;CHD7;NACC2;MEF2D;ETV1;IFI16;CREB3L2;RFX7
2573,GO:0005859,0.572740659255498,0.813718822275621,1,7,muscle myosin complex,CC,OBSL1
1143,GO:0002739,0.572821449279501,0.806566789629578,1,10,regulation of cytokine secretion involved in immune response,BP,F2RL1
19145,GO:1905146,0.572856437778435,0.808360408924474,1,9,lysosomal protein catabolic process,BP,LRP1
2775,GO:0006198,0.573210170361689,0.810375926275056,1,8,cAMP catabolic process,BP,RAPGEF3
13661,GO:0060174,0.57322916228083,0.810361004687068,1,8,limb bud formation,BP,SOX4
2095,GO:0004861,0.573521765413517,0.804521955891724,1,11,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,KAT2B
5407,GO:0016247,0.573543866798778,0.594630167737035,6,72,channel regulator activity,MF,NOS1;DLG1;PTPN3;AKAP9;SLC30A1;PRSS8
1185,GO:0002832,0.574013714804036,0.660161707255768,3,36,negative regulation of response to biotic stimulus,BP,HTRA1;ARG2;CEACAM1
4588,GO:0010692,0.574023896633135,0.80973585931805,1,8,regulation of alkaline phosphatase activity,BP,ITGA2
443,GO:0001191,0.574172023325576,0.660301548869607,3,35,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,ZMYND8;PHF12;PARP9
12598,GO:0050774,0.574339010201691,0.80718290353264,1,9,negative regulation of dendrite morphogenesis,BP,NFATC4
15318,GO:0071526,0.57439801716806,0.662307685440117,3,29,semaphorin-plexin signaling pathway,BP,SEMA4B;PLXNB3;SEMA3F
6289,GO:0019899,0.574507031660669,0.461132374654698,159,1825,enzyme binding,MF,TNIP1;DOCK4;SORL1;FAM83A;CCND1;ASAP2;CBS;PRNP;PAG1;UHRF1BP1;XPOT;ACTA2;BTBD2;FMNL2;RAPGEF3;PKN1;MST1R;MICALCL;APPL2;EXOC2;DENND5B;BRSK1;EGFR;TBC1D14;STK39;RIN2;FYN;TSPAN5;BNIP3;HLTF;KIF13B;UBE2J1;UBXN7;ARAP1;DLG1;DLG4;SNX9;TYSND1;NET1;EVI5L;GRK5;GDI1;STOM;SHC1;DLG3;PAK1;TRIB2;ATXN10;NEK9;TGFBR2;PTPN3;EPHA1;RAC2;OBSCN;FKBP1A;ABCD1;CCND2;RGS14;PKD2;PRKACB;SRGAP2B;LRP1;LDHA;AKAP9;RAB11FIP4;ABTB1;UBE2G1;ATF4;PPARA;WWC3;FGFR1;ITGA1;PPP1R35;LONP2;PITPNM1;CEACAM1;MAPKAPK3;DMXL2;NLK;TRIM5;SLC9A3R2;DVL1;DNMBP;DOCK9;TWF2;CST3;RABGGTA;TRIB3;TOM1L2;RANBP9;BTBD3;RIMS3;PPP3CB;SYTL1;FNBP1L;ASAP1;PRKAR1A;BOK;PARP9;NACC2;USP6NL;SPRY2;BEX4;TBC1D2B;ACVR1B;NGFR;PER3;BCL2L1;YTHDC2;MEF2D;ARF4;SLC12A7;UBASH3B;ARRDC1;ANKIB1;RIN1;RET;MTMR4;NCKAP1;GABARAPL2;RMRP;DOCK11;PAK6;PSD3;COL1A2;CCDC88A;SHC2;PRKACA;NEK6;RGL2;TMSB4X;TIMP2;RHOBTB1;AP2A2;IL1RAP;MOAP1;PJA2;MAP4K2;ZMYM2;PPARG;GRB7;EVI5;RPH3AL;WFS1;ACAP2;TBC1D16;FZD8;RAPGEFL1;HSPA2;TMEM173;RNF180;RALGDS;DNAJC3;KAT2B;USP25;RALGPS2;LRP4;RB1CC1;FADD
10394,GO:0043225,0.574569406138993,0.809305921387729,1,8,ATPase-coupled anion transmembrane transporter activity,MF,PCYOX1
17016,GO:0099133,0.574569406138993,0.809305921387729,1,8,ATP hydrolysis coupled anion transmembrane transport,BP,PCYOX1
1107,GO:0002696,0.574635934654885,0.536256132420105,14,174,positive regulation of leukocyte activation,BP,FYN;PAK1;RAG1;TGFBR2;MMP14;CD46;F2RL1;XBP1;SLC39A10;CARD11;AP3D1;IGF2;ADAM8;FADD
18084,GO:1902686,0.574804184668974,0.628762098782557,4,53,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,BNIP3;BNIP3L;BOK;MOAP1
19483,GO:1990253,0.574924408667557,0.80671657320198,1,9,cellular response to leucine starvation,BP,IMPACT
7452,GO:0031588,0.575211611931376,0.806487498096975,1,9,nucleotide-activated protein kinase complex,CC,PRKAR1A
3486,GO:0007351,0.575285492958259,0.806428539445301,1,9,tripartite regional subdivision,BP,PCSK6
3924,GO:0008595,0.575285492958259,0.806428539445301,1,9,anterior/posterior axis specification, embryo,BP,PCSK6
13607,GO:0060077,0.575300522885804,0.806416543700613,1,9,inhibitory synapse,CC,NLGN2
9286,GO:0035723,0.575500662944935,0.8062567575753,1,9,interleukin-15-mediated signaling pathway,BP,SHC1
15205,GO:0071350,0.575500662944935,0.8062567575753,1,9,cellular response to interleukin-15,BP,SHC1
18803,GO:1904354,0.575524728642753,0.808551352338223,1,8,negative regulation of telomere capping,BP,ERCC1
6713,GO:0030123,0.575850768895243,0.80597702111384,1,9,AP-3 adaptor complex,CC,AP3D1
11742,GO:0046578,0.575901327201502,0.522861270379734,18,190,regulation of Ras protein signal transduction,BP,F2R;ASAP2;APPL2;ARAP1;NET1;RASA3;OBSCN;APOE;DNMBP;F2RL1;ASAP1;SPRY2;PSD3;RGL2;TIMP2;LPAR1;ACAP2;RALGPS2
13963,GO:0060669,0.57595638017254,0.707173593692116,2,22,embryonic placenta morphogenesis,BP,IGF2;ZNF568
5422,GO:0016273,0.576113060357842,0.802428112498426,1,11,arginine N-methyltransferase activity,MF,PRMT3
5423,GO:0016274,0.576113060357842,0.802428112498426,1,11,protein-arginine N-methyltransferase activity,MF,PRMT3
9032,GO:0035246,0.576113060357842,0.802428112498426,1,11,peptidyl-arginine N-methylation,BP,PRMT3
16335,GO:0090557,0.576415983603607,0.807845499862866,1,8,establishment of endothelial intestinal barrier,BP,PTPRS
9944,GO:0042303,0.577005502755192,0.579313946082247,7,80,molting cycle,BP,EGFR;DKK1;FERMT1;ACVR1B;LAMA5;HPSE;LRP4
10115,GO:0042633,0.577005502755192,0.579313946082247,7,80,hair cycle,BP,EGFR;DKK1;FERMT1;ACVR1B;LAMA5;HPSE;LRP4
10986,GO:0044782,0.577119061173158,0.506547801079661,25,290,cilium organization,BP,NEURL1;BBS2;WWTR1;EVI5L;TTBK2;UNC119B;SEPT10;ATXN10;NUDCD3;AKAP9;PTPDC1;CEP120;RFX2;FNBP1L;ASAP1;SEPT5;MARK4;SPATA6;TCTN1;CCDC88A;PRKACA;LAMA5;WDR60;TMEM107;SEPT6
12416,GO:0048863,0.577181945582554,0.529631814758984,15,200,stem cell differentiation,BP,PSMD2;SEMA4B;WNT7A;EDNRA;HMGA2;EPCAM;PSMD7;RET;EIF2AK2;LAMA5;ALDH1A2;TBX1;LRP6;JARID2;SEMA3F
4551,GO:0010632,0.577205321180593,0.534120261376896,14,158,regulation of epithelial cell migration,BP,WNT7A;TGFBR2;APOE;ANXA3;FGFR1;HYAL1;ITGA2;PFN2;CEACAM1;TMSB4X;PPARG;SRPX2;AKT3;FOXP1
7056,GO:0030834,0.577483667136641,0.65805586363945,3,32,regulation of actin filament depolymerization,BP,TMOD2;TWF2;F2RL1
6543,GO:0021955,0.577573303417742,0.706971666783202,2,20,central nervous system neuron axonogenesis,BP,ADARB1;TCTN1
17514,GO:1900746,0.577807447625296,0.804408415612942,1,9,regulation of vascular endothelial growth factor signaling pathway,BP,XDH
18033,GO:1902547,0.577807447625296,0.804408415612942,1,9,regulation of cellular response to vascular endothelial growth factor stimulus,BP,XDH
10404,GO:0043236,0.577940458809096,0.705930817479684,2,21,laminin binding,MF,ITGA6;ITGA2
18177,GO:1902946,0.57821917048611,0.806411828468888,1,8,protein localization to early endosome,BP,SORL1
11041,GO:0045019,0.578259711080106,0.802190163158988,1,10,negative regulation of nitric oxide biosynthetic process,BP,ACP5
18825,GO:1904406,0.578259711080106,0.802190163158988,1,10,negative regulation of nitric oxide metabolic process,BP,ACP5
1074,GO:0002643,0.578669898702964,0.803714202937339,1,9,regulation of tolerance induction,BP,TGFBR2
4641,GO:0010763,0.578683683900026,0.803703092806155,1,9,positive regulation of fibroblast migration,BP,PAK1
6823,GO:0030282,0.578746493530326,0.605646268658771,5,55,bone mineralization,BP,CYP27B1;ACVR2B;FAM20C;PTHLH;ZBTB40
13467,GO:0055001,0.579026185477073,0.567732560606859,8,87,muscle cell development,BP,FLNC;NFATC4;SDC1;PAK1;OBSCN;TMOD2;OBSL1;PRKAR1A
14552,GO:0070070,0.579241008105682,0.80559605672258,1,8,proton-transporting V-type ATPase complex assembly,BP,DMXL2
14554,GO:0070072,0.579241008105682,0.80559605672258,1,8,vacuolar proton-transporting V-type ATPase complex assembly,BP,DMXL2
15592,GO:0072070,0.579317318177254,0.803191940913381,1,9,loop of Henle development,BP,PKD2
20229,GO:2001170,0.579366410720487,0.803152299066289,1,9,negative regulation of ATP biosynthetic process,BP,PPARA
15569,GO:0072017,0.579576281538778,0.808371048177891,1,7,distal tubule development,BP,PKD2
3043,GO:0006596,0.579652072241239,0.798286697029043,1,12,polyamine biosynthetic process,BP,AZIN2
12972,GO:0051354,0.57978338798283,0.800951636495505,1,10,negative regulation of oxidoreductase activity,BP,CYP27B1
3953,GO:0008655,0.579869574659068,0.798107560237117,1,12,pyrimidine-containing compound salvage,BP,TK2
16158,GO:0090175,0.57996005419481,0.565744910219741,8,101,regulation of establishment of planar polarity,BP,SMURF2;PSMD2;GPC4;DKK1;DVL1;PSMD7;AP2A2;ANKRD6
675,GO:0001885,0.580160828385647,0.625096856733231,4,44,endothelial cell development,BP,RAPGEF3;PTPRS;WNT7A;F2RL1
9764,GO:0039528,0.580224404685104,0.703770695020559,2,21,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,DDX60;PUM2
8674,GO:0034244,0.580421799977214,0.800431090285792,1,10,negative regulation of transcription elongation from RNA polymerase II promoter,BP,EAPP
2355,GO:0005451,0.58102356266089,0.801810868193648,1,9,monovalent cation:proton antiporter activity,MF,SLC9A7
7573,GO:0031935,0.581025025831674,0.703710681626874,2,20,regulation of chromatin silencing,BP,UHRF2;TET1
3590,GO:0008013,0.58105426049133,0.588103395764294,6,63,beta-catenin binding,MF,CTNNBIP1;BTRC;SLC9A3R2;DVL1;CSNK2A1;TBL1X
9039,GO:0035253,0.58107062046582,0.801772682297412,1,9,ciliary rootlet,CC,PSEN2
11425,GO:0045838,0.581153164854785,0.799833580599942,1,10,positive regulation of membrane potential,BP,ANK3
11200,GO:0045324,0.581215427378169,0.798259644437986,1,11,late endosome to vacuole transport,BP,TMEM50B
9081,GO:0035331,0.581789824794399,0.803550682084181,1,8,negative regulation of hippo signaling,BP,WWC3
17730,GO:1901659,0.581941371613712,0.650864045368013,3,42,glycosyl compound biosynthetic process,BP,NT5E;TK2;NME4
10117,GO:0042635,0.582328250624294,0.797342407895714,1,11,positive regulation of hair cycle,BP,HPSE
13192,GO:0051798,0.582328250624294,0.797342407895714,1,11,positive regulation of hair follicle development,BP,HPSE
1970,GO:0004683,0.582375589197447,0.701727364439306,2,21,calmodulin-dependent protein kinase activity,MF,MAPKAPK3;EEF2K
16473,GO:0097153,0.582671708573056,0.795789756178899,1,12,cysteine-type endopeptidase activity involved in apoptotic process,MF,CASP4
18584,GO:1903829,0.582676700249379,0.502434258189667,24,285,positive regulation of cellular protein localization,BP,EDEM1;SORL1;PRNP;RAPGEF3;SSH1;EGFR;ANK3;FYN;DLG1;CEMIP;STOM;PAK1;RAC2;LRP1;VAMP2;ABHD17C;VPS11;PARP9;NGFR;CCDC88A;EFCAB7;TMEM173;GNAI1;LRP4
4414,GO:0010181,0.582774905406332,0.798504177095399,1,10,FMN binding,MF,NOS1
12340,GO:0048701,0.582815611781304,0.652790514038288,3,32,embryonic cranial skeleton morphogenesis,BP,TGFBR2;MMP14;TBX1
11760,GO:0046607,0.582985440832376,0.800214470378708,1,9,positive regulation of centrosome cycle,BP,CEP120
8864,GO:0034661,0.583113456484758,0.699811926009276,2,23,ncRNA catabolic process,BP,XRN1;DEDD2
904,GO:0002286,0.583290654184632,0.621293393845186,4,47,T cell activation involved in immune response,BP,CEACAM1;CD46;F2RL1;FOXP1
7093,GO:0030888,0.583295646170077,0.65129730111515,3,35,regulation of B cell proliferation,BP,PKN1;SLC39A10;CARD11
3245,GO:0006901,0.583348167156058,0.600205451371786,5,60,vesicle coating,BP,SEC23A;MCFD2;LMAN1;RAB1A;CTSZ
11488,GO:0045948,0.583400915766414,0.699537130914009,2,23,positive regulation of translational initiation,BP,IMPACT;DNAJC3
9069,GO:0035305,0.583971977478712,0.572185004673135,7,80,negative regulation of dephosphorylation,BP,PPP1R14A;DLG3;FKBP1A;ELFN2;PPP1R35;PPP1R10;PPP1R2
10243,GO:0042975,0.584377237155652,0.799076474331239,1,9,peroxisome proliferator activated receptor binding,MF,NFATC4
7889,GO:0032456,0.584450931328832,0.650805365213499,3,33,endocytic recycling,BP,SORL1;RAB11FIP4;INPP5F
4235,GO:0009415,0.584543078668052,0.797047681637664,1,10,response to water,BP,PKD2
14392,GO:0061640,0.584588361840688,0.583713332798368,6,69,cytoskeleton-dependent cytokinesis,BP,ANK3;SNX9;SEPT10;SEPT5;SPIRE1;SEPT6
4568,GO:0010649,0.584686209418633,0.798823225700367,1,9,regulation of cell communication by electrical coupling,BP,ANK3
983,GO:0002440,0.585124783648312,0.552340360072559,9,112,production of molecular mediator of immune response,BP,ERCC1;PKN1;POU2F2;DLG1;DNAJB9;F2RL1;POLL;XBP1;CARD11
6625,GO:0022853,0.585216486377236,0.649385231845111,3,35,active ion transmembrane transporter activity,MF,ATP7B;ATP12A;ATP6V1B2
10108,GO:0042625,0.585216486377236,0.649385231845111,3,35,ATPase coupled ion transmembrane transporter activity,MF,ATP7B;ATP12A;ATP6V1B2
4511,GO:0010561,0.585254150401273,0.794916813352799,1,11,negative regulation of glycoprotein biosynthetic process,BP,ABCA7
9690,GO:0038083,0.585288715676772,0.650720103814511,3,31,peptidyl-tyrosine autophosphorylation,BP,EGFR;FYN;PTK6
17386,GO:1900112,0.585557810524073,0.798107604658907,1,9,regulation of histone H3-K9 trimethylation,BP,ATRX
1330,GO:0003183,0.585566201509947,0.800492322434643,1,8,mitral valve morphogenesis,BP,SOX4
8042,GO:0032691,0.585585201513109,0.794641092254457,1,11,negative regulation of interleukin-1 beta production,BP,ACP5
11446,GO:0045892,0.585763181552317,0.463504184566596,75,892,negative regulation of transcription, DNA-templated,BP,SMURF2;ZMYND8;CCND1;CTNNBIP1;VLDLR;NR1D1;NFATC4;ZC3H6;ACVR2B;SALL2;WWTR1;PEG3;DDIT3;ELK3;SCMH1;DLG1;DNAJB5;SHC1;DKK1;DAP;IMPACT;HMGA2;PPARA;WWC3;FGFR1;TCFL5;BTRC;ATRX;ZNF692;ATF7IP;RCOR1;MDFI;HES2;PHF12;KLF12;TRIB3;PRDX5;UHRF2;AEBP1;PARP9;NACC2;THRA;TSHZ1;PER3;H2AFJ;SATB1;TLE4;LOXL2;EAPP;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;ARID4A;TENM2;IGF2;PPARG;SNX6;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;ARID5B;E2F7;TET1;DEDD2;FOXP1;ZBTB33;PTCH1;JARID2;MXD4;DNMT3A
12872,GO:0051195,0.586005019580362,0.797739730113347,1,9,negative regulation of cofactor metabolic process,BP,PPARA
1912,GO:0004602,0.586015753565755,0.790197662309624,1,15,glutathione peroxidase activity,MF,GPX3
9226,GO:0035612,0.586239491328711,0.799943527305465,1,8,AP-2 adaptor complex binding,MF,FCHO1
786,GO:0002043,0.586580429205218,0.795360287140021,1,10,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,NGFR
10849,GO:0044344,0.586617192078485,0.551087069083845,9,107,cellular response to fibroblast growth factor stimulus,BP,POSTN;APLN;CD44;FGFR1;HYAL1;GALNT3;FAM20C;SPRY2;TBX1
15596,GO:0072075,0.586778785147085,0.797102111060512,1,9,metanephric mesenchyme development,BP,PKD2
3117,GO:0006694,0.586827039429742,0.543522893235558,10,127,steroid biosynthetic process,BP,CYP27B1;NR1D1;PLPP6;APOE;ABCG1;HSD17B7;SRD5A3;IGFBP7;HSD17B12;AMACR
18832,GO:1904424,0.586868054580663,0.797028457520625,1,9,regulation of GTP binding,BP,CCPG1
7442,GO:0031572,0.586875117244279,0.648389381867694,3,33,G2 DNA damage checkpoint,BP,BRSK1;HMGA2;TAOK1
9544,GO:0036296,0.586971342604627,0.69558021981093,2,24,response to increased oxygen levels,BP,BNIP3;PPARG
144,GO:0000295,0.587057156220804,0.793411995311983,1,11,adenine nucleotide transmembrane transporter activity,MF,SLC25A4
2331,GO:0005346,0.587057156220804,0.793411995311983,1,11,purine ribonucleotide transmembrane transporter activity,MF,SLC25A4
5038,GO:0015216,0.587057156220804,0.793411995311983,1,11,purine nucleotide transmembrane transporter activity,MF,SLC25A4
11294,GO:0045604,0.587510546172833,0.616819045127835,4,48,regulation of epidermal cell differentiation,BP,CYP27B1;ALOX15B;CTSL;PTCH1
15005,GO:0070933,0.587950340608393,0.796133989673569,1,9,histone H4 deacetylation,BP,RCOR1
1087,GO:0002675,0.588224783623481,0.79243333953586,1,11,positive regulation of acute inflammatory response,BP,ADAM8
10515,GO:0043422,0.588346522508743,0.793889571997632,1,10,protein kinase B binding,MF,CCDC88A
17273,GO:0120103,0.588348216862785,0.795804459754592,1,9,centriolar subdistal appendage,CC,CEP170
5737,GO:0016884,0.58836205478285,0.793876604485205,1,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,ASNS
11259,GO:0045504,0.588369210249032,0.793870630368035,1,10,dynein heavy chain binding,MF,WDR60
11871,GO:0046875,0.588424003504591,0.695294143657414,2,22,ephrin receptor binding,MF,FYN;SHC1
17874,GO:1902108,0.588497127767836,0.614784715740495,4,54,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,BNIP3;BNIP3L;BOK;MOAP1
19699,GO:2000027,0.588815549091529,0.518026684407612,15,184,regulation of organ morphogenesis,BP,SMURF2;ETV5;PSMD2;GPC4;DKK1;TGFBR2;FGFR1;CEACAM1;DVL1;PSMD7;WNT2B;XBP1;AP2A2;TBX1;ANKRD6
12782,GO:0051057,0.588905140926972,0.64672306128055,3,32,positive regulation of small GTPase mediated signal transduction,BP,F2R;F2RL1;LPAR1
19889,GO:2000378,0.588965048396706,0.645050759934486,3,37,negative regulation of reactive oxygen species metabolic process,BP,BNIP3;ACP5;SLC18A2
20075,GO:2000725,0.589275828563691,0.694471992143793,2,22,regulation of cardiac muscle cell differentiation,BP,DKK1;PAK1
5288,GO:0015949,0.589507720510489,0.691391252366776,2,28,nucleobase-containing small molecule interconversion,BP,NME4;AK9
15920,GO:0072698,0.589516847673215,0.616124476961637,4,42,protein localization to microtubule cytoskeleton,BP,TTBK2;NUDCD3;DVL1;ABHD17C
11291,GO:0045601,0.589599361742807,0.69480303109391,2,21,regulation of endothelial cell differentiation,BP,XDH;CEACAM1
14884,GO:0070669,0.589649883935084,0.794723752384346,1,9,response to interleukin-2,BP,SHC1
15207,GO:0071352,0.589649883935084,0.794723752384346,1,9,cellular response to interleukin-2,BP,SHC1
16070,GO:0090025,0.58981734433471,0.791093261328987,1,11,regulation of monocyte chemotaxis,BP,MOSPD2
13764,GO:0060340,0.589824591290018,0.794578393750982,1,9,positive regulation of type I interferon-mediated signaling pathway,BP,FADD
13701,GO:0060253,0.589922516408465,0.794496886936918,1,9,negative regulation of glial cell proliferation,BP,IDH2
17117,GO:0101031,0.590235415497722,0.790740461680165,1,11,chaperone complex,CC,FYCO1
3584,GO:0007631,0.590247302293435,0.644350173178717,3,35,feeding behavior,BP,ADM2;APLN;FYN
7547,GO:0031848,0.590306088803886,0.792249020072741,1,10,protection from non-homologous end joining at telomere,BP,ERCC1
7479,GO:0031643,0.590582588785354,0.793946884523497,1,9,positive regulation of myelination,BP,WASF3
11456,GO:0045910,0.59062131995246,0.693815574751336,2,21,negative regulation of DNA recombination,BP,MAGEF1;KLHL15
15783,GO:0072386,0.590687087865506,0.796291333372443,1,8,plus-end-directed organelle transport along microtubule,BP,FYCO1
15927,GO:0072710,0.590981868550885,0.793613679520129,1,9,response to hydroxyurea,BP,ATRX
14646,GO:0070230,0.591107482990715,0.788699529415919,1,12,positive regulation of lymphocyte apoptotic process,BP,ADAM8
20174,GO:2001020,0.591115708317008,0.523372714033211,13,162,regulation of response to DNA damage stimulus,BP,ERCC1;EGFR;CD44;HMGA2;ETAA1;CEBPG;PARP9;NACC2;PPP1R10;BCL2L1;RNF169;MAGEF1;KLHL15
3919,GO:0008589,0.59116860163295,0.593146831136845,5,54,regulation of smoothened signaling pathway,BP,SERPINE2;PRKACB;BTRC;TCTN1;PTCH1
10075,GO:0042573,0.591239162787492,0.789891707238434,1,11,retinoic acid metabolic process,BP,ALDH1A2
614,GO:0001782,0.591485989417677,0.69233248843677,2,22,B cell homeostasis,BP,PKN1;DOCK11
18242,GO:1903052,0.591669951659715,0.553801899219744,8,99,positive regulation of proteolysis involved in cellular protein catabolic process,BP,EDEM1;TRIB2;DVL1;TRIB3;XBP1;ANKIB1;MAGEF1;RNF180
2054,GO:0004806,0.591790017438921,0.791000539501762,1,10,triglyceride lipase activity,MF,DDHD2
8980,GO:0035082,0.59199294615512,0.691840446344004,2,22,axoneme assembly,BP,NEURL1;BBS2
15467,GO:0071803,0.592068710583437,0.790765473729441,1,10,positive regulation of podosome assembly,BP,ASAP1
5354,GO:0016125,0.592113807950024,0.545222683349285,9,110,sterol metabolic process,BP,SORL1;VLDLR;LMF1;PLPP6;APOE;ABCG1;LRP5;HSD17B7;OSBPL5
12704,GO:0050922,0.592261037434609,0.642988804072081,3,33,negative regulation of chemotaxis,BP,SEMA4B;C5;SEMA3F
19901,GO:2000392,0.592388168159009,0.792437051505209,1,9,regulation of lamellipodium morphogenesis,BP,CD44
18598,GO:1903861,0.592650273825794,0.794664235288124,1,8,positive regulation of dendrite extension,BP,SYT2
10121,GO:0042641,0.593033984713868,0.591227729987586,5,54,actomyosin,CC,MST1R;FHOD1;CDC42BPA;FLNB;KAT2B
6470,GO:0021799,0.593047035568774,0.69146389625822,2,21,cerebral cortex radially oriented cell migration,BP,LAMB1;MBOAT7
10827,GO:0044320,0.593306829930621,0.789718905164773,1,10,cellular response to leptin stimulus,BP,BBS2
4753,GO:0010927,0.593307669220272,0.57581672084274,6,61,cellular component assembly involved in morphogenesis,BP,OBSCN;TMOD2;OBSL1;RFX2;PRKAR1A;EPB41L3
3873,GO:0008499,0.593359826718131,0.788090504583815,1,11,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,B3GNT3
7730,GO:0032225,0.593480757767035,0.787987462620604,1,11,regulation of synaptic transmission, dopaminergic,BP,RAB3B
3323,GO:0007030,0.593806097286343,0.537001490242322,10,113,Golgi organization,BP,MAP2K1;AKAP9;OBSL1;LMAN1;USP6NL;GOLGA2P5;MAP2K2;RAB43;TMED4;RAB1A
1311,GO:0003159,0.594038118281815,0.787512092424401,1,11,morphogenesis of an endothelium,BP,FOXP1
14218,GO:0061154,0.594038118281815,0.787512092424401,1,11,endothelial tube morphogenesis,BP,FOXP1
9684,GO:0038061,0.594120805494128,0.550554649829989,8,111,NIK/NF-kappaB signaling,BP,TNFSF15;PSMD2;EGFR;BTRC;UACA;PSMD7;TMSB4X;EIF2AK2
852,GO:0002178,0.594183557737521,0.787387923622621,1,11,palmitoyltransferase complex,CC,SPTLC2
10579,GO:0043542,0.594324699089164,0.525016398853695,12,140,endothelial cell migration,BP,PRSS3;WNT7A;APOE;ANXA3;FGFR1;CEACAM1;LOXL2;TMSB4X;PPARG;SRPX2;AKT3;FOXP1
7586,GO:0031953,0.594572761561829,0.788644989755402,1,10,negative regulation of protein autophosphorylation,BP,IMPACT
12995,GO:0051412,0.594641467908202,0.788586593509171,1,10,response to corticosterone,BP,CCND1
6478,GO:0021819,0.594698695749619,0.788537944540013,1,10,layer formation in cerebral cortex,BP,MBOAT7
3261,GO:0006929,0.595028392558727,0.689534780845925,2,21,substrate-dependent cell migration,BP,ITGA2;ADAM8
9645,GO:0036513,0.595522974025471,0.787836348124407,1,10,Derlin-1 retrotranslocation complex,CC,SEL1L
3905,GO:0008544,0.5958417098093,0.492411583591073,22,270,epidermis development,BP,CYP27B1;MAP2K1;ALOX15B;EGFR;DKK1;SLITRK6;PPARA;FGFR1;FERMT1;PRR9;CTSL;PCSK6;PTHLH;ACVR1B;SATB1;LAMA5;PPL;PRSS8;FLNB;HPSE;PTCH1;LRP4
17372,GO:1900087,0.596197549027976,0.68714833358854,2,23,positive regulation of G1/S transition of mitotic cell cycle,BP,CCND2;HYAL1
12652,GO:0050856,0.596312727705221,0.686494525709234,2,24,regulation of T cell receptor signaling pathway,BP,PRNP;CEACAM1
10680,GO:0043931,0.596455577409988,0.791483962190027,1,8,ossification involved in bone maturation,BP,THBS3
5785,GO:0017014,0.596580386509039,0.786933892475408,1,10,protein nitrosylation,BP,NOS1
5905,GO:0018119,0.596580386509039,0.786933892475408,1,10,peptidyl-cysteine S-nitrosylation,BP,NOS1
13120,GO:0051657,0.596914355818476,0.791098171203533,1,8,maintenance of organelle location,BP,AKAP9
20026,GO:2000647,0.596965270162448,0.786604733408487,1,10,negative regulation of stem cell proliferation,BP,FERMT1
11502,GO:0045986,0.596994666715466,0.786579578090076,1,10,negative regulation of smooth muscle contraction,BP,DOCK4
2326,GO:0005338,0.597156337810721,0.784838617835177,1,11,nucleotide-sugar transmembrane transporter activity,MF,SLC35B4
18510,GO:1903671,0.597290599633306,0.687323128249829,2,21,negative regulation of sprouting angiogenesis,BP,EPN2;NGFR
10807,GO:0044292,0.597384399306936,0.786245874993958,1,10,dendrite terminus,CC,PTCH1
4455,GO:0010421,0.597529508098998,0.78451707933901,1,11,hydrogen peroxide-mediated programmed cell death,BP,ENDOG
16622,GO:0097468,0.597529508098998,0.78451707933901,1,11,programmed cell death in response to reactive oxygen species,BP,ENDOG
9597,GO:0036452,0.597768289607943,0.684109865308099,2,26,ESCRT complex,CC,MVB12B;MVB12A
11763,GO:0046620,0.597864984815219,0.585895220778283,5,56,regulation of organ growth,BP,PAK1;TGFBR2;WWC3;FGFR1;JARID2
6114,GO:0019359,0.598177138750149,0.54731327736141,8,95,nicotinamide nucleotide biosynthetic process,BP,NAPRT;DHTKD1;PGM1;IDH2;NMRK1;LDHA;PPARA;PARP9
6116,GO:0019363,0.598177138750149,0.54731327736141,8,95,pyridine nucleotide biosynthetic process,BP,NAPRT;DHTKD1;PGM1;IDH2;NMRK1;LDHA;PPARA;PARP9
16829,GO:0098719,0.598818154472414,0.786996211719823,1,9,sodium ion import across plasma membrane,BP,SLC9A7
775,GO:0002029,0.598865587217321,0.782027256500148,1,12,desensitization of G-protein coupled receptor protein signaling pathway,BP,APLN
6575,GO:0022401,0.598865587217321,0.782027256500148,1,12,negative adaptation of signaling pathway,BP,APLN
11302,GO:0045619,0.598909841875302,0.5462057200656,8,100,regulation of lymphocyte differentiation,BP,RAG1;TGFBR2;MMP14;CD46;XBP1;CARD11;AP3D1;ADAM8
8101,GO:0032786,0.599055286176794,0.683795792736891,2,24,positive regulation of DNA-templated transcription, elongation,BP,ERCC6;EAPP
14523,GO:0070008,0.599067315201058,0.784800627132779,1,10,serine-type exopeptidase activity,MF,AEBP1
14194,GO:0061099,0.599149285379448,0.683703042188592,2,24,negative regulation of protein tyrosine kinase activity,BP,PTK6;SNX6
16001,GO:0086009,0.599463314297902,0.685189801832903,2,21,membrane repolarization,BP,DLG1;AKAP9
802,GO:0002070,0.599491613331053,0.782820821851328,1,11,epithelial cell maturation,BP,XBP1
6609,GO:0022821,0.599627212547968,0.786304469954422,1,9,potassium ion antiporter activity,MF,SLC9A7
363,GO:0000981,0.599654456015442,0.453904505717848,62,715,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,ETV5;NR1D1;NFATC4;ETV4;SALL2;PEG3;POU2F2;TEF;ZKSCAN2;DDIT3;SOX12;ELK3;HLTF;KIAA1549;DDN;HMGA2;ATF4;PPARA;E2F5;TCFL5;NFAT5;SOX4;ZNF692;RCOR1;HES2;ZMYM3;KLF12;ZNF322;RFX2;CEBPG;PLAG1;AEBP1;NACC2;THRA;TSHZ1;MEF2D;XBP1;SATB1;TLE4;THAP10;GTF2IRD2;ETV1;ZNF398;UNKL;IFI16;NR2F6;HOXA3;ZSCAN18;ZMYM2;PPARG;ZNF37A;TBX1;CREB3L2;ARID5B;E2F7;FOXP1;ZBTB33;PBX3;JARID2;MXD4;ADNP;RFX7
5274,GO:0015924,0.59977262622285,0.786179971333382,1,9,mannosyl-oligosaccharide mannosidase activity,MF,EDEM1
1527,GO:0003906,0.600223147550276,0.779714338697073,1,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,HMGA2
7071,GO:0030858,0.600232117897403,0.633932279036746,3,36,positive regulation of epithelial cell differentiation,BP,CYP27B1;ALOX15B;PTCH1
4639,GO:0010761,0.600366949485053,0.634774553466274,3,33,fibroblast migration,BP,CYGB;PAK1;ARID5B
10710,GO:0044003,0.600462602331552,0.634329946305217,3,34,modification by symbiont of host morphology or physiology,BP,TNIP1;BCL2L1;EIF2AK2
10795,GO:0044267,0.601315355011304,0.426073876358162,324,3914,cellular protein metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;GID4;NOS1;ZMYND8;F2R;SORL1;RAB3B;CCND1;NEURL1;VLDLR;MMP1;RPS6KA2;SERPINE2;ADCY7;IGFBP4;PRNP;ADM2;BTBD2;NR1D1;HECW2;ADARB1;MAP2K1;TFPI2;RAPGEF3;ACVR2B;LTBP1;LMF1;PKN1;WWTR1;MST1R;MARCH9;LY6K;TNFSF15;EIF4EBP1;SSH1;DDIT3;PTPRS;B4GALT6;CARS;PSMD2;LAMB1;LTA4H;CAPN2;BRSK1;EGFR;STK39;LOXL1;PPP1R14A;FYN;TNFRSF6B;JADE2;BNIP3;HLTF;ERCC6;UBE2J1;UBXN7;MAPK13;ADAMTS7;DLG1;DLG4;B3GNT3;CTSB;SNX9;TGM2;FKBP9;WNT7A;UBXN4;IGF2BP3;MAP4K4;TTBK2;GRK5;STRADB;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;NEK9;RAG1;TGFBR2;PTPN3;SERPING1;EPHA1;IMPACT;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;CCND2;PTPN12;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;RBCK1;LRP1;ST3GAL5;IDE;AKAP9;PPP2R3B;ABTB1;UBE2G1;HMGA2;ATF4;ABCA7;PIGH;EIF4E3;LPAR3;PCMTD2;ELFN2;FGFR1;ITGA1;AARS;PPP1R35;MARCH4;PTPDC1;DCAF10;BTRC;ITGA2;PTK6;GALNT3;ULK2;LONP2;INPP5F;CHAC1;ATRX;FAM20C;MTHFR;PFN2;FKBP10;SOX4;RMND5A;FBXO2;DDB2;CEACAM1;MAPKAPK3;SPATA18;OBSL1;PRR9;LMAN1;MRPS6;RCOR1;SH3D19;NLK;XRN1;TRIM5;TNRC6B;DVL1;MMP14;MVB12B;CTH;LRP5;ETAA1;ABHD17C;CTSL;CST3;RABGGTA;CNTN1;TRIB3;CASP4;NTNG1;GFPT1;VPS11;RANBP9;DNAJB9;FBXL8;BTBD3;PPP3CB;MEX3C;ZDHHC2;APLP2;DNAJC6;SLK;PRDX5;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;TAOK1;FBXO41;OTUB2;CSNK2A1;PHF1;PSMD7;BLMH;QSOX1;PRKAR1A;MSRB2;BOK;PARP9;CPEB4;ATXN2;KLHL29;MAST3;NACC2;SPRY2;BEX4;ACVR1B;NGFR;PPP1R10;PSKH1;MVB12A;MARK4;PTPRZ1;MTA1;RNF165;PM20D2;TRIM7;ARF4;ANAPC13;PCYOX1;XBP1;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;ARRDC1;ANKIB1;LYPLAL1;RET;LOXL2;PDE5A;VWA1;C5;MTMR4;GABARAPL2;PAK6;UBE2E1;PUM2;RNF135;CCDC88A;CTSO;ADAMTSL1;SHC2;PRKACA;NEK6;UNKL;TIMP2;EIF2AK2;RAB1A;ZDHHC1;SEL1L;IFI16;AP2A2;SRD5A3;SLC39A10;ST6GALNAC2;LAMB2;FICD;SECISBP2L;LPAR1;CTSZ;TBL1X;RNF169;ARID4A;IGF2;PJA2;MAP4K2;ZMYM2;ERLEC1;PPARG;SNX6;EVA1A;USP20;GRB7;LYPLA1;TBX1;ADAM8;AKT3;GARS;WFS1;PHF21A;IGFBP7;MARCH2;FZD8;USP32;HSPA2;LRP6;ARID5B;MAGEF1;RNF180;EEF2K;TNRC6C;TRIM2;RCAN1;TET1;DNAJC3;PSEN2;ADCY1;KAT2B;CNOT11;RNF103;USP25;PRMT3;UFL1;FAM162A;ANKRD6;JARID2;PPM1M;KLHL15;ADNP;LRP4;STT3B;RB1CC1;TRIM38;FBXL5;FADD
11299,GO:0045616,0.60132875382855,0.633118993388795,3,35,regulation of keratinocyte differentiation,BP,CYP27B1;ALOX15B;CTSL
975,GO:0002429,0.601554097180778,0.495493114059185,18,228,immune response-activating cell surface receptor signaling pathway,BP,PRNP;PAG1;PSMD2;WIPF1;FYN;PAK1;PRKACB;RBCK1;BTRC;CEACAM1;PSMD7;WASF2;NCKAP1;PRKACA;SLC39A10;CARD11;ARPC1A;WASL
13499,GO:0055064,0.601895120078271,0.784356830463886,1,9,chloride ion homeostasis,BP,SLC12A7
10059,GO:0042542,0.602002759465735,0.542663572021766,8,105,response to hydrogen peroxide,BP,BNIP3;MAPK13;NET1;SDC1;IMPACT;LDHA;CST3;ENDOG
17887,GO:1902166,0.60203690007583,0.778120715139945,1,13,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CD44
11328,GO:0045651,0.602242781615241,0.782054615305998,1,10,positive regulation of macrophage differentiation,BP,FADD
4148,GO:0009209,0.602259035669961,0.777924977227124,1,13,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,NME4
12604,GO:0050780,0.602346875381417,0.781964177038792,1,10,dopamine receptor binding,MF,DLG4
4274,GO:0009635,0.602404937938515,0.778934164794196,1,12,response to herbicide,BP,MAPK13
8891,GO:0034706,0.603429395080637,0.78556406024966,1,8,sodium channel complex,CC,SCN8A
4334,GO:0009886,0.603669275495543,0.780812912044276,1,10,post-embryonic animal morphogenesis,BP,ATRX
2199,GO:0005080,0.603756722494158,0.630632148736871,3,35,protein kinase C binding,MF,PKN1;GRK5;TWF2
66,GO:0000137,0.603832282327771,0.780670699103931,1,10,Golgi cis cisterna,CC,GOLGA2P5
13580,GO:0060047,0.604162617505706,0.520051630205102,11,127,heart contraction,BP,NOS1;APLN;DLG1;ASPH;AKAP9;ITPR3;THRA;TRPC1;PDE5A;PRKACA;ITPR2
7027,GO:0030800,0.604174429031965,0.780371982796777,1,10,negative regulation of cyclic nucleotide metabolic process,BP,AKAP9
7042,GO:0030815,0.604174429031965,0.780371982796777,1,10,negative regulation of cAMP metabolic process,BP,AKAP9
12642,GO:0050840,0.604231061928617,0.630473023017813,3,34,extracellular matrix binding,MF,ITGA6;SMOC1;ITGA2
15067,GO:0071027,0.604310361567109,0.776111603926964,1,13,nuclear RNA surveillance,BP,XRN1
15068,GO:0071028,0.604310361567109,0.776111603926964,1,13,nuclear mRNA surveillance,BP,XRN1
12552,GO:0050704,0.60449833498655,0.677893776348052,2,25,regulation of interleukin-1 secretion,BP,ARG2;FOXP1
3034,GO:0006582,0.604502999315516,0.782101500091353,1,9,melanin metabolic process,BP,TRPC1
13133,GO:0051693,0.604655582777788,0.680055041741188,2,21,actin filament capping,BP,TMOD2;TWF2
10610,GO:0043588,0.604742542269783,0.487464541862192,20,241,skin development,BP,ITGA6;CYP27B1;ITGB4;MAP2K1;ALOX15B;EGFR;DKK1;ITGA2;FERMT1;PRR9;CTSL;PCSK6;ACVR1B;COL1A2;LAMA5;PPL;PRSS8;FLNB;HPSE;LRP4
5452,GO:0016324,0.604745351281713,0.501825622159877,15,171,apical plasma membrane,CC,SLC29A4;EGFR;STK39;DLG1;PODXL;SHANK2;CD44;EPCAM;CEACAM1;SLC9A3R2;MPDZ;SLC2A9;ANO1;PSEN2;SLC23A2
4036,GO:0009068,0.604849385387494,0.778140463290425,1,11,aspartate family amino acid catabolic process,BP,ALDH7A1
4966,GO:0015074,0.604883764212207,0.779751756565387,1,10,DNA integration,BP,NYNRIN
13468,GO:0055002,0.605546857291225,0.549983030623846,7,78,striated muscle cell development,BP,FLNC;SDC1;PAK1;OBSCN;TMOD2;OBSL1;PRKAR1A
6067,GO:0019216,0.605594768964354,0.482395157704457,22,262,regulation of lipid metabolic process,BP,CYP27B1;NR1D1;LMF1;TYSND1;APOE;ANGPTL4;PPARA;LPCAT1;LONP2;ABCG1;CEACAM1;TRIB3;MLYCD;CPT2;THRA;ABHD6;MTMR4;SAMD8;TBL1X;PPARG;IGFBP7;ALAS1
68,GO:0000139,0.605607360746396,0.454002859365181,49,583,Golgi membrane,CC,EDEM1;SORL1;ASAP2;MARCH9;B4GALT6;EGFR;SLC33A1;ARAP1;B3GNT3;SLC9A7;SEC23A;MALL;B4GALNT4;ATP7B;MCFD2;ST3GAL5;ABCA7;ICA1;MARCH4;LPCAT1;GALNT3;ABCG1;PITPNM1;RAB31;LMAN1;BSG;CLCN3;SLC35B4;COPB1;COPG1;QSOX1;BOK;USP6NL;AGPAT3;GOLGA2P5;STX10;RAB43;GABARAPL2;SAMD8;RAB1A;KDELR3;ST6GALNAC2;CTSZ;AP3D1;PJA2;MAP4K2;TMEM50B;PSEN2;COG8
15996,GO:0086004,0.60584867698619,0.679602467892712,2,20,regulation of cardiac muscle cell contraction,BP,DLG1;AKAP9
9323,GO:0035794,0.605968203162615,0.596621708711734,4,55,positive regulation of mitochondrial membrane permeability,BP,BNIP3;BNIP3L;BOK;MOAP1
19346,GO:1905710,0.605968203162615,0.596621708711734,4,55,positive regulation of membrane permeability,BP,BNIP3;BNIP3L;BOK;MOAP1
3664,GO:0008150,0.606136801473796,0.444846664149882,939,11215,biological_process,BP,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EDEM1;TSPAN1;GID4;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;FAM83A;ADAM19;ETV5;RAB3B;PGF;MBOAT2;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;H1F0;SERPINE2;PEAR1;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;PAG1;ADGRF1;MXRA5;OSBP2;ITGB4;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;CMTM4;THBS2;FAM210B;FMNL2;ETV4;TFPI2;LTBP2;RAPGEF3;FNDC4;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;SLC29A4;ALOX15B;LMF1;SALL2;COL13A1;TK2;THSD4;GPX3;PKN1;NAPRT;WWTR1;DCBLD2;PEG3;CCNI;MST1R;ARHGAP22;MICALCL;WDR66;MARCH9;H6PD;APLN;RBMS2;MARVELD1;POU2F2;TRIM65;LY6K;DHTKD1;PITPNC1;DGKA;TEF;TNFSF15;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;KCNG1;PTPRS;B4GALT6;CCNG2;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;SDK2;EXOC2;ELK3;CRTC1;ADGRL1;DENND5B;AVL9;LTA4H;CAPN2;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;BCORL1;DYSF;CGREF1;PDZD2;LOXL1;ARHGAP12;PPP1R14A;FYN;HEBP1;MYH15;TNFRSF6B;TMPRSS11D;OSBPL10;TSPAN5;PCDHAC2;PSAT1;JADE2;BNIP3;HLTF;KIF13B;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;MYCBPAP;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;CSMD3;DLG4;B3GNT3;IDH2;TMEM245;CTSB;CD68;DNAJB5;ACOT1;PLXNB3;GPC4;DHX32;SNX9;TYSND1;PODXL;SLCO4A1;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;EVI5L;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;TTC7B;RSAD1;GRK5;HTR7;NMRK1;STRADB;RDH14;NME4;MALL;CRTAP;ASPH;MCTP1;GDI1;CEMIP;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;WISP1;DAP;SMOC2;HYI;SLFN5;PAK1;RASA3;SOCS2;TRIB2;ATXN10;NEK9;KIAA1549;RHPN1;ZNF652;CBR4;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;NUDCD3;EDNRA;LCN2;HAGH;SHANK2;SLITRK6;SCRN1;EPHA1;IMPACT;RALGAPA2;PLPP6;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCPG1;CCND2;ACP5;ANGPTL4;PRR15;PTPN12;ALDH1L2;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;ICA1;EIF4E3;AGPAT4;LPAR3;PCMTD2;ELFN2;FAM155B;KIF21B;ASNS;FGFR1;ABHD10;ITGA1;AARS;PPP1R35;E2F5;EPCAM;TMOD2;MARCH4;TUB;PTPDC1;CMTM7;LPCAT4;TACC1;TCFL5;RNPEPL1;UROS;SMOC1;NFAT5;ITGB5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;AIG1;ITGA2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;FAT1;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;NELL2;GAMT;CEP120;ENDOV;IAH1;ZNF558;KDSR;MBLAC2;CEACAM1;ADM5;FERMT1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PRR9;SLC5A1;PDIA5;RAB31;LMAN1;DMXL2;SLC35F2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLEK2;PLA2G4D;HES2;ANXA6;NLGN2;CD46;ZBTB10;ACAD10;PHF12;MVB12B;EPOR;CTH;ORAI3;ZNF704;NXPH4;MPDZ;FAM50A;MAP6;LRP5;ETAA1;NIPA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;THBS3;CTSL;DOCK9;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;NTNG1;GFPT1;PCSK6;TPBG;TOM1L2;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;FBXL8;BTBD3;RIMS3;PLPPR2;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;INPP4A;RFX2;SYTL1;HIBADH;ADGRB2;TTYH3;KIAA1147;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;TTC9;ANO8;SCYL3;F2RL1;DDX60;UHRF2;SLC2A9;RASIP1;GSDMA;PROCR;C6ORF120;TAOK1;PLD3;PHC3;AEBP1;ATP10D;ABHD15;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;CPNE8;SUGCT;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;ANO1;MSRB2;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;C18ORF32;ATXN2;KLHL29;MAST3;NACC2;DHRS12;USP6NL;SPRY2;SEPT5;LACTB2;SLC6A14;ZNF337;BEX4;TBC1D2B;THRA;LMBR1L;MGLL;CD99;WNT2B;CYYR1;ACVR1B;DBNDD1;NDUFA4L2;SLC43A1;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;MARK4;NPL;ZNF449;PTPRZ1;CHD6;NUDT6;SPESP1;PER3;MTA1;AZIN2;BCL2L1;IFITM1;CRAT;RNF165;YTHDC2;PM20D2;GRIN3B;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;NYNRIN;SKAP2;ARF4;GOLGA2P5;H2AFJ;POLL;TMEM187;ANAPC13;YPEL5;UAP1;CNNM1;HSD17B7;SLC12A7;PCYOX1;XBP1;PANK4;SPIRE1;SLC46A3;NT5DC1;NFU1;UBASH3B;TXNRD3;CADM4;MAP2K2;ABHD6;SATB1;SLC22A17;GPATCH8;PPP1R2;PAIP1;ARRDC1;SPIN4;REC8;CYP4F22;ANKIB1;MICU3;LYPLAL1;TLE4;SLC38A2;RIN1;TRPC1;RET;SPATA6;SDR9C7;CCDC71L;TUBG2;STX10;LOXL2;PDE5A;VWA1;TCTN1;RAB43;MLH3;OSBPL5;SLC13A3;NAV1;SH3PXD2B;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;MBOAT7;THAP10;NOP10;NCKAP1;GABARAPL2;EPM2A;KCNJ15;RMRP;GTF2IRD2;DNASE1L1;C1ORF56;ELMO3;DOCK11;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;TSPAN3;RNF135;PSD3;TMBIM1;ETV1;FRMD4B;COL1A2;SFXN3;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;SHC2;PRKACA;SAMD5;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;EEPD1;SNX30;SEL1L;PCDH1;CBX7;IFI16;RHOBTB1;BCAP29;AP2A2;SRD5A3;NR2F6;SLC39A10;KDELR3;CMTM6;SCAND1;IL1RAP;SBNO1;SLC25A43;ST6GALNAC2;ORAI1;CARD11;FCHO1;LAMB2;LTB4R;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;NRSN2;ACP6;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;SLC2A13;ZSCAN18;GRB10;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;SLC10A6;TMEM63A;CITED4;SNX6;EVA1A;USP20;ANKRD50;ZFP30;GRB7;SRPX2;PPL;ALDH1A2;GPR153;ARHGAP29;LYPLA1;TMEM50B;ATP12A;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;ROBO3;GARS;IL20RB;CLDN11;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;IKBIP;PHF21A;ZBTB40;ZNF92;WDR60;ACAP2;MPLKIP;MAML3;CKLF;ZNF568;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;OSGEPL1;PLCXD1;FZD8;TMEM107;WASL;USP32;RAPGEFL1;REEP6;HSPA2;PRSS8;ZNF107;FLNB;LRP6;ARID5B;MAGEF1;ZNF165;SYT2;PLCH2;TMEM173;RNF180;GGACT;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;SEMA6C;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;TNRC6C;TRIM2;COQ2;RCAN1;TET1;OMG;KCTD18;SH3TC1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;DNAJC4;AOX1;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;RNF103;USP25;LRP3;PANK1;PRMT3;REEP3;NYAP1;UFL1;FAM162A;ANKRD6;SNX27;N4BP2;AMACR;GALE;PBX3;JARID2;PPM1M;SLC23A2;SEMA3F;RALGPS2;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
5583,GO:0016601,0.606305167654753,0.628340497014683,3,34,Rac protein signal transduction,BP,RAC2;WASF2;NCKAP1
9463,GO:0036065,0.606416567689857,0.677032522999504,2,23,fucosylation,BP,ADAMTS7;ADAMTSL1
9126,GO:0035437,0.606465725486405,0.776714426554433,1,11,maintenance of protein localization in endoplasmic reticulum,BP,KDELR3
4049,GO:0009086,0.606685950912141,0.776519622047813,1,11,methionine biosynthetic process,BP,CTH
276,GO:0000778,0.607333628046003,0.774574889972029,1,12,condensed nuclear chromosome kinetochore,CC,REC8
11604,GO:0046209,0.607412852438874,0.596318885442532,4,48,nitric oxide metabolic process,BP,NOS1;ARG2;ACP5;PKD2
16165,GO:0090183,0.607711680788688,0.626250932262377,3,36,regulation of kidney development,BP,WWTR1;WNT2B;RET
11799,GO:0046676,0.607805621113452,0.675641990469106,2,23,negative regulation of insulin secretion,BP,HADH;MAP4K4
16231,GO:0090278,0.607805621113452,0.675641990469106,2,23,negative regulation of peptide hormone secretion,BP,HADH;MAP4K4
17531,GO:1901021,0.607980766861527,0.676072398693711,2,22,positive regulation of calcium ion transmembrane transporter activity,BP,PKD2;HSPA2
4826,GO:0014029,0.608435307521113,0.776627408902196,1,10,neural crest formation,BP,LRP6
16385,GO:0090734,0.608543635724469,0.625701404747144,3,35,site of DNA damage,CC,PHF1;PARP9;RNF169
17861,GO:1902074,0.608688215946493,0.773366094966971,1,12,response to salt,BP,MAPK13
16412,GO:0097038,0.608825163402133,0.776282513014885,1,10,perinuclear endoplasmic reticulum,CC,CAPN2
13915,GO:0060572,0.60926730364095,0.77589089762998,1,10,morphogenesis of an epithelial bud,BP,WNT2B
15665,GO:0072182,0.609460461224189,0.777767394891052,1,9,regulation of nephron tubule epithelial cell differentiation,BP,WWTR1
4458,GO:0010447,0.610064155277874,0.773516032022868,1,11,response to acidic pH,BP,IMPACT
15759,GO:0072349,0.610100099215991,0.777203681422642,1,9,modified amino acid transmembrane transporter activity,MF,SLC7A11
12686,GO:0050901,0.610251263622351,0.775017601968601,1,10,leukocyte tethering or rolling,BP,ITGA4
11366,GO:0045725,0.610563201032852,0.779383694661915,1,8,positive regulation of glycogen biosynthetic process,BP,IGF2
3316,GO:0007019,0.610587218086803,0.624643219246627,3,32,microtubule depolymerization,BP,MAP1B;TTBK2;CCSAP
7295,GO:0031293,0.610746930287928,0.672685174001659,2,23,membrane protein intracellular domain proteolysis,BP,NGFR;PSEN2
200,GO:0000421,0.610770173671486,0.671596477555566,2,25,autophagosome membrane,CC,WDFY3;GABARAPL2
12653,GO:0050857,0.610899700081869,0.772768681904544,1,11,positive regulation of antigen receptor-mediated signaling pathway,BP,SLC39A10
587,GO:0001741,0.61099896803176,0.772679774004173,1,11,XY body,CC,DNMT3A
10050,GO:0042532,0.611073026962301,0.77261342785427,1,11,negative regulation of tyrosine phosphorylation of STAT protein,BP,INPP5F
16934,GO:0098911,0.611265333899067,0.776174096203665,1,9,regulation of ventricular cardiac muscle cell action potential,BP,DLG1
1,GO:0000002,0.611745304435934,0.671120790646524,2,24,mitochondrial genome maintenance,BP,SLC25A4;AKT3
4785,GO:0010972,0.611978923942487,0.553523208971397,6,87,negative regulation of G2/M transition of mitotic cell cycle,BP,FHL1;PSMD2;BRSK1;HMGA2;TAOK1;PSMD7
6879,GO:0030374,0.612007203058484,0.570950092318166,5,57,ligand-dependent nuclear receptor transcription coactivator activity,MF,NR1D1;PKN1;PPARA;THRA;PPARG
4675,GO:0010823,0.612010673129105,0.620711369225326,3,40,negative regulation of mitochondrion organization,BP,BNIP3;BOK;BCL2L1
11415,GO:0045822,0.612013738174754,0.773447204758697,1,10,negative regulation of heart contraction,BP,PDE5A
10272,GO:0043014,0.612187425750858,0.671230925985913,2,23,alpha-tubulin binding,MF,FAM110C;BEX4
76,GO:0000153,0.612361354769875,0.771457033807241,1,11,cytoplasmic ubiquitin ligase complex,CC,SEL1L
15509,GO:0071880,0.612392333327174,0.777778411673459,1,8,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,NOS1
433,GO:0001161,0.613072051815043,0.772500424319331,1,10,intronic transcription regulatory region sequence-specific DNA binding,MF,ZC3H6
10768,GO:0044213,0.613072051815043,0.772500424319331,1,10,intronic transcription regulatory region DNA binding,MF,ZC3H6
8056,GO:0032720,0.613110077856341,0.668757064004807,2,26,negative regulation of tumor necrosis factor production,BP,ARG2;ACP5
3815,GO:0008406,0.613217885258914,0.505036597594436,12,145,gonad development,BP,ERCC1;CCND1;SDC1;ATRX;MMP14;CST3;BOK;WNT2B;BCL2L1;REC8;ARID4A;ARID5B
9782,GO:0039694,0.613358873305491,0.669486738302656,2,24,viral RNA genome replication,BP,HMGA2;APOBEC3C
3114,GO:0006691,0.613648928393302,0.768899489974756,1,12,leukotriene metabolic process,BP,LTA4H
7756,GO:0032272,0.613666502090808,0.589763042305325,4,48,negative regulation of protein polymerization,BP,TMOD2;PFN2;TWF2;TMSB4X
4201,GO:0009309,0.614368734479021,0.767066306643759,1,13,amine biosynthetic process,BP,AZIN2
9992,GO:0042401,0.614368734479021,0.767066306643759,1,13,cellular biogenic amine biosynthetic process,BP,AZIN2
18303,GO:1903209,0.614461639265673,0.769562730289673,1,11,positive regulation of oxidative stress-induced cell death,BP,ENDOG
17512,GO:1900744,0.614494081305783,0.668893775743618,2,23,regulation of p38MAPK cascade,BP,XDH;DLG1
10116,GO:0042634,0.614538842187265,0.668848319653775,2,23,regulation of hair cycle,BP,FERMT1;HPSE
11325,GO:0045648,0.61463116219436,0.668754553307156,2,23,positive regulation of erythrocyte differentiation,BP,FAM210B;ACVR1B
4719,GO:0010881,0.614642212980638,0.769399337411687,1,11,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,PRKACA
16106,GO:0090085,0.614670747694879,0.769373509982214,1,11,regulation of protein deubiquitination,BP,TNIP1
8927,GO:0034770,0.614743359915919,0.773080408668987,1,9,histone H4-K20 methylation,BP,ARID4A
16764,GO:0098554,0.61483690954986,0.766638995343709,1,13,cytoplasmic side of endoplasmic reticulum membrane,CC,PKD2
713,GO:0001938,0.615383158521734,0.566925994226534,5,60,positive regulation of endothelial cell proliferation,BP,PGF;APLN;PLXNB3;FGFR1;AKT3
7417,GO:0031507,0.61546452948768,0.770349513284672,1,10,heterochromatin assembly,BP,HMGA2
18511,GO:1903672,0.61559770836426,0.667771856094244,2,23,positive regulation of sprouting angiogenesis,BP,SRPX2;AKT3
4439,GO:0010314,0.61560707876196,0.770220892821262,1,10,phosphatidylinositol-5-phosphate binding,MF,SH3PXD2B
10912,GO:0044458,0.615651727443876,0.767078318543096,1,12,motile cilium assembly,BP,SPATA6
18926,GO:1904668,0.616148536390168,0.766624962289118,1,12,positive regulation of ubiquitin protein ligase activity,BP,RAB1A
16326,GO:0090527,0.61615690829598,0.7718142134575,1,9,actin filament reorganization,BP,ARAP1
4390,GO:0010043,0.616186150306643,0.665623789319626,2,26,response to zinc ion,BP,MT2A;SLC30A1
17528,GO:1901018,0.616218087407771,0.771759295829513,1,9,positive regulation of potassium ion transmembrane transporter activity,BP,AKAP9
1108,GO:0002697,0.61682764876798,0.485304420467796,16,202,regulation of immune effector process,BP,PKN1;HTRA1;SERPING1;RAC2;CEACAM1;CD46;PPP3CB;F2RL1;DDX60;PARP9;XBP1;C5;PUM2;IL20RB;TMEM173;FADD
8324,GO:0033160,0.616871416033677,0.771172231666456,1,9,positive regulation of protein import into nucleus, translocation,BP,TMEM173
11477,GO:0045933,0.617043481477561,0.665220971974279,2,25,positive regulation of muscle contraction,BP,F2R;ITGA2
4500,GO:0010528,0.617190279735155,0.767084745207941,1,11,regulation of transposition,BP,APOBEC3C
4501,GO:0010529,0.617190279735155,0.767084745207941,1,11,negative regulation of transposition,BP,APOBEC3C
7929,GO:0032506,0.617458450741384,0.665874825239147,2,23,cytokinetic process,BP,SNX9;SPIRE1
19956,GO:2000514,0.617859547096215,0.664385917241946,2,25,regulation of CD4-positive, alpha-beta T cell activation,BP,ARG2;TGFBR2
16172,GO:0090190,0.617873319247059,0.766461436906898,1,11,positive regulation of branching involved in ureteric bud morphogenesis,BP,WNT2B
12747,GO:0051015,0.618021774324881,0.505750691551577,11,121,actin filament binding,MF,FLNC;SYNE3;WIPF1;EGFR;MYH15;ESPN;OBSL1;TWF2;ARPC1A;WASL;SSFA2
4418,GO:0010212,0.618089982482089,0.504972522499143,11,136,response to ionizing radiation,BP,ERCC1;CCND1;ERCC6;NET1;CCND2;HMGA2;MTA1;BCL2L1;IFI16;IKBIP;DNMT3A
7150,GO:0031005,0.618387816223034,0.767701370401056,1,10,filamin binding,MF,CEACAM1
12085,GO:0048038,0.618445414835438,0.76230672627869,1,14,quinone binding,MF,CBR4
13211,GO:0051861,0.618625205838315,0.764355370171741,1,12,glycolipid binding,MF,HSPA2
3490,GO:0007368,0.618795570435654,0.547990761181481,6,69,determination of left/right symmetry,BP,ACVR2B;TGFBR2;PKD2;PCSK6;PSKH1;TBX1
7284,GO:0031269,0.618814960057353,0.765600155238567,1,11,pseudopodium assembly,BP,F2RL1
8100,GO:0032785,0.618834491672602,0.765582266026659,1,11,negative regulation of DNA-templated transcription, elongation,BP,EAPP
8045,GO:0032695,0.618887318868429,0.765533876063699,1,11,negative regulation of interleukin-12 production,BP,ACP5
930,GO:0002328,0.619203441508694,0.76906773518576,1,9,pro-B cell differentiation,BP,SOX4
10575,GO:0043537,0.619355118553455,0.663934106215871,2,23,negative regulation of blood vessel endothelial cell migration,BP,APOE;PPARG
418,GO:0001105,0.619359754154781,0.615113873104779,3,33,RNA polymerase II transcription coactivator activity,MF,SOX12;SOX4;CITED4
5455,GO:0016331,0.619736780178961,0.509644268740467,10,115,morphogenesis of embryonic epithelium,BP,PRKACB;SOX4;DVL1;WNT2B;RET;TCTN1;LAMA5;ALDH1A2;LRP6;PTCH1
998,GO:0002467,0.61990616174289,0.766317189057302,1,10,germinal center formation,BP,PKN1
6311,GO:0019956,0.619987744699022,0.764524226857017,1,11,chemokine binding,MF,ITGA4
14887,GO:0070672,0.62002734582683,0.766206454291229,1,10,response to interleukin-15,BP,SHC1
9551,GO:0036312,0.620040541387627,0.768308866920702,1,9,phosphatidylinositol 3-kinase regulatory subunit binding,MF,FAM83A
1323,GO:0003174,0.620461072288069,0.767926948406632,1,9,mitral valve development,BP,SOX4
17560,GO:1901137,0.620672645516437,0.44077208605597,45,554,carbohydrate derivative biosynthetic process,BP,TNIP1;NT5E;NOS1;PYGL;ADCY7;CRYL1;LMF1;TK2;DHTKD1;B4GALT6;UBE2J1;PGM1;ADAMTS7;B3GNT3;GPC4;ACOT7;NME4;CEMIP;SDC1;APOE;MCFD2;LDHA;ST3GAL5;AKAP9;PPARA;ABCA7;PIGH;HYAL1;GALNT3;LMAN1;GFPT1;PTHLH;UAP1;PANK4;ADAMTSL1;TMSB4X;TIMP2;SRD5A3;ST6GALNAC2;AK9;TET1;ADCY1;PANK1;ADNP;STT3B
5401,GO:0016239,0.620730612415245,0.561545350709368,5,58,positive regulation of macroautophagy,BP,BNIP3;SPTLC2;BNIP3L;FYCO1;EPM2A
5546,GO:0016538,0.620759567649555,0.660083461644176,2,28,cyclin-dependent protein serine/threonine kinase regulator activity,MF,CCND1;KAT2B
5141,GO:0015662,0.620909601831446,0.662958664263651,2,22,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,ATP7B;ATP12A
17773,GO:1901800,0.620940522357432,0.532639806315897,7,90,positive regulation of proteasomal protein catabolic process,BP,EDEM1;TRIB2;DVL1;TRIB3;XBP1;ANKIB1;RNF180
12253,GO:0048532,0.621114860926977,0.765210995710519,1,10,anatomical structure arrangement,BP,SEMA3F
16636,GO:0097493,0.621174316253071,0.778120795239655,1,6,structural molecule activity conferring elasticity,MF,OBSL1
12791,GO:0051085,0.621279303891599,0.660394858007812,2,26,chaperone cofactor-dependent protein refolding,BP,HSPA13;HSPA2
5242,GO:0015865,0.621617133746074,0.761592283105985,1,12,purine nucleotide transport,BP,SLC25A4
5245,GO:0015868,0.621617133746074,0.761592283105985,1,12,purine ribonucleotide transport,BP,SLC25A4
13044,GO:0051503,0.621617133746074,0.761592283105985,1,12,adenine nucleotide transport,BP,SLC25A4
18687,GO:1904036,0.621657570661116,0.661568554819907,2,23,negative regulation of epithelial cell apoptotic process,BP,ANGPTL4;WFS1
15454,GO:0071774,0.62168556179331,0.514130553277181,9,110,response to fibroblast growth factor,BP,POSTN;APLN;CD44;FGFR1;HYAL1;GALNT3;FAM20C;SPRY2;TBX1
75,GO:0000152,0.621820811293326,0.610416394921756,3,40,nuclear ubiquitin ligase complex,CC,PHC3;ANAPC13;CBX7
7767,GO:0032287,0.621909755913023,0.769287482046724,1,8,peripheral nervous system myelin maintenance,BP,SH3TC2
6162,GO:0019511,0.622293499003894,0.762398409951303,1,11,peptidyl-proline hydroxylation,BP,CRTAP
11474,GO:0045930,0.622391468875238,0.46645146556879,21,275,negative regulation of mitotic cell cycle,BP,FHL1;CCND1;PSMD2;BRSK1;EGFR;DLG1;XPC;PTPN3;PKD2;HMGA2;ATRX;SOX4;TOM1L2;TAOK1;PSMD7;NACC2;PPP1R10;BCL2L1;TIMP2;E2F7;CNOT11
7265,GO:0031233,0.622397155289385,0.760868066083635,1,12,intrinsic component of external side of plasma membrane,CC,PRNP
3149,GO:0006744,0.622491353994457,0.758540055054063,1,14,ubiquinone biosynthetic process,BP,COQ2
17734,GO:1901663,0.622491353994457,0.758540055054063,1,14,quinone biosynthetic process,BP,COQ2
14739,GO:0070405,0.622531260461502,0.659101631401551,2,26,ammonium ion binding,MF,HTR7;PITPNM1
12692,GO:0050909,0.622623201479581,0.760657892544622,1,12,sensory perception of taste,BP,ITPR3
17589,GO:1901224,0.623050900604971,0.609633603559498,3,38,positive regulation of NIK/NF-kappaB signaling,BP,TNFSF15;EGFR;EIF2AK2
81,GO:0000164,0.623152771012157,0.761602623442717,1,11,protein phosphatase type 1 complex,CC,PPP1R2
4283,GO:0009650,0.623213117039649,0.760108765767839,1,12,UV protection,BP,ERCC1
8614,GO:0034123,0.623447540447672,0.759890296304328,1,12,positive regulation of toll-like receptor signaling pathway,BP,F2RL1
3547,GO:0007569,0.623630438607405,0.530002161962041,7,87,cell aging,BP,ERCC1;MAP2K1;ARG2;HMGA2;NEK6;ZNF354A;AKT3
16546,GO:0097296,0.623703768711115,0.759651339940781,1,12,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
3042,GO:0006595,0.623722157054629,0.757385667055828,1,14,polyamine metabolic process,BP,AZIN2
3306,GO:0007006,0.624178595182729,0.528562005067326,7,99,mitochondrial membrane organization,BP,BNIP3;BNIP3L;COX18;SLC25A4;BOK;BCL2L1;MOAP1
4343,GO:0009895,0.624475339853397,0.474347094549994,17,208,negative regulation of catabolic process,BP,SERPINE2;EGFR;TBC1D14;FYN;UBE2J1;DAP;PTPN3;PPARA;CST3;RASIP1;QSOX1;AZIN2;PAIP1;GABARAPL2;TIMP2;ERLEC1;USP25
14802,GO:0070525,0.624924769761582,0.757293071186321,1,13,tRNA threonylcarbamoyladenosine metabolic process,BP,OSGEPL1
7222,GO:0031116,0.624934594185483,0.65880834065604,2,22,positive regulation of microtubule polymerization,BP,PAK1;AKAP9
13821,GO:0060415,0.625264709721272,0.578595039943077,4,43,muscle tissue morphogenesis,BP,ADARB1;FKBP1A;CHD7;TBX1
12349,GO:0048711,0.62534820030228,0.758113621248448,1,12,positive regulation of astrocyte differentiation,BP,SERPINE2
15498,GO:0071868,0.625358126604665,0.65774434298414,2,23,cellular response to monoamine stimulus,BP,ATF4;PRKACA
15500,GO:0071870,0.625358126604665,0.65774434298414,2,23,cellular response to catecholamine stimulus,BP,ATF4;PRKACA
3781,GO:0008340,0.62561349749175,0.763209990174582,1,9,determination of adult lifespan,BP,IDE
4253,GO:0009566,0.625623667317394,0.555223891025945,5,66,fertilization,BP,MST1R;CD46;SPESP1;BCL2L1;REC8
14863,GO:0070633,0.625791790130083,0.759146393376555,1,11,transepithelial transport,BP,SLC23A2
4239,GO:0009437,0.625858003526712,0.757635444476606,1,12,carnitine metabolic process,BP,CRAT
9360,GO:0035871,0.625862417870842,0.762980336184317,1,9,protein K11-linked deubiquitination,BP,OTUB2
1094,GO:0002683,0.626132107550653,0.462605484791802,21,268,negative regulation of immune system process,BP,PRNP;PAG1;NR1D1;PKN1;PTPRS;DLG1;HTRA1;ARG2;SERPING1;CEACAM1;PPP3CB;F2RL1;PRKAR1A;UBASH3B;PDE5A;C5;IFI16;PPARG;IL20RB;WASL;FADD
5192,GO:0015780,0.626211135095602,0.757303814881849,1,12,nucleotide-sugar transmembrane transport,BP,SLC35B4
6570,GO:0022029,0.626705843976562,0.606990947230415,3,34,telencephalon cell migration,BP,LAMB1;EGFR;MBOAT7
10728,GO:0044068,0.626742385603549,0.655734690842361,2,24,modulation by symbiont of host cellular process,BP,TNIP1;BCL2L1
2562,GO:0005845,0.626985861730927,0.758028957306107,1,11,mRNA cap binding complex,CC,EIF4E3
14527,GO:0070016,0.627020481164315,0.759750975053472,1,10,armadillo repeat domain binding,MF,CTNNBIP1
8680,GO:0034260,0.627203215167109,0.605805792618003,3,36,negative regulation of GTPase activity,BP,PLXNB3;SPRY2;FICD
468,GO:0001508,0.627345944920351,0.539099786216227,6,67,action potential,BP,SCN8A;ANK3;DLG1;PTPN3;AKAP9;NTSR1
11883,GO:0046890,0.627363890876624,0.500908386576688,10,127,regulation of lipid biosynthetic process,BP,CYP27B1;NR1D1;APOE;LPCAT1;ABCG1;CEACAM1;TRIB3;ABHD6;SAMD8;IGFBP7
846,GO:0002161,0.627418717204693,0.75762294457651,1,11,aminoacyl-tRNA editing activity,MF,AARS
17216,GO:0106074,0.627418717204693,0.75762294457651,1,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,AARS
9135,GO:0035458,0.627434123288316,0.756152726052139,1,12,cellular response to interferon-beta,BP,TMEM173
18398,GO:1903426,0.62766729171421,0.574311725301365,4,51,regulation of reactive oxygen species biosynthetic process,BP,ARG2;ACP5;PKD2;SLC18A2
14625,GO:0070192,0.627743300885674,0.605230325606769,3,36,chromosome organization involved in meiotic cell cycle,BP,ATRX;REC8;MLH3
20273,GO:2001241,0.628037194540077,0.755583639267106,1,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,RET
13830,GO:0060428,0.62804308742876,0.654952385649539,2,23,lung epithelium development,BP,MAP2K1;THRA
241,GO:0000502,0.628423622091768,0.571782127958173,4,63,proteasome complex,CC,PSMD2;IDE;PSMD7;WFS1
5798,GO:0017048,0.628623437625209,0.484754012689876,13,140,Rho GTPase binding,MF,DOCK4;FMNL2;PKN1;NET1;PAK1;OBSCN;SRGAP2B;DVL1;DNMBP;NCKAP1;DOCK11;PAK6;RGL2
11459,GO:0045913,0.628636199232938,0.57449554026154,4,45,positive regulation of carbohydrate metabolic process,BP,PPARA;NTSR1;IGF2;KAT2B
6789,GO:0030225,0.628862428200288,0.652997305102156,2,25,macrophage differentiation,BP,L3MBTL3;FADD
1659,GO:0004114,0.629287189901571,0.757630719029451,1,10,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,PDE5A
16506,GO:0097201,0.629318471818465,0.754371332285734,1,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,IMPACT
6650,GO:0023058,0.629399750462006,0.753061197611099,1,13,adaptation of signaling pathway,BP,APLN
6352,GO:0021533,0.629407851264774,0.759691435224804,1,9,cell differentiation in hindbrain,BP,WNT7A
5741,GO:0016888,0.629469803799995,0.755692242432913,1,11,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,ENDOV
18463,GO:1903556,0.629505600354435,0.651393025672489,2,27,negative regulation of tumor necrosis factor superfamily cytokine production,BP,ARG2;ACP5
322,GO:0000900,0.629570481852578,0.757364764178034,1,10,translation repressor activity, mRNA regulatory element binding,MF,CPEB4
8055,GO:0032717,0.629712444468651,0.753997681265816,1,12,negative regulation of interleukin-8 production,BP,TMSB4X
5986,GO:0018904,0.629759309266495,0.752718844808685,1,13,ether metabolic process,BP,TMEM86B
11665,GO:0046427,0.629943343909847,0.601530400849046,3,41,positive regulation of JAK-STAT cascade,BP,FYN;PTK6;PARP9
1668,GO:0004129,0.630231970240823,0.748186124991248,1,18,cytochrome-c oxidase activity,MF,NDUFA4L2
4949,GO:0015002,0.630231970240823,0.748186124991248,1,18,heme-copper terminal oxidase activity,MF,NDUFA4L2
5621,GO:0016676,0.630231970240823,0.748186124991248,1,18,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,NDUFA4L2
7960,GO:0032559,0.630337744965201,0.411111864158978,104,1166,adenyl ribonucleotide binding,MF,PYGL;RPS6KA2;SCN8A;ADCY7;ACTA2;MAP2K1;RAPGEF3;ACVR2B;TK2;PKN1;MST1R;DGKA;PC;SMARCA1;CARS;BRSK1;EGFR;STK39;FYN;MYH15;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;DHX32;GLUL;ACSF2;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;SLFN5;PAK1;NEK9;TGFBR2;EPHA1;OBSCN;ATP7B;ABCD1;CDK17;PRKACB;FYCO1;IDE;UBE2G1;ABCA7;KIF21B;ASNS;FGFR1;AARS;PTK6;ULK2;LONP2;ATRX;FAM20C;ABCG1;MAPKAPK3;NLK;CLCN3;TWF2;TRIB3;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;PRKAR1A;MAST3;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;YTHDC2;PANK4;MAP2K2;RET;MLH3;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;FICD;MAP4K2;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;TMEM173;EEF2K;ADCY1;OAS1;PANK1;N4BP2
11777,GO:0046635,0.630366246224794,0.65093687368918,2,26,positive regulation of alpha-beta T cell activation,BP,TGFBR2;AP3D1
11866,GO:0046856,0.63036874333077,0.653847472481464,2,21,phosphatidylinositol dephosphorylation,BP,INPP5F;MTMR4
13641,GO:0060143,0.630607812468726,0.75314694451451,1,12,positive regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3
16003,GO:0086011,0.630689056715102,0.754539202035124,1,11,membrane repolarization during action potential,BP,DLG1
7094,GO:0030889,0.630775443639902,0.756231136351293,1,10,negative regulation of B cell proliferation,BP,PKN1
5225,GO:0015833,0.630781608451975,0.407548795972304,123,1518,peptide transport,BP,EDEM1;F2R;SORL1;RAB3B;PCK2;VLDLR;PRNP;XPOT;BBS2;POSTN;SH3TC2;NR1D1;LTBP2;RAPGEF3;ACVR2B;ALOX15B;LMF1;APLN;POU2F2;HADH;EXOC2;EGFR;TBC1D14;ANK3;FYN;KIF13B;UBE2J1;IDH2;SNX9;GLUL;EVI5L;MAP4K4;SEC23A;STRADB;GDI1;CEMIP;UNC119B;ARG2;STOM;PAK1;RAC2;APOE;BNIP3L;MCFD2;LRP1;EHBP1;ICA1;SNX14;VAMP2;LONP2;LTBP4;ABCG1;SOX4;PITPNM1;ITPR3;VPS13A;FERMT1;RAB31;NLGN2;MVB12B;LRP5;COX18;SEC22C;CLTCL1;TOM1L2;VPS11;SEC63;PPP3CB;SYTL1;ZDHHC2;COPB1;COPG1;F2RL1;CHD7;SLC25A4;ANO1;SDCCAG3;USP6NL;TBC1D2B;NGFR;PPP1R10;MVB12A;GLUD1;ARF4;XBP1;SPIRE1;ARRDC1;STX10;RAB43;C5;ZFYVE9;GABARAPL2;TMED4;TMSB4X;RAB1A;ZDHHC1;SNX30;SEL1L;BCAP29;AP2A2;KDELR3;IL1RAP;CARD11;AP3D1;ITPR2;EFCAB7;ERLEC1;PPARG;SNX6;ANKRD50;LYPLA1;TMEM50B;EVI5;ATP6V1B2;RPH3AL;ADAM8;TBC1D16;SSR3;TMEM173;SSR1;FOXP1;COG8;SNX27
13237,GO:0051900,0.630849571658727,0.751678626376979,1,13,regulation of mitochondrial depolarization,BP,BOK
4474,GO:0010470,0.631025650065429,0.651833811911236,2,23,regulation of gastrulation,BP,DKK1;FGFR1
2614,GO:0005923,0.631396622370011,0.512590899917716,8,89,bicellular tight junction,CC,CCND1;ANK3;DLG1;DLG3;EPCAM;MPDZ;FRMD4B;CLDN11
3480,GO:0007340,0.631431982158037,0.752361946628912,1,12,acrosome reaction,BP,SPESP1
10022,GO:0042454,0.631440698883674,0.750054372368836,1,14,ribonucleoside catabolic process,BP,APOBEC3C
6935,GO:0030540,0.631455313604627,0.755589790313438,1,10,female genitalia development,BP,CHD7
13918,GO:0060575,0.631569112700287,0.75223115571075,1,12,intestinal epithelial cell differentiation,BP,PTK6
3585,GO:0007632,0.631753706645774,0.601261727373855,3,35,visual behavior,BP,RAG1;RGS14;DDHD2
8031,GO:0032675,0.631767644601282,0.548854726342024,5,64,regulation of interleukin-6 production,BP,F2R;MAPK13;F2RL1;XBP1;IL1RAP
11172,GO:0045240,0.632315552082206,0.752994795515801,1,11,dihydrolipoyl dehydrogenase complex,CC,DHTKD1
6121,GO:0019369,0.632491184060701,0.648701065480019,2,26,arachidonic acid metabolic process,BP,ALOX15B;MGLL
15295,GO:0071479,0.632496679133344,0.548196304253275,5,63,cellular response to ionizing radiation,BP,NET1;CCND2;HMGA2;BCL2L1;IFI16
287,GO:0000791,0.632608995275562,0.64812769673007,2,27,euchromatin,CC,H1F0;DNMT3A
1261,GO:0003015,0.632916615509091,0.489469819706347,11,129,heart process,BP,NOS1;APLN;DLG1;ASPH;AKAP9;ITPR3;THRA;TRPC1;PDE5A;PRKACA;ITPR2
4147,GO:0009208,0.632940833745526,0.748610903882052,1,14,pyrimidine ribonucleoside triphosphate metabolic process,BP,NME4
8612,GO:0034121,0.632948080344269,0.599659407408411,3,36,regulation of toll-like receptor signaling pathway,BP,NR1D1;PTPRS;F2RL1
3700,GO:0008206,0.633005353075889,0.648158684220889,2,26,bile acid metabolic process,BP,NR1D1;AMACR
4681,GO:0010829,0.633029695359742,0.750834937620872,1,12,negative regulation of glucose transmembrane transport,BP,GRB10
2974,GO:0006515,0.633101837426639,0.649073890198997,2,24,protein quality control for misfolded or incompletely synthesized proteins,BP,LONP2;KLHL15
16587,GO:0097386,0.633155226371508,0.752194697830909,1,11,glial cell projection,CC,GLUL
7083,GO:0030877,0.633264301650502,0.753877224849411,1,10,beta-catenin destruction complex,CC,CTNNBIP1
3633,GO:0008093,0.633375405806268,0.75198457962336,1,11,cytoskeletal adaptor activity,MF,OBSL1
2721,GO:0006099,0.633626388142546,0.646636539728659,2,28,tricarboxylic acid cycle,BP,DHTKD1;IDH2
18648,GO:1903960,0.633661092373836,0.753500398249509,1,10,negative regulation of anion transmembrane transport,BP,STK39
12663,GO:0050867,0.633930180225382,0.474016559116514,14,181,positive regulation of cell activation,BP,FYN;PAK1;RAG1;TGFBR2;MMP14;CD46;F2RL1;XBP1;SLC39A10;CARD11;AP3D1;IGF2;ADAM8;FADD
17554,GO:1901096,0.633931850188824,0.753243017896031,1,10,regulation of autophagosome maturation,BP,FYCO1
12255,GO:0048535,0.634243366109155,0.74967034473268,1,12,lymph node development,BP,FADD
4640,GO:0010762,0.634525068520343,0.647571903026374,2,24,regulation of fibroblast migration,BP,CYGB;PAK1
18361,GO:1903350,0.634790555599888,0.75063094892645,1,11,response to dopamine,BP,ATF4
18362,GO:1903351,0.634790555599888,0.75063094892645,1,11,cellular response to dopamine,BP,ATF4
17871,GO:1902105,0.634964062301969,0.477160395748482,13,162,regulation of leukocyte differentiation,BP,CTNNBIP1;RAG1;TGFBR2;CEACAM1;MMP14;CD46;XBP1;UBASH3B;CARD11;AP3D1;ADAM8;FOXP1;FADD
4386,GO:0010039,0.635379071546099,0.646136766554166,2,25,response to iron ion,BP,CCND1;FKBP1A
5016,GO:0015179,0.635519957923707,0.596586682083589,3,37,L-amino acid transmembrane transporter activity,MF,SLC43A1;SLC38A2;SLC7A11
10585,GO:0043548,0.63558792304671,0.648365372539608,2,21,phosphatidylinositol 3-kinase binding,MF,FAM83A;FYN
3939,GO:0008625,0.635611111702291,0.544443782599541,5,66,extrinsic apoptotic signaling pathway via death domain receptors,BP,BCL2L1;TMBIM1;MOAP1;DEDD2;FADD
15035,GO:0070977,0.635919772098176,0.753562722525404,1,9,bone maturation,BP,THBS3
3445,GO:0007254,0.636043923799362,0.476167186132657,13,157,JNK cascade,BP,PKN1;EGFR;ERCC6;WNT7A;MAP4K4;DKK1;PAK1;F2RL1;TAOK1;MAP4K2;FZD8;ANKRD6;RB1CC1
11132,GO:0045176,0.636056918822288,0.753432409053738,1,9,apical protein localization,BP,ARF4
8832,GO:0034614,0.636176539867526,0.498011973575295,9,121,cellular response to reactive oxygen species,BP,EGFR;BNIP3;MAPK13;NET1;IMPACT;PKD2;CST3;PRDX5;ENDOG
9990,GO:0042393,0.636179578156837,0.471858977454099,14,172,histone binding,MF,ZMYND8;PKN1;RAG1;ATRX;PHF12;CTSL;UHRF2;PHF1;PARP9;SPIN4;SBNO1;TBL1X;RSF1;PHF21A
16183,GO:0090201,0.636321817569224,0.746408876373225,1,13,negative regulation of release of cytochrome c from mitochondria,BP,BCL2L1
7476,GO:0031640,0.636718401874389,0.743210687895934,1,16,killing of cells of other organism,BP,F2RL1
10860,GO:0044364,0.636718401874389,0.743210687895934,1,16,disruption of cells of other organism,BP,F2RL1
17468,GO:1900273,0.636790326463758,0.750513581869824,1,10,positive regulation of long-term synaptic potentiation,BP,CRTC1
8580,GO:0034058,0.636845111411125,0.75046105187829,1,10,endosomal vesicle fusion,BP,VPS11
5848,GO:0017144,0.637468580915882,0.42658271460987,40,534,drug metabolic process,BP,NT5E;NOS1;PCK2;CBS;CYP27B1;PRSS3;GPX3;DHTKD1;PC;EGFR;PSAT1;ELOVL1;PGM1;IDH2;ARG2;CBR4;RAC2;ABCD1;ACP5;ALDH1L2;PKD2;LDHA;IDE;PPARA;ASNS;FAM20C;MTHFR;AHCYL2;GAMT;CTH;PRDX5;NDUFV3;CTBS;NPL;PM20D2;TMSB4X;ALDH1A2;ATP6V1B2;AK9;AOX1
10562,GO:0043518,0.637530846749142,0.746495596078605,1,12,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,CD44
538,GO:0001656,0.637827108032004,0.543296442756446,5,57,metanephros development,BP,WWTR1;PKD2;RET;LAMB2;PTCH1
3449,GO:0007259,0.637915633740638,0.514222637396595,7,92,JAK-STAT cascade,BP,FYN;SOCS2;PKD2;PTK6;INPP5F;PARP9;RET
19042,GO:1904888,0.638006205125665,0.564140238675937,4,46,cranial skeletal system development,BP,TGFBR2;MMP14;SH3PXD2B;TBX1
17197,GO:0106019,0.638064494734462,0.749289725520888,1,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,INPP4A
3654,GO:0008134,0.638284839428367,0.424511126216569,42,505,transcription factor binding,MF,ERCC1;ZMYND8;CCND1;BBS2;NR1D1;NFATC4;GPX3;PKN1;DDIT3;SMARCA1;CRTC1;UBXN7;ZNF516;TRIB2;HMGA2;ATF4;PPARA;E2F5;NFAT5;HYAL1;RCOR1;NLK;MDFI;HES2;PHF12;CEBPG;THRA;CHD6;PER3;MTA1;MEF2D;XBP1;TLE4;NEK6;IFI16;TBL1X;PPARG;WFS1;TMEM173;FOXP1;KAT2B;JARID2
17489,GO:1900409,0.638932367069786,0.745133109389101,1,12,positive regulation of cellular response to oxidative stress,BP,ENDOG
18147,GO:1902884,0.638932367069786,0.745133109389101,1,12,positive regulation of response to oxidative stress,BP,ENDOG
7261,GO:0031228,0.639119352664743,0.591873313715174,3,40,intrinsic component of Golgi membrane,CC,SLC35B4;QSOX1;SAMD8
5475,GO:0016408,0.639203203971182,0.74360117784488,1,13,C-acyltransferase activity,MF,SPTLC2
17841,GO:1902017,0.639398058024312,0.592387513204777,3,37,regulation of cilium assembly,BP,EVI5L;CEP120;CCDC88A
7283,GO:0031268,0.639405391980056,0.744672034478757,1,12,pseudopodium organization,BP,F2RL1
13954,GO:0060644,0.639633644417368,0.744449326914771,1,12,mammary gland epithelial cell differentiation,BP,PTCH1
11205,GO:0045335,0.639900188144149,0.502260426350104,8,105,phagocytic vesicle,CC,RAC2;ANXA3;ITGB5;RAB31;CLCN3;RAB43;ADAM8;FLNB
4659,GO:0010804,0.64018709998217,0.741551756383995,1,14,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,F2RL1
7592,GO:0031960,0.640209709396739,0.50198472748143,8,104,response to corticosteroid,BP,CCND1;PCK2;EIF4EBP1;EGFR;SDC1;ANXA3;GLB1;IGFBP7
12126,GO:0048199,0.640479852518532,0.539389478818779,5,64,vesicle targeting, to, from or within Golgi,BP,SEC23A;MCFD2;LMAN1;RAB1A;CTSZ
20030,GO:2000651,0.64079990881468,0.746647204265731,1,10,positive regulation of sodium ion transmembrane transporter activity,BP,ANK3
3212,GO:0006853,0.641100878778369,0.746355189851787,1,10,carnitine shuttle,BP,CPT2
1020,GO:0002520,0.641102713813141,0.414840982690683,53,657,immune system development,BP,ERCC1;CTNNBIP1;MAP2K1;FAM210B;PKN1;POU2F2;DHTKD1;PSMD2;GLO1;RAG1;TGFBR2;CMTM7;FAM20C;SOX4;CEACAM1;TNRC6B;MMP14;CD46;LRP5;L3MBTL3;DNAJB9;PPP3CB;CEBPG;F2RL1;PSMD7;CHD7;THRA;WNT2B;ACVR1B;PTPRZ1;WASF2;POLL;XBP1;UBASH3B;SATB1;RET;DOCK11;EIF2AK2;IFI16;CARD11;HOXA3;AP3D1;ARID4A;PPARG;TBX1;ADAM8;ITGA4;FZD8;TNRC6C;FOXP1;KAT2B;JARID2;FADD
9229,GO:0035615,0.64140083417422,0.744235293180952,1,11,clathrin adaptor activity,MF,AP2A2
16843,GO:0098748,0.64140083417422,0.744235293180952,1,11,endocytic adaptor activity,MF,AP2A2
18262,GO:1903115,0.641520604829158,0.64135771553134,2,22,regulation of actin filament-based movement,BP,DLG1;AKAP9
19233,GO:1905369,0.641950326963589,0.556977077576528,4,64,endopeptidase complex,CC,PSMD2;IDE;PSMD7;WFS1
4369,GO:0009987,0.642209144007723,0.394903826749872,876,10469,cellular process,BP,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EDEM1;TSPAN1;GID4;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;FAM83A;ADAM19;ETV5;RAB3B;PGF;MBOAT2;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;H1F0;SERPINE2;PEAR1;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;PAG1;ADGRF1;OSBP2;ITGB4;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;CMTM4;THBS2;FAM210B;FMNL2;ETV4;TFPI2;LTBP2;RAPGEF3;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;ALOX15B;LMF1;SALL2;COL13A1;TK2;THSD4;GPX3;PKN1;NAPRT;WWTR1;DCBLD2;PEG3;CCNI;MST1R;ARHGAP22;MICALCL;WDR66;MARCH9;H6PD;APLN;RBMS2;MARVELD1;POU2F2;TRIM65;LY6K;DHTKD1;PITPNC1;DGKA;TEF;TNFSF15;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;KCNG1;PTPRS;B4GALT6;CCNG2;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;SDK2;EXOC2;ELK3;CRTC1;ADGRL1;AVL9;LTA4H;CAPN2;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;BCORL1;DYSF;CGREF1;LOXL1;ARHGAP12;PPP1R14A;FYN;HEBP1;MYH15;TNFRSF6B;OSBPL10;TSPAN5;PCDHAC2;PSAT1;JADE2;BNIP3;HLTF;KIF13B;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;MYCBPAP;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;CSMD3;DLG4;B3GNT3;IDH2;CTSB;CD68;DNAJB5;ACOT1;PLXNB3;GPC4;DHX32;SNX9;TYSND1;PODXL;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;EVI5L;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;TTC7B;RSAD1;GRK5;HTR7;NMRK1;STRADB;RDH14;NME4;MALL;CRTAP;ASPH;MCTP1;GDI1;CEMIP;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;WISP1;DAP;SMOC2;SLFN5;PAK1;RASA3;SOCS2;TRIB2;ATXN10;NEK9;KIAA1549;RHPN1;ZNF652;CBR4;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;NUDCD3;EDNRA;LCN2;HAGH;SHANK2;SLITRK6;SCRN1;EPHA1;IMPACT;RALGAPA2;PLPP6;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCPG1;CCND2;ACP5;ANGPTL4;PTPN12;ALDH1L2;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;RAB11FIP4;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;ICA1;EIF4E3;AGPAT4;LPAR3;PCMTD2;ELFN2;FAM155B;KIF21B;ASNS;FGFR1;ABHD10;ITGA1;AARS;PPP1R35;E2F5;EPCAM;TMOD2;MARCH4;TUB;PTPDC1;CMTM7;LPCAT4;TACC1;TCFL5;RNPEPL1;UROS;SMOC1;NFAT5;ITGB5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;AIG1;ITGA2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;FAT1;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;NELL2;GAMT;CEP120;ENDOV;ZNF558;KDSR;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PRR9;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLEK2;PLA2G4D;HES2;ANXA6;NLGN2;CD46;ZBTB10;ACAD10;PHF12;MVB12B;EPOR;CTH;ZNF704;NXPH4;MAP6;LRP5;ETAA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;THBS3;CTSL;DOCK9;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;NTNG1;GFPT1;PCSK6;TPBG;TOM1L2;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;FBXL8;BTBD3;RIMS3;PLPPR2;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;INPP4A;RFX2;SYTL1;HIBADH;ADGRB2;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;DDX60;UHRF2;SLC2A9;RASIP1;GSDMA;PROCR;C6ORF120;TAOK1;PHC3;AEBP1;ATP10D;ABHD15;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;ANO1;MSRB2;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;SDCCAG3;C18ORF32;ATXN2;KLHL29;MAST3;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;SLC6A14;ZNF337;BEX4;TBC1D2B;THRA;MGLL;WNT2B;ACVR1B;DBNDD1;NDUFA4L2;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;MARK4;NPL;ZNF449;PTPRZ1;CHD6;NUDT6;SPESP1;PER3;MTA1;AZIN2;BCL2L1;IFITM1;CRAT;RNF165;YTHDC2;PM20D2;GRIN3B;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;NYNRIN;SKAP2;ARF4;GOLGA2P5;H2AFJ;POLL;ANAPC13;YPEL5;UAP1;HSD17B7;SLC12A7;PCYOX1;XBP1;PANK4;SPIRE1;NT5DC1;NFU1;UBASH3B;TXNRD3;CADM4;MAP2K2;ABHD6;SATB1;SLC22A17;PPP1R2;PAIP1;ARRDC1;REC8;CYP4F22;ANKIB1;LYPLAL1;TLE4;SLC38A2;RIN1;TRPC1;RET;SPATA6;CCDC71L;TUBG2;STX10;LOXL2;PDE5A;VWA1;TCTN1;RAB43;MLH3;OSBPL5;NAV1;SH3PXD2B;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;MBOAT7;THAP10;NOP10;NCKAP1;GABARAPL2;EPM2A;KCNJ15;RMRP;GTF2IRD2;DNASE1L1;C1ORF56;ELMO3;DOCK11;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;TSPAN3;RNF135;PSD3;TMBIM1;ETV1;FRMD4B;COL1A2;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;SHC2;PRKACA;SAMD5;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;EEPD1;SNX30;SEL1L;PCDH1;CBX7;IFI16;RHOBTB1;BCAP29;AP2A2;SRD5A3;NR2F6;SLC39A10;KDELR3;CMTM6;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;FCHO1;LAMB2;LTB4R;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;ACP6;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;ZSCAN18;GRB10;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;TMEM63A;CITED4;SNX6;EVA1A;USP20;ZFP30;GRB7;SRPX2;PPL;ALDH1A2;GPR153;ARHGAP29;LYPLA1;ATP12A;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;ROBO3;GARS;IL20RB;CLDN11;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;PHF21A;ZBTB40;ZNF92;WDR60;ACAP2;MPLKIP;MAML3;CKLF;ZNF568;IGFBP7;TBC1D16;DDHD2;MARCH2;OSGEPL1;FZD8;TMEM107;WASL;USP32;RAPGEFL1;HSPA2;PRSS8;ZNF107;FLNB;LRP6;ARID5B;MAGEF1;ZNF165;SYT2;PLCH2;TMEM173;RNF180;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;SEMA6C;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;TNRC6C;TRIM2;COQ2;RCAN1;TET1;OMG;KCTD18;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;DNAJC4;AOX1;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;REEP3;NYAP1;UFL1;FAM162A;ANKRD6;SNX27;N4BP2;AMACR;PBX3;JARID2;PPM1M;SLC23A2;SEMA3F;RALGPS2;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
9187,GO:0035563,0.642344233462198,0.741793526671182,1,12,positive regulation of chromatin binding,BP,PARP9
6834,GO:0030296,0.642399794218643,0.743258250176522,1,11,protein tyrosine kinase activator activity,MF,ERCC6
12061,GO:0048009,0.64248447694659,0.641034797130984,2,21,insulin-like growth factor receptor signaling pathway,BP,IGFBP4;GRB10
2642,GO:0005978,0.642606834274334,0.58952305851821,3,35,glycogen biosynthetic process,BP,NR1D1;PGM1;IGF2
4176,GO:0009250,0.642606834274334,0.58952305851821,3,35,glucan biosynthetic process,BP,NR1D1;PGM1;IGF2
12748,GO:0051016,0.642661507136263,0.741481327993116,1,12,barbed-end actin filament capping,BP,TWF2
16064,GO:0089718,0.642754370883084,0.742910783470937,1,11,amino acid import across plasma membrane,BP,NTSR1
10360,GO:0043173,0.642775635686907,0.73899488704005,1,14,nucleotide salvage,BP,NAPRT
16126,GO:0090114,0.643162086998269,0.536585829774576,5,63,COPII-coated vesicle budding,BP,SEC23A;MCFD2;LMAN1;RAB1A;CTSZ
20171,GO:2001014,0.643195165821091,0.74247833743789,1,11,regulation of skeletal muscle cell differentiation,BP,TBX1
3471,GO:0007292,0.643343807875902,0.520939565259954,6,74,female gamete generation,BP,ERCC1;PRKAR1A;SPIRE1;REC8;PDE5A;MLH3
2167,GO:0005003,0.643621327704725,0.742059730393271,1,11,ephrin receptor activity,MF,EPHA1
2169,GO:0005005,0.643621327704725,0.742059730393271,1,11,transmembrane-ephrin receptor activity,MF,EPHA1
6719,GO:0030130,0.643724042178405,0.741958760725712,1,11,clathrin coat of trans-Golgi network vesicle,CC,CLTCL1
19047,GO:1904894,0.643746378724671,0.586348243320937,3,42,positive regulation of STAT cascade,BP,FYN;PTK6;PARP9
6911,GO:0030501,0.643836054392136,0.638230956425886,2,23,positive regulation of bone mineralization,BP,ACVR2B;FAM20C
14610,GO:0070169,0.643836054392136,0.638230956425886,2,23,positive regulation of biomineral tissue development,BP,ACVR2B;FAM20C
7505,GO:0031683,0.643956439939404,0.740204187986342,1,12,G-protein beta/gamma-subunit complex binding,MF,GNAI1
18851,GO:1904467,0.643993266234164,0.743536002145828,1,10,regulation of tumor necrosis factor secretion,BP,ARG2
6292,GO:0019902,0.644204490778812,0.472067484208405,12,142,phosphatase binding,MF,EGFR;DLG1;DLG4;DLG3;PPARA;ITGA1;PPP1R35;CEACAM1;SLC9A3R2;PPP3CB;MTMR4;PPARG
15497,GO:0071867,0.644258677483207,0.637187224603419,2,24,response to monoamine,BP,ATF4;PRKACA
15499,GO:0071869,0.644258677483207,0.637187224603419,2,24,response to catecholamine,BP,ATF4;PRKACA
16144,GO:0090153,0.644321459365688,0.738557037359692,1,13,regulation of sphingolipid biosynthetic process,BP,SAMD8
19107,GO:1905038,0.644321459365688,0.738557037359692,1,13,regulation of membrane lipid metabolic process,BP,SAMD8
19835,GO:2000303,0.644321459365688,0.738557037359692,1,13,regulation of ceramide biosynthetic process,BP,SAMD8
15214,GO:0071360,0.644343702986813,0.739821332892434,1,12,cellular response to exogenous dsRNA,BP,TMEM173
2571,GO:0005856,0.644349588753164,0.392048344674883,136,1566,cytoskeleton,CC,NOS1;FLNC;CLIP2;H1F0;ACTA2;BBS2;HECW2;MAP2K1;RAPGEF3;SH3KBP1;ALOX15B;MPRIP;MST1R;WDR66;MARVELD1;SSH1;MAP1B;SNTB2;CAPN2;BRSK1;WIPF1;SNPH;STK39;ANK3;DYSF;FYN;MYH15;OSBPL10;KIF13B;PARVB;PGM1;DLG1;DLG4;PODXL;ESPN;TTBK2;RSPH3;SEPT10;STOM;PAK1;CEP170;TRIB2;NEK9;PTPN3;NUDCD3;SHANK2;RAC2;PTPN12;AFAP1;RGS14;PKD2;PRKACB;AKAP9;RAB11FIP4;ATF4;KIF21B;TMOD2;TACC1;PFN2;PITPNM1;FHOD1;CEP120;FERMT1;GSDMC;OBSL1;UACA;FAM110C;DVL1;MMP14;PLEK2;MAP6;DNMBP;TWF2;CLTCL1;RANBP9;WASF3;RIMS3;ZNF322;ACOT13;ADGRB2;FNBP1L;CDC42BPA;DDX60;PROCR;PHF1;ASAP1;PRKAR1A;JMY;SPRY2;SEPT5;BEX4;ENKD1;PSKH1;MVB12A;MARK4;MTA1;BCL2L1;MYH16;WASF2;SPIRE1;MAP2K2;RIN1;TUBG2;TCTN1;NAV1;SH3PXD2B;NCKAP1;FRMD4B;CCDC88A;CCSAP;PRKACA;NEK6;TMSB4X;EPB41L3;TBL1X;NIT2;ARPC1A;FNBP1;PJA2;TMEM63A;USP20;PPL;SLC7A11;EVI5;ADAM8;WDR60;MPLKIP;DDHD2;WASL;HSPA2;FLNB;PSEN2;KAT2B;SEPT6;REEP3;GNAI1
13117,GO:0051653,0.64437080189858,0.587940923804087,3,34,spindle localization,BP,SPRY2;SPIRE1;WASL
7421,GO:0031514,0.644402260285488,0.519676772160191,6,75,motile cilium,CC,BBS2;WDR66;PKD2;SPATA6;PRKACA;SEPT6
135,GO:0000281,0.644828889836287,0.535178082074202,5,60,mitotic cytokinesis,BP,ANK3;SNX9;SEPT10;SEPT5;SEPT6
11677,GO:0046459,0.644894976992719,0.737987258837362,1,13,short-chain fatty acid metabolic process,BP,PCK2
4538,GO:0010611,0.644911425922476,0.587004318017902,3,35,regulation of cardiac muscle hypertrophy,BP,PAK1;PDE5A;JARID2
4881,GO:0014743,0.644911425922476,0.587004318017902,3,35,regulation of muscle hypertrophy,BP,PAK1;PDE5A;JARID2
3161,GO:0006768,0.645154338616357,0.740549683782002,1,11,biotin metabolic process,BP,PC
12648,GO:0050852,0.645313883247724,0.481025331469448,10,140,T cell receptor signaling pathway,BP,PRNP;PAG1;PSMD2;FYN;PAK1;RBCK1;BTRC;CEACAM1;PSMD7;CARD11
12916,GO:0051262,0.645402479632872,0.495630499966062,8,117,protein tetramerization,BP,GPX3;CRTC1;CBR4;PKD2;IDE;CTH;ACOT13;LRP4
6679,GO:0030042,0.64557455080017,0.586277862672364,3,35,actin filament depolymerization,BP,TMOD2;TWF2;F2RL1
12252,GO:0048531,0.645668341354867,0.737217470090278,1,13,beta-1,3-galactosyltransferase activity,MF,B3GNT3
11063,GO:0045061,0.6456791355236,0.740031229792329,1,11,thymic T cell selection,BP,CARD11
19799,GO:2000242,0.646209731506521,0.633158296647425,2,28,negative regulation of reproductive process,BP,PRKACB;PRKAR1A
6917,GO:0030509,0.646387716686884,0.496091304919175,8,92,BMP signaling pathway,BP,SMURF2;ACVR2B;SLC33A1;HTRA1;DKK1;PCSK6;RNF165;LRP4
13819,GO:0060413,0.646574477218569,0.741000319426951,1,10,atrial septum morphogenesis,BP,SOX4
15919,GO:0072697,0.64674791703122,0.738972963517623,1,11,protein localization to cell cortex,BP,GNAI1
7341,GO:0031365,0.646789388517485,0.634454749688977,2,24,N-terminal protein amino acid modification,BP,SOX4;KAT2B
10389,GO:0043218,0.646802641414759,0.737380531246057,1,12,compact myelin,CC,MPDZ
2669,GO:0006020,0.646917071875686,0.740662355604094,1,10,inositol metabolic process,BP,ISYNA1
16714,GO:0097696,0.647009064273839,0.504231582912683,7,93,STAT cascade,BP,FYN;SOCS2;PKD2;PTK6;INPP5F;PARP9;RET
13800,GO:0060389,0.647095945529162,0.583685599335835,3,38,pathway-restricted SMAD protein phosphorylation,BP,DKK1;TGFBR2;ACVR1B
14971,GO:0070875,0.647162648403296,0.742707475237326,1,9,positive regulation of glycogen metabolic process,BP,IGF2
2820,GO:0006284,0.647280046519727,0.582702129494461,3,41,base-excision repair,BP,ERCC6;HMGA2;POLL
10155,GO:0042733,0.647664238570963,0.553131844912103,4,48,embryonic digit morphogenesis,BP,WNT7A;LRP5;TMEM107;LRP4
2410,GO:0005583,0.647761186484446,0.74211965999597,1,9,fibrillar collagen trimer,CC,COL1A2
16801,GO:0098643,0.647761186484446,0.74211965999597,1,9,banded collagen fibril,CC,COL1A2
5936,GO:0018216,0.647953884039246,0.734932615849439,1,13,peptidyl-arginine methylation,BP,PRMT3
14149,GO:0061029,0.64826495260261,0.737465302121901,1,11,eyelid development in camera-type eye,BP,EGFR
8472,GO:0033612,0.648424411380709,0.735761364819406,1,12,receptor serine/threonine kinase binding,MF,FADD
12578,GO:0050732,0.648600297654014,0.581754415811884,3,39,negative regulation of peptidyl-tyrosine phosphorylation,BP,PTK6;INPP5F;SNX6
19942,GO:2000479,0.648640831060032,0.735544727539827,1,12,regulation of cAMP-dependent protein kinase activity,BP,PRKAR1A
20027,GO:2000648,0.64892033028006,0.632736956245504,2,23,positive regulation of stem cell proliferation,BP,HMGA2;EPCAM
954,GO:0002374,0.648943033217139,0.7352419984373,1,12,cytokine secretion involved in immune response,BP,F2RL1
7252,GO:0031210,0.649101749587529,0.735082901110241,1,12,phosphatidylcholine binding,MF,PITPNM1
12734,GO:0050997,0.649101749587529,0.735082901110241,1,12,quaternary ammonium group binding,MF,PITPNM1
10273,GO:0043015,0.64941800073909,0.631058028736909,2,25,gamma-tubulin binding,MF,BRSK1;MARK4
17503,GO:1900543,0.649441160597463,0.631032810617932,2,25,negative regulation of purine nucleotide metabolic process,BP,AKAP9;PPARA
10357,GO:0043169,0.649492144390158,0.37887759954399,256,2967,cation binding,MF,FHL1;XDH;NT5E;EDEM1;NOS1;ZMYND8;ADAM19;NEURL1;PCK2;VLDLR;PYGL;ASAP2;CBS;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;PRSS3;ADCY7;PRNP;POSTN;NR1D1;ZC3H6;ADARB1;THBS2;LTBP2;ACVR2B;ANTXR2;LTBP1;ZKSCAN1;ALOX15B;SALL2;PEG3;MARCH9;TRIM65;DHTKD1;DGKA;ZKSCAN2;PC;B4GALT6;CARS;LTA4H;CAPN2;BRSK1;DYSF;CGREF1;LOXL1;FYN;PCDHAC2;JADE2;HLTF;ARAP1;PGM1;ADAMTS7;ZNF516;IDH2;ZSCAN30;TGM2;GLUL;GLO1;FKBP9;WDFY3;SEC23A;RSAD1;HTR7;NMRK1;NME4;ASPH;MCTP1;ARG2;NAGS;SMOC2;RASA3;NEK9;ZNF652;RAG1;TGFBR2;LCN2;HAGH;NUCB2;CLCA2;OBSCN;APOE;ATP7B;ACP5;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;FYCO1;IDE;ZCCHC14;RAB11FIP4;PPP2R3B;ANXA3;PPARA;ITGA1;AARS;MARCH4;RNPEPL1;SMOC1;LPCAT1;ITGA2;GALNT3;LENG9;ZNF559;FAT1;ZNF81;LTBP4;ATRX;FAM20C;CHURC1;FKBP10;PITPNM1;APOBEC3C;ITPR3;NELL2;ENDOV;ZNF558;MBLAC2;ZNF692;LMAN1;MT2A;NLK;TRIM5;TCEA1;MMP14;PLA2G4D;ANXA6;ZBTB10;PHF12;ZNF704;ZMYM3;KLF12;THBS3;NPEPL1;RABGGTA;L3MBTL3;VPS11;ZNF322;PPP3CB;MEX3C;SYTL1;APLP2;PLAG1;CDC42BPA;UHRF2;PHC3;AEBP1;ATP10D;PHF1;ASAP1;MSRB2;CPEB4;MAST3;LACTB2;ZNF337;THRA;ACVR1B;ZNF280D;PPP1R10;GLUD1;TSHZ1;ZNF449;MTA1;RNF165;GRIN3B;TRIM7;POLL;YPEL5;NT5DC1;NFU1;MAP2K2;GPATCH8;CYP4F22;ANKIB1;MICU3;RET;LOXL2;PDE5A;MCTP2;MTMR4;ZFYVE9;THAP10;RNF135;COL1A2;ZNF398;NEK6;UNKL;TIMP2;PCDH1;NR2F6;ZNF354A;MMP10;RNF169;BLVRA;TENM2;ITPR2;PJA2;ZSCAN18;ZMYM2;EFCAB7;PPARG;USP20;ZFP30;ARHGAP29;ATP12A;ZNF37A;ESYT3;RPH3AL;RSF1;ADAM8;ENDOG;ATP11B;ITGA4;PHF21A;ZBTB40;ZNF92;ACAP2;ZNF568;DDHD2;MARCH2;OSGEPL1;CMC1;USP32;ZNF107;ZNF165;SYT2;PLCH2;RNF180;EEF2K;ZNF320;GALNS;TRIM2;TET1;ZC3H7A;FOXP1;ZBTB33;ZFYVE21;AOX1;ADCY1;OAS1;RNF103;PRMT3;PPM1M;ADNP;GNAI1;LRP4;STT3B;DNMT3A;TRIM38;FBXL5
7127,GO:0030950,0.649592808923874,0.734590208160609,1,12,establishment or maintenance of actin cytoskeleton polarity,BP,RHOBTB1
16440,GO:0097094,0.649750320242337,0.735982775386756,1,11,craniofacial suture morphogenesis,BP,MMP14
15649,GO:0072160,0.649954317151343,0.737651604604483,1,10,nephron tubule epithelial cell differentiation,BP,WWTR1
17041,GO:0099516,0.650180230596497,0.580884370327506,3,36,ion antiporter activity,MF,SLC9A7;SLC25A4;SLC7A11
2372,GO:0005501,0.650297805093002,0.733881662702931,1,12,retinoid binding,MF,ALDH1A2
20134,GO:2000826,0.650341375008775,0.630596673659019,2,24,regulation of heart morphogenesis,BP,DKK1;TGFBR2
9593,GO:0036445,0.650389797850682,0.73721776910875,1,10,neuronal stem cell division,BP,FGFR1
13496,GO:0055057,0.650389797850682,0.73721776910875,1,10,neuroblast division,BP,FGFR1
14829,GO:0070566,0.650675938546531,0.629686639943935,2,25,adenylyltransferase activity,MF,FICD;OAS1
2386,GO:0005522,0.650722737859783,0.73688572114254,1,10,profilin binding,MF,WIPF1
17886,GO:1902165,0.650931778038334,0.729849720221271,1,15,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CD44
20200,GO:2001057,0.650967319833724,0.548898359572644,4,51,reactive nitrogen species metabolic process,BP,NOS1;ARG2;ACP5;PKD2
17161,GO:0102567,0.651087914098189,0.733085885754176,1,12,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,PLA2G4D
17162,GO:0102568,0.651087914098189,0.733085885754176,1,12,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,PLA2G4D
14123,GO:0060986,0.651190128578608,0.629670797579993,2,24,endocrine hormone secretion,BP,APLN;FGFR1
12733,GO:0050996,0.651194426971374,0.736414752495296,1,10,positive regulation of lipid catabolic process,BP,PPARA
11906,GO:0046934,0.651706161821197,0.579871926646946,3,34,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,EGFR;FYN;FGFR1
6856,GO:0030325,0.651717189534367,0.734009968716555,1,11,adrenal gland development,BP,ARID5B
13536,GO:0055119,0.651806293523058,0.733920333101344,1,11,relaxation of cardiac muscle,BP,PDE5A
12008,GO:0047496,0.652044954916892,0.578821707110296,3,36,vesicle transport along microtubule,BP,FYCO1;RAB1A;AP3D1
5660,GO:0016765,0.652126009771346,0.576090263260499,3,47,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,CTH;RABGGTA;COQ2
7915,GO:0032488,0.652154089267129,0.733570243881971,1,11,Cdc42 protein signal transduction,BP,APOE
4812,GO:0014003,0.6522925418571,0.626952989329297,2,27,oligodendrocyte development,BP,WASF3;LPAR1
16495,GO:0097190,0.652715869350637,0.413933053558372,36,468,apoptotic signaling pathway,BP,ITGA6;NFATC4;DDIT3;FYN;TNFRSF6B;BNIP3;ERCC6;STRADB;DAP;CD44;BNIP3L;RBCK1;ATF4;FGFR1;CHAC1;UACA;ANXA6;CTH;TRIB3;CASP4;JMY;BOK;NACC2;ACVR1B;NGFR;BCL2L1;XBP1;RET;TMBIM1;IFI16;MOAP1;WFS1;DEDD2;FAM162A;RB1CC1;FADD
5206,GO:0015804,0.652932961366366,0.626714478321215,2,26,neutral amino acid transport,BP,SLC43A1;SLC38A2
5610,GO:0016653,0.653070501097077,0.731081182964798,1,12,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,NOS1
9158,GO:0035510,0.653152025702252,0.626977354077682,2,25,DNA dealkylation,BP,APOBEC3C;TET1
5518,GO:0016482,0.653387236007559,0.467227621514744,11,131,cytosolic transport,BP,SORL1;MAP2K1;TBC1D14;VPS13A;CLTCL1;VPS11;MAP2K2;STX10;SNX6;EVI5;ZFYVE21
6354,GO:0021535,0.653455316832748,0.734148443057367,1,10,cell migration in hindbrain,BP,TTBK2
19030,GO:1904874,0.653463448370404,0.727265542556828,1,15,positive regulation of telomerase RNA localization to Cajal body,BP,NOP10
605,GO:0001773,0.653837533292996,0.727855255889402,1,14,myeloid dendritic cell activation,BP,TGFBR2
7407,GO:0031489,0.653851037568963,0.72896842762849,1,13,myosin V binding,MF,RAB3B
15606,GO:0072089,0.653943588192683,0.509607820829034,6,71,stem cell proliferation,BP,HMGA2;FGFR1;EPCAM;FERMT1;WNT2B;EIF2AK2
16166,GO:0090184,0.654032356870291,0.625042052638747,2,27,positive regulation of kidney development,BP,WNT2B;RET
11326,GO:0045649,0.654065105986043,0.730071214594279,1,12,regulation of macrophage differentiation,BP,FADD
15045,GO:0070989,0.654176915526497,0.731527168276092,1,11,oxidative demethylation,BP,TET1
4517,GO:0010569,0.654589331043117,0.62539864346649,2,25,regulation of double-strand break repair via homologous recombination,BP,MAGEF1;KLHL15
11374,GO:0045739,0.654684682509047,0.574750719360295,3,40,positive regulation of DNA repair,BP,EGFR;CEBPG;PARP9
5835,GO:0017119,0.65502424157708,0.729094550959935,1,12,Golgi transport complex,CC,COG8
14736,GO:0070402,0.655161281883402,0.72762969093169,1,13,NADPH binding,MF,CBR4
2828,GO:0006294,0.655648422719657,0.622429545891638,2,29,nucleotide-excision repair, preincision complex assembly,BP,XPC;DDB2
13640,GO:0060142,0.655657410215169,0.727121473034104,1,13,regulation of syncytium formation by plasma membrane fusion,BP,RAPGEF3
10967,GO:0044728,0.655941224556175,0.522750323467302,5,61,DNA methylation or demethylation,BP,ATRX;APOBEC3C;ATF7IP;TET1;DNMT3A
10798,GO:0044272,0.656158540231723,0.463667591784602,11,144,sulfur compound biosynthetic process,BP,CBS;B4GALT6;ELOVL1;B3GNT3;CBR4;HAGH;CHAC1;CTH;MLYCD;PPT2;HSD17B12
1400,GO:0003334,0.656337061635473,0.729332315239142,1,11,keratinocyte development,BP,FLNB
16777,GO:0098586,0.656473738337935,0.573587998887381,3,37,cellular response to virus,BP,DDX60;BCL2L1;PUM2
14601,GO:0070160,0.656775505857915,0.484768387677015,8,91,occluding junction,CC,CCND1;ANK3;DLG1;DLG3;EPCAM;MPDZ;FRMD4B;CLDN11
18243,GO:1903053,0.656947661366411,0.623950257775416,2,23,regulation of extracellular matrix organization,BP,LRP1;CST3
3110,GO:0006687,0.656962311492607,0.541875810356788,4,53,glycosphingolipid metabolic process,BP,B4GALT6;ST3GAL5;GLB1;ESYT3
8811,GO:0034518,0.657025078384278,0.727048540984474,1,12,RNA cap binding complex,CC,EIF4E3
4389,GO:0010042,0.657159247434673,0.726910925070335,1,12,response to manganese ion,BP,ATF4
15566,GO:0072012,0.658029547850735,0.726016987434862,1,12,glomerulus vasculature development,BP,ACTA2
12783,GO:0051058,0.658034312228939,0.541827733362704,4,47,negative regulation of small GTPase mediated signal transduction,BP,ARHGAP12;RASA3;SPRY2;TIMP2
5620,GO:0016675,0.658098320499269,0.719604932243431,1,19,oxidoreductase activity, acting on a heme group of donors,MF,NDUFA4L2
1339,GO:0003198,0.658123894003063,0.727506497982836,1,11,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,TGFBR2
18596,GO:1903859,0.658514744070348,0.729023254815699,1,10,regulation of dendrite extension,BP,SYT2
3329,GO:0007039,0.658648238941941,0.725380142870051,1,12,protein catabolic process in the vacuole,BP,LRP1
12737,GO:0051000,0.659004518159081,0.725012899798164,1,12,positive regulation of nitric-oxide synthase activity,BP,APOE
5625,GO:0016701,0.659320526427948,0.722203214207998,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,ALOX15B
5626,GO:0016702,0.659320526427948,0.722203214207998,1,14,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,ALOX15B
12651,GO:0050855,0.659429343927671,0.72457451285047,1,12,regulation of B cell receptor signaling pathway,BP,SLC39A10
12489,GO:0050482,0.65948735089733,0.724514612978195,1,12,arachidonic acid secretion,BP,NTSR1
18650,GO:1903963,0.65948735089733,0.724514612978195,1,12,arachidonate transport,BP,NTSR1
3259,GO:0006925,0.659518699298195,0.723141525637866,1,13,inflammatory cell apoptotic process,BP,CTSL
7063,GO:0030850,0.659534152017593,0.570475405843098,3,36,prostate gland development,BP,ALOX15B;PLAG1;PTCH1
6502,GO:0021871,0.659733677079939,0.725853578861341,1,11,forebrain regionalization,BP,WNT2B
13949,GO:0060628,0.659922822087114,0.724064614777803,1,12,regulation of ER to Golgi vesicle-mediated transport,BP,SORL1
12913,GO:0051259,0.659949651016157,0.413664871208807,29,379,protein complex oligomerization,BP,SORL1;MMP1;PRNP;GPX3;DDIT3;KCNG1;CRTC1;SNX9;TYSND1;TGM2;GLUL;STOM;ATXN10;CBR4;APOE;ANGPTL4;PKD2;IDE;ITPR3;ANXA6;CTH;ACOT13;BOK;NACC2;COL6A1;COL1A2;SIGMAR1;KCTD18;LRP4
2278,GO:0005227,0.660017921002697,0.723966269053473,1,12,calcium activated cation channel activity,MF,ANO1
12818,GO:0051123,0.660024079087336,0.617976851611678,2,28,RNA polymerase II transcriptional preinitiation complex assembly,BP,ATF7IP;THRA
733,GO:0001963,0.660077356154572,0.721416133529095,1,14,synaptic transmission, dopaminergic,BP,RAB3B
3148,GO:0006743,0.660151436259596,0.720349339036602,1,15,ubiquinone metabolic process,BP,COQ2
17343,GO:1900025,0.660348431551383,0.723624266873429,1,12,negative regulation of substrate adhesion-dependent cell spreading,BP,POSTN
11516,GO:0046030,0.660465809085757,0.725099304406505,1,11,inositol trisphosphate phosphatase activity,MF,INPP4A
8039,GO:0032688,0.660581800091822,0.722038067901706,1,13,negative regulation of interferon-beta production,BP,PTPRS
9075,GO:0035315,0.660914174421745,0.618398383455365,2,25,hair cell differentiation,BP,SLITRK6;FGFR1
11042,GO:0045022,0.661307217305232,0.567878674609048,3,38,early endosome to late endosome transport,BP,MAP2K1;VPS11;MAP2K2
8345,GO:0033194,0.661832363768644,0.720735754312292,1,13,response to hydroperoxide,BP,GPX3
8163,GO:0032892,0.66201612439071,0.720543998834829,1,13,positive regulation of organic acid transport,BP,NTSR1
19717,GO:2000060,0.66202156233602,0.499702714826626,6,80,positive regulation of ubiquitin-dependent protein catabolic process,BP,TRIB2;DVL1;TRIB3;ANKIB1;MAGEF1;RNF180
4338,GO:0009890,0.662134216814209,0.378553637272602,101,1219,negative regulation of biosynthetic process,BP,SMURF2;ZMYND8;CCND1;CTNNBIP1;VLDLR;CYGB;CYP27B1;NR1D1;NFATC4;ZC3H6;MAP2K1;ACVR2B;SALL2;WWTR1;PEG3;EIF4EBP1;DDIT3;ELK3;EGFR;SCMH1;DLG1;DNAJB5;IGF2BP3;SHC1;DKK1;DAP;TRIB2;IMPACT;APOE;ACP5;AKAP9;HMGA2;ATF4;PPARA;ABCA7;WWC3;FGFR1;TCFL5;BTRC;LPCAT1;ATRX;CEACAM1;ZNF692;ATF7IP;RCOR1;MDFI;XRN1;TNRC6B;HES2;PHF12;KLF12;TRIB3;MEX3C;PRDX5;UHRF2;AEBP1;PARP9;CPEB4;NACC2;THRA;TSHZ1;PER3;MTA1;H2AFJ;MAP2K2;SATB1;TLE4;LOXL2;EAPP;PUM2;EIF2AK2;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;ARID4A;TENM2;IGF2;PPARG;SNX6;GRB7;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;ARID5B;E2F7;SLC18A2;TNRC6C;TET1;ZC3H7A;DEDD2;FOXP1;ZBTB33;PTCH1;JARID2;MXD4;DNMT3A
11500,GO:0045980,0.662297351096697,0.616345557973893,2,26,negative regulation of nucleotide metabolic process,BP,AKAP9;PPARA
14290,GO:0061383,0.663028577101012,0.567229684659438,3,34,trabecula morphogenesis,BP,FKBP1A;THBS3;CHD7
7485,GO:0031649,0.663062037731376,0.719450670000453,1,13,heat generation,BP,APLN
20094,GO:2000758,0.663210868533555,0.614852398697864,2,27,positive regulation of peptidyl-lysine acetylation,BP,NOS1;SOX4
20176,GO:2001022,0.663384900901852,0.513645349381952,5,67,positive regulation of response to DNA damage stimulus,BP,EGFR;HMGA2;CEBPG;PARP9;NACC2
11634,GO:0046339,0.663490354280086,0.720356943297487,1,12,diacylglycerol metabolic process,BP,DGKA
15065,GO:0071025,0.663584920703781,0.716747581169754,1,15,RNA surveillance,BP,XRN1
18080,GO:1902679,0.663937705943628,0.382304578722662,76,925,negative regulation of RNA biosynthetic process,BP,SMURF2;ZMYND8;CCND1;CTNNBIP1;VLDLR;NR1D1;NFATC4;ZC3H6;ACVR2B;SALL2;WWTR1;PEG3;DDIT3;ELK3;SCMH1;DLG1;DNAJB5;SHC1;DKK1;DAP;IMPACT;HMGA2;PPARA;WWC3;FGFR1;TCFL5;BTRC;ATRX;ZNF692;ATF7IP;RCOR1;MDFI;HES2;PHF12;KLF12;TRIB3;PRDX5;UHRF2;AEBP1;PARP9;NACC2;THRA;TSHZ1;PER3;MTA1;H2AFJ;SATB1;TLE4;LOXL2;EAPP;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;ARID4A;TENM2;IGF2;PPARG;SNX6;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;ARID5B;E2F7;TET1;DEDD2;FOXP1;ZBTB33;PTCH1;JARID2;MXD4;DNMT3A
18427,GO:1903507,0.663937705943628,0.382304578722662,76,925,negative regulation of nucleic acid-templated transcription,BP,SMURF2;ZMYND8;CCND1;CTNNBIP1;VLDLR;NR1D1;NFATC4;ZC3H6;ACVR2B;SALL2;WWTR1;PEG3;DDIT3;ELK3;SCMH1;DLG1;DNAJB5;SHC1;DKK1;DAP;IMPACT;HMGA2;PPARA;WWC3;FGFR1;TCFL5;BTRC;ATRX;ZNF692;ATF7IP;RCOR1;MDFI;HES2;PHF12;KLF12;TRIB3;PRDX5;UHRF2;AEBP1;PARP9;NACC2;THRA;TSHZ1;PER3;MTA1;H2AFJ;SATB1;TLE4;LOXL2;EAPP;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;ARID4A;TENM2;IGF2;PPARG;SNX6;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;ARID5B;E2F7;TET1;DEDD2;FOXP1;ZBTB33;PTCH1;JARID2;MXD4;DNMT3A
4769,GO:0010954,0.664299186630986,0.719511074345104,1,12,positive regulation of protein processing,BP,ADAM8
10724,GO:0044058,0.66442693575869,0.719377296762389,1,12,regulation of digestive system process,BP,STK39
5483,GO:0016417,0.664481277251175,0.61342753320488,2,27,S-acyltransferase activity,MF,ZDHHC2;ZDHHC1
1428,GO:0003401,0.664539362805671,0.615511482875388,2,23,axis elongation,BP,SPRY2;LRP6
19747,GO:2000134,0.665101603779232,0.484215573961733,7,93,negative regulation of G1/S transition of mitotic cell cycle,BP,FHL1;CCND1;PKD2;SOX4;NACC2;E2F7;CNOT11
6293,GO:0019903,0.665148442802726,0.474895434436989,8,99,protein phosphatase binding,MF,EGFR;DLG4;DLG3;ITGA1;CEACAM1;PPP3CB;MTMR4;PPARG
7247,GO:0031201,0.665768960294475,0.561579534308678,3,43,SNARE complex,CC,VAMP2;SEC22C;STX10
10889,GO:0044429,0.665797492541299,0.38546477223871,60,852,mitochondrial part,CC,PCK2;CYP27B1;GPT2;FAM210B;TK2;DHTKD1;PC;HADH;SNPH;ARMCX2;BNIP3;IDH2;ACSF2;NME4;ACAD11;ARG2;SHC1;NAGS;CBR4;HAGH;BNIP3L;ALDH1L2;ABHD10;OCIAD2;SPATA18;MRPS6;ACAD10;COX18;HIBADH;PRDX5;MLYCD;ALDH7A1;TST;SLC25A4;NDUFV3;CPT2;CRLS1;BOK;NIPSNAP1;LACTB2;NDUFA4L2;BPHL;GLUD1;BCL2L1;CRAT;MICU3;SFXN3;SLC25A30;SLC25A43;ACP6;MOAP1;ALDH4A1;GARS;TMEM173;COQ2;ARMCX3;PSEN2;CDS2;SLC44A1;ALAS1
1218,GO:0002888,0.665855118591889,0.716514966300687,1,13,positive regulation of myeloid leukocyte mediated immunity,BP,F2RL1
7220,GO:0031114,0.665956673694079,0.614589735539786,2,22,regulation of microtubule depolymerization,BP,MAP1B;TTBK2
12625,GO:0050810,0.665977941544426,0.510847123810916,5,66,regulation of steroid biosynthetic process,BP,CYP27B1;NR1D1;APOE;ABCG1;IGFBP7
7443,GO:0031573,0.666130547654176,0.715059830496163,1,14,intra-S DNA damage checkpoint,BP,XPC
7218,GO:0031112,0.666133671101755,0.613113735996191,2,24,positive regulation of microtubule polymerization or depolymerization,BP,PAK1;AKAP9
12352,GO:0048714,0.666165997643276,0.717551303473867,1,12,positive regulation of oligodendrocyte differentiation,BP,PPARG
6946,GO:0030554,0.666319617579389,0.37377120731639,104,1178,adenyl nucleotide binding,MF,PYGL;RPS6KA2;SCN8A;ADCY7;ACTA2;MAP2K1;RAPGEF3;ACVR2B;TK2;PKN1;MST1R;DGKA;PC;SMARCA1;CARS;BRSK1;EGFR;STK39;FYN;MYH15;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;DHX32;GLUL;ACSF2;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;SLFN5;PAK1;NEK9;TGFBR2;EPHA1;OBSCN;ATP7B;ABCD1;CDK17;PRKACB;FYCO1;IDE;UBE2G1;ABCA7;KIF21B;ASNS;FGFR1;AARS;PTK6;ULK2;LONP2;ATRX;FAM20C;ABCG1;MAPKAPK3;NLK;CLCN3;TWF2;TRIB3;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;PRKAR1A;MAST3;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;YTHDC2;PANK4;MAP2K2;RET;MLH3;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;FICD;MAP4K2;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;TMEM173;EEF2K;ADCY1;OAS1;PANK1;N4BP2
15184,GO:0071318,0.666591222975937,0.717103439518484,1,12,cellular response to ATP,BP,SSH1
8430,GO:0033523,0.666686749863132,0.717002751943088,1,12,histone H2B ubiquitination,BP,UBE2E1
6993,GO:0030673,0.666777457830191,0.720491052584485,1,10,axolemma,CC,EPB41L3
10693,GO:0043970,0.666907324841039,0.716770155659856,1,12,histone H3-K9 acetylation,BP,KAT2B
8313,GO:0033145,0.667066575464239,0.71523437011232,1,13,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,PAK1
10606,GO:0043584,0.66706724863662,0.720188106483209,1,10,nose development,BP,CHD7
14291,GO:0061384,0.667315055324651,0.61239430222334,2,23,heart trabecula morphogenesis,BP,FKBP1A;CHD7
16171,GO:0090189,0.66756028342813,0.714711216419223,1,13,regulation of branching involved in ureteric bud morphogenesis,BP,WNT2B
10313,GO:0043090,0.667815679733842,0.715810747834874,1,12,amino acid import,BP,NTSR1
12839,GO:0051149,0.668118173362205,0.529144282522459,4,54,positive regulation of muscle cell differentiation,BP,MMP14;CTH;THRA;TBX1
1657,GO:0004112,0.668253210825528,0.716977641603717,1,11,cyclic-nucleotide phosphodiesterase activity,MF,PDE5A
19958,GO:2000516,0.668828774741384,0.712191099477327,1,14,positive regulation of CD4-positive, alpha-beta T cell activation,BP,TGFBR2
20060,GO:2000696,0.668940066246749,0.716252554446476,1,11,regulation of epithelial cell differentiation involved in kidney development,BP,WWTR1
13817,GO:0060411,0.668943101687627,0.529319250197885,4,48,cardiac septum morphogenesis,BP,TGFBR2;SOX4;CHD7;TBX1
14301,GO:0061430,0.669100817264982,0.718055079413061,1,10,bone trabecula morphogenesis,BP,THBS3
9083,GO:0035333,0.669187631000191,0.714356953198307,1,12,Notch receptor processing, ligand-dependent,BP,PSEN2
7203,GO:0031092,0.66934564832682,0.715823724348383,1,11,platelet alpha granule membrane,CC,APLP2
10535,GO:0043476,0.669456775812403,0.714071082314562,1,12,pigment accumulation,BP,AP3D1
10536,GO:0043482,0.669456775812403,0.714071082314562,1,12,cellular pigment accumulation,BP,AP3D1
8291,GO:0033116,0.669547701430512,0.527359445813165,4,55,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,MCFD2;LMAN1;AZIN2;CTSZ
4203,GO:0009311,0.669558308988396,0.527507902511697,4,54,oligosaccharide metabolic process,BP,ST3GAL5;GALNT3;CTBS;ST6GALNAC2
10434,GO:0043279,0.669795217398468,0.506658293514467,5,65,response to alkaloid,BP,FKBP1A;BCL2L1;PPARG;DNMT3A;FADD
15329,GO:0071545,0.669817667544645,0.713687417056023,1,12,inositol phosphate catabolic process,BP,NTSR1
14119,GO:0060977,0.669818110771378,0.717299711149692,1,10,coronary vasculature morphogenesis,BP,TBX1
14915,GO:0070742,0.670298930028392,0.713175168057615,1,12,C2H2 zinc finger domain binding,MF,HMGA2
11379,GO:0045744,0.670341280515914,0.60636801179824,2,28,negative regulation of G-protein coupled receptor protein signaling pathway,BP,APLN;RPH3AL
15595,GO:0072074,0.670418255320914,0.713048050654785,1,12,kidney mesenchyme development,BP,PKD2
1610,GO:0004033,0.670507960069503,0.708491158934009,1,16,aldo-keto reductase (NADP) activity,MF,RDH14
4678,GO:0010826,0.670526516529385,0.712932682248068,1,12,negative regulation of centrosome duplication,BP,KAT2B
11369,GO:0045730,0.670579648236186,0.710317779176829,1,14,respiratory burst,BP,RAC2
9543,GO:0036295,0.670629897457973,0.71144194839658,1,13,cellular response to increased oxygen levels,BP,PPARG
8775,GO:0034452,0.670927789361247,0.71612804104741,1,10,dynactin binding,MF,SNX6
3945,GO:0008637,0.670950267333067,0.476959569349942,7,104,apoptotic mitochondrial changes,BP,BNIP3;BNIP3L;SLC25A4;BOK;BCL2L1;MOAP1;FAM162A
7342,GO:0031369,0.671221395317352,0.605366771914802,2,28,translation initiation factor binding,MF,EIF4EBP1;ANGEL1
6621,GO:0022843,0.671317764716465,0.556526567155417,3,38,voltage-gated cation channel activity,MF,KCNG1;PKD2;KCNJ15
4268,GO:0009617,0.671325982073685,0.412055067784561,22,298,response to bacterium,BP,TNIP1;NOS1;F2R;PCK2;CYP27B1;NR1D1;LOXL1;TNFRSF6B;ARG2;SHC1;ACP5;ANXA3;MAPKAPK3;GSDMC;TRIM5;F2RL1;GSDMA;NGFR;XBP1;RAB1A;WASL;FOXP1
7973,GO:0032587,0.671757647802951,0.489573591457314,6,72,ruffle membrane,CC,PAK1;ABCA7;FERMT1;SPRY2;ARF4;PSD3
15287,GO:0071470,0.671763839167716,0.605667729696113,2,26,cellular response to osmotic stress,BP,STK39;PKD2
8029,GO:0032673,0.672455941224729,0.708299881969848,1,14,regulation of interleukin-4 production,BP,IL20RB
14110,GO:0060965,0.672713638645101,0.710594299498492,1,12,negative regulation of gene silencing by miRNA,BP,PPARG
18392,GO:1903409,0.672742651351117,0.50318973273012,5,66,reactive oxygen species biosynthetic process,BP,NOS1;ARG2;ACP5;PKD2;SLC18A2
6658,GO:0030010,0.672863033339588,0.458678106969901,9,104,establishment of cell polarity,BP,MAP1B;BRSK1;WNT7A;PAK1;FERMT1;SPRY2;MARK4;FRMD4B;SNX27
288,GO:0000792,0.672965386377697,0.502936504809213,5,66,heterochromatin,CC,HMGA2;ATRX;UHRF2;SATB1;DNMT3A
13469,GO:0055003,0.673713097543394,0.718731795356988,1,8,cardiac myofibril assembly,BP,OBSL1
7484,GO:0031648,0.673761763386834,0.553727158947012,3,38,protein destabilization,BP,PRNP;BTRC;XBP1
2287,GO:0005245,0.673778897181233,0.709450048834515,1,12,voltage-gated calcium channel activity,MF,PKD2
8437,GO:0033554,0.673862210981882,0.361932257542161,131,1619,cellular response to stress,BP,XDH;EDEM1;ERCC1;ETV5;CCND1;CBS;RPS6KA2;NFATC4;MAP2K1;TFPI2;GPX3;PKN1;DDIT3;PTPRS;PSMD2;BRSK1;EGFR;STK39;BNIP3;ERCC6;UBE2J1;MAPK13;DLG1;NET1;XPC;GLUL;WNT7A;UBXN4;MAP4K4;STRADB;ARG2;SHC1;DKK1;DAP;PAK1;IMPACT;CD44;APOE;BNIP3L;RGS14;PKD2;HMGA2;ATF4;ASNS;BTRC;TMX4;INPP5F;CHAC1;ATRX;SOX4;FBXO2;DDB2;ENDOV;SPATA18;PDIA5;TCEA1;CTH;ETAA1;CST3;TRIB3;CASP4;GFPT1;DNAJB9;SEC63;MYOF;SLK;PRDX5;CEBPG;F2RL1;TAOK1;PHF1;PSMD7;ANO1;JMY;BOK;PARP9;CPEB4;NACC2;WNT2B;PPP1R10;HSPA13;CHD6;MTA1;BCL2L1;POLL;XBP1;MAP2K2;REC8;SLC38A2;MLH3;TXNDC11;GABARAPL2;PAK6;PRKACA;NEK6;EIF2AK2;EEPD1;SEL1L;IFI16;KDELR3;LAMB2;FICD;RNF169;MOAP1;MAP4K2;ERLEC1;PPARG;CREB3L2;ERP44;ADAM8;AKT3;WFS1;ENDOG;ZBTB40;FZD8;HSPA2;MAGEF1;E2F7;EEF2K;SSR1;DNAJC3;CNOT11;RNF103;USP25;UFL1;FAM162A;ANKRD6;KLHL15;STT3B;RB1CC1;DNMT3A
13110,GO:0051645,0.674130503768502,0.70907160166046,1,12,Golgi localization,BP,COPG1
15751,GO:0072337,0.674343054736174,0.708842640025811,1,12,modified amino acid transport,BP,SLC38A2
1216,GO:0002886,0.674418990665259,0.602157749515337,2,27,regulation of myeloid leukocyte mediated immunity,BP,RAC2;F2RL1
10221,GO:0042886,0.674607378021831,0.362133506485331,123,1532,amide transport,BP,EDEM1;F2R;SORL1;RAB3B;PCK2;VLDLR;PRNP;XPOT;BBS2;POSTN;SH3TC2;NR1D1;LTBP2;RAPGEF3;ACVR2B;ALOX15B;LMF1;APLN;POU2F2;HADH;EXOC2;EGFR;TBC1D14;ANK3;FYN;KIF13B;UBE2J1;IDH2;SNX9;GLUL;EVI5L;MAP4K4;SEC23A;STRADB;GDI1;CEMIP;UNC119B;ARG2;STOM;PAK1;RAC2;APOE;BNIP3L;MCFD2;LRP1;EHBP1;ICA1;SNX14;VAMP2;LONP2;LTBP4;ABCG1;SOX4;PITPNM1;ITPR3;VPS13A;FERMT1;RAB31;NLGN2;MVB12B;LRP5;COX18;SEC22C;CLTCL1;TOM1L2;VPS11;SEC63;PPP3CB;SYTL1;ZDHHC2;COPB1;COPG1;F2RL1;CHD7;SLC25A4;ANO1;SDCCAG3;USP6NL;TBC1D2B;NGFR;PPP1R10;MVB12A;GLUD1;ARF4;XBP1;SPIRE1;ARRDC1;STX10;RAB43;C5;ZFYVE9;GABARAPL2;TMED4;TMSB4X;RAB1A;ZDHHC1;SNX30;SEL1L;BCAP29;AP2A2;KDELR3;IL1RAP;CARD11;AP3D1;ITPR2;EFCAB7;ERLEC1;PPARG;SNX6;ANKRD50;LYPLA1;TMEM50B;EVI5;ATP6V1B2;RPH3AL;ADAM8;TBC1D16;SSR3;TMEM173;SSR1;FOXP1;COG8;SNX27
13625,GO:0060119,0.674770546558812,0.60275386016334,2,25,inner ear receptor cell development,BP,SLITRK6;FGFR1
19957,GO:2000515,0.675104641624029,0.708021105111431,1,12,negative regulation of CD4-positive, alpha-beta T cell activation,BP,ARG2
11118,GO:0045143,0.675151044954505,0.601318793831756,2,27,homologous chromosome segregation,BP,REC8;MLH3
19620,GO:1990774,0.675212372357064,0.709564434047037,1,11,tumor necrosis factor secretion,BP,ARG2
10446,GO:0043302,0.675371947471044,0.706334817478382,1,13,positive regulation of leukocyte degranulation,BP,F2RL1
7776,GO:0032300,0.67544529783026,0.707653052752691,1,12,mismatch repair complex,CC,MLH3
8606,GO:0034114,0.675765340985373,0.704714331701939,1,14,regulation of heterotypic cell-cell adhesion,BP,CD44
10211,GO:0042826,0.675815947828976,0.472483727121558,7,89,histone deacetylase binding,MF,CCND1;UHRF1BP1;PKN1;NACC2;BEX4;MEF2D;KAT2B
7070,GO:0030857,0.675844539841262,0.601523251937834,2,25,negative regulation of epithelial cell differentiation,BP,XDH;CCND1
83,GO:0000166,0.675894150085621,0.358999399388639,139,1626,nucleotide binding,MF,XDH;NT5E;NOS1;RAB3B;PCK2;PYGL;RPS6KA2;SCN8A;ADCY7;CRYL1;ACTA2;MAP2K1;RAPGEF3;ACVR2B;TK2;PKN1;MST1R;H6PD;DGKA;PC;SMARCA1;HADH;CARS;BRSK1;EGFR;STK39;FYN;MYH15;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;IDH2;DHX32;TGM2;GLUL;ACSF2;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;ACAD11;SEPT10;SLFN5;PAK1;NEK9;CBR4;TGFBR2;EPHA1;RAC2;OBSCN;ATP7B;ABCD1;CDK17;PRKACB;LDHA;FYCO1;IDE;UBE2G1;ABCA7;KIF21B;ASNS;FGFR1;AARS;PTK6;ULK2;LONP2;ATRX;FAM20C;MTHFR;ABCG1;MAPKAPK3;RAB31;NLK;CLCN3;ANXA6;ACAD10;TWF2;TRIB3;VPS11;HIBADH;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;PRKAR1A;MAST3;SEPT5;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;NUDT6;YTHDC2;ARF4;PANK4;TXNRD3;MAP2K2;RET;TUBG2;PDE5A;RAB43;MLH3;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;RAB1A;RHOBTB1;LTB4R;FICD;MAP4K2;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;TMEM173;EEF2K;ZBTB33;AOX1;ADCY1;SEPT6;OAS1;PANK1;N4BP2;GNAI1
6069,GO:0019218,0.675906314663286,0.483974983527001,6,81,regulation of steroid metabolic process,BP,CYP27B1;NR1D1;LMF1;APOE;ABCG1;IGFBP7
15078,GO:0071044,0.675913921127724,0.708808838791938,1,11,histone mRNA catabolic process,BP,XRN1
6849,GO:0030317,0.676567506437441,0.600172512099567,2,26,flagellated sperm motility,BP,NEURL1;BBS2
1015,GO:0002507,0.676628399017014,0.706372005452725,1,12,tolerance induction,BP,TGFBR2
3232,GO:0006885,0.67668611453751,0.498345000864325,5,69,regulation of pH,BP,SLC9A7;DMXL2;CLCN3;ATP12A;ATP6V1B2
8820,GO:0034593,0.676781454451085,0.60163305020003,2,23,phosphatidylinositol bisphosphate phosphatase activity,MF,INPP4A;MTMR4
11196,GO:0045309,0.676787034450836,0.550861637216535,3,36,protein phosphorylated amino acid binding,MF,SHC1;PTPN3;BTRC
5074,GO:0015297,0.676817686336803,0.519733064494993,4,51,antiporter activity,MF,SLC9A7;CLCN3;SLC25A4;SLC7A11
11355,GO:0045687,0.67717979421103,0.598987423998193,2,27,positive regulation of glial cell differentiation,BP,SERPINE2;PPARG
6211,GO:0019730,0.677225560040022,0.595148743763683,2,39,antimicrobial humoral response,BP,PRSS3;LCN2
11127,GO:0045165,0.677259388987184,0.446655618761183,10,121,cell fate commitment,BP,SOX12;WNT7A;DKK1;FGFR1;SPRY2;WNT2B;SH3PXD2B;PPARG;TBX1;PTCH1
18342,GO:1903306,0.677679677516956,0.705230036455194,1,12,negative regulation of regulated secretory pathway,BP,CEACAM1
6256,GO:0019840,0.677690551763865,0.703812393436092,1,13,isoprenoid binding,MF,ALDH1A2
17603,GO:1901265,0.67769280829094,0.357126454634213,139,1627,nucleoside phosphate binding,MF,XDH;NT5E;NOS1;RAB3B;PCK2;PYGL;RPS6KA2;SCN8A;ADCY7;CRYL1;ACTA2;MAP2K1;RAPGEF3;ACVR2B;TK2;PKN1;MST1R;H6PD;DGKA;PC;SMARCA1;HADH;CARS;BRSK1;EGFR;STK39;FYN;MYH15;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;IDH2;DHX32;TGM2;GLUL;ACSF2;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;ACAD11;SEPT10;SLFN5;PAK1;NEK9;CBR4;TGFBR2;EPHA1;RAC2;OBSCN;ATP7B;ABCD1;CDK17;PRKACB;LDHA;FYCO1;IDE;UBE2G1;ABCA7;KIF21B;ASNS;FGFR1;AARS;PTK6;ULK2;LONP2;ATRX;FAM20C;MTHFR;ABCG1;MAPKAPK3;RAB31;NLK;CLCN3;ANXA6;ACAD10;TWF2;TRIB3;VPS11;HIBADH;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;PRKAR1A;MAST3;SEPT5;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;NUDT6;YTHDC2;ARF4;PANK4;TXNRD3;MAP2K2;RET;TUBG2;PDE5A;RAB43;MLH3;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;RAB1A;RHOBTB1;LTB4R;FICD;MAP4K2;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;TMEM173;EEF2K;ZBTB33;AOX1;ADCY1;SEPT6;OAS1;PANK1;N4BP2;GNAI1
8161,GO:0032890,0.677899673919312,0.598639268493517,2,26,regulation of organic acid transport,BP,STK39;NTSR1
5076,GO:0015299,0.678028731448007,0.704850107414211,1,12,solute:proton antiporter activity,MF,SLC9A7
19657,GO:1990907,0.678094494216672,0.706450494151197,1,11,beta-catenin-TCF complex,CC,TLE4
1093,GO:0002682,0.678325643161527,0.367975616855777,73,927,regulation of immune system process,BP,TNIP1;PGF;CTNNBIP1;PRNP;PAG1;NR1D1;FAM210B;PKN1;PTPRS;PSMD2;FCGRT;WIPF1;FYN;DLG1;CTSB;HTRA1;ARG2;SHC1;PAK1;RAG1;TGFBR2;SERPING1;RAC2;FKBP1A;PRKACB;RBCK1;BTRC;ITGA2;CEACAM1;MAPKAPK3;TRIM5;TNRC6B;MMP14;CD46;CTSL;MOSPD2;PPP3CB;F2RL1;DDX60;PSMD7;PRKAR1A;PARP9;CD99;ACVR1B;IFITM1;WASF2;SKAP2;XBP1;UBASH3B;PDE5A;C5;NCKAP1;PUM2;RNF135;COL1A2;PRKACA;EIF2AK2;IFI16;SLC39A10;CARD11;AP3D1;ARPC1A;IGF2;PPARG;ADAM8;IL20RB;ITGA4;WASL;TMEM173;TNRC6C;FOXP1;KAT2B;FADD
4636,GO:0010758,0.678441163695938,0.701790386395436,1,14,regulation of macrophage chemotaxis,BP,C5
442,GO:0001190,0.678642497459354,0.518444422418925,4,47,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,SOX12;PPARA;SOX4;CITED4
18241,GO:1903051,0.678844140230641,0.516877493277435,4,54,negative regulation of proteolysis involved in cellular protein catabolic process,BP,UBE2J1;GABARAPL2;ERLEC1;USP25
11770,GO:0046627,0.678952811150552,0.596942243327526,2,27,negative regulation of insulin receptor signaling pathway,BP,SOCS2;GRB10
9369,GO:0035886,0.678989630351787,0.702391782895515,1,13,vascular smooth muscle cell differentiation,BP,CTH
13012,GO:0051445,0.679215939308212,0.596638110709281,2,27,regulation of meiotic cell cycle,BP,PRKACB;PRKAR1A
1949,GO:0004653,0.679390680629667,0.703364038374398,1,12,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT3
5941,GO:0018243,0.679390680629667,0.703364038374398,1,12,protein O-linked glycosylation via threonine,BP,GALNT3
8692,GO:0034312,0.679483065470548,0.699605583034651,1,15,diol biosynthetic process,BP,SPTLC2
4169,GO:0009235,0.679628418113227,0.701691293803397,1,13,cobalamin metabolic process,BP,PRSS3
7650,GO:0032069,0.680211027828805,0.594625017415861,2,29,regulation of nuclease activity,BP,TCEA1;OAS1
10898,GO:0044441,0.68074464119404,0.402198569447568,22,269,ciliary part,CC,BBS2;WDR66;MAP1B;TTBK2;UNC119B;CEP170;SHANK2;PKD2;PRKACB;PRKAR1A;MARK4;SPATA6;TCTN1;CCDC88A;CCSAP;PRKACA;EFCAB7;WDR60;TMEM107;PSEN2;PTCH1;SEPT6
10863,GO:0044380,0.680955278347947,0.51577774420927,4,47,protein localization to cytoskeleton,BP,TTBK2;NUDCD3;DVL1;ABHD17C
10387,GO:0043209,0.681222412049732,0.441432890985746,10,139,myelin sheath,CC,DLG1;GLUL;GDI1;ITPR3;MPDZ;CNTN1;SLC25A4;ATP6V1B2;CLDN11;HSPA2
7215,GO:0031109,0.681408181330549,0.466394809076993,7,86,microtubule polymerization or depolymerization,BP,MAP1B;TTBK2;PAK1;AKAP9;RANBP9;TUBG2;CCSAP
11171,GO:0045239,0.681541818521686,0.699585384622974,1,13,tricarboxylic acid cycle enzyme complex,CC,DHTKD1
13967,GO:0060674,0.681579951260344,0.594382333689879,2,26,placenta blood vessel development,BP,MAP2K1;PKD2
11776,GO:0046634,0.68161167562573,0.5438529172231,3,41,regulation of alpha-beta T cell activation,BP,ARG2;TGFBR2;AP3D1
16004,GO:0086012,0.681933871761946,0.702261858612261,1,11,membrane depolarization during cardiac muscle cell action potential,BP,ANK3
3324,GO:0007031,0.682059926082158,0.592892832230731,2,28,peroxisome organization,BP,ABCD1;LONP2
11511,GO:0045995,0.68214328169815,0.465645479432269,7,85,regulation of embryonic development,BP,DKK1;PRKACB;FGFR1;DVL1;WNT2B;CCSAP;LAMA5
1388,GO:0003298,0.682290756071751,0.70018020425473,1,12,physiological muscle hypertrophy,BP,PAK1
1391,GO:0003301,0.682290756071751,0.70018020425473,1,12,physiological cardiac muscle hypertrophy,BP,PAK1
14167,GO:0061049,0.682290756071751,0.70018020425473,1,12,cell growth involved in cardiac muscle cell development,BP,PAK1
11475,GO:0045931,0.68237821697608,0.447406419080664,9,114,positive regulation of mitotic cell cycle,BP,CCND1;EIF4EBP1;CCND2;ASNS;FGFR1;HYAL1;LRP5;PPP1R10;IGF2
18453,GO:1903541,0.683050091418001,0.696701392746395,1,14,regulation of exosomal secretion,BP,SDC1
18455,GO:1903543,0.683050091418001,0.696701392746395,1,14,positive regulation of exosomal secretion,BP,SDC1
6510,GO:0021885,0.683066775512872,0.54326746855166,3,37,forebrain cell migration,BP,LAMB1;EGFR;MBOAT7
9443,GO:0036020,0.683124142937765,0.699260346623523,1,12,endolysosome membrane,CC,AP2A2
20266,GO:2001234,0.683190250350154,0.428443506973723,12,166,negative regulation of apoptotic signaling pathway,BP,ITGA6;FYN;STRADB;CD44;CTH;BOK;BCL2L1;XBP1;TMBIM1;WFS1;RB1CC1;FADD
8351,GO:0033209,0.683385832602286,0.445174132259611,9,139,tumor necrosis factor-mediated signaling pathway,BP,TNFSF15;PSMD2;TNFRSF6B;RBCK1;CASP4;F2RL1;PSMD7;NGFR;TMSB4X
12387,GO:0048806,0.683422675769676,0.593961158756148,2,23,genitalia development,BP,CHD7;LRP6
2166,GO:0005001,0.683461463861967,0.702629422094381,1,10,transmembrane receptor protein tyrosine phosphatase activity,MF,PTPRZ1
6051,GO:0019198,0.683461463861967,0.702629422094381,1,10,transmembrane receptor protein phosphatase activity,MF,PTPRZ1
9931,GO:0042277,0.683638166142556,0.423722388765462,13,172,peptide binding,MF,SORL1;PRNP;LTA4H;CEMIP;APOE;IDE;RNPEPL1;ITGA2;FBXO2;CST3;KDELR3;PPARG;ADNP
4139,GO:0009200,0.683757800883201,0.693945840454832,1,16,deoxyribonucleoside triphosphate metabolic process,BP,AK9
9902,GO:0042220,0.68385126795204,0.592265559909095,2,25,response to cocaine,BP,DNMT3A;FADD
5118,GO:0015459,0.684178548685468,0.591357719641979,2,26,potassium channel regulator activity,MF,DLG1;AKAP9
7892,GO:0032460,0.684305854008564,0.696522773183635,1,13,negative regulation of protein oligomerization,BP,SORL1
7057,GO:0030835,0.684306428087141,0.592307396905142,2,24,negative regulation of actin filament depolymerization,BP,TMOD2;TWF2
2058,GO:0004812,0.684441026506679,0.539860915642818,3,44,aminoacyl-tRNA ligase activity,MF,CARS;AARS;GARS
5730,GO:0016875,0.684441026506679,0.539860915642818,3,44,ligase activity, forming carbon-oxygen bonds,MF,CARS;AARS;GARS
2388,GO:0005524,0.684485813345544,0.355293941095779,101,1147,ATP binding,MF,PYGL;RPS6KA2;SCN8A;ADCY7;ACTA2;MAP2K1;ACVR2B;TK2;PKN1;MST1R;DGKA;PC;SMARCA1;CARS;BRSK1;EGFR;STK39;FYN;MYH15;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;DHX32;GLUL;ACSF2;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;SLFN5;PAK1;NEK9;TGFBR2;EPHA1;OBSCN;ATP7B;ABCD1;CDK17;PRKACB;FYCO1;IDE;UBE2G1;ABCA7;KIF21B;ASNS;FGFR1;AARS;PTK6;ULK2;LONP2;ATRX;FAM20C;ABCG1;MAPKAPK3;NLK;CLCN3;TWF2;TRIB3;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;MAST3;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;YTHDC2;PANK4;MAP2K2;RET;MLH3;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;FICD;MAP4K2;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;EEF2K;ADCY1;OAS1;PANK1;N4BP2
4959,GO:0015031,0.684803746287617,0.35188061164737,120,1500,protein transport,BP,EDEM1;F2R;SORL1;RAB3B;PCK2;VLDLR;PRNP;XPOT;BBS2;POSTN;SH3TC2;NR1D1;LTBP2;RAPGEF3;ACVR2B;ALOX15B;LMF1;POU2F2;HADH;EXOC2;EGFR;TBC1D14;ANK3;FYN;KIF13B;UBE2J1;IDH2;SNX9;GLUL;EVI5L;MAP4K4;SEC23A;STRADB;GDI1;CEMIP;UNC119B;ARG2;STOM;PAK1;RAC2;APOE;BNIP3L;MCFD2;LRP1;EHBP1;ICA1;SNX14;VAMP2;LONP2;ABCG1;SOX4;PITPNM1;ITPR3;VPS13A;FERMT1;RAB31;NLGN2;MVB12B;LRP5;COX18;SEC22C;CLTCL1;TOM1L2;VPS11;SEC63;PPP3CB;SYTL1;ZDHHC2;COPB1;COPG1;F2RL1;SLC25A4;ANO1;SDCCAG3;USP6NL;TBC1D2B;NGFR;PPP1R10;MVB12A;GLUD1;ARF4;XBP1;SPIRE1;ARRDC1;STX10;RAB43;C5;ZFYVE9;GABARAPL2;TMED4;TMSB4X;RAB1A;ZDHHC1;SNX30;SEL1L;BCAP29;AP2A2;KDELR3;IL1RAP;CARD11;AP3D1;ITPR2;EFCAB7;ERLEC1;PPARG;SNX6;ANKRD50;LYPLA1;TMEM50B;EVI5;ATP6V1B2;RPH3AL;ADAM8;TBC1D16;SSR3;TMEM173;SSR1;FOXP1;COG8;SNX27
4620,GO:0010738,0.684861132687693,0.697336014575616,1,12,regulation of protein kinase A signaling,BP,PJA2
8514,GO:0033692,0.684987268879304,0.510294826849365,4,51,cellular polysaccharide biosynthetic process,BP,NR1D1;PGM1;B3GNT3;IGF2
2607,GO:0005911,0.685128210153814,0.391022341701808,26,300,cell-cell junction,CC,CCND1;ITGA6;SH3KBP1;COL13A1;ANK3;PDZD2;DLG1;PODXL;DLG3;PAK1;PKD2;EPCAM;FAT1;FHOD1;CEACAM1;OBSL1;MPDZ;CDC42BPA;WASF2;CADM4;MAP2K2;FRMD4B;EPB41L3;PCDH1;PPL;CLDN11
5550,GO:0016556,0.68531461133672,0.693120875866701,1,15,mRNA modification,BP,CMTR2
3865,GO:0008484,0.685352669428289,0.696789711518266,1,12,sulfuric ester hydrolase activity,MF,GALNS
12542,GO:0050691,0.685376637586855,0.589021802833489,2,28,regulation of defense response to virus by host,BP,PARP9;TMEM173
10638,GO:0043647,0.685716920368512,0.509636969445082,4,50,inositol phosphate metabolic process,BP,ISYNA1;NTSR1;INPP4A;PLCH2
4810,GO:0012510,0.6857537671619,0.69490872411726,1,13,trans-Golgi network transport vesicle membrane,CC,CLTCL1
15247,GO:0071404,0.685871406133191,0.696212337156386,1,12,cellular response to low-density lipoprotein particle stimulus,BP,PPARG
3702,GO:0008209,0.685915815145238,0.694727664172886,1,13,androgen metabolic process,BP,SRD5A3
8007,GO:0032635,0.686106306450351,0.487632173858323,5,68,interleukin-6 production,BP,F2R;MAPK13;F2RL1;XBP1;IL1RAP
8461,GO:0033598,0.686157145531051,0.58904420922911,2,26,mammary gland epithelial cell proliferation,BP,CCND1;BTRC
400,GO:0001076,0.686184075995432,0.425719639164409,12,147,transcription factor activity, RNA polymerase II transcription factor binding,MF,ZMYND8;NR1D1;SOX12;ATF4;PPARA;SOX4;PHF12;PARP9;NACC2;THRA;PPARG;CITED4
12681,GO:0050892,0.686196396249161,0.695850169790391,1,12,intestinal absorption,BP,SLC5A1
10838,GO:0044331,0.68686330742926,0.693667318680178,1,13,cell-cell adhesion mediated by cadherin,BP,EPCAM
6254,GO:0019835,0.687145120868541,0.689325324122217,1,17,cytolysis,BP,C5
8061,GO:0032729,0.687270711002478,0.586381138306774,2,29,positive regulation of interferon-gamma production,BP,CEBPG;FADD
5453,GO:0016327,0.687464352623613,0.692993184991058,1,13,apicolateral plasma membrane,CC,MPDZ
10361,GO:0043174,0.687504864695131,0.689732009755269,1,16,nucleoside salvage,BP,TK2
11922,GO:0046965,0.687513459186269,0.694378957827983,1,12,retinoid X receptor binding,MF,PPARG
7299,GO:0031297,0.687533148891911,0.587429890078311,2,26,replication fork processing,BP,ATRX;ETAA1
8589,GO:0034086,0.68759790537574,0.69428443703954,1,12,maintenance of sister chromatid cohesion,BP,ATRX
8591,GO:0034088,0.68759790537574,0.69428443703954,1,12,maintenance of mitotic sister chromatid cohesion,BP,ATRX
16136,GO:0090136,0.687911893956762,0.693932786677967,1,12,epithelial cell-cell adhesion,BP,ITGB5
18168,GO:1902930,0.687927398699622,0.506512977521939,4,53,regulation of alcohol biosynthetic process,BP,CYP27B1;APOE;ABCG1;NTSR1
13222,GO:0051882,0.688367405282587,0.689682838229658,1,15,mitochondrial depolarization,BP,BOK
17097,GO:0099632,0.688745456555996,0.691552398120714,1,13,protein transport within plasma membrane,BP,AP3D1
17099,GO:0099637,0.688745456555996,0.691552398120714,1,13,neurotransmitter receptor transport,BP,AP3D1
14553,GO:0070071,0.689011095191556,0.692699223814659,1,12,proton-transporting two-sector ATPase complex assembly,BP,DMXL2
3397,GO:0007175,0.689056502426428,0.691201779441104,1,13,negative regulation of epidermal growth factor-activated receptor activity,BP,SNX6
7508,GO:0031690,0.689096579145656,0.691156581113425,1,13,adrenergic receptor binding,MF,DLG4
2525,GO:0005779,0.689252092394923,0.688680883982245,1,15,integral component of peroxisomal membrane,CC,ABCD1
7263,GO:0031231,0.689252092394923,0.688680883982245,1,15,intrinsic component of peroxisomal membrane,CC,ABCD1
18123,GO:1902807,0.689345790944719,0.456578976147452,7,96,negative regulation of cell cycle G1/S phase transition,BP,FHL1;CCND1;PKD2;SOX4;NACC2;E2F7;CNOT11
15465,GO:0071801,0.689979796431036,0.690159167086362,1,13,regulation of podosome assembly,BP,ASAP1
10314,GO:0043094,0.690125484372095,0.581918052981774,2,32,cellular metabolic compound salvage,BP,TK2;NAPRT
18464,GO:1903557,0.690209965779701,0.534039265492066,3,40,positive regulation of tumor necrosis factor superfamily cytokine production,BP,NFATC4;ADAM8;FADD
13419,GO:0052813,0.69051824967377,0.534854392156136,3,36,phosphatidylinositol bisphosphate kinase activity,MF,EGFR;FYN;FGFR1
6072,GO:0019221,0.690556783676844,0.370900249116104,39,532,cytokine-mediated signaling pathway,BP,CCND1;MMP1;BBS2;MST1R;TNFSF15;PSMD2;FYN;TNFRSF6B;SDC1;SHC1;SOCS2;LCN2;CD44;FKBP1A;RBCK1;BTRC;CEACAM1;MT2A;TRIM5;EPOR;CASP4;F2RL1;PSMD7;PARP9;NGFR;PTPRZ1;BCL2L1;IFITM1;COL1A2;PRKACA;TMSB4X;IL1RAP;LAMA5;AGPAT1;PPARG;IL20RB;OAS1;TRIM38;FADD
18781,GO:1904294,0.690639663392834,0.689412323128484,1,13,positive regulation of ERAD pathway,BP,EDEM1
13578,GO:0060045,0.69066815577117,0.690832185854886,1,12,positive regulation of cardiac muscle cell proliferation,BP,FGFR1
12286,GO:0048599,0.691471880630032,0.5822942675077,2,27,oocyte development,BP,REC8;PDE5A
7805,GO:0032354,0.691573310063293,0.689808546692192,1,12,response to follicle-stimulating hormone,BP,ASNS
13114,GO:0051649,0.691860806866605,0.342602748587916,136,1670,establishment of localization in cell,BP,EDEM1;NOS1;F2R;SORL1;RAB3B;PRNP;XPOT;BBS2;SH3TC2;NR1D1;MAP2K1;LTBP2;RAPGEF3;LMF1;MAP1B;DDIT3;BRSK1;SNPH;TBC1D14;ANK3;FYN;KIF13B;UBE2J1;DLG1;SNX9;EVI5L;WNT7A;MAP4K4;SEC23A;STRADB;MCTP1;GDI1;CEMIP;STOM;PAK1;RASA3;RAC2;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;RGS14;MCFD2;PKD2;FYCO1;RAB11FIP4;FAM155B;VAMP2;LONP2;INPP5F;PFN2;ABCG1;SOX4;FHOD1;ITPR3;VPS13A;CEP120;RAB31;LMAN1;DVL1;NTSR1;NLGN2;MVB12B;LRP5;COX18;SEC22C;CLTCL1;TOM1L2;VPS11;RIMS3;SEC63;PPP3CB;SYTL1;ZDHHC2;DNAJC6;COPB1;COPG1;FNBP1L;CHD7;CPT2;ANO1;FCHO2;SDCCAG3;USP6NL;SPRY2;SEPT5;TBC1D2B;NGFR;PPP1R10;MVB12A;ARF4;SPIRE1;UBASH3B;MAP2K2;TRPC1;STX10;RAB43;ZFYVE9;SLC30A1;CCDC88A;TMED4;PRKACA;RAB1A;ZDHHC1;SEL1L;BCAP29;AP2A2;CTSZ;AP3D1;ITPR2;MOAP1;MAP4K2;EFCAB7;ERLEC1;SNX6;ANKRD50;TMEM50B;EVI5;CREB3L2;RPH3AL;ITGA4;WDR60;TBC1D16;SSR3;DDHD2;WASL;REEP6;LRP6;SYT2;TMEM173;SLC18A2;SSR1;ZFYVE21;COG8;SNX27
7477,GO:0031641,0.691945499326539,0.582223236762978,2,26,regulation of myelination,BP,DLG1;WASF3
6939,GO:0030547,0.692014424202762,0.685536006141366,1,15,receptor inhibitor activity,MF,DKK1
13213,GO:0051865,0.692049855138064,0.50186399072895,4,52,protein autoubiquitination,BP,RAG1;DDB2;UHRF2;MTA1
7040,GO:0030813,0.692210727521571,0.690818308691443,1,11,positive regulation of nucleotide catabolic process,BP,RAPGEF3
11133,GO:0045177,0.692279208043281,0.398352381519616,18,216,apical part of cell,CC,PLAT;SLC29A4;EGFR;STK39;DLG1;PODXL;SHANK2;CD44;EPCAM;ITPR3;CEACAM1;SLC9A3R2;MPDZ;SLC2A9;ANO1;REEP6;PSEN2;SLC23A2
7425,GO:0031526,0.692345082123607,0.582281318363227,2,25,brush border membrane,CC,SHANK2;SLC6A14
3193,GO:0006817,0.692723791125185,0.688503589271987,1,12,phosphate ion transport,BP,FGFR1
11700,GO:0046488,0.692735257304054,0.413923935771571,13,160,phosphatidylinositol metabolic process,BP,EGFR;FYN;TTC7B;PIGH;FGFR1;INPP5F;PITPNM1;PLA2G4D;INPP4A;MTMR4;MBOAT7;PLCH2;ZFYVE21
10998,GO:0044798,0.69290368357252,0.417837757339483,12,157,nuclear transcription factor complex,CC,ERCC1;NR1D1;NFATC4;DDIT3;ATF4;PPARA;NFAT5;SOX4;TCEA1;THRA;TLE4;PPARG
1109,GO:0002698,0.692920950341529,0.479388017148997,5,71,negative regulation of immune effector process,BP,HTRA1;SERPING1;CEACAM1;PPP3CB;IL20RB
15505,GO:0071875,0.693657155421951,0.689180080692135,1,11,adrenergic receptor signaling pathway,BP,NOS1
11759,GO:0046606,0.693673392877464,0.685960367873061,1,13,negative regulation of centrosome cycle,BP,KAT2B
7638,GO:0032048,0.693850397612261,0.684509555669342,1,14,cardiolipin metabolic process,BP,CRLS1
2101,GO:0004869,0.69399351262211,0.578422202235768,2,29,cysteine-type endopeptidase inhibitor activity,MF,CST3;PRDX5
6235,GO:0019787,0.694218855780145,0.372534869714634,33,401,ubiquitin-like protein transferase activity,MF,SMURF2;GID4;NEURL1;HECW2;HLTF;UBE2J1;RAG1;ZNF862;RBCK1;UBE2G1;MARCH4;BTRC;RMND5A;FBXO2;DDB2;TRIM5;FBXL8;UHRF2;FBXO41;KLHL29;RNF165;ANKIB1;UBE2E1;RNF135;UNKL;PJA2;MARCH2;RNF180;TRIM2;RNF103;UFL1;KLHL15;FBXL5
7309,GO:0031312,0.694309378095803,0.578467911252856,2,28,extrinsic component of organelle membrane,CC,WDFY3;FKBP1A
9945,GO:0042304,0.694662417782643,0.578046912776684,2,28,regulation of fatty acid biosynthetic process,BP,CEACAM1;TRIB3
4094,GO:0009148,0.695102920316921,0.680218861117276,1,17,pyrimidine nucleoside triphosphate biosynthetic process,BP,NME4
1703,GO:0004190,0.695443353889617,0.682679117347782,1,14,aspartic-type endopeptidase activity,MF,PSEN2
14519,GO:0070001,0.695443353889617,0.682679117347782,1,14,aspartic-type peptidase activity,MF,PSEN2
8831,GO:0034613,0.695523189134723,0.340939177077772,118,1459,cellular protein localization,BP,EDEM1;ZMYND8;SORL1;ETV5;RAB3B;SYNE3;PRNP;XPOT;BBS2;SH3TC2;LTBP2;RAPGEF3;SSH1;DDIT3;EGFR;TBC1D14;ANK3;FYN;TSPAN5;KIF13B;UBE2J1;DLG1;DLG4;SNX9;EVI5L;TTBK2;SEC23A;TTC7B;STRADB;GDI1;CEMIP;SEPT10;STOM;DLG3;PAK1;NUDCD3;RAC2;OBSCN;APOE;BNIP3L;LRP1;ABCA7;TUB;VAMP2;LONP2;ATRX;SOX4;VPS13A;OBSL1;RAB31;BSG;DVL1;NLGN2;ABHD17C;TWF2;COX18;CLTCL1;TOM1L2;VPS11;SEC63;SYTL1;ZDHHC2;COPB1;COPG1;CSNK2A1;PARP9;FCHO2;NACC2;USP6NL;SEPT5;TBC1D2B;NGFR;PPP1R10;BCL2L1;GRIN3B;ARF4;STX10;TCTN1;RAB43;SH3PXD2B;ZFYVE9;TMBIM1;CCDC88A;TMED4;TMSB4X;RAB1A;ZDHHC1;EPB41L3;SEL1L;BCAP29;AP2A2;KDELR3;AP3D1;MOAP1;LAMA5;EFCAB7;ERLEC1;SNX6;LYPLA1;TMEM50B;EVI5;RPH3AL;ITGA4;ACAP2;TBC1D16;SSR3;TMEM107;WASL;FLNB;LRP6;TMEM173;SSR1;ARMCX3;PTCH1;SEPT6;SNX27;GNAI1;LRP4
9347,GO:0035855,0.695754225876952,0.685045353244091,1,12,megakaryocyte development,BP,WASF2
4447,GO:0010369,0.696023353106944,0.683265580076621,1,13,chromocenter,CC,SCMH1
3760,GO:0008301,0.696451850958899,0.682772228501475,1,13,DNA binding, bending,MF,HMGA2
15899,GO:0072665,0.696519028719942,0.49660161334391,4,52,protein localization to vacuole,BP,SORL1;VPS13A;AP3D1;TMEM50B
2409,GO:0005581,0.69677082816022,0.527786178366809,3,35,collagen trimer,CC,COL13A1;COL6A1;COL1A2
10410,GO:0043247,0.69680354051928,0.682366852946591,1,13,telomere maintenance in response to DNA damage,BP,ERCC1
1979,GO:0004697,0.697051167019002,0.683556006390094,1,12,protein kinase C activity,MF,PKN1
12532,GO:0050680,0.697822934209101,0.447493606232008,7,87,negative regulation of epithelial cell proliferation,BP,XDH;DLG1;APOE;CEACAM1;NGFR;PPARG;PTCH1
6910,GO:0030500,0.69786895283819,0.525510312868343,3,38,regulation of bone mineralization,BP,CYP27B1;ACVR2B;FAM20C
830,GO:0002116,0.697897383890135,0.686459466829902,1,10,semaphorin receptor complex,CC,PLXNB3
5856,GO:0017154,0.697897383890135,0.686459466829902,1,10,semaphorin receptor activity,MF,PLXNB3
10873,GO:0044403,0.698161139490828,0.353871412985056,54,714,symbiont process,BP,TNIP1;MMP1;ADARB1;PC;EXOC2;CRTC1;EGFR;FYN;BNIP3;DLG1;CTSB;STOM;SHC1;APOE;BNIP3L;RBCK1;IDE;RAB11FIP4;HMGA2;ITGB5;BTRC;ITGA2;ULK2;APOBEC3C;ATF7IP;RCOR1;TRIM5;CD46;MVB12B;MPDZ;COPB1;F2RL1;SLC25A4;USP6NL;MVB12A;CHD6;BCL2L1;IFITM1;YTHDC2;WASF2;SATB1;RAB43;NCKAP1;EIF2AK2;RAB1A;IFI16;AP2A2;RSF1;TMEM173;KAT2B;SEPT6;OAS1;TRIM38;FADD
8830,GO:0034612,0.698291280866738,0.399554618730777,15,217,response to tumor necrosis factor,BP,PCK2;POSTN;TNFSF15;PSMD2;TNFRSF6B;ADAMTS7;RBCK1;HYAL1;CASP4;F2RL1;PSMD7;NGFR;YTHDC2;TMSB4X;ENDOG
2577,GO:0005865,0.698403756368089,0.681996765001596,1,12,striated muscle thin filament,CC,TMOD2
17646,GO:1901381,0.698424355204786,0.683731591637324,1,11,positive regulation of potassium ion transmembrane transport,BP,AKAP9
9146,GO:0035493,0.698497104402205,0.679146511454148,1,14,SNARE complex assembly,BP,VPS11
5503,GO:0016446,0.69870564311235,0.678904134324163,1,14,somatic hypermutation of immunoglobulin genes,BP,POLL
9070,GO:0035306,0.69886304614741,0.524035030811672,3,39,positive regulation of dephosphorylation,BP,ITGA1;ITGA2;SLC39A10
14240,GO:0061213,0.699306791020523,0.678204623776885,1,14,positive regulation of mesonephros development,BP,WNT2B
10023,GO:0042455,0.699514586382732,0.57006965502,2,34,ribonucleoside biosynthetic process,BP,NT5E;NME4
13378,GO:0052629,0.699516955305408,0.682472130282792,1,11,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,MTMR4
11773,GO:0046631,0.699527349312764,0.472101048903694,5,67,alpha-beta T cell activation,BP,ARG2;TGFBR2;SATB1;AP3D1;FOXP1
8968,GO:0035036,0.699663161991161,0.674906236253421,1,17,sperm-egg recognition,BP,SPESP1
16680,GO:0097617,0.699939768907798,0.678733557432942,1,13,annealing activity,MF,SMARCA1
5037,GO:0015215,0.700075948812358,0.676214140469247,1,15,nucleotide transmembrane transporter activity,MF,SLC25A4
15625,GO:0072111,0.700304117249349,0.677041426413628,1,14,cell proliferation involved in kidney development,BP,PTCH1
11351,GO:0045683,0.700306296638455,0.678306778338122,1,13,negative regulation of epidermis development,BP,FERMT1
16151,GO:0090162,0.70032457038826,0.572744852264212,2,25,establishment of epithelial cell polarity,BP,FERMT1;FRMD4B
19705,GO:2000045,0.700447243660226,0.419803769523794,10,136,regulation of G1/S transition of mitotic cell cycle,BP,FHL1;CCND1;EGFR;CCND2;PKD2;HYAL1;SOX4;NACC2;E2F7;CNOT11
9080,GO:0035330,0.700657031391878,0.681153646089177,1,11,regulation of hippo signaling,BP,WWC3
4603,GO:0010718,0.701411339950935,0.521269230603858,3,38,positive regulation of epithelial to mesenchymal transition,BP,WWTR1;TGFBR2;LOXL2
20289,GO:2001269,0.70146079340925,0.674590900668351,1,15,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
39,GO:0000079,0.70170232251715,0.468985232941747,5,72,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,CCND1;EGFR;CCND2;PKD2;KAT2B
5304,GO:0016010,0.702007721240804,0.677812091476614,1,12,dystrophin-associated glycoprotein complex,CC,SNTB2
16365,GO:0090665,0.702007721240804,0.677812091476614,1,12,glycoprotein complex,CC,SNTB2
7875,GO:0032436,0.702065368957879,0.468661281336942,5,71,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,TRIB2;DVL1;TRIB3;ANKIB1;RNF180
7792,GO:0032332,0.702097587404985,0.677707182646046,1,12,positive regulation of chondrocyte differentiation,BP,LOXL2
3531,GO:0007517,0.702365356453544,0.384783892429911,19,226,muscle organ development,BP,FHL1;NEURL1;ADARB1;MYH15;DKK1;PAK1;TGFBR2;FKBP1A;FGFR1;AEBP1;CHD7;MEF2D;XBP1;ETV1;LAMA5;TBX1;FLNB;ARID5B;JARID2
20295,GO:2001275,0.70257692802473,0.678923342757924,1,11,positive regulation of glucose import in response to insulin stimulus,BP,PAK1
15993,GO:0086001,0.702866194552659,0.52014807001118,3,36,cardiac muscle cell action potential,BP,ANK3;DLG1;AKAP9
17365,GO:1900077,0.702916374474234,0.568118420726319,2,28,negative regulation of cellular response to insulin stimulus,BP,SOCS2;GRB10
11068,GO:0045066,0.70295148390567,0.673937433795633,1,14,regulatory T cell differentiation,BP,CD46
11282,GO:0045589,0.70295148390567,0.673937433795633,1,14,regulation of regulatory T cell differentiation,BP,CD46
14154,GO:0061035,0.70369786334768,0.518229880798536,3,39,regulation of cartilage development,BP,ADAMTS7;PTHLH;LOXL2
7267,GO:0031235,0.704465516472403,0.676717133855153,1,11,intrinsic component of the cytoplasmic side of the plasma membrane,CC,RASA3
745,GO:0001975,0.704501779722575,0.673389129255425,1,13,response to amphetamine,BP,SLC18A2
8941,GO:0034975,0.704624357682025,0.671963710053969,1,14,protein folding in endoplasmic reticulum,BP,ERO1B
8145,GO:0032870,0.704935019938527,0.355682471953,39,474,cellular response to hormone stimulus,BP,PGF;PCK2;ADCY7;BBS2;NR1D1;FAM210B;EIF4EBP1;EGFR;FYN;CTSB;SHC1;PAK1;SOCS2;PRKACB;IDE;PPARA;ASNS;ITGA2;VAMP2;CEACAM1;RAB31;CTSL;TRIB3;PRKAR1A;THRA;NGFR;XBP1;PRKACA;NR2F6;IGF2;GRB10;PPARG;ATP6V1B2;IGFBP7;EEF2K;FOXP1;ADCY1;KAT2B;UFL1
2082,GO:0004842,0.705073975513678,0.362807742131605,31,377,ubiquitin-protein transferase activity,MF,SMURF2;GID4;NEURL1;HECW2;HLTF;UBE2J1;RAG1;RBCK1;UBE2G1;MARCH4;BTRC;RMND5A;FBXO2;DDB2;TRIM5;FBXL8;UHRF2;FBXO41;KLHL29;RNF165;ANKIB1;UBE2E1;RNF135;UNKL;PJA2;MARCH2;RNF180;TRIM2;RNF103;KLHL15;FBXL5
5940,GO:0018242,0.70521334177017,0.672549120551049,1,13,protein O-linked glycosylation via serine,BP,GALNT3
12599,GO:0050775,0.705290835562471,0.566731250920468,2,25,positive regulation of dendrite morphogenesis,BP,OBSL1;EEF2K
15264,GO:0071437,0.705343933051937,0.672394766702959,1,13,invadopodium,CC,PAK1
11769,GO:0046626,0.705388059621271,0.515656167158014,3,41,regulation of insulin receptor signaling pathway,BP,SOCS2;IGF2;GRB10
13232,GO:0051895,0.705759906282494,0.673408335586679,1,12,negative regulation of focal adhesion assembly,BP,MMP14
2948,GO:0006476,0.706046783604942,0.437698580100313,7,90,protein deacetylation,BP,RCOR1;NACC2;BEX4;MTA1;TBL1X;ARID4A;PHF21A
15991,GO:0085029,0.706232375980733,0.565584280008084,2,25,extracellular matrix assembly,BP,THSD4;LOXL1
9947,GO:0042307,0.706316594565758,0.564940612091965,2,26,positive regulation of protein import into nucleus,BP,EFCAB7;TMEM173
11339,GO:0045662,0.706568895015356,0.669657397060567,1,14,negative regulation of myoblast differentiation,BP,DDIT3
14443,GO:0061756,0.706682907524549,0.67080875895729,1,13,leukocyte adhesion to vascular endothelial cell,BP,ITGA4
13870,GO:0060487,0.706997970350564,0.670434668605501,1,13,lung epithelial cell differentiation,BP,THRA
1841,GO:0004497,0.707285739053674,0.512876012194944,3,43,monooxygenase activity,MF,NOS1;CYP27B1;CYP4F22
1857,GO:0004520,0.707336138620637,0.512377967880929,3,45,endodeoxyribonuclease activity,MF,ERCC1;ENDOV;DNASE1L1
5315,GO:0016032,0.707501027506582,0.345285192455693,51,679,viral process,BP,TNIP1;MMP1;ADARB1;PC;CRTC1;EGFR;FYN;BNIP3;DLG1;CTSB;STOM;SHC1;APOE;BNIP3L;RBCK1;IDE;RAB11FIP4;HMGA2;ITGB5;BTRC;ITGA2;APOBEC3C;ATF7IP;RCOR1;TRIM5;CD46;MVB12B;MPDZ;COPB1;SLC25A4;USP6NL;MVB12A;CHD6;BCL2L1;IFITM1;YTHDC2;WASF2;SATB1;RAB43;NCKAP1;EIF2AK2;RAB1A;IFI16;AP2A2;RSF1;TMEM173;KAT2B;SEPT6;OAS1;TRIM38;FADD
19820,GO:2000279,0.707575806772014,0.562902488867463,2,27,negative regulation of DNA biosynthetic process,BP,XRN1;PPARG
1354,GO:0003222,0.70813413807064,0.672396411771085,1,11,ventricular trabecula myocardium morphogenesis,BP,CHD7
16162,GO:0090179,0.708181043665001,0.670541020508733,1,12,planar cell polarity pathway involved in neural tube closure,BP,DVL1
13055,GO:0051546,0.708440512740996,0.668717467203648,1,13,keratinocyte migration,BP,FERMT1
3583,GO:0007628,0.709234414082467,0.669287170055605,1,12,adult walking behavior,BP,CHD7
4373,GO:0009994,0.709356163324987,0.560256320811812,2,28,oocyte differentiation,BP,REC8;PDE5A
9729,GO:0038179,0.70954637082539,0.560485878739401,2,27,neurotrophin signaling pathway,BP,SPRY2;NGFR
16724,GO:0097722,0.709606175754528,0.560412384894445,2,27,sperm motility,BP,NEURL1;BBS2
13046,GO:0051536,0.709769679812753,0.479424457693831,4,61,iron-sulfur cluster binding,MF,XDH;RSAD1;NFU1;AOX1
13050,GO:0051540,0.709769679812753,0.479424457693831,4,61,metal cluster binding,MF,XDH;RSAD1;NFU1;AOX1
14063,GO:0060841,0.709821069454455,0.670393925195988,1,11,venous blood vessel development,BP,ACVR2B
11251,GO:0045471,0.709913713403256,0.45935398206476,5,71,response to ethanol,BP,CCND1;ADCY7;FYN;ITPR2;DNMT3A
12876,GO:0051204,0.71027400185565,0.557574148381069,2,32,protein insertion into mitochondrial membrane,BP,COX18;MOAP1
17819,GO:1901976,0.710292368605791,0.558274094845212,2,30,regulation of cell cycle checkpoint,BP,ETAA1;PPP1R10
7990,GO:0032608,0.710378182831043,0.509114081619467,3,43,interferon-beta production,BP,PTPRS;RNF135;TMEM173
8279,GO:0033081,0.710735518317929,0.663550421582857,1,15,regulation of T cell differentiation in thymus,BP,ADAM8
12233,GO:0048490,0.71086832148396,0.663390169279909,1,15,anterograde synaptic vesicle transport,BP,AP3D1
17039,GO:0099514,0.71086832148396,0.663390169279909,1,15,synaptic vesicle cytoskeletal transport,BP,AP3D1
17042,GO:0099517,0.71086832148396,0.663390169279909,1,15,synaptic vesicle transport along microtubule,BP,AP3D1
5472,GO:0016405,0.710897427158575,0.664476509707344,1,14,CoA-ligase activity,MF,ACSF2
11045,GO:0045026,0.711048306347365,0.662194908154671,1,16,plasma membrane fusion,BP,SPESP1
3762,GO:0008306,0.711329777564089,0.508696162425688,3,40,associative learning,BP,RAG1;RGS14;DDHD2
14608,GO:0070167,0.711585422187461,0.508658689875074,3,39,regulation of biomineral tissue development,BP,CYP27B1;ACVR2B;FAM20C
1390,GO:0003300,0.712157426971452,0.478707726881468,4,48,cardiac muscle hypertrophy,BP,PAK1;INPP5F;PDE5A;JARID2
4937,GO:0014897,0.712157426971452,0.478707726881468,4,48,striated muscle hypertrophy,BP,PAK1;INPP5F;PDE5A;JARID2
9689,GO:0038066,0.712343260750458,0.556574399549258,2,28,p38MAPK cascade,BP,XDH;DLG1
5563,GO:0016575,0.712547737528069,0.441663558615417,6,79,histone deacetylation,BP,RCOR1;NACC2;MTA1;TBL1X;ARID4A;PHF21A
12798,GO:0051092,0.712647528895223,0.419938598524516,8,113,positive regulation of NF-kappaB transcription factor activity,BP,RBCK1;TRIM5;CTH;EIF2AK2;IL1RAP;CARD11;ADAM8;TRIM38
16794,GO:0098632,0.712781558443448,0.555600778205002,2,29,cell-cell adhesion mediator activity,MF,PLXNB3;EPCAM
4421,GO:0010225,0.712902574452737,0.663359795000932,1,13,response to UV-C,BP,IMPACT
2939,GO:0006464,0.712921674920877,0.313218507431998,258,3079,cellular protein modification process,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;GID4;NOS1;ZMYND8;F2R;SORL1;RAB3B;CCND1;NEURL1;VLDLR;RPS6KA2;ADCY7;IGFBP4;PRNP;ADM2;HECW2;ADARB1;MAP2K1;RAPGEF3;ACVR2B;LTBP1;LMF1;PKN1;WWTR1;MST1R;MARCH9;LY6K;TNFSF15;SSH1;PTPRS;B4GALT6;PSMD2;LAMB1;BRSK1;EGFR;STK39;LOXL1;PPP1R14A;FYN;JADE2;HLTF;ERCC6;UBE2J1;UBXN7;MAPK13;ADAMTS7;DLG1;DLG4;B3GNT3;SNX9;TGM2;FKBP9;WNT7A;MAP4K4;TTBK2;GRK5;STRADB;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;PAK1;RASA3;SOCS2;TRIB2;NEK9;RAG1;TGFBR2;PTPN3;EPHA1;IMPACT;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;CCND2;PTPN12;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;RBCK1;ST3GAL5;AKAP9;PPP2R3B;UBE2G1;HMGA2;ABCA7;PIGH;LPAR3;PCMTD2;ELFN2;FGFR1;ITGA1;PPP1R35;MARCH4;PTPDC1;DCAF10;BTRC;PTK6;GALNT3;ULK2;INPP5F;ATRX;FAM20C;MTHFR;PFN2;FKBP10;SOX4;RMND5A;FBXO2;DDB2;CEACAM1;MAPKAPK3;OBSL1;PRR9;LMAN1;RCOR1;NLK;TRIM5;DVL1;CTH;LRP5;ETAA1;ABHD17C;CST3;RABGGTA;CNTN1;TRIB3;NTNG1;GFPT1;RANBP9;FBXL8;PPP3CB;ZDHHC2;APLP2;DNAJC6;SLK;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;TAOK1;FBXO41;OTUB2;CSNK2A1;PHF1;PSMD7;BLMH;QSOX1;PRKAR1A;PARP9;KLHL29;MAST3;NACC2;SPRY2;BEX4;ACVR1B;NGFR;PPP1R10;PSKH1;MARK4;PTPRZ1;MTA1;RNF165;TRIM7;ARF4;ANAPC13;UBASH3B;MAP2K2;SATB1;PPP1R2;ARRDC1;ANKIB1;LYPLAL1;RET;LOXL2;PDE5A;VWA1;C5;MTMR4;PAK6;UBE2E1;RNF135;CCDC88A;ADAMTSL1;SHC2;PRKACA;NEK6;UNKL;TIMP2;EIF2AK2;RAB1A;ZDHHC1;SEL1L;SRD5A3;SLC39A10;ST6GALNAC2;LAMB2;FICD;LPAR1;TBL1X;RNF169;ARID4A;IGF2;PJA2;MAP4K2;ZMYM2;SNX6;EVA1A;USP20;LYPLA1;TBX1;ADAM8;AKT3;WFS1;PHF21A;IGFBP7;MARCH2;FZD8;USP32;HSPA2;LRP6;ARID5B;MAGEF1;RNF180;EEF2K;TRIM2;RCAN1;TET1;DNAJC3;ADCY1;KAT2B;RNF103;USP25;PRMT3;UFL1;ANKRD6;JARID2;PPM1M;KLHL15;ADNP;LRP4;STT3B;RB1CC1;TRIM38;FBXL5
9517,GO:0036211,0.712921674920877,0.313218507431998,258,3079,protein modification process,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;GID4;NOS1;ZMYND8;F2R;SORL1;RAB3B;CCND1;NEURL1;VLDLR;RPS6KA2;ADCY7;IGFBP4;PRNP;ADM2;HECW2;ADARB1;MAP2K1;RAPGEF3;ACVR2B;LTBP1;LMF1;PKN1;WWTR1;MST1R;MARCH9;LY6K;TNFSF15;SSH1;PTPRS;B4GALT6;PSMD2;LAMB1;BRSK1;EGFR;STK39;LOXL1;PPP1R14A;FYN;JADE2;HLTF;ERCC6;UBE2J1;UBXN7;MAPK13;ADAMTS7;DLG1;DLG4;B3GNT3;SNX9;TGM2;FKBP9;WNT7A;MAP4K4;TTBK2;GRK5;STRADB;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;PAK1;RASA3;SOCS2;TRIB2;NEK9;RAG1;TGFBR2;PTPN3;EPHA1;IMPACT;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;CCND2;PTPN12;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;RBCK1;ST3GAL5;AKAP9;PPP2R3B;UBE2G1;HMGA2;ABCA7;PIGH;LPAR3;PCMTD2;ELFN2;FGFR1;ITGA1;PPP1R35;MARCH4;PTPDC1;DCAF10;BTRC;PTK6;GALNT3;ULK2;INPP5F;ATRX;FAM20C;MTHFR;PFN2;FKBP10;SOX4;RMND5A;FBXO2;DDB2;CEACAM1;MAPKAPK3;OBSL1;PRR9;LMAN1;RCOR1;NLK;TRIM5;DVL1;CTH;LRP5;ETAA1;ABHD17C;CST3;RABGGTA;CNTN1;TRIB3;NTNG1;GFPT1;RANBP9;FBXL8;PPP3CB;ZDHHC2;APLP2;DNAJC6;SLK;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;TAOK1;FBXO41;OTUB2;CSNK2A1;PHF1;PSMD7;BLMH;QSOX1;PRKAR1A;PARP9;KLHL29;MAST3;NACC2;SPRY2;BEX4;ACVR1B;NGFR;PPP1R10;PSKH1;MARK4;PTPRZ1;MTA1;RNF165;TRIM7;ARF4;ANAPC13;UBASH3B;MAP2K2;SATB1;PPP1R2;ARRDC1;ANKIB1;LYPLAL1;RET;LOXL2;PDE5A;VWA1;C5;MTMR4;PAK6;UBE2E1;RNF135;CCDC88A;ADAMTSL1;SHC2;PRKACA;NEK6;UNKL;TIMP2;EIF2AK2;RAB1A;ZDHHC1;SEL1L;SRD5A3;SLC39A10;ST6GALNAC2;LAMB2;FICD;LPAR1;TBL1X;RNF169;ARID4A;IGF2;PJA2;MAP4K2;ZMYM2;SNX6;EVA1A;USP20;LYPLA1;TBX1;ADAM8;AKT3;WFS1;PHF21A;IGFBP7;MARCH2;FZD8;USP32;HSPA2;LRP6;ARID5B;MAGEF1;RNF180;EEF2K;TRIM2;RCAN1;TET1;DNAJC3;ADCY1;KAT2B;RNF103;USP25;PRMT3;UFL1;ANKRD6;JARID2;PPM1M;KLHL15;ADNP;LRP4;STT3B;RB1CC1;TRIM38;FBXL5
15228,GO:0071380,0.712975765424893,0.664802300219925,1,12,cellular response to prostaglandin E stimulus,BP,PPARG
6632,GO:0022900,0.713094899447558,0.41824561841376,8,142,electron transport chain,BP,XDH;ASPH;NDUFV3;NDUFA4L2;TXNRD3;LOXL2;ALDH4A1;AOX1
11139,GO:0045184,0.71315976806299,0.321362840252796,126,1582,establishment of protein localization,BP,EDEM1;F2R;SORL1;RAB3B;PCK2;VLDLR;SYNE3;PRNP;XPOT;BBS2;POSTN;SH3TC2;NR1D1;LTBP2;RAPGEF3;ACVR2B;ALOX15B;LMF1;POU2F2;DDIT3;HADH;EXOC2;EGFR;TBC1D14;ANK3;FYN;KIF13B;UBE2J1;DLG4;IDH2;SNX9;GLUL;EVI5L;MAP4K4;SEC23A;STRADB;GDI1;CEMIP;UNC119B;ARG2;STOM;PAK1;RAC2;APOE;BNIP3L;MCFD2;LRP1;EHBP1;ICA1;SNX14;ITGA2;VAMP2;LONP2;ABCG1;SOX4;PITPNM1;ITPR3;VPS13A;FERMT1;RAB31;NLGN2;MVB12B;LRP5;COX18;SEC22C;CLTCL1;TOM1L2;VPS11;SEC63;PPP3CB;SYTL1;ZDHHC2;COPB1;COPG1;F2RL1;SLC25A4;ANO1;SDCCAG3;USP6NL;TBC1D2B;NGFR;PPP1R10;MVB12A;GLUD1;GRIN3B;ARF4;XBP1;SPIRE1;ARRDC1;STX10;RAB43;C5;ZFYVE9;GABARAPL2;TMED4;TMSB4X;RAB1A;ZDHHC1;SNX30;SEL1L;BCAP29;AP2A2;KDELR3;IL1RAP;CARD11;AP3D1;ITPR2;MOAP1;EFCAB7;ERLEC1;PPARG;SNX6;ANKRD50;LYPLA1;TMEM50B;EVI5;ATP6V1B2;RPH3AL;ADAM8;TBC1D16;SSR3;TMEM173;SSR1;FOXP1;COG8;SNX27
20055,GO:2000679,0.713224998841991,0.660536072604957,1,15,positive regulation of transcription regulatory region DNA binding,BP,HMGA2
8318,GO:0033151,0.713234378472565,0.664490467644675,1,12,V(D)J recombination,BP,RAG1
7355,GO:0031397,0.713366579101449,0.475489904245574,4,58,negative regulation of protein ubiquitination,BP,FYN;SOX4;PRMT3;UFL1
5733,GO:0016879,0.713638063271869,0.505363218287488,3,42,ligase activity, forming carbon-nitrogen bonds,MF,NAPRT;GLUL;ASNS
7709,GO:0032196,0.713774982012274,0.660995987537691,1,14,transposition,BP,APOBEC3C
10624,GO:0043620,0.714093772107618,0.427172077368047,7,107,regulation of DNA-templated transcription in response to stress,BP,DDIT3;PSMD2;IMPACT;RGS14;ATF4;PSMD7;CHD6
13010,GO:0051443,0.714645334619846,0.552886869671311,2,30,positive regulation of ubiquitin-protein transferase activity,BP,TRIB3;RAB1A
15231,GO:0071385,0.714926502924898,0.503545784323106,3,43,cellular response to glucocorticoid stimulus,BP,PCK2;EIF4EBP1;EGFR
1552,GO:0003951,0.715380286053655,0.660354404959127,1,13,NAD+ kinase activity,MF,DGKA
2458,GO:0005671,0.715440975471855,0.658967489834675,1,14,Ada2/Gcn5/Ada3 transcription activator complex,CC,KAT2B
6442,GO:0021756,0.715635238433233,0.660043914090238,1,13,striatum development,BP,BBS2
11193,GO:0045296,0.715912517148306,0.361476374937703,23,298,cadherin binding,MF,ITGA6;FMNL2;MPRIP;EGFR;ANK3;DLG1;SNX9;LDHA;EPCAM;BSG;EPN2;SLC9A3R2;CD46;DOCK9;TWF2;SLK;FNBP1L;ASAP1;WASF2;PAK6;RAB1A;PPL;FLNB
1175,GO:0002822,0.715916457849432,0.451965264730813,5,73,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,PKN1;CEACAM1;PPP3CB;IL20RB;FADD
10551,GO:0043502,0.716199222599304,0.473207126514952,4,51,regulation of muscle adaptation,BP,PAK1;PDE5A;MTMR4;JARID2
2874,GO:0006367,0.716333716388642,0.395878606505773,11,151,transcription initiation from RNA polymerase II promoter,BP,CCND1;CTNNBIP1;NR1D1;WWTR1;PPARA;ATF7IP;THRA;NR2F6;PPARG;MAML3;KAT2B
1473,GO:0003730,0.716404853618712,0.472424137069659,4,54,mRNA 3'-UTR binding,MF,IGF2BP3;CPEB4;PUM2;SECISBP2L
1977,GO:0004693,0.716515300489738,0.550557885148715,2,30,cyclin-dependent protein serine/threonine kinase activity,MF,CCND1;CDK17
18298,GO:1903204,0.716597663625285,0.657553292172814,1,14,negative regulation of oxidative stress-induced neuron death,BP,ATF4
5208,GO:0015807,0.716656290634454,0.501653125596757,3,42,L-amino acid transport,BP,NTSR1;SLC43A1;SLC7A11
2356,GO:0005452,0.716684758025786,0.658763317710946,1,13,inorganic anion exchanger activity,MF,SLC22A17
11485,GO:0045944,0.716708146208834,0.3295186502747,66,791,positive regulation of transcription by RNA polymerase II,BP,TNIP1;NOS1;ETV5;ITGA6;NR1D1;NFATC4;ETV4;SALL2;WWTR1;PEG3;APLN;POU2F2;TEF;DDIT3;SOX12;ELK3;CRTC1;EGFR;HLTF;WNT7A;CCPG1;PKD2;DDN;HMGA2;ATF4;PPARA;E2F5;EPCAM;NFAT5;ATRX;SOX4;FHOD1;LRP5;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;CHD7;THRA;ACVR1B;NGFR;CHD6;MEF2D;ARF4;XBP1;EAPP;ETV1;IFI16;TBL1X;ARID4A;EFCAB7;PPARG;CITED4;TBX1;CREB3L2;MAML3;FZD8;LRP6;TMEM173;E2F7;TET1;ARMCX3;KAT2B;PBX3;FADD
9875,GO:0042136,0.716881836870531,0.471522094322772,4,56,neurotransmitter biosynthetic process,BP,NOS1;ARG2;ACP5;PKD2
5560,GO:0016572,0.717086939003062,0.550247459537889,2,29,histone phosphorylation,BP,PKN1;HMGA2
8741,GO:0034389,0.717107993705296,0.655790557970349,1,15,lipid particle organization,BP,DDHD2
11345,GO:0045668,0.717179242467814,0.551032914290332,2,27,negative regulation of osteoblast differentiation,BP,LRP5;PTCH1
17899,GO:1902188,0.717483762818847,0.655328460285651,1,15,positive regulation of viral release from host cell,BP,PC
18158,GO:1902904,0.717828608921707,0.423858747742198,7,90,negative regulation of supramolecular fiber organization,BP,ARAP1;TTBK2;TMOD2;PFN2;TWF2;WASF2;TMSB4X
13509,GO:0055078,0.717842305538232,0.657346320760848,1,13,sodium ion homeostasis,BP,ATP12A
2453,GO:0005665,0.717870437135001,0.652986116207043,1,17,DNA-directed RNA polymerase II, core complex,CC,CHD6
8021,GO:0032655,0.71805530972732,0.54825659296584,2,31,regulation of interleukin-12 production,BP,ACP5;FOXP1
11624,GO:0046326,0.71858426336032,0.550330799778776,2,25,positive regulation of glucose import,BP,PAK1;CLTCL1
4896,GO:0014823,0.718605030585814,0.499496260404541,3,41,response to activity,BP,POSTN;HADH;ITGA2
478,GO:0001522,0.718876925087092,0.650964677440726,1,18,pseudouridine synthesis,BP,NOP10
20265,GO:2001233,0.718940188611121,0.359607345094942,22,306,regulation of apoptotic signaling pathway,BP,ITGA6;NFATC4;DDIT3;FYN;BNIP3;STRADB;CD44;RBCK1;FGFR1;CTH;BOK;NACC2;BCL2L1;XBP1;RET;TMBIM1;MOAP1;WFS1;DEDD2;FAM162A;RB1CC1;FADD
9010,GO:0035173,0.719017122541609,0.654579657935741,1,14,histone kinase activity,MF,PKN1
14492,GO:0061912,0.719257958531377,0.49868863688208,3,41,selective autophagy,BP,SPTLC2;WDFY3;RB1CC1
4936,GO:0014896,0.719572790427703,0.469491470949726,4,49,muscle hypertrophy,BP,PAK1;INPP5F;PDE5A;JARID2
9006,GO:0035148,0.719584053208054,0.404771951281256,9,113,tube formation,BP,PODXL;TGM2;PRKACB;SOX4;DVL1;RET;TCTN1;LRP6;PTCH1
18924,GO:1904666,0.719827191647808,0.649783534700792,1,18,regulation of ubiquitin protein ligase activity,BP,RAB1A
3241,GO:0006896,0.71987366747002,0.653521854020577,1,14,Golgi to vacuole transport,BP,AP3D1
14137,GO:0061003,0.719882611439437,0.656391980888971,1,12,positive regulation of dendritic spine morphogenesis,BP,EEF2K
8270,GO:0033059,0.719931929730798,0.497143406306216,3,44,cellular pigmentation,BP,BBS2;RAB1A;AP3D1
2270,GO:0005201,0.720590895441925,0.498847905765062,3,35,extracellular matrix structural constituent,MF,TFPI2;LAMB1;COL1A2
6991,GO:0030670,0.720710736908892,0.466014611623565,4,62,phagocytic vesicle membrane,CC,RAC2;ANXA3;RAB31;RAB43
1705,GO:0004198,0.720930853063544,0.650065931814166,1,16,calcium-dependent cysteine-type endopeptidase activity,MF,CAPN2
17530,GO:1901020,0.721096189369795,0.649860026115514,1,16,negative regulation of calcium ion transmembrane transporter activity,BP,PKD2
8637,GO:0034162,0.721316883761826,0.651733500239781,1,14,toll-like receptor 9 signaling pathway,BP,PTPRS
5410,GO:0016254,0.7216042477548,0.648346235683447,1,17,preassembly of GPI anchor in ER membrane,BP,PIGH
4838,GO:0014044,0.722113186430121,0.546499970139749,2,24,Schwann cell development,BP,SH3TC2;LAMB2
1471,GO:0003727,0.722153800765806,0.444647902708899,5,71,single-stranded RNA binding,MF,ENDOV;MEX3C;DDX60;LACTB2;THRA
3285,GO:0006972,0.722287767645988,0.650526158137147,1,14,hyperosmotic response,BP,PKN1
10976,GO:0044764,0.722452825091415,0.543509046653051,2,29,multi-organism cellular process,BP,DDX60;PUM2
17897,GO:1902186,0.722455093166245,0.543506182679891,2,29,regulation of viral release from host cell,BP,PC;TRIM5
14906,GO:0070727,0.722581078732968,0.31243037082323,118,1469,cellular macromolecule localization,BP,EDEM1;ZMYND8;SORL1;ETV5;RAB3B;SYNE3;PRNP;XPOT;BBS2;SH3TC2;LTBP2;RAPGEF3;SSH1;DDIT3;EGFR;TBC1D14;ANK3;FYN;TSPAN5;KIF13B;UBE2J1;DLG1;DLG4;SNX9;EVI5L;TTBK2;SEC23A;TTC7B;STRADB;GDI1;CEMIP;SEPT10;STOM;DLG3;PAK1;NUDCD3;RAC2;OBSCN;APOE;BNIP3L;LRP1;ABCA7;TUB;VAMP2;LONP2;ATRX;SOX4;VPS13A;OBSL1;RAB31;BSG;DVL1;NLGN2;ABHD17C;TWF2;COX18;CLTCL1;TOM1L2;VPS11;SEC63;SYTL1;ZDHHC2;COPB1;COPG1;CSNK2A1;PARP9;FCHO2;NACC2;USP6NL;SEPT5;TBC1D2B;NGFR;PPP1R10;BCL2L1;GRIN3B;ARF4;STX10;TCTN1;RAB43;SH3PXD2B;ZFYVE9;TMBIM1;CCDC88A;TMED4;TMSB4X;RAB1A;ZDHHC1;EPB41L3;SEL1L;BCAP29;AP2A2;KDELR3;AP3D1;MOAP1;LAMA5;EFCAB7;ERLEC1;SNX6;LYPLA1;TMEM50B;EVI5;RPH3AL;ITGA4;ACAP2;TBC1D16;SSR3;TMEM107;WASL;FLNB;LRP6;TMEM173;SSR1;ARMCX3;PTCH1;SEPT6;SNX27;GNAI1;LRP4
6908,GO:0030496,0.722843337411466,0.383770584401933,12,156,midbody,CC,PKN1;SSH1;EXOC2;GDI1;RAB11FIP4;TACC1;PITPNM1;SDCCAG3;MPLKIP;PTCH1;SEPT6;GNAI1
12647,GO:0050851,0.722860898255319,0.388028878301198,11,161,antigen receptor-mediated signaling pathway,BP,PRNP;PAG1;PSMD2;FYN;PAK1;RBCK1;BTRC;CEACAM1;PSMD7;SLC39A10;CARD11
6541,GO:0021953,0.722943281215825,0.41787187098908,7,89,central nervous system neuron differentiation,BP,ADARB1;WNT7A;DKK1;SOX4;TCTN1;LRP6;PTCH1
22,GO:0000041,0.722954803771746,0.443372630409383,5,74,transition metal ion transport,BP,ATP7B;TRPC1;SLC30A1;SLC39A10;ATP6V1B2
8691,GO:0034311,0.723484585571879,0.645990404501357,1,17,diol metabolic process,BP,SPTLC2
11685,GO:0046467,0.723530754597329,0.40696527867388,8,117,membrane lipid biosynthetic process,BP,B4GALT6;ELOVL1;SPTLC2;ST3GAL5;PIGH;KDSR;SAMD8;ELOVL4
2522,GO:0005776,0.72358553728094,0.428143438865211,6,83,autophagosome,CC,PEG3;TBC1D14;WDFY3;FYCO1;VPS11;GABARAPL2
11868,GO:0046872,0.723823061065095,0.302149222432196,250,2925,metal ion binding,MF,FHL1;XDH;NT5E;EDEM1;NOS1;ZMYND8;ADAM19;NEURL1;PCK2;VLDLR;ASAP2;CBS;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;PRSS3;ADCY7;PRNP;POSTN;NR1D1;ZC3H6;ADARB1;THBS2;LTBP2;ACVR2B;ANTXR2;LTBP1;ZKSCAN1;ALOX15B;SALL2;PEG3;MARCH9;TRIM65;DGKA;ZKSCAN2;PC;B4GALT6;CARS;LTA4H;CAPN2;BRSK1;DYSF;CGREF1;LOXL1;FYN;PCDHAC2;JADE2;HLTF;ARAP1;PGM1;ADAMTS7;ZNF516;IDH2;ZSCAN30;TGM2;GLUL;GLO1;FKBP9;WDFY3;SEC23A;RSAD1;NMRK1;NME4;ASPH;MCTP1;ARG2;SMOC2;RASA3;NEK9;ZNF652;RAG1;TGFBR2;LCN2;HAGH;NUCB2;CLCA2;OBSCN;APOE;ATP7B;ACP5;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;FYCO1;IDE;ZCCHC14;RAB11FIP4;PPP2R3B;ANXA3;PPARA;ITGA1;AARS;MARCH4;RNPEPL1;SMOC1;LPCAT1;ITGA2;GALNT3;LENG9;ZNF559;FAT1;ZNF81;LTBP4;ATRX;FAM20C;CHURC1;FKBP10;PITPNM1;APOBEC3C;ITPR3;NELL2;ENDOV;ZNF558;MBLAC2;ZNF692;LMAN1;MT2A;NLK;TRIM5;TCEA1;MMP14;PLA2G4D;ANXA6;ZBTB10;PHF12;ZNF704;ZMYM3;KLF12;THBS3;NPEPL1;RABGGTA;L3MBTL3;VPS11;ZNF322;PPP3CB;MEX3C;SYTL1;APLP2;PLAG1;CDC42BPA;UHRF2;PHC3;AEBP1;ATP10D;PHF1;ASAP1;MSRB2;CPEB4;MAST3;LACTB2;ZNF337;THRA;ACVR1B;ZNF280D;PPP1R10;TSHZ1;ZNF449;MTA1;RNF165;TRIM7;POLL;YPEL5;NT5DC1;NFU1;MAP2K2;GPATCH8;CYP4F22;ANKIB1;MICU3;RET;LOXL2;PDE5A;MCTP2;MTMR4;ZFYVE9;THAP10;RNF135;COL1A2;ZNF398;NEK6;UNKL;TIMP2;PCDH1;NR2F6;ZNF354A;MMP10;RNF169;BLVRA;TENM2;ITPR2;PJA2;ZSCAN18;ZMYM2;EFCAB7;PPARG;USP20;ZFP30;ARHGAP29;ATP12A;ZNF37A;ESYT3;RPH3AL;RSF1;ADAM8;ENDOG;ATP11B;ITGA4;PHF21A;ZBTB40;ZNF92;ACAP2;ZNF568;DDHD2;MARCH2;OSGEPL1;CMC1;USP32;ZNF107;ZNF165;SYT2;PLCH2;RNF180;EEF2K;ZNF320;GALNS;TRIM2;TET1;ZC3H7A;FOXP1;ZBTB33;ZFYVE21;AOX1;ADCY1;OAS1;RNF103;PRMT3;PPM1M;ADNP;GNAI1;LRP4;STT3B;DNMT3A;TRIM38;FBXL5
6717,GO:0030127,0.724057770738308,0.64831617224625,1,14,COPII vesicle coat,CC,SEC23A
7655,GO:0032075,0.724421668062931,0.6456973355873,1,16,positive regulation of nuclease activity,BP,TCEA1
14503,GO:0061980,0.724711405522357,0.541087294375764,2,28,regulatory RNA binding,MF,PUM2;ZC3H7A
3092,GO:0006665,0.724967798782019,0.397790660862071,9,127,sphingolipid metabolic process,BP,B4GALT6;ELOVL1;SPTLC2;ST3GAL5;KDSR;GLB1;SAMD8;ESYT3;ELOVL4
5852,GO:0017148,0.724983713015573,0.366607039774008,16,216,negative regulation of translation,BP,MAP2K1;EIF4EBP1;EGFR;IGF2BP3;ATF4;XRN1;TNRC6B;MEX3C;CPEB4;MAP2K2;PUM2;EIF2AK2;PPARG;GRB7;TNRC6C;ZC3H7A
3216,GO:0006862,0.72518482469401,0.644736313566479,1,16,nucleotide transport,BP,SLC25A4
10526,GO:0043457,0.725214833009193,0.644698480942615,1,16,regulation of cellular respiration,BP,BNIP3
1871,GO:0004536,0.725248506964573,0.46057064874458,4,61,deoxyribonuclease activity,MF,ERCC1;ENDOV;DNASE1L1;ENDOG
33,GO:0000062,0.725253942697269,0.643761763483915,1,17,fatty-acyl-CoA binding,MF,ACOT7
10740,GO:0044106,0.725256601394806,0.439726719553505,5,84,cellular amine metabolic process,BP,PSMD2;ALDH7A1;PSMD7;AZIN2;SLC44A1
16085,GO:0090049,0.725344053469099,0.540284446697811,2,28,regulation of cell migration involved in sprouting angiogenesis,BP,SRPX2;AKT3
7560,GO:0031902,0.725675251976373,0.413614639129842,7,104,late endosome membrane,CC,SNX14;CLCN3;ANXA6;MVB12B;VPS11;MVB12A;TMEM9
12790,GO:0051084,0.725851987450685,0.538415287411613,2,31,'de novo' posttranslational protein folding,BP,HSPA13;HSPA2
2535,GO:0005791,0.725895740069805,0.45964554285139,4,62,rough endoplasmic reticulum,CC,SYNE3;GLUL;SLC7A11;DNAJC3
1389,GO:0003299,0.725958110165172,0.648850583407327,1,12,muscle hypertrophy in response to stress,BP,INPP5F
4930,GO:0014887,0.725958110165172,0.648850583407327,1,12,cardiac muscle adaptation,BP,INPP5F
4938,GO:0014898,0.725958110165172,0.648850583407327,1,12,cardiac muscle hypertrophy in response to stress,BP,INPP5F
9577,GO:0036379,0.725971814589484,0.647257301388002,1,13,myofilament,CC,TMOD2
4663,GO:0010811,0.726514410535839,0.425166972978381,6,77,positive regulation of cell-substrate adhesion,BP,ITGA6;NET1;SMOC2;EPHA1;FERMT1;HSD17B12
2722,GO:0006101,0.727016218984176,0.536576926041714,2,32,citrate metabolic process,BP,DHTKD1;IDH2
18110,GO:1902750,0.727367274847152,0.42259351106194,6,97,negative regulation of cell cycle G2/M phase transition,BP,FHL1;PSMD2;BRSK1;HMGA2;TAOK1;PSMD7
5261,GO:0015893,0.727399110733282,0.411855353015687,7,99,drug transport,BP,RAB3B;CYGB;NTSR1;SLC25A4;SLC13A3;SLC7A11;SLC18A2
8822,GO:0034595,0.727777308011823,0.644983505325181,1,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,INPP5F
5819,GO:0017085,0.728141651643166,0.642007872825384,1,15,response to insecticide,BP,MAPK13
1880,GO:0004559,0.728162026331393,0.644497423591287,1,13,alpha-mannosidase activity,MF,EDEM1
11774,GO:0046632,0.728338730280375,0.457623072804951,4,55,alpha-beta T cell differentiation,BP,TGFBR2;SATB1;AP3D1;FOXP1
4158,GO:0009220,0.728694098015723,0.638603230809202,1,18,pyrimidine ribonucleotide biosynthetic process,BP,NME4
11579,GO:0046132,0.728694098015723,0.638603230809202,1,18,pyrimidine ribonucleoside biosynthetic process,BP,NME4
7704,GO:0032183,0.728733092638248,0.643774871020584,1,13,SUMO binding,MF,SIMC1
19740,GO:2000113,0.728951604611356,0.31001141787426,91,1115,negative regulation of cellular macromolecule biosynthetic process,BP,SMURF2;ZMYND8;CCND1;CTNNBIP1;VLDLR;NR1D1;NFATC4;ZC3H6;MAP2K1;ACVR2B;SALL2;WWTR1;PEG3;EIF4EBP1;DDIT3;ELK3;EGFR;SCMH1;DLG1;DNAJB5;IGF2BP3;SHC1;DKK1;DAP;IMPACT;HMGA2;ATF4;PPARA;ABCA7;WWC3;FGFR1;TCFL5;BTRC;ATRX;ZNF692;ATF7IP;RCOR1;MDFI;XRN1;TNRC6B;HES2;PHF12;KLF12;TRIB3;MEX3C;PRDX5;UHRF2;AEBP1;PARP9;CPEB4;NACC2;THRA;TSHZ1;PER3;H2AFJ;MAP2K2;SATB1;TLE4;LOXL2;EAPP;PUM2;EIF2AK2;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;ARID4A;TENM2;IGF2;PPARG;SNX6;GRB7;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;ARID5B;E2F7;TNRC6C;TET1;ZC3H7A;DEDD2;FOXP1;ZBTB33;PTCH1;JARID2;MXD4;DNMT3A
7894,GO:0032462,0.729107637606073,0.638867572660131,1,17,regulation of protein homooligomerization,BP,APOE
1327,GO:0003179,0.729166161609711,0.536949973877061,2,25,heart valve morphogenesis,BP,TGFBR2;SOX4
7320,GO:0031329,0.729324036701578,0.320002116074192,55,690,regulation of cellular catabolic process,BP,EDEM1;RAPGEF3;TRIM65;PSMD2;TBC1D14;BNIP3;UBE2J1;SNX9;TYSND1;IGF2BP3;SPTLC2;DAP;TRIB2;PTPN3;APOE;BNIP3L;LRP1;FYCO1;PPARA;BTRC;ULK2;LONP2;SH3D19;XRN1;TNRC6B;DVL1;CST3;TRIB3;VPS11;MLYCD;RASIP1;PSMD7;QSOX1;BOK;XBP1;PAIP1;ANKIB1;GABARAPL2;EPM2A;PUM2;PRKACA;TIMP2;IFI16;ERLEC1;SNX6;ATP6V1B2;ADAM8;ENDOG;MAGEF1;RNF180;TNRC6C;USP25;UFL1;RB1CC1;FBXL5
6783,GO:0030218,0.730036056467843,0.420453240781108,6,82,erythrocyte differentiation,BP,FAM210B;L3MBTL3;CEBPG;THRA;ACVR1B;ARID4A
1110,GO:0002699,0.730085804261624,0.408516810151446,7,101,positive regulation of immune effector process,BP,RAC2;CD46;F2RL1;DDX60;XBP1;PUM2;FADD
18566,GO:1903792,0.730292741065722,0.641795234949904,1,13,negative regulation of anion transport,BP,STK39
19773,GO:2000191,0.73033865851094,0.640380141902973,1,14,regulation of fatty acid transport,BP,NTSR1
18683,GO:1904029,0.731086168838482,0.433365184460811,5,75,regulation of cyclin-dependent protein kinase activity,BP,CCND1;EGFR;CCND2;PKD2;KAT2B
1476,GO:0003746,0.731296630142982,0.636961624734612,1,16,translation elongation factor activity,MF,ABTB1
15660,GO:0072175,0.73137708636603,0.398485679283044,8,102,epithelial tube formation,BP,PODXL;PRKACB;SOX4;DVL1;RET;TCTN1;LRP6;PTCH1
5920,GO:0018195,0.731480032239125,0.635826968432157,1,17,peptidyl-arginine modification,BP,PRMT3
17898,GO:1902187,0.731733561092829,0.638597533551018,1,14,negative regulation of viral release from host cell,BP,TRIM5
3357,GO:0007093,0.731839556383158,0.377792020880663,11,154,mitotic cell cycle checkpoint,BP,CCND1;BRSK1;DLG1;XPC;HMGA2;SOX4;TAOK1;PPP1R10;BCL2L1;E2F7;CNOT11
924,GO:0002320,0.731881172035377,0.639769597675692,1,13,lymphoid progenitor cell differentiation,BP,SOX4
15200,GO:0071345,0.731931618400624,0.316625368227862,56,747,cellular response to cytokine stimulus,BP,CCND1;PCK2;MMP1;BBS2;POSTN;MST1R;TNFSF15;PSMD2;FYN;TNFRSF6B;MAPK13;ADAMTS7;SDC1;SHC1;SOCS2;LCN2;CD44;FKBP1A;PTPN12;RBCK1;HYAL1;BTRC;CEACAM1;MT2A;TRIM5;EPOR;CTH;CASP4;RFX2;F2RL1;PSMD7;PARP9;SPRY2;NGFR;PTPRZ1;BCL2L1;IFITM1;XBP1;TLE4;RAB43;COL1A2;PRKACA;TMSB4X;IL1RAP;LAMA5;AGPAT1;PPARG;IL20RB;ITGA4;FLNB;ARID5B;TMEM173;OAS1;JARID2;TRIM38;FADD
18124,GO:1902808,0.731996912030121,0.530928371693955,2,30,positive regulation of cell cycle G1/S phase transition,BP,CCND2;HYAL1
5406,GO:0016246,0.732128145028787,0.636917014315187,1,15,RNA interference,BP,RMRP
392,GO:0001047,0.732179501666457,0.38980424172026,9,116,core promoter binding,MF,NR1D1;HMGA2;ATF4;SOX4;MTA1;XBP1;IFI16;PPARG;E2F7
6720,GO:0030131,0.732609948572121,0.53098778964704,2,28,clathrin adaptor complex,CC,EGFR;AP2A2
13863,GO:0060479,0.732704539937277,0.637352309827846,1,14,lung cell differentiation,BP,THRA
1044,GO:0002566,0.732858390768196,0.6359779457545,1,15,somatic diversification of immune receptors via somatic mutation,BP,POLL
16624,GO:0097472,0.732888689715624,0.529396336820439,2,31,cyclin-dependent protein kinase activity,MF,CCND1;CDK17
20109,GO:2000781,0.73290206808681,0.637098551277604,1,14,positive regulation of double-strand break repair,BP,PARP9
6669,GO:0030029,0.732995669728809,0.32182051150986,44,515,actin filament-based process,BP,FMNL2;RAPGEF3;SSH1;WIPF1;ARHGAP12;PARVB;ARAP1;DLG1;ESPN;SHC1;PAK1;EPHA1;RAC2;OBSCN;LRP1;TMOD2;ITGB5;FAT1;PFN2;FHOD1;OBSL1;PLEK2;TWF2;WASF3;FNBP1L;CDC42BPA;F2RL1;TAOK1;PRKAR1A;MSRB2;JMY;WASF2;SPIRE1;SH3PXD2B;NCKAP1;PAK6;CCDC88A;TMSB4X;EPB41L3;RHOBTB1;LPAR1;ARPC1A;WASL;FLNB
4947,GO:0014912,0.733261548767533,0.635458628179716,1,15,negative regulation of smooth muscle cell migration,BP,LRP1
3484,GO:0007346,0.733468058332086,0.320477253365296,45,577,regulation of mitotic cell cycle,BP,FHL1;CCND1;HECW2;MAP2K1;EIF4EBP1;PSMD2;BRSK1;EGFR;STK39;DLG1;XPC;MAP4K4;STRADB;PAK1;PTPN3;CCND2;PKD2;AKAP9;HMGA2;ASNS;FGFR1;HYAL1;ATRX;SOX4;OBSL1;LRP5;TOM1L2;SLK;TAOK1;PSMD7;NACC2;PPP1R10;BCL2L1;MAP2K2;PAK6;CCSAP;PRKACA;NEK6;TIMP2;IGF2;MAP4K2;E2F7;PTCH1;CNOT11;GNAI1
4480,GO:0010494,0.733529699700984,0.481073983056347,3,40,cytoplasmic stress granule,CC,ATXN2;PUM2;GRB7
17513,GO:1900745,0.733619111493975,0.634997523138638,1,15,positive regulation of p38MAPK cascade,BP,XDH
3691,GO:0008194,0.733729328686303,0.40420146985017,7,100,UDP-glycosyltransferase activity,MF,B4GALT6;B3GNT3;WDFY3;B4GALNT4;PIGH;HYAL1;GALNT3
5508,GO:0016459,0.733743569380287,0.482361327229161,3,35,myosin complex,CC,MYH15;OBSL1;MYH16
3337,GO:0007050,0.733830157483927,0.356504224782285,16,216,cell cycle arrest,BP,CCND1;PRNP;MAP2K1;DDIT3;CGREF1;STRADB;PKD2;PPP2R3B;HMGA2;SOX4;UHRF2;JMY;PRKACA;E2F7;KAT2B;CNOT11
10697,GO:0043981,0.733850019017958,0.634699489829922,1,15,histone H4-K5 acetylation,BP,JADE2
10698,GO:0043982,0.733850019017958,0.634699489829922,1,15,histone H4-K8 acetylation,BP,JADE2
9853,GO:0042100,0.734146140261189,0.479096787031131,3,45,B cell proliferation,BP,PKN1;SLC39A10;CARD11
12400,GO:0048841,0.734172714374603,0.531121362193582,2,24,regulation of axon extension involved in axon guidance,BP,SEMA4B;SEMA3F
7996,GO:0032615,0.734318394697506,0.527190085579594,2,32,interleukin-12 production,BP,ACP5;FOXP1
7318,GO:0031327,0.734396427947414,0.302911218259532,98,1203,negative regulation of cellular biosynthetic process,BP,SMURF2;ZMYND8;CCND1;CTNNBIP1;VLDLR;CYP27B1;NR1D1;NFATC4;ZC3H6;MAP2K1;ACVR2B;SALL2;WWTR1;PEG3;EIF4EBP1;DDIT3;ELK3;EGFR;SCMH1;DLG1;DNAJB5;IGF2BP3;SHC1;DKK1;DAP;TRIB2;IMPACT;ACP5;AKAP9;HMGA2;ATF4;PPARA;ABCA7;WWC3;FGFR1;TCFL5;BTRC;LPCAT1;ATRX;CEACAM1;ZNF692;ATF7IP;RCOR1;MDFI;XRN1;TNRC6B;HES2;PHF12;KLF12;TRIB3;MEX3C;PRDX5;UHRF2;AEBP1;PARP9;CPEB4;NACC2;THRA;TSHZ1;PER3;MTA1;H2AFJ;MAP2K2;SATB1;TLE4;LOXL2;EAPP;PUM2;EIF2AK2;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;ARID4A;TENM2;IGF2;PPARG;SNX6;GRB7;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;ARID5B;E2F7;TNRC6C;TET1;ZC3H7A;DEDD2;FOXP1;ZBTB33;PTCH1;JARID2;MXD4;DNMT3A
561,GO:0001701,0.734760815920523,0.346036828344918,20,250,in utero embryonic development,BP,MAP2K1;CAPN2;EGFR;TGFBR2;EDNRA;PKD2;FGFR1;MDFI;CHD7;ACVR1B;BCL2L1;TCTN1;C5;SLC30A1;IGF2;ENDOG;ZNF568;E2F7;TET1;PTCH1
797,GO:0002065,0.734987094942483,0.429190791253516,5,69,columnar/cuboidal epithelial cell differentiation,BP,SLITRK6;FGFR1;PTK6;FAM20C;SOX4
18384,GO:1903392,0.735073348676064,0.635669652387156,1,13,negative regulation of adherens junction organization,BP,MMP14
6527,GO:0021915,0.735089264862079,0.380144740408534,10,124,neural tube development,BP,SALL2;PKD2;PRKACB;SOX4;DVL1;TCTN1;ALDH1A2;TMEM107;LRP6;PTCH1
8215,GO:0032968,0.73524986731847,0.632888319563626,1,15,positive regulation of transcription elongation from RNA polymerase II promoter,BP,EAPP
17878,GO:1902116,0.735636116775613,0.526222006684016,2,30,negative regulation of organelle assembly,BP,EVI5L;KAT2B
4427,GO:0010256,0.735874129206709,0.331037813985694,29,357,endomembrane system organization,BP,F2R;SERPINE2;SH3TC2;MAP2K1;ANK3;DYSF;SNX9;NEK9;AKAP9;OBSL1;LMAN1;CLCN3;VPS11;MYOF;RFX2;FNBP1L;ASAP1;USP6NL;MVB12A;GOLGA2P5;MAP2K2;RAB43;TMED4;NEK6;RAB1A;EPB41L3;AP3D1;WASL;REEP3
7632,GO:0032039,0.736099593235659,0.634343240038463,1,13,integrator complex,CC,INTS8
10881,GO:0044419,0.736156087731354,0.312882528709425,54,726,interspecies interaction between organisms,BP,TNIP1;MMP1;ADARB1;PC;EXOC2;CRTC1;EGFR;FYN;BNIP3;DLG1;CTSB;STOM;SHC1;APOE;BNIP3L;RBCK1;IDE;RAB11FIP4;HMGA2;ITGB5;BTRC;ITGA2;ULK2;APOBEC3C;ATF7IP;RCOR1;TRIM5;CD46;MVB12B;MPDZ;COPB1;F2RL1;SLC25A4;USP6NL;MVB12A;CHD6;BCL2L1;IFITM1;YTHDC2;WASF2;SATB1;RAB43;NCKAP1;EIF2AK2;RAB1A;IFI16;AP2A2;RSF1;TMEM173;KAT2B;SEPT6;OAS1;TRIM38;FADD
12933,GO:0051290,0.736563103659761,0.521468270575807,2,43,protein heterotetramerization,BP,CBR4;LRP4
18478,GO:1903579,0.737038757326844,0.630562798523256,1,15,negative regulation of ATP metabolic process,BP,PPARA
7188,GO:0031076,0.737097819027426,0.526724450872896,2,25,embryonic camera-type eye development,BP,ALDH1A2;LRP6
15336,GO:0071556,0.737207355115268,0.627591942796363,1,18,integral component of lumenal side of endoplasmic reticulum membrane,CC,PKD2
16763,GO:0098553,0.737207355115268,0.627591942796363,1,18,lumenal side of endoplasmic reticulum membrane,CC,PKD2
16160,GO:0090177,0.737537404077342,0.632478010918557,1,13,establishment of planar polarity involved in neural tube closure,BP,DVL1
16161,GO:0090178,0.737537404077342,0.632478010918557,1,13,regulation of establishment of planar polarity involved in neural tube closure,BP,DVL1
4189,GO:0009266,0.737787164612329,0.362026988862789,13,176,response to temperature stimulus,BP,NOS1;ZNF516;NTSR1;MYOF;ANO1;THRA;HSPA13;PRKACA;NR2F6;PPARG;IGFBP7;HSPA2;DNAJC3
256,GO:0000722,0.73804962948846,0.630432707458853,1,14,telomere maintenance via recombination,BP,ERCC1
2908,GO:0006418,0.738109869229925,0.473273097480816,3,49,tRNA aminoacylation for protein translation,BP,CARS;AARS;GARS
14242,GO:0061217,0.738413968670999,0.627729192581079,1,16,regulation of mesonephros development,BP,WNT2B
5418,GO:0016266,0.738500869835764,0.474479847105938,3,41,O-glycan processing,BP,B3GNT3;GALNT3;ST6GALNAC2
17852,GO:1902041,0.738539523375762,0.473497314445133,3,45,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,BCL2L1;TMBIM1;FADD
12305,GO:0048643,0.738578227218443,0.629742381486781,1,14,positive regulation of skeletal muscle tissue development,BP,TBX1
4657,GO:0010801,0.738785277278091,0.628280375823699,1,15,negative regulation of peptidyl-threonine phosphorylation,BP,SPRY2
5646,GO:0016740,0.739050607928194,0.291164990715735,156,1892,transferase activity,MF,SMURF2;GID4;MBOAT2;CCND1;NEURL1;PYGL;RPS6KA2;PYGB;GPT2;HECW2;MAP2K1;ACVR2B;LTBP1;TK2;PKN1;NAPRT;MST1R;MARCH9;DGKA;B4GALT6;BRSK1;EGFR;STK39;FYN;PSAT1;JADE2;HLTF;UBE2J1;MAPK13;ELOVL1;DLG1;DLG4;B3GNT3;TGM2;MAP4K4;TTBK2;SPTLC2;WDFY3;GRK5;NMRK1;STRADB;NME4;NAGS;DLG3;PAK1;NEK9;RAG1;TGFBR2;B4GALNT4;EPHA1;OBSCN;ALDH1L2;CDK17;ZNF862;PRKACB;RBCK1;ST3GAL5;UBE2G1;HMGA2;PIGH;AGPAT4;PCMTD2;FGFR1;MARCH4;LPCAT4;HYAL1;BTRC;LPCAT1;PTK6;GALNT3;ULK2;LTBP4;FAM20C;RMND5A;FBXO2;DDB2;GAMT;MAPKAPK3;NLK;TRIM5;CTH;RABGGTA;GFPT1;FBXL8;MEX3C;ZDHHC2;SLK;CDC42BPA;UHRF2;TAOK1;FBXO41;CSNK2A1;TST;SUGCT;CPT2;CRLS1;PARP9;KLHL29;MAST3;ACVR1B;PSKH1;MARK4;CRAT;RNF165;AGPAT3;TRIM7;POLL;UAP1;PANK4;MAP2K2;ANKIB1;RET;MBOAT7;RMRP;PAK6;UBE2E1;RNF135;SAMD8;PRKACA;NEK6;UNKL;EIF2AK2;ZDHHC1;ST6GALNAC2;CARD11;FICD;RNF169;AGPAT1;PJA2;MAP4K2;ZMYM2;AK9;AKT3;MARCH2;OSGEPL1;RNF180;EEF2K;CMTR2;TRIM2;COQ2;ZFYVE21;ELOVL4;CDS2;KAT2B;OAS1;RNF103;PANK1;PRMT3;UFL1;N4BP2;KLHL15;STT3B;DNMT3A;ALAS1;TRIM38;FBXL5
11853,GO:0046834,0.73940117568048,0.4096141634466,6,76,lipid phosphorylation,BP,DGKA;EGFR;FYN;TTC7B;FGFR1;ZFYVE21
8960,GO:0035023,0.740068483875668,0.388491798382182,8,96,regulation of Rho protein signal transduction,BP,F2R;ARAP1;NET1;OBSCN;APOE;DNMBP;F2RL1;LPAR1
8753,GO:0034405,0.740372516913651,0.520042769654334,2,30,response to fluid shear stress,BP,TFPI2;PKD2
10572,GO:0043534,0.740714173362864,0.407533205524887,6,81,blood vessel endothelial cell migration,BP,APOE;FGFR1;TMSB4X;PPARG;SRPX2;AKT3
12805,GO:0051099,0.740979910988324,0.372518966665151,10,140,positive regulation of binding,BP,APOE;FKBP1A;LRP1;HMGA2;ITGA2;TRIB3;CEBPG;PARP9;PPARG;TMEM173
15828,GO:0072528,0.741204824484799,0.516974281097428,2,36,pyrimidine-containing compound biosynthetic process,BP,TK2;NME4
18223,GO:1903020,0.741707324745526,0.624435021128622,1,15,positive regulation of glycoprotein metabolic process,BP,RAB1A
16271,GO:0090329,0.742454556324912,0.468688529866875,3,44,regulation of DNA-dependent DNA replication,BP,FGFR1;ATRX;E2F7
15174,GO:0071305,0.742579856242452,0.624480810063681,1,14,cellular response to vitamin D,BP,CYP27B1
3227,GO:0006879,0.743430030063694,0.466809406329401,3,47,cellular iron ion homeostasis,BP,LCN2;SLC22A17;FBXL5
10569,GO:0043531,0.743696585010182,0.516082660501951,2,29,ADP binding,MF,ABCG1;GLUD1
16362,GO:0090659,0.744097945421833,0.623864180466955,1,13,walking behavior,BP,CHD7
8450,GO:0033574,0.744169483771886,0.514298058421973,2,32,response to testosterone,BP,XRN1;CSNK2A1
18401,GO:1903429,0.744215461402762,0.621107438968622,1,15,regulation of cell maturation,BP,RET
19029,GO:1904872,0.744532447846506,0.617893161690289,1,18,regulation of telomerase RNA localization to Cajal body,BP,NOP10
3118,GO:0006695,0.744769659382936,0.436441159704126,4,59,cholesterol biosynthetic process,BP,PLPP6;APOE;ABCG1;HSD17B7
7304,GO:0031304,0.744773508591418,0.512263647663266,2,36,intrinsic component of mitochondrial inner membrane,CC,COX18;COQ2
7305,GO:0031305,0.744773508591418,0.512263647663266,2,36,integral component of mitochondrial inner membrane,CC,COX18;COQ2
19186,GO:1905268,0.745546935818718,0.465677811306421,3,40,negative regulation of chromatin organization,BP,PHF1;TET1;JARID2
3249,GO:0006907,0.745982971164085,0.617694026179259,1,16,pinocytosis,BP,MAPKAPK3
12660,GO:0050864,0.745996904963465,0.415203123092057,5,72,regulation of B cell activation,BP,PKN1;MMP14;XBP1;SLC39A10;CARD11
4163,GO:0009225,0.746121720896698,0.511372926739852,2,33,nucleotide-sugar metabolic process,BP,GFPT1;UAP1
16731,GO:0097734,0.746140769905902,0.616556027880239,1,17,extracellular exosome biogenesis,BP,SDC1
19473,GO:1990182,0.746140769905902,0.616556027880239,1,17,exosomal secretion,BP,SDC1
3432,GO:0007220,0.746211515286322,0.618441286989112,1,15,Notch receptor processing,BP,PSEN2
9008,GO:0035162,0.746219987228176,0.619639285377394,1,14,embryonic hemopoiesis,BP,TGFBR2
724,GO:0001953,0.746301445553333,0.513560158889406,2,27,negative regulation of cell-matrix adhesion,BP,POSTN;MMP14
6655,GO:0030004,0.746450763206561,0.414534206440141,5,73,cellular monovalent inorganic cation homeostasis,BP,SLC9A7;DMXL2;CLCN3;ATP12A;ATP6V1B2
8861,GO:0034656,0.746731750643079,0.509945467989043,2,35,nucleobase-containing small molecule catabolic process,BP,NT5E;APOBEC3C
12637,GO:0050829,0.746764451485213,0.612910088568072,1,21,defense response to Gram-negative bacterium,BP,F2RL1
10978,GO:0044769,0.747356280730013,0.614097449053921,1,18,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,ATP6V1B2
11919,GO:0046961,0.747356280730013,0.614097449053921,1,18,proton-transporting ATPase activity, rotational mechanism,MF,ATP6V1B2
11401,GO:0045787,0.747575215527372,0.325861122535316,23,302,positive regulation of cell cycle,BP,CCND1;EIF4EBP1;EGFR;CCPG1;CCND2;PKD2;RAB11FIP4;HMGA2;ASNS;FGFR1;HYAL1;PTK6;ATRX;SOX4;CEP120;LRP5;UHRF2;PPP1R10;PRKACA;IGF2;LRP6;E2F7;CNOT11
9923,GO:0042269,0.747600443335009,0.615519904029062,1,16,regulation of natural killer cell mediated cytotoxicity,BP,CEACAM1
12125,GO:0048194,0.747666885112452,0.413216744666067,5,71,Golgi vesicle budding,BP,SEC23A;MCFD2;LMAN1;RAB1A;CTSZ
11396,GO:0045778,0.747764271078969,0.433234543103015,4,55,positive regulation of ossification,BP,CTNNBIP1;ACVR2B;FAM20C;IFITM1
14515,GO:0065007,0.747925261237074,0.274780104113201,665,7892,biological regulation,BP,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FAM83A;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;SCN8A;SERPINE2;PEAR1;ADCY7;IGFBP4;PRNP;PAG1;ADGRF1;ITGB4;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;ADM2;BTBD2;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;CMTM4;THBS2;FAM210B;FMNL2;ETV4;TFPI2;LTBP2;RAPGEF3;FNDC4;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;ALOX15B;LMF1;SALL2;PKN1;WWTR1;DCBLD2;PEG3;CCNI;MST1R;ARHGAP22;APLN;POU2F2;TRIM65;PITPNC1;DGKA;TEF;TNFSF15;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;KCNG1;PTPRS;CCNG2;SMARCA1;HADH;SOX12;PSMD2;LAMB1;EXOC2;ELK3;CRTC1;ADGRL1;DENND5B;CAPN2;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;BCORL1;CGREF1;ARHGAP12;PPP1R14A;FYN;HEBP1;TNFRSF6B;TSPAN5;BNIP3;HLTF;KIF13B;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;PARVB;ARAP1;ADAMTS7;ZNF516;DLG1;CSMD3;DLG4;IDH2;CTSB;DNAJB5;PLXNB3;GPC4;SNX9;TYSND1;PODXL;SLCO4A1;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;EVI5L;SLC9A7;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;TTBK2;SPTLC2;GRK5;HTR7;STRADB;RDH14;NME4;MALL;CRTAP;ASPH;MCTP1;GDI1;CEMIP;SDC1;ARG2;STOM;SHC1;DLG3;DKK1;WISP1;DAP;SMOC2;PAK1;RASA3;SOCS2;TRIB2;KIAA1549;RHPN1;ZNF652;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;EDNRA;LCN2;SHANK2;SLITRK6;EPHA1;IMPACT;RALGAPA2;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;CCPG1;CCND2;ACP5;ANGPTL4;PTPN12;AFAP1;RGS14;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;FYCO1;IDE;AKAP9;RAB11FIP4;FAM208A;PPP2R3B;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;ICA1;EIF4E3;LPAR3;ELFN2;FAM155B;ASNS;FGFR1;ITGA1;AARS;PPP1R35;E2F5;EPCAM;TMOD2;TUB;CMTM7;TCFL5;SMOC1;NFAT5;ITGB5;HYAL1;BTRC;LPCAT1;ITGA2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;ABCG1;KIAA1109;SOX4;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;NELL2;GAMT;CEP120;ZNF558;CEACAM1;FERMT1;MAPKAPK3;ZNF692;OBSL1;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLEK2;HES2;ANXA6;NLGN2;CD46;ZBTB10;PHF12;MVB12B;EPOR;CTH;ZNF704;NXPH4;LRP5;ETAA1;ABHD17C;ZMYM3;DNMBP;KLF12;CTSL;DOCK9;TWF2;CST3;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;TPBG;TOM1L2;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;BTBD3;RIMS3;PLPPR2;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;INPP4A;RFX2;SYTL1;ADGRB2;APLP2;DNAJC6;SLK;PRDX5;MLYCD;CEBPG;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;F2RL1;DDX60;UHRF2;RASIP1;PROCR;TAOK1;PHC3;AEBP1;ATP10D;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;SLC25A4;QSOX1;ASAP1;CPT2;PRKAR1A;ANO1;MSRB2;JMY;BOK;PARP9;CPEB4;SDCCAG3;C18ORF32;ATXN2;MAST3;NACC2;USP6NL;SPRY2;SEPT5;ZNF337;BEX4;TBC1D2B;THRA;MGLL;CD99;WNT2B;ACVR1B;NGFR;ZNF280D;PPP1R10;PSKH1;MVB12A;GLUD1;TSHZ1;MARK4;ZNF449;PTPRZ1;CHD6;NUDT6;PER3;MTA1;AZIN2;BCL2L1;IFITM1;RNF165;YTHDC2;PM20D2;GRIN3B;MEF2D;WASF2;SKAP2;ARF4;H2AFJ;HSD17B7;SLC12A7;XBP1;SPIRE1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SATB1;SLC22A17;PPP1R2;PAIP1;ARRDC1;ANKIB1;TLE4;RIN1;TRPC1;RET;CCDC71L;STX10;LOXL2;PDE5A;TCTN1;RAB43;SH3PXD2B;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;THAP10;NOP10;NCKAP1;GABARAPL2;EPM2A;KCNJ15;RMRP;GTF2IRD2;C1ORF56;DOCK11;PAK6;EAPP;PUM2;SLC30A1;TSPAN3;RNF135;PSD3;TMBIM1;ETV1;COL1A2;SFXN3;CCDC88A;CCSAP;TMED4;SAMD8;SHC2;PRKACA;SAMD5;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;EPB41L3;SEL1L;CBX7;IFI16;RHOBTB1;AP2A2;SRD5A3;NR2F6;SLC39A10;KDELR3;CMTM6;SCAND1;IL1RAP;SBNO1;ORAI1;CARD11;LTB4R;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;AP3D1;ARID4A;ARPC1A;TENM2;IGF2;ITPR2;MOAP1;LAMA5;AGPAT1;PJA2;ZSCAN18;GRB10;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;CITED4;SNX6;USP20;ZFP30;GRB7;SRPX2;ALDH1A2;GPR153;ARHGAP29;LYPLA1;ATP12A;ZNF37A;TBX1;SLC7A11;EVI5;CREB3L2;ERP44;ATP6V1B2;RPH3AL;RSF1;ADAM8;AKT3;ROBO3;IL20RB;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;PHF21A;ZBTB40;ZNF92;ACAP2;MAML3;CKLF;ZNF568;IGFBP7;TBC1D16;DDHD2;FZD8;WASL;RAPGEFL1;REEP6;HSPA2;PRSS8;ZNF107;FLNB;LRP6;ARID5B;MAGEF1;ZNF165;SYT2;PLCH2;TMEM173;RNF180;E2F7;EEF2K;ZNF320;SLC18A2;SIGMAR1;HPSE;RALGDS;SSR1;TNRC6C;TRIM2;RCAN1;TET1;OMG;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;HSD17B12;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;USP25;PRMT3;NYAP1;UFL1;FAM162A;ANKRD6;SNX27;PBX3;JARID2;SEMA3F;RALGPS2;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
6709,GO:0030119,0.748009117180302,0.461727657344093,3,43,AP-type membrane coat adaptor complex,CC,EGFR;AP2A2;AP3D1
2380,GO:0005515,0.748121419776085,0.275034768688582,689,8305,protein binding,MF,TNIP1;DOCK4;FHL1;DDIT4L;XDH;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;FAM83A;ADAM19;ETV5;RAB3B;PGF;CCND1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;ITGA6;CYGB;RPS6KA2;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PRSS3;LRRC20;CRYL1;IGFBP4;PRNP;PAG1;OSBP2;UHRF1BP1;ITGB4;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;ADM2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ADARB1;MAP2K1;CMTM4;THBS2;FMNL2;ETV4;LTBP2;RAPGEF3;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;MPRIP;SALL2;COL13A1;GPX3;PKN1;NAPRT;WWTR1;DCBLD2;MST1R;ARHGAP22;MICALCL;APLN;POU2F2;PITPNC1;TEF;TNFSF15;APPL2;EIF4EBP1;SSH1;MAP1B;PC;DDIT3;PTPRS;SMARCA1;CARS;PSMD2;LAMB1;EXOC2;ELK3;SNTB2;CRTC1;ADGRL1;DENND5B;LTA4H;CAPN2;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;DYSF;FYN;MYH15;TNFRSF6B;TSPAN5;JADE2;BNIP3;HLTF;KIF13B;SCMH1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;MYCBPAP;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;DLG4;CTSB;DNAJB5;PLXNB3;GPC4;DHX32;SNX9;TYSND1;PODXL;NET1;TGM2;ESPN;XPC;GLUL;EVI5L;SLC9A7;HTRA1;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;ACOT7;WDFY3;SEC23A;TTC7B;GRK5;NMRK1;STRADB;NME4;MALL;RSPH3;ASPH;GDI1;CEMIP;UNC119B;SEPT10;SDC1;STOM;SHC1;DLG3;DKK1;WISP1;DAP;HYI;PAK1;CEP170;SOCS2;TRIB2;ATXN10;NEK9;RHPN1;ZNF652;CBR4;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;NUDCD3;EDNRA;HAGH;NUCB2;SHANK2;SCRN1;EPHA1;IMPACT;RALGAPA2;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCPG1;CCND2;ANGPTL4;PTPN12;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;FYCO1;IDE;AKAP9;RAB11FIP4;FAM208A;PPP2R3B;FAM167A;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;ICA1;AGPAT4;LPAR3;KIF21B;ASNS;FGFR1;ITGA1;PPP1R35;E2F5;FAM114A1;EPCAM;TMOD2;CMTM7;TACC1;TCFL5;SMOC1;NFAT5;ITGB5;HYAL1;BTRC;AIG1;ITGA2;PTK6;VAMP2;ULK2;ZNF559;FAT1;INTS8;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;PFN2;AHCYL2;ABCG1;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;NELL2;CEP120;CEACAM1;MAPKAPK3;SPATA18;OBSL1;SLC5A1;PDIA5;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;C5ORF24;HES2;ANXA6;NLGN2;CD46;ZBTB10;PHF12;MVB12B;EPOR;CTH;ORAI3;NXPH4;MPDZ;MAP6;LRP5;ETAA1;DNMBP;KLF12;TMEM86B;CTSL;DOCK9;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;SNORA64;NTNG1;PCSK6;TOM1L2;L3MBTL3;VPS11;RANBP9;WASF3;DNAJB9;FBXL8;BTBD3;RIMS3;SEC63;PPP3CB;MEX3C;MYOF;INPP4A;RFX2;SYTL1;ADGRB2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;FNBP1L;CDC42BPA;SCYL3;F2RL1;DDX60;UHRF2;PROCR;TAOK1;PLD3;PHC3;AEBP1;ATP10D;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;BLMH;SLC25A4;ASAP1;PRKAR1A;ANO1;MSRB2;FAM84B;JMY;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;MAST3;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;PCED1B;ZNF337;BEX4;TBC1D2B;THRA;LMBR1L;MGLL;CD99;WNT2B;ENKD1;ACVR1B;COL6A1;NGFR;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;MARK4;NPL;ZNF449;PTPRZ1;CHD6;NUDT6;PER3;MTA1;AZIN2;BCL2L1;IFITM1;CRAT;RNF165;YTHDC2;MEF2D;GLB1;WASF2;TRIM7;SKAP2;ARF4;H2AFJ;ANAPC13;YPEL5;UAP1;CNNM1;SLC12A7;XBP1;SPIRE1;NFU1;UBASH3B;CADM4;MAP2K2;SATB1;GPATCH8;PPP1R2;PAIP1;ARRDC1;SPIN4;ANKIB1;TLE4;SLC38A2;RIN1;TRPC1;RET;SPATA6;STX10;LOXL2;PDE5A;VWA1;RAB43;MLH3;SIMC1;SH3PXD2B;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;MBOAT7;THAP10;NOP10;NCKAP1;GABARAPL2;EPM2A;KCNJ15;RMRP;GTF2IRD2;ELMO3;DOCK11;PAK6;UBE2E1;PUM2;SLC30A1;RNF135;PSD3;TMBIM1;ETV1;COL1A2;CCDC88A;CCSAP;SHC2;PRKACA;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;EPB41L3;SNX30;S100PBP;SEL1L;CBX7;IFI16;ANGEL1;RHOBTB1;AP2A2;NR2F6;CMTM6;SCAND1;IL1RAP;SBNO1;ORAI1;CARD11;FCHO1;LAMB2;FICD;SECISBP2L;LPAR1;CTSZ;TBL1X;RNF169;HOXA3;BLVRA;ARPC1A;TENM2;IGF2;TMEM134;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;GRB10;LARP1B;MAP4K2;ZMYM2;ERLEC1;PPARG;SNX6;USP20;ANKRD50;GRB7;SRPX2;PPL;ARHGAP29;TBX1;SLC7A11;EVI5;ESYT3;ERP44;ATP6V1B2;RPH3AL;RSF1;ADAM8;ALDH4A1;AKT3;ROBO3;GARS;IL20RB;CLDN11;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;IKBIP;PHF21A;WDR60;ACAP2;MPLKIP;CKLF;IGFBP7;TBC1D16;MARCH2;FZD8;TMEM107;WASL;USP32;ANKS6;RAPGEFL1;REEP6;HSPA2;PRSS8;FLNB;LRP6;ARID5B;MAGEF1;ZNF165;SYT2;TMEM173;RNF180;GGACT;E2F7;EEF2K;ZNF320;HPSE;RALGDS;SSR1;TNRC6C;TRIM2;GRAMD1C;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;DNAJC4;AOX1;SSFA2;HSD17B12;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;SPRYD7;TMEM139;RNF103;USP25;PRMT3;UFL1;FAM162A;SNX27;N4BP2;AMACR;GALE;JARID2;SEMA3F;RALGPS2;KLHL15;JMJD7;MXD4;ADNP;GNAI1;LRP4;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FCGBP;FADD
9801,GO:0040020,0.748749146724135,0.61396944688253,1,16,regulation of meiotic nuclear division,BP,PRKAR1A
13596,GO:0060065,0.748839462931668,0.617531574498777,1,13,uterus development,BP,WNT7A
7409,GO:0031491,0.749109147359222,0.430053302281153,4,66,nucleosome binding,MF,SMARCA1;HMGA2;PHF1;RNF169
10269,GO:0043009,0.749123350365979,0.311241454793923,34,415,chordate embryonic development,BP,MAP2K1;SALL2;CAPN2;EGFR;DLG1;DKK1;TGFBR2;EDNRA;PKD2;PRKACB;FGFR1;HYAL1;SOX4;MDFI;DVL1;MMP14;CHD7;ACVR1B;BCL2L1;TCTN1;C5;SLC30A1;HOXA3;IGF2;ALDH1A2;TBX1;ENDOG;WDR60;ZNF568;TMEM107;LRP6;E2F7;TET1;PTCH1
9074,GO:0035313,0.749137987783043,0.617129818417377,1,13,wound healing, spreading of epidermal cells,BP,WNT7A
12230,GO:0048487,0.749173213471676,0.507646578631956,2,32,beta-tubulin binding,MF,GABARAPL2;ADNP
2966,GO:0006501,0.749265261483138,0.507184345934463,2,33,C-terminal protein lipidation,BP,LY6K;NTNG1
15230,GO:0071384,0.749475406296046,0.459165911415142,3,46,cellular response to corticosteroid stimulus,BP,PCK2;EIF4EBP1;EGFR
13501,GO:0055067,0.749731570673135,0.396000916246499,6,86,monovalent inorganic cation homeostasis,BP,SLC9A7;DMXL2;CLCN3;SLC12A7;ATP12A;ATP6V1B2
12303,GO:0048641,0.749853964914678,0.507901386912737,2,29,regulation of skeletal muscle tissue development,BP,DKK1;TBX1
7105,GO:0030901,0.750009445525891,0.429769543372214,4,59,midbrain development,BP,DKK1;FGFR1;GLUD1;LRP6
3561,GO:0007601,0.750204559601937,0.395740063199089,6,82,visual perception,BP,BBS2;SLITRK6;RABGGTA;LAMB2;WFS1;REEP6
19798,GO:2000241,0.750254162447666,0.409569336321482,5,75,regulation of reproductive process,BP,SMURF2;PRKACB;PRKAR1A;ACVR1B;PDE5A
18686,GO:1904035,0.750314793983207,0.458723250533031,3,43,regulation of epithelial cell apoptotic process,BP,ANGPTL4;BOK;WFS1
13018,GO:0051453,0.750378354326918,0.429028979481786,4,61,regulation of intracellular pH,BP,SLC9A7;DMXL2;CLCN3;ATP6V1B2
9079,GO:0035329,0.750431617696447,0.459901290556355,3,38,hippo signaling,BP,WWTR1;WWC3;PJA2
5403,GO:0016241,0.750919990944216,0.355395847848873,11,151,regulation of macroautophagy,BP,TBC1D14;BNIP3;SPTLC2;BNIP3L;FYCO1;QSOX1;EPM2A;PRKACA;SNX6;ATP6V1B2;RB1CC1
11845,GO:0046823,0.751129062647962,0.610740049674882,1,16,negative regulation of nucleocytoplasmic transport,BP,SOX4
5273,GO:0015923,0.751639129993324,0.612332252262089,1,14,mannosidase activity,MF,EDEM1
4093,GO:0009147,0.751701592202581,0.606788953327473,1,20,pyrimidine nucleoside triphosphate metabolic process,BP,NME4
2933,GO:0006450,0.751907004699901,0.607912599643254,1,18,regulation of translational fidelity,BP,AARS
13801,GO:0060390,0.752070135919614,0.610522599790373,1,15,regulation of SMAD protein signal transduction,BP,WWTR1
15274,GO:0071453,0.752253676082344,0.348944466149739,12,172,cellular response to oxygen levels,BP,PSMD2;BNIP3;BNIP3L;PSMD7;CPEB4;LPAR1;PPARG;ADAM8;ENDOG;EEF2K;FAM162A;DNMT3A
460,GO:0001325,0.752265250692463,0.610256455586926,1,15,formation of extrachromosomal circular DNA,BP,ERCC1
16360,GO:0090656,0.752265250692463,0.610256455586926,1,15,t-circle formation,BP,ERCC1
16387,GO:0090737,0.752265250692463,0.610256455586926,1,15,telomere maintenance via telomere trimming,BP,ERCC1
15523,GO:0071901,0.752362384867568,0.372446440344516,8,116,negative regulation of protein serine/threonine kinase activity,BP,SORL1;APOE;RGS14;LRP5;PRKAR1A;SPRY2;LRP6;KAT2B
4720,GO:0010882,0.752485878649057,0.609955320684099,1,15,regulation of cardiac muscle contraction by calcium ion signaling,BP,PRKACA
5382,GO:0016202,0.752742219695681,0.392761868456876,6,80,regulation of striated muscle tissue development,BP,DKK1;PAK1;TGFBR2;FGFR1;TBX1;JARID2
17790,GO:1901861,0.752742219695681,0.392761868456876,6,80,regulation of muscle tissue development,BP,DKK1;PAK1;TGFBR2;FGFR1;TBX1;JARID2
12262,GO:0048546,0.752791014803448,0.505412599459527,2,26,digestive tract morphogenesis,BP,ACVR2B;EGFR
3442,GO:0007250,0.752826649717772,0.608422316734906,1,16,activation of NF-kappaB-inducing kinase activity,BP,TNFSF15
7101,GO:0030897,0.752858569629213,0.610671368042728,1,14,HOPS complex,CC,VPS11
6984,GO:0030660,0.753103198250721,0.391660383526574,6,88,Golgi-associated vesicle membrane,CC,SEC23A;MCFD2;LMAN1;CLTCL1;COPB1;COPG1
11744,GO:0046580,0.753218093256083,0.455414174761803,3,41,negative regulation of Ras protein signal transduction,BP,RASA3;SPRY2;TIMP2
17542,GO:1901071,0.753556685038607,0.607421927918874,1,16,glucosamine-containing compound metabolic process,BP,CTBS
5271,GO:0015919,0.753573863319385,0.607398361383063,1,16,peroxisomal membrane transport,BP,ABCD1
11779,GO:0046637,0.753814854966333,0.501776121093345,2,31,regulation of alpha-beta T cell differentiation,BP,TGFBR2;AP3D1
2204,GO:0005089,0.75388314499768,0.406934714749505,5,59,Rho guanyl-nucleotide exchange factor activity,MF,NET1;OBSCN;DNMBP;DOCK11;RGL2
820,GO:0002092,0.754065475106025,0.607793432607334,1,15,positive regulation of receptor internalization,BP,APLN
5860,GO:0017160,0.754127396828472,0.608936660706511,1,14,Ral GTPase binding,MF,EXOC2
18902,GO:1904591,0.754142015779853,0.502139991669861,2,29,positive regulation of protein import,BP,EFCAB7;TMEM173
12971,GO:0051353,0.754176785747844,0.500924171434649,2,32,positive regulation of oxidoreductase activity,BP,CYP27B1;APOE
2673,GO:0006024,0.754304324797822,0.390639723433718,6,82,glycosaminoglycan biosynthetic process,BP,B4GALT6;B3GNT3;GPC4;CEMIP;SDC1;HYAL1
4809,GO:0012507,0.754452315038566,0.452648003841071,3,46,ER to Golgi transport vesicle membrane,CC,SEC23A;MCFD2;LMAN1
18073,GO:1902653,0.754648900777432,0.423680860817797,4,60,secondary alcohol biosynthetic process,BP,PLPP6;APOE;ABCG1;HSD17B7
1154,GO:0002762,0.755008343958439,0.500969541555729,2,29,negative regulation of myeloid leukocyte differentiation,BP,CEACAM1;UBASH3B
5440,GO:0016307,0.75526284655846,0.60737860404429,1,14,phosphatidylinositol phosphate kinase activity,MF,ZFYVE21
2457,GO:0005669,0.756055486295869,0.497419618466905,2,35,transcription factor TFIID complex,CC,ERCC1;TCEA1
9071,GO:0035307,0.756215397134302,0.498917703371184,2,30,positive regulation of protein dephosphorylation,BP,ITGA1;SLC39A10
903,GO:0002285,0.756635608956242,0.376325722519115,7,99,lymphocyte activation involved in immune response,BP,ERCC1;CEACAM1;CD46;F2RL1;XBP1;DOCK11;FOXP1
2755,GO:0006165,0.756648365809469,0.387386825769615,6,86,nucleoside diphosphate phosphorylation,BP,DHTKD1;PGM1;NME4;LDHA;PPARA;AK9
3693,GO:0008198,0.756816030216344,0.601982902767858,1,17,ferrous iron binding,MF,ACP5
8975,GO:0035064,0.756823684774271,0.421453876599155,4,56,methylated histone binding,MF,ZMYND8;ATRX;PHF1;SPIN4
17285,GO:0140034,0.756823684774271,0.421453876599155,4,56,methylation-dependent protein binding,MF,ZMYND8;ATRX;PHF1;SPIN4
19873,GO:2000352,0.756891678337815,0.603899396146528,1,15,negative regulation of endothelial cell apoptotic process,BP,ANGPTL4
7405,GO:0031468,0.757027971301423,0.60085074519628,1,18,nuclear envelope reassembly,BP,REEP3
1376,GO:0003272,0.757135944041268,0.604796513076714,1,14,endocardial cushion formation,BP,TGFBR2
15781,GO:0072384,0.757895611661751,0.400637197159334,5,68,organelle transport along microtubule,BP,MAP1B;FYCO1;COPG1;RAB1A;AP3D1
12192,GO:0048339,0.758100085391952,0.60346165037038,1,14,paraxial mesoderm development,BP,FGFR1
3270,GO:0006941,0.758149586727795,0.386006964948782,6,80,striated muscle contraction,BP,NOS1;DLG1;ARG2;OBSL1;PDE5A;PRKACA
9921,GO:0042267,0.758274119460723,0.494703584906911,2,34,natural killer cell mediated cytotoxicity,BP,CEACAM1;CEBPG
616,GO:0001784,0.758283801955175,0.497458129427354,2,27,phosphotyrosine residue binding,MF,SHC1;PTPN3
6660,GO:0030014,0.758308841651637,0.601934117530828,1,15,CCR4-NOT complex,CC,CNOT11
5391,GO:0016226,0.759105097310866,0.596530906567305,1,20,iron-sulfur cluster assembly,BP,NFU1
7241,GO:0031163,0.759105097310866,0.596530906567305,1,20,metallo-sulfur cluster assembly,BP,NFU1
15030,GO:0070971,0.759544717726563,0.600213281892308,1,15,endoplasmic reticulum exit site,CC,SEC23A
7129,GO:0030952,0.759558682802124,0.5991126514605,1,16,establishment or maintenance of cytoskeleton polarity,BP,RHOBTB1
2955,GO:0006486,0.75971710842693,0.329482481901129,15,201,protein glycosylation,BP,LMF1;B4GALT6;UBE2J1;ADAMTS7;B3GNT3;MCFD2;ST3GAL5;GALNT3;LMAN1;GFPT1;ADAMTSL1;SRD5A3;ST6GALNAC2;TET1;STT3B
10510,GO:0043413,0.75971710842693,0.329482481901129,15,201,macromolecule glycosylation,BP,LMF1;B4GALT6;UBE2J1;ADAMTS7;B3GNT3;MCFD2;ST3GAL5;GALNT3;LMAN1;GFPT1;ADAMTSL1;SRD5A3;ST6GALNAC2;TET1;STT3B
11416,GO:0045823,0.759965664776426,0.597592609832585,1,17,positive regulation of heart contraction,BP,APLN
12717,GO:0050953,0.760591521002579,0.382682017406446,6,83,sensory perception of light stimulus,BP,BBS2;SLITRK6;RABGGTA;LAMB2;WFS1;REEP6
5397,GO:0016234,0.760841742322804,0.396884105894484,5,68,inclusion body,CC,EDEM1;PRNP;WDFY3;STRADB;ATF4
9699,GO:0038095,0.760865976340152,0.370524552944703,7,109,Fc-epsilon receptor signaling pathway,BP,PSMD2;SHC1;PAK1;BTRC;PPP3CB;PSMD7;CARD11
16799,GO:0098641,0.761019416681474,0.594517007293788,1,19,cadherin binding involved in cell-cell adhesion,MF,EPCAM
3773,GO:0008327,0.761066713973227,0.597000916592837,1,16,methyl-CpG binding,MF,ZBTB33
629,GO:0001818,0.761214400717332,0.342821304901466,11,160,negative regulation of cytokine production,BP,PRNP;PTPRS;ARG2;TRIB2;ACP5;FGFR1;CEACAM1;F2RL1;RNF135;TMSB4X;IL20RB
16098,GO:0090075,0.761324201166016,0.59663937670924,1,16,relaxation of muscle,BP,PDE5A
16370,GO:0090670,0.761484634668989,0.593861515255933,1,19,RNA localization to Cajal body,BP,NOP10
16371,GO:0090671,0.761484634668989,0.593861515255933,1,19,telomerase RNA localization to Cajal body,BP,NOP10
16372,GO:0090672,0.761484634668989,0.593861515255933,1,19,telomerase RNA localization,BP,NOP10
16376,GO:0090685,0.761484634668989,0.593861515255933,1,19,RNA localization to nucleus,BP,NOP10
8605,GO:0034113,0.761617849483485,0.491548372632861,2,30,heterotypic cell-cell adhesion,BP,CD44;ITGA4
8883,GO:0034695,0.761661214660306,0.598496856972584,1,14,response to prostaglandin E,BP,PPARG
11664,GO:0046426,0.761666653105835,0.490725557553025,2,32,negative regulation of JAK-STAT cascade,BP,SOCS2;INPP5F
19046,GO:1904893,0.761666653105835,0.490725557553025,2,32,negative regulation of STAT cascade,BP,SOCS2;INPP5F
7493,GO:0031664,0.762034325533223,0.595640807732294,1,16,regulation of lipopolysaccharide-mediated signaling pathway,BP,TRIM5
17928,GO:1902254,0.762080190661568,0.593775591168449,1,18,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,CD44
15227,GO:0071379,0.762706270271254,0.597029525340485,1,14,cellular response to prostaglandin stimulus,BP,PPARG
12224,GO:0048477,0.762739536586198,0.441874583591462,3,45,oogenesis,BP,ERCC1;REC8;PDE5A
1856,GO:0004519,0.762786619184197,0.368187454799399,7,108,endonuclease activity,MF,ERCC1;RAG1;ENDOV;LACTB2;DNASE1L1;ENDOG;N4BP2
12297,GO:0048634,0.763164457208503,0.379611850958784,6,81,regulation of muscle organ development,BP,DKK1;PAK1;TGFBR2;FGFR1;TBX1;JARID2
16991,GO:0099072,0.763272094794984,0.59389506886125,1,16,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,DLG4
16036,GO:0086064,0.763395412882863,0.593720778889292,1,16,cell communication by electrical coupling involved in cardiac conduction,BP,PRKACA
11130,GO:0045171,0.763441036016778,0.440341340277293,3,48,intercellular bridge,CC,PRKACB;QSOX1;PRKACA
11778,GO:0046636,0.764266996002637,0.593577587981265,1,15,negative regulation of alpha-beta T cell activation,BP,ARG2
3498,GO:0007398,0.764285870235974,0.593550872337169,1,15,ectoderm development,BP,ITGA6
12793,GO:0051087,0.764398871874467,0.39125014677875,5,79,chaperone binding,MF,PRNP;DNAJB5;DNAJB9;FICD;DNAJC3
12360,GO:0048738,0.764592255515204,0.344757102900716,10,126,cardiac muscle tissue development,BP,DKK1;PAK1;TGFBR2;FKBP1A;FGFR1;OBSL1;CHD7;PRKAR1A;ALDH1A2;JARID2
11864,GO:0046854,0.764670458430588,0.392221189744658,5,66,phosphatidylinositol phosphorylation,BP,EGFR;FYN;TTC7B;FGFR1;ZFYVE21
5611,GO:0016655,0.765564791284582,0.481479720928328,2,49,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,CBR4;NDUFV3
9913,GO:0042249,0.765807232442151,0.592647579985635,1,14,establishment of planar polarity of embryonic epithelium,BP,DVL1
6006,GO:0019048,0.766025367127445,0.485471780895363,2,30,modulation by virus of host morphology or physiology,BP,BCL2L1;EIF2AK2
9802,GO:0040029,0.766359632120324,0.307584626211555,21,291,regulation of gene expression, epigenetic,BP,MAP2K1;EGFR;ERCC6;TNRC6B;UHRF2;PHF1;MTA1;H2AFJ;MAP2K2;RMRP;PUM2;IFI16;ARID4A;IGF2;PPARG;TNRC6C;TET1;ZC3H7A;KAT2B;JARID2;DNMT3A
13179,GO:0051784,0.766707831441595,0.436152075453204,3,47,negative regulation of nuclear division,BP,ATRX;TOM1L2;PRKAR1A
13119,GO:0051656,0.766718898121821,0.298524829296773,27,348,establishment of organelle localization,BP,BBS2;MAP1B;SNPH;DLG1;SEC23A;RAC2;MCFD2;FYCO1;VAMP2;PFN2;FHOD1;CEP120;LMAN1;RIMS3;SYTL1;COPG1;FNBP1L;SPRY2;SEPT5;SPIRE1;RAB1A;CTSZ;AP3D1;MAP4K2;ITGA4;WASL;SYT2
13475,GO:0055010,0.767020586867122,0.484963663533601,2,28,ventricular cardiac muscle tissue morphogenesis,BP,FKBP1A;CHD7
3334,GO:0007044,0.767390754673051,0.374832570171848,6,75,cell-substrate junction assembly,BP,ITGA6;ITGB4;ITGA2;MMP14;SLK;LAMA5
6698,GO:0030097,0.76786406318444,0.282526169580863,45,591,hemopoiesis,BP,ERCC1;CTNNBIP1;FAM210B;POU2F2;DHTKD1;PSMD2;GLO1;RAG1;TGFBR2;CMTM7;FAM20C;SOX4;CEACAM1;TNRC6B;MMP14;CD46;L3MBTL3;DNAJB9;PPP3CB;CEBPG;F2RL1;PSMD7;CHD7;THRA;WNT2B;ACVR1B;PTPRZ1;WASF2;XBP1;UBASH3B;SATB1;DOCK11;EIF2AK2;IFI16;CARD11;AP3D1;ARID4A;PPARG;ADAM8;ITGA4;FZD8;TNRC6C;FOXP1;KAT2B;FADD
17854,GO:1902043,0.767875651151442,0.58844128914001,1,15,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,FADD
13938,GO:0060602,0.767934456720607,0.588357113986524,1,15,branch elongation of an epithelium,BP,SPRY2
11320,GO:0045639,0.768019330654553,0.406287227510637,4,60,positive regulation of myeloid cell differentiation,BP,CTNNBIP1;FAM210B;ACVR1B;FADD
5707,GO:0016836,0.768166178296741,0.480485552637328,2,36,hydro-lyase activity,MF,CBS;UROS
8355,GO:0033218,0.768518991224061,0.322066885729183,14,198,amide binding,MF,SORL1;PRNP;PC;LTA4H;CEMIP;APOE;IDE;RNPEPL1;ITGA2;FBXO2;CST3;KDELR3;PPARG;ADNP
501,GO:0001556,0.769822194428807,0.583577321409221,1,17,oocyte maturation,BP,REC8
69,GO:0000145,0.769926505271318,0.584394968789263,1,16,exocyst,CC,EXOC2
4156,GO:0009218,0.769933609297345,0.581106902335603,1,20,pyrimidine ribonucleotide metabolic process,BP,NME4
407,GO:0001091,0.770158925243832,0.584059615245611,1,16,RNA polymerase II basal transcription factor binding,MF,ERCC1
2815,GO:0006275,0.770227594764913,0.359387813062258,7,99,regulation of DNA replication,BP,EGFR;SHC1;FGFR1;ATRX;CST3;CCDC88A;E2F7
1037,GO:0002548,0.770585788997421,0.58084903325201,1,19,monocyte chemotaxis,BP,MOSPD2
15108,GO:0071157,0.770606259665866,0.581585348695687,1,18,negative regulation of cell cycle arrest,BP,CCND1
7954,GO:0032553,0.770695052810995,0.260883501038854,121,1431,ribonucleotide binding,MF,NOS1;RAB3B;PCK2;PYGL;RPS6KA2;SCN8A;ADCY7;ACTA2;MAP2K1;RAPGEF3;ACVR2B;TK2;PKN1;MST1R;DGKA;PC;SMARCA1;CARS;BRSK1;EGFR;STK39;FYN;MYH15;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;DHX32;TGM2;GLUL;ACSF2;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;SEPT10;SLFN5;PAK1;NEK9;TGFBR2;EPHA1;RAC2;OBSCN;ATP7B;ABCD1;CDK17;PRKACB;FYCO1;IDE;UBE2G1;ABCA7;KIF21B;ASNS;FGFR1;AARS;PTK6;ULK2;LONP2;ATRX;FAM20C;ABCG1;MAPKAPK3;RAB31;NLK;CLCN3;ANXA6;TWF2;TRIB3;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;PRKAR1A;MAST3;SEPT5;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;YTHDC2;ARF4;PANK4;MAP2K2;RET;TUBG2;PDE5A;RAB43;MLH3;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;RAB1A;RHOBTB1;FICD;MAP4K2;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;TMEM173;EEF2K;ADCY1;SEPT6;OAS1;PANK1;N4BP2;GNAI1
14551,GO:0070069,0.771069472674791,0.577761747503673,1,23,cytochrome complex,CC,NDUFA4L2
3063,GO:0006625,0.771169683306759,0.581628050503584,1,17,protein targeting to peroxisome,BP,LONP2
15897,GO:0072662,0.771169683306759,0.581628050503584,1,17,protein localization to peroxisome,BP,LONP2
15898,GO:0072663,0.771169683306759,0.581628050503584,1,17,establishment of protein localization to peroxisome,BP,LONP2
10549,GO:0043500,0.771236734936512,0.402324411433115,4,58,muscle adaptation,BP,PAK1;INPP5F;PDE5A;JARID2
1383,GO:0003283,0.771377040190635,0.584670268733845,1,14,atrial septum development,BP,SOX4
7784,GO:0032309,0.771451432935373,0.581219444494281,1,17,icosanoid secretion,BP,NTSR1
574,GO:0001725,0.771582638637606,0.430422096775695,3,43,stress fiber,CC,MST1R;FHOD1;FLNB
16651,GO:0097517,0.771582638637606,0.430422096775695,3,43,contractile actin filament bundle,CC,MST1R;FHOD1;FLNB
4680,GO:0010828,0.771608237750232,0.478564293139001,2,28,positive regulation of glucose transmembrane transport,BP,PAK1;CLTCL1
6673,GO:0030033,0.772035045352486,0.582449411452362,1,15,microvillus assembly,BP,PODXL
4145,GO:0009206,0.772190074865912,0.356628006702054,7,104,purine ribonucleoside triphosphate biosynthetic process,BP,DHTKD1;PGM1;NME4;LDHA;PPARA;TMSB4X;AK9
3716,GO:0008234,0.772307020659804,0.329727326078836,11,150,cysteine-type peptidase activity,MF,CAPN2;CTSB;CTSL;CASP4;OTUB2;BLMH;CTSO;CTSZ;USP20;USP32;USP25
10292,GO:0043039,0.772318737548059,0.427696811653376,3,52,tRNA aminoacylation,BP,CARS;AARS;GARS
5918,GO:0018193,0.772395106166729,0.26665826575366,75,941,peptidyl-amino acid modification,BP,NOS1;RAB3B;NEURL1;PRNP;MAP2K1;RAPGEF3;PKN1;MST1R;EGFR;STK39;FYN;JADE2;ERCC6;UBE2J1;MAPK13;DLG4;TGM2;FKBP9;TTBK2;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;PAK1;TGFBR2;EPHA1;CD44;FKBP1A;MCFD2;ST3GAL5;AKAP9;HMGA2;FGFR1;PTK6;GALNT3;INPP5F;ATRX;PFN2;FKBP10;SOX4;MAPKAPK3;LMAN1;NLK;CTH;CNTN1;ZDHHC2;CSNK2A1;PHF1;PARP9;MAST3;SPRY2;ACVR1B;PSKH1;MTA1;MAP2K2;RET;LOXL2;PRKACA;NEK6;EIF2AK2;ZDHHC1;ST6GALNAC2;ARID4A;IGF2;ZMYM2;SNX6;AKT3;KAT2B;PRMT3;JARID2;ADNP;LRP4;STT3B
2402,GO:0005547,0.772404662646319,0.476993539980461,2,29,phosphatidylinositol-3,4,5-trisphosphate binding,MF,ARAP1;ASAP1
2437,GO:0005637,0.772467222134093,0.428774962541564,3,45,nuclear inner membrane,CC,ATP11B;SIGMAR1;PSEN2
16498,GO:0097193,0.772987691470751,0.308130947689401,17,244,intrinsic apoptotic signaling pathway,BP,NFATC4;DDIT3;BNIP3;ERCC6;CD44;ATF4;CHAC1;TRIB3;CASP4;JMY;BOK;NACC2;BCL2L1;XBP1;IFI16;MOAP1;WFS1
8688,GO:0034308,0.773028746215596,0.473962395935097,2,35,primary alcohol metabolic process,BP,RDH14;ALDH1A2
4200,GO:0009308,0.773636988287149,0.378587467106022,5,89,amine metabolic process,BP,PSMD2;ALDH7A1;PSMD7;AZIN2;SLC44A1
8088,GO:0032770,0.773812658635934,0.576917553579692,1,18,positive regulation of monooxygenase activity,BP,APOE
5797,GO:0017046,0.77396501199921,0.579642697558982,1,15,peptide hormone binding,MF,IDE
131,GO:0000271,0.773979803379628,0.398691934642712,4,58,polysaccharide biosynthetic process,BP,NR1D1;PGM1;B3GNT3;IGF2
7956,GO:0032555,0.774212010956632,0.257221648241963,120,1420,purine ribonucleotide binding,MF,RAB3B;PCK2;PYGL;RPS6KA2;SCN8A;ADCY7;ACTA2;MAP2K1;RAPGEF3;ACVR2B;TK2;PKN1;MST1R;DGKA;PC;SMARCA1;CARS;BRSK1;EGFR;STK39;FYN;MYH15;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;DHX32;TGM2;GLUL;ACSF2;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;SEPT10;SLFN5;PAK1;NEK9;TGFBR2;EPHA1;RAC2;OBSCN;ATP7B;ABCD1;CDK17;PRKACB;FYCO1;IDE;UBE2G1;ABCA7;KIF21B;ASNS;FGFR1;AARS;PTK6;ULK2;LONP2;ATRX;FAM20C;ABCG1;MAPKAPK3;RAB31;NLK;CLCN3;ANXA6;TWF2;TRIB3;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;PRKAR1A;MAST3;SEPT5;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;YTHDC2;ARF4;PANK4;MAP2K2;RET;TUBG2;PDE5A;RAB43;MLH3;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;RAB1A;RHOBTB1;FICD;MAP4K2;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;TMEM173;EEF2K;ADCY1;SEPT6;OAS1;PANK1;N4BP2;GNAI1
1999,GO:0004722,0.774578574619271,0.397361538059486,4,62,protein serine/threonine phosphatase activity,MF,PPP2R3B;PPP3CB;MTMR4;PPM1M
2288,GO:0005246,0.774763613675894,0.575524239677947,1,18,calcium channel regulator activity,MF,SLC30A1
12934,GO:0051291,0.775256631132587,0.362862270442398,6,101,protein heterooligomerization,BP,CBR4;IDE;ITPR3;COL6A1;COL1A2;LRP4
16345,GO:0090596,0.7758053300261,0.325778414862181,11,141,sensory organ morphogenesis,BP,SDK2;SLITRK6;FGFR1;DVL1;LRP5;CHD7;SPRY2;WNT2B;TSHZ1;TBX1;LRP6
15966,GO:0080008,0.775841339999484,0.470963421845298,2,32,Cul4-RING E3 ubiquitin ligase complex,CC,DCAF10;DDB2
4859,GO:0014072,0.775852426608148,0.574790322599598,1,17,response to isoquinoline alkaloid,BP,FADD
10433,GO:0043278,0.775852426608148,0.574790322599598,1,17,response to morphine,BP,FADD
10505,GO:0043407,0.775911739891178,0.395347711225546,4,64,negative regulation of MAP kinase activity,BP,SORL1;APOE;RGS14;SPRY2
1798,GO:0004438,0.77669145381235,0.576928195982339,1,14,phosphatidylinositol-3-phosphatase activity,MF,MTMR4
13407,GO:0052744,0.77669145381235,0.576928195982339,1,14,phosphatidylinositol monophosphate phosphatase activity,MF,MTMR4
8475,GO:0033617,0.776786644684829,0.571077695888668,1,20,mitochondrial respiratory chain complex IV assembly,BP,COX18
11881,GO:0046888,0.776929025813243,0.469421306275572,2,32,negative regulation of hormone secretion,BP,HADH;MAP4K4
1321,GO:0003170,0.777381770239028,0.470417458150977,2,28,heart valve development,BP,TGFBR2;SOX4
14258,GO:0061311,0.777420221555599,0.573459399847613,1,16,cell surface receptor signaling pathway involved in heart development,BP,DKK1
6020,GO:0019076,0.777470086974147,0.468307780693769,2,33,viral release from host cell,BP,PC;TRIM5
9371,GO:0035890,0.777470086974147,0.468307780693769,2,33,exit from host,BP,PC;TRIM5
9372,GO:0035891,0.777470086974147,0.468307780693769,2,33,exit from host cell,BP,PC;TRIM5
13311,GO:0052126,0.777470086974147,0.468307780693769,2,33,movement in host environment,BP,PC;TRIM5
13320,GO:0052192,0.777470086974147,0.468307780693769,2,33,movement in environment of other organism involved in symbiotic interaction,BP,PC;TRIM5
8331,GO:0033176,0.777483444690214,0.570045992752271,1,20,proton-transporting V-type ATPase complex,CC,ATP6V1B2
12272,GO:0048566,0.777521379383402,0.573310022790477,1,16,embryonic digestive tract development,BP,ALDH1A2
6250,GO:0019827,0.777540986655422,0.334658268062139,9,120,stem cell population maintenance,BP,WNT7A;EPHA1;HMGA2;SOX4;LRP5;ZNF322;LOXL2;TET1;FOXP1
12395,GO:0048820,0.777827248132579,0.573974739307012,1,15,hair follicle maturation,BP,FERMT1
7921,GO:0032496,0.777966958530633,0.310656129766512,14,205,response to lipopolysaccharide,BP,TNIP1;NOS1;F2R;PCK2;CYP27B1;NR1D1;LOXL1;TNFRSF6B;ACP5;MAPKAPK3;TRIM5;NGFR;XBP1;FOXP1
2837,GO:0006305,0.777994746368209,0.421445221039825,3,44,DNA alkylation,BP,ATRX;ATF7IP;DNMT3A
2838,GO:0006306,0.777994746368209,0.421445221039825,3,44,DNA methylation,BP,ATRX;ATF7IP;DNMT3A
5509,GO:0016460,0.778032499613907,0.576441437325384,1,13,myosin II complex,CC,OBSL1
5997,GO:0019003,0.778096914246402,0.419807817584356,3,52,GDP binding,MF,RAB3B;RAB31;GNAI1
9884,GO:0042158,0.778148947623751,0.348786224159364,7,110,lipoprotein biosynthetic process,BP,LY6K;APOE;PIGH;ABHD17C;NTNG1;ZDHHC2;ZDHHC1
337,GO:0000932,0.778258600426328,0.373745879658167,5,74,P-body,CC,BTBD2;APOBEC3C;XRN1;TRIM5;TNRC6B
9824,GO:0042036,0.778396803311263,0.570162875065477,1,18,negative regulation of cytokine biosynthetic process,BP,TRIB2
8677,GO:0034248,0.778662224354466,0.2804240424599,31,424,regulation of cellular amide metabolic process,BP,SORL1;NEURL1;PRNP;MAP2K1;EIF4EBP1;EGFR;IGF2BP3;IMPACT;APOE;ATF4;ABCA7;EIF4E3;ITGA2;SOX4;XRN1;TNRC6B;MEX3C;CPEB4;ATXN2;MAP2K2;PAIP1;PUM2;SAMD8;EIF2AK2;SECISBP2L;PPARG;GRB7;TNRC6C;ZC3H7A;DNAJC3;CNOT11
7663,GO:0032092,0.778731095102188,0.373127487038299,5,74,positive regulation of protein binding,BP,APOE;FKBP1A;LRP1;TRIB3;TMEM173
3627,GO:0008083,0.778926626362805,0.390888020760285,4,68,growth factor activity,MF,PGF;DKK1;NUDT6;IGF2
3478,GO:0007338,0.778951713478087,0.418793938097288,3,51,single fertilization,BP,MST1R;CD46;SPESP1
391,GO:0001046,0.779168331396134,0.372854382550496,5,71,core promoter sequence-specific DNA binding,MF,NR1D1;ATF4;SOX4;MTA1;PPARG
4091,GO:0009145,0.779205522968756,0.34770174437404,7,105,purine nucleoside triphosphate biosynthetic process,BP,DHTKD1;PGM1;NME4;LDHA;PPARA;TMSB4X;AK9
1153,GO:0002761,0.779281294157497,0.372503805420109,5,73,regulation of myeloid leukocyte differentiation,BP,CTNNBIP1;CEACAM1;UBASH3B;FOXP1;FADD
20178,GO:2001024,0.779289325247521,0.568836489819934,1,18,negative regulation of response to drug,BP,STK39
8197,GO:0032941,0.779415795642685,0.56951982024733,1,17,secretion by tissue,BP,STK39
9859,GO:0042108,0.779581754099473,0.465299222022439,2,33,positive regulation of cytokine biosynthetic process,BP,CEBPG;CARD11
4174,GO:0009247,0.779583312586012,0.417610963926014,3,53,glycolipid biosynthetic process,BP,B4GALT6;ST3GAL5;PIGH
14619,GO:0070182,0.779625888530732,0.568335357766157,1,18,DNA polymerase binding,MF,RMRP
7659,GO:0032088,0.779801115367584,0.390154966646082,4,64,negative regulation of NF-kappaB transcription factor activity,BP,DAP;RBCK1;TMSB4X;UFL1
15211,GO:0071356,0.779954161932197,0.311490153344272,13,203,cellular response to tumor necrosis factor,BP,PCK2;POSTN;TNFSF15;PSMD2;TNFRSF6B;ADAMTS7;RBCK1;HYAL1;CASP4;F2RL1;PSMD7;NGFR;TMSB4X
15988,GO:0080182,0.780001642387741,0.569632602473172,1,16,histone H3-K4 trimethylation,BP,ARID4A
17196,GO:0106018,0.780607712352161,0.571139449464409,1,14,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,MTMR4
16341,GO:0090575,0.780819185400668,0.330122516238896,9,131,RNA polymerase II transcription factor complex,CC,ERCC1;NR1D1;DDIT3;ATF4;PPARA;TCEA1;THRA;TLE4;PPARG
201,GO:0000422,0.780959264735872,0.369930953256316,5,77,autophagy of mitochondrion,BP,BNIP3;BNIP3L;SPATA18;GABARAPL2;RB1CC1
14425,GO:0061726,0.780959264735872,0.369930953256316,5,77,mitochondrion disassembly,BP,BNIP3;BNIP3L;SPATA18;GABARAPL2;RB1CC1
7751,GO:0032266,0.780975754602617,0.464414385074022,2,30,phosphatidylinositol-3-phosphate binding,MF,SH3PXD2B;SNX27
8322,GO:0033158,0.781000119981669,0.568144065902512,1,16,regulation of protein import into nucleus, translocation,BP,TMEM173
12778,GO:0051053,0.78108517503656,0.337246377811341,8,109,negative regulation of DNA metabolic process,BP,ERCC1;HMGA2;XRN1;RNF169;PPARG;MAGEF1;TET1;KLHL15
2488,GO:0005732,0.781533876389484,0.561799793482108,1,24,small nucleolar ribonucleoprotein complex,CC,NOP10
4658,GO:0010803,0.781973322986917,0.414468348150814,3,52,regulation of tumor necrosis factor-mediated signaling pathway,BP,RBCK1;CASP4;F2RL1
7835,GO:0032388,0.782427260011964,0.305557502909093,14,192,positive regulation of intracellular transport,BP,EDEM1;SORL1;PRNP;RAPGEF3;ANK3;FYN;CEMIP;STOM;PAK1;RAC2;VAMP2;VPS11;EFCAB7;TMEM173
10178,GO:0042769,0.782613723549187,0.459765668189457,2,37,DNA damage response, detection of DNA damage,BP,HMGA2;SOX4
4063,GO:0009112,0.782839630560427,0.459999788169672,2,35,nucleobase metabolic process,BP,XDH;AOX1
18162,GO:1902911,0.783115452129176,0.353557053417921,6,88,protein kinase complex,CC,CCND1;TGFBR2;CCND2;PRKAR1A;ACVR1B;RB1CC1
11936,GO:0046982,0.783117799515921,0.2832351106775,24,353,protein heterodimerization activity,MF,PGF;DDIT3;CAPN2;EGFR;BNIP3;RALGAPA2;BNIP3L;ATF4;ITGA2;ABCG1;SOX4;RALGAPA1;CLCN3;NTSR1;RABGGTA;CEBPG;BOK;BCL2L1;MEF2D;H2AFJ;XBP1;TENM2;PPARG;SNX6
455,GO:0001228,0.783299391410943,0.289907267698559,20,260,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,ETV5;ETV4;SALL2;POU2F2;TEF;DDIT3;SOX12;ELK3;HLTF;HMGA2;ATF4;PPARA;NFAT5;SOX4;CEBPG;PLAG1;MEF2D;ETV1;CREB3L2;PBX3
14223,GO:0061162,0.783414141868068,0.565652795182461,1,15,establishment of monopolar cell polarity,BP,MAP1B
14270,GO:0061339,0.783414141868068,0.565652795182461,1,15,establishment or maintenance of monopolar cell polarity,BP,MAP1B
1181,GO:0002828,0.783526377262379,0.561706352721714,1,19,regulation of type 2 immune response,BP,ARG2
14113,GO:0060968,0.783596003910579,0.333271534029486,8,127,regulation of gene silencing,BP,MAP2K1;EGFR;UHRF2;MAP2K2;RMRP;PUM2;PPARG;TET1
3213,GO:0006855,0.78365244386987,0.413214386155612,3,46,drug transmembrane transport,BP,NTSR1;SLC13A3;SLC7A11
9017,GO:0035194,0.784000774405558,0.325835979376724,9,140,posttranscriptional gene silencing by RNA,BP,MAP2K1;EGFR;TNRC6B;MAP2K2;RMRP;PUM2;PPARG;TNRC6C;ZC3H7A
3197,GO:0006825,0.784049462985208,0.56169937056309,1,18,copper ion transport,BP,ATP7B
3817,GO:0008409,0.784109875681655,0.563477836077973,1,16,5'-3' exonuclease activity,MF,XRN1
16832,GO:0098727,0.784457976440999,0.325996559248427,9,121,maintenance of cell number,BP,WNT7A;EPHA1;HMGA2;SOX4;LRP5;ZNF322;LOXL2;TET1;FOXP1
17837,GO:1902001,0.784473525056716,0.56405810849613,1,15,fatty acid transmembrane transport,BP,CPT2
18238,GO:1903046,0.784573441392411,0.332501112102434,8,116,meiotic cell cycle process,BP,ERCC1;ATRX;PRKAR1A;SPIRE1;REC8;TUBG2;MLH3;HSPA2
12701,GO:0050919,0.784587473294177,0.460100361173463,2,28,negative chemotaxis,BP,SEMA4B;SEMA3F
190,GO:0000407,0.784810322761183,0.458134397914883,2,32,phagophore assembly site,CC,ULK2;RB1CC1
5050,GO:0015238,0.784981561747381,0.383427969511305,4,62,drug transmembrane transporter activity,MF,SLC25A4;SLC38A2;SLC13A3;SLC7A11
8597,GO:0034101,0.784997028373454,0.351046353984222,6,89,erythrocyte homeostasis,BP,FAM210B;L3MBTL3;CEBPG;THRA;ACVR1B;ARID4A
1126,GO:0002715,0.785057692707309,0.560173908415545,1,18,regulation of natural killer cell mediated immunity,BP,CEACAM1
6976,GO:0030641,0.785158910294395,0.382948176290978,4,64,regulation of cellular pH,BP,SLC9A7;DMXL2;CLCN3;ATP6V1B2
10291,GO:0043038,0.785252365106243,0.409767950190266,3,53,amino acid activation,BP,CARS;AARS;GARS
9784,GO:0039702,0.785264781397164,0.558371092478542,1,20,viral budding via host ESCRT complex,BP,MVB12A
20287,GO:2001267,0.785273152215278,0.558358379225491,1,20,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,FADD
10282,GO:0043027,0.785398929496801,0.560536514110131,1,17,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,PRDX5
6363,GO:0021544,0.785471542131057,0.561420122109501,1,16,subpallium development,BP,BBS2
14316,GO:0061462,0.785551527865669,0.457062565806717,2,32,protein localization to lysosome,BP,SORL1;AP3D1
1071,GO:0002637,0.785656065693509,0.45624020164684,2,34,regulation of immunoglobulin production,BP,PKN1;XBP1
149,GO:0000303,0.785791817013566,0.55756999846021,1,20,response to superoxide,BP,ERCC6
18146,GO:1902883,0.785859168968319,0.455640471031056,2,35,negative regulation of response to oxidative stress,BP,MCTP1;ATF4
8256,GO:0033032,0.785964741218592,0.558797375958145,1,18,regulation of myeloid cell apoptotic process,BP,THRA
6540,GO:0021952,0.786109236441745,0.561585287298157,1,15,central nervous system projection neuron axonogenesis,BP,ADARB1
3435,GO:0007224,0.786149384248245,0.339309647975143,7,97,smoothened signaling pathway,BP,SERPINE2;TTBK2;TGFBR2;PRKACB;BTRC;TCTN1;PTCH1
16092,GO:0090068,0.786801111934631,0.294456649348816,16,219,positive regulation of cell cycle process,BP,CCND1;CCND2;PKD2;RAB11FIP4;HMGA2;FGFR1;HYAL1;ATRX;SOX4;CEP120;LRP5;UHRF2;PRKACA;IGF2;E2F7;CNOT11
13818,GO:0060412,0.787020156585556,0.455698726785242,2,30,ventricular septum morphogenesis,BP,TGFBR2;SOX4
5732,GO:0016878,0.787024295684391,0.55718438885925,1,18,acid-thiol ligase activity,MF,ACSF2
7216,GO:0031110,0.787067346943642,0.381283736301934,4,57,regulation of microtubule polymerization or depolymerization,BP,MAP1B;TTBK2;PAK1;AKAP9
17796,GO:1901880,0.787183535104415,0.409193947875582,3,42,negative regulation of protein depolymerization,BP,TTBK2;TMOD2;TWF2
8953,GO:0035004,0.787268160267127,0.409327781207014,3,41,phosphatidylinositol 3-kinase activity,MF,EGFR;FYN;FGFR1
855,GO:0002183,0.787269204309682,0.556810786850184,1,18,cytoplasmic translational initiation,BP,EIF4EBP1
11033,GO:0045005,0.787454506823361,0.454302465343117,2,32,DNA-dependent DNA replication maintenance of fidelity,BP,ATRX;ETAA1
15455,GO:0071782,0.787571991359716,0.556348491308109,1,18,endoplasmic reticulum tubular network,CC,ASPH
1048,GO:0002576,0.787657991982598,0.361269914439246,5,75,platelet degranulation,BP,SERPING1;APLP2;QSOX1;TMSB4X;IGF2
10622,GO:0043618,0.787743422131917,0.346683647359251,6,102,regulation of transcription from RNA polymerase II promoter in response to stress,BP,DDIT3;PSMD2;IMPACT;ATF4;PSMD7;CHD6
18122,GO:1902806,0.787760600095479,0.315514347956622,10,147,regulation of cell cycle G1/S phase transition,BP,FHL1;CCND1;EGFR;CCND2;PKD2;HYAL1;SOX4;NACC2;E2F7;CNOT11
9350,GO:0035861,0.787855336087593,0.453719574808026,2,32,site of double-strand break,CC,PHF1;RNF169
4978,GO:0015095,0.787900559656827,0.556729775394663,1,17,magnesium ion transmembrane transporter activity,MF,NIPA1
5155,GO:0015693,0.787900559656827,0.556729775394663,1,17,magnesium ion transport,BP,NIPA1
18585,GO:1903830,0.787900559656827,0.556729775394663,1,17,magnesium ion transmembrane transport,BP,NIPA1
2960,GO:0006491,0.788052255876721,0.557495677828367,1,16,N-glycan processing,BP,EDEM1
10441,GO:0043296,0.788642489426471,0.328028556789431,8,103,apical junction complex,CC,CCND1;ANK3;DLG1;DLG3;EPCAM;MPDZ;FRMD4B;CLDN11
15997,GO:0086005,0.78875688200703,0.557555169063356,1,15,ventricular cardiac muscle cell action potential,BP,DLG1
2830,GO:0006296,0.78884797389434,0.450735916120528,2,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,ERCC1;DDB2
7733,GO:0032228,0.788941403488657,0.557273023386618,1,15,regulation of synaptic transmission, GABAergic,BP,NLGN2
99,GO:0000209,0.788974630715404,0.283030092529521,20,276,protein polyubiquitination,BP,SMURF2;HECW2;PSMD2;RBCK1;UBE2G1;BTRC;FBXO2;DDB2;TRIM5;FBXL8;FBXO41;PSMD7;BLMH;RNF165;ANAPC13;ANKIB1;UBE2E1;UNKL;RNF180;FBXL5
4508,GO:0010558,0.78960429286911,0.244255061890821,93,1161,negative regulation of macromolecule biosynthetic process,BP,SMURF2;ZMYND8;CCND1;CTNNBIP1;VLDLR;NR1D1;NFATC4;ZC3H6;MAP2K1;ACVR2B;SALL2;WWTR1;PEG3;EIF4EBP1;DDIT3;ELK3;EGFR;SCMH1;DLG1;DNAJB5;IGF2BP3;SHC1;DKK1;DAP;TRIB2;IMPACT;HMGA2;ATF4;PPARA;ABCA7;WWC3;FGFR1;TCFL5;BTRC;ATRX;ZNF692;ATF7IP;RCOR1;MDFI;XRN1;TNRC6B;HES2;PHF12;KLF12;TRIB3;MEX3C;PRDX5;UHRF2;AEBP1;PARP9;CPEB4;NACC2;THRA;TSHZ1;PER3;MTA1;H2AFJ;MAP2K2;SATB1;TLE4;LOXL2;EAPP;PUM2;EIF2AK2;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;ARID4A;TENM2;IGF2;PPARG;SNX6;GRB7;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;ARID5B;E2F7;TNRC6C;TET1;ZC3H7A;DEDD2;FOXP1;ZBTB33;PTCH1;JARID2;MXD4;DNMT3A
3749,GO:0008286,0.789952662510251,0.334240727420239,7,100,insulin receptor signaling pathway,BP,EIF4EBP1;SHC1;SOCS2;IDE;IGF2;GRB10;ATP6V1B2
950,GO:0002369,0.790066297699563,0.551732694848096,1,19,T cell cytokine production,BP,DLG1
876,GO:0002228,0.790398416885936,0.448742550271024,2,36,natural killer cell mediated immunity,BP,CEACAM1;CEBPG
5562,GO:0016574,0.790580218074286,0.403751417452873,3,45,histone ubiquitination,BP,RAG1;DDB2;UBE2E1
3236,GO:0006890,0.790916898981227,0.356757648288097,5,77,retrograde vesicle-mediated transport, Golgi to ER,BP,COPB1;COPG1;ARF4;RAB1A;KDELR3
13513,GO:0055083,0.790923213152811,0.554232136140938,1,15,monovalent inorganic anion homeostasis,BP,SLC12A7
3328,GO:0007035,0.791096881746147,0.550142061391083,1,19,vacuolar acidification,BP,DMXL2
4485,GO:0010507,0.791149319946645,0.375311218611301,4,60,negative regulation of autophagy,BP,TBC1D14;DAP;RASIP1;QSOX1
18035,GO:1902554,0.791167421425758,0.356423716313149,5,77,serine/threonine protein kinase complex,CC,CCND1;TGFBR2;CCND2;ACVR1B;RB1CC1
9165,GO:0035518,0.791495271775661,0.551206296073249,1,17,histone H2A monoubiquitination,BP,DDB2
12936,GO:0051293,0.791612715748314,0.448995840520331,2,30,establishment of spindle localization,BP,SPRY2;SPIRE1
8314,GO:0033146,0.791723056414015,0.448067605333331,2,32,regulation of intracellular estrogen receptor signaling pathway,BP,PAK1;UFL1
5355,GO:0016126,0.791840801280221,0.373871614837107,4,64,sterol biosynthetic process,BP,PLPP6;APOE;ABCG1;HSD17B7
12634,GO:0050821,0.791949164234689,0.316106427523108,9,133,protein stabilization,BP,TSPAN1;CRTAP;PFN2;SOX4;NLK;DVL1;PER3;SEL1L;WFS1
17291,GO:0140056,0.791973642450655,0.305458451687472,11,155,organelle localization by membrane tethering,BP,RAB3B;EXOC2;SNPH;TTBK2;AKAP9;VPS11;MARK4;STX10;TCTN1;PRKACA;ESYT3
7321,GO:0031330,0.793058925118588,0.296043289589416,13,180,negative regulation of cellular catabolic process,BP,TBC1D14;UBE2J1;DAP;PTPN3;PPARA;CST3;RASIP1;QSOX1;PAIP1;GABARAPL2;TIMP2;ERLEC1;USP25
14909,GO:0070734,0.793145541774209,0.547758692339532,1,18,histone H3-K27 methylation,BP,PHF1
3613,GO:0008053,0.793199991657759,0.546167089848712,1,20,mitochondrial fusion,BP,BNIP3
12840,GO:0051150,0.793251801996542,0.54759343618028,1,18,regulation of smooth muscle cell differentiation,BP,CTH
2873,GO:0006366,0.793308517464768,0.234318762314349,144,1761,transcription by RNA polymerase II,BP,TNIP1;SMURF2;NOS1;ZMYND8;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;NR1D1;NFATC4;ZC3H6;ETV4;ACVR2B;SALL2;PKN1;WWTR1;PEG3;APLN;POU2F2;TEF;ZKSCAN2;DDIT3;SOX12;PSMD2;ELK3;CRTC1;EGFR;HLTF;SLC33A1;ERCC6;ZNF516;DLG1;DNAJB5;HTRA1;GLO1;WNT7A;DKK1;KIAA1549;IMPACT;APOE;CCPG1;PKD2;DDN;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;INTS8;ATRX;SOX4;FHOD1;ZNF692;ATF7IP;RCOR1;MDFI;TCEA1;DVL1;HES2;PHF12;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;PCSK6;ZNF322;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;AEBP1;PSMD7;CHD7;PRKAR1A;JMY;PARP9;NACC2;THRA;ACVR1B;NGFR;TSHZ1;CHD6;PER3;RNF165;MEF2D;ARF4;XBP1;SATB1;TLE4;LOXL2;THAP10;GTF2IRD2;EAPP;ETV1;ZNF398;TCEAL8;UNKL;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;ZNF37A;TBX1;CREB3L2;WFS1;PHF21A;MAML3;ZNF568;FZD8;LRP6;ARID5B;TMEM173;E2F7;TET1;ARMCX3;FOXP1;ZBTB33;PTCH1;KAT2B;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;DNMT3A;FADD
5608,GO:0016651,0.793443878115331,0.370004769864532,4,83,oxidoreductase activity, acting on NAD(P)H,MF,NOS1;CBR4;NDUFV3;TXNRD3
14822,GO:0070555,0.793728061020296,0.313494345456136,9,144,response to interleukin-1,BP,PSMD2;MAPK13;ADAMTS7;HYAL1;BTRC;MTHFR;PSMD7;YTHDC2;IL1RAP
14561,GO:0070085,0.794034687411523,0.288469760874347,15,207,glycosylation,BP,LMF1;B4GALT6;UBE2J1;ADAMTS7;B3GNT3;MCFD2;ST3GAL5;GALNT3;LMAN1;GFPT1;ADAMTSL1;SRD5A3;ST6GALNAC2;TET1;STT3B
2835,GO:0006303,0.794109151069285,0.370437091964596,4,67,double-strand break repair via nonhomologous end joining,BP,ERCC1;HMGA2;PARP9;POLL
18367,GO:1903363,0.794131600776229,0.370736736678322,4,64,negative regulation of cellular protein catabolic process,BP,UBE2J1;GABARAPL2;ERLEC1;USP25
7075,GO:0030863,0.794292844753923,0.339695028070234,6,79,cortical cytoskeleton,CC,RAPGEF3;CAPN2;WIPF1;DLG4;RIMS3;WASL
11666,GO:0046434,0.794313496138253,0.298186398598688,12,171,organophosphate catabolic process,BP,XDH;NT5E;RAPGEF3;DHTKD1;PGM1;LDHA;PPARA;INPP5F;NTSR1;PLA2G4D;ABHD6;PDE5A
16291,GO:0090383,0.794579016806779,0.543370209323013,1,21,phagosome acidification,BP,ATP6V1B2
5499,GO:0016441,0.7946641511626,0.312406076864609,9,141,posttranscriptional gene silencing,BP,MAP2K1;EGFR;TNRC6B;MAP2K2;RMRP;PUM2;PPARG;TNRC6C;ZC3H7A
5729,GO:0016874,0.794911434587438,0.312330418168578,9,134,ligase activity,MF,NAPRT;PC;CARS;GLUL;ACSF2;ASNS;AARS;BTRC;GARS
6392,GO:0021591,0.794948361312246,0.54584017188342,1,17,ventricular system development,BP,MBOAT7
12153,GO:0048260,0.795461215564567,0.442209969403492,2,33,positive regulation of receptor-mediated endocytosis,BP,APLN;WASL
2672,GO:0006023,0.795609399519777,0.337313514545266,6,87,aminoglycan biosynthetic process,BP,B4GALT6;B3GNT3;GPC4;CEMIP;SDC1;HYAL1
19191,GO:1905276,0.796153350551771,0.544963515156218,1,16,regulation of epithelial tube formation,BP,DVL1
3657,GO:0008138,0.796185761060173,0.440504033273329,2,35,protein tyrosine/serine/threonine phosphatase activity,MF,SSH1;PTPDC1
8462,GO:0033599,0.796214336629758,0.543857835226559,1,17,regulation of mammary gland epithelial cell proliferation,BP,CCND1
1172,GO:0002819,0.796278936354592,0.349254021648956,5,81,regulation of adaptive immune response,BP,PKN1;CEACAM1;PPP3CB;IL20RB;FADD
6552,GO:0021983,0.796283361364617,0.543749519026423,1,17,pituitary gland development,BP,ALDH1A2
11753,GO:0046599,0.796427952227971,0.543522543223155,1,17,regulation of centriole replication,BP,KAT2B
7398,GO:0031461,0.797095937005097,0.299040705872879,11,157,cullin-RING ubiquitin ligase complex,CC,BTBD2;ABTB1;DCAF10;BTRC;FBXO2;DDB2;BTBD3;KLHL29;ANAPC13;KLHL15;FBXL5
7717,GO:0032206,0.797113813656248,0.393739234640455,3,49,positive regulation of telomere maintenance,BP,ERCC1;ATRX;PPP1R10
5559,GO:0016571,0.797375916314297,0.316443260321953,8,111,histone methylation,BP,ATRX;MTHFR;PHF1;SATB1;ARID4A;TET1;PRMT3;JARID2
10466,GO:0043325,0.798564506840442,0.540156200524591,1,17,phosphatidylinositol-3,4-bisphosphate binding,MF,PLEK2
12348,GO:0048710,0.798760882124941,0.538947812965596,1,18,regulation of astrocyte differentiation,BP,SERPINE2
19735,GO:2000108,0.79897529689826,0.53708870554551,1,20,positive regulation of leukocyte apoptotic process,BP,ADAM8
12907,GO:0051253,0.799079630485322,0.236710666781752,78,990,negative regulation of RNA metabolic process,BP,SMURF2;ZMYND8;CCND1;CTNNBIP1;VLDLR;NR1D1;NFATC4;ZC3H6;ACVR2B;SALL2;WWTR1;PEG3;DDIT3;ELK3;SCMH1;DLG1;DNAJB5;SHC1;DKK1;DAP;IMPACT;HMGA2;PPARA;WWC3;FGFR1;TCFL5;BTRC;ATRX;ZNF692;ATF7IP;RCOR1;MDFI;HES2;PHF12;KLF12;TRIB3;PRDX5;UHRF2;AEBP1;PARP9;NACC2;THRA;TSHZ1;PER3;MTA1;H2AFJ;SATB1;PAIP1;TLE4;LOXL2;RMRP;EAPP;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;ARID4A;TENM2;IGF2;PPARG;SNX6;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;ARID5B;E2F7;TET1;DEDD2;FOXP1;ZBTB33;PTCH1;JARID2;MXD4;DNMT3A
13807,GO:0060396,0.799119005895308,0.54029305137082,1,16,growth hormone receptor signaling pathway,BP,SOCS2
4314,GO:0009792,0.799373148610015,0.254349418145725,34,425,embryo development ending in birth or egg hatching,BP,MAP2K1;SALL2;CAPN2;EGFR;DLG1;DKK1;TGFBR2;EDNRA;PKD2;PRKACB;FGFR1;HYAL1;SOX4;MDFI;DVL1;MMP14;CHD7;ACVR1B;BCL2L1;TCTN1;C5;SLC30A1;HOXA3;IGF2;ALDH1A2;TBX1;ENDOG;WDR60;ZNF568;TMEM107;LRP6;E2F7;TET1;PTCH1
11837,GO:0046785,0.799452164419517,0.364036592217423,4,59,microtubule polymerization,BP,PAK1;AKAP9;RANBP9;TUBG2
3099,GO:0006672,0.79946387218424,0.36317018402938,4,66,ceramide metabolic process,BP,B4GALT6;SPTLC2;ST3GAL5;SAMD8
5587,GO:0016605,0.799483365316476,0.332196962863301,6,87,PML body,CC,WDFY3;RGS14;ATRX;SATB1;TENM2;ZMYM2
18489,GO:1903599,0.799544652619962,0.538604057870371,1,17,positive regulation of autophagy of mitochondrion,BP,BNIP3
2215,GO:0005112,0.800008734615144,0.540038974942659,1,15,Notch binding,MF,CHAC1
128,GO:0000266,0.800025916653544,0.435415677804247,2,33,mitochondrial fission,BP,BNIP3;DDHD2
6700,GO:0030099,0.800261437583347,0.267884136245819,21,294,myeloid cell differentiation,BP,CTNNBIP1;FAM210B;GLO1;TGFBR2;FAM20C;CEACAM1;TNRC6B;L3MBTL3;CEBPG;F2RL1;THRA;ACVR1B;WASF2;UBASH3B;IFI16;ARID4A;PPARG;TNRC6C;FOXP1;KAT2B;FADD
1551,GO:0003950,0.800294982057123,0.537412497508321,1,17,NAD+ ADP-ribosyltransferase activity,MF,PARP9
7167,GO:0031047,0.800571545056372,0.299248403767126,10,155,gene silencing by RNA,BP,MAP2K1;EGFR;TNRC6B;MAP2K2;RMRP;PUM2;PPARG;TNRC6C;ZC3H7A;CNOT11
6417,GO:0021680,0.800968187665343,0.538515445614911,1,15,cerebellar Purkinje cell layer development,BP,AARS
20230,GO:2001171,0.80103949462103,0.536227289725971,1,17,positive regulation of ATP biosynthetic process,BP,TMSB4X
11466,GO:0045920,0.801118601404283,0.535200399585062,1,18,negative regulation of exocytosis,BP,CEACAM1
9691,GO:0038084,0.801366477260754,0.535705846924496,1,17,vascular endothelial growth factor signaling pathway,BP,XDH
15413,GO:0071675,0.801475819776008,0.533105338108201,1,20,regulation of mononuclear cell migration,BP,MOSPD2
13572,GO:0060039,0.801556079976529,0.53890997227113,1,14,pericardium development,BP,LRP6
15438,GO:0071711,0.801949831953205,0.536951699949169,1,15,basement membrane organization,BP,FERMT1
2557,GO:0005834,0.802474181455186,0.532227988458728,1,19,heterotrimeric G-protein complex,CC,GNAI1
19229,GO:1905360,0.802474181455186,0.532227988458728,1,19,GTPase complex,CC,GNAI1
1122,GO:0002711,0.802619721047115,0.531272292112934,1,20,positive regulation of T cell mediated immunity,BP,FADD
4655,GO:0010799,0.802937495094486,0.431044020185782,2,33,regulation of peptidyl-threonine phosphorylation,BP,CEMIP;SPRY2
11908,GO:0046939,0.803058072412346,0.327109151855127,6,92,nucleotide phosphorylation,BP,DHTKD1;PGM1;NME4;LDHA;PPARA;AK9
13504,GO:0055072,0.803617676964388,0.357404405818774,4,66,iron ion homeostasis,BP,LCN2;SLC22A17;SFXN3;FBXL5
10509,GO:0043412,0.803731961898981,0.21748536352093,266,3237,macromolecule modification,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;GID4;NOS1;ZMYND8;F2R;SORL1;RAB3B;CCND1;NEURL1;VLDLR;RPS6KA2;ADCY7;IGFBP4;PRNP;ADM2;HECW2;ADARB1;MAP2K1;RAPGEF3;ACVR2B;LTBP1;LMF1;PKN1;WWTR1;MST1R;MARCH9;LY6K;TNFSF15;SSH1;PTPRS;B4GALT6;PSMD2;LAMB1;BRSK1;EGFR;STK39;LOXL1;PPP1R14A;FYN;JADE2;HLTF;ERCC6;UBE2J1;UBXN7;MAPK13;ADAMTS7;DLG1;DLG4;B3GNT3;SNX9;TGM2;FKBP9;WNT7A;MAP4K4;TTBK2;GRK5;STRADB;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;PAK1;RASA3;SOCS2;TRIB2;NEK9;RAG1;TGFBR2;PTPN3;EPHA1;IMPACT;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;CCND2;PTPN12;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;RBCK1;ST3GAL5;AKAP9;PPP2R3B;UBE2G1;HMGA2;ABCA7;PIGH;LPAR3;PCMTD2;ELFN2;FGFR1;ITGA1;AARS;PPP1R35;MARCH4;PTPDC1;DCAF10;BTRC;PTK6;GALNT3;ULK2;INPP5F;ATRX;FAM20C;MTHFR;PFN2;FKBP10;SOX4;RMND5A;APOBEC3C;FBXO2;DDB2;CEACAM1;MAPKAPK3;OBSL1;PRR9;LMAN1;ATF7IP;RCOR1;NLK;TRIM5;DVL1;CTH;LRP5;ETAA1;ABHD17C;CST3;RABGGTA;CNTN1;TRIB3;NTNG1;GFPT1;RANBP9;FBXL8;PPP3CB;ZDHHC2;APLP2;DNAJC6;SLK;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;TAOK1;FBXO41;OTUB2;CSNK2A1;PHF1;PSMD7;BLMH;QSOX1;PRKAR1A;PARP9;KLHL29;MAST3;NACC2;SPRY2;BEX4;ACVR1B;NGFR;PPP1R10;PSKH1;MARK4;PTPRZ1;MTA1;RNF165;TRIM7;ARF4;ANAPC13;UBASH3B;MAP2K2;SATB1;PPP1R2;ARRDC1;ANKIB1;LYPLAL1;RET;LOXL2;PDE5A;VWA1;C5;MTMR4;NOP10;PAK6;UBE2E1;RNF135;CCDC88A;ADAMTSL1;SHC2;PRKACA;NEK6;UNKL;TIMP2;EIF2AK2;RAB1A;ZDHHC1;SEL1L;SRD5A3;SLC39A10;ST6GALNAC2;LAMB2;FICD;LPAR1;TBL1X;RNF169;ARID4A;IGF2;PJA2;MAP4K2;ZMYM2;SNX6;EVA1A;USP20;LYPLA1;TBX1;ADAM8;AKT3;WFS1;PHF21A;IGFBP7;MARCH2;OSGEPL1;FZD8;USP32;HSPA2;LRP6;ARID5B;MAGEF1;RNF180;PPT2;EEF2K;CMTR2;TRIM2;RCAN1;TET1;DNAJC3;ADCY1;KAT2B;RNF103;USP25;PRMT3;UFL1;ANKRD6;JARID2;PPM1M;KLHL15;ADNP;LRP4;STT3B;RB1CC1;DNMT3A;TRIM38;FBXL5
17799,GO:1901889,0.803764784561336,0.532885092124574,1,16,negative regulation of cell junction assembly,BP,MMP14
8239,GO:0033006,0.803845183580244,0.530024395796244,1,19,regulation of mast cell activation involved in immune response,BP,RAC2
10448,GO:0043304,0.803845183580244,0.530024395796244,1,19,regulation of mast cell degranulation,BP,RAC2
10597,GO:0043565,0.804431086866926,0.235254320113361,61,754,sequence-specific DNA binding,MF,ZMYND8;ETV5;H1F0;NR1D1;NFATC4;ZC3H6;ETV4;SALL2;POU2F2;TEF;DDIT3;SOX12;ELK3;HLTF;ZNF516;RAG1;DDN;HMGA2;ATF4;PPARA;TCFL5;NFAT5;ZNF559;SOX4;ZNF558;ZNF692;HES2;PHF12;ZNF704;RFX2;CEBPG;PLAG1;AEBP1;PHF1;CHD7;NACC2;ZNF337;THRA;PER3;MTA1;MEF2D;XBP1;SATB1;MLH3;ETV1;IFI16;NR2F6;HOXA3;PPARG;TBX1;CREB3L2;PHF21A;ZNF568;ARID5B;E2F7;FOXP1;ZBTB33;KAT2B;PBX3;JARID2;RFX7
5814,GO:0017076,0.804638672572199,0.224344083955167,120,1434,purine nucleotide binding,MF,RAB3B;PCK2;PYGL;RPS6KA2;SCN8A;ADCY7;ACTA2;MAP2K1;RAPGEF3;ACVR2B;TK2;PKN1;MST1R;DGKA;PC;SMARCA1;CARS;BRSK1;EGFR;STK39;FYN;MYH15;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;DHX32;TGM2;GLUL;ACSF2;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;SEPT10;SLFN5;PAK1;NEK9;TGFBR2;EPHA1;RAC2;OBSCN;ATP7B;ABCD1;CDK17;PRKACB;FYCO1;IDE;UBE2G1;ABCA7;KIF21B;ASNS;FGFR1;AARS;PTK6;ULK2;LONP2;ATRX;FAM20C;ABCG1;MAPKAPK3;RAB31;NLK;CLCN3;ANXA6;TWF2;TRIB3;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;PRKAR1A;MAST3;SEPT5;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;YTHDC2;ARF4;PANK4;MAP2K2;RET;TUBG2;PDE5A;RAB43;MLH3;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;RAB1A;RHOBTB1;FICD;MAP4K2;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;TMEM173;EEF2K;ADCY1;SEPT6;OAS1;PANK1;N4BP2;GNAI1
2481,GO:0005719,0.804838191032071,0.527044185060808,1,21,nuclear euchromatin,CC,H1F0
2464,GO:0005680,0.805307961125983,0.526283538226285,1,21,anaphase-promoting complex,CC,ANAPC13
16163,GO:0090181,0.805332461298156,0.381955630354402,3,49,regulation of cholesterol metabolic process,BP,LMF1;APOE;ABCG1
12835,GO:0051145,0.805412152467049,0.426978531052729,2,34,smooth muscle cell differentiation,BP,NFATC4;CTH
1155,GO:0002763,0.805860373820556,0.425992082791772,2,35,positive regulation of myeloid leukocyte differentiation,BP,CTNNBIP1;FADD
3157,GO:0006757,0.805876490364956,0.336771231642008,5,75,ATP generation from ADP,BP,DHTKD1;PGM1;LDHA;PPARA;AK9
17072,GO:0099568,0.806107089609835,0.253129585856845,27,339,cytoplasmic region,CC,RAPGEF3;WDR66;EXOC2;CAPN2;WIPF1;DLG4;ASPH;SEPT10;PKD2;FAM110C;RIMS3;FNBP1L;PRKAR1A;SEPT5;SPIRE1;CCSAP;PRKACA;RHOBTB1;CTSZ;AP3D1;ITPR2;FNBP1;WASL;FLNB;PSEN2;SEPT6;GNAI1
12391,GO:0048814,0.806147257510378,0.354857435596873,4,58,regulation of dendrite morphogenesis,BP,HECW2;NFATC4;OBSL1;EEF2K
38,GO:0000077,0.806665624791356,0.291773485417105,10,147,DNA damage checkpoint,BP,CCND1;BRSK1;XPC;HMGA2;SOX4;ETAA1;TAOK1;PPP1R10;E2F7;CNOT11
11348,GO:0045671,0.80688994986229,0.527837743363544,1,16,negative regulation of osteoclast differentiation,BP,UBASH3B
4558,GO:0010639,0.807197967020384,0.259778316183689,21,281,negative regulation of organelle organization,BP,ERCC1;BNIP3;ARAP1;ESPN;EVI5L;TTBK2;TMOD2;ATRX;PFN2;XRN1;TWF2;TOM1L2;PHF1;PRKAR1A;BOK;BCL2L1;WASF2;TMSB4X;TET1;KAT2B;JARID2
5844,GO:0017134,0.807478014512008,0.524947489866446,1,18,fibroblast growth factor binding,MF,FGFR1
18299,GO:1903205,0.807511542680579,0.523355759461114,1,20,regulation of hydrogen peroxide-induced cell death,BP,ENDOG
152,GO:0000307,0.807756667044505,0.422546855410266,2,37,cyclin-dependent protein kinase holoenzyme complex,CC,CCND1;CCND2
13804,GO:0060393,0.807983640161052,0.422762824378631,2,35,regulation of pathway-restricted SMAD protein phosphorylation,BP,DKK1;ACVR1B
12405,GO:0048846,0.808182465186458,0.425092806223421,2,28,axon extension involved in axon guidance,BP,SEMA4B;SEMA3F
17944,GO:1902284,0.808182465186458,0.425092806223421,2,28,neuron projection extension involved in neuron projection guidance,BP,SEMA4B;SEMA3F
6848,GO:0030316,0.808246284026501,0.351642318584056,4,60,osteoclast differentiation,BP,GLO1;FAM20C;UBASH3B;FOXP1
5556,GO:0016567,0.808262033381088,0.233267205954548,54,707,protein ubiquitination,BP,SMURF2;GID4;NEURL1;HECW2;WWTR1;MARCH9;PSMD2;FYN;JADE2;HLTF;UBE2J1;SOCS2;RAG1;FKBP1A;RBCK1;UBE2G1;MARCH4;DCAF10;BTRC;SOX4;RMND5A;FBXO2;DDB2;TRIM5;TRIB3;FBXL8;UHRF2;FBXO41;PSMD7;BLMH;KLHL29;MTA1;RNF165;TRIM7;ANAPC13;ARRDC1;ANKIB1;UBE2E1;RNF135;UNKL;RAB1A;RNF169;PJA2;WFS1;MARCH2;MAGEF1;RNF180;TRIM2;RNF103;PRMT3;UFL1;KLHL15;TRIM38;FBXL5
20124,GO:2000810,0.808736887296526,0.523802380800735,1,17,regulation of bicellular tight junction assembly,BP,PRKACA
2961,GO:0006493,0.808786083486805,0.319724683137235,6,88,protein O-linked glycosylation,BP,ADAMTS7;B3GNT3;GALNT3;ADAMTSL1;ST6GALNAC2;TET1
4549,GO:0010629,0.808930704185373,0.220602140431716,111,1429,negative regulation of gene expression,BP,XDH;SMURF2;ZMYND8;CCND1;CTNNBIP1;VLDLR;SERPINE2;PRNP;BBS2;NR1D1;NFATC4;ZC3H6;MAP2K1;ACVR2B;SALL2;WWTR1;PEG3;APLN;EIF4EBP1;PC;DDIT3;PSMD2;ELK3;EGFR;FYN;SCMH1;DLG1;DNAJB5;IGF2BP3;SHC1;DKK1;DAP;SERPING1;IMPACT;HMGA2;ATF4;PPARA;WWC3;FGFR1;TCFL5;BTRC;CHAC1;ATRX;FERMT1;ZNF692;ATF7IP;RCOR1;MDFI;XRN1;TNRC6B;HES2;CD46;PHF12;KLF12;TRIB3;MEX3C;PRDX5;PLAG1;UHRF2;AEBP1;PHF1;PSMD7;PARP9;CPEB4;NACC2;THRA;ACVR1B;TSHZ1;PER3;H2AFJ;MAP2K2;SATB1;PAIP1;TLE4;LOXL2;RMRP;EAPP;PUM2;EIF2AK2;CBX7;IFI16;NR2F6;ZNF354A;CTSZ;TBL1X;ARID4A;TENM2;IGF2;PPARG;SNX6;GRB7;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;ARID5B;E2F7;TNRC6C;TET1;ZC3H7A;DEDD2;FOXP1;ZBTB33;PTCH1;CNOT11;JARID2;MXD4;ADNP;DNMT3A
7585,GO:0031952,0.809335200829258,0.421331935570708,2,33,regulation of protein autophosphorylation,BP,IMPACT;EEF2K
450,GO:0001223,0.809339336478776,0.523845111187024,1,16,transcription coactivator binding,MF,PPARA
18351,GO:1903321,0.809514708129938,0.349043100738935,4,67,negative regulation of protein modification by small protein conjugation or removal,BP,FYN;SOX4;PRMT3;UFL1
65,GO:0000132,0.809807731817723,0.521137369115987,1,18,establishment of mitotic spindle orientation,BP,SPRY2
4691,GO:0010842,0.810112393191092,0.523750226725393,1,15,retina layer formation,BP,SDK2
8206,GO:0032958,0.810154014981244,0.521480242164523,1,17,inositol phosphate biosynthetic process,BP,NTSR1
10779,GO:0044232,0.810238303171099,0.520429967329435,1,18,organelle membrane contact site,CC,ESYT3
11600,GO:0046189,0.810291658712688,0.520342237046988,1,18,phenol-containing compound biosynthetic process,BP,TRPC1
10547,GO:0043496,0.81031485138389,0.518761482845689,1,20,regulation of protein homodimerization activity,BP,ITGA4
13486,GO:0055023,0.810594106832117,0.520756865886501,1,17,positive regulation of cardiac muscle tissue growth,BP,FGFR1
3211,GO:0006851,0.810734449887396,0.518070146462035,1,20,mitochondrial calcium ion transmembrane transport,BP,MICU3
156,GO:0000314,0.810883313129307,0.51389883733392,1,28,organellar small ribosomal subunit,CC,MRPS6
2510,GO:0005763,0.810883313129307,0.51389883733392,1,28,mitochondrial small ribosomal subunit,CC,MRPS6
2957,GO:0006488,0.811306415821911,0.51712621900695,1,20,dolichol-linked oligosaccharide biosynthetic process,BP,SRD5A3
15718,GO:0072273,0.811348389218744,0.519514585015077,1,17,metanephric nephron morphogenesis,BP,PKD2
648,GO:0001838,0.811488214773554,0.306179153461409,7,99,embryonic epithelial tube formation,BP,PRKACB;SOX4;DVL1;RET;TCTN1;LRP6;PTCH1
17927,GO:1902253,0.811657015505694,0.515289614317773,1,22,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,CD44
18297,GO:1903203,0.811825150827095,0.517814114249078,1,18,regulation of oxidative stress-induced neuron death,BP,ATF4
8506,GO:0033683,0.811849939455234,0.415776552561691,2,39,nucleotide-excision repair, DNA incision,BP,ERCC1;DDB2
15387,GO:0071634,0.812086925914822,0.518295201252946,1,17,regulation of transforming growth factor beta production,BP,CD46
980,GO:0002437,0.812165072062454,0.515046097238938,1,21,inflammatory response to antigenic stimulus,BP,IL20RB
1929,GO:0004623,0.81271426413612,0.514795173685969,1,20,phospholipase A2 activity,MF,PLA2G4D
12939,GO:0051298,0.812888542476367,0.344966951406592,4,61,centrosome duplication,BP,BRSK1;PKD2;CEP120;KAT2B
2712,GO:0006085,0.812984685282711,0.515893901898437,1,18,acetyl-CoA biosynthetic process,BP,MLYCD
3778,GO:0008333,0.813064263103717,0.370875416403467,3,48,endosome to lysosome transport,BP,VPS11;AP3D1;SNX27
4784,GO:0010971,0.813363421473522,0.514448915020528,1,19,positive regulation of G2/M transition of mitotic cell cycle,BP,CCND1
3533,GO:0007519,0.813403507018626,0.313439207124728,6,89,skeletal muscle tissue development,BP,NEURL1;MYH15;DKK1;MEF2D;TBX1;FLNB
11878,GO:0046885,0.813451825062339,0.515118204324912,1,18,regulation of hormone biosynthetic process,BP,CYP27B1
5658,GO:0016758,0.813532225235809,0.282881314777047,10,152,transferase activity, transferring hexosyl groups,MF,PYGL;PYGB;B4GALT6;B3GNT3;WDFY3;B4GALNT4;PIGH;HYAL1;GALNT3;STT3B
13642,GO:0060147,0.813638804011018,0.312156837465006,6,106,regulation of posttranscriptional gene silencing,BP,MAP2K1;EGFR;MAP2K2;RMRP;PUM2;PPARG
14111,GO:0060966,0.813638804011018,0.312156837465006,6,106,regulation of gene silencing by RNA,BP,MAP2K1;EGFR;MAP2K2;RMRP;PUM2;PPARG
5657,GO:0016757,0.813791266833943,0.266978819115325,14,207,transferase activity, transferring glycosyl groups,MF,PYGL;PYGB;NAPRT;B4GALT6;B3GNT3;WDFY3;B4GALNT4;ST3GAL5;PIGH;HYAL1;GALNT3;PARP9;ST6GALNAC2;STT3B
17879,GO:1902117,0.813828210745026,0.343896087319514,4,59,positive regulation of organelle assembly,BP,SDC1;CEP120;ASAP1;CCDC88A
12982,GO:0051385,0.813958961212753,0.512725157446794,1,20,response to mineralocorticoid,BP,CCND1
13623,GO:0060113,0.813983289745977,0.414182326999327,2,33,inner ear receptor cell differentiation,BP,SLITRK6;FGFR1
18077,GO:1902667,0.81403074499408,0.415650861576061,2,29,regulation of axon guidance,BP,SEMA4B;SEMA3F
959,GO:0002381,0.814616934508222,0.41256838115398,2,35,immunoglobulin production involved in immunoglobulin mediated immune response,BP,ERCC1;POU2F2
15441,GO:0071715,0.814631590976258,0.512336328561768,1,19,icosanoid transport,BP,NTSR1
17693,GO:1901571,0.814631590976258,0.512336328561768,1,19,fatty acid derivative transport,BP,NTSR1
15226,GO:0071378,0.81470177336718,0.513953546386809,1,17,cellular response to growth hormone stimulus,BP,SOCS2
917,GO:0002312,0.814754782378039,0.368038947057101,3,50,B cell activation involved in immune response,BP,ERCC1;XBP1;DOCK11
7176,GO:0031057,0.815102194595824,0.412796860177549,2,32,negative regulation of histone modification,BP,PHF1;JARID2
11595,GO:0046174,0.815332964411744,0.51198220757921,1,18,polyol catabolic process,BP,NTSR1
2716,GO:0006091,0.815375762925072,0.245325521001461,24,363,generation of precursor metabolites and energy,BP,XDH;PYGL;PYGB;NR1D1;NFATC4;DHTKD1;BNIP3;PGM1;IDH2;ASPH;LDHA;PPARA;GFPT1;SLC25A4;NDUFV3;NDUFA4L2;TXNRD3;PPP1R2;LOXL2;IGF2;AK9;ALDH4A1;AOX1;RB1CC1
7871,GO:0032432,0.81565017609583,0.367257810489978,3,47,actin filament bundle,CC,MST1R;FHOD1;FLNB
13092,GO:0051602,0.815771594016383,0.511248127903395,1,18,response to electrical stimulus,BP,AKAP9
4046,GO:0009083,0.81586453343369,0.509539356786307,1,20,branched-chain amino acid catabolic process,BP,HIBADH
12665,GO:0050869,0.816095313391805,0.510705663917205,1,18,negative regulation of B cell activation,BP,PKN1
9077,GO:0035326,0.81616817749365,0.322536693952206,5,76,enhancer binding,MF,ZNF704;ZNF322;XBP1;NR2F6;PBX3
11243,GO:0045428,0.81636421524957,0.409855886722279,2,35,regulation of nitric oxide biosynthetic process,BP,ACP5;PKD2
2836,GO:0006304,0.816449664028632,0.32189526849542,5,79,DNA modification,BP,ATRX;APOBEC3C;ATF7IP;TET1;DNMT3A
25,GO:0000049,0.816452680850548,0.364914510737262,3,54,tRNA binding,MF,XPOT;CARS;AARS
4140,GO:0009201,0.818147358191765,0.296747622549348,7,110,ribonucleoside triphosphate biosynthetic process,BP,DHTKD1;PGM1;NME4;LDHA;PPARA;TMSB4X;AK9
6355,GO:0021536,0.81842785539357,0.407270235527357,2,33,diencephalon development,BP,ALDH1A2;LRP6
3369,GO:0007131,0.819046948941895,0.405379825286685,2,36,reciprocal meiotic recombination,BP,REC8;MLH3
9339,GO:0035825,0.819046948941895,0.405379825286685,2,36,homologous recombination,BP,REC8;MLH3
6588,GO:0022600,0.819165981636929,0.405788952532967,2,34,digestive system process,BP,STK39;SLC5A1
4436,GO:0010288,0.819381308692344,0.503606154004429,1,20,response to lead ion,BP,DNMT3A
2541,GO:0005798,0.819635176718359,0.280540079488899,9,136,Golgi-associated vesicle,CC,SEC23A;MCFD2;LMAN1;CLTCL1;COPB1;COPG1;TMED4;CTSZ;DDHD2
9243,GO:0035635,0.820067959155421,0.504000087526798,1,18,entry of bacterium into host cell,BP,EXOC2
7932,GO:0032509,0.820090706285937,0.50240077048412,1,20,endosome transport via multivesicular body sorting pathway,BP,TMEM50B
14842,GO:0070584,0.820115717561869,0.501692398311985,1,21,mitochondrion morphogenesis,BP,BCL2L1
3899,GO:0008536,0.820244106360367,0.404771384236242,2,32,Ran GTPase binding,MF,XPOT;RANBP9
1005,GO:0002479,0.820501776542597,0.357520570015476,3,66,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,PSMD2;ITGB5;PSMD7
8347,GO:0033198,0.821326549195151,0.501032965468987,1,19,response to ATP,BP,SSH1
10038,GO:0042490,0.821521542686609,0.402088533632593,2,34,mechanoreceptor differentiation,BP,SLITRK6;FGFR1
79,GO:0000159,0.821533858237189,0.499939661884159,1,20,protein phosphatase type 2A complex,CC,PPP2R3B
7441,GO:0031571,0.822105446605996,0.331030411059087,4,68,mitotic G1 DNA damage checkpoint,BP,CCND1;SOX4;E2F7;CNOT11
11006,GO:0044819,0.822105446605996,0.331030411059087,4,68,mitotic G1/S transition checkpoint,BP,CCND1;SOX4;E2F7;CNOT11
9060,GO:0035282,0.82237734848188,0.331545066012126,4,60,segmentation,BP,DKK1;PCSK6;LRP6;SEMA3F
5971,GO:0018410,0.822814903227538,0.39892251023094,2,38,C-terminal protein amino acid modification,BP,LY6K;NTNG1
2483,GO:0005721,0.823000958577838,0.498990972036143,1,18,pericentric heterochromatin,CC,ATRX
1432,GO:0003407,0.823049601714337,0.400720362585877,2,31,neural retina development,BP,SDK2;RAB11FIP4
5296,GO:0015980,0.823180720603145,0.258048355458687,13,214,energy derivation by oxidation of organic compounds,BP,PYGL;PYGB;NR1D1;NFATC4;DHTKD1;BNIP3;PGM1;IDH2;GFPT1;NDUFV3;PPP1R2;IGF2;RB1CC1
12006,GO:0047485,0.823183487293067,0.299642726676351,6,97,protein N-terminus binding,MF,ZMYND8;MAP2K1;EXOC2;ERCC6;NTSR1;CSNK2A1
17739,GO:1901673,0.823324500501526,0.497609751840722,1,19,regulation of mitotic spindle assembly,BP,CCSAP
11823,GO:0046717,0.823706910361998,0.3547383704942,3,50,acid secretion,BP,VAMP2;NTSR1;SLC38A2
12079,GO:0048027,0.823784308355061,0.494803103639995,1,22,mRNA 5'-UTR binding,MF,IGF2BP3
14839,GO:0070577,0.823984559791884,0.499273331235086,1,16,lysine-acetylated histone binding,MF,ZMYND8
17284,GO:0140033,0.823984559791884,0.499273331235086,1,16,acetylation-dependent protein binding,MF,ZMYND8
10621,GO:0043616,0.824546212452588,0.397631121402814,2,33,keratinocyte proliferation,BP,FERMT1;PTCH1
2663,GO:0006007,0.824581000066286,0.494034294941376,1,21,glucose catabolic process,BP,LRP5
2959,GO:0006490,0.825601485600429,0.492267719129371,1,21,oligosaccharide-lipid intermediate biosynthetic process,BP,SRD5A3
13910,GO:0060561,0.825631280006662,0.494455794291109,1,18,apoptotic process involved in morphogenesis,BP,LRP5
731,GO:0001960,0.825954886813842,0.393941216462381,2,38,negative regulation of cytokine-mediated signaling pathway,BP,F2RL1;PPARG
5123,GO:0015491,0.826134544879907,0.493583379859899,1,18,cation:cation antiporter activity,MF,SLC9A7
431,GO:0001158,0.826298381113418,0.325287272058327,4,65,enhancer sequence-specific DNA binding,MF,ZNF704;XBP1;NR2F6;PBX3
16629,GO:0097484,0.826474402126868,0.493922524911574,1,17,dendrite extension,BP,SYT2
6449,GO:0021766,0.826601345172039,0.350555999312743,3,49,hippocampus development,BP,BBS2;PTPRS;ANXA3
5398,GO:0016235,0.826764186139728,0.393775000322689,2,34,aggresome,CC,EDEM1;STRADB
590,GO:0001754,0.827017511942109,0.492049078806253,1,18,eye photoreceptor cell differentiation,BP,SDK2
6784,GO:0030219,0.827025800786148,0.323066403609909,4,78,megakaryocyte differentiation,BP,TNRC6B;WASF2;TNRC6C;KAT2B
9591,GO:0036442,0.827361181988019,0.488598658321293,1,22,proton-exporting ATPase activity,MF,ATP6V1B2
6453,GO:0021772,0.82739397844764,0.492323510955467,1,17,olfactory bulb development,BP,CHD7
651,GO:0001841,0.828125444153939,0.293473252537742,6,87,neural tube formation,BP,PRKACB;SOX4;DVL1;TCTN1;LRP6;PTCH1
4531,GO:0010596,0.828197620308764,0.39148295684011,2,34,negative regulation of endothelial cell migration,BP,APOE;PPARG
1073,GO:0002639,0.82822270670607,0.487701651641088,1,21,positive regulation of immunoglobulin production,BP,XBP1
907,GO:0002292,0.828389833736076,0.390868997345088,2,35,T cell differentiation involved in immune response,BP,CD46;FOXP1
12283,GO:0048596,0.828571568412501,0.492517902398718,1,15,embryonic camera-type eye morphogenesis,BP,LRP6
5832,GO:0017112,0.828817341222463,0.347205508641462,3,49,Rab guanyl-nucleotide exchange factor activity,MF,DENND5B;RIN2;RIN1
13745,GO:0060317,0.829125600770481,0.48753635721691,1,19,cardiac epithelial to mesenchymal transition,BP,TGFBR2
5512,GO:0016469,0.829370590228172,0.484016807397932,1,24,proton-transporting two-sector ATPase complex,CC,ATP6V1B2
7021,GO:0030742,0.829597293171864,0.4859630108061,1,20,GTP-dependent protein binding,MF,RAB3B
4832,GO:0014037,0.82981563356831,0.389927713483769,2,31,Schwann cell differentiation,BP,SH3TC2;LAMB2
4552,GO:0010633,0.830161254583819,0.345166003912565,3,49,negative regulation of epithelial cell migration,BP,APOE;PFN2;PPARG
17008,GO:0099106,0.830260189091375,0.344526815774114,3,52,ion channel regulator activity,MF,DLG1;AKAP9;SLC30A1
8882,GO:0034694,0.83074112302618,0.485526728880338,1,18,response to prostaglandin,BP,PPARG
878,GO:0002237,0.830947422008065,0.245428160214923,14,214,response to molecule of bacterial origin,BP,TNIP1;NOS1;F2R;PCK2;CYP27B1;NR1D1;LOXL1;TNFRSF6B;ACP5;MAPKAPK3;TRIM5;NGFR;XBP1;FOXP1
15367,GO:0071604,0.830952668687577,0.48515363453323,1,18,transforming growth factor beta production,BP,CD46
11832,GO:0046755,0.831094916156703,0.48148430558799,1,23,viral budding,BP,MVB12A
16054,GO:0086091,0.831161463953611,0.485718643895029,1,17,regulation of heart rate by cardiac conduction,BP,AKAP9
3155,GO:0006754,0.831204894005194,0.288703422348576,6,95,ATP biosynthetic process,BP,DHTKD1;PGM1;LDHA;PPARA;TMSB4X;AK9
10987,GO:0044783,0.831304210977403,0.317591628100082,4,69,G1 DNA damage checkpoint,BP,CCND1;SOX4;E2F7;CNOT11
9611,GO:0036474,0.831370183222555,0.481553424323132,1,22,cell death in response to hydrogen peroxide,BP,ENDOG
8236,GO:0033003,0.831898744010727,0.481228139732629,1,21,regulation of mast cell activation,BP,RAC2
12538,GO:0050687,0.83190076021145,0.481224566485163,1,21,negative regulation of defense response to virus,BP,HTRA1
10902,GO:0044447,0.831946873344202,0.485386109553884,1,16,axoneme part,CC,WDR66
5372,GO:0016180,0.831998244264292,0.480440816112161,1,22,snRNA processing,BP,INTS8
11329,GO:0045652,0.832133518333168,0.340100257996116,3,65,regulation of megakaryocyte differentiation,BP,TNRC6B;TNRC6C;KAT2B
9462,GO:0036064,0.832204526866093,0.287434456241324,6,93,ciliary basal body,CC,BBS2;TTBK2;PKD2;MARK4;CCDC88A;CCSAP
7980,GO:0032594,0.832336335217394,0.480452021939292,1,21,protein transport within lipid bilayer,BP,AP3D1
6916,GO:0030507,0.832548145424905,0.483265593971812,1,17,spectrin binding,MF,ANK3
8164,GO:0032897,0.832792566262528,0.479641582252051,1,21,negative regulation of viral transcription,BP,HMGA2
14805,GO:0070530,0.83298959882469,0.48071340075294,1,19,K63-linked polyubiquitin modification-dependent protein binding,MF,RNF169
5131,GO:0015605,0.833096634860508,0.479100723642982,1,21,organophosphate ester transmembrane transporter activity,MF,SLC25A4
1346,GO:0003209,0.833858733042947,0.480936112235415,1,17,cardiac atrium morphogenesis,BP,SOX4
4348,GO:0009913,0.833950034823578,0.248076895657324,12,183,epidermal cell differentiation,BP,CYP27B1;MAP2K1;ALOX15B;SLITRK6;FGFR1;PRR9;CTSL;PCSK6;PPL;PRSS8;FLNB;PTCH1
7076,GO:0030864,0.834103677500191,0.314605357208769,4,59,cortical actin cytoskeleton,CC,RAPGEF3;CAPN2;WIPF1;WASL
11517,GO:0046031,0.834160070085055,0.29699465912633,5,79,ADP metabolic process,BP,DHTKD1;PGM1;LDHA;PPARA;AK9
6009,GO:0019054,0.834402075338314,0.477447472394183,1,20,modulation by virus of host process,BP,BCL2L1
5627,GO:0016705,0.83448743439933,0.284140779598142,6,95,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,NOS1;CYGB;CYP27B1;ASPH;CYP4F22;TET1
3254,GO:0006914,0.834867259999374,0.215213177243411,31,427,autophagy,BP,ITGB4;TRIM65;TBC1D14;BNIP3;SPTLC2;WDFY3;DAP;BNIP3L;FYCO1;SNX14;ULK2;VPS13A;SPATA18;TRIM5;VPS11;FNBP1L;RASIP1;CSNK2A1;QSOX1;BOK;MVB12A;XBP1;GABARAPL2;EPM2A;PRKACA;RAB1A;IFI16;SNX6;EVA1A;ATP6V1B2;RB1CC1
14493,GO:0061919,0.834867259999374,0.215213177243411,31,427,process utilizing autophagic mechanism,BP,ITGB4;TRIM65;TBC1D14;BNIP3;SPTLC2;WDFY3;DAP;BNIP3L;FYCO1;SNX14;ULK2;VPS13A;SPATA18;TRIM5;VPS11;FNBP1L;RASIP1;CSNK2A1;QSOX1;BOK;MVB12A;XBP1;GABARAPL2;EPM2A;PRKACA;RAB1A;IFI16;SNX6;EVA1A;ATP6V1B2;RB1CC1
2619,GO:0005930,0.835663881255349,0.311931238049048,4,62,axoneme,CC,WDR66;PRKAR1A;CCSAP;PRKACA
7721,GO:0032211,0.836081074021586,0.475187587259442,1,19,negative regulation of telomere maintenance via telomerase,BP,XRN1
19369,GO:1905818,0.836150164868625,0.335371584003386,3,53,regulation of chromosome separation,BP,HECW2;CSNK2A1;NEK6
1341,GO:0003203,0.836167335515933,0.475868503683789,1,18,endocardial cushion morphogenesis,BP,TGFBR2
14959,GO:0070851,0.836293269169837,0.293720500024094,5,82,growth factor receptor binding,MF,PGF;FYN;SHC1;ATXN2;ARF4
3310,GO:0007010,0.836446897067487,0.19456877206546,82,982,cytoskeleton organization,BP,NEURL1;SYNE3;BBS2;FMNL2;RAPGEF3;SH3KBP1;SSH1;MAP1B;CAPN2;BRSK1;WIPF1;ANK3;ARHGAP12;PARVB;ARAP1;DLG1;ESPN;TTBK2;SEPT10;SHC1;PAK1;EPHA1;RAC2;OBSCN;APOE;AFAP1;RGS14;PKD2;LRP1;AKAP9;TMOD2;TACC1;ITGB5;FAT1;ATRX;PFN2;FHOD1;CEP120;OBSL1;SH3D19;DVL1;PLEK2;MAP6;ZMYM3;TWF2;RANBP9;WASF3;SLK;CDC42BPA;F2RL1;TAOK1;PRKAR1A;MSRB2;JMY;MAST3;SPRY2;SEPT5;MARK4;WASF2;GOLGA2P5;SPIRE1;TUBG2;NAV1;SH3PXD2B;NCKAP1;PAK6;CCDC88A;CCSAP;NEK6;TMSB4X;EPB41L3;RHOBTB1;LPAR1;ARPC1A;LAMA5;ZMYM2;PPL;WASL;FLNB;KAT2B;SEPT6;GNAI1
7079,GO:0030867,0.836452899500989,0.470940598928231,1,25,rough endoplasmic reticulum membrane,CC,DNAJC3
8071,GO:0032743,0.836605997991727,0.473493197671935,1,20,positive regulation of interleukin-2 production,BP,CARD11
9542,GO:0036294,0.836901677633916,0.252433485024265,10,158,cellular response to decreased oxygen levels,BP,PSMD2;BNIP3;BNIP3L;PSMD7;CPEB4;ADAM8;ENDOG;EEF2K;FAM162A;DNMT3A
9491,GO:0036126,0.836979876902144,0.376137805477286,2,38,sperm flagellum,CC,SPATA6;SEPT6
16726,GO:0097729,0.836979876902144,0.376137805477286,2,38,9+2 motile cilium,CC,SPATA6;SEPT6
4111,GO:0009166,0.837076981881435,0.263658914590523,8,124,nucleotide catabolic process,BP,XDH;NT5E;RAPGEF3;DHTKD1;PGM1;LDHA;PPARA;PDE5A
335,GO:0000930,0.837121862007106,0.473313624812333,1,19,gamma-tubulin complex,CC,TUBG2
3553,GO:0007588,0.837250478461138,0.471654071615816,1,21,excretion,BP,NFAT5
14504,GO:0061982,0.837314467643507,0.308752518164286,4,69,meiosis I cell cycle process,BP,ERCC1;REC8;MLH3;HSPA2
9847,GO:0042092,0.837922617156457,0.469265531485557,1,23,type 2 immune response,BP,ARG2
10090,GO:0042590,0.838061788297782,0.330736117473655,3,68,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,PSMD2;ITGB5;PSMD7
9246,GO:0035639,0.838497601693294,0.187723688451494,116,1401,purine ribonucleoside triphosphate binding,MF,RAB3B;PCK2;PYGL;RPS6KA2;SCN8A;ADCY7;ACTA2;MAP2K1;ACVR2B;TK2;PKN1;MST1R;DGKA;PC;SMARCA1;CARS;BRSK1;EGFR;STK39;FYN;MYH15;HLTF;KIF13B;ERCC6;UBE2J1;MAPK13;DHX32;TGM2;GLUL;ACSF2;MAP4K4;TTBK2;GRK5;NMRK1;STRADB;NME4;SEPT10;SLFN5;PAK1;NEK9;TGFBR2;EPHA1;RAC2;OBSCN;ATP7B;ABCD1;CDK17;PRKACB;FYCO1;IDE;UBE2G1;ABCA7;KIF21B;ASNS;FGFR1;AARS;PTK6;ULK2;LONP2;ATRX;FAM20C;ABCG1;MAPKAPK3;RAB31;NLK;CLCN3;ANXA6;TWF2;TRIB3;SLK;CDC42BPA;SCYL3;DDX60;TAOK1;ATP10D;CSNK2A1;CHD7;MAST3;SEPT5;ACVR1B;PSKH1;GLUD1;HSPA13;MARK4;CHD6;YTHDC2;ARF4;PANK4;MAP2K2;RET;TUBG2;RAB43;MLH3;PAK6;UBE2E1;PRKACA;NEK6;EIF2AK2;RAB1A;RHOBTB1;FICD;MAP4K2;ATP12A;ATP6V1B2;AK9;AKT3;GARS;ATP11B;HSPA2;EEF2K;ADCY1;SEPT6;OAS1;PANK1;N4BP2;GNAI1
2477,GO:0005697,0.839288889513688,0.467344939178707,1,22,telomerase holoenzyme complex,CC,NOP10
12779,GO:0051054,0.839332565979645,0.241182279224876,12,181,positive regulation of DNA metabolic process,BP,ERCC1;EGFR;SHC1;ANXA3;FGFR1;ATRX;CST3;CEBPG;PARP9;PPP1R10;ENDOG;E2F7
6579,GO:0022406,0.839336526020522,0.245068964387738,11,163,membrane docking,BP,RAB3B;EXOC2;SNPH;TTBK2;AKAP9;VPS11;MARK4;STX10;TCTN1;PRKACA;ESYT3
1358,GO:0003229,0.839557411031705,0.373344796531013,2,33,ventricular cardiac muscle tissue development,BP,FKBP1A;CHD7
8147,GO:0032873,0.839937471260774,0.371531974468905,2,37,negative regulation of stress-activated MAPK cascade,BP,DLG1;F2RL1
14688,GO:0070303,0.839937471260774,0.371531974468905,2,37,negative regulation of stress-activated protein kinase signaling cascade,BP,DLG1;F2RL1
9018,GO:0035195,0.840544627579128,0.258629533754493,8,134,gene silencing by miRNA,BP,MAP2K1;EGFR;TNRC6B;MAP2K2;PUM2;PPARG;TNRC6C;ZC3H7A
15876,GO:0072595,0.840569573628656,0.370232300122375,2,38,maintenance of protein localization in organelle,BP,SOX4;KDELR3
15749,GO:0072332,0.841303209292725,0.302561933184841,4,72,intrinsic apoptotic signaling pathway by p53 class mediator,BP,CD44;JMY;BOK;IFI16
8850,GO:0034643,0.841501761502696,0.465350932438492,1,19,establishment of mitochondrion localization, microtubule-mediated,BP,MAP1B
12009,GO:0047497,0.841501761502696,0.465350932438492,1,19,mitochondrion transport along microtubule,BP,MAP1B
2973,GO:0006513,0.841512192282862,0.302919291536275,4,65,protein monoubiquitination,BP,NEURL1;RAG1;DDB2;UBE2E1
17877,GO:1902115,0.841573371908573,0.246680518649717,10,143,regulation of organelle assembly,BP,TBC1D14;EVI5L;SDC1;CEP120;VPS11;ASAP1;ATXN2;CCDC88A;CCSAP;KAT2B
4619,GO:0010737,0.841765026128704,0.465708123762623,1,18,protein kinase A signaling,BP,PJA2
11794,GO:0046660,0.841882458984543,0.285904939404251,5,79,female sex differentiation,BP,MMP14;CHD7;ACVR1B;BCL2L1;ARID5B
6445,GO:0021761,0.842143743396217,0.302084868987964,4,64,limbic system development,BP,BBS2;PTPRS;ANXA3;FGFR1
6556,GO:0021988,0.842351030379826,0.464632607134425,1,18,olfactory lobe development,BP,CHD7
4676,GO:0010824,0.842476819946679,0.367327622412376,2,37,regulation of centrosome duplication,BP,CEP120;KAT2B
11323,GO:0045646,0.842605405824561,0.367113982802974,2,37,regulation of erythrocyte differentiation,BP,FAM210B;ACVR1B
3898,GO:0008535,0.842650383135557,0.460117636929692,1,24,respiratory chain complex IV assembly,BP,COX18
13896,GO:0060538,0.84278952662146,0.272612065770599,6,93,skeletal muscle organ development,BP,NEURL1;MYH15;DKK1;MEF2D;TBX1;FLNB
11849,GO:0046827,0.8432625743506,0.461360271960214,1,20,positive regulation of protein export from nucleus,BP,RAPGEF3
3735,GO:0008270,0.843358830608992,0.197383709902652,44,570,zinc ion binding,MF,MMP1;NR1D1;MARCH9;TRIM65;LTA4H;HLTF;GLO1;SEC23A;RAG1;IDE;ZCCHC14;PPARA;MARCH4;RNPEPL1;CHURC1;APOBEC3C;MT2A;TRIM5;TCEA1;MMP14;ZMYM3;RABGGTA;L3MBTL3;PHC3;AEBP1;MSRB2;LACTB2;THRA;MTA1;RNF165;TRIM7;TIMP2;NR2F6;MMP10;BLVRA;ZMYM2;PPARG;USP20;ADAM8;ZNF92;MARCH2;TRIM2;TET1;TRIM38
13692,GO:0060236,0.843366361142251,0.366404520598695,2,35,regulation of mitotic spindle organization,BP,CCSAP;GNAI1
6683,GO:0030048,0.843646174199848,0.284140257168368,5,70,actin filament-based movement,BP,WIPF1;DLG1;FNBP1L;WASF2;WASL
15242,GO:0071398,0.843666344923112,0.36590472823308,2,35,cellular response to fatty acid,BP,NFATC4;PPARG
15128,GO:0071218,0.843738084992298,0.460482427346821,1,20,cellular response to misfolded protein,BP,KLHL15
405,GO:0001085,0.843931011275403,0.261861649233808,7,106,RNA polymerase II transcription factor binding,MF,ERCC1;BBS2;ATF4;PPARA;MTA1;MEF2D;XBP1
6285,GO:0019894,0.843966386052939,0.365708175056492,2,34,kinesin binding,MF,TTBK2;NEK6
14986,GO:0070897,0.8440788774131,0.364164024703585,2,39,DNA-templated transcriptional preinitiation complex assembly,BP,ATF7IP;THRA
9800,GO:0040019,0.844406771972242,0.460000077799877,1,19,positive regulation of embryonic development,BP,WNT2B
16398,GO:0097014,0.844659953073668,0.298429430844717,4,63,ciliary plasm,CC,WDR66;PRKAR1A;CCSAP;PRKACA
17426,GO:1900180,0.844664065486255,0.281581947192933,5,83,regulation of protein localization to nucleus,BP,FYN;PARP9;NGFR;EFCAB7;TMEM173
15218,GO:0071364,0.844715721703721,0.363867313738954,2,36,cellular response to epidermal growth factor stimulus,BP,EGFR;PTPN12
3320,GO:0007026,0.845056778006604,0.459636913678563,1,18,negative regulation of microtubule depolymerization,BP,TTBK2
13049,GO:0051539,0.845566580416508,0.361231981714801,2,41,4 iron, 4 sulfur cluster binding,MF,RSAD1;NFU1
10475,GO:0043367,0.845836983454932,0.361721085274762,2,37,CD4-positive, alpha-beta T cell differentiation,BP,SATB1;FOXP1
1000,GO:0002474,0.846419457208821,0.294095617477983,4,83,antigen processing and presentation of peptide antigen via MHC class I,BP,PSMD2;SEC23A;ITGB5;PSMD7
4540,GO:0010613,0.846646352360286,0.455836243817148,1,19,positive regulation of cardiac muscle hypertrophy,BP,PDE5A
4880,GO:0014742,0.846646352360286,0.455836243817148,1,19,positive regulation of muscle hypertrophy,BP,PDE5A
17833,GO:1901992,0.846701444224667,0.318674863996247,3,55,positive regulation of mitotic cell cycle phase transition,BP,CCND1;CCND2;HYAL1
1114,GO:0002703,0.84672547886212,0.266557550240205,6,102,regulation of leukocyte mediated immunity,BP,RAC2;CEACAM1;PPP3CB;F2RL1;IL20RB;FADD
290,GO:0000794,0.846752272474041,0.294961213645848,4,66,condensed nuclear chromosome,CC,ATRX;REC8;MLH3;HSPA2
4587,GO:0010677,0.847093673022611,0.454244450101281,1,20,negative regulation of cellular carbohydrate metabolic process,BP,PPARA
1381,GO:0003279,0.847240478776834,0.278533590649067,5,74,cardiac septum development,BP,LTBP1;TGFBR2;SOX4;CHD7;TBX1
1117,GO:0002706,0.847336344642767,0.293438423964647,4,73,regulation of lymphocyte mediated immunity,BP,CEACAM1;PPP3CB;IL20RB;FADD
1343,GO:0003206,0.847489626147967,0.277916939204943,5,77,cardiac chamber morphogenesis,BP,TGFBR2;FKBP1A;SOX4;CHD7;TBX1
5793,GO:0017025,0.847589533223222,0.451452692540685,1,23,TBP-class protein binding,MF,THRA
14550,GO:0070064,0.84785392019396,0.453576959989967,1,19,proline-rich region binding,MF,CCND1
3335,GO:0007045,0.848063094496061,0.293660217945517,4,60,cell-substrate adherens junction assembly,BP,ITGA2;MMP14;SLK;LAMA5
12088,GO:0048041,0.848063094496061,0.293660217945517,4,60,focal adhesion assembly,BP,ITGA2;MMP14;SLK;LAMA5
19232,GO:1905368,0.84811642498736,0.291417785800038,4,85,peptidase complex,CC,PSMD2;IDE;PSMD7;WFS1
4662,GO:0010810,0.848281430216023,0.237889639670754,10,139,regulation of cell-substrate adhesion,BP,ITGA6;POSTN;NET1;SMOC2;EPHA1;RAC2;FERMT1;MMP14;SLK;HSD17B12
14389,GO:0061630,0.848504658100533,0.223348035496588,14,198,ubiquitin protein ligase activity,MF,SMURF2;GID4;NEURL1;HECW2;HLTF;UBE2J1;RAG1;UBE2G1;BTRC;UHRF2;RNF165;ANKIB1;PJA2;RNF180
16802,GO:0098644,0.848506758365568,0.455211720851378,1,16,complex of collagen trimers,CC,COL1A2
13254,GO:0051932,0.848582555186403,0.452208880806433,1,19,synaptic transmission, GABAergic,BP,NLGN2
5726,GO:0016866,0.849134502355755,0.448032477432754,1,24,intramolecular transferase activity,MF,PGM1
7457,GO:0031593,0.849292878775714,0.355902526936366,2,37,polyubiquitin modification-dependent protein binding,MF,TNIP1;RNF169
15178,GO:0071312,0.849779249298317,0.448513677407805,1,21,cellular response to alkaloid,BP,BCL2L1
8556,GO:0033962,0.849788389637777,0.450781192167011,1,18,cytoplasmic mRNA processing body assembly,BP,ATXN2
2455,GO:0005667,0.849903538895214,0.21260837584847,18,259,transcription factor complex,CC,ERCC1;NR1D1;NFATC4;WWTR1;DDIT3;ATF4;PPARA;E2F5;NFAT5;SOX4;ATF7IP;RCOR1;TCEA1;THRA;TLE4;PPARG;E2F7;PBX3
13895,GO:0060537,0.850027547278689,0.214605385923994,17,226,muscle tissue development,BP,NEURL1;MYH15;DLG1;DKK1;PAK1;TGFBR2;FKBP1A;PKD2;FGFR1;OBSL1;CHD7;PRKAR1A;MEF2D;ALDH1A2;TBX1;FLNB;JARID2
7877,GO:0032438,0.850030952833809,0.447418711306234,1,22,melanosome organization,BP,AP3D1
2951,GO:0006479,0.85023772434862,0.234985916905593,10,149,protein methylation,BP,RAB3B;PCMTD2;ATRX;MTHFR;PHF1;SATB1;ARID4A;TET1;PRMT3;JARID2
3706,GO:0008213,0.85023772434862,0.234985916905593,10,149,protein alkylation,BP,RAB3B;PCMTD2;ATRX;MTHFR;PHF1;SATB1;ARID4A;TET1;PRMT3;JARID2
5075,GO:0015298,0.850444397173407,0.447938764800853,1,20,solute:cation antiporter activity,MF,SLC9A7
9707,GO:0038111,0.850814000546771,0.443945805715857,1,26,interleukin-7-mediated signaling pathway,BP,SOCS2
16851,GO:0098760,0.850814000546771,0.443945805715857,1,26,response to interleukin-7,BP,SOCS2
16852,GO:0098761,0.850814000546771,0.443945805715857,1,26,cellular response to interleukin-7,BP,SOCS2
589,GO:0001750,0.851001268206948,0.353559488106231,2,35,photoreceptor outer segment,CC,MAP1B;SHANK2
8063,GO:0032731,0.851074821152942,0.446060146740316,1,21,positive regulation of interleukin-1 beta production,BP,IFI16
12646,GO:0050850,0.851874429795225,0.44392016025169,1,22,positive regulation of calcium-mediated signaling,BP,PKD2
4557,GO:0010638,0.852243336002005,0.189966961376551,38,513,positive regulation of organelle organization,BP,NOS1;ERCC1;RAPGEF3;WIPF1;BNIP3;DLG1;SDC1;PAK1;EPHA1;RAC2;FYCO1;AKAP9;ATRX;PFN2;FHOD1;CEP120;LMAN1;LRP5;VPS11;F2RL1;PHF1;ASAP1;JMY;BOK;PPP1R10;SPIRE1;SH3PXD2B;NCKAP1;CCDC88A;LPAR1;ARPC1A;IGF2;MOAP1;DDHD2;WASL;TET1;FAM162A;JARID2
7483,GO:0031647,0.852297940835182,0.218255865473635,14,211,regulation of protein stability,BP,TSPAN1;PRNP;CRTAP;ASPH;BTRC;PFN2;SOX4;NLK;DVL1;VPS11;PER3;XBP1;SEL1L;WFS1
10407,GO:0043242,0.852775969466114,0.310119998766382,3,48,negative regulation of protein complex disassembly,BP,TTBK2;TMOD2;TWF2
260,GO:0000726,0.852844083487663,0.285013114300756,4,74,non-recombinational repair,BP,ERCC1;HMGA2;PARP9;POLL
6827,GO:0030286,0.852954798789915,0.350531997874619,2,34,dynein complex,CC,NUDCD3;WDR60
7219,GO:0031113,0.853199964417426,0.349527114840544,2,36,regulation of microtubule polymerization,BP,PAK1;AKAP9
5885,GO:0018023,0.853346146683568,0.349009088439163,2,37,peptidyl-lysine trimethylation,BP,ATRX;ARID4A
1382,GO:0003281,0.853643215030316,0.308733784468229,3,48,ventricular septum development,BP,LTBP1;TGFBR2;SOX4
8099,GO:0032784,0.853915660880444,0.347314270124044,2,40,regulation of DNA-templated transcription, elongation,BP,ERCC6;EAPP
9383,GO:0035914,0.8541240961156,0.347677336508499,2,37,skeletal muscle cell differentiation,BP,MEF2D;TBX1
18479,GO:1903580,0.854538696589855,0.439442253457634,1,21,positive regulation of ATP metabolic process,BP,TMSB4X
7716,GO:0032205,0.854621711836751,0.347375520252594,2,35,negative regulation of telomere maintenance,BP,ERCC1;XRN1
1131,GO:0002720,0.854653524816034,0.438035495456244,1,23,positive regulation of cytokine production involved in immune response,BP,F2RL1
17345,GO:1900027,0.854810466316089,0.43773341068467,1,23,regulation of ruffle assembly,BP,PFN2
11846,GO:0046824,0.855031649197054,0.306014218894318,3,51,positive regulation of nucleocytoplasmic transport,BP,RAPGEF3;EFCAB7;TMEM173
2495,GO:0005743,0.855274504086477,0.198049506432826,23,407,mitochondrial inner membrane,CC,HADH;IDH2;NME4;ACAD11;OCIAD2;MRPS6;COX18;TST;SLC25A4;NDUFV3;CPT2;CRLS1;BOK;NIPSNAP1;NDUFA4L2;BCL2L1;CRAT;MICU3;SLC25A30;SLC25A43;COQ2;PSEN2;CDS2
19814,GO:2000272,0.855349289164614,0.437881212669686,1,21,negative regulation of signaling receptor activity,BP,SNX6
1360,GO:0003231,0.855373054097803,0.266405278839759,5,76,cardiac ventricle development,BP,LTBP1;TGFBR2;FKBP1A;SOX4;CHD7
10242,GO:0042974,0.855921671736993,0.43746124819796,1,20,retinoic acid receptor binding,MF,PPARG
20274,GO:2001242,0.856022323461197,0.24413878729751,7,127,regulation of intrinsic apoptotic signaling pathway,BP,DDIT3;CD44;BOK;NACC2;BCL2L1;XBP1;WFS1
13118,GO:0051654,0.856196576166492,0.436929704100888,1,20,establishment of mitochondrion localization,BP,MAP1B
9260,GO:0035666,0.856458605067492,0.434033086817023,1,24,TRIF-dependent toll-like receptor signaling pathway,BP,FADD
721,GO:0001947,0.856484051083932,0.344170577904559,2,35,heart looping,BP,TGFBR2;PKD2
4220,GO:0009394,0.856612241293935,0.432044294618204,1,28,2'-deoxyribonucleotide metabolic process,BP,AK9
2979,GO:0006521,0.856624441959182,0.340771411814438,2,51,regulation of cellular amino acid metabolic process,BP,PSMD2;PSMD7
5659,GO:0016763,0.856765216699167,0.342416625477174,2,40,transferase activity, transferring pentosyl groups,MF,NAPRT;PARP9
7595,GO:0031966,0.85723832030938,0.184909373600725,36,578,mitochondrial membrane,CC,CYP27B1;FAM210B;HADH;SNPH;ARMCX2;BNIP3;IDH2;NME4;ACAD11;BNIP3L;OCIAD2;SPATA18;MRPS6;COX18;TST;SLC25A4;NDUFV3;CPT2;CRLS1;BOK;NIPSNAP1;NDUFA4L2;BPHL;BCL2L1;CRAT;MICU3;SFXN3;SLC25A30;SLC25A43;MOAP1;TMEM173;COQ2;ARMCX3;PSEN2;CDS2;SLC44A1
8079,GO:0032760,0.857554469280011,0.341518651657458,2,38,positive regulation of tumor necrosis factor production,BP,NFATC4;FADD
2643,GO:0005979,0.857634387845428,0.435748917885763,1,18,regulation of glycogen biosynthetic process,BP,IGF2
4777,GO:0010962,0.857634387845428,0.435748917885763,1,18,regulation of glucan biosynthetic process,BP,IGF2
636,GO:0001825,0.857711269774633,0.432683803215745,1,22,blastocyst formation,BP,TET1
11427,GO:0045840,0.857938124186512,0.34085470406669,2,38,positive regulation of mitotic nuclear division,BP,LRP5;IGF2
4656,GO:0010800,0.858386513032321,0.43198966928393,1,21,positive regulation of peptidyl-threonine phosphorylation,BP,CEMIP
13825,GO:0060421,0.858502183409045,0.432449893529315,1,20,positive regulation of heart growth,BP,FGFR1
17342,GO:1900024,0.859073159472646,0.338647785791377,2,39,regulation of substrate adhesion-dependent cell spreading,BP,POSTN;NET1
16117,GO:0090100,0.859559494097715,0.275324568738122,4,67,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,ACVR2B;FERMT1;ACVR1B;RNF165
19815,GO:2000273,0.859635081942942,0.428926060690306,1,22,positive regulation of signaling receptor activity,BP,NEURL1
14036,GO:0060765,0.859957995690699,0.428292630879405,1,22,regulation of androgen receptor signaling pathway,BP,FOXP1
19216,GO:1905332,0.860018300027889,0.428796314146209,1,21,positive regulation of morphogenesis of an epithelium,BP,WNT2B
785,GO:0002042,0.860163650092115,0.337240957259072,2,37,cell migration involved in sprouting angiogenesis,BP,SRPX2;AKT3
10890,GO:0044430,0.860374990865643,0.165636368065038,96,1192,cytoskeletal part,CC,CLIP2;BBS2;HECW2;MAP2K1;RAPGEF3;MST1R;WDR66;MAP1B;SNTB2;CAPN2;BRSK1;WIPF1;SNPH;DYSF;FYN;MYH15;KIF13B;DLG1;PODXL;ESPN;TTBK2;SEPT10;PAK1;CEP170;NEK9;NUDCD3;SHANK2;RAC2;PTPN12;RGS14;PKD2;PRKACB;AKAP9;RAB11FIP4;ATF4;KIF21B;TMOD2;TACC1;PITPNM1;FHOD1;CEP120;FERMT1;GSDMC;OBSL1;FAM110C;DVL1;MAP6;TWF2;CLTCL1;RANBP9;ZNF322;ACOT13;ADGRB2;CDC42BPA;PROCR;PHF1;ASAP1;PRKAR1A;SPRY2;SEPT5;BEX4;ENKD1;PSKH1;MVB12A;MARK4;MTA1;BCL2L1;MYH16;MAP2K2;TUBG2;NAV1;SH3PXD2B;NCKAP1;CCDC88A;CCSAP;PRKACA;NEK6;TMSB4X;TBL1X;NIT2;ARPC1A;TMEM63A;USP20;EVI5;ADAM8;WDR60;MPLKIP;DDHD2;WASL;HSPA2;FLNB;PSEN2;KAT2B;SEPT6;REEP3;GNAI1
13022,GO:0051457,0.860409900078245,0.427404865621989,1,22,maintenance of protein location in nucleus,BP,SOX4
15757,GO:0072347,0.860532879168415,0.336345656921648,2,38,response to anesthetic,BP,DNMT3A;FADD
8014,GO:0032647,0.860686710180519,0.427482521473669,1,21,regulation of interferon-alpha production,BP,PTPRS
12547,GO:0050699,0.860964424464822,0.426313414225504,1,22,WW domain binding,MF,TCEAL8
17825,GO:1901983,0.861140531244656,0.295326512123816,3,57,regulation of protein acetylation,BP,NOS1;RAPGEF3;SOX4
9102,GO:0035371,0.861144017834422,0.428878832549045,1,18,microtubule plus-end,CC,CLIP2
10990,GO:0044786,0.861330221261092,0.295018051770281,3,57,cell cycle DNA replication,BP,FGFR1;ATRX;E2F7
2788,GO:0006221,0.861494123394071,0.422490051077768,1,28,pyrimidine nucleotide biosynthetic process,BP,NME4
8885,GO:0034698,0.861767932535104,0.425350209594512,1,21,response to gonadotropin,BP,ASNS
13581,GO:0060048,0.861798073690339,0.272056213053954,4,65,cardiac muscle contraction,BP,NOS1;DLG1;PDE5A;PRKACA
8139,GO:0032839,0.861803880236848,0.424656740878802,1,22,dendrite cytoplasm,CC,DLG4
1404,GO:0003338,0.862706285325667,0.424179403444442,1,20,metanephros morphogenesis,BP,PKD2
10180,GO:0042771,0.86278874752063,0.331325838314556,2,43,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,CD44;IFI16
3288,GO:0006977,0.862951274722898,0.292143160459605,3,59,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,SOX4;E2F7;CNOT11
14032,GO:0060761,0.863034093853667,0.331088692779539,2,42,negative regulation of response to cytokine stimulus,BP,F2RL1;PPARG
14278,GO:0061351,0.863243717960327,0.254431591883895,5,79,neural precursor cell proliferation,BP,WNT7A;FGFR1;CEP120;PTPRZ1;CTSZ
23,GO:0000045,0.863295170421325,0.25400781754489,5,84,autophagosome assembly,BP,TBC1D14;ULK2;GABARAPL2;RAB1A;RB1CC1
3562,GO:0007602,0.863368556885732,0.420987603588209,1,23,phototransduction,BP,PITPNM1
12369,GO:0048753,0.863986324191296,0.419757572106809,1,23,pigment granule organization,BP,AP3D1
3345,GO:0007063,0.86420079952227,0.420519773080308,1,21,regulation of sister chromatid cohesion,BP,ATRX
4820,GO:0014014,0.864405384380081,0.419488639087772,1,22,negative regulation of gliogenesis,BP,IDH2
2851,GO:0006336,0.864486364732295,0.327213635512586,2,50,DNA replication-independent nucleosome assembly,BP,ATRX;RSF1
4258,GO:0009593,0.864541133472904,0.417655881971171,1,25,detection of chemical stimulus,BP,ABCG1
18111,GO:1902751,0.864703360968412,0.418326211030595,1,23,positive regulation of cell cycle G2/M phase transition,BP,CCND1
17607,GO:1901292,0.864761789210492,0.225387734329939,8,129,nucleoside phosphate catabolic process,BP,XDH;NT5E;RAPGEF3;DHTKD1;PGM1;LDHA;PPARA;PDE5A
15202,GO:0071347,0.86497776250914,0.23139118499987,7,128,cellular response to interleukin-1,BP,PSMD2;MAPK13;ADAMTS7;HYAL1;BTRC;PSMD7;IL1RAP
11484,GO:0045943,0.864979798265553,0.418963460290698,1,21,positive regulation of transcription by RNA polymerase I,BP,ATF4
9898,GO:0042181,0.86526495247899,0.415769256349608,1,26,ketone biosynthetic process,BP,COQ2
5399,GO:0016236,0.865418782029514,0.19288739386377,18,270,macroautophagy,BP,TBC1D14;BNIP3;SPTLC2;WDFY3;BNIP3L;FYCO1;SNX14;ULK2;CSNK2A1;QSOX1;MVB12A;GABARAPL2;EPM2A;PRKACA;RAB1A;SNX6;ATP6V1B2;RB1CC1
3060,GO:0006622,0.865464922517427,0.417991881167107,1,21,protein targeting to lysosome,BP,SORL1
1486,GO:0003823,0.865488949414153,0.416234792319477,1,24,antigen binding,MF,ITGA4
11368,GO:0045727,0.865558709029983,0.239258576608171,6,105,positive regulation of translation,BP,IMPACT;ITGA2;SOX4;PAIP1;PPARG;DNAJC3
7440,GO:0031570,0.865668511431023,0.213942579928577,10,157,DNA integrity checkpoint,BP,CCND1;BRSK1;XPC;HMGA2;SOX4;ETAA1;TAOK1;PPP1R10;E2F7;CNOT11
5507,GO:0016458,0.865744320080208,0.198240809843363,15,237,gene silencing,BP,MAP2K1;EGFR;SCMH1;TNRC6B;UHRF2;H2AFJ;MAP2K2;RMRP;PUM2;PPARG;TNRC6C;TET1;ZC3H7A;CNOT11;DNMT3A
4088,GO:0009142,0.865797075826471,0.230514429445706,7,119,nucleoside triphosphate biosynthetic process,BP,DHTKD1;PGM1;NME4;LDHA;PPARA;TMSB4X;AK9
7186,GO:0031072,0.865858304973945,0.238953624791617,6,102,heat shock protein binding,MF,FKBP1A;DNAJB9;CSNK2A1;HSPA13;FICD;HSPA2
4044,GO:0009081,0.86590031092975,0.415927985133871,1,23,branched-chain amino acid metabolic process,BP,HIBADH
11847,GO:0046825,0.866036653084649,0.326435440349627,2,39,regulation of protein export from nucleus,BP,RAPGEF3;SOX4
13183,GO:0051788,0.866190445985553,0.415912317769524,1,22,response to misfolded protein,BP,KLHL15
14807,GO:0070534,0.866370179778979,0.325620240159312,2,40,protein K63-linked ubiquitination,BP,UBE2G1;TRIM5
10809,GO:0044295,0.866375344284063,0.416851127101756,1,20,axonal growth cone,CC,PTCH1
12533,GO:0050681,0.866408821078788,0.325775944109248,2,39,androgen receptor binding,MF,PKN1;FOXP1
17770,GO:1901797,0.867016089683063,0.412687388091287,1,25,negative regulation of signal transduction by p53 class mediator,BP,CD44
4028,GO:0009060,0.867522062731316,0.283776012076818,3,68,aerobic respiration,BP,DHTKD1;BNIP3;IDH2
417,GO:0001104,0.867714544706982,0.247543751446305,5,81,RNA polymerase II transcription cofactor activity,MF,ZMYND8;SOX12;SOX4;PHF12;CITED4
13106,GO:0051640,0.868205215019805,0.17052662027212,39,522,organelle localization,BP,RAB3B;BBS2;MAP1B;EXOC2;SNPH;DLG1;TTBK2;SEC23A;RAC2;MCFD2;FYCO1;AKAP9;VAMP2;PFN2;FHOD1;CEP120;LMAN1;NLGN2;MAP6;VPS11;RIMS3;SYTL1;COPG1;FNBP1L;SPRY2;SEPT5;MARK4;SPIRE1;STX10;TCTN1;PRKACA;RAB1A;CTSZ;AP3D1;MAP4K2;ESYT3;ITGA4;WASL;SYT2
3904,GO:0008543,0.868412013541835,0.246286637283808,5,84,fibroblast growth factor receptor signaling pathway,BP,APLN;FGFR1;GALNT3;FAM20C;SPRY2
15036,GO:0070979,0.86853097166277,0.408778630492976,1,27,protein K11-linked ubiquitination,BP,ANAPC13
17688,GO:1901566,0.868619256489872,0.154752611751898,110,1529,organonitrogen compound biosynthetic process,BP,TNIP1;NT5E;NOS1;NEURL1;CBS;ADCY7;GPT2;MAP2K1;LMF1;TK2;NAPRT;LY6K;DHTKD1;EIF4EBP1;B4GALT6;CARS;EGFR;PSAT1;UBE2J1;ELOVL1;PGM1;ADAMTS7;B3GNT3;IDH2;GPC4;GLUL;IGF2BP3;SPTLC2;ACOT7;RSAD1;NMRK1;NME4;CEMIP;SDC1;ARG2;NAGS;TRIB2;HAGH;IMPACT;APOE;MCFD2;LDHA;ST3GAL5;AKAP9;ABTB1;ATF4;PPARA;ABCA7;PIGH;EIF4E3;ASNS;AARS;UROS;HYAL1;LPCAT1;ITGA2;GALNT3;CHAC1;SOX4;GAMT;KDSR;LMAN1;MRPS6;XRN1;TNRC6B;CTH;ABHD17C;NTNG1;GFPT1;MEX3C;ZDHHC2;ALDH7A1;CSNK2A1;PTHLH;PARP9;CPEB4;ATXN2;GLUD1;AZIN2;PANK4;MAP2K2;PAIP1;PUM2;SAMD8;ADAMTSL1;TMSB4X;TIMP2;EIF2AK2;ZDHHC1;SRD5A3;IL1RAP;ST6GALNAC2;CARD11;SECISBP2L;PPARG;GRB7;AK9;GARS;EEF2K;TNRC6C;TET1;DNAJC3;ELOVL4;ADCY1;CNOT11;PANK1;SLC44A1;ADNP;STT3B;ALAS1
2844,GO:0006312,0.869058281791179,0.410114334665851,1,22,mitotic recombination,BP,ERCC1
7989,GO:0032607,0.869059814257856,0.410111218971566,1,22,interferon-alpha production,BP,PTPRS
20275,GO:2001243,0.869151515260998,0.259400323029298,4,79,negative regulation of intrinsic apoptotic signaling pathway,BP,CD44;BCL2L1;XBP1;WFS1
2962,GO:0006497,0.869357003501798,0.233549460158156,6,108,protein lipidation,BP,LY6K;PIGH;ABHD17C;NTNG1;ZDHHC2;ZDHHC1
19801,GO:2000249,0.86942322010626,0.408285319647768,1,24,regulation of actin cytoskeleton reorganization,BP,RAPGEF3
14402,GO:0061659,0.869466153512485,0.196008911904966,14,203,ubiquitin-like protein ligase activity,MF,SMURF2;GID4;NEURL1;HECW2;HLTF;UBE2J1;RAG1;UBE2G1;BTRC;UHRF2;RNF165;ANKIB1;PJA2;RNF180
19770,GO:2000179,0.869611810366215,0.409611129780035,1,21,positive regulation of neural precursor cell proliferation,BP,CTSZ
14144,GO:0061014,0.869968151294422,0.320180212713307,2,36,positive regulation of mRNA catabolic process,BP,TNRC6B;TNRC6C
6919,GO:0030511,0.870054410499341,0.408085106177874,1,22,positive regulation of transforming growth factor beta receptor signaling pathway,BP,FERMT1
18591,GO:1903846,0.870054410499341,0.408085106177874,1,22,positive regulation of cellular response to transforming growth factor beta stimulus,BP,FERMT1
8015,GO:0032648,0.870535804368317,0.317980611546691,2,41,regulation of interferon-beta production,BP,PTPRS;RNF135
798,GO:0002066,0.870819237483511,0.317906495395562,2,39,columnar/cuboidal epithelial cell development,BP,SLITRK6;FGFR1
105,GO:0000217,0.871077577591295,0.405424813781491,1,23,DNA secondary structure binding,MF,XPC
7354,GO:0031396,0.871153491506547,0.206318892936946,10,162,regulation of protein ubiquitination,BP,FYN;FKBP1A;SOX4;FBXO2;TRIB3;MTA1;RAB1A;WFS1;PRMT3;UFL1
4313,GO:0009791,0.871692482747148,0.241861440492906,5,76,post-embryonic development,BP,ERCC1;ACVR2B;ATRX;ARID5B;SLC18A2
865,GO:0002200,0.871942475638959,0.277915440967636,3,54,somatic diversification of immune receptors,BP,ERCC1;RAG1;POLL
3240,GO:0006895,0.872313964313514,0.405526996248035,1,19,Golgi to endosome transport,BP,VPS13A
7873,GO:0032434,0.873066026388622,0.228185245880651,6,105,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,TRIB2;DVL1;TRIB3;ANKIB1;RNF180;UFL1
138,GO:0000288,0.873206260010643,0.253501013170465,4,72,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,TNRC6B;PAIP1;TNRC6C;CNOT11
20097,GO:2000765,0.87323650036605,0.400981201590486,1,23,regulation of cytoplasmic translation,BP,CPEB4
13806,GO:0060395,0.873355474223173,0.313816994703614,2,37,SMAD protein signal transduction,BP,WWTR1;SLC33A1
12108,GO:0048147,0.873389315937114,0.400146220762876,1,24,negative regulation of fibroblast proliferation,BP,PPARG
10507,GO:0043409,0.873510422024838,0.212988299602925,8,130,negative regulation of MAPK cascade,BP,TNIP1;SORL1;DLG1;APOE;RGS14;RANBP9;F2RL1;SPRY2
5628,GO:0016706,0.874255281440134,0.311705161653166,2,39,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,ASPH;TET1
14155,GO:0061036,0.874350690576801,0.39986404816665,1,21,positive regulation of cartilage development,BP,LOXL2
3779,GO:0008334,0.874368065726553,0.398117837177583,1,24,histone mRNA metabolic process,BP,XRN1
15001,GO:0070925,0.874404901426715,0.159409297938729,48,636,organelle assembly,BP,NEURL1;BBS2;WWTR1;TBC1D14;EVI5L;TTBK2;UNC119B;SEPT10;SDC1;ATXN10;NUDCD3;SHANK2;OBSCN;AKAP9;TMOD2;PTPDC1;ULK2;CEP120;OBSL1;NLGN2;VPS11;RFX2;FNBP1L;ASAP1;PRKAR1A;ATXN2;SEPT5;MVB12A;MARK4;GOLGA2P5;SPATA6;TUBG2;TCTN1;SH3PXD2B;GABARAPL2;PUM2;CCDC88A;CCSAP;PRKACA;NEK6;RAB1A;LAMA5;GRB7;WDR60;TMEM107;KAT2B;SEPT6;RB1CC1
7768,GO:0032288,0.87471433147402,0.399796451460098,1,20,myelin assembly,BP,EPB41L3
2534,GO:0005790,0.874878208819644,0.397576403694468,1,23,smooth endoplasmic reticulum,CC,DNAJC3
8905,GO:0034724,0.875316590419893,0.307711822909709,2,51,DNA replication-independent nucleosome organization,BP,ATRX;RSF1
8752,GO:0034404,0.875434235593577,0.200353667000654,10,165,nucleobase-containing small molecule biosynthetic process,BP,XDH;NT5E;RAPGEF3;TK2;DHTKD1;PGM1;NME4;LDHA;PPARA;PDE5A
7356,GO:0031398,0.875502665091263,0.235055599241771,5,91,positive regulation of protein ubiquitination,BP,FKBP1A;TRIB3;MTA1;RAB1A;WFS1
489,GO:0001541,0.875753588399105,0.308350343668633,2,42,ovarian follicle development,BP,MMP14;BCL2L1
11426,GO:0045839,0.876104556847561,0.307710879290506,2,42,negative regulation of mitotic nuclear division,BP,ATRX;TOM1L2
7695,GO:0032148,0.876136717356278,0.394951066515576,1,23,activation of protein kinase B activity,BP,CCDC88A
3656,GO:0008137,0.876175380643365,0.390006855012385,1,38,NADH dehydrogenase (ubiquinone) activity,MF,NDUFV3
12445,GO:0050136,0.876175380643365,0.390006855012385,1,38,NADH dehydrogenase (quinone) activity,MF,NDUFV3
16198,GO:0090224,0.876234189928972,0.308338210920583,2,38,regulation of spindle organization,BP,CCSAP;GNAI1
9788,GO:0040001,0.876290573992633,0.395196759767729,1,22,establishment of mitotic spindle localization,BP,SPRY2
12381,GO:0048786,0.876419848828542,0.397000590016153,1,19,presynaptic active zone,CC,RIMS3
2825,GO:0006289,0.876435052467759,0.222855794208144,6,113,nucleotide-excision repair,BP,ERCC1;ERCC6;XPC;DDB2;TCEA1;POLL
15799,GO:0072431,0.877153157528065,0.268455251364286,3,60,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,SOX4;E2F7;CNOT11
17983,GO:1902400,0.877153157528065,0.268455251364286,3,60,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,SOX4;E2F7;CNOT11
4486,GO:0010508,0.877257988975144,0.222301203847995,6,97,positive regulation of autophagy,BP,TRIM65;BNIP3;SPTLC2;BNIP3L;FYCO1;EPM2A
6201,GO:0019692,0.87731359665467,0.389595486170383,1,30,deoxyribose phosphate metabolic process,BP,AK9
8382,GO:0033280,0.877494720444762,0.392670613003017,1,22,response to vitamin D,BP,CYP27B1
9473,GO:0036092,0.877556288650892,0.307306888068978,2,33,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGFR1;INPP4A
14958,GO:0070849,0.877579350650469,0.305645545045749,2,39,response to epidermal growth factor,BP,EGFR;PTPN12
13698,GO:0060249,0.877628805902541,0.17567228587129,19,286,anatomical structure homeostasis,BP,ERCC1;F2R;BBS2;EGFR;STK39;ERCC6;RAC2;ACP5;TUB;LPCAT1;ATRX;NELL2;XRN1;PPP1R10;UBASH3B;NOP10;ADAM8;AKT3;IL20RB
14969,GO:0070873,0.877630914507864,0.393695319007708,1,20,regulation of glycogen metabolic process,BP,IGF2
5474,GO:0016407,0.877784532286651,0.231705766013272,5,88,acetyltransferase activity,MF,NAGS;LPCAT4;LPCAT1;CRAT;KAT2B
1858,GO:0004521,0.878024765664996,0.30333740902827,2,47,endoribonuclease activity,MF,ENDOV;LACTB2
10137,GO:0042698,0.878236694059227,0.304440073888571,2,39,ovulation cycle,BP,EGFR;ADNP
2189,GO:0005048,0.878421312876318,0.303880767755876,2,40,signal sequence binding,MF,CEMIP;KDELR3
14288,GO:0061371,0.878688160756333,0.304088545362683,2,37,determination of heart left/right asymmetry,BP,TGFBR2;PKD2
7897,GO:0032465,0.878692713014704,0.245066273543676,4,68,regulation of cytokinesis,BP,RAB11FIP4;SDCCAG3;BCL2L1;E2F7
3695,GO:0008200,0.879030348973128,0.388344993138018,1,24,ion channel inhibitor activity,MF,SLC30A1
5744,GO:0016891,0.879177004470992,0.386715180917919,1,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,ENDOV
11675,GO:0046456,0.879364328655658,0.386318455383792,1,27,icosanoid biosynthetic process,BP,LTA4H
15240,GO:0071396,0.879463331272378,0.163759131507338,28,389,cellular response to lipid,BP,TNIP1;PCK2;CYP27B1;NR1D1;NFATC4;FAM210B;EIF4EBP1;EGFR;PAK1;PPARA;ITGA2;PTK6;TRIM5;TWF2;THRA;XBP1;RET;NR2F6;LPAR1;PPARG;ALDH1A2;TBX1;LRP6;FOXP1;PTCH1;ADCY1;UFL1;GNAI1
18352,GO:1903322,0.879579432076637,0.218373869604181,6,107,positive regulation of protein modification by small protein conjugation or removal,BP,TNIP1;FKBP1A;TRIB3;MTA1;RAB1A;WFS1
3048,GO:0006605,0.87990502258219,0.168626812496258,22,366,protein targeting,BP,SORL1;PRNP;LTBP2;ANK3;FYN;KIF13B;GDI1;CEMIP;STOM;PAK1;RAC2;BNIP3L;LONP2;VPS13A;VPS11;SEC63;ZDHHC2;ZDHHC1;AP3D1;TMEM50B;SSR3;SSR1
11734,GO:0046545,0.880294620988108,0.242228261255867,4,71,development of primary female sexual characteristics,BP,MMP14;ACVR1B;BCL2L1;ARID5B
17832,GO:1901991,0.880780390233772,0.185920768153858,12,202,negative regulation of mitotic cell cycle phase transition,BP,FHL1;CCND1;PSMD2;BRSK1;PKD2;HMGA2;SOX4;TAOK1;PSMD7;NACC2;E2F7;CNOT11
12942,GO:0051301,0.880981646879153,0.156169464436839,37,508,cell division,BP,ETV5;PGF;CCND1;WWTR1;CCNG2;ANK3;SNX9;WNT7A;SEPT10;PAK1;NEK9;CCND2;RGS14;RAB11FIP4;HMGA2;FGFR1;TACC1;SDCCAG3;SEPT5;MARK4;ZNF449;BCL2L1;ANAPC13;SPIRE1;PAK6;CCSAP;NEK6;RHOBTB1;IGF2;EVI5;MPLKIP;WASL;E2F7;PTCH1;SEPT6;REEP3;GNAI1
8736,GO:0034383,0.881874122036314,0.381816410751405,1,25,low-density lipoprotein particle clearance,BP,AP2A2
9946,GO:0042306,0.881906576563086,0.297238843776634,2,41,regulation of protein import into nucleus,BP,EFCAB7;TMEM173
11525,GO:0046039,0.88192571587938,0.380863174431278,1,27,GTP metabolic process,BP,NME4
15412,GO:0071674,0.881997321643213,0.380709840340288,1,27,mononuclear cell migration,BP,MOSPD2
2907,GO:0006417,0.882060798668307,0.162081205102481,26,387,regulation of translation,BP,NEURL1;MAP2K1;EIF4EBP1;EGFR;IGF2BP3;IMPACT;ATF4;EIF4E3;ITGA2;SOX4;XRN1;TNRC6B;MEX3C;CPEB4;ATXN2;MAP2K2;PAIP1;PUM2;EIF2AK2;SECISBP2L;PPARG;GRB7;TNRC6C;ZC3H7A;DNAJC3;CNOT11
5672,GO:0016782,0.882107992935564,0.295966603121981,2,46,transferase activity, transferring sulfur-containing groups,MF,TST;SUGCT
11478,GO:0045934,0.88214512388379,0.142532874484247,84,1095,negative regulation of nucleobase-containing compound metabolic process,BP,SMURF2;ERCC1;ZMYND8;CCND1;CTNNBIP1;VLDLR;NR1D1;NFATC4;ZC3H6;ACVR2B;SALL2;WWTR1;PEG3;DDIT3;ELK3;SCMH1;DLG1;DNAJB5;SHC1;DKK1;DAP;IMPACT;AKAP9;HMGA2;PPARA;WWC3;FGFR1;TCFL5;BTRC;ATRX;ZNF692;ATF7IP;RCOR1;MDFI;XRN1;HES2;PHF12;KLF12;TRIB3;PRDX5;UHRF2;AEBP1;PARP9;NACC2;THRA;TSHZ1;PER3;MTA1;H2AFJ;SATB1;PAIP1;TLE4;LOXL2;RMRP;EAPP;CBX7;IFI16;NR2F6;ZNF354A;TBL1X;RNF169;ARID4A;TENM2;IGF2;PPARG;SNX6;RSF1;WFS1;DEPDC1;PHF21A;ZNF568;FZD8;ARID5B;MAGEF1;E2F7;TET1;DEDD2;FOXP1;ZBTB33;PTCH1;JARID2;KLHL15;MXD4;DNMT3A
74,GO:0000151,0.882328027148089,0.171183482200367,18,266,ubiquitin ligase complex,CC,SMURF2;BTBD2;RBCK1;ABTB1;DCAF10;BTRC;FBXO2;DDB2;BTBD3;PHC3;KLHL29;ANAPC13;ANKIB1;UBE2E1;SEL1L;CBX7;KLHL15;FBXL5
725,GO:0001954,0.882924229399702,0.296004243398266,2,38,positive regulation of cell-matrix adhesion,BP,EPHA1;FERMT1
7801,GO:0032350,0.883136913729267,0.379581299729865,1,24,regulation of hormone metabolic process,BP,CYP27B1
12638,GO:0050830,0.883246046209768,0.376127361619564,1,33,defense response to Gram-positive bacterium,BP,ACP5
3346,GO:0007064,0.883324633959111,0.380261860624605,1,22,mitotic sister chromatid cohesion,BP,ATRX
6921,GO:0030513,0.883437537346649,0.380018570880472,1,22,positive regulation of BMP signaling pathway,BP,RNF165
11353,GO:0045685,0.883451431105338,0.294168484194508,2,42,regulation of glial cell differentiation,BP,SERPINE2;PPARG
11265,GO:0045540,0.883508495956185,0.294259079627241,2,41,regulation of cholesterol biosynthetic process,BP,APOE;ABCG1
41,GO:0000083,0.883681293015504,0.377932957922892,1,25,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,E2F7
6781,GO:0030216,0.883754126817599,0.193002802299441,9,152,keratinocyte differentiation,BP,CYP27B1;MAP2K1;ALOX15B;PRR9;CTSL;PCSK6;PPL;PRSS8;FLNB
6593,GO:0022607,0.883798588846905,0.133906971513877,174,2212,cellular component assembly,BP,ERCC1;ZMYND8;SORL1;FLNC;NEURL1;CTNNBIP1;ITGA6;MMP1;H1F0;PRNP;ADGRF1;ITGB4;BBS2;THBS2;RAPGEF3;THSD4;GPX3;WWTR1;SSH1;DDIT3;KCNG1;SOX12;SDK2;EXOC2;CRTC1;ADGRL1;WIPF1;TBC1D14;ANK3;LOXL1;PARVB;ARAP1;DLG1;DLG4;PLXNB3;SNX9;TYSND1;PODXL;TGM2;ESPN;XPC;GLUL;EVI5L;WNT7A;TTBK2;SEC23A;UNC119B;SEPT10;SDC1;STOM;DKK1;PAK1;ATXN10;CBR4;NUDCD3;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;OBSCN;APOE;FKBP1A;ANGPTL4;MCFD2;PKD2;PRKACB;IDE;AKAP9;HMGA2;ABCA7;LPAR3;TMOD2;PTPDC1;ITGB5;HYAL1;ITGA2;VAMP2;ULK2;ATRX;PFN2;FHOD1;ITPR3;DDB2;CEP120;OBSL1;LMAN1;DMXL2;ATF7IP;FAM110C;SLC9A3R2;DVL1;MMP14;ANXA6;NLGN2;CTH;TWF2;COX18;RABGGTA;CLTCL1;TPBG;VPS11;RANBP9;WASF3;ACOT13;RFX2;ADGRB2;SLK;FNBP1L;F2RL1;ASAP1;NDUFV3;PRKAR1A;MSRB2;JMY;BOK;FCHO2;ATXN2;NACC2;SEPT5;THRA;COL6A1;MVB12A;MARK4;WASF2;SKAP2;GOLGA2P5;SPIRE1;NFU1;REC8;TLE4;SPATA6;TUBG2;TCTN1;MLH3;SH3PXD2B;ZFYVE9;NCKAP1;GABARAPL2;DOCK11;PUM2;COL1A2;CCDC88A;CCSAP;PRKACA;NEK6;TMSB4X;EIF2AK2;RAB1A;EPB41L3;RHOBTB1;IL1RAP;FCHO1;LPAR1;CTSZ;ARPC1A;TENM2;LAMA5;GRB7;SRPX2;RSF1;WDR60;TMEM107;WASL;HSPA2;EEF2K;SIGMAR1;KCTD18;KAT2B;SEPT6;ADNP;LRP4;RB1CC1;FADD
15792,GO:0072413,0.88408893710904,0.256533760310735,3,61,signal transduction involved in mitotic cell cycle checkpoint,BP,SOX4;E2F7;CNOT11
17984,GO:1902402,0.88408893710904,0.256533760310735,3,61,signal transduction involved in mitotic DNA damage checkpoint,BP,SOX4;E2F7;CNOT11
17985,GO:1902403,0.88408893710904,0.256533760310735,3,61,signal transduction involved in mitotic DNA integrity checkpoint,BP,SOX4;E2F7;CNOT11
18145,GO:1902882,0.884291043241951,0.256186233186573,3,61,regulation of response to oxidative stress,BP,MCTP1;ATF4;ENDOG
10676,GO:0043921,0.884329640298142,0.377007806536392,1,24,modulation by host of viral transcription,BP,HMGA2
13337,GO:0052312,0.884329640298142,0.377007806536392,1,24,modulation of transcription in other organism involved in symbiotic interaction,BP,HMGA2
13355,GO:0052472,0.884329640298142,0.377007806536392,1,24,modulation by host of symbiont transcription,BP,HMGA2
19106,GO:1905037,0.884605191199642,0.221158032161628,5,87,autophagosome organization,BP,TBC1D14;ULK2;GABARAPL2;RAB1A;RB1CC1
1147,GO:0002755,0.884658981219604,0.376294933670665,1,24,MyD88-dependent toll-like receptor signaling pathway,BP,TNIP1
3141,GO:0006734,0.884662152122979,0.375375292882922,1,26,NADH metabolic process,BP,PCK2
12351,GO:0048713,0.884942490534046,0.375680474747301,1,24,regulation of oligodendrocyte differentiation,BP,PPARG
483,GO:0001533,0.885124199693983,0.290507569193365,2,45,cornified envelope,CC,PRR9;PPL
18524,GO:1903706,0.885590768673548,0.162674977017393,21,332,regulation of hemopoiesis,BP,CTNNBIP1;FAM210B;PSMD2;RAG1;TGFBR2;CEACAM1;TNRC6B;MMP14;CD46;PSMD7;ACVR1B;XBP1;UBASH3B;EIF2AK2;CARD11;AP3D1;ADAM8;TNRC6C;FOXP1;KAT2B;FADD
18104,GO:1902742,0.88564744811834,0.375233198417803,1,22,apoptotic process involved in development,BP,LRP5
13473,GO:0055008,0.885903477661042,0.290928055125333,2,36,cardiac muscle tissue morphogenesis,BP,FKBP1A;CHD7
10468,GO:0043330,0.886572151666841,0.37122217371168,1,26,response to exogenous dsRNA,BP,TMEM173
1148,GO:0002756,0.886737736264236,0.370860547761727,1,26,MyD88-independent toll-like receptor signaling pathway,BP,FADD
11458,GO:0045912,0.886795397910629,0.372163779298987,1,23,negative regulation of carbohydrate metabolic process,BP,PPARA
12713,GO:0050931,0.887321720026054,0.371011991204593,1,23,pigment cell differentiation,BP,AP3D1
11410,GO:0045814,0.88776450480327,0.205501125087993,6,121,negative regulation of gene expression, epigenetic,BP,UHRF2;PHF1;H2AFJ;TET1;JARID2;DNMT3A
12282,GO:0048593,0.888298185781908,0.229616183248722,4,66,camera-type eye morphogenesis,BP,SDK2;LRP5;WNT2B;LRP6
12937,GO:0051294,0.888440122121647,0.368555901556392,1,23,establishment of spindle orientation,BP,SPRY2
15208,GO:0071353,0.888554520491779,0.366876081889508,1,26,cellular response to interleukin-4,BP,XBP1
6863,GO:0030332,0.889085891030765,0.366615667559067,1,24,cyclin binding,MF,PTCH1
3115,GO:0006692,0.889294678250137,0.364840579092968,1,27,prostanoid metabolic process,BP,PTGR2
3116,GO:0006693,0.889294678250137,0.364840579092968,1,27,prostaglandin metabolic process,BP,PTGR2
14109,GO:0060964,0.889851217602038,0.212151252272912,5,103,regulation of gene silencing by miRNA,BP,MAP2K1;EGFR;MAP2K2;PUM2;PPARG
2584,GO:0005876,0.890031379689032,0.246777341668617,3,56,spindle microtubule,CC,TUBG2;CCSAP;TBL1X
5408,GO:0016248,0.890289438991202,0.363478536457317,1,25,channel inhibitor activity,MF,SLC30A1
10560,GO:0043516,0.890382900611796,0.363271164580479,1,25,regulation of DNA damage response, signal transduction by p53 class mediator,BP,CD44
8977,GO:0035066,0.890394083292165,0.362810047134708,1,26,positive regulation of histone acetylation,BP,NOS1
11447,GO:0045893,0.890561445261209,0.13304979067961,83,1058,positive regulation of transcription, DNA-templated,BP,TNIP1;NOS1;F2R;ETV5;ITGA6;NR1D1;NFATC4;MAP2K1;ETV4;SALL2;WWTR1;PEG3;APLN;POU2F2;TEF;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;HLTF;ERCC6;ZNF516;WNT7A;SHC1;CCPG1;PKD2;DDN;HMGA2;ATF4;PPARA;E2F5;EPCAM;NFAT5;BTRC;ATRX;CHURC1;SOX4;FHOD1;ATF7IP;DVL1;LRP5;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;PHF1;CHD7;PARP9;THRA;ACVR1B;NGFR;CHD6;MEF2D;ARF4;XBP1;MAP2K2;RET;EAPP;ETV1;ZNF398;IFI16;TBL1X;ARID4A;EFCAB7;PPARG;CITED4;TBX1;CREB3L2;RSF1;MAML3;FZD8;LRP6;TMEM173;E2F7;TET1;ARMCX3;PTCH1;KAT2B;PBX3;FADD
18428,GO:1903508,0.890561445261209,0.13304979067961,83,1058,positive regulation of nucleic acid-templated transcription,BP,TNIP1;NOS1;F2R;ETV5;ITGA6;NR1D1;NFATC4;MAP2K1;ETV4;SALL2;WWTR1;PEG3;APLN;POU2F2;TEF;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;HLTF;ERCC6;ZNF516;WNT7A;SHC1;CCPG1;PKD2;DDN;HMGA2;ATF4;PPARA;E2F5;EPCAM;NFAT5;BTRC;ATRX;CHURC1;SOX4;FHOD1;ATF7IP;DVL1;LRP5;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;PHF1;CHD7;PARP9;THRA;ACVR1B;NGFR;CHD6;MEF2D;ARF4;XBP1;MAP2K2;RET;EAPP;ETV1;ZNF398;IFI16;TBL1X;ARID4A;EFCAB7;PPARG;CITED4;TBX1;CREB3L2;RSF1;MAML3;FZD8;LRP6;TMEM173;E2F7;TET1;ARMCX3;PTCH1;KAT2B;PBX3;FADD
2867,GO:0006359,0.890869531421622,0.362663720857585,1,24,regulation of transcription by RNA polymerase III,BP,PRDX5
1113,GO:0002702,0.891010787196543,0.27922123454589,2,46,positive regulation of production of molecular mediator of immune response,BP,F2RL1;XBP1
1425,GO:0003382,0.891040516448076,0.363363996648662,1,22,epithelial cell morphogenesis,BP,FLNB
3035,GO:0006584,0.891360131550412,0.360661840896331,1,26,catecholamine metabolic process,BP,RNF180
4290,GO:0009712,0.891360131550412,0.360661840896331,1,26,catechol-containing compound metabolic process,BP,RNF180
4931,GO:0014888,0.891606865973166,0.362101436132431,1,22,striated muscle adaptation,BP,INPP5F
16576,GO:0097366,0.891886940373191,0.360395778860538,1,24,response to bronchodilator,BP,SLC18A2
1555,GO:0003954,0.892187561571839,0.355044097217405,1,40,NADH dehydrogenase activity,MF,NDUFV3
18081,GO:1902680,0.89218908091357,0.131177403010245,83,1059,positive regulation of RNA biosynthetic process,BP,TNIP1;NOS1;F2R;ETV5;ITGA6;NR1D1;NFATC4;MAP2K1;ETV4;SALL2;WWTR1;PEG3;APLN;POU2F2;TEF;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;HLTF;ERCC6;ZNF516;WNT7A;SHC1;CCPG1;PKD2;DDN;HMGA2;ATF4;PPARA;E2F5;EPCAM;NFAT5;BTRC;ATRX;CHURC1;SOX4;FHOD1;ATF7IP;DVL1;LRP5;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;PHF1;CHD7;PARP9;THRA;ACVR1B;NGFR;CHD6;MEF2D;ARF4;XBP1;MAP2K2;RET;EAPP;ETV1;ZNF398;IFI16;TBL1X;ARID4A;EFCAB7;PPARG;CITED4;TBX1;CREB3L2;RSF1;MAML3;FZD8;LRP6;TMEM173;E2F7;TET1;ARMCX3;PTCH1;KAT2B;PBX3;FADD
6259,GO:0019843,0.892344997090149,0.275397181199645,2,56,rRNA binding,MF,MRPS6;TST
19872,GO:2000351,0.892534728999453,0.359462119661667,1,23,regulation of endothelial cell apoptotic process,BP,ANGPTL4
1359,GO:0003230,0.892561491499774,0.360585900081648,1,21,cardiac atrium development,BP,SOX4
17038,GO:0099513,0.892650847913546,0.143031561768889,35,471,polymeric cytoskeletal fiber,CC,CLIP2;MAP1B;SNTB2;WIPF1;SNPH;FYN;KIF13B;DLG1;ESPN;PAK1;CEP170;SHANK2;RAC2;RGS14;PKD2;KIF21B;FERMT1;FAM110C;DVL1;MAP6;TWF2;SPRY2;BEX4;ENKD1;MTA1;MAP2K2;TUBG2;NAV1;NCKAP1;CCSAP;NEK6;TMSB4X;TBL1X;WASL;REEP3
13478,GO:0055013,0.892655715845747,0.2778370086602,2,37,cardiac muscle cell development,BP,PAK1;OBSL1
16874,GO:0098803,0.892680277443184,0.273878594330675,2,66,respiratory chain complex,CC,NDUFV3;NDUFA4L2
11431,GO:0045844,0.892766772342159,0.276944573404101,2,40,positive regulation of striated muscle tissue development,BP,FGFR1;TBX1
12299,GO:0048636,0.892766772342159,0.276944573404101,2,40,positive regulation of muscle organ development,BP,FGFR1;TBX1
17792,GO:1901863,0.892766772342159,0.276944573404101,2,40,positive regulation of muscle tissue development,BP,FGFR1;TBX1
3350,GO:0007077,0.892954623188884,0.276187292286516,2,42,mitotic nuclear envelope disassembly,BP,NEK9;NEK6
7907,GO:0032480,0.893347108257477,0.275074277059845,2,44,negative regulation of type I interferon production,BP,PTPRS;RNF135
4232,GO:0009410,0.893495844859318,0.174954504215927,10,169,response to xenobiotic stimulus,BP,PCK2;EIF4EBP1;EGFR;FKBP1A;PRKACB;BPHL;PPARG;SLC18A2;DNMT3A;FADD
7962,GO:0032561,0.893615778548467,0.15627805548396,18,285,guanyl ribonucleotide binding,MF,RAB3B;PCK2;TGM2;SEPT10;RAC2;RAB31;ANXA6;SEPT5;GLUD1;ARF4;TUBG2;PDE5A;RAB43;RAB1A;RHOBTB1;TMEM173;SEPT6;GNAI1
1459,GO:0003705,0.89368511259873,0.240245215814201,3,57,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,MEF2D;TLE4;PBX3
8673,GO:0034243,0.893693004506108,0.355872216101119,1,25,regulation of transcription elongation from RNA polymerase II promoter,BP,EAPP
19443,GO:1990089,0.893734348859572,0.27529690892459,2,39,response to nerve growth factor,BP,ACAP2;EEF2K
19444,GO:1990090,0.893734348859572,0.27529690892459,2,39,cellular response to nerve growth factor stimulus,BP,ACAP2;EEF2K
7177,GO:0031058,0.893895079078358,0.219698426418932,4,74,positive regulation of histone modification,BP,NOS1;PHF1;TET1;JARID2
4204,GO:0009312,0.893920582375858,0.35492435656988,1,26,oligosaccharide biosynthetic process,BP,GALNT3
12943,GO:0051302,0.894373183753907,0.188648001113958,7,116,regulation of cell division,BP,PGF;RAB11FIP4;SDCCAG3;BCL2L1;IGF2;E2F7;PTCH1
6929,GO:0030522,0.894762253203331,0.160016865456884,15,223,intracellular receptor signaling pathway,BP,CYP27B1;NR1D1;ALOX15B;DCBLD2;PAK1;PPARA;DDX60;THRA;PUM2;NR2F6;PPARG;ALDH1A2;TBX1;FOXP1;UFL1
6146,GO:0019432,0.895026719498738,0.352860581773484,1,25,triglyceride biosynthetic process,BP,PCK2
2618,GO:0005929,0.895068927053419,0.147588745513874,24,339,cilium,CC,BBS2;WDR66;MAP1B;TTBK2;UNC119B;CEP170;SHANK2;PKD2;PRKACB;TUB;PRKAR1A;MARK4;SPATA6;TCTN1;CCDC88A;CCSAP;PRKACA;EFCAB7;WDR60;TMEM107;ANKS6;PSEN2;PTCH1;SEPT6
3914,GO:0008574,0.895664716501928,0.352399982008169,1,23,ATP-dependent microtubule motor activity, plus-end-directed,MF,WDR60
7237,GO:0031145,0.895942879525357,0.234615974711779,3,77,anaphase-promoting complex-dependent catabolic process,BP,PSMD2;PSMD7;UBE2E1
2870,GO:0006362,0.896060804007007,0.34895992679269,1,29,transcription elongation from RNA polymerase I promoter,BP,ERCC6
12398,GO:0048839,0.896111383422003,0.193504497928644,6,98,inner ear development,BP,SLITRK6;FGFR1;DVL1;CHD7;SPRY2;TBX1
12880,GO:0051213,0.896296056395155,0.215758795767656,4,73,dioxygenase activity,MF,CYGB;ALOX15B;ASPH;TET1
14770,GO:0070461,0.896526135216793,0.349019206012109,1,26,SAGA-type complex,CC,KAT2B
7013,GO:0030705,0.896753574827213,0.170641438792772,10,152,cytoskeleton-dependent intracellular transport,BP,MAP1B;KIF13B;FYCO1;COPG1;FNBP1L;CCDC88A;RAB1A;AP3D1;WDR60;WASL
5995,GO:0019001,0.896831030196934,0.152033857194164,18,286,guanyl nucleotide binding,MF,RAB3B;PCK2;TGM2;SEPT10;RAC2;RAB31;ANXA6;SEPT5;GLUD1;ARF4;TUBG2;PDE5A;RAB43;RAB1A;RHOBTB1;TMEM173;SEPT6;GNAI1
14171,GO:0061053,0.897053785312335,0.234884443527944,3,52,somite development,BP,DKK1;LRP6;PTCH1
900,GO:0002279,0.897153539868822,0.347587044748862,1,26,mast cell activation involved in immune response,BP,RAC2
10447,GO:0043303,0.897153539868822,0.347587044748862,1,26,mast cell degranulation,BP,RAC2
13488,GO:0055025,0.898300873998992,0.345862049225617,1,24,positive regulation of cardiac muscle tissue development,BP,FGFR1
15296,GO:0071480,0.898459340132298,0.344593400986366,1,26,cellular response to gamma radiation,BP,BCL2L1
11244,GO:0045429,0.898700234007249,0.344472606988835,1,25,positive regulation of nitric oxide biosynthetic process,BP,PKD2
18826,GO:1904407,0.898700234007249,0.344472606988835,1,25,positive regulation of nitric oxide metabolic process,BP,PKD2
18029,GO:1902532,0.898946667154209,0.140090118638257,27,391,negative regulation of intracellular signal transduction,BP,TNIP1;XDH;SORL1;SERPINE2;PRNP;DDIT3;ARHGAP12;DLG1;RASA3;SOCS2;CD44;APOE;RGS14;PKD2;WWC3;INPP5F;TRIB3;RANBP9;F2RL1;SPRY2;BCL2L1;XBP1;EPM2A;TMSB4X;TIMP2;LPAR1;WFS1
19715,GO:2000058,0.899272746080273,0.180981905569253,7,124,regulation of ubiquitin-dependent protein catabolic process,BP,TRIB2;DVL1;TRIB3;ANKIB1;MAGEF1;RNF180;UFL1
9530,GO:0036258,0.899362676179431,0.341396768861574,1,29,multivesicular body assembly,BP,MVB12A
4185,GO:0009262,0.899459830455128,0.340271425345272,1,32,deoxyribonucleotide metabolic process,BP,AK9
723,GO:0001952,0.899641793662684,0.197514622259825,5,82,regulation of cell-matrix adhesion,BP,POSTN;EPHA1;FERMT1;MMP14;SLK
12149,GO:0048255,0.899970670605023,0.341539341487987,1,25,mRNA stabilization,BP,PAIP1
298,GO:0000803,0.900188018294647,0.341035817803782,1,25,sex chromosome,CC,DNMT3A
14885,GO:0070670,0.900195036968847,0.340187057595711,1,27,response to interleukin-4,BP,XBP1
1458,GO:0003700,0.900224616312239,0.121660645461124,85,1085,DNA binding transcription factor activity,MF,ETV5;NR1D1;NFATC4;ZC3H6;ETV4;ZKSCAN1;SALL2;PEG3;POU2F2;TEF;ZKSCAN2;DDIT3;SOX12;ELK3;HLTF;ZNF516;ZSCAN30;KIAA1549;ZNF624;DDN;HMGA2;ATF4;PPARA;E2F5;TCFL5;NFAT5;ZNF559;ZNF81;SOX4;ZNF558;ZNF692;RCOR1;HES2;ZMYM3;KLF12;L3MBTL3;ZNF322;RFX2;CEBPG;PLAG1;AEBP1;PHF1;MSRB2;NACC2;ZNF337;THRA;TSHZ1;ZNF449;MTA1;MEF2D;XBP1;SATB1;TLE4;THAP10;GTF2IRD2;ETV1;ZNF398;UNKL;IFI16;NR2F6;SCAND1;ZNF354A;HOXA3;ARID4A;ZSCAN18;ZMYM2;PPARG;ZFP30;ZNF37A;TBX1;CREB3L2;ZNF92;ZNF568;ARID5B;ZNF165;E2F7;ZNF320;RCAN1;FOXP1;ZBTB33;PBX3;JARID2;MXD4;ADNP;RFX7
5791,GO:0017022,0.900312871868244,0.261698682117588,2,43,myosin binding,MF,RAB3B;SPATA6
890,GO:0002262,0.900347160373832,0.186567605026718,6,106,myeloid cell homeostasis,BP,FAM210B;L3MBTL3;CEBPG;THRA;ACVR1B;ARID4A
11400,GO:0045786,0.900373444171003,0.132457498509294,37,536,negative regulation of cell cycle,BP,FHL1;CCND1;RPS6KA2;PRNP;MAP2K1;ALOX15B;DDIT3;PSMD2;BRSK1;EGFR;CGREF1;DLG1;XPC;STRADB;PTPN3;PKD2;PRKACB;PPP2R3B;HMGA2;ATRX;SOX4;ETAA1;TOM1L2;UHRF2;TAOK1;PHC3;PSMD7;PRKAR1A;JMY;NACC2;PPP1R10;BCL2L1;PRKACA;TIMP2;E2F7;KAT2B;CNOT11
6565,GO:0022011,0.90045480188405,0.342574820776423,1,21,myelination in peripheral nervous system,BP,SH3TC2
7772,GO:0032292,0.90045480188405,0.342574820776423,1,21,peripheral nervous system axon ensheathment,BP,SH3TC2
17309,GO:0140104,0.901124680589895,0.33802850428151,1,27,molecular carrier activity,MF,CYGB
6767,GO:0030201,0.901263210237041,0.339007006866061,1,24,heparan sulfate proteoglycan metabolic process,BP,HPSE
13289,GO:0051983,0.901264265618551,0.194495017098498,5,89,regulation of chromosome segregation,BP,HECW2;ATRX;CSNK2A1;PUM2;NEK6
17344,GO:1900026,0.901303330894807,0.338011918668097,1,26,positive regulation of substrate adhesion-dependent cell spreading,BP,NET1
1303,GO:0003143,0.901725884352058,0.259478505222919,2,40,embryonic heart tube morphogenesis,BP,TGFBR2;PKD2
15514,GO:0071889,0.901998708554748,0.337290572802053,1,24,14-3-3 protein binding,MF,KIF13B
5320,GO:0016043,0.902064532445595,0.110181182777152,375,4592,cellular component organization,BP,FHL1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;ADAM19;ETV5;RAB3B;NEURL1;CTNNBIP1;VLDLR;SYNE3;ITGA6;MMP1;CYP27B1;H1F0;SERPINE2;IGFBP4;PRNP;ADGRF1;ITGB4;BBS2;POSTN;SH3TC2;HECW2;NFATC4;ADARB1;MAP2K1;THBS2;FMNL2;LTBP2;RAPGEF3;SH3KBP1;COL13A1;THSD4;GPX3;PKN1;WWTR1;DCBLD2;APLN;MARVELD1;SSH1;MAP1B;DDIT3;KCNG1;PTPRS;SMARCA1;SOX12;LAMB1;SDK2;EXOC2;CRTC1;ADGRL1;CAPN2;BRSK1;WIPF1;EGFR;TBC1D14;SEMA4B;ANK3;BCORL1;DYSF;LOXL1;ARHGAP12;FYN;JADE2;BNIP3;HLTF;KIF13B;SCMH1;PARVB;ARAP1;DLG1;CSMD3;DLG4;IDH2;PLXNB3;SNX9;TYSND1;PODXL;NET1;TGM2;ESPN;XPC;GLUL;EVI5L;HTRA1;WNT7A;MAP4K4;TTBK2;SEC23A;STRADB;MALL;ASPH;MCTP1;GDI1;UNC119B;SEPT10;SDC1;STOM;SHC1;DKK1;WISP1;SMOC2;PAK1;SOCS2;ATXN10;NEK9;CBR4;RAG1;NUDCD3;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ABCD1;ANGPTL4;AFAP1;RGS14;MCFD2;PKD2;PRKACB;LRP1;FYCO1;IDE;AKAP9;HMGA2;ABCA7;LPAR3;FGFR1;ITGA1;E2F5;TMOD2;TUB;PTPDC1;TACC1;ITGB5;SNX14;HYAL1;ITGA2;PTK6;VAMP2;ULK2;FAT1;LONP2;LTBP4;INPP5F;ATRX;MTHFR;PFN2;ABCG1;FKBP10;KIAA1109;FHOD1;ITPR3;DDB2;CEP120;CEACAM1;FERMT1;SPATA18;OBSL1;RAB31;LMAN1;DMXL2;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;EPN2;XRN1;SLC9A3R2;DVL1;CLCN3;MMP14;PLEK2;ANXA6;NLGN2;CTH;MAP6;LRP5;ZMYM3;THBS3;CTSL;TWF2;CST3;COX18;SEC22C;RABGGTA;CNTN1;CLTCL1;NTNG1;TPBG;TOM1L2;L3MBTL3;VPS11;RANBP9;WASF3;BTBD3;PPP3CB;MYOF;ACOT13;RFX2;SYTL1;ADGRB2;DNAJC6;SLK;FNBP1L;CDC42BPA;F2RL1;UHRF2;TAOK1;ATP10D;CSNK2A1;PHF1;CHD7;SLC25A4;ASAP1;NDUFV3;PRKAR1A;MSRB2;JMY;BOK;FCHO2;ATXN2;MAST3;NACC2;USP6NL;SPRY2;SEPT5;TBC1D2B;THRA;ACVR1B;DBNDD1;COL6A1;NGFR;PPP1R10;MVB12A;GLUD1;MARK4;PTPRZ1;CHD6;SPESP1;MTA1;AZIN2;BCL2L1;RNF165;GRIN3B;WASF2;SKAP2;ARF4;GOLGA2P5;H2AFJ;SLC12A7;SPIRE1;NFU1;MAP2K2;SATB1;REC8;TLE4;RET;SPATA6;TUBG2;STX10;LOXL2;VWA1;TCTN1;RAB43;MLH3;NAV1;SH3PXD2B;ZFYVE9;NOP10;NCKAP1;GABARAPL2;DOCK11;PAK6;UBE2E1;PUM2;ETV1;COL1A2;CCDC88A;CCSAP;TMED4;PRKACA;NEK6;TMSB4X;TIMP2;EIF2AK2;RAB1A;EPB41L3;SNX30;CBX7;RHOBTB1;AP2A2;IL1RAP;FCHO1;LAMB2;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;AP3D1;ARID4A;ARPC1A;TENM2;IGF2;MOAP1;LAMA5;FNBP1;GRB10;ZMYM2;PPARG;SNX6;GRB7;SRPX2;PPL;EVI5;ATP6V1B2;RSF1;ADAM8;AKT3;ROBO3;ENDOG;ATP11B;ITGA4;PHF21A;WDR60;IGFBP7;TBC1D16;DDHD2;TMEM107;WASL;HSPA2;FLNB;LRP6;ARID5B;SYT2;EEF2K;SEMA6C;SIGMAR1;TET1;OMG;KCTD18;DEDD2;HSD17B12;PTCH1;ADCY1;KAT2B;SEPT6;PRMT3;REEP3;NYAP1;FAM162A;JARID2;SEMA3F;ADNP;GNAI1;LRP4;RB1CC1;DNMT3A;ALAS1;FADD
6923,GO:0030515,0.90241566185165,0.333983067360548,1,30,snoRNA binding,MF,NOP10
15044,GO:0070988,0.902459365491233,0.224794824543251,3,55,demethylation,BP,APOBEC3C;ARID5B;TET1
3070,GO:0006636,0.902656544404936,0.333738974940159,1,29,unsaturated fatty acid biosynthetic process,BP,ALOX15B
8060,GO:0032728,0.902672701266632,0.334812353575334,1,26,positive regulation of interferon-beta production,BP,RNF135
16331,GO:0090543,0.902682804507257,0.334788672089297,1,26,Flemming body,CC,EXOC2
2499,GO:0005747,0.902807658061774,0.330438388235962,1,42,mitochondrial respiratory chain complex I,CC,NDUFV3
7135,GO:0030964,0.902807658061774,0.330438388235962,1,42,NADH dehydrogenase complex,CC,NDUFV3
11180,GO:0045271,0.902807658061774,0.330438388235962,1,42,respiratory chain complex I,CC,NDUFV3
2083,GO:0004843,0.902821349653899,0.204955909539886,4,70,thiol-dependent ubiquitin-specific protease activity,MF,OTUB2;USP20;USP32;USP25
3655,GO:0008135,0.90287116458593,0.20413898304107,4,81,translation factor activity, RNA binding,MF,ABTB1;EIF4E3;CPEB4;EEF2K
18343,GO:1903307,0.902948365474212,0.333767304782227,1,27,positive regulation of regulated secretory pathway,BP,F2RL1
17282,GO:0140030,0.903366321448389,0.175041124196095,7,114,modification-dependent protein binding,MF,TNIP1;ZMYND8;IDE;ATRX;PHF1;SPIN4;RNF169
8825,GO:0034599,0.903545660928481,0.151987225359462,13,217,cellular response to oxidative stress,BP,ETV5;GPX3;EGFR;BNIP3;MAPK13;NET1;IMPACT;PKD2;ATF4;CST3;PRDX5;CHD6;ENDOG
8312,GO:0033144,0.903601656391189,0.333061344364714,1,25,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,FOXP1
2718,GO:0006096,0.903953828933727,0.202731364876115,4,74,glycolytic process,BP,DHTKD1;PGM1;LDHA;PPARA
18275,GO:1903146,0.904114192040609,0.253998423527469,2,44,regulation of autophagy of mitochondrion,BP,BNIP3;BNIP3L
14630,GO:0070198,0.904757148419336,0.329902946300617,1,26,protein localization to chromosome, telomeric region,BP,ATRX
14944,GO:0070830,0.904826020844688,0.253112805866661,2,41,bicellular tight junction assembly,BP,DLG1;PRKACA
10605,GO:0043583,0.90516875140251,0.172270571283289,7,114,ear development,BP,SLITRK6;FGFR1;DVL1;CHD7;SPRY2;TSHZ1;TBX1
3091,GO:0006664,0.905251652549923,0.187505103050158,5,100,glycolipid metabolic process,BP,B4GALT6;ST3GAL5;PIGH;GLB1;ESYT3
18429,GO:1903509,0.905251652549923,0.187505103050158,5,100,liposaccharide metabolic process,BP,B4GALT6;ST3GAL5;PIGH;GLB1;ESYT3
2434,GO:0005623,0.905632258460824,0.115965911809555,920,11084,cell,CC,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;FAM83A;ADAM19;ETV5;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;ITGA6;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PEAR1;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;PAG1;ADGRF1;OSBP2;ITGB4;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;THBS2;FAM210B;FMNL2;ETV4;LTBP2;RAPGEF3;FNDC4;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;SLC29A4;ALOX15B;MPRIP;LMF1;SALL2;COL13A1;TK2;PKN1;NAPRT;WWTR1;DCBLD2;PEG3;MST1R;ARHGAP22;MICALCL;WDR66;MARCH9;H6PD;APLN;RBMS2;MARVELD1;POU2F2;TRIM65;LY6K;DHTKD1;PITPNC1;DGKA;TEF;TNFSF15;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;KCNG1;PTPRS;B4GALT6;CCNG2;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;SDK2;EXOC2;ELK3;SNTB2;CRTC1;ADGRL1;DENND5B;AVL9;LTA4H;CAPN2;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;BCORL1;C2CD2;DYSF;PDZD2;LOXL1;ARHGAP12;ARMCX2;PPP1R14A;FYN;HEBP1;MYH15;TNFRSF6B;TMPRSS11D;OSBPL10;TSPAN5;PCDHAC2;PSAT1;JADE2;BNIP3;HLTF;KIF13B;SPATS2;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;MYCBPAP;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;CSMD3;DLG4;B3GNT3;IDH2;CTSB;CD68;DNAJB5;CSMD2;ACOT1;PLXNB3;GPC4;DHX32;SNX9;TYSND1;PODXL;SLCO4A1;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;EVI5L;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;TTC7B;RSAD1;GRK5;HTR7;NMRK1;STRADB;RDH14;NME4;MALL;CRTAP;RSPH3;ASPH;GLCCI1;MCTP1;GDI1;CEMIP;VWA5A;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;WISP1;SLFN5;PAK1;RASA3;CEP170;SOCS2;TRIB2;ATXN10;NEK9;KIAA1549;RHPN1;ZNF652;CBR4;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;NUDCD3;B4GALNT4;EDNRA;LCN2;HAGH;NUCB2;SHANK2;SLITRK6;SCRN1;EPHA1;IMPACT;RALGAPA2;PLPP6;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;ACP5;TIGD2;KLHDC2;PTPN12;ALDH1L2;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;ICA1;EIF4E3;AGPAT4;LPAR3;PCMTD2;FAM155B;KIF21B;ASNS;FGFR1;ABHD10;ITGA1;AARS;E2F5;FAM114A1;EPCAM;TMOD2;MARCH4;TUB;PTPDC1;LPCAT4;TACC1;TCFL5;RNPEPL1;UROS;NFAT5;ITGB5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;AIG1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;FAT1;INTS8;ZNF81;LONP2;INPP5F;CHAC1;BIVM;ATRX;FAM20C;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;NELL2;GAMT;CEP120;ENDOV;ZNF558;KDSR;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PRR9;SLC5A1;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLEK2;PLA2G4D;HES2;ANXA6;NLGN2;CD46;ZBTB10;ACAD10;PHF12;MVB12B;EPOR;CTH;ZNF704;MPDZ;FAM50A;MAP6;LRP5;ETAA1;NIPA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;THBS3;CTSL;DOCK9;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;NTNG1;GFPT1;PCSK6;SLC35G2;TPBG;TOM1L2;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;FBXL8;BTBD3;RIMS3;PLPPR2;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;INPP4A;RFX2;SYTL1;HIBADH;ADGRB2;TTYH3;KIAA1147;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;DDX60;UHRF2;SLC2A9;RASIP1;GSDMA;PROCR;C6ORF120;TAOK1;PLD3;PHC3;AEBP1;ATP10D;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;SUGCT;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;ANO1;MSRB2;FAM84B;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;KLHL29;MAST3;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;SLC6A14;ZNF337;BEX4;TBC1D2B;THRA;LMBR1L;MGLL;GOLGA6L9;CD99;WNT2B;ENKD1;ACVR1B;DBNDD1;NDUFA4L2;SLC43A1;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;MARK4;NPL;ZNF449;PTPRZ1;CHD6;NUDT6;SPESP1;PER3;MTA1;AZIN2;BCL2L1;IFITM1;CRAT;MYH16;RNF165;YTHDC2;PM20D2;GRIN3B;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;SKAP2;ARF4;GOLGA2P5;H2AFJ;POLL;TMEM187;ANAPC13;YPEL5;UAP1;CNNM1;HSD17B7;SLC12A7;PCYOX1;XBP1;PANK4;SPIRE1;NFU1;UBASH3B;TXNRD3;CADM4;MAP2K2;ABHD6;SATB1;SLC22A17;PPP1R2;PAIP1;ARRDC1;REC8;CYP4F22;ANKIB1;MICU3;LYPLAL1;TLE4;SLC38A2;RIN1;TRPC1;RET;SPATA6;SDR9C7;FAM222B;TUBG2;STX10;LOXL2;PDE5A;VWA1;TCTN1;RAB43;MLH3;OSBPL5;SLC13A3;NAV1;SH3PXD2B;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;MBOAT7;NOP10;NCKAP1;GABARAPL2;EPM2A;KCNJ15;RMRP;GTF2IRD2;DNASE1L1;ELMO3;DOCK11;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;TSPAN3;RNF135;PSD3;TMBIM1;ETV1;FRMD4B;COL1A2;SFXN3;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;SNX30;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;RHOBTB1;BCAP29;AP2A2;SRD5A3;NR2F6;SLC39A10;KDELR3;CMTM6;SCAND1;IL1RAP;SBNO1;SLC25A43;ST6GALNAC2;ORAI1;CARD11;FCHO1;LAMB2;LTB4R;FICD;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;NRSN2;ACP6;TMEM134;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;SLC2A13;ZSCAN18;GRB10;LARP1B;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;SLC10A6;TMEM63A;CITED4;SNX6;EVA1A;USP20;ANKRD50;ZFP30;GRB7;TRIQK;SRPX2;PPL;ALDH1A2;GPR153;ARHGAP29;LYPLA1;TMEM50B;ATP12A;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;ROBO3;GARS;IL20RB;CLDN11;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;IKBIP;PHF21A;ZBTB40;ZNF92;WDR60;ACAP2;MPLKIP;MAML3;ZNF568;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;OSGEPL1;PLCXD1;FZD8;TMEM107;CMC1;WASL;USP32;ANKS6;RAPGEFL1;REEP6;HSPA2;PRSS8;ZNF107;FLNB;LRP6;ARID5B;ZNF165;SYT2;PLCH2;TMEM173;RNF180;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;SEMA6C;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;TNRC6C;TRIM2;COQ2;RCAN1;TET1;OMG;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;RNF103;USP25;LRP3;PANK1;PRMT3;REEP3;NYAP1;UFL1;VSIG10L;FAM162A;ANKRD6;SNX27;N4BP2;AMACR;GALE;PBX3;JARID2;PPM1M;SLC23A2;RALGPS2;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
654,GO:0001844,0.905909553713628,0.325743173141425,1,30,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,MOAP1
13822,GO:0060416,0.905988258878329,0.327877283581711,1,24,response to growth hormone,BP,SOCS2
5740,GO:0016887,0.906317831615285,0.131596951809356,26,350,ATPase activity,MF,SMARCA1;HLTF;KIF13B;ERCC6;DHX32;ATP7B;ABCD1;IDE;ABCA7;KIF21B;LONP2;ATRX;PFN2;ABCG1;ATF7IP;ATP10D;HSPA13;CHD6;YTHDC2;PCYOX1;MLH3;ATP12A;ATP6V1B2;ATP11B;WDR60;HSPA2
11371,GO:0045736,0.906475136700133,0.325820544621552,1,26,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,KAT2B
3054,GO:0006613,0.906746960117057,0.214322336390614,3,96,cotranslational protein targeting to membrane,BP,SEC63;SSR3;SSR1
592,GO:0001756,0.906884447589624,0.249383136199096,2,39,somitogenesis,BP,DKK1;LRP6
13180,GO:0051785,0.906898054871901,0.248421802052817,2,44,positive regulation of nuclear division,BP,LRP5;IGF2
2730,GO:0006109,0.906958875127073,0.16404818520783,8,128,regulation of carbohydrate metabolic process,BP,IGFBP4;NR1D1;PPARA;NTSR1;SLC35B4;MLYCD;IGF2;KAT2B
991,GO:0002448,0.907066100945023,0.324012238170766,1,27,mast cell mediated immunity,BP,RAC2
2554,GO:0005829,0.907094783531333,0.105079575292237,326,4105,cytosol,CC,TNIP1;DOCK4;FHL1;XDH;NT5E;SMURF2;NOS1;ERCC1;FLNC;RAB3B;CCND1;PCK2;SH2D2A;CTNNBIP1;PYGL;ASAP2;CBS;NOL4L;CYGB;RPS6KA2;SERPINE2;ADCY7;CRYL1;PRNP;XPOT;ACTA2;BBS2;BTBD2;NFATC4;ADARB1;MAP2K1;FMNL2;SH3KBP1;ALOX15B;MPRIP;PKN1;NAPRT;WWTR1;ARHGAP22;TRIM65;DHTKD1;PITPNC1;DGKA;APPL2;EIF4EBP1;SSH1;MAP1B;PC;DDIT3;CARS;PSMD2;EXOC2;CRTC1;DENND5B;LTA4H;CAPN2;WIPF1;TBC1D14;STK39;RIN2;ANK3;C2CD2;ARHGAP12;PPP1R14A;FYN;OSBPL10;PSAT1;KIF13B;SPATS2;UBXN7;MAPK13;PARVB;ARAP1;PGM1;DLG1;ISYNA1;DLG4;IDH2;DNAJB5;ACOT1;SNX9;NET1;TGM2;GLUL;HTRA1;GLO1;PGLS;UBXN4;IGF2BP3;TTBK2;ACOT7;WDFY3;SEC23A;TTC7B;GRK5;NMRK1;STRADB;GDI1;UNC119B;ARG2;SHC1;DLG3;WISP1;PAK1;RASA3;CEP170;SOCS2;ATXN10;NEK9;RHPN1;TGFBR2;HAGH;NUCB2;SHANK2;RALGAPA2;RAC2;CLCA2;CD44;OBSCN;FKBP1A;BNIP3L;ABCD1;CCND2;ACP5;PTPN12;AFAP1;PRKACB;RBCK1;LDHA;FYCO1;IDE;AKAP9;EHBP1;ABTB1;UBE2G1;ANXA3;WWC3;ICA1;EIF4E3;ASNS;FGFR1;ABHD10;AARS;FAM114A1;TUB;UROS;NFAT5;BTRC;PTK6;VAMP2;ULK2;CHAC1;MTHFR;AHCYL2;PITPNM1;FHOD1;VPS13A;FBXO2;GAMT;FERMT1;MAPKAPK3;GSDMC;OBSL1;RAB31;MT2A;UACA;ATF7IP;SH3D19;NLK;EPN2;XRN1;TRIM5;TNRC6B;DVL1;MMP14;PLA2G4D;MVB12B;CTH;KLF12;DOCK9;RABGGTA;TRIB3;CLTCL1;CASP4;GFPT1;RANBP9;FBXL8;BTBD3;SEC63;ZNF322;PPP3CB;MEX3C;ACOT13;INPP4A;DNAJC6;COPB1;PRDX5;MLYCD;COPG1;ALDH7A1;FNBP1L;DDX60;GSDMA;TAOK1;FBXO41;CSNK2A1;PSMD7;PTHLH;BLMH;ASAP1;PRKAR1A;MSRB2;PARP9;FCHO2;ATXN2;USP6NL;SPRY2;TBC1D2B;THRA;MGLL;ACVR1B;NGFR;MVB12A;HSPA13;MARK4;NPL;MTA1;AZIN2;BCL2L1;WASF2;SKAP2;ARF4;UAP1;SPIRE1;NFU1;MAP2K2;PAIP1;LYPLAL1;RIN1;RET;SDR9C7;TUBG2;STX10;PDE5A;TCTN1;OSBPL5;MCTP2;MTMR4;ZFYVE9;NCKAP1;GABARAPL2;DOCK11;UBE2E1;PUM2;RNF135;CCDC88A;SAMD8;SHC2;PRKACA;NEK6;UNKL;TMSB4X;EIF2AK2;RAB1A;EPB41L3;S100PBP;CBX7;IFI16;ANGEL1;RHOBTB1;AP2A2;CARD11;FCHO1;ZNF354A;ARID4A;NIT2;BLVRA;ARPC1A;MOAP1;FNBP1;GRB10;ZMYM2;PPARG;SNX6;USP20;GRB7;PPL;ALDH1A2;ARHGAP29;LYPLA1;EVI5;ATP6V1B2;AK9;GARS;ENDOG;ACAP2;TBC1D16;DDHD2;WASL;USP32;HSPA2;FLNB;EEF2K;RALGDS;TNRC6C;DNAJC3;ZBTB33;ZFYVE21;AOX1;SSFA2;ADCY1;CNOT11;OAS1;USP25;PANK1;PRMT3;UFL1;FAM162A;SNX27;N4BP2;GALE;RB1CC1;ALAS1;TRIM38;FBXL5;FADD
5994,GO:0018995,0.907230667890593,0.215475864494718,3,61,host,CC,LMAN1;MVB12B;MVB12A
10647,GO:0043657,0.907230667890593,0.215475864494718,3,61,host cell,CC,LMAN1;MVB12B;MVB12A
10770,GO:0044215,0.907230667890593,0.215475864494718,3,61,other organism,CC,LMAN1;MVB12B;MVB12A
10771,GO:0044216,0.907230667890593,0.215475864494718,3,61,other organism cell,CC,LMAN1;MVB12B;MVB12A
10772,GO:0044217,0.907230667890593,0.215475864494718,3,61,other organism part,CC,LMAN1;MVB12B;MVB12A
9529,GO:0036257,0.907353739113996,0.322297847949507,1,30,multivesicular body organization,BP,MVB12A
4509,GO:0010559,0.907525367951029,0.322912467756589,1,27,regulation of glycoprotein biosynthetic process,BP,ABCA7
3076,GO:0006643,0.907630678973268,0.154494852675956,10,177,membrane lipid metabolic process,BP,B4GALT6;ELOVL1;SPTLC2;ST3GAL5;PIGH;KDSR;GLB1;SAMD8;ESYT3;ELOVL4
8449,GO:0033572,0.908017412564595,0.321024079522573,1,29,transferrin transport,BP,ATP6V1B2
18900,GO:1904589,0.908226514983517,0.245581052802465,2,45,regulation of protein import,BP,EFCAB7;TMEM173
6694,GO:0030071,0.908315339703794,0.245248492856394,2,46,regulation of mitotic metaphase/anaphase transition,BP,HECW2;NEK6
17866,GO:1902099,0.908315339703794,0.245248492856394,2,46,regulation of metaphase/anaphase transition of cell cycle,BP,HECW2;NEK6
18802,GO:1904353,0.908327133742806,0.321810690320383,1,25,regulation of telomere capping,BP,ERCC1
4702,GO:0010862,0.908519693390845,0.320918696131296,1,26,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,ACVR1B
7175,GO:0031056,0.908537211279747,0.166969416473977,7,117,regulation of histone modification,BP,NOS1;ATRX;MTHFR;PHF1;IGF2;TET1;JARID2
8429,GO:0033522,0.908555245638502,0.32126117930208,1,25,histone H2A ubiquitination,BP,DDB2
17536,GO:1901031,0.908571526699405,0.319691457354423,1,29,regulation of response to reactive oxygen species,BP,ENDOG
1523,GO:0003887,0.908675713348039,0.320542669529041,1,26,DNA-directed DNA polymerase activity,MF,POLL
13761,GO:0060337,0.908886622322661,0.211854773068145,3,68,type I interferon signaling pathway,BP,IFITM1;OAS1;FADD
15212,GO:0071357,0.908886622322661,0.211854773068145,3,68,cellular response to type I interferon,BP,IFITM1;OAS1;FADD
3604,GO:0008038,0.908996592930299,0.321721804550868,1,22,neuron recognition,BP,ROBO3
4484,GO:0010506,0.909281634596349,0.135561116754755,18,272,regulation of autophagy,BP,TRIM65;TBC1D14;BNIP3;SPTLC2;DAP;BNIP3L;FYCO1;ULK2;RASIP1;QSOX1;BOK;XBP1;EPM2A;PRKACA;IFI16;SNX6;ATP6V1B2;RB1CC1
19768,GO:2000177,0.909576664189591,0.243346672262022,2,42,regulation of neural precursor cell proliferation,BP,PTPRZ1;CTSZ
7158,GO:0031018,0.909830181627501,0.317751486105261,1,26,endocrine pancreas development,BP,SOX4
4864,GO:0014706,0.910029723425733,0.139278367631665,15,217,striated muscle tissue development,BP,NEURL1;MYH15;DKK1;PAK1;TGFBR2;FKBP1A;FGFR1;OBSL1;CHD7;PRKAR1A;MEF2D;ALDH1A2;TBX1;FLNB;JARID2
8267,GO:0033047,0.910140646488168,0.210117767278458,3,61,regulation of mitotic sister chromatid segregation,BP,HECW2;ATRX;NEK6
13009,GO:0051438,0.910216876009212,0.241105827487716,2,48,regulation of ubiquitin-protein transferase activity,BP,TRIB3;RAB1A
6542,GO:0021954,0.910287251939948,0.241899820852793,2,42,central nervous system neuron development,BP,ADARB1;TCTN1
7908,GO:0032481,0.91064771563194,0.209001779176763,3,63,positive regulation of type I interferon production,BP,RNF135;IFI16;TMEM173
16155,GO:0090169,0.910761343884773,0.315915493549494,1,25,regulation of spindle assembly,BP,CCSAP
7568,GO:0031929,0.910870288212211,0.178579472996084,5,92,TOR signaling,BP,EIF4EBP1;EPM2A;CCDC88A;CARD11;AKT3
11765,GO:0046622,0.911022436215069,0.315279036916704,1,25,positive regulation of organ growth,BP,FGFR1
5731,GO:0016877,0.91127914623226,0.313467573295512,1,28,ligase activity, forming carbon-sulfur bonds,MF,ACSF2
18217,GO:1903008,0.911490588215108,0.177375855803426,5,96,organelle disassembly,BP,BNIP3;BNIP3L;SPATA18;GABARAPL2;RB1CC1
8368,GO:0033260,0.911844045645147,0.23765220056688,2,49,nuclear DNA replication,BP,FGFR1;ATRX
11678,GO:0046460,0.912218998316434,0.311533037842232,1,27,neutral lipid biosynthetic process,BP,PCK2
11681,GO:0046463,0.912218998316434,0.311533037842232,1,27,acylglycerol biosynthetic process,BP,PCK2
1338,GO:0003197,0.912386242457944,0.312403448799859,1,24,endocardial cushion development,BP,TGFBR2
8064,GO:0032732,0.912421969621057,0.310670965251944,1,28,positive regulation of interleukin-1 production,BP,IFI16
730,GO:0001959,0.912886245692885,0.159917829404469,7,127,regulation of cytokine-mediated signaling pathway,BP,RBCK1;CASP4;F2RL1;PARP9;AGPAT1;PPARG;FADD
635,GO:0001824,0.912946068481792,0.235661639327667,2,47,blastocyst development,BP,CAPN2;TET1
5502,GO:0016445,0.91298612000303,0.235873711602851,2,45,somatic diversification of immunoglobulins,BP,ERCC1;POLL
10278,GO:0043022,0.912996077254624,0.235558813759753,2,47,ribosome binding,MF,IMPACT;CPEB4
4056,GO:0009101,0.913199988050186,0.13165370970503,17,256,glycoprotein biosynthetic process,BP,TNIP1;LMF1;B4GALT6;UBE2J1;ADAMTS7;B3GNT3;MCFD2;ST3GAL5;ABCA7;GALNT3;LMAN1;GFPT1;ADAMTSL1;SRD5A3;ST6GALNAC2;TET1;STT3B
10220,GO:0042866,0.913333476134773,0.186378739882908,4,76,pyruvate biosynthetic process,BP,DHTKD1;PGM1;LDHA;PPARA
15553,GO:0071985,0.913455989033673,0.308127080194649,1,28,multivesicular body sorting pathway,BP,TMEM50B
11411,GO:0045815,0.913475164223769,0.20278054596261,3,77,positive regulation of gene expression, epigenetic,BP,ERCC6;TET1;KAT2B
18295,GO:1903201,0.913533382508617,0.234315443054113,2,48,regulation of oxidative stress-induced cell death,BP,ATF4;ENDOG
18304,GO:1903214,0.913604643925301,0.203184041115438,3,67,regulation of protein targeting to mitochondrion,BP,RAC2;BNIP3L;VPS11
8700,GO:0034333,0.913681110591227,0.186251427462926,4,69,adherens junction assembly,BP,ITGA2;MMP14;SLK;LAMA5
2861,GO:0006352,0.91374843412623,0.139930916198746,12,206,DNA-templated transcription, initiation,BP,CCND1;CTNNBIP1;NR1D1;WWTR1;PPARA;ATF7IP;THRA;NR2F6;PPARG;RSF1;MAML3;KAT2B
7715,GO:0032204,0.913758069488072,0.185634751634885,4,76,regulation of telomere maintenance,BP,ERCC1;ATRX;XRN1;PPP1R10
4073,GO:0009126,0.913868958006252,0.135360578916114,14,247,purine nucleoside monophosphate metabolic process,BP,NT5E;DHTKD1;PGM1;DLG1;DLG4;DLG3;LDHA;PPARA;FAM20C;NDUFV3;TMSB4X;CARD11;ATP6V1B2;AK9
4112,GO:0009167,0.913868958006252,0.135360578916114,14,247,purine ribonucleoside monophosphate metabolic process,BP,NT5E;DHTKD1;PGM1;DLG1;DLG4;DLG3;LDHA;PPARA;FAM20C;NDUFV3;TMSB4X;CARD11;ATP6V1B2;AK9
2544,GO:0005811,0.914136622207345,0.202423833573853,3,64,lipid droplet,CC,LPCAT1;PITPNM1;SIGMAR1
773,GO:0002027,0.914349064019095,0.233219522462728,2,44,regulation of heart rate,BP,AKAP9;PRKACA
11060,GO:0045058,0.91441963952651,0.306498958571429,1,26,T cell selection,BP,CARD11
12089,GO:0048048,0.914658772895767,0.307840480490103,1,22,embryonic eye morphogenesis,BP,LRP6
10615,GO:0043603,0.914786236242586,0.108384613104979,59,905,cellular amide metabolic process,BP,TNIP1;SORL1;NEURL1;PRNP;MAP2K1;EIF4EBP1;PC;B4GALT6;CARS;LTA4H;EGFR;GLO1;IGF2BP3;SPTLC2;ARG2;NAGS;HAGH;IMPACT;ERO1B;APOE;ALDH1L2;ST3GAL5;IDE;ABTB1;ATF4;ABCA7;EIF4E3;ASNS;AARS;RNPEPL1;ITGA2;CHAC1;MTHFR;SOX4;MRPS6;XRN1;TNRC6B;PCSK6;MEX3C;AEBP1;CPEB4;ATXN2;PM20D2;MAP2K2;PAIP1;PUM2;SAMD8;EIF2AK2;SECISBP2L;CTSZ;NIT2;PPARG;GRB7;GARS;EEF2K;TNRC6C;DNAJC3;PSEN2;CNOT11
7858,GO:0032418,0.915093867891101,0.231091611828644,2,48,lysosome localization,BP,RAC2;MAP6
6272,GO:0019866,0.915119771812097,0.120544759504923,25,451,organelle inner membrane,CC,HADH;IDH2;NME4;ACAD11;OCIAD2;MRPS6;COX18;TST;SLC25A4;NDUFV3;CPT2;CRLS1;BOK;NIPSNAP1;NDUFA4L2;BCL2L1;CRAT;MICU3;SLC25A30;SLC25A43;ATP11B;SIGMAR1;COQ2;PSEN2;CDS2
3565,GO:0007606,0.915201097964144,0.303467620047587,1,29,sensory perception of chemical stimulus,BP,ITPR3
10915,GO:0044464,0.91530785556438,0.104603149313205,919,11078,cell part,CC,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;FAM83A;ADAM19;ETV5;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;ITGA6;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PEAR1;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;PAG1;ADGRF1;OSBP2;ITGB4;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;THBS2;FAM210B;FMNL2;ETV4;LTBP2;RAPGEF3;FNDC4;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;SLC29A4;ALOX15B;MPRIP;LMF1;SALL2;COL13A1;TK2;PKN1;NAPRT;WWTR1;DCBLD2;PEG3;MST1R;ARHGAP22;MICALCL;WDR66;MARCH9;H6PD;APLN;RBMS2;MARVELD1;POU2F2;TRIM65;LY6K;DHTKD1;PITPNC1;DGKA;TEF;TNFSF15;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;KCNG1;PTPRS;B4GALT6;CCNG2;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;SDK2;EXOC2;ELK3;SNTB2;CRTC1;ADGRL1;DENND5B;AVL9;LTA4H;CAPN2;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;BCORL1;C2CD2;DYSF;PDZD2;LOXL1;ARHGAP12;ARMCX2;PPP1R14A;FYN;HEBP1;MYH15;TNFRSF6B;TMPRSS11D;OSBPL10;TSPAN5;PCDHAC2;PSAT1;JADE2;BNIP3;HLTF;KIF13B;SPATS2;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;MYCBPAP;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;CSMD3;DLG4;B3GNT3;IDH2;CTSB;CD68;DNAJB5;CSMD2;ACOT1;PLXNB3;GPC4;DHX32;SNX9;TYSND1;PODXL;SLCO4A1;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;EVI5L;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;TTC7B;RSAD1;GRK5;HTR7;NMRK1;STRADB;RDH14;NME4;MALL;CRTAP;RSPH3;ASPH;GLCCI1;MCTP1;GDI1;CEMIP;VWA5A;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;WISP1;SLFN5;PAK1;RASA3;CEP170;SOCS2;TRIB2;ATXN10;NEK9;KIAA1549;RHPN1;ZNF652;CBR4;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;NUDCD3;B4GALNT4;EDNRA;LCN2;HAGH;NUCB2;SHANK2;SLITRK6;SCRN1;EPHA1;IMPACT;RALGAPA2;PLPP6;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;ACP5;TIGD2;KLHDC2;PTPN12;ALDH1L2;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;ICA1;EIF4E3;AGPAT4;LPAR3;PCMTD2;FAM155B;KIF21B;ASNS;FGFR1;ABHD10;ITGA1;AARS;E2F5;FAM114A1;EPCAM;TMOD2;MARCH4;TUB;PTPDC1;LPCAT4;TACC1;TCFL5;RNPEPL1;UROS;NFAT5;ITGB5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;AIG1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;FAT1;INTS8;ZNF81;LONP2;INPP5F;CHAC1;BIVM;ATRX;FAM20C;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;GAMT;CEP120;ENDOV;ZNF558;KDSR;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PRR9;SLC5A1;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLEK2;PLA2G4D;HES2;ANXA6;NLGN2;CD46;ZBTB10;ACAD10;PHF12;MVB12B;EPOR;CTH;ZNF704;MPDZ;FAM50A;MAP6;LRP5;ETAA1;NIPA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;THBS3;CTSL;DOCK9;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;NTNG1;GFPT1;PCSK6;SLC35G2;TPBG;TOM1L2;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;FBXL8;BTBD3;RIMS3;PLPPR2;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;INPP4A;RFX2;SYTL1;HIBADH;ADGRB2;TTYH3;KIAA1147;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;DDX60;UHRF2;SLC2A9;RASIP1;GSDMA;PROCR;C6ORF120;TAOK1;PLD3;PHC3;AEBP1;ATP10D;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;SUGCT;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;ANO1;MSRB2;FAM84B;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;KLHL29;MAST3;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;SLC6A14;ZNF337;BEX4;TBC1D2B;THRA;LMBR1L;MGLL;GOLGA6L9;CD99;WNT2B;ENKD1;ACVR1B;DBNDD1;NDUFA4L2;SLC43A1;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;MARK4;NPL;ZNF449;PTPRZ1;CHD6;NUDT6;SPESP1;PER3;MTA1;AZIN2;BCL2L1;IFITM1;CRAT;MYH16;RNF165;YTHDC2;PM20D2;GRIN3B;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;SKAP2;ARF4;GOLGA2P5;H2AFJ;POLL;TMEM187;ANAPC13;YPEL5;UAP1;CNNM1;HSD17B7;SLC12A7;PCYOX1;XBP1;PANK4;SPIRE1;NFU1;UBASH3B;TXNRD3;CADM4;MAP2K2;ABHD6;SATB1;SLC22A17;PPP1R2;PAIP1;ARRDC1;REC8;CYP4F22;ANKIB1;MICU3;LYPLAL1;TLE4;SLC38A2;RIN1;TRPC1;RET;SPATA6;SDR9C7;FAM222B;TUBG2;STX10;LOXL2;PDE5A;VWA1;TCTN1;RAB43;MLH3;OSBPL5;SLC13A3;NAV1;SH3PXD2B;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;MBOAT7;NOP10;NCKAP1;GABARAPL2;EPM2A;KCNJ15;RMRP;GTF2IRD2;DNASE1L1;ELMO3;DOCK11;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;TSPAN3;RNF135;PSD3;TMBIM1;ETV1;FRMD4B;COL1A2;SFXN3;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;SNX30;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;RHOBTB1;BCAP29;AP2A2;SRD5A3;NR2F6;SLC39A10;KDELR3;CMTM6;SCAND1;IL1RAP;SBNO1;SLC25A43;ST6GALNAC2;ORAI1;CARD11;FCHO1;LAMB2;LTB4R;FICD;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;NRSN2;ACP6;TMEM134;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;SLC2A13;ZSCAN18;GRB10;LARP1B;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;SLC10A6;TMEM63A;CITED4;SNX6;EVA1A;USP20;ANKRD50;ZFP30;GRB7;TRIQK;SRPX2;PPL;ALDH1A2;GPR153;ARHGAP29;LYPLA1;TMEM50B;ATP12A;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;ROBO3;GARS;IL20RB;CLDN11;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;IKBIP;PHF21A;ZBTB40;ZNF92;WDR60;ACAP2;MPLKIP;MAML3;ZNF568;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;OSGEPL1;PLCXD1;FZD8;TMEM107;CMC1;WASL;USP32;ANKS6;RAPGEFL1;REEP6;HSPA2;PRSS8;ZNF107;FLNB;LRP6;ARID5B;ZNF165;SYT2;PLCH2;TMEM173;RNF180;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;SEMA6C;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;TNRC6C;TRIM2;COQ2;RCAN1;TET1;OMG;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;RNF103;USP25;LRP3;PANK1;PRMT3;REEP3;NYAP1;UFL1;VSIG10L;FAM162A;ANKRD6;SNX27;N4BP2;AMACR;GALE;PBX3;JARID2;PPM1M;SLC23A2;RALGPS2;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
8311,GO:0033143,0.915969456991019,0.199151769191857,3,62,regulation of intracellular steroid hormone receptor signaling pathway,BP,PAK1;FOXP1;UFL1
2968,GO:0006506,0.916034036436195,0.300512845596797,1,32,GPI anchor biosynthetic process,BP,PIGH
2877,GO:0006370,0.916560797267779,0.299196374341225,1,32,7-methylguanosine mRNA capping,BP,CMTR2
18350,GO:1903320,0.917030945788395,0.137806057700025,11,188,regulation of protein modification by small protein conjugation or removal,BP,TNIP1;FYN;FKBP1A;SOX4;FBXO2;TRIB3;MTA1;RAB1A;WFS1;PRMT3;UFL1
2267,GO:0005198,0.917309163495765,0.113142357019271,33,510,structural molecule activity,MF,TFPI2;MARVELD1;MAP1B;LAMB1;SNTB2;ANK3;DLG1;MALL;ASPH;SEPT10;SHANK2;OBSCN;APOE;RGS14;AKAP9;WWC3;OBSL1;PRR9;MRPS6;SLC9A3R2;CLTCL1;COPB1;COPG1;SEPT5;TUBG2;COL1A2;EPB41L3;LAMB2;PPL;CLDN11;DEDD2;SEPT6;RB1CC1
14792,GO:0070498,0.917669173679311,0.177900926267853,4,93,interleukin-1-mediated signaling pathway,BP,PSMD2;BTRC;PSMD7;IL1RAP
13178,GO:0051783,0.918122545769872,0.14265138650486,9,153,regulation of nuclear division,BP,HECW2;ATRX;OBSL1;LRP5;TOM1L2;PRKAR1A;CCSAP;NEK6;IGF2
2819,GO:0006283,0.9184509447033,0.193665641561493,3,73,transcription-coupled nucleotide-excision repair,BP,ERCC1;ERCC6;TCEA1
3798,GO:0008375,0.918609197615266,0.223630445044963,2,49,acetylglucosaminyltransferase activity,MF,B3GNT3;PIGH
4765,GO:0010948,0.918667499222203,0.122721461774227,18,295,negative regulation of cell cycle process,BP,FHL1;CCND1;PSMD2;BRSK1;PKD2;HMGA2;ATRX;SOX4;TOM1L2;TAOK1;PHC3;PSMD7;PRKAR1A;NACC2;PPP1R10;E2F7;KAT2B;CNOT11
17830,GO:1901989,0.918760012253259,0.193553060901822,3,66,positive regulation of cell cycle phase transition,BP,CCND1;CCND2;HYAL1
6689,GO:0030057,0.918794051067309,0.296407966454146,1,24,desmosome,CC,PPL
18684,GO:1904030,0.91896040007418,0.294361999497864,1,28,negative regulation of cyclin-dependent protein kinase activity,BP,KAT2B
77,GO:0000154,0.919146161017974,0.292189879217267,1,34,rRNA modification,BP,NOP10
11338,GO:0045661,0.919224091984233,0.293692876059395,1,28,regulation of myoblast differentiation,BP,DDIT3
15994,GO:0086002,0.919226890048755,0.29530854376752,1,24,cardiac muscle cell action potential involved in contraction,BP,DLG1
19283,GO:1905515,0.919362386634664,0.222310063112638,2,47,non-motile cilium assembly,BP,BBS2;TMEM107
14135,GO:0061001,0.919393164277148,0.294429689486971,1,25,regulation of dendritic spine morphogenesis,BP,EEF2K
11271,GO:0045576,0.919453375918124,0.292776782531352,1,29,mast cell activation,BP,RAC2
12954,GO:0051321,0.919493844728316,0.140575469051525,9,153,meiotic cell cycle,BP,ERCC1;PRKACB;ATRX;PRKAR1A;SPIRE1;REC8;TUBG2;MLH3;HSPA2
8156,GO:0032885,0.919895684212348,0.293604922605815,1,24,regulation of polysaccharide biosynthetic process,BP,IGF2
6887,GO:0030397,0.920182078227862,0.220720672953735,2,46,membrane disassembly,BP,NEK9;NEK6
12787,GO:0051081,0.920182078227862,0.220720672953735,2,46,nuclear envelope disassembly,BP,NEK9;NEK6
12649,GO:0050853,0.920414501841833,0.290660821805299,1,28,B cell receptor signaling pathway,BP,SLC39A10
7596,GO:0031967,0.920637805801139,0.100359642426274,65,974,organelle envelope,CC,SORL1;SYNE3;CYP27B1;PRNP;XPOT;SLC16A3;FAM210B;HADH;SNPH;EGFR;ARMCX2;BNIP3;IDH2;UBXN4;WDFY3;GRK5;NME4;ACAD11;PAK1;NUCB2;SCRN1;RAC2;CLCA2;BNIP3L;CCND2;KLHDC2;OCIAD2;ITPR3;SPATA18;MRPS6;CST3;COX18;MYOF;SLC2A9;TST;SLC25A4;NDUFV3;CPT2;CRLS1;BOK;NIPSNAP1;NDUFA4L2;BPHL;MTA1;BCL2L1;CRAT;AGPAT3;MICU3;PUM2;SLC30A1;SFXN3;SLC25A30;SLC25A43;MOAP1;AK9;ATP11B;TMEM173;RNF180;SIGMAR1;COQ2;ARMCX3;PSEN2;CDS2;SLC44A1;RB1CC1
7600,GO:0031975,0.920637805801139,0.100359642426274,65,974,envelope,CC,SORL1;SYNE3;CYP27B1;PRNP;XPOT;SLC16A3;FAM210B;HADH;SNPH;EGFR;ARMCX2;BNIP3;IDH2;UBXN4;WDFY3;GRK5;NME4;ACAD11;PAK1;NUCB2;SCRN1;RAC2;CLCA2;BNIP3L;CCND2;KLHDC2;OCIAD2;ITPR3;SPATA18;MRPS6;CST3;COX18;MYOF;SLC2A9;TST;SLC25A4;NDUFV3;CPT2;CRLS1;BOK;NIPSNAP1;NDUFA4L2;BPHL;MTA1;BCL2L1;CRAT;AGPAT3;MICU3;PUM2;SLC30A1;SFXN3;SLC25A30;SLC25A43;MOAP1;AK9;ATP11B;TMEM173;RNF180;SIGMAR1;COQ2;ARMCX3;PSEN2;CDS2;SLC44A1;RB1CC1
18806,GO:1904357,0.921237910200724,0.289296032622691,1,26,negative regulation of telomere maintenance via telomere lengthening,BP,XRN1
1043,GO:0002562,0.921259467632139,0.218584356848319,2,45,somatic diversification of immune receptors via germline recombination within a single locus,BP,ERCC1;RAG1
5501,GO:0016444,0.921259467632139,0.218584356848319,2,45,somatic cell DNA recombination,BP,ERCC1;RAG1
11627,GO:0046329,0.921600053135534,0.287622434816664,1,28,negative regulation of JNK cascade,BP,F2RL1
2967,GO:0006505,0.92212157687111,0.28482873706606,1,33,GPI anchor metabolic process,BP,PIGH
10062,GO:0042551,0.922317562242247,0.286515910043615,1,26,neuron maturation,BP,RET
1469,GO:0003725,0.922555645152354,0.186534039872642,3,63,double-stranded RNA binding,MF,DDX60;EIF2AK2;OAS1
17829,GO:1901988,0.923225591895585,0.126173050039615,12,215,negative regulation of cell cycle phase transition,BP,FHL1;CCND1;PSMD2;BRSK1;PKD2;HMGA2;SOX4;TAOK1;PSMD7;NACC2;E2F7;CNOT11
3354,GO:0007088,0.923367418696022,0.138579678058052,8,140,regulation of mitotic nuclear division,BP,HECW2;ATRX;OBSL1;LRP5;TOM1L2;CCSAP;NEK6;IGF2
8361,GO:0033238,0.923489550400116,0.212183443301199,2,60,regulation of cellular amine metabolic process,BP,PSMD2;PSMD7
4252,GO:0009452,0.924180165358844,0.279500618662109,1,33,7-methylguanosine RNA capping,BP,CMTR2
9531,GO:0036260,0.924180165358844,0.279500618662109,1,33,RNA capping,BP,CMTR2
1307,GO:0003151,0.924574663126466,0.211498566083003,2,45,outflow tract morphogenesis,BP,TGFBR2;TBX1
2739,GO:0006120,0.9245816607131,0.276326495945811,1,45,mitochondrial electron transport, NADH to ubiquinone,BP,NDUFV3
18536,GO:1903725,0.924652041738611,0.211188406183772,2,46,regulation of phospholipid metabolic process,BP,LPCAT1;MTMR4
15277,GO:0071456,0.924659666973422,0.136354087617424,8,151,cellular response to hypoxia,BP,PSMD2;BNIP3;BNIP3L;PSMD7;ADAM8;ENDOG;FAM162A;DNMT3A
3366,GO:0007127,0.924776170327572,0.181945581383062,3,67,meiosis I,BP,REC8;MLH3;HSPA2
14668,GO:0070268,0.924777237926563,0.181556461184633,3,73,cornification,BP,PCSK6;PPL;PRSS8
6446,GO:0021762,0.92483982847518,0.278299920023665,1,31,substantia nigra development,BP,GLUD1
4602,GO:0010717,0.925026082065474,0.181843300622124,3,62,regulation of epithelial to mesenchymal transition,BP,WWTR1;TGFBR2;LOXL2
16720,GO:0097711,0.925135597149298,0.15436986462296,5,94,ciliary basal body-plasma membrane docking,BP,TTBK2;AKAP9;MARK4;TCTN1;PRKACA
13777,GO:0060359,0.925505957191682,0.180675534883515,3,65,response to ammonium ion,BP,ATF4;DNMT3A;FADD
2269,GO:0005200,0.92552984424934,0.164422055225431,4,80,structural constituent of cytoskeleton,MF,ANK3;TUBG2;EPB41L3;PPL
7618,GO:0032008,0.925579554953415,0.27664881275632,1,30,positive regulation of TOR signaling,BP,AKT3
2498,GO:0005746,0.925585068147902,0.206889163751198,2,72,mitochondrial respiratory chain,CC,NDUFV3;NDUFA4L2
653,GO:0001843,0.925604112409915,0.164567252858302,4,75,neural tube closure,BP,PRKACB;DVL1;LRP6;PTCH1
13941,GO:0060606,0.925604112409915,0.164567252858302,4,75,tube closure,BP,PRKACB;DVL1;LRP6;PTCH1
9387,GO:0035924,0.925860780550993,0.276544122492642,1,28,cellular response to vascular endothelial growth factor stimulus,BP,XDH
8587,GO:0034080,0.926154631627886,0.272941330739188,1,40,CENP-A containing nucleosome assembly,BP,RSF1
14393,GO:0061641,0.926154631627886,0.272941330739188,1,40,CENP-A containing chromatin organization,BP,RSF1
5404,GO:0016242,0.926403234492777,0.274787693248359,1,29,negative regulation of macroautophagy,BP,QSOX1
4074,GO:0009127,0.926431542642612,0.144223316156661,6,115,purine nucleoside monophosphate biosynthetic process,BP,DHTKD1;PGM1;LDHA;PPARA;TMSB4X;AK9
4113,GO:0009168,0.926431542642612,0.144223316156661,6,115,purine ribonucleoside monophosphate biosynthetic process,BP,DHTKD1;PGM1;LDHA;PPARA;TMSB4X;AK9
948,GO:0002367,0.926571941496645,0.206306203068658,2,52,cytokine production involved in immune response,BP,DLG1;F2RL1
5990,GO:0018958,0.927288160580607,0.205350088148673,2,47,phenol-containing compound metabolic process,BP,TRPC1;RNF180
10542,GO:0043489,0.927930213505968,0.270744448850955,1,29,RNA stabilization,BP,PAIP1
6728,GO:0030140,0.928018059326231,0.270836948969404,1,28,trans-Golgi network transport vesicle,CC,CLTCL1
6927,GO:0030520,0.928197651628434,0.203503713532803,2,46,intracellular estrogen receptor signaling pathway,BP,PAK1;UFL1
19187,GO:1905269,0.928557874332698,0.158905739464088,4,80,positive regulation of chromatin organization,BP,NOS1;PHF1;TET1;JARID2
3356,GO:0007091,0.928906383464972,0.201567567883559,2,49,metaphase/anaphase transition of mitotic cell cycle,BP,HECW2;NEK6
10988,GO:0044784,0.928906383464972,0.201567567883559,2,49,metaphase/anaphase transition of cell cycle,BP,HECW2;NEK6
5782,GO:0017004,0.929009256692662,0.266535267022432,1,34,cytochrome complex assembly,BP,COX18
16980,GO:0099023,0.929253888864389,0.173348257653657,3,65,tethering complex,CC,EXOC2;VPS11;COG8
647,GO:0001837,0.929367930041297,0.147032696531873,5,94,epithelial to mesenchymal transition,BP,WWTR1;TGFBR2;HMGA2;LOXL2;LRP6
7217,GO:0031111,0.929372678577845,0.267567952917978,1,27,negative regulation of microtubule polymerization or depolymerization,BP,TTBK2
8226,GO:0032984,0.929416121137201,0.110374060637152,16,275,protein-containing complex disassembly,BP,MAP1B;BNIP3;TTBK2;ASPH;FYCO1;TMOD2;SNX14;MRPS6;DVL1;LRP5;TWF2;DNAJC6;F2RL1;GABARAPL2;CCSAP;LRP6
20092,GO:2000756,0.92961517990629,0.199896770667273,2,50,regulation of peptidyl-lysine acetylation,BP,NOS1;SOX4
11112,GO:0045132,0.929680206684562,0.199871737380707,2,49,meiotic chromosome segregation,BP,REC8;MLH3
1342,GO:0003205,0.929713618304608,0.139103917267368,6,103,cardiac chamber development,BP,LTBP1;TGFBR2;FKBP1A;SOX4;CHD7;TBX1
4070,GO:0009123,0.929993630652326,0.110904654756917,15,270,nucleoside monophosphate metabolic process,BP,NT5E;TK2;DHTKD1;PGM1;DLG1;DLG4;DLG3;LDHA;PPARA;FAM20C;NDUFV3;TMSB4X;CARD11;ATP6V1B2;AK9
7838,GO:0032392,0.930362458070854,0.155543089783765,4,81,DNA geometric change,BP,SMARCA1;XPC;ATRX;DDB2
6770,GO:0030204,0.930365032868591,0.264898471019183,1,27,chondroitin sulfate metabolic process,BP,HYAL1
5149,GO:0015682,0.930475489689126,0.263082183753706,1,32,ferric iron transport,BP,ATP6V1B2
15816,GO:0072512,0.930475489689126,0.263082183753706,1,32,trivalent inorganic cation transport,BP,ATP6V1B2
1451,GO:0003684,0.930637316152499,0.170547411263152,3,66,damaged DNA binding,MF,ERCC1;XPC;DDB2
13471,GO:0055006,0.930811754578696,0.198363758278871,2,42,cardiac cell development,BP,PAK1;OBSL1
6280,GO:0019884,0.930862673015812,0.130896670828642,7,144,antigen processing and presentation of exogenous antigen,BP,PSMD2;SEC23A;ITGB5;CTSL;PSMD7;AP2A2;AP3D1
8155,GO:0032881,0.931153022478118,0.263143333106405,1,26,regulation of polysaccharide metabolic process,BP,IGF2
12908,GO:0051254,0.931369650862541,0.0851933405906206,86,1120,positive regulation of RNA metabolic process,BP,TNIP1;NOS1;F2R;ETV5;ITGA6;NR1D1;NFATC4;MAP2K1;ETV4;SALL2;WWTR1;PEG3;APLN;POU2F2;TEF;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;HLTF;ERCC6;ZNF516;WNT7A;SHC1;CCPG1;PKD2;DDN;HMGA2;ATF4;PPARA;E2F5;EPCAM;NFAT5;BTRC;ATRX;CHURC1;SOX4;FHOD1;ATF7IP;TCEA1;TNRC6B;DVL1;LRP5;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;PHF1;CHD7;PARP9;THRA;ACVR1B;NGFR;CHD6;MEF2D;ARF4;XBP1;MAP2K2;RET;EAPP;ETV1;ZNF398;IFI16;TBL1X;ARID4A;EFCAB7;PPARG;CITED4;TBX1;CREB3L2;RSF1;MAML3;FZD8;LRP6;TMEM173;E2F7;TNRC6C;TET1;ARMCX3;PTCH1;KAT2B;PBX3;FADD
4779,GO:0010965,0.931696139969034,0.195311108629873,2,50,regulation of mitotic sister chromatid separation,BP,HECW2;NEK6
15008,GO:0070936,0.932531126718101,0.193575421369712,2,49,protein K48-linked ubiquitination,BP,UBE2G1;UBE2E1
5528,GO:0016504,0.932613939903451,0.257285428346077,1,32,peptidase activator activity,MF,MMP14
2492,GO:0005740,0.932874685208278,0.0920220862009322,36,618,mitochondrial envelope,CC,CYP27B1;FAM210B;HADH;SNPH;ARMCX2;BNIP3;IDH2;NME4;ACAD11;BNIP3L;OCIAD2;SPATA18;MRPS6;COX18;TST;SLC25A4;NDUFV3;CPT2;CRLS1;BOK;NIPSNAP1;NDUFA4L2;BPHL;BCL2L1;CRAT;MICU3;SFXN3;SLC25A30;SLC25A43;MOAP1;TMEM173;COQ2;ARMCX3;PSEN2;CDS2;SLC44A1
13272,GO:0051959,0.933233461679803,0.258789540871131,1,23,dynein light intermediate chain binding,MF,CCDC88A
15323,GO:0071539,0.93324601980456,0.257434987399985,1,26,protein localization to centrosome,BP,NUDCD3
2711,GO:0006084,0.933451260806896,0.255833849177819,1,29,acetyl-CoA metabolic process,BP,MLYCD
4071,GO:0009124,0.933516581259838,0.126726250238463,7,135,nucleoside monophosphate biosynthetic process,BP,TK2;DHTKD1;PGM1;LDHA;PPARA;TMSB4X;AK9
11479,GO:0045935,0.933767529788007,0.0813927473295345,98,1279,positive regulation of nucleobase-containing compound metabolic process,BP,TNIP1;NOS1;ERCC1;F2R;ETV5;ITGA6;NR1D1;NFATC4;MAP2K1;ETV4;RAPGEF3;SALL2;WWTR1;PEG3;APLN;POU2F2;TEF;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;HLTF;ERCC6;ZNF516;WNT7A;SHC1;APOE;CCPG1;PKD2;DDN;ANXA3;HMGA2;ATF4;PPARA;FGFR1;E2F5;EPCAM;NFAT5;BTRC;ATRX;CHURC1;SOX4;FHOD1;ATF7IP;TCEA1;TNRC6B;DVL1;LRP5;CST3;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;PHF1;PTHLH;CHD7;PARP9;THRA;ACVR1B;NGFR;PPP1R10;CHD6;MEF2D;ARF4;XBP1;MAP2K2;RET;EAPP;ETV1;ZNF398;TMSB4X;TIMP2;IFI16;TBL1X;ARID4A;EFCAB7;PPARG;CITED4;TBX1;CREB3L2;RSF1;ENDOG;MAML3;FZD8;LRP6;TMEM173;E2F7;TNRC6C;TET1;ARMCX3;PTCH1;KAT2B;PBX3;ADNP;FADD
8697,GO:0034330,0.933841646919278,0.10732625462366,14,205,cell junction organization,BP,F2R;FLNC;ITGA6;ITGB4;SDK2;DLG1;ITGA2;MMP14;NLGN2;SLK;F2RL1;PRKACA;EPB41L3;LAMA5
2524,GO:0005778,0.933941390031048,0.190206652802117,2,51,peroxisomal membrane,CC,ABCD1;MAP2K2
7561,GO:0031903,0.933941390031048,0.190206652802117,2,51,microbody membrane,CC,ABCD1;MAP2K2
13762,GO:0060338,0.934121158552615,0.253992378077757,1,29,regulation of type I interferon-mediated signaling pathway,BP,FADD
8703,GO:0034340,0.934373739452926,0.162675284684816,3,73,response to type I interferon,BP,IFITM1;OAS1;FADD
12366,GO:0048747,0.934456376272972,0.253731037368322,1,27,muscle fiber development,BP,FLNC
14794,GO:0070507,0.934555843162105,0.117451882536318,9,148,regulation of microtubule cytoskeleton organization,BP,MAP1B;TTBK2;PAK1;AKAP9;CEP120;TAOK1;CCSAP;KAT2B;GNAI1
4664,GO:0010812,0.934977093472588,0.188621004025485,2,45,negative regulation of cell-substrate adhesion,BP,POSTN;MMP14
11725,GO:0046530,0.935135488898743,0.251508692771714,1,28,photoreceptor cell differentiation,BP,SDK2
16490,GO:0097178,0.935328976577541,0.249822151335967,1,32,ruffle assembly,BP,PFN2
9605,GO:0036464,0.935609523499247,0.115607741818174,9,160,cytoplasmic ribonucleoprotein granule,CC,BTBD2;PITPNM1;APOBEC3C;XRN1;TRIM5;TNRC6B;ATXN2;PUM2;GRB7
11246,GO:0045445,0.935686983809193,0.186399865050057,2,50,myoblast differentiation,BP,DDIT3;SDC1
10910,GO:0044455,0.935792699694146,0.122503161974476,7,166,mitochondrial membrane part,CC,BNIP3;COX18;SLC25A4;NDUFV3;NDUFA4L2;COQ2;ARMCX3
16727,GO:0097730,0.935887012571014,0.160205870253181,3,64,non-motile cilium,CC,MAP1B;SHANK2;PKD2
13230,GO:0051893,0.935896956520578,0.186689665470374,2,44,regulation of focal adhesion assembly,BP,MMP14;SLK
16123,GO:0090109,0.935896956520578,0.186689665470374,2,44,regulation of cell-substrate junction assembly,BP,MMP14;SLK
3363,GO:0007099,0.93593823004915,0.248960803697951,1,29,centriole replication,BP,KAT2B
12511,GO:0050654,0.935981724713584,0.249157057566789,1,28,chondroitin sulfate proteoglycan metabolic process,BP,HYAL1
3634,GO:0008094,0.936003809165619,0.145160667582568,4,79,DNA-dependent ATPase activity,MF,SMARCA1;ERCC6;ATRX;CHD6
2583,GO:0005875,0.936057795064988,0.122893299393665,7,119,microtubule associated complex,CC,CLIP2;MAP1B;KIF13B;NUDCD3;KIF21B;RANBP9;WDR60
7174,GO:0031055,0.936087580682989,0.245825529862454,1,42,chromatin remodeling at centromere,BP,RSF1
3325,GO:0007032,0.936105400160019,0.159430509874336,3,69,endosome organization,BP,CLCN3;VPS11;MVB12A
13219,GO:0051879,0.936127967889847,0.247861136581202,1,31,Hsp90 protein binding,MF,CSNK2A1
6861,GO:0030330,0.936888494024503,0.13352996666415,5,101,DNA damage response, signal transduction by p53 class mediator,BP,CD44;ATRX;SOX4;E2F7;CNOT11
2582,GO:0005874,0.93697340499938,0.093356952108704,23,332,microtubule,CC,CLIP2;MAP1B;SNTB2;SNPH;KIF13B;DLG1;CEP170;RGS14;KIF21B;FAM110C;DVL1;MAP6;SPRY2;BEX4;ENKD1;MTA1;MAP2K2;TUBG2;NAV1;CCSAP;NEK6;TBL1X;REEP3
284,GO:0000786,0.937184793837215,0.180813966021411,2,84,nucleosome,CC,H1F0;H2AFJ
7885,GO:0032452,0.937270876224138,0.246656052542713,1,25,histone demethylase activity,MF,ARID5B
17488,GO:1900408,0.937315168379562,0.244045535938792,1,33,negative regulation of cellular response to oxidative stress,BP,ATF4
18296,GO:1903202,0.937315168379562,0.244045535938792,1,33,negative regulation of oxidative stress-induced cell death,BP,ATF4
2580,GO:0005871,0.937491534590819,0.183073730959727,2,44,kinesin complex,CC,KIF13B;KIF21B
11318,GO:0045637,0.937543397367304,0.109582840921934,10,185,regulation of myeloid cell differentiation,BP,CTNNBIP1;FAM210B;CEACAM1;TNRC6B;ACVR1B;UBASH3B;TNRC6C;FOXP1;KAT2B;FADD
10627,GO:0043624,0.937578029422094,0.11226749142214,9,179,cellular protein complex disassembly,BP,MAP1B;TTBK2;ASPH;TMOD2;MRPS6;TWF2;DNAJC6;F2RL1;CCSAP
2865,GO:0006356,0.937619018679976,0.243964222003408,1,30,regulation of transcription by RNA polymerase I,BP,ATF4
12092,GO:0048066,0.937642672733598,0.243897724067809,1,30,developmental pigmentation,BP,AP3D1
12777,GO:0051052,0.937669524046007,0.0938253386699704,21,324,regulation of DNA metabolic process,BP,ERCC1;EGFR;SHC1;ANXA3;HMGA2;FGFR1;ATRX;XRN1;CST3;CEBPG;UHRF2;PARP9;PPP1R10;CCDC88A;RNF169;PPARG;ENDOG;MAGEF1;E2F7;TET1;KLHL15
9743,GO:0038202,0.938226305076928,0.241980531847905,1,31,TORC1 signaling,BP,CARD11
1462,GO:0003712,0.938367317171692,0.0870592840542652,31,456,transcription cofactor activity,MF,ZMYND8;CCND1;NR1D1;NFATC4;PKN1;WWTR1;DDIT3;SOX12;ELK3;PPARA;SOX4;ATF7IP;RCOR1;PHF12;KLF12;TRIB3;AEBP1;JMY;THRA;MTA1;TLE4;SCAND1;TBL1X;PPARG;CITED4;PHF21A;MAML3;ARID5B;E2F7;KAT2B;MXD4
368,GO:0000989,0.938700368685206,0.0847401784343872,36,517,transcription factor activity, transcription factor binding,MF,ZMYND8;CCND1;NR1D1;NFATC4;PKN1;WWTR1;DDIT3;SOX12;ELK3;HMGA2;ATF4;PPARA;SOX4;ATF7IP;RCOR1;PHF12;KLF12;TRIB3;AEBP1;JMY;PARP9;NACC2;THRA;PER3;MTA1;TLE4;SCAND1;TBL1X;PPARG;CITED4;PHF21A;MAML3;ARID5B;E2F7;KAT2B;MXD4
6810,GO:0030261,0.938828969552484,0.24115625559616,1,28,chromosome condensation,BP,HMGA2
12261,GO:0048545,0.939083073957447,0.0956091831177368,17,270,response to steroid hormone,BP,CCND1;PCK2;NR1D1;EIF4EBP1;EGFR;SDC1;PAK1;TGFBR2;ANXA3;PPARA;THRA;GLB1;NR2F6;PPARG;IGFBP7;FOXP1;UFL1
14030,GO:0060759,0.939118469168373,0.117468843196094,7,135,regulation of response to cytokine stimulus,BP,RBCK1;CASP4;F2RL1;PARP9;AGPAT1;PPARG;FADD
4106,GO:0009161,0.939475237227695,0.0987005852034842,14,258,ribonucleoside monophosphate metabolic process,BP,NT5E;DHTKD1;PGM1;DLG1;DLG4;DLG3;LDHA;PPARA;FAM20C;NDUFV3;TMSB4X;CARD11;ATP6V1B2;AK9
5746,GO:0016893,0.939491727987778,0.23746961929851,1,35,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,ENDOV
18400,GO:1903428,0.939631861679427,0.237999329792341,1,31,positive regulation of reactive oxygen species biosynthetic process,BP,PKD2
19610,GO:1990752,0.93971618483178,0.23972775854484,1,25,microtubule end,CC,CLIP2
36,GO:0000075,0.939817264377657,0.101711655412163,12,208,cell cycle checkpoint,BP,CCND1;BRSK1;DLG1;XPC;HMGA2;SOX4;ETAA1;TAOK1;PPP1R10;BCL2L1;E2F7;CNOT11
17535,GO:1901030,0.940063083191929,0.235845155719718,1,35,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
8679,GO:0034250,0.940084782511335,0.120932469263804,6,122,positive regulation of cellular amide metabolic process,BP,IMPACT;ITGA2;SOX4;PAIP1;PPARG;DNAJC3
16756,GO:0098534,0.940420060834124,0.236022444366761,1,30,centriole assembly,BP,KAT2B
12947,GO:0051306,0.940551327585182,0.175111156423117,2,52,mitotic sister chromatid separation,BP,HECW2;NEK6
1146,GO:0002753,0.940593111050684,0.17522244733135,2,50,cytoplasmic pattern recognition receptor signaling pathway,BP,DDX60;PUM2
15143,GO:0071242,0.940904521031082,0.234111782717318,1,32,cellular response to ammonium ion,BP,ATF4
10283,GO:0043028,0.940956605063034,0.233962475523031,1,32,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,PRDX5
17849,GO:1902036,0.941019055109035,0.14831140360785,3,95,regulation of hematopoietic stem cell differentiation,BP,PSMD2;PSMD7;EIF2AK2
19282,GO:1905508,0.941085878953785,0.23504851413134,1,27,protein localization to microtubule organizing center,BP,NUDCD3
11758,GO:0046605,0.941299424954066,0.173592054532058,2,50,regulation of centrosome cycle,BP,CEP120;KAT2B
4674,GO:0010822,0.941453679637412,0.113496831968037,7,139,positive regulation of mitochondrion organization,BP,BNIP3;RAC2;VPS11;BOK;MOAP1;DDHD2;FAM162A
19477,GO:1990204,0.941559527179695,0.147400072711151,3,89,oxidoreductase complex,CC,DHTKD1;CBR4;NDUFV3
1111,GO:0002700,0.941656809484097,0.147941648892539,3,72,regulation of production of molecular mediator of immune response,BP,PKN1;F2RL1;XBP1
4251,GO:0009451,0.941755442850447,0.117862688616723,6,131,RNA modification,BP,ADARB1;AARS;APOBEC3C;NOP10;OSGEPL1;CMTR2
15861,GO:0072577,0.942490640647043,0.230349357574388,1,29,endothelial cell apoptotic process,BP,ANGPTL4
15790,GO:0072401,0.94264547786364,0.145900659957759,3,72,signal transduction involved in DNA integrity checkpoint,BP,SOX4;E2F7;CNOT11
15794,GO:0072422,0.94264547786364,0.145900659957759,3,72,signal transduction involved in DNA damage checkpoint,BP,SOX4;E2F7;CNOT11
8970,GO:0035050,0.942941917260465,0.170119436312334,2,47,embryonic heart tube development,BP,TGFBR2;PKD2
4441,GO:0010332,0.943122615307818,0.16935784952278,2,50,response to gamma radiation,BP,ERCC6;BCL2L1
12945,GO:0051304,0.943165689183676,0.144991746410198,3,69,chromosome separation,BP,HECW2;CSNK2A1;NEK6
5749,GO:0016896,0.943615713594479,0.226273981588229,1,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,XRN1
17279,GO:0140013,0.943758941812855,0.121091001907006,5,103,meiotic nuclear division,BP,PRKAR1A;SPIRE1;REC8;MLH3;HSPA2
15965,GO:0075733,0.943834870795021,0.167490562189228,2,52,intracellular transport of virus,BP,MVB12B;MVB12A
8157,GO:0032886,0.944207139425406,0.0994185419729532,10,166,regulation of microtubule-based process,BP,BBS2;MAP1B;TTBK2;PAK1;AKAP9;CEP120;TAOK1;CCSAP;KAT2B;GNAI1
4823,GO:0014020,0.94481106578746,0.128332703566534,4,80,primary neural tube formation,BP,PRKACB;DVL1;LRP6;PTCH1
2787,GO:0006220,0.945044939131466,0.220414006115187,1,41,pyrimidine nucleotide metabolic process,BP,NME4
2853,GO:0006338,0.945053707749443,0.103597835415452,8,155,chromatin remodeling,BP,SMARCA1;SCMH1;HMGA2;ATRX;CHD7;SATB1;RSF1;KAT2B
20280,GO:2001251,0.945380401730351,0.111969653796161,6,111,negative regulation of chromosome organization,BP,ERCC1;ATRX;XRN1;PHF1;TET1;JARID2
5439,GO:0016303,0.945429717601115,0.222732358245214,1,26,1-phosphatidylinositol-3-kinase activity,MF,FGFR1
367,GO:0000988,0.945855811583452,0.0754795907634938,36,522,transcription factor activity, protein binding,MF,ZMYND8;CCND1;NR1D1;NFATC4;PKN1;WWTR1;DDIT3;SOX12;ELK3;HMGA2;ATF4;PPARA;SOX4;ATF7IP;RCOR1;PHF12;KLF12;TRIB3;AEBP1;JMY;PARP9;NACC2;THRA;PER3;MTA1;TLE4;SCAND1;TBL1X;PPARG;CITED4;PHF21A;MAML3;ARID5B;E2F7;KAT2B;MXD4
2389,GO:0005525,0.945878836310946,0.0868436131107643,16,278,GTP binding,MF,RAB3B;PCK2;TGM2;SEPT10;RAC2;RAB31;ANXA6;SEPT5;GLUD1;ARF4;TUBG2;RAB43;RAB1A;RHOBTB1;SEPT6;GNAI1
110,GO:0000226,0.945977145362063,0.0774915758138572,30,426,microtubule cytoskeleton organization,BP,NEURL1;BBS2;MAP1B;BRSK1;DLG1;TTBK2;PAK1;RGS14;PKD2;AKAP9;TACC1;ATRX;CEP120;OBSL1;DVL1;MAP6;RANBP9;SLK;TAOK1;SPRY2;MARK4;GOLGA2P5;SPIRE1;TUBG2;NAV1;CCDC88A;CCSAP;NEK6;KAT2B;GNAI1
3338,GO:0007051,0.946382587493576,0.0985287886786352,9,155,spindle organization,BP,DLG1;RGS14;ATRX;CEP120;GOLGA2P5;TUBG2;CCSAP;NEK6;GNAI1
17487,GO:1900407,0.946489914899306,0.160967725827931,2,55,regulation of cellular response to oxidative stress,BP,ATF4;ENDOG
5565,GO:0016577,0.946525963938494,0.219123920143539,1,27,histone demethylation,BP,ARID5B
362,GO:0000980,0.946757740014663,0.160602512279459,2,52,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,NR2F6;PBX3
5557,GO:0016569,0.946866620284836,0.0776082764034766,27,396,covalent chromatin modification,BP,NOS1;ZMYND8;PKN1;JADE2;RAG1;HMGA2;ATRX;MTHFR;FKBP10;DDB2;RCOR1;UHRF2;PHF1;NACC2;MTA1;SATB1;UBE2E1;TBL1X;ARID4A;IGF2;PHF21A;ARID5B;TET1;KAT2B;PRMT3;JARID2;DNMT3A
15788,GO:0072395,0.947983763494042,0.134681822713321,3,73,signal transduction involved in cell cycle checkpoint,BP,SOX4;E2F7;CNOT11
8265,GO:0033045,0.948107609848559,0.134576306131573,3,70,regulation of sister chromatid segregation,BP,HECW2;ATRX;NEK6
16320,GO:0090502,0.948219571850723,0.156540736699729,2,59,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,ENDOV;LACTB2
3918,GO:0008585,0.948720879488597,0.133330391595302,3,69,female gonad development,BP,MMP14;BCL2L1;ARID5B
5669,GO:0016779,0.94877438791071,0.105634524949182,6,127,nucleotidyltransferase activity,MF,POLL;UAP1;RMRP;FICD;CDS2;OAS1
4339,GO:0009891,0.948840860900364,0.0634796931649572,100,1325,positive regulation of biosynthetic process,BP,TNIP1;NOS1;F2R;ETV5;ITGA6;NR1D1;NFATC4;MAP2K1;ETV4;RAPGEF3;SALL2;WWTR1;PEG3;APLN;POU2F2;TEF;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;HLTF;ERCC6;ZNF516;WNT7A;SHC1;IMPACT;APOE;CCPG1;PKD2;DDN;HMGA2;ATF4;PPARA;FGFR1;E2F5;EPCAM;NFAT5;BTRC;ITGA2;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ATF7IP;DVL1;NTSR1;LRP5;CST3;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;PHF1;PTHLH;CHD7;PARP9;THRA;ACVR1B;NGFR;CHD6;MEF2D;ARF4;XBP1;MAP2K2;ABHD6;PAIP1;RET;EAPP;ETV1;ZNF398;TMSB4X;TIMP2;IFI16;CARD11;TBL1X;ARID4A;IGF2;EFCAB7;PPARG;CITED4;TBX1;CREB3L2;RSF1;MAML3;FZD8;LRP6;TMEM173;E2F7;TET1;ARMCX3;DNAJC3;PTCH1;KAT2B;PBX3;ADNP;FADD
10442,GO:0043297,0.948981067033145,0.155592298437231,2,49,apical junction assembly,BP,DLG1;PRKACA
7408,GO:0031490,0.949088724836724,0.11953166254981,4,92,chromatin DNA binding,MF,H1F0;HMGA2;THRA;SBNO1
16037,GO:0086065,0.94912032481954,0.210169126435672,1,31,cell communication involved in cardiac conduction,BP,PRKACA
866,GO:0002204,0.949154634051514,0.209596280841974,1,33,somatic recombination of immunoglobulin genes involved in immune response,BP,ERCC1
867,GO:0002208,0.949154634051514,0.209596280841974,1,33,somatic diversification of immunoglobulins involved in immune response,BP,ERCC1
11144,GO:0045190,0.949154634051514,0.209596280841974,1,33,isotype switching,BP,ERCC1
14772,GO:0070469,0.949304202801028,0.152920668933184,2,78,respiratory chain,CC,NDUFV3;NDUFA4L2
7410,GO:0031492,0.949358007487648,0.207438026736849,1,42,nucleosomal DNA binding,MF,HMGA2
10689,GO:0043966,0.949358930253783,0.15412132136158,2,55,histone H3 acetylation,BP,JADE2;KAT2B
14814,GO:0070542,0.94955745553851,0.153907289780666,2,52,response to fatty acid,BP,NFATC4;PPARG
15995,GO:0086003,0.949585391805299,0.209293728544706,1,29,cardiac muscle cell contraction,BP,DLG1
17975,GO:1902373,0.949832969911623,0.207765733310355,1,32,negative regulation of mRNA catabolic process,BP,PAIP1
17941,GO:1902275,0.950185154415407,0.0952883736745301,8,141,regulation of chromatin organization,BP,NOS1;ATRX;MTHFR;UHRF2;PHF1;IGF2;TET1;JARID2
7400,GO:0031463,0.95055404245932,0.151594275543742,2,51,Cul3-RING ubiquitin ligase complex,CC,KLHL29;KLHL15
18383,GO:1903391,0.950590459883207,0.151924555816781,2,47,regulation of adherens junction organization,BP,MMP14;SLK
16258,GO:0090311,0.950609151230515,0.205399469155911,1,32,regulation of protein deacetylation,BP,BEX4
11159,GO:0045216,0.95061325185147,0.0872415433828555,11,174,cell-cell junction organization,BP,F2R;SDK2;DLG1;ITGA2;MMP14;NLGN2;SLK;F2RL1;PRKACA;EPB41L3;LAMA5
14549,GO:0070063,0.950703054254863,0.151048646272102,2,53,RNA polymerase binding,MF,STOM;YTHDC2
7951,GO:0032550,0.950960135011927,0.0794121969198473,16,281,purine ribonucleoside binding,MF,RAB3B;PCK2;TGM2;SEPT10;RAC2;RAB31;ANXA6;SEPT5;GLUD1;ARF4;TUBG2;RAB43;RAB1A;RHOBTB1;SEPT6;GNAI1
2902,GO:0006409,0.951048998171148,0.204052792533871,1,32,tRNA export from nucleus,BP,XPOT
15262,GO:0071431,0.951048998171148,0.204052792533871,1,32,tRNA-containing ribonucleoprotein complex export from nucleus,BP,XPOT
2854,GO:0006342,0.951126859297076,0.11510499711733,4,107,chromatin silencing,BP,UHRF2;H2AFJ;TET1;DNMT3A
1868,GO:0004532,0.951181929047618,0.203210404717899,1,34,exoribonuclease activity,MF,XRN1
905,GO:0002287,0.951292449601316,0.203081700102044,1,33,alpha-beta T cell activation involved in immune response,BP,FOXP1
908,GO:0002293,0.951292449601316,0.203081700102044,1,33,alpha-beta T cell differentiation involved in immune response,BP,FOXP1
909,GO:0002294,0.951292449601316,0.203081700102044,1,33,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,FOXP1
9848,GO:0042093,0.951292449601316,0.203081700102044,1,33,T-helper cell differentiation,BP,FOXP1
3629,GO:0008089,0.951425013211438,0.202464331278472,1,34,anterograde axonal transport,BP,AP3D1
8268,GO:0033048,0.951577455814082,0.201995795409761,1,34,negative regulation of mitotic sister chromatid segregation,BP,ATRX
17798,GO:1901888,0.951612912940829,0.127376218179305,3,65,regulation of cell junction assembly,BP,MMP14;SLK;PRKACA
13472,GO:0055007,0.951726981791298,0.127192770968534,3,64,cardiac muscle cell differentiation,BP,DKK1;PAK1;OBSL1
11467,GO:0045921,0.951946171505306,0.147857591683529,2,55,positive regulation of exocytosis,BP,SDC1;F2RL1
1778,GO:0004386,0.952243205658072,0.0918807446407915,8,138,helicase activity,MF,SMARCA1;HLTF;DHX32;ATRX;DDX60;CHD7;CHD6;YTHDC2
8582,GO:0034061,0.952946746189284,0.197764175535608,1,34,DNA polymerase activity,MF,POLL
2547,GO:0005815,0.953107530396243,0.0643288751705925,43,611,microtubule organizing center,CC,BBS2;MAP2K1;BRSK1;DYSF;PODXL;TTBK2;CEP170;NEK9;RGS14;PKD2;PRKACB;AKAP9;RAB11FIP4;ATF4;TACC1;PITPNM1;CEP120;GSDMC;OBSL1;FAM110C;ZNF322;ADGRB2;PROCR;PHF1;PSKH1;MVB12A;MARK4;BCL2L1;TUBG2;CCDC88A;CCSAP;PRKACA;NEK6;NIT2;TMEM63A;USP20;EVI5;WDR60;MPLKIP;DDHD2;PSEN2;KAT2B;GNAI1
17872,GO:1902106,0.953694177596047,0.143741089628323,2,53,negative regulation of leukocyte differentiation,BP,CEACAM1;UBASH3B
8263,GO:0033043,0.953752458177067,0.0593080183875373,75,1016,regulation of organelle organization,BP,NOS1;ERCC1;ZMYND8;HECW2;MAP2K1;RAPGEF3;SSH1;MAP1B;CAPN2;WIPF1;TBC1D14;BNIP3;ARAP1;DLG1;ESPN;EVI5L;TTBK2;SDC1;PAK1;EPHA1;RAC2;BNIP3L;AFAP1;LRP1;FYCO1;AKAP9;TMOD2;ATRX;MTHFR;PFN2;FHOD1;CEP120;OBSL1;LMAN1;XRN1;LRP5;TWF2;TOM1L2;VPS11;F2RL1;UHRF2;TAOK1;PHF1;ASAP1;PRKAR1A;JMY;BOK;ATXN2;USP6NL;TBC1D2B;PPP1R10;BCL2L1;WASF2;SPIRE1;MAP2K2;SH3PXD2B;NCKAP1;CCDC88A;CCSAP;NEK6;TMSB4X;RHOBTB1;LPAR1;ARPC1A;IGF2;MOAP1;EVI5;TBC1D16;DDHD2;WASL;TET1;KAT2B;FAM162A;JARID2;GNAI1
673,GO:0001883,0.953870091349094,0.075117459775452,16,283,purine nucleoside binding,MF,RAB3B;PCK2;TGM2;SEPT10;RAC2;RAB31;ANXA6;SEPT5;GLUD1;ARF4;TUBG2;RAB43;RAB1A;RHOBTB1;SEPT6;GNAI1
2954,GO:0006482,0.953957212908308,0.195794587456409,1,29,protein demethylation,BP,ARID5B
3707,GO:0008214,0.953957212908308,0.195794587456409,1,29,protein dealkylation,BP,ARID5B
16321,GO:0090503,0.954093903446553,0.193992237703753,1,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,XRN1
1463,GO:0003713,0.954094977625944,0.0748897257507087,16,261,transcription coactivator activity,MF,NR1D1;NFATC4;PKN1;WWTR1;SOX12;PPARA;SOX4;JMY;THRA;MTA1;SCAND1;PPARG;CITED4;MAML3;ARID5B;KAT2B
1253,GO:0003007,0.954165837782819,0.0858698910155944,9,151,heart morphogenesis,BP,DKK1;TGFBR2;FKBP1A;PKD2;SOX4;CHD7;ALDH1A2;TBX1;PTCH1
7931,GO:0032508,0.95436405262855,0.121080260797043,3,71,DNA duplex unwinding,BP,XPC;ATRX;DDB2
13176,GO:0051781,0.954427242939013,0.141847465190324,2,54,positive regulation of cell division,BP,PGF;IGF2
6862,GO:0030331,0.955215605198387,0.190863223012497,1,33,estrogen receptor binding,MF,PPARG
8971,GO:0035051,0.95523626437781,0.107684938424264,4,81,cardiocyte differentiation,BP,EGFR;DKK1;PAK1;OBSL1
4102,GO:0009156,0.955293758262541,0.0939595412167379,6,126,ribonucleoside monophosphate biosynthetic process,BP,DHTKD1;PGM1;LDHA;PPARA;TMSB4X;AK9
12762,GO:0051031,0.955323195206218,0.190523115068747,1,33,tRNA transport,BP,XPOT
11840,GO:0046794,0.955346903529648,0.139487107099069,2,55,transport of virus,BP,MVB12B;MVB12A
20110,GO:2000785,0.955352627381118,0.190225593061053,1,34,regulation of autophagosome assembly,BP,TBC1D14
15031,GO:0070972,0.955675461973293,0.105693562905256,4,125,protein localization to endoplasmic reticulum,BP,SEC63;BCAP29;KDELR3;SSR3
6282,GO:0019886,0.955715969810197,0.117981988271857,3,74,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,SEC23A;CTSL;AP2A2
10277,GO:0043021,0.956351369579054,0.0974555777840646,5,110,ribonucleoprotein complex binding,MF,IMPACT;CSNK2A1;CPEB4;RNF135;SECISBP2L
14143,GO:0061013,0.956402374204996,0.084539379863913,8,160,regulation of mRNA catabolic process,BP,PSMD2;IGF2BP3;XRN1;TNRC6B;PSMD7;PAIP1;PUM2;TNRC6C
1539,GO:0003924,0.956801883245062,0.0755042882655855,12,227,GTPase activity,MF,RAB3B;SEPT10;RAC2;RAB31;SEPT5;ARF4;TUBG2;RAB43;RAB1A;RHOBTB1;SEPT6;GNAI1
12107,GO:0048146,0.956815857598762,0.185204018511206,1,36,positive regulation of fibroblast proliferation,BP,EGFR
16728,GO:0097731,0.957178802018374,0.135154955050807,2,52,9+0 non-motile cilium,CC,MAP1B;SHANK2
16730,GO:0097733,0.957178802018374,0.135154955050807,2,52,photoreceptor cell cilium,CC,MAP1B;SHANK2
9313,GO:0035770,0.95733471926904,0.0803995498621686,9,169,ribonucleoprotein granule,CC,BTBD2;PITPNM1;APOBEC3C;XRN1;TRIM5;TNRC6B;ATXN2;PUM2;GRB7
32,GO:0000060,0.957543959441991,0.182871767275721,1,36,protein import into nucleus, translocation,BP,TMEM173
10533,GO:0043473,0.957685513757002,0.11368503121858,3,73,pigmentation,BP,BBS2;RAB1A;AP3D1
6278,GO:0019882,0.958623629628636,0.0806294238682274,8,171,antigen processing and presentation,BP,RAB3B;PSMD2;SEC23A;ITGB5;CTSL;PSMD7;AP2A2;AP3D1
3055,GO:0006614,0.958678826017317,0.129499606276688,2,91,SRP-dependent cotranslational protein targeting to membrane,BP,SEC63;SSR3
15229,GO:0071383,0.95874424276771,0.0741434559598811,11,193,cellular response to steroid hormone stimulus,BP,PCK2;NR1D1;EIF4EBP1;EGFR;PAK1;PPARA;THRA;NR2F6;PPARG;FOXP1;UFL1
13684,GO:0060218,0.958749110604481,0.110453312205051,3,100,hematopoietic stem cell differentiation,BP,PSMD2;PSMD7;EIF2AK2
7950,GO:0032549,0.95886367661441,0.0676841810823047,16,285,ribonucleoside binding,MF,RAB3B;PCK2;TGM2;SEPT10;RAC2;RAB31;ANXA6;SEPT5;GLUD1;ARF4;TUBG2;RAB43;RAB1A;RHOBTB1;SEPT6;GNAI1
5336,GO:0016073,0.958914694448281,0.110529783373751,3,84,snRNA metabolic process,BP,POU2F2;INTS8;NOP10
1116,GO:0002705,0.958949642888813,0.130156141473484,2,59,positive regulation of leukocyte mediated immunity,BP,F2RL1;FADD
19013,GO:1904837,0.958971744057831,0.177510924902192,1,41,beta-catenin-TCF complex assembly,BP,TLE4
7319,GO:0031328,0.959376930081564,0.0510006924260888,98,1311,positive regulation of cellular biosynthetic process,BP,TNIP1;NOS1;F2R;ETV5;ITGA6;NR1D1;NFATC4;MAP2K1;ETV4;RAPGEF3;SALL2;WWTR1;PEG3;APLN;POU2F2;TEF;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;HLTF;ERCC6;ZNF516;WNT7A;SHC1;IMPACT;APOE;CCPG1;PKD2;DDN;HMGA2;ATF4;PPARA;FGFR1;E2F5;EPCAM;NFAT5;BTRC;ITGA2;ATRX;CHURC1;SOX4;FHOD1;ATF7IP;DVL1;NTSR1;LRP5;CST3;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;PHF1;PTHLH;CHD7;PARP9;THRA;ACVR1B;NGFR;CHD6;MEF2D;ARF4;XBP1;MAP2K2;PAIP1;RET;EAPP;ETV1;ZNF398;TMSB4X;TIMP2;IFI16;CARD11;TBL1X;ARID4A;IGF2;EFCAB7;PPARG;CITED4;TBX1;CREB3L2;RSF1;MAML3;FZD8;LRP6;TMEM173;E2F7;TET1;ARMCX3;DNAJC3;PTCH1;KAT2B;PBX3;ADNP;FADD
4536,GO:0010608,0.959501840092475,0.0588602420535115,31,506,posttranscriptional regulation of gene expression,BP,NEURL1;MAP2K1;EIF4EBP1;PSMD2;EGFR;IGF2BP3;IMPACT;ATF4;EIF4E3;ITGA2;SOX4;XRN1;TNRC6B;MEX3C;PSMD7;PARP9;CPEB4;ATXN2;NACC2;MAP2K2;PAIP1;RMRP;PUM2;EIF2AK2;SECISBP2L;PPARG;GRB7;TNRC6C;ZC3H7A;DNAJC3;CNOT11
4230,GO:0009408,0.959622508784418,0.082174423384173,7,139,response to heat,BP,NOS1;MYOF;ANO1;HSPA13;PRKACA;IGFBP7;HSPA2
3327,GO:0007034,0.959760939809886,0.0859035127052285,6,119,vacuolar transport,BP,SORL1;VPS13A;VPS11;AP3D1;TMEM50B;SNX27
11835,GO:0046782,0.959813580812488,0.127895622435435,2,60,regulation of viral transcription,BP,HMGA2;RSF1
10106,GO:0042623,0.960072106449745,0.0636784482149456,19,291,ATPase activity, coupled,MF,SMARCA1;ERCC6;DHX32;ATP7B;ABCD1;ABCA7;LONP2;ATRX;ABCG1;ATP10D;HSPA13;CHD6;YTHDC2;PCYOX1;ATP12A;ATP6V1B2;ATP11B;WDR60;HSPA2
8266,GO:0033046,0.96056757788742,0.173041689184453,1,36,negative regulation of sister chromatid segregation,BP,ATRX
13291,GO:0051985,0.96056757788742,0.173041689184453,1,36,negative regulation of chromosome segregation,BP,ATRX
7617,GO:0032007,0.960626179404692,0.173022377695705,1,35,negative regulation of TOR signaling,BP,EPM2A
19643,GO:1990841,0.960682245100809,0.173217231270413,1,33,promoter-specific chromatin binding,MF,CHD7
1011,GO:0002495,0.960822947503421,0.106550442980424,3,76,antigen processing and presentation of peptide antigen via MHC class II,BP,SEC23A;CTSL;AP2A2
4451,GO:0010389,0.961230151462598,0.0737658349241352,9,180,regulation of G2/M transition of mitotic cell cycle,BP,FHL1;CCND1;PSMD2;BRSK1;AKAP9;HMGA2;TAOK1;PSMD7;PRKACA
2977,GO:0006518,0.961509693883117,0.0526678937332312,47,783,peptide metabolic process,BP,TNIP1;SORL1;NEURL1;PRNP;MAP2K1;EIF4EBP1;CARS;LTA4H;EGFR;GLO1;IGF2BP3;HAGH;IMPACT;ERO1B;APOE;IDE;ABTB1;ATF4;ABCA7;EIF4E3;AARS;RNPEPL1;ITGA2;CHAC1;SOX4;MRPS6;XRN1;TNRC6B;PCSK6;MEX3C;AEBP1;CPEB4;ATXN2;MAP2K2;PAIP1;PUM2;EIF2AK2;SECISBP2L;CTSZ;PPARG;GRB7;GARS;EEF2K;TNRC6C;DNAJC3;PSEN2;CNOT11
7492,GO:0031663,0.96160359874387,0.169301512107792,1,38,lipopolysaccharide-mediated signaling pathway,BP,TRIM5
3233,GO:0006886,0.96164342028574,0.0507908488693113,61,917,intracellular protein transport,BP,EDEM1;SORL1;RAB3B;PRNP;XPOT;SH3TC2;LTBP2;RAPGEF3;TBC1D14;ANK3;FYN;KIF13B;UBE2J1;SNX9;EVI5L;SEC23A;STRADB;GDI1;CEMIP;STOM;PAK1;RAC2;BNIP3L;VAMP2;LONP2;SOX4;VPS13A;RAB31;CLTCL1;TOM1L2;VPS11;SEC63;SYTL1;ZDHHC2;COPB1;COPG1;USP6NL;TBC1D2B;NGFR;PPP1R10;STX10;RAB43;ZFYVE9;TMED4;RAB1A;ZDHHC1;SEL1L;BCAP29;AP2A2;AP3D1;EFCAB7;ERLEC1;SNX6;TMEM50B;EVI5;RPH3AL;TBC1D16;SSR3;TMEM173;SSR1;SNX27
2545,GO:0005813,0.961949179844247,0.0562318336098274,29,440,centrosome,CC,BRSK1;CEP170;NEK9;RGS14;PRKACB;AKAP9;RAB11FIP4;ATF4;CEP120;OBSL1;ZNF322;ADGRB2;PROCR;PHF1;MVB12A;MARK4;BCL2L1;TUBG2;CCDC88A;CCSAP;PRKACA;NEK6;NIT2;USP20;WDR60;MPLKIP;PSEN2;KAT2B;GNAI1
13155,GO:0051726,0.962028530033754,0.0494390216264276,71,1002,regulation of cell cycle,BP,FHL1;CCND1;RPS6KA2;PRNP;HECW2;ADARB1;MAP2K1;ALOX15B;CCNI;EIF4EBP1;DDIT3;CCNG2;PSMD2;BRSK1;EGFR;STK39;CGREF1;DLG1;XPC;MAP4K4;GRK5;STRADB;PAK1;PTPN3;CCPG1;CCND2;PKD2;PRKACB;AKAP9;RAB11FIP4;PPP2R3B;HMGA2;ASNS;FGFR1;E2F5;HYAL1;PTK6;ATRX;SOX4;CEP120;OBSL1;LRP5;ETAA1;TOM1L2;SLK;UHRF2;TAOK1;PHC3;CSNK2A1;PSMD7;PRKAR1A;JMY;SDCCAG3;NACC2;PPP1R10;BCL2L1;MAP2K2;BEX2;PAK6;CCSAP;PRKACA;NEK6;TIMP2;IGF2;MAP4K2;LRP6;E2F7;PTCH1;KAT2B;CNOT11;GNAI1
1004,GO:0002478,0.962135484765924,0.0811678153528994,6,141,antigen processing and presentation of exogenous peptide antigen,BP,PSMD2;SEC23A;ITGB5;CTSL;PSMD7;AP2A2
2868,GO:0006360,0.962259927565183,0.121673073356732,2,59,transcription by RNA polymerase I,BP,ERCC6;ATF4
8583,GO:0034062,0.962343382356688,0.166187021163131,1,43,5'-3' RNA polymerase activity,MF,RMRP
16735,GO:0097747,0.962343382356688,0.166187021163131,1,43,RNA polymerase activity,MF,RMRP
7428,GO:0031529,0.962492415689631,0.16634291194568,1,38,ruffle organization,BP,PFN2
7880,GO:0032446,0.962611709677236,0.0503643641556673,54,787,protein modification by small protein conjugation,BP,SMURF2;GID4;NEURL1;HECW2;WWTR1;MARCH9;PSMD2;FYN;JADE2;HLTF;UBE2J1;SOCS2;RAG1;FKBP1A;RBCK1;UBE2G1;MARCH4;DCAF10;BTRC;SOX4;RMND5A;FBXO2;DDB2;TRIM5;TRIB3;FBXL8;UHRF2;FBXO41;PSMD7;BLMH;KLHL29;MTA1;RNF165;TRIM7;ANAPC13;ARRDC1;ANKIB1;UBE2E1;RNF135;UNKL;RAB1A;RNF169;PJA2;WFS1;MARCH2;MAGEF1;RNF180;TRIM2;RNF103;PRMT3;UFL1;KLHL15;TRIM38;FBXL5
10500,GO:0043401,0.962719628445306,0.0737760137046601,8,149,steroid hormone mediated signaling pathway,BP,NR1D1;PAK1;PPARA;THRA;NR2F6;PPARG;FOXP1;UFL1
10539,GO:0043486,0.962727942865891,0.164391878996333,1,48,histone exchange,BP,RSF1
13997,GO:0060711,0.962732854339507,0.165690678145358,1,37,labyrinthine layer development,BP,MAP2K1
6702,GO:0030101,0.962841941415396,0.164893182993734,1,40,natural killer cell activation,BP,SNX27
415,GO:0001102,0.962866626334884,0.165572652598712,1,35,RNA polymerase II activating transcription factor binding,MF,MEF2D
7374,GO:0031424,0.963194072676514,0.100837517393793,3,86,keratinization,BP,PCSK6;PPL;PRSS8
4428,GO:0010257,0.963453020995248,0.161412007012111,1,55,NADH dehydrogenase complex assembly,BP,NDUFV3
8224,GO:0032981,0.963453020995248,0.161412007012111,1,55,mitochondrial respiratory chain complex I assembly,BP,NDUFV3
6503,GO:0021872,0.963544532130664,0.163290446116165,1,35,forebrain generation of neurons,BP,FGFR1
1014,GO:0002504,0.964046524334513,0.0991900175355792,3,77,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,SEC23A;CTSL;AP2A2
5135,GO:0015631,0.964147057531395,0.0583610749066925,18,276,tubulin binding,MF,CLIP2;PRNP;MAP1B;BRSK1;FYN;MYH15;KIF13B;TTBK2;RGS14;KIF21B;FAM110C;MAP6;BEX4;MARK4;GABARAPL2;CCDC88A;CCSAP;ADNP
40,GO:0000082,0.96434692881827,0.0635647870216477,12,222,G1/S transition of mitotic cell cycle,BP,FHL1;CCND1;EIF4EBP1;EGFR;CCND2;PKD2;HYAL1;SOX4;NACC2;ACVR1B;E2F7;CNOT11
3502,GO:0007405,0.964347197237971,0.160936802446909,1,33,neuroblast proliferation,BP,FGFR1
9044,GO:0035258,0.964743433211487,0.0976649888517389,3,75,steroid hormone receptor binding,MF,PKN1;PPARG;FOXP1
11844,GO:0046822,0.965160164476263,0.0868610674116028,4,91,regulation of nucleocytoplasmic transport,BP,RAPGEF3;SOX4;EFCAB7;TMEM173
18646,GO:1903955,0.965349805382541,0.11341594289036,2,62,positive regulation of protein targeting to mitochondrion,BP,RAC2;VPS11
15127,GO:0071216,0.965366594403481,0.0752517251126401,6,130,cellular response to biotic stimulus,BP,TNIP1;NR1D1;DDIT3;TRIM5;XBP1;WFS1
18709,GO:1904115,0.965451183993515,0.156477035375044,1,37,axon cytoplasm,CC,AP3D1
3088,GO:0006661,0.965733225268696,0.0747248110600318,6,119,phosphatidylinositol biosynthetic process,BP,PIGH;FGFR1;INPP5F;PITPNM1;INPP4A;MTMR4
9,GO:0000018,0.965769745586881,0.112536601540131,2,58,regulation of DNA recombination,BP,MAGEF1;KLHL15
8138,GO:0032838,0.965882684899062,0.0743928075726529,6,122,plasma membrane bounded cell projection cytoplasm,CC,WDR66;DLG4;PRKAR1A;CCSAP;PRKACA;AP3D1
12483,GO:0050434,0.96598725950979,0.154216086719662,1,40,positive regulation of viral transcription,BP,RSF1
17533,GO:1901028,0.966085450421239,0.153520596181717,1,43,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,BOK
17671,GO:1901532,0.966288593205588,0.0933278183034074,3,103,regulation of hematopoietic progenitor cell differentiation,BP,PSMD2;PSMD7;EIF2AK2
18346,GO:1903313,0.966412716071994,0.110954504030809,2,56,positive regulation of mRNA metabolic process,BP,TNRC6B;TNRC6C
11004,GO:0044815,0.966555906335212,0.10917192326259,2,91,DNA packaging complex,CC,H1F0;H2AFJ
2561,GO:0005844,0.966578465540024,0.109821061698759,2,69,polysome,CC,IMPACT;ATXN2
10511,GO:0043414,0.966580670989352,0.0588120476920362,13,234,macromolecule methylation,BP,RAB3B;PCMTD2;ATRX;MTHFR;ATF7IP;PHF1;SATB1;ARID4A;CMTR2;TET1;PRMT3;JARID2;DNMT3A
672,GO:0001882,0.966613287354963,0.055942906451127,16,291,nucleoside binding,MF,RAB3B;PCK2;TGM2;SEPT10;RAC2;RAB31;ANXA6;SEPT5;GLUD1;ARF4;TUBG2;RAB43;RAB1A;RHOBTB1;SEPT6;GNAI1
7038,GO:0030811,0.966778843075138,0.110113452948878,2,54,regulation of nucleotide catabolic process,BP,RAPGEF3;PPARA
16428,GO:0097064,0.966883147840031,0.151532697396856,1,37,ncRNA export from nucleus,BP,XPOT
13111,GO:0051646,0.966957843754607,0.151588802745901,1,35,mitochondrion localization,BP,MAP1B
5504,GO:0016447,0.966996290338739,0.15113924993205,1,37,somatic recombination of immunoglobulin gene segments,BP,ERCC1
10332,GO:0043124,0.96727533458915,0.150481717262276,1,35,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,TNIP1
1480,GO:0003774,0.967514088304007,0.07597683866868,5,94,motor activity,MF,MYH15;KIF13B;KIF21B;MYH16;WDR60
17275,GO:0120111,0.967717083512788,0.107275052543764,2,59,neuron projection cytoplasm,CC,DLG4;AP3D1
10732,GO:0044088,0.967777690558975,0.148266942774361,1,38,regulation of vacuole organization,BP,TBC1D14
19555,GO:1990542,0.968042730678437,0.105992060598119,2,67,mitochondrial transmembrane transport,BP,TST;CPT2
1129,GO:0002718,0.968115340284592,0.146696201941626,1,41,regulation of cytokine production involved in immune response,BP,F2RL1
14697,GO:0070317,0.968334977453857,0.146452131986312,1,37,negative regulation of G0 to G1 transition,BP,PHC3
9602,GO:0036459,0.968637858422894,0.0795442971102269,4,87,thiol-dependent ubiquitinyl hydrolase activity,MF,OTUB2;USP20;USP32;USP25
17112,GO:0101005,0.968637858422894,0.0795442971102269,4,87,ubiquitinyl hydrolase activity,MF,OTUB2;USP20;USP32;USP25
8937,GO:0034968,0.96864743400824,0.0794690772662986,4,89,histone lysine methylation,BP,ATRX;PHF1;ARID4A;JARID2
17304,GO:0140097,0.968700078381728,0.0610010867681884,9,178,catalytic activity, acting on DNA,MF,ERCC1;SMARCA1;HMGA2;ATRX;ENDOV;POLL;DNASE1L1;ENDOG;DNMT3A
3331,GO:0007041,0.968829064413103,0.079050940135963,4,90,lysosomal transport,BP,SORL1;VPS11;AP3D1;SNX27
10295,GO:0043044,0.969058608105498,0.10316457452922,2,69,ATP-dependent chromatin remodeling,BP,SMARCA1;RSF1
2905,GO:0006414,0.969079436707865,0.0778682015205991,4,125,translational elongation,BP,ABTB1;MRPS6;SECISBP2L;EEF2K
14298,GO:0061418,0.969131416707673,0.102887399055343,2,71,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,PSMD2;PSMD7
12106,GO:0048145,0.969221228704432,0.103097296033876,2,61,regulation of fibroblast proliferation,BP,EGFR;PPARG
346,GO:0000959,0.969575896360919,0.141534201448215,1,41,mitochondrial RNA metabolic process,BP,GARS
10612,GO:0043596,0.970132189456824,0.139548667631733,1,41,nuclear replication fork,CC,ETAA1
18039,GO:1902562,0.970404545564132,0.138572555440084,1,41,H4 histone acetyltransferase complex,CC,KAT2B
17974,GO:1902369,0.970574857814405,0.138334346293365,1,38,negative regulation of RNA catabolic process,BP,PAIP1
5558,GO:0016570,0.970740673885695,0.0452468844876722,25,388,histone modification,BP,NOS1;ZMYND8;PKN1;JADE2;RAG1;HMGA2;ATRX;MTHFR;FKBP10;DDB2;RCOR1;PHF1;NACC2;MTA1;SATB1;UBE2E1;TBL1X;ARID4A;IGF2;PHF21A;ARID5B;TET1;KAT2B;PRMT3;JARID2
9863,GO:0042116,0.97123434659606,0.135952030059879,1,38,macrophage activation,BP,FOXP1
3198,GO:0006826,0.971369097486378,0.134982947069141,1,42,iron ion transport,BP,ATP6V1B2
1872,GO:0004540,0.971379689350926,0.081736722132744,3,86,ribonuclease activity,MF,ENDOV;XRN1;LACTB2
13405,GO:0052742,0.971401230022212,0.136116380309308,1,33,phosphatidylinositol kinase activity,MF,FGFR1
12281,GO:0048592,0.971482545750345,0.0733819267214785,4,86,eye morphogenesis,BP,SDK2;LRP5;WNT2B;LRP6
13284,GO:0051972,0.971530699209304,0.134397051894946,1,42,regulation of telomerase activity,BP,PPARG
5477,GO:0016410,0.971561847732804,0.0814678416932952,3,80,N-acyltransferase activity,MF,NAGS;KAT2B;ALAS1
12105,GO:0048144,0.971678900232262,0.0963033549412472,2,62,fibroblast proliferation,BP,EGFR;PPARG
7884,GO:0032451,0.971864992686117,0.134090334500114,1,35,demethylase activity,MF,ARID5B
5574,GO:0016591,0.971896131705605,0.0720949441826041,4,103,DNA-directed RNA polymerase II, holoenzyme,CC,ERCC1;INTS8;TCEA1;CHD6
12412,GO:0048857,0.971971478909123,0.132904046249136,1,41,neural nucleus development,BP,GLUD1
4673,GO:0010821,0.97205825725313,0.0550628601071969,9,188,regulation of mitochondrion organization,BP,BNIP3;RAC2;BNIP3L;VPS11;BOK;BCL2L1;MOAP1;DDHD2;FAM162A
3301,GO:0006998,0.972300446473627,0.0796894122012728,3,80,nuclear envelope organization,BP,NEK9;NEK6;REEP3
9610,GO:0036473,0.972641251579426,0.093533853986017,2,64,cell death in response to oxidative stress,BP,ATF4;ENDOG
11319,GO:0045638,0.972705183682354,0.093185871931334,2,68,negative regulation of myeloid cell differentiation,BP,CEACAM1;UBASH3B
9296,GO:0035735,0.972713678342601,0.130421614585316,1,39,intraciliary transport involved in cilium assembly,BP,WDR60
4195,GO:0009301,0.972734464285701,0.0931446249992341,2,67,snRNA transcription,BP,POU2F2;INTS8
10193,GO:0042795,0.972734464285701,0.0931446249992341,2,67,snRNA transcription by RNA polymerase II,BP,POU2F2;INTS8
1592,GO:0004004,0.972978366799766,0.0927840067334617,2,60,ATP-dependent RNA helicase activity,MF,DHX32;YTHDC2
2904,GO:0006413,0.973063778153372,0.0572199961676583,7,186,translational initiation,BP,EIF4EBP1;IMPACT;ATF4;EIF4E3;PAIP1;EIF2AK2;DNAJC3
10541,GO:0043488,0.973323936812769,0.0597976667577547,6,141,regulation of mRNA stability,BP,PSMD2;IGF2BP3;XRN1;PSMD7;PAIP1;PUM2
8806,GO:0034508,0.973383799804492,0.12690488779468,1,50,centromere complex assembly,BP,RSF1
8829,GO:0034605,0.973716493841375,0.0629262884241941,5,113,cellular response to heat,BP,MYOF;ANO1;HSPA13;PRKACA;HSPA2
15284,GO:0071466,0.973954569614588,0.0674839361035113,4,107,cellular response to xenobiotic stimulus,BP,PCK2;EIF4EBP1;EGFR;BPHL
20281,GO:2001252,0.973957685839038,0.0558311489089968,7,146,positive regulation of chromosome organization,BP,NOS1;ERCC1;ATRX;PHF1;PPP1R10;TET1;JARID2
20228,GO:2001169,0.97426632217731,0.0892068356039744,2,59,regulation of ATP biosynthetic process,BP,PPARA;TMSB4X
3205,GO:0006839,0.974328120450502,0.0471414265711551,12,249,mitochondrial transport,BP,BNIP3;RAC2;BNIP3L;VPS11;TST;SLC25A4;CPT2;BOK;BCL2L1;SLC25A30;SLC25A43;MOAP1
12056,GO:0048002,0.974549481163294,0.0573090977956566,6,149,antigen processing and presentation of peptide antigen,BP,PSMD2;SEC23A;ITGB5;CTSL;PSMD7;AP2A2
3593,GO:0008017,0.974623139002328,0.0459140653155242,13,213,microtubule binding,MF,CLIP2;PRNP;MAP1B;MYH15;KIF13B;TTBK2;RGS14;KIF21B;MAP6;MARK4;GABARAPL2;CCDC88A;CCSAP
1468,GO:0003724,0.974890463659621,0.0873346257928656,2,61,RNA helicase activity,MF,DHX32;YTHDC2
11347,GO:0045670,0.975105844742475,0.121504505022783,1,39,regulation of osteoclast differentiation,BP,UBASH3B
3684,GO:0008186,0.975154803135475,0.0865811430245657,2,61,RNA-dependent ATPase activity,MF,DHX32;YTHDC2
412,GO:0001098,0.97539991610897,0.12006327924445,1,42,basal transcription machinery binding,MF,ERCC1
413,GO:0001099,0.97539991610897,0.12006327924445,1,42,basal RNA polymerase II transcription machinery binding,MF,ERCC1
8696,GO:0034329,0.97595678283179,0.0468808582855406,10,175,cell junction assembly,BP,FLNC;ITGA6;ITGB4;DLG1;ITGA2;MMP14;SLK;PRKACA;EPB41L3;LAMA5
3304,GO:0007004,0.976446444170287,0.0827418103166488,2,64,telomere maintenance via telomerase,BP,XRN1;NOP10
2676,GO:0006029,0.976698551199054,0.0822895484885911,2,58,proteoglycan metabolic process,BP,HYAL1;HPSE
880,GO:0002244,0.977098855691319,0.0521725693459981,6,157,hematopoietic progenitor cell differentiation,BP,DHTKD1;PSMD2;SOX4;PSMD7;PTPRZ1;EIF2AK2
2546,GO:0005814,0.977150241504164,0.0557475464510591,5,111,centriole,CC,TTBK2;CEP170;CEP120;CCDC88A;CCSAP
17831,GO:1901990,0.977247847768717,0.0374310688405293,20,358,regulation of mitotic cell cycle phase transition,BP,FHL1;CCND1;HECW2;PSMD2;BRSK1;EGFR;XPC;CCND2;PKD2;AKAP9;HMGA2;HYAL1;SOX4;TAOK1;PSMD7;NACC2;PRKACA;NEK6;E2F7;CNOT11
1450,GO:0003682,0.97725189658264,0.0350165440480257,28,436,chromatin binding,MF,ZMYND8;H1F0;NFATC4;PKN1;SMARCA1;EGFR;ERCC6;HMGA2;NFAT5;ATRX;PHF12;PHF1;CHD7;THRA;TSHZ1;MTA1;SATB1;REC8;TLE4;MLH3;SBNO1;RNF169;PPARG;PHF21A;KAT2B;JARID2;ADNP;DNMT3A
19672,GO:1990939,0.977316534879295,0.113701307395286,1,34,ATP-dependent microtubule motor activity,MF,WDR60
16948,GO:0098930,0.977461529044541,0.112266050999782,1,41,axonal transport,BP,AP3D1
16666,GO:0097542,0.977669804298026,0.111456875321677,1,41,ciliary tip,CC,WDR60
1481,GO:0003777,0.977672754003382,0.0596105248070111,4,82,microtubule motor activity,MF,MYH15;KIF13B;KIF21B;WDR60
4507,GO:0010557,0.977711578796465,0.0288936897694732,91,1251,positive regulation of macromolecule biosynthetic process,BP,TNIP1;NOS1;F2R;ETV5;ITGA6;NR1D1;NFATC4;MAP2K1;ETV4;SALL2;WWTR1;PEG3;APLN;POU2F2;TEF;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;HLTF;ERCC6;ZNF516;WNT7A;SHC1;IMPACT;CCPG1;PKD2;DDN;HMGA2;ATF4;PPARA;FGFR1;E2F5;EPCAM;NFAT5;BTRC;ITGA2;ATRX;CHURC1;SOX4;FHOD1;ATF7IP;DVL1;LRP5;CST3;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;PHF1;CHD7;PARP9;THRA;ACVR1B;NGFR;CHD6;MEF2D;ARF4;XBP1;MAP2K2;PAIP1;RET;EAPP;ETV1;ZNF398;IFI16;CARD11;TBL1X;ARID4A;IGF2;EFCAB7;PPARG;CITED4;TBX1;CREB3L2;RSF1;MAML3;FZD8;LRP6;TMEM173;E2F7;TET1;ARMCX3;DNAJC3;PTCH1;KAT2B;PBX3;FADD
14696,GO:0070316,0.977747090092985,0.111156080873866,1,41,regulation of G0 to G1 transition,BP,PHC3
5884,GO:0018022,0.97781336071751,0.0590013042581518,4,95,peptidyl-lysine methylation,BP,ATRX;PHF1;ARID4A;JARID2
7598,GO:0031970,0.978148340035298,0.0773355177707982,2,78,organelle envelope lumen,CC,SORL1;NME4
14511,GO:0065002,0.97816071000762,0.108800081877242,1,50,intracellular protein transmembrane transport,BP,SEC63
4304,GO:0009755,0.97850314304549,0.045186986807446,8,160,hormone-mediated signaling pathway,BP,NR1D1;PAK1;PPARA;THRA;NR2F6;PPARG;FOXP1;UFL1
11054,GO:0045047,0.97853491320604,0.075739417575039,2,101,protein targeting to ER,BP,SEC63;SSR3
286,GO:0000790,0.978582138511788,0.0372269130982097,16,304,nuclear chromatin,CC,H1F0;NR1D1;SALL2;APPL2;SMARCA1;ATRX;PHF12;UHRF2;CSNK2A1;NACC2;MEF2D;H2AFJ;SATB1;CBX7;RSF1;DNMT3A
11014,GO:0044843,0.978621966738782,0.0399761343815742,12,234,cell cycle G1/S phase transition,BP,FHL1;CCND1;EIF4EBP1;EGFR;CCND2;PKD2;HYAL1;SOX4;NACC2;ACVR1B;E2F7;CNOT11
1177,GO:0002824,0.97893291691985,0.10606291288563,1,46,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,FADD
15132,GO:0071222,0.979094744922724,0.0558632677632371,4,107,cellular response to lipopolysaccharide,BP,TNIP1;NR1D1;TRIM5;XBP1
258,GO:0000724,0.979106586148853,0.0559264874449637,4,101,double-strand break repair via homologous recombination,BP,POLL;REC8;MAGEF1;KLHL15
11520,GO:0046034,0.979235420924933,0.0421189379945809,9,207,ATP metabolic process,BP,DHTKD1;PGM1;LDHA;PPARA;FAM20C;NDUFV3;TMSB4X;ATP6V1B2;AK9
5134,GO:0015630,0.979518160539803,0.0275323702586579,69,967,microtubule cytoskeleton,CC,CLIP2;BBS2;HECW2;MAP2K1;MAP1B;SNTB2;BRSK1;SNPH;DYSF;KIF13B;DLG1;PODXL;TTBK2;SEPT10;CEP170;NEK9;NUDCD3;RGS14;PKD2;PRKACB;AKAP9;RAB11FIP4;ATF4;KIF21B;TACC1;PITPNM1;CEP120;GSDMC;OBSL1;FAM110C;DVL1;MAP6;CLTCL1;RANBP9;ZNF322;ACOT13;ADGRB2;PROCR;PHF1;SPRY2;SEPT5;BEX4;ENKD1;PSKH1;MVB12A;MARK4;MTA1;BCL2L1;MAP2K2;TUBG2;NAV1;CCDC88A;CCSAP;PRKACA;NEK6;TBL1X;NIT2;TMEM63A;USP20;EVI5;WDR60;MPLKIP;DDHD2;HSPA2;PSEN2;KAT2B;SEPT6;REEP3;GNAI1
3322,GO:0007029,0.979567188684601,0.103800202105038,1,43,endoplasmic reticulum organization,BP,LMAN1
2893,GO:0006400,0.97983442948422,0.0724774331077408,2,74,tRNA modification,BP,AARS;OSGEPL1
4783,GO:0010970,0.980105433208768,0.0462939846945437,6,131,transport along microtubule,BP,MAP1B;FYCO1;COPG1;RAB1A;AP3D1;WDR60
17009,GO:0099111,0.980105433208768,0.0462939846945437,6,131,microtubule-based transport,BP,MAP1B;FYCO1;COPG1;RAB1A;AP3D1;WDR60
10179,GO:0042770,0.980132236148193,0.0492293555899377,5,121,signal transduction in response to DNA damage,BP,CD44;ATRX;SOX4;E2F7;CNOT11
259,GO:0000725,0.980321770276316,0.0530941768051189,4,102,recombinational repair,BP,POLL;REC8;MAGEF1;KLHL15
18109,GO:1902749,0.98039008688183,0.0400582322144084,9,195,regulation of cell cycle G2/M phase transition,BP,FHL1;CCND1;PSMD2;BRSK1;AKAP9;HMGA2;TAOK1;PSMD7;PRKACA
1119,GO:0002708,0.980403580470209,0.100208121026636,1,46,positive regulation of lymphocyte mediated immunity,BP,FADD
8290,GO:0033108,0.980475318596834,0.0702196331217571,2,89,mitochondrial respiratory chain complex assembly,BP,COX18;NDUFV3
2816,GO:0006278,0.980517714816309,0.0706892362273135,2,66,RNA-dependent DNA biosynthetic process,BP,XRN1;NOP10
10977,GO:0044766,0.98066374649463,0.0701823635961443,2,68,multi-organism transport,BP,MVB12B;MVB12A
18049,GO:1902579,0.98066374649463,0.0701823635961443,2,68,multi-organism localization,BP,MVB12B;MVB12A
11043,GO:0045023,0.980719049423726,0.0992673376135785,1,42,G0 to G1 transition,BP,PHC3
2550,GO:0005819,0.980846446258576,0.0331515219197695,17,299,spindle,CC,HECW2;CEP170;RGS14;PKD2;RAB11FIP4;FAM110C;CLTCL1;ACOT13;BEX4;TUBG2;CCSAP;NEK6;TBL1X;EVI5;WDR60;HSPA2;SEPT6
1855,GO:0004518,0.981001081337794,0.0403657244145672,8,177,nuclease activity,MF,ERCC1;RAG1;ENDOV;XRN1;LACTB2;DNASE1L1;ENDOG;N4BP2
1475,GO:0003743,0.981490440214446,0.0955987385653087,1,49,translation initiation factor activity,MF,EIF4E3
8699,GO:0034332,0.981660737383487,0.0501189306451567,4,92,adherens junction organization,BP,ITGA2;MMP14;SLK;LAMA5
853,GO:0002181,0.981981872485962,0.0657642905681826,2,85,cytoplasmic translation,BP,EIF4EBP1;CPEB4
12887,GO:0051225,0.981994054230585,0.0492156665868123,4,99,spindle assembly,BP,GOLGA2P5;TUBG2;CCSAP;NEK6
8976,GO:0035065,0.982095181690254,0.0933271743344681,1,46,regulation of histone acetylation,BP,NOS1
7906,GO:0032479,0.982127287119722,0.0487887612469575,4,107,regulation of type I interferon production,BP,PTPRS;RNF135;IFI16;TMEM173
5282,GO:0015935,0.982193791024954,0.0918547753315767,1,68,small ribosomal subunit,CC,MRPS6
10540,GO:0043487,0.982413764507437,0.0413860943743163,6,148,regulation of RNA stability,BP,PSMD2;IGF2BP3;XRN1;PSMD7;PAIP1;PUM2
11099,GO:0045111,0.982565850191256,0.0478030687516517,4,103,intermediate filament cytoskeleton,CC,SHANK2;MMP14;DDX60;PJA2
11891,GO:0046907,0.982743549765236,0.0223049099866603,102,1457,intracellular transport,BP,EDEM1;SORL1;RAB3B;PRNP;XPOT;BBS2;SH3TC2;MAP2K1;LTBP2;RAPGEF3;LMF1;MAP1B;SNPH;TBC1D14;ANK3;FYN;KIF13B;UBE2J1;SNX9;EVI5L;SEC23A;STRADB;GDI1;CEMIP;STOM;PAK1;RAC2;APOE;BNIP3L;ATP7B;ABCD1;RGS14;MCFD2;FYCO1;RAB11FIP4;VAMP2;LONP2;INPP5F;PFN2;ABCG1;SOX4;FHOD1;VPS13A;CEP120;RAB31;LMAN1;MVB12B;SEC22C;CLTCL1;TOM1L2;VPS11;RIMS3;SEC63;SYTL1;ZDHHC2;COPB1;COPG1;FNBP1L;CPT2;SDCCAG3;USP6NL;SEPT5;TBC1D2B;NGFR;PPP1R10;MVB12A;ARF4;SPIRE1;MAP2K2;STX10;RAB43;ZFYVE9;CCDC88A;TMED4;RAB1A;ZDHHC1;SEL1L;BCAP29;AP2A2;CTSZ;AP3D1;EFCAB7;ERLEC1;SNX6;ANKRD50;TMEM50B;EVI5;CREB3L2;RPH3AL;WDR60;TBC1D16;SSR3;DDHD2;WASL;REEP6;LRP6;SYT2;TMEM173;SSR1;ZFYVE21;COG8;SNX27
3315,GO:0007018,0.982750271497752,0.0322510544408547,13,227,microtubule-based movement,BP,BBS2;WDR66;MAP1B;MYH15;KIF13B;FYCO1;KIF21B;COPG1;CCSAP;RAB1A;AP2A2;AP3D1;WDR60
7086,GO:0030880,0.982761031922473,0.0433956431872226,5,130,RNA polymerase complex,CC,ERCC1;INTS8;TCEA1;CHD6;RMRP
15891,GO:0072655,0.982858333684242,0.0404019447184832,6,157,establishment of protein localization to mitochondrion,BP,DDIT3;RAC2;BNIP3L;COX18;VPS11;MOAP1
7988,GO:0032606,0.982909817245153,0.0469205700258779,4,108,type I interferon production,BP,PTPRS;RNF135;IFI16;TMEM173
6232,GO:0019783,0.983128967322234,0.0465483631915669,4,97,ubiquitin-like protein-specific protease activity,MF,OTUB2;USP20;USP32;USP25
11203,GO:0045333,0.983170718636064,0.0423186951511084,5,154,cellular respiration,BP,NFATC4;DHTKD1;BNIP3;IDH2;NDUFV3
5396,GO:0016233,0.9833691252774,0.0877184839862306,1,51,telomere capping,BP,ERCC1
4548,GO:0010628,0.983606277331127,0.0213274484807926,98,1366,positive regulation of gene expression,BP,TNIP1;NOS1;F2R;ETV5;ITGA6;ACTA2;ADM2;NR1D1;NFATC4;MAP2K1;ETV4;SALL2;WWTR1;PEG3;APLN;POU2F2;TEF;DDIT3;SMARCA1;SOX12;ELK3;CRTC1;EGFR;ANK3;HLTF;ERCC6;ZNF516;WNT7A;SHC1;DKK1;IMPACT;CCPG1;PKD2;DDN;HMGA2;ATF4;PPARA;E2F5;EPCAM;NFAT5;BTRC;ITGA2;ATRX;CHURC1;SOX4;FHOD1;ATF7IP;DVL1;CD46;LRP5;CNTN1;PPP3CB;RFX2;CEBPG;PLAG1;F2RL1;PHF1;CHD7;PARP9;SPRY2;THRA;ACVR1B;NGFR;CHD6;MEF2D;ARF4;XBP1;MAP2K2;PAIP1;RET;SH3PXD2B;RMRP;EAPP;ETV1;ZNF398;IFI16;TBL1X;ARID4A;EFCAB7;PPARG;CITED4;ALDH1A2;TBX1;CREB3L2;RSF1;ADAM8;MAML3;FZD8;LRP6;TMEM173;E2F7;TET1;ARMCX3;DNAJC3;PTCH1;KAT2B;PBX3;FADD
2834,GO:0006302,0.983643416495409,0.0340247470556358,9,194,double-strand break repair,BP,ERCC1;HMGA2;PARP9;MTA1;POLL;REC8;RNF169;MAGEF1;KLHL15
10905,GO:0044450,0.983749500048937,0.0367290303667573,7,147,microtubule organizing center part,CC,TTBK2;CEP170;CEP120;TUBG2;CCDC88A;CCSAP;WDR60
15470,GO:0071806,0.983778354301852,0.0858418421053251,1,54,protein transmembrane transport,BP,SEC63
15877,GO:0072599,0.983843473655484,0.0597613317123614,2,104,establishment of protein localization to endoplasmic reticulum,BP,SEC63;SSR3
3911,GO:0008565,0.983855183842636,0.0603322392787607,2,71,protein transporter activity,MF,LRP1;COX18
2849,GO:0006334,0.983963145715245,0.0496470060152959,3,116,nucleosome assembly,BP,H1F0;ATRX;RSF1
15488,GO:0071840,0.984045050663881,0.0188577801376944,377,4801,cellular component organization or biogenesis,BP,FHL1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;ADAM19;ETV5;RAB3B;NEURL1;CTNNBIP1;VLDLR;SYNE3;ITGA6;MMP1;CYP27B1;H1F0;SERPINE2;IGFBP4;PRNP;ADGRF1;ITGB4;BBS2;POSTN;SH3TC2;HECW2;NFATC4;ADARB1;MAP2K1;THBS2;FMNL2;LTBP2;RAPGEF3;SH3KBP1;COL13A1;THSD4;GPX3;PKN1;WWTR1;DCBLD2;APLN;MARVELD1;SSH1;MAP1B;DDIT3;KCNG1;PTPRS;SMARCA1;SOX12;LAMB1;SDK2;EXOC2;CRTC1;ADGRL1;CAPN2;BRSK1;WIPF1;EGFR;TBC1D14;SEMA4B;ANK3;BCORL1;DYSF;LOXL1;ARHGAP12;FYN;JADE2;BNIP3;HLTF;KIF13B;SCMH1;PARVB;ARAP1;DLG1;CSMD3;DLG4;IDH2;PLXNB3;SNX9;TYSND1;PODXL;NET1;TGM2;ESPN;XPC;GLUL;EVI5L;HTRA1;WNT7A;MAP4K4;TTBK2;SEC23A;STRADB;MALL;ASPH;MCTP1;GDI1;UNC119B;SEPT10;SDC1;STOM;SHC1;DKK1;WISP1;SMOC2;PAK1;SOCS2;ATXN10;NEK9;CBR4;RAG1;NUDCD3;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ABCD1;ANGPTL4;AFAP1;RGS14;MCFD2;PKD2;PRKACB;LRP1;FYCO1;IDE;AKAP9;HMGA2;ABCA7;LPAR3;FGFR1;ITGA1;E2F5;TMOD2;TUB;PTPDC1;TACC1;ITGB5;SNX14;HYAL1;ITGA2;PTK6;VAMP2;ULK2;FAT1;LONP2;LTBP4;INPP5F;ATRX;MTHFR;PFN2;ABCG1;FKBP10;KIAA1109;FHOD1;ITPR3;DDB2;CEP120;CEACAM1;FERMT1;SPATA18;OBSL1;RAB31;LMAN1;DMXL2;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;EPN2;XRN1;SLC9A3R2;DVL1;CLCN3;MMP14;PLEK2;ANXA6;NLGN2;CTH;MAP6;LRP5;ZMYM3;THBS3;CTSL;TWF2;CST3;COX18;SEC22C;RABGGTA;CNTN1;CLTCL1;NTNG1;TPBG;TOM1L2;L3MBTL3;VPS11;RANBP9;WASF3;BTBD3;PPP3CB;MYOF;ACOT13;RFX2;SYTL1;ADGRB2;DNAJC6;SLK;FNBP1L;CDC42BPA;F2RL1;UHRF2;TAOK1;ATP10D;CSNK2A1;PHF1;CHD7;SLC25A4;ASAP1;NDUFV3;PRKAR1A;MSRB2;JMY;BOK;FCHO2;ATXN2;MAST3;NACC2;USP6NL;SPRY2;SEPT5;TBC1D2B;THRA;ACVR1B;DBNDD1;COL6A1;NGFR;PPP1R10;MVB12A;GLUD1;MARK4;PTPRZ1;CHD6;SPESP1;MTA1;AZIN2;BCL2L1;RNF165;GRIN3B;WASF2;SKAP2;ARF4;GOLGA2P5;H2AFJ;SLC12A7;SPIRE1;NFU1;MAP2K2;SATB1;ARRDC1;REC8;TLE4;RET;SPATA6;TUBG2;STX10;LOXL2;VWA1;TCTN1;RAB43;MLH3;NAV1;SH3PXD2B;ZFYVE9;NOP10;NCKAP1;GABARAPL2;DOCK11;PAK6;UBE2E1;PUM2;ETV1;COL1A2;CCDC88A;CCSAP;TMED4;SAMD8;PRKACA;NEK6;TMSB4X;TIMP2;EIF2AK2;RAB1A;EPB41L3;SNX30;CBX7;RHOBTB1;AP2A2;IL1RAP;FCHO1;LAMB2;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;AP3D1;ARID4A;ARPC1A;TENM2;IGF2;MOAP1;LAMA5;FNBP1;GRB10;ZMYM2;PPARG;SNX6;GRB7;SRPX2;PPL;EVI5;ATP6V1B2;RSF1;ADAM8;AKT3;ROBO3;ENDOG;ATP11B;ITGA4;PHF21A;WDR60;IGFBP7;TBC1D16;DDHD2;TMEM107;WASL;HSPA2;FLNB;LRP6;ARID5B;SYT2;EEF2K;SEMA6C;SIGMAR1;TET1;OMG;KCTD18;DEDD2;HSD17B12;PTCH1;ADCY1;KAT2B;SEPT6;PRMT3;REEP3;NYAP1;FAM162A;JARID2;SEMA3F;ADNP;GNAI1;LRP4;RB1CC1;DNMT3A;ALAS1;FADD
15973,GO:0080090,0.984295406725333,0.0186073943991035,354,4501,regulation of primary metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;CYP27B1;SERPINE2;ADCY7;IGFBP4;PRNP;ADGRF1;BTBD2;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;ZKSCAN1;LMF1;SALL2;PKN1;WWTR1;PEG3;MST1R;ARHGAP22;APLN;POU2F2;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;STK39;BCORL1;PPP1R14A;FYN;TNFRSF6B;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;ZNF516;DLG1;DLG4;DNAJB5;SNX9;TYSND1;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;STRADB;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;SOCS2;TRIB2;KIAA1549;ZNF652;RAG1;TGFBR2;PTPN3;SERPING1;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;CCPG1;CCND2;ANGPTL4;RGS14;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;EIF4E3;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;E2F5;EPCAM;TCFL5;NFAT5;BTRC;LPCAT1;ITGA2;PTK6;ZNF559;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;CHURC1;MTHFR;PFN2;ABCG1;SOX4;FHOD1;FBXO2;ZNF558;CEACAM1;MAPKAPK3;ZNF692;ATF7IP;RCOR1;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;HES2;CD46;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ZMYM3;KLF12;CST3;SLC35B4;CNTN1;TRIB3;CASP4;PCSK6;L3MBTL3;VPS11;RANBP9;BTBD3;ZNF322;PPP3CB;MEX3C;RFX2;APLP2;SLK;PRDX5;MLYCD;CEBPG;PLAG1;F2RL1;UHRF2;TAOK1;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;CPT2;PRKAR1A;MSRB2;JMY;BOK;PARP9;CPEB4;ATXN2;NACC2;SPRY2;ZNF337;BEX4;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;AZIN2;RNF165;PM20D2;MEF2D;ARF4;H2AFJ;XBP1;UBASH3B;MAP2K2;ABHD6;SATB1;PPP1R2;PAIP1;ANKIB1;TLE4;RET;LOXL2;PDE5A;C5;MTMR4;THAP10;GABARAPL2;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;SHC2;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;CBX7;IFI16;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;CITED4;SNX6;ZFP30;GRB7;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;FZD8;WASL;HSPA2;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;E2F7;EEF2K;ZNF320;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;USP25;PRMT3;UFL1;FAM162A;ANKRD6;PBX3;JARID2;KLHL15;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
7412,GO:0031497,0.984497719478358,0.0428739077171574,4,134,chromatin assembly,BP,H1F0;HMGA2;ATRX;RSF1
4958,GO:0015030,0.984626504424417,0.0824025380862522,1,51,Cajal body,CC,NOP10
10616,GO:0043604,0.984681499105822,0.0224887363028175,41,734,amide biosynthetic process,BP,TNIP1;NEURL1;MAP2K1;EIF4EBP1;B4GALT6;CARS;EGFR;IGF2BP3;SPTLC2;ARG2;NAGS;HAGH;IMPACT;ST3GAL5;ABTB1;ATF4;EIF4E3;ASNS;AARS;ITGA2;CHAC1;SOX4;MRPS6;XRN1;TNRC6B;MEX3C;CPEB4;ATXN2;MAP2K2;PAIP1;PUM2;SAMD8;EIF2AK2;SECISBP2L;PPARG;GRB7;GARS;EEF2K;TNRC6C;DNAJC3;CNOT11
4144,GO:0009205,0.984742327498955,0.0308905976477896,10,232,purine ribonucleoside triphosphate metabolic process,BP,DHTKD1;PGM1;NME4;LDHA;PPARA;FAM20C;NDUFV3;TMSB4X;ATP6V1B2;AK9
9545,GO:0036297,0.984875537722182,0.0815090728547133,1,48,interstrand cross-link repair,BP,ERCC1
2882,GO:0006383,0.985002593501693,0.0808463644069379,1,50,transcription by RNA polymerase III,BP,PRDX5
15129,GO:0071219,0.985167707766977,0.0414461293609022,4,112,cellular response to molecule of bacterial origin,BP,TNIP1;NR1D1;TRIM5;XBP1
1174,GO:0002821,0.985192196759439,0.0800300503136668,1,50,positive regulation of adaptive immune response,BP,FADD
3333,GO:0007043,0.985487269930538,0.0460487717928435,3,81,cell-cell junction assembly,BP,DLG1;PRKACA;EPB41L3
3968,GO:0008757,0.985500902749303,0.0372661461261164,5,131,S-adenosylmethionine-dependent methyltransferase activity,MF,PCMTD2;GAMT;CMTR2;PRMT3;DNMT3A
14843,GO:0070585,0.985714120545779,0.0343569495806206,6,160,protein localization to mitochondrion,BP,DDIT3;RAC2;BNIP3L;COX18;VPS11;MOAP1
3326,GO:0007033,0.985731277728556,0.0344236170935875,6,142,vacuole organization,BP,TBC1D14;ULK2;VPS11;GABARAPL2;RAB1A;RB1CC1
3597,GO:0008023,0.985791841236497,0.0776681225767308,1,46,transcription elongation factor complex,CC,ERCC6
5682,GO:0016796,0.985861846013463,0.0772390795268747,1,48,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,XRN1
16871,GO:0098800,0.985876310002499,0.0534536036202679,2,99,inner mitochondrial membrane protein complex,CC,NDUFV3;NDUFA4L2
6073,GO:0019222,0.98608189909649,0.0164935292017635,385,4905,regulation of metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;CYGB;CYP27B1;SERPINE2;ADCY7;IGFBP4;PRNP;ADGRF1;ACTA2;BBS2;ADM2;BTBD2;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;ZKSCAN1;LMF1;SALL2;PKN1;WWTR1;PEG3;MST1R;ARHGAP22;APLN;POU2F2;TRIM65;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;PC;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;TBC1D14;STK39;ANK3;BCORL1;PPP1R14A;FYN;TNFRSF6B;BNIP3;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;ARAP1;ZNF516;DLG1;DLG4;DNAJB5;SNX9;TYSND1;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;SPTLC2;STRADB;CRTAP;ASPH;CEMIP;ARG2;SHC1;DLG3;DKK1;DAP;PAK1;SOCS2;TRIB2;KIAA1549;ZNF652;RAG1;TGFBR2;PTPN3;SERPING1;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;BNIP3L;CCPG1;CCND2;ACP5;ANGPTL4;RGS14;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;FYCO1;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;EIF4E3;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;E2F5;EPCAM;TCFL5;NFAT5;BTRC;LPCAT1;ITGA2;PTK6;ULK2;ZNF559;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;ABCG1;SOX4;FHOD1;FBXO2;ZNF558;CEACAM1;FERMT1;MAPKAPK3;ZNF692;ATF7IP;RCOR1;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;HES2;CD46;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ZMYM3;KLF12;CST3;SLC35B4;CNTN1;TRIB3;CASP4;GFPT1;PCSK6;L3MBTL3;VPS11;RANBP9;BTBD3;ZNF322;PPP3CB;MEX3C;RFX2;APLP2;SLK;PRDX5;MLYCD;CEBPG;PLAG1;F2RL1;UHRF2;RASIP1;TAOK1;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;QSOX1;CPT2;PRKAR1A;MSRB2;JMY;BOK;PARP9;CPEB4;ATXN2;NACC2;SPRY2;ZNF337;BEX4;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;AZIN2;RNF165;PM20D2;MEF2D;ARF4;H2AFJ;XBP1;UBASH3B;MAP2K2;ABHD6;SATB1;PPP1R2;PAIP1;ANKIB1;TLE4;RET;LOXL2;PDE5A;SH3PXD2B;C5;MTMR4;THAP10;GABARAPL2;EPM2A;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;SHC2;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;CBX7;IFI16;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;ARID4A;TENM2;IGF2;AGPAT1;ZSCAN18;GRB10;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;CITED4;SNX6;ZFP30;GRB7;SRPX2;ALDH1A2;LYPLA1;ZNF37A;TBX1;CREB3L2;ATP6V1B2;RSF1;ADAM8;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;TBC1D16;FZD8;WASL;HSPA2;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;E2F7;EEF2K;ZNF320;SLC18A2;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;USP25;PRMT3;UFL1;FAM162A;ANKRD6;PBX3;JARID2;KLHL15;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
13065,GO:0051568,0.986107852179213,0.0763501986127585,1,45,histone H3-K4 methylation,BP,ARID4A
8232,GO:0032993,0.986308392172992,0.0352461898796131,5,163,protein-DNA complex,CC,H1F0;DDIT3;SOX12;HMGA2;H2AFJ
1445,GO:0003674,0.986752138870259,0.0182822271699581,930,11298,molecular_function,MF,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;GID4;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;FAM83A;ADAM19;ETV5;RAB3B;PGF;MBOAT2;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PRSS3;LRRC20;ADCY7;CRYL1;IGFBP4;PRNP;PAG1;ADGRF1;MXRA5;OSBP2;UHRF1BP1;ITGB4;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;CMTM4;THBS2;FMNL2;ETV4;TFPI2;LTBP2;RAPGEF3;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;SLC29A4;ALOX15B;MPRIP;SALL2;COL13A1;TK2;THSD4;GPX3;PKN1;NAPRT;WWTR1;DCBLD2;PEG3;MST1R;ARHGAP22;MICALCL;MARCH9;H6PD;APLN;RBMS2;MARVELD1;POU2F2;TRIM65;DHTKD1;PITPNC1;DGKA;TEF;TNFSF15;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;KCNG1;PTPRS;B4GALT6;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;EXOC2;ELK3;SNTB2;CRTC1;ADGRL1;DENND5B;LTA4H;CAPN2;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;DYSF;CGREF1;LOXL1;ARHGAP12;PPP1R14A;FYN;HEBP1;MYH15;TNFRSF6B;TMPRSS11D;OSBPL10;TSPAN5;PCDHAC2;PSAT1;JADE2;BNIP3;HLTF;KIF13B;SPATS2;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;MYCBPAP;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;DLG4;B3GNT3;IDH2;TMEM245;CTSB;DNAJB5;ACOT1;PLXNB3;GPC4;DHX32;SNX9;TYSND1;PODXL;SLCO4A1;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;EVI5L;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;TTC7B;RSAD1;GRK5;HTR7;NMRK1;STRADB;RDH14;NME4;MALL;CRTAP;RSPH3;ASPH;MCTP1;GDI1;CEMIP;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;WISP1;DAP;SMOC2;HYI;SLFN5;PAK1;RASA3;CEP170;SOCS2;TRIB2;ATXN10;NEK9;KIAA1549;RHPN1;ZNF652;CBR4;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;NUDCD3;B4GALNT4;EDNRA;LCN2;HAGH;NUCB2;SHANK2;SCRN1;EPHA1;IMPACT;RALGAPA2;PLPP6;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCPG1;CCND2;ACP5;ANGPTL4;TIGD2;PTPN12;ALDH1L2;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;ZCCHC14;RAB11FIP4;FAM208A;PPP2R3B;FAM167A;ABHD8;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;ICA1;EIF4E3;AGPAT4;LPAR3;PCMTD2;ELFN2;FAM155B;KIF21B;ASNS;FGFR1;ABHD10;ITGA1;AARS;PPP1R35;E2F5;FAM114A1;EPCAM;TMOD2;MARCH4;TUB;PTPDC1;CMTM7;LPCAT4;TACC1;TCFL5;RNPEPL1;UROS;SMOC1;NFAT5;ITGB5;SNX14;HYAL1;BTRC;LPCAT1;AIG1;ITGA2;PTK6;GALNT3;TMX4;VAMP2;ULK2;LENG9;ZNF559;FAT1;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;NELL2;GAMT;CEP120;ENDOV;IAH1;ZNF558;KDSR;MBLAC2;CEACAM1;ADM5;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PRR9;SLC5A1;PDIA5;RAB31;LMAN1;DMXL2;SLC35F2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;C5ORF24;PLEK2;PLA2G4D;HES2;ANXA6;NLGN2;CD46;ZBTB10;ACAD10;PHF12;MVB12B;EPOR;CTH;ORAI3;ZNF704;NXPH4;MPDZ;FAM50A;MAP6;LRP5;ETAA1;NIPA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;THBS3;CTSL;DOCK9;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;SNORA64;NTNG1;GFPT1;PCSK6;SLC35G2;TOM1L2;L3MBTL3;VPS11;RANBP9;WASF3;DNAJB9;FBXL8;BTBD3;RIMS3;PLPPR2;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;INPP4A;RFX2;SYTL1;HIBADH;ADGRB2;TTYH3;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;DDX60;UHRF2;SLC2A9;GSDMA;PROCR;TAOK1;PLD3;PHC3;AEBP1;ATP10D;ABHD15;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;CPNE8;SUGCT;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;ANO1;MSRB2;FAM84B;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;C18ORF32;ATXN2;KLHL29;MAST3;NACC2;DHRS12;USP6NL;SPRY2;SEPT5;LACTB2;SLC6A14;PCED1B;ZNF337;BEX4;TBC1D2B;THRA;LMBR1L;MGLL;CD99;WNT2B;CYYR1;ENKD1;ACVR1B;NDUFA4L2;SLC43A1;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;MARK4;NPL;ZNF449;PTPRZ1;CHD6;NUDT6;PER3;MTA1;AZIN2;BCL2L1;IFITM1;CRAT;MYH16;RNF165;YTHDC2;PM20D2;GRIN3B;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;NYNRIN;SKAP2;ARF4;H2AFJ;POLL;TMEM187;ANAPC13;YPEL5;UAP1;CNNM1;HSD17B7;SLC12A7;PCYOX1;XBP1;PANK4;SPIRE1;SLC46A3;NT5DC1;NFU1;UBASH3B;TXNRD3;CADM4;MAP2K2;ABHD6;SATB1;SLC22A17;GPATCH8;PPP1R2;PAIP1;ARRDC1;SPIN4;REC8;CYP4F22;ANKIB1;MICU3;LYPLAL1;TLE4;SLC38A2;RIN1;TRPC1;RET;SPATA6;SDR9C7;TUBG2;STX10;LOXL2;PDE5A;VWA1;RAB43;MLH3;OSBPL5;SIMC1;SLC13A3;SH3PXD2B;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;MBOAT7;THAP10;NOP10;NCKAP1;GABARAPL2;EPM2A;KCNJ15;RMRP;GTF2IRD2;DNASE1L1;C1ORF56;ELMO3;DOCK11;PAK6;UBE2E1;PUM2;SLC30A1;TSPAN3;RNF135;PSD3;TMBIM1;ETV1;COL1A2;SFXN3;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;EEPD1;SNX30;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;RHOBTB1;AP2A2;SRD5A3;NR2F6;SLC39A10;KDELR3;CMTM6;SCAND1;IL1RAP;SBNO1;SLC25A43;ST6GALNAC2;ORAI1;CARD11;FCHO1;LAMB2;LTB4R;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;NRSN2;ACP6;TMEM134;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;SLC2A13;ZSCAN18;GRB10;LARP1B;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;SLC10A6;TMEM63A;CITED4;SNX6;USP20;ANKRD50;ZFP30;GRB7;SRPX2;PPL;ALDH1A2;GPR153;ARHGAP29;LYPLA1;TMEM50B;ATP12A;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;ROBO3;GARS;IL20RB;CLDN11;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;IKBIP;PHF21A;ZBTB40;ZNF92;WDR60;ACAP2;MPLKIP;MAML3;CKLF;ZNF568;TMEM9;IGFBP7;TBC1D16;DDHD2;MARCH2;OSGEPL1;PLCXD1;FZD8;TMEM107;CMC1;WASL;USP32;ANKS6;RAPGEFL1;REEP6;HSPA2;PRSS8;ZNF107;FLNB;LRP6;ARID5B;MAGEF1;ZNF165;SYT2;PLCH2;TMEM173;RNF180;GGACT;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;TNRC6C;TRIM2;COQ2;RCAN1;TET1;GRAMD1C;ZC3H7A;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;DNAJC4;AOX1;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;SPRYD7;TMEM139;RNF103;USP25;PANK1;PRMT3;UFL1;FAM162A;SNX27;N4BP2;AMACR;GALE;PBX3;JARID2;PPM1M;SLC23A2;SEMA3F;RALGPS2;KLHL15;JMJD7;SLC44A1;MXD4;ADNP;GNAI1;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FCGBP;FADD
18540,GO:1903747,0.986823173687106,0.0421334000665716,3,98,regulation of establishment of protein localization to mitochondrion,BP,RAC2;BNIP3L;VPS11
7314,GO:0031323,0.986855469797585,0.0156282094531064,362,4609,regulation of cellular metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;CYP27B1;SERPINE2;ADCY7;IGFBP4;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;ZKSCAN1;LMF1;SALL2;PKN1;WWTR1;PEG3;MST1R;ARHGAP22;APLN;POU2F2;TRIM65;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;TBC1D14;STK39;BCORL1;PPP1R14A;FYN;TNFRSF6B;BNIP3;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;ARAP1;ZNF516;DLG1;DLG4;DNAJB5;SNX9;TYSND1;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;SPTLC2;STRADB;CRTAP;ASPH;CEMIP;ARG2;SHC1;DLG3;DKK1;DAP;PAK1;SOCS2;TRIB2;KIAA1549;ZNF652;RAG1;TGFBR2;PTPN3;SERPING1;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;BNIP3L;CCPG1;CCND2;ACP5;RGS14;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;FYCO1;IDE;AKAP9;FAM208A;PPP2R3B;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;EIF4E3;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;E2F5;EPCAM;TCFL5;NFAT5;BTRC;LPCAT1;ITGA2;PTK6;ULK2;ZNF559;ZNF81;LONP2;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;ABCG1;SOX4;FHOD1;FBXO2;ZNF558;CEACAM1;MAPKAPK3;ZNF692;ATF7IP;RCOR1;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ZMYM3;KLF12;CST3;SLC35B4;CNTN1;TRIB3;CASP4;PCSK6;L3MBTL3;VPS11;RANBP9;ZNF322;PPP3CB;MEX3C;RFX2;APLP2;SLK;PRDX5;MLYCD;CEBPG;PLAG1;F2RL1;UHRF2;RASIP1;TAOK1;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;QSOX1;PRKAR1A;MSRB2;JMY;BOK;PARP9;CPEB4;ATXN2;NACC2;SPRY2;ZNF337;BEX4;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;PM20D2;MEF2D;ARF4;H2AFJ;XBP1;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;ANKIB1;TLE4;RET;LOXL2;PDE5A;C5;MTMR4;THAP10;GABARAPL2;EPM2A;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;SHC2;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;CBX7;IFI16;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;ARID4A;TENM2;IGF2;AGPAT1;ZSCAN18;GRB10;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;CITED4;SNX6;ZFP30;GRB7;SRPX2;ZNF37A;TBX1;CREB3L2;ATP6V1B2;RSF1;ADAM8;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;TBC1D16;FZD8;WASL;HSPA2;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;E2F7;EEF2K;ZNF320;SLC18A2;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;USP25;PRMT3;UFL1;FAM162A;ANKRD6;PBX3;JARID2;KLHL15;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FBXL5;FADD
10396,GO:0043227,0.986993065349601,0.0157611369870803,740,9229,membrane-bounded organelle,CC,TNIP1;DOCK4;FHL1;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;ADAM19;ETV5;RAB3B;MBOAT2;CCND1;PCK2;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;H1F0;SERPINE2;PRSS3;CRYL1;IGFBP4;PRNP;MXRA5;ITGB4;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;GPT2;NR1D1;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;THBS2;FAM210B;ETV4;LTBP2;RAPGEF3;FNDC4;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;ALOX15B;LMF1;SALL2;COL13A1;TK2;THSD4;GPX3;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;MARCH9;H6PD;RBMS2;MARVELD1;POU2F2;TRIM65;LY6K;DHTKD1;PITPNC1;TEF;APPL2;ZKSCAN2;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;HADH;SOX12;PSMD2;LAMB1;ELK3;SNTB2;CRTC1;AVL9;LTA4H;CAPN2;BRSK1;WIPF1;SNPH;EGFR;TBC1D14;STK39;ANK3;BCORL1;C2CD2;DYSF;PDZD2;LOXL1;ARMCX2;FYN;HEBP1;TMPRSS11D;PSAT1;JADE2;BNIP3;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;DLG4;B3GNT3;IDH2;CTSB;CD68;DNAJB5;GPC4;DHX32;SNX9;TYSND1;PODXL;NET1;ZSCAN30;TGM2;XPC;GLUL;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;RSAD1;GRK5;STRADB;RDH14;NME4;MALL;CRTAP;ASPH;MCTP1;GDI1;CEMIP;VWA5A;ACAD11;SDC1;ARG2;STOM;SHC1;NAGS;DKK1;SLFN5;PAK1;TRIB2;NEK9;ZNF652;CBR4;RAG1;SERPING1;SLC2A3;B4GALNT4;LCN2;HAGH;NUCB2;SHANK2;SCRN1;RALGAPA2;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;ACP5;TIGD2;KLHDC2;PTPN12;ALDH1L2;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;FAM208A;PPP2R3B;ABHD8;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;ICA1;AGPAT4;KIF21B;FGFR1;ABHD10;ITGA1;AARS;E2F5;FAM114A1;EPCAM;MARCH4;TUB;PTPDC1;LPCAT4;TACC1;TCFL5;UROS;NFAT5;ITGB5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;FAT1;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;BIVM;ATRX;FAM20C;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;GAMT;ENDOV;IAH1;ZNF558;KDSR;MBLAC2;CEACAM1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;SLC5A1;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;DVL1;CLCN3;NTSR1;MMP14;HES2;ANXA6;CD46;ZBTB10;ACAD10;PHF12;MVB12B;CTH;ZNF704;MPDZ;FAM50A;MAP6;LRP5;ETAA1;NIPA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;CTSL;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;SLC35G2;TPBG;TOM1L2;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;BTBD3;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;RFX2;SYTL1;HIBADH;TTYH3;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;SLC2A9;RASIP1;PROCR;C6ORF120;TAOK1;PLD3;PHC3;AEBP1;ATP10D;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;CPNE8;SUGCT;ASAP1;NDUFV3;CPT2;CTBS;ANO1;MSRB2;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;SLC6A14;ZNF337;BEX4;THRA;MGLL;GOLGA6L9;WNT2B;ACVR1B;DBNDD1;NDUFA4L2;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;ZNF449;CHD6;NUDT6;SPESP1;PER3;MTA1;AZIN2;BCL2L1;CRAT;RNF165;YTHDC2;PM20D2;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;SKAP2;ARF4;GOLGA2P5;H2AFJ;POLL;TMEM187;ANAPC13;YPEL5;UAP1;HSD17B7;PCYOX1;XBP1;SPIRE1;SLC46A3;NFU1;UBASH3B;TXNRD3;CADM4;MAP2K2;ABHD6;SATB1;SLC22A17;ARRDC1;REC8;CYP4F22;MICU3;LYPLAL1;TLE4;RET;SDR9C7;FAM222B;TUBG2;STX10;LOXL2;VWA1;RAB43;MLH3;OSBPL5;SLC13A3;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;MBOAT7;NOP10;NCKAP1;GABARAPL2;EPM2A;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;TSPAN3;TMBIM1;ETV1;COL1A2;SFXN3;CCDC88A;CTSO;TMED4;SAMD8;ADAMTSL1;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;SNX30;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;RHOBTB1;BCAP29;AP2A2;SRD5A3;NR2F6;KDELR3;CMTM6;SCAND1;SBNO1;SLC25A43;ST6GALNAC2;CARD11;FCHO1;LAMB2;FICD;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;NRSN2;ACP6;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;ZSCAN18;LARP1B;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;TMEM63A;CITED4;SNX6;EVA1A;ANKRD50;ZFP30;TRIQK;PPL;LYPLA1;TMEM50B;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;GARS;CLDN11;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;IKBIP;PHF21A;ZBTB40;ZNF92;WDR60;ACAP2;MPLKIP;MAML3;ZNF568;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;OSGEPL1;FZD8;CMC1;WASL;USP32;REEP6;HSPA2;PRSS8;ZNF107;FLNB;LRP6;ARID5B;MAGEF1;ZNF165;SYT2;TMEM173;RNF180;GGACT;E2F7;PPT2;ZNF320;SLC18A2;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;COQ2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;RNF103;USP25;PANK1;REEP3;UFL1;VSIG10L;FAM162A;ANKRD6;SNX27;AMACR;GALE;PBX3;JARID2;PPM1M;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;FCGBP;FADD
3741,GO:0008276,0.987108339238043,0.049956251016219,2,72,protein methyltransferase activity,MF,PCMTD2;PRMT3
3625,GO:0008080,0.987558351301553,0.0484869922112036,2,72,N-acetyltransferase activity,MF,NAGS;KAT2B
13002,GO:0051427,0.987774616628628,0.0299978623863029,6,143,hormone receptor binding,MF,PKN1;FYN;SOCS2;PTHLH;PPARG;FOXP1
15916,GO:0072686,0.987994961434314,0.0390200775321985,3,88,mitotic spindle,CC,HECW2;PKD2;CCSAP
1457,GO:0003697,0.988332009509061,0.0379697111052372,3,96,single-stranded DNA binding,MF,ERCC1;XPC;MLH3
3330,GO:0007040,0.988337150038278,0.0660341655458333,1,51,lysosome organization,BP,VPS11
15987,GO:0080171,0.988337150038278,0.0660341655458333,1,51,lytic vacuole organization,BP,VPS11
10900,GO:0044445,0.988386498231816,0.0269827567507631,7,203,cytosolic part,CC,ADCY7;PSMD2;FYCO1;IDE;CASP4;ADCY1;FADD
4138,GO:0009199,0.988474771800558,0.0239248504157758,10,238,ribonucleoside triphosphate metabolic process,BP,DHTKD1;PGM1;NME4;LDHA;PPARA;FAM20C;NDUFV3;TMSB4X;ATP6V1B2;AK9
14512,GO:0065003,0.988498019498653,0.015202108032322,95,1421,protein-containing complex assembly,BP,ERCC1;SORL1;CTNNBIP1;MMP1;H1F0;PRNP;GPX3;DDIT3;KCNG1;SOX12;EXOC2;CRTC1;WIPF1;DLG1;DLG4;SNX9;TYSND1;TGM2;XPC;GLUL;SEC23A;SEPT10;STOM;DKK1;PAK1;ATXN10;CBR4;IMPACT;RAC2;APOE;FKBP1A;ANGPTL4;MCFD2;PKD2;PRKACB;IDE;AKAP9;ABCA7;TMOD2;VAMP2;ATRX;PFN2;ITPR3;DDB2;OBSL1;LMAN1;DMXL2;ATF7IP;SLC9A3R2;ANXA6;CTH;TWF2;COX18;RABGGTA;CLTCL1;VPS11;RANBP9;WASF3;ACOT13;ASAP1;NDUFV3;MSRB2;JMY;BOK;FCHO2;ATXN2;NACC2;SEPT5;THRA;COL6A1;SKAP2;SPIRE1;TLE4;TUBG2;SH3PXD2B;ZFYVE9;NCKAP1;PUM2;COL1A2;PRKACA;TMSB4X;EIF2AK2;RAB1A;IL1RAP;FCHO1;CTSZ;ARPC1A;GRB7;RSF1;WASL;SIGMAR1;KCTD18;SEPT6;LRP4;FADD
4090,GO:0009144,0.988533488958832,0.0238117331135264,10,239,purine nucleoside triphosphate metabolic process,BP,DHTKD1;PGM1;NME4;LDHA;PPARA;FAM20C;NDUFV3;TMSB4X;ATP6V1B2;AK9
10395,GO:0043226,0.988567451850083,0.0141092603885653,790,9764,organelle,CC,TNIP1;DOCK4;FHL1;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;ADAM19;ETV5;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PRSS3;CRYL1;IGFBP4;PRNP;MXRA5;ITGB4;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;THBS2;FAM210B;ETV4;LTBP2;RAPGEF3;FNDC4;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;ALOX15B;MPRIP;LMF1;SALL2;COL13A1;TK2;THSD4;GPX3;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;WDR66;MARCH9;H6PD;RBMS2;MARVELD1;POU2F2;TRIM65;LY6K;DHTKD1;PITPNC1;TEF;APPL2;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;HADH;SOX12;PSMD2;LAMB1;ELK3;SNTB2;CRTC1;AVL9;LTA4H;CAPN2;BRSK1;WIPF1;SNPH;EGFR;TBC1D14;STK39;ANK3;BCORL1;C2CD2;DYSF;PDZD2;LOXL1;ARMCX2;FYN;HEBP1;MYH15;TMPRSS11D;OSBPL10;PSAT1;JADE2;BNIP3;HLTF;KIF13B;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;DLG4;B3GNT3;IDH2;CTSB;CD68;DNAJB5;GPC4;DHX32;SNX9;TYSND1;PODXL;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;RSAD1;GRK5;STRADB;RDH14;NME4;MALL;CRTAP;RSPH3;ASPH;MCTP1;GDI1;CEMIP;VWA5A;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;SLFN5;PAK1;CEP170;TRIB2;NEK9;ZNF652;CBR4;RAG1;PTPN3;SERPING1;SLC2A3;NUDCD3;B4GALNT4;LCN2;HAGH;NUCB2;SHANK2;SCRN1;RALGAPA2;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;ACP5;TIGD2;KLHDC2;PTPN12;ALDH1L2;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;FAM208A;PPP2R3B;ABHD8;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;ICA1;AGPAT4;KIF21B;FGFR1;ABHD10;ITGA1;AARS;E2F5;FAM114A1;EPCAM;TMOD2;MARCH4;TUB;PTPDC1;LPCAT4;TACC1;TCFL5;UROS;NFAT5;ITGB5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;FAT1;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;BIVM;ATRX;FAM20C;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;GAMT;CEP120;ENDOV;IAH1;ZNF558;KDSR;MBLAC2;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;SLC5A1;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLEK2;HES2;ANXA6;CD46;ZBTB10;ACAD10;PHF12;MVB12B;CTH;ZNF704;MPDZ;FAM50A;MAP6;LRP5;ETAA1;NIPA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;CTSL;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;SLC35G2;TPBG;TOM1L2;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;BTBD3;RIMS3;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;RFX2;SYTL1;HIBADH;ADGRB2;TTYH3;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;DDX60;UHRF2;SLC2A9;RASIP1;PROCR;C6ORF120;TAOK1;PLD3;PHC3;AEBP1;ATP10D;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;CPNE8;SUGCT;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;ANO1;MSRB2;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;SLC6A14;ZNF337;BEX4;THRA;MGLL;GOLGA6L9;WNT2B;ENKD1;ACVR1B;DBNDD1;NDUFA4L2;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;MARK4;ZNF449;CHD6;NUDT6;SPESP1;PER3;MTA1;AZIN2;BCL2L1;CRAT;MYH16;RNF165;YTHDC2;PM20D2;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;SKAP2;ARF4;GOLGA2P5;H2AFJ;POLL;TMEM187;ANAPC13;YPEL5;UAP1;HSD17B7;PCYOX1;XBP1;SPIRE1;SLC46A3;NFU1;UBASH3B;TXNRD3;CADM4;MAP2K2;ABHD6;SATB1;SLC22A17;ARRDC1;REC8;CYP4F22;MICU3;LYPLAL1;TLE4;RIN1;RET;SPATA6;SDR9C7;FAM222B;TUBG2;STX10;LOXL2;VWA1;TCTN1;RAB43;MLH3;OSBPL5;SLC13A3;NAV1;SH3PXD2B;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;MBOAT7;NOP10;NCKAP1;GABARAPL2;EPM2A;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;TSPAN3;PSD3;TMBIM1;ETV1;FRMD4B;COL1A2;SFXN3;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;SNX30;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;RHOBTB1;BCAP29;AP2A2;SRD5A3;NR2F6;KDELR3;CMTM6;SCAND1;SBNO1;SLC25A43;ST6GALNAC2;CARD11;FCHO1;LAMB2;FICD;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;NRSN2;ACP6;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;ZSCAN18;LARP1B;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;TMEM63A;CITED4;SNX6;EVA1A;USP20;ANKRD50;ZFP30;GRB7;TRIQK;PPL;LYPLA1;TMEM50B;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;GARS;CLDN11;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;IKBIP;PHF21A;ZBTB40;ZNF92;WDR60;ACAP2;MPLKIP;MAML3;ZNF568;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;OSGEPL1;FZD8;TMEM107;CMC1;WASL;USP32;ANKS6;REEP6;HSPA2;PRSS8;ZNF107;FLNB;LRP6;ARID5B;MAGEF1;ZNF165;SYT2;TMEM173;RNF180;GGACT;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;COQ2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;REEP3;UFL1;VSIG10L;FAM162A;ANKRD6;SNX27;AMACR;GALE;PBX3;JARID2;PPM1M;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;FCGBP;FADD
1448,GO:0003678,0.988581584570503,0.0651739998664395,1,46,DNA helicase activity,MF,ATRX
3628,GO:0008088,0.988748682261073,0.0642945937748387,1,48,axo-dendritic transport,BP,AP3D1
9838,GO:0042073,0.988753454369981,0.0642214090315952,1,49,intraciliary transport,BP,WDR60
8990,GO:0035097,0.988968928647209,0.0438575820853121,2,70,histone methyltransferase complex,CC,PHF1;JARID2
14513,GO:0065004,0.989062963041892,0.0244621357772438,8,213,protein-DNA complex assembly,BP,H1F0;SOX12;XPC;ATRX;DDB2;ATF7IP;THRA;RSF1
3676,GO:0008173,0.989071251425483,0.06248880625693,1,55,RNA methyltransferase activity,MF,CMTR2
12853,GO:0051171,0.989075723035251,0.0130721770798611,342,4384,regulation of nitrogen compound metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;SERPINE2;ADCY7;IGFBP4;PRNP;ADGRF1;BTBD2;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;MST1R;ARHGAP22;APLN;POU2F2;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;STK39;BCORL1;PPP1R14A;FYN;TNFRSF6B;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;ZNF516;DLG1;DLG4;DNAJB5;SNX9;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;STRADB;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;SOCS2;TRIB2;KIAA1549;ZNF652;RAG1;TGFBR2;PTPN3;SERPING1;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;CCPG1;CCND2;ACP5;RGS14;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;EIF4E3;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;E2F5;EPCAM;TCFL5;NFAT5;BTRC;LPCAT1;ITGA2;PTK6;ZNF559;ZNF81;LTBP4;INPP5F;CHAC1;ATRX;CHURC1;MTHFR;PFN2;ABCG1;SOX4;FHOD1;FBXO2;ZNF558;CEACAM1;MAPKAPK3;ZNF692;ATF7IP;RCOR1;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;MMP14;HES2;CD46;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ZMYM3;KLF12;CST3;CNTN1;TRIB3;CASP4;PCSK6;L3MBTL3;VPS11;RANBP9;BTBD3;ZNF322;PPP3CB;MEX3C;RFX2;APLP2;SLK;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;TAOK1;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;BOK;PARP9;CPEB4;ATXN2;NACC2;SPRY2;ZNF337;BEX4;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;AZIN2;RNF165;PM20D2;MEF2D;ARF4;H2AFJ;XBP1;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;ANKIB1;TLE4;RET;LOXL2;PDE5A;C5;THAP10;GABARAPL2;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;SHC2;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;CBX7;IFI16;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;CITED4;SNX6;ZFP30;GRB7;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;HSPA2;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;E2F7;EEF2K;ZNF320;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;USP25;PRMT3;UFL1;FAM162A;ANKRD6;PBX3;JARID2;KLHL15;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FBXL5;FADD
4685,GO:0010833,0.989347288642603,0.0425020780462997,2,74,telomere maintenance via telomere lengthening,BP,XRN1;NOP10
9831,GO:0042054,0.989496624534334,0.0607213225777083,1,50,histone methyltransferase activity,MF,PRMT3
3314,GO:0007017,0.989888274364428,0.0152682893924584,40,604,microtubule-based process,BP,NEURL1;BBS2;WDR66;MAP1B;BRSK1;MYH15;KIF13B;DLG1;TTBK2;PAK1;RGS14;PKD2;FYCO1;AKAP9;KIF21B;TACC1;ATRX;CEP120;OBSL1;DVL1;MAP6;RANBP9;SLK;COPG1;TAOK1;SPRY2;MARK4;GOLGA2P5;SPIRE1;TUBG2;NAV1;CCDC88A;CCSAP;NEK6;RAB1A;AP2A2;AP3D1;WDR60;KAT2B;GNAI1
3362,GO:0007098,0.989902855219201,0.0296535671878023,4,108,centrosome cycle,BP,BRSK1;PKD2;CEP120;KAT2B
17828,GO:1901987,0.990063490673172,0.0173151521381336,20,380,regulation of cell cycle phase transition,BP,FHL1;CCND1;HECW2;PSMD2;BRSK1;EGFR;XPC;CCND2;PKD2;AKAP9;HMGA2;HYAL1;SOX4;TAOK1;PSMD7;NACC2;PRKACA;NEK6;E2F7;CNOT11
4514,GO:0010564,0.990098820398581,0.0150888992841431,38,622,regulation of cell cycle process,BP,FHL1;CCND1;HECW2;PSMD2;BRSK1;EGFR;XPC;CCND2;PKD2;AKAP9;RAB11FIP4;HMGA2;FGFR1;HYAL1;ATRX;SOX4;CEP120;OBSL1;LRP5;TOM1L2;UHRF2;TAOK1;PHC3;CSNK2A1;PSMD7;PRKAR1A;SDCCAG3;NACC2;PPP1R10;BCL2L1;CCSAP;PRKACA;NEK6;IGF2;E2F7;KAT2B;CNOT11;GNAI1
7720,GO:0032210,0.990440439282527,0.0562132339247157,1,51,regulation of telomere maintenance via telomerase,BP,XRN1
42,GO:0000086,0.990629345642024,0.0198344543495103,10,225,G2/M transition of mitotic cell cycle,BP,FHL1;CCND1;PSMD2;BRSK1;AKAP9;HMGA2;BTRC;TAOK1;PSMD7;PRKACA
18477,GO:1903578,0.990640450937988,0.0381112671464703,2,73,regulation of ATP metabolic process,BP,PPARA;TMSB4X
15433,GO:0071704,0.990868841578829,0.0109531279485299,624,7898,organic substance metabolic process,BP,TNIP1;XDH;NT5E;PLAT;SMURF2;EDEM1;GID4;NOS1;ERCC1;ZMYND8;F2R;SORL1;ADAM19;ETV5;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;CTNNBIP1;VLDLR;PYGL;CBS;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;PYGB;H1F0;SERPINE2;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;ADGRF1;ACTA2;BBS2;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;LTBP1;ZKSCAN1;ALOX15B;LMF1;SALL2;TK2;THSD4;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;MARCH9;H6PD;APLN;RBMS2;POU2F2;LY6K;DHTKD1;DGKA;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;ELK3;CRTC1;LTA4H;CAPN2;BRSK1;EGFR;STK39;ANK3;BCORL1;LOXL1;PPP1R14A;FYN;TNFRSF6B;TMPRSS11D;OSBPL10;TSPAN5;PSAT1;JADE2;BNIP3;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;DLG4;B3GNT3;IDH2;CTSB;DNAJB5;ACOT1;GPC4;DHX32;SNX9;TYSND1;ZSCAN30;TGM2;XPC;GLUL;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;TTC7B;RSAD1;GRK5;NMRK1;STRADB;RDH14;NME4;CRTAP;ASPH;CEMIP;ACAD11;SDC1;ARG2;SHC1;NAGS;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;NEK9;KIAA1549;ZNF652;CBR4;RAG1;TGFBR2;PTPN3;SERPING1;SLC2A3;HAGH;SCRN1;EPHA1;IMPACT;PLPP6;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ABCD1;CCPG1;CCND2;ACP5;ANGPTL4;PTPN12;ALDH1L2;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;AGPAT4;LPAR3;PCMTD2;ELFN2;ASNS;FGFR1;ABHD10;ITGA1;AARS;PPP1R35;E2F5;EPCAM;MARCH4;PTPDC1;LPCAT4;TCFL5;RNPEPL1;UROS;NFAT5;HYAL1;DCAF10;BTRC;LPCAT1;AIG1;ITGA2;PTK6;GALNT3;ULK2;ZNF559;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;FBXO2;DDB2;GAMT;ENDOV;IAH1;ZNF558;KDSR;CEACAM1;FERMT1;MAPKAPK3;SPATA18;ZNF692;OBSL1;PRR9;RAB31;LMAN1;ATF7IP;MRPS6;RCOR1;BSG;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;PLA2G4D;HES2;CD46;ZBTB10;ACAD10;PHF12;MVB12B;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;TMEM86B;CTSL;NPEPL1;CST3;RABGGTA;SLC35B4;CNTN1;TRIB3;CASP4;NTNG1;GFPT1;PCSK6;L3MBTL3;VPS11;RANBP9;DNAJB9;FBXL8;BTBD3;PLPPR2;ZNF322;PPP3CB;MEX3C;ACOT13;INPP4A;RFX2;HIBADH;ZDHHC2;APLP2;DNAJC6;SLK;PRDX5;MLYCD;CEBPG;ALDH7A1;PLAG1;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;SLC2A9;TAOK1;PLD3;AEBP1;ABHD15;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;QSOX1;NDUFV3;CPT2;PRKAR1A;CTBS;MSRB2;JMY;CRLS1;BOK;PARP9;CPEB4;ATXN2;KLHL29;MAST3;NACC2;SPRY2;LACTB2;SLC6A14;ZNF337;BEX4;THRA;MGLL;ACVR1B;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;TSHZ1;MARK4;NPL;ZNF449;PTPRZ1;CHD6;PER3;MTA1;AZIN2;CRAT;RNF165;YTHDC2;PM20D2;MEF2D;AGPAT3;GLB1;TRIM7;NYNRIN;ARF4;H2AFJ;POLL;ANAPC13;UAP1;HSD17B7;PCYOX1;XBP1;PANK4;NFU1;UBASH3B;MAP2K2;ABHD6;SATB1;PPP1R2;PAIP1;ARRDC1;REC8;CYP4F22;ANKIB1;LYPLAL1;TLE4;TRPC1;RET;CCDC71L;LOXL2;PDE5A;VWA1;MLH3;OSBPL5;SH3PXD2B;C5;MTMR4;ZFYVE9;MBOAT7;THAP10;NOP10;GABARAPL2;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;RNF135;ETV1;CCDC88A;CTSO;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EEPD1;SEL1L;CBX7;IFI16;AP2A2;SRD5A3;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;LAMB2;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;ARID4A;NIT2;BLVRA;TENM2;IGF2;ACP6;AGPAT1;PJA2;ZSCAN18;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;CITED4;SNX6;EVA1A;USP20;ZFP30;GRB7;ALDH1A2;LYPLA1;ZNF37A;TBX1;ESYT3;CREB3L2;ERP44;ATP6V1B2;AK9;RSF1;ADAM8;ALDH4A1;AKT3;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;TBC1D16;DDHD2;MARCH2;OSGEPL1;PLCXD1;FZD8;WASL;USP32;HSPA2;PRSS8;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;PLCH2;TMEM173;RNF180;GGACT;E2F7;PPT2;EEF2K;ZNF320;HPSE;GALNS;CMTR2;TNRC6C;TRIM2;COQ2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;UFL1;FAM162A;ANKRD6;N4BP2;AMACR;GALE;PBX3;JARID2;PPM1M;SLC23A2;KLHL15;SLC44A1;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
5831,GO:0017111,0.990883548140666,0.0137109130257824,42,648,nucleoside-triphosphatase activity,MF,RAB3B;SMARCA1;MYH15;HLTF;KIF13B;ERCC6;DHX32;SEPT10;RAC2;ATP7B;ABCD1;IDE;ABCA7;KIF21B;LONP2;ATRX;PFN2;ABCG1;RAB31;ATF7IP;DDX60;ATP10D;CHD7;SEPT5;HSPA13;CHD6;MYH16;YTHDC2;ARF4;PCYOX1;TUBG2;RAB43;MLH3;RAB1A;RHOBTB1;ATP12A;ATP6V1B2;ATP11B;WDR60;HSPA2;SEPT6;GNAI1
7746,GO:0032259,0.991116990645557,0.017110783325578,14,284,methylation,BP,RAB3B;PCMTD2;ATRX;MTHFR;GAMT;ATF7IP;PHF1;SATB1;ARID4A;CMTR2;TET1;PRMT3;JARID2;DNMT3A
1784,GO:0004402,0.991201049920851,0.0525440600217581,1,51,histone acetyltransferase activity,MF,KAT2B
597,GO:0001764,0.991362918432747,0.0293826537671787,3,86,neuron migration,BP,FYN;FGFR1;NAV1
20080,GO:2000736,0.991367923405359,0.0290629796976464,3,121,regulation of stem cell differentiation,BP,PSMD2;PSMD7;EIF2AK2
10530,GO:0043467,0.991422799633318,0.0291367760317506,3,92,regulation of generation of precursor metabolites and energy,BP,BNIP3;PPARA;IGF2
7616,GO:0032006,0.991509309615934,0.0350362523806405,2,76,regulation of TOR signaling,BP,EPM2A;AKT3
10730,GO:0044085,0.99157642797141,0.0105637321050945,178,2475,cellular component biogenesis,BP,ERCC1;ZMYND8;SORL1;FLNC;NEURL1;CTNNBIP1;ITGA6;MMP1;H1F0;PRNP;ADGRF1;ITGB4;BBS2;THBS2;RAPGEF3;THSD4;GPX3;WWTR1;SSH1;DDIT3;KCNG1;SOX12;SDK2;EXOC2;CRTC1;ADGRL1;WIPF1;TBC1D14;ANK3;LOXL1;PARVB;ARAP1;DLG1;DLG4;PLXNB3;SNX9;TYSND1;PODXL;TGM2;ESPN;XPC;GLUL;EVI5L;WNT7A;TTBK2;SEC23A;UNC119B;SEPT10;SDC1;STOM;DKK1;PAK1;ATXN10;CBR4;NUDCD3;SHANK2;SLITRK6;EPHA1;IMPACT;RAC2;OBSCN;APOE;FKBP1A;ANGPTL4;MCFD2;PKD2;PRKACB;IDE;AKAP9;HMGA2;ABCA7;LPAR3;TMOD2;PTPDC1;ITGB5;HYAL1;ITGA2;VAMP2;ULK2;ATRX;PFN2;FHOD1;ITPR3;DDB2;CEP120;OBSL1;LMAN1;DMXL2;ATF7IP;FAM110C;SLC9A3R2;DVL1;MMP14;ANXA6;NLGN2;CTH;TWF2;COX18;RABGGTA;CLTCL1;TPBG;VPS11;RANBP9;WASF3;ACOT13;RFX2;ADGRB2;SLK;FNBP1L;F2RL1;CHD7;ASAP1;NDUFV3;PRKAR1A;MSRB2;JMY;BOK;FCHO2;ATXN2;NACC2;SEPT5;THRA;COL6A1;MVB12A;MARK4;WASF2;SKAP2;GOLGA2P5;SPIRE1;NFU1;ARRDC1;REC8;TLE4;SPATA6;TUBG2;TCTN1;MLH3;SH3PXD2B;ZFYVE9;NOP10;NCKAP1;GABARAPL2;DOCK11;PUM2;COL1A2;CCDC88A;CCSAP;SAMD8;PRKACA;NEK6;TMSB4X;EIF2AK2;RAB1A;EPB41L3;RHOBTB1;IL1RAP;FCHO1;LPAR1;CTSZ;ARPC1A;TENM2;LAMA5;GRB7;SRPX2;RSF1;WDR60;TMEM107;WASL;HSPA2;EEF2K;SIGMAR1;KCTD18;KAT2B;SEPT6;ADNP;LRP4;RB1CC1;FADD
10682,GO:0043933,0.991628473283539,0.0109775516757152,112,1671,protein-containing complex subunit organization,BP,ERCC1;SORL1;CTNNBIP1;MMP1;H1F0;PRNP;GPX3;MAP1B;DDIT3;KCNG1;SOX12;EXOC2;CRTC1;WIPF1;LOXL1;BNIP3;DLG1;DLG4;SNX9;TYSND1;TGM2;XPC;GLUL;TTBK2;SEC23A;ASPH;SEPT10;STOM;DKK1;PAK1;ATXN10;CBR4;IMPACT;RAC2;APOE;FKBP1A;ANGPTL4;MCFD2;PKD2;PRKACB;FYCO1;IDE;AKAP9;ABCA7;TMOD2;SNX14;VAMP2;ATRX;PFN2;ABCG1;ITPR3;DDB2;OBSL1;LMAN1;DMXL2;ATF7IP;MRPS6;SLC9A3R2;DVL1;ANXA6;CTH;LRP5;TWF2;COX18;RABGGTA;CLTCL1;VPS11;RANBP9;WASF3;ACOT13;DNAJC6;F2RL1;ASAP1;NDUFV3;MSRB2;JMY;BOK;FCHO2;ATXN2;NACC2;SEPT5;THRA;COL6A1;SKAP2;SPIRE1;TLE4;TUBG2;LOXL2;SH3PXD2B;ZFYVE9;NCKAP1;GABARAPL2;PUM2;COL1A2;CCSAP;PRKACA;TMSB4X;EIF2AK2;RAB1A;IL1RAP;FCHO1;CTSZ;ARPC1A;GRB7;RSF1;WASL;LRP6;SIGMAR1;KCTD18;SEPT6;LRP4;FADD
60,GO:0000123,0.991700233163429,0.0343195529812605,2,79,histone acetyltransferase complex,CC,JADE2;KAT2B
5467,GO:0016363,0.991821471810712,0.0279369708862633,3,94,nuclear matrix,CC,XPOT;SATB1;DNMT3A
3665,GO:0008152,0.991984611419618,0.00967647535708617,653,8255,metabolic process,BP,TNIP1;XDH;NT5E;PLAT;SMURF2;EDEM1;GID4;NOS1;ERCC1;ZMYND8;F2R;SORL1;ADAM19;ETV5;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;CTNNBIP1;VLDLR;PYGL;CBS;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;PYGB;H1F0;SERPINE2;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;ADGRF1;ITGB4;ACTA2;BBS2;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;LTBP1;ZKSCAN1;ALOX15B;LMF1;SALL2;COL13A1;TK2;THSD4;GPX3;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;MARCH9;H6PD;APLN;RBMS2;POU2F2;TRIM65;LY6K;DHTKD1;DGKA;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;ELK3;CRTC1;LTA4H;CAPN2;BRSK1;EGFR;TBC1D14;STK39;ANK3;BCORL1;LOXL1;PPP1R14A;FYN;TNFRSF6B;TMPRSS11D;OSBPL10;TSPAN5;PSAT1;JADE2;BNIP3;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;DLG4;B3GNT3;IDH2;CTSB;DNAJB5;ACOT1;GPC4;DHX32;SNX9;TYSND1;ZSCAN30;TGM2;XPC;GLUL;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;TTC7B;RSAD1;GRK5;NMRK1;STRADB;RDH14;NME4;CRTAP;ASPH;CEMIP;ACAD11;SDC1;ARG2;SHC1;NAGS;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;NEK9;KIAA1549;ZNF652;CBR4;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;HAGH;SCRN1;EPHA1;IMPACT;PLPP6;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ABCD1;CCPG1;CCND2;ACP5;ANGPTL4;PTPN12;ALDH1L2;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;AGPAT4;LPAR3;PCMTD2;ELFN2;ASNS;FGFR1;ABHD10;ITGA1;AARS;PPP1R35;E2F5;EPCAM;MARCH4;PTPDC1;LPCAT4;TCFL5;RNPEPL1;UROS;NFAT5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;AIG1;ITGA2;PTK6;GALNT3;TMX4;ULK2;ZNF559;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;VPS13A;FBXO2;DDB2;GAMT;ENDOV;IAH1;ZNF558;KDSR;CEACAM1;FERMT1;MAPKAPK3;SPATA18;ZNF692;OBSL1;PRR9;PDIA5;RAB31;LMAN1;ATF7IP;MRPS6;RCOR1;BSG;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;PLA2G4D;HES2;CD46;ZBTB10;ACAD10;PHF12;MVB12B;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;TMEM86B;CTSL;NPEPL1;CST3;RABGGTA;SLC35B4;CNTN1;TRIB3;CASP4;NTNG1;GFPT1;PCSK6;L3MBTL3;VPS11;RANBP9;DNAJB9;FBXL8;BTBD3;PLPPR2;SEC63;ZNF322;PPP3CB;MEX3C;ACOT13;INPP4A;RFX2;HIBADH;ZDHHC2;APLP2;DNAJC6;SLK;PRDX5;MLYCD;CEBPG;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;SLC2A9;RASIP1;TAOK1;PLD3;AEBP1;ABHD15;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;SUGCT;NDUFV3;CPT2;PRKAR1A;CTBS;MSRB2;JMY;CRLS1;BOK;PARP9;CPEB4;ATXN2;KLHL29;MAST3;NACC2;DHRS12;SPRY2;LACTB2;SLC6A14;ZNF337;BEX4;THRA;MGLL;ACVR1B;NDUFA4L2;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;TSHZ1;MARK4;NPL;ZNF449;PTPRZ1;CHD6;PER3;MTA1;AZIN2;CRAT;RNF165;YTHDC2;PM20D2;MEF2D;AGPAT3;GLB1;TRIM7;NYNRIN;ARF4;H2AFJ;POLL;ANAPC13;UAP1;HSD17B7;PCYOX1;XBP1;PANK4;NT5DC1;NFU1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SATB1;PPP1R2;PAIP1;ARRDC1;REC8;CYP4F22;ANKIB1;LYPLAL1;TLE4;TRPC1;RET;SDR9C7;CCDC71L;LOXL2;PDE5A;VWA1;MLH3;OSBPL5;SH3PXD2B;C5;MTMR4;ZFYVE9;MBOAT7;THAP10;NOP10;GABARAPL2;EPM2A;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;RNF135;ETV1;COL1A2;CCDC88A;CTSO;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EEPD1;SEL1L;CBX7;IFI16;AP2A2;SRD5A3;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;LAMB2;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;AP3D1;ARID4A;NIT2;BLVRA;TENM2;IGF2;ACP6;AGPAT1;PJA2;ZSCAN18;GRB10;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;CITED4;SNX6;EVA1A;USP20;ZFP30;GRB7;SRPX2;ALDH1A2;LYPLA1;ZNF37A;TBX1;ESYT3;CREB3L2;ERP44;ATP6V1B2;AK9;RSF1;ADAM8;ALDH4A1;AKT3;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;TBC1D16;DDHD2;MARCH2;OSGEPL1;PLCXD1;FZD8;WASL;USP32;HSPA2;PRSS8;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;PLCH2;TMEM173;RNF180;GGACT;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;HPSE;GALNS;CMTR2;TNRC6C;TRIM2;COQ2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;UFL1;FAM162A;ANKRD6;N4BP2;AMACR;GALE;PBX3;JARID2;PPM1M;SLC23A2;KLHL15;SLC44A1;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
17310,GO:0140110,0.992381942729409,0.0101589704859746,100,1402,transcription regulator activity,MF,ZMYND8;ETV5;CCND1;NR1D1;NFATC4;ZC3H6;ETV4;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;POU2F2;TEF;ZKSCAN2;DDIT3;SOX12;ELK3;HLTF;ZNF516;ZSCAN30;KIAA1549;ZNF624;DDN;HMGA2;ATF4;PPARA;E2F5;TCFL5;NFAT5;ZNF559;ZNF81;SOX4;ZNF558;ZNF692;ATF7IP;RCOR1;HES2;PHF12;ZMYM3;KLF12;TRIB3;L3MBTL3;ZNF322;RFX2;CEBPG;PLAG1;AEBP1;PHF1;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;TSHZ1;ZNF449;PER3;MTA1;MEF2D;XBP1;SATB1;TLE4;THAP10;GTF2IRD2;ETV1;ZNF398;UNKL;IFI16;NR2F6;SCAND1;ZNF354A;TBL1X;HOXA3;ARID4A;ZSCAN18;ZMYM2;PPARG;CITED4;ZFP30;ZNF37A;TBX1;CREB3L2;PHF21A;ZNF92;MAML3;ZNF568;ARID5B;ZNF165;E2F7;ZNF320;RCAN1;FOXP1;ZBTB33;KAT2B;PBX3;JARID2;MXD4;ADNP;RFX7
10184,GO:0042775,0.992480504769973,0.0455500635204591,1,79,mitochondrial ATP synthesis coupled electron transport,BP,NDUFV3
133,GO:0000278,0.992482962990945,0.0107723318613921,59,913,mitotic cell cycle,BP,FHL1;CCND1;HECW2;MAP2K1;EIF4EBP1;PSMD2;BRSK1;EGFR;STK39;ANK3;DLG1;SNX9;XPC;MAP4K4;STRADB;SEPT10;PAK1;NEK9;PTPN3;CCND2;RGS14;PKD2;AKAP9;HMGA2;ASNS;FGFR1;HYAL1;BTRC;ATRX;SOX4;OBSL1;LRP5;CLTCL1;TOM1L2;SLK;TAOK1;PSMD7;NACC2;SPRY2;SEPT5;ACVR1B;PPP1R10;BCL2L1;MAP2K2;TUBG2;PAK6;CCSAP;PRKACA;NEK6;TIMP2;IGF2;MAP4K2;E2F7;PTCH1;SEPT6;CNOT11;REEP3;GNAI1;DNMT3A
2609,GO:0005913,0.99248339306462,0.0316132870794177,2,74,cell-cell adherens junction,CC,ITGA6;CADM4
5511,GO:0016462,0.992598240784715,0.0111485756982149,44,686,pyrophosphatase activity,MF,RAB3B;SMARCA1;MYH15;HLTF;KIF13B;ERCC6;DHX32;SEPT10;RAC2;ATP7B;ABCD1;IDE;ABCA7;KIF21B;LONP2;ATRX;PFN2;ABCG1;RAB31;ATF7IP;DDX60;ATP10D;CHD7;SEPT5;HSPA13;CHD6;NUDT6;MYH16;YTHDC2;ARF4;PCYOX1;TUBG2;RAB43;MLH3;RAB1A;RHOBTB1;ATP12A;ATP6V1B2;GARS;ATP11B;WDR60;HSPA2;SEPT6;GNAI1
14429,GO:0061733,0.992721256850513,0.0449212626349472,1,53,peptide-lysine-N-acetyltransferase activity,MF,KAT2B
14413,GO:0061695,0.992786504289124,0.01515621492061,11,239,transferase complex, transferring phosphorus-containing groups,CC,ERCC1;CCND1;TGFBR2;CCND2;INTS8;TCEA1;PRKAR1A;ACVR1B;CHD6;RMRP;RB1CC1
5696,GO:0016817,0.992870671257371,0.0107566274563017,44,688,hydrolase activity, acting on acid anhydrides,MF,RAB3B;SMARCA1;MYH15;HLTF;KIF13B;ERCC6;DHX32;SEPT10;RAC2;ATP7B;ABCD1;IDE;ABCA7;KIF21B;LONP2;ATRX;PFN2;ABCG1;RAB31;ATF7IP;DDX60;ATP10D;CHD7;SEPT5;HSPA13;CHD6;NUDT6;MYH16;YTHDC2;ARF4;PCYOX1;TUBG2;RAB43;MLH3;RAB1A;RHOBTB1;ATP12A;ATP6V1B2;GARS;ATP11B;WDR60;HSPA2;SEPT6;GNAI1
5697,GO:0016818,0.992870671257371,0.0107566274563017,44,688,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,RAB3B;SMARCA1;MYH15;HLTF;KIF13B;ERCC6;DHX32;SEPT10;RAC2;ATP7B;ABCD1;IDE;ABCA7;KIF21B;LONP2;ATRX;PFN2;ABCG1;RAB31;ATF7IP;DDX60;ATP10D;CHD7;SEPT5;HSPA13;CHD6;NUDT6;MYH16;YTHDC2;ARF4;PCYOX1;TUBG2;RAB43;MLH3;RAB1A;RHOBTB1;ATP12A;ATP6V1B2;GARS;ATP11B;WDR60;HSPA2;SEPT6;GNAI1
469,GO:0001510,0.992913083362273,0.0437186454762631,1,61,RNA methylation,BP,CMTR2
277,GO:0000779,0.99296692574004,0.0244185321776901,3,104,condensed chromosome, centromeric region,CC,ATRX;REC8;SEPT6
274,GO:0000776,0.99296934432727,0.0214864311189627,4,121,kinetochore,CC,REC8;PSEN2;KAT2B;SEPT6
2731,GO:0006110,0.992994673957839,0.0435976216028886,1,51,regulation of glycolytic process,BP,PPARA
10182,GO:0042773,0.993088366981895,0.0424770048101601,1,80,ATP synthesis coupled electron transport,BP,NDUFV3
12870,GO:0051193,0.993371144241076,0.0283675662809608,2,76,regulation of cofactor metabolic process,BP,RAC2;PPARA
17638,GO:1901361,0.993415885214048,0.0107223334548535,30,568,organic cyclic compound catabolic process,BP,XDH;NT5E;CYP27B1;H1F0;RAPGEF3;DHTKD1;PSMD2;PGM1;IGF2BP3;APOE;ALDH1L2;LDHA;PPARA;APOBEC3C;XRN1;TNRC6B;PSMD7;PM20D2;PAIP1;PDE5A;DNASE1L1;PUM2;BLVRA;ALDH4A1;ENDOG;TNRC6C;TET1;DEDD2;AOX1;CNOT11
13491,GO:0055029,0.993474892577938,0.0200855691620629,4,127,nuclear DNA-directed RNA polymerase complex,CC,ERCC1;INTS8;TCEA1;CHD6
13702,GO:0060255,0.993760849884607,0.00755125036245365,353,4567,regulation of macromolecule metabolic process,BP,TNIP1;XDH;PLAT;SMURF2;EDEM1;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;SERPINE2;ADCY7;IGFBP4;PRNP;ADGRF1;ACTA2;BBS2;ADM2;BTBD2;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;MST1R;ARHGAP22;APLN;POU2F2;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;PC;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;STK39;ANK3;BCORL1;PPP1R14A;FYN;TNFRSF6B;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;ARAP1;ZNF516;DLG1;DLG4;DNAJB5;SNX9;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;MAP4K4;STRADB;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;SOCS2;TRIB2;KIAA1549;ZNF652;RAG1;TGFBR2;PTPN3;SERPING1;EPHA1;IMPACT;RAC2;CD44;APOE;FKBP1A;CCPG1;CCND2;RGS14;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;EIF4E3;LPAR3;ELFN2;FGFR1;ITGA1;PPP1R35;E2F5;EPCAM;TCFL5;NFAT5;BTRC;LPCAT1;ITGA2;PTK6;ZNF559;ZNF81;LTBP4;INPP5F;CHAC1;ATRX;CHURC1;MTHFR;PFN2;ABCG1;SOX4;FHOD1;FBXO2;ZNF558;CEACAM1;FERMT1;MAPKAPK3;ZNF692;ATF7IP;RCOR1;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;MMP14;HES2;CD46;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ZMYM3;KLF12;CST3;CNTN1;TRIB3;CASP4;GFPT1;PCSK6;L3MBTL3;VPS11;RANBP9;BTBD3;ZNF322;PPP3CB;MEX3C;RFX2;APLP2;SLK;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;TAOK1;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;BOK;PARP9;CPEB4;ATXN2;NACC2;SPRY2;ZNF337;BEX4;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;AZIN2;RNF165;PM20D2;MEF2D;ARF4;H2AFJ;XBP1;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;ANKIB1;TLE4;RET;LOXL2;PDE5A;SH3PXD2B;C5;MTMR4;THAP10;GABARAPL2;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;SHC2;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;CBX7;IFI16;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;CITED4;SNX6;ZFP30;GRB7;ALDH1A2;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;TBC1D16;FZD8;WASL;HSPA2;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;E2F7;EEF2K;ZNF320;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;USP25;PRMT3;UFL1;FAM162A;ANKRD6;PBX3;JARID2;KLHL15;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FBXL5;FADD
2505,GO:0005758,0.993787036466469,0.0390246179059719,1,71,mitochondrial intermembrane space,CC,NME4
155,GO:0000313,0.993862959623494,0.038448010327639,1,84,organellar ribosome,CC,MRPS6
2508,GO:0005761,0.993862959623494,0.038448010327639,1,84,mitochondrial ribosome,CC,MRPS6
203,GO:0000428,0.99393469423521,0.018822626661648,4,128,DNA-directed RNA polymerase complex,CC,ERCC1;INTS8;TCEA1;CHD6
10781,GO:0044237,0.993995867177057,0.00726778030050824,620,7882,cellular metabolic process,BP,TNIP1;XDH;NT5E;PLAT;SMURF2;EDEM1;GID4;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;CTNNBIP1;VLDLR;PYGL;CBS;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;PYGB;H1F0;SERPINE2;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;ADGRF1;ITGB4;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;LTBP1;ZKSCAN1;ALOX15B;LMF1;SALL2;TK2;GPX3;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;MARCH9;H6PD;APLN;RBMS2;POU2F2;TRIM65;LY6K;DHTKD1;DGKA;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;ELK3;CRTC1;LTA4H;CAPN2;BRSK1;EGFR;TBC1D14;STK39;BCORL1;LOXL1;PPP1R14A;FYN;TNFRSF6B;OSBPL10;PSAT1;JADE2;BNIP3;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;DLG4;B3GNT3;IDH2;CTSB;DNAJB5;ACOT1;GPC4;DHX32;SNX9;TYSND1;ZSCAN30;TGM2;XPC;GLUL;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;TTC7B;RSAD1;GRK5;NMRK1;STRADB;RDH14;NME4;CRTAP;ASPH;CEMIP;ACAD11;SDC1;ARG2;SHC1;NAGS;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;NEK9;KIAA1549;ZNF652;CBR4;RAG1;TGFBR2;PTPN3;SERPING1;SLC2A3;HAGH;EPHA1;IMPACT;PLPP6;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ABCD1;CCPG1;CCND2;ACP5;PTPN12;ALDH1L2;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;AGPAT4;LPAR3;PCMTD2;ELFN2;ASNS;FGFR1;ABHD10;ITGA1;AARS;PPP1R35;E2F5;EPCAM;MARCH4;PTPDC1;LPCAT4;TCFL5;RNPEPL1;UROS;NFAT5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;AIG1;ITGA2;PTK6;GALNT3;ULK2;ZNF559;INTS8;ZNF81;LONP2;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;VPS13A;FBXO2;DDB2;GAMT;ENDOV;ZNF558;KDSR;CEACAM1;MAPKAPK3;SPATA18;ZNF692;OBSL1;PRR9;RAB31;LMAN1;ATF7IP;MRPS6;RCOR1;BSG;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;PLA2G4D;HES2;ZBTB10;ACAD10;PHF12;MVB12B;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;TMEM86B;CTSL;CST3;RABGGTA;SLC35B4;CNTN1;TRIB3;CASP4;NTNG1;GFPT1;PCSK6;L3MBTL3;VPS11;RANBP9;DNAJB9;FBXL8;BTBD3;PLPPR2;ZNF322;PPP3CB;MEX3C;ACOT13;INPP4A;RFX2;HIBADH;ZDHHC2;APLP2;DNAJC6;SLK;PRDX5;MLYCD;CEBPG;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;SLC2A9;RASIP1;TAOK1;AEBP1;ABHD15;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;NDUFV3;CPT2;PRKAR1A;CTBS;MSRB2;JMY;CRLS1;BOK;PARP9;CPEB4;ATXN2;KLHL29;MAST3;NACC2;SPRY2;LACTB2;SLC6A14;ZNF337;BEX4;THRA;MGLL;ACVR1B;NDUFA4L2;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;TSHZ1;MARK4;NPL;ZNF449;PTPRZ1;CHD6;PER3;MTA1;AZIN2;CRAT;RNF165;YTHDC2;PM20D2;MEF2D;AGPAT3;GLB1;TRIM7;NYNRIN;ARF4;H2AFJ;POLL;ANAPC13;UAP1;HSD17B7;PCYOX1;XBP1;PANK4;NT5DC1;NFU1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SATB1;PPP1R2;PAIP1;ARRDC1;REC8;CYP4F22;ANKIB1;LYPLAL1;TLE4;TRPC1;RET;CCDC71L;LOXL2;PDE5A;VWA1;MLH3;OSBPL5;SH3PXD2B;C5;MTMR4;MBOAT7;THAP10;NOP10;GABARAPL2;EPM2A;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;RNF135;ETV1;CCDC88A;CTSO;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EEPD1;SEL1L;CBX7;IFI16;AP2A2;SRD5A3;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;LAMB2;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;ARID4A;NIT2;BLVRA;TENM2;IGF2;ACP6;AGPAT1;PJA2;ZSCAN18;GRB10;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;CITED4;SNX6;EVA1A;USP20;ZFP30;GRB7;SRPX2;ALDH1A2;LYPLA1;ZNF37A;TBX1;ESYT3;CREB3L2;ERP44;ATP6V1B2;AK9;RSF1;ADAM8;ALDH4A1;AKT3;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;TBC1D16;DDHD2;MARCH2;OSGEPL1;FZD8;WASL;USP32;HSPA2;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;PLCH2;TMEM173;RNF180;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;HPSE;GALNS;CMTR2;TNRC6C;TRIM2;COQ2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;UFL1;FAM162A;ANKRD6;N4BP2;AMACR;PBX3;JARID2;PPM1M;SLC23A2;KLHL15;SLC44A1;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
2864,GO:0006355,0.994165935480531,0.00728879329424285,211,2827,regulation of transcription, DNA-templated,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;TRIM5;TCEA1;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;TLE4;RET;LOXL2;THAP10;GTF2IRD2;PAK6;EAPP;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
7161,GO:0031023,0.994196839847516,0.0181599719343482,4,115,microtubule organizing center organization,BP,BRSK1;PKD2;CEP120;KAT2B
8803,GO:0034504,0.994474715192122,0.0126707208941686,9,205,protein localization to nucleus,BP,FYN;ABCA7;SOX4;DVL1;PARP9;NGFR;PPP1R10;EFCAB7;TMEM173
4087,GO:0009141,0.994593128483676,0.0119497536804352,10,256,nucleoside triphosphate metabolic process,BP,DHTKD1;PGM1;NME4;LDHA;PPARA;FAM20C;NDUFV3;TMSB4X;ATP6V1B2;AK9
14657,GO:0070252,0.994633724598028,0.0349853238926533,1,51,actin-mediated cell contraction,BP,DLG1
5567,GO:0016579,0.994727456627428,0.0113536535786221,11,243,protein deubiquitination,BP,TNIP1;SMURF2;PSMD2;DDB2;OTUB2;PSMD7;RNF135;USP20;USP32;KAT2B;USP25
10796,GO:0044270,0.994777969537121,0.00873906517351009,28,543,cellular nitrogen compound catabolic process,BP,XDH;NT5E;H1F0;RAPGEF3;DHTKD1;PSMD2;PGM1;IGF2BP3;ALDH1L2;LDHA;PPARA;APOBEC3C;XRN1;TNRC6B;PSMD7;TST;PM20D2;PAIP1;PDE5A;DNASE1L1;PUM2;BLVRA;ENDOG;TNRC6C;TET1;DEDD2;AOX1;CNOT11
19819,GO:2000278,0.994814906354241,0.0228924295469321,2,84,regulation of DNA biosynthetic process,BP,XRN1;PPARG
14871,GO:0070647,0.994905905957138,0.00737661597428037,61,947,protein modification by small protein conjugation or removal,BP,TNIP1;SMURF2;GID4;NEURL1;HECW2;WWTR1;MARCH9;PSMD2;FYN;JADE2;HLTF;UBE2J1;SOCS2;RAG1;FKBP1A;ZNF862;RBCK1;UBE2G1;MARCH4;DCAF10;BTRC;SOX4;RMND5A;FBXO2;DDB2;TRIM5;TRIB3;FBXL8;UHRF2;FBXO41;OTUB2;PSMD7;BLMH;KLHL29;MTA1;RNF165;TRIM7;ANAPC13;ARRDC1;ANKIB1;UBE2E1;RNF135;UNKL;RAB1A;RNF169;PJA2;USP20;WFS1;MARCH2;USP32;MAGEF1;RNF180;TRIM2;KAT2B;RNF103;USP25;PRMT3;UFL1;KLHL15;TRIM38;FBXL5
11813,GO:0046700,0.994907767266365,0.00853340971387013,28,543,heterocycle catabolic process,BP,XDH;NT5E;H1F0;RAPGEF3;DHTKD1;PSMD2;PGM1;IGF2BP3;ALDH1L2;LDHA;PPARA;APOBEC3C;XRN1;TNRC6B;PSMD7;PM20D2;PAIP1;PDE5A;DNASE1L1;PUM2;BLVRA;ALDH4A1;ENDOG;TNRC6C;TET1;DEDD2;AOX1;CNOT11
14585,GO:0070125,0.994939687657111,0.0327258830504749,1,86,mitochondrial translational elongation,BP,MRPS6
17306,GO:0140101,0.994967701096119,0.0181514744181649,3,117,catalytic activity, acting on a tRNA,MF,CARS;AARS;GARS
10690,GO:0043967,0.994968876709404,0.0329621913865798,1,59,histone H4 acetylation,BP,JADE2
18542,GO:1903749,0.995006440222818,0.0221104481541824,2,90,positive regulation of establishment of protein localization to mitochondrion,BP,RAC2;VPS11
3183,GO:0006805,0.995110384713567,0.0320403980743739,1,67,xenobiotic metabolic process,BP,BPHL
18805,GO:1904356,0.995142612792035,0.032033063545565,1,58,regulation of telomere maintenance via telomere lengthening,BP,XRN1
10580,GO:0043543,0.995183937288369,0.0116298394953548,8,198,protein acylation,BP,NOS1;RAPGEF3;JADE2;SOX4;ABHD17C;ZDHHC2;ZDHHC1;KAT2B
11013,GO:0044839,0.995242627881352,0.0106396205322323,10,239,cell cycle G2/M phase transition,BP,FHL1;CCND1;PSMD2;BRSK1;AKAP9;HMGA2;BTRC;TAOK1;PSMD7;PRKACA
3064,GO:0006626,0.995335635641574,0.0169668780473939,3,120,protein targeting to mitochondrion,BP,RAC2;BNIP3L;VPS11
8750,GO:0034399,0.995413379749924,0.0147194474953835,4,119,nuclear periphery,CC,XPOT;ATF4;SATB1;DNMT3A
2847,GO:0006325,0.995437218877427,0.00718265102390163,39,660,chromatin organization,BP,NOS1;ZMYND8;H1F0;PKN1;SMARCA1;BCORL1;JADE2;HLTF;SCMH1;RAG1;HMGA2;ATRX;MTHFR;FKBP10;DDB2;RCOR1;L3MBTL3;UHRF2;PHF1;CHD7;NACC2;CHD6;MTA1;H2AFJ;SATB1;LOXL2;UBE2E1;CBX7;TBL1X;ARID4A;IGF2;RSF1;PHF21A;ARID5B;TET1;KAT2B;PRMT3;JARID2;DNMT3A
18345,GO:1903312,0.995460797852543,0.0302334737888631,1,60,negative regulation of mRNA metabolic process,BP,PAIP1
332,GO:0000922,0.995487570045586,0.0131608201019806,5,142,spindle pole,CC,RGS14;FAM110C;BEX4;NEK6;WDR60
6928,GO:0030521,0.995629560693004,0.0293309923122022,1,58,androgen receptor signaling pathway,BP,FOXP1
18426,GO:1903506,0.995636762294919,0.00549004311804446,211,2844,regulation of nucleic acid-templated transcription,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;TRIM5;TCEA1;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;TLE4;RET;LOXL2;THAP10;GTF2IRD2;PAK6;EAPP;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
14586,GO:0070126,0.995663048971237,0.0287460249194028,1,88,mitochondrial translational termination,BP,MRPS6
10294,GO:0043043,0.995736044961015,0.00690915127153881,34,673,peptide biosynthetic process,BP,TNIP1;NEURL1;MAP2K1;EIF4EBP1;CARS;EGFR;IGF2BP3;HAGH;IMPACT;ABTB1;ATF4;EIF4E3;AARS;ITGA2;CHAC1;SOX4;MRPS6;XRN1;TNRC6B;MEX3C;CPEB4;ATXN2;MAP2K2;PAIP1;PUM2;EIF2AK2;SECISBP2L;PPARG;GRB7;GARS;EEF2K;TNRC6C;DNAJC3;CNOT11
20214,GO:2001141,0.995765384607564,0.00533203681040088,211,2846,regulation of RNA biosynthetic process,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;TRIM5;TCEA1;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;TLE4;RET;LOXL2;THAP10;GTF2IRD2;PAK6;EAPP;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
10531,GO:0043470,0.995803264475601,0.0283734500582586,1,57,regulation of carbohydrate catabolic process,BP,PPARA
2842,GO:0006310,0.995806567357468,0.00982787370284301,9,215,DNA recombination,BP,ERCC1;RAG1;ATRX;POLL;REC8;MLH3;ENDOG;MAGEF1;KLHL15
282,GO:0000784,0.995854470790318,0.015316841937348,3,114,nuclear chromosome, telomeric region,CC,ERCC1;ATRX;PPP1R10
257,GO:0000723,0.995945393730824,0.0119277756935661,5,153,telomere maintenance,BP,ERCC1;ATRX;XRN1;PPP1R10;NOP10
3300,GO:0006997,0.995971023032042,0.013096520994336,4,124,nucleus organization,BP,NEK9;NEK6;ZNF354A;REEP3
8659,GO:0034212,0.995974369401739,0.0273449975491187,1,60,peptide N-acetyltransferase activity,MF,KAT2B
7269,GO:0031248,0.996054477137476,0.0180501915703716,2,88,protein acetyltransferase complex,CC,JADE2;KAT2B
18011,GO:1902493,0.996054477137476,0.0180501915703716,2,88,acetyltransferase complex,CC,JADE2;KAT2B
18135,GO:1902850,0.996139407534567,0.0126138511466136,4,122,microtubule cytoskeleton organization involved in mitosis,BP,SPRY2;TUBG2;CCSAP;GNAI1
16859,GO:0098781,0.996295287209076,0.0170525747632754,2,94,ncRNA transcription,BP,POU2F2;INTS8
275,GO:0000777,0.996406180714698,0.0166204066856017,2,92,condensed chromosome kinetochore,CC,REC8;SEPT6
8893,GO:0034708,0.996590412937501,0.0158895725426531,2,90,methyltransferase complex,CC,PHF1;JARID2
3339,GO:0007052,0.996618462935367,0.0128309864418611,3,105,mitotic spindle organization,BP,TUBG2;CCSAP;GNAI1
16254,GO:0090307,0.996669364715279,0.0233051974997392,1,61,mitotic spindle assembly,BP,CCSAP
18525,GO:1903707,0.996752239550597,0.0151981478575991,2,96,negative regulation of hemopoiesis,BP,CEACAM1;UBASH3B
2848,GO:0006333,0.996866033160829,0.010391941670397,4,156,chromatin assembly or disassembly,BP,H1F0;HMGA2;ATRX;RSF1
16252,GO:0090305,0.99698361320329,0.00698227647937997,10,249,nucleic acid phosphodiester bond hydrolysis,BP,ERCC1;H1F0;RAG1;DDB2;ENDOV;XRN1;LACTB2;DNASE1L1;ENDOG;N4BP2
2903,GO:0006412,0.997066256840787,0.00490229696749838,32,654,translation,BP,TNIP1;NEURL1;MAP2K1;EIF4EBP1;CARS;EGFR;IGF2BP3;IMPACT;ABTB1;ATF4;EIF4E3;AARS;ITGA2;SOX4;MRPS6;XRN1;TNRC6B;MEX3C;CPEB4;ATXN2;MAP2K2;PAIP1;PUM2;EIF2AK2;SECISBP2L;PPARG;GRB7;GARS;EEF2K;TNRC6C;DNAJC3;CNOT11
5279,GO:0015931,0.997075390859961,0.00735717013795785,8,207,nucleobase-containing compound transport,BP,XPOT;SLC29A4;IGF2BP3;TGFBR2;SLC35B4;TST;SLC25A4;ATXN2
2448,GO:0005657,0.997092050625337,0.0206949785203358,1,68,replication fork,CC,ETAA1
8907,GO:0034728,0.997184109837588,0.0108159428473469,3,139,nucleosome organization,BP,H1F0;ATRX;RSF1
2875,GO:0006368,0.997217510433548,0.01327701008194,2,97,transcription elongation from RNA polymerase II promoter,BP,TCEA1;EAPP
15480,GO:0071824,0.997231096413564,0.00697274803681277,8,237,protein-DNA complex subunit organization,BP,H1F0;SOX12;XPC;ATRX;DDB2;ATF7IP;THRA;RSF1
2863,GO:0006354,0.997267299113202,0.0105743888610773,3,121,DNA-templated transcription, elongation,BP,ERCC6;TCEA1;EAPP
10782,GO:0044238,0.99733703481689,0.00327293805581423,600,7685,primary metabolic process,BP,TNIP1;XDH;NT5E;PLAT;SMURF2;EDEM1;GID4;NOS1;ERCC1;ZMYND8;F2R;SORL1;ADAM19;ETV5;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;CTNNBIP1;VLDLR;PYGL;CBS;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;PYGB;H1F0;SERPINE2;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;ADGRF1;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;LTBP1;ZKSCAN1;ALOX15B;LMF1;SALL2;TK2;THSD4;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;MARCH9;H6PD;APLN;RBMS2;POU2F2;LY6K;DHTKD1;DGKA;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;ELK3;CRTC1;LTA4H;CAPN2;BRSK1;EGFR;STK39;BCORL1;LOXL1;PPP1R14A;FYN;TNFRSF6B;TMPRSS11D;OSBPL10;TSPAN5;PSAT1;JADE2;BNIP3;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;DLG4;B3GNT3;IDH2;CTSB;DNAJB5;ACOT1;GPC4;DHX32;SNX9;TYSND1;ZSCAN30;TGM2;XPC;GLUL;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;TTC7B;GRK5;NMRK1;STRADB;RDH14;NME4;CRTAP;ASPH;CEMIP;ACAD11;SDC1;ARG2;SHC1;NAGS;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;NEK9;KIAA1549;ZNF652;CBR4;RAG1;TGFBR2;PTPN3;SERPING1;SLC2A3;SCRN1;EPHA1;IMPACT;PLPP6;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ABCD1;CCPG1;CCND2;ANGPTL4;PTPN12;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;AGPAT4;LPAR3;PCMTD2;ELFN2;ASNS;FGFR1;ABHD10;ITGA1;AARS;PPP1R35;E2F5;EPCAM;MARCH4;PTPDC1;LPCAT4;TCFL5;RNPEPL1;NFAT5;HYAL1;DCAF10;BTRC;LPCAT1;AIG1;ITGA2;PTK6;GALNT3;ULK2;ZNF559;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;FBXO2;DDB2;GAMT;ENDOV;IAH1;ZNF558;KDSR;CEACAM1;MAPKAPK3;SPATA18;ZNF692;OBSL1;PRR9;LMAN1;ATF7IP;MRPS6;RCOR1;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;MMP14;PLA2G4D;HES2;CD46;ZBTB10;ACAD10;PHF12;MVB12B;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;TMEM86B;CTSL;NPEPL1;CST3;RABGGTA;SLC35B4;CNTN1;TRIB3;CASP4;NTNG1;GFPT1;PCSK6;L3MBTL3;VPS11;RANBP9;DNAJB9;FBXL8;BTBD3;PLPPR2;ZNF322;PPP3CB;MEX3C;INPP4A;RFX2;HIBADH;ZDHHC2;APLP2;DNAJC6;SLK;PRDX5;MLYCD;CEBPG;ALDH7A1;PLAG1;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;TAOK1;PLD3;AEBP1;ABHD15;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;BLMH;QSOX1;NDUFV3;CPT2;PRKAR1A;CTBS;MSRB2;JMY;CRLS1;BOK;PARP9;CPEB4;ATXN2;KLHL29;MAST3;NACC2;SPRY2;LACTB2;SLC6A14;ZNF337;BEX4;THRA;MGLL;ACVR1B;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;TSHZ1;MARK4;NPL;ZNF449;PTPRZ1;CHD6;PER3;MTA1;AZIN2;CRAT;RNF165;YTHDC2;PM20D2;MEF2D;AGPAT3;GLB1;TRIM7;NYNRIN;ARF4;H2AFJ;POLL;ANAPC13;UAP1;HSD17B7;PCYOX1;XBP1;PANK4;NFU1;UBASH3B;MAP2K2;ABHD6;SATB1;PPP1R2;PAIP1;ARRDC1;REC8;ANKIB1;LYPLAL1;TLE4;RET;CCDC71L;LOXL2;PDE5A;VWA1;MLH3;OSBPL5;C5;MTMR4;ZFYVE9;MBOAT7;THAP10;NOP10;GABARAPL2;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;RNF135;ETV1;CCDC88A;CTSO;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EEPD1;SEL1L;CBX7;IFI16;AP2A2;SRD5A3;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;LAMB2;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;ARID4A;NIT2;TENM2;IGF2;ACP6;AGPAT1;PJA2;ZSCAN18;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;PTGR2;CITED4;SNX6;EVA1A;USP20;ZFP30;GRB7;ALDH1A2;LYPLA1;ZNF37A;TBX1;ESYT3;CREB3L2;ERP44;ATP6V1B2;AK9;RSF1;ADAM8;ALDH4A1;AKT3;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;DDHD2;MARCH2;OSGEPL1;PLCXD1;FZD8;WASL;USP32;HSPA2;PRSS8;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;PLCH2;TMEM173;RNF180;E2F7;EEF2K;ZNF320;HPSE;CMTR2;TNRC6C;TRIM2;COQ2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;UFL1;FAM162A;ANKRD6;N4BP2;AMACR;GALE;PBX3;JARID2;PPM1M;SLC23A2;KLHL15;SLC44A1;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
3599,GO:0008026,0.997401936168506,0.0125484567256246,2,88,ATP-dependent helicase activity,MF,DHX32;YTHDC2
14534,GO:0070035,0.997401936168506,0.0125484567256246,2,88,purine NTP-dependent helicase activity,MF,DHX32;YTHDC2
14870,GO:0070646,0.997484702049944,0.0057164799813679,11,258,protein modification by small protein removal,BP,TNIP1;SMURF2;PSMD2;DDB2;OTUB2;PSMD7;RNF135;USP20;USP32;KAT2B;USP25
2804,GO:0006261,0.997499820421976,0.00851506800747563,4,138,DNA-dependent DNA replication,BP,FGFR1;ATRX;ETAA1;E2F7
8264,GO:0033044,0.997503475361507,0.00537903019929609,13,279,regulation of chromosome organization,BP,NOS1;ERCC1;HECW2;ATRX;MTHFR;XRN1;UHRF2;PHF1;PPP1R10;NEK6;IGF2;TET1;JARID2
16319,GO:0090501,0.997594613176272,0.00943619203119085,3,123,RNA phosphodiester bond hydrolysis,BP,ENDOV;XRN1;LACTB2
7711,GO:0032200,0.99759662621258,0.00742073233088316,5,166,telomere organization,BP,ERCC1;ATRX;XRN1;PPP1R10;NOP10
2368,GO:0005488,0.997675797369922,0.00304103823067597,822,10131,binding,MF,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;FAM83A;ADAM19;ETV5;RAB3B;PGF;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;ITGA6;MMP1;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PRSS3;LRRC20;ADCY7;CRYL1;IGFBP4;PRNP;PAG1;OSBP2;UHRF1BP1;ITGB4;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;CMTM4;THBS2;FMNL2;ETV4;LTBP2;RAPGEF3;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;ALOX15B;MPRIP;SALL2;COL13A1;TK2;GPX3;PKN1;NAPRT;WWTR1;DCBLD2;PEG3;MST1R;ARHGAP22;MICALCL;MARCH9;H6PD;APLN;RBMS2;POU2F2;TRIM65;DHTKD1;PITPNC1;DGKA;TEF;TNFSF15;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;EXOC2;ELK3;SNTB2;CRTC1;ADGRL1;DENND5B;LTA4H;CAPN2;BRSK1;FCGRT;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;SEMA4B;ANK3;DYSF;CGREF1;LOXL1;FYN;HEBP1;MYH15;TNFRSF6B;OSBPL10;TSPAN5;PCDHAC2;JADE2;BNIP3;HLTF;KIF13B;SPATS2;SCMH1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;MYCBPAP;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;DLG4;IDH2;CTSB;DNAJB5;PLXNB3;GPC4;DHX32;SNX9;TYSND1;PODXL;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;EVI5L;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;TTC7B;RSAD1;GRK5;HTR7;NMRK1;STRADB;NME4;MALL;CRTAP;RSPH3;ASPH;MCTP1;GDI1;CEMIP;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;WISP1;DAP;SMOC2;HYI;SLFN5;PAK1;RASA3;CEP170;SOCS2;TRIB2;ATXN10;NEK9;RHPN1;ZNF652;CBR4;RAG1;MRC2;TGFBR2;PTPN3;SERPING1;SLC2A3;NUDCD3;EDNRA;LCN2;HAGH;NUCB2;SHANK2;SCRN1;EPHA1;IMPACT;RALGAPA2;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCPG1;CCND2;ACP5;ANGPTL4;TIGD2;PTPN12;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;FYCO1;IDE;AKAP9;ZCCHC14;RAB11FIP4;FAM208A;PPP2R3B;FAM167A;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;ICA1;EIF4E3;AGPAT4;LPAR3;KIF21B;ASNS;FGFR1;ITGA1;AARS;PPP1R35;E2F5;FAM114A1;EPCAM;TMOD2;MARCH4;TUB;CMTM7;TACC1;TCFL5;RNPEPL1;UROS;SMOC1;NFAT5;ITGB5;SNX14;HYAL1;BTRC;LPCAT1;AIG1;ITGA2;PTK6;GALNT3;VAMP2;ULK2;LENG9;ZNF559;FAT1;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;NELL2;CEP120;ENDOV;ZNF558;MBLAC2;CEACAM1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;SLC5A1;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;C5ORF24;PLEK2;PLA2G4D;HES2;ANXA6;NLGN2;CD46;ZBTB10;ACAD10;PHF12;MVB12B;EPOR;CTH;ORAI3;ZNF704;NXPH4;MPDZ;FAM50A;MAP6;LRP5;ETAA1;ZMYM3;DNMBP;KLF12;TMEM86B;THBS3;CTSL;DOCK9;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CNTN1;TRIB3;CLTCL1;CASP4;SNORA64;NTNG1;GFPT1;PCSK6;TOM1L2;L3MBTL3;VPS11;RANBP9;WASF3;DNAJB9;FBXL8;BTBD3;RIMS3;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;INPP4A;RFX2;SYTL1;HIBADH;ADGRB2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;SCYL3;F2RL1;DDX60;UHRF2;GSDMA;PROCR;TAOK1;PLD3;PHC3;AEBP1;ATP10D;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;ASAP1;NDUFV3;PRKAR1A;CTBS;ANO1;MSRB2;FAM84B;JMY;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;MAST3;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;PCED1B;ZNF337;BEX4;TBC1D2B;THRA;LMBR1L;MGLL;CD99;WNT2B;ENKD1;ACVR1B;COL6A1;NGFR;ZNF280D;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;MARK4;NPL;ZNF449;PTPRZ1;CHD6;NUDT6;PER3;MTA1;AZIN2;BCL2L1;IFITM1;CRAT;RNF165;YTHDC2;GRIN3B;MEF2D;GLB1;WASF2;TRIM7;NYNRIN;SKAP2;ARF4;H2AFJ;POLL;ANAPC13;YPEL5;UAP1;CNNM1;SLC12A7;XBP1;PANK4;SPIRE1;NT5DC1;NFU1;UBASH3B;TXNRD3;CADM4;MAP2K2;SATB1;GPATCH8;PPP1R2;PAIP1;ARRDC1;SPIN4;REC8;CYP4F22;ANKIB1;MICU3;TLE4;SLC38A2;RIN1;TRPC1;RET;SPATA6;TUBG2;STX10;LOXL2;PDE5A;VWA1;RAB43;MLH3;OSBPL5;SIMC1;SH3PXD2B;MCTP2;BEX2;C5;TXNDC11;MTMR4;ZFYVE9;MBOAT7;THAP10;NOP10;NCKAP1;GABARAPL2;EPM2A;KCNJ15;RMRP;GTF2IRD2;DNASE1L1;ELMO3;DOCK11;PAK6;UBE2E1;PUM2;SLC30A1;RNF135;PSD3;TMBIM1;ETV1;COL1A2;CCDC88A;CCSAP;SHC2;PRKACA;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;EEPD1;SNX30;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;RHOBTB1;AP2A2;NR2F6;KDELR3;CMTM6;SCAND1;IL1RAP;SBNO1;ORAI1;CARD11;FCHO1;LAMB2;LTB4R;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;ARID4A;BLVRA;ARPC1A;TENM2;IGF2;TMEM134;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;ZSCAN18;GRB10;LARP1B;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;TMEM63A;SNX6;USP20;ANKRD50;ZFP30;GRB7;SRPX2;PPL;ALDH1A2;ARHGAP29;ATP12A;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;ROBO3;GARS;IL20RB;CLDN11;WFS1;DEPDC1;ENDOG;ATP11B;ITGA4;IKBIP;PHF21A;ZBTB40;ZNF92;WDR60;ACAP2;MPLKIP;CKLF;ZNF568;IGFBP7;TBC1D16;DDHD2;MARCH2;OSGEPL1;FZD8;TMEM107;CMC1;WASL;USP32;ANKS6;RAPGEFL1;REEP6;HSPA2;PRSS8;ZNF107;FLNB;LRP6;ARID5B;MAGEF1;ZNF165;SYT2;PLCH2;TMEM173;RNF180;GGACT;E2F7;EEF2K;ZNF320;SIGMAR1;HPSE;GALNS;RALGDS;SSR1;TNRC6C;TRIM2;RCAN1;TET1;GRAMD1C;ZC3H7A;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;DNAJC4;AOX1;SSFA2;HSD17B12;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;SPRYD7;TMEM139;RNF103;USP25;PANK1;PRMT3;UFL1;FAM162A;SNX27;N4BP2;AMACR;GALE;PBX3;JARID2;PPM1M;SEMA3F;RALGPS2;KLHL15;JMJD7;MXD4;ADNP;GNAI1;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FCGBP;FADD
273,GO:0000775,0.997696286723431,0.00662128966244423,6,173,chromosome, centromeric region,CC,ATRX;REC8;PSEN2;KAT2B;SEPT6;DNMT3A
6633,GO:0022904,0.997736599235367,0.0165510647828638,1,94,respiratory electron transport chain,BP,NDUFV3
6149,GO:0019439,0.997775786802486,0.0039209264367595,27,552,aromatic compound catabolic process,BP,XDH;NT5E;H1F0;RAPGEF3;DHTKD1;PSMD2;PGM1;IGF2BP3;ALDH1L2;LDHA;PPARA;APOBEC3C;XRN1;TNRC6B;PSMD7;PM20D2;PAIP1;PDE5A;DNASE1L1;PUM2;BLVRA;ENDOG;TNRC6C;TET1;DEDD2;AOX1;CNOT11
3336,GO:0007049,0.997844286270114,0.00297420543147716,104,1548,cell cycle,BP,FHL1;ERCC1;CCND1;RPS6KA2;CYP27B1;PRNP;HECW2;ADARB1;MAP2K1;ALOX15B;CCNI;MARVELD1;APPL2;EIF4EBP1;DDIT3;CCNG2;PSMD2;BRSK1;EGFR;STK39;ANK3;CGREF1;MAPK13;ARAP1;DLG1;SNX9;XPC;MAP4K4;GRK5;STRADB;SEPT10;PAK1;NEK9;PTPN3;CCPG1;CCND2;RGS14;PKD2;PRKACB;AKAP9;RAB11FIP4;PPP2R3B;HMGA2;ASNS;FGFR1;E2F5;TACC1;HYAL1;BTRC;PTK6;ATRX;SOX4;CEP120;OBSL1;LRP5;ETAA1;CLTCL1;TOM1L2;SLK;UHRF2;TAOK1;PHC3;CSNK2A1;PSMD7;PRKAR1A;JMY;SDCCAG3;NACC2;SPRY2;SEPT5;ACVR1B;PPP1R10;MARK4;BCL2L1;GOLGA2P5;ANAPC13;SPIRE1;MAP2K2;REC8;TUBG2;MLH3;BEX2;PAK6;CCSAP;PRKACA;NEK6;TIMP2;RHOBTB1;IGF2;MAP4K2;EVI5;MPLKIP;WASL;HSPA2;LRP6;E2F7;PTCH1;KAT2B;SEPT6;CNOT11;REEP3;GNAI1;RB1CC1;DNMT3A
1863,GO:0004527,0.997936096406893,0.0154568148639556,1,69,exonuclease activity,MF,XRN1
8802,GO:0034502,0.997936808169647,0.0154270328332306,1,72,protein localization to chromosome,BP,ATRX
2588,GO:0005882,0.997965158147387,0.0152540141135744,1,71,intermediate filament,CC,SHANK2
3049,GO:0006606,0.998140202742609,0.00752252392167369,3,114,protein import into nucleus,BP,PPP1R10;EFCAB7;TMEM173
2738,GO:0006119,0.998166822819044,0.0138120165879679,1,96,oxidative phosphorylation,BP,NDUFV3
5647,GO:0016741,0.998171796113938,0.00535171955905505,6,184,transferase activity, transferring one-carbon groups,MF,ALDH1L2;PCMTD2;GAMT;CMTR2;PRMT3;DNMT3A
6926,GO:0030518,0.998252428541286,0.00711594336251242,3,114,intracellular steroid hormone receptor signaling pathway,BP,PAK1;FOXP1;UFL1
5966,GO:0018394,0.998310236752862,0.00598084149936277,4,140,peptidyl-lysine acetylation,BP,NOS1;JADE2;SOX4;KAT2B
7948,GO:0032543,0.998352118331759,0.00831055135233573,2,129,mitochondrial translation,BP,MRPS6;GARS
3344,GO:0007062,0.998387568517464,0.00661018078224051,3,120,sister chromatid cohesion,BP,ATRX;TAOK1;REC8
2945,GO:0006473,0.998398840699731,0.00513550460551461,5,162,protein acetylation,BP,NOS1;RAPGEF3;JADE2;SOX4;KAT2B
12873,GO:0051196,0.998418804519515,0.0123213971517975,1,67,regulation of coenzyme metabolic process,BP,PPARA
2906,GO:0006415,0.998557000854062,0.0112304215678288,1,100,translational termination,BP,MRPS6
3673,GO:0008170,0.998630867590667,0.0108372180183645,1,75,N-methyltransferase activity,MF,PRMT3
35,GO:0000070,0.998665555677845,0.00482921748023667,4,142,mitotic sister chromatid segregation,BP,HECW2;ATRX;TUBG2;NEK6
2846,GO:0006323,0.998687884657756,0.00473329713450249,4,166,DNA packaging,BP,H1F0;HMGA2;ATRX;RSF1
7415,GO:0031503,0.998820461821235,0.00318016970730303,8,219,protein-containing complex localization,BP,XPOT;DLG1;DLG4;DLG3;NACC2;AP3D1;WDR60;WASL
10909,GO:0044454,0.99885616675887,0.0021998686839182,22,464,nuclear chromosome part,CC,ERCC1;H1F0;NR1D1;SALL2;APPL2;SMARCA1;ATRX;PHF12;ETAA1;UHRF2;CSNK2A1;NACC2;PPP1R10;MEF2D;H2AFJ;SATB1;REC8;MLH3;CBX7;RSF1;HSPA2;DNMT3A
134,GO:0000280,0.998892169212142,0.00244991710008048,14,317,nuclear division,BP,HECW2;ATRX;OBSL1;LRP5;TOM1L2;PRKAR1A;SPIRE1;REC8;TUBG2;MLH3;CCSAP;NEK6;IGF2;HSPA2
15748,GO:0072331,0.998917968482531,0.00280087445784455,9,246,signal transduction by p53 class mediator,BP,CD44;ATRX;SOX4;CSNK2A1;JMY;BOK;IFI16;E2F7;CNOT11
6576,GO:0022402,0.998939023736145,0.00158316303796061,71,1140,cell cycle process,BP,FHL1;ERCC1;CCND1;CYP27B1;PRNP;HECW2;MAP2K1;EIF4EBP1;DDIT3;PSMD2;BRSK1;EGFR;ANK3;CGREF1;ARAP1;DLG1;SNX9;XPC;STRADB;SEPT10;PAK1;NEK9;CCND2;RGS14;PKD2;AKAP9;RAB11FIP4;PPP2R3B;HMGA2;FGFR1;HYAL1;BTRC;ATRX;SOX4;CEP120;OBSL1;LRP5;TOM1L2;UHRF2;TAOK1;PHC3;CSNK2A1;PSMD7;PRKAR1A;JMY;SDCCAG3;NACC2;SPRY2;SEPT5;ACVR1B;PPP1R10;BCL2L1;GOLGA2P5;SPIRE1;REC8;TUBG2;MLH3;PAK6;CCSAP;PRKACA;NEK6;RHOBTB1;IGF2;WASL;HSPA2;E2F7;KAT2B;SEPT6;CNOT11;REEP3;GNAI1
18239,GO:1903047,0.998946049511211,0.00172943492337582,43,760,mitotic cell cycle process,BP,FHL1;CCND1;HECW2;EIF4EBP1;PSMD2;BRSK1;EGFR;ANK3;DLG1;SNX9;XPC;SEPT10;NEK9;CCND2;PKD2;AKAP9;HMGA2;FGFR1;HYAL1;BTRC;ATRX;SOX4;OBSL1;LRP5;TOM1L2;TAOK1;PSMD7;NACC2;SPRY2;SEPT5;ACVR1B;PPP1R10;BCL2L1;TUBG2;CCSAP;PRKACA;NEK6;IGF2;E2F7;SEPT6;CNOT11;REEP3;GNAI1
283,GO:0000785,0.999061613984161,0.00184632689357909,21,457,chromatin,CC,H1F0;NR1D1;SALL2;APPL2;SMARCA1;CAPN2;CCND2;HMGA2;ATRX;PHF12;UHRF2;CSNK2A1;NACC2;PPP1R10;MEF2D;H2AFJ;SATB1;LOXL2;CBX7;RSF1;DNMT3A
3671,GO:0008168,0.999066004253185,0.00313208501817458,5,176,methyltransferase activity,MF,PCMTD2;GAMT;CMTR2;PRMT3;DNMT3A
3601,GO:0008033,0.999080977269779,0.00496419967377242,2,120,tRNA processing,BP,AARS;OSGEPL1
343,GO:0000956,0.999143140680389,0.00288379666542063,5,200,nuclear-transcribed mRNA catabolic process,BP,XRN1;TNRC6B;PAIP1;TNRC6C;CNOT11
12167,GO:0048285,0.99914473902204,0.00183821820956051,16,354,organelle fission,BP,HECW2;BNIP3;ATRX;OBSL1;LRP5;TOM1L2;PRKAR1A;SPIRE1;REC8;TUBG2;MLH3;CCSAP;NEK6;IGF2;DDHD2;HSPA2
4337,GO:0009889,0.999164506802226,0.00107595329209544,249,3399,regulation of biosynthetic process,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;CYGB;CYP27B1;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;EIF4EBP1;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;ARG2;SHC1;DKK1;DAP;TRIB2;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;ACP5;RGS14;PKD2;ZNF862;ZNF624;RBCK1;AKAP9;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;EIF4E3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;LPCAT1;ITGA2;ZNF559;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;CEACAM1;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;CST3;SLC35B4;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;PARP9;CPEB4;ATXN2;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;ABHD6;SATB1;PAIP1;TLE4;RET;LOXL2;THAP10;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;SLC18A2;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
12906,GO:0051252,0.999183017664606,0.00106379648194522,219,3021,regulation of RNA metabolic process,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;PAIP1;TLE4;RET;LOXL2;THAP10;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;TNRC6C;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;OAS1;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
17280,GO:0140014,0.999210309689595,0.00209120998629604,9,239,mitotic nuclear division,BP,HECW2;ATRX;OBSL1;LRP5;TOM1L2;TUBG2;CCSAP;NEK6;IGF2
19479,GO:1990234,0.999221948182803,0.00131955488306088,39,712,transferase complex,CC,SMURF2;ERCC1;CCND1;BTBD2;DHTKD1;JADE2;SPTLC2;WDFY3;TGFBR2;CCND2;RBCK1;ABTB1;PIGH;DCAF10;BTRC;INTS8;FBXO2;DDB2;TCEA1;RABGGTA;BTBD3;PHC3;PHF1;PRKAR1A;KLHL29;ACVR1B;CHD6;ANAPC13;ANKIB1;RMRP;UBE2E1;SEL1L;CBX7;KAT2B;JARID2;KLHL15;STT3B;RB1CC1;FBXL5
10981,GO:0044772,0.999223539137575,0.00150336694555097,23,485,mitotic cell cycle phase transition,BP,FHL1;CCND1;HECW2;EIF4EBP1;PSMD2;BRSK1;EGFR;XPC;CCND2;PKD2;AKAP9;HMGA2;HYAL1;BTRC;SOX4;TAOK1;PSMD7;NACC2;ACVR1B;PRKACA;NEK6;E2F7;CNOT11
2443,GO:0005643,0.999231691477806,0.0065675976567921,1,76,nuclear pore,CC,XPOT
5561,GO:0016573,0.999321461183559,0.00302569180355604,3,131,histone acetylation,BP,NOS1;JADE2;KAT2B
2802,GO:0006259,0.999331848521762,0.00109404462339459,47,844,DNA metabolic process,BP,NT5E;ERCC1;CBS;H1F0;IGFBP4;TK2;SMARCA1;EGFR;ERCC6;XPC;SHC1;RAG1;ANXA3;HMGA2;FGFR1;ATRX;APOBEC3C;DDB2;ENDOV;ATF7IP;XRN1;TCEA1;ETAA1;CST3;CEBPG;UHRF2;TAOK1;JMY;PARP9;PPP1R10;MTA1;NYNRIN;POLL;REC8;MLH3;NOP10;DNASE1L1;CCDC88A;EEPD1;RNF169;PPARG;ENDOG;MAGEF1;E2F7;TET1;KLHL15;DNMT3A
12514,GO:0050657,0.999337551302507,0.00228730227823392,5,173,nucleic acid transport,BP,XPOT;IGF2BP3;TGFBR2;TST;ATXN2
12515,GO:0050658,0.999337551302507,0.00228730227823392,5,173,RNA transport,BP,XPOT;IGF2BP3;TGFBR2;TST;ATXN2
8837,GO:0034622,0.999373278349613,0.0010278329279464,47,883,cellular protein-containing complex assembly,BP,H1F0;SOX12;EXOC2;WIPF1;DLG1;SNX9;XPC;SEC23A;SEPT10;PAK1;RAC2;FKBP1A;AKAP9;TMOD2;ATRX;PFN2;DDB2;OBSL1;DMXL2;ATF7IP;TWF2;COX18;CLTCL1;VPS11;RANBP9;WASF3;NDUFV3;MSRB2;JMY;FCHO2;ATXN2;SEPT5;THRA;SPIRE1;TUBG2;ZFYVE9;NCKAP1;PUM2;TMSB4X;EIF2AK2;RAB1A;FCHO1;ARPC1A;GRB7;RSF1;WASL;SEPT6
9043,GO:0035257,0.999411613005271,0.00266032983327684,3,130,nuclear hormone receptor binding,MF,PKN1;PPARG;FOXP1
289,GO:0000793,0.999431088875139,0.00198811806441729,5,175,condensed chromosome,CC,ATRX;REC8;MLH3;HSPA2;SEPT6
5965,GO:0018393,0.999450124827616,0.00249941022461322,3,134,internal peptidyl-lysine acetylation,BP,NOS1;JADE2;KAT2B
12852,GO:0051170,0.999458533679063,0.00246475107620077,3,134,import into nucleus,BP,PPP1R10;EFCAB7;TMEM173
1472,GO:0003729,0.999460402769063,0.00189203001502494,5,180,mRNA binding,MF,ADARB1;IGF2BP3;CPEB4;PUM2;SECISBP2L
15519,GO:0071897,0.999461758950286,0.00188832938484655,5,178,DNA biosynthetic process,BP,TK2;XRN1;POLL;NOP10;PPARG
12895,GO:0051236,0.999499814183385,0.00176581235839563,5,176,establishment of RNA localization,BP,XPOT;IGF2BP3;TGFBR2;TST;ATXN2
2433,GO:0005622,0.999506221890614,0.000685180992725021,847,10512,intracellular,CC,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;FAM83A;ADAM19;ETV5;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;PAG1;ADGRF1;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;THBS2;FAM210B;FMNL2;ETV4;LTBP2;RAPGEF3;FNDC4;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;ALOX15B;MPRIP;LMF1;SALL2;COL13A1;TK2;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;MICALCL;WDR66;MARCH9;H6PD;APLN;RBMS2;MARVELD1;POU2F2;TRIM65;LY6K;DHTKD1;PITPNC1;DGKA;TEF;TNFSF15;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;PTPRS;B4GALT6;CCNG2;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;EXOC2;ELK3;SNTB2;CRTC1;ADGRL1;DENND5B;AVL9;LTA4H;CAPN2;BRSK1;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;ANK3;BCORL1;C2CD2;DYSF;PDZD2;LOXL1;ARHGAP12;ARMCX2;PPP1R14A;FYN;HEBP1;MYH15;OSBPL10;PSAT1;JADE2;BNIP3;HLTF;KIF13B;SPATS2;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;MYCBPAP;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;DLG4;B3GNT3;IDH2;CTSB;CD68;DNAJB5;ACOT1;GPC4;DHX32;SNX9;TYSND1;PODXL;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;EVI5L;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;TTC7B;RSAD1;GRK5;NMRK1;STRADB;RDH14;NME4;MALL;CRTAP;RSPH3;ASPH;GLCCI1;MCTP1;GDI1;CEMIP;VWA5A;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;WISP1;SLFN5;PAK1;RASA3;CEP170;SOCS2;TRIB2;ATXN10;NEK9;RHPN1;ZNF652;CBR4;RAG1;TGFBR2;PTPN3;SERPING1;SLC2A3;NUDCD3;B4GALNT4;LCN2;HAGH;NUCB2;SHANK2;SCRN1;EPHA1;IMPACT;RALGAPA2;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;ACP5;TIGD2;KLHDC2;PTPN12;ALDH1L2;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;ICA1;EIF4E3;AGPAT4;PCMTD2;KIF21B;ASNS;FGFR1;ABHD10;ITGA1;AARS;E2F5;FAM114A1;TMOD2;MARCH4;TUB;PTPDC1;LPCAT4;TACC1;TCFL5;RNPEPL1;UROS;NFAT5;ITGB5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;FAT1;INTS8;ZNF81;LONP2;INPP5F;CHAC1;BIVM;ATRX;FAM20C;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;GAMT;CEP120;ENDOV;ZNF558;KDSR;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PRR9;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLEK2;PLA2G4D;HES2;ANXA6;CD46;ZBTB10;ACAD10;PHF12;MVB12B;CTH;ZNF704;MPDZ;FAM50A;MAP6;LRP5;ETAA1;NIPA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;THBS3;CTSL;DOCK9;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;SLC35G2;TPBG;TOM1L2;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;FBXL8;BTBD3;RIMS3;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;INPP4A;RFX2;SYTL1;HIBADH;ADGRB2;KIAA1147;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;DDX60;UHRF2;SLC2A9;RASIP1;GSDMA;PROCR;C6ORF120;TAOK1;PLD3;PHC3;AEBP1;ATP10D;FBXO41;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;SUGCT;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;ANO1;MSRB2;FAM84B;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;KLHL29;MAST3;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;ZNF337;BEX4;TBC1D2B;THRA;MGLL;GOLGA6L9;CD99;WNT2B;ENKD1;ACVR1B;DBNDD1;NDUFA4L2;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;MARK4;NPL;ZNF449;CHD6;NUDT6;SPESP1;PER3;MTA1;AZIN2;BCL2L1;CRAT;MYH16;RNF165;YTHDC2;PM20D2;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;SKAP2;ARF4;GOLGA2P5;H2AFJ;POLL;TMEM187;ANAPC13;YPEL5;UAP1;HSD17B7;PCYOX1;XBP1;PANK4;SPIRE1;NFU1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SATB1;SLC22A17;PPP1R2;PAIP1;ARRDC1;REC8;CYP4F22;ANKIB1;MICU3;LYPLAL1;TLE4;RIN1;RET;SDR9C7;FAM222B;TUBG2;STX10;LOXL2;PDE5A;VWA1;TCTN1;RAB43;MLH3;OSBPL5;NAV1;SH3PXD2B;MCTP2;BEX2;TXNDC11;MTMR4;ZFYVE9;MBOAT7;NOP10;NCKAP1;GABARAPL2;EPM2A;RMRP;GTF2IRD2;DNASE1L1;ELMO3;DOCK11;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;RNF135;TMBIM1;ETV1;FRMD4B;COL1A2;SFXN3;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;RGL2;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;SNX30;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;RHOBTB1;BCAP29;AP2A2;SRD5A3;NR2F6;KDELR3;CMTM6;SCAND1;SBNO1;SLC25A43;ST6GALNAC2;CARD11;FCHO1;LAMB2;FICD;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;NRSN2;ACP6;TMEM134;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;ZSCAN18;GRB10;LARP1B;MAP4K2;ZMYM2;ERLEC1;PPARG;PTGR2;TMEM63A;CITED4;SNX6;EVA1A;USP20;ANKRD50;ZFP30;GRB7;TRIQK;SRPX2;PPL;ALDH1A2;ARHGAP29;LYPLA1;TMEM50B;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;GARS;WFS1;DEPDC1;ENDOG;ATP11B;IKBIP;PHF21A;ZBTB40;ZNF92;WDR60;ACAP2;MPLKIP;MAML3;ZNF568;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;OSGEPL1;PLCXD1;FZD8;CMC1;WASL;USP32;ANKS6;RAPGEFL1;REEP6;HSPA2;ZNF107;FLNB;LRP6;ARID5B;ZNF165;SYT2;PLCH2;TMEM173;RNF180;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;TNRC6C;TRIM2;COQ2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;REEP3;NYAP1;UFL1;VSIG10L;FAM162A;ANKRD6;SNX27;N4BP2;AMACR;GALE;PBX3;JARID2;PPM1M;SLC23A2;RALGPS2;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
16704,GO:0097659,0.999516013521045,0.000638529059862071,213,2987,nucleic acid-templated transcription,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;TRIM5;TCEA1;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;TLE4;RET;LOXL2;THAP10;RMRP;GTF2IRD2;PAK6;EAPP;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
2860,GO:0006351,0.999518944831473,0.000635019272304965,212,2973,transcription, DNA-templated,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;TRIM5;TCEA1;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;TLE4;RET;LOXL2;THAP10;GTF2IRD2;PAK6;EAPP;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
7317,GO:0031326,0.999520688738273,0.000625252248996326,243,3349,regulation of cellular biosynthetic process,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;CYP27B1;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;EIF4EBP1;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;SHC1;DKK1;DAP;TRIB2;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;ACP5;RGS14;PKD2;ZNF862;ZNF624;RBCK1;AKAP9;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;EIF4E3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;LPCAT1;ITGA2;ZNF559;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;CEACAM1;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;CST3;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;PARP9;CPEB4;ATXN2;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;PAIP1;TLE4;RET;LOXL2;THAP10;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
111,GO:0000228,0.999526981720688,0.000937279493277566,23,495,nuclear chromosome,CC,ERCC1;H1F0;NR1D1;SALL2;APPL2;SMARCA1;HMGA2;ATRX;PHF12;ETAA1;UHRF2;CSNK2A1;NACC2;PPP1R10;MEF2D;H2AFJ;SATB1;REC8;MLH3;CBX7;RSF1;HSPA2;DNMT3A
5588,GO:0016607,0.999550985174846,0.00104447583748854,14,342,nuclear speck,CC,SMURF2;CYGB;NFATC4;GRK5;BNIP3L;PLAG1;PSKH1;PRKACA;NEK6;S100PBP;IFI16;RNF169;MAML3;E2F7
2817,GO:0006281,0.999567734857816,0.000871153035254549,22,484,DNA repair,BP,ERCC1;EGFR;ERCC6;XPC;HMGA2;ATRX;DDB2;ENDOV;TCEA1;ETAA1;CEBPG;TAOK1;JMY;PARP9;MTA1;POLL;REC8;MLH3;EEPD1;RNF169;MAGEF1;KLHL15
2947,GO:0006475,0.999583789860264,0.00193925179602338,3,138,internal protein amino acid acetylation,BP,NOS1;JADE2;KAT2B
3286,GO:0006974,0.999586203504796,0.000718587335814128,39,740,cellular response to DNA damage stimulus,BP,ERCC1;CCND1;NFATC4;DDIT3;BRSK1;EGFR;ERCC6;XPC;CD44;HMGA2;ATRX;SOX4;DDB2;ENDOV;SPATA18;TCEA1;ETAA1;CEBPG;TAOK1;PHF1;JMY;BOK;PARP9;NACC2;PPP1R10;MTA1;BCL2L1;POLL;REC8;MLH3;EEPD1;IFI16;RNF169;MOAP1;ZBTB40;MAGEF1;E2F7;CNOT11;KLHL15
5761,GO:0016925,0.999587314333617,0.00379416044012662,1,85,protein sumoylation,BP,MTA1
19739,GO:2000112,0.999598659740045,0.000527607363177584,231,3205,regulation of cellular macromolecule biosynthetic process,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;EIF4EBP1;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;EIF4E3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ITGA2;ZNF559;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;CST3;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;CPEB4;ATXN2;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;PAIP1;TLE4;RET;LOXL2;THAP10;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
8091,GO:0032774,0.999604118882654,0.000524387863751763,213,2997,RNA biosynthetic process,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;TRIM5;TCEA1;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;TLE4;RET;LOXL2;THAP10;RMRP;GTF2IRD2;PAK6;EAPP;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
279,GO:0000781,0.999614329459249,0.00180590938178949,3,146,chromosome, telomeric region,CC,ERCC1;ATRX;PPP1R10
10885,GO:0044424,0.999614766582058,0.000532533263103775,835,10389,intracellular part,CC,TNIP1;DOCK4;FHL1;DDIT4L;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;FAM83A;ADAM19;ETV5;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;SH2D2A;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PRSS3;ADCY7;CRYL1;IGFBP4;PRNP;XPOT;ACTA2;BBS2;MARCKSL1;POSTN;SH3TC2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;THBS2;FAM210B;FMNL2;ETV4;RAPGEF3;FNDC4;ACVR2B;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;ALOX15B;MPRIP;LMF1;SALL2;COL13A1;TK2;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;MICALCL;WDR66;MARCH9;H6PD;APLN;RBMS2;MARVELD1;POU2F2;TRIM65;LY6K;DHTKD1;PITPNC1;DGKA;TEF;APPL2;EIF4EBP1;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;PTPRS;B4GALT6;CCNG2;SMARCA1;HADH;SOX12;CARS;PSMD2;LAMB1;EXOC2;ELK3;SNTB2;CRTC1;DENND5B;AVL9;LTA4H;CAPN2;BRSK1;WIPF1;SNPH;EGFR;TBC1D14;STK39;RIN2;ANK3;BCORL1;C2CD2;DYSF;PDZD2;LOXL1;ARHGAP12;ARMCX2;PPP1R14A;FYN;HEBP1;MYH15;OSBPL10;PSAT1;JADE2;BNIP3;HLTF;KIF13B;SPATS2;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;MYCBPAP;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;DLG4;B3GNT3;IDH2;CTSB;CD68;DNAJB5;ACOT1;GPC4;DHX32;SNX9;TYSND1;PODXL;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;SLC9A7;HTRA1;GLO1;FKBP9;WNT7A;ACSF2;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;TTC7B;RSAD1;GRK5;NMRK1;STRADB;RDH14;NME4;MALL;CRTAP;RSPH3;ASPH;GLCCI1;MCTP1;GDI1;CEMIP;VWA5A;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;WISP1;SLFN5;PAK1;RASA3;CEP170;SOCS2;TRIB2;ATXN10;NEK9;RHPN1;ZNF652;CBR4;RAG1;TGFBR2;PTPN3;SERPING1;SLC2A3;NUDCD3;B4GALNT4;LCN2;HAGH;NUCB2;SHANK2;SCRN1;EPHA1;IMPACT;RALGAPA2;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;ACP5;TIGD2;KLHDC2;PTPN12;ALDH1L2;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;SRGAP2B;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;ICA1;EIF4E3;AGPAT4;PCMTD2;KIF21B;ASNS;FGFR1;ABHD10;ITGA1;AARS;E2F5;FAM114A1;TMOD2;MARCH4;TUB;PTPDC1;LPCAT4;TACC1;TCFL5;RNPEPL1;UROS;NFAT5;ITGB5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;FAT1;INTS8;ZNF81;LONP2;INPP5F;CHAC1;BIVM;ATRX;FAM20C;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;GAMT;CEP120;ENDOV;ZNF558;KDSR;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PRR9;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLEK2;PLA2G4D;HES2;ANXA6;CD46;ZBTB10;ACAD10;PHF12;MVB12B;CTH;ZNF704;MPDZ;FAM50A;MAP6;LRP5;ETAA1;NIPA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;THBS3;CTSL;DOCK9;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;TRIB3;CLTCL1;CASP4;GFPT1;PCSK6;SLC35G2;TPBG;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;FBXL8;BTBD3;RIMS3;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;INPP4A;RFX2;SYTL1;HIBADH;ADGRB2;KIAA1147;ZDHHC2;APLP2;DNAJC6;COPB1;SLK;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;DDX60;UHRF2;SLC2A9;RASIP1;GSDMA;PROCR;C6ORF120;TAOK1;PLD3;PHC3;AEBP1;ATP10D;FBXO41;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;SUGCT;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;ANO1;MSRB2;FAM84B;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;KLHL29;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;ZNF337;BEX4;TBC1D2B;THRA;MGLL;GOLGA6L9;CD99;WNT2B;ENKD1;ACVR1B;DBNDD1;NDUFA4L2;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;MARK4;NPL;ZNF449;CHD6;NUDT6;SPESP1;PER3;MTA1;AZIN2;BCL2L1;CRAT;MYH16;RNF165;YTHDC2;PM20D2;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;SKAP2;ARF4;GOLGA2P5;H2AFJ;POLL;TMEM187;ANAPC13;YPEL5;UAP1;HSD17B7;PCYOX1;XBP1;PANK4;SPIRE1;NFU1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SATB1;SLC22A17;PPP1R2;PAIP1;ARRDC1;REC8;CYP4F22;ANKIB1;MICU3;LYPLAL1;TLE4;RIN1;RET;SDR9C7;FAM222B;TUBG2;STX10;LOXL2;PDE5A;VWA1;TCTN1;RAB43;MLH3;OSBPL5;NAV1;SH3PXD2B;MCTP2;BEX2;TXNDC11;MTMR4;ZFYVE9;MBOAT7;NOP10;NCKAP1;GABARAPL2;EPM2A;RMRP;GTF2IRD2;DNASE1L1;ELMO3;DOCK11;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;RNF135;TMBIM1;ETV1;FRMD4B;COL1A2;SFXN3;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;SNX30;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;RHOBTB1;BCAP29;AP2A2;SRD5A3;NR2F6;KDELR3;CMTM6;SCAND1;SBNO1;SLC25A43;ST6GALNAC2;CARD11;FCHO1;LAMB2;FICD;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;AP3D1;ARID4A;NIT2;BLVRA;ARPC1A;TENM2;IGF2;NRSN2;ACP6;TMEM134;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;ZSCAN18;GRB10;LARP1B;MAP4K2;ZMYM2;ERLEC1;PPARG;PTGR2;TMEM63A;CITED4;SNX6;EVA1A;USP20;ANKRD50;ZFP30;GRB7;TRIQK;SRPX2;PPL;ALDH1A2;ARHGAP29;LYPLA1;TMEM50B;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;GARS;WFS1;DEPDC1;ENDOG;ATP11B;IKBIP;PHF21A;ZBTB40;ZNF92;WDR60;ACAP2;MPLKIP;MAML3;ZNF568;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;OSGEPL1;PLCXD1;FZD8;CMC1;WASL;USP32;ANKS6;REEP6;HSPA2;ZNF107;FLNB;LRP6;ARID5B;ZNF165;SYT2;PLCH2;TMEM173;RNF180;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;TNRC6C;TRIM2;COQ2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;AOX1;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;REEP3;UFL1;VSIG10L;FAM162A;ANKRD6;SNX27;N4BP2;AMACR;GALE;PBX3;JARID2;PPM1M;SLC23A2;RALGPS2;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
2892,GO:0006399,0.999626501085513,0.00150073646223271,4,183,tRNA metabolic process,BP,CARS;AARS;GARS;OSGEPL1
10398,GO:0043229,0.999649754207125,0.000460188905007338,734,9289,intracellular organelle,CC,TNIP1;DOCK4;FHL1;XDH;NT5E;PLAT;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;FLNC;ADAM19;ETV5;RAB3B;MBOAT2;CCND1;PCK2;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;CBS;NOL4L;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;SERPINE2;PRSS3;IGFBP4;PRNP;XPOT;ACTA2;BBS2;POSTN;SH3TC2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;THBS2;FAM210B;ETV4;RAPGEF3;FNDC4;ANTXR2;LTBP1;SH3KBP1;ZKSCAN1;ALOX15B;MPRIP;LMF1;SALL2;COL13A1;TK2;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;WDR66;MARCH9;H6PD;RBMS2;MARVELD1;POU2F2;TRIM65;LY6K;DHTKD1;PITPNC1;TEF;APPL2;ZKSCAN2;SSH1;MAP1B;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;HADH;SOX12;PSMD2;LAMB1;ELK3;SNTB2;CRTC1;AVL9;LTA4H;CAPN2;BRSK1;WIPF1;SNPH;EGFR;TBC1D14;STK39;ANK3;BCORL1;C2CD2;DYSF;PDZD2;LOXL1;ARMCX2;FYN;MYH15;OSBPL10;JADE2;BNIP3;HLTF;KIF13B;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PARVB;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;DLG4;B3GNT3;IDH2;CTSB;CD68;DNAJB5;GPC4;DHX32;SNX9;TYSND1;PODXL;NET1;ZSCAN30;TGM2;ESPN;XPC;GLUL;SLC9A7;GLO1;FKBP9;WNT7A;ACSF2;UBXN4;IGF2BP3;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;RSAD1;GRK5;STRADB;RDH14;NME4;MALL;CRTAP;RSPH3;ASPH;MCTP1;GDI1;CEMIP;VWA5A;ACAD11;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DKK1;SLFN5;PAK1;CEP170;TRIB2;NEK9;ZNF652;CBR4;RAG1;PTPN3;SERPING1;SLC2A3;NUDCD3;B4GALNT4;LCN2;HAGH;NUCB2;SHANK2;SCRN1;RALGAPA2;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;ACP5;TIGD2;KLHDC2;PTPN12;ALDH1L2;CDK17;AFAP1;RGS14;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;EHBP1;RAB11FIP4;FAM208A;PPP2R3B;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;ICA1;AGPAT4;KIF21B;FGFR1;ABHD10;ITGA1;AARS;E2F5;FAM114A1;TMOD2;MARCH4;TUB;PTPDC1;LPCAT4;TACC1;TCFL5;UROS;NFAT5;ITGB5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ULK2;ZNF559;FAT1;INTS8;ZNF81;LONP2;INPP5F;CHAC1;BIVM;ATRX;FAM20C;PFN2;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;VPS13A;FBXO2;DDB2;GAMT;CEP120;ENDOV;ZNF558;KDSR;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PDIA5;RAB31;LMAN1;DMXL2;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;TNRC6B;DVL1;CLCN3;NTSR1;MMP14;PLEK2;HES2;ANXA6;CD46;ZBTB10;ACAD10;PHF12;MVB12B;ZNF704;MPDZ;FAM50A;MAP6;LRP5;ETAA1;NIPA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;CTSL;NPEPL1;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;TRIB3;CLTCL1;CASP4;PCSK6;SLC35G2;TPBG;L3MBTL3;VPS11;MOSPD2;RANBP9;WASF3;DNAJB9;BTBD3;RIMS3;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;RFX2;SYTL1;HIBADH;ADGRB2;ZDHHC2;APLP2;DNAJC6;COPB1;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;FNBP1L;CDC42BPA;ANO8;SCYL3;F2RL1;DDX60;UHRF2;SLC2A9;RASIP1;PROCR;C6ORF120;TAOK1;PLD3;PHC3;AEBP1;ATP10D;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;SUGCT;ASAP1;NDUFV3;CPT2;PRKAR1A;CTBS;MSRB2;JMY;CRLS1;BOK;PARP9;FCHO2;CPEB4;NIPSNAP1;SDCCAG3;ATXN2;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;ZNF337;BEX4;THRA;MGLL;GOLGA6L9;WNT2B;ENKD1;DBNDD1;NDUFA4L2;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;MARK4;ZNF449;CHD6;NUDT6;SPESP1;PER3;MTA1;AZIN2;BCL2L1;CRAT;MYH16;RNF165;YTHDC2;PM20D2;MEF2D;AGPAT3;GLB1;WASF2;TRIM7;SKAP2;ARF4;GOLGA2P5;H2AFJ;POLL;TMEM187;ANAPC13;YPEL5;UAP1;HSD17B7;PCYOX1;XBP1;SPIRE1;NFU1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SATB1;SLC22A17;ARRDC1;REC8;CYP4F22;MICU3;TLE4;RIN1;RET;SDR9C7;FAM222B;TUBG2;STX10;LOXL2;VWA1;TCTN1;RAB43;MLH3;OSBPL5;NAV1;SH3PXD2B;MCTP2;BEX2;TXNDC11;MTMR4;ZFYVE9;MBOAT7;NOP10;NCKAP1;GABARAPL2;EPM2A;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;TMBIM1;ETV1;FRMD4B;COL1A2;SFXN3;CCDC88A;CCSAP;CTSO;TMED4;SAMD8;ADAMTSL1;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;SLC25A30;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EPB41L3;SNX30;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;RHOBTB1;BCAP29;AP2A2;SRD5A3;NR2F6;KDELR3;CMTM6;SCAND1;SBNO1;SLC25A43;ST6GALNAC2;FCHO1;LAMB2;FICD;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;AP3D1;ARID4A;NIT2;ARPC1A;TENM2;IGF2;NRSN2;ACP6;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;ZSCAN18;LARP1B;MAP4K2;ZMYM2;ERLEC1;PPARG;TMEM63A;CITED4;SNX6;EVA1A;USP20;ANKRD50;ZFP30;GRB7;TRIQK;PPL;LYPLA1;TMEM50B;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;AKT3;GARS;WFS1;DEPDC1;ENDOG;ATP11B;IKBIP;PHF21A;ZBTB40;ZNF92;WDR60;ACAP2;MPLKIP;MAML3;ZNF568;TMEM9;IGFBP7;TBC1D16;SSR3;DDHD2;MARCH2;OSGEPL1;FZD8;CMC1;WASL;USP32;REEP6;HSPA2;ZNF107;FLNB;LRP6;ARID5B;ZNF165;SYT2;TMEM173;RNF180;E2F7;PPT2;ZNF320;SLC18A2;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;COQ2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;SEPT6;COG8;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;REEP3;UFL1;VSIG10L;FAM162A;ANKRD6;SNX27;AMACR;PBX3;JARID2;PPM1M;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;FADD
8409,GO:0033365,0.999652621333795,0.000614592406992162,37,730,protein localization to organelle,BP,SORL1;BBS2;DDIT3;FYN;TTBK2;NUDCD3;RAC2;OBSCN;BNIP3L;ABCA7;TUB;LONP2;ATRX;SOX4;VPS13A;OBSL1;DVL1;ABHD17C;COX18;VPS11;SEC63;PARP9;NGFR;PPP1R10;ARF4;TCTN1;CCDC88A;BCAP29;KDELR3;AP3D1;MOAP1;EFCAB7;TMEM50B;ACAP2;SSR3;TMEM107;TMEM173
6148,GO:0019438,0.999669733218684,0.000433567786952947,245,3428,aromatic compound biosynthetic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;ADCY7;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;DHTKD1;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;PSAT1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;PGM1;ZNF516;DLG1;IDH2;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;ACOT7;RSAD1;NMRK1;NME4;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;LDHA;AKAP9;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;UROS;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;POLL;UAP1;XBP1;PANK4;MAP2K2;SATB1;TLE4;TRPC1;RET;LOXL2;PDE5A;THAP10;NOP10;RMRP;GTF2IRD2;PAK6;EAPP;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;AK9;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;ADCY1;KAT2B;CNOT11;PANK1;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FADD
17639,GO:1901362,0.999672563414772,0.000428918413012265,252,3524,organic cyclic compound biosynthetic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;CYP27B1;ADCY7;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;DHTKD1;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;PSAT1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;PGM1;ZNF516;DLG1;IDH2;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;ACOT7;RSAD1;NMRK1;NME4;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;PLPP6;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;LDHA;AKAP9;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;UROS;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;POLL;UAP1;HSD17B7;XBP1;PANK4;MAP2K2;SATB1;TLE4;TRPC1;RET;LOXL2;PDE5A;THAP10;NOP10;RMRP;GTF2IRD2;PAK6;EAPP;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;CBX7;IFI16;SRD5A3;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;AK9;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;HSD17B12;PTCH1;ADCY1;KAT2B;CNOT11;PANK1;PRMT3;UFL1;AMACR;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FADD
5795,GO:0017038,0.999676500696802,0.00131937706107821,4,166,protein import,BP,APOE;PPP1R10;EFCAB7;TMEM173
8860,GO:0034655,0.999682915946074,0.000647344362480313,22,518,nucleobase-containing compound catabolic process,BP,XDH;NT5E;H1F0;RAPGEF3;DHTKD1;PSMD2;PGM1;IGF2BP3;LDHA;PPARA;APOBEC3C;XRN1;TNRC6B;PSMD7;PAIP1;PDE5A;DNASE1L1;PUM2;ENDOG;TNRC6C;DEDD2;CNOT11
532,GO:0001650,0.999685220623594,0.00190272970842947,2,118,fibrillar center,CC,E2F5;PAK6
4506,GO:0010556,0.999688225745469,0.000411386481746886,234,3254,regulation of macromolecule biosynthetic process,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;EIF4EBP1;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;SHC1;DKK1;DAP;TRIB2;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;EIF4E3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ITGA2;ZNF559;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;CST3;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;CPEB4;ATXN2;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;PAIP1;TLE4;RET;LOXL2;THAP10;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
18344,GO:1903311,0.999707619218649,0.000865415815976152,8,250,regulation of mRNA metabolic process,BP,PSMD2;IGF2BP3;XRN1;TNRC6B;PSMD7;PAIP1;PUM2;TNRC6C
2803,GO:0006260,0.999707922043757,0.000823704317307709,9,260,DNA replication,BP,EGFR;SHC1;FGFR1;ATRX;ETAA1;CST3;POLL;CCDC88A;E2F7
15092,GO:0071103,0.999718699127742,0.000883314568864695,7,245,DNA conformation change,BP,H1F0;SMARCA1;XPC;HMGA2;ATRX;DDB2;RSF1
2896,GO:0006403,0.999731675765164,0.000908830678968578,6,209,RNA localization,BP,XPOT;IGF2BP3;TGFBR2;TST;ATXN2;NOP10
17290,GO:0140053,0.999745795604624,0.00155528869563062,2,153,mitochondrial gene expression,BP,MRPS6;GARS
5908,GO:0018130,0.999754434149506,0.00032426931911042,244,3431,heterocycle biosynthetic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;ADCY7;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;DHTKD1;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;PSAT1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;PGM1;ZNF516;DLG1;IDH2;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;ACOT7;RSAD1;NMRK1;NME4;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;LDHA;AKAP9;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;UROS;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;POLL;UAP1;XBP1;PANK4;MAP2K2;SATB1;TLE4;RET;LOXL2;PDE5A;THAP10;NOP10;RMRP;GTF2IRD2;PAK6;EAPP;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;AK9;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;ADCY1;KAT2B;CNOT11;PANK1;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FADD
10979,GO:0044770,0.999767579437181,0.000475255957809704,23,512,cell cycle phase transition,BP,FHL1;CCND1;HECW2;EIF4EBP1;PSMD2;BRSK1;EGFR;XPC;CCND2;PKD2;AKAP9;HMGA2;HYAL1;BTRC;SOX4;TAOK1;PSMD7;NACC2;ACVR1B;PRKACA;NEK6;E2F7;CNOT11
3052,GO:0006611,0.999772528661121,0.000953701801974514,4,170,protein export from nucleus,BP,XPOT;RAPGEF3;STRADB;SOX4
4472,GO:0010468,0.999776204490323,0.00029523550761466,252,3511,regulation of gene expression,BP,TNIP1;XDH;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;SERPINE2;PRNP;ADGRF1;ACTA2;BBS2;ADM2;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;EIF4EBP1;ZKSCAN2;PC;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;ANK3;BCORL1;FYN;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;SHC1;DKK1;DAP;KIAA1549;ZNF652;RAG1;TGFBR2;SERPING1;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;EIF4E3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ITGA2;ZNF559;ZNF81;CHAC1;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;FERMT1;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;CD46;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;CNTN1;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;PARP9;CPEB4;ATXN2;NACC2;SPRY2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;PAIP1;TLE4;RET;LOXL2;SH3PXD2B;C5;THAP10;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;ZNF354A;CTSZ;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ALDH1A2;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
8859,GO:0034654,0.999782997699549,0.000287618225973821,240,3382,nucleobase-containing compound biosynthetic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;ADCY7;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;DHTKD1;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;PGM1;ZNF516;DLG1;IDH2;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;ACOT7;NMRK1;NME4;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;LDHA;AKAP9;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;POLL;UAP1;XBP1;PANK4;MAP2K2;SATB1;TLE4;RET;LOXL2;PDE5A;THAP10;NOP10;RMRP;GTF2IRD2;PAK6;EAPP;ETV1;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;AK9;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;ADCY1;KAT2B;CNOT11;PANK1;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
3342,GO:0007059,0.999791854690318,0.000552310686262226,11,301,chromosome segregation,BP,HECW2;RGS14;ATRX;TAOK1;CSNK2A1;BEX4;REC8;TUBG2;MLH3;PUM2;NEK6
3305,GO:0007005,0.999810857948879,0.000413609600547323,19,485,mitochondrion organization,BP,BNIP3;IDH2;RAC2;BNIP3L;SPATA18;COX18;VPS11;SLC25A4;NDUFV3;BOK;GLUD1;BCL2L1;GABARAPL2;MOAP1;AKT3;DDHD2;FAM162A;RB1CC1;ALAS1
1474,GO:0003735,0.999825827137801,0.00173193381791366,1,154,structural constituent of ribosome,MF,MRPS6
308,GO:0000819,0.999866594592388,0.000473737953993662,6,216,sister chromatid segregation,BP,HECW2;ATRX;TAOK1;REC8;TUBG2;NEK6
6070,GO:0019219,0.999873551522099,0.000169785829602407,232,3265,regulation of nucleobase-containing compound metabolic process,BP,TNIP1;SMURF2;NOS1;ERCC1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;AKAP9;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;CST3;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;PARP9;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;PAIP1;TLE4;RET;LOXL2;PDE5A;THAP10;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;RNF169;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;E2F7;ZNF320;TNRC6C;RCAN1;TET1;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;OAS1;PRMT3;UFL1;PBX3;JARID2;KLHL15;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
10791,GO:0044260,0.999883547281514,0.000150463793625946,469,6220,cellular macromolecule metabolic process,BP,TNIP1;XDH;NT5E;PLAT;SMURF2;EDEM1;GID4;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;RAB3B;CCND1;NEURL1;CTNNBIP1;VLDLR;PYGL;CBS;ITGA6;MMP1;RPS6KA2;PYGB;H1F0;SERPINE2;ADCY7;IGFBP4;PRNP;ADGRF1;ADM2;BTBD2;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;LTBP1;ZKSCAN1;LMF1;SALL2;TK2;PKN1;WWTR1;PEG3;MST1R;ARHGAP22;MARCH9;APLN;POU2F2;LY6K;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;DDIT3;PTPRS;B4GALT6;SMARCA1;SOX12;CARS;PSMD2;LAMB1;ELK3;CRTC1;LTA4H;CAPN2;BRSK1;EGFR;STK39;BCORL1;LOXL1;PPP1R14A;FYN;TNFRSF6B;JADE2;BNIP3;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;DLG4;B3GNT3;CTSB;DNAJB5;SNX9;ZSCAN30;TGM2;XPC;HTRA1;GLO1;FKBP9;WNT7A;UBXN4;IGF2BP3;MAP4K4;TTBK2;GRK5;STRADB;CRTAP;ASPH;CEMIP;SHC1;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;NEK9;KIAA1549;ZNF652;RAG1;TGFBR2;PTPN3;SERPING1;EPHA1;IMPACT;RAC2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;CCPG1;CCND2;PTPN12;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;ST3GAL5;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;LPAR3;PCMTD2;ELFN2;FGFR1;ITGA1;AARS;PPP1R35;E2F5;EPCAM;MARCH4;PTPDC1;TCFL5;NFAT5;HYAL1;DCAF10;BTRC;ITGA2;PTK6;GALNT3;ULK2;ZNF559;INTS8;ZNF81;LONP2;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;ABCG1;FKBP10;SOX4;RMND5A;APOBEC3C;FHOD1;FBXO2;DDB2;ENDOV;ZNF558;CEACAM1;MAPKAPK3;SPATA18;ZNF692;OBSL1;PRR9;RAB31;LMAN1;ATF7IP;MRPS6;RCOR1;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;MMP14;HES2;ZBTB10;PHF12;MVB12B;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;CTSL;CST3;RABGGTA;CNTN1;TRIB3;CASP4;NTNG1;GFPT1;PCSK6;L3MBTL3;VPS11;RANBP9;DNAJB9;FBXL8;BTBD3;ZNF322;PPP3CB;MEX3C;RFX2;ZDHHC2;APLP2;DNAJC6;SLK;PRDX5;CEBPG;PLAG1;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;TAOK1;AEBP1;FBXO41;OTUB2;CSNK2A1;PHF1;PSMD7;CHD7;BLMH;QSOX1;PRKAR1A;MSRB2;JMY;BOK;PARP9;CPEB4;ATXN2;KLHL29;MAST3;NACC2;SPRY2;ZNF337;BEX4;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;PSKH1;MVB12A;TSHZ1;MARK4;ZNF449;PTPRZ1;CHD6;PER3;MTA1;RNF165;PM20D2;MEF2D;TRIM7;NYNRIN;ARF4;H2AFJ;POLL;ANAPC13;PCYOX1;XBP1;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;ARRDC1;REC8;ANKIB1;LYPLAL1;TLE4;RET;LOXL2;PDE5A;VWA1;MLH3;C5;MTMR4;THAP10;NOP10;GABARAPL2;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;RNF135;ETV1;CCDC88A;CTSO;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EEPD1;SEL1L;CBX7;IFI16;AP2A2;SRD5A3;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;LAMB2;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;ARID4A;TENM2;IGF2;PJA2;ZSCAN18;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;CITED4;SNX6;EVA1A;USP20;ZFP30;GRB7;LYPLA1;ZNF37A;TBX1;CREB3L2;ERP44;RSF1;ADAM8;AKT3;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;TBC1D16;MARCH2;FZD8;WASL;USP32;HSPA2;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;E2F7;EEF2K;ZNF320;HPSE;CMTR2;TNRC6C;TRIM2;RCAN1;TET1;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;PTCH1;ADCY1;KAT2B;CNOT11;RNF103;USP25;PRMT3;UFL1;FAM162A;ANKRD6;PBX3;JARID2;PPM1M;KLHL15;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;TRIM38;FBXL5;FADD
10907,GO:0044452,0.9998984092077,0.000530803035084777,3,163,nucleolar part,CC,E2F5;NOP10;PAK6
17769,GO:1901796,0.999904648426104,0.000500950077177295,3,161,regulation of signal transduction by p53 class mediator,BP,CD44;CSNK2A1;JMY
16869,GO:0098798,0.999918891128439,0.000427553731973771,3,218,mitochondrial protein complex,CC,MRPS6;NDUFV3;NDUFA4L2
3184,GO:0006807,0.999923137464766,0.00010026104838574,558,7367,nitrogen compound metabolic process,BP,TNIP1;XDH;NT5E;PLAT;SMURF2;EDEM1;GID4;NOS1;ERCC1;ZMYND8;F2R;SORL1;ADAM19;ETV5;RAB3B;MBOAT2;CCND1;NEURL1;PCK2;CTNNBIP1;VLDLR;CBS;ITGA6;MMP1;RPS6KA2;H1F0;SERPINE2;PRSS3;ADCY7;IGFBP4;PRNP;ADGRF1;ADM2;GPT2;BTBD2;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;LTBP1;ZKSCAN1;LMF1;SALL2;TK2;THSD4;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;MARCH9;H6PD;APLN;RBMS2;POU2F2;LY6K;DHTKD1;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;SOX12;CARS;PSMD2;LAMB1;ELK3;CRTC1;LTA4H;CAPN2;BRSK1;EGFR;STK39;BCORL1;LOXL1;PPP1R14A;FYN;TNFRSF6B;TMPRSS11D;OSBPL10;TSPAN5;PSAT1;JADE2;BNIP3;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;PGM1;ADAMTS7;ZNF516;DLG1;DLG4;B3GNT3;IDH2;CTSB;DNAJB5;GPC4;DHX32;SNX9;TYSND1;ZSCAN30;TGM2;XPC;GLUL;HTRA1;GLO1;FKBP9;WNT7A;PGLS;UBXN4;IGF2BP3;MAP4K4;TTBK2;SPTLC2;ACOT7;RSAD1;GRK5;NMRK1;STRADB;NME4;CRTAP;ASPH;CEMIP;SDC1;ARG2;SHC1;NAGS;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;NEK9;KIAA1549;ZNF652;CBR4;RAG1;TGFBR2;PTPN3;SERPING1;HAGH;SCRN1;EPHA1;IMPACT;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;CCPG1;CCND2;ACP5;PTPN12;ALDH1L2;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;LDHA;ST3GAL5;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;LPAR3;PCMTD2;ELFN2;ASNS;FGFR1;ITGA1;AARS;PPP1R35;E2F5;EPCAM;MARCH4;PTPDC1;LPCAT4;TCFL5;RNPEPL1;UROS;NFAT5;HYAL1;DCAF10;BTRC;LPCAT1;ITGA2;PTK6;GALNT3;ULK2;ZNF559;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;AHCYL2;ABCG1;FKBP10;SOX4;RMND5A;APOBEC3C;FHOD1;FBXO2;DDB2;GAMT;ENDOV;ZNF558;KDSR;CEACAM1;MAPKAPK3;SPATA18;ZNF692;OBSL1;PRR9;LMAN1;ATF7IP;MRPS6;RCOR1;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;MMP14;PLA2G4D;HES2;CD46;ZBTB10;PHF12;MVB12B;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;TMEM86B;CTSL;NPEPL1;CST3;RABGGTA;CNTN1;TRIB3;CASP4;NTNG1;GFPT1;PCSK6;L3MBTL3;VPS11;RANBP9;DNAJB9;FBXL8;BTBD3;SEC63;ZNF322;PPP3CB;MEX3C;RFX2;HIBADH;ZDHHC2;APLP2;DNAJC6;SLK;PRDX5;CEBPG;ALDH7A1;PLAG1;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;SLC2A9;TAOK1;AEBP1;FBXO41;SLC6A6;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;QSOX1;NDUFV3;PRKAR1A;CTBS;MSRB2;JMY;BOK;PARP9;CPEB4;ATXN2;KLHL29;MAST3;NACC2;SPRY2;LACTB2;SLC6A14;ZNF337;BEX4;THRA;ACVR1B;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;TSHZ1;MARK4;ZNF449;PTPRZ1;CHD6;PER3;MTA1;AZIN2;CRAT;RNF165;YTHDC2;PM20D2;MEF2D;GLB1;TRIM7;NYNRIN;ARF4;H2AFJ;POLL;ANAPC13;UAP1;PCYOX1;XBP1;PANK4;NFU1;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;ARRDC1;REC8;ANKIB1;LYPLAL1;TLE4;RET;LOXL2;PDE5A;VWA1;MLH3;OSBPL5;C5;MTMR4;ZFYVE9;THAP10;NOP10;GABARAPL2;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;RNF135;ETV1;CCDC88A;CTSO;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EEPD1;SEL1L;CBX7;IFI16;AP2A2;SRD5A3;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;LAMB2;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;ARID4A;NIT2;BLVRA;TENM2;IGF2;PJA2;ZSCAN18;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;CITED4;SNX6;EVA1A;USP20;ZFP30;GRB7;LYPLA1;ZNF37A;TBX1;ESYT3;CREB3L2;ERP44;ATP6V1B2;AK9;RSF1;ADAM8;ALDH4A1;AKT3;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;MARCH2;OSGEPL1;FZD8;WASL;USP32;HSPA2;PRSS8;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;GGACT;E2F7;EEF2K;ZNF320;HPSE;GALNS;CMTR2;TNRC6C;TRIM2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;ELOVL4;AOX1;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;RNF103;USP25;PANK1;PRMT3;UFL1;FAM162A;ANKRD6;N4BP2;PBX3;JARID2;PPM1M;SLC23A2;KLHL15;SLC44A1;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FBXL5;FADD
2895,GO:0006402,0.9999276353103,0.000220376624674033,9,322,mRNA catabolic process,BP,PSMD2;IGF2BP3;XRN1;TNRC6B;PSMD7;PAIP1;PUM2;TNRC6C;CNOT11
10797,GO:0044271,0.999929175801297,9.46000488312589e-05,276,3948,cellular nitrogen compound biosynthetic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;ADCY7;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;DHTKD1;TEF;EIF4EBP1;ZKSCAN2;DDIT3;B4GALT6;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;EGFR;BCORL1;PSAT1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;PGM1;ZNF516;DLG1;IDH2;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;SPTLC2;ACOT7;RSAD1;NMRK1;NME4;ARG2;SHC1;NAGS;DKK1;DAP;KIAA1549;ZNF652;HAGH;IMPACT;APOE;CCPG1;ACP5;RGS14;PKD2;ZNF862;ZNF624;RBCK1;LDHA;ST3GAL5;AKAP9;FAM208A;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;EIF4E3;ASNS;FGFR1;AARS;E2F5;EPCAM;TCFL5;UROS;NFAT5;BTRC;ITGA2;ZNF559;INTS8;ZNF81;CHAC1;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;ATF7IP;MRPS6;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;RFX2;PRDX5;CEBPG;ALDH7A1;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;PARP9;CPEB4;ATXN2;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;AZIN2;RNF165;MEF2D;ARF4;H2AFJ;POLL;UAP1;XBP1;PANK4;MAP2K2;SATB1;PAIP1;TLE4;RET;LOXL2;PDE5A;THAP10;NOP10;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;SAMD8;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ZNF37A;TBX1;CREB3L2;AK9;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;EEF2K;ZNF320;TNRC6C;RCAN1;TET1;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;ADCY1;KAT2B;CNOT11;PANK1;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FADD
6025,GO:0019083,0.999931775116956,0.000468412252206058,2,171,viral transcription,BP,HMGA2;RSF1
5586,GO:0016604,0.99993443783671,0.000128088606542062,32,654,nuclear body,CC,SMURF2;CYGB;H1F0;NR1D1;NFATC4;WWTR1;CRTC1;UBXN7;WDFY3;GRK5;OBSCN;BNIP3L;KLHDC2;RGS14;PTK6;ATRX;ATF7IP;PLAG1;NACC2;PPP1R10;PSKH1;SATB1;NOP10;PRKACA;NEK6;S100PBP;IFI16;RNF169;TENM2;ZMYM2;MAML3;E2F7
2560,GO:0005840,0.999936183884049,0.000342371088892553,3,225,ribosome,CC,MRPS6;EIF2AK2;PRMT3
5928,GO:0018205,0.999940364348218,0.000163208098140727,12,337,peptidyl-lysine modification,BP,NOS1;JADE2;TGM2;ATRX;SOX4;CTH;PHF1;MTA1;LOXL2;ARID4A;KAT2B;JARID2
4026,GO:0009058,0.999943260396785,7.47898126886435e-05,355,4935,biosynthetic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ZMYND8;F2R;ETV5;MBOAT2;CCND1;NEURL1;PCK2;CTNNBIP1;VLDLR;PYGL;CBS;ITGA6;CYGB;CYP27B1;ADCY7;CRYL1;PRNP;ADGRF1;GPT2;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;ALOX15B;LMF1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;LY6K;DHTKD1;DGKA;TEF;EIF4EBP1;ZKSCAN2;PC;DDIT3;B4GALT6;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;LTA4H;EGFR;BCORL1;PSAT1;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;ELOVL1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;B3GNT3;IDH2;DNAJB5;GPC4;ZSCAN30;GLUL;HTRA1;GLO1;WNT7A;IGF2BP3;SPTLC2;ACOT7;RSAD1;NMRK1;NME4;CEMIP;SDC1;ARG2;SHC1;NAGS;DKK1;DAP;TRIB2;KIAA1549;ZNF652;CBR4;HAGH;IMPACT;PLPP6;APOE;CCPG1;ACP5;ALDH1L2;RGS14;MCFD2;PKD2;ZNF862;ZNF624;RBCK1;LDHA;ST3GAL5;AKAP9;FAM208A;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;AGPAT4;ASNS;FGFR1;AARS;E2F5;EPCAM;LPCAT4;TCFL5;UROS;NFAT5;HYAL1;BTRC;LPCAT1;ITGA2;GALNT3;ZNF559;INTS8;ZNF81;INPP5F;CHAC1;ATRX;CHURC1;ABCG1;SOX4;PITPNM1;FHOD1;GAMT;ZNF558;KDSR;CEACAM1;ZNF692;LMAN1;ATF7IP;MRPS6;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;PLA2G4D;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;CST3;SLC35B4;TRIB3;NTNG1;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;INPP4A;RFX2;ZDHHC2;PRDX5;MLYCD;CEBPG;ALDH7A1;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;CRLS1;PARP9;CPEB4;ATXN2;NACC2;ZNF337;THRA;MGLL;ACVR1B;NGFR;ZNF280D;GLUD1;TSHZ1;ZNF449;CHD6;PER3;MTA1;AZIN2;RNF165;MEF2D;AGPAT3;ARF4;H2AFJ;POLL;UAP1;HSD17B7;XBP1;PANK4;MAP2K2;ABHD6;SATB1;PAIP1;TLE4;TRPC1;RET;LOXL2;PDE5A;MTMR4;MBOAT7;THAP10;NOP10;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;ADAMTSL1;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;ZDHHC1;CBX7;IFI16;SRD5A3;NR2F6;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ACP6;AGPAT1;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ALDH1A2;ZNF37A;TBX1;CREB3L2;AK9;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;DDHD2;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;PPT2;EEF2K;ZNF320;SLC18A2;TNRC6C;COQ2;RCAN1;TET1;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ELOVL4;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;CNOT11;PANK1;PRMT3;UFL1;AMACR;PBX3;JARID2;SLC44A1;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FADD
2894,GO:0006401,0.999943452210234,0.00016673810341928,10,346,RNA catabolic process,BP,PSMD2;IGF2BP3;XRN1;TNRC6B;PSMD7;PAIP1;PUM2;TNRC6C;DEDD2;CNOT11
12850,GO:0051168,0.999943506869794,0.000262017895923251,4,187,nuclear export,BP,XPOT;RAPGEF3;STRADB;SOX4
17305,GO:0140098,0.999952309819724,0.000142065171046981,10,331,catalytic activity, acting on RNA,MF,CARS;DHX32;AARS;ENDOV;XRN1;LACTB2;YTHDC2;RMRP;GARS;CMTR2
15875,GO:0072594,0.999953396620949,0.000115126282409201,16,460,establishment of protein localization to organelle,BP,SORL1;DDIT3;RAC2;BNIP3L;LONP2;VPS13A;COX18;VPS11;SEC63;PPP1R10;AP3D1;MOAP1;EFCAB7;TMEM50B;SSR3;TMEM173
17695,GO:1901576,0.999955933756517,5.83486312337827e-05,351,4895,organic substance biosynthetic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ZMYND8;F2R;ETV5;MBOAT2;CCND1;NEURL1;PCK2;CTNNBIP1;VLDLR;PYGL;CBS;ITGA6;CYP27B1;ADCY7;CRYL1;PRNP;ADGRF1;GPT2;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;ALOX15B;LMF1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;LY6K;DHTKD1;DGKA;TEF;EIF4EBP1;ZKSCAN2;PC;DDIT3;B4GALT6;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;LTA4H;EGFR;BCORL1;PSAT1;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;ELOVL1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;B3GNT3;IDH2;DNAJB5;GPC4;ZSCAN30;GLUL;HTRA1;GLO1;WNT7A;IGF2BP3;SPTLC2;ACOT7;RSAD1;NMRK1;NME4;CEMIP;SDC1;ARG2;SHC1;NAGS;DKK1;DAP;TRIB2;KIAA1549;ZNF652;CBR4;HAGH;IMPACT;PLPP6;APOE;CCPG1;RGS14;MCFD2;PKD2;ZNF862;ZNF624;RBCK1;LDHA;ST3GAL5;AKAP9;FAM208A;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;AGPAT4;ASNS;FGFR1;AARS;E2F5;EPCAM;LPCAT4;TCFL5;UROS;NFAT5;HYAL1;BTRC;LPCAT1;ITGA2;GALNT3;ZNF559;INTS8;ZNF81;INPP5F;CHAC1;ATRX;CHURC1;ABCG1;SOX4;PITPNM1;FHOD1;GAMT;ZNF558;KDSR;CEACAM1;ZNF692;LMAN1;ATF7IP;MRPS6;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;PLA2G4D;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;CST3;SLC35B4;TRIB3;NTNG1;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;INPP4A;RFX2;ZDHHC2;PRDX5;MLYCD;CEBPG;ALDH7A1;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;CRLS1;PARP9;CPEB4;ATXN2;NACC2;ZNF337;THRA;MGLL;ACVR1B;NGFR;ZNF280D;GLUD1;TSHZ1;ZNF449;CHD6;PER3;MTA1;AZIN2;RNF165;MEF2D;AGPAT3;ARF4;H2AFJ;POLL;UAP1;HSD17B7;XBP1;PANK4;MAP2K2;ABHD6;SATB1;PAIP1;TLE4;TRPC1;RET;LOXL2;PDE5A;MTMR4;MBOAT7;THAP10;NOP10;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;ADAMTSL1;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;ZDHHC1;CBX7;IFI16;SRD5A3;NR2F6;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ACP6;AGPAT1;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ALDH1A2;ZNF37A;TBX1;CREB3L2;AK9;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;DDHD2;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;PPT2;EEF2K;ZNF320;TNRC6C;COQ2;RCAN1;TET1;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ELOVL4;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;CNOT11;PANK1;PRMT3;UFL1;AMACR;PBX3;JARID2;SLC44A1;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FADD
16879,GO:0098813,0.999956490103001,0.000153558003990825,7,253,nuclear chromosome segregation,BP,HECW2;ATRX;TAOK1;REC8;TUBG2;MLH3;NEK6
1447,GO:0003677,0.999959135751028,6.06297056814937e-05,123,1912,DNA binding,MF,ERCC1;ZMYND8;ETV5;H1F0;NR1D1;NFATC4;ZC3H6;ETV4;ZKSCAN1;SALL2;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;ELK3;EGFR;HLTF;ERCC6;ZNF516;ZSCAN30;XPC;ZNF652;RAG1;NUCB2;TIGD2;ZNF624;AKAP9;DDN;HMGA2;ATF4;PPARA;E2F5;TCFL5;NFAT5;ZNF559;ZNF81;ATRX;SOX4;DDB2;ENDOV;ZNF558;ZNF692;RCOR1;XRN1;TCEA1;HES2;ZBTB10;PHF12;ZNF704;ZMYM3;KLF12;ZNF322;RFX2;APLP2;PRDX5;CEBPG;PLAG1;DDX60;UHRF2;PHC3;AEBP1;PHF1;CHD7;NACC2;ZNF337;THRA;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;MEF2D;H2AFJ;POLL;XBP1;SATB1;MLH3;THAP10;GTF2IRD2;DNASE1L1;ETV1;ZNF398;ZDHHC1;EEPD1;IFI16;NR2F6;SBNO1;ZNF354A;TBL1X;HOXA3;ARID4A;ZSCAN18;ZMYM2;PPARG;ZFP30;ZNF37A;TBX1;CREB3L2;PHF21A;ZBTB40;ZNF92;ZNF568;ZNF107;ARID5B;ZNF165;E2F7;ZNF320;RCAN1;TET1;DEDD2;FOXP1;ZBTB33;KAT2B;PBX3;JARID2;MXD4;ADNP;RFX7;DNMT3A
15259,GO:0071426,0.999975220761615,0.000300939828686664,1,121,ribonucleoprotein complex export from nucleus,BP,XPOT
15113,GO:0071166,0.999976998007368,0.000281150339160822,1,122,ribonucleoprotein complex localization,BP,XPOT
6022,GO:0019080,0.999978307583055,0.000163020822394836,2,185,viral gene expression,BP,HMGA2;RSF1
18012,GO:1902494,0.999978353118221,3.65056850707113e-05,66,1229,catalytic complex,CC,SMURF2;ERCC1;CCND1;BTBD2;SALL2;DHTKD1;APPL2;SMARCA1;PSMD2;JADE2;SPTLC2;WDFY3;CBR4;TGFBR2;NUDCD3;CCND2;RBCK1;IDE;PPP2R3B;ABTB1;ABCA7;PIGH;DCAF10;BTRC;INTS8;ATRX;FBXO2;DDB2;TCEA1;PHF12;RABGGTA;BTBD3;PPP3CB;PHC3;CSNK2A1;PHF1;PSMD7;NDUFV3;PRKAR1A;KLHL29;NACC2;ACVR1B;PPP1R10;CHD6;ANAPC13;PPP1R2;ANKIB1;NOP10;RMRP;UBE2E1;SEL1L;CBX7;TBL1X;ATP12A;RSF1;WFS1;PHF21A;WDR60;KAT2B;JARID2;KLHL15;GNAI1;STT3B;RB1CC1;FBXL5;FADD
10869,GO:0044391,0.999979989827185,0.000244336971678559,1,182,ribosomal subunit,CC,MRPS6
10788,GO:0044249,0.999980580336274,2.6069315537207e-05,343,4830,cellular biosynthetic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ZMYND8;F2R;ETV5;MBOAT2;CCND1;NEURL1;PCK2;CTNNBIP1;VLDLR;CBS;ITGA6;CYP27B1;ADCY7;PRNP;ADGRF1;GPT2;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;ALOX15B;LMF1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;LY6K;DHTKD1;DGKA;TEF;EIF4EBP1;ZKSCAN2;DDIT3;B4GALT6;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;LTA4H;EGFR;BCORL1;PSAT1;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;ELOVL1;PGM1;ADAMTS7;ZNF516;DLG1;ISYNA1;B3GNT3;IDH2;DNAJB5;ZSCAN30;GLUL;HTRA1;GLO1;WNT7A;IGF2BP3;SPTLC2;ACOT7;RSAD1;NMRK1;NME4;CEMIP;ARG2;SHC1;NAGS;DKK1;DAP;TRIB2;KIAA1549;ZNF652;CBR4;HAGH;IMPACT;APOE;CCPG1;ACP5;RGS14;MCFD2;PKD2;ZNF862;ZNF624;RBCK1;LDHA;ST3GAL5;AKAP9;FAM208A;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;AGPAT4;ASNS;FGFR1;AARS;E2F5;EPCAM;LPCAT4;TCFL5;UROS;NFAT5;HYAL1;BTRC;LPCAT1;ITGA2;GALNT3;ZNF559;INTS8;ZNF81;INPP5F;CHAC1;ATRX;CHURC1;ABCG1;SOX4;PITPNM1;FHOD1;GAMT;ZNF558;KDSR;CEACAM1;ZNF692;LMAN1;ATF7IP;MRPS6;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;NTSR1;PLA2G4D;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;CST3;TRIB3;NTNG1;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;INPP4A;RFX2;ZDHHC2;PRDX5;MLYCD;CEBPG;ALDH7A1;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;CRLS1;PARP9;CPEB4;ATXN2;NACC2;ZNF337;THRA;MGLL;ACVR1B;NGFR;ZNF280D;GLUD1;TSHZ1;ZNF449;CHD6;PER3;MTA1;AZIN2;RNF165;MEF2D;AGPAT3;ARF4;H2AFJ;POLL;UAP1;HSD17B7;XBP1;PANK4;MAP2K2;SATB1;PAIP1;TLE4;TRPC1;RET;LOXL2;PDE5A;MTMR4;MBOAT7;THAP10;NOP10;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;ADAMTSL1;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;ZDHHC1;CBX7;IFI16;SRD5A3;NR2F6;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ACP6;AGPAT1;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ALDH1A2;ZNF37A;TBX1;CREB3L2;AK9;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;DDHD2;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;PPT2;EEF2K;ZNF320;TNRC6C;COQ2;RCAN1;TET1;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ELOVL4;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;CNOT11;PANK1;PRMT3;UFL1;AMACR;PBX3;JARID2;SLC44A1;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;TRIM38;FADD
10884,GO:0044422,0.999981231209581,2.497187633491e-05,534,7166,organelle part,CC,TNIP1;DOCK4;NT5E;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;SORL1;FLNC;ETV5;RAB3B;MBOAT2;CCND1;PCK2;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;NOL4L;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;CLIP2;H1F0;PRSS3;IGFBP4;PRNP;XPOT;BBS2;POSTN;GPT2;NR1D1;HECW2;NFATC4;SLC16A3;ADARB1;MAP2K1;FAM210B;ETV4;RAPGEF3;ANTXR2;LTBP1;SH3KBP1;LMF1;SALL2;COL13A1;TK2;PKN1;NAPRT;WWTR1;MST1R;WDR66;MARCH9;H6PD;POU2F2;TRIM65;DHTKD1;PITPNC1;APPL2;MAP1B;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;HADH;SOX12;PSMD2;LAMB1;ELK3;SNTB2;CRTC1;LTA4H;CAPN2;BRSK1;WIPF1;SNPH;EGFR;TBC1D14;STK39;ANK3;BCORL1;DYSF;ARMCX2;FYN;MYH15;JADE2;BNIP3;HLTF;KIF13B;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;ELOVL1;PARVB;ARAP1;PGM1;ADAMTS7;DLG1;DLG4;B3GNT3;IDH2;CTSB;CD68;GPC4;DHX32;SNX9;PODXL;ESPN;XPC;SLC9A7;WNT7A;ACSF2;UBXN4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;GRK5;RDH14;NME4;MALL;CRTAP;ASPH;MCTP1;CEMIP;VWA5A;ACAD11;UNC119B;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DLG3;DKK1;PAK1;CEP170;NEK9;CBR4;RAG1;SERPING1;SLC2A3;NUDCD3;B4GALNT4;LCN2;HAGH;NUCB2;SHANK2;SCRN1;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;KLHDC2;PTPN12;ALDH1L2;RGS14;MCFD2;PKD2;PRKACB;LRP1;ST3GAL5;IDE;AKAP9;RAB11FIP4;FAM208A;PPP2R3B;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;ICA1;AGPAT4;KIF21B;FGFR1;ABHD10;E2F5;FAM114A1;TMOD2;MARCH4;PTPDC1;LPCAT4;TACC1;NFAT5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;OCIAD2;PTK6;GALNT3;VAMP2;ULK2;INTS8;LONP2;INPP5F;CHAC1;ATRX;FAM20C;ABCG1;FKBP10;SOX4;PITPNM1;FHOD1;ITPR3;FBXO2;DDB2;CEP120;ENDOV;KDSR;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PDIA5;RAB31;LMAN1;DMXL2;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;TCEA1;DVL1;CLCN3;MMP14;ANXA6;CD46;ZBTB10;ACAD10;PHF12;MVB12B;FAM50A;MAP6;ETAA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;CTSL;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CLTCL1;CASP4;PCSK6;L3MBTL3;VPS11;MOSPD2;RANBP9;DNAJB9;SEC63;ZNF322;PPP3CB;MYOF;ACOT13;HIBADH;ADGRB2;ZDHHC2;APLP2;COPB1;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;CDC42BPA;ANO8;UHRF2;SLC2A9;RASIP1;PROCR;C6ORF120;PLD3;PHC3;ATP10D;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;SLC25A4;QSOX1;ASAP1;NDUFV3;CPT2;PRKAR1A;JMY;CRLS1;BOK;PARP9;NIPSNAP1;ATXN2;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;BEX4;THRA;MGLL;ENKD1;DBNDD1;NDUFA4L2;COL6A1;NGFR;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;MARK4;CHD6;MTA1;AZIN2;BCL2L1;CRAT;MYH16;PM20D2;MEF2D;AGPAT3;GLB1;SKAP2;GOLGA2P5;H2AFJ;POLL;ANAPC13;YPEL5;UAP1;HSD17B7;PCYOX1;XBP1;SPIRE1;NFU1;MAP2K2;SATB1;SLC22A17;REC8;CYP4F22;MICU3;TLE4;RET;SPATA6;SDR9C7;FAM222B;TUBG2;STX10;LOXL2;VWA1;TCTN1;RAB43;MLH3;OSBPL5;NAV1;SH3PXD2B;MCTP2;TXNDC11;MTMR4;ZFYVE9;MBOAT7;NOP10;NCKAP1;GABARAPL2;GTF2IRD2;DNASE1L1;PAK6;UBE2E1;PUM2;SLC30A1;TMBIM1;COL1A2;SFXN3;CCDC88A;CCSAP;TMED4;SAMD8;ADAMTSL1;PRKACA;NEK6;TMSB4X;SLC25A30;TIMP2;RAB1A;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;BCAP29;AP2A2;SRD5A3;NR2F6;KDELR3;CMTM6;SLC25A43;ST6GALNAC2;FCHO1;LAMB2;FICD;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;AP3D1;ARID4A;NIT2;ARPC1A;TENM2;IGF2;ACP6;ITPR2;MOAP1;AGPAT1;PJA2;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;TMEM63A;CITED4;SNX6;EVA1A;USP20;TRIQK;TMEM50B;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;GARS;WFS1;ATP11B;IKBIP;PHF21A;WDR60;ACAP2;MPLKIP;MAML3;TMEM9;IGFBP7;SSR3;DDHD2;MARCH2;TMEM107;WASL;REEP6;HSPA2;FLNB;LRP6;ARID5B;SYT2;TMEM173;RNF180;E2F7;PPT2;SLC18A2;SIGMAR1;HPSE;GALNS;SSR1;COQ2;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;HSD17B12;CDS2;PTCH1;KAT2B;SEPT6;COG8;OAS1;RNF103;REEP3;UFL1;VSIG10L;SNX27;AMACR;JARID2;SLC44A1;GNAI1;STT3B;RB1CC1;DNMT3A;ALAS1
16819,GO:0098687,0.999982261085178,5.82958877658867e-05,9,312,chromosomal region,CC,ERCC1;SCMH1;ATRX;PPP1R10;REC8;PSEN2;KAT2B;SEPT6;DNMT3A
6601,GO:0022618,0.999982767771298,0.000102149662295208,3,193,ribonucleoprotein complex assembly,BP,ATXN2;PUM2;GRB7
10901,GO:0044446,0.999991030981082,1.20534875343442e-05,523,7071,intracellular organelle part,CC,TNIP1;DOCK4;NT5E;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;SORL1;ETV5;RAB3B;MBOAT2;CCND1;PCK2;CTNNBIP1;VLDLR;PYGL;ASAP2;SYNE3;NOL4L;CYGB;RPS6KA2;CYP27B1;PYGB;CLIP2;H1F0;PRSS3;IGFBP4;PRNP;XPOT;BBS2;POSTN;GPT2;NR1D1;HECW2;NFATC4;SLC16A3;ADARB1;MAP2K1;FAM210B;ETV4;RAPGEF3;ANTXR2;LTBP1;SH3KBP1;LMF1;SALL2;COL13A1;TK2;PKN1;NAPRT;WWTR1;MST1R;WDR66;MARCH9;H6PD;POU2F2;TRIM65;DHTKD1;PITPNC1;APPL2;MAP1B;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;HADH;SOX12;PSMD2;LAMB1;ELK3;SNTB2;CRTC1;LTA4H;CAPN2;BRSK1;WIPF1;SNPH;EGFR;TBC1D14;STK39;BCORL1;DYSF;ARMCX2;FYN;MYH15;JADE2;BNIP3;HLTF;KIF13B;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;ELOVL1;ARAP1;PGM1;ADAMTS7;DLG1;DLG4;B3GNT3;IDH2;CTSB;CD68;GPC4;DHX32;SNX9;PODXL;ESPN;XPC;SLC9A7;WNT7A;ACSF2;UBXN4;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;GRK5;RDH14;NME4;MALL;CRTAP;ASPH;MCTP1;CEMIP;VWA5A;ACAD11;SEPT10;SDC1;ARG2;STOM;SHC1;NAGS;DKK1;PAK1;CEP170;NEK9;CBR4;RAG1;SERPING1;SLC2A3;NUDCD3;B4GALNT4;LCN2;HAGH;NUCB2;SHANK2;SCRN1;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;KLHDC2;PTPN12;ALDH1L2;RGS14;MCFD2;PKD2;PRKACB;LRP1;ST3GAL5;IDE;AKAP9;RAB11FIP4;FAM208A;PPP2R3B;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;ICA1;AGPAT4;KIF21B;FGFR1;ABHD10;E2F5;FAM114A1;TMOD2;MARCH4;PTPDC1;LPCAT4;TACC1;NFAT5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;OCIAD2;PTK6;GALNT3;VAMP2;ULK2;INTS8;LONP2;INPP5F;CHAC1;ATRX;FAM20C;ABCG1;FKBP10;SOX4;PITPNM1;FHOD1;ITPR3;DDB2;CEP120;ENDOV;KDSR;CEACAM1;FERMT1;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PDIA5;RAB31;LMAN1;DMXL2;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;TCEA1;DVL1;CLCN3;MMP14;ANXA6;CD46;ZBTB10;ACAD10;PHF12;MVB12B;FAM50A;MAP6;ETAA1;ABHD17C;ZMYM3;DNMBP;KLF12;TMEM86B;CTSL;TWF2;CST3;COX18;SEC22C;RABGGTA;SLC35B4;CLTCL1;CASP4;PCSK6;L3MBTL3;VPS11;MOSPD2;RANBP9;DNAJB9;SEC63;ZNF322;PPP3CB;MYOF;ACOT13;HIBADH;ADGRB2;ZDHHC2;APLP2;COPB1;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;CDC42BPA;ANO8;UHRF2;SLC2A9;RASIP1;PROCR;C6ORF120;PLD3;PHC3;ATP10D;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;SLC25A4;QSOX1;ASAP1;NDUFV3;CPT2;PRKAR1A;JMY;CRLS1;BOK;PARP9;NIPSNAP1;ATXN2;NACC2;USP6NL;SPRY2;SEPT5;LACTB2;BEX4;THRA;MGLL;ENKD1;DBNDD1;NDUFA4L2;COL6A1;NGFR;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;MARK4;CHD6;MTA1;AZIN2;BCL2L1;CRAT;MYH16;PM20D2;MEF2D;AGPAT3;GLB1;SKAP2;GOLGA2P5;H2AFJ;POLL;ANAPC13;YPEL5;UAP1;HSD17B7;PCYOX1;XBP1;SPIRE1;NFU1;MAP2K2;SATB1;SLC22A17;REC8;CYP4F22;MICU3;TLE4;RET;SDR9C7;FAM222B;TUBG2;STX10;LOXL2;VWA1;RAB43;MLH3;OSBPL5;NAV1;SH3PXD2B;MCTP2;TXNDC11;MTMR4;ZFYVE9;MBOAT7;NOP10;NCKAP1;GABARAPL2;GTF2IRD2;DNASE1L1;PAK6;UBE2E1;PUM2;SLC30A1;TMBIM1;COL1A2;SFXN3;CCDC88A;CCSAP;TMED4;SAMD8;ADAMTSL1;PRKACA;NEK6;TMSB4X;SLC25A30;TIMP2;RAB1A;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;BCAP29;AP2A2;SRD5A3;NR2F6;KDELR3;CMTM6;SLC25A43;ST6GALNAC2;FCHO1;LAMB2;FICD;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;AP3D1;ARID4A;NIT2;ARPC1A;TENM2;IGF2;ACP6;ITPR2;MOAP1;AGPAT1;PJA2;MAP4K2;ZMYM2;ERLEC1;PPARG;TMEM63A;CITED4;SNX6;EVA1A;USP20;TRIQK;TMEM50B;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;RPH3AL;AK9;RSF1;ADAM8;ALDH4A1;GARS;WFS1;ATP11B;IKBIP;PHF21A;WDR60;ACAP2;MPLKIP;MAML3;TMEM9;IGFBP7;SSR3;DDHD2;MARCH2;WASL;REEP6;HSPA2;FLNB;LRP6;ARID5B;SYT2;TMEM173;RNF180;E2F7;PPT2;SLC18A2;SIGMAR1;HPSE;GALNS;SSR1;COQ2;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;ZFYVE21;PSEN2;ELOVL4;HSD17B12;CDS2;PTCH1;KAT2B;SEPT6;COG8;OAS1;RNF103;REEP3;UFL1;VSIG10L;SNX27;AMACR;JARID2;SLC44A1;GNAI1;STT3B;RB1CC1;DNMT3A;ALAS1
10358,GO:0043170,0.999991047482159,1.20243828519765e-05,511,6842,macromolecule metabolic process,BP,TNIP1;XDH;NT5E;PLAT;SMURF2;EDEM1;GID4;NOS1;ERCC1;ZMYND8;F2R;SORL1;ADAM19;ETV5;RAB3B;CCND1;NEURL1;CTNNBIP1;VLDLR;PYGL;CBS;ITGA6;MMP1;RPS6KA2;PYGB;H1F0;SERPINE2;PRSS3;ADCY7;IGFBP4;PRNP;ADGRF1;ACTA2;BBS2;ADM2;BTBD2;NR1D1;HECW2;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;TFPI2;RAPGEF3;ACVR2B;LTBP1;ZKSCAN1;LMF1;SALL2;TK2;THSD4;PKN1;WWTR1;PEG3;MST1R;ARHGAP22;MARCH9;APLN;RBMS2;POU2F2;LY6K;TEF;TNFSF15;EIF4EBP1;ZKSCAN2;SSH1;PC;DDIT3;PTPRS;B4GALT6;SMARCA1;SOX12;CARS;PSMD2;LAMB1;ELK3;CRTC1;LTA4H;CAPN2;BRSK1;EGFR;STK39;ANK3;BCORL1;LOXL1;PPP1R14A;FYN;TNFRSF6B;TMPRSS11D;TSPAN5;JADE2;BNIP3;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ARAP1;PGM1;ADAMTS7;ZNF516;DLG1;DLG4;B3GNT3;CTSB;DNAJB5;GPC4;DHX32;SNX9;TYSND1;ZSCAN30;TGM2;XPC;HTRA1;GLO1;FKBP9;WNT7A;UBXN4;IGF2BP3;MAP4K4;TTBK2;GRK5;STRADB;CRTAP;ASPH;CEMIP;SDC1;SHC1;DLG3;DKK1;DAP;PAK1;RASA3;SOCS2;TRIB2;NEK9;KIAA1549;ZNF652;RAG1;TGFBR2;PTPN3;SERPING1;SCRN1;EPHA1;IMPACT;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;CCPG1;CCND2;PTPN12;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;LRP1;ST3GAL5;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;UBE2G1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;LPAR3;PCMTD2;ELFN2;FGFR1;ITGA1;AARS;PPP1R35;E2F5;EPCAM;MARCH4;PTPDC1;TCFL5;RNPEPL1;NFAT5;HYAL1;DCAF10;BTRC;LPCAT1;ITGA2;PTK6;GALNT3;ULK2;ZNF559;INTS8;ZNF81;LONP2;LTBP4;INPP5F;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;PFN2;ABCG1;FKBP10;SOX4;RMND5A;APOBEC3C;FHOD1;FBXO2;DDB2;ENDOV;ZNF558;CEACAM1;FERMT1;MAPKAPK3;SPATA18;ZNF692;OBSL1;PRR9;RAB31;LMAN1;ATF7IP;MRPS6;RCOR1;SH3D19;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;MMP14;HES2;CD46;ZBTB10;PHF12;MVB12B;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;CTSL;NPEPL1;CST3;RABGGTA;CNTN1;TRIB3;CASP4;NTNG1;GFPT1;PCSK6;L3MBTL3;VPS11;RANBP9;DNAJB9;FBXL8;BTBD3;ZNF322;PPP3CB;MEX3C;RFX2;ZDHHC2;APLP2;DNAJC6;SLK;PRDX5;CEBPG;PLAG1;CDC42BPA;ANO8;SCYL3;F2RL1;UHRF2;TAOK1;AEBP1;FBXO41;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;BLMH;QSOX1;PRKAR1A;CTBS;MSRB2;JMY;BOK;PARP9;CPEB4;ATXN2;KLHL29;MAST3;NACC2;SPRY2;LACTB2;ZNF337;BEX4;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;PSKH1;MVB12A;TSHZ1;MARK4;ZNF449;PTPRZ1;CHD6;PER3;MTA1;AZIN2;RNF165;YTHDC2;PM20D2;MEF2D;GLB1;TRIM7;NYNRIN;ARF4;H2AFJ;POLL;ANAPC13;PCYOX1;XBP1;NFU1;UBASH3B;MAP2K2;SATB1;PPP1R2;PAIP1;ARRDC1;REC8;ANKIB1;LYPLAL1;TLE4;RET;LOXL2;PDE5A;VWA1;MLH3;SH3PXD2B;C5;MTMR4;ZFYVE9;THAP10;NOP10;GABARAPL2;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;RNF135;ETV1;CCDC88A;CTSO;SAMD8;ADAMTSL1;SHC2;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;RAB1A;ZDHHC1;EEPD1;SEL1L;CBX7;IFI16;AP2A2;SRD5A3;NR2F6;SLC39A10;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;LAMB2;FICD;SECISBP2L;LPAR1;ZNF354A;CTSZ;TBL1X;MMP10;RNF169;HOXA3;ARID4A;TENM2;IGF2;PJA2;ZSCAN18;MAP4K2;ZMYM2;EFCAB7;ERLEC1;PPARG;CITED4;SNX6;EVA1A;USP20;ZFP30;GRB7;ALDH1A2;LYPLA1;ZNF37A;TBX1;CREB3L2;ERP44;RSF1;ADAM8;AKT3;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;TBC1D16;MARCH2;OSGEPL1;FZD8;WASL;USP32;HSPA2;PRSS8;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;E2F7;PPT2;EEF2K;ZNF320;HPSE;GALNS;CMTR2;TNRC6C;TRIM2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;RNF103;USP25;PRMT3;UFL1;FAM162A;ANKRD6;N4BP2;PBX3;JARID2;PPM1M;KLHL15;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;TRIM38;FBXL5;FADD
2898,GO:0006405,0.99999188943159,0.00010810303342595,1,133,RNA export from nucleus,BP,XPOT
15482,GO:0071826,0.999992069703468,4.94431430361077e-05,3,204,ribonucleoprotein complex subunit organization,BP,ATXN2;PUM2;GRB7
3253,GO:0006913,0.999994279723291,2.10292500549728e-05,8,302,nucleocytoplasmic transport,BP,XPOT;RAPGEF3;STRADB;RGS14;SOX4;PPP1R10;EFCAB7;TMEM173
12851,GO:0051169,0.999995164522597,1.7918337737679e-05,8,305,nuclear transport,BP,XPOT;RAPGEF3;STRADB;RGS14;SOX4;PPP1R10;EFCAB7;TMEM173
12759,GO:0051028,0.999995644404434,6.10146080131566e-05,1,135,mRNA transport,BP,IGF2BP3
3299,GO:0006996,0.999996341018931,5.27831233929962e-06,206,3094,organelle organization,BP,NOS1;ERCC1;ZMYND8;F2R;NEURL1;SYNE3;H1F0;SERPINE2;BBS2;HECW2;MAP2K1;FMNL2;RAPGEF3;SH3KBP1;PKN1;WWTR1;SSH1;MAP1B;SMARCA1;CAPN2;BRSK1;WIPF1;TBC1D14;ANK3;BCORL1;DYSF;ARHGAP12;JADE2;BNIP3;HLTF;SCMH1;PARVB;ARAP1;DLG1;DLG4;IDH2;SNX9;ESPN;XPC;EVI5L;TTBK2;SEC23A;UNC119B;SEPT10;SDC1;SHC1;PAK1;ATXN10;NEK9;RAG1;NUDCD3;SHANK2;EPHA1;RAC2;OBSCN;APOE;BNIP3L;ABCD1;AFAP1;RGS14;MCFD2;PKD2;LRP1;FYCO1;AKAP9;HMGA2;TMOD2;PTPDC1;TACC1;ITGB5;VAMP2;ULK2;FAT1;LONP2;ATRX;MTHFR;PFN2;FKBP10;FHOD1;DDB2;CEP120;SPATA18;OBSL1;RAB31;LMAN1;RCOR1;SH3D19;XRN1;DVL1;CLCN3;PLEK2;NLGN2;MAP6;LRP5;ZMYM3;TWF2;COX18;SEC22C;TOM1L2;L3MBTL3;VPS11;RANBP9;WASF3;RFX2;SYTL1;SLK;FNBP1L;CDC42BPA;F2RL1;UHRF2;TAOK1;PHF1;CHD7;SLC25A4;ASAP1;NDUFV3;PRKAR1A;MSRB2;JMY;BOK;ATXN2;MAST3;NACC2;USP6NL;SPRY2;SEPT5;TBC1D2B;PPP1R10;MVB12A;GLUD1;MARK4;CHD6;MTA1;BCL2L1;WASF2;GOLGA2P5;H2AFJ;SPIRE1;MAP2K2;SATB1;REC8;SPATA6;TUBG2;STX10;LOXL2;TCTN1;RAB43;MLH3;NAV1;SH3PXD2B;NOP10;NCKAP1;GABARAPL2;PAK6;UBE2E1;PUM2;CCDC88A;CCSAP;TMED4;PRKACA;NEK6;TMSB4X;RAB1A;EPB41L3;SNX30;CBX7;RHOBTB1;LPAR1;ZNF354A;CTSZ;TBL1X;AP3D1;ARID4A;ARPC1A;IGF2;MOAP1;LAMA5;ZMYM2;SNX6;GRB7;PPL;EVI5;ATP6V1B2;RSF1;AKT3;PHF21A;WDR60;TBC1D16;DDHD2;TMEM107;WASL;HSPA2;FLNB;ARID5B;SYT2;TET1;KAT2B;SEPT6;PRMT3;REEP3;FAM162A;JARID2;GNAI1;RB1CC1;DNMT3A;ALAS1
10887,GO:0044427,0.999997435803268,5.49576449240468e-06,33,772,chromosomal part,CC,ERCC1;H1F0;NR1D1;SALL2;APPL2;SMARCA1;CAPN2;SCMH1;CCND2;HMGA2;ATRX;PHF12;ETAA1;UHRF2;CSNK2A1;PHF1;PARP9;NACC2;PPP1R10;MEF2D;H2AFJ;SATB1;REC8;LOXL2;MLH3;CBX7;RNF169;RSF1;HSPA2;PSEN2;KAT2B;SEPT6;DNMT3A
5335,GO:0016072,0.999998622833013,7.92735778256064e-06,4,284,rRNA metabolic process,BP,XRN1;CHD7;NOP10;DEDD2
12923,GO:0051276,0.999998976096286,1.98110266768445e-06,51,1048,chromosome organization,BP,NOS1;ERCC1;ZMYND8;H1F0;HECW2;PKN1;SMARCA1;BCORL1;JADE2;HLTF;SCMH1;XPC;RAG1;HMGA2;ATRX;MTHFR;FKBP10;DDB2;RCOR1;XRN1;L3MBTL3;UHRF2;TAOK1;PHF1;CHD7;NACC2;PPP1R10;CHD6;MTA1;H2AFJ;SATB1;REC8;TUBG2;LOXL2;MLH3;NOP10;UBE2E1;NEK6;CBX7;TBL1X;ARID4A;IGF2;RSF1;PHF21A;HSPA2;ARID5B;TET1;KAT2B;PRMT3;JARID2;DNMT3A
10906,GO:0044451,0.999999144569165,1.70067944337766e-06,47,977,nucleoplasm part,CC,SMURF2;ERCC1;CYGB;H1F0;NR1D1;NFATC4;SALL2;WWTR1;APPL2;CRTC1;JADE2;ERCC6;UBXN7;WDFY3;GRK5;OBSCN;BNIP3L;KLHDC2;RGS14;PTK6;INTS8;ATRX;ATF7IP;TCEA1;PHF12;PLAG1;CSNK2A1;PHF1;NACC2;PPP1R10;PSKH1;CHD6;SATB1;NOP10;PRKACA;NEK6;S100PBP;IFI16;TBL1X;RNF169;TENM2;ZMYM2;PHF21A;MAML3;E2F7;KAT2B;JARID2
2465,GO:0005681,0.999999623069582,6.23100260300943e-06,1,181,spliceosomal complex,CC,DHX32
10400,GO:0043231,0.999999732832608,3.81083553880731e-07,618,8289,intracellular membrane-bounded organelle,CC,TNIP1;DOCK4;FHL1;XDH;NT5E;SMURF2;EPN3;EDEM1;TSPAN1;NOS1;ERCC1;ZMYND8;F2R;SORL1;ADAM19;ETV5;MBOAT2;CCND1;PCK2;CTNNBIP1;VLDLR;ASAP2;SYNE3;CBS;NOL4L;CYGB;RPS6KA2;CYP27B1;PYGB;H1F0;IGFBP4;PRNP;XPOT;POSTN;GPT2;NR1D1;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;FAM210B;ETV4;FNDC4;ANTXR2;LTBP1;ZKSCAN1;ALOX15B;LMF1;SALL2;COL13A1;TK2;PKN1;NAPRT;WWTR1;PEG3;MST1R;ARHGAP22;MARCH9;H6PD;RBMS2;MARVELD1;POU2F2;TRIM65;DHTKD1;PITPNC1;TEF;APPL2;ZKSCAN2;PC;DDIT3;B4GALT6;SMARCA1;HADH;SOX12;PSMD2;LAMB1;ELK3;CRTC1;LTA4H;CAPN2;BRSK1;SNPH;EGFR;TBC1D14;STK39;ANK3;BCORL1;C2CD2;PDZD2;ARMCX2;FYN;JADE2;BNIP3;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;UBXN7;MAPK13;ELOVL1;ARAP1;ADAMTS7;ZNF516;DLG1;DLG4;B3GNT3;IDH2;CTSB;CD68;DNAJB5;GPC4;DHX32;SNX9;TYSND1;PODXL;NET1;ZSCAN30;TGM2;XPC;GLUL;SLC9A7;GLO1;FKBP9;WNT7A;ACSF2;UBXN4;IGF2BP3;TTBK2;SPTLC2;ACOT7;WDFY3;SEC23A;RSAD1;GRK5;STRADB;RDH14;NME4;MALL;CRTAP;ASPH;MCTP1;GDI1;CEMIP;VWA5A;ACAD11;SDC1;ARG2;STOM;SHC1;NAGS;SLFN5;PAK1;TRIB2;NEK9;ZNF652;CBR4;RAG1;B4GALNT4;HAGH;NUCB2;SCRN1;RALGAPA2;RAC2;CLCA2;ERO1B;CD44;OBSCN;APOE;FKBP1A;BNIP3L;ATP7B;ABCD1;CCND2;ACP5;TIGD2;KLHDC2;PTPN12;ALDH1L2;CDK17;RGS14;MCFD2;PKD2;ZNF862;PRKACB;ZNF624;LRP1;LDHA;ST3GAL5;FYCO1;IDE;AKAP9;FAM208A;PPP2R3B;ABTB1;DDN;HMGA2;ATF4;PPARA;ABCA7;PIGH;ICA1;AGPAT4;FGFR1;ABHD10;AARS;E2F5;FAM114A1;MARCH4;TUB;PTPDC1;LPCAT4;TACC1;TCFL5;UROS;NFAT5;SNX14;HYAL1;DCAF10;BTRC;LPCAT1;ITGA2;OCIAD2;PTK6;GALNT3;TMX4;VAMP2;ZNF559;FAT1;INTS8;ZNF81;LONP2;CHAC1;BIVM;ATRX;FAM20C;AHCYL2;ABCG1;FKBP10;KIAA1109;SOX4;RMND5A;PITPNM1;APOBEC3C;FHOD1;ITPR3;FBXO2;DDB2;GAMT;ENDOV;ZNF558;KDSR;MAPKAPK3;GSDMC;SPATA18;ZNF692;OBSL1;PDIA5;RAB31;LMAN1;MT2A;UACA;SARAF;ATF7IP;FAM110C;MRPS6;RCOR1;BSG;SH3D19;NLK;EPN2;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;CLCN3;NTSR1;MMP14;HES2;ANXA6;ZBTB10;ACAD10;PHF12;MVB12B;ZNF704;FAM50A;MAP6;LRP5;ETAA1;ZMYM3;DNMBP;KLF12;TMEM86B;CTSL;NPEPL1;CST3;COX18;SEC22C;RABGGTA;SLC35B4;TRIB3;CLTCL1;CASP4;PCSK6;SLC35G2;TPBG;L3MBTL3;VPS11;RANBP9;DNAJB9;BTBD3;SEC63;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;RFX2;HIBADH;ZDHHC2;APLP2;DNAJC6;COPB1;PRDX5;MLYCD;CEBPG;COPG1;ALDH7A1;PLAG1;ANO8;SCYL3;F2RL1;UHRF2;SLC2A9;RASIP1;C6ORF120;TAOK1;PLD3;PHC3;AEBP1;ATP10D;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;BLMH;SLC25A4;QSOX1;SUGCT;ASAP1;NDUFV3;CPT2;CTBS;MSRB2;JMY;CRLS1;BOK;PARP9;CPEB4;NIPSNAP1;ATXN2;NACC2;USP6NL;SPRY2;LACTB2;ZNF337;BEX4;THRA;MGLL;GOLGA6L9;WNT2B;NDUFA4L2;COL6A1;NGFR;ZNF280D;BPHL;PPP1R10;PSKH1;MVB12A;GLUD1;HSPA13;TSHZ1;ZNF449;CHD6;NUDT6;PER3;MTA1;AZIN2;BCL2L1;CRAT;RNF165;YTHDC2;PM20D2;MEF2D;AGPAT3;GLB1;TRIM7;SKAP2;ARF4;GOLGA2P5;H2AFJ;POLL;ANAPC13;UAP1;HSD17B7;PCYOX1;XBP1;SPIRE1;NFU1;UBASH3B;TXNRD3;MAP2K2;ABHD6;SATB1;SLC22A17;REC8;CYP4F22;MICU3;TLE4;RET;SDR9C7;FAM222B;TUBG2;STX10;LOXL2;VWA1;RAB43;MLH3;OSBPL5;MCTP2;BEX2;TXNDC11;ZFYVE9;MBOAT7;NOP10;GABARAPL2;EPM2A;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;TMBIM1;ETV1;COL1A2;SFXN3;CCDC88A;CTSO;TMED4;SAMD8;ADAMTSL1;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;SLC25A30;EIF2AK2;RAB1A;ZDHHC1;S100PBP;SEL1L;PCDH1;CBX7;IFI16;ANGEL1;RHOBTB1;BCAP29;AP2A2;SRD5A3;NR2F6;KDELR3;CMTM6;SCAND1;SBNO1;SLC25A43;ST6GALNAC2;FCHO1;LAMB2;FICD;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;AP3D1;ARID4A;NIT2;TENM2;ACP6;ITPR2;MOAP1;LAMA5;FNBP1;AGPAT1;PJA2;ZSCAN18;LARP1B;MAP4K2;ZMYM2;ERLEC1;PPARG;TMEM63A;CITED4;SNX6;EVA1A;ZFP30;TRIQK;PPL;LYPLA1;TMEM50B;ZNF37A;TBX1;SLC7A11;EVI5;ESYT3;CREB3L2;ERP44;ATP6V1B2;AK9;RSF1;ADAM8;ALDH4A1;AKT3;GARS;WFS1;DEPDC1;ENDOG;ATP11B;IKBIP;PHF21A;ZBTB40;ZNF92;ACAP2;MPLKIP;MAML3;ZNF568;TMEM9;IGFBP7;SSR3;DDHD2;MARCH2;OSGEPL1;FZD8;CMC1;WASL;USP32;REEP6;HSPA2;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;RNF180;E2F7;PPT2;ZNF320;SIGMAR1;HPSE;GALNS;CMTR2;RALGDS;SSR1;COQ2;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;ELOVL4;SSFA2;HSD17B12;CDS2;PTCH1;ADCY1;KAT2B;COG8;CNOT11;OAS1;RNF103;USP25;PANK1;REEP3;UFL1;VSIG10L;FAM162A;ANKRD6;SNX27;AMACR;PBX3;JARID2;PPM1M;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;RFX7;STT3B;RB1CC1;DNMT3A;ALAS1;FADD
10397,GO:0043228,0.999999748752759,3.76086880673278e-07,210,3275,non-membrane-bounded organelle,CC,DOCK4;NOS1;ERCC1;FLNC;SCN8A;CLIP2;H1F0;ACTA2;BBS2;BTBD2;NR1D1;HECW2;ADARB1;MAP2K1;ETV4;RAPGEF3;SH3KBP1;ALOX15B;MPRIP;SALL2;MST1R;WDR66;MARVELD1;APPL2;SSH1;MAP1B;SMARCA1;SNTB2;CAPN2;BRSK1;WIPF1;SNPH;STK39;ANK3;DYSF;FYN;MYH15;OSBPL10;HLTF;KIF13B;SCMH1;ERCC6;PARVB;PGM1;DLG1;DLG4;CTSB;PODXL;ESPN;XPC;TTBK2;WDFY3;RSPH3;SEPT10;STOM;PAK1;CEP170;TRIB2;NEK9;PTPN3;NUDCD3;SHANK2;RAC2;OBSCN;FKBP1A;CCND2;PTPN12;AFAP1;RGS14;PKD2;PRKACB;AKAP9;RAB11FIP4;FAM208A;ABTB1;HMGA2;ATF4;KIF21B;FGFR1;E2F5;TMOD2;TACC1;LPCAT1;ATRX;PFN2;FKBP10;PITPNM1;APOBEC3C;FHOD1;ITPR3;CEP120;ENDOV;FERMT1;GSDMC;ZNF692;OBSL1;LMAN1;UACA;FAM110C;MRPS6;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;MMP14;PLEK2;PHF12;MAP6;ETAA1;DNMBP;TWF2;CST3;CLTCL1;L3MBTL3;RANBP9;WASF3;DNAJB9;RIMS3;ZNF322;PPP3CB;ACOT13;ADGRB2;FNBP1L;CDC42BPA;DDX60;UHRF2;PROCR;CSNK2A1;PHF1;CHD7;ASAP1;CPT2;PRKAR1A;JMY;PARP9;ATXN2;NACC2;SPRY2;SEPT5;BEX4;ENKD1;PPP1R10;PSKH1;MVB12A;MARK4;MTA1;BCL2L1;MYH16;MEF2D;WASF2;H2AFJ;SPIRE1;MAP2K2;SATB1;REC8;RIN1;SDR9C7;TUBG2;LOXL2;TCTN1;MLH3;NAV1;SH3PXD2B;NOP10;NCKAP1;PAK6;PUM2;FRMD4B;CCDC88A;CCSAP;PRKACA;NEK6;TMSB4X;EIF2AK2;EPB41L3;PCDH1;CBX7;IFI16;ZNF354A;TBL1X;RNF169;NIT2;ARPC1A;FNBP1;PJA2;TMEM63A;USP20;GRB7;PPL;SLC7A11;EVI5;RSF1;ADAM8;WDR60;MPLKIP;DDHD2;WASL;HSPA2;FLNB;SIGMAR1;DEDD2;ZBTB33;PSEN2;KAT2B;SEPT6;PRMT3;REEP3;GNAI1;DNMT3A
10401,GO:0043232,0.999999748752759,3.76086880673278e-07,210,3275,intracellular non-membrane-bounded organelle,CC,DOCK4;NOS1;ERCC1;FLNC;SCN8A;CLIP2;H1F0;ACTA2;BBS2;BTBD2;NR1D1;HECW2;ADARB1;MAP2K1;ETV4;RAPGEF3;SH3KBP1;ALOX15B;MPRIP;SALL2;MST1R;WDR66;MARVELD1;APPL2;SSH1;MAP1B;SMARCA1;SNTB2;CAPN2;BRSK1;WIPF1;SNPH;STK39;ANK3;DYSF;FYN;MYH15;OSBPL10;HLTF;KIF13B;SCMH1;ERCC6;PARVB;PGM1;DLG1;DLG4;CTSB;PODXL;ESPN;XPC;TTBK2;WDFY3;RSPH3;SEPT10;STOM;PAK1;CEP170;TRIB2;NEK9;PTPN3;NUDCD3;SHANK2;RAC2;OBSCN;FKBP1A;CCND2;PTPN12;AFAP1;RGS14;PKD2;PRKACB;AKAP9;RAB11FIP4;FAM208A;ABTB1;HMGA2;ATF4;KIF21B;FGFR1;E2F5;TMOD2;TACC1;LPCAT1;ATRX;PFN2;FKBP10;PITPNM1;APOBEC3C;FHOD1;ITPR3;CEP120;ENDOV;FERMT1;GSDMC;ZNF692;OBSL1;LMAN1;UACA;FAM110C;MRPS6;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;MMP14;PLEK2;PHF12;MAP6;ETAA1;DNMBP;TWF2;CST3;CLTCL1;L3MBTL3;RANBP9;WASF3;DNAJB9;RIMS3;ZNF322;PPP3CB;ACOT13;ADGRB2;FNBP1L;CDC42BPA;DDX60;UHRF2;PROCR;CSNK2A1;PHF1;CHD7;ASAP1;CPT2;PRKAR1A;JMY;PARP9;ATXN2;NACC2;SPRY2;SEPT5;BEX4;ENKD1;PPP1R10;PSKH1;MVB12A;MARK4;MTA1;BCL2L1;MYH16;MEF2D;WASF2;H2AFJ;SPIRE1;MAP2K2;SATB1;REC8;RIN1;SDR9C7;TUBG2;LOXL2;TCTN1;MLH3;NAV1;SH3PXD2B;NOP10;NCKAP1;PAK6;PUM2;FRMD4B;CCDC88A;CCSAP;PRKACA;NEK6;TMSB4X;EIF2AK2;EPB41L3;PCDH1;CBX7;IFI16;ZNF354A;TBL1X;RNF169;NIT2;ARPC1A;FNBP1;PJA2;TMEM63A;USP20;GRB7;PPL;SLC7A11;EVI5;RSF1;ADAM8;WDR60;MPLKIP;DDHD2;WASL;HSPA2;FLNB;SIGMAR1;DEDD2;ZBTB33;PSEN2;KAT2B;SEPT6;PRMT3;REEP3;GNAI1;DNMT3A
2872,GO:0006364,0.999999808238533,1.9472436293784e-06,2,255,rRNA processing,BP,CHD7;NOP10
4471,GO:0010467,0.999999928975153,1.04508947633265e-07,282,4264,gene expression,BP,TNIP1;XDH;PLAT;SMURF2;NOS1;ZMYND8;F2R;SORL1;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;SERPINE2;PRSS3;PRNP;ADGRF1;ACTA2;BBS2;ADM2;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;ACVR2B;ZKSCAN1;LMF1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;RBMS2;POU2F2;TEF;EIF4EBP1;ZKSCAN2;PC;DDIT3;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;CAPN2;EGFR;ANK3;BCORL1;FYN;TSPAN5;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;DHX32;TYSND1;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;ASPH;SHC1;DKK1;DAP;KIAA1549;ZNF652;RAG1;TGFBR2;SERPING1;IMPACT;ERO1B;APOE;FKBP1A;CCPG1;RGS14;PKD2;ZNF862;PRKACB;ZNF624;RBCK1;FAM208A;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;EIF4E3;FGFR1;AARS;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ITGA2;ZNF559;INTS8;ZNF81;LONP2;CHAC1;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;FERMT1;ZNF692;ATF7IP;MRPS6;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;MMP14;HES2;CD46;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;CNTN1;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;PRKAR1A;MSRB2;JMY;PARP9;CPEB4;ATXN2;NACC2;SPRY2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;YTHDC2;MEF2D;ARF4;H2AFJ;XBP1;NFU1;MAP2K2;SATB1;PAIP1;TLE4;RET;LOXL2;SH3PXD2B;C5;THAP10;NOP10;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;ZNF354A;CTSZ;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ALDH1A2;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;OSGEPL1;FZD8;WASL;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;E2F7;EEF2K;ZNF320;CMTR2;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
2486,GO:0005730,0.999999936424686,1.51948392893537e-07,32,834,nucleolus,CC,DOCK4;ADARB1;ETV4;HLTF;ERCC6;CTSB;PODXL;XPC;WDFY3;CCND2;ABTB1;FGFR1;E2F5;FKBP10;ITPR3;ENDOV;ZNF692;TCEA1;L3MBTL3;DNAJB9;CHD7;CPT2;NACC2;SDR9C7;NOP10;PAK6;PCDH1;IFI16;ZNF354A;DEDD2;ZBTB33;GNAI1
16479,GO:0097159,0.999999950087997,7.30637391354826e-08,314,4608,organic cyclic compound binding,MF,XDH;NT5E;NOS1;ERCC1;ZMYND8;ETV5;RAB3B;PCK2;PYGL;CBS;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;H1F0;ADCY7;CRYL1;OSBP2;XPOT;ACTA2;GPT2;NR1D1;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;PEG3;MST1R;H6PD;RBMS2;POU2F2;DHTKD1;DGKA;TEF;ZKSCAN2;PC;DDIT3;SMARCA1;HADH;SOX12;CARS;ELK3;SNTB2;LTA4H;BRSK1;EGFR;STK39;FYN;HEBP1;MYH15;OSBPL10;HLTF;KIF13B;SPATS2;ERCC6;UBE2J1;MAPK13;ZNF516;IDH2;DHX32;ZSCAN30;TGM2;XPC;GLUL;FKBP9;ACSF2;IGF2BP3;MAP4K4;TTBK2;SPTLC2;GRK5;HTR7;NMRK1;STRADB;NME4;ACAD11;SEPT10;SLFN5;PAK1;NEK9;ZNF652;CBR4;RAG1;TGFBR2;NUCB2;EPHA1;RAC2;OBSCN;APOE;FKBP1A;ATP7B;ABCD1;TIGD2;CDK17;ZNF862;PRKACB;ZNF624;LRP1;LDHA;FYCO1;IDE;AKAP9;ZCCHC14;FAM208A;ABTB1;UBE2G1;DDN;HMGA2;ATF4;PPARA;ABCA7;EIF4E3;KIF21B;ASNS;FGFR1;AARS;E2F5;TCFL5;NFAT5;PTK6;ULK2;ZNF559;ZNF81;LONP2;ATRX;FAM20C;MTHFR;ABCG1;FKBP10;SOX4;APOBEC3C;DDB2;ENDOV;ZNF558;MAPKAPK3;ZNF692;RAB31;MRPS6;RCOR1;NLK;XRN1;TCEA1;TNRC6B;CLCN3;HES2;ANXA6;ZBTB10;ACAD10;PHF12;CTH;ZNF704;FAM50A;ZMYM3;KLF12;TWF2;TRIB3;VPS11;SEC63;ZNF322;MEX3C;RFX2;HIBADH;APLP2;SLK;PRDX5;CEBPG;PLAG1;CDC42BPA;SCYL3;DDX60;UHRF2;TAOK1;PHC3;AEBP1;ATP10D;CSNK2A1;PHF1;TST;CHD7;NDUFV3;PRKAR1A;PARP9;CPEB4;ATXN2;MAST3;NACC2;SEPT5;LACTB2;ZNF337;THRA;ACVR1B;ZNF280D;PPP1R10;PSKH1;GLUD1;HSPA13;TSHZ1;MARK4;ZNF449;CHD6;NUDT6;PER3;MTA1;YTHDC2;MEF2D;NYNRIN;ARF4;H2AFJ;POLL;XBP1;PANK4;TXNRD3;MAP2K2;SATB1;GPATCH8;PAIP1;CYP4F22;RET;TUBG2;PDE5A;RAB43;MLH3;OSBPL5;THAP10;NOP10;GTF2IRD2;DNASE1L1;PAK6;UBE2E1;PUM2;ETV1;PRKACA;ZNF398;NEK6;TMSB4X;EIF2AK2;RAB1A;ZDHHC1;EEPD1;IFI16;RHOBTB1;NR2F6;SBNO1;LTB4R;FICD;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;ZSCAN18;LARP1B;MAP4K2;ZMYM2;PPARG;TMEM63A;ZFP30;GRB7;ATP12A;ZNF37A;TBX1;CREB3L2;ATP6V1B2;AK9;AKT3;GARS;ENDOG;ATP11B;PHF21A;ZBTB40;ZNF92;ZNF568;HSPA2;ZNF107;FLNB;ARID5B;ZNF165;TMEM173;E2F7;EEF2K;ZNF320;TNRC6C;RCAN1;TET1;ZC3H7A;DEDD2;FOXP1;ZBTB33;AOX1;PTCH1;ADCY1;KAT2B;SEPT6;OAS1;PANK1;PRMT3;N4BP2;PBX3;JARID2;MXD4;ADNP;GNAI1;RFX7;DNMT3A;ALAS1
4027,GO:0009059,0.999999972629093,4.09988947381921e-08,269,4111,macromolecule biosynthetic process,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;LMF1;SALL2;TK2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;LY6K;TEF;EIF4EBP1;ZKSCAN2;DDIT3;B4GALT6;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;PGM1;ADAMTS7;ZNF516;DLG1;B3GNT3;DNAJB5;GPC4;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;CEMIP;SDC1;SHC1;DKK1;DAP;TRIB2;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;MCFD2;PKD2;ZNF862;ZNF624;RBCK1;ST3GAL5;FAM208A;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;FGFR1;AARS;E2F5;EPCAM;TCFL5;NFAT5;HYAL1;BTRC;ITGA2;GALNT3;ZNF559;INTS8;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;LMAN1;ATF7IP;MRPS6;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;CST3;TRIB3;NTNG1;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;RFX2;ZDHHC2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;CPEB4;ATXN2;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;POLL;XBP1;MAP2K2;SATB1;PAIP1;TLE4;RET;LOXL2;THAP10;NOP10;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;ADAMTSL1;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;ZDHHC1;CBX7;IFI16;SRD5A3;NR2F6;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;EEF2K;ZNF320;TNRC6C;RCAN1;TET1;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;TRIM38;FADD
17640,GO:1901363,0.999999977549476,3.32597727041941e-08,309,4570,heterocyclic compound binding,MF,XDH;NT5E;NOS1;ERCC1;ZMYND8;ETV5;RAB3B;PCK2;PYGL;CBS;CYGB;RPS6KA2;CYP27B1;SCN8A;PYGB;H1F0;ADCY7;CRYL1;XPOT;ACTA2;GPT2;NR1D1;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;PEG3;MST1R;H6PD;RBMS2;POU2F2;DHTKD1;DGKA;TEF;ZKSCAN2;PC;DDIT3;SMARCA1;HADH;SOX12;CARS;ELK3;SNTB2;LTA4H;BRSK1;EGFR;STK39;FYN;HEBP1;MYH15;HLTF;KIF13B;SPATS2;ERCC6;UBE2J1;MAPK13;ZNF516;IDH2;DHX32;ZSCAN30;TGM2;XPC;GLUL;FKBP9;ACSF2;IGF2BP3;MAP4K4;TTBK2;SPTLC2;GRK5;HTR7;NMRK1;STRADB;NME4;ACAD11;SEPT10;SLFN5;PAK1;NEK9;ZNF652;CBR4;RAG1;TGFBR2;NUCB2;EPHA1;RAC2;OBSCN;FKBP1A;ATP7B;ABCD1;TIGD2;CDK17;ZNF862;PRKACB;ZNF624;LRP1;LDHA;FYCO1;IDE;AKAP9;ZCCHC14;FAM208A;ABTB1;UBE2G1;DDN;HMGA2;ATF4;PPARA;ABCA7;EIF4E3;KIF21B;ASNS;FGFR1;AARS;E2F5;TCFL5;NFAT5;PTK6;ULK2;ZNF559;ZNF81;LONP2;ATRX;FAM20C;MTHFR;ABCG1;FKBP10;SOX4;APOBEC3C;DDB2;ENDOV;ZNF558;MAPKAPK3;ZNF692;RAB31;MRPS6;RCOR1;NLK;XRN1;TCEA1;TNRC6B;CLCN3;HES2;ANXA6;ZBTB10;ACAD10;PHF12;CTH;ZNF704;FAM50A;ZMYM3;KLF12;TWF2;TRIB3;VPS11;SEC63;ZNF322;MEX3C;RFX2;HIBADH;APLP2;SLK;PRDX5;CEBPG;PLAG1;CDC42BPA;SCYL3;DDX60;UHRF2;TAOK1;PHC3;AEBP1;ATP10D;CSNK2A1;PHF1;TST;CHD7;NDUFV3;PRKAR1A;PARP9;CPEB4;ATXN2;MAST3;NACC2;SEPT5;LACTB2;ZNF337;THRA;ACVR1B;ZNF280D;PPP1R10;PSKH1;GLUD1;HSPA13;TSHZ1;MARK4;ZNF449;CHD6;NUDT6;PER3;MTA1;YTHDC2;MEF2D;NYNRIN;ARF4;H2AFJ;POLL;XBP1;PANK4;TXNRD3;MAP2K2;SATB1;GPATCH8;PAIP1;CYP4F22;RET;TUBG2;PDE5A;RAB43;MLH3;THAP10;NOP10;GTF2IRD2;DNASE1L1;PAK6;UBE2E1;PUM2;ETV1;PRKACA;ZNF398;NEK6;TMSB4X;EIF2AK2;RAB1A;ZDHHC1;EEPD1;IFI16;RHOBTB1;NR2F6;SBNO1;LTB4R;FICD;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;ZSCAN18;LARP1B;MAP4K2;ZMYM2;PPARG;TMEM63A;ZFP30;GRB7;ATP12A;ZNF37A;TBX1;CREB3L2;ATP6V1B2;AK9;AKT3;GARS;ENDOG;ATP11B;PHF21A;ZBTB40;ZNF92;ZNF568;HSPA2;ZNF107;FLNB;ARID5B;ZNF165;TMEM173;E2F7;EEF2K;ZNF320;TNRC6C;RCAN1;TET1;ZC3H7A;DEDD2;FOXP1;ZBTB33;AOX1;ADCY1;KAT2B;SEPT6;OAS1;PANK1;PRMT3;N4BP2;PBX3;JARID2;MXD4;ADNP;GNAI1;RFX7;DNMT3A;ALAS1
8852,GO:0034645,0.999999984430604,2.35677787459263e-08,262,4040,cellular macromolecule biosynthetic process,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;NEURL1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;MAP2K1;ETV4;ACVR2B;ZKSCAN1;LMF1;SALL2;TK2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;POU2F2;LY6K;TEF;EIF4EBP1;ZKSCAN2;DDIT3;B4GALT6;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;UBE2J1;MAPK13;PGM1;ADAMTS7;ZNF516;DLG1;B3GNT3;DNAJB5;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;MCFD2;PKD2;ZNF862;ZNF624;RBCK1;ST3GAL5;FAM208A;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;PIGH;WWC3;EIF4E3;FGFR1;AARS;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ITGA2;GALNT3;ZNF559;INTS8;ZNF81;ATRX;CHURC1;ABCG1;SOX4;FHOD1;ZNF558;ZNF692;LMAN1;ATF7IP;MRPS6;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ABHD17C;ZMYM3;KLF12;CST3;TRIB3;NTNG1;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;RFX2;ZDHHC2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;CPEB4;ATXN2;NACC2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;MEF2D;ARF4;H2AFJ;POLL;XBP1;MAP2K2;SATB1;PAIP1;TLE4;RET;LOXL2;THAP10;NOP10;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;CCDC88A;ADAMTSL1;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;ZDHHC1;CBX7;IFI16;SRD5A3;NR2F6;SCAND1;IL1RAP;SBNO1;ST6GALNAC2;CARD11;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;EEF2K;ZNF320;TNRC6C;RCAN1;TET1;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;STT3B;RB1CC1;DNMT3A;TRIM38;FADD
2476,GO:0005694,0.99999998786957,2.95698105063037e-08,34,882,chromosome,CC,ERCC1;H1F0;NR1D1;SALL2;APPL2;SMARCA1;CAPN2;SCMH1;CCND2;FAM208A;HMGA2;ATRX;PHF12;ETAA1;UHRF2;CSNK2A1;PHF1;PARP9;NACC2;PPP1R10;MEF2D;H2AFJ;SATB1;REC8;LOXL2;MLH3;CBX7;RNF169;RSF1;HSPA2;PSEN2;KAT2B;SEPT6;DNMT3A
8848,GO:0034641,0.999999992930402,1.05826798770608e-08,341,5137,cellular nitrogen compound metabolic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;CCND1;NEURL1;PCK2;CTNNBIP1;VLDLR;CBS;ITGA6;H1F0;ADCY7;IGFBP4;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;H6PD;APLN;RBMS2;POU2F2;DHTKD1;TEF;EIF4EBP1;ZKSCAN2;PC;DDIT3;B4GALT6;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;LTA4H;EGFR;BCORL1;PSAT1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;PGM1;ZNF516;DLG1;DLG4;IDH2;DNAJB5;DHX32;ZSCAN30;XPC;HTRA1;GLO1;WNT7A;PGLS;IGF2BP3;SPTLC2;ACOT7;RSAD1;NMRK1;NME4;ARG2;SHC1;NAGS;DLG3;DKK1;DAP;KIAA1549;ZNF652;RAG1;HAGH;IMPACT;ERO1B;APOE;CCPG1;ACP5;ALDH1L2;RGS14;PKD2;ZNF862;ZNF624;RBCK1;LDHA;ST3GAL5;IDE;AKAP9;FAM208A;ABTB1;DDN;ANXA3;HMGA2;ATF4;PPARA;ABCA7;WWC3;EIF4E3;ASNS;FGFR1;AARS;E2F5;EPCAM;TCFL5;RNPEPL1;UROS;NFAT5;BTRC;ITGA2;ZNF559;INTS8;ZNF81;CHAC1;ATRX;FAM20C;CHURC1;MTHFR;AHCYL2;ABCG1;SOX4;APOBEC3C;FHOD1;DDB2;GAMT;ENDOV;ZNF558;ZNF692;ATF7IP;MRPS6;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ZMYM3;KLF12;CST3;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;MEX3C;RFX2;PRDX5;CEBPG;ALDH7A1;PLAG1;F2RL1;UHRF2;SLC2A9;TAOK1;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;NDUFV3;PRKAR1A;MSRB2;JMY;PARP9;CPEB4;ATXN2;NACC2;LACTB2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;AZIN2;CRAT;RNF165;YTHDC2;PM20D2;MEF2D;NYNRIN;ARF4;H2AFJ;POLL;UAP1;XBP1;PANK4;MAP2K2;SATB1;PAIP1;REC8;TLE4;RET;LOXL2;PDE5A;MLH3;THAP10;NOP10;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;PUM2;ETV1;CCDC88A;SAMD8;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;EEPD1;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;SECISBP2L;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;ARID4A;NIT2;BLVRA;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;GRB7;ZNF37A;TBX1;CREB3L2;ATP6V1B2;AK9;RSF1;ADAM8;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;OSGEPL1;FZD8;WASL;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;E2F7;EEF2K;ZNF320;CMTR2;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;DNAJC3;FOXP1;ZBTB33;PSEN2;AOX1;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;PANK1;PRMT3;UFL1;N4BP2;PBX3;JARID2;SLC23A2;KLHL15;SLC44A1;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FADD
17637,GO:1901360,0.999999994564429,8.19924117125392e-09,320,4856,organic cyclic compound metabolic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ERCC1;ZMYND8;F2R;SORL1;ETV5;CCND1;PCK2;CTNNBIP1;VLDLR;CBS;ITGA6;CYP27B1;H1F0;PRSS3;ADCY7;IGFBP4;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;LMF1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;H6PD;APLN;RBMS2;POU2F2;DHTKD1;TEF;ZKSCAN2;PC;DDIT3;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;EGFR;BCORL1;PSAT1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;PGM1;ZNF516;DLG1;DLG4;IDH2;DNAJB5;DHX32;ZSCAN30;XPC;HTRA1;GLO1;WNT7A;PGLS;IGF2BP3;ACOT7;RSAD1;NMRK1;NME4;SHC1;DLG3;DKK1;DAP;KIAA1549;ZNF652;CBR4;RAG1;IMPACT;PLPP6;APOE;CCPG1;ACP5;ALDH1L2;RGS14;PKD2;ZNF862;ZNF624;RBCK1;LDHA;AKAP9;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;AARS;E2F5;EPCAM;TCFL5;UROS;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;FAM20C;CHURC1;MTHFR;AHCYL2;ABCG1;SOX4;APOBEC3C;FHOD1;DDB2;GAMT;ENDOV;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ZMYM3;KLF12;CST3;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;SLC2A9;TAOK1;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;NDUFV3;PRKAR1A;MSRB2;JMY;PARP9;ATXN2;NACC2;LACTB2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;YTHDC2;PM20D2;MEF2D;NYNRIN;ARF4;H2AFJ;POLL;UAP1;HSD17B7;XBP1;PANK4;MAP2K2;SATB1;PAIP1;REC8;TLE4;TRPC1;RET;LOXL2;PDE5A;MLH3;OSBPL5;THAP10;NOP10;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;PUM2;ETV1;CCDC88A;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;EEPD1;CBX7;IFI16;SRD5A3;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;RNF169;HOXA3;ARID4A;BLVRA;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;ATP6V1B2;AK9;RSF1;ADAM8;ALDH4A1;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;IGFBP7;OSGEPL1;FZD8;WASL;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;E2F7;ZNF320;CMTR2;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;FOXP1;ZBTB33;AOX1;HSD17B12;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;PANK1;PRMT3;UFL1;N4BP2;AMACR;PBX3;JARID2;SLC23A2;KLHL15;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FADD
11696,GO:0046483,0.999999996208251,5.78279448922994e-09,308,4709,heterocycle metabolic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ERCC1;ZMYND8;F2R;ETV5;CCND1;PCK2;CTNNBIP1;VLDLR;CBS;ITGA6;H1F0;PRSS3;ADCY7;IGFBP4;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;H6PD;APLN;RBMS2;POU2F2;DHTKD1;TEF;ZKSCAN2;PC;DDIT3;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;EGFR;BCORL1;PSAT1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;PGM1;ZNF516;DLG1;DLG4;IDH2;DNAJB5;DHX32;ZSCAN30;XPC;HTRA1;GLO1;WNT7A;PGLS;IGF2BP3;ACOT7;RSAD1;NMRK1;NME4;SHC1;DLG3;DKK1;DAP;KIAA1549;ZNF652;RAG1;IMPACT;APOE;CCPG1;ACP5;ALDH1L2;RGS14;PKD2;ZNF862;ZNF624;RBCK1;LDHA;AKAP9;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;AARS;E2F5;EPCAM;TCFL5;UROS;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;FAM20C;CHURC1;MTHFR;AHCYL2;ABCG1;SOX4;APOBEC3C;FHOD1;DDB2;GAMT;ENDOV;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ZMYM3;KLF12;CST3;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;SLC2A9;TAOK1;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;NDUFV3;PRKAR1A;MSRB2;JMY;PARP9;ATXN2;NACC2;LACTB2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;YTHDC2;PM20D2;MEF2D;NYNRIN;ARF4;H2AFJ;POLL;UAP1;XBP1;PANK4;MAP2K2;SATB1;PAIP1;REC8;TLE4;RET;LOXL2;PDE5A;MLH3;THAP10;NOP10;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;PUM2;ETV1;CCDC88A;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;EEPD1;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;RNF169;HOXA3;ARID4A;BLVRA;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;ATP6V1B2;AK9;RSF1;ADAM8;ALDH4A1;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;OSGEPL1;FZD8;WASL;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;E2F7;ZNF320;CMTR2;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;FOXP1;ZBTB33;AOX1;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;PANK1;PRMT3;UFL1;N4BP2;PBX3;JARID2;SLC23A2;KLHL15;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FADD
8787,GO:0034470,0.9999999967063,2.1559156996256e-08,5,396,ncRNA processing,BP,AARS;INTS8;CHD7;NOP10;OSGEPL1
5333,GO:0016070,0.999999997341347,4.20878017004276e-09,236,3757,RNA metabolic process,BP,TNIP1;SMURF2;NOS1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;ITGA6;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;RBMS2;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;DHX32;ZSCAN30;HTRA1;GLO1;WNT7A;IGF2BP3;SHC1;DKK1;DAP;KIAA1549;ZNF652;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;AARS;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;CHURC1;ABCG1;SOX4;APOBEC3C;FHOD1;ENDOV;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ZMYM3;KLF12;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;ATXN2;NACC2;LACTB2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;YTHDC2;MEF2D;ARF4;H2AFJ;XBP1;MAP2K2;SATB1;PAIP1;TLE4;RET;LOXL2;THAP10;NOP10;RMRP;GTF2IRD2;PAK6;EAPP;PUM2;ETV1;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;GARS;WFS1;DEPDC1;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;OSGEPL1;FZD8;WASL;ZNF107;LRP6;ARID5B;ZNF165;TMEM173;E2F7;ZNF320;CMTR2;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;OAS1;PRMT3;UFL1;PBX3;JARID2;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
3135,GO:0006725,0.999999998448176,2.42723526360541e-09,307,4723,cellular aromatic compound metabolic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ERCC1;ZMYND8;F2R;ETV5;CCND1;PCK2;CTNNBIP1;VLDLR;CBS;ITGA6;H1F0;PRSS3;ADCY7;IGFBP4;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;H6PD;APLN;RBMS2;POU2F2;DHTKD1;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;EGFR;BCORL1;PSAT1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;PGM1;ZNF516;DLG1;DLG4;IDH2;DNAJB5;DHX32;ZSCAN30;XPC;HTRA1;GLO1;WNT7A;PGLS;IGF2BP3;ACOT7;RSAD1;NMRK1;NME4;SHC1;DLG3;DKK1;DAP;KIAA1549;ZNF652;CBR4;RAG1;IMPACT;APOE;CCPG1;ALDH1L2;RGS14;PKD2;ZNF862;ZNF624;RBCK1;LDHA;AKAP9;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;AARS;E2F5;EPCAM;TCFL5;UROS;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;FAM20C;CHURC1;MTHFR;AHCYL2;ABCG1;SOX4;APOBEC3C;FHOD1;DDB2;GAMT;ENDOV;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ZMYM3;KLF12;CST3;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;SLC2A9;TAOK1;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;NDUFV3;PRKAR1A;MSRB2;JMY;PARP9;ATXN2;NACC2;LACTB2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;YTHDC2;PM20D2;MEF2D;NYNRIN;ARF4;H2AFJ;POLL;UAP1;XBP1;PANK4;MAP2K2;SATB1;PAIP1;REC8;TLE4;TRPC1;RET;LOXL2;PDE5A;MLH3;THAP10;NOP10;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;PUM2;ETV1;CCDC88A;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;EEPD1;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;RNF169;HOXA3;ARID4A;BLVRA;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;ATP6V1B2;AK9;RSF1;ADAM8;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;OSGEPL1;FZD8;WASL;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;RNF180;E2F7;ZNF320;CMTR2;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;FOXP1;ZBTB33;AOX1;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;PANK1;PRMT3;UFL1;N4BP2;PBX3;JARID2;SLC23A2;KLHL15;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;ALAS1;TRIM38;FADD
9915,GO:0042254,0.999999998510982,1.91444355972065e-08,2,317,ribosome biogenesis,BP,CHD7;NOP10
8863,GO:0034660,0.999999999441859,2.62797235484776e-09,10,545,ncRNA metabolic process,BP,POU2F2;CARS;AARS;INTS8;XRN1;CHD7;NOP10;GARS;OSGEPL1;DEDD2
19656,GO:1990904,0.999999999445209,1.95741721963256e-09,17,701,ribonucleoprotein complex,CC,BTBD2;DHX32;IMPACT;PITPNM1;APOBEC3C;MRPS6;XRN1;TRIM5;TNRC6B;CPEB4;ATXN2;NOP10;RMRP;PUM2;EIF2AK2;GRB7;PRMT3
8231,GO:0032991,0.999999999554112,7.92401269055929e-10,234,3842,protein-containing complex,CC,SMURF2;NOS1;ERCC1;SORL1;CCND1;CTNNBIP1;VLDLR;SYNE3;ITGA6;SCN8A;CLIP2;H1F0;ADCY7;PRNP;ITGB4;XPOT;BBS2;BTBD2;NR1D1;NFATC4;ACVR2B;LTBP1;SALL2;COL13A1;WWTR1;MST1R;WDR66;DHTKD1;APPL2;MAP1B;DDIT3;KCNG1;SMARCA1;SOX12;PSMD2;LAMB1;EXOC2;SNTB2;EGFR;MYH15;JADE2;KIF13B;ERCC6;UBXN7;DLG1;DLG4;PLXNB3;DHX32;ESPN;XPC;SPTLC2;WDFY3;SEC23A;CRTAP;SEPT10;SHC1;DLG3;PAK1;CEP170;CBR4;TGFBR2;NUDCD3;SHANK2;EPHA1;IMPACT;CD44;APOE;FKBP1A;CCND2;PTPN12;PKD2;PRKACB;RBCK1;LRP1;FYCO1;IDE;AKAP9;PPP2R3B;ABTB1;HMGA2;ATF4;PPARA;ABCA7;PIGH;EIF4E3;KIF21B;FGFR1;ITGA1;E2F5;NFAT5;ITGB5;DCAF10;BTRC;ITGA2;VAMP2;INTS8;ATRX;SOX4;RMND5A;PITPNM1;APOBEC3C;ITPR3;FBXO2;DDB2;CEACAM1;FERMT1;OBSL1;DMXL2;ATF7IP;MRPS6;RCOR1;EPN2;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;PHF12;MVB12B;LRP5;SEC22C;RABGGTA;CLTCL1;CASP4;VPS11;RANBP9;BTBD3;PPP3CB;TTYH3;COPB1;COPG1;PHC3;CSNK2A1;PHF1;PSMD7;ASAP1;NDUFV3;PRKAR1A;ANO1;PARP9;CPEB4;SDCCAG3;ATXN2;KLHL29;NACC2;SEPT5;THRA;ACVR1B;NDUFA4L2;COL6A1;PPP1R10;MVB12A;CHD6;BCL2L1;MYH16;GRIN3B;WASF2;H2AFJ;ANAPC13;PCYOX1;ABHD6;PPP1R2;REC8;ANKIB1;TLE4;TRPC1;RET;TUBG2;STX10;TCTN1;MLH3;SH3PXD2B;C5;ZFYVE9;NOP10;NCKAP1;RMRP;UBE2E1;PUM2;COL1A2;PRKACA;NEK6;TMSB4X;EIF2AK2;SEL1L;CBX7;AP2A2;CARD11;LAMB2;TBL1X;AP3D1;ARID4A;ARPC1A;ITPR2;LAMA5;GRB10;EFCAB7;PPARG;SNX6;GRB7;ATP12A;ATP6V1B2;RSF1;ADAM8;WFS1;DEPDC1;ITGA4;PHF21A;WDR60;OSGEPL1;FZD8;TMEM107;HSPA2;LRP6;E2F7;DNAJC3;PSEN2;ADCY1;KAT2B;SEPT6;COG8;CNOT11;PANK1;PRMT3;SNX27;PBX3;JARID2;KLHL15;GNAI1;LRP4;STT3B;RB1CC1;FBXL5;FADD
2744,GO:0006139,0.999999999908864,2.32177467893861e-10,294,4607,nucleobase-containing compound metabolic process,BP,TNIP1;XDH;NT5E;SMURF2;NOS1;ERCC1;ZMYND8;F2R;ETV5;CCND1;PCK2;CTNNBIP1;VLDLR;CBS;ITGA6;H1F0;ADCY7;IGFBP4;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;RAPGEF3;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;NAPRT;WWTR1;PEG3;ARHGAP22;H6PD;APLN;RBMS2;POU2F2;DHTKD1;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;PGM1;ZNF516;DLG1;DLG4;IDH2;DNAJB5;DHX32;ZSCAN30;XPC;HTRA1;GLO1;WNT7A;PGLS;IGF2BP3;ACOT7;NMRK1;NME4;SHC1;DLG3;DKK1;DAP;KIAA1549;ZNF652;RAG1;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;LDHA;AKAP9;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;AARS;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;FAM20C;CHURC1;AHCYL2;ABCG1;SOX4;APOBEC3C;FHOD1;DDB2;GAMT;ENDOV;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ZMYM3;KLF12;CST3;TRIB3;GFPT1;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;TAOK1;AEBP1;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;NDUFV3;PRKAR1A;MSRB2;JMY;PARP9;ATXN2;NACC2;LACTB2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;YTHDC2;MEF2D;NYNRIN;ARF4;H2AFJ;POLL;UAP1;XBP1;PANK4;MAP2K2;SATB1;PAIP1;REC8;TLE4;RET;LOXL2;PDE5A;MLH3;THAP10;NOP10;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;PUM2;ETV1;CCDC88A;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;TIMP2;EIF2AK2;EEPD1;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;RNF169;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;ATP6V1B2;AK9;RSF1;ADAM8;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;OSGEPL1;FZD8;WASL;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;E2F7;ZNF320;CMTR2;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;FOXP1;ZBTB33;AOX1;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;PANK1;PRMT3;UFL1;N4BP2;PBX3;JARID2;SLC23A2;KLHL15;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
7599,GO:0031974,0.999999999932995,1.72236239238518e-10,266,4304,membrane-enclosed lumen,CC,TNIP1;DOCK4;NT5E;SMURF2;EPN3;TSPAN1;NOS1;ERCC1;SORL1;ETV5;CCND1;PCK2;CTNNBIP1;PYGL;NOL4L;CYGB;RPS6KA2;PYGB;H1F0;PRSS3;IGFBP4;XPOT;GPT2;NR1D1;NFATC4;ADARB1;ETV4;LTBP1;SALL2;COL13A1;TK2;PKN1;NAPRT;WWTR1;H6PD;POU2F2;TRIM65;DHTKD1;PITPNC1;APPL2;PC;DDIT3;SMARCA1;HADH;SOX12;PSMD2;LAMB1;ELK3;CRTC1;LTA4H;BRSK1;EGFR;TBC1D14;STK39;BCORL1;JADE2;BNIP3;HLTF;SCMH1;ERCC6;UBXN7;ARAP1;PGM1;ADAMTS7;IDH2;CTSB;GPC4;PODXL;XPC;WNT7A;ACSF2;ACOT7;WDFY3;GRK5;NME4;CRTAP;VWA5A;SDC1;ARG2;SHC1;NAGS;CBR4;RAG1;SERPING1;LCN2;HAGH;OBSCN;APOE;BNIP3L;CCND2;KLHDC2;PTPN12;ALDH1L2;RGS14;PRKACB;IDE;FAM208A;PPP2R3B;ABTB1;HMGA2;ATF4;PPARA;FGFR1;ABHD10;E2F5;FAM114A1;PTPDC1;NFAT5;HYAL1;DCAF10;BTRC;PTK6;INTS8;LONP2;ATRX;FAM20C;FKBP10;SOX4;ITPR3;DDB2;ENDOV;MAPKAPK3;ZNF692;PDIA5;ATF7IP;MRPS6;RCOR1;SH3D19;NLK;TCEA1;MMP14;ZBTB10;ACAD10;PHF12;FAM50A;ETAA1;ZMYM3;KLF12;CTSL;CST3;RABGGTA;PCSK6;L3MBTL3;DNAJB9;PPP3CB;HIBADH;APLP2;PRDX5;MLYCD;CEBPG;ALDH7A1;PLAG1;ANO8;UHRF2;C6ORF120;PHC3;ATP10D;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;QSOX1;NDUFV3;CPT2;JMY;PARP9;NACC2;LACTB2;THRA;MGLL;COL6A1;NGFR;PPP1R10;PSKH1;MVB12A;GLUD1;CHD6;MTA1;BCL2L1;CRAT;PM20D2;MEF2D;GLB1;SKAP2;H2AFJ;POLL;YPEL5;UAP1;XBP1;SPIRE1;NFU1;SATB1;REC8;TLE4;SDR9C7;FAM222B;LOXL2;VWA1;MLH3;MCTP2;NOP10;GTF2IRD2;DNASE1L1;PAK6;UBE2E1;COL1A2;ADAMTSL1;PRKACA;NEK6;TMSB4X;TIMP2;S100PBP;PCDH1;CBX7;IFI16;NR2F6;FCHO1;LAMB2;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;ARID4A;NIT2;TENM2;IGF2;ACP6;ZMYM2;ERLEC1;PPARG;CITED4;EVA1A;CREB3L2;ERP44;AK9;RSF1;ALDH4A1;GARS;WFS1;PHF21A;MPLKIP;MAML3;IGFBP7;HSPA2;ARID5B;E2F7;PPT2;HPSE;GALNS;DEDD2;DNAJC3;FOXP1;ZBTB33;KAT2B;OAS1;VSIG10L;SNX27;AMACR;JARID2;SLC44A1;GNAI1;DNMT3A;ALAS1
10402,GO:0043233,0.999999999932995,1.72236239238518e-10,266,4304,organelle lumen,CC,TNIP1;DOCK4;NT5E;SMURF2;EPN3;TSPAN1;NOS1;ERCC1;SORL1;ETV5;CCND1;PCK2;CTNNBIP1;PYGL;NOL4L;CYGB;RPS6KA2;PYGB;H1F0;PRSS3;IGFBP4;XPOT;GPT2;NR1D1;NFATC4;ADARB1;ETV4;LTBP1;SALL2;COL13A1;TK2;PKN1;NAPRT;WWTR1;H6PD;POU2F2;TRIM65;DHTKD1;PITPNC1;APPL2;PC;DDIT3;SMARCA1;HADH;SOX12;PSMD2;LAMB1;ELK3;CRTC1;LTA4H;BRSK1;EGFR;TBC1D14;STK39;BCORL1;JADE2;BNIP3;HLTF;SCMH1;ERCC6;UBXN7;ARAP1;PGM1;ADAMTS7;IDH2;CTSB;GPC4;PODXL;XPC;WNT7A;ACSF2;ACOT7;WDFY3;GRK5;NME4;CRTAP;VWA5A;SDC1;ARG2;SHC1;NAGS;CBR4;RAG1;SERPING1;LCN2;HAGH;OBSCN;APOE;BNIP3L;CCND2;KLHDC2;PTPN12;ALDH1L2;RGS14;PRKACB;IDE;FAM208A;PPP2R3B;ABTB1;HMGA2;ATF4;PPARA;FGFR1;ABHD10;E2F5;FAM114A1;PTPDC1;NFAT5;HYAL1;DCAF10;BTRC;PTK6;INTS8;LONP2;ATRX;FAM20C;FKBP10;SOX4;ITPR3;DDB2;ENDOV;MAPKAPK3;ZNF692;PDIA5;ATF7IP;MRPS6;RCOR1;SH3D19;NLK;TCEA1;MMP14;ZBTB10;ACAD10;PHF12;FAM50A;ETAA1;ZMYM3;KLF12;CTSL;CST3;RABGGTA;PCSK6;L3MBTL3;DNAJB9;PPP3CB;HIBADH;APLP2;PRDX5;MLYCD;CEBPG;ALDH7A1;PLAG1;ANO8;UHRF2;C6ORF120;PHC3;ATP10D;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;QSOX1;NDUFV3;CPT2;JMY;PARP9;NACC2;LACTB2;THRA;MGLL;COL6A1;NGFR;PPP1R10;PSKH1;MVB12A;GLUD1;CHD6;MTA1;BCL2L1;CRAT;PM20D2;MEF2D;GLB1;SKAP2;H2AFJ;POLL;YPEL5;UAP1;XBP1;SPIRE1;NFU1;SATB1;REC8;TLE4;SDR9C7;FAM222B;LOXL2;VWA1;MLH3;MCTP2;NOP10;GTF2IRD2;DNASE1L1;PAK6;UBE2E1;COL1A2;ADAMTSL1;PRKACA;NEK6;TMSB4X;TIMP2;S100PBP;PCDH1;CBX7;IFI16;NR2F6;FCHO1;LAMB2;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;ARID4A;NIT2;TENM2;IGF2;ACP6;ZMYM2;ERLEC1;PPARG;CITED4;EVA1A;CREB3L2;ERP44;AK9;RSF1;ALDH4A1;GARS;WFS1;PHF21A;MPLKIP;MAML3;IGFBP7;HSPA2;ARID5B;E2F7;PPT2;HPSE;GALNS;DEDD2;DNAJC3;FOXP1;ZBTB33;KAT2B;OAS1;VSIG10L;SNX27;AMACR;JARID2;SLC44A1;GNAI1;DNMT3A;ALAS1
14526,GO:0070013,0.999999999932995,1.72236239238518e-10,266,4304,intracellular organelle lumen,CC,TNIP1;DOCK4;NT5E;SMURF2;EPN3;TSPAN1;NOS1;ERCC1;SORL1;ETV5;CCND1;PCK2;CTNNBIP1;PYGL;NOL4L;CYGB;RPS6KA2;PYGB;H1F0;PRSS3;IGFBP4;XPOT;GPT2;NR1D1;NFATC4;ADARB1;ETV4;LTBP1;SALL2;COL13A1;TK2;PKN1;NAPRT;WWTR1;H6PD;POU2F2;TRIM65;DHTKD1;PITPNC1;APPL2;PC;DDIT3;SMARCA1;HADH;SOX12;PSMD2;LAMB1;ELK3;CRTC1;LTA4H;BRSK1;EGFR;TBC1D14;STK39;BCORL1;JADE2;BNIP3;HLTF;SCMH1;ERCC6;UBXN7;ARAP1;PGM1;ADAMTS7;IDH2;CTSB;GPC4;PODXL;XPC;WNT7A;ACSF2;ACOT7;WDFY3;GRK5;NME4;CRTAP;VWA5A;SDC1;ARG2;SHC1;NAGS;CBR4;RAG1;SERPING1;LCN2;HAGH;OBSCN;APOE;BNIP3L;CCND2;KLHDC2;PTPN12;ALDH1L2;RGS14;PRKACB;IDE;FAM208A;PPP2R3B;ABTB1;HMGA2;ATF4;PPARA;FGFR1;ABHD10;E2F5;FAM114A1;PTPDC1;NFAT5;HYAL1;DCAF10;BTRC;PTK6;INTS8;LONP2;ATRX;FAM20C;FKBP10;SOX4;ITPR3;DDB2;ENDOV;MAPKAPK3;ZNF692;PDIA5;ATF7IP;MRPS6;RCOR1;SH3D19;NLK;TCEA1;MMP14;ZBTB10;ACAD10;PHF12;FAM50A;ETAA1;ZMYM3;KLF12;CTSL;CST3;RABGGTA;PCSK6;L3MBTL3;DNAJB9;PPP3CB;HIBADH;APLP2;PRDX5;MLYCD;CEBPG;ALDH7A1;PLAG1;ANO8;UHRF2;C6ORF120;PHC3;ATP10D;CSNK2A1;PHF1;PSMD7;PTHLH;TST;CHD7;QSOX1;NDUFV3;CPT2;JMY;PARP9;NACC2;LACTB2;THRA;MGLL;COL6A1;NGFR;PPP1R10;PSKH1;MVB12A;GLUD1;CHD6;MTA1;BCL2L1;CRAT;PM20D2;MEF2D;GLB1;SKAP2;H2AFJ;POLL;YPEL5;UAP1;XBP1;SPIRE1;NFU1;SATB1;REC8;TLE4;SDR9C7;FAM222B;LOXL2;VWA1;MLH3;MCTP2;NOP10;GTF2IRD2;DNASE1L1;PAK6;UBE2E1;COL1A2;ADAMTSL1;PRKACA;NEK6;TMSB4X;TIMP2;S100PBP;PCDH1;CBX7;IFI16;NR2F6;FCHO1;LAMB2;ZNF354A;CTSZ;TBL1X;RNF169;HOXA3;ARID4A;NIT2;TENM2;IGF2;ACP6;ZMYM2;ERLEC1;PPARG;CITED4;EVA1A;CREB3L2;ERP44;AK9;RSF1;ALDH4A1;GARS;WFS1;PHF21A;MPLKIP;MAML3;IGFBP7;HSPA2;ARID5B;E2F7;PPT2;HPSE;GALNS;DEDD2;DNAJC3;FOXP1;ZBTB33;KAT2B;OAS1;VSIG10L;SNX27;AMACR;JARID2;SLC44A1;GNAI1;DNMT3A;ALAS1
2043,GO:0004790,0.999999999933514,0.924068156556072,0,1,thioether S-methyltransferase activity,MF,
7022,GO:0030748,0.999999999933514,0.924068156556072,0,1,amine N-methyltransferase activity,MF,
17165,GO:0102707,0.999999999933514,0.924068156556072,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
8656,GO:0034203,0.999999999934698,0.895783915132405,0,1,glycolipid translocation,BP,
4296,GO:0009737,0.99999999993606,0.90176969626861,0,1,response to abscisic acid,BP,
4297,GO:0009738,0.99999999993606,0.90176969626861,0,1,abscisic acid-activated signaling pathway,BP,
4310,GO:0009787,0.99999999993606,0.90176969626861,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4311,GO:0009789,0.99999999993606,0.90176969626861,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
15126,GO:0071215,0.99999999993606,0.90176969626861,0,1,cellular response to abscisic acid stimulus,BP,
17655,GO:1901419,0.99999999993606,0.90176969626861,0,1,regulation of response to alcohol,BP,
17656,GO:1901421,0.99999999993606,0.90176969626861,0,1,positive regulation of response to alcohol,BP,
19414,GO:1905957,0.99999999993606,0.90176969626861,0,1,regulation of cellular response to alcohol,BP,
19415,GO:1905959,0.99999999993606,0.90176969626861,0,1,positive regulation of cellular response to alcohol,BP,
28,GO:0000053,0.999999999936227,0.934184495230873,0,1,argininosuccinate metabolic process,BP,
1621,GO:0004055,0.999999999936227,0.934184495230873,0,1,argininosuccinate synthase activity,MF,
12792,GO:0051086,0.99999999993661,0.932181173198798,0,1,chaperone mediated protein folding independent of cofactor,BP,
7656,GO:0032076,0.999999999937368,0.9219620749257,0,1,negative regulation of deoxyribonuclease activity,BP,
9555,GO:0036316,0.999999999937368,0.9219620749257,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
13991,GO:0060703,0.999999999937368,0.9219620749257,0,1,deoxyribonuclease inhibitor activity,MF,
14716,GO:0070346,0.999999999937368,0.9219620749257,0,1,positive regulation of fat cell proliferation,BP,
17616,GO:1901303,0.999999999937368,0.9219620749257,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18018,GO:1902511,0.999999999937368,0.9219620749257,0,1,negative regulation of apoptotic DNA fragmentation,BP,
18496,GO:1903625,0.999999999937368,0.9219620749257,0,1,negative regulation of DNA catabolic process,BP,
2245,GO:0005157,0.999999999937517,0.925786986237622,0,1,macrophage colony-stimulating factor receptor binding,MF,
10037,GO:0042488,0.999999999937517,0.925786986237622,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
13942,GO:0060611,0.999999999937517,0.925786986237622,0,1,mammary gland fat development,BP,
17916,GO:1902228,0.999999999937517,0.925786986237622,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
18655,GO:1903971,0.999999999937517,0.925786986237622,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
18658,GO:1903974,0.999999999937517,0.925786986237622,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18713,GO:1904124,0.999999999937517,0.925786986237622,0,1,microglial cell migration,BP,
18714,GO:1904139,0.999999999937517,0.925786986237622,0,1,regulation of microglial cell migration,BP,
18715,GO:1904141,0.999999999937517,0.925786986237622,0,1,positive regulation of microglial cell migration,BP,
19588,GO:1990682,0.999999999937517,0.925786986237622,0,1,CSF1-CSF1R complex,CC,
6350,GO:0021527,0.999999999938109,0.893796011313173,0,1,spinal cord association neuron differentiation,BP,
16677,GO:0097598,0.999999999938109,0.893796011313173,0,1,sperm cytoplasmic droplet,CC,
14922,GO:0070773,0.999999999939178,0.941596363024822,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15328,GO:0071544,0.999999999939178,0.941596363024822,0,1,diphosphoinositol polyphosphate catabolic process,BP,
15506,GO:0071877,0.999999999939178,0.941596363024822,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
15510,GO:0071881,0.999999999939178,0.941596363024822,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16056,GO:0086096,0.999999999939178,0.941596363024822,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17318,GO:0140193,0.999999999939178,0.941596363024822,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17319,GO:0140194,0.999999999939178,0.941596363024822,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
12091,GO:0048058,0.999999999939402,0.913801550488889,0,1,compound eye corneal lens development,BP,
12367,GO:0048749,0.999999999939402,0.913801550488889,0,1,compound eye development,BP,
470,GO:0001512,0.999999999939423,0.945050556383262,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
18827,GO:1904408,0.999999999939423,0.945050556383262,0,1,melatonin binding,MF,
19312,GO:1905594,0.999999999939423,0.945050556383262,0,1,resveratrol binding,MF,
14319,GO:0061474,0.999999999939758,0.924242468818739,0,1,phagolysosome membrane,CC,
15686,GO:0072209,0.999999999939969,0.919741305883988,0,1,metanephric mesangial cell differentiation,BP,
15709,GO:0072254,0.999999999939969,0.919741305883988,0,1,metanephric glomerular mesangial cell differentiation,BP,
15710,GO:0072255,0.999999999939969,0.919741305883988,0,1,metanephric glomerular mesangial cell development,BP,
17454,GO:1900241,0.999999999939969,0.919741305883988,0,1,positive regulation of phenotypic switching,BP,
19161,GO:1905176,0.999999999939969,0.919741305883988,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
15034,GO:0070976,0.999999999940025,0.922002390137447,0,1,TIR domain binding,MF,
5240,GO:0015862,0.999999999940476,0.927110195179326,0,1,uridine transport,BP,
9384,GO:0035915,0.999999999940593,0.931069943522385,0,1,pore formation in membrane of other organism,BP,
19887,GO:2000374,0.999999999940593,0.931069943522385,0,1,regulation of oxygen metabolic process,BP,
2800,GO:0006256,0.999999999941326,0.919014849613283,0,1,UDP catabolic process,BP,
4086,GO:0009140,0.999999999941326,0.919014849613283,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4134,GO:0009193,0.999999999941326,0.919014849613283,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4135,GO:0009195,0.999999999941326,0.919014849613283,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4160,GO:0009222,0.999999999941326,0.919014849613283,0,1,pyrimidine ribonucleotide catabolic process,BP,
11528,GO:0046048,0.999999999941326,0.919014849613283,0,1,UDP metabolic process,BP,
20264,GO:2001229,0.999999999941349,0.849261476945127,0,1,negative regulation of response to gamma radiation,BP,
19289,GO:1905524,0.999999999941381,0.879994958366614,0,1,negative regulation of protein autoubiquitination,BP,
1792,GO:0004421,0.999999999941911,0.911596557224368,0,1,hydroxymethylglutaryl-CoA synthase activity,MF,
3711,GO:0008218,0.999999999941911,0.911596557224368,0,1,bioluminescence,BP,
4279,GO:0009645,0.999999999941911,0.911596557224368,0,1,response to low light intensity stimulus,BP,
4404,GO:0010142,0.999999999941911,0.911596557224368,0,1,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
11809,GO:0046690,0.999999999941911,0.911596557224368,0,1,response to tellurium ion,BP,
18113,GO:1902767,0.999999999941911,0.911596557224368,0,1,isoprenoid biosynthetic process via mevalonate,BP,
17234,GO:0110025,0.999999999942157,0.917315269780341,0,1,DNA strand resection involved in replication fork processing,BP,
17235,GO:0110026,0.999999999942157,0.917315269780341,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
8899,GO:0034718,0.999999999942269,0.893635338383997,0,1,SMN-Gemin2 complex,CC,
15094,GO:0071105,0.999999999942528,0.898131617680261,0,1,response to interleukin-11,BP,
15203,GO:0071348,0.999999999942528,0.898131617680261,0,1,cellular response to interleukin-11,BP,
10484,GO:0043376,0.999999999942563,0.909945542961602,0,1,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
16594,GO:0097409,0.999999999942678,0.932273916892583,0,1,glial cytoplasmic inclusion,CC,
16597,GO:0097414,0.999999999942678,0.932273916892583,0,1,classical Lewy body,CC,
16620,GO:0097462,0.999999999942678,0.932273916892583,0,1,Lewy neurite,CC,
19431,GO:1990038,0.999999999942678,0.932273916892583,0,1,Lewy body corona,CC,
6885,GO:0030389,0.999999999942914,0.953048377239784,0,1,fructosamine metabolic process,BP,
5395,GO:0016232,0.99999999994309,0.920587707122425,0,1,HNK-1 sulfotransferase activity,MF,
4851,GO:0014063,0.999999999943289,0.944578615064109,0,1,negative regulation of serotonin secretion,BP,
11978,GO:0047273,0.999999999943352,0.913821545012037,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
13181,GO:0051786,0.999999999943352,0.913821545012037,0,1,all-trans-retinol 13,14-reductase activity,MF,
659,GO:0001850,0.999999999943427,0.934162473017207,0,1,complement component C3a binding,MF,
660,GO:0001851,0.999999999943427,0.934162473017207,0,1,complement component C3b binding,MF,
6463,GO:0021784,0.999999999943447,0.953119950091602,0,1,postganglionic parasympathetic fiber development,BP,
2022,GO:0004751,0.999999999943494,0.93403049858737,0,1,ribose-5-phosphate isomerase activity,MF,
7878,GO:0032440,0.99999999994351,0.943192078016388,0,1,2-alkenal reductase [NAD(P)] activity,MF,
19327,GO:1905636,0.99999999994351,0.943192078016388,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
4592,GO:0010700,0.999999999943682,0.916704140616813,0,1,negative regulation of norepinephrine secretion,BP,
7507,GO:0031686,0.999999999943682,0.916704140616813,0,1,A1 adenosine receptor binding,MF,
11049,GO:0045032,0.999999999943682,0.916704140616813,0,1,ADP-activated adenosine receptor activity,MF,
5080,GO:0015317,0.999999999943684,0.936328399058158,0,1,phosphate:proton symporter activity,MF,
6332,GO:0021501,0.999999999943701,0.930474636594553,0,1,prechordal plate formation,BP,
6366,GO:0021547,0.999999999943701,0.930474636594553,0,1,midbrain-hindbrain boundary initiation,BP,
20086,GO:2000742,0.999999999943701,0.930474636594553,0,1,regulation of anterior head development,BP,
20087,GO:2000744,0.999999999943701,0.930474636594553,0,1,positive regulation of anterior head development,BP,
1590,GO:0004001,0.999999999943732,0.930908446688544,0,1,adenosine kinase activity,MF,
2003,GO:0004727,0.999999999943732,0.930908446688544,0,1,prenylated protein tyrosine phosphatase activity,MF,
2759,GO:0006169,0.999999999943732,0.930908446688544,0,1,adenosine salvage,BP,
2763,GO:0006175,0.999999999943732,0.930908446688544,0,1,dATP biosynthetic process,BP,
1840,GO:0004496,0.999999999944154,0.930649296780879,0,1,mevalonate kinase activity,MF,
13449,GO:0052894,0.999999999944154,0.930649296780879,0,1,norspermine:oxygen oxidoreductase activity,MF,
13450,GO:0052895,0.999999999944154,0.930649296780879,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
9811,GO:0042000,0.999999999944282,0.925968774992236,0,1,translocation of peptides or proteins into host,BP,
10722,GO:0044053,0.999999999944282,0.925968774992236,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
13198,GO:0051808,0.999999999944282,0.925968774992236,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14181,GO:0061078,0.999999999944384,0.955261312708034,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
16266,GO:0090323,0.999999999944384,0.955261312708034,0,1,prostaglandin secretion involved in immune response,BP,
18500,GO:1903636,0.999999999944384,0.955261312708034,0,1,regulation of protein import into mitochondrial outer membrane,BP,
18501,GO:1903638,0.999999999944384,0.955261312708034,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
18503,GO:1903645,0.999999999944384,0.955261312708034,0,1,negative regulation of chaperone-mediated protein folding,BP,
3841,GO:0008448,0.999999999944532,0.934052475491243,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
19437,GO:1990070,0.999999999944534,0.951534203766215,0,1,TRAPPI protein complex,CC,
4982,GO:0015105,0.999999999944644,0.942679140573203,0,1,arsenite transmembrane transporter activity,MF,
5161,GO:0015700,0.999999999944644,0.942679140573203,0,1,arsenite transport,BP,
7501,GO:0031673,0.999999999944891,0.830768777857135,0,1,H zone,CC,
1825,GO:0004478,0.999999999944988,0.920520112805111,0,1,methionine adenosyltransferase activity,MF,
5967,GO:0018395,0.999999999945047,0.909832208631183,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6559,GO:0021998,0.999999999945047,0.909832208631183,0,1,neural plate mediolateral regionalization,BP,
8522,GO:0033746,0.999999999945047,0.909832208631183,0,1,histone demethylase activity (H3-R2 specific),MF,
8523,GO:0033749,0.999999999945047,0.909832208631183,0,1,histone demethylase activity (H4-R3 specific),MF,
12191,GO:0048338,0.999999999945047,0.909832208631183,0,1,mesoderm structural organization,BP,
12195,GO:0048352,0.999999999945047,0.909832208631183,0,1,paraxial mesoderm structural organization,BP,
14556,GO:0070077,0.999999999945047,0.909832208631183,0,1,histone arginine demethylation,BP,
14557,GO:0070078,0.999999999945047,0.909832208631183,0,1,histone H3-R2 demethylation,BP,
14558,GO:0070079,0.999999999945047,0.909832208631183,0,1,histone H4-R3 demethylation,BP,
18828,GO:1904412,0.999999999945047,0.909832208631183,0,1,regulation of cardiac ventricle development,BP,
18829,GO:1904414,0.999999999945047,0.909832208631183,0,1,positive regulation of cardiac ventricle development,BP,
19195,GO:1905285,0.999999999945047,0.909832208631183,0,1,fibrous ring of heart morphogenesis,BP,
1615,GO:0004044,0.999999999945076,0.908274684121605,0,1,amidophosphoribosyltransferase activity,MF,
17907,GO:1902216,0.999999999945138,0.87984161462203,0,1,positive regulation of interleukin-4-mediated signaling pathway,BP,
5456,GO:0016332,0.999999999945554,0.906363734566342,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
15589,GO:0072060,0.999999999945554,0.906363734566342,0,1,outer medullary collecting duct development,BP,
2352,GO:0005427,0.999999999945703,0.91614831227785,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
5084,GO:0015322,0.999999999945703,0.91614831227785,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5974,GO:0018455,0.999999999945831,0.942745171805835,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
19505,GO:1990384,0.999999999945831,0.942745171805835,0,1,hyaloid vascular plexus regression,BP,
2300,GO:0005275,0.999999999945834,0.917791075233081,0,1,amine transmembrane transporter activity,MF,
5057,GO:0015265,0.999999999945834,0.917791075233081,0,1,urea channel activity,MF,
13962,GO:0060668,0.999999999945954,0.909882547349642,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
10429,GO:0043273,0.999999999945968,0.893770252089429,0,1,CTPase activity,MF,
11998,GO:0047395,0.999999999945984,0.918960487570402,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12020,GO:0047620,0.999999999945984,0.918960487570402,0,1,acylglycerol kinase activity,MF,
7270,GO:0031249,0.999999999946052,0.925867764932351,0,1,denatured protein binding,MF,
17978,GO:1902380,0.999999999946052,0.925867764932351,0,1,positive regulation of endoribonuclease activity,BP,
18957,GO:1904722,0.999999999946052,0.925867764932351,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
1516,GO:0003877,0.999999999946098,0.930133297078152,0,1,ATP adenylyltransferase activity,MF,
2070,GO:0004824,0.999999999946098,0.930133297078152,0,1,lysine-tRNA ligase activity,MF,
2920,GO:0006430,0.999999999946098,0.930133297078152,0,1,lysyl-tRNA aminoacylation,BP,
16824,GO:0098705,0.999999999946122,0.89818210826545,0,1,copper ion import across plasma membrane,BP,
7406,GO:0031475,0.999999999946156,0.938853119127979,0,1,myosin V complex,CC,
3970,GO:0008768,0.999999999946183,0.949823076706942,0,1,UDP-sugar diphosphatase activity,MF,
780,GO:0002037,0.99999999994622,0.929945755548579,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
14535,GO:0070037,0.999999999946271,0.946598290899461,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
858,GO:0002189,0.999999999946279,0.924329636711923,0,1,ribose phosphate diphosphokinase complex,CC,
4698,GO:0010856,0.999999999946305,0.914235579896879,0,1,adenylate cyclase activator activity,MF,
19629,GO:1990796,0.999999999946328,0.918838155599216,0,1,photoreceptor cell terminal bouton,CC,
1831,GO:0004486,0.999999999946332,0.911752449426787,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
11733,GO:0046544,0.999999999946381,0.895763101523995,0,1,development of secondary male sexual characteristics,BP,
949,GO:0002368,0.999999999946469,0.927313578624657,0,1,B cell cytokine production,BP,
1194,GO:0002842,0.999999999946469,0.927313578624657,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
9565,GO:0036351,0.999999999946469,0.927313578624657,0,1,histone H2A-K13 ubiquitination,BP,
9566,GO:0036352,0.999999999946469,0.927313578624657,0,1,histone H2A-K15 ubiquitination,BP,
2119,GO:0004910,0.99999999994651,0.940253311944219,0,1,interleukin-1, Type II, blocking receptor activity,MF,
8041,GO:0032690,0.99999999994651,0.940253311944219,0,1,negative regulation of interleukin-1 alpha production,BP,
12560,GO:0050712,0.99999999994651,0.940253311944219,0,1,negative regulation of interleukin-1 alpha secretion,BP,
5104,GO:0015389,0.999999999946609,0.928581119029404,0,1,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5105,GO:0015390,0.999999999946609,0.928581119029404,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5106,GO:0015391,0.999999999946609,0.928581119029404,0,1,nucleobase:cation symporter activity,MF,
18773,GO:1904274,0.999999999946609,0.928581119029404,0,1,tricellular tight junction assembly,BP,
11064,GO:0045062,0.999999999946663,0.935934365665764,0,1,extrathymic T cell selection,BP,
15064,GO:0071021,0.999999999946663,0.935934365665764,0,1,U2-type post-spliceosomal complex,CC,
7550,GO:0031859,0.999999999946846,0.933041849469767,0,1,platelet activating factor receptor binding,MF,
4921,GO:0014859,0.999999999946895,0.913661695359159,0,1,negative regulation of skeletal muscle cell proliferation,BP,
18094,GO:1902723,0.999999999946895,0.913661695359159,0,1,negative regulation of skeletal muscle satellite cell proliferation,BP,
11524,GO:0046038,0.999999999947247,0.940494453612225,0,1,GMP catabolic process,BP,
13387,GO:0052657,0.999999999947247,0.940494453612225,0,1,guanine phosphoribosyltransferase activity,MF,
1419,GO:0003363,0.999999999947249,0.890165204710282,0,1,lamellipodium assembly involved in ameboidal cell migration,BP,
1923,GO:0004617,0.999999999947251,0.931386840589575,0,1,phosphoglycerate dehydrogenase activity,MF,
8517,GO:0033699,0.999999999947251,0.931386840589575,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
17274,GO:0120108,0.999999999947251,0.931386840589575,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
19461,GO:1990165,0.999999999947251,0.931386840589575,0,1,single-strand break-containing DNA binding,MF,
2322,GO:0005330,0.999999999947412,0.900108158858604,0,1,dopamine:sodium symporter activity,MF,
2324,GO:0005335,0.999999999947412,0.900108158858604,0,1,serotonin:sodium symporter activity,MF,
4852,GO:0014064,0.999999999947412,0.900108158858604,0,1,positive regulation of serotonin secretion,BP,
6245,GO:0019811,0.999999999947412,0.900108158858604,0,1,cocaine binding,MF,
6537,GO:0021941,0.999999999947412,0.900108158858604,0,1,negative regulation of cerebellar granule cell precursor proliferation,BP,
16091,GO:0090067,0.999999999947412,0.900108158858604,0,1,regulation of thalamus size,BP,
7539,GO:0031798,0.999999999947464,0.880226676870223,0,1,type 1 metabotropic glutamate receptor binding,MF,
14468,GO:0061828,0.999999999947464,0.880226676870223,0,1,apical tubulobulbar complex,CC,
14469,GO:0061829,0.999999999947464,0.880226676870223,0,1,basal tubulobulbar complex,CC,
198,GO:0000416,0.999999999947487,0.908542493984203,0,1,positive regulation of histone H3-K36 methylation,BP,
8,GO:0000015,0.999999999947529,0.934294720684782,0,1,phosphopyruvate hydratase complex,CC,
1935,GO:0004634,0.999999999947529,0.934294720684782,0,1,phosphopyruvate hydratase activity,MF,
10261,GO:0042999,0.999999999947579,0.899671567742221,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10264,GO:0043002,0.999999999947579,0.899671567742221,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10265,GO:0043004,0.999999999947579,0.899671567742221,0,1,cytoplasmic sequestering of CFTR protein,BP,
2748,GO:0006147,0.999999999947654,0.893564879424085,0,1,guanine catabolic process,BP,
3994,GO:0008892,0.999999999947654,0.893564879424085,0,1,guanine deaminase activity,MF,
16648,GO:0097510,0.999999999947665,0.93095756467979,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
6829,GO:0030290,0.99999999994779,0.910375992986912,0,1,sphingolipid activator protein activity,MF,
7867,GO:0032428,0.99999999994779,0.910375992986912,0,1,beta-N-acetylgalactosaminidase activity,MF,
17764,GO:1901740,0.999999999947821,0.932252504109017,0,1,negative regulation of myoblast fusion,BP,
18640,GO:1903943,0.999999999947821,0.932252504109017,0,1,regulation of hepatocyte apoptotic process,BP,
18641,GO:1903944,0.999999999947821,0.932252504109017,0,1,negative regulation of hepatocyte apoptotic process,BP,
19598,GO:1990729,0.999999999947821,0.932252504109017,0,1,primary miRNA modification,BP,
19606,GO:1990744,0.999999999947821,0.932252504109017,0,1,primary miRNA methylation,BP,
476,GO:0001519,0.999999999947829,0.90851196850565,0,1,peptide amidation,BP,
1845,GO:0004504,0.999999999947829,0.90851196850565,0,1,peptidylglycine monooxygenase activity,MF,
1910,GO:0004598,0.999999999947829,0.90851196850565,0,1,peptidylamidoglycolate lyase activity,MF,
5890,GO:0018032,0.999999999947829,0.90851196850565,0,1,protein amidation,BP,
7246,GO:0031179,0.999999999947829,0.90851196850565,0,1,peptide modification,BP,
13403,GO:0052739,0.99999999994784,0.930726258998991,0,1,phosphatidylserine 1-acylhydrolase activity,MF,
13404,GO:0052740,0.99999999994784,0.930726258998991,0,1,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
18878,GO:1904550,0.99999999994784,0.930726258998991,0,1,response to arachidonic acid,BP,
19852,GO:2000324,0.99999999994784,0.930726258998991,0,1,positive regulation of glucocorticoid receptor signaling pathway,BP,
784,GO:0002041,0.999999999947865,0.927653154487106,0,1,intussusceptive angiogenesis,BP,
3033,GO:0006580,0.999999999947994,0.922224042123634,0,1,ethanolamine metabolic process,BP,
18277,GO:1903165,0.999999999947994,0.922224042123634,0,1,response to polycyclic arene,BP,
18931,GO:1904681,0.999999999947994,0.922224042123634,0,1,response to 3-methylcholanthrene,BP,
3929,GO:0008609,0.999999999948174,0.880067337272426,0,1,alkylglycerone-phosphate synthase activity,MF,
1411,GO:0003345,0.999999999948281,0.906807555643872,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
14485,GO:0061889,0.999999999948329,0.894625259730719,0,1,negative regulation of astrocyte activation,BP,
18663,GO:1903979,0.999999999948329,0.894625259730719,0,1,negative regulation of microglial cell activation,BP,
3519,GO:0007468,0.999999999948391,0.93096458389723,0,1,regulation of rhodopsin gene expression,BP,
11440,GO:0045872,0.999999999948391,0.93096458389723,0,1,positive regulation of rhodopsin gene expression,BP,
8223,GO:0032980,0.999999999948406,0.925948569639909,0,1,keratinocyte activation,BP,
17518,GO:1900753,0.99999999994844,0.901741781861477,0,1,doxorubicin transport,BP,
8641,GO:0034166,0.999999999948476,0.913901560458587,0,1,toll-like receptor 10 signaling pathway,BP,
1790,GO:0004419,0.999999999948581,0.939113735890302,0,1,hydroxymethylglutaryl-CoA lyase activity,MF,
520,GO:0001605,0.999999999948583,0.896488956560885,0,1,adrenomedullin receptor activity,MF,
2137,GO:0004948,0.999999999948583,0.896488956560885,0,1,calcitonin receptor activity,MF,
15188,GO:0071324,0.999999999948583,0.896488956560885,0,1,cellular response to disaccharide stimulus,BP,
15190,GO:0071329,0.999999999948583,0.896488956560885,0,1,cellular response to sucrose stimulus,BP,
18274,GO:1903143,0.999999999948583,0.896488956560885,0,1,adrenomedullin receptor complex,CC,
19519,GO:1990409,0.999999999948583,0.896488956560885,0,1,adrenomedullin binding,MF,
492,GO:0001544,0.999999999948648,0.882129648820125,0,1,initiation of primordial ovarian follicle growth,BP,
1534,GO:0003919,0.999999999948747,0.932074305758876,0,1,FMN adenylyltransferase activity,MF,
3150,GO:0006747,0.999999999948747,0.932074305758876,0,1,FAD biosynthetic process,BP,
11670,GO:0046443,0.999999999948747,0.932074305758876,0,1,FAD metabolic process,BP,
15785,GO:0072388,0.999999999948747,0.932074305758876,0,1,flavin adenine dinucleotide biosynthetic process,BP,
19086,GO:1904980,0.999999999948797,0.883494434842331,0,1,positive regulation of endosome organization,BP,
16122,GO:0090108,0.999999999948818,0.93068427105876,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
16169,GO:0090187,0.999999999948818,0.93068427105876,0,1,positive regulation of pancreatic juice secretion,BP,
16276,GO:0090340,0.999999999948818,0.93068427105876,0,1,positive regulation of secretion of lysosomal enzymes,BP,
16609,GO:0097442,0.999999999948832,0.892130384320689,0,1,CA3 pyramidal cell dendrite,CC,
17456,GO:1900243,0.999999999948946,0.894804711575594,0,1,negative regulation of synaptic vesicle endocytosis,BP,
19149,GO:1905154,0.999999999948946,0.894804711575594,0,1,negative regulation of membrane invagination,BP,
19151,GO:1905161,0.999999999948946,0.894804711575594,0,1,protein localization to phagocytic vesicle,BP,
19152,GO:1905162,0.999999999948946,0.894804711575594,0,1,regulation of phagosome maturation,BP,
19157,GO:1905169,0.999999999948946,0.894804711575594,0,1,regulation of protein localization to phagocytic vesicle,BP,
19158,GO:1905171,0.999999999948946,0.894804711575594,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
19275,GO:1905468,0.999999999948946,0.894804711575594,0,1,regulation of clathrin-coated pit assembly,BP,
19276,GO:1905469,0.999999999948946,0.894804711575594,0,1,negative regulation of clathrin-coated pit assembly,BP,
814,GO:0002086,0.999999999948977,0.910059135351921,0,1,diaphragm contraction,BP,
1892,GO:0004574,0.999999999948977,0.910059135351921,0,1,oligo-1,6-glucosidase activity,MF,
2649,GO:0005985,0.999999999948977,0.910059135351921,0,1,sucrose metabolic process,BP,
10367,GO:0043181,0.999999999948977,0.910059135351921,0,1,vacuolar sequestering,BP,
1236,GO:0002924,0.99999999994901,0.92811629722974,0,1,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
9857,GO:0042105,0.99999999994901,0.92811629722974,0,1,alpha-beta T cell receptor complex,CC,
19383,GO:1905878,0.99999999994902,0.868267964516772,0,1,invadopodium disassembly,BP,
19401,GO:1905927,0.99999999994902,0.868267964516772,0,1,regulation of invadopodium disassembly,BP,
19402,GO:1905929,0.99999999994902,0.868267964516772,0,1,positive regulation of invadopodium disassembly,BP,
4225,GO:0009400,0.999999999949035,0.920181812505076,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
8721,GO:0034366,0.999999999949035,0.920181812505076,0,1,spherical high-density lipoprotein particle,CC,
14334,GO:0061517,0.999999999949035,0.920181812505076,0,1,macrophage proliferation,BP,
14335,GO:0061518,0.999999999949035,0.920181812505076,0,1,microglial cell proliferation,BP,
18134,GO:1902847,0.999999999949035,0.920181812505076,0,1,regulation of neuronal signal transduction,BP,
18210,GO:1902998,0.999999999949035,0.920181812505076,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19388,GO:1905891,0.999999999949035,0.920181812505076,0,1,regulation of cellular response to thapsigargin,BP,
19389,GO:1905892,0.999999999949035,0.920181812505076,0,1,negative regulation of cellular response to thapsigargin,BP,
19390,GO:1905894,0.999999999949035,0.920181812505076,0,1,regulation of cellular response to tunicamycin,BP,
19391,GO:1905895,0.999999999949035,0.920181812505076,0,1,negative regulation of cellular response to tunicamycin,BP,
3853,GO:0008466,0.999999999949046,0.934471481667538,0,1,glycogenin glucosyltransferase activity,MF,
17166,GO:0102751,0.999999999949046,0.934471481667538,0,1,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
2252,GO:0005166,0.999999999949108,0.947560874094894,0,1,neurotrophin p75 receptor binding,MF,
3500,GO:0007402,0.999999999949108,0.947560874094894,0,1,ganglion mother cell fate determination,BP,
3612,GO:0008052,0.999999999949108,0.947560874094894,0,1,sensory organ boundary specification,BP,
4408,GO:0010160,0.999999999949108,0.947560874094894,0,1,formation of animal organ boundary,BP,
12420,GO:0048867,0.999999999949108,0.947560874094894,0,1,stem cell fate determination,BP,
14232,GO:0061193,0.999999999949108,0.947560874094894,0,1,taste bud development,BP,
16999,GO:0099082,0.999999999949108,0.947560874094894,0,1,retrograde trans-synaptic signaling by neuropeptide,BP,
17000,GO:0099083,0.999999999949108,0.947560874094894,0,1,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
17057,GO:0099538,0.999999999949108,0.947560874094894,0,1,synaptic signaling via neuropeptide,BP,
17058,GO:0099540,0.999999999949108,0.947560874094894,0,1,trans-synaptic signaling by neuropeptide,BP,
17066,GO:0099551,0.999999999949108,0.947560874094894,0,1,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
2586,GO:0005880,0.999999999949205,0.939829034047937,0,1,nuclear microtubule,CC,
11096,GO:0045105,0.999999999949244,0.910299772378843,0,1,intermediate filament polymerization or depolymerization,BP,
18638,GO:1903937,0.999999999949244,0.910299772378843,0,1,response to acrylamide,BP,
12888,GO:0051228,0.999999999949258,0.89529281278652,0,1,mitotic spindle disassembly,BP,
12889,GO:0051230,0.999999999949258,0.89529281278652,0,1,spindle disassembly,BP,
1517,GO:0003878,0.999999999949266,0.901727838968659,0,1,ATP citrate synthase activity,MF,
4210,GO:0009346,0.999999999949266,0.901727838968659,0,1,citrate lyase complex,CC,
1513,GO:0003874,0.99999999994933,0.948617715569,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
4243,GO:0009441,0.99999999994933,0.948617715569,0,1,glycolate metabolic process,BP,
5956,GO:0018323,0.99999999994933,0.948617715569,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
8689,GO:0034309,0.99999999994933,0.948617715569,0,1,primary alcohol biosynthetic process,BP,
9608,GO:0036470,0.99999999994933,0.948617715569,0,1,tyrosine 3-monooxygenase activator activity,MF,
9609,GO:0036471,0.99999999994933,0.948617715569,0,1,cellular response to glyoxal,BP,
9615,GO:0036478,0.99999999994933,0.948617715569,0,1,L-dopa decarboxylase activator activity,MF,
9650,GO:0036524,0.99999999994933,0.948617715569,0,1,protein deglycase activity,MF,
9651,GO:0036525,0.99999999994933,0.948617715569,0,1,protein deglycation,BP,
9652,GO:0036526,0.99999999994933,0.948617715569,0,1,peptidyl-cysteine deglycation,BP,
9653,GO:0036527,0.99999999994933,0.948617715569,0,1,peptidyl-arginine deglycation,BP,
9654,GO:0036528,0.99999999994933,0.948617715569,0,1,peptidyl-lysine deglycation,BP,
9655,GO:0036529,0.99999999994933,0.948617715569,0,1,protein deglycation, glyoxal removal,BP,
9656,GO:0036530,0.99999999994933,0.948617715569,0,1,protein deglycation, methylglyoxal removal,BP,
9657,GO:0036531,0.99999999994933,0.948617715569,0,1,glutathione deglycation,BP,
11208,GO:0045340,0.99999999994933,0.948617715569,0,1,mercury ion binding,MF,
11613,GO:0046295,0.99999999994933,0.948617715569,0,1,glycolate biosynthetic process,BP,
17203,GO:0106044,0.99999999994933,0.948617715569,0,1,guanine deglycation,BP,
17204,GO:0106045,0.99999999994933,0.948617715569,0,1,guanine deglycation, methylglyoxal removal,BP,
17205,GO:0106046,0.99999999994933,0.948617715569,0,1,guanine deglycation, glyoxal removal,BP,
17288,GO:0140041,0.99999999994933,0.948617715569,0,1,cellular detoxification of methylglyoxal,BP,
18251,GO:1903072,0.99999999994933,0.948617715569,0,1,regulation of death-inducing signaling complex assembly,BP,
18252,GO:1903073,0.99999999994933,0.948617715569,0,1,negative regulation of death-inducing signaling complex assembly,BP,
18266,GO:1903122,0.99999999994933,0.948617715569,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
18278,GO:1903167,0.99999999994933,0.948617715569,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
18279,GO:1903168,0.99999999994933,0.948617715569,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
18283,GO:1903176,0.99999999994933,0.948617715569,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
18284,GO:1903178,0.99999999994933,0.948617715569,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
18288,GO:1903184,0.99999999994933,0.948617715569,0,1,L-dopa metabolic process,BP,
18289,GO:1903185,0.99999999994933,0.948617715569,0,1,L-dopa biosynthetic process,BP,
18290,GO:1903189,0.99999999994933,0.948617715569,0,1,glyoxal metabolic process,BP,
18291,GO:1903195,0.99999999994933,0.948617715569,0,1,regulation of L-dopa biosynthetic process,BP,
18292,GO:1903197,0.99999999994933,0.948617715569,0,1,positive regulation of L-dopa biosynthetic process,BP,
18293,GO:1903198,0.99999999994933,0.948617715569,0,1,regulation of L-dopa decarboxylase activity,BP,
18294,GO:1903200,0.99999999994933,0.948617715569,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19818,GO:2000277,0.99999999994933,0.948617715569,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
19824,GO:2000284,0.99999999994933,0.948617715569,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
2360,GO:0005461,0.99999999994935,0.887235832920728,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
5196,GO:0015787,0.99999999994935,0.887235832920728,0,1,UDP-glucuronic acid transmembrane transport,BP,
12291,GO:0048619,0.999999999949372,0.920249514191786,0,1,embryonic hindgut morphogenesis,BP,
17597,GO:1901254,0.999999999949456,0.901584318488436,0,1,positive regulation of intracellular transport of viral material,BP,
18101,GO:1902737,0.999999999949456,0.901584318488436,0,1,dendritic filopodium,CC,
6241,GO:0019800,0.999999999949459,0.939256268288971,0,1,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
8386,GO:0033290,0.999999999949465,0.90359851366156,0,1,eukaryotic 48S preinitiation complex,CC,
10762,GO:0044207,0.999999999949465,0.90359851366156,0,1,translation initiation ternary complex,CC,
15886,GO:0072616,0.999999999949509,0.905348269766359,0,1,interleukin-18 secretion,BP,
1907,GO:0004595,0.999999999949546,0.927557994157926,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
1033,GO:0002542,0.999999999949571,0.930866368476952,0,1,Factor XII activation,BP,
13246,GO:0051919,0.999999999949571,0.930866368476952,0,1,positive regulation of fibrinolysis,BP,
18009,GO:1902480,0.999999999949611,0.925827372392356,0,1,protein localization to mitotic spindle,BP,
19564,GO:1990578,0.99999999994979,0.891240356241267,0,1,perinuclear endoplasmic reticulum membrane,CC,
6424,GO:0021688,0.999999999949797,0.913848210210886,0,1,cerebellar molecular layer formation,BP,
14071,GO:0060853,0.999999999949797,0.913848210210886,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
6548,GO:0021966,0.999999999949797,0.896647156962634,0,1,corticospinal neuron axon guidance,BP,
6549,GO:0021972,0.999999999949797,0.896647156962634,0,1,corticospinal neuron axon guidance through spinal cord,BP,
12706,GO:0050924,0.999999999949797,0.896647156962634,0,1,positive regulation of negative chemotaxis,BP,
12711,GO:0050929,0.999999999949797,0.896647156962634,0,1,induction of negative chemotaxis,BP,
15381,GO:0071623,0.999999999949797,0.896647156962634,0,1,negative regulation of granulocyte chemotaxis,BP,
16069,GO:0090024,0.999999999949797,0.896647156962634,0,1,negative regulation of neutrophil chemotaxis,BP,
16220,GO:0090260,0.999999999949797,0.896647156962634,0,1,negative regulation of retinal ganglion cell axon guidance,BP,
18065,GO:1902623,0.999999999949797,0.896647156962634,0,1,negative regulation of neutrophil migration,BP,
9111,GO:0035400,0.999999999949829,0.894433821947375,0,1,histone tyrosine kinase activity,MF,
9112,GO:0035401,0.999999999949829,0.894433821947375,0,1,histone kinase activity (H3-Y41 specific),MF,
9117,GO:0035406,0.999999999949829,0.894433821947375,0,1,histone-tyrosine phosphorylation,BP,
9120,GO:0035409,0.999999999949829,0.894433821947375,0,1,histone H3-Y41 phosphorylation,BP,
16486,GO:0097168,0.999999999949871,0.899759803104789,0,1,mesenchymal stem cell proliferation,BP,
18000,GO:1902460,0.999999999949871,0.899759803104789,0,1,regulation of mesenchymal stem cell proliferation,BP,
18001,GO:1902462,0.999999999949871,0.899759803104789,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
1682,GO:0004148,0.999999999949895,0.910287079569659,0,1,dihydrolipoyl dehydrogenase activity,MF,
10351,GO:0043159,0.999999999949895,0.910287079569659,0,1,acrosomal matrix,CC,
10581,GO:0043544,0.999999999949895,0.910287079569659,0,1,lipoamide binding,MF,
12786,GO:0051068,0.999999999949895,0.910287079569659,0,1,dihydrolipoamide metabolic process,BP,
15503,GO:0071873,0.999999999949925,0.911713442677918,0,1,response to norepinephrine,BP,
15504,GO:0071874,0.999999999949925,0.911713442677918,0,1,cellular response to norepinephrine stimulus,BP,
1780,GO:0004394,0.999999999950012,0.903588354363812,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
5674,GO:0016784,0.999999999950015,0.939573953622871,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6261,GO:0019853,0.999999999950015,0.939573953622871,0,1,L-ascorbic acid biosynthetic process,BP,
6705,GO:0030108,0.999999999950015,0.939573953622871,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7564,GO:0031906,0.999999999950015,0.939573953622871,0,1,late endosome lumen,CC,
7841,GO:0032397,0.999999999950015,0.939573953622871,0,1,activating MHC class I receptor activity,MF,
10216,GO:0042839,0.999999999950015,0.939573953622871,0,1,D-glucuronate metabolic process,BP,
10217,GO:0042840,0.999999999950015,0.939573953622871,0,1,D-glucuronate catabolic process,BP,
12053,GO:0047939,0.999999999950015,0.939573953622871,0,1,L-glucuronate reductase activity,MF,
16631,GO:0097486,0.999999999950015,0.939573953622871,0,1,multivesicular body lumen,CC,
6110,GO:0019353,0.999999999950046,0.922029264302683,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
8431,GO:0033526,0.999999999950046,0.922029264302683,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
2225,GO:0005128,0.999999999950114,0.914436449255719,0,1,erythropoietin receptor binding,MF,
2231,GO:0005135,0.999999999950114,0.914436449255719,0,1,interleukin-3 receptor binding,MF,
19354,GO:1905767,0.999999999950179,0.885435996318719,0,1,regulation of double-stranded telomeric DNA binding,BP,
19355,GO:1905768,0.999999999950179,0.885435996318719,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
2412,GO:0005586,0.999999999950245,0.892942883016276,0,1,collagen type III trimer,CC,
4487,GO:0010509,0.999999999950245,0.892942883016276,0,1,polyamine homeostasis,BP,
9143,GO:0035485,0.999999999950284,0.933935351784232,0,1,adenine/guanine mispair binding,MF,
389,GO:0001034,0.999999999950291,0.934508369481938,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
7809,GO:0032358,0.999999999950308,0.950244690732023,0,1,oxidized pyrimidine DNA binding,MF,
14322,GO:0061481,0.999999999950308,0.950244690732023,0,1,response to TNF agonist,BP,
18032,GO:1902546,0.999999999950308,0.950244690732023,0,1,positive regulation of DNA N-glycosylase activity,BP,
20292,GO:2001272,0.999999999950308,0.950244690732023,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
13287,GO:0051977,0.999999999950317,0.929040916598523,0,1,lysophospholipid transport,BP,
13288,GO:0051978,0.999999999950317,0.929040916598523,0,1,lysophospholipid transporter activity,MF,
4437,GO:0010309,0.999999999950367,0.93646536662911,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
19558,GO:1990565,0.999999999950367,0.93646536662911,0,1,HSP90-CDC37 chaperone complex,CC,
8932,GO:0034777,0.999999999950378,0.928410022498776,0,1,recycling endosome lumen,CC,
1807,GO:0004454,0.999999999950659,0.925935100342135,0,1,ketohexokinase activity,MF,
1666,GO:0004127,0.999999999950685,0.844842277919601,0,2,cytidylate kinase activity,MF,
4029,GO:0009061,0.999999999950713,0.926218118676031,0,1,anaerobic respiration,BP,
11183,GO:0045274,0.999999999950713,0.926218118676031,0,1,plasma membrane respiratory chain complex II,CC,
11187,GO:0045282,0.999999999950713,0.926218118676031,0,1,plasma membrane succinate dehydrogenase complex,CC,
4359,GO:0009955,0.999999999950728,0.928841668272586,0,1,adaxial/abaxial pattern specification,BP,
9278,GO:0035709,0.999999999950728,0.928841668272586,0,1,memory T cell activation,BP,
16308,GO:0090427,0.999999999950728,0.928841668272586,0,1,activation of meiosis,BP,
19691,GO:2000011,0.999999999950728,0.928841668272586,0,1,regulation of adaxial/abaxial pattern formation,BP,
19979,GO:2000567,0.999999999950728,0.928841668272586,0,1,regulation of memory T cell activation,BP,
19980,GO:2000568,0.999999999950728,0.928841668272586,0,1,positive regulation of memory T cell activation,BP,
20198,GO:2001055,0.999999999950728,0.928841668272586,0,1,positive regulation of mesenchymal cell apoptotic process,BP,
16941,GO:0098920,0.99999999995074,0.92182093265112,0,1,retrograde trans-synaptic signaling by lipid,BP,
16942,GO:0098921,0.99999999995074,0.92182093265112,0,1,retrograde trans-synaptic signaling by endocannabinoid,BP,
2855,GO:0006343,0.999999999950841,0.907146267081034,0,1,establishment of chromatin silencing,BP,
10094,GO:0042595,0.999999999950841,0.907146267081034,0,1,behavioral response to starvation,BP,
15268,GO:0071441,0.999999999950841,0.907146267081034,0,1,negative regulation of histone H3-K14 acetylation,BP,
20032,GO:2000654,0.999999999950841,0.907146267081034,0,1,regulation of cellular response to testosterone stimulus,BP,
20033,GO:2000655,0.999999999950841,0.907146267081034,0,1,negative regulation of cellular response to testosterone stimulus,BP,
1317,GO:0003165,0.999999999950895,0.892155222518968,0,1,Purkinje myocyte development,BP,
17169,GO:0102758,0.999999999951071,0.944561798403458,0,1,very-long-chain enoyl-CoA reductase activity,MF,
927,GO:0002325,0.99999999995115,0.944477755130463,0,1,natural killer cell differentiation involved in immune response,BP,
8132,GO:0032824,0.99999999995115,0.944477755130463,0,1,negative regulation of natural killer cell differentiation,BP,
8134,GO:0032826,0.99999999995115,0.944477755130463,0,1,regulation of natural killer cell differentiation involved in immune response,BP,
8135,GO:0032827,0.99999999995115,0.944477755130463,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
7780,GO:0032304,0.999999999951157,0.896225471550874,0,1,negative regulation of icosanoid secretion,BP,
17406,GO:1900139,0.999999999951157,0.896225471550874,0,1,negative regulation of arachidonic acid secretion,BP,
6231,GO:0019782,0.999999999951252,0.913621771512909,0,1,ISG15 activating enzyme activity,MF,
420,GO:0001112,0.999999999951291,0.917655102926741,0,1,DNA-templated transcriptional open complex formation,BP,
421,GO:0001113,0.999999999951291,0.917655102926741,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
422,GO:0001120,0.999999999951291,0.917655102926741,0,1,protein-DNA complex remodeling,BP,
14020,GO:0060743,0.999999999951346,0.924094972064523,0,1,epithelial cell maturation involved in prostate gland development,BP,
4276,GO:0009637,0.999999999951392,0.826584433551031,0,2,response to blue light,BP,
4308,GO:0009785,0.999999999951392,0.826584433551031,0,2,blue light signaling pathway,BP,
4333,GO:0009882,0.999999999951392,0.826584433551031,0,2,blue light photoreceptor activity,MF,
15299,GO:0071483,0.999999999951392,0.826584433551031,0,2,cellular response to blue light,BP,
18407,GO:1903435,0.99999999995142,0.92077009406804,0,1,positive regulation of constitutive secretory pathway,BP,
16203,GO:0090233,0.999999999951422,0.922432147201443,0,1,negative regulation of spindle checkpoint,BP,
17993,GO:1902426,0.999999999951422,0.922432147201443,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19221,GO:1905341,0.999999999951422,0.922432147201443,0,1,negative regulation of protein localization to kinetochore,BP,
18741,GO:1904210,0.999999999951518,0.940995036064491,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18758,GO:1904239,0.999999999951518,0.940995036064491,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
18759,GO:1904240,0.999999999951518,0.940995036064491,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
1762,GO:0004365,0.999999999951529,0.942168969063747,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
6251,GO:0019828,0.999999999951529,0.942168969063747,0,1,aspartic-type endopeptidase inhibitor activity,MF,
9219,GO:0035605,0.999999999951529,0.942168969063747,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
10669,GO:0043891,0.999999999951529,0.942168969063747,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
9292,GO:0035730,0.999999999951648,0.948166224868052,0,1,S-nitrosoglutathione binding,MF,
9293,GO:0035731,0.999999999951648,0.948166224868052,0,1,dinitrosyl-iron complex binding,MF,
9294,GO:0035732,0.999999999951648,0.948166224868052,0,1,nitric oxide storage,BP,
2047,GO:0004795,0.999999999951696,0.930070741199007,0,1,threonine synthase activity,MF,
4050,GO:0009088,0.999999999951696,0.930070741199007,0,1,threonine biosynthetic process,BP,
11643,GO:0046360,0.999999999951696,0.930070741199007,0,1,2-oxobutyrate biosynthetic process,BP,
11644,GO:0046361,0.999999999951696,0.930070741199007,0,1,2-oxobutyrate metabolic process,BP,
19192,GO:1905277,0.999999999951707,0.917172596196052,0,1,negative regulation of epithelial tube formation,BP,
19998,GO:2000606,0.999999999951707,0.917172596196052,0,1,regulation of cell proliferation involved in mesonephros development,BP,
19999,GO:2000607,0.999999999951707,0.917172596196052,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
20063,GO:2000699,0.999999999951707,0.917172596196052,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20064,GO:2000701,0.999999999951707,0.917172596196052,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20065,GO:2000702,0.999999999951707,0.917172596196052,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20066,GO:2000703,0.999999999951707,0.917172596196052,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
20078,GO:2000733,0.999999999951707,0.917172596196052,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
20079,GO:2000734,0.999999999951707,0.917172596196052,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
8881,GO:0034693,0.99999999995171,0.925329686061141,0,1,U11/U12 snRNP,CC,
1623,GO:0004057,0.999999999951737,0.928690751695881,0,1,arginyltransferase activity,MF,
9803,GO:0040030,0.999999999951763,0.907744731235392,0,1,regulation of molecular function, epigenetic,BP,
10290,GO:0043035,0.999999999951763,0.907744731235392,0,1,chromatin insulator sequence binding,MF,
557,GO:0001680,0.999999999951856,0.927857286310533,0,1,tRNA 3'-terminal CCA addition,BP,
2057,GO:0004810,0.999999999951856,0.927857286310533,0,1,tRNA adenylyltransferase activity,MF,
13464,GO:0052927,0.999999999951856,0.927857286310533,0,1,CTP:tRNA cytidylyltransferase activity,MF,
13465,GO:0052928,0.999999999951856,0.927857286310533,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
13466,GO:0052929,0.999999999951856,0.927857286310533,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
19632,GO:1990817,0.999999999951856,0.927857286310533,0,1,RNA adenylyltransferase activity,MF,
15341,GO:0071561,0.999999999951884,0.89614069194601,0,1,nucleus-vacuole junction,CC,
2503,GO:0005753,0.999999999951902,0.928951553657105,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
4695,GO:0010849,0.999999999951902,0.928951553657105,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
19817,GO:2000276,0.999999999951902,0.928951553657105,0,1,negative regulation of oxidative phosphorylation uncoupler activity,BP,
11179,GO:0045263,0.999999999952025,0.940865568819498,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11859,GO:0046848,0.999999999952038,0.941092265497218,0,1,hydroxyapatite binding,MF,
4899,GO:0014826,0.999999999952046,0.930314254669466,0,1,vein smooth muscle contraction,BP,
6760,GO:0030185,0.999999999952046,0.930314254669466,0,1,nitric oxide transport,BP,
7448,GO:0031583,0.999999999952046,0.930314254669466,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7519,GO:0031705,0.999999999952046,0.930314254669466,0,1,bombesin receptor binding,MF,
7520,GO:0031707,0.999999999952046,0.930314254669466,0,1,endothelin A receptor binding,MF,
7521,GO:0031708,0.999999999952046,0.930314254669466,0,1,endothelin B receptor binding,MF,
9336,GO:0035815,0.999999999952046,0.930314254669466,0,1,positive regulation of renal sodium excretion,BP,
9951,GO:0042313,0.999999999952046,0.930314254669466,0,1,protein kinase C deactivation,BP,
10366,GO:0043179,0.999999999952046,0.930314254669466,0,1,rhythmic excitation,BP,
472,GO:0001515,0.99999999995205,0.932010258867621,0,1,opioid peptide activity,MF,
2236,GO:0005142,0.999999999952073,0.926798827592392,0,1,interleukin-11 receptor binding,MF,
5843,GO:0017133,0.999999999952073,0.926798827592392,0,1,mitochondrial electron transfer flavoprotein complex,CC,
10660,GO:0043783,0.999999999952073,0.926798827592392,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11174,GO:0045251,0.999999999952073,0.926798827592392,0,1,electron transfer flavoprotein complex,CC,
14597,GO:0070143,0.999999999952076,0.898011728175583,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
458,GO:0001306,0.999999999952099,0.947061459088552,0,1,age-dependent response to oxidative stress,BP,
459,GO:0001315,0.999999999952099,0.947061459088552,0,1,age-dependent response to reactive oxygen species,BP,
1274,GO:0003068,0.999999999952099,0.947061459088552,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1275,GO:0003069,0.999999999952099,0.947061459088552,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1276,GO:0003070,0.999999999952099,0.947061459088552,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
3548,GO:0007571,0.999999999952099,0.947061459088552,0,1,age-dependent general metabolic decline,BP,
9929,GO:0042275,0.999999999952102,0.93883735312367,0,1,error-free postreplication DNA repair,BP,
4324,GO:0009822,0.999999999952118,0.935858873065701,0,1,alkaloid catabolic process,BP,
161,GO:0000332,0.999999999952142,0.957296060896059,0,1,template for synthesis of G-rich strand of telomere DNA activity,MF,
239,GO:0000496,0.999999999952142,0.957296060896059,0,1,base pairing,MF,
240,GO:0000497,0.999999999952142,0.957296060896059,0,1,base pairing with DNA,MF,
1466,GO:0003721,0.999999999952142,0.957296060896059,0,1,telomerase RNA reverse transcriptase activity,MF,
19033,GO:1904877,0.999999999952151,0.930084638846793,0,1,positive regulation of DNA ligase activity,BP,
1625,GO:0004061,0.999999999952284,0.936115921309253,0,1,arylformamidase activity,MF,
4781,GO:0010967,0.999999999952284,0.936115921309253,0,1,regulation of polyamine biosynthetic process,BP,
13451,GO:0052899,0.999999999952284,0.936115921309253,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13453,GO:0052902,0.999999999952284,0.936115921309253,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
13454,GO:0052903,0.999999999952284,0.936115921309253,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
13455,GO:0052904,0.999999999952284,0.936115921309253,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
17617,GO:1901304,0.999999999952284,0.936115921309253,0,1,regulation of spermidine biosynthetic process,BP,
17618,GO:1901307,0.999999999952284,0.936115921309253,0,1,positive regulation of spermidine biosynthetic process,BP,
2088,GO:0004853,0.9999999999523,0.940962650795119,0,1,uroporphyrinogen decarboxylase activity,MF,
9153,GO:0035504,0.999999999952332,0.939169133585747,0,1,regulation of myosin light chain kinase activity,BP,
9154,GO:0035505,0.999999999952332,0.939169133585747,0,1,positive regulation of myosin light chain kinase activity,BP,
10334,GO:0043126,0.999999999952332,0.939169133585747,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
10335,GO:0043128,0.999999999952332,0.939169133585747,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
3558,GO:0007598,0.999999999952334,0.926825880738638,0,1,blood coagulation, extrinsic pathway,BP,
17580,GO:1901202,0.999999999952334,0.926825880738638,0,1,negative regulation of extracellular matrix assembly,BP,
18386,GO:1903394,0.999999999952334,0.926825880738638,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
15929,GO:0072714,0.999999999952388,0.935467797402794,0,1,response to selenite ion,BP,
15930,GO:0072715,0.999999999952388,0.935467797402794,0,1,cellular response to selenite ion,BP,
18886,GO:1904569,0.999999999952388,0.935467797402794,0,1,regulation of selenocysteine incorporation,BP,
18887,GO:1904570,0.999999999952388,0.935467797402794,0,1,negative regulation of selenocysteine incorporation,BP,
18888,GO:1904572,0.999999999952388,0.935467797402794,0,1,negative regulation of mRNA binding,BP,
18889,GO:1904573,0.999999999952388,0.935467797402794,0,1,regulation of selenocysteine insertion sequence binding,BP,
18890,GO:1904574,0.999999999952388,0.935467797402794,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
19171,GO:1905215,0.999999999952388,0.935467797402794,0,1,negative regulation of RNA binding,BP,
14152,GO:0061032,0.999999999952397,0.918042658264679,0,1,visceral serous pericardium development,BP,
15654,GO:0072166,0.999999999952397,0.918042658264679,0,1,posterior mesonephric tubule development,BP,
15728,GO:0072299,0.999999999952397,0.918042658264679,0,1,negative regulation of metanephric glomerulus development,BP,
15731,GO:0072302,0.999999999952397,0.918042658264679,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
10683,GO:0043946,0.999999999952451,0.935370420335229,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10684,GO:0043947,0.999999999952451,0.935370420335229,0,1,positive regulation by host of symbiont catalytic activity,BP,
13352,GO:0052422,0.999999999952451,0.935370420335229,0,1,modulation by host of symbiont catalytic activity,BP,
6468,GO:0021797,0.9999999999525,0.912714724160152,0,1,forebrain anterior/posterior pattern specification,BP,
6507,GO:0021881,0.9999999999525,0.912714724160152,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
12188,GO:0048320,0.9999999999525,0.912714724160152,0,1,axial mesoderm formation,BP,
14053,GO:0060823,0.9999999999525,0.912714724160152,0,1,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
126,GO:0000257,0.999999999952525,0.941352081280699,0,1,nitrilase activity,MF,
5695,GO:0016815,0.999999999952525,0.941352081280699,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6037,GO:0019118,0.999999999952525,0.941352081280699,0,1,phenanthrene-epoxide hydrolase activity,MF,
6038,GO:0019119,0.999999999952525,0.941352081280699,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
9969,GO:0042356,0.999999999952525,0.941352081280699,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
12502,GO:0050577,0.999999999952525,0.941352081280699,0,1,GDP-L-fucose synthase activity,MF,
2015,GO:0004742,0.999999999952614,0.901788327106308,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
6930,GO:0030523,0.999999999952614,0.901788327106308,0,1,dihydrolipoamide S-acyltransferase activity,MF,
4914,GO:0014852,0.999999999952653,0.919890481401958,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
4915,GO:0014853,0.999999999952653,0.919890481401958,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5790,GO:0017020,0.999999999952653,0.919890481401958,0,1,myosin phosphatase regulator activity,MF,
18721,GO:1904167,0.999999999952667,0.864539887583515,0,1,regulation of thyroid hormone receptor activity,BP,
18722,GO:1904168,0.999999999952667,0.864539887583515,0,1,negative regulation of thyroid hormone receptor activity,BP,
3580,GO:0007624,0.999999999952679,0.903812972685002,0,1,ultradian rhythm,BP,
4321,GO:0009814,0.99999999995268,0.928882862517403,0,1,defense response, incompatible interaction,BP,
4322,GO:0009817,0.99999999995268,0.928882862517403,0,1,defense response to fungus, incompatible interaction,BP,
19207,GO:1905313,0.99999999995268,0.928882862517403,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
19512,GO:1990402,0.99999999995268,0.928882862517403,0,1,embryonic liver development,BP,
3642,GO:0008112,0.999999999952695,0.93797538685889,0,1,nicotinamide N-methyltransferase activity,MF,
7023,GO:0030760,0.999999999952695,0.93797538685889,0,1,pyridine N-methyltransferase activity,MF,
12448,GO:0050146,0.999999999952696,0.894292728166081,0,1,nucleoside phosphotransferase activity,MF,
2308,GO:0005295,0.999999999952708,0.91510824193015,0,1,neutral amino acid:sodium symporter activity,MF,
5098,GO:0015375,0.999999999952708,0.91510824193015,0,1,glycine:sodium symporter activity,MF,
13551,GO:0060012,0.999999999952708,0.91510824193015,0,1,synaptic transmission, glycinergic,BP,
13620,GO:0060092,0.999999999952708,0.91510824193015,0,1,regulation of synaptic transmission, glycinergic,BP,
14341,GO:0061536,0.999999999952708,0.91510824193015,0,1,glycine secretion,BP,
14342,GO:0061537,0.999999999952708,0.91510824193015,0,1,glycine secretion, neurotransmission,BP,
20220,GO:2001151,0.999999999952708,0.91510824193015,0,1,regulation of renal water transport,BP,
20221,GO:2001153,0.999999999952708,0.91510824193015,0,1,positive regulation of renal water transport,BP,
19260,GO:1905443,0.99999999995275,0.900462743440925,0,1,regulation of clathrin coat assembly,BP,
19261,GO:1905445,0.99999999995275,0.900462743440925,0,1,positive regulation of clathrin coat assembly,BP,
8918,GO:0034757,0.999999999952781,0.875354419009444,0,1,negative regulation of iron ion transport,BP,
8919,GO:0034759,0.999999999952781,0.875354419009444,0,1,regulation of iron ion transmembrane transport,BP,
8920,GO:0034760,0.999999999952781,0.875354419009444,0,1,negative regulation of iron ion transmembrane transport,BP,
14801,GO:0070524,0.999999999952802,0.94059916725135,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
121,GO:0000250,0.999999999952804,0.902688440822959,0,1,lanosterol synthase activity,MF,
7439,GO:0031559,0.999999999952804,0.902688440822959,0,1,oxidosqualene cyclase activity,MF,
16711,GO:0097692,0.999999999952813,0.888536743643315,0,1,histone H3-K4 monomethylation,BP,
17802,GO:1901895,0.999999999952813,0.888536743643315,0,1,negative regulation of calcium-transporting ATPase activity,BP,
1508,GO:0003867,0.999999999952818,0.897114200233957,0,1,4-aminobutyrate transaminase activity,MF,
4846,GO:0014053,0.999999999952818,0.897114200233957,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
7692,GO:0032144,0.999999999952818,0.897114200233957,0,1,4-aminobutyrate transaminase complex,CC,
7693,GO:0032145,0.999999999952818,0.897114200233957,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8465,GO:0033602,0.999999999952818,0.897114200233957,0,1,negative regulation of dopamine secretion,BP,
8739,GO:0034386,0.999999999952818,0.897114200233957,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
11986,GO:0047298,0.999999999952818,0.897114200233957,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
14338,GO:0061528,0.999999999952818,0.897114200233957,0,1,aspartate secretion,BP,
18844,GO:1904448,0.999999999952818,0.897114200233957,0,1,regulation of aspartate secretion,BP,
18845,GO:1904450,0.999999999952818,0.897114200233957,0,1,positive regulation of aspartate secretion,BP,
7774,GO:0032298,0.999999999952819,0.928314314612416,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
16460,GO:0097123,0.999999999952819,0.928314314612416,0,1,cyclin A1-CDK2 complex,CC,
17109,GO:0100057,0.999999999952824,0.880389063402959,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
19007,GO:1904826,0.999999999952824,0.880389063402959,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
19008,GO:1904828,0.999999999952824,0.880389063402959,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
1408,GO:0003342,0.999999999952879,0.917831869986126,0,1,proepicardium development,BP,
1409,GO:0003343,0.999999999952879,0.917831869986126,0,1,septum transversum development,BP,
16593,GO:0097403,0.999999999952879,0.917831869986126,0,1,cellular response to raffinose,BP,
17678,GO:1901545,0.999999999952879,0.917831869986126,0,1,response to raffinose,BP,
1689,GO:0004163,0.999999999952906,0.934574822406813,0,1,diphosphomevalonate decarboxylase activity,MF,
1838,GO:0004493,0.999999999952965,0.949752923693757,0,1,methylmalonyl-CoA epimerase activity,MF,
11702,GO:0046491,0.999999999952965,0.949752923693757,0,1,L-methylmalonyl-CoA metabolic process,BP,
6360,GO:0021541,0.999999999953004,0.903012171810023,0,1,ammon gyrus development,BP,
11264,GO:0045519,0.999999999953019,0.946769629319778,0,1,interleukin-23 receptor binding,MF,
14916,GO:0070743,0.999999999953019,0.946769629319778,0,1,interleukin-23 complex,CC,
753,GO:0001992,0.999999999953092,0.901751082421196,0,1,regulation of systemic arterial blood pressure by vasopressin,BP,
2159,GO:0004990,0.999999999953092,0.901751082421196,0,1,oxytocin receptor activity,MF,
2309,GO:0005298,0.999999999953092,0.901751082421196,0,1,proline:sodium symporter activity,MF,
10070,GO:0042564,0.999999999953092,0.901751082421196,0,1,NLS-dependent protein nuclear import complex,CC,
19311,GO:1905590,0.999999999953119,0.916324426520685,0,1,fibronectin fibril organization,BP,
19856,GO:2000329,0.999999999953119,0.916324426520685,0,1,negative regulation of T-helper 17 cell lineage commitment,BP,
9300,GO:0035744,0.999999999953128,0.944966129792512,0,1,T-helper 1 cell cytokine production,BP,
9908,GO:0042231,0.999999999953128,0.944966129792512,0,1,interleukin-13 biosynthetic process,BP,
2122,GO:0004917,0.999999999953133,0.934500990181223,0,1,interleukin-7 receptor activity,MF,
4383,GO:0010034,0.999999999953147,0.910899680802854,0,1,response to acetate,BP,
16663,GO:0097536,0.999999999953157,0.922177036063777,0,1,thymus epithelium morphogenesis,BP,
18692,GO:1904045,0.999999999953217,0.928745607205425,0,1,cellular response to aldosterone,BP,
953,GO:0002373,0.999999999953224,0.948530773035397,0,1,plasmacytoid dendritic cell cytokine production,BP,
1141,GO:0002736,0.999999999953224,0.948530773035397,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1142,GO:0002737,0.999999999953224,0.948530773035397,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
17596,GO:1901253,0.999999999953224,0.948530773035397,0,1,negative regulation of intracellular transport of viral material,BP,
7349,GO:0031389,0.999999999953225,0.919476681926802,0,1,Rad17 RFC-like complex,CC,
12812,GO:0051107,0.999999999953225,0.919476681926802,0,1,negative regulation of DNA ligation,BP,
12970,GO:0051352,0.999999999953225,0.919476681926802,0,1,negative regulation of ligase activity,BP,
19032,GO:1904876,0.999999999953225,0.919476681926802,0,1,negative regulation of DNA ligase activity,BP,
1967,GO:0004676,0.999999999953227,0.883742633304208,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
11083,GO:0045083,0.999999999953272,0.904274544267754,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
4372,GO:0009992,0.999999999953279,0.929178542954867,0,1,cellular water homeostasis,BP,
14614,GO:0070176,0.999999999953311,0.934589599335348,0,1,DRM complex,CC,
15271,GO:0071449,0.999999999953414,0.948931165770198,0,1,cellular response to lipid hydroperoxide,BP,
11981,GO:0047280,0.999999999953414,0.899734552798016,0,1,nicotinamide phosphoribosyltransferase activity,MF,
4212,GO:0009360,0.999999999953464,0.922150172878862,0,1,DNA polymerase III complex,CC,
8969,GO:0035037,0.999999999953488,0.900280336420998,0,1,sperm entry,BP,
17120,GO:0102008,0.999999999953502,0.896417429469531,0,1,cytosolic dipeptidase activity,MF,
17181,GO:0103046,0.999999999953502,0.896417429469531,0,1,alanylglutamate dipeptidase activity,MF,
5429,GO:0016286,0.999999999953657,0.92471867132607,0,1,small conductance calcium-activated potassium channel activity,MF,
9178,GO:0035544,0.999999999953776,0.900664458706525,0,1,negative regulation of SNARE complex assembly,BP,
16910,GO:0098871,0.999999999953777,0.93616139231428,0,1,postsynaptic actin cytoskeleton,CC,
17074,GO:0099571,0.999999999953777,0.93616139231428,0,1,postsynaptic cytoskeleton,CC,
8769,GO:0034441,0.99999999995378,0.934582210433205,0,1,plasma lipoprotein particle oxidation,BP,
8401,GO:0033328,0.999999999953793,0.909914035160092,0,1,peroxisome membrane targeting sequence binding,MF,
9476,GO:0036105,0.999999999953793,0.909914035160092,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
17400,GO:1900130,0.999999999953793,0.909914035160092,0,1,regulation of lipid binding,BP,
17401,GO:1900131,0.999999999953793,0.909914035160092,0,1,negative regulation of lipid binding,BP,
4996,GO:0015136,0.999999999953806,0.913781559735783,0,1,sialic acid transmembrane transporter activity,MF,
5127,GO:0015538,0.999999999953806,0.913781559735783,0,1,sialic acid:proton symporter activity,MF,
5178,GO:0015739,0.999999999953806,0.913781559735783,0,1,sialic acid transport,BP,
8847,GO:0034640,0.999999999953843,0.915013999596642,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
17007,GO:0099098,0.999999999953843,0.915013999596642,0,1,microtubule polymerization based movement,BP,
5977,GO:0018479,0.999999999953861,0.930237651694196,0,1,benzaldehyde dehydrogenase (NAD+) activity,MF,
238,GO:0000495,0.999999999953887,0.923779917713013,0,1,box H/ACA snoRNA 3'-end processing,BP,
2737,GO:0006117,0.999999999953887,0.923779917713013,0,1,acetaldehyde metabolic process,BP,
8558,GO:0033979,0.999999999953887,0.923779917713013,0,1,box H/ACA snoRNA metabolic process,BP,
8936,GO:0034964,0.999999999953887,0.923779917713013,0,1,box H/ACA snoRNA processing,BP,
9172,GO:0035525,0.999999999953887,0.923779917713013,0,1,NF-kappaB p50/p65 complex,CC,
11445,GO:0045887,0.999999999953914,0.88198906309138,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
8501,GO:0033678,0.999999999953933,0.922633450005618,0,1,5'-3' DNA/RNA helicase activity,MF,
8505,GO:0033682,0.999999999953933,0.922633450005618,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
14014,GO:0060735,0.999999999953949,0.941319561741902,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
18068,GO:1902629,0.999999999953949,0.941319561741902,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
1886,GO:0004567,0.999999999953951,0.913741589609203,0,1,beta-mannosidase activity,MF,
4453,GO:0010412,0.999999999953951,0.913741589609203,0,1,mannan metabolic process,BP,
11640,GO:0046355,0.999999999953951,0.913741589609203,0,1,mannan catabolic process,BP,
1749,GO:0004349,0.999999999953958,0.911765456624724,0,1,glutamate 5-kinase activity,MF,
1750,GO:0004350,0.999999999953958,0.911765456624724,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
3041,GO:0006592,0.999999999953958,0.911765456624724,0,1,ornithine biosynthetic process,BP,
5818,GO:0017084,0.999999999953958,0.911765456624724,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6055,GO:0019202,0.999999999953958,0.911765456624724,0,1,amino acid kinase activity,MF,
1933,GO:0004632,0.999999999953968,0.943001475585044,0,1,phosphopantothenate--cysteine ligase activity,MF,
3890,GO:0008523,0.999999999953982,0.913974959750026,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
5250,GO:0015878,0.999999999953982,0.913974959750026,0,1,biotin transport,BP,
5257,GO:0015887,0.999999999953982,0.913974959750026,0,1,pantothenate transmembrane transport,BP,
1897,GO:0004581,0.999999999954051,0.944553391072872,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
18494,GO:1903621,0.999999999954052,0.932459758313118,0,1,protein localization to photoreceptor connecting cilium,BP,
2637,GO:0005969,0.999999999954054,0.878074970795339,0,1,serine-pyruvate aminotransferase complex,CC,
5376,GO:0016189,0.999999999954054,0.878074970795339,0,1,synaptic vesicle to endosome fusion,BP,
1273,GO:0003065,0.999999999954072,0.93472274996804,0,1,positive regulation of heart rate by epinephrine,BP,
11841,GO:0046811,0.999999999954089,0.891870049190122,0,1,histone deacetylase inhibitor activity,MF,
1542,GO:0003937,0.999999999954136,0.930307288073092,0,1,IMP cyclohydrolase activity,MF,
1941,GO:0004643,0.999999999954136,0.930307288073092,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
13413,GO:0052798,0.999999999954136,0.930307288073092,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
1772,GO:0004377,0.999999999954149,0.924363165271136,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
17077,GO:0099580,0.999999999954163,0.889843867339752,0,1,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
1545,GO:0003940,0.999999999954217,0.928979042139218,0,1,L-iduronidase activity,MF,
3839,GO:0008444,0.999999999954217,0.928979042139218,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
6775,GO:0030209,0.999999999954217,0.928979042139218,0,1,dermatan sulfate catabolic process,BP,
16911,GO:0098875,0.999999999954222,0.898464084139404,0,1,epididymosome,CC,
6012,GO:0019061,0.999999999954242,0.927870905882437,0,1,uncoating of virus,BP,
3872,GO:0008496,0.999999999954248,0.902712791815814,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
19218,GO:1905335,0.999999999954365,0.849285221915841,0,1,regulation of aggrephagy,BP,
19219,GO:1905337,0.999999999954365,0.849285221915841,0,1,positive regulation of aggrephagy,BP,
10812,GO:0044299,0.999999999954425,0.88691054261492,0,1,C-fiber,CC,
14478,GO:0061851,0.999999999954432,0.921881429806456,0,1,leading edge of lamellipodium,CC,
18795,GO:1904328,0.999999999954432,0.921881429806456,0,1,regulation of myofibroblast contraction,BP,
19616,GO:1990764,0.999999999954432,0.921881429806456,0,1,myofibroblast contraction,BP,
15986,GO:0080163,0.999999999954437,0.926265323164572,0,1,regulation of protein serine/threonine phosphatase activity,BP,
1693,GO:0004168,0.999999999954438,0.928910333841444,0,1,dolichol kinase activity,MF,
10299,GO:0043048,0.999999999954438,0.928910333841444,0,1,dolichyl monophosphate biosynthetic process,BP,
12567,GO:0050719,0.999999999954448,0.950253486932082,0,1,interleukin-1 alpha biosynthetic process,BP,
12569,GO:0050721,0.999999999954448,0.950253486932082,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
12572,GO:0050726,0.999999999954448,0.950253486932082,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
6566,GO:0022012,0.999999999954471,0.876956499134378,0,1,subpallium cell proliferation in forebrain,BP,
6567,GO:0022018,0.999999999954471,0.876956499134378,0,1,lateral ganglionic eminence cell proliferation,BP,
13780,GO:0060366,0.999999999954471,0.876956499134378,0,1,lambdoid suture morphogenesis,BP,
13781,GO:0060367,0.999999999954471,0.876956499134378,0,1,sagittal suture morphogenesis,BP,
14075,GO:0060873,0.999999999954471,0.876956499134378,0,1,anterior semicircular canal development,BP,
14076,GO:0060875,0.999999999954471,0.876956499134378,0,1,lateral semicircular canal development,BP,
19424,GO:1990026,0.999999999954476,0.910983146682647,0,1,hippocampal mossy fiber expansion,CC,
4943,GO:0014908,0.999999999954584,0.888372865599674,0,1,myotube differentiation involved in skeletal muscle regeneration,BP,
3529,GO:0007509,0.999999999954598,0.886681982611263,0,1,mesoderm migration involved in gastrulation,BP,
3623,GO:0008078,0.999999999954598,0.886681982611263,0,1,mesodermal cell migration,BP,
12047,GO:0047874,0.999999999954686,0.930098538581492,0,1,dolichyldiphosphatase activity,MF,
11740,GO:0046573,0.999999999954706,0.937000778917729,0,1,lactonohydrolase activity,MF,
17119,GO:0102007,0.999999999954706,0.937000778917729,0,1,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
13799,GO:0060386,0.999999999954713,0.891740159642263,0,1,synapse assembly involved in innervation,BP,
2037,GO:0004777,0.999999999954771,0.895432584209732,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
4015,GO:0009013,0.999999999954771,0.895432584209732,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
10338,GO:0043131,0.999999999954771,0.895432584209732,0,1,erythrocyte enucleation,BP,
10473,GO:0043354,0.999999999954771,0.895432584209732,0,1,enucleate erythrocyte maturation,BP,
14496,GO:0061930,0.999999999954771,0.895432584209732,0,1,regulation of erythrocyte enucleation,BP,
14497,GO:0061931,0.999999999954771,0.895432584209732,0,1,positive regulation of erythrocyte enucleation,BP,
16348,GO:0090601,0.999999999954771,0.895432584209732,0,1,enucleation,BP,
18132,GO:1902838,0.999999999954771,0.895432584209732,0,1,regulation of nuclear migration along microtubule,BP,
5827,GO:0017102,0.999999999954791,0.846471292337255,0,2,methionyl glutamyl tRNA synthetase complex,CC,
2018,GO:0004747,0.999999999954806,0.944075282673339,0,1,ribokinase activity,MF,
119,GO:0000247,0.999999999954806,0.944814327207619,0,1,C-8 sterol isomerase activity,MF,
2030,GO:0004769,0.999999999954806,0.944814327207619,0,1,steroid delta-isomerase activity,MF,
10086,GO:0042586,0.999999999954806,0.944814327207619,0,1,peptide deformylase activity,MF,
13531,GO:0055108,0.999999999954847,0.931996033665182,0,1,Golgi to transport vesicle transport,BP,
19506,GO:1990386,0.999999999954847,0.931996033665182,0,1,mitotic cleavage furrow ingression,BP,
19566,GO:1990583,0.999999999954847,0.931996033665182,0,1,phospholipase D activator activity,MF,
1210,GO:0002876,0.999999999954904,0.936587360496812,0,1,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1237,GO:0002925,0.999999999954904,0.936587360496812,0,1,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
14166,GO:0061048,0.999999999954904,0.936587360496812,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15852,GO:0072564,0.999999999954904,0.936587360496812,0,1,blood microparticle formation,BP,
19048,GO:1904895,0.999999999954904,0.936587360496812,0,1,ESCRT complex assembly,BP,
19050,GO:1904902,0.999999999954904,0.936587360496812,0,1,ESCRT III complex assembly,BP,
19095,GO:1904999,0.999999999954904,0.936587360496812,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
19859,GO:2000332,0.999999999954904,0.936587360496812,0,1,regulation of blood microparticle formation,BP,
19860,GO:2000334,0.999999999954904,0.936587360496812,0,1,positive regulation of blood microparticle formation,BP,
3131,GO:0006713,0.999999999954921,0.934737562152447,0,1,glucocorticoid catabolic process,BP,
11801,GO:0046680,0.999999999954943,0.930404869778461,0,1,response to DDT,BP,
20104,GO:2000775,0.999999999954943,0.930404869778461,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
1924,GO:0004618,0.999999999954964,0.925813909637166,0,1,phosphoglycerate kinase activity,MF,
620,GO:0001794,0.999999999954972,0.895562859491553,0,1,type IIa hypersensitivity,BP,
621,GO:0001796,0.999999999954972,0.895562859491553,0,1,regulation of type IIa hypersensitivity,BP,
622,GO:0001798,0.999999999954972,0.895562859491553,0,1,positive regulation of type IIa hypersensitivity,BP,
740,GO:0001970,0.999999999954972,0.895562859491553,0,1,positive regulation of activation of membrane attack complex,BP,
988,GO:0002445,0.999999999954972,0.895562859491553,0,1,type II hypersensitivity,BP,
1222,GO:0002892,0.999999999954972,0.895562859491553,0,1,regulation of type II hypersensitivity,BP,
1223,GO:0002894,0.999999999954972,0.895562859491553,0,1,positive regulation of type II hypersensitivity,BP,
7522,GO:0031714,0.999999999954972,0.895562859491553,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
7523,GO:0031715,0.999999999954972,0.895562859491553,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
9534,GO:0036266,0.999999999954999,0.924155309164411,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
15902,GO:0072671,0.999999999954999,0.924155309164411,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
1263,GO:0003017,0.999999999955009,0.87166550524515,0,1,lymph circulation,BP,
3648,GO:0008120,0.999999999955011,0.93709300111006,0,1,ceramide glucosyltransferase activity,MF,
17170,GO:0102769,0.999999999955011,0.93709300111006,0,1,dihydroceramide glucosyltransferase activity,MF,
2173,GO:0005009,0.999999999955025,0.872270046720061,0,1,insulin-activated receptor activity,MF,
17118,GO:0102005,0.999999999955044,0.939010961368535,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
839,GO:0002144,0.999999999955124,0.93022373084437,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
8247,GO:0033018,0.999999999955157,0.851322820079563,0,2,sarcoplasmic reticulum lumen,CC,
14786,GO:0070489,0.999999999955169,0.905619183381718,0,1,T cell aggregation,BP,
3997,GO:0008897,0.999999999955202,0.919965039367805,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
1596,GO:0004014,0.999999999955263,0.914510182962411,0,1,adenosylmethionine decarboxylase activity,MF,
3012,GO:0006557,0.999999999955263,0.914510182962411,0,1,S-adenosylmethioninamine biosynthetic process,BP,
6244,GO:0019810,0.999999999955263,0.914510182962411,0,1,putrescine binding,MF,
11708,GO:0046499,0.999999999955263,0.914510182962411,0,1,S-adenosylmethioninamine metabolic process,BP,
14445,GO:0061760,0.999999999955293,0.919069206427621,0,1,antifungal innate immune response,BP,
15137,GO:0071228,0.999999999955293,0.919069206427621,0,1,cellular response to tumor cell,BP,
19104,GO:1905034,0.999999999955293,0.919069206427621,0,1,regulation of antifungal innate immune response,BP,
19105,GO:1905035,0.999999999955293,0.919069206427621,0,1,negative regulation of antifungal innate immune response,BP,
5809,GO:0017064,0.999999999955305,0.93020981212611,0,1,fatty acid amide hydrolase activity,MF,
17122,GO:0102077,0.999999999955305,0.93020981212611,0,1,oleamide hydrolase activity,MF,
17186,GO:0103073,0.999999999955305,0.93020981212611,0,1,anandamide amidohydrolase activity,MF,
19119,GO:1905062,0.999999999955307,0.922042700605395,0,1,positive regulation of cardioblast proliferation,BP,
6452,GO:0021771,0.999999999955321,0.891814362096035,0,1,lateral geniculate nucleus development,BP,
9953,GO:0042320,0.999999999955321,0.891814362096035,0,1,regulation of circadian sleep/wake cycle, REM sleep,BP,
13613,GO:0060084,0.999999999955321,0.891814362096035,0,1,synaptic transmission involved in micturition,BP,
16888,GO:0098829,0.999999999955328,0.887109262108678,0,1,intestinal folate absorption,BP,
18843,GO:1904447,0.999999999955328,0.887109262108678,0,1,folic acid import across plasma membrane,BP,
14890,GO:0070678,0.999999999955385,0.922405300527648,0,1,preprotein binding,MF,
9225,GO:0035611,0.999999999955423,0.920215665826286,0,1,protein branching point deglutamylation,BP,
14707,GO:0070335,0.999999999955429,0.883187620205823,0,1,aspartate binding,MF,
6419,GO:0021682,0.999999999955434,0.891919576022784,0,1,nerve maturation,BP,
12050,GO:0047915,0.99999999995548,0.936343603231335,0,1,ganglioside galactosyltransferase activity,MF,
9637,GO:0036505,0.999999999955499,0.918729398371829,0,1,prosaposin receptor activity,MF,
2256,GO:0005170,0.999999999955521,0.894237135783899,0,1,neurotrophin TRKC receptor binding,MF,
8544,GO:0033871,0.999999999955528,0.932438290748245,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
11927,GO:0046970,0.999999999955528,0.932438290748245,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
14302,GO:0061433,0.999999999955528,0.932438290748245,0,1,cellular response to caloric restriction,BP,
14765,GO:0070446,0.999999999955528,0.932438290748245,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
1802,GO:0004446,0.999999999955611,0.920168269807589,0,1,inositol-hexakisphosphate phosphatase activity,MF,
6874,GO:0030351,0.999999999955611,0.920168269807589,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
8530,GO:0033787,0.999999999955611,0.920168269807589,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
8756,GO:0034417,0.999999999955611,0.920168269807589,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
13424,GO:0052826,0.999999999955611,0.920168269807589,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
2487,GO:0005731,0.999999999955619,0.935798545110541,0,1,nucleolus organizer region,CC,
3348,GO:0007072,0.999999999955619,0.935798545110541,0,1,positive regulation of transcription involved in exit from mitosis,BP,
7082,GO:0030874,0.999999999955619,0.935798545110541,0,1,nucleolar chromatin,CC,
16580,GO:0097372,0.999999999955619,0.935798545110541,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
14251,GO:0061301,0.999999999955626,0.881819338128103,0,1,cerebellum vasculature morphogenesis,BP,
14575,GO:0070103,0.999999999955709,0.93600994989291,0,1,regulation of interleukin-6-mediated signaling pathway,BP,
14576,GO:0070104,0.999999999955709,0.93600994989291,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
17901,GO:1902205,0.999999999955709,0.93600994989291,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
17902,GO:1902206,0.999999999955709,0.93600994989291,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
17906,GO:1902215,0.999999999955709,0.93600994989291,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
17915,GO:1902227,0.999999999955709,0.93600994989291,0,1,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
17921,GO:1902233,0.999999999955709,0.93600994989291,0,1,negative regulation of positive thymic T cell selection,BP,
18654,GO:1903970,0.999999999955709,0.93600994989291,0,1,negative regulation of response to macrophage colony-stimulating factor,BP,
18657,GO:1903973,0.999999999955709,0.93600994989291,0,1,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18313,GO:1903237,0.999999999955714,0.950720408282402,0,1,negative regulation of leukocyte tethering or rolling,BP,
13971,GO:0060678,0.999999999955748,0.928048086862676,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
15631,GO:0072127,0.999999999955748,0.928048086862676,0,1,renal capsule development,BP,
15632,GO:0072128,0.999999999955748,0.928048086862676,0,1,renal capsule morphogenesis,BP,
15633,GO:0072129,0.999999999955748,0.928048086862676,0,1,renal capsule formation,BP,
15634,GO:0072130,0.999999999955748,0.928048086862676,0,1,renal capsule specification,BP,
15688,GO:0072213,0.999999999955748,0.928048086862676,0,1,metanephric capsule development,BP,
15713,GO:0072265,0.999999999955748,0.928048086862676,0,1,metanephric capsule morphogenesis,BP,
15714,GO:0072266,0.999999999955748,0.928048086862676,0,1,metanephric capsule formation,BP,
15715,GO:0072267,0.999999999955748,0.928048086862676,0,1,metanephric capsule specification,BP,
2233,GO:0005137,0.99999999995577,0.929350828935846,0,1,interleukin-5 receptor binding,MF,
2598,GO:0005895,0.99999999995577,0.929350828935846,0,1,interleukin-5 receptor complex,CC,
13416,GO:0052810,0.999999999955779,0.908432712672089,0,1,1-phosphatidylinositol-5-kinase activity,MF,
641,GO:0001831,0.999999999955808,0.885268921637291,0,1,trophectodermal cellular morphogenesis,BP,
14639,GO:0070209,0.999999999955808,0.913462234553626,0,1,ASTRA complex,CC,
18639,GO:1903939,0.999999999955808,0.913462234553626,0,1,regulation of TORC2 signaling,BP,
18866,GO:1904515,0.999999999955808,0.913462234553626,0,1,positive regulation of TORC2 signaling,BP,
3877,GO:0008507,0.999999999955862,0.910312468232297,0,1,sodium:iodide symporter activity,MF,
8548,GO:0033882,0.999999999955888,0.944763773760718,0,1,choloyl-CoA hydrolase activity,MF,
11164,GO:0045222,0.999999999955888,0.944763773760718,0,1,CD4 biosynthetic process,BP,
11165,GO:0045223,0.999999999955888,0.944763773760718,0,1,regulation of CD4 biosynthetic process,BP,
11166,GO:0045225,0.999999999955888,0.944763773760718,0,1,negative regulation of CD4 biosynthetic process,BP,
13420,GO:0052815,0.999999999955888,0.944763773760718,0,1,medium-chain acyl-CoA hydrolase activity,MF,
9349,GO:0035860,0.999999999955925,0.828043777942131,0,2,glial cell-derived neurotrophic factor receptor signaling pathway,BP,
2055,GO:0004807,0.999999999955948,0.939805085290636,0,1,triose-phosphate isomerase activity,MF,
1940,GO:0004642,0.999999999955983,0.893763815399073,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
17246,GO:0120012,0.999999999955983,0.893763815399073,0,1,intermembrane sphingolipid transfer,BP,
17248,GO:0120016,0.999999999955983,0.893763815399073,0,1,intermembrane sphingolipid transfer activity,MF,
17249,GO:0120017,0.999999999955983,0.893763815399073,0,1,intermembrane ceramide transfer activity,MF,
14992,GO:0070903,0.999999999956004,0.932124158072409,0,1,mitochondrial tRNA thio-modification,BP,
12027,GO:0047676,0.999999999956036,0.895191046043031,0,1,arachidonate-CoA ligase activity,MF,
1553,GO:0003952,0.999999999956039,0.925585147107009,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1580,GO:0003990,0.999999999956039,0.925585147107009,0,1,acetylcholinesterase activity,MF,
4822,GO:0014016,0.999999999956039,0.925585147107009,0,1,neuroblast differentiation,BP,
11672,GO:0046448,0.999999999956039,0.925585147107009,0,1,tropane alkaloid metabolic process,BP,
12605,GO:0050783,0.999999999956039,0.925585147107009,0,1,cocaine metabolic process,BP,
1566,GO:0003973,0.999999999956069,0.889474253911372,0,1,(S)-2-hydroxy-acid oxidase activity,MF,
6317,GO:0019962,0.999999999956069,0.889474253911372,0,1,type I interferon binding,MF,
12014,GO:0047545,0.999999999956069,0.889474253911372,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
14771,GO:0070463,0.999999999956088,0.911726442448346,0,1,tubulin-dependent ATPase activity,MF,
1695,GO:0004170,0.999999999956113,0.933505267099432,0,1,dUTP diphosphatase activity,MF,
11548,GO:0046080,0.999999999956113,0.933505267099432,0,1,dUTP metabolic process,BP,
11549,GO:0046081,0.999999999956113,0.933505267099432,0,1,dUTP catabolic process,BP,
5661,GO:0016768,0.999999999956178,0.936176556593749,0,1,spermine synthase activity,MF,
8555,GO:0033961,0.999999999956293,0.935340489872257,0,1,cis-stilbene-oxide hydrolase activity,MF,
14852,GO:0070611,0.999999999956318,0.922995620814747,0,1,histone methyltransferase activity (H3-R2 specific),MF,
14853,GO:0070612,0.999999999956318,0.922995620814747,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
8903,GO:0034722,0.999999999956321,0.939295907702363,0,1,gamma-glutamyl-peptidase activity,MF,
4442,GO:0010335,0.999999999956329,0.900488938638884,0,1,response to non-ionic osmotic stress,BP,
8554,GO:0033925,0.999999999956329,0.900488938638884,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
15288,GO:0071471,0.999999999956329,0.900488938638884,0,1,cellular response to non-ionic osmotic stress,BP,
5005,GO:0015152,0.999999999956358,0.930181981066452,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
7629,GO:0032028,0.999999999956358,0.930181981066452,0,1,myosin head/neck binding,MF,
15923,GO:0072706,0.999999999956382,0.923900570807148,0,1,response to sodium dodecyl sulfate,BP,
15924,GO:0072707,0.999999999956382,0.923900570807148,0,1,cellular response to sodium dodecyl sulfate,BP,
8487,GO:0033633,0.999999999956403,0.897607095172555,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
1642,GO:0004085,0.999999999956413,0.932811311366122,0,1,butyryl-CoA dehydrogenase activity,MF,
6185,GO:0019605,0.999999999956413,0.932811311366122,0,1,butyrate metabolic process,BP,
11642,GO:0046359,0.999999999956413,0.932811311366122,0,1,butyrate catabolic process,BP,
13448,GO:0052890,0.999999999956413,0.932811311366122,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
16367,GO:0090667,0.999999999956489,0.878973298908918,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
16368,GO:0090668,0.999999999956489,0.878973298908918,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
3532,GO:0007518,0.999999999956506,0.926589302056625,0,1,myoblast fate determination,BP,
8531,GO:0033814,0.999999999956541,0.940430080099191,0,1,propanoyl-CoA C-acyltransferase activity,MF,
12506,GO:0050632,0.999999999956541,0.940430080099191,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
14811,GO:0070538,0.999999999956541,0.940430080099191,0,1,oleic acid binding,MF,
17641,GO:1901373,0.999999999956541,0.940430080099191,0,1,lipid hydroperoxide transport,BP,
1839,GO:0004494,0.999999999956573,0.918593432665629,0,1,methylmalonyl-CoA mutase activity,MF,
14190,GO:0061091,0.999999999956583,0.896253803888931,0,1,regulation of phospholipid translocation,BP,
14191,GO:0061092,0.999999999956583,0.896253803888931,0,1,positive regulation of phospholipid translocation,BP,
18382,GO:1903387,0.999999999956594,0.894572316879735,0,1,positive regulation of homophilic cell adhesion,BP,
6043,GO:0019150,0.999999999956596,0.930845337266233,0,1,D-ribulokinase activity,MF,
9701,GO:0038098,0.999999999956596,0.93116840103031,0,1,sequestering of BMP from receptor via BMP binding,BP,
15040,GO:0070984,0.999999999956598,0.903568050161391,0,1,SET domain binding,MF,
2696,GO:0006061,0.999999999956628,0.940720154220845,0,1,sorbitol biosynthetic process,BP,
5989,GO:0018931,0.999999999956628,0.940720154220845,0,1,naphthalene metabolic process,BP,
6138,GO:0019406,0.999999999956628,0.940720154220845,0,1,hexitol biosynthetic process,BP,
10661,GO:0043795,0.999999999956628,0.940720154220845,0,1,glyceraldehyde oxidoreductase activity,MF,
16306,GO:0090420,0.999999999956628,0.940720154220845,0,1,naphthalene-containing compound metabolic process,BP,
1791,GO:0004420,0.999999999956637,0.900332282181627,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
9934,GO:0042282,0.999999999956637,0.900332282181627,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
1498,GO:0003844,0.999999999956654,0.916595600936339,0,1,1,4-alpha-glucan branching enzyme activity,MF,
17167,GO:0102752,0.999999999956654,0.916595600936339,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
494,GO:0001546,0.999999999956661,0.936816716924082,0,1,preantral ovarian follicle growth,BP,
1686,GO:0004155,0.999999999956661,0.936816716924082,0,1,6,7-dihydropteridine reductase activity,MF,
12113,GO:0048162,0.999999999956661,0.936816716924082,0,1,multi-layer follicle stage,BP,
1958,GO:0004662,0.999999999956678,0.864184824522242,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2627,GO:0005953,0.999999999956678,0.864184824522242,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
20072,GO:2000721,0.999999999956684,0.899692540473864,0,1,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
8873,GO:0034677,0.999999999956691,0.908081085516369,0,1,integrin alpha7-beta1 complex,CC,
8876,GO:0034681,0.999999999956691,0.908081085516369,0,1,integrin alpha11-beta1 complex,CC,
3915,GO:0008579,0.999999999956708,0.894559097110325,0,1,JUN kinase phosphatase activity,MF,
19088,GO:1904990,0.99999999995672,0.925645683273365,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
19089,GO:1904992,0.99999999995672,0.925645683273365,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
12461,GO:0050290,0.999999999956737,0.898408942149892,0,1,sphingomyelin phosphodiesterase D activity,MF,
9269,GO:0035691,0.999999999956769,0.942185382466528,0,1,macrophage migration inhibitory factor signaling pathway,BP,
9271,GO:0035693,0.999999999956769,0.942185382466528,0,1,NOS2-CD74 complex,CC,
10124,GO:0042658,0.999999999956769,0.942185382466528,0,1,MHC class II protein binding, via antigen binding groove,MF,
16129,GO:0090119,0.999999999956792,0.900176850724311,0,1,vesicle-mediated cholesterol transport,BP,
19665,GO:1990926,0.999999999956792,0.900176850724311,0,1,short-term synaptic potentiation,BP,
5767,GO:0016941,0.999999999956796,0.912104494302779,0,1,natriuretic peptide receptor activity,MF,
13718,GO:0060283,0.999999999956796,0.912104494302779,0,1,negative regulation of oocyte development,BP,
13859,GO:0060465,0.999999999956796,0.912104494302779,0,1,pharynx development,BP,
17431,GO:1900194,0.999999999956796,0.912104494302779,0,1,negative regulation of oocyte maturation,BP,
19385,GO:1905880,0.999999999956796,0.912104494302779,0,1,negative regulation of oogenesis,BP,
58,GO:0000121,0.999999999956798,0.916283773746705,0,1,glycerol-1-phosphatase activity,MF,
10340,GO:0043136,0.999999999956798,0.916283773746705,0,1,glycerol-3-phosphatase activity,MF,
12568,GO:0050720,0.999999999956798,0.916283773746705,0,1,interleukin-1 beta biosynthetic process,BP,
12570,GO:0050722,0.999999999956798,0.916283773746705,0,1,regulation of interleukin-1 beta biosynthetic process,BP,
12571,GO:0050725,0.999999999956798,0.916283773746705,0,1,positive regulation of interleukin-1 beta biosynthetic process,BP,
15732,GO:0072303,0.999999999956798,0.916283773746705,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
1783,GO:0004397,0.999999999956805,0.915985861249166,0,1,histidine ammonia-lyase activity,MF,
2110,GO:0004890,0.999999999956805,0.915985861249166,0,1,GABA-A receptor activity,MF,
2283,GO:0005237,0.999999999956805,0.915985861249166,0,1,inhibitory extracellular ligand-gated ion channel activity,MF,
6181,GO:0019556,0.999999999956805,0.915985861249166,0,1,histidine catabolic process to glutamate and formamide,BP,
6182,GO:0019557,0.999999999956805,0.915985861249166,0,1,histidine catabolic process to glutamate and formate,BP,
6624,GO:0022851,0.999999999956805,0.915985861249166,0,1,GABA-gated chloride ion channel activity,MF,
10617,GO:0043606,0.999999999956805,0.915985861249166,0,1,formamide metabolic process,BP,
17006,GO:0099095,0.999999999956805,0.915985861249166,0,1,ligand-gated anion channel activity,MF,
18088,GO:1902710,0.999999999956805,0.915985861249166,0,1,GABA receptor complex,CC,
18089,GO:1902711,0.999999999956805,0.915985861249166,0,1,GABA-A receptor complex,CC,
2163,GO:0004998,0.999999999956823,0.895354076520802,0,1,transferrin receptor activity,MF,
4975,GO:0015091,0.999999999956823,0.895354076520802,0,1,ferric iron transmembrane transporter activity,MF,
8448,GO:0033570,0.999999999956823,0.895354076520802,0,1,transferrin transmembrane transporter activity,MF,
15814,GO:0072510,0.999999999956823,0.895354076520802,0,1,trivalent inorganic cation transmembrane transporter activity,MF,
4523,GO:0010585,0.999999999956836,0.932725055428011,0,1,glutamine secretion,BP,
18575,GO:1903803,0.999999999956836,0.932725055428011,0,1,L-glutamine import across plasma membrane,BP,
5093,GO:0015367,0.999999999956886,0.934871032135391,0,1,oxoglutarate:malate antiporter activity,MF,
5180,GO:0015742,0.999999999956886,0.934871032135391,0,1,alpha-ketoglutarate transport,BP,
18521,GO:1903699,0.99999999995689,0.857801554052895,0,1,tarsal gland development,BP,
18527,GO:1903709,0.99999999995689,0.857801554052895,0,1,uterine gland development,BP,
2617,GO:0005927,0.999999999956942,0.938412932028615,0,1,muscle tendon junction,CC,
8660,GO:0034213,0.999999999956942,0.938412932028615,0,1,quinolinate catabolic process,BP,
11870,GO:0046874,0.999999999956942,0.938412932028615,0,1,quinolinate metabolic process,BP,
3813,GO:0008404,0.999999999956978,0.93369444915431,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
3814,GO:0008405,0.999999999956978,0.93369444915431,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
15374,GO:0071614,0.999999999956978,0.93369444915431,0,1,linoleic acid epoxygenase activity,MF,
5917,GO:0018192,0.999999999957041,0.925450667441452,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
7881,GO:0032447,0.999999999957041,0.925450667441452,0,1,protein urmylation,BP,
9940,GO:0042292,0.999999999957041,0.925450667441452,0,1,URM1 activating enzyme activity,MF,
14372,GO:0061604,0.999999999957041,0.925450667441452,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
14373,GO:0061605,0.999999999957041,0.925450667441452,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
16884,GO:0098822,0.999999999957041,0.925450667441452,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
16468,GO:0097145,0.999999999957049,0.928992788975033,0,1,BAK complex,CC,
18237,GO:1903045,0.999999999957071,0.892136593086925,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
8035,GO:0032681,0.99999999995711,0.921941915504683,0,1,regulation of lymphotoxin A production,BP,
8080,GO:0032761,0.99999999995711,0.921941915504683,0,1,positive regulation of lymphotoxin A production,BP,
10274,GO:0043016,0.99999999995711,0.921941915504683,0,1,regulation of lymphotoxin A biosynthetic process,BP,
10275,GO:0043017,0.99999999995711,0.921941915504683,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11234,GO:0045404,0.99999999995711,0.921941915504683,0,1,positive regulation of interleukin-4 biosynthetic process,BP,
19440,GO:1990074,0.999999999957148,0.911182650932067,0,1,polyuridylation-dependent mRNA catabolic process,BP,
14856,GO:0070618,0.999999999957187,0.922311324410258,0,1,Grb2-Sos complex,CC,
8494,GO:0033650,0.999999999957226,0.935273200891107,0,1,host cell mitochondrion,CC,
10758,GO:0044190,0.999999999957226,0.935273200891107,0,1,host cell mitochondrial envelope,CC,
15804,GO:0072492,0.999999999957226,0.935273200891107,0,1,host cell mitochondrial intermembrane space,CC,
6318,GO:0019964,0.999999999957231,0.911804492991547,0,1,interferon-gamma binding,MF,
19507,GO:1990390,0.999999999957231,0.911804492991547,0,1,protein K33-linked ubiquitination,BP,
1746,GO:0004346,0.999999999957242,0.937031505520147,0,1,glucose-6-phosphatase activity,MF,
12465,GO:0050309,0.999999999957242,0.937031505520147,0,1,sugar-terminal-phosphatase activity,MF,
2843,GO:0006311,0.999999999957253,0.915972328980766,0,1,meiotic gene conversion,BP,
5388,GO:0016213,0.999999999957253,0.915972328980766,0,1,linoleoyl-CoA desaturase activity,MF,
11110,GO:0045128,0.999999999957253,0.915972328980766,0,1,negative regulation of reciprocal meiotic recombination,BP,
17237,GO:0110029,0.999999999957253,0.915972328980766,0,1,negative regulation of meiosis I,BP,
1526,GO:0003905,0.999999999957341,0.945983505969998,0,1,alkylbase DNA N-glycosylase activity,MF,
3961,GO:0008725,0.999999999957341,0.945983505969998,0,1,DNA-3-methyladenine glycosylase activity,MF,
10656,GO:0043733,0.999999999957341,0.945983505969998,0,1,DNA-3-methylbase glycosylase activity,MF,
10675,GO:0043916,0.999999999957341,0.945983505969998,0,1,DNA-7-methylguanine glycosylase activity,MF,
13421,GO:0052821,0.999999999957341,0.945983505969998,0,1,DNA-7-methyladenine glycosylase activity,MF,
13422,GO:0052822,0.999999999957341,0.945983505969998,0,1,DNA-3-methylguanine glycosylase activity,MF,
8412,GO:0033385,0.999999999957438,0.920655277984712,0,1,geranylgeranyl diphosphate metabolic process,BP,
8413,GO:0033386,0.999999999957438,0.920655277984712,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
5370,GO:0016175,0.999999999957469,0.883426404430834,0,2,superoxide-generating NADPH oxidase activity,MF,
4450,GO:0010387,0.999999999957482,0.927639556282481,0,1,COP9 signalosome assembly,BP,
6161,GO:0019510,0.999999999957482,0.927639556282481,0,1,S-adenosylhomocysteine catabolic process,BP,
15158,GO:0071268,0.999999999957482,0.927639556282481,0,1,homocysteine biosynthetic process,BP,
4319,GO:0009810,0.999999999957503,0.928786766209772,0,1,stilbene metabolic process,BP,
8550,GO:0033885,0.999999999957503,0.928786766209772,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
11609,GO:0046272,0.999999999957503,0.928786766209772,0,1,stilbene catabolic process,BP,
19083,GO:1904977,0.999999999957505,0.919734523376728,0,1,lymphatic endothelial cell migration,BP,
15344,GO:0071566,0.999999999957524,0.918797373433358,0,1,UFM1 activating enzyme activity,MF,
2033,GO:0004773,0.999999999957548,0.887761134838622,0,1,steryl-sulfatase activity,MF,
16736,GO:0097749,0.999999999957548,0.887761134838622,0,1,membrane tubulation,BP,
1599,GO:0004018,0.99999999995755,0.939486460565844,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
14858,GO:0070626,0.99999999995755,0.939486460565844,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
269,GO:0000741,0.999999999957576,0.935362936318846,0,1,karyogamy,BP,
3483,GO:0007344,0.999999999957576,0.935362936318846,0,1,pronuclear fusion,BP,
13159,GO:0051732,0.999999999957576,0.935362936318846,0,1,polyribonucleotide kinase activity,MF,
13162,GO:0051736,0.999999999957576,0.935362936318846,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
2080,GO:0004835,0.999999999957599,0.89539159178085,0,1,tubulin-tyrosine ligase activity,MF,
5914,GO:0018166,0.999999999957599,0.89539159178085,0,1,C-terminal protein-tyrosinylation,BP,
5955,GO:0018322,0.999999999957599,0.89539159178085,0,1,protein tyrosinylation,BP,
4890,GO:0014810,0.999999999957604,0.951268385483909,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
7556,GO:0031883,0.999999999957607,0.930265499806454,0,1,taste receptor binding,MF,
11046,GO:0045027,0.999999999957607,0.930265499806454,0,1,DNA end binding,MF,
341,GO:0000941,0.999999999957615,0.928157240844007,0,1,condensed nuclear chromosome inner kinetochore,CC,
13021,GO:0051456,0.999999999957615,0.928157240844007,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
9935,GO:0042284,0.99999999995762,0.933796541752877,0,1,sphingolipid delta-4 desaturase activity,MF,
16478,GO:0097158,0.999999999957644,0.936939368171477,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17948,GO:1902296,0.999999999957689,0.914155326216879,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
17961,GO:1902319,0.999999999957689,0.914155326216879,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
18200,GO:1902983,0.999999999957689,0.914155326216879,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
6357,GO:0021538,0.999999999957735,0.91098957200578,0,1,epithalamus development,BP,
6554,GO:0021986,0.999999999957735,0.91098957200578,0,1,habenula development,BP,
13214,GO:0051866,0.999999999957735,0.91098957200578,0,1,general adaptation syndrome,BP,
3473,GO:0007308,0.999999999957812,0.923867055509002,0,1,oocyte construction,BP,
3474,GO:0007309,0.999999999957812,0.923867055509002,0,1,oocyte axis specification,BP,
3475,GO:0007314,0.999999999957812,0.923867055509002,0,1,oocyte anterior/posterior axis specification,BP,
3476,GO:0007315,0.999999999957812,0.923867055509002,0,1,pole plasm assembly,BP,
3792,GO:0008358,0.999999999957812,0.923867055509002,0,1,maternal determination of anterior/posterior axis, embryo,BP,
7015,GO:0030719,0.999999999957812,0.923867055509002,0,1,P granule organization,BP,
9309,GO:0035755,0.999999999957812,0.923867055509002,0,1,cardiolipin hydrolase activity,MF,
6335,GO:0021508,0.999999999957816,0.885382276846465,0,1,floor plate formation,BP,
8427,GO:0033505,0.999999999957816,0.885382276846465,0,1,floor plate morphogenesis,BP,
13568,GO:0060032,0.999999999957816,0.885382276846465,0,1,notochord regression,BP,
12435,GO:0050023,0.999999999957825,0.933665308961899,0,1,L-fuconate dehydratase activity,MF,
1514,GO:0003875,0.999999999957853,0.912209135054874,0,1,ADP-ribosylarginine hydrolase activity,MF,
20040,GO:2000663,0.999999999957869,0.909694044718639,0,1,negative regulation of interleukin-5 secretion,BP,
20034,GO:2000656,0.999999999957907,0.933418133557517,0,1,regulation of apolipoprotein binding,BP,
20035,GO:2000657,0.999999999957907,0.933418133557517,0,1,negative regulation of apolipoprotein binding,BP,
4701,GO:0010859,0.999999999957922,0.901556656913903,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
1661,GO:0004117,0.999999999957926,0.922069571672684,0,1,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
2041,GO:0004782,0.999999999957926,0.922069571672684,0,1,sulfinoalanine decarboxylase activity,MF,
3846,GO:0008455,0.999999999957926,0.922069571672684,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
3895,GO:0008531,0.999999999957926,0.922069571672684,0,1,riboflavin kinase activity,MF,
4166,GO:0009231,0.999999999957926,0.922069571672684,0,1,riboflavin biosynthetic process,BP,
4224,GO:0009398,0.999999999957926,0.922069571672684,0,1,FMN biosynthetic process,BP,
9998,GO:0042412,0.999999999957926,0.922069571672684,0,1,taurine biosynthetic process,BP,
11614,GO:0046305,0.999999999957926,0.922069571672684,0,1,alkanesulfonate biosynthetic process,BP,
11671,GO:0046444,0.999999999957926,0.922069571672684,0,1,FMN metabolic process,BP,
19787,GO:2000211,0.999999999957934,0.896218394153933,0,1,regulation of glutamate metabolic process,BP,
19788,GO:2000212,0.999999999957934,0.896218394153933,0,1,negative regulation of glutamate metabolic process,BP,
11153,GO:0045208,0.999999999957952,0.910528758615175,0,1,MAPK phosphatase export from nucleus,BP,
11154,GO:0045209,0.999999999957952,0.910528758615175,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
4736,GO:0010900,0.999999999957954,0.95705901437573,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
10177,GO:0042766,0.999999999957967,0.876658148433293,0,1,nucleosome mobilization,BP,
19590,GO:1990700,0.999999999957981,0.905988822974181,0,1,nucleolar chromatin organization,BP,
14498,GO:0061944,0.999999999958009,0.901937988270941,0,1,negative regulation of protein K48-linked ubiquitination,BP,
6878,GO:0030372,0.999999999958025,0.897996310622144,0,1,high molecular weight B cell growth factor receptor binding,MF,
11111,GO:0045131,0.999999999958034,0.918321457276006,0,1,pre-mRNA branch point binding,MF,
12635,GO:0050822,0.999999999958039,0.91135047701036,0,1,peptide stabilization,BP,
12636,GO:0050823,0.999999999958039,0.91135047701036,0,1,peptide antigen stabilization,BP,
491,GO:0001543,0.999999999958045,0.880792784163305,0,1,ovarian follicle rupture,BP,
4909,GO:0014843,0.999999999958045,0.885406150191006,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
10126,GO:0042660,0.999999999958045,0.885406150191006,0,1,positive regulation of cell fate specification,BP,
736,GO:0001966,0.999999999958099,0.941417156694752,0,1,thigmotaxis,BP,
15971,GO:0080058,0.999999999958099,0.941417156694752,0,1,protein deglutathionylation,BP,
16671,GO:0097573,0.999999999958099,0.941417156694752,0,1,glutathione oxidoreductase activity,MF,
10614,GO:0043602,0.9999999999581,0.924711961648157,0,1,nitrate catabolic process,BP,
11605,GO:0046210,0.9999999999581,0.924711961648157,0,1,nitric oxide catabolic process,BP,
12034,GO:0047726,0.9999999999581,0.924711961648157,0,1,iron-cytochrome-c reductase activity,MF,
16281,GO:0090345,0.9999999999581,0.924711961648157,0,1,cellular organohalogen metabolic process,BP,
16282,GO:0090346,0.9999999999581,0.924711961648157,0,1,cellular organofluorine metabolic process,BP,
16242,GO:0090290,0.999999999958115,0.94678677650505,0,1,positive regulation of osteoclast proliferation,BP,
17982,GO:1902396,0.999999999958151,0.90638662196745,0,1,protein localization to bicellular tight junction,BP,
4925,GO:0014876,0.999999999958163,0.941076052933414,0,1,response to injury involved in regulation of muscle adaptation,BP,
966,GO:0002408,0.999999999958179,0.893189253220341,0,1,myeloid dendritic cell chemotaxis,BP,
8287,GO:0033091,0.999999999958221,0.923625754779338,0,1,positive regulation of immature T cell proliferation,BP,
15105,GO:0071148,0.999999999958228,0.77835155957432,0,2,TEAD-1-YAP complex,CC,
16389,GO:0093001,0.999999999958229,0.91520254176166,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17823,GO:1901980,0.999999999958304,0.866758686937924,0,1,positive regulation of inward rectifier potassium channel activity,BP,
6501,GO:0021870,0.999999999958316,0.889523086088171,0,1,Cajal-Retzius cell differentiation,BP,
18994,GO:1904797,0.999999999958316,0.889523086088171,0,1,negative regulation of core promoter binding,BP,
6886,GO:0030395,0.999999999958341,0.955333676627132,0,1,lactose binding,MF,
8609,GO:0034117,0.999999999958341,0.955333676627132,0,1,erythrocyte aggregation,BP,
8610,GO:0034118,0.999999999958341,0.955333676627132,0,1,regulation of erythrocyte aggregation,BP,
8611,GO:0034120,0.999999999958341,0.955333676627132,0,1,positive regulation of erythrocyte aggregation,BP,
12081,GO:0048030,0.999999999958341,0.955333676627132,0,1,disaccharide binding,MF,
14449,GO:0061768,0.999999999958342,0.897546714678525,0,1,magnesium:sodium antiporter activity,MF,
2652,GO:0005991,0.999999999958356,0.918675014393839,0,1,trehalose metabolic process,BP,
14746,GO:0070413,0.999999999958356,0.918675014393839,0,1,trehalose metabolism in response to stress,BP,
14617,GO:0070180,0.999999999958365,0.954935972156321,0,1,large ribosomal subunit rRNA binding,MF,
14778,GO:0070476,0.999999999958365,0.954935972156321,0,1,rRNA (guanine-N7)-methylation,BP,
8326,GO:0033167,0.999999999958398,0.865690495660452,0,1,ARC complex,CC,
8327,GO:0033168,0.999999999958398,0.865690495660452,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
9586,GO:0036404,0.999999999958398,0.865690495660452,0,1,conversion of ds siRNA to ss siRNA,BP,
9237,GO:0035625,0.999999999958398,0.910567016810449,0,1,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9630,GO:0036497,0.999999999958436,0.926447497037547,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
17958,GO:1902310,0.999999999958436,0.926447497037547,0,1,positive regulation of peptidyl-serine dephosphorylation,BP,
18626,GO:1903916,0.999999999958436,0.926447497037547,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
18627,GO:1903917,0.999999999958436,0.926447497037547,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
1769,GO:0004373,0.999999999958465,0.912117566284305,0,1,glycogen (starch) synthase activity,MF,
14344,GO:0061547,0.999999999958465,0.912117566284305,0,1,glycogen synthase activity, transferring glucose-1-phosphate,MF,
11747,GO:0046587,0.999999999958501,0.917954260652491,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
18884,GO:1904567,0.999999999958501,0.917954260652491,0,1,response to wortmannin,BP,
18885,GO:1904568,0.999999999958501,0.917954260652491,0,1,cellular response to wortmannin,BP,
19583,GO:1990646,0.999999999958501,0.917954260652491,0,1,cellular response to prolactin,BP,
5115,GO:0015439,0.999999999958516,0.918280657899207,0,1,heme-transporting ATPase activity,MF,
18016,GO:1902504,0.999999999958516,0.918280657899207,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
13659,GO:0060171,0.999999999958537,0.898306938919253,0,1,stereocilium membrane,CC,
8349,GO:0033204,0.999999999958541,0.925054277934177,0,1,ribonuclease P RNA binding,MF,
2576,GO:0005863,0.99999999995855,0.908695471879688,0,1,striated muscle myosin thick filament,CC,
3311,GO:0007014,0.99999999995855,0.908695471879688,0,1,actin ubiquitination,BP,
9580,GO:0036392,0.99999999995855,0.908695471879688,0,1,chemokine (C-C motif) ligand 20 production,BP,
18602,GO:1903881,0.99999999995855,0.908695471879688,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
18603,GO:1903883,0.99999999995855,0.908695471879688,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
18604,GO:1903884,0.99999999995855,0.908695471879688,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
18605,GO:1903886,0.99999999995855,0.908695471879688,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
11827,GO:0046725,0.999999999958567,0.91047778905612,0,1,negative regulation by virus of viral protein levels in host cell,BP,
15666,GO:0072183,0.999999999958567,0.91047778905612,0,1,negative regulation of nephron tubule epithelial cell differentiation,BP,
15736,GO:0072308,0.999999999958567,0.91047778905612,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
19367,GO:1905799,0.999999999958572,0.95320945493469,0,1,regulation of intraciliary retrograde transport,BP,
1624,GO:0004060,0.999999999958581,0.931443309022982,0,1,arylamine N-acetyltransferase activity,MF,
6268,GO:0019862,0.999999999958606,0.93810012782335,0,1,IgA binding,MF,
10516,GO:0043423,0.999999999958628,0.901816305270888,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
19965,GO:2000537,0.999999999958628,0.901816305270888,0,1,regulation of B cell chemotaxis,BP,
19966,GO:2000538,0.999999999958628,0.901816305270888,0,1,positive regulation of B cell chemotaxis,BP,
15431,GO:0071701,0.999999999958652,0.897584431488412,0,1,regulation of MAPK export from nucleus,BP,
4666,GO:0010814,0.999999999958659,0.895604148378184,0,1,substance P catabolic process,BP,
4668,GO:0010816,0.999999999958659,0.895604148378184,0,1,calcitonin catabolic process,BP,
7303,GO:0031302,0.999999999958659,0.895604148378184,0,1,intrinsic component of endosome membrane,CC,
8934,GO:0034959,0.999999999958659,0.895604148378184,0,1,endothelin maturation,BP,
5339,GO:0016077,0.999999999958673,0.889905031557538,0,1,snoRNA catabolic process,BP,
9351,GO:0035862,0.999999999958673,0.889905031557538,0,1,dITP metabolic process,BP,
9352,GO:0035863,0.999999999958673,0.889905031557538,0,1,dITP catabolic process,BP,
12684,GO:0050897,0.999999999958673,0.889905031557538,0,1,cobalt ion binding,MF,
16584,GO:0097382,0.999999999958673,0.889905031557538,0,1,deoxynucleoside-diphosphatase activity,MF,
16585,GO:0097383,0.999999999958673,0.889905031557538,0,1,dIDP diphosphatase activity,MF,
17719,GO:1901639,0.999999999958673,0.889905031557538,0,1,XDP catabolic process,BP,
17720,GO:1901640,0.999999999958673,0.889905031557538,0,1,XTP binding,MF,
17721,GO:1901641,0.999999999958673,0.889905031557538,0,1,ITP binding,MF,
19419,GO:1990003,0.999999999958673,0.889905031557538,0,1,IDP phosphatase activity,MF,
3728,GO:0008254,0.999999999958684,0.882728389705293,0,1,3'-nucleotidase activity,MF,
3980,GO:0008803,0.999999999958688,0.947664447820757,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
16035,GO:0086057,0.999999999958696,0.906999816125095,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
19469,GO:1990174,0.999999999958696,0.906999816125095,0,1,phosphodiesterase decapping endonuclease activity,MF,
13995,GO:0060709,0.9999999999587,0.919924373937734,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
17107,GO:0100002,0.9999999999587,0.919924373937734,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
9709,GO:0038113,0.999999999958711,0.800550129397449,0,2,interleukin-9-mediated signaling pathway,BP,
15093,GO:0071104,0.999999999958711,0.800550129397449,0,2,response to interleukin-9,BP,
15210,GO:0071355,0.999999999958711,0.800550129397449,0,2,cellular response to interleukin-9,BP,
18406,GO:1903434,0.999999999958752,0.906964769874971,0,1,negative regulation of constitutive secretory pathway,BP,
10708,GO:0043997,0.999999999958777,0.916392195221785,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
17217,GO:0106075,0.999999999958777,0.916392195221785,0,1,peptide N-succinyltransferase activity,MF,
17219,GO:0106078,0.999999999958777,0.916392195221785,0,1,histone succinyltransferase activity,MF,
8408,GO:0033364,0.999999999958791,0.849342226584488,0,1,mast cell secretory granule organization,BP,
13059,GO:0051552,0.999999999958815,0.926758255550096,0,1,flavone metabolic process,BP,
15037,GO:0070980,0.999999999958815,0.926758255550096,0,1,biphenyl catabolic process,BP,
15180,GO:0071314,0.999999999958839,0.920803850740557,0,1,cellular response to cocaine,BP,
17969,GO:1902362,0.999999999958839,0.920803850740557,0,1,melanocyte apoptotic process,BP,
16709,GO:0097682,0.999999999958851,0.930195895534877,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
3646,GO:0008118,0.999999999958865,0.928560574392879,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
12013,GO:0047536,0.999999999958865,0.928560574392879,0,1,2-aminoadipate transaminase activity,MF,
16402,GO:0097020,0.999999999958907,0.913157190042853,0,1,COPII adaptor activity,MF,
3819,GO:0008413,0.999999999958956,0.887151232760596,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
9176,GO:0035539,0.999999999958956,0.887151232760596,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
14680,GO:0070292,0.999999999959026,0.895039173131303,0,1,N-acylphosphatidylethanolamine metabolic process,BP,
17133,GO:0102200,0.999999999959026,0.895039173131303,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
558,GO:0001681,0.999999999959036,0.920222435898463,0,1,sialate O-acetylesterase activity,MF,
3651,GO:0008126,0.999999999959036,0.920222435898463,0,1,acetylesterase activity,MF,
6269,GO:0019863,0.999999999959049,0.940671738452485,0,1,IgE binding,MF,
3733,GO:0008267,0.999999999959072,0.878080696049609,0,1,poly-glutamine tract binding,MF,
8947,GO:0034987,0.999999999959083,0.875154518582468,0,1,immunoglobulin receptor binding,MF,
8948,GO:0034988,0.999999999959083,0.875154518582468,0,1,Fc-gamma receptor I complex binding,MF,
13786,GO:0060372,0.999999999959083,0.875154518582468,0,1,regulation of atrial cardiac muscle cell membrane repolarization,BP,
19096,GO:1905000,0.999999999959083,0.875154518582468,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
5759,GO:0016920,0.999999999959088,0.883553498357499,0,1,pyroglutamyl-peptidase activity,MF,
14336,GO:0061519,0.999999999959179,0.910198315571834,0,1,macrophage homeostasis,BP,
1747,GO:0004347,0.999999999959185,0.930446723263744,0,1,glucose-6-phosphate isomerase activity,MF,
6085,GO:0019242,0.999999999959185,0.930446723263744,0,1,methylglyoxal biosynthetic process,BP,
17524,GO:1901004,0.999999999959195,0.942844304738669,0,1,ubiquinone-6 metabolic process,BP,
17525,GO:1901006,0.999999999959195,0.942844304738669,0,1,ubiquinone-6 biosynthetic process,BP,
2156,GO:0004980,0.999999999959196,0.916812716255599,0,1,melanocyte-stimulating hormone receptor activity,MF,
15853,GO:0072566,0.999999999959217,0.856237561075215,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
19861,GO:2000338,0.999999999959217,0.856237561075215,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
19862,GO:2000340,0.999999999959217,0.856237561075215,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
2105,GO:0004882,0.999999999959253,0.914342669088012,0,1,androgen receptor activity,MF,
9397,GO:0035935,0.999999999959253,0.914342669088012,0,1,androgen secretion,BP,
16481,GO:0097162,0.999999999959253,0.914342669088012,0,1,MADS box domain binding,MF,
20141,GO:2000834,0.999999999959253,0.914342669088012,0,1,regulation of androgen secretion,BP,
20142,GO:2000836,0.999999999959253,0.914342669088012,0,1,positive regulation of androgen secretion,BP,
18063,GO:1902618,0.999999999959265,0.890250988702726,0,1,cellular response to fluoride,BP,
5331,GO:0016062,0.99999999995928,0.923947493124811,0,1,adaptation of rhodopsin mediated signaling,BP,
9570,GO:0036367,0.99999999995928,0.923947493124811,0,1,light adaption,BP,
5430,GO:0016287,0.999999999959293,0.922284470303233,0,1,glycerone-phosphate O-acyltransferase activity,MF,
1084,GO:0002669,0.999999999959299,0.887646284763195,0,1,positive regulation of T cell anergy,BP,
1231,GO:0002913,0.999999999959299,0.887646284763195,0,1,positive regulation of lymphocyte anergy,BP,
6030,GO:0019089,0.999999999959299,0.887646284763195,0,1,transmission of virus,BP,
10712,GO:0044007,0.999999999959299,0.887646284763195,0,1,dissemination or transmission of symbiont from host,BP,
13201,GO:0051821,0.999999999959299,0.887646284763195,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
18952,GO:1904716,0.999999999959343,0.926623080518058,0,1,positive regulation of chaperone-mediated autophagy,BP,
3163,GO:0006772,0.99999999995935,0.93464874214618,0,1,thiamine metabolic process,BP,
9970,GO:0042357,0.99999999995935,0.93464874214618,0,1,thiamine diphosphate metabolic process,BP,
12468,GO:0050333,0.99999999995935,0.93464874214618,0,1,thiamin-triphosphatase activity,MF,
1793,GO:0004422,0.999999999959359,0.877178385186093,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
2765,GO:0006178,0.999999999959359,0.877178385186093,0,2,guanine salvage,BP,
7749,GO:0032263,0.999999999959359,0.877178385186093,0,2,GMP salvage,BP,
11558,GO:0046099,0.999999999959359,0.877178385186093,0,2,guanine biosynthetic process,BP,
10097,GO:0042602,0.999999999959364,0.949963482646618,0,1,riboflavin reductase (NADPH) activity,MF,
2185,GO:0005042,0.999999999959382,0.896446011960573,0,1,netrin receptor activity,MF,
1827,GO:0004482,0.999999999959387,0.888791955689998,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
7432,GO:0031533,0.999999999959387,0.888791955689998,0,1,mRNA cap methyltransferase complex,CC,
17192,GO:0106005,0.999999999959387,0.888791955689998,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
3396,GO:0007174,0.999999999959443,0.928444222184594,0,1,epidermal growth factor catabolic process,BP,
7859,GO:0032419,0.999999999959443,0.928444222184594,0,1,extrinsic component of lysosome membrane,CC,
19085,GO:1904979,0.999999999959443,0.928444222184594,0,1,negative regulation of endosome organization,BP,
19230,GO:1905365,0.999999999959443,0.928444222184594,0,1,regulation of intralumenal vesicle formation,BP,
19231,GO:1905366,0.999999999959443,0.928444222184594,0,1,negative regulation of intralumenal vesicle formation,BP,
4013,GO:0009007,0.999999999959444,0.90915782807072,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
8092,GO:0032775,0.999999999959444,0.90915782807072,0,1,DNA methylation on adenine,BP,
6001,GO:0019035,0.999999999959547,0.89176488807649,0,1,viral integration complex,CC,
11439,GO:0045870,0.999999999959547,0.89176488807649,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
19273,GO:1905463,0.999999999959547,0.89176488807649,0,1,negative regulation of DNA duplex unwinding,BP,
19532,GO:1990439,0.999999999959586,0.918804170616605,0,1,MAP kinase serine/threonine phosphatase activity,MF,
1658,GO:0004113,0.999999999959595,0.894985393410198,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1603,GO:0004022,0.999999999959618,0.922888330582025,0,1,alcohol dehydrogenase (NAD) activity,MF,
5975,GO:0018467,0.999999999959618,0.922888330582025,0,1,formaldehyde dehydrogenase activity,MF,
13240,GO:0051903,0.999999999959618,0.922888330582025,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
3522,GO:0007495,0.999999999959623,0.915580280617252,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
14782,GO:0070483,0.999999999959623,0.915580280617252,0,1,detection of hypoxia,BP,
13784,GO:0060370,0.999999999959689,0.891570290589182,0,1,susceptibility to T cell mediated cytotoxicity,BP,
513,GO:0001576,0.999999999959731,0.930432769905029,0,1,globoside biosynthetic process,BP,
1550,GO:0003948,0.999999999959731,0.930432769905029,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
12495,GO:0050512,0.999999999959731,0.930432769905029,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
9966,GO:0042352,0.999999999959735,0.906204048778942,0,1,GDP-L-fucose salvage,BP,
12452,GO:0050201,0.999999999959735,0.906204048778942,0,1,fucokinase activity,MF,
8783,GO:0034462,0.999999999959796,0.928211852870201,0,1,small-subunit processome assembly,BP,
16761,GO:0098547,0.999999999959796,0.928211852870201,0,1,lumenal side of Golgi membrane,CC,
3847,GO:0008456,0.999999999959807,0.908518071719829,0,1,alpha-N-acetylgalactosaminidase activity,MF,
9635,GO:0036502,0.999999999959816,0.916270224261061,0,1,Derlin-1-VIMP complex,CC,
14431,GO:0061736,0.999999999959829,0.891848389351376,0,1,engulfment of target by autophagosome,BP,
14442,GO:0061753,0.999999999959829,0.891848389351376,0,1,substrate localization to autophagosome,BP,
8877,GO:0034683,0.999999999959832,0.884370578185183,0,1,integrin alphav-beta3 complex,CC,
11358,GO:0045715,0.999999999959832,0.884370578185183,0,1,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12582,GO:0050748,0.999999999959832,0.884370578185183,0,1,negative regulation of lipoprotein metabolic process,BP,
13308,GO:0052066,0.999999999959832,0.884370578185183,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
13318,GO:0052190,0.999999999959832,0.884370578185183,0,1,modulation by symbiont of host phagocytosis,BP,
13319,GO:0052191,0.999999999959832,0.884370578185183,0,1,positive regulation by symbiont of host phagocytosis,BP,
13329,GO:0052231,0.999999999959832,0.884370578185183,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
13345,GO:0052370,0.999999999959832,0.884370578185183,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
13361,GO:0052522,0.999999999959832,0.884370578185183,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
19964,GO:2000536,0.999999999959832,0.884370578185183,0,1,negative regulation of entry of bacterium into host cell,BP,
9724,GO:0038163,0.999999999959859,0.947837256208046,0,1,thrombopoietin-mediated signaling pathway,BP,
19405,GO:1905938,0.999999999959859,0.947837256208046,0,1,positive regulation of germ cell proliferation,BP,
19807,GO:2000256,0.999999999959859,0.947837256208046,0,1,positive regulation of male germ cell proliferation,BP,
19302,GO:1905572,0.999999999959866,0.920317195725338,0,1,ganglioside GM1 transport to membrane,BP,
19304,GO:1905574,0.999999999959866,0.920317195725338,0,1,ganglioside GM2 binding,MF,
19305,GO:1905575,0.999999999959866,0.920317195725338,0,1,ganglioside GM3 binding,MF,
19307,GO:1905577,0.999999999959866,0.920317195725338,0,1,ganglioside GP1c binding,MF,
15851,GO:0072563,0.999999999959867,0.858975459552636,0,2,endothelial microparticle,CC,
379,GO:0001011,0.999999999959869,0.876280987458645,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
406,GO:0001087,0.999999999959869,0.876280987458645,0,1,transcription factor activity, TFIIB-class binding,MF,
16611,GO:0097444,0.999999999959903,0.895559422014777,0,1,spine apparatus,CC,
19227,GO:1905355,0.999999999959903,0.895559422014777,0,1,spine apparatus assembly,BP,
963,GO:0002396,0.999999999959916,0.932897673590416,0,1,MHC protein complex assembly,BP,
964,GO:0002397,0.999999999959916,0.932897673590416,0,1,MHC class I protein complex assembly,BP,
1012,GO:0002501,0.999999999959916,0.932897673590416,0,1,peptide antigen assembly with MHC protein complex,BP,
1013,GO:0002502,0.999999999959916,0.932897673590416,0,1,peptide antigen assembly with MHC class I protein complex,BP,
2021,GO:0004750,0.999999999959965,0.927544404946546,0,1,ribulose-phosphate 3-epimerase activity,MF,
16681,GO:0097621,0.999999999959965,0.927544404946546,0,1,monoamine oxidase activity,MF,
8791,GO:0034474,0.99999999995999,0.883949729602722,0,1,U2 snRNA 3'-end processing,BP,
5978,GO:0018585,0.999999999960003,0.929412922243295,0,1,fluorene oxygenase activity,MF,
5988,GO:0018917,0.999999999960003,0.929412922243295,0,1,fluorene metabolic process,BP,
18535,GO:1903724,0.999999999960032,0.912945581823854,0,1,positive regulation of centriole elongation,BP,
1835,GO:0004490,0.999999999960041,0.937742088470944,0,1,methylglutaconyl-CoA hydratase activity,MF,
12434,GO:0050011,0.999999999960041,0.937742088470944,0,1,itaconyl-CoA hydratase activity,MF,
2008,GO:0004733,0.999999999960053,0.911843551411419,0,1,pyridoxamine-phosphate oxidase activity,MF,
10824,GO:0044316,0.999999999960107,0.908628089942118,0,1,cone cell pedicle,CC,
1548,GO:0003944,0.999999999960134,0.928800489210451,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
2006,GO:0004730,0.999999999960143,0.936572098691462,0,1,pseudouridylate synthase activity,MF,
14991,GO:0070902,0.999999999960143,0.936572098691462,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
4012,GO:0009000,0.999999999960149,0.925289368951262,0,1,selenocysteine lyase activity,MF,
109,GO:0000225,0.999999999960171,0.944848042698386,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
2050,GO:0004799,0.999999999960194,0.937835315052914,0,1,thymidylate synthase activity,MF,
6029,GO:0019088,0.999999999960194,0.937835315052914,0,1,immortalization of host cell by virus,BP,
6329,GO:0020021,0.999999999960194,0.937835315052914,0,1,immortalization of host cell,BP,
9841,GO:0042083,0.999999999960194,0.937835315052914,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
5983,GO:0018872,0.999999999960202,0.925235620269848,0,1,arsonoacetate metabolic process,BP,
7024,GO:0030791,0.999999999960202,0.925235620269848,0,1,arsenite methyltransferase activity,MF,
7025,GO:0030792,0.999999999960202,0.925235620269848,0,1,methylarsonite methyltransferase activity,MF,
9757,GO:0039513,0.999999999960232,0.921329761371677,0,1,suppression by virus of host catalytic activity,BP,
9759,GO:0039516,0.999999999960232,0.921329761371677,0,1,modulation by virus of host catalytic activity,BP,
9777,GO:0039650,0.999999999960232,0.921329761371677,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
13305,GO:0052053,0.999999999960232,0.921329761371677,0,1,negative regulation by symbiont of host catalytic activity,BP,
13312,GO:0052148,0.999999999960232,0.921329761371677,0,1,modulation by symbiont of host catalytic activity,BP,
13321,GO:0052199,0.999999999960232,0.921329761371677,0,1,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
7900,GO:0032468,0.99999999996027,0.911402205688166,0,1,Golgi calcium ion homeostasis,BP,
5765,GO:0016938,0.999999999960305,0.918736196132377,0,1,kinesin I complex,CC,
13078,GO:0051585,0.999999999960348,0.915803248367579,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13102,GO:0051620,0.999999999960348,0.915803248367579,0,1,norepinephrine uptake,BP,
13103,GO:0051621,0.999999999960348,0.915803248367579,0,1,regulation of norepinephrine uptake,BP,
13104,GO:0051622,0.999999999960348,0.915803248367579,0,1,negative regulation of norepinephrine uptake,BP,
13263,GO:0051945,0.999999999960348,0.915803248367579,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
18188,GO:1902957,0.999999999960348,0.915803248367579,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18327,GO:1903282,0.999999999960348,0.915803248367579,0,1,regulation of glutathione peroxidase activity,BP,
18328,GO:1903284,0.999999999960348,0.915803248367579,0,1,positive regulation of glutathione peroxidase activity,BP,
18329,GO:1903285,0.999999999960348,0.915803248367579,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19263,GO:1905447,0.999999999960348,0.915803248367579,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19828,GO:2000295,0.999999999960348,0.915803248367579,0,1,regulation of hydrogen peroxide catabolic process,BP,
19939,GO:2000468,0.999999999960348,0.915803248367579,0,1,regulation of peroxidase activity,BP,
19940,GO:2000470,0.999999999960348,0.915803248367579,0,1,positive regulation of peroxidase activity,BP,
8676,GO:0034247,0.999999999960371,0.942547216380907,0,1,snoRNA splicing,BP,
15460,GO:0071796,0.999999999960371,0.942547216380907,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
8284,GO:0033087,0.99999999996038,0.786035594823932,0,3,negative regulation of immature T cell proliferation,BP,
86,GO:0000173,0.999999999960436,0.936824375963728,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
497,GO:0001552,0.999999999960455,0.932524199434456,0,1,ovarian follicle atresia,BP,
19876,GO:2000355,0.999999999960455,0.932524199434456,0,1,negative regulation of ovarian follicle development,BP,
14785,GO:0070488,0.999999999960466,0.914939130490018,0,2,neutrophil aggregation,BP,
5783,GO:0017005,0.999999999960479,0.909556278527482,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6443,GO:0021757,0.999999999960479,0.909556278527482,0,1,caudate nucleus development,BP,
6444,GO:0021758,0.999999999960479,0.909556278527482,0,1,putamen development,BP,
8234,GO:0032996,0.999999999960482,0.933592514736357,0,1,Bcl3-Bcl10 complex,CC,
11082,GO:0045082,0.999999999960482,0.933592514736357,0,1,positive regulation of interleukin-10 biosynthetic process,BP,
2232,GO:0005136,0.999999999960544,0.916405751027028,0,1,interleukin-4 receptor binding,MF,
1375,GO:0003270,0.999999999960556,0.870808068661887,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
14065,GO:0060843,0.999999999960556,0.870808068661887,0,1,venous endothelial cell differentiation,BP,
16570,GO:0097356,0.999999999960562,0.881002272826829,0,1,perinucleolar compartment,CC,
609,GO:0001777,0.99999999996057,0.9507733558465,0,1,T cell homeostatic proliferation,BP,
944,GO:0002358,0.99999999996057,0.9507733558465,0,1,B cell homeostatic proliferation,BP,
8219,GO:0032976,0.99999999996057,0.9507733558465,0,1,release of matrix enzymes from mitochondria,BP,
16467,GO:0097144,0.99999999996057,0.9507733558465,0,1,BAX complex,CC,
19449,GO:1990117,0.99999999996057,0.9507733558465,0,1,B cell receptor apoptotic signaling pathway,BP,
11722,GO:0046525,0.999999999960582,0.935678066029659,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
5773,GO:0016979,0.99999999996059,0.940558877168669,0,1,lipoate-protein ligase activity,MF,
78,GO:0000155,0.999999999960615,0.877814673550827,0,1,phosphorelay sensor kinase activity,MF,
1687,GO:0004157,0.999999999960658,0.900039704139086,0,1,dihydropyrimidinase activity,MF,
18695,GO:1904048,0.999999999960658,0.900039704139086,0,1,regulation of spontaneous neurotransmitter secretion,BP,
18696,GO:1904050,0.999999999960658,0.900039704139086,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
19200,GO:1905301,0.999999999960658,0.900039704139086,0,1,regulation of macropinocytosis,BP,
19201,GO:1905302,0.999999999960658,0.900039704139086,0,1,negative regulation of macropinocytosis,BP,
11650,GO:0046380,0.999999999960663,0.907732777185634,0,1,N-acetylneuraminate biosynthetic process,BP,
12443,GO:0050124,0.999999999960663,0.907732777185634,0,1,N-acylneuraminate-9-phosphatase activity,MF,
5573,GO:0016590,0.999999999960665,0.890149890308256,0,1,ACF complex,CC,
15943,GO:0072749,0.999999999960668,0.934441987028746,0,1,cellular response to cytochalasin B,BP,
16940,GO:0098918,0.999999999960668,0.934441987028746,0,1,structural constituent of synapse,MF,
16964,GO:0098973,0.999999999960668,0.934441987028746,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
16965,GO:0098974,0.999999999960668,0.934441987028746,0,1,postsynaptic actin cytoskeleton organization,BP,
17026,GO:0099186,0.999999999960668,0.934441987028746,0,1,structural constituent of postsynapse,MF,
17027,GO:0099188,0.999999999960668,0.934441987028746,0,1,postsynaptic cytoskeleton organization,BP,
17624,GO:1901328,0.999999999960668,0.934441987028746,0,1,response to cytochalasin B,BP,
17891,GO:1902173,0.999999999960671,0.915620800792021,0,1,negative regulation of keratinocyte apoptotic process,BP,
14401,GO:0061656,0.999999999960678,0.944041813682495,0,1,SUMO conjugating enzyme activity,MF,
18287,GO:1903182,0.999999999960678,0.944041813682495,0,1,regulation of SUMO transferase activity,BP,
18546,GO:1903755,0.999999999960678,0.944041813682495,0,1,positive regulation of SUMO transferase activity,BP,
19500,GO:1990356,0.999999999960678,0.944041813682495,0,1,sumoylated E2 ligase complex,CC,
2796,GO:0006238,0.999999999960722,0.943291671002902,0,1,CMP salvage,BP,
4162,GO:0009224,0.999999999960722,0.943291671002902,0,1,CMP biosynthetic process,BP,
11521,GO:0046035,0.999999999960722,0.943291671002902,0,1,CMP metabolic process,BP,
423,GO:0001128,0.999999999960735,0.941645300610833,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
4125,GO:0009184,0.999999999960748,0.938868888450538,0,1,purine deoxyribonucleoside diphosphate catabolic process,BP,
4133,GO:0009192,0.999999999960748,0.938868888450538,0,1,deoxyribonucleoside diphosphate catabolic process,BP,
10962,GO:0044716,0.999999999960748,0.938868888450538,0,1,8-oxo-GDP phosphatase activity,MF,
10963,GO:0044717,0.999999999960748,0.938868888450538,0,1,8-hydroxy-dADP phosphatase activity,MF,
11533,GO:0046057,0.999999999960748,0.938868888450538,0,1,dADP catabolic process,BP,
11539,GO:0046067,0.999999999960748,0.938868888450538,0,1,dGDP catabolic process,BP,
11819,GO:0046712,0.999999999960748,0.938868888450538,0,1,GDP catabolic process,BP,
7088,GO:0030882,0.999999999960756,0.907864495675279,0,1,lipid antigen binding,MF,
7089,GO:0030883,0.999999999960756,0.907864495675279,0,1,endogenous lipid antigen binding,MF,
7090,GO:0030884,0.999999999960756,0.907864495675279,0,1,exogenous lipid antigen binding,MF,
12058,GO:0048006,0.999999999960756,0.907864495675279,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
9175,GO:0035538,0.999999999960788,0.914590668106101,0,1,carbohydrate response element binding,MF,
10805,GO:0044284,0.999999999960798,0.949210382008804,0,1,mitochondrial crista junction,CC,
12973,GO:0051365,0.999999999960816,0.913794886484716,0,1,cellular response to potassium ion starvation,BP,
15849,GO:0072560,0.999999999960819,0.916365085660787,0,1,type B pancreatic cell maturation,BP,
8972,GO:0035054,0.999999999960821,0.916080610275334,0,1,embryonic heart tube anterior/posterior pattern specification,BP,
12766,GO:0051040,0.999999999960821,0.916080610275334,0,1,regulation of calcium-independent cell-cell adhesion,BP,
12767,GO:0051042,0.999999999960821,0.916080610275334,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13633,GO:0060128,0.999999999960821,0.916080610275334,0,1,corticotropin hormone secreting cell differentiation,BP,
14048,GO:0060804,0.999999999960821,0.916080610275334,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
14905,GO:0070724,0.999999999960821,0.916080610275334,0,1,BMP receptor complex,CC,
4017,GO:0009020,0.999999999960853,0.932266778602906,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
13390,GO:0052666,0.999999999960853,0.932266778602906,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
17207,GO:0106050,0.999999999960853,0.932266778602906,0,1,tRNA 2'-O-methyltransferase activity,MF,
13132,GO:0051686,0.999999999960891,0.855679241321567,0,1,establishment of ER localization,BP,
17003,GO:0099089,0.999999999960891,0.855679241321567,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
9813,GO:0042008,0.999999999960898,0.911092470945238,0,1,interleukin-18 receptor activity,MF,
19575,GO:1990613,0.999999999960898,0.911092470945238,0,1,mitochondrial membrane fusion,BP,
17349,GO:1900036,0.999999999960924,0.927042457741185,0,1,positive regulation of cellular response to heat,BP,
7239,GO:0031151,0.999999999960942,0.881357812557336,0,1,histone methyltransferase activity (H3-K79 specific),MF,
3782,GO:0008343,0.99999999996097,0.878195241226146,0,1,adult feeding behavior,BP,
19087,GO:1904983,0.999999999960987,0.929918003540796,0,1,glycine import into mitochondrion,BP,
5400,GO:0016237,0.999999999960992,0.896690506195978,0,1,lysosomal microautophagy,BP,
6227,GO:0019778,0.999999999960992,0.896690506195978,0,1,Atg12 activating enzyme activity,MF,
6228,GO:0019779,0.999999999960992,0.896690506195978,0,1,Atg8 activating enzyme activity,MF,
8906,GO:0034727,0.999999999960992,0.896690506195978,0,1,piecemeal microautophagy of the nucleus,BP,
9762,GO:0039521,0.999999999960992,0.896690506195978,0,1,suppression by virus of host autophagy,BP,
8183,GO:0032919,0.999999999961057,0.948079574319967,0,1,spermine acetylation,BP,
8184,GO:0032920,0.999999999961057,0.948079574319967,0,1,putrescine acetylation,BP,
11602,GO:0046204,0.999999999961057,0.948079574319967,0,1,nor-spermidine metabolic process,BP,
12466,GO:0050313,0.999999999961057,0.948079574319967,0,1,sulfur dioxygenase activity,MF,
2556,GO:0005833,0.999999999961069,0.918267058012947,0,1,hemoglobin complex,CC,
8538,GO:0033862,0.999999999961069,0.918267058012947,0,1,UMP kinase activity,MF,
4900,GO:0014827,0.999999999961077,0.928498961971941,0,1,intestine smooth muscle contraction,BP,
12157,GO:0048264,0.999999999961094,0.917967860095428,0,1,determination of ventral identity,BP,
20282,GO:2001253,0.999999999961094,0.917967860095428,0,1,regulation of histone H3-K36 trimethylation,BP,
7728,GO:0032222,0.999999999961119,0.868519101541089,0,1,regulation of synaptic transmission, cholinergic,BP,
7729,GO:0032224,0.999999999961119,0.868519101541089,0,1,positive regulation of synaptic transmission, cholinergic,BP,
14988,GO:0070899,0.999999999961144,0.918022258583101,0,1,mitochondrial tRNA wobble uridine modification,BP,
16286,GO:0090365,0.999999999961182,0.929144119704827,0,1,regulation of mRNA modification,BP,
16287,GO:0090367,0.999999999961182,0.929144119704827,0,1,negative regulation of mRNA modification,BP,
18305,GO:1903215,0.999999999961182,0.929144119704827,0,1,negative regulation of protein targeting to mitochondrion,BP,
20216,GO:2001144,0.999999999961182,0.929144119704827,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
20217,GO:2001145,0.999999999961182,0.929144119704827,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
12323,GO:0048674,0.999999999961193,0.925598598470535,0,1,collateral sprouting of injured axon,BP,
12331,GO:0048686,0.999999999961193,0.925598598470535,0,1,regulation of sprouting of injured axon,BP,
12332,GO:0048687,0.999999999961193,0.925598598470535,0,1,positive regulation of sprouting of injured axon,BP,
12333,GO:0048688,0.999999999961193,0.925598598470535,0,1,negative regulation of sprouting of injured axon,BP,
12334,GO:0048689,0.999999999961193,0.925598598470535,0,1,formation of growth cone in injured axon,BP,
12335,GO:0048693,0.999999999961193,0.925598598470535,0,1,regulation of collateral sprouting of injured axon,BP,
12336,GO:0048694,0.999999999961193,0.925598598470535,0,1,positive regulation of collateral sprouting of injured axon,BP,
19308,GO:1905578,0.999999999961193,0.925598598470535,0,1,regulation of ERBB3 signaling pathway,BP,
19309,GO:1905580,0.999999999961193,0.925598598470535,0,1,positive regulation of ERBB3 signaling pathway,BP,
19409,GO:1905942,0.999999999961193,0.925598598470535,0,1,regulation of formation of growth cone in injured axon,BP,
19410,GO:1905943,0.999999999961193,0.925598598470535,0,1,negative regulation of formation of growth cone in injured axon,BP,
3022,GO:0006567,0.9999999999612,0.937850864859852,0,1,threonine catabolic process,BP,
3993,GO:0008890,0.9999999999612,0.937850864859852,0,1,glycine C-acetyltransferase activity,MF,
6164,GO:0019518,0.9999999999612,0.937850864859852,0,1,L-threonine catabolic process to glycine,BP,
2938,GO:0006463,0.999999999961234,0.908335387616225,0,1,steroid hormone receptor complex assembly,BP,
5351,GO:0016103,0.999999999961263,0.900211286051244,0,1,diterpenoid catabolic process,BP,
5353,GO:0016115,0.999999999961263,0.900211286051244,0,1,terpenoid catabolic process,BP,
8858,GO:0034653,0.999999999961263,0.900211286051244,0,1,retinoic acid catabolic process,BP,
17045,GO:0099522,0.999999999961264,0.931203593240676,0,1,region of cytosol,CC,
17046,GO:0099523,0.999999999961264,0.931203593240676,0,1,presynaptic cytosol,CC,
17047,GO:0099524,0.999999999961264,0.931203593240676,0,1,postsynaptic cytosol,CC,
18978,GO:1904764,0.999999999961264,0.931203593240676,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
19638,GO:1990832,0.999999999961264,0.931203593240676,0,1,slow axonal transport,BP,
19639,GO:1990833,0.999999999961264,0.931203593240676,0,1,clathrin-uncoating ATPase activity,MF,
4416,GO:0010189,0.999999999961265,0.936412066728811,0,1,vitamin E biosynthetic process,BP,
9972,GO:0042360,0.999999999961265,0.936412066728811,0,1,vitamin E metabolic process,BP,
18712,GO:1904121,0.999999999961265,0.936412066728811,0,1,phosphatidylethanolamine transporter activity,MF,
16305,GO:0090416,0.999999999961273,0.92396089971693,0,1,nicotinate transmembrane transporter activity,MF,
20215,GO:2001142,0.999999999961273,0.92396089971693,0,1,nicotinate transport,BP,
8559,GO:0033981,0.99999999996129,0.953747375516452,0,1,D-dopachrome decarboxylase activity,MF,
1936,GO:0004637,0.999999999961321,0.912097959186549,0,1,phosphoribosylamine-glycine ligase activity,MF,
1939,GO:0004641,0.999999999961321,0.912097959186549,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
1942,GO:0004644,0.999999999961321,0.912097959186549,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
16373,GO:0090673,0.999999999961332,0.882018342544143,0,1,endothelial cell-matrix adhesion,BP,
1430,GO:0003404,0.999999999961335,0.914021693782605,0,1,optic vesicle morphogenesis,BP,
1434,GO:0003409,0.999999999961335,0.914021693782605,0,1,optic cup structural organization,BP,
6403,GO:0021622,0.999999999961335,0.914021693782605,0,1,oculomotor nerve morphogenesis,BP,
6404,GO:0021623,0.999999999961335,0.914021693782605,0,1,oculomotor nerve formation,BP,
14613,GO:0070172,0.999999999961335,0.914021693782605,0,1,positive regulation of tooth mineralization,BP,
14440,GO:0061750,0.999999999961368,0.927177960772671,0,1,acid sphingomyelin phosphodiesterase activity,MF,
11728,GO:0046534,0.999999999961377,0.900788247504724,0,1,positive regulation of photoreceptor cell differentiation,BP,
19538,GO:1990450,0.999999999961405,0.930418818744724,0,1,linear polyubiquitin binding,MF,
11741,GO:0046577,0.999999999961448,0.908050926470099,0,1,long-chain-alcohol oxidase activity,MF,
8109,GO:0032795,0.999999999961469,0.946119847106239,0,1,heterotrimeric G-protein binding,MF,
8166,GO:0032899,0.999999999961472,0.906628059050986,0,1,regulation of neurotrophin production,BP,
8167,GO:0032901,0.999999999961472,0.906628059050986,0,1,positive regulation of neurotrophin production,BP,
8855,GO:0034649,0.999999999961472,0.906628059050986,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
12215,GO:0048403,0.999999999961472,0.906628059050986,0,1,brain-derived neurotrophic factor binding,MF,
14397,GO:0061646,0.999999999961481,0.896915899833508,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
11991,GO:0047341,0.999999999961504,0.912379488021199,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
16288,GO:0090370,0.999999999961505,0.902117141743098,0,1,negative regulation of cholesterol efflux,BP,
20279,GO:2001247,0.999999999961505,0.902117141743098,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
4910,GO:0014846,0.999999999961516,0.902830072247849,0,1,esophagus smooth muscle contraction,BP,
2168,GO:0005004,0.999999999961517,0.88788815832856,0,1,GPI-linked ephrin receptor activity,MF,
13255,GO:0051933,0.999999999961517,0.88788815832856,0,1,amino acid neurotransmitter reuptake,BP,
13257,GO:0051935,0.999999999961517,0.88788815832856,0,1,glutamate reuptake,BP,
13261,GO:0051941,0.999999999961517,0.88788815832856,0,1,regulation of amino acid uptake involved in synaptic transmission,BP,
13264,GO:0051946,0.999999999961517,0.88788815832856,0,1,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
16476,GO:0097156,0.999999999961517,0.88788815832856,0,1,fasciculation of motor neuron axon,BP,
16480,GO:0097161,0.999999999961517,0.88788815832856,0,1,DH domain binding,MF,
18855,GO:1904477,0.999999999961517,0.88788815832856,0,1,positive regulation of Ras GTPase binding,BP,
19136,GO:1905099,0.999999999961517,0.88788815832856,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20206,GO:2001108,0.999999999961517,0.88788815832856,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
9128,GO:0035441,0.99999999996152,0.87568152769188,0,1,cell migration involved in vasculogenesis,BP,
10739,GO:0044105,0.999999999961535,0.950403100050444,0,1,L-xylulose reductase (NAD+) activity,MF,
12436,GO:0050038,0.999999999961535,0.950403100050444,0,1,L-xylulose reductase (NADP+) activity,MF,
9307,GO:0035752,0.999999999961537,0.933049066165869,0,1,lysosomal lumen pH elevation,BP,
15416,GO:0071678,0.999999999961568,0.879922609561448,0,1,olfactory bulb axon guidance,BP,
1238,GO:0002930,0.999999999961582,0.895459951448773,0,1,trabecular meshwork development,BP,
7538,GO:0031775,0.999999999961591,0.876825728758476,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
7902,GO:0032470,0.999999999961591,0.876825728758476,0,1,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
16022,GO:0086039,0.999999999961591,0.876825728758476,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
18433,GO:1903515,0.999999999961591,0.876825728758476,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19429,GO:1990036,0.999999999961591,0.876825728758476,0,1,calcium ion import into sarcoplasmic reticulum,BP,
7277,GO:0031260,0.999999999961625,0.946034615141372,0,1,pseudopodium membrane,CC,
444,GO:0001192,0.999999999961647,0.949682804149037,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
445,GO:0001193,0.999999999961647,0.949682804149037,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
15386,GO:0071633,0.999999999961687,0.920086997543752,0,1,dihydroceramidase activity,MF,
2749,GO:0006148,0.999999999961702,0.925988982044043,0,1,inosine catabolic process,BP,
3143,GO:0006738,0.999999999961702,0.925988982044043,0,1,nicotinamide riboside catabolic process,BP,
11704,GO:0046495,0.999999999961702,0.925988982044043,0,1,nicotinamide riboside metabolic process,BP,
14865,GO:0070637,0.999999999961702,0.925988982044043,0,1,pyridine nucleoside metabolic process,BP,
14866,GO:0070638,0.999999999961702,0.925988982044043,0,1,pyridine nucleoside catabolic process,BP,
3881,GO:0008511,0.999999999961715,0.88475673144701,0,1,sodium:potassium:chloride symporter activity,MF,
4287,GO:0009674,0.999999999961715,0.88475673144701,0,1,potassium:sodium symporter activity,MF,
5100,GO:0015378,0.999999999961715,0.88475673144701,0,1,sodium:chloride symporter activity,MF,
11405,GO:0045795,0.999999999961715,0.88475673144701,0,1,positive regulation of cell volume,BP,
2120,GO:0004913,0.999999999961816,0.926326030007919,0,1,interleukin-4 receptor activity,MF,
1505,GO:0003860,0.999999999961877,0.932689146591217,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
879,GO:0002238,0.999999999961882,0.89627153014304,0,1,response to molecule of fungal origin,BP,
940,GO:0002351,0.999999999961882,0.89627153014304,0,1,serotonin production involved in inflammatory response,BP,
985,GO:0002442,0.999999999961882,0.89627153014304,0,1,serotonin secretion involved in inflammatory response,BP,
1040,GO:0002554,0.999999999961882,0.89627153014304,0,1,serotonin secretion by platelet,BP,
6246,GO:0019814,0.999999999961882,0.89627153014304,0,1,immunoglobulin complex,CC,
6247,GO:0019815,0.999999999961882,0.89627153014304,0,1,B cell receptor complex,CC,
8073,GO:0032752,0.999999999961882,0.89627153014304,0,1,positive regulation of interleukin-3 production,BP,
9905,GO:0042223,0.999999999961882,0.89627153014304,0,1,interleukin-3 biosynthetic process,BP,
11230,GO:0045399,0.999999999961882,0.89627153014304,0,1,regulation of interleukin-3 biosynthetic process,BP,
11231,GO:0045401,0.999999999961882,0.89627153014304,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
11241,GO:0045423,0.999999999961882,0.89627153014304,0,1,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
11242,GO:0045425,0.999999999961882,0.89627153014304,0,1,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
15136,GO:0071226,0.999999999961882,0.89627153014304,0,1,cellular response to molecule of fungal origin,BP,
4280,GO:0009646,0.999999999961905,0.914128587250411,0,1,response to absence of light,BP,
6955,GO:0030586,0.999999999961905,0.914128587250411,0,1,[methionine synthase] reductase activity,MF,
7347,GO:0031380,0.999999999961905,0.914128587250411,0,1,nuclear RNA-directed RNA polymerase complex,CC,
12486,GO:0050444,0.999999999961905,0.914128587250411,0,1,aquacobalamin reductase (NADPH) activity,MF,
15301,GO:0071485,0.999999999961905,0.914128587250411,0,1,cellular response to absence of light,BP,
18689,GO:1904041,0.999999999961905,0.914128587250411,0,1,regulation of cystathionine beta-synthase activity,BP,
18690,GO:1904042,0.999999999961905,0.914128587250411,0,1,negative regulation of cystathionine beta-synthase activity,BP,
19573,GO:1990603,0.999999999961905,0.914128587250411,0,1,dark adaptation,BP,
10315,GO:0043095,0.999999999961999,0.952530310554346,0,1,regulation of GTP cyclohydrolase I activity,BP,
10321,GO:0043105,0.999999999961999,0.952530310554346,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
10931,GO:0044549,0.999999999961999,0.952530310554346,0,1,GTP cyclohydrolase binding,MF,
8397,GO:0033319,0.999999999962018,0.930376978410368,0,1,UDP-D-xylose metabolic process,BP,
8398,GO:0033320,0.999999999962018,0.930376978410368,0,1,UDP-D-xylose biosynthetic process,BP,
12087,GO:0048040,0.999999999962018,0.930376978410368,0,1,UDP-glucuronate decarboxylase activity,MF,
2025,GO:0004757,0.999999999962033,0.939852990015448,0,1,sepiapterin reductase activity,MF,
4754,GO:0010931,0.99999999996204,0.876802996330476,0,1,macrophage tolerance induction,BP,
4755,GO:0010932,0.99999999996204,0.876802996330476,0,1,regulation of macrophage tolerance induction,BP,
4756,GO:0010933,0.99999999996204,0.876802996330476,0,1,positive regulation of macrophage tolerance induction,BP,
1721,GO:0004313,0.999999999962043,0.875410771827159,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1724,GO:0004316,0.999999999962043,0.875410771827159,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1725,GO:0004317,0.999999999962043,0.875410771827159,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1726,GO:0004319,0.999999999962043,0.875410771827159,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
6047,GO:0019171,0.999999999962043,0.875410771827159,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
11958,GO:0047117,0.999999999962043,0.875410771827159,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12003,GO:0047451,0.999999999962043,0.875410771827159,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
17127,GO:0102131,0.999999999962043,0.875410771827159,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
17128,GO:0102132,0.999999999962043,0.875410771827159,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
17925,GO:1902238,0.999999999962111,0.903315857543022,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
17926,GO:1902239,0.999999999962111,0.903315857543022,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19452,GO:1990127,0.999999999962111,0.903315857543022,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
7569,GO:0031930,0.999999999962134,0.939773164841193,0,1,mitochondria-nucleus signaling pathway,BP,
6738,GO:0030156,0.999999999962151,0.952067114250139,0,1,benzodiazepine receptor binding,MF,
3969,GO:0008761,0.999999999962164,0.894453565029601,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4218,GO:0009384,0.999999999962164,0.894453565029601,0,1,N-acylmannosamine kinase activity,MF,
10974,GO:0044753,0.999999999962167,0.91940879710518,0,1,amphisome,CC,
18708,GO:1904106,0.999999999962167,0.91940879710518,0,1,protein localization to microvillus,BP,
19078,GO:1904970,0.999999999962167,0.91940879710518,0,1,brush border assembly,BP,
15033,GO:0070975,0.999999999962216,0.881831038049563,0,1,FHA domain binding,MF,
9677,GO:0038039,0.99999999996222,0.90165826721729,0,1,G-protein coupled receptor heterodimeric complex,CC,
9022,GO:0035226,0.999999999962224,0.917057129117281,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9023,GO:0035227,0.999999999962224,0.917057129117281,0,1,regulation of glutamate-cysteine ligase activity,BP,
9024,GO:0035229,0.999999999962224,0.917057129117281,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
1951,GO:0004655,0.999999999962236,0.91552626763625,0,1,porphobilinogen synthase activity,MF,
19022,GO:1904854,0.999999999962236,0.91552626763625,0,1,proteasome core complex binding,MF,
705,GO:0001928,0.99999999996224,0.928102652269148,0,1,regulation of exocyst assembly,BP,
13662,GO:0060178,0.99999999996224,0.928102652269148,0,1,regulation of exocyst localization,BP,
5876,GO:0017198,0.99999999996224,0.949455148256123,0,1,N-terminal peptidyl-serine acetylation,BP,
5877,GO:0018002,0.99999999996224,0.949455148256123,0,1,N-terminal peptidyl-glutamic acid acetylation,BP,
7118,GO:0030920,0.99999999996224,0.949455148256123,0,1,peptidyl-serine acetylation,BP,
14477,GO:0061850,0.99999999996224,0.949455148256123,0,1,growth cone leading edge,CC,
15549,GO:0071960,0.99999999996224,0.949455148256123,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
19476,GO:1990190,0.99999999996224,0.949455148256123,0,1,peptide-glutamate-N-acetyltransferase activity,MF,
20070,GO:2000718,0.99999999996224,0.949455148256123,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
20071,GO:2000719,0.99999999996224,0.949455148256123,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
237,GO:0000494,0.99999999996226,0.944595434389152,0,1,box C/D snoRNA 3'-end processing,BP,
8557,GO:0033967,0.99999999996226,0.944595434389152,0,1,box C/D snoRNA metabolic process,BP,
8935,GO:0034963,0.99999999996226,0.944595434389152,0,1,box C/D snoRNA processing,BP,
9436,GO:0036009,0.99999999996226,0.944595434389152,0,1,protein-glutamine N-methyltransferase activity,MF,
19486,GO:1990258,0.99999999996226,0.944595434389152,0,1,histone glutamine methylation,BP,
19487,GO:1990259,0.99999999996226,0.944595434389152,0,1,histone-glutamine methyltransferase activity,MF,
661,GO:0001855,0.999999999962284,0.937843089526793,0,1,complement component C4b binding,MF,
15817,GO:0072513,0.999999999962294,0.950879304384635,0,1,positive regulation of secondary heart field cardioblast proliferation,BP,
12410,GO:0048855,0.999999999962317,0.887797418269345,0,1,adenohypophysis morphogenesis,BP,
4273,GO:0009631,0.999999999962382,0.895735379226569,0,1,cold acclimation,BP,
11616,GO:0046317,0.999999999962382,0.895735379226569,0,1,regulation of glucosylceramide biosynthetic process,BP,
11617,GO:0046318,0.999999999962382,0.895735379226569,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
18260,GO:1903108,0.999999999962382,0.895735379226569,0,1,regulation of mitochondrial transcription,BP,
18261,GO:1903109,0.999999999962382,0.895735379226569,0,1,positive regulation of mitochondrial transcription,BP,
573,GO:0001715,0.999999999962387,0.907105192045619,0,1,ectodermal cell fate specification,BP,
10130,GO:0042665,0.999999999962387,0.907105192045619,0,1,regulation of ectodermal cell fate specification,BP,
10131,GO:0042666,0.999999999962387,0.907105192045619,0,1,negative regulation of ectodermal cell fate specification,BP,
19894,GO:2000383,0.999999999962387,0.907105192045619,0,1,regulation of ectoderm development,BP,
19895,GO:2000384,0.999999999962387,0.907105192045619,0,1,negative regulation of ectoderm development,BP,
529,GO:0001640,0.99999999996239,0.889193718974802,0,1,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
530,GO:0001642,0.99999999996239,0.889193718974802,0,1,group III metabotropic glutamate receptor activity,MF,
3414,GO:0007196,0.99999999996239,0.889193718974802,0,1,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
9341,GO:0035841,0.99999999996239,0.889193718974802,0,1,new growing cell tip,CC,
16972,GO:0098988,0.99999999996239,0.889193718974802,0,1,G-protein coupled glutamate receptor activity,MF,
16295,GO:0090389,0.999999999962421,0.880232473785,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
16514,GO:0097213,0.999999999962441,0.928362159171957,0,1,regulation of lysosomal membrane permeability,BP,
3218,GO:0006864,0.999999999962448,0.844945710527077,0,2,pyrimidine nucleotide transport,BP,
5040,GO:0015218,0.999999999962448,0.844945710527077,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
19552,GO:1990519,0.999999999962448,0.844945710527077,0,2,pyrimidine nucleotide import into mitochondrion,BP,
1272,GO:0003064,0.999999999962462,0.933942665798766,0,1,regulation of heart rate by hormone,BP,
19399,GO:1905912,0.999999999962462,0.933942665798766,0,1,regulation of calcium ion export across plasma membrane,BP,
19400,GO:1905913,0.999999999962462,0.933942665798766,0,1,negative regulation of calcium ion export across plasma membrane,BP,
18083,GO:1902685,0.999999999962525,0.902528432377282,0,1,positive regulation of receptor localization to synapse,BP,
1572,GO:0003979,0.999999999962555,0.915431784125717,0,1,UDP-glucose 6-dehydrogenase activity,MF,
6639,GO:0023024,0.999999999962555,0.915431784125717,0,1,MHC class I protein complex binding,MF,
13681,GO:0060214,0.999999999962556,0.938318948564839,0,1,endocardium formation,BP,
19142,GO:1905143,0.999999999962556,0.938318948564839,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
1386,GO:0003292,0.999999999962609,0.891789622168507,0,1,cardiac septum cell differentiation,BP,
14094,GO:0060922,0.999999999962609,0.891789622168507,0,1,atrioventricular node cell differentiation,BP,
14097,GO:0060928,0.999999999962609,0.891789622168507,0,1,atrioventricular node cell development,BP,
2005,GO:0004729,0.999999999962637,0.935385391167863,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
14936,GO:0070818,0.999999999962637,0.935385391167863,0,1,protoporphyrinogen oxidase activity,MF,
5469,GO:0016402,0.999999999962653,0.92010731816107,0,1,pristanoyl-CoA oxidase activity,MF,
6457,GO:0021778,0.999999999962689,0.872879587946943,0,1,oligodendrocyte cell fate specification,BP,
6458,GO:0021779,0.999999999962689,0.872879587946943,0,1,oligodendrocyte cell fate commitment,BP,
6459,GO:0021780,0.999999999962689,0.872879587946943,0,1,glial cell fate specification,BP,
16246,GO:0090297,0.99999999996269,0.942761686795475,0,1,positive regulation of mitochondrial DNA replication,BP,
17789,GO:1901860,0.99999999996269,0.942761686795475,0,1,positive regulation of mitochondrial DNA metabolic process,BP,
19432,GO:1990046,0.99999999996269,0.942761686795475,0,1,stress-induced mitochondrial fusion,BP,
2268,GO:0005199,0.999999999962705,0.91311747534508,0,1,structural constituent of cell wall,MF,
15407,GO:0071665,0.999999999962705,0.91311747534508,0,1,gamma-catenin-TCF7L2 complex,CC,
9066,GO:0035299,0.999999999962721,0.901273009227275,0,1,inositol pentakisphosphate 2-kinase activity,MF,
3869,GO:0008493,0.99999999996274,0.933643462269817,0,1,tetracycline transmembrane transporter activity,MF,
5262,GO:0015904,0.99999999996274,0.933643462269817,0,1,tetracycline transport,BP,
8747,GO:0034395,0.999999999962755,0.938381590708478,0,1,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
14108,GO:0060957,0.999999999962775,0.918627425835193,0,1,endocardial cell fate commitment,BP,
14311,GO:0061445,0.999999999962775,0.918627425835193,0,1,endocardial cushion cell fate commitment,BP,
3,GO:0000009,0.999999999962779,0.926501505879128,0,1,alpha-1,6-mannosyltransferase activity,MF,
13460,GO:0052917,0.999999999962779,0.926501505879128,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
7099,GO:0030895,0.999999999962792,0.921531720331328,0,1,apolipoprotein B mRNA editing enzyme complex,CC,
9212,GO:0035597,0.999999999962808,0.931330412199004,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
6334,GO:0021503,0.999999999962824,0.875644837404193,0,1,neural fold bending,BP,
4607,GO:0010722,0.999999999962825,0.883057973276585,0,1,regulation of ferrochelatase activity,BP,
8946,GO:0034986,0.999999999962825,0.883057973276585,0,1,iron chaperone activity,MF,
18751,GO:1904229,0.999999999962825,0.883057973276585,0,1,regulation of succinate dehydrogenase activity,BP,
18752,GO:1904231,0.999999999962825,0.883057973276585,0,1,positive regulation of succinate dehydrogenase activity,BP,
18753,GO:1904232,0.999999999962825,0.883057973276585,0,1,regulation of aconitate hydratase activity,BP,
18754,GO:1904234,0.999999999962825,0.883057973276585,0,1,positive regulation of aconitate hydratase activity,BP,
11947,GO:0047021,0.999999999962841,0.943341505442108,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12455,GO:0050221,0.999999999962841,0.943341505442108,0,1,prostaglandin-E2 9-reductase activity,MF,
4955,GO:0015019,0.999999999962857,0.894951838483304,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
6349,GO:0021526,0.999999999962929,0.933534336919548,0,1,medial motor column neuron differentiation,BP,
18061,GO:1902616,0.999999999962929,0.933534336919548,0,1,acyl carnitine transmembrane transport,BP,
3134,GO:0006722,0.999999999962958,0.926090043315339,0,1,triterpenoid metabolic process,BP,
6215,GO:0019742,0.999999999962958,0.926090043315339,0,1,pentacyclic triterpenoid metabolic process,BP,
19059,GO:1904924,0.999999999962958,0.926090043315339,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
19234,GO:1905370,0.999999999962958,0.926090043315339,0,1,serine-type endopeptidase complex,CC,
11091,GO:0045092,0.999999999962975,0.910071772498155,0,1,interleukin-18 receptor complex,CC,
4612,GO:0010729,0.999999999963004,0.931316311324486,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
1540,GO:0003933,0.99999999996301,0.932345338153665,0,1,GTP cyclohydrolase activity,MF,
1541,GO:0003934,0.99999999996301,0.932345338153665,0,1,GTP cyclohydrolase I activity,MF,
9429,GO:0035998,0.99999999996301,0.932345338153665,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
4270,GO:0009624,0.999999999963025,0.923371046333627,0,1,response to nematode,BP,
4288,GO:0009692,0.999999999963025,0.923371046333627,0,1,ethylene metabolic process,BP,
4289,GO:0009698,0.999999999963025,0.923371046333627,0,1,phenylpropanoid metabolic process,BP,
4318,GO:0009804,0.999999999963025,0.923371046333627,0,1,coumarin metabolic process,BP,
5631,GO:0016711,0.999999999963025,0.923371046333627,0,1,flavonoid 3'-monooxygenase activity,MF,
6105,GO:0019341,0.999999999963025,0.923371046333627,0,1,dibenzo-p-dioxin catabolic process,BP,
10523,GO:0043449,0.999999999963025,0.923371046333627,0,1,cellular alkene metabolic process,BP,
16303,GO:0090409,0.999999999963078,0.927680354807797,0,1,malonyl-CoA synthetase activity,MF,
16304,GO:0090410,0.999999999963078,0.927680354807797,0,1,malonate catabolic process,BP,
199,GO:0000417,0.999999999963081,0.905004483285247,0,1,HIR complex,CC,
5864,GO:0017168,0.999999999963081,0.905004483285247,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
7012,GO:0030702,0.999999999963081,0.905004483285247,0,1,chromatin silencing at centromere,BP,
19126,GO:1905069,0.999999999963081,0.905004483285247,0,1,allantois development,BP,
1932,GO:0004631,0.999999999963111,0.942431934569899,0,1,phosphomevalonate kinase activity,MF,
19613,GO:1990758,0.999999999963125,0.934074459908425,0,1,mitotic sister chromatid biorientation,BP,
3867,GO:0008488,0.999999999963128,0.915769448928005,0,1,gamma-glutamyl carboxylase activity,MF,
3848,GO:0008457,0.999999999963131,0.904091861480039,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
11976,GO:0047256,0.999999999963131,0.904091861480039,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
3501,GO:0007403,0.999999999963141,0.912366370447831,0,1,glial cell fate determination,BP,
14040,GO:0060769,0.999999999963141,0.912366370447831,0,1,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14265,GO:0061324,0.999999999963141,0.912366370447831,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
18860,GO:1904499,0.999999999963141,0.912366370447831,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
18861,GO:1904501,0.999999999963141,0.912366370447831,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
18992,GO:1904793,0.999999999963141,0.912366370447831,0,1,regulation of euchromatin binding,BP,
12046,GO:0047860,0.999999999963162,0.942860836913296,0,1,diiodophenylpyruvate reductase activity,MF,
758,GO:0001998,0.999999999963167,0.932840086916514,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
778,GO:0002034,0.999999999963167,0.932840086916514,0,1,regulation of blood vessel diameter by renin-angiotensin,BP,
1278,GO:0003072,0.999999999963167,0.932840086916514,0,1,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
18512,GO:1903673,0.999999999963167,0.932840086916514,0,1,mitotic cleavage furrow formation,BP,
18941,GO:1904695,0.999999999963167,0.932840086916514,0,1,positive regulation of vascular smooth muscle contraction,BP,
18719,GO:1904155,0.999999999963193,0.913455592764087,0,1,DN2 thymocyte differentiation,BP,
18720,GO:1904156,0.999999999963193,0.913455592764087,0,1,DN3 thymocyte differentiation,BP,
6338,GO:0021512,0.999999999963213,0.902703048017389,0,1,spinal cord anterior/posterior patterning,BP,
10965,GO:0044725,0.999999999963213,0.861952627453963,0,1,chromatin reprogramming in the zygote,BP,
10966,GO:0044727,0.999999999963213,0.861952627453963,0,1,DNA demethylation of male pronucleus,BP,
2845,GO:0006313,0.999999999963219,0.904950389032199,0,1,transposition, DNA-mediated,BP,
5810,GO:0017065,0.999999999963231,0.938084523260301,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
3958,GO:0008705,0.99999999996324,0.86403471924437,0,1,methionine synthase activity,MF,
9842,GO:0042084,0.99999999996324,0.86403471924437,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
2226,GO:0005129,0.999999999963244,0.951321514681377,0,1,granulocyte macrophage colony-stimulating factor receptor binding,MF,
8564,GO:0034021,0.999999999963244,0.951321514681377,0,1,response to silicon dioxide,BP,
10694,GO:0043972,0.999999999963251,0.898582762980444,0,1,histone H3-K23 acetylation,BP,
10705,GO:0043994,0.999999999963251,0.898582762980444,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
3376,GO:0007147,0.999999999963252,0.909744240477427,0,1,female meiosis II,BP,
1544,GO:0003939,0.999999999963267,0.924443639912488,0,1,L-iditol 2-dehydrogenase activity,MF,
2697,GO:0006062,0.999999999963267,0.924443639912488,0,1,sorbitol catabolic process,BP,
6139,GO:0019407,0.999999999963267,0.924443639912488,0,1,hexitol catabolic process,BP,
6165,GO:0019519,0.999999999963267,0.924443639912488,0,1,pentitol metabolic process,BP,
6168,GO:0019527,0.999999999963267,0.924443639912488,0,1,pentitol catabolic process,BP,
7313,GO:0031320,0.999999999963267,0.924443639912488,0,1,hexitol dehydrogenase activity,MF,
11723,GO:0046526,0.999999999963267,0.924443639912488,0,1,D-xylulose reductase activity,MF,
12847,GO:0051160,0.999999999963267,0.924443639912488,0,1,L-xylitol catabolic process,BP,
12848,GO:0051164,0.999999999963267,0.924443639912488,0,1,L-xylitol metabolic process,BP,
8251,GO:0033026,0.999999999963271,0.893844364102669,0,1,negative regulation of mast cell apoptotic process,BP,
1041,GO:0002560,0.999999999963279,0.903376113057641,0,1,basophil mediated immunity,BP,
1042,GO:0002561,0.999999999963279,0.903376113057641,0,1,basophil degranulation,BP,
8490,GO:0033644,0.999999999963279,0.903376113057641,0,1,host cell membrane,CC,
10773,GO:0044218,0.999999999963279,0.903376113057641,0,1,other organism cell membrane,CC,
10775,GO:0044221,0.999999999963279,0.903376113057641,0,1,host cell synapse,CC,
10778,GO:0044231,0.999999999963279,0.903376113057641,0,1,host cell presynaptic membrane,CC,
10801,GO:0044279,0.999999999963279,0.903376113057641,0,1,other organism membrane,CC,
15845,GO:0072556,0.999999999963279,0.903376113057641,0,1,other organism presynaptic membrane,CC,
12066,GO:0048014,0.999999999963305,0.89468494376809,0,1,Tie signaling pathway,BP,
12710,GO:0050928,0.999999999963305,0.89468494376809,0,1,negative regulation of positive chemotaxis,BP,
18587,GO:1903837,0.999999999963327,0.925181879863936,0,1,regulation of mRNA 3'-UTR binding,BP,
18588,GO:1903839,0.999999999963327,0.925181879863936,0,1,positive regulation of mRNA 3'-UTR binding,BP,
16844,GO:0098749,0.999999999963337,0.899417476523302,0,1,cerebellar neuron development,BP,
19853,GO:2000325,0.999999999963356,0.888962293804595,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
19854,GO:2000327,0.999999999963356,0.888962293804595,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
12135,GO:0048213,0.999999999963378,0.9203307295557,0,1,Golgi vesicle prefusion complex stabilization,BP,
9786,GO:0039713,0.999999999963388,0.912176418937257,0,1,viral factory,CC,
9787,GO:0039714,0.999999999963388,0.912176418937257,0,1,cytoplasmic viral factory,CC,
15818,GO:0072517,0.999999999963388,0.912176418937257,0,1,host cell viral assembly compartment,CC,
17471,GO:1900276,0.999999999963388,0.912176418937257,0,1,regulation of proteinase activated receptor activity,BP,
17508,GO:1900736,0.999999999963388,0.912176418937257,0,1,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
17509,GO:1900737,0.999999999963388,0.912176418937257,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
8158,GO:0032887,0.999999999963393,0.882846027811024,0,1,regulation of spindle elongation,BP,
8159,GO:0032888,0.999999999963393,0.882846027811024,0,1,regulation of mitotic spindle elongation,BP,
13490,GO:0055028,0.999999999963393,0.882846027811024,0,1,cortical microtubule,CC,
13494,GO:0055048,0.999999999963393,0.882846027811024,0,1,anastral spindle assembly,BP,
15556,GO:0071988,0.999999999963393,0.882846027811024,0,1,protein localization to spindle pole body,BP,
17236,GO:0110028,0.999999999963393,0.882846027811024,0,1,positive regulation of mitotic spindle organization,BP,
17970,GO:1902363,0.999999999963393,0.882846027811024,0,1,regulation of protein localization to spindle pole body,BP,
17971,GO:1902365,0.999999999963393,0.882846027811024,0,1,positive regulation of protein localization to spindle pole body,BP,
18133,GO:1902846,0.999999999963393,0.882846027811024,0,1,positive regulation of mitotic spindle elongation,BP,
19351,GO:1905720,0.999999999963393,0.882846027811024,0,1,cytoplasmic microtubule bundle,CC,
9213,GO:0035598,0.9999999999634,0.914302499494785,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
14421,GO:0061712,0.9999999999634,0.914302499494785,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
17462,GO:1900259,0.999999999963429,0.93320079245479,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
17463,GO:1900260,0.999999999963429,0.93320079245479,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
2323,GO:0005332,0.999999999963436,0.931712089733262,0,1,gamma-aminobutyric acid:sodium symporter activity,MF,
5022,GO:0015185,0.999999999963436,0.931712089733262,0,1,gamma-aminobutyric acid transmembrane transporter activity,MF,
15423,GO:0071691,0.999999999963438,0.88440618826346,0,1,cardiac muscle thin filament assembly,BP,
18961,GO:1904734,0.999999999963448,0.957770793553067,0,1,positive regulation of electron transfer activity,BP,
19077,GO:1904960,0.999999999963448,0.957770793553067,0,1,positive regulation of cytochrome-c oxidase activity,BP,
1367,GO:0003252,0.999999999963456,0.856391586693449,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
13151,GO:0051722,0.999999999963488,0.925356566865923,0,1,protein C-terminal methylesterase activity,MF,
13152,GO:0051723,0.999999999963488,0.925356566865923,0,1,protein methylesterase activity,MF,
1337,GO:0003195,0.999999999963497,0.914771938579996,0,1,tricuspid valve formation,BP,
11233,GO:0045403,0.999999999963497,0.914771938579996,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12919,GO:0051267,0.999999999963497,0.914771938579996,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13528,GO:0055103,0.999999999963497,0.914771938579996,0,1,ligase regulator activity,MF,
13789,GO:0060375,0.999999999963497,0.914771938579996,0,1,regulation of mast cell differentiation,BP,
13790,GO:0060377,0.999999999963497,0.914771938579996,0,1,negative regulation of mast cell differentiation,BP,
20015,GO:2000631,0.999999999963497,0.914771938579996,0,1,regulation of pre-miRNA processing,BP,
20016,GO:2000632,0.999999999963497,0.914771938579996,0,1,negative regulation of pre-miRNA processing,BP,
13537,GO:0055120,0.999999999963502,0.9466667971017,0,1,striated muscle dense body,CC,
18871,GO:1904530,0.999999999963532,0.916738066766374,0,1,negative regulation of actin filament binding,BP,
18913,GO:1904617,0.999999999963532,0.916738066766374,0,1,negative regulation of actin binding,BP,
3959,GO:0008709,0.999999999963549,0.948313660689871,0,1,cholate 7-alpha-dehydrogenase activity,MF,
6824,GO:0030283,0.999999999963549,0.948313660689871,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
11944,GO:0047015,0.999999999963549,0.948313660689871,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
1877,GO:0004556,0.999999999963561,0.929116589138683,0,1,alpha-amylase activity,MF,
17179,GO:0103025,0.999999999963561,0.929116589138683,0,1,alpha-amylase activity (releasing maltohexaose),MF,
122,GO:0000252,0.999999999963597,0.937602481523408,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
11943,GO:0047012,0.999999999963597,0.937602481523408,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
17183,GO:0103066,0.999999999963597,0.937602481523408,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
17184,GO:0103067,0.999999999963597,0.937602481523408,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
3852,GO:0008465,0.999999999963624,0.943407990598648,0,1,glycerate dehydrogenase activity,MF,
192,GO:0000409,0.99999999996364,0.884596228320847,0,1,regulation of transcription by galactose,BP,
193,GO:0000411,0.99999999996364,0.884596228320847,0,1,positive regulation of transcription by galactose,BP,
206,GO:0000431,0.99999999996364,0.884596228320847,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
208,GO:0000435,0.99999999996364,0.884596228320847,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
4018,GO:0009032,0.99999999996364,0.936663723283079,0,1,thymidine phosphorylase activity,MF,
5365,GO:0016154,0.99999999996364,0.936663723283079,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
7487,GO:0031651,0.999999999963648,0.903629020377479,0,1,negative regulation of heat generation,BP,
7514,GO:0031699,0.999999999963648,0.903629020377479,0,1,beta-3 adrenergic receptor binding,MF,
14459,GO:0061798,0.999999999963648,0.903629020377479,0,1,GTP 3',8'-cyclase activity,MF,
14460,GO:0061799,0.999999999963648,0.903629020377479,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
16270,GO:0090327,0.999999999963648,0.903629020377479,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
15466,GO:0071802,0.999999999963654,0.903305831490306,0,1,negative regulation of podosome assembly,BP,
16034,GO:0086056,0.999999999963654,0.903305831490306,0,1,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
16935,GO:0098912,0.999999999963654,0.903305831490306,0,1,membrane depolarization during atrial cardiac muscle cell action potential,BP,
17239,GO:0110057,0.99999999996366,0.893252660687407,0,1,regulation of blood vessel endothelial cell differentiation,BP,
17240,GO:0110059,0.99999999996366,0.893252660687407,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
17635,GO:1901350,0.999999999963682,0.883668728574131,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
765,GO:0002016,0.999999999963685,0.952941069958898,0,1,regulation of blood volume by renin-angiotensin,BP,
767,GO:0002019,0.999999999963685,0.952941069958898,0,1,regulation of renal output by angiotensin,BP,
1281,GO:0003083,0.999999999963685,0.952941069958898,0,1,negative regulation of renal output by angiotensin,BP,
1293,GO:0003106,0.999999999963685,0.952941069958898,0,1,negative regulation of glomerular filtration by angiotensin,BP,
4935,GO:0014895,0.999999999963685,0.952941069958898,0,1,smooth muscle hypertrophy,BP,
10107,GO:0042624,0.999999999963685,0.952941069958898,0,1,ATPase activity, uncoupled,MF,
12585,GO:0050757,0.999999999963739,0.922962094150907,0,1,thymidylate synthase biosynthetic process,BP,
12586,GO:0050758,0.999999999963739,0.922962094150907,0,1,regulation of thymidylate synthase biosynthetic process,BP,
12587,GO:0050760,0.999999999963739,0.922962094150907,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
6666,GO:0030021,0.999999999963787,0.917002802136145,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
6870,GO:0030345,0.999999999963787,0.917002802136145,0,1,structural constituent of tooth enamel,MF,
1371,GO:0003257,0.999999999963788,0.902107673584177,0,1,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
4618,GO:0010736,0.999999999963788,0.902107673584177,0,1,serum response element binding,MF,
4905,GO:0014835,0.999999999963788,0.902107673584177,0,1,myoblast differentiation involved in skeletal muscle regeneration,BP,
17590,GO:1901228,0.999999999963788,0.902107673584177,0,1,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
1847,GO:0004506,0.999999999963824,0.918185458074061,0,1,squalene monooxygenase activity,MF,
8336,GO:0033181,0.999999999963832,0.936480603277951,0,1,plasma membrane proton-transporting V-type ATPase complex,CC,
17680,GO:1901551,0.999999999963854,0.903245774101704,0,1,negative regulation of endothelial cell development,BP,
18272,GO:1903141,0.999999999963854,0.903245774101704,0,1,negative regulation of establishment of endothelial barrier,BP,
9012,GO:0035175,0.999999999963855,0.935919259808264,0,1,histone kinase activity (H3-S10 specific),MF,
15761,GO:0072354,0.999999999963855,0.935919259808264,0,1,histone kinase activity (H3-T3 specific),MF,
15762,GO:0072355,0.999999999963855,0.935919259808264,0,1,histone H3-T3 phosphorylation,BP,
19650,GO:1990876,0.999999999963891,0.886249708697039,0,1,cytoplasmic side of nuclear pore,CC,
17959,GO:1902311,0.999999999963915,0.934989916245688,0,1,regulation of copper ion transmembrane transport,BP,
9812,GO:0042007,0.999999999963944,0.94046226059285,0,1,interleukin-18 binding,MF,
18676,GO:1904021,0.999999999963963,0.912537071068518,0,1,negative regulation of G-protein coupled receptor internalization,BP,
17432,GO:1900195,0.999999999963964,0.865674130002665,0,2,positive regulation of oocyte maturation,BP,
8871,GO:0034673,0.999999999963975,0.794097182703969,0,2,inhibin-betaglycan-ActRII complex,CC,
14364,GO:0061580,0.99999999996398,0.904050318596363,0,1,colon epithelial cell migration,BP,
14952,GO:0070843,0.99999999996398,0.904050318596363,0,1,misfolded protein transport,BP,
14953,GO:0070844,0.99999999996398,0.904050318596363,0,1,polyubiquitinated protein transport,BP,
14954,GO:0070845,0.99999999996398,0.904050318596363,0,1,polyubiquitinated misfolded protein transport,BP,
14955,GO:0070846,0.99999999996398,0.904050318596363,0,1,Hsp90 deacetylation,BP,
2688,GO:0006050,0.999999999964,0.937959809614984,0,1,mannosamine metabolic process,BP,
2689,GO:0006051,0.999999999964,0.937959809614984,0,1,N-acetylmannosamine metabolic process,BP,
11109,GO:0045127,0.999999999964,0.937959809614984,0,1,N-acetylglucosamine kinase activity,MF,
19537,GO:1990448,0.999999999964039,0.886315683918054,0,1,exon-exon junction complex binding,MF,
11254,GO:0045485,0.999999999964067,0.901164270008745,0,1,omega-6 fatty acid desaturase activity,MF,
2227,GO:0005130,0.999999999964084,0.938900437042862,0,1,granulocyte colony-stimulating factor receptor binding,MF,
9163,GO:0035516,0.999999999964102,0.902336117630366,0,1,oxidative DNA demethylase activity,MF,
14713,GO:0070343,0.999999999964102,0.902336117630366,0,1,white fat cell proliferation,BP,
14717,GO:0070350,0.999999999964102,0.902336117630366,0,1,regulation of white fat cell proliferation,BP,
19669,GO:1990931,0.999999999964102,0.902336117630366,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
13549,GO:0060010,0.999999999964115,0.913774896992165,0,1,Sertoli cell fate commitment,BP,
17742,GO:1901676,0.999999999964127,0.90629518476257,0,1,positive regulation of histone H3-K27 acetylation,BP,
14741,GO:0070408,0.999999999964129,0.89158572404471,0,1,carbamoyl phosphate metabolic process,BP,
14742,GO:0070409,0.999999999964129,0.89158572404471,0,1,carbamoyl phosphate biosynthetic process,BP,
18529,GO:1903717,0.999999999964129,0.89158572404471,0,1,response to ammonia,BP,
18530,GO:1903718,0.999999999964129,0.89158572404471,0,1,cellular response to ammonia,BP,
1583,GO:0003994,0.99999999996416,0.839059482985453,0,2,aconitate hydratase activity,MF,
5052,GO:0015247,0.999999999964176,0.723001819212203,0,3,aminophospholipid transmembrane transporter activity,MF,
7890,GO:0032458,0.999999999964205,0.906778531220693,0,1,slow endocytic recycling,BP,
5300,GO:0015990,0.999999999964208,0.951162179143166,0,1,electron transport coupled proton transport,BP,
8280,GO:0033082,0.999999999964232,0.897110510806834,0,1,regulation of extrathymic T cell differentiation,BP,
19584,GO:1990654,0.999999999964232,0.897110510806834,0,1,sebum secreting cell proliferation,BP,
13446,GO:0052858,0.999999999964234,0.910426867071966,0,1,peptidyl-lysine acetyltransferase activity,MF,
10814,GO:0044301,0.999999999964275,0.900589673839985,0,1,climbing fiber,CC,
19427,GO:1990032,0.999999999964275,0.900589673839985,0,1,parallel fiber,CC,
16436,GO:0097086,0.999999999964282,0.909356615131694,0,1,amniotic stem cell differentiation,BP,
20068,GO:2000706,0.999999999964282,0.909356615131694,0,1,negative regulation of dense core granule biogenesis,BP,
20084,GO:2000740,0.999999999964282,0.909356615131694,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
20117,GO:2000797,0.999999999964282,0.909356615131694,0,1,regulation of amniotic stem cell differentiation,BP,
20118,GO:2000798,0.999999999964282,0.909356615131694,0,1,negative regulation of amniotic stem cell differentiation,BP,
15774,GO:0072368,0.999999999964296,0.792483330537223,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
3856,GO:0008470,0.999999999964319,0.8993885264144,0,1,isovaleryl-CoA dehydrogenase activity,MF,
3096,GO:0006669,0.999999999964348,0.918579835106161,0,1,sphinganine-1-phosphate biosynthetic process,BP,
14921,GO:0070772,0.999999999964362,0.916622732339725,0,1,PAS complex,CC,
11980,GO:0047277,0.999999999964368,0.932409677248989,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
13880,GO:0060510,0.999999999964373,0.827965273506367,0,2,Type II pneumocyte differentiation,BP,
5807,GO:0017061,0.999999999964374,0.897084703140683,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
3982,GO:0008817,0.999999999964387,0.903874639477955,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
12051,GO:0047933,0.999999999964399,0.875326249663917,0,1,glucose-1,6-bisphosphate synthase activity,MF,
2213,GO:0005105,0.999999999964402,0.927850477038126,0,1,type 1 fibroblast growth factor receptor binding,MF,
1519,GO:0003881,0.999999999964409,0.933490736945538,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
18003,GO:1902464,0.999999999964421,0.901245769410512,0,1,regulation of histone H3-K27 trimethylation,BP,
18004,GO:1902466,0.999999999964421,0.901245769410512,0,1,positive regulation of histone H3-K27 trimethylation,BP,
10749,GO:0044128,0.999999999964433,0.895867358767452,0,1,positive regulation of growth of symbiont in host,BP,
10755,GO:0044148,0.999999999964433,0.895867358767452,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
6157,GO:0019482,0.999999999964437,0.834370663279901,0,2,beta-alanine metabolic process,BP,
14894,GO:0070685,0.999999999964442,0.93011939210648,0,1,macropinocytic cup,CC,
17362,GO:1900062,0.999999999964448,0.908677083874553,0,1,regulation of replicative cell aging,BP,
1654,GO:0004108,0.999999999964465,0.918335056956689,0,1,citrate (Si)-synthase activity,MF,
3421,GO:0007206,0.999999999964465,0.903096369174972,0,1,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
9590,GO:0036440,0.999999999964465,0.918335056956689,0,1,citrate synthase activity,MF,
15451,GO:0071765,0.999999999964465,0.903096369174972,0,1,nuclear inner membrane organization,BP,
1611,GO:0004034,0.999999999964466,0.925047563221638,0,1,aldose 1-epimerase activity,MF,
9400,GO:0035945,0.999999999964466,0.925047563221638,0,1,mitochondrial ncRNA surveillance,BP,
9401,GO:0035946,0.999999999964466,0.925047563221638,0,1,mitochondrial mRNA surveillance,BP,
15066,GO:0071026,0.999999999964466,0.925047563221638,0,1,cytoplasmic RNA surveillance,BP,
20135,GO:2000827,0.999999999964466,0.925047563221638,0,1,mitochondrial RNA surveillance,BP,
16952,GO:0098939,0.999999999964489,0.886814271809019,0,1,dendritic transport of mitochondrion,BP,
16963,GO:0098972,0.999999999964489,0.886814271809019,0,1,anterograde dendritic transport of mitochondrion,BP,
2691,GO:0006055,0.999999999964491,0.943391365111091,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
11651,GO:0046381,0.999999999964491,0.943391365111091,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12002,GO:0047444,0.999999999964491,0.943391365111091,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12487,GO:0050462,0.999999999964491,0.943391365111091,0,1,N-acetylneuraminate synthase activity,MF,
6786,GO:0030222,0.999999999964516,0.909769357977668,0,1,eosinophil differentiation,BP,
11321,GO:0045643,0.999999999964516,0.909769357977668,0,1,regulation of eosinophil differentiation,BP,
11322,GO:0045645,0.999999999964516,0.909769357977668,0,1,positive regulation of eosinophil differentiation,BP,
13462,GO:0052925,0.99999999996453,0.938876774355471,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
3714,GO:0008228,0.999999999964543,0.787500714608403,0,2,opsonization,BP,
9235,GO:0035623,0.999999999964561,0.914825694507581,0,1,renal glucose absorption,BP,
1484,GO:0003796,0.999999999964561,0.93893199888579,0,1,lysozyme activity,MF,
1268,GO:0003050,0.999999999964562,0.915485768520671,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
14628,GO:0070195,0.99999999996459,0.901686067414951,0,1,growth hormone receptor complex,CC,
9619,GO:0036483,0.999999999964597,0.899937463461859,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
18377,GO:1903381,0.999999999964597,0.899937463461859,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18378,GO:1903382,0.999999999964597,0.899937463461859,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
7613,GO:0031999,0.999999999964622,0.801214841039934,0,2,negative regulation of fatty acid beta-oxidation,BP,
943,GO:0002357,0.999999999964627,0.921275878054829,0,1,defense response to tumor cell,BP,
15331,GO:0071547,0.999999999964627,0.921275878054829,0,1,piP-body,CC,
2221,GO:0005124,0.999999999964633,0.926123740249811,0,1,scavenger receptor binding,MF,
5424,GO:0016277,0.999999999964633,0.926123740249811,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
17774,GO:1901804,0.999999999964633,0.926123740249811,0,1,beta-glucoside metabolic process,BP,
17775,GO:1901805,0.999999999964633,0.926123740249811,0,1,beta-glucoside catabolic process,BP,
18848,GO:1904457,0.999999999964633,0.926123740249811,0,1,positive regulation of neuronal action potential,BP,
8669,GO:0034238,0.99999999996468,0.905497172671039,0,1,macrophage fusion,BP,
8670,GO:0034239,0.99999999996468,0.905497172671039,0,1,regulation of macrophage fusion,BP,
8671,GO:0034241,0.99999999996468,0.905497172671039,0,1,positive regulation of macrophage fusion,BP,
13089,GO:0051598,0.999999999964712,0.89958789862971,0,1,meiotic recombination checkpoint,BP,
18661,GO:1903977,0.999999999964762,0.817221595864699,0,2,positive regulation of glial cell migration,BP,
517,GO:0001582,0.999999999964782,0.924041341601854,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
8262,GO:0033041,0.999999999964782,0.924041341601854,0,1,sweet taste receptor activity,MF,
10664,GO:0043843,0.999999999964782,0.924041341601854,0,1,ADP-specific glucokinase activity,MF,
18554,GO:1903767,0.999999999964782,0.924041341601854,0,1,sweet taste receptor complex,CC,
18555,GO:1903768,0.999999999964782,0.924041341601854,0,1,taste receptor complex,CC,
9618,GO:0036482,0.999999999964796,0.875248084255832,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18189,GO:1902958,0.999999999964796,0.875248084255832,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
18379,GO:1903383,0.999999999964796,0.875248084255832,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
18380,GO:1903384,0.999999999964796,0.875248084255832,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
15378,GO:0071619,0.999999999964808,0.927891337815824,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20224,GO:2001163,0.999999999964808,0.927891337815824,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
20225,GO:2001165,0.999999999964808,0.927891337815824,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
4927,GO:0014878,0.999999999964813,0.89428945510433,0,1,response to electrical stimulus involved in regulation of muscle adaptation,BP,
9332,GO:0035811,0.999999999964827,0.888627850168727,0,1,negative regulation of urine volume,BP,
2416,GO:0005590,0.999999999964851,0.871032985709155,0,1,collagen type VII trimer,CC,
16806,GO:0098648,0.999999999964851,0.871032985709155,0,1,collagen anchoring fibril,CC,
16808,GO:0098652,0.999999999964851,0.871032985709155,0,1,collagen type VII anchoring fibril,CC,
7010,GO:0030696,0.999999999964861,0.915884389997838,0,1,tRNA (m5U54) methyltransferase activity,MF,
7011,GO:0030697,0.999999999964861,0.915884389997838,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
748,GO:0001978,0.999999999964909,0.929137236395531,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
749,GO:0001983,0.999999999964909,0.929137236395531,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
750,GO:0001985,0.999999999964909,0.929137236395531,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
755,GO:0001994,0.999999999964909,0.929137236395531,0,1,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
757,GO:0001997,0.999999999964909,0.929137236395531,0,1,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
1289,GO:0003099,0.999999999964909,0.929137236395531,0,1,positive regulation of the force of heart contraction by chemical signal,BP,
2131,GO:0004936,0.999999999964909,0.929137236395531,0,1,alpha-adrenergic receptor activity,MF,
2132,GO:0004937,0.999999999964909,0.929137236395531,0,1,alpha1-adrenergic receptor activity,MF,
18666,GO:1903995,0.999999999964909,0.929137236395531,0,1,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
18667,GO:1903997,0.999999999964909,0.929137236395531,0,1,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
11093,GO:0045098,0.999999999964971,0.936602625888377,0,1,type III intermediate filament,CC,
12142,GO:0048244,0.999999999964971,0.936602625888377,0,1,phytanoyl-CoA dioxygenase activity,MF,
16437,GO:0097089,0.999999999964971,0.936602625888377,0,1,methyl-branched fatty acid metabolic process,BP,
1036,GO:0002545,0.999999999964984,0.933374609266787,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1211,GO:0002880,0.999999999964984,0.933374609266787,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1212,GO:0002882,0.999999999964984,0.933374609266787,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1535,GO:0003920,0.999999999964984,0.933374609266787,0,1,GMP reductase activity,MF,
5289,GO:0015950,0.999999999964984,0.933374609266787,0,1,purine nucleotide interconversion,BP,
5290,GO:0015951,0.999999999964984,0.933374609266787,0,1,purine ribonucleotide interconversion,BP,
5612,GO:0016657,0.999999999964984,0.933374609266787,0,1,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
18038,GO:1902560,0.999999999964984,0.933374609266787,0,1,GMP reductase complex,CC,
18256,GO:1903093,0.999999999965005,0.790007763164698,0,3,regulation of protein K48-linked deubiquitination,BP,
1954,GO:0004658,0.999999999965013,0.864363852772235,0,2,propionyl-CoA carboxylase activity,MF,
16411,GO:0097037,0.999999999965018,0.912235318268368,0,1,heme export,BP,
16782,GO:0098594,0.999999999965039,0.952031534818009,0,1,mucin granule,CC,
5838,GO:0017125,0.999999999965043,0.898397145857686,0,1,deoxycytidyl transferase activity,MF,
4082,GO:0009136,0.999999999965045,0.879145580370806,0,2,purine nucleoside diphosphate biosynthetic process,BP,
4121,GO:0009180,0.999999999965045,0.879145580370806,0,2,purine ribonucleoside diphosphate biosynthetic process,BP,
4129,GO:0009188,0.999999999965045,0.879145580370806,0,2,ribonucleoside diphosphate biosynthetic process,BP,
14124,GO:0060987,0.999999999965047,0.927245755070988,0,1,lipid tube,CC,
13766,GO:0060342,0.999999999965047,0.933389114229094,0,1,photoreceptor inner segment membrane,CC,
329,GO:0000917,0.999999999965068,0.93385495199865,0,1,division septum assembly,BP,
16327,GO:0090529,0.999999999965068,0.93385495199865,0,1,cell septum assembly,BP,
15002,GO:0070926,0.999999999965089,0.906871507923663,0,1,regulation of ATP:ADP antiporter activity,BP,
9506,GO:0036153,0.999999999965093,0.920682299650992,0,1,triglyceride acyl-chain remodeling,BP,
12917,GO:0051264,0.999999999965093,0.920682299650992,0,1,mono-olein transacylation activity,MF,
12918,GO:0051265,0.999999999965093,0.920682299650992,0,1,diolein transacylation activity,MF,
5364,GO:0016150,0.999999999965155,0.937308679180378,0,1,translation release factor activity, codon nonspecific,MF,
13891,GO:0060532,0.999999999965161,0.817495747826472,0,2,bronchus cartilage development,BP,
14211,GO:0061145,0.999999999965161,0.817495747826472,0,2,lung smooth muscle development,BP,
6136,GO:0019402,0.999999999965195,0.941368345595016,0,1,galactitol metabolic process,BP,
14383,GO:0061623,0.999999999965195,0.941368345595016,0,1,glycolytic process from galactose,BP,
10113,GO:0042631,0.99999999996522,0.910420505185314,0,1,cellular response to water deprivation,BP,
9526,GO:0036245,0.999999999965242,0.843330275978671,0,2,cellular response to menadione,BP,
4058,GO:0009107,0.999999999965253,0.936442518408525,0,1,lipoate biosynthetic process,BP,
5774,GO:0016992,0.999999999965253,0.936442518408525,0,1,lipoate synthase activity,MF,
14675,GO:0070283,0.999999999965253,0.936442518408525,0,1,radical SAM enzyme activity,MF,
11721,GO:0046523,0.999999999965262,0.916643082451271,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12028,GO:0047685,0.999999999965286,0.939066284204204,0,1,amine sulfotransferase activity,MF,
3470,GO:0007290,0.999999999965298,0.898193778060282,0,1,spermatid nucleus elongation,BP,
11611,GO:0046293,0.999999999965298,0.898193778060282,0,1,formaldehyde biosynthetic process,BP,
8179,GO:0032915,0.999999999965306,0.93002906073315,0,1,positive regulation of transforming growth factor beta2 production,BP,
19655,GO:1990889,0.999999999965331,0.933650743696759,0,1,H4K20me3 modified histone binding,MF,
11731,GO:0046541,0.999999999965401,0.921572093366537,0,1,saliva secretion,BP,
12017,GO:0047578,0.999999999965417,0.925477558538281,0,1,4-hydroxyglutamate transaminase activity,MF,
19664,GO:1990923,0.999999999965422,0.833709741364248,0,2,PET complex,CC,
1685,GO:0004152,0.999999999965461,0.930712260732513,0,1,dihydroorotate dehydrogenase activity,MF,
18476,GO:1903576,0.999999999965461,0.930712260732513,0,1,response to L-arginine,BP,
1247,GO:0002947,0.999999999965486,0.904019213234348,0,1,tumor necrosis factor receptor superfamily complex,CC,
12337,GO:0048696,0.999999999965487,0.939232494452592,0,1,regulation of collateral sprouting in absence of injury,BP,
12338,GO:0048697,0.999999999965487,0.939232494452592,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13595,GO:0060064,0.999999999965487,0.939232494452592,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
19277,GO:1905474,0.999999999965487,0.939232494452592,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
15998,GO:0086006,0.999999999965493,0.808297180495371,0,2,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
15797,GO:0072428,0.999999999965496,0.933577965498846,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
18633,GO:1903925,0.999999999965496,0.933577965498846,0,1,response to bisphenol A,BP,
18634,GO:1903926,0.999999999965496,0.933577965498846,0,1,cellular response to bisphenol A,BP,
10073,GO:0042568,0.999999999965498,0.948062251029696,0,1,insulin-like growth factor binary complex,CC,
16697,GO:0097643,0.9999999999655,0.949105610958974,0,1,amylin receptor activity,MF,
18411,GO:1903440,0.9999999999655,0.949105610958974,0,1,amylin receptor complex,CC,
19517,GO:1990407,0.9999999999655,0.949105610958974,0,1,calcitonin gene-related peptide binding,MF,
14403,GO:0061663,0.999999999965504,0.881877845509179,0,1,NEDD8 ligase activity,MF,
15173,GO:0071301,0.999999999965504,0.881877845509179,0,1,cellular response to vitamin B1,BP,
18824,GO:1904404,0.999999999965504,0.881877845509179,0,1,response to formaldehyde,BP,
12509,GO:0050652,0.999999999965518,0.908579155533979,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
12510,GO:0050653,0.999999999965518,0.908579155533979,0,1,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
2628,GO:0005954,0.999999999965545,0.925141579822249,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
11806,GO:0046687,0.999999999965562,0.945838819379081,0,1,response to chromate,BP,
15146,GO:0071247,0.999999999965562,0.945838819379081,0,1,cellular response to chromate,BP,
17910,GO:1902220,0.999999999965562,0.945838819379081,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
7014,GO:0030718,0.999999999965565,0.907252132183874,0,1,germ-line stem cell population maintenance,BP,
8816,GO:0034584,0.999999999965565,0.907252132183874,0,1,piRNA binding,MF,
15145,GO:0071245,0.999999999965617,0.909587553752848,0,1,cellular response to carbon monoxide,BP,
18390,GO:1903406,0.999999999965617,0.909587553752848,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
18391,GO:1903408,0.999999999965617,0.909587553752848,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
7842,GO:0032398,0.999999999965626,0.93638923743793,0,1,MHC class Ib protein complex,CC,
8009,GO:0032639,0.999999999965626,0.93638923743793,0,1,TRAIL production,BP,
8033,GO:0032679,0.999999999965626,0.93638923743793,0,1,regulation of TRAIL production,BP,
8078,GO:0032759,0.999999999965626,0.93638923743793,0,1,positive regulation of TRAIL production,BP,
19978,GO:2000566,0.999999999965626,0.93638923743793,0,1,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
20242,GO:2001187,0.999999999965626,0.93638923743793,0,1,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
14733,GO:0070390,0.999999999965628,0.935873964244617,0,1,transcription export complex 2,CC,
1336,GO:0003193,0.999999999965641,0.915870864172755,0,1,pulmonary valve formation,BP,
9386,GO:0035922,0.999999999965641,0.915870864172755,0,1,foramen ovale closure,BP,
16026,GO:0086044,0.999999999965641,0.915870864172755,0,1,atrial cardiac muscle cell to AV node cell communication by electrical coupling,BP,
16032,GO:0086054,0.999999999965641,0.915870864172755,0,1,bundle of His cell to Purkinje myocyte communication by electrical coupling,BP,
16033,GO:0086055,0.999999999965641,0.915870864172755,0,1,Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling,BP,
16046,GO:0086076,0.999999999965641,0.915870864172755,0,1,gap junction channel activity involved in atrial cardiac muscle cell-AV node cell electrical coupling,MF,
16048,GO:0086078,0.999999999965641,0.915870864172755,0,1,gap junction channel activity involved in bundle of His cell-Purkinje myocyte electrical coupling,MF,
16049,GO:0086079,0.999999999965641,0.915870864172755,0,1,gap junction channel activity involved in Purkinje myocyte-ventricular cardiac muscle cell electrical coupling,MF,
16929,GO:0098906,0.999999999965641,0.915870864172755,0,1,regulation of Purkinje myocyte action potential,BP,
19425,GO:1990029,0.999999999965641,0.915870864172755,0,1,vasomotion,BP,
16277,GO:0090341,0.999999999965674,0.938225086811831,0,1,negative regulation of secretion of lysosomal enzymes,BP,
6024,GO:0019082,0.999999999965683,0.903356008971598,0,1,viral protein processing,BP,
16311,GO:0090472,0.999999999965683,0.903356008971598,0,1,dibasic protein processing,BP,
437,GO:0001165,0.999999999965689,0.899726143188811,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
14667,GO:0070267,0.999999999965697,0.910274389809986,0,1,oncosis,BP,
215,GO:0000448,0.999999999965699,0.820531385986634,0,2,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
1786,GO:0004408,0.999999999965713,0.927693956932664,0,1,holocytochrome-c synthase activity,MF,
5781,GO:0017003,0.999999999965713,0.927693956932664,0,1,protein-heme linkage,BP,
5784,GO:0017006,0.999999999965713,0.927693956932664,0,1,protein-tetrapyrrole linkage,BP,
5892,GO:0018063,0.999999999965713,0.927693956932664,0,1,cytochrome c-heme linkage,BP,
15436,GO:0071707,0.999999999965721,0.942926994169263,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
1064,GO:0002605,0.999999999965725,0.891265003712764,0,1,negative regulation of dendritic cell antigen processing and presentation,BP,
4632,GO:0010754,0.999999999965725,0.891265003712764,0,1,negative regulation of cGMP-mediated signaling,BP,
100,GO:0000210,0.999999999965733,0.911544673739861,0,1,NAD+ diphosphatase activity,MF,
3147,GO:0006742,0.999999999965733,0.911544673739861,0,1,NADP catabolic process,BP,
6117,GO:0019364,0.999999999965733,0.911544673739861,0,1,pyridine nucleotide catabolic process,BP,
6199,GO:0019677,0.999999999965733,0.911544673739861,0,1,NAD catabolic process,BP,
17840,GO:1902010,0.999999999965733,0.911544673739861,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
373,GO:0000994,0.999999999965756,0.93490073152221,0,1,RNA polymerase III core binding,MF,
3487,GO:0007352,0.999999999965758,0.864756137105012,0,1,zygotic specification of dorsal/ventral axis,BP,
17448,GO:1900224,0.999999999965758,0.864756137105012,0,1,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
19893,GO:2000382,0.999999999965758,0.864756137105012,0,1,positive regulation of mesoderm development,BP,
18769,GO:1904265,0.999999999965761,0.888476031030166,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
15050,GO:0070995,0.999999999965777,0.915911444270688,0,1,NADPH oxidation,BP,
19426,GO:1990031,0.999999999965777,0.915911444270688,0,1,pinceau fiber,CC,
11739,GO:0046570,0.999999999965798,0.943059445367736,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
3987,GO:0008852,0.999999999965804,0.920357794697532,0,1,exodeoxyribonuclease I activity,MF,
11945,GO:0047016,0.999999999965856,0.929075306595998,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
3978,GO:0008798,0.999999999965885,0.891718526763913,0,1,beta-aspartyl-peptidase activity,MF,
15003,GO:0070931,0.999999999965885,0.891718526763913,0,1,Golgi-associated vesicle lumen,CC,
12162,GO:0048270,0.999999999965891,0.930481616308209,0,1,methionine adenosyltransferase regulator activity,MF,
4694,GO:0010848,0.999999999965894,0.914329277749387,0,1,regulation of chromatin disassembly,BP,
16423,GO:0097058,0.999999999965898,0.934611771301631,0,1,CRLF-CLCF1 complex,CC,
16424,GO:0097059,0.999999999965898,0.934611771301631,0,1,CNTFR-CLCF1 complex,CC,
2799,GO:0006253,0.999999999965899,0.945473663940118,0,1,dCTP catabolic process,BP,
11537,GO:0046065,0.999999999965899,0.945473663940118,0,1,dCTP metabolic process,BP,
12044,GO:0047840,0.999999999965899,0.945473663940118,0,1,dCTP diphosphatase activity,MF,
1718,GO:0004310,0.999999999965944,0.930168068716162,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
7165,GO:0031038,0.999999999965944,0.930168068716162,0,1,myosin II filament organization,BP,
10563,GO:0043519,0.999999999965944,0.930168068716162,0,1,regulation of myosin II filament organization,BP,
13295,GO:0051996,0.999999999965944,0.930168068716162,0,1,squalene synthase activity,MF,
19132,GO:1905089,0.99999999996596,0.855364035977763,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
19133,GO:1905090,0.99999999996596,0.855364035977763,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
13392,GO:0052692,0.999999999966008,0.940446168779338,0,1,raffinose alpha-galactosidase activity,MF,
16582,GO:0097376,0.999999999966008,0.940446168779338,0,1,interneuron axon guidance,BP,
4594,GO:0010705,0.999999999966048,0.899793520406991,0,1,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
16023,GO:0086040,0.999999999966048,0.899793520406991,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16055,GO:0086092,0.999999999966048,0.899793520406991,0,1,regulation of the force of heart contraction by cardiac conduction,BP,
13593,GO:0060060,0.999999999966079,0.883240684868926,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14848,GO:0070593,0.999999999966079,0.883240684868926,0,1,dendrite self-avoidance,BP,
9527,GO:0036250,0.999999999966091,0.93271068970325,0,1,peroxisome transport along microtubule,BP,
10964,GO:0044721,0.999999999966091,0.93271068970325,0,1,protein import into peroxisome matrix, substrate release,BP,
14310,GO:0061444,0.999999999966091,0.890024359836674,0,1,endocardial cushion cell development,BP,
1427,GO:0003400,0.999999999966109,0.92933703552813,0,1,regulation of COPII vesicle coating,BP,
2205,GO:0005090,0.999999999966109,0.92933703552813,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
13956,GO:0060661,0.999999999966109,0.92933703552813,0,1,submandibular salivary gland formation,BP,
15194,GO:0071335,0.999999999966109,0.92933703552813,0,1,hair follicle cell proliferation,BP,
15195,GO:0071336,0.999999999966109,0.92933703552813,0,1,regulation of hair follicle cell proliferation,BP,
15196,GO:0071338,0.999999999966109,0.92933703552813,0,1,positive regulation of hair follicle cell proliferation,BP,
16125,GO:0090113,0.999999999966109,0.92933703552813,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
1528,GO:0003908,0.999999999966148,0.942976642044097,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
11085,GO:0045085,0.999999999966154,0.93543781845742,0,1,negative regulation of interleukin-2 biosynthetic process,BP,
13434,GO:0052836,0.999999999966154,0.849877593565525,0,2,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
13435,GO:0052839,0.999999999966154,0.849877593565525,0,2,inositol diphosphate tetrakisphosphate kinase activity,MF,
16841,GO:0098745,0.999999999966154,0.93543781845742,0,1,Dcp1-Dcp2 complex,CC,
17776,GO:1901834,0.999999999966154,0.93543781845742,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
17777,GO:1901835,0.999999999966154,0.93543781845742,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
18761,GO:1904246,0.999999999966154,0.93543781845742,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
7365,GO:0031407,0.999999999966159,0.926636593592865,0,1,oxylipin metabolic process,BP,
12054,GO:0047977,0.999999999966159,0.926636593592865,0,1,hepoxilin-epoxide hydrolase activity,MF,
17768,GO:1901751,0.999999999966159,0.926636593592865,0,1,leukotriene A4 metabolic process,BP,
20304,GO:2001300,0.999999999966159,0.926636593592865,0,1,lipoxin metabolic process,BP,
20305,GO:2001301,0.999999999966159,0.926636593592865,0,1,lipoxin biosynthetic process,BP,
20306,GO:2001302,0.999999999966159,0.926636593592865,0,1,lipoxin A4 metabolic process,BP,
20307,GO:2001303,0.999999999966159,0.926636593592865,0,1,lipoxin A4 biosynthetic process,BP,
20308,GO:2001304,0.999999999966159,0.926636593592865,0,1,lipoxin B4 metabolic process,BP,
20309,GO:2001306,0.999999999966159,0.926636593592865,0,1,lipoxin B4 biosynthetic process,BP,
9537,GO:0036284,0.999999999966173,0.826633329303407,0,2,tubulobulbar complex,CC,
7312,GO:0031315,0.999999999966204,0.884026712320013,0,1,extrinsic component of mitochondrial outer membrane,CC,
7557,GO:0031893,0.999999999966205,0.92886226348957,0,1,vasopressin receptor binding,MF,
7558,GO:0031896,0.999999999966205,0.92886226348957,0,1,V2 vasopressin receptor binding,MF,
2172,GO:0005008,0.999999999966207,0.886051927069879,0,1,hepatocyte growth factor-activated receptor activity,MF,
18970,GO:1904750,0.999999999966207,0.886051927069879,0,1,negative regulation of protein localization to nucleolus,BP,
3645,GO:0008117,0.999999999966225,0.891443795083857,0,1,sphinganine-1-phosphate aldolase activity,MF,
8536,GO:0033858,0.999999999966239,0.915789727906882,0,1,N-acetylgalactosamine kinase activity,MF,
5111,GO:0015421,0.99999999996624,0.910938188868645,0,1,oligopeptide-transporting ATPase activity,MF,
836,GO:0002135,0.99999999996627,0.924229059134717,0,1,CTP binding,MF,
5824,GO:0017098,0.99999999996627,0.924229059134717,0,1,sulfonylurea receptor binding,MF,
17651,GO:1901388,0.99999999996627,0.924229059134717,0,1,regulation of transforming growth factor beta activation,BP,
17652,GO:1901389,0.99999999996627,0.924229059134717,0,1,negative regulation of transforming growth factor beta activation,BP,
18507,GO:1903659,0.99999999996627,0.924229059134717,0,1,regulation of complement-dependent cytotoxicity,BP,
18508,GO:1903660,0.99999999996627,0.924229059134717,0,1,negative regulation of complement-dependent cytotoxicity,BP,
19661,GO:1990913,0.99999999996627,0.924229059134717,0,1,sperm head plasma membrane,CC,
19662,GO:1990917,0.99999999996627,0.924229059134717,0,1,ooplasm,CC,
4211,GO:0009353,0.999999999966272,0.941972237779861,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
7430,GO:0031531,0.999999999966272,0.941972237779861,0,1,thyrotropin-releasing hormone receptor binding,MF,
1888,GO:0004569,0.99999999996628,0.89982729528066,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
9563,GO:0036343,0.999999999966294,0.955605251679262,0,1,psychomotor behavior,BP,
1765,GO:0004368,0.999999999966296,0.890520853544193,0,1,glycerol-3-phosphate dehydrogenase activity,MF,
2743,GO:0006127,0.999999999966296,0.890520853544193,0,1,glycerophosphate shuttle,BP,
5753,GO:0016901,0.999999999966296,0.890520853544193,0,1,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
13372,GO:0052590,0.999999999966296,0.890520853544193,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
13373,GO:0052591,0.999999999966296,0.890520853544193,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
19375,GO:1905843,0.999999999966299,0.861316441134146,0,1,regulation of cellular response to gamma radiation,BP,
10489,GO:0043385,0.999999999966303,0.921625914795182,0,1,mycotoxin metabolic process,BP,
10490,GO:0043387,0.999999999966303,0.921625914795182,0,1,mycotoxin catabolic process,BP,
11607,GO:0046222,0.999999999966303,0.921625914795182,0,1,aflatoxin metabolic process,BP,
11608,GO:0046223,0.999999999966303,0.921625914795182,0,1,aflatoxin catabolic process,BP,
17642,GO:1901376,0.999999999966303,0.921625914795182,0,1,organic heteropentacyclic compound metabolic process,BP,
17643,GO:1901377,0.999999999966303,0.921625914795182,0,1,organic heteropentacyclic compound catabolic process,BP,
18563,GO:1903786,0.999999999966303,0.921625914795182,0,1,regulation of glutathione biosynthetic process,BP,
18564,GO:1903788,0.999999999966303,0.921625914795182,0,1,positive regulation of glutathione biosynthetic process,BP,
5839,GO:0017126,0.999999999966364,0.894233868912781,0,1,nucleologenesis,BP,
19475,GO:1990189,0.999999999966372,0.867362975951716,0,2,peptide-serine-N-acetyltransferase activity,MF,
19290,GO:1905535,0.999999999966385,0.894898241412142,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19291,GO:1905537,0.999999999966385,0.894898241412142,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
19322,GO:1905610,0.999999999966385,0.894898241412142,0,1,regulation of mRNA cap binding,BP,
19323,GO:1905612,0.999999999966385,0.894898241412142,0,1,positive regulation of mRNA cap binding,BP,
3971,GO:0008775,0.999999999966399,0.934206525049839,0,1,acetate CoA-transferase activity,MF,
4328,GO:0009850,0.999999999966399,0.934206525049839,0,1,auxin metabolic process,BP,
4329,GO:0009852,0.999999999966399,0.934206525049839,0,1,auxin catabolic process,BP,
4400,GO:0010124,0.999999999966399,0.934206525049839,0,1,phenylacetate catabolic process,BP,
8879,GO:0034685,0.99999999996641,0.818993205033538,0,2,integrin alphav-beta6 complex,CC,
2192,GO:0005053,0.99999999996646,0.939391125535899,0,1,peroxisome matrix targeting signal-2 binding,MF,
15955,GO:0075341,0.999999999966472,0.927591972759065,0,1,host cell PML body,CC,
14780,GO:0070481,0.999999999966476,0.919232242137526,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
14874,GO:0070651,0.999999999966476,0.919232242137526,0,1,nonfunctional rRNA decay,BP,
16715,GO:0097698,0.999999999966482,0.939311769185726,0,1,telomere maintenance via base-excision repair,BP,
1917,GO:0004610,0.999999999966505,0.931683753261667,0,1,phosphoacetylglucosamine mutase activity,MF,
6596,GO:0022613,0.999999999966522,2.81596999698843e-10,5,447,ribonucleoprotein complex biogenesis,BP,CHD7;ATXN2;NOP10;PUM2;GRB7
7185,GO:0031071,0.999999999966528,0.926460997870599,0,1,cysteine desulfurase activity,MF,
477,GO:0001520,0.999999999966533,0.815722774287059,0,2,outer dense fiber,CC,
825,GO:0002100,0.999999999966548,0.88853067147949,0,1,tRNA wobble adenosine to inosine editing,BP,
2149,GO:0004968,0.999999999966548,0.88853067147949,0,1,gonadotropin-releasing hormone receptor activity,MF,
8913,GO:0034752,0.999999999966548,0.88853067147949,0,1,cytosolic aryl hydrocarbon receptor complex,CC,
8914,GO:0034753,0.999999999966548,0.88853067147949,0,1,nuclear aryl hydrocarbon receptor complex,CC,
13396,GO:0052717,0.999999999966548,0.88853067147949,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
13397,GO:0052718,0.999999999966548,0.88853067147949,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
1028,GO:0002536,0.999999999966549,0.881998196081944,0,2,respiratory burst involved in inflammatory response,BP,
13707,GO:0060264,0.999999999966549,0.881998196081944,0,2,regulation of respiratory burst involved in inflammatory response,BP,
13709,GO:0060266,0.999999999966549,0.881998196081944,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
9753,GO:0039502,0.999999999966575,0.895045903603143,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
9754,GO:0039503,0.999999999966575,0.895045903603143,0,1,suppression by virus of host innate immune response,BP,
9758,GO:0039514,0.999999999966575,0.895045903603143,0,1,suppression by virus of host JAK-STAT cascade,BP,
9774,GO:0039562,0.999999999966575,0.895045903603143,0,1,suppression by virus of host STAT activity,BP,
9775,GO:0039563,0.999999999966575,0.895045903603143,0,1,suppression by virus of host STAT1 activity,BP,
9776,GO:0039564,0.999999999966575,0.895045903603143,0,1,suppression by virus of host STAT2 activity,BP,
10877,GO:0044414,0.999999999966575,0.895045903603143,0,1,suppression of host defenses,BP,
13205,GO:0051833,0.999999999966575,0.895045903603143,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
13298,GO:0052029,0.999999999966575,0.895045903603143,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
13300,GO:0052037,0.999999999966575,0.895045903603143,0,1,negative regulation by symbiont of host defense response,BP,
13315,GO:0052167,0.999999999966575,0.895045903603143,0,1,modulation by symbiont of host innate immune response,BP,
13316,GO:0052170,0.999999999966575,0.895045903603143,0,1,negative regulation by symbiont of host innate immune response,BP,
13334,GO:0052261,0.999999999966575,0.895045903603143,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
13335,GO:0052306,0.999999999966575,0.895045903603143,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13336,GO:0052309,0.999999999966575,0.895045903603143,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
13357,GO:0052493,0.999999999966575,0.895045903603143,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
13367,GO:0052561,0.999999999966575,0.895045903603143,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13368,GO:0052562,0.999999999966575,0.895045903603143,0,1,negative regulation by symbiont of host immune response,BP,
15950,GO:0075109,0.999999999966575,0.895045903603143,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
15951,GO:0075111,0.999999999966575,0.895045903603143,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
15952,GO:0075112,0.999999999966575,0.895045903603143,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
15953,GO:0075114,0.999999999966575,0.895045903603143,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
16959,GO:0098968,0.999999999966575,0.895045903603143,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
13101,GO:0051615,0.999999999966578,0.892360476843347,0,1,histamine uptake,BP,
14379,GO:0061618,0.999999999966645,0.859441601816105,0,1,sublamina densa,CC,
7298,GO:0031296,0.999999999966698,0.94426794010553,0,1,B cell costimulation,BP,
1401,GO:0003335,0.999999999966704,0.924255878697661,0,1,corneocyte development,BP,
1402,GO:0003336,0.999999999966704,0.924255878697661,0,1,corneocyte desquamation,BP,
19348,GO:1905715,0.999999999966704,0.924255878697661,0,1,regulation of cornification,BP,
19349,GO:1905716,0.999999999966704,0.924255878697661,0,1,negative regulation of cornification,BP,
14740,GO:0070407,0.999999999966716,0.916419307508476,0,1,oxidation-dependent protein catabolic process,BP,
3744,GO:0008281,0.999999999966731,0.898766126456429,0,1,sulfonylurea receptor activity,MF,
14467,GO:0061827,0.999999999966754,0.867463648603301,0,2,sperm head,CC,
7710,GO:0032197,0.999999999966761,0.906135896003204,0,1,transposition, RNA-mediated,BP,
3365,GO:0007113,0.999999999966793,0.816925788990598,0,3,endomitotic cell cycle,BP,
14620,GO:0070183,0.999999999966833,0.920540393523877,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
11838,GO:0046786,0.999999999966842,0.897158524589865,0,1,viral replication complex formation and maintenance,BP,
20038,GO:2000661,0.999999999966842,0.897158524589865,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
7725,GO:0032216,0.999999999966852,0.928184543908013,0,1,glucosaminyl-phosphotidylinositol O-acyltransferase activity,MF,
297,GO:0000801,0.999999999966856,0.903736135361638,0,1,central element,CC,
1800,GO:0004441,0.999999999966862,0.93039789611679,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
13427,GO:0052829,0.999999999966862,0.93039789611679,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
10996,GO:0044795,0.999999999966902,0.944797473418262,0,1,trans-Golgi network to recycling endosome transport,BP,
9469,GO:0036085,0.999999999966915,0.915229494883491,0,1,GDP-fucose import into Golgi lumen,BP,
11989,GO:0047325,0.999999999966935,0.914624218224678,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
13400,GO:0052725,0.999999999966935,0.914624218224678,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
13401,GO:0052726,0.999999999966935,0.914624218224678,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
13423,GO:0052825,0.999999999966935,0.914624218224678,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
13428,GO:0052830,0.999999999966935,0.914624218224678,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
13429,GO:0052831,0.999999999966935,0.914624218224678,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
13433,GO:0052835,0.999999999966935,0.914624218224678,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14473,GO:0061845,0.999999999966935,0.914624218224678,0,1,neuron projection branch point,CC,
14474,GO:0061846,0.999999999966935,0.914624218224678,0,1,dendritic spine cytoplasm,CC,
8560,GO:0033989,0.999999999966937,0.922271042596881,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9478,GO:0036111,0.999999999966937,0.922271042596881,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10936,GO:0044594,0.999999999966937,0.922271042596881,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
17630,GO:1901340,0.999999999966949,0.903972638250445,0,1,negative regulation of store-operated calcium channel activity,BP,
7967,GO:0032574,0.999999999966992,0.905764158191287,0,1,5'-3' RNA helicase activity,MF,
7968,GO:0032575,0.999999999966992,0.905764158191287,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
17226,GO:0110008,0.999999999966999,0.917376427007066,0,1,ncRNA deadenylation,BP,
11052,GO:0045041,0.999999999967032,0.870658232091391,0,2,protein import into mitochondrial intermembrane space,BP,
13541,GO:0060001,0.999999999967041,0.874304084860496,0,1,minus-end directed microfilament motor activity,MF,
3614,GO:0008057,0.999999999967079,0.881404494210289,0,1,eye pigment granule organization,BP,
3834,GO:0008434,0.999999999967087,0.898650330445671,0,1,calcitriol receptor activity,MF,
9731,GO:0038181,0.999999999967087,0.898650330445671,0,1,bile acid receptor activity,MF,
9732,GO:0038183,0.999999999967087,0.898650330445671,0,1,bile acid signaling pathway,BP,
9733,GO:0038186,0.999999999967087,0.898650330445671,0,1,lithocholic acid receptor activity,MF,
17865,GO:1902098,0.999999999967087,0.898650330445671,0,1,calcitriol binding,MF,
17880,GO:1902121,0.999999999967087,0.898650330445671,0,1,lithocholic acid binding,MF,
17940,GO:1902271,0.999999999967087,0.898650330445671,0,1,D3 vitamins binding,MF,
19493,GO:1990275,0.99999999996709,0.919646337244672,0,1,preribosome binding,MF,
19563,GO:1990575,0.999999999967129,0.838702410118,0,2,mitochondrial L-ornithine transmembrane transport,BP,
11121,GO:0045153,0.999999999967133,0.943874632498326,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
9599,GO:0036455,0.999999999967138,0.94534656204668,0,1,iron-sulfur transferase activity,MF,
17760,GO:1901726,0.999999999967141,0.862352244375068,0,1,negative regulation of histone deacetylase activity,BP,
2123,GO:0004918,0.999999999967159,0.925087853226309,0,1,interleukin-8 receptor activity,MF,
6314,GO:0019959,0.999999999967159,0.925087853226309,0,1,interleukin-8 binding,MF,
9708,GO:0038112,0.999999999967159,0.925087853226309,0,1,interleukin-8-mediated signaling pathway,BP,
5980,GO:0018738,0.999999999967189,0.944125506560334,0,1,S-formylglutathione hydrolase activity,MF,
15779,GO:0072382,0.999999999967192,0.845182604061375,0,1,minus-end-directed vesicle transport along microtubule,BP,
17477,GO:1900370,0.999999999967192,0.893873410142182,0,1,positive regulation of RNA interference,BP,
13747,GO:0060319,0.999999999967226,0.833476221818988,0,2,primitive erythrocyte differentiation,BP,
13457,GO:0052906,0.999999999967235,0.89459877550555,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
1319,GO:0003167,0.999999999967245,0.898350030429869,0,1,atrioventricular bundle cell differentiation,BP,
13933,GO:0060596,0.999999999967245,0.898350030429869,0,1,mammary placode formation,BP,
14099,GO:0060932,0.999999999967245,0.898350030429869,0,1,His-Purkinje system cell differentiation,BP,
3976,GO:0008794,0.999999999967245,0.949018361209847,0,1,arsenate reductase (glutaredoxin) activity,MF,
6959,GO:0030611,0.999999999967245,0.949018361209847,0,1,arsenate reductase activity,MF,
4307,GO:0009758,0.999999999967249,0.87382882829893,0,1,carbohydrate utilization,BP,
4873,GO:0014734,0.999999999967249,0.87382882829893,0,1,skeletal muscle hypertrophy,BP,
10618,GO:0043610,0.999999999967249,0.87382882829893,0,1,regulation of carbohydrate utilization,BP,
18010,GO:1902488,0.999999999967249,0.87382882829893,0,1,cholangiocyte apoptotic process,BP,
18670,GO:1904000,0.999999999967249,0.87382882829893,0,1,positive regulation of eating behavior,BP,
18697,GO:1904054,0.999999999967249,0.87382882829893,0,1,regulation of cholangiocyte proliferation,BP,
18698,GO:1904056,0.999999999967249,0.87382882829893,0,1,positive regulation of cholangiocyte proliferation,BP,
18729,GO:1904192,0.999999999967249,0.87382882829893,0,1,regulation of cholangiocyte apoptotic process,BP,
18730,GO:1904193,0.999999999967249,0.87382882829893,0,1,negative regulation of cholangiocyte apoptotic process,BP,
18731,GO:1904195,0.999999999967249,0.87382882829893,0,1,regulation of granulosa cell proliferation,BP,
18732,GO:1904197,0.999999999967249,0.87382882829893,0,1,positive regulation of granulosa cell proliferation,BP,
18734,GO:1904200,0.999999999967249,0.87382882829893,0,1,iodide transmembrane transport,BP,
18735,GO:1904201,0.999999999967249,0.87382882829893,0,1,regulation of iodide transport,BP,
18736,GO:1904202,0.999999999967249,0.87382882829893,0,1,negative regulation of iodide transport,BP,
18737,GO:1904204,0.999999999967249,0.87382882829893,0,1,regulation of skeletal muscle hypertrophy,BP,
18738,GO:1904206,0.999999999967249,0.87382882829893,0,1,positive regulation of skeletal muscle hypertrophy,BP,
18743,GO:1904212,0.999999999967249,0.87382882829893,0,1,regulation of iodide transmembrane transport,BP,
18744,GO:1904213,0.999999999967249,0.87382882829893,0,1,negative regulation of iodide transmembrane transport,BP,
19591,GO:1990705,0.999999999967249,0.87382882829893,0,1,cholangiocyte proliferation,BP,
19603,GO:1990739,0.999999999967249,0.87382882829893,0,1,granulosa cell proliferation,BP,
7653,GO:0032072,0.99999999996725,0.912392607820449,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
7863,GO:0032423,0.99999999996725,0.912392607820449,0,1,regulation of mismatch repair,BP,
7864,GO:0032425,0.99999999996725,0.912392607820449,0,1,positive regulation of mismatch repair,BP,
9280,GO:0035711,0.99999999996725,0.912392607820449,0,1,T-helper 1 cell activation,BP,
19926,GO:2000426,0.99999999996725,0.912392607820449,0,1,negative regulation of apoptotic cell clearance,BP,
254,GO:0000718,0.999999999967259,0.935663022757846,0,1,nucleotide-excision repair, DNA damage removal,BP,
1675,GO:0004139,0.999999999967259,0.935663022757846,0,1,deoxyribose-phosphate aldolase activity,MF,
10852,GO:0044349,0.999999999967259,0.935663022757846,0,1,DNA excision,BP,
11659,GO:0046403,0.999999999967259,0.935663022757846,0,1,polynucleotide 3'-phosphatase activity,MF,
16743,GO:0098503,0.999999999967259,0.935663022757846,0,1,DNA 3' dephosphorylation,BP,
16744,GO:0098504,0.999999999967259,0.935663022757846,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
16746,GO:0098506,0.999999999967259,0.935663022757846,0,1,polynucleotide 3' dephosphorylation,BP,
6216,GO:0019747,0.999999999967268,0.94926279660206,0,1,regulation of isoprenoid metabolic process,BP,
6889,GO:0030421,0.999999999967268,0.94926279660206,0,1,defecation,BP,
18534,GO:1903723,0.999999999967286,0.94912306740489,0,1,negative regulation of centriole elongation,BP,
7761,GO:0032277,0.999999999967291,0.929295666367328,0,1,negative regulation of gonadotropin secretion,BP,
10556,GO:0043509,0.999999999967291,0.929295666367328,0,1,activin A complex,CC,
10557,GO:0043511,0.999999999967291,0.929295666367328,0,1,inhibin complex,CC,
10558,GO:0043512,0.999999999967291,0.929295666367328,0,1,inhibin A complex,CC,
11077,GO:0045077,0.999999999967291,0.929295666367328,0,1,negative regulation of interferon-gamma biosynthetic process,BP,
11875,GO:0046882,0.999999999967291,0.929295666367328,0,1,negative regulation of follicle-stimulating hormone secretion,BP,
12121,GO:0048180,0.999999999967291,0.929295666367328,0,1,activin complex,CC,
13714,GO:0060278,0.999999999967291,0.929295666367328,0,1,regulation of ovulation,BP,
13715,GO:0060279,0.999999999967291,0.929295666367328,0,1,positive regulation of ovulation,BP,
9454,GO:0036046,0.999999999967307,0.916039998641524,0,1,protein demalonylation,BP,
9455,GO:0036047,0.999999999967307,0.916039998641524,0,1,peptidyl-lysine demalonylation,BP,
9456,GO:0036048,0.999999999967307,0.916039998641524,0,1,protein desuccinylation,BP,
9457,GO:0036049,0.999999999967307,0.916039998641524,0,1,peptidyl-lysine desuccinylation,BP,
9458,GO:0036054,0.999999999967307,0.916039998641524,0,1,protein-malonyllysine demalonylase activity,MF,
9459,GO:0036055,0.999999999967307,0.916039998641524,0,1,protein-succinyllysine desuccinylase activity,MF,
14414,GO:0061697,0.999999999967307,0.916039998641524,0,1,protein-glutaryllysine deglutarylase activity,MF,
14415,GO:0061698,0.999999999967307,0.916039998641524,0,1,protein deglutarylation,BP,
14416,GO:0061699,0.999999999967307,0.916039998641524,0,1,peptidyl-lysine deglutarylation,BP,
3985,GO:0008832,0.99999999996733,0.915377816520885,0,1,dGTPase activity,MF,
5680,GO:0016793,0.99999999996733,0.915377816520885,0,1,triphosphoric monoester hydrolase activity,MF,
7961,GO:0032560,0.99999999996733,0.915377816520885,0,1,guanyl deoxyribonucleotide binding,MF,
7964,GO:0032567,0.99999999996733,0.915377816520885,0,1,dGTP binding,MF,
9346,GO:0035853,0.99999999996738,0.900594065199258,0,1,chromosome passenger complex localization to spindle midzone,BP,
4831,GO:0014036,0.999999999967389,0.906215424216504,0,1,neural crest cell fate specification,BP,
9234,GO:0035622,0.999999999967389,0.906215424216504,0,1,intrahepatic bile duct development,BP,
12419,GO:0048866,0.999999999967389,0.906215424216504,0,1,stem cell fate specification,BP,
13555,GO:0060018,0.999999999967389,0.906215424216504,0,1,astrocyte fate commitment,BP,
13686,GO:0060221,0.999999999967389,0.906215424216504,0,1,retinal rod cell differentiation,BP,
13883,GO:0060516,0.999999999967389,0.906215424216504,0,1,primary prostatic bud elongation,BP,
13884,GO:0060517,0.999999999967389,0.906215424216504,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14043,GO:0060784,0.999999999967389,0.906215424216504,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
17712,GO:1901622,0.999999999967415,0.923719592738309,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
6381,GO:0021569,0.999999999967421,0.937648986049808,0,1,rhombomere 3 development,BP,
6382,GO:0021570,0.999999999967421,0.937648986049808,0,1,rhombomere 4 development,BP,
7017,GO:0030729,0.999999999967435,0.913568564170505,0,1,acetoacetate-CoA ligase activity,MF,
12041,GO:0047760,0.999999999967435,0.913568564170505,0,1,butyrate-CoA ligase activity,MF,
13796,GO:0060383,0.999999999967435,0.904342786744865,0,1,positive regulation of DNA strand elongation,BP,
19274,GO:1905464,0.999999999967435,0.904342786744865,0,1,positive regulation of DNA duplex unwinding,BP,
19359,GO:1905774,0.999999999967435,0.904342786744865,0,1,regulation of DNA helicase activity,BP,
19360,GO:1905776,0.999999999967435,0.904342786744865,0,1,positive regulation of DNA helicase activity,BP,
19674,GO:1990955,0.999999999967435,0.904342786744865,0,1,G-rich single-stranded DNA binding,MF,
6393,GO:0021592,0.99999999996745,0.894585543004038,0,1,fourth ventricle development,BP,
6557,GO:0021993,0.99999999996745,0.894585543004038,0,1,initiation of neural tube closure,BP,
1209,GO:0002875,0.999999999967455,0.937154553116,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
2235,GO:0005141,0.999999999967455,0.937154553116,0,1,interleukin-10 receptor binding,MF,
18699,GO:1904057,0.999999999967455,0.937154553116,0,1,negative regulation of sensory perception of pain,BP,
9399,GO:0035938,0.999999999967461,0.88761607304457,0,1,estradiol secretion,BP,
20155,GO:2000864,0.999999999967461,0.88761607304457,0,1,regulation of estradiol secretion,BP,
19864,GO:2000342,0.999999999967461,0.851618532072394,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
20126,GO:2000812,0.999999999967473,0.906708987426401,0,1,regulation of barbed-end actin filament capping,BP,
3670,GO:0008160,0.999999999967493,0.923277200049842,0,1,protein tyrosine phosphatase activator activity,MF,
10072,GO:0042567,0.999999999967493,0.923277200049842,0,1,insulin-like growth factor ternary complex,CC,
7271,GO:0031251,0.999999999967506,0.797964960509618,0,2,PAN complex,CC,
15479,GO:0071821,0.999999999967518,0.883193515497108,0,1,FANCM-MHF complex,CC,
3812,GO:0008403,0.999999999967521,0.915735655238337,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
6868,GO:0030342,0.999999999967521,0.915735655238337,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
13836,GO:0060435,0.999999999967526,0.941923121398807,0,1,bronchiole development,BP,
13864,GO:0060480,0.999999999967526,0.941923121398807,0,1,lung goblet cell differentiation,BP,
9761,GO:0039520,0.999999999967532,0.892879933330881,0,1,induction by virus of host autophagy,BP,
16738,GO:0097753,0.999999999967569,0.907661138988794,0,1,membrane bending,BP,
10499,GO:0043400,0.999999999967571,0.845058110292921,0,2,cortisol secretion,BP,
13026,GO:0051462,0.999999999967571,0.845058110292921,0,2,regulation of cortisol secretion,BP,
15361,GO:0071596,0.999999999967606,0.690858117523696,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
3731,GO:0008265,0.999999999967615,0.92166627405339,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
17174,GO:0102867,0.999999999967615,0.92166627405339,0,1,molybdenum cofactor sulfurtransferase activity,MF,
1352,GO:0003220,0.999999999967693,0.873834411695257,0,1,left ventricular cardiac muscle tissue morphogenesis,BP,
1366,GO:0003251,0.999999999967693,0.873834411695257,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
6962,GO:0030616,0.999999999967693,0.873834411695257,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
9047,GO:0035262,0.999999999967693,0.873834411695257,0,1,gonad morphogenesis,BP,
14158,GO:0061040,0.999999999967693,0.873834411695257,0,1,female gonad morphogenesis,BP,
19202,GO:1905304,0.999999999967693,0.873834411695257,0,1,regulation of cardiac myofibril assembly,BP,
19203,GO:1905305,0.999999999967693,0.873834411695257,0,1,negative regulation of cardiac myofibril assembly,BP,
1770,GO:0004375,0.999999999967705,0.9073406189809,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
5603,GO:0016642,0.999999999967705,0.9073406189809,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
9528,GO:0036255,0.999999999967705,0.9073406189809,0,1,response to methylamine,BP,
14674,GO:0070280,0.999999999967705,0.9073406189809,0,1,pyridoxal binding,MF,
18413,GO:1903442,0.999999999967705,0.9073406189809,0,1,response to lipoic acid,BP,
17352,GO:1900039,0.999999999967721,0.944460954495156,0,1,positive regulation of cellular response to hypoxia,BP,
17859,GO:1902071,0.999999999967721,0.944460954495156,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
17860,GO:1902073,0.999999999967721,0.944460954495156,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
658,GO:0001849,0.999999999967746,0.881270093507103,0,2,complement component C1q binding,MF,
2180,GO:0005030,0.999999999967754,0.883855027184682,0,1,neurotrophin receptor activity,MF,
4469,GO:0010465,0.999999999967754,0.883855027184682,0,1,nerve growth factor receptor activity,MF,
6883,GO:0030379,0.999999999967754,0.883855027184682,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
18096,GO:1902725,0.999999999967756,0.88877371451665,0,1,negative regulation of satellite cell differentiation,BP,
626,GO:0001809,0.999999999967774,0.940914095949714,0,1,positive regulation of type IV hypersensitivity,BP,
13860,GO:0060467,0.999999999967774,0.940914095949714,0,1,negative regulation of fertilization,BP,
19877,GO:2000359,0.999999999967774,0.940914095949714,0,1,regulation of binding of sperm to zona pellucida,BP,
19878,GO:2000360,0.999999999967774,0.940914095949714,0,1,negative regulation of binding of sperm to zona pellucida,BP,
19897,GO:2000387,0.999999999967774,0.940914095949714,0,1,regulation of antral ovarian follicle growth,BP,
19898,GO:2000388,0.999999999967774,0.940914095949714,0,1,positive regulation of antral ovarian follicle growth,BP,
3647,GO:0008119,0.99999999996778,0.914704773014521,0,1,thiopurine S-methyltransferase activity,MF,
1736,GO:0004334,0.999999999967807,0.939868964663322,0,1,fumarylacetoacetase activity,MF,
9773,GO:0039552,0.999999999967878,0.893163918074277,0,1,RIG-I binding,MF,
9433,GO:0036004,0.999999999967882,0.943507802170484,0,1,GAF domain binding,MF,
11262,GO:0045517,0.999999999967882,0.943507802170484,0,1,interleukin-20 receptor binding,MF,
11263,GO:0045518,0.999999999967882,0.943507802170484,0,1,interleukin-22 receptor binding,MF,
17888,GO:1902167,0.999999999967888,0.954863741023532,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
18998,GO:1904803,0.999999999967888,0.954863741023532,0,1,regulation of translation involved in cellular response to UV,BP,
1650,GO:0004098,0.999999999967905,0.93305628361858,0,1,cerebroside-sulfatase activity,MF,
8260,GO:0033037,0.99999999996791,0.891613508595789,0,1,polysaccharide localization,BP,
6963,GO:0030617,0.999999999967915,0.916934903514126,0,1,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
19066,GO:1904947,0.999999999967962,0.917750281783283,0,1,folic acid import into mitochondrion,BP,
8417,GO:0033477,0.999999999967966,0.931768793982872,0,1,S-methylmethionine metabolic process,BP,
11963,GO:0047150,0.999999999967966,0.931768793982872,0,1,betaine-homocysteine S-methyltransferase activity,MF,
14386,GO:0061627,0.999999999967966,0.931768793982872,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
6422,GO:0021685,0.99999999996799,0.882270346650089,0,1,cerebellar granular layer structural organization,BP,
18505,GO:1903650,0.999999999968004,0.897078933272253,0,2,negative regulation of cytoplasmic transport,BP,
20021,GO:2000642,0.999999999968004,0.897078933272253,0,2,negative regulation of early endosome to late endosome transport,BP,
3021,GO:0006566,0.999999999968016,0.872263522782192,0,2,threonine metabolic process,BP,
9539,GO:0036290,0.999999999968022,0.905123948860091,0,1,protein trans-autophosphorylation,BP,
17943,GO:1902283,0.999999999968022,0.905123948860091,0,1,negative regulation of primary amine oxidase activity,BP,
19498,GO:1990332,0.999999999968022,0.905123948860091,0,1,Ire1 complex,CC,
19565,GO:1990579,0.999999999968022,0.905123948860091,0,1,peptidyl-serine trans-autophosphorylation,BP,
19579,GO:1990630,0.999999999968022,0.905123948860091,0,1,IRE1-RACK1-PP2A complex,CC,
16400,GO:0097017,0.999999999968027,0.852301341207544,0,2,renal protein absorption,BP,
12004,GO:0047464,0.999999999968029,0.896211319026635,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12475,GO:0050379,0.999999999968029,0.896211319026635,0,1,UDP-glucuronate 5'-epimerase activity,MF,
7904,GO:0032472,0.999999999968042,0.849573442512059,0,2,Golgi calcium ion transport,BP,
19777,GO:2000195,0.999999999968045,0.85609185827808,0,2,negative regulation of female gonad development,BP,
19329,GO:1905643,0.999999999968087,0.890284700396079,0,1,positive regulation of DNA methylation,BP,
20129,GO:2000820,0.999999999968087,0.890284700396079,0,1,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
5394,GO:0016231,0.999999999968114,0.895583494882205,0,1,beta-N-acetylglucosaminidase activity,MF,
17131,GO:0102166,0.999999999968114,0.895583494882205,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17132,GO:0102167,0.999999999968114,0.895583494882205,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
17163,GO:0102571,0.999999999968114,0.895583494882205,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
3921,GO:0008592,0.999999999968139,0.914852580182871,0,1,regulation of Toll signaling pathway,BP,
9909,GO:0042241,0.999999999968139,0.914852580182871,0,1,interleukin-18 biosynthetic process,BP,
11229,GO:0045381,0.999999999968139,0.914852580182871,0,1,regulation of interleukin-18 biosynthetic process,BP,
11383,GO:0045751,0.999999999968139,0.914852580182871,0,1,negative regulation of Toll signaling pathway,BP,
3586,GO:0007634,0.999999999968144,0.925625503107429,0,1,optokinetic behavior,BP,
14077,GO:0060876,0.999999999968144,0.925625503107429,0,1,semicircular canal formation,BP,
16716,GO:0097699,0.999999999968174,0.900797118957726,0,1,vascular endothelial cell response to fluid shear stress,BP,
15957,GO:0075519,0.999999999968196,0.952815957495133,0,1,microtubule-dependent intracellular transport of viral material,BP,
15958,GO:0075521,0.999999999968196,0.952815957495133,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
15962,GO:0075606,0.999999999968196,0.952815957495133,0,1,transport of viral material towards nucleus,BP,
4350,GO:0009918,0.999999999968201,0.922747488245031,0,1,sterol delta7 reductase activity,MF,
5124,GO:0015499,0.999999999968201,0.922747488245031,0,1,formate transmembrane transporter activity,MF,
5140,GO:0015660,0.999999999968201,0.922747488245031,0,1,formate efflux transmembrane transporter activity,MF,
5172,GO:0015724,0.999999999968201,0.922747488245031,0,1,formate transport,BP,
5200,GO:0015797,0.999999999968201,0.922747488245031,0,1,mannitol transport,BP,
5359,GO:0016131,0.999999999968201,0.922747488245031,0,1,brassinosteroid metabolic process,BP,
5360,GO:0016132,0.999999999968201,0.922747488245031,0,1,brassinosteroid biosynthetic process,BP,
11826,GO:0046724,0.999999999968201,0.922747488245031,0,1,oxalic acid secretion,BP,
12018,GO:0047598,0.999999999968201,0.922747488245031,0,1,7-dehydrocholesterol reductase activity,MF,
1363,GO:0003247,0.999999999968206,0.93701614045133,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1557,GO:0003956,0.999999999968206,0.93701614045133,0,1,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
2484,GO:0005724,0.999999999968206,0.93701614045133,0,1,nuclear telomeric heterochromatin,CC,
7419,GO:0031509,0.999999999968206,0.93701614045133,0,1,telomeric heterochromatin assembly,BP,
7577,GO:0031940,0.999999999968206,0.93701614045133,0,1,positive regulation of chromatin silencing at telomere,BP,
18100,GO:1902732,0.999999999968206,0.93701614045133,0,1,positive regulation of chondrocyte proliferation,BP,
19293,GO:1905547,0.999999999968206,0.93701614045133,0,1,regulation of telomeric heterochromatin assembly,BP,
19294,GO:1905549,0.999999999968206,0.93701614045133,0,1,positive regulation of telomeric heterochromatin assembly,BP,
2023,GO:0004753,0.99999999996824,0.890760379485211,0,1,saccharopine dehydrogenase activity,MF,
11959,GO:0047130,0.99999999996824,0.890760379485211,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
11960,GO:0047131,0.99999999996824,0.890760379485211,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
9933,GO:0042281,0.999999999968243,0.854407771074672,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
18199,GO:1902977,0.999999999968245,0.932782547625252,0,1,mitotic DNA replication preinitiation complex assembly,BP,
10237,GO:0042942,0.999999999968261,0.923732998229214,0,1,D-serine transport,BP,
10060,GO:0042543,0.999999999968278,0.955496582031656,0,1,protein N-linked glycosylation via arginine,BP,
19744,GO:2000118,0.999999999968289,0.903869493874812,0,1,regulation of sodium-dependent phosphate transport,BP,
960,GO:0002384,0.999999999968304,0.903941643516848,0,1,hepatic immune response,BP,
14579,GO:0070119,0.999999999968304,0.903941643516848,0,1,ciliary neurotrophic factor binding,MF,
12451,GO:0050185,0.999999999968304,0.861177145810319,0,1,phosphatidylinositol deacylase activity,MF,
3849,GO:0008458,0.999999999968318,0.914677916050058,0,1,carnitine O-octanoyltransferase activity,MF,
5480,GO:0016414,0.999999999968318,0.914677916050058,0,1,O-octanoyltransferase activity,MF,
5481,GO:0016415,0.999999999968318,0.914677916050058,0,1,octanoyltransferase activity,MF,
3868,GO:0008489,0.999999999968345,0.919415586137413,0,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,
11977,GO:0047263,0.999999999968345,0.919415586137413,0,1,N-acylsphingosine galactosyltransferase activity,MF,
2079,GO:0004833,0.999999999968371,0.938037730029227,0,1,tryptophan 2,3-dioxygenase activity,MF,
8525,GO:0033754,0.999999999968371,0.938037730029227,0,1,indoleamine 2,3-dioxygenase activity,MF,
8684,GO:0034275,0.999999999968371,0.938037730029227,0,1,kynurenic acid metabolic process,BP,
8685,GO:0034276,0.999999999968371,0.938037730029227,0,1,kynurenic acid biosynthetic process,BP,
9535,GO:0036269,0.999999999968371,0.938037730029227,0,1,swimming behavior,BP,
7714,GO:0032203,0.999999999968385,0.933730892557464,0,1,telomere formation via telomerase,BP,
11992,GO:0047349,0.999999999968385,0.893465832433062,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
4475,GO:0010477,0.999999999968461,0.914731635292118,0,1,response to sulfur dioxide,BP,
10658,GO:0043739,0.999999999968461,0.914731635292118,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
2160,GO:0004992,0.999999999968472,0.903859206328458,0,1,platelet activating factor receptor activity,MF,
4994,GO:0015130,0.999999999968472,0.903859206328458,0,1,mevalonate transmembrane transporter activity,MF,
5174,GO:0015728,0.999999999968472,0.903859206328458,0,1,mevalonate transport,BP,
10458,GO:0043315,0.999999999968472,0.903859206328458,0,1,positive regulation of neutrophil degranulation,BP,
13175,GO:0051780,0.999999999968472,0.903859206328458,0,1,behavioral response to nutrient,BP,
15151,GO:0071258,0.999999999968472,0.903859206328458,0,1,cellular response to gravity,BP,
18042,GO:1902565,0.999999999968472,0.903859206328458,0,1,positive regulation of neutrophil activation,BP,
18175,GO:1902941,0.999999999968472,0.903859206328458,0,1,regulation of voltage-gated chloride channel activity,BP,
18176,GO:1902943,0.999999999968472,0.903859206328458,0,1,positive regulation of voltage-gated chloride channel activity,BP,
18570,GO:1903797,0.999999999968472,0.903859206328458,0,1,positive regulation of inorganic anion transmembrane transport,BP,
18782,GO:1904298,0.999999999968472,0.903859206328458,0,1,regulation of transcytosis,BP,
18783,GO:1904300,0.999999999968472,0.903859206328458,0,1,positive regulation of transcytosis,BP,
18784,GO:1904301,0.999999999968472,0.903859206328458,0,1,regulation of maternal process involved in parturition,BP,
18785,GO:1904303,0.999999999968472,0.903859206328458,0,1,positive regulation of maternal process involved in parturition,BP,
18790,GO:1904316,0.999999999968472,0.903859206328458,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
18791,GO:1904317,0.999999999968472,0.903859206328458,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
8160,GO:0032889,0.999999999968477,0.924483880687118,0,1,regulation of vacuole fusion, non-autophagic,BP,
8499,GO:0033676,0.999999999968489,0.940655606075111,0,1,double-stranded DNA-dependent ATPase activity,MF,
19541,GO:1990456,0.999999999968493,0.907222690162087,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
12031,GO:0047708,0.999999999968509,0.93079628480485,0,1,biotinidase activity,MF,
13793,GO:0060380,0.999999999968509,0.93079628480485,0,1,regulation of single-stranded telomeric DNA binding,BP,
13794,GO:0060381,0.999999999968509,0.93079628480485,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
7981,GO:0032595,0.999999999968527,0.92922675437496,0,1,B cell receptor transport within lipid bilayer,BP,
7983,GO:0032597,0.999999999968527,0.92922675437496,0,1,B cell receptor transport into membrane raft,BP,
7984,GO:0032599,0.999999999968527,0.92922675437496,0,1,protein transport out of membrane raft,BP,
7985,GO:0032600,0.999999999968527,0.92922675437496,0,1,chemokine receptor transport out of membrane raft,BP,
8177,GO:0032913,0.999999999968527,0.92922675437496,0,1,negative regulation of transforming growth factor beta3 production,BP,
8469,GO:0033606,0.999999999968527,0.92922675437496,0,1,chemokine receptor transport within lipid bilayer,BP,
15643,GO:0072139,0.999999999968527,0.92922675437496,0,1,glomerular parietal epithelial cell differentiation,BP,
20100,GO:2000768,0.999999999968527,0.92922675437496,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
1758,GO:0004361,0.99999999996853,0.935889059095857,0,1,glutaryl-CoA dehydrogenase activity,MF,
2265,GO:0005183,0.99999999996853,0.935889059095857,0,1,gonadotropin hormone-releasing hormone activity,MF,
7429,GO:0031530,0.99999999996853,0.935889059095857,0,1,gonadotropin-releasing hormone receptor binding,MF,
19421,GO:1990008,0.99999999996853,0.935889059095857,0,1,neurosecretory vesicle,CC,
18610,GO:1903893,0.999999999968539,0.924859595579394,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
15159,GO:0071275,0.999999999968542,0.929585603722892,0,1,cellular response to aluminum ion,BP,
19339,GO:1905672,0.999999999968542,0.929585603722892,0,1,negative regulation of lysosome organization,BP,
9092,GO:0035354,0.999999999968552,0.912734487199581,0,1,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9711,GO:0038123,0.999999999968552,0.912734487199581,0,1,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10043,GO:0042495,0.999999999968552,0.912734487199581,0,1,detection of triacyl bacterial lipopeptide,BP,
10045,GO:0042497,0.999999999968552,0.912734487199581,0,1,triacyl lipopeptide binding,MF,
15444,GO:0071725,0.999999999968552,0.912734487199581,0,1,response to triacyl bacterial lipopeptide,BP,
15446,GO:0071727,0.999999999968552,0.912734487199581,0,1,cellular response to triacyl bacterial lipopeptide,BP,
1160,GO:0002774,0.999999999968568,0.917213356040895,0,1,Fc receptor mediated inhibitory signaling pathway,BP,
14882,GO:0070667,0.999999999968568,0.917213356040895,0,1,negative regulation of mast cell proliferation,BP,
8507,GO:0033684,0.999999999968596,0.803295313754228,0,2,regulation of luteinizing hormone secretion,BP,
8508,GO:0033686,0.999999999968596,0.803295313754228,0,2,positive regulation of luteinizing hormone secretion,BP,
7343,GO:0031370,0.999999999968607,0.898385356549336,0,1,eukaryotic initiation factor 4G binding,MF,
17598,GO:1901255,0.999999999968617,0.830386686705284,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
20247,GO:2001199,0.99999999996865,0.937897534889739,0,1,negative regulation of dendritic cell differentiation,BP,
6439,GO:0021730,0.99999999996867,0.877298112080139,0,1,trigeminal sensory nucleus development,BP,
6440,GO:0021740,0.99999999996867,0.877298112080139,0,1,principal sensory nucleus of trigeminal nerve development,BP,
14210,GO:0061141,0.99999999996867,0.877298112080139,0,1,lung ciliated cell differentiation,BP,
20116,GO:2000795,0.99999999996867,0.877298112080139,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
2086,GO:0004850,0.999999999968679,0.934412506228521,0,1,uridine phosphorylase activity,MF,
2786,GO:0006218,0.999999999968679,0.934412506228521,0,1,uridine catabolic process,BP,
11564,GO:0046108,0.999999999968679,0.934412506228521,0,1,uridine metabolic process,BP,
3809,GO:0008396,0.999999999968698,0.92623160461898,0,1,oxysterol 7-alpha-hydroxylase activity,MF,
7718,GO:0032207,0.999999999968748,0.919463105952665,0,1,regulation of telomere maintenance via recombination,BP,
7719,GO:0032208,0.999999999968748,0.919463105952665,0,1,negative regulation of telomere maintenance via recombination,BP,
18435,GO:1903517,0.999999999968748,0.919463105952665,0,1,negative regulation of single strand break repair,BP,
18556,GO:1903770,0.999999999968748,0.919463105952665,0,1,negative regulation of beta-galactosidase activity,BP,
18578,GO:1903823,0.999999999968748,0.919463105952665,0,1,telomere single strand break repair,BP,
18579,GO:1903824,0.999999999968748,0.919463105952665,0,1,negative regulation of telomere single strand break repair,BP,
7630,GO:0032029,0.999999999968753,0.857857024136898,0,1,myosin tail binding,MF,
18056,GO:1902605,0.99999999996882,0.921585549709922,0,1,heterotrimeric G-protein complex assembly,BP,
10695,GO:0043973,0.999999999968845,0.928834804044384,0,1,histone H3-K4 acetylation,BP,
8392,GO:0033301,0.999999999968849,0.908615850747197,0,1,cell cycle comprising mitosis without cytokinesis,BP,
12987,GO:0051391,0.999999999968852,0.90585940155656,0,1,tRNA acetylation,BP,
12988,GO:0051392,0.999999999968852,0.90585940155656,0,1,tRNA N-acetyltransferase activity,MF,
19001,GO:1904812,0.999999999968852,0.90585940155656,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
19652,GO:1990882,0.999999999968852,0.90585940155656,0,1,rRNA acetylation,BP,
19653,GO:1990883,0.999999999968852,0.90585940155656,0,1,rRNA cytidine N-acetyltransferase activity,MF,
19654,GO:1990884,0.999999999968852,0.90585940155656,0,1,RNA acetylation,BP,
496,GO:0001550,0.999999999968858,0.802951995545215,0,2,ovarian cumulus expansion,BP,
12114,GO:0048165,0.999999999968858,0.802951995545215,0,2,fused antrum stage,BP,
14466,GO:0061825,0.999999999968878,0.90615859454267,0,1,podosome core,CC,
16547,GO:0097298,0.999999999968878,0.90615859454267,0,1,regulation of nucleus size,BP,
14013,GO:0060734,0.99999999996894,0.899129866810775,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
6358,GO:0021539,0.999999999968949,0.870726782605015,0,2,subthalamus development,BP,
7636,GO:0032044,0.999999999968958,0.853411127844041,0,2,DSIF complex,CC,
17851,GO:1902038,0.999999999968986,0.912143717226548,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
17931,GO:1902257,0.999999999968986,0.912143717226548,0,1,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
5130,GO:0015578,0.999999999968992,0.92543722277592,0,1,mannose transmembrane transporter activity,MF,
5188,GO:0015761,0.999999999968992,0.92543722277592,0,1,mannose transmembrane transport,BP,
6751,GO:0030172,0.999999999969016,0.945118144674631,0,1,troponin C binding,MF,
8217,GO:0032971,0.999999999969016,0.945118144674631,0,1,regulation of muscle filament sliding,BP,
8218,GO:0032972,0.999999999969016,0.945118144674631,0,1,regulation of muscle filament sliding speed,BP,
19567,GO:1990584,0.999999999969016,0.945118144674631,0,1,cardiac Troponin complex,CC,
15945,GO:0072752,0.999999999969018,0.886417692868161,0,1,cellular response to rapamycin,BP,
15348,GO:0071573,0.999999999969019,0.918980873927797,0,1,shelterin complex assembly,BP,
18990,GO:1904790,0.999999999969019,0.918980873927797,0,1,regulation of shelterin complex assembly,BP,
18991,GO:1904792,0.999999999969019,0.918980873927797,0,1,positive regulation of shelterin complex assembly,BP,
19020,GO:1904850,0.999999999969019,0.918980873927797,0,1,negative regulation of establishment of protein localization to telomere,BP,
19054,GO:1904910,0.999999999969019,0.918980873927797,0,1,regulation of establishment of RNA localization to telomere,BP,
19055,GO:1904911,0.999999999969019,0.918980873927797,0,1,negative regulation of establishment of RNA localization to telomere,BP,
19056,GO:1904913,0.999999999969019,0.918980873927797,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
19057,GO:1904914,0.999999999969019,0.918980873927797,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
3871,GO:0008495,0.99999999996905,0.918090257911517,0,1,protoheme IX farnesyltransferase activity,MF,
12082,GO:0048033,0.99999999996905,0.918090257911517,0,1,heme o metabolic process,BP,
12083,GO:0048034,0.99999999996905,0.918090257911517,0,1,heme O biosynthetic process,BP,
11983,GO:0047290,0.999999999969063,0.936878014134556,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12891,GO:0051232,0.999999999969064,0.926515010399794,0,1,meiotic spindle elongation,BP,
9326,GO:0035800,0.999999999969088,0.853386172200993,0,2,deubiquitinase activator activity,MF,
19760,GO:2000158,0.999999999969088,0.853386172200993,0,2,positive regulation of ubiquitin-specific protease activity,BP,
4973,GO:0015086,0.999999999969094,0.903537629796584,0,1,cadmium ion transmembrane transporter activity,MF,
4974,GO:0015087,0.999999999969094,0.903537629796584,0,1,cobalt ion transmembrane transporter activity,MF,
4977,GO:0015094,0.999999999969094,0.903537629796584,0,1,lead ion transmembrane transporter activity,MF,
5154,GO:0015692,0.999999999969094,0.903537629796584,0,1,lead ion transport,BP,
14859,GO:0070627,0.999999999969094,0.903537629796584,0,1,ferrous iron import,BP,
14940,GO:0070826,0.999999999969094,0.903537629796584,0,1,paraferritin complex,CC,
18875,GO:1904535,0.999999999969112,0.899789302599569,0,1,positive regulation of telomeric loop disassembly,BP,
5113,GO:0015432,0.99999999996912,0.910880436232147,0,1,bile acid-exporting ATPase activity,MF,
8383,GO:0033283,0.99999999996912,0.910880436232147,0,1,organic acid-transporting ATPase activity,MF,
8384,GO:0033284,0.99999999996912,0.910880436232147,0,1,carboxylic acid-transporting ATPase activity,MF,
8385,GO:0033285,0.99999999996912,0.910880436232147,0,1,monocarboxylic acid-transporting ATPase activity,MF,
3950,GO:0008650,0.999999999969131,0.9104650540873,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
145,GO:0000296,0.999999999969154,0.927666753994103,0,1,spermine transport,BP,
2316,GO:0005316,0.999999999969183,0.914195446199172,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
13631,GO:0060126,0.999999999969205,0.841562362064257,0,2,somatotropin secreting cell differentiation,BP,
2162,GO:0004996,0.999999999969213,0.906824983756187,0,1,thyroid-stimulating hormone receptor activity,MF,
9740,GO:0038194,0.999999999969213,0.906824983756187,0,1,thyroid-stimulating hormone signaling pathway,BP,
9745,GO:0039003,0.999999999969213,0.906824983756187,0,1,pronephric field specification,BP,
9748,GO:0039017,0.999999999969213,0.906824983756187,0,1,pattern specification involved in pronephros development,BP,
10151,GO:0042728,0.999999999969213,0.906824983756187,0,1,flavin-containing compound catabolic process,BP,
14769,GO:0070460,0.999999999969213,0.906824983756187,0,1,thyroid-stimulating hormone secretion,BP,
15559,GO:0072003,0.999999999969213,0.906824983756187,0,1,kidney rudiment formation,BP,
15560,GO:0072004,0.999999999969213,0.906824983756187,0,1,kidney field specification,BP,
15572,GO:0072025,0.999999999969213,0.906824983756187,0,1,distal convoluted tubule development,BP,
15591,GO:0072069,0.999999999969213,0.906824983756187,0,1,DCT cell differentiation,BP,
15695,GO:0072221,0.999999999969213,0.906824983756187,0,1,metanephric distal convoluted tubule development,BP,
15704,GO:0072240,0.999999999969213,0.906824983756187,0,1,metanephric DCT cell differentiation,BP,
15733,GO:0072304,0.999999999969213,0.906824983756187,0,1,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15734,GO:0072305,0.999999999969213,0.906824983756187,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
15737,GO:0072309,0.999999999969213,0.906824983756187,0,1,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
15786,GO:0072389,0.999999999969213,0.906824983756187,0,1,flavin adenine dinucleotide catabolic process,BP,
17433,GO:1900200,0.999999999969213,0.906824983756187,0,1,mesenchymal cell apoptotic process involved in metanephros development,BP,
17434,GO:1900204,0.999999999969213,0.906824983756187,0,1,apoptotic process involved in metanephric collecting duct development,BP,
17435,GO:1900205,0.999999999969213,0.906824983756187,0,1,apoptotic process involved in metanephric nephron tubule development,BP,
17438,GO:1900211,0.999999999969213,0.906824983756187,0,1,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17439,GO:1900212,0.999999999969213,0.906824983756187,0,1,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
17440,GO:1900214,0.999999999969213,0.906824983756187,0,1,regulation of apoptotic process involved in metanephric collecting duct development,BP,
17441,GO:1900215,0.999999999969213,0.906824983756187,0,1,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
17442,GO:1900217,0.999999999969213,0.906824983756187,0,1,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17443,GO:1900218,0.999999999969213,0.906824983756187,0,1,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
17564,GO:1901147,0.999999999969213,0.906824983756187,0,1,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18214,GO:1903004,0.999999999969213,0.906824983756187,0,1,regulation of protein K63-linked deubiquitination,BP,
18215,GO:1903006,0.999999999969213,0.906824983756187,0,1,positive regulation of protein K63-linked deubiquitination,BP,
18216,GO:1903007,0.999999999969213,0.906824983756187,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19995,GO:2000592,0.999999999969213,0.906824983756187,0,1,regulation of metanephric DCT cell differentiation,BP,
19996,GO:2000594,0.999999999969213,0.906824983756187,0,1,positive regulation of metanephric DCT cell differentiation,BP,
20002,GO:2000612,0.999999999969213,0.906824983756187,0,1,regulation of thyroid-stimulating hormone secretion,BP,
15302,GO:0071486,0.999999999969232,0.894651769735471,0,1,cellular response to high light intensity,BP,
16625,GO:0097473,0.999999999969232,0.894651769735471,0,1,retinal rod cell apoptotic process,BP,
19422,GO:1990009,0.999999999969232,0.894651769735471,0,1,retinal cell apoptotic process,BP,
10370,GO:0043185,0.999999999969233,0.930544458707817,0,1,vascular endothelial growth factor receptor 3 binding,MF,
14857,GO:0070625,0.999999999969233,0.930544458707817,0,1,zymogen granule exocytosis,BP,
11020,GO:0044855,0.999999999969236,0.921673000038125,0,1,plasma membrane raft distribution,BP,
11021,GO:0044856,0.999999999969236,0.921673000038125,0,1,plasma membrane raft localization,BP,
11023,GO:0044858,0.999999999969236,0.921673000038125,0,1,plasma membrane raft polarization,BP,
18622,GO:1903906,0.999999999969236,0.921673000038125,0,1,regulation of plasma membrane raft polarization,BP,
19313,GO:1905595,0.999999999969255,0.852294068380025,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
19586,GO:1990667,0.999999999969255,0.852294068380025,0,2,PCSK9-AnxA2 complex,CC,
7856,GO:0032416,0.999999999969255,0.931627111444654,0,1,negative regulation of sodium:proton antiporter activity,BP,
16545,GO:0097291,0.999999999969255,0.931627111444654,0,1,renal phosphate ion absorption,BP,
6867,GO:0030337,0.999999999969296,0.866008025436898,0,2,DNA polymerase processivity factor activity,MF,
6793,GO:0030233,0.999999999969309,0.936924024341243,0,1,deoxynucleotide transmembrane transporter activity,MF,
6839,GO:0030302,0.999999999969309,0.936924024341243,0,1,deoxynucleotide transport,BP,
7140,GO:0030974,0.999999999969309,0.936924024341243,0,1,thiamine pyrophosphate transmembrane transport,BP,
15079,GO:0071045,0.999999999969309,0.936924024341243,0,1,nuclear histone mRNA catabolic process,BP,
15384,GO:0071629,0.999999999969309,0.936924024341243,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16307,GO:0090422,0.999999999969309,0.936924024341243,0,1,thiamine pyrophosphate transmembrane transporter activity,MF,
11026,GO:0044868,0.999999999969316,0.887308198567168,0,1,modulation by host of viral molecular function,BP,
19182,GO:1905255,0.999999999969316,0.887308198567168,0,1,regulation of RNA binding transcription factor activity,BP,
19677,GO:1990968,0.999999999969316,0.887308198567168,0,1,modulation by host of RNA binding by virus,BP,
19678,GO:1990969,0.999999999969316,0.887308198567168,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
8387,GO:0033291,0.999999999969317,0.958658527102152,0,1,eukaryotic 80S initiation complex,CC,
8784,GO:0034463,0.999999999969317,0.958658527102152,0,1,90S preribosome assembly,BP,
19094,GO:1904998,0.999999999969323,0.919028439320127,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
3810,GO:0008398,0.999999999969325,0.917070711941813,0,1,sterol 14-demethylase activity,MF,
8420,GO:0033488,0.999999999969325,0.917070711941813,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
2782,GO:0006212,0.999999999969357,0.916378640098114,0,1,uracil catabolic process,BP,
2784,GO:0006214,0.999999999969357,0.916378640098114,0,1,thymidine catabolic process,BP,
4423,GO:0010232,0.999999999969357,0.916378640098114,0,1,vascular transport,BP,
5833,GO:0017113,0.999999999969357,0.916378640098114,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6158,GO:0019483,0.999999999969357,0.916378640098114,0,1,beta-alanine biosynthetic process,BP,
11574,GO:0046127,0.999999999969357,0.916378640098114,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
13649,GO:0060156,0.999999999969357,0.916378640098114,0,1,milk ejection reflex,BP,
18370,GO:1903367,0.999999999969357,0.916378640098114,0,1,positive regulation of fear response,BP,
20168,GO:2000987,0.999999999969357,0.916378640098114,0,1,positive regulation of behavioral fear response,BP,
14965,GO:0070860,0.999999999969383,0.927435736501033,0,1,RNA polymerase I core factor complex,CC,
3973,GO:0008783,0.999999999969407,0.928924072065005,0,1,agmatinase activity,MF,
8415,GO:0033388,0.999999999969407,0.928924072065005,0,1,putrescine biosynthetic process from arginine,BP,
19585,GO:1990666,0.999999999969408,0.81372598650073,0,2,PCSK9-LDLR complex,CC,
14699,GO:0070320,0.999999999969411,0.922532808641804,0,1,inward rectifier potassium channel inhibitor activity,MF,
17370,GO:1900085,0.999999999969411,0.922532808641804,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18487,GO:1903596,0.999999999969411,0.922532808641804,0,1,regulation of gap junction assembly,BP,
18488,GO:1903598,0.999999999969411,0.922532808641804,0,1,positive regulation of gap junction assembly,BP,
18491,GO:1903609,0.999999999969411,0.922532808641804,0,1,negative regulation of inward rectifier potassium channel activity,BP,
1734,GO:0004332,0.999999999969426,0.879235794065084,0,2,fructose-bisphosphate aldolase activity,MF,
2261,GO:0005175,0.999999999969434,0.953245268886205,0,1,CD27 receptor binding,MF,
13062,GO:0051562,0.999999999969436,0.844706606326248,0,2,negative regulation of mitochondrial calcium ion concentration,BP,
108,GO:0000224,0.999999999969456,0.924322931169692,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
581,GO:0001733,0.999999999969456,0.924322931169692,0,1,galactosylceramide sulfotransferase activity,MF,
12545,GO:0050694,0.999999999969456,0.924322931169692,0,1,galactose 3-O-sulfotransferase activity,MF,
12546,GO:0050698,0.999999999969456,0.924322931169692,0,1,proteoglycan sulfotransferase activity,MF,
2479,GO:0005713,0.999999999969466,0.925249056653503,0,1,recombination nodule,CC,
2480,GO:0005715,0.999999999969466,0.925249056653503,0,1,late recombination nodule,CC,
5013,GO:0015173,0.999999999969466,0.925249056653503,0,1,aromatic amino acid transmembrane transporter activity,MF,
5031,GO:0015196,0.999999999969466,0.925249056653503,0,1,L-tryptophan transmembrane transporter activity,MF,
10300,GO:0043060,0.999999999969466,0.925249056653503,0,1,meiotic metaphase I plate congression,BP,
12911,GO:0051257,0.999999999969466,0.925249056653503,0,1,meiotic spindle midzone assembly,BP,
12951,GO:0051311,0.999999999969466,0.925249056653503,0,1,meiotic metaphase plate congression,BP,
18772,GO:1904271,0.999999999969466,0.925249056653503,0,1,L-proline import across plasma membrane,BP,
18879,GO:1904555,0.999999999969466,0.925249056653503,0,1,L-proline transmembrane transport,BP,
18880,GO:1904556,0.999999999969466,0.925249056653503,0,1,L-tryptophan transmembrane transport,BP,
19330,GO:1905647,0.999999999969466,0.925249056653503,0,1,proline import across plasma membrane,BP,
18263,GO:1903116,0.999999999969473,0.819202841045402,0,2,positive regulation of actin filament-based movement,BP,
18562,GO:1903781,0.999999999969473,0.819202841045402,0,2,positive regulation of cardiac conduction,BP,
18643,GO:1903949,0.999999999969473,0.819202841045402,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
1490,GO:0003828,0.99999999996948,0.785705671613653,0,2,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,
1662,GO:0004118,0.99999999996951,0.903215808870929,0,1,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
15391,GO:0071638,0.999999999969529,0.854100591663371,0,2,negative regulation of monocyte chemotactic protein-1 production,BP,
1420,GO:0003365,0.999999999969539,0.692822722494378,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
2024,GO:0004756,0.999999999969539,0.857027148161127,0,2,selenide, water dikinase activity,MF,
5414,GO:0016260,0.999999999969539,0.857027148161127,0,2,selenocysteine biosynthetic process,BP,
5671,GO:0016781,0.999999999969539,0.857027148161127,0,2,phosphotransferase activity, paired acceptors,MF,
14705,GO:0070329,0.999999999969539,0.857027148161127,0,2,tRNA seleno-modification,BP,
5307,GO:0016013,0.999999999969539,0.817343893567954,0,2,syntrophin complex,CC,
19404,GO:1905937,0.999999999969549,0.94880918385015,0,1,negative regulation of germ cell proliferation,BP,
19806,GO:2000255,0.999999999969549,0.94880918385015,0,1,negative regulation of male germ cell proliferation,BP,
1900,GO:0004584,0.999999999969565,0.926677138669019,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
16338,GO:0090560,0.999999999969572,0.929495772331335,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
2475,GO:0005691,0.999999999969591,0.90150144655149,0,1,U6atac snRNP,CC,
6970,GO:0030624,0.999999999969591,0.90150144655149,0,1,U6atac snRNA binding,MF,
18480,GO:1903584,0.999999999969591,0.90150144655149,0,1,regulation of histone deubiquitination,BP,
18481,GO:1903586,0.999999999969591,0.90150144655149,0,1,positive regulation of histone deubiquitination,BP,
8870,GO:0034670,0.999999999969599,0.868432644417154,0,1,chemotaxis to arachidonic acid,BP,
19225,GO:1905349,0.999999999969629,0.944066914404631,0,1,ciliary transition zone assembly,BP,
16828,GO:0098713,0.999999999969636,0.928020812759291,0,1,leucine import across plasma membrane,BP,
18574,GO:1903801,0.999999999969636,0.928020812759291,0,1,L-leucine import across plasma membrane,BP,
451,GO:0001224,0.999999999969662,0.716280630266776,0,3,RNA polymerase II transcription cofactor binding,MF,
17483,GO:1900378,0.999999999969677,0.794464274068684,0,2,positive regulation of secondary metabolite biosynthetic process,BP,
7386,GO:0031438,0.999999999969681,0.917084295187796,0,1,negative regulation of mRNA cleavage,BP,
12757,GO:0051025,0.999999999969681,0.917084295187796,0,1,negative regulation of immunoglobulin secretion,BP,
18956,GO:1904721,0.999999999969681,0.917084295187796,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
14567,GO:0070095,0.999999999969687,0.915722139390488,0,1,fructose-6-phosphate binding,MF,
14583,GO:0070123,0.99999999996969,0.887471126279313,0,1,transforming growth factor beta receptor activity, type III,MF,
792,GO:0002055,0.999999999969703,0.952049323613635,0,1,adenine binding,MF,
1588,GO:0003999,0.999999999969703,0.952049323613635,0,1,adenine phosphoribosyltransferase activity,MF,
5409,GO:0016250,0.99999999996971,0.921221982592891,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5700,GO:0016826,0.99999999996971,0.921221982592891,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
5895,GO:0018094,0.999999999969713,0.912589668458031,0,1,protein polyglycylation,BP,
14910,GO:0070735,0.999999999969713,0.912589668458031,0,1,protein-glycine ligase activity,MF,
14911,GO:0070736,0.999999999969713,0.912589668458031,0,1,protein-glycine ligase activity, initiating,MF,
2091,GO:0004856,0.999999999969728,0.908910608040587,0,1,xylulokinase activity,MF,
2655,GO:0005998,0.999999999969728,0.908910608040587,0,1,xylulose catabolic process,BP,
8651,GO:0034196,0.999999999969749,0.923558727614868,0,1,acylglycerol transport,BP,
8652,GO:0034197,0.999999999969749,0.923558727614868,0,1,triglyceride transport,BP,
10871,GO:0044395,0.999999999969749,0.923558727614868,0,1,protein targeting to vacuolar membrane,BP,
17499,GO:1900483,0.999999999969749,0.923558727614868,0,1,regulation of protein targeting to vacuolar membrane,BP,
15531,GO:0071920,0.999999999969773,0.858522089895023,0,2,cleavage body,CC,
10150,GO:0042727,0.999999999969786,0.859432419574053,0,2,flavin-containing compound biosynthetic process,BP,
17159,GO:0102522,0.999999999969792,0.928718176156468,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
5564,GO:0016576,0.999999999969808,0.775776153527233,0,3,histone dephosphorylation,BP,
16248,GO:0090299,0.999999999969813,0.93663316742388,0,1,regulation of neural crest formation,BP,
16249,GO:0090301,0.999999999969813,0.93663316742388,0,1,negative regulation of neural crest formation,BP,
19843,GO:2000314,0.999999999969813,0.93663316742388,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
4593,GO:0010701,0.999999999969847,0.838786361512425,0,2,positive regulation of norepinephrine secretion,BP,
518,GO:0001588,0.999999999969871,0.889574430155244,0,2,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
2139,GO:0004952,0.999999999969871,0.889574430155244,0,2,dopamine neurotransmitter receptor activity,MF,
15771,GO:0072365,0.999999999969883,0.874497369173809,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
8141,GO:0032848,0.999999999969888,0.907111056645037,0,1,negative regulation of cellular pH reduction,BP,
10483,GO:0043375,0.999999999969888,0.907111056645037,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11797,GO:0046668,0.999999999969888,0.907111056645037,0,1,regulation of retinal cell programmed cell death,BP,
11798,GO:0046671,0.999999999969888,0.907111056645037,0,1,negative regulation of retinal cell programmed cell death,BP,
1164,GO:0002785,0.9999999999699,0.909281966179157,0,1,negative regulation of antimicrobial peptide production,BP,
1166,GO:0002787,0.9999999999699,0.909281966179157,0,1,negative regulation of antibacterial peptide production,BP,
3785,GO:0008348,0.9999999999699,0.909281966179157,0,1,negative regulation of antimicrobial humoral response,BP,
7456,GO:0031592,0.999999999969914,0.878527854377971,0,1,centrosomal corona,CC,
18846,GO:1904454,0.999999999969914,0.878527854377971,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
4168,GO:0009234,0.999999999969923,0.909493790826799,0,1,menaquinone biosynthetic process,BP,
7708,GO:0032194,0.999999999969923,0.909493790826799,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
9980,GO:0042371,0.999999999969923,0.909493790826799,0,1,vitamin K biosynthetic process,BP,
5405,GO:0016243,0.999999999969926,0.905309817354195,0,1,regulation of autophagosome size,BP,
5937,GO:0018217,0.999999999969926,0.905309817354195,0,1,peptidyl-aspartic acid phosphorylation,BP,
19137,GO:1905103,0.999999999969926,0.905309817354195,0,1,integral component of lysosomal membrane,CC,
19671,GO:1990938,0.999999999969926,0.905309817354195,0,1,peptidyl-aspartic acid autophosphorylation,BP,
18059,GO:1902612,0.999999999969932,0.921518261303622,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
18060,GO:1902613,0.999999999969932,0.921518261303622,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19489,GO:1990262,0.999999999969932,0.921518261303622,0,1,anti-Mullerian hormone signaling pathway,BP,
2417,GO:0005591,0.999999999969941,0.92313641939499,0,1,collagen type VIII trimer,CC,
2423,GO:0005598,0.999999999969941,0.92313641939499,0,1,short-chain collagen trimer,CC,
7120,GO:0030935,0.999999999969941,0.92313641939499,0,1,sheet-forming collagen trimer,CC,
16804,GO:0098646,0.999999999969941,0.92313641939499,0,1,collagen sheet,CC,
3610,GO:0008049,0.999999999969949,0.932998565152899,0,1,male courtship behavior,BP,
3851,GO:0008460,0.999999999969949,0.932998565152899,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
6365,GO:0021546,0.999999999969954,0.856364996885629,0,2,rhombomere development,BP,
18129,GO:1902822,0.999999999969957,0.806680235469642,0,3,regulation of late endosome to lysosome transport,BP,
9572,GO:0036371,0.999999999969973,0.877526234263659,0,1,protein localization to T-tubule,BP,
16028,GO:0086046,0.999999999969973,0.877526234263659,0,1,membrane depolarization during SA node cell action potential,BP,
16930,GO:0098907,0.999999999969973,0.877526234263659,0,1,regulation of SA node cell action potential,BP,
7548,GO:0031849,0.999999999969992,0.908165661809668,0,1,olfactory receptor binding,MF,
15843,GO:0072554,0.999999999970024,0.926737972951745,0,1,blood vessel lumenization,BP,
17576,GO:1901189,0.999999999970024,0.926737972951745,0,1,positive regulation of ephrin receptor signaling pathway,BP,
17611,GO:1901297,0.999999999970024,0.926737972951745,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
19125,GO:1905068,0.999999999970024,0.926737972951745,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
7006,GO:0030690,0.999999999970026,0.920628252496127,0,1,Noc1p-Noc2p complex,CC,
7007,GO:0030691,0.999999999970026,0.920628252496127,0,1,Noc2p-Noc3p complex,CC,
957,GO:0002378,0.999999999970027,0.90072625726912,0,1,immunoglobulin biosynthetic process,BP,
12096,GO:0048075,0.999999999970051,0.90218354099097,0,1,positive regulation of eye pigmentation,BP,
16159,GO:0090176,0.999999999970056,0.892422803949019,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
15547,GO:0071953,0.999999999970084,0.852565137646386,0,2,elastic fiber,CC,
2106,GO:0004883,0.999999999970112,0.886333681328276,0,1,glucocorticoid receptor activity,MF,
9682,GO:0038051,0.999999999970112,0.886333681328276,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
9305,GO:0035750,0.999999999970145,0.894028769159003,0,1,protein localization to myelin sheath abaxonal region,BP,
2027,GO:0004766,0.999999999970149,0.94279472537929,0,1,spermidine synthase activity,MF,
16921,GO:0098888,0.999999999970161,0.882487475607501,0,1,extrinsic component of presynaptic membrane,CC,
16922,GO:0098890,0.999999999970161,0.882487475607501,0,1,extrinsic component of postsynaptic membrane,CC,
17029,GO:0099243,0.999999999970161,0.882487475607501,0,1,extrinsic component of synaptic membrane,CC,
2338,GO:0005367,0.999999999970194,0.858935239839256,0,1,myo-inositol:sodium symporter activity,MF,
3347,GO:0007066,0.999999999970225,0.948565543384246,0,1,female meiosis sister chromatid cohesion,BP,
4379,GO:0010015,0.999999999970226,0.95133922825685,0,1,root morphogenesis,BP,
4393,GO:0010053,0.999999999970226,0.95133922825685,0,1,root epidermal cell differentiation,BP,
4394,GO:0010054,0.999999999970226,0.95133922825685,0,1,trichoblast differentiation,BP,
6602,GO:0022622,0.999999999970226,0.95133922825685,0,1,root system development,BP,
7534,GO:0031763,0.999999999970226,0.95133922825685,0,1,galanin receptor binding,MF,
7535,GO:0031764,0.999999999970226,0.95133922825685,0,1,type 1 galanin receptor binding,MF,
7536,GO:0031765,0.999999999970226,0.95133922825685,0,1,type 2 galanin receptor binding,MF,
7537,GO:0031766,0.999999999970226,0.95133922825685,0,1,type 3 galanin receptor binding,MF,
12196,GO:0048364,0.999999999970226,0.95133922825685,0,1,root development,BP,
12375,GO:0048764,0.999999999970226,0.95133922825685,0,1,trichoblast maturation,BP,
12376,GO:0048765,0.999999999970226,0.95133922825685,0,1,root hair cell differentiation,BP,
12377,GO:0048767,0.999999999970226,0.95133922825685,0,1,root hair elongation,BP,
13028,GO:0051464,0.999999999970226,0.95133922825685,0,1,positive regulation of cortisol secretion,BP,
15984,GO:0080147,0.999999999970226,0.95133922825685,0,1,root hair cell development,BP,
16336,GO:0090558,0.999999999970226,0.95133922825685,0,1,plant epidermis development,BP,
16354,GO:0090627,0.999999999970226,0.95133922825685,0,1,plant epidermal cell differentiation,BP,
17030,GO:0099402,0.999999999970226,0.95133922825685,0,1,plant organ development,BP,
18057,GO:1902606,0.999999999970226,0.95133922825685,0,1,regulation of large conductance calcium-activated potassium channel activity,BP,
18058,GO:1902608,0.999999999970226,0.95133922825685,0,1,positive regulation of large conductance calcium-activated potassium channel activity,BP,
18149,GO:1902890,0.999999999970226,0.95133922825685,0,1,regulation of root hair elongation,BP,
18150,GO:1902891,0.999999999970226,0.95133922825685,0,1,negative regulation of root hair elongation,BP,
18606,GO:1903888,0.999999999970226,0.95133922825685,0,1,regulation of plant epidermal cell differentiation,BP,
18607,GO:1903889,0.999999999970226,0.95133922825685,0,1,negative regulation of plant epidermal cell differentiation,BP,
19240,GO:1905392,0.999999999970226,0.95133922825685,0,1,plant organ morphogenesis,BP,
19251,GO:1905421,0.999999999970226,0.95133922825685,0,1,regulation of plant organ morphogenesis,BP,
19252,GO:1905422,0.999999999970226,0.95133922825685,0,1,negative regulation of plant organ morphogenesis,BP,
19721,GO:2000067,0.999999999970226,0.95133922825685,0,1,regulation of root morphogenesis,BP,
19821,GO:2000280,0.999999999970226,0.95133922825685,0,1,regulation of root development,BP,
20150,GO:2000851,0.999999999970226,0.95133922825685,0,1,positive regulation of glucocorticoid secretion,BP,
1052,GO:0002580,0.99999999997024,0.79633228245422,0,3,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
5363,GO:0016149,0.999999999970254,0.908984624491057,0,1,translation release factor activity, codon specific,MF,
10570,GO:0043532,0.999999999970265,0.885627128594542,0,1,angiostatin binding,MF,
9241,GO:0035633,0.999999999970272,0.835678260308465,0,2,maintenance of permeability of blood-brain barrier,BP,
3886,GO:0008518,0.999999999970274,0.920276589260591,0,1,reduced folate carrier activity,MF,
16894,GO:0098838,0.999999999970274,0.920276589260591,0,1,reduced folate transmembrane transport,BP,
3652,GO:0008127,0.999999999970275,0.942415477349745,0,1,quercetin 2,3-dioxygenase activity,MF,
5530,GO:0016507,0.999999999970294,0.917396814140952,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
9490,GO:0036125,0.999999999970294,0.917396814140952,0,1,fatty acid beta-oxidation multienzyme complex,CC,
8072,GO:0032747,0.999999999970344,0.800323023487573,0,3,positive regulation of interleukin-23 production,BP,
1340,GO:0003199,0.999999999970365,0.938687741931217,0,1,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
4825,GO:0014028,0.999999999970365,0.938687741931217,0,1,notochord formation,BP,
15768,GO:0072362,0.999999999970377,0.878481938468359,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
18635,GO:1903929,0.999999999970423,0.915843815171014,0,1,primary palate development,BP,
18628,GO:1903918,0.999999999970426,0.880880040634338,0,1,regulation of actin filament severing,BP,
18629,GO:1903919,0.999999999970426,0.880880040634338,0,1,negative regulation of actin filament severing,BP,
11048,GO:0045031,0.999999999970428,0.85445071437661,0,2,ATP-activated adenosine receptor activity,MF,
6044,GO:0019153,0.999999999970435,0.937633481078559,0,1,protein-disulfide reductase (glutathione) activity,MF,
15844,GO:0072555,0.999999999970435,0.937633481078559,0,1,17-beta-ketosteroid reductase activity,MF,
15864,GO:0072582,0.999999999970435,0.937633481078559,0,1,17-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
19456,GO:1990136,0.99999999997044,0.924671705384341,0,1,linoleate 9S-lipoxygenase activity,MF,
18226,GO:1903027,0.999999999970447,0.880548697464973,0,1,regulation of opsonization,BP,
18227,GO:1903028,0.999999999970447,0.880548697464973,0,1,positive regulation of opsonization,BP,
229,GO:0000472,0.999999999970469,0.744027283281435,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
354,GO:0000967,0.999999999970469,0.744027283281435,0,3,rRNA 5'-end processing,BP,
11392,GO:0045769,0.999999999970488,0.862336655331655,0,1,negative regulation of asymmetric cell division,BP,
1536,GO:0003921,0.999999999970503,0.925302807447401,0,1,GMP synthase activity,MF,
1537,GO:0003922,0.999999999970503,0.925302807447401,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
16236,GO:0090284,0.999999999970515,0.882599077958282,0,1,positive regulation of protein glycosylation in Golgi,BP,
7553,GO:0031867,0.999999999970515,0.90721092088624,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
15085,GO:0071062,0.999999999970533,0.902547762079799,0,1,alphav-beta3 integrin-vitronectin complex,CC,
5036,GO:0015211,0.99999999997058,0.925155012676958,0,1,purine nucleoside transmembrane transporter activity,MF,
9521,GO:0036219,0.999999999970583,0.952494636713764,0,1,GTP diphosphatase activity,MF,
10959,GO:0044713,0.999999999970583,0.952494636713764,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
10960,GO:0044714,0.999999999970583,0.952494636713764,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
12029,GO:0047693,0.999999999970583,0.952494636713764,0,1,ATP diphosphatase activity,MF,
4877,GO:0014739,0.999999999970586,0.918491447332419,0,1,positive regulation of muscle hyperplasia,BP,
18309,GO:1903231,0.999999999970586,0.918491447332419,0,1,mRNA binding involved in posttranscriptional gene silencing,MF,
9029,GO:0035241,0.999999999970597,0.786019001390316,0,3,protein-arginine omega-N monomethyltransferase activity,MF,
1789,GO:0004418,0.999999999970624,0.93966154451415,0,1,hydroxymethylbilane synthase activity,MF,
5913,GO:0018160,0.999999999970624,0.93966154451415,0,1,peptidyl-pyrromethane cofactor linkage,BP,
5776,GO:0016998,0.999999999970636,0.85793630185567,0,2,cell wall macromolecule catabolic process,BP,
17300,GO:0140074,0.999999999970665,0.895221531942731,0,1,cardiac endothelial to mesenchymal transition,BP,
2116,GO:0004906,0.999999999970693,0.863563900203155,0,2,interferon-gamma receptor activity,MF,
19242,GO:1905395,0.999999999970694,0.856901822671934,0,2,response to flavonoid,BP,
18996,GO:1904799,0.999999999970706,0.905842568099969,0,1,regulation of neuron remodeling,BP,
18997,GO:1904800,0.999999999970706,0.905842568099969,0,1,negative regulation of neuron remodeling,BP,
19765,GO:2000173,0.999999999970706,0.905842568099969,0,1,negative regulation of branching morphogenesis of a nerve,BP,
1914,GO:0004607,0.999999999970724,0.941498568939075,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
9685,GO:0038062,0.999999999970748,0.907234463744969,0,1,protein tyrosine kinase collagen receptor activity,MF,
10718,GO:0044035,0.99999999997075,0.937023822543972,0,1,multi-organism catabolic process,BP,
10745,GO:0044115,0.99999999997075,0.937023822543972,0,1,development of symbiont involved in interaction with host,BP,
10752,GO:0044145,0.99999999997075,0.937023822543972,0,1,modulation of development of symbiont involved in interaction with host,BP,
10754,GO:0044147,0.99999999997075,0.937023822543972,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
10969,GO:0044730,0.99999999997075,0.937023822543972,0,1,bone sialoprotein binding,MF,
13326,GO:0052214,0.99999999997075,0.937023822543972,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
13327,GO:0052227,0.99999999997075,0.937023822543972,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
13328,GO:0052229,0.99999999997075,0.937023822543972,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
13340,GO:0052360,0.99999999997075,0.937023822543972,0,1,catabolism by host of symbiont macromolecule,BP,
13341,GO:0052361,0.99999999997075,0.937023822543972,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
13342,GO:0052362,0.99999999997075,0.937023822543972,0,1,catabolism by host of symbiont protein,BP,
13343,GO:0052363,0.99999999997075,0.937023822543972,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13344,GO:0052364,0.99999999997075,0.937023822543972,0,1,catabolism by host of substance in symbiont,BP,
13348,GO:0052416,0.99999999997075,0.937023822543972,0,1,metabolism by host of symbiont macromolecule,BP,
13349,GO:0052417,0.99999999997075,0.937023822543972,0,1,metabolism by host of symbiont protein,BP,
13350,GO:0052418,0.99999999997075,0.937023822543972,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
13351,GO:0052419,0.99999999997075,0.937023822543972,0,1,metabolism by host of substance in symbiont,BP,
19310,GO:1905581,0.99999999997075,0.937023822543972,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
19315,GO:1905597,0.99999999997075,0.937023822543972,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
19317,GO:1905599,0.99999999997075,0.937023822543972,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
13402,GO:0052735,0.999999999970752,0.753683066501366,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
14088,GO:0060913,0.999999999970754,0.921988952266324,0,1,cardiac cell fate determination,BP,
15403,GO:0071657,0.999999999970754,0.921988952266324,0,1,positive regulation of granulocyte colony-stimulating factor production,BP,
17601,GO:1901258,0.999999999970754,0.921988952266324,0,1,positive regulation of macrophage colony-stimulating factor production,BP,
12268,GO:0048561,0.999999999970757,0.928608517490471,0,1,establishment of animal organ orientation,BP,
16522,GO:0097229,0.99999999997077,0.941906755197348,0,1,sperm end piece,CC,
13006,GO:0051431,0.999999999970781,0.939454669225417,0,1,corticotropin-releasing hormone receptor 2 binding,MF,
2143,GO:0004957,0.999999999970782,0.912550217181611,0,1,prostaglandin E receptor activity,MF,
15913,GO:0072682,0.999999999970782,0.912550217181611,0,1,eosinophil extravasation,BP,
19919,GO:2000417,0.999999999970782,0.912550217181611,0,1,negative regulation of eosinophil migration,BP,
19921,GO:2000419,0.999999999970782,0.912550217181611,0,1,regulation of eosinophil extravasation,BP,
19922,GO:2000420,0.999999999970782,0.912550217181611,0,1,negative regulation of eosinophil extravasation,BP,
3170,GO:0006781,0.999999999970795,0.929323243967123,0,1,succinyl-CoA pathway,BP,
11974,GO:0047237,0.999999999970798,0.835768206508378,0,2,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
3725,GO:0008251,0.9999999999708,0.818956838245063,0,2,tRNA-specific adenosine deaminase activity,MF,
7472,GO:0031630,0.999999999970818,0.906278073744121,0,1,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
17199,GO:0106022,0.999999999970818,0.906278073744121,0,1,positive regulation of vesicle docking,BP,
9345,GO:0035851,0.999999999970823,0.918484648036306,0,1,Krueppel-associated box domain binding,MF,
13304,GO:0052047,0.999999999970833,0.875964027245487,0,1,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
18755,GO:1904235,0.999999999970833,0.875964027245487,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
18756,GO:1904237,0.999999999970833,0.875964027245487,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20250,GO:2001202,0.999999999970833,0.875964027245487,0,1,negative regulation of transforming growth factor-beta secretion,BP,
328,GO:0000916,0.99999999997086,0.929157887662639,0,1,actomyosin contractile ring contraction,BP,
9518,GO:0036213,0.99999999997086,0.929157887662639,0,1,contractile ring contraction,BP,
12032,GO:0047710,0.999999999970862,0.945957959844344,0,1,bis(5'-adenosyl)-triphosphatase activity,MF,
8089,GO:0032771,0.999999999970865,0.902412829873195,0,1,regulation of monophenol monooxygenase activity,BP,
8090,GO:0032773,0.999999999970865,0.902412829873195,0,1,positive regulation of monophenol monooxygenase activity,BP,
8176,GO:0032912,0.999999999970865,0.902412829873195,0,1,negative regulation of transforming growth factor beta2 production,BP,
12075,GO:0048023,0.999999999970865,0.902412829873195,0,1,positive regulation of melanin biosynthetic process,BP,
13190,GO:0051796,0.999999999970865,0.902412829873195,0,1,negative regulation of timing of catagen,BP,
14082,GO:0060901,0.999999999970865,0.902412829873195,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
18160,GO:1902908,0.999999999970865,0.902412829873195,0,1,regulation of melanosome transport,BP,
18161,GO:1902910,0.999999999970865,0.902412829873195,0,1,positive regulation of melanosome transport,BP,
1674,GO:0004138,0.999999999970896,0.947267872644447,0,1,deoxyguanosine kinase activity,MF,
3936,GO:0008617,0.999999999970896,0.947267872644447,0,1,guanosine metabolic process,BP,
5285,GO:0015938,0.999999999970896,0.947267872644447,0,1,coenzyme A catabolic process,BP,
8543,GO:0033869,0.999999999970896,0.947267872644447,0,1,nucleoside bisphosphate catabolic process,BP,
8566,GO:0034031,0.999999999970896,0.947267872644447,0,1,ribonucleoside bisphosphate catabolic process,BP,
8569,GO:0034034,0.999999999970896,0.947267872644447,0,1,purine nucleoside bisphosphate catabolic process,BP,
16967,GO:0098978,0.999999999970919,0.89482472558098,0,1,glutamatergic synapse,CC,
16971,GO:0098985,0.999999999970919,0.89482472558098,0,1,asymmetric, glutamatergic, excitatory synapse,CC,
16575,GO:0097363,0.999999999970934,0.821395470801404,0,2,protein O-GlcNAc transferase activity,MF,
1836,GO:0004491,0.99999999997094,0.929102826521362,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
4737,GO:0010904,0.99999999997094,0.929102826521362,0,1,regulation of UDP-glucose catabolic process,BP,
4738,GO:0010905,0.99999999997094,0.929102826521362,0,1,negative regulation of UDP-glucose catabolic process,BP,
5976,GO:0018478,0.99999999997094,0.929102826521362,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
18749,GO:1904226,0.99999999997094,0.929102826521362,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
18750,GO:1904227,0.99999999997094,0.929102826521362,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
19174,GO:1905223,0.999999999970965,0.88788210759168,0,1,epicardium morphogenesis,BP,
7074,GO:0030862,0.999999999970978,0.892839061891996,0,1,positive regulation of polarized epithelial cell differentiation,BP,
9746,GO:0039007,0.999999999970978,0.892839061891996,0,1,pronephric nephron morphogenesis,BP,
9747,GO:0039008,0.999999999970978,0.892839061891996,0,1,pronephric nephron tubule morphogenesis,BP,
9750,GO:0039020,0.999999999970978,0.892839061891996,0,1,pronephric nephron tubule development,BP,
9751,GO:0039022,0.999999999970978,0.892839061891996,0,1,pronephric duct development,BP,
9752,GO:0039023,0.999999999970978,0.892839061891996,0,1,pronephric duct morphogenesis,BP,
14581,GO:0070121,0.999999999970978,0.892839061891996,0,1,Kupffer's vesicle development,BP,
15627,GO:0072114,0.999999999970978,0.892839061891996,0,1,pronephros morphogenesis,BP,
2052,GO:0004802,0.999999999970981,0.930140250352329,0,1,transketolase activity,MF,
18856,GO:1904481,0.999999999970982,0.925383449896747,0,1,response to tetrahydrofolate,BP,
18857,GO:1904482,0.999999999970982,0.925383449896747,0,1,cellular response to tetrahydrofolate,BP,
9252,GO:0035651,0.999999999971016,0.802215543383081,0,3,AP-3 adaptor complex binding,MF,
18701,GO:1904059,0.999999999971028,0.845143448778111,0,1,regulation of locomotor rhythm,BP,
15106,GO:0071149,0.999999999971029,0.831297376462215,0,2,TEAD-2-YAP complex,CC,
3005,GO:0006550,0.999999999971075,0.871425627101137,0,2,isoleucine catabolic process,BP,
19455,GO:1990134,0.999999999971078,0.896236091907459,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
14708,GO:0070336,0.999999999971081,0.819725854987596,0,2,flap-structured DNA binding,MF,
1837,GO:0004492,0.999999999971124,0.930056845633776,0,1,methylmalonyl-CoA decarboxylase activity,MF,
8572,GO:0034038,0.999999999971158,0.944276324633643,0,1,deoxyhypusine synthase activity,MF,
2357,GO:0005456,0.999999999971167,0.934368310895634,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
5193,GO:0015782,0.999999999971167,0.934368310895634,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
1794,GO:0004423,0.999999999971169,0.891228033723913,0,1,iduronate-2-sulfatase activity,MF,
12469,GO:0050337,0.999999999971181,0.954827634656219,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
5348,GO:0016098,0.999999999971202,0.91633797886693,0,1,monoterpenoid metabolic process,BP,
8516,GO:0033695,0.999999999971202,0.91633797886693,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
8933,GO:0034875,0.999999999971202,0.91633797886693,0,1,caffeine oxidase activity,MF,
15375,GO:0071615,0.999999999971202,0.91633797886693,0,1,oxidative deethylation,BP,
15471,GO:0071812,0.999999999971202,0.91633797886693,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
15490,GO:0071848,0.999999999971202,0.91633797886693,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
8403,GO:0033342,0.999999999971222,0.924497294819378,0,1,negative regulation of collagen binding,BP,
18334,GO:1903294,0.99999999997123,0.812846689021723,0,2,regulation of glutamate secretion, neurotransmission,BP,
18335,GO:1903296,0.99999999997123,0.812846689021723,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
7581,GO:0031945,0.999999999971238,0.906455396011334,0,1,positive regulation of glucocorticoid metabolic process,BP,
7584,GO:0031948,0.999999999971238,0.906455396011334,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
14024,GO:0060748,0.999999999971238,0.906455396011334,0,1,tertiary branching involved in mammary gland duct morphogenesis,BP,
14172,GO:0061054,0.999999999971238,0.906455396011334,0,1,dermatome development,BP,
14228,GO:0061183,0.999999999971238,0.906455396011334,0,1,regulation of dermatome development,BP,
14229,GO:0061184,0.999999999971238,0.906455396011334,0,1,positive regulation of dermatome development,BP,
14238,GO:0061205,0.999999999971238,0.906455396011334,0,1,paramesonephric duct development,BP,
14286,GO:0061369,0.999999999971238,0.906455396011334,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
19696,GO:2000019,0.999999999971238,0.906455396011334,0,1,negative regulation of male gonad development,BP,
19720,GO:2000066,0.999999999971238,0.906455396011334,0,1,positive regulation of cortisol biosynthetic process,BP,
19789,GO:2000224,0.999999999971238,0.906455396011334,0,1,regulation of testosterone biosynthetic process,BP,
19790,GO:2000225,0.999999999971238,0.906455396011334,0,1,negative regulation of testosterone biosynthetic process,BP,
4303,GO:0009753,0.99999999997125,0.883900356123625,0,2,response to jasmonic acid,BP,
5979,GO:0018636,0.99999999997125,0.883900356123625,0,2,phenanthrene 9,10-monooxygenase activity,MF,
11948,GO:0047023,0.99999999997125,0.883900356123625,0,2,androsterone dehydrogenase activity,MF,
11955,GO:0047086,0.99999999997125,0.883900356123625,0,2,ketosteroid monooxygenase activity,MF,
11957,GO:0047115,0.99999999997125,0.883900356123625,0,2,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
15239,GO:0071395,0.99999999997125,0.883900356123625,0,2,cellular response to jasmonic acid stimulus,BP,
8083,GO:0032764,0.999999999971271,0.854826629653993,0,2,negative regulation of mast cell cytokine production,BP,
3516,GO:0007439,0.99999999997128,0.918566237387907,0,1,ectodermal digestive tract development,BP,
9519,GO:0036215,0.99999999997128,0.918566237387907,0,1,response to stem cell factor,BP,
9520,GO:0036216,0.99999999997128,0.918566237387907,0,1,cellular response to stem cell factor stimulus,BP,
9705,GO:0038109,0.99999999997128,0.918566237387907,0,1,Kit signaling pathway,BP,
12289,GO:0048611,0.99999999997128,0.918566237387907,0,1,embryonic ectodermal digestive tract development,BP,
14727,GO:0070376,0.999999999971291,0.91950383235333,0,1,regulation of ERK5 cascade,BP,
14728,GO:0070377,0.999999999971291,0.91950383235333,0,1,negative regulation of ERK5 cascade,BP,
3492,GO:0007371,0.999999999971293,0.908359695935481,0,1,ventral midline determination,BP,
13695,GO:0060245,0.999999999971293,0.908359695935481,0,1,detection of cell density,BP,
13696,GO:0060246,0.999999999971293,0.908359695935481,0,1,detection of cell density by contact stimulus,BP,
13697,GO:0060248,0.999999999971293,0.908359695935481,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14202,GO:0061113,0.999999999971293,0.908359695935481,0,1,pancreas morphogenesis,BP,
15576,GO:0072036,0.999999999971293,0.908359695935481,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
15724,GO:0072285,0.999999999971293,0.908359695935481,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
15414,GO:0071676,0.999999999971305,0.834923043426553,0,2,negative regulation of mononuclear cell migration,BP,
16072,GO:0090027,0.999999999971305,0.834923043426553,0,2,negative regulation of monocyte chemotaxis,BP,
5981,GO:0018773,0.99999999997133,0.936374022422986,0,1,acetylpyruvate hydrolase activity,MF,
8812,GO:0034545,0.99999999997133,0.936374022422986,0,1,fumarylpyruvate hydrolase activity,MF,
12021,GO:0047621,0.99999999997133,0.936374022422986,0,1,acylpyruvate hydrolase activity,MF,
13364,GO:0052550,0.99999999997133,0.936374022422986,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
13370,GO:0052567,0.99999999997133,0.936374022422986,0,1,response to defense-related host reactive oxygen species production,BP,
4976,GO:0015093,0.999999999971333,0.812125661923106,0,2,ferrous iron transmembrane transporter activity,MF,
5150,GO:0015684,0.999999999971333,0.812125661923106,0,2,ferrous iron transport,BP,
18601,GO:1903874,0.999999999971333,0.812125661923106,0,2,ferrous iron transmembrane transport,BP,
13934,GO:0060598,0.999999999971364,0.94345788382861,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
8310,GO:0033142,0.999999999971383,0.929020287858253,0,1,progesterone receptor binding,MF,
7593,GO:0031962,0.999999999971393,0.890634436424286,0,1,mineralocorticoid receptor binding,MF,
13722,GO:0060290,0.999999999971393,0.890634436424286,0,1,transdifferentiation,BP,
14448,GO:0061767,0.999999999971393,0.890634436424286,0,1,negative regulation of lung blood pressure,BP,
527,GO:0001635,0.999999999971411,0.784608381640045,0,3,calcitonin gene-related peptide receptor activity,MF,
16696,GO:0097642,0.999999999971411,0.784608381640045,0,3,calcitonin family receptor activity,MF,
9398,GO:0035936,0.999999999971419,0.884709159993955,0,1,testosterone secretion,BP,
20143,GO:2000843,0.999999999971419,0.884709159993955,0,1,regulation of testosterone secretion,BP,
20144,GO:2000845,0.999999999971419,0.884709159993955,0,1,positive regulation of testosterone secretion,BP,
12808,GO:0051102,0.999999999971424,0.904767436127803,0,1,DNA ligation involved in DNA recombination,BP,
11412,GO:0045819,0.999999999971428,0.906101884029048,0,1,positive regulation of glycogen catabolic process,BP,
19246,GO:1905404,0.999999999971456,0.938538431954777,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
14052,GO:0060821,0.99999999997146,0.874180947559955,0,1,inactivation of X chromosome by DNA methylation,BP,
16484,GO:0097166,0.99999999997146,0.874180947559955,0,1,lens epithelial cell proliferation,BP,
20207,GO:2001109,0.99999999997146,0.874180947559955,0,1,regulation of lens epithelial cell proliferation,BP,
20208,GO:2001111,0.99999999997146,0.874180947559955,0,1,positive regulation of lens epithelial cell proliferation,BP,
9702,GO:0038101,0.999999999971481,0.935632947310125,0,1,sequestering of nodal from receptor via nodal binding,BP,
17383,GO:1900108,0.999999999971481,0.935632947310125,0,1,negative regulation of nodal signaling pathway,BP,
17410,GO:1900146,0.999999999971481,0.935632947310125,0,1,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17425,GO:1900176,0.999999999971481,0.935632947310125,0,1,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
16992,GO:0099073,0.999999999971505,0.822728113076656,0,2,mitochondrion-derived vesicle,CC,
8551,GO:0033897,0.999999999971505,0.943225264417794,0,1,ribonuclease T2 activity,MF,
1297,GO:0003130,0.999999999971512,0.856371354269859,0,2,BMP signaling pathway involved in heart induction,BP,
1299,GO:0003133,0.999999999971512,0.856371354269859,0,2,endodermal-mesodermal cell signaling,BP,
1300,GO:0003134,0.999999999971512,0.856371354269859,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
15642,GO:0072138,0.999999999971512,0.856371354269859,0,2,mesenchymal cell proliferation involved in ureteric bud development,BP,
2182,GO:0005034,0.999999999971514,0.915952032159015,0,1,osmosensor activity,MF,
6703,GO:0030103,0.999999999971514,0.915952032159015,0,1,vasopressin secretion,BP,
16638,GO:0097497,0.999999999971514,0.915952032159015,0,1,blood vessel endothelial cell delamination,BP,
18414,GO:1903444,0.999999999971514,0.915952032159015,0,1,negative regulation of brown fat cell differentiation,BP,
18549,GO:1903759,0.999999999971514,0.915952032159015,0,1,signal transduction involved in regulation of aerobic respiration,BP,
3832,GO:0008431,0.999999999971536,0.917390018354726,0,1,vitamin E binding,MF,
16646,GO:0097505,0.999999999971542,0.891641298930429,0,1,Rad6-Rad18 complex,CC,
18485,GO:1903593,0.999999999971552,0.812776591916982,0,3,regulation of histamine secretion by mast cell,BP,
18486,GO:1903595,0.999999999971552,0.812776591916982,0,3,positive regulation of histamine secretion by mast cell,BP,
4805,GO:0010999,0.999999999971561,0.900712998618271,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
11509,GO:0045993,0.999999999971561,0.900712998618271,0,1,negative regulation of translational initiation by iron,BP,
11940,GO:0046986,0.999999999971561,0.900712998618271,0,1,negative regulation of hemoglobin biosynthetic process,BP,
18498,GO:1903630,0.999999999971572,0.943774455345038,0,1,regulation of aminoacyl-tRNA ligase activity,BP,
18499,GO:1903632,0.999999999971572,0.943774455345038,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19438,GO:1990071,0.999999999971577,0.841283558447493,0,2,TRAPPII protein complex,CC,
19350,GO:1905719,0.999999999971582,0.846825035194778,0,2,protein localization to perinuclear region of cytoplasm,BP,
17782,GO:1901842,0.999999999971585,0.873799723509073,0,2,negative regulation of high voltage-gated calcium channel activity,BP,
13052,GO:0051542,0.999999999971587,0.811222009547568,0,2,elastin biosynthetic process,BP,
17550,GO:1901090,0.999999999971614,0.854016647810153,0,2,regulation of protein tetramerization,BP,
17551,GO:1901091,0.999999999971614,0.854016647810153,0,2,negative regulation of protein tetramerization,BP,
17552,GO:1901093,0.999999999971614,0.854016647810153,0,2,regulation of protein homotetramerization,BP,
17553,GO:1901094,0.999999999971614,0.854016647810153,0,2,negative regulation of protein homotetramerization,BP,
19156,GO:1905168,0.999999999971625,0.908750685677131,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
19589,GO:1990698,0.999999999971635,0.846764940326481,0,2,palmitoleoyltransferase activity,MF,
1066,GO:0002625,0.999999999971665,0.932452601748382,0,1,regulation of T cell antigen processing and presentation,BP,
1067,GO:0002626,0.999999999971665,0.932452601748382,0,1,negative regulation of T cell antigen processing and presentation,BP,
4397,GO:0010106,0.999999999971665,0.932452601748382,0,1,cellular response to iron ion starvation,BP,
18774,GO:1904282,0.999999999971665,0.932452601748382,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
18775,GO:1904283,0.999999999971665,0.932452601748382,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20241,GO:2001186,0.999999999971665,0.932452601748382,0,1,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
19668,GO:1990930,0.999999999971687,0.938006551608757,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
2365,GO:0005477,0.999999999971687,0.910886850386479,0,1,pyruvate secondary active transmembrane transporter activity,MF,
18797,GO:1904339,0.999999999971706,0.883441294426982,0,1,negative regulation of dopaminergic neuron differentiation,BP,
17582,GO:1901207,0.999999999971727,0.90563030539676,0,1,regulation of heart looping,BP,
18551,GO:1903762,0.999999999971727,0.90563030539676,0,1,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
18642,GO:1903947,0.999999999971727,0.90563030539676,0,1,positive regulation of ventricular cardiac muscle cell action potential,BP,
18644,GO:1903952,0.999999999971727,0.90563030539676,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
18645,GO:1903954,0.999999999971727,0.90563030539676,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19101,GO:1905026,0.999999999971727,0.90563030539676,0,1,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
19103,GO:1905033,0.999999999971727,0.90563030539676,0,1,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
5619,GO:0016672,0.999999999971728,0.893474340794833,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
11131,GO:0045174,0.999999999971728,0.893474340794833,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
12503,GO:0050610,0.999999999971728,0.893474340794833,0,2,methylarsonate reductase activity,MF,
9394,GO:0035931,0.999999999971737,0.845110459489942,0,2,mineralocorticoid secretion,BP,
9395,GO:0035932,0.999999999971737,0.845110459489942,0,2,aldosterone secretion,BP,
20151,GO:2000855,0.999999999971737,0.845110459489942,0,2,regulation of mineralocorticoid secretion,BP,
20152,GO:2000857,0.999999999971737,0.845110459489942,0,2,positive regulation of mineralocorticoid secretion,BP,
20153,GO:2000858,0.999999999971737,0.845110459489942,0,2,regulation of aldosterone secretion,BP,
20154,GO:2000860,0.999999999971737,0.845110459489942,0,2,positive regulation of aldosterone secretion,BP,
15121,GO:0071207,0.999999999971754,0.841578752324197,0,2,histone pre-mRNA stem-loop binding,MF,
14292,GO:0061386,0.999999999971764,0.77695308600452,0,2,closure of optic fissure,BP,
17088,GO:0099617,0.999999999971778,0.912774027355707,0,1,matrix side of mitochondrial inner membrane,CC,
9257,GO:0035663,0.999999999971795,0.832755700737738,0,2,Toll-like receptor 2 binding,MF,
1895,GO:0004578,0.999999999971829,0.906033989581303,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
6050,GO:0019187,0.999999999971829,0.906033989581303,0,1,beta-1,4-mannosyltransferase activity,MF,
12763,GO:0051032,0.999999999971829,0.906033989581303,0,1,nucleic acid transmembrane transporter activity,MF,
12764,GO:0051033,0.999999999971829,0.906033989581303,0,1,RNA transmembrane transporter activity,MF,
9532,GO:0036261,0.999999999971835,0.90889828455207,0,1,7-methylguanosine cap hypermethylation,BP,
15112,GO:0071164,0.999999999971835,0.90889828455207,0,1,RNA trimethylguanosine synthase activity,MF,
2631,GO:0005958,0.999999999971839,0.71972908115935,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2154,GO:0004977,0.99999999997184,0.855951046207732,0,2,melanocortin receptor activity,MF,
2262,GO:0005176,0.999999999971846,0.875390159839252,0,2,ErbB-2 class receptor binding,MF,
1759,GO:0004362,0.999999999971849,0.92793902442438,0,1,glutathione-disulfide reductase activity,MF,
5195,GO:0015786,0.999999999971849,0.92793902442438,0,1,UDP-glucose transmembrane transport,BP,
1032,GO:0002541,0.99999999997185,0.86274630504611,0,2,activation of plasma proteins involved in acute inflammatory response,BP,
5868,GO:0017177,0.999999999971854,0.906420988056682,0,1,glucosidase II complex,CC,
8553,GO:0033919,0.999999999971854,0.906420988056682,0,1,glucan 1,3-alpha-glucosidase activity,MF,
16347,GO:0090600,0.999999999971854,0.906420988056682,0,1,alpha-1,3-glucosidase activity,MF,
997,GO:0002461,0.999999999971885,0.927232193888493,0,1,tolerance induction dependent upon immune response,BP,
1019,GO:0002519,0.999999999971885,0.927232193888493,0,1,natural killer cell tolerance induction,BP,
1078,GO:0002652,0.999999999971885,0.927232193888493,0,1,regulation of tolerance induction dependent upon immune response,BP,
8051,GO:0032712,0.999999999971885,0.927232193888493,0,1,negative regulation of interleukin-3 production,BP,
15402,GO:0071656,0.999999999971885,0.927232193888493,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
17600,GO:1901257,0.999999999971885,0.927232193888493,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
17171,GO:0102773,0.999999999971888,0.900886050392482,0,1,dihydroceramide kinase activity,MF,
6039,GO:0019135,0.999999999971892,0.933309375587169,0,1,deoxyhypusine monooxygenase activity,MF,
9411,GO:0035971,0.999999999971924,0.943724403929462,0,1,peptidyl-histidine dephosphorylation,BP,
17084,GO:0099606,0.999999999971935,0.874505777901824,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
17085,GO:0099607,0.999999999971935,0.874505777901824,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
15725,GO:0072287,0.999999999971968,0.846272049333315,0,1,metanephric distal tubule morphogenesis,BP,
7424,GO:0031523,0.99999999997198,0.806756579725641,0,2,Myb complex,CC,
15221,GO:0071373,0.999999999971983,0.849478475772809,0,2,cellular response to luteinizing hormone stimulus,BP,
9267,GO:0035686,0.999999999972007,0.808020781723711,0,3,sperm fibrous sheath,CC,
1950,GO:0004654,0.999999999972018,0.899592073683785,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
16351,GO:0090616,0.999999999972018,0.899592073683785,0,1,mitochondrial mRNA 3'-end processing,BP,
16515,GO:0097222,0.999999999972018,0.899592073683785,0,1,mitochondrial mRNA polyadenylation,BP,
8542,GO:0033867,0.999999999972024,0.936908684056987,0,1,Fas-activated serine/threonine kinase activity,MF,
14480,GO:0061880,0.999999999972035,0.936040209188053,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
14481,GO:0061881,0.999999999972035,0.936040209188053,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
14600,GO:0070159,0.999999999972053,0.926393502771559,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
2772,GO:0006193,0.99999999997207,0.945736797378804,0,1,ITP catabolic process,BP,
4142,GO:0009203,0.99999999997207,0.945736797378804,0,1,ribonucleoside triphosphate catabolic process,BP,
4146,GO:0009207,0.99999999997207,0.945736797378804,0,1,purine ribonucleoside triphosphate catabolic process,BP,
9522,GO:0036220,0.99999999997207,0.945736797378804,0,1,ITP diphosphatase activity,MF,
9523,GO:0036222,0.99999999997207,0.945736797378804,0,1,XTP diphosphatase activity,MF,
9097,GO:0035359,0.99999999997207,0.904756720552766,0,1,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
2383,GO:0005519,0.999999999972075,0.905608066372143,0,1,cytoskeletal regulatory protein binding,MF,
4325,GO:0009826,0.999999999972132,0.828025593485456,0,2,unidimensional cell growth,BP,
15944,GO:0072750,0.999999999972145,0.942646142218585,0,1,cellular response to leptomycin B,BP,
17634,GO:1901344,0.999999999972145,0.942646142218585,0,1,response to leptomycin B,BP,
17755,GO:1901707,0.999999999972145,0.942646142218585,0,1,leptomycin B binding,MF,
17289,GO:0140052,0.999999999972152,0.757401207630395,0,3,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
5842,GO:0017130,0.999999999972154,0.885081147723226,0,1,poly(C) RNA binding,MF,
16774,GO:0098577,0.999999999972154,0.885081147723226,0,1,inactive sex chromosome,CC,
18148,GO:1902889,0.999999999972154,0.885081147723226,0,1,protein localization to spindle microtubule,BP,
19494,GO:1990280,0.999999999972154,0.885081147723226,0,1,RNA localization to chromatin,BP,
197,GO:0000415,0.999999999972159,0.887806490251201,0,1,negative regulation of histone H3-K36 methylation,BP,
10035,GO:0042483,0.999999999972159,0.887806490251201,0,1,negative regulation of odontogenesis,BP,
14612,GO:0070171,0.999999999972159,0.887806490251201,0,1,negative regulation of tooth mineralization,BP,
18669,GO:1903999,0.999999999972178,0.850911374250339,0,2,negative regulation of eating behavior,BP,
19803,GO:2000252,0.999999999972178,0.850911374250339,0,2,negative regulation of feeding behavior,BP,
17997,GO:1902445,0.99999999997218,0.835159189357517,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
15104,GO:0071144,0.999999999972181,0.770169082727668,0,2,heteromeric SMAD protein complex,CC,
19281,GO:1905502,0.999999999972188,0.944209267315611,0,1,acetyl-CoA binding,MF,
9873,GO:0042134,0.999999999972207,0.882174481422946,0,2,rRNA primary transcript binding,MF,
6623,GO:0022849,0.999999999972261,0.895811695936002,0,1,glutamate-gated calcium ion channel activity,MF,
13653,GO:0060161,0.999999999972264,0.77447600642363,0,3,positive regulation of dopamine receptor signaling pathway,BP,
10142,GO:0042709,0.999999999972265,0.926771778546466,0,1,succinate-CoA ligase complex,CC,
11173,GO:0045244,0.999999999972265,0.926771778546466,0,1,succinate-CoA ligase complex (GDP-forming),CC,
16617,GO:0097454,0.999999999972276,0.747108556715849,0,3,Schwann cell microvillus,CC,
6348,GO:0021524,0.999999999972284,0.861676511017935,0,2,visceral motor neuron differentiation,BP,
2600,GO:0005898,0.9999999999723,0.905244045676027,0,1,interleukin-13 receptor complex,CC,
7384,GO:0031436,0.999999999972301,0.815698358591413,0,2,BRCA1-BARD1 complex,CC,
7148,GO:0030997,0.999999999972304,0.743303423870109,0,3,regulation of centriole-centriole cohesion,BP,
13,GO:0000026,0.999999999972312,0.75716830371445,0,3,alpha-1,2-mannosyltransferase activity,MF,
14066,GO:0060844,0.99999999997232,0.846892045542836,0,2,arterial endothelial cell fate commitment,BP,
7563,GO:0031905,0.999999999972332,0.793230111176267,0,3,early endosome lumen,CC,
5010,GO:0015168,0.999999999972372,0.857455331920227,0,2,glycerol transmembrane transporter activity,MF,
5056,GO:0015254,0.999999999972372,0.857455331920227,0,2,glycerol channel activity,MF,
5199,GO:0015793,0.999999999972372,0.857455331920227,0,2,glycerol transport,BP,
2074,GO:0004828,0.999999999972374,0.868384112008931,0,2,serine-tRNA ligase activity,MF,
2924,GO:0006434,0.999999999972374,0.868384112008931,0,2,seryl-tRNA aminoacylation,BP,
20046,GO:2000669,0.999999999972404,0.830866913494317,0,2,negative regulation of dendritic cell apoptotic process,BP,
9613,GO:0036476,0.999999999972412,0.820235485189388,0,3,neuron death in response to hydrogen peroxide,BP,
18301,GO:1903207,0.999999999972412,0.820235485189388,0,3,regulation of hydrogen peroxide-induced neuron death,BP,
18302,GO:1903208,0.999999999972412,0.820235485189388,0,3,negative regulation of hydrogen peroxide-induced neuron death,BP,
1867,GO:0004531,0.999999999972417,0.931556367165535,0,1,deoxyribonuclease II activity,MF,
4992,GO:0015127,0.999999999972425,0.89596509726294,0,1,bilirubin transmembrane transporter activity,MF,
5156,GO:0015694,0.999999999972425,0.89596509726294,0,1,mercury ion transport,BP,
5171,GO:0015723,0.999999999972425,0.89596509726294,0,1,bilirubin transport,BP,
6980,GO:0030653,0.999999999972425,0.89596509726294,0,1,beta-lactam antibiotic metabolic process,BP,
9952,GO:0042316,0.999999999972425,0.89596509726294,0,1,penicillin metabolic process,BP,
17549,GO:1901086,0.999999999972425,0.89596509726294,0,1,benzylpenicillin metabolic process,BP,
11120,GO:0045145,0.999999999972428,0.84171207597328,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
1980,GO:0004698,0.999999999972429,0.87380091412109,0,1,calcium-dependent protein kinase C activity,MF,
9114,GO:0035403,0.999999999972429,0.87380091412109,0,1,histone kinase activity (H3-T6 specific),MF,
9119,GO:0035408,0.999999999972429,0.87380091412109,0,1,histone H3-T6 phosphorylation,BP,
20069,GO:2000707,0.999999999972429,0.87380091412109,0,1,positive regulation of dense core granule biogenesis,BP,
2051,GO:0004801,0.99999999997243,0.943308279676235,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
453,GO:0001226,0.999999999972452,0.914168698011887,0,1,RNA polymerase II transcription corepressor binding,MF,
3825,GO:0008424,0.999999999972452,0.914168698011887,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
9465,GO:0036071,0.999999999972452,0.914168698011887,0,1,N-glycan fucosylation,BP,
11898,GO:0046921,0.999999999972452,0.914168698011887,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
11169,GO:0045234,0.999999999972466,0.934782020027226,0,1,protein palmitoleylation,BP,
19625,GO:1990784,0.999999999972466,0.904939585751679,0,1,response to dsDNA,BP,
19627,GO:1990786,0.999999999972466,0.904939585751679,0,1,cellular response to dsDNA,BP,
7235,GO:0031134,0.999999999972491,0.771352488566753,0,3,sister chromatid biorientation,BP,
1418,GO:0003360,0.999999999972495,0.741454886965817,0,3,brainstem development,BP,
2370,GO:0005497,0.999999999972504,0.885298220221016,0,2,androgen binding,MF,
16434,GO:0097070,0.999999999972504,0.891480807986852,0,1,ductus arteriosus closure,BP,
16535,GO:0097272,0.999999999972504,0.891480807986852,0,1,ammonia homeostasis,BP,
16536,GO:0097273,0.999999999972504,0.891480807986852,0,1,creatinine homeostasis,BP,
16538,GO:0097275,0.999999999972504,0.891480807986852,0,1,cellular ammonia homeostasis,BP,
16539,GO:0097276,0.999999999972504,0.891480807986852,0,1,cellular creatinine homeostasis,BP,
16540,GO:0097277,0.999999999972504,0.891480807986852,0,1,cellular urea homeostasis,BP,
781,GO:0002038,0.999999999972517,0.928007177842074,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
4717,GO:0010879,0.999999999972517,0.928007177842074,0,1,cholesterol transport involved in cholesterol storage,BP,
9091,GO:0035352,0.999999999972517,0.928007177842074,0,1,NAD transmembrane transport,BP,
10339,GO:0043132,0.999999999972517,0.928007177842074,0,1,NAD transport,BP,
10946,GO:0044610,0.999999999972517,0.928007177842074,0,1,FMN transmembrane transporter activity,MF,
13153,GO:0051724,0.999999999972517,0.928007177842074,0,1,NAD transmembrane transporter activity,MF,
8209,GO:0032962,0.999999999972541,0.760057759385113,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
14812,GO:0070539,0.999999999972547,0.911195544605768,0,1,linoleic acid binding,MF,
3220,GO:0006867,0.999999999972564,0.92107370520974,0,1,asparagine transport,BP,
5019,GO:0015182,0.999999999972564,0.92107370520974,0,1,L-asparagine transmembrane transporter activity,MF,
5026,GO:0015190,0.999999999972564,0.92107370520974,0,1,L-leucine transmembrane transporter activity,MF,
5027,GO:0015191,0.999999999972564,0.92107370520974,0,1,L-methionine transmembrane transporter activity,MF,
5139,GO:0015658,0.999999999972564,0.92107370520974,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5219,GO:0015821,0.999999999972564,0.92107370520974,0,1,methionine transport,BP,
10666,GO:0043865,0.999999999972564,0.92107370520974,0,1,methionine transmembrane transporter activity,MF,
1089,GO:0002677,0.999999999972569,0.844431552453097,0,2,negative regulation of chronic inflammatory response,BP,
112,GO:0000229,0.999999999972583,0.937680006370057,0,1,cytoplasmic chromosome,CC,
127,GO:0000262,0.999999999972583,0.937680006370057,0,1,mitochondrial chromosome,CC,
2034,GO:0004774,0.999999999972587,0.809400517811698,0,3,succinate-CoA ligase activity,MF,
20222,GO:2001160,0.999999999972589,0.851629928415498,0,2,regulation of histone H3-K79 methylation,BP,
20223,GO:2001162,0.999999999972589,0.851629928415498,0,2,positive regulation of histone H3-K79 methylation,BP,
669,GO:0001878,0.999999999972596,0.927422158535036,0,1,response to yeast,BP,
4219,GO:0009386,0.999999999972596,0.927422158535036,0,1,translational attenuation,BP,
14475,GO:0061847,0.999999999972596,0.927422158535036,0,1,response to cholecystokinin,BP,
15322,GO:0071538,0.999999999972596,0.927422158535036,0,1,SH2 domain-mediated complex assembly,BP,
19642,GO:1990839,0.999999999972596,0.927422158535036,0,1,response to endothelin,BP,
19646,GO:1990859,0.999999999972596,0.927422158535036,0,1,cellular response to endothelin,BP,
1829,GO:0004484,0.999999999972597,0.900690920398653,0,1,mRNA guanylyltransferase activity,MF,
12474,GO:0050355,0.999999999972597,0.900690920398653,0,1,triphosphatase activity,MF,
12441,GO:0050115,0.999999999972606,0.897351702560303,0,1,myosin-light-chain-phosphatase activity,MF,
15575,GO:0072034,0.999999999972621,0.821436049381926,0,2,renal vesicle induction,BP,
16725,GO:0097726,0.999999999972629,0.945397385443885,0,1,LEM domain binding,MF,
4217,GO:0009383,0.999999999972635,0.830796352803161,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
11748,GO:0046588,0.99999999997265,0.949088156675866,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
8037,GO:0032685,0.999999999972695,0.914490069524638,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
9129,GO:0035442,0.999999999972696,0.864200869314281,0,2,dipeptide transmembrane transport,BP,
10234,GO:0042938,0.999999999972696,0.864200869314281,0,2,dipeptide transport,BP,
16109,GO:0090088,0.999999999972696,0.864200869314281,0,2,regulation of oligopeptide transport,BP,
16110,GO:0090089,0.999999999972696,0.864200869314281,0,2,regulation of dipeptide transport,BP,
20156,GO:2000878,0.999999999972696,0.864200869314281,0,2,positive regulation of oligopeptide transport,BP,
20157,GO:2000880,0.999999999972696,0.864200869314281,0,2,positive regulation of dipeptide transport,BP,
20218,GO:2001148,0.999999999972696,0.864200869314281,0,2,regulation of dipeptide transmembrane transport,BP,
20219,GO:2001150,0.999999999972696,0.864200869314281,0,2,positive regulation of dipeptide transmembrane transport,BP,
16164,GO:0090182,0.99999999997272,0.873187260086344,0,2,regulation of secretion of lysosomal enzymes,BP,
8023,GO:0032658,0.99999999997272,0.934811676424338,0,1,regulation of interleukin-15 production,BP,
8068,GO:0032738,0.99999999997272,0.934811676424338,0,1,positive regulation of interleukin-15 production,BP,
9258,GO:0035664,0.99999999997272,0.934811676424338,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9259,GO:0035665,0.99999999997272,0.934811676424338,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
18415,GO:1903445,0.999999999972722,0.81690250189219,0,3,protein transport from ciliary membrane to plasma membrane,BP,
6042,GO:0019145,0.999999999972737,0.9247522210371,0,1,aminobutyraldehyde dehydrogenase activity,MF,
8519,GO:0033737,0.999999999972737,0.9247522210371,0,1,1-pyrroline dehydrogenase activity,MF,
11956,GO:0047105,0.999999999972737,0.9247522210371,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12795,GO:0051089,0.999999999972749,0.906056601832186,0,1,constitutive protein ectodomain proteolysis,BP,
19729,GO:2000097,0.999999999972756,0.84675764318854,0,2,regulation of smooth muscle cell-matrix adhesion,BP,
13532,GO:0055113,0.999999999972784,0.861864540970669,0,1,epiboly involved in gastrulation with mouth forming second,BP,
5,GO:0000011,0.999999999972786,0.919544554109259,0,1,vacuole inheritance,BP,
334,GO:0000928,0.999999999972786,0.919544554109259,0,1,gamma-tubulin small complex, spindle pole body,CC,
644,GO:0001834,0.999999999972786,0.919544554109259,0,1,trophectodermal cell proliferation,BP,
1565,GO:0003972,0.999999999972786,0.919544554109259,0,1,RNA ligase (ATP) activity,MF,
1640,GO:0004083,0.999999999972786,0.919544554109259,0,1,bisphosphoglycerate 2-phosphatase activity,MF,
1767,GO:0004371,0.999999999972786,0.919544554109259,0,1,glycerone kinase activity,MF,
2016,GO:0004743,0.999999999972786,0.919544554109259,0,1,pyruvate kinase activity,MF,
2734,GO:0006113,0.999999999972786,0.919544554109259,0,1,fermentation,BP,
2952,GO:0006480,0.999999999972786,0.919544554109259,0,1,N-terminal protein amino acid methylation,BP,
3375,GO:0007146,0.999999999972786,0.919544554109259,0,1,meiotic recombination nodule assembly,BP,
3843,GO:0008452,0.999999999972786,0.919544554109259,0,1,RNA ligase activity,MF,
3844,GO:0008453,0.999999999972786,0.919544554109259,0,1,alanine-glyoxylate transaminase activity,MF,
3957,GO:0008700,0.999999999972786,0.919544554109259,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4105,GO:0009159,0.999999999972786,0.919544554109259,0,1,deoxyribonucleoside monophosphate catabolic process,BP,
4238,GO:0009436,0.999999999972786,0.919544554109259,0,1,glyoxylate catabolic process,BP,
4430,GO:0010260,0.999999999972786,0.919544554109259,0,1,animal organ senescence,BP,
4444,GO:0010348,0.999999999972786,0.919544554109259,0,1,lithium:proton antiporter activity,MF,
4817,GO:0014011,0.999999999972786,0.919544554109259,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5069,GO:0015292,0.999999999972786,0.919544554109259,0,1,uniporter activity,MF,
5494,GO:0016430,0.999999999972786,0.919544554109259,0,1,tRNA (adenine-N6-)-methyltransferase activity,MF,
5579,GO:0016596,0.999999999972786,0.919544554109259,0,1,thienylcyclohexylpiperidine binding,MF,
5689,GO:0016807,0.999999999972786,0.919544554109259,0,1,cysteine-type carboxypeptidase activity,MF,
5712,GO:0016843,0.999999999972786,0.919544554109259,0,1,amine-lyase activity,MF,
5713,GO:0016844,0.999999999972786,0.919544554109259,0,1,strictosidine synthase activity,MF,
5817,GO:0017082,0.999999999972786,0.919544554109259,0,1,mineralocorticoid receptor activity,MF,
5869,GO:0017178,0.999999999972786,0.919544554109259,0,1,diphthine-ammonia ligase activity,MF,
5880,GO:0018011,0.999999999972786,0.919544554109259,0,1,N-terminal peptidyl-alanine methylation,BP,
5881,GO:0018012,0.999999999972786,0.919544554109259,0,1,N-terminal peptidyl-alanine trimethylation,BP,
5882,GO:0018013,0.999999999972786,0.919544554109259,0,1,N-terminal peptidyl-glycine methylation,BP,
5883,GO:0018016,0.999999999972786,0.919544554109259,0,1,N-terminal peptidyl-proline dimethylation,BP,
5887,GO:0018025,0.999999999972786,0.919544554109259,0,1,calmodulin-lysine N-methyltransferase activity,MF,
5919,GO:0018194,0.999999999972786,0.919544554109259,0,1,peptidyl-alanine modification,BP,
6192,GO:0019659,0.999999999972786,0.919544554109259,0,1,glucose catabolic process to lactate,BP,
6193,GO:0019660,0.999999999972786,0.919544554109259,0,1,glycolytic fermentation,BP,
6194,GO:0019661,0.999999999972786,0.919544554109259,0,1,glucose catabolic process to lactate via pyruvate,BP,
6195,GO:0019666,0.999999999972786,0.919544554109259,0,1,nitrogenous compound fermentation,BP,
6240,GO:0019799,0.999999999972786,0.919544554109259,0,1,tubulin N-acetyltransferase activity,MF,
6325,GO:0020003,0.999999999972786,0.919544554109259,0,1,symbiont-containing vacuole,CC,
6813,GO:0030264,0.999999999972786,0.919544554109259,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
6902,GO:0030474,0.999999999972786,0.919544554109259,0,1,spindle pole body duplication,BP,
6974,GO:0030629,0.999999999972786,0.919544554109259,0,1,U6 snRNA 3'-end binding,MF,
7020,GO:0030735,0.999999999972786,0.919544554109259,0,1,carnosine N-methyltransferase activity,MF,
7134,GO:0030961,0.999999999972786,0.919544554109259,0,1,peptidyl-arginine hydroxylation,BP,
7664,GO:0032093,0.999999999972786,0.919544554109259,0,1,SAM domain binding,MF,
7744,GO:0032253,0.999999999972786,0.919544554109259,0,1,dense core granule localization,BP,
8269,GO:0033058,0.999999999972786,0.919544554109259,0,1,directional locomotion,BP,
8471,GO:0033609,0.999999999972786,0.919544554109259,0,1,oxalate metabolic process,BP,
8562,GO:0034012,0.999999999972786,0.919544554109259,0,1,FAD-AMP lyase (cyclizing) activity,MF,
8712,GO:0034353,0.999999999972786,0.919544554109259,0,1,RNA pyrophosphohydrolase activity,MF,
8794,GO:0034477,0.999999999972786,0.919544554109259,0,1,U6 snRNA 3'-end processing,BP,
8808,GO:0034512,0.999999999972786,0.919544554109259,0,1,box C/D snoRNA binding,MF,
8952,GO:0034998,0.999999999972786,0.919544554109259,0,1,oligosaccharyltransferase I complex,CC,
9149,GO:0035498,0.999999999972786,0.919544554109259,0,1,carnosine metabolic process,BP,
9189,GO:0035568,0.999999999972786,0.919544554109259,0,1,N-terminal peptidyl-proline methylation,BP,
9190,GO:0035570,0.999999999972786,0.919544554109259,0,1,N-terminal peptidyl-serine methylation,BP,
9191,GO:0035572,0.999999999972786,0.919544554109259,0,1,N-terminal peptidyl-serine dimethylation,BP,
9192,GO:0035573,0.999999999972786,0.919544554109259,0,1,N-terminal peptidyl-serine trimethylation,BP,
9203,GO:0035585,0.999999999972786,0.919544554109259,0,1,calcium-mediated signaling using extracellular calcium source,BP,
9556,GO:0036317,0.999999999972786,0.919544554109259,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
9722,GO:0038161,0.999999999972786,0.919544554109259,0,1,prolactin signaling pathway,BP,
9878,GO:0042140,0.999999999972786,0.919544554109259,0,1,late meiotic recombination nodule assembly,BP,
10183,GO:0042774,0.999999999972786,0.919544554109259,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10201,GO:0042806,0.999999999972786,0.919544554109259,0,1,fucose binding,MF,
10238,GO:0042946,0.999999999972786,0.919544554109259,0,1,glucoside transport,BP,
10239,GO:0042947,0.999999999972786,0.919544554109259,0,1,glucoside transmembrane transporter activity,MF,
10529,GO:0043465,0.999999999972786,0.919544554109259,0,1,regulation of fermentation,BP,
10835,GO:0044328,0.999999999972786,0.919544554109259,0,1,canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration,BP,
10836,GO:0044329,0.999999999972786,0.919544554109259,0,1,canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion,BP,
10837,GO:0044330,0.999999999972786,0.919544554109259,0,1,canonical Wnt signaling pathway involved in positive regulation of wound healing,BP,
10941,GO:0044599,0.999999999972786,0.919544554109259,0,1,AP-5 adaptor complex,CC,
10952,GO:0044648,0.999999999972786,0.919544554109259,0,1,histone H3-K4 dimethylation,BP,
10970,GO:0044732,0.999999999972786,0.919544554109259,0,1,mitotic spindle pole body,CC,
10971,GO:0044736,0.999999999972786,0.919544554109259,0,1,acid-sensing ion channel activity,MF,
11596,GO:0046176,0.999999999972786,0.919544554109259,0,1,aldonic acid catabolic process,BP,
11597,GO:0046177,0.999999999972786,0.919544554109259,0,1,D-gluconate catabolic process,BP,
11615,GO:0046316,0.999999999972786,0.919544554109259,0,1,gluconokinase activity,MF,
11831,GO:0046745,0.999999999972786,0.919544554109259,0,1,viral capsid secondary envelopment,BP,
11941,GO:0046996,0.999999999972786,0.919544554109259,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
11946,GO:0047017,0.999999999972786,0.919544554109259,0,1,prostaglandin-F synthase activity,MF,
12035,GO:0047734,0.999999999972786,0.919544554109259,0,1,CDP-glycerol diphosphatase activity,MF,
12437,GO:0050046,0.999999999972786,0.919544554109259,0,1,lathosterol oxidase activity,MF,
12446,GO:0050144,0.999999999972786,0.919544554109259,0,1,nucleoside deoxyribosyltransferase activity,MF,
12470,GO:0050346,0.999999999972786,0.919544554109259,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
12473,GO:0050354,0.999999999972786,0.919544554109259,0,1,triokinase activity,MF,
12697,GO:0050915,0.999999999972786,0.919544554109259,0,1,sensory perception of sour taste,BP,
12941,GO:0051300,0.999999999972786,0.919544554109259,0,1,spindle pole body organization,BP,
12949,GO:0051308,0.999999999972786,0.919544554109259,0,1,male meiosis chromosome separation,BP,
12999,GO:0051417,0.999999999972786,0.919544554109259,0,1,microtubule nucleation by spindle pole body,BP,
13020,GO:0051455,0.999999999972786,0.919544554109259,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13131,GO:0051685,0.999999999972786,0.919544554109259,0,1,maintenance of ER location,BP,
13458,GO:0052907,0.999999999972786,0.919544554109259,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
13459,GO:0052909,0.999999999972786,0.919544554109259,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
13753,GO:0060327,0.999999999972786,0.919544554109259,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
13946,GO:0060620,0.999999999972786,0.919544554109259,0,1,regulation of cholesterol import,BP,
14078,GO:0060887,0.999999999972786,0.919544554109259,0,1,limb epidermis development,BP,
14087,GO:0060912,0.999999999972786,0.919544554109259,0,1,cardiac cell fate specification,BP,
14174,GO:0061056,0.999999999972786,0.919544554109259,0,1,sclerotome development,BP,
14224,GO:0061163,0.999999999972786,0.919544554109259,0,1,endoplasmic reticulum polarization,BP,
14296,GO:0061400,0.999999999972786,0.919544554109259,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
14325,GO:0061495,0.999999999972786,0.919544554109259,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
14359,GO:0061573,0.999999999972786,0.919544554109259,0,1,actin filament bundle retrograde transport,BP,
14410,GO:0061685,0.999999999972786,0.919544554109259,0,1,diphthine methylesterase activity,MF,
14518,GO:0065010,0.999999999972786,0.919544554109259,0,1,extracellular membrane-bounded organelle,CC,
14521,GO:0070004,0.999999999972786,0.919544554109259,0,1,cysteine-type exopeptidase activity,MF,
14589,GO:0070130,0.999999999972786,0.919544554109259,0,1,negative regulation of mitochondrial translation,BP,
14606,GO:0070165,0.999999999972786,0.919544554109259,0,1,positive regulation of adiponectin secretion,BP,
14663,GO:0070260,0.999999999972786,0.919544554109259,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
14819,GO:0070551,0.999999999972786,0.919544554109259,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
14821,GO:0070553,0.999999999972786,0.919544554109259,0,1,nicotinic acid receptor activity,MF,
14824,GO:0070560,0.999999999972786,0.919544554109259,0,1,protein secretion by platelet,BP,
14836,GO:0070573,0.999999999972786,0.919544554109259,0,1,metallodipeptidase activity,MF,
14861,GO:0070631,0.999999999972786,0.919544554109259,0,1,spindle pole body localization,BP,
14862,GO:0070632,0.999999999972786,0.919544554109259,0,1,establishment of spindle pole body localization,BP,
14873,GO:0070650,0.999999999972786,0.919544554109259,0,1,actin filament bundle distribution,BP,
14895,GO:0070694,0.999999999972786,0.919544554109259,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
14919,GO:0070762,0.999999999972786,0.919544554109259,0,1,nuclear pore transmembrane ring,CC,
15257,GO:0071424,0.999999999972786,0.919544554109259,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
15458,GO:0071789,0.999999999972786,0.919544554109259,0,1,spindle pole body localization to nuclear envelope,BP,
15459,GO:0071790,0.999999999972786,0.919544554109259,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
15511,GO:0071885,0.999999999972786,0.919544554109259,0,1,N-terminal protein N-methyltransferase activity,MF,
15935,GO:0072720,0.999999999972786,0.919544554109259,0,1,response to dithiothreitol,BP,
16021,GO:0086038,0.999999999972786,0.919544554109259,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
16352,GO:0090624,0.999999999972786,0.919544554109259,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
16353,GO:0090625,0.999999999972786,0.919544554109259,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
16665,GO:0097541,0.999999999972786,0.919544554109259,0,1,axonemal basal plate,CC,
16687,GO:0097630,0.999999999972786,0.919544554109259,0,1,intrinsic component of omegasome membrane,CC,
16688,GO:0097631,0.999999999972786,0.919544554109259,0,1,integral component of omegasome membrane,CC,
16721,GO:0097712,0.999999999972786,0.919544554109259,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
16831,GO:0098725,0.999999999972786,0.919544554109259,0,1,symmetric cell division,BP,
17044,GO:0099519,0.999999999972786,0.919544554109259,0,1,dense core granule cytoskeletal transport,BP,
17093,GO:0099627,0.999999999972786,0.919544554109259,0,1,neurotransmitter receptor cycle,BP,
17095,GO:0099630,0.999999999972786,0.919544554109259,0,1,postsynaptic neurotransmitter receptor cycle,BP,
17160,GO:0102524,0.999999999972786,0.919544554109259,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
17261,GO:0120048,0.999999999972786,0.919544554109259,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
17262,GO:0120049,0.999999999972786,0.919544554109259,0,1,snRNA (adenine-N6)-methylation,BP,
17412,GO:1900148,0.999999999972786,0.919544554109259,0,1,negative regulation of Schwann cell migration,BP,
17423,GO:1900170,0.999999999972786,0.919544554109259,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
17523,GO:1901003,0.999999999972786,0.919544554109259,0,1,negative regulation of fermentation,BP,
17622,GO:1901318,0.999999999972786,0.919544554109259,0,1,negative regulation of flagellated sperm motility,BP,
17666,GO:1901523,0.999999999972786,0.919544554109259,0,1,icosanoid catabolic process,BP,
17814,GO:1901950,0.999999999972786,0.919544554109259,0,1,dense core granule transport,BP,
17881,GO:1902145,0.999999999972786,0.919544554109259,0,1,regulation of response to cell cycle checkpoint signaling,BP,
17882,GO:1902151,0.999999999972786,0.919544554109259,0,1,regulation of response to DNA integrity checkpoint signaling,BP,
17883,GO:1902153,0.999999999972786,0.919544554109259,0,1,regulation of response to DNA damage checkpoint signaling,BP,
17903,GO:1902211,0.999999999972786,0.919544554109259,0,1,regulation of prolactin signaling pathway,BP,
17904,GO:1902213,0.999999999972786,0.919544554109259,0,1,positive regulation of prolactin signaling pathway,BP,
17979,GO:1902387,0.999999999972786,0.919544554109259,0,1,ceramide 1-phosphate binding,MF,
17980,GO:1902388,0.999999999972786,0.919544554109259,0,1,ceramide 1-phosphate transporter activity,MF,
17981,GO:1902389,0.999999999972786,0.919544554109259,0,1,ceramide 1-phosphate transport,BP,
18085,GO:1902688,0.999999999972786,0.919544554109259,0,1,regulation of NAD metabolic process,BP,
18086,GO:1902689,0.999999999972786,0.919544554109259,0,1,negative regulation of NAD metabolic process,BP,
18163,GO:1902912,0.999999999972786,0.919544554109259,0,1,pyruvate kinase complex,CC,
18174,GO:1902939,0.999999999972786,0.919544554109259,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
18321,GO:1903259,0.999999999972786,0.919544554109259,0,1,exon-exon junction complex disassembly,BP,
18678,GO:1904023,0.999999999972786,0.919544554109259,0,1,regulation of glucose catabolic process to lactate via pyruvate,BP,
18679,GO:1904024,0.999999999972786,0.919544554109259,0,1,negative regulation of glucose catabolic process to lactate via pyruvate,BP,
18682,GO:1904028,0.999999999972786,0.919544554109259,0,1,positive regulation of collagen fibril organization,BP,
18949,GO:1904713,0.999999999972786,0.919544554109259,0,1,beta-catenin destruction complex binding,MF,
18983,GO:1904777,0.999999999972786,0.919544554109259,0,1,negative regulation of protein localization to cell cortex,BP,
18999,GO:1904806,0.999999999972786,0.919544554109259,0,1,regulation of protein oxidation,BP,
19000,GO:1904808,0.999999999972786,0.919544554109259,0,1,positive regulation of protein oxidation,BP,
19112,GO:1905044,0.999999999972786,0.919544554109259,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
19113,GO:1905045,0.999999999972786,0.919544554109259,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
19194,GO:1905279,0.999999999972786,0.919544554109259,0,1,regulation of retrograde transport, endosome to Golgi,BP,
19210,GO:1905319,0.999999999972786,0.919544554109259,0,1,mesenchymal stem cell migration,BP,
19211,GO:1905320,0.999999999972786,0.919544554109259,0,1,regulation of mesenchymal stem cell migration,BP,
19212,GO:1905322,0.999999999972786,0.919544554109259,0,1,positive regulation of mesenchymal stem cell migration,BP,
19223,GO:1905344,0.999999999972786,0.919544554109259,0,1,prostaglandin catabolic process,BP,
19257,GO:1905435,0.999999999972786,0.919544554109259,0,1,regulation of histone H3-K4 trimethylation,BP,
19258,GO:1905437,0.999999999972786,0.919544554109259,0,1,positive regulation of histone H3-K4 trimethylation,BP,
19328,GO:1905642,0.999999999972786,0.919544554109259,0,1,negative regulation of DNA methylation,BP,
19434,GO:1990048,0.999999999972786,0.919544554109259,0,1,anterograde neuronal dense core vesicle transport,BP,
19488,GO:1990261,0.999999999972786,0.919544554109259,0,1,pre-mRNA catabolic process,BP,
19560,GO:1990570,0.999999999972786,0.919544554109259,0,1,GDP-mannose transmembrane transport,BP,
19602,GO:1990738,0.999999999972786,0.919544554109259,0,1,pseudouridine 5'-phosphatase activity,MF,
19683,GO:2000003,0.999999999972786,0.919544554109259,0,1,positive regulation of DNA damage checkpoint,BP,
20073,GO:2000722,0.999999999972786,0.919544554109259,0,1,regulation of cardiac vascular smooth muscle cell differentiation,BP,
20074,GO:2000724,0.999999999972786,0.919544554109259,0,1,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
20158,GO:2000909,0.999999999972786,0.919544554109259,0,1,regulation of sterol import,BP,
5536,GO:0016520,0.999999999972791,0.899633872805781,0,1,growth hormone-releasing hormone receptor activity,MF,
4986,GO:0015112,0.999999999972795,0.922781024826548,0,1,nitrate transmembrane transporter activity,MF,
5164,GO:0015706,0.999999999972795,0.922781024826548,0,1,nitrate transport,BP,
10207,GO:0042822,0.999999999972799,0.749071900434405,0,3,pyridoxal phosphate metabolic process,BP,
14083,GO:0060903,0.999999999972803,0.837456266880214,0,2,positive regulation of meiosis I,BP,
4309,GO:0009786,0.999999999972805,0.811251956105951,0,2,regulation of asymmetric cell division,BP,
13710,GO:0060267,0.999999999972809,0.772296927083253,0,3,positive regulation of respiratory burst,BP,
17470,GO:1900275,0.999999999972813,0.813933542662706,0,2,negative regulation of phospholipase C activity,BP,
13846,GO:0060447,0.999999999972815,0.880409372356673,0,1,bud outgrowth involved in lung branching,BP,
14017,GO:0060739,0.999999999972815,0.880409372356673,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14447,GO:0061763,0.999999999972824,0.848840885245709,0,2,multivesicular body-lysosome fusion,BP,
1554,GO:0003953,0.99999999997283,0.939264194536935,0,1,NAD+ nucleosidase activity,MF,
12444,GO:0050135,0.99999999997283,0.939264194536935,0,1,NAD(P)+ nucleosidase activity,MF,
14461,GO:0061809,0.99999999997283,0.939264194536935,0,1,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
14797,GO:0070510,0.999999999972838,0.883284917527086,0,1,regulation of histone H4-K20 methylation,BP,
14798,GO:0070512,0.999999999972838,0.883284917527086,0,1,positive regulation of histone H4-K20 methylation,BP,
14962,GO:0070856,0.999999999972844,0.889559718682367,0,1,myosin VI light chain binding,MF,
6526,GO:0021914,0.999999999972855,0.837090027115993,0,2,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
2266,GO:0005184,0.999999999972878,0.831240075371637,0,3,neuropeptide hormone activity,MF,
18187,GO:1902956,0.999999999972886,0.801545590151253,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
4692,GO:0010845,0.999999999972892,0.923076079633206,0,1,positive regulation of reciprocal meiotic recombination,BP,
11952,GO:0047045,0.999999999972911,0.943374742421176,0,1,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
11907,GO:0046935,0.999999999972933,0.721483886060465,0,3,1-phosphatidylinositol-3-kinase regulator activity,MF,
916,GO:0002309,0.999999999972942,0.950420711214467,0,1,T cell proliferation involved in immune response,BP,
1357,GO:0003228,0.999999999972964,0.79388637010453,0,3,atrial cardiac muscle tissue development,BP,
13474,GO:0055009,0.999999999972964,0.79388637010453,0,3,atrial cardiac muscle tissue morphogenesis,BP,
20004,GO:2000616,0.999999999972966,0.835624700487143,0,2,negative regulation of histone H3-K9 acetylation,BP,
2164,GO:0004999,0.999999999972969,0.920830851984717,0,1,vasoactive intestinal polypeptide receptor activity,MF,
8781,GO:0034458,0.999999999972971,0.831974180568986,0,2,3'-5' RNA helicase activity,MF,
18917,GO:1904631,0.999999999972995,0.928341652073706,0,1,response to glucoside,BP,
18723,GO:1904170,0.999999999972997,0.898104483103861,0,1,regulation of bleb assembly,BP,
18724,GO:1904172,0.999999999972997,0.898104483103861,0,1,positive regulation of bleb assembly,BP,
7062,GO:0030849,0.99999999997302,0.895507919718311,0,1,autosome,CC,
3787,GO:0008352,0.999999999973034,0.922673701337191,0,1,katanin complex,CC,
12049,GO:0047894,0.999999999973049,0.8816693659198,0,2,flavonol 3-sulfotransferase activity,MF,
4490,GO:0010512,0.999999999973062,0.847242920114468,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
9318,GO:0035788,0.999999999973062,0.847242920114468,0,2,cell migration involved in metanephros development,BP,
9319,GO:0035789,0.999999999973062,0.847242920114468,0,2,metanephric mesenchymal cell migration,BP,
9322,GO:0035793,0.999999999973062,0.847242920114468,0,2,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
17452,GO:1900238,0.999999999973062,0.847242920114468,0,2,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
19993,GO:2000589,0.999999999973062,0.847242920114468,0,2,regulation of metanephric mesenchymal cell migration,BP,
19994,GO:2000591,0.999999999973062,0.847242920114468,0,2,positive regulation of metanephric mesenchymal cell migration,BP,
18597,GO:1903860,0.999999999973071,0.83844024363112,0,2,negative regulation of dendrite extension,BP,
19764,GO:2000172,0.999999999973071,0.83844024363112,0,2,regulation of branching morphogenesis of a nerve,BP,
19403,GO:1905936,0.999999999973084,0.899314040353349,0,2,regulation of germ cell proliferation,BP,
19805,GO:2000254,0.999999999973084,0.899314040353349,0,2,regulation of male germ cell proliferation,BP,
15049,GO:0070993,0.999999999973089,0.81369569881687,0,2,translation preinitiation complex,CC,
13007,GO:0051433,0.999999999973135,0.900048248060807,0,1,BH2 domain binding,MF,
9496,GO:0036138,0.999999999973155,0.884560580457003,0,1,peptidyl-histidine hydroxylation,BP,
9497,GO:0036139,0.999999999973155,0.884560580457003,0,1,peptidyl-histidine dioxygenase activity,MF,
9498,GO:0036140,0.999999999973155,0.884560580457003,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
9920,GO:0042265,0.999999999973155,0.884560580457003,0,1,peptidyl-asparagine hydroxylation,BP,
17125,GO:0102113,0.999999999973155,0.884560580457003,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
20248,GO:2001200,0.999999999973157,0.85921990524312,0,2,positive regulation of dendritic cell differentiation,BP,
13042,GO:0051499,0.999999999973159,0.865580826809103,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13043,GO:0051500,0.999999999973159,0.865580826809103,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
9805,GO:0040032,0.999999999973174,0.933222495185822,0,1,post-embryonic body morphogenesis,BP,
3618,GO:0008065,0.999999999973182,0.825203419852757,0,2,establishment of blood-nerve barrier,BP,
9211,GO:0035596,0.999999999973216,0.85151228846028,0,2,methylthiotransferase activity,MF,
9214,GO:0035600,0.999999999973216,0.85151228846028,0,2,tRNA methylthiolation,BP,
12490,GO:0050497,0.999999999973216,0.85151228846028,0,2,transferase activity, transferring alkylthio groups,MF,
10439,GO:0043293,0.999999999973235,0.826256241852363,0,2,apoptosome,CC,
4448,GO:0010370,0.999999999973235,0.845086547445896,0,2,perinucleolar chromocenter,CC,
14142,GO:0061010,0.999999999973249,0.866307619879347,0,1,gall bladder development,BP,
14455,GO:0061780,0.999999999973249,0.866307619879347,0,1,mitotic cohesin loading,BP,
14818,GO:0070550,0.999999999973249,0.866307619879347,0,1,rDNA condensation,BP,
19204,GO:1905309,0.999999999973249,0.866307619879347,0,1,positive regulation of cohesin loading,BP,
19247,GO:1905405,0.999999999973249,0.866307619879347,0,1,regulation of mitotic cohesin loading,BP,
19248,GO:1905406,0.999999999973249,0.866307619879347,0,1,positive regulation of mitotic cohesin loading,BP,
4591,GO:0010698,0.99999999997326,0.869340427532172,0,2,acetyltransferase activator activity,MF,
4360,GO:0009956,0.999999999973282,0.906358015637556,0,1,radial pattern formation,BP,
14069,GO:0060849,0.999999999973282,0.906358015637556,0,1,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
302,GO:0000811,0.999999999973286,0.783173760316571,0,3,GINS complex,CC,
5991,GO:0018963,0.999999999973293,0.860756079769317,0,2,phthalate metabolic process,BP,
10225,GO:0042903,0.999999999973325,0.842965199477086,0,2,tubulin deacetylase activity,MF,
18228,GO:1903031,0.999999999973328,0.861806060221487,0,2,regulation of microtubule plus-end binding,BP,
18229,GO:1903033,0.999999999973328,0.861806060221487,0,2,positive regulation of microtubule plus-end binding,BP,
15315,GO:0071505,0.999999999973329,0.842737903386848,0,2,response to mycophenolic acid,BP,
15316,GO:0071506,0.999999999973329,0.842737903386848,0,2,cellular response to mycophenolic acid,BP,
674,GO:0001884,0.99999999997334,0.82477273355036,0,2,pyrimidine nucleoside binding,MF,
835,GO:0002134,0.99999999997334,0.82477273355036,0,2,UTP binding,MF,
7952,GO:0032551,0.99999999997334,0.82477273355036,0,2,pyrimidine ribonucleoside binding,MF,
9638,GO:0036506,0.999999999973372,0.75159261368597,0,3,maintenance of unfolded protein,BP,
18811,GO:1904378,0.999999999973372,0.75159261368597,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
10777,GO:0044228,0.999999999973388,0.898495662607312,0,1,host cell surface,CC,
17682,GO:1901555,0.999999999973421,0.884358709732682,0,1,response to paclitaxel,BP,
19344,GO:1905705,0.999999999973421,0.884358709732682,0,1,cellular response to paclitaxel,BP,
16219,GO:0090259,0.999999999973437,0.75570476441972,0,3,regulation of retinal ganglion cell axon guidance,BP,
2768,GO:0006185,0.999999999973448,0.947629913939389,0,1,dGDP biosynthetic process,BP,
4115,GO:0009170,0.999999999973448,0.947629913939389,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4124,GO:0009183,0.999999999973448,0.947629913939389,0,1,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
11531,GO:0046054,0.999999999973448,0.947629913939389,0,1,dGMP metabolic process,BP,
11818,GO:0046711,0.999999999973448,0.947629913939389,0,1,GDP biosynthetic process,BP,
6913,GO:0030504,0.999999999973449,0.877007697482762,0,1,inorganic diphosphate transmembrane transporter activity,MF,
11337,GO:0045660,0.999999999973464,0.931797161832586,0,1,positive regulation of neutrophil differentiation,BP,
18786,GO:1904304,0.999999999973467,0.859296974459588,0,2,regulation of gastro-intestinal system smooth muscle contraction,BP,
18787,GO:1904306,0.999999999973467,0.859296974459588,0,2,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
6447,GO:0021763,0.999999999973472,0.928416861659981,0,1,subthalamic nucleus development,BP,
13632,GO:0060127,0.999999999973472,0.928416861659981,0,1,prolactin secreting cell differentiation,BP,
13855,GO:0060459,0.999999999973472,0.928416861659981,0,1,left lung development,BP,
13856,GO:0060460,0.999999999973472,0.928416861659981,0,1,left lung morphogenesis,BP,
13920,GO:0060577,0.999999999973472,0.928416861659981,0,1,pulmonary vein morphogenesis,BP,
13921,GO:0060578,0.999999999973472,0.928416861659981,0,1,superior vena cava morphogenesis,BP,
9961,GO:0042335,0.999999999973497,0.735830808949852,0,3,cuticle development,BP,
741,GO:0001971,0.999999999973498,0.880133952459412,0,1,negative regulation of activation of membrane attack complex,BP,
14748,GO:0070418,0.9999999999735,0.895296212288653,0,1,DNA-dependent protein kinase complex,CC,
16790,GO:0098625,0.999999999973511,0.907637292510651,0,1,methylselenol reductase activity,MF,
16791,GO:0098626,0.999999999973511,0.907637292510651,0,1,methylseleninic acid reductase activity,MF,
3207,GO:0006843,0.999999999973515,0.937556008186121,0,1,mitochondrial citrate transmembrane transport,BP,
16083,GO:0090044,0.999999999973515,0.937556008186121,0,1,positive regulation of tubulin deacetylation,BP,
19556,GO:1990546,0.999999999973515,0.937556008186121,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
1500,GO:0003846,0.999999999973532,0.840906049977929,0,2,2-acylglycerol O-acyltransferase activity,MF,
1679,GO:0004144,0.999999999973532,0.840906049977929,0,2,diacylglycerol O-acyltransferase activity,MF,
12456,GO:0050252,0.999999999973532,0.840906049977929,0,2,retinol O-fatty-acyltransferase activity,MF,
9664,GO:0038021,0.999999999973536,0.902644680371104,0,1,leptin receptor activity,MF,
17198,GO:0106020,0.999999999973552,0.841112937072807,0,2,regulation of vesicle docking,BP,
8974,GO:0035063,0.999999999973578,0.908966108272505,0,1,nuclear speck organization,BP,
1729,GO:0004324,0.999999999973588,0.933142952281575,0,1,ferredoxin-NADP+ reductase activity,MF,
4964,GO:0015039,0.999999999973588,0.933142952281575,0,1,NADPH-adrenodoxin reductase activity,MF,
5644,GO:0016730,0.999999999973588,0.933142952281575,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
5645,GO:0016731,0.999999999973588,0.933142952281575,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
16772,GO:0098575,0.999999999973597,0.864375015553499,0,2,lumenal side of lysosomal membrane,CC,
5527,GO:0016503,0.99999999997361,0.942283924436384,0,1,pheromone receptor activity,MF,
11738,GO:0046554,0.99999999997361,0.942283924436384,0,1,malate dehydrogenase (NADP+) activity,MF,
10600,GO:0043569,0.999999999973612,0.739159947453498,0,3,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
9471,GO:0036090,0.999999999973619,0.867585475763337,0,2,cleavage furrow ingression,BP,
19596,GO:1990723,0.999999999973628,0.787454698759218,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
15847,GO:0072558,0.999999999973629,0.802340625346638,0,3,NLRP1 inflammasome complex,CC,
4327,GO:0009841,0.99999999997363,0.926731212588973,0,1,mitochondrial endopeptidase Clp complex,CC,
15712,GO:0072262,0.999999999973633,0.841181342293461,0,2,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
15730,GO:0072301,0.999999999973633,0.841181342293461,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
17621,GO:1901317,0.999999999973636,0.803881840372073,0,3,regulation of flagellated sperm motility,BP,
11157,GO:0045213,0.999999999973638,0.868579420598037,0,2,neurotransmitter receptor metabolic process,BP,
12205,GO:0048382,0.999999999973664,0.835066296744581,0,2,mesendoderm development,BP,
9104,GO:0035373,0.999999999973682,0.754443389446833,0,2,chondroitin sulfate proteoglycan binding,MF,
6832,GO:0030294,0.999999999973685,0.928779905335621,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
11979,GO:0047275,0.999999999973707,0.91083555688379,0,1,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
1804,GO:0004449,0.999999999973712,0.811982457803288,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
3860,GO:0008478,0.999999999973716,0.881778394524428,0,1,pyridoxal kinase activity,MF,
4244,GO:0009443,0.999999999973716,0.881778394524428,0,1,pyridoxal 5'-phosphate salvage,BP,
8545,GO:0033872,0.999999999973717,0.931274023564242,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
12785,GO:0051066,0.99999999997372,0.873432634292482,0,2,dihydrobiopterin metabolic process,BP,
8399,GO:0033326,0.999999999973734,0.897088387989362,0,1,cerebrospinal fluid secretion,BP,
10392,GO:0043221,0.999999999973749,0.906883150120544,0,1,SMC family protein binding,MF,
1136,GO:0002728,0.999999999973759,0.900766086068701,0,1,negative regulation of natural killer cell cytokine production,BP,
19679,GO:1990983,0.999999999973791,0.923679376402396,0,1,tRNA demethylation,BP,
19680,GO:1990984,0.999999999973791,0.923679376402396,0,1,tRNA demethylase activity,MF,
3927,GO:0008607,0.999999999973848,0.786310915098262,0,3,phosphorylase kinase regulator activity,MF,
7392,GO:0031444,0.999999999973854,0.947319529379386,0,1,slow-twitch skeletal muscle fiber contraction,BP,
18973,GO:1904753,0.999999999973861,0.781687432340991,0,3,negative regulation of vascular associated smooth muscle cell migration,BP,
6515,GO:0021892,0.999999999973873,0.81446921835189,0,3,cerebral cortex GABAergic interneuron differentiation,BP,
14735,GO:0070401,0.999999999973875,0.869524512103205,0,2,NADP+ binding,MF,
6969,GO:0030623,0.99999999997388,0.882094491881319,0,1,U5 snRNA binding,MF,
1651,GO:0004103,0.999999999973886,0.864176734758123,0,2,choline kinase activity,MF,
1719,GO:0004311,0.999999999973908,0.786204441600025,0,3,farnesyltranstransferase activity,MF,
176,GO:0000384,0.99999999997399,0.877808369801266,0,2,first spliceosomal transesterification activity,MF,
4456,GO:0010428,0.99999999997399,0.89067436037389,0,1,methyl-CpNpG binding,MF,
13194,GO:0051800,0.999999999974013,0.892854777465635,0,1,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
20122,GO:2000808,0.999999999974013,0.892854777465635,0,1,negative regulation of synaptic vesicle clustering,BP,
9320,GO:0035790,0.999999999974017,0.907128656972582,0,1,platelet-derived growth factor receptor-alpha signaling pathway,BP,
19988,GO:2000583,0.999999999974017,0.907128656972582,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
19989,GO:2000584,0.999999999974017,0.907128656972582,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
9282,GO:0035718,0.999999999974036,0.885032320899752,0,2,macrophage migration inhibitory factor binding,MF,
312,GO:0000823,0.999999999974056,0.934663536645769,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
313,GO:0000824,0.999999999974056,0.934663536645769,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
314,GO:0000825,0.999999999974056,0.934663536645769,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
11990,GO:0047326,0.999999999974056,0.934663536645769,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
2687,GO:0006049,0.999999999974061,0.919164317260597,0,1,UDP-N-acetylglucosamine catabolic process,BP,
16317,GO:0090498,0.999999999974072,0.823166573992975,0,2,extrinsic component of Golgi membrane,CC,
19485,GO:1990256,0.999999999974073,0.85765037779731,0,1,signal clustering,BP,
18267,GO:1903126,0.999999999974081,0.929820935335807,0,1,negative regulation of centriole-centriole cohesion,BP,
20231,GO:2001173,0.999999999974081,0.929820935335807,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
15449,GO:0071733,0.999999999974112,0.744271999062482,0,3,transcriptional activation by promoter-enhancer looping,BP,
16184,GO:0090202,0.999999999974112,0.744271999062482,0,3,gene looping,BP,
16343,GO:0090579,0.999999999974112,0.744271999062482,0,3,dsDNA loop formation,BP,
5216,GO:0015817,0.999999999974115,0.920911834243149,0,1,histidine transport,BP,
7531,GO:0031753,0.999999999974115,0.920911834243149,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
7532,GO:0031755,0.999999999974115,0.920911834243149,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
4906,GO:0014839,0.999999999974134,0.878432134096657,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
4614,GO:0010731,0.999999999974147,0.926981517665034,0,1,protein glutathionylation,BP,
4615,GO:0010732,0.999999999974147,0.926981517665034,0,1,regulation of protein glutathionylation,BP,
4616,GO:0010734,0.999999999974147,0.926981517665034,0,1,negative regulation of protein glutathionylation,BP,
10632,GO:0043629,0.999999999974149,0.877951923983758,0,1,ncRNA polyadenylation,BP,
10633,GO:0043630,0.999999999974149,0.877951923983758,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
14566,GO:0070094,0.999999999974182,0.923706187273035,0,1,positive regulation of glucagon secretion,BP,
19269,GO:1905458,0.999999999974205,0.905641432412277,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
19766,GO:2000174,0.999999999974205,0.905641432412277,0,1,regulation of pro-T cell differentiation,BP,
19767,GO:2000176,0.999999999974205,0.905641432412277,0,1,positive regulation of pro-T cell differentiation,BP,
1634,GO:0004077,0.999999999974231,0.889975395358691,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1635,GO:0004078,0.999999999974231,0.889975395358691,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1636,GO:0004079,0.999999999974231,0.889975395358691,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1637,GO:0004080,0.999999999974231,0.889975395358691,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
4198,GO:0009305,0.999999999974231,0.889975395358691,0,1,protein biotinylation,BP,
5943,GO:0018271,0.999999999974231,0.889975395358691,0,1,biotin-protein ligase activity,MF,
14930,GO:0070781,0.999999999974231,0.889975395358691,0,1,response to biotin,BP,
15099,GO:0071110,0.999999999974231,0.889975395358691,0,1,histone biotinylation,BP,
6941,GO:0030549,0.999999999974271,0.944907070151662,0,1,acetylcholine receptor activator activity,MF,
452,GO:0001225,0.99999999997428,0.783549022659774,0,2,RNA polymerase II transcription coactivator binding,MF,
16029,GO:0086047,0.999999999974283,0.904575338567814,0,1,membrane depolarization during Purkinje myocyte cell action potential,BP,
18733,GO:1904199,0.999999999974283,0.904575338567814,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
19600,GO:1990736,0.999999999974283,0.904575338567814,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
5061,GO:0015272,0.999999999974291,0.917029964752734,0,1,ATP-activated inward rectifier potassium channel activity,MF,
8573,GO:0034039,0.999999999974295,0.871268642255953,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
1692,GO:0004167,0.999999999974327,0.911075861603105,0,2,dopachrome isomerase activity,MF,
5723,GO:0016862,0.999999999974327,0.911075861603105,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
12450,GO:0050178,0.999999999974327,0.911075861603105,0,2,phenylpyruvate tautomerase activity,MF,
4403,GO:0010139,0.999999999974339,0.937354985339436,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4409,GO:0010164,0.999999999974339,0.937354985339436,0,1,response to cesium ion,BP,
6869,GO:0030343,0.999999999974339,0.937354985339436,0,1,vitamin D3 25-hydroxylase activity,MF,
14868,GO:0070643,0.999999999974339,0.937354985339436,0,1,vitamin D 25-hydroxylase activity,MF,
461,GO:0001401,0.999999999974345,0.854653680258913,0,2,mitochondrial sorting and assembly machinery complex,CC,
3057,GO:0006617,0.999999999974346,0.881376328306331,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
15793,GO:0072414,0.999999999974346,0.88360076327693,0,1,response to mitotic cell cycle checkpoint signaling,BP,
15800,GO:0072432,0.999999999974346,0.88360076327693,0,1,response to G1 DNA damage checkpoint signaling,BP,
16788,GO:0098619,0.999999999974358,0.933099604258002,0,1,selenocysteine-tRNA ligase activity,MF,
3722,GO:0008240,0.999999999974427,0.818444349061882,0,2,tripeptidyl-peptidase activity,MF,
11746,GO:0046586,0.999999999974428,0.871215532888752,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
7212,GO:0031104,0.99999999997443,0.904379620418369,0,1,dendrite regeneration,BP,
18989,GO:1904784,0.999999999974446,0.893227285657084,0,1,NLRP1 inflammasome complex assembly,BP,
14537,GO:0070042,0.999999999974448,0.917600719228622,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
3923,GO:0008594,0.999999999974458,0.818822492125014,0,2,photoreceptor cell morphogenesis,BP,
13708,GO:0060265,0.999999999974474,0.950104020983229,0,1,positive regulation of respiratory burst involved in inflammatory response,BP,
9634,GO:0036501,0.999999999974484,0.901437223818501,0,1,UFD1-NPL4 complex,CC,
10744,GO:0044111,0.999999999974492,0.831739292385922,0,2,development involved in symbiotic interaction,BP,
17421,GO:1900165,0.999999999974523,0.76285798859733,0,3,negative regulation of interleukin-6 secretion,BP,
1843,GO:0004499,0.999999999974538,0.929682436294345,0,1,N,N-dimethylaniline monooxygenase activity,MF,
439,GO:0001179,0.999999999974548,0.933679877446311,0,1,RNA polymerase I transcription factor binding,MF,
1009,GO:0002488,0.999999999974552,0.905058707564222,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1010,GO:0002489,0.999999999974552,0.905058707564222,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
8805,GO:0034506,0.999999999974552,0.905058707564222,0,1,chromosome, centromeric core domain,CC,
11925,GO:0046968,0.999999999974552,0.905058707564222,0,1,peptide antigen transport,BP,
11935,GO:0046980,0.999999999974552,0.905058707564222,0,1,tapasin binding,MF,
15763,GO:0072356,0.999999999974552,0.905058707564222,0,1,chromosome passenger complex localization to kinetochore,BP,
18979,GO:1904766,0.999999999974558,0.884602170320759,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
12432,GO:0048936,0.999999999974568,0.781183954510116,0,3,peripheral nervous system neuron axonogenesis,BP,
7469,GO:0031627,0.999999999974573,0.768497579958773,0,3,telomeric loop formation,BP,
11126,GO:0045163,0.999999999974574,0.803369413972566,0,2,clustering of voltage-gated potassium channels,BP,
18515,GO:1903677,0.999999999974585,0.800537848847749,0,3,regulation of cap-independent translational initiation,BP,
18516,GO:1903679,0.999999999974585,0.800537848847749,0,3,positive regulation of cap-independent translational initiation,BP,
14683,GO:0070295,0.999999999974588,0.79342041740754,0,3,renal water absorption,BP,
18154,GO:1902896,0.999999999974599,0.832362269078418,0,2,terminal web assembly,BP,
11283,GO:0045590,0.9999999999746,0.910643612389579,0,1,negative regulation of regulatory T cell differentiation,BP,
912,GO:0002299,0.999999999974608,0.938201640437585,0,1,alpha-beta intraepithelial T cell differentiation,BP,
913,GO:0002300,0.999999999974608,0.938201640437585,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
914,GO:0002304,0.999999999974608,0.938201640437585,0,1,gamma-delta intraepithelial T cell differentiation,BP,
915,GO:0002305,0.999999999974608,0.938201640437585,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
1059,GO:0002587,0.99999999997461,0.941222075976508,0,1,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
18592,GO:1903847,0.999999999974623,0.785568270579066,0,2,regulation of aorta morphogenesis,BP,
18593,GO:1903849,0.999999999974623,0.785568270579066,0,2,positive regulation of aorta morphogenesis,BP,
5030,GO:0015195,0.999999999974693,0.90224538944043,0,1,L-threonine transmembrane transporter activity,MF,
5223,GO:0015826,0.999999999974693,0.90224538944043,0,1,threonine transport,BP,
8818,GO:0034589,0.999999999974693,0.90224538944043,0,1,hydroxyproline transport,BP,
8819,GO:0034590,0.999999999974693,0.90224538944043,0,1,L-hydroxyproline transmembrane transporter activity,MF,
5457,GO:0016333,0.999999999974703,0.918899324441326,0,1,morphogenesis of follicular epithelium,BP,
5458,GO:0016334,0.999999999974703,0.918899324441326,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
9912,GO:0042247,0.999999999974703,0.918899324441326,0,1,establishment of planar polarity of follicular epithelium,BP,
10122,GO:0042643,0.999999999974703,0.918899324441326,0,1,actomyosin, actin portion,CC,
500,GO:0001555,0.999999999974713,0.84531901918843,0,2,oocyte growth,BP,
7454,GO:0031590,0.999999999974713,0.84531901918843,0,2,wybutosine metabolic process,BP,
7455,GO:0031591,0.999999999974713,0.84531901918843,0,2,wybutosine biosynthetic process,BP,
4654,GO:0010797,0.999999999974715,0.943824531551591,0,1,regulation of multivesicular body size involved in endosome transport,BP,
2187,GO:0005046,0.999999999974743,0.864819598763385,0,2,KDEL sequence binding,MF,
14100,GO:0060935,0.999999999974749,0.74772171981228,0,3,cardiac fibroblast cell differentiation,BP,
14101,GO:0060936,0.999999999974749,0.74772171981228,0,3,cardiac fibroblast cell development,BP,
14102,GO:0060938,0.999999999974749,0.74772171981228,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
14103,GO:0060939,0.999999999974749,0.74772171981228,0,3,epicardium-derived cardiac fibroblast cell development,BP,
3639,GO:0008108,0.999999999974757,0.941775932517006,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
5316,GO:0016034,0.999999999974757,0.941775932517006,0,1,maleylacetoacetate isomerase activity,MF,
17116,GO:0101030,0.999999999974757,0.941775932517006,0,1,tRNA-guanine transglycosylation,BP,
15070,GO:0071030,0.999999999974777,0.861971432192878,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
15082,GO:0071048,0.999999999974777,0.861971432192878,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
17741,GO:1901675,0.999999999974792,0.885866328878978,0,1,negative regulation of histone H3-K27 acetylation,BP,
233,GO:0000481,0.999999999974798,0.909932937447208,0,1,maturation of 5S rRNA,BP,
8630,GO:0034146,0.999999999974821,0.901065105413693,0,1,toll-like receptor 5 signaling pathway,BP,
8631,GO:0034147,0.999999999974821,0.901065105413693,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
8632,GO:0034148,0.999999999974821,0.901065105413693,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
14752,GO:0070425,0.999999999974821,0.901065105413693,0,1,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14755,GO:0070428,0.999999999974821,0.901065105413693,0,1,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14756,GO:0070429,0.999999999974821,0.901065105413693,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
14759,GO:0070433,0.999999999974821,0.901065105413693,0,1,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15857,GO:0072573,0.999999999974821,0.901065105413693,0,1,tolerance induction to lipopolysaccharide,BP,
16243,GO:0090291,0.999999999974821,0.901065105413693,0,1,negative regulation of osteoclast proliferation,BP,
19871,GO:2000349,0.999999999974821,0.901065105413693,0,1,negative regulation of CD40 signaling pathway,BP,
17457,GO:1900244,0.999999999974826,0.837227369233533,0,2,positive regulation of synaptic vesicle endocytosis,BP,
20238,GO:2001183,0.999999999974836,0.933316620658098,0,1,negative regulation of interleukin-12 secretion,BP,
43,GO:0000095,0.999999999974843,0.928512650848404,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
5207,GO:0015805,0.999999999974843,0.928512650848404,0,1,S-adenosyl-L-methionine transport,BP,
17815,GO:1901962,0.999999999974843,0.928512650848404,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
1822,GO:0004475,0.999999999974847,0.937525043312927,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
4000,GO:0008905,0.999999999974847,0.937525043312927,0,1,mannose-phosphate guanylyltransferase activity,MF,
19036,GO:1904880,0.999999999974861,0.853449723815145,0,2,response to hydrogen sulfide,BP,
18108,GO:1902746,0.999999999974895,0.926029401305793,0,1,regulation of lens fiber cell differentiation,BP,
1781,GO:0004395,0.999999999974908,0.942960089905439,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
3826,GO:0008425,0.999999999974908,0.942960089905439,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
3956,GO:0008689,0.999999999974908,0.942960089905439,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4454,GO:0010420,0.999999999974908,0.942960089905439,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4652,GO:0010795,0.999999999974908,0.942960089905439,0,1,regulation of ubiquinone biosynthetic process,BP,
6953,GO:0030580,0.999999999974908,0.942960089905439,0,1,quinone cofactor methyltransferase activity,MF,
10937,GO:0044595,0.999999999974908,0.942960089905439,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
10938,GO:0044596,0.999999999974908,0.942960089905439,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
13165,GO:0051750,0.999999999974908,0.942960089905439,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14343,GO:0061542,0.999999999974908,0.942960089905439,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
20139,GO:2000832,0.999999999974911,0.812333985467413,0,2,negative regulation of steroid hormone secretion,BP,
20146,GO:2000847,0.999999999974911,0.812333985467413,0,2,negative regulation of corticosteroid hormone secretion,BP,
20149,GO:2000850,0.999999999974911,0.812333985467413,0,2,negative regulation of glucocorticoid secretion,BP,
9283,GO:0035720,0.999999999974915,0.753982249903091,0,3,intraciliary anterograde transport,BP,
8940,GO:0034971,0.999999999974941,0.918389454982398,0,1,histone H3-R17 methylation,BP,
9249,GO:0035642,0.999999999974941,0.918389454982398,0,1,histone methyltransferase activity (H3-R17 specific),MF,
12043,GO:0047801,0.99999999997496,0.929862523891889,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
19522,GO:1990415,0.999999999974962,0.774599097255647,0,3,Pex17p-Pex14p docking complex,CC,
19530,GO:1990429,0.999999999974962,0.774599097255647,0,3,peroxisomal importomer complex,CC,
698,GO:0001918,0.99999999997498,0.920938821285388,0,1,farnesylated protein binding,MF,
702,GO:0001922,0.99999999997501,0.727869814699791,0,3,B-1 B cell homeostasis,BP,
5468,GO:0016401,0.999999999975013,0.823014715762246,0,2,palmitoyl-CoA oxidase activity,MF,
9558,GO:0036333,0.999999999975045,0.923042555975595,0,1,hepatocyte homeostasis,BP,
18981,GO:1904772,0.999999999975045,0.923042555975595,0,1,response to tetrachloromethane,BP,
13679,GO:0060212,0.999999999975057,0.934265308531656,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
17416,GO:1900152,0.999999999975057,0.934265308531656,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
11359,GO:0045716,0.999999999975061,0.782645150918003,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
9924,GO:0042270,0.999999999975076,0.791955088554123,0,3,protection from natural killer cell mediated cytotoxicity,BP,
16401,GO:0097018,0.999999999975086,0.924738800886299,0,1,renal albumin absorption,BP,
17407,GO:1900141,0.999999999975086,0.924738800886299,0,1,regulation of oligodendrocyte apoptotic process,BP,
17408,GO:1900142,0.999999999975086,0.924738800886299,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
19961,GO:2000532,0.999999999975086,0.924738800886299,0,1,regulation of renal albumin absorption,BP,
19962,GO:2000533,0.999999999975086,0.924738800886299,0,1,negative regulation of renal albumin absorption,BP,
5768,GO:0016942,0.999999999975088,0.875320444312246,0,2,insulin-like growth factor binding protein complex,CC,
9598,GO:0036454,0.999999999975088,0.875320444312246,0,2,growth factor complex,CC,
6242,GO:0019808,0.999999999975094,0.819705078831512,0,3,polyamine binding,MF,
2193,GO:0005055,0.999999999975106,0.875087892440629,0,2,laminin receptor activity,MF,
5766,GO:0016939,0.999999999975165,0.725368916104481,0,3,kinesin II complex,CC,
7734,GO:0032229,0.999999999975169,0.856046033094513,0,2,negative regulation of synaptic transmission, GABAergic,BP,
1669,GO:0004132,0.999999999975212,0.931252888017212,0,1,dCMP deaminase activity,MF,
2129,GO:0004931,0.999999999975246,0.931217674398645,0,1,extracellularly ATP-gated cation channel activity,MF,
5535,GO:0016519,0.999999999975246,0.931217674398645,0,1,gastric inhibitory peptide receptor activity,MF,
9107,GO:0035381,0.999999999975246,0.931217674398645,0,1,ATP-gated ion channel activity,MF,
9738,GO:0038192,0.999999999975246,0.931217674398645,0,1,gastric inhibitory peptide signaling pathway,BP,
19464,GO:1990168,0.999999999975254,0.74610444441556,0,3,protein K33-linked deubiquitination,BP,
16053,GO:0086089,0.999999999975265,0.919517406795142,0,1,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17942,GO:1902282,0.999999999975265,0.919517406795142,0,1,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
1844,GO:0004500,0.999999999975268,0.917478369164754,0,1,dopamine beta-monooxygenase activity,MF,
3038,GO:0006589,0.999999999975268,0.917478369164754,0,1,octopamine biosynthetic process,BP,
11631,GO:0046333,0.999999999975268,0.917478369164754,0,1,octopamine metabolic process,BP,
15233,GO:0071387,0.999999999975272,0.895106558678259,0,1,cellular response to cortisol stimulus,BP,
14889,GO:0070676,0.999999999975317,0.816208437520308,0,3,intralumenal vesicle formation,BP,
15280,GO:0071460,0.999999999975339,0.890148350914551,0,2,cellular response to cell-matrix adhesion,BP,
17816,GO:1901963,0.99999999997534,0.852898980201103,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
933,GO:0002332,0.999999999975352,0.892307547701955,0,1,transitional stage B cell differentiation,BP,
934,GO:0002333,0.999999999975352,0.892307547701955,0,1,transitional one stage B cell differentiation,BP,
18872,GO:1904531,0.999999999975352,0.892307547701955,0,1,positive regulation of actin filament binding,BP,
18914,GO:1904618,0.999999999975352,0.892307547701955,0,1,positive regulation of actin binding,BP,
19436,GO:1990051,0.999999999975352,0.892307547701955,0,1,activation of protein kinase C activity,BP,
13229,GO:0051892,0.999999999975366,0.902717665416877,0,1,negative regulation of cardioblast differentiation,BP,
20058,GO:2000690,0.999999999975366,0.902717665416877,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
20059,GO:2000691,0.999999999975366,0.902717665416877,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
3539,GO:0007538,0.999999999975378,0.809802827992973,0,2,primary sex determination,BP,
3540,GO:0007542,0.999999999975378,0.809802827992973,0,2,primary sex determination, germ-line,BP,
5992,GO:0018992,0.999999999975378,0.809802827992973,0,2,germ-line sex determination,BP,
6032,GO:0019100,0.999999999975378,0.809802827992973,0,2,male germ-line sex determination,BP,
14779,GO:0070478,0.999999999975403,0.90333592380789,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
18558,GO:1903774,0.999999999975408,0.803673051367614,0,3,positive regulation of viral budding via host ESCRT complex,BP,
10463,GO:0043321,0.999999999975413,0.817837452416721,0,2,regulation of natural killer cell degranulation,BP,
10464,GO:0043323,0.999999999975413,0.817837452416721,0,2,positive regulation of natural killer cell degranulation,BP,
863,GO:0002196,0.999999999975425,0.93313572570417,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
4979,GO:0015098,0.999999999975425,0.93313572570417,0,1,molybdate ion transmembrane transporter activity,MF,
5152,GO:0015689,0.999999999975425,0.93313572570417,0,1,molybdate ion transport,BP,
10254,GO:0042988,0.999999999975426,0.895197817442081,0,1,X11-like protein binding,MF,
15516,GO:0071894,0.999999999975427,0.848356092116059,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
8460,GO:0033597,0.999999999975427,0.92953722293602,0,1,mitotic checkpoint complex,CC,
19495,GO:1990298,0.999999999975427,0.92953722293602,0,1,bub1-bub3 complex,CC,
17497,GO:1900453,0.999999999975445,0.849040915808935,0,2,negative regulation of long term synaptic depression,BP,
9760,GO:0039519,0.999999999975462,0.800627319373336,0,2,modulation by virus of host autophagy,BP,
19617,GO:1990769,0.99999999997549,0.850474128371105,0,2,proximal neuron projection,CC,
6815,GO:0030272,0.999999999975506,0.949507652518524,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
13811,GO:0060400,0.999999999975513,0.899269040137476,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
19147,GO:1905152,0.999999999975544,0.890637507193565,0,1,positive regulation of voltage-gated sodium channel activity,BP,
12176,GO:0048297,0.999999999975544,0.929807076494482,0,1,negative regulation of isotype switching to IgA isotypes,BP,
17968,GO:1902359,0.999999999975552,0.858043664420481,0,2,Notch signaling pathway involved in somitogenesis,BP,
17972,GO:1902366,0.999999999975552,0.858043664420481,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
17973,GO:1902367,0.999999999975552,0.858043664420481,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
11167,GO:0045226,0.999999999975552,0.843358000541217,0,2,extracellular polysaccharide biosynthetic process,BP,
11649,GO:0046379,0.999999999975552,0.843358000541217,0,2,extracellular polysaccharide metabolic process,BP,
118,GO:0000246,0.999999999975561,0.902384029508773,0,1,delta24(24-1) sterol reductase activity,MF,
12505,GO:0050614,0.999999999975561,0.902384029508773,0,1,delta24-sterol reductase activity,MF,
16310,GO:0090461,0.999999999975561,0.902384029508773,0,1,glutamate homeostasis,BP,
19381,GO:1905867,0.999999999975561,0.80097491887633,0,3,epididymis development,BP,
15199,GO:0071344,0.999999999975562,0.88360041464171,0,2,diphosphate metabolic process,BP,
1768,GO:0004372,0.999999999975592,0.859060693891963,0,2,glycine hydroxymethyltransferase activity,MF,
2046,GO:0004793,0.999999999975592,0.859060693891963,0,2,threonine aldolase activity,MF,
3000,GO:0006545,0.999999999975592,0.859060693891963,0,2,glycine biosynthetic process,BP,
3962,GO:0008732,0.999999999975592,0.859060693891963,0,2,L-allo-threonine aldolase activity,MF,
6091,GO:0019264,0.999999999975592,0.859060693891963,0,2,glycine biosynthetic process from serine,BP,
2218,GO:0005115,0.99999999997561,0.891074070771494,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
6412,GO:0021650,0.99999999997561,0.891074070771494,0,1,vestibulocochlear nerve formation,BP,
9648,GO:0036517,0.99999999997561,0.891074070771494,0,1,chemoattraction of serotonergic neuron axon,BP,
13225,GO:0051885,0.99999999997561,0.891074070771494,0,1,positive regulation of timing of anagen,BP,
13567,GO:0060031,0.99999999997561,0.891074070771494,0,1,mediolateral intercalation,BP,
13598,GO:0060067,0.99999999997561,0.891074070771494,0,1,cervix development,BP,
13935,GO:0060599,0.99999999997561,0.891074070771494,0,1,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14042,GO:0060775,0.99999999997561,0.891074070771494,0,1,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14049,GO:0060809,0.99999999997561,0.891074070771494,0,1,mesodermal to mesenchymal transition involved in gastrulation,BP,
14274,GO:0061347,0.99999999997561,0.891074070771494,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
14275,GO:0061348,0.99999999997561,0.891074070771494,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
14276,GO:0061349,0.99999999997561,0.891074070771494,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
14277,GO:0061350,0.99999999997561,0.891074070771494,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
14279,GO:0061354,0.99999999997561,0.891074070771494,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
14394,GO:0061642,0.99999999997561,0.891074070771494,0,1,chemoattraction of axon,BP,
17977,GO:1902379,0.99999999997561,0.891074070771494,0,1,chemoattractant activity involved in axon guidance,MF,
19063,GO:1904933,0.99999999997561,0.891074070771494,0,1,regulation of cell proliferation in midbrain,BP,
19064,GO:1904934,0.99999999997561,0.891074070771494,0,1,negative regulation of cell proliferation in midbrain,BP,
19073,GO:1904955,0.99999999997561,0.891074070771494,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
19259,GO:1905438,0.99999999997561,0.891074070771494,0,1,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
14151,GO:0061031,0.999999999975625,0.874023567146527,0,2,endodermal digestive tract morphogenesis,BP,
1683,GO:0004149,0.999999999975646,0.920100544808715,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
5655,GO:0016751,0.999999999975646,0.920100544808715,0,1,S-succinyltransferase activity,MF,
18988,GO:1904783,0.999999999975657,0.828002283230035,0,2,positive regulation of NMDA glutamate receptor activity,BP,
2366,GO:0005483,0.999999999975671,0.769431552170656,0,3,soluble NSF attachment protein activity,MF,
1921,GO:0004615,0.999999999975676,0.873994231981945,0,2,phosphomannomutase activity,MF,
10252,GO:0042986,0.999999999975686,0.850949504789597,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
6546,GO:0021960,0.999999999975699,0.721330658679742,0,3,anterior commissure morphogenesis,BP,
14951,GO:0070842,0.999999999975715,0.741458849762521,0,3,aggresome assembly,BP,
6881,GO:0030377,0.999999999975715,0.940141021760999,0,1,urokinase plasminogen activator receptor activity,MF,
9741,GO:0038195,0.999999999975715,0.940141021760999,0,1,urokinase plasminogen activator signaling pathway,BP,
1579,GO:0003989,0.999999999975715,0.756237476933778,0,2,acetyl-CoA carboxylase activity,MF,
20303,GO:2001295,0.999999999975715,0.756237476933778,0,2,malonyl-CoA biosynthetic process,BP,
1670,GO:0004133,0.999999999975719,0.882810728179356,0,1,glycogen debranching enzyme activity,MF,
1671,GO:0004134,0.999999999975719,0.882810728179356,0,1,4-alpha-glucanotransferase activity,MF,
1672,GO:0004135,0.999999999975719,0.882810728179356,0,1,amylo-alpha-1,6-glucosidase activity,MF,
10288,GO:0043033,0.999999999975719,0.882810728179356,0,1,isoamylase complex,CC,
17157,GO:0102500,0.999999999975719,0.882810728179356,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
12534,GO:0050682,0.999999999975719,0.802271660687247,0,2,AF-2 domain binding,MF,
16012,GO:0086020,0.999999999975728,0.80623681259116,0,2,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
16013,GO:0086021,0.999999999975728,0.80623681259116,0,2,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
16031,GO:0086053,0.999999999975728,0.80623681259116,0,2,AV node cell to bundle of His cell communication by electrical coupling,BP,
16047,GO:0086077,0.999999999975728,0.80623681259116,0,2,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
4009,GO:0008973,0.999999999975743,0.914745068410334,0,1,phosphopentomutase activity,MF,
20210,GO:2001136,0.999999999975753,0.913369290887864,0,1,negative regulation of endocytic recycling,BP,
1029,GO:0002537,0.999999999975753,0.880705571203304,0,1,nitric oxide production involved in inflammatory response,BP,
14315,GO:0061459,0.999999999975753,0.880705571203304,0,1,L-arginine transmembrane transporter activity,MF,
16683,GO:0097625,0.999999999975753,0.880705571203304,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
16684,GO:0097626,0.999999999975753,0.880705571203304,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
16685,GO:0097627,0.999999999975753,0.880705571203304,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
16694,GO:0097639,0.999999999975753,0.880705571203304,0,1,L-lysine import across plasma membrane,BP,
16695,GO:0097640,0.999999999975753,0.880705571203304,0,1,L-ornithine import across plasma membrane,BP,
440,GO:0001181,0.999999999975771,0.851279626450222,0,2,transcription factor activity, core RNA polymerase I binding,MF,
6538,GO:0021942,0.999999999975773,0.750492682552023,0,3,radial glia guided migration of Purkinje cell,BP,
16414,GO:0097045,0.999999999975773,0.898112232089184,0,1,phosphatidylserine exposure on blood platelet,BP,
17952,GO:1902304,0.999999999975773,0.898112232089184,0,1,positive regulation of potassium ion export,BP,
2314,GO:0005314,0.999999999975803,0.837916484464511,0,2,high-affinity glutamate transmembrane transporter activity,MF,
5125,GO:0015501,0.999999999975803,0.837916484464511,0,2,glutamate:sodium symporter activity,MF,
13294,GO:0051990,0.999999999975832,0.856260227118767,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
7379,GO:0031431,0.999999999975843,0.834404137951137,0,2,Dbf4-dependent protein kinase complex,CC,
3729,GO:0008260,0.999999999975857,0.910516011783057,0,1,3-oxoacid CoA-transferase activity,MF,
10293,GO:0043041,0.999999999975857,0.910516011783057,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
13409,GO:0052746,0.999999999975882,0.824318588780978,0,2,inositol phosphorylation,BP,
13972,GO:0060681,0.99999999997589,0.753937326404288,0,3,branch elongation involved in ureteric bud branching,BP,
6415,GO:0021678,0.999999999975904,0.812943522524277,0,3,third ventricle development,BP,
9138,GO:0035469,0.999999999975925,0.893860497585873,0,1,determination of pancreatic left/right asymmetry,BP,
15526,GO:0071908,0.999999999975925,0.893860497585873,0,1,determination of intestine left/right asymmetry,BP,
15527,GO:0071909,0.999999999975925,0.893860497585873,0,1,determination of stomach left/right asymmetry,BP,
19761,GO:2000167,0.999999999975925,0.893860497585873,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
519,GO:0001595,0.999999999975937,0.944360206975858,0,1,angiotensin receptor activity,MF,
2135,GO:0004945,0.999999999975937,0.944360206975858,0,1,angiotensin type II receptor activity,MF,
17296,GO:0140066,0.999999999975937,0.797899223563566,0,2,peptidyl-lysine crotonylation,BP,
14050,GO:0060816,0.999999999975938,0.788950388517948,0,2,random inactivation of X chromosome,BP,
1806,GO:0004452,0.999999999975942,0.875347544804716,0,2,isopentenyl-diphosphate delta-isomerase activity,MF,
12729,GO:0050992,0.999999999975942,0.875347544804716,0,2,dimethylallyl diphosphate biosynthetic process,BP,
12730,GO:0050993,0.999999999975942,0.875347544804716,0,2,dimethylallyl diphosphate metabolic process,BP,
177,GO:0000386,0.999999999975944,0.751676084068029,0,3,second spliceosomal transesterification activity,MF,
16241,GO:0090289,0.999999999975962,0.853111611312442,0,2,regulation of osteoclast proliferation,BP,
17947,GO:1902292,0.999999999975963,0.944410568661536,0,1,cell cycle DNA replication initiation,BP,
17960,GO:1902315,0.999999999975963,0.944410568661536,0,1,nuclear cell cycle DNA replication initiation,BP,
18198,GO:1902975,0.999999999975963,0.944410568661536,0,1,mitotic DNA replication initiation,BP,
16043,GO:0086072,0.999999999975963,0.925208749049915,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
16051,GO:0086082,0.999999999975963,0.925208749049915,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
5949,GO:0018293,0.999999999975975,0.943958188916764,0,1,protein-FAD linkage,BP,
13524,GO:0055095,0.999999999975982,0.907269810285448,0,1,lipoprotein particle mediated signaling,BP,
13525,GO:0055096,0.999999999975982,0.907269810285448,0,1,low-density lipoprotein particle mediated signaling,BP,
19407,GO:1905940,0.999999999975986,0.775997320340525,0,3,negative regulation of gonad development,BP,
17215,GO:0106073,0.999999999975995,0.794304717670213,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
16141,GO:0090149,0.999999999975996,0.834486105286359,0,2,mitochondrial membrane fission,BP,
18938,GO:1904691,0.999999999976005,0.929876390769433,0,1,negative regulation of type B pancreatic cell proliferation,BP,
5571,GO:0016586,0.99999999997603,0.793203305795774,0,2,RSC-type complex,CC,
11899,GO:0046922,0.999999999976044,0.837410007081405,0,2,peptide-O-fucosyltransferase activity,MF,
1070,GO:0002636,0.999999999976073,0.9385698405238,0,1,positive regulation of germinal center formation,BP,
2752,GO:0006157,0.999999999976073,0.9385698405238,0,1,deoxyadenosine catabolic process,BP,
9954,GO:0042321,0.999999999976073,0.9385698405238,0,1,negative regulation of circadian sleep/wake cycle, sleep,BP,
9955,GO:0042323,0.999999999976073,0.9385698405238,0,1,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11555,GO:0046090,0.999999999976073,0.9385698405238,0,1,deoxyadenosine metabolic process,BP,
11566,GO:0046111,0.999999999976073,0.9385698405238,0,1,xanthine biosynthetic process,BP,
11572,GO:0046124,0.999999999976073,0.9385698405238,0,1,purine deoxyribonucleoside catabolic process,BP,
13656,GO:0060167,0.999999999976073,0.9385698405238,0,1,regulation of adenosine receptor signaling pathway,BP,
13657,GO:0060169,0.999999999976073,0.9385698405238,0,1,negative regulation of adenosine receptor signaling pathway,BP,
13816,GO:0060407,0.999999999976073,0.9385698405238,0,1,negative regulation of penile erection,BP,
14660,GO:0070256,0.999999999976073,0.9385698405238,0,1,negative regulation of mucus secretion,BP,
13027,GO:0051463,0.99999999997609,0.888287949321999,0,1,negative regulation of cortisol secretion,BP,
13630,GO:0060125,0.99999999997609,0.888287949321999,0,1,negative regulation of growth hormone secretion,BP,
15819,GO:0072518,0.999999999976115,0.887465089325848,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
17330,GO:0150031,0.999999999976115,0.887465089325848,0,1,regulation of protein localization to lysosome,BP,
17331,GO:0150033,0.999999999976115,0.887465089325848,0,1,negative regulation of protein localization to lysosome,BP,
9357,GO:0035868,0.999999999976126,0.806884283508306,0,2,alphav-beta3 integrin-HMGB1 complex,CC,
2155,GO:0004979,0.999999999976143,0.933621622805494,0,1,beta-endorphin receptor activity,MF,
7473,GO:0031635,0.999999999976143,0.933621622805494,0,1,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7668,GO:0032097,0.999999999976143,0.933621622805494,0,1,positive regulation of response to food,BP,
7671,GO:0032100,0.999999999976143,0.933621622805494,0,1,positive regulation of appetite,BP,
9680,GO:0038047,0.999999999976143,0.933621622805494,0,1,morphine receptor activity,MF,
11720,GO:0046521,0.999999999976143,0.933621622805494,0,1,sphingoid catabolic process,BP,
14283,GO:0061358,0.999999999976143,0.933621622805494,0,1,negative regulation of Wnt protein secretion,BP,
2461,GO:0005674,0.999999999976148,0.868502994997469,0,2,transcription factor TFIIF complex,CC,
6619,GO:0022841,0.999999999976148,0.801936574908044,0,3,potassium ion leak channel activity,MF,
17113,GO:0101006,0.999999999976175,0.813659398158303,0,3,protein histidine phosphatase activity,MF,
13829,GO:0060426,0.999999999976185,0.785438076493261,0,3,lung vasculature development,BP,
15867,GO:0072586,0.999999999976186,0.90039305764222,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
15868,GO:0072587,0.999999999976186,0.90039305764222,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
2315,GO:0005315,0.999999999976186,0.729069113757202,0,3,inorganic phosphate transmembrane transporter activity,MF,
5900,GO:0018106,0.999999999976191,0.952191700084383,0,1,peptidyl-histidine phosphorylation,BP,
16918,GO:0098885,0.999999999976199,0.882740150002066,0,1,modification of postsynaptic actin cytoskeleton,BP,
17018,GO:0099159,0.999999999976199,0.882740150002066,0,1,regulation of modification of postsynaptic structure,BP,
17413,GO:1900149,0.999999999976199,0.882740150002066,0,1,positive regulation of Schwann cell migration,BP,
18770,GO:1904266,0.999999999976199,0.882740150002066,0,1,regulation of Schwann cell chemotaxis,BP,
18771,GO:1904268,0.999999999976199,0.882740150002066,0,1,positive regulation of Schwann cell chemotaxis,BP,
19190,GO:1905274,0.999999999976199,0.882740150002066,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
19609,GO:1990751,0.999999999976199,0.882740150002066,0,1,Schwann cell chemotaxis,BP,
1069,GO:0002635,0.999999999976203,0.861828284836781,0,1,negative regulation of germinal center formation,BP,
9904,GO:0042222,0.999999999976212,0.870697876755579,0,2,interleukin-1 biosynthetic process,BP,
11227,GO:0045360,0.999999999976212,0.870697876755579,0,2,regulation of interleukin-1 biosynthetic process,BP,
11228,GO:0045362,0.999999999976212,0.870697876755579,0,2,positive regulation of interleukin-1 biosynthetic process,BP,
159,GO:0000322,0.999999999976225,0.781622450247913,0,3,storage vacuole,CC,
5821,GO:0017089,0.999999999976226,0.863702843879094,0,2,glycolipid transporter activity,MF,
9693,GO:0038086,0.999999999976236,0.911137544326097,0,1,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
9695,GO:0038091,0.999999999976236,0.911137544326097,0,1,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
18472,GO:1903570,0.999999999976236,0.911137544326097,0,1,regulation of protein kinase D signaling,BP,
18473,GO:1903572,0.999999999976236,0.911137544326097,0,1,positive regulation of protein kinase D signaling,BP,
15090,GO:0071074,0.999999999976237,0.932940894864402,0,1,eukaryotic initiation factor eIF2 binding,MF,
18513,GO:1903674,0.999999999976237,0.932940894864402,0,1,regulation of cap-dependent translational initiation,BP,
18514,GO:1903676,0.999999999976237,0.932940894864402,0,1,positive regulation of cap-dependent translational initiation,BP,
13775,GO:0060353,0.999999999976251,0.809257931591942,0,3,regulation of cell adhesion molecule production,BP,
13776,GO:0060355,0.999999999976251,0.809257931591942,0,3,positive regulation of cell adhesion molecule production,BP,
19253,GO:1905424,0.999999999976251,0.85866978795563,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
19254,GO:1905426,0.999999999976251,0.85866978795563,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
16708,GO:0097681,0.999999999976268,0.74196551179426,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
4446,GO:0010360,0.999999999976271,0.760709606436965,0,3,negative regulation of anion channel activity,BP,
11280,GO:0045586,0.999999999976282,0.726151745573612,0,3,regulation of gamma-delta T cell differentiation,BP,
19111,GO:1905042,0.999999999976285,0.928321148407658,0,1,negative regulation of epithelium regeneration,BP,
11762,GO:0046619,0.999999999976287,0.884854887401475,0,1,optic placode formation involved in camera-type eye formation,BP,
19490,GO:1990264,0.999999999976293,0.848277064442108,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
11942,GO:0047006,0.999999999976324,0.941059843430496,0,1,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
11951,GO:0047042,0.999999999976324,0.941059843430496,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12033,GO:0047718,0.999999999976324,0.941059843430496,0,1,indanol dehydrogenase activity,MF,
7292,GO:0031289,0.999999999976326,0.917451183041503,0,1,actin phosphorylation,BP,
10576,GO:0043538,0.999999999976326,0.917451183041503,0,1,regulation of actin phosphorylation,BP,
10719,GO:0044036,0.999999999976344,0.802127912336411,0,3,cell wall macromolecule metabolic process,BP,
15335,GO:0071554,0.999999999976344,0.802127912336411,0,3,cell wall organization or biogenesis,BP,
5534,GO:0016517,0.999999999976348,0.931875227828459,0,1,interleukin-12 receptor activity,MF,
9815,GO:0042019,0.999999999976348,0.931875227828459,0,1,interleukin-23 binding,MF,
9816,GO:0042020,0.999999999976348,0.931875227828459,0,1,interleukin-23 receptor activity,MF,
9817,GO:0042022,0.999999999976348,0.931875227828459,0,1,interleukin-12 receptor complex,CC,
15834,GO:0072536,0.999999999976348,0.931875227828459,0,1,interleukin-23 receptor complex,CC,
15089,GO:0071073,0.999999999976352,0.78810901702777,0,3,positive regulation of phospholipid biosynthetic process,BP,
13461,GO:0052918,0.999999999976374,0.888272789833144,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
13463,GO:0052926,0.999999999976374,0.888272789833144,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
11181,GO:0045272,0.999999999976377,0.823175965198192,0,3,plasma membrane respiratory chain complex I,CC,
8248,GO:0033023,0.999999999976392,0.813896806024282,0,2,mast cell homeostasis,BP,
8249,GO:0033024,0.999999999976392,0.813896806024282,0,2,mast cell apoptotic process,BP,
8250,GO:0033025,0.999999999976392,0.813896806024282,0,2,regulation of mast cell apoptotic process,BP,
13730,GO:0060298,0.999999999976394,0.816995310368452,0,2,positive regulation of sarcomere organization,BP,
7723,GO:0032213,0.999999999976401,0.844963038480505,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
7724,GO:0032214,0.999999999976401,0.844963038480505,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
18874,GO:1904534,0.999999999976401,0.844963038480505,0,2,negative regulation of telomeric loop disassembly,BP,
19362,GO:1905778,0.999999999976401,0.844963038480505,0,2,negative regulation of exonuclease activity,BP,
19373,GO:1905838,0.999999999976401,0.844963038480505,0,2,regulation of telomeric D-loop disassembly,BP,
19374,GO:1905839,0.999999999976401,0.844963038480505,0,2,negative regulation of telomeric D-loop disassembly,BP,
11988,GO:0047323,0.999999999976401,0.929834796179522,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
13346,GO:0052381,0.999999999976401,0.929834796179522,0,1,tRNA dimethylallyltransferase activity,MF,
18977,GO:1904762,0.999999999976424,0.905342772714137,0,1,positive regulation of myofibroblast differentiation,BP,
16247,GO:0090298,0.999999999976425,0.754595007629694,0,3,negative regulation of mitochondrial DNA replication,BP,
17788,GO:1901859,0.999999999976425,0.754595007629694,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
14931,GO:0070782,0.999999999976427,0.929502679576176,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
16451,GO:0097111,0.999999999976468,0.785122746483873,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
10262,GO:0043000,0.999999999976491,0.845718918159533,0,2,Golgi to plasma membrane CFTR protein transport,BP,
771,GO:0002025,0.999999999976514,0.931161364415339,0,1,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
2133,GO:0004939,0.999999999976514,0.931161364415339,0,1,beta-adrenergic receptor activity,MF,
2134,GO:0004941,0.999999999976514,0.931161364415339,0,1,beta2-adrenergic receptor activity,MF,
12978,GO:0051380,0.999999999976514,0.931161364415339,0,1,norepinephrine binding,MF,
14482,GO:0061884,0.999999999976514,0.931161364415339,0,1,regulation of mini excitatory postsynaptic potential,BP,
14483,GO:0061885,0.999999999976514,0.931161364415339,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
16882,GO:0098816,0.999999999976514,0.931161364415339,0,1,mini excitatory postsynaptic potential,BP,
7155,GO:0031014,0.999999999976537,0.901976682280471,0,2,troponin T binding,MF,
3995,GO:0008893,0.999999999976539,0.946735342212059,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
5681,GO:0016794,0.999999999976539,0.946735342212059,0,1,diphosphoric monoester hydrolase activity,MF,
8396,GO:0033316,0.999999999976541,0.917661901117534,0,1,meiotic spindle assembly checkpoint,BP,
10985,GO:0044779,0.999999999976541,0.917661901117534,0,1,meiotic spindle checkpoint,BP,
10989,GO:0044785,0.999999999976541,0.917661901117534,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
17869,GO:1902102,0.999999999976541,0.917661901117534,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
17870,GO:1902103,0.999999999976541,0.917661901117534,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
18259,GO:1903096,0.999999999976541,0.917661901117534,0,1,protein localization to meiotic spindle midzone,BP,
19140,GO:1905132,0.999999999976541,0.917661901117534,0,1,regulation of meiotic chromosome separation,BP,
19141,GO:1905133,0.999999999976541,0.917661901117534,0,1,negative regulation of meiotic chromosome separation,BP,
19228,GO:1905359,0.999999999976541,0.917661901117534,0,1,protein localization to meiotic spindle,BP,
3308,GO:0007008,0.999999999976545,0.912932373145689,0,1,outer mitochondrial membrane organization,BP,
5314,GO:0016031,0.999999999976545,0.912932373145689,0,1,tRNA import into mitochondrion,BP,
14568,GO:0070096,0.999999999976545,0.912932373145689,0,1,mitochondrial outer membrane translocase complex assembly,BP,
19177,GO:1905242,0.999999999976545,0.912932373145689,0,1,response to 3,3',5-triiodo-L-thyronine,BP,
12457,GO:0050253,0.999999999976545,0.824902513084798,0,2,retinyl-palmitate esterase activity,MF,
3767,GO:0008311,0.999999999976545,0.875444269004947,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
398,GO:0001074,0.999999999976552,0.923639160181243,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
404,GO:0001084,0.999999999976552,0.923639160181243,0,1,transcription factor activity, TFIID-class binding,MF,
8435,GO:0033552,0.999999999976552,0.923639160181243,0,1,response to vitamin B3,BP,
14679,GO:0070291,0.999999999976558,0.768870635109197,0,3,N-acylethanolamine metabolic process,BP,
4537,GO:0010609,0.999999999976568,0.854168931508881,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
3609,GO:0008048,0.999999999976572,0.927966281575468,0,1,calcium sensitive guanylate cyclase activator activity,MF,
18026,GO:1902528,0.999999999976575,0.87586792444102,0,1,regulation of protein linear polyubiquitination,BP,
18027,GO:1902530,0.999999999976575,0.87586792444102,0,1,positive regulation of protein linear polyubiquitination,BP,
20300,GO:2001288,0.999999999976575,0.87586792444102,0,1,positive regulation of caveolin-mediated endocytosis,BP,
14129,GO:0060995,0.999999999976582,0.820621507114928,0,2,cell-cell signaling involved in kidney development,BP,
14246,GO:0061289,0.999999999976582,0.820621507114928,0,2,Wnt signaling pathway involved in kidney development,BP,
14247,GO:0061290,0.999999999976582,0.820621507114928,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15682,GO:0072204,0.999999999976582,0.820621507114928,0,2,cell-cell signaling involved in metanephros development,BP,
7391,GO:0031443,0.999999999976591,0.884735917384622,0,1,fast-twitch skeletal muscle fiber contraction,BP,
1811,GO:0004461,0.999999999976602,0.840245677915553,0,2,lactose synthase activity,MF,
9164,GO:0035517,0.999999999976623,0.72711840275807,0,3,PR-DUB complex,CC,
13803,GO:0060392,0.99999999997664,0.877029584698022,0,2,negative regulation of SMAD protein signal transduction,BP,
16269,GO:0090326,0.999999999976645,0.914101854482719,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
18130,GO:1902823,0.999999999976645,0.914101854482719,0,1,negative regulation of late endosome to lysosome transport,BP,
18356,GO:1903336,0.999999999976645,0.914101854482719,0,1,negative regulation of vacuolar transport,BP,
19858,GO:2000331,0.999999999976645,0.914101854482719,0,1,regulation of terminal button organization,BP,
13584,GO:0060051,0.999999999976674,0.861303310635485,0,2,negative regulation of protein glycosylation,BP,
16237,GO:0090285,0.999999999976674,0.861303310635485,0,2,negative regulation of protein glycosylation in Golgi,BP,
19849,GO:2000321,0.999999999976677,0.882267662183995,0,2,positive regulation of T-helper 17 cell differentiation,BP,
19857,GO:2000330,0.999999999976677,0.882267662183995,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
16693,GO:0097638,0.999999999976681,0.776760705760523,0,2,L-arginine import across plasma membrane,BP,
16993,GO:0099074,0.999999999976692,0.843399408724773,0,2,mitochondrion to lysosome transport,BP,
16994,GO:0099075,0.999999999976692,0.843399408724773,0,2,mitochondrion-derived vesicle mediated transport,BP,
8908,GO:0034729,0.999999999976693,0.750575719111262,0,3,histone H3-K79 methylation,BP,
2038,GO:0004778,0.999999999976702,0.937169949918806,0,1,succinyl-CoA hydrolase activity,MF,
8103,GO:0032788,0.999999999976702,0.937169949918806,0,1,saturated monocarboxylic acid metabolic process,BP,
8104,GO:0032789,0.999999999976702,0.937169949918806,0,1,unsaturated monocarboxylic acid metabolic process,BP,
19950,GO:2000491,0.999999999976714,0.915755930757619,0,1,positive regulation of hepatic stellate cell activation,BP,
10840,GO:0044334,0.999999999976728,0.826178173527063,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
18922,GO:1904647,0.999999999976739,0.87176197242346,0,1,response to rotenone,BP,
13947,GO:0060623,0.999999999976759,0.778314379149409,0,3,regulation of chromosome condensation,BP,
4417,GO:0010193,0.999999999976775,0.862801950993751,0,2,response to ozone,BP,
15269,GO:0071442,0.999999999976797,0.775883700386973,0,3,positive regulation of histone H3-K14 acetylation,BP,
19342,GO:1905696,0.999999999976827,0.804855658119267,0,2,regulation of polysome binding,BP,
7242,GO:0031166,0.999999999976827,0.75254523323354,0,3,integral component of vacuolar membrane,CC,
7308,GO:0031310,0.999999999976827,0.75254523323354,0,3,intrinsic component of vacuolar membrane,CC,
16461,GO:0097124,0.999999999976854,0.854790135048205,0,2,cyclin A2-CDK2 complex,CC,
410,GO:0001096,0.999999999976857,0.909170226197402,0,1,TFIIF-class transcription factor binding,MF,
13899,GO:0060542,0.999999999976868,0.891456131851352,0,1,regulation of strand invasion,BP,
14709,GO:0070337,0.999999999976868,0.891456131851352,0,1,3'-flap-structured DNA binding,MF,
16752,GO:0098530,0.999999999976868,0.891456131851352,0,1,positive regulation of strand invasion,BP,
18418,GO:1903461,0.999999999976893,0.916649866115385,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
14388,GO:0061629,0.999999999976938,0.758366902053383,0,3,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
6092,GO:0019276,0.999999999976952,0.919870143876499,0,1,UDP-N-acetylgalactosamine metabolic process,BP,
9034,GO:0035248,0.999999999976952,0.919870143876499,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
4057,GO:0009106,0.99999999997697,0.85242624336208,0,2,lipoate metabolic process,BP,
6096,GO:0019303,0.999999999977014,0.891132964330379,0,2,D-ribose catabolic process,BP,
13785,GO:0060371,0.999999999977023,0.75289563274433,0,3,regulation of atrial cardiac muscle cell membrane depolarization,BP,
17896,GO:1902178,0.999999999977024,0.902288316344663,0,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,
1030,GO:0002538,0.999999999977061,0.915891153239257,0,1,arachidonic acid metabolite production involved in inflammatory response,BP,
1031,GO:0002540,0.999999999977061,0.915891153239257,0,1,leukotriene production involved in inflammatory response,BP,
9144,GO:0035490,0.999999999977061,0.915891153239257,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9145,GO:0035491,0.999999999977061,0.915891153239257,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
14162,GO:0061044,0.999999999977061,0.915891153239257,0,1,negative regulation of vascular wound healing,BP,
17626,GO:1901331,0.999999999977061,0.915891153239257,0,1,positive regulation of odontoblast differentiation,BP,
18164,GO:1902913,0.999999999977061,0.915891153239257,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19730,GO:2000098,0.999999999977061,0.915891153239257,0,1,negative regulation of smooth muscle cell-matrix adhesion,BP,
1520,GO:0003882,0.999999999977071,0.925491004978292,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1618,GO:0004047,0.999999999977072,0.873971778496858,0,2,aminomethyltransferase activity,MF,
645,GO:0001835,0.999999999977074,0.914691343865653,0,1,blastocyst hatching,BP,
9015,GO:0035188,0.999999999977074,0.914691343865653,0,1,hatching,BP,
15421,GO:0071684,0.999999999977074,0.914691343865653,0,1,organism emergence from protective structure,BP,
7061,GO:0030846,0.999999999977084,0.861683346423974,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7438,GO:0031554,0.999999999977084,0.861683346423974,0,1,regulation of DNA-templated transcription, termination,BP,
13913,GO:0060566,0.999999999977084,0.861683346423974,0,1,positive regulation of DNA-templated transcription, termination,BP,
18903,GO:1904594,0.999999999977084,0.861683346423974,0,1,regulation of termination of RNA polymerase II transcription,BP,
18904,GO:1904595,0.999999999977084,0.861683346423974,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20119,GO:2000804,0.999999999977084,0.861683346423974,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
20120,GO:2000806,0.999999999977084,0.861683346423974,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
9973,GO:0042361,0.999999999977108,0.915492517734119,0,1,menaquinone catabolic process,BP,
9984,GO:0042377,0.999999999977108,0.915492517734119,0,1,vitamin K catabolic process,BP,
15664,GO:0072179,0.999999999977112,0.857392231869652,0,2,nephric duct formation,BP,
16691,GO:0097636,0.999999999977126,0.831272178875878,0,2,intrinsic component of autophagosome membrane,CC,
16692,GO:0097637,0.999999999977126,0.831272178875878,0,2,integral component of autophagosome membrane,CC,
4850,GO:0014062,0.999999999977145,0.850217774325652,0,2,regulation of serotonin secretion,BP,
7515,GO:0031700,0.999999999977156,0.939996876888937,0,1,adrenomedullin receptor binding,MF,
16541,GO:0097278,0.999999999977169,0.850996943166829,0,2,complement-dependent cytotoxicity,BP,
1568,GO:0003975,0.999999999977181,0.929654760122775,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
4006,GO:0008963,0.999999999977181,0.929654760122775,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
9055,GO:0035276,0.999999999977194,0.892986999977501,0,1,ethanol binding,MF,
9261,GO:0035668,0.999999999977194,0.892986999977501,0,1,TRAM-dependent toll-like receptor signaling pathway,BP,
9262,GO:0035669,0.999999999977194,0.892986999977501,0,1,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
20183,GO:2001029,0.999999999977194,0.892986999977501,0,1,regulation of cellular glucuronidation,BP,
20184,GO:2001031,0.999999999977194,0.892986999977501,0,1,positive regulation of cellular glucuronidation,BP,
5820,GO:0017087,0.999999999977196,0.906192678087638,0,1,mitochondrial processing peptidase complex,CC,
10674,GO:0043914,0.999999999977196,0.906192678087638,0,1,NADPH:sulfur oxidoreductase activity,MF,
17,GO:0000032,0.999999999977198,0.934960173540905,0,1,cell wall mannoprotein biosynthetic process,BP,
1823,GO:0004476,0.999999999977198,0.934960173540905,0,1,mannose-6-phosphate isomerase activity,MF,
2692,GO:0006056,0.999999999977198,0.934960173540905,0,1,mannoprotein metabolic process,BP,
2693,GO:0006057,0.999999999977198,0.934960173540905,0,1,mannoprotein biosynthetic process,BP,
7416,GO:0031506,0.999999999977198,0.934960173540905,0,1,cell wall glycoprotein biosynthetic process,BP,
10061,GO:0042546,0.999999999977198,0.934960173540905,0,1,cell wall biogenesis,BP,
10720,GO:0044038,0.999999999977198,0.934960173540905,0,1,cell wall macromolecule biosynthetic process,BP,
14375,GO:0061611,0.999999999977198,0.934960173540905,0,1,mannose to fructose-6-phosphate metabolic process,BP,
14847,GO:0070589,0.999999999977198,0.934960173540905,0,1,cellular component macromolecule biosynthetic process,BP,
8826,GO:0034602,0.999999999977233,0.902221579640538,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
14153,GO:0061034,0.999999999977233,0.902221579640538,0,1,olfactory bulb mitral cell layer development,BP,
6229,GO:0019780,0.999999999977238,0.887193632884429,0,1,FAT10 activating enzyme activity,MF,
862,GO:0002193,0.99999999997725,0.719659272381865,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
12319,GO:0048669,0.999999999977252,0.76582270974358,0,3,collateral sprouting in absence of injury,BP,
9276,GO:0035700,0.999999999977266,0.93485618783164,0,1,astrocyte chemotaxis,BP,
9499,GO:0036145,0.999999999977266,0.93485618783164,0,1,dendritic cell homeostasis,BP,
19934,GO:2000458,0.999999999977266,0.93485618783164,0,1,regulation of astrocyte chemotaxis,BP,
2157,GO:0004984,0.999999999977274,0.823624354548387,0,3,olfactory receptor activity,MF,
12694,GO:0050911,0.999999999977274,0.823624354548387,0,3,detection of chemical stimulus involved in sensory perception of smell,BP,
11971,GO:0047220,0.999999999977313,0.92099278500973,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
11367,GO:0045726,0.999999999977348,0.895143697872481,0,1,positive regulation of integrin biosynthetic process,BP,
13228,GO:0051891,0.999999999977348,0.895143697872481,0,1,positive regulation of cardioblast differentiation,BP,
18522,GO:1903701,0.999999999977348,0.895143697872481,0,1,substantia propria of cornea development,BP,
1760,GO:0004363,0.999999999977365,0.933012990241506,0,1,glutathione synthase activity,MF,
7132,GO:0030956,0.999999999977374,0.79638711992479,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
12501,GO:0050567,0.999999999977374,0.79638711992479,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
14892,GO:0070681,0.999999999977374,0.79638711992479,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
18794,GO:1904327,0.999999999977378,0.814469900827397,0,2,protein localization to cytosolic proteasome complex,BP,
18812,GO:1904379,0.999999999977378,0.814469900827397,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
5114,GO:0015433,0.999999999977397,0.824818161721897,0,2,peptide antigen-transporting ATPase activity,MF,
831,GO:0002118,0.999999999977421,0.912300816150352,0,1,aggressive behavior,BP,
832,GO:0002121,0.999999999977421,0.912300816150352,0,1,inter-male aggressive behavior,BP,
15303,GO:0071492,0.999999999977424,0.833222675929701,0,2,cellular response to UV-A,BP,
6488,GO:0021840,0.999999999977427,0.92643399711563,0,1,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6489,GO:0021842,0.999999999977427,0.92643399711563,0,1,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
15667,GO:0072185,0.999999999977456,0.926690655659638,0,1,metanephric cap development,BP,
15668,GO:0072186,0.999999999977456,0.926690655659638,0,1,metanephric cap morphogenesis,BP,
16114,GO:0090094,0.999999999977456,0.926690655659638,0,1,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
16115,GO:0090095,0.999999999977456,0.926690655659638,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
16116,GO:0090096,0.999999999977456,0.926690655659638,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
1058,GO:0002586,0.999999999977466,0.893497068653718,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
3822,GO:0008419,0.99999999997748,0.922794438970395,0,1,RNA lariat debranching enzyme activity,MF,
7362,GO:0031404,0.999999999977485,0.76895228261329,0,3,chloride ion binding,MF,
2422,GO:0005597,0.99999999997749,0.89222978858106,0,1,collagen type XVI trimer,CC,
5675,GO:0016785,0.99999999997749,0.89222978858106,0,1,transferase activity, transferring selenium-containing groups,MF,
16789,GO:0098621,0.99999999997749,0.89222978858106,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
8547,GO:0033878,0.999999999977493,0.907542072271682,0,1,hormone-sensitive lipase activity,MF,
1727,GO:0004320,0.999999999977499,0.818675627939098,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
5433,GO:0016295,0.999999999977499,0.818675627939098,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5434,GO:0016296,0.999999999977499,0.818675627939098,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5435,GO:0016297,0.999999999977499,0.818675627939098,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
16853,GO:0098770,0.999999999977507,0.779801130278572,0,2,FBXO family protein binding,MF,
14762,GO:0070436,0.999999999977521,0.824914501765391,0,2,Grb2-EGFR complex,CC,
17956,GO:1902308,0.999999999977532,0.776637339404608,0,3,regulation of peptidyl-serine dephosphorylation,BP,
5996,GO:0019002,0.999999999977578,0.837904147346512,0,2,GMP binding,MF,
1809,GO:0004458,0.999999999977584,0.923612349373018,0,1,D-lactate dehydrogenase (cytochrome) activity,MF,
4011,GO:0008995,0.999999999977584,0.923612349373018,0,1,ribonuclease E activity,MF,
5750,GO:0016898,0.999999999977584,0.923612349373018,0,1,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6163,GO:0019516,0.999999999977584,0.923612349373018,0,1,lactate oxidation,BP,
16214,GO:0090247,0.999999999977584,0.923612349373018,0,1,cell motility involved in somitogenic axis elongation,BP,
16215,GO:0090249,0.999999999977584,0.923612349373018,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17591,GO:1901229,0.999999999977584,0.923612349373018,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17592,GO:1901231,0.999999999977584,0.923612349373018,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
17593,GO:1901232,0.999999999977584,0.923612349373018,0,1,regulation of convergent extension involved in axis elongation,BP,
17594,GO:1901233,0.999999999977584,0.923612349373018,0,1,negative regulation of convergent extension involved in axis elongation,BP,
8479,GO:0033624,0.999999999977584,0.805106971354361,0,2,negative regulation of integrin activation,BP,
19574,GO:1990604,0.999999999977594,0.75155706584603,0,3,IRE1-TRAF2-ASK1 complex,CC,
1270,GO:0003057,0.999999999977598,0.793117921242504,0,3,regulation of the force of heart contraction by chemical signal,BP,
5698,GO:0016822,0.999999999977607,0.880065208022205,0,2,hydrolase activity, acting on acid carbon-carbon bonds,MF,
5699,GO:0016823,0.999999999977607,0.880065208022205,0,2,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
19272,GO:1905462,0.999999999977628,0.80645206832129,0,2,regulation of DNA duplex unwinding,BP,
9200,GO:0035582,0.999999999977632,0.747505082611201,0,3,sequestering of BMP in extracellular matrix,BP,
14324,GO:0061485,0.999999999977658,0.881142071295341,0,1,memory T cell proliferation,BP,
18760,GO:1904245,0.999999999977658,0.857832225238928,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
6386,GO:0021577,0.999999999977676,0.905719461116306,0,1,hindbrain structural organization,BP,
6390,GO:0021589,0.999999999977676,0.905719461116306,0,1,cerebellum structural organization,BP,
14084,GO:0060904,0.999999999977676,0.905719461116306,0,1,regulation of protein folding in endoplasmic reticulum,BP,
18788,GO:1904313,0.999999999977676,0.905719461116306,0,1,response to methamphetamine hydrochloride,BP,
20001,GO:2000611,0.999999999977676,0.83170807113576,0,2,positive regulation of thyroid hormone generation,BP,
2710,GO:0006083,0.999999999977684,0.740462401503843,0,3,acetate metabolic process,BP,
11603,GO:0046208,0.999999999977704,0.823645073037983,0,3,spermine catabolic process,BP,
6026,GO:0019085,0.999999999977706,0.822559261391277,0,2,early viral transcription,BP,
766,GO:0002017,0.999999999977751,0.933403622324478,0,1,regulation of blood volume by renal aldosterone,BP,
18934,GO:1904685,0.999999999977753,0.832213462320642,0,2,positive regulation of metalloendopeptidase activity,BP,
17374,GO:1900095,0.999999999977773,0.863979565972583,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
4544,GO:0010621,0.999999999977773,0.945762294339179,0,1,negative regulation of transcription by transcription factor localization,BP,
9512,GO:0036164,0.999999999977773,0.945762294339179,0,1,cell-abiotic substrate adhesion,BP,
923,GO:0002318,0.99999999997778,0.775318314968283,0,3,myeloid progenitor cell differentiation,BP,
13299,GO:0052031,0.999999999977786,0.781027224102427,0,3,modulation by symbiont of host defense response,BP,
13333,GO:0052255,0.999999999977786,0.781027224102427,0,3,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
13365,GO:0052552,0.999999999977786,0.781027224102427,0,3,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
13366,GO:0052553,0.999999999977786,0.781027224102427,0,3,modulation by symbiont of host immune response,BP,
15961,GO:0075528,0.999999999977786,0.781027224102427,0,3,modulation by virus of host immune response,BP,
9925,GO:0042271,0.999999999977791,0.804714363987968,0,2,susceptibility to natural killer cell mediated cytotoxicity,BP,
9216,GO:0035602,0.999999999977799,0.904311263933615,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9217,GO:0035603,0.999999999977799,0.904311263933615,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9218,GO:0035604,0.999999999977799,0.904311263933615,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
13932,GO:0060595,0.999999999977799,0.904311263933615,0,1,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
13945,GO:0060615,0.999999999977799,0.904311263933615,0,1,mammary gland bud formation,BP,
13955,GO:0060648,0.999999999977799,0.904311263933615,0,1,mammary gland bud morphogenesis,BP,
13961,GO:0060667,0.999999999977799,0.904311263933615,0,1,branch elongation involved in salivary gland morphogenesis,BP,
14090,GO:0060915,0.999999999977799,0.904311263933615,0,1,mesenchymal cell differentiation involved in lung development,BP,
1962,GO:0004671,0.999999999977818,0.897904052823112,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
6046,GO:0019166,0.999999999977827,0.811058154633633,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
1003,GO:0002477,0.999999999977829,0.947716266048671,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1007,GO:0002481,0.999999999977829,0.947716266048671,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1714,GO:0004306,0.999999999977839,0.9337236022594,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
777,GO:0002032,0.999999999977846,0.868808169079965,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
4247,GO:0009447,0.999999999977853,0.83907309328736,0,3,putrescine catabolic process,BP,
15618,GO:0072103,0.999999999977912,0.820455723499233,0,2,glomerulus vasculature morphogenesis,BP,
15619,GO:0072104,0.999999999977912,0.820455723499233,0,2,glomerular capillary formation,BP,
11067,GO:0045065,0.999999999977919,0.852268082927167,0,2,cytotoxic T cell differentiation,BP,
11278,GO:0045583,0.999999999977919,0.852268082927167,0,2,regulation of cytotoxic T cell differentiation,BP,
11279,GO:0045585,0.999999999977919,0.852268082927167,0,2,positive regulation of cytotoxic T cell differentiation,BP,
4865,GO:0014717,0.999999999977927,0.86071709288512,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4866,GO:0014718,0.999999999977927,0.86071709288512,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
4940,GO:0014901,0.999999999977927,0.86071709288512,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
7294,GO:0031291,0.999999999977929,0.787532442724412,0,3,Ran protein signal transduction,BP,
2793,GO:0006231,0.999999999977936,0.808182260716152,0,3,dTMP biosynthetic process,BP,
11544,GO:0046073,0.999999999977936,0.808182260716152,0,3,dTMP metabolic process,BP,
14150,GO:0061030,0.99999999997795,0.852269041823384,0,2,epithelial cell differentiation involved in mammary gland alveolus development,BP,
19035,GO:1904879,0.999999999977953,0.837341397619248,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
1488,GO:0003826,0.999999999977955,0.862945139016214,0,2,alpha-ketoacid dehydrogenase activity,MF,
1506,GO:0003863,0.999999999977955,0.862945139016214,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
5999,GO:0019008,0.999999999977955,0.849750995425593,0,2,molybdopterin synthase complex,CC,
12095,GO:0048073,0.999999999977965,0.813536499864706,0,2,regulation of eye pigmentation,BP,
2064,GO:0004818,0.999999999977973,0.812209392664989,0,2,glutamate-tRNA ligase activity,MF,
2914,GO:0006424,0.999999999977973,0.812209392664989,0,2,glutamyl-tRNA aminoacylation,BP,
3777,GO:0008331,0.99999999997798,0.777899229476038,0,3,high voltage-gated calcium channel activity,MF,
16500,GO:0097195,0.999999999977983,0.835931388952599,0,2,pilomotor reflex,BP,
7352,GO:0031393,0.999999999978008,0.831307066135449,0,2,negative regulation of prostaglandin biosynthetic process,BP,
3882,GO:0008513,0.999999999978015,0.928965297034788,0,1,secondary active organic cation transmembrane transporter activity,MF,
833,GO:0002127,0.999999999978055,0.940189127151273,0,1,tRNA wobble base cytosine methylation,BP,
1246,GO:0002946,0.999999999978055,0.940189127151273,0,1,tRNA C5-cytosine methylation,BP,
2118,GO:0004909,0.999999999978083,0.836244005419552,0,2,interleukin-1, Type I, activating receptor activity,MF,
3080,GO:0006651,0.999999999978108,0.836555994667587,0,2,diacylglycerol biosynthetic process,BP,
16614,GO:0097450,0.999999999978111,0.830892107659264,0,2,astrocyte end-foot,CC,
16615,GO:0097451,0.999999999978111,0.830892107659264,0,2,glial limiting end-foot,CC,
1600,GO:0004019,0.999999999978118,0.921289350011857,0,1,adenylosuccinate synthase activity,MF,
9359,GO:0035870,0.999999999978126,0.841610423617478,0,2,dITP diphosphatase activity,MF,
1934,GO:0004633,0.999999999978134,0.928635922398309,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
1953,GO:0004657,0.999999999978134,0.928635922398309,0,1,proline dehydrogenase activity,MF,
2067,GO:0004821,0.999999999978139,0.862065360458702,0,2,histidine-tRNA ligase activity,MF,
2917,GO:0006427,0.999999999978139,0.862065360458702,0,2,histidyl-tRNA aminoacylation,BP,
16977,GO:0099010,0.999999999978145,0.726918697154906,0,3,modification of postsynaptic structure,BP,
15291,GO:0071475,0.999999999978157,0.797733275601271,0,3,cellular hyperosmotic salinity response,BP,
2333,GO:0005350,0.999999999978159,0.852238039872423,0,2,pyrimidine nucleobase transmembrane transporter activity,MF,
5237,GO:0015855,0.999999999978159,0.852238039872423,0,2,pyrimidine nucleobase transport,BP,
19006,GO:1904823,0.999999999978159,0.852238039872423,0,2,purine nucleobase transmembrane transport,BP,
19841,GO:2000312,0.99999999997817,0.743672768748586,0,3,regulation of kainate selective glutamate receptor activity,BP,
11223,GO:0045356,0.999999999978178,0.82267359372269,0,2,positive regulation of interferon-alpha biosynthetic process,BP,
4099,GO:0009153,0.999999999978208,0.882153196009874,0,2,purine deoxyribonucleotide biosynthetic process,BP,
7769,GO:0032289,0.99999999997821,0.780034553587244,0,3,central nervous system myelin formation,BP,
16007,GO:0086015,0.999999999978233,0.803691682248606,0,2,SA node cell action potential,BP,
16010,GO:0086018,0.999999999978233,0.803691682248606,0,2,SA node cell to atrial cardiac muscle cell signaling,BP,
3827,GO:0008426,0.999999999978239,0.812445173717176,0,3,protein kinase C inhibitor activity,MF,
1730,GO:0004325,0.999999999978242,0.882434635902328,0,1,ferrochelatase activity,MF,
17414,GO:1900150,0.999999999978247,0.863888208781248,0,2,regulation of defense response to fungus,BP,
3840,GO:0008446,0.999999999978265,0.936419678296463,0,1,GDP-mannose 4,6-dehydratase activity,MF,
13602,GO:0060072,0.999999999978279,0.888406236311629,0,1,large conductance calcium-activated potassium channel activity,MF,
5143,GO:0015670,0.999999999978284,0.936556840474562,0,1,carbon dioxide transport,BP,
8142,GO:0032849,0.999999999978284,0.936556840474562,0,1,positive regulation of cellular pH reduction,BP,
13889,GO:0060528,0.999999999978285,0.720074313671134,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
5272,GO:0015920,0.999999999978289,0.922365027522282,0,1,lipopolysaccharide transport,BP,
7922,GO:0032497,0.999999999978289,0.922365027522282,0,1,detection of lipopolysaccharide,BP,
14793,GO:0070506,0.999999999978289,0.922365027522282,0,1,high-density lipoprotein particle receptor activity,MF,
14047,GO:0060800,0.999999999978317,0.817330179200571,0,2,regulation of cell differentiation involved in embryonic placenta development,BP,
20011,GO:2000625,0.999999999978318,0.829370634646135,0,2,regulation of miRNA catabolic process,BP,
20012,GO:2000627,0.999999999978318,0.829370634646135,0,2,positive regulation of miRNA catabolic process,BP,
8986,GO:0035092,0.999999999978323,0.711078174410369,0,3,sperm chromatin condensation,BP,
8503,GO:0033680,0.999999999978346,0.829802745900054,0,2,ATP-dependent DNA/RNA helicase activity,MF,
18394,GO:1903420,0.999999999978365,0.887573785025956,0,1,protein localization to endoplasmic reticulum tubular network,BP,
20254,GO:2001206,0.999999999978377,0.787508697480088,0,3,positive regulation of osteoclast development,BP,
7008,GO:0030692,0.999999999978378,0.861083253297912,0,2,Noc4p-Nop14p complex,CC,
7370,GO:0031417,0.999999999978427,0.709712480771502,0,3,NatC complex,CC,
3679,GO:0008176,0.99999999997845,0.881695750979068,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
17191,GO:0106004,0.99999999997845,0.881695750979068,0,2,tRNA (guanine-N7)-methylation,BP,
1002,GO:0002476,0.999999999978454,0.847481668101383,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
16216,GO:0090251,0.999999999978489,0.859714576899698,0,1,protein localization involved in establishment of planar polarity,BP,
1903,GO:0004588,0.999999999978505,0.92272736543673,0,1,orotate phosphoribosyltransferase activity,MF,
1904,GO:0004590,0.999999999978505,0.92272736543673,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
1235,GO:0002923,0.999999999978521,0.86925768406032,0,2,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
18533,GO:1903722,0.999999999978528,0.866493508601499,0,2,regulation of centriole elongation,BP,
6799,GO:0030240,0.999999999978536,0.746705632412794,0,1,skeletal muscle thin filament assembly,BP,
7381,GO:0031433,0.999999999978536,0.746705632412794,0,1,telethonin binding,MF,
9428,GO:0035995,0.999999999978536,0.746705632412794,0,1,detection of muscle stretch,BP,
12397,GO:0048822,0.999999999978543,0.730460083444552,0,3,enucleate erythrocyte development,BP,
16027,GO:0086045,0.999999999978559,0.817100000863354,0,2,membrane depolarization during AV node cell action potential,BP,
1764,GO:0004367,0.999999999978562,0.906340865872001,0,1,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
11593,GO:0046168,0.999999999978562,0.906340865872001,0,1,glycerol-3-phosphate catabolic process,BP,
19433,GO:1990047,0.999999999978589,0.927802821664362,0,1,spindle matrix,CC,
11162,GO:0045219,0.999999999978614,0.893481789437929,0,1,regulation of FasL biosynthetic process,BP,
11163,GO:0045221,0.999999999978614,0.893481789437929,0,1,negative regulation of FasL biosynthetic process,BP,
9959,GO:0042328,0.999999999978635,0.728444551928595,0,3,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
3436,GO:0007225,0.999999999978641,0.898424681420038,0,1,patched ligand maturation,BP,
9245,GO:0035638,0.999999999978641,0.898424681420038,0,1,signal maturation,BP,
2751,GO:0006154,0.999999999978657,0.867134510341696,0,2,adenosine catabolic process,BP,
11562,GO:0046103,0.999999999978657,0.867134510341696,0,2,inosine biosynthetic process,BP,
19091,GO:1904995,0.99999999997867,0.873735270159611,0,2,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
1575,GO:0003985,0.999999999978678,0.800328471884994,0,3,acetyl-CoA C-acetyltransferase activity,MF,
11918,GO:0046958,0.999999999978689,0.914449852188859,0,1,nonassociative learning,BP,
17660,GO:1901491,0.99999999997869,0.811687641627787,0,2,negative regulation of lymphangiogenesis,BP,
17900,GO:1902202,0.999999999978692,0.855303505903029,0,2,regulation of hepatocyte growth factor receptor signaling pathway,BP,
13425,GO:0052827,0.999999999978695,0.841601973003341,0,2,inositol pentakisphosphate phosphatase activity,MF,
11310,GO:0045627,0.999999999978724,0.782609600854247,0,3,positive regulation of T-helper 1 cell differentiation,BP,
2371,GO:0005499,0.999999999978738,0.836517001738592,0,2,vitamin D binding,MF,
3906,GO:0008545,0.999999999978738,0.82926928373424,0,2,JUN kinase kinase activity,MF,
17259,GO:0120043,0.999999999978739,0.898416810229438,0,1,stereocilium shaft,CC,
17260,GO:0120044,0.999999999978739,0.898416810229438,0,1,stereocilium base,CC,
3862,GO:0008481,0.99999999997875,0.857600965772588,0,2,sphinganine kinase activity,MF,
5800,GO:0017050,0.99999999997875,0.857600965772588,0,2,D-erythro-sphingosine kinase activity,MF,
2406,GO:0005577,0.999999999978757,0.721132918169506,0,3,fibrinogen complex,CC,
1814,GO:0004464,0.999999999978758,0.906707396085263,0,2,leukotriene-C4 synthase activity,MF,
1937,GO:0004638,0.999999999978766,0.913448951426718,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
1938,GO:0004639,0.999999999978766,0.913448951426718,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
16732,GO:0097742,0.999999999978766,0.726852933870121,0,3,de novo centriole assembly,BP,
16757,GO:0098535,0.999999999978766,0.726852933870121,0,3,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
1773,GO:0004378,0.99999999997877,0.919368060419035,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
17164,GO:0102704,0.99999999997877,0.919368060419035,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
5416,GO:0016263,0.999999999978783,0.871472826827006,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5419,GO:0016267,0.999999999978783,0.871472826827006,0,2,O-glycan processing, core 1,BP,
13958,GO:0060664,0.999999999978788,0.774401050271787,0,3,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
19163,GO:1905203,0.999999999978794,0.846760129742421,0,2,regulation of connective tissue replacement,BP,
6316,GO:0019961,0.999999999978803,0.811018029114495,0,2,interferon binding,MF,
9658,GO:0038001,0.999999999978824,0.859861941399746,0,2,paracrine signaling,BP,
14994,GO:0070905,0.999999999978826,0.860667199112452,0,2,serine binding,MF,
17283,GO:0140031,0.999999999978832,0.851275173050672,0,2,phosphorylation-dependent protein binding,MF,
19780,GO:2000199,0.999999999978833,0.916744852410434,0,1,positive regulation of ribonucleoprotein complex localization,BP,
19781,GO:2000200,0.999999999978833,0.916744852410434,0,1,regulation of ribosomal subunit export from nucleus,BP,
19782,GO:2000202,0.999999999978833,0.916744852410434,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
19783,GO:2000206,0.999999999978833,0.916744852410434,0,1,regulation of ribosomal small subunit export from nucleus,BP,
19784,GO:2000208,0.999999999978833,0.916744852410434,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
18519,GO:1903691,0.999999999978851,0.764645790033986,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
9780,GO:0039689,0.999999999978857,0.776178249822077,0,3,negative stranded viral RNA replication,BP,
17957,GO:1902309,0.99999999997886,0.838307396279956,0,2,negative regulation of peptidyl-serine dephosphorylation,BP,
1312,GO:0003160,0.999999999978874,0.757215439888863,0,3,endocardium morphogenesis,BP,
9629,GO:0036496,0.999999999978912,0.870498603052573,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
2112,GO:0004897,0.999999999978924,0.716683346058762,0,3,ciliary neurotrophic factor receptor activity,MF,
14580,GO:0070120,0.999999999978924,0.716683346058762,0,3,ciliary neurotrophic factor-mediated signaling pathway,BP,
3854,GO:0008467,0.999999999978938,0.809502040871755,0,3,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
12500,GO:0050561,0.999999999978966,0.906272372427493,0,1,glutamate-tRNA(Gln) ligase activity,MF,
4837,GO:0014043,0.999999999978987,0.846518475991678,0,2,negative regulation of neuron maturation,BP,
20112,GO:2000790,0.999999999978992,0.795812365963842,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
20113,GO:2000791,0.999999999978992,0.795812365963842,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
2474,GO:0005690,0.999999999979006,0.854257612633272,0,2,U4atac snRNP,CC,
15054,GO:0071005,0.999999999979006,0.854257612633272,0,2,U2-type precatalytic spliceosome,CC,
11011,GO:0044830,0.999999999979008,0.828892939217835,0,2,modulation by host of viral RNA genome replication,BP,
16945,GO:0098926,0.999999999979027,0.884287515538044,0,1,postsynaptic signal transduction,BP,
17050,GO:0099527,0.999999999979027,0.884287515538044,0,1,postsynapse to nucleus signaling pathway,BP,
978,GO:0002432,0.999999999979038,0.901209506772678,0,1,granuloma formation,BP,
16776,GO:0098582,0.999999999979095,0.809858493653195,0,2,innate vocalization behavior,BP,
12962,GO:0051344,0.999999999979104,0.766451057609183,0,3,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12629,GO:0050816,0.999999999979114,0.763995448941245,0,3,phosphothreonine residue binding,MF,
1587,GO:0003998,0.999999999979119,0.900087990058412,0,2,acylphosphatase activity,MF,
12042,GO:0047800,0.999999999979127,0.908640332857426,0,1,cysteamine dioxygenase activity,MF,
10667,GO:0043874,0.999999999979138,0.931485686798527,0,1,acireductone synthase activity,MF,
1690,GO:0004164,0.999999999979146,0.93469313623296,0,1,diphthine synthase activity,MF,
1735,GO:0004333,0.999999999979146,0.93469313623296,0,1,fumarate hydratase activity,MF,
14128,GO:0060994,0.99999999997915,0.849564685617354,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
8640,GO:0034165,0.999999999979163,0.831396384040193,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9659,GO:0038002,0.999999999979167,0.894070978304881,0,1,endocrine signaling,BP,
897,GO:0002276,0.999999999979174,0.840254045627932,0,2,basophil activation involved in immune response,BP,
11270,GO:0045575,0.999999999979174,0.840254045627932,0,2,basophil activation,BP,
16422,GO:0097057,0.999999999979196,0.879681880260035,0,2,TRAF2-GSTP1 complex,CC,
3790,GO:0008355,0.999999999979208,0.901263925202704,0,1,olfactory learning,BP,
2694,GO:0006059,0.999999999979211,0.818643111962034,0,3,hexitol metabolic process,BP,
1320,GO:0003169,0.999999999979223,0.793415971998851,0,2,coronary vein morphogenesis,BP,
14106,GO:0060948,0.999999999979223,0.793415971998851,0,2,cardiac vascular smooth muscle cell development,BP,
9424,GO:0035990,0.999999999979225,0.859609732069681,0,2,tendon cell differentiation,BP,
9425,GO:0035992,0.999999999979225,0.859609732069681,0,2,tendon formation,BP,
937,GO:0002339,0.999999999979236,0.883258202748372,0,2,B cell selection,BP,
941,GO:0002352,0.999999999979236,0.883258202748372,0,2,B cell negative selection,BP,
9156,GO:0035508,0.999999999979247,0.892528910321768,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
1712,GO:0004304,0.999999999979261,0.934841347114892,0,1,estrone sulfotransferase activity,MF,
3087,GO:0006660,0.999999999979261,0.934841347114892,0,1,phosphatidylserine catabolic process,BP,
3130,GO:0006711,0.999999999979261,0.934841347114892,0,1,estrogen catabolic process,BP,
11219,GO:0045352,0.999999999979261,0.934841347114892,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11220,GO:0045353,0.999999999979261,0.934841347114892,0,1,interleukin-1 Type II receptor antagonist activity,MF,
18002,GO:1902463,0.999999999979277,0.881423017610913,0,2,protein localization to cell leading edge,BP,
13323,GO:0052203,0.999999999979277,0.861779847176196,0,2,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
10665,GO:0043849,0.999999999979278,0.919198280941974,0,1,Ras palmitoyltransferase activity,MF,
19631,GO:1990812,0.999999999979309,0.758643446288001,0,3,growth cone filopodium,CC,
5390,GO:0016222,0.99999999997933,0.849871924305328,0,2,procollagen-proline 4-dioxygenase complex,CC,
14987,GO:0070898,0.999999999979334,0.86130611858027,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
619,GO:0001792,0.99999999997936,0.902489826739418,0,1,polymeric immunoglobulin receptor activity,MF,
962,GO:0002386,0.99999999997936,0.902489826739418,0,1,immune response in mucosal-associated lymphoid tissue,BP,
968,GO:0002415,0.99999999997936,0.902489826739418,0,1,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
7855,GO:0032415,0.999999999979363,0.776460252645008,0,3,regulation of sodium:proton antiporter activity,BP,
17779,GO:1901837,0.999999999979392,0.86669829735114,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
18053,GO:1902595,0.999999999979404,0.867500838463727,0,2,regulation of DNA replication origin binding,BP,
19951,GO:2000501,0.999999999979406,0.879573490154764,0,2,regulation of natural killer cell chemotaxis,BP,
19952,GO:2000503,0.999999999979406,0.879573490154764,0,2,positive regulation of natural killer cell chemotaxis,BP,
19778,GO:2000196,0.999999999979418,0.851298172731588,0,2,positive regulation of female gonad development,BP,
19896,GO:2000386,0.999999999979418,0.851298172731588,0,2,positive regulation of ovarian follicle development,BP,
9281,GO:0035712,0.999999999979429,0.914396249064543,0,1,T-helper 2 cell activation,BP,
19981,GO:2000569,0.999999999979429,0.914396249064543,0,1,regulation of T-helper 2 cell activation,BP,
19982,GO:2000570,0.999999999979429,0.914396249064543,0,1,positive regulation of T-helper 2 cell activation,BP,
130,GO:0000270,0.999999999979455,0.882181333186547,0,2,peptidoglycan metabolic process,BP,
3963,GO:0008745,0.999999999979455,0.882181333186547,0,2,N-acetylmuramoyl-L-alanine amidase activity,MF,
4178,GO:0009253,0.999999999979455,0.882181333186547,0,2,peptidoglycan catabolic process,BP,
5310,GO:0016019,0.999999999979455,0.882181333186547,0,2,peptidoglycan receptor activity,MF,
13144,GO:0051710,0.999999999979455,0.882181333186547,0,2,regulation of cytolysis in other organism,BP,
13146,GO:0051714,0.999999999979455,0.882181333186547,0,2,positive regulation of cytolysis in other organism,BP,
5545,GO:0016534,0.999999999979456,0.907070027345387,0,1,cyclin-dependent protein kinase 5 activator activity,MF,
6388,GO:0021586,0.999999999979456,0.907070027345387,0,1,pons maturation,BP,
6437,GO:0021718,0.999999999979456,0.907070027345387,0,1,superior olivary nucleus development,BP,
6438,GO:0021722,0.999999999979456,0.907070027345387,0,1,superior olivary nucleus maturation,BP,
8388,GO:0033292,0.999999999979469,0.769424837164047,0,2,T-tubule organization,BP,
3095,GO:0006668,0.99999999997948,0.839558732546459,0,2,sphinganine-1-phosphate metabolic process,BP,
15977,GO:0080121,0.999999999979482,0.850287215574606,0,2,AMP transport,BP,
6371,GO:0021555,0.999999999979486,0.840844570836435,0,2,midbrain-hindbrain boundary morphogenesis,BP,
1723,GO:0004315,0.99999999997949,0.825326197151165,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
12815,GO:0051120,0.999999999979496,0.846663561779251,0,2,hepoxilin A3 synthase activity,MF,
12151,GO:0048257,0.999999999979535,0.851544585530412,0,2,3'-flap endonuclease activity,MF,
18873,GO:1904533,0.99999999997954,0.760275353832057,0,3,regulation of telomeric loop disassembly,BP,
15979,GO:0080129,0.999999999979542,0.945881355383232,0,1,proteasome core complex assembly,BP,
11815,GO:0046707,0.999999999979549,0.835280805563511,0,2,IDP metabolic process,BP,
11816,GO:0046709,0.999999999979549,0.835280805563511,0,2,IDP catabolic process,BP,
6299,GO:0019912,0.999999999979553,0.861165417840145,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
3098,GO:0006671,0.999999999979559,0.901418911789807,0,1,phytosphingosine metabolic process,BP,
14923,GO:0070774,0.999999999979559,0.901418911789807,0,1,phytoceramidase activity,MF,
15365,GO:0071602,0.999999999979559,0.901418911789807,0,1,phytosphingosine biosynthetic process,BP,
2103,GO:0004874,0.999999999979583,0.797928519193095,0,2,aryl hydrocarbon receptor activity,MF,
2127,GO:0004924,0.999999999979601,0.721125925080378,0,3,oncostatin-M receptor activity,MF,
9725,GO:0038165,0.999999999979601,0.721125925080378,0,3,oncostatin-M-mediated signaling pathway,BP,
17355,GO:1900042,0.999999999979612,0.775302483305402,0,2,positive regulation of interleukin-2 secretion,BP,
9239,GO:0035630,0.999999999979627,0.822735571120032,0,2,bone mineralization involved in bone maturation,BP,
2275,GO:0005219,0.999999999979654,0.795880925396279,0,2,ryanodine-sensitive calcium-release channel activity,MF,
5993,GO:0018993,0.999999999979657,0.919286574675127,0,1,somatic sex determination,BP,
6033,GO:0019101,0.999999999979657,0.919286574675127,0,1,female somatic sex determination,BP,
13553,GO:0060014,0.999999999979657,0.919286574675127,0,1,granulosa cell differentiation,BP,
1413,GO:0003350,0.999999999979707,0.831131991752323,0,2,pulmonary myocardium development,BP,
12139,GO:0048239,0.999999999979747,0.855173289388747,0,2,negative regulation of DNA recombination at telomere,BP,
15918,GO:0072695,0.999999999979747,0.855173289388747,0,2,regulation of DNA recombination at telomere,BP,
580,GO:0001732,0.999999999979754,0.833753156547169,0,2,formation of cytoplasmic translation initiation complex,BP,
8875,GO:0034680,0.999999999979756,0.812876044130475,0,2,integrin alpha10-beta1 complex,CC,
10521,GO:0043435,0.999999999979758,0.841340061735525,0,2,response to corticotropin-releasing hormone,BP,
15224,GO:0071376,0.999999999979758,0.841340061735525,0,2,cellular response to corticotropin-releasing hormone stimulus,BP,
17444,GO:1900220,0.99999999997977,0.794447910866832,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
17914,GO:1902226,0.999999999979776,0.866541358115259,0,2,regulation of macrophage colony-stimulating factor signaling pathway,BP,
18653,GO:1903969,0.999999999979776,0.866541358115259,0,2,regulation of response to macrophage colony-stimulating factor,BP,
18656,GO:1903972,0.999999999979776,0.866541358115259,0,2,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
18814,GO:1904381,0.999999999979779,0.808007019083816,0,2,Golgi apparatus mannose trimming,BP,
14056,GO:0060830,0.999999999979785,0.773353650317805,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
19822,GO:2000282,0.999999999979785,0.828629884219667,0,2,regulation of cellular amino acid biosynthetic process,BP,
9524,GO:0036228,0.999999999979789,0.836093790887961,0,2,protein localization to nuclear inner membrane,BP,
3863,GO:0008482,0.999999999979801,0.927069549373062,0,1,sulfite oxidase activity,MF,
9869,GO:0042128,0.999999999979801,0.927069549373062,0,1,nitrate assimilation,BP,
17013,GO:0099130,0.999999999979802,0.928567422205227,0,1,estrogen binding,MF,
18632,GO:1903924,0.999999999979802,0.928567422205227,0,1,estradiol binding,MF,
11039,GO:0045016,0.999999999979805,0.913409112935928,0,1,mitochondrial magnesium ion transmembrane transport,BP,
8110,GO:0032796,0.999999999979806,0.825568259265868,0,2,uropod organization,BP,
787,GO:0002046,0.999999999979808,0.947889143707158,0,1,opsin binding,MF,
9573,GO:0036372,0.999999999979808,0.947889143707158,0,1,opsin transport,BP,
15921,GO:0072702,0.999999999979815,0.892344904871406,0,1,response to methyl methanesulfonate,BP,
15922,GO:0072703,0.999999999979815,0.892344904871406,0,1,cellular response to methyl methanesulfonate,BP,
9404,GO:0035962,0.999999999979815,0.907187395275775,0,1,response to interleukin-13,BP,
9405,GO:0035963,0.999999999979815,0.907187395275775,0,1,cellular response to interleukin-13,BP,
12460,GO:0050277,0.999999999979815,0.907187395275775,0,1,sedoheptulokinase activity,MF,
15529,GO:0071914,0.999999999979815,0.907187395275775,0,1,prominosome,CC,
7363,GO:0031405,0.999999999979841,0.862805017306124,0,1,lipoic acid binding,MF,
10659,GO:0043754,0.999999999979841,0.862805017306124,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
19928,GO:2000434,0.999999999979856,0.903687168532971,0,2,regulation of protein neddylation,BP,
19929,GO:2000435,0.999999999979856,0.903687168532971,0,2,negative regulation of protein neddylation,BP,
6383,GO:0021571,0.999999999979858,0.913316220640371,0,1,rhombomere 5 development,BP,
6384,GO:0021572,0.999999999979858,0.913316220640371,0,1,rhombomere 6 development,BP,
9061,GO:0035283,0.999999999979858,0.913316220640371,0,1,central nervous system segmentation,BP,
9062,GO:0035284,0.999999999979858,0.913316220640371,0,1,brain segmentation,BP,
9964,GO:0042350,0.999999999979862,0.798806203348115,0,3,GDP-L-fucose biosynthetic process,BP,
19594,GO:1990715,0.999999999979863,0.904713909544705,0,1,mRNA CDS binding,MF,
12074,GO:0048022,0.99999999997987,0.788606347439428,0,2,negative regulation of melanin biosynthetic process,BP,
17482,GO:1900377,0.99999999997987,0.788606347439428,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
7660,GO:0032089,0.999999999979878,0.822739144643013,0,2,NACHT domain binding,MF,
7504,GO:0031682,0.99999999997989,0.91756673116649,0,1,G-protein gamma-subunit binding,MF,
18116,GO:1902773,0.99999999997989,0.91756673116649,0,1,GTPase activator complex,CC,
2727,GO:0006106,0.999999999979919,0.804353153880573,0,3,fumarate metabolic process,BP,
18067,GO:1902626,0.999999999979929,0.849121369326388,0,3,assembly of large subunit precursor of preribosome,BP,
2009,GO:0004735,0.999999999979937,0.873676694642643,0,2,pyrroline-5-carboxylate reductase activity,MF,
8790,GO:0034473,0.999999999979937,0.83299337474031,0,3,U1 snRNA 3'-end processing,BP,
8793,GO:0034476,0.999999999979937,0.83299337474031,0,3,U5 snRNA 3'-end processing,BP,
55,GO:0000117,0.999999999979968,0.89229821179051,0,1,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
1318,GO:0003166,0.99999999997997,0.845716636731292,0,2,bundle of His development,BP,
921,GO:0002316,0.999999999979972,0.90259616493563,0,1,follicular B cell differentiation,BP,
5953,GO:0018315,0.999999999979972,0.90259616493563,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
9825,GO:0042040,0.999999999979972,0.90259616493563,0,1,metal incorporation into metallo-molybdopterin complex,BP,
14370,GO:0061598,0.999999999979972,0.90259616493563,0,1,molybdopterin adenylyltransferase activity,MF,
14371,GO:0061599,0.999999999979972,0.90259616493563,0,1,molybdopterin molybdotransferase activity,MF,
15863,GO:0072579,0.999999999979972,0.90259616493563,0,1,glycine receptor clustering,BP,
16452,GO:0097112,0.999999999979972,0.90259616493563,0,1,gamma-aminobutyric acid receptor clustering,BP,
20041,GO:2000664,0.999999999979975,0.778261630682749,0,3,positive regulation of interleukin-5 secretion,BP,
20044,GO:2000667,0.999999999979975,0.778261630682749,0,3,positive regulation of interleukin-13 secretion,BP,
16456,GO:0097117,0.999999999979983,0.883087430177869,0,1,guanylate kinase-associated protein clustering,BP,
5806,GO:0017060,0.999999999979988,0.851751555741829,0,2,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
16383,GO:0090725,0.999999999979998,0.860677904559119,0,2,peripheral region of growth cone,CC,
10842,GO:0044336,0.999999999980002,0.755345489740656,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
8097,GO:0032782,0.999999999980002,0.86812276284789,0,2,bile acid secretion,BP,
19941,GO:2000474,0.999999999980019,0.90479961367629,0,1,regulation of opioid receptor signaling pathway,BP,
8706,GO:0034343,0.999999999980026,0.751898559075866,0,3,type III interferon production,BP,
8707,GO:0034344,0.999999999980026,0.751898559075866,0,3,regulation of type III interferon production,BP,
1189,GO:0002836,0.999999999980031,0.763082600605914,0,3,positive regulation of response to tumor cell,BP,
1192,GO:0002839,0.999999999980031,0.763082600605914,0,3,positive regulation of immune response to tumor cell,BP,
13561,GO:0060024,0.999999999980039,0.830628781818059,0,2,rhythmic synaptic transmission,BP,
14339,GO:0061534,0.999999999980059,0.854723336018935,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
1878,GO:0004557,0.99999999998009,0.854407271332571,0,2,alpha-galactosidase activity,MF,
4608,GO:0010724,0.9999999999801,0.755764745014442,0,3,regulation of definitive erythrocyte differentiation,BP,
19463,GO:1990167,0.999999999980102,0.737840089193821,0,3,protein K27-linked deubiquitination,BP,
1271,GO:0003062,0.999999999980113,0.686890216027834,0,4,regulation of heart rate by chemical signal,BP,
1731,GO:0004326,0.999999999980115,0.924953568972416,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
3986,GO:0008841,0.999999999980115,0.924953568972416,0,1,dihydrofolate synthase activity,MF,
11887,GO:0046901,0.999999999980115,0.924953568972416,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
7741,GO:0032240,0.999999999980116,0.774584270312072,0,2,negative regulation of nucleobase-containing compound transport,BP,
11851,GO:0046832,0.999999999980116,0.774584270312072,0,2,negative regulation of RNA export from nucleus,BP,
17221,GO:0106088,0.999999999980119,0.884804315511499,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
17222,GO:0106089,0.999999999980119,0.884804315511499,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
17268,GO:0120077,0.999999999980119,0.884804315511499,0,1,angiogenic sprout fusion,BP,
17269,GO:0120078,0.999999999980119,0.884804315511499,0,1,cell adhesion involved in sprouting angiogenesis,BP,
9559,GO:0036335,0.999999999980126,0.894738107467039,0,1,intestinal stem cell homeostasis,BP,
10376,GO:0043196,0.99999999998014,0.857787733070204,0,2,varicosity,CC,
8445,GO:0033565,0.999999999980159,0.752836788907739,0,3,ESCRT-0 complex,CC,
14827,GO:0070563,0.999999999980186,0.833495747625283,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
16524,GO:0097232,0.999999999980216,0.913488806221721,0,1,lamellar body membrane,CC,
16525,GO:0097233,0.999999999980216,0.913488806221721,0,1,alveolar lamellar body membrane,CC,
2884,GO:0006386,0.999999999980221,0.951056042555891,0,1,termination of RNA polymerase III transcription,BP,
13053,GO:0051543,0.99999999998023,0.926744733565795,0,1,regulation of elastin biosynthetic process,BP,
13054,GO:0051545,0.99999999998023,0.926744733565795,0,1,negative regulation of elastin biosynthetic process,BP,
1518,GO:0003880,0.999999999980243,0.777971550892103,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
2953,GO:0006481,0.999999999980243,0.777971550892103,0,3,C-terminal protein methylation,BP,
6004,GO:0019045,0.999999999980254,0.776997496125256,0,2,latent virus replication,BP,
6005,GO:0019046,0.999999999980254,0.776997496125256,0,2,release from viral latency,BP,
2373,GO:0005502,0.999999999980259,0.898886631843638,0,1,11-cis retinal binding,MF,
2374,GO:0005503,0.999999999980259,0.898886631843638,0,1,all-trans retinal binding,MF,
14487,GO:0061896,0.999999999980259,0.898886631843638,0,1,all-trans retinol 3,4-desaturase activity,MF,
14488,GO:0061897,0.999999999980259,0.898886631843638,0,1,all-trans retinal 3,4-desaturase activity,MF,
14489,GO:0061898,0.999999999980259,0.898886631843638,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
14490,GO:0061899,0.999999999980259,0.898886631843638,0,1,11-cis-retinal 3,4-desaturase activity,MF,
2144,GO:0004960,0.999999999980261,0.927945838187626,0,1,thromboxane receptor activity,MF,
2145,GO:0004961,0.999999999980261,0.927945838187626,0,1,thromboxane A2 receptor activity,MF,
5318,GO:0016036,0.999999999980261,0.927945838187626,0,1,cellular response to phosphate starvation,BP,
7326,GO:0031335,0.999999999980261,0.927945838187626,0,1,regulation of sulfur amino acid metabolic process,BP,
7327,GO:0031337,0.999999999980261,0.927945838187626,0,1,positive regulation of sulfur amino acid metabolic process,BP,
9335,GO:0035814,0.999999999980261,0.927945838187626,0,1,negative regulation of renal sodium excretion,BP,
9739,GO:0038193,0.999999999980261,0.927945838187626,0,1,thromboxane A2 signaling pathway,BP,
12523,GO:0050666,0.999999999980261,0.927945838187626,0,1,regulation of homocysteine metabolic process,BP,
12525,GO:0050668,0.999999999980261,0.927945838187626,0,1,positive regulation of homocysteine metabolic process,BP,
19724,GO:2000078,0.999999999980273,0.866729383517368,0,2,positive regulation of type B pancreatic cell development,BP,
9223,GO:0035609,0.999999999980293,0.901002254329686,0,1,C-terminal protein deglutamylation,BP,
9224,GO:0035610,0.999999999980293,0.901002254329686,0,1,protein side chain deglutamylation,BP,
3577,GO:0007621,0.999999999980296,0.881293645547123,0,1,negative regulation of female receptivity,BP,
8084,GO:0032765,0.999999999980298,0.916717710659845,0,1,positive regulation of mast cell cytokine production,BP,
6089,GO:0019255,0.999999999980307,0.866152607960567,0,2,glucose 1-phosphate metabolic process,BP,
1533,GO:0003918,0.999999999980315,0.798112663427086,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
14327,GO:0061505,0.999999999980315,0.798112663427086,0,2,DNA topoisomerase II activity,MF,
14453,GO:0061772,0.999999999980332,0.912471373076274,0,1,drug transport across blood-nerve barrier,BP,
18456,GO:1903544,0.999999999980332,0.912471373076274,0,1,response to butyrate,BP,
18457,GO:1903545,0.999999999980332,0.912471373076274,0,1,cellular response to butyrate,BP,
8664,GO:0034224,0.999999999980335,0.92823233848369,0,1,cellular response to zinc ion starvation,BP,
6837,GO:0030299,0.99999999998034,0.841890198926018,0,2,intestinal cholesterol absorption,BP,
10783,GO:0044241,0.99999999998034,0.841890198926018,0,2,lipid digestion,BP,
16903,GO:0098856,0.99999999998034,0.841890198926018,0,2,intestinal lipid absorption,BP,
2965,GO:0006500,0.999999999980342,0.929779364801087,0,1,N-terminal protein palmitoylation,BP,
5879,GO:0018009,0.999999999980342,0.929779364801087,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
7743,GO:0032252,0.999999999980348,0.705480903787032,0,3,secretory granule localization,BP,
1491,GO:0003829,0.99999999998036,0.814297843750178,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
12606,GO:0050785,0.999999999980363,0.941726923144512,0,1,advanced glycation end-product receptor activity,MF,
18905,GO:1904596,0.999999999980363,0.941726923144512,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18906,GO:1904597,0.999999999980363,0.941726923144512,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
18907,GO:1904599,0.999999999980363,0.941726923144512,0,1,advanced glycation end-product binding,MF,
18908,GO:1904603,0.999999999980363,0.941726923144512,0,1,regulation of advanced glycation end-product receptor activity,BP,
18909,GO:1904604,0.999999999980363,0.941726923144512,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
19164,GO:1905204,0.999999999980363,0.941726923144512,0,1,negative regulation of connective tissue replacement,BP,
17991,GO:1902423,0.999999999980367,0.822751439761815,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
17992,GO:1902425,0.999999999980367,0.822751439761815,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
3780,GO:0008336,0.999999999980374,0.933258681817236,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4989,GO:0015117,0.999999999980374,0.933258681817236,0,1,thiosulfate transmembrane transporter activity,MF,
4995,GO:0015131,0.999999999980374,0.933258681817236,0,1,oxaloacetate transmembrane transporter activity,MF,
5165,GO:0015709,0.999999999980374,0.933258681817236,0,1,thiosulfate transport,BP,
5175,GO:0015729,0.999999999980374,0.933258681817236,0,1,oxaloacetate transport,BP,
5181,GO:0015743,0.999999999980374,0.933258681817236,0,1,malate transport,BP,
15256,GO:0071423,0.999999999980374,0.933258681817236,0,1,malate transmembrane transport,BP,
17966,GO:1902356,0.999999999980374,0.933258681817236,0,1,oxaloacetate(2-) transmembrane transport,BP,
1961,GO:0004668,0.999999999980374,0.915418290637438,0,1,protein-arginine deiminase activity,MF,
2125,GO:0004921,0.999999999980374,0.915418290637438,0,1,interleukin-11 receptor activity,MF,
5897,GO:0018101,0.999999999980374,0.915418290637438,0,1,protein citrullination,BP,
6320,GO:0019970,0.999999999980374,0.915418290637438,0,1,interleukin-11 binding,MF,
9587,GO:0036414,0.999999999980374,0.915418290637438,0,1,histone citrullination,BP,
9719,GO:0038154,0.999999999980374,0.915418290637438,0,1,interleukin-11-mediated signaling pathway,BP,
8963,GO:0035026,0.999999999980381,0.821996802537034,0,2,leading edge cell differentiation,BP,
16523,GO:0097231,0.999999999980404,0.935828701732362,0,1,cell motility in response to calcium ion,BP,
19595,GO:1990716,0.999999999980404,0.935828701732362,0,1,axonemal central apparatus,CC,
13586,GO:0060053,0.999999999980412,0.819570210301483,0,2,neurofilament cytoskeleton,CC,
19599,GO:1990730,0.999999999980438,0.825868091325466,0,2,VCP-NSFL1C complex,CC,
6166,GO:0019520,0.999999999980453,0.857452985037752,0,2,aldonic acid metabolic process,BP,
6167,GO:0019521,0.999999999980453,0.857452985037752,0,2,D-gluconate metabolic process,BP,
17636,GO:1901355,0.999999999980472,0.823895944997807,0,2,response to rapamycin,BP,
2507,GO:0005760,0.999999999980484,0.811700311093722,0,2,gamma DNA polymerase complex,CC,
9385,GO:0035921,0.999999999980504,0.930335157701735,0,1,desmosome disassembly,BP,
17484,GO:1900387,0.999999999980504,0.930335157701735,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
6493,GO:0021849,0.999999999980514,0.829189024949302,0,2,neuroblast division in subventricular zone,BP,
19737,GO:2000110,0.999999999980533,0.791989312034729,0,3,negative regulation of macrophage apoptotic process,BP,
11755,GO:0046601,0.999999999980534,0.756958999088097,0,3,positive regulation of centriole replication,BP,
16457,GO:0097118,0.999999999980549,0.88466754531565,0,1,neuroligin clustering involved in postsynaptic membrane assembly,BP,
8451,GO:0033577,0.999999999980549,0.849824355893568,0,2,protein glycosylation in endoplasmic reticulum,BP,
8442,GO:0033560,0.999999999980551,0.906283776239291,0,1,folate reductase activity,MF,
13215,GO:0051870,0.999999999980551,0.906283776239291,0,1,methotrexate binding,MF,
19173,GO:1905222,0.999999999980561,0.916236353743602,0,1,atrioventricular canal morphogenesis,BP,
4613,GO:0010730,0.999999999980578,0.751242272508462,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
2292,GO:0005250,0.999999999980579,0.832071420854918,0,2,A-type (transient outward) potassium channel activity,MF,
952,GO:0002371,0.999999999980581,0.700246542961793,0,4,dendritic cell cytokine production,BP,
1138,GO:0002730,0.999999999980581,0.700246542961793,0,4,regulation of dendritic cell cytokine production,BP,
2224,GO:0005127,0.999999999980589,0.741005318937388,0,3,ciliary neurotrophic factor receptor binding,MF,
13166,GO:0051754,0.999999999980595,0.766645268334776,0,3,meiotic sister chromatid cohesion, centromeric,BP,
12174,GO:0048295,0.999999999980607,0.846241307277437,0,2,positive regulation of isotype switching to IgE isotypes,BP,
13711,GO:0060268,0.999999999980634,0.78036023798469,0,3,negative regulation of respiratory burst,BP,
1604,GO:0004027,0.999999999980646,0.943607713986618,0,1,alcohol sulfotransferase activity,MF,
13929,GO:0060591,0.999999999980646,0.750508918355503,0,3,chondroblast differentiation,BP,
16639,GO:0097498,0.999999999980668,0.831027844417999,0,2,endothelial tube lumen extension,BP,
4954,GO:0015018,0.999999999980673,0.940108967340129,0,1,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
14141,GO:0061009,0.9999999999807,0.788823441855029,0,3,common bile duct development,BP,
577,GO:0001729,0.999999999980711,0.827871474322746,0,2,ceramide kinase activity,MF,
3351,GO:0007079,0.999999999980714,0.724493984406267,0,3,mitotic chromosome movement towards spindle pole,BP,
9487,GO:0036122,0.999999999980738,0.730625732256304,0,3,BMP binding,MF,
8874,GO:0034678,0.999999999980757,0.816985607125642,0,2,integrin alpha8-beta1 complex,CC,
19758,GO:2000156,0.999999999980763,0.834098534171275,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
14738,GO:0070404,0.999999999980767,0.823377178681867,0,3,NADH binding,MF,
6312,GO:0019957,0.999999999980784,0.854475721581588,0,2,C-C chemokine binding,MF,
8004,GO:0032632,0.999999999980784,0.831045004386518,0,2,interleukin-3 production,BP,
8028,GO:0032672,0.999999999980784,0.831045004386518,0,2,regulation of interleukin-3 production,BP,
12314,GO:0048664,0.999999999980787,0.823145476918838,0,3,neuron fate determination,BP,
4876,GO:0014738,0.999999999980797,0.781050532400066,0,3,regulation of muscle hyperplasia,BP,
12211,GO:0048389,0.999999999980798,0.934826509980662,0,1,intermediate mesoderm development,BP,
12212,GO:0048390,0.999999999980798,0.934826509980662,0,1,intermediate mesoderm morphogenesis,BP,
12213,GO:0048391,0.999999999980798,0.934826509980662,0,1,intermediate mesoderm formation,BP,
12214,GO:0048392,0.999999999980798,0.934826509980662,0,1,intermediate mesodermal cell differentiation,BP,
13482,GO:0055018,0.999999999980798,0.934826509980662,0,1,regulation of cardiac muscle fiber development,BP,
13483,GO:0055020,0.999999999980798,0.934826509980662,0,1,positive regulation of cardiac muscle fiber development,BP,
13878,GO:0060503,0.999999999980798,0.934826509980662,0,1,bud dilation involved in lung branching,BP,
14213,GO:0061149,0.999999999980798,0.934826509980662,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
14214,GO:0061150,0.999999999980798,0.934826509980662,0,1,renal system segmentation,BP,
14215,GO:0061151,0.999999999980798,0.934826509980662,0,1,BMP signaling pathway involved in renal system segmentation,BP,
14219,GO:0061155,0.999999999980798,0.934826509980662,0,1,pulmonary artery endothelial tube morphogenesis,BP,
14241,GO:0061216,0.999999999980798,0.934826509980662,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
14244,GO:0061227,0.999999999980798,0.934826509980662,0,1,pattern specification involved in mesonephros development,BP,
15515,GO:0071893,0.999999999980798,0.934826509980662,0,1,BMP signaling pathway involved in nephric duct formation,BP,
15611,GO:0072096,0.999999999980798,0.934826509980662,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
15612,GO:0072097,0.999999999980798,0.934826509980662,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
15613,GO:0072098,0.999999999980798,0.934826509980662,0,1,anterior/posterior pattern specification involved in kidney development,BP,
15614,GO:0072099,0.999999999980798,0.934826509980662,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
15615,GO:0072100,0.999999999980798,0.934826509980662,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
15616,GO:0072101,0.999999999980798,0.934826509980662,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
15672,GO:0072192,0.999999999980798,0.934826509980662,0,1,ureter epithelial cell differentiation,BP,
15676,GO:0072198,0.999999999980798,0.934826509980662,0,1,mesenchymal cell proliferation involved in ureter development,BP,
15677,GO:0072199,0.999999999980798,0.934826509980662,0,1,regulation of mesenchymal cell proliferation involved in ureter development,BP,
15678,GO:0072200,0.999999999980798,0.934826509980662,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
17817,GO:1901964,0.999999999980798,0.934826509980662,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19684,GO:2000004,0.999999999980798,0.934826509980662,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
19685,GO:2000005,0.999999999980798,0.934826509980662,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
19686,GO:2000006,0.999999999980798,0.934826509980662,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
19687,GO:2000007,0.999999999980798,0.934826509980662,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
4735,GO:0010899,0.999999999980801,0.789723510390314,0,3,regulation of phosphatidylcholine catabolic process,BP,
15597,GO:0072076,0.999999999980811,0.733900426032522,0,3,nephrogenic mesenchyme development,BP,
80,GO:0000160,0.999999999980812,0.797704987882063,0,2,phosphorelay signal transduction system,BP,
5736,GO:0016882,0.999999999980821,0.866039781385029,0,2,cyclo-ligase activity,MF,
893,GO:0002266,0.999999999980827,0.85627938622182,0,2,follicular dendritic cell activation,BP,
894,GO:0002268,0.999999999980827,0.85627938622182,0,2,follicular dendritic cell differentiation,BP,
8367,GO:0033257,0.999999999980827,0.85627938622182,0,2,Bcl3/NF-kappaB2 complex,CC,
16672,GO:0097574,0.999999999980847,0.810019616765901,0,2,lateral part of cell,CC,
16673,GO:0097575,0.999999999980847,0.810019616765901,0,2,lateral cell cortex,CC,
13526,GO:0055100,0.999999999980849,0.764060542407871,0,3,adiponectin binding,MF,
10833,GO:0044326,0.999999999980873,0.839934255708733,0,2,dendritic spine neck,CC,
8590,GO:0034087,0.99999999998089,0.788699395379616,0,2,establishment of mitotic sister chromatid cohesion,BP,
5045,GO:0015228,0.999999999980893,0.785838699477921,0,3,coenzyme A transmembrane transporter activity,MF,
5252,GO:0015880,0.999999999980893,0.785838699477921,0,3,coenzyme A transport,BP,
9089,GO:0035349,0.999999999980893,0.785838699477921,0,3,coenzyme A transmembrane transport,BP,
15091,GO:0071077,0.999999999980893,0.785838699477921,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
15095,GO:0071106,0.999999999980893,0.785838699477921,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
15978,GO:0080122,0.999999999980893,0.785838699477921,0,3,AMP transmembrane transporter activity,MF,
8757,GO:0034418,0.99999999998091,0.860691575822805,0,2,urate biosynthetic process,BP,
4263,GO:0009608,0.999999999980918,0.855772657438129,0,2,response to symbiont,BP,
4264,GO:0009609,0.999999999980918,0.855772657438129,0,2,response to symbiotic bacterium,BP,
20201,GO:2001069,0.999999999980948,0.850458497425771,0,2,glycogen binding,MF,
1287,GO:0003096,0.999999999980953,0.709293395359556,0,4,renal sodium ion transport,BP,
7551,GO:0031860,0.999999999980961,0.72877969482258,0,3,telomeric 3' overhang formation,BP,
12133,GO:0048210,0.999999999980961,0.787840795388666,0,3,Golgi vesicle fusion to target membrane,BP,
13869,GO:0060486,0.999999999980986,0.813017498381881,0,2,Clara cell differentiation,BP,
19034,GO:1904878,0.999999999981027,0.864698089499784,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
4791,GO:0010982,0.999999999981044,0.838456117293283,0,2,regulation of high-density lipoprotein particle clearance,BP,
4792,GO:0010983,0.999999999981044,0.838456117293283,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
8513,GO:0033691,0.999999999981055,0.797740923612796,0,2,sialic acid binding,MF,
20018,GO:2000638,0.999999999981058,0.837489128517399,0,2,regulation of SREBP signaling pathway,BP,
20019,GO:2000639,0.999999999981058,0.837489128517399,0,2,negative regulation of SREBP signaling pathway,BP,
4542,GO:0010615,0.99999999998106,0.899162525405779,0,1,positive regulation of cardiac muscle adaptation,BP,
18317,GO:1903244,0.99999999998106,0.899162525405779,0,1,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19165,GO:1905205,0.99999999998106,0.899162525405779,0,1,positive regulation of connective tissue replacement,BP,
1630,GO:0004069,0.999999999981061,0.860562018780941,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
2988,GO:0006532,0.999999999981061,0.860562018780941,0,2,aspartate biosynthetic process,BP,
2989,GO:0006533,0.999999999981061,0.860562018780941,0,2,aspartate catabolic process,BP,
6179,GO:0019550,0.999999999981061,0.860562018780941,0,2,glutamate catabolic process to aspartate,BP,
6180,GO:0019551,0.999999999981061,0.860562018780941,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
8171,GO:0032907,0.999999999981065,0.718691301055733,0,3,transforming growth factor beta3 production,BP,
8174,GO:0032910,0.999999999981065,0.718691301055733,0,3,regulation of transforming growth factor beta3 production,BP,
9220,GO:0035606,0.999999999981066,0.899759501654434,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
7369,GO:0031416,0.999999999981071,0.843255184652553,0,2,NatB complex,CC,
12977,GO:0051379,0.999999999981072,0.863688837428828,0,2,epinephrine binding,MF,
9821,GO:0042030,0.999999999981075,0.790181541098979,0,2,ATPase inhibitor activity,MF,
9581,GO:0036396,0.999999999981094,0.811326267676611,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
11190,GO:0045293,0.999999999981094,0.811326267676611,0,3,mRNA editing complex,CC,
15947,GO:0072757,0.999999999981097,0.698331512439568,0,4,cellular response to camptothecin,BP,
9231,GO:0035617,0.999999999981126,0.764720411296673,0,3,stress granule disassembly,BP,
851,GO:0002177,0.999999999981129,0.809309272425652,0,3,manchette,CC,
11515,GO:0046016,0.999999999981134,0.790465651262784,0,3,positive regulation of transcription by glucose,BP,
5095,GO:0015369,0.999999999981143,0.893367052207778,0,1,calcium:proton antiporter activity,MF,
12832,GO:0051139,0.999999999981143,0.893367052207778,0,1,metal ion:proton antiporter activity,MF,
13470,GO:0055005,0.999999999981143,0.893367052207778,0,1,ventricular cardiac myofibril assembly,BP,
9445,GO:0036022,0.999999999981147,0.85230648149929,0,2,limb joint morphogenesis,BP,
9446,GO:0036023,0.999999999981147,0.85230648149929,0,2,embryonic skeletal limb joint morphogenesis,BP,
9588,GO:0036435,0.999999999981153,0.781462022215633,0,3,K48-linked polyubiquitin modification-dependent protein binding,MF,
15871,GO:0072590,0.999999999981153,0.891104853213805,0,1,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
15872,GO:0072591,0.999999999981153,0.891104853213805,0,1,citrate-L-glutamate ligase activity,MF,
14201,GO:0061110,0.999999999981175,0.794586717900618,0,2,dense core granule biogenesis,BP,
20067,GO:2000705,0.999999999981175,0.794586717900618,0,2,regulation of dense core granule biogenesis,BP,
11954,GO:0047066,0.999999999981182,0.948496011590276,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
16717,GO:0097707,0.999999999981182,0.948496011590276,0,1,ferroptosis,BP,
17241,GO:0110075,0.999999999981182,0.948496011590276,0,1,regulation of ferroptosis,BP,
17242,GO:0110076,0.999999999981182,0.948496011590276,0,1,negative regulation of ferroptosis,BP,
19959,GO:2000520,0.999999999981183,0.87221701794504,0,2,regulation of immunological synapse formation,BP,
19960,GO:2000521,0.999999999981183,0.87221701794504,0,2,negative regulation of immunological synapse formation,BP,
20243,GO:2001188,0.999999999981183,0.87221701794504,0,2,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
20244,GO:2001189,0.999999999981183,0.87221701794504,0,2,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
18219,GO:1903011,0.999999999981226,0.701814232602836,0,3,negative regulation of bone development,BP,
20253,GO:2001205,0.999999999981226,0.701814232602836,0,3,negative regulation of osteoclast development,BP,
8849,GO:0034642,0.999999999981227,0.907447119033216,0,1,mitochondrion migration along actin filament,BP,
6667,GO:0030023,0.999999999981236,0.656430525691785,0,3,extracellular matrix constituent conferring elasticity,MF,
4496,GO:0010521,0.999999999981252,0.789819726681752,0,3,telomerase inhibitor activity,MF,
2191,GO:0005052,0.999999999981257,0.833483249649958,0,2,peroxisome matrix targeting signal-1 binding,MF,
8635,GO:0034155,0.999999999981271,0.911234241743097,0,1,regulation of toll-like receptor 7 signaling pathway,BP,
8636,GO:0034157,0.999999999981271,0.911234241743097,0,1,positive regulation of toll-like receptor 7 signaling pathway,BP,
1061,GO:0002589,0.999999999981279,0.871195056003964,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1062,GO:0002590,0.999999999981279,0.871195056003964,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
2569,GO:0005853,0.999999999981288,0.81358553511525,0,3,eukaryotic translation elongation factor 1 complex,CC,
5551,GO:0016557,0.999999999981304,0.812735327622878,0,3,peroxisome membrane biogenesis,BP,
12682,GO:0050893,0.999999999981307,0.859285736955968,0,2,sensory processing,BP,
15098,GO:0071109,0.999999999981315,0.766484571845812,0,2,superior temporal gyrus development,BP,
19846,GO:2000318,0.999999999981342,0.75141456676397,0,4,positive regulation of T-helper 17 type immune response,BP,
1227,GO:0002904,0.999999999981355,0.78990256310337,0,3,positive regulation of B cell apoptotic process,BP,
17995,GO:1902442,0.999999999981367,0.908384019578035,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
17996,GO:1902443,0.999999999981367,0.908384019578035,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
3972,GO:0008781,0.999999999981367,0.882466298326933,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
8886,GO:0034699,0.999999999981372,0.753873166829482,0,3,response to luteinizing hormone,BP,
8357,GO:0033227,0.999999999981383,0.776873019181662,0,3,dsRNA transport,BP,
4503,GO:0010536,0.999999999981399,0.893407729906411,0,2,positive regulation of activation of Janus kinase activity,BP,
7825,GO:0032378,0.999999999981419,0.909581297040401,0,1,negative regulation of intracellular lipid transport,BP,
7828,GO:0032381,0.999999999981419,0.909581297040401,0,1,negative regulation of intracellular sterol transport,BP,
7831,GO:0032384,0.999999999981419,0.909581297040401,0,1,negative regulation of intracellular cholesterol transport,BP,
19314,GO:1905596,0.999999999981419,0.909581297040401,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
19316,GO:1905598,0.999999999981419,0.909581297040401,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
19319,GO:1905601,0.999999999981419,0.909581297040401,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
4589,GO:0010693,0.999999999981419,0.754703750463036,0,3,negative regulation of alkaline phosphatase activity,BP,
3103,GO:0006680,0.999999999981429,0.775987437231281,0,3,glucosylceramide catabolic process,BP,
13418,GO:0052812,0.999999999981436,0.814030321495527,0,2,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
4886,GO:0014806,0.999999999981439,0.868282772899592,0,2,smooth muscle hyperplasia,BP,
4213,GO:0009368,0.999999999981441,0.875631936096183,0,2,endopeptidase Clp complex,CC,
10328,GO:0043120,0.999999999981447,0.805802836418523,0,3,tumor necrosis factor binding,MF,
9851,GO:0042097,0.999999999981448,0.843360517046714,0,2,interleukin-4 biosynthetic process,BP,
11232,GO:0045402,0.999999999981448,0.843360517046714,0,2,regulation of interleukin-4 biosynthetic process,BP,
1314,GO:0003162,0.999999999981448,0.776565702088777,0,2,atrioventricular node development,BP,
13005,GO:0051430,0.99999999998146,0.838219340541245,0,2,corticotropin-releasing hormone receptor 1 binding,MF,
1964,GO:0004673,0.999999999981473,0.835842445269603,0,2,protein histidine kinase activity,MF,
4734,GO:0010898,0.999999999981479,0.83206190225132,0,2,positive regulation of triglyceride catabolic process,BP,
9676,GO:0038037,0.999999999981498,0.767170257011008,0,3,G-protein coupled receptor dimeric complex,CC,
16701,GO:0097648,0.999999999981498,0.767170257011008,0,3,G-protein coupled receptor complex,CC,
11612,GO:0046294,0.999999999981501,0.871318317107021,0,2,formaldehyde catabolic process,BP,
17850,GO:1902037,0.999999999981521,0.782274542890063,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
16707,GO:0097680,0.999999999981531,0.753077955130813,0,3,double-strand break repair via classical nonhomologous end joining,BP,
13130,GO:0051684,0.999999999981543,0.726907281896757,0,3,maintenance of Golgi location,BP,
2824,GO:0006288,0.999999999981564,0.80050300790417,0,3,base-excision repair, DNA ligation,BP,
18436,GO:1903518,0.999999999981567,0.842039358837806,0,2,positive regulation of single strand break repair,BP,
18031,GO:1902544,0.999999999981567,0.86921483797274,0,2,regulation of DNA N-glycosylase activity,BP,
15702,GO:0072237,0.999999999981591,0.78680173807479,0,2,metanephric proximal tubule development,BP,
3916,GO:0008582,0.999999999981619,0.783877451482215,0,2,regulation of synaptic growth at neuromuscular junction,BP,
4609,GO:0010726,0.99999999998162,0.852897153499635,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
5203,GO:0015801,0.999999999981629,0.85864537167612,0,2,aromatic amino acid transport,BP,
5224,GO:0015827,0.999999999981629,0.85864537167612,0,2,tryptophan transport,BP,
10619,GO:0043614,0.999999999981629,0.808099268363482,0,2,multi-eIF complex,CC,
10474,GO:0043366,0.99999999998164,0.836071677825891,0,2,beta selection,BP,
8800,GO:0034499,0.99999999998165,0.794022724762967,0,2,late endosome to Golgi transport,BP,
4005,GO:0008962,0.999999999981657,0.860539788397299,0,2,phosphatidylglycerophosphatase activity,MF,
3129,GO:0006710,0.999999999981662,0.933476209956552,0,1,androgen catabolic process,BP,
17277,GO:0140007,0.999999999981668,0.736642782030717,0,4,KICSTOR complex,CC,
1846,GO:0004505,0.999999999981673,0.877737136191296,0,2,phenylalanine 4-monooxygenase activity,MF,
3650,GO:0008124,0.999999999981673,0.877737136191296,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
5496,GO:0016434,0.999999999981699,0.763942476892949,0,3,rRNA (cytosine) methyltransferase activity,MF,
5757,GO:0016917,0.999999999981731,0.746066407854975,0,3,GABA receptor activity,MF,
18075,GO:1902659,0.999999999981773,0.789539952351562,0,3,regulation of glucose mediated signaling pathway,BP,
18076,GO:1902661,0.999999999981773,0.789539952351562,0,3,positive regulation of glucose mediated signaling pathway,BP,
1546,GO:0003941,0.99999999998178,0.925101284160526,0,1,L-serine ammonia-lyase activity,MF,
3960,GO:0008721,0.99999999998178,0.925101284160526,0,1,D-serine ammonia-lyase activity,MF,
5718,GO:0016855,0.99999999998178,0.925101284160526,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
5903,GO:0018114,0.99999999998178,0.925101284160526,0,1,threonine racemase activity,MF,
6882,GO:0030378,0.99999999998178,0.925101284160526,0,1,serine racemase activity,MF,
9568,GO:0036361,0.99999999998178,0.925101284160526,0,1,racemase activity, acting on amino acids and derivatives,MF,
11662,GO:0046416,0.99999999998178,0.925101284160526,0,1,D-amino acid metabolic process,BP,
11667,GO:0046437,0.99999999998178,0.925101284160526,0,1,D-amino acid biosynthetic process,BP,
12026,GO:0047661,0.99999999998178,0.925101284160526,0,1,amino-acid racemase activity,MF,
14615,GO:0070178,0.99999999998178,0.925101284160526,0,1,D-serine metabolic process,BP,
14616,GO:0070179,0.99999999998178,0.925101284160526,0,1,D-serine biosynthetic process,BP,
10843,GO:0044338,0.99999999998179,0.847053553025575,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11886,GO:0046900,0.999999999981813,0.868800795016522,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
13733,GO:0060302,0.999999999981845,0.874630772454423,0,2,negative regulation of cytokine activity,BP,
2447,GO:0005656,0.999999999981868,0.804789555593128,0,3,nuclear pre-replicative complex,CC,
2808,GO:0006267,0.999999999981868,0.804789555593128,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
9578,GO:0036387,0.999999999981868,0.804789555593128,0,3,pre-replicative complex,CC,
9579,GO:0036388,0.999999999981868,0.804789555593128,0,3,pre-replicative complex assembly,BP,
17950,GO:1902299,0.999999999981868,0.804789555593128,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
6416,GO:0021679,0.999999999981877,0.838280451704589,0,2,cerebellar molecular layer development,BP,
6423,GO:0021687,0.999999999981877,0.838280451704589,0,2,cerebellar molecular layer morphogenesis,BP,
3620,GO:0008073,0.999999999981883,0.881555283342835,0,2,ornithine decarboxylase inhibitor activity,MF,
17938,GO:1902268,0.999999999981883,0.881555283342835,0,2,negative regulation of polyamine transmembrane transport,BP,
8578,GO:0034056,0.999999999981945,0.744266081550859,0,3,estrogen response element binding,MF,
14136,GO:0061002,0.999999999981948,0.737706837744399,0,3,negative regulation of dendritic spine morphogenesis,BP,
5109,GO:0015410,0.999999999981956,0.754136346872155,0,3,manganese-transporting ATPase activity,MF,
2758,GO:0006168,0.999999999981967,0.835111494273953,0,3,adenine salvage,BP,
11550,GO:0046083,0.999999999981967,0.835111494273953,0,3,adenine metabolic process,BP,
11551,GO:0046084,0.999999999981967,0.835111494273953,0,3,adenine biosynthetic process,BP,
411,GO:0001097,0.999999999981967,0.762287780842211,0,3,TFIIH-class transcription factor binding,MF,
14850,GO:0070602,0.999999999981983,0.786320012756087,0,3,regulation of centromeric sister chromatid cohesion,BP,
2761,GO:0006172,0.999999999981987,0.927734771218712,0,1,ADP biosynthetic process,BP,
16519,GO:0097226,0.999999999981987,0.927734771218712,0,1,sperm mitochondrial sheath,CC,
48,GO:0000101,0.999999999981989,0.750270841638988,0,3,sulfur amino acid transport,BP,
7506,GO:0031685,0.999999999982003,0.829289123095758,0,2,adenosine receptor binding,MF,
14458,GO:0061792,0.999999999982018,0.889565824819909,0,1,secretory granule maturation,BP,
19547,GO:1990502,0.999999999982018,0.889565824819909,0,1,dense core granule maturation,BP,
7418,GO:0031508,0.999999999982019,0.865820710516428,0,2,pericentric heterochromatin assembly,BP,
18816,GO:1904383,0.99999999998203,0.929475053441633,0,1,response to sodium phosphate,BP,
18897,GO:1904585,0.99999999998203,0.929475053441633,0,1,response to putrescine,BP,
18898,GO:1904586,0.99999999998203,0.929475053441633,0,1,cellular response to putrescine,BP,
19636,GO:1990828,0.99999999998203,0.929475053441633,0,1,hepatocyte dedifferentiation,BP,
3821,GO:0008418,0.999999999982038,0.945507582172416,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
10968,GO:0044729,0.999999999982041,0.761632560698812,0,3,hemi-methylated DNA-binding,MF,
1826,GO:0004479,0.999999999982043,0.92149134119842,0,1,methionyl-tRNA formyltransferase activity,MF,
6323,GO:0019988,0.999999999982043,0.92149134119842,0,1,charged-tRNA amino acid modification,BP,
15546,GO:0071951,0.999999999982043,0.92149134119842,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
8868,GO:0034667,0.999999999982047,0.814262579838349,0,2,integrin alpha3-beta1 complex,CC,
14584,GO:0070124,0.999999999982062,0.872243548302025,0,2,mitochondrial translational initiation,BP,
13163,GO:0051747,0.999999999982067,0.889643456412958,0,2,cytosine C-5 DNA demethylase activity,MF,
15915,GO:0072684,0.999999999982073,0.907435268779564,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
5592,GO:0016618,0.999999999982085,0.797066045670252,0,3,hydroxypyruvate reductase activity,MF,
6814,GO:0030267,0.999999999982085,0.797066045670252,0,3,glyoxylate reductase (NADP) activity,MF,
1902,GO:0004587,0.999999999982123,0.931932053547932,0,1,ornithine-oxo-acid transaminase activity,MF,
4399,GO:0010121,0.999999999982123,0.931932053547932,0,1,arginine catabolic process to proline via ornithine,BP,
6159,GO:0019493,0.999999999982123,0.931932053547932,0,1,arginine catabolic process to proline,BP,
6177,GO:0019544,0.999999999982123,0.931932053547932,0,1,arginine catabolic process to glutamate,BP,
668,GO:0001875,0.999999999982139,0.76091724017177,0,3,lipopolysaccharide receptor activity,MF,
15801,GO:0072434,0.999999999982141,0.790920401705082,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
14869,GO:0070644,0.999999999982151,0.724261122614715,0,3,vitamin D response element binding,MF,
11002,GO:0044805,0.999999999982154,0.814340565484545,0,2,late nucleophagy,BP,
15041,GO:0070985,0.999999999982154,0.883484203431068,0,2,TFIIK complex,CC,
10704,GO:0043990,0.999999999982157,0.916799142425268,0,1,histone H2A-S1 phosphorylation,BP,
593,GO:0001757,0.999999999982165,0.817290633702672,0,2,somite specification,BP,
3806,GO:0008391,0.999999999982178,0.861953881478662,0,2,arachidonic acid monooxygenase activity,MF,
3807,GO:0008392,0.999999999982178,0.861953881478662,0,2,arachidonic acid epoxygenase activity,MF,
7511,GO:0031694,0.999999999982188,0.94528729741707,0,1,alpha-2A adrenergic receptor binding,MF,
17577,GO:1901193,0.999999999982188,0.94528729741707,0,1,regulation of formation of translation preinitiation complex,BP,
17578,GO:1901194,0.999999999982188,0.94528729741707,0,1,negative regulation of formation of translation preinitiation complex,BP,
18936,GO:1904689,0.999999999982188,0.94528729741707,0,1,negative regulation of cytoplasmic translational initiation,BP,
6479,GO:0021822,0.999999999982211,0.929717042526008,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
19320,GO:1905602,0.999999999982218,0.861070357204925,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
16392,GO:0097003,0.999999999982219,0.842167531952104,0,2,adipokinetic hormone receptor activity,MF,
16928,GO:0098905,0.999999999982233,0.870490925282706,0,2,regulation of bundle of His cell action potential,BP,
8195,GO:0032937,0.999999999982248,0.768256481106472,0,3,SREBP-SCAP-Insig complex,CC,
1894,GO:0004577,0.999999999982252,0.868346456262342,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
18,GO:0000033,0.999999999982257,0.807796086783968,0,3,alpha-1,3-mannosyltransferase activity,MF,
8048,GO:0032701,0.999999999982262,0.857013527345137,0,2,negative regulation of interleukin-18 production,BP,
16649,GO:0097512,0.999999999982264,0.900622422869902,0,2,cardiac myofibril,CC,
3384,GO:0007161,0.999999999982271,0.618404819417817,0,4,calcium-independent cell-matrix adhesion,BP,
1396,GO:0003310,0.999999999982271,0.939932895235563,0,1,pancreatic A cell differentiation,BP,
6373,GO:0021558,0.999999999982271,0.939932895235563,0,1,trochlear nerve development,BP,
11499,GO:0045977,0.999999999982271,0.939932895235563,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
13654,GO:0060164,0.999999999982271,0.939932895235563,0,1,regulation of timing of neuron differentiation,BP,
14196,GO:0061102,0.999999999982271,0.939932895235563,0,1,stomach neuroendocrine cell differentiation,BP,
14197,GO:0061105,0.999999999982271,0.939932895235563,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
14198,GO:0061106,0.999999999982271,0.939932895235563,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15478,GO:0071820,0.999999999982271,0.939932895235563,0,1,N-box binding,MF,
15593,GO:0072071,0.999999999982271,0.939932895235563,0,1,kidney interstitial fibroblast differentiation,BP,
15644,GO:0072141,0.999999999982271,0.939932895235563,0,1,renal interstitial fibroblast development,BP,
19791,GO:2000226,0.999999999982271,0.939932895235563,0,1,regulation of pancreatic A cell differentiation,BP,
19792,GO:2000227,0.999999999982271,0.939932895235563,0,1,negative regulation of pancreatic A cell differentiation,BP,
18594,GO:1903850,0.999999999982286,0.922660284544046,0,1,regulation of cristae formation,BP,
18595,GO:1903852,0.999999999982286,0.922660284544046,0,1,positive regulation of cristae formation,BP,
18876,GO:1904542,0.999999999982286,0.922660284544046,0,1,regulation of free ubiquitin chain polymerization,BP,
18877,GO:1904544,0.999999999982286,0.922660284544046,0,1,positive regulation of free ubiquitin chain polymerization,BP,
19037,GO:1904881,0.999999999982286,0.922660284544046,0,1,cellular response to hydrogen sulfide,BP,
8457,GO:0033593,0.999999999982291,0.85977076425961,0,1,BRCA2-MAGE-D1 complex,CC,
16973,GO:0098989,0.9999999999823,0.828945034407263,0,2,NMDA selective glutamate receptor signaling pathway,BP,
16795,GO:0098633,0.999999999982303,0.9243899891687,0,1,collagen fibril binding,MF,
18681,GO:1904027,0.999999999982303,0.9243899891687,0,1,negative regulation of collagen fibril organization,BP,
17519,GO:1900756,0.999999999982309,0.811875097296297,0,2,protein processing in phagocytic vesicle,BP,
18630,GO:1903921,0.999999999982309,0.811875097296297,0,2,regulation of protein processing in phagocytic vesicle,BP,
18631,GO:1903923,0.999999999982309,0.811875097296297,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
18955,GO:1904720,0.999999999982313,0.849093132005364,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
16698,GO:0097644,0.999999999982352,0.850857779569391,0,2,calcitonin family binding,MF,
18410,GO:1903439,0.999999999982352,0.850857779569391,0,2,calcitonin family receptor complex,CC,
19516,GO:1990406,0.999999999982352,0.850857779569391,0,2,CGRP receptor complex,CC,
19518,GO:1990408,0.999999999982352,0.850857779569391,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
17934,GO:1902261,0.999999999982363,0.783391999544003,0,2,positive regulation of delayed rectifier potassium channel activity,BP,
6041,GO:0019144,0.999999999982374,0.88598788439749,0,2,ADP-sugar diphosphatase activity,MF,
11810,GO:0046695,0.999999999982376,0.811178918197538,0,3,SLIK (SAGA-like) complex,CC,
9193,GO:0035574,0.99999999998238,0.818038056979363,0,2,histone H4-K20 demethylation,BP,
9194,GO:0035575,0.99999999998238,0.818038056979363,0,2,histone demethylase activity (H4-K20 specific),MF,
8050,GO:0032707,0.999999999982383,0.926582547084326,0,1,negative regulation of interleukin-23 production,BP,
12036,GO:0047747,0.999999999982383,0.926582547084326,0,1,cholate-CoA ligase activity,MF,
8276,GO:0033078,0.999999999982399,0.839630532457113,0,2,extrathymic T cell differentiation,BP,
7268,GO:0031247,0.999999999982401,0.857954904024036,0,2,actin rod assembly,BP,
9417,GO:0035983,0.999999999982415,0.780686249436248,0,3,response to trichostatin A,BP,
9418,GO:0035984,0.999999999982415,0.780686249436248,0,3,cellular response to trichostatin A,BP,
12463,GO:0050294,0.999999999982417,0.831943745314943,0,3,steroid sulfotransferase activity,MF,
271,GO:0000773,0.999999999982427,0.947578130561538,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
1915,GO:0004608,0.999999999982427,0.947578130561538,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
11950,GO:0047035,0.999999999982427,0.947578130561538,0,1,testosterone dehydrogenase (NAD+) activity,MF,
15974,GO:0080101,0.999999999982427,0.947578130561538,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
12744,GO:0051012,0.999999999982451,0.837933415779778,0,2,microtubule sliding,BP,
15577,GO:0072038,0.999999999982458,0.820672800920266,0,2,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
15578,GO:0072039,0.999999999982458,0.820672800920266,0,2,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
15579,GO:0072040,0.999999999982458,0.820672800920266,0,2,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
17563,GO:1901145,0.999999999982458,0.820672800920266,0,2,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18928,GO:1904673,0.999999999982458,0.820672800920266,0,2,negative regulation of somatic stem cell population maintenance,BP,
6637,GO:0023021,0.999999999982458,0.790772800605962,0,3,termination of signal transduction,BP,
16564,GO:0097344,0.999999999982466,0.860503198273154,0,2,Rix1 complex,CC,
11236,GO:0045409,0.999999999982489,0.821173858583273,0,2,negative regulation of interleukin-6 biosynthetic process,BP,
2321,GO:0005329,0.99999999998249,0.803211553897571,0,2,dopamine transmembrane transporter activity,MF,
20239,GO:2001184,0.999999999982556,0.83557842857916,0,2,positive regulation of interleukin-12 secretion,BP,
7005,GO:0030689,0.999999999982561,0.792727741972065,0,3,Noc complex,CC,
17738,GO:1901671,0.999999999982563,0.888460184523576,0,2,positive regulation of superoxide dismutase activity,BP,
19011,GO:1904833,0.999999999982563,0.888460184523576,0,2,positive regulation of removal of superoxide radicals,BP,
24,GO:0000048,0.99999999998258,0.926643350494554,0,1,peptidyltransferase activity,MF,
1250,GO:0002951,0.99999999998258,0.926643350494554,0,1,leukotriene-C(4) hydrolase,MF,
7958,GO:0032557,0.999999999982581,0.766754566823572,0,3,pyrimidine ribonucleotide binding,MF,
1866,GO:0004530,0.999999999982582,0.793584093727369,0,2,deoxyribonuclease I activity,MF,
7122,GO:0030942,0.9999999999826,0.811247230306993,0,3,endoplasmic reticulum signal peptide binding,MF,
7970,GO:0032581,0.9999999999826,0.933906103977811,0,1,ER-dependent peroxisome organization,BP,
17224,GO:0106101,0.9999999999826,0.933906103977811,0,1,ER-dependent peroxisome localization,BP,
4630,GO:0010751,0.999999999982603,0.778525407278466,0,2,negative regulation of nitric oxide mediated signal transduction,BP,
6971,GO:0030626,0.999999999982609,0.846705362704259,0,2,U12 snRNA binding,MF,
8254,GO:0033030,0.999999999982625,0.889071880063765,0,1,negative regulation of neutrophil apoptotic process,BP,
14120,GO:0060978,0.999999999982634,0.821313747583087,0,2,angiogenesis involved in coronary vascular morphogenesis,BP,
11335,GO:0045658,0.999999999982639,0.760904659356309,0,3,regulation of neutrophil differentiation,BP,
17661,GO:1901492,0.999999999982665,0.826742528784805,0,2,positive regulation of lymphangiogenesis,BP,
7137,GO:0030969,0.999999999982669,0.768522115887984,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
14543,GO:0070054,0.999999999982669,0.768522115887984,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
14544,GO:0070055,0.999999999982669,0.768522115887984,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
4892,GO:0014816,0.999999999982711,0.780225451518772,0,2,skeletal muscle satellite cell differentiation,BP,
11968,GO:0047186,0.999999999982746,0.906604977640178,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
3440,GO:0007231,0.999999999982746,0.858081240243106,0,2,osmosensory signaling pathway,BP,
10354,GO:0043163,0.999999999982754,0.800513568495615,0,2,cell envelope organization,BP,
11168,GO:0045229,0.999999999982754,0.800513568495615,0,2,external encapsulating structure organization,BP,
4665,GO:0010813,0.999999999982756,0.841480541590136,0,2,neuropeptide catabolic process,BP,
1562,GO:0003963,0.999999999982769,0.85449814509399,0,2,RNA-3'-phosphate cyclase activity,MF,
15181,GO:0071315,0.999999999982792,0.75745183268763,0,3,cellular response to morphine,BP,
15183,GO:0071317,0.999999999982792,0.75745183268763,0,3,cellular response to isoquinoline alkaloid,BP,
13820,GO:0060414,0.999999999982801,0.786367280492664,0,2,aorta smooth muscle tissue morphogenesis,BP,
5078,GO:0015307,0.999999999982809,0.857886082121409,0,2,drug:proton antiporter activity,MF,
11761,GO:0046618,0.999999999982809,0.857886082121409,0,2,drug export,BP,
1985,GO:0004705,0.99999999998282,0.768251576037122,0,3,JUN kinase activity,MF,
5756,GO:0016909,0.99999999998282,0.768251576037122,0,3,SAP kinase activity,MF,
10956,GO:0044691,0.999999999982823,0.806056552297654,0,2,tooth eruption,BP,
349,GO:0000962,0.999999999982825,0.832158660351169,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
11044,GO:0045025,0.999999999982825,0.832158660351169,0,2,mitochondrial degradosome,CC,
5306,GO:0016012,0.999999999982855,0.844588345363191,0,2,sarcoglycan complex,CC,
6411,GO:0021649,0.999999999982866,0.925034134138142,0,1,vestibulocochlear nerve structural organization,BP,
9692,GO:0038085,0.999999999982866,0.925034134138142,0,1,vascular endothelial growth factor binding,MF,
13732,GO:0060301,0.999999999982866,0.925034134138142,0,1,positive regulation of cytokine activity,BP,
14349,GO:0061552,0.999999999982866,0.925034134138142,0,1,ganglion morphogenesis,BP,
16581,GO:0097374,0.999999999982866,0.925034134138142,0,1,sensory neuron axon guidance,BP,
17976,GO:1902378,0.999999999982866,0.925034134138142,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19012,GO:1904835,0.999999999982866,0.925034134138142,0,1,dorsal root ganglion morphogenesis,BP,
19109,GO:1905040,0.999999999982866,0.925034134138142,0,1,otic placode development,BP,
17243,GO:0110095,0.999999999982868,0.826541791835891,0,3,cellular detoxification of aldehyde,BP,
17892,GO:1902174,0.999999999982869,0.862176859556446,0,2,positive regulation of keratinocyte apoptotic process,BP,
9266,GO:0035674,0.999999999982873,0.857991858174822,0,2,tricarboxylic acid transmembrane transport,BP,
13149,GO:0051717,0.999999999982878,0.821569004208002,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
3196,GO:0006824,0.999999999982912,0.840165876606102,0,2,cobalt ion transport,BP,
11518,GO:0046032,0.999999999982917,0.938624837768171,0,1,ADP catabolic process,BP,
1944,GO:0004647,0.999999999982949,0.866449180344616,0,2,phosphoserine phosphatase activity,MF,
3062,GO:0006624,0.999999999982952,0.8849204024021,0,2,vacuolar protein processing,BP,
12134,GO:0048211,0.999999999982953,0.835380301771611,0,2,Golgi vesicle docking,BP,
14451,GO:0061770,0.999999999982953,0.929461243213406,0,1,translation elongation factor binding,MF,
14621,GO:0070184,0.999999999982953,0.929461243213406,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15840,GO:0072545,0.999999999982953,0.929461243213406,0,1,tyrosine binding,MF,
18172,GO:1902937,0.999999999982953,0.929461243213406,0,1,inward rectifier potassium channel complex,CC,
19014,GO:1904842,0.999999999982953,0.929461243213406,0,1,response to nitroglycerin,BP,
19015,GO:1904843,0.999999999982953,0.929461243213406,0,1,cellular response to nitroglycerin,BP,
16275,GO:0090336,0.999999999982963,0.76514226722863,0,3,positive regulation of brown fat cell differentiation,BP,
19723,GO:2000077,0.999999999982988,0.820800411552203,0,2,negative regulation of type B pancreatic cell development,BP,
6213,GO:0019732,0.999999999982989,0.84511912484901,0,2,antifungal humoral response,BP,
7689,GO:0032139,0.999999999983001,0.775757858763519,0,3,dinucleotide insertion or deletion binding,MF,
1882,GO:0004561,0.99999999998301,0.92106022059318,0,1,alpha-N-acetylglucosaminidase activity,MF,
4878,GO:0014740,0.999999999983018,0.85037402273809,0,2,negative regulation of muscle hyperplasia,BP,
1158,GO:0002767,0.999999999983035,0.860247337823862,0,2,immune response-inhibiting cell surface receptor signaling pathway,BP,
13815,GO:0060406,0.999999999983039,0.826631617583737,0,2,positive regulation of penile erection,BP,
17121,GO:0102009,0.999999999983045,0.933186327811273,0,1,proline dipeptidase activity,MF,
17436,GO:1900208,0.999999999983045,0.880192769942396,0,2,regulation of cardiolipin metabolic process,BP,
17437,GO:1900210,0.999999999983045,0.880192769942396,0,2,positive regulation of cardiolipin metabolic process,BP,
16199,GO:0090226,0.999999999983058,0.950455939596363,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
14983,GO:0070893,0.999999999983059,0.823135256746158,0,2,transposon integration,BP,
14984,GO:0070894,0.999999999983059,0.823135256746158,0,2,regulation of transposon integration,BP,
14985,GO:0070895,0.999999999983059,0.823135256746158,0,2,negative regulation of transposon integration,BP,
8515,GO:0033693,0.99999999998306,0.7606388777542,0,3,neurofilament bundle assembly,BP,
11122,GO:0045155,0.999999999983069,0.843011309607643,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
6476,GO:0021816,0.99999999998307,0.818538706515915,0,2,extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration,BP,
16489,GO:0097177,0.99999999998309,0.814092275714537,0,3,mitochondrial ribosome binding,MF,
5543,GO:0016532,0.999999999983105,0.786247250575504,0,3,superoxide dismutase copper chaperone activity,MF,
14758,GO:0070432,0.999999999983109,0.771350193094945,0,3,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
19659,GO:1990910,0.999999999983116,0.796447975618409,0,3,response to hypobaric hypoxia,BP,
142,GO:0000293,0.999999999983128,0.764525510356389,0,3,ferric-chelate reductase activity,MF,
7607,GO:0031990,0.999999999983137,0.805266086311095,0,2,mRNA export from nucleus in response to heat stress,BP,
9016,GO:0035189,0.999999999983167,0.76934107183435,0,3,Rb-E2F complex,CC,
13985,GO:0060697,0.999999999983173,0.920932074851019,0,1,positive regulation of phospholipid catabolic process,BP,
17418,GO:1900161,0.999999999983173,0.920932074851019,0,1,regulation of phospholipid scramblase activity,BP,
17419,GO:1900163,0.999999999983173,0.920932074851019,0,1,positive regulation of phospholipid scramblase activity,BP,
20088,GO:2000752,0.999999999983173,0.920932074851019,0,1,regulation of glucosylceramide catabolic process,BP,
20089,GO:2000753,0.999999999983173,0.920932074851019,0,1,positive regulation of glucosylceramide catabolic process,BP,
20090,GO:2000754,0.999999999983173,0.920932074851019,0,1,regulation of sphingomyelin catabolic process,BP,
20091,GO:2000755,0.999999999983173,0.920932074851019,0,1,positive regulation of sphingomyelin catabolic process,BP,
2257,GO:0005171,0.999999999983176,0.931062915365101,0,1,hepatocyte growth factor receptor binding,MF,
1240,GO:0002933,0.999999999983185,0.864140372221723,0,2,lipid hydroxylation,BP,
17114,GO:0101020,0.999999999983185,0.864140372221723,0,2,estrogen 16-alpha-hydroxylase activity,MF,
844,GO:0002158,0.999999999983193,0.789789925687066,0,3,osteoclast proliferation,BP,
8175,GO:0032911,0.999999999983239,0.749457173244085,0,3,negative regulation of transforming growth factor beta1 production,BP,
5950,GO:0018298,0.999999999983245,0.762999851471715,0,3,protein-chromophore linkage,BP,
906,GO:0002291,0.999999999983256,0.797834740261563,0,3,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
8011,GO:0032641,0.99999999998326,0.845154532096253,0,2,lymphotoxin A production,BP,
9860,GO:0042109,0.99999999998326,0.845154532096253,0,2,lymphotoxin A biosynthetic process,BP,
12284,GO:0048597,0.999999999983263,0.832389885984839,0,3,post-embryonic camera-type eye morphogenesis,BP,
14893,GO:0070682,0.99999999998327,0.794593085616116,0,3,proteasome regulatory particle assembly,BP,
8532,GO:0033823,0.999999999983273,0.918226258145105,0,1,procollagen glucosyltransferase activity,MF,
13156,GO:0051728,0.999999999983273,0.918226258145105,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
13157,GO:0051729,0.999999999983273,0.918226258145105,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
13666,GO:0060184,0.999999999983273,0.918226258145105,0,1,cell cycle switching,BP,
5287,GO:0015942,0.999999999983275,0.791354071637677,0,3,formate metabolic process,BP,
18285,GO:1903179,0.999999999983291,0.867129024260989,0,2,regulation of dopamine biosynthetic process,BP,
18286,GO:1903181,0.999999999983291,0.867129024260989,0,2,positive regulation of dopamine biosynthetic process,BP,
5951,GO:0018307,0.999999999983292,0.8778952161701,0,2,enzyme active site formation,BP,
976,GO:0002430,0.999999999983297,0.927673554237349,0,1,complement receptor mediated signaling pathway,BP,
1927,GO:0004621,0.999999999983297,0.927673554237349,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2969,GO:0006507,0.999999999983297,0.927673554237349,0,1,GPI anchor release,BP,
4733,GO:0010897,0.999999999983297,0.927673554237349,0,1,negative regulation of triglyceride catabolic process,BP,
8563,GO:0034014,0.999999999983297,0.927673554237349,0,1,response to triglyceride,BP,
15244,GO:0071401,0.999999999983297,0.927673554237349,0,1,cellular response to triglyceride,BP,
8617,GO:0034128,0.999999999983301,0.747990363206828,0,3,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
5633,GO:0016714,0.999999999983334,0.818945274441156,0,3,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
5488,GO:0016422,0.999999999983345,0.797335004761293,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
13508,GO:0055077,0.999999999983357,0.843751342790375,0,2,gap junction hemi-channel activity,MF,
5317,GO:0016035,0.99999999998337,0.815882860883943,0,2,zeta DNA polymerase complex,CC,
10921,GO:0044530,0.999999999983393,0.737862748305555,0,3,supraspliceosomal complex,CC,
18893,GO:1904578,0.999999999983403,0.788495337209964,0,3,response to thapsigargin,BP,
18894,GO:1904579,0.999999999983403,0.788495337209964,0,3,cellular response to thapsigargin,BP,
9082,GO:0035332,0.999999999983415,0.770219123096967,0,2,positive regulation of hippo signaling,BP,
15620,GO:0072106,0.999999999983416,0.776928636816413,0,3,regulation of ureteric bud formation,BP,
15621,GO:0072107,0.999999999983416,0.776928636816413,0,3,positive regulation of ureteric bud formation,BP,
19193,GO:1905278,0.999999999983416,0.776928636816413,0,3,positive regulation of epithelial tube formation,BP,
14693,GO:0070309,0.999999999983435,0.816002239625801,0,2,lens fiber cell morphogenesis,BP,
14624,GO:0070191,0.999999999983438,0.857512263626786,0,2,methionine-R-sulfoxide reductase activity,MF,
14753,GO:0070426,0.999999999983462,0.856056425044278,0,2,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14760,GO:0070434,0.999999999983462,0.856056425044278,0,2,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
16897,GO:0098842,0.999999999983465,0.859805159154152,0,2,postsynaptic early endosome,CC,
18762,GO:1904247,0.999999999983469,0.917043546719128,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
5973,GO:0018444,0.999999999983504,0.738695015274387,0,3,translation release factor complex,CC,
19562,GO:1990573,0.999999999983522,0.779461714904054,0,3,potassium ion import across plasma membrane,BP,
19614,GO:1990761,0.999999999983524,0.841470748854226,0,2,growth cone lamellipodium,CC,
3263,GO:0006931,0.999999999983532,0.73548250630965,0,3,substrate-dependent cell migration, cell attachment to substrate,BP,
16995,GO:0099077,0.999999999983561,0.891502402565468,0,1,histone-dependent DNA binding,MF,
19340,GO:1905687,0.999999999983561,0.891502402565468,0,1,regulation of diacylglycerol kinase activity,BP,
19341,GO:1905689,0.999999999983561,0.891502402565468,0,1,positive regulation of diacylglycerol kinase activity,BP,
310,GO:0000821,0.999999999983562,0.873519242737871,0,1,regulation of arginine metabolic process,BP,
8364,GO:0033241,0.999999999983562,0.873519242737871,0,1,regulation of cellular amine catabolic process,BP,
8365,GO:0033242,0.999999999983562,0.873519242737871,0,1,negative regulation of cellular amine catabolic process,BP,
9622,GO:0036487,0.999999999983562,0.873519242737871,0,1,nitric-oxide synthase inhibitor activity,MF,
15507,GO:0071878,0.999999999983562,0.873519242737871,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16837,GO:0098736,0.999999999983562,0.873519242737871,0,1,negative regulation of the force of heart contraction,BP,
17321,GO:0140199,0.999999999983562,0.873519242737871,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17367,GO:1900081,0.999999999983562,0.873519242737871,0,1,regulation of arginine catabolic process,BP,
17368,GO:1900082,0.999999999983562,0.873519242737871,0,1,negative regulation of arginine catabolic process,BP,
18318,GO:1903248,0.999999999983562,0.873519242737871,0,1,regulation of citrulline biosynthetic process,BP,
18319,GO:1903249,0.999999999983562,0.873519242737871,0,1,negative regulation of citrulline biosynthetic process,BP,
19823,GO:2000283,0.999999999983562,0.873519242737871,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
7420,GO:0031510,0.999999999983573,0.802307342519822,0,3,SUMO activating enzyme complex,CC,
1046,GO:0002572,0.999999999983602,0.830622470196215,0,2,pro-T cell differentiation,BP,
8931,GO:0034776,0.999999999983606,0.803676354859499,0,2,response to histamine,BP,
15253,GO:0071420,0.999999999983606,0.803676354859499,0,2,cellular response to histamine,BP,
14433,GO:0061738,0.999999999983634,0.789898026025002,0,3,late endosomal microautophagy,BP,
11178,GO:0045259,0.999999999983643,0.874014530269808,0,2,proton-transporting ATP synthase complex,CC,
1622,GO:0004056,0.99999999998366,0.931782976593616,0,1,argininosuccinate lyase activity,MF,
10020,GO:0042450,0.99999999998366,0.931782976593616,0,1,arginine biosynthetic process via ornithine,BP,
5090,GO:0015350,0.999999999983661,0.816377895929629,0,2,methotrexate transmembrane transporter activity,MF,
13271,GO:0051958,0.999999999983661,0.816377895929629,0,2,methotrexate transport,BP,
10763,GO:0044208,0.999999999983662,0.865534385324458,0,2,'de novo' AMP biosynthetic process,BP,
1558,GO:0003957,0.999999999983676,0.898975471052144,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
3964,GO:0008746,0.999999999983676,0.898975471052144,0,1,NAD(P)+ transhydrogenase activity,MF,
3966,GO:0008750,0.999999999983676,0.898975471052144,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
5609,GO:0016652,0.999999999983676,0.898975471052144,0,1,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
19604,GO:1990742,0.999999999983711,0.859879000068588,0,2,microvesicle,CC,
17231,GO:0110021,0.999999999983718,0.846458002527406,0,2,cardiac muscle myoblast proliferation,BP,
17232,GO:0110022,0.999999999983718,0.846458002527406,0,2,regulation of cardiac muscle myoblast proliferation,BP,
17233,GO:0110024,0.999999999983718,0.846458002527406,0,2,positive regulation of cardiac muscle myoblast proliferation,BP,
172,GO:0000377,0.999999999983727,4.43332899823964e-10,1,298,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,DHX32
184,GO:0000398,0.999999999983727,4.43332899823964e-10,1,298,mRNA splicing, via spliceosome,BP,DHX32
2029,GO:0004768,0.999999999983738,0.755783099909919,0,3,stearoyl-CoA 9-desaturase activity,MF,
5389,GO:0016215,0.999999999983738,0.755783099909919,0,3,acyl-CoA desaturase activity,MF,
1489,GO:0003827,0.999999999983765,0.84571144763177,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
17676,GO:1901537,0.999999999983772,0.674791675360153,0,3,positive regulation of DNA demethylation,BP,
14016,GO:0060737,0.999999999983776,0.727675584627256,0,3,prostate gland morphogenetic growth,BP,
14284,GO:0061364,0.999999999983778,0.713724162073671,0,3,apoptotic process involved in luteolysis,BP,
1574,GO:0003983,0.999999999983778,0.92966859723183,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
13164,GO:0051748,0.999999999983778,0.92966859723183,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
2310,GO:0005308,0.999999999983786,0.910848376024901,0,1,creatine transmembrane transporter activity,MF,
2311,GO:0005309,0.999999999983786,0.910848376024901,0,1,creatine:sodium symporter activity,MF,
5253,GO:0015881,0.999999999983786,0.910848376024901,0,1,creatine transmembrane transport,BP,
15520,GO:0071898,0.999999999983787,0.78261911822746,0,3,regulation of estrogen receptor binding,BP,
15521,GO:0071899,0.999999999983787,0.78261911822746,0,3,negative regulation of estrogen receptor binding,BP,
2998,GO:0006543,0.999999999983818,0.756017650166487,0,3,glutamine catabolic process,BP,
2656,GO:0005999,0.999999999983827,0.877405206455674,0,2,xylulose biosynthetic process,BP,
5650,GO:0016744,0.999999999983827,0.877405206455674,0,2,transferase activity, transferring aldehyde or ketonic groups,MF,
11101,GO:0045113,0.99999999998383,0.8548489674621,0,2,regulation of integrin biosynthetic process,BP,
1947,GO:0004651,0.99999999998384,0.843900855263622,0,2,polynucleotide 5'-phosphatase activity,MF,
16747,GO:0098507,0.99999999998384,0.843900855263622,0,2,polynucleotide 5' dephosphorylation,BP,
3105,GO:0006682,0.999999999983857,0.780782081772643,0,3,galactosylceramide biosynthetic process,BP,
6127,GO:0019375,0.999999999983857,0.780782081772643,0,3,galactolipid biosynthetic process,BP,
14773,GO:0070470,0.999999999983861,0.762428967834819,0,4,plasma membrane respiratory chain,CC,
4214,GO:0009372,0.999999999983869,0.914289112589,0,1,quorum sensing,BP,
9582,GO:0036398,0.999999999983869,0.914289112589,0,1,TCR signalosome,CC,
9583,GO:0036399,0.999999999983869,0.914289112589,0,1,TCR signalosome assembly,BP,
12426,GO:0048874,0.999999999983869,0.914289112589,0,1,homeostasis of number of cells in a free-living population,BP,
13309,GO:0052097,0.999999999983869,0.914289112589,0,1,interspecies quorum sensing,BP,
13310,GO:0052106,0.999999999983869,0.914289112589,0,1,quorum sensing involved in interaction with host,BP,
14009,GO:0060730,0.999999999983869,0.914289112589,0,1,regulation of intestinal epithelial structure maintenance,BP,
14010,GO:0060731,0.999999999983869,0.914289112589,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14902,GO:0070715,0.999999999983869,0.914289112589,0,1,sodium-dependent organic cation transport,BP,
17625,GO:1901329,0.99999999998387,0.855518813429638,0,2,regulation of odontoblast differentiation,BP,
8965,GO:0035033,0.99999999998387,0.838757049328749,0,2,histone deacetylase regulator activity,MF,
11199,GO:0045323,0.999999999983881,0.775885356203695,0,3,interleukin-1 receptor complex,CC,
7509,GO:0031691,0.999999999983923,0.866662879718132,0,2,alpha-1A adrenergic receptor binding,MF,
7510,GO:0031692,0.999999999983923,0.866662879718132,0,2,alpha-1B adrenergic receptor binding,MF,
7533,GO:0031762,0.999999999983923,0.866662879718132,0,2,follicle-stimulating hormone receptor binding,MF,
10138,GO:0042699,0.999999999983923,0.866662879718132,0,2,follicle-stimulating hormone signaling pathway,BP,
12073,GO:0048021,0.999999999983936,0.711631561862478,0,3,regulation of melanin biosynthetic process,BP,
17086,GO:0099609,0.999999999983952,0.793995210881016,0,2,microtubule lateral binding,MF,
13476,GO:0055011,0.999999999983953,0.936085625518463,0,1,atrial cardiac muscle cell differentiation,BP,
13479,GO:0055014,0.999999999983953,0.936085625518463,0,1,atrial cardiac muscle cell development,BP,
15101,GO:0071139,0.999999999983955,0.820177481874918,0,2,resolution of recombination intermediates,BP,
15102,GO:0071140,0.999999999983955,0.820177481874918,0,2,resolution of mitotic recombination intermediates,BP,
305,GO:0000814,0.999999999983957,0.804295890181198,0,3,ESCRT II complex,CC,
19098,GO:1905006,0.999999999983971,0.835420195925177,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
4278,GO:0009644,0.999999999983977,0.832444151556164,0,2,response to high light intensity,BP,
20008,GO:2000620,0.999999999983982,0.786464260484579,0,2,positive regulation of histone H4-K16 acetylation,BP,
6230,GO:0019781,0.999999999983983,0.868917924861454,0,2,NEDD8 activating enzyme activity,MF,
3343,GO:0007060,0.999999999983992,0.85080218763184,0,2,male meiosis chromosome segregation,BP,
4555,GO:0010636,0.999999999984013,0.820165643064127,0,2,positive regulation of mitochondrial fusion,BP,
6011,GO:0019060,0.999999999984015,0.889705375839696,0,2,intracellular transport of viral protein in host cell,BP,
6954,GO:0030581,0.999999999984015,0.889705375839696,0,2,symbiont intracellular protein transport in host,BP,
13142,GO:0051708,0.999999999984015,0.889705375839696,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
1824,GO:0004477,0.999999999984015,0.71371427397506,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1833,GO:0004488,0.999999999984015,0.71371427397506,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
3003,GO:0006548,0.999999999984026,0.842283645581166,0,2,histidine catabolic process,BP,
13415,GO:0052805,0.999999999984026,0.842283645581166,0,2,imidazole-containing compound catabolic process,BP,
20262,GO:2001226,0.999999999984026,0.842283645581166,0,2,negative regulation of chloride transport,BP,
18099,GO:1902731,0.999999999984031,0.764571927026797,0,2,negative regulation of chondrocyte proliferation,BP,
12705,GO:0050923,0.999999999984048,0.703935239305114,0,3,regulation of negative chemotaxis,BP,
16767,GO:0098560,0.99999999998405,0.849833357231589,0,2,cytoplasmic side of late endosome membrane,CC,
14720,GO:0070369,0.999999999984055,0.723946429736056,0,3,beta-catenin-TCF7L2 complex,CC,
16758,GO:0098536,0.999999999984061,0.736654434800354,0,3,deuterosome,CC,
9242,GO:0035634,0.999999999984076,0.898380353475907,0,2,response to stilbenoid,BP,
154,GO:0000309,0.999999999984084,0.810588931730796,0,2,nicotinamide-nucleotide adenylyltransferase activity,MF,
6111,GO:0019355,0.999999999984084,0.810588931730796,0,2,nicotinamide nucleotide biosynthetic process from aspartate,BP,
8840,GO:0034627,0.999999999984084,0.810588931730796,0,2,'de novo' NAD biosynthetic process,BP,
8841,GO:0034628,0.999999999984084,0.810588931730796,0,2,'de novo' NAD biosynthetic process from aspartate,BP,
1387,GO:0003294,0.999999999984103,0.839278104206539,0,2,atrial ventricular junction remodeling,BP,
4564,GO:0010645,0.999999999984103,0.839278104206539,0,2,regulation of cell communication by chemical coupling,BP,
4570,GO:0010652,0.999999999984103,0.839278104206539,0,2,positive regulation of cell communication by chemical coupling,BP,
809,GO:0002081,0.999999999984106,0.877628988591954,0,1,outer acrosomal membrane,CC,
7187,GO:0031074,0.999999999984116,0.762699595500283,0,3,nucleocytoplasmic transport complex,CC,
18700,GO:1904058,0.999999999984144,0.750863352762188,0,3,positive regulation of sensory perception of pain,BP,
245,GO:0000701,0.999999999984152,0.87956177509542,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
18372,GO:1903373,0.999999999984155,0.734063116334869,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
16849,GO:0098758,0.999999999984161,0.847637230429875,0,2,response to interleukin-8,BP,
16850,GO:0098759,0.999999999984161,0.847637230429875,0,2,cellular response to interleukin-8,BP,
6028,GO:0019087,0.999999999984168,0.759766530362067,0,3,transformation of host cell by virus,BP,
12789,GO:0051083,0.999999999984187,0.868681610272444,0,2,'de novo' cotranslational protein folding,BP,
14726,GO:0070375,0.999999999984208,0.761187950962079,0,3,ERK5 cascade,BP,
19904,GO:2000395,0.999999999984211,0.889145347425653,0,2,regulation of ubiquitin-dependent endocytosis,BP,
19905,GO:2000397,0.999999999984211,0.889145347425653,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
6682,GO:0030047,0.999999999984218,0.748975017228692,0,3,actin modification,BP,
18323,GO:1903276,0.999999999984222,0.871584425935246,0,2,regulation of sodium ion export across plasma membrane,BP,
18324,GO:1903278,0.999999999984222,0.871584425935246,0,2,positive regulation of sodium ion export across plasma membrane,BP,
18331,GO:1903288,0.999999999984222,0.871584425935246,0,2,positive regulation of potassium ion import,BP,
2240,GO:0005150,0.999999999984227,0.850767307481752,0,2,interleukin-1, Type I receptor binding,MF,
2497,GO:0005745,0.999999999984227,0.846930960289302,0,2,m-AAA complex,CC,
10596,GO:0043564,0.999999999984227,0.848011408211176,0,2,Ku70:Ku80 complex,CC,
13612,GO:0060083,0.999999999984227,0.803021371244702,0,2,smooth muscle contraction involved in micturition,BP,
9147,GO:0035494,0.999999999984233,0.779825563943704,0,3,SNARE complex disassembly,BP,
7591,GO:0031959,0.999999999984234,0.822464166708632,0,2,mineralocorticoid receptor signaling pathway,BP,
6521,GO:0021898,0.999999999984245,0.785453097629229,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
14934,GO:0070815,0.999999999984282,0.69385637127849,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
11527,GO:0046041,0.999999999984303,0.872843519657291,0,2,ITP metabolic process,BP,
7876,GO:0032437,0.999999999984304,0.732524305040782,0,3,cuticular plate,CC,
147,GO:0000301,0.999999999984307,0.777559840592783,0,3,retrograde transport, vesicle recycling within Golgi,BP,
18665,GO:1903984,0.999999999984316,0.742542669634736,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
3989,GO:0008859,0.999999999984318,0.948235586107953,0,1,exoribonuclease II activity,MF,
15856,GO:0072572,0.999999999984325,0.929723965246797,0,1,poly-ADP-D-ribose binding,MF,
3996,GO:0008894,0.999999999984329,0.921652821607682,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
2364,GO:0005476,0.999999999984332,0.844958497941963,0,2,carnitine:acyl carnitine antiporter activity,MF,
7345,GO:0031372,0.999999999984338,0.867646029733039,0,2,UBC13-MMS2 complex,CC,
5461,GO:0016340,0.999999999984347,0.787018392252959,0,2,calcium-dependent cell-matrix adhesion,BP,
12407,GO:0048852,0.999999999984353,0.735202709550969,0,3,diencephalon morphogenesis,BP,
9910,GO:0042245,0.999999999984353,0.833462525777583,0,2,RNA repair,BP,
553,GO:0001674,0.999999999984354,0.83780551375,0,2,female germ cell nucleus,CC,
10085,GO:0042585,0.999999999984354,0.83780551375,0,2,germinal vesicle,CC,
15345,GO:0071567,0.999999999984376,0.878008841146108,0,2,UFM1 hydrolase activity,MF,
2150,GO:0004969,0.999999999984386,0.828484137817456,0,2,histamine receptor activity,MF,
11281,GO:0045588,0.99999999998439,0.802837525910161,0,2,positive regulation of gamma-delta T cell differentiation,BP,
14766,GO:0070447,0.999999999984393,0.851513240274641,0,2,positive regulation of oligodendrocyte progenitor proliferation,BP,
12378,GO:0048769,0.999999999984398,0.65573400382234,0,2,sarcomerogenesis,BP,
11240,GO:0045416,0.9999999999844,0.769788460102418,0,3,positive regulation of interleukin-8 biosynthetic process,BP,
898,GO:0002277,0.99999999998441,0.949297750395056,0,1,myeloid dendritic cell activation involved in immune response,BP,
1054,GO:0002582,0.99999999998441,0.949297750395056,0,1,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1057,GO:0002585,0.99999999998441,0.949297750395056,0,1,positive regulation of antigen processing and presentation of peptide antigen,BP,
1060,GO:0002588,0.99999999998441,0.949297750395056,0,1,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
5792,GO:0017024,0.99999999998441,0.949297750395056,0,1,myosin I binding,MF,
17102,GO:0099640,0.99999999998441,0.949297750395056,0,1,axo-dendritic protein transport,BP,
17103,GO:0099641,0.99999999998441,0.949297750395056,0,1,anterograde axonal protein transport,BP,
1056,GO:0002584,0.999999999984435,0.819981011838991,0,3,negative regulation of antigen processing and presentation of peptide antigen,BP,
4432,GO:0010266,0.999999999984455,0.768364208761594,0,3,response to vitamin B1,BP,
1133,GO:0002725,0.999999999984466,0.803655601944672,0,3,negative regulation of T cell cytokine production,BP,
4228,GO:0009405,0.999999999984477,0.79568841819497,0,2,pathogenesis,BP,
13634,GO:0060129,0.999999999984478,0.83037915029079,0,2,thyroid-stimulating hormone-secreting cell differentiation,BP,
17371,GO:1900086,0.999999999984478,0.720743345198506,0,3,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18980,GO:1904768,0.999999999984498,0.853259127109398,0,2,all-trans-retinol binding,MF,
1034,GO:0002543,0.999999999984519,0.832386923193687,0,2,activation of blood coagulation via clotting cascade,BP,
11610,GO:0046292,0.999999999984521,0.782601158952497,0,3,formaldehyde metabolic process,BP,
7998,GO:0032618,0.99999999998453,0.875329415126935,0,2,interleukin-15 production,BP,
7411,GO:0031493,0.999999999984535,0.779229761077767,0,3,nucleosomal histone binding,MF,
1370,GO:0003256,0.999999999984544,0.72798745896951,0,3,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
974,GO:0002428,0.999999999984544,0.803164867804525,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
7840,GO:0032395,0.999999999984556,0.833078367346435,0,3,MHC class II receptor activity,MF,
18693,GO:1904046,0.999999999984557,0.885932935814982,0,2,negative regulation of vascular endothelial growth factor production,BP,
19127,GO:1905071,0.999999999984557,0.81291898466372,0,2,occluding junction disassembly,BP,
19128,GO:1905073,0.999999999984557,0.81291898466372,0,2,regulation of occluding junction disassembly,BP,
19129,GO:1905075,0.999999999984557,0.81291898466372,0,2,positive regulation of occluding junction disassembly,BP,
3489,GO:0007356,0.999999999984562,0.858164790229122,0,2,thorax and anterior abdomen determination,BP,
20203,GO:2001074,0.999999999984562,0.858164790229122,0,2,regulation of metanephric ureteric bud development,BP,
20204,GO:2001076,0.999999999984562,0.858164790229122,0,2,positive regulation of metanephric ureteric bud development,BP,
8282,GO:0033084,0.99999999998457,0.839890939498557,0,2,regulation of immature T cell proliferation in thymus,BP,
8285,GO:0033088,0.99999999998457,0.839890939498557,0,2,negative regulation of immature T cell proliferation in thymus,BP,
13542,GO:0060002,0.999999999984574,0.779921372809275,0,2,plus-end directed microfilament motor activity,MF,
2650,GO:0005988,0.999999999984576,0.821225728916299,0,2,lactose metabolic process,BP,
2651,GO:0005989,0.999999999984576,0.821225728916299,0,2,lactose biosynthetic process,BP,
11639,GO:0046351,0.999999999984576,0.821225728916299,0,2,disaccharide biosynthetic process,BP,
15659,GO:0072174,0.999999999984603,0.744884637803646,0,3,metanephric tubule formation,BP,
1577,GO:0003987,0.999999999984606,0.826949623150937,0,2,acetate-CoA ligase activity,MF,
6141,GO:0019413,0.999999999984606,0.826949623150937,0,2,acetate biosynthetic process,BP,
6144,GO:0019427,0.999999999984606,0.826949623150937,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6175,GO:0019542,0.999999999984606,0.826949623150937,0,2,propionate biosynthetic process,BP,
4519,GO:0010572,0.99999999998462,0.847705278090507,0,2,positive regulation of platelet activation,BP,
17762,GO:1901731,0.99999999998462,0.847705278090507,0,2,positive regulation of platelet aggregation,BP,
15410,GO:0071672,0.999999999984621,0.793132961245092,0,3,negative regulation of smooth muscle cell chemotaxis,BP,
4457,GO:0010430,0.999999999984621,0.898718128809911,0,1,fatty acid omega-oxidation,BP,
10215,GO:0042835,0.999999999984621,0.898718128809911,0,1,BRE binding,MF,
17214,GO:0106072,0.999999999984636,0.815528959531295,0,2,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
19358,GO:1905773,0.999999999984638,0.725612835066262,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
34,GO:0000064,0.999999999984642,0.656303148854266,0,4,L-ornithine transmembrane transporter activity,MF,
4990,GO:0015119,0.999999999984645,0.77029063159451,0,3,hexose phosphate transmembrane transporter activity,MF,
5079,GO:0015315,0.999999999984645,0.77029063159451,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5126,GO:0015526,0.999999999984645,0.77029063159451,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
14332,GO:0061513,0.999999999984645,0.77029063159451,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
5420,GO:0016269,0.999999999984649,0.924926717368817,0,1,O-glycan processing, core 3,BP,
11973,GO:0047224,0.999999999984649,0.924926717368817,0,1,acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
19902,GO:2000393,0.99999999998465,0.823360640267328,0,2,negative regulation of lamellipodium morphogenesis,BP,
204,GO:0000429,0.999999999984681,0.775119432884773,0,3,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
209,GO:0000436,0.999999999984681,0.775119432884773,0,3,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
512,GO:0001575,0.999999999984696,0.868135033127572,0,2,globoside metabolic process,BP,
13871,GO:0060488,0.999999999984699,0.768697625818361,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13872,GO:0060489,0.999999999984699,0.768697625818361,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
13873,GO:0060490,0.999999999984699,0.768697625818361,0,2,lateral sprouting involved in lung morphogenesis,BP,
18620,GO:1903903,0.999999999984704,0.749567711005497,0,3,regulation of establishment of T cell polarity,BP,
11498,GO:0045976,0.999999999984721,0.82690757260894,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
11570,GO:0046121,0.999999999984726,0.804737395921655,0,3,deoxyribonucleoside catabolic process,BP,
4929,GO:0014886,0.999999999984765,0.823536739225228,0,2,transition between slow and fast fiber,BP,
6267,GO:0019860,0.999999999984791,0.859407394391457,0,2,uracil metabolic process,BP,
16045,GO:0086075,0.9999999999848,0.738804509507053,0,3,gap junction channel activity involved in cardiac conduction electrical coupling,MF,
16985,GO:0099053,0.999999999984816,0.765655195432408,0,3,activating signal cointegrator 1 complex,CC,
4019,GO:0009041,0.999999999984824,0.798468032284868,0,3,uridylate kinase activity,MF,
5514,GO:0016476,0.999999999984826,0.758222132412608,0,3,regulation of embryonic cell shape,BP,
10232,GO:0042923,0.999999999984832,0.86583149814393,0,2,neuropeptide binding,MF,
4882,GO:0014744,0.999999999984834,0.721647141666974,0,3,positive regulation of muscle adaptation,BP,
14064,GO:0060842,0.999999999984868,0.737463823926943,0,3,arterial endothelial cell differentiation,BP,
18082,GO:1902683,0.999999999984871,0.837405046711277,0,2,regulation of receptor localization to synapse,BP,
2061,GO:0004815,0.999999999984876,0.846640476593419,0,2,aspartate-tRNA ligase activity,MF,
5449,GO:0016321,0.999999999984882,0.788983295255422,0,3,female meiosis chromosome segregation,BP,
10856,GO:0044355,0.999999999984892,0.94006090950509,0,1,clearance of foreign intracellular DNA,BP,
10857,GO:0044356,0.999999999984892,0.94006090950509,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
16984,GO:0099046,0.999999999984892,0.94006090950509,0,1,clearance of foreign intracellular nucleic acids,BP,
18915,GO:1904627,0.999999999984892,0.94006090950509,0,1,response to phorbol 13-acetate 12-myristate,BP,
18916,GO:1904628,0.999999999984892,0.94006090950509,0,1,cellular response to phorbol 13-acetate 12-myristate,BP,
12719,GO:0050955,0.999999999984896,0.903900385808093,0,1,thermoception,BP,
12721,GO:0050960,0.999999999984896,0.903900385808093,0,1,detection of temperature stimulus involved in thermoception,BP,
12726,GO:0050968,0.999999999984896,0.903900385808093,0,1,detection of chemical stimulus involved in sensory perception of pain,BP,
13851,GO:0060454,0.999999999984896,0.903900385808093,0,1,positive regulation of gastric acid secretion,BP,
16192,GO:0090212,0.999999999984896,0.903900385808093,0,1,negative regulation of establishment of blood-brain barrier,BP,
16679,GO:0097603,0.999999999984896,0.903900385808093,0,1,temperature-gated ion channel activity,MF,
17700,GO:1901594,0.999999999984896,0.903900385808093,0,1,response to capsazepine,BP,
1380,GO:0003278,0.999999999984911,0.757409487183611,0,3,apoptotic process involved in heart morphogenesis,BP,
5205,GO:0015803,0.999999999984926,0.770777650975514,0,3,branched-chain amino acid transport,BP,
564,GO:0001705,0.999999999984937,0.824727996443623,0,2,ectoderm formation,BP,
571,GO:0001712,0.999999999984937,0.824727996443623,0,2,ectodermal cell fate commitment,BP,
6950,GO:0030576,0.999999999984937,0.775416330429915,0,3,Cajal body organization,BP,
13832,GO:0060430,0.99999999998495,0.785709498087284,0,2,lung saccule development,BP,
11389,GO:0045764,0.999999999984951,0.880262291703526,0,2,positive regulation of cellular amino acid metabolic process,BP,
13154,GO:0051725,0.999999999984965,0.86023252921449,0,2,protein de-ADP-ribosylation,BP,
6640,GO:0023025,0.999999999984977,0.85028563887712,0,2,MHC class Ib protein complex binding,MF,
6643,GO:0023030,0.999999999984977,0.85028563887712,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
1617,GO:0004046,0.999999999984987,0.808537420232505,0,3,aminoacylase activity,MF,
2601,GO:0005899,0.999999999984997,0.762420539081753,0,2,insulin receptor complex,CC,
14441,GO:0061752,0.999999999985004,0.856246321560185,0,2,telomeric repeat-containing RNA binding,MF,
8778,GO:0034455,0.999999999985009,0.753013422039431,0,3,t-UTP complex,CC,
3090,GO:0006663,0.999999999985034,0.770545915935653,0,3,platelet activating factor biosynthetic process,BP,
19220,GO:1905340,0.999999999985046,0.737315334135579,0,4,regulation of protein localization to kinetochore,BP,
19222,GO:1905342,0.999999999985046,0.737315334135579,0,4,positive regulation of protein localization to kinetochore,BP,
1748,GO:0004348,0.999999999985049,0.842622776177742,0,2,glucosylceramidase activity,MF,
7959,GO:0032558,0.999999999985055,0.804820255207531,0,3,adenyl deoxyribonucleotide binding,MF,
7963,GO:0032564,0.999999999985055,0.804820255207531,0,3,dATP binding,MF,
15938,GO:0072737,0.999999999985056,0.858575241980406,0,2,response to diamide,BP,
15939,GO:0072738,0.999999999985056,0.858575241980406,0,2,cellular response to diamide,BP,
3401,GO:0007181,0.999999999985058,0.835099861519901,0,2,transforming growth factor beta receptor complex assembly,BP,
4007,GO:0008967,0.99999999998506,0.853409332175559,0,2,phosphoglycolate phosphatase activity,MF,
6519,GO:0021896,0.99999999998507,0.764170374206886,0,2,forebrain astrocyte differentiation,BP,
6520,GO:0021897,0.99999999998507,0.764170374206886,0,2,forebrain astrocyte development,BP,
14091,GO:0060916,0.999999999985071,0.656561288172272,0,4,mesenchymal cell proliferation involved in lung development,BP,
9338,GO:0035822,0.999999999985077,0.812741389461063,0,2,gene conversion,BP,
9366,GO:0035880,0.999999999985084,0.843423952440906,0,2,embryonic nail plate morphogenesis,BP,
1740,GO:0004339,0.999999999985091,0.886880452515307,0,1,glucan 1,4-alpha-glucosidase activity,MF,
2646,GO:0005982,0.999999999985091,0.886880452515307,0,1,starch metabolic process,BP,
2647,GO:0005983,0.999999999985091,0.886880452515307,0,1,starch catabolic process,BP,
10785,GO:0044245,0.999999999985091,0.886880452515307,0,1,polysaccharide digestion,BP,
3001,GO:0006546,0.999999999985101,0.792979695399203,0,3,glycine catabolic process,BP,
6152,GO:0019464,0.999999999985101,0.792979695399203,0,3,glycine decarboxylation via glycine cleavage system,BP,
2065,GO:0004819,0.999999999985101,0.830589459339236,0,2,glutamine-tRNA ligase activity,MF,
2915,GO:0006425,0.999999999985101,0.830589459339236,0,2,glutaminyl-tRNA aminoacylation,BP,
1161,GO:0002775,0.999999999985139,0.797479307195723,0,3,antimicrobial peptide production,BP,
1162,GO:0002778,0.999999999985139,0.797479307195723,0,3,antibacterial peptide production,BP,
1163,GO:0002784,0.999999999985139,0.797479307195723,0,3,regulation of antimicrobial peptide production,BP,
1165,GO:0002786,0.999999999985139,0.797479307195723,0,3,regulation of antibacterial peptide production,BP,
12655,GO:0050859,0.99999999998516,0.783741328711155,0,3,negative regulation of B cell receptor signaling pathway,BP,
7529,GO:0031749,0.999999999985161,0.831997127832942,0,2,D2 dopamine receptor binding,MF,
14540,GO:0070051,0.999999999985173,0.823265551217315,0,2,fibrinogen binding,MF,
14348,GO:0061551,0.999999999985177,0.733443863408614,0,3,trigeminal ganglion development,BP,
5606,GO:0016647,0.999999999985186,0.871191425053992,0,2,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
11749,GO:0046592,0.999999999985186,0.871191425053992,0,2,polyamine oxidase activity,MF,
13452,GO:0052901,0.999999999985186,0.871191425053992,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
9494,GO:0036135,0.999999999985204,0.811710560590011,0,2,Schwann cell migration,BP,
17411,GO:1900147,0.999999999985204,0.811710560590011,0,2,regulation of Schwann cell migration,BP,
6450,GO:0021768,0.999999999985235,0.911389269593968,0,1,nucleus accumbens development,BP,
6618,GO:0022840,0.99999999998525,0.738780595807221,0,4,leak channel activity,MF,
6620,GO:0022842,0.99999999998525,0.738780595807221,0,4,narrow pore channel activity,MF,
19831,GO:2000299,0.999999999985252,0.913210169889985,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
51,GO:0000105,0.9999999999853,0.844931204416068,0,2,histidine biosynthetic process,BP,
7196,GO:0031085,0.999999999985303,0.832238641072876,0,2,BLOC-3 complex,CC,
180,GO:0000390,0.999999999985307,0.868050944846323,0,2,spliceosomal complex disassembly,BP,
493,GO:0001545,0.999999999985321,0.904762077698626,0,1,primary ovarian follicle growth,BP,
15237,GO:0071393,0.999999999985321,0.904762077698626,0,1,cellular response to progesterone stimulus,BP,
1266,GO:0003032,0.999999999985329,0.849771886106613,0,2,detection of oxygen,BP,
15964,GO:0075732,0.999999999985334,0.80321795179674,0,2,viral penetration into host nucleus,BP,
18052,GO:1902594,0.999999999985334,0.80321795179674,0,2,multi-organism nuclear import,BP,
3828,GO:0008427,0.99999999998534,0.878540555504451,0,2,calcium-dependent protein kinase inhibitor activity,MF,
4700,GO:0010858,0.99999999998534,0.878540555504451,0,2,calcium-dependent protein kinase regulator activity,MF,
11997,GO:0047391,0.999999999985347,0.856535028305486,0,2,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,
1306,GO:0003150,0.999999999985352,0.666936755805735,0,4,muscular septum morphogenesis,BP,
14690,GO:0070305,0.999999999985403,0.719487696446028,0,3,response to cGMP,BP,
15186,GO:0071321,0.999999999985403,0.719487696446028,0,3,cellular response to cGMP,BP,
10945,GO:0044609,0.999999999985407,0.854968314088074,0,2,DBIRD complex,CC,
11146,GO:0045196,0.999999999985412,0.802057300666601,0,2,establishment or maintenance of neuroblast polarity,BP,
11150,GO:0045200,0.999999999985412,0.802057300666601,0,2,establishment of neuroblast polarity,BP,
756,GO:0001996,0.999999999985419,0.762061631191406,0,3,positive regulation of heart rate by epinephrine-norepinephrine,BP,
1397,GO:0003321,0.999999999985419,0.762061631191406,0,3,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
5021,GO:0015184,0.999999999985423,0.814574720149005,0,2,L-cystine transmembrane transporter activity,MF,
5212,GO:0015811,0.999999999985423,0.814574720149005,0,2,L-cystine transport,BP,
5471,GO:0016404,0.999999999985428,0.900695334090994,0,1,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
7576,GO:0031938,0.999999999985429,0.874028273685131,0,2,regulation of chromatin silencing at telomere,BP,
12267,GO:0048560,0.999999999985445,0.862819192926705,0,2,establishment of anatomical structure orientation,BP,
1715,GO:0004307,0.999999999985449,0.878329486057278,0,2,ethanolaminephosphotransferase activity,MF,
3026,GO:0006572,0.999999999985457,0.827277321776215,0,3,tyrosine catabolic process,BP,
1676,GO:0004140,0.999999999985464,0.86362320816606,0,2,dephospho-CoA kinase activity,MF,
522,GO:0001609,0.999999999985468,0.797513874862462,0,3,G-protein coupled adenosine receptor activity,MF,
1737,GO:0004335,0.999999999985483,0.862090826158663,0,2,galactokinase activity,MF,
4903,GO:0014832,0.999999999985487,0.735558593672956,0,3,urinary bladder smooth muscle contraction,BP,
4912,GO:0014848,0.999999999985487,0.735558593672956,0,3,urinary tract smooth muscle contraction,BP,
13731,GO:0060300,0.99999999998549,0.809054781395768,0,3,regulation of cytokine activity,BP,
12292,GO:0048625,0.999999999985493,0.751180352401177,0,3,myoblast fate commitment,BP,
339,GO:0000939,0.999999999985505,0.803095549156578,0,3,condensed chromosome inner kinetochore,CC,
2073,GO:0004827,0.999999999985532,0.785249619622488,0,3,proline-tRNA ligase activity,MF,
2923,GO:0006433,0.999999999985532,0.785249619622488,0,3,prolyl-tRNA aminoacylation,BP,
9256,GO:0035662,0.999999999985532,0.855290417836312,0,3,Toll-like receptor 4 binding,MF,
15165,GO:0071283,0.999999999985533,0.881756315952354,0,2,cellular response to iron(III) ion,BP,
2438,GO:0005638,0.999999999985571,0.709253283134131,0,4,lamin filament,CC,
6238,GO:0019797,0.999999999985578,0.777515753138608,0,3,procollagen-proline 3-dioxygenase activity,MF,
8439,GO:0033557,0.999999999985578,0.777515753138608,0,3,Slx1-Slx4 complex,CC,
13456,GO:0052905,0.999999999985578,0.777515753138608,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
3448,GO:0007258,0.999999999985578,0.704723419947295,0,4,JUN phosphorylation,BP,
13885,GO:0060523,0.999999999985584,0.802999996214553,0,2,prostate epithelial cord elongation,BP,
9879,GO:0042144,0.9999999999856,0.829628577433817,0,2,vacuole fusion, non-autophagic,BP,
16674,GO:0097576,0.9999999999856,0.829628577433817,0,2,vacuole fusion,BP,
9298,GO:0035740,0.999999999985601,0.852711610951097,0,2,CD8-positive, alpha-beta T cell proliferation,BP,
19977,GO:2000564,0.999999999985601,0.852711610951097,0,2,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
5055,GO:0015252,0.999999999985604,0.916514221375186,0,1,proton channel activity,MF,
9131,GO:0035445,0.999999999985604,0.916514221375186,0,1,borate transmembrane transport,BP,
11820,GO:0046713,0.999999999985604,0.916514221375186,0,1,borate transport,BP,
11821,GO:0046715,0.999999999985604,0.916514221375186,0,1,active borate transmembrane transporter activity,MF,
1820,GO:0004471,0.999999999985605,0.762932106147339,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1821,GO:0004473,0.999999999985605,0.762932106147339,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
18387,GO:1903400,0.999999999985608,0.719750736055555,0,3,L-arginine transmembrane transport,BP,
6836,GO:0030298,0.999999999985608,0.943641040131852,0,1,receptor signaling protein tyrosine kinase activator activity,MF,
7524,GO:0031726,0.999999999985608,0.943641040131852,0,1,CCR1 chemokine receptor binding,MF,
7525,GO:0031729,0.999999999985608,0.943641040131852,0,1,CCR4 chemokine receptor binding,MF,
11843,GO:0046817,0.999999999985608,0.943641040131852,0,1,chemokine receptor antagonist activity,MF,
7766,GO:0032286,0.999999999985615,0.755468096510621,0,3,central nervous system myelin maintenance,BP,
3185,GO:0006808,0.999999999985633,0.862452696159762,0,2,regulation of nitrogen utilization,BP,
11796,GO:0046666,0.999999999985633,0.862452696159762,0,2,retinal cell programmed cell death,BP,
14623,GO:0070189,0.999999999985636,0.754593416800347,0,4,kynurenine metabolic process,BP,
6308,GO:0019948,0.999999999985647,0.853573356413764,0,2,SUMO activating enzyme activity,MF,
15055,GO:0071006,0.999999999985674,0.785249788466031,0,3,U2-type catalytic step 1 spliceosome,CC,
20291,GO:2001271,0.999999999985678,0.748403257266932,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
3525,GO:0007499,0.999999999985692,0.899289589732145,0,1,ectoderm and mesoderm interaction,BP,
12388,GO:0048807,0.999999999985692,0.899289589732145,0,1,female genitalia morphogenesis,BP,
18929,GO:1904674,0.999999999985692,0.899289589732145,0,1,positive regulation of somatic stem cell population maintenance,BP,
19700,GO:2000035,0.999999999985692,0.770129812010676,0,3,regulation of stem cell division,BP,
6831,GO:0030292,0.999999999985693,0.772904793787623,0,3,protein tyrosine kinase inhibitor activity,MF,
6372,GO:0021557,0.999999999985704,0.859114228977197,0,2,oculomotor nerve development,BP,
429,GO:0001147,0.999999999985708,0.785777277819702,0,2,transcription termination site sequence-specific DNA binding,MF,
432,GO:0001160,0.999999999985708,0.785777277819702,0,2,transcription termination site DNA binding,MF,
1406,GO:0003340,0.99999999998571,0.830682257578467,0,2,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
20061,GO:2000697,0.99999999998571,0.830682257578467,0,2,negative regulation of epithelial cell differentiation involved in kidney development,BP,
11786,GO:0046645,0.999999999985725,0.722965172170164,0,3,positive regulation of gamma-delta T cell activation,BP,
11035,GO:0045007,0.999999999985725,0.824199276622232,0,3,depurination,BP,
14929,GO:0070780,0.999999999985726,0.862862942804779,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
5357,GO:0016128,0.999999999985738,0.79798987492487,0,3,phytosteroid metabolic process,BP,
5358,GO:0016129,0.999999999985738,0.79798987492487,0,3,phytosteroid biosynthetic process,BP,
5387,GO:0016212,0.99999999998574,0.859357011462178,0,2,kynurenine-oxoglutarate transaminase activity,MF,
9495,GO:0036137,0.99999999998574,0.859357011462178,0,2,kynurenine aminotransferase activity,MF,
16419,GO:0097052,0.99999999998574,0.859357011462178,0,2,L-kynurenine metabolic process,BP,
2032,GO:0004772,0.999999999985742,0.912668628768907,0,1,sterol O-acyltransferase activity,MF,
8909,GO:0034736,0.999999999985742,0.912668628768907,0,1,cholesterol O-acyltransferase activity,MF,
18467,GO:1903565,0.999999999985742,0.912668628768907,0,1,negative regulation of protein localization to cilium,BP,
18470,GO:1903568,0.999999999985742,0.912668628768907,0,1,negative regulation of protein localization to ciliary membrane,BP,
15641,GO:0072137,0.999999999985747,0.722854876121287,0,2,condensed mesenchymal cell proliferation,BP,
143,GO:0000294,0.99999999998575,0.824259156335203,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
19539,GO:1990452,0.999999999985762,0.831201541207254,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
9236,GO:0035624,0.999999999985778,0.799643515739423,0,2,receptor transactivation,BP,
2259,GO:0005173,0.999999999985791,0.712008884424834,0,3,stem cell factor receptor binding,MF,
5305,GO:0016011,0.999999999985808,0.753290555308279,0,3,dystroglycan complex,CC,
2301,GO:0005280,0.999999999985811,0.749357164169824,0,3,amino acid:proton symporter activity,MF,
18939,GO:1904693,0.999999999985813,0.721185517263352,0,3,midbrain morphogenesis,BP,
107,GO:0000221,0.999999999985819,0.759695003541048,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
13986,GO:0060698,0.999999999985821,0.828322406915116,0,2,endoribonuclease inhibitor activity,MF,
13989,GO:0060701,0.999999999985821,0.828322406915116,0,2,negative regulation of ribonuclease activity,BP,
13990,GO:0060702,0.999999999985821,0.828322406915116,0,2,negative regulation of endoribonuclease activity,BP,
8853,GO:0034647,0.999999999985847,0.765424686916907,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
8902,GO:0034721,0.999999999985847,0.765424686916907,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
11225,GO:0045358,0.999999999985855,0.880598871585503,0,2,negative regulation of interferon-beta biosynthetic process,BP,
19121,GO:1905064,0.999999999985861,0.836844216283566,0,2,negative regulation of vascular smooth muscle cell differentiation,BP,
15489,GO:0071847,0.999999999985867,0.825144765629915,0,2,TNFSF11-mediated signaling pathway,BP,
8338,GO:0033183,0.999999999985875,0.715008496423885,0,3,negative regulation of histone ubiquitination,BP,
17619,GO:1901314,0.999999999985875,0.715008496423885,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
17620,GO:1901315,0.999999999985875,0.715008496423885,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18520,GO:1903697,0.999999999985879,0.913329485420745,0,1,negative regulation of microvillus assembly,BP,
1586,GO:0003997,0.999999999985881,0.757249697588736,0,3,acyl-CoA oxidase activity,MF,
2136,GO:0004947,0.999999999985882,0.851502057384639,0,2,bradykinin receptor activity,MF,
5033,GO:0015204,0.999999999985885,0.774774660416467,0,3,urea transmembrane transporter activity,MF,
5228,GO:0015840,0.999999999985885,0.774774660416467,0,3,urea transport,BP,
11460,GO:0045914,0.999999999985918,0.849810225218536,0,2,negative regulation of catecholamine metabolic process,BP,
11494,GO:0045963,0.999999999985918,0.849810225218536,0,2,negative regulation of dopamine metabolic process,BP,
8529,GO:0033768,0.999999999985942,0.842745800558313,0,2,SUMO-targeted ubiquitin ligase complex,CC,
1891,GO:0004573,0.999999999985946,0.921740251277413,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
5544,GO:0016533,0.999999999985962,0.857092090373753,0,2,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
10141,GO:0042704,0.999999999985965,0.819568044300871,0,2,uterine wall breakdown,BP,
17909,GO:1902219,0.999999999985994,0.675617726641935,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
16350,GO:0090615,0.999999999986023,0.839156452176137,0,2,mitochondrial mRNA processing,BP,
856,GO:0002184,0.999999999986036,0.812675331709385,0,2,cytoplasmic translational termination,BP,
11129,GO:0045168,0.999999999986066,0.858951157204485,0,2,cell-cell signaling involved in cell fate commitment,BP,
11629,GO:0046331,0.999999999986066,0.858951157204485,0,2,lateral inhibition,BP,
4778,GO:0010963,0.999999999986075,0.939964879684548,0,1,regulation of L-arginine import,BP,
15017,GO:0070947,0.999999999986075,0.939964879684548,0,1,neutrophil mediated killing of fungus,BP,
15022,GO:0070953,0.999999999986075,0.939964879684548,0,1,regulation of neutrophil mediated killing of fungus,BP,
15027,GO:0070965,0.999999999986075,0.939964879684548,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
19972,GO:2000552,0.999999999986075,0.939964879684548,0,1,negative regulation of T-helper 2 cell cytokine production,BP,
3690,GO:0008193,0.999999999986078,0.851984846055314,0,2,tRNA guanylyltransferase activity,MF,
631,GO:0001820,0.999999999986084,0.762012614287708,0,3,serotonin secretion,BP,
1732,GO:0004329,0.999999999986092,0.829591977639315,0,2,formate-tetrahydrofolate ligase activity,MF,
4180,GO:0009257,0.999999999986092,0.829591977639315,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4741,GO:0010908,0.9999999999861,0.759695582658068,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
4742,GO:0010909,0.9999999999861,0.759695582658068,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
18098,GO:1902730,0.9999999999861,0.759695582658068,0,3,positive regulation of proteoglycan biosynthetic process,BP,
17485,GO:1900390,0.99999999998612,0.883697079030531,0,2,regulation of iron ion import,BP,
18839,GO:1904432,0.99999999998612,0.883697079030531,0,2,regulation of ferrous iron binding,BP,
18840,GO:1904434,0.99999999998612,0.883697079030531,0,2,positive regulation of ferrous iron binding,BP,
18841,GO:1904435,0.99999999998612,0.883697079030531,0,2,regulation of transferrin receptor binding,BP,
18842,GO:1904437,0.99999999998612,0.883697079030531,0,2,positive regulation of transferrin receptor binding,BP,
14239,GO:0061209,0.999999999986123,0.785429822872061,0,3,cell proliferation involved in mesonephros development,BP,
5217,GO:0015819,0.999999999986128,0.933287645034721,0,1,lysine transport,BP,
17278,GO:0140009,0.999999999986128,0.909431387319039,0,1,L-aspartate import across plasma membrane,BP,
2420,GO:0005594,0.999999999986147,0.850722562585626,0,2,collagen type IX trimer,CC,
13057,GO:0051548,0.999999999986152,0.786596135222953,0,2,negative regulation of keratinocyte migration,BP,
19175,GO:1905224,0.999999999986187,0.805320012607556,0,2,clathrin-coated pit assembly,BP,
1641,GO:0004084,0.999999999986215,0.821695996700221,0,2,branched-chain-amino-acid transaminase activity,MF,
4045,GO:0009082,0.999999999986215,0.821695996700221,0,2,branched-chain amino acid biosynthetic process,BP,
4053,GO:0009098,0.999999999986215,0.821695996700221,0,2,leucine biosynthetic process,BP,
4054,GO:0009099,0.999999999986215,0.821695996700221,0,2,valine biosynthetic process,BP,
13384,GO:0052654,0.999999999986215,0.821695996700221,0,2,L-leucine transaminase activity,MF,
13385,GO:0052655,0.999999999986215,0.821695996700221,0,2,L-valine transaminase activity,MF,
13386,GO:0052656,0.999999999986215,0.821695996700221,0,2,L-isoleucine transaminase activity,MF,
12187,GO:0048319,0.999999999986216,0.809278996051311,0,2,axial mesoderm morphogenesis,BP,
9914,GO:0042253,0.999999999986229,0.846940950276142,0,2,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
15609,GO:0072093,0.999999999986232,0.685165290852707,0,3,metanephric renal vesicle formation,BP,
10501,GO:0043402,0.999999999986257,0.692989568317563,0,3,glucocorticoid mediated signaling pathway,BP,
3992,GO:0008889,0.999999999986266,0.751621663400801,0,3,glycerophosphodiester phosphodiesterase activity,MF,
16492,GO:0097180,0.999999999986276,0.890896256437064,0,2,serine protease inhibitor complex,CC,
11510,GO:0045994,0.999999999986279,0.836365966319334,0,2,positive regulation of translational initiation by iron,BP,
5484,GO:0016418,0.999999999986286,0.789424665706863,0,2,S-acetyltransferase activity,MF,
16936,GO:0098914,0.999999999986296,0.804710990835245,0,2,membrane repolarization during atrial cardiac muscle cell action potential,BP,
17091,GO:0099624,0.999999999986296,0.804710990835245,0,2,atrial cardiac muscle cell membrane repolarization,BP,
13674,GO:0060200,0.999999999986298,0.89788871756313,0,1,clathrin-sculpted acetylcholine transport vesicle,CC,
13675,GO:0060201,0.999999999986298,0.89788871756313,0,1,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
16842,GO:0098746,0.999999999986298,0.89788871756313,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18023,GO:1902524,0.999999999986312,0.853380456918441,0,2,positive regulation of protein K48-linked ubiquitination,BP,
14366,GO:0061588,0.999999999986323,0.690112653569837,0,4,calcium activated phospholipid scrambling,BP,
14367,GO:0061589,0.999999999986323,0.690112653569837,0,4,calcium activated phosphatidylserine scrambling,BP,
14368,GO:0061590,0.999999999986323,0.690112653569837,0,4,calcium activated phosphatidylcholine scrambling,BP,
14369,GO:0061591,0.999999999986323,0.690112653569837,0,4,calcium activated galactosylceramide scrambling,BP,
15312,GO:0071502,0.999999999986339,0.792743080257889,0,3,cellular response to temperature stimulus,BP,
7080,GO:0030868,0.999999999986387,0.776542492929033,0,3,smooth endoplasmic reticulum membrane,CC,
16601,GO:0097425,0.999999999986387,0.776542492929033,0,3,smooth endoplasmic reticulum part,CC,
16529,GO:0097241,0.99999999998639,0.857850667076757,0,2,hematopoietic stem cell migration to bone marrow,BP,
12364,GO:0048743,0.999999999986391,0.822673018054265,0,2,positive regulation of skeletal muscle fiber development,BP,
1755,GO:0004357,0.999999999986395,0.833178525458388,0,2,glutamate-cysteine ligase activity,MF,
5829,GO:0017109,0.999999999986395,0.833178525458388,0,2,glutamate-cysteine ligase complex,CC,
16433,GO:0097069,0.999999999986395,0.833178525458388,0,2,cellular response to thyroxine stimulus,BP,
18819,GO:1904387,0.999999999986395,0.833178525458388,0,2,cellular response to L-phenylalanine derivative,BP,
10488,GO:0043383,0.999999999986399,0.755816829838186,0,3,negative T cell selection,BP,
11062,GO:0045060,0.999999999986399,0.755816829838186,0,3,negative thymic T cell selection,BP,
5531,GO:0016508,0.999999999986403,0.766841300438456,0,3,long-chain-enoyl-CoA hydratase activity,MF,
12,GO:0000023,0.999999999986423,0.726035443767183,0,3,maltose metabolic process,BP,
1879,GO:0004558,0.999999999986423,0.726035443767183,0,3,alpha-1,4-glucosidase activity,MF,
7883,GO:0032450,0.999999999986423,0.726035443767183,0,3,maltose alpha-glucosidase activity,MF,
16567,GO:0097350,0.99999999998643,0.771114536861829,0,3,neutrophil clearance,BP,
2126,GO:0004923,0.999999999986436,0.792860641843618,0,2,leukemia inhibitory factor receptor activity,MF,
13866,GO:0060482,0.999999999986442,0.773778582251576,0,3,lobar bronchus development,BP,
4491,GO:0010513,0.999999999986446,0.873633739534896,0,2,positive regulation of phosphatidylinositol biosynthetic process,BP,
16395,GO:0097010,0.999999999986452,0.74876355256362,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
2602,GO:0005900,0.999999999986465,0.832606107854102,0,2,oncostatin-M receptor complex,CC,
2208,GO:0005094,0.999999999986495,0.8811658769092,0,2,Rho GDP-dissociation inhibitor activity,MF,
5752,GO:0016900,0.999999999986499,0.896350058915367,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
11953,GO:0047057,0.999999999986499,0.896350058915367,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
15476,GO:0071818,0.999999999986504,0.793498489666293,0,3,BAT3 complex,CC,
15778,GO:0072379,0.999999999986504,0.793498489666293,0,3,ER membrane insertion complex,CC,
18359,GO:1903348,0.999999999986505,0.754427147895503,0,3,positive regulation of bicellular tight junction assembly,BP,
1203,GO:0002863,0.999999999986506,0.748638532635855,0,4,positive regulation of inflammatory response to antigenic stimulus,BP,
20235,GO:2001180,0.999999999986515,0.84902702137225,0,2,negative regulation of interleukin-10 secretion,BP,
3044,GO:0006597,0.999999999986525,0.856137919435124,0,2,spermine biosynthetic process,BP,
2354,GO:0005436,0.999999999986546,0.831334059390961,0,2,sodium:phosphate symporter activity,MF,
5082,GO:0015319,0.999999999986546,0.831334059390961,0,2,sodium:inorganic phosphate symporter activity,MF,
5083,GO:0015321,0.999999999986546,0.831334059390961,0,2,sodium-dependent phosphate transmembrane transporter activity,MF,
688,GO:0001907,0.99999999998655,0.799434940614994,0,3,killing by symbiont of host cells,BP,
10711,GO:0044004,0.99999999998655,0.799434940614994,0,3,disruption by symbiont of host cell,BP,
10924,GO:0044533,0.99999999998655,0.799434940614994,0,3,positive regulation of apoptotic process in other organism,BP,
13303,GO:0052042,0.99999999998655,0.799434940614994,0,3,positive regulation by symbiont of host programmed cell death,BP,
13339,GO:0052330,0.99999999998655,0.799434940614994,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
13358,GO:0052501,0.99999999998655,0.799434940614994,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
1335,GO:0003192,0.999999999986551,0.687496427446804,0,3,mitral valve formation,BP,
14406,GO:0061669,0.999999999986559,0.804329747265859,0,2,spontaneous neurotransmitter secretion,BP,
10973,GO:0044752,0.999999999986566,0.772482835456539,0,3,response to human chorionic gonadotropin,BP,
13788,GO:0060374,0.99999999998659,0.749732362829409,0,3,mast cell differentiation,BP,
7393,GO:0031445,0.999999999986599,0.8137761009866,0,2,regulation of heterochromatin assembly,BP,
7394,GO:0031453,0.999999999986599,0.8137761009866,0,2,positive regulation of heterochromatin assembly,BP,
11406,GO:0045799,0.999999999986599,0.8137761009866,0,2,positive regulation of chromatin assembly or disassembly,BP,
8446,GO:0033566,0.9999999999866,0.851420695801326,0,2,gamma-tubulin complex localization,BP,
15071,GO:0071031,0.999999999986624,0.877837242305687,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
15083,GO:0071049,0.999999999986624,0.877837242305687,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
1511,GO:0003872,0.99999999998663,0.773575381257371,0,3,6-phosphofructokinase activity,MF,
7611,GO:0031997,0.999999999986659,0.789595270377967,0,3,N-terminal myristoylation domain binding,MF,
12961,GO:0051343,0.999999999986659,0.789595270377967,0,3,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
9233,GO:0035621,0.999999999986664,0.832926947764023,0,2,ER to Golgi ceramide transport,BP,
13950,GO:0060631,0.999999999986668,0.767074920122152,0,3,regulation of meiosis I,BP,
15650,GO:0072161,0.99999999998667,0.709415408924862,0,4,mesenchymal cell differentiation involved in kidney development,BP,
20169,GO:2001012,0.99999999998667,0.709415408924862,0,4,mesenchymal cell differentiation involved in renal system development,BP,
19081,GO:1904975,0.999999999986696,0.811199927108654,0,2,response to bleomycin,BP,
19082,GO:1904976,0.999999999986696,0.811199927108654,0,2,cellular response to bleomycin,BP,
6333,GO:0021502,0.999999999986707,0.819301452484617,0,2,neural fold elevation formation,BP,
12128,GO:0048203,0.999999999986715,0.85802921924584,0,2,vesicle targeting, trans-Golgi to endosome,BP,
6467,GO:0021796,0.999999999986724,0.764048573949904,0,3,cerebral cortex regionalization,BP,
1090,GO:0002678,0.99999999998673,0.820009284487132,0,3,positive regulation of chronic inflammatory response,BP,
11536,GO:0046061,0.999999999986736,0.818321094576361,0,3,dATP catabolic process,BP,
17461,GO:1900248,0.99999999998677,0.79533606253867,0,2,negative regulation of cytoplasmic translational elongation,BP,
1242,GO:0002940,0.999999999986786,0.854308202097999,0,2,tRNA N2-guanine methylation,BP,
17670,GO:1901529,0.999999999986788,0.831131843308692,0,2,positive regulation of anion channel activity,BP,
11007,GO:0044821,0.999999999986795,0.688892292202272,0,4,meiotic telomere tethering at nuclear periphery,BP,
14629,GO:0070197,0.999999999986795,0.688892292202272,0,4,meiotic attachment of telomere to nuclear envelope,BP,
16528,GO:0097240,0.999999999986795,0.688892292202272,0,4,chromosome attachment to the nuclear envelope,BP,
6828,GO:0030289,0.999999999986797,0.737284543354843,0,4,protein phosphatase 4 complex,CC,
10764,GO:0044209,0.999999999986797,0.886267528772663,0,2,AMP salvage,BP,
15873,GO:0072592,0.999999999986815,0.864263667395059,0,2,oxygen metabolic process,BP,
16511,GO:0097210,0.999999999986828,0.826469674315832,0,2,response to gonadotropin-releasing hormone,BP,
16512,GO:0097211,0.999999999986828,0.826469674315832,0,2,cellular response to gonadotropin-releasing hormone,BP,
6964,GO:0030618,0.999999999986832,0.625324476477509,0,4,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
12499,GO:0050560,0.99999999998687,0.913236671257078,0,1,aspartate-tRNA(Asn) ligase activity,MF,
14598,GO:0070145,0.99999999998687,0.913236671257078,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
14177,GO:0061073,0.999999999986874,0.820656736125435,0,2,ciliary body morphogenesis,BP,
16147,GO:0090156,0.999999999986877,0.814682603847648,0,3,cellular sphingolipid homeostasis,BP,
1743,GO:0004343,0.999999999986877,0.906169950964567,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
8912,GO:0034751,0.999999999986881,0.774798066301197,0,3,aryl hydrocarbon receptor complex,CC,
1361,GO:0003241,0.99999999998689,0.748584948370404,0,3,growth involved in heart morphogenesis,BP,
16410,GO:0097036,0.999999999986901,0.940157053725047,0,1,regulation of plasma membrane sterol distribution,BP,
5710,GO:0016841,0.999999999986924,0.847373920059483,0,2,ammonia-lyase activity,MF,
7866,GO:0032427,0.999999999986927,0.836505405140362,0,2,GBD domain binding,MF,
16330,GO:0090541,0.999999999986932,0.828972075859044,0,2,MIT domain binding,MF,
16374,GO:0090677,0.999999999986937,0.858738988474502,0,2,reversible differentiation,BP,
16375,GO:0090678,0.999999999986937,0.858738988474502,0,2,cell dedifferentiation involved in phenotypic switching,BP,
19160,GO:1905174,0.999999999986937,0.858738988474502,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
19670,GO:1990936,0.999999999986937,0.858738988474502,0,2,vascular smooth muscle cell dedifferentiation,BP,
3643,GO:0008113,0.999999999986951,0.884783488041826,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
2060,GO:0004814,0.999999999986951,0.805900299097477,0,3,arginine-tRNA ligase activity,MF,
2910,GO:0006420,0.999999999986951,0.805900299097477,0,3,arginyl-tRNA aminoacylation,BP,
19910,GO:2000405,0.999999999986964,0.89324631541181,0,1,negative regulation of T cell migration,BP,
15544,GO:0071947,0.999999999986967,0.717259180918899,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
3644,GO:0008116,0.999999999986977,0.892503926534592,0,1,prostaglandin-I synthase activity,MF,
2260,GO:0005174,0.999999999986991,0.927775597464359,0,1,CD40 receptor binding,MF,
171,GO:0000375,0.99999999998701,3.57010180789293e-10,1,301,RNA splicing, via transesterification reactions,BP,DHX32
10164,GO:0042748,0.999999999987021,0.731805784397177,0,3,circadian sleep/wake cycle, non-REM sleep,BP,
20147,GO:2000848,0.99999999998703,0.803979803853827,0,3,positive regulation of corticosteroid hormone secretion,BP,
5415,GO:0016262,0.999999999987035,0.766790504143761,0,3,protein N-acetylglucosaminyltransferase activity,MF,
15358,GO:0071586,0.999999999987037,0.860630019778091,0,2,CAAX-box protein processing,BP,
15976,GO:0080120,0.999999999987037,0.860630019778091,0,2,CAAX-box protein maturation,BP,
5708,GO:0016838,0.999999999987046,0.882278108289664,0,2,carbon-oxygen lyase activity, acting on phosphates,MF,
13127,GO:0051673,0.999999999987051,0.874531435111593,0,2,membrane disruption in other organism,BP,
3638,GO:0008107,0.999999999987065,0.827776856136882,0,2,galactoside 2-alpha-L-fucosyltransferase activity,MF,
7232,GO:0031127,0.999999999987065,0.827776856136882,0,2,alpha-(1,2)-fucosyltransferase activity,MF,
18837,GO:1904430,0.999999999987076,0.754607123933885,0,3,negative regulation of t-circle formation,BP,
13168,GO:0051765,0.999999999987077,0.854860729104668,0,2,inositol tetrakisphosphate kinase activity,MF,
11057,GO:0045054,0.999999999987079,0.782646551171663,0,3,constitutive secretory pathway,BP,
19546,GO:1990498,0.999999999987109,0.774264542589246,0,2,mitotic spindle microtubule,CC,
3173,GO:0006784,0.99999999998713,0.81124125043539,0,2,heme a biosynthetic process,BP,
11588,GO:0046160,0.99999999998713,0.81124125043539,0,2,heme a metabolic process,BP,
16030,GO:0086048,0.999999999987193,0.820441772030038,0,2,membrane depolarization during bundle of His cell action potential,BP,
4207,GO:0009328,0.999999999987193,0.733893073258112,0,4,phenylalanine-tRNA ligase complex,CC,
19459,GO:1990145,0.999999999987205,0.835563607508566,0,2,maintenance of translational fidelity,BP,
826,GO:0002101,0.999999999987219,0.786663615781371,0,3,tRNA wobble cytosine modification,BP,
10604,GO:0043578,0.999999999987227,0.679030093843499,0,3,nuclear matrix organization,BP,
16244,GO:0090292,0.999999999987227,0.679030093843499,0,3,nuclear matrix anchoring at nuclear membrane,BP,
5241,GO:0015864,0.99999999998723,0.860892160850293,0,2,pyrimidine nucleoside transport,BP,
9877,GO:0042138,0.999999999987243,0.927056003002841,0,1,meiotic DNA double-strand break formation,BP,
20105,GO:2000777,0.999999999987246,0.864014190889084,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
3991,GO:0008887,0.999999999987252,0.914866024930342,0,1,glycerate kinase activity,MF,
11384,GO:0045759,0.999999999987266,0.838253970951078,0,2,negative regulation of action potential,BP,
2049,GO:0004798,0.999999999987276,0.867866609319446,0,2,thymidylate kinase activity,MF,
2791,GO:0006227,0.999999999987276,0.867866609319446,0,2,dUDP biosynthetic process,BP,
2794,GO:0006233,0.999999999987276,0.867866609319446,0,2,dTDP biosynthetic process,BP,
4085,GO:0009139,0.999999999987276,0.867866609319446,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4136,GO:0009196,0.999999999987276,0.867866609319446,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4137,GO:0009197,0.999999999987276,0.867866609319446,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
11543,GO:0046072,0.999999999987276,0.867866609319446,0,2,dTDP metabolic process,BP,
11546,GO:0046077,0.999999999987276,0.867866609319446,0,2,dUDP metabolic process,BP,
4732,GO:0010896,0.999999999987303,0.771871192912117,0,3,regulation of triglyceride catabolic process,BP,
1206,GO:0002866,0.999999999987325,0.799337794620792,0,3,positive regulation of acute inflammatory response to antigenic stimulus,BP,
2230,GO:0005134,0.999999999987341,0.789856596227083,0,3,interleukin-2 receptor binding,MF,
189,GO:0000406,0.999999999987345,0.823720587603415,0,2,double-strand/single-strand DNA junction binding,MF,
7702,GO:0032181,0.999999999987345,0.823720587603415,0,2,dinucleotide repeat insertion binding,MF,
7778,GO:0032302,0.999999999987345,0.823720587603415,0,2,MutSbeta complex,CC,
15254,GO:0071421,0.999999999987351,0.819216781040035,0,2,manganese ion transmembrane transport,BP,
17422,GO:1900169,0.999999999987368,0.781883294611886,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
5170,GO:0015722,0.999999999987371,0.749004538459528,0,3,canalicular bile acid transport,BP,
2418,GO:0005592,0.999999999987382,0.882323137252753,0,1,collagen type XI trimer,CC,
2624,GO:0005945,0.999999999987383,0.838064744656473,0,2,6-phosphofructokinase complex,CC,
19441,GO:1990075,0.999999999987392,0.756123382379525,0,3,periciliary membrane compartment,CC,
17615,GO:1901301,0.999999999987395,0.829313558799734,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
20085,GO:2000741,0.999999999987412,0.71169880518257,0,3,positive regulation of mesenchymal stem cell differentiation,BP,
10154,GO:0042732,0.999999999987427,0.863827179753116,0,2,D-xylose metabolic process,BP,
2623,GO:0005943,0.999999999987437,0.809764560849643,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
16702,GO:0097651,0.999999999987437,0.809764560849643,0,2,phosphatidylinositol 3-kinase complex, class I,CC,
2071,GO:0004825,0.999999999987439,0.84496311051074,0,2,methionine-tRNA ligase activity,MF,
2921,GO:0006431,0.999999999987439,0.84496311051074,0,2,methionyl-tRNA aminoacylation,BP,
8118,GO:0032804,0.99999999998744,0.846460496456495,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
2242,GO:0005152,0.999999999987451,0.760763679205448,0,3,interleukin-1 receptor antagonist activity,MF,
9716,GO:0038131,0.999999999987458,0.852833690440685,0,2,neuregulin receptor activity,MF,
14682,GO:0070294,0.999999999987476,0.761363746421341,0,3,renal sodium ion absorption,BP,
3938,GO:0008623,0.999999999987477,0.824105847962304,0,2,CHRAC,CC,
3804,GO:0008384,0.999999999987489,0.754625727533285,0,3,IkappaB kinase activity,MF,
4998,GO:0015140,0.99999999998749,0.872472380474326,0,2,malate transmembrane transporter activity,MF,
14340,GO:0061535,0.999999999987502,0.694737175470669,0,3,glutamate secretion, neurotransmission,BP,
2950,GO:0006478,0.999999999987507,0.868049304542795,0,2,peptidyl-tyrosine sulfation,BP,
3859,GO:0008476,0.999999999987507,0.868049304542795,0,2,protein-tyrosine sulfotransferase activity,MF,
1612,GO:0004040,0.999999999987515,0.84096001977323,0,2,amidase activity,MF,
17606,GO:1901291,0.999999999987544,0.932904875270648,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
19445,GO:1990108,0.999999999987564,0.804406472686125,0,2,protein linear deubiquitination,BP,
12173,GO:0048294,0.999999999987617,0.829104455348667,0,2,negative regulation of isotype switching to IgE isotypes,BP,
18706,GO:1904098,0.999999999987621,0.769953724415259,0,3,regulation of protein O-linked glycosylation,BP,
18707,GO:1904100,0.999999999987621,0.769953724415259,0,3,positive regulation of protein O-linked glycosylation,BP,
999,GO:0002468,0.999999999987628,0.680876407704648,0,4,dendritic cell antigen processing and presentation,BP,
1063,GO:0002604,0.999999999987628,0.680876407704648,0,4,regulation of dendritic cell antigen processing and presentation,BP,
17555,GO:1901097,0.999999999987631,0.690186778793427,0,4,negative regulation of autophagosome maturation,BP,
8323,GO:0033159,0.999999999987637,0.760971823115405,0,3,negative regulation of protein import into nucleus, translocation,BP,
8615,GO:0034124,0.999999999987651,0.848723593970957,0,2,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
10276,GO:0043020,0.999999999987688,0.834742344235588,0,3,NADPH oxidase complex,CC,
14436,GO:0061741,0.99999999998769,0.856871506566952,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
1627,GO:0004064,0.999999999987697,0.806938014759542,0,3,arylesterase activity,MF,
17004,GO:0099093,0.999999999987703,0.821483155174068,0,2,calcium export from the mitochondrion,BP,
17384,GO:1900109,0.999999999987705,0.883029035084074,0,2,regulation of histone H3-K9 dimethylation,BP,
17385,GO:1900110,0.999999999987705,0.883029035084074,0,2,negative regulation of histone H3-K9 dimethylation,BP,
7691,GO:0032143,0.999999999987727,0.826246343435533,0,2,single thymine insertion binding,MF,
7777,GO:0032301,0.999999999987727,0.826246343435533,0,2,MutSalpha complex,CC,
18976,GO:1904761,0.999999999987728,0.811914881086257,0,2,negative regulation of myofibroblast differentiation,BP,
3024,GO:0006569,0.999999999987741,0.815368739032729,0,3,tryptophan catabolic process,BP,
6150,GO:0019441,0.999999999987741,0.815368739032729,0,3,tryptophan catabolic process to kynurenine,BP,
10011,GO:0042436,0.999999999987741,0.815368739032729,0,3,indole-containing compound catabolic process,BP,
11606,GO:0046218,0.999999999987741,0.815368739032729,0,3,indolalkylamine catabolic process,BP,
6225,GO:0019776,0.999999999987744,0.777389929480062,0,3,Atg8 ligase activity,MF,
17673,GO:1901534,0.999999999987747,0.82606772218892,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
8237,GO:0033004,0.999999999987749,0.788244263766744,0,3,negative regulation of mast cell activation,BP,
8240,GO:0033007,0.999999999987749,0.788244263766744,0,3,negative regulation of mast cell activation involved in immune response,BP,
1499,GO:0003845,0.999999999987756,0.877954881515154,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
6480,GO:0021823,0.999999999987759,0.790374164872746,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6484,GO:0021827,0.999999999987759,0.790374164872746,0,2,postnatal olfactory bulb interneuron migration,BP,
6487,GO:0021836,0.999999999987759,0.790374164872746,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
17398,GO:1900126,0.999999999987759,0.740763861544438,0,3,negative regulation of hyaluronan biosynthetic process,BP,
1509,GO:0003868,0.99999999998776,0.934633951169828,0,1,4-hydroxyphenylpyruvate dioxygenase activity,MF,
15265,GO:0071438,0.999999999987786,0.704870853151591,0,4,invadopodium membrane,CC,
16650,GO:0097513,0.999999999987787,0.686126861462208,0,3,myosin II filament,CC,
10333,GO:0043125,0.999999999987791,0.700928115391323,0,4,ErbB-3 class receptor binding,MF,
4380,GO:0010025,0.999999999987805,0.832201571134782,0,2,wax biosynthetic process,BP,
4411,GO:0010166,0.999999999987805,0.832201571134782,0,2,wax metabolic process,BP,
15968,GO:0080019,0.999999999987805,0.832201571134782,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17177,GO:0102965,0.999999999987805,0.832201571134782,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
10133,GO:0042670,0.99999999998782,0.757743522353234,0,3,retinal cone cell differentiation,BP,
11737,GO:0046549,0.99999999998782,0.757743522353234,0,3,retinal cone cell development,BP,
18965,GO:1904744,0.999999999987823,0.881102548737952,0,2,positive regulation of telomeric DNA binding,BP,
9122,GO:0035425,0.999999999987836,0.775299764183063,0,3,autocrine signaling,BP,
11842,GO:0046813,0.999999999987837,0.794417782457275,0,3,receptor-mediated virion attachment to host cell,BP,
4862,GO:0014701,0.999999999987846,0.709851773621077,0,3,junctional sarcoplasmic reticulum membrane,CC,
2460,GO:0005673,0.999999999987852,0.861278666171717,0,2,transcription factor TFIIE complex,CC,
10057,GO:0042539,0.999999999987863,0.807059077241386,0,2,hypotonic salinity response,BP,
15293,GO:0071477,0.999999999987863,0.807059077241386,0,2,cellular hypotonic salinity response,BP,
20166,GO:2000983,0.999999999987872,0.89944615397234,0,2,regulation of ATP citrate synthase activity,BP,
20167,GO:2000984,0.999999999987872,0.89944615397234,0,2,negative regulation of ATP citrate synthase activity,BP,
9183,GO:0035553,0.999999999987876,0.772163118825122,0,3,oxidative single-stranded RNA demethylation,BP,
1224,GO:0002901,0.999999999987881,0.774372707013835,0,4,mature B cell apoptotic process,BP,
1228,GO:0002905,0.999999999987881,0.774372707013835,0,4,regulation of mature B cell apoptotic process,BP,
1229,GO:0002906,0.999999999987881,0.774372707013835,0,4,negative regulation of mature B cell apoptotic process,BP,
6410,GO:0021648,0.999999999987882,0.82426661568112,0,2,vestibulocochlear nerve morphogenesis,BP,
9755,GO:0039506,0.9999999999879,0.824625037517797,0,2,modulation by virus of host molecular function,BP,
9756,GO:0039507,0.9999999999879,0.824625037517797,0,2,suppression by virus of host molecular function,BP,
13306,GO:0052055,0.9999999999879,0.824625037517797,0,2,modulation by symbiont of host molecular function,BP,
13307,GO:0052056,0.9999999999879,0.824625037517797,0,2,negative regulation by symbiont of host molecular function,BP,
16301,GO:0090403,0.999999999987902,0.762123446214141,0,3,oxidative stress-induced premature senescence,BP,
19675,GO:1990966,0.999999999987911,0.70029432162243,0,4,ATP generation from poly-ADP-D-ribose,BP,
19380,GO:1905863,0.999999999987913,0.80043110290438,0,2,invadopodium organization,BP,
4953,GO:0015016,0.999999999987918,0.794842873571002,0,2,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
12442,GO:0050119,0.999999999987918,0.794842873571002,0,2,N-acetylglucosamine deacetylase activity,MF,
13779,GO:0060364,0.999999999987922,0.692717021854458,0,4,frontal suture morphogenesis,BP,
17785,GO:1901856,0.999999999987926,0.849330600791526,0,2,negative regulation of cellular respiration,BP,
16689,GO:0097632,0.99999999998794,0.822829783546544,0,2,extrinsic component of phagophore assembly site membrane,CC,
13615,GO:0060087,0.999999999987942,0.756075398969261,0,4,relaxation of vascular smooth muscle,BP,
16121,GO:0090107,0.999999999987951,0.757681990294217,0,3,regulation of high-density lipoprotein particle assembly,BP,
9683,GO:0038052,0.999999999987952,0.821725484405139,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
9540,GO:0036292,0.999999999987954,0.854827938060443,0,2,DNA rewinding,BP,
8178,GO:0032914,0.999999999987954,0.771946170347441,0,3,positive regulation of transforming growth factor beta1 production,BP,
7826,GO:0032379,0.999999999987961,0.809768891637568,0,3,positive regulation of intracellular lipid transport,BP,
7829,GO:0032382,0.999999999987961,0.809768891637568,0,3,positive regulation of intracellular sterol transport,BP,
7832,GO:0032385,0.999999999987961,0.809768891637568,0,3,positive regulation of intracellular cholesterol transport,BP,
6265,GO:0019858,0.999999999987974,0.861712814103639,0,2,cytosine metabolic process,BP,
9340,GO:0035838,0.999999999987993,0.803267010728152,0,2,growing cell tip,CC,
4898,GO:0014825,0.999999999988011,0.950702763063664,0,1,stomach fundus smooth muscle contraction,BP,
4911,GO:0014847,0.999999999988011,0.950702763063664,0,1,proximal stomach smooth muscle contraction,BP,
7545,GO:0031839,0.999999999988011,0.950702763063664,0,1,type 1 neuromedin U receptor binding,MF,
7546,GO:0031840,0.999999999988011,0.950702763063664,0,1,type 2 neuromedin U receptor binding,MF,
9142,GO:0035483,0.999999999988011,0.950702763063664,0,1,gastric emptying,BP,
10231,GO:0042922,0.999999999988011,0.950702763063664,0,1,neuromedin U receptor binding,MF,
10916,GO:0044495,0.999999999988011,0.950702763063664,0,1,modulation of blood pressure in other organism,BP,
10917,GO:0044497,0.999999999988011,0.950702763063664,0,1,positive regulation of blood pressure in other organism,BP,
17263,GO:0120060,0.999999999988011,0.950702763063664,0,1,regulation of gastric emptying,BP,
17264,GO:0120061,0.999999999988011,0.950702763063664,0,1,negative regulation of gastric emptying,BP,
17265,GO:0120063,0.999999999988011,0.950702763063664,0,1,stomach smooth muscle contraction,BP,
17266,GO:0120068,0.999999999988011,0.950702763063664,0,1,regulation of stomach fundus smooth muscle contraction,BP,
17267,GO:0120069,0.999999999988011,0.950702763063664,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
9749,GO:0039019,0.999999999988036,0.812112339815273,0,2,pronephric nephron development,BP,
11506,GO:0045990,0.999999999988058,0.699223065279457,0,4,carbon catabolite regulation of transcription,BP,
11507,GO:0045991,0.999999999988058,0.699223065279457,0,4,carbon catabolite activation of transcription,BP,
14243,GO:0061218,0.999999999988072,0.798012593965391,0,3,negative regulation of mesonephros development,BP,
8070,GO:0032741,0.999999999988088,0.82089888152549,0,2,positive regulation of interleukin-18 production,BP,
15373,GO:0071612,0.999999999988092,0.857978122064918,0,1,IP-10 production,BP,
15404,GO:0071658,0.999999999988092,0.857978122064918,0,1,regulation of IP-10 production,BP,
15405,GO:0071660,0.999999999988092,0.857978122064918,0,1,positive regulation of IP-10 production,BP,
17399,GO:1900127,0.99999999998811,0.76047223792817,0,3,positive regulation of hyaluronan biosynthetic process,BP,
6933,GO:0030538,0.99999999998812,0.83221412964861,0,2,embryonic genitalia morphogenesis,BP,
19474,GO:1990188,0.999999999988131,0.923149827770065,0,1,euchromatin binding,MF,
18092,GO:1902715,0.99999999998814,0.800068895800064,0,2,positive regulation of interferon-gamma secretion,BP,
12608,GO:0050787,0.999999999988143,0.849923379337378,0,2,detoxification of mercury ion,BP,
4209,GO:0009331,0.999999999988146,0.80710644549104,0,2,glycerol-3-phosphate dehydrogenase complex,CC,
3438,GO:0007228,0.999999999988161,0.814727186457137,0,2,positive regulation of hh target transcription factor activity,BP,
11309,GO:0045626,0.999999999988165,0.827648381668962,0,2,negative regulation of T-helper 1 cell differentiation,BP,
5751,GO:0016899,0.999999999988174,0.807678997160015,0,2,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
20170,GO:2001013,0.999999999988174,0.802036547366588,0,2,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
15716,GO:0072268,0.999999999988183,0.799353706257975,0,3,pattern specification involved in metanephros development,BP,
4799,GO:0010991,0.999999999988184,0.790105558713684,0,2,negative regulation of SMAD protein complex assembly,BP,
210,GO:0000438,0.999999999988208,0.819062132221123,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
9770,GO:0039534,0.999999999988217,0.725640673693779,0,4,negative regulation of MDA-5 signaling pathway,BP,
11633,GO:0046338,0.999999999988218,0.839734341512191,0,2,phosphatidylethanolamine catabolic process,BP,
13650,GO:0060157,0.99999999998822,0.801324071909951,0,2,urinary bladder development,BP,
6495,GO:0021855,0.999999999988222,0.766164705091252,0,3,hypothalamus cell migration,BP,
5066,GO:0015280,0.999999999988228,0.740417290832695,0,3,ligand-gated sodium channel activity,MF,
6427,GO:0021693,0.999999999988233,0.806252273808179,0,2,cerebellar Purkinje cell layer structural organization,BP,
6432,GO:0021698,0.999999999988233,0.806252273808179,0,2,cerebellar cortex structural organization,BP,
10994,GO:0044793,0.999999999988235,0.675557424582386,0,4,negative regulation by host of viral process,BP,
11009,GO:0044828,0.999999999988235,0.675557424582386,0,4,negative regulation by host of viral genome replication,BP,
6978,GO:0030644,0.999999999988244,0.842399675910608,0,2,cellular chloride ion homeostasis,BP,
6327,GO:0020016,0.999999999988249,0.746155751519543,0,3,ciliary pocket,CC,
6328,GO:0020018,0.999999999988249,0.746155751519543,0,3,ciliary pocket membrane,CC,
3102,GO:0006679,0.999999999988255,0.839381357568297,0,2,glucosylceramide biosynthetic process,BP,
15942,GO:0072741,0.99999999998826,0.739258752373532,0,3,protein localization to cell division site,BP,
18264,GO:1903119,0.99999999998826,0.739258752373532,0,3,protein localization to actin cytoskeleton,BP,
18859,GO:1904498,0.99999999998826,0.739258752373532,0,3,protein localization to mitotic actomyosin contractile ring,BP,
19471,GO:1990179,0.99999999998826,0.739258752373532,0,3,protein localization to actomyosin contractile ring,BP,
3836,GO:0008441,0.999999999988266,0.816806992428936,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
15324,GO:0071540,0.99999999998827,0.894322202292805,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
4171,GO:0009237,0.99999999998828,0.919123557677345,0,1,siderophore metabolic process,BP,
6095,GO:0019290,0.99999999998828,0.919123557677345,0,1,siderophore biosynthetic process,BP,
14470,GO:0061833,0.999999999988283,0.837490084159877,0,2,protein localization to tricellular tight junction,BP,
2912,GO:0006422,0.999999999988286,0.927083096856168,0,1,aspartyl-tRNA aminoacylation,BP,
4724,GO:0010886,0.999999999988286,0.758806617952459,0,3,positive regulation of cholesterol storage,BP,
300,GO:0000806,0.999999999988293,0.83130605525498,0,2,Y chromosome,CC,
10947,GO:0044611,0.999999999988304,0.714644636222394,0,3,nuclear pore inner ring,CC,
4631,GO:0010752,0.999999999988307,0.803747981335031,0,2,regulation of cGMP-mediated signaling,BP,
15932,GO:0072717,0.99999999998831,0.777815416455532,0,3,cellular response to actinomycin D,BP,
16000,GO:0086008,0.999999999988328,0.851420329470408,0,2,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
6517,GO:0021894,0.99999999998833,0.94642719641299,0,1,cerebral cortex GABAergic interneuron development,BP,
10714,GO:0044028,0.999999999988341,0.824015673490819,0,2,DNA hypomethylation,BP,
10715,GO:0044029,0.999999999988341,0.824015673490819,0,2,hypomethylation of CpG island,BP,
17949,GO:1902298,0.999999999988351,0.79815220396975,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19528,GO:1990426,0.999999999988351,0.79815220396975,0,2,mitotic recombination-dependent replication fork processing,BP,
19549,GO:1990505,0.999999999988351,0.79815220396975,0,2,mitotic DNA replication maintenance of fidelity,BP,
16978,GO:0099011,0.999999999988355,0.804423244429731,0,2,neuronal dense core vesicle exocytosis,BP,
17048,GO:0099525,0.999999999988355,0.804423244429731,0,2,presynaptic dense core vesicle exocytosis,BP,
6313,GO:0019958,0.999999999988362,0.77611892581245,0,3,C-X-C chemokine binding,MF,
11451,GO:0045901,0.999999999988377,0.772599075131589,0,3,positive regulation of translational elongation,BP,
19536,GO:1990446,0.999999999988401,0.771531280290656,0,4,U1 snRNP binding,MF,
9557,GO:0036324,0.999999999988401,0.851173790033785,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
18710,GO:1904116,0.999999999988404,0.747985672675954,0,3,response to vasopressin,BP,
18711,GO:1904117,0.999999999988404,0.747985672675954,0,3,cellular response to vasopressin,BP,
7144,GO:0030984,0.99999999998841,0.868655256674626,0,2,kininogen binding,MF,
8675,GO:0034245,0.999999999988412,0.90747083217132,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
5524,GO:0016494,0.99999999998842,0.782757293230384,0,3,C-X-C chemokine receptor activity,MF,
6249,GO:0019826,0.999999999988425,0.822672093687818,0,2,oxygen sensor activity,MF,
6483,GO:0021826,0.999999999988431,0.846133639843655,0,2,substrate-independent telencephalic tangential migration,BP,
6486,GO:0021830,0.999999999988431,0.846133639843655,0,2,interneuron migration from the subpallium to the cortex,BP,
6490,GO:0021843,0.999999999988431,0.846133639843655,0,2,substrate-independent telencephalic tangential interneuron migration,BP,
10525,GO:0043456,0.999999999988432,0.802431946553731,0,3,regulation of pentose-phosphate shunt,BP,
13645,GO:0060151,0.999999999988433,0.811525933238488,0,2,peroxisome localization,BP,
13646,GO:0060152,0.999999999988433,0.811525933238488,0,2,microtubule-based peroxisome localization,BP,
7810,GO:0032361,0.999999999988435,0.931655427177405,0,1,pyridoxal phosphate catabolic process,BP,
10206,GO:0042820,0.999999999988435,0.931655427177405,0,1,vitamin B6 catabolic process,BP,
9426,GO:0035993,0.999999999988444,0.798067140172992,0,3,deltoid tuberosity development,BP,
6522,GO:0021902,0.999999999988449,0.786860063337217,0,2,commitment of neuronal cell to specific neuron type in forebrain,BP,
14434,GO:0061739,0.999999999988457,0.752360085449047,0,3,protein lipidation involved in autophagosome assembly,BP,
14611,GO:0070170,0.99999999998846,0.811465882119492,0,2,regulation of tooth mineralization,BP,
9649,GO:0036518,0.999999999988467,0.818738935379594,0,2,chemorepulsion of dopaminergic neuron axon,BP,
14395,GO:0061643,0.999999999988467,0.818738935379594,0,2,chemorepulsion of axon,BP,
1504,GO:0003858,0.999999999988468,0.838945702501778,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
2107,GO:0004886,0.999999999988474,0.821314913465241,0,2,9-cis retinoic acid receptor activity,MF,
15648,GO:0072156,0.999999999988475,0.749062782558174,0,2,distal tubule morphogenesis,BP,
5211,GO:0015810,0.999999999988482,0.828638778508251,0,2,aspartate transmembrane transport,BP,
10543,GO:0043490,0.999999999988482,0.828638778508251,0,2,malate-aspartate shuttle,BP,
4661,GO:0010808,0.999999999988495,0.887622114988867,0,1,positive regulation of synaptic vesicle priming,BP,
10817,GO:0044305,0.999999999988495,0.887622114988867,0,1,calyx of Held,CC,
14457,GO:0061789,0.999999999988495,0.887622114988867,0,1,dense core granule priming,BP,
18454,GO:1903542,0.999999999988504,0.847613327025646,0,2,negative regulation of exosomal secretion,BP,
4250,GO:0009450,0.999999999988525,0.803295889429967,0,2,gamma-aminobutyric acid catabolic process,BP,
14877,GO:0070662,0.999999999988525,0.819838167070104,0,2,mast cell proliferation,BP,
14881,GO:0070666,0.999999999988525,0.819838167070104,0,2,regulation of mast cell proliferation,BP,
14883,GO:0070668,0.999999999988525,0.819838167070104,0,2,positive regulation of mast cell proliferation,BP,
1053,GO:0002581,0.999999999988525,0.838872439423895,0,2,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
10368,GO:0043183,0.999999999988532,0.861405651959484,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11261,GO:0045509,0.999999999988539,0.837134380497924,0,2,interleukin-27 receptor activity,MF,
3730,GO:0008263,0.999999999988563,0.846299574627521,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
7361,GO:0031403,0.99999999998857,0.80479727202364,0,2,lithium ion binding,MF,
216,GO:0000451,0.999999999988577,0.836427082454108,0,2,rRNA 2'-O-methylation,BP,
217,GO:0000453,0.999999999988577,0.836427082454108,0,2,enzyme-directed rRNA 2'-O-methylation,BP,
14536,GO:0070039,0.999999999988577,0.836427082454108,0,2,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
11674,GO:0046452,0.999999999988584,0.797767821296766,0,3,dihydrofolate metabolic process,BP,
11141,GO:0045186,0.999999999988596,0.881089633798508,0,1,zonula adherens assembly,BP,
16527,GO:0097238,0.999999999988597,0.892380814560296,0,2,cellular response to methylglyoxal,BP,
15052,GO:0071001,0.999999999988603,0.789986554372387,0,3,U4/U6 snRNP,CC,
1139,GO:0002731,0.999999999988615,0.847489872647159,0,2,negative regulation of dendritic cell cytokine production,BP,
848,GO:0002169,0.999999999988635,0.840170745713576,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
1830,GO:0004485,0.999999999988635,0.840170745713576,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
19162,GO:1905202,0.999999999988635,0.840170745713576,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
6406,GO:0021631,0.999999999988656,0.701824302195593,0,3,optic nerve morphogenesis,BP,
7770,GO:0032290,0.999999999988685,0.590282386672392,0,4,peripheral nervous system myelin formation,BP,
13629,GO:0060124,0.999999999988699,0.818610019162418,0,2,positive regulation of growth hormone secretion,BP,
4634,GO:0010756,0.99999999998871,0.799717784024026,0,3,positive regulation of plasminogen activation,BP,
10607,GO:0043585,0.999999999988712,0.78211985559621,0,2,nose morphogenesis,BP,
6690,GO:0030060,0.999999999988716,0.82747364670715,0,3,L-malate dehydrogenase activity,MF,
5963,GO:0018364,0.999999999988721,0.902025661357354,0,2,peptidyl-glutamine methylation,BP,
49,GO:0000103,0.999999999988727,0.790954622379242,0,3,sulfate assimilation,BP,
10846,GO:0044341,0.999999999988734,0.751403680754284,0,3,sodium-dependent phosphate transport,BP,
2178,GO:0005025,0.999999999988751,0.728171902668958,0,3,transforming growth factor beta receptor activity, type I,MF,
8502,GO:0033679,0.999999999988759,0.899392659547868,0,1,3'-5' DNA/RNA helicase activity,MF,
8504,GO:0033681,0.999999999988759,0.899392659547868,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
8782,GO:0034459,0.999999999988759,0.899392659547868,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9783,GO:0039695,0.999999999988759,0.899392659547868,0,1,DNA-templated viral transcription,BP,
19079,GO:1904971,0.999999999988759,0.899392659547868,0,1,regulation of viral translation,BP,
19080,GO:1904973,0.999999999988759,0.899392659547868,0,1,positive regulation of viral translation,BP,
19159,GO:1905172,0.999999999988759,0.899392659547868,0,1,RISC complex binding,MF,
19343,GO:1905698,0.999999999988759,0.899392659547868,0,1,positive regulation of polysome binding,BP,
19551,GO:1990518,0.999999999988759,0.899392659547868,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
1433,GO:0003408,0.999999999988761,0.781155864085048,0,2,optic cup formation involved in camera-type eye development,BP,
18742,GO:1904211,0.99999999998878,0.838111922435926,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
14360,GO:0061574,0.99999999998879,0.776087695524851,0,3,ASAP complex,CC,
18964,GO:1904743,0.99999999998879,0.769597688661048,0,2,negative regulation of telomeric DNA binding,BP,
5463,GO:0016344,0.999999999988793,0.835376326540628,0,2,meiotic chromosome movement towards spindle pole,BP,
19004,GO:1904815,0.999999999988797,0.857217471616044,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
9140,GO:0035473,0.999999999988799,0.844485316892426,0,2,lipase binding,MF,
3228,GO:0006880,0.999999999988834,0.834908857505551,0,3,intracellular sequestering of iron ion,BP,
16675,GO:0097577,0.999999999988834,0.834908857505551,0,3,sequestering of iron ion,BP,
6015,GO:0019065,0.999999999988839,0.758279076966055,0,3,receptor-mediated endocytosis of virus by host cell,BP,
15956,GO:0075509,0.999999999988839,0.758279076966055,0,3,endocytosis involved in viral entry into host cell,BP,
17575,GO:1901187,0.99999999998884,0.822781855017122,0,2,regulation of ephrin receptor signaling pathway,BP,
19501,GO:1990357,0.999999999988847,0.795982964963593,0,3,terminal web,CC,
4813,GO:0014004,0.999999999988855,0.832145358490154,0,2,microglia differentiation,BP,
4814,GO:0014005,0.999999999988855,0.832145358490154,0,2,microglia development,BP,
7732,GO:0032227,0.999999999988863,0.742271295473379,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
10144,GO:0042713,0.999999999988868,0.72625967347525,0,3,sperm ejaculation,BP,
10139,GO:0042700,0.999999999988891,0.89937613219969,0,1,luteinizing hormone signaling pathway,BP,
12112,GO:0048160,0.999999999988891,0.89937613219969,0,1,primary follicle stage,BP,
15525,GO:0071907,0.999999999988903,0.726587029565373,0,3,determination of digestive tract left/right asymmetry,BP,
7092,GO:0030886,0.999999999988908,0.868955550508388,0,2,negative regulation of myeloid dendritic cell activation,BP,
11024,GO:0044860,0.999999999988914,0.708139940463209,0,4,protein localization to plasma membrane raft,BP,
2007,GO:0004731,0.999999999988915,0.830683681665859,0,2,purine-nucleoside phosphorylase activity,MF,
15063,GO:0071020,0.999999999988928,0.875196716360346,0,2,post-spliceosomal complex,CC,
754,GO:0001993,0.999999999988936,0.709588582827907,0,4,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
9508,GO:0036156,0.99999999998894,0.742256502393278,0,2,inner dynein arm,CC,
10140,GO:0042701,0.999999999988948,0.819463423254657,0,2,progesterone secretion,BP,
16749,GO:0098518,0.999999999988948,0.789597846775789,0,3,polynucleotide phosphatase activity,MF,
9222,GO:0035608,0.99999999998895,0.829109288683882,0,2,protein deglutamylation,BP,
5952,GO:0018312,0.999999999988951,0.845077290109523,0,2,peptidyl-serine ADP-ribosylation,BP,
19514,GO:1990404,0.999999999988951,0.845077290109523,0,2,protein ADP-ribosylase activity,MF,
205,GO:0000430,0.99999999998897,0.876255055819267,0,2,regulation of transcription from RNA polymerase II promoter by glucose,BP,
207,GO:0000432,0.99999999998897,0.876255055819267,0,2,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
8633,GO:0034150,0.999999999988987,0.890834141759555,0,1,toll-like receptor 6 signaling pathway,BP,
9093,GO:0035355,0.999999999988987,0.890834141759555,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
19467,GO:1990172,0.999999999988987,0.890834141759555,0,1,G-protein coupled receptor catabolic process,BP,
12177,GO:0048298,0.999999999988999,0.73092659819773,0,4,positive regulation of isotype switching to IgA isotypes,BP,
2421,GO:0005595,0.999999999989,0.867753420445338,0,1,collagen type XII trimer,CC,
20048,GO:2000671,0.999999999989004,0.762571314330202,0,3,regulation of motor neuron apoptotic process,BP,
20049,GO:2000672,0.999999999989004,0.762571314330202,0,3,negative regulation of motor neuron apoptotic process,BP,
4871,GO:0014732,0.999999999989008,0.780276314674503,0,3,skeletal muscle atrophy,BP,
1426,GO:0003383,0.999999999989012,0.704620449045332,0,3,apical constriction,BP,
18475,GO:1903575,0.999999999989021,0.857745752910819,0,2,cornified envelope assembly,BP,
19183,GO:1905258,0.999999999989049,0.890281311016515,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19184,GO:1905259,0.999999999989049,0.890281311016515,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
19540,GO:1990454,0.999999999989049,0.755430490621199,0,3,L-type voltage-gated calcium channel complex,CC,
17844,GO:1902022,0.999999999989065,0.76162141391001,0,3,L-lysine transport,BP,
18388,GO:1903401,0.999999999989065,0.76162141391001,0,3,L-lysine transmembrane transport,BP,
13975,GO:0060685,0.999999999989073,0.753849047361016,0,3,regulation of prostatic bud formation,BP,
13976,GO:0060686,0.999999999989073,0.753849047361016,0,3,negative regulation of prostatic bud formation,BP,
17474,GO:1900365,0.999999999989081,0.746396921325707,0,3,positive regulation of mRNA polyadenylation,BP,
12132,GO:0048209,0.999999999989099,0.831755095530988,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
16979,GO:0099022,0.999999999989106,0.862500896839797,0,2,vesicle tethering,BP,
16983,GO:0099044,0.999999999989106,0.862500896839797,0,2,vesicle tethering to endoplasmic reticulum,BP,
247,GO:0000703,0.99999999998911,0.887697233902232,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
19297,GO:1905553,0.999999999989124,0.787410675879535,0,3,regulation of blood vessel branching,BP,
6375,GO:0021560,0.999999999989128,0.845382881016284,0,2,abducens nerve development,BP,
6394,GO:0021598,0.999999999989128,0.845382881016284,0,2,abducens nerve morphogenesis,BP,
6395,GO:0021599,0.999999999989128,0.845382881016284,0,2,abducens nerve formation,BP,
14479,GO:0061857,0.999999999989132,0.833859203028206,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15330,GO:0071546,0.999999999989144,0.835822892588405,0,2,pi-body,CC,
2012,GO:0004739,0.999999999989146,0.856902887991232,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
3672,GO:0008169,0.999999999989181,0.783399179152514,0,3,C-methyltransferase activity,MF,
8987,GO:0035093,0.999999999989182,0.788685060333331,0,2,spermatogenesis, exchange of chromosomal proteins,BP,
982,GO:0002439,0.999999999989185,0.814202758405337,0,3,chronic inflammatory response to antigenic stimulus,BP,
3145,GO:0006740,0.999999999989206,0.772552712185832,0,3,NADPH regeneration,BP,
15784,GO:0072387,0.999999999989212,0.84522246050042,0,2,flavin adenine dinucleotide metabolic process,BP,
1245,GO:0002945,0.999999999989215,0.820889981871529,0,2,cyclin K-CDK13 complex,CC,
8081,GO:0032762,0.999999999989217,0.783624045172784,0,3,mast cell cytokine production,BP,
8082,GO:0032763,0.999999999989217,0.783624045172784,0,3,regulation of mast cell cytokine production,BP,
1848,GO:0004511,0.999999999989244,0.933027418345607,0,1,tyrosine 3-monooxygenase activity,MF,
3036,GO:0006585,0.999999999989244,0.933027418345607,0,1,dopamine biosynthetic process from tyrosine,BP,
8274,GO:0033076,0.999999999989244,0.933027418345607,0,1,isoquinoline alkaloid metabolic process,BP,
9028,GO:0035240,0.999999999989244,0.933027418345607,0,1,dopamine binding,MF,
9900,GO:0042214,0.999999999989244,0.933027418345607,0,1,terpene metabolic process,BP,
10003,GO:0042418,0.999999999989244,0.933027418345607,0,1,epinephrine biosynthetic process,BP,
13338,GO:0052314,0.999999999989244,0.933027418345607,0,1,phytoalexin metabolic process,BP,
2683,GO:0006045,0.999999999989244,0.811916232428758,0,2,N-acetylglucosamine biosynthetic process,BP,
17544,GO:1901073,0.999999999989244,0.811916232428758,0,2,glucosamine-containing compound biosynthetic process,BP,
16340,GO:0090571,0.999999999989248,0.797078722678578,0,3,RNA polymerase II transcription repressor complex,CC,
5490,GO:0016426,0.999999999989248,0.722447210922197,0,4,tRNA (adenine) methyltransferase activity,MF,
2595,GO:0005890,0.999999999989289,0.710975349845127,0,4,sodium:potassium-exchanging ATPase complex,CC,
2901,GO:0006408,0.999999999989306,0.870225867692455,0,2,snRNA export from nucleus,BP,
18560,GO:1903778,0.999999999989311,0.819914234168425,0,2,protein localization to vacuolar membrane,BP,
14592,GO:0070138,0.999999999989321,0.745407347423452,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
14594,GO:0070140,0.999999999989321,0.745407347423452,0,3,SUMO-specific isopeptidase activity,MF,
16015,GO:0086024,0.999999999989326,0.877480585472145,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17322,GO:0140200,0.999999999989326,0.877480585472145,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
17548,GO:1901078,0.999999999989326,0.877480585472145,0,1,negative regulation of relaxation of muscle,BP,
17805,GO:1901898,0.999999999989326,0.877480585472145,0,1,negative regulation of relaxation of cardiac muscle,BP,
14981,GO:0070889,0.999999999989331,0.855364725254878,0,2,platelet alpha granule organization,BP,
20246,GO:2001198,0.999999999989337,0.805852275820323,0,3,regulation of dendritic cell differentiation,BP,
17323,GO:0150003,0.999999999989343,0.772744037423521,0,3,regulation of spontaneous synaptic transmission,BP,
9356,GO:0035867,0.999999999989372,0.761026445360888,0,2,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
2013,GO:0004740,0.999999999989375,0.736373180037057,0,3,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
13795,GO:0060382,0.999999999989395,0.80242135685742,0,2,regulation of DNA strand elongation,BP,
12169,GO:0048289,0.999999999989406,0.701600662254656,0,4,isotype switching to IgE isotypes,BP,
12172,GO:0048293,0.999999999989406,0.701600662254656,0,4,regulation of isotype switching to IgE isotypes,BP,
9251,GO:0035650,0.999999999989425,0.740179280676972,0,4,AP-1 adaptor complex binding,MF,
1852,GO:0004515,0.999999999989428,0.723277735498097,0,3,nicotinate-nucleotide adenylyltransferase activity,MF,
8140,GO:0032847,0.999999999989433,0.84955562260292,0,2,regulation of cellular pH reduction,BP,
16465,GO:0097135,0.999999999989436,0.855665708316395,0,2,cyclin E2-CDK2 complex,CC,
11452,GO:0045903,0.999999999989459,0.836966506304578,0,3,positive regulation of translational fidelity,BP,
7879,GO:0032444,0.999999999989463,0.755639443079677,0,2,activin responsive factor complex,CC,
1244,GO:0002944,0.999999999989476,0.813382924663998,0,2,cyclin K-CDK12 complex,CC,
2078,GO:0004832,0.99999999998948,0.736514944979799,0,3,valine-tRNA ligase activity,MF,
2928,GO:0006438,0.99999999998948,0.736514944979799,0,3,valyl-tRNA aminoacylation,BP,
7223,GO:0031117,0.999999999989481,0.845118903169261,0,2,positive regulation of microtubule depolymerization,BP,
19954,GO:2000508,0.999999999989482,0.744394446368696,0,4,regulation of dendritic cell chemotaxis,BP,
19955,GO:2000510,0.999999999989482,0.744394446368696,0,4,positive regulation of dendritic cell chemotaxis,BP,
1576,GO:0003986,0.999999999989483,0.837411175137903,0,3,acetyl-CoA hydrolase activity,MF,
15123,GO:0071209,0.999999999989492,0.826154447669387,0,3,U7 snRNA binding,MF,
19676,GO:1990967,0.999999999989501,0.85993811586021,0,2,multi-organism toxin transport,BP,
11736,GO:0046548,0.999999999989516,0.769861055471952,0,3,retinal rod cell development,BP,
13814,GO:0060405,0.999999999989516,0.775842089374252,0,3,regulation of penile erection,BP,
6622,GO:0022848,0.999999999989525,0.764217499027386,0,3,acetylcholine-gated cation-selective channel activity,MF,
8897,GO:0034714,0.999999999989543,0.761271586474786,0,3,type III transforming growth factor beta receptor binding,MF,
15111,GO:0071163,0.999999999989545,0.812067455965307,0,3,DNA replication preinitiation complex assembly,BP,
5581,GO:0016598,0.999999999989552,0.867461880985429,0,2,protein arginylation,BP,
3829,GO:0008428,0.999999999989557,0.772945108391752,0,3,ribonuclease inhibitor activity,MF,
14542,GO:0070053,0.999999999989571,0.825790135242521,0,2,thrombospondin receptor activity,MF,
17270,GO:0120092,0.999999999989584,0.91317043213105,0,1,crotonyl-CoA hydratase activity,MF,
17271,GO:0120093,0.999999999989584,0.91317043213105,0,1,regulation of peptidyl-lysine crotonylation,BP,
17272,GO:0120094,0.999999999989584,0.91317043213105,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
10820,GO:0044308,0.999999999989586,0.789279229509677,0,2,axonal spine,CC,
9342,GO:0035844,0.999999999989596,0.750571840572751,0,3,cloaca development,BP,
14235,GO:0061198,0.999999999989599,0.752077874319081,0,3,fungiform papilla formation,BP,
12406,GO:0048850,0.999999999989605,0.791082715347774,0,2,hypophysis morphogenesis,BP,
6905,GO:0030485,0.999999999989627,0.843939836618581,0,2,smooth muscle contractile fiber,CC,
1722,GO:0004314,0.999999999989628,0.816240221905868,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
5485,GO:0016419,0.999999999989628,0.816240221905868,0,2,S-malonyltransferase activity,MF,
5486,GO:0016420,0.999999999989628,0.816240221905868,0,2,malonyltransferase activity,MF,
1946,GO:0004649,0.999999999989629,0.845047373469382,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
14547,GO:0070061,0.999999999989633,0.786586576802619,0,3,fructose binding,MF,
1379,GO:0003275,0.999999999989633,0.816491535709574,0,2,apoptotic process involved in outflow tract morphogenesis,BP,
17930,GO:1902256,0.999999999989633,0.816491535709574,0,2,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19796,GO:2000233,0.999999999989638,0.818794277297497,0,2,negative regulation of rRNA processing,BP,
1560,GO:0003960,0.999999999989656,0.817079101725429,0,3,NADPH:quinone reductase activity,MF,
8552,GO:0033906,0.99999999998966,0.866105216915879,0,2,hyaluronoglucuronidase activity,MF,
7797,GO:0032346,0.999999999989667,0.830895198856801,0,2,positive regulation of aldosterone metabolic process,BP,
7800,GO:0032349,0.999999999989667,0.830895198856801,0,2,positive regulation of aldosterone biosynthetic process,BP,
13810,GO:0060399,0.999999999989677,0.795970235888814,0,2,positive regulation of growth hormone receptor signaling pathway,BP,
7073,GO:0030860,0.999999999989679,0.825755536034439,0,2,regulation of polarized epithelial cell differentiation,BP,
397,GO:0001069,0.999999999989692,0.804705639480807,0,2,regulatory region RNA binding,MF,
4,GO:0000010,0.999999999989693,0.853540695842288,0,2,trans-hexaprenyltranstransferase activity,MF,
12471,GO:0050347,0.999999999989693,0.853540695842288,0,2,trans-octaprenyltranstransferase activity,MF,
10148,GO:0042723,0.999999999989707,0.796589800924602,0,3,thiamine-containing compound metabolic process,BP,
19708,GO:2000049,0.999999999989719,0.765322386432056,0,3,positive regulation of cell-cell adhesion mediated by cadherin,BP,
5470,GO:0016403,0.999999999989721,0.852708556454652,0,2,dimethylargininase activity,MF,
5097,GO:0015373,0.999999999989721,0.805396025244593,0,2,anion:sodium symporter activity,MF,
15982,GO:0080144,0.999999999989723,0.842177906924823,0,2,amino acid homeostasis,BP,
2570,GO:0005854,0.999999999989739,0.84958017953,0,2,nascent polypeptide-associated complex,CC,
2900,GO:0006407,0.999999999989748,0.77835796716612,0,3,rRNA export from nucleus,BP,
20227,GO:2001168,0.999999999989753,0.682468054937101,0,4,positive regulation of histone H2B ubiquitination,BP,
7554,GO:0031870,0.99999999998976,0.889596358530516,0,1,thromboxane A2 receptor binding,MF,
5412,GO:0016256,0.999999999989761,0.841685445834976,0,2,N-glycan processing to lysosome,BP,
7422,GO:0031515,0.999999999989763,0.79230090257408,0,3,tRNA (m1A) methyltransferase complex,CC,
9099,GO:0035363,0.999999999989775,0.717373059359989,0,4,histone locus body,CC,
18569,GO:1903796,0.999999999989776,0.803515636453978,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19804,GO:2000253,0.999999999989776,0.803515636453978,0,2,positive regulation of feeding behavior,BP,
11920,GO:0046963,0.999999999989799,0.866625711360745,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
11921,GO:0046964,0.999999999989799,0.866625711360745,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
18037,GO:1902559,0.999999999989799,0.866625711360745,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
10766,GO:0044211,0.999999999989806,0.819219334616454,0,3,CTP salvage,BP,
16405,GO:0097026,0.999999999989811,0.877543355701202,0,1,dendritic cell dendrite assembly,BP,
12794,GO:0051088,0.999999999989812,0.747037202574211,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13605,GO:0060075,0.999999999989839,0.762982840858782,0,3,regulation of resting membrane potential,BP,
11226,GO:0045359,0.999999999989845,0.696493078498192,0,4,positive regulation of interferon-beta biosynthetic process,BP,
11125,GO:0045162,0.999999999989847,0.622728247534904,0,4,clustering of voltage-gated sodium channels,BP,
6482,GO:0021825,0.999999999989897,0.652227099108082,0,4,substrate-dependent cerebral cortex tangential migration,BP,
17822,GO:1901979,0.99999999998991,0.799604293023069,0,2,regulation of inward rectifier potassium channel activity,BP,
5446,GO:0016314,0.99999999998991,0.801426593630974,0,2,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
8474,GO:0033615,0.999999999989914,0.787929837806853,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
10208,GO:0042823,0.999999999989915,0.80403481739367,0,2,pyridoxal phosphate biosynthetic process,BP,
13931,GO:0060594,0.999999999989916,0.793031450907149,0,2,mammary gland specification,BP,
2341,GO:0005372,0.999999999989918,0.743834978773285,0,4,water transmembrane transporter activity,MF,
5054,GO:0015250,0.999999999989918,0.743834978773285,0,4,water channel activity,MF,
16080,GO:0090038,0.999999999989922,0.830753316036888,0,2,negative regulation of protein kinase C signaling,BP,
162,GO:0000333,0.999999999989924,0.85110344903305,0,2,telomerase catalytic core complex,CC,
5259,GO:0015889,0.999999999989926,0.786290530904559,0,3,cobalamin transport,BP,
2635,GO:0005967,0.999999999989951,0.752641360891443,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
3988,GO:0008853,0.999999999989964,0.783654173576989,0,3,exodeoxyribonuclease III activity,MF,
18559,GO:1903775,0.999999999989978,0.848968617978628,0,2,regulation of DNA double-strand break processing,BP,
10578,GO:0043541,0.99999999998998,0.833608370016616,0,2,UDP-N-acetylglucosamine transferase complex,CC,
170,GO:0000354,0.99999999998998,0.806966596481073,0,2,cis assembly of pre-catalytic spliceosome,BP,
6220,GO:0019755,0.999999999989985,0.72560827148274,0,4,one-carbon compound transport,BP,
16088,GO:0090063,0.999999999989991,0.687546253440722,0,4,positive regulation of microtubule nucleation,BP,
14946,GO:0070836,0.999999999990003,0.785380916736631,0,3,caveola assembly,BP,
15570,GO:0072019,0.999999999990028,0.929737812167428,0,1,proximal convoluted tubule development,BP,
15698,GO:0072229,0.999999999990028,0.929737812167428,0,1,metanephric proximal convoluted tubule development,BP,
18139,GO:1902858,0.999999999990028,0.929737812167428,0,1,propionyl-CoA metabolic process,BP,
18140,GO:1902860,0.999999999990028,0.929737812167428,0,1,propionyl-CoA biosynthetic process,BP,
19333,GO:1905661,0.999999999990043,0.844889869750181,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
19334,GO:1905663,0.999999999990043,0.844889869750181,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
10629,GO:0043626,0.999999999990046,0.941784103355273,0,1,PCNA complex,CC,
10997,GO:0044796,0.999999999990046,0.941784103355273,0,1,DNA polymerase processivity factor complex,CC,
20172,GO:2001015,0.999999999990048,0.813016877058271,0,2,negative regulation of skeletal muscle cell differentiation,BP,
13973,GO:0060683,0.999999999990076,0.921181552861241,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
19511,GO:1990401,0.999999999990076,0.921181552861241,0,1,embryonic lung development,BP,
15222,GO:0071374,0.999999999990152,0.79962729655727,0,2,cellular response to parathyroid hormone stimulus,BP,
8759,GO:0034423,0.99999999999016,0.923035851101478,0,1,autophagosome lumen,CC,
19923,GO:2000422,0.99999999999016,0.923035851101478,0,1,regulation of eosinophil chemotaxis,BP,
19924,GO:2000424,0.99999999999016,0.923035851101478,0,1,positive regulation of eosinophil chemotaxis,BP,
19196,GO:1905286,0.999999999990177,0.858319186647145,0,2,serine-type peptidase complex,CC,
18531,GO:1903719,0.999999999990186,0.804986126491647,0,3,regulation of I-kappaB phosphorylation,BP,
18532,GO:1903721,0.999999999990186,0.804986126491647,0,3,positive regulation of I-kappaB phosphorylation,BP,
1351,GO:0003219,0.999999999990206,0.81526236841844,0,2,cardiac right ventricle formation,BP,
14060,GO:0060838,0.999999999990216,0.83554800009919,0,2,lymphatic endothelial cell fate commitment,BP,
19298,GO:1905555,0.999999999990238,0.836100392420454,0,2,positive regulation blood vessel branching,BP,
1973,GO:0004689,0.999999999990262,0.643045022942988,0,4,phosphorylase kinase activity,MF,
2633,GO:0005964,0.999999999990262,0.643045022942988,0,4,phosphorylase kinase complex,CC,
18311,GO:1903233,0.999999999990273,0.786428027568813,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
307,GO:0000818,0.999999999990297,0.858422565440446,0,2,nuclear MIS12/MIND complex,CC,
3209,GO:0006848,0.999999999990299,0.770194116660078,0,3,pyruvate transport,BP,
12640,GO:0050833,0.999999999990299,0.770194116660078,0,3,pyruvate transmembrane transporter activity,MF,
17658,GO:1901475,0.999999999990299,0.770194116660078,0,3,pyruvate transmembrane transport,BP,
2069,GO:0004823,0.999999999990319,0.810427149479243,0,2,leucine-tRNA ligase activity,MF,
2919,GO:0006429,0.999999999990319,0.810427149479243,0,2,leucyl-tRNA aminoacylation,BP,
13218,GO:0051877,0.999999999990319,0.845780541783847,0,2,pigment granule aggregation in cell center,BP,
4889,GO:0014809,0.999999999990329,0.78989035299761,0,3,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
18025,GO:1902527,0.999999999990331,0.762991120029548,0,4,positive regulation of protein monoubiquitination,BP,
18434,GO:1903516,0.999999999990334,0.774213000661129,0,3,regulation of single strand break repair,BP,
16464,GO:0097134,0.999999999990338,0.866615551190035,0,2,cyclin E1-CDK2 complex,CC,
16748,GO:0098508,0.999999999990344,0.858089126625333,0,2,endothelial to hematopoietic transition,BP,
18680,GO:1904026,0.999999999990348,0.850012178910746,0,2,regulation of collagen fibril organization,BP,
1140,GO:0002732,0.999999999990354,0.900532674003742,0,1,positive regulation of dendritic cell cytokine production,BP,
7923,GO:0032498,0.999999999990354,0.900532674003742,0,1,detection of muramyl dipeptide,BP,
7924,GO:0032499,0.999999999990354,0.900532674003742,0,1,detection of peptidoglycan,BP,
7925,GO:0032500,0.999999999990354,0.900532674003742,0,1,muramyl dipeptide binding,MF,
19879,GO:2000361,0.999999999990354,0.900532674003742,0,1,regulation of prostaglandin-E synthase activity,BP,
19880,GO:2000363,0.999999999990354,0.900532674003742,0,1,positive regulation of prostaglandin-E synthase activity,BP,
1493,GO:0003835,0.999999999990355,0.798967850208716,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
8341,GO:0033186,0.999999999990367,0.744378809200924,0,3,CAF-1 complex,CC,
12565,GO:0050717,0.999999999990373,0.811959643589516,0,3,positive regulation of interleukin-1 alpha secretion,BP,
15622,GO:0072108,0.999999999990377,0.783307731503125,0,3,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
14054,GO:0060825,0.999999999990381,0.874144139560529,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
19842,GO:2000313,0.999999999990381,0.874144139560529,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
20047,GO:2000670,0.999999999990383,0.811742473846404,0,2,positive regulation of dendritic cell apoptotic process,BP,
11464,GO:0045918,0.999999999990391,0.899794195206992,0,2,negative regulation of cytolysis,BP,
17569,GO:1901164,0.999999999990406,0.835457116582845,0,3,negative regulation of trophoblast cell migration,BP,
12857,GO:0051176,0.999999999990407,0.752906017801621,0,3,positive regulation of sulfur metabolic process,BP,
1633,GO:0004075,0.99999999999041,0.698901262779466,0,3,biotin carboxylase activity,MF,
10681,GO:0043932,0.999999999990412,0.850461297012503,0,2,ossification involved in bone remodeling,BP,
102,GO:0000213,0.999999999990427,0.750107368449237,0,4,tRNA-intron endonuclease activity,MF,
5218,GO:0015820,0.99999999999043,0.836837350235479,0,2,leucine transport,BP,
19454,GO:1990131,0.999999999990437,0.818638384729086,0,3,Gtr1-Gtr2 GTPase complex,CC,
4626,GO:0010746,0.999999999990438,0.648456359685033,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4627,GO:0010748,0.999999999990438,0.648456359685033,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4249,GO:0009449,0.999999999990439,0.755945874953513,0,3,gamma-aminobutyric acid biosynthetic process,BP,
13245,GO:0051918,0.999999999990439,0.690586009636713,0,4,negative regulation of fibrinolysis,BP,
2014,GO:0004741,0.999999999990451,0.71944204596356,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
8362,GO:0033239,0.999999999990452,0.665250215160458,0,4,negative regulation of cellular amine metabolic process,BP,
11987,GO:0047322,0.999999999990479,0.779845028477344,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12476,GO:0050405,0.999999999990479,0.779845028477344,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
4502,GO:0010533,0.99999999999048,0.843229347230972,0,3,regulation of activation of Janus kinase activity,BP,
7857,GO:0032417,0.999999999990483,0.833456080930397,0,2,positive regulation of sodium:proton antiporter activity,BP,
11079,GO:0045079,0.999999999990484,0.936450133581376,0,1,negative regulation of chemokine biosynthetic process,BP,
19667,GO:1990928,0.999999999990513,0.803652115771102,0,2,response to amino acid starvation,BP,
11155,GO:0045210,0.999999999990515,0.795752808525544,0,2,FasL biosynthetic process,BP,
9982,GO:0042374,0.999999999990528,0.865693984349263,0,2,phylloquinone metabolic process,BP,
9983,GO:0042376,0.999999999990528,0.865693984349263,0,2,phylloquinone catabolic process,BP,
17733,GO:1901662,0.999999999990528,0.865693984349263,0,2,quinone catabolic process,BP,
1316,GO:0003164,0.999999999990533,0.754496307812315,0,3,His-Purkinje system development,BP,
8380,GO:0033277,0.999999999990538,0.824427317968702,0,2,abortive mitotic cell cycle,BP,
8758,GO:0034421,0.999999999990549,0.762970161417738,0,3,post-translational protein acetylation,BP,
19543,GO:1990460,0.999999999990584,0.755071173031992,0,3,leptin receptor binding,MF,
10005,GO:0042421,0.999999999990587,0.785114281052289,0,3,norepinephrine biosynthetic process,BP,
2695,GO:0006060,0.999999999990588,0.869638522025716,0,2,sorbitol metabolic process,BP,
11648,GO:0046370,0.999999999990588,0.869638522025716,0,2,fructose biosynthetic process,BP,
14252,GO:0061302,0.999999999990592,0.768195393032544,0,3,smooth muscle cell-matrix adhesion,BP,
12738,GO:0051001,0.99999999999062,0.716699969780334,0,4,negative regulation of nitric-oxide synthase activity,BP,
5498,GO:0016436,0.999999999990623,0.835436713481171,0,2,rRNA (uridine) methyltransferase activity,MF,
11198,GO:0045322,0.999999999990629,0.844619074071685,0,2,unmethylated CpG binding,MF,
9703,GO:0038107,0.99999999999063,0.75627284196621,0,3,nodal signaling pathway involved in determination of left/right asymmetry,BP,
17373,GO:1900094,0.99999999999063,0.75627284196621,0,3,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
17420,GO:1900164,0.99999999999063,0.75627284196621,0,3,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
2353,GO:0005432,0.999999999990646,0.759335404430005,0,3,calcium:sodium antiporter activity,MF,
14282,GO:0061357,0.999999999990653,0.757096457456059,0,3,positive regulation of Wnt protein secretion,BP,
11803,GO:0046684,0.999999999990656,0.837005228387688,0,2,response to pyrethroid,BP,
16537,GO:0097274,0.99999999999066,0.812894190368393,0,2,urea homeostasis,BP,
16503,GO:0097198,0.999999999990677,0.803838555300457,0,2,histone H3-K36 trimethylation,BP,
11601,GO:0046203,0.99999999999068,0.883948658946019,0,2,spermidine catabolic process,BP,
2528,GO:0005784,0.999999999990695,0.793699917458754,0,4,Sec61 translocon complex,CC,
15149,GO:0071256,0.999999999990695,0.793699917458754,0,4,translocon complex,CC,
515,GO:0001579,0.999999999990697,0.836662432622079,0,2,medium-chain fatty acid transport,BP,
17481,GO:1900376,0.999999999990717,0.626486315757677,0,4,regulation of secondary metabolite biosynthetic process,BP,
3885,GO:0008517,0.999999999990723,0.681531541331284,0,4,folic acid transmembrane transporter activity,MF,
11489,GO:0045950,0.999999999990746,0.850726822699069,0,2,negative regulation of mitotic recombination,BP,
8708,GO:0034346,0.999999999990753,0.917559933724737,0,1,positive regulation of type III interferon production,BP,
10848,GO:0044343,0.999999999990755,0.900770516392164,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
10850,GO:0044345,0.999999999990755,0.900770516392164,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
16213,GO:0090246,0.999999999990755,0.900770516392164,0,1,convergent extension involved in somitogenesis,BP,
19702,GO:2000040,0.999999999990755,0.900770516392164,0,1,regulation of planar cell polarity pathway involved in axis elongation,BP,
19703,GO:2000041,0.999999999990755,0.900770516392164,0,1,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
19713,GO:2000054,0.999999999990755,0.900770516392164,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
19725,GO:2000079,0.999999999990755,0.900770516392164,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
19726,GO:2000080,0.999999999990755,0.900770516392164,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
18651,GO:1903964,0.999999999990757,0.825129409673277,0,2,monounsaturated fatty acid metabolic process,BP,
18652,GO:1903966,0.999999999990757,0.825129409673277,0,2,monounsaturated fatty acid biosynthetic process,BP,
11143,GO:0045188,0.999999999990758,0.837023994965666,0,2,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
2935,GO:0006452,0.999999999990771,0.841341364869827,0,2,translational frameshifting,BP,
11453,GO:0045905,0.999999999990771,0.841341364869827,0,2,positive regulation of translational termination,BP,
6645,GO:0023041,0.999999999990774,0.80014302027581,0,3,neuronal signal transduction,BP,
1257,GO:0003011,0.999999999990783,0.815635701740364,0,2,involuntary skeletal muscle contraction,BP,
1256,GO:0003010,0.999999999990797,0.83812202039336,0,2,voluntary skeletal muscle contraction,BP,
4868,GO:0014721,0.999999999990797,0.83812202039336,0,2,twitch skeletal muscle contraction,BP,
8911,GO:0034750,0.999999999990803,0.816601630053669,0,2,Scrib-APC-beta-catenin complex,CC,
13374,GO:0052593,0.999999999990809,0.835606961834675,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
13375,GO:0052594,0.999999999990809,0.835606961834675,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
13376,GO:0052595,0.999999999990809,0.835606961834675,0,2,aliphatic-amine oxidase activity,MF,
13377,GO:0052596,0.999999999990809,0.835606961834675,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
13410,GO:0052794,0.999999999990817,0.857675069731437,0,2,exo-alpha-(2->3)-sialidase activity,MF,
13411,GO:0052795,0.999999999990817,0.857675069731437,0,2,exo-alpha-(2->6)-sialidase activity,MF,
13412,GO:0052796,0.999999999990817,0.857675069731437,0,2,exo-alpha-(2->8)-sialidase activity,MF,
18332,GO:1903292,0.999999999990819,0.836748408788633,0,2,protein localization to Golgi membrane,BP,
2075,GO:0004829,0.99999999999082,0.778890258333093,0,3,threonine-tRNA ligase activity,MF,
2925,GO:0006435,0.99999999999082,0.778890258333093,0,3,threonyl-tRNA aminoacylation,BP,
1779,GO:0004392,0.999999999990834,0.877793820542014,0,2,heme oxygenase (decyclizing) activity,MF,
3175,GO:0006788,0.999999999990834,0.877793820542014,0,2,heme oxidation,BP,
18800,GO:1904351,0.999999999990852,0.768244269569026,0,3,negative regulation of protein catabolic process in the vacuole,BP,
19154,GO:1905166,0.999999999990852,0.768244269569026,0,3,negative regulation of lysosomal protein catabolic process,BP,
17096,GO:0099631,0.999999999990856,0.892583554091591,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
4084,GO:0009138,0.99999999999086,0.797572715291877,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
3640,GO:0008109,0.999999999990862,0.821326587170491,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
13809,GO:0060398,0.99999999999087,0.715774476569045,0,3,regulation of growth hormone receptor signaling pathway,BP,
8298,GO:0033128,0.999999999990885,0.861037700308277,0,2,negative regulation of histone phosphorylation,BP,
4798,GO:0010990,0.999999999990927,0.715299990945913,0,3,regulation of SMAD protein complex assembly,BP,
6592,GO:0022605,0.999999999990932,0.714903590948083,0,4,mammalian oogenesis stage,BP,
10862,GO:0044378,0.99999999999094,0.835466060842988,0,2,non-sequence-specific DNA binding, bending,MF,
19521,GO:1990414,0.99999999999094,0.679820865597768,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
2241,GO:0005151,0.999999999990944,0.835881231296269,0,2,interleukin-1, Type II receptor binding,MF,
19580,GO:1990635,0.999999999990947,0.689314580984614,0,4,proximal dendrite,CC,
7353,GO:0031394,0.999999999990947,0.847044515185859,0,2,positive regulation of prostaglandin biosynthetic process,BP,
20297,GO:2001280,0.999999999990947,0.847044515185859,0,2,positive regulation of unsaturated fatty acid biosynthetic process,BP,
1741,GO:0004340,0.999999999990967,0.72849441122986,0,3,glucokinase activity,MF,
1782,GO:0004396,0.999999999990967,0.72849441122986,0,3,hexokinase activity,MF,
3990,GO:0008865,0.999999999990967,0.72849441122986,0,3,fructokinase activity,MF,
6045,GO:0019158,0.999999999990967,0.72849441122986,0,3,mannokinase activity,MF,
10709,GO:0043998,0.999999999990967,0.913541971071172,0,1,H2A histone acetyltransferase activity,MF,
6551,GO:0021979,0.999999999990968,0.709284644656698,0,4,hypothalamus cell differentiation,BP,
16062,GO:0089709,0.999999999990968,0.853482797507842,0,2,L-histidine transmembrane transport,BP,
18449,GO:1903537,0.999999999990977,0.852807651471905,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
18450,GO:1903538,0.999999999990977,0.852807651471905,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
13562,GO:0060025,0.999999999990995,0.82761939048537,0,2,regulation of synaptic activity,BP,
4167,GO:0009233,0.999999999991009,0.832627863211442,0,2,menaquinone metabolic process,BP,
10657,GO:0043734,0.999999999991033,0.741468494685574,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
8751,GO:0034402,0.999999999991046,0.825575209511501,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
10934,GO:0044565,0.999999999991051,0.863037623261108,0,2,dendritic cell proliferation,BP,
1091,GO:0002679,0.999999999991062,0.788162317088944,0,3,respiratory burst involved in defense response,BP,
4706,GO:0010868,0.999999999991069,0.816351205100546,0,2,negative regulation of triglyceride biosynthetic process,BP,
503,GO:0001560,0.999999999991086,0.801138037792197,0,2,regulation of cell growth by extracellular stimulus,BP,
8780,GO:0034457,0.99999999999109,0.8260370289493,0,3,Mpp10 complex,CC,
17628,GO:1901338,0.999999999991106,0.805837080793164,0,3,catecholamine binding,MF,
5442,GO:0016309,0.999999999991118,0.741326485410166,0,3,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
17062,GO:0099545,0.999999999991122,0.897415252283904,0,1,trans-synaptic signaling by trans-synaptic complex,BP,
17069,GO:0099557,0.999999999991122,0.897415252283904,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
17201,GO:0106028,0.999999999991122,0.897415252283904,0,1,neuron projection retraction,BP,
17494,GO:1900450,0.999999999991122,0.897415252283904,0,1,negative regulation of glutamate receptor signaling pathway,BP,
18987,GO:1904782,0.999999999991122,0.897415252283904,0,1,negative regulation of NMDA glutamate receptor activity,BP,
1859,GO:0004522,0.99999999999115,0.938146961944983,0,1,ribonuclease A activity,MF,
3974,GO:0008785,0.99999999999115,0.938146961944983,0,1,alkyl hydroperoxide reductase activity,MF,
17595,GO:1901252,0.999999999991173,0.855175723519671,0,2,regulation of intracellular transport of viral material,BP,
14051,GO:0060819,0.999999999991185,0.787970138429164,0,2,inactivation of X chromosome by genetic imprinting,BP,
3653,GO:0008131,0.999999999991197,0.755776269865482,0,3,primary amine oxidase activity,MF,
11924,GO:0046967,0.999999999991198,0.831447864899672,0,2,cytosol to ER transport,BP,
6714,GO:0030124,0.999999999991199,0.718335703116784,0,4,AP-4 adaptor complex,CC,
1653,GO:0004105,0.999999999991205,0.837703975936916,0,2,choline-phosphate cytidylyltransferase activity,MF,
120,GO:0000248,0.999999999991254,0.828653552503673,0,2,C-5 sterol desaturase activity,MF,
14901,GO:0070704,0.999999999991254,0.828653552503673,0,2,sterol desaturase activity,MF,
1899,GO:0004583,0.999999999991281,0.678635844752331,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
18249,GO:1903070,0.99999999999129,0.788869921338686,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
12975,GO:0051377,0.999999999991295,0.750893989930772,0,3,mannose-ethanolamine phosphotransferase activity,MF,
2019,GO:0004748,0.999999999991301,0.749922840125243,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2638,GO:0005971,0.999999999991301,0.749922840125243,0,3,ribonucleoside-diphosphate reductase complex,CC,
5643,GO:0016728,0.999999999991301,0.749922840125243,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
14427,GO:0061731,0.999999999991301,0.749922840125243,0,3,ribonucleoside-diphosphate reductase activity,MF,
3932,GO:0008612,0.999999999991306,0.741456428392403,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
15936,GO:0072733,0.999999999991307,0.80037602235869,0,3,response to staurosporine,BP,
15937,GO:0072734,0.999999999991307,0.80037602235869,0,3,cellular response to staurosporine,BP,
3935,GO:0008616,0.999999999991311,0.818523157517567,0,3,queuosine biosynthetic process,BP,
11569,GO:0046116,0.999999999991311,0.818523157517567,0,3,queuosine metabolic process,BP,
5823,GO:0017095,0.999999999991329,0.815705037513252,0,2,heparan sulfate 6-O-sulfotransferase activity,MF,
9819,GO:0042025,0.999999999991365,0.750275687829139,0,3,host cell nucleus,CC,
10738,GO:0044094,0.999999999991365,0.750275687829139,0,3,host cell nuclear part,CC,
7684,GO:0032129,0.999999999991368,0.85000528904913,0,2,histone deacetylase activity (H3-K9 specific),MF,
11926,GO:0046969,0.999999999991368,0.85000528904913,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
19577,GO:1990619,0.999999999991368,0.85000528904913,0,2,histone H3-K9 deacetylation,BP,
17446,GO:1900222,0.999999999991376,0.846191381439804,0,2,negative regulation of amyloid-beta clearance,BP,
4387,GO:0010040,0.999999999991382,0.735174210567917,0,4,response to iron(II) ion,BP,
10393,GO:0043224,0.999999999991384,0.896443330479342,0,2,nuclear SCF ubiquitin ligase complex,CC,
12720,GO:0050957,0.999999999991391,0.824739478085561,0,2,equilibrioception,BP,
12833,GO:0051140,0.99999999999141,0.894662347408081,0,2,regulation of NK T cell proliferation,BP,
12834,GO:0051142,0.99999999999141,0.894662347408081,0,2,positive regulation of NK T cell proliferation,BP,
9317,GO:0035787,0.999999999991421,0.757544846808888,0,3,cell migration involved in kidney development,BP,
408,GO:0001093,0.999999999991437,0.727135483828002,0,3,TFIIB-class transcription factor binding,MF,
16235,GO:0090283,0.999999999991467,0.760171513710324,0,3,regulation of protein glycosylation in Golgi,BP,
19548,GO:1990504,0.999999999991477,0.715594250231789,0,3,dense core granule exocytosis,BP,
5374,GO:0016185,0.999999999991486,0.673392012929523,0,4,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
16899,GO:0098844,0.999999999991486,0.673392012929523,0,4,postsynaptic endocytic zone membrane,CC,
16917,GO:0098884,0.999999999991486,0.673392012929523,0,4,postsynaptic neurotransmitter receptor internalization,BP,
1364,GO:0003249,0.999999999991487,0.748329431361063,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1365,GO:0003250,0.999999999991487,0.748329431361063,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
20114,GO:2000793,0.999999999991487,0.748329431361063,0,2,cell proliferation involved in heart valve development,BP,
17659,GO:1901490,0.9999999999915,0.671030522626501,0,4,regulation of lymphangiogenesis,BP,
7192,GO:0031081,0.999999999991508,0.830678339649846,0,2,nuclear pore distribution,BP,
13123,GO:0051664,0.999999999991508,0.830678339649846,0,2,nuclear pore localization,BP,
19303,GO:1905573,0.999999999991543,0.858570046507889,0,2,ganglioside GM1 binding,MF,
19306,GO:1905576,0.999999999991543,0.858570046507889,0,2,ganglioside GT1b binding,MF,
4208,GO:0009330,0.999999999991549,0.809980380348831,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
104,GO:0000215,0.999999999991559,0.871122237351783,0,2,tRNA 2'-phosphotransferase activity,MF,
13652,GO:0060159,0.999999999991564,0.728067800897998,0,4,regulation of dopamine receptor signaling pathway,BP,
10870,GO:0044393,0.999999999991565,0.765587551047917,0,3,microspike,CC,
9302,GO:0035747,0.999999999991578,0.785995346959846,0,3,natural killer cell chemotaxis,BP,
13314,GO:0052151,0.999999999991581,0.848513282427899,0,2,positive regulation by symbiont of host apoptotic process,BP,
13639,GO:0060139,0.999999999991581,0.848513282427899,0,2,positive regulation of apoptotic process by virus,BP,
13787,GO:0060373,0.999999999991584,0.697458469697824,0,4,regulation of ventricular cardiac muscle cell membrane depolarization,BP,
8308,GO:0033140,0.999999999991588,0.859893300431644,0,2,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
11239,GO:0045415,0.999999999991601,0.795055840466195,0,3,negative regulation of interleukin-8 biosynthetic process,BP,
5448,GO:0016320,0.999999999991605,0.827131697266168,0,2,endoplasmic reticulum membrane fusion,BP,
14790,GO:0070494,0.999999999991609,0.760572700409706,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
14791,GO:0070495,0.999999999991609,0.760572700409706,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
19292,GO:1905538,0.999999999991614,0.827024361856129,0,2,polysome binding,MF,
18891,GO:1904576,0.99999999999162,0.862008795768223,0,2,response to tunicamycin,BP,
18892,GO:1904577,0.99999999999162,0.862008795768223,0,2,cellular response to tunicamycin,BP,
3842,GO:0008449,0.99999999999162,0.808538376653952,0,2,N-acetylglucosamine-6-sulfatase activity,MF,
16712,GO:0097694,0.999999999991631,0.693796294964116,0,3,establishment of RNA localization to telomere,BP,
16713,GO:0097695,0.999999999991631,0.693796294964116,0,3,establishment of protein-containing complex localization to telomere,BP,
16112,GO:0090091,0.999999999991652,0.658202122008705,0,4,positive regulation of extracellular matrix disassembly,BP,
3422,GO:0007207,0.999999999991653,0.856879138584658,0,2,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
16060,GO:0089700,0.999999999991654,0.742044585198408,0,3,protein kinase D signaling,BP,
5369,GO:0016174,0.99999999999166,0.682956297274337,0,4,NAD(P)H oxidase activity,MF,
2779,GO:0006208,0.999999999991664,0.851404512799826,0,2,pyrimidine nucleobase catabolic process,BP,
2780,GO:0006210,0.999999999991664,0.851404512799826,0,2,thymine catabolic process,BP,
6266,GO:0019859,0.999999999991664,0.851404512799826,0,2,thymine metabolic process,BP,
9101,GO:0035370,0.999999999991686,0.856970220133782,0,2,UBC13-UEV1A complex,CC,
13063,GO:0051563,0.999999999991691,0.810981558533751,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
15395,GO:0071642,0.999999999991705,0.840272709618696,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
7707,GO:0032190,0.999999999991708,0.884618691571893,0,2,acrosin binding,MF,
9329,GO:0035803,0.999999999991708,0.884618691571893,0,2,egg coat formation,BP,
15134,GO:0071224,0.999999999991719,0.768341226022518,0,3,cellular response to peptidoglycan,BP,
5947,GO:0018282,0.999999999991734,0.818111106550755,0,2,metal incorporation into metallo-sulfur cluster,BP,
5948,GO:0018283,0.999999999991734,0.818111106550755,0,2,iron incorporation into metallo-sulfur cluster,BP,
16705,GO:0097676,0.999999999991735,0.698193684087379,0,3,histone H3-K36 dimethylation,BP,
6880,GO:0030375,0.99999999999178,0.716721568343885,0,3,thyroid hormone receptor coactivator activity,MF,
20007,GO:2000619,0.999999999991786,0.782703119615015,0,3,negative regulation of histone H4-K16 acetylation,BP,
9179,GO:0035546,0.999999999991823,0.632308570066819,0,4,interferon-beta secretion,BP,
9180,GO:0035547,0.999999999991823,0.632308570066819,0,4,regulation of interferon-beta secretion,BP,
9181,GO:0035549,0.999999999991823,0.632308570066819,0,4,positive regulation of interferon-beta secretion,BP,
928,GO:0002326,0.999999999991827,0.695267221062487,0,3,B cell lineage commitment,BP,
309,GO:0000820,0.999999999991858,0.782852772599416,0,2,regulation of glutamine family amino acid metabolic process,BP,
11388,GO:0045763,0.999999999991858,0.782852772599416,0,2,negative regulation of cellular amino acid metabolic process,BP,
13667,GO:0060187,0.999999999991875,0.803791323875635,0,2,cell pole,CC,
6075,GO:0019227,0.999999999991882,0.75211707219103,0,3,neuronal action potential propagation,BP,
16909,GO:0098870,0.999999999991882,0.75211707219103,0,3,action potential propagation,BP,
13280,GO:0051967,0.99999999999189,0.793895459732138,0,3,negative regulation of synaptic transmission, glutamatergic,BP,
18910,GO:1904612,0.999999999991902,0.802525529666032,0,2,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
18911,GO:1904613,0.999999999991902,0.802525529666032,0,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,
4646,GO:0010768,0.999999999991903,0.78111273627396,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
18405,GO:1903433,0.999999999991908,0.83509936707247,0,2,regulation of constitutive secretory pathway,BP,
7530,GO:0031752,0.999999999991911,0.800725798674521,0,2,D5 dopamine receptor binding,MF,
7513,GO:0031698,0.999999999991915,0.677143990702638,0,4,beta-2 adrenergic receptor binding,MF,
19462,GO:1990166,0.999999999991928,0.783564783840494,0,3,protein localization to site of double-strand break,BP,
11996,GO:0047389,0.999999999991929,0.81791795916032,0,2,glycerophosphocholine phosphodiesterase activity,MF,
14486,GO:0061890,0.999999999991941,0.85858028348258,0,2,positive regulation of astrocyte activation,BP,
18664,GO:1903980,0.999999999991941,0.85858028348258,0,2,positive regulation of microglial cell activation,BP,
8705,GO:0034342,0.999999999991946,0.855095807984382,0,2,response to type III interferon,BP,
16474,GO:0097154,0.99999999999196,0.756871178865884,0,4,GABAergic neuron differentiation,BP,
16283,GO:0090360,0.999999999991988,0.779607089662173,0,3,platelet-derived growth factor production,BP,
16284,GO:0090361,0.999999999991988,0.779607089662173,0,3,regulation of platelet-derived growth factor production,BP,
16742,GO:0098502,0.999999999991999,0.828709008609291,0,3,DNA dephosphorylation,BP,
295,GO:0000799,0.999999999992003,0.721265586014373,0,3,nuclear condensin complex,CC,
212,GO:0000444,0.999999999992007,0.691100264330677,0,4,MIS12/MIND type complex,CC,
10004,GO:0042420,0.99999999999201,0.723097199010514,0,4,dopamine catabolic process,BP,
15243,GO:0071400,0.999999999992013,0.82509936713885,0,2,cellular response to oleic acid,BP,
19265,GO:1905449,0.999999999992015,0.830189242979249,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
19266,GO:1905451,0.999999999992015,0.830189242979249,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
4391,GO:0010044,0.999999999992045,0.73062252079154,0,4,response to aluminum ion,BP,
1815,GO:0004465,0.999999999992048,0.774388049492661,0,3,lipoprotein lipase activity,MF,
10196,GO:0042799,0.999999999992048,0.663789136341243,0,4,histone methyltransferase activity (H4-K20 specific),MF,
6508,GO:0021882,0.99999999999205,0.860579791360009,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6516,GO:0021893,0.99999999999205,0.860579791360009,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
9367,GO:0035881,0.99999999999205,0.860579791360009,0,2,amacrine cell differentiation,BP,
14178,GO:0061074,0.99999999999205,0.860579791360009,0,2,regulation of neural retina development,BP,
14179,GO:0061075,0.99999999999205,0.860579791360009,0,2,positive regulation of neural retina development,BP,
18141,GO:1902866,0.99999999999205,0.860579791360009,0,2,regulation of retina development in camera-type eye,BP,
18142,GO:1902868,0.99999999999205,0.860579791360009,0,2,positive regulation of retina development in camera-type eye,BP,
18143,GO:1902869,0.99999999999205,0.860579791360009,0,2,regulation of amacrine cell differentiation,BP,
18144,GO:1902871,0.99999999999205,0.860579791360009,0,2,positive regulation of amacrine cell differentiation,BP,
15537,GO:0071931,0.999999999992051,0.865670576420456,0,2,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
15610,GO:0072095,0.999999999992052,0.830842664396446,0,2,regulation of branch elongation involved in ureteric bud branching,BP,
9228,GO:0035614,0.999999999992053,0.812150322579934,0,3,snRNA stem-loop binding,MF,
16469,GO:0097149,0.999999999992064,0.754813495289379,0,3,centralspindlin complex,CC,
1179,GO:0002826,0.99999999999209,0.767411298106643,0,3,negative regulation of T-helper 1 type immune response,BP,
4130,GO:0009189,0.99999999999209,0.82240990660254,0,3,deoxyribonucleoside diphosphate biosynthetic process,BP,
17929,GO:1902255,0.999999999992095,0.861968761866693,0,3,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
11327,GO:0045650,0.999999999992111,0.869825710391802,0,2,negative regulation of macrophage differentiation,BP,
19439,GO:1990072,0.999999999992119,0.874974350935939,0,2,TRAPPIII protein complex,CC,
5147,GO:0015679,0.99999999999212,0.786216773386803,0,2,plasma membrane copper ion transport,BP,
9160,GO:0035513,0.999999999992134,0.713216540730025,0,4,oxidative RNA demethylation,BP,
9162,GO:0035515,0.999999999992134,0.713216540730025,0,4,oxidative RNA demethylase activity,MF,
7971,GO:0032584,0.999999999992141,0.759339722265602,0,3,growth cone membrane,CC,
8585,GO:0034066,0.999999999992159,0.866573513757039,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
8459,GO:0033596,0.999999999992166,0.710615895511633,0,3,TSC1-TSC2 complex,CC,
14435,GO:0061740,0.999999999992169,0.775056519594529,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
11745,GO:0046581,0.999999999992206,0.734776216104655,0,3,intercellular canaliculus,CC,
14564,GO:0070091,0.999999999992214,0.748404242096223,0,3,glucagon secretion,BP,
14565,GO:0070092,0.999999999992214,0.748404242096223,0,3,regulation of glucagon secretion,BP,
1543,GO:0003938,0.999999999992215,0.865610845685725,0,2,IMP dehydrogenase activity,MF,
17149,GO:0102485,0.999999999992216,0.786234425475688,0,2,dATP phosphohydrolase activity,MF,
17150,GO:0102486,0.999999999992216,0.786234425475688,0,2,dCTP phosphohydrolase activity,MF,
17151,GO:0102487,0.999999999992216,0.786234425475688,0,2,dUTP phosphohydrolase activity,MF,
17152,GO:0102488,0.999999999992216,0.786234425475688,0,2,dTTP phosphohydrolase activity,MF,
17153,GO:0102489,0.999999999992216,0.786234425475688,0,2,GTP phosphohydrolase activity,MF,
17154,GO:0102490,0.999999999992216,0.786234425475688,0,2,8-oxo-dGTP phosphohydrolase activity,MF,
17155,GO:0102491,0.999999999992216,0.786234425475688,0,2,dGTP phosphohydrolase activity,MF,
2813,GO:0006272,0.999999999992217,0.739440637189084,0,3,leading strand elongation,BP,
6155,GO:0019474,0.999999999992225,0.761019748613868,0,3,L-lysine catabolic process to acetyl-CoA,BP,
6156,GO:0019477,0.999999999992225,0.761019748613868,0,3,L-lysine catabolic process,BP,
8428,GO:0033512,0.999999999992225,0.761019748613868,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
11669,GO:0046440,0.999999999992225,0.761019748613868,0,3,L-lysine metabolic process,BP,
17327,GO:0150018,0.999999999992241,0.741193341883016,0,3,basal dendrite development,BP,
17328,GO:0150019,0.999999999992241,0.741193341883016,0,3,basal dendrite morphogenesis,BP,
17329,GO:0150020,0.999999999992241,0.741193341883016,0,3,basal dendrite arborization,BP,
12803,GO:0051097,0.999999999992249,0.782365551846915,0,3,negative regulation of helicase activity,BP,
15442,GO:0071723,0.999999999992251,0.738157982351576,0,3,lipopeptide binding,MF,
18325,GO:1903279,0.999999999992261,0.839870967685913,0,2,regulation of calcium:sodium antiporter activity,BP,
18326,GO:1903281,0.999999999992261,0.839870967685913,0,2,positive regulation of calcium:sodium antiporter activity,BP,
18691,GO:1904044,0.999999999992263,0.801251671147614,0,3,response to aldosterone,BP,
1065,GO:0002606,0.999999999992267,0.763967075690882,0,3,positive regulation of dendritic cell antigen processing and presentation,BP,
2581,GO:0005873,0.999999999992295,0.734039858723796,0,3,plus-end kinesin complex,CC,
13187,GO:0051793,0.999999999992323,0.750109924817863,0,3,medium-chain fatty acid catabolic process,BP,
18881,GO:1904562,0.999999999992324,0.777107460211044,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
19855,GO:2000328,0.999999999992331,0.80843447508572,0,3,regulation of T-helper 17 cell lineage commitment,BP,
7250,GO:0031208,0.999999999992338,0.817922363786356,0,2,POZ domain binding,MF,
3506,GO:0007412,0.999999999992346,0.856688352499795,0,2,axon target recognition,BP,
16256,GO:0090309,0.999999999992347,0.666401986615515,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
9141,GO:0035482,0.999999999992371,0.890485731837111,0,2,gastric motility,BP,
19217,GO:1905333,0.999999999992371,0.890485731837111,0,2,regulation of gastric motility,BP,
13852,GO:0060455,0.999999999992381,0.857292686363572,0,2,negative regulation of gastric acid secretion,BP,
20128,GO:2000819,0.999999999992393,0.837568904824798,0,2,regulation of nucleotide-excision repair,BP,
7160,GO:0031022,0.999999999992433,0.775060668084118,0,2,nuclear migration along microfilament,BP,
3413,GO:0007195,0.999999999992457,0.81007479211578,0,2,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
17507,GO:1900673,0.999999999992486,0.857609733504984,0,2,olefin metabolic process,BP,
18071,GO:1902636,0.999999999992491,0.875376646188239,0,2,kinociliary basal body,CC,
14250,GO:0061300,0.999999999992511,0.827892291494346,0,2,cerebellum vasculature development,BP,
8754,GO:0034414,0.999999999992521,0.842521816272866,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
10186,GO:0042779,0.999999999992521,0.842521816272866,0,2,tRNA 3'-trailer cleavage,BP,
10188,GO:0042781,0.999999999992521,0.842521816272866,0,2,3'-tRNA processing endoribonuclease activity,MF,
19185,GO:1905267,0.999999999992521,0.842521816272866,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
2887,GO:0006391,0.999999999992527,0.791107950568686,0,3,transcription initiation from mitochondrial promoter,BP,
11152,GO:0045204,0.999999999992539,0.734254578846925,0,3,MAPK export from nucleus,BP,
11561,GO:0046102,0.999999999992565,0.802948127894735,0,3,inosine metabolic process,BP,
14484,GO:0061888,0.999999999992581,0.768094700386352,0,3,regulation of astrocyte activation,BP,
17735,GO:1901664,0.999999999992594,0.78041362529424,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
17736,GO:1901666,0.999999999992594,0.78041362529424,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
2305,GO:0005290,0.999999999992599,0.848221940958993,0,2,L-histidine transmembrane transporter activity,MF,
8880,GO:0034686,0.999999999992599,0.772751452672781,0,2,integrin alphav-beta8 complex,CC,
9355,GO:0035866,0.999999999992599,0.772751452672781,0,2,alphav-beta3 integrin-PKCalpha complex,CC,
19531,GO:1990430,0.999999999992599,0.772751452672781,0,2,extracellular matrix protein binding,MF,
14320,GO:0061476,0.999999999992614,0.67061259341869,0,4,response to anticoagulant,BP,
15313,GO:0071503,0.999999999992614,0.67061259341869,0,4,response to heparin,BP,
15314,GO:0071504,0.999999999992614,0.67061259341869,0,4,cellular response to heparin,BP,
16781,GO:0098592,0.999999999992625,0.763296978249143,0,3,cytoplasmic side of apical plasma membrane,CC,
13729,GO:0060297,0.999999999992627,0.694673464437096,0,3,regulation of sarcomere organization,BP,
3535,GO:0007525,0.999999999992627,0.739245317361575,0,2,somatic muscle development,BP,
1377,GO:0003273,0.999999999992655,0.640609206907387,0,4,cell migration involved in endocardial cushion formation,BP,
16415,GO:0097048,0.999999999992658,0.674424329206216,0,4,dendritic cell apoptotic process,BP,
20045,GO:2000668,0.999999999992658,0.674424329206216,0,4,regulation of dendritic cell apoptotic process,BP,
13847,GO:0060448,0.999999999992659,0.72223647680432,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
7387,GO:0031439,0.999999999992667,0.834461416012178,0,2,positive regulation of mRNA cleavage,BP,
3526,GO:0007500,0.999999999992675,0.859127225733036,0,2,mesodermal cell fate determination,BP,
6730,GO:0030144,0.999999999992733,0.774000056019222,0,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,
14195,GO:0061101,0.999999999992733,0.733673280113311,0,4,neuroendocrine cell differentiation,BP,
15717,GO:0072272,0.999999999992739,0.861337567381436,0,2,proximal/distal pattern formation involved in metanephric nephron development,BP,
13655,GO:0060166,0.999999999992745,0.857107623125234,0,2,olfactory pit development,BP,
14399,GO:0061649,0.999999999992762,0.742998300764809,0,3,ubiquitin modification-dependent histone binding,MF,
18518,GO:1903690,0.999999999992801,0.616059637130701,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
1573,GO:0003980,0.999999999992808,0.77342638685057,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
16571,GO:0097359,0.999999999992808,0.77342638685057,0,2,UDP-glucosylation,BP,
15048,GO:0070992,0.999999999992825,0.879310611433321,0,2,translation initiation complex,CC,
9254,GO:0035658,0.999999999992831,0.783096023025844,0,3,Mon1-Ccz1 complex,CC,
588,GO:0001743,0.999999999992833,0.807611253007146,0,2,optic placode formation,BP,
12986,GO:0051389,0.999999999992843,0.772253347836513,0,2,inactivation of MAPKK activity,BP,
13994,GO:0060708,0.99999999999285,0.787519398432831,0,3,spongiotrophoblast differentiation,BP,
8273,GO:0033065,0.999999999992855,0.875912331245225,0,2,Rad51C-XRCC3 complex,CC,
5585,GO:0016603,0.999999999992862,0.869922550157022,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5873,GO:0017186,0.999999999992862,0.869922550157022,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
17905,GO:1902214,0.999999999992877,0.823533583227067,0,2,regulation of interleukin-4-mediated signaling pathway,BP,
8124,GO:0032810,0.999999999992886,0.84134263643997,0,2,sterol response element binding,MF,
11214,GO:0045347,0.99999999999289,0.756248754059754,0,3,negative regulation of MHC class II biosynthetic process,BP,
6872,GO:0030348,0.999999999992905,0.837845820229425,0,2,syntaxin-3 binding,MF,
15477,GO:0071819,0.999999999992905,0.86913804100906,0,2,DUBm complex,CC,
7643,GO:0032053,0.999999999992952,0.814623946580941,0,2,ciliary basal body organization,BP,
6740,GO:0030158,0.999999999992962,0.728956408496182,0,3,protein xylosyltransferase activity,MF,
11557,GO:0046098,0.999999999992968,0.718671718068099,0,4,guanine metabolic process,BP,
13147,GO:0051715,0.999999999992995,0.844326874047886,0,3,cytolysis in other organism,BP,
18621,GO:1903905,0.999999999993013,0.813282163459699,0,2,positive regulation of establishment of T cell polarity,BP,
370,GO:0000991,0.999999999993028,0.837105007722879,0,2,transcription factor activity, core RNA polymerase II binding,MF,
18306,GO:1903223,0.999999999993063,0.733802284379756,0,3,positive regulation of oxidative stress-induced neuron death,BP,
18308,GO:1903225,0.999999999993087,0.773999165585905,0,2,negative regulation of endodermal cell differentiation,BP,
16443,GO:0097102,0.999999999993088,0.84533487316885,0,2,endothelial tip cell fate specification,BP,
11939,GO:0046985,0.99999999999309,0.802700477564119,0,3,positive regulation of hemoglobin biosynthetic process,BP,
3355,GO:0007089,0.999999999993103,0.693923899905595,0,4,traversing start control point of mitotic cell cycle,BP,
3264,GO:0006933,0.999999999993114,0.868827732751072,0,2,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
19117,GO:1905051,0.999999999993119,0.888494324201174,0,2,regulation of base-excision repair,BP,
19118,GO:1905053,0.999999999993119,0.888494324201174,0,2,positive regulation of base-excision repair,BP,
345,GO:0000958,0.999999999993125,0.753485359557472,0,3,mitochondrial mRNA catabolic process,BP,
14266,GO:0061325,0.999999999993126,0.791836394030493,0,3,cell proliferation involved in outflow tract morphogenesis,BP,
15006,GO:0070934,0.999999999993133,0.661343918572688,0,4,CRD-mediated mRNA stabilization,BP,
18745,GO:1904217,0.999999999993143,0.796045369551205,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18746,GO:1904219,0.999999999993143,0.796045369551205,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
18748,GO:1904222,0.999999999993143,0.796045369551205,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
951,GO:0002370,0.999999999993143,0.786182001016263,0,3,natural killer cell cytokine production,BP,
1135,GO:0002727,0.999999999993143,0.786182001016263,0,3,regulation of natural killer cell cytokine production,BP,
19472,GO:1990180,0.99999999999315,0.809094938473901,0,3,mitochondrial tRNA 3'-end processing,BP,
995,GO:0002457,0.999999999993155,0.69928854825046,0,4,T cell antigen processing and presentation,BP,
4687,GO:0010836,0.999999999993165,0.81060944022601,0,3,negative regulation of protein ADP-ribosylation,BP,
14927,GO:0070778,0.999999999993179,0.694083797690292,0,4,L-aspartate transmembrane transport,BP,
11496,GO:0045967,0.999999999993193,0.748484685610159,0,2,negative regulation of growth rate,BP,
4170,GO:0009236,0.999999999993198,0.740552680831407,0,3,cobalamin biosynthetic process,BP,
6469,GO:0021798,0.999999999993221,0.786712776709476,0,2,forebrain dorsal/ventral pattern formation,BP,
15281,GO:0071461,0.999999999993239,0.868988699691048,0,2,cellular response to redox state,BP,
4797,GO:0010989,0.99999999999324,0.771601342431083,0,3,negative regulation of low-density lipoprotein particle clearance,BP,
7745,GO:0032258,0.99999999999324,0.854790129011423,0,2,protein localization by the Cvt pathway,BP,
1976,GO:0004692,0.999999999993261,0.907411580928044,0,1,cGMP-dependent protein kinase activity,MF,
6674,GO:0030035,0.999999999993262,0.736757596545605,0,3,microspike assembly,BP,
543,GO:0001661,0.999999999993264,0.828949285617593,0,2,conditioned taste aversion,BP,
11811,GO:0046696,0.999999999993267,0.850079204246854,0,2,lipopolysaccharide receptor complex,CC,
1051,GO:0002579,0.999999999993278,0.725221856155924,0,4,positive regulation of antigen processing and presentation,BP,
16661,GO:0097534,0.999999999993291,0.811436160629018,0,2,lymphoid lineage cell migration,BP,
16662,GO:0097535,0.999999999993291,0.811436160629018,0,2,lymphoid lineage cell migration into thymus,BP,
3738,GO:0008273,0.999999999993292,0.803299408765394,0,2,calcium, potassium:sodium antiporter activity,MF,
17650,GO:1901387,0.9999999999933,0.742607570364138,0,3,positive regulation of voltage-gated calcium channel activity,BP,
11982,GO:0047288,0.999999999993301,0.842649550475307,0,2,monosialoganglioside sialyltransferase activity,MF,
17681,GO:1901552,0.999999999993308,0.824073432062114,0,2,positive regulation of endothelial cell development,BP,
18273,GO:1903142,0.999999999993308,0.824073432062114,0,2,positive regulation of establishment of endothelial barrier,BP,
5393,GO:0016230,0.999999999993315,0.856784425095648,0,2,sphingomyelin phosphodiesterase activator activity,MF,
19198,GO:1905292,0.999999999993329,0.75735836121086,0,3,regulation of neural crest cell differentiation,BP,
19199,GO:1905294,0.999999999993329,0.75735836121086,0,3,positive regulation of neural crest cell differentiation,BP,
19205,GO:1905310,0.999999999993329,0.75735836121086,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19206,GO:1905312,0.999999999993329,0.75735836121086,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
16210,GO:0090241,0.999999999993338,0.725014091224144,0,4,negative regulation of histone H4 acetylation,BP,
2563,GO:0005846,0.999999999993347,0.831640169687794,0,2,nuclear cap binding complex,CC,
5428,GO:0016282,0.999999999993348,0.900515168335018,0,1,eukaryotic 43S preinitiation complex,CC,
6448,GO:0021764,0.99999999999336,0.758291390263493,0,2,amygdala development,BP,
2115,GO:0004905,0.999999999993361,0.836582568748165,0,2,type I interferon receptor activity,MF,
5116,GO:0015440,0.999999999993369,0.690225344596127,0,4,peptide-transporting ATPase activity,MF,
8356,GO:0033220,0.999999999993369,0.690225344596127,0,4,amide-transporting ATPase activity,MF,
16595,GO:0097411,0.999999999993388,0.678747890272695,0,4,hypoxia-inducible factor-1alpha signaling pathway,BP,
19973,GO:2000553,0.999999999993425,0.777217489295117,0,3,positive regulation of T-helper 2 cell cytokine production,BP,
10830,GO:0044323,0.999999999993447,0.815992454507669,0,2,retinoic acid-responsive element binding,MF,
3858,GO:0008475,0.999999999993469,0.762639443525437,0,3,procollagen-lysine 5-dioxygenase activity,MF,
11912,GO:0046946,0.999999999993469,0.762639443525437,0,3,hydroxylysine metabolic process,BP,
11913,GO:0046947,0.999999999993469,0.762639443525437,0,3,hydroxylysine biosynthetic process,BP,
1898,GO:0004582,0.999999999993476,0.850410013913395,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
8340,GO:0033185,0.999999999993476,0.850410013913395,0,3,dolichol-phosphate-mannose synthase complex,CC,
3955,GO:0008670,0.999999999993477,0.884478540571331,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
15585,GO:0072053,0.999999999993482,0.826928438865315,0,2,renal inner medulla development,BP,
15586,GO:0072054,0.999999999993482,0.826928438865315,0,2,renal outer medulla development,BP,
16137,GO:0090138,0.999999999993483,0.909257110768573,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
13965,GO:0060671,0.999999999993494,0.765280004210931,0,3,epithelial cell differentiation involved in embryonic placenta development,BP,
13966,GO:0060672,0.999999999993494,0.765280004210931,0,3,epithelial cell morphogenesis involved in placental branching,BP,
7839,GO:0032393,0.999999999993498,0.886008505210185,0,2,MHC class I receptor activity,MF,
8620,GO:0034136,0.9999999999935,0.736224340991478,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
1952,GO:0004656,0.999999999993516,0.788921269681254,0,3,procollagen-proline 4-dioxygenase activity,MF,
14323,GO:0061484,0.999999999993518,0.743559350589688,0,3,hematopoietic stem cell homeostasis,BP,
169,GO:0000350,0.999999999993535,0.813780352790119,0,3,generation of catalytic spliceosome for second transesterification step,BP,
2243,GO:0005153,0.999999999993539,0.842657314876822,0,2,interleukin-8 receptor binding,MF,
15535,GO:0071929,0.999999999993539,0.842657314876822,0,2,alpha-tubulin acetylation,BP,
5258,GO:0015888,0.999999999993541,0.836473740889614,0,2,thiamine transport,BP,
3340,GO:0007056,0.999999999993542,0.862756315639752,0,2,spindle assembly involved in female meiosis,BP,
3341,GO:0007057,0.999999999993542,0.862756315639752,0,2,spindle assembly involved in female meiosis I,BP,
8884,GO:0034696,0.999999999993545,0.859232301029017,0,2,response to prostaglandin F,BP,
12037,GO:0047750,0.99999999999355,0.895560062027121,0,2,cholestenol delta-isomerase activity,MF,
6533,GO:0021936,0.999999999993562,0.723883512408957,0,3,regulation of cerebellar granule cell precursor proliferation,BP,
7245,GO:0031177,0.999999999993563,0.795946830668817,0,3,phosphopantetheine binding,MF,
10925,GO:0044539,0.999999999993581,0.752021843963356,0,3,long-chain fatty acid import,BP,
13594,GO:0060061,0.999999999993582,0.832794264223265,0,2,Spemann organizer formation,BP,
11932,GO:0046977,0.999999999993597,0.714257147601541,0,4,TAP binding,MF,
11933,GO:0046978,0.999999999993597,0.714257147601541,0,4,TAP1 binding,MF,
10320,GO:0043103,0.999999999993598,0.815527918267822,0,3,hypoxanthine salvage,BP,
8467,GO:0033604,0.9999999999936,0.822380655781485,0,2,negative regulation of catecholamine secretion,BP,
16009,GO:0086017,0.9999999999936,0.828466990029815,0,2,Purkinje myocyte action potential,BP,
16019,GO:0086029,0.9999999999936,0.828466990029815,0,2,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
16040,GO:0086068,0.9999999999936,0.828466990029815,0,2,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
2056,GO:0004809,0.999999999993608,0.796458689655758,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
9926,GO:0042272,0.999999999993616,0.772189294376289,0,2,nuclear RNA export factor complex,CC,
2229,GO:0005132,0.999999999993623,0.888134785988853,0,2,type I interferon receptor binding,MF,
11560,GO:0046101,0.999999999993631,0.75801266617202,0,4,hypoxanthine biosynthetic process,BP,
19710,GO:2000051,0.999999999993633,0.617235666120984,0,4,negative regulation of non-canonical Wnt signaling pathway,BP,
1197,GO:0002857,0.99999999999365,0.822908008350317,0,2,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1200,GO:0002860,0.99999999999365,0.822908008350317,0,2,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
20000,GO:2000609,0.999999999993652,0.776273249673453,0,3,regulation of thyroid hormone generation,BP,
1368,GO:0003253,0.999999999993657,0.703129788011951,0,4,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
19146,GO:1905150,0.999999999993665,0.802480922710636,0,2,regulation of voltage-gated sodium channel activity,BP,
16462,GO:0097125,0.999999999993677,0.870261973625988,0,2,cyclin B1-CDK1 complex,CC,
10210,GO:0042825,0.999999999993685,0.75772757997499,0,3,TAP complex,CC,
5972,GO:0018423,0.999999999993687,0.866443901740474,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
14499,GO:0061945,0.999999999993692,0.769683775486584,0,3,regulation of protein K48-linked ubiquitination,BP,
2822,GO:0006286,0.999999999993698,0.88569906526089,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
1055,GO:0002583,0.999999999993699,0.778397805677122,0,4,regulation of antigen processing and presentation of peptide antigen,BP,
3900,GO:0008537,0.999999999993699,0.822956318512472,0,3,proteasome activator complex,CC,
6049,GO:0019185,0.999999999993703,0.829540902845818,0,2,snRNA-activating protein complex,CC,
293,GO:0000797,0.999999999993745,0.897751222383391,0,1,condensin core heterodimer,CC,
1681,GO:0004146,0.999999999993753,0.857541111385791,0,2,dihydrofolate reductase activity,MF,
13001,GO:0051425,0.999999999993753,0.652250157785094,0,4,PTB domain binding,MF,
6078,GO:0019230,0.999999999993756,0.78616198724894,0,2,proprioception,BP,
6234,GO:0019785,0.999999999993764,0.842244479258916,0,2,ISG15-specific protease activity,MF,
6345,GO:0021521,0.999999999993815,0.696602238692174,0,3,ventral spinal cord interneuron specification,BP,
6455,GO:0021775,0.999999999993815,0.696602238692174,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6456,GO:0021776,0.999999999993815,0.696602238692174,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
13916,GO:0060573,0.999999999993815,0.696602238692174,0,3,cell fate specification involved in pattern specification,BP,
13922,GO:0060579,0.999999999993815,0.696602238692174,0,3,ventral spinal cord interneuron fate commitment,BP,
13923,GO:0060581,0.999999999993815,0.696602238692174,0,3,cell fate commitment involved in pattern specification,BP,
14446,GO:0061762,0.99999999999382,0.80037654919693,0,2,CAMKK-AMPK signaling cascade,BP,
16976,GO:0099004,0.99999999999382,0.80037654919693,0,2,calmodulin dependent kinase signaling pathway,BP,
1832,GO:0004487,0.999999999993849,0.784409646619787,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
9182,GO:0035552,0.999999999993863,0.781784134547154,0,3,oxidative single-stranded DNA demethylation,BP,
8579,GO:0034057,0.999999999993875,0.836718731463315,0,2,RNA strand-exchange activity,MF,
10844,GO:0044339,0.999999999993885,0.761050557303977,0,3,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
10449,GO:0043305,0.999999999993889,0.858135729748965,0,2,negative regulation of mast cell degranulation,BP,
15166,GO:0071284,0.999999999993899,0.65845300605327,0,4,cellular response to lead ion,BP,
7182,GO:0031064,0.999999999993918,0.769093558252048,0,2,negative regulation of histone deacetylation,BP,
1696,GO:0004174,0.999999999993935,0.847816282874867,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
5607,GO:0016649,0.999999999993935,0.847816282874867,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
2995,GO:0006540,0.999999999993935,0.8296852863211,0,2,glutamate decarboxylation to succinate,BP,
19845,GO:2000317,0.999999999993942,0.764527020196319,0,3,negative regulation of T-helper 17 type immune response,BP,
19848,GO:2000320,0.999999999993942,0.764527020196319,0,3,negative regulation of T-helper 17 cell differentiation,BP,
1315,GO:0003163,0.999999999993969,0.802529707755928,0,2,sinoatrial node development,BP,
14093,GO:0060921,0.999999999993969,0.802529707755928,0,2,sinoatrial node cell differentiation,BP,
14098,GO:0060931,0.999999999993969,0.802529707755928,0,2,sinoatrial node cell development,BP,
9663,GO:0038018,0.999999999993974,0.798031776494154,0,2,Wnt receptor catabolic process,BP,
7154,GO:0031013,0.999999999994003,0.884736747187201,0,2,troponin I binding,MF,
9735,GO:0038189,0.999999999994021,0.698890287608108,0,4,neuropilin signaling pathway,BP,
13347,GO:0052405,0.999999999994024,0.829245357640925,0,3,negative regulation by host of symbiont molecular function,BP,
8797,GO:0034485,0.999999999994032,0.685102897156043,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
5789,GO:0017018,0.999999999994058,0.798413520895925,0,2,myosin phosphatase activity,MF,
19571,GO:1990597,0.99999999999407,0.756252646765441,0,3,AIP1-IRE1 complex,CC,
2121,GO:0004915,0.999999999994072,0.827477428325103,0,2,interleukin-6 receptor activity,MF,
2599,GO:0005896,0.999999999994072,0.827477428325103,0,2,interleukin-6 receptor complex,CC,
6321,GO:0019981,0.999999999994072,0.827477428325103,0,2,interleukin-6 binding,MF,
14578,GO:0070110,0.999999999994072,0.827477428325103,0,2,ciliary neurotrophic factor receptor complex,CC,
19484,GO:1990254,0.999999999994088,0.705342742416762,0,4,keratin filament binding,MF,
4951,GO:0015014,0.999999999994108,0.658193302013126,0,4,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
2176,GO:0005021,0.999999999994115,0.826922055379146,0,2,vascular endothelial growth factor-activated receptor activity,MF,
7690,GO:0032142,0.999999999994138,0.743023355750749,0,3,single guanine insertion binding,MF,
5167,GO:0015712,0.999999999994164,0.721774244174884,0,4,hexose phosphate transport,BP,
5187,GO:0015760,0.999999999994164,0.721774244174884,0,4,glucose-6-phosphate transport,BP,
9778,GO:0039656,0.999999999994173,0.857183217975834,0,2,modulation by virus of host gene expression,BP,
11834,GO:0046778,0.999999999994173,0.857183217975834,0,2,modification by virus of host mRNA processing,BP,
11025,GO:0044861,0.999999999994173,0.831674206436316,0,2,protein transport into plasma membrane raft,BP,
2684,GO:0006046,0.999999999994174,0.808224482202958,0,3,N-acetylglucosamine catabolic process,BP,
15232,GO:0071386,0.999999999994185,0.780518896977924,0,2,cellular response to corticosterone stimulus,BP,
6942,GO:0030550,0.999999999994189,0.774648864534619,0,3,acetylcholine receptor inhibitor activity,MF,
11641,GO:0046356,0.999999999994203,0.880707188239185,0,2,acetyl-CoA catabolic process,BP,
13969,GO:0060676,0.999999999994205,0.72508518819935,0,4,ureteric bud formation,BP,
15657,GO:0072172,0.999999999994205,0.72508518819935,0,4,mesonephric tubule formation,BP,
10132,GO:0042668,0.999999999994211,0.885742103643187,0,2,auditory receptor cell fate determination,BP,
20162,GO:2000977,0.999999999994211,0.885742103643187,0,2,regulation of forebrain neuron differentiation,BP,
20163,GO:2000978,0.999999999994211,0.885742103643187,0,2,negative regulation of forebrain neuron differentiation,BP,
14387,GO:0061628,0.999999999994246,0.816334338593136,0,2,H3K27me3 modified histone binding,MF,
14115,GO:0060971,0.999999999994273,0.729803176058331,0,3,embryonic heart tube left/right pattern formation,BP,
4048,GO:0009085,0.999999999994279,0.8194606234511,0,2,lysine biosynthetic process,BP,
6277,GO:0019878,0.999999999994279,0.8194606234511,0,2,lysine biosynthetic process via aminoadipic acid,BP,
14216,GO:0061152,0.99999999999428,0.860627760327286,0,2,trachea submucosa development,BP,
14217,GO:0061153,0.99999999999428,0.860627760327286,0,2,trachea gland development,BP,
7329,GO:0031339,0.999999999994306,0.749359679743556,0,3,negative regulation of vesicle fusion,BP,
11206,GO:0045337,0.999999999994319,0.788371165015362,0,3,farnesyl diphosphate biosynthetic process,BP,
2068,GO:0004822,0.999999999994323,0.820084836890235,0,2,isoleucine-tRNA ligase activity,MF,
2918,GO:0006428,0.999999999994323,0.820084836890235,0,2,isoleucyl-tRNA aminoacylation,BP,
14695,GO:0070315,0.999999999994326,0.837651856184877,0,2,G1 to G0 transition involved in cell differentiation,BP,
17388,GO:1900114,0.999999999994344,0.802355863088247,0,2,positive regulation of histone H3-K9 trimethylation,BP,
424,GO:0001129,0.999999999994358,0.737006379864568,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
425,GO:0001132,0.999999999994358,0.737006379864568,0,3,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
18870,GO:1904529,0.999999999994359,0.818004330775234,0,2,regulation of actin filament binding,BP,
18912,GO:1904616,0.999999999994359,0.818004330775234,0,2,regulation of actin binding,BP,
3824,GO:0008422,0.999999999994389,0.809391411474158,0,2,beta-glucosidase activity,MF,
4745,GO:0010915,0.999999999994428,0.89773989520873,0,2,regulation of very-low-density lipoprotein particle clearance,BP,
4746,GO:0010916,0.999999999994428,0.89773989520873,0,2,negative regulation of very-low-density lipoprotein particle clearance,BP,
5087,GO:0015333,0.999999999994431,0.753578206760638,0,3,peptide:proton symporter activity,MF,
11100,GO:0045112,0.999999999994441,0.7483190055717,0,3,integrin biosynthetic process,BP,
10703,GO:0043988,0.999999999994443,0.792423710967972,0,3,histone H3-S28 phosphorylation,BP,
19660,GO:1990911,0.999999999994458,0.865473835799695,0,2,response to psychosocial stress,BP,
16574,GO:0097362,0.99999999999446,0.840862499198512,0,2,MCM8-MCM9 complex,CC,
9232,GO:0035620,0.999999999994462,0.769578462828106,0,3,ceramide transporter activity,MF,
15550,GO:0071962,0.999999999994464,0.807410679162912,0,3,mitotic sister chromatid cohesion, centromeric,BP,
7527,GO:0031731,0.9999999999945,0.909446495533058,0,2,CCR6 chemokine receptor binding,MF,
16927,GO:0098904,0.99999999999451,0.847365960435324,0,2,regulation of AV node cell action potential,BP,
4849,GO:0014061,0.99999999999451,0.768907259613875,0,3,regulation of norepinephrine secretion,BP,
686,GO:0001905,0.999999999994512,0.78820450642635,0,2,activation of membrane attack complex,BP,
739,GO:0001969,0.999999999994512,0.78820450642635,0,2,regulation of activation of membrane attack complex,BP,
14034,GO:0060763,0.999999999994524,0.821735952791929,0,2,mammary duct terminal end bud growth,BP,
7615,GO:0032002,0.999999999994525,0.857545219237737,0,2,interleukin-28 receptor complex,CC,
18833,GO:1904426,0.999999999994558,0.817586919089889,0,2,positive regulation of GTP binding,BP,
1916,GO:0004609,0.999999999994565,0.857680091772694,0,2,phosphatidylserine decarboxylase activity,MF,
12454,GO:0050220,0.999999999994606,0.776021460552084,0,4,prostaglandin-E synthase activity,MF,
8681,GO:0034271,0.99999999999462,0.763824915629268,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
8682,GO:0034272,0.99999999999462,0.763824915629268,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
3689,GO:0008192,0.999999999994622,0.767362291150641,0,3,RNA guanylyltransferase activity,MF,
1431,GO:0003406,0.999999999994639,0.742453484510653,0,3,retinal pigment epithelium development,BP,
11785,GO:0046643,0.999999999994663,0.653901930837755,0,4,regulation of gamma-delta T cell activation,BP,
7128,GO:0030951,0.999999999994664,0.686445058300554,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
746,GO:0001976,0.999999999994678,0.675710516730026,0,4,neurological system process involved in regulation of systemic arterial blood pressure,BP,
2042,GO:0004784,0.999999999994685,0.786414743934027,0,4,superoxide dismutase activity,MF,
5636,GO:0016721,0.999999999994685,0.786414743934027,0,4,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
13243,GO:0051908,0.999999999994687,0.91536432728183,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
5634,GO:0016715,0.999999999994694,0.833533263011293,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
17129,GO:0102148,0.999999999994695,0.8018105187199,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
7949,GO:0032545,0.9999999999947,0.784107368586967,0,3,CURI complex,CC,
8779,GO:0034456,0.9999999999947,0.784107368586967,0,3,UTP-C complex,CC,
3415,GO:0007197,0.999999999994709,0.83096176957139,0,2,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
5755,GO:0016907,0.999999999994709,0.83096176957139,0,2,G-protein coupled acetylcholine receptor activity,MF,
17193,GO:0106014,0.999999999994722,0.864982860199583,0,2,regulation of inflammatory response to wounding,BP,
17194,GO:0106015,0.999999999994722,0.864982860199583,0,2,negative regulation of inflammatory response to wounding,BP,
18420,GO:1903464,0.999999999994773,0.850450341118215,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
14569,GO:0070097,0.999999999994776,0.801792051177444,0,2,delta-catenin binding,MF,
10146,GO:0042720,0.999999999994786,0.892849187891636,0,2,mitochondrial inner membrane peptidase complex,CC,
7091,GO:0030885,0.999999999994803,0.82270912394769,0,3,regulation of myeloid dendritic cell activation,BP,
17382,GO:1900107,0.999999999994854,0.809086596226044,0,2,regulation of nodal signaling pathway,BP,
17409,GO:1900145,0.999999999994854,0.809086596226044,0,2,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
17424,GO:1900175,0.999999999994854,0.809086596226044,0,2,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
356,GO:0000973,0.999999999994859,0.767196421721195,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
6968,GO:0030622,0.999999999994862,0.763381430365124,0,3,U4atac snRNA binding,MF,
8303,GO:0033133,0.999999999994867,0.684688027582287,0,4,positive regulation of glucokinase activity,BP,
14591,GO:0070137,0.999999999994878,0.647237404949772,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
14593,GO:0070139,0.999999999994878,0.647237404949772,0,4,SUMO-specific endopeptidase activity,MF,
10322,GO:0043111,0.999999999994886,0.844055012630897,0,2,replication fork arrest,BP,
9710,GO:0038114,0.999999999994887,0.653594697618919,0,4,interleukin-21-mediated signaling pathway,BP,
16847,GO:0098756,0.999999999994887,0.653594697618919,0,4,response to interleukin-21,BP,
16848,GO:0098757,0.999999999994887,0.653594697618919,0,4,cellular response to interleukin-21,BP,
19825,GO:2000286,0.999999999994924,0.773933772634424,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
2485,GO:0005726,0.999999999994933,0.658080704075268,0,4,perichromatin fibrils,CC,
11418,GO:0045829,0.999999999994942,0.770896690992955,0,3,negative regulation of isotype switching,BP,
383,GO:0001018,0.999999999994951,0.854630494002495,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
4645,GO:0010767,0.999999999994956,0.720446431119263,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
7103,GO:0030899,0.999999999994962,0.895326025116751,0,2,calcium-dependent ATPase activity,MF,
8098,GO:0032783,0.999999999994975,0.645549945760561,0,4,ELL-EAF complex,CC,
14754,GO:0070427,0.999999999994996,0.780728332582288,0,3,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
13417,GO:0052811,0.99999999999501,0.658488892503462,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
6142,GO:0019417,0.999999999995039,0.825518787793885,0,2,sulfur oxidation,BP,
18668,GO:1903998,0.99999999999504,0.74353500140756,0,3,regulation of eating behavior,BP,
15400,GO:0071651,0.999999999995047,0.644310967564264,0,4,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
2575,GO:0005862,0.999999999995054,0.733228112986502,0,4,muscle thin filament tropomyosin,CC,
13590,GO:0060057,0.999999999995062,0.771745350865162,0,3,apoptotic process involved in mammary gland involution,BP,
13591,GO:0060058,0.999999999995062,0.771745350865162,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
17965,GO:1902339,0.999999999995062,0.771745350865162,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
18437,GO:1903519,0.999999999995062,0.771745350865162,0,3,regulation of mammary gland involution,BP,
18438,GO:1903521,0.999999999995062,0.771745350865162,0,3,positive regulation of mammary gland involution,BP,
18967,GO:1904747,0.999999999995062,0.771745350865162,0,3,positive regulation of apoptotic process involved in development,BP,
8444,GO:0033564,0.999999999995069,0.79814001203741,0,2,anterior/posterior axon guidance,BP,
1512,GO:0003873,0.999999999995069,0.734868566517799,0,3,6-phosphofructo-2-kinase activity,MF,
14774,GO:0070471,0.999999999995076,0.743866137056444,0,3,uterine smooth muscle contraction,BP,
14775,GO:0070472,0.999999999995076,0.743866137056444,0,3,regulation of uterine smooth muscle contraction,BP,
14776,GO:0070474,0.999999999995076,0.743866137056444,0,3,positive regulation of uterine smooth muscle contraction,BP,
10185,GO:0042776,0.999999999995091,0.800606204719998,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
8426,GO:0033504,0.999999999995095,0.709704950029124,0,3,floor plate development,BP,
16667,GO:0097543,0.9999999999951,0.822264352035103,0,2,ciliary inversin compartment,CC,
153,GO:0000308,0.999999999995104,0.812424431627881,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
5367,GO:0016160,0.999999999995106,0.824008146919702,0,2,amylase activity,MF,
5049,GO:0015234,0.999999999995109,0.852297177830591,0,2,thiamine transmembrane transporter activity,MF,
15539,GO:0071934,0.999999999995109,0.852297177830591,0,2,thiamine transmembrane transport,BP,
17354,GO:1900041,0.99999999999513,0.771925833401139,0,3,negative regulation of interleukin-2 secretion,BP,
18951,GO:1904715,0.999999999995131,0.792880837428679,0,3,negative regulation of chaperone-mediated autophagy,BP,
14209,GO:0061140,0.99999999999514,0.77987074407375,0,3,lung secretory cell differentiation,BP,
18895,GO:1904580,0.999999999995146,0.858569695777322,0,2,regulation of intracellular mRNA localization,BP,
18896,GO:1904582,0.999999999995146,0.858569695777322,0,2,positive regulation of intracellular mRNA localization,BP,
14838,GO:0070576,0.999999999995151,0.845557876538827,0,2,vitamin D 24-hydroxylase activity,MF,
11905,GO:0046933,0.999999999995151,0.837430055930339,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
15076,GO:0071042,0.999999999995157,0.749339691287386,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
15081,GO:0071047,0.999999999995157,0.749339691287386,0,4,polyadenylation-dependent mRNA catabolic process,BP,
12516,GO:0050659,0.999999999995186,0.801507485999677,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
7905,GO:0032474,0.999999999995204,0.814667252636314,0,2,otolith morphogenesis,BP,
11917,GO:0046952,0.999999999995215,0.77268385193217,0,3,ketone body catabolic process,BP,
15300,GO:0071484,0.999999999995232,0.81781872777554,0,2,cellular response to light intensity,BP,
11433,GO:0045852,0.999999999995256,0.780978479566526,0,3,pH elevation,BP,
13019,GO:0051454,0.999999999995256,0.780978479566526,0,3,intracellular pH elevation,BP,
15590,GO:0072061,0.999999999995266,0.852629476974839,0,2,inner medullary collecting duct development,BP,
16915,GO:0098881,0.999999999995276,0.766290995403158,0,3,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
16958,GO:0098967,0.999999999995276,0.766290995403158,0,3,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
5402,GO:0016240,0.999999999995284,0.699002594142507,0,4,autophagosome membrane docking,BP,
2165,GO:0005000,0.999999999995306,0.825192386687345,0,2,vasopressin receptor activity,MF,
3391,GO:0007168,0.999999999995313,0.846396407137593,0,2,receptor guanylyl cyclase signaling pathway,BP,
17964,GO:1902338,0.999999999995327,0.748558128839493,0,3,negative regulation of apoptotic process involved in morphogenesis,BP,
18966,GO:1904746,0.999999999995327,0.748558128839493,0,3,negative regulation of apoptotic process involved in development,BP,
6873,GO:0030350,0.999999999995343,0.808369151672107,0,2,iron-responsive element binding,MF,
6800,GO:0030241,0.999999999995346,0.660337529235967,0,2,skeletal muscle myosin thick filament assembly,BP,
9396,GO:0035933,0.999999999995349,0.772797029188402,0,3,glucocorticoid secretion,BP,
20148,GO:2000849,0.999999999995349,0.772797029188402,0,3,regulation of glucocorticoid secretion,BP,
20298,GO:2001286,0.999999999995353,0.674940191097907,0,4,regulation of caveolin-mediated endocytosis,BP,
11547,GO:0046078,0.999999999995355,0.764193068620491,0,4,dUMP metabolic process,BP,
678,GO:0001888,0.99999999999536,0.817766762934169,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
8533,GO:0033829,0.999999999995375,0.807827895738701,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
351,GO:0000964,0.999999999995378,0.724298159352949,0,4,mitochondrial RNA 5'-end processing,BP,
19072,GO:1904954,0.999999999995379,0.856919177686005,0,2,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
19757,GO:2000152,0.999999999995381,0.76301076788143,0,4,regulation of ubiquitin-specific protease activity,BP,
456,GO:0001300,0.999999999995386,0.839166369379061,0,2,chronological cell aging,BP,
15629,GO:0072125,0.999999999995389,0.776668170735486,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16176,GO:0090194,0.999999999995389,0.776668170735486,0,3,negative regulation of glomerulus development,BP,
16501,GO:0097196,0.999999999995401,0.857499086003165,0,2,Shu complex,CC,
3176,GO:0006789,0.999999999995413,0.858662940632337,0,2,bilirubin conjugation,BP,
13691,GO:0060235,0.999999999995416,0.695966714414507,0,3,lens induction in camera-type eye,BP,
6257,GO:0019841,0.999999999995421,0.767347698474799,0,4,retinol binding,MF,
20159,GO:2000969,0.999999999995426,0.755583466605677,0,3,positive regulation of AMPA receptor activity,BP,
8463,GO:0033600,0.99999999999543,0.6535277215214,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
1639,GO:0004082,0.999999999995431,0.872650675156941,0,2,bisphosphoglycerate mutase activity,MF,
1925,GO:0004619,0.999999999995431,0.872650675156941,0,2,phosphoglycerate mutase activity,MF,
11729,GO:0046538,0.999999999995431,0.872650675156941,0,2,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
14085,GO:0060907,0.999999999995431,0.766908578415872,0,3,positive regulation of macrophage cytokine production,BP,
1881,GO:0004560,0.999999999995463,0.865234153295493,0,2,alpha-L-fucosidase activity,MF,
5277,GO:0015928,0.999999999995463,0.865234153295493,0,2,fucosidase activity,MF,
13663,GO:0060179,0.999999999995469,0.772657749031315,0,3,male mating behavior,BP,
5743,GO:0016890,0.999999999995504,0.846383972016489,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
9230,GO:0035616,0.999999999995527,0.735867181882247,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
18137,GO:1902856,0.999999999995534,0.814434896345721,0,2,negative regulation of non-motile cilium assembly,BP,
8702,GO:0034338,0.999999999995536,0.747605901934066,0,3,short-chain carboxylesterase activity,MF,
1728,GO:0004322,0.999999999995537,0.741828674983076,0,3,ferroxidase activity,MF,
5639,GO:0016724,0.999999999995537,0.741828674983076,0,3,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
14662,GO:0070259,0.999999999995543,0.836370930691176,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
2035,GO:0004775,0.999999999995544,0.873363828572878,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
7685,GO:0032133,0.99999999999555,0.749819130821097,0,4,chromosome passenger complex,CC,
18960,GO:1904732,0.99999999999556,0.838383975576909,0,2,regulation of electron transfer activity,BP,
19076,GO:1904959,0.99999999999556,0.838383975576909,0,2,regulation of cytochrome-c oxidase activity,BP,
16700,GO:0097647,0.999999999995589,0.831539981305382,0,3,amylin receptor signaling pathway,BP,
14220,GO:0061156,0.999999999995607,0.748394535631702,0,3,pulmonary artery morphogenesis,BP,
9661,GO:0038007,0.999999999995625,0.742441582019205,0,3,netrin-activated signaling pathway,BP,
9965,GO:0042351,0.999999999995629,0.881497022780985,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
14092,GO:0060920,0.999999999995641,0.715670103858682,0,3,cardiac pacemaker cell differentiation,BP,
14096,GO:0060926,0.999999999995641,0.715670103858682,0,3,cardiac pacemaker cell development,BP,
6875,GO:0030366,0.999999999995653,0.880969000677427,0,2,molybdopterin synthase activity,MF,
1691,GO:0004165,0.999999999995654,0.766364181549415,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
129,GO:0000268,0.99999999999566,0.712407936613277,0,4,peroxisome targeting sequence binding,MF,
6143,GO:0019418,0.99999999999567,0.783202787510389,0,4,sulfide oxidation,BP,
14642,GO:0070221,0.99999999999567,0.783202787510389,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
63,GO:0000126,0.999999999995701,0.78360622410356,0,2,transcription factor TFIIIB complex,CC,
385,GO:0001026,0.999999999995701,0.78360622410356,0,2,TFIIIB-type transcription factor activity,MF,
2801,GO:0006258,0.999999999995702,0.875002742693381,0,2,UDP-glucose catabolic process,BP,
7110,GO:0030906,0.999999999995705,0.725659862340134,0,4,retromer, cargo-selective complex,CC,
13671,GO:0060197,0.999999999995705,0.840673747262473,0,2,cloacal septation,BP,
16555,GO:0097325,0.999999999995707,0.820496745683275,0,2,melanocyte proliferation,BP,
248,GO:0000706,0.999999999995724,0.827392997477452,0,2,meiotic DNA double-strand break processing,BP,
19663,GO:1990918,0.999999999995724,0.827392997477452,0,2,double-strand break repair involved in meiotic recombination,BP,
7796,GO:0032345,0.999999999995746,0.767647508101075,0,3,negative regulation of aldosterone metabolic process,BP,
7799,GO:0032348,0.999999999995746,0.767647508101075,0,3,negative regulation of aldosterone biosynthetic process,BP,
19719,GO:2000065,0.999999999995746,0.767647508101075,0,3,negative regulation of cortisol biosynthetic process,BP,
14767,GO:0070458,0.999999999995746,0.804987691595442,0,3,cellular detoxification of nitrogen compound,BP,
11877,GO:0046884,0.999999999995747,0.67058597018715,0,4,follicle-stimulating hormone secretion,BP,
15638,GO:0072134,0.999999999995757,0.790813707953339,0,2,nephrogenic mesenchyme morphogenesis,BP,
10861,GO:0044375,0.999999999995759,0.885709472492119,0,2,regulation of peroxisome size,BP,
16042,GO:0086070,0.999999999995774,0.707474630508506,0,3,SA node cell to atrial cardiac muscle cell communication,BP,
371,GO:0000992,0.999999999995779,0.817608222676459,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0001002,0.999999999995779,0.817608222676459,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
376,GO:0001003,0.999999999995779,0.817608222676459,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
6891,GO:0030423,0.999999999995791,0.684524454668505,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
10518,GO:0043426,0.99999999999583,0.679665357395771,0,4,MRF binding,MF,
15720,GO:0072278,0.999999999995885,0.847718442051718,0,2,metanephric comma-shaped body morphogenesis,BP,
19534,GO:1990441,0.999999999995902,0.725132426884853,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
9513,GO:0036166,0.999999999995913,0.756009956302192,0,3,phenotypic switching,BP,
17453,GO:1900239,0.999999999995913,0.756009956302192,0,3,regulation of phenotypic switching,BP,
10696,GO:0043974,0.999999999995931,0.738240221340272,0,3,histone H3-K27 acetylation,BP,
17740,GO:1901674,0.999999999995931,0.738240221340272,0,3,regulation of histone H3-K27 acetylation,BP,
14073,GO:0060857,0.999999999995937,0.927843668107245,0,1,establishment of glial blood-brain barrier,BP,
14510,GO:0065001,0.99999999999594,0.79265792484432,0,2,specification of axis polarity,BP,
4476,GO:0010481,0.999999999995969,0.779139218198208,0,3,epidermal cell division,BP,
4477,GO:0010482,0.999999999995969,0.779139218198208,0,3,regulation of epidermal cell division,BP,
6000,GO:0019034,0.999999999995972,0.808855164905877,0,2,viral replication complex,CC,
14271,GO:0061341,0.999999999995975,0.796740132440373,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
14273,GO:0061346,0.999999999995975,0.796740132440373,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
17884,GO:1902162,0.999999999995976,0.885157219352232,0,2,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
17885,GO:1902164,0.999999999995976,0.885157219352232,0,2,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
15518,GO:0071896,0.999999999996017,0.616410983889542,0,4,protein localization to adherens junction,BP,
2790,GO:0006226,0.99999999999603,0.814858751201167,0,3,dUMP biosynthetic process,BP,
8374,GO:0033269,0.999999999996037,0.839303845940673,0,2,internode region of axon,CC,
919,GO:0002314,0.999999999996049,0.86968352852324,0,2,germinal center B cell differentiation,BP,
19031,GO:1904875,0.999999999996086,0.855185916994331,0,2,regulation of DNA ligase activity,BP,
20236,GO:2001181,0.999999999996088,0.828552209941453,0,3,positive regulation of interleukin-10 secretion,BP,
10209,GO:0042824,0.999999999996093,0.706868654162794,0,4,MHC class I peptide loading complex,CC,
16293,GO:0090386,0.999999999996101,0.793675004058723,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
16294,GO:0090387,0.999999999996101,0.793675004058723,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
19830,GO:2000298,0.999999999996105,0.845850570288316,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
18055,GO:1902603,0.999999999996105,0.792876517094429,0,3,carnitine transmembrane transport,BP,
19870,GO:2000348,0.999999999996119,0.68605540301084,0,4,regulation of CD40 signaling pathway,BP,
2654,GO:0005997,0.99999999999612,0.757911730403186,0,4,xylulose metabolic process,BP,
16185,GO:0090204,0.999999999996125,0.787702082417599,0,3,protein localization to nuclear pore,BP,
14145,GO:0061015,0.999999999996172,0.885743321740069,0,2,snRNA import into nucleus,BP,
4830,GO:0014034,0.999999999996184,0.81628389469885,0,2,neural crest cell fate commitment,BP,
17920,GO:1902232,0.999999999996194,0.863162211333595,0,2,regulation of positive thymic T cell selection,BP,
7463,GO:0031620,0.9999999999962,0.725787809714236,0,4,regulation of fever generation,BP,
7464,GO:0031622,0.9999999999962,0.725787809714236,0,4,positive regulation of fever generation,BP,
2152,GO:0004972,0.999999999996224,0.80784861574782,0,2,NMDA glutamate receptor activity,MF,
12472,GO:0050353,0.999999999996237,0.920019250182956,0,1,trimethyllysine dioxygenase activity,MF,
9999,GO:0042414,0.999999999996256,0.816722217789909,0,2,epinephrine metabolic process,BP,
16318,GO:0090500,0.999999999996264,0.858315074693651,0,2,endocardial cushion to mesenchymal transition,BP,
11117,GO:0045142,0.999999999996276,0.814831334254833,0,2,triplex DNA binding,MF,
15782,GO:0072385,0.999999999996277,0.628299036277627,0,4,minus-end-directed organelle transport along microtubule,BP,
10980,GO:0044771,0.99999999999628,0.842615110728083,0,2,meiotic cell cycle phase transition,BP,
17834,GO:1901993,0.99999999999628,0.842615110728083,0,2,regulation of meiotic cell cycle phase transition,BP,
17835,GO:1901994,0.99999999999628,0.842615110728083,0,2,negative regulation of meiotic cell cycle phase transition,BP,
1265,GO:0003025,0.99999999999628,0.801442788863065,0,2,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
12707,GO:0050925,0.999999999996287,0.785095121809707,0,2,negative regulation of negative chemotaxis,BP,
219,GO:0000455,0.999999999996316,0.86955812399323,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
19971,GO:2000551,0.99999999999632,0.730545605997606,0,4,regulation of T-helper 2 cell cytokine production,BP,
11113,GO:0045134,0.999999999996326,0.718796389909442,0,4,uridine-diphosphatase activity,MF,
14121,GO:0060979,0.999999999996345,0.682010087424437,0,3,vasculogenesis involved in coronary vascular morphogenesis,BP,
16531,GO:0097252,0.999999999996364,0.776976031132336,0,3,oligodendrocyte apoptotic process,BP,
10327,GO:0043117,0.999999999996401,0.768449485562736,0,3,positive regulation of vascular permeability,BP,
11938,GO:0046984,0.999999999996409,0.722986237424802,0,4,regulation of hemoglobin biosynthetic process,BP,
16766,GO:0098559,0.999999999996414,0.788687868355918,0,3,cytoplasmic side of early endosome membrane,CC,
11336,GO:0045659,0.99999999999642,0.816610683239569,0,2,negative regulation of neutrophil differentiation,BP,
14412,GO:0061689,0.999999999996421,0.757957799345569,0,3,tricellular tight junction,CC,
9736,GO:0038190,0.999999999996432,0.842827245864708,0,2,VEGF-activated neuropilin signaling pathway,BP,
17962,GO:1902336,0.999999999996432,0.842827245864708,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19772,GO:2000182,0.999999999996443,0.82388797872994,0,2,regulation of progesterone biosynthetic process,BP,
173,GO:0000379,0.999999999996447,0.804569027758674,0,3,tRNA-type intron splice site recognition and cleavage,BP,
5874,GO:0017187,0.999999999996462,0.747167072781673,0,4,peptidyl-glutamic acid carboxylation,BP,
5935,GO:0018214,0.999999999996462,0.747167072781673,0,4,protein carboxylation,BP,
845,GO:0002159,0.999999999996473,0.662161438426271,0,4,desmosome assembly,BP,
11893,GO:0046912,0.999999999996478,0.754862850521829,0,3,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12858,GO:0051177,0.999999999996491,0.727202875120693,0,4,meiotic sister chromatid cohesion,BP,
2414,GO:0005588,0.999999999996492,0.687781774496246,0,3,collagen type V trimer,CC,
7116,GO:0030916,0.999999999996507,0.719665987865148,0,3,otic vesicle formation,BP,
15364,GO:0071600,0.999999999996507,0.719665987865148,0,3,otic vesicle morphogenesis,BP,
2680,GO:0006041,0.999999999996544,0.73051570610246,0,4,glucosamine metabolic process,BP,
18120,GO:1902804,0.999999999996549,0.773309726032097,0,3,negative regulation of synaptic vesicle transport,BP,
19833,GO:2000301,0.999999999996549,0.773309726032097,0,3,negative regulation of synaptic vesicle exocytosis,BP,
1502,GO:0003854,0.999999999996555,0.802431284347654,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
10984,GO:0044778,0.999999999996566,0.859445568151032,0,2,meiotic DNA integrity checkpoint,BP,
15011,GO:0070939,0.999999999996585,0.744834602538775,0,3,Dsl1/NZR complex,CC,
18118,GO:1902775,0.999999999996609,0.738559542893216,0,3,mitochondrial large ribosomal subunit assembly,BP,
3771,GO:0008321,0.999999999996626,0.795259441788817,0,2,Ral guanyl-nucleotide exchange factor activity,MF,
16475,GO:0097155,0.999999999996627,0.765226281636144,0,2,fasciculation of sensory neuron axon,BP,
486,GO:0001537,0.999999999996645,0.828307846816697,0,2,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
1348,GO:0003213,0.999999999996675,0.775942523192189,0,2,cardiac right atrium morphogenesis,BP,
8939,GO:0034970,0.999999999996675,0.847663675511968,0,2,histone H3-R2 methylation,BP,
125,GO:0000255,0.99999999999668,0.728651903338797,0,3,allantoin metabolic process,BP,
11542,GO:0046070,0.999999999996685,0.769238751475971,0,4,dGTP metabolic process,BP,
17012,GO:0099122,0.999999999996686,0.737380075698172,0,3,RNA polymerase II C-terminal domain binding,MF,
15726,GO:0072289,0.999999999996706,0.821771003497151,0,2,metanephric nephron tubule formation,BP,
14026,GO:0060750,0.999999999996722,0.654891816710096,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
7713,GO:0032202,0.999999999996737,0.732099120087911,0,4,telomere assembly,BP,
19480,GO:1990239,0.99999999999675,0.698412485635476,0,4,steroid hormone binding,MF,
4874,GO:0014735,0.999999999996771,0.822332672756453,0,2,regulation of muscle atrophy,BP,
4875,GO:0014736,0.999999999996771,0.822332672756453,0,2,negative regulation of muscle atrophy,BP,
9574,GO:0036374,0.999999999996773,0.78994521485422,0,3,glutathione hydrolase activity,MF,
17176,GO:0102953,0.999999999996773,0.78994521485422,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
17185,GO:0103068,0.999999999996773,0.78994521485422,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
17766,GO:1901748,0.999999999996773,0.78994521485422,0,3,leukotriene D4 metabolic process,BP,
17767,GO:1901750,0.999999999996773,0.78994521485422,0,3,leukotriene D4 biosynthetic process,BP,
146,GO:0000298,0.999999999996793,0.729819146881876,0,4,endopolyphosphatase activity,MF,
3866,GO:0008486,0.999999999996793,0.729819146881876,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
5293,GO:0015961,0.999999999996793,0.729819146881876,0,4,diadenosine polyphosphate catabolic process,BP,
8761,GO:0034431,0.999999999996793,0.729819146881876,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
8762,GO:0034432,0.999999999996793,0.729819146881876,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
13436,GO:0052840,0.999999999996793,0.729819146881876,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
13437,GO:0052841,0.999999999996793,0.729819146881876,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
13438,GO:0052842,0.999999999996793,0.729819146881876,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
13439,GO:0052843,0.999999999996793,0.729819146881876,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
13440,GO:0052844,0.999999999996793,0.729819146881876,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
13441,GO:0052845,0.999999999996793,0.729819146881876,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
13442,GO:0052846,0.999999999996793,0.729819146881876,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
13443,GO:0052847,0.999999999996793,0.729819146881876,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
13444,GO:0052848,0.999999999996793,0.729819146881876,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
15327,GO:0071543,0.999999999996793,0.729819146881876,0,4,diphosphoinositol polyphosphate metabolic process,BP,
17806,GO:1901906,0.999999999996793,0.729819146881876,0,4,diadenosine pentaphosphate metabolic process,BP,
17807,GO:1901907,0.999999999996793,0.729819146881876,0,4,diadenosine pentaphosphate catabolic process,BP,
17808,GO:1901908,0.999999999996793,0.729819146881876,0,4,diadenosine hexaphosphate metabolic process,BP,
17809,GO:1901909,0.999999999996793,0.729819146881876,0,4,diadenosine hexaphosphate catabolic process,BP,
17810,GO:1901910,0.999999999996793,0.729819146881876,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
17811,GO:1901911,0.999999999996793,0.729819146881876,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19264,GO:1905448,0.999999999996793,0.761680780036521,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
14640,GO:0070212,0.999999999996795,0.664680932365281,0,4,protein poly-ADP-ribosylation,BP,
14439,GO:0061749,0.999999999996853,0.802382197044826,0,2,forked DNA-dependent helicase activity,MF,
14476,GO:0061849,0.999999999996853,0.802382197044826,0,2,telomeric G-quadruplex DNA binding,MF,
8393,GO:0033306,0.999999999996857,0.847611931517067,0,2,phytol metabolic process,BP,
18282,GO:1903173,0.999999999996857,0.847611931517067,0,2,fatty alcohol metabolic process,BP,
14444,GO:0061757,0.999999999996863,0.8607456183117,0,2,leukocyte adhesion to arterial endothelial cell,BP,
19093,GO:1904997,0.999999999996863,0.8607456183117,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
5516,GO:0016479,0.999999999996864,0.758480640562481,0,3,negative regulation of transcription by RNA polymerase I,BP,
11934,GO:0046979,0.999999999996884,0.789201713312457,0,3,TAP2 binding,MF,
1215,GO:0002885,0.999999999996888,0.842642043681424,0,2,positive regulation of hypersensitivity,BP,
16883,GO:0098821,0.999999999996921,0.697173468797122,0,3,BMP receptor activity,MF,
18393,GO:1903416,0.999999999996953,0.787083975978593,0,3,response to glycoside,BP,
9594,GO:0036446,0.999999999996959,0.735046332503937,0,3,myofibroblast differentiation,BP,
18975,GO:1904760,0.999999999996959,0.735046332503937,0,3,regulation of myofibroblast differentiation,BP,
6340,GO:0021514,0.999999999996967,0.622595744091942,0,4,ventral spinal cord interneuron differentiation,BP,
13550,GO:0060011,0.999999999996986,0.774692389065038,0,3,Sertoli cell proliferation,BP,
1680,GO:0004145,0.999999999996992,0.896341286872196,0,2,diamine N-acetyltransferase activity,MF,
6243,GO:0019809,0.999999999996992,0.896341286872196,0,2,spermidine binding,MF,
8181,GO:0032917,0.999999999996992,0.896341286872196,0,2,polyamine acetylation,BP,
8182,GO:0032918,0.999999999996992,0.896341286872196,0,2,spermidine acetylation,BP,
12143,GO:0048245,0.999999999997001,0.738761216016424,0,4,eosinophil chemotaxis,BP,
8053,GO:0032714,0.999999999997004,0.829054674161449,0,2,negative regulation of interleukin-5 production,BP,
1774,GO:0004379,0.999999999997017,0.804391577509315,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
5878,GO:0018008,0.999999999997017,0.804391577509315,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6036,GO:0019107,0.999999999997017,0.804391577509315,0,2,myristoyltransferase activity,MF,
9552,GO:0036313,0.999999999997033,0.847840017996634,0,2,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
9166,GO:0035519,0.999999999997068,0.748286768245769,0,4,protein K29-linked ubiquitination,BP,
19324,GO:1905616,0.999999999997075,0.822891251266978,0,2,regulation of miRNA mediated inhibition of translation,BP,
19325,GO:1905618,0.999999999997075,0.822891251266978,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
8992,GO:0035101,0.99999999999709,0.759930355008641,0,3,FACT complex,CC,
1288,GO:0003097,0.99999999999709,0.726050690185361,0,4,renal water transport,BP,
15670,GO:0072190,0.999999999997097,0.847148576432774,0,2,ureter urothelium development,BP,
15671,GO:0072191,0.999999999997097,0.847148576432774,0,2,ureter smooth muscle development,BP,
15673,GO:0072193,0.999999999997097,0.847148576432774,0,2,ureter smooth muscle cell differentiation,BP,
15675,GO:0072197,0.999999999997097,0.847148576432774,0,2,ureter morphogenesis,BP,
1742,GO:0004342,0.999999999997113,0.865296747340043,0,2,glucosamine-6-phosphate deaminase activity,MF,
2681,GO:0006043,0.999999999997113,0.865296747340043,0,2,glucosamine catabolic process,BP,
8425,GO:0033503,0.99999999999712,0.705564283007642,0,4,HULC complex,CC,
2350,GO:0005415,0.999999999997152,0.859076496840067,0,2,nucleoside:sodium symporter activity,MF,
5239,GO:0015860,0.999999999997152,0.859076496840067,0,2,purine nucleoside transmembrane transport,BP,
236,GO:0000493,0.999999999997205,0.860279878955554,0,2,box H/ACA snoRNP assembly,BP,
1524,GO:0003896,0.999999999997205,0.801603498321524,0,3,DNA primase activity,MF,
12101,GO:0048104,0.999999999997206,0.627445418747832,0,4,establishment of body hair or bristle planar orientation,BP,
12102,GO:0048105,0.999999999997206,0.627445418747832,0,4,establishment of body hair planar orientation,BP,
12415,GO:0048861,0.99999999999722,0.673041422869602,0,4,leukemia inhibitory factor signaling pathway,BP,
11463,GO:0045917,0.999999999997228,0.836594956171419,0,2,positive regulation of complement activation,BP,
19810,GO:2000259,0.999999999997228,0.836594956171419,0,2,positive regulation of protein activation cascade,BP,
10590,GO:0043553,0.999999999997251,0.766611795267691,0,3,negative regulation of phosphatidylinositol 3-kinase activity,BP,
12828,GO:0051133,0.999999999997265,0.813369446808395,0,3,regulation of NK T cell activation,BP,
12829,GO:0051135,0.999999999997265,0.813369446808395,0,3,positive regulation of NK T cell activation,BP,
3845,GO:0008454,0.999999999997271,0.820582525956689,0,2,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
14671,GO:0070274,0.999999999997306,0.874486475492618,0,2,RES complex,CC,
11195,GO:0045298,0.999999999997311,0.701032469037518,0,4,tubulin complex,CC,
3861,GO:0008479,0.999999999997315,0.770855913499928,0,4,queuine tRNA-ribosyltransferase activity,MF,
196,GO:0000414,0.999999999997318,0.632115052721362,0,4,regulation of histone H3-K36 methylation,BP,
11317,GO:0045636,0.99999999999732,0.715128702398503,0,3,positive regulation of melanocyte differentiation,BP,
19026,GO:1904868,0.999999999997334,0.754980251251227,0,2,telomerase catalytic core complex assembly,BP,
19038,GO:1904882,0.999999999997334,0.754980251251227,0,2,regulation of telomerase catalytic core complex assembly,BP,
19039,GO:1904884,0.999999999997334,0.754980251251227,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
12235,GO:0048496,0.999999999997355,0.746310227128225,0,3,maintenance of animal organ identity,BP,
19875,GO:2000354,0.999999999997374,0.742941362997946,0,4,regulation of ovarian follicle development,BP,
16949,GO:0098935,0.999999999997392,0.717018778534617,0,3,dendritic transport,BP,
16951,GO:0098937,0.999999999997392,0.717018778534617,0,3,anterograde dendritic transport,BP,
6835,GO:0030297,0.999999999997393,0.744898548086062,0,3,transmembrane receptor protein tyrosine kinase activator activity,MF,
3208,GO:0006844,0.999999999997408,0.86502988116585,0,2,acyl carnitine transport,BP,
5044,GO:0015227,0.999999999997408,0.86502988116585,0,2,acyl carnitine transmembrane transporter activity,MF,
15567,GO:0072014,0.999999999997431,0.675926562068394,0,4,proximal tubule development,BP,
16020,GO:0086036,0.999999999997442,0.657553516915791,0,4,regulation of cardiac muscle cell membrane potential,BP,
19268,GO:1905457,0.999999999997444,0.771298478330872,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20161,GO:2000974,0.999999999997444,0.771298478330872,0,3,negative regulation of pro-B cell differentiation,BP,
16957,GO:0098960,0.999999999997454,0.69999604443672,0,4,postsynaptic neurotransmitter receptor activity,MF,
17052,GO:0099529,0.999999999997454,0.69999604443672,0,4,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,
18789,GO:1904315,0.999999999997454,0.69999604443672,0,4,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
16057,GO:0086098,0.999999999997466,0.834666026089646,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
3437,GO:0007227,0.999999999997484,0.738063977966565,0,3,signal transduction downstream of smoothened,BP,
8958,GO:0035021,0.999999999997486,0.652501507123111,0,4,negative regulation of Rac protein signal transduction,BP,
12040,GO:0047757,0.999999999997491,0.78841163619746,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
13048,GO:0051538,0.999999999997495,0.792874791986928,0,3,3 iron, 4 sulfur cluster binding,MF,
4478,GO:0010484,0.999999999997506,0.647769403578613,0,4,H3 histone acetyltransferase activity,MF,
6846,GO:0030314,0.999999999997539,0.820626455104958,0,2,junctional membrane complex,CC,
10470,GO:0043335,0.999999999997541,0.855865645371007,0,2,protein unfolding,BP,
6796,GO:0030237,0.999999999997543,0.833285459608049,0,2,female sex determination,BP,
4948,GO:0014916,0.999999999997561,0.711103833879072,0,3,regulation of lung blood pressure,BP,
19241,GO:1905394,0.999999999997565,0.761457338927668,0,3,retromer complex binding,MF,
4315,GO:0009794,0.999999999997615,0.717947616996879,0,4,regulation of mitotic cell cycle, embryonic,BP,
11248,GO:0045448,0.999999999997615,0.717947616996879,0,4,mitotic cell cycle, embryonic,BP,
5984,GO:0018879,0.999999999997644,0.794612927505605,0,3,biphenyl metabolic process,BP,
16218,GO:0090258,0.99999999999765,0.822546361138586,0,2,negative regulation of mitochondrial fission,BP,
12985,GO:0051388,0.999999999997654,0.678876530270635,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
9681,GO:0038049,0.999999999997658,0.761831297457063,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
5555,GO:0016561,0.999999999997661,0.849972617665263,0,2,protein import into peroxisome matrix, translocation,BP,
3876,GO:0008506,0.999999999997667,0.833498985621755,0,2,sucrose:proton symporter activity,MF,
3884,GO:0008515,0.999999999997667,0.833498985621755,0,2,sucrose transmembrane transporter activity,MF,
4286,GO:0009669,0.999999999997667,0.833498985621755,0,2,sucrose:cation symporter activity,MF,
5006,GO:0015154,0.999999999997667,0.833498985621755,0,2,disaccharide transmembrane transporter activity,MF,
5007,GO:0015157,0.999999999997667,0.833498985621755,0,2,oligosaccharide transmembrane transporter activity,MF,
5189,GO:0015766,0.999999999997667,0.833498985621755,0,2,disaccharide transport,BP,
5190,GO:0015770,0.999999999997667,0.833498985621755,0,2,sucrose transport,BP,
5191,GO:0015772,0.999999999997667,0.833498985621755,0,2,oligosaccharide transport,BP,
13069,GO:0051572,0.999999999997682,0.731463632603101,0,3,negative regulation of histone H3-K4 methylation,BP,
2147,GO:0004965,0.99999999999769,0.814510013984372,0,2,G-protein coupled GABA receptor activity,MF,
13862,GO:0060478,0.999999999997724,0.877421348683536,0,2,acrosomal vesicle exocytosis,BP,
19881,GO:2000367,0.999999999997724,0.877421348683536,0,2,regulation of acrosomal vesicle exocytosis,BP,
19882,GO:2000368,0.999999999997724,0.877421348683536,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
8203,GO:0032954,0.999999999997731,0.811449378964998,0,2,regulation of cytokinetic process,BP,
18408,GO:1903436,0.999999999997731,0.811449378964998,0,2,regulation of mitotic cytokinetic process,BP,
18409,GO:1903438,0.999999999997731,0.811449378964998,0,2,positive regulation of mitotic cytokinetic process,BP,
18424,GO:1903490,0.999999999997731,0.811449378964998,0,2,positive regulation of mitotic cytokinesis,BP,
3404,GO:0007185,0.999999999997752,0.601349744309166,0,4,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
14067,GO:0060846,0.999999999997788,0.783393903374903,0,3,blood vessel endothelial cell fate commitment,BP,
14068,GO:0060847,0.999999999997788,0.783393903374903,0,3,endothelial cell fate specification,BP,
16442,GO:0097101,0.999999999997788,0.783393903374903,0,3,blood vessel endothelial cell fate specification,BP,
14000,GO:0060715,0.999999999997792,0.760862077760325,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
2740,GO:0006121,0.999999999997843,0.758742649706762,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
17657,GO:1901474,0.999999999997843,0.722918157426587,0,4,azole transmembrane transporter activity,MF,
14960,GO:0070852,0.999999999997865,0.714542145894556,0,3,cell body fiber,CC,
1795,GO:0004427,0.999999999997866,0.827920656681931,0,3,inorganic diphosphatase activity,MF,
11673,GO:0046449,0.999999999997891,0.650002445675697,0,4,creatinine metabolic process,BP,
11331,GO:0045654,0.999999999997926,0.868178950885777,0,2,positive regulation of megakaryocyte differentiation,BP,
2303,GO:0005287,0.999999999997926,0.816074321930578,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2304,GO:0005289,0.999999999997926,0.816074321930578,0,2,high-affinity arginine transmembrane transporter activity,MF,
2306,GO:0005292,0.999999999997926,0.816074321930578,0,2,high-affinity lysine transmembrane transporter activity,MF,
925,GO:0002322,0.999999999997929,0.807345740267501,0,2,B cell proliferation involved in immune response,BP,
11995,GO:0047374,0.999999999997933,0.855629971901259,0,2,methylumbelliferyl-acetate deacetylase activity,MF,
15555,GO:0071987,0.999999999997968,0.672136225109023,0,4,WD40-repeat domain binding,MF,
19550,GO:1990511,0.999999999997976,0.68612713819135,0,4,piRNA biosynthetic process,BP,
9533,GO:0036265,0.999999999997994,0.748310141370425,0,4,RNA (guanine-N7)-methylation,BP,
7947,GO:0032542,0.999999999997999,0.842286609840186,0,2,sulfiredoxin activity,MF,
4095,GO:0009149,0.999999999998006,0.882601144350732,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4151,GO:0009213,0.999999999998006,0.882601144350732,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
7957,GO:0032556,0.999999999998006,0.882601144350732,0,2,pyrimidine deoxyribonucleotide binding,MF,
15999,GO:0086007,0.999999999998073,0.819290234210494,0,2,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17783,GO:1901843,0.999999999998073,0.819290234210494,0,2,positive regulation of high voltage-gated calcium channel activity,BP,
874,GO:0002225,0.999999999998088,0.877053896491925,0,2,positive regulation of antimicrobial peptide production,BP,
1152,GO:0002760,0.999999999998088,0.877053896491925,0,2,positive regulation of antimicrobial humoral response,BP,
1171,GO:0002803,0.999999999998088,0.877053896491925,0,2,positive regulation of antibacterial peptide production,BP,
16876,GO:0098808,0.999999999998098,0.857268900314845,0,2,mRNA cap binding,MF,
19428,GO:1990034,0.999999999998137,0.759871149419752,0,3,calcium ion export across plasma membrane,BP,
16962,GO:0098971,0.9999999999982,0.808553292054896,0,2,anterograde dendritic transport of neurotransmitter receptor complex,BP,
7111,GO:0030910,0.999999999998201,0.811188295568664,0,2,olfactory placode formation,BP,
15429,GO:0071698,0.999999999998201,0.811188295568664,0,2,olfactory placode development,BP,
15430,GO:0071699,0.999999999998201,0.811188295568664,0,2,olfactory placode morphogenesis,BP,
12141,GO:0048243,0.999999999998221,0.687971322181342,0,4,norepinephrine secretion,BP,
13086,GO:0051595,0.999999999998226,0.790519167184053,0,3,response to methylglyoxal,BP,
18022,GO:1902523,0.999999999998261,0.81802140476541,0,2,positive regulation of protein K63-linked ubiquitination,BP,
13861,GO:0060474,0.999999999998273,0.874227319403335,0,2,positive regulation of flagellated sperm motility involved in capacitation,BP,
17864,GO:1902093,0.999999999998273,0.874227319403335,0,2,positive regulation of flagellated sperm motility,BP,
14973,GO:0070877,0.999999999998278,0.828430513770911,0,2,microprocessor complex,CC,
18258,GO:1903095,0.999999999998278,0.828430513770911,0,2,ribonuclease III complex,CC,
20290,GO:2001270,0.999999999998293,0.711155501267345,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
6087,GO:0019249,0.999999999998303,0.774485510775662,0,3,lactate biosynthetic process,BP,
10750,GO:0044130,0.999999999998305,0.754361010632634,0,4,negative regulation of growth of symbiont in host,BP,
10753,GO:0044146,0.999999999998305,0.754361010632634,0,4,negative regulation of growth of symbiont involved in interaction with host,BP,
8302,GO:0033132,0.999999999998312,0.858274812983227,0,2,negative regulation of glucokinase activity,BP,
18339,GO:1903300,0.999999999998312,0.858274812983227,0,2,negative regulation of hexokinase activity,BP,
15028,GO:0070966,0.999999999998314,0.738675061904751,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
18459,GO:1903547,0.999999999998325,0.893196279497159,0,2,regulation of growth hormone activity,BP,
4693,GO:0010847,0.999999999998328,0.661110490195455,0,4,regulation of chromatin assembly,BP,
14230,GO:0061187,0.99999999999833,0.795347993940471,0,2,regulation of chromatin silencing at rDNA,BP,
14231,GO:0061188,0.99999999999833,0.795347993940471,0,2,negative regulation of chromatin silencing at rDNA,BP,
6812,GO:0030263,0.999999999998336,0.675572366250796,0,4,apoptotic chromosome condensation,BP,
10692,GO:0043969,0.999999999998338,0.873778586143015,0,1,histone H2B acetylation,BP,
14494,GO:0061920,0.999999999998338,0.873778586143015,0,1,protein propionyltransferase activity,MF,
14495,GO:0061921,0.999999999998338,0.873778586143015,0,1,peptidyl-lysine propionylation,BP,
17294,GO:0140064,0.999999999998338,0.873778586143015,0,1,peptide crotonyltransferase activity,MF,
17295,GO:0140065,0.999999999998338,0.873778586143015,0,1,peptide butyryltransferase activity,MF,
17297,GO:0140067,0.999999999998338,0.873778586143015,0,1,peptidyl-lysine butyrylation,BP,
17298,GO:0140068,0.999999999998338,0.873778586143015,0,1,histone crotonyltransferase activity,MF,
17299,GO:0140069,0.999999999998338,0.873778586143015,0,1,histone butyryltransferase activity,MF,
2456,GO:0005668,0.999999999998342,0.874454216528623,0,2,RNA polymerase transcription factor SL1 complex,CC,
14972,GO:0070876,0.999999999998345,0.700044771982661,0,4,SOSS complex,CC,
4165,GO:0009227,0.999999999998378,0.804262178177507,0,3,nucleotide-sugar catabolic process,BP,
13207,GO:0051835,0.999999999998384,0.770902431441678,0,3,positive regulation of synapse structural plasticity,BP,
19110,GO:1905041,0.999999999998388,0.817845435084484,0,2,regulation of epithelium regeneration,BP,
19510,GO:1990399,0.999999999998388,0.817845435084484,0,2,epithelium regeneration,BP,
16076,GO:0090034,0.999999999998391,0.847592282932743,0,2,regulation of chaperone-mediated protein complex assembly,BP,
16077,GO:0090035,0.999999999998391,0.847592282932743,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
9161,GO:0035514,0.999999999998392,0.802747703255971,0,3,DNA demethylase activity,MF,
20202,GO:2001070,0.9999999999984,0.826796507689037,0,2,starch binding,MF,
14562,GO:0070086,0.999999999998401,0.723065732609785,0,4,ubiquitin-dependent endocytosis,BP,
5413,GO:0016259,0.999999999998404,0.713483044004038,0,4,selenocysteine metabolic process,BP,
7555,GO:0031871,0.999999999998439,0.760425780592131,0,3,proteinase activated receptor binding,MF,
8973,GO:0035061,0.999999999998461,0.649181630216242,0,4,interchromatin granule,CC,
13034,GO:0051490,0.999999999998482,0.792506656892037,0,3,negative regulation of filopodium assembly,BP,
13135,GO:0051697,0.999999999998494,0.745194524755002,0,4,protein delipidation,BP,
244,GO:0000700,0.999999999998505,0.744356650490073,0,4,mismatch base pair DNA N-glycosylase activity,MF,
9382,GO:0035912,0.999999999998508,0.696888365616741,0,4,dorsal aorta morphogenesis,BP,
813,GO:0002085,0.99999999999851,0.74796612632417,0,3,inhibition of neuroepithelial cell differentiation,BP,
11298,GO:0045608,0.99999999999851,0.74796612632417,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
9448,GO:0036034,0.999999999998564,0.855003620212907,0,2,mediator complex assembly,BP,
20232,GO:2001176,0.999999999998564,0.855003620212907,0,2,regulation of mediator complex assembly,BP,
20233,GO:2001178,0.999999999998564,0.855003620212907,0,2,positive regulation of mediator complex assembly,BP,
7775,GO:0032299,0.99999999999859,0.816391229196546,0,3,ribonuclease H2 complex,CC,
6997,GO:0030678,0.999999999998597,0.805159022886684,0,3,mitochondrial ribonuclease P complex,CC,
16733,GO:0097745,0.999999999998597,0.805159022886684,0,3,mitochondrial tRNA 5'-end processing,BP,
9939,GO:0042289,0.999999999998605,0.883728555958631,0,2,MHC class II protein binding,MF,
13651,GO:0060158,0.999999999998612,0.754848471167797,0,4,phospholipase C-activating dopamine receptor signaling pathway,BP,
7918,GO:0032493,0.999999999998616,0.76007228473029,0,3,response to bacterial lipoprotein,BP,
14710,GO:0070339,0.999999999998616,0.76007228473029,0,3,response to bacterial lipopeptide,BP,
15130,GO:0071220,0.999999999998616,0.76007228473029,0,3,cellular response to bacterial lipoprotein,BP,
15131,GO:0071221,0.999999999998616,0.76007228473029,0,3,cellular response to bacterial lipopeptide,BP,
8423,GO:0033499,0.999999999998617,0.871183388858699,0,2,galactose catabolic process via UDP-galactose,BP,
17126,GO:0102121,0.99999999999862,0.850180496351365,0,2,ceramidase activity,MF,
1631,GO:0004070,0.999999999998652,0.787426586717315,0,2,aspartate carbamoyltransferase activity,MF,
1643,GO:0004087,0.999999999998652,0.787426586717315,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1644,GO:0004088,0.999999999998652,0.787426586717315,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1684,GO:0004151,0.999999999998652,0.787426586717315,0,2,dihydroorotase activity,MF,
5649,GO:0016743,0.999999999998652,0.787426586717315,0,2,carboxyl- or carbamoyltransferase activity,MF,
16074,GO:0090031,0.999999999998664,0.76832763994361,0,3,positive regulation of steroid hormone biosynthetic process,BP,
534,GO:0001652,0.999999999998674,0.727039238696983,0,4,granular component,CC,
11161,GO:0045218,0.999999999998712,0.753757686049764,0,3,zonula adherens maintenance,BP,
19526,GO:1990423,0.999999999998734,0.743586124438338,0,3,RZZ complex,CC,
1775,GO:0004382,0.999999999998734,0.848654257522714,0,2,guanosine-diphosphatase activity,MF,
9170,GO:0035523,0.999999999998784,0.655449307705421,0,4,protein K29-linked deubiquitination,BP,
8052,GO:0032713,0.999999999998788,0.701982622649603,0,4,negative regulation of interleukin-4 production,BP,
17675,GO:1901536,0.999999999998805,0.842402790797941,0,2,negative regulation of DNA demethylation,BP,
8466,GO:0033603,0.999999999998813,0.784252189763344,0,3,positive regulation of dopamine secretion,BP,
1733,GO:0004331,0.999999999998817,0.675727132131289,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
2660,GO:0006003,0.999999999998817,0.675727132131289,0,4,fructose 2,6-bisphosphate metabolic process,BP,
16931,GO:0098908,0.999999999998836,0.834972055278402,0,2,regulation of neuronal action potential,BP,
16152,GO:0090164,0.999999999998853,0.812285506211213,0,2,asymmetric Golgi ribbon formation,BP,
11591,GO:0046166,0.999999999998861,0.874146532581289,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
13901,GO:0060545,0.999999999998863,0.845882089890478,0,2,positive regulation of necroptotic process,BP,
2238,GO:0005146,0.999999999998873,0.848909124369858,0,2,leukemia inhibitory factor receptor binding,MF,
11207,GO:0045338,0.999999999998886,0.733304984806859,0,4,farnesyl diphosphate metabolic process,BP,
6914,GO:0030505,0.999999999998905,0.772934983668026,0,2,inorganic diphosphate transport,BP,
7119,GO:0030934,0.999999999998941,0.755827630235798,0,2,anchoring collagen complex,CC,
11757,GO:0046604,0.999999999998946,0.743654994538726,0,3,positive regulation of mitotic centrosome separation,BP,
9059,GO:0035281,0.999999999998946,0.845812842445447,0,2,pre-miRNA export from nucleus,BP,
10071,GO:0042565,0.999999999998946,0.845812842445447,0,2,RNA nuclear export complex,CC,
7661,GO:0032090,0.999999999998951,0.864796076428698,0,2,Pyrin domain binding,MF,
11885,GO:0046899,0.999999999998953,0.848668236951875,0,2,nucleoside triphosphate adenylate kinase activity,MF,
6094,GO:0019287,0.999999999998966,0.819679933224543,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
7433,GO:0031536,0.999999999998966,0.767488039775723,0,4,positive regulation of exit from mitosis,BP,
6103,GO:0019323,0.999999999998992,0.751253661821727,0,4,pentose catabolic process,BP,
15581,GO:0072047,0.99999999999902,0.75276336703279,0,4,proximal/distal pattern formation involved in nephron development,BP,
15602,GO:0072081,0.99999999999902,0.75276336703279,0,4,specification of nephron tubule identity,BP,
15603,GO:0072086,0.99999999999902,0.75276336703279,0,4,specification of loop of Henle identity,BP,
19738,GO:2000111,0.999999999999023,0.857049416754834,0,2,positive regulation of macrophage apoptotic process,BP,
3510,GO:0007418,0.999999999999028,0.804236383440256,0,2,ventral midline development,BP,
6534,GO:0021937,0.999999999999028,0.804236383440256,0,2,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6535,GO:0021938,0.999999999999028,0.804236383440256,0,2,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6536,GO:0021940,0.999999999999028,0.804236383440256,0,2,positive regulation of cerebellar granule cell precursor proliferation,BP,
13497,GO:0055059,0.999999999999036,0.665156094984212,0,4,asymmetric neuroblast division,BP,
124,GO:0000254,0.999999999999053,0.845556260046855,0,2,C-4 methylsterol oxidase activity,MF,
2888,GO:0006393,0.999999999999053,0.845556260046855,0,2,termination of mitochondrial transcription,BP,
3210,GO:0006850,0.999999999999053,0.845556260046855,0,2,mitochondrial pyruvate transmembrane transport,BP,
4010,GO:0008988,0.999999999999053,0.845556260046855,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
7726,GO:0032217,0.999999999999053,0.845556260046855,0,2,riboflavin transmembrane transporter activity,MF,
7727,GO:0032218,0.999999999999053,0.845556260046855,0,2,riboflavin transport,BP,
8112,GO:0032798,0.999999999999053,0.845556260046855,0,2,Swi5-Sfr1 complex,CC,
15360,GO:0071595,0.999999999999053,0.845556260046855,0,2,Nem1-Spo7 phosphatase complex,CC,
15969,GO:0080023,0.999999999999053,0.845556260046855,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
19447,GO:1990112,0.999999999999053,0.845556260046855,0,2,RQC complex,CC,
19448,GO:1990116,0.999999999999053,0.845556260046855,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
19651,GO:1990879,0.999999999999053,0.845556260046855,0,2,CST complex,CC,
19968,GO:2000543,0.999999999999053,0.845556260046855,0,2,positive regulation of gastrulation,BP,
14729,GO:0070381,0.999999999999066,0.828374659698788,0,2,endosome to plasma membrane transport vesicle,CC,
9571,GO:0036369,0.99999999999908,0.776036007831944,0,2,transcription factor catabolic process,BP,
14233,GO:0061196,0.999999999999099,0.668405075272882,0,4,fungiform papilla development,BP,
14234,GO:0061197,0.999999999999099,0.668405075272882,0,4,fungiform papilla morphogenesis,BP,
16919,GO:0098886,0.999999999999117,0.823499279270037,0,2,modification of dendritic spine,BP,
11216,GO:0045349,0.999999999999117,0.72427243915212,0,4,interferon-alpha biosynthetic process,BP,
11221,GO:0045354,0.999999999999117,0.72427243915212,0,4,regulation of interferon-alpha biosynthetic process,BP,
6539,GO:0021943,0.999999999999119,0.661456708082286,0,4,formation of radial glial scaffolds,BP,
5308,GO:0016015,0.99999999999912,0.871227636648039,0,2,morphogen activity,MF,
13277,GO:0051964,0.999999999999145,0.652407123768736,0,4,negative regulation of synapse assembly,BP,
18541,GO:1903748,0.999999999999213,0.70673617007423,0,4,negative regulation of establishment of protein localization to mitochondrion,BP,
18502,GO:1903644,0.999999999999229,0.8827616800293,0,2,regulation of chaperone-mediated protein folding,BP,
14698,GO:0070318,0.999999999999269,0.703606280450905,0,4,positive regulation of G0 to G1 transition,BP,
14008,GO:0060729,0.999999999999272,0.776176506653479,0,3,intestinal epithelial structure maintenance,BP,
2174,GO:0005010,0.999999999999279,0.669638594462901,0,3,insulin-like growth factor-activated receptor activity,MF,
6080,GO:0019236,0.999999999999284,0.853907187161868,0,2,response to pheromone,BP,
19666,GO:1990927,0.999999999999298,0.805473293940941,0,2,calcium ion regulated lysosome exocytosis,BP,
973,GO:0002424,0.999999999999345,0.846068215048254,0,2,T cell mediated immune response to tumor cell,BP,
1193,GO:0002840,0.999999999999345,0.846068215048254,0,2,regulation of T cell mediated immune response to tumor cell,BP,
6884,GO:0030388,0.999999999999346,0.740336169963443,0,4,fructose 1,6-bisphosphate metabolic process,BP,
20024,GO:2000645,0.99999999999939,0.760527691302909,0,3,negative regulation of receptor catabolic process,BP,
10726,GO:0044062,0.999999999999411,0.804243360929271,0,3,regulation of excretion,BP,
3850,GO:0008459,0.999999999999411,0.820057335988055,0,2,chondroitin 6-sulfotransferase activity,MF,
4392,GO:0010046,0.999999999999417,0.73155075934836,0,4,response to mycotoxin,BP,
12138,GO:0048237,0.999999999999444,0.872651264336504,0,2,rough endoplasmic reticulum lumen,CC,
9603,GO:0036461,0.999999999999503,0.888030222815487,0,2,BLOC-2 complex binding,MF,
16018,GO:0086028,0.999999999999525,0.714167533499955,0,4,bundle of His cell to Purkinje myocyte signaling,BP,
16025,GO:0086043,0.999999999999525,0.714167533499955,0,4,bundle of His cell action potential,BP,
19986,GO:2000580,0.999999999999539,0.77531678567968,0,4,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19987,GO:2000582,0.999999999999539,0.77531678567968,0,4,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
19749,GO:2000137,0.999999999999541,0.800569304049497,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
728,GO:0001957,0.999999999999547,0.669283011817619,0,4,intramembranous ossification,BP,
9466,GO:0036072,0.999999999999547,0.669283011817619,0,4,direct ossification,BP,
5523,GO:0016493,0.999999999999572,0.849610838221044,0,2,C-C chemokine receptor activity,MF,
13853,GO:0060456,0.99999999999959,0.769124557998271,0,3,positive regulation of digestive system process,BP,
13189,GO:0051795,0.999999999999611,0.790974062548402,0,3,positive regulation of timing of catagen,BP,
6441,GO:0021747,0.999999999999641,0.730299827658702,0,3,cochlear nucleus development,BP,
10702,GO:0043987,0.999999999999659,0.731408690342754,0,4,histone H3-S10 phosphorylation,BP,
18265,GO:1903121,0.99999999999967,0.7043778959369,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
18257,GO:1903094,0.999999999999721,0.894114081795967,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19759,GO:2000157,0.999999999999721,0.894114081795967,0,2,negative regulation of ubiquitin-specific protease activity,BP,
16534,GO:0097267,0.999999999999726,0.680645478956114,0,4,omega-hydroxylase P450 pathway,BP,
15530,GO:0071918,0.999999999999731,0.829298203767975,0,2,urea transmembrane transport,BP,
2392,GO:0005534,0.999999999999744,0.789868697791062,0,3,galactose binding,MF,
1960,GO:0004666,0.999999999999747,0.807016137992189,0,2,prostaglandin-endoperoxide synthase activity,MF,
9867,GO:0042126,0.999999999999749,0.724848911522609,0,4,nitrate metabolic process,BP,
16107,GO:0090086,0.999999999999754,0.833904558492077,0,3,negative regulation of protein deubiquitination,BP,
586,GO:0001740,0.999999999999769,0.757636748335135,0,3,Barr body,CC,
2795,GO:0006235,0.999999999999778,0.76676284733905,0,4,dTTP biosynthetic process,BP,
4150,GO:0009212,0.999999999999778,0.76676284733905,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
11545,GO:0046075,0.999999999999778,0.76676284733905,0,4,dTTP metabolic process,BP,
6511,GO:0021886,0.99999999999978,0.78235120959372,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6512,GO:0021888,0.99999999999978,0.78235120959372,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
16737,GO:0097752,0.999999999999797,0.778649208616105,0,3,regulation of DNA stability,BP,
533,GO:0001651,0.9999999999998,0.868593363094844,0,2,dense fibrillar component,CC,
12246,GO:0048520,0.999999999999821,0.673044758941352,0,4,positive regulation of behavior,BP,
20031,GO:2000653,0.999999999999832,0.752726841418843,0,3,regulation of genetic imprinting,BP,
6545,GO:0021957,0.999999999999844,0.645600277220679,0,4,corticospinal tract morphogenesis,BP,
7142,GO:0030981,0.999999999999872,0.715989592278426,0,3,cortical microtubule cytoskeleton,CC,
3002,GO:0006547,0.999999999999885,0.711651251556685,0,4,histidine metabolic process,BP,
13414,GO:0052803,0.999999999999885,0.711651251556685,0,4,imidazole-containing compound metabolic process,BP,
10104,GO:0042613,0.999999999999905,0.836831874933263,0,3,MHC class II protein complex,CC,
7033,GO:0030806,0.999999999999941,0.812351935769682,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7048,GO:0030821,0.999999999999941,0.812351935769682,0,2,negative regulation of cAMP catabolic process,BP,
8295,GO:0033122,0.999999999999941,0.812351935769682,0,2,negative regulation of purine nucleotide catabolic process,BP,
16173,GO:0090191,0.999999999999952,0.87008948895293,0,2,negative regulation of branching involved in ureteric bud morphogenesis,BP,
11032,GO:0045004,0.999999999999953,0.80137784496267,0,2,DNA replication proofreading,BP,
1864,GO:0004528,0.999999999999956,0.709465273108789,0,4,phosphodiesterase I activity,MF,
9210,GO:0035594,0.999999999999965,0.784089590405335,0,3,ganglioside binding,MF,
14961,GO:0070853,0.999999999999974,0.776444354088788,0,2,myosin VI binding,MF,
16195,GO:0090219,0.999999999999979,0.702396974759184,0,4,negative regulation of lipid kinase activity,BP,
6,GO:0000012,1,0.488170136277716,0,8,single strand break repair,BP,
11,GO:0000022,1,0.399726872795925,0,10,mitotic spindle elongation,BP,
14,GO:0000027,1,0.159987127362504,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.362181938608164,0,18,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.161132275129042,0,22,mannosyltransferase activity,MF,
27,GO:0000052,1,0.499482628905295,0,7,citrulline metabolic process,BP,
29,GO:0000054,1,0.391080618254136,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.559244840690003,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.606419201418679,0,7,ribosomal small subunit export from nucleus,BP,
37,GO:0000076,1,0.266751745972293,0,16,DNA replication checkpoint,BP,
50,GO:0000104,1,0.698426604242048,0,5,succinate dehydrogenase activity,MF,
57,GO:0000120,1,0.678047335231225,0,5,RNA polymerase I transcription factor complex,CC,
61,GO:0000124,1,0.373291205730882,0,13,SAGA complex,CC,
64,GO:0000127,1,0.585659795197114,0,6,transcription factor TFIIIC complex,CC,
67,GO:0000138,1,0.636144426675491,0,6,Golgi trans cisterna,CC,
70,GO:0000146,1,0.176424566959875,0,14,microfilament motor activity,MF,
73,GO:0000150,1,0.542171977323833,0,8,recombinase activity,MF,
85,GO:0000172,1,0.6363672939657,0,6,ribonuclease MRP complex,CC,
87,GO:0000175,1,0.0745985671980722,0,30,3'-5'-exoribonuclease activity,MF,
88,GO:0000176,1,0.421107211789726,0,13,nuclear exosome (RNase complex),CC,
89,GO:0000177,1,0.307701558299712,0,15,cytoplasmic exosome (RNase complex),CC,
90,GO:0000178,1,0.177633015488953,0,22,exosome (RNase complex),CC,
92,GO:0000182,1,0.358826247791928,0,10,rDNA binding,MF,
93,GO:0000183,1,0.102593140770022,0,39,chromatin silencing at rDNA,BP,
94,GO:0000184,1,0.000398590335272583,0,119,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
98,GO:0000188,1,0.155198657861168,0,23,inactivation of MAPK activity,BP,
106,GO:0000220,1,0.663355917379352,0,5,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
115,GO:0000243,1,0.570767498720616,0,8,commitment complex,CC,
116,GO:0000244,1,0.368890758064188,0,11,spliceosomal tri-snRNP complex assembly,BP,
117,GO:0000245,1,0.0120830714447538,0,53,spliceosomal complex assembly,BP,
140,GO:0000290,1,0.443091423089318,0,9,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
141,GO:0000291,1,0.0636023856375894,0,35,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
157,GO:0000315,1,0.0444142481327432,0,51,organellar large ribosomal subunit,CC,
163,GO:0000338,1,0.488473520544355,0,10,protein deneddylation,BP,
164,GO:0000339,1,0.222335308311321,0,17,RNA cap binding,MF,
165,GO:0000340,1,0.42595967279499,0,9,RNA 7-methylguanosine cap binding,MF,
166,GO:0000346,1,0.35152315463647,0,13,transcription export complex,CC,
167,GO:0000347,1,0.638529942783271,0,6,THO complex,CC,
174,GO:0000380,1,0.0170017390918574,0,45,alternative mRNA splicing, via spliceosome,BP,
175,GO:0000381,1,0.0489111446643681,0,33,regulation of alternative mRNA splicing, via spliceosome,BP,
178,GO:0000387,1,0.0636429518309031,0,36,spliceosomal snRNP assembly,BP,
179,GO:0000389,1,0.604027838615499,0,6,mRNA 3'-splice site recognition,BP,
181,GO:0000393,1,0.695833212206094,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
182,GO:0000394,1,0.288882864086354,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
183,GO:0000395,1,0.670319766828495,0,5,mRNA 5'-splice site recognition,BP,
185,GO:0000400,1,0.257482866311061,0,16,four-way junction DNA binding,MF,
186,GO:0000403,1,0.542791845711744,0,6,Y-form DNA binding,MF,
202,GO:0000423,1,0.167854688102902,0,19,mitophagy,BP,
211,GO:0000439,1,0.48221798982825,0,9,core TFIIH complex,CC,
213,GO:0000445,1,0.638529942783271,0,6,THO complex part of transcription export complex,CC,
214,GO:0000447,1,0.498269369073239,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
220,GO:0000459,1,0.608265336122427,0,7,exonucleolytic trimming involved in rRNA processing,BP,
221,GO:0000460,1,0.0748176466528579,0,33,maturation of 5.8S rRNA,BP,
223,GO:0000462,1,0.0586071763187606,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
224,GO:0000463,1,0.48330084386565,0,10,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000466,1,0.172752751536847,0,22,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000467,1,0.608265336122427,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000469,1,0.126757941456837,0,26,cleavage involved in rRNA processing,BP,
228,GO:0000470,1,0.164859511213717,0,24,maturation of LSU-rRNA,BP,
230,GO:0000478,1,0.270840534806544,0,15,endonucleolytic cleavage involved in rRNA processing,BP,
231,GO:0000479,1,0.292647500172697,0,14,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000480,1,0.582004720892215,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000491,1,0.501232640903458,0,9,small nucleolar ribonucleoprotein complex assembly,BP,
235,GO:0000492,1,0.582686663990191,0,7,box C/D snoRNP assembly,BP,
246,GO:0000702,1,0.734918508309478,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
249,GO:0000707,1,0.537961443388246,0,8,meiotic DNA recombinase assembly,BP,
251,GO:0000712,1,0.429195354910852,0,9,resolution of meiotic recombination intermediates,BP,
261,GO:0000727,1,0.677140278938086,0,5,double-strand break repair via break-induced replication,BP,
262,GO:0000729,1,0.128993056893208,0,22,DNA double-strand break processing,BP,
263,GO:0000730,1,0.456251935996542,0,10,DNA recombinase assembly,BP,
264,GO:0000731,1,0.00216804366309642,0,68,DNA synthesis involved in DNA repair,BP,
265,GO:0000732,1,0.0881537581343291,0,25,strand displacement,BP,
272,GO:0000774,1,0.415714563652731,0,11,adenyl-nucleotide exchange factor activity,MF,
280,GO:0000782,1,0.441720154471097,0,10,telomere cap complex,CC,
281,GO:0000783,1,0.441720154471097,0,10,nuclear telomere cap complex,CC,
285,GO:0000788,1,0.221222503447012,0,31,nuclear nucleosome,CC,
292,GO:0000796,1,0.467811972352216,0,7,condensin complex,CC,
299,GO:0000805,1,0.496206978549125,0,7,X chromosome,CC,
301,GO:0000808,1,0.46967280747348,0,9,origin recognition complex,CC,
303,GO:0000812,1,0.413587040407019,0,10,Swr1 complex,CC,
306,GO:0000815,1,0.400055617057071,0,12,ESCRT III complex,CC,
326,GO:0000912,1,0.549488552741432,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
327,GO:0000915,1,0.549488552741432,0,6,actomyosin contractile ring assembly,BP,
330,GO:0000920,1,0.273035388744031,0,17,cell separation after cytokinesis,BP,
333,GO:0000923,1,0.565953612823275,0,6,equatorial microtubule organizing center,CC,
336,GO:0000931,1,0.453015577956769,0,8,gamma-tubulin large complex,CC,
340,GO:0000940,1,0.303124014057288,0,13,condensed chromosome outer kinetochore,CC,
344,GO:0000957,1,0.613921610634671,0,5,mitochondrial RNA catabolic process,BP,
350,GO:0000963,1,0.280536991468904,0,16,mitochondrial RNA processing,BP,
352,GO:0000965,1,0.673269130243951,0,5,mitochondrial RNA 3'-end processing,BP,
353,GO:0000966,1,0.192763005028385,0,21,RNA 5'-end processing,BP,
355,GO:0000972,1,0.542462445558309,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
357,GO:0000974,1,0.356522721948158,0,13,Prp19 complex,CC,
361,GO:0000979,1,0.0740739164370333,0,29,RNA polymerase II core promoter sequence-specific DNA binding,MF,
365,GO:0000983,1,0.235990043633925,0,15,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
369,GO:0000990,1,0.418436970035267,0,9,transcription factor activity, core RNA polymerase binding,MF,
372,GO:0000993,1,0.0923746187754325,0,27,RNA polymerase II core binding,MF,
381,GO:0001013,1,0.47383460798301,0,8,RNA polymerase I regulatory region DNA binding,MF,
386,GO:0001030,1,0.591843974886749,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
387,GO:0001031,1,0.591843974886749,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
390,GO:0001042,1,0.554122916426983,0,6,RNA polymerase I core binding,MF,
393,GO:0001054,1,0.44074815717142,0,11,RNA polymerase I activity,MF,
394,GO:0001055,1,0.457347193622185,0,11,RNA polymerase II activity,MF,
395,GO:0001056,1,0.328960435695044,0,15,RNA polymerase III activity,MF,
399,GO:0001075,1,0.554658898512612,0,6,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
403,GO:0001083,1,0.596465103979019,0,5,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
428,GO:0001135,1,0.519823686816118,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
435,GO:0001163,1,0.47383460798301,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
436,GO:0001164,1,0.47383460798301,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
441,GO:0001188,1,0.47383460798301,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
447,GO:0001206,1,0.506536627585135,0,6,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,
462,GO:0001405,1,0.676461975743019,0,5,presequence translocase-associated import motor,CC,
473,GO:0001516,1,0.263464877580165,0,17,prostaglandin biosynthetic process,BP,
474,GO:0001517,1,0.608940518232128,0,5,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
482,GO:0001530,1,0.464010108355206,0,10,lipopolysaccharide binding,MF,
490,GO:0001542,1,0.53626249974399,0,6,ovulation from ovarian follicle,BP,
495,GO:0001547,1,0.591743463306308,0,5,antral ovarian follicle growth,BP,
498,GO:0001553,1,0.59444471499739,0,5,luteinization,BP,
499,GO:0001554,1,0.59080100598736,0,5,luteolysis,BP,
504,GO:0001561,1,0.617572417536746,0,6,fatty acid alpha-oxidation,BP,
505,GO:0001562,1,0.476003226372222,0,9,response to protozoan,BP,
516,GO:0001580,1,0.717825676772274,0,5,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
521,GO:0001608,1,0.669735784364267,0,5,G-protein coupled nucleotide receptor activity,MF,
523,GO:0001614,1,0.623651868993643,0,6,purinergic nucleotide receptor activity,MF,
528,GO:0001637,1,0.611487801564587,0,6,G-protein coupled chemoattractant receptor activity,MF,
542,GO:0001660,1,0.563593149857087,0,7,fever generation,BP,
550,GO:0001671,1,0.180810711473244,0,22,ATPase activator activity,MF,
551,GO:0001672,1,0.483147925382669,0,7,regulation of chromatin assembly or disassembly,BP,
559,GO:0001682,1,0.427666114724103,0,12,tRNA 5'-leader removal,BP,
560,GO:0001696,1,0.58279830987139,0,6,gastric acid secretion,BP,
576,GO:0001727,1,0.624977664817099,0,5,lipid kinase activity,MF,
579,GO:0001731,1,0.485832464403136,0,8,formation of translation preinitiation complex,BP,
585,GO:0001739,1,0.613752246503134,0,6,sex chromatin,CC,
598,GO:0001765,1,0.493466716662822,0,9,membrane raft assembly,BP,
601,GO:0001768,1,0.594344223275768,0,5,establishment of T cell polarity,BP,
606,GO:0001774,1,0.274409861914627,0,13,microglial cell activation,BP,
611,GO:0001779,1,0.26278893139547,0,15,natural killer cell differentiation,BP,
612,GO:0001780,1,0.427208535521861,0,9,neutrophil homeostasis,BP,
613,GO:0001781,1,0.628751777838786,0,5,neutrophil apoptotic process,BP,
618,GO:0001787,1,0.677924803006907,0,5,natural killer cell proliferation,BP,
632,GO:0001821,1,0.574893672959383,0,8,histamine secretion,BP,
640,GO:0001829,1,0.413272303708353,0,10,trophectodermal cell differentiation,BP,
642,GO:0001832,1,0.265513651047105,0,14,blastocyst growth,BP,
643,GO:0001833,1,0.389970733408297,0,10,inner cell mass cell proliferation,BP,
652,GO:0001842,1,0.634857941966874,0,5,neural fold formation,BP,
655,GO:0001845,1,0.48007470563334,0,9,phagolysosome assembly,BP,
656,GO:0001846,1,0.682767452961282,0,5,opsonin binding,MF,
657,GO:0001848,1,0.67949580329802,0,5,complement binding,MF,
667,GO:0001871,1,0.548684182853211,0,6,pattern binding,MF,
676,GO:0001886,1,0.494768745257224,0,7,endothelial cell morphogenesis,BP,
706,GO:0001931,1,0.466284665059105,0,8,uropod,CC,
714,GO:0001939,1,0.578700820062948,0,6,female pronucleus,CC,
715,GO:0001940,1,0.602275913560373,0,5,male pronucleus,CC,
727,GO:0001956,1,0.430276406391344,0,9,positive regulation of neurotransmitter secretion,BP,
737,GO:0001967,1,0.506999393571436,0,7,suckling behavior,BP,
742,GO:0001972,1,0.424839415944549,0,9,retinoic acid binding,MF,
743,GO:0001973,1,0.695527195506285,0,5,adenosine receptor signaling pathway,BP,
770,GO:0002024,1,0.641791980624205,0,5,diet induced thermogenesis,BP,
782,GO:0002039,1,0.0029356768967533,0,61,p53 binding,MF,
789,GO:0002052,1,0.295134888899107,0,12,positive regulation of neuroblast proliferation,BP,
799,GO:0002067,1,0.0669908245152858,0,29,glandular epithelial cell differentiation,BP,
800,GO:0002068,1,0.182775991665994,0,18,glandular epithelial cell development,BP,
801,GO:0002069,1,0.625881734652381,0,6,columnar/cuboidal epithelial cell maturation,BP,
804,GO:0002072,1,0.505503739353176,0,6,optic cup morphogenesis involved in camera-type eye development,BP,
810,GO:0002082,1,0.312932268919184,0,14,regulation of oxidative phosphorylation,BP,
817,GO:0002089,1,0.270857811706083,0,12,lens morphogenesis in camera-type eye,BP,
823,GO:0002097,1,0.277020066900281,0,16,tRNA wobble base modification,BP,
824,GO:0002098,1,0.396465595943253,0,12,tRNA wobble uridine modification,BP,
847,GO:0002162,1,0.428630241793798,0,7,dystroglycan binding,MF,
854,GO:0002182,1,0.379632668027327,0,11,cytoplasmic translational elongation,BP,
864,GO:0002199,1,0.591903498097218,0,7,zona pellucida receptor complex,CC,
875,GO:0002227,1,0.623542124651327,0,10,innate immune response in mucosa,BP,
885,GO:0002251,1,0.415043235857699,0,14,organ or tissue specific immune response,BP,
901,GO:0002281,1,0.614583568185503,0,5,macrophage activation involved in immune response,BP,
910,GO:0002295,1,0.531189086863649,0,7,T-helper cell lineage commitment,BP,
926,GO:0002323,1,0.492638565065329,0,9,natural killer cell activation involved in immune response,BP,
939,GO:0002349,1,0.692148394102131,0,5,histamine production involved in inflammatory response,BP,
945,GO:0002360,1,0.282749922198431,0,13,T cell lineage commitment,BP,
946,GO:0002363,1,0.449436424257027,0,9,alpha-beta T cell lineage commitment,BP,
961,GO:0002385,1,0.459184608270668,0,13,mucosal immune response,BP,
965,GO:0002407,1,0.402059039125583,0,11,dendritic cell chemotaxis,BP,
984,GO:0002441,1,0.692148394102131,0,5,histamine secretion involved in inflammatory response,BP,
1006,GO:0002480,1,0.546048662090826,0,9,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1008,GO:0002483,1,0.500736811571571,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1026,GO:0002532,1,0.0483615275535272,0,35,production of molecular mediator involved in inflammatory response,BP,
1027,GO:0002534,1,0.131995139095487,0,23,cytokine production involved in inflammatory response,BP,
1035,GO:0002544,1,0.399426225444674,0,12,chronic inflammatory response,BP,
1039,GO:0002553,1,0.692148394102131,0,5,histamine secretion by mast cell,BP,
1045,GO:0002568,1,0.566978327223644,0,5,somatic diversification of T cell receptor genes,BP,
1049,GO:0002577,1,0.529941362715556,0,8,regulation of antigen processing and presentation,BP,
1072,GO:0002638,1,0.600361994363908,0,5,negative regulation of immunoglobulin production,BP,
1088,GO:0002676,1,0.653380071696008,0,6,regulation of chronic inflammatory response,BP,
1092,GO:0002681,1,0.566978327223644,0,5,somatic recombination of T cell receptor gene segments,BP,
1112,GO:0002701,1,0.173598753977012,0,20,negative regulation of production of molecular mediator of immune response,BP,
1123,GO:0002712,1,0.092719015783964,0,27,regulation of B cell mediated immunity,BP,
1125,GO:0002714,1,0.187432806214583,0,19,positive regulation of B cell mediated immunity,BP,
1128,GO:0002717,1,0.410047806686796,0,10,positive regulation of natural killer cell mediated immunity,BP,
1130,GO:0002719,1,0.289873745832483,0,15,negative regulation of cytokine production involved in immune response,BP,
1132,GO:0002724,1,0.33555466669511,0,13,regulation of T cell cytokine production,BP,
1134,GO:0002726,1,0.461705314654605,0,9,positive regulation of T cell cytokine production,BP,
1178,GO:0002825,1,0.45123831615355,0,10,regulation of T-helper 1 type immune response,BP,
1180,GO:0002827,1,0.588083193185415,0,7,positive regulation of T-helper 1 type immune response,BP,
1183,GO:0002830,1,0.456047852027537,0,10,positive regulation of type 2 immune response,BP,
1219,GO:0002889,1,0.092719015783964,0,27,regulation of immunoglobulin mediated immune response,BP,
1221,GO:0002891,1,0.187432806214583,0,19,positive regulation of immunoglobulin mediated immune response,BP,
1234,GO:0002922,1,0.646562536477888,0,6,positive regulation of humoral immune response,BP,
1241,GO:0002934,1,0.39398950240993,0,9,desmosome organization,BP,
1255,GO:0003009,1,0.186256586424255,0,19,skeletal muscle contraction,BP,
1282,GO:0003084,1,0.604593578095137,0,6,positive regulation of systemic arterial blood pressure,BP,
1309,GO:0003157,1,0.460153989555925,0,8,endocardium development,BP,
1313,GO:0003161,1,0.375381990780923,0,10,cardiac conduction system development,BP,
1326,GO:0003177,1,0.510473070896605,0,6,pulmonary valve development,BP,
1331,GO:0003184,1,0.510473070896605,0,6,pulmonary valve morphogenesis,BP,
1333,GO:0003188,1,0.430276495033226,0,8,heart valve formation,BP,
1372,GO:0003263,1,0.693178276522103,0,5,cardioblast proliferation,BP,
1373,GO:0003264,1,0.603595082636974,0,6,regulation of cardioblast proliferation,BP,
1374,GO:0003266,1,0.654650577964425,0,5,regulation of secondary heart field cardioblast proliferation,BP,
1395,GO:0003309,1,0.217777829733078,0,16,type B pancreatic cell differentiation,BP,
1398,GO:0003323,1,0.236442649182955,0,15,type B pancreatic cell development,BP,
1403,GO:0003337,1,0.552463307200407,0,7,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1405,GO:0003339,1,0.650650545366815,0,5,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1414,GO:0003351,1,0.489706428760731,0,9,epithelial cilium movement,BP,
1422,GO:0003373,1,0.452349297344466,0,8,dynamin family protein polymerization involved in membrane fission,BP,
1423,GO:0003374,1,0.452349297344466,0,8,dynamin family protein polymerization involved in mitochondrial fission,BP,
1424,GO:0003376,1,0.460721533698806,0,9,sphingosine-1-phosphate signaling pathway,BP,
1452,GO:0003688,1,0.298997908751331,0,14,DNA replication origin binding,MF,
1453,GO:0003689,1,0.535500801914331,0,8,DNA clamp loader activity,MF,
1455,GO:0003691,1,0.46968087368103,0,9,double-stranded telomeric DNA binding,MF,
1465,GO:0003720,1,0.516044586399534,0,8,telomerase activity,MF,
1477,GO:0003747,1,0.583827826327536,0,6,translation release factor activity,MF,
1525,GO:0003899,1,0.0422601591681345,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1529,GO:0003909,1,0.551320767555671,0,7,DNA ligase activity,MF,
1530,GO:0003910,1,0.592786591519212,0,6,DNA ligase (ATP) activity,MF,
1531,GO:0003916,1,0.560209613813361,0,6,DNA topoisomerase activity,MF,
1538,GO:0003923,1,0.667500889732538,0,5,GPI-anchor transamidase activity,MF,
1563,GO:0003964,1,0.516044586399534,0,8,RNA-directed DNA polymerase activity,MF,
1578,GO:0003988,1,0.64765580381738,0,6,acetyl-CoA C-acyltransferase activity,MF,
1591,GO:0004003,1,0.0420526854348592,0,33,ATP-dependent DNA helicase activity,MF,
1598,GO:0004017,1,0.648568003850857,0,5,adenylate kinase activity,MF,
1607,GO:0004030,1,0.65174180833004,0,5,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1609,GO:0004032,1,0.735413566515345,0,5,alditol:NADP+ 1-oxidoreductase activity,MF,
1628,GO:0004065,1,0.520452260169468,0,7,arylsulfatase activity,MF,
1645,GO:0004089,1,0.629530546977814,0,5,carbonate dehydratase activity,MF,
1660,GO:0004115,1,0.590385699117804,0,5,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1667,GO:0004128,1,0.585738384169693,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1694,GO:0004169,1,0.699752663558131,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1708,GO:0004298,1,0.365865316567467,0,18,threonine-type endopeptidase activity,MF,
1709,GO:0004300,1,0.55092993358856,0,8,enoyl-CoA hydratase activity,MF,
1761,GO:0004364,1,0.331832514452341,0,18,glutathione transferase activity,MF,
1763,GO:0004366,1,0.637030372546112,0,5,glycerol-3-phosphate O-acyltransferase activity,MF,
1796,GO:0004430,1,0.577990655008461,0,6,1-phosphatidylinositol 4-kinase activity,MF,
1799,GO:0004439,1,0.451887864884023,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1801,GO:0004445,1,0.639617932753904,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1817,GO:0004467,1,0.44459498018973,0,9,long-chain fatty acid-CoA ligase activity,MF,
1860,GO:0004523,1,0.662900913687281,0,6,RNA-DNA hybrid ribonuclease activity,MF,
1862,GO:0004526,1,0.456481352207945,0,11,ribonuclease P activity,MF,
1865,GO:0004529,1,0.238688269863787,0,17,exodeoxyribonuclease activity,MF,
1870,GO:0004535,1,0.304401809094959,0,12,poly(A)-specific ribonuclease activity,MF,
1873,GO:0004549,1,0.310611733999977,0,16,tRNA-specific ribonuclease activity,MF,
1883,GO:0004563,1,0.653694350769908,0,5,beta-N-acetylhexosaminidase activity,MF,
1908,GO:0004596,1,0.424129624733922,0,10,peptide alpha-N-acetyltransferase activity,MF,
1948,GO:0004652,1,0.450632909969673,0,8,polynucleotide adenylyltransferase activity,MF,
1969,GO:0004679,1,0.511973955578256,0,7,AMP-activated protein kinase activity,MF,
1984,GO:0004704,1,0.659448273707731,0,5,NF-kappaB-inducing kinase activity,MF,
2011,GO:0004738,1,0.648954473030576,0,5,pyruvate dehydrogenase activity,MF,
2028,GO:0004767,1,0.652747098331599,0,5,sphingomyelin phosphodiesterase activity,MF,
2031,GO:0004771,1,0.629143491427468,0,5,sterol esterase activity,MF,
2072,GO:0004826,1,0.685399411606281,0,5,phenylalanine-tRNA ligase activity,MF,
2081,GO:0004839,1,0.612180238109382,0,5,ubiquitin activating enzyme activity,MF,
2084,GO:0004844,1,0.705551195979498,0,5,uracil DNA N-glycosylase activity,MF,
2085,GO:0004849,1,0.696617778894333,0,5,uridine kinase activity,MF,
2114,GO:0004904,1,0.665192607244737,0,5,interferon receptor activity,MF,
2138,GO:0004950,1,0.611487801564587,0,6,chemokine receptor activity,MF,
2188,GO:0005047,1,0.665584885847122,0,5,signal recognition particle binding,MF,
2190,GO:0005049,1,0.424222241686026,0,8,nuclear export signal receptor activity,MF,
2197,GO:0005072,1,0.425015635854219,0,8,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2198,GO:0005078,1,0.449290588048218,0,7,MAP-kinase scaffold activity,MF,
2209,GO:0005095,1,0.379852823509781,0,11,GTPase inhibitor activity,MF,
2212,GO:0005104,1,0.357059981087845,0,10,fibroblast growth factor receptor binding,MF,
2217,GO:0005114,1,0.51421054342414,0,7,type II transforming growth factor beta receptor binding,MF,
2234,GO:0005138,1,0.639514329771915,0,5,interleukin-6 receptor binding,MF,
2239,GO:0005149,1,0.468932245333204,0,9,interleukin-1 receptor binding,MF,
2249,GO:0005161,1,0.37967667051529,0,10,platelet-derived growth factor receptor binding,MF,
2285,GO:0005243,1,0.545887736731914,0,7,gap junction channel activity,MF,
2302,GO:0005283,1,0.514162062080632,0,7,amino acid:sodium symporter activity,MF,
2343,GO:0005381,1,0.592502255088975,0,6,iron ion transmembrane transporter activity,MF,
2346,GO:0005388,1,0.407950974382285,0,8,calcium-transporting ATPase activity,MF,
2351,GO:0005416,1,0.418122299104856,0,9,amino acid:cation symporter activity,MF,
2379,GO:0005513,1,0.521370660154978,0,8,detection of calcium ion,BP,
2397,GO:0005542,1,0.625951849734929,0,6,folic acid binding,MF,
2413,GO:0005587,1,0.535412854120521,0,5,collagen type IV trimer,CC,
2439,GO:0005639,1,0.478412657756719,0,8,integral component of nuclear inner membrane,CC,
2442,GO:0005642,1,0.592184918326157,0,5,annulate lamellae,CC,
2444,GO:0005652,1,0.444454493294484,0,9,nuclear lamina,CC,
2446,GO:0005655,1,0.584167319668989,0,8,nucleolar ribonuclease P complex,CC,
2449,GO:0005658,1,0.602698227186307,0,6,alpha DNA polymerase:primase complex,CC,
2450,GO:0005662,1,0.311096362405041,0,14,DNA replication factor A complex,CC,
2451,GO:0005663,1,0.644901450690614,0,6,DNA replication factor C complex,CC,
2452,GO:0005664,1,0.46967280747348,0,9,nuclear origin of replication recognition complex,CC,
2454,GO:0005666,1,0.284032177641165,0,17,DNA-directed RNA polymerase III complex,CC,
2462,GO:0005675,1,0.373802251673988,0,13,holo TFIIH complex,CC,
2463,GO:0005677,1,0.389168153875097,0,9,chromatin silencing complex,CC,
2466,GO:0005682,1,0.143060039270703,0,22,U5 snRNP,CC,
2467,GO:0005683,1,0.666197242833287,0,7,U7 snRNP,CC,
2468,GO:0005684,1,0.0108292023251723,0,58,U2-type spliceosomal complex,CC,
2469,GO:0005685,1,0.227403645264461,0,20,U1 snRNP,CC,
2470,GO:0005686,1,0.237109817935867,0,20,U2 snRNP,CC,
2471,GO:0005687,1,0.462575805783671,0,11,U4 snRNP,CC,
2472,GO:0005688,1,0.609638610144751,0,8,U6 snRNP,CC,
2473,GO:0005689,1,0.167663477242935,0,26,U12-type spliceosomal complex,CC,
2489,GO:0005736,1,0.397200801528875,0,12,DNA-directed RNA polymerase I complex,CC,
2494,GO:0005742,1,0.588330888616206,0,8,mitochondrial outer membrane translocase complex,CC,
2496,GO:0005744,1,0.396351247545336,0,13,mitochondrial inner membrane presequence translocase complex,CC,
2500,GO:0005749,1,0.698426604242048,0,5,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2501,GO:0005750,1,0.468199234810564,0,11,mitochondrial respiratory chain complex III,CC,
2509,GO:0005762,1,0.0444142481327432,0,51,mitochondrial large ribosomal subunit,CC,
2529,GO:0005785,1,0.596104562236517,0,7,signal recognition particle receptor complex,CC,
2530,GO:0005786,1,0.655208159544373,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2531,GO:0005787,1,0.702508572702576,0,5,signal peptidase complex,CC,
2540,GO:0005797,1,0.572404023686292,0,7,Golgi medial cisterna,CC,
2548,GO:0005816,1,0.52039492822799,0,7,spindle pole body,CC,
2551,GO:0005826,1,0.605483510646111,0,5,actomyosin contractile ring,CC,
2552,GO:0005827,1,0.622414204767177,0,5,polar microtubule,CC,
2553,GO:0005828,1,0.465201650394919,0,7,kinetochore microtubule,CC,
2559,GO:0005839,1,0.290104596816938,0,20,proteasome core complex,CC,
2564,GO:0005847,1,0.238369618067404,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2565,GO:0005849,1,0.198507554503287,0,18,mRNA cleavage factor complex,CC,
2567,GO:0005851,1,0.636103420743214,0,6,eukaryotic translation initiation factor 2B complex,CC,
2568,GO:0005852,1,0.278900556638391,0,17,eukaryotic translation initiation factor 3 complex,CC,
2572,GO:0005858,1,0.348560185837418,0,8,axonemal dynein complex,CC,
2579,GO:0005869,1,0.543359386697171,0,8,dynactin complex,CC,
2585,GO:0005879,1,0.617567003012396,0,5,axonemal microtubule,CC,
2610,GO:0005915,1,0.556629467177328,0,6,zonula adherens,CC,
2611,GO:0005916,1,0.541309782785767,0,6,fascia adherens,CC,
2612,GO:0005921,1,0.246511558870728,0,16,gap junction,CC,
2613,GO:0005922,1,0.433078825671441,0,10,connexin complex,CC,
2622,GO:0005942,1,0.194630870745994,0,16,phosphatidylinositol 3-kinase complex,CC,
2625,GO:0005947,1,0.652095974949284,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2648,GO:0005984,1,0.508772176227189,0,7,disaccharide metabolic process,BP,
2657,GO:0006000,1,0.407021366517821,0,11,fructose metabolic process,BP,
2661,GO:0006004,1,0.314226032422391,0,13,fucose metabolic process,BP,
2664,GO:0006011,1,0.575887730147144,0,6,UDP-glucose metabolic process,BP,
2666,GO:0006013,1,0.490762815546443,0,8,mannose metabolic process,BP,
2682,GO:0006044,1,0.316279158025145,0,13,N-acetylglucosamine metabolic process,BP,
2702,GO:0006067,1,0.424757512298069,0,11,ethanol metabolic process,BP,
2703,GO:0006068,1,0.598426171904141,0,7,ethanol catabolic process,BP,
2704,GO:0006069,1,0.603392064282943,0,6,ethanol oxidation,BP,
2706,GO:0006072,1,0.478323761209852,0,7,glycerol-3-phosphate metabolic process,BP,
2713,GO:0006086,1,0.290544687644899,0,13,acetyl-CoA biosynthetic process from pyruvate,BP,
2725,GO:0006104,1,0.629648546891958,0,6,succinyl-CoA metabolic process,BP,
2726,GO:0006105,1,0.393689299104291,0,11,succinate metabolic process,BP,
2729,GO:0006108,1,0.633515373155647,0,6,malate metabolic process,BP,
2741,GO:0006122,1,0.373669659645065,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2742,GO:0006123,1,0.431657041171858,0,14,mitochondrial electron transport, cytochrome c to oxygen,BP,
2750,GO:0006152,1,0.657662052459309,0,6,purine nucleoside catabolic process,BP,
2756,GO:0006166,1,0.697376438208935,0,5,purine ribonucleoside salvage,BP,
2757,GO:0006167,1,0.709021082215526,0,5,AMP biosynthetic process,BP,
2764,GO:0006177,1,0.702549242678555,0,5,GMP biosynthetic process,BP,
2770,GO:0006188,1,0.424635248146164,0,10,IMP biosynthetic process,BP,
2771,GO:0006189,1,0.591062427230611,0,6,'de novo' IMP biosynthetic process,BP,
2777,GO:0006206,1,0.242622155845451,0,17,pyrimidine nucleobase metabolic process,BP,
2778,GO:0006207,1,0.543595359580122,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
2789,GO:0006222,1,0.493630528966088,0,9,UMP biosynthetic process,BP,
2798,GO:0006244,1,0.435434775434776,0,12,pyrimidine nucleotide catabolic process,BP,
2805,GO:0006264,1,0.40405983188794,0,10,mitochondrial DNA replication,BP,
2806,GO:0006265,1,0.442458958871644,0,9,DNA topological change,BP,
2807,GO:0006266,1,0.163459890374984,0,23,DNA ligation,BP,
2809,GO:0006268,1,0.554901126913676,0,7,DNA unwinding involved in DNA replication,BP,
2810,GO:0006269,1,0.653824047659725,0,5,DNA replication, synthesis of RNA primer,BP,
2811,GO:0006270,1,0.0328861690518838,0,41,DNA replication initiation,BP,
2812,GO:0006271,1,0.193516699605556,0,20,DNA strand elongation involved in DNA replication,BP,
2814,GO:0006273,1,0.392142130943773,0,11,lagging strand elongation,BP,
2821,GO:0006285,1,0.500084663618724,0,10,base-excision repair, AP site formation,BP,
2831,GO:0006297,1,0.160998822568592,0,23,nucleotide-excision repair, DNA gap filling,BP,
2833,GO:0006301,1,0.0155059353803889,0,49,postreplication repair,BP,
2839,GO:0006307,1,0.461588720634652,0,10,DNA dealkylation involved in DNA repair,BP,
2850,GO:0006335,1,0.177708137144434,0,32,DNA replication-dependent nucleosome assembly,BP,
2852,GO:0006337,1,0.223938245197577,0,16,nucleosome disassembly,BP,
2858,GO:0006348,1,0.533513113573698,0,8,chromatin silencing at telomere,BP,
2862,GO:0006353,1,0.000171678235042589,0,107,DNA-templated transcription, termination,BP,
2869,GO:0006361,1,0.0621261437146534,0,35,transcription initiation from RNA polymerase I promoter,BP,
2871,GO:0006363,1,0.0975437939688408,0,30,termination of RNA polymerase I transcription,BP,
2876,GO:0006369,1,0.00353326592546775,0,69,termination of RNA polymerase II transcription,BP,
2878,GO:0006376,1,0.110733361785705,0,25,mRNA splice site selection,BP,
2879,GO:0006378,1,0.02885180873008,0,39,mRNA polyadenylation,BP,
2880,GO:0006379,1,0.104908769564808,0,27,mRNA cleavage,BP,
2883,GO:0006384,1,0.496255877676111,0,7,transcription initiation from RNA polymerase III promoter,BP,
2885,GO:0006388,1,0.375991211171347,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
2886,GO:0006390,1,0.316063676131,0,13,mitochondrial transcription,BP,
2891,GO:0006398,1,0.647381750804098,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
2899,GO:0006406,1,0.000100275149079693,0,103,mRNA export from nucleus,BP,
2922,GO:0006432,1,0.685399411606281,0,5,phenylalanyl-tRNA aminoacylation,BP,
2931,GO:0006448,1,0.237681557171277,0,17,regulation of translational elongation,BP,
2932,GO:0006449,1,0.536733064939698,0,7,regulation of translational termination,BP,
2940,GO:0006465,1,0.289155491384046,0,16,signal peptide processing,BP,
2949,GO:0006477,1,0.628402603029382,0,5,protein sulfation,BP,
2963,GO:0006498,1,0.60606208122679,0,5,N-terminal protein lipidation,BP,
2987,GO:0006531,1,0.600305146884638,0,6,aspartate metabolic process,BP,
2999,GO:0006544,1,0.534713916231098,0,8,glycine metabolic process,BP,
3004,GO:0006549,1,0.63493835971017,0,5,isoleucine metabolic process,BP,
3006,GO:0006551,1,0.546723781213673,0,7,leucine metabolic process,BP,
3007,GO:0006552,1,0.665412931851856,0,5,leucine catabolic process,BP,
3023,GO:0006568,1,0.667945280176476,0,5,tryptophan metabolic process,BP,
3037,GO:0006586,1,0.667945280176476,0,5,indolalkylamine metabolic process,BP,
3039,GO:0006590,1,0.411862059484498,0,9,thyroid hormone generation,BP,
3045,GO:0006598,1,0.737348811172209,0,5,polyamine catabolic process,BP,
3050,GO:0006607,1,0.121142082391765,0,20,NLS-bearing protein import into nucleus,BP,
3051,GO:0006610,1,0.449358686213075,0,8,ribosomal protein import into nucleus,BP,
3056,GO:0006616,1,0.675040350953056,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3065,GO:0006627,1,0.652699313186576,0,6,protein processing involved in protein targeting to mitochondrion,BP,
3078,GO:0006646,1,0.376583019446171,0,11,phosphatidylethanolamine biosynthetic process,BP,
3084,GO:0006657,1,0.567399428543448,0,7,CDP-choline pathway,BP,
3100,GO:0006677,1,0.308923852456833,0,14,glycosylceramide metabolic process,BP,
3101,GO:0006678,1,0.544121241890341,0,7,glucosylceramide metabolic process,BP,
3104,GO:0006681,1,0.599643195315081,0,6,galactosylceramide metabolic process,BP,
3108,GO:0006685,1,0.642020567783364,0,5,sphingomyelin catabolic process,BP,
3121,GO:0006700,1,0.2853430536844,0,16,C21-steroid hormone biosynthetic process,BP,
3125,GO:0006704,1,0.49878620363924,0,8,glucocorticoid biosynthetic process,BP,
3126,GO:0006705,1,0.637803693964439,0,5,mineralocorticoid biosynthetic process,BP,
3137,GO:0006729,1,0.619398286605713,0,7,tetrahydrobiopterin biosynthetic process,BP,
3142,GO:0006735,1,0.251951945496645,0,17,NADH regeneration,BP,
3166,GO:0006777,1,0.606034026650135,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3180,GO:0006797,1,0.60384324382103,0,5,polyphosphate metabolic process,BP,
3201,GO:0006833,1,0.614870083514783,0,6,water transport,BP,
3214,GO:0006857,1,0.490459338659992,0,8,oligopeptide transport,BP,
3262,GO:0006930,1,0.472889157407529,0,8,substrate-dependent cell migration, cell extension,BP,
3275,GO:0006953,1,0.247209207937978,0,17,acute-phase response,BP,
3282,GO:0006968,1,0.188075198665196,0,19,cellular defense response,BP,
3287,GO:0006975,1,0.528196026101912,0,7,DNA damage induced protein phosphorylation,BP,
3289,GO:0006978,1,0.196120166704256,0,18,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3295,GO:0006987,1,0.500698817095784,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3297,GO:0006991,1,0.447134333296966,0,9,response to sterol depletion,BP,
3302,GO:0006999,1,0.232845616186772,0,15,nuclear pore organization,BP,
3307,GO:0007007,1,0.200974363421006,0,22,inner mitochondrial membrane organization,BP,
3318,GO:0007021,1,0.630431097259142,0,7,tubulin complex assembly,BP,
3321,GO:0007028,1,0.418651544699988,0,8,cytoplasm organization,BP,
3332,GO:0007042,1,0.583033189194239,0,8,lysosomal lumen acidification,BP,
3349,GO:0007076,1,0.172089303774084,0,16,mitotic chromosome condensation,BP,
3352,GO:0007080,1,0.0297851090552698,0,43,mitotic metaphase plate congression,BP,
3358,GO:0007094,1,0.0788772829336734,0,29,mitotic spindle assembly checkpoint,BP,
3360,GO:0007096,1,0.286078928255493,0,15,regulation of exit from mitosis,BP,
3364,GO:0007100,1,0.294713639621279,0,13,mitotic centrosome separation,BP,
3370,GO:0007135,1,0.614002359150849,0,6,meiosis II,BP,
3393,GO:0007171,1,0.584809577957421,0,6,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3394,GO:0007172,1,0.52786638185907,0,7,signal complex assembly,BP,
3410,GO:0007191,1,0.612054305548431,0,6,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3424,GO:0007212,1,0.112263351650935,0,26,dopamine receptor signaling pathway,BP,
3425,GO:0007213,1,0.435380025908059,0,10,G-protein coupled acetylcholine receptor signaling pathway,BP,
3428,GO:0007216,1,0.647931190995037,0,5,G-protein coupled glutamate receptor signaling pathway,BP,
3443,GO:0007252,1,0.312033148115641,0,13,I-kappaB phosphorylation,BP,
3469,GO:0007289,1,0.339674991568512,0,11,spermatid nucleus differentiation,BP,
3479,GO:0007339,1,0.336036496623037,0,15,binding of sperm to zona pellucida,BP,
3493,GO:0007379,1,0.387534622316941,0,11,segment specification,BP,
3507,GO:0007413,1,0.220492861801656,0,14,axonal fasciculation,BP,
3538,GO:0007530,1,0.339740798179875,0,12,sex determination,BP,
3542,GO:0007549,1,0.285421096832229,0,12,dosage compensation,BP,
3545,GO:0007567,1,0.454442276429831,0,9,parturition,BP,
3563,GO:0007603,1,0.248091565946263,0,16,phototransduction, visible light,BP,
3566,GO:0007608,1,0.283197827307709,0,14,sensory perception of smell,BP,
3598,GO:0008024,1,0.462065855624354,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3624,GO:0008079,1,0.583827826327536,0,6,translation termination factor activity,MF,
3630,GO:0008090,1,0.508758633517492,0,7,retrograde axonal transport,BP,
3631,GO:0008091,1,0.459539726635954,0,6,spectrin,CC,
3649,GO:0008121,1,0.638326679839907,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3658,GO:0008139,1,0.0952547586916456,0,23,nuclear localization sequence binding,MF,
3661,GO:0008143,1,0.270415876498169,0,14,poly(A) binding,MF,
3663,GO:0008146,1,0.0849655091449015,0,28,sulfotransferase activity,MF,
3667,GO:0008156,1,0.0473136067630272,0,33,negative regulation of DNA replication,BP,
3668,GO:0008157,1,0.293382123101576,0,14,protein phosphatase 1 binding,MF,
3675,GO:0008172,1,0.641641202999577,0,5,S-methyltransferase activity,MF,
3678,GO:0008175,1,0.0919274965043713,0,28,tRNA methyltransferase activity,MF,
3680,GO:0008177,1,0.698426604242048,0,5,succinate dehydrogenase (ubiquinone) activity,MF,
3681,GO:0008179,1,0.381968401540061,0,10,adenylate cyclase binding,MF,
3682,GO:0008180,1,0.098644797121658,0,27,COP9 signalosome,CC,
3685,GO:0008187,1,0.163991999252536,0,20,poly-pyrimidine tract binding,MF,
3701,GO:0008207,1,0.20958113651027,0,20,C21-steroid hormone metabolic process,BP,
3704,GO:0008211,1,0.341440335019047,0,13,glucocorticoid metabolic process,BP,
3705,GO:0008212,1,0.637803693964439,0,5,mineralocorticoid metabolic process,BP,
3708,GO:0008215,1,0.668508645202183,0,6,spermine metabolic process,BP,
3709,GO:0008216,1,0.634527181230835,0,7,spermidine metabolic process,BP,
3721,GO:0008239,1,0.615075085576389,0,6,dipeptidyl-peptidase activity,MF,
3723,GO:0008242,1,0.508954461939789,0,8,omega peptidase activity,MF,
3732,GO:0008266,1,0.240551004505025,0,16,poly(U) RNA binding,MF,
3736,GO:0008271,1,0.609667042202123,0,5,secondary active sulfate transmembrane transporter activity,MF,
3737,GO:0008272,1,0.519801044261539,0,7,sulfate transport,BP,
3739,GO:0008274,1,0.453015577956769,0,8,gamma-tubulin ring complex,CC,
3752,GO:0008290,1,0.616579797038156,0,6,F-actin capping protein complex,CC,
3755,GO:0008296,1,0.527342266624068,0,8,3'-5'-exodeoxyribonuclease activity,MF,
3756,GO:0008297,1,0.593606496190313,0,6,single-stranded DNA exodeoxyribonuclease activity,MF,
3757,GO:0008298,1,0.392508803305769,0,12,intracellular mRNA localization,BP,
3768,GO:0008312,1,0.60861944845621,0,7,7S RNA binding,MF,
3770,GO:0008320,1,0.422463461626397,0,13,protein transmembrane transporter activity,MF,
3788,GO:0008353,1,0.281338905849244,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
3789,GO:0008354,1,0.534339520622392,0,7,germ cell migration,BP,
3805,GO:0008385,1,0.451367256501167,0,9,IkappaB kinase complex,CC,
3808,GO:0008395,1,0.53414767139427,0,8,steroid hydroxylase activity,MF,
3816,GO:0008408,1,0.017831051265803,0,46,3'-5' exonuclease activity,MF,
3820,GO:0008417,1,0.407110317437211,0,10,fucosyltransferase activity,MF,
3830,GO:0008429,1,0.518524307693985,0,8,phosphatidylethanolamine binding,MF,
3833,GO:0008432,1,0.478732985610659,0,8,JUN kinase binding,MF,
3838,GO:0008443,1,0.568431834691332,0,6,phosphofructokinase activity,MF,
3880,GO:0008510,1,0.578863416390841,0,5,sodium:bicarbonate symporter activity,MF,
3893,GO:0008527,1,0.734971261775896,0,5,taste receptor activity,MF,
3902,GO:0008541,1,0.629531018671453,0,7,proteasome regulatory particle, lid subcomplex,CC,
3907,GO:0008553,1,0.458876659451994,0,9,proton-exporting ATPase activity, phosphorylative mechanism,MF,
3912,GO:0008568,1,0.40121945762775,0,10,microtubule-severing ATPase activity,MF,
3913,GO:0008569,1,0.218139303976814,0,11,ATP-dependent microtubule motor activity, minus-end-directed,MF,
3928,GO:0008608,1,0.0898223068530742,0,28,attachment of spindle microtubules to kinetochore,BP,
3931,GO:0008611,1,0.641920647184298,0,5,ether lipid biosynthetic process,BP,
3937,GO:0008622,1,0.672755660650174,0,5,epsilon DNA polymerase complex,CC,
3941,GO:0008627,1,0.515564146323908,0,7,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
3943,GO:0008631,1,0.0387995212485505,0,39,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
3946,GO:0008641,1,0.41713800592239,0,10,ubiquitin-like modifier activating enzyme activity,MF,
3949,GO:0008649,1,0.291473658637744,0,16,rRNA methyltransferase activity,MF,
3954,GO:0008656,1,0.299907867905618,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
3983,GO:0008821,1,0.488962426806247,0,9,crossover junction endodeoxyribonuclease activity,MF,
3984,GO:0008823,1,0.626466906412561,0,5,cupric reductase activity,MF,
4020,GO:0009048,1,0.329372011437259,0,10,dosage compensation by inactivation of X chromosome,BP,
4022,GO:0009052,1,0.689558059290009,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4040,GO:0009072,1,0.457480778366017,0,11,aromatic amino acid family metabolic process,BP,
4041,GO:0009074,1,0.59860491657799,0,8,aromatic amino acid family catabolic process,BP,
4064,GO:0009113,1,0.361652661567215,0,13,purine nucleobase biosynthetic process,BP,
4076,GO:0009129,1,0.348987968861819,0,14,pyrimidine nucleoside monophosphate metabolic process,BP,
4077,GO:0009130,1,0.348987968861819,0,14,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4080,GO:0009134,1,0.582959861255437,0,7,nucleoside diphosphate catabolic process,BP,
4089,GO:0009143,1,0.426706979406752,0,11,nucleoside triphosphate catabolic process,BP,
4092,GO:0009146,1,0.641423385688346,0,6,purine nucleoside triphosphate catabolic process,BP,
4101,GO:0009155,1,0.636763668696253,0,6,purine deoxyribonucleotide catabolic process,BP,
4116,GO:0009173,1,0.493630528966088,0,9,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4117,GO:0009174,1,0.493630528966088,0,9,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4118,GO:0009176,1,0.707156706915458,0,5,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4119,GO:0009177,1,0.707156706915458,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4132,GO:0009191,1,0.633104200009986,0,6,ribonucleoside diphosphate catabolic process,BP,
4143,GO:0009204,1,0.598586925593554,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4149,GO:0009211,1,0.676722795751235,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4155,GO:0009217,1,0.678241127323996,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4157,GO:0009219,1,0.293354581678437,0,18,pyrimidine deoxyribonucleotide metabolic process,BP,
4159,GO:0009221,1,0.578129399673347,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4161,GO:0009223,1,0.473836120399507,0,11,pyrimidine deoxyribonucleotide catabolic process,BP,
4172,GO:0009240,1,0.717485446948953,0,5,isopentenyl diphosphate biosynthetic process,BP,
4175,GO:0009249,1,0.668951194836618,0,7,protein lipoylation,BP,
4186,GO:0009263,1,0.382358562583342,0,13,deoxyribonucleotide biosynthetic process,BP,
4187,GO:0009264,1,0.282190549075981,0,18,deoxyribonucleotide catabolic process,BP,
4188,GO:0009265,1,0.50996289926703,0,10,2'-deoxyribonucleotide biosynthetic process,BP,
4192,GO:0009295,1,0.0344156028956213,0,40,nucleoid,CC,
4196,GO:0009303,1,0.101348309693567,0,27,rRNA transcription,BP,
4197,GO:0009304,1,0.532807085942731,0,7,tRNA transcription,BP,
4216,GO:0009378,1,0.601390544632782,0,5,four-way junction helicase activity,MF,
4222,GO:0009396,1,0.494189013719882,0,9,folic acid-containing compound biosynthetic process,BP,
4234,GO:0009414,1,0.637931425762028,0,6,response to water deprivation,BP,
4259,GO:0009595,1,0.442287321558532,0,9,detection of biotic stimulus,BP,
4260,GO:0009597,1,0.651611211989306,0,5,detection of virus,BP,
4269,GO:0009620,1,0.226684511587994,0,20,response to fungus,BP,
4272,GO:0009629,1,0.616616045349106,0,6,response to gravity,BP,
4277,GO:0009642,1,0.529827726174753,0,7,response to light intensity,BP,
4284,GO:0009651,1,0.283436919412739,0,15,response to salt stress,BP,
4291,GO:0009713,1,0.435377144993879,0,10,catechol-containing compound biosynthetic process,BP,
4305,GO:0009756,1,0.629560975642452,0,6,carbohydrate mediated signaling,BP,
4306,GO:0009757,1,0.679998744634687,0,5,hexose mediated signaling,BP,
4320,GO:0009812,1,0.519006967124002,0,9,flavonoid metabolic process,BP,
4326,GO:0009838,1,0.698427872752901,0,5,abscission,BP,
4347,GO:0009912,1,0.640586132688988,0,5,auditory receptor cell fate commitment,BP,
4367,GO:0009982,1,0.371944980711248,0,13,pseudouridine synthase activity,MF,
4376,GO:0010002,1,0.456817605294206,0,8,cardioblast differentiation,BP,
4378,GO:0010009,1,0.666853430438419,0,5,cytoplasmic side of endosome membrane,CC,
4381,GO:0010032,1,0.574530132350664,0,5,meiotic chromosome condensation,BP,
4388,GO:0010041,1,0.660621176926466,0,5,response to iron(III) ion,BP,
4413,GO:0010172,1,0.343626436204942,0,10,embryonic body morphogenesis,BP,
4415,GO:0010182,1,0.679998744634687,0,5,sugar mediated signaling pathway,BP,
4426,GO:0010255,1,0.679998744634687,0,5,glucose mediated signaling pathway,BP,
4431,GO:0010265,1,0.585452109822165,0,6,SCF complex assembly,BP,
4435,GO:0010286,1,0.708244123867685,0,5,heat acclimation,BP,
4449,GO:0010385,1,0.640330348741392,0,5,double-stranded methylated DNA binding,MF,
4459,GO:0010452,1,0.383894503148534,0,9,histone H3-K36 methylation,BP,
4463,GO:0010457,1,0.305169212650811,0,11,centriole-centriole cohesion,BP,
4464,GO:0010458,1,0.109124555464197,0,26,exit from mitosis,BP,
4466,GO:0010460,1,0.43961469077572,0,10,positive regulation of heart rate,BP,
4479,GO:0010485,1,0.18100363810568,0,18,H4 histone acetyltransferase activity,MF,
4482,GO:0010499,1,0.240922187686167,0,22,proteasomal ubiquitin-independent protein catabolic process,BP,
4483,GO:0010501,1,0.0248475121158141,0,42,RNA secondary structure unwinding,BP,
4488,GO:0010510,1,0.343674675423788,0,11,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4494,GO:0010519,1,0.601486729966435,0,6,negative regulation of phospholipase activity,BP,
4510,GO:0010560,1,0.299731183459895,0,13,positive regulation of glycoprotein biosynthetic process,BP,
4516,GO:0010566,1,0.453818731882606,0,9,regulation of ketone biosynthetic process,BP,
4524,GO:0010586,1,0.152644908339139,0,21,miRNA metabolic process,BP,
4525,GO:0010587,1,0.619094863454971,0,5,miRNA catabolic process,BP,
4535,GO:0010606,1,0.560939761225449,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4539,GO:0010612,1,0.523608833496653,0,6,regulation of cardiac muscle adaptation,BP,
4543,GO:0010616,1,0.582362169539511,0,5,negative regulation of cardiac muscle adaptation,BP,
4545,GO:0010623,1,0.511388537139615,0,7,programmed cell death involved in cell development,BP,
4584,GO:0010669,1,0.310949433388608,0,13,epithelial structure maintenance,BP,
4604,GO:0010719,1,0.234079842130034,0,18,negative regulation of epithelial to mesenchymal transition,BP,
4621,GO:0010739,1,0.666076666822762,0,5,positive regulation of protein kinase A signaling,BP,
4637,GO:0010759,1,0.55848922462158,0,7,positive regulation of macrophage chemotaxis,BP,
4650,GO:0010792,1,0.600115397095378,0,6,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4651,GO:0010793,1,0.608641577409868,0,5,regulation of mRNA export from nucleus,BP,
4660,GO:0010807,1,0.570223484455802,0,6,regulation of synaptic vesicle priming,BP,
4670,GO:0010818,1,0.463851184908719,0,9,T cell chemotaxis,BP,
4671,GO:0010819,1,0.595002367590198,0,6,regulation of T cell chemotaxis,BP,
4672,GO:0010820,1,0.595002367590198,0,6,positive regulation of T cell chemotaxis,BP,
4688,GO:0010837,1,0.0912268043608859,0,24,regulation of keratinocyte proliferation,BP,
4689,GO:0010838,1,0.607999261618362,0,5,positive regulation of keratinocyte proliferation,BP,
4690,GO:0010839,1,0.257790723811287,0,13,negative regulation of keratinocyte proliferation,BP,
4704,GO:0010866,1,0.324977284803556,0,13,regulation of triglyceride biosynthetic process,BP,
4705,GO:0010867,1,0.468921489671178,0,9,positive regulation of triglyceride biosynthetic process,BP,
4708,GO:0010870,1,0.433995687601077,0,10,positive regulation of receptor biosynthetic process,BP,
4722,GO:0010884,1,0.310853622083535,0,13,positive regulation of lipid storage,BP,
4743,GO:0010911,1,0.504412929053088,0,7,regulation of isomerase activity,BP,
4744,GO:0010912,1,0.504412929053088,0,7,positive regulation of isomerase activity,BP,
4748,GO:0010918,1,0.558046827295019,0,7,positive regulation of mitochondrial membrane potential,BP,
4757,GO:0010934,1,0.405269698982911,0,10,macrophage cytokine production,BP,
4758,GO:0010935,1,0.483176766049219,0,8,regulation of macrophage cytokine production,BP,
4759,GO:0010936,1,0.630108240059697,0,5,negative regulation of macrophage cytokine production,BP,
4764,GO:0010944,1,0.608879413483473,0,6,negative regulation of transcription by competitive promoter binding,BP,
4782,GO:0010968,1,0.606449866236753,0,6,regulation of microtubule nucleation,BP,
4793,GO:0010984,1,0.422072047981787,0,11,regulation of lipoprotein particle clearance,BP,
4794,GO:0010985,1,0.692677549398625,0,5,negative regulation of lipoprotein particle clearance,BP,
4796,GO:0010988,1,0.626927118007369,0,6,regulation of low-density lipoprotein particle clearance,BP,
4801,GO:0010994,1,0.678321862772327,0,5,free ubiquitin chain polymerization,BP,
4803,GO:0010997,1,0.638628779656293,0,5,anaphase-promoting complex binding,MF,
4816,GO:0014010,1,0.573254292527338,0,5,Schwann cell proliferation,BP,
4840,GO:0014046,1,0.462338233187094,0,9,dopamine secretion,BP,
4848,GO:0014059,1,0.462338233187094,0,9,regulation of dopamine secretion,BP,
4872,GO:0014733,1,0.434160581216097,0,8,regulation of skeletal muscle adaptation,BP,
4883,GO:0014745,1,0.407149949013672,0,9,negative regulation of muscle adaptation,BP,
4887,GO:0014807,1,0.590533163616368,0,6,regulation of somitogenesis,BP,
4893,GO:0014819,1,0.694330727215486,0,5,regulation of skeletal muscle contraction,BP,
4907,GO:0014841,1,0.506738595249808,0,7,skeletal muscle satellite cell proliferation,BP,
4908,GO:0014842,1,0.506738595249808,0,7,regulation of skeletal muscle satellite cell proliferation,BP,
4918,GO:0014856,1,0.506738595249808,0,7,skeletal muscle cell proliferation,BP,
4919,GO:0014857,1,0.506738595249808,0,7,regulation of skeletal muscle cell proliferation,BP,
4932,GO:0014889,1,0.551374983291947,0,7,muscle atrophy,BP,
4942,GO:0014904,1,0.251154703296105,0,15,myotube cell development,BP,
4950,GO:0015012,1,0.139764732595237,0,20,heparan sulfate proteoglycan biosynthetic process,BP,
4956,GO:0015020,1,0.308675517305808,0,14,glucuronosyltransferase activity,MF,
4963,GO:0015038,1,0.740702133750752,0,5,glutathione disulfide oxidoreductase activity,MF,
4983,GO:0015106,1,0.323335975542215,0,11,bicarbonate transmembrane transporter activity,MF,
4987,GO:0015114,1,0.491831895633437,0,7,phosphate ion transmembrane transporter activity,MF,
4988,GO:0015116,1,0.568957626678276,0,6,sulfate transmembrane transporter activity,MF,
5014,GO:0015174,1,0.489525548412602,0,8,basic amino acid transmembrane transporter activity,MF,
5017,GO:0015180,1,0.625326140650379,0,5,L-alanine transmembrane transporter activity,MF,
5018,GO:0015181,1,0.622398214049916,0,5,arginine transmembrane transporter activity,MF,
5024,GO:0015187,1,0.644791311460363,0,5,glycine transmembrane transporter activity,MF,
5025,GO:0015189,1,0.622398214049916,0,5,L-lysine transmembrane transporter activity,MF,
5028,GO:0015193,1,0.606892430689866,0,5,L-proline transmembrane transporter activity,MF,
5029,GO:0015194,1,0.573398307191127,0,7,L-serine transmembrane transporter activity,MF,
5048,GO:0015232,1,0.517426713898423,0,7,heme transporter activity,MF,
5051,GO:0015245,1,0.663813053388629,0,5,fatty acid transmembrane transporter activity,MF,
5059,GO:0015269,1,0.562863110088214,0,7,calcium-activated potassium channel activity,MF,
5067,GO:0015288,1,0.653709523876258,0,6,porin activity,MF,
5094,GO:0015368,1,0.544868394314075,0,6,calcium:cation antiporter activity,MF,
5117,GO:0015450,1,0.643001653635726,0,7,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5119,GO:0015464,1,0.59313212437186,0,6,acetylcholine receptor activity,MF,
5136,GO:0015643,1,0.599807027612124,0,6,toxic substance binding,MF,
5137,GO:0015645,1,0.412416961251766,0,10,fatty acid ligase activity,MF,
5138,GO:0015651,1,0.59335714671662,0,6,quaternary ammonium group transmembrane transporter activity,MF,
5162,GO:0015701,1,0.164955309217945,0,19,bicarbonate transport,BP,
5176,GO:0015732,1,0.520348531487382,0,8,prostaglandin transport,BP,
5204,GO:0015802,1,0.503049277074547,0,8,basic amino acid transport,BP,
5209,GO:0015808,1,0.625326140650379,0,5,L-alanine transport,BP,
5210,GO:0015809,1,0.589086818410013,0,6,arginine transport,BP,
5215,GO:0015816,1,0.576371428143563,0,6,glycine transport,BP,
5221,GO:0015824,1,0.547238179179461,0,6,proline transport,BP,
5222,GO:0015825,1,0.573398307191127,0,7,L-serine transport,BP,
5248,GO:0015874,1,0.630025856955664,0,5,norepinephrine transport,BP,
5255,GO:0015884,1,0.647548858423637,0,5,folic acid transport,BP,
5256,GO:0015886,1,0.517426713898423,0,7,heme transport,BP,
5266,GO:0015911,1,0.600828680284081,0,5,plasma membrane long-chain fatty acid transport,BP,
5276,GO:0015926,1,0.433323203063949,0,8,glucosidase activity,MF,
5281,GO:0015934,1,0.00107620009051279,0,115,large ribosomal subunit,CC,
5286,GO:0015939,1,0.64920060607765,0,5,pantothenate metabolic process,BP,
5297,GO:0015985,1,0.544861108103867,0,8,energy coupled proton transport, down electrochemical gradient,BP,
5298,GO:0015986,1,0.544861108103867,0,8,ATP synthesis coupled proton transport,BP,
5302,GO:0016004,1,0.502042396505017,0,8,phospholipase activator activity,MF,
5309,GO:0016018,1,0.456881683478572,0,10,cyclosporin A binding,MF,
5321,GO:0016045,1,0.527953633395178,0,7,detection of bacterium,BP,
5330,GO:0016056,1,0.309216426973948,0,13,rhodopsin mediated signaling pathway,BP,
5340,GO:0016078,1,0.657215981844147,0,6,tRNA catabolic process,BP,
5344,GO:0016082,1,0.347933047585604,0,11,synaptic vesicle priming,BP,
5411,GO:0016255,1,0.540376807353804,0,7,attachment of GPI anchor to protein,BP,
5417,GO:0016264,1,0.519183873106564,0,7,gap junction assembly,BP,
5421,GO:0016272,1,0.679808437261508,0,7,prefoldin complex,CC,
5425,GO:0016278,1,0.011605707977619,0,48,lysine N-methyltransferase activity,MF,
5426,GO:0016279,1,0.0126257501279717,0,47,protein-lysine N-methyltransferase activity,MF,
5427,GO:0016281,1,0.449817787855219,0,9,eukaryotic translation initiation factor 4F complex,CC,
5441,GO:0016308,1,0.552078517861604,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5450,GO:0016322,1,0.561182949468055,0,6,neuron remodeling,BP,
5460,GO:0016339,1,0.197110926422839,0,17,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,
5462,GO:0016342,1,0.269118441841056,0,13,catenin complex,CC,
5487,GO:0016421,1,0.54912754105615,0,6,CoA carboxylase activity,MF,
5489,GO:0016423,1,0.342806010209182,0,13,tRNA (guanine) methyltransferase activity,MF,
5491,GO:0016427,1,0.49507191316445,0,8,tRNA (cytosine) methyltransferase activity,MF,
5495,GO:0016433,1,0.639834322143809,0,6,rRNA (adenine) methyltransferase activity,MF,
5500,GO:0016442,1,0.327935591251213,0,11,RISC complex,CC,
5510,GO:0016461,1,0.49866810298218,0,7,unconventional myosin complex,CC,
5513,GO:0016471,1,0.414192703035605,0,11,vacuolar proton-transporting V-type ATPase complex,CC,
5525,GO:0016500,1,0.529509010407454,0,6,protein-hormone receptor activity,MF,
5526,GO:0016502,1,0.623651868993643,0,6,nucleotide receptor activity,MF,
5529,GO:0016505,1,0.250238636859885,0,16,peptidase activator activity involved in apoptotic process,MF,
5533,GO:0016514,1,0.279482437634393,0,13,SWI/SNF complex,CC,
5541,GO:0016530,1,0.636059141577388,0,6,metallochaperone activity,MF,
5542,GO:0016531,1,0.72032071052937,0,5,copper chaperone activity,MF,
5552,GO:0016558,1,0.360476834862271,0,12,protein import into peroxisome matrix,BP,
5553,GO:0016559,1,0.60767765280456,0,7,peroxisome fission,BP,
5566,GO:0016578,1,0.144382907555972,0,21,histone deubiquitination,BP,
5575,GO:0016592,1,0.0472395508816532,0,35,mediator complex,CC,
5576,GO:0016593,1,0.468615864645588,0,8,Cdc73/Paf1 complex,CC,
5590,GO:0016615,1,0.631273604146206,0,6,malate dehydrogenase activity,MF,
5599,GO:0016635,1,0.650017259077705,0,6,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5622,GO:0016679,1,0.589391015627714,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5623,GO:0016681,1,0.638326679839907,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5632,GO:0016712,1,0.439739776227755,0,10,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
5635,GO:0016717,1,0.626249814222278,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
5637,GO:0016722,1,0.276812451333044,0,14,oxidoreductase activity, oxidizing metal ions,MF,
5638,GO:0016723,1,0.402765857829597,0,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
5684,GO:0016799,1,0.229249423511103,0,20,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
5692,GO:0016812,1,0.584085963553615,0,5,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
5704,GO:0016832,1,0.57924794884813,0,7,aldehyde-lyase activity,MF,
5724,GO:0016863,1,0.51604320430451,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
5735,GO:0016881,1,0.26964124456106,0,15,acid-amino acid ligase activity,MF,
5739,GO:0016886,1,0.433132027563479,0,10,ligase activity, forming phosphoric ester bonds,MF,
5742,GO:0016889,1,0.22502056811965,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
5745,GO:0016892,1,0.663731576860969,0,6,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
5747,GO:0016894,1,0.149260791151693,0,26,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
5748,GO:0016895,1,0.238688269863787,0,17,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
5760,GO:0016922,1,0.158740464048973,0,18,ligand-dependent nuclear receptor binding,MF,
5762,GO:0016926,1,0.508088277422308,0,7,protein desumoylation,BP,
5763,GO:0016929,1,0.542599061881153,0,6,SUMO-specific protease activity,MF,
5772,GO:0016973,1,0.425148460431033,0,10,poly(A)+ mRNA export from nucleus,BP,
5778,GO:0017000,1,0.285527725559123,0,14,antibiotic biosynthetic process,BP,
5788,GO:0017017,1,0.38362437790886,0,12,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
5803,GO:0017056,1,0.0898364258376142,0,25,structural constituent of nuclear pore,MF,
5808,GO:0017062,1,0.479540112763424,0,9,respiratory chain complex III assembly,BP,
5811,GO:0017069,1,0.0530450707976098,0,38,snRNA binding,MF,
5812,GO:0017070,1,0.426914145983003,0,11,U6 snRNA binding,MF,
5816,GO:0017081,1,0.382102093740217,0,11,chloride channel regulator activity,MF,
5822,GO:0017091,1,0.165209468672378,0,21,AU-rich element binding,MF,
5826,GO:0017101,1,0.375397734222851,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
5828,GO:0017108,1,0.597992851881434,0,6,5'-flap endonuclease activity,MF,
5830,GO:0017110,1,0.332111977036811,0,13,nucleoside-diphosphatase activity,MF,
5836,GO:0017121,1,0.55715968195758,0,7,phospholipid scrambling,BP,
5841,GO:0017128,1,0.599439451546972,0,6,phospholipid scramblase activity,MF,
5845,GO:0017136,1,0.238616646285134,0,16,NAD-dependent histone deacetylase activity,MF,
5854,GO:0017151,1,0.523370958855711,0,7,DEAD/H-box RNA helicase binding,MF,
5862,GO:0017162,1,0.476201700178241,0,8,aryl hydrocarbon receptor binding,MF,
5863,GO:0017166,1,0.330791027126287,0,10,vinculin binding,MF,
5865,GO:0017169,1,0.595127623464395,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
5870,GO:0017182,1,0.477403268596458,0,9,peptidyl-diphthamide metabolic process,BP,
5871,GO:0017183,1,0.477403268596458,0,9,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
5872,GO:0017185,1,0.497726813481946,0,8,peptidyl-lysine hydroxylation,BP,
5875,GO:0017196,1,0.582337608669656,0,6,N-terminal peptidyl-methionine acetylation,BP,
5886,GO:0018024,1,0.0225029202017803,0,40,histone-lysine N-methyltransferase activity,MF,
5888,GO:0018026,1,0.441329794064462,0,9,peptidyl-lysine monomethylation,BP,
5889,GO:0018027,1,0.271819772771342,0,14,peptidyl-lysine dimethylation,BP,
5896,GO:0018095,1,0.525365042466108,0,7,protein polyglutamylation,BP,
5898,GO:0018103,1,0.555964714921005,0,6,protein C-linked glycosylation,BP,
5925,GO:0018200,1,0.281845775797692,0,15,peptidyl-glutamic acid modification,BP,
5927,GO:0018202,1,0.402049732999294,0,11,peptidyl-histidine modification,BP,
5929,GO:0018206,1,0.424610822205955,0,10,peptidyl-methionine modification,BP,
5933,GO:0018211,1,0.555964714921005,0,6,peptidyl-tryptophan modification,BP,
5954,GO:0018317,1,0.555964714921005,0,6,protein C-linked glycosylation via tryptophan,BP,
5969,GO:0018401,1,0.643719148446572,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
5970,GO:0018406,1,0.555964714921005,0,6,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6002,GO:0019042,1,0.388314527414909,0,11,viral latency,BP,
6003,GO:0019043,1,0.499849112310247,0,9,establishment of viral latency,BP,
6023,GO:0019081,1,0.293423844858135,0,14,viral translation,BP,
6034,GO:0019103,1,0.641848643160647,0,6,pyrimidine nucleotide binding,MF,
6035,GO:0019104,1,0.365975062042771,0,15,DNA N-glycosylase activity,MF,
6053,GO:0019200,1,0.189397691969233,0,19,carbohydrate kinase activity,MF,
6056,GO:0019203,1,0.633161422937574,0,5,carbohydrate phosphatase activity,MF,
6063,GO:0019211,1,0.422568923245207,0,10,phosphatase activator activity,MF,
6066,GO:0019215,1,0.339650513283387,0,11,intermediate filament binding,MF,
6082,GO:0019238,1,0.619019675971904,0,6,cyclohydrolase activity,MF,
6097,GO:0019317,1,0.562406775018455,0,6,fucose catabolic process,BP,
6101,GO:0019321,1,0.47070193564047,0,11,pentose metabolic process,BP,
6104,GO:0019336,1,0.663309262223338,0,5,phenol-containing compound catabolic process,BP,
6123,GO:0019371,1,0.555587600568883,0,7,cyclooxygenase pathway,BP,
6125,GO:0019373,1,0.606506796205149,0,6,epoxygenase P450 pathway,BP,
6126,GO:0019374,1,0.599643195315081,0,6,galactolipid metabolic process,BP,
6129,GO:0019377,1,0.412823661345878,0,11,glycolipid catabolic process,BP,
6137,GO:0019405,1,0.559643269513598,0,6,alditol catabolic process,BP,
6145,GO:0019430,1,0.272846456668926,0,17,removal of superoxide radicals,BP,
6160,GO:0019509,1,0.676416799524474,0,5,L-methionine salvage from methylthioadenosine,BP,
6170,GO:0019531,1,0.609667042202123,0,5,oxalate transmembrane transporter activity,MF,
6171,GO:0019532,1,0.609667042202123,0,5,oxalate transport,BP,
6183,GO:0019563,1,0.605407555066777,0,5,glycerol catabolic process,BP,
6186,GO:0019614,1,0.663309262223338,0,5,catechol-containing compound catabolic process,BP,
6191,GO:0019646,1,0.431657041171858,0,14,aerobic electron transport chain,BP,
6196,GO:0019673,1,0.639896854648435,0,7,GDP-mannose metabolic process,BP,
6207,GO:0019720,1,0.606034026650135,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6212,GO:0019731,1,0.382299211752937,0,17,antibacterial humoral response,BP,
6223,GO:0019773,1,0.6761226860236,0,7,proteasome core complex, alpha-subunit complex,CC,
6224,GO:0019774,1,0.584075309270519,0,10,proteasome core complex, beta-subunit complex,CC,
6236,GO:0019788,1,0.649934053520678,0,6,NEDD8 transferase activity,MF,
6237,GO:0019789,1,0.242593310614887,0,16,SUMO transferase activity,MF,
6239,GO:0019798,1,0.613362146987267,0,6,procollagen-proline dioxygenase activity,MF,
6263,GO:0019856,1,0.543595359580122,0,6,pyrimidine nucleobase biosynthetic process,BP,
6274,GO:0019869,1,0.543420403639711,0,7,chloride channel inhibitor activity,MF,
6275,GO:0019870,1,0.596677257850127,0,5,potassium channel inhibitor activity,MF,
6276,GO:0019871,1,0.596843390762234,0,5,sodium channel inhibitor activity,MF,
6279,GO:0019883,1,0.391739861002955,0,11,antigen processing and presentation of endogenous antigen,BP,
6281,GO:0019885,1,0.534774981796347,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6286,GO:0019896,1,0.342645008047657,0,11,axonal transport of mitochondrion,BP,
6296,GO:0019907,1,0.571681135603657,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6297,GO:0019908,1,0.248185590083868,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6319,GO:0019966,1,0.557910821917723,0,7,interleukin-1 binding,MF,
6322,GO:0019985,1,0.0360529238908376,0,39,translesion synthesis,BP,
6324,GO:0019992,1,0.470778722110569,0,8,diacylglycerol binding,MF,
6330,GO:0020027,1,0.510566038775268,0,8,hemoglobin metabolic process,BP,
6337,GO:0021511,1,0.437262108829047,0,8,spinal cord patterning,BP,
6339,GO:0021513,1,0.484427197198075,0,7,spinal cord dorsal/ventral patterning,BP,
6344,GO:0021520,1,0.559582333371979,0,6,spinal cord motor neuron cell fate specification,BP,
6353,GO:0021534,1,0.5982848001413,0,5,cell proliferation in hindbrain,BP,
6361,GO:0021542,1,0.470148792753317,0,8,dentate gyrus development,BP,
6367,GO:0021548,1,0.621238609309985,0,5,pons development,BP,
6413,GO:0021670,1,0.464799988903398,0,8,lateral ventricle development,BP,
6426,GO:0021692,1,0.376429660887262,0,8,cerebellar Purkinje cell layer morphogenesis,BP,
6428,GO:0021694,1,0.531400175242341,0,5,cerebellar Purkinje cell layer formation,BP,
6435,GO:0021702,1,0.531400175242341,0,5,cerebellar Purkinje cell differentiation,BP,
6460,GO:0021781,1,0.630007379569875,0,5,glial cell fate commitment,BP,
6471,GO:0021800,1,0.581589328995881,0,5,cerebral cortex tangential migration,BP,
6474,GO:0021814,1,0.482504086563152,0,7,cell motility involved in cerebral cortex radial glia guided migration,BP,
6475,GO:0021815,1,0.576326165497506,0,5,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6494,GO:0021854,1,0.398753894906913,0,11,hypothalamus development,BP,
6497,GO:0021859,1,0.592993307528189,0,5,pyramidal neuron differentiation,BP,
6498,GO:0021860,1,0.592993307528189,0,5,pyramidal neuron development,BP,
6499,GO:0021861,1,0.572537705514116,0,7,forebrain radial glial cell differentiation,BP,
6505,GO:0021877,1,0.618006434931579,0,5,forebrain neuron fate commitment,BP,
6506,GO:0021879,1,0.0807306014039511,0,27,forebrain neuron differentiation,BP,
6509,GO:0021884,1,0.210054411185877,0,16,forebrain neuron development,BP,
6513,GO:0021889,1,0.54743171682323,0,6,olfactory bulb interneuron differentiation,BP,
6514,GO:0021891,1,0.582117269535521,0,5,olfactory bulb interneuron development,BP,
6518,GO:0021895,1,0.394563108991448,0,10,cerebral cortex neuron differentiation,BP,
6525,GO:0021910,1,0.529621278471434,0,6,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6528,GO:0021924,1,0.5982848001413,0,5,cell proliferation in external granule layer,BP,
6529,GO:0021930,1,0.5982848001413,0,5,cerebellar granule cell precursor proliferation,BP,
6530,GO:0021932,1,0.496360548928815,0,7,hindbrain radial glia guided cell migration,BP,
6550,GO:0021978,1,0.654282085566749,0,5,telencephalon regionalization,BP,
6553,GO:0021984,1,0.643280998344039,0,5,adenohypophysis development,BP,
6560,GO:0021999,1,0.641457192779914,0,5,neural plate anterior/posterior regionalization,BP,
6564,GO:0022010,1,0.496010056096389,0,8,central nervous system myelination,BP,
6574,GO:0022400,1,0.365314615986329,0,11,regulation of rhodopsin mediated signaling pathway,BP,
6589,GO:0022602,1,0.075352059763641,0,26,ovulation cycle process,BP,
6599,GO:0022616,1,0.113060079640999,0,25,DNA strand elongation,BP,
6604,GO:0022625,1,0.0261569016204503,0,63,cytosolic large ribosomal subunit,CC,
6605,GO:0022626,1,0.0014808697603133,0,110,cytosolic ribosome,CC,
6606,GO:0022627,1,0.0788745355771438,0,43,cytosolic small ribosomal subunit,CC,
6611,GO:0022829,1,0.356759863114028,0,13,wide pore channel activity,MF,
6627,GO:0022858,1,0.625326140650379,0,5,alanine transmembrane transporter activity,MF,
6628,GO:0022884,1,0.382733649812371,0,14,macromolecule transmembrane transporter activity,MF,
6629,GO:0022889,1,0.573398307191127,0,7,serine transmembrane transporter activity,MF,
6638,GO:0023023,1,0.410654304830012,0,12,MHC protein complex binding,MF,
6641,GO:0023026,1,0.483017704997371,0,10,MHC class II protein complex binding,MF,
6644,GO:0023035,1,0.583437810045124,0,6,CD40 signaling pathway,BP,
6653,GO:0030002,1,0.541155830738613,0,6,cellular anion homeostasis,BP,
6657,GO:0030008,1,0.380996387953601,0,13,TRAPP complex,CC,
6659,GO:0030011,1,0.389919725097107,0,9,maintenance of cell polarity,BP,
6661,GO:0030015,1,0.638936092886373,0,5,CCR4-NOT core complex,CC,
6684,GO:0030049,1,0.21887524192391,0,15,muscle filament sliding,BP,
6691,GO:0030061,1,0.647004160001821,0,5,mitochondrial crista,CC,
6692,GO:0030062,1,0.604324491717156,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
6711,GO:0030121,1,0.560370507994858,0,6,AP-1 adaptor complex,CC,
6733,GO:0030149,1,0.213060463032694,0,19,sphingolipid catabolic process,BP,
6734,GO:0030150,1,0.277295696726426,0,18,protein import into mitochondrial matrix,BP,
6746,GO:0030166,1,0.0129090439279475,0,43,proteoglycan biosynthetic process,BP,
6753,GO:0030174,1,0.613417213795646,0,6,regulation of DNA-dependent DNA replication initiation,BP,
6771,GO:0030205,1,0.41180397338133,0,9,dermatan sulfate metabolic process,BP,
6772,GO:0030206,1,0.160222341714263,0,18,chondroitin sulfate biosynthetic process,BP,
6774,GO:0030208,1,0.443313048424307,0,8,dermatan sulfate biosynthetic process,BP,
6785,GO:0030220,1,0.267263348830931,0,14,platelet formation,BP,
6787,GO:0030223,1,0.580182804341566,0,7,neutrophil differentiation,BP,
6797,GO:0030238,1,0.512123428072556,0,7,male sex determination,BP,
6803,GO:0030247,1,0.548684182853211,0,6,polysaccharide binding,MF,
6819,GO:0030277,1,0.489079068286375,0,8,maintenance of gastrointestinal epithelium,BP,
6822,GO:0030280,1,0.363870286778903,0,11,structural constituent of epidermis,MF,
6825,GO:0030284,1,0.629604055832062,0,5,estrogen receptor activity,MF,
6850,GO:0030318,1,0.259146956515781,0,13,melanocyte differentiation,BP,
6851,GO:0030320,1,0.541155830738613,0,6,cellular monovalent inorganic anion homeostasis,BP,
6876,GO:0030368,1,0.569692268735511,0,6,interleukin-17 receptor activity,MF,
6901,GO:0030473,1,0.571631093667548,0,5,nuclear migration along microtubule,BP,
6906,GO:0030488,1,0.0723421643389579,0,32,tRNA methylation,BP,
6907,GO:0030490,1,0.0159497182004587,0,53,maturation of SSU-rRNA,BP,
6912,GO:0030502,1,0.553836436874849,0,6,negative regulation of bone mineralization,BP,
6931,GO:0030532,1,0.00370690935712677,0,69,small nuclear ribonucleoprotein complex,CC,
6934,GO:0030539,1,0.413515187755159,0,9,male genitalia development,BP,
6940,GO:0030548,1,0.643671072045772,0,6,acetylcholine receptor regulator activity,MF,
6949,GO:0030575,1,0.421275105512779,0,9,nuclear body organization,BP,
6965,GO:0030619,1,0.566146443028996,0,7,U1 snRNA binding,MF,
6966,GO:0030620,1,0.65293502496286,0,6,U2 snRNA binding,MF,
6967,GO:0030621,1,0.583142696964121,0,6,U4 snRNA binding,MF,
6973,GO:0030628,1,0.649961672467167,0,6,pre-mRNA 3'-splice site binding,MF,
6995,GO:0030676,1,0.328687350350219,0,11,Rac guanyl-nucleotide exchange factor activity,MF,
6996,GO:0030677,1,0.398014160858439,0,13,ribonuclease P complex,CC,
6998,GO:0030681,1,0.494406280765481,0,10,multimeric ribonuclease P complex,CC,
7001,GO:0030684,1,0.00218079076411952,0,74,preribosome,CC,
7002,GO:0030686,1,0.0645972937032631,0,32,90S preribosome,CC,
7003,GO:0030687,1,0.142756615527665,0,24,preribosome, large subunit precursor,CC,
7004,GO:0030688,1,0.354339047573189,0,12,preribosome, small subunit precursor,CC,
7016,GO:0030728,1,0.322629055592418,0,12,ovulation,BP,
7067,GO:0030854,1,0.650397683225694,0,5,positive regulation of granulocyte differentiation,BP,
7072,GO:0030859,1,0.228683268175872,0,15,polarized epithelial cell differentiation,BP,
7081,GO:0030870,1,0.616510254329936,0,5,Mre11 complex,CC,
7098,GO:0030894,1,0.121863493262009,0,26,replisome,CC,
7100,GO:0030896,1,0.670929961530009,0,5,checkpoint clamp complex,CC,
7102,GO:0030898,1,0.404785419242432,0,8,actin-dependent ATPase activity,MF,
7107,GO:0030903,1,0.350526762867402,0,11,notochord development,BP,
7112,GO:0030911,1,0.460940725640146,0,8,TPR domain binding,MF,
7114,GO:0030914,1,0.367378445282059,0,12,STAGA complex,CC,
7115,GO:0030915,1,0.578648854119571,0,7,Smc5-Smc6 complex,CC,
7131,GO:0030955,1,0.402901022965143,0,9,potassium ion binding,MF,
7133,GO:0030957,1,0.435509376849476,0,10,Tat protein binding,MF,
7145,GO:0030990,1,0.0696309921682569,0,30,intraciliary transport particle,CC,
7146,GO:0030991,1,0.443935109288304,0,8,intraciliary transport particle A,CC,
7147,GO:0030992,1,0.204598288484053,0,19,intraciliary transport particle B,CC,
7152,GO:0031011,1,0.326095403723526,0,15,Ino80 complex,CC,
7172,GO:0031053,1,0.380968420200471,0,10,primary miRNA processing,BP,
7173,GO:0031054,1,0.310495531340443,0,13,pre-miRNA processing,BP,
7181,GO:0031063,1,0.145679228652734,0,21,regulation of histone deacetylation,BP,
7183,GO:0031065,1,0.254998998605166,0,15,positive regulation of histone deacetylation,BP,
7184,GO:0031069,1,0.205390963838153,0,17,hair follicle morphogenesis,BP,
7189,GO:0031077,1,0.543737655307925,0,7,post-embryonic camera-type eye development,BP,
7190,GO:0031078,1,0.34970098386265,0,11,histone deacetylase activity (H3-K14 specific),MF,
7191,GO:0031080,1,0.398061241025783,0,10,nuclear pore outer ring,CC,
7193,GO:0031082,1,0.23522503618259,0,18,BLOC complex,CC,
7194,GO:0031083,1,0.378595400299079,0,13,BLOC-1 complex,CC,
7197,GO:0031086,1,0.498697956739903,0,8,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7198,GO:0031087,1,0.543371719528674,0,7,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
7199,GO:0031088,1,0.629621575354346,0,5,platelet dense granule membrane,CC,
7200,GO:0031089,1,0.668791399323625,0,5,platelet dense granule lumen,CC,
7221,GO:0031115,1,0.456485767677112,0,9,negative regulation of microtubule polymerization,BP,
7225,GO:0031119,1,0.608772937657213,0,7,tRNA pseudouridine synthesis,BP,
7228,GO:0031123,1,4.33938885843829e-05,0,119,RNA 3'-end processing,BP,
7229,GO:0031124,1,0.000511950000797665,0,88,mRNA 3'-end processing,BP,
7230,GO:0031125,1,0.463964649406057,0,12,rRNA 3'-end processing,BP,
7231,GO:0031126,1,0.645017751832421,0,7,snoRNA 3'-end processing,BP,
7243,GO:0031167,1,0.204697118890763,0,21,rRNA methylation,BP,
7262,GO:0031229,1,0.478412657756719,0,8,intrinsic component of nuclear inner membrane,CC,
7274,GO:0031254,1,0.466284665059105,0,8,cell trailing edge,CC,
7278,GO:0031261,1,0.671726447705082,0,5,DNA replication preinitiation complex,CC,
7293,GO:0031290,1,0.240921535758284,0,14,retinal ganglion cell axon guidance,BP,
7300,GO:0031298,1,0.462282231619379,0,9,replication fork protection complex,CC,
7310,GO:0031313,1,0.540218635148405,0,7,extrinsic component of endosome membrane,CC,
7311,GO:0031314,1,0.634675754311468,0,5,extrinsic component of mitochondrial inner membrane,CC,
7323,GO:0031332,1,0.327935591251213,0,11,RNAi effector complex,CC,
7330,GO:0031340,1,0.579801006255485,0,6,positive regulation of vesicle fusion,BP,
7344,GO:0031371,1,0.532153060279765,0,8,ubiquitin conjugating enzyme complex,CC,
7348,GO:0031386,1,0.453587559831303,0,12,protein tag,MF,
7350,GO:0031390,1,0.540821743917615,0,8,Ctf18 RFC-like complex,CC,
7360,GO:0031402,1,0.436173387607026,0,8,sodium ion binding,MF,
7367,GO:0031414,1,0.431292111558817,0,9,N-terminal protein acetyltransferase complex,CC,
7371,GO:0031418,1,0.223144439995565,0,18,L-ascorbic acid binding,MF,
7372,GO:0031419,1,0.577944666220671,0,6,cobalamin binding,MF,
7373,GO:0031420,1,0.267082504844275,0,13,alkali metal ion binding,MF,
7376,GO:0031428,1,0.707381549769693,0,5,box C/D snoRNP complex,CC,
7388,GO:0031440,1,0.137044118712954,0,22,regulation of mRNA 3'-end processing,BP,
7389,GO:0031441,1,0.440525716006396,0,9,negative regulation of mRNA 3'-end processing,BP,
7390,GO:0031442,1,0.444306771668155,0,9,positive regulation of mRNA 3'-end processing,BP,
7399,GO:0031462,1,0.345956325104918,0,12,Cul2-RING ubiquitin ligase complex,CC,
7401,GO:0031464,1,0.36953968829366,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7404,GO:0031467,1,0.666440707330917,0,5,Cul7-RING ubiquitin ligase complex,CC,
7413,GO:0031498,1,0.204726138602613,0,17,chromatin disassembly,BP,
7426,GO:0031527,1,0.28056400999424,0,11,filopodium membrane,CC,
7434,GO:0031543,1,0.426288902934688,0,10,peptidyl-proline dioxygenase activity,MF,
7436,GO:0031545,1,0.597540918412142,0,6,peptidyl-proline 4-dioxygenase activity,MF,
7444,GO:0031577,1,0.0625149723245726,0,32,spindle checkpoint,BP,
7459,GO:0031595,1,0.584366171649415,0,8,nuclear proteasome complex,CC,
7461,GO:0031616,1,0.495332789328818,0,9,spindle pole centrosome,CC,
7471,GO:0031629,1,0.440172049683921,0,10,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7478,GO:0031642,1,0.571740644072209,0,6,negative regulation of myelination,BP,
7481,GO:0031645,1,0.535789805163248,0,7,negative regulation of neurological system process,BP,
7490,GO:0031658,1,0.544692527775678,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7494,GO:0031665,1,0.507315745902647,0,8,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,
7495,GO:0031666,1,0.622250211964065,0,5,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7526,GO:0031730,1,0.658655969052918,0,5,CCR5 chemokine receptor binding,MF,
7570,GO:0031931,1,0.5030709007193,0,7,TORC1 complex,CC,
7571,GO:0031932,1,0.317544645123544,0,13,TORC2 complex,CC,
7575,GO:0031937,1,0.451117106417984,0,8,positive regulation of chromatin silencing,BP,
7579,GO:0031943,1,0.506730542223483,0,8,regulation of glucocorticoid metabolic process,BP,
7582,GO:0031946,1,0.568164818678377,0,6,regulation of glucocorticoid biosynthetic process,BP,
7587,GO:0031954,1,0.147976234183417,0,20,positive regulation of protein autophosphorylation,BP,
7589,GO:0031957,1,0.549382429931681,0,7,very long-chain fatty acid-CoA ligase activity,MF,
7590,GO:0031958,1,0.206783457026622,0,16,corticosteroid receptor signaling pathway,BP,
7601,GO:0031981,1,0,182,3517,nuclear lumen,CC,TNIP1;DOCK4;NT5E;SMURF2;EPN3;TSPAN1;NOS1;ERCC1;ETV5;CCND1;CTNNBIP1;NOL4L;CYGB;RPS6KA2;H1F0;XPOT;NR1D1;NFATC4;ADARB1;ETV4;SALL2;PKN1;WWTR1;POU2F2;TRIM65;PITPNC1;APPL2;DDIT3;SMARCA1;HADH;SOX12;PSMD2;ELK3;CRTC1;LTA4H;BRSK1;TBC1D14;STK39;BCORL1;JADE2;BNIP3;HLTF;SCMH1;ERCC6;UBXN7;ARAP1;CTSB;PODXL;XPC;ACOT7;WDFY3;GRK5;VWA5A;RAG1;OBSCN;BNIP3L;CCND2;KLHDC2;PTPN12;RGS14;PRKACB;FAM208A;PPP2R3B;ABTB1;HMGA2;ATF4;PPARA;FGFR1;E2F5;FAM114A1;PTPDC1;NFAT5;DCAF10;BTRC;PTK6;INTS8;ATRX;FKBP10;SOX4;ITPR3;DDB2;ENDOV;MAPKAPK3;ZNF692;ATF7IP;RCOR1;SH3D19;NLK;TCEA1;ZBTB10;PHF12;FAM50A;ETAA1;ZMYM3;KLF12;RABGGTA;L3MBTL3;DNAJB9;PPP3CB;CEBPG;PLAG1;UHRF2;PHC3;ATP10D;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;NDUFV3;CPT2;JMY;PARP9;NACC2;THRA;MGLL;NGFR;PPP1R10;PSKH1;MVB12A;CHD6;MTA1;PM20D2;MEF2D;SKAP2;H2AFJ;POLL;UAP1;XBP1;SPIRE1;NFU1;SATB1;REC8;TLE4;SDR9C7;FAM222B;LOXL2;MLH3;MCTP2;NOP10;GTF2IRD2;PAK6;UBE2E1;PRKACA;NEK6;S100PBP;PCDH1;CBX7;IFI16;NR2F6;FCHO1;ZNF354A;TBL1X;RNF169;HOXA3;ARID4A;TENM2;ZMYM2;PPARG;CITED4;CREB3L2;AK9;RSF1;PHF21A;MPLKIP;MAML3;HSPA2;ARID5B;E2F7;HPSE;DEDD2;FOXP1;ZBTB33;KAT2B;OAS1;VSIG10L;SNX27;JARID2;SLC44A1;GNAI1;DNMT3A;ALAS1
7610,GO:0031996,1,0.43316161832871,0,10,thioesterase binding,MF,
7619,GO:0032009,1,0.500969436306728,0,7,early phagosome,CC,
7631,GO:0032036,1,0.636869626109103,0,5,myosin heavy chain binding,MF,
7633,GO:0032040,1,0.0657497168233569,0,33,small-subunit processome,CC,
7634,GO:0032041,1,0.34970098386265,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
7635,GO:0032042,1,0.286439105365444,0,14,mitochondrial DNA metabolic process,BP,
7637,GO:0032045,1,0.479601991585323,0,8,guanyl-nucleotide exchange factor complex,CC,
7651,GO:0032070,1,0.49329017710287,0,9,regulation of deoxyribonuclease activity,BP,
7652,GO:0032071,1,0.568165832512301,0,7,regulation of endodeoxyribonuclease activity,BP,
7654,GO:0032074,1,0.602114575516379,0,6,negative regulation of nuclease activity,BP,
7657,GO:0032077,1,0.686854888540233,0,5,positive regulation of deoxyribonuclease activity,BP,
7712,GO:0032201,1,0.111902775554202,0,27,telomere maintenance via semi-conservative replication,BP,
7722,GO:0032212,1,0.0575925122360555,0,33,positive regulation of telomere maintenance via telomerase,BP,
7740,GO:0032239,1,0.193992841547278,0,16,regulation of nucleobase-containing compound transport,BP,
7742,GO:0032241,1,0.50578832583976,0,7,positive regulation of nucleobase-containing compound transport,BP,
7747,GO:0032261,1,0.597666687959473,0,7,purine nucleotide salvage,BP,
7748,GO:0032262,1,0.717512183066974,0,5,pyrimidine nucleotide salvage,BP,
7758,GO:0032274,1,0.499268163760736,0,7,gonadotropin secretion,BP,
7759,GO:0032275,1,0.592448458580843,0,5,luteinizing hormone secretion,BP,
7771,GO:0032291,1,0.496010056096389,0,8,axon ensheathment in central nervous system,BP,
7782,GO:0032306,1,0.712167902595988,0,5,regulation of prostaglandin secretion,BP,
7783,GO:0032308,1,0.712167902595988,0,5,positive regulation of prostaglandin secretion,BP,
7785,GO:0032310,1,0.641423577211463,0,6,prostaglandin secretion,BP,
7787,GO:0032324,1,0.567728717899404,0,7,molybdopterin cofactor biosynthetic process,BP,
7789,GO:0032329,1,0.529643530207608,0,8,serine transport,BP,
7793,GO:0032341,1,0.637803693964439,0,5,aldosterone metabolic process,BP,
7794,GO:0032342,1,0.637803693964439,0,5,aldosterone biosynthetic process,BP,
7795,GO:0032344,1,0.637803693964439,0,5,regulation of aldosterone metabolic process,BP,
7798,GO:0032347,1,0.637803693964439,0,5,regulation of aldosterone biosynthetic process,BP,
7803,GO:0032352,1,0.418601185520327,0,10,positive regulation of hormone metabolic process,BP,
7807,GO:0032356,1,0.418731071003463,0,10,oxidized DNA binding,MF,
7808,GO:0032357,1,0.450233563754115,0,9,oxidized purine DNA binding,MF,
7811,GO:0032364,1,0.638682398007882,0,5,oxygen homeostasis,BP,
7816,GO:0032369,1,0.25869774622834,0,14,negative regulation of lipid transport,BP,
7824,GO:0032377,1,0.545315284629038,0,7,regulation of intracellular lipid transport,BP,
7827,GO:0032380,1,0.545315284629038,0,7,regulation of intracellular sterol transport,BP,
7830,GO:0032383,1,0.545315284629038,0,7,regulation of intracellular cholesterol transport,BP,
7836,GO:0032389,1,0.538482663471715,0,7,MutLalpha complex,CC,
7837,GO:0032391,1,0.111017257397455,0,24,photoreceptor connecting cilium,CC,
7846,GO:0032404,1,0.508021895948994,0,8,mismatch repair complex binding,MF,
7847,GO:0032405,1,0.638944409177322,0,5,MutLalpha complex binding,MF,
7848,GO:0032407,1,0.652939277809025,0,5,MutSalpha complex binding,MF,
7872,GO:0032433,1,0.279408158057006,0,12,filopodium tip,CC,
7874,GO:0032435,1,0.106697044843048,0,26,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
7886,GO:0032453,1,0.504018136875663,0,6,histone demethylase activity (H3-K4 specific),MF,
7887,GO:0032454,1,0.277481597959765,0,12,histone demethylase activity (H3-K9 specific),MF,
7895,GO:0032463,1,0.419228392510046,0,11,negative regulation of protein homooligomerization,BP,
7896,GO:0032464,1,0.629814799261314,0,6,positive regulation of protein homooligomerization,BP,
7899,GO:0032467,1,0.0913359059255029,0,25,positive regulation of cytokinesis,BP,
7919,GO:0032494,1,0.619961715284969,0,5,response to peptidoglycan,BP,
7920,GO:0032495,1,0.303434831646891,0,12,response to muramyl dipeptide,BP,
7933,GO:0032510,1,0.557139979580454,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
7937,GO:0032525,1,0.554107039178349,0,6,somite rostral/caudal axis specification,BP,
7953,GO:0032552,1,0.650187446005514,0,6,deoxyribonucleotide binding,MF,
7965,GO:0032570,1,0.0876977282286169,0,28,response to progesterone,BP,
7972,GO:0032585,1,0.454277846802343,0,10,multivesicular body membrane,CC,
7979,GO:0032593,1,0.572397260819496,0,6,insulin-responsive compartment,CC,
7982,GO:0032596,1,0.659936933355455,0,5,protein transport into membrane raft,BP,
7987,GO:0032604,1,0.511305750634597,0,8,granulocyte macrophage colony-stimulating factor production,BP,
7992,GO:0032610,1,0.638335417044083,0,7,interleukin-1 alpha production,BP,
8000,GO:0032621,1,0.582637883433377,0,6,interleukin-18 production,BP,
8003,GO:0032627,1,0.688800249066574,0,5,interleukin-23 production,BP,
8013,GO:0032645,1,0.511305750634597,0,8,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8017,GO:0032650,1,0.668838342582233,0,6,regulation of interleukin-1 alpha production,BP,
8025,GO:0032661,1,0.643578956785188,0,5,regulation of interleukin-18 production,BP,
8027,GO:0032667,1,0.688800249066574,0,5,regulation of interleukin-23 production,BP,
8054,GO:0032715,1,0.187777230945849,0,19,negative regulation of interleukin-6 production,BP,
8058,GO:0032725,1,0.559144584639347,0,7,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8059,GO:0032727,1,0.217141141262285,0,16,positive regulation of interferon-alpha production,BP,
8062,GO:0032730,1,0.711353726101846,0,5,positive regulation of interleukin-1 alpha production,BP,
8066,GO:0032735,1,0.247912928986329,0,18,positive regulation of interleukin-12 production,BP,
8069,GO:0032740,1,0.590447454876564,0,7,positive regulation of interleukin-17 production,BP,
8095,GO:0032780,1,0.534818829904382,0,8,negative regulation of ATPase activity,BP,
8105,GO:0032790,1,0.503930356265743,0,8,ribosome disassembly,BP,
8111,GO:0032797,1,0.40394112262283,0,11,SMN complex,CC,
8120,GO:0032806,1,0.120095652404895,0,25,carboxy-terminal domain protein kinase complex,CC,
8123,GO:0032809,1,0.486144587737352,0,7,neuronal cell body membrane,CC,
8126,GO:0032814,1,0.228847583735831,0,18,regulation of natural killer cell activation,BP,
8127,GO:0032815,1,0.706614974382817,0,5,negative regulation of natural killer cell activation,BP,
8128,GO:0032816,1,0.36118998644549,0,12,positive regulation of natural killer cell activation,BP,
8131,GO:0032823,1,0.453648099228665,0,9,regulation of natural killer cell differentiation,BP,
8133,GO:0032825,1,0.535462220691971,0,7,positive regulation of natural killer cell differentiation,BP,
8152,GO:0032878,1,0.129584667835667,0,20,regulation of establishment or maintenance of cell polarity,BP,
8169,GO:0032905,1,0.578497856244776,0,6,transforming growth factor beta1 production,BP,
8170,GO:0032906,1,0.529235771109549,0,6,transforming growth factor beta2 production,BP,
8172,GO:0032908,1,0.578497856244776,0,6,regulation of transforming growth factor beta1 production,BP,
8173,GO:0032909,1,0.529235771109549,0,6,regulation of transforming growth factor beta2 production,BP,
8188,GO:0032926,1,0.531195345626393,0,7,negative regulation of activin receptor signaling pathway,BP,
8193,GO:0032933,1,0.487522210392554,0,8,SREBP signaling pathway,BP,
8205,GO:0032957,1,0.454604122610644,0,8,inositol trisphosphate metabolic process,BP,
8207,GO:0032959,1,0.559125841099628,0,6,inositol trisphosphate biosynthetic process,BP,
8227,GO:0032986,1,0.198132426749088,0,18,protein-DNA complex disassembly,BP,
8228,GO:0032988,1,0.334410811266868,0,13,ribonucleoprotein complex disassembly,BP,
8238,GO:0033005,1,0.468535410475806,0,9,positive regulation of mast cell activation,BP,
8241,GO:0033008,1,0.507652268069033,0,8,positive regulation of mast cell activation involved in immune response,BP,
8242,GO:0033010,1,0.535796226159694,0,6,paranodal junction,CC,
8253,GO:0033029,1,0.628751777838786,0,5,regulation of neutrophil apoptotic process,BP,
8257,GO:0033033,1,0.507038499727031,0,8,negative regulation of myeloid cell apoptotic process,BP,
8258,GO:0033034,1,0.606097381194857,0,6,positive regulation of myeloid cell apoptotic process,BP,
8271,GO:0033061,1,0.49465378525461,0,9,DNA recombinase mediator complex,CC,
8272,GO:0033063,1,0.585056644566907,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8277,GO:0033079,1,0.658055951415326,0,5,immature T cell proliferation,BP,
8283,GO:0033085,1,0.688299627859835,0,5,negative regulation of T cell differentiation in thymus,BP,
8292,GO:0033119,1,0.170167107995215,0,22,negative regulation of RNA splicing,BP,
8293,GO:0033120,1,0.105449557647392,0,25,positive regulation of RNA splicing,BP,
8297,GO:0033127,1,0.358869904018818,0,12,regulation of histone phosphorylation,BP,
8299,GO:0033129,1,0.492107797466743,0,8,positive regulation of histone phosphorylation,BP,
8301,GO:0033131,1,0.587616613667859,0,6,regulation of glucokinase activity,BP,
8315,GO:0033147,1,0.376706366489804,0,10,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8320,GO:0033153,1,0.566978327223644,0,5,T cell receptor V(D)J recombination,BP,
8325,GO:0033162,1,0.665842003674423,0,6,melanosome membrane,CC,
8328,GO:0033169,1,0.256341515887882,0,13,histone H3-K9 demethylation,BP,
8329,GO:0033170,1,0.535500801914331,0,8,protein-DNA loading ATPase activity,MF,
8332,GO:0033177,1,0.512126506487223,0,9,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8334,GO:0033179,1,0.54433475949024,0,8,proton-transporting V-type ATPase, V0 domain,CC,
8337,GO:0033182,1,0.384364211190313,0,10,regulation of histone ubiquitination,BP,
8339,GO:0033184,1,0.625748994041575,0,5,positive regulation of histone ubiquitination,BP,
8348,GO:0033202,1,0.326095403723526,0,15,DNA helicase complex,CC,
8353,GO:0033211,1,0.657802100543714,0,5,adiponectin-activated signaling pathway,BP,
8354,GO:0033216,1,0.62590165202204,0,5,ferric iron import,BP,
8358,GO:0033233,1,0.185490274887948,0,20,regulation of protein sumoylation,BP,
8359,GO:0033234,1,0.426232353809018,0,10,negative regulation of protein sumoylation,BP,
8360,GO:0033235,1,0.436928084595872,0,10,positive regulation of protein sumoylation,BP,
8363,GO:0033240,1,0.583815953269185,0,7,positive regulation of cellular amine metabolic process,BP,
8366,GO:0033256,1,0.574961394759758,0,7,I-kappaB/NF-kappaB complex,CC,
8378,GO:0033275,1,0.21887524192391,0,15,actin-myosin filament sliding,BP,
8379,GO:0033276,1,0.303879803677701,0,14,transcription factor TFTC complex,CC,
8390,GO:0033299,1,0.669712617012686,0,5,secretion of lysosomal enzymes,BP,
8394,GO:0033313,1,0.65068336578061,0,5,meiotic cell cycle checkpoint,BP,
8395,GO:0033314,1,0.512375326164323,0,8,mitotic DNA replication checkpoint,BP,
8416,GO:0033391,1,0.556868118745244,0,6,chromatoid body,CC,
8434,GO:0033549,1,0.346798458636408,0,13,MAP kinase phosphatase activity,MF,
8443,GO:0033561,1,0.112603013335639,0,23,regulation of water loss via skin,BP,
8447,GO:0033567,1,0.678914813103396,0,5,DNA replication, Okazaki fragment processing,BP,
8453,GO:0033588,1,0.671080045293082,0,5,Elongator holoenzyme complex,CC,
8456,GO:0033592,1,0.621079338652694,0,5,RNA strand annealing activity,MF,
8468,GO:0033605,1,0.657792049352762,0,5,positive regulation of catecholamine secretion,BP,
8477,GO:0033622,1,0.325782971577536,0,11,integrin activation,BP,
8478,GO:0033623,1,0.558380040799742,0,6,regulation of integrin activation,BP,
8483,GO:0033629,1,0.530361071309824,0,7,negative regulation of cell adhesion mediated by integrin,BP,
8492,GO:0033647,1,0.640052846129121,0,5,host intracellular organelle,CC,
8493,GO:0033648,1,0.640052846129121,0,5,host intracellular membrane-bounded organelle,CC,
8524,GO:0033750,1,0.391080618254136,0,13,ribosome localization,BP,
8570,GO:0034035,1,0.230058154333585,0,18,purine ribonucleoside bisphosphate metabolic process,BP,
8571,GO:0034036,1,0.581957887377113,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
8577,GO:0034046,1,0.485855345060935,0,7,poly(G) binding,MF,
8588,GO:0034085,1,0.516331660728995,0,7,establishment of sister chromatid cohesion,BP,
8594,GO:0034093,1,0.66260982319353,0,5,positive regulation of maintenance of sister chromatid cohesion,BP,
8607,GO:0034115,1,0.583505184178252,0,7,negative regulation of heterotypic cell-cell adhesion,BP,
8644,GO:0034184,1,0.66260982319353,0,5,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
8655,GO:0034201,1,0.646904740007353,0,5,response to oleic acid,BP,
8661,GO:0034214,1,0.519170041090564,0,7,protein hexamerization,BP,
8665,GO:0034227,1,0.704842469180423,0,5,tRNA thio-modification,BP,
8666,GO:0034235,1,0.666645043151682,0,5,GPI anchor binding,MF,
8690,GO:0034310,1,0.598426171904141,0,7,primary alcohol catabolic process,BP,
8709,GO:0034349,1,0.296868967202929,0,13,glial cell apoptotic process,BP,
8710,GO:0034350,1,0.515769267485068,0,7,regulation of glial cell apoptotic process,BP,
8711,GO:0034351,1,0.515769267485068,0,7,negative regulation of glial cell apoptotic process,BP,
8732,GO:0034379,1,0.616345879332927,0,6,very-low-density lipoprotein particle assembly,BP,
8740,GO:0034388,1,0.589075269359063,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
8746,GO:0034394,1,0.0232823250777226,0,40,protein localization to cell surface,BP,
8748,GO:0034397,1,0.416626367266416,0,9,telomere localization,BP,
8749,GO:0034398,1,0.61643351658671,0,5,telomere tethering at nuclear periphery,BP,
8760,GO:0034427,1,0.506761754875163,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
8773,GO:0034450,1,0.334481419808275,0,12,ubiquitin-ubiquitin ligase activity,MF,
8774,GO:0034451,1,0.10665551955664,0,22,centriolar satellite,CC,
8776,GO:0034453,1,0.0900395175901639,0,23,microtubule anchoring,BP,
8777,GO:0034454,1,0.365877894899926,0,9,microtubule anchoring at centrosome,BP,
8788,GO:0034471,1,0.23625499408399,0,19,ncRNA 5'-end processing,BP,
8789,GO:0034472,1,0.332356662232727,0,14,snRNA 3'-end processing,BP,
8792,GO:0034475,1,0.61573587698593,0,8,U4 snRNA 3'-end processing,BP,
8796,GO:0034483,1,0.474149858467696,0,8,heparan sulfate sulfotransferase activity,MF,
8798,GO:0034497,1,0.327945556898073,0,12,protein localization to phagophore assembly site,BP,
8799,GO:0034498,1,0.482119927310404,0,8,early endosome to Golgi transport,BP,
8801,GO:0034501,1,0.279475483516969,0,16,protein localization to kinetochore,BP,
8807,GO:0034511,1,0.592624492780723,0,6,U3 snoRNA binding,MF,
8813,GO:0034551,1,0.479540112763424,0,9,mitochondrial respiratory chain complex III assembly,BP,
8817,GO:0034587,1,0.493396192744033,0,8,piRNA metabolic process,BP,
8821,GO:0034594,1,0.611671704496877,0,5,phosphatidylinositol trisphosphate phosphatase activity,MF,
8827,GO:0034603,1,0.648954473030576,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
8828,GO:0034604,1,0.648954473030576,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
8833,GO:0034616,1,0.311382421939271,0,13,response to laminar fluid shear stress,BP,
8846,GO:0034638,1,0.627115510302736,0,6,phosphatidylcholine catabolic process,BP,
8856,GO:0034650,1,0.625637569338674,0,5,cortisol metabolic process,BP,
8857,GO:0034651,1,0.625637569338674,0,5,cortisol biosynthetic process,BP,
8865,GO:0034663,1,0.483749372970602,0,9,endoplasmic reticulum chaperone complex,CC,
8894,GO:0034709,1,0.487949463440708,0,12,methylosome,CC,
8898,GO:0034715,1,0.704741319133031,0,6,pICln-Sm protein complex,CC,
8900,GO:0034719,1,0.329561109154263,0,16,SMN-Sm protein complex,CC,
8901,GO:0034720,1,0.504018136875663,0,6,histone H3-K4 demethylation,BP,
8904,GO:0034723,1,0.177708137144434,0,32,DNA replication-dependent nucleosome organization,BP,
8916,GO:0034755,1,0.323664070676599,0,12,iron ion transmembrane transport,BP,
8943,GO:0034979,1,0.218555139804487,0,17,NAD-dependent protein deacetylase activity,MF,
8944,GO:0034982,1,0.477540470077136,0,10,mitochondrial protein processing,BP,
8945,GO:0034983,1,0.554400321973336,0,6,peptidyl-lysine deacetylation,BP,
8954,GO:0035005,1,0.514347402743835,0,6,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
8955,GO:0035014,1,0.542858905385727,0,6,phosphatidylinositol 3-kinase regulator activity,MF,
8957,GO:0035020,1,0.227578316597519,0,15,regulation of Rac protein signal transduction,BP,
8961,GO:0035024,1,0.186108191102782,0,17,negative regulation of Rho protein signal transduction,BP,
8964,GO:0035032,1,0.600753120802353,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
8967,GO:0035035,1,0.106525669619176,0,24,histone acetyltransferase binding,MF,
8978,GO:0035067,1,0.27834970023923,0,14,negative regulation of histone acetylation,BP,
8979,GO:0035068,1,0.409462255090344,0,9,micro-ribonucleoprotein complex,CC,
8983,GO:0035089,1,0.284878943507559,0,13,establishment of apical/basal cell polarity,BP,
8984,GO:0035090,1,0.6354211078355,0,5,maintenance of apical/basal cell polarity,BP,
9005,GO:0035145,1,0.166538103850946,0,21,exon-exon junction complex,CC,
9011,GO:0035174,1,0.59157922356621,0,6,histone serine kinase activity,MF,
9020,GO:0035197,1,0.406303050750256,0,9,siRNA binding,MF,
9025,GO:0035234,1,0.563786181831045,0,6,ectopic germ cell programmed cell death,BP,
9037,GO:0035251,1,0.536480883819079,0,7,UDP-glucosyltransferase activity,MF,
9038,GO:0035252,1,0.55443206808477,0,6,UDP-xylosyltransferase activity,MF,
9045,GO:0035259,1,0.321796535762724,0,12,glucocorticoid receptor binding,MF,
9050,GO:0035267,1,0.20774727336276,0,19,NuA4 histone acetyltransferase complex,CC,
9051,GO:0035268,1,0.198958187907637,0,18,protein mannosylation,BP,
9052,GO:0035269,1,0.381765899831571,0,12,protein O-linked mannosylation,BP,
9058,GO:0035280,1,0.515828480956106,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9073,GO:0035312,1,0.583246690933957,0,6,5'-3' exodeoxyribonuclease activity,MF,
9076,GO:0035325,1,0.525885511364954,0,8,Toll-like receptor binding,MF,
9078,GO:0035327,1,0.181965237261557,0,20,transcriptionally active chromatin,CC,
9106,GO:0035376,1,0.663434801972679,0,5,sterol import,BP,
9125,GO:0035435,1,0.458983922568467,0,8,phosphate ion transmembrane transport,BP,
9134,GO:0035457,1,0.414444158192487,0,9,cellular response to interferon-alpha,BP,
9155,GO:0035507,1,0.527054374301699,0,6,regulation of myosin-light-chain-phosphatase activity,BP,
9159,GO:0035511,1,0.678226621200339,0,5,oxidative DNA demethylation,BP,
9167,GO:0035520,1,0.398204697148136,0,9,monoubiquitinated protein deubiquitination,BP,
9171,GO:0035524,1,0.606892430689866,0,5,proline transmembrane transport,BP,
9204,GO:0035586,1,0.582081697166935,0,7,purinergic receptor activity,MF,
9205,GO:0035587,1,0.455869090504515,0,10,purinergic receptor signaling pathway,BP,
9206,GO:0035588,1,0.545140768441402,0,8,G-protein coupled purinergic receptor signaling pathway,BP,
9207,GO:0035589,1,0.669735784364267,0,5,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9208,GO:0035590,1,0.560081245998847,0,7,purinergic nucleotide receptor signaling pathway,BP,
9227,GO:0035613,1,0.247191925713318,0,15,RNA stem-loop binding,MF,
9238,GO:0035627,1,0.577236890971646,0,6,ceramide transport,BP,
9240,GO:0035631,1,0.395639205154389,0,11,CD40 receptor complex,CC,
9253,GO:0035655,1,0.685035505964917,0,5,interleukin-18-mediated signaling pathway,BP,
9264,GO:0035672,1,0.57171877353878,0,6,oligopeptide transmembrane transport,BP,
9284,GO:0035721,1,0.309162617518128,0,12,intraciliary retrograde transport,BP,
9285,GO:0035722,1,0.0460756532422743,0,40,interleukin-12-mediated signaling pathway,BP,
9290,GO:0035728,1,0.353196667168041,0,11,response to hepatocyte growth factor,BP,
9291,GO:0035729,1,0.433351864423403,0,9,cellular response to hepatocyte growth factor stimulus,BP,
9299,GO:0035743,1,0.543698778233702,0,8,CD4-positive, alpha-beta T cell cytokine production,BP,
9301,GO:0035745,1,0.625430795384911,0,6,T-helper 2 cell cytokine production,BP,
9304,GO:0035749,1,0.629814660228104,0,5,myelin sheath adaxonal region,CC,
9306,GO:0035751,1,0.469120036685045,0,11,regulation of lysosomal lumen pH,BP,
9308,GO:0035754,1,0.641250968594522,0,5,B cell chemotaxis,BP,
9314,GO:0035771,1,0.617107873440399,0,5,interleukin-4-mediated signaling pathway,BP,
9330,GO:0035809,1,0.506378137631544,0,8,regulation of urine volume,BP,
9331,GO:0035810,1,0.644498626077772,0,5,positive regulation of urine volume,BP,
9343,GO:0035845,1,0.512982750911078,0,7,photoreceptor cell outer segment organization,BP,
9348,GO:0035859,1,0.33676298406485,0,13,Seh1-associated complex,CC,
9353,GO:0035864,1,0.626483421379025,0,6,response to potassium ion,BP,
9361,GO:0035872,1,0.058094388076683,0,32,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
9368,GO:0035883,1,0.204677073533036,0,17,enteroendocrine cell differentiation,BP,
9375,GO:0035900,1,0.620964115535342,0,6,response to isolation stress,BP,
9379,GO:0035907,1,0.6371743580162,0,5,dorsal aorta development,BP,
9388,GO:0035925,1,0.358789982228263,0,11,mRNA 3'-UTR AU-rich region binding,MF,
9392,GO:0035929,1,0.489258299218321,0,8,steroid hormone secretion,BP,
9393,GO:0035930,1,0.653070659341628,0,5,corticosteroid hormone secretion,BP,
9406,GO:0035964,1,0.595598249425606,0,6,COPI-coated vesicle budding,BP,
9407,GO:0035965,1,0.655704526071964,0,5,cardiolipin acyl-chain remodeling,BP,
9410,GO:0035970,1,0.285213747900615,0,15,peptidyl-threonine dephosphorylation,BP,
9427,GO:0035994,1,0.250300104151473,0,13,response to muscle stretch,BP,
9431,GO:0036002,1,0.0635353870000622,0,32,pre-mRNA binding,MF,
9488,GO:0036123,1,0.670419228226268,0,5,histone H3-K9 dimethylation,BP,
9510,GO:0036158,1,0.563234809798805,0,6,outer dynein arm assembly,BP,
9511,GO:0036159,1,0.591910348171402,0,5,inner dynein arm assembly,BP,
9560,GO:0036336,1,0.272274108684722,0,15,dendritic cell migration,BP,
9562,GO:0036342,1,0.314623992962271,0,11,post-anal tail morphogenesis,BP,
9564,GO:0036344,1,0.249721665304817,0,15,platelet morphogenesis,BP,
9567,GO:0036353,1,0.481562090530328,0,8,histone H2A-K119 monoubiquitination,BP,
9584,GO:0036402,1,0.685911056642352,0,6,proteasome-activating ATPase activity,MF,
9592,GO:0036444,1,0.488693370986541,0,8,calcium import into the mitochondrion,BP,
9595,GO:0036449,1,0.442147846075595,0,7,microtubule minus-end,CC,
9616,GO:0036480,1,0.541802118963849,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
9617,GO:0036481,1,0.646601113083379,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
9646,GO:0036514,1,0.568459143468901,0,5,dopaminergic neuron axon guidance,BP,
9671,GO:0038030,1,0.554559484655528,0,6,non-canonical Wnt signaling pathway via MAPK cascade,BP,
9672,GO:0038031,1,0.611818084965387,0,5,non-canonical Wnt signaling pathway via JNK cascade,BP,
9675,GO:0038036,1,0.599197911828505,0,6,sphingosine-1-phosphate receptor activity,MF,
9694,GO:0038089,1,0.624485123670063,0,5,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
9720,GO:0038155,1,0.589938824124806,0,6,interleukin-23-mediated signaling pathway,BP,
9726,GO:0038166,1,0.668052816263388,0,5,angiotensin-activated signaling pathway,BP,
9730,GO:0038180,1,0.449761938759815,0,8,nerve growth factor signaling pathway,BP,
9742,GO:0038201,1,0.232247603131563,0,16,TOR complex,CC,
9744,GO:0038203,1,0.555511221038208,0,7,TORC2 signaling,BP,
9768,GO:0039532,1,0.410946190766788,0,10,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
9772,GO:0039536,1,0.530732772295087,0,7,negative regulation of RIG-I signaling pathway,BP,
9797,GO:0040016,1,0.52939167475892,0,7,embryonic cleavage,BP,
9822,GO:0042033,1,0.504508409811247,0,9,chemokine biosynthetic process,BP,
9827,GO:0042044,1,0.360693127411407,0,12,fluid transport,BP,
9828,GO:0042045,1,0.640242031695352,0,5,epithelial fluid transport,BP,
9830,GO:0042053,1,0.425989494931152,0,10,regulation of dopamine metabolic process,BP,
9832,GO:0042056,1,0.33923976468955,0,14,chemoattractant activity,MF,
9837,GO:0042069,1,0.425989494931152,0,10,regulation of catecholamine metabolic process,BP,
9843,GO:0042088,1,0.149873808320549,0,23,T-helper 1 type immune response,BP,
9845,GO:0042090,1,0.626888407043179,0,5,interleukin-12 biosynthetic process,BP,
9881,GO:0042148,1,0.521520570687724,0,8,strand invasion,BP,
9886,GO:0042162,1,0.039700957339542,0,35,telomeric DNA binding,MF,
9896,GO:0042178,1,0.485441187020438,0,10,xenobiotic catabolic process,BP,
9906,GO:0042226,1,0.413136387162464,0,10,interleukin-6 biosynthetic process,BP,
9907,GO:0042228,1,0.551023098461425,0,7,interleukin-8 biosynthetic process,BP,
9916,GO:0042255,1,0.0256263888879512,0,54,ribosome assembly,BP,
9917,GO:0042256,1,0.674648056887322,0,5,mature ribosome assembly,BP,
9922,GO:0042268,1,0.689887157663027,0,6,regulation of cytolysis,BP,
9927,GO:0042273,1,0.00850416691760874,0,67,ribosomal large subunit biogenesis,BP,
9928,GO:0042274,1,0.00574240190485488,0,70,ribosomal small subunit biogenesis,BP,
9930,GO:0042276,1,0.215164049476943,0,19,error-prone translesion synthesis,BP,
9936,GO:0042285,1,0.55443206808477,0,6,xylosyltransferase activity,MF,
9937,GO:0042287,1,0.268586972220805,0,16,MHC protein binding,MF,
9938,GO:0042288,1,0.47766456955878,0,9,MHC class I protein binding,MF,
9943,GO:0042301,1,0.612619435634083,0,6,phosphate ion binding,MF,
9948,GO:0042308,1,0.548203421271457,0,7,negative regulation of protein import into nucleus,BP,
9967,GO:0042354,1,0.562406775018455,0,6,L-fucose metabolic process,BP,
9968,GO:0042355,1,0.562406775018455,0,6,L-fucose catabolic process,BP,
9981,GO:0042373,1,0.704013697400495,0,5,vitamin K metabolic process,BP,
9986,GO:0042382,1,0.580056693317452,0,6,paraspeckles,CC,
9989,GO:0042392,1,0.670864565213968,0,5,sphingosine-1-phosphate phosphatase activity,MF,
9994,GO:0042403,1,0.375711921257146,0,10,thyroid hormone metabolic process,BP,
9995,GO:0042405,1,0.263676558140033,0,12,nuclear inclusion body,CC,
9997,GO:0042407,1,0.327591807799289,0,15,cristae formation,BP,
10001,GO:0042416,1,0.517453270164634,0,8,dopamine biosynthetic process,BP,
10002,GO:0042417,1,0.207399655834572,0,18,dopamine metabolic process,BP,
10006,GO:0042423,1,0.435377144993879,0,10,catecholamine biosynthetic process,BP,
10007,GO:0042424,1,0.663309262223338,0,5,catecholamine catabolic process,BP,
10013,GO:0042439,1,0.650524347927596,0,5,ethanolamine-containing compound metabolic process,BP,
10019,GO:0042448,1,0.523569880742416,0,8,progesterone metabolic process,BP,
10024,GO:0042461,1,0.186796864943523,0,18,photoreceptor cell development,BP,
10025,GO:0042462,1,0.335830336662002,0,12,eye photoreceptor cell development,BP,
10033,GO:0042481,1,0.382537187773047,0,11,regulation of odontogenesis,BP,
10034,GO:0042482,1,0.669829141990165,0,5,positive regulation of odontogenesis,BP,
10036,GO:0042487,1,0.655792606638031,0,5,regulation of odontogenesis of dentin-containing tooth,BP,
10040,GO:0042492,1,0.610547174057099,0,5,gamma-delta T cell differentiation,BP,
10055,GO:0042537,1,0.395838776236106,0,13,benzene-containing compound metabolic process,BP,
10056,GO:0042538,1,0.666697221284959,0,5,hyperosmotic salinity response,BP,
10058,GO:0042541,1,0.60821027528563,0,6,hemoglobin biosynthetic process,BP,
10065,GO:0042555,1,0.384447824996603,0,11,MCM complex,CC,
10067,GO:0042559,1,0.362202571722768,0,14,pteridine-containing compound biosynthetic process,BP,
10077,GO:0042575,1,0.258018999401888,0,16,DNA polymerase complex,CC,
10087,GO:0042587,1,0.628109468558416,0,5,glycogen granule,CC,
10096,GO:0042599,1,0.418546849350759,0,11,lamellar body,CC,
10098,GO:0042605,1,0.332382024310634,0,14,peptide antigen binding,MF,
10102,GO:0042611,1,0.477919056954205,0,12,MHC protein complex,CC,
10103,GO:0042612,1,0.571163945524509,0,9,MHC class I protein complex,CC,
10105,GO:0042622,1,0.540564472707901,0,6,photoreceptor outer segment membrane,CC,
10112,GO:0042629,1,0.425931307999814,0,10,mast cell granule,CC,
10123,GO:0042645,1,0.0344156028956213,0,40,mitochondrial nucleoid,CC,
10136,GO:0042695,1,0.644116518223919,0,5,thelarche,BP,
10143,GO:0042711,1,0.589710703397496,0,6,maternal behavior,BP,
10145,GO:0042719,1,0.732954424311653,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10147,GO:0042721,1,0.713694516981664,0,5,mitochondrial inner membrane protein insertion complex,CC,
10168,GO:0042754,1,0.434859393472458,0,9,negative regulation of circadian rhythm,BP,
10169,GO:0042755,1,0.296864774773164,0,14,eating behavior,BP,
10175,GO:0042762,1,0.236869756078754,0,15,regulation of sulfur metabolic process,BP,
10176,GO:0042765,1,0.667500889732538,0,5,GPI-anchor transamidase complex,CC,
10181,GO:0042772,1,0.18533444174362,0,19,DNA damage response, signal transduction resulting in transcription,BP,
10187,GO:0042780,1,0.585649422043244,0,7,tRNA 3'-end processing,BP,
10189,GO:0042788,1,0.160305122359381,0,29,polysomal ribosome,CC,
10191,GO:0042790,1,0.35542581897284,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10192,GO:0042791,1,0.585659795197114,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10194,GO:0042796,1,0.595053636838349,0,6,snRNA transcription by RNA polymerase III,BP,
10195,GO:0042797,1,0.585659795197114,0,6,tRNA transcription by RNA polymerase III,BP,
10197,GO:0042800,1,0.23763531931193,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10202,GO:0042809,1,0.233572682268293,0,15,vitamin D receptor binding,MF,
10212,GO:0042827,1,0.379792712594966,0,11,platelet dense granule,CC,
10213,GO:0042832,1,0.476003226372222,0,9,defense response to protozoan,BP,
10214,GO:0042834,1,0.556336689603174,0,7,peptidoglycan binding,MF,
10222,GO:0042887,1,0.0946521561547303,0,29,amide transmembrane transporter activity,MF,
10230,GO:0042921,1,0.251486172312054,0,14,glucocorticoid receptor signaling pathway,BP,
10244,GO:0042976,1,0.561951182556153,0,7,activation of Janus kinase activity,BP,
10279,GO:0043023,1,0.406653749434883,0,11,ribosomal large subunit binding,MF,
10280,GO:0043024,1,0.300136494583813,0,14,ribosomal small subunit binding,MF,
10285,GO:0043030,1,0.121353776391134,0,23,regulation of macrophage activation,BP,
10287,GO:0043032,1,0.393787262965375,0,11,positive regulation of macrophage activation,BP,
10298,GO:0043047,1,0.383351549971717,0,11,single-stranded telomeric DNA binding,MF,
10316,GO:0043096,1,0.724134986990829,0,5,purine nucleobase salvage,BP,
10318,GO:0043101,1,0.374374384022842,0,13,purine-containing compound salvage,BP,
10319,GO:0043102,1,0.630246512610809,0,6,amino acid salvage,BP,
10342,GO:0043138,1,0.324905999048779,0,12,3'-5' DNA helicase activity,MF,
10343,GO:0043139,1,0.56105090240598,0,7,5'-3' DNA helicase activity,MF,
10344,GO:0043140,1,0.482881305055237,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
10345,GO:0043141,1,0.669993061964044,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
10346,GO:0043142,1,0.320345823816025,0,13,single-stranded DNA-dependent ATPase activity,MF,
10347,GO:0043144,1,0.607943437347184,0,8,snoRNA processing,BP,
10362,GO:0043175,1,0.0439233436351221,0,35,RNA polymerase core enzyme binding,MF,
10369,GO:0043184,1,0.662430109207295,0,5,vascular endothelial growth factor receptor 2 binding,MF,
10371,GO:0043186,1,0.551338433303065,0,7,P granule,CC,
10372,GO:0043189,1,0.20774727336276,0,19,H4/H2A histone acetyltransferase complex,CC,
10381,GO:0043201,1,0.350600869918487,0,10,response to leucine,BP,
10383,GO:0043203,1,0.645155792872403,0,6,axon hillock,CC,
10406,GO:0043240,1,0.376653185955074,0,11,Fanconi anaemia nuclear complex,CC,
10411,GO:0043248,1,0.464143517603134,0,12,proteasome assembly,BP,
10430,GO:0043274,1,0.335254717910771,0,11,phospholipase binding,MF,
10431,GO:0043276,1,0.0828176002768104,0,27,anoikis,BP,
10440,GO:0043295,1,0.461789943385575,0,11,glutathione binding,MF,
10450,GO:0043306,1,0.507652268069033,0,8,positive regulation of mast cell degranulation,BP,
10462,GO:0043320,1,0.587356803040596,0,6,natural killer cell degranulation,BP,
10476,GO:0043368,1,0.202999856731107,0,17,positive T cell selection,BP,
10477,GO:0043369,1,0.387150361241156,0,10,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
10478,GO:0043370,1,0.196373535257079,0,19,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10479,GO:0043371,1,0.383918092040547,0,10,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10480,GO:0043372,1,0.437970126515138,0,11,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
10481,GO:0043373,1,0.531189086863649,0,7,CD4-positive, alpha-beta T cell lineage commitment,BP,
10517,GO:0043425,1,0.134227808800288,0,21,bHLH transcription factor binding,MF,
10524,GO:0043455,1,0.502661389924735,0,7,regulation of secondary metabolic process,BP,
10532,GO:0043471,1,0.516764551765876,0,8,regulation of cellular carbohydrate catabolic process,BP,
10537,GO:0043484,1,0.000119495601027787,0,100,regulation of RNA splicing,BP,
10546,GO:0043495,1,0.501173124008383,0,7,protein membrane anchor,MF,
10548,GO:0043497,1,0.473087000622217,0,9,regulation of protein heterodimerization activity,BP,
10550,GO:0043501,1,0.338695890549089,0,11,skeletal muscle adaptation,BP,
10555,GO:0043508,1,0.366371334614157,0,12,negative regulation of JUN kinase activity,BP,
10559,GO:0043515,1,0.612773633061811,0,5,kinetochore binding,MF,
10561,GO:0043517,1,0.351773251393158,0,11,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
10568,GO:0043527,1,0.698547558903874,0,5,tRNA methyltransferase complex,CC,
10582,GO:0043545,1,0.567728717899404,0,7,molybdopterin cofactor metabolic process,BP,
10587,GO:0043550,1,0.0456817668284365,0,32,regulation of lipid kinase activity,BP,
10588,GO:0043551,1,0.0778656363184907,0,26,regulation of phosphatidylinositol 3-kinase activity,BP,
10589,GO:0043552,1,0.187404859235684,0,17,positive regulation of phosphatidylinositol 3-kinase activity,BP,
10594,GO:0043560,1,0.346043153614757,0,10,insulin receptor substrate binding,MF,
10613,GO:0043601,1,0.139285182348137,0,24,nuclear replisome,CC,
10631,GO:0043628,1,0.127829406864639,0,27,ncRNA 3'-end processing,BP,
10634,GO:0043631,1,0.0231373058368816,0,41,RNA polyadenylation,BP,
10636,GO:0043633,1,0.531806531394568,0,8,polyadenylation-dependent RNA catabolic process,BP,
10637,GO:0043634,1,0.591196726638871,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
10654,GO:0043696,1,0.601684452256814,0,5,dedifferentiation,BP,
10655,GO:0043697,1,0.601684452256814,0,5,cell dedifferentiation,BP,
10663,GO:0043813,1,0.571352763133948,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
10678,GO:0043923,1,0.221414402522979,0,16,positive regulation by host of viral transcription,BP,
10679,GO:0043928,1,0.0734823582091682,0,33,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
10691,GO:0043968,1,0.26161043035769,0,16,histone H2A acetylation,BP,
10700,GO:0043984,1,0.16821928376325,0,19,histone H4-K16 acetylation,BP,
10701,GO:0043985,1,0.61799766457756,0,6,histone H4-R3 methylation,BP,
10706,GO:0043995,1,0.391842917643154,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
10707,GO:0043996,1,0.391842917643154,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
10716,GO:0044030,1,0.257085515389792,0,14,regulation of DNA methylation,BP,
10734,GO:0044090,1,0.304761060024011,0,12,positive regulation of vacuole organization,BP,
10743,GO:0044110,1,0.638250809273147,0,6,growth involved in symbiotic interaction,BP,
10746,GO:0044116,1,0.638250809273147,0,6,growth of symbiont involved in interaction with host,BP,
10747,GO:0044117,1,0.638250809273147,0,6,growth of symbiont in host,BP,
10748,GO:0044126,1,0.675786576795061,0,5,regulation of growth of symbiont in host,BP,
10751,GO:0044144,1,0.675786576795061,0,5,modulation of growth of symbiont involved in interaction with host,BP,
10756,GO:0044154,1,0.55126593849526,0,7,histone H3-K14 acetylation,BP,
10780,GO:0044233,1,0.339193324011494,0,12,ER-mitochondrion membrane contact site,CC,
10811,GO:0044298,1,0.486144587737352,0,7,cell body membrane,CC,
10834,GO:0044327,1,0.465863349187528,0,8,dendritic spine head,CC,
10851,GO:0044346,1,0.203920616521275,0,17,fibroblast apoptotic process,BP,
10858,GO:0044359,1,0.606706698605837,0,6,modulation of molecular function in other organism,BP,
10859,GO:0044362,1,0.683791648510748,0,5,negative regulation of molecular function in other organism,BP,
10866,GO:0044388,1,0.718473946501653,0,5,small protein activating enzyme binding,MF,
10874,GO:0044406,1,0.677193274933847,0,5,adhesion of symbiont to host,BP,
10880,GO:0044417,1,0.499881063970698,0,9,translocation of molecules into host,BP,
10908,GO:0044453,1,0.478412657756719,0,8,nuclear membrane part,CC,
10927,GO:0044545,1,0.66759282367996,0,5,NSL complex,CC,
10929,GO:0044547,1,0.641147971068158,0,5,DNA topoisomerase binding,MF,
10930,GO:0044548,1,0.380240765267768,0,11,S100 protein binding,MF,
10933,GO:0044557,1,0.672767259353607,0,5,relaxation of smooth muscle,BP,
10948,GO:0044613,1,0.353873954127769,0,12,nuclear pore central transport channel,CC,
10950,GO:0044615,1,0.359985697567361,0,9,nuclear pore nuclear basket,CC,
10954,GO:0044665,1,0.0765742134618272,0,29,MLL1/2 complex,CC,
10955,GO:0044666,1,0.36565164196722,0,11,MLL3/4 complex,CC,
10972,GO:0044743,1,0.0600244514626566,0,38,protein transmembrane import into intracellular organelle,BP,
10975,GO:0044754,1,0.545232700960799,0,8,autolysosome,CC,
11001,GO:0044804,1,0.204565273743612,0,18,autophagy of nucleus,BP,
11003,GO:0044806,1,0.493995489996173,0,7,G-quadruplex DNA unwinding,BP,
11012,GO:0044837,1,0.510539255671888,0,7,actomyosin contractile ring organization,BP,
11030,GO:0045002,1,0.559830622998808,0,7,double-strand break repair via single-strand annealing,BP,
11031,GO:0045003,1,0.456251935996542,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11036,GO:0045008,1,0.566077757670384,0,8,depyrimidination,BP,
11037,GO:0045009,1,0.665842003674423,0,6,chitosome,CC,
11047,GO:0045028,1,0.669735784364267,0,5,G-protein coupled purinergic nucleotide receptor activity,MF,
11050,GO:0045039,1,0.691464525459787,0,6,protein import into mitochondrial inner membrane,BP,
11051,GO:0045040,1,0.664752217470127,0,6,protein import into mitochondrial outer membrane,BP,
11053,GO:0045046,1,0.593770049162916,0,6,protein import into peroxisome membrane,BP,
11055,GO:0045048,1,0.658329397303086,0,5,protein insertion into ER membrane,BP,
11061,GO:0045059,1,0.596296605127987,0,6,positive thymic T cell selection,BP,
11065,GO:0045063,1,0.333537118659506,0,12,T-helper 1 cell differentiation,BP,
11066,GO:0045064,1,0.453146342184605,0,10,T-helper 2 cell differentiation,BP,
11073,GO:0045073,1,0.533909834621034,0,8,regulation of chemokine biosynthetic process,BP,
11075,GO:0045075,1,0.626888407043179,0,5,regulation of interleukin-12 biosynthetic process,BP,
11080,GO:0045080,1,0.570163564177586,0,7,positive regulation of chemokine biosynthetic process,BP,
11092,GO:0045095,1,0.129324138676346,0,26,keratin filament,CC,
11094,GO:0045103,1,0.043923768148145,0,33,intermediate filament-based process,BP,
11095,GO:0045104,1,0.0481742946066503,0,32,intermediate filament cytoskeleton organization,BP,
11097,GO:0045109,1,0.216667259307325,0,16,intermediate filament organization,BP,
11098,GO:0045110,1,0.57419619642756,0,6,intermediate filament bundle assembly,BP,
11102,GO:0045116,1,0.353546167656585,0,14,protein neddylation,BP,
11103,GO:0045117,1,0.315858663916815,0,15,azole transport,BP,
11104,GO:0045120,1,0.319249944300282,0,12,pronucleus,CC,
11114,GO:0045136,1,0.455552325654467,0,9,development of secondary sexual characteristics,BP,
11116,GO:0045141,1,0.465618628179976,0,8,meiotic telomere clustering,BP,
11119,GO:0045144,1,0.67494251432548,0,5,meiotic sister chromatid segregation,BP,
11124,GO:0045161,1,0.434160754085635,0,8,neuronal ion channel clustering,BP,
11135,GO:0045179,1,0.620215433455718,0,5,apical cortex,CC,
11145,GO:0045191,1,0.129131595665121,0,23,regulation of isotype switching,BP,
11148,GO:0045198,1,0.385219203704162,0,10,establishment of epithelial cell apical/basal polarity,BP,
11149,GO:0045199,1,0.6354211078355,0,5,maintenance of epithelial cell apical/basal polarity,BP,
11170,GO:0045236,1,0.583963422758735,0,7,CXCR chemokine receptor binding,MF,
11176,GO:0045254,1,0.541591723249859,0,7,pyruvate dehydrogenase complex,CC,
11177,GO:0045257,1,0.698426604242048,0,5,succinate dehydrogenase complex (ubiquinone),CC,
11182,GO:0045273,1,0.698426604242048,0,5,respiratory chain complex II,CC,
11184,GO:0045275,1,0.468199234810564,0,11,respiratory chain complex III,CC,
11186,GO:0045281,1,0.698426604242048,0,5,succinate dehydrogenase complex,CC,
11188,GO:0045283,1,0.698426604242048,0,5,fumarate reductase complex,CC,
11189,GO:0045292,1,0.269282315041765,0,16,mRNA cis splicing, via spliceosome,BP,
11191,GO:0045294,1,0.481120663592268,0,8,alpha-catenin binding,MF,
11192,GO:0045295,1,0.356523986043709,0,9,gamma-catenin binding,MF,
11201,GO:0045329,1,0.678366761857538,0,5,carnitine biosynthetic process,BP,
11217,GO:0045350,1,0.613302600849789,0,6,interferon-beta biosynthetic process,BP,
11218,GO:0045351,1,0.535643353565951,0,8,type I interferon biosynthetic process,BP,
11224,GO:0045357,1,0.613302600849789,0,6,regulation of interferon-beta biosynthetic process,BP,
11235,GO:0045408,1,0.450700151928169,0,9,regulation of interleukin-6 biosynthetic process,BP,
11237,GO:0045410,1,0.587666386076132,0,6,positive regulation of interleukin-6 biosynthetic process,BP,
11238,GO:0045414,1,0.611988119821966,0,6,regulation of interleukin-8 biosynthetic process,BP,
11256,GO:0045495,1,0.551338433303065,0,7,pole plasm,CC,
11260,GO:0045505,1,0.0893786426238586,0,21,dynein intermediate chain binding,MF,
11276,GO:0045581,1,0.160410040105254,0,20,negative regulation of T cell differentiation,BP,
11293,GO:0045603,1,0.453466514332633,0,8,positive regulation of endothelial cell differentiation,BP,
11295,GO:0045605,1,0.408441906011991,0,10,negative regulation of epidermal cell differentiation,BP,
11297,GO:0045607,1,0.648106779326986,0,5,regulation of inner ear auditory receptor cell differentiation,BP,
11300,GO:0045617,1,0.591725530256293,0,6,negative regulation of keratinocyte differentiation,BP,
11303,GO:0045620,1,0.101273033854373,0,26,negative regulation of lymphocyte differentiation,BP,
11305,GO:0045622,1,0.253735364394408,0,16,regulation of T-helper cell differentiation,BP,
11306,GO:0045623,1,0.420814645856995,0,9,negative regulation of T-helper cell differentiation,BP,
11307,GO:0045624,1,0.473412380684836,0,10,positive regulation of T-helper cell differentiation,BP,
11308,GO:0045625,1,0.647695757904073,0,5,regulation of T-helper 1 cell differentiation,BP,
11311,GO:0045628,1,0.529267998951651,0,8,regulation of T-helper 2 cell differentiation,BP,
11313,GO:0045630,1,0.685754589858716,0,5,positive regulation of T-helper 2 cell differentiation,BP,
11314,GO:0045631,1,0.648106779326986,0,5,regulation of mechanoreceptor differentiation,BP,
11316,GO:0045634,1,0.623160684426067,0,5,regulation of melanocyte differentiation,BP,
11324,GO:0045647,1,0.500387532660176,0,8,negative regulation of erythrocyte differentiation,BP,
11330,GO:0045653,1,0.441933330369644,0,17,negative regulation of megakaryocyte differentiation,BP,
11333,GO:0045656,1,0.612363393729208,0,5,negative regulation of monocyte differentiation,BP,
11340,GO:0045663,1,0.382197957782358,0,10,positive regulation of myoblast differentiation,BP,
11349,GO:0045672,1,0.283022692209793,0,15,positive regulation of osteoclast differentiation,BP,
11354,GO:0045686,1,0.312481512492749,0,13,negative regulation of glial cell differentiation,BP,
11357,GO:0045714,1,0.554920316537926,0,6,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
11361,GO:0045719,1,0.59580160598913,0,5,negative regulation of glycogen biosynthetic process,BP,
11362,GO:0045721,1,0.547604226404188,0,7,negative regulation of gluconeogenesis,BP,
11364,GO:0045723,1,0.464654808670676,0,9,positive regulation of fatty acid biosynthetic process,BP,
11378,GO:0045743,1,0.642698999049546,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
11395,GO:0045777,1,0.307531093876511,0,14,positive regulation of blood pressure,BP,
11402,GO:0045792,1,0.491076129065258,0,7,negative regulation of cell size,BP,
11414,GO:0045821,1,0.345850983699665,0,10,positive regulation of glycolytic process,BP,
11419,GO:0045830,1,0.242196304107281,0,16,positive regulation of isotype switching,BP,
11423,GO:0045836,1,0.585782701733137,0,6,positive regulation of meiotic nuclear division,BP,
11428,GO:0045841,1,0.0716162920383029,0,30,negative regulation of mitotic metaphase/anaphase transition,BP,
11429,GO:0045842,1,0.494090608234568,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
11442,GO:0045876,1,0.401953366656338,0,10,positive regulation of sister chromatid cohesion,BP,
11444,GO:0045880,1,0.117721123408634,0,22,positive regulation of smoothened signaling pathway,BP,
11449,GO:0045899,1,0.434983717789216,0,10,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
11457,GO:0045911,1,0.181034287641601,0,19,positive regulation of DNA recombination,BP,
11461,GO:0045915,1,0.672125465023985,0,5,positive regulation of catecholamine metabolic process,BP,
11486,GO:0045945,1,0.368480292171187,0,10,positive regulation of transcription by RNA polymerase III,BP,
11491,GO:0045954,1,0.463128097581849,0,8,positive regulation of natural killer cell mediated cytotoxicity,BP,
11492,GO:0045955,1,0.520627890931268,0,7,negative regulation of calcium ion-dependent exocytosis,BP,
11493,GO:0045956,1,0.383831355294435,0,11,positive regulation of calcium ion-dependent exocytosis,BP,
11495,GO:0045964,1,0.672125465023985,0,5,positive regulation of dopamine metabolic process,BP,
11505,GO:0045989,1,0.573885378389342,0,7,positive regulation of striated muscle contraction,BP,
11526,GO:0046040,1,0.349797368786462,0,12,IMP metabolic process,BP,
11529,GO:0046049,1,0.493630528966088,0,9,UMP metabolic process,BP,
11535,GO:0046060,1,0.721866006776285,0,5,dATP metabolic process,BP,
11559,GO:0046100,1,0.706970890966734,0,5,hypoxanthine metabolic process,BP,
11567,GO:0046112,1,0.196471777311982,0,19,nucleobase biosynthetic process,BP,
11577,GO:0046130,1,0.657662052459309,0,6,purine ribonucleoside catabolic process,BP,
11585,GO:0046146,1,0.619398286605713,0,7,tetrahydrobiopterin metabolic process,BP,
11598,GO:0046184,1,0.374508208327266,0,11,aldehyde biosynthetic process,BP,
11632,GO:0046337,1,0.282954501141083,0,14,phosphatidylethanolamine metabolic process,BP,
11652,GO:0046385,1,0.50996289926703,0,10,deoxyribose phosphate biosynthetic process,BP,
11653,GO:0046386,1,0.258103226743569,0,19,deoxyribose phosphate catabolic process,BP,
11676,GO:0046457,1,0.263464877580165,0,17,prostanoid biosynthetic process,BP,
11684,GO:0046466,1,0.168676621717515,0,22,membrane lipid catabolic process,BP,
11686,GO:0046469,1,0.642632955649028,0,5,platelet activating factor metabolic process,BP,
11692,GO:0046476,1,0.655345660628918,0,5,glycosylceramide biosynthetic process,BP,
11693,GO:0046477,1,0.609468249850177,0,6,glycosylceramide catabolic process,BP,
11695,GO:0046479,1,0.443908824411663,0,10,glycosphingolipid catabolic process,BP,
11701,GO:0046490,1,0.717485446948953,0,5,isopentenyl diphosphate metabolic process,BP,
11713,GO:0046504,1,0.641920647184298,0,5,glycerol ether biosynthetic process,BP,
11717,GO:0046514,1,0.42345583636375,0,11,ceramide catabolic process,BP,
11724,GO:0046527,1,0.280373609369913,0,14,glucosyltransferase activity,MF,
11726,GO:0046532,1,0.611687332618127,0,5,regulation of photoreceptor cell differentiation,BP,
11730,GO:0046540,1,0.153981970774515,0,24,U4/U6 x U5 tri-snRNP complex,CC,
11732,GO:0046543,1,0.530505391557608,0,7,development of secondary female sexual characteristics,BP,
11756,GO:0046602,1,0.463319285682165,0,8,regulation of mitotic centrosome separation,BP,
11767,GO:0046624,1,0.573278867823552,0,6,sphingolipid transporter activity,MF,
11768,GO:0046625,1,0.40745482413923,0,11,sphingolipid binding,MF,
11772,GO:0046629,1,0.442863619937248,0,9,gamma-delta T cell activation,BP,
11781,GO:0046639,1,0.336638198942037,0,11,negative regulation of alpha-beta T cell differentiation,BP,
11790,GO:0046654,1,0.56274189274327,0,7,tetrahydrofolate biosynthetic process,BP,
11814,GO:0046703,1,0.57179227671563,0,9,natural killer cell lectin-like receptor binding,MF,
11822,GO:0046716,1,0.335270386900148,0,12,muscle cell cellular homeostasis,BP,
11825,GO:0046719,1,0.551197284112835,0,7,regulation by virus of viral protein levels in host cell,BP,
11836,GO:0046784,1,0.539872279697012,0,8,viral mRNA export from host cell nucleus,BP,
11850,GO:0046831,1,0.21394604890925,0,15,regulation of RNA export from nucleus,BP,
11852,GO:0046833,1,0.50578832583976,0,7,positive regulation of RNA export from nucleus,BP,
11854,GO:0046835,1,0.119023957776263,0,24,carbohydrate phosphorylation,BP,
11855,GO:0046836,1,0.675876867626905,0,5,glycolipid transport,BP,
11856,GO:0046838,1,0.38797145793085,0,10,phosphorylated carbohydrate dephosphorylation,BP,
11865,GO:0046855,1,0.38797145793085,0,10,inositol phosphate dephosphorylation,BP,
11879,GO:0046886,1,0.503366161679799,0,8,positive regulation of hormone biosynthetic process,BP,
11897,GO:0046920,1,0.642613283769419,0,5,alpha-(1->3)-fucosyltransferase activity,MF,
11904,GO:0046931,1,0.254452397688873,0,15,pore complex assembly,BP,
11915,GO:0046950,1,0.56450539474838,0,7,cellular ketone body metabolic process,BP,
11916,GO:0046951,1,0.620011661114404,0,6,ketone body biosynthetic process,BP,
11923,GO:0046966,1,0.0767244082685963,0,27,thyroid hormone receptor binding,MF,
11928,GO:0046972,1,0.391842917643154,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
11929,GO:0046974,1,0.618455940862611,0,5,histone methyltransferase activity (H3-K9 specific),MF,
11930,GO:0046975,1,0.518582066907335,0,6,histone methyltransferase activity (H3-K36 specific),MF,
11931,GO:0046976,1,0.634342994229988,0,5,histone methyltransferase activity (H3-K27 specific),MF,
11961,GO:0047134,1,0.711752468262328,0,5,protein-disulfide reductase activity,MF,
12001,GO:0047429,1,0.485893861281632,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12005,GO:0047484,1,0.585280919113403,0,6,regulation of response to osmotic stress,BP,
12011,GO:0047499,1,0.673215280225022,0,5,calcium-independent phospholipase A2 activity,MF,
12072,GO:0048020,1,0.550796702553789,0,8,CCR chemokine receptor binding,MF,
12076,GO:0048024,1,0.00366040436458101,0,63,regulation of mRNA splicing, via spliceosome,BP,
12077,GO:0048025,1,0.243135874561114,0,17,negative regulation of mRNA splicing, via spliceosome,BP,
12078,GO:0048026,1,0.369507539349297,0,12,positive regulation of mRNA splicing, via spliceosome,BP,
12086,GO:0048039,1,0.671294154971679,0,6,ubiquinone binding,MF,
12090,GO:0048050,1,0.622631306491341,0,6,post-embryonic eye morphogenesis,BP,
12094,GO:0048070,1,0.33746675316021,0,12,regulation of developmental pigmentation,BP,
12097,GO:0048087,1,0.51860769214175,0,7,positive regulation of developmental pigmentation,BP,
12098,GO:0048096,1,0.478530561954182,0,8,chromatin-mediated maintenance of transcription,BP,
12119,GO:0048172,1,0.553408625372399,0,6,regulation of short-term neuronal synaptic plasticity,BP,
12123,GO:0048188,1,0.316712843372521,0,12,Set1C/COMPASS complex,CC,
12127,GO:0048200,1,0.595598249425606,0,6,Golgi transport vesicle coating,BP,
12129,GO:0048205,1,0.595598249425606,0,6,COPI coating of Golgi vesicle,BP,
12150,GO:0048256,1,0.506859602265418,0,8,flap endonuclease activity,MF,
12163,GO:0048273,1,0.575047787706852,0,6,mitogen-activated protein kinase p38 binding,MF,
12168,GO:0048286,1,0.0941298033184216,0,23,lung alveolus development,BP,
12170,GO:0048290,1,0.620767459065818,0,6,isotype switching to IgA isotypes,BP,
12171,GO:0048291,1,0.49506697274875,0,8,isotype switching to IgG isotypes,BP,
12175,GO:0048296,1,0.679605121569822,0,5,regulation of isotype switching to IgA isotypes,BP,
12178,GO:0048302,1,0.5338974855187,0,7,regulation of isotype switching to IgG isotypes,BP,
12179,GO:0048304,1,0.641513323512756,0,5,positive regulation of isotype switching to IgG isotypes,BP,
12183,GO:0048311,1,0.23186005008563,0,14,mitochondrion distribution,BP,
12184,GO:0048312,1,0.530370046063307,0,6,intracellular distribution of mitochondria,BP,
12186,GO:0048318,1,0.665774422143903,0,5,axial mesoderm development,BP,
12193,GO:0048340,1,0.477107896724179,0,7,paraxial mesoderm morphogenesis,BP,
12207,GO:0048385,1,0.398892316571983,0,11,regulation of retinoic acid receptor signaling pathway,BP,
12209,GO:0048387,1,0.64143246641493,0,5,negative regulation of retinoic acid receptor signaling pathway,BP,
12223,GO:0048476,1,0.705172000908649,0,5,Holliday junction resolvase complex,CC,
12225,GO:0048478,1,0.516658639722319,0,7,replication fork protection,BP,
12237,GO:0048500,1,0.520195001104147,0,9,signal recognition particle,CC,
12263,GO:0048548,1,0.445148105412902,0,9,regulation of pinocytosis,BP,
12265,GO:0048550,1,0.657687761858169,0,5,negative regulation of pinocytosis,BP,
12266,GO:0048557,1,0.453142985439833,0,8,embryonic digestive tract morphogenesis,BP,
12270,GO:0048563,1,0.558538368317486,0,7,post-embryonic animal organ morphogenesis,BP,
12275,GO:0048570,1,0.616014152914,0,5,notochord morphogenesis,BP,
12313,GO:0048663,1,0.104233648398672,0,24,neuron fate commitment,BP,
12315,GO:0048665,1,0.511346899740463,0,7,neuron fate specification,BP,
12341,GO:0048702,1,0.504136705010151,0,7,embryonic neurocranium morphogenesis,BP,
12350,GO:0048712,1,0.605359889571577,0,5,negative regulation of astrocyte differentiation,BP,
12353,GO:0048715,1,0.45225317445201,0,9,negative regulation of oligodendrocyte differentiation,BP,
12355,GO:0048730,1,0.173277069286106,0,19,epidermis morphogenesis,BP,
12358,GO:0048733,1,0.589086620800431,0,5,sebaceous gland development,BP,
12361,GO:0048739,1,0.475574105894794,0,6,cardiac muscle fiber development,BP,
12362,GO:0048741,1,0.292345186863174,0,13,skeletal muscle fiber development,BP,
12363,GO:0048742,1,0.600903253328428,0,5,regulation of skeletal muscle fiber development,BP,
12371,GO:0048755,1,0.617462230993517,0,5,branching morphogenesis of a nerve,BP,
12401,GO:0048842,1,0.471134017903152,0,6,positive regulation of axon extension involved in axon guidance,BP,
12404,GO:0048845,1,0.440319905113581,0,8,venous blood vessel morphogenesis,BP,
12408,GO:0048853,1,0.476912023971469,0,7,forebrain morphogenesis,BP,
12433,GO:0050000,1,0.00283643376853311,0,67,chromosome localization,BP,
12438,GO:0050072,1,0.532528098777965,0,7,m7G(5')pppN diphosphatase activity,MF,
12462,GO:0050291,1,0.657405656321233,0,5,sphingosine N-acyltransferase activity,MF,
12464,GO:0050308,1,0.633161422937574,0,5,sugar-phosphatase activity,MF,
12478,GO:0050427,1,0.230058154333585,0,18,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
12479,GO:0050428,1,0.581957887377113,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
12481,GO:0050432,1,0.283059692474719,0,14,catecholamine secretion,BP,
12482,GO:0050433,1,0.35542359950655,0,12,regulation of catecholamine secretion,BP,
12507,GO:0050650,1,0.138470220790901,0,20,chondroitin sulfate proteoglycan biosynthetic process,BP,
12508,GO:0050651,1,0.378611372337853,0,10,dermatan sulfate proteoglycan biosynthetic process,BP,
12512,GO:0050655,1,0.351696943561847,0,11,dermatan sulfate proteoglycan metabolic process,BP,
12521,GO:0050664,1,0.603312913983324,0,6,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
12522,GO:0050665,1,0.423650406811323,0,10,hydrogen peroxide biosynthetic process,BP,
12535,GO:0050684,1,0.000142905241773518,0,99,regulation of mRNA processing,BP,
12536,GO:0050685,1,0.169931471887245,0,21,positive regulation of mRNA processing,BP,
12537,GO:0050686,1,0.0980946658602447,0,27,negative regulation of mRNA processing,BP,
12540,GO:0050689,1,0.704330433994037,0,5,negative regulation of defense response to virus by host,BP,
12551,GO:0050703,1,0.728625220837732,0,5,interleukin-1 alpha secretion,BP,
12559,GO:0050711,1,0.528058223783054,0,8,negative regulation of interleukin-1 secretion,BP,
12561,GO:0050713,1,0.663918976065611,0,5,negative regulation of interleukin-1 beta secretion,BP,
12564,GO:0050716,1,0.227842050525981,0,17,positive regulation of interleukin-1 secretion,BP,
12566,GO:0050718,1,0.28117220616437,0,14,positive regulation of interleukin-1 beta secretion,BP,
12580,GO:0050746,1,0.483093956524145,0,8,regulation of lipoprotein metabolic process,BP,
12581,GO:0050747,1,0.653175314562256,0,5,positive regulation of lipoprotein metabolic process,BP,
12584,GO:0050755,1,0.504508409811247,0,9,chemokine metabolic process,BP,
12589,GO:0050765,1,0.46381191379727,0,9,negative regulation of phagocytosis,BP,
12603,GO:0050779,1,0.111801982820982,0,22,RNA destabilization,BP,
12607,GO:0050786,1,0.68413199921758,0,7,RAGE receptor binding,MF,
12627,GO:0050812,1,0.31470915287524,0,12,regulation of acyl-CoA biosynthetic process,BP,
12628,GO:0050815,1,0.600258891369949,0,6,phosphoserine residue binding,MF,
12639,GO:0050832,1,0.390790576138011,0,14,defense response to fungus,BP,
12643,GO:0050847,1,0.49007698232867,0,7,progesterone receptor signaling pathway,BP,
12658,GO:0050862,1,0.559321233442105,0,7,positive regulation of T cell receptor signaling pathway,BP,
12672,GO:0050879,1,0.0722262347623865,0,27,multicellular organismal movement,BP,
12674,GO:0050881,1,0.0722262347623865,0,27,musculoskeletal movement,BP,
12675,GO:0050882,1,0.488198424918037,0,6,voluntary musculoskeletal movement,BP,
12690,GO:0050907,1,0.493726938604863,0,10,detection of chemical stimulus involved in sensory perception,BP,
12695,GO:0050912,1,0.663283038457855,0,6,detection of chemical stimulus involved in sensory perception of taste,BP,
12714,GO:0050932,1,0.526875966463314,0,7,regulation of pigment cell differentiation,BP,
12715,GO:0050942,1,0.604648036060063,0,5,positive regulation of pigment cell differentiation,BP,
12732,GO:0050995,1,0.405853634840666,0,11,negative regulation of lipid catabolic process,BP,
12735,GO:0050998,1,0.351340152332233,0,11,nitric-oxide synthase binding,MF,
12743,GO:0051011,1,0.334415056995491,0,10,microtubule minus-end binding,MF,
12745,GO:0051013,1,0.580308383396317,0,6,microtubule severing,BP,
12746,GO:0051014,1,0.553572804024573,0,6,actin filament severing,BP,
12765,GO:0051036,1,0.67767532366883,0,5,regulation of endosome size,BP,
12784,GO:0051059,1,0.109521194591406,0,27,NF-kappaB binding,MF,
12801,GO:0051095,1,0.461067446927172,0,9,regulation of helicase activity,BP,
12802,GO:0051096,1,0.589400965980599,0,6,positive regulation of helicase activity,BP,
12809,GO:0051103,1,0.417417257285208,0,11,DNA ligation involved in DNA repair,BP,
12810,GO:0051105,1,0.608794032387064,0,6,regulation of DNA ligation,BP,
12811,GO:0051106,1,0.662132121352138,0,5,positive regulation of DNA ligation,BP,
12821,GO:0051126,1,0.608644470700477,0,6,negative regulation of actin nucleation,BP,
12826,GO:0051131,1,0.259841546477253,0,17,chaperone-mediated protein complex assembly,BP,
12827,GO:0051132,1,0.688055452520386,0,5,NK T cell activation,BP,
12841,GO:0051151,1,0.503905647904427,0,7,negative regulation of smooth muscle cell differentiation,BP,
12868,GO:0051189,1,0.567728717899404,0,7,prosthetic group metabolic process,BP,
12871,GO:0051194,1,0.271784613280232,0,13,positive regulation of cofactor metabolic process,BP,
12874,GO:0051197,1,0.345850983699665,0,10,positive regulation of coenzyme metabolic process,BP,
12890,GO:0051231,1,0.370327096636525,0,11,spindle elongation,BP,
12892,GO:0051233,1,0.0575380332348178,0,31,spindle midzone,CC,
12909,GO:0051255,1,0.416927884310456,0,10,spindle midzone assembly,BP,
12910,GO:0051256,1,0.4937845352549,0,8,mitotic spindle midzone assembly,BP,
12930,GO:0051286,1,0.59468182698832,0,5,cell tip,CC,
12935,GO:0051292,1,0.370800700711687,0,10,nuclear pore complex assembly,BP,
12940,GO:0051299,1,0.267642747430616,0,14,centrosome separation,BP,
12944,GO:0051303,1,0.00317171358330403,0,66,establishment of chromosome localization,BP,
12946,GO:0051305,1,0.605190609742678,0,5,chromosome movement towards spindle pole,BP,
12948,GO:0051307,1,0.320845935732955,0,12,meiotic chromosome separation,BP,
12950,GO:0051310,1,0.00980527502798326,0,54,metaphase plate congression,BP,
12952,GO:0051315,1,0.328304011853756,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
12958,GO:0051340,1,0.560382498161781,0,8,regulation of ligase activity,BP,
12960,GO:0051342,1,0.605148218447272,0,6,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
12969,GO:0051351,1,0.609483540805092,0,7,positive regulation of ligase activity,BP,
12979,GO:0051382,1,0.279887383507105,0,14,kinetochore assembly,BP,
12980,GO:0051383,1,0.178128769545118,0,19,kinetochore organization,BP,
12994,GO:0051410,1,0.680637523452013,0,5,detoxification of nitrogen compound,BP,
12998,GO:0051415,1,0.565953612823275,0,6,microtubule nucleation by interphase microtubule organizing center,BP,
13000,GO:0051418,1,0.440264256467274,0,8,microtubule nucleation by microtubule organizing center,BP,
13011,GO:0051444,1,0.368344903323848,0,13,negative regulation of ubiquitin-protein transferase activity,BP,
13013,GO:0051446,1,0.435957016350119,0,9,positive regulation of meiotic cell cycle,BP,
13015,GO:0051450,1,0.513012581698699,0,8,myoblast proliferation,BP,
13056,GO:0051547,1,0.439306027296613,0,8,regulation of keratinocyte migration,BP,
13058,GO:0051549,1,0.558566238761591,0,6,positive regulation of keratinocyte migration,BP,
13066,GO:0051569,1,0.137518489096252,0,21,regulation of histone H3-K4 methylation,BP,
13068,GO:0051571,1,0.253350123277643,0,14,positive regulation of histone H3-K4 methylation,BP,
13070,GO:0051573,1,0.416525501014007,0,9,negative regulation of histone H3-K9 methylation,BP,
13088,GO:0051597,1,0.555394469781183,0,6,response to methylmercury,BP,
13091,GO:0051601,1,0.550598030917823,0,7,exocyst localization,BP,
13097,GO:0051608,1,0.512980235110347,0,9,histamine transport,BP,
13105,GO:0051639,1,0.458739908446188,0,8,actin filament network formation,BP,
13150,GO:0051721,1,0.0962396870748543,0,25,protein phosphatase 2A binding,MF,
13167,GO:0051764,1,0.319761055168163,0,12,actin crosslink formation,BP,
13169,GO:0051766,1,0.626374965660278,0,5,inositol trisphosphate kinase activity,MF,
13170,GO:0051767,1,0.422494355336708,0,10,nitric-oxide synthase biosynthetic process,BP,
13171,GO:0051769,1,0.422494355336708,0,10,regulation of nitric-oxide synthase biosynthetic process,BP,
13172,GO:0051770,1,0.519708924000646,0,7,positive regulation of nitric-oxide synthase biosynthetic process,BP,
13174,GO:0051775,1,0.468399223652462,0,10,response to redox state,BP,
13208,GO:0051836,1,0.499881063970698,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
13212,GO:0051864,1,0.430969018368961,0,8,histone demethylase activity (H3-K36 specific),MF,
13231,GO:0051894,1,0.132781951898718,0,20,positive regulation of focal adhesion assembly,BP,
13238,GO:0051901,1,0.71117980502571,0,5,positive regulation of mitochondrial depolarization,BP,
13244,GO:0051917,1,0.591895408186104,0,6,regulation of fibrinolysis,BP,
13248,GO:0051923,1,0.468207589293647,0,9,sulfation,BP,
13285,GO:0051973,1,0.0622912785895522,0,33,positive regulation of telomerase activity,BP,
13290,GO:0051984,1,0.0876420713528463,0,26,positive regulation of chromosome segregation,BP,
13292,GO:0051987,1,0.645964703869234,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
13293,GO:0051988,1,0.332468787701845,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
13324,GO:0052204,1,0.683791648510748,0,5,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
13325,GO:0052205,1,0.606706698605837,0,6,modulation of molecular function in other organism involved in symbiotic interaction,BP,
13388,GO:0052658,1,0.556076640040913,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
13389,GO:0052659,1,0.410105826314581,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
13394,GO:0052696,1,0.686409989742538,0,5,flavonoid glucuronidation,BP,
13395,GO:0052697,1,0.686409989742538,0,5,xenobiotic glucuronidation,BP,
13406,GO:0052743,1,0.33687219194525,0,11,inositol tetrakisphosphate phosphatase activity,MF,
13445,GO:0052851,1,0.626466906412561,0,5,ferric-chelate reductase (NADPH) activity,MF,
13477,GO:0055012,1,0.461964587732654,0,9,ventricular cardiac muscle cell differentiation,BP,
13480,GO:0055015,1,0.566203158901009,0,7,ventricular cardiac muscle cell development,BP,
13498,GO:0055062,1,0.525485047164215,0,6,phosphate ion homeostasis,BP,
13529,GO:0055105,1,0.710947073919924,0,6,ubiquitin-protein transferase inhibitor activity,MF,
13540,GO:0055131,1,0.690247754336314,0,5,C3HC4-type RING finger domain binding,MF,
13552,GO:0060013,1,0.595263826433359,0,5,righting reflex,BP,
13556,GO:0060019,1,0.485070809477606,0,9,radial glial cell differentiation,BP,
13565,GO:0060028,1,0.608774020329048,0,5,convergent extension involved in axis elongation,BP,
13579,GO:0060046,1,0.667040805813845,0,5,regulation of acrosome reaction,BP,
13582,GO:0060049,1,0.352116582925245,0,11,regulation of protein glycosylation,BP,
13583,GO:0060050,1,0.463822415232388,0,8,positive regulation of protein glycosylation,BP,
13585,GO:0060052,1,0.53935243082503,0,7,neurofilament cytoskeleton organization,BP,
13589,GO:0060056,1,0.562267582414727,0,7,mammary gland involution,BP,
13599,GO:0060068,1,0.568703811506223,0,6,vagina development,BP,
13616,GO:0060088,1,0.638841924234146,0,5,auditory receptor cell stereocilium organization,BP,
13619,GO:0060091,1,0.672194942631452,0,5,kinocilium,CC,
13626,GO:0060120,1,0.640586132688988,0,5,inner ear receptor cell fate commitment,BP,
13627,GO:0060122,1,0.228406457206993,0,16,inner ear receptor cell stereocilium organization,BP,
13638,GO:0060137,1,0.606728467996251,0,6,maternal process involved in parturition,BP,
13682,GO:0060215,1,0.629356331490278,0,5,primitive hemopoiesis,BP,
13683,GO:0060216,1,0.247989074340341,0,14,definitive hemopoiesis,BP,
13688,GO:0060229,1,0.502042396505017,0,8,lipase activator activity,MF,
13689,GO:0060231,1,0.328530348251241,0,13,mesenchymal to epithelial transition,BP,
13703,GO:0060259,1,0.494060379621615,0,7,regulation of feeding behavior,BP,
13705,GO:0060261,1,0.230161100400242,0,17,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
13725,GO:0060293,1,0.551338433303065,0,7,germ plasm,CC,
13744,GO:0060316,1,0.556845765582157,0,7,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
13763,GO:0060339,1,0.518804554470258,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
13774,GO:0060352,1,0.66630729569011,0,5,cell adhesion molecule production,BP,
13778,GO:0060363,1,0.551437490021766,0,7,cranial suture morphogenesis,BP,
13782,GO:0060368,1,0.603700415051795,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
13792,GO:0060379,1,0.510366066791887,0,7,cardiac muscle cell myoblast differentiation,BP,
13802,GO:0060391,1,0.31549746060305,0,12,positive regulation of SMAD protein signal transduction,BP,
13808,GO:0060397,1,0.371107332771802,0,10,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
13842,GO:0060442,1,0.408426553231591,0,9,branching involved in prostate gland morphogenesis,BP,
13849,GO:0060452,1,0.664323259450502,0,5,positive regulation of cardiac muscle contraction,BP,
13850,GO:0060453,1,0.644835384703831,0,5,regulation of gastric acid secretion,BP,
13881,GO:0060512,1,0.147643824619907,0,19,prostate gland morphogenesis,BP,
13882,GO:0060513,1,0.560121382013756,0,6,prostatic bud formation,BP,
13886,GO:0060525,1,0.414338435229573,0,8,prostate glandular acinus development,BP,
13897,GO:0060539,1,0.641126936188282,0,5,diaphragm development,BP,
13919,GO:0060576,1,0.492730631898769,0,9,intestinal epithelial cell development,BP,
13926,GO:0060586,1,0.627076541782622,0,5,multicellular organismal iron ion homeostasis,BP,
13928,GO:0060590,1,0.0592693844251573,0,35,ATPase regulator activity,MF,
13936,GO:0060600,1,0.360012747607804,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
13937,GO:0060601,1,0.389273646449614,0,9,lateral sprouting from an epithelium,BP,
13960,GO:0060666,1,0.569476942128284,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
13964,GO:0060670,1,0.421841133229738,0,10,branching involved in labyrinthine layer morphogenesis,BP,
13970,GO:0060677,1,0.568657167384822,0,5,ureteric bud elongation,BP,
13977,GO:0060687,1,0.546390626366124,0,6,regulation of branching involved in prostate gland morphogenesis,BP,
13984,GO:0060696,1,0.674221152572801,0,5,regulation of phospholipid catabolic process,BP,
13996,GO:0060710,1,0.592758775613131,0,6,chorio-allantoic fusion,BP,
13998,GO:0060712,1,0.322871019702911,0,12,spongiotrophoblast layer development,BP,
13999,GO:0060713,1,0.208381812605617,0,18,labyrinthine layer morphogenesis,BP,
14001,GO:0060716,1,0.255579814161241,0,16,labyrinthine layer blood vessel development,BP,
14018,GO:0060740,1,0.159977873026094,0,18,prostate gland epithelium morphogenesis,BP,
14019,GO:0060742,1,0.454273519740627,0,8,epithelial cell differentiation involved in prostate gland development,BP,
14021,GO:0060744,1,0.644116518223919,0,5,mammary gland branching involved in thelarche,BP,
14023,GO:0060746,1,0.528664496429528,0,7,parental behavior,BP,
14027,GO:0060751,1,0.608298915844029,0,5,branch elongation involved in mammary gland duct branching,BP,
14038,GO:0060767,1,0.458636032772029,0,9,epithelial cell proliferation involved in prostate gland development,BP,
14039,GO:0060768,1,0.50613402860496,0,8,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14041,GO:0060770,1,0.637123718949858,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14044,GO:0060788,1,0.397044231989519,0,10,ectodermal placode formation,BP,
14045,GO:0060789,1,0.615909243736505,0,6,hair follicle placode formation,BP,
14059,GO:0060837,1,0.569129410854049,0,6,blood vessel endothelial cell differentiation,BP,
14061,GO:0060839,1,0.601251946311223,0,6,endothelial cell fate commitment,BP,
14080,GO:0060897,1,0.583594196113624,0,6,neural plate regionalization,BP,
14081,GO:0060900,1,0.447261209925062,0,7,embryonic camera-type eye formation,BP,
14116,GO:0060972,1,0.217864155777493,0,16,left/right pattern formation,BP,
14117,GO:0060973,1,0.332885506780184,0,11,cell migration involved in heart development,BP,
14138,GO:0061004,1,0.592168671247832,0,7,pattern specification involved in kidney development,BP,
14169,GO:0061051,1,0.612653073997848,0,5,positive regulation of cell growth involved in cardiac muscle cell development,BP,
14182,GO:0061081,1,0.671559095717958,0,5,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
14183,GO:0061082,1,0.303288104033032,0,14,myeloid leukocyte cytokine production,BP,
14204,GO:0061133,1,0.724363265896956,0,5,endopeptidase activator activity,MF,
14221,GO:0061157,1,0.121605359708264,0,21,mRNA destabilization,BP,
14222,GO:0061158,1,0.317606960523359,0,11,3'-UTR-mediated mRNA destabilization,BP,
14255,GO:0061307,1,0.498880059814618,0,8,cardiac neural crest cell differentiation involved in heart development,BP,
14256,GO:0061308,1,0.498880059814618,0,8,cardiac neural crest cell development involved in heart development,BP,
14257,GO:0061309,1,0.588171577191522,0,6,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
14259,GO:0061312,1,0.677271166801421,0,5,BMP signaling pathway involved in heart development,BP,
14260,GO:0061314,1,0.569004459440588,0,5,Notch signaling involved in heart development,BP,
14264,GO:0061323,1,0.377962659695281,0,11,cell proliferation involved in heart morphogenesis,BP,
14299,GO:0061419,1,0.613444004081824,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
14303,GO:0061436,1,0.134828203637643,0,21,establishment of skin barrier,BP,
14337,GO:0061525,1,0.569001205112081,0,5,hindgut development,BP,
14363,GO:0061578,1,0.347034194003705,0,11,Lys63-specific deubiquitinase activity,MF,
14374,GO:0061608,1,0.457653902076482,0,9,nuclear import signal receptor activity,MF,
14377,GO:0061615,1,0.23715951919747,0,18,glycolytic process through fructose-6-phosphate,BP,
14378,GO:0061617,1,0.564925998215205,0,8,MICOS complex,CC,
14380,GO:0061620,1,0.23715951919747,0,18,glycolytic process through glucose-6-phosphate,BP,
14381,GO:0061621,1,0.251951945496645,0,17,canonical glycolysis,BP,
14385,GO:0061626,1,0.571893694265467,0,6,pharyngeal arch artery morphogenesis,BP,
14391,GO:0061635,1,0.580667307141892,0,7,regulation of protein complex stability,BP,
14404,GO:0061665,1,0.664190487922455,0,5,SUMO ligase activity,MF,
14405,GO:0061668,1,0.58790329720027,0,6,mitochondrial ribosome assembly,BP,
14408,GO:0061676,1,0.572267173388836,0,6,importin-alpha family protein binding,MF,
14409,GO:0061684,1,0.42724174086628,0,10,chaperone-mediated autophagy,BP,
14417,GO:0061700,1,0.474264314780876,0,9,GATOR2 complex,CC,
14422,GO:0061718,1,0.251951945496645,0,17,glucose catabolic process to pyruvate,BP,
14428,GO:0061732,1,0.608475127720812,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
14430,GO:0061734,1,0.564773306685003,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
14464,GO:0061820,1,0.432395663745023,0,9,telomeric D-loop disassembly,BP,
14472,GO:0061844,1,0.275990647042275,0,23,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,
14505,GO:0061983,1,0.614002359150849,0,6,meiosis II cell cycle process,BP,
14520,GO:0070003,1,0.365865316567467,0,18,threonine-type peptidase activity,MF,
14555,GO:0070076,1,0.0667488187761261,0,25,histone lysine demethylation,BP,
14570,GO:0070098,1,0.167696202020789,0,22,chemokine-mediated signaling pathway,BP,
14571,GO:0070099,1,0.561341182977088,0,6,regulation of chemokine-mediated signaling pathway,BP,
14574,GO:0070102,1,0.258353451499119,0,13,interleukin-6-mediated signaling pathway,BP,
14577,GO:0070106,1,0.443376842757381,0,8,interleukin-27-mediated signaling pathway,BP,
14588,GO:0070129,1,0.241053049616862,0,18,regulation of mitochondrial translation,BP,
14590,GO:0070131,1,0.424448623041697,0,11,positive regulation of mitochondrial translation,BP,
14603,GO:0070162,1,0.625872696432042,0,5,adiponectin secretion,BP,
14604,GO:0070163,1,0.625872696432042,0,5,regulation of adiponectin secretion,BP,
14609,GO:0070168,1,0.512130525757868,0,7,negative regulation of biomineral tissue development,BP,
14622,GO:0070187,1,0.616147749166441,0,6,shelterin complex,CC,
14631,GO:0070199,1,0.153775854914651,0,23,establishment of protein localization to chromosome,BP,
14632,GO:0070200,1,0.309790908119812,0,14,establishment of protein localization to telomere,BP,
14634,GO:0070202,1,0.428184024391298,0,11,regulation of establishment of protein localization to chromosome,BP,
14635,GO:0070203,1,0.465677818340375,0,10,regulation of establishment of protein localization to telomere,BP,
14658,GO:0070254,1,0.537357858376115,0,8,mucus secretion,BP,
14659,GO:0070255,1,0.564449166682494,0,7,regulation of mucus secretion,BP,
14661,GO:0070257,1,0.601412413566884,0,6,positive regulation of mucus secretion,BP,
14664,GO:0070262,1,0.328614970608058,0,14,peptidyl-serine dephosphorylation,BP,
14676,GO:0070286,1,0.320667474421765,0,11,axonemal dynein complex assembly,BP,
14681,GO:0070293,1,0.409849457392849,0,11,renal absorption,BP,
14706,GO:0070330,1,0.469151521280903,0,9,aromatase activity,MF,
14712,GO:0070341,1,0.564331015087,0,6,fat cell proliferation,BP,
14714,GO:0070344,1,0.564331015087,0,6,regulation of fat cell proliferation,BP,
14721,GO:0070370,1,0.708244123867685,0,5,cellular heat acclimation,BP,
14734,GO:0070391,1,0.624009186008084,0,6,response to lipoteichoic acid,BP,
14743,GO:0070410,1,0.431420438202127,0,7,co-SMAD binding,MF,
14744,GO:0070411,1,0.392021739968874,0,9,I-SMAD binding,MF,
14745,GO:0070412,1,0.204910691520987,0,15,R-SMAD binding,MF,
14749,GO:0070419,1,0.515616794288899,0,7,nonhomologous end joining complex,CC,
14750,GO:0070423,1,0.0624076964527809,0,31,nucleotide-binding oligomerization domain containing signaling pathway,BP,
14751,GO:0070424,1,0.555885442758515,0,6,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
14757,GO:0070431,1,0.511174830143165,0,8,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
14777,GO:0070475,1,0.52548398581811,0,9,rRNA base methylation,BP,
14795,GO:0070508,1,0.663434801972679,0,5,cholesterol import,BP,
14804,GO:0070528,1,0.177559087526305,0,19,protein kinase C signaling,BP,
14806,GO:0070531,1,0.636883304469897,0,5,BRCA1-A complex,CC,
14808,GO:0070535,1,0.59203757520666,0,5,histone H2A K63-linked ubiquitination,BP,
14815,GO:0070544,1,0.430969018368961,0,8,histone H3-K36 demethylation,BP,
14831,GO:0070568,1,0.656354306901006,0,5,guanylyltransferase activity,MF,
14840,GO:0070578,1,0.457133470368831,0,9,RISC-loading complex,CC,
14844,GO:0070586,1,0.538040181032826,0,8,cell-cell adhesion involved in gastrulation,BP,
14845,GO:0070587,1,0.583505184178252,0,7,regulation of cell-cell adhesion involved in gastrulation,BP,
14849,GO:0070601,1,0.512571412240973,0,8,centromeric sister chromatid cohesion,BP,
14860,GO:0070628,1,0.227873422388395,0,18,proteasome binding,MF,
14875,GO:0070652,1,0.503366990248588,0,8,HAUS complex,CC,
14886,GO:0070671,1,0.0425462100016664,0,41,response to interleukin-12,BP,
14888,GO:0070673,1,0.532785426842428,0,8,response to interleukin-18,BP,
14896,GO:0070695,1,0.588345279088337,0,5,FHF complex,CC,
14897,GO:0070696,1,0.376508897996333,0,11,transmembrane receptor protein serine/threonine kinase binding,MF,
14900,GO:0070700,1,0.458047775179475,0,9,BMP receptor binding,MF,
14903,GO:0070717,1,0.133831728707509,0,21,poly-purine tract binding,MF,
14912,GO:0070739,1,0.621373929443932,0,5,protein-glutamic acid ligase activity,MF,
14913,GO:0070740,1,0.621373929443932,0,5,tubulin-glutamic acid ligase activity,MF,
14914,GO:0070741,1,0.113442429124529,0,22,response to interleukin-6,BP,
14917,GO:0070757,1,0.444465737490171,0,8,interleukin-35-mediated signaling pathway,BP,
14918,GO:0070761,1,0.626349861078703,0,6,pre-snoRNP complex,CC,
14920,GO:0070765,1,0.592885965645932,0,6,gamma-secretase complex,CC,
14924,GO:0070775,1,0.505991116507659,0,7,H3 histone acetyltransferase complex,CC,
14925,GO:0070776,1,0.505991116507659,0,7,MOZ/MORF histone acetyltransferase complex,CC,
14935,GO:0070816,1,0.276012136741743,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
14945,GO:0070831,1,0.45213645266617,0,7,basement membrane assembly,BP,
14949,GO:0070840,1,0.144034665586864,0,18,dynein complex binding,MF,
14956,GO:0070847,1,0.552139620716341,0,8,core mediator complex,CC,
14970,GO:0070874,1,0.59580160598913,0,5,negative regulation of glycogen metabolic process,BP,
14974,GO:0070878,1,0.443030686718908,0,8,primary miRNA binding,MF,
14975,GO:0070883,1,0.642907685422892,0,5,pre-miRNA binding,MF,
14978,GO:0070886,1,0.494206442420098,0,8,positive regulation of calcineurin-NFAT signaling cascade,BP,
14980,GO:0070888,1,0.171911053519162,0,19,E-box binding,MF,
14989,GO:0070900,1,0.505546588983971,0,9,mitochondrial tRNA modification,BP,
15000,GO:0070922,1,0.433892881149058,0,9,small RNA loading onto RISC,BP,
15004,GO:0070932,1,0.155877875643904,0,20,histone H3 deacetylation,BP,
15007,GO:0070935,1,0.370982432142793,0,11,3'-UTR-mediated mRNA stabilization,BP,
15009,GO:0070937,1,0.597815756430103,0,5,CRD-mediated mRNA stability complex,CC,
15010,GO:0070938,1,0.325706644584542,0,11,contractile ring,CC,
15012,GO:0070940,1,0.642629986345463,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
15042,GO:0070986,1,0.320739525477495,0,12,left/right axis specification,BP,
15043,GO:0070987,1,0.232573447408728,0,18,error-free translesion synthesis,BP,
15046,GO:0070990,1,0.676239812833008,0,6,snRNP binding,MF,
15053,GO:0071004,1,0.24786038718042,0,17,U2-type prespliceosome,CC,
15056,GO:0071007,1,0.108339055949163,0,29,U2-type catalytic step 2 spliceosome,CC,
15058,GO:0071010,1,0.171577352386769,0,22,prespliceosome,CC,
15059,GO:0071011,1,0.0886346213826199,0,31,precatalytic spliceosome,CC,
15060,GO:0071012,1,0.61047623183501,0,6,catalytic step 1 spliceosome,CC,
15061,GO:0071013,1,0.00034819447097954,0,96,catalytic step 2 spliceosome,CC,
15062,GO:0071014,1,0.495523621765167,0,9,post-mRNA release spliceosomal complex,CC,
15069,GO:0071029,1,0.673416071600322,0,6,nuclear ncRNA surveillance,BP,
15072,GO:0071033,1,0.70812111532025,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
15074,GO:0071035,1,0.673416071600322,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
15075,GO:0071038,1,0.731214745190769,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
15080,GO:0071046,1,0.673416071600322,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
15084,GO:0071051,1,0.739226663271803,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
15114,GO:0071168,1,0.151098043313229,0,22,protein localization to chromatin,BP,
15115,GO:0071169,1,0.540288203266479,0,8,establishment of protein localization to chromatin,BP,
15116,GO:0071173,1,0.0788772829336734,0,29,spindle assembly checkpoint,BP,
15117,GO:0071174,1,0.0788772829336734,0,29,mitotic spindle checkpoint,BP,
15119,GO:0071204,1,0.611190257681198,0,6,histone pre-mRNA 3'end processing complex,CC,
15133,GO:0071223,1,0.624009186008084,0,6,cellular response to lipoteichoic acid,BP,
15140,GO:0071233,1,0.427634075783851,0,8,cellular response to leucine,BP,
15148,GO:0071253,1,0.63686870519039,0,5,connexin binding,MF,
15150,GO:0071257,1,0.618852981163029,0,5,cellular response to electrical stimulus,BP,
15157,GO:0071267,1,0.630246512610809,0,6,L-methionine salvage,BP,
15164,GO:0071281,1,0.565771356633147,0,7,cellular response to iron ion,BP,
15182,GO:0071316,1,0.633103086413472,0,6,cellular response to nicotine,BP,
15197,GO:0071339,1,0.0765742134618272,0,29,MLL1 complex,CC,
15204,GO:0071349,1,0.0460756532422743,0,40,cellular response to interleukin-12,BP,
15206,GO:0071351,1,0.685035505964917,0,5,cellular response to interleukin-18,BP,
15209,GO:0071354,1,0.113442429124529,0,22,cellular response to interleukin-6,BP,
15219,GO:0071371,1,0.300676503296977,0,13,cellular response to gonadotropin stimulus,BP,
15220,GO:0071372,1,0.468771373337645,0,8,cellular response to follicle-stimulating hormone stimulus,BP,
15234,GO:0071389,1,0.586732153298851,0,6,cellular response to mineralocorticoid stimulus,BP,
15235,GO:0071391,1,0.347475888493562,0,11,cellular response to estrogen stimulus,BP,
15238,GO:0071394,1,0.536937081653178,0,7,cellular response to testosterone stimulus,BP,
15260,GO:0071427,1,0.000100275149079693,0,103,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
15261,GO:0071428,1,0.323322707867256,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
15267,GO:0071440,1,0.647177438356539,0,5,regulation of histone H3-K14 acetylation,BP,
15270,GO:0071447,1,0.625085125485617,0,5,cellular response to hydroperoxide,BP,
15272,GO:0071450,1,0.242379106723466,0,19,cellular response to oxygen radical,BP,
15273,GO:0071451,1,0.242379106723466,0,19,cellular response to superoxide,BP,
15279,GO:0071459,1,0.200158798873311,0,20,protein localization to chromosome, centromeric region,BP,
15289,GO:0071472,1,0.54048251840244,0,7,cellular response to salt stress,BP,
15290,GO:0071474,1,0.551984818360036,0,7,cellular hyperosmotic response,BP,
15309,GO:0071499,1,0.569757772041944,0,7,cellular response to laminar fluid shear stress,BP,
15311,GO:0071501,1,0.487522210392554,0,8,cellular response to sterol depletion,BP,
15325,GO:0071541,1,0.602827223347104,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
15337,GO:0071557,1,0.579207361757227,0,5,histone H3-K27 demethylation,BP,
15338,GO:0071558,1,0.579207361757227,0,5,histone demethylase activity (H3-K27 specific),MF,
15342,GO:0071564,1,0.329011816370491,0,12,npBAF complex,CC,
15343,GO:0071565,1,0.301922164794611,0,12,nBAF complex,CC,
15362,GO:0071598,1,0.664480913597093,0,5,neuronal ribonucleoprotein granule,CC,
15363,GO:0071599,1,0.534348431233721,0,6,otic vesicle development,BP,
15368,GO:0071605,1,0.583299611467141,0,7,monocyte chemotactic protein-1 production,BP,
15388,GO:0071635,1,0.580781167682458,0,6,negative regulation of transforming growth factor beta production,BP,
15390,GO:0071637,1,0.583299611467141,0,7,regulation of monocyte chemotactic protein-1 production,BP,
15392,GO:0071639,1,0.682981403519317,0,5,positive regulation of monocyte chemotactic protein-1 production,BP,
15418,GO:0071680,1,0.599808663610954,0,5,response to indole-3-methanol,BP,
15419,GO:0071681,1,0.599808663610954,0,5,cellular response to indole-3-methanol,BP,
15427,GO:0071696,1,0.367253135642943,0,11,ectodermal placode development,BP,
15428,GO:0071697,1,0.397044231989519,0,10,ectodermal placode morphogenesis,BP,
15439,GO:0071712,1,0.372386787576473,0,11,ER-associated misfolded protein catabolic process,BP,
15447,GO:0071731,1,0.366310340442156,0,11,response to nitric oxide,BP,
15448,GO:0071732,1,0.414667976691214,0,10,cellular response to nitric oxide,BP,
15450,GO:0071763,1,0.589799753879505,0,6,nuclear membrane organization,BP,
15456,GO:0071786,1,0.267153054599512,0,15,endoplasmic reticulum tubular network organization,BP,
15475,GO:0071817,1,0.684807268648665,0,5,MMXD complex,CC,
15491,GO:0071850,1,0.3067851370132,0,14,mitotic cell cycle arrest,BP,
15532,GO:0071921,1,0.567161182517875,0,6,cohesin loading,BP,
15533,GO:0071922,1,0.616809650026762,0,5,regulation of cohesin loading,BP,
15545,GO:0071949,1,0.155903230090118,0,21,FAD binding,MF,
15554,GO:0071986,1,0.607582161516891,0,6,Ragulator complex,CC,
15574,GO:0072033,1,0.513433769995318,0,6,renal vesicle formation,BP,
15580,GO:0072044,1,0.418256689848606,0,8,collecting duct development,BP,
15582,GO:0072048,1,0.592168671247832,0,7,renal system pattern specification,BP,
15598,GO:0072077,1,0.342201153446382,0,11,renal vesicle morphogenesis,BP,
15600,GO:0072079,1,0.409114180437236,0,11,nephron tubule formation,BP,
15604,GO:0072087,1,0.342201153446382,0,11,renal vesicle development,BP,
15624,GO:0072110,1,0.567525653263905,0,7,glomerular mesangial cell proliferation,BP,
15628,GO:0072124,1,0.567525653263905,0,7,regulation of glomerular mesangial cell proliferation,BP,
15647,GO:0072148,1,0.37967623048616,0,11,epithelial cell fate commitment,BP,
15658,GO:0072173,1,0.499493272346267,0,7,metanephric tubule morphogenesis,BP,
15663,GO:0072178,1,0.613112954533149,0,5,nephric duct morphogenesis,BP,
15683,GO:0072205,1,0.572843091395381,0,5,metanephric collecting duct development,BP,
15692,GO:0072217,1,0.646432628921543,0,5,negative regulation of metanephros development,BP,
15721,GO:0072282,1,0.551071808179576,0,6,metanephric nephron tubule morphogenesis,BP,
15722,GO:0072283,1,0.416659522244958,0,9,metanephric renal vesicle morphogenesis,BP,
15745,GO:0072321,1,0.500187845795704,0,10,chaperone-mediated protein transport,BP,
15752,GO:0072338,1,0.582352602466985,0,5,cellular lactam metabolic process,BP,
15756,GO:0072345,1,0.629682131867743,0,5,NAADP-sensitive calcium-release channel activity,MF,
15787,GO:0072393,1,0.297979631539693,0,11,microtubule anchoring at microtubule organizing center,BP,
15789,GO:0072396,1,0.556984788893358,0,6,response to cell cycle checkpoint signaling,BP,
15791,GO:0072402,1,0.556984788893358,0,6,response to DNA integrity checkpoint signaling,BP,
15795,GO:0072423,1,0.556984788893358,0,6,response to DNA damage checkpoint signaling,BP,
15796,GO:0072425,1,0.343091993695245,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
15802,GO:0072487,1,0.641928983769917,0,5,MSL complex,CC,
15803,GO:0072488,1,0.56327089864785,0,7,ammonium transmembrane transport,BP,
15805,GO:0072497,1,0.548146480377412,0,6,mesenchymal stem cell differentiation,BP,
15810,GO:0072505,1,0.525485047164215,0,6,divalent inorganic anion homeostasis,BP,
15811,GO:0072506,1,0.525485047164215,0,6,trivalent inorganic anion homeostasis,BP,
15830,GO:0072530,1,0.53688358788168,0,8,purine-containing compound transmembrane transport,BP,
15831,GO:0072531,1,0.613686124607337,0,6,pyrimidine-containing compound transmembrane transport,BP,
15836,GO:0072538,1,0.444155949235921,0,9,T-helper 17 type immune response,BP,
15837,GO:0072539,1,0.52154586455075,0,7,T-helper 17 cell differentiation,BP,
15839,GO:0072542,1,0.56426532472889,0,7,protein phosphatase activator activity,MF,
15841,GO:0072546,1,0.427397677381289,0,10,ER membrane protein complex,CC,
15866,GO:0072584,1,0.491177635022712,0,8,caveolin-mediated endocytosis,BP,
15888,GO:0072641,1,0.524088643371439,0,6,type I interferon secretion,BP,
15889,GO:0072642,1,0.524088643371439,0,6,interferon-alpha secretion,BP,
15892,GO:0072656,1,0.647443561726225,0,5,maintenance of protein location in mitochondrion,BP,
15901,GO:0072669,1,0.627257179405561,0,7,tRNA-splicing ligase complex,CC,
15933,GO:0072718,1,0.435538125894869,0,9,response to cisplatin,BP,
15934,GO:0072719,1,0.583586726464011,0,6,cellular response to cisplatin,BP,
15959,GO:0075522,1,0.414780277150632,0,10,IRES-dependent viral translational initiation,BP,
15960,GO:0075525,1,0.673949747532375,0,5,viral translational termination-reinitiation,BP,
15963,GO:0075713,1,0.536336614245782,0,8,establishment of integrated proviral latency,BP,
15972,GO:0080084,1,0.591843974886749,0,5,5S rDNA binding,MF,
15985,GO:0080154,1,0.597783323966172,0,6,regulation of fertilization,BP,
15990,GO:0085020,1,0.576570474607633,0,7,protein K6-linked ubiquitination,BP,
16006,GO:0086014,1,0.34815806206927,0,10,atrial cardiac muscle cell action potential,BP,
16008,GO:0086016,1,0.623812863012196,0,5,AV node cell action potential,BP,
16011,GO:0086019,1,0.225451063816288,0,15,cell-cell signaling involved in cardiac conduction,BP,
16016,GO:0086026,1,0.34815806206927,0,10,atrial cardiac muscle cell to AV node cell signaling,BP,
16017,GO:0086027,1,0.623812863012196,0,5,AV node cell to bundle of His cell signaling,BP,
16024,GO:0086042,1,0.531039801073901,0,6,cardiac muscle cell-cardiac muscle cell adhesion,BP,
16038,GO:0086066,1,0.34815806206927,0,10,atrial cardiac muscle cell to AV node cell communication,BP,
16039,GO:0086067,1,0.549113296067237,0,6,AV node cell to bundle of His cell communication,BP,
16041,GO:0086069,1,0.409850987585554,0,9,bundle of His cell to Purkinje myocyte communication,BP,
16044,GO:0086073,1,0.573992054414377,0,5,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,
16050,GO:0086080,1,0.408770164358153,0,8,protein binding involved in heterotypic cell-cell adhesion,MF,
16052,GO:0086083,1,0.573992054414377,0,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,
16061,GO:0089701,1,0.713871426747214,0,5,U2AF,CC,
16073,GO:0090030,1,0.481549639434431,0,8,regulation of steroid hormone biosynthetic process,BP,
16078,GO:0090036,1,0.345886863666069,0,11,regulation of protein kinase C signaling,BP,
16079,GO:0090037,1,0.594031647345169,0,6,positive regulation of protein kinase C signaling,BP,
16084,GO:0090045,1,0.600188866074375,0,6,positive regulation of deacetylase activity,BP,
16087,GO:0090051,1,0.289724397796986,0,13,negative regulation of cell migration involved in sprouting angiogenesis,BP,
16093,GO:0090069,1,0.304316090364052,0,13,regulation of ribosome biogenesis,BP,
16094,GO:0090070,1,0.506119736208006,0,8,positive regulation of ribosome biogenesis,BP,
16096,GO:0090073,1,0.51800382930078,0,8,positive regulation of protein homodimerization activity,BP,
16140,GO:0090148,1,0.312204577786253,0,12,membrane fission,BP,
16143,GO:0090151,1,0.45958172455328,0,12,establishment of protein localization to mitochondrial membrane,BP,
16145,GO:0090154,1,0.519151375534482,0,8,positive regulation of sphingolipid biosynthetic process,BP,
16148,GO:0090158,1,0.677377717843836,0,5,endoplasmic reticulum membrane organization,BP,
16149,GO:0090160,1,0.476020332988785,0,8,Golgi to lysosome transport,BP,
16150,GO:0090161,1,0.328771744803015,0,11,Golgi ribbon formation,BP,
16153,GO:0090166,1,0.607211992634794,0,6,Golgi disassembly,BP,
16167,GO:0090185,1,0.460325783543641,0,9,negative regulation of kidney development,BP,
16189,GO:0090208,1,0.390117782976782,0,11,positive regulation of triglyceride metabolic process,BP,
16194,GO:0090218,1,0.175986261931292,0,18,positive regulation of lipid kinase activity,BP,
16196,GO:0090220,1,0.465618628179976,0,8,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
16201,GO:0090231,1,0.303143675079084,0,14,regulation of spindle checkpoint,BP,
16202,GO:0090232,1,0.492310146535646,0,8,positive regulation of spindle checkpoint,BP,
16205,GO:0090235,1,0.459728133654578,0,7,regulation of metaphase plate congression,BP,
16208,GO:0090239,1,0.39649748836052,0,11,regulation of histone H4 acetylation,BP,
16209,GO:0090240,1,0.562045904516979,0,7,positive regulation of histone H4 acetylation,BP,
16223,GO:0090266,1,0.331640893623533,0,13,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16224,GO:0090267,1,0.538566740865538,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
16233,GO:0090280,1,0.61531361885694,0,5,positive regulation of calcium ion import,BP,
16251,GO:0090304,1,7.02209894171586e-11,261,4171,nucleic acid metabolic process,BP,TNIP1;NT5E;SMURF2;NOS1;ERCC1;ZMYND8;F2R;ETV5;CCND1;CTNNBIP1;VLDLR;CBS;ITGA6;H1F0;IGFBP4;PRNP;ADGRF1;NR1D1;NFATC4;ZC3H6;ADARB1;MAP2K1;ETV4;ACVR2B;ZKSCAN1;SALL2;TK2;PKN1;WWTR1;PEG3;ARHGAP22;APLN;RBMS2;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;CARS;PSMD2;ELK3;CRTC1;EGFR;BCORL1;HLTF;SCMH1;SLC33A1;ERCC6;MAPK13;ZNF516;DLG1;DNAJB5;DHX32;ZSCAN30;XPC;HTRA1;GLO1;WNT7A;IGF2BP3;SHC1;DKK1;DAP;KIAA1549;ZNF652;RAG1;IMPACT;APOE;CCPG1;RGS14;PKD2;ZNF862;ZNF624;RBCK1;FAM208A;DDN;ANXA3;HMGA2;ATF4;PPARA;WWC3;FGFR1;AARS;E2F5;EPCAM;TCFL5;NFAT5;BTRC;ZNF559;INTS8;ZNF81;ATRX;CHURC1;ABCG1;SOX4;APOBEC3C;FHOD1;DDB2;ENDOV;ZNF558;ZNF692;ATF7IP;RCOR1;NLK;MDFI;XRN1;TRIM5;TCEA1;TNRC6B;DVL1;HES2;ZBTB10;PHF12;CTH;ZNF704;LRP5;ETAA1;ZMYM3;KLF12;CST3;TRIB3;PCSK6;L3MBTL3;ZNF322;PPP3CB;RFX2;PRDX5;CEBPG;PLAG1;F2RL1;UHRF2;TAOK1;AEBP1;CSNK2A1;PHF1;PSMD7;CHD7;PRKAR1A;MSRB2;JMY;PARP9;ATXN2;NACC2;LACTB2;ZNF337;THRA;ACVR1B;NGFR;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;RNF165;YTHDC2;MEF2D;NYNRIN;ARF4;H2AFJ;POLL;XBP1;MAP2K2;SATB1;PAIP1;REC8;TLE4;RET;LOXL2;MLH3;THAP10;NOP10;RMRP;GTF2IRD2;DNASE1L1;PAK6;EAPP;PUM2;ETV1;CCDC88A;PRKACA;ZNF398;TCEAL8;UNKL;TMSB4X;EIF2AK2;EEPD1;CBX7;IFI16;NR2F6;SCAND1;IL1RAP;SBNO1;CARD11;ZNF354A;TBL1X;RNF169;HOXA3;ARID4A;TENM2;IGF2;ZSCAN18;ZMYM2;EFCAB7;PPARG;CITED4;SNX6;ZFP30;ZNF37A;TBX1;CREB3L2;RSF1;ADAM8;GARS;WFS1;DEPDC1;ENDOG;PHF21A;ZBTB40;ZNF92;MAML3;ZNF568;OSGEPL1;FZD8;WASL;ZNF107;LRP6;ARID5B;MAGEF1;ZNF165;TMEM173;E2F7;ZNF320;CMTR2;TNRC6C;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;FOXP1;ZBTB33;PTCH1;KAT2B;CNOT11;OAS1;PRMT3;UFL1;N4BP2;PBX3;JARID2;KLHL15;MXD4;ADNP;LRP4;RFX7;RB1CC1;DNMT3A;TRIM38;FADD
16259,GO:0090312,1,0.201229845483537,0,18,positive regulation of protein deacetylation,BP,
16267,GO:0090324,1,0.657166355652881,0,5,negative regulation of oxidative phosphorylation,BP,
16274,GO:0090335,1,0.465249933922138,0,8,regulation of brown fat cell differentiation,BP,
16292,GO:0090385,1,0.608087200221551,0,6,phagosome-lysosome fusion,BP,
16298,GO:0090399,1,0.354659871050517,0,11,replicative senescence,BP,
16299,GO:0090400,1,0.539260897772234,0,7,stress-induced premature senescence,BP,
16309,GO:0090435,1,0.563439128186815,0,7,protein localization to nuclear envelope,BP,
16324,GO:0090520,1,0.460721533698806,0,9,sphingolipid mediated signaling pathway,BP,
16342,GO:0090576,1,0.458867982405477,0,8,RNA polymerase III transcription factor complex,CC,
16346,GO:0090599,1,0.580924832461671,0,5,alpha-glucosidase activity,MF,
16349,GO:0090611,1,0.66233038893305,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
16356,GO:0090646,1,0.39295052870875,0,12,mitochondrial tRNA processing,BP,
16358,GO:0090649,1,0.587818439975637,0,5,response to oxygen-glucose deprivation,BP,
16359,GO:0090650,1,0.587818439975637,0,5,cellular response to oxygen-glucose deprivation,BP,
16361,GO:0090657,1,0.359208863357891,0,11,telomeric loop disassembly,BP,
16381,GO:0090723,1,0.382671072253981,0,11,growth cone part,CC,
16386,GO:0090735,1,0.456251935996542,0,10,DNA repair complex assembly,BP,
16388,GO:0090741,1,0.665842003674423,0,6,pigment granule membrane,CC,
16390,GO:0095500,1,0.388241740937959,0,11,acetylcholine receptor signaling pathway,BP,
16391,GO:0097001,1,0.521989580844426,0,8,ceramide binding,MF,
16396,GO:0097011,1,0.577268407097836,0,7,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
16397,GO:0097012,1,0.577268407097836,0,7,response to granulocyte macrophage colony-stimulating factor,BP,
16406,GO:0097027,1,0.587144189808696,0,7,ubiquitin-protein transferase activator activity,MF,
16435,GO:0097084,1,0.579592011370884,0,6,vascular smooth muscle cell development,BP,
16441,GO:0097100,1,0.675529553392258,0,5,supercoiled DNA binding,MF,
16470,GO:0097150,1,0.158147045472948,0,17,neuronal stem cell population maintenance,BP,
16477,GO:0097157,1,0.469125651852453,0,8,pre-mRNA intronic binding,MF,
16483,GO:0097165,1,0.638123219246132,0,5,nuclear stress granule,CC,
16502,GO:0097197,1,0.602798437727535,0,6,tetraspanin-enriched microdomain,CC,
16518,GO:0097225,1,0.463211476111209,0,10,sperm midpiece,CC,
16521,GO:0097228,1,0.376611283809181,0,11,sperm principal piece,CC,
16532,GO:0097255,1,0.700450914184951,0,5,R2TP complex,CC,
16542,GO:0097283,1,0.67774476577896,0,5,keratinocyte apoptotic process,BP,
16544,GO:0097286,1,0.375309534268864,0,11,iron ion import,BP,
16554,GO:0097322,1,0.588068882239222,0,6,7SK snRNA binding,MF,
16560,GO:0097340,1,0.334772036892364,0,11,inhibition of cysteine-type endopeptidase activity,BP,
16561,GO:0097341,1,0.334772036892364,0,11,zymogen inhibition,BP,
16566,GO:0097346,1,0.153473045935795,0,23,INO80-type complex,CC,
16583,GO:0097381,1,0.593758035035402,0,5,photoreceptor disc membrane,CC,
16586,GO:0097384,1,0.555102214415677,0,7,cellular lipid biosynthetic process,BP,
16598,GO:0097418,1,0.622137312570737,0,5,neurofibrillary tangle,CC,
16602,GO:0097427,1,0.597970398709977,0,5,microtubule bundle,CC,
16604,GO:0097431,1,0.0787579564256614,0,26,mitotic spindle pole,CC,
16605,GO:0097433,1,0.662482727657505,0,5,dense body,CC,
16613,GO:0097449,1,0.593669449108622,0,6,astrocyte projection,CC,
16623,GO:0097470,1,0.584577121513626,0,5,ribbon synapse,CC,
16643,GO:0097502,1,0.0877890854448963,0,28,mannosylation,BP,
16645,GO:0097504,1,0.39431024400704,0,11,Gemini of coiled bodies,CC,
16647,GO:0097506,1,0.705551195979498,0,5,deaminated base DNA N-glycosylase activity,MF,
16653,GO:0097525,1,0.00735273987138385,0,62,spliceosomal snRNP complex,CC,
16654,GO:0097526,1,0.117147449858042,0,29,spliceosomal tri-snRNP complex,CC,
16664,GO:0097539,1,0.356397217299967,0,10,ciliary transition fiber,CC,
16669,GO:0097550,1,0.629575638246057,0,6,transcriptional preinitiation complex,CC,
16678,GO:0097602,1,0.240044620095801,0,17,cullin family protein binding,MF,
16686,GO:0097629,1,0.645185003447472,0,5,extrinsic component of omegasome membrane,CC,
16729,GO:0097732,1,0.672194942631452,0,5,9+2 non-motile cilium,CC,
16741,GO:0098501,1,0.699325695014532,0,5,polynucleotide dephosphorylation,BP,
16745,GO:0098505,1,0.430294230764531,0,10,G-rich strand telomeric DNA binding,MF,
16750,GO:0098519,1,0.654469782628458,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
16754,GO:0098532,1,0.635259705708604,0,6,histone H3-K27 trimethylation,BP,
16760,GO:0098543,1,0.527953633395178,0,7,detection of other organism,BP,
16765,GO:0098556,1,0.782173430351817,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
16775,GO:0098581,1,0.48694096422669,0,8,detection of external biotic stimulus,BP,
16784,GO:0098597,1,0.505787925946137,0,5,observational learning,BP,
16800,GO:0098642,1,0.494234802305555,0,6,network-forming collagen trimer,CC,
16803,GO:0098645,1,0.494234802305555,0,6,collagen network,CC,
16807,GO:0098651,1,0.494234802305555,0,6,basement membrane collagen trimer,CC,
16826,GO:0098711,1,0.558927433179165,0,6,iron ion import across plasma membrane,BP,
16857,GO:0098779,1,0.464651161772842,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
16858,GO:0098780,1,0.210853671868271,0,17,response to mitochondrial depolarisation,BP,
16860,GO:0098787,1,0.280233661626678,0,14,mRNA cleavage involved in mRNA processing,BP,
16861,GO:0098789,1,0.36473566669722,0,11,pre-mRNA cleavage required for polyadenylation,BP,
16863,GO:0098792,1,0.411048396673305,0,10,xenophagy,BP,
16870,GO:0098799,1,0.423280079278734,0,12,outer mitochondrial membrane protein complex,CC,
16880,GO:0098814,1,0.634980152285252,0,5,spontaneous synaptic transmission,BP,
16898,GO:0098843,1,0.601031332659064,0,6,postsynaptic endocytic zone,CC,
16900,GO:0098845,1,0.626439518840066,0,6,postsynaptic endosome,CC,
16901,GO:0098847,1,0.333249012023289,0,13,sequence-specific single stranded DNA binding,MF,
16913,GO:0098877,1,0.41781831904063,0,10,neurotransmitter receptor transport to plasma membrane,BP,
16920,GO:0098887,1,0.642087276479167,0,5,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
16933,GO:0098910,1,0.576134151361002,0,5,regulation of atrial cardiac muscle cell action potential,BP,
16960,GO:0098969,1,0.457112589652012,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
16996,GO:0099078,1,0.553925819622607,0,8,BORC complex,CC,
17010,GO:0099116,1,0.317642861909899,0,16,tRNA 5'-end processing,BP,
17033,GO:0099500,1,0.440172049683921,0,10,vesicle fusion to plasma membrane,BP,
17070,GO:0099563,1,0.315953447528725,0,12,modification of synaptic structure,BP,
17080,GO:0099590,1,0.564621356085645,0,6,neurotransmitter receptor internalization,BP,
17082,GO:0099602,1,0.643671072045772,0,6,neurotransmitter receptor regulator activity,MF,
17100,GO:0099638,1,0.586910021950929,0,6,endosome to plasma membrane protein transport,BP,
17101,GO:0099639,1,0.586910021950929,0,6,neurotransmitter receptor transport, endosome to plasma membrane,BP,
17202,GO:0106030,1,0.220492861801656,0,14,neuron projection fasciculation,BP,
17206,GO:0106049,1,0.639011344544281,0,5,regulation of cellular response to osmotic stress,BP,
17210,GO:0106058,1,0.494206442420098,0,8,positive regulation of calcineurin-mediated signaling,BP,
17211,GO:0106068,1,0.578648854119571,0,7,SUMO ligase complex,CC,
17228,GO:0110011,1,0.549679333108919,0,5,regulation of basement membrane organization,BP,
17244,GO:0110096,1,0.722118759940236,0,5,cellular response to aldehyde,BP,
17245,GO:0120009,1,0.652685208239858,0,5,intermembrane lipid transfer,BP,
17247,GO:0120013,1,0.652685208239858,0,5,intermembrane lipid transfer activity,MF,
17276,GO:0120114,1,0.0017685877916799,0,79,Sm-like protein family complex,CC,
17301,GO:0140078,1,0.494313494110928,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17302,GO:0140080,1,0.494313494110928,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
17307,GO:0140102,1,0.291473658637744,0,16,catalytic activity, acting on a rRNA,MF,
17313,GO:0140131,1,0.50010575009137,0,8,positive regulation of lymphocyte chemotaxis,BP,
17315,GO:0140142,1,0.183571256462754,0,18,nucleocytoplasmic carrier activity,MF,
17324,GO:0150005,1,0.449526033181922,0,10,enzyme activator complex,CC,
17337,GO:1900015,1,0.16947236141285,0,20,regulation of cytokine production involved in inflammatory response,BP,
17338,GO:1900016,1,0.504491496762014,0,8,negative regulation of cytokine production involved in inflammatory response,BP,
17339,GO:1900017,1,0.455753213002706,0,9,positive regulation of cytokine production involved in inflammatory response,BP,
17347,GO:1900029,1,0.396223714136369,0,11,positive regulation of ruffle assembly,BP,
17348,GO:1900034,1,0.00129780842137914,0,72,regulation of cellular response to heat,BP,
17350,GO:1900037,1,0.450895937013935,0,10,regulation of cellular response to hypoxia,BP,
17351,GO:1900038,1,0.606090555018383,0,6,negative regulation of cellular response to hypoxia,BP,
17353,GO:1900040,1,0.598437372817406,0,5,regulation of interleukin-2 secretion,BP,
17356,GO:1900044,1,0.420346511608471,0,8,regulation of protein K63-linked ubiquitination,BP,
17357,GO:1900045,1,0.58416887830119,0,5,negative regulation of protein K63-linked ubiquitination,BP,
17387,GO:1900113,1,0.651091012821537,0,5,negative regulation of histone H3-K9 trimethylation,BP,
17394,GO:1900120,1,0.288712313754756,0,16,regulation of receptor binding,BP,
17395,GO:1900121,1,0.444826046615345,0,10,negative regulation of receptor binding,BP,
17396,GO:1900122,1,0.64236672025158,0,6,positive regulation of receptor binding,BP,
17397,GO:1900125,1,0.563284727157878,0,6,regulation of hyaluronan biosynthetic process,BP,
17427,GO:1900181,1,0.246437649562845,0,15,negative regulation of protein localization to nucleus,BP,
17430,GO:1900193,1,0.673330048428694,0,5,regulation of oocyte maturation,BP,
17455,GO:1900242,1,0.53703476763016,0,6,regulation of synaptic vesicle endocytosis,BP,
17460,GO:1900247,1,0.379632668027327,0,11,regulation of cytoplasmic translational elongation,BP,
17464,GO:1900262,1,0.649169169787493,0,6,regulation of DNA-directed DNA polymerase activity,BP,
17465,GO:1900264,1,0.649169169787493,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
17472,GO:1900363,1,0.333729505913782,0,12,regulation of mRNA polyadenylation,BP,
17473,GO:1900364,1,0.477049805579534,0,8,negative regulation of mRNA polyadenylation,BP,
17495,GO:1900451,1,0.625592173196292,0,5,positive regulation of glutamate receptor signaling pathway,BP,
17510,GO:1900739,1,0.106901429539994,0,28,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
17511,GO:1900740,1,0.106901429539994,0,28,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
17517,GO:1900750,1,0.461789943385575,0,11,oligopeptide binding,MF,
17522,GO:1900864,1,0.505546588983971,0,9,mitochondrial RNA modification,BP,
17537,GO:1901032,1,0.355927821974463,0,13,negative regulation of response to reactive oxygen species,BP,
17579,GO:1901201,1,0.303975043284408,0,11,regulation of extracellular matrix assembly,BP,
17581,GO:1901203,1,0.412018223798545,0,8,positive regulation of extracellular matrix assembly,BP,
17583,GO:1901213,1,0.492984486172207,0,8,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
17613,GO:1901299,1,0.653841315301104,0,5,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
17629,GO:1901339,1,0.556644603194794,0,6,regulation of store-operated calcium channel activity,BP,
17648,GO:1901385,1,0.278017105608565,0,14,regulation of voltage-gated calcium channel activity,BP,
17649,GO:1901386,1,0.664663660316643,0,5,negative regulation of voltage-gated calcium channel activity,BP,
17653,GO:1901407,1,0.480123393643696,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17654,GO:1901409,1,0.578576239923361,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
17662,GO:1901503,1,0.641920647184298,0,5,ether biosynthetic process,BP,
17667,GO:1901524,1,0.259324359452225,0,14,regulation of mitophagy,BP,
17668,GO:1901525,1,0.558351162174203,0,6,negative regulation of mitophagy,BP,
17669,GO:1901526,1,0.464651161772842,0,8,positive regulation of mitophagy,BP,
17672,GO:1901533,1,0.603328837596695,0,6,negative regulation of hematopoietic progenitor cell differentiation,BP,
17674,GO:1901535,1,0.568408830366648,0,5,regulation of DNA demethylation,BP,
17679,GO:1901550,1,0.433126572557162,0,9,regulation of endothelial cell development,BP,
17685,GO:1901563,1,0.625495933120977,0,5,response to camptothecin,BP,
17713,GO:1901623,1,0.459842918833832,0,9,regulation of lymphocyte chemotaxis,BP,
17731,GO:1901660,1,0.545206451469095,0,6,calcium ion export,BP,
17744,GO:1901679,1,0.52802507655363,0,8,nucleotide transmembrane transport,BP,
17748,GO:1901685,1,0.38914427023873,0,16,glutathione derivative metabolic process,BP,
17749,GO:1901687,1,0.38914427023873,0,16,glutathione derivative biosynthetic process,BP,
17756,GO:1901722,1,0.408821568111111,0,11,regulation of cell proliferation involved in kidney development,BP,
17757,GO:1901723,1,0.656678685012763,0,5,negative regulation of cell proliferation involved in kidney development,BP,
17758,GO:1901724,1,0.622683485786821,0,6,positive regulation of cell proliferation involved in kidney development,BP,
17759,GO:1901725,1,0.530541613441337,0,6,regulation of histone deacetylase activity,BP,
17763,GO:1901739,1,0.454946764054341,0,10,regulation of myoblast fusion,BP,
17765,GO:1901741,1,0.488032838734047,0,9,positive regulation of myoblast fusion,BP,
17771,GO:1901798,1,0.254077289572698,0,16,positive regulation of signal transduction by p53 class mediator,BP,
17778,GO:1901836,1,0.383262675346802,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17780,GO:1901838,1,0.442261698821693,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
17781,GO:1901841,1,0.666913930902927,0,5,regulation of high voltage-gated calcium channel activity,BP,
17784,GO:1901844,1,0.538157607712049,0,7,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
17786,GO:1901857,1,0.719187274487488,0,5,positive regulation of cellular respiration,BP,
17800,GO:1901890,1,0.0862406524669152,0,25,positive regulation of cell junction assembly,BP,
17818,GO:1901970,1,0.494090608234568,0,8,positive regulation of mitotic sister chromatid separation,BP,
17821,GO:1901978,1,0.452674360519037,0,9,positive regulation of cell cycle checkpoint,BP,
17826,GO:1901984,1,0.207484940092683,0,18,negative regulation of protein acetylation,BP,
17839,GO:1902004,1,0.481086272455508,0,8,positive regulation of amyloid-beta formation,BP,
17846,GO:1902031,1,0.65950099429826,0,5,regulation of NADP metabolic process,BP,
17863,GO:1902083,1,0.574314967307694,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
17867,GO:1902100,1,0.0716162920383029,0,30,negative regulation of metaphase/anaphase transition of cell cycle,BP,
17868,GO:1902101,1,0.494090608234568,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
17889,GO:1902170,1,0.335973434015325,0,12,cellular response to reactive nitrogen species,BP,
17890,GO:1902172,1,0.67774476577896,0,5,regulation of keratinocyte apoptotic process,BP,
17893,GO:1902175,1,0.155960821201177,0,23,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17894,GO:1902176,1,0.288316015363137,0,16,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17895,GO:1902177,1,0.679376370981034,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
17908,GO:1902218,1,0.639011344544281,0,5,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
17913,GO:1902224,1,0.56450539474838,0,7,ketone body metabolic process,BP,
17963,GO:1902337,1,0.51705190282386,0,7,regulation of apoptotic process involved in morphogenesis,BP,
17967,GO:1902358,1,0.568957626678276,0,6,sulfate transmembrane transport,BP,
17986,GO:1902410,1,0.598308561894315,0,6,mitotic cytokinetic process,BP,
17988,GO:1902414,1,0.4357847425112,0,8,protein localization to cell junction,BP,
17989,GO:1902415,1,0.484952054823422,0,9,regulation of mRNA binding,BP,
17990,GO:1902416,1,0.564525231369493,0,7,positive regulation of mRNA binding,BP,
18020,GO:1902513,1,0.583886112145421,0,6,regulation of organelle transport along microtubule,BP,
18024,GO:1902525,1,0.693416387366895,0,5,regulation of protein monoubiquitination,BP,
18036,GO:1902555,1,0.102484970617239,0,29,endoribonuclease complex,CC,
18045,GO:1902570,1,0.48713826109343,0,9,protein localization to nucleolus,BP,
18050,GO:1902581,1,0.66345794560483,0,5,multi-organism cellular localization,BP,
18051,GO:1902583,1,0.66345794560483,0,5,multi-organism intracellular transport,BP,
18079,GO:1902669,1,0.43881140867332,0,7,positive regulation of axon guidance,BP,
18087,GO:1902692,1,0.195080669654149,0,16,regulation of neuroblast proliferation,BP,
18102,GO:1902739,1,0.524088643371439,0,6,regulation of interferon-alpha secretion,BP,
18103,GO:1902741,1,0.524088643371439,0,6,positive regulation of interferon-alpha secretion,BP,
18117,GO:1902774,1,0.600508609486755,0,6,late endosome to lysosome transport,BP,
18136,GO:1902855,1,0.400759908226925,0,10,regulation of non-motile cilium assembly,BP,
18138,GO:1902857,1,0.532182972640227,0,7,positive regulation of non-motile cilium assembly,BP,
18156,GO:1902902,1,0.425050585166736,0,11,negative regulation of autophagosome assembly,BP,
18165,GO:1902914,1,0.228559543317017,0,15,regulation of protein polyubiquitination,BP,
18166,GO:1902915,1,0.526855501154144,0,6,negative regulation of protein polyubiquitination,BP,
18167,GO:1902916,1,0.49338330574649,0,8,positive regulation of protein polyubiquitination,BP,
18192,GO:1902961,1,0.575657222710133,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
18205,GO:1902993,1,0.412510698031678,0,10,positive regulation of amyloid precursor protein catabolic process,BP,
18218,GO:1903010,1,0.318124892572337,0,11,regulation of bone development,BP,
18236,GO:1903044,1,0.524810795727276,0,8,protein localization to membrane raft,BP,
18245,GO:1903055,1,0.299833622826311,0,12,positive regulation of extracellular matrix organization,BP,
18248,GO:1903069,1,0.482494977770452,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18250,GO:1903071,1,0.567166248066264,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
18271,GO:1903140,1,0.433126572557162,0,9,regulation of establishment of endothelial barrier,BP,
18276,GO:1903147,1,0.490243379594556,0,8,negative regulation of autophagy of mitochondrion,BP,
18300,GO:1903206,1,0.355927821974463,0,13,negative regulation of hydrogen peroxide-induced cell death,BP,
18310,GO:1903232,1,0.702841318995444,0,5,melanosome assembly,BP,
18315,GO:1903242,1,0.523608833496653,0,6,regulation of cardiac muscle hypertrophy in response to stress,BP,
18316,GO:1903243,1,0.582362169539511,0,5,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
18320,GO:1903251,1,0.635752408820077,0,5,multi-ciliated epithelial cell differentiation,BP,
18336,GO:1903297,1,0.669490311435999,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18337,GO:1903298,1,0.669490311435999,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
18338,GO:1903299,1,0.540315700890442,0,7,regulation of hexokinase activity,BP,
18340,GO:1903301,1,0.629581315846684,0,5,positive regulation of hexokinase activity,BP,
18353,GO:1903332,1,0.564664178255254,0,7,regulation of protein folding,BP,
18354,GO:1903333,1,0.674694726762423,0,5,negative regulation of protein folding,BP,
18360,GO:1903349,1,0.593254667769451,0,6,omegasome membrane,CC,
18365,GO:1903361,1,0.661897716714339,0,5,protein localization to basolateral plasma membrane,BP,
18374,GO:1903376,1,0.541802118963849,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
18385,GO:1903393,1,0.107478977230866,0,22,positive regulation of adherens junction organization,BP,
18389,GO:1903405,1,0.510314244206267,0,9,protein localization to nuclear body,BP,
18395,GO:1903421,1,0.273608453641807,0,13,regulation of synaptic vesicle recycling,BP,
18397,GO:1903423,1,0.604464843728341,0,5,positive regulation of synaptic vesicle recycling,BP,
18404,GO:1903432,1,0.124613054934199,0,24,regulation of TORC1 signaling,BP,
18425,GO:1903504,1,0.331640893623533,0,13,regulation of mitotic spindle checkpoint,BP,
18451,GO:1903539,1,0.457112589652012,0,9,protein localization to postsynaptic membrane,BP,
18452,GO:1903540,1,0.457112589652012,0,9,establishment of protein localization to postsynaptic membrane,BP,
18490,GO:1903608,1,0.521327329768129,0,7,protein localization to cytoplasmic stress granule,BP,
18517,GO:1903689,1,0.471008244518739,0,6,regulation of wound healing, spreading of epidermal cells,BP,
18538,GO:1903727,1,0.112332860481389,0,24,positive regulation of phospholipid metabolic process,BP,
18572,GO:1903799,1,0.446768536307235,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
18586,GO:1903831,1,0.388241740937959,0,11,signal transduction involved in cellular response to ammonium ion,BP,
18599,GO:1903862,1,0.690692762555641,0,5,positive regulation of oxidative phosphorylation,BP,
18613,GO:1903896,1,0.531108617269547,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
18615,GO:1903898,1,0.655338828738896,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
18688,GO:1904037,1,0.195665541929378,0,17,positive regulation of epithelial cell apoptotic process,BP,
18765,GO:1904259,1,0.549679333108919,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18766,GO:1904261,1,0.549679333108919,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
18767,GO:1904262,1,0.380214011463841,0,11,negative regulation of TORC1 signaling,BP,
18768,GO:1904263,1,0.516033122267293,0,8,positive regulation of TORC1 signaling,BP,
18804,GO:1904355,1,0.242042526051755,0,16,positive regulation of telomere capping,BP,
18807,GO:1904358,1,0.0470783766075828,0,35,positive regulation of telomere maintenance via telomere lengthening,BP,
18817,GO:1904385,1,0.303678645823458,0,14,cellular response to angiotensin,BP,
18830,GO:1904415,1,0.59453544751346,0,6,regulation of xenophagy,BP,
18831,GO:1904417,1,0.59453544751346,0,6,positive regulation of xenophagy,BP,
18853,GO:1904469,1,0.463153872214167,0,7,positive regulation of tumor necrosis factor secretion,BP,
18869,GO:1904528,1,0.615644992958514,0,6,positive regulation of microtubule binding,BP,
18901,GO:1904590,1,0.548203421271457,0,7,negative regulation of protein import,BP,
18925,GO:1904667,1,0.730124586817936,0,6,negative regulation of ubiquitin protein ligase activity,BP,
18930,GO:1904680,1,0.194872455647444,0,21,peptide transmembrane transporter activity,MF,
18935,GO:1904688,1,0.661226651815016,0,5,regulation of cytoplasmic translational initiation,BP,
18950,GO:1904714,1,0.606039585351646,0,6,regulation of chaperone-mediated autophagy,BP,
18968,GO:1904748,1,0.51705190282386,0,7,regulation of apoptotic process involved in development,BP,
18985,GO:1904779,1,0.515283066379772,0,6,regulation of protein localization to centrosome,BP,
18986,GO:1904781,1,0.556533090693906,0,5,positive regulation of protein localization to centrosome,BP,
18993,GO:1904796,1,0.637344506271622,0,5,regulation of core promoter binding,BP,
19003,GO:1904814,1,0.357822673449027,0,13,regulation of protein localization to chromosome, telomeric region,BP,
19005,GO:1904816,1,0.417479810905579,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
19021,GO:1904851,1,0.506762011178278,0,9,positive regulation of establishment of protein localization to telomere,BP,
19025,GO:1904867,1,0.510314244206267,0,9,protein localization to Cajal body,BP,
19027,GO:1904869,1,0.546555361664724,0,8,regulation of protein localization to Cajal body,BP,
19028,GO:1904871,1,0.546555361664724,0,8,positive regulation of protein localization to Cajal body,BP,
19040,GO:1904885,1,0.586186802258167,0,5,beta-catenin destruction complex assembly,BP,
19049,GO:1904896,1,0.455293012811992,0,10,ESCRT complex disassembly,BP,
19051,GO:1904903,1,0.455293012811992,0,10,ESCRT III complex disassembly,BP,
19058,GO:1904923,1,0.325723182562901,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19060,GO:1904925,1,0.351746794041742,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
19065,GO:1904938,1,0.568459143468901,0,5,planar cell polarity pathway involved in axon guidance,BP,
19116,GO:1905050,1,0.569715229322731,0,7,positive regulation of metallopeptidase activity,BP,
19143,GO:1905144,1,0.388241740937959,0,11,response to acetylcholine,BP,
19144,GO:1905145,1,0.388241740937959,0,11,cellular response to acetylcholine,BP,
19169,GO:1905209,1,0.256190637069074,0,15,positive regulation of cardiocyte differentiation,BP,
19170,GO:1905214,1,0.384550141189477,0,11,regulation of RNA binding,BP,
19172,GO:1905216,1,0.504560289684938,0,8,positive regulation of RNA binding,BP,
19178,GO:1905244,1,0.455573852016238,0,8,regulation of modification of synaptic structure,BP,
19181,GO:1905247,1,0.575657222710133,0,6,positive regulation of aspartic-type peptidase activity,BP,
19208,GO:1905314,1,0.376286056544191,0,9,semi-lunar valve development,BP,
19213,GO:1905323,1,0.553624423573179,0,6,telomerase holoenzyme complex assembly,BP,
19215,GO:1905331,1,0.284713363475235,0,13,negative regulation of morphogenesis of an epithelium,BP,
19224,GO:1905348,1,0.102484970617239,0,29,endonuclease complex,CC,
19226,GO:1905354,1,0.177633015488953,0,22,exoribonuclease complex,CC,
19262,GO:1905446,1,0.697532952283198,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
19267,GO:1905456,1,0.500201237602063,0,7,regulation of lymphoid progenitor cell differentiation,BP,
19284,GO:1905516,1,0.661829749263729,0,5,positive regulation of fertilization,BP,
19326,GO:1905634,1,0.540095061420665,0,6,regulation of protein localization to chromatin,BP,
19370,GO:1905819,1,0.0682064177979058,0,31,negative regulation of chromosome separation,BP,
19371,GO:1905820,1,0.436168378966335,0,9,positive regulation of chromosome separation,BP,
19406,GO:1905939,1,0.367185013378378,0,12,regulation of gonad development,BP,
19408,GO:1905941,1,0.560594222985437,0,7,positive regulation of gonad development,BP,
19418,GO:1990001,1,0.435843455995984,0,8,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
19423,GO:1990023,1,0.276061524183725,0,13,mitotic spindle midzone,CC,
19435,GO:1990050,1,0.656386054828536,0,6,phosphatidic acid transporter activity,MF,
19453,GO:1990130,1,0.65309254000366,0,5,GATOR1 complex,CC,
19468,GO:1990173,1,0.457126122703087,0,10,protein localization to nucleoplasm,BP,
19478,GO:1990226,1,0.673325251334385,0,5,histone methyltransferase binding,MF,
19496,GO:1990314,1,0.451830428013877,0,8,cellular response to insulin-like growth factor stimulus,BP,
19503,GO:1990380,1,0.356950401355223,0,9,Lys48-specific deubiquitinase activity,MF,
19504,GO:1990381,1,0.293784067164748,0,13,ubiquitin-specific protease binding,MF,
19513,GO:1990403,1,0.475649989288036,0,8,embryonic brain development,BP,
19542,GO:1990459,1,0.605916065082023,0,6,transferrin receptor binding,MF,
19587,GO:1990668,1,0.621351706973161,0,6,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
19593,GO:1990712,1,0.642660189407655,0,5,HFE-transferrin receptor complex,CC,
19597,GO:1990726,1,0.761202857773591,0,5,Lsm1-7-Pat1 complex,CC,
19621,GO:1990776,1,0.241291614248611,0,16,response to angiotensin,BP,
19633,GO:1990822,1,0.622912288153934,0,5,basic amino acid transmembrane transport,BP,
19635,GO:1990825,1,0.429943174019927,0,10,sequence-specific mRNA binding,MF,
19644,GO:1990845,1,0.570226431359666,0,6,adaptive thermogenesis,BP,
19647,GO:1990868,1,0.617383492169003,0,5,response to chemokine,BP,
19648,GO:1990869,1,0.617383492169003,0,5,cellular response to chemokine,BP,
19673,GO:1990948,1,0.763601636625655,0,5,ubiquitin ligase inhibitor activity,MF,
19688,GO:2000008,1,0.0858029587664405,0,28,regulation of protein localization to cell surface,BP,
19689,GO:2000009,1,0.401690266512836,0,10,negative regulation of protein localization to cell surface,BP,
19690,GO:2000010,1,0.36015601604411,0,12,positive regulation of protein localization to cell surface,BP,
19695,GO:2000018,1,0.59693202267757,0,6,regulation of male gonad development,BP,
19697,GO:2000020,1,0.658561109561987,0,5,positive regulation of male gonad development,BP,
19716,GO:2000059,1,0.0429612321112493,0,36,negative regulation of ubiquitin-dependent protein catabolic process,BP,
19718,GO:2000064,1,0.625637569338674,0,5,regulation of cortisol biosynthetic process,BP,
19722,GO:2000074,1,0.543124860412806,0,7,regulation of type B pancreatic cell development,BP,
19731,GO:2000104,1,0.167457604585908,0,19,negative regulation of DNA-dependent DNA replication,BP,
19736,GO:2000109,1,0.628482001054406,0,6,regulation of macrophage apoptotic process,BP,
19741,GO:2000114,1,0.157588444473359,0,18,regulation of establishment of cell polarity,BP,
19745,GO:2000121,1,0.531344645590771,0,8,regulation of removal of superoxide radicals,BP,
19748,GO:2000136,1,0.354490489767882,0,11,regulation of cell proliferation involved in heart morphogenesis,BP,
19750,GO:2000138,1,0.632505244369505,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
19753,GO:2000144,1,0.122940474510151,0,23,positive regulation of DNA-templated transcription, initiation,BP,
19762,GO:2000169,1,0.574314967307694,0,5,regulation of peptidyl-cysteine S-nitrosylation,BP,
19769,GO:2000178,1,0.276293610393542,0,14,negative regulation of neural precursor cell proliferation,BP,
19774,GO:2000192,1,0.581136186672883,0,5,negative regulation of fatty acid transport,BP,
19776,GO:2000194,1,0.564824436823614,0,7,regulation of female gonad development,BP,
19779,GO:2000197,1,0.557945238390871,0,6,regulation of ribonucleoprotein complex localization,BP,
19785,GO:2000209,1,0.17358146156017,0,19,regulation of anoikis,BP,
19786,GO:2000210,1,0.633806718748194,0,6,positive regulation of anoikis,BP,
19795,GO:2000232,1,0.370731312447631,0,11,regulation of rRNA processing,BP,
19797,GO:2000234,1,0.506119736208006,0,8,positive regulation of rRNA processing,BP,
19802,GO:2000251,1,0.427623723370659,0,11,positive regulation of actin cytoskeleton reorganization,BP,
19811,GO:2000269,1,0.267671947164912,0,14,regulation of fibroblast apoptotic process,BP,
19812,GO:2000270,1,0.569294251456063,0,6,negative regulation of fibroblast apoptotic process,BP,
19813,GO:2000271,1,0.491696381766398,0,7,positive regulation of fibroblast apoptotic process,BP,
19826,GO:2000288,1,0.619504379207912,0,6,positive regulation of myoblast proliferation,BP,
19827,GO:2000291,1,0.541854622248858,0,7,regulation of myoblast proliferation,BP,
19836,GO:2000304,1,0.519151375534482,0,8,positive regulation of ceramide biosynthetic process,BP,
19844,GO:2000316,1,0.574432593032546,0,7,regulation of T-helper 17 type immune response,BP,
19847,GO:2000319,1,0.674494583342606,0,5,regulation of T-helper 17 cell differentiation,BP,
19850,GO:2000322,1,0.529789817158759,0,7,regulation of glucocorticoid receptor signaling pathway,BP,
19851,GO:2000323,1,0.569244960625073,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
19874,GO:2000353,1,0.442548924419732,0,8,positive regulation of endothelial cell apoptotic process,BP,
19885,GO:2000371,1,0.56016068640355,0,6,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19886,GO:2000373,1,0.56016068640355,0,6,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
19903,GO:2000394,1,0.59908480743843,0,5,positive regulation of lamellipodium morphogenesis,BP,
19983,GO:2000573,1,0.00869969113903525,0,56,positive regulation of DNA biosynthetic process,BP,
19984,GO:2000574,1,0.536488417683867,0,8,regulation of microtubule motor activity,BP,
19985,GO:2000576,1,0.712922949134067,0,5,positive regulation of microtubule motor activity,BP,
20003,GO:2000615,1,0.401800101605516,0,10,regulation of histone H3-K9 acetylation,BP,
20005,GO:2000617,1,0.567060281675764,0,6,positive regulation of histone H3-K9 acetylation,BP,
20006,GO:2000618,1,0.615532373860249,0,5,regulation of histone H4-K16 acetylation,BP,
20013,GO:2000628,1,0.550432189679016,0,7,regulation of miRNA metabolic process,BP,
20014,GO:2000630,1,0.654587778464408,0,5,positive regulation of miRNA metabolic process,BP,
20036,GO:2000659,1,0.603189634442312,0,6,regulation of interleukin-1-mediated signaling pathway,BP,
20077,GO:2000727,1,0.384334008284923,0,11,positive regulation of cardiac muscle cell differentiation,BP,
20081,GO:2000737,1,0.201389544600089,0,16,negative regulation of stem cell differentiation,BP,
20082,GO:2000738,1,0.382316549285858,0,10,positive regulation of stem cell differentiation,BP,
20093,GO:2000757,1,0.218741348161413,0,17,negative regulation of peptidyl-lysine acetylation,BP,
20099,GO:2000767,1,0.487108191786888,0,8,positive regulation of cytoplasmic translation,BP,
20111,GO:2000786,1,0.325267466520485,0,11,positive regulation of autophagosome assembly,BP,
20115,GO:2000794,1,0.558743166620721,0,6,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
20125,GO:2000811,1,0.292169249766731,0,13,negative regulation of anoikis,BP,
20127,GO:2000816,1,0.0682064177979058,0,31,negative regulation of mitotic sister chromatid separation,BP,
20138,GO:2000831,1,0.59710774658325,0,6,regulation of steroid hormone secretion,BP,
20145,GO:2000846,1,0.653070659341628,0,5,regulation of corticosteroid hormone secretion,BP,
20160,GO:2000973,1,0.552349027795089,0,6,regulation of pro-B cell differentiation,BP,
20164,GO:2000980,1,0.648106779326986,0,5,regulation of inner ear receptor cell differentiation,BP,
20191,GO:2001039,1,0.355927821974463,0,13,negative regulation of cellular response to drug,BP,
20193,GO:2001044,1,0.447063805712022,0,9,regulation of integrin-mediated signaling pathway,BP,
20195,GO:2001046,1,0.625249428929266,0,5,positive regulation of integrin-mediated signaling pathway,BP,
20226,GO:2001166,1,0.63455548313473,0,5,regulation of histone H2B ubiquitination,BP,
20234,GO:2001179,1,0.703441289404685,0,5,regulation of interleukin-10 secretion,BP,
20245,GO:2001197,1,0.549679333108919,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
20252,GO:2001204,1,0.474977119474045,0,7,regulation of osteoclast development,BP,
20258,GO:2001222,1,0.0770844137469429,0,24,regulation of neuron migration,BP,
20259,GO:2001223,1,0.568229126737267,0,6,negative regulation of neuron migration,BP,
20260,GO:2001224,1,0.212486766190462,0,14,positive regulation of neuron migration,BP,
20288,GO:2001268,1,0.719547860606151,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
10888,GO:0044428,1,0,208,3795,nuclear part,CC,TNIP1;DOCK4;NT5E;SMURF2;EPN3;TSPAN1;NOS1;ERCC1;SORL1;ETV5;CCND1;CTNNBIP1;SYNE3;NOL4L;CYGB;RPS6KA2;H1F0;PRNP;XPOT;NR1D1;NFATC4;SLC16A3;ADARB1;ETV4;SALL2;PKN1;WWTR1;POU2F2;TRIM65;PITPNC1;APPL2;DDIT3;SMARCA1;HADH;SOX12;PSMD2;ELK3;CRTC1;LTA4H;BRSK1;EGFR;TBC1D14;STK39;BCORL1;JADE2;BNIP3;HLTF;SCMH1;ERCC6;UBXN7;ARAP1;CTSB;DHX32;PODXL;XPC;UBXN4;ACOT7;WDFY3;GRK5;VWA5A;PAK1;RAG1;NUCB2;SCRN1;RAC2;CLCA2;OBSCN;BNIP3L;CCND2;KLHDC2;PTPN12;RGS14;PRKACB;FAM208A;PPP2R3B;ABTB1;HMGA2;ATF4;PPARA;FGFR1;E2F5;FAM114A1;PTPDC1;NFAT5;DCAF10;BTRC;PTK6;INTS8;ATRX;FKBP10;SOX4;ITPR3;DDB2;ENDOV;MAPKAPK3;ZNF692;ATF7IP;RCOR1;SH3D19;NLK;TCEA1;ZBTB10;PHF12;FAM50A;ETAA1;ZMYM3;KLF12;CST3;RABGGTA;L3MBTL3;DNAJB9;PPP3CB;MYOF;CEBPG;PLAG1;UHRF2;SLC2A9;PHC3;ATP10D;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;NDUFV3;CPT2;JMY;BOK;PARP9;NACC2;THRA;MGLL;NGFR;PPP1R10;PSKH1;MVB12A;CHD6;MTA1;BCL2L1;PM20D2;MEF2D;AGPAT3;SKAP2;H2AFJ;POLL;ANAPC13;UAP1;XBP1;SPIRE1;NFU1;SATB1;REC8;TLE4;SDR9C7;FAM222B;LOXL2;MLH3;MCTP2;NOP10;GTF2IRD2;PAK6;UBE2E1;PUM2;SLC30A1;PRKACA;NEK6;S100PBP;PCDH1;CBX7;IFI16;NR2F6;FCHO1;ZNF354A;TBL1X;RNF169;HOXA3;ARID4A;TENM2;ZMYM2;PPARG;CITED4;CREB3L2;AK9;RSF1;ATP11B;PHF21A;MPLKIP;MAML3;HSPA2;ARID5B;RNF180;E2F7;SIGMAR1;HPSE;DEDD2;FOXP1;ZBTB33;PSEN2;KAT2B;OAS1;VSIG10L;SNX27;JARID2;SLC44A1;GNAI1;RB1CC1;DNMT3A;ALAS1
1467,GO:0003723,1,0,50,1483,RNA binding,MF,H1F0;XPOT;SLC16A3;ADARB1;RBMS2;CARS;SNTB2;LTA4H;HLTF;SPATS2;DHX32;IGF2BP3;LRP1;FAM208A;ABTB1;EIF4E3;AARS;APOBEC3C;ENDOV;MRPS6;XRN1;TNRC6B;FAM50A;TWF2;SEC63;MEX3C;DDX60;TST;NDUFV3;CPEB4;ATXN2;LACTB2;THRA;PPP1R10;YTHDC2;GPATCH8;PAIP1;NOP10;PUM2;TMSB4X;EIF2AK2;IFI16;SECISBP2L;LARP1B;GRB7;FLNB;EEF2K;TNRC6C;ZC3H7A;OAS1
1446,GO:0003676,1,0,172,3232,nucleic acid binding,MF,ERCC1;ZMYND8;ETV5;H1F0;XPOT;NR1D1;NFATC4;SLC16A3;ZC3H6;ADARB1;ETV4;ZKSCAN1;SALL2;PEG3;RBMS2;POU2F2;TEF;ZKSCAN2;DDIT3;SMARCA1;SOX12;CARS;ELK3;SNTB2;LTA4H;EGFR;HLTF;SPATS2;ERCC6;ZNF516;DHX32;ZSCAN30;XPC;IGF2BP3;ZNF652;RAG1;NUCB2;TIGD2;ZNF862;ZNF624;LRP1;AKAP9;ZCCHC14;FAM208A;ABTB1;DDN;HMGA2;ATF4;PPARA;EIF4E3;AARS;E2F5;TCFL5;NFAT5;ZNF559;ZNF81;ATRX;SOX4;APOBEC3C;DDB2;ENDOV;ZNF558;ZNF692;MRPS6;RCOR1;XRN1;TCEA1;TNRC6B;HES2;ZBTB10;PHF12;ZNF704;FAM50A;ZMYM3;KLF12;TWF2;SEC63;ZNF322;MEX3C;RFX2;APLP2;PRDX5;CEBPG;PLAG1;DDX60;UHRF2;PHC3;AEBP1;PHF1;TST;CHD7;NDUFV3;CPEB4;ATXN2;NACC2;LACTB2;ZNF337;THRA;ZNF280D;PPP1R10;TSHZ1;ZNF449;CHD6;PER3;MTA1;YTHDC2;MEF2D;NYNRIN;H2AFJ;POLL;XBP1;SATB1;GPATCH8;PAIP1;MLH3;THAP10;NOP10;GTF2IRD2;DNASE1L1;PUM2;ETV1;ZNF398;TMSB4X;EIF2AK2;ZDHHC1;EEPD1;IFI16;NR2F6;SBNO1;SECISBP2L;ZNF354A;TBL1X;HOXA3;ARID4A;ZSCAN18;LARP1B;ZMYM2;PPARG;TMEM63A;ZFP30;GRB7;ZNF37A;TBX1;CREB3L2;ENDOG;PHF21A;ZBTB40;ZNF92;ZNF568;ZNF107;FLNB;ARID5B;ZNF165;E2F7;EEF2K;ZNF320;TNRC6C;RCAN1;TET1;ZC3H7A;DEDD2;FOXP1;ZBTB33;KAT2B;OAS1;PRMT3;PBX3;JARID2;MXD4;ADNP;RFX7;DNMT3A
2889,GO:0006396,1.00000000000002,0,18,876,RNA processing,BP,ADARB1;MAP2K1;RBMS2;EGFR;DHX32;AARS;INTS8;CHD7;YTHDC2;MAP2K2;NOP10;RMRP;PUM2;PRKACA;OSGEPL1;CMTR2;ZC3H7A;DEDD2
2445,GO:0005654,1.00000000000003,0,161,3043,nucleoplasm,CC,TNIP1;NT5E;SMURF2;EPN3;TSPAN1;NOS1;ERCC1;ETV5;CCND1;CTNNBIP1;NOL4L;CYGB;RPS6KA2;H1F0;XPOT;NR1D1;NFATC4;ADARB1;ETV4;SALL2;PKN1;WWTR1;POU2F2;TRIM65;PITPNC1;APPL2;DDIT3;SMARCA1;HADH;SOX12;PSMD2;ELK3;CRTC1;LTA4H;BRSK1;TBC1D14;STK39;BCORL1;JADE2;BNIP3;HLTF;SCMH1;ERCC6;UBXN7;ARAP1;XPC;ACOT7;WDFY3;GRK5;VWA5A;RAG1;OBSCN;BNIP3L;CCND2;KLHDC2;PTPN12;RGS14;PRKACB;FAM208A;PPP2R3B;HMGA2;ATF4;PPARA;E2F5;FAM114A1;PTPDC1;NFAT5;DCAF10;BTRC;PTK6;INTS8;ATRX;SOX4;ITPR3;DDB2;MAPKAPK3;ATF7IP;RCOR1;SH3D19;NLK;TCEA1;ZBTB10;PHF12;FAM50A;ZMYM3;KLF12;RABGGTA;PPP3CB;CEBPG;PLAG1;UHRF2;PHC3;ATP10D;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;NDUFV3;CPT2;JMY;PARP9;NACC2;THRA;MGLL;NGFR;PPP1R10;PSKH1;MVB12A;CHD6;MTA1;PM20D2;MEF2D;SKAP2;POLL;UAP1;XBP1;SPIRE1;NFU1;SATB1;TLE4;FAM222B;LOXL2;MCTP2;NOP10;GTF2IRD2;UBE2E1;PRKACA;NEK6;S100PBP;CBX7;IFI16;NR2F6;FCHO1;TBL1X;RNF169;HOXA3;ARID4A;TENM2;ZMYM2;PPARG;CITED4;CREB3L2;AK9;RSF1;PHF21A;MPLKIP;MAML3;ARID5B;E2F7;HPSE;FOXP1;ZBTB33;KAT2B;OAS1;VSIG10L;SNX27;JARID2;SLC44A1;DNMT3A;ALAS1
3119,GO:0006696,1.00000000000004,0.86480781821696,0,2,ergosterol biosynthetic process,BP,
3699,GO:0008204,1.00000000000004,0.86480781821696,0,2,ergosterol metabolic process,BP,
12418,GO:0048865,1.00000000000005,0.773470109917593,0,3,stem cell fate commitment,BP,
1515,GO:0003876,1.00000000000007,0.81918364710658,0,2,AMP deaminase activity,MF,
12022,GO:0047623,1.00000000000007,0.81918364710658,0,2,adenosine-phosphate deaminase activity,MF,
13516,GO:0055087,1.00000000000009,0.76348127089897,0,3,Ski complex,CC,
17727,GO:1901656,1.0000000000001,0.829184638218037,0,2,glycoside transport,BP,
3874,GO:0008503,1.0000000000001,0.871734273546959,0,2,benzodiazepine receptor activity,MF,
6013,GO:0019062,1.00000000000012,0.734210639394949,0,4,virion attachment to host cell,BP,
10953,GO:0044650,1.00000000000012,0.734210639394949,0,4,adhesion of symbiont to host cell,BP,
4952,GO:0015015,1.00000000000014,0.686377532499287,0,4,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
10309,GO:0043084,1.00000000000016,0.694202689538027,0,4,penile erection,BP,
17987,GO:1902412,1.00000000000016,0.715728247127151,0,3,regulation of mitotic cytokinesis,BP,
3802,GO:0008380,1.00000000000017,0,1,391,RNA splicing,BP,DHX32
8650,GO:0034191,1.00000000000017,0.756457877418614,0,3,apolipoprotein A-I receptor binding,MF,
2435,GO:0005634,1.00000000000019,0,370,5696,nucleus,CC,TNIP1;DOCK4;FHL1;NT5E;SMURF2;EPN3;TSPAN1;NOS1;ERCC1;ZMYND8;SORL1;ETV5;CCND1;CTNNBIP1;SYNE3;CBS;NOL4L;CYGB;RPS6KA2;H1F0;PRNP;XPOT;NR1D1;NFATC4;SLC16A3;ZC3H6;ADARB1;MAP2K1;ETV4;ZKSCAN1;ALOX15B;SALL2;PKN1;WWTR1;PEG3;ARHGAP22;RBMS2;MARVELD1;POU2F2;TRIM65;PITPNC1;TEF;APPL2;ZKSCAN2;DDIT3;SMARCA1;HADH;SOX12;PSMD2;ELK3;CRTC1;LTA4H;CAPN2;BRSK1;EGFR;TBC1D14;STK39;BCORL1;C2CD2;PDZD2;FYN;JADE2;BNIP3;HLTF;SCMH1;ERCC6;UBXN7;MAPK13;ARAP1;ZNF516;DLG1;CTSB;DNAJB5;GPC4;DHX32;PODXL;NET1;ZSCAN30;XPC;GLUL;GLO1;UBXN4;IGF2BP3;TTBK2;ACOT7;WDFY3;GRK5;STRADB;RDH14;CEMIP;VWA5A;ACAD11;ARG2;SLFN5;PAK1;TRIB2;NEK9;ZNF652;RAG1;NUCB2;SCRN1;RALGAPA2;RAC2;CLCA2;OBSCN;APOE;BNIP3L;CCND2;TIGD2;KLHDC2;PTPN12;ALDH1L2;CDK17;RGS14;ZNF862;PRKACB;ZNF624;LRP1;LDHA;IDE;FAM208A;PPP2R3B;ABTB1;DDN;HMGA2;ATF4;PPARA;FGFR1;E2F5;FAM114A1;TUB;PTPDC1;TACC1;TCFL5;NFAT5;DCAF10;BTRC;ITGA2;PTK6;ZNF559;FAT1;INTS8;ZNF81;LONP2;BIVM;ATRX;FKBP10;KIAA1109;SOX4;RMND5A;APOBEC3C;FHOD1;ITPR3;DDB2;GAMT;ENDOV;ZNF558;MAPKAPK3;ZNF692;MT2A;UACA;ATF7IP;FAM110C;RCOR1;SH3D19;NLK;MDFI;XRN1;TRIM5;RALGAPA1;TCEA1;SLC9A3R2;MMP14;HES2;ZBTB10;PHF12;MVB12B;ZNF704;FAM50A;ETAA1;ZMYM3;KLF12;CTSL;NPEPL1;CST3;RABGGTA;TRIB3;L3MBTL3;RANBP9;DNAJB9;BTBD3;ZNF322;PPP3CB;MEX3C;MYOF;ACOT13;RFX2;APLP2;PRDX5;CEBPG;ALDH7A1;PLAG1;UHRF2;SLC2A9;TAOK1;PHC3;AEBP1;ATP10D;OTUB2;CSNK2A1;PHF1;PSMD7;PTHLH;CHD7;BLMH;NDUFV3;CPT2;JMY;BOK;PARP9;CPEB4;NACC2;SPRY2;ZNF337;BEX4;THRA;MGLL;NGFR;ZNF280D;PPP1R10;PSKH1;MVB12A;HSPA13;TSHZ1;ZNF449;CHD6;NUDT6;PER3;MTA1;AZIN2;BCL2L1;RNF165;PM20D2;MEF2D;AGPAT3;TRIM7;SKAP2;H2AFJ;POLL;ANAPC13;UAP1;XBP1;SPIRE1;NFU1;UBASH3B;TXNRD3;MAP2K2;SATB1;REC8;TLE4;SDR9C7;FAM222B;TUBG2;LOXL2;MLH3;MCTP2;BEX2;NOP10;EPM2A;GTF2IRD2;DNASE1L1;PAK6;EAPP;UBE2E1;PUM2;SLC30A1;ETV1;PRKACA;ZNF398;NEK6;TCEAL8;UNKL;TMSB4X;EIF2AK2;S100PBP;PCDH1;CBX7;IFI16;ANGEL1;NR2F6;SCAND1;SBNO1;FCHO1;ZNF354A;TBL1X;RNF169;HOXA3;ARID4A;TENM2;ITPR2;LAMA5;ZSCAN18;LARP1B;ZMYM2;PPARG;CITED4;SNX6;ZFP30;PPL;ZNF37A;TBX1;EVI5;CREB3L2;AK9;RSF1;AKT3;DEPDC1;ENDOG;ATP11B;PHF21A;ZBTB40;ZNF92;MPLKIP;MAML3;ZNF568;WASL;REEP6;HSPA2;ZNF107;ARID5B;ZNF165;RNF180;E2F7;ZNF320;SIGMAR1;HPSE;CMTR2;RALGDS;RCAN1;TET1;ZC3H7A;ARMCX3;DEDD2;FOXP1;ZBTB33;PSEN2;SSFA2;PTCH1;ADCY1;KAT2B;CNOT11;OAS1;USP25;PANK1;VSIG10L;ANKRD6;SNX27;PBX3;JARID2;PPM1M;KLHL15;SLC44A1;MXD4;ADNP;GNAI1;RFX7;RB1CC1;DNMT3A;ALAS1;FADD
18963,GO:1904742,1.00000000000019,0.678072120703153,0,4,regulation of telomeric DNA binding,BP,
3605,GO:0008043,1.00000000000025,0.896190665212348,0,2,intracellular ferritin complex,CC,
14677,GO:0070288,1.00000000000025,0.896190665212348,0,2,ferritin complex,CC,
15905,GO:0072674,1.00000000000025,0.625234332534461,0,4,multinuclear osteoclast differentiation,BP,
15906,GO:0072675,1.00000000000025,0.625234332534461,0,4,osteoclast fusion,BP,
9569,GO:0036363,1.00000000000027,0.831577303950322,0,2,transforming growth factor beta activation,BP,
7688,GO:0032138,1.00000000000028,0.683735077298006,0,4,single base insertion or deletion binding,MF,
1626,GO:0004062,1.00000000000035,0.777815140640684,0,4,aryl sulfotransferase activity,MF,
11966,GO:0047179,1.00000000000038,0.89334852732732,0,2,platelet-activating factor acetyltransferase activity,MF,
12208,GO:0048386,1.00000000000039,0.705574080736662,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
19016,GO:1904844,1.0000000000004,0.885718556899456,0,2,response to L-glutamine,BP,
19017,GO:1904845,1.0000000000004,0.885718556899456,0,2,cellular response to L-glutamine,BP,
2897,GO:0006404,1.0000000000004,0.769240779439685,0,3,RNA import into nucleus,BP,
13184,GO:0051790,1.00000000000041,0.725102500140976,0,4,short-chain fatty acid biosynthetic process,BP,
9673,GO:0038033,1.00000000000041,0.790954025464131,0,3,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
11222,GO:0045355,1.00000000000043,0.880410564004801,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
14330,GO:0061511,1.00000000000044,0.688962072451933,0,4,centriole elongation,BP,
17369,GO:1900084,1.00000000000052,0.664892037737838,0,4,regulation of peptidyl-tyrosine autophosphorylation,BP,
3518,GO:0007442,1.00000000000052,0.636643363160285,0,4,hindgut morphogenesis,BP,
13987,GO:0060699,1.00000000000052,0.721891846298847,0,4,regulation of endoribonuclease activity,BP,
84,GO:0000171,1.00000000000054,0.831459977107695,0,2,ribonuclease MRP activity,MF,
18747,GO:1904220,1.00000000000057,0.731985165799734,0,4,regulation of serine C-palmitoyltransferase activity,BP,
2359,GO:0005459,1.00000000000057,0.883516536905395,0,2,UDP-galactose transmembrane transporter activity,MF,
15750,GO:0072334,1.00000000000057,0.883516536905395,0,2,UDP-galactose transmembrane transport,BP,
7687,GO:0032137,1.00000000000059,0.764472375666965,0,3,guanine/thymine mispair binding,MF,
13974,GO:0060684,1.0000000000006,0.726927110662716,0,4,epithelial-mesenchymal cell signaling,BP,
13173,GO:0051771,1.0000000000006,0.813054510392674,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
13865,GO:0060481,1.0000000000006,0.853730675054218,0,2,lobar bronchus epithelium development,BP,
17158,GO:0102521,1.00000000000063,0.846213400924686,0,2,tRNA-4-demethylwyosine synthase activity,MF,
8537,GO:0033860,1.00000000000064,0.8335202326828,0,3,regulation of NAD(P)H oxidase activity,BP,
8539,GO:0033864,1.00000000000064,0.8335202326828,0,3,positive regulation of NAD(P)H oxidase activity,BP,
14715,GO:0070345,1.00000000000065,0.678401352569944,0,4,negative regulation of fat cell proliferation,BP,
7123,GO:0030943,1.00000000000065,0.788628161045551,0,3,mitochondrion targeting sequence binding,MF,
15755,GO:0072344,1.00000000000065,0.725414542489486,0,4,rescue of stalled ribosome,BP,
15124,GO:0071211,1.00000000000065,0.691213070950428,0,4,protein targeting to vacuole involved in autophagy,BP,
11571,GO:0046122,1.00000000000069,0.889073895586175,0,2,purine deoxyribonucleoside metabolic process,BP,
11514,GO:0046015,1.00000000000072,0.74023214475707,0,4,regulation of transcription by glucose,BP,
1124,GO:0002713,1.00000000000073,0.715467887900371,0,4,negative regulation of B cell mediated immunity,BP,
1220,GO:0002890,1.00000000000073,0.715467887900371,0,4,negative regulation of immunoglobulin mediated immune response,BP,
5493,GO:0016429,1.00000000000075,0.785673516556441,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
14501,GO:0061953,1.00000000000075,0.785673516556441,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
19520,GO:1990410,1.00000000000077,0.842691111206529,0,2,adrenomedullin receptor signaling pathway,BP,
3602,GO:0008035,1.00000000000078,0.713087811705688,0,4,high-density lipoprotein particle binding,MF,
883,GO:0002249,1.00000000000078,0.787835348078282,0,2,lymphocyte anergy,BP,
1083,GO:0002667,1.00000000000078,0.787835348078282,0,2,regulation of T cell anergy,BP,
1207,GO:0002870,1.00000000000078,0.787835348078282,0,2,T cell anergy,BP,
1230,GO:0002911,1.00000000000078,0.787835348078282,0,2,regulation of lymphocyte anergy,BP,
5959,GO:0018343,1.0000000000008,0.794745595971088,0,3,protein farnesylation,BP,
20194,GO:2001045,1.00000000000082,0.807000486337953,0,2,negative regulation of integrin-mediated signaling pathway,BP,
12399,GO:0048840,1.00000000000084,0.745221328986289,0,3,otolith development,BP,
6960,GO:0030613,1.00000000000086,0.847918332532069,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
6961,GO:0030614,1.00000000000086,0.847918332532069,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
10119,GO:0042637,1.00000000000086,0.713768101390302,0,4,catagen,BP,
13188,GO:0051794,1.00000000000086,0.713768101390302,0,4,regulation of timing of catagen,BP,
14732,GO:0070384,1.00000000000088,0.76010733515612,0,3,Harderian gland development,BP,
8535,GO:0033857,1.00000000000089,0.798075736809519,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
17124,GO:0102092,1.00000000000089,0.798075736809519,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
9888,GO:0042166,1.00000000000089,0.704266133734956,0,4,acetylcholine binding,MF,
14280,GO:0061355,1.00000000000091,0.706828086872748,0,4,Wnt protein secretion,BP,
14281,GO:0061356,1.00000000000091,0.706828086872748,0,4,regulation of Wnt protein secretion,BP,
15474,GO:0071816,1.00000000000091,0.74500505139568,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
18581,GO:1903826,1.00000000000094,0.671719286039906,0,4,arginine transmembrane transport,BP,
374,GO:0000995,1.000000000001,0.635887987969825,0,4,transcription factor activity, core RNA polymerase III binding,MF,
15462,GO:0071798,1.000000000001,0.826930425464988,0,2,response to prostaglandin D,BP,
15463,GO:0071799,1.000000000001,0.826930425464988,0,2,cellular response to prostaglandin D stimulus,BP,
6735,GO:0030151,1.00000000000101,0.722460951677475,0,4,molybdenum ion binding,MF,
18375,GO:1903377,1.00000000000101,0.726581865266342,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
8910,GO:0034739,1.00000000000102,0.872570277172352,0,2,histone deacetylase activity (H4-K16 specific),MF,
342,GO:0000942,1.00000000000102,0.731904422939813,0,4,condensed nuclear chromosome outer kinetochore,CC,
10552,GO:0043504,1.00000000000103,0.750126620787616,0,3,mitochondrial DNA repair,BP,
14105,GO:0060947,1.00000000000108,0.658127415831208,0,4,cardiac vascular smooth muscle cell differentiation,BP,
19816,GO:2000275,1.00000000000109,0.881216376596113,0,2,regulation of oxidative phosphorylation uncoupler activity,BP,
17020,GO:0099170,1.00000000000111,0.762532445780762,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
17063,GO:0099547,1.00000000000111,0.762532445780762,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
17076,GO:0099578,1.00000000000111,0.762532445780762,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
13890,GO:0060529,1.00000000000111,0.813229199712895,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
16285,GO:0090362,1.00000000000111,0.837618530671551,0,2,positive regulation of platelet-derived growth factor production,BP,
15366,GO:0071603,1.00000000000112,0.817652070063501,0,2,endothelial cell-cell adhesion,BP,
1677,GO:0004142,1.00000000000113,0.78386476493921,0,3,diacylglycerol cholinephosphotransferase activity,MF,
8150,GO:0032876,1.00000000000122,0.634065338974568,0,4,negative regulation of DNA endoreduplication,BP,
14297,GO:0061408,1.00000000000123,0.79212861041612,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
10,GO:0000019,1.00000000000124,0.757975984287345,0,3,regulation of mitotic recombination,BP,
19295,GO:1905550,1.00000000000125,0.873013241340897,0,2,regulation of protein localization to endoplasmic reticulum,BP,
19296,GO:1905552,1.00000000000125,0.873013241340897,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
2344,GO:0005384,1.00000000000126,0.681371377242607,0,4,manganese ion transmembrane transporter activity,MF,
4610,GO:0010727,1.00000000000128,0.679141542611683,0,4,negative regulation of hydrogen peroxide metabolic process,BP,
338,GO:0000938,1.00000000000128,0.678343714373996,0,4,GARP complex,CC,
12414,GO:0048859,1.0000000000013,0.828005258124589,0,2,formation of anatomical boundary,BP,
8278,GO:0033080,1.0000000000013,0.761310782057445,0,3,immature T cell proliferation in thymus,BP,
16616,GO:0097452,1.0000000000013,0.706644371026983,0,4,GAIT complex,CC,
15372,GO:0071611,1.00000000000131,0.854892578887267,0,2,granulocyte colony-stimulating factor production,BP,
15401,GO:0071655,1.00000000000131,0.854892578887267,0,2,regulation of granulocyte colony-stimulating factor production,BP,
15879,GO:0072603,1.00000000000134,0.707963314762795,0,4,interleukin-5 secretion,BP,
20039,GO:2000662,1.00000000000134,0.707963314762795,0,4,regulation of interleukin-5 secretion,BP,
13721,GO:0060287,1.00000000000135,0.702430842783386,0,4,epithelial cilium movement involved in determination of left/right asymmetry,BP,
2632,GO:0005960,1.00000000000136,0.852062098202843,0,2,glycine cleavage complex,CC,
12459,GO:0050265,1.00000000000137,0.731565568583133,0,3,RNA uridylyltransferase activity,MF,
19630,GO:1990809,1.00000000000138,0.728823948458727,0,4,endoplasmic reticulum tubular network membrane organization,BP,
7658,GO:0032079,1.00000000000138,0.729326509189102,0,4,positive regulation of endodeoxyribonuclease activity,BP,
3811,GO:0008401,1.00000000000145,0.831041087973115,0,2,retinoic acid 4-hydroxylase activity,MF,
6014,GO:0019064,1.00000000000147,0.796914899235318,0,3,fusion of virus membrane with host plasma membrane,BP,
9779,GO:0039663,1.00000000000147,0.796914899235318,0,3,membrane fusion involved in viral entry into host cell,BP,
10999,GO:0044800,1.00000000000147,0.796914899235318,0,3,multi-organism membrane fusion,BP,
3503,GO:0007406,1.00000000000147,0.661315423006856,0,4,negative regulation of neuroblast proliferation,BP,
1440,GO:0003419,1.00000000000148,0.849240061872667,0,2,growth plate cartilage chondrocyte proliferation,BP,
1441,GO:0003420,1.00000000000148,0.849240061872667,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
9509,GO:0036157,1.00000000000151,0.708599599037592,0,3,outer dynein arm,CC,
12385,GO:0048793,1.00000000000152,0.646711925436303,0,4,pronephros development,BP,
1103,GO:0002692,1.00000000000152,0.686728805178449,0,4,negative regulation of cellular extravasation,BP,
2667,GO:0006014,1.00000000000154,0.832338644241446,0,3,D-ribose metabolic process,BP,
3754,GO:0008295,1.00000000000158,0.749724977636212,0,4,spermidine biosynthetic process,BP,
19582,GO:1990641,1.0000000000016,0.839866058979278,0,2,response to iron ion starvation,BP,
2053,GO:0004803,1.00000000000163,0.81481054877022,0,2,transposase activity,MF,
13930,GO:0060592,1.00000000000163,0.665957652913124,0,4,mammary gland formation,BP,
18355,GO:1903335,1.00000000000164,0.745003762436445,0,4,regulation of vacuolar transport,BP,
12294,GO:0048630,1.00000000000168,0.745413041056312,0,3,skeletal muscle tissue growth,BP,
12295,GO:0048631,1.00000000000168,0.745413041056312,0,3,regulation of skeletal muscle tissue growth,BP,
12296,GO:0048633,1.00000000000168,0.745413041056312,0,3,positive regulation of skeletal muscle tissue growth,BP,
12328,GO:0048680,1.00000000000168,0.746690147059228,0,4,positive regulation of axon regeneration,BP,
14835,GO:0070572,1.00000000000168,0.746690147059228,0,4,positive regulation of neuron projection regeneration,BP,
6454,GO:0021773,1.00000000000169,0.722083595980908,0,3,striatal medium spiny neuron differentiation,BP,
5047,GO:0015230,1.0000000000017,0.851673383090443,0,2,FAD transmembrane transporter activity,MF,
9090,GO:0035350,1.0000000000017,0.851673383090443,0,2,FAD transmembrane transport,BP,
10628,GO:0043625,1.0000000000017,0.738420876658648,0,4,delta DNA polymerase complex,CC,
16563,GO:0097343,1.00000000000173,0.720622494240835,0,3,ripoptosome assembly,BP,
17532,GO:1901026,1.00000000000173,0.720622494240835,0,3,ripoptosome assembly involved in necroptotic process,BP,
4495,GO:0010520,1.00000000000175,0.845506227345101,0,2,regulation of reciprocal meiotic recombination,BP,
11680,GO:0046462,1.00000000000181,0.859623376487296,0,2,monoacylglycerol metabolic process,BP,
13382,GO:0052651,1.00000000000181,0.859623376487296,0,2,monoacylglycerol catabolic process,BP,
8786,GO:0034465,1.00000000000183,0.717964107505004,0,4,response to carbon monoxide,BP,
8616,GO:0034127,1.00000000000184,0.697120453466449,0,4,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
19139,GO:1905123,1.00000000000186,0.813280156493886,0,2,regulation of glucosylceramidase activity,BP,
1144,GO:0002740,1.00000000000186,0.877723295708621,0,2,negative regulation of cytokine secretion involved in immune response,BP,
1208,GO:0002874,1.00000000000186,0.877723295708621,0,2,regulation of chronic inflammatory response to antigenic stimulus,BP,
1738,GO:0004336,1.00000000000186,0.919313738373419,0,1,galactosylceramidase activity,MF,
3106,GO:0006683,1.00000000000186,0.919313738373419,0,1,galactosylceramide catabolic process,BP,
6128,GO:0019376,1.00000000000186,0.919313738373419,0,1,galactolipid catabolic process,BP,
6665,GO:0030020,1.00000000000188,0.738200825034592,0,3,extracellular matrix structural constituent conferring tensile strength,MF,
1137,GO:0002729,1.00000000000192,0.872805013634522,0,2,positive regulation of natural killer cell cytokine production,BP,
16773,GO:0098576,1.00000000000192,0.732316990023104,0,4,lumenal side of membrane,CC,
17363,GO:1900063,1.00000000000194,0.719278280982813,0,3,regulation of peroxisome organization,BP,
857,GO:0002188,1.00000000000198,0.712646422543001,0,3,translation reinitiation,BP,
12429,GO:0048880,1.00000000000201,0.822532564246323,0,2,sensory system development,BP,
1956,GO:0004660,1.00000000000203,0.862983789483186,0,2,protein farnesyltransferase activity,MF,
2634,GO:0005965,1.00000000000203,0.862983789483186,0,2,protein farnesyltransferase complex,CC,
7403,GO:0031466,1.00000000000203,0.719793732723443,0,4,Cul5-RING ubiquitin ligase complex,CC,
18376,GO:1903378,1.00000000000204,0.823742983015112,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
10601,GO:0043570,1.00000000000204,0.672818973902076,0,4,maintenance of DNA repeat elements,BP,
15639,GO:0072135,1.00000000000206,0.823978886754508,0,2,kidney mesenchymal cell proliferation,BP,
15640,GO:0072136,1.00000000000206,0.823978886754508,0,2,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
8480,GO:0033625,1.00000000000209,0.831962133120645,0,2,positive regulation of integrin activation,BP,
17405,GO:1900138,1.0000000000021,0.784884250494527,0,3,negative regulation of phospholipase A2 activity,BP,
17540,GO:1901069,1.0000000000021,0.882997471834124,0,2,guanosine-containing compound catabolic process,BP,
5303,GO:0016005,1.00000000000211,0.828293100732717,0,2,phospholipase A2 activator activity,MF,
7681,GO:0032116,1.00000000000212,0.796599077019037,0,2,SMC loading complex,CC,
16377,GO:0090694,1.00000000000212,0.796599077019037,0,2,Scc2-Scc4 cohesin loading complex,CC,
11084,GO:0045084,1.00000000000212,0.777646115241185,0,3,positive regulation of interleukin-12 biosynthetic process,BP,
12234,GO:0048495,1.00000000000213,0.659111379185137,0,4,Roundabout binding,MF,
4004,GO:0008948,1.00000000000213,0.714377026473457,0,4,oxaloacetate decarboxylase activity,MF,
7750,GO:0032264,1.00000000000216,0.718551374115729,0,4,IMP salvage,BP,
20037,GO:2000660,1.00000000000217,0.721328036078395,0,4,negative regulation of interleukin-1-mediated signaling pathway,BP,
15630,GO:0072126,1.00000000000221,0.730776205911844,0,4,positive regulation of glomerular mesangial cell proliferation,BP,
20140,GO:2000833,1.00000000000221,0.735098671332227,0,4,positive regulation of steroid hormone secretion,BP,
16191,GO:0090210,1.00000000000224,0.831169712380924,0,2,regulation of establishment of blood-brain barrier,BP,
4833,GO:0014038,1.00000000000224,0.747997231122871,0,3,regulation of Schwann cell differentiation,BP,
1766,GO:0004370,1.00000000000227,0.786736904562706,0,2,glycerol kinase activity,MF,
11592,GO:0046167,1.00000000000227,0.786736904562706,0,2,glycerol-3-phosphate biosynthetic process,BP,
16197,GO:0090222,1.00000000000228,0.778024367891718,0,2,centrosome-templated microtubule nucleation,BP,
2419,GO:0005593,1.00000000000231,0.658622491175745,0,4,FACIT collagen trimer,CC,
9712,GO:0038124,1.00000000000232,0.813086628390122,0,2,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10042,GO:0042494,1.00000000000232,0.813086628390122,0,2,detection of bacterial lipoprotein,BP,
10044,GO:0042496,1.00000000000232,0.813086628390122,0,2,detection of diacyl bacterial lipopeptide,BP,
14711,GO:0070340,1.00000000000232,0.813086628390122,0,2,detection of bacterial lipopeptide,BP,
15443,GO:0071724,1.00000000000232,0.813086628390122,0,2,response to diacyl bacterial lipopeptide,BP,
15445,GO:0071726,1.00000000000232,0.813086628390122,0,2,cellular response to diacyl bacterial lipopeptide,BP,
2700,GO:0006065,1.00000000000234,0.755061223222266,0,3,UDP-glucuronate biosynthetic process,BP,
11658,GO:0046398,1.00000000000234,0.755061223222266,0,3,UDP-glucuronate metabolic process,BP,
11620,GO:0046322,1.00000000000234,0.688030855008274,0,4,negative regulation of fatty acid oxidation,BP,
19628,GO:1990791,1.00000000000234,0.843964028441333,0,2,dorsal root ganglion development,BP,
5110,GO:0015420,1.00000000000237,0.887585866318539,0,1,cobalamin-transporting ATPase activity,MF,
5112,GO:0015431,1.00000000000237,0.887585866318539,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
8843,GO:0034634,1.00000000000237,0.887585866318539,0,1,glutathione transmembrane transporter activity,MF,
8930,GO:0034775,1.00000000000237,0.887585866318539,0,1,glutathione transmembrane transport,BP,
9130,GO:0035443,1.00000000000237,0.887585866318539,0,1,tripeptide transmembrane transport,BP,
10233,GO:0042937,1.00000000000237,0.887585866318539,0,1,tripeptide transmembrane transporter activity,MF,
11766,GO:0046623,1.00000000000237,0.887585866318539,0,1,sphingolipid-translocating ATPase activity,MF,
15557,GO:0071997,1.00000000000237,0.887585866318539,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16982,GO:0099039,1.00000000000237,0.887585866318539,0,1,sphingolipid translocation,BP,
11123,GO:0045159,1.0000000000024,0.709333828193971,0,4,myosin II binding,MF,
11269,GO:0045569,1.00000000000241,0.725201567413735,0,4,TRAIL binding,MF,
12039,GO:0047756,1.00000000000243,0.829891275986436,0,2,chondroitin 4-sulfotransferase activity,MF,
14173,GO:0061055,1.00000000000244,0.799906772232715,0,2,myotome development,BP,
4002,GO:0008940,1.00000000000244,0.763182870158731,0,3,nitrate reductase activity,MF,
9678,GO:0038042,1.00000000000245,0.745451349673987,0,4,dimeric G-protein coupled receptor signaling pathway,BP,
16699,GO:0097646,1.00000000000245,0.745451349673987,0,4,calcitonin family receptor signaling pathway,BP,
15608,GO:0072092,1.00000000000245,0.75430840462466,0,2,ureteric bud invasion,BP,
1619,GO:0004052,1.00000000000245,0.856829506068922,0,2,arachidonate 12-lipoxygenase activity,MF,
10386,GO:0043208,1.00000000000247,0.719162379188117,0,4,glycosphingolipid binding,MF,
10760,GO:0044205,1.00000000000247,0.758457386229769,0,3,'de novo' UMP biosynthetic process,BP,
2566,GO:0005850,1.00000000000247,0.689849615845381,0,4,eukaryotic translation initiation factor 2 complex,CC,
16200,GO:0090230,1.00000000000251,0.672334346353135,0,4,regulation of centromere complex assembly,BP,
12758,GO:0051026,1.00000000000252,0.719412916956859,0,4,chiasma assembly,BP,
5985,GO:0018894,1.00000000000253,0.780568858450675,0,3,dibenzo-p-dioxin metabolic process,BP,
18577,GO:1903818,1.00000000000254,0.678988968451072,0,3,positive regulation of voltage-gated potassium channel activity,BP,
9057,GO:0035279,1.00000000000257,0.836967180863623,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
16866,GO:0098795,1.00000000000257,0.836967180863623,0,2,mRNA cleavage involved in gene silencing,BP,
10260,GO:0042998,1.00000000000257,0.817824577236884,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
8094,GO:0032777,1.0000000000026,0.726463314842183,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
5982,GO:0018812,1.00000000000261,0.714945339628398,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
7624,GO:0032021,1.00000000000261,0.714945339628398,0,4,NELF complex,CC,
17130,GO:0102158,1.00000000000261,0.714945339628398,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
17142,GO:0102343,1.00000000000261,0.714945339628398,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
17143,GO:0102344,1.00000000000261,0.714945339628398,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
17144,GO:0102345,1.00000000000261,0.714945339628398,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
19481,GO:1990246,1.00000000000261,0.714945339628398,0,4,uniplex complex,CC,
8370,GO:0033263,1.00000000000263,0.669418115965183,0,4,CORVET complex,CC,
5834,GO:0017116,1.00000000000263,0.757639785887301,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
18672,GO:1904017,1.00000000000263,0.786399384198882,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
16421,GO:0097056,1.00000000000264,0.725183157676352,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
1532,GO:0003917,1.00000000000265,0.70197301358721,0,4,DNA topoisomerase type I activity,MF,
7385,GO:0031437,1.00000000000266,0.765259571331714,0,3,regulation of mRNA cleavage,BP,
11647,GO:0046368,1.00000000000266,0.73022892304634,0,4,GDP-L-fucose metabolic process,BP,
7544,GO:0031826,1.00000000000267,0.813078907215611,0,3,type 2A serotonin receptor binding,MF,
12382,GO:0048787,1.0000000000027,0.678883810747753,0,4,presynaptic active zone membrane,CC,
18062,GO:1902617,1.00000000000271,0.67767619572668,0,4,response to fluoride,BP,
8549,GO:0033883,1.00000000000272,0.880757331973311,0,2,pyridoxal phosphatase activity,MF,
16825,GO:0098706,1.00000000000272,0.6604463790457,0,4,ferric iron import across plasma membrane,BP,
13227,GO:0051890,1.00000000000273,0.808053074161106,0,2,regulation of cardioblast differentiation,BP,
12492,GO:0050508,1.00000000000279,0.829682642676574,0,2,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
12493,GO:0050509,1.00000000000279,0.829682642676574,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
1050,GO:0002578,1.0000000000028,0.730803745279717,0,4,negative regulation of antigen processing and presentation,BP,
16885,GO:0098826,1.00000000000281,0.728834659306973,0,4,endoplasmic reticulum tubular network membrane,CC,
14810,GO:0070537,1.00000000000283,0.779771511378482,0,3,histone H2A K63-linked deubiquitination,BP,
4939,GO:0014900,1.00000000000285,0.732911790976059,0,4,muscle hyperplasia,BP,
1290,GO:0003100,1.00000000000287,0.719149860700375,0,4,regulation of systemic arterial blood pressure by endothelin,BP,
17429,GO:1900186,1.00000000000289,0.766634596016552,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18396,GO:1903422,1.00000000000291,0.730036161244062,0,3,negative regulation of synaptic vesicle recycling,BP,
9354,GO:0035865,1.00000000000291,0.810308492754652,0,3,cellular response to potassium ion,BP,
19372,GO:1905832,1.00000000000291,0.621151151579475,0,4,positive regulation of spindle assembly,BP,
5987,GO:0018916,1.00000000000292,0.757622812655782,0,4,nitrobenzene metabolic process,BP,
16227,GO:0090271,1.00000000000292,0.784914182645363,0,2,positive regulation of fibroblast growth factor production,BP,
4617,GO:0010735,1.00000000000295,0.736090741672438,0,3,positive regulation of transcription via serum response element binding,BP,
16947,GO:0098928,1.00000000000297,0.693031727085574,0,2,presynaptic signal transduction,BP,
17049,GO:0099526,1.00000000000297,0.693031727085574,0,2,presynapse to nucleus signaling pathway,BP,
19545,GO:1990481,1.00000000000297,0.737325222578462,0,4,mRNA pseudouridine synthesis,BP,
14365,GO:0061582,1.00000000000298,0.803047639383433,0,2,intestinal epithelial cell migration,BP,
11839,GO:0046790,1.00000000000298,0.732947764428816,0,3,virion binding,MF,
5926,GO:0018201,1.00000000000299,0.739660576498972,0,3,peptidyl-glycine modification,BP,
19084,GO:1904978,1.00000000000299,0.736875532011997,0,3,regulation of endosome organization,BP,
1301,GO:0003139,1.00000000000299,0.747788373426681,0,4,secondary heart field specification,BP,
15635,GO:0072131,1.00000000000312,0.732826732979915,0,3,kidney mesenchyme morphogenesis,BP,
15637,GO:0072133,1.00000000000312,0.732826732979915,0,3,metanephric mesenchyme morphogenesis,BP,
16652,GO:0097524,1.00000000000313,0.677618886542695,0,4,sperm plasma membrane,CC,
13603,GO:0060073,1.00000000000315,0.665365433960275,0,4,micturition,BP,
12453,GO:0050211,1.00000000000315,0.844343939953063,0,2,procollagen galactosyltransferase activity,MF,
10769,GO:0044214,1.00000000000317,0.716447182762759,0,3,spanning component of plasma membrane,CC,
1429,GO:0003402,1.00000000000317,0.634868427633106,0,4,planar cell polarity pathway involved in axis elongation,BP,
12146,GO:0048250,1.00000000000317,0.876071944986196,0,2,iron import into the mitochondrion,BP,
8959,GO:0035022,1.00000000000318,0.680442788937072,0,4,positive regulation of Rac protein signal transduction,BP,
6481,GO:0021824,1.0000000000032,0.825249549577935,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6485,GO:0021828,1.0000000000032,0.825249549577935,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6496,GO:0021856,1.0000000000032,0.825249549577935,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
13798,GO:0060385,1.0000000000032,0.825249549577935,0,2,axonogenesis involved in innervation,BP,
18373,GO:1903375,1.0000000000032,0.825249549577935,0,2,facioacoustic ganglion development,BP,
6226,GO:0019777,1.00000000000323,0.874168604015124,0,2,Atg12 transferase activity,MF,
91,GO:0000179,1.00000000000325,0.745069252715807,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
1601,GO:0004020,1.00000000000325,0.838232694847243,0,2,adenylylsulfate kinase activity,MF,
2039,GO:0004779,1.00000000000325,0.838232694847243,0,2,sulfate adenylyltransferase activity,MF,
2040,GO:0004781,1.00000000000325,0.838232694847243,0,2,sulfate adenylyltransferase (ATP) activity,MF,
11315,GO:0045632,1.00000000000327,0.704833376657686,0,4,negative regulation of mechanoreceptor differentiation,BP,
20165,GO:2000981,1.00000000000327,0.704833376657686,0,4,negative regulation of inner ear receptor cell differentiation,BP,
10822,GO:0044313,1.00000000000329,0.707717009767853,0,3,protein K6-linked deubiquitination,BP,
3481,GO:0007341,1.00000000000336,0.785865764689147,0,3,penetration of zona pellucida,BP,
5437,GO:0016300,1.00000000000337,0.761811638727048,0,3,tRNA (uracil) methyltransferase activity,MF,
16509,GO:0097208,1.00000000000337,0.736479574790794,0,4,alveolar lamellar body,CC,
1243,GO:0002943,1.00000000000338,0.745174308920595,0,4,tRNA dihydrouridine synthesis,BP,
5853,GO:0017150,1.00000000000338,0.745174308920595,0,4,tRNA dihydrouridine synthase activity,MF,
15406,GO:0071664,1.00000000000339,0.66102905369156,0,4,catenin-TCF7L2 complex,CC,
10379,GO:0043199,1.00000000000348,0.758933083389996,0,3,sulfate binding,MF,
18927,GO:1904672,1.00000000000349,0.73800732836331,0,3,regulation of somatic stem cell population maintenance,BP,
8085,GO:0032767,1.00000000000353,0.760564047206496,0,3,copper-dependent protein binding,MF,
12579,GO:0050733,1.00000000000355,0.694490302820804,0,4,RS domain binding,MF,
9327,GO:0035801,1.00000000000355,0.85812397292117,0,2,adrenal cortex development,BP,
9328,GO:0035802,1.00000000000355,0.85812397292117,0,2,adrenal cortex formation,BP,
16204,GO:0090234,1.00000000000356,0.74866995471117,0,3,regulation of kinetochore assembly,BP,
17737,GO:1901668,1.00000000000357,0.816970498778618,0,3,regulation of superoxide dismutase activity,BP,
16513,GO:0097212,1.00000000000357,0.865225272968852,0,2,lysosomal membrane organization,BP,
2202,GO:0005087,1.00000000000359,0.755944636245544,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2255,GO:0005169,1.00000000000361,0.847338968999068,0,2,neurotrophin TRKB receptor binding,MF,
8695,GO:0034316,1.00000000000362,0.706278513732204,0,4,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
16221,GO:0090261,1.00000000000364,0.757332040311865,0,4,positive regulation of inclusion body assembly,BP,
14823,GO:0070557,1.00000000000367,0.874783764149721,0,2,PCNA-p21 complex,CC,
3011,GO:0006556,1.00000000000367,0.856521909952714,0,2,S-adenosylmethionine biosynthetic process,BP,
12161,GO:0048269,1.00000000000367,0.856521909952714,0,2,methionine adenosyltransferase complex,CC,
10053,GO:0042535,1.00000000000371,0.683921102509123,0,4,positive regulation of tumor necrosis factor biosynthetic process,BP,
20132,GO:2000823,1.00000000000371,0.746331851743161,0,4,regulation of androgen receptor activity,BP,
20133,GO:2000825,1.00000000000371,0.746331851743161,0,4,positive regulation of androgen receptor activity,BP,
4433,GO:0010269,1.00000000000372,0.814772635522379,0,3,response to selenium ion,BP,
1501,GO:0003847,1.00000000000375,0.760007865673307,0,4,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
18202,GO:1902990,1.00000000000381,0.763558859923943,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19937,GO:2000466,1.00000000000381,0.751108230614036,0,3,negative regulation of glycogen (starch) synthase activity,BP,
13004,GO:0051429,1.00000000000383,0.787460312133709,0,3,corticotropin-releasing hormone receptor binding,MF,
14641,GO:0070213,1.00000000000385,0.650204639172302,0,4,protein auto-ADP-ribosylation,BP,
1461,GO:0003708,1.00000000000388,0.690687149879216,0,4,retinoic acid receptor activity,MF,
1972,GO:0004687,1.00000000000389,0.773383329795932,0,2,myosin light chain kinase activity,MF,
1362,GO:0003245,1.00000000000391,0.859661709679153,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
4728,GO:0010890,1.00000000000394,0.805577337641792,0,3,positive regulation of sequestering of triglyceride,BP,
838,GO:0002143,1.00000000000394,0.751108189866631,0,4,tRNA wobble position uridine thiolation,BP,
3075,GO:0006642,1.00000000000395,0.751435916740803,0,3,triglyceride mobilization,BP,
19,GO:0000035,1.00000000000402,0.909238352088259,0,2,acyl binding,MF,
20,GO:0000036,1.00000000000402,0.909238352088259,0,2,acyl carrier activity,MF,
4173,GO:0009245,1.00000000000402,0.909238352088259,0,2,lipid A biosynthetic process,BP,
10951,GO:0044620,1.00000000000402,0.909238352088259,0,2,ACP phosphopantetheine attachment site binding,MF,
11703,GO:0046493,1.00000000000402,0.909238352088259,0,2,lipid A metabolic process,BP,
12869,GO:0051192,1.00000000000402,0.909238352088259,0,2,prosthetic group binding,MF,
17604,GO:1901269,1.00000000000402,0.909238352088259,0,2,lipooligosaccharide metabolic process,BP,
17605,GO:1901271,1.00000000000402,0.909238352088259,0,2,lipooligosaccharide biosynthetic process,BP,
3766,GO:0008310,1.00000000000403,0.705279157463173,0,4,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
1334,GO:0003190,1.00000000000405,0.600728739089187,0,4,atrioventricular valve formation,BP,
4922,GO:0014866,1.00000000000409,0.615583775478638,0,3,skeletal myofibril assembly,BP,
911,GO:0002296,1.0000000000041,0.801085325161789,0,2,T-helper 1 cell lineage commitment,BP,
1861,GO:0004525,1.00000000000411,0.670797923319249,0,4,ribonuclease III activity,MF,
7773,GO:0032296,1.00000000000411,0.670797923319249,0,4,double-stranded RNA-specific ribonuclease activity,MF,
2020,GO:0004749,1.00000000000412,0.74290555873752,0,4,ribose phosphate diphosphokinase activity,MF,
5668,GO:0016778,1.00000000000412,0.74290555873752,0,4,diphosphotransferase activity,MF,
10662,GO:0043812,1.00000000000415,0.735629738504503,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
10422,GO:0043262,1.00000000000415,0.784044142974633,0,3,adenosine-diphosphatase activity,MF,
6359,GO:0021540,1.00000000000417,0.723051121883027,0,4,corpus callosum morphogenesis,BP,
9333,GO:0035812,1.00000000000418,0.863276536143276,0,2,renal sodium excretion,BP,
9334,GO:0035813,1.00000000000418,0.863276536143276,0,2,regulation of renal sodium excretion,BP,
14361,GO:0061575,1.00000000000419,0.793724534377148,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
7195,GO:0031084,1.0000000000042,0.74693583217407,0,3,BLOC-2 complex,CC,
18971,GO:1904751,1.00000000000421,0.81464989112752,0,3,positive regulation of protein localization to nucleolus,BP,
9600,GO:0036457,1.00000000000421,0.588634372590494,0,4,keratohyalin granule,CC,
8436,GO:0033553,1.00000000000423,0.683433171126078,0,4,rDNA heterochromatin,CC,
8121,GO:0032807,1.00000000000424,0.71961622191893,0,4,DNA ligase IV complex,CC,
1890,GO:0004572,1.00000000000426,0.795496137525729,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
18112,GO:1902766,1.00000000000428,0.878675176917529,0,2,skeletal muscle satellite cell migration,BP,
20009,GO:2000622,1.00000000000429,0.666843721114807,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
20010,GO:2000623,1.00000000000429,0.666843721114807,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
12494,GO:0050510,1.00000000000431,0.682289913846353,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
14573,GO:0070101,1.00000000000431,0.842216597160776,0,2,positive regulation of chemokine-mediated signaling pathway,BP,
4016,GO:0009019,1.00000000000432,0.695545428874216,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
7552,GO:0031862,1.00000000000435,0.80704254352633,0,2,prostanoid receptor binding,MF,
3910,GO:0008559,1.00000000000436,0.665601853905384,0,4,xenobiotic transmembrane transporting ATPase activity,MF,
12194,GO:0048341,1.00000000000437,0.680985258371987,0,4,paraxial mesoderm formation,BP,
3013,GO:0006558,1.00000000000438,0.785561051267131,0,4,L-phenylalanine metabolic process,BP,
3014,GO:0006559,1.00000000000438,0.785561051267131,0,4,L-phenylalanine catabolic process,BP,
17911,GO:1902221,1.00000000000438,0.785561051267131,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
17912,GO:1902222,1.00000000000438,0.785561051267131,0,4,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
6102,GO:0019322,1.00000000000439,0.758404060791635,0,4,pentose biosynthetic process,BP,
860,GO:0002191,1.00000000000441,0.778333652120539,0,3,cap-dependent translational initiation,BP,
7414,GO:0031501,1.00000000000441,0.788045546730901,0,4,mannosyltransferase complex,CC,
6972,GO:0030627,1.00000000000441,0.868407206574232,0,2,pre-mRNA 5'-splice site binding,MF,
13924,GO:0060584,1.00000000000446,0.837772077363486,0,2,regulation of prostaglandin-endoperoxide synthase activity,BP,
13925,GO:0060585,1.00000000000446,0.837772077363486,0,2,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
11828,GO:0046726,1.00000000000446,0.680505295774826,0,4,positive regulation by virus of viral protein levels in host cell,BP,
4653,GO:0010796,1.00000000000449,0.81714519513612,0,3,regulation of multivesicular body size,BP,
18048,GO:1902576,1.00000000000453,0.718579537566042,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
16382,GO:0090724,1.00000000000453,0.699867047988827,0,4,central region of growth cone,CC,
663,GO:0001866,1.00000000000453,0.756835695009789,0,4,NK T cell proliferation,BP,
10949,GO:0044614,1.00000000000454,0.648740076034789,0,4,nuclear pore cytoplasmic filaments,CC,
14541,GO:0070052,1.00000000000454,0.816221294635961,0,2,collagen V binding,MF,
8755,GO:0034416,1.00000000000454,0.846129836207405,0,2,bisphosphoglycerate phosphatase activity,MF,
20240,GO:2001185,1.00000000000459,0.723485964016726,0,4,regulation of CD8-positive, alpha-beta T cell activation,BP,
5554,GO:0016560,1.00000000000461,0.69990349612599,0,4,protein import into peroxisome matrix, docking,BP,
1986,GO:0004706,1.00000000000465,0.741170953534064,0,3,JUN kinase kinase kinase activity,MF,
14525,GO:0070012,1.00000000000465,0.852257167840766,0,2,oligopeptidase activity,MF,
5847,GO:0017143,1.0000000000047,0.851846998990994,0,2,insecticide metabolic process,BP,
8814,GO:0034552,1.0000000000047,0.75446900278389,0,4,respiratory chain complex II assembly,BP,
8815,GO:0034553,1.0000000000047,0.75446900278389,0,4,mitochondrial respiratory chain complex II assembly,BP,
16573,GO:0097361,1.00000000000471,0.728022973108788,0,4,CIA complex,CC,
12504,GO:0050613,1.00000000000472,0.851256043781441,0,2,delta14-sterol reductase activity,MF,
10527,GO:0043461,1.00000000000473,0.739305796886866,0,4,proton-transporting ATP synthase complex assembly,BP,
1981,GO:0004699,1.00000000000473,0.749371453705827,0,3,calcium-independent protein kinase C activity,MF,
4902,GO:0014831,1.00000000000475,0.720304024967421,0,4,gastro-intestinal system smooth muscle contraction,BP,
2911,GO:0006421,1.00000000000475,0.779364339436161,0,3,asparaginyl-tRNA aminoacylation,BP,
3112,GO:0006689,1.00000000000478,0.728468578527019,0,4,ganglioside catabolic process,BP,
2271,GO:0005212,1.0000000000048,0.759476651420672,0,4,structural constituent of eye lens,MF,
7580,GO:0031944,1.0000000000048,0.697142842739135,0,4,negative regulation of glucocorticoid metabolic process,BP,
7583,GO:0031947,1.0000000000048,0.697142842739135,0,4,negative regulation of glucocorticoid biosynthetic process,BP,
16075,GO:0090032,1.0000000000048,0.697142842739135,0,4,negative regulation of steroid hormone biosynthetic process,BP,
14820,GO:0070552,1.0000000000048,0.785076944761903,0,3,BRISC complex,CC,
2237,GO:0005143,1.00000000000483,0.833494202033029,0,2,interleukin-12 receptor binding,MF,
13573,GO:0060040,1.00000000000483,0.842573878254884,0,2,retinal bipolar neuron differentiation,BP,
13876,GO:0060501,1.00000000000483,0.702867628878996,0,4,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
5492,GO:0016428,1.00000000000486,0.704694992293891,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
14572,GO:0070100,1.00000000000486,0.666550398616117,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
15798,GO:0072429,1.00000000000486,0.789379509328016,0,3,response to intra-S DNA damage checkpoint signaling,BP,
2504,GO:0005757,1.00000000000489,0.761041134417138,0,4,mitochondrial permeability transition pore complex,CC,
18091,GO:1902714,1.00000000000489,0.84776708118523,0,2,negative regulation of interferon-gamma secretion,BP,
15073,GO:0071034,1.00000000000496,0.711795260516996,0,4,CUT catabolic process,BP,
15077,GO:0071043,1.00000000000496,0.711795260516996,0,4,CUT metabolic process,BP,
16135,GO:0090135,1.00000000000503,0.773616971130751,0,3,actin filament branching,BP,
18662,GO:1903978,1.00000000000507,0.661547189101794,0,4,regulation of microglial cell activation,BP,
6598,GO:0022615,1.00000000000509,0.754120888224973,0,4,protein to membrane docking,BP,
850,GO:0002176,1.00000000000509,0.830574206048788,0,3,male germ cell proliferation,BP,
9474,GO:0036093,1.00000000000509,0.830574206048788,0,3,germ cell proliferation,BP,
9500,GO:0036146,1.0000000000051,0.78748048977126,0,3,cellular response to mycotoxin,BP,
12148,GO:0048254,1.00000000000516,0.738402675837538,0,4,snoRNA localization,BP,
19944,GO:2000481,1.00000000000519,0.652978225398611,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
1616,GO:0004045,1.0000000000052,0.779284482378453,0,4,aminoacyl-tRNA hydrolase activity,MF,
2776,GO:0006203,1.00000000000521,0.812069858412559,0,3,dGTP catabolic process,BP,
12393,GO:0048818,1.00000000000523,0.704797654965193,0,4,positive regulation of hair follicle maturation,BP,
4079,GO:0009133,1.00000000000524,0.762966915819863,0,4,nucleoside diphosphate biosynthetic process,BP,
2890,GO:0006397,1.00000000000525,0,4,439,mRNA processing,BP,ADARB1;DHX32;PRKACA;CMTR2
13917,GO:0060574,1.00000000000526,0.742807481568526,0,4,intestinal epithelial cell maturation,BP,
16245,GO:0090296,1.00000000000527,0.711391331478846,0,4,regulation of mitochondrial DNA replication,BP,
17787,GO:1901858,1.00000000000527,0.711391331478846,0,4,regulation of mitochondrial DNA metabolic process,BP,
17450,GO:1900226,1.00000000000528,0.693519215876985,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
7435,GO:0031544,1.00000000000532,0.71352881106821,0,4,peptidyl-proline 3-dioxygenase activity,MF,
9088,GO:0035339,1.00000000000534,0.760422690441938,0,4,SPOTS complex,CC,
16154,GO:0090168,1.00000000000534,0.705556703063846,0,4,Golgi reassembly,BP,
18969,GO:1904749,1.00000000000535,0.721804331914587,0,4,regulation of protein localization to nucleolus,BP,
18220,GO:1903012,1.00000000000535,0.708451785911857,0,4,positive regulation of bone development,BP,
7819,GO:0032372,1.00000000000541,0.710108913485132,0,4,negative regulation of sterol transport,BP,
7822,GO:0032375,1.00000000000541,0.710108913485132,0,4,negative regulation of cholesterol transport,BP,
10456,GO:0043313,1.00000000000543,0.641219725521256,0,4,regulation of neutrophil degranulation,BP,
18040,GO:1902563,1.00000000000543,0.641219725521256,0,4,regulation of neutrophil activation,BP,
14465,GO:0061821,1.00000000000544,0.658306467340431,0,4,telomeric D-loop binding,MF,
4920,GO:0014858,1.00000000000546,0.802079116426007,0,2,positive regulation of skeletal muscle cell proliferation,BP,
18095,GO:1902724,1.00000000000546,0.802079116426007,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
18097,GO:1902728,1.00000000000546,0.802079116426007,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
18121,GO:1902805,1.00000000000556,0.798892960058852,0,2,positive regulation of synaptic vesicle transport,BP,
19834,GO:2000302,1.00000000000556,0.798892960058852,0,2,positive regulation of synaptic vesicle exocytosis,BP,
10341,GO:0043137,1.00000000000557,0.740667268258751,0,4,DNA replication, removal of RNA primer,BP,
779,GO:0002036,1.00000000000558,0.698811846773871,0,4,regulation of L-glutamate import across plasma membrane,BP,
4773,GO:0010958,1.00000000000558,0.698811846773871,0,4,regulation of amino acid import across plasma membrane,BP,
16095,GO:0090071,1.00000000000558,0.672213933778364,0,4,negative regulation of ribosome biogenesis,BP,
11583,GO:0046136,1.00000000000559,0.879610237444833,0,2,positive regulation of vitamin metabolic process,BP,
13906,GO:0060557,1.00000000000559,0.879610237444833,0,2,positive regulation of vitamin D biosynthetic process,BP,
13908,GO:0060559,1.00000000000559,0.879610237444833,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
388,GO:0001032,1.00000000000561,0.674704760959559,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
11975,GO:0047238,1.00000000000563,0.684453173839388,0,4,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
10759,GO:0044194,1.00000000000567,0.79665967626906,0,3,cytolytic granule,CC,
4696,GO:0010851,1.00000000000568,0.866391910559455,0,2,cyclase regulator activity,MF,
4697,GO:0010853,1.00000000000568,0.866391910559455,0,2,cyclase activator activity,MF,
6804,GO:0030249,1.00000000000568,0.866391910559455,0,2,guanylate cyclase regulator activity,MF,
6805,GO:0030250,1.00000000000568,0.866391910559455,0,2,guanylate cyclase activator activity,MF,
6569,GO:0022028,1.00000000000569,0.643249252092155,0,4,tangential migration from the subventricular zone to the olfactory bulb,BP,
19492,GO:1990269,1.00000000000571,0.833139609218688,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
4869,GO:0014722,1.00000000000574,0.72659831282987,0,4,regulation of skeletal muscle contraction by calcium ion signaling,BP,
9168,GO:0035521,1.00000000000575,0.698301819148387,0,4,monoubiquitinated histone deubiquitination,BP,
9169,GO:0035522,1.00000000000575,0.698301819148387,0,4,monoubiquitinated histone H2A deubiquitination,BP,
16893,GO:0098837,1.00000000000576,0.79238392207706,0,3,postsynaptic recycling endosome,CC,
8317,GO:0033149,1.00000000000576,0.80415870400641,0,2,FFAT motif binding,MF,
5957,GO:0018335,1.00000000000578,0.692447031808592,0,4,protein succinylation,BP,
17218,GO:0106077,1.00000000000578,0.692447031808592,0,4,histone succinylation,BP,
18246,GO:1903059,1.00000000000579,0.689324288902229,0,4,regulation of protein lipidation,BP,
18247,GO:1903061,1.00000000000579,0.689324288902229,0,4,positive regulation of protein lipidation,BP,
8966,GO:0035034,1.0000000000058,0.85200659045353,0,2,histone acetyltransferase regulator activity,MF,
16626,GO:0097475,1.00000000000582,0.743840681640492,0,3,motor neuron migration,BP,
17845,GO:1902023,1.00000000000584,0.676526615288789,0,4,L-arginine transport,BP,
11273,GO:0045578,1.00000000000588,0.717647972862961,0,4,negative regulation of B cell differentiation,BP,
4928,GO:0014883,1.0000000000059,0.664067658512988,0,4,transition between fast and slow fiber,BP,
4560,GO:0010641,1.00000000000591,0.66631678478844,0,4,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
20263,GO:2001228,1.00000000000594,0.731465828463996,0,2,regulation of response to gamma radiation,BP,
11465,GO:0045919,1.00000000000598,0.766738854877819,0,4,positive regulation of cytolysis,BP,
9996,GO:0042406,1.00000000000598,0.738435175220618,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
9791,GO:0040009,1.000000000006,0.618930042418697,0,4,regulation of growth rate,BP,
8288,GO:0033093,1.00000000000604,0.69135483880124,0,4,Weibel-Palade body,CC,
16325,GO:0090521,1.00000000000604,0.678551654064877,0,4,glomerular visceral epithelial cell migration,BP,
700,GO:0001920,1.00000000000605,0.761934329313343,0,3,negative regulation of receptor recycling,BP,
19626,GO:1990785,1.00000000000605,0.711404194190004,0,3,response to water-immersion restraint stress,BP,
11312,GO:0045629,1.00000000000607,0.77187921406543,0,3,negative regulation of T-helper 2 cell differentiation,BP,
15110,GO:0071159,1.00000000000608,0.877813312691705,0,2,NF-kappaB complex,CC,
10713,GO:0044020,1.00000000000609,0.744033036888276,0,4,histone methyltransferase activity (H4-R3 specific),MF,
222,GO:0000461,1.00000000000613,0.905912103854302,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
6027,GO:0019086,1.00000000000613,0.72075307362121,0,4,late viral transcription,BP,
8854,GO:0034648,1.00000000000613,0.636266580851886,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
14582,GO:0070122,1.00000000000613,0.690711384328773,0,4,isopeptidase activity,MF,
15320,GO:0071532,1.00000000000618,0.669150589012578,0,4,ankyrin repeat binding,MF,
7786,GO:0032311,1.00000000000621,0.884494116131346,0,2,angiogenin-PRI complex,CC,
20294,GO:2001274,1.00000000000625,0.825826755158218,0,2,negative regulation of glucose import in response to insulin stimulus,BP,
6853,GO:0030322,1.00000000000625,0.857758941048684,0,2,stabilization of membrane potential,BP,
3472,GO:0007296,1.00000000000625,0.643396797028445,0,4,vitellogenesis,BP,
14990,GO:0070901,1.00000000000629,0.728546549135916,0,4,mitochondrial tRNA methylation,BP,
14864,GO:0070634,1.00000000000635,0.770370989032341,0,3,transepithelial ammonium transport,BP,
1713,GO:0004305,1.00000000000637,0.722345523391831,0,4,ethanolamine kinase activity,MF,
20052,GO:2000676,1.00000000000638,0.7220000060357,0,4,positive regulation of type B pancreatic cell apoptotic process,BP,
8180,GO:0032916,1.0000000000064,0.773443810677397,0,2,positive regulation of transforming growth factor beta3 production,BP,
347,GO:0000960,1.00000000000641,0.67803624581228,0,4,regulation of mitochondrial RNA catabolic process,BP,
16253,GO:0090306,1.00000000000643,0.671398545818913,0,4,spindle assembly involved in meiosis,BP,
1717,GO:0004309,1.00000000000643,0.6562540429188,0,4,exopolyphosphatase activity,MF,
3181,GO:0006798,1.00000000000643,0.6562540429188,0,4,polyphosphate catabolic process,BP,
15651,GO:0072162,1.00000000000646,0.825300015836148,0,2,metanephric mesenchymal cell differentiation,BP,
9715,GO:0038129,1.0000000000065,0.857500920833934,0,2,ERBB3 signaling pathway,BP,
11019,GO:0044854,1.00000000000653,0.733569041208215,0,4,plasma membrane raft assembly,BP,
11022,GO:0044857,1.00000000000653,0.733569041208215,0,4,plasma membrane raft organization,BP,
168,GO:0000349,1.00000000000654,0.855090528301661,0,2,generation of catalytic spliceosome for first transesterification step,BP,
15057,GO:0071008,1.00000000000655,0.732557643924208,0,4,U2-type post-mRNA release spliceosomal complex,CC,
14004,GO:0060720,1.00000000000657,0.832903261201108,0,2,spongiotrophoblast cell proliferation,BP,
14005,GO:0060721,1.00000000000657,0.832903261201108,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14006,GO:0060722,1.00000000000657,0.832903261201108,0,2,cell proliferation involved in embryonic placenta development,BP,
14007,GO:0060723,1.00000000000657,0.832903261201108,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
16193,GO:0090214,1.00000000000657,0.832903261201108,0,2,spongiotrophoblast layer developmental growth,BP,
19866,GO:2000344,1.0000000000066,0.738499410682628,0,4,positive regulation of acrosome reaction,BP,
348,GO:0000961,1.00000000000661,0.814822215312503,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
9647,GO:0036515,1.00000000000664,0.618700966135647,0,4,serotonergic neuron axon guidance,BP,
12264,GO:0048549,1.00000000000664,0.676947662919408,0,4,positive regulation of pinocytosis,BP,
16510,GO:0097209,1.00000000000671,0.697471118351771,0,4,epidermal lamellar body,CC,
19694,GO:2000017,1.00000000000672,0.838118298349185,0,2,positive regulation of determination of dorsal identity,BP,
19338,GO:1905671,1.00000000000672,0.775255960225295,0,3,regulation of lysosome organization,BP,
8917,GO:0034756,1.00000000000674,0.773535464404128,0,3,regulation of iron ion transport,BP,
4489,GO:0010511,1.00000000000679,0.740163297534144,0,4,regulation of phosphatidylinositol biosynthetic process,BP,
8319,GO:0033152,1.00000000000679,0.653877943548912,0,4,immunoglobulin V(D)J recombination,BP,
20083,GO:2000739,1.00000000000689,0.647167527607375,0,4,regulation of mesenchymal stem cell differentiation,BP,
6977,GO:0030643,1.00000000000695,0.642445966952148,0,4,cellular phosphate ion homeostasis,BP,
15807,GO:0072501,1.00000000000695,0.642445966952148,0,4,cellular divalent inorganic anion homeostasis,BP,
15808,GO:0072502,1.00000000000695,0.642445966952148,0,4,cellular trivalent inorganic anion homeostasis,BP,
7588,GO:0031956,1.00000000000698,0.6721060528907,0,4,medium-chain fatty acid-CoA ligase activity,MF,
17147,GO:0102391,1.00000000000698,0.6721060528907,0,4,decanoate-CoA ligase activity,MF,
3122,GO:0006701,1.000000000007,0.712634051955029,0,4,progesterone biosynthetic process,BP,
17516,GO:1900748,1.00000000000701,0.703495273854088,0,3,positive regulation of vascular endothelial growth factor signaling pathway,BP,
11635,GO:0046340,1.00000000000702,0.836584727640749,0,2,diacylglycerol catabolic process,BP,
18776,GO:1904288,1.00000000000703,0.672249191025671,0,4,BAT3 complex binding,MF,
8208,GO:0032960,1.00000000000704,0.685413349851058,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
9641,GO:0036509,1.00000000000704,0.859724687448669,0,2,trimming of terminal mannose on B branch,BP,
9643,GO:0036511,1.00000000000704,0.859724687448669,0,2,trimming of first mannose on A branch,BP,
9644,GO:0036512,1.00000000000704,0.859724687448669,0,2,trimming of second mannose on A branch,BP,
8122,GO:0032808,1.00000000000711,0.659775819373338,0,4,lacrimal gland development,BP,
2036,GO:0004776,1.00000000000712,0.870965856373587,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
8634,GO:0034154,1.00000000000712,0.702409732832711,0,4,toll-like receptor 7 signaling pathway,BP,
6391,GO:0021590,1.00000000000712,0.796108072999913,0,2,cerebellum maturation,BP,
6425,GO:0021691,1.00000000000712,0.796108072999913,0,2,cerebellar Purkinje cell layer maturation,BP,
6433,GO:0021699,1.00000000000712,0.796108072999913,0,2,cerebellar cortex maturation,BP,
2076,GO:0004830,1.00000000000715,0.848975888144746,0,2,tryptophan-tRNA ligase activity,MF,
2926,GO:0006436,1.00000000000715,0.848975888144746,0,2,tryptophanyl-tRNA aminoacylation,BP,
9447,GO:0036033,1.00000000000716,0.59663339939188,0,4,mediator complex binding,MF,
20299,GO:2001287,1.00000000000717,0.851753385880892,0,2,negative regulation of caveolin-mediated endocytosis,BP,
13031,GO:0051481,1.00000000000719,0.599137912379525,0,4,negative regulation of cytosolic calcium ion concentration,BP,
1771,GO:0004376,1.0000000000072,0.731463474186665,0,4,glycolipid mannosyltransferase activity,MF,
2062,GO:0004816,1.00000000000721,0.853421162724779,0,2,asparagine-tRNA ligase activity,MF,
7739,GO:0032237,1.00000000000722,0.672295431396052,0,4,activation of store-operated calcium channel activity,BP,
17631,GO:1901341,1.00000000000722,0.672295431396052,0,4,positive regulation of store-operated calcium channel activity,BP,
10153,GO:0042731,1.00000000000727,0.702849477988975,0,4,PH domain binding,MF,
14816,GO:0070545,1.00000000000727,0.717226068147087,0,4,PeBoW complex,CC,
6951,GO:0030578,1.00000000000727,0.65101598769696,0,4,PML body organization,BP,
16268,GO:0090325,1.00000000000729,0.826001552745123,0,2,regulation of locomotion involved in locomotory behavior,BP,
2459,GO:0005672,1.00000000000733,0.774815249925279,0,4,transcription factor TFIIA complex,CC,
8795,GO:0034481,1.00000000000734,0.680533630255297,0,4,chondroitin sulfotransferase activity,MF,
16590,GO:0097396,1.0000000000074,0.707504005539079,0,4,response to interleukin-17,BP,
16591,GO:0097398,1.0000000000074,0.707504005539079,0,4,cellular response to interleukin-17,BP,
16592,GO:0097400,1.0000000000074,0.707504005539079,0,4,interleukin-17-mediated signaling pathway,BP,
7437,GO:0031547,1.00000000000744,0.795521310437134,0,2,brain-derived neurotrophic factor receptor signaling pathway,BP,
4795,GO:0010986,1.00000000000748,0.702838582800565,0,4,positive regulation of lipoprotein particle clearance,BP,
6642,GO:0023029,1.00000000000753,0.706947144166954,0,4,MHC class Ib protein binding,MF,
8500,GO:0033677,1.00000000000758,0.764901263966163,0,3,DNA/RNA helicase activity,MF,
18649,GO:1903961,1.00000000000762,0.771285681722193,0,3,positive regulation of anion transmembrane transport,BP,
9265,GO:0035673,1.00000000000763,0.661597420456419,0,4,oligopeptide transmembrane transporter activity,MF,
5915,GO:0018171,1.00000000000765,0.750625592810427,0,4,peptidyl-cysteine oxidation,BP,
3745,GO:0008282,1.0000000000077,0.824187961062519,0,2,inward rectifying potassium channel,CC,
14347,GO:0061550,1.00000000000773,0.669150789563017,0,4,cranial ganglion development,BP,
7168,GO:0031048,1.00000000000775,0.827888448168791,0,2,chromatin silencing by small RNA,BP,
888,GO:0002254,1.00000000000776,0.864955690177012,0,2,kinin cascade,BP,
942,GO:0002353,1.00000000000776,0.864955690177012,0,2,plasma kallikrein-kinin cascade,BP,
10879,GO:0044416,1.00000000000783,0.872624488960524,0,2,induction by symbiont of host defense response,BP,
11829,GO:0046730,1.00000000000783,0.872624488960524,0,2,induction of host immune response by virus,BP,
11830,GO:0046732,1.00000000000783,0.872624488960524,0,2,active induction of host immune response by virus,BP,
13332,GO:0052251,1.00000000000783,0.872624488960524,0,2,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
13359,GO:0052509,1.00000000000783,0.872624488960524,0,2,positive regulation by symbiont of host defense response,BP,
13360,GO:0052510,1.00000000000783,0.872624488960524,0,2,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
17023,GO:0099174,1.00000000000785,0.749132425785987,0,3,regulation of presynapse organization,BP,
19321,GO:1905606,1.00000000000785,0.749132425785987,0,3,regulation of presynapse assembly,BP,
19992,GO:2000588,1.00000000000796,0.794636961024156,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
12953,GO:0051316,1.00000000000797,0.853476588987359,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
670,GO:0001880,1.00000000000798,0.804252936660908,0,2,Mullerian duct regression,BP,
3835,GO:0008440,1.00000000000801,0.684866937680151,0,4,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
5334,GO:0016071,1.00000000000811,0,16,737,mRNA metabolic process,BP,ADARB1;DDIT3;PSMD2;DHX32;IGF2BP3;ATF4;XRN1;TNRC6B;CEBPG;PSMD7;PAIP1;PUM2;PRKACA;CMTR2;TNRC6C;CNOT11
18131,GO:1902824,1.00000000000811,0.882493965290319,0,2,positive regulation of late endosome to lysosome transport,BP,
18357,GO:1903337,1.00000000000811,0.882493965290319,0,2,positive regulation of vacuolar transport,BP,
17761,GO:1901727,1.00000000000812,0.680731680967684,0,4,positive regulation of histone deacetylase activity,BP,
15122,GO:0071208,1.00000000000812,0.791406500944484,0,4,histone pre-mRNA DCP binding,MF,
377,GO:0001007,1.00000000000816,0.645036246049294,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
8646,GO:0034186,1.00000000000824,0.696312079852961,0,4,apolipoprotein A-I binding,MF,
13202,GO:0051823,1.00000000000834,0.709130476407447,0,4,regulation of synapse structural plasticity,BP,
17182,GO:0103053,1.00000000000837,0.8760542844238,0,2,1-ethyladenine demethylase activity,MF,
14898,GO:0070697,1.00000000000842,0.822110412031737,0,2,activin receptor binding,MF,
14899,GO:0070699,1.00000000000842,0.822110412031737,0,2,type II activin receptor binding,MF,
384,GO:0001025,1.00000000000844,0.666919093345076,0,3,RNA polymerase III transcription factor binding,MF,
430,GO:0001156,1.00000000000844,0.666919093345076,0,3,TFIIIC-class transcription factor binding,MF,
13887,GO:0060526,1.00000000000846,0.639993100964785,0,4,prostate glandular acinus morphogenesis,BP,
13888,GO:0060527,1.00000000000846,0.639993100964785,0,4,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
3086,GO:0006659,1.00000000000852,0.723778489962321,0,4,phosphatidylserine biosynthetic process,BP,
16659,GO:0097532,1.00000000000856,0.853647476114078,0,2,stress response to acid chemical,BP,
16660,GO:0097533,1.00000000000856,0.853647476114078,0,2,cellular stress response to acid chemical,BP,
14287,GO:0061370,1.00000000000858,0.836240441171488,0,2,testosterone biosynthetic process,BP,
15179,GO:0071313,1.0000000000086,0.703516206368593,0,3,cellular response to caffeine,BP,
15250,GO:0071415,1.0000000000086,0.703516206368593,0,3,cellular response to purine-containing compound,BP,
4323,GO:0009820,1.00000000000867,0.740563147375644,0,4,alkaloid metabolic process,BP,
18484,GO:1903589,1.00000000000867,0.854989606910625,0,2,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
12513,GO:0050656,1.00000000000868,0.681602640608786,0,4,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
20181,GO:2001027,1.00000000000869,0.776108808067928,0,2,negative regulation of endothelial cell chemotaxis,BP,
5796,GO:0017040,1.00000000000877,0.731065815156866,0,4,N-acylsphingosine amidohydrolase activity,MF,
5020,GO:0015183,1.00000000000881,0.763225683461783,0,3,L-aspartate transmembrane transporter activity,MF,
7470,GO:0031628,1.00000000000885,0.679163385576712,0,4,opioid receptor binding,MF,
7549,GO:0031852,1.00000000000885,0.679163385576712,0,4,mu-type opioid receptor binding,MF,
6597,GO:0022614,1.00000000000888,0.672407152148996,0,4,membrane to membrane docking,BP,
16418,GO:0097051,1.00000000000899,0.718097049729401,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17334,GO:1900003,1.00000000000902,0.806782754855889,0,3,regulation of serine-type endopeptidase activity,BP,
17335,GO:1900004,1.00000000000902,0.806782754855889,0,3,negative regulation of serine-type endopeptidase activity,BP,
18046,GO:1902571,1.00000000000902,0.806782754855889,0,3,regulation of serine-type peptidase activity,BP,
18047,GO:1902572,1.00000000000902,0.806782754855889,0,3,negative regulation of serine-type peptidase activity,BP,
8261,GO:0033038,1.00000000000903,0.795402525525103,0,4,bitter taste receptor activity,MF,
17496,GO:1900452,1.00000000000907,0.668393308847844,0,4,regulation of long term synaptic depression,BP,
638,GO:0001827,1.00000000000917,0.802108672838598,0,2,inner cell mass cell fate commitment,BP,
639,GO:0001828,1.00000000000917,0.802108672838598,0,2,inner cell mass cellular morphogenesis,BP,
7279,GO:0031262,1.00000000000917,0.778137788875249,0,4,Ndc80 complex,CC,
15457,GO:0071787,1.0000000000092,0.729649976300906,0,4,endoplasmic reticulum tubular network formation,BP,
16488,GO:0097176,1.00000000000925,0.752397746965718,0,4,epoxide metabolic process,BP,
1151,GO:0002759,1.00000000000928,0.744811641574404,0,4,regulation of antimicrobial humoral response,BP,
16896,GO:0098840,1.00000000000931,0.87291767722125,0,2,protein transport along microtubule,BP,
17011,GO:0099118,1.00000000000931,0.87291767722125,0,2,microtubule-based protein transport,BP,
16491,GO:0097179,1.00000000000935,0.80276128651054,0,4,protease inhibitor complex,CC,
18705,GO:1904090,1.00000000000935,0.80276128651054,0,4,peptidase inhibitor complex,CC,
18543,GO:1903750,1.00000000000941,0.737953421272686,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
18544,GO:1903751,1.00000000000941,0.737953421272686,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
14104,GO:0060940,1.00000000000941,0.842547683017632,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
6852,GO:0030321,1.00000000000948,0.816399141198705,0,2,transepithelial chloride transport,BP,
16369,GO:0090669,1.00000000000948,0.721026466417345,0,4,telomerase RNA stabilization,BP,
1412,GO:0003348,1.00000000000948,0.647554149568383,0,4,cardiac endothelial cell differentiation,BP,
14107,GO:0060956,1.00000000000948,0.647554149568383,0,4,endocardial cell differentiation,BP,
2856,GO:0006344,1.0000000000095,0.650440326485453,0,4,maintenance of chromatin silencing,BP,
2597,GO:0005892,1.00000000000955,0.678324272071739,0,4,acetylcholine-gated channel complex,CC,
4248,GO:0009448,1.00000000000958,0.676878043160317,0,4,gamma-aminobutyric acid metabolic process,BP,
12247,GO:0048521,1.0000000000096,0.721650232930649,0,4,negative regulation of behavior,BP,
7351,GO:0031392,1.0000000000096,0.704132650301345,0,4,regulation of prostaglandin biosynthetic process,BP,
20296,GO:2001279,1.0000000000096,0.704132650301345,0,4,regulation of unsaturated fatty acid biosynthetic process,BP,
9157,GO:0035509,1.00000000000963,0.667246178617227,0,4,negative regulation of myosin-light-chain-phosphatase activity,BP,
18358,GO:1903347,1.00000000000963,0.667246178617227,0,4,negative regulation of bicellular tight junction assembly,BP,
4776,GO:0010961,1.00000000000966,0.791984291298889,0,2,cellular magnesium ion homeostasis,BP,
13690,GO:0060232,1.00000000000966,0.726412441385818,0,4,delamination,BP,
2930,GO:0006447,1.00000000000971,0.753311834560874,0,3,regulation of translational initiation by iron,BP,
15931,GO:0072716,1.00000000000972,0.715220909612127,0,4,response to actinomycin D,BP,
1688,GO:0004161,1.00000000000973,0.864836254180088,0,2,dimethylallyltranstransferase activity,MF,
1739,GO:0004337,1.00000000000973,0.864836254180088,0,2,geranyltranstransferase activity,MF,
8410,GO:0033383,1.00000000000973,0.864836254180088,0,2,geranyl diphosphate metabolic process,BP,
8411,GO:0033384,1.00000000000973,0.864836254180088,0,2,geranyl diphosphate biosynthetic process,BP,
8129,GO:0032817,1.00000000000974,0.750042546757619,0,4,regulation of natural killer cell proliferation,BP,
8130,GO:0032819,1.00000000000974,0.750042546757619,0,4,positive regulation of natural killer cell proliferation,BP,
16485,GO:0097167,1.00000000000978,0.694775677339082,0,4,circadian regulation of translation,BP,
1325,GO:0003176,1.00000000000981,0.700819185098001,0,4,aortic valve development,BP,
1328,GO:0003180,1.00000000000981,0.700819185098001,0,4,aortic valve morphogenesis,BP,
1652,GO:0004104,1.00000000000982,0.853591522208047,0,2,cholinesterase activity,MF,
8371,GO:0033265,1.00000000000982,0.853591522208047,0,2,choline binding,MF,
1569,GO:0003976,1.00000000000989,0.78246702618785,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
19607,GO:1990745,1.00000000000991,0.688912112333139,0,4,EARP complex,CC,
16146,GO:0090155,1.00000000001003,0.729723629505712,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17361,GO:1900060,1.00000000001003,0.729723629505712,0,4,negative regulation of ceramide biosynthetic process,BP,
7917,GO:0032490,1.00000000001003,0.675334719519621,0,4,detection of molecule of bacterial origin,BP,
10457,GO:0043314,1.00000000001006,0.791574928880102,0,2,negative regulation of neutrophil degranulation,BP,
18041,GO:1902564,1.00000000001006,0.791574928880102,0,2,negative regulation of neutrophil activation,BP,
6680,GO:0030043,1.00000000001016,0.743691289451236,0,4,actin filament fragmentation,BP,
7910,GO:0032483,1.00000000001016,0.663878559190583,0,4,regulation of Rab protein signal transduction,BP,
18090,GO:1902713,1.00000000001017,0.678247433928257,0,4,regulation of interferon-gamma secretion,BP,
1646,GO:0004090,1.00000000001017,0.79923479408556,0,4,carbonyl reductase (NADPH) activity,MF,
6768,GO:0030202,1.00000000001018,0.648540165964077,0,4,heparin metabolic process,BP,
6776,GO:0030210,1.00000000001018,0.648540165964077,0,4,heparin biosynthetic process,BP,
4083,GO:0009137,1.00000000001021,0.729855737545113,0,4,purine nucleoside diphosphate catabolic process,BP,
4122,GO:0009181,1.00000000001021,0.729855737545113,0,4,purine ribonucleoside diphosphate catabolic process,BP,
13746,GO:0060318,1.00000000001026,0.670697445667536,0,4,definitive erythrocyte differentiation,BP,
8844,GO:0034635,1.00000000001042,0.826892133612497,0,2,glutathione transport,BP,
10235,GO:0042939,1.00000000001042,0.826892133612497,0,2,tripeptide transport,BP,
8981,GO:0035087,1.00000000001044,0.699866002951609,0,4,siRNA loading onto RISC involved in RNA interference,BP,
3765,GO:0008309,1.00000000001063,0.743878465594972,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
6387,GO:0021578,1.00000000001063,0.722110058122017,0,3,hindbrain maturation,BP,
6405,GO:0021626,1.00000000001063,0.722110058122017,0,3,central nervous system maturation,BP,
8281,GO:0033083,1.00000000001063,0.725988820604574,0,4,regulation of immature T cell proliferation,BP,
3616,GO:0008063,1.00000000001072,0.708373578994081,0,4,Toll signaling pathway,BP,
14605,GO:0070164,1.00000000001082,0.68065511704446,0,4,negative regulation of adiponectin secretion,BP,
315,GO:0000827,1.00000000001082,0.678242139857085,0,4,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
316,GO:0000828,1.00000000001082,0.678242139857085,0,4,inositol hexakisphosphate kinase activity,MF,
317,GO:0000829,1.00000000001082,0.678242139857085,0,4,inositol heptakisphosphate kinase activity,MF,
318,GO:0000832,1.00000000001082,0.678242139857085,0,4,inositol hexakisphosphate 5-kinase activity,MF,
13398,GO:0052723,1.00000000001082,0.678242139857085,0,4,inositol hexakisphosphate 1-kinase activity,MF,
13399,GO:0052724,1.00000000001082,0.678242139857085,0,4,inositol hexakisphosphate 3-kinase activity,MF,
3025,GO:0006570,1.00000000001087,0.771862072460047,0,4,tyrosine metabolic process,BP,
12110,GO:0048149,1.0000000000109,0.65697486886414,0,4,behavioral response to ethanol,BP,
268,GO:0000738,1.00000000001093,0.719338623541047,0,4,DNA catabolic process, exonucleolytic,BP,
16366,GO:0090666,1.00000000001102,0.747078069264999,0,4,scaRNA localization to Cajal body,BP,
4465,GO:0010459,1.00000000001104,0.761092846250042,0,4,negative regulation of heart rate,BP,
15495,GO:0071865,1.00000000001107,0.718558705347995,0,4,regulation of apoptotic process in bone marrow,BP,
15496,GO:0071866,1.00000000001107,0.718558705347995,0,4,negative regulation of apoptotic process in bone marrow,BP,
17293,GO:0140059,1.00000000001107,0.679890606139355,0,4,dendrite arborization,BP,
20062,GO:2000698,1.0000000000111,0.727857398976373,0,4,positive regulation of epithelial cell differentiation involved in kidney development,BP,
10961,GO:0044715,1.00000000001113,0.886218261934629,0,2,8-oxo-dGDP phosphatase activity,MF,
19135,GO:1905098,1.0000000000113,0.69636341148899,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
6301,GO:0019918,1.00000000001138,0.724840572273274,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
9031,GO:0035243,1.00000000001138,0.724840572273274,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
4885,GO:0014805,1.00000000001138,0.777074529963995,0,4,smooth muscle adaptation,BP,
8701,GO:0034334,1.00000000001143,0.672859071996489,0,4,adherens junction maintenance,BP,
803,GO:0002071,1.00000000001144,0.842632384619017,0,2,glandular epithelial cell maturation,BP,
15617,GO:0072102,1.00000000001149,0.735443509813946,0,3,glomerulus morphogenesis,BP,
14672,GO:0070278,1.00000000001151,0.849322333379455,0,2,extracellular matrix constituent secretion,BP,
10054,GO:0042536,1.00000000001155,0.801733519779925,0,3,negative regulation of tumor necrosis factor biosynthetic process,BP,
9423,GO:0035989,1.00000000001157,0.663913615217615,0,4,tendon development,BP,
15583,GO:0072049,1.00000000001158,0.750844653475929,0,4,comma-shaped body morphogenesis,BP,
14309,GO:0061443,1.00000000001161,0.817592836329451,0,2,endocardial cushion cell differentiation,BP,
11727,GO:0046533,1.00000000001164,0.679084811750456,0,4,negative regulation of photoreceptor cell differentiation,BP,
10467,GO:0043328,1.0000000000117,0.761922902076525,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
12553,GO:0050705,1.00000000001177,0.763437734099907,0,4,regulation of interleukin-1 alpha secretion,BP,
4818,GO:0014012,1.00000000001184,0.701325190543232,0,4,peripheral nervous system axon regeneration,BP,
3607,GO:0008046,1.00000000001185,0.636153236336727,0,4,axon guidance receptor activity,MF,
5043,GO:0015226,1.00000000001188,0.717635035651676,0,4,carnitine transmembrane transporter activity,MF,
5251,GO:0015879,1.00000000001188,0.717635035651676,0,4,carnitine transport,BP,
5584,GO:0016602,1.00000000001189,0.712877748841838,0,4,CCAAT-binding factor complex,CC,
6169,GO:0019530,1.0000000000119,0.671850685288423,0,4,taurine metabolic process,BP,
6203,GO:0019694,1.0000000000119,0.671850685288423,0,4,alkanesulfonate metabolic process,BP,
9277,GO:0035701,1.00000000001191,0.754827610850876,0,3,hematopoietic stem cell migration,BP,
7955,GO:0032554,1.00000000001194,0.736700447189638,0,4,purine deoxyribonucleotide binding,MF,
10405,GO:0043237,1.00000000001228,0.648136764898699,0,4,laminin-1 binding,MF,
18552,GO:1903763,1.00000000001229,0.685872903258819,0,4,gap junction channel activity involved in cell communication by electrical coupling,MF,
18995,GO:1904798,1.00000000001232,0.716528883863812,0,4,positive regulation of core promoter binding,BP,
10823,GO:0044314,1.00000000001238,0.769373084580443,0,4,protein K27-linked ubiquitination,BP,
17804,GO:1901897,1.00000000001245,0.720701440633586,0,3,regulation of relaxation of cardiac muscle,BP,
6477,GO:0021817,1.00000000001249,0.704139828895022,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
4462,GO:0010455,1.00000000001253,0.723910828644931,0,4,positive regulation of cell fate commitment,BP,
17547,GO:1901077,1.00000000001254,0.671409514988982,0,4,regulation of relaxation of muscle,BP,
7760,GO:0032276,1.00000000001268,0.746486955626557,0,3,regulation of gonadotropin secretion,BP,
7762,GO:0032278,1.00000000001268,0.746486955626557,0,3,positive regulation of gonadotropin secretion,BP,
11873,GO:0046880,1.00000000001268,0.746486955626557,0,3,regulation of follicle-stimulating hormone secretion,BP,
11874,GO:0046881,1.00000000001268,0.746486955626557,0,3,positive regulation of follicle-stimulating hormone secretion,BP,
1521,GO:0003883,1.00000000001281,0.833048796366506,0,2,CTP synthase activity,MF,
10765,GO:0044210,1.00000000001281,0.833048796366506,0,2,'de novo' CTP biosynthetic process,BP,
8649,GO:0034190,1.00000000001288,0.688041975080495,0,4,apolipoprotein receptor binding,MF,
14456,GO:0061783,1.00000000001292,0.828301568824886,0,3,peptidoglycan muralytic activity,MF,
6397,GO:0021603,1.00000000001299,0.688500952133351,0,4,cranial nerve formation,BP,
2077,GO:0004831,1.00000000001307,0.851745583111081,0,2,tyrosine-tRNA ligase activity,MF,
2927,GO:0006437,1.00000000001307,0.851745583111081,0,2,tyrosyl-tRNA aminoacylation,BP,
1756,GO:0004359,1.00000000001317,0.770428834145115,0,3,glutaminase activity,MF,
7368,GO:0031415,1.00000000001319,0.720820737905702,0,4,NatA complex,CC,
18371,GO:1903371,1.00000000001323,0.645834411107057,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
15838,GO:0072540,1.00000000001329,0.72495151602931,0,4,T-helper 17 cell lineage commitment,BP,
12693,GO:0050910,1.00000000001336,0.814821933080161,0,2,detection of mechanical stimulus involved in sensory perception of sound,BP,
5505,GO:0016453,1.00000000001337,0.750577852686172,0,4,C-acetyltransferase activity,MF,
16429,GO:0097065,1.00000000001343,0.689801811502111,0,4,anterior head development,BP,
5129,GO:0015562,1.00000000001346,0.678183799268086,0,4,efflux transmembrane transporter activity,MF,
3016,GO:0006561,1.0000000000135,0.742344800729636,0,4,proline biosynthetic process,BP,
13539,GO:0055129,1.0000000000135,0.742344800729636,0,4,L-proline biosynthetic process,BP,
5220,GO:0015822,1.00000000001369,0.651442722520521,0,4,ornithine transport,BP,
18363,GO:1903352,1.00000000001369,0.651442722520521,0,4,L-ornithine transmembrane transport,BP,
677,GO:0001887,1.00000000001373,0.719729916552562,0,4,selenium compound metabolic process,BP,
1217,GO:0002887,1.00000000001398,0.679254726472786,0,4,negative regulation of myeloid leukocyte mediated immunity,BP,
17848,GO:1902035,1.000000000014,0.697695144800504,0,4,positive regulation of hematopoietic stem cell proliferation,BP,
5383,GO:0016206,1.00000000001402,0.851238613892039,0,2,catechol O-methyltransferase activity,MF,
17123,GO:0102084,1.00000000001402,0.851238613892039,0,2,L-dopa O-methyltransferase activity,MF,
17175,GO:0102938,1.00000000001402,0.851238613892039,0,2,orcinol O-methyltransferase activity,MF,
15696,GO:0072223,1.0000000000141,0.773658086103984,0,3,metanephric glomerular mesangium development,BP,
15703,GO:0072239,1.0000000000141,0.773658086103984,0,3,metanephric glomerulus vasculature development,BP,
10920,GO:0044528,1.00000000001418,0.718030312647151,0,4,regulation of mitochondrial mRNA stability,BP,
3776,GO:0008330,1.00000000001419,0.743912103239994,0,4,protein tyrosine/threonine phosphatase activity,MF,
11000,GO:0044803,1.00000000001419,0.714941538152874,0,4,multi-organism membrane organization,BP,
13783,GO:0060369,1.00000000001423,0.702798385893176,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
2574,GO:0005861,1.00000000001426,0.75798564751134,0,4,troponin complex,CC,
19318,GO:1905600,1.00000000001436,0.783202426853331,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
8421,GO:0033489,1.00000000001438,0.723396935005259,0,4,cholesterol biosynthetic process via desmosterol,BP,
8422,GO:0033490,1.00000000001438,0.723396935005259,0,4,cholesterol biosynthetic process via lathosterol,BP,
14184,GO:0061083,1.00000000001438,0.70630496421958,0,4,regulation of protein refolding,BP,
14185,GO:0061084,1.00000000001438,0.70630496421958,0,4,negative regulation of protein refolding,BP,
1302,GO:0003140,1.00000000001443,0.686949575600684,0,4,determination of left/right asymmetry in lateral mesoderm,BP,
5497,GO:0016435,1.00000000001444,0.72719822224307,0,4,rRNA (guanine) methyltransferase activity,MF,
19446,GO:1990111,1.0000000000146,0.746396535814624,0,4,spermatoproteasome complex,CC,
3319,GO:0007023,1.00000000001463,0.750014436023084,0,4,post-chaperonin tubulin folding pathway,BP,
11450,GO:0045900,1.0000000000147,0.698101886532336,0,4,negative regulation of translational elongation,BP,
14382,GO:0061622,1.00000000001479,0.861538038323076,0,2,glycolytic process through glucose-1-phosphate,BP,
11209,GO:0045341,1.0000000000151,0.676337080321036,0,4,MHC class I biosynthetic process,BP,
11211,GO:0045343,1.0000000000151,0.676337080321036,0,4,regulation of MHC class I biosynthetic process,BP,
11212,GO:0045345,1.0000000000151,0.676337080321036,0,4,positive regulation of MHC class I biosynthetic process,BP,
17936,GO:1902263,1.00000000001528,0.742731445165552,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
15321,GO:0071535,1.00000000001528,0.71498832003038,0,4,RING-like zinc finger domain binding,MF,
2130,GO:0004935,1.00000000001557,0.865172114112339,0,2,adrenergic receptor activity,MF,
10935,GO:0044571,1.00000000001577,0.784169429188186,0,4,[2Fe-2S] cluster assembly,BP,
4402,GO:0010138,1.00000000001579,0.765478244759796,0,4,pyrimidine ribonucleotide salvage,BP,
10761,GO:0044206,1.00000000001579,0.765478244759796,0,4,UMP salvage,BP,
17148,GO:0102420,1.0000000000159,0.690729755495186,0,4,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
6084,GO:0019240,1.00000000001597,0.627100927536988,0,4,citrulline biosynthetic process,BP,
15135,GO:0071225,1.00000000001604,0.676479856991698,0,4,cellular response to muramyl dipeptide,BP,
8772,GO:0034448,1.00000000001611,0.764850974249881,0,4,EGO complex,CC,
8255,GO:0033031,1.00000000001616,0.707228457340243,0,4,positive regulation of neutrophil apoptotic process,BP,
2645,GO:0005981,1.00000000001644,0.693225462870085,0,4,regulation of glycogen catabolic process,BP,
11029,GO:0044878,1.00000000001666,0.759554370044087,0,4,mitotic cytokinesis checkpoint,BP,
4834,GO:0014040,1.00000000001685,0.799698530514642,0,2,positive regulation of Schwann cell differentiation,BP,
19397,GO:1905907,1.00000000001713,0.731146351288453,0,4,negative regulation of amyloid fibril formation,BP,
1819,GO:0004470,1.00000000001765,0.719327211982262,0,4,malic enzyme activity,MF,
18937,GO:1904690,1.0000000000178,0.699512367020661,0,4,positive regulation of cytoplasmic translational initiation,BP,
17451,GO:1900227,1.00000000001786,0.670889013774527,0,4,positive regulation of NLRP3 inflammasome complex assembly,BP,
4611,GO:0010728,1.00000000001791,0.69962995649286,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
7096,GO:0030891,1.00000000001827,0.729066757381857,0,4,VCB complex,CC,
4193,GO:0009298,1.00000000001872,0.766081148050364,0,4,GDP-mannose biosynthetic process,BP,
16771,GO:0098574,1.00000000001892,0.712066873210506,0,4,cytoplasmic side of lysosomal membrane,CC,
16956,GO:0098957,1.00000000001906,0.675367151864677,0,4,anterograde axonal transport of mitochondrion,BP,
14022,GO:0060745,1.00000000001906,0.634549735329089,0,4,mammary gland branching involved in pregnancy,BP,
3740,GO:0008275,1.0000000000191,0.682879958473419,0,4,gamma-tubulin small complex,CC,
4546,GO:0010624,1.00000000001918,0.643876593102231,0,4,regulation of Schwann cell proliferation,BP,
4547,GO:0010626,1.00000000001918,0.643876593102231,0,4,negative regulation of Schwann cell proliferation,BP,
16296,GO:0090394,1.00000000001919,0.683151985149163,0,4,negative regulation of excitatory postsynaptic potential,BP,
4933,GO:0014891,1.00000000001929,0.719145083078409,0,4,striated muscle atrophy,BP,
4229,GO:0009407,1.00000000001964,0.76925394732962,0,4,toxin catabolic process,BP,
13353,GO:0052428,1.00000000001966,0.735779758425783,0,4,modulation by host of symbiont molecular function,BP,
9942,GO:0042297,1.00000000001966,0.591803082004359,0,4,vocal learning,BP,
16783,GO:0098596,1.00000000001966,0.591803082004359,0,4,imitative learning,BP,
16785,GO:0098598,1.00000000001966,0.591803082004359,0,4,learned vocalization behavior or vocal learning,BP,
2964,GO:0006499,1.00000000001971,0.651854480378111,0,4,N-terminal protein myristoylation,BP,
5964,GO:0018377,1.00000000001971,0.651854480378111,0,4,protein myristoylation,BP,
3897,GO:0008534,1.00000000001976,0.783437167736909,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
15826,GO:0072526,1.00000000001982,0.737934893364375,0,4,pyridine-containing compound catabolic process,BP,
8381,GO:0033278,1.00000000002069,0.673788571883445,0,4,cell proliferation in midbrain,BP,
1549,GO:0003945,1.00000000002083,0.726631930672206,0,4,N-acetyllactosamine synthase activity,MF,
2658,GO:0006001,1.00000000002135,0.724582546842911,0,4,fructose catabolic process,BP,
14384,GO:0061624,1.00000000002135,0.724582546842911,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
10286,GO:0043031,1.00000000002193,0.716669307281284,0,4,negative regulation of macrophage activation,BP,
18402,GO:1903430,1.00000000002234,0.734520779949556,0,4,negative regulation of cell maturation,BP,
13637,GO:0060136,1.0000000000225,0.690312759802369,0,4,embryonic process involved in female pregnancy,BP,
6808,GO:0030259,1.00000000002256,0.719066913345385,0,4,lipid glycosylation,BP,
12761,GO:0051030,1.0000000000227,0.770783457510104,0,4,snRNA transport,BP,
103,GO:0000214,1.00000000002295,0.752552952338917,0,4,tRNA-intron endonuclease complex,CC,
4562,GO:0010643,1.00000000002365,0.770413137584406,0,3,cell communication by chemical coupling,BP,
14300,GO:0061428,1.00000000002866,0.7089837044248,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
